Rank,NCT Number,Title,Acronym,Status,Conditions.1,Conditions.2,Conditions.3,Conditions.4,Conditions.5,Conditions.6,Conditions.7,Interventions,Sponsor/Collaborators,Gender,Age,Enrollment,Funded Bys,Study Type,Start Date,Primary Completion Date,Completion Date,First Posted,Last Update Posted,Locations.1,Country,Generalized Condition,Has Chronic Condition,Condition Count,Total Days Taken
1.0,NCT04785898,Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay,COVID-IDNow,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: ID Now™ COVID-19 Screening Test,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-09-11,22/12/20,2021-04-30,08/03/21,08/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,1,231.0
2.0,NCT04595136,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,COVID-19,Not yet recruiting,COVID-19,,,,,,,Drug: Drug COVID19-0001-USR|Drug: normal saline,United Medical Specialties,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-02-11,15/12/20,2021-01-29,20/10/20,20/10/20,"Cimedical, Barranquilla, Atlantico",Colombia,Respiratory Diseases,1,1,353.0
3.0,NCT04395482,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,TAC-COVID19,Recruiting,COVID-19,,,,,,,Other: Lung CT scan analysis in COVID-19 patients,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-07-05,15/06/21,2021-06-15,20/05/20,09/11/20,"Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino",San Marino,Respiratory Diseases,1,1,345.0
4.0,NCT04416061,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,COVID-19,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: COVID 19 Diagnostic Test,Hong Kong Sanatorium & Hospital,All,"Child, Adult, Older Adult",2500.0,Industry,Observational,2020-05-25,31/07/20,2020-08-31,04/06/20,04/06/20,"Hong Kong Sanatorium & Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,98.0
5.0,NCT04395924,Maternal-foetal Transmission of SARS-Cov-2,TMF-COVID-19,Recruiting,Maternal Fetal Infection Transmission,COVID-19,SARS-CoV 2,,,,,"Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta",Centre Hospitalier Régional d'Orléans|Centre de Biophysique Moléculaire - Pr Chantal Pichon|Professeur TOUMI Hechmi,Female,18 Years to 48 Years   (Adult),50.0,Other,Observational,2020-05-05,01/05/21,2021-01-05,20/05/20,04/06/20,"CHR Orléans, Orléans",France,Respiratory Diseases,1,3,245.0
6.0,NCT04516954,Convalescent Plasma for COVID-19 Patients,CPCP,Enrolling by invitation,COVID-19,,,,,,,Biological: Convalescent COVID 19 Plasma,"Vinmec Research Institute of Stem Cell and Gene Technology|National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",All,"18 Years to 75 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-08,30/11/20,2020-12-30,18/08/20,20/08/20,"Vinmec Research Institute of Stem cell and Gene Technology, Hanoi",Vietnam,Respiratory Diseases,1,1,357.0
7.0,NCT04476940,COVID-19 Breastfeeding Guideline for African-Americans,COVID-BF,Not yet recruiting,COVID-19,Exclusive Breastfeeding,,,,,,Behavioral: COVID-19 Breastfeeding Support,Meharry Medical College,Female,18 Years to 45 Years   (Adult),200.0,Other,Interventional,2020-01-09,01/10/21,2022-01-06,20/07/20,20/07/20,"Meharry Medical College, Nashville, Tennessee",United States,Respiratory Diseases,1,2,728.0
8.0,NCT04634214,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,COVID19,Not yet recruiting,COVID-19,Type2 Diabetes,,,,,,,India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals,All,"18 Years to 99 Years   (Adult, Older Adult)",1050.0,Other,Observational,2020-11-16,16/02/21,2021-05-16,18/11/20,18/11/20,"Orthomed Hospital, Chennai, Tamil Nadu, India|Medway Hospital, Chennai, Tamil Nadu, India|Venkateswara Hospital, Chennai, Tamil Nadu, India|Dr. Rela Institute & Medical Center, Chennai, Tamil Nadu",India,"Metabolic Disorders, Respiratory Diseases",1,2,181.0
9.0,NCT04602884,Early Detection of COVID-19 Using Breath Analysis,COVID-19,Suspended,COVID-19,,,,,,,Diagnostic Test: Breath biopsy sampling using the ReCIVA Breath Sampler,Scentech Medical Technologies Ltd,All,18 Years to 55 Years   (Adult),50.0,Industry,Interventional,2020-09-22,30/12/21,2021-12-30,26/10/20,13/04/21,"IDF COVID 19 Isolation Facility, Ashkelon",Israel,Respiratory Diseases,1,1,464.0
10.0,NCT04384588,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),FALP-COVID,Recruiting,COVID-19,Cancer Patients,General Population,,,,,Biological: Convalescent Plasma from COVID-19 donors,Fundacion Arturo Lopez Perez|Confederación de la Producción y del Comercio (CPC)|Bolsa de Santiago,All,"15 Years and older   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-07-04,06/04/21,2021-06-04,12/05/20,12/05/20,"Fundacion Arturo Lopez Perez, Providencia, Santiago",Chile,"Respiratory Diseases, Cancers",1,3,335.0
11.0,NCT04355897,CoVID-19 Plasma in Treatment of COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Biological: Convalescent COVID 19 Plasma,The Christ Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-28,01/07/20,2020-01-08,21/04/20,20/05/20,"The Christ Hospital, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio",United States,Respiratory Diseases,1,1,-111.0
12.0,NCT04412265,Frailty in Elderly Patients With COVID-19,FRA-COVID,Recruiting,COVID-19,,,,,,,Other: Relation between frailty and clinical outcomes in elderly patients with COVID-19.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-16,01/03/21,2021-01-03,02/06/20,22/01/21,"Dipartimento di Geriatria, Fondazione Poliambulanza, Brescia, Italy|Dipartimento di Medicina e Riabilitazione, Istituto Clinico Ospedale S. Anna, Brescia, Italy|UO Malattie Infettive, Spedali Civili, Brescia, Italy|UOC Medicina I a indirizzo Geriatrico, Spedali Civili, Montichiari, Italy|ASST Monza-Ospedale San Gerardo, Monza, Italy|SCDU Geriatria, AOU Città della Salute e della Scienza - Presidio Molinette, Torino",Italy,Respiratory Diseases,1,1,262.0
13.0,NCT04659759,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",COVID-PRICE,Recruiting,COVID-19,,,,,,,Other: COVID-19 exposure|Biological: COVID-19 vaccine,Thomas Jefferson University|Nemours,Female,"Child, Adult, Older Adult",300.0,Other,Observational,2020-11-17,31/12/21,2022-06-30,09/12/20,05/03/21,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,590.0
14.0,NCT04427332,Smell and Taste Disorders in COVID-19 Patients,COVID-19 ORL,Completed,COVID-19,,,,,,,Other: Investigation of smell and taste disorders,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",376.0,Other,Observational,2020-11-06,16/10/20,2020-10-16,11/06/20,27/01/21,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,-21.0
15.0,NCT04842708,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: vaccination against COVID19,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Industry,Interventional,2020-12-24,24/10/21,2021-10-24,13/04/21,13/04/21,"Shamir Medical Center, Be'er Ya'aqov",Israel,Respiratory Diseases,1,1,304.0
16.0,NCT04367805,COVID-19 Infection in Patients With Hepatocellular Carcinoma,COVID19-CHIEF,Recruiting,Hepatocellular Carcinoma,COVID-19,,,,,,Diagnostic Test: nasopharyngeal Covid 19 RT-PCR,"Centre Hospitalier Universitaire, Amiens|Centre Hospitalier-Universitaire Bondy|University Hospital, Bordeaux|Centre Hospitalier-Universitaire CLICHY|Centre Hospitalier Général CORBEIL-ESSONNE|CHU CRETEIL|University Hospital, Grenoble|University Hospital, Lille|CHU LYON|Poitiers University Hospital|Rennes University Hospital|University Hospital, Rouen|University Hospital, Toulouse|CHU VILLEJUIF|Central Hospital, Nancy, France|Centre Hospitalier Universitaire de Nice|University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-27,01/10/20,2020-01-10,29/04/20,29/04/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,2,-108.0
17.0,NCT04609969,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,COVID-VIRO,Completed,COVID-19,COVID-19,,,,,,Diagnostic Test: RT-qPCR test|Diagnostic Test: COVID-VIRO® test,Centre Hospitalier Régional d'Orléans,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-13,17/10/20,2020-10-17,30/10/20,07/12/20,"Centre Hospitalier Régional d'Orléans, France, Orléans",France,Respiratory Diseases,1,2,4.0
18.0,NCT04817553,Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients,IgG4-COVID,Recruiting,IgG4 Related Disease,COVID-19,,,,,,Other: exposure to COVID19,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-03-24,01/07/21,2021-01-10,26/03/21,26/03/21,"Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, New Territories",Hong Kong,Respiratory Diseases,1,2,-73.0
19.0,NCT04632355,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,Covid19-Pain,Not yet recruiting,COVID-19,,,,,,,Other: Interview,Fondazione Don Carlo Gnocchi Onlus,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-12,31/07/21,2021-07-31,17/11/20,19/11/20,"Jorge Hugo Villafañe, Milan",Italy,Respiratory Diseases,1,1,566.0
20.0,NCT04407585,Testing the Accuracy of a Digital Test to Diagnose Covid-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Covid-19 swab PCR test,"King's College London|Zoe Global Limited|Department of Health, United Kingdom",All,"18 Years and older   (Adult, Older Adult)",1000000.0,Other,Observational,2020-01-06,10/05/21,2021-10-05,29/05/20,24/06/20,"King's College London, London",United Kingdom,Respiratory Diseases,1,1,638.0
21.0,NCT04657510,Femoral frACturEs and COVID-19.,FACE COVID-19,Recruiting,COVID-19,Femur Fracture,Fragility Fracture,,,,,Other: COVID-19,Istituto Ortopedico Galeazzi,All,"45 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-11-14,01/12/20,2020-12-31,08/12/20,08/12/20,"IRCCS Istituto Ortopedico Galeazzi, Milano",Italy,Respiratory Diseases,1,3,47.0
22.0,NCT04473170,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,SENTAD-COVID,Completed,COVID-19,,,,,,,Biological: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)|Drug: COVID-19 standard care,Abu Dhabi Stem Cells Center,All,"18 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-04-04,20/05/20,2020-07-14,16/07/20,16/07/20,"Abu Dhabi Stem Cells Center, Abu Dhabi",United Arab Emirates,Respiratory Diseases,1,1,101.0
23.0,NCT04497298,Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,COVID-19-101,"Active, not recruiting",COVID-19,,,,,,,Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose|Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose|Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose|Other: Placebo,Institut Pasteur|Themis Bioscience GmbH|Coalition for Epidemic Preparedness Innovations,All,18 Years to 55 Years   (Adult),90.0,Industry|Other,Interventional,2020-10-08,01/06/21,2021-01-07,04/08/20,13/04/21,"SGS Life Sciences, Clinical Pharmacology Unit, Antwerp, Belgium|CIC Cochin - Pasteur, Paris",France,Respiratory Diseases,1,1,91.0
24.0,NCT04549831,Genetic Bases of COVID-19 Clinical Variability,GEN-COVID,Recruiting,COVID-19,,,,,,,Genetic: Massive parallel sequencing of host genome,"University of Siena|Policlinico San Matteo Pavia Fondazione IRCCS|Ospedale San Donato, Arezzo|Ospedale della Misericordia|Azienda Ospedaliera Ospedale Maggiore di Crema|University of Modena and Reggio Emilia|ASST Fatebenefratelli Sacco|Azienda Ospedaliera di Perugia|Ospedale dell'Angelo, Venezia-Mestre|Azienda Ulss 2 Marca Trevigiana|Cardarelli Hospital|Azienda Ospedaliera dei Colli|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Istituto Giannina Gaslini|Istituti Ospitalieri di Cremona|IRCSS Lazzaro Spallanzani, Roma|ASST Santi Paolo e Carlo|ASST Valtellina e Alto Lario|Azienda USL Toscana Sud Est|ULSS1 Dolomiti, Belluno|ASST Spedali Civili, Brescia|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo|Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Ospedale Luigi Curto, Polla|Istituto Auxologico Italiano|CEINGE Biotecnologie Avanzate, Napoli",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-08-04,08/04/21,2026-08-04,16/09/20,17/09/20,"University of Siena, Siena",Italy,Respiratory Diseases,1,1,2191.0
25.0,NCT04706390,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,COVID19vac-1,Recruiting,COVID-19,,,,,,,Biological: covid-19 vaccine,University of Bergen|Haukeland University Hospital,All,"20 Years to 100 Years   (Adult, Older Adult)",2500.0,Other,Observational,2021-12-01,12/01/22,2024-12-01,12/01/21,12/01/21,"University of Bergen, Bergen",Norway,Respiratory Diseases,1,1,1096.0
26.0,NCT04632719,The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,MP-COVID,Recruiting,Cognitive Impairment,COVID-19,Cognitive Dysfunction,"Depression, Anxiety",Quality of Life,,,Device: The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19,University of Sao Paulo,All,"8 Years to 88 Years   (Child, Adult, Older Adult)",200.0,Other,Interventional,2020-08-11,29/12/20,2023-12-29,17/11/20,17/11/20,"Livia Stocco Sanches Valentin, São Paulo, SP, Brazil|Livia Stocco Sanches Valentin, Sao Paulo",Brazil,"Mental Health, Respiratory Diseases",1,5,1235.0
27.0,NCT04427345,Predictive Factors COVID-19 Patients,MI-COVID,Recruiting,COVID-19,,,,,,,Other: Predictive factors for clinical response in patients with COVID-19.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-30,30/04/21,2021-04-30,11/06/20,09/11/20,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,365.0
28.0,NCT04424004,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,C3PI,"Active, not recruiting",COVID-19,,,,,,,Other: COVID-19 PCR and serology testing,Duke University|North Carolina Department of Health and Human Services,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-09-06,30/06/21,2021-06-30,09/06/20,17/11/20,"Duke CTSI Translational Population Health Office, Kannapolis, North Carolina",United States,Respiratory Diseases,1,1,297.0
29.0,NCT04407494,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),COVID-OLFA,Completed,COVID-19,,,,,,,"Biological: Reporting of anosmia, ageusia and other clinical symptoms","University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",809.0,Other,Observational,2020-01-03,01/04/20,2020-04-30,29/05/20,01/06/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,118.0
30.0,NCT04360811,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",COroFet,Recruiting,Pregnancy,,,,,,,Diagnostic Test: COVID 19 diagnostic test by PCR,"University Hospital, Toulouse",Female,"18 Years and older   (Adult, Older Adult)",3600.0,Other,Interventional,2020-04-17,01/04/21,2022-01-04,24/04/20,24/04/20,"University Hospital of Toulouse, Toulouse",France,Others,0,1,627.0
31.0,NCT04403672,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,,Recruiting,COVID-19,,,,,,,Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection,Bangladesh Medical Research Council (BMRC),All,"5 Years to 65 Years   (Child, Adult, Older Adult)",120.0,Other,Observational,2020-05-18,24/07/20,2020-07-24,27/05/20,28/05/20,"Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (For sample collection & sample storage), Institute for Developing Science & Health Initiatives (ideSHi); Mohakhali, Dhaka (For sample analysis, data collection, data analys, Dhaka",Bangladesh,Respiratory Diseases,1,1,67.0
32.0,NCT04363099,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,COVID AMBU 60,Recruiting,COVID-19,,,,,,,Other: observational,Maison de Sante Pluridisciplinaire de Creil,All,"up to 99 Years   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-03,30/06/20,2020-12-31,27/04/20,27/04/20,"Msp de Creil, Creil",France,Respiratory Diseases,1,1,363.0
33.0,NCT04377425,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Neuro-Covid,Withdrawn,Neurological Diseases or Conditions,"Stroke, Acute",Seizure Disorder,,,,,Diagnostic Test: COVID-19 swap test PCR,Aarhus University Hospital,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Observational,2020-07-05,29/11/20,2022-06-30,06/05/20,03/09/20,"Aalborg University Hospital, Aalborg, DK, Denmark|Aarhus University Hospital, Aarhus, DK, Denmark|Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark|Regional Hospital Central Jutland, Viborg, Viborg, DK",Denmark,Cardiovascular Diseases,1,3,725.0
34.0,NCT04602871,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,COVID-19,Completed,COVID-19,,,,,,,Diagnostic Test: Breath Biopsy,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",108.0,Industry,Interventional,2020-03-07,30/01/21,2021-01-30,26/10/20,13/04/21,"Soroka Medical Center, Be'er Sheva, Israel|Meir Medical Center, Kfar Saba",Israel,Respiratory Diseases,1,1,329.0
35.0,NCT04691895,Gastrointestinal Symptoms in COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Other: SARS-CoV2 infection,University of Bologna,All,"18 Years to 85 Years   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-05,30/09/20,2021-12-31,31/12/20,05/01/21,"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna",Italy,Respiratory Diseases,1,1,726.0
36.0,NCT04645498,COVID-19 and Hereditary Metabolic Diseases,COVID19-MHM,Not yet recruiting,COVID-19,"Metabolism, Inborn Errors",,,,,,,"University Hospital, Lille",All,"Child, Adult, Older Adult",77.0,Other,Observational,2021-01-01,01/01/23,2023-01-01,27/11/20,27/11/20,,,Respiratory Diseases,1,2,730.0
37.0,NCT04747821,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,Projeto S,"Active, not recruiting",COVID-19,,,,,,,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",27711.0,Other,Interventional,2021-07-02,01/05/21,2022-01-02,10/02/21,08/04/21,"Hospital Estadual de Serrana, Serrana, SP",Brazil,Respiratory Diseases,1,1,184.0
38.0,NCT04372004,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),CATCH COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: diagnostic tests for COVID-19 infection,Texas Cardiac Arrhythmia Research Foundation,All,"18 Years to 85 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-05,01/05/21,2021-01-06,01/05/20,11/08/20,"Texas Cardiac Arrhythmia Institute, Austin, Texas",United States,Respiratory Diseases,1,1,154.0
39.0,NCT04377685,Prediction of Clinical Course in COVID19 Patients,COVID-CTPRED,Recruiting,COVID-19,,,,,,,Other: CT-Scan,"Centre Hospitalier Universitaire de Saint Etienne|Institut National des Sciences Appliquées (INSA)|Institut National de la Santé Et de la Recherche Médicale, France|Centre National pour le Recherche Scientifique (CNRS)|Université de Lyon|Université Jean Monnet",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-01-03,30/06/21,2021-06-30,06/05/20,19/01/21,"Chu Saint-Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,544.0
40.0,NCT04717011,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,COVID-19CAST,Recruiting,COVID-19,,,,,,,Diagnostic Test: PCR test,Igenomix,Male,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Industry,Observational,2021-01-02,01/07/21,2021-01-07,20/01/21,10/02/21,"Hospital Ruber Internacional, Madrid",Spain,Respiratory Diseases,1,1,5.0
41.0,NCT04412486,COVID-19 Convalescent Plasma (CCP) Transfusion,,Recruiting,COVID-19,,,,,,,Biological: COVID Convalescent Plasma,"Gailen D. Marshall Jr., MD PhD|University of Mississippi Medical Center",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-06,31/05/22,2022-05-31,02/06/20,02/07/20,"University of Mississippi Medical Center, Jackson, Mississippi",United States,Respiratory Diseases,1,1,876.0
42.0,NCT04581135,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,,Recruiting,COVID-19,,,,,,,Other: COVID-19,"University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-05,30/04/23,2023-01-06,09/10/20,09/10/20,"St. Claraspital AG - Department of Pulmonary Medicine, Basel, Switzerland|Universtiy Hospital Bern (Inselspital), Department of Pulmonary Medicine - Lead Center, Bern, Switzerland|University and Hospital of Fribourg, Fribourg, Switzerland|Hôpitaux Universitaires de Genève - Service de Pneumologie, Genève, Switzerland|CHUV - Service de Pneumologie, Lausanne, Switzerland|Clinica Moncucco, Lugano, Switzerland|Hôpital du Valais - Service de Pneumologie, Sion, Switzerland|Kantonspital St. Gallen - Klinik für Pneumologie und Schlafmedizin Lungenzentrum, St. Gallen, Switzerland|Universitätsspital Zürich - Klinik für Pneumologie, Zürich",Switzerland,Respiratory Diseases,1,1,1097.0
43.0,NCT04387968,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",COVIDOR,Recruiting,Coronavirus Infection,,,,,,,Diagnostic Test: Covid-19 presto test,"Raphael Serreau|François Rabelais University|Assistance Publique - Hôpitaux de Paris|University Hospital, Paris|Orléans Métropole Service de Médecine Préventive",All,"18 Years to 65 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-08-24,24/03/21,2021-03-24,14/05/20,09/12/20,"Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans, France|Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans",France,Respiratory Diseases,1,1,212.0
44.0,NCT04845048,Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine,,Not yet recruiting,COVID-19,,,,,,,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2021-01-04,01/09/21,2021-01-11,14/04/21,14/04/21,"Centro de Saúde Escola da Faculdade de Medicina de Botucatu - Unesp., Botucatu, São Paulo, Brazil|Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP) Dr. Joel Domingos Machado., Ribeirão Preto, São Paulo, Brazil|Centro de Referência de Imunobiológicos Especiais. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (CRIEHCFMUSP), São Paulo",Brazil,Respiratory Diseases,1,1,7.0
45.0,NCT04490837,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),YCOVID,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: ELISA and Rapid test to detect antibodies against COVID-19,Corporacion Parc Tauli,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-06-22,31/07/20,2020-09-30,29/07/20,29/07/20,"Parc Tauli University Hospital, Sabadell, Barcelona",Spain,Respiratory Diseases,1,1,100.0
46.0,NCT04834908,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,PROTECT,Not yet recruiting,COVID-19,,,,,,,Biological: Equine COVID-19 Antiserum|Drug: Standard of care,Bharat Serums and Vaccines Limited,All,"18 Years to 65 Years   (Adult, Older Adult)",160.0,Industry,Interventional,2021-01-05,01/03/22,2022-01-09,08/04/21,08/04/21,,,Respiratory Diseases,1,1,369.0
47.0,NCT04730401,Convalescent Plasma in the Treatment of Covid-19,CP_COVID-19,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma from COVID-19 donors|Biological: Placebo,Helsinki University Central Hospital|Finnish Red Cross,All,"18 Years and older   (Adult, Older Adult)",390.0,Other,Interventional,2021-01-27,31/08/21,2021-12-31,29/01/21,08/03/21,"Helsinki University Central Hospital, Helsinki, Uusimaa",Finland,Respiratory Diseases,1,1,338.0
48.0,NCT04799444,LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults,LATE-COVID,Recruiting,COVID-19,,,,,,,,Polish Mother Memorial Hospital Research Institute,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-01-10,30/06/22,2022-06-30,16/03/21,16/03/21,"Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland, Lodz",Poland,Respiratory Diseases,1,1,902.0
49.0,NCT04425707,Ivermectin In Treatment of COVID 19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,"Ministry of Health and Population, Egypt",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-06,01/07/20,2020-01-09,11/06/20,11/06/20,"isolation and referal hospitals for COVID 19 patients, Cairo",Egypt,Respiratory Diseases,1,1,-241.0
50.0,NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,,Enrolling by invitation,COVID-19,,,,,,,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2","Rigshospitalet, Denmark",All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-03-23,30/09/20,2020-12-31,22/04/20,24/04/20,"Rigshospitalet University Hospital of Copenhagen, Copenhagen",Denmark,Respiratory Diseases,1,1,283.0
51.0,NCT04598620,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,VTE-COVID-19,Recruiting,COVID-19,Corona Virus Infection,,,,,,,Inger Lise Gade|Aarhus University Hospital Skejby|Aalborg University Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-09-19,01/10/21,2021-01-10,22/10/20,30/10/20,"Aalborg Hospital, Aalborg",Denmark,Respiratory Diseases,1,2,113.0
52.0,NCT04386109,Neonatal Complications of Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Other: No intervention - exposure is to COVID-19,"University of Oxford|Imperial College London|University of Leicester|University of Nottingham|University of Glasgow|University Hospital of Wales|Public Health England|St George's, University of London",All,up to 29 Days   (Child),500.0,Other,Observational,2020-01-04,31/03/21,2021-09-30,13/05/20,13/05/20,"Imperial College, London",United Kingdom,Respiratory Diseases,1,1,635.0
53.0,NCT04575168,Clinical Study Spartan COVID-19 V2 System,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 Test,Spartan Bioscience Inc.|Beaufort,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|Other,Observational,2020-10-30,01/11/20,2020-01-11,05/10/20,13/11/20,"Wake Research Mt. Vernon, Sandy Springs, Georgia, United States|Clinical Chemistry Research Lab, University of Maryand-Baltimore, Baltimore, Maryland, United States|Wake Research ClinSearch, Chattanooga, Tennessee",United States,Respiratory Diseases,1,1,-293.0
54.0,NCT04437940,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,,Completed,COVID-19,Sars-CoV2,,,,,,Diagnostic Test: Vaginal fluid Covid-19 PCR test,Acibadem University,Female,"18 Years to 70 Years   (Adult, Older Adult)",38.0,Other,Observational,2020-06-15,10/07/20,2020-11-30,18/06/20,12/01/21,"Acibadem Maslak Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,168.0
55.0,NCT04508075,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",COVID-19,"Active, not recruiting",SARS-CoV2 Infection,,,,,,,Biological: SARS-CoV-2 vaccine (inactivated)|Biological: Placebo,"PT Bio Farma|Faculty of Medicine Universitas Padjadjaran|National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia|Sinovac Life Sciences Co., Ltd.",All,18 Years to 59 Years   (Adult),1620.0,Industry|Other,Interventional,2020-10-08,09/01/21,2021-01-09,11/08/20,10/03/21,"Hasan Sadikin Hospital/School of Medicine, Padjadjaran University, Bandung, West Java",Indonesia,Respiratory Diseases,1,1,93.0
56.0,NCT04628208,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 v2 System,Spartan Bioscience Inc.,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Observational,2020-11-17,01/01/21,2021-01-01,13/11/20,02/12/20,"The Ottawa hospital, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,45.0
57.0,NCT04750330,Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection,mtDNA-COVID,Not yet recruiting,COVID-19,,,,,,,,Maastricht University|Innovative Medicines Initiative,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-01-04,31/03/22,2022-03-31,11/02/21,11/02/21,,,Respiratory Diseases,1,1,451.0
58.0,NCT04602949,Detection of COVID-19 Using Breath Analysis - Validation Study,COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: Breath Biopsy Analysis,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",4000.0,Industry,Interventional,2020-12-11,28/07/21,2021-07-28,26/10/20,14/04/21,"Shamir Medical Center, Be'er Ya'aqov",Israel,Respiratory Diseases,1,1,229.0
59.0,NCT04376398,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,COVID,Completed,COVID-19,,,,,,,,Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Society for Anesthesia and Resuscitation of Belgium,All,"up to 100 Years   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-06-04,30/06/20,2020-08-30,06/05/20,03/11/20,"Cliniques Universitaires Saint Luc, Brussels",Belgium,Respiratory Diseases,1,1,87.0
60.0,NCT04563247,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,,Completed,COVID-19,,,,,,,Diagnostic Test: IgG SARS CoV 2 antibodies,Lahore General Hospital,All,20 Years to 60 Years   (Adult),970.0,Other,Observational,2020-01-07,08/02/21,2021-08-02,24/09/20,18/02/21,"Lahore General Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,573.0
61.0,NCT04379310,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Covid-19,Completed,COVID-19,,,,,,,Drug: ACE Inhibitors and Calcium Channel Blockers,Nisantasi University,All,"18 Years to 99 Years   (Adult, Older Adult)",54.0,Other,Observational,2020-01-05,05/05/20,2020-08-05,07/05/20,05/06/20,"Vital Hospital, Bahcelievler, Istanbul",Turkey,Respiratory Diseases,1,1,213.0
62.0,NCT04682132,Polk COVID-19 and Flu Response,PCFR,"Active, not recruiting",COVID-19,,,,,,,"Diagnostic Test: COVID-19 antigen and antibody tests, and influenza rapid test",Polk County Fire Rescue,All,"18 Years and older   (Adult, Older Adult)",686.0,Other,Observational,2020-05-26,31/12/20,2021-01-01,23/12/20,23/12/20,"Polk County Fire Rescue, Bartow, Florida",United States,Respiratory Diseases,1,1,220.0
63.0,NCT04390074,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,,Completed,COVID-19,Critical Illness,,,,,,Other: COVID-19 and Intensive Care,"Uppsala University|Center for Clinical Research Dalarna, Sweden",All,"18 Years and older   (Adult, Older Adult)",9905.0,Other,Observational,2020-05-27,04/06/20,2020-04-06,15/05/20,25/08/20,"Björn Ahlström, Falun",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,2,-51.0
64.0,NCT04353206,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,,Recruiting,COVID-19,Sars-CoV2,,,,,,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,Noah Merin|Johns Hopkins University|Cedars-Sinai Medical Center,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-27,01/05/21,2021-01-05,20/04/20,15/07/20,"8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland",United States,Respiratory Diseases,1,2,192.0
65.0,NCT04460274,Forecast Number of Covid-19 Cases Worldwide,Covid19TmeSer,Completed,COVID-19,,,,,,,Other: Model Building|Other: Model validation,Turkish Ministry of Health Izmir Teaching Hospital,All,"Child, Adult, Older Adult",7882471.0,Other,Observational,2019-12-31,15/06/20,2020-06-20,07/07/20,08/07/20,"Republic of Turkey, Health Sciences University, Izmir Bozyaka Education and Training Hospital, İzmir",Turkey,Respiratory Diseases,1,1,172.0
66.0,NCT04366271,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,MESCEL-COVID19,Recruiting,COVID-19,,,,,,,Biological: Mesenchymal cells|Drug: Standard of care,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Apices Soluciones S.L.",All,"40 Years to 80 Years   (Adult, Older Adult)",106.0,Other|Industry,Interventional,2020-07-05,31/07/20,2021-05-31,28/04/20,11/05/20,"Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Cruces, Barakaldo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Complejo Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,1,330.0
67.0,NCT04345679,Anti COVID-19 Convalescent Plasma Therapy,,Recruiting,COVID-19,,,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,Orthosera Kft.|Semmelweis University|University of Pecs|Hungarian National Blood Service|Humán Bioplazma Kft - Kedrion,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-14,01/06/21,2021-01-09,14/04/20,25/02/21,"Semmelweis University's Department of Pulmonology, Budapest",Hungary,Respiratory Diseases,1,1,270.0
68.0,NCT04668404,Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19,COVID-19,Recruiting,COVID-19,Hypercoagulable States Nec,,,,,,Diagnostic Test: Sonoclot,Postgraduate Institute of Medical Education and Research,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-08-24,01/01/21,2021-01-02,16/12/20,16/12/20,"PGIMER, Chandigarh",India,Respiratory Diseases,1,2,131.0
69.0,NCT04355715,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,COVID-Scan,Completed,COVID-19,SARS-Cov-2,,,,,,,"University Hospital, Montpellier",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Other,Observational,2019-01-04,01/10/20,2020-10-20,21/04/20,29/12/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,655.0
70.0,NCT04339322,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,COVID-19,Not yet recruiting,Characteristics Diseases,"Outcome, Fatal",,,,,,Other: Follow up,Assiut University,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-05,30/07/20,2020-07-30,09/04/20,09/04/20,,,Others,0,2,207.0
71.0,NCT04674644,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,,Completed,COVID-19,,,,,,,Behavioral: The psychosocial effects of COVID-19 pandemic on dental professionals,Suleyman Demirel University,All,"23 Years and older   (Adult, Older Adult)",850.0,Other,Interventional,2020-10-16,23/10/20,2020-10-23,19/12/20,02/02/21,"Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department, Isparta",Turkey,Respiratory Diseases,1,1,7.0
72.0,NCT04453748,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",,Enrolling by invitation,COVID-19,Coronavirus Infection,Sars-CoV2,Complications,,,,Other: Complex diagnostic panel,Silesian Centre for Heart Diseases|Medical Research Agency - Agencja Badań Medycznych|Medical University of Silesia,All,"18 Years to 120 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-08-06,31/10/21,2021-11-30,01/07/20,30/09/20,"Silesian Centre for Heart Disease, Zabrze, Silesia",Poland,Respiratory Diseases,1,4,481.0
73.0,NCT04811391,COVID-19 Vaccine Effectiveness in Albanian Health Workers,COVEAL,Recruiting,COVID-19,,,,,,,Biological: COVID-19 vaccine,"Institute of Public Health, Albania|World Health Organization|Centers for Disease Control and Prevention|Southeast Europe Center for Infectious Diseases Surveillance and Control|EPICONCEPT",All,"16 Years and older   (Child, Adult, Older Adult)",1500.0,Other|U.S. Fed,Observational,2021-02-19,20/05/22,2022-05-20,23/03/21,26/03/21,"Durres Regional Hospital, Durrës, Albania|Fier Regional Hospital, Fier, Albania|Tirana University Hospital  Mother Theresa, Tirana",Albania,Respiratory Diseases,1,1,455.0
74.0,NCT04381871,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,GA&COVID19,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,Al-Neelain University|University of Khartoum,All,"5 Years to 90 Years   (Child, Adult, Older Adult)",110.0,Other,Interventional,2020-01-06,01/08/20,2020-01-09,11/05/20,12/05/20,"Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum",Sudan,Respiratory Diseases,1,1,3.0
75.0,NCT04323787,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,COVID-19,Recruiting,Coronavirus,,,,,,,Other: observational,Mayo Clinic|Society of Critical Care Medicine|Boston University,All,"Child, Adult, Older Adult",50000.0,Other,Observational,2020-03-30,30/04/21,2021-04-30,27/03/20,11/08/20,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Society of Critical Care Medicine (150+ sites), Chicago, Illinois, United States|Rahul Kashyap, Rochester, Minnesota",United States,Respiratory Diseases,1,1,396.0
76.0,NCT04510207,"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",COVID-19,Recruiting,COVID-19,,,,,,,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,"China National Biotec Group Company Limited|G42 Healthcare company|Abu Dhabi Health Services Company|Wuhan Institute of Biological Products Co., Ltd|Beijing Institute of Biological Products Co Ltd.",All,"18 Years and older   (Adult, Older Adult)",45000.0,Industry|Other,Interventional,2020-07-16,16/06/21,2021-09-16,12/08/20,05/04/21,"Bahrain International Exhibition & Convention Centre Affiliated to Salymynia Medical Complex S, Sanabis, Bahrain|Katameya Medical Center, Cairo, Egypt|Vacsera health Care facilities , MoH, Cairo, Egypt|Prince Hamza Hospital, Amman, Jordan|Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates|Al Qarain Primary Health Care Centre-MOHAP, Sharjah",United Arab Emirates,Respiratory Diseases,1,1,427.0
77.0,NCT04760990,A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.,MS COVID-19,Recruiting,Multiple Sclerosis,COVID-19,,,,,,Other: data collection|Other: analysis of blood samples,"University Hospital, Basel, Switzerland|Swiss Multiple Sclerosis Society",All,"18 Years and older   (Adult, Older Adult)",1400.0,Other,Observational,2021-01-02,01/12/23,2023-01-12,18/02/21,02/03/21,"Kantonsspital Aarau, Aarau, Switzerland|University Hospital Basel, Department of Neurology and Department of Biomedicine, Basel, Switzerland|Inselspital Bern, Bern, Switzerland|Hôpitaux Universitaires Genève, Genève, Switzerland|Lausanne University Hospital (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland|Kantonsspital St. Gallen, St. Gallen",Switzerland,"Respiratory Diseases, Immunological Disorders",1,2,740.0
78.0,NCT04387929,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Detection of anti-COVID-19 antibody level,Istituto Clinico Humanitas,All,"18 Years to 90 Years   (Adult, Older Adult)",6000.0,Other,Observational,2020-04-05,30/05/21,2021-05-30,14/05/20,15/05/20,"Humanitas Rozzano/San Pio X, Rozzano, Lombardia",Italy,Respiratory Diseases,1,1,420.0
79.0,NCT04330261,Clinical Characteristics and Outcomes of Pediatric COVID-19,PERN-COVID-19,Recruiting,COVID-19,COVID-19,Pediatric ALL,"Pneumonia, Viral",Pandemic Response,,,Other: Exposure (not intervention) - SARS-CoV-2 infection,University of Calgary,All,"up to 18 Years   (Child, Adult)",12500.0,Other,Observational,2020-03-18,17/03/21,2022-03-17,01/04/20,01/04/20,"University of Calgary/Alberta Children's Hospital, Calgary, Alberta",Canada,Respiratory Diseases,1,5,729.0
80.0,NCT04529460,Healthy Volunteer COVID-19 Antibody Testing Study,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 antibody point of care test kit,Royal Free Hospital NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-09,29/01/21,2021-04-30,27/08/20,14/09/20,,,Respiratory Diseases,1,1,477.0
81.0,NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: COVID-19 PCR and Serology,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-05-13,01/07/20,2020-07-31,18/05/20,18/05/20,"North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York",United States,Respiratory Diseases,1,1,79.0
82.0,NCT04565522,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,DIAL-COVID-19,Not yet recruiting,COVID-19,Dialysis,Nurse-Patient Relations,,,,,Other: Prospective observation,"Simeone Andrulli, MD|A. Manzoni Hospital",All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-09-21,30/09/21,2021-10-31,25/09/20,25/09/20,"AOU Mater Domini, Catanzaro",Italy,Respiratory Diseases,1,3,405.0
83.0,NCT04799392,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,,Recruiting,COVID-19,COVID-19,Coronavirus,,,,,Device: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",All,"2 Years and older   (Child, Adult, Older Adult)",339.0,Industry,Interventional,2021-01-04,30/04/21,2021-04-30,16/03/21,05/04/21,"Goodrich Pharmacy, Anoka, Minnesota, United States|Bremo Pharmacy, Richmond, Virginia, United States|Kirk's Pharmacy, Eatonville, Washington",United States,Respiratory Diseases,1,3,116.0
84.0,NCT04816318,Policy Responses Against the COVID-19 Pandemic in Latin America,,Not yet recruiting,COVID-19,Infectious Disease,Death,SARS-CoV Infection,,,,Other: Social and public health measures against COVID-19|Other: Control,University of Chile,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2021-03-22,31/05/21,2021-05-31,25/03/21,29/03/21,"Escuela de Salud Pública, Santiago, Región Metropolitana",Chile,Respiratory Diseases,1,4,70.0
85.0,NCT04690413,NOWDx Test for the Detection of Antibodies to COVID-19,,Completed,COVID-19,COVID-19,Coronavirus,,,,,Device: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",All,"18 Years and older   (Adult, Older Adult)",129.0,Industry,Interventional,2020-01-09,31/12/20,2020-12-31,30/12/20,03/03/21,"Del Sol Research Management, LLC, Tucson, Arizona, United States|Comprehensive Clinical Research, LLC, West Palm Beach, Florida, United States|Clinical Research Solutions, LLC, Jackson, Tennessee",United States,Respiratory Diseases,1,3,357.0
86.0,NCT04349202,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,BLAST COVID-19,Recruiting,COVID-19,Coronavirus Infection,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,Diagnostic Test: EUROIMMUN assay,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",56000.0,Other,Observational,2020-10-04,01/06/21,2021-01-06,16/04/20,25/08/20,"Beaumont Health System, Royal Oak, Michigan, United States|Beaumont Health, Royal Oak, Michigan",United States,Respiratory Diseases,1,3,94.0
87.0,NCT04474496,Impact of COVID-19 on Marshallese Communities in the U.S.,,Completed,COVID-19,,,,,,,Other: Assessing the impact of COVID-19,University of Arkansas|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-07-27,30/11/20,2020-11-30,16/07/20,05/04/21,"University of Arkansas for Medical Sciences Northwest, Fayetteville, Arkansas",United States,Respiratory Diseases,1,1,126.0
88.0,NCT04466657,Antioxidant Therapy for COVID-19 Study,GSHSOD-COVID,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Antioxidation Therapy|Other: Standard of Care,Obafemi Awolowo University|Borno State Ministry of Health|Ogun State Ministry of Health|Abia State Ministry of Health|Sokoto State Ministry of Health|Benue State Minsitry of Health|University of Calabar Teaching Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-11,28/02/21,2021-04-30,10/07/20,02/09/20,"Abia State Isolation Centre, Amachara, Umuahia, Abia State, Nigeria|Benue State University Teaching Hospital, Makurdi, Benue State, Nigeria|Brigadier Abba Kyari Memorial Hospital, Borno, Borno State, Nigeria|University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria|University of Calabar Teaching Hospital, Calabar, Cross River, Nigeria|Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria|Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria|Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria|Occupational Therapy Center, Sokoto, Sokoto State, Nigeria|Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State",Nigeria,Respiratory Diseases,1,1,475.0
89.0,NCT04427358,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,COVID-19GAOM,Completed,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,70 Years and older   (Older Adult),100.0,Other,Observational,2020-07-05,07/08/20,2020-07-09,11/06/20,25/11/20,"Service SSR Gériatrique, Strasbourg",France,Respiratory Diseases,1,1,4.0
90.0,NCT04811664,A Study of SARS CoV-2 Infection and Potential Transmission in University Students Immunized With Moderna COVID-19 Vaccine,CoVPN 3006,Recruiting,COVID-19,,,,,,,Biological: Moderna COVID-19 Vaccine,National Institute of Allergy and Infectious Diseases (NIAID),All,18 Years to 26 Years   (Adult),37500.0,NIH,Interventional,2021-03-22,22/12/21,2021-12-22,23/03/21,26/03/21,"University of Arizona, Tucson, Arizona, United States|Charles Drew University, Los Angeles, California, United States|University of California, San Diego, San Diego, California, United States|University of Colorado- Boulder, Boulder, Colorado, United States|University of Florida, Gainesville, Florida, United States|Morehouse University, Atlanta, Georgia, United States|Champaign-Urbana Public Health District, Champaign, Illinois, United States|Northwestern University, Evanston, Illinois, United States|Indiana University, Bloomington, Indiana, United States|University of Kentucky, Lexington, Kentucky, United States|University of Maryland College Park, College Park, Maryland, United States|University of Nebraska, Omaha, Nebraska, United States|Stony Brook University, Stony Brook, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Clemson University, Clemson, South Carolina, United States|Texas A&M University, College Station, Texas, United States|Texas A&M - Kingsville, Kingsville, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States|West Virginia University, Morgantown, West Virginia",United States,Respiratory Diseases,1,1,275.0
91.0,NCT04664023,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",BIOMARK-COVID,Recruiting,COVID-19,,,,,,,"Procedure: Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection",Poitiers University Hospital,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-09-12,30/07/22,2022-07-30,11/12/20,14/12/20,"C.H.U.de Poitiers, Poitiers",France,Respiratory Diseases,1,1,686.0
92.0,NCT04404062,Validation of COVID-19 Tests,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Covid-19 Rapid Test Kit (RAPG-COV-019)|Diagnostic Test: Quantitative IgG Test,Richmond Pharmacology Limited,All,"18 Years to 70 Years   (Adult, Older Adult)",500.0,Industry,Observational,2020-03-16,01/08/20,2020-01-08,27/05/20,27/05/20,"Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London",United Kingdom,Respiratory Diseases,1,1,-68.0
93.0,NCT04376996,Slovenian National COVID-19 Prevalence Study,SLO-COVID-19,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: NO intervention planned due to the observational study design - only a diagnostic testing,University of Ljubljana,All,"Child, Adult, Older Adult",3000.0,Other,Observational,2020-04-20,01/10/20,2020-01-12,06/05/20,07/05/20,"University of Ljubljana, Ljubljana",Slovenia,Respiratory Diseases,1,2,-99.0
94.0,NCT04370288,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Covid-19,Recruiting,COVID-19,,,,,,,"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)",Mashhad University of Medical Sciences,All,"18 Years to 90 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-19,20/09/20,2020-09-21,30/04/20,04/05/20,"Imam Reza Hospital, Mashhad, Razavi Khorasan, Iran",Islamic Republic of,Respiratory Diseases,1,1,155.0
95.0,NCT04706403,Views on COVID-19 and Vaccination,,"Active, not recruiting",COVID-19,,,,,,,Behavioral: Healthcare Providers' Communication about the COVID-19 Vaccine,"University of Massachusetts, Worcester",All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2021-04-01,01/06/21,2021-12-26,12/01/21,08/03/21,"Meyers Primary Care Institute, Worcester, Massachusetts",United States,Respiratory Diseases,1,1,269.0
96.0,NCT04393402,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),LUS-COVID19,Recruiting,COVID-19,,,,,,,Procedure: lung ultrasound (LUS),Centre Hospitalier Universitaire de Nice,All,"18 Years to 95 Years   (Adult, Older Adult)",14.0,Other,Observational,2020-03-20,31/12/20,2020-12-31,19/05/20,19/05/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,286.0
97.0,NCT04548908,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,POCAH-COVID,Recruiting,COVID-19,,,,,,,"Diagnostic Test: Serelogy testing, RT PCR",Centre Hospitalier Sud Essonne,All,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Observational,2020-03-08,30/04/21,2021-06-30,16/09/20,16/09/20,"Centre Hospitalier Sud Essonne, Etampes",France,Respiratory Diseases,1,1,479.0
98.0,NCT04582331,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,,Recruiting,COVID-19,,,,,,,Other: Smartphone-based voice and self-reported symptom collection,Sonde Health,All,"12 Years and older   (Child, Adult, Older Adult)",300.0,Industry,Observational,2020-10-09,30/04/21,2021-04-30,09/10/20,29/01/21,"UC San Diego Medical Center, San Diego, California, United States|Brigham & Woman's Hospital, Boston, Massachusetts, United States|Montefiore Medical Center, New York, New York, United States|Deenanath Mangeshkar Hospital & Research Centre, Pune",India,Respiratory Diseases,1,1,203.0
99.0,NCT04379284,Risks of COVID19 in the Pregnant Population,,Recruiting,COVID-19,,,,,,,Other: Biospecimen collection,Mayo Clinic,Female,18 Years to 45 Years   (Adult),100.0,Other,Observational,2020-08-05,30/04/21,2021-07-31,07/05/20,13/07/20,"Mayo Clinic Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,1,360.0
100.0,NCT04352764,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,,Recruiting,COVID-19,,,,,,,Diagnostic Test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test,Texas Cardiac Arrhythmia Research Foundation,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-03-27,31/12/20,2021-01-31,20/04/20,27/04/20,"St. David's Medical Center, Austin, Texas",United States,Respiratory Diseases,1,1,310.0
101.0,NCT04780698,DCI COVID-19 Surveillance Project,,Recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection,"Temple University|Dialysis Clinic, Inc.",All,"18 Years to 90 Years   (Adult, Older Adult)",160.0,Other|Industry,Interventional,2021-01-03,01/10/21,2022-01-03,03/03/21,03/03/21,"Dialysis Clinic, Inc., Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,365.0
102.0,NCT04598334,Cytokine Storm Among Bangladeshi Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,,"International Centre for Diarrhoeal Disease Research, Bangladesh",All,"18 Years to 90 Years   (Adult, Older Adult)",75.0,Other,Observational,2021-06-15,01/10/21,2021-01-10,22/10/20,30/03/21,"Icddr,B, Dhaka",Bangladesh,Respiratory Diseases,1,1,-156.0
103.0,NCT04418245,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,COVID 19-IA,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Imaging by thoracic scanner,Centre Hospitalier Universitaire de Nīmes,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-01-03,01/06/20,2020-01-07,05/06/20,05/06/20,"CHU la Timone, Marseille, France|CHU Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France|CHU Poitiers, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Martinique, Fort-de-France",Martinique,Respiratory Diseases,1,1,4.0
104.0,NCT04416373,COVID-19 and Pregnancy Outcomes,COVID&PREG,Recruiting,Coronavirus Infection,Pregnancy Complications,Vertical Transmission of Infectious Disease,Breastfeeding,Neonatal Infection,,,Diagnostic Test: RT PCR SARS-CoV-2,Universidade Nova de Lisboa,Female,"16 Years to 55 Years   (Child, Adult)",300.0,Other,Observational,2020-03-22,01/12/23,2023-01-12,04/06/20,04/06/20,"Nova Medical School - UNL, Lisbon",Portugal,Respiratory Diseases,1,5,1026.0
105.0,NCT04342637,COVID-19 Endoscopy Survey,COVID-19 Endo,Completed,COVID-19,,,,,,,Other: Practice details,Al-Azhar University,All,"30 Years to 70 Years   (Adult, Older Adult)",163.0,Other,Observational,2020-10-04,25/04/20,2020-01-05,13/04/20,20/05/20,"Kings County Hospital Center, Brooklyn, NY, USA, Albertson, New York, United States|Faculty of Medicine, Zagazig University, Zagazig, Sharkia, Egypt|Al-Azhar Univerisity, Cairo, Egypt|Ahvaz Imam hospital, Ahvaz, Iran",Islamic Republic of,Respiratory Diseases,1,1,-273.0
106.0,NCT04382235,Non-invasive Ventilatory Support of Patients Affected by COVID-19,WARd-COVID,"Active, not recruiting",COVID-19,,,,,,,Device: Non-invasive ventilatory support,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-03-26,30/12/20,2020-12-30,11/05/20,09/11/20,"Policlinico San Marco - Ospedale Zingonia, Zingonia, BG, Italy|ASST Papa Giovanni XXIII - Bergamo, Bergamo, Italy|Azienda Ospedaliera - Universitaria di Bologna, Policlinico S. Orsola Malpighi, Bologna, Italy|ASST Spedali Civili - Brescia, Brescia, Italy|ASST Valle Olona - Ospedale di Busto Arsizio, Busto Arsizio, Italy|ASST Lariana - Ospedale Sant'Anna, Como, Italy|ASST Crema - Ospedale Maggiore di Crema, Crema, Italy|ASST Cremona - Ospedale di Cremona, Cremona, Italy|Istituto Clinico Humanitas Gavazzeni, Cremona, Italy|ASST Garda - Presidio di Desenzano del Garda, Desenzano Del Garda, Italy|ASST Monza - Desio, Desio, Italy|ASST Spedali Civili -Ospedale di Gardone Val Trompia, Gardone Val Trompia, Italy|ASST Lecco - Ospedale A. Manzoni, Lecco, Italy|ASST Ovest milanese - Ospedale di Legnano, Legnano, Italy|ASST Lodi - Ospedale Maggiore di Lodi, Lodi, Italy|ASST OVEST Milanese - Ospedale di Magenta, Magenta, Italy|ASST Garda - Ospedale di Manerbio, Manerbio, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|ASST Melegnano e della Martesana - Presidio di Melzo-Gorgonzola, Melzo, Italy|ASST Fatebenefratelli - Presidi Fatebenefratelli & M. Melloni, Milano, Italy|ASST Fatebenefratelli - Sacco, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale San Giuseppe, Milano, Italy|ASST Spedali Civili -Presidio Ospedaliero di Montichiari, Montichiari, Italy|ASST Monza - Ospedale San Gerardo, Monza, Italy|Fondazione IRCCS Policlinico San Matteo - Pavia, Pavia, Italy|Policlinico San Pietro, Ponte San Pietro, Italy|Istituto Clinico Humanitas Rozzano, Rozzano, Italy|ASST Valle Olona - Ospedale di Saronno, Saronno, Italy|ASST Bergamo OVEST - Ospedale Treviglio-Caravaggio di Treviglio, Treviglio, Italy|Ospedale di Circolo e Fondazione Macchi - Varese, Varese, Italy|ASST Vimercate - Ospedale di Vimercate, Vimercate, Italy|ASST Melegnano e della Martesana - Ospedale di Vizzolo Predabissi, Vizzolo Predabissi",Italy,Respiratory Diseases,1,1,279.0
107.0,NCT04694703,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",,Recruiting,COVID-19,,,,,,,Drug: Covid-19 group,Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,All,"35 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Observational,2021-06-01,01/02/21,2021-01-03,05/01/21,11/02/21,"Kadirhan Ozdemir, İzmir",Turkey,Respiratory Diseases,1,1,-149.0
108.0,NCT04361422,Isotretinoin in Treatment of COVID-19,Randomized,Not yet recruiting,COVID-19,,,,,,,Drug: Isotretinoin Only Product in Oral Dose Form,Tanta University,All,18 Years to 40 Years   (Adult),300.0,Other,Interventional,2020-01-12,01/08/21,2021-01-12,24/04/20,23/09/20,,,Respiratory Diseases,1,1,366.0
109.0,NCT04332380,Convalescent Plasma for Patients With COVID-19: A Pilot Study,CP-COVID-19,Completed,Coronavirus,Coronavirus Infection,,,,,,Drug: Plasma,Universidad del Rosario|CES University|Instituto Distrital de Ciencia Biotecnologia e Innovacion en salud|Fundación Universitaria de Ciencias de la Salud,All,18 Years to 60 Years   (Adult),10.0,Other,Interventional,2020-01-05,28/07/20,2020-07-28,02/04/20,17/08/20,"Universidad del Rosario, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,2,205.0
110.0,NCT04410471,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,,Recruiting,Liver Transplant Infection,COVID-19,Mortality,Immune Response,,,,Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2,Magdalena Salcedo|Hospital General Universitario Gregorio Marañon,All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-05-29,29/05/20,2021-06-30,01/06/20,02/06/20,"Victor Fernandez Alonso, Madrid, Spain|Victor Fernández Alonso, Madrid",Spain,Respiratory Diseases,1,4,397.0
111.0,NCT04595110,Hemostatic Profile in Patients Affected by COVID-19,EMO-COVID,Recruiting,COVID-19,Thrombosis,,,,,,Other: Observational study,ANNA FALANGA|A.O. Ospedale Papa Giovanni XXIII,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-03-25,25/04/21,2021-10-05,20/10/20,20/10/20,"Papa Giovanni XXIII Hospital - S.I.M.T., Bergamo",Italy,Respiratory Diseases,1,2,559.0
112.0,NCT04713163,COVID-19 Vaccine Induced Immunity,,Not yet recruiting,COVID-19,,,,,,,Drug: covid19 vaccine,University of Manitoba|Public Health Agency of Canada (PHAC)|Cadham Provincial Lab,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-01,01/04/21,2021-01-12,19/01/21,19/01/21,,,Respiratory Diseases,1,1,11.0
113.0,NCT04481633,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,PREPCOV,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID 19 serology|Other: COVID 19 Self-Questionnaire,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-09-09,01/09/21,2021-01-09,22/07/20,12/11/20,"Limoges university Hospital, Limoges, France|Montpellier University Hospital, Montpellier, France|Pitié Salpêtrière Hospital - Hépatologie, Paris, France|Pitié Salpêtrière Hospital - Médecine interne, Paris, France|Haut-Lévêque Hospital - Gastro-entérologie, Pessac, France|Haut-Lévêque Hospital - Médecine interne, Pessac, France|Joseph Ducuing Hospital - Médecine interne, Toulouse, France|Toulouse university Hospital - Larrey Dermatologie, Toulouse, France|Toulouse University Hospital - Rhumatologie, Toulouse, France|Toulouse University Hospital, Toulouse, France|University Hospital of Toulouse - Rangueil Médecine interne, Toulouse, France|University hospital Toulouse - Purpan Médecine interne, Toulouse",France,Respiratory Diseases,1,1,122.0
114.0,NCT04780126,Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19,SARCO-COVID,Recruiting,Sarcopenia,COVID-19,,,,,,Other: Sarcopenia diagnosis,Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz,All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Observational,2021-02-26,30/04/21,2021-05-31,03/03/21,03/03/21,"Hospital de Emergencias Isabel Zendal, Madrid",Spain,Respiratory Diseases,1,2,94.0
115.0,NCT04706039,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,COVIDAIR,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Performance evaluation (sensitivity and specificity) for COVID-19 diagnosis of the Vocus PTR-TOF process,Hospices Civils de Lyon,All,"6 Years and older   (Child, Adult, Older Adult)",3000.0,Other,Interventional,2021-01-01,01/03/21,2021-01-03,12/01/21,12/01/21,"Centre de prélèvement COVID-19 HCL et Métropole de Lyon, Lyon",France,Respiratory Diseases,1,1,2.0
116.0,NCT04365959,The Prone Position in Covid-19 Affected Patients,PRON-COVID,"Active, not recruiting",Sars-CoV2,,,,,,,Procedure: Prone position,University of Milano Bicocca,All,"18 Years to 75 Years   (Adult, Older Adult)",56.0,Other,Observational,2020-03-20,09/04/20,2020-12-31,28/04/20,09/11/20,"ASST Monza, Monza, MB",Italy,Respiratory Diseases,1,1,286.0
117.0,NCT04332835,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",CP-COVID-19,Completed,Coronavirus,Coronavirus Infection,,,,,,Drug: Plasma|Drug: Standard Therapy,Universidad del Rosario|Fundación Universitaria de Ciencias de la Salud|CES University|Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud,All,"18 Years to 100 Years   (Adult, Older Adult)",92.0,Other,Interventional,2020-08-08,31/10/20,2020-11-15,03/04/20,27/11/20,"Universidad del Rosario, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,2,99.0
118.0,NCT04834752,Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Other: No intervention (Retrospective Cohort Observational),"Seoul National University Hospital|Dong-A ST Co., Ltd.",All,"18 Years and older   (Adult, Older Adult)",400000.0,Other|Industry,Observational,2021-01-05,31/12/21,2021-12-31,08/04/21,08/04/21,"Seoul National University Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,360.0
119.0,NCT04384887,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",,Completed,COVID-19,Anxiety,"Depression, Postpartum",,,,,Behavioral: covid-19 positive pregnant women,Kanuni Sultan Suleyman Training and Research Hospital|Ayşegül Bestel|İbrahim Polat|Merve Aldıkaçtıoğlu Talmaç,Female,18 Years to 45 Years   (Adult),100.0,Other,Observational,2020-04-25,25/08/20,2020-08-26,12/05/20,02/09/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,"Mental Health, Respiratory Diseases",1,3,123.0
120.0,NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),CEDiD,Recruiting,COVID-19,,,,,,,Device: Wearable Medical Device (Empatica E4)|Diagnostic Test: COVID-19 PCR Swab|Diagnostic Test: Pulse Oximeter,King's College London|Guy's and St Thomas' NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-08-20,30/05/21,2021-06-30,27/04/20,19/03/21,"Guy's and St Thomas' NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,314.0
121.0,NCT04420468,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,HEART-COVID,Completed,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,up to 17 Years   (Child),20.0,Other,Observational,2020-10-06,30/06/20,2020-06-30,09/06/20,26/03/21,"Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Armand Trousseau, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Robert Debré, Paris",France,Respiratory Diseases,1,1,-98.0
122.0,NCT03305341,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,COV19-APTP-B,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair|PPD|Medicine Invention Design, Inc",All,"22 Years to 72 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-07-18,28/06/21,2021-06-28,09/10/17,24/02/21,"Medicine Invention Design Incorporation (MIDI) - IORG0007849, North Bethesda, Maryland",United States,Respiratory Diseases,1,1,345.0
123.0,NCT04441502,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,COVID_OMICS,Recruiting,COVID-19,Interstitial Pneumonia,,,,,,,IRCCS Policlinico S. Donato,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Observational,2020-03-30,30/09/21,2021-12-31,22/06/20,03/02/21,"IRCCS Policlinico San Donato, San Donato Milanese, MI",Italy,Respiratory Diseases,1,2,641.0
124.0,NCT04822012,Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Anti COVID19 IgG Antibodies,Meir Medical Center,All,18 Years to 45 Years   (Adult),50.0,Other,Observational,2021-01-03,30/04/21,2021-01-06,30/03/21,30/03/21,"Meir Medical Center, Kfar Saba",Israel,Respiratory Diseases,1,1,3.0
125.0,NCT04364828,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,COVID-19 NGS,Recruiting,COVID-19,,,,,,,Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-10-21,01/04/22,2022-01-08,28/04/20,17/02/21,"University Hospital Tübingen, Tübingen",Germany,Respiratory Diseases,1,1,444.0
126.0,NCT04410549,Pulmonary Optical Coherence Tomography in COVID-19 Patients,,Recruiting,COVID-19,Pulmonary Embolism,,,,,,Diagnostic Test: Optical Coherence Tomography (OCT),IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-06,31/12/21,2021-12-31,01/06/20,25/02/21,"Incor - Heart Institute - University of Sao Paulo, São Paulo, Brazil|IRCCS San Raffaele, Milano",Italy,Respiratory Diseases,1,2,725.0
127.0,NCT04303299,Fight COVID-19 Trial,FIGHT-COVID-19,Recruiting,SARS-COV-2 Infections,COVID-19,,,,,,Drug: Oral,Rajavithi Hospital,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",320.0,Other,Interventional,2020-08-19,31/12/21,2021-12-31,11/03/20,10/03/21,"Assistant Professor Subsai Kongsaengdao, Bangkok",Thailand,Respiratory Diseases,1,2,499.0
128.0,NCT04337996,Dynamic Evaluation of COVID-19 Diagnostic Tests,TRODVID-19,Completed,COVID-19,,,,,,,Diagnostic Test: COVID-19 diagnostic test,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",8.0,Other,Interventional,2020-07-13,13/01/21,2021-01-13,08/04/20,26/01/21,"CH Tourcoing, Tourcoing",France,Respiratory Diseases,1,1,184.0
129.0,NCT04716543,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,LACOVISS,Not yet recruiting,Influenza -Like Illness,COVID-19,,,,,,Diagnostic Test: ILI and COVID-19 detection,"ANRS, Emerging Infectious Diseases|Institut de Recherche pour le Developpement|Centre d'Infectiologie Charles Mérieux|University Hospital, Caen|Department of livestock and fisheries National animal health laboratory, Vientiane, Laos",All,"6 Months and older   (Child, Adult, Older Adult)",5400.0,Other,Observational,2021-01-03,01/03/22,2022-01-03,20/01/21,22/01/21,,,"Infectious Diseases, Respiratory Diseases",1,2,365.0
130.0,NCT04463472,Study of COVID-19 DNA Vaccine (AG0301-COVID19),,"Active, not recruiting",COVID-19,,,,,,,Biological: AG0301-COVID19,"AnGes, Inc.|Japan Agency for Medical Research and Development",All,"20 Years to 65 Years   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2020-06-29,28/09/20,2021-07-31,09/07/20,16/11/20,"Osaka City University Hospital, Osaka",Japan,Respiratory Diseases,1,1,397.0
131.0,NCT04794361,Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner,COVID-19 ULD,Completed,COVID-19,,,,,,,,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-05-03,05/05/20,2020-05-05,12/03/21,12/03/21,"Julien FRANDON, Nîmes",France,Respiratory Diseases,1,1,2.0
132.0,NCT04542421,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lung ultrasound use in patients hospitalized with COVID,"University of Colorado, Denver",All,"18 Years to 100 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-07,01/07/21,2021-01-12,09/09/20,28/09/20,"University of Colorado, Denver, Colorado",United States,Respiratory Diseases,1,1,371.0
133.0,NCT04771559,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,,Not yet recruiting,COVID-19,Cancer,,,,,,Other: COVID-19 antibody test,Bezmialem Vakif University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-01-03,01/06/21,2021-01-07,25/02/21,04/03/21,"Bezmialem University, Istanbul, Fatih, Turkey|Okmeydani Research Hospital, Istanbul, Fatih, Turkey|Acibadem University, Istanbul, Turkey|Medeniyet University, Istanbul, Turkey|Medipol University, Istanbul",Turkey,"Respiratory Diseases, Cancers",1,2,4.0
134.0,NCT04695756,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,Liver Transplant,,,,,,Other: COVID-19 pandemic,"Hospital Italiano de Buenos Aires|National Agency for Scientific and Technological Promotion, Argentina",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-12-15,15/06/21,2021-07-15,05/01/21,12/01/21,"Hospital Italiano de Buenos Aires, Buenos Aires",Argentina,Respiratory Diseases,1,2,212.0
135.0,NCT04473248,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,,Completed,COVID-19,,,,,,,Device: Spartan COVID-19 System,Spartan Bioscience Inc.|Humber River Hospital|The Ottawa Hospital,All,"18 Years and older   (Adult, Older Adult)",27.0,Industry|Other,Interventional,2020-06-28,30/08/20,2020-08-30,16/07/20,13/11/20,"Humber River Hospital, North York, Ontario, Canada|The Univeristy of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,63.0
136.0,NCT04431310,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,,Recruiting,COVID-19,Health Personnel,"Personnel, Hospital",,,,,Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic,Nordsjaellands Hospital|University of Oxford|Nykøbing Falster County Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-03-27,01/08/25,2025-01-08,16/06/20,16/06/20,"Nordsjællands Hospital, Hillerød, Capital Region, Denmark|Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region",Denmark,Respiratory Diseases,1,3,1748.0
137.0,NCT04334291,"International COVID19 Clinical Evaluation Registry,",HOPE COVID 19,Completed,COVID-19,,,,,,,Combination Product: Observational (registry),"IVAN J NUÑEZ GIL|St Carlos Hospital, Madrid, Spain",All,"Child, Adult, Older Adult",8168.0,Other,Observational,2020-03-23,01/05/20,2020-05-31,06/04/20,23/02/21,"Hospital Lclinico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,69.0
138.0,NCT04413045,"Novel COVID-19, A National Analysis",,Completed,COVID-19,,,,,,,Other: Prevalence of COVID-19,Assiut University,All,"Child, Adult, Older Adult",61.0,Other,Observational,2020-05-20,28/07/20,2020-07-28,02/06/20,04/08/20,"Assiut University Hospitals, Assiut",Egypt,Respiratory Diseases,1,1,69.0
139.0,NCT04817319,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,Bu-Covid,Not yet recruiting,COVID-19,,,,,,,Procedure: Oral care with/without aerosolization,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-03-30,30/03/21,2022-03-30,26/03/21,26/03/21,,,Respiratory Diseases,1,1,365.0
140.0,NCT04333862,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Covid-19,Recruiting,COVID-19,,,,,,,,"University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-19,31/01/22,2022-01-31,03/04/20,30/09/20,"Guido Beldi, Bern",Switzerland,Respiratory Diseases,1,1,683.0
141.0,NCT04521036,Convalescent Plasma for COVID-19 Patients (CPCP),CPCP,Not yet recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma as Therapy for Covid-19 patients,"Vinmec Research Institute of Stem Cell and Gene Technology|National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",All,"18 Years to 75 Years   (Adult, Older Adult)",44.0,Other,Interventional,2020-01-12,30/06/21,2021-10-30,20/08/20,01/09/20,"Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi",Vietnam,Respiratory Diseases,1,1,657.0
142.0,NCT04343781,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,COVID19PUGG2,Completed,COVID-19,COVID-19,,,,,,Other: observation,"University Hospital, Angers",All,70 Years and older   (Older Adult),353.0,Other,Observational,2020-03-22,05/04/20,2020-05-04,13/04/20,16/06/20,"Angers University Hospital, Angers",France,Respiratory Diseases,1,2,43.0
143.0,NCT04720235,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,,Completed,COVID-19,Corona Virus Infection,,,,,,Device: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,All,"14 Years to 75 Years   (Child, Adult, Older Adult)",304.0,Industry,Interventional,2020-09-12,09/03/21,2021-03-30,22/01/21,12/04/21,"Neeraj Kochhar Family Medicine, Los Gatos, California",United States,Respiratory Diseases,1,2,199.0
144.0,NCT04460690,"Rapid, Onsite COVID-19 Detection",,Enrolling by invitation,COVID-19,Sars-CoV2,,,,,,Device: Rapid Onsite COVID-19 Detection,"University of Wisconsin, Madison|National Institutes of Health (NIH)|AIDS Vaccine Research Lab",All,"5 Years and older   (Child, Adult, Older Adult)",10000.0,Other|NIH,Interventional,2020-07-13,01/07/21,2021-01-07,07/07/20,28/09/20,"University of Wisconsin, Madison, Wisconsin",United States,Respiratory Diseases,1,2,178.0
145.0,NCT04424849,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Diagnostic Test: CT-Scan,Tepecik Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-03-15,15/06/20,2020-07-15,11/06/20,11/06/20,"Tepecik Training and Research Hospital, Izmir, Izmir, Konak",Turkey,Respiratory Diseases,1,1,122.0
146.0,NCT04578158,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Standard COVID-19 care|Dietary Supplement: Quercetin Phytosome,Liaquat University of Medical & Health Sciences,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-29,28/04/21,2021-06-28,08/10/20,14/04/21,"Liaquat University Hospital, Jāmshoro, Sindh",Pakistan,Respiratory Diseases,1,1,272.0
147.0,NCT04344912,Impact of COVID19 Outbreak in Cardiac Acute Care,CCU-COVID19,Recruiting,Acute Coronary Syndrome,Heart Failure,COVID-19,,,,,Other: Data collection,"Assistance Publique - Hôpitaux de Paris|Action, France",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-20,01/06/20,2020-01-08,14/04/20,28/04/20,"Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP, Paris",France,Respiratory Diseases,1,3,-72.0
148.0,NCT04707833,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,SeroCOV,Recruiting,Corona Virus Infection,,,,,,,Diagnostic Test: Serological testing for COVID-19 infection,"University Hospital, Rouen",All,"18 Years to 80 Years   (Adult, Older Adult)",385.0,Other,Interventional,2020-11-26,01/12/23,2023-01-12,13/01/21,13/01/21,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,1,777.0
149.0,NCT04768244,Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health,MilkCorona,Recruiting,COVID-19,,,,,,,Other: maternal SARS-CoV-2 infection,"Institute of Agrochemistry and Food Technology, National Research Council|Hospital Universitario La Fe|INCLIVA|Hospital Clínico Universitario de Valencia|Hospital Universitario Doctor Peset|Universidad de Granada|Universitat Jaume I|Hospital Sant Joan de Deu|Fetal Medicine Research Center, Spain|Instituto de Investigación Sanitaria Aragón",Female,18 Years to 45 Years   (Adult),100.0,Other|Industry,Observational,2020-01-04,01/12/21,2021-01-12,24/02/21,25/02/21,"Fundacion Investigacion Sanitaria INCLIVA, Valencia, Spain|Hospital Universitario y Politecnico la Fe, Valencia",Spain,Respiratory Diseases,1,1,374.0
150.0,NCT04347278,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,RegCOVID19,Recruiting,COVID-19,,,,,,,Drug: Patients with the treatment agains COVID19,Instituto de Investigación Marqués de Valdecilla|Hospital Universitario Marqués de Valdecilla|Hospital Universitario de Canarias|Hospital San Pedro de Alcántara,All,"1 Year to 100 Years   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-04-22,15/10/20,2021-01-01,15/04/20,02/06/20,"Hospital Universitario Marqués de Valdecilla, Santander, Cantabria",Spain,Respiratory Diseases,1,1,254.0
151.0,NCT04391738,Association Between BMI and COVID-19,BMI-SARS-CoV-2,Completed,SARS-CoV 2,,,,,,,Other: Patients admitted to Intensive Care Unit with SARS-CoV2,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-01-02,15/05/20,2020-01-09,18/05/20,26/03/21,"Centre Hospitalier Régional & Universitaire de Lille (CHRU), Lille",France,Respiratory Diseases,1,1,7.0
152.0,NCT04331834,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,PrEP_COVID,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebos,Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Laboratorios Rubió|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Hospital Plató|Hospital de Granollers,All,"18 Years and older   (Adult, Older Adult)",275.0,Other,Interventional,2020-03-04,25/06/20,2020-12-31,02/04/20,16/02/21,"ISGlobal, Barcelona",Spain,Respiratory Diseases,1,1,302.0
153.0,NCT04333732,CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,CROWN CORONA,Recruiting,COVID-19,,,,,,,Drug: MR or M-M-R II ® vaccine|Drug: Placebo,Washington University School of Medicine|COVID -19 Therapeutics Accelerator,All,"18 Years and older   (Adult, Older Adult)",30000.0,Other,Interventional,2020-04-09,01/08/21,2021-01-08,03/04/20,14/04/21,"Washington University School of Medicine, Saint Louis, Missouri, United States|University of Ghana Medical Centre, Accra, Greater Accra Region, Ghana|Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray, Cape Town, South Africa|Masiphumelele, Desmond Tutu Health Foundation, Sunnydale, Cape Town, South Africa|JOSHA Research, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Hillbrow, Johannesburg,Gauteng, South Africa|Clinical HIV Research Unit (CHRU), Auckland Park, Johannesburg, South Africa|Perinatal HIV Research Unit (PHRU), Diepkloof, Johannesburg, South Africa|Setshaba Research Centre, Soshanguve, Tshwane, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|FAMCRU (Family Clinical Research with Ubuntu), Cape Town, South Africa|Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth, South Africa|Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa|Aurum Institute Tembisa, Tembisa, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka",Zambia,Respiratory Diseases,1,1,274.0
154.0,NCT04416256,COVID-19 Pandemic and Worldwide Organ Procurement,COVID,Recruiting,COVID-19,,,,,,,,"Paris Translational Research Center for Organ Transplantation|Agence de La Biomédecine|Eurotransplant|United Network for Organ Sharing|Deutsche Stiftung Organtransplantation|Centro Nazionale Trapianti|Brazilian Organ Transplant Association|The Canadian Association of Transplantation|Scandiatransplant|Nederlandse Transplantatie Vereniging|Austrotransplant|Centro Nacional de Trasplantes|Instituto Nacional de Donación y Trasplante de Células, Tejidos y Órganos|Donor Network of Croatia|Instituto Nacional Central Único Coordinador de Ablación e Implante|Corporación Nacional de Trasplantes de Chile|Australian Organ and Tissue Donation and Transplantation Authority|Organización Nacional de Trasplantes|Autoridade Para Services de Sangue e Transplantacáo",All,"Child, Adult, Older Adult",230000.0,Other,Observational,2020-01-02,01/02/22,2022-01-02,04/06/20,04/06/20,"Paris Transplant Group, Paris",France,Respiratory Diseases,1,1,731.0
155.0,NCT04767958,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,RAPID COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 Platform,Ottawa Heart Institute Research Corporation,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Interventional,2021-03-19,28/02/22,2022-07-31,23/02/21,25/03/21,"University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,499.0
156.0,NCT04424992,The Natural History of Hospitalized COVID-19 Patients,STORM,Recruiting,Sars-CoV2,,,,,,,Other: Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",1433.0,Other,Observational,2020-02-28,01/12/21,2021-01-12,11/06/20,22/01/21,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,319.0
157.0,NCT04452682,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,,Completed,COVID-19,Critical Limb Ischemia,,,,,,Other: COVID 19 impact,Mansoura University,,"Child, Adult, Older Adult",998.0,Other,Observational,2020-05-25,21/06/20,2020-06-21,30/06/20,30/06/20,"Mansoura university, Mansoura",Egypt,Respiratory Diseases,1,2,27.0
158.0,NCT04808986,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,COVID-SeroPRIM,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Serological test for the detection of IgG anti-SARS-CoV-2,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",2000.0,Other,Interventional,2021-02-04,31/08/21,2021-11-15,22/03/21,22/03/21,,,Respiratory Diseases,1,1,284.0
159.0,NCT04756869,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology,,"Active, not recruiting",COVID-19,,,,,,,Other: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology,University of Michigan,All,"18 Years and older   (Adult, Older Adult)",226.0,Other,Observational,2020-04-28,16/01/21,2023-01-01,16/02/21,16/02/21,"Michigan Medicine, Ann Arbor, Michigan",United States,Respiratory Diseases,1,1,978.0
160.0,NCT04614883,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,VOC-COVID-Diag,Recruiting,COVID-19,,,,,,,Device: Volatile Organic Compounds analysis|Other: Canine odor detection of Volatile Organic Compounds,Hopital Foch,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-21,01/10/21,2021-01-10,04/11/20,04/11/20,"Foch hospital, Suresnes",France,Respiratory Diseases,1,1,81.0
161.0,NCT04378452,Assessment of the Psycho-social Impact of COVID-19 Outbreak,COM-COVID,Completed,SARS-CoV 2,COVID-19,Quality of Life,Mental Health Wellness 1,Social Distance,SARS (Disease),Psychological,Behavioral: COM-COVID anonimous survey,"Fundació Institut Germans Trias i Pujol|Anaxomics SL|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Fundació Sant Joan de Déu",All,"16 Years and older   (Child, Adult, Older Adult)",56656.0,Other,Observational,2020-03-31,22/03/21,2021-07-04,07/05/20,08/04/21,"Fundació Institut Germans Trias i Pujol, Badalona, Catalonia, Spain|Fundació Lluita contra la Sida (FLS, Fight AIDS Foundation), Badalona, Catalonia, Spain|Anaxomics biotech, Barcelona, Spain|Fundació Privada per a la Recerca i la Docència Sant Joan de Déu, Esplugues De Llobregat",Spain,Respiratory Diseases,1,7,460.0
162.0,NCT04413864,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,DEXDO-COVID,Recruiting,SARS-CoV 2,,,,,,,Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-24,28/02/21,2021-02-28,04/06/20,04/06/20,"Intensive Care Unit and Respiratory division ; Groupe hospitalier Pitie-Salpetriere and Universite Pierre et Marie Curie Paris 6, Paris",France,Respiratory Diseases,1,1,310.0
163.0,NCT04649879,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,,Not yet recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 convalescent plasma|Other: Standard of care,Joakim Dillner|Karolinska Institutet|Danderyd Hospital|Falu Hospital|Karolinska University Hospital,All,"18 Years and older   (Adult, Older Adult)",920.0,Other,Interventional,2020-03-12,01/02/22,2022-01-02,02/12/20,02/12/20,"Department of Infectious Disease, Falu Hospital, Falun, Dalarn, Sweden|Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden|Danderyd Hospital, Stockholm",Sweden,Respiratory Diseases,1,1,661.0
164.0,NCT04583982,ImmuneSense™ COVID-19 Study,,Completed,COVID-19,COVID-19,,,,,,Other: T-Detect™ SARS-CoV-2 Assay,Adaptive Biotechnologies|Covance,All,"18 Years to 89 Years   (Adult, Older Adult)",180.0,Industry,Observational,2020-09-10,04/12/20,2020-04-12,12/10/20,29/12/20,"Adaptive Biotechnologies Clinical Investigational Site, Secaucus, New Jersey",United States,Respiratory Diseases,1,2,-151.0
165.0,NCT04496141,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 antibody immunoassays,Hong Kong Sanatorium & Hospital,All,"Child, Adult, Older Adult",70.0,Industry,Observational,2020-07-27,30/11/20,2020-11-30,03/08/20,03/08/20,"Hong Kong Sanatorium & Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,126.0
166.0,NCT04375098,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Biological: COVID-19 convalescent plasma,Pontificia Universidad Catolica de Chile|Fundacion Arturo Lopez Perez,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Interventional,2020-04-05,17/08/20,2020-08-17,05/05/20,16/09/20,"Hospital Clínico Universidad Católica, Santiago",Chile,Respiratory Diseases,1,1,134.0
167.0,NCT04805892,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care",,Recruiting,COVID-19,,,,,,,Diagnostic Test: BIOZEK COVID-19 Antigen Rapid Test,Mach-E B.V.,All,"18 Years and older   (Adult, Older Adult)",250.0,Industry,Interventional,2021-03-17,27/04/21,2021-05-17,18/03/21,18/03/21,"Mobile Covid Services LLC, Flushing, New York",United States,Respiratory Diseases,1,1,61.0
168.0,NCT04534595,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,SBHC,Recruiting,COVID-19,,,,,,,Other: COVID-19,Unity Health Toronto,All,4 Years to 13 Years   (Child),1500.0,Other,Observational,2019-04-30,01/03/21,2021-01-03,01/09/20,01/09/20,"Unity Health Toronto, Toronto, Ontario",Canada,Respiratory Diseases,1,1,614.0
169.0,NCT04615208,Screening for COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: suspected of COVID-19 infection,"University of Manitoba|Natural Sciences and Engineering Research Council, Canada|ID Fusion Software, Inc.|Function Four Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-12-19,30/10/21,2021-12-30,04/11/20,01/03/21,"University of Manitoba, Winnipeg, Manitoba",Canada,Respiratory Diseases,1,1,376.0
170.0,NCT04728828,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,COVADIAL,Recruiting,COVID-19,,,,,,,Biological: Serological COVID-19 vaccine immunogenicity,Centre Hospitalier de Cornouaille|Centre Hospitalier Régional et Universitaire de Brest,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-01-25,15/02/23,2023-08-15,28/01/21,26/02/21,"Centre Hospitalier de Quimper, Quimper",France,Respiratory Diseases,1,1,932.0
171.0,NCT04497272,Assesment of the Metabolomic Signature in COVID-19 Patients,SignCov,Recruiting,COVID-19,,,,,,,Other: COVID-19 patients,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-07-08,07/08/21,2021-07-10,04/08/20,10/11/20,"CHU de nice, Nice, Alpes-Maritimes",France,Respiratory Diseases,1,1,367.0
172.0,NCT04404179,Setting up a COVID-19 Care Facility at a Prison in Pakistan,,Completed,COVID-19,,,,,,,Other: COVID-19 FACILITY,"Services Institute of Medical Sciences, Pakistan",All,"Child, Adult, Older Adult",69.0,Other,Observational,2020-03-27,02/05/20,2020-02-05,27/05/20,29/05/20,"Camp Jail / COVID-19 CARE FACILITY/ SIMS, Lahore",Pakistan,Respiratory Diseases,1,1,-51.0
173.0,NCT04374838,Effect of COVID-19 Pandemic on Pediatric Cancer Care,,Recruiting,COVID-19,,,,,,,,South Egypt Cancer Institute,All,"Child, Adult, Older Adult",20.0,Other,Observational,2020-05-15,01/08/20,2021-01-09,05/05/20,12/08/20,"South Egypt Cancer Institute, Assiut University, Assiut",Egypt,Respiratory Diseases,1,1,239.0
174.0,NCT04367402,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",COST ACTION,Recruiting,COVID-19,,,,,,,Other: BioMedomics COVID-19 IgM-IgG Rapid Test,Azienda Ospedaliera San Paolo,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-03-30,24/04/20,2020-01-09,29/04/20,30/04/20,"AO San Paolo, Milan, IT",Italy,Respiratory Diseases,1,1,-81.0
175.0,NCT04347174,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,,Completed,COVID-19,,,,,,,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Placebo,"Cadila Pharnmaceuticals|Council of Scientific and Industrial Research, India",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-04-30,10/08/20,2020-08-21,15/04/20,27/01/21,"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi",India,Respiratory Diseases,1,1,113.0
176.0,NCT04408001,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,IMMUNO-COVID,"Active, not recruiting",Sars-CoV2,,,,,,,Other: Clinical interview|Biological: Blood collection|Biological: Saliva collection,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",499.0,Other,Observational,2020-04-06,04/06/21,2021-04-06,29/05/20,09/03/21,"Hôpital d'Instuction des Armées Percy, Clamart",France,Respiratory Diseases,1,1,365.0
177.0,NCT04839068,the Impact of Covid-19 Pandemic Stress on Pregnancy Outcomes,,Not yet recruiting,COVID-19,,,,,,,Device: covid 19 on pregnancy outcomes,Assiut University,Female,"Child, Adult, Older Adult",7000.0,Other,Observational,2021-01-05,01/05/22,2022-01-06,09/04/21,09/04/21,"The Clinical Obstetrics and Gynaecology department, Assuit University Hospital, Egypt, Assiut",Egypt,Respiratory Diseases,1,1,366.0
178.0,NCT04477889,Methodist Health System COVID-19 Patient Registry,,Recruiting,COVID-19,,,,,,,Other: Treatment for COVID-19,Methodist Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-20,01/12/25,2026-01-12,20/07/20,24/09/20,"Clinical Research Institute Methodist Health System, Dallas, Texas",United States,Respiratory Diseases,1,1,2032.0
179.0,NCT04470557,Relation Between Lab Finding and COVID-19 Severity,,Not yet recruiting,COVID-19,,,,,,,"Diagnostic Test: D-dimer,CBC.ESR,CRP,|Diagnostic Test: Liver function tests ,serum ferritin and PCR for COVID-19 .",Assiut University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-07-15,01/10/20,2020-01-12,14/07/20,14/07/20,,,Respiratory Diseases,1,1,-185.0
180.0,NCT04445415,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 antibodies testing,Assiut University,All,"Child, Adult, Older Adult",250.0,Other,Observational,2020-01-07,01/06/21,2021-01-09,24/06/20,24/06/20,,,Respiratory Diseases,1,1,368.0
181.0,NCT04581148,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),SARS-CoV2_KIDS,Not yet recruiting,SARS-Cov2,,,,,,,Diagnostic Test: Blood test for IgG antibodies against SARS-CoV-2,University of Erlangen-Nürnberg Medical School,All,"up to 18 Years   (Child, Adult)",2000.0,Other,Observational,2020-05-10,01/05/22,2022-01-05,09/10/20,09/10/20,,,Respiratory Diseases,1,1,605.0
182.0,NCT04803370,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,,Recruiting,COVID-19,,,,,,,Other: Convalescent Plasma with antibody against SARS-CoV-2.|Other: Standard treatment for COVID-19,Hospital Son Llatzer|Fundació d'investigació Sanitària de les Illes Balears,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-07,01/09/21,2021-01-09,17/03/21,17/03/21,"University Hospital Son Llatzer, Palma De Mallorca, Islas De Balears",Spain,Respiratory Diseases,1,1,155.0
183.0,NCT04336956,Covid-19 Pediatric Observatory,PANDOR,Recruiting,COVID-19,,,,,,,Other: hospitalized children with Covid19,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne|GPIP|Société Française de Pédiatrie|GFRUP,All,"up to 18 Years   (Child, Adult)",250.0,Other,Observational,2020-07-04,30/06/21,2021-06-30,07/04/20,17/07/20,"Chu Felix Guyon, Saint Denis, La Réunion, France|Ch St Esprit, Agen, France|Ch General Aix En Provence -, Aix-en-Provence, France|CHU Angers, Angers, France|CH d'ANGOULEME, Angoulème, France|Pringy - Ch D'Annecy, Annecy, France|CH Argenteuil, Argenteuil, France|Ch Armentieres, Armentières, France|CH Arpajon, Arpajon, France|Ch Auxerre, Auxerre, France|CH GENERAL Henri Duffaut, Avignon, France|CHU de BESANCON, Besançon, France|Hopital Femme Enfant, Caen, France|Ch de Pontoise, Cergy-Pontoise, France|Ch W. Morey, Chalon-sur-Saône, France|CH de CHAMBERY, Chambéry, France|Ch Hotel Dieu, Chartres, France|CHU Estaing, Clermont-Ferrand, France|Hopital Louis Pasteur, Colmar, France|Hopital Louis Mourrier, Colombes, France|CH Sud Francilien, Corbeil-Essonnes, France|Centre Hospitalier intercommunal de Creteil, Creteil, France|Ch de Dax, Dax, France|Hopital D'Enfants Chu Dijon, Dijon, France|CH Louviers Val de Reuil, Elbeuf, France|CH Gonesse, Gonesse, France|CH d'HYERES, Hyères, France|Ch de Marne La Vallee, Jossigny, France|Chru de Grenoble, La Tronche, France|CHGénéral du HAVRE, Le Havre, France|Hopital Jeanne de Flandre, Lille, France|Hopital Roger Salengro - Lille, Lille, France|Hopital Saint Vincent de Paul, Lille, France|Ch de Longjumeau, Longjumeau, France|Lorient - Ch de Bretagne Sud, Lorient, France|Hopital Femme Mere Enfant-Bron, Lyon, France|Hopital de Mantes, Mantes-la-Jolie, France|Hopital Nord Enfants, Marseille, France|Hopital de Meaux, Meaux, France|Ch de Melun, Meulin, France|CH de Montargis, Montargis, France|CH de MONTBRISON, Montbrison, France|Hopital Arnaud de Villeneuve, Montpellier, France|CHRU de Nancy, Nancy, France|Nantes - Hopital Mere Enfant, Nantes, France|Ch de Neuilly Sur Seine, Neuilly-sur-Seine, France|Hopital Lenval, Nice, France|CHU Nimes Caremeau, Nîmes, France|Chr Orleans, Orléans, France|Assistance Publique Hôpitaux de Paris, Paris, France|Hopital St Jean Roussillon, Perpignan, France|POISSY - CH de POISSY, Poissy, France|QUIMPER - CH de Cornouaille, Quimper, France|RANG du FLIERS - C.H.A.M., RANG du FLIERS, France|Hopital Américain CHU REIMS, Reims, France|CH RODEZ, Rodez, France|CH de ROMANS, Romans-sur-Isère, France|Chu Rouen, Rouen, France|Hopital Charles-Nicolle, Rouen, France|Chu St Etienne, Saint Etienne, France|Ch de Saint Denis, Saint-Denis, France|Ch de Saint Malo, Saint-Malo, France|Ch Du Pays Du Mont Blanc, Sallanches, France|Chg Salon de Provence, Salon de Provence, France|CH Hautepierre, Strasbourg, France|CH Tarbes, Tarbes, France|CH Bel Air, Thionville, France|Hopital Sainte Musse, Toulon, France|CHU Toulouse-hôpital des Enfants, Toulouse, France|Hôpital Gatien De Clocheville, Tours, France|CH de TROYES, Troyes, France|Hôpital Nord Franche-Comté, Trévenans, France|Ch Bretagne Atlantique, Vannes, France|Ch Le Chesnay, Versailles, France|Hopital de Villeneuve Saint Georges, Villeneuve-Saint-Georges, France|CH Jean Monnet, Épinal",France,Respiratory Diseases,1,1,361.0
184.0,NCT04629001,Effect of Covid-19 on Outcomes of Pregnancy,,"Active, not recruiting",COVID-19,,,,,,,"Diagnostic Test: Covid-19 PCR , IGM",Assiut University,Female,18 Years to 40 Years   (Adult),1000.0,Other,Observational,2020-01-09,01/09/21,2021-01-12,16/11/20,16/11/20,"Medicine, Assiut",Egypt,Respiratory Diseases,1,1,369.0
185.0,NCT04483622,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,COVID-19,Recruiting,COVID-19,,,,,,,,Sohag University,All,"16 Years to 90 Years   (Child, Adult, Older Adult)",30.0,Other,Observational,2020-12-06,13/01/21,2021-02-15,23/07/20,23/07/20,"Sohag University Hospital, Sohag",Egypt,Respiratory Diseases,1,1,71.0
186.0,NCT04632732,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,APEL-COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 test|Diagnostic Test: Blood sampling,"Centre de recherche du Centre hospitalier universitaire de Sherbrooke|University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-10-26,07/10/21,2021-01-12,17/11/20,22/01/21,"Sherbrooke University, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,1,78.0
187.0,NCT04420260,Primary Prevention of Infection by COVID-19 in Health Providers,PI-Covid-19,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO,Unidad de Investigación Genética Molecular|Universidad de Antioquia,All,18 Years to 60 Years   (Adult),300.0,Other,Interventional,2020-01-07,01/09/20,2020-01-09,09/06/20,09/06/20,,,Respiratory Diseases,1,1,2.0
188.0,NCT04318301,Hypertension in Patients Hospitalized With COVID-19,HT-COVID19,Completed,COVID-19,Hypertension,,,,,,,Zhenhua Zen|Nanfang Hospital of Southern Medical University,All,"18 Years to 100 Years   (Adult, Older Adult)",275.0,Other,Observational,2020-03-21,28/03/20,2020-03-30,23/03/20,29/04/20,"Hankou Hospital, Hankou, Hubei",China,"Cardiovascular Diseases, Respiratory Diseases",1,2,9.0
189.0,NCT04366882,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,MIA-COVID-19,Recruiting,COVID-19,,,,,,,Procedure: CT-scan with minimal invasive autopsy,"Jessa Hospital|Hasselt University|University Hospital, Antwerp",All,"Child, Adult, Older Adult",45.0,Other,Interventional,2020-04-14,01/12/20,2020-01-12,29/04/20,29/04/20,"Jessa Hospital, Hasselt",Belgium,Respiratory Diseases,1,1,-93.0
190.0,NCT04420312,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,COVID-EP,Completed,Pulmonary Embolism,COVID-19,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",1024.0,Other,Observational,2020-01-03,20/04/20,2020-04-20,09/06/20,25/06/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,2,108.0
191.0,NCT04437693,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,HCQ-COVID19,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine,Hamad Medical Corporation,All,18 Years to 60 Years   (Adult),500.0,Industry,Interventional,2020-08-31,30/08/21,2021-12-31,18/06/20,11/08/20,,,Respiratory Diseases,1,1,487.0
192.0,NCT04347070,Implementation of Physiotherapy on COVID-19 Patients in ICU,PHYSIO-COVID,"Active, not recruiting",Sars-CoV2,COVID-19,,,,,,Other: Phsyiotherapy,"University Hospital, Montpellier|Société espagnole de pneumologie (SEPAR)|Societe française de kinésithérapie en réanimation (SKR)",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2017-01-04,01/09/20,2022-01-12,15/04/20,29/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,2,1834.0
193.0,NCT04720794,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,,Completed,COVID-19,SARS (Severe Acute Respiratory Syndrome),Corona Virus Infection,,,,,Device: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,All,"18 Years to 75 Years   (Adult, Older Adult)",101.0,Industry,Interventional,2020-09-25,20/10/20,2020-10-20,22/01/21,26/01/21,"Neeraj Kochhar Family Medicine, Los Gatos, California",United States,Respiratory Diseases,1,3,25.0
194.0,NCT04799834,Genotype and Susceptibility to COVID-19,ORIGIN,Recruiting,COVID-19,,,,,,,"Other: Questionnaire administration,blood sampling and genetic analyses.",Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-11-30,01/10/21,2021-01-10,16/03/21,16/03/21,"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò, Ranica, BG",Italy,Respiratory Diseases,1,1,41.0
195.0,NCT04795414,Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers,,Recruiting,COVID-19,COVID-19,,,,,,"Biological: SARS-CoV-2 Vaccine(Vero Cell), Inactivated",Ruijin Hospital,All,18 Years to 59 Years   (Adult),1370.0,Other,Observational,2021-01-14,30/04/22,2023-01-31,12/03/21,19/03/21,"Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai",China,Respiratory Diseases,1,2,747.0
196.0,NCT04775563,COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients,,Recruiting,COVID-19,,,,,,,Other: COVID-19 vaccine hesitancy scale in rheumatic diseases|Other: COVID-19 vaccine hesitancy associated factors,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran",All,"18 Years to 99 Years   (Adult, Older Adult)",740.0,Other,Observational,2021-01-02,30/08/21,2021-01-10,01/03/21,01/03/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City",Mexico,Respiratory Diseases,1,1,8.0
197.0,NCT04736732,The IRCM POST-COVID-19 (IPCO) Clinic,IPCO,Recruiting,COVID-19,,,,,,,Other: Medical follow-up,Institut de Recherches Cliniques de Montreal,All,"18 Years and older   (Adult, Older Adult)",570.0,Other,Observational,2021-01-01,01/01/23,2023-12-12,03/02/21,03/02/21,"Montreal Clinical Research Institute, Montréal, Quebec",Canada,Respiratory Diseases,1,1,1075.0
198.0,NCT04784689,Host Immune Response to Novel RNA COVID-19 Vaccination,,Recruiting,COVID-19,Cancer,,,,,,Biological: COVID-19 Vaccine,The University of Texas Health Science Center at San Antonio,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2021-02-24,01/02/23,2024-01-01,05/03/21,29/03/21,"Mays Cancer Center, UT Health San Antonio, San Antonio, Texas",United States,"Respiratory Diseases, Cancers",1,2,1041.0
199.0,NCT04350320,Trial to Study the Benefit of Colchicine in Patients With COVID-19,COL-COVID,Completed,COVID-19,,,,,,,Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-04-30,20/10/20,2020-12-30,17/04/20,12/01/21,"Virgen de la Arrixaca University Clinical Hospital, Murcia",Spain,Respiratory Diseases,1,1,244.0
200.0,NCT04507893,Comparison Between Positive and Negative COVID-19 Pneumonia,,Recruiting,COVID-19,Interstitial Pneumonia,,,,,,"Other: Clinical, laboratory and imaging characteristics of pneumonia",University of Palermo,All,"18 Years to 95 Years   (Adult, Older Adult)",80.0,Other,Observational,2020-03-15,30/09/20,2022-01-12,11/08/20,23/02/21,"Infectious diseases Unit of the Cervello-Villa Sofia Hospital, Palermo, PA, Italy|Internal Medicine Division of the Cervello-Villa Sofia Hospital, Palermo, PA, Italy|Pulmonology Unit Dedicated to COVID-19 Patients, Palermo, PA",Italy,Respiratory Diseases,1,2,668.0
201.0,NCT04457726,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,,Recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 Specific T Cells,"KK Women's and Children's Hospital|Duke-NUS Graduate Medical School|National University Hospital, Singapore|Singapore General Hospital|Sengkang General Hospital|Changi General Hospital",All,"1 Year to 90 Years   (Child, Adult, Older Adult)",18.0,Other,Interventional,2020-01-07,01/03/21,2022-01-12,07/07/20,07/07/20,"Changi General Hospital, Singapore, Singapore|KK Women's and Children's Hospital, Singapore, Singapore|National University Hospital, Singapore, Singapore|Sengkang General Hospital, Singapore, Singapore|Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,736.0
202.0,NCT04537338,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,RESPIRA,Not yet recruiting,COVID-19,,,,,,,Genetic: 1. Characterize the immune response after infection with SARS-CoV-2,"Agencia Costarricense de Investigaciones Biomedicas|Caja Costarricense de Seguro Social|Fundación INCIENSA (FUNIN)|Ministerio de Salud de Costa Rica|Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer|Agencia Costarricense de Investigaciones Biomedicas (ACIB)",All,"6 Months to 100 Years   (Child, Adult, Older Adult)",2000.0,Other,Observational,2020-09-14,14/09/22,2022-09-14,03/09/20,03/09/20,,,Respiratory Diseases,1,1,730.0
203.0,NCT04647994,Exploratory Study: COVID-19 and Pregnancy,,Recruiting,Pregnant Women,COVID-19,,,,,,Diagnostic Test: SARS-CoV-2 serology,University of Sao Paulo General Hospital,Female,"17 Years to 50 Years   (Child, Adult)",500.0,Other,Observational,2020-09-21,01/07/21,2022-06-13,01/12/20,02/12/20,"Rossana P Fracisco, São Paulo",Brazil,Respiratory Diseases,1,2,630.0
204.0,NCT04474483,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,COVID-19,Recruiting,COVID-19,,,,,,,Drug: Melatonin|Other: Placebo (Methylcellulose) capsule,State University of New York at Buffalo,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-11,31/03/21,2021-03-31,16/07/20,10/11/20,"University at Buffalo, Buffalo, New York",United States,Respiratory Diseases,1,1,293.0
205.0,NCT04740658,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,PIANO-COVID-19,Not yet recruiting,COVID-19,,,,,,,Other: No intervention,"University Hospital, Toulouse",All,"Child, Adult, Older Adult",9600.0,Other,Observational,2021-01-02,01/07/21,2021-01-07,05/02/21,05/02/21,"University Hospital Toulouse - Gérontopôle, Toulouse",France,Respiratory Diseases,1,1,5.0
206.0,NCT04636294,Borderline COVID-19 PCR Test Result,,Completed,COVID-19,Virus,,,,,,Diagnostic Test: SARS-CoV-2 PCR,Jessa Hospital,All,"Child, Adult, Older Adult",30000.0,Other,Observational,2020-01-08,15/02/21,2021-02-15,19/11/20,16/02/21,"Clinical Laboratory Jessa Hospital, Hasselt, Limburg",Belgium,Respiratory Diseases,1,2,404.0
207.0,NCT04610502,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,SECR-01,Completed,COVID-19,,,,,,,Biological: Administration of Equine immunoglobulin anti SARS-CoV-2,Caja Costarricense de Seguro Social|Universidad de Costa Rica|Ministry of Health Costa Rica,All,"18 Years and older   (Adult, Older Adult)",26.0,Other,Interventional,2020-06-09,06/10/20,2020-06-12,30/10/20,19/03/21,"Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica|Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica|Hospital México, San José, Costa Rica|Hospital San Juan de Dios, San José",Costa Rica,Respiratory Diseases,1,1,3.0
208.0,NCT04354831,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,Medical College of Wisconsin|Froedtert Hospital,All,"18 Years and older   (Adult, Older Adult)",131.0,Other,Interventional,2020-11-05,01/05/22,2023-01-05,21/04/20,08/01/21,"Froedtert Hospital, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,1,791.0
209.0,NCT04780334,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,COR-DIAL-S,Not yet recruiting,SARS-CoV Infection,COVID-19,,,,,,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,"University Hospital, Lille",All,"Child, Adult, Older Adult",200.0,Other,Observational,2021-01-04,01/04/22,2022-01-04,03/03/21,03/03/21,,,Respiratory Diseases,1,2,365.0
210.0,NCT04596098,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,AcNT-COVID19,Recruiting,SARS-CoV 2,,,,,,,Other: Blood sampling,"University Hospital, Grenoble|Commissariat A L'energie Atomique",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-30,30/06/21,2021-09-30,22/10/20,15/01/21,"UniversityGrenobleHospital, Grenoble",France,Respiratory Diseases,1,1,518.0
211.0,NCT04453969,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,,Recruiting,SARS-CoV2,Breastmilk,,,,,,Other: COVID-19,Deborah O'Connor|University of Toronto|Sinai Health System|The Hospital for Sick Children,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-05-24,01/01/21,2021-01-01,01/07/20,23/10/20,"Sinai Health System, Toronto, Ontario, Canada|University of Toronto, Toronto, Ontario",Canada,Respiratory Diseases,1,2,222.0
212.0,NCT04605952,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,,Completed,COVID-19,,,,,,,Diagnostic Test: Repeat SARS-CoV-2 IgG antibodies at 45-65 days,Tata Main Hospital,All,18 Years to 60 Years   (Adult),201.0,Other,Observational,2020-01-07,30/08/20,2020-08-30,28/10/20,28/10/20,"Dr.Deb Sanjay Nag, Jamshedpur, Jharkhand",India,Respiratory Diseases,1,1,236.0
213.0,NCT04558307,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Pilot a rapid SARS-CoV-2 testing strategy|Other: Community-driven messages to promote COVID-19 testing,Mayo Clinic,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-03-06,01/06/21,2021-01-12,22/09/20,22/09/20,"Mayo Clinic, Rochester, Minnesota",United States,Respiratory Diseases,1,1,312.0
214.0,NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,,Not yet recruiting,COVID-19,,,,,,,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,Centro Medico ABC,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Interventional,2020-06-19,30/07/20,2020-09-30,16/06/20,17/06/20,,,Respiratory Diseases,1,1,103.0
215.0,NCT04393428,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),COVID-AKI,Completed,COVID-19,Renal Replacement Therapy,Acute Kidney Injury,,,,,Other: [TIMP-2]*[IGFBP-7],"University Hospital, Montpellier",All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-03,01/06/20,2020-06-30,19/05/20,29/07/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,179.0
216.0,NCT04579289,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,REMPAR-EHPAD,Completed,COVID-19,,,,,,,Other: questionnaire,Rennes University Hospital,All,"Child, Adult, Older Adult",230.0,Other,Observational,2020-06-15,01/09/20,2020-01-09,08/10/20,14/10/20,"Centre Hospitalier Universitaire de Rennes, Rennes",France,Respiratory Diseases,1,1,-158.0
217.0,NCT04488484,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,PERSO-COVID,"Active, not recruiting",COVID-19,,,,,,,Other: Serology test follow-up,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2020-01-07,31/12/21,2021-12-31,28/07/20,12/08/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,1,724.0
218.0,NCT04771117,Defiances to Face COVID-19 Pandemic in Mexico,,Completed,Health Behavior,Risk-Taking,COVID-19,,,,,Behavioral: Fear of Covid-19 Scale,Instituto Mexicano del Seguro Social,All,"16 Years and older   (Child, Adult, Older Adult)",4004.0,Other,Observational,2020-01-05,01/08/20,2020-01-12,25/02/21,26/02/21,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco",Mexico,Respiratory Diseases,1,3,7.0
219.0,NCT04761822,COVID-19: SARS Vaccination,SARS,Recruiting,SARS-CoV Infection,COVID-19,Allergic Reaction,Mast Cell Disorder,Non-atopic,,,Biological: Moderna COVID-19 Vaccine|Biological: Pfizer-BioNTech COVID-19 Vaccine|Biological: Placebo,"National Institute of Allergy and Infectious Diseases (NIAID)|Immune Tolerance Network (ITN)|Rho Federal Systems Division, Inc.",All,"18 Years to 69 Years   (Adult, Older Adult)",3400.0,NIH|Other|Industry,Interventional,2021-01-04,01/06/21,2021-01-07,21/02/21,08/04/21,"University of Arizona Health Sciences, College of Medicine Tucson, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Tucson, Arizona, United States|Arkansas Children's, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|University of California, Los Angeles Medical Center, Los Angeles, California, United States|Stanford Medicine, Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States|National Jewish Health, Denver, Colorado, United States|University Health, University of Miami Health System, Miami, Florida, United States|University of South Florida Asthma Allergy and Immunology Clinical Research Unit, Tampa, Florida, United States|Emory University School of Medicine, Emory Healthcare: Emory Clinic Allergy and Immunology, Atlanta, Georgia, United States|Sinus and Allergy Center of Northwestern University, Chicago, Illinois, United States|NorthShore University HealthSystem, Skokie, Illinois, United States|University of Iowa Health Care, Iowa City, Iowa, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan Health, Ann Arbor, Michigan, United States|Henry Ford Hospital and Health System, Detroit, Michigan, United States|Saint Louis University Care Center for Specialized Medicine, Saint Louis, Missouri, United States|Mount Sinai Hospital, Department of Medicine, Division of Clinical Immunology, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Rochester Regional Health, Rochester, New York, United States|North Carolina Translational and Clinical Sciences Institute-Clinical & Translational Research Center (CTRC) at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Cleveland Clinic, Allergy & Clinical Immunology, Cleveland, Ohio, United States|Penn State Health Allergy, Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine Medical Center, Houston, Texas, United States|University of Virginia Health System: Department of Medicine, Division of Allergy and Immunology, Charlottesville, Virginia, United States|Virginia Commonwealth University, Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, Richmond, Virginia, United States|University of Wisconsin Asthma Allergy Pulmonary Research, Madison, Wisconsin",United States,Respiratory Diseases,1,5,3.0
220.0,NCT04376788,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,COVID-19,Recruiting,COVID-19,,,,,,,Biological: exchange blood transfusion from normal donor|Biological: plasma from convalescent patients with COVID-19|Drug: Methylene Blue 5 MG/ML,Ain Shams University,All,"18 Years to 65 Years   (Adult, Older Adult)",15.0,Other,Interventional,2020-05-20,01/07/20,2020-01-09,06/05/20,09/07/20,"Ain Shams University, Cairo",Egypt,Respiratory Diseases,1,1,-132.0
221.0,NCT04567173,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,Co-CLARITY,Recruiting,COVID-19,,,,,,,Drug: Anti-SARS-CoV-2 convalescent plasma,University of the Philippines,All,"19 Years and older   (Adult, Older Adult)",136.0,Other,Interventional,2020-09-21,30/06/21,2021-06-30,28/09/20,29/09/20,"UP Philippine General Hospital, Manila",Philippines,Respiratory Diseases,1,1,282.0
222.0,NCT04488081,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,I-SPY_COVID,Recruiting,COVID-19,,,,,,,Drug: Remdesivir|Drug: Cenicriviroc|Drug: Icatibant|Drug: Pulmozyme|Drug: IC14|Drug: Celecoxib Famotidine|Drug: Narsoplimab,"QuantumLeap Healthcare Collaborative|University of California, San Francisco|University of Pennsylvania|University of Minnesota|Emory University|University of Alabama at Birmingham|University of California, San Diego|University of Colorado, Denver|University of Southern California|Yale University|Columbia University|Wake Forest University Health Sciences|Sanford Health|Montefiore Medical Center|Long Beach Memorial Medical Center|Georgetown University|Kalispell Regional Medical Center",All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Interventional,2020-07-31,24/07/22,2022-01-11,27/07/20,05/04/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|University of Southern California, Los Angeles, California, United States|University of California San Francisco (UCSF), San Francisco, California, United States|University of Colorado, Aurora, Colorado, United States|Yale Cancer Center, New Haven, Connecticut, United States|Montefiore Medical Center, Bronx, New York, United States|Columbia University Medical Center, New York, New York, United States|Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States|University of Pennsylvania (U Penn), Philadelphia, Pennsylvania, United States|Sanford Health, Sioux Falls, South Dakota",United States,Respiratory Diseases,1,1,529.0
223.0,NCT04636021,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,RECIPE,Recruiting,Corona Virus Infection,,,,,,,Diagnostic Test: COVID-19 testing,Pinnacle Health Cardiovascular Institute,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-01-08,31/12/21,2022-06-30,19/11/20,19/11/20,"UPMC Pinnacle Harrisburg, Harrisburg, Pennsylvania",United States,Respiratory Diseases,1,1,904.0
224.0,NCT04527081,Study of COVID-19 DNA Vaccine (AG0302-COVID19),,"Active, not recruiting",COVID-19,,,,,,,Biological: AG0302-COVID19,"AnGes, Inc.",All,"20 Years to 65 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-08-31,09/11/20,2021-09-30,26/08/20,07/12/20,"Osaka University Hospital, Osaka",Japan,Respiratory Diseases,1,1,395.0
225.0,NCT04461340,Efficacy and Safety of Sirolimus in COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Sirolimus,Alexandria University,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-08-15,30/10/20,2020-11-30,08/07/20,09/09/20,"Faculty of Medicine, Alexandria university, Egypt, Alexandria",Egypt,Respiratory Diseases,1,1,107.0
226.0,NCT04480060,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Diagnostic Test: COVID-19 diagnostic PCR,Kanuni Sultan Suleyman Training and Research Hospital,All,18 Years to 50 Years   (Adult),100000.0,Other,Observational,2020-10-03,30/06/20,2020-07-14,21/07/20,21/07/20,"Seda Yilmaz Semerci, Istanbul",Turkey,Respiratory Diseases,1,1,-81.0
227.0,NCT04649840,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Humoral and cellular immunity,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus|Belarusian State Medical University|The Republican Research and Practical Center for Epidemiology and Microbiology,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-01-10,31/12/21,2021-12-31,02/12/20,02/12/20,"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk",Belarus,Respiratory Diseases,1,1,721.0
228.0,NCT04342156,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,SHARP COVID-19,Withdrawn,Coronavirus Infection,Hydroxychloroquine Adverse Reaction,,,,,,Drug: Hydroxychloroquine Sulfate 200 milligram (mg) Tab,"Tan Tock Seng Hospital|National Center for Infectious Diseases|Singapore Clinical Research Institute|Singapore Eye Research Institute|Saw Swee Hock School of Public Health|Duke-NUS Graduate Medical School|Netherlands: Ministry of Health, Welfare and Sports",All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,01/08/20,2020-01-10,10/04/20,08/10/20,,,Respiratory Diseases,1,2,6.0
229.0,NCT04345991,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",CORIPLASM,Recruiting,COVID-19,,,,,,,Drug: Transfusion of COVID-19 convalescent plasma,Assistance Publique - Hôpitaux de Paris|Etablissement Français du Sang,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-15,15/05/20,2020-01-06,15/04/20,20/05/20,"SMIT, Saint Antoine hospital, Paris",France,Respiratory Diseases,1,1,-100.0
230.0,NCT04386252,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,,Not yet recruiting,COVID-19,,,,,,,Biological: AV-COVID-19,"Aivita Biomedical, Inc.",All,"18 Years and older   (Adult, Older Adult)",175.0,Industry,Interventional,2021-01-06,01/11/21,2022-01-06,13/05/20,05/04/21,,,Respiratory Diseases,1,1,365.0
231.0,NCT04354610,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Nancy-CovH-AKI,"Active, not recruiting",COVID-19,,,,,,,Procedure: Biological samples specific to research|Procedure: Clinical examination|Procedure: Telephone follow-up,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",57.0,Other,Interventional,2020-04-27,19/12/20,2021-03-19,21/04/20,20/01/21,"CHRU de Nancy, Nancy, France|CHRU de Nancy, Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,1,326.0
232.0,NCT04364698,Observational Cohort of COVID-19 Patients at Raymond-Poincare,COVID-RPC,Recruiting,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-07-05,01/06/20,2020-01-06,28/04/20,14/05/20,"Department of Infectiology, Raymond Poincaré Hospital, APHP, Garches",France,Respiratory Diseases,1,1,-181.0
233.0,NCT04355741,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",,Completed,COVID-19,,,,,,,Other: Exposure,"Universidade Nova de Lisboa|NOVA Medical School of Universidade NOVA de Lisboa|Hospital de São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental|Centro Hospitalar Universitário São João|CUF Academic and Research Medical Center|Hospital CUF Infante Santo, S.A.|Centro de Medicina Laboratorial Germano de Sousa, S.A.|CINTESIS - Center for Health Technology and Services Research",All,"18 Years and older   (Adult, Older Adult)",115.0,Other,Observational,2020-04-20,01/07/20,2020-07-16,21/04/20,25/08/20,"Hospital CUF Infante Santo, S.A., Lisbon, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário São João, Oporto",Portugal,Respiratory Diseases,1,1,87.0
234.0,NCT04347681,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,,Recruiting,COVID-19,,,,,,,Other: convalescent plasma from recovered COVID 19 donor,King Fahad Specialist Hospital Dammam|King Fahad Medical City|King Faisal Specialist Hospital And Research Center|King Abdulaziz Medical City|King Fahad University Hospital|John Hopkins Aramco Healthcare|Taibah University|King Saud University|King Khaled University Hospital|King Fahad Military Medical Complex|Qatif Central Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",575.0,Other,Interventional,2020-04-18,31/12/20,2021-11-04,15/04/20,11/08/20,"John Hopkins Aramco Healthcare, Dhahran, Eastern Provence, Saudi Arabia|Dammam Medical Complex, Dammam, Saudi Arabia|Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia|king Fahad specialist hospital, Dammam, Saudi Arabia|DHahran Military Medical Complex, Dhahran, Saudi Arabia|International Medical Center, Jeddah, Saudi Arabia|Madinah General Hospital, Medina, Saudi Arabia|Ohud Hospital, Medina, Saudi Arabia|Taibah University, Medina, Saudi Arabia|Qatif Central Hospital, Qatif, Saudi Arabia|King Abdulaziz Medical City, Riyadh, Saudi Arabia|King Fahad Medical City, Riyadh, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia|King Khalid University Hospital, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,565.0
235.0,NCT04421404,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,CAPRI,"Active, not recruiting",COVID-19,Sars-CoV2,,,,,,Biological: COVID-19 Convalescent Plasma (CCP)|Biological: Placebo,"Priscilla Hsue, MD|Blood Systems Research Institute|San Francisco General Hospital|University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-09-06,30/04/21,2021-04-30,09/06/20,22/10/20,"San Francisco General Hospital, San Francisco, California, United States|UCSF Medical Center at Mount Zion, San Francisco, California, United States|University of California, San Francisco Medical Center (Parnassus Campus), San Francisco, California",United States,Respiratory Diseases,1,2,236.0
236.0,NCT04453280,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),SARSCoV2CZImun,Completed,COVID-19,COVID-19,,,,,,Diagnostic Test: Quantitative analysis of anti-SARS-CoV-2-antibodies|Diagnostic Test: SARS-CoV-2 diagnostic rapid test,"Institute of Health Information and Statistics of the Czech Republic|Ministry of Health, Czech Republic|Faculty of Medicine, Masaryk University|Institute for Clinical and Experimental Medicine|Brno University Hospital|St. Anne's University Hospital Brno, Czech Republic|Masaryk Memorial Cancer Institute|Regional Public Health Office of the South Moravian Region based in Brno, Czech Republic|Public Health Office of the Capital City of Prague, Czech Republic|Regional Public Health Office of the Central Bohemian Region based in Prague, Czech Republic",All,"8 Years and older   (Child, Adult, Older Adult)",695.0,Other,Observational,2020-05-18,03/06/20,2020-03-06,01/07/20,01/07/20,"Institute of Health Information and Statistics of the Czech Republic, Prague",Czechia,Respiratory Diseases,1,2,-73.0
237.0,NCT04361981,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,TVP-COVID-RIV,Not yet recruiting,COVID-19,,,,,,,Other: Deep Venous Disease Diagnostic,Sociedad Espanola de Angiologia y Cirugia Vascular,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-01-04,31/08/20,2020-12-31,24/04/20,27/04/20,"Red de Investigacion Vascular (SEACV), Madrid",Spain,Respiratory Diseases,1,1,362.0
238.0,NCT04470648,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,,Recruiting,SARS-COV2 Infection,,,,,,,Diagnostic Test: blood test for SARS-COV2 serology,"Institut National de la Santé Et de la Recherche Médicale, France|Samusocial de Paris|Assistance Publique - Hôpitaux de Paris",All,"18 Years and older   (Adult, Older Adult)",183.0,Other,Observational,2020-07-22,01/08/21,2021-01-08,14/07/20,16/02/21,"Haltes pour femmes, Paris, France|LHSS Saint-Michel, Paris, France|LHSS Ridder-Plaisance, Paris",France,Respiratory Diseases,1,1,170.0
239.0,NCT04710381,IMUNOR® Preparation in the Prevention of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: IMUNOR,University Hospital Ostrava,All,18 Years to 60 Years   (Adult),100.0,Other,Interventional,2021-01-02,31/05/21,2021-06-30,14/01/21,14/01/21,"University Hospital Ostrava, Ostrava, Moravian-Silesian Region",Czechia,Respiratory Diseases,1,1,179.0
240.0,NCT04470258,Elmo Respiratory Support Project - COVID-19,,Recruiting,COVID-19,Respiratory Failure With Hypoxia,,,,,,Other: ELMO PROJECT AT COVID-19: STUDY IN HUMANS|Device: ELMO PROJECT AT COVID-19: PROOF OF CONCEPT AND USABILITY,Escola de Saúde Pública do Ceará,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-02-08,29/09/20,2020-01-12,14/07/20,27/11/20,"Hospital Leonardo Da Vinci, Fortaleza",Brazil,Respiratory Diseases,1,2,-27.0
241.0,NCT04355871,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,COVID19@Spain,Completed,COVID-19,,,,,,,,Fundacion SEIMC-GESIDA,All,"Child, Adult, Older Adult",4035.0,Other,Observational,2020-03-18,15/04/20,2020-04-17,21/04/20,11/05/20,"Comp. Hosp. Univ. A Coruña, A Coruña, Spain|H. Quiron A Coruña, A Coruña, Spain|H. de Alcaniz, Alcañiz, Spain|H. Gral Univ. de Alicante, Alicante, Spain|H. Univ. San Juan de Alicante, Alicante, Spain|H. Univ. de la Ribera, Alzira, Spain|H. Santos Reyes, Aranda De Duero, Spain|H. Dr. Jose Molina Orosa, Arrecife, Spain|Consorcio Sanitari Integral (CAIDM), Barcelona, Spain|H. Clinic, Barcelona, Spain|H. del Mar, Barcelona, Spain|H. Parc Sanitari Sant Joan de Deu, Barcelona, Spain|H. Santa Creu y Sant Pau, Barcelona, Spain|H. Univ. de Bellvitge, Barcelona, Spain|H. Vall d'Hebron, Barcelona, Spain|Hospital CIMA-Sanitas, Barcelona, Spain|SCIAS H. de Barcelona, Barcelona, Spain|H. Clinica de Benidorm, Benidorm, Spain|H. de Cruces, Bilbao, Spain|H. San Eloy_Barakaldo, Bilbao, Spain|H. Univ. de Basurto, Bilbao, Spain|H. Urduliz-Alfredo Espinosa, Bilbao, Spain|H. Gral de La Palma, Breña Alta, Spain|H. de Puerto Real, Cadiz, Spain|H. de Calahorra, Calahorra, Spain|H. Sant Jaume de Calella, Calella, Spain|H. Univ Santa Lucia, Cartagena, Spain|H. Univ de Henares, Coslada, Spain|Hospital Marina Salud de Dénia, Denia, Spain|Hospital Don Benito-Villanueva de la Serena, Don Benito, Spain|H. Gral Univ. de Elche, Elche, Spain|H. Univ. del Vinalopo, Elche, Spain|Comp. Hospt. Univ. de Ferrol, Ferrol, Spain|H. Francesc de Borja, Gandia, Spain|H. de Figueres, Gerona, Spain|H. Comarcal de Blanes, Girona, Spain|H. Josep Trueta, Girona, Spain|H. Clinico San Cecilio, Granada, Spain|Hospital HLA Inmaculada, Granada, Spain|H. de Guadalajara, Guadalajara, Spain|H. de Guadarrama, Guadarrama, Spain|H. Juan Ramón Jiménez, Huelva, Spain|H. Riotinto, Huelva, Spain|H. Can Misses, Ibiza, Spain|H. Universitario de Jaén, Jaén, Spain|H. Univ. de Jerez de la Frontera, Jerez De La Frontera, Spain|H. Univ Insular de Gran Canaria, Las Palmas De Gran Canaria, Spain|H. Universitario de Gran Canaria Dr. Negrin, Las Palmas De Gran Canaria, Spain|H. Univ. Severo Ochoa, Leganés, Spain|H. San Pedro, Logroño, Spain|H. Univ. Menez Rafael Mendez, Lorca, Spain|H. Lucus Augusti, Lugo, Spain|H. 12 de Octubre, Madrid, Spain|H. Clinica Univ. de Navarra_ Campus Madrid, Madrid, Spain|H. Clinico San Carlos, Madrid, Spain|H. Fundacion Jiménez Díaz, Madrid, Spain|H. Gral de la Defensa Gomez Ulla, Madrid, Spain|H. HLA Univ. Moncloa, Madrid, Spain|H. HM Sanchinarro, Madrid, Spain|H. Puerta de Hierro, Madrid, Spain|H. Univ HM Madrid, Madrid, Spain|H. Univ Principe de Asturias, Madrid, Spain|H. Univ. de Alcorcón, Madrid, Spain|H. Univ. de Getafe, Madrid, Spain|H. Univ. de Móstoles, Madrid, Spain|H. Univ. Gregorio Marañon, Madrid, Spain|H. Univ. HM Monteprincipe, Madrid, Spain|H. UNiv. HM Puerta del Sur, Madrid, Spain|H. Univ. Infanta Leonor, Madrid, Spain|H. Univ. La Paz, Madrid, Spain|H. Univ. La Princesa, Madrid, Spain|H. Univ. Ramón y Cajal, Madrid, Spain|H. Univ. Rey Juan Carlos, Madrid, Spain|H. Costa del Sol, Marbella, Spain|H. de Mataro, Mataró, Spain|H. de Melilla, Melilla, Spain|H. de Mendaro, Mendaro, Spain|Hospital Alto Deba, Mondragón, Spain|H. Virgen de la Arrixaca, Murcia, Spain|H. Marbella Internacional, Málaga, Spain|H. Virgen de la Victoria, Málaga, Spain|H. Vega Baja, Orihuela, Spain|H. Univ. Central de Asturias, Oviedo, Spain|H. de Palamos, Palamós, Spain|H. Son Espases, Palma De Mallorca, Spain|H. Son Llatzer, Palma De Mallorca, Spain|H. Clinica Univ. Navarra, Pamplona, Spain|H. Virgen del Puerto, Plasencia, Spain|H. El Bierzo, Ponferrada, Spain|H. Do Salnes, Pontevedra, Spain|H. UNiv. Los Arcos del Mar Menor, Pozo Aledo, Spain|H. Santa Barbara, Puertollano, Spain|H. Parc Tauli, Sabadell, Spain|Complejo Asist. Univ. de Salamanca, Salamanca, Spain|H. Infanta Sofia, San Sebastián De Los Reyes, Spain|H. de Donostia, San Sebastián, Spain|H. de l'Esperit Sant, Santa Coloma De Gramenet, Spain|H. Univ. Marques de Valdecilla, Santander, Spain|H. Clinico Univ. Santiago de Compostela, Santiago De Compostela, Spain|H. Univ de Valme, Sevilla, Spain|H. Univ. Virgen del Rocio, Sevilla, Spain|H. Univ. Virgen Macarena, Sevilla, Spain|H. Virgen Macarena, Sevilla, Spain|H. Univ Joan XXIII, Tarragona, Spain|H. U. de Canarias, Tenerife, Spain|H. Univ. Nuestra Sra. de la Candelaria, Tenerife, Spain|H. Mutua de Terrasa, Terrassa, Spain|Complejo Hospitalario Virgen de la Salud, Toledo, Spain|H. Univ. HM Torrelodones, Torrelodones, Spain|H. Quiron Salud Torrevieja, Torrevieja, Spain|H. Virgen de la Cinta, Tortosa, Spain|H. Reina Sofia de Tudela, Tudela, Spain|H. Arnau de Vilanova-Lliria, Valencia, Spain|H. Clinico Univ. de Valencia, Valencia, Spain|H. de Sagunto, Valencia, Spain|H. Univ. y Polit. La Fe, Valencia, Spain|H. Clin. Univ. de Valladolid, Valladolid, Spain|H. Rio Hortega, Valladolid, Spain|H. Alvaro Cunqueiro, Vigo, Spain|H. de Viladecans, Viladecans, Spain|H. de la Marina Baixa, Villajoyosa, Spain|Hospital de la Plana, Villareal, Spain|H. Univ de Alava, Vitoria, Spain|H. Virgen de la Concha, Zamora, Spain|H. Lozano Blesa, Zaragoza, Spain|H. Miguel Servet, Zaragoza, Spain|H. Ntra. Sra. de Gracia, Zaragoza, Spain|Complejo Asistencial de Avila, Ávila",Spain,Respiratory Diseases,1,1,30.0
242.0,NCT04705116,COVID-19 Vaccines International Pregnancy Exposure Registry,C-VIPER,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 vaccine,Pregistry|Harvard School of Public Health,Female,18 Years to 50 Years   (Adult),5000.0,Industry|Other,Observational,2021-01-04,31/12/25,2025-12-31,12/01/21,10/03/21,"Pregistry, Los Angeles, California",United States,Respiratory Diseases,1,1,1822.0
243.0,NCT04482673,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,VitD-COVID19,Recruiting,COVID-19,Vitamin D Deficiency,Respiratory Viral Infection,,,,,Drug: Daily Vitamin D3|Drug: Daily placebo|Drug: Bolus vitamin D3|Drug: Bolus placebo,Medical University of South Carolina|Grassroots Health Nutrition Institute|ZRT Laboratory,All,"50 Years and older   (Adult, Older Adult)",140.0,Other,Interventional,2020-07-31,31/12/21,2021-12-31,22/07/20,04/08/20,"Medical University of South Carolina, Charleston, South Carolina",United States,Respiratory Diseases,1,3,518.0
244.0,NCT04733807,Antibodies Response to mRNA Vaccine Against Covid-19,SABREVAC,Recruiting,COVID-19,,,,,,,Biological: BNT162b2 mRNA Covid-19 Vaccine,University of Roma La Sapienza|ICOT University Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",600.0,Other,Observational,2021-01-28,31/07/21,2022-01-02,02/02/21,17/02/21,"ICOT-Sapienza University Hospital, Latina, LT",Italy,Respiratory Diseases,1,1,339.0
245.0,NCT04336384,Impact of Covid-19 in Congenital Heart Disease,COVID-CHD,Completed,Congenital Heart Disease,COVID-19,,,,,,,"University Hospital, Montpellier|Pr. Jean-Benoît THAMBO, Bordeaux (président)|Dr. Céline GRUNENWALD GRONIER, Strasbourg|Dr. Sébastien HASCOET, Le Plessis-Robinson|Dr. Adeline BASQUIN, Rennes|Dr. Nicolas COMBES, Toulouse|Dr. Xavier IRIART, Bordeaux|Dr. Daniela LAUX, Paris|Dr. Magalie LADOUCEUR, Paris|Pr. BERTRAND LEOBON, Toulouse|Pr. Caroline OVAERT, Marseille|Dr. Karine WARIN-FRESSE, Nantes|Alexis BLANC, Montpellier|Pr. Roland HENAINE, Lyon|Hamouda ABASSI, Montpellier",All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-01-03,01/12/20,2020-12-30,07/04/20,02/02/21,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,362.0
246.0,NCT04470583,Evaluating Clinical Parameters of COVID-19 in Pregnancy,COpregVID,Recruiting,COVID-19,COVID-19,COVID-19,,,,,,Chelsea and Westminster NHS Foundation Trust,All,18 Years to 60 Years   (Adult),116.0,Other,Observational,2020-09-10,01/11/21,2021-02-12,14/07/20,12/10/20,"Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster Hospital, London",United Kingdom,Respiratory Diseases,1,3,155.0
247.0,NCT04465981,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,SARS-CoV-2,Recruiting,COVID-19,Corona Virus Infection,,,,,,Diagnostic Test: Sampling,INanoBio Inc.|TMC HealthCare,All,"18 Years and older   (Adult, Older Adult)",80.0,Industry|Other,Observational,2020-01-07,01/12/20,2021-01-06,10/07/20,27/07/20,"TMC HealthCare, Tucson, Arizona",United States,Respiratory Diseases,1,2,365.0
248.0,NCT04614012,Hyperimmune Plasma for Patients With COVID-19,IMMUNO-COVID19,Recruiting,COVID-19,,,,,,,Other: treated with hyperimmune plasma,ANNA FALANGA|A.O. Ospedale Papa Giovanni XXIII,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-02-07,02/07/22,2022-02-07,03/11/20,03/11/20,"Anna Falanga, Bergamo",Italy,Respiratory Diseases,1,1,731.0
249.0,NCT04526821,Lactoferrin for Prevention of COVID-19 in Health Care Workers,LF-COVID,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Bovine Lactoferrin|Dietary Supplement: Maltodextrin,Universidad Peruana Cayetano Heredia,All,18 Years to 59 Years   (Adult),336.0,Other,Interventional,2020-01-09,30/06/21,2021-01-11,26/08/20,02/09/20,"Hospital Nacional Arzobispo Loayza, Lima, Lim, Peru|Hospital Cayetano Heredia, Lima",Peru,Respiratory Diseases,1,1,368.0
250.0,NCT04430049,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",HAD-Covid,Recruiting,COVID-19,Family Members,Critical Illness,,,,,Procedure: Covid ICU containment measures,"University Hospital, Clermont-Ferrand",All,"18 Years and older   (Adult, Older Adult)",480.0,Other,Observational,2020-06-22,22/10/21,2023-01-22,12/06/20,01/02/21,"University hospital, Clermont-Ferrand, Clermont-Ferrand, Auvergne, France|CH Aurillac, Aurillac, France|CH Cannes, Cannes, France|Centre Jean Perrin, Clermont-Ferrand, France|CH Grenoble, Grenoble, France|CH Le Puy-en-Velay, Le Puy-en-Velay, France|University hopistal, Lyon, Lyon, France|CH Moulins, Moulins, France|CH Périgueux, Périgueux, France|CH Rodez, Rodez, France|CH Vichy, Vichy",France,"Cardiovascular Diseases, Respiratory Diseases",1,3,944.0
251.0,NCT04341441,Will Hydroxychloroquine Impede or Prevent COVID-19,WHIP COVID-19,Terminated,COVID-19,Coronavirus,Coronavirus Infections,SARS-CoV 2,,,,Drug: Hydroxychloroquine - Daily Dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Placebo oral tablet|Diagnostic Test: Monitoring Visit - Baseline|Diagnostic Test: Monitoring Visit - Week 4|Diagnostic Test: Monitoring Visit - Week 8|Other: Weekly Assessment,Henry Ford Health System,All,"18 Years to 75 Years   (Adult, Older Adult)",624.0,Other,Interventional,2020-07-04,15/12/20,2020-12-15,10/04/20,21/12/20,"Henry Ford Hospital, Detroit, Michigan, United States|Detroit Department of Transportation (DDOT), Detroit, Michigan, United States|Detroit Fire Department & Detroit EMS, Detroit, Michigan, United States|Detroit Police Department, Detroit, Michigan",United States,Respiratory Diseases,1,4,164.0
252.0,NCT04588363,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C,PRISM,Recruiting,COVID-19,Multisystem Inflammatory Syndrome in Children (MIS-C),COVID-19,,,,,Other: SARS-CoV-2 and/or MIS-C Exposure,National Institute of Allergy and Infectious Diseases (NIAID)|Autoimmunity Centers of Excellence|Clinical Trials in Organ Transplantation in Children,All,"up to 20 Years   (Child, Adult)",250.0,NIH|Other,Observational,2020-11-19,01/11/21,2022-01-11,19/10/20,09/04/21,"Loma Linda University Health, Loma Linda, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Johns Hopkins Children's Center, Baltimore, Maryland, United States|Mayo Clinic Rochester, Rochester, Minnesota, United States|St. Louis Children's Hospital, Saint Louis, Missouri, United States|Children's Hospital at Montefiore, Bronx, New York, United States|NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|NewYork-Presbyterian Queens Hospital, Flushing, New York, United States|Cohen Children's Medical Center - Northwell Health, New Hyde Park, New York, United States|Hassenfeld Children's Hospital at NYU Langone, New York, New York, United States|NewYork-Presbyterian Komansky Children's Hospital, New York, New York, United States|Mount Sinai Kravis Children's Hospital, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Duke University Children's Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Pediatric Rheumatology, Charleston, South Carolina, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Eccles Primary Children's: University of Utah Health, Salt Lake City, Utah",United States,Respiratory Diseases,1,3,418.0
253.0,NCT04376879,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),,Recruiting,COVID-19,,,,,,,Other: Data monitoring for 48h within the first 24 hours of admission for COVID-19,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",384.0,Other,Observational,2020-05-16,01/05/22,2022-01-05,06/05/20,20/01/21,"Louis Mourier hospital (AP-HP), Colombes, France|Brabois Hospital (CHRU de Nancy), Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,1,599.0
254.0,NCT04358536,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,,Completed,COVID-19,,,,,,,Device: CovX,Dascena,All,"18 Years and older   (Adult, Older Adult)",230.0,Industry,Observational,2020-01-04,17/04/20,2020-04-17,24/04/20,24/04/20,"Dascena, Oakland, California",United States,Respiratory Diseases,1,1,104.0
255.0,NCT04564716,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",,"Active, not recruiting",COVID-19,,,,,,,Biological: Gam-COVID-Vac|Other: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|RDIF (Russian Direct Investment Fund)|CRO: iPharma",All,18 Years to 60 Years   (Adult),100.0,Other,Interventional,2020-09-28,28/03/21,2021-10-04,25/09/20,02/12/20,"Health Institution 14th Central Regional Polyclinic of the Partisan district of Minsk, Minsk, Belarus|Health Institution 19th Central Regional Polyclinic of the Pervomaysk district of Minsk, Minsk, Belarus|Health Institution 1st Central Regional Clinical Polyclinic of the Central district of Minsk, Minsk, Belarus|Health Institution 28th Regional Polyclinic of Minsk, Minsk, Belarus|Health Institution 4th City Polyclinic of Minsk, Minsk, Belarus|Health Institution 5th City Clinical Polyclinic of Minsk, Minsk, Belarus|Health Institution Minsk Order of the Red Banner of Labor Regional Clinical Hospital, Minsk, Belarus|Health Institution Vitebsk Regional Clinical Hospital, Vitebsk",Belarus,Respiratory Diseases,1,1,371.0
256.0,NCT04533360,Prevalence of COVID-19 Antibodies Kingman AZ,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: VITROS Anti-SARS-CoV-2 IgG test,Kingman Regional Medical Center,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-09-28,09/10/20,2021-01-05,31/08/20,17/02/21,"Kingman Regional Medical Center, Kingman, Arizona",United States,Respiratory Diseases,1,1,99.0
257.0,NCT04832919,A Nurse-Community Health Worker-Family Partnership Model: Addressing Uptake of COVID-19 Testing and Control Measures,,Not yet recruiting,COVID-19,,,,,,,Behavioral: Nurse-Community-Family Partnership Intervention,New York University,All,"10 Years and older   (Child, Adult, Older Adult)",810.0,Other,Interventional,2021-01-04,01/05/22,2022-01-05,06/04/21,06/04/21,,,Respiratory Diseases,1,1,366.0
258.0,NCT04685447,Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients,,Recruiting,COVID-19,Hemodialysis Complication,Inflammatory Response,,,,,Procedure: Expanded Hemodialysis for Covid19 maintenance hemodialysis patients|Procedure: Hemodialysis by protein-leaking dialyzer for Covid19 maintenance hemodialysis patients,"Universita degli Studi di Genova|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-03-16,20/04/20,2021-01-12,28/12/20,13/04/21,"Ospedale IRCCS San Martino, Genova, Italy|Policlinico IRCCS Ospedale San Matteo, Pavia",Italy,Respiratory Diseases,1,3,302.0
259.0,NCT04716907,Thymic Function in Patients With COVID-19,COVITHYM,Recruiting,COVID-19,,,,,,,Genetic: Single-Nucleotide Polymorphisms (SNP) within the TCRA/D region|Biological: Blood sample|Diagnostic Test: CT Scan,CMC Ambroise Paré,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Observational,2021-03-19,19/03/23,2023-03-19,20/01/21,24/03/21,"CMC Ambroise Paré, Neuilly-sur-Seine",France,Respiratory Diseases,1,1,730.0
260.0,NCT04816084,SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes,SERUR,Completed,COVID-19,,,,,,,Diagnostic Test: Anti-SARS-CoV2 Serology,Université de Reims Champagne-Ardenne,All,"18 Years and older   (Adult, Older Adult)",389.0,Other,Interventional,2020-05-11,01/12/20,2021-03-15,25/03/21,25/03/21,"Université de Reims Champagne-Ardenne, Reims",France,Respiratory Diseases,1,1,308.0
261.0,NCT04613297,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,HLA-G-COVID,Recruiting,COVID-19,,,,,,,Other: Baseline and during hospitalization blood samples|Other: Baseline blood sample,Hopital Foch,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-10-19,01/10/21,2021-01-10,03/11/20,03/11/20,"Foch hospital, Suresnes",France,Respiratory Diseases,1,1,83.0
262.0,NCT04483908,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,SEROBL-COVID19,Recruiting,COVID-19,,,,,,,Diagnostic Test: blood draw|Diagnostic Test: fingertip tests for POC assays|Diagnostic Test: saliva collection|Diagnostic Test: collection of swabs,"University Hospital, Basel, Switzerland|ETH Zurich (Switzerland)|Department of Health, Canton Basel-Land",All,"18 Years and older   (Adult, Older Adult)",550.0,Other,Observational,2020-10-04,30/05/22,2022-05-30,23/07/20,23/07/20,"Department of Health, Economics and Health Directorate Canton Basel-Land, Liestal",Switzerland,Respiratory Diseases,1,1,603.0
263.0,NCT04789356,Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity,COVACMANAUS,Recruiting,COVID-19,,,,,,,Biological: Adsorbed SARS-CoV-2 (inactivated) vaccine,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado|Butantan Institute,All,18 Years to 49 Years   (Adult),10156.0,Other,Interventional,2021-03-18,01/06/21,2022-01-03,09/03/21,22/03/21,"Escola Normal Superior - Universidade do Estado do Amazonas, Manaus, Amazonas",Brazil,Respiratory Diseases,1,1,291.0
264.0,NCT04459390,Association of Comorbidities With COVID19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: realtime PCR,Assiut University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-07-20,20/10/20,2020-11-20,07/07/20,06/08/20,"Faculty of Medicine, Assiut",Egypt,Respiratory Diseases,1,1,123.0
265.0,NCT04406090,Endovascular Thrombectomy in COVID-19 Infected Patients,ET-COVID-19,Completed,Ischemic Stroke,COVID-19,,,,,,Other: Mechanical Trombectomy,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-04,30/06/20,2020-06-30,28/05/20,29/07/20,"Uhmontpellier, Montpellier",France,"Cardiovascular Diseases, Respiratory Diseases",1,2,178.0
266.0,NCT04387838,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,SEROSARSCOV,Completed,Sars-CoV2,,,,,,,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,Direction Centrale du Service de Santé des Armées,All,18 Years to 62 Years   (Adult),845.0,Other,Observational,2020-05-14,15/08/20,2020-08-15,14/05/20,09/03/21,"Hôpital d'Instuction des Armées Sainte-Anne, Toulon, France|Hôpital d'Instruction des Armées Robert Picqué, Villenave-d'Ornon",France,Respiratory Diseases,1,1,93.0
267.0,NCT04685603,Dendritic Cell Vaccine to Prevent COVID-19,,Recruiting,COVID-19,,,,,,,Biological: AV-COVID-19,"Indonesia-MoH|Aivita Biomedical, Inc.|PT AIVITA Biomedika Indonesia|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia|RSUP Dr. Kariadi Semarang, indonesia|Faculty of Medicine University of Diponegoro, Indonesia",All,"18 Years and older   (Adult, Older Adult)",27.0,Other|Industry,Interventional,2020-07-12,31/01/21,2022-01-31,28/12/20,29/12/20,"Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah",Indonesia,Respiratory Diseases,1,1,568.0
268.0,NCT04411602,Intermediate IND Severe Illness COVID-19 CP,,Recruiting,Severe Acute Respiratory Syndrome,COVID-19,,,,,,Drug: SARS-CoV-2 plasma,Ascension South East Michigan,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-07-04,03/05/21,2021-01-11,02/06/20,02/03/21,"Ascension Providence Hospital, Novi Campus, Novi, Michigan, United States|Ascension Providence Hospital, Southfield Campus, Southfield, Michigan, United States|Ascension Macomb-Oakland Hospital, Warren Campus, Warren, Michigan",United States,Respiratory Diseases,1,2,191.0
269.0,NCT04695678,Epidemiological Multicohort Study of Latent COVID-19 Infections,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: COVID-19 nasal/pharyngeal swab,Wissenschaftliches Institut Bethanien e.V,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-01-07,31/01/21,2021-06-30,05/01/21,05/01/21,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen",Germany,Respiratory Diseases,1,1,540.0
270.0,NCT04709744,Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Drug: Vitamin D|Diagnostic Test: ELISA,Mansoura University,All,"18 Years to 80 Years   (Adult, Older Adult)",38.0,Other,Observational,2020-01-04,25/12/20,2020-12-30,14/01/21,15/01/21,"Mansoura University Hospital, Mansoura, DK",Egypt,Respiratory Diseases,1,1,361.0
271.0,NCT04712344,Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO),IPCO,Recruiting,COVID-19,,,,,,,Biological: COVID-19 convalescent plasma,University of Erlangen-Nürnberg Medical School,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Interventional,2021-01-18,01/09/21,2021-01-09,15/01/21,20/01/21,"University Hospital Erlangen, Erlangen",Germany,Respiratory Diseases,1,1,-9.0
272.0,NCT04456595,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,PROFISCOV,"Active, not recruiting",COVID-19,,,,,,,Biological: Adsorbed COVID-19 (inactivated) Vaccine|Biological: Placebo,"Butantan Institute|Sinovac Life Sciences Co., Ltd.",All,"18 Years and older   (Adult, Older Adult)",12688.0,Other,Interventional,2020-07-21,17/12/20,2022-01-02,02/07/20,11/02/21,"Universidade de Brasília, Brasilia, DF, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil|Hospital Universitário Júlio Müller, Cuiabá, Mount, Brazil|Hospital Universitário Maria Aparecida Pedrossian, Campo Grande, MS, Brazil|Hospital das Clínicas da Universidade Federal do Paraná, Curitiba, PR, Brazil|Hospital Escola da Universidade Federal de Pelotas, Pelotas, RS, Brazil|Hospital São Lucas da Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, RS, Brazil|Hospital de Amor - Fundação Pio XII, Barretos, SP, Brazil|Hospital das Clínicas da UNICAMP, Campinas, SP, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirao Preto, SP, Brazil|Instituto de Infectologia Emílio Ribas, Sao Paulo, SP, Brazil|Centro de Pesquisas Clínicas do Instituto Central do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, SP, Brazil|Instituto Israelita de Ensino e Pesquisa Albert Einstein, Sao Paulo, SP, Brazil|Universidade Municipal de São Caetano do Sul, São Caetano do Sul, SP, Brazil|Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil|Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro",Brazil,Respiratory Diseases,1,1,530.0
273.0,NCT04799600,The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU,,Recruiting,COVID-19,Acute Renal Failure,,,,,,Other: BRESCİA-COVİD Respiratory Severity Scale,Ankara City Hospital Bilkent,All,"Child, Adult, Older Adult",158.0,Other,Observational,2020-01-09,15/06/21,2021-01-07,16/03/21,16/03/21,"Ankara City Hospital, Ankara",Turkey,Respiratory Diseases,1,2,364.0
274.0,NCT04763395,Liver Function Test Abnormalities in COVID-19,COVID-19,Recruiting,Liver Function Tests Abnormalities,,,,,,,Other: No intervention,Sohag University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2021-01-29,20/02/21,2021-01-03,21/02/21,21/02/21,"Mona Mohammed Abdelrhman, Sohag",Egypt,Others,0,1,-26.0
275.0,NCT04768257,Physical Activity Post COVID-19,PA-COVID19,Not yet recruiting,COVID-19,,,,,,,Behavioral: Physical activity,University of Alcala|Professional College of Physiotherapists of the Community of Madrid (CPFCM)|University Hospital of Guadalajara (HUGU),All,"18 Years and older   (Adult, Older Adult)",195.0,Other,Observational,2021-01-04,01/07/22,2022-01-12,24/02/21,24/02/21,,,Respiratory Diseases,1,1,373.0
276.0,NCT04842305,Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Blood- and saliva tests,Lenanrt Friis-Hansen|University Hospital Bispebjerg and Frederiksberg,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-01-04,01/05/21,2024-03-15,13/04/21,13/04/21,,,Respiratory Diseases,1,1,1166.0
277.0,NCT04427878,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,TA/SARS-Cov2,Not yet recruiting,COVID-19,,,,,,,Procedure: biopsies of subcutaneous adipose tissue,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-01-07,09/07/20,2021-09-07,11/06/20,11/06/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,609.0
278.0,NCT04590378,Pulmonary Embolism and COVID-19,COVID-19-PE,Recruiting,COVID-19,Pulmonary Embolism,,,,,,Other: intensive care unit admission ratio,Uşak University,All,"18 Years to 80 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-01-03,01/11/20,2020-01-12,19/10/20,19/10/20,"Uşak University, Usak",Turkey,Respiratory Diseases,1,2,9.0
279.0,NCT04832932,The COVID-19 Back-to-Normal Study,,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 vaccine,"Mebo Research, Inc.|Aurametrix",All,"16 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2021-01-05,15/05/22,2022-12-31,06/04/21,13/04/21,"MEBO Research, Inc, Miami, Florida, United States|Kahite, Vonore, Tennessee, United States|Mary Washington Hospital Research, Fredericksburg, Virginia, United States|Mebo Research (Uk), London, England",United Kingdom,Respiratory Diseases,1,1,725.0
280.0,NCT04655625,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),,"Active, not recruiting",COVID-19,,,,,,,Biological: Group A (AG0302-COVID19)|Biological: Group A (Placebo)|Biological: Group B (AG0302-COVID19)|Biological: Group B (Placebo),"AnGes, Inc.|Japan Agency for Medical Research and Development",All,"18 Years and older   (Adult, Older Adult)",500.0,Industry|Other,Interventional,2020-11-23,02/04/21,2022-03-31,07/12/20,08/04/21,"UHW Narita Hospital, Narita, Chiba, Japan|Medical Corporation Heishinkai OCROM Clinic, Suita, Osaka, Japan|Medical Corporation Tsurukamekai Shinjuku Tsurukame C linic, Shibuya-ku, Tokyo, Japan|Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku, Tokyo, Japan|Medical Corporation Shinanokai Shinanozaka Clinic, Shinjuku-ku, Tokyo, Japan|Sekino Clinical Pharmacology Clinic, Toshima-ku, Tokyo, Japan|NISHI-UMEDA Clinic for Asian Medical Collaboration, Osaka, Japan|Medical Corporation Heishinkai OPHAC Hospital, Osaka",Japan,Respiratory Diseases,1,1,493.0
281.0,NCT04468256,The Heart Hive COVID-19 Study,,Recruiting,COVID-19,Cardiomyopathies,,,,,,Other: COVID-19 experience surveys,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-07-26,01/07/22,2022-01-07,13/07/20,02/09/20,"Imperial College London, London",United Kingdom,Respiratory Diseases,1,2,530.0
282.0,NCT04542395,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,,Not yet recruiting,Coronavirus,,,,,,,Behavioral: Increasing Willingness and Uptake of COVID-19 Testing and Vaccination,Charles Drew University of Medicine and Science,All,"18 Years and older   (Adult, Older Adult)",310.0,Other,Interventional,2021-01-06,30/11/22,2022-11-30,09/09/20,04/02/21,,,Respiratory Diseases,1,1,693.0
283.0,NCT04399681,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Device: Bedside lung ultrasound,Kanuni Sultan Suleyman Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-05,10/08/20,2020-10-09,22/05/20,22/05/20,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,4.0
284.0,NCT04382781,Immunosupressive Treatment in COVID-19 Patients,SAM-COVID,Recruiting,COVID-19,,,,,,,Drug: NO-Immunosuppressive|Drug: Immunosuppressive|Drug: Immunoglubulins,Spanish Network for Research in Infectious Diseases|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-05,01/05/20,2020-01-05,11/05/20,12/05/20,"Hospital Virgen Macarena, Sevilla",Spain,Respiratory Diseases,1,1,0.0
285.0,NCT04428021,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,PLACO-COVID,"Active, not recruiting",COVID-19,,,,,,,Drug: Standard Therapy Protocol (STP)|Other: STP + Standard Plasma (SP)|Other: STP + COVID-19 Convalescent Plasma (CP),Azienda Ospedaliera Città della Salute e della Scienza di Torino,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-06-15,31/03/21,2021-10-31,11/06/20,06/04/21,"AO Città della salute e della scienza di Torino, Torino",Italy,Respiratory Diseases,1,1,503.0
286.0,NCT04482023,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,WWCOVID-19,Recruiting,COVID-19,,,,,,,"Behavioral: Training video on anxiety, fear and loneliness in the COVID-19 environment.",Corporacion Parc Tauli,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-03-23,30/04/21,2021-04-30,22/07/20,24/03/21,"Montserrat Montaña, Sabadell, Barcelona",Spain,Respiratory Diseases,1,1,38.0
287.0,NCT04397757,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 Convalescent Plasma,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-05-13,05/02/21,2021-05-30,21/05/20,12/04/21,"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,382.0
288.0,NCT04519502,Maternal Morbidity and Mortality During the COVID-19 Pandemic,MFMU COVID-19,Recruiting,COVID-19,Pregnancy Complications,,,,,,,The George Washington University Biostatistics Center|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),Female,"Child, Adult, Older Adult",26400.0,Other|NIH,Observational,2020-06-23,31/03/21,2021-12-31,19/08/20,21/08/20,"University of Alabama - Birmingham, Birmingham, Alabama, United States|Northwestern University, Chicago, Illinois, United States|Columbia University-St. Luke's Hospital, New York, New York, United States|University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States|Case Western Reserve University, Cleveland, Ohio, United States|Ohio State University, Columbus, Ohio, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Magee Women's Hospital, Pittsburgh, Pennsylvania, United States|Brown Univeristy, Providence, Rhode Island, United States|University of Texas Medical Branch, Galveston, Texas, United States|University of Texas - Houston, Houston, Texas, United States|University of Utah Medical Center, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,556.0
289.0,NCT04836351,Rehabilitation for Patients With Persistent Symptoms Post COVID-19,,Recruiting,COVID-19,,,,,,,Other: Concentrated rehabilitation for patients with persistent symptoms post COVID-19,Western Norway University of Applied Sciences|Helse-Bergen HF,All,"18 Years to 67 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-03,30/12/23,2023-12-30,08/04/21,08/04/21,"Helse i Hardanger, Øystese, Kvam Herad",Norway,Respiratory Diseases,1,1,1091.0
290.0,NCT04381858,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Drug: Plasma from COVID-19 convalescent patient|Drug: Human immunoglobulin,Centenario Hospital Miguel Hidalgo,All,"16 Years to 90 Years   (Child, Adult, Older Adult)",196.0,Other,Interventional,2020-06-05,26/11/20,2020-11-26,11/05/20,30/11/20,"Centenario Hospital Miguel Hidalgo, Aguascalientes",Mexico,Respiratory Diseases,1,1,174.0
291.0,NCT04543006,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,PANCOLIN,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: serology,"University Hospital, Grenoble",All,"18 Years and older   (Adult, Older Adult)",170.0,Other,Interventional,2020-08-09,30/09/21,2021-12-31,09/09/20,16/09/20,,,Respiratory Diseases,1,1,509.0
292.0,NCT04530370,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,,Recruiting,COVID-19,,,,,,,Biological: recovered covid 19 patients plasma,South Valley University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-05-29,01/09/20,2020-01-09,28/08/20,28/08/20,"South Valley University, Qinā",Egypt,Respiratory Diseases,1,1,-141.0
293.0,NCT04627519,Effectiveness and Safety of Rhea Health Tone® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,RHEA-COVID19,Recruiting,COVID-19,,,,,,,Dietary Supplement: Rhea Health Tone®,Universitas Padjadjaran|PT. Rhea Pharmaceutical Sciences Indonesia|Prodia Diacro Laboratories P.T.,All,18 Years to 50 Years   (Adult),85.0,Other|Industry,Interventional,2020-09-12,31/01/21,2021-03-15,13/11/20,09/02/21,"Rumah Sakit Darurat Penanganan Covid-19 Wisma Atlet Kemayoran (RSDCWA), Jakarta, DKI Jakarta, Indonesia|Dr. Hasan Sadikin Central General Hospital, Bandung, West Java",Indonesia,Respiratory Diseases,1,1,184.0
294.0,NCT04422535,Effects on the Qt Interval of COVID-19 Coronavirus Infection,QT-COVID-19,Recruiting,Coronavirus Infection,Intensive Care Patients,,,,,,,Matilde Zaballos|Hospital General Universitario Gregorio Marañon,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-05-29,01/09/20,2020-01-12,09/06/20,09/06/20,"Servicio de Anestesia, Hospital General Universitario Gregorio Marañon, Madrid",Spain,Respiratory Diseases,1,2,-138.0
295.0,NCT04331899,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,COVID-Lambda,"Active, not recruiting",COVID-19,,,,,,,Drug: Peginterferon Lambda-1a|Other: Placebo,Stanford University,All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-24,14/08/20,2021-01-05,02/04/20,28/09/20,"Stanford University School of Medicine, Stanford, California",United States,Respiratory Diseases,1,1,256.0
296.0,NCT04358835,Keto-diet for Intubated Critical Care COVID-19,KICC-COVID19,Withdrawn,COVID-19,,,,,,,Dietary Supplement: Ketogenic diet|Other: standard of care,Johns Hopkins University,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-09,01/09/21,2021-12-31,24/04/20,25/08/20,,,Respiratory Diseases,1,1,722.0
297.0,NCT04459637,COVID-19 Surveillance Based on Smart Wearable Device,COVID-19SWD,Not yet recruiting,COVID-19,,,,,,,,Peking University First Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-01-07,10/03/21,2021-10-03,07/07/20,07/07/20,"Peking University First Hospital, Beijing, Beijing",China,Respiratory Diseases,1,1,635.0
298.0,NCT04402853,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,,Completed,Sars-CoV2,Tear,,,,,,Diagnostic Test: Tears swab,Università degli Studi dell'Insubria,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-02,01/03/20,2020-05-20,27/05/20,03/12/20,"ASST Sette Laghi, Varese",Italy,Respiratory Diseases,1,2,139.0
299.0,NCT04590365,Iota-carrageenan Nasal Spray COVID-19 Prophylaxis for Healthcare Professionals,ICE-COVID,Not yet recruiting,COVID-19,SARS-CoV 2,,,,,,Device: Carrageenan nasal and throat spray|Device: Saline nasal and throat spray,Swansea University|Cardiff University|Marinomed Biotech AG|Walgreens Boots Alliance|Abertawe Bro Morgannwg University Health Board,All,"18 Years and older   (Adult, Older Adult)",480.0,Other|Industry,Interventional,2021-01-30,01/11/21,2021-01-12,19/10/20,28/01/21,,,Respiratory Diseases,1,2,-18.0
300.0,NCT04459962,Covid-19 Breath Test,,Completed,COVID-19,,,,,,,Diagnostic Test: Breath Test & Cheek Swab,Ancon Technologies Ltd,All,"16 Years and older   (Child, Adult, Older Adult)",330.0,Industry,Interventional,2020-06-29,07/01/21,2021-07-01,07/07/20,29/01/21,"Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, Surrey",United Kingdom,Respiratory Diseases,1,1,367.0
301.0,NCT04398264,Characteristics of COVID-19 Infection Among PREGnant Women,CCOVID-PREG,Recruiting,Corona Virus Infection,Pregnancy Related,,,,,,Other: COVID-19 positive via testing,Inova Health System,Female,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-07-22,31/03/21,2021-03-31,21/05/20,10/02/21,"INOVA Health System, Falls Church, Virginia",United States,Respiratory Diseases,1,2,252.0
302.0,NCT04401072,Attitude of Egyptian Population Toward COVID 19 in Ramadan,,Recruiting,COVID-19,,,,,,,,Damanhour University,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-04-24,22/05/20,2020-01-10,26/05/20,26/05/20,"Damanhour University, Damanhūr, Beheira",Egypt,Respiratory Diseases,1,1,-105.0
303.0,NCT04560881,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",,"Active, not recruiting",COVID-19,,,,,,,Biological: Inactivated SARS-CoV-2 vaccine (Vero cell)|Biological: Placebo/Aluminum Adjuvant of Inactivated SARS-CoV-2 vaccine,Laboratorio Elea Phoenix S.A.|Beijing Institute of Biological Products Co Ltd.|China National Biotec Group Company Limited|Fundación Huésped,All,"18 Years to 85 Years   (Adult, Older Adult)",3000.0,Industry|Other,Interventional,2020-09-16,01/12/21,2021-01-12,23/09/20,27/11/20,"Fundación Huésped, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Liniers, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Cañitas, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Vacunar Coghlan, Ciudad Autónoma de Buenos Aires, Buenos Aires",Argentina,Respiratory Diseases,1,1,118.0
304.0,NCT04465656,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,COVID-EP,Recruiting,Pulmonary Embolism,,,,,,,Diagnostic Test: Serology test for COVID-19,"Hospital St. Joseph, Marseille, France",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-07-07,31/10/20,2021-04-30,10/07/20,06/10/20,"Hôpital Saint Joseph Marseille, Marseille",France,Others,0,1,297.0
305.0,NCT04388436,Post Covid-19 Cardiopulmonary and Immunological Changes,covid-19,"Active, not recruiting",COVID-19,,,,,,,,Mansoura University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-11-05,10/07/21,2021-10-10,14/05/20,19/05/20,"Mansoura faculty of medicine, Mansoura, Dakahlia",Egypt,Respiratory Diseases,1,1,339.0
306.0,NCT04741386,The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study,RECOVAC-IR,"Active, not recruiting",COVID-19,Chronic Kidney Diseases,,,,,,Biological: SARS-CoV-2 vaccination,University Medical Center Groningen|Erasmus Medical Center|Radboud University|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),All,"18 Years and older   (Adult, Older Adult)",849.0,Other,Observational,2021-02-17,05/04/22,2022-12-31,05/02/21,25/03/21,"Radboud university medical center, Nijmegen, Gelderland, Netherlands|Amsterdam University Medical Center, Amsterdam, Noord-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Groningen, Groningen",Netherlands,Respiratory Diseases,1,2,682.0
307.0,NCT04331574,Renin-Angiotensin System Inhibitors and COVID-19,SARS-RAS,Recruiting,COVID-19,Hypertension,Cardiovascular Diseases,,,,,,Societa Italiana dell'Ipertensione Arteriosa,All,"18 Years to 120 Years   (Adult, Older Adult)",2000.0,Other,Observational,2020-10-03,10/04/20,2020-04-30,02/04/20,02/04/20,"Spedali Civili di Brescia, Brescia",Italy,"Cardiovascular Diseases, Respiratory Diseases",1,3,-156.0
308.0,NCT04508777,COVID SAFE: COVID-19 Screening Assessment for Exposure,COVID SAFE,Enrolling by invitation,COVID-19,,,,,,,Behavioral: Saliva-based testing,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-09-09,08/12/20,2021-01-07,11/08/20,09/04/21,"Penn Medicine, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,120.0
309.0,NCT04375761,COVID-19: Human Epidemiology and Response to SARS-CoV-2,HEROS,Completed,COVID-19,COVID-19,,,,,,Procedure: Collection of Biological Samples|Procedure: Symptom and Exposure Surveys,"National Institute of Allergy and Infectious Diseases (NIAID)|Rho Federal Systems Division, Inc.",All,"Child, Adult, Older Adult",5599.0,NIH|Industry,Observational,2020-01-05,24/01/21,2021-01-24,05/05/20,15/02/21,"Children's Hospital Colorado: Inner City Asthma Consortium (ICAC) Site, Aurora, Colorado, United States|Children's Hospital Colorado: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Aurora, Colorado, United States|Children's National Medical Center: Inner City Asthma Consortium (ICAC) Site, Washington, District of Columbia, United States|Ann & Robert H. Lurie Children's Hospital of Chicago: Food Allergy Outcomes Related to White and African American Racial Differences (FORWARD) and Improving Technology-Assisted Recording of Asthma Control in Children (iTRACC) Site, Chicago, Illinois, United States|Massachusetts General Hospital:Childhood Microbiome (CHIME) and Wheezing Index (WIND) Site, Boston, Massachusetts, United States|Boston Children's Hospital: School Inner-City Asthma Study (SICAS-2), Environmental Assessment of Sleep in Youth (EASY), Severe Asthma Research Program (SARP) and Preventing Asthma in High Risk Kids (PARK) Site, Boston, Massachusetts, United States|Boston Medical Center: Inner City Asthma Consortium (ICAC) Site, Boston, Massachusetts, United States|Henry Ford Health System: Childhood Allergy Study (CAS) Site, Detroit, Michigan, United States|Henry Ford Health System: Inner City Asthma Consortium (ICAC) Site, Detroit, Michigan, United States|Henry Ford Health System: Microbes, Asthma, Allergy and Pets (MAAP) and Wayne County Health, Environment, Allergy, and Asthma Longitudinal Study (WHEALS) Site, Detroit, Michigan, United States|St. Louis Children's Hospital: Inner City Asthma Consortium (ICAC) Site, Saint Louis, Missouri, United States|Columbia University Medical Center: Inner City Asthma Consortium (ICAC) Site, New York, New York, United States|Cincinnati Children's Hospital Medical Center: Greater Cincinnati Pediatric Clinic Repository (GCPCR) and Mechanisms of Progression of Atopic Dermatitis to Asthma in Children (MPAACH) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Inner City Asthma Consortium (ICAC) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages (OMEGA) Site, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center:Cincinnati Childhood Allergy & Air Pollution Study (CCAAPS) Site, Cincinnati, Ohio, United States|Vanderbilt University Medical Center: Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE) Site, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center: Inner City Asthma Consortium (ICAC) Site, Dallas, Texas, United States|University of Wisconsin Hospital and Clinics: Childhood Origins of Asthma (COAST) Site, Madison, Wisconsin, United States|University of Wisconsin Hospital and Clinics: Wisconsin Infant Study Cohort (WISC) Site, Madison, Wisconsin",United States,Respiratory Diseases,1,2,385.0
310.0,NCT04522830,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,BTL-TML-COVID,Completed,COVID-19,,,,,,,Drug: BTL-TML-COVID|Drug: Placebo,"Beech Tree Labs, Inc.|Norwich Clinical Research Associates Ltd.|Curavit Clinical Research",All,"40 Years and older   (Adult, Older Adult)",28.0,Industry|Other,Interventional,2020-07-30,28/02/21,2021-02-28,21/08/20,13/04/21,"Intermountain Clinical Reserach, Draper, Utah",United States,Respiratory Diseases,1,1,213.0
311.0,NCT04403828,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,,Completed,COVID-19,,,,,,,Other: Survey,Fayoum University,All,"18 Years to 75 Years   (Adult, Older Adult)",323.0,Other,Observational,2020-05-20,01/06/20,2020-07-15,27/05/20,22/07/20,"Faculty of Dentistry, Fayoum",Egypt,Respiratory Diseases,1,1,56.0
312.0,NCT04395170,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 convalescent plasma|Biological: Anti-COVID-19 human immunoglobulin|Drug: Standard (specific) therapy for COVID-19,"Lifefactors Zona Franca, SAS",All,"18 Years and older   (Adult, Older Adult)",75.0,Industry,Interventional,2020-01-09,01/12/20,2021-01-06,20/05/20,10/07/20,"LifeFactors Zona Franca SAS, Medellín, Antioquia",Colombia,Respiratory Diseases,1,1,363.0
313.0,NCT04473690,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,,Recruiting,COVID-19,,,,,,,Biological: Low Dose of KBP-COVID-19|Biological: High Dose of KBP-COVID-19|Biological: Placebo,"Kentucky BioProcessing, Inc.",All,"18 Years to 85 Years   (Adult, Older Adult)",180.0,Industry,Interventional,2020-12-30,06/05/21,2022-03-23,16/07/20,13/04/21,"Velocity Clinical Research, Meridian, Idaho, United States|PMG Research of Winston-Salem, Winston-Salem, North Carolina, United States|PanAmerican Clinical Research, Brownsville, Texas, United States|ICON, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas",United States,Respiratory Diseases,1,1,448.0
314.0,NCT04337320,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",,Completed,COVID-19,Maternal-Fetal Relations,,,,,,Other: newborns from covid 19 positive mothers,Kanuni Sultan Suleyman Training and Research Hospital|Seda Yilmaz Semerci,All,up to 15 Minutes   (Child),40.0,Other,Observational,2020-03-15,25/05/20,2020-05-30,07/04/20,11/06/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,Respiratory Diseases,1,2,76.0
315.0,NCT03348670,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),AP-TP-Bio,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair|Medicine Invention Design, Inc",All,"22 Years to 72 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-07-20,28/06/21,2021-06-28,21/11/17,24/02/21,"Medicine Invention Design, Inc. (MIDI) - c/o - MIDINC Clinical Investigator Working Site, North Bethesda, Maryland",United States,Respiratory Diseases,1,1,343.0
316.0,NCT04432948,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,,Recruiting,COVID-19,Maternal Psychological Distress,Anesthesia,,,,,Other: PHQ-9 Depression Scale|Other: GAD-7 General anxiety disorder scale|Other: 38-questions questionnaire,General and Maternity Hospital of Athens Elena Venizelou,Female,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-05-15,01/08/20,2020-01-12,16/06/20,16/06/20,"Elena Venizelou General and Maternity Hospital of Athens, Athens, Attica",Greece,Respiratory Diseases,1,3,-124.0
317.0,NCT04666116,Changes in Viral Load in COVID-19 After Probiotics,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Dietary supplementation in patients with covid disease admitted to hospital,Hospital de Sagunto|Biopolis S.L.|Laboratorios Heel España,All,"18 Years to 99 Years   (Adult, Older Adult)",96.0,Other|Industry,Interventional,2020-01-04,01/12/20,2021-01-02,14/12/20,16/12/20,"Hospital de Sagunto, Sagunto, Valencia, Spain|Hospital de Sagunto, Valencia",Spain,Respiratory Diseases,1,1,364.0
318.0,NCT04525716,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,,Recruiting,COVID-19,Surgery,,,,,,Other: COVID-19 infection status,Karolinska Institutet,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-01-03,31/08/20,2020-12-31,25/08/20,25/08/20,"Samtliga akutsjukhus i Region Stockholm, Stockholm",Sweden,Respiratory Diseases,1,2,363.0
319.0,NCT04625075,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),MEMORY-COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: Cardiac MRI|Diagnostic Test: Cardiac CT|Diagnostic Test: Electrocardiogram (ECG)|Diagnostic Test: Blood samples,University of Edinburgh,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-10-06,10/06/21,2022-10-06,12/11/20,12/11/20,"University of Edinburgh, Edinburgh, Scotland",United Kingdom,Respiratory Diseases,1,1,730.0
320.0,NCT04416139,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,COVID-19,Recruiting,COVID-19,,,,,,,Biological: Infusion IV of Mesenchymal Stem cells,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-05,30/04/21,2021-01-05,04/06/20,04/06/20,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City",Mexico,Respiratory Diseases,1,1,366.0
321.0,NCT04380532,Tableted COVID-19 Therapeutic Vaccine,COVID-19,"Active, not recruiting",COVID-19,,,,,,,Biological: V-SARS,Immunitor LLC|Immunitor Inc.,All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-05-15,15/05/21,2021-06-15,08/05/20,27/05/20,"Immunitor Inc, Vancouver, BC - British Columbia, Canada|Aldar Bourinbayar, Ulaanbaatar, BZD, 3-khoroo",Mongolia,Respiratory Diseases,1,1,396.0
322.0,NCT04653857,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,CADE,"Active, not recruiting",COVID-19,,,,,,,,"University Hospital, Montpellier|Clinique du Millenaire|CHU de Nîmes|CHU de Perpignan|ligue nationale de Basket|Rennes University Hospital",All,"10 Years to 50 Years   (Child, Adult)",250.0,Other,Observational,2020-01-04,30/04/20,2021-01-01,04/12/20,07/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,363.0
323.0,NCT04421625,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,PAPESCO-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: Diagnostic test for SARS-Cov2 for patients and health staff,Institut Cancerologie de l'Ouest,All,"18 Years and older   (Adult, Older Adult)",12000.0,Other,Interventional,2020-06-15,15/06/22,2022-06-15,09/06/20,07/08/20,"Institut de Cancerologie de l'Ouest, Angers",France,Respiratory Diseases,1,1,730.0
324.0,NCT04568811,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,,"Active, not recruiting",COVID-19,,,,,,,Biological: Adenovirus Type-5 Vectored COVID-19 Vaccine,Jiangsu Province Centers for Disease Control and Prevention,All,"Child, Adult, Older Adult",89.0,Other,Interventional,2020-09-26,25/10/20,2021-09-27,29/09/20,10/02/21,"A rehabilitation centre in Wuhan, Wuhan, Hubei",China,Respiratory Diseases,1,1,366.0
325.0,NCT04467047,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,COVID19,Not yet recruiting,COVID-19,Sars-CoV2,,,,,,Biological: Mesenchymal Stromal Cells infusion,Hospital de Clinicas de Porto Alegre,All,"Child, Adult, Older Adult",10.0,Other,Interventional,2020-07-25,30/10/20,2020-12-30,10/07/20,10/07/20,,,Respiratory Diseases,1,2,158.0
326.0,NCT04779138,Increasing Vaccine Uptake in Underresourced Public Housing Areas,,Not yet recruiting,Coronavirus,Vaccine Refusal,,,,,,Behavioral: Increasing Willingness and Uptake of COVID-19 Vaccination,Charles Drew University of Medicine and Science,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2021-11-09,31/10/23,2023-11-30,03/03/21,03/03/21,,,Respiratory Diseases,1,2,751.0
327.0,NCT04800133,Covid-19 Vaccination in Adolescents,COVA,Recruiting,COVID-19,,,,,,,Biological: Tozinameran|Biological: Oxford-AstraZeneca COVID-19 vaccine|Biological: CoronaVac,The University of Hong Kong,All,"11 Years to 100 Years   (Child, Adult, Older Adult)",900.0,Other,Interventional,2021-01-04,31/03/25,2025-03-31,16/03/21,12/04/21,"Queen Mary Hospital, Hong Kong, Hong Kong",China,Respiratory Diseases,1,1,1547.0
328.0,NCT04839315,COVID-19 Vaccination in Rheumatic Disease Patients,,Recruiting,Systemic Lupus Erythematosus,Sjogren's Syndrome,Inflammatory Myositis,Psoriatic Arthritis,Gout,Ankylosing Spondylitis,Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis),Biological: mRNA COVD19 vaccine,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-02-15,01/12/21,2021-01-12,09/04/21,09/04/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Immunological Disorders,1,7,-34.0
329.0,NCT04756830,A Study to Assess the Safety and Immunogenicity of the Coronavac Vaccine Against COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: Adsorbed COVID-19 (inactivated) Vaccine,D'Or Institute for Research and Education|Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Interventional,2021-01-02,01/07/21,2023-01-06,16/02/21,18/02/21,"Hospital Gloria D'Or - Hospitais Integrados da Gavea S/A, Rio De Janeiro, Brazil|D'Or Institute for Research and Education, Rio De Janeiro",Brazil,Respiratory Diseases,1,1,734.0
330.0,NCT04535791,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,COVID-19,Recruiting,COVID-19,Vitamin D,,,,,,Drug: Cholecalciferol,"Coordinación de Investigación en Salud, Mexico|Hospital Infantil de Mexico Federico Gomez",All,"18 Years to 70 Years   (Adult, Older Adult)",400.0,Other,Interventional,2020-07-15,01/05/21,2021-01-07,02/09/20,02/09/20,"Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal",Mexico,Respiratory Diseases,1,2,176.0
331.0,NCT04412382,Covid-19: Possible Role of Neutrophil Extracellular Traps,NETSINCOVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: NETosis markers,Azienda Ospedaliera Universitaria Integrata Verona,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-06,31/12/20,2021-12-31,02/06/20,08/07/20,"Univeristy of Verona, Verona",Italy,Respiratory Diseases,1,1,725.0
332.0,NCT04422379,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,,Not yet recruiting,COVID-19,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years to 75 Years   (Adult, Older Adult)",314.0,Other,Observational,2020-07-06,30/07/20,2020-08-30,09/06/20,09/06/20,"Max Super Speciality Hospital, Saket (A Unit Of Devki Devi Foundation), New Delhi, Dlelhi",India,Respiratory Diseases,1,1,55.0
333.0,NCT04586413,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),,Recruiting,COVID-19,,,,,,,Other: No intervention - quality of life measure,Medialis Ltd.,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Observational,2020-07-10,01/10/22,2025-01-10,14/10/20,19/11/20,"Medialis, Oxford",United Kingdom,Respiratory Diseases,1,1,1645.0
334.0,NCT04367142,Rapid Detection of COVID-19 by Portable and Connected Biosensor,COR-DIAL-1,Not yet recruiting,Sars-CoV2,,,,,,,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,"University Hospital, Lille",All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-09,01/11/20,2020-01-12,29/04/20,07/07/20,,,Respiratory Diseases,1,1,3.0
335.0,NCT04366960,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,X-Covid 19,Recruiting,COVID-19,,,,,,,Drug: Enoxaparin,Niguarda Hospital,All,"18 Years and older   (Adult, Older Adult)",2712.0,Other,Interventional,2020-05-14,01/08/21,2021-01-11,29/04/20,13/01/21,"Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano",Italy,Respiratory Diseases,1,1,242.0
336.0,NCT04359927,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,CV-COVID-19,Recruiting,Sars-CoV2,COVID-19,Cardiovascular Diseases,Cardiovascular Risk Factor,,,,,Hospital Clinic of Barcelona,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-04-20,31/08/21,2025-08-31,24/04/20,07/05/20,"Hospital Clínic of Barcelona, Barcelona, Catalonia",Spain,Respiratory Diseases,1,4,1959.0
337.0,NCT04348877,Plasma Rich Antibodies From Recovered Patients From COVID19,PRA-001,Not yet recruiting,COVID-19,,,,,,,Other: Antibody-Rich Plasma from COVID-19 recovered patients,Ain Shams University,All,"18 Years to 80 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-20,01/10/20,2020-01-12,16/04/20,20/04/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,-99.0
338.0,NCT04582344,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: CoronaVac|Biological: Placebo,Health Institutes of Turkey,All,18 Years to 59 Years   (Adult),13000.0,Other,Interventional,2020-09-14,15/02/21,2021-04-15,09/10/20,17/02/21,"T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey Region, Turkey|T.R. Ministry of Health Ankara Provincial Health Directorate Ankara Training and Research Hospital, Infectious Diseases, Ankara, Turkey Region, Turkey|Ankara University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Ankara, Turkey Region, Turkey|Çukurova University Faculty of Medicine, Department of Infectious Diseases, Adana, Turkey|Hacettepe University Faculty of Medicine Department of Infections Diseases and Clinical Microbiology, Ankara, Turkey|T.C Ministry of Health Ankara Provincial Health Directorate Health Sciences University Ankara Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey|Akdeniz University Faculty of Medicine, Department of Infectious Diseases, Antalya, Turkey|Bursa Uludağ University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa, Turkey|Dicle University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Diyarbakır, Turkey|Gaziantep University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Gaziantep, Turkey|Acıbadem Atakent Hospital, Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|Cerrahpaşa Faculty of Medicine, Department of Internal Medicine - Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|Istanbul Medipol University Faculty of Medicine, Department of Internal Medicine, Istanbul, Turkey|Istanbul University Istanbul Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey|T.R. Ministry of Health Istanbul Provincial Health Directorate Marmara Univesity Istanbul Pendik Education and Research Hospital, Istanbul, Turkey|T.R. Ministry of Health Istanbul Provincial Health Directorate Prof. Dr. Cemil Taşçıoğlu City Hospital, Infectious Diseases Clinic, Istanbul, Turkey|T.R. Ministry of Health Istanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey|University of Health Sciences İstanbul Ümraniye Training and Research Hospital, Istanbul, Turkey|Ege University Faculty of Medicine Hospital, Department of Infectious Diseasesaculty of Medicine Hospital, Department of Infectious Diseases, İzmir, Turkey|Republic Of Turkey Ministry Of Health Izmir Provincial Health Directorate Health Sciences University Dr Suat Seren Chest Diseases And Chest Surgery Training And Research Hospital, İzmir, Turkey|T.R. Ministry of Health İzmir Provincial Health Directorate İzmir Health Sciences University Tepecik Training and Research Hospital, Infectious Diseases, İzmir, Turkey|T.R. Ministry of Health Kayseri City Training and Research Hospital, Infectious Diseases and Clinical Microbiology Department, Kayseri, Turkey|Kocaeli University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Kocaeli, Turkey|Malatya İnönü University Faculty of Medicine, Department of Infectious Diseases, Malatya, Turkey|Karadeniz Technical University Medical Faculty Hospital, Department of Infectious Diseases and Clinical Microbiology, Trabzon",Turkey,Respiratory Diseases,1,1,213.0
339.0,NCT04376476,Host-pathogen Interactions During SARS-CoV-2 Infection,HPI-COVID-19,Recruiting,"Infection, Coronavirus",Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,Biological: Blood sample|Biological: Low or upper respiratory tract sample|Biological: Stool collection or fecal swab|Genetic: Blood sample for whole genome sequencing|Other: phone call,Hospices Civils de Lyon,All,"up to 70 Years   (Child, Adult, Older Adult)",450.0,Other,Interventional,2020-05-05,05/06/21,2021-05-06,06/05/20,08/05/20,"Groupement Hospitalier Nord-Daupine, Bourgoin-Jallieu, France|Hôpital femme-mère-enfant, Bron, France|Hôpital Louis Pradel, Bron, France|Hôpital Louis Mourier, Colombes, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Hopital de la Croix-Rousse, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital mère - enfant Nantes, Nantes, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital Nord de Saint Etienne, Saint-Priest-en-Jarez, France|Hôpital Nord-Ouest, Villefranche-sur-Saône, France|Centre Hospitalier D'Annecy-Genevois, Épagny",France,Respiratory Diseases,1,2,366.0
340.0,NCT04813497,Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Serology to determine SARS-CoV-2 infection,Grand Hôpital de Charleroi,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Interventional,2021-05-02,30/05/21,2021-12-31,24/03/21,24/03/21,"Grand Hôpital de Charleroi, Charleroi, Hainaut",Belgium,Respiratory Diseases,1,1,243.0
341.0,NCT04357028,Measles Vaccine in HCW,MV-COVID19,Suspended,COVID-19,,,,,,,Drug: Measles-Mumps-Rubella Vaccine|Drug: Placebos,Kasr El Aini Hospital,All,18 Years to 50 Years   (Adult),200.0,Other,Interventional,2020-07-13,31/12/20,2021-01-01,22/04/20,22/12/20,"Cairo University Hospital, Cairo",Egypt,Respiratory Diseases,1,1,172.0
342.0,NCT04833101,Study on Sequential Immunization of Recombinant COVID-19 Vaccine (Ad5 Vector) and RBD-based Protein Subunit Vaccine,,Recruiting,COVID-19,,,,,,,Biological: recombinant Ad5 vectored COVID-19 vaccine|Biological: RBD-based protein subunit vaccine (ZF2001) against COVID-19|Biological: trivalent split influenza vaccine,Jiangsu Province Centers for Disease Control and Prevention,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-07-04,15/06/21,2021-12-15,06/04/21,14/04/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,164.0
343.0,NCT04351802,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,COR-DLUS,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lung ultrasound,University Hospital Plymouth NHS Trust,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Observational,2020-11-05,20/01/21,2021-01-20,17/04/20,04/12/20,"Derriford Hospital, Plymouth, Devon",United Kingdom,Respiratory Diseases,1,1,76.0
344.0,NCT04775407,COVID-19 Serological Testing of Patients With a Mental Disorder From the Catchment Area of the Capital Region of Denmark,,Recruiting,COVID-19,Severe Mental Disorder,,,,,,Procedure: blood sampling,"Anders Fink-Jensen, MD, DMSci|Psychiatric Centre Rigshospitalet",All,"18 Years and older   (Adult, Older Adult)",1400.0,Other,Observational,2021-01-18,01/03/22,2022-01-09,01/03/21,03/03/21,"Psychiatric Centre Copenhagen, Copenhagen",Denmark,Respiratory Diseases,1,2,356.0
345.0,NCT04479319,Decision Support System Algorithm for COVID-19 Diagnosis,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Thorax CT,Ankara University|Presidency of Health Institute Turkey (TUSEB),All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-12-31,01/06/21,2021-01-10,21/07/20,20/01/21,"Ankara University Faculty of Medicine, Ankara",Turkey,Respiratory Diseases,1,1,10.0
346.0,NCT04664049,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,,Recruiting,COVID-19,COVID-19,,,,,,Dietary Supplement: NRICM101,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare",All,"Child, Adult, Older Adult",51000.0,Other,Observational,2020-12-23,31/12/22,2022-12-31,11/12/20,13/01/21,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei",Taiwan,Respiratory Diseases,1,2,738.0
347.0,NCT04631367,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,,Not yet recruiting,"Knowledge, Attitudes, Practice",COVID-19,,,,,,Behavioral: Kukaa Salama: mHealth intervention|Device: Face Mask + Soap,University of Toronto,All,"16 Years to 24 Years   (Child, Adult)",404.0,Other,Interventional,2021-01-02,20/05/21,2021-09-20,17/11/20,17/11/20,,,Respiratory Diseases,1,2,261.0
348.0,NCT04818892,Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease,,Recruiting,IBD,COVID-19,,,,,,Diagnostic Test: Serological Assay for SARS-CoV-2,"University of Wisconsin, Madison",All,"18 Years to 85 Years   (Adult, Older Adult)",210.0,Other,Observational,2021-01-04,01/10/21,2023-01-04,26/03/21,14/04/21,"University of Wisconsin, Madison, Wisconsin",United States,Respiratory Diseases,1,2,730.0
349.0,NCT04377646,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,COVID-Milit,Not yet recruiting,Sars-CoV2,COVID-19,,,,,,Drug: Hydroxychloroquine|Drug: Hydroxychloroquine (placebo)|Drug: Zinc|Drug: Zinc (Placebo),Military Hospital of Tunis|UR17DN02 : Autoimmune Diseases Research Unit|Dacima Consulting,All,"18 Years to 65 Years   (Adult, Older Adult)",660.0,Other,Interventional,2020-04-05,24/05/20,2020-07-31,06/05/20,06/05/20,"Military Hospital of Tunis, Tunis",Tunisia,Respiratory Diseases,1,2,117.0
350.0,NCT04401436,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood,,Recruiting,Corona Virus Disease 2019,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",350.0,NIH,Observational,2020-05-22,30/06/22,2022-06-30,26/05/20,19/03/21,"MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Others,0,1,769.0
351.0,NCT04624048,Exercise Influence on COVID-19,,Not yet recruiting,Infection Viral,Exercise,Coronavirus,Habits,,,,Diagnostic Test: COVID-19 survey,University of Salamanca,All,"17 Years to 85 Years   (Child, Adult, Older Adult)",30000.0,Other,Observational,2020-04-12,04/01/21,2021-04-04,10/11/20,12/11/20,,,Respiratory Diseases,1,4,357.0
352.0,NCT04570254,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,ANTIOX-COVID,"Active, not recruiting","Pneumonia, Viral",COVID-19,ARDS,Oxidative Stress,,,,Drug: Vitamin C|Drug: Vitamin E|Drug: Melatonin|Drug: N-acetyl cysteine|Drug: Pentoxifylline,Unidad Temporal COVID-19 en Centro Citibanamex|Instituto Nacional de Cardiologia Ignacio Chavez|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"Child, Adult, Older Adult",11.0,Other,Interventional,2020-08-19,15/10/20,2020-11-15,30/09/20,05/10/20,"Unidad Temporal COVID-19 en Centro Citibanamex, Mexico City",Mexico,"Mental Health, Respiratory Diseases",1,4,88.0
353.0,NCT04392414,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,,Completed,COVID-19,,,,,,,Biological: COVID-19 convalescent hyperimmune plasma|Biological: Non-convalescent fresh frozen plasma (Standard plasma),"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-05,10/07/20,2020-09-23,18/05/20,25/09/20,"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow",Russian Federation,Respiratory Diseases,1,1,262.0
354.0,NCT04361591,COVID-19 in Liver Transplant Recipients,COVID19-SETH,Recruiting,Liver Transplant; Complications,COVID-19,Respiratory Failure,,,,,Other: Observational only,Hospital Clinic of Barcelona|Sociedad Española de Trasplante Hepático,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-03,01/03/21,2021-01-03,24/04/20,24/04/20,"SETH-affiliated Liver Transplant Programs in Spain, Barcelona",Spain,Respiratory Diseases,1,3,366.0
355.0,NCT04797858,COVID-19 Self-Testing Through Rapid Network Distribution,C-STRAND,Not yet recruiting,COVID-19,,,,,,,Behavioral: COVID-19 self-test|Behavioral: COVID-19 test referral,University of Pennsylvania|Public Health Management Corporation,All,"18 Years and older   (Adult, Older Adult)",1048.0,Other,Interventional,2021-01-04,30/03/22,2022-10-31,15/03/21,15/03/21,,,Respiratory Diseases,1,1,665.0
356.0,NCT04403581,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",,Not yet recruiting,COVID-19,,,,,,,Other: Questionnaire,Ain Shams University,All,23 Years to 55 Years   (Adult),384.0,Other,Observational,2020-01-05,01/06/20,2020-01-06,27/05/20,27/05/20,,,Respiratory Diseases,1,1,1.0
357.0,NCT04454307,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Tramadol|Other: Standard care delivered in the isolation hospitals.,Tanta University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-07,01/08/20,2020-01-10,01/07/20,02/07/20,,,Respiratory Diseases,1,1,3.0
358.0,NCT04583995,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",,Recruiting,COVID-19,COVID-19,,,,,,Biological: SARS-CoV-2 rS/Matrix M1-Adjuvant|Other: Placebo|Biological: Licensed seasonal influenza vaccine,Novavax,All,"18 Years to 84 Years   (Adult, Older Adult)",15000.0,Industry,Interventional,2020-09-28,01/01/21,2022-01-14,12/10/20,17/11/20,"Belfast Health and Social Care Trust (BHSCT) (Site UK011), Belfast, Antrim, United Kingdom|Synexus Midlands Clinical Research Centre (Site UK024), Edgbaston, Birmingham, United Kingdom|The Royal Cornwall Hospitals NHS Trust (Site UK036), Truro, Cornwall, United Kingdom|Royal Devon and Exeter Hospital (Site UK013), Exeter, Devon, United Kingdom|Maidstone Hospital - Central Research and Development Office Above Breast Care Centre - 1st Floor (Site UK028), Maidstone, Kent, United Kingdom|Queen Elizabeth University Hospital (Site UK008), Glasgow, Lanarkshire, United Kingdom|Blackpool Teaching Hospitals (Site UK010), Blackpool, Lancashire, United Kingdom|Salford Hospital (Site UK030), Oldham, Lancashire, United Kingdom|Synexus Merseyside Clinical Research Centre (Site UK026), Waterloo, Liverpool, United Kingdom|Royal Free (Site UK012), Hampstead, London, United Kingdom|St. George's University Hospitals NHS Foundation Trust Clinical Research Facility (Site UK001), Tooting, London, United Kingdom|North Wales Clinical Research Centre (NWCRC) (Site UK027), Wrexham, North Wales, United Kingdom|Lakeside Healthcare, Lakeside Surgery (Site UK005), Corby, Northants, United Kingdom|Warneford Hospital (Site UK016), Oxford, Oxfordshire, United Kingdom|Aberdeen Royal Infirmary (Site UK007), Foresterhill, Aberdeen, United Kingdom|Bradford Teaching Hospitals NHS Trust (Site UK018), Bradford, United Kingdom|Synexus Wales Clinical Research Centre (Site UK025), Cardiff, United Kingdom|Synexus Lancashire Clinical Research Centre (Site UK022), Chorley, United Kingdom|Colchester Hospital (Site UK034), Colchester, United Kingdom|AES - Glasgow (Site UK033), Glasgow, United Kingdom|University Hartlepool Hospital (Site UK021), Hartlepool, United Kingdom|Synexus Hexham Clinical Research Centre (Site UK023), Hexham, United Kingdom|Royal Lancaster Infirmary (Site UK029), Lancaster, United Kingdom|Research & Innovation Centre, St. James's University Hospital (Site UK019), Leeds, United Kingdom|St. Thomas' Hospital (Site UK020), London, United Kingdom|Chelsea & Westminster NHS Foundation Trust (Site UK006), London, United Kingdom|AES - Synexus Manchester (Site UK032), Manchester, United Kingdom|Norfolk and Norwich University Hospital NHS Foundation Trust, Norfolk and Norwich University Hospital (Site UK015), Norwich, United Kingdom|Wansford and Kingscliffe Practice (Site UK035), Peterborough, United Kingdom|AES - Synexus Thames Valley (Site UK031), Reading, United Kingdom|University Hospital Southampton NHS Foundation Trust (UHS) (Site UK014), Southampton, United Kingdom|Midlands Partnership NHS Foundation Trust Headquarters (Site UK017), Stafford, United Kingdom|Stockport NHS Foundation Trust (Site UK009), Stockport",United Kingdom,Respiratory Diseases,1,2,473.0
359.0,NCT04818281,Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults,COVID-19,Recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 VLP Vaccine|Biological: Placebo,"Ihsan GURSEL, PhD, Prof.|Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital|The Scientific and Technological Research Council of Turkey|MonitorCRO|Nobel Pharmaceuticals",All,18 Years to 59 Years   (Adult),36.0,Other|Industry,Interventional,2021-03-27,01/01/22,2022-01-03,26/03/21,08/04/21,"Dr. Abdurahman Yurtaslan Ankara Oncology Training and Research Hospital Phase I Clinical Study Center, Ankara",Turkey,Respiratory Diseases,1,1,282.0
360.0,NCT04642014,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,EPIC-19,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 convalescent plasma treatment,Wroclaw Medical University|Medical Research Agency,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-01-12,21/02/22,2022-01-05,24/11/20,24/11/20,"Wroclaw Medical University, Wroclaw, Dolnośląskie",Poland,Respiratory Diseases,1,1,724.0
361.0,NCT04656691,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,UNITED,"Active, not recruiting",COVID-19,,,,,,,Drug: bamlanivimab,"Daniel Griffin|Eli Lilly and Company|Optum, Inc.|UnitedHealth Group",All,65 Years and older   (Older Adult),4000.0,Industry,Interventional,2021-04-01,01/05/21,2021-01-05,07/12/20,24/03/21,"QueryLab, Minnetonka, Minnesota",United States,Respiratory Diseases,1,1,-86.0
362.0,NCT04481477,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,WW2COVID-19,Recruiting,COVID-19,,,,,,,"Other: Nursing care to reduce anxiety, fear and loneliness",Corporacion Parc Tauli,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-11-27,15/04/21,2021-04-15,22/07/20,25/03/21,"CorporacionPT, Sabadell, Barcelona",Spain,Respiratory Diseases,1,1,139.0
363.0,NCT04347850,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),COVIDothèque,Recruiting,COVID-19,COVID-19,,,,,,Other: blood sample,"University Hospital, Montpellier",All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-01-02,01/12/22,2022-12-30,15/04/20,08/07/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,1093.0
364.0,NCT04579471,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,COVITRA,Recruiting,COVID-19,SARS-CoV Infection,Transplantation Infection,,,,,Diagnostic Test: SARS-CoV-2 IgG,Universitaire Ziekenhuizen Leuven|KU Leuven|Hasselt University|Ziekenhuis Oost-Limburg|Jessa Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-07,31/12/21,2021-12-31,08/10/20,09/10/20,"UZ Leuven, Leuven, Vlaams Brabant",Belgium,Respiratory Diseases,1,3,724.0
365.0,NCT04500639,Over-the-counter Medications & COVID-19,OTC℞&COVID19,Recruiting,COVID-19,COVID-19,,,,,,,University of Alberta,All,"Child, Adult, Older Adult",14000.0,Other,Observational,2020-07-23,31/12/20,2023-03-31,05/08/20,07/08/20,"University of Alberta, Edmonton, Alberta",Canada,Respiratory Diseases,1,2,981.0
366.0,NCT04374513,Community Pharmacists Behaviour During Covid-19,,Completed,COVID-19,,,,,,,,Damanhour University,All,"Child, Adult, Older Adult",318.0,Other,Observational,2020-02-04,01/06/20,2020-01-07,05/05/20,03/02/21,"Damanhour university, Beheira, Damanhour, Egypt|Damanhour universty, Alexandria",Egypt,Respiratory Diseases,1,1,-28.0
367.0,NCT04436471,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",,Completed,COVID-19,,,,,,,Biological: Gam-COVID-Vac,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|Acellena Contract Drug Research and Development",All,18 Years to 60 Years   (Adult),38.0,Other,Interventional,2020-06-17,03/08/20,2020-10-08,18/06/20,12/08/20,"Main military clinical hospital named after academician N. N. Burdenko, Moscow",Russian Federation,Respiratory Diseases,1,1,113.0
368.0,NCT04351659,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,,Recruiting,COVID-19,,,,,,,Other: Blood donation from convalescent donor,"KK Women's and Children's Hospital|Singapore General Hospital|National University Hospital, Singapore",All,"21 Years to 65 Years   (Adult, Older Adult)",8.0,Other,Observational,2020-04-14,01/08/20,2020-01-08,17/04/20,07/07/20,"National University Hospital, Singapore, Singapore|Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,-97.0
369.0,NCT04422574,COVID 19 Serology in Pulmonologists,Pneumoserocov,Completed,COVID-19,,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",97.0,Other,Observational,2020-01-05,01/05/20,2020-05-30,09/06/20,09/06/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,1,146.0
370.0,NCT04651387,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,HOO-COVID,Not yet recruiting,SARS-CoV Infection,,,,,,,Dietary Supplement: Ozonized oil (HOO,Neuromed IRCCS,All,"18 Years to 80 Years   (Adult, Older Adult)",74.0,Other,Interventional,2021-01-01,01/06/21,2021-01-08,03/12/20,03/12/20,,,Respiratory Diseases,1,1,7.0
371.0,NCT04530396,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",RESIST,"Active, not recruiting",COVID-19,,,,,,,Biological: Gam-COVID-Vac|Other: placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|Government of the city of Moscow|CRO: Crocus Medical BV",All,"18 Years to 111 Years   (Adult, Older Adult)",33758.0,Other,Interventional,2020-07-09,01/05/21,2021-01-05,28/08/20,22/01/21,"ARCHIMED V Clinic of new medical technologies limited liability company, Moscow, Russian Federation|Hadassah LTD, Moscow, Russian Federation|Medsi Group of companies joint-stock company, Moscow, Russian Federation|Niarmedic Plus, Moscow, Russian Federation|State budgetary healthcare institution of the city of Moscow City clinical hospital No. 52 of the Moscow city health Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, M. Konchalovsky Municipal Clinical Hospital, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, M. Zhadkevich Municipal Clinical Hospital, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 115, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 2, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 212, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 220, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Municipal Polyclinic No. 62, Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 109 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 170 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 36 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 46 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 6 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow  city polyclinic No. 68 Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Diagnostic center No. 5 with polyclinic Department Of the Department of health of the city of Moscow, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Diagnostic clinical center No. 1 Of the Department of health of the city of Moscow, Moscow",Russian Federation,Respiratory Diseases,1,1,180.0
372.0,NCT04839913,"Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study",COVID-19,Completed,SARS-CoV Infection,Seroprevalence,COVID-19,,,,,Diagnostic Test: Antibodies testing,University of Cagliari,All,"18 Years and older   (Adult, Older Adult)",121.0,Other,Observational,2020-01-09,10/12/20,2021-10-01,09/04/21,09/04/21,"University of Cagliari, Cagliari",Italy,Respiratory Diseases,1,3,631.0
373.0,NCT04354857,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Anosmie-COVID,Recruiting,COVID-19,,,,,,,Other: olfactory and gustatory tests,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",454.0,Other,Observational,2020-03-27,01/07/20,2020-01-11,21/04/20,21/04/20,"CHU de Nimes, Nîmes",France,Respiratory Diseases,1,1,-76.0
374.0,NCT04368338,Lung Ultrasound to Diagnose COVID-19,COVILUS,Recruiting,COVID-19,Lung Ultrasound,Respiratory Complication,,,,,Diagnostic Test: COVID-19 RT-PCR|Procedure: lung ultrasound,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-28,28/01/21,2021-09-28,29/04/20,04/12/20,"BAR, Amiens",France,Respiratory Diseases,1,3,518.0
375.0,NCT04813575,COVID-19 Pathophysiology of Long Term Implications,,Enrolling by invitation,COVID-19,Pulmonary Fibrosis,Organising Pneumonia,Thromboembolism,,,,Other: Cryo lung biopsies,King Faisal Specialist Hospital & Research Center,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-04,01/04/22,2022-01-06,24/03/21,24/03/21,"King Faisal Specialist Hospital and Research Centre, Riyadh",Saudi Arabia,Respiratory Diseases,1,4,367.0
376.0,NCT04350073,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),,Recruiting,COVID-19,,,,,,,Device: Q-NRG Metobolic Cart Device|Device: MuscleSound Ultrasound|Device: Multifrequency Bioimpedance Spectroscopy,Duke University,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-04-20,01/10/21,2021-01-12,16/04/20,14/12/20,"Duke University Medial Center, Durham, North Carolina",United States,Respiratory Diseases,1,1,267.0
377.0,NCT04642339,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",VENEZUELA,Not yet recruiting,COVID-19,,,,,,,Biological: Gam-COVID-Vac|Biological: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|Ministerio del Poder Popular para la Salud de la República Bolivariana de Venezuela",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-01-11,01/10/21,2021-01-12,24/11/20,24/11/20,,,Respiratory Diseases,1,1,367.0
378.0,NCT04627467,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),TS-COVID,"Active, not recruiting",COVID-19,,,,,,,Drug: Chloroquine,Fundacion Clinica Valle del Lili,All,"18 Years and older   (Adult, Older Adult)",3217.0,Other,Interventional,2020-03-28,09/07/20,2021-01-07,13/11/20,06/04/21,"Fundacion Valle del Lili, Cali, Valle Del Cauca",Colombia,Respiratory Diseases,1,1,285.0
379.0,NCT04386759,COVID-19 Infection in Healthcare Workers,HOP-COVID,Not yet recruiting,COVID-19,,,,,,,Other: Cohort,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",6000.0,Other,Observational,2020-01-05,01/10/20,2020-01-10,13/05/20,13/05/20,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil",France,Respiratory Diseases,1,1,5.0
380.0,NCT04695158,Blood Sample Measurements and Physical Activity Levels in Type II Diabetes and/or COVID-19,,Recruiting,COVID-19,"Diabetes Mellitus, Type 2",,,,,,Drug: COVID-19 group (Group I)|Drug: Type II Diabetes Mellitus and COVID-19 group (Group II),Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,All,"35 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Observational,2021-06-01,01/02/21,2021-01-03,05/01/21,11/02/21,"Kadirhan Ozdemir, İzmir",Turkey,"Metabolic Disorders, Respiratory Diseases",1,2,-149.0
381.0,NCT04762186,Adoptive SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19,ACT-COVID-19,Not yet recruiting,COVID-19,,,,,,,"Drug: IMP 1,000 plus SoC|Drug: IMP 5,000 plus SoC|Drug: IMP RP2D plus SoC|Drug: SoC",Universitätsklinikum Köln|ZKS Köln|MMH Institute for Transfusion Medicine|Miltenyi Biomedicine GmbH,All,"18 Years to 99 Years   (Adult, Older Adult)",51.0,Other|Industry,Interventional,2021-01-04,01/09/22,2022-01-12,21/02/21,21/02/21,"Department I for Internal Medicine University Hospital of Cologne, Cologne, NRW",Germany,Respiratory Diseases,1,1,373.0
382.0,NCT04575545,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,,Not yet recruiting,COVID-19,Virus-HIV,,,,,,Diagnostic Test: Serology test for COVID-19,Hôpital Européen Marseille,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-01-10,01/03/21,2022-01-04,05/10/20,05/10/20,"BENNANI, Marseille",France,Respiratory Diseases,1,2,725.0
383.0,NCT04525417,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,,Completed,COVID-19,,,,,,,Diagnostic Test: AAZ Covid-19 rapid test,Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2020-04-25,25/09/20,2020-10-25,25/08/20,03/02/21,"Bichat University Hospital, Paris",France,Respiratory Diseases,1,1,183.0
384.0,NCT04813770,The Impact of Theory-based Messaging on Covid-19 Vaccination Intentions,,Not yet recruiting,Vaccination,COVID-19,,,,,,Behavioral: Theory-based messages|Behavioral: General messages,University of Glasgow,All,"18 Years and older   (Adult, Older Adult)",1094.0,Other,Interventional,2021-01-03,01/03/21,2021-01-03,24/03/21,24/03/21,"University of Glasgow, Glasgow",United Kingdom,Respiratory Diseases,1,2,0.0
385.0,NCT04563442,Comorbidities And Complications Associated With Covid-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Other: complication,Assiut University,All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-10-15,15/10/22,2023-02-25,24/09/20,24/09/20,,,Respiratory Diseases,1,1,863.0
386.0,NCT04408157,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,SWitCh,"Active, not recruiting",COVID-19,,,,,,,Behavioral: Self-management booklet (SWitCh: Stay well during COVID-19),King's College London,All,"18 Years and older   (Adult, Older Adult)",185.0,Other,Interventional,2020-05-20,22/08/21,2021-12-22,29/05/20,16/03/21,"Online recruitment through Qualtrics, London",United Kingdom,Respiratory Diseases,1,1,581.0
387.0,NCT04359537,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,CHEER,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate 200 MG|Other: Placebo,Shaheed Zulfiqar Ali Bhutto Medical University,All,18 Years to 60 Years   (Adult),200.0,Other,Interventional,2020-01-05,25/08/20,2020-09-25,24/04/20,19/05/20,"Shaheed Zulfiaqar Ali Bhutto Medical University, Islamabad, Federal Capital",Pakistan,Respiratory Diseases,1,1,264.0
388.0,NCT04434261,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,ASTANA,Recruiting,COVID-19,Oncology,Surgery,,,,,Diagnostic Test: PT-PCR test for SARS-CoV-2,Instituto Brasileiro de Controle do Cancer,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-11-05,31/12/20,2021-09-30,16/06/20,08/03/21,"Instituto Brasileiro de Controle do Cancer - IBCC, Sao Paulo",Brazil,Respiratory Diseases,1,3,329.0
389.0,NCT04423640,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Other: Active COVID-19 disease,"Coordinación de Investigación en Salud, Mexico|Instituto Mexicano del Seguro Social",All,"16 Years and older   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-04-15,15/06/20,2020-08-15,09/06/20,13/08/20,"UMAE Hospital de Especialidades del Centro Médico Nacional Siglo XXI, IMSS., México, Ciudad De México",Mexico,Respiratory Diseases,1,1,122.0
390.0,NCT04786197,Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence,Kaïssa Covid,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",603.0,Other,Observational,2020-12-17,16/06/21,2021-12-31,08/03/21,10/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,1,379.0
391.0,NCT04838821,Efficacy and Safety of Three Different Doses of an Anti SARS-CoV-2 Hyperimmune Equine Serum in COVID-19 Patients,SECR-02,Not yet recruiting,COVID-19,,,,,,,Biological: Anti SARS-CoV-2 equine hyperimmune serum|Biological: placebo,Caja Costarricense de Seguro Social|Universidad de Costa Rica|Ministry of Health Costa Rica,All,"18 Years and older   (Adult, Older Adult)",156.0,Other,Interventional,2021-03-29,29/07/21,2021-09-29,09/04/21,09/04/21,"Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica|Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica|Hospital México, San José, Costa Rica|Hospital San Juan de Dios, San José",Costa Rica,Respiratory Diseases,1,1,184.0
392.0,NCT04444687,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,LapCoVIDSurg,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Test for SARS-CoV-2,"University Hospital, Basel, Switzerland",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-01-08,01/12/20,2021-01-02,23/06/20,23/06/20,,,Respiratory Diseases,1,1,360.0
393.0,NCT04680819,Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Anatolian Propolis,Ataturk University,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-12-25,25/01/21,2021-01-25,23/12/20,23/12/20,,,Respiratory Diseases,1,1,31.0
394.0,NCT04822402,COVID-19 Among Pregnant Women in Assiut,,Not yet recruiting,COVID-19,,,,,,,,Assiut University,Female,"Child, Adult, Older Adult",50.0,Other,Observational,2021-01-05,01/04/22,2022-01-06,30/03/21,30/03/21,,,Respiratory Diseases,1,1,366.0
395.0,NCT04611802,"A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2",,"Active, not recruiting",SARS-CoV Infection,COVID-19,,,,,,Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)|Other: Placebo (Initial Vaccination Period)|Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Crossover Vaccination period)|Other: Placebo (Crossover Vaccination period),Novavax|Department of Health and Human Services,All,"18 Years and older   (Adult, Older Adult)",30000.0,Industry|U.S. Fed,Interventional,2020-12-27,31/03/21,2022-12-30,02/11/20,24/02/21,"Accel Research Sites, Birmingham, Alabama, United States|HOPE Research Institute, Phoenix, Arizona, United States|AMR Tempe Clinical Research Consortium, Tempe, Arizona, United States|Lynn Institute of the Ozarks, Little Rock, Arkansas, United States|Preferred Research Partners, Inc., Little Rock, Arkansas, United States|Anaheim Clinical Trials, Anaheim, California, United States|Advanced Clinical Research - Rancho Paseo, Banning, California, United States|eStudy Site, Chula Vista, California, United States|eStudySite - Corporate Offices, La Mesa, California, United States|Wr-Pri, Llc, Los Alamitos, California, United States|National Research Institute, Los Angeles, California, United States|Transitional Research Group, Inc., North Hollywood, California, United States|Empire Clinical Research, Pomona, California, United States|University of California Davis Health, Sacramento, California, United States|Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Synexus Clinical Research US, Inc., Vista, California, United States|Dignity Health Medical Foundation - Woodland, Woodland, California, United States|University of Colorado Hospital CRS, Aurora, Colorado, United States|Lynn Institute of the Rockies, Colorado Springs, Colorado, United States|Howard University Hospital Howard/ University College of Medicine, Washington, District of Columbia, United States|University Clinical Research-Deland, LLC dba Accel Research Sites, DeLand, Florida, United States|SIMED Health, LLC / SIMED Research, Gainesville, Florida, United States|M D Clinical, Hallandale Beach, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Meridien Research/Accel Research, Lakeland, Florida, United States|Miami Veterans Affairs Medical Center, Miami, Florida, United States|Suncoast Research Associates, LLC, Miami, Florida, United States|Clinical Neuroscience Solutions Inc, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Pinellas Park, Florida, United States|University of South Florida, Tampa, Florida, United States|Jedidiah Clinical Research, Tampa, Florida, United States|Synexus Clinical Research US, Inc., The Villages, Florida, United States|Comprehensive Clinical Trials, Llc, West Palm Beach, Florida, United States|Atlanta - Morehouse School of Medicine, Atlanta, Georgia, United States|Ponce CRS Emory University, Atlanta, Georgia, United States|Synexus Clinical Research US, Inc., Atlanta, Georgia, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|IACT Health (DBA John B. Amos Cancer Center), Columbus, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Advanced Clinical Research, Meridian, Idaho, United States|Synexus, Chicago, Illinois, United States|Cedar Crosse Research Center, Chicago, Illinois, United States|Providea Health Partners LLC, Mokena, Illinois, United States|Synexus USA, Evansville, Indiana, United States|Buynak Clinical Research, P.C., Valparaiso, Indiana, United States|University of Iowa Medical Center, Iowa City, Iowa, United States|Meridian Clinical Research, Sioux City, Iowa, United States|Johnson County Clin-Trials, Inc., Lenexa, Kansas, United States|Meridian Clinical Research, LLC, Baton Rouge, Louisiana, United States|Med Pharmics, LLC, Metairie, Louisiana, United States|Willis-Knighton Physician Network, Shreveport, Louisiana, United States|University Of Maryland School Of Medicine CVD, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|VA Ann Arbor Healthcare System, Ann Arbor, Michigan, United States|Wayne State University/ Children's Hospital of Michigan, Detroit, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|Synexus Clinical Research US, Inc., Richfield, Minnesota, United States|MedPharmics, LLC-Biloxi, Gulfport, Mississippi, United States|The Curators of University of Missouri, Columbia, Missouri, United States|Sundance Clinical Research, LLC, Saint Louis, Missouri, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Meridian Clinical Research Associates, LLC, Omaha, Nebraska, United States|University Of Nebraska Medical Center, Omaha, Nebraska, United States|Synexus Clinical Research US, Inc., Henderson, Nevada, United States|Clinical Research Consortium, Las Vegas, Nevada, United States|Stony Brook Responder Vaccine Program, Commack, New York, United States|Weill Cornell Chelsea CRS, New York, New York, United States|Rochester Clinical Research, Rochester, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|The Charlotte-Mecklenburg Hospital Authority d/b/a Atrium Health, Charlotte, North Carolina, United States|M3-Emerging Medical Research, LLC, Durham, North Carolina, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Womack Army Medical Center, Fort Bragg, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|PMG Research of Rocky Mount, LLC, Rocky Mount, North Carolina, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Synexus Clinical Research, US, Inc., Akron, Ohio, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc., Cincinnati, Ohio, United States|Sterling Research Group, Ltd, Cincinnati, Ohio, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Medical Research International, Oklahoma City, Oklahoma, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|CRISOR, LLC - Clinical Research Institute of Southern Oregon, PC, Medford, Oregon, United States|The Miriam Hospital (TMH), Providence, Rhode Island, United States|Velocity Clinical Research, Providence, Warwick, Rhode Island, United States|Synexus Clinical Research US, Inc., Anderson, South Carolina, United States|Medical University of South Carolina, SCTR Research Nexus, Charleston, South Carolina, United States|Missouri Breaks Industries Research Inc., Eagle Butte, South Dakota, United States|PMG Research of Bristol, Bristol, Tennessee, United States|WR Clinsearch, LLC, Chattanooga, Tennessee, United States|PMG Research, Inc. d/b/a PMG Research of Knoxville, Knoxville, Tennessee, United States|Clinical Neurosciecne Solutions, Inc. dba CNS Healthcare, Memphis, Tennessee, United States|Clinical and Translational Research Center at Meharry Medical College, Nashville, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Centex Studies, Inc, McAllen, Texas, United States|Research Your Health, Plano, Texas, United States|Synexus, US - San Antonio, San Antonio, Texas, United States|University of Texas Health Science Center San Antonio, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Advanced Clinical Research, West Jordan, Utah, United States|Health Research of Hampton Roads, Inc, Newport News, Virginia, United States|MultiCare Institute for Research & Innovation, Cheney, Washington, United States|University of Washington VTEU, Seattle, Washington, United States|PanAmerican Clinical Research Mexico, Juriquilla, Queretaro, Mexico|Unidad de Atencion Medica e Investigacion en Salud (UNAMIS), Merida, Yucatan, Mexico|Instituto Nacional de Salud Publica (INSP) - Cuernavaca - Centro de Investigacion en Salud Poblacional (CISP), Cuernavaca, Mexico|CAIMED Investigacion en Salud S.A de C.V, Mexico City, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico|Faicic S. de R.L. de C.V., Veracruz, Mexico|Ponce Medical School Foundation Inc. / CAIMED Cneter, Ponce, Puerto Rico|University of Puerto Rico Medical Sciences Campus Maternal Infant Studies Cente",Puerto Rico,Respiratory Diseases,1,2,733.0
396.0,NCT04411576,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,,Recruiting,SARS-CoV 2,,,,,,,Diagnostic Test: Throat swab sample for measuring current infection with SARS-CoV-2|Diagnostic Test: Blood sample for serology to measure past infection with SARS-CoV-2,Karolinska University Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",40000.0,Other,Observational,2020-04-23,01/07/20,2020-12-31,02/06/20,02/06/20,"Karolinska University Hospital, Stockholm",Sweden,Respiratory Diseases,1,1,252.0
397.0,NCT04569292,COVID-19 Infection in Cancer Pantients,COICA,Recruiting,COVID-19,,,,,,,Other: No intervention on patients,Ospedale Andrea Tortora di Pagani,All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-01-01,01/04/21,2021-01-08,29/09/20,29/09/20,"Oncology Unit, Hospital Andrea Tortora, Pagani, Salerno",Italy,Respiratory Diseases,1,1,373.0
398.0,NCT04388618,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,,Recruiting,Anosmia,Ageusia,COVID-19,Corona Virus Infection,,,,Other: NHANES smell and taste tests,Princess Nourah Bint Abdulrahman University,All,"12 Years to 65 Years   (Child, Adult, Older Adult)",250.0,Other,Observational,2020-06-15,31/08/21,2021-11-30,14/05/20,16/03/21,"Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central, Saudi Arabia|prince Mohammed bin Abdulaziz Hospital, Riyadh, Central",Saudi Arabia,Respiratory Diseases,1,4,533.0
399.0,NCT04347889,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine|Other: Vitamin C,Stony Brook University,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-20,30/12/20,2020-12-30,15/04/20,02/11/20,,,Respiratory Diseases,1,1,254.0
400.0,NCT04810117,Monitoring the IgG/IgM Antibodies in COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Serodiagnosis of IgG and IgM,"University of Sargodha|Dr Fariha Kanwal, Med-X Research Institute, School of biomedical engineering, Shanghai",All,18 Years to 60 Years   (Adult),100.0,Other,Observational,2021-01-04,30/08/21,2021-10-30,22/03/21,24/03/21,,,Respiratory Diseases,1,1,299.0
401.0,NCT04558385,Seroconversion in COVID-19 Recovered Population,,Completed,COVID-19,,,,,,,Diagnostic Test: IgG SARS CoV2,Lahore General Hospital,All,"Child, Adult, Older Adult",275.0,Other,Observational,2020-01-07,31/03/21,2021-03-31,22/09/20,01/04/21,"Lahore General Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,449.0
402.0,NCT04388683,Inhaled Nitric Oxide for Preventing Progression in COVID-19,NO-COVID-19,"Active, not recruiting",COVID-19,,,,,,,Drug: Nitric Oxide,Tufts Medical Center|Bellerophon,All,"18 Years to 85 Years   (Adult, Older Adult)",42.0,Other|Industry,Interventional,2020-12-05,30/04/21,2021-07-31,14/05/20,02/02/21,"Tufts Medical Center, Boston, Massachusetts",United States,Respiratory Diseases,1,1,238.0
403.0,NCT04607928,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,FIBRO-COVID,Recruiting,COVID-19,,,,,,,Drug: Pirfenidone|Drug: Placebo,Institut d'Investigació Biomèdica de Bellvitge,All,"18 Years and older   (Adult, Older Adult)",148.0,Other,Interventional,2020-01-08,01/08/21,2021-01-08,29/10/20,05/11/20,"University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital La Princes, Madrid, Spain|Hospital Puerta de Hierro, Madrid, Spain|Hospital Ramón y Cajal, Madrid",Spain,Respiratory Diseases,1,1,366.0
404.0,NCT04474288,The COVID-19 PUI Reality Check (CPRC) Study,CPRC,Recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 antibody testing,"Bassett Healthcare|Bioreference, Inc",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-07-16,01/07/21,2021-01-07,16/07/20,20/08/20,"Bassett Medical Center, Cooperstown, New York",United States,Respiratory Diseases,1,1,175.0
405.0,NCT04359862,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,SEVO-COVID19,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Drug: Sevoflurane|Drug: Propofol,Fundación para la Investigación del Hospital Clínico de Valencia,All,"18 Years to 99 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-16,31/03/21,2021-04-30,24/04/20,14/10/20,"Hospital Universitario Cruces, Barakaldo, Bizkaia, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General Universitario de Valencia, Valencia",Spain,Respiratory Diseases,1,2,379.0
406.0,NCT04602442,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,COVID-19EXO2,Enrolling by invitation,COVID-19,COVID-19,COVID-19,,,,,Drug: EXO 1 inhalation|Drug: EXO 2 inhalation|Drug: Placebo inhalation,"Olga Tyumina|Clinics of the Federal State Budgetary Educational Institution SSMU|Samara Regional Clinical Hospital V.D. Seredavin|State-Financed Health Facility ""Samara Regional Medical Center Dinasty""",All,"18 Years to 65 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-10,01/08/21,2021-12-30,26/10/20,26/10/20,"Medical Centre Dinasty, Samara",Russian Federation,Respiratory Diseases,1,3,720.0
407.0,NCT04399733,EMPOWER - BAME vs COVID,,Not yet recruiting,COVID-19,Health Disparities,,,,,,,Future Genetics Limited,All,"6 Years and older   (Child, Adult, Older Adult)",12800.0,Other,Observational,2021-01-02,01/02/23,2024-01-02,22/05/20,22/07/20,"Future Genetics Limited, Birmingham, West Midlands",United Kingdom,Respiratory Diseases,1,2,1095.0
408.0,NCT04357990,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,KONS-COVID19,Recruiting,COVID-19,,,,,,,Device: Viruxal Oral and Nasal Spray|Other: Placebo,Kerecis Ltd.,All,"18 Years and older   (Adult, Older Adult)",128.0,Industry,Interventional,2020-04-09,01/03/21,2021-01-03,22/04/20,17/09/20,"National Hospital of Iceland (Landspítali), Reykjavík",Iceland,Respiratory Diseases,1,1,269.0
409.0,NCT04502472,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,Inova-CCP,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma transfusion,Inova Health Care Services,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-06-06,31/12/21,2021-12-31,06/08/20,06/08/20,"Inova Fairfax Medical Campus, Falls Church, Virginia",United States,Respiratory Diseases,1,1,573.0
410.0,NCT04387890,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,,Not yet recruiting,COVID-19,SARS-CoV 2,Health Personnel,,,,,Diagnostic Test: Serologic SARS-CoV-2 screening,Hospital Italiano de Buenos Aires|Roche Pharma AG,All,"18 Years and older   (Adult, Older Adult)",50.0,Other|Industry,Observational,2020-01-06,31/08/20,2020-08-31,14/05/20,28/05/20,,,Respiratory Diseases,1,3,238.0
411.0,NCT04738695,SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19),SCOPE,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Point-of-care rapid anti-SARS-CoV-2 antibody test (Orient Gene Biotech) and Dry Blood Spot collection (Euroimmun),Sciensano|KU Leuven|University of Liege|Universiteit Antwerpen,All,"18 Years and older   (Adult, Older Adult)",3036.0,Other,Observational,2021-01-02,31/03/22,2022-03-31,04/02/21,18/03/21,"Ghent University, Ghent, Oost-Vlaanderen",Belgium,Respiratory Diseases,1,2,453.0
412.0,NCT04336462,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,COVID-19,Recruiting,COVID-19,,,,,,,Device: oxyhydrogen|Device: Oxygen,"Shanghai Asclepius Meditec Inc.|Shanghai Public Health Clinical Center|Henan Provincial People's Hospital|Shenzhen Third People's Hospital|The First People's Hospital of Yunnan|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Shanghai 6th People's Hospital|Guangdong Provincial Hospital of Traditional Chinese Medicine",All,"18 Years to 85 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2020-02-15,21/02/20,2020-01-08,07/04/20,07/04/20,"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,-38.0
413.0,NCT04453852,Monovalent Recombinant COVID19 Vaccine,COVAX19,Recruiting,Coronavirus Infection,COVID-19,,,,,,Biological: COVID19 vaccine|Biological: Saline,Vaxine Pty Ltd|Central Adelaide Local Health Network Incorporated,All,"18 Years to 65 Years   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-06-30,01/07/21,2021-01-07,01/07/20,01/07/20,"PARC,, Adelaide, South Australia",Australia,Respiratory Diseases,1,2,191.0
414.0,NCT04726176,COVID-19 and the Brain,,Recruiting,COVID-19,Brain,Neurocognition,fMRI,,,,Biological: Exposure to COVID-19,Vrije Universiteit Brussel|Universitair Ziekenhuis Brussel,All,"40 Years to 76 Years   (Adult, Older Adult)",40.0,Other,Observational,2021-01-30,01/07/21,2021-01-07,27/01/21,04/02/21,"Vrije Universiteit Brussel, Brussels",Belgium,Respiratory Diseases,1,4,-23.0
415.0,NCT04506528,The C3I COVID-19 Project,,Recruiting,COVID-19,Cancer,Nicotine Dependence,Pulmonary Disease,Cardiovascular Diseases,Immunosuppression Disorders,,,"University of Wisconsin, Madison|National Cancer Institute (NCI)",All,"Child, Adult, Older Adult",170000.0,Other|NIH,Observational,2020-10-08,01/01/23,2023-01-12,10/08/20,26/01/21,"University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention, Madison, Wisconsin",United States,"Respiratory Diseases, Cancers",1,6,826.0
416.0,NCT04348422,Evaluating the Immune Response for COVID-19,COVIDIMMUNE,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: COVID-19 Serology|Other: Symptoms questionnare,Assaf-Harofeh Medical Center,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-05,01/12/21,2021-12-31,16/04/20,15/02/21,"Assaf-Harofeh Medical Center, Ramla",Israel,Respiratory Diseases,1,1,726.0
417.0,NCT04830683,Endothelial Dysfunction in Covid-19,ENDOCOVID,Recruiting,COVID-19,Hypoxemic Respiratory Failure,,,,,,,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,"18 Years to 75 Years   (Adult, Older Adult)",85.0,Other,Observational,2020-04-27,25/03/21,2021-01-04,05/04/21,09/04/21,"Cliniques Universitaires Saint Luc, Brussels, Belgique",Belgium,Respiratory Diseases,1,2,252.0
418.0,NCT04706156,Oral Side Effects of COVID-19 Vaccine,,Recruiting,Oral Manifestations,COVID-19,Vaccine Adverse Reaction,,,,,Biological: COVID-19 Vaccine,Masaryk University|F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica|University of Giessen|University of Kiel|Yeditepe University,All,"18 Years and older   (Adult, Older Adult)",1540.0,Other,Observational,2021-01-27,28/02/21,2021-03-31,12/01/21,25/02/21,"Department of Public Health, Faculty of Medicine, Masaryk University, Brno, South-Moravia, Czechia|Department of Cranio-Maxillofacial Surgery, Justus-Liebig University Giessen, Giessen, Hesse, Germany|Clinic for Conservative Dentistry and Periodontology, School of Dental Medicine, Christian-Albrecht's University, Kiel, Schleswig-Holstein, Germany|Department of Maxillofacial Surgery, F. D. Roosevelt University Hospital, Banská Bystrica, Banska Bystrica",Slovakia,Respiratory Diseases,1,3,63.0
419.0,NCT04701944,Clinical Study of Pregnant Women With COVID-19,PregWom-Covid,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",Female,"18 Years and older   (Adult, Older Adult)",54.0,Other,Observational,2020-04-21,21/04/21,2021-04-21,08/01/21,08/01/21,"Department of Gynecology-Obstetrics and Fertility - Strasbourg University Hospitals, Strasbourg",France,Respiratory Diseases,1,1,365.0
420.0,NCT04374123,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,,Completed,COVID-19,,,,,,,Diagnostic Test: Serological screening for IgG and IgM antibodies against COVID-19,Instituto Ecuatoriano de Enfermedades Digestivas,All,"18 Years to 80 Years   (Adult, Older Adult)",111.0,Other,Observational,2020-04-20,20/05/20,2020-06-15,05/05/20,28/07/20,"Ecuadorian Institute of Digestive Diseases, Guayaquil, Guayas",Ecuador,Respiratory Diseases,1,1,56.0
421.0,NCT04389476,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,,Not yet recruiting,COVID-19,,,,,,,Other: Standardized crisis management and coping protocol plan toward Coronavirus disease 2019 (COVID-19),Kaohsiung Kai-Suan Psychiatric Hospital,All,"20 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2020-06-15,31/07/23,2023-07-31,15/05/20,16/06/20,,,Respiratory Diseases,1,1,1141.0
422.0,NCT04470414,COVID-19 IgG Antibodies in the Serum of Recovered Patients,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: IgG antibodies immunoassay,Assiut University,All,"20 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-08,01/07/21,2021-01-09,14/07/20,16/07/20,"Faculty of medicine- Assiut university, Assiut",Egypt,Respiratory Diseases,1,1,367.0
423.0,NCT04709302,Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan Africa,ENDOCOVID,Recruiting,COVID-19,Hiv,ART,,,,,Biological: COVID-19|Biological: HIV|Drug: ART,Medical University of Graz|University of Olso|Kristiania University College|Walter Sisulu University|Lagos State University|Management Sciences for Health,All,"18 Years and older   (Adult, Older Adult)",342.0,Other,Observational,2021-01-02,01/06/22,2022-01-12,14/01/21,14/01/21,"University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria|Lagos Stae University Teaching Hospital Ikeja, Lagos, Nigeria|Walter Sisulu University, Mthatha",South Africa,Respiratory Diseases,1,3,375.0
424.0,NCT04753463,Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland,,Not yet recruiting,COVID-19,,,,,,,Other: Survey,Medical University of Bialystok,All,25 Years to 35 Years   (Adult),130.0,Other,Observational,2021-03-15,28/03/21,2021-04-15,15/02/21,11/03/21,"Medical University, Białystok, Poland|Ophthalmology Clinic Medical University of Bialystok, Białystok",Poland,Respiratory Diseases,1,1,31.0
425.0,NCT04516928,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,SeroCovEms,Completed,SARS-CoV Infection,COVID-19,,,,,,Diagnostic Test: Anti-SARS-CoV2 Serology|Other: Questionnaire,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",392.0,Other,Observational,2020-09-21,25/09/20,2020-09-25,18/08/20,09/03/21,"Antenne Médicale des Ecoles Militaires de Santé de Lyon-Bron (EMSLB), Bron",France,Respiratory Diseases,1,2,4.0
426.0,NCT04573855,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: Anti-SARS-CoV-2 immunoglobulin,D'Or Institute for Research and Education,All,"18 Years to 75 Years   (Adult, Older Adult)",41.0,Other,Interventional,2020-01-12,28/02/21,2021-03-31,05/10/20,05/10/20,,,Respiratory Diseases,1,1,444.0
427.0,NCT04501458,Western Kenya Integrated COVID-19 Response,,"Active, not recruiting",COVID-19,,,,,,,"Other: Training of youth, community health assistants and community health workers.|Other: Training clinicians in basic critical care and the management of severe COVID-19 cases",Surgical Systems Research Group|Wellcome Trust|Tropical Institute of Community Health,All,"18 Years to 100 Years   (Adult, Older Adult)",200000.0,Other,Interventional,2020-10-08,10/06/21,2021-10-06,06/08/20,16/02/21,"Surgical Systems Research Group/Tropical Institute of Community Health, Kisumu",Kenya,Respiratory Diseases,1,1,363.0
428.0,NCT04651790,"Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults",CoronaVac3CL,Recruiting,COVID-19,Vaccines,,,,,,Biological: SARS-CoV-2 inactivated vaccine,"Pontificia Universidad Catolica de Chile|Ministry of Health, Chile|Sinovac Biotech Co., Ltd",All,"18 Years and older   (Adult, Older Adult)",2300.0,Other|Industry,Interventional,2020-11-27,01/01/22,2022-01-03,03/12/20,02/03/21,"Centro de Especialidades Médicas, Red de Salud UC Christus, Santiago, RM",Chile,Respiratory Diseases,1,2,402.0
429.0,NCT04393961,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,,Recruiting,COVID-19,COVID-19,Coronavirus,,,,,Device: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette,ProofPilot|Radish Health|Sanesco,All,"18 Years to 100 Years   (Adult, Older Adult)",600.0,Industry|Other,Interventional,2020-05-04,29/07/20,2020-08-29,19/05/20,19/05/20,"ProofPilot Online App (https://p.proofpilot.com), New York, New York",United States,Respiratory Diseases,1,3,117.0
430.0,NCT04423315,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,Covid-19,Completed,Corona Virus Infection,Thromboembolic Disease,,,,,,,Nisantasi University,All,"18 Years to 99 Years   (Adult, Older Adult)",70.0,Other,Observational,2020-08-06,15/07/20,2020-07-20,09/06/20,23/09/20,"Vital Hospital, Bahcelievler, Istanbul",Turkey,Respiratory Diseases,1,2,-17.0
431.0,NCT04361916,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Mon-Covid,Terminated,COVID-19,,,,,,,Other: home care monitoring,Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",37.0,Other,Interventional,2020-04-21,30/06/20,2020-06-30,24/04/20,14/09/20,"Asl Alessandria, Casale Monferrato, Alessandria",Italy,Respiratory Diseases,1,1,70.0
432.0,NCT04367740,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",,Enrolling by invitation,Asymptomatic Condition,Infection Viral,Coronavirus Infections,Severe Acute Respiratory Syndrome Coronavirus 2,Coronaviridae Infections,RNA Virus Infections,Virus Diseases,Diagnostic Test: To assess for development of IgG antibodies against SARS-CoV2,"University of North Carolina, Chapel Hill",All,"18 Years to 99 Years   (Adult, Older Adult)",10000.0,Other,Observational,2020-04-28,01/12/21,2021-01-12,29/04/20,26/03/21,"Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,7,259.0
433.0,NCT04515199,Home Management of Adult Egyptian Mild COVID-19 Cases,COVID-19,Recruiting,COVID-19,Telemedicine,Quality of Life,Safety Issues,Symptoms,,,,Cairo University,All,"18 Years to 65 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-01-07,01/01/21,2021-01-03,17/08/20,17/08/20,"Faculty of Medicine Cairo University, Cairo",Egypt,Respiratory Diseases,1,5,362.0
434.0,NCT04404270,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),EpiCovCreil,"Active, not recruiting",Sars-CoV2,,,,,,,Diagnostic Test: Anti-SARS-CoV2 Serology|Behavioral: Questionnaire|Diagnostic Test: Anti-SARS-CoV2 serological controls and serum neutralization,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",1146.0,Other,Observational,2020-05-26,01/03/21,2021-01-03,27/05/20,09/03/21,"24e antenne médicale de Creil, Creil",France,Respiratory Diseases,1,1,222.0
435.0,NCT04554979,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,,Completed,COVID-19,Diarrhea,,,,,,Drug: Hydroxychloroquine Pill,Cairo University,All,"18 Years and older   (Adult, Older Adult)",199.0,Other,Observational,2020-01-06,15/07/20,2020-07-15,18/09/20,22/09/20,"Faculty of Medicine Cairo University, Cairo",Egypt,Respiratory Diseases,1,2,191.0
436.0,NCT04832022,Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination,COVID-RIC3,Not yet recruiting,Rheumatic Diseases,SARS-CoV Infection,COVID-19,,,,,Other: Biological samples,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2021-01-04,01/04/23,2023-01-08,05/04/21,05/04/21,,,Respiratory Diseases,1,3,734.0
437.0,NCT04388527,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 Convalescent Plasma,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-30,29/12/20,2021-05-30,14/05/20,14/04/21,"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,395.0
438.0,NCT04368234,Duke COVID-19 Shared Data and Specimen Repository,,Recruiting,COVID-19,,,,,,,,Duke University,All,"Child, Adult, Older Adult",100000.0,Other,Observational,2020-04-18,30/04/25,2025-04-30,29/04/20,23/07/20,"Duke University Medical Center, Durham, North Carolina",United States,Respiratory Diseases,1,1,1838.0
439.0,NCT04760184,Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden,AutoCOVID-19,Not yet recruiting,COVID-19,Myeloma Multiple,Malignant Lymphoma,Hematologic Neoplasms,Stem Cell Transplant Complications,,,Other: Autologous stem cell transplantation,"Uppsala University|Karolinska University Hospital|Sahlgrenska University Hospital, Sweden|Lund University Hospital|University Hospital, Linkoeping|University Hospital, Umeå|Region Örebro County|Uppsala University Hospital",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2021-01-04,30/06/21,2021-12-31,18/02/21,18/02/21,,,Respiratory Diseases,1,5,361.0
440.0,NCT04390165,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,,Completed,SARS-CoV Infection,COVID-19,Anosmia,Dysgeusia,,,,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,"Hospital Sultanah Bahiyah|Hospital Tuanku Fauziah, Kangar, Perlis|Penang Hospital, Malaysia|Hospital Raja Permaisuri Bainun|Hospital Sungai Buloh, Selangor|Kuala Lumpur General Hospital|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan|Hospital Melaka, Melaka|Hospital Enche Besar Hajjah Khalsom, Kluang, Johor|Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu|Hospital Tengku Ampuan Afzan, Kuantan, Pahang|Sarawak General Hospital|Hospital Queen Elizabeth, Malaysia",All,"18 Years and older   (Adult, Older Adult)",498.0,Other,Observational,2020-06-06,30/11/20,2020-11-30,15/05/20,25/02/21,"Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka",Malaysia,Respiratory Diseases,1,4,177.0
441.0,NCT04589936,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,PRONE-COVID,Recruiting,Pneumonia,COVID-19,,,,,,Procedure: Prone positioning,Cambridge University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",56.0,Other,Interventional,2020-03-09,30/06/21,2021-06-30,19/10/20,19/10/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire",United Kingdom,Respiratory Diseases,1,2,478.0
442.0,NCT04605757,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,,Recruiting,SARS-COV-2 Pneumonia,,,,,,,"Other: Clinical, functional and radiological lung involvement evolution",IRCCS Azienda Ospedaliero-Universitaria di Bologna,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-07-30,30/04/21,2021-07-30,28/10/20,12/01/21,"Respiratory and Critical Care Unit - S.Orsola-Malpighi University Hospital, Bologna",Italy,Respiratory Diseases,1,1,365.0
443.0,NCT04490174,Serological Surveillance for COVID-19 in Central North Carolina,,Recruiting,COVID-19,,,,,,,,National Institute of Environmental Health Sciences (NIEHS)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",2500.0,NIH,Observational,2020-08-01,01/06/22,2022-01-06,29/07/20,12/03/21,"NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina",United States,Respiratory Diseases,1,1,523.0
444.0,NCT04710316,"Study of COVID-19 Outbreak in Hospital Departments of Bamako, Mali",BAMACOV,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 screening by molecular biology|Diagnostic Test: Serological screening,"Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2021-01-30,30/04/22,2022-09-30,14/01/21,14/01/21,"Hopital du Point-G, Bamako, Mali|Hopital Gabriel Toure, Bamako, Mali|Hôpital dermatologique de Bamako, Bamako, Mali|Hôpital du Mali, Bamako",Mali,Respiratory Diseases,1,1,608.0
445.0,NCT04581863,COVID-19 Watch + COVID-19 Pulse,,"Active, not recruiting",COVID-19,,,,,,,Device: pulse oximeter|Other: COVID Watch,University of Pennsylvania|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",850.0,Other,Interventional,2020-11-30,05/02/21,2021-10-31,09/10/20,12/02/21,"Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,335.0
446.0,NCT04358029,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),,Recruiting,COVID-19,COVID-19,COVID-19,,,,,,Vivek Reddy|Icahn School of Medicine at Mount Sinai,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-09-04,01/05/22,2022-01-05,22/04/20,13/04/21,"Icahn School of Medicine at Mount Sinai, New York, New York",United States,Respiratory Diseases,1,3,488.0
447.0,NCT04527601,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,,Completed,Extreme Prematurity,COVID-19,,,,,,,"Rigshospitalet, Denmark",All,22 Weeks to 28 Weeks   (Child),885.0,Other,Observational,2020-08-21,13/09/20,2020-09-13,26/08/20,08/10/20,"Neonatalklinikken, Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,2,23.0
448.0,NCT04475562,Can the Electronic Nose Smell COVID-19?,,Completed,SARS-CoV Infection,COVID-19,,,,,,Device: Aeonose,Maastricht University Medical Center,All,"18 Years and older   (Adult, Older Adult)",219.0,Other,Interventional,2020-06-04,06/05/20,2020-01-07,17/07/20,17/07/20,"Maastricht University Medical Center, Maastricht",Netherlands,Respiratory Diseases,1,2,-149.0
449.0,NCT04372368,Convalescent Plasma for the Treatment of Patients With COVID-19,,No longer available,COVID-19,SARS-CoV 2,,,,,,Biological: COVID-19 Convalescent Plasma,"University of Colorado, Denver",All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Treatment IND/Protocol,,,,04/05/20,28/08/20,"Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado",United States,Respiratory Diseases,1,2,
450.0,NCT04679584,COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of Life,NAPKON-POP,Recruiting,COVID-19,,,,,,,Other: Observation of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,"University Hospital Schleswig-Holstein|Charite University, Berlin, Germany|Wuerzburg University Hospital|German Federal Ministry of Education and Research",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-11-16,31/12/21,2030-12-31,22/12/20,22/12/20,"University Hospital Wuerzburg, Würzburg, Bavaria, Germany|University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Schleswig-Holstein, Germany|University Hospital Charité Berlin, Berlin",Germany,Respiratory Diseases,1,1,3697.0
451.0,NCT04525742,COVID-19 Pandemic and Parents of Disabled Children,,Completed,COVID-19,Disabilities Multiple,Cerebral Palsy,Muscular Dystrophies,,,,Other: Difficulties lived by disabled children's parents in the period of COVID-19 pandemic,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",309.0,Other,Interventional,2020-05-07,30/08/20,2020-09-15,25/08/20,03/11/20,"Health Science University Gaziosmanpasa Training and Research Hospital, İstanbul, Gaziosmanpasa",Turkey,Respiratory Diseases,1,4,131.0
452.0,NCT04568356,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,,Completed,SARS CoV-2,,,,,,,Diagnostic Test: Direct Antigen Tests for COVID-19,"E25Bio, Inc.|SCRI Development Innovations, LLC",All,"18 Years and older   (Adult, Older Adult)",200.0,Industry|Other,Interventional,2020-04-24,12/06/20,2020-09-24,29/09/20,19/10/20,"JFK Medical Center, Miami, Florida, United States|Kendall Regional, Miami, Florida, United States|Aventura Hospital and Medical Center, Miami, Florida",United States,Others,0,1,153.0
453.0,NCT04550325,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",,Completed,COVID-19,"Pneumonia, Viral",,,,,,Biological: Kamada Anti-SARS-CoV-2,"Kamada, Ltd.",All,"18 Years and older   (Adult, Older Adult)",12.0,Industry,Interventional,2020-05-08,26/11/20,2020-11-26,16/09/20,05/01/21,"Wolfson Medical Center, Holon, Israel|Hadassah Medical Center, Jerusalem, Israel|Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan, Israel|Kaplan Medical Center, Reẖovot",Israel,Respiratory Diseases,1,2,202.0
454.0,NCT04341766,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,,Completed,"Pneumonia, Viral",COVID-19,,,,,,Other: No special intervention,Centre Hospitalier Intercommunal Creteil,All,"18 Years to 105 Years   (Adult, Older Adult)",106.0,Other,Observational,2020-03-31,27/05/20,2020-06-30,10/04/20,17/07/20,"CHU Amiens, Amiens, France|CH de la Côte Basque, Bayonne, France|CHU Ambroise Paré, Boulogne-Billancourt, France|CHU Caen, Caen, France|CHG de Chambery, Chambéry, France|Centre Hospitalier Intercommunal de Créteil, Créteil, France|CHU de Limoges, Limoges, France|APHM - Hopital Nord, Marseille, France|CHU de Nancy, Nancy, France|CHU Nîmes, Nîmes, France|CHR Orléans, Orléans, France|CHU Cochin, Paris, France|CHU Poitiers, Poitiers, France|CHU Rouen, Rouen, France|CH Saint-Quentin, Saint-Quentin, France|CHU Larrey - Toulouse, Toulouse, France|CHU de Tours, Tours",France,Respiratory Diseases,1,2,91.0
455.0,NCT04569344,COVID-19 and Venous Thromboembolism Risk,,Enrolling by invitation,Venous Thromboembolism,COVID-19,,,,,,Other: Laboratory test positive for SARS-CoV-2 virus,"University of California, San Francisco|Kaiser Permanente|Patient-Centered Outcomes Research Institute",All,"18 Years and older   (Adult, Older Adult)",40000.0,Other,Observational,2020-01-01,31/03/21,2022-06-21,29/09/20,19/10/20,"Kaiser Permanente Northern California, Oakland, California, United States|Kaiser Permanente Southern California, Pasadena, California",United States,Respiratory Diseases,1,2,902.0
456.0,NCT04368390,Neuroradiolological Analysis of COVID-19 Patients,NEURO-COVID-19,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-04,01/04/21,2021-01-04,29/04/20,24/12/20,"Service d'Imagerie 2 - Neuroradiologie, Strasbourg",France,Respiratory Diseases,1,1,306.0
457.0,NCT04359667,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,UHID-COVID19,Recruiting,COVID-19,Severe Pneumonia,,,,,,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA],"University Hospital for Infectious Diseases, Croatia",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-06-16,16/04/21,2021-05-15,24/04/20,12/11/20,"University Hospital for Infectious Diseases Dr Fran Mihaljevic, Zagreb",Croatia,Respiratory Diseases,1,2,333.0
458.0,NCT04819165,Healthcare-associated Infections in Severe COVID-19 During 2020,COVIACS,Completed,"Respiration, Artificial",COVID-19,Health Care Associated Infection,,,,,Other: COVID-19,Sanatorio Anchorena San Martin,All,"18 Years and older   (Adult, Older Adult)",252.0,Other,Observational,2020-01-03,31/12/20,2021-01-31,26/03/21,26/03/21,"Sanatorio Anchorena de San Martin, San Martín, Buenos Aires",Argentina,Respiratory Diseases,1,3,394.0
459.0,NCT04416347,COVID19 Clinical Predictors and Outcome,,Recruiting,COVID-19,SARS-CoV 2,,,,,,Other: SARS-CoV2 Infection,"St George's University Hospitals NHS Foundation Trust|St George's, University of London",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-06-15,30/04/22,2022-04-30,04/06/20,22/10/20,"St. George's University Hospitals Foundation Trust., London",United Kingdom,Respiratory Diseases,1,2,684.0
460.0,NCT04606732,CardioVascular Disease Progression and Prognosis in COVID-19,CVP-Covid19,Recruiting,COVID-19,,,,,,,,University of Bologna,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-09-20,31/12/21,2021-12-31,28/10/20,21/02/21,"Policlinico Sant'Orsola, Bologna",Italy,Respiratory Diseases,1,1,467.0
461.0,NCT04794387,The Lymphoma and Leukemia Society COVID-19 Registry,,Recruiting,COVID-19,,,,,,,Biological: Observational study: This registry data will provide more specific information about how people with blood cancer respond to COVID-19 virus and/or a COVID-19 vaccination.,Lymphoma and Leukemia Society,All,"21 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-02-23,23/02/31,2031-02-23,12/03/21,12/03/21,"Lymphoma and Leukemia Society, Rye Brook, New York",United States,Respiratory Diseases,1,1,3652.0
462.0,NCT04321811,"Behavior, Environment And Treatments for Covid-19",BEAT19,"Active, not recruiting",Coronavirus,,,,,,,"Other: Observation of patients with known, suspected, or at risk for COVID-19 infection",xCures|Genetic Alliance|LunaDNA|Cancer Commons|REDCap Cloud,All,"18 Years and older   (Adult, Older Adult)",100000.0,Industry|Other,Observational,2020-03-21,09/02/21,2022-03-20,25/03/20,10/02/21,"BEAT19.org, San Francisco, California",United States,Respiratory Diseases,1,1,729.0
463.0,NCT04463862,COVID - AirPollution,,Recruiting,COVID-19,COVID-19,,,,,,,"University Hospital, Strasbourg, France",All,"50 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-04-06,04/09/20,2020-04-09,09/07/20,22/07/20,"Unité de neurologie-gériatrie, Hôpital Erasme, Cliniques Universitaires de Bruxelles, Bruxelles, Belgium|Service de Gériatrie, Hôpital Larrey, Hôpitaux Universitaires d'Angers, Angers, France|Unité de soins palliatifs gériatriques, Centre Hospitalier Départemental de Bischwiller, Bischwiller, France|Unité post urgence gériatriques, Hôpital Pellegrin, Hôpitaux Universitaires de Bordeaux, Bordeaux, France|Service de Gériatrie, Centre Hospitalier Départemental de Vendée, La Roche Sur Yon, France|Service de gériatrie-gérontologie, Hôpitaux Universitaires de Lille, Lille, France|Service de médecine aigüe gériatrique, Hôpital Nord Laennec, Hôpitaux Universitaires de Nantes, Nantes, France|Service de Gériatrie, Hôpitaux Bichat et Bretonnaux, Assistance Publique des Hôpitaux de Paris, Paris, France|Service de Médecine Interne et Gériatrie, Hôpitaux Universitaires de Reims, Reims, France|Service de Gériatrie, Hôpital de la Robertsau, Hôpitaux Universitaires de Strasbourg, Strasbourg, France|Service de médecine gériatrique, Hôpitaux Universitaires de Tours, Tours",France,Respiratory Diseases,1,2,3.0
464.0,NCT04383548,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,,Not yet recruiting,COVID-19,,,,,,,Other: hyper immunoglobulins containing anti-Corona VS2 immunoglobulin,Assiut University,All,21 Years to 50 Years   (Adult),100.0,Other,Interventional,2020-01-06,01/12/20,2021-01-01,12/05/20,12/05/20,,,Respiratory Diseases,1,1,361.0
465.0,NCT04418206,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,EliSpot,Recruiting,COVID-19,,,,,,,Other: patients COVID 19,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-06,01/12/20,2021-01-06,05/06/20,09/11/20,"CH Antibes, Antibes, Alpes Maritimes, France|Ch Cannes, Pneumologie, Cannes, Alpes Maritimes, France|Ch Grasse, Grasse, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes",France,Respiratory Diseases,1,1,366.0
466.0,NCT04545047,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 convalescent plasma,VA Office of Research and Development|Mayo Clinic,All,"21 Years to 80 Years   (Adult, Older Adult)",10000.0,U.S. Fed|Other,Observational,2020-01-05,31/12/21,2022-06-30,10/09/20,20/01/21,"VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington",United States,Respiratory Diseases,1,1,907.0
467.0,NCT04348864,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,,Recruiting,Communicable Disease,COVID-19,Sars-CoV2,Infectious Disease,Coronavirus,Virus,,"Diagnostic Test: COVID-19 Antigen/Antibody Rapid Testing, mobile device image capture and telemedicine support|Other: Telemedicine","Neuroganics LLC|Neuroganics Diagnostics LLC|Artron Laboratories Inc|Cellex, Inc.|AllBio Science Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Industry|Other,Interventional,2020-04-16,01/04/21,2021-01-04,16/04/20,16/02/21,"Neuroganics, Northglenn, Colorado",United States,Respiratory Diseases,1,6,263.0
468.0,NCT04352348,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,COVIDeF,Recruiting,COVID-19,,,,,,,Other: blood samples|Other: feces samples (COVI-BIOME ancillary study)|Other: sweat samples (COVIDOG ancillary study)|Other: saliva samples|Other: 6 minutes walk test|Other: Phone call|Other: Urine samples,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-03-31,31/05/21,2022-03-31,20/04/20,11/01/21,"GH Pitié-Salpêtrière / Service d'Accueil des Urgences, Paris, Ile-de-France",France,Respiratory Diseases,1,1,730.0
469.0,NCT04510233,Ivermectin Nasal Spray for COVID19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin nasal|Drug: Ivermectin oral|Other: standard care,Tanta University,All,18 Years to 60 Years   (Adult),60.0,Other,Interventional,2020-01-09,01/10/20,2020-01-12,12/08/20,12/08/20,,,Respiratory Diseases,1,1,3.0
470.0,NCT04673214,Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment,,Recruiting,COVID-19,,,,,,,Drug: Azithromycin / Ivermectin / Ribaroxaban / Paracetamol|Drug: Azithromycin / Ribaroxaban / Paracetamol,"Gilberto Cruz Arteaga|Coordinación de Investigación en Salud, Mexico",All,"18 Years and older   (Adult, Older Adult)",62.0,Other,Interventional,2020-12-16,02/02/21,2021-12-02,17/12/20,22/12/20,"Alma Italia Guerrero Martinez, Mexico, Distrito Federal",Mexico,Respiratory Diseases,1,1,351.0
471.0,NCT04665245,Symptom-Based Markers for COVID-19 Transmission,,Enrolling by invitation,COVID-19,,,,,,,,University of Iowa,All,"18 Years to 100 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-12-15,01/04/21,2021-01-04,11/12/20,12/01/21,"University of Iowa Hospitals & Clinics, Iowa City, Iowa",United States,Respiratory Diseases,1,1,20.0
472.0,NCT04437875,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",,Completed,COVID-19,,,,,,,Biological: Gam-COVID-Vac Lyo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|Acellena Contract Drug Research and Development",All,18 Years to 60 Years   (Adult),38.0,Other,Interventional,2020-06-17,03/08/20,2020-10-08,18/06/20,12/08/20,"Sechenov First Moscow State Medical University, Moscow",Russian Federation,Respiratory Diseases,1,1,113.0
473.0,NCT04334876,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,COVID-Antibody,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 IgG Antibody Testing Kit,Indiana University,All,"18 Years and older   (Adult, Older Adult)",340.0,Other,Observational,2020-01-04,01/11/20,2021-01-01,06/04/20,06/04/20,,,Respiratory Diseases,1,1,363.0
474.0,NCT04604249,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,RINCOVID,"Active, not recruiting",COVID-19,High Altitude,,,,,,"Diagnostic Test: SARS-CoV-2 rapid diagnostic test (COVID-PRESTO® IgM/IgG, AAZ, Boulogne-Billancourt, France)",Centre d'Expertise sur l'Altitude EXALT,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-10-26,30/11/21,2021-12-31,27/10/20,04/02/21,"La Rinconada, Puno",Peru,Respiratory Diseases,1,2,431.0
475.0,NCT04558372,Genosvid Diagnostic Test for Early Detection of COVID-19,,Completed,COVID-19,,,,,,,Other: exhaled breath sampling,Gadjah Mada University,All,"4 Years and older   (Child, Adult, Older Adult)",1999.0,Other,Interventional,2020-01-04,12/12/20,2020-12-12,22/09/20,29/12/20,"RS Bhayangkara Tk I R.Said Soekanto, Jakarta, Indonesia|Saiful Anwar, Malang, Indonesia|Dr Sardjito Hospital, Yogyakarta, Indonesia|Bambanglipuro Hospital, Yogyakarta, Indonesia|Bhayangkara Tk III Polda DIY, Yogyakarta, Indonesia|RS Akademik UGM, Yogyakarta, Indonesia|RSPAU Hardjolukito, Yogyakarta, Indonesia|RST Tk III Dr Soetarto, Yogyakarta",Indonesia,Respiratory Diseases,1,1,343.0
476.0,NCT04469647,COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Serology Test,Johns Hopkins Aramco Healthcare,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-07-19,15/01/21,2021-06-15,14/07/20,29/07/20,"Johns Hopkins Aramco Healthcare, Dhahran, Eastern",Saudi Arabia,Respiratory Diseases,1,1,331.0
477.0,NCT04784403,SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY,UB-GTMS-COVID,Completed,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 PCR and serology tests,Dr. Francisco Ciruela Alférez|Gerencia Territorial del Área Metropolitana Sur - Instituto Catalán de la Salud|Hospital Universitario de Bellvitge|Fundació IDIBELL|University of Barcelona,All,"18 Years and older   (Adult, Older Adult)",3356.0,Other,Observational,2020-12-14,24/02/21,2021-02-24,05/03/21,05/03/21,"Francisco Ciruela Alférez, L'Hospitalet De Llobregat, Barcelona",Spain,Respiratory Diseases,1,1,72.0
478.0,NCT04452630,Cardiovascular Consequences After COVID-19,,Recruiting,COVID-19,,,,,,,Other: Infectious Disease and Cardiology Clinical Consultations,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-06-23,23/07/20,2021-11-30,30/06/20,30/06/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,525.0
479.0,NCT04366739,Repurposing of Chlorpromazine in Covid-19 Treatment,reCoVery,Not yet recruiting,COVID-19,,,,,,,Drug: CHLORPROMAZINE (CPZ)|Combination Product: Standard of Care (SOC),Centre Hospitalier St Anne|Hôpital Cochin,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-29,30/08/20,2020-09-30,29/04/20,29/04/20,"Centre Hospitalier Sainte-Anne, Paris",France,Respiratory Diseases,1,1,154.0
480.0,NCT04514627,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,PENFS COVID-19,Recruiting,COVID-19,,,,,,,Device: Auricular percutaneous neurostimulation,Olive View-UCLA Education & Research Institute,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-13,31/07/21,2021-07-31,17/08/20,19/08/20,"Olive View-UCLA Medical Center, Sylmar, California",United States,Respiratory Diseases,1,1,383.0
481.0,NCT04399109,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),ReCOVER,Recruiting,COVID-19,,,,,,,Device: TCC-COVID mHealth solution,"Dr Sze-Yuan Ooi|The University of New South Wales|The George Institute|South Eastern Sydney Local Health District|Prince of Wales Hospital, Sydney",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-05-20,19/05/21,2021-05-19,22/05/20,22/05/20,"The Sutherland Hospital, Caringbah, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales",Australia,Respiratory Diseases,1,1,364.0
482.0,NCT04384614,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,CONNAITRE,Withdrawn,COVID-19,BCG Vaccination,,,,,,Diagnostic Test: Test PCR|Genetic: TDR|Other: Clinical Examination,Direction des Soins de Santé de Base|Eshmoun Clinical Research Centre|Dacima Consulting,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Observational,2020-05-15,15/07/20,2020-07-15,12/05/20,27/08/20,"Eshmoun Clinical Research Centre, Tunis",Tunisia,Respiratory Diseases,1,2,61.0
483.0,NCT04616976,COVID-19 With Convalescent Plasma,,Completed,COVID-19,,,,,,,Biological: convalescent plasma,"Southeast University, China",All,"18 Years and older   (Adult, Older Adult)",78.0,Other,Observational,2020-01-01,29/02/20,2020-01-11,05/11/20,05/11/20,"Zhongda Hospital, Southeast University, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,10.0
484.0,NCT04408378,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,,Recruiting,Coronavirus Infection,,,,,,,Other: observation of covid 19 pneumonia,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",156.0,Other,Observational,2020-05-06,20/07/20,2020-08-20,29/05/20,29/05/20,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa",Turkey,Respiratory Diseases,1,1,106.0
485.0,NCT04367896,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,,Completed,COVID-19,,,,,,,Other: Survey Group,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,,"Child, Adult, Older Adult",1819.0,Other,Observational,2020-03-24,17/04/20,2020-04-17,29/04/20,29/04/20,"Fondazione Policlinico Universitario Agostino Gemelli, Rome",Italy,Respiratory Diseases,1,1,24.0
486.0,NCT04373460,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,CSSC-004,Recruiting,SARS-CoV 2,,,,,,,Biological: SARS-CoV-2 convalescent plasma|Biological: Plasma from a volunteer donor,Johns Hopkins University|State of Maryland|Bloomberg Foundation|United States Department of Defense|National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years and older   (Adult, Older Adult)",1344.0,Other|U.S. Fed|NIH,Interventional,2020-03-06,21/12/22,2023-01-31,04/05/20,08/04/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Center for American Indian Health - Chinle Office, Chinle, Arizona, United States|Mayo Clinic, Phoenix, Phoenix, Arizona, United States|University of Arizona, Phoenix, Tucson, Arizona, United States|University of Arizona, Tuscon, Tucson, Arizona, United States|Center for American Indian Health - Whiteriver Office, Whiteriver, Arizona, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|University of California, Davis, Sacramento, California, United States|Western Connecticut Health Netowrk, Danbury Hospital, Danbury, Connecticut, United States|Western Connecticut Health Network, Norwalk Hospital, Norwalk, Connecticut, United States|University of Miami, Coral Gables, Florida, United States|University of Miami Clinical Translational Research Site, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|MedStar Washington Hospital Center, Hyattsville, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|Center for American Indian Health - Gallup Office, Gallup, New Mexico, United States|Center for American Indian Health - Shiprock Office, Shiprock, New Mexico, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|The University of Utah, Salt Lake City, Utah",United States,Respiratory Diseases,1,1,1061.0
487.0,NCT04800731,Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19,,Not yet recruiting,Lymphopenia,COVID-19,Older People,,,,,Other: observation no intervention,Universitair Ziekenhuis Brussel,All,70 Years and older   (Older Adult),300.0,Other,Observational,2021-06-30,31/12/23,2023-12-31,16/03/21,14/04/21,,,Respiratory Diseases,1,3,914.0
488.0,NCT04379063,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,COPING,"Active, not recruiting","Burnout, Professional",Psychological Distress,,,,,,Other: COVID-19 pandemic,Jon Bailey|Nova Scotia Health Authority,All,"Child, Adult, Older Adult",342.0,Other,Observational,2020-05-13,01/05/21,2022-01-05,07/05/20,28/09/20,"Nova Scotia Health Authority, Halifax, Nova Scotia",Canada,Others,0,2,602.0
489.0,NCT04362865,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,,Recruiting,COVID-19,,,,,,,,National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",360.0,NIH,Observational,2020-04-27,01/12/23,2024-01-12,27/04/20,15/03/21,"Medstar Washington Hospital Center, Washington, District of Columbia, United States|Medstar Franklin Square Medical Center, Baltimore, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|Medstar Montgomery Medical Center, Olney, Maryland",United States,Respiratory Diseases,1,1,1355.0
490.0,NCT04714333,Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath,Covid-VOC,Enrolling by invitation,COVID-19,,,,,,,,British Columbia Cancer Agency,All,"18 Years to 85 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-06-05,05/05/21,2021-05-05,19/01/21,22/01/21,"BC Cancer Research Centre, Vancouver, British Columbia, Canada|British Columbia Research Centre, Vancouver, British Columbia",Canada,Respiratory Diseases,1,1,334.0
491.0,NCT04386239,Study on the Use of Sarilumab in Patients With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Sarilumab Prefilled Syringe,ASST Fatebenefratelli Sacco,All,"18 Years to 84 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-01,01/01/21,2021-01-12,13/05/20,20/01/21,"Divisione Clinicizzata di Malattie Infettive, ASST FBF-Sacco, Milano, MI",Italy,Respiratory Diseases,1,1,11.0
492.0,NCT04463706,COVID19 Severity Prediction and Health Services Research Evaluation,,Recruiting,COVID-19,,,,,,,Other: Predictors adverse evolution|Other: Predictors of health care provide,Hospital Galdakao-Usansolo|Hospital Costa del Sol|Hospital del Mar|University Hospital of the Nuestra Señora de Candelaria|Instituto de Salud Carlos III|Hospital Universitario Araba|Biocruces Bizkaia Health Research Institute|Hospital de Basurto|Hospital Donostia,All,"Child, Adult, Older Adult",20000.0,Other,Observational,2020-01-06,30/06/21,2021-12-31,09/07/20,15/07/20,"Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain|Hospital Galdakao-Usansolo, Galdakao, Bizkaia",Spain,Respiratory Diseases,1,1,725.0
493.0,NCT04385017,Role of Inflammasomes in COVID-19 Disease,CoVInnate,Recruiting,COVID-19,,,,,,,Other: COVID-19 patients,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-11-05,12/06/21,2021-12-06,12/05/20,12/05/20,"Ch Cannes, Réanimation, Cannes, Alpes Maritimes, France|CHU de nice, Nice, Alpes-Maritimes",France,Respiratory Diseases,1,1,396.0
494.0,NCT04756518,COVID-19 Infection and Machine Learning Using Artificial Intelligence (AI),,Recruiting,COVID-19,COVID-19,SARS-CoV 2,,,,,,East Suffolk and North Essex NHS Foundation Trust|University of Suffolk,All,"18 Years and older   (Adult, Older Adult)",785.0,Other,Observational,2020-06-07,01/07/21,2021-01-07,16/02/21,16/02/21,"East Suffolk and North Essex NHS Foundation Trust, Ipswich",United Kingdom,Respiratory Diseases,1,3,214.0
495.0,NCT04764773,Persistence of Symptoms After Improvement of Acute COVID-19,COVID-19,Recruiting,Corona Virus Infection,,,,,,,Other: No intervention,Sohag University,All,"Child, Adult, Older Adult",250.0,Other,Observational,2020-01-05,28/02/21,2021-03-31,21/02/21,21/02/21,"Mona Mohammed Abdelrahman, Sohag",Egypt,Respiratory Diseases,1,1,451.0
496.0,NCT04479982,Microbial Infection and AMR in Hospitalized Patients With Covid 19,,Recruiting,COVID-19,,,,,,,,Assiut University,All,"Child, Adult, Older Adult",70.0,Other,Observational,2020-09-24,31/12/20,2020-12-31,21/07/20,22/09/20,"Assiut hopital, Assiut",Egypt,Respiratory Diseases,1,1,98.0
497.0,NCT04401098,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,,Recruiting,COVID-19,,,,,,,,Damanhour University,All,"Child, Adult, Older Adult",700.0,Other,Observational,2020-02-05,01/10/20,2021-01-04,26/05/20,26/05/20,"Damanhour University, Damanhūr, Beheira",Egypt,Respiratory Diseases,1,1,334.0
498.0,NCT04359849,Sequencing and Tracking of Phylogeny in COVID-19 Study,STOP COVID 19,Recruiting,Coronavirus Infection,,,,,,,,Portsmouth Hospitals NHS Trust|University of Portsmouth,All,"7 Years and older   (Child, Adult, Older Adult)",500.0,Other,Observational,2020-01-05,01/05/22,2022-01-09,24/04/20,24/04/20,"Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, Hampshire",United Kingdom,Respiratory Diseases,1,1,735.0
499.0,NCT04347798,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,IMPACT,Enrolling by invitation,COVID-19,Rheumatoid Arthritis,Psoriatic Arthritis,Hydroxychloroquine,,,,Other: Hydroxychloroquine/Chloroquine,University of Alberta,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-09,01/04/21,2021-01-04,15/04/20,04/06/20,"University of Alberta, Edmonton, Alberta",Canada,"Respiratory Diseases, Immunological Disorders",1,4,361.0
500.0,NCT04579458,Assessment of COVID-19 in Tearfilm,,Withdrawn,COVID-19,Ophthalmopathy,Eye Diseases,,,,,Procedure: Collection of tears and saliva.,Vanderbilt University Medical Center,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Observational,2020-12-28,22/01/21,2021-01-22,08/10/20,05/02/21,"Vanderbilt University Medical Center, Nashville, Tennessee",United States,Respiratory Diseases,1,3,25.0
501.0,NCT04374526,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,LIFESAVER,Recruiting,COVID-19,,,,,,,Biological: COVID-19 Convalescent Plasma,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,All,65 Years and older   (Older Adult),182.0,Other,Interventional,2020-05-27,30/04/21,2021-06-30,05/05/20,06/10/20,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, RM, Italy|Ospedale SS Annunziata, Chieti, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Rome",Italy,Respiratory Diseases,1,1,399.0
502.0,NCT04771052,Minimizing the Effects of COVID-19 Hospitalization With the COVID Rehabilitation Program for the Elderly,CORE,Enrolling by invitation,COVID-19,,,,,,,Other: COVID Rehabilitation Program for the Elderly (CORE),Université de Sherbrooke,All,"Child, Adult, Older Adult",128.0,Other,Observational,2020-01-09,01/04/21,2021-01-04,25/02/21,25/02/21,"CIUSSS de l'Estrie-Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional (CHAUR), Trois-Rivières, Quebec",Canada,Respiratory Diseases,1,1,361.0
503.0,NCT04459286,The Nitazoxanide Plus Atazanavir for COVID-19 Study,NACOVID,Recruiting,COVID-19,,,,,,,Drug: Nitazoxanide and atazanavir/ritonavir|Other: Standard of Care,Obafemi Awolowo University|University of Liverpool|African Centre of Excellence for Genomics of Infectious Diseases|Infectious Disease Hospital Olodo|Obafemi Awolowo University Teaching Hospitals Complex|Osun State Ministry of Health|Olabisi Onabanjo University Teaching Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",98.0,Other,Interventional,2020-09-10,31/03/21,2021-04-30,07/07/20,02/02/21,"Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Osun State, Nigeria|State Specialist Hospital Asubiaro, Osogbo, Osun State, Nigeria|Infectious Disease Hospital, Olodo, Ibadan, Oyo State",Nigeria,Respiratory Diseases,1,1,232.0
504.0,NCT04386564,Kidney Injury Severity and COVID-19,,Completed,COVID-19,Kidney Injury,,,,,,Diagnostic Test: mRNA in urine test,I.M. Sechenov First Moscow State Medical University,All,"18 Years and older   (Adult, Older Adult)",340.0,Other,Observational,2020-05-15,01/08/20,2020-01-09,13/05/20,09/02/21,"Sechenov University., Moscow",Russian Federation,Respiratory Diseases,1,2,-127.0
505.0,NCT04453670,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,,Completed,COVID-19,,,,,,,Procedure: autopsy,University of Versailles,All,"18 Years and older   (Adult, Older Adult)",7.0,Other,Observational,2020-10-03,11/05/20,2020-05-15,01/07/20,01/07/20,"Hôpital Raymond Poincaré, Garches",France,Respiratory Diseases,1,1,-141.0
506.0,NCT04479137,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,,Completed,COVID-19,"Risk Factor, Mortality",,,,,,Diagnostic Test: PCR for COVID-19,Kanuni Sultan Suleyman Training and Research Hospital,All,18 Years to 50 Years   (Adult),5000.0,Other,Observational,2020-10-03,30/06/20,2020-07-14,21/07/20,22/07/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,-81.0
507.0,NCT04765475,Protecting Native Families From COVID-19,,Recruiting,COVID-19,,,,,,,Behavioral: Motivational Interviewing|Behavioral: COVID-19 Symptom Monitoring System|Behavioral: Motivational Interviewing and COVID-19 Symptom Monitoring System|Other: Supportive Services,Johns Hopkins Bloomberg School of Public Health,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2021-08-03,01/02/22,2022-01-09,21/02/21,24/03/21,"Johns Hopkins Center for American Indian Health Whiteriver Office, Whiteriver, Arizona",United States,Respiratory Diseases,1,1,159.0
508.0,NCT04471649,Hydroxy Chloroquine and Covid in RA Patients,Covid-19,Recruiting,COVID-19,,,,,,,,Tanta University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-06-15,01/10/20,2020-01-11,15/07/20,09/09/20,"Tanta University Hospital, Tanta",Egypt,Respiratory Diseases,1,1,-156.0
509.0,NCT04631172,Covid-19 Anxiety and Phobia Levels of the Parents,,Completed,COVID-19,Anxiety and Fear,Parents,,,,,"Other: Coronavirus Anxiety Scale , COVID-19 Phobia Scale",Selcuk University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-01-05,30/09/20,2020-10-15,17/11/20,18/11/20,"Selcuk University, School of Medicine, Konya",Turkey,"Mental Health, Respiratory Diseases",1,3,284.0
510.0,NCT04723446,Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva,COVID-19,Not yet recruiting,COVID-19,Coronavirus,,,,,,Drug: Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate|Drug: Colgate Peroxyl® -1.5% Hydrogen peroxide|Other: Oral-B® Gum & Enamel Care -Cetylpyridinium chloride|Other: No rinsing,Queen Mary University of London|GlaxoSmithKline,All,"18 Years and older   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2021-01-02,01/07/21,2022-01-01,25/01/21,25/01/21,,,Respiratory Diseases,1,2,364.0
511.0,NCT04480580,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,,Completed,COVID-19,Surgery,SARS (Severe Acute Respiratory Syndrome),,,,,Diagnostic Test: SARS-CoV-2 Ab,University of Cagliari,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-03-30,30/04/20,2020-06-30,21/07/20,21/07/20,"AOU Cagliari, Cagliari, CA",Italy,Respiratory Diseases,1,3,92.0
512.0,NCT04383626,Fear Among Dentists During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,,Cairo University,All,"20 Years and older   (Adult, Older Adult)",216.0,Other,Observational,2020-02-03,05/04/20,2020-05-05,12/05/20,12/05/20,"Cairo University, Cairo",Egypt,Respiratory Diseases,1,1,92.0
513.0,NCT04298814,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,,Withdrawn,COVID-19,Endotracheal Intubation,,,,,,Other: severe covid-19 pneumonia with ET,Tongji Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",0.0,Other,Observational,2020-07-08,30/12/20,2020-12-30,06/03/20,20/07/20,"Tongji Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,2,175.0
514.0,NCT04699903,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 (COVID-19) IgG Antibody Test in Fingerstick Whole Blood",,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: POC SARS-Cov-2 IgG Antibody test,"Rapid Pathogen Screening|Lumos Diagnostics, Inc|RapidPS",All,"1 Year and older   (Child, Adult, Older Adult)",215.0,Industry|Other,Observational,2020-12-28,22/01/21,2021-05-02,07/01/21,07/01/21,"Benchmark - SoCal, Colton, California, United States|Comprehensive Clinical Research, West Palm Beach, Florida, United States|Great Lakes Clinical Trials (GLCT), Chicago, Illinois, United States|UCCT- AFC Urgent Care Throgs Neck, Bronx, New York",United States,Respiratory Diseases,1,1,125.0
515.0,NCT04432272,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),ABACCuS,"Active, not recruiting",COVID-19,Severe Acute Respiratory Syndrome (SARS),Coronavirus Infections,,,,,Biological: COVID-19 convalescent plasma,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-07-16,01/06/21,2021-01-08,16/06/20,08/01/21,"William Beaumont Hospital, Royal Oak, Michigan",United States,Respiratory Diseases,1,3,176.0
516.0,NCT04316728,Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,,Not yet recruiting,Coronavirus Infections,,,,,,,Device: VivaDiag™ COVID-19 lgM/IgG Rapid Test,"Centro Studi Internazionali, Italy|VivaChek Laboratories, Inc.",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-03,01/09/20,2020-01-11,20/03/20,20/03/20,"Unità' Complesse di cure primarie (UCCP), ASP Catanzaro, Catanzaro",Italy,Respiratory Diseases,1,1,8.0
517.0,NCT04359810,Plasma Therapy of COVID-19 in Severely Ill Patients,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Non-convalescent Plasma (control plasma),"Max R. O'Donnell|New York Blood Center|Amazon.com, Inc.|Columbia University",All,"18 Years and older   (Adult, Older Adult)",219.0,Other,Interventional,2020-04-21,01/12/20,2021-01-04,24/04/20,13/11/20,"Columbia University Irving Medical Center/NYP, New York, New York, United States|Hospital Federal dos Servidores do Estado, Rio De Janeiro, Brazil|Hospital Geral de Nova Iguaçu, Rio De Janeiro, Brazil|Instituto Nacional de Infectologia Evandro Chagas, Rio De Janeiro",Brazil,Respiratory Diseases,1,1,258.0
518.0,NCT04554992,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID 19 Convalescent Plasma,The Methodist Hospital System,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2020-03-20,01/06/22,2022-01-06,18/09/20,02/11/20,"Houston Methodist Hopsital, Houston, Texas",United States,Respiratory Diseases,1,1,657.0
519.0,NCT04584450,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,,Completed,COVID-19,,,,,,,Other: Questionnaire,Hacettepe University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-02-09,31/12/20,2020-12-31,14/10/20,29/01/21,"Hacettepe University, Ankara",Turkey,Respiratory Diseases,1,1,326.0
520.0,NCT04437719,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",OBVIONCO,Recruiting,Oncology,COVID-19,,,,,,Other: Obvio-19 app,Groupe Hospitalier Paris Saint Joseph|ObvioHealth,All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-06-29,29/12/21,2021-12-31,18/06/20,14/08/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,2,550.0
521.0,NCT04370223,Ozone Auto-hemotherapy for COVID-19 Pneumonia,COVID-OZONE,Not yet recruiting,COVID-19,,,,,,,Biological: Ozone auto-hemotherapy,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta|Clinica Nuestra Senora del Rosario,All,"18 Years to 90 Years   (Adult, Older Adult)",208.0,Other,Interventional,2020-05-25,25/10/20,2020-12-25,30/04/20,09/06/20,"Hospital Universitari Dr Josep Trueta, Girona, Spain|Clinica Nuestra Señora del Rosario, Ibiza, Spain|Hospital Quirón Rey Juan Carlos I, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Príncipe de Asturias de Alcalá de Henares, Madrid, Spain|Fundació Althaia de Manresa, Manresa, Spain|Hospital Vithas Valencia Consuelo, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Clinica Claro, Vigo",Spain,Respiratory Diseases,1,1,214.0
522.0,NCT04615000,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,,Recruiting,COVID-19,"Children, Only",,,,,,Diagnostic Test: SARS-CoV-2 serological assessment (IgG),"University Hospital, Ghent|University Ghent",All,"up to 18 Years   (Child, Adult)",1000.0,Other,Observational,2020-10-29,01/11/21,2021-01-11,04/11/20,04/11/20,"Ghent University Hospital, Ghent",Belgium,Respiratory Diseases,1,2,74.0
523.0,NCT04583189,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,,Completed,COVID-19,,,,,,,Diagnostic Test: Performance of the test antigenic and test RT-PCR,Centre Hospitalier Intercommunal Creteil,All,"up to 18 Years   (Child, Adult)",500.0,Other,Interventional,2020-01-10,25/11/20,2020-11-25,12/10/20,02/12/20,"Centre hospitalier intercommunal de Créteil, Créteil, France|Cabinet de ville, Nogent sur Marne, France|Cabinet Dr Cohen, Saint-Maur-des-Fossés, France|Cabinet de ville 13 Villa Beauséjour, Vincennes",France,Respiratory Diseases,1,1,320.0
524.0,NCT04696913,Does COVID-19 Infection Increase the Risk of Pulmonary Embolism?,,Not yet recruiting,COVID-19,Pulmonary Embolism,,,,,,Diagnostic Test: Exposure: Positive COVID-19 infection|Diagnostic Test: Exposure: Negative COVID-19 infection,University of Aberdeen,All,"16 Years and older   (Child, Adult, Older Adult)",347.0,Other,Observational,2021-01-01,22/11/21,2021-11-22,06/01/21,06/01/21,,,Respiratory Diseases,1,2,325.0
525.0,NCT04465058,Characteristics of Critically Ill COVID 19 Patients,,Recruiting,COVID-19,,,,,,,Other: COVID19,Assiut University,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-08-07,08/08/20,2020-10-08,09/07/20,09/07/20,"Assiut university, Assiut",Egypt,Respiratory Diseases,1,1,62.0
526.0,NCT04380987,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Predi-COVID,Recruiting,COVID-19,,,,,,,Biological: Biological sampling,Luxembourg Institute of Health|Centre Hospitalier du Luxembourg|Hopitaux Robert Schuman (Luxembourg)|Laboratoire National de Santé (Luxembourg)|University of Luxembourg,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-05,31/07/21,2021-12-31,08/05/20,08/05/20,"Luxembourg Institute of Health, Luxembourg",Luxembourg,Respiratory Diseases,1,1,635.0
527.0,NCT04335136,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,APN01-COVID-19,Completed,COVID-19,,,,,,,Drug: RhACE2 APN01|Drug: Physiological saline solution,Apeiron Biologics,All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Industry,Interventional,2020-04-30,26/12/20,2020-12-26,06/04/20,22/01/21,"Medizinische Universität Innsbruck, Innsbruck, Austria|Kaiser Franz Josef Spital, 4. Medizinische Abteilung mit Infektions- und Tropenmedizin, Wien, Austria|Medizinische Universität Wien, Wien, Austria|The National University Hospital, Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Klinikum rechts der Isar, Technische Universität München, München, Germany|Regional State Budgetary Educational Institution Clinical Hospital № 5, Barnaul, Barnaul, Russian Federation|State Healthcare Institution State Clinical Hspital № 15 named after O.M. Filatov, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution City Clinical Hospital №52 of Health Department of Moscow, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution N.V. Sklifosovsky Research Institute for Emergency Medicine of Health Department of Moscow, Moscow, Russian Federation|Saint Petersburg SBHI City Hospital 38 named after N A Semashko, Pushkin, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Ryazan State Medical University named after I.P. Pavlov HD RF, Ryazan, Russian Federation|Alexandrovskaya Hospital, Saint-Petersburg, Russian Federation|Saint-Petersburg State Budget Healthcare Institution City Hospital 15, Saint-Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education  Saratov State Medical University named after V.I. Razumovsky HD RF, Saratov, Russian Federation|Regional State Budgetary Healthcare Institution Clinical Hospital №1, Smolensk, Russian Federation|State budgetary institution of Healthcare of Tver region Regional clinical hospital, Tver, Russian Federation|Yaroslavl Regional Clinical Hospital for Military Veterans - International Centre for Gerontological Problems Healthy Ageing, Yaroslavl, Russian Federation|Cambridge University Hospitals NHS Trust/University of Cambridge, Cambridge",United Kingdom,Respiratory Diseases,1,1,240.0
528.0,NCT04390503,Convalescent Plasma for Early Treatment of COVID-19,,Recruiting,SARS-CoV 2,COVID-19,,,,,,Biological: Convalescent Plasma (anti-SARS-CoV-2 plasma)|Biological: Control (albumin 5%),Andrew Eisenberger|Columbia University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-01-03,01/04/22,2022-01-04,15/05/20,08/03/21,"National Institute of Infectious Diseases Evandro Chagas (INI), Rio de Janeiro",Brazil,Respiratory Diseases,1,2,366.0
529.0,NCT04474340,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Drug: COVID-19 Convalscent Plasma,"Ministry of Health, Kuwait",All,"15 Years to 85 Years   (Child, Adult, Older Adult)",300.0,Other,Interventional,2020-05-21,30/09/20,2020-12-30,16/07/20,21/07/20,"Ministry Of Health, Kuwait",Kuwait,Respiratory Diseases,1,2,223.0
530.0,NCT04667442,Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Nanomix eLab® COVID-19 Rapid Antigen Panel (non-interventional),Nanomix,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Observational,2020-01-12,01/03/21,2021-01-03,14/12/20,25/01/21,"Nanomix, Emeryville, California",United States,Respiratory Diseases,1,1,357.0
531.0,NCT04339608,Max COVID19- Study,,Recruiting,COVID-19,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-02-04,30/05/20,2020-06-30,09/04/20,09/04/20,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi",India,Respiratory Diseases,1,1,147.0
532.0,NCT04649918,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,STEPCO,"Active, not recruiting",COVID-19,SARS-CoV Infection,Pulmonary Rehabilitation,Quality of Life,,,,Other: pulmonary rehabilitation,Schön Klinik Berchtesgadener Land,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-11-25,16/01/21,2021-04-30,02/12/20,18/02/21,"Schön Klinik Berchtesgadener Land, Schönau Am Königssee, Bavaria",Germany,Respiratory Diseases,1,4,156.0
533.0,NCT04678687,COVID-19 and Tissue Damage in Vital Organs,,"Active, not recruiting",COVID-19,Postmortem Changes,,,,,,"Procedure: Liver, lung, heart and kidney biopsy",Dokuz Eylul University,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2021-01-01,01/06/21,2022-01-01,22/12/20,03/02/21,"Dokuz Eylul University, İzmir, Balçova",Turkey,Respiratory Diseases,1,2,365.0
534.0,NCT04382092,Co-infection Management in COVID-19 Critically Ill,,Completed,COVID-19,,,,,,,Diagnostic Test: FilmArray Pneumonia,Cliniques universitaires Saint-Luc- Université Catholique de Louvain|BioMérieux,All,"18 Years and older   (Adult, Older Adult)",32.0,Other|Industry,Interventional,2020-03-23,24/04/20,2020-04-24,11/05/20,11/05/20,"Cliniques Universitaires Saint-Luc, Brussels",Belgium,Respiratory Diseases,1,1,32.0
535.0,NCT04425837,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,,Not yet recruiting,Sars-CoV2,COVID-19,,,,,,Biological: SARS-CoV-2 convalescent plasma treatment|Other: Standard care,Fundación Santa Fe de Bogota,All,"18 Years and older   (Adult, Older Adult)",236.0,Other,Interventional,2020-01-07,01/02/21,2021-01-02,11/06/20,11/06/20,"Fundación Santa Fe de Bogotá, Bogotá, Cundinamarca",Colombia,Respiratory Diseases,1,2,361.0
536.0,NCT04765436,"PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64",,Recruiting,COVID-19,,,,,,,Biological: PTX-COVID19-B|Biological: Placebo,Providence Therapeutics Holdings Inc.,All,18 Years to 64 Years   (Adult),60.0,Industry,Interventional,2021-01-14,30/04/21,2022-02-14,21/02/21,21/02/21,"Manna Research, Toronto, Ontario",Canada,Respiratory Diseases,1,1,396.0
537.0,NCT04584567,"OD-doxy-PNV-COVID-19 Old Drug "" DOXY "" for Prevention of New Virus "" COVID-19 """,,Recruiting,COVID-19,,,,,,,Drug: Doxycyclin,"Hedi Gharsallah|Dacima Consulting|General Administration of Military Health, Tunisia",All,"18 Years to 65 Years   (Adult, Older Adult)",1100.0,Other,Interventional,2020-11-20,01/02/21,2021-01-03,14/10/20,05/02/21,"Military Hospital of Tunis, Tunis, Montfleury",Tunisia,Respiratory Diseases,1,1,44.0
538.0,NCT04682041,Evaluating the Impact of EnteraGam In People With COVID-19,PICNIC,Recruiting,COVID-19,,,,,,,Dietary Supplement: Bovine Plasma-Derived Immunoglobulin Concentrate|Other: Standard of care,"Entera Health, Inc|Lemus Buhils, SL|Clinical Research Unit, IMIM (Hospital del Mar Medical Research Institute)",All,"18 Years and older   (Adult, Older Adult)",420.0,Industry|Other,Interventional,2020-12-22,30/06/21,2021-06-30,23/12/20,28/01/21,"Hospital del Mar, Barcelona",Spain,Respiratory Diseases,1,1,190.0
539.0,NCT04657419,Fatigue and Sleep in Patients With COVID-19,COFATSOM,Not yet recruiting,COVID-19,,,,,,,Other: survey,"University Hospital, Bordeaux",All,18 Years to 45 Years   (Adult),720.0,Other,Observational,2020-05-12,31/05/21,2021-06-30,08/12/20,14/12/20,,,Respiratory Diseases,1,1,414.0
540.0,NCT04462627,Reduction of COVID 19 Transmission to Health Care Professionals,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Blood group determination|Diagnostic Test: Antibody titration|Dietary Supplement: Probiotic,Hanane EL KENZ|Brugmann University Hospital,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-14,01/12/21,2021-01-12,08/07/20,28/01/21,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,273.0
541.0,NCT04474457,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,,"Active, not recruiting",COVID-19,,,,,,,Drug: Favipiravir,"Ministry of Health, Turkey|Hacettepe University, School of Medicine|Prof. Dr. Cemil Tascıoglu City Hospital|Umraniye Training and Research Hospital|Istanbul Training and Research Hospital|Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey|Tepecik Training and Research Hospital|Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine|Ankara University|Ankara City Hospital Bilkent|Ankara Training and Research Hospital|Ege University Hospital (Application and Research Center)|Derince Training and Research Hospital|Istanbul University, Istanbul Faculty of Medicine|Kayseri City Hospital",All,"15 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-11-06,31/12/20,2021-01-06,16/07/20,01/02/21,"Hacettepe University, School of Medicine, Ankara",Turkey,Respiratory Diseases,1,1,61.0
542.0,NCT04747158,COVID-19 Convalescent Plasma Therapy,TPCC,Completed,COVID-19,COVID-19,,,,,,Biological: Convalescent plasma,"Universidad Nacional de Asunción|Consejo Nacional de Ciencias y Tecnología, Paraguay|Ministerio de Salud Pública y Bienestar Social, Paraguay|Centro de información y recursos para el desarrollo, Paraguay",All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2020-10-08,10/12/20,2021-10-01,10/02/21,02/03/21,"Facultad de Ciencias Médicas - Universidad Nacional de Asunción, Asunción",Paraguay,Respiratory Diseases,1,2,358.0
543.0,NCT04425915,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma|Other: Standard of Care,"Institute of Liver and Biliary Sciences, India",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-06-14,30/05/21,2021-05-30,11/06/20,03/09/20,"Maulana Azad Medical College, New Delhi, Delhi, India|Institute of Liver & Biliary Sciences, New Delhi, Delhi, India|Rajiv Gandhi Super Speciality Hospital, New Delhi, Delhi",India,Respiratory Diseases,1,1,350.0
544.0,NCT04339634,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,,"Active, not recruiting",COVID-19,Drug Effect,Drug Interaction,Adverse Drug Event,,,,Other: Simulation of Repurposed Drugs for COVID-19,Tabula Rasa HealthCare,All,"55 Years and older   (Adult, Older Adult)",12123.0,Industry,Observational,2020-07-04,07/07/20,2021-06-04,09/04/20,14/04/20,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida",United States,Respiratory Diseases,1,4,335.0
545.0,NCT04817371,Analysis of Volatile Organic Compounds in Exhaled Air and Sweat: Interest in Rapid Screening for COVID-19 Infection.,VOCSARSCOVDep,Recruiting,COVID-19,,,,,,,Device: Volatile Organic Compounds analysis (e-noses)|Other: Canine odor detection of Volatile Organic Compounds|Device: Volatile Organic Compounds analysis (mass spectrometry)|Device: Volatile Organic Compounds analysis in sweat (mass spectrometry),Hopital Foch,All,"18 Years and older   (Adult, Older Adult)",192.0,Other,Interventional,2021-01-03,01/03/22,2022-01-03,26/03/21,30/03/21,"Foch hospital, Suresnes",France,Respiratory Diseases,1,1,365.0
546.0,NCT04695652,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult,COVID-19,"Active, not recruiting",COVID-19,,,,,,,Biological: MVC-COV1901(S protein with adjuvant)|Biological: MVC-COV1901(Saline),Medigen Vaccine Biologics Corp.,All,"20 Years and older   (Adult, Older Adult)",3700.0,Industry,Interventional,2020-12-30,01/06/21,2022-01-06,05/01/21,30/03/21,"Changhua Christian Hospital, Changhua, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Taipei Municipal Wan Fang Hospital, Taipei, Taiwan|Taipei Veteran General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang-Guang Memorial Hospital Lin-Kou, Taoyuan, Taiwan|Tao-Yuan General Hospital, Taoyuan, Taiwan|National Institute of Hygiene and Epidemiology, Hanoi",Vietnam,Respiratory Diseases,1,1,372.0
547.0,NCT04636320,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,COVID-CMR,Recruiting,COVID-19,Virus Disease,,,,,,Device: Contrast-enhanced CMR|Diagnostic Test: Exercise test ECG|Biological: Blood sample|Diagnostic Test: Resting 12 lead ECG|Diagnostic Test: 24 hour Holter ECG,"University Hospital, Bordeaux|Grant Agreement ERC n°715093|University of Bordeaux - mission UB-C19",All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Interventional,2020-06-13,13/01/21,2021-04-13,19/11/20,19/11/20,"Bordeaux University Hospital, Pessac",France,Respiratory Diseases,1,2,304.0
548.0,NCT04492865,MSCT Chest in Suspected COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Device: MSCT,Assiut University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-07-30,30/08/20,2020-10-30,30/07/20,30/07/20,"Assiut university, Assiut",Egypt,Respiratory Diseases,1,1,92.0
549.0,NCT04443881,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),ANA-COVID-GEAS,Recruiting,COVID-19,,,,,,,Drug: Anakinra 149 MG/ML Prefilled Syringe [Kineret],Fundacion Miguel Servet,All,"18 Years to 80 Years   (Adult, Older Adult)",180.0,Other,Interventional,2020-08-05,01/12/20,2021-01-03,23/06/20,23/06/20,"Hospital Clinic, Barcelona, Cataluña, Spain|Hospital Universitario Vall d´Hebron, Barcelona, Cataluña, Spain|Complexo Hospitalario Universitario de Santiago, Santiago De Compostela, Galicia, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Mallorca, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Universitario y Politecnico La Fe, Valencia, Spain|Complejo Hospitalario Universitario de Vigo, Vigo, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza",Spain,Respiratory Diseases,1,1,151.0
550.0,NCT04527458,Case Fatalities in Hospitalised COVID-19 Patients in the UK,,Completed,COVID-19,,,,,,,Other: Patient Characteristics|Other: COVID-19 treatments|Other: Differences in triage|Other: Surge capacity,University of Edinburgh|International Severe Acute Respiratory and Emerging Infection Consortium|BREATHE Health Data Research Hub,All,"Child, Adult, Older Adult",70000.0,Other,Observational,2020-02-24,02/08/20,2020-02-08,26/08/20,26/08/20,"University of Edinburgh, Edinburgh",United Kingdom,Respiratory Diseases,1,1,-16.0
551.0,NCT04352933,PROLIFIC ChemoprophylaxisTrial (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine - Daily dosing|Drug: Hydroxychloroquine - Weekly Dosing|Other: Matched Placebo Hydroxychloroquine,Cambridge University Hospitals NHS Foundation Trust,All,"18 Years to 70 Years   (Adult, Older Adult)",1000.0,Other,Interventional,2020-11-05,31/10/20,2021-01-04,20/04/20,13/05/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge",United Kingdom,Respiratory Diseases,1,1,60.0
552.0,NCT04318418,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",CODIV-ACE,Completed,COVID-19,,,,,,,,Neuromed IRCCS,All,"Child, Adult, Older Adult",3400.0,Other,Observational,2020-03-23,10/05/20,2020-06-30,24/03/20,16/09/20,"IRCCS Neuromed, Department of Epidemiology and Prevention, Pozzilli",Italy,Respiratory Diseases,1,1,99.0
553.0,NCT04376580,Use of the Nasal Cannula During COVID-19,,Enrolling by invitation,COVID-19,,,,,,,,Tiva Group,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-04-30,31/10/20,2020-11-30,06/05/20,06/10/20,"Carolina Frederico, Buenos Aires, Caba",Argentina,Respiratory Diseases,1,1,214.0
554.0,NCT04345523,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients,ConPlas-19,Recruiting,COVID-19,,,,,,,Other: Blood and derivatives.|Drug: Standard of Care,Cristina Avendaño Solá|Instituto de Salud Carlos III|Puerta de Hierro University Hospital,All,"18 Years and older   (Adult, Older Adult)",278.0,Other,Interventional,2020-03-04,01/02/21,2021-01-04,14/04/20,01/02/21,"Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital Universitario Mútua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Meco, Madrid, Spain|Hospital General de Albacete, Albacete, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Ciudad Real, Ciudad Real, Spain|Hospital Universitario Donostia, Donostia, Spain|Hospital Doctor Josep Trueta, Girona, Spain|Hospital Doctor Negrín, Las Palmas, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital Universitario Arnau de Vilanova, Lleida, Spain|Hospital San Pedro, Logroño, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Quironsalud Pozuelo, Madrid, Spain|Hospital Sant Joan de Deu de Manresa. Fundación Althaia, Manresa, Spain|Hospital Universitario de Asturias, Oviedo, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Clínica Universidad de Navarra (CUN). Sedes Pamplona y Madrid, Pamplona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Sant Joan de Reus, Reus, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario Marqués de Valdecilla, Santander, Spain|Complejo Hospitalario de Toledo, Toledo, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Miguel Servet, Zaragoza",Spain,Respiratory Diseases,1,1,306.0
555.0,NCT04343755,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Biological: Convalescent Plasma,Hackensack Meridian Health,All,"18 Years and older   (Adult, Older Adult)",52.0,Other,Interventional,2020-09-04,01/04/21,2021-01-04,13/04/20,01/12/20,"Hackensack University Medical Center, Hackensack, New Jersey",United States,Respiratory Diseases,1,1,122.0
556.0,NCT04420182,COVID-19 Virtual Care at Home,,Recruiting,COVID-19,,,,,,,Other: Virtual Care at Home,Lawson Health Research Institute|Cardiac Arrhythmia Network of Canada,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-08-17,30/06/21,2021-12-31,09/06/20,08/12/20,"St. Mary's General Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|Ottawa Heart Research Institute, Ottawa, Ontario, Canada|Niagara Health, St. Catharines, Ontario, Canada|St. Joseph's Health Centre, Toronto, Ontario",Canada,Respiratory Diseases,1,1,501.0
557.0,NCT04467151,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",,Withdrawn,COVID-19,,,,,,,Drug: anti-SARS-CoV-2 plasma|Other: Placebo,Kashif Khan|University of Southern California,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-10,01/10/21,2021-01-12,10/07/20,22/10/20,,,Respiratory Diseases,1,1,368.0
558.0,NCT04397523,Efficacy and Safety of COVID-19 Convalescent Plasma,,Recruiting,Convalescent Plasma,COVID-19,SARS-CoV 2,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,"Institute for Transfusion Medicine of RNM|University Clinic for Infectious Diseases, North Macedonia",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-30,29/04/21,2021-04-29,21/05/20,01/03/21,"Institute for Transfusion Medicine of RNM, Skopje",North Macedonia,Respiratory Diseases,1,3,364.0
559.0,NCT04362930,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),CoCo-Neuro,Recruiting,Neurologic Manifestations,Psychiatric Disorders,COVID-19,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-04-27,24/04/22,2022-04-24,27/04/20,13/05/20,"Hôpital Pitié Salpétrière, Paris",France,Respiratory Diseases,1,3,727.0
560.0,NCT04723394,Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults,TACKLE,Recruiting,COVID-19,,,,,,,Drug: AZD7442|Drug: Placebo,AstraZeneca,All,"18 Years and older   (Adult, Older Adult)",1700.0,Industry,Interventional,2021-01-28,30/06/21,2022-05-27,25/01/21,15/02/21,"Research Site, Tempe, Arizona, United States|Research Site, Tucson, Arizona, United States|Research Site, Huntington Beach, California, United States|Research Site, Long Beach, California, United States|Research Site, Pomona, California, United States|Research Site, Rolling Hills Estates, California, United States|Research Site, Pompano Beach, Florida, United States|Research Site, Conyers, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, La Vista, Nebraska, United States|Research Site, North Las Vegas, Nevada, United States|Research Site, New York, New York, United States|Research Site, Statesville, North Carolina, United States|Research Site, Fargo, North Dakota, United States|Research Site, Columbus, Ohio, United States|Research Site, West Columbia, South Carolina, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Berlin - Friedrichshain, Germany|Research Site, Berlin, Germany|Research Site, Berlin, Germany|Research Site, Frankfurt, Germany|Research Site, Hamburg, Germany|Research Site, Hannover, Germany|Research Site, Köln, Germany|Research Site, Mainz, Germany|Research Site, München-Pasing, Germany|Research Site, München, Germany|Research Site, Budapest, Hungary|Research Site, Chihuahua, Mexico|Research Site, Cuautitlan Izcalli, Mexico|Research Site, Mérida, Mexico|Research Site, Tlalpan, Mexico|Research Site, Blackpool, United Kingdom|Research Site, Bristol, United Kingdom|Research Site, Connor Downs, United Kingdom|Research Site, Leicester, United Kingdom|Research Site, Rochdale",United Kingdom,Respiratory Diseases,1,1,484.0
561.0,NCT04372979,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,PLASCOSSA,Recruiting,COVID-19,,,,,,,Drug: Transfusion of SARS-CoV-2 Convalescent Plasma.|Drug: Transfusion of standard Plasma.,"Direction Centrale du Service de Santé des Armées|University Hospital, Grenoble",All,"18 Years to 90 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-09-14,01/05/21,2021-01-06,04/05/20,21/12/20,"HIA Percy, Clamart, France|HIA Laveran, Marseille, France|HIA Bégin, Saint-Mandé, France|HIA Sainte Anne, Toulon",France,Respiratory Diseases,1,1,114.0
562.0,NCT04329559,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,,Completed,COVID-19,Liver Cirrhosis,,,,,,,"Hepatopancreatobiliary Surgery Institute of Gansu Province|Renmin Hospital of Wuhan University|LanZhou University|Minda Hospital Affiliated to Hubei University for Nationalities|Wuhan Union Hospital, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture|Tianjin Second People's Hospital|Sixth People's Hospital of Shenyang|Guangxi Zhuang Autonomous Region|Shenzhen Third People's Hospital|Ankang Central Hospital|Xingtai People's Hospital|Dalian Sixth People's Hospital|The Central Hospital of Lishui City|The Affiliated Third Hospital of Jiangsu University|Suizhou Hospital, Hubei University of Medicine",All,"18 Years and older   (Adult, Older Adult)",21.0,Other,Observational,2020-03-30,10/02/21,2021-10-02,01/04/20,24/02/21,"Dalian Sixth People's Hospital, Dalian, China|Minda Hospital Affiliated to Hubei University for Nationalities, Enshi, China|The Central Hospital of Enshi Tujia And Miao Autonomous Prefecture, Enshi, China|The First Hospital of Lanzhou University, Lanzhou, China|The Central Hospital of Lishui City, Lishui, China|Guangxi Zhuang Autonomous Region, Nanning, China|The Sixth Peoples Hospital of Shenyang, Shenyang, China|Shenzhen Third People's Hospital, Shenzhen, China|Suizhou Hospital, Hubei University of Medicine, Suizhou, China|Tianjin Second People's Hospital, Tianjin, China|Ankang Central Hospital, Wuhan, China|Renmin Hospital of Wuhan University, Wuhan, China|Wuhan Union Hospital, Wuhan, China|Xingtai People's Hospital, Xingtai, China|The Affiliated Third Hospital of Jiangsu University, Zhenjiang",China,Respiratory Diseases,1,2,551.0
563.0,NCT04383535,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,PLASM-AR,Completed,SARS Virus,COVID-19,COVID-19,,,,,Other: Convalescent SARS COVID-19 plasma|Other: Placebo,Hospital Italiano de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",333.0,Other,Interventional,2020-05-15,27/09/20,2020-09-27,12/05/20,30/09/20,"Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires",Argentina,Respiratory Diseases,1,3,135.0
564.0,NCT04824664,The ALIGHIERI Survey: an Italian Overview of Global Impact of tHe COVID-19 pandemIc on General surgERy practIce,ALIGHIERI,Completed,COVID-19,,,,,,,Other: survey,Associazione Chirurghi Ospedalieri Italiani,All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-01-01,30/07/20,2020-12-30,01/04/21,01/04/21,"ACOI, Roma, Lazio",Italy,Respiratory Diseases,1,1,364.0
565.0,NCT04313946,Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,AI-COVID-Xr,Recruiting,COVID-19,"Pneumonia, Viral",Influenza With Pneumonia,Flu Symptom,Flu Like Illness,"Pneumonia, Interstitial","Pneumonia, Ventilator-Associated",Diagnostic Test: Scanning Chest X-rays and performing AI algorithms on images,Professor Adrian Covic|Falcon Trading Iasi|Romanian Academy of Medical Sciences|Grigore T. Popa University of Medicine and Pharmacy,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-03-18,16/08/20,2020-08-18,18/03/20,27/04/20,"U.O. Multidisciplinare di Patologia Mammaria e Ricerca Traslazionale; Dipartimento Universitario Clinico di Scienze Mediche, Chirurgiche e della Salute Università degli Studi di Trieste, Cremona, Italy|University of Medicine and Pharmacy Gr T Popa, Iaşi, Romania|Department of Cardiology at Chelsea and Westminster NHS hospital, London",United Kingdom,"Infectious Diseases, Respiratory Diseases",1,7,153.0
566.0,NCT04387799,Determinants of COVID-19 Pneumonia (MC-19),MC-19,Completed,"Pneumonia, Viral","Pneumonia, Bacterial",Coronavirus Infection,Obstructive Lung Disease,,,,Diagnostic Test: Serology for Covid-19,Catholic University of the Sacred Heart,All,"18 Years to 100 Years   (Adult, Older Adult)",520.0,Other,Observational,2020-05-13,12/06/20,2020-06-17,14/05/20,19/06/20,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma",Italy,Respiratory Diseases,1,4,35.0
567.0,NCT04554433,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,,Not yet recruiting,COVID-19,Drug Effect,,,,,,Drug: Ethanol with Asprin,Mansoura University,All,20 Years to 60 Years   (Adult),80.0,Other,Interventional,2020-01-12,01/10/21,2022-01-06,18/09/20,28/10/20,,,Respiratory Diseases,1,2,725.0
568.0,NCT04465552,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,,Recruiting,Coronavirus Infections,,,,,,,Other: Patients received standard of care treatment during hospitalization,Kansas City Heart Rhythm Research Foundation,All,"18 Years and older   (Adult, Older Adult)",750.0,Other,Observational,2020-10-07,01/06/21,2021-01-10,10/07/20,04/02/21,"Kansas City Heart Rhythm Institute, Overland Park, Kansas",United States,Respiratory Diseases,1,1,95.0
569.0,NCT04818736,COVID-19 Vaccine For Indirect Protection,,Not yet recruiting,Vaccine Preventable Disease,,,,,,,Biological: COVID-19 Vaccination|Other: Usual care,McMaster University|University of Alberta|University of Saskatchewan|University of Manitoba,All,"Child, Adult, Older Adult",4000.0,Other,Interventional,2021-04-15,01/09/21,2021-01-12,26/03/21,02/04/21,"McMaster University, Hamilton, Ontario",Canada,Others,0,1,-93.0
570.0,NCT04757818,"Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%.",CPC COVID,Recruiting,COVID-19,,,,,,,Other: 0.07% cetylpyridinium chloride (CPC) in mouthwash|Other: Distilled water with the same colorant as the experimental product,"Dentaid SL|IrsiCaixa|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",All,"18 Years and older   (Adult, Older Adult)",140.0,Industry|Other,Interventional,2021-04-02,25/03/21,2021-03-25,17/02/21,17/02/21,"CAP Gorg, Badalona, Barcelona, Spain|CAP Gran Sol, Badalona, Barcelona, Spain|CAP St Roc, Badalona, Barcelona, Spain|CAP Dr Barraquer, Sant Adrià De Besòs, Barcelona, Spain|CAP Barri Llatí, Santa Coloma De Gramenet, Barcelona, Spain|CAP Fondo, Santa Coloma De Gramenet, Barcelona, Spain|CAP Santa Rosa, Santa Coloma De Gramenet, Barcelona, Spain|CAP Singuerlin, Santa Coloma De Gramenet, Barcelona, Spain|CAP Dr Robert, Badalona",Spain,Respiratory Diseases,1,1,-8.0
571.0,NCT04603729,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,covid19,Completed,COVID-19,,,,,,,Drug: Dexamethasone 2 MG/ML|Drug: Methylprednisolone Injection,Fatima Memorial Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-30,30/06/20,2020-01-07,27/10/20,27/10/20,"Fatima Memorial Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,-144.0
572.0,NCT04733170,Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: KnowNow SARS-CoV-2 Rapid Antigen Test,Vatic Ltd.,All,"18 Years and older   (Adult, Older Adult)",600.0,Industry,Observational,2021-02-15,31/08/21,2021-08-31,01/02/21,25/02/21,,,Respiratory Diseases,1,1,197.0
573.0,NCT04401241,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,MONACOVID,Completed,COVID-19,,,,,,,,Centre Hospitalier Princesse Grace,All,"18 Years and older   (Adult, Older Adult)",257.0,Other,Observational,2020-01-02,01/05/20,2020-05-15,26/05/20,26/05/20,"Centre Hospitalier Princesse Grace, Monaco, MON",Monaco,Respiratory Diseases,1,1,134.0
574.0,NCT04418557,COVID-19 and Obstetric Transmission,COVIDOB,Recruiting,COVID-19,Pregnancy Complications,,,,,,Diagnostic Test: RT-PCR and antibody testing,University Hospitals Cleveland Medical Center|Cuyahoga County Board of Health|The Cleveland Clinic|MetroHealth Medical Center|Case Western Reserve University,Female,18 Years to 50 Years   (Adult),200.0,Other,Observational,2020-04-28,31/07/21,2021-07-31,05/06/20,01/04/21,"University Hospitals Cleveland Medical Center, Cleveland, Ohio",United States,Respiratory Diseases,1,2,459.0
575.0,NCT04444596,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,,Recruiting,COVID-19,SARS-CoV 2,,,,,,Diagnostic Test: Conjunctival swab and nasopharyngeal swab,Medical University Innsbruck,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-17,31/03/21,2021-03-31,23/06/20,23/06/20,"Medical University Innsbruck, Innsbruck, Tirol",Austria,Respiratory Diseases,1,2,287.0
576.0,NCT04674553,Effect of Obesity Among COVID-19 Patients in Critical Care Settings,,Completed,Obesity,COVID-19,,,,,,,"Services Institute of Medical Sciences, Pakistan",All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-10-11,10/12/20,2020-10-12,19/12/20,19/12/20,"Mehwish Iftikhar, Lahore, Punjab",Pakistan,"Respiratory Diseases, Metabolic Disorders",1,2,1.0
577.0,NCT04374695,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",COVHYP,Not yet recruiting,COVID-19,,,,,,,,"Versailles Hospital|Bernard LIVAREK, MD, Cardiology department, Versailles Hospital|Jean-Paul BERESSI, MD, Department of diabetology, Versailles Hospital|Mehrsa KOUKABI FRADELIZZI, MD, Emergency department, Versailles Hospital|Floriane GILLES, MD, Cardiology department, Versailles Hospital|Alisson BERTRAND, Cardiology department, Versailles Hospital|Marie DE TOURNEMIRE, Cardiology department, Versailles Hospital|Victorien MONGUILLON, Cardiology department, Versailles Hospital|Maeva PASQUALINI, Cardiology department, Versailles Hospital|Alix PREVOT, Cardiology department, Versailles Hospital|Guillaume ROGER, Cardiology department, Versailles Hospital|Joseph SABA, Cardiology department, Versailles Hospital|Joséphine SOLTANI, Cardiology department, Versailles Hospital|Jean-François PROST, Cardiology department, Versailles Hospital|Cécile LAUREANA, Department of medical information, Versailles Hospital",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-01-05,01/06/20,2020-01-07,05/05/20,05/05/20,,,Respiratory Diseases,1,1,2.0
578.0,NCT04359264,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,DISTANSE COVID,"Active, not recruiting",COVID-19,,,,,,,Other: Cash transfer,Unity Health Toronto,All,"18 Years and older   (Adult, Older Adult)",392.0,Other,Interventional,2020-04-20,29/05/20,2020-12-30,24/04/20,07/07/20,"Municipality of Assiginack Family Health Team, Assiginack, Ontario, Canada|St Michael's Hospital Academic Family Health Team, Toronto, Ontario",Canada,Respiratory Diseases,1,1,254.0
579.0,NCT04490850,COVID-19 Seroprevalence Study in French Guiana,EPI-COVID-POP,Recruiting,Coronavirus Infection,Severe Acute Respiratory Syndrome,SARS-CoV Infection,COVID-19,,,,Procedure: Blood sample,"Institut Pasteur|Institut Pasteur de la Guyane|Laboratoire de biologie médicale, Institut Pasteur de la Guyane|Laboratoire de biologie médicale de Kourou, French Guiana|Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, French Guiana|Laboratoire Eurofins Guyane de Rémire-Montjoly, French Guiana|Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana",All,"Child, Adult, Older Adult",1500.0,Industry|Other,Interventional,2020-07-15,15/07/21,2021-07-15,29/07/20,29/07/20,"Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Laboratoire de biologie méicale, Institut Pasteur de la Guyane, Cayenne, French Guiana|Laboratoires Eurofins Guyane, Cayenne, French Guiana|Laboratoire de biologie médicale de Kourou, Kourou, French Guiana|Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, Saint-Laurent du Maroni",French Guiana,Respiratory Diseases,1,4,365.0
580.0,NCT04377789,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,,Completed,COVID-19,,,,,,,Dietary Supplement: Quercetin Prophylaxis|Dietary Supplement: Quercetin Treatment,Kanuni Sultan Suleyman Training and Research Hospital|Orbiteratec (funding),All,"18 Years and older   (Adult, Older Adult)",447.0,Other,Interventional,2020-03-20,31/07/20,2020-08-31,06/05/20,18/02/21,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,164.0
581.0,NCT04521088,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,,Recruiting,COVID-19,,,,,,,,Wissenschaftliches Institut Bethanien e.V,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-02-07,31/12/20,2020-12-31,20/08/20,14/12/20,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen",Germany,Respiratory Diseases,1,1,328.0
582.0,NCT04394884,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),,Suspended,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",120.0,NIH,Observational,2021-09-09,30/04/23,2023-04-30,20/05/20,24/03/21,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Walter Reed National Medical Center, Bethesda, Maryland, United States|National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,598.0
583.0,NCT04344457,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",COVID-19,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Indomethacin|Drug: Zithromax Oral Product,"Perseverance Research Center, LLC|Athena Medical Group",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-04-16,20/06/20,2020-09-30,14/04/20,01/07/20,"Perseverance Research Center, Scottsdale, Arizona, United States|Covidcraz 19, Llc, New Orleans, Louisiana",United States,Respiratory Diseases,1,1,167.0
584.0,NCT04608383,Laparoscopy and COVID-19 Contamination,LAPCOV,Recruiting,COVID-19,,,,,,,Other: Additional and minimal collection of products of the human body carried out during a sample for standard of care,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-11-19,01/01/22,2022-01-01,29/10/20,02/03/21,"AP-HP, Bicêtre Hospital, Anesthesia Department, Le Kremlin Bicêtre, France|AP-HP, Bicêtre Hospital, Gynecology department, Le Kremlin Bicêtre, France|AP-HP, Bicêtre Hospital, Department of Digestive and Oncological Surgery, Le Kremlin-Bicêtre, France|AP-HP, Bicêtre Hospital, Urology Department, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,1,408.0
585.0,NCT04817332,STOP-COVID19: Superiority Trial Of Protease Inhibition in COVID-19,STOP-COVID19,Completed,COVID-19,,,,,,,Drug: Brensocatib|Drug: Placebo,University of Dundee|NHS Tayside|Insmed Incorporated,All,"16 Years and older   (Child, Adult, Older Adult)",400.0,Other|Industry,Interventional,2020-05-06,28/02/21,2021-02-28,26/03/21,26/03/21,"NHS Grampian, Aberdeen, United Kingdom|Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Cardiff & Vale University Health Board, Cardiff, United Kingdom|NHS Tayside, Dundee, United Kingdom|NHS Fife, Dunfermline, United Kingdom|Frimley Health NHS Foundation Trust, Frimley, United Kingdom|Princess Alexandra Hospital NHS Trust, Harlow, United Kingdom|NHS Highland, Inverness, United Kingdom|NHS Forth Valley, Larbert, United Kingdom|University Hospitals of Leicester NHS Trust, Leicester, United Kingdom|Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom|University Hospitals North Midlands NHS Trust, Stoke-on-Trent, United Kingdom|NHS Lanarkshire, Wishaw",United Kingdom,Respiratory Diseases,1,1,298.0
586.0,NCT04364815,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine plus standard preventive measures|Drug: Placebo plus standard preventive measures,University of the Philippines,All,18 Years to 59 Years   (Adult),0.0,Other,Interventional,2020-01-12,01/05/21,2021-01-05,28/04/20,06/11/20,"Philippine General Hospital - University of the Philippines Manila, Manila",Philippines,Respiratory Diseases,1,1,359.0
587.0,NCT04663737,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Silmitasertib|Drug: SOC,"Chris Recknor, MD|Senhwa Biosciences, Inc.",All,"18 Years and older   (Adult, Older Adult)",20.0,Industry,Interventional,2020-03-12,31/05/21,2021-06-30,11/12/20,17/03/21,"Center for Advanced Research and Education, Gainesville, Georgia",United States,Respiratory Diseases,1,1,475.0
588.0,NCT04437342,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,,Completed,Postpartum Depression,Psychological Stress,Maternal Distress,,,,,Other: PHQ-9 (Patient Health Questionnaire) Depression Scale|Other: GAD-7 (General Anxiety Disorder) scale|Other: 38 questions questionnaire|Other: EPDS (Edinburgh Postnatal Depression Scale),"General and Maternity Hospital of Athens Elena Venizelou|National and Kapodistrian University of Athens|Alexandra Hospital, Athens, Greece|University of Ioannina|Larissa University Hospital",Female,"18 Years and older   (Adult, Older Adult)",330.0,Other,Observational,2020-06-30,30/08/20,2020-10-27,18/06/20,06/01/21,"Elena Venizelou General and Maternity Hospital of Athens, Athens, Attica, Greece|Aretaieio University Hospital, Athens, Attica, Greece|Alexandra Genaral Hospital Athens, Athens, Greece|University of Ioannina Health Science, Ioannina, Greece|University of Ioannina, Medical School, Ioannina, Greece|University of Thessaly Medical School, Larisa",Greece,Mental Health,1,3,119.0
589.0,NCT04420988,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,,Available,COVID-19,SARS-CoV 2,SARS-CoV Infection,,,,,Biological: COVID-19 Convalescent Plasma,"Rutgers, The State University of New Jersey|University Hospital - Newark, NJ",All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Individual Patients|Intermediate-size Population,,,,09/06/20,09/06/20,"Rutgers New Jersey Medical School, Newark, New Jersey, United States|University Hospital, Newark, New Jersey",United States,Respiratory Diseases,1,3,
590.0,NCT04514874,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,Covaé,Completed,COVID-19,SARS-CoV Infection,,,,,,Other: Questionnaire,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",479.0,Other,Observational,2020-01-09,05/10/20,2020-05-10,17/08/20,09/03/21,"Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy, Clamart, France|Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Sainte-Anne, Toulon",France,Respiratory Diseases,1,2,122.0
591.0,NCT04800965,Text-based Interventions to Promote COVID-19 Vaccinations,,Enrolling by invitation,COVID-19,,,,,,,Behavioral: Patient MyChart Scheduling Link|Behavioral: Patient Educational Video|Behavioral: Enhanced Follow through Message,"University of California, Los Angeles|Carnegie Mellon University",All,"18 Years and older   (Adult, Older Adult)",400000.0,Other,Interventional,2021-01-31,31/12/21,2022-01-01,16/03/21,24/03/21,"UCLA Health Department of Medicine, Quality Office, Westwood, California",United States,Respiratory Diseases,1,1,335.0
592.0,NCT04666064,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,COVILUS2,Recruiting,COVID-19,Lung Ultrasound,Respiratory Complication,,,,,Diagnostic Test: Covid19 RT-PCR|Other: lung ultrasound,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-10-12,01/06/21,2021-01-07,14/12/20,14/12/20,"BAR, Amiens",France,Respiratory Diseases,1,3,87.0
593.0,NCT04801940,HElping Alleviate the Longer-term Consequences of COVID-19 (HEAL-COVID),HEAL-COVID,Not yet recruiting,COVID-19,,,,,,,Drug: Apixaban|Drug: Atorvastatin,Cambridge University Hospitals NHS Foundation Trust|University of Liverpool|Cambridge University Hospitals NHS Foundation Trust (joint Sponsor)|The University of Cambridge (joint Sponsor),All,"18 Years and older   (Adult, Older Adult)",2631.0,Other,Interventional,2021-01-03,31/01/24,2024-01-31,17/03/21,17/03/21,,,Respiratory Diseases,1,1,1123.0
594.0,NCT04382794,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,SIDIACO-RETRO',Completed,COVID-19,,,,,,,Drug: Retrospective case-control analysis,"University of Milan|Papa Giovanni XXIII Hospital|IRCCS Policlinico S. Matteo|Humanitas Hospital, Italy|Ospedale dell'Angelo, Venezia-Mestre|University of Pavia",All,"18 Years and older   (Adult, Older Adult)",338.0,Other,Observational,2020-05-14,15/06/20,2020-06-15,11/05/20,09/07/20,"ASST FBF-Sacco P.O. Sacco, Milan, MI, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|Ospedale dell'Angelo, Venezia-Mestre, Mestre, Italy|Humanitas Hospital, Milan, Italy|University of Pavia, Pavia, Italy|IRCCS Policlinico S. Matteo, Pavia",Italy,Respiratory Diseases,1,1,32.0
595.0,NCT04563156,Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection,SegCov,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Lung Function Test,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-06-23,30/06/21,2021-12-31,24/09/20,24/09/20,"Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo-HCFMUSP, São Paulo",Brazil,Respiratory Diseases,1,1,556.0
596.0,NCT04393155,COVID Cohort Study,,Terminated,COVID-19,Acute Respiratory Failure,,,,,,Other: COVID-19+ observational,University of Vermont,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Observational,2020-04-16,20/01/21,2021-01-25,19/05/20,12/02/21,"University of Vermont College of Medicine, Burlington, Vermont",United States,Respiratory Diseases,1,2,284.0
597.0,NCT04490824,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,,Recruiting,COVID-19,,,,,,,Device: KELEA Excellerated Water|Device: Water Without an Elevated Level of KELEA,Institute of Progressive Medicine,All,"Child, Adult, Older Adult",100.0,Other,Interventional,2020-01-10,30/03/21,2021-04-30,29/07/20,12/02/21,"Institute of Progressive Medicine, South Pasadena, California",United States,Respiratory Diseases,1,1,476.0
598.0,NCT04466644,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),,Completed,COVID-19,,,,,,,Diagnostic Test: ELISA|Diagnostic Test: RT-PCR,Igenomix,All,"18 Years and older   (Adult, Older Adult)",340.0,Industry,Observational,2020-08-06,24/08/20,2020-08-25,10/07/20,14/09/20,"Boston IVF Fertility Clinic, Boston, Massachusetts, United States|Utah Fertility Clinic, Pleasant Grove, Utah",United States,Respiratory Diseases,1,1,19.0
599.0,NCT04525911,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,ALCOVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: Diagnostic Test: serology test for COVID-19,Hôpital Européen Marseille,All,"18 Years and older   (Adult, Older Adult)",258.0,Other,Observational,2020-08-26,01/03/21,2022-01-10,25/08/20,14/09/20,"BENNANI, Marseille",France,Respiratory Diseases,1,1,502.0
600.0,NCT04484597,Predictors of COVID-19 Infection and Disease Progression,Portsaiduni,Recruiting,COVID-19,,,,,,,Diagnostic Test: Rt PCR,Port Said University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-03-15,15/08/20,2020-09-15,23/07/20,23/07/20,"Prof. Refat Sadeq, Port Said",Egypt,Respiratory Diseases,1,1,184.0
601.0,NCT04524156,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,COVID-pO2-RAAS,Not yet recruiting,COVID-19,Acute Respiratory Distress Syndrome,Endothelial Dysfunction,,,,,Other: Physiology,Erasme University Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-10,04/09/21,2023-04-05,24/08/20,24/08/20,"Erasme Hospital, Bruxelles",Belgium,Respiratory Diseases,1,3,1090.0
602.0,NCT04724538,Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19,,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Radiation: 99mTc-pertechnetate|Radiation: 99mTc-pertechnetate aerosol|Drug: 99mTc-pertechnetate aerosol,National Medical Research Radiological Centre of the Ministry of Health of Russia,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-10-15,10/02/21,2021-03-15,26/01/21,26/01/21,"P. Hertsen Moscow Oncology Research Institute, Moscow",Russian Federation,Respiratory Diseases,1,2,151.0
603.0,NCT04353609,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",covid19 fai2r,Recruiting,Sars-CoV2,Chronic Inflammatory Rheumatism,Autoimmune Diseases,,,,,,"University Hospital, Lille|FAI²R (Auto-immune and auto-inflammatory rare diseases French network)",All,"Child, Adult, Older Adult",13770.0,Other,Observational,2020-04-18,01/12/20,2020-01-12,20/04/20,22/04/20,"Hôpital Huriez, Lille",France,Respiratory Diseases,1,3,-97.0
604.0,NCT04334252,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,,Completed,COVID-19,,,,,,,Other: Questionnaire,Jessa Hospital,All,"18 Years and older   (Adult, Older Adult)",528.0,Other,Observational,2020-04-17,20/12/20,2020-12-20,06/04/20,06/01/21,"Jessa hospital, Hasselt",Belgium,Respiratory Diseases,1,1,247.0
605.0,NCT04473131,Immune Profiling of COVID19-patients Admitted to ICU,IMPROVISE,Recruiting,COVID-19,,,,,,,Other: No intervention,Hamad Medical Corporation|Qatar University|Weill Cornell Medical College in Qatar,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry|Other,Observational,2020-04-27,01/06/22,2022-01-06,16/07/20,16/07/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,1,619.0
606.0,NCT04745377,Responses to COVID-19 Vaccination in Patients With Cancer,ReCOVer,Recruiting,Cancer,,,,,,,Diagnostic Test: IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus,Hellenic Cooperative Oncology Group,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-12-01,30/08/21,2022-01-31,09/02/21,09/02/21,"Metropolitan Hospital, Athens, Attica",Greece,Cancers,1,1,61.0
607.0,NCT04352634,The Covid-19 HEalth caRe wOrkErS (HEROES) Study,HEROES,Recruiting,COVID-19,Mental Health Disorder,Stress Disorder,Anxiety,Depression,COVID-19,,Other: Exposure to the SARS-CoV-2 and its consequences,University of Chile|Columbia University,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-04-26,31/12/21,2021-12-31,20/04/20,01/04/21,"Columbia University, New York, New York, United States|Universidad del Chubut, Rawson, Chubut, Argentina|National Institute of Health Named After Academician S. Avdalbekyan, Yerevan, Armenia|University of Sydney, Sidney, New South Wales, Australia|Salud Global, Sucre, Chuquisaca, Bolivia|University of Chile, Santiago, Chile|Universidad Nacional de Costa Rica, Heredia, Costa Rica|Society for Emergecy and Disaster Medicine CzMA JEP, Kladno, Bohemia, Czechia|Hochschule Emden/Leer, Emden, Niedersachsen, Germany|Centro de Investigaciones de las Ciencias de la Salud -CICS- Facultad de Ciencias Médicas Universidad de San Carlos de Guatemala -USAC-, Guatemala City, Guatemala|University of Cagliari, Cagliari, CA, Italy|University of Cagliari, Cagliari, Italy|The Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon|Logotipo del comercio Instituto Jalisciense De Salud Mental (SALME), Guadalajara, Jalisco, Mexico|Maastricht University, Maastricht, Limburg, Netherlands|University of Ibadan, Ibadan, Oyo State, Nigeria|Ponce Health Sciences University, Ponce, Puerto Rico|King Abdullah International medical research center, Riyadh, Central, Saudi Arabia|Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain|Razi Hospital La Manouba, Tunis, La Manouba, Tunisia|Koc University, Istanbul, Sariyer, Turkey|PNFA Salud Colectiva Instituto de Altos Estudios Dr Arnoldo Gabaldon, Maracay, Aragua",Venezuela,"Mental Health, Respiratory Diseases",1,6,614.0
608.0,NCT04591704,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,COVID-19-DM2,Recruiting,COVID-19,Diabetes Mellitus,,,,,,"Other: hospitalisation, necessity of ICU, mortality rate, lung involvement",Uşak University,All,"18 Years to 80 Years   (Adult, Older Adult)",2000.0,Other,Observational,2020-03-20,15/10/20,2020-01-11,19/10/20,19/10/20,"Usak University Training and Research Hospital, Usak",Turkey,"Metabolic Disorders, Respiratory Diseases",1,2,-69.0
609.0,NCT04317040,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,SAC-COVID,Completed,COVID-19,,,,,,,Drug: CD24Fc|Drug: Placebo,"OncoImmune, Inc.",All,"18 Years and older   (Adult, Older Adult)",243.0,Industry,Interventional,2020-04-24,20/10/20,2020-10-20,20/03/20,26/03/21,"Baptist Health Research Institute, Jacksonville, Florida, United States|Anne Anundel Medical Center, Annapolis, Maryland, United States|Institute of Human Virology, University of Maryland Baltimore, Baltimore, Maryland, United States|Shady Grove Medical Center, Rockville, Maryland, United States|White Oak Medical Center, Silver Spring, Maryland, United States|Cooper University Hospital, Camden, New Jersey, United States|Atlantic Health System, Morristown, New Jersey, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|The Ohio State University Medical Center, Columbus, Ohio, United States|University of Texas at Houston, Houston, Texas",United States,Respiratory Diseases,1,1,179.0
610.0,NCT04572360,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,Covid19Reh,Not yet recruiting,COVID-19,,,,,,,Other: Cardiorespiratory Exercise|Other: Modified Bai He Gu Jin Tang,"Hong Kong Baptist University|The University of Hong Kong|Chinese University of Hong Kong|The Hong Kong Polytechnic University|University of South Wales|Yale University|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",172.0,Other,Interventional,2020-01-10,31/12/22,2023-06-30,01/10/20,01/10/20,"Linda Zhong, Kowloon Tong, Kowloon",Hong Kong,Respiratory Diseases,1,1,1267.0
611.0,NCT04497818,Correlation Fear of COVID-19 & Dental Treatment Anxiety,,Completed,COVID-19,Fear,Dental Anxiety,,,,,Other: Cross Sectional study using scientifically validated psychometric Scales,Qassim University,All,"20 Years and older   (Adult, Older Adult)",385.0,Other,Observational,2020-06-16,16/07/20,2020-07-25,04/08/20,04/08/20,"Dr Bugude Shiva Shankar, Ar Rass, Al Qassim",Saudi Arabia,"Mental Health, Respiratory Diseases",1,3,39.0
612.0,NCT04381312,Direct and Indirect Impact of COVID-19 In Older Populations,COVID-OLD,Recruiting,COVID-19,,,,,,,,"University Hospital, Grenoble",All,70 Years and older   (Older Adult),1000.0,Other,Observational,2020-09-04,09/07/21,2021-09-10,08/05/20,08/05/20,"Chu Grenoble Alpes, Grenoble Cedex 9, Grenoble",France,Respiratory Diseases,1,1,371.0
613.0,NCT04438629,Evaluation of Immune Response in COVID-19 Patients,IMMUNOVID,Recruiting,Allergy and Immunology,Infection Viral,,,,,,Drug: COVID-19 treatment,Azienda Ospedaliera Universitaria Integrata Verona,All,"18 Years to 90 Years   (Adult, Older Adult)",80.0,Other,Observational,2020-03-26,10/06/20,2020-11-26,19/06/20,22/06/20,"Azienda Ospedaliera Universitaria Integrata Verona, Verona",Italy,Others,0,2,245.0
614.0,NCT04610138,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,,Not yet recruiting,COVID-19,,,,,,,Drug: CNM-ZnAg|Drug: Placebo,Clene Nanomedicine|ICL Pharma|Azidus Brazil,All,"40 Years to 90 Years   (Adult, Older Adult)",276.0,Industry|Other,Interventional,2021-01-02,01/07/21,2021-01-08,30/10/20,01/02/21,,,Respiratory Diseases,1,1,6.0
615.0,NCT04659941,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,ProBCG,Recruiting,COVID-19,,,,,,,Biological: BCG vaccine,"Universidade Federal do Rio de Janeiro|Ministry of Science and Technology, Brazil",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-01-10,01/10/21,2022-01-10,09/12/20,09/12/20,"Universidade Federal do Rio de Janeiro, Rio De Janeiro, RJ",Brazil,Respiratory Diseases,1,1,731.0
616.0,NCT04475575,Can the Electronic Nose Smell COVID-19 Antibodies?,,Completed,SARS-CoV Infection,COVID-19,,,,,,Device: Aeonose,Maastricht University Medical Center,All,"18 Years and older   (Adult, Older Adult)",222.0,Other,Interventional,2020-06-04,30/06/20,2020-01-07,17/07/20,17/07/20,"Maastricht University Medical Center, Maastricht",Netherlands,Respiratory Diseases,1,2,-149.0
617.0,NCT04345692,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,OAHU-COVID19,Terminated,COVID-19,,,,,,,Drug: Hydroxychloroquine,Queen's Medical Centre,All,"18 Years to 95 Years   (Adult, Older Adult)",17.0,Other,Interventional,2020-03-26,31/08/20,2020-08-31,14/04/20,17/11/20,"Queen's Medical Center, Honolulu, Hawaii",United States,Respiratory Diseases,1,1,158.0
618.0,NCT04824313,Vascular Abnormalities Detected With Chest CT in COVID-19,COVID-CAVA,"Active, not recruiting",COVID-19,"Pneumonia, Viral",Pulmonary Embolism,,,,,Diagnostic Test: Chest CT|Diagnostic Test: Chest CTA,"Salah D. Qanadli|University of Geneva, Switzerland|University of Bern|University of Basel|University of Zurich|University of Lausanne",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-03,31/07/20,2021-03-31,01/04/21,01/04/21,"CHUV, Lausanne, Vaud",Switzerland,Respiratory Diseases,1,3,453.0
619.0,NCT04718467,Phase IIb Clinical Trial of Recombinant Novel Coronavirus Pneumonia (COVID-19) Vaccine (Sf9 Cells),,Not yet recruiting,COVID-19,,,,,,,Biological: Recombinant COVID-19 vaccine (Sf9 cells)|Biological: Placebo,Jiangsu Province Centers for Disease Control and Prevention|West China Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",4000.0,Other,Interventional,2021-01-02,15/05/21,2022-03-15,22/01/21,25/01/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,437.0
620.0,NCT04780659,COVID-19 Vaccination of Immunodeficient Persons (COVAXID),COVAXID,Recruiting,COVID-19,,,,,,,"Biological: Comirnaty (COVID-19, mRNA vaccine)",Karolinska University Hospital|Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",540.0,Other,Interventional,2021-02-23,31/12/22,2022-12-31,03/03/21,03/03/21,"Karolinska University Hospital, Stockholm, Huddinge",Sweden,Respiratory Diseases,1,1,676.0
621.0,NCT04815018,Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2,COVID-19,Recruiting,COVID-19,Bacterial Respiratory Tract Infection,Viral Respiratory Tract Infection,,,,,,Pathnostics,All,"60 Years and older   (Adult, Older Adult)",300.0,Industry,Observational,2020-07-10,01/04/21,2021-01-05,24/03/21,24/03/21,"Willow Brook Christian Village, Delaware, Ohio, United States|Willow Brook Delaware Run, Delaware, Ohio, United States|Kendall at Granville, Granville, Ohio, United States|Inniswood Village, Westerville, Ohio",United States,Respiratory Diseases,1,3,179.0
622.0,NCT04624997,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,SARCODO,Recruiting,COVID-19,COVID-19,,,,,,Other: biological sample,"Assistance Publique - Hôpitaux de Paris|National Research Agency, France",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-08-06,01/12/20,2020-01-12,12/11/20,12/11/20,"Hôpital Cochin, Paris, France|Hôpital Européen Georges Pompidou, Paris",France,Respiratory Diseases,1,2,-207.0
623.0,NCT04325061,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,DEXA-COVID19,Terminated,COVID-19,,,,,,,Drug: Dexamethasone,"Dr. Negrin University Hospital|Li Ka Shing Knowledge Institute|Consorcio Centro de Investigación Biomédica en Red, M.P.",All,"18 Years and older   (Adult, Older Adult)",19.0,Other,Interventional,2020-03-04,19/06/20,2020-06-19,27/03/20,03/02/21,"ICU, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain|Department of Anesthesia, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|Intensive Care Unit, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain|AVI, Hospital Clinic, Barcelona, Spain|Cardiac ICU, Hospital Clinic, Barcelona, Spain|Department of Anesthesia, Hospital Clinic, Barcelona, Spain|Hepatic ICU, Hospital Clínic, Barcelona, Spain|UVIR, Hospital Clinic, Barcelona, Spain|Intensive Care Unit, Hospital General de Ciudad Real, Ciudad Real, Spain|Department of Anesthesia, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Princesa, Madrid, Spain|Intensive Care Unit, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Department of Anesthesia, Hospital Universitario La Paz, Madrid, Spain|Intensive Care Unit, Hospital Universitario La Paz, Madrid, Spain|Department of Anesthesia, Hospital Universitario Virgen de Arrixaca, Murcia, Spain|Intensive Care Unit, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Department of Anesthesia, Hospital Unversitario Montecelo, Pontevedra, Spain|Anesthesia, Hospital General Universitario de Valencia, Valencia, Spain|Department of Anesthesia, Hospital Clinico Universitario, Valencia, Spain|Intensive Care Unit, Hospital Clinico Universitario, Valencia, Spain|Department of Anesthesia, Hospital Clínico Universitario, Valladolid, Spain|Anesthesia, Hospital Universitario Río Hortega, Valladolid, Spain|Intensive Care Unit, Hospital Universitario Río Hortega, Valladolid",Spain,Respiratory Diseases,1,1,107.0
624.0,NCT04743908,Community Network-driven COVID-19 Testing of Vulnerable Populations in the Central US,C3,Not yet recruiting,COVID-19,,,,,,,Other: Social Network Strategy + COVID-19 messaging,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",2400.0,Other,Interventional,2021-01-02,01/12/23,2023-01-12,08/02/21,08/02/21,,,Respiratory Diseases,1,1,740.0
625.0,NCT04407559,COVID-SErology in Rheumatoid Arthritis (COVID-19),COVID-SERA,Completed,COVID-19,Rheumatoid Arthritis,,,,,,Other: Serological analyses to be lead on a pre-existing biobank,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Observational,2020-01-05,01/09/20,2020-09-30,29/05/20,29/12/20,"Uhmontpellier, Montpellier",France,"Respiratory Diseases, Immunological Disorders",1,2,269.0
626.0,NCT04828915,Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning,COVID-19,Recruiting,COVID-19,,,,,,,Other: Machine learning|Other: Machine based evaluation,University Hospital Tuebingen|Max-Planck-Institute Tuebingen,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-02,31/07/21,2021-12-31,02/04/21,02/04/21,"University Hospital of Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,1,363.0
627.0,NCT04343261,Convalescent Plasma in the Treatment of COVID 19,,Completed,COVID-19,COVID-19,Coronavirus,,,,,Biological: Convalescent Plasma,Saint Francis Care,All,"18 Years to 90 Years   (Adult, Older Adult)",48.0,Other,Interventional,2020-10-04,23/07/20,2020-08-13,13/04/20,24/09/20,"Trinity Health Of New England, Hartford, Connecticut",United States,Respiratory Diseases,1,3,-52.0
628.0,NCT04568655,The Noninvasive Ventilation to COVID-19 Patients,,Completed,COVID-19,,,,,,,Device: noninvasive ventilation,The First Affiliated Hospital of Guangzhou Medical University,All,"20 Years to 80 Years   (Adult, Older Adult)",23.0,Other,Observational,2020-01-02,01/07/20,2020-01-07,29/09/20,29/09/20,"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,5.0
629.0,NCT04495933,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",,Recruiting,SARS-CoV2,COVID-19,,,,,,Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 5mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 15mcg|Biological: MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 45mcg|Other: Placebo,The University of Queensland|Syneos Health|Coalition for Epidemic Preparedness Innovations,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2020-07-13,01/10/20,2021-01-09,03/08/20,04/09/20,"Nucleus Network Brisbane (Q-Pharm Pty Ltd), Herston, Queensland",Australia,Respiratory Diseases,1,2,180.0
630.0,NCT04837651,Comparing the Antibody Response to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab or Natalizumab,OCR-VAX,Recruiting,Multiple Sclerosis,"Demyelinating Autoimmune Diseases, CNS",Autoimmune Diseases of the Nervous System,Nervous System Diseases,Demyelinating Diseases,Autoimmune Diseases,Immune System Diseases,Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test,"Dragonfly Research, LLC",All,18 Years to 55 Years   (Adult),100.0,Other,Observational,2021-08-03,08/03/22,2022-08-09,08/04/21,08/04/21,"Dragonfly Research, LLC, Wellesley, Massachusetts",United States,Immunological Disorders,1,7,371.0
631.0,NCT04756609,"Systematic Offer of Nurse-Driven Screening for COVID-19 in Emergency Departments in the Paris Metropolitan Area, DEPIST-COVID",DEPIST-COVID,Not yet recruiting,SARS-CoV Infection,Nurse's Role,,,,,,Procedure: Systematic offer of nurse-driven SARS-CoV-2 screening combined with usual practice|Other: Usual emergency department practice with physician-directed diagnostic testing,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",104000.0,Other,Interventional,2021-12-02,01/06/21,2021-01-06,16/02/21,16/02/21,"URC-EST, Hôpital saint-Antoine, Paris",France,Respiratory Diseases,1,2,-330.0
632.0,NCT04377737,Incidence of Covid-19 in School Children,COVIDECOLE,Withdrawn,"Infection; Viral, Coronavirus",,,,,,,Diagnostic Test: RT-PCR Covid-19,Fondation Lenval,All,3 Years to 10 Years   (Child),0.0,Other,Interventional,2020-05-15,01/08/20,2020-01-09,06/05/20,27/05/20,"Hôpitaux Pédiatrique de Nice CHU Lenval, Nice",France,Respiratory Diseases,1,1,-127.0
633.0,NCT04760730,Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Biological: AZD1222|Biological: rAd26-S,R-Pharm|AstraZeneca,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2021-03-17,01/05/21,2021-12-31,18/02/21,18/02/21,,,Respiratory Diseases,1,1,289.0
634.0,NCT04577235,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,,Completed,COVID-19,,,,,,,Other: severity of lung involvement with COVID-19.,Gaziosmanpasa Research and Education Hospital,All,"18 Years and older   (Adult, Older Adult)",29.0,Other,Interventional,2020-05-06,05/08/20,2020-05-09,06/10/20,06/10/20,"Gaziosmanpasa Taksim Research and Education Hospital, Istanbul, Gazi̇osmanpaşa",Turkey,Respiratory Diseases,1,1,3.0
635.0,NCT04347460,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,COVIDHLH,Recruiting,COVID-19,,,,,,,,Technische Universität München,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-03-27,01/07/20,2020-08-31,15/04/20,15/04/20,"Department of nephrology, Klinikum rechts der Isar, München, Bavaria",Germany,Respiratory Diseases,1,1,157.0
636.0,NCT04361903,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,RESPIRE,Not yet recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Drug: Ruxolitinib Oral Tablet,"Azienda USL Toscana Nord Ovest|Fondazione C.N.R./Regione Toscana ""G. Monasterio"", Pisa, Italy|Azienda Ospedaliera Universitaria Senese|Azienda Ospedaliero, Universitaria Pisana",All,"18 Years and older   (Adult, Older Adult)",13.0,Other,Observational,2020-04-25,24/05/20,2020-05-31,24/04/20,24/04/20,,,Respiratory Diseases,1,1,36.0
637.0,NCT04346147,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Covid19COVINIB,Recruiting,COVID-19,,,,,,,Drug: Imatinib tablets|Drug: Baricitinib Oral Tablet|Other: Supportive tratment,Hospital Universitario de Fuenlabrada|Centro Nacional de Investigaciones Oncologicas CARLOS III,All,"18 Years and older   (Adult, Older Adult)",165.0,Other,Interventional,2020-07-05,01/06/21,2021-01-09,15/04/20,10/02/21,"Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid",Spain,Respiratory Diseases,1,1,188.0
638.0,NCT04568421,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,SAR-COVID,Recruiting,Rheumatic Diseases,,,,,,,Drug: Immunosuppressive Agents,Sociedad Argentina de Reumatologia,All,"18 Years to 100 Years   (Adult, Older Adult)",3000.0,Other,Observational,2020-08-18,31/12/21,2021-12-31,29/09/20,29/09/20,"Sociedad Argentina de Reumatología, Ciudad Autónoma de Buenos Aires, Caba",Argentina,Others,0,1,500.0
639.0,NCT04530500,COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression,,Enrolling by invitation,COVID-19,Androgen Receptor Gene Overexpression,,,,,,Genetic: COVID-19 Androgen Sensitivity Test (CoVAST),"University of California, Irvine|Applied Biology, Inc.",Male,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other|Industry,Observational,2020-08-13,24/06/23,2023-06-24,28/08/20,11/12/20,"Applied Biology, Inc, Irvine, California, United States|University of California, Irvine - Dermatology Clinical Research, Irvine, California",United States,Respiratory Diseases,1,2,1045.0
640.0,NCT04805840,Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen,,Recruiting,COVID-19,,,,,,,Device: CoV-SCAN rapid COVID-19 antigen test,Columbia University,All,"18 Years and older   (Adult, Older Adult)",4400.0,Other,Observational,2021-02-19,28/05/21,2021-07-31,18/03/21,18/03/21,"Columbia University Medical Center, New York, New York",United States,Respiratory Diseases,1,1,162.0
641.0,NCT04359212,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,VTE-COVID,Completed,COVID-19,"Thromboembolism, Venous",,,,,,Drug: thromboprophylaxis with low-molecular-weight heparin or fondaparinux,Quovadis Associazione|Azienda Ospedaliera di Padova,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Observational,2020-01-05,30/06/20,2020-07-31,24/04/20,17/09/20,"Giuseppe Camporese, Padova",Italy,Respiratory Diseases,1,2,208.0
642.0,NCT04342663,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",STOP COVID,Completed,COVID-19,Coronavirus,,,,,,Drug: Fluvoxamine|Drug: Placebo,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",152.0,Other,Interventional,2020-10-04,20/08/20,2020-12-12,13/04/20,11/01/21,"BJC, Belleville, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri",United States,Respiratory Diseases,1,2,69.0
643.0,NCT04536363,Cri Analog PG1 Effectiveness and Safety in Covid-19,PGE1-COVID19,Not yet recruiting,COVID-19,,,,,,,"Drug: Analogs, Prostaglandin E1|Drug: Standard therapeutic protocol",Alonso Vera Torres|Fundación Santa Fe de Bogota,All,"18 Years and older   (Adult, Older Adult)",284.0,Other,Interventional,2020-01-10,01/12/20,2021-01-03,02/09/20,02/09/20,,,Respiratory Diseases,1,1,359.0
644.0,NCT04506229,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,GenCov,Recruiting,COVID-19,,,,,,,Genetic: Whole exome sequencing,Texas Cardiac Arrhythmia Research Foundation,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-08-20,01/08/21,2021-01-09,10/08/20,27/08/20,"Texas Cardiac Arrhythmia Institute, Austin, Texas",United States,Respiratory Diseases,1,1,142.0
645.0,NCT04370275,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,POCUSars-CoV-2,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,,Ospedale di Latisana,All,"18 Years and older   (Adult, Older Adult)",235.0,Other,Observational,2020-04-23,23/05/20,2020-05-31,30/04/20,30/04/20,"SC Pronto Soccorso e Medicina d'Urgenza, Latisana, Udine",Italy,Respiratory Diseases,1,2,38.0
646.0,NCT04667780,Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Colchicine|Drug: Standard COVID-19 care,Ayub Teaching Hospital|Universidad de Murcia,All,"18 Years to 65 Years   (Adult, Older Adult)",102.0,Other,Interventional,2020-10-12,09/05/21,2021-09-07,16/12/20,16/12/20,"Ayub Teaching Hospital, Abbottabad, Khyber Pakhtunkhwa",Pakistan,Respiratory Diseases,1,1,330.0
647.0,NCT04482361,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,,Completed,COVID-19,,,,,,,Diagnostic Test: Presence of specific anti-SARS-CoV-2 antibodies,Ministerio de Salud de Ciudad Autónoma de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",5900.0,Other,Observational,2020-06-08,22/12/20,2020-12-22,22/07/20,25/01/21,"Ministerio de Salud de la Ciudad Autónoma de Buenos Aires, Ciudad Autónoma de Buenos Aires",Argentina,Respiratory Diseases,1,1,197.0
648.0,NCT04358809,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",,Recruiting,COVID-19,,,,,,,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,"Cadila Pharnmaceuticals|Council of Scientific and Industrial Research, India",All,"18 Years and older   (Adult, Older Adult)",480.0,Industry|Other,Interventional,2020-06-30,28/02/21,2021-04-30,24/04/20,22/12/20,"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India|All India Institute of Medical Sciences, Delhi, Delhi",India,Respiratory Diseases,1,1,304.0
649.0,NCT04449965,Povidone-Iodine Rinses in the Management of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Povidone-iodine|Drug: Placebo,"St. Paul's Hospital, Canada",All,"19 Years and older   (Adult, Older Adult)",81.0,Other,Interventional,2020-01-07,01/11/20,2020-01-12,29/06/20,29/06/20,,,Respiratory Diseases,1,1,5.0
650.0,NCT04742595,SARS-CoV-2 Specific Cytotoxic T Lymphocytes for the Treatment of COVID-19 in Patients With Cancer,,Recruiting,COVID-19,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,COVID-19,,,Biological: SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes,M.D. Anderson Cancer Center,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Interventional,2020-12-18,31/03/22,2022-03-31,08/02/21,08/02/21,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,5,468.0
651.0,NCT04764032,Right Ventricular Dysfunction in Ventilated Patients With COVID-19,COVID-RV,Recruiting,COVID-19,Right Ventricular Dysfunction,ARDS,,,,,Diagnostic Test: Echocardiography,University of Glasgow|Golden Jubilee National Hospital|Robertson Centre for Biostatistics,All,"17 Years and older   (Child, Adult, Older Adult)",150.0,Other,Observational,2020-02-09,31/03/21,2021-04-30,21/02/21,21/02/21,"Aberdeen Royal Infirmary, Aberdeen, United Kingdom|Univeristy Hospital, Ayr, Ayr, United Kingdom|Golden Jubilee National Hospital, Clydebank, United Kingdom|Dumfries and Galloway Royal Infirmary, Dumfries, United Kingdom|University Hospital Hairmyres, East Kilbride, United Kingdom|Queen Elizabeth University Hospital, Glasgow, United Kingdom|Glasgow Royal Infirmary, Glasgow, United Kingdom|Raigmore Hospital, Inverness, United Kingdom|University Hospital, Crosshouse, Kilmarnock, United Kingdom|Royal Alexandra hospital, Paisley, United Kingdom|University Hospital, Wishaw, Wishaw",United Kingdom,Respiratory Diseases,1,3,446.0
652.0,NCT04427254,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,CORONEVRAXE,Recruiting,COVID-19,,,,,,,"Drug: Cerebrospinal fluid sampling, meningeal and brain parenchyma biopsies",Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-06-26,01/01/23,2023-01-01,11/06/20,02/03/21,"Fondation A de Rothschild, Paris",France,Respiratory Diseases,1,1,919.0
653.0,NCT04386369,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,APRV-COVID19,Completed,ARDS,COVID-19,,,,,,Other: Airway pressure release ventilation,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",17.0,Other,Observational,2020-04-15,01/06/20,2020-01-06,13/05/20,14/09/20,"Centre Hospitalier Régional Universitaire de Nancy, Nancy",France,Respiratory Diseases,1,2,-100.0
654.0,NCT04371926,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,PREVENT,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate,Texas Cardiac Arrhythmia Research Foundation,All,"18 Months to 85 Years   (Child, Adult, Older Adult)",0.0,Other,Interventional,2020-01-06,01/06/21,2021-01-07,01/05/20,04/06/20,,,Respiratory Diseases,1,1,367.0
655.0,NCT04373161,Home Pulse Oximeter Use in Patients With COVID-19,,Completed,Sars-CoV2,COVID-19,COVID-19,,,,,Device: Home Pulse Oximetry Monitoring,Swedish Hospital,All,"18 Years and older   (Adult, Older Adult)",209.0,Other,Interventional,2020-03-20,22/04/20,2020-04-22,04/05/20,06/05/20,"Swedish Hospital, Chicago, Illinois",United States,Respiratory Diseases,1,3,33.0
656.0,NCT04750720,Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection,ABCOVID,Recruiting,COVID-19,COVID-19,,,,,,Other: Sampling by venipuncture (and eventually by nasopharyngeal swab),Centre Hospitalier Régional d'Orléans|Institut Pasteur,All,"18 Years and older   (Adult, Older Adult)",300.0,Other|Industry,Interventional,2020-08-27,01/12/23,2023-01-12,11/02/21,16/03/21,"Centre Hospitalier Régional d'Orléans, France, Orléans",France,Respiratory Diseases,1,2,868.0
657.0,NCT04395391,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,,Completed,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2,Exact Sciences Corporation,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Observational,2020-05-18,21/05/20,2020-06-16,20/05/20,11/08/20,"Exact Sciences, Madison, Wisconsin",United States,Respiratory Diseases,1,1,29.0
658.0,NCT04825301,Prognostic Prediction of COVID-19 Clinical Course Through the Development of a Convolutional Neural Network,,Recruiting,COVID-19,,,,,,,,University of L'Aquila,All,"18 Years and older   (Adult, Older Adult)",325.0,Other,Observational,2020-07-21,21/07/21,2021-07-21,01/04/21,14/04/21,"University of L'Aquila, L'Aquila",Italy,Respiratory Diseases,1,1,365.0
659.0,NCT04734223,Neuroimaging Findings in Patients With COVID-19,,Completed,Neuroimaging,COVID-19,,,,,,Diagnostic Test: Neuroimaging Findings in Patients With COVID-19,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",436.0,Other,Observational,2020-01-04,31/12/20,2020-12-31,02/02/21,04/02/21,"Sağlik Bilimleri Üniversitesi Training and Research Hospital, Di̇yarbakir",Turkey,Respiratory Diseases,1,2,362.0
660.0,NCT04533347,Tafenoquine in Patients With Mild to Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Tafenoquine Oral Tablet|Drug: Placebo,60 Degrees Pharmaceuticals LLC,All,"18 Years and older   (Adult, Older Adult)",275.0,Industry,Interventional,2021-02-19,08/06/21,2021-06-22,31/08/20,21/02/21,"Clinical Trial Network, Houston, Texas",United States,Respiratory Diseases,1,1,123.0
661.0,NCT04602832,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,EN-COVID-19,Enrolling by invitation,Well-Being,,,,,,,Other: Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,University of British Columbia|University of Virginia|University of Utah,All,"19 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2020-10-14,01/12/20,2020-01-12,26/10/20,04/11/20,"University of British Columbia, Kelowna, British Columbia",Canada,Others,0,1,-276.0
662.0,NCT04448717,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,CiaoCorona,Recruiting,SARS-CoV 2,COVID-19,,,,,,Diagnostic Test: COVID-19 Antibody testing,University of Zurich|Swiss School of Public Health (SSPH+),All,"5 Years and older   (Child, Adult, Older Adult)",8000.0,Other,Observational,2020-06-16,01/03/21,2021-01-03,26/06/20,21/07/20,"Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich",Switzerland,Respiratory Diseases,1,2,201.0
663.0,NCT04701996,Transmission Dynamics of COVID-19 in a Rural Setting of the Democratic Republic of the Congo,DynaCovid,Recruiting,COVID-19,,,,,,,Biological: serological surveillance,"Institute of Tropical Medicine, Belgium|Centre de Recherche en Santé de Kimpese|Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo",All,"1 Month to 99 Years   (Child, Adult, Older Adult)",1600.0,Other,Observational,2020-09-23,20/11/21,2021-12-31,08/01/21,19/01/21,"Centre de Recherche en Santé de Kimpese, Kimpese, Congo",The Democratic Republic of the,Respiratory Diseases,1,1,464.0
664.0,NCT04519372,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Diagnostic Test: Testing for SARS-CoV-2,"University Hospital, Basel, Switzerland",All,"18 Years and older   (Adult, Older Adult)",4099.0,Other,Observational,2020-01-04,14/06/20,2021-03-31,19/08/20,27/08/20,"University Hospital Basel, Division of Infectious Diseases and Hospital Epidemiology, Basel",Switzerland,Respiratory Diseases,1,2,452.0
665.0,NCT04599998,Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia,,Enrolling by invitation,COVID-19,,,,,,,"Diagnostic Test: spirometry, thoracic CT, CPET, 6 minute walking test, SF-36 questionnaire",Koc University Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",37.0,Other,Observational,2020-10-15,15/02/21,2021-01-03,23/10/20,23/10/20,"Koç University Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,80.0
666.0,NCT04657263,Impact of the COVID-19 Pandemic on Vaccination,COVIDVacImpac,Recruiting,COVID-19,,,,,,,Other: Vaccine coverage assessment,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-11,01/05/21,2021-05-30,08/12/20,10/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,505.0
667.0,NCT04374903,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,COVID19-HOPE,Not yet recruiting,COVID-19,,,,,,,Drug: HCQ & AZ vs HCQ+SIR,King Hussein Cancer Center,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Interventional,2020-01-05,01/08/20,2020-01-09,05/05/20,05/05/20,"King Hussein Cancer Center, Amman",Jordan,Respiratory Diseases,1,1,4.0
668.0,NCT04491240,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,COVID-19EXO,Completed,COVID-19,COVID-19,COVID-19,,,,,Drug: EXO 1 inhalation|Drug: EXO 2 inhalation|Drug: Placebo inhalation,"State-Financed Health Facility ""Samara Regional Medical Center Dinasty""|Clinics of the Federal State Budgetary Educational Institution SSMU|Samara Regional Clinical Hospital V.D. Seredavin",All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-20,01/10/20,2020-10-20,29/07/20,04/11/20,"Medical Centre Dinasty, Samara",Russian Federation,Respiratory Diseases,1,3,92.0
669.0,NCT04445597,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,ANOSMIC-19,Recruiting,COVID-19,,,,,,,Other: Sampling of tissue,Universitaire Ziekenhuizen Leuven|Max Planck Research Unit for Neurogenetics|AZ Sint-Jan Brugge-Oostende AV|Hospital Clinic of Barcelona|Centro Hospitalar Lisboa Norte,All,"Child, Adult, Older Adult",90.0,Other,Interventional,2020-07-05,31/12/22,2022-12-31,24/06/20,01/12/20,"UZ Leuven, Leuven, Vlaams-Brabant",Belgium,Respiratory Diseases,1,1,909.0
670.0,NCT04395794,SARS-CoV-2 Disguise Study,Disguise,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: SARS-CoV-2-test|Other: SARS-CoV-2 questionnaire survey,Meshalkin Research Institute of Pathology of Circulation,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-07-05,31/08/20,2020-11-30,20/05/20,20/05/20,"Meshalkin National Medical Research Center, Novosibirsk",Russian Federation,Respiratory Diseases,1,1,148.0
671.0,NCT04801524,Text-based Reminders to Promote COVID-19 Vaccinations,,Enrolling by invitation,COVID-19,,,,,,,Behavioral: Self-benefit|Behavioral: Prosocial-benefit|Behavioral: Early access|Behavioral: Fresh start,"University of California, Los Angeles|Carnegie Mellon University",All,"18 Years and older   (Adult, Older Adult)",250000.0,Other,Interventional,2021-07-02,31/12/21,2022-01-01,17/03/21,24/03/21,"UCLA Health Department of Medicine, Quality Office, Westwood, California",United States,Respiratory Diseases,1,1,183.0
672.0,NCT04828772,A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan,,"Active, not recruiting",COVID-19,,,,,,,,Bristol-Myers Squibb,All,"Child, Adult, Older Adult",9282.0,Industry,Observational,2020-08-17,31/01/21,2021-06-30,02/04/21,02/04/21,"Medical Data Vision, Tokyo",Japan,Respiratory Diseases,1,1,317.0
673.0,NCT04610801,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,,Recruiting,COVID-19,,,,,,,Drug: Nasal Spray,Larkin Community Hospital|Ferrer Medical Innovations|Xlear,All,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-08-08,08/08/21,2021-08-08,02/11/20,10/11/20,"Larkin Community Hospital Palm Springs Campus, Miami, Florida, United States|Larkin Community Hospital, Miami, Florida",United States,Respiratory Diseases,1,1,365.0
674.0,NCT04408066,COVID-19: A POC Test Under Research & Evaluation,CAPTURE,Recruiting,COVID-19,,,,,,,Diagnostic Test: Sample Collection/Performance Evaluation (A)|Diagnostic Test: Sample Collection/Performance Evaluation (B),LumiraDx UK Limited,All,"18 Years and older   (Adult, Older Adult)",2000.0,Industry,Interventional,2020-04-30,30/04/22,2022-04-30,29/05/20,04/06/20,"Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,730.0
675.0,NCT04379154,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),VOC-COVID,Recruiting,COVID-19,,,,,,,Device: Volatile Organic Compounds analysis,Hopital Foch,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-14,01/04/21,2021-01-04,07/05/20,17/03/21,"Hôpital Foch, Suresnes",France,Respiratory Diseases,1,1,265.0
676.0,NCT04405232,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,COVID19,Recruiting,COVID-19,Thrombosis,Bleeding,Anticoagulation,,,,Other: Non-interventional,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-05-25,25/04/21,2021-06-25,28/05/20,31/07/20,"Imperial College Healthcare NHS Trust, London",United Kingdom,Respiratory Diseases,1,4,396.0
677.0,NCT04361318,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Combination Product: Hydroxychloroquine plus Nitazoxanide|Other: Standard care,Tanta University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-05,01/10/20,2020-01-12,24/04/20,24/04/20,,,Respiratory Diseases,1,1,7.0
678.0,NCT04371679,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,COVID-HO,Recruiting,COVID-19,,,,,,,Other: No interventions planned,Hasselt University,All,"Child, Adult, Older Adult",40.0,Other,Observational,2020-01-04,01/10/20,2020-01-12,01/05/20,01/05/20,"Jessa Hospital, Hasselt",Belgium,Respiratory Diseases,1,1,8.0
679.0,NCT04344002,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),GRAVID,Recruiting,COVID-19,Lung Cancer,,,,,,,Spanish Lung Cancer Group,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-04-21,30/06/21,2021-06-30,14/04/20,02/02/21,"Complejo Hospitalario Universitario de Ferrol, Ferrol, A Coruña, Spain|H. Clínica Benidorm, Benidorm, Alicante, Spain|Hospital de Elche, Elche, Alicante, Spain|Hospital General Universitario de Elda, Elda, Alicante, Spain|Hospital de Torrevieja, Torrevieja, Alicante, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Cetir Centre Mèdic, Esplugues De Llobregat, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Complejo Hospitalario de la Coruña, La Coruña, Coruña, Spain|H. Insular de Gran Canarias, Las Palmas De Gran Canaria, Gran Canarias, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital Universitario de Móstoles, Móstoles, Madrid, Spain|Hospital de Manacor, Manacor, Mallorca, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Clínica Universitaria de Navarra, Pamplona, Navarra, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Instituto Onkologikoa, San Sebastián, País Vasco, Spain|Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|H. Universitario de Canarias, La Laguna, Tenerife, Spain|Hospital Universitario de La Ribera, Alzira, Valencia, Spain|Hospital de Manises, Manises, Valencia, Spain|Hospital de Cruces, Baracaldo, Vizcaya, Spain|Hospital de Basurto, Bilbao, Vizcaya, Spain|H. Gen. Universitario Alicante, Alicante, Spain|H. Universitario Quirón Dexeus, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|H. Duran i Reynals-ICO, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital La Mancha Centro, Ciudad Real, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Universitario de Puerto Real, Cádiz, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital San Millan Y San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|MD Anderson, Madrid, Spain|H.U. Puerta de Hierro, Madrid, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital Carlos Haya, Málaga, Spain|Hospital Santa María Naí, Ourense, Spain|Hospital Son Espases, Palma de Mallorca, Spain|H. Son Llàtzer, Palma de Mallorca, Spain|Hospital Clinico de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital universitario Nuestra Señora Candelaria, Tenerife, Spain|H. General U. de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital Politècnic i Universitari La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|H. Miguel Servet, Zaragoza, Spain|Hospital Ntra. Sra. Sónsoles, Ávila, Spain|Hospital Universitario de Áraba, Vitoria, Áraba",Spain,"Respiratory Diseases, Cancers",1,2,435.0
680.0,NCT04834934,Artificial Intelligence - SARS-CoV-2 Risk Evaluation,AI-SCoRE,Recruiting,COVID-19,,,,,,,,IRCCS San Raffaele|Regione Lombardia|Orobix Srl|Microsoft Corporation|ASST Bergamo Est|Centro Cardiologico Monzino|NVIDIA Corporation|PORINI Srl,All,"18 Years to 100 Years   (Adult, Older Adult)",2000.0,Other|Industry,Observational,2020-02-16,30/09/20,2021-01-06,08/04/21,08/04/21,"IRCCS San Raffaele, Milano",Italy,Respiratory Diseases,1,1,325.0
681.0,NCT04604678,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Metformin|Drug: Naltrexone,AgelessRx,All,"30 Years to 70 Years   (Adult, Older Adult)",80.0,Industry,Interventional,2021-01-02,01/08/21,2021-01-10,27/10/20,07/01/21,"AgelessRx, Ann Arbor, Michigan",United States,Respiratory Diseases,1,1,8.0
682.0,NCT04568707,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),,Recruiting,COVID-19,Neurologic Manifestations,Psychiatric Manifestations,,,,,Other: blood sample,Assistance Publique - Hôpitaux de Paris|Brain & Spine Institute (ICM),All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-23,15/10/22,2022-10-15,29/09/20,25/02/21,"Hôpital Pitié Salpétrière, Paris",France,Respiratory Diseases,1,3,722.0
683.0,NCT04648410,Corticosteroids in Severe COVID-19(ASAP-C Study),ASAP-C,Recruiting,COVID-19,,,,,,,Other: questionnaire,Brno University Hospital,All,"up to 100 Years   (Child, Adult, Older Adult)",2000.0,Other,Observational,2021-02-16,30/03/21,2021-01-12,01/12/20,18/02/21,"University Hospital Brno, Brno",Czechia,Respiratory Diseases,1,1,-35.0
684.0,NCT04513964,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,REACARDIOCOVID,Recruiting,Heart Failure,COVID-19,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-01-11,31/12/20,2021-06-30,14/08/20,31/12/20,"Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph, France|Hôpital Corentin Celton, Issy-les-Moulineaux",France,Respiratory Diseases,1,2,536.0
685.0,NCT04409899,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,UroCovid,"Active, not recruiting",COVID-19,Urologic Diseases,Surgery--Complications,Epidemic Disease,,,,Diagnostic Test: Blood tests,Fundacio Puigvert,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-03-20,30/06/20,2020-12-31,01/06/20,21/07/20,"Fundacio Puigvert, Barcelona",Spain,Respiratory Diseases,1,4,286.0
686.0,NCT04768179,Safety & Efficacy of Low Dose Aspirin / Ivermectin Combination Therapy for Treatment of Covid-19 Patients,IVCOM,Not yet recruiting,COVID-19,,,,,,,Drug: 3-dayIVM 200 mcg/kg/day/14-day 75mgASA/day + standard of care (intervention 1),"Makerere University|Ministry of Health, Uganda|Mbarara University of Science and Technology|Joint Clinical Research Center",All,18 Years to 64 Years   (Adult),490.0,Other,Interventional,2021-02-19,30/06/21,2021-09-30,24/02/21,24/02/21,,,Respiratory Diseases,1,1,223.0
687.0,NCT04542044,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,PneumoCoV-Ambu,Completed,COVID-19,Pneumonia,,,,,,Other: management strategy of outpatient with mild to moderate SARS-CoV-2 pneumonia,"University Hospital, Geneva",All,"18 Years to 99 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-02-04,05/05/20,2020-06-30,09/09/20,09/09/20,"Geneva University Hospital, Geneva",Switzerland,Respiratory Diseases,1,2,147.0
688.0,NCT04363840,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",LEAD COVID-19,Not yet recruiting,COVID-19,Vitamin D Deficiency,Coagulopathy,Disseminated Intravascular Coagulation,,,,Drug: Aspirin 81 mg|Dietary Supplement: Vitamin D,Louisiana State University Health Sciences Center in New Orleans,All,"18 Years and older   (Adult, Older Adult)",1080.0,Other,Interventional,2020-01-05,01/12/20,2020-01-12,27/04/20,27/04/20,,,Respiratory Diseases,1,4,7.0
689.0,NCT04384497,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,,Recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 convalescent plasma,Joakim Dillner|Danderyd Hospital|Karolinska University Hospital|Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-07-05,01/06/20,2020-01-12,12/05/20,27/05/20,"Danderyd Hospital, Danderyd, Stockholm, Sweden|Karolinska University Hospital, Stockholm",Sweden,Respiratory Diseases,1,1,-175.0
690.0,NCT04766294,Macrophage Activation Markers in COVID-19 Patients,COVID-19,Recruiting,COVID-19,,,,,,,,Sohag University,All,"19 Years to 70 Years   (Adult, Older Adult)",70.0,Other,Observational,2020-04-25,15/03/21,2021-01-04,23/02/21,01/03/21,"Faculty of medicine - sohag university, Sohag",Egypt,Respiratory Diseases,1,1,254.0
691.0,NCT04401085,COVID-19: Herd Immunity Study in the Czech Republic,SARSCoV2CZPrev,Completed,COVID-19,SARS-CoV 2,,,,,,Diagnostic Test: SARS-CoV-2 diagnostic rapid test|Diagnostic Test: Quantitative analysis of SARS-CoV-2 antibodies,"Institute of Health Information and Statistics of the Czech Republic|Ministry of Health, Czech Republic|Faculty of Medicine, Palacky University|Faculty of Medicine, Masaryk University|Faculty of medicine, University of Ostrava|Faculty of Military Health Sciences, University of Defence in Brno|Faculty of Health Studies, J. E. Purkyně University in Ústí nad Labem|First Faculty of Medicine, Charles University, Czech Republic|Institute for Clinical and Experimental Medicine|General University Hospital, Prague|University Hospital Olomouc|Brno University Hospital|Krajská zdravotní, a.s., Ústí nad Labem Region Hospitals|Military University Hospital, Prague|Masaryk Memorial Cancer Institute|Institute Of Sociology, Czech Academy of Sciences|Czech Statistical Office|Faculty of Medicine in Hradec Králové, Charles University",All,"8 Years to 89 Years   (Child, Adult, Older Adult)",27000.0,Other,Observational,2020-04-23,01/05/20,2020-01-05,26/05/20,01/06/20,"Institute of Health Information and Statistics of the Czech Republic, Prague",Czechia,Respiratory Diseases,1,2,-109.0
692.0,NCT04623138,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,,"Evidation Health|Biomedical Advanced Research and Development Authority|Eli Lilly and Company|Bill and Melinda Gates Foundation|Vir Biotechnology, Inc.|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",950.0,Industry|U.S. Fed|Other,Observational,2020-01-11,01/05/21,2021-01-05,10/11/20,10/11/20,,,Respiratory Diseases,1,2,360.0
693.0,NCT04420741,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,COMBAT-COVID,"Active, not recruiting",COVID-19,Respiratory Failure,,,,,,Drug: Iloprost|Drug: Isotonic saline,"Pär Johansson|Rigshospitalet, Denmark",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-06-15,23/02/21,2021-04-23,09/06/20,10/03/21,"Dept. of Anaesthesia and Intensive Care, Bispebjerg Hospital, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Copenhagen University Hospital Herlev, Herlev, Denmark|Dept. of Anaesthesia and Intensive Care, Nordsjaelands Hospital, Hillerød, Denmark|Dept. of Anaesthesia and Intensive Care, Hvidovre Hospital, Hvidovre",Denmark,Respiratory Diseases,1,2,312.0
694.0,NCT04824365,Sodium Pyruvate Nasal Spray Treatment of COVID-19 and Influenza Infections,,Recruiting,COVID-19,Influenza,,,,,,Drug: Sodium Pyruvate|Other: Saline,"Cellular Sciences, inc.|Missouri State University|Dynamic DNA Labs|Trinity Health Care",All,18 Years to 40 Years   (Adult),60.0,Industry|Other,Interventional,2021-03-04,01/05/22,2022-01-06,01/04/21,08/04/21,"Missouri State University, Springfield, Missouri",United States,"Infectious Diseases, Respiratory Diseases",1,2,308.0
695.0,NCT04355702,Covid-19 in Lupus Patients,,Completed,Systemic Lupus Erythematosus,COVID-19,,,,,,,"University Hospital, Montpellier",All,"18 Years to 90 Years   (Adult, Older Adult)",130.0,Other,Observational,2020-01-03,01/12/20,2020-12-30,21/04/20,01/03/21,"Uhmontpellier, Montpellier",France,"Respiratory Diseases, Immunological Disorders",1,2,362.0
696.0,NCT04432779,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,ELIKYA COVID,Recruiting,Pregnancy,COVID-19,,,,,,Other: no intervention,Centre Hospitalier Universitaire Saint Pierre|Institute for Medical Immunology (IMI)|Laboratoire Hospitalier Universitaire de Bruxelles (LHUB),All,"Child, Adult, Older Adult",3000.0,Other,Observational,2020-05-25,01/06/24,2024-01-06,16/06/20,13/01/21,"CHU SAINT Pierre, Brussels",Belgium,Respiratory Diseases,1,2,1321.0
697.0,NCT04818489,Colchicine and Post-COVID-19 Pulmonary Fibrosis,,Recruiting,COVID-19,Pulmonary Fibrosis Interstitial,,,,,,Drug: Colchicine 0.5 MG|Other: the standard protocol only,ClinAmygate,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2021-03-25,25/05/21,2021-10-07,26/03/21,30/03/21,"El-Demerdash Hospital, Cairo",Egypt,Respiratory Diseases,1,2,196.0
698.0,NCT04333693,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Covid-VAS,Not yet recruiting,Vascular Surgical Procedures,COVID-19,Postoperative Complications,,,,,Procedure: Vascular surgery,Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-04,01/10/20,2020-01-11,03/04/20,03/04/20,"Spanish Society for Angiology and Vascular Surgery, Madrid",Spain,Respiratory Diseases,1,3,7.0
699.0,NCT04709003,Covid-19 Vaccine Effectiveness in Healthcare Personnel in Clalit Health Services in Israel (CoVEHPI),CoVEHPI,Recruiting,COVID-19,Corona Virus Infection,Vaccine Effectiveness,,,,,Diagnostic Test: Serologic test|Diagnostic Test: Respiratory swabs,Clalit Health Services,All,"18 Years to 120 Years   (Adult, Older Adult)",4504.0,Other,Observational,2020-12-23,01/06/22,2022-01-06,14/01/21,14/01/21,"Haemek Medical Center, Afula, Israel|Soroka Medical Center, Be'er Sheva, Israel|Meir Medical Center, Kefar Saba, Israel|Beilinson hospital, Petach Tikva, Israel|Schneider Children's Medical Center of Israel, Petah tikva, Israel|Kaplan Medical Center, Reẖovot",Israel,Respiratory Diseases,1,3,379.0
700.0,NCT04844632,"COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring",SAPIENZAVAX,Recruiting,Health Care Utilization,Health Care Associated Infection,,,,,,Biological: Vaccine anti-Covid19,University of Roma La Sapienza|Istituto Superiore di Sanità,All,"18 Years to 99 Years   (Adult, Older Adult)",5000.0,Other,Observational,2021-11-02,01/04/22,2022-05-21,14/04/21,14/04/21,"AOU Policlinico Umberto I, Roma",Italy,Others,0,2,200.0
701.0,NCT04534621,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,,Not yet recruiting,COVID-19,,,,,,,Other: Electronic survey,Trate - Tratamentos Especializados,All,"Child, Adult, Older Adult",948.0,Other,Observational,2020-08-26,06/09/20,2020-09-18,01/09/20,01/09/20,,,Respiratory Diseases,1,1,23.0
702.0,NCT04357496,COVID-19 Epidemic Response Study,COVeR,Not yet recruiting,Fever,Pneumonia,Cough,,,,,,CENTOGENE GmbH Rostock,All,"60 Years and older   (Adult, Older Adult)",400.0,Industry,Observational,2020-12-20,30/10/21,2021-11-30,22/04/20,24/11/20,,,Respiratory Diseases,1,3,345.0
703.0,NCT04741178,PAtterns and Extension in COVID-19 Related Interstitial Pneumonia: CT Analysis,Paesi-COV-19,Recruiting,COVID-19,,,,,,,,Morgagni Pierantoni Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-03-20,02/01/21,2021-12-31,05/02/21,10/02/21,"Morgagni Pierantoni Hospital, Forlì, FC",Italy,Respiratory Diseases,1,1,651.0
704.0,NCT04542980,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,,Not yet recruiting,SARS-CoV 2 Infection,COVID-19,,,,,,Diagnostic Test: SARS-CoV2 Autoantibody detection,Namida Lab,All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Industry,Observational,2020-09-15,31/12/20,2020-12-31,09/09/20,09/09/20,,,Respiratory Diseases,1,2,107.0
705.0,NCT04565067,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,,Recruiting,COVID-19,,,,,,,,National Institute on Aging (NIA)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",120.0,NIH,Observational,2021-04-19,31/12/21,2022-01-09,25/09/20,14/04/21,"National Institute of Aging, Clinical Research Unit, Baltimore, Maryland",United States,Respiratory Diseases,1,1,265.0
706.0,NCT04809948,Effects of COVID 19 Vaccine on Egyptian Population,,Not yet recruiting,COVID-19,,,,,,,Biological: viral vector vaccine,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",800.0,Other,Observational,2021-01-03,01/09/21,2021-12-30,22/03/21,24/03/21,,,Respiratory Diseases,1,1,361.0
707.0,NCT04562285,Sustained Immunity to SARS-CoV-2,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Serologic immunoassays to SARS-CoV-2 antibodies,Henry Ford Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-23,01/06/21,2021-01-06,24/09/20,24/09/20,"Henry Ford Health System, Detroit, Michigan",United States,Respiratory Diseases,1,1,197.0
708.0,NCT04701658,A Real World Study of Bamlanivimab in Participants With Mild-to-moderate Coronavirus Disease 2019 (COVID-19),BLAZE-5,Recruiting,COVID-19,,,,,,,Drug: Bamlanivimab,Eli Lilly and Company|AbCellera Biologics Inc.,All,"12 Years and older   (Child, Adult, Older Adult)",3000.0,Industry|Other,Interventional,2021-01-02,07/06/21,2021-07-08,08/01/21,14/04/21,"Presbyterian Medical Center, Albuquerque, New Mexico, United States|Univ of NM, Dept of Emergency Med, Albuquerque, New Mexico",United States,Respiratory Diseases,1,1,187.0
709.0,NCT04359303,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,OzonoCOVID19,Not yet recruiting,COVID-19,,,,,,,Other: Systemic indirect endovenous ozone therapy,Javier Hidalgo Tallón|Sociedad Española de Ozonoterapia|Universidad Católica San Antonio de Murcia,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-07,01/11/20,2020-01-12,24/04/20,23/06/20,"SEOT, Valencia",Spain,Respiratory Diseases,1,1,5.0
710.0,NCT04395599,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,COELIOCOVID,Not yet recruiting,Sars-CoV2,Surgery,COVID-19,,,,,"Other: Cartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.","University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-05,01/10/20,2020-01-10,20/05/20,20/05/20,,,Respiratory Diseases,1,3,5.0
711.0,NCT04772833,"Spanish Study to Analyze the Histopathological, Ultrastructural and Microbiological Findings Obtained in Autopsies of Patients Who Died Due to COVID-19",,Recruiting,COVID-19,,,,,,,Other: Autopsy,Maimónides Biomedical Research Institute of Córdoba|Spanish Society of Infectious Diseases and Clinical Microbiology|Spanish Society of Pathological Anatomy,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-05-06,31/12/21,2021-12-31,26/02/21,26/02/21,"Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain|Puerta de Hierro University Hospital, Majadahonda, Madrid, Spain|Navarra University Hospital, Pamplona, Navarra, Spain|Barcelona Clinic University Hospital, Barcelona, Spain|Reina Sofía University Hospital, Córdoba, Spain|Ramón y Cajal University Hospital, Madrid, Spain|Fundación Jiménez Díaz University Hospital, Madrid, Spain|12 de Octubre University Hospital, Madrid, Spain|Virgen del Rocío University Hospital, Sevilla, Spain|Araba University Hospital, Vitoria, Álava",Spain,Respiratory Diseases,1,1,604.0
712.0,NCT04676867,Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Dalcetrapib|Other: Placebo,DalCor Pharmaceuticals|The Montreal Health Innovations Coordinating Center (MHICC)|Covance,All,"18 Years and older   (Adult, Older Adult)",208.0,Industry|Other,Interventional,2021-11-01,01/05/21,2021-01-05,21/12/20,17/03/21,"Institut de Cardiologie de Montréal, Montréal, Quebec",Canada,Respiratory Diseases,1,1,-300.0
713.0,NCT04604704,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,,Recruiting,COVID-19,COVID-19,COVID-19,,,,,Drug: Naltrexone|Dietary Supplement: NAD+|Other: Placebo,AgelessRx,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2021-01-28,01/08/21,2021-01-10,27/10/20,03/03/21,"AgelessRx, Ann Arbor, Michigan",United States,Respiratory Diseases,1,3,-18.0
714.0,NCT04337762,Beat COVID-19 - Observational Trial,JUPITER,Recruiting,COVID-19,,,,,,,,Beat COVID LLC,All,"18 Years to 110 Years   (Adult, Older Adult)",100000.0,Industry,Observational,2020-06-04,01/12/20,2021-01-07,08/04/20,09/04/20,"Beat COIVD, LLC, Chicago, Illinois",United States,Respiratory Diseases,1,1,217.0
715.0,NCT04834947,Hemodynamic Effect of Prone Position in Non-intubated Patient With COVID 19,,Not yet recruiting,COVID-19,"Pneumonia, Viral",,,,,,Procedure: prone position,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2021-04-15,15/12/21,2021-12-15,08/04/21,08/04/21,"Service d'Anesthésie-Réanimation, Hôpital Louis Pradel,, Bron",France,Respiratory Diseases,1,2,244.0
716.0,NCT04533399,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,,Recruiting,COVID-19,COVID-19,,,,,,Biological: SARS-CoV-2 rS/Matrix-M1 Adjuvant|Other: Placebo,Novavax|Bill and Melinda Gates Foundation,All,"18 Years to 84 Years   (Adult, Older Adult)",4400.0,Industry|Other,Interventional,2020-08-17,01/11/21,2021-01-11,31/08/20,02/11/20,"ZA018, Bloemfontein, Free State Of South Africa, South Africa|ZA003, Hillbrow, Gauteng, South Africa|Site ZA001, Johannesburg, Gauteng, South Africa|ZA012, Johannesburg, Gauteng, South Africa|Site ZA015, Pretoria, Gauteng, South Africa|ZA023, Pretoria, Gauteng, South Africa|ZA019, Durban, KwaZulu-Natal, South Africa|ZA020, Durban, KwaZulu-Natal, South Africa|ZA021, Durban, KwaZulu-Natal, South Africa|ZA024, Durban, KwaZulu-Natal, South Africa|ZA007, Thabazimbi, Limpopo, South Africa|ZA022, Madibeng, North-West, South Africa|ZA013, Cape Town, Western Cape, South Africa|ZA014, Worcester, Western Cape",South Africa,Respiratory Diseases,1,2,147.0
717.0,NCT04753476,Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia,,Recruiting,COVID-19,Cytokine Storm,,,,,,Biological: Injection of Secretome-MSCs|Drug: Standard treatment of Covid-19,"Stem Cell and Cancer Research Indonesia|Provincial Government of Central Java, Indonesia",All,"Child, Adult, Older Adult",48.0,Other,Interventional,2020-08-06,08/06/21,2021-08-08,15/02/21,17/02/21,"Sultan Imanuddin Hospital, Kalimantan, Central Borneo, Indonesia|Charlie Hospital, Kendal, Central Java, Indonesia|RS PKU Muhammadiyah Yogyakarta, Yogyakarta, Central Java, Indonesia|Bhayangkara Hospital, Makassar, South Celebes, Indonesia|Gatot Soebroto Army Hospital, Jakarta, Indonesia|Dr. Esnawan Antariksa Air Force Hospital, Jakarta",Indonesia,Respiratory Diseases,1,2,367.0
718.0,NCT04341506,Non-contact ECG Sensor System for COVID19,,Recruiting,COVID-19,,,,,,,Device: Non-contact ECG,Northwestern Medicine,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-08-09,15/07/21,2021-12-15,10/04/20,09/09/20,"Northwestern Medicine, Chicago, Illinois",United States,Respiratory Diseases,1,1,493.0
719.0,NCT04361604,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,COVIDHIV,Not yet recruiting,COVID-19,,,,,,,Biological: Biological collection (patients co infected HIV Sras-CoV-2)|Other: Auto-questionnaires (patients co infected HIV Sras-CoV-2)|Other: Qualitative interviews (in 40 patients : 20 with COVID-19 and 20 without COVID-19),Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",270.0,Other,Observational,2020-01-04,01/10/20,2020-01-10,24/04/20,24/04/20,"Department of Internal Medicine and Clinical Immunology of Professor Cécile Goujard, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,1,6.0
720.0,NCT04729140,An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin Tablets|Drug: Doxycycline Tablets|Drug: Placebo,"Max Health, Subsero Health",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-12-28,28/12/21,2022-03-28,28/01/21,01/04/21,"MAX HEALTH, Subsero Health 2055 Wood Street, Suite 100, Sarasota, Florida",United States,Respiratory Diseases,1,1,455.0
721.0,NCT04621123,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,,Recruiting,COVID-19,Safety and Efficacy,,,,,,Biological: Convalescent anti-SARS-CoV-2 MBT plasma|Other: Control Group,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Germans Trias i Pujol Hospital|IrsiCaixa|Banc de Sang i Teixits|Grifols Biologicals, LLC",All,"50 Years and older   (Adult, Older Adult)",474.0,Other|Industry,Interventional,2020-10-30,15/06/21,2021-01-10,09/11/20,17/03/21,"Germans Trias i Pujol Hospital, Badalona, Barcelona",Spain,Respiratory Diseases,1,2,72.0
722.0,NCT04751734,Impact of Maternal COVID-19 Vaccines on Breast Milk,MilkCorona,Enrolling by invitation,COVID-19,,,,,,,Biological: Covid vaccines,"Institute of Agrochemistry and Food Technology, National Research Council|Hospital Clínico Universitario de Valencia|Hospital Sant Joan de Deu|Hospital Universitario La Fe|Hospital Universitario Doctor Peset|Fundacion Para La Investigacion Hospital La Fe|Universitat Jaume I|University of Barcelona",Female,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-16,01/12/21,2021-01-12,12/02/21,16/02/21,"Fundacion Investigacion Sanitaria INCLIVA, Valencia, Spain|Hospital Universitario y Politecnico la Fe, Valencia",Spain,Respiratory Diseases,1,1,-4.0
723.0,NCT04526054,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,,Recruiting,Olfaction Disorders,COVID-19,,,,,,Diagnostic Test: ENT exam|Diagnostic Test: Olfactometry|Diagnostic Test: Brain MRI,Hopital Foch|Hôpital Raymond Poincaré,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-03-09,03/09/21,2021-03-09,25/08/20,05/10/20,"Hopital Foch, Suresnes, Ile-de-France, France|Hopital Raymond Poincare, Garches",France,Respiratory Diseases,1,2,365.0
724.0,NCT04506268,COVID-19 SAFE Enrollment,COVID SAFE,Completed,COVID-19,,,,,,,Behavioral: Opt-out Recruitment Email|Behavioral: Opt-in Recruitment Email,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",412.0,Other,Interventional,2020-09-09,30/10/20,2020-10-30,10/08/20,11/03/21,"Penn Medicine, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,51.0
725.0,NCT04365985,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,SINK COVID-19,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,Severe Acute Respiratory Syndrome (SARS),Coronavirus Infections,,,,Drug: Naltrexone|Drug: Ketamine|Other: Placebo,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-29,01/05/21,2021-01-08,28/04/20,02/07/20,"William Beaumont Hospital, Royal Oak, Michigan",United States,Respiratory Diseases,1,4,254.0
726.0,NCT04786353,Long COVID Kids DK - Investigating Long-term Covid-19,,Not yet recruiting,COVID-19,,,,,,,Other: LongCOVIDkidsDK,"Rigshospitalet, Denmark",All,"Child, Adult, Older Adult",300000.0,Other,Observational,2021-01-04,01/04/23,2023-01-04,08/03/21,08/03/21,,,Respiratory Diseases,1,1,730.0
727.0,NCT04335747,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,,Recruiting,Rheumatoid Arthritis,Psoriatic Arthritis,Axial Spondyloarthritis,Systemic Lupus Erythematosus,Giant Cell Arteritis,,,Other: COVID-19 infection,Salome Kristensen|Aalborg University Hospital,All,"18 Years and older   (Adult, Older Adult)",333.0,Other,Observational,2020-04-23,01/08/21,2021-01-09,06/04/20,29/05/20,"Aalborg University Hospital, Aalborg",Denmark,Immunological Disorders,1,5,261.0
728.0,NCT04659239,"The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",,Enrolling by invitation,COVID-19,,,,,,,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,Chinese Academy of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",34020.0,Other,Interventional,2021-01-28,01/09/21,2022-01-07,09/12/20,10/02/21,"CEMEC Pesquisa Clinica, São Bernardo do Campo, São Paulo, Brazil|Hospital Sungai Buloh, Sungai Buloh, Selangor",Malaysia,Respiratory Diseases,1,1,344.0
729.0,NCT04390178,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: SARS-CoV-2 convalescent plasma,Joakim Dillner|Danderyd Hospital|Karolinska Institutet|Karolinska University Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-10-04,01/06/20,2020-01-12,15/05/20,15/05/20,"Danderyd Hospital, Danderyd",Sweden,Respiratory Diseases,1,1,-266.0
730.0,NCT04338360,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,,Approved for marketing,COVID-19,,,,,,,Biological: COVID-19 convalescent plasma,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Intermediate-size Population,,,,08/04/20,02/09/20,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States|Mayo Clinic Health System in Austin, Austin, Minnesota, United States|Mayo Clinic Health System in Cannon Falls, Cannon Falls, Minnesota, United States|Mayo Clinic Health System in Lake City, Lake City, Minnesota, United States|Mayo Clinic Health System in Mankato, Mankato, Minnesota, United States|Mayo Clinic Health System in Owatonna, Owatonna, Minnesota, United States|Mayo Clinic Health System in Red Wing, Red Wing, Minnesota, United States|Mayo Clinic in Rochester, Rochester, Minnesota, United States|Mayo Clinic Health System - Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System - Franciscan Healthcare, La Crosse, Wisconsin",United States,Respiratory Diseases,1,1,
731.0,NCT04438941,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,COVID-PRONE,Recruiting,Sars-CoV2,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-25,20/06/20,2020-06-20,19/06/20,23/06/20,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg",France,Respiratory Diseases,1,1,87.0
732.0,NCT04340050,COVID-19 Convalescent Plasma,,Completed,Coronavirus,,,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-10-04,23/12/20,2020-12-23,09/04/20,28/12/20,"University of Chicago Medicine, Chicago, Illinois",United States,Respiratory Diseases,1,1,80.0
733.0,NCT04406324,COVID-19: Respiratory and Sleep Follow-up,Co-SURVIVORS,Recruiting,COVID-19,,,,,,,Other: No intervention,"University Hospital, Grenoble",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-06,05/03/21,2026-05-03,28/05/20,30/06/20,"Hôpital Avicenne, Bobigny, France|Centre Hospitalier Henri Mondor, APHP, Créteil, France|CHU Grenoble Alpes, Grenoble, France|CHRU Nancy, Nancy",France,Respiratory Diseases,1,1,2309.0
734.0,NCT04516746,"Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",,"Active, not recruiting",COVID-19,COVID-19,,,,,,Biological: AZD1222|Biological: Placebo,AstraZeneca|Iqvia Pty Ltd,All,"18 Years to 130 Years   (Adult, Older Adult)",32459.0,Industry,Interventional,2020-08-28,05/03/21,2023-02-14,18/08/20,13/04/21,"Research Site, Birmingham, Alabama, United States|Research Site, Phoenix, Arizona, United States|Research Site, Scottsdale, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Berkeley, California, United States|Research Site, El Centro, California, United States|Research Site, Los Angeles, California, United States|Research Site, Los Angeles, California, United States|Research Site, San Diego, California, United States|Research Site, San Diego, California, United States|Research Site, San Francisco, California, United States|Research Site, San Francisco, California, United States|Research Site, Torrance, California, United States|Research Site, Denver, Colorado, United States|Research Site, Danbury, Connecticut, United States|Research Site, Atlantis, Florida, United States|Research Site, Coral Gables, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Orlando, Florida, United States|Research Site, Stockbridge, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Meridian, Idaho, United States|Research Site, Chicago, Illinois, United States|Research Site, Indianapolis, Indiana, United States|Research Site, Ankeny, Iowa, United States|Research Site, Fairway, Kansas, United States|Research Site, Kansas City, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Lexington, Kentucky, United States|Research Site, Lake Charles, Louisiana, United States|Research Site, Monroe, Louisiana, United States|Research Site, Portland, Maine, United States|Research Site, Baltimore, Maryland, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Boston, Massachusetts, United States|Research Site, Boston, Massachusetts, United States|Research Site, Ann Arbor, Michigan, United States|Research Site, Royal Oak, Michigan, United States|Research Site, Bloomington, Minnesota, United States|Research Site, Gulfport, Mississippi, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Butte, Montana, United States|Research Site, Henderson, Nevada, United States|Research Site, Portsmouth, New Hampshire, United States|Research Site, Berlin, New Jersey, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, Bronx, New York, United States|Research Site, Brooklyn, New York, United States|Research Site, Mineola, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, Rochester, New York, United States|Research Site, Rochester, New York, United States|Research Site, Valhalla, New York, United States|Research Site, Durham, North Carolina, United States|Research Site, Fargo, North Dakota, United States|Research Site, Cincinnati, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Columbus, Ohio, United States|Research Site, Yukon, Oklahoma, United States|Research Site, Portland, Oregon, United States|Research Site, Pittsburgh, Pennsylvania, United States|Research Site, Warwick, Rhode Island, United States|Research Site, Charleston, South Carolina, United States|Research Site, Charleston, South Carolina, United States|Research Site, Spartanburg, South Carolina, United States|Research Site, Knoxville, Tennessee, United States|Research Site, Nashville, Tennessee, United States|Research Site, Austin, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, Houston, Texas, United States|Research Site, McAllen, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, The Woodlands, Texas, United States|Research Site, West Jordan, Utah, United States|Research Site, Burlington, Vermont, United States|Research Site, Fort Belvoir, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Seattle, Washington, United States|Research Site, Seattle, Washington, United States|Research Site, South Charleston, West Virginia, United States|Research Site, Madison, Wisconsin, United States|Research Site, Caba, Argentina|Research Site, Ciudad Autónoma de Bs. As., Argentina|Research Site, Ciudad Autónoma de Buenos Aire, Argentina|Research Site, Quillota, Chile|Research Site, Region Metropolitana, Chile|Research Site, Santiago, Chile|Research Site, Santiago, Chile|Research Site, Barranquilla, Colombia|Research Site, Bogota, Colombia|Research Site, Floridablanca, Colombia|Research Site, Manizales, Colombia|Research Site, Medellin, Colombia|Research Site, Angers, France|Research Site, Bron, France|Research Site, Creteil, France|Research Site, Dijon Cedex, France|Research Site, Lille, France|Research Site, Limoges cedex, France|Research Site, Marseille, France|Research Site, Paris, France|Research Site, Paris, France|Research Site, St Etienne, France|Research Site, Callao, Peru|Research Site, Cercado De Lima, Peru|Research Site, Cercardo De Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima",Peru,Respiratory Diseases,1,2,900.0
735.0,NCT04716179,Prospective Two-arm Study of Fertility in Men With COVID-19,,Recruiting,COVID-19,Fertility Issues,,,,,,"Diagnostic Test: Sperm test|Diagnostic Test: hormone levels (testosterone, FSH, LH, prolactin)|Diagnostic Test: SARS-CoV-2 Ig G levels|Other: Testis pathology samples",I.M. Sechenov First Moscow State Medical University,Male,"18 Years to 65 Years   (Adult, Older Adult)",88.0,Other,Interventional,2021-01-18,18/05/21,2021-05-18,20/01/21,20/01/21,"Sechenov University., Moscow",Russian Federation,Respiratory Diseases,1,2,120.0
736.0,NCT04584671,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,LIVECOVIDFREE,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Hyperpolarized Xenon-129 MRI of the lungs|Diagnostic Test: Computed Tomography (CT)|Diagnostic Test: Pulmonary Function Tests (PFT)|Diagnostic Test: Six Minute Walk Test (6MWT)|Diagnostic Test: Sputum analysis|Diagnostic Test: Blood analysis|Other: Questionnaires,"Western University, Canada|London Health Sciences Centre",All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-01-12,01/12/22,2024-01-12,14/10/20,13/11/20,"Department of Medicine (Respirology), McMaster University, Hamilton, Ontario",Canada,Respiratory Diseases,1,1,1461.0
737.0,NCT04448119,Control of COVID-19 Outbreaks in Long Term Care,,Recruiting,COVID-19,COVID-19,,,,,,Drug: Favipiravir|Drug: Favipiravir Placebo,"Appili Therapeutics Inc.|MOUNT SINAI HOSPITAL|Applied Health Research Centre|Sunnybrook Health Sciences Centre|University Health Network, Toronto|University of Toronto",All,65 Years and older   (Older Adult),760.0,Industry|Other,Interventional,2020-10-16,01/03/21,2021-01-03,25/06/20,23/10/20,"Mount Sinai Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,2,79.0
738.0,NCT04555109,Convalescent Plasma for COVID-19 Research Donor Study,CONCOR-Donor,Recruiting,COVID-19,,,,,,,,The Hospital for Sick Children,All,"17 Years to 65 Years   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-06-30,30/06/21,2022-03-31,18/09/20,18/09/20,"The Hospital for Sick Children, Toronto, Ontario",Canada,Respiratory Diseases,1,1,639.0
739.0,NCT04369859,Obstetric and Perinatal Outcomes of Women With COVID-19,GROCO,Recruiting,Pregnant Women,,,,,,,Behavioral: Examine the impact of COVID-19 during pregnancy,Assistance Publique Hopitaux De Marseille,Female,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Observational,2020-04-23,22/04/21,2021-04-22,30/04/20,04/05/20,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca",France,Others,0,1,364.0
740.0,NCT04412746,Covid-19 and Diabetes in West of Algeria,COVIDIAB-13,Recruiting,Coronavirus Infections,Diabetes Mellitus,Prevalence,Risk Factors,Patient Outcome Assessment,Severe Acute Respiratory Syndrome,,Drug: MANAGEMENT OF COVID-19,"Laboratoire De Recherche Sur Le Diabete, Université de Tlemcen|ATRSS, DGRST, Algeria",All,"16 Years and older   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-01-04,30/06/20,2020-06-30,02/06/20,02/06/20,"Department of Internal Medicine, Acedemic Hospital of Tlemcen, Tlemcen",Algeria,"Metabolic Disorders, Respiratory Diseases",1,6,178.0
741.0,NCT04524507,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,UNC CCP RCT,Recruiting,COVID-19,,,,,,,Biological: High-titer Convalescent COVID-19 Plasma (CCP1)|Biological: Standard-titer Convalescent COVID-19 plasma (CCP2),"University of North Carolina, Chapel Hill",All,"18 Years to 99 Years   (Adult, Older Adult)",56.0,Other,Interventional,2020-08-27,01/05/21,2021-01-05,24/08/20,05/10/20,"University of North Carolina Health Care, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,1,131.0
742.0,NCT04753242,Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals,,Recruiting,COVID-19,COVID-19,,,,,,,"University Hospital, Basel, Switzerland",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-08-12,31/07/21,2021-07-31,15/02/21,04/03/21,"Medical University of Graz, Graz, Steiermark, Austria|Klinikum Nürnberg, Department of Psychosomatic Medicine and Psychotherapy, Nürnberg, Bayern, Germany|Universitätsklinikum Köln, Polyclinic for Psychosomatics and Psychotherapy, Köln, Nordrhein-Westfalen, Germany|University Hospital Basel, Department for Psychosomatics, Basel, Basel-City, Switzerland|University of Basel, Department of Psychiatry (UPK), Basel",Switzerland,Respiratory Diseases,1,2,353.0
743.0,NCT04539626,Estrogen Therapy in Non-severe COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Estrogen Therapy,"CMN ""20 de Noviembre""",All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-10,01/07/21,2022-01-12,07/09/20,11/03/21,"CMN 20 de Noviembre, Mexico City, Benito Juárez",Mexico,Respiratory Diseases,1,1,733.0
744.0,NCT04591015,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,,Recruiting,"Diabetes Mellitus, Type 2",COVID-19,,,,,,Behavioral: Hospital: DD-CA|Behavioral: Hospital: Usual Care (UC),Scripps Whittier Diabetes Institute|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),All,"18 Years and older   (Adult, Older Adult)",172.0,Other|NIH,Interventional,2021-01-02,31/07/21,2021-08-31,19/10/20,09/02/21,"Scripps Mercy Hospital Chula Vista, Chula Vista, California",United States,"Respiratory Diseases, Metabolic Disorders",1,2,241.0
745.0,NCT04610554,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,,Completed,COVID-19,,,,,,,,"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy",All,"Child, Adult, Older Adult",74.0,Other,Observational,2020-05-14,12/10/20,2020-12-10,30/10/20,30/10/20,"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa",Italy,Respiratory Diseases,1,1,210.0
746.0,NCT04369820,C5a Receptor Expression - COVID-19 (C5-COV),C5-COV,Recruiting,COVID-19,,,,,,,Other: draw blood,Assistance Publique Hopitaux De Marseille|Innate Pharma,All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-03-31,01/09/20,2020-01-11,30/04/20,04/05/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,-80.0
747.0,NCT04788394,Renal Involvement in Hospitalized Children With COVID-19,RIHCC,Recruiting,Acute Kidney Injury,COVID-19,Renal Dysfunction,Coronavirus Infection,AKI,Pediatric Kidney Disease,Renal Insufficiency,Other: To determine the prevalence of renal dysfunction in hospitalized children with COVID19 in Qatar.,Hamad Medical Corporation,All,up to 14 Years   (Child),500.0,Industry,Observational,2021-01-03,31/12/21,2021-12-31,09/03/21,16/03/21,"Hamad General corporation, Doha",Qatar,Respiratory Diseases,1,7,362.0
748.0,NCT04503525,Nutritional Assessment of Hospitalized Patients With COVID-19,DenutCOVID,Recruiting,SARS-CoV,Nutrition Disorders,,,,,,Other: Nutritional assessment,Lille Catholic University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-05-25,25/05/21,2021-06-30,07/08/20,07/08/20,"Saint-Vincent Hospital, Lille, Haut-de-France",France,Others,0,2,401.0
749.0,NCT04625738,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,MSC-COVID19,Not yet recruiting,COVID-19,,,,,,,Biological: Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells|Biological: Placebo,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-11,16/05/22,2022-06-08,12/11/20,12/11/20,,,Respiratory Diseases,1,1,727.0
750.0,NCT04395872,Psychiatric Consultation for COVID-19 Patients,,Not yet recruiting,COVID-19,Psychiatric Problem,"Isolation, Social",,,,,Behavioral: Psychiatric counseling,Daegu Catholic University Medical Center,All,"Child, Adult, Older Adult",54.0,Other,Observational,2020-05-28,31/12/20,2020-12-31,20/05/20,27/05/20,,,Respiratory Diseases,1,3,217.0
751.0,NCT04497441,Netizens' Perception of COVID-19 Information & Information Sources.,,Recruiting,COVID-19,Information Seeking Behavior,Social Media,"Perception, Self",,,,Other: Electronic Survey questionnaire,Qassim University,All,"19 Years and older   (Adult, Older Adult)",385.0,Other,Observational,2020-10-06,10/08/20,2020-08-15,04/08/20,04/08/20,"Dr Bugude Shiva Shankar, Ar Rass, Al Qassim",Saudi Arabia,Respiratory Diseases,1,4,-52.0
752.0,NCT04402892,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,MEMO-COV2,Not yet recruiting,COVID-19,COVID-19,,,,,,"Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (hospitalized Patients )|Other: 35 ml blood, 5 tubes LITHIUM HEPARINATE at each time (cured Patients)",Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-06,01/03/21,2021-01-03,27/05/20,27/05/20,,,Respiratory Diseases,1,2,363.0
753.0,NCT04609774,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,COVID-19,Completed,COVID-19,,,,,,,Other: Severe Acute Respiratory Syndrome CoronaVirus 2 detection,Hospital Italiano de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",8.0,Other,Observational,2020-08-10,20/11/20,2020-01-12,30/10/20,04/02/21,"Hospital Italiano de Buenos Aires, Ciudad autónoma de Buenos Aires",Argentina,Respiratory Diseases,1,1,-211.0
754.0,NCT04552951,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,COVID-VIT-D,Recruiting,COVID-19,,,,,,,Drug: Cholecalciferol,Fundación para la Investigación Biosanitaria del Principado de Asturias|Hospital Universitario Central de Asturias|Instituto de Investigación Sanitaria del Principado de Asturias,All,"Child, Adult, Older Adult",80.0,Other,Interventional,2020-04-04,14/09/20,2020-12-30,17/09/20,17/09/20,"Hospital Universitario Central de Asturias, Oviedo, Asturias",Spain,Respiratory Diseases,1,1,270.0
755.0,NCT04383444,Surveillance of Individuals Following SARS-CoV-2 Exposure,,Recruiting,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1050.0,NIH,Observational,2020-07-07,01/08/23,2023-01-08,12/05/20,26/03/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,915.0
756.0,NCT04434118,Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients,,Enrolling by invitation,Rheumatoid Arthritis,COVID-19,,,,,,Drug: Traditional antirheumatic drugs,Sadat City University,All,18 Years to 60 Years   (Adult),600.0,Other,Observational,2020-03-20,30/12/21,2021-12-30,16/06/20,01/02/21,"Faculty of Medicine, Shibīn Al Kawm",Egypt,"Respiratory Diseases, Immunological Disorders",1,2,650.0
757.0,NCT04473352,COVID-19 Detection Tests in Different Body Fluids,,Not yet recruiting,COVID-19,,,,,,,,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara|Universidade Federal do Ceará,Male,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-01-09,01/09/21,2021-01-11,16/07/20,13/08/20,,,Respiratory Diseases,1,1,368.0
758.0,NCT04406493,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,,Recruiting,ARDS,COVID-19,,,,,,Diagnostic Test: Lung impedance technique,Hillel Yaffe Medical Center,All,"18 Years to 95 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-28,28/04/21,2021-04-28,28/05/20,28/05/20,"Hillel Yaffe MC,, Hadera",Israel,Respiratory Diseases,1,2,365.0
759.0,NCT04425889,COVID-19 Antibodies Among Healthcare Workers,,Completed,COVID-19,SARS-CoV 2,,,,,,"Diagnostic Test: COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)",Hospital Universitario Dr. Jose E. Gonzalez,All,"18 Years to 99 Years   (Adult, Older Adult)",156.0,Other,Observational,2020-05-05,30/05/20,2020-01-06,11/06/20,12/06/20,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,2,-120.0
760.0,NCT04408170,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),FALCON-C19,Recruiting,Coronavirus Infection,COVID-19,,,,,,Diagnostic Test: Point-of-care test for SARS-CoV-2,Manchester University NHS Foundation Trust,All,"18 Years to 100 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-06-19,30/06/21,2021-06-30,29/05/20,25/02/21,"Sandwell General Hospital Birmingham NHS Trust, Birmingham, United Kingdom|University Hospitals of Derby and Burton NHS FT, Derby, United Kingdom|Frimley Health NHS FT, Frimley, United Kingdom|Airedale NHS FT, Keighley, United Kingdom|Leeds Teaching Hospital NHS FT, Leeds, United Kingdom|St George's University Hospitals NHS FT, London, United Kingdom|Manchester University NHS FT, Manchester, United Kingdom|Newcastle upon Tyne Hospitals NHS FT, Newcastle Upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Oxford University Hospitals NHS FT, Oxford, United Kingdom|Royal Berkshire Hospital NHS FT, Reading, United Kingdom|Barking, Havering & Redbridge Hospitals NHS FT, Romford, United Kingdom|Salford Royal NHS FT, Salford, United Kingdom|University Hospital Southampton NHS FT, Southampton, United Kingdom|University Hospitals of North Midlands NHS Trust, Stoke-on-Trent",United Kingdom,Respiratory Diseases,1,2,376.0
761.0,NCT04323514,Use of Ascorbic Acid in Patients With COVID 19,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin C,University of Palermo,All,"Child, Adult, Older Adult",500.0,Other,Interventional,2020-03-13,13/03/21,2021-03-13,26/03/20,26/03/20,"A.R.N.A.S. Civico - Di Cristina - Benfratelli, Palermo",Italy,Respiratory Diseases,1,1,365.0
762.0,NCT04323800,Convalescent Plasma to Stem Coronavirus (CSSC-001),CSSC-001,"Active, not recruiting",Coronavirus,Convalescence,,,,,,Biological: Anti- SARS-CoV-2 Plasma|Biological: SARS-CoV-2 non-immune Plasma,Johns Hopkins University,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-10-06,31/12/22,2023-01-01,27/03/20,08/04/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Center for American Indian Health - Whiteriver Office, Whiteriver, Arizona, United States|University of California, San Diego, La Jolla, California, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, Irvine Health, Orange, California, United States|Western Connecticut Health Network, Danbury Hospital, Danbury, Connecticut, United States|Western Connecticut Health Netowrk, Norwalk Hospital, Norwalk, Connecticut, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|University of Miami, Coral Gables, Florida, United States|University of Miami Clinical Translational Research Site, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|The Johns Hopkins University, Baltimore, Maryland, United States|University of Massachusetts Worcester, Worcester, Massachusetts, United States|Wayne State University, Detroit, Michigan, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|Center for American Indian Health - Gallup Office, Gallup, New Mexico, United States|Center for American Indian Health - Shiprock Office, Shiprock, New Mexico, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|University of Rochester, Rochester, New York, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Lifespan/BrownUniversity (Rhode Island Hospital), Providence, Rhode Island, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|The University of Utah, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,817.0
763.0,NCT04501822,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,Cardiac Complication,,,,,,"Diagnostic Test: Evaluation of clinical, instrumental and laboratory diagnostics tests",Tomsk National Research Medical Center of the Russian Academy of Sciences,All,"18 Years and older   (Adult, Older Adult)",380.0,Other,Observational,2020-07-19,19/07/21,2021-12-31,06/08/20,06/08/20,"Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tyumen",Russian Federation,Respiratory Diseases,1,2,530.0
764.0,NCT04705844,Study of Adalimumab or Placebo in Patients With Mild to Moderate COVID-19 (COMBAAT),COMBAAT,Not yet recruiting,COVID-19,,,,,,,Drug: Adalimumab|Drug: Placebo,"Ology Bioservices|Pharm-Olam, LLC|Chemical, Biological, Radiological, and Nuclear Medical",All,"40 Years to 80 Years   (Adult, Older Adult)",1444.0,Industry|Other,Interventional,2021-01-05,01/11/21,2022-01-01,12/01/21,24/03/21,,,Respiratory Diseases,1,1,361.0
765.0,NCT04716426,APT™ T3X on the COVID-19 Contamination Rate,,Completed,COVID-19,,,,,,,Drug: Tetracycline hydrochloride 3%|Drug: Placebo,University of Nove de Julho|Santa Casa de Misericórdia de Porto Alegre,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-28,25/03/21,2021-03-25,20/01/21,08/04/21,"Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,Respiratory Diseases,1,1,56.0
766.0,NCT04491994,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,COVID-19,Completed,COVID-19,Progression,,,,,,Drug: HCQ,"UNICEF|Pak Emirates Military Hospital Rawalpindi, Pakistan",All,"18 Years to 80 Years   (Adult, Older Adult)",540.0,Other,Interventional,2020-10-04,31/05/20,2020-05-31,30/07/20,21/08/20,"Pak Emirates Military Hospital, Rawalpindi, Punjab",Pakistan,Respiratory Diseases,1,2,-126.0
767.0,NCT04826640,Observational Maternal COVID-19 Vaccination Study,,Not yet recruiting,Pregnancy,,,,,,,Other: Observational,"Duke University|Centers for Disease Control and Prevention|Children's Hospital Medical Center, Cincinnati|Boston Medical Center",Female,18 Years to 45 Years   (Adult),350.0,Other|U.S. Fed,Observational,2021-01-05,01/05/23,2023-01-05,01/04/21,01/04/21,"Centers for Disease Control and Prevention, Atlanta, Georgia, United States|Boston Medical Center, Boston, Massachusetts, United States|Duke University, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio",United States,Others,0,1,730.0
768.0,NCT04389515,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",,Recruiting,COVID-19,Prenatal Care,Postoperative Care,,,,,,Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),75.0,Other,Observational,2020-05-14,25/09/20,2020-09-30,15/05/20,02/09/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali",Turkey,Respiratory Diseases,1,3,139.0
769.0,NCT04526769,Detecting SARS-CoV-2 in Tears,,Not yet recruiting,COVID-19,COVID-19,Corona Virus Infection,COVID-19,,,,Diagnostic Test: Tear Collection,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-09,01/04/21,2021-01-04,26/08/20,26/08/20,"University of Minnesota, Minneapolis, Minnesota",United States,Respiratory Diseases,1,4,361.0
770.0,NCT04836065,ESICM UNITE COVID-19 Project (UNITE-COVID),UNITE-COVID,Completed,COVID-19,,,,,,,,"University Hospital, Ghent|European Society of Intensive Care Medicine",All,"18 Years and older   (Adult, Older Adult)",4995.0,Other,Observational,2020-01-07,30/09/20,2020-12-31,08/04/21,08/04/21,"Ghent University Hospital, Ghent",Belgium,Respiratory Diseases,1,1,359.0
771.0,NCT04389294,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,,Completed,COVID-19,,,,,,,Diagnostic Test: SARS-CoV2 serum antibody testing,"Hospital for Special Surgery, New York",All,"21 Years and older   (Adult, Older Adult)",143.0,Other,Interventional,2020-05-05,16/06/20,2020-04-09,15/05/20,11/02/21,"Hospital for Special Surgery, New York, New York",United States,Respiratory Diseases,1,1,-26.0
772.0,NCT04405271,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),,Not yet recruiting,Healthcare Workers,COVID-19,SARS-CoV 2,,,,,Drug: Emtricitabine/Tenofovir Alafenamide 200 MG-25 MG Oral Tablet|Drug: Placebo,Hospital Italiano de Buenos Aires|Sociedad Argentina de Infectología (SADI) (Argentine Society of Infectious Diseases),All,"18 Years and older   (Adult, Older Adult)",1378.0,Other,Interventional,2020-07-31,15/11/20,2020-11-15,28/05/20,28/07/20,"Sociedad Argentina de Infectología, A. J. Carranza 974, Ciudad Autonoma de Buenos Aires, Capital Federal",Argentina,Respiratory Diseases,1,3,107.0
773.0,NCT04380896,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Co-Stars,Recruiting,COVID-19,,,,,,,Other: Blood test|Other: Standardised questionnaires,Great Ormond Street Hospital for Children NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-27,27/07/26,2026-07-27,08/05/20,15/05/20,"Great Ormond Street Hospital, London",United Kingdom,Respiratory Diseases,1,1,2282.0
774.0,NCT04527575,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",EpiVacCorona,"Active, not recruiting",COVID-19,,,,,,,"Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride bufus, solvent for the preparation of dosage forms for injection 0.9%)","Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""",All,18 Years to 60 Years   (Adult),100.0,Other,Interventional,2020-07-27,01/05/21,2021-01-05,26/08/20,23/02/21,"Federal State Budgetary Institution of Healthcare Medical and Sanitary Unit No. 163 of the Federal Medical and Biological Agency (FGBUZ MSCH-163, FMBA of Russia), Koltsovo, Novosibirsk Region",Russian Federation,Respiratory Diseases,1,1,162.0
775.0,NCT04369300,Anxiety And Depression During COVID-19 IN INDIA,,Recruiting,COVID-19,,,,,,,Behavioral: Registery Data Collection,Max Healthcare Insititute Limited,All,"18 Years to 90 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-24,24/11/20,2021-02-24,30/04/20,15/07/20,"Max Super Speciality hospital, New Delhi, Delhi",India,Respiratory Diseases,1,1,306.0
776.0,NCT04573634,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,START,Recruiting,COVID-19,SARS-CoV Infection,,,,,,,Jill M Kolesar|University of Kentucky,All,"18 Years and older   (Adult, Older Adult)",960.0,Other,Observational,2020-05-15,31/12/23,2023-12-31,05/10/20,05/10/20,"University of Kentucky, Lexington, Kentucky",United States,Respiratory Diseases,1,2,1325.0
777.0,NCT04628637,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,,Completed,COVID-19,Endoplasmic Reticulum Stress,,,,,,Other: Serum protein level analysis,Kafkas University|Pamukkale University Faculty of Medicine|Acibadem Mehmet Ali Aydinlar University Faculty of Medicine,All,"18 Years and older   (Adult, Older Adult)",144.0,Other,Observational,2020-04-16,01/10/20,2020-10-10,13/11/20,13/11/20,"Aylin Koseler, Denizli, Outside Of The US",Turkey,"Mental Health, Respiratory Diseases",1,2,177.0
778.0,NCT04394026,Imaging Feature of SARS-CoV2 Infection,COVID19IF,Recruiting,Viral Pneumonia,COVID-19,,,,,,,Francesco De Cobelli|IRCCS San Raffaele,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-04-16,30/06/21,2021-07-31,19/05/20,10/02/21,"Deaprtment of Radiology, IRCCS Ospedale San Raffaele, Milano",Italy,Respiratory Diseases,1,2,471.0
779.0,NCT04384055,Predicting Outcomes for Covid-19 Using Sonography,POCUS,Enrolling by invitation,COVID-19,"Pneumonia, Viral",,,,,,Diagnostic Test: Lung Ultrasound,Stanford University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-03-21,31/12/21,2021-12-31,12/05/20,22/01/21,"University of California San Francisco, San Francisco, California, United States|Stanford University, Stanford, California",United States,Respiratory Diseases,1,2,650.0
780.0,NCT04327505,Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,COVID-19-HBO,Recruiting,SARS (Severe Acute Respiratory Syndrome),Cytokine Storm,"ARDS, Human",COVID-19,Sars-CoV2,Acute Respiratory Failure,,Drug: Hyperbaric oxygen,"Karolinska Institutet|Karolinska Trial Alliance|University of California, San Diego|Blekinge County Council Hospital|JK Biostatistics AB|The Swedish Research Council|University of Regensburg|University Hospital Bergmannsheil Bochum",All,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-06,31/12/21,2022-12-31,31/03/20,03/12/20,"Bergmannsheil und Kinderklinik Buer GmbH, Gelsenkirchen, Germany|Krankenhaus St. Joesf, Regensburg, Germany|Medical Centre Maria Brasov, Braşov, Romania|Blekingesjukhuset, Karlskrona, Blekinge, Sweden|Sahlgrenska University hospital, Östra sjukhuset, Gothenburg, Sweden|Karolinska University Hospital, Stockholm",Sweden,Respiratory Diseases,1,6,1030.0
781.0,NCT04405934,COG-UK Project Hospital-Onset COVID-19 Infections Study,COG-UK HOCI,Not yet recruiting,COVID-19,Nosocomial Infection,Coronavirus,Coronavirus Infection,SARS-CoV 2,,,Other: Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures,"University College, London|Public Health England",All,"Child, Adult, Older Adult",2000.0,Other,Interventional,2020-01-07,01/10/20,2021-01-04,28/05/20,17/06/20,,,Respiratory Diseases,1,5,363.0
782.0,NCT04435587,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,IDRA-COVID19,Recruiting,Asymptomatic Infections,SARS-CoV2 Infection,,,,,,Drug: Ivermectin Pill|Drug: Combined ART/hydroxychloroquine,Mahidol University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-07-13,01/06/21,2021-01-11,17/06/20,11/01/21,"Siriraj Hospital, Bangkok Noi, Bangkok, Thailand|Siriaj Hospital, Bangkok, N/A = Not Applicable, Thailand|Sireethorn Nimitvilai, Amphoe Maueng, Nakhonpathom, Thailand|Golden Jubilee Medical Center, Phutthamonthon District, Nakhonpathom",Thailand,Respiratory Diseases,1,2,182.0
783.0,NCT04578132,Description of the Population With Genitourinary Tumors and COVID-19,SOGUGCOVID,Recruiting,COVID-19,Genito Urinary Cancer,,,,,,,Spanish Oncology Genito-Urinary Group,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-11-24,01/06/21,2021-01-10,08/10/20,15/03/21,"Institut Català d'Oncologia L'Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Althaia, Manresa, Barcelona, Spain|Hospital Universitari Parc Taulí, Sabadell, Barcelona, Spain|Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario de Badajoz, Badajoz, Spain|Hospital del Mar, Barcelona, Spain|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Vall d Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital de Ciudad Real, Ciudad Real, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Instituto Catalán de Oncología- Girona, Girona, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Clínico San Carlos de Madrid, Madrid, Spain|Hospital Infanta Leonor,, Madrid, Spain|Hospital Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Quironsalud, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Complejo Hospitalario Universitario Ourense, Orense, Spain|Clinica Universidad de Navarra, Pamplona, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Instituto Valenciano de Oncología, Valencia, Spain|Hospital Txagorritxu, Vitoria, Spain|Hospital Miguel Servet, Zaragoza",Spain,"Respiratory Diseases, Cancers",1,2,47.0
784.0,NCT04521309,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,,Completed,COVID-19,,,,,,,Biological: SARS-CoV-2 antibody based IVIG therapy,Dow University of Health Sciences|Higher Education Commission (Pakistan),All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-06-19,26/01/21,2021-08-02,20/08/20,24/03/21,"Dow University of Health Sciences, Karachi, Sindh",Pakistan,Respiratory Diseases,1,1,409.0
785.0,NCT04322682,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),COVID-19,Completed,Corona Virus Infection,,,,,,,Drug: Colchicine|Drug: Placebo oral tablet,"Montreal Heart Institute|National Heart, Lung, and Blood Institute (NHLBI)|Bill and Melinda Gates Foundation|The Government of Quebec|DACIMA Software",All,"40 Years and older   (Adult, Older Adult)",4506.0,Other|NIH,Interventional,2020-03-23,21/01/21,2021-01-21,26/03/20,25/01/21,"Mayo Clinic - Arizona, Phoenix, Arizona, United States|Yuma Regional Medical Center Cancer Center, Yuma, Arizona, United States|University of Arkansas for medical Sciences, Little Rock, Arkansas, United States|Centric Health Resources Inc., Bakersfield, California, United States|Westside Medical Associates of Los Angeles, Beverly Hills, California, United States|Rancho Research Institute, Downey, California, United States|University of California, San Francisco - San Francisco General Hospital, San Francisco, California, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|South Florida Research Organization, Medley, Florida, United States|Miami Center for Advanced Cardiology, Miami Beach, Florida, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|North Mississippi Medical Clinics, Inc., Tupelo, Mississippi, United States|New York University School of Medecine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Prisma Health, Greenville, South Carolina, United States|Baylor Scott & White Research Institute - Pharmacy, Dallas, Texas, United States|University of Texas(UT) Southwestern Medical Center, Dallas, Texas, United States|Spring Clinical Research, Houston, Texas, United States|Heart Institute (inCor), Scholl of Medecine, University of Sao Paulo, São Paulo, Sao Paulo, Brazil|Montreal Heart Institute, Montreal, Quebec, Canada|Tread Research, Tygerberg Hospital, Cape Town, South Africa|Hospital Universitario La Paz, IdiPaz, La Paz, Madrid",Spain,Respiratory Diseases,1,1,304.0
786.0,NCT04471766,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,,"Active, not recruiting",COVID-19,Respiratory Illness,,,,,,Other: Certified cloth face mask plus preventive information|Behavioral: Preventive information,"Bandim Health Project|University of Southern Denmark|Engineers without Borders, Denmark (https://iug.dk/en)",All,"10 Years and older   (Child, Adult, Older Adult)",40000.0,Other,Interventional,2020-07-20,01/06/21,2021-01-08,15/07/20,08/03/21,"Bandim Health Project, Bissau, Bissau Codex",Guinea-Bissau,Respiratory Diseases,1,2,172.0
787.0,NCT04441684,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",SeroCoV-HUS,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Blood sample for serological test,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",1800.0,Other,Interventional,2020-04-17,07/05/20,2021-01-08,22/06/20,22/06/20,"Hôpitaux Universitaires de Strasbourg - Centre d'Investigation Clinique - Nouvel Hôpital Civil et Hautepierre, Strasbourg",France,Respiratory Diseases,1,2,266.0
788.0,NCT04362943,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,COVID-AGE,Recruiting,COVID-19,,,,,,,Drug: Baricitinib or Anakinra,Complejo Hospitalario Universitario de Albacete,All,70 Years and older   (Older Adult),576.0,Other,Observational,2020-04-20,15/05/20,2020-07-31,27/04/20,27/04/20,"Complejo Hospitalario Universitario de Albacete, Albacete",Spain,Respiratory Diseases,1,1,102.0
789.0,NCT04795583,Corticosteroids for COVID-19,CORE-COVID,Not yet recruiting,COVID-19,,,,,,,Drug: Prednisone|Device: Point of Care testing device for C-reactive protein,University of Alberta,All,"18 Years and older   (Adult, Older Adult)",1526.0,Other,Interventional,2021-01-04,01/04/22,2022-01-08,12/03/21,18/03/21,"Clinica de la Mujer, Bogotá, Colombia|ABC Medical Center, Mexico City",Mexico,Respiratory Diseases,1,1,369.0
790.0,NCT04529447,Response of Korean Medicine Hospital to COVID-19,,Completed,COVID-19,,,,,,,Other: Survey,Jaseng Hospital of Korean Medicine|Jaseng Medical Academy,All,"Child, Adult, Older Adult",485.0,Other,Observational,2020-10-06,10/08/20,2020-10-08,27/08/20,27/08/20,"Jaseng Hospital of Korean Medicine, Seoul, Korea",Republic of,Respiratory Diseases,1,1,2.0
791.0,NCT04646551,Covid-19 Risk Factors and Pattern Between Healthcare Workers,,Not yet recruiting,COVID-19,,,,,,,,Assiut University,All,"18 Years to 70 Years   (Adult, Older Adult)",165.0,Other,Observational,2020-01-12,01/12/21,2022-01-01,30/11/20,30/11/20,,,Respiratory Diseases,1,1,720.0
792.0,NCT04364022,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,COPEP,Completed,COVID-19,,,,,,,Drug: Lopinavir/ritonavir,"Calmy Alexandra|University Hospital, Geneva",All,"16 Years and older   (Child, Adult, Older Adult)",326.0,Other,Interventional,2020-04-23,24/03/21,2021-03-24,27/04/20,12/04/21,"Instituto Nacional de Infectiologia Evandro Chagas, Fiocruz, Rio De Janeiro, Brazil|Universitätsspital Basel and SwissTPH, Basel, Switzerland|Hôpitaux Universitaires de Genève, Geneva, Switzerland|Ospedale Regionale di Lugano, Lugano",Switzerland,Respiratory Diseases,1,1,335.0
793.0,NCT04460638,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,CoviDiagMS,Recruiting,SARS-CoV 2,,,,,,,Biological: Saliva collection|Other: Clinical assessment,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-07-23,01/07/22,2022-01-07,07/07/20,09/03/21,"Hôpital d'Instruction des Armées Laveran, Marseille",France,Respiratory Diseases,1,1,533.0
794.0,NCT04540926,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: Cyclosporin A,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-09,01/09/20,2020-09-30,07/09/20,07/09/20,"Jose Luis Jl Galvez-Romero, Puebla",Mexico,Respiratory Diseases,1,1,265.0
795.0,NCT04590794,SuPAR in Adult Patients With Covid-19,SPARCOL,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Soluble Urokinase Plasminogen Activator Receptor,University of Thessaly,All,"18 Years to 120 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-11-10,31/03/21,2021-02-04,19/10/20,09/03/21,"University Hospital of Larisa, Department of Anesthesiology, Larissa, Thessaly",Greece,Respiratory Diseases,1,1,86.0
796.0,NCT04389658,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),CONDITION,Completed,COVID-19,,,,,,,,Igenomix,All,"Child, Adult, Older Adult",1526.0,Industry,Observational,2020-07-05,10/06/20,2020-08-25,15/05/20,09/10/20,"Igenomix, Paterna, Valencia",Spain,Respiratory Diseases,1,1,51.0
797.0,NCT04368871,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,,Recruiting,COVID-19,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-04-28,30/06/20,2021-05-30,30/04/20,09/06/20,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi",India,Respiratory Diseases,1,1,397.0
798.0,NCT04733651,Study to Investigate the Clinical Efficacy of Isoquercetin in Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Hospital standard of care for COVID-19|Drug: Isoquercetin,Nepal Health Research Council,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2021-02-20,20/05/21,2021-08-15,02/02/21,05/02/21,,,Respiratory Diseases,1,1,176.0
799.0,NCT04476589,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,PREDICT-COVID,Recruiting,COVID-19,Coma,Consciousness Disorder,,,,,Diagnostic Test: Functional MRI,Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,30/06/22,2023-03-30,20/07/20,19/10/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,3,1178.0
800.0,NCT04370808,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,VITACOV,Not yet recruiting,COVID-19,,,,,,,Other: Exposure,"University of Lisbon|Cardiovascular Centre of Universidade de Lisboa (CCUL)|Faculty of Medicine of Universidade de Lisboa (FMUL)|Centro Hospitalar Universitário Lisboa Norte (CHULN)|Centro Hospitalar Universitário São João (CHUSJ)|CINTESIS - Center for Health Technology and Services Research|NOVA Medical School of Universidade NOVA de Lisboa|HeartGenetics, Genetics and Biotechnology SA|Instituto Gulbenkian de Ciência (IGC)",All,"18 Years and older   (Adult, Older Adult)",500.0,Other|Industry,Observational,2020-01-06,01/10/20,2021-01-03,01/05/20,19/05/20,"Cardiovascular Center at Universidade de Lisboa, Lisbon, Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Lisbon, Lisboa, Portugal|Centro Hospitalar de São João, Oporto",Portugal,Respiratory Diseases,1,1,363.0
801.0,NCT04355338,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),AVISA,Recruiting,COVID-19,,,,,,,,Butantan Institute,All,"Child, Adult, Older Adult",4100.0,Other,Observational,2020-10-25,30/05/21,2022-05-30,21/04/20,12/11/20,"Universidade Federal do Ceará, Fortaleza, CE, Brazil|Universidade de Brasília, Brasilia, DF, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil|Hospital Universitário Júlio Müller da Universidade Federal de Mato Grosso, Cuiabá, Mount, Brazil|Universidade Federal de Roraima - UFRR, Boa Vista, Roraima, Brazil|Centro de Pesquisas em Medicina Tropical de Rondônia (CEPEM), Porto Velho, RO, Brazil|Universidade Federal de Sergipe, Laranjeiras, SE, Brazil|Hospital Estadual de Serrana, Serrana, SP, Brazil|Faculdade Santa Marcelina, São Paulo, SP, Brazil|Faculdade de Medicina de São José do Rio Preto - FAMERP, São José Do Rio Preto, São Paulo, Brazil|Instituto de Infectologia Evandro Chagas - Fiocruz, Rio De Janeiro",Brazil,Respiratory Diseases,1,1,582.0
802.0,NCT04427098,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,INHIXACOV19,Recruiting,COVID-19,,,,,,,Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution|Drug: Enoxaparin,IRCCS Azienda Ospedaliero-Universitaria di Bologna,All,"18 Years to 90 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-05-22,30/10/20,2020-10-30,11/06/20,17/06/20,"Policlinico S. Orsola Malpighi Dipartimento Malattie Infettive, Bologna, Emilia Romagna, Italy|Azienda Ospedaliero-Universitaria di Parma Anestesia e Rianimazione Dipartimento di Medicina e Chirurgia, Parma, Emilia Romagna, Italy|I.R.C.C.S. Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG) UOVD Emostasi e trombosi- Poliambulatorio Giovanni Paolo II Viale Padre Pio n.7 San Giovanni Rotondo (FG), San Giovanni Rotondo, Foggia, Italy|Fondazione Poliambulanza Chirurgia Vascolare, Brescia, Italy|Piazzale Spedali Civili, 1, 25123 Brescia BS Medicina Interna UniBS 2° Medicina ASST Spedali Civili, Brescia, Italy|Azienda Ospedaliero-Universitaria Policlinico - V. Emanuele, Catania Anestesia e Rianimazione UO Malattie Infettive, Catania, Italy|ASST Cremona Unità Operativa di Chirurgia Vascolare Dipartimento di Medicina di Laboratorio e di Radiologia- Centro Emostasi e Trombosi, Cremona, Italy|Ospedale Morgagni Pierantoni U.O.C. Malattie Infettive, Forlì, Italy|Ospedale Carlo Poma di Mantova MALATTIE INFETTIVE Padiglione 37 Str. Lago Paiolo, 10, 46100 Mantova, Mantova, Italy|AZIENDA OSPEDALIERA Regionale S CARLO POTENZA Struttura Complessa Interaziendale Malattie Infettive, Matera, Italy|Ospedale San Raffaele Unità Funzionale dell'Unità Operativa di Malattie Infettive Osp. San Raffaele, Milano, Italy|Ospedale Amedeo di Savoia Torino Università di Torino Malattie Infettive, Torino, Italy|Azienda Ospedaliera Universitaria Integrata Verona UOC Malattie Infettive e Tropicali, Verona",Italy,Respiratory Diseases,1,1,161.0
803.0,NCT04438239,Rehabilitation Needs After COVID-19 Hospital Treatment,REACT,Completed,COVID-19,,,,,,,"Other: none, this study is observational",Azienda Unità Sanitaria Locale Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-06-22,31/12/20,2020-12-31,18/06/20,26/01/21,"Azienda USL-IRCCS S.Maria Nuova Hospital, Reggio Emilia",Italy,Respiratory Diseases,1,1,192.0
804.0,NCT04359095,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,,Recruiting,COVID-19,,,,,,,Drug: Emtricitabine/tenofovir|Drug: Colchicine Pill|Drug: Rosuvastatin|Other: Standard treatment,Universidad Nacional de Colombia|Pontificia Universidad Javeriana|Clínica Universitaria Colombia|Hospital Universitario San Ignacio|Hospital Universitario Nacional de Colombia|Clínica Reina Sofía|Fundación Cardio Infantil|Clinica Santa maria del Lago,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Interventional,2020-08-18,28/02/21,2021-05-31,24/04/20,08/02/21,"Clinica santa Maria del lago, Bogota, DC, Colombia|Hospital Universitario de Neiva, Neiva, Huila, Colombia|Clínica Reina Sofía, Bogotá, Colombia|Fundacion Cardio Infantil, Bogotá, Colombia|Hospital Universitario San Ignacio, Bogotá, Colombia|Clinica Universitaria Colombia, Bogotá, Colombia|Hospital Universitario Nacional de Colombia, Bogotá",Colombia,Respiratory Diseases,1,1,286.0
805.0,NCT04542967,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,PC-COVID-HCM,Recruiting,COVID-19,,,,,,,Biological: Biological,Hospital Central Militar,All,"18 Years to 90 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-06-23,02/09/20,2020-09-30,09/09/20,10/09/20,"Hospital Central Militar, Mexico City",Mexico,Respiratory Diseases,1,1,99.0
806.0,NCT04767087,Honey and Nigella Sativa in COVID-19 Prophylaxis,HNS-COVID-PK,Recruiting,COVID-19,,,,,,,Drug: Honey|Drug: Nigella sativa seed|Other: Placebo,Sohaib Ashraf|Sheikh Zayed Federal Postgraduate Medical Institute,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-05-02,15/06/21,2021-07-15,23/02/21,23/02/21,"Shaikh Zayed Post-Graduate Medical Institute, Lahore, MA",Pakistan,Respiratory Diseases,1,1,74.0
807.0,NCT04353518,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Other: Placebo,"Cadila Pharnmaceuticals|Council of Scientific and Industrial Research, India",All,"18 Years and older   (Adult, Older Adult)",4000.0,Industry|Other,Interventional,2020-06-30,30/03/21,2021-05-30,20/04/20,22/12/20,"All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Post Graduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi",India,Respiratory Diseases,1,1,334.0
808.0,NCT04357639,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),,Recruiting,HIV Patients,,,,,,,Other: No intervention,Centre Hospitalier Intercommunal Creteil|Centre Hospitalier Intercommunal Villeneuve St Georges,All,"18 Years and older   (Adult, Older Adult)",1040.0,Other,Observational,2020-05-28,31/01/21,2021-07-31,22/04/20,21/07/20,"CHI Créteil, Créteil, France|CHU Henri Mondor, Créteil, France|Centre hospitalier de Melun (GHSIF), Melun, France|CHI Villeneuve St Georges, Villeneuve-Saint-Georges",France,Others,0,1,429.0
809.0,NCT04603664,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,,Recruiting,COVID-19,,,,,,,Diagnostic Test: serum NGAL and cystatin c,Ain Shams University,All,"18 Years to 65 Years   (Adult, Older Adult)",88.0,Other,Observational,2020-10-30,01/02/21,2021-01-03,27/10/20,03/11/20,"Ainshams hospitals, Cairo, Egypt|Sanaa Wasfy, New Cairo",Egypt,Respiratory Diseases,1,1,65.0
810.0,NCT04794374,Effects of Telerehabilitation After Discharge in COVID-19 Survivors,,Recruiting,COVID-19,,,,,,,Other: Telerehabilitation,Hacettepe University,All,"18 Years to 90 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-11-16,16/01/22,2022-01-16,12/03/21,15/03/21,"Hacettepe University, Ankara",Turkey,Respiratory Diseases,1,1,426.0
811.0,NCT04519034,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Other: no intervention,Guy's and St Thomas' NHS Foundation Trust,All,"1 Year to 100 Years   (Child, Adult, Older Adult)",27000.0,Other,Observational,2020-01-09,30/09/20,2020-12-31,19/08/20,19/08/20,"GSTT NHS Trust, London",United Kingdom,Respiratory Diseases,1,1,357.0
812.0,NCT04644159,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",COVID-OISE,Recruiting,SARS (Severe Acute Respiratory Syndrome),COVID-19,,,,,,Other: Human biological samples,Institut Pasteur,All,"5 Years and older   (Child, Adult, Older Adult)",2000.0,Industry,Observational,2020-11-13,30/06/22,2023-01-11,25/11/20,27/11/20,"Hôpital de Crépy en Valois, Crépy-en-Valois, France|Institut Pasteur, Paris",France,Respiratory Diseases,1,2,789.0
813.0,NCT04389944,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,,Completed,COVID-19,,,,,,,Other: convalescent plasma application to SARS-CoV-2 infected patients,"University Hospital, Basel, Switzerland",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-03-31,30/06/20,2020-06-30,15/05/20,04/08/20,"Blutspendezentrum SRK beider Basel, University Hospital Basel, Basel",Switzerland,Respiratory Diseases,1,1,91.0
814.0,NCT04828564,Efficacy and Safety of Favipiravir and Ribavirin Formulation for Treatment of COVID-19,COVID-19,Not yet recruiting,SARS-CoV2,COVID-19,,,,,,Drug: Ribavirin Capsules|Drug: Favipiravir,The Scientific and Technological Research Council of Turkey|Ankara City Hospital Bilkent|Istanbul Umraniye Training and Research Hospital|Koç University|Monitor CRO,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-04,30/09/21,2021-12-31,02/04/21,02/04/21,"Ankara University, School of Medicine, Ankara, Cebeci, Turkey|Ankara City Hospital, Ankara, Turkey|Koc University Hospital, Istanbul, Turkey|Umraniye Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,361.0
815.0,NCT04702945,Canadian COVID-19 Emergency Department Registry,CCEDRRN,Recruiting,COVID-19,,,,,,,,University of British Columbia|Genome British Columbia|Canadian Institutes of Health Research (CIHR)|Canadian Critical Care Trials Group,All,"Child, Adult, Older Adult",200000.0,Other|Industry,Observational,2020-01-03,31/12/22,2023-12-31,11/01/21,11/01/21,"Foothills Medical Centre, Calgary, Alberta, Canada|Peter Lougheed Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Northeast Community Health Centre, Edmonton, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Abbotsford Regional Hospital, Abbotsford, British Columbia, Canada|Royal Inland Hospital, Kamloops, British Columbia, Canada|Kelowna General Hospital, Kelowna, British Columbia, Canada|Royal Columbian Hospital, New Westminster, British Columbia, Canada|Lions Gate Hospital, North Vancouver, British Columbia, Canada|Eagle Ridge Hospital, Port Moody, British Columbia, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|Mount Saint Joseph Hospital, Vancouver, British Columbia, Canada|St. Paul's Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Saint John Regional Hospital, Saint John, New Brunswick, Canada|Dartmouth General Hospital, Dartmouth, Nova Scotia, Canada|Halifax Infirmary, Halifax, Nova Scotia, Canada|Cobequid Community Health Centre, Lower Sackville, Nova Scotia, Canada|Hants Community Hospital, Windsor, Nova Scotia, Canada|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|Hotel Dieu Hospital, Kingston, Ontario, Canada|Kingston General Hospital, Kingston, Ontario, Canada|London Health Sciences Centre (University Hospital), London, Ontario, Canada|London Health Sciences Centre (Victoria Hospital), London, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Health Science North, Sudbury, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Hôtel-Dieu de Lévis, Lévis, Quebec, Canada|Hôpital du Sacré-Coeur, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|Montréal General Hospital (MUHC), Montréal, Quebec, Canada|Royal Victoria Hospital (MUHC), Montréal, Quebec, Canada|Centre Hospitalier de l'Université Laval (CHU de Québec), Québec, Quebec, Canada|Hôpital de l'Enfant-Jésus (CHU de Québec), Québec, Quebec, Canada|Hôpital du Saint-Sacrement (CHU de Québec), Québec, Quebec, Canada|Hôpital Saint-François d'Assise (CHU de Québec), Québec, Quebec, Canada|Hôtel-Dieu de Québec (CHU de Québec), Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec, Canada|Pasqua Hospital, Regina, Saskatchewan, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Royal University, Saskatoon, Saskatchewan, Canada|Saskatoon City Hospital, Saskatoon, Saskatchewan, Canada|St Paul's Hospital, Saskatoon, Saskatchewan",Canada,Respiratory Diseases,1,1,1458.0
816.0,NCT04391946,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,COVID19_LLC-MW,Recruiting,"Chronic Lymphocytic Leukemia, Lymphocytic Lymphoma or Waldenstrom Disease",,,,,,,Behavioral: Data registry,French Innovative Leukemia Organisation|Institut de cancérologie Strasbourg Europe,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-03-14,01/05/22,2022-12-31,18/05/20,12/08/20,"Chu Angers, Angers, France|CHU Jean Minjoz - Hématologie, Besançon, France|Hôpital Avicenne - Centre de Recherche Clinique, Bobigny, France|CHU Estaing - Hématologie Clinique Adulte, Clermont-Ferrand, France|Chu Creteil, Créteil, France|CHU Grenoble - Hématologie, Grenoble, France|Chd Vendee, La Roche-sur-Yon, France|Centre Hospitalier du Mans, Le Mans, France|Hôpital Saint Vicent de Paul, Lille, France|Centre Léon Bérard - Hématologie, Lyon, France|Institut Paoli Calmette, Marseille, France|Hopital E.Muller, Mulhouse, France|CHU DE NANTES - Hematologie clinique, Nantes, France|Hopital Pitie Salpetriere Service Hematologie Clinique - Pavillon de L'Enfant Et Adolescent, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Hôpital de la Milétrie - Hématologie et Thérapie Cellulaire, Poitiers, France|Hôpital Robert Debré - Hématologie Clinique, Reims, France|Centre Henri Becquerel - Service Hématologie Clinique, Rouen, France|Hôpital Hautepierre - Hématologie, Strasbourg, France|IUCT ONCOPOLE - Hématologie, Toulouse, France|Hôpital Bretonneau - Hématologie et Thérapie Cellulaire, Tours, France|CHU Nancy Brabois, Vandœuvre-lès-Nancy",France,Cancers,1,1,1022.0
817.0,NCT04388670,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,2019nCoV_ICU,Recruiting,COVID-19,Critical Illness,,,,,,,Policlinico Hospital,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-02-22,22/08/20,2020-08-31,14/05/20,14/05/20,"Fondazione IRCCS Ca'Granda - Ospedale Maggiore Policlinico, Milan",Italy,"Cardiovascular Diseases, Respiratory Diseases",1,2,191.0
818.0,NCT04824222,The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters,FeMToCOVID,Not yet recruiting,COVID-19,,,,,,,"Drug: Human fecal microbiota, MBiotix HBI|Drug: Placebo|Drug: SOC","Medical University of Warsaw|Human Biome Institute, Poland",All,"18 Years and older   (Adult, Older Adult)",366.0,Other,Interventional,2021-01-04,01/07/22,2022-01-12,01/04/21,01/04/21,,,Respiratory Diseases,1,1,373.0
819.0,NCT04367792,Cardiac Injury in COVID-19: a Pathology Study,,"Active, not recruiting",COVID-19,,,,,,,,"A.O. Ospedale Papa Giovanni XXIII|CVPath Institute Inc. Renu Virmani, Aloke Finn|A.O. Ospedale Papa Giovanni XXIII, Anatomia Patologica, Dr Andrea Gianatti, co-PI",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-04-23,01/10/20,2021-01-03,29/04/20,10/08/20,"ASST Ospedale Papa Giovanni XXIII, Bergamo",Italy,Respiratory Diseases,1,1,255.0
820.0,NCT04790240,Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID),COVID,Recruiting,COVID-19,,,,,,,Dietary Supplement: Inflammation (I)|Dietary Supplement: Inflammation (II)|Dietary Supplement: Inflammation (III)|Drug: Standard of care,"All Natural Medicine Clinic, LLC",All,"10 Years to 70 Years   (Child, Adult, Older Adult)",120.0,Other,Interventional,2021-01-02,01/12/22,2023-01-03,10/03/21,10/03/21,"All Natural Medicine Clinic, LLC, Rockville, Maryland",United States,Respiratory Diseases,1,1,731.0
821.0,NCT04493359,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,SWITCH-COVID,Recruiting,COVID-19,Angiotensin II Receptor Antagonist Adverse Reaction,,,,,,Drug: Renin-angiotensin system inhibitors,University of Sao Paulo,All,"18 Years to 80 Years   (Adult, Older Adult)",240.0,Other,Interventional,2020-07-25,14/02/22,2022-02-14,30/07/20,31/07/20,"Instituto do Coração - Incor HCFMUSP, São Paulo, SP",Brazil,Respiratory Diseases,1,2,569.0
822.0,NCT04618796,Effect of COVID-19 Pandemic on Vaccination Compliance,,Not yet recruiting,Vaccine Refusal,,,,,,,Other: vaccine,Assiut University,All,1 Year to 2 Years   (Child),100.0,Other,Observational,2021-01-04,01/04/22,2022-01-05,06/11/20,06/11/20,,,Others,0,1,366.0
823.0,NCT04384042,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,,Recruiting,SARS-CoV Infection,COVID-19,Anosmia,Dysgeusia,,,,Other: Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances,"Hospital Sultanah Bahiyah|Hospital Tuanku Fauziah, Kangar, Perlis|Penang Hospital, Malaysia|Hospital Raja Permaisuri Bainun|Hospital Sungai Buloh, Selangor|Kuala Lumpur General Hospital|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan|Hospital Melaka, Melaka|Hospital Enche Besar Hajjah Khalsom, Kluang, Johor|Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu|Hospital Tengku Ampuan Afzan, Kuantan, Pahang|Sarawak General Hospital|Hospital Queen Elizabeth, Malaysia",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-06-06,31/03/21,2021-03-31,12/05/20,25/02/21,"Hospital Enche' Besar Hajjah Khalsom, Kluang, Johor, Malaysia|Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia|Hospital Raja Perempuan Zainab II, Kota Bharu, Kelantan, Malaysia|Hospital Tuanku Jaafar, Seremban, Negeri Sembilan, Malaysia|Hospital Tengku Ampuan Afzan, Kuantan, Pahang, Malaysia|Penang Hospital, George Town, Penang, Malaysia|Hospital Raja Permaisuri Bainun, Ipoh, Perak, Malaysia|Hospital Tuanku Fauziah, Kangar, Perlis, Malaysia|Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia|Sarawak General Hospital, Kuching, Sarawak, Malaysia|Hospital Sungai Buloh, Sungai Buloh, Selangor, Malaysia|Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia|Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia|Hospital Melaka, Melaka",Malaysia,Respiratory Diseases,1,4,298.0
824.0,NCT04513158,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma,"Joseph M. Flynn, D.O., MPH|Norton Healthcare",All,"18 Years to 99 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-14,01/08/21,2021-12-31,14/08/20,19/10/20,"Norton Hospital, Louisville, Kentucky, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Norton Audubon Hospital, Louisville, Kentucky, United States|Norton Brownsboro Hospital, Louisville, Kentucky",United States,Respiratory Diseases,1,1,504.0
825.0,NCT04344249,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,IBD-COVID-19,Recruiting,IBD,COVID-19,,,,,,,Nantes University Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",850.0,Other,Observational,2020-10-04,30/09/20,2021-01-09,14/04/20,30/04/20,"Chu Nantes, Nantes",France,Respiratory Diseases,1,2,97.0
826.0,NCT04828629,Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity,,Recruiting,COVID-19,Heart Failure,,,,,,Diagnostic Test: Diagnostic tests,Polish Mother Memorial Hospital Research Institute,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-12-23,01/12/21,2022-01-12,02/04/21,02/04/21,"Heart Failure Unit; Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute, Łódź, Polska",Poland,Respiratory Diseases,1,2,385.0
827.0,NCT04358211,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,,No longer available,COVID-19,,,,,,,Biological: Biological: COVID-19 convalescent plasma,"Nakhle Saba, MD|Tulane University",All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,,24/04/20,08/03/21,"Tulane Medical Center, New Orleans, Louisiana",United States,Respiratory Diseases,1,1,
828.0,NCT04372056,The COVID-ICU Healthcare Professional Study,,Recruiting,COVID-19,Critical Care,Intensive Care Units,Health Personnel,,,,Behavioral: Views and experiences of health care professionals working in intensive care units during the COVID-19 pandemic,Oslo University Hospital,All,"20 Years and older   (Adult, Older Adult)",2200.0,Other,Observational,2020-06-05,06/05/21,2021-06-05,01/05/20,27/08/20,"Oslo university hospital, Oslo",Norway,Respiratory Diseases,1,4,365.0
829.0,NCT04794998,A Simple Approach to Treat COVID-19 Patients at Home.,COVER,Recruiting,COVID-19,,,,,,,Drug: Recommended treatment schedule|Drug: Control treatment schedule,Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Observational,2021-08-02,30/03/21,2021-03-30,12/03/21,12/03/21,"Clinical Reserach Center for Rare Diseases Aldo e Cele Daccò, Ranica, BG",Italy,Respiratory Diseases,1,1,-125.0
830.0,NCT04416893,Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2 ),COVILLE2,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: RT-PCR SARS-Cov2|Diagnostic Test: Sars-Cov2 serology,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne|GPIP|GFRUP,All,up to 15 Years   (Child),630.0,Other,Observational,2020-07-06,15/09/20,2020-11-15,04/06/20,04/06/20,,,Respiratory Diseases,1,1,132.0
831.0,NCT04429815,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,MAGIC,Not yet recruiting,Smoking Behaviors,,,,,,,Diagnostic Test: Serological test for COVID-19.,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",489.0,Other,Observational,2020-01-07,01/03/21,2021-01-04,12/06/20,12/06/20,,,Others,0,1,363.0
832.0,NCT04385043,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,COV2-CP,Recruiting,COVID-19,,,,,,,Other: plasma hyperimmune|Drug: standard therapy,"University of Catanzaro|Azienda Ospedaliera Universitaria Mater Domini, Catanzaro|Azienda Sanitaria Provinciale Di Catanzaro|Annunziata Hospital, Cosenza, Italy|Azienda Ospedaliera Bianchi-Melacrino-Morelli",All,18 Years to 60 Years   (Adult),400.0,Other,Interventional,2020-01-05,15/10/20,2021-05-15,12/05/20,12/05/20,"Azienda Ospedaliera Policlinico Mater Domini, Catanzaro, Italy|Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Catanzaro, Italy|Azienda Ospedaliera Annunziata, Cosenza, Italy|Azienda Sanitaria Provinciale, Crotone, Italy|Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy|Azienda Sanitaria Provinciale, Vibo Valentia",Italy,Respiratory Diseases,1,1,496.0
833.0,NCT04401228,Predictive Models for Intensive Care Admission and Death of COVID-19,,"Active, not recruiting",COVID-19,"Pneumonia, Viral",Inflammatory Response,,,,,"Other: predict admission of covid-19 patients to ICU and death with routine and quickly avalaible clinical, biological and radiological variables?",Clinique Saint Pierre Ottignies,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-01-03,01/05/20,2021-01-01,26/05/20,26/05/20,"Clinique Saint-Pierre, Ottignies, Brabant Wallon",Belgium,Respiratory Diseases,1,3,364.0
834.0,NCT04723290,COVID-19 Seroconversion Study Among GHdC Staff Members - Summer 2020,,Completed,COVID-19,,,,,,,Diagnostic Test: Serological tests for SARS Cov-2,Grand Hôpital de Charleroi,All,"18 Years and older   (Adult, Older Adult)",2817.0,Other,Interventional,2020-06-20,31/10/20,2020-12-31,25/01/21,25/03/21,"Grand Hôpital de Charleroi, Charleroi, Hainaut",Belgium,Respiratory Diseases,1,1,194.0
835.0,NCT04584411,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Cardiac Magnetic resonance imaging,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-01-11,01/11/21,2024-01-01,14/10/20,14/10/20,,,Respiratory Diseases,1,1,1451.0
836.0,NCT04434248,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: Favipiravir|Drug: Standard of Care,Chromis LLC|Chemical Diversity Research Institute,All,"18 Years and older   (Adult, Older Adult)",330.0,Industry,Interventional,2020-04-23,01/07/20,2020-01-07,16/06/20,16/06/20,"Republican Clinical Hospital, Makhachkala, Russian Federation|K+31 Clinic, Moscow, Russian Federation|Khaven Llc, Moscow, Russian Federation|Central Clinical Hospital with Polyclinic, Moscow, Russian Federation|Central Research Institute of Epidemiology, Moscow, Russian Federation|City Clinical Hospital n.a. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital named after S.S. Yudin, Moscow, Russian Federation|City Clinical Hospital No. 24, Moscow, Russian Federation|City Clinical Hospital No. 51, Moscow, Russian Federation|First Moscow State Medical University n.a. I.M. Sechenov, Moscow, Russian Federation|Moscow State University n.a. M. V. Lomonosov, Moscow, Russian Federation|National Medical and Surgical Center named after N.I. Pirogov, Moscow, Russian Federation|City Hospital № 33 of the Leninsky region of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Infectious clinical hospital No.2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Ryazan State Medical University named after I.P. Pavlov, Ryazan, Russian Federation|Military Medical Academy named after S.M. Kirova, Saint Petersburg, Russian Federation|Saratov State Medical University named after V.I. Razumovsky, Saratov, Russian Federation|Clinical hospital No.1, Smolensk, Russian Federation|Regional Clinic Hospital, Tver, Russian Federation|Bashkir State Medical University, Ufa, Russian Federation|Yakutsk City Clinical Hospital, Yakutsk, Russian Federation|Yaroslavl Regional Clinical Hospital for War Veterans, Yaroslavl",Russian Federation,Respiratory Diseases,1,1,-107.0
837.0,NCT04523831,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,,Completed,COVID-19,,,,,,,Drug: Ivermectin and Doxycycline|Drug: Standard of care,Dhaka Medical College,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-01-06,22/08/20,2020-10-09,24/08/20,09/10/20,"Dhaka Medical College, Dhaka",Bangladesh,Respiratory Diseases,1,1,277.0
838.0,NCT04438070,COVID Screening Strategies in Homeless Shelters,,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 Swab,St. Joseph's Healthcare Hamilton|Timothy O'Shea|Marek Smieja|Lawrence Mbuagbaw,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-10-04,01/06/20,2020-01-06,18/06/20,18/06/20,"Various Homeless Shelters, Hamilton, Ontario",Canada,Respiratory Diseases,1,1,-272.0
839.0,NCT04652115,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,DF in COVID19,Not yet recruiting,COVID-19,,,,,,,Drug: Defibrotide,Brigham and Women's Hospital|Jazz Pharmaceuticals,All,"18 Years to 100 Years   (Adult, Older Adult)",42.0,Other|Industry,Interventional,2021-01-01,01/11/22,2023-01-11,03/12/20,03/12/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,740.0
840.0,NCT04358783,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,COP-COVID-19,"Active, not recruiting",Coronavirus Infection,,,,,,,Biological: Plasma|Other: Best Available Therapy,Hospital Universitario Dr. Jose E. Gonzalez,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-27,01/05/21,2021-05-30,24/04/20,23/02/21,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,1,398.0
841.0,NCT04343794,Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,,Recruiting,COVID-19,,,,,,,Device: BIOVITALS,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-04,31/12/21,2022-01-31,13/04/20,15/04/20,"The University of Hong Kong, Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,758.0
842.0,NCT04800146,A Study on the Immune-response to COVID-19 Vaccination in Cancer Patients - the IOSI-COVID-19-001 Study,,Recruiting,COVID-19,Cancer,,,,,,Procedure: Blood sample,"Ilaria Colombo|Institute for Research in Biomedicine|Ente Ospedaliero Cantonale, Bellinzona|Oncology Institute of Southern Switzerland",All,"Child, Adult, Older Adult",240.0,Other,Observational,2021-02-25,30/06/22,2022-12-30,16/03/21,16/03/21,"Oncology Institute of Southern Switzerland, Bellinzona",Switzerland,"Respiratory Diseases, Cancers",1,2,673.0
843.0,NCT04568499,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",,Recruiting,COVID-19,,,,,,,,Johns Hopkins Bloomberg School of Public Health|International Medical Corps|Centers for Disease Control and Prevention,All,"5 Years and older   (Child, Adult, Older Adult)",1000.0,Other|U.S. Fed,Observational,2020-11-27,01/06/21,2021-01-09,29/09/20,06/04/21,"Goma General Hospital, Goma, Congo, The Democratic Republic of the|Bukavu General Hospital, Kinshasa, Congo, The Democratic Republic of the|Dr John Garang Infectious Diseases Unit, Juba",South Sudan,Respiratory Diseases,1,1,43.0
844.0,NCT04519398,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,iGenes-COVID19,Recruiting,COVID-19,Corona Virus Infection,Thrombosis,ARDS,Thrombophilia,"Thromboses, Intracranial","Thromboses, Deep Vein",Genetic: Complete thrombophilic profile testing by multiplex PCR,Grigore T. Popa University of Medicine and Pharmacy,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-08-18,17/02/21,2021-08-18,19/08/20,19/08/20,"University of Medicine and Pharmacy Gr T. Popa Iasi, Romania, Iasi",Romania,Respiratory Diseases,1,7,365.0
845.0,NCT04375176,Monocytes and NK Cells Activity in Covid-19 Patients,,Recruiting,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,Immunomodulation,,,,,Diagnostic Test: Study of immune-mediated mechanisms in patients tested positive for SARS-CoV-2,Università degli Studi dell'Insubria,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-04-27,30/06/20,2020-10-31,05/05/20,05/05/20,"ATS Insubria, Varese",Italy,Respiratory Diseases,1,3,187.0
846.0,NCT04621071,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,PROVID-19,Recruiting,COVID-19,,,,,,,Dietary Supplement: Probiotics (2 strains 10x10^9 UFC)|Dietary Supplement: Placebo (potato starch and magnesium stearate),Centre de recherche du Centre hospitalier universitaire de Sherbrooke|Lallemand Health Solutions,All,"18 Years and older   (Adult, Older Adult)",84.0,Other|Industry,Interventional,2021-12-01,01/06/21,2021-01-07,09/11/20,09/04/21,"CIUSSS de L'Estrie-CHUS Hospital, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,1,-328.0
847.0,NCT04357444,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,LILIADE-COVID,"Active, not recruiting",COVID-19,,,,,,,Drug: 1: ILT101|Drug: 2: Placebo Comparator,Assistance Publique - Hôpitaux de Paris|Iltoo Pharma,All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-10-23,02/11/20,2021-04-23,22/04/20,09/04/21,"Service Anesthésie Réanimation - Groupe Hospitalier Pitié-Salpêtrière, Paris",France,Respiratory Diseases,1,1,182.0
848.0,NCT04487977,Survey on COVID-19 Airway Management,ISAM-COVID,Recruiting,Airway Management,,,,,,,Other: Survey,Spanish Society of Anesthesia and Critical Care (SEDAR)|Confederation of Latin American Societies of Anaesthesiology (CLASA),All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-04-22,30/09/20,2020-09-30,27/07/20,27/07/20,"Consorcio Hospital General Universitario de Valencia, Valencia",Spain,Others,0,1,161.0
849.0,NCT04449731,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),COVIDiet_Int,Recruiting,COVID-19,,,,,,,,"Universidad de Granada|Agricultural University of Athens|University of Zagreb|University of Belgrade|Institute of Technology, Sligo|University of Sarajevo|Lithuanian University of Health Sciences|Jozef Stefan Institute|University of Southern Denmark|Institut Za Javno Zdeavlje|University of Skopje|Poznan University of Life Sciences|Bezmialem Vakif University|Centro Hospitalar e Universitário de Coimbra, E.P.E.|Kuwait University|Universidad Nacional de Colombia|Manay Rachna International institute of Research and Studies",All,"18 Years and older   (Adult, Older Adult)",30000.0,Other,Observational,2020-03-20,30/08/20,2021-06-30,29/06/20,09/04/21,"Universidad de Granada, Granada",Spain,Respiratory Diseases,1,1,467.0
850.0,NCT04420286,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,FRENCH ICU,Recruiting,Coronavirus Infections,COVID-19,,,,,,,Centre Hospitalier Universitaire de Nīmes,All,"Child, Adult, Older Adult",9000.0,Other,Observational,2020-06-05,05/06/21,2021-05-06,09/06/20,19/12/20,"CHU de Nîmes, Hôpital Universitaire Carémeau, Nimes",France,Respiratory Diseases,1,2,335.0
851.0,NCT04333355,Safety in Convalescent Plasma Transfusion to COVID-19,,Terminated,COVID-19,,,,,,,Biological: Convalescent Plasma,Hospital San Jose Tec de Monterrey|Tecnologico de Monterrey,All,"18 Years and older   (Adult, Older Adult)",12.0,Other,Interventional,2020-08-05,20/08/20,2020-08-20,03/04/20,10/02/21,"Hospital San José, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,1,15.0
852.0,NCT04621903,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,,Completed,COVID-19,,,,,,,Other: Shanshamani Vati Plus,"Aarogyam UK|University of Warwick|All India Institute of Ayurveda, Ministry of AYUSH, Government of India",All,"20 Years to 70 Years   (Adult, Older Adult)",26.0,Other,Interventional,2020-08-10,27/10/20,2020-03-11,09/11/20,19/11/20,"Aarogyam (UK) CIC, Leicester",United Kingdom,Respiratory Diseases,1,1,-152.0
853.0,NCT04625972,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",STORM CHASER,Recruiting,COVID-19,,,,,,,Drug: AZD7442|Drug: Placebo,AstraZeneca|QuintilesIMS,All,"18 Years to 120 Years   (Adult, Older Adult)",1125.0,Industry|Other,Interventional,2020-02-12,21/01/22,2022-01-21,12/11/20,11/01/21,"Research Site, Birmingham, Alabama, United States|Research Site, Guntersville, Alabama, United States|Research Site, Montgomery, Alabama, United States|Research Site, Tempe, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Corona, California, United States|Research Site, Garden Grove, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Huntington Park, California, United States|Research Site, Modesto, California, United States|Research Site, Coral Springs, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Mount Dora, Florida, United States|Research Site, Ocala, Florida, United States|Research Site, Ocala, Florida, United States|Research Site, Pembroke Pines, Florida, United States|Research Site, Tampa, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Winter Haven, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Buford, Georgia, United States|Research Site, Conyers, Georgia, United States|Research Site, Honolulu, Hawaii, United States|Research Site, Chicago, Illinois, United States|Research Site, Chicago, Illinois, United States|Research Site, Hazel Crest, Illinois, United States|Research Site, Greenwood, Indiana, United States|Research Site, Ankeny, Iowa, United States|Research Site, Wichita, Kansas, United States|Research Site, Owensboro, Kentucky, United States|Research Site, Bethesda, Maryland, United States|Research Site, Kansas City, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, Charlotte, North Carolina, United States|Research Site, Fayetteville, North Carolina, United States|Research Site, Wilmington, North Carolina, United States|Research Site, Greer, South Carolina, United States|Research Site, Dakota Dunes, South Dakota, United States|Research Site, Rapid City, South Dakota, United States|Research Site, Arlington, Texas, United States|Research Site, Austin, Texas, United States|Research Site, Cypress, Texas, United States|Research Site, Dallas, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, Friendswood, Texas, United States|Research Site, Gonzales, Texas, United States|Research Site, Harlingen, Texas, United States|Research Site, Houston, Texas, United States|Research Site, McKinney, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Waxahachie, Texas, United States|Research Site, Riverton, Utah, United States|Research Site, Norfolk, Virginia, United States|Research Site, Portsmouth, Virginia, United States|Research Site, Richmond, Virginia, United States|Research Site, Tacoma, Washington, United States|Research Site, London, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Southampton, United Kingdom|Research Site, Wakefield",United Kingdom,Respiratory Diseases,1,1,709.0
854.0,NCT04784468,DNA Damage and Oxidative Stress in Hospitalized COVID-19 Patients,ABCD,Recruiting,COVID-19,,,,,,,Other: No intervention,University of Vienna|SMZ-Ost Donauspital,All,"40 Years and older   (Adult, Older Adult)",135.0,Other,Observational,2020-11-19,31/03/21,2021-09-30,05/03/21,09/03/21,"Klinik Donaustadt, Vienna",Austria,Respiratory Diseases,1,1,315.0
855.0,NCT04668911,"Oral Health, Microbial Burden and COVID-19",ORACLE,Recruiting,COVID-19,Periodontitis,,,,,,Other: Swab,"Eastman Dental Insitute and Hospital|DermBiont, Inc.|University College London Hospitals|The Whittington Hospital NHS Trust",All,"18 Years and older   (Adult, Older Adult)",150.0,Other|Industry,Observational,2020-12-13,12/12/21,2021-12-12,16/12/20,04/02/21,"University College Hospital (UCH), UCL Eastman Dental Institute, London",United Kingdom,Respiratory Diseases,1,2,364.0
856.0,NCT04299724,Safety and Immunity of Covid-19 aAPC Vaccine,,Recruiting,COVID-19,,,,,,,Biological: Pathogen-specific aAPC,Shenzhen Geno-Immune Medical Institute|Shenzhen Third People's Hospital|Shenzhen Second People's Hospital,All,"6 Months to 80 Years   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-02-15,31/07/23,2024-12-31,09/03/20,09/03/20,"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong",China,Respiratory Diseases,1,1,1781.0
857.0,NCT04418375,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),COVID-HOP,Recruiting,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris|Fondation Université de Paris|Fondation Hôpitaux de Paris-Hôpitaux de France,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-08-06,01/02/21,2022-01-03,05/06/20,08/10/20,"HEGP, Paris",France,Respiratory Diseases,1,1,515.0
858.0,NCT04384549,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,COVID-BCG,Recruiting,Infection,"Viral, Agent as Cause of Disease Classified Elsewhere",,,,,,Biological: BCG GROUP|Other: PLACEBO GROUP,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1120.0,Other,Interventional,2020-05-20,20/02/21,2021-02-20,12/05/20,18/08/20,"I-REIVAC/CIC 1417 Cochin Hospital, APHP, Paris",France,Others,0,2,276.0
859.0,NCT04339686,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,,Recruiting,The Gold Standard for Current SARS CoV2 Detection is RT-PCR,,,,,,,Diagnostic Test: Thoracic CT Scan,Poitiers University Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",56000.0,Other,Observational,2020-04-20,01/09/20,2020-01-11,09/04/20,28/04/20,"Chu de Poitiers, Poitiers",France,Others,0,1,-100.0
860.0,NCT04503447,COVID-19 Seroprevalence Study in ITM Staff,CovAb,Completed,COVID-19,,,,,,,,"Institute of Tropical Medicine, Belgium",All,"Child, Adult, Older Adult",330.0,Other,Observational,2020-01-08,09/09/20,2020-09-09,07/08/20,22/10/20,"Institute of Tropical Medicine, Antwerp",Belgium,Respiratory Diseases,1,1,245.0
861.0,NCT04483830,Suloexide in the Treatment of Early Stages of COVID-19,SulES-COVID,Completed,COVID-19,,,,,,,Drug: Sulodexide|Drug: Placebo,Clinedem|Alfasigma S.p.A.,All,"40 Years to 80 Years   (Adult, Older Adult)",243.0,Other|Industry,Interventional,2020-05-06,06/08/20,2020-07-09,23/07/20,09/09/20,"Clinedem, San Luis Rio Colorado, Sonora",Mexico,Respiratory Diseases,1,1,64.0
862.0,NCT04739020,Respiratory Aerosols in Patients With COVID-19 and Healthy Controls,,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Resp-Aer-Meter|Diagnostic Test: Spirometry|Diagnostic Test: Qualitative and quantitative virus PCR of respiratory secretions in patients with high aerosol concentrations,Johann Wolfgang Goethe University Hospital|Palas GmbH,All,"6 Years and older   (Child, Adult, Older Adult)",525.0,Other,Interventional,2021-01-18,30/06/21,2021-12-31,04/02/21,10/02/21,"Johann Wolfgang Goethe University Hospital, Frankfurt, Hessen",Germany,Respiratory Diseases,1,2,347.0
863.0,NCT04424446,Saliva as Source of Detection for SARS-CoV-2,,Recruiting,COVID-19,,,,,,,,National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",5000.0,NIH,Observational,2020-07-13,01/06/21,2021-01-06,11/06/20,17/09/20,"Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,177.0
864.0,NCT04363749,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,CRC-COVID,Recruiting,COVID-19,Neurological Complication,,,,,,"Other: hypoxia : 14.3 and 12.7% FIO2, hypercapnia 7% CO2, inspiratory mechanical constraint",Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-27,27/04/21,2021-11-27,27/04/20,02/03/21,"Département R3S, hôpital de la pitié-salpêtrière, Paris",France,Respiratory Diseases,1,2,579.0
865.0,NCT04424017,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,,Completed,COVID-19,Corona Virus Infection,,,,,,Biological: Specific anti-SARS-CoV-2 antibodies,"Egyptian Center for Research and Regenerative Medicine|Cairo University|National Research Centre, Egypt|Academy of Scientific Research and Technology, Egypt",All,18 Years to 60 Years   (Adult),1546.0,Other,Observational,2020-07-06,30/10/20,2020-10-30,09/06/20,09/03/21,"ECRRM, Cairo, Egypt|Faculty of Medicine, Cairo University, Cairo",Egypt,Respiratory Diseases,1,2,116.0
866.0,NCT04349540,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,(COVID19_BMT),"Active, not recruiting",COVID-19,,,,,,,Other: no intervention,Great Ormond Street Hospital for Children NHS Foundation Trust,All,"3 Months and older   (Child, Adult, Older Adult)",40.0,Other,Observational,2020-04-15,15/10/20,2021-01-15,16/04/20,16/04/20,"Great Ormond Street Hospital NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,275.0
867.0,NCT04717024,The Nanowear Wearable Covid-19 Observational and Analysis Trend,NanoCOAT,Recruiting,COVID-19,,,,,,,Device: Observational Study - no intervention,Nanowear Inc.,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Observational,2020-09-15,31/12/21,2021-12-31,20/01/21,20/01/21,"Hackensack University Medical Center, Hackensack, New Jersey, United States|Maimonides Medical Center, Brooklyn, New York",United States,Respiratory Diseases,1,1,472.0
868.0,NCT04535063,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Biological: COVID19 convalescent plasma infusion,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-18,30/12/20,2021-02-25,01/09/20,02/09/20,"Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires",Argentina,Respiratory Diseases,1,1,313.0
869.0,NCT04380662,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,COVIDADOMEVA,Not yet recruiting,COVID-19,,,,,,,Other: Risk factors,"University Hospital, Grenoble",All,"Child, Adult, Older Adult",800.0,Other,Observational,2020-06-30,30/09/20,2020-12-30,08/05/20,22/06/20,"Grenoble University Hospital, Grenoble",France,Respiratory Diseases,1,1,183.0
870.0,NCT04359953,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",COVID-Aging,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Telmisartan,"University Hospital, Strasbourg, France",All,"60 Years and older   (Adult, Older Adult)",1600.0,Other,Interventional,2020-04-25,01/06/21,2021-01-06,24/04/20,27/07/20,"CHU de Strasbourg, Strasbourg",France,Respiratory Diseases,1,1,256.0
871.0,NCT04824677,Risk Factors and Prognoses in Patients Hospitalized for COVID-19,,Recruiting,COVID-19,,,,,,,Other: Hospital treatment of COVID disease,Sociedad Española de Neumología y Cirugía Torácica,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-05-18,01/12/21,2021-01-12,01/04/21,01/04/21,"Hospital Universitari Arnau de Vilanova, Lleida, Spain|Hospital Universitari Santa Maria, Lleida",Spain,Respiratory Diseases,1,1,239.0
872.0,NCT04678700,Implementation of a Respiratory Physiotherapy Program in Post COVID-19 Patients Through Tele-assistance,,Recruiting,COVID-19,,,,,,,Other: Chest physiotherapy post-covid19,European University of Madrid,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-03,01/06/21,2021-01-08,22/12/20,03/02/21,"Marta de la plaza, Madrid",Spain,Respiratory Diseases,1,1,5.0
873.0,NCT04342689,The Role of Resistant Starch in COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Dietary Supplement containing resistant starch|Dietary Supplement: Placebo Starch,Yale University|University of Michigan,All,"19 Years and older   (Adult, Older Adult)",1500.0,Other,Interventional,2020-03-06,01/06/21,2021-01-06,13/04/20,26/01/21,"Yale University, New Haven, Connecticut, United States|University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,1,306.0
874.0,NCT04381273,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,,Recruiting,COVID-19,Periodontal Diseases,,,,,,Other: No intervention,Heidelberg University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-08-05,31/07/20,2020-07-31,08/05/20,08/05/20,"University Hospital Heidelberg, Heidelberg, Baden-Württemberg",Germany,Respiratory Diseases,1,2,-5.0
875.0,NCT04561102,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Diagnostic test for detection of SARS-CoV-2,"Illumina, Inc.|Helix OpCo, LLC",All,"18 Years and older   (Adult, Older Adult)",2500.0,Industry|Other,Observational,2020-11-09,28/02/21,2021-04-30,23/09/20,15/02/21,"Rollins College Alfonds Sports Center, Winter Park, Florida",United States,Respiratory Diseases,1,1,172.0
876.0,NCT04521322,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,CARR-COV-02,Recruiting,COVID-19,,,,,,,Drug: Iota-Carrageenan,Ariel Dogliotti|Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-07-24,30/10/20,2020-11-30,20/08/20,21/08/20,"centro de educación médica e investigaciones clinicas (CEMIC), Buenos Aires, Capital Federal",Argentina,Respiratory Diseases,1,1,129.0
877.0,NCT04764721,Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID,TEP-COV,Not yet recruiting,COVID-19,,,,,,,Device: 18F-FDG PET-CT,"Central Hospital, Nancy, France",All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-12-04,12/04/22,2022-12-05,21/02/21,21/02/21,,,Respiratory Diseases,1,1,366.0
878.0,NCT04563676,Physiopathology and Sequelae of COVID-19 Infection,SEQ-COV-PHYSIO,Recruiting,COVID-19,TSH,Cortisol,,,,,Biological: blood test,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-09-22,01/03/21,2021-01-03,24/09/20,24/09/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,3,103.0
879.0,NCT04367662,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,COVID'HEMOS,Completed,COVID-19,,,,,,,Procedure: blood sampling,"University Hospital, Rouen",All,"18 Years and older   (Adult, Older Adult)",99.0,Other,Interventional,2020-09-04,14/05/20,2020-05-14,29/04/20,09/06/20,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,1,-113.0
880.0,NCT04760132,National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE),ENFORCE,Recruiting,SARS-CoV Infection,,,,,,,Biological: COMIRNATY - BioNTech Manufacturing GmbH|Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH|Biological: COVID-19 Vaccine AstraZeneca suspension for injection,"Jens D Lundgren, MD|Ministry of the Interior and Health, Denmark|Rigshospitalet, Denmark",All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Interventional,2021-08-02,31/12/24,2024-12-31,18/02/21,26/02/21,"Aarhus Universitetshospital, Skejby, Aarhus, Aarhus N, Denmark|Aalborg Universityhospital Syd, Aalborg, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universityhospital, Odense, Denmark|Sjællandsuniversitetshospital, Roskilde",Denmark,Respiratory Diseases,1,1,1247.0
881.0,NCT04459819,Respiratory Physiotherapy in Severe COVID-19 Patients,FTR-COVID,Completed,COVID-19,,,,,,,Other: Respiratory physiotherapy,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",All,"18 Years to 80 Years   (Adult, Older Adult)",84.0,Other,Observational,2020-01-03,30/09/20,2020-09-30,07/07/20,16/02/21,"Department of Pathophysiology and Transplantation, University of Milan Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan",Italy,Respiratory Diseases,1,1,271.0
882.0,NCT04691921,Current Pharmacological Practices in Severe COVID-19,,Completed,COVID-19,,,,,,,Behavioral: Current clinical practices of participating physicians,NMC Specialty Hospital,All,"20 Years to 70 Years   (Adult, Older Adult)",1055.0,Other,Observational,2021-04-01,18/01/21,2021-01-31,31/12/20,16/02/21,"Reliance Hospital, Mumbai, Mumbai, Mahrastra",India,Respiratory Diseases,1,1,-60.0
883.0,NCT04583566,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",,Recruiting,Corona Virus Infection,,,,,,,Genetic: COVID-19 Diagnostic and Assessment Tests,Tanta University,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-04-10,03/10/21,2022-03-10,12/10/20,14/10/20,"Tanta University Hospital, Tanta, El Gharbia, Egypt|Center of Excellence in Cancer Research, Tanta University Hospital., Tanta, Gharbia",Egypt,Respiratory Diseases,1,1,699.0
884.0,NCT04385160,Myeloproliferative Neoplasms (MPN) and COVID-19,MPN-COVID,Recruiting,Myeloproliferative Neoplasm,COVID-19,,,,,,,Fondazione per la Ricerca Ospedale Maggiore|European Leukemia Net,All,"18 Years and older   (Adult, Older Adult)",552.0,Other,Observational,2020-05-13,15/02/22,2022-08-31,12/05/20,15/02/21,"New York-Presbyterian/Weill Cornell Medical Center, New York, New York, United States|Hopital Saint-Louis, Paris, France|University Medical Center RWTH, Aachen, Germany|University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center, Minden, Germany|Ospedale San Gerardo di Monza, Monza, Monza Brianza, Italy|A.S.O. SS. Antonio e Biagio e C.Arrigo di Alessandria, Alessandria, Italy|ASST-Papa Giovanni XXIII, Bergamo, Italy|Policlinico S.Orsola-Malpighi, Bologna, Italy|ASST-Spedali Civili, Brescia, Italy|AOU Ospedale Careggi, Firenze, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy|IRCCS Policlinico San Matteo, Pavia, Italy|Policlinico Universitario Fondazione Agostino Gemelli, Roma, Italy|A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy|Ospedale Policlinico G.B. Rossi Borgo Roma, Verona, Italy|Ospedale San Bortolo, Vicenza, Italy|Sobas Wroclaw Medical University ·, Wrocław, Poland|Hospital Clínic De Barcelona, Barcelona, Barcellona, Spain|Hospital del Mar, Barcelona, Barcellona, Spain|Institut Català d' Oncologia - Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|ICO L'Hospitalet - Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Universitario Príncipe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital General de La Palma, Breña Alta, Santa Cruz De Tenerife, Spain|Servicio de Hematología Hospital General Universitario de Albacete, Albacete, Spain|Hospital General de Elche, Alicante, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|ICO Girona Hospital Josep Trueta Servei d'hematologia, Girona, Spain|FEA Hematología Hospital Universitario de Móstoles, Madrid, Spain|Hospital 12 de octubre, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Moncloa, Madrid, Spain|Hospital Ramón y Cajal, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario, Valencia, Spain|Guy's and St. Thomas' NHS Foundation Trust., London",United Kingdom,Respiratory Diseases,1,2,840.0
885.0,NCT04351139,Impact of the COVID-19 Pandemic in Gynecological Oncology,COVID-GYN,Completed,Gynecologic Cancer,Breast Neoplasm Female,Uterine Neoplasms,Ovarian Neoplasms,Uterine Cervical Neoplasms,Vulvar Neoplasms,Vaginal Neoplasms,Other: modification of the planned therapeutic management,Hospices Civils de Lyon,Female,"18 Years and older   (Adult, Older Adult)",205.0,Other,Observational,2020-06-05,30/11/20,2020-11-30,17/04/20,19/01/21,"Service de Gynécologie, HFME, Hospices Civils de Lyon, Bron, France|Service de Gynécologie, Croix-Rousse, Hospices Civils de Lyon, Lyon, France|Service Gynécologie, CHLS, Hospices Civils de Lyon, Pierre-Bénite",France,Cancers,1,7,178.0
886.0,NCT04341168,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",,Not yet recruiting,COVID-19,COVID-19,,,,,,Other: this study is non- interventional,"University Hospital of Cologne|Clinic for Internal Medicine I, University Hospital Cologne, Germany|Institute of Virology, University Hospital Cologne, Germany|Center for Molecular Medicine Cologne (CMMC) Cologne, Germany",All,"Child, Adult, Older Adult",160.0,Other,Observational,2020-01-04,01/10/20,2020-01-10,10/04/20,14/04/20,"University Hospital Cologne, Cologne, NRW",Germany,Respiratory Diseases,1,2,6.0
887.0,NCT04458519,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,,Recruiting,COVID-19,,,,,,,Other: Probiorinse|Other: Saline solution,Centre hospitalier de l'Université de Montréal (CHUM),All,18 Years to 59 Years   (Adult),40.0,Other,Interventional,2020-07-16,30/04/21,2021-04-30,07/07/20,12/01/21,"Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec",Canada,Respiratory Diseases,1,1,288.0
888.0,NCT04689477,Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients,HEMOCOVID19,Recruiting,COVID-19,Endothelial Function,,,,,,Device: Vascular occlusion test,Corporacion Parc Tauli|Institut de Ciències Fotòniques (ICFO)|Centre de Recerca Matemàtica|Institute of Physics University of Campinas,All,"18 Years and older   (Adult, Older Adult)",612.0,Other,Observational,2020-05-25,01/12/21,2021-01-12,30/12/20,30/12/20,"Hospital de Clinicas da UNICAMP, Campinas, Sao Paulo, Brazil|Hospital General de México, México, Mexico|Institut d'Investigació i Innovació Parc Taulí, Sabadell, Barcelona, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, Spain|Hospital Parc Salut Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona",Spain,Respiratory Diseases,1,2,232.0
889.0,NCT04312464,Myocardial Damage in COVID-19,,Enrolling by invitation,COVID-19,Cardiovascular Diseases,,,,,,Other: non,"Wuhan Union Hospital, China",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-01,15/03/20,2020-03-18,18/03/20,18/03/20,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,2,77.0
890.0,NCT04389385,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),,"Active, not recruiting",Corona Virus Infection,Pneumonia,,,,,,Biological: COVID-19 Specific T Cell derived exosomes (CSTC-Exo),TC Erciyes University,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-05,30/09/20,2021-05-31,15/05/20,15/05/20,"GENKOK, Kayseri, Melikgazi",Turkey,Respiratory Diseases,1,2,512.0
891.0,NCT04625725,"Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",PROVENT,"Active, not recruiting",COVID-19,,,,,,,Drug: AZD7442|Drug: Placebo,AstraZeneca|QuintilesIMS,All,"18 Years and older   (Adult, Older Adult)",5247.0,Industry|Other,Interventional,2020-11-21,21/04/21,2022-06-22,12/11/20,08/04/21,"Research Site, Birmingham, Alabama, United States|Research Site, Tempe, Arizona, United States|Research Site, Little Rock, Arkansas, United States|Research Site, Cerritos, California, United States|Research Site, Fountain Valley, California, United States|Research Site, Fresno, California, United States|Research Site, Garden Grove, California, United States|Research Site, Huntington Beach, California, United States|Research Site, Lancaster, California, United States|Research Site, Modesto, California, United States|Research Site, Victorville, California, United States|Research Site, Hartford, Connecticut, United States|Research Site, Middlebury, Connecticut, United States|Research Site, Clearwater, Florida, United States|Research Site, Coral Springs, Florida, United States|Research Site, Hollywood, Florida, United States|Research Site, Lauderdale Lakes, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Miami, Florida, United States|Research Site, Ormond Beach, Florida, United States|Research Site, Wesley Chapel, Florida, United States|Research Site, West Palm Beach, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Columbus, Georgia, United States|Research Site, Conyers, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Hazel Crest, Illinois, United States|Research Site, Quincy, Illinois, United States|Research Site, Evansville, Indiana, United States|Research Site, Noblesville, Indiana, United States|Research Site, Wichita, Kansas, United States|Research Site, Wichita, Kansas, United States|Research Site, Minneapolis, Minnesota, United States|Research Site, Saint Louis, Missouri, United States|Research Site, Omaha, Nebraska, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Las Vegas, Nevada, United States|Research Site, Albuquerque, New Mexico, United States|Research Site, Bronx, New York, United States|Research Site, Jamaica, New York, United States|Research Site, Ridgewood, New York, United States|Research Site, Greensboro, North Carolina, United States|Research Site, Columbus, Ohio, United States|Research Site, Oklahoma City, Oklahoma, United States|Research Site, Summerville, South Carolina, United States|Research Site, Rapid City, South Dakota, United States|Research Site, Austin, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, El Paso, Texas, United States|Research Site, Houston, Texas, United States|Research Site, San Antonio, Texas, United States|Research Site, Sugar Land, Texas, United States|Research Site, The Woodlands, Texas, United States|Research Site, Layton, Utah, United States|Research Site, Alexandria, Virginia, United States|Research Site, Chesapeake, Virginia, United States|Research Site, Alken, Belgium|Research Site, Bruxelles, Belgium|Research Site, Gozée, Belgium|Research Site, Namur, Belgium|Research Site, Wetteren, Belgium|Research Site, Clermont-Ferrand cedex, France|Research Site, Dijon cedex, France|Research Site, La Roche S/ Yon Cedex 9, France|Research Site, Lille, France|Research Site, Limoges cedex, France|Research Site, Nantes Cedex 1, France|Research Site, Paris cedex 10, France|Research Site, Paris cedex 14, France|Research Site, Saint Etienne Cedex 2, France|Research Site, Tours cedex 9, France|Research Site, Barcelona, Spain|Research Site, Madrid, Spain|Research Site, Madrid, Spain|Research Site, Marbella (Málaga), Spain|Research Site, Pozuelo de Alarcón, Spain|Research Site, Enfield, United Kingdom|Research Site, Hayle, United Kingdom|Research Site, London, United Kingdom|Research Site, Manchester, United Kingdom|Research Site, Preston, United Kingdom|Research Site, Rochdale, United Kingdom|Research Site, Southampton, United Kingdom|Research Site, Torpoint, United Kingdom|Research Site, Wakefield",United Kingdom,Respiratory Diseases,1,1,578.0
892.0,NCT04387656,"NCI COVID-19 in Cancer Patients, NCCAPS Study",,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,Metastatic Malignant Solid Neoplasm,,,,Procedure: Biospecimen Collection|Other: Data Collection|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,National Cancer Institute (NCI),All,"Child, Adult, Older Adult",2000.0,NIH,Observational,2020-05-21,31/05/23,2023-05-31,14/05/20,02/04/21,"University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States|Veterans Administration Medical Center - Birmingham, Birmingham, Alabama, United States|USA Health Strada Patient Care Center, Mobile, Alabama, United States|Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States|Anchorage Radiation Therapy Center, Anchorage, Alaska, United States|Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States|Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States|Alaska Women's Cancer Care, Anchorage, Alaska, United States|Anchorage Oncology Centre, Anchorage, Alaska, United States|Katmai Oncology Group, Anchorage, Alaska, United States|Providence Alaska Medical Center, Anchorage, Alaska, United States|Fairbanks Memorial Hospital, Fairbanks, Alaska, United States|Kingman Regional Medical Center, Kingman, Arizona, United States|Banner Children's at Desert, Mesa, Arizona, United States|Cancer Center at Saint Joseph's, Phoenix, Arizona, United States|Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States|Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States|CHI Saint Vincent Cancer Center Hot Springs, Hot Springs, Arkansas, United States|Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States|NEA Baptist Memorial Hospital, Jonesboro, Arkansas, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kaiser Permanente-Anaheim, Anaheim, California, United States|Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States|Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande, California, United States|PCR Oncology, Arroyo Grande, California, United States|Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States|Kaiser Permanente-Bellflower, Bellflower, California, United States|Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States|Enloe Medical Center, Chico, California, United States|UC Irvine Health Cancer Center-Newport, Costa Mesa, California, United States|Kaiser Permanente Dublin, Dublin, California, United States|Kaiser Permanente-Fontana, Fontana, California, United States|Kaiser Permanente-Fremont, Fremont, California, United States|Fresno Cancer Center, Fresno, California, United States|Kaiser Permanente-Fresno, Fresno, California, United States|Kaiser Permanente - Harbor City, Harbor City, California, United States|Kaiser Permanente-Irvine, Irvine, California, United States|UC San Diego Moores Cancer Center, La Jolla, California, United States|Veterans Affairs Loma Linda Healthcare System, Loma Linda, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente-Cadillac, Los Angeles, California, United States|UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Fremont - Rideout Cancer Center, Marysville, California, United States|Kaiser Permanente-Modesto, Modesto, California, United States|Kaiser Permanente Oakland-Broadway, Oakland, California, United States|Kaiser Permanente-Oakland, Oakland, California, United States|Kaiser Permanente-Ontario, Ontario, California, United States|UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States|Kaiser Permanente - Panorama City, Panorama City, California, United States|Kaiser Permanente-Rancho Cordova Cancer Center, Rancho Cordova, California, United States|Kaiser Permanente-Redwood City, Redwood City, California, United States|Kaiser Permanente-Richmond, Richmond, California, United States|Kaiser Permanente-Riverside, Riverside, California, United States|Rohnert Park Cancer Center, Rohnert Park, California, United States|Kaiser Permanente-Roseville, Roseville, California, United States|The Permanente Medical Group-Roseville Radiation Oncology, Roseville, California, United States|Kaiser Permanente Downtown Commons, Sacramento, California, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, United States|Kaiser Permanente-South Sacramento, Sacramento, California, United States|South Sacramento Cancer Center, Sacramento, California, United States|Salinas Valley Memorial, Salinas, California, United States|Kaiser Permanente-San Diego Mission, San Diego, California, United States|Kaiser Permanente-San Diego Zion, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California, United States|Kaiser Permanente-San Francisco, San Francisco, California, United States|UCSF Medical Center-Mission Bay, San Francisco, California, United States|Kaiser Permanente-Santa Teresa-San Jose, San Jose, California, United States|Kaiser Permanente San Leandro, San Leandro, California, United States|Pacific Central Coast Health Center-San Luis Obispo, San Luis Obispo, California, United States|Kaiser Permanente-San Marcos, San Marcos, California, United States|Kaiser San Rafael-Gallinas, San Rafael, California, United States|Kaiser Permanente Medical Center - Santa Clara, Santa Clara, California, United States|Mission Hope Medical Oncology - Santa Maria, Santa Maria, California, United States|Kaiser Permanente-Santa Rosa, Santa Rosa, California, United States|Kaiser Permanente Cancer Treatment Center, South San Francisco, California, United States|Kaiser Permanente-South San Francisco, South San Francisco, California, United States|Kaiser Permanente-Stockton, Stockton, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|Kaiser Permanente Medical Center-Vacaville, Vacaville, California, United States|Kaiser Permanente-Vallejo, Vallejo, California, United States|Kaiser Permanente-Walnut Creek, Walnut Creek, California, United States|Kaiser Permanente-Woodland Hills, Woodland Hills, California, United States|Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States|The Medical Center of Aurora, Aurora, Colorado, United States|Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States|Boulder Community Hospital, Boulder, Colorado, United States|Boulder Community Foothills Hospital, Boulder, Colorado, United States|Rocky Mountain Cancer Centers-Boulder, Boulder, Colorado, United States|Rocky Mountain Cancer Centers - Centennial, Centennial, Colorado, United States|Penrose-Saint Francis Healthcare, Colorado Springs, Colorado, United States|Rocky Mountain Cancer Centers-Penrose, Colorado Springs, Colorado, United States|Cancer Center of Colorado at Sloan's Lake, Denver, Colorado, United States|Kaiser Permanente-Franklin, Denver, Colorado, United States|National Jewish Health-Main Campus, Denver, Colorado, United States|The Women's Imaging Center, Denver, Colorado, United States|Porter Adventist Hospital, Denver, Colorado, United States|Colorado Blood Cancer Institute, Denver, Colorado, United States|Presbyterian - Saint Lukes Medical Center - Health One, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Midtown, Denver, Colorado, United States|SCL Health Saint Joseph Hospital, Denver, Colorado, United States|Rocky Mountain Cancer Centers-Rose, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Western Surgical Care, Denver, Colorado, United States|Mercy Medical Center, Durango, Colorado, United States|Southwest Oncology PC, Durango, Colorado, United States|Mountain Blue Cancer Care Center - Swedish, Englewood, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|National Jewish Health-Western Hematology Oncology, Golden, Colorado, United States|Saint Mary's Hospital and Regional Medical Center, Grand Junction, Colorado, United States|North Colorado Medical Center, Greeley, Colorado, United States|Good Samaritan Medical Center, Lafayette, Colorado, United States|Kaiser Permanente-Rock Creek, Lafayette, Colorado, United States|Saint Anthony Hospital, Lakewood, Colorado, United States|Rocky M",Puerto Rico,Respiratory Diseases,1,4,1105.0
893.0,NCT04815096,Imaging Immune Activation in COVID-19,,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine),"CellSight Technologies, Inc.|University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",20.0,Industry|Other,Interventional,2021-04-15,01/03/23,2023-01-03,24/03/21,29/03/21,"University of California, San Francisco, San Francisco, California",United States,Respiratory Diseases,1,2,628.0
894.0,NCT04467008,Covid-19 Rapid Diagnostic Tests on Blood Drop,COVID-TEST,Completed,COVID-19,,,,,,,,CMC Ambroise Paré,All,"Child, Adult, Older Adult",113.0,Other,Observational,2020-07-15,15/08/20,2020-08-15,10/07/20,10/11/20,"CMC Ambroise Paré, Neuilly-sur-Seine",France,Respiratory Diseases,1,1,31.0
895.0,NCT04698993,Dräger COVID-19 Antigen Test Clinical Performance Study,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Dräger Antigen Test SARS-CoV-2,Drägerwerk AG & Co. KGaA,All,"18 Years and older   (Adult, Older Adult)",831.0,Industry,Interventional,2021-12-02,01/03/21,2021-01-03,07/01/21,11/03/21,"Charité - Universitätsmedizin Berlin, Berlin",Germany,Respiratory Diseases,1,1,-333.0
896.0,NCT04649944,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Serological test and phone interview,University of Milan,All,"4 Years to 99 Years   (Child, Adult, Older Adult)",40.0,Other,Observational,2021-05-02,01/11/21,2021-12-31,02/12/20,22/12/20,"UOC Maxillofacial Surgery and Odontology, University of Milan, Milan, Lombardy",Italy,Respiratory Diseases,1,1,243.0
897.0,NCT04612972,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru",Cov-Peru,Recruiting,COVID-19,,,,,,,Biological: Inactivated SARS CoV 2 vaccine (Vero cell). Wuhan,"Universidad Peruana Cayetano Heredia|National University of San Marcos, Peru",All,18 Years to 60 Years   (Adult),6000.0,Other,Interventional,2020-10-09,31/12/20,2021-01-09,03/11/20,03/11/20,"Av. Honorio Delgado 430, Urb. Ingeniería, San Martin De Porres, Lima",Peru,Respiratory Diseases,1,1,92.0
898.0,NCT04371406,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,MG-COVID,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine and Azithromycin|Dietary Supplement: Azinc,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 75 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,01/08/20,2020-01-09,01/05/20,27/10/20,,,Respiratory Diseases,1,1,5.0
899.0,NCT04389359,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,PROTECT,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate 200 MG,Cambridge University Hospitals NHS Foundation Trust|University of Cambridge,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-09,01/08/21,2025-01-08,15/05/20,08/03/21,,,Respiratory Diseases,1,1,1826.0
900.0,NCT04838080,Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo,,Recruiting,COVID-19,,,,,,,Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 4 µg/0.5 ml Vaccine|Biological: Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine 6 µg/0.5 ml Vaccine|Biological: Placebo,Kocak Farma,All,18 Years to 55 Years   (Adult),38.0,Industry,Interventional,2021-03-19,01/06/21,2021-10-20,08/04/21,13/04/21,"Yeditepe AR-GE ve Analiz Merkezi İyi Klinik Uygulamaları Merkezi (Center for GCP), Istanbul",Turkey,Respiratory Diseases,1,1,215.0
901.0,NCT04464395,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: CPI-006|Other: Standard of Care,"Corvus Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",70.0,Industry,Interventional,2020-01-07,31/03/21,2021-08-31,09/07/20,29/01/21,"El Centro Regional Medical Center, El Centro, California, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Temple University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,602.0
902.0,NCT04370171,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,TeleCoviDiab,Completed,Diabetes,COVID-19,,,,,,Other: care modalities|Other: Teleconsultation either by phone or by computer consultation,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",610.0,Other,Observational,2020-04-05,29/05/20,2020-05-29,30/04/20,10/11/20,"Hôpitaux Universitaires de Strasbourg, Strasbourg",France,"Respiratory Diseases, Metabolic Disorders",1,2,54.0
903.0,NCT04347915,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Clevudine|Drug: Placebo,Bukwang Pharmaceutical,All,"19 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-06-05,30/01/21,2021-03-31,15/04/20,27/01/21,"Korea University Guro Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,299.0
904.0,NCT04362176,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,PassItOn,Recruiting,COVID-19,Coronavirus,COVID-19,,,,,Biological: pathogen reduced SARS-CoV-2 convalescent plasma|Biological: Placebo,Vanderbilt University Medical Center|Dolly Parton|National Center for Advancing Translational Science (NCATS),All,"18 Years and older   (Adult, Older Adult)",1000.0,Other|NIH,Interventional,2020-04-24,01/04/21,2021-01-04,24/04/20,11/12/20,"University of Arizona, Phoenix, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Scripps Health, La Jolla, California, United States|University of Colorado Denver, Aurora, Colorado, United States|MedStar Health Research Institute/MedStar Washington Hospital Center, Washington, District of Columbia, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana, United States|University of Maryland, Baltimore (University of Maryland Medical Center), Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Newton-Wellelsey Hospital, Newton, Massachusetts, United States|Mercy Health Muskegon, Muskegon, Michigan, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States|University at Buffalo/Buffalo General Medical Center, Buffalo, New York, United States|Rochester General Hospital, Rochester, New York, United States|The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus, Ohio, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Utah Valley Hospital, Provo, Utah, United States|University of Utah Health, Salt Lake City, Utah, United States|Sentara Norfolk General Hospital, Norfolk, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia, United States|University of Washington, Seattle, Washington",United States,Respiratory Diseases,1,3,255.0
905.0,NCT04479293,Post COVID-19 Functional Status in Egypt,,Recruiting,COVID-19,Coronavirus Disease,COVID-19,,,,,Other: Post COVID-19 Functional Satus Scale,Assiut University,All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-01-07,30/10/20,2020-11-30,21/07/20,09/09/20,"Aliaa Hussein, Assiut",Egypt,Respiratory Diseases,1,3,328.0
906.0,NCT04817293,Prolonged Symptoms and Reasons for Consultation in Town Medicine Associated With COVID-19 Infection in the Hauts de France Region,COCO_Vi_LATE,Not yet recruiting,COVID-19,,,,,,,Other: Questionnaire|Other: medical consultation,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-03,01/09/21,2021-01-12,26/03/21,26/03/21,"CH Tourcoing, Tourcoing",France,Respiratory Diseases,1,1,9.0
907.0,NCT04584593,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,COVSPERM,Recruiting,COVID-19,,,,,,,Biological: Sample,"University Hospital, Toulouse",Male,18 Years to 50 Years   (Adult),50.0,Other,Interventional,2020-02-10,01/02/22,2022-01-02,14/10/20,03/11/20,"University Hospital Toulouse, Toulouse",France,Respiratory Diseases,1,1,692.0
908.0,NCT04438694,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,CP IN COVID19,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma|Drug: Standard of Care,Cairo University,All,"21 Years to 70 Years   (Adult, Older Adult)",67.0,Other,Interventional,2020-01-06,31/05/21,2021-12-31,19/06/20,29/09/20,"Cairo University Hospital, Cairo",Egypt,Respiratory Diseases,1,1,725.0
909.0,NCT04497402,Sex-Informed Data in the COVID-19 Pandemic.,G-COV,Recruiting,COVID-19,,,,,,,,University of Roma La Sapienza,All,"18 Years to 100 Years   (Adult, Older Adult)",88.0,Other,Observational,2020-01-09,01/09/21,2022-01-06,04/08/20,18/11/20,"Sapienza University of Rome - Policlinico Umberto I Roma, Rome",Italy,Respiratory Diseases,1,1,728.0
910.0,NCT04593940,Immune Modulators for Treating COVID-19,ACTIV-1 IM,Recruiting,COVID-19,,,,,,,Drug: Infliximab|Drug: Abatacept|Drug: Remdesivir|Drug: cenicriviroc,Daniel Benjamin|National Center for Advancing Translational Science (NCATS)|Biomedical Advanced Research and Development Authority|Duke University,All,"18 Years and older   (Adult, Older Adult)",2160.0,Other|NIH|U.S. Fed,Interventional,2020-10-15,01/08/21,2021-01-09,20/10/20,14/04/21,"Banner University Medical Center, Phoenix, Arizona, United States|University of Arkansas Medical Sciences, Little Rock, Arkansas, United States|Scripps Clinical Medical Group, La Jolla, California, United States|UCLA - Ronald Reagan Medical Center, Los Angeles, California, United States|Riverside University, Moreno Valley, California, United States|UC Irvine Medical Center, Orange, California, United States|Stanford University Medical Center, Palo Alto, California, United States|UCLA Medical Center- Santa Monica, Santa Monica, California, United States|Medstar Washington Hospital Center, Washington, District of Columbia, United States|University of Florida-Jacksonville, Jacksonville, Florida, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kansas, Kansas City, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|Tulane School of Medicine, New Orleans, Louisiana, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|Johns Hopkins Medical Center, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|U Mass Memorial Medical Center, Worcester, Massachusetts, United States|U Mass University Medical Center, Worcester, Massachusetts, United States|MidMichigan Medical Center- Gratiot, Alma, Michigan, United States|MidMichigan Medical Center - Midland, Midland, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Trinitas Hospital, Elizabeth, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers New Jersey Medical School, New Brunswick, New Jersey, United States|NYU Brooklyn, Brooklyn, New York, United States|Flushing Hospital Medical Center, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|NYU Long Island, Long Island City, New York, United States|New York University Langone Medical Center, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|St Lawrence Health System, Potsdam, New York, United States|University of Rochester Medical Center-Strong Memorial Hospital, Rochester, New York, United States|University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Mercy Saint Vincent Medical Center, Toledo, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Avera McKennan Hospital, Sioux Falls, South Dakota, United States|University of Tennessee Medical Center, Knoxville, Tennessee, United States|Methodist Health System Clinical Research Institute, Dallas, Texas, United States|University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Trinity Mother Frances Hospital, Tyler, Texas, United States|University of Utah, Salt Lake City, Utah, United States|Virginia Commonwealth University Medical Center, Richmond, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Providence Medical Research Center, Spokane, Washington, United States|West Virginia University, Morgantown, West Virginia, United States|Gundersen Health System, La Crosse, Wisconsin, United States|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Hospital Rawson, Cordoba, Argentina|Sanatorio Britanico, Rosario, Argentina|Sanatorio Diagnóstico/ Instituto del Buen Aire, Santa Fe, Argentina|Hospital Ernesto Dornelles, Porto Alegre, Rio Grande D Sul /RS, Brazil|Hospital de Clinicas de Porto Alegre HCPA, Porto Alegre, Rio Grande Do Sul / RS, Brazil|Hospital e Maternidade Celso Pierro - PUC Campinas, Campinas, São Paulo/SP, Brazil|Hospital Central FAP, Lima, Lima/Lima, Peru|Hospital Regional Lambayeque, Chiclayo, Peru|Hospitala Nacional Hipólito Unánue, Lima, Peru|Hospital de Chancay y Servicios Basicos de Salud, Lima, Peru|Clínica Belén SANNA, Piura",Peru,Respiratory Diseases,1,1,86.0
911.0,NCT04492202,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals",,Not yet recruiting,COVID-19,"Knowledge, Attitudes, Practice",,,,,,Other: Survey,Istinye University,All,"22 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-01-08,20/11/20,2020-10-12,30/07/20,30/07/20,,,Respiratory Diseases,1,2,278.0
912.0,NCT04407195,COVID-19 and Mental Health,,"Active, not recruiting",COVID-19,Mental Health Disorder,,,,,,Other: Exposure to the SARS-CoV-2,Northeastern University,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-06,01/06/21,2021-01-06,29/05/20,11/09/20,"Northeastern University, Boston, Massachusetts",United States,Respiratory Diseases,1,2,366.0
913.0,NCT04407286,Vitamin D Testing and Treatment for COVID 19,,Completed,COVID-19,Vitamin D Deficiency,,,,,,Dietary Supplement: Vitamin D3,Arizona State University|Southwest College of Naturopathic Medicine,All,"18 Years and older   (Adult, Older Adult)",41.0,Other,Interventional,2020-05-19,30/08/20,2020-11-30,29/05/20,02/12/20,"Arizona State University, Tempe, Arizona",United States,Respiratory Diseases,1,2,195.0
914.0,NCT04367064,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),SCOPe,Recruiting,COVID-19,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years to 75 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-25,25/11/20,2020-12-25,29/04/20,14/07/20,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi",India,Respiratory Diseases,1,1,244.0
915.0,NCT04405726,Prognostic Factors of COVID19,Covid-HUS,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"1 Year and older   (Child, Adult, Older Adult)",500.0,Other,Observational,2020-03-27,01/03/22,2022-01-03,28/05/20,25/06/20,"Service de Virologie - Hôpital Civil, Strasbourg",France,Respiratory Diseases,1,1,647.0
916.0,NCT04404244,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,PedCan-COVID,Recruiting,COVID-19,,,,,,,,Fatma Soliman Elsayed Ebeid|Ain Shams University,All,"up to 18 Years   (Child, Adult)",100.0,Other,Observational,2020-01-01,01/01/21,2021-01-06,27/05/20,27/05/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,371.0
917.0,NCT04531748,Selective Estrogen Modulation and Melatonin in Early COVID-19,SENTINEL,Not yet recruiting,COVID-19,,,,,,,Drug: Toremifene|Drug: Melatonin|Other: Placebo,"Reena Mehra, MD|The Cleveland Clinic",All,"18 Years and older   (Adult, Older Adult)",390.0,Other,Interventional,2021-01-03,01/09/21,2021-01-09,28/08/20,21/12/20,,,Respiratory Diseases,1,1,6.0
918.0,NCT04360538,Long Term Outcomes of Patients With COVID-19,COVID19 LTFU,Recruiting,Critical Illness,Corona Virus Infection,Respiratory Failure,COVID-19,,,,Other: Quality of Life|Other: Impact Event Score|Other: Hospital anxiety and depression scale,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-08-04,01/07/21,2021-12-30,24/04/20,24/04/20,"University of Chicago Medical Center, Chicago, Illinois",United States,"Cardiovascular Diseases, Respiratory Diseases",1,4,513.0
919.0,NCT04381884,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,,Completed,COVID-19,,,,,,,Drug: IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care.,Laboratorio Elea Phoenix S.A.|Universidad Nacional de Salta|Centro de Investigación Veterinaria Tandil CIVETAN|Hospital de Pediatría Prof Dr. Juan P. Garrahan|Universidad Nacional de Quilmes,All,"18 Years to 69 Years   (Adult, Older Adult)",45.0,Industry|Other,Interventional,2020-05-18,29/09/20,2020-09-29,11/05/20,05/10/20,"Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina|Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno CEMIC, Buenos Aires, Ciudad De Buenos Aires, Argentina|Hospital de Infecciosas Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aires",Argentina,Respiratory Diseases,1,1,134.0
920.0,NCT04523012,COVID-19 and HIV Patients,COCOVIH,Recruiting,COVID-19,,,,,,,Other: Seroprevalence of SARS-CoV-2 infection in patients with HIV infection,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,All,"18 Years and older   (Adult, Older Adult)",2200.0,Other,Observational,2020-01-07,30/06/21,2022-06-30,21/08/20,21/08/20,"Valérie POURCHER, Paris, Ile De France",France,Respiratory Diseases,1,1,905.0
921.0,NCT04824469,"The Effects of Web-Based Training for Covid-19 Patients on Symptom Management, Medication Compliance and Quality of Life",,Not yet recruiting,COVID-19,,,,,,,Other: intervention group,Eskisehir Osmangazi University,All,"18 Years and older   (Adult, Older Adult)",128.0,Other,Interventional,2021-01-05,01/11/21,2022-01-06,01/04/21,05/04/21,,,Respiratory Diseases,1,1,366.0
922.0,NCT04318366,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",COVID-BioB,Recruiting,Coronavirus Infections,,,,,,,Other: Observational Study,Università Vita-Salute San Raffaele,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-19,19/03/22,2022-03-19,24/03/20,17/12/20,"Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -, Milan, Lombardy, Italy|Department of Internal Medicine - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Diabetes Research Institute -IRCCS San Raffaele Scientific Istitute, Milan, Lombardy, Italy|Division of Immunology, Transplantation and Infectious Diseases - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Division of Research of Regenerative Medicine, Cell and Gene Therapy - IRCCS San Raffaele Scientific Istitute, Milan, Lombardy, Italy|Laboratory of Microbiology and Virology - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Nephrology Unit - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Strategic Program in Nephrology and Dialysis - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Viral pathogens and biosafety Unit - IRCCS San Raffaele Scietific Institute, Milan, Lombardy, Italy|Unit of Immunology, Rheumatology, Allergy and Rare Diseases - IRCCS San Raffaele Scientific Institute, Milan, Lombardy, Italy|Università Vita-Salute San Raffaele, Milano, Mi",Italy,Respiratory Diseases,1,1,730.0
923.0,NCT04340921,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,,Recruiting,Cardiovascular Disease Acute,Cardiomyopathies,COVID-19,,,,,Biological: COVID-19 exposure,Barts & The London NHS Trust|Queen Mary University of London,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-05-14,10/11/21,2021-10-11,10/04/20,18/05/20,"Barts Health Nhs Trust, London",United Kingdom,Respiratory Diseases,1,3,515.0
924.0,NCT04475302,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,,Recruiting,COVID-19,,,,,,,Biological: BCG vaccine (Freeze-dried),"Tuberculosis Research Centre, India|ICMR-National Institute for Research in Tuberculosis, Chennai, Tamil Nadu|All India Institute of Medical Sciences, New Delhi|National Institute for Research in Environmental Health, Bhopal, Madhya Pradesh|National Institute of Occupational Health, Ahmedabad, Gujarat|King Edward Memorial Hospital|National Institute for Implementation Research on Non-Communicable Disease",All,"60 Years to 80 Years   (Adult, Older Adult)",2175.0,Other,Interventional,2020-01-07,01/01/21,2021-01-05,17/07/20,23/07/20,"Tuberculosis Research Centre, Chennai, Tamilnadu",India,Respiratory Diseases,1,1,364.0
925.0,NCT04386850,Oral 25-hydroxyvitamin D3 and COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Oral 25-Hydroxyvitamin D3,Tehran University of Medical Sciences|Boston University,All,"18 Years to 75 Years   (Adult, Older Adult)",1500.0,Other,Interventional,2020-04-14,15/11/20,2021-03-15,13/05/20,12/06/20,"Tehran University of Medical Sciences, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,335.0
926.0,NCT04413838,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,NIVISCO,Not yet recruiting,COVID-19,,,,,,,Drug: NIVOLUMAB|Other: Routine standard of care,Hospices Civils de Lyon,All,"18 Years to 70 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-06-15,15/06/21,2021-09-15,04/06/20,04/06/20,"Hôpital Lyon Sud Service Endocrinologie, Diabète et Nutrition, Pierre-Bénite",France,Respiratory Diseases,1,1,457.0
927.0,NCT04805203,Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma,Covimmunomm,Recruiting,Multiple Myeloma,COVID-19,,,,,,Other: blood sample analyses,Intergroupe Francophone du Myelome,All,"18 Years to 110 Years   (Adult, Older Adult)",400.0,Other,Interventional,2020-12-16,01/12/22,2022-01-12,18/03/21,18/03/21,"CHU Amiens SUD, Amiens, France|CHRU Hôpital du Bocage, Angers, France|Ch Annecy Genevois, Annecy, France|CH Victor Dupouy, Argenteuil, France|CH d'ARRAS, Arras, France|CH Auch, Auch, France|Centre Hospitalier H.Duffaut, Avignon, France|Centre Hospitalier Simone Veil de Blois, Blois, France|CHU Bordeaux-hopital haut leveque, Bordeaux, France|Centre hospitalier Pierre Oudot, Bourgoin-Jallieu, France|Hôpital A.Morvan, Brest, France|CHU de Caen, Caen, France|CH de Cannes, Cannes, France|Clinique du Parc, Castelnau-le-Lez, France|Centre Hospitalier William Morey, Chalon Sur Saone, France|Centre Hospitalier Métropole de Savoie, Chambéry, France|Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France|CHU Henri Mondor, Créteil, France|CH de Dax côte d'Argent, Dax, France|CHU François Mitterand, Dijon, France|CH de Dunkerque, Dunkerque, France|CHU grenoble, Grenoble, France|Institut Daniel Hollard - Groupe Hospitalier Mutualiste de Grenoble, Grenoble, France|CH de Lens, Lens, France|Hopital Claude Huriez-CHRU LILLE, Lille, France|CHU Limoges, Limoges, France|Centre Hospitalier Lyon sud, Lyon, France|Centre Léon Bérard, Lyon, France|Institut Paoli Calmettes, Marseille, France|GHT des Landes, Mont-de-Marsan, France|CHU saint Eloi, Montpellier, France|Hôpital E. MULLER, Mulhouse, France|Hôpitaux de Brabois - CHRU de Nancy, Nancy, France|CHRU Nantes, Nantes, France|Hopital Archet 1, Nice, France|Hopital Cochin, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Necker Enfants Malades, Paris, France|Hôpital Pitié-Salpêtrière, Paris, France|CHU Poitiers, Poitiers, France|CH René Dubos, Pontoise, France|CHU de Reims, Reims, France|Chu Pontchaillou, Rennes, France|CH Roubaix, Roubaix, France|Centre Henri Becquerel, Rouen, France|Centre Hospitalier Yves Le Foll, Saint brieuc, France|Institut de Cancérologie Lucien Neuwirth, Saint-Priest, France|Centre Hospitalier, Saint-Quentin, France|ICANS, Strasbourg, France|CH Tarbes, Tarbes, France|CHU Toulouse, Toulouse, France|CHRU Bretonneau, Tours, France|CH de valenciennes, Valenciennes, France|CH Bretagne Atlantique Vannes et Auray-P.Chubert, Vannes, France|CHV André Mignot, Versailles",France,Respiratory Diseases,1,2,392.0
928.0,NCT04516850,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,,Not yet recruiting,COVID-19,,,,,,,Genetic: Expression of receptors and activating proteases|Genetic: Polymorphism of the HSD3B1,Ricardo Pereira Mestre|Institute of Oncology Research (IOR)|Istituto Cantonale di Patologia|Oncology Institute of Southern Switzerland,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-09,31/08/21,2021-08-31,18/08/20,18/08/20,"Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland|Clinica Luganese Moncucco, Lugano",Switzerland,Respiratory Diseases,1,1,600.0
929.0,NCT04360356,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Combination Product: Ivermectin plus Nitazoxanide|Other: Standard Care,Tanta University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-05,01/10/20,2020-01-12,24/04/20,24/04/20,,,Respiratory Diseases,1,1,7.0
930.0,NCT04783025,A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes,BGCTS,Not yet recruiting,Infection Control,COVID-19,,,,,,"Behavioral: Blended Gaming COVID-19 Training System (BGCTS)|Behavioral: Usual care, infection control briefing",The Hong Kong Polytechnic University,All,"18 Years to 65 Years   (Adult, Older Adult)",188.0,Other,Interventional,2021-01-03,31/12/21,2022-01-03,04/03/21,04/03/21,"The Hong Kong Polytechnic University, Hong Kong",Hong Kong,Respiratory Diseases,1,2,365.0
931.0,NCT04343976,Pegylated Interferon Lambda Treatment for COVID-19,,Enrolling by invitation,COVID-19,COVID-19,,,,,,Drug: Pegylated interferon lambda,Raymond Chung|Eiger BioPharmaceuticals|Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other|Industry,Interventional,2020-06-22,01/09/21,2021-12-30,14/04/20,08/04/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,2,556.0
932.0,NCT04570397,Ravulizumab and COVID-19,,Recruiting,COVID-19,Thrombotic Microangiopathies,Acute Kidney Injury,,,,,Drug: Ravulizumab,Brigham and Women's Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",32.0,Other,Interventional,2020-12-18,01/05/21,2021-01-11,30/09/20,14/01/21,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,3,24.0
933.0,NCT04388631,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,COVID-19,Recruiting,Coronavirus Disease 2019,,,,,,,Other: Coronavirus Disease 2019,Tongji Hospital,Male,18 Years to 60 Years   (Adult),200.0,Other,Observational,2020-10-05,01/05/21,2021-01-05,14/05/20,18/05/20,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,1,92.0
934.0,NCT04416048,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,COVID-PREVENT,Recruiting,COVID-19,,,,,,,Drug: Rivaroxaban|Other: Standard Of Care (SOC),"Charite University, Berlin, Germany|Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)|Bayer",All,"18 Years and older   (Adult, Older Adult)",400.0,Other|Industry,Interventional,2020-11-30,30/04/21,2021-05-30,04/06/20,25/02/21,"Kardiologie und Angiologie I Universitätsherzzentrum Freiburg, Freiburg, Baden-Württemberg, Germany|Friedrichshafen Hospital Clinic for cardiology, angiology, pneumology and internal intensive care medicine, Friedrichshafen, Baden-Württemberg, Germany|Clinic for Gastroenterology, Infectology and Poisoning Universitäsklinikum Heidelberg, Heidelberg, Baden-Württemberg, Germany|Cardiology and Pneumology Clinic Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Bayern, Germany|Medical Clinic and Polyclinic I. L. Ludwigs-Maximilians-University Clinic, Munich, Munich, Bayern, Germany|Cardiology, Pneumology and Intensive Care Clinic, München Klinik Neuperlach, München, Bayern, Germany|Immanuel Klinikum Bernau Herzzentrum Brandenburg ( Immanuel Clinic Bernau Heart Center Brandenburg), Bernau, Brandenburg, Germany|Internal Medicine and Cardiology Klinik Henningsdorf. Oberhavel Kliniken, Hennigsdorf, Brandenburg, Germany|Clinic for Cardiology, Angiology und Nephrology Universitätsklinikum Frankfurt, Goethe-Universität, Frankfurt am Main, Hessen, Germany|Clinic and Polyclinic Internal Medicine Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany|Cardiology and Pneumology Clinic Universitätsmedizin Göttingen, Göttingen, Niedersachsen, Germany|Clinic for Cardiology and Intensive Care - Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany|Westdeutsches Herz- und Gefäßzentrum Essen (West German Heart and Vascular Center Essen), Essen, Nordrhein-Westfalen, Germany|Medical Clinic I. Marien Hospital, Universitätsklinikum der Ruhr Universität Bochum, Herne, Herne, Nordrhein-Westfalen, Germany|Pneumology, Allergology, Sleep-and Respiratory Medicine Clinic Helios Universitätsklinikum Wupperthal, Wuppertal, Nordrhein-Westfalen, Germany|Katholisches Klinikum Koblenz-Montabaur (Catholic Hospital Koblenz-Montabaur), Koblenz, Rheinland-Pfalz, Germany|Center for Cardiology, University Medicine Mainz, Mainz, Rheinland-Pfalz, Germany|Universitätsklinikum Halle (Saale) (University Hospital Halle (Saale)), Halle, Sachsen-Anhalt, Germany|Clinic for Vascular Medicine, Städtisches Krankenhaus Dresden, Dresden, Sachsen, Germany|Medical Clinic I. Universitätsklinikum Carl Gustav Carus, Dresden, Dresden, Sachsen, Germany|Cardiology, Pneumology and Intensive Care Clinic Helios Klinikum Pirna, Dresden, Pirna, Sachsen, Germany|Medical Clinic II, University Clinic Schleswig-Holstein - Campus Lübeck, Lübeck, Schleswig-Holstein, Germany|Department of Pneumology and Infectology Charité University Medicine Berlin, Campus Mitte, Berlin, Germany|Internal Medicine II, Cardiology, Sana Klinikum, Lichtenberg. Berlin, Berlin, Germany|Medical Clinic II. St. Joseph Hospital Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Benjamin Franklin, Berlin, Germany|Internal Medicine, Hospital Bethel Berlin in Lichterfelde, Berlin, Germany|Internal Medicine/Cardiology department Unfallkrankenhaus Berlin, Berlin, Germany|Department of Cardiology Charité University Medicine Berlin, Campus Virchow, Berlin, Germany|Internal Medicine, Cardiology and Intensive Care Clinic Vivantes Humboldt Klinikum, Berlin, Berlin, Germany|Berlin Vivantes Hospital Spandau Clinic for internal medicine, cardiology and conservative intensive care medicine, Berlin, Germany|Intensive Care and Cardiology, Hospital Havelhöhe, Berlin, Germany|Internal Medicine Deparment Hospital Waldfriede, Berlin, Berlin",Germany,Respiratory Diseases,1,1,181.0
935.0,NCT04371432,Genetics of COVID-19 Susceptibility and Manifestations,,Recruiting,COVID-19,Coronavirus 2019,,,,,,,National Human Genome Research Institute (NHGRI)|National Institutes of Health Clinical Center (CC),All,"3 Years and older   (Child, Adult, Older Adult)",2500.0,NIH,Observational,2020-05-05,01/06/25,2025-01-06,01/05/20,29/03/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,2,1707.0
936.0,NCT04679428,Immunological Characteristics of COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,"The University Clinic of Pulmonary and Allergic Diseases Golnik|National Institute of Chemistry, Slovenia",All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Observational,2020-07-05,07/05/22,2023-07-05,22/12/20,22/12/20,"University Clinic of Respiratory and Allergic Diseases Golnik, Golnik",Slovenia,Respiratory Diseases,1,1,1095.0
937.0,NCT04368884,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-22,30/06/21,2021-07-30,30/04/20,22/07/20,"Max Super Speciality Hospital, A Unit of Devki Devi Foundation, New Delhi, Delhi",India,Respiratory Diseases,1,1,464.0
938.0,NCT04428073,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,,Not yet recruiting,COVID-19,,,,,,,Biological: Covax-19™,GeneCure Biotechnologies,All,18 Years to 60 Years   (Adult),32.0,Industry,Interventional,2020-01-07,01/07/21,2021-01-12,11/06/20,11/06/20,,,Respiratory Diseases,1,1,371.0
939.0,NCT04370197,Covid-19 Epidemic on Acute Stroke Management,Stroke-Covid19,Recruiting,"Stroke, Acute",,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-03-03,30/04/20,2020-04-30,30/04/20,30/04/20,"Service de Neuroradiologie Interventionnelle, Strasbourg",France,Cardiovascular Diseases,1,1,58.0
940.0,NCT04690387,"Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection",,Completed,COVID-19,,,,,,,Biological: AV-COVID-19|Other: GM-CSF,"Aivita Biomedical, Inc.|PT AIVITA Biomedika Indonesia|Indonesia Ministry of Health|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia",All,"18 Years and older   (Adult, Older Adult)",27.0,Industry|Other,Interventional,2020-07-12,13/01/21,2021-01-15,30/12/20,05/04/21,"Rumah Sakit Umum Pusat Dr. Kariadi, Semarang, Jawa Tengah",Indonesia,Respiratory Diseases,1,1,187.0
941.0,NCT04843774,Covid19 Multiple Sclerosis Vaccine Biospecimen Study,,Not yet recruiting,Multiple Sclerosis,,,,,,,Drug: SARS-COV-2 mRNA Vaccine,NYU Langone Health,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Observational,2021-04-19,30/06/22,2022-10-14,14/04/21,14/04/21,"University of Colorado, Denver (UCD), Denver, Colorado, United States|NYU Langone Health Multiple Sclerosis Comprehensive Care Center (NYULH MSCCC), New York, New York",United States,Immunological Disorders,1,1,543.0
942.0,NCT04370119,Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers,SeCo,Recruiting,COVID-19,,,,,,,Diagnostic Test: Nasal swab|Diagnostic Test: Serum testing,University Medicine Greifswald|Friedrich Loefler Institute for Animal Health|EUROIMMUN AG,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-04-27,01/05/21,2025-01-05,30/04/20,01/04/21,"Greifswald University Medicine, Greifswald",Germany,Respiratory Diseases,1,1,1714.0
943.0,NCT04384029,The Geneva Covid-19 CVD Study,,"Active, not recruiting",COVID-19,CVD,,,,,,Other: Covid-19 + patients,"François MACH|University Hospital, Geneva",All,"18 Years and older   (Adult, Older Adult)",7000.0,Other,Observational,2020-03-24,31/03/21,2022-03-31,12/05/20,12/05/20,"Geneva University Hospital (HUG), Geneva",Switzerland,Respiratory Diseases,1,2,737.0
944.0,NCT04473547,COVID 19 Preventive Measures Among Mansoura Nursing Students,,Completed,COVID-19,,,,,,,,Mansoura University,All,"Child, Adult, Older Adult",144.0,Other,Observational,2020-10-07,20/08/20,2021-02-15,16/07/20,08/03/21,"Faculty of Nursing Mansoura University, Mansoura",Egypt,Respiratory Diseases,1,1,131.0
945.0,NCT04458363,Convalescent Plasma in Pediatric COVID-19,,Completed,COVID-19,,,,,,,Biological: Convalescent Plasma (CP)|Drug: Standard COVID-19 therapies,Emory University,All,"up to 22 Years   (Child, Adult)",3.0,Other,Interventional,2020-04-07,01/09/20,2020-01-09,07/07/20,19/01/21,"Children's Healthcare of Atlanta, Atlanta, Georgia",United States,Respiratory Diseases,1,1,-89.0
946.0,NCT04707664,Sargramostim Use in COVID-19 to Recover Patient Health,SCOPE,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Sargramostim|Drug: Placebo,"Partner Therapeutics, Inc.|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|U.S. Fed,Interventional,2021-01-04,01/06/21,2021-01-06,13/01/21,06/04/21,"West Valley Research Clinic, LLC, Phoenix, Arizona",United States,Respiratory Diseases,1,2,2.0
947.0,NCT04493242,Extracellular Vesicle Infusion Therapy for Severe COVID-19,EXIT COVID-19,Not yet recruiting,COVID-19,ARDS,"Pneumonia, Viral",,,,,Biological: DB-001,"Direct Biologics, LLC",All,"18 Years to 85 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-01-09,30/11/20,2020-12-31,30/07/20,30/07/20,,,Respiratory Diseases,1,3,357.0
948.0,NCT04361942,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),COVID_MSV,Recruiting,COVID-19,,,,,,,Biological: Mesenchymal Stromal Cells|Other: Placebo,Red de Terapia Celular|Citospin|University of Valladolid|Castilla-León Health Service|Hospital del Río Hortega|Instituto de Salud Carlos III,All,"18 Years and older   (Adult, Older Adult)",24.0,Industry|Other,Interventional,2020-01-05,30/11/21,2021-12-31,24/04/20,10/03/21,"Hospital Universitario Rio Hortega, Valladolid",Spain,Respiratory Diseases,1,1,726.0
949.0,NCT04448769,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),COVAL-NANCY,Completed,Coronavirus Infection,Prevalence,,,,,,Biological: Anti-SARS-CoV-2 IgT seropositivity,"Central Hospital, Nancy, France|University of Lorraine|Métropole du Grand Nancy",All,"5 Years and older   (Child, Adult, Older Adult)",2006.0,Other,Interventional,2020-06-26,24/07/20,2020-07-24,26/06/20,19/08/20,"Chru Nancy, Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,2,28.0
950.0,NCT04466839,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,ERCO-Park,Completed,Parkinson Disease,COVID-19,,,,,,Other: Questionnaire and interview,"University Hospital, Toulouse",All,"Child, Adult, Older Adult",411.0,Other,Observational,2020-02-07,18/12/20,2020-12-18,10/07/20,23/03/21,"Centre Hospitalier Régionale Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire Lille, Lille, France|Centre Hospitalier Universitaire de Marseille, Marseille, France|Centre Hospitalier Universitaire de Nîmes - Caremeau, Nimes, France|Centre Hospitalier Universitaire de la Pitié-Salpêtrière, Paris, France|Centre Hospitalier Universitaire de Reims, Reims, France|Centre Hospitalier Universitaire de Rouen, Rouen, France|CHU Toulouse, Toulouse",France,Respiratory Diseases,1,2,315.0
951.0,NCT04583410,Efficacy of Nicotine in Preventing COVID-19 Infection,NICOVID-PREV,Recruiting,COVID-19,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,,,,,,Drug: Nicotine patch|Drug: Placebo patch,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1633.0,Other,Interventional,2020-10-22,01/12/21,2022-01-06,12/10/20,17/02/21,"Centre Hospitalier Gonesse, Gonesse, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Hôpital Pitié Salpêtrière - Service de Médecine Interne, Paris, France|Hôpital Sainte-Anne, Paris",France,Respiratory Diseases,1,2,441.0
952.0,NCT04810728,Efficacy of Psidii Guava's Extract For COVID-19,,Completed,COVID-19,,,,,,,Drug: Extract Psidii guava|Combination Product: Standard therapy for Covid-19 patient,Faculty of Medicine Baiturrahmah University,All,"13 Years to 59 Years   (Child, Adult)",90.0,Other,Interventional,2020-06-20,04/12/20,2021-01-30,23/03/21,23/03/21,"Faculty of Medicine, Baiturrahmah University, Padang, West Sumatera",Indonesia,Respiratory Diseases,1,1,224.0
953.0,NCT04387279,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,,Recruiting,COVID-19,"Perception, Self",Facilities and Services Utilization,,,,,Other: Interview,Keimyung University Dongsan Medical Center|Yeungnam University College of Medicine,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-04-24,30/03/21,2021-03-30,13/05/20,13/05/20,"KeimyungUniversity, Daegu, Jung-gu, Korea",Republic of,Respiratory Diseases,1,3,340.0
954.0,NCT04830020,Use of Inhaled High-molecular Weight Hyaluronan in Patients With Severe COVID19: Feasibility and Outcomes,HA-COVID,Recruiting,COVID-19,,,,,,,Drug: HMW-HA,Campus Bio-Medico University|National Institute of Environmental Health Sciences (NIEHS),All,"18 Years and older   (Adult, Older Adult)",200.0,Other|NIH,Interventional,2021-02-26,31/08/21,2021-08-31,02/04/21,02/04/21,"Università Campus Biomedico di Roma, Roma",Italy,Respiratory Diseases,1,1,186.0
955.0,NCT04411147,A Longitudinal Study of COVID-19 Sequelae and Immunity,,Recruiting,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",900.0,NIH,Observational,2020-06-17,31/12/27,2027-12-31,02/06/20,21/02/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,2753.0
956.0,NCT04816630,Feasibility Study of Hematology Parameters in COVID-19 Disease,,Recruiting,COVID-19,Sepsis,Adults,Emergency Department,,,,Device: CBC-Diff Monocyte Volume Width Distribution,"Beckman Coulter, Inc.",All,"18 Years to 89 Years   (Adult, Older Adult)",500.0,Industry,Observational,2020-12-21,31/03/21,2021-05-31,25/03/21,29/03/21,"Washington University, Saint Louis, Missouri",United States,Respiratory Diseases,1,4,161.0
957.0,NCT04558996,Spanish Registry of Pregnant Women With COVID-19,OBS COVID,Recruiting,COVID-19,Pregnancy Complications,Premature Rupture of Membrane,Abruptio Placentae,Prelabor Rupture of Membranes,Stillbirth,,,Puerta de Hierro University Hospital|Hospital Universitario La Paz|Hospital Universitario 12 de Octubre|Hospital General Universitario Gregorio Marañon|Hospital Universitario La Fe,Female,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-01-03,31/12/20,2021-03-31,22/09/20,22/09/20,"Puerta de Hierro University Hospital, Majadahonda, Madrid",Spain,Respiratory Diseases,1,6,453.0
958.0,NCT04459520,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,,Completed,COVID-19,,,,,,,Behavioral: Positive COVID Test Result - Hypothetical Scenario|Behavioral: Negative COVID Test Result - Hypothetical Scenario|Behavioral: Unavailable COVID Test Result - Hypothetical Scenario,"University of California, Los Angeles",All,"18 Years to 110 Years   (Adult, Older Adult)",1400.0,Other,Interventional,2020-07-23,28/07/20,2020-07-29,07/07/20,20/08/20,"UCLA Health Department of Medicine, Quality Office, Los Angeles, California",United States,Respiratory Diseases,1,1,6.0
959.0,NCT04451577,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",UNICODE,Recruiting,COVID-19,,,,,,,Other: No intervention,Istituto Clinico Humanitas,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-01-06,01/06/21,2023-01-06,30/06/20,30/06/20,"Humanitas reseach hospital (ICH), Rozzano, Milan",Italy,Respiratory Diseases,1,1,1096.0
960.0,NCT04433026,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",,Not yet recruiting,COVID-19,,,,,,,"Diagnostic Test: N terminal pro B type natriuretic peptide (NTproBNP), D-Dimer, and serum Tropinin - I",Assiut University,All,"Child, Adult, Older Adult",90.0,Other,Observational,2020-01-08,01/07/21,2021-01-09,16/06/20,21/08/20,,,Respiratory Diseases,1,1,367.0
961.0,NCT04475107,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Pyronaridine-Artesunate|Drug: Placebo,Shin Poong Pharmaceutical Co. Ltd.,All,"19 Years and older   (Adult, Older Adult)",110.0,Industry,Interventional,2020-09-07,01/04/21,2021-01-09,17/07/20,29/03/21,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Chungnam national University Hospital, Daejeon, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Kyungpook National University Hospital, Seoul, Korea, Republic of|National Medical Center, Seoul, Korea, Republic of|Sahmyook Medical Center, Seoul, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|The Catholic University of Korea, Eunpyeong St. Marys' Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea",Republic of,Respiratory Diseases,1,1,124.0
962.0,NCT04480593,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,Bee-Covid,Completed,COVID-19,,,,,,,Drug: Brazilian Green Propolis Extract (EPP-AF)|Other: Standard care,D'Or Institute for Research and Education|Hospital Sao Rafael,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-02-06,30/08/20,2020-08-30,21/07/20,30/09/20,"Hospital Sao Rafael, Salvador, BA",Brazil,Respiratory Diseases,1,1,206.0
963.0,NCT04447235,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,TITAN,Recruiting,Cancer,COVID-19,Coronavirus Infection,,,,,Drug: Placebo|Drug: Ivermectin|Drug: Losartan,Instituto do Cancer do Estado de São Paulo,All,"18 Years and older   (Adult, Older Adult)",176.0,Other,Interventional,2020-07-23,01/12/20,2021-01-02,25/06/20,29/07/20,"Instituto do Cancer do Estado de Sao Paulo, SAo Paulo",Brazil,"Respiratory Diseases, Cancers",1,3,163.0
964.0,NCT04338945,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,,Completed,COVID-19,,,,,,,Behavioral: COVID-surgRES questionaire,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-03-15,15/04/20,2020-01-05,08/04/20,27/07/20,"U.O.C. Chirurgia Generale Universitaria V. Bonomo, Bari, Italy|Ospedale Perrino Asl Brindisi, Brindisi, Italy|Dipartimento di scienze mediche e chirurgiche, Università di Catanzaro, Catanzaro, Italy|Ospedale Policlinico San Martino, Genova, Italy|Azienda Ospedaliera San Camillo-Forlanini, Roma, Italy|IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Ospedale Cristo re, Roma",Italy,Respiratory Diseases,1,1,-70.0
965.0,NCT04343404,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,ECMO-COVID-19,Completed,Respiratory Distress Syndrome,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,15/04/20,2020-04-15,13/04/20,29/06/20,"Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg",France,Others,0,1,102.0
966.0,NCT04780035,"Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19",,"Active, not recruiting",COVID-19,,,,,,,"Biological: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)|Other: Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)","Federal Budgetary Research Institution State Research Center of Virology and Biotechnology ""Vector""",All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2020-11-18,01/08/21,2021-01-09,03/03/21,03/03/21,"State Budgetary Healthcare Institution of the Moscow region - Krasnogorsk City Hospital # 1 (short name: SBHI MR KCH # 1), Krasnogorsk, Moscow Region, Russian Federation|Federal State Autonomous Educational Institution of Higher Education - Immanuel Kant Baltic University (short name: FSAEIHE- I. Kant Baltic Federal University), Kaliningrad, Russian Federation|State Autonomous Healthcare Institution - Clinical City Hospital # 7 of Kazan (short name: SAHI CCH # 7), Kazan, Russian Federation|Federal State Budgetary Institution - N.I. Pirogov National Medical and Surgical Center, Ministry of Health of the Russian Federation (short name: FSBI - N.I. Pirogov NMSC, Ministry of Health of the Russian Federation), Moscow, Russian Federation|Federal State Budgetary Research Institution - Academician B.V. Petrovsky Russian Research Center for Surgery (short name: FSBRI - Academician B.V. Petrovsky RRCS), Moscow, Russian Federation|Research Center: Federal State Budgetary Institution - Central Clinical Hospital with Polyclinic, Administrative Office of the President of the Russian Federation (short name: FSBI Central Clinical Hospital with Polyclinic), Moscow, Russian Federation|State Budgetary Healthcare Institution of the Moscow region - M.F. Vladimirsky Moscow Regional Research Clinical Institute (short name: M.F. Vladimirsky SBHI MRRCI), Moscow, Russian Federation|State Budgetary Educational Institution of Higher Professional Education - Tyumen State Medical University, Ministry of Health of the Russian Federation (short name: SBEIHPE - Tyumen State Medical University, Ministry of Health of Russian Federation), Tyumen",Russian Federation,Respiratory Diseases,1,1,52.0
967.0,NCT04678830,COVID-19 Long-Haulers Study,,"Active, not recruiting",Coronavirus Disease 2019,,,,,,,Drug: Placebos|Drug: Leronlimab (700mg),"CytoDyn, Inc.|Amarex Clinical Research",All,"18 Years and older   (Adult, Older Adult)",56.0,Industry|Other,Interventional,2021-01-03,23/06/21,2021-07-23,22/12/20,14/04/21,"Arthritis & Rheumatic Disease Specialties, Aventura, Florida, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia",United States,Respiratory Diseases,1,1,201.0
968.0,NCT04535869,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),CCOVID-19,Recruiting,COVID-19,,,,,,,Drug: Sofosbuvir 400 MG plus Daclatasvir 200mg,Mansoura University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-12-28,01/04/21,2021-03-09,02/09/20,24/02/21,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia",Egypt,Respiratory Diseases,1,1,71.0
969.0,NCT04352491,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,,Completed,COVID-19,,,,,,,Other: No intervention,"Institute of Liver and Biliary Sciences, India",All,"18 Years to 75 Years   (Adult, Older Adult)",347.0,Other,Observational,2020-04-24,31/05/20,2020-05-31,20/04/20,17/06/20,"Institute of Liver and Biliary Sciences, New Delhi, Delhi",India,Respiratory Diseases,1,1,37.0
970.0,NCT04518735,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),CORONA,Completed,COVID-19,,,,,,,Other: Antithrombotic Therapy (anticoagulant and/or antiplatelet) before admission for Covid19,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,All,"Child, Adult, Older Adult",1707.0,Other,Observational,2020-01-04,30/06/20,2020-06-30,19/08/20,19/08/20,"Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia",Spain,Respiratory Diseases,1,1,178.0
971.0,NCT04487951,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,"Other: Pro BNP , Vitamin D",Cairo University|Kasr El Aini Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,01/11/20,2021-01-01,27/07/20,27/07/20,"Kasr Alainy Cairo University, Cairo, Giza",Egypt,Respiratory Diseases,1,1,360.0
972.0,NCT04609839,FOLLOW-UP OF PATIENTS WITH COVID-19.,TeleRea'nCo,Recruiting,COVID-19,,,,,,,Other: Follow-up of patients with COVID-19,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-10-27,27/04/23,2023-04-27,30/10/20,30/10/20,"Hopitaux Universitaires de Strasbourg, Strasbourg",France,Respiratory Diseases,1,1,912.0
973.0,NCT04451889,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Device: miniprobe Alveoflex,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",All,"18 Years to 90 Years   (Adult, Older Adult)",15.0,Other,Interventional,2020-01-08,01/07/21,2021-01-09,30/06/20,24/07/20,"Federal Research Clinical Center FMBA Russia, Moscow",Russian Federation,Respiratory Diseases,1,1,367.0
974.0,NCT04345445,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,,Not yet recruiting,COVID-19,,,,,,,Drug: Tocilizumab|Drug: Methylprednisolone,University of Malaya,All,"18 Years and older   (Adult, Older Adult)",310.0,Other,Interventional,2020-04-15,31/10/20,2020-10-31,14/04/20,14/04/20,"University Malaya Medical Centre, Kuala Lumpur",Malaysia,Respiratory Diseases,1,1,199.0
975.0,NCT04362813,Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,CAN-COVID,Completed,COVID-19,,,,,,,Drug: Canakinumab|Drug: Placebo,Novartis Pharmaceuticals|Novartis,All,"12 Years and older   (Child, Adult, Older Adult)",451.0,Industry,Interventional,2020-04-30,16/09/20,2020-12-22,27/04/20,11/02/21,"Novartis Investigative Site, Birmingham, Alabama, United States|Novartis Investigative Site, Glendale, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, San Francisco, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Cleveland, Ohio, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Richmond, Virginia, United States|Novartis Investigative Site, Tacoma, Washington, United States|Novartis Investigative Site, Toulouse Cedex 4, France|Novartis Investigative Site, Bergamo, BG, Italy|Novartis Investigative Site, Cona, FE, Italy|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, S-Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Hospitalet de Llobregat, Barcelona, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, San Sebastian de los Reyes, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Barnet, United Kingdom|Novartis Investigative Site, Coventry, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London",United Kingdom,Respiratory Diseases,1,1,236.0
976.0,NCT04371315,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",,Recruiting,Corona Virus Infection,Pediatric Cancer,Adult Children,Cancer,,,,,St. Jude Children's Research Hospital,All,"up to 24 Years   (Child, Adult)",400.0,Other,Observational,2020-04-27,01/06/21,2022-06-30,01/05/20,29/06/20,"St. Jude Children's Research Hospital, Memphis, Tennessee",United States,"Respiratory Diseases, Cancers",1,4,794.0
977.0,NCT04392427,New Antiviral Drugs for Treatment of COVID-19,,Not yet recruiting,COVID-19,Drug Effect,,,,,,"Drug: Treatment group: will receive a combination of Nitazoxanide, Ribavirin and Ivermectin for a duration of seven days :",Mansoura University,All,"12 Years and older   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-01-10,01/05/22,2022-01-05,18/05/20,03/09/20,"Mansoura University, Mansoura, Select A State Or Province",Egypt,Respiratory Diseases,1,2,726.0
978.0,NCT04678193,COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy,COROMEC,Enrolling by invitation,COVID-19,,,,,,,Drug: Coromec Registry with ECL-19,"Aventyn, Inc.|Intel Corporation|Abrazo Health Network|Karolinska Institutet|ASU College of Health Solutions",All,"18 Years and older   (Adult, Older Adult)",27000.0,Industry|Other,Observational,2020-12-24,30/06/21,2022-06-30,21/12/20,12/01/21,"Multiple Locations, Phoenix, Arizona, United States|Multiple Locations, Bangalore, India|Multiple Locations, Stockholm",Sweden,Respiratory Diseases,1,1,553.0
979.0,NCT04694573,Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies,,Recruiting,COVID-19,Kidney Transplant; Complications,Kidney Transplant Failure and Rejection,Liver Transplant; Complications,Liver Transplant Failure and Rejection,,,,Heidelberg University,All,"18 Years to 75 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-12-28,28/12/21,2022-12-28,05/01/21,19/01/21,"Nierenzentrum Heidelberg, Heidelberg, DE",Germany,Respiratory Diseases,1,5,730.0
980.0,NCT04723589,Restoration of Endothelial Integrity in Patients With COVID-19 (RELIC),RELIC,Not yet recruiting,COVID-19,,,,,,,Biological: Thawed plasma,University of Alabama at Birmingham,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-02,01/12/21,2021-01-12,25/01/21,25/01/21,,,Respiratory Diseases,1,1,10.0
981.0,NCT04703608,Prevention and Treatment for COVID -19 (Severe Acute Respiratory Syndrome Coronavirus 2 SARS-CoV-2) Associated Severe Pneumonia in the Gambia,PaTS-COVID,Recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: ASP|Drug: Placebo,London School of Hygiene and Tropical Medicine,All,"5 Years and older   (Child, Adult, Older Adult)",1200.0,Other,Interventional,2021-01-22,01/03/22,2022-01-07,11/01/21,18/02/21,"Mrcg@Lshtm, Fajara",Gambia,Respiratory Diseases,1,1,350.0
982.0,NCT04522076,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,TARGET-VIP,"Active, not recruiting",COVID-19,,,,,,,,National Research Center for Preventive Medicine|National Medical and Surgical Center named after N.I. Pirogov of the Ministry of Healthcare of the Russian Federation|National Medical Research Center for Therapy and Preventive Medicine,All,"18 Years and older   (Adult, Older Adult)",1124.0,Other,Observational,2020-06-04,01/05/22,2022-01-05,21/08/20,21/08/20,"National Research Center for Preventive Medicine of the Ministry of Health, Moscow, Russian Federation|National Medical and Surgical Center named after N.I.Pirogov of the Ministry of Health of Russian Federation, Moscow",Russian Federation,Respiratory Diseases,1,1,580.0
983.0,NCT04757298,COVID-19 Treatment Cascade Optimization Study,,Recruiting,COVID-19,,,,,,,Behavioral: Navigation Services|Behavioral: Critical Dialogue|Behavioral: Brief Counseling|Behavioral: Referral and Digital Brochure,University of Illinois at Urbana-Champaign|North Jersey Community Research Initiative|National Institute on Minority Health and Health Disparities (NIMHD)|University of Michigan,All,"18 Years and older   (Adult, Older Adult)",670.0,Other|NIH,Interventional,2021-12-02,30/01/22,2022-12-31,17/02/21,18/02/21,"North Jersey Community Research Initiative, Newark, New Jersey",United States,Respiratory Diseases,1,1,394.0
984.0,NCT04658121,SARS-CoV-2/COVID-19 Prevalence Study,,Enrolling by invitation,COVID-19,,,,,,,,COVID-19 Prevention Network,All,"2 Months and older   (Child, Adult, Older Adult)",3920.0,Other,Observational,2021-04-02,30/05/21,2021-05-30,08/12/20,09/02/21,"Children's Hospital Colorado CRS, Aurora, Colorado, United States|U of Miami, IDRU at Jackson Memorial Hospital CRS, Miami, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|UIC Project Wish CRS, Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|John's Hopkins CRS, Baltimore, Maryland, United States|New Jersey Medical School CRS, Newark, New Jersey, United States|Harlem Prevention, New York, New York, United States|Bronx Prevention Center, New York, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Cincinnati CRS, Cincinnati, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States|St. Louis University VTEU-CAIMED-PHSU, Ponce",Puerto Rico,Respiratory Diseases,1,1,58.0
985.0,NCT04514003,The Corona and COVID-19 Study in Telemark and Agder,COVITA,Recruiting,COVID-19,,,,,,,,"Sykehuset Telemark|Sorlandet Hospital HF|Norwegian Institute of Public Health|London School of Hygiene and Tropical Medicine, UK|Leiden University|Aalborg University",All,"18 Years to 85 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-01-07,31/12/23,2035-12-31,14/08/20,18/08/20,"Telemark Hospital, Skien, Vestfold And Telemark",Norway,Respiratory Diseases,1,1,5837.0
986.0,NCT04378829,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",,Recruiting,COVID-19,Mean Platelet Volume,Platelet Destruction,,,,,"Diagnostic Test: Platelet count, platelet, mean platelet volume and platelet distribution Width in COVID-19",Konya Training and Research Hospital,All,"Child, Adult, Older Adult",40.0,Other,Observational,2020-12-09,11/10/20,2020-10-21,07/05/20,16/09/20,"Yasin Tire, Konya",Turkey,Respiratory Diseases,1,3,-49.0
987.0,NCT04780373,Prognostic Score in Covid-19,,Completed,COVID-19,,,,,,,Other: data collection,University of L'Aquila,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-02-27,30/04/20,2020-05-15,03/03/21,03/03/21,"University of L'Aquila, L'Aquila",Italy,Respiratory Diseases,1,1,78.0
988.0,NCT04412395,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,COVID-19_LF,Not yet recruiting,Corona Virus Infection,Middle East Respiratory Syndrome (MERS),Acute Respiratory Distress Syndrome,Coronavirus Infection,COVID-19,SARS-CoV 2,,Dietary Supplement: Lactoferrin (Apolactoferrin)|Drug: Placebo of excipient(s) will be administered,"National Research Centre, Egypt|Egyptian Military Medical Services",All,"18 Years to 80 Years   (Adult, Older Adult)",516.0,Other,Interventional,2021-01-06,31/08/21,2021-09-30,02/06/20,11/03/21,"National Research Center, Egypt (Clinical and Molecular Pharmacology), Cairo, Giza, Egypt|Clinmax CRO (Clinical Research Organization), Cairo, Egypt|Clinical Trial Unit National Research Center, Cairo, Egypt|Egyptian Military Medical Services (Hospitals), Cairo",Egypt,Respiratory Diseases,1,6,267.0
989.0,NCT04482699,RAPA-501-Allo Therapy of COVID-19-ARDS,,Recruiting,COVID-19,,,,,,,Biological: RAPA-501-Allo off-the-shelf Therapy of COVID-19|Other: Placebo,Rapa Therapeutics LLC|Hackensack Meridian Health,All,"18 Years and older   (Adult, Older Adult)",88.0,Industry|Other,Interventional,2020-12-30,30/12/21,2022-01-06,22/07/20,12/04/21,"Hackensack University Medical Center, Hackensack, New Jersey",United States,Respiratory Diseases,1,1,372.0
990.0,NCT04459533,Sparing in Neuromuscular Blockade in COVID 19 ICU,TOF-COVID,Completed,Neuromuscular Blockade,Human Characteristics,Complication of Medical Care,Intensive Care Unit Acquired Weakness,,,,Device: TOF protocol,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-01-06,01/06/20,2020-01-06,07/07/20,07/07/20,"Department of Anesthesiology and Intensive Care Medicine, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon",France,Others,0,4,0.0
991.0,NCT04513470,Allocetra-OTS in COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: Allocetra-OTS,Hadassah Medical Organization,All,"18 Years to 80 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-01-08,01/01/21,2021-01-02,14/08/20,19/10/20,"Hadassah Medical Center, Jerusalem",Israel,Respiratory Diseases,1,1,360.0
992.0,NCT04471051,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,"University of Colorado, Denver",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-04-30,01/04/21,2021-01-04,14/07/20,14/07/20,"Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|UCHealth Memorial Hospital North, Colorado Springs, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado",United States,Respiratory Diseases,1,1,249.0
993.0,NCT04734171,"Social Activity, Loneliness and Stigma During COVID-19 Outbreak",,Completed,COVID-19,Fear,Loneliness,,,,,Behavioral: Digital social activity video intervention|Behavioral: Informational sheet|Behavioral: Stigma awareness video intervention,Columbia University|New York State Psychiatric Institute,All,"18 Years to 70 Years   (Adult, Older Adult)",1200.0,Other,Interventional,2020-02-04,16/04/20,2020-04-16,02/02/21,02/02/21,"Columbia University, New York, New York",United States,Respiratory Diseases,1,3,72.0
994.0,NCT04323228,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,ONSCOVID19,Recruiting,COVID-19,,,,,,,Dietary Supplement: Oral supplement enriched in antioxidants|Dietary Supplement: cellulose-containing placebo capsules,King Saud University,All,"18 Years to 65 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-09,01/12/20,2020-12-30,26/03/20,22/09/20,"Prince Mohamed BinAbdulaziz Hospital, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,356.0
995.0,NCT04785157,Neurotropism and Neuroinflammation in COVID-19 Patients With Delirium.,BRAINSTORM,Not yet recruiting,COVID-19,Delirium,Post-traumatic Stress Disorder,,,,,Biological: serology testing profiles description|Biological: immune response characterization|Other: in vivo brain PET-TSPO acquisitions|Other: brain MRI assessment|Behavioral: neurocognitive assessment,"University Hospital, Toulouse|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Observational,2021-01-04,01/08/22,2022-01-08,05/03/21,05/03/21,"University Hospital of Toulouse, Toulouse, France|CHRU Tours, Tours",France,"Mental Health, Respiratory Diseases",1,3,369.0
996.0,NCT04836806,Cetirizine and Famotidine for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Cetirizine and Famotidine|Drug: Placebo,Emory University,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2021-01-04,01/07/22,2022-01-07,08/04/21,08/04/21,"Emory University Hospital at Wesley Woods COVID-19 Testing Facility, Atlanta, Georgia, United States|Emory Healthcare Network Peachtree Immediate Care COVID-19 Testing Centers, Atlanta, Georgia",United States,Respiratory Diseases,1,1,368.0
997.0,NCT04627623,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,EpiSARS2,Recruiting,COVID-19,Respiratory Tract Infections,Severe Acute Respiratory Syndrome,Corona Virus Infection,RNA Virus Infections,Virus Disease,Respiratory Tract Disease,Diagnostic Test: IgM and IgG antibodies assay,Medical University of Silesia,All,"Child, Adult, Older Adult",6000.0,Other,Observational,2020-06-22,22/03/21,2021-04-22,13/11/20,17/11/20,"Diagnostyka sp zoo, Katowice",Poland,Respiratory Diseases,1,7,304.0
998.0,NCT04575532,Detection of COVID-19 Decompensation,DeCODe,Enrolling by invitation,COVID-19,,,,,,,"Device: Use of the pinpointIQ solution (physIQ, Inc.)","physIQ, Inc.|National Institute for Biomedical Imaging and Bioengineering (NIBIB)|National Cancer Institute (NCI)|University of Illinois at Chicago",All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|NIH|Other,Observational,2020-05-10,15/01/21,2021-01-22,05/10/20,05/10/20,"University of Illinois Hospital and Health Sciences System, Chicago, Illinois",United States,Respiratory Diseases,1,1,257.0
999.0,NCT04745533,COVID-19 Contact Study by Antigen Detection Test,DETAC,Not yet recruiting,SARS-CoV Infection,,,,,,,Diagnostic Test: Antigen detection test,Juan Fernando Masa Jiménez|University of Extremadura,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2021-02-15,30/04/21,2021-06-30,09/02/21,11/02/21,,,Respiratory Diseases,1,1,135.0
1000.0,NCT04643522,Semen Parameters and COVID-19 in Infertile Men,,Completed,"Sperm Count, Low",Hormone Disturbance,COVID-19,,,,,Other: Clinical assessment,Ankara City Hospital Bilkent,Male,18 Years to 40 Years   (Adult),21.0,Other,Observational,2020-07-01,05/10/20,2020-10-10,25/11/20,30/11/20,"Ankara City Hospital, Ankara",Turkey,Respiratory Diseases,1,3,101.0
1001.0,NCT04341207,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,ONCOVID,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,"Gustave Roussy, Cancer Campus, Grand Paris",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-03-04,01/04/22,2022-01-04,10/04/20,10/04/20,"Gustave Roussy, Villejuif, Val De Marne",France,Respiratory Diseases,1,1,671.0
1002.0,NCT04651413,PCR Cycle Threshold Values and COVID-19 Outcomes,,Recruiting,COVID-19,,,,,,,Diagnostic Test: PCR Value,University Hospitals of North Midlands NHS Trust,All,"Child, Adult, Older Adult",800.0,Other,Observational,2020-11-24,31/03/21,2021-03-31,03/12/20,04/12/20,"University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, Staffordshire",United Kingdom,Respiratory Diseases,1,1,127.0
1003.0,NCT04401254,Recovery of Patients From COVID-19 After Critical Illness,COVID-Recovery,Recruiting,COVID-19,Critical Illness,,,,,,,Australian and New Zealand Intensive Care Research Centre|The Alfred,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-07,01/12/21,2022-01-04,26/05/20,23/10/20,"Canberra Hospital, Garran, Australian Capital Territory, Australia|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, Saint Leonards, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|The Prince Charles Hospital, Chermside, Queensland, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Ipswich Hospital, Ipswich, Queensland, Australia|Redcliffe Hospital, Redcliffe, Queensland, Australia|Gold Coast Hospital, Southport, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Launceston Hospital, Launceston, Tasmania, Australia|Casey Hospital, Berwick, Victoria, Australia|Box Hill Hospital (Eastern Health), Box Hill, Victoria, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Dandenong Hospital, Dandenong, Victoria, Australia|Northern Health, Epping, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Footscray Hospital, Footscray, Victoria, Australia|Frankston Hospital, Frankston, Victoria, Australia|Austin Hospital, Heidelberg, Victoria, Australia|Cabrini Health, Malvern, Victoria, Australia|Australian New Zealand Intensive Care Research Centre, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Alfred Hospital, Prahran, Victoria, Australia|Epworth Richmond, Richmond, Victoria, Australia|Sunshine Hospital, St Albans, Victoria",Australia,"Cardiovascular Diseases, Respiratory Diseases",1,2,728.0
1004.0,NCT04553575,CoViD-19 Patient in Reims University Hospital in March to April 2020,COVID-Reims,Recruiting,Coronavirus Infections,,,,,,,Biological: serology,CHU de Reims,All,"Child, Adult, Older Adult",499.0,Other,Observational,2020-09-25,01/09/22,2022-01-09,17/09/20,05/10/20,"Chu Reims, Reims",France,Respiratory Diseases,1,1,471.0
1005.0,NCT04756128,Impact of Colchicine and Low-dose Naltrexone on COVID-19,COLTREXONE,Enrolling by invitation,COVID-19,,,,,,,Drug: Colchicine 0.6 mg|Drug: Naltrexone,HealthPartners Institute|Park Nicollet Foundation,All,"18 Years and older   (Adult, Older Adult)",164.0,Other,Interventional,2021-01-25,31/12/21,2021-12-31,16/02/21,18/02/21,"Park Nicollet Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota",United States,Respiratory Diseases,1,1,340.0
1006.0,NCT04405492,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",ERap-COV,Not yet recruiting,SARS-CoV 2,COVID-19,,,,,,"Device: Taking blood samples (capillary and venous), saliva sampling and nasopharyngeal sampling.|Device: Capillary and salivary sampling",Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1210.0,Other,Interventional,2020-05-25,25/03/21,2021-03-25,28/05/20,28/05/20,,,Respiratory Diseases,1,2,304.0
1007.0,NCT04374565,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,,"Active, not recruiting",Corona Virus Infection,SARS-CoV 2,SARS Pneumonia,Pneumonia,,,,Drug: High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma,University of Virginia,All,"18 Years and older   (Adult, Older Adult)",29.0,Other,Interventional,2020-05-05,05/04/21,2021-05-04,05/05/20,21/08/20,"University of Virginia Medical Center, Charlottesville, Virginia, United States|University of Virginia, Charlottesville, Virginia",United States,Respiratory Diseases,1,4,364.0
1008.0,NCT04351529,Austrian COVID-19 Registry,,Recruiting,Infectious Disease,COVID-19,,,,,,,Arbeitsgemeinschaft medikamentoese Tumortherapie,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-04,01/12/21,2021-01-12,17/04/20,30/11/20,"LKH Feldkirch: Innere Medizin II/ Interne E (Hämatologie und Onkologie), Feldkirch, Austria|Kepler Universitätsklinikum Linz, Med. Campus III., Klinik für Lungenheilkunde / Pneumologie, Linz, Austria|IIIrd Medical Department, Private Medical University Hospital Salzburg, Salzburg, Austria|KH Zams: Innere Medizin Internistische Onkologie und Hämatologie, Zams",Austria,Respiratory Diseases,1,2,374.0
1009.0,NCT04510623,Host Response Mediators in Coronavirus (COVID-19) Infection,ARBS CORONA I,Recruiting,COVID-19,SARS-CoV2,,,,,,Other: ARBs and/or ACE inhibitors|Other: Usual Care,University of British Columbia|Canadian Institutes of Health Research (CIHR)|British Columbia Centre for Disease Control|McGill University Health Centre/Research Institute of the McGill University Health Centre|University of Toronto|University of Ottawa|University of Calgary|University of Alberta|University of Victoria|Wuhan University|Peking Union Medical College|University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-17,30/06/21,2022-06-30,12/08/20,12/08/20,"University of Calgary - Foothills, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|St Pauls Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|William Osler Health System, Brampton, Ontario, Canada|Queens University, Kingston, Ontario, Canada|Humber River Hospital, North York, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|St Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Center, Montréal, Quebec, Canada|Université de Sherbrooke, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,2,835.0
1010.0,NCT04450017,Clinical Features of Severe Patients With COVID-19,,Recruiting,SARS-CoV2,,,,,,,"Diagnostic Test: The demographic, clinical, laboratory, and instrumental data","Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",All,"18 Years to 90 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-06-04,01/07/20,2020-01-08,29/06/20,29/06/20,"Federal Research Clinical Center of Federal Medical & Biological Agency, Moscow",Russian Federation,Respiratory Diseases,1,1,-148.0
1011.0,NCT04769700,"Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19",,Recruiting,"Breast Feeding, Exclusive",Post Partum Depression,COVID-19,,,,,Behavioral: Edinburgh Postnatal Depression Scale|Behavioral: Breast Feeding Adherence|Behavioral: Fear of Covid-19 Scale,Instituto Mexicano del Seguro Social,Female,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2021-01-01,01/06/21,2021-01-06,24/02/21,24/02/21,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco",Mexico,"Mental Health, Respiratory Diseases",1,3,5.0
1012.0,NCT04649827,A Clinical Trial for Hospitalized Patients With COVID-19 in Ceará: ResCOVID Study,ResCOVID,Recruiting,COVID-19,,,,,,,Other: Clinical Observation,Escola de Saúde Pública do Ceará,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-02-04,30/06/20,2021-12-30,02/12/20,02/12/20,"Hospital Leonardo Da Vinci, Fortaleza, Ceara",Brazil,Respiratory Diseases,1,1,695.0
1013.0,NCT04252274,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,DC-COVID-19,Recruiting,"Pneumonia, Pneumocystis",Coronavirus,,,,,,Drug: Darunavir and Cobicistat,Shanghai Public Health Clinical Center,All,"Child, Adult, Older Adult",30.0,Other,Interventional,2020-01-30,31/08/20,2020-12-31,05/02/20,13/04/20,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai",China,Respiratory Diseases,1,2,336.0
1014.0,NCT04391829,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,COVIDSPERM,Recruiting,COVID-19,Sars-CoV2,Corona Virus Infection,Semen,,,,Diagnostic Test: Ejaculated semen sample,Universitair Ziekenhuis Brussel,Male,18 Years to 50 Years   (Adult),20.0,Other,Interventional,2020-08-31,31/08/21,2021-08-31,18/05/20,28/10/20,"UZ Brussel, Brussels",Belgium,Respiratory Diseases,1,4,365.0
1015.0,NCT04359459,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,CIPOLLINI,Not yet recruiting,COVID-19,,,,,,,,University Medical Center Groningen,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-01-06,01/06/22,2022-01-06,24/04/20,27/04/20,,,Respiratory Diseases,1,1,731.0
1016.0,NCT04352751,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,,Recruiting,COVID-19,,,,,,,Other: convalescent plasma,Hilton Pharma,All,18 Years to 55 Years   (Adult),2000.0,Industry,Interventional,2020-01-05,01/04/21,2021-01-04,20/04/20,29/09/20,"National Institute of Blood Diseases and Bone Marrow Transplantation (NIBD), Karachi, Sindh",Pakistan,Respiratory Diseases,1,1,365.0
1017.0,NCT04367207,African Covid-19 Critical Care Outcomes Study,,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,,University of Cape Town|University of KwaZulu,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-05,01/12/20,2020-12-31,29/04/20,10/09/20,"Groote Schuur Hospital, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,1,361.0
1018.0,NCT04363450,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),HCQPreP,Recruiting,COVID-19,Corona Virus Infection,Wuhan Coronavirus,Prophylaxis,Healthcare Worker,Sars-CoV2,Hydroxychloroquine,Drug: Hydroxychloroquine|Drug: Placebo,Louisiana State University Health Sciences Center in New Orleans|Lafayette General Health|University of Louisiana at Lafayette,All,"18 Years and older   (Adult, Older Adult)",1700.0,Other,Interventional,2020-04-27,31/03/21,2021-01-06,27/04/20,02/09/20,"Lafayette General Medical Center, Lafayette, Louisiana, United States|University Hospital and Clinics, Lafayette, Louisiana",United States,Respiratory Diseases,1,7,254.0
1019.0,NCT04373486,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,COVID-APE,Completed,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Observational,2020-03-03,30/04/20,2020-01-05,04/05/20,11/01/21,"Service de Radiologie B - NHC, Strasbourg",France,Respiratory Diseases,1,1,-58.0
1020.0,NCT04715243,"Comparison of High Flow Nasal Cannula (HFNC), Face-mask Non-Invasive Ventilation (NIV) & Helmet NIV in COVID-19 ARDS Patients",NIV COVID19,Recruiting,COVID-19,,,,,,,Device: High flow nasal cannula (HFNC)|Device: Helmet NIV|Device: Face-mask NIV,Sultan Qaboos University,All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Interventional,2021-01-01,30/04/21,2021-07-30,20/01/21,26/01/21,"Sultan Qaboos University Hospital, Muscat",Oman,Respiratory Diseases,1,1,210.0
1021.0,NCT04474249,Follow-up of Critical COVID-19 Patients,FUP-COVID,Recruiting,COVID-19,ARDS,AKI,Circulatory Failure,Coagulation Disorder,Inflammatory Response,,,Uppsala University|Uppsala University Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-06-25,01/12/22,2022-01-12,16/07/20,20/07/20,"Uppsala University Hospital, Uppsala",Sweden,Respiratory Diseases,1,6,566.0
1022.0,NCT04539834,Electrolyte State in Patients With COVID-19,,"Active, not recruiting",Electrolyte Imbalance,,,,,,,Other: electrolytes,Zagazig University,All,"18 Years to 80 Years   (Adult, Older Adult)",52.0,Other,Observational,2020-01-05,01/08/20,2020-01-10,07/09/20,07/09/20,"Zagazig University, Zagazig",Egypt,Others,0,1,5.0
1023.0,NCT04492371,COVID-19 Infection and Multiple Myeloma,EMN-COVID,Recruiting,Multiple Myeloma,COVID-19,Corona Virus Infection,,,,,,European Myeloma Network|Fondazione EMN Italy Onlus,All,"18 Years to 99 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-01-07,01/07/21,2021-01-07,30/07/20,30/07/20,"General Hopspital Vienna/Medical University, Vienna, Austria|UCL Saint-Luc, Brussels, Belgium|University Hospital Ostrava, Ostrava, Czechia|University Hospital Würzburg, Würzburg, Germany|Alexandra Clinical Terapeutics, Athens, Greece|AOU Consorziale Policlinico di Bari, Bari, Italy|Amsterdam UMC, Amsterdam, Netherlands|St James's University Hospital, Leeds",United Kingdom,Respiratory Diseases,1,3,366.0
1024.0,NCT04685512,Effect of Tenofovir/Emtricitabine in Patients Recently Infected With SARS-COV2 (Covid-19) Discharged Home,AR0-CORONA,Recruiting,COVID-19,,,,,,,Drug: tenofovir disoproxil and emtricitabine,"University Hospital, Caen",All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-11-18,01/04/21,2021-01-04,28/12/20,28/12/20,"Caen University Hospital, Caen, Calvados, France|Regional Hospital, Orléans",France,Respiratory Diseases,1,1,47.0
1025.0,NCT04812327,Capturing Infectious COVID-19 Asymptomatic Cases in Singapore,,Not yet recruiting,COVID-19,SARS CoV-2,,,,,,Diagnostic Test: BD Veritor Plus System for Rapid Detection of SARS CoV-2|Diagnostic Test: rt-PCR|Diagnostic Test: viral culture,"Becton, Dickinson and Company",All,"21 Years and older   (Adult, Older Adult)",150.0,Industry,Observational,2021-01-06,01/09/21,2021-01-11,23/03/21,23/03/21,"Changi General Hospital, Singapore",Singapore,Respiratory Diseases,1,2,5.0
1026.0,NCT04333225,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine,Baylor Research Institute,All,"18 Years to 75 Years   (Adult, Older Adult)",228.0,Other,Interventional,2020-03-04,30/06/20,2020-06-30,03/04/20,26/01/21,"Baylor University Medical Center, Dallas, Texas",United States,Respiratory Diseases,1,1,118.0
1027.0,NCT04603677,Northern Colorado COVID-19 Biobank,NoCo-CoBio,Enrolling by invitation,COVID-19,,,,,,,,Colorado State University|University of Colorado Health,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-08-07,30/07/22,2022-07-30,27/10/20,27/10/20,"Colorado State University, Fort Collins, Colorado, United States|Poudre Valley Hospital, UCHealth, Fort Collins, Colorado, United States|Greeley Hospital, UCHealth, Greeley, Colorado, United States|Medical Center of the Rockies, UCHealth, Loveland, Colorado",United States,Respiratory Diseases,1,1,722.0
1028.0,NCT04463849,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,COBETOX,Recruiting,COVID-19,BETA-CELL FUNCTION,,,,,,Diagnostic Test: Stimulation test with arginine infusion in order to verify the possible existence of damage to the beta cell function induced by COVID-19 infection,University of Milan|Luigi Sacco University Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-06-30,30/06/21,2021-06-30,09/07/20,17/02/21,"Sacco University Hospital, Milan, MI",Italy,Respiratory Diseases,1,2,365.0
1029.0,NCT04649320,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,,Recruiting,COVID-19,,,,,,,Other: questionnaire,Medical University Innsbruck,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-11-23,31/12/20,2020-12-31,02/12/20,02/12/20,"Medical University of Innsbruck, Innsbruck, Tyrol",Austria,Respiratory Diseases,1,1,38.0
1030.0,NCT04355533,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,PED-COVID,Recruiting,COVID-19,,,,,,,Biological: serology test|Biological: nasopharyngeal swab|Biological: rectal swab|Biological: saliva sample,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France|Commissariat a l'energie atomique et aux energies alternatives|Institut Pasteur",All,"Child, Adult, Older Adult",1000.0,Other|Industry,Interventional,2020-07-29,01/07/22,2022-01-12,21/04/20,26/03/21,"Hôpital necker Enfants-Malades, ¨Paris",France,Respiratory Diseases,1,1,532.0
1031.0,NCT04431908,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,,Recruiting,COVID-19,,,,,,,Device: olfactory device,Yale University,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-06-15,01/09/20,2020-01-10,16/06/20,04/08/20,"Yale New Haven Hospital, New Haven, Connecticut",United States,Respiratory Diseases,1,1,-157.0
1032.0,NCT04370249,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,VIRUS,Completed,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Other: pulmonary ultrasound,Nantes University Hospital|WINFOCUS-France,All,"18 Years and older   (Adult, Older Adult)",313.0,Other,Observational,2020-09-04,31/08/20,2020-08-31,30/04/20,24/02/21,"Chu de Nantes, Nantes",France,Respiratory Diseases,1,2,-4.0
1033.0,NCT04841759,The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-COVID-19 Fatigue Syndrome,,Recruiting,COVID-19,,,,,,,Other: Exercise,Medical University of Vienna,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,30/09/21,2021-10-31,12/04/21,12/04/21,"Medical University of Vienna, Vienna",Austria,Respiratory Diseases,1,1,300.0
1034.0,NCT04364594,COVID-19 Search in Conjunctival Cells,COVID-T,Completed,COVID-19,Pulmonary Disease,,,,,,Diagnostic Test: conjunctival swab,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-03-26,24/04/20,2020-05-30,28/04/20,23/07/20,"Maria Cristina Savastano, Roma",Italy,Respiratory Diseases,1,2,65.0
1035.0,NCT04426344,Core Warming of COVID-19 Patients,,Withdrawn,COVID-19,,,,,,,Device: ensoETM device,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-10,01/12/20,2020-01-12,11/06/20,19/10/20,"Barnes-Jewish Hospital, Saint Louis, Missouri",United States,Respiratory Diseases,1,1,2.0
1036.0,NCT04590053,"Allocetra-OTS in COVID-19, Phase II",,Recruiting,COVID-19,,,,,,,Biological: Allocetra-OTS,Hadassah Medical Organization|Barzilai Medical Center|Tel-Aviv Sourasky Medical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-10-20,01/02/21,2021-01-03,19/10/20,22/10/20,"Barzilai Medical Center, Ashkelon, Israel|Hadassah Medical Center, Jerusalem, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv",Israel,Respiratory Diseases,1,1,75.0
1037.0,NCT04516512,Assessment of SARS-CoV-2 Seroprevalence in Detention,COVIDET,Not yet recruiting,COVID-19,,,,,,,Biological: Blood draw,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 80 Years   (Adult, Older Adult)",2500.0,Other,Interventional,2020-01-09,01/01/21,2021-01-01,18/08/20,18/08/20,,,Respiratory Diseases,1,1,358.0
1038.0,NCT04508556,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,COVID,Completed,COVID-19,,,,,,,Device: Breath Biopsy face masks with removable filters and fitted PVA strip|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: oropharyngeal swabs,Owlstone Ltd|OLVG|Maastricht University,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Observational,2020-09-30,19/12/20,2020-12-19,11/08/20,01/04/21,"OLVG, Amsterdam",Netherlands,Respiratory Diseases,1,1,80.0
1039.0,NCT04330586,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Ciclesonide Metered Dose Inhaler [Alvesco],Korea University Guro Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",66.0,Other,Interventional,2020-01-04,31/03/21,2021-03-31,01/04/20,05/02/21,"Korea University Guro Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,452.0
1040.0,NCT04592055,The Effect of COVID-19 on Diabetes Mellitus,COVID-19-DM,Recruiting,Diabetes Mellitus,COVID-19,,,,,,,Uşak University,All,"18 Years to 80 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-03-20,15/10/20,2020-01-11,19/10/20,19/10/20,"Usak University Training and Research Hospital, Usak",Turkey,"Respiratory Diseases, Metabolic Disorders",1,2,-69.0
1041.0,NCT04654325,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,COVIDEYE,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: conjunctival swab,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1280.0,Other,Interventional,2020-01-12,01/12/21,2021-01-12,04/12/20,04/12/20,,,Respiratory Diseases,1,1,366.0
1042.0,NCT04646655,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,EMOS-COVID,Recruiting,COVID-19,Thrombosis,,,,,,Drug: Enoxaparin,ASST Fatebenefratelli Sacco|Massimo Arquati|Riccardo Colombo|Umberto Russo|Manuela Nebuloni|Spinello Antinori,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-07-27,31/05/21,2021-07-31,30/11/20,30/11/20,"ASST Fatebenefratelli Sacco, Milan",Italy,Respiratory Diseases,1,2,369.0
1043.0,NCT04610567,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),Nano-COVID19,Recruiting,Coronavirus,Inflammation,COVID-19,,,,,Drug: Methotrexate-LDE phase 1|Drug: Methotrexate-LDE phase 2|Drug: Placebo-LDE phase 2,University of Sao Paulo General Hospital|Hospital Santa Marcelina,All,"18 Years to 85 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-27,15/03/21,2021-07-15,30/10/20,14/01/21,"Heart Institute (InCor) - University of São Paulo Medical School, São Paulo, Brazil, São Paulo, SP, Brazil|Hospital Santa Marcelina, São Paulo, SP, Brazil|Institute Prevent Senior, São Paulo, SP",Brazil,Respiratory Diseases,1,3,261.0
1044.0,NCT04433364,COPE - COVID-19 in Pregnancy and Early Childhood,COPE,Recruiting,Sars-CoV2,COVID-19,Pregnancy Complications,Pregnancy Preterm,Pregnancy in Diabetic,Neonatal Infection,,"Other: biological samples, questionnaires and interviews","Sahlgrenska University Hospital, Sweden",Female,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-02-06,02/06/21,2041-02-06,16/06/20,16/06/20,"Falu Hospital, Falun, Dalarna, Sweden|Halmstad lasarett, Halmstad, Halland, Sweden|Varbergs sjukhus, Varberg, Halland, Sweden|Helsingborgs lasarett, Helsingborg, Skåne, Sweden|Skåne Universitetssjukhus, Lund, Skåne, Sweden|Eskiltuna hospital, Eskilstuna, Södermanland, Sweden|Boras hospital, Boras, VGR, Sweden|Sahlgrenska Univeristy Hospital, Gothenburg, VGR, Sweden|Ryhovs sjukhus, Jönköping, Sweden|Kalmar Lasarett, Kalmar, Sweden|Karlstad lasarett, Karlstad, Sweden|Kristiandstad länssjukhus, Kristianstad, Sweden|Skaraborgs sjukhus Skövde, Skövde, Sweden|BB Stockholm, Stockholm, Sweden|Danderyd, Stockholm, Sweden|Karolinska University Hospital Solna, Stockholm, Sweden|Karolinska University Hospital- Huddinge, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden|Södertälje, Stockholm, Sweden|Sundsvall, Sundsvall, Sweden|Umeå University Hospital, Umeå, Sweden|Uppsala University Hospital, Uppsala, Sweden|Västerås, Västerås, Sweden|Ystad, Ystad, Sweden|Örebro University Hospital, Örebro, Sweden|Linköping University Hospital, Linköping, Östergötland, Sweden|Vrinnevisjukhuset, Norrköping, Östergötland",Sweden,Respiratory Diseases,1,6,7671.0
1045.0,NCT04505709,"Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",,Enrolling by invitation,COVID-19,,,,,,,,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|Hospital Universitario 12 de Octubre|Fundacion Investigacion Biomedica Hospital 12 de Octubre|Hospital Universitario Fundacion Jimenez Diaz|Hospital Universitario Infanta Elena|Hospital Universitario Virgen de la Arrixaca|Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca,All,"18 Months and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-08,01/08/21,2021-01-08,10/08/20,10/08/20,"Fundacion Jimenez Diaz, Madrid",Spain,Respiratory Diseases,1,1,366.0
1046.0,NCT04428008,Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients,Ta1,Recruiting,COVID-19,,,,,,,Drug: Thymalfasin,"Inova Health System|Davita Clinical Research|Clinical Research Consultants, LLC",All,"60 Years and older   (Adult, Older Adult)",240.0,Other|Industry,Interventional,2021-12-01,01/04/21,2022-01-01,11/06/20,13/01/21,"Clinical Research Consultants, Kansas City, Kansas",United States,Respiratory Diseases,1,1,31.0
1047.0,NCT04514302,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Placebo|Drug: Anti-SARS-CoV-2 equine immunoglobulin fragments (INOSARS),Hospital San Jose Tec de Monterrey,All,"18 Years and older   (Adult, Older Adult)",51.0,Other,Interventional,2020-10-20,20/02/21,2021-06-20,14/08/20,14/08/20,"Hospital San José, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,1,243.0
1048.0,NCT04341415,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,SOS-COVID19,Terminated,COVID-19,SARS-CoV Infection,,,,,,Procedure: Auricular neuromodulation|Procedure: Control,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",31.0,Other,Interventional,2020-09-04,20/11/20,2021-01-15,10/04/20,13/04/21,"Centre Hospitalier Simone Veil, Beauvais, France|Fondation Adolphe de Rothschild, Paris",France,Respiratory Diseases,1,2,133.0
1049.0,NCT04447131,Effect of COVID-19 on Platelet Aggregation,,Recruiting,COVID-19,COVID-19,,,,,,Other: venipuncture in peripheral vein,University of Sao Paulo|Fundação de Amparo à Pesquisa do Estado de São Paulo,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-29,30/06/21,2021-07-30,25/06/20,05/11/20,"Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo",Brazil,Respiratory Diseases,1,2,457.0
1050.0,NCT04329611,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,,Terminated,COVID-19,,,,,,,Drug: Hydroxychloroquine,Dr. Michael Hill|Alberta Health Services|University of Alberta|University of Calgary|Calgary Health Trust|Alberta Innovates Health Solutions|Government of Alberta,All,"18 Years and older   (Adult, Older Adult)",148.0,Other,Interventional,2020-04-13,20/07/20,2020-07-20,01/04/20,31/07/20,"University of Calgary/Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta",Canada,Respiratory Diseases,1,1,98.0
1051.0,NCT04407390,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,NR-COVID19,Recruiting,COVID-19,,,,,,,Dietary Supplement: Nicotinamide riboside|Dietary Supplement: Placebo,University of Copenhagen|Bispebjerg Hospital|Elysium Health,All,70 Years and older   (Older Adult),100.0,Other|Industry,Interventional,2020-01-06,01/05/21,2022-01-05,29/05/20,02/06/20,"Bispebjerg Hospital, Copenhagen NV",Denmark,Respiratory Diseases,1,1,730.0
1052.0,NCT04313023,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,,Recruiting,COVID-19,,,,,,,Drug: PUL-042 Inhalation Solution|Drug: Placebo,"Pulmotect, Inc.|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",200.0,Industry|U.S. Fed,Interventional,2020-09-06,01/05/21,2021-01-06,18/03/20,17/03/21,"University of California Irvine, Orange, California, United States|Premier Urgent Care of California, San Bernardino, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Invesclinic US LLC, Fort Lauderdale, Florida, United States|Luminous Cinical Research- South Florida Urgent Care, Miami, Florida, United States|DBC Research, Tamarac, Florida, United States|Affinity Clinical Research, LLC, Tampa, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Willis-Knighton Physcian Network, Bossier City, Louisiana, United States|Englewood Health, Englewood, New Jersey, United States|Ascension St John, Bartlesville, Oklahoma, United States|Ascension St. John, Tulsa, Oklahoma, United States|Invesclinic US LLC, Edinburg, Texas, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas",United States,Respiratory Diseases,1,1,122.0
1053.0,NCT04753762,Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection,IMACovid,Recruiting,COVID-19,Cardiac Complication,,,,,,,"Central Hospital, Nancy, France",All,"18 Years to 79 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-01-03,01/01/22,2022-01-11,15/02/21,15/02/21,"Laura FILIPPETTI, Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,2,739.0
1054.0,NCT04347876,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,,Recruiting,COVID-19,BCG Vaccination,,,,,,Diagnostic Test: Tuberculin test,Assiut University,All,"12 Years to 80 Years   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-11-04,16/06/20,2020-06-30,15/04/20,15/04/20,"AssiutU, Assiut",Egypt,Respiratory Diseases,1,2,-127.0
1055.0,NCT04689672,Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity,COVID-PEGALUS,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lung ultrasound,IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-12-16,10/05/21,2021-10-05,30/12/20,30/12/20,"IRCCS San Raffaele, Milan, MI",Italy,Respiratory Diseases,1,1,293.0
1056.0,NCT04549376,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,VEP-COV,Recruiting,COVID-19,,,,,,,Drug: Povidone-Iodine 0.4% NI|Drug: Povidone-Iodine 0.5% NI|Drug: Povidone-Iodine 0.6% NI|Drug: Povidone-Iodine 0.5% NS|Drug: Povidone-Iodine 0.6% NS|Other: Placebo comparator: DW-NI|Other: Placebo comparator: DW-NS,"Pi Research Consultancy Center, Bangladesh|Dhaka Medical College",All,"15 Years to 90 Years   (Child, Adult, Older Adult)",200.0,Other,Interventional,2020-01-07,20/10/20,2020-10-30,16/09/20,16/09/20,"Dhaka Medical College, Dhaka",Bangladesh,Respiratory Diseases,1,1,297.0
1057.0,NCT04568044,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,ImmunoCOVID,Recruiting,COVID-19,Pregnancy Related,"Influenza, Human",,,,,Procedure: Blood sample,Imperial College London,All,18 Years to 60 Years   (Adult),128.0,Other,Observational,2020-09-16,31/12/22,2023-03-07,29/09/20,17/03/21,"Chelsea and Westminster NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London",United Kingdom,"Infectious Diseases, Respiratory Diseases",1,3,902.0
1058.0,NCT04689724,Covid-19 Airway Management,,Recruiting,COVID-19,,,,,,,,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-10-08,01/02/21,2022-01-05,30/12/20,30/12/20,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,1,454.0
1059.0,NCT04534725,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,C-SMART,Recruiting,Cancer,COVID-19,Respiratory Viral Infection,,,,,Drug: Interferon alfa|Drug: Selinexor|Drug: Lenzilumab,"Peter MacCallum Cancer Centre, Australia",All,"18 Years and older   (Adult, Older Adult)",2282.0,Other,Interventional,2020-12-17,01/12/21,2021-01-12,01/09/20,05/01/21,"Peter MacCallum Cancer Centre, Melbourne, Victoria",Australia,"Respiratory Diseases, Cancers",1,3,26.0
1060.0,NCT04401410,Anti-SARS Cov-2 T Cell Infusions for COVID 19,BATIT,Recruiting,SARS-CoV 2,Viral Infection,COVID-19,,,,,Biological: Dose Finding Phase (MTD)|Biological: Partially HLA-matched SARS-CoVSTs|Other: Routine care (no SARS-CoVSTs),"Baylor College of Medicine|Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital System|AlloVir",All,"18 Years and older   (Adult, Older Adult)",58.0,Other|Industry,Interventional,2020-04-11,15/08/21,2021-08-15,26/05/20,01/04/21,"Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,3,491.0
1061.0,NCT04422444,Post Intensive Care Syndrome in COVID19 Patients,PICS-COVID19,Recruiting,COVID-19,Post Intensive Care Unit Syndrome,,,,,,Diagnostic Test: Questionnaires,Corporacion Parc Tauli,All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-06,01/05/21,2022-01-06,09/06/20,12/06/20,"Corporació Parc Taulí, Sabadell, Barcelona",Spain,Respiratory Diseases,1,2,731.0
1062.0,NCT04471636,Telemedicine in Outpatient Covid-19 Patients,COVID-SMART,Recruiting,COVID-19,Cardiovascular Risk Factor,,,,,,Device: Withings ScanWatch,"Ludwig-Maximilians - University of Munich|Gesundheitsreferat (GSR), Landeshauptstadt München|Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-09-18,01/11/21,2021-01-12,15/07/20,14/04/21,"LMU Klinikum, Munich, BY",Germany,Respiratory Diseases,1,2,116.0
1063.0,NCT04422977,Serological Study of the Exposure of Personnel to Sars-cov-2,SEROPHUGAC,Not yet recruiting,Sars-CoV2,,,,,,,Diagnostic Test: Sars-Cov-2 serology,Centre Hospitalier Saint Joseph Saint Luc de Lyon,All,"18 Years to 70 Years   (Adult, Older Adult)",900.0,Other,Interventional,2020-08-06,30/06/20,2020-06-30,09/06/20,09/06/20,,,Respiratory Diseases,1,1,-37.0
1064.0,NCT04515108,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,,Completed,"Pregnancy, Infections in",COVID-19,,,,,,Other: Clinical assessment,Ankara City Hospital Bilkent,Female,18 Years to 42 Years   (Adult),108.0,Other,Observational,2020-10-03,05/08/20,2020-10-08,17/08/20,17/08/20,"Ankara City Hospital, Ankara",Turkey,Respiratory Diseases,1,2,5.0
1065.0,NCT04376658,Quality of Life and Long-term Outcomes After Hospitalization for COVID-19,,Recruiting,Quality of Life,Long-term Outcomes,Coronavirus Infection,,,,,Other: COVID-19,Hospital Moinhos de Vento|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital do Coracao|Hospital Alemão Oswaldo Cruz|Beneficência Portuguesa de São Paulo|Brazilian Clinical Research Institute|Brazilian Research In Intensive Care Network,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-07-15,15/04/22,2022-07-15,06/05/20,02/02/21,"Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul",Brazil,Respiratory Diseases,1,3,730.0
1066.0,NCT04323878,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,EC-COVID-PCS,Recruiting,COVID-19,,,,,,,,Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-01-06,01/03/21,2021-01-12,27/03/20,17/12/20,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan",Italy,Respiratory Diseases,1,1,372.0
1067.0,NCT04405973,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,,Completed,COVID-19,SARS-CoV 2,Extracorporeal Membrane Oxygenation,ARDS,,,,Device: vv-ECMO,Dr. Alexander Supady|University Hospital Freiburg,All,"18 Years to 100 Years   (Adult, Older Adult)",133.0,Other,Observational,2020-05-19,30/09/20,2020-09-30,28/05/20,04/11/20,"University Clinic Freiburg, Freiburg",Germany,Respiratory Diseases,1,4,134.0
1068.0,NCT04635592,Serological Diagnostics of COVID-19 in Health Care Workers,KORANIT,Not yet recruiting,SARS-CoV Infection,,,,,,,Diagnostic Test: SARS-CoV2 nasal swab,University Medical Centre Ljubljana,All,"18 Years to 70 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-01-11,31/12/20,2021-01-31,19/11/20,20/11/20,"University Medical Centre Ljubljana, Ljubljana",Slovenia,Respiratory Diseases,1,1,386.0
1069.0,NCT04379089,Neurologic Manifestations of COVID 19 in Children,,Recruiting,COVID-19,Neurologic Manifestations,,,,,,Other: Observational study only,University of Pittsburgh|University of Utah|Johns Hopkins University,All,up to 17 Years   (Child),1000.0,Other,Observational,2020-04-29,31/12/21,2022-12-31,07/05/20,04/03/21,"UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,2,976.0
1070.0,NCT04438837,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,,Not yet recruiting,COVID-19,Post-Exposure Prophylaxis,,,,,,Drug: Hydroxychloroquine,Rambam Health Care Campus,All,"18 Years and older   (Adult, Older Adult)",582.0,Other,Interventional,2020-01-07,01/06/22,2022-01-06,19/06/20,23/07/20,"Rambam Health Care Campus, Haifa",Israel,Respiratory Diseases,1,2,730.0
1071.0,NCT04649515,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",,Recruiting,COVID-19,,,,,,,Biological: TY027|Other: 0.9% saline,Tychan Pte Ltd.,All,"21 Years to 100 Years   (Adult, Older Adult)",1305.0,Industry,Interventional,2020-04-12,31/08/21,2021-12-30,02/12/20,14/12/20,"Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,627.0
1072.0,NCT04477213,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,,Not yet recruiting,COVID-19,Healthcare Workers,,,,,,,NMC Specialty Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",600.0,Other,Observational,2021-01-15,15/02/21,2021-02-15,20/07/20,10/12/20,,,Respiratory Diseases,1,2,31.0
1073.0,NCT04493307,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,TARGET-COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: Phlebotomy,"LifeBridge Health|Haemonetics Corporation|Inflammatory Markers Laboratory|Chronolog Corporation|Precision Biologics, Inc",All,"3 Years and older   (Child, Adult, Older Adult)",100.0,Other|Industry,Observational,2020-06-30,01/02/21,2021-01-06,30/07/20,22/10/20,"Sinai Center for Thrombosis Research, Baltimore, Maryland",United States,Respiratory Diseases,1,1,190.0
1074.0,NCT04493294,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,,Not yet recruiting,COVID-19,,,,,,,Radiation: Low dose whole lung radiotherapy for older patients with COVID-19 pneumonitis,International Geriatric Radiotherapy Group|Brigitta G. Baumert,All,65 Years and older   (Older Adult),500.0,Other,Interventional,2020-01-11,01/12/21,2021-01-12,30/07/20,30/07/20,,,Respiratory Diseases,1,1,367.0
1075.0,NCT04656613,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,SPUTNIK-UAE,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,Biological: Gam-COVID-Vac|Other: placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|PDC-CRO",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-01-12,01/08/21,2021-01-12,07/12/20,07/12/20,,,Respiratory Diseases,1,2,366.0
1076.0,NCT04625036,NO-mediated Vascular Function in Covid-19 Patient,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Single passive leg movement,Istituti Clinici Scientifici Maugeri SpA|Universita di Verona,All,"30 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Observational,2020-05-30,01/04/21,2021-01-06,12/11/20,01/03/21,"ICS Maugeri IRCCS, U.O. Emergenza Coronavirus di Lumezzane, Lumezzane, Brescia",Italy,Respiratory Diseases,1,1,221.0
1077.0,NCT04654442,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,GraphealNpas,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: TestNPass,"University Hospital, Grenoble|Grapheal",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2021-04-03,01/05/21,2021-05-15,04/12/20,10/03/21,"Grenoble University Hospital, Grenoble cedex 9",France,Respiratory Diseases,1,2,42.0
1078.0,NCT04492358,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",,Recruiting,COVID-19,,,,,,,Drug: Colchicine|Drug: Prednisone tablet|Drug: standard of care,Maria Joyera Rodríguez|Fundacion Clinic per a la Recerca Biomédica,All,65 Years and older   (Older Adult),144.0,Other,Interventional,2020-10-22,01/10/21,2021-01-10,30/07/20,09/11/20,"Centre Blauclínic Dolors Aleu, Barcelona, Spain|Hospital Clinic, Department of Internal Medicine, Barcelona, Spain|Clinica Sant Antoni, Barcelona",Spain,Respiratory Diseases,1,1,80.0
1079.0,NCT04408456,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,PEP-CQ,Completed,COVID-19,,,,,,,Drug: HCQ|Other: Standard therapy,Postgraduate Institute of Medical Education and Research,All,"18 Years and older   (Adult, Older Adult)",325.0,Other,Interventional,2020-01-03,31/07/20,2020-07-31,29/05/20,04/08/20,"Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India|Post Graduate Institute of Medical Education and Research, Chandigarh",India,Respiratory Diseases,1,1,210.0
1080.0,NCT04345406,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,,Not yet recruiting,COVID-19,,,,,,,Drug: ACEIs|Drug: Conventional treatment,Tanta University,All,"Child, Adult, Older Adult",60.0,Other,Interventional,2020-04-15,01/12/29,2029-01-12,14/04/20,14/04/20,"Tanta University, Tanta",Egypt,Respiratory Diseases,1,1,3194.0
1081.0,NCT04706143,Immunologic Responses to Single and Double Doses of COVID-19 Vaccines in Egyptians,,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 Vaccines,Assiut University,All,"25 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Observational,2021-01-15,01/06/21,2021-01-08,12/01/21,14/01/21,,,Respiratory Diseases,1,1,-7.0
1082.0,NCT04344977,Collection of Anti-SARS-CoV-2 Immune Plasma,NIAID,Completed,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years to 70 Years   (Adult, Older Adult)",151.0,NIH,Observational,2020-01-06,20/11/20,2021-03-03,14/04/20,05/03/21,"Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center, Torrance, California, United States|University of Miami Infectious Diseases Research Unit, Miami, Florida, United States|Bloodworks Northwest, Seattle, Washington",United States,Respiratory Diseases,1,1,422.0
1083.0,NCT04659356,NOSOcomial COVID-19 in ICU (NOSOCOVID),NOSOCOVID,Recruiting,COVID-19,Nosocomial Infection,COVID-19,,,,,Other: Patients admitted in Intensive Care Units,Nantes University Hospital,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-01-09,01/07/21,2021-07-14,09/12/20,23/03/21,"Nantes University Hospital, Nantes",France,Respiratory Diseases,1,3,552.0
1084.0,NCT04542941,Assessment of Safety and Efficacy of CCP,COVIDIT,Completed,COVID-19,,,,,,,Biological: COVID Convalescent Plasma,"Makerere University|Uganda Blood Transfusion Services|Joint Clinical Research Center|Uganda Peoples Defence Forces Medical Services|Mulago Hospital, Uganda",All,"18 Years to 100 Years   (Adult, Older Adult)",136.0,Other,Interventional,2020-06-16,31/12/20,2020-12-31,09/09/20,15/01/21,"Mulago Specialised Hospital, Kampala",Uganda,Respiratory Diseases,1,1,198.0
1085.0,NCT04456413,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma|Other: Best Supportive Care,Hackensack Meridian Health|United States Department of Defense,All,"18 Years and older   (Adult, Older Adult)",306.0,Other|U.S. Fed,Interventional,2020-06-11,01/11/21,2021-01-11,02/07/20,01/03/21,"Hackensack University Medical Center, Hackensack, New Jersey",United States,Respiratory Diseases,1,1,214.0
1086.0,NCT04830774,Natural History of COVID-19-Related Atrial Fibrillation,unCOVer-AF,Not yet recruiting,COVID-19,Atrial Fibrillation New Onset,,,,,,"Device: ILR, PMK, ICD",Texas Cardiac Arrhythmia Research Foundation,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-04-15,31/12/21,2023-12-31,05/04/21,06/04/21,"Department of Cardiovascular/Respiratory Diseases, Nephrology, Anesthesiology, and Geriatric Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Lazio, Italy|Cardiology Unit, ASST-Fatebenefratelli Sacco, Luigi Sacco University Hospital, Milan, Italy, Milan, Lombardia",Italy,Respiratory Diseases,1,2,990.0
1087.0,NCT04569877,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,GI-COVID,Recruiting,Severe Acute Respiratory Syndrome (SARS) Pneumonia,COVID-19,,,,,,Drug: Molgramostim nebuliser solution|Other: Placebo nebuliser solution,University of Giessen,All,"18 Years and older   (Adult, Older Adult)",238.0,Other,Interventional,2020-09-24,25/12/22,2022-12-25,30/09/20,05/10/20,"Prof. Dr. Susanne Herold, PhD, Gießen",Germany,Respiratory Diseases,1,2,822.0
1088.0,NCT04536285,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,,Completed,Type 1 Diabetes,COVID-19,,,,,,,Ain Shams University,All,"1 Year to 18 Years   (Child, Adult)",36.0,Other,Observational,2020-01-05,31/08/20,2020-08-31,02/09/20,02/09/20,"Pediatrics and Adolescents Diabetes Unit (PADU), Pediatrics Hospital, Faculty of Medicine, Ain Shams University, Cairo",Egypt,"Respiratory Diseases, Metabolic Disorders",1,2,239.0
1089.0,NCT04381338,Rehabilitation for People With COVID-19 in ICU,COVID_REHAB,Not yet recruiting,COVID-19,COVID-19,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),Critical Illness,,,,Other: Pulmonary and Motor Rehabilitation,"University of Padova|Prof. S Masiero, University of Padova, Italy|Dr. A. Venturin, General Hosipital, Padova, Italy|Dr. I. Tiberio, General Hospital, Padova, Italy|Dr. D. Zampieri, University of Padova, Italy|Dr.ssa M Cattelan, University of Padova, Italy|Prof. P. Zanatta, University Hosiptal, Verona, Italy|Dr.ssa C. Carollo, General Hospital, Padova, Italy|Prof. E. Polati, University Hospital, Verona, Italy|Prof. K. Donadello, University Hospital, Verona, Italy",All,"18 Years and older   (Adult, Older Adult)",92.0,Other,Interventional,2020-10-05,30/09/20,2020-09-30,08/05/20,08/05/20,"Teaching Hospital, University of Padova, Padova, Italy|Teaching Hospital, University of Verona, Verona",Italy,"Cardiovascular Diseases, Respiratory Diseases",1,4,-5.0
1090.0,NCT04343742,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,,Recruiting,COVID-19,,,,,,,Drug: chlorine dioxide 3000 ppm,Genesis Foundation,All,"Child, Adult, Older Adult",20.0,Other,Observational,2020-01-04,07/04/20,2020-01-06,13/04/20,27/05/20,"Hospital Fhsj, Bogota, Cundinamarca, Colombia|San Carlos Hospital, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,1,2.0
1091.0,NCT04729153,Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity,,Not yet recruiting,COVID-19,,,,,,,Drug: DAAD Compound,Assiut University,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Observational,2021-01-02,01/02/22,2022-01-03,28/01/21,03/02/21,,,Respiratory Diseases,1,1,366.0
1092.0,NCT04531345,Cytokine Status of Covid-19 Patients,,Completed,COVID-19,,,,,,,Diagnostic Test: Flow cytometric analysis,Istanbul Training and Research Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-01-10,01/11/20,2020-11-15,28/08/20,12/01/21,"Istanbul Training and Reseach Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,310.0
1093.0,NCT04457349,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,,Recruiting,COVID-19,,,,,,,Procedure: Therapeutic Plasma Exchange (TPE),Alexandria University,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-07-25,29/12/20,2021-01-20,07/07/20,05/01/21,"Faculty of Medicine, Alexandria university, Egypt, Alexandria",Egypt,Respiratory Diseases,1,1,179.0
1094.0,NCT04363008,COVID 19 Biomarkers,,Recruiting,COVID-19,,,,,,,Diagnostic Test: serum inflammatory biomarkers,University of British Columbia,All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-03-30,30/04/20,2021-09-30,27/04/20,08/05/20,"Vancouver General Hospital, Vancouver, British Columbia",Canada,Respiratory Diseases,1,1,549.0
1095.0,NCT04346602,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,,Recruiting,COVID-19,,,,,,,Other: all treatment about COVID-2019,Jilin University,All,"1 Year to 80 Years   (Child, Adult, Older Adult)",132.0,Other,Observational,2020-01-02,01/06/20,2020-01-12,15/04/20,15/04/20,"the First Hospital of Jilin University, Chang chun, Jilin",China,Respiratory Diseases,1,1,10.0
1096.0,NCT04327531,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",,Completed,COVID-19,Physician-Patient Relations,,,,,,Behavioral: turkish physicians,Kanuni Sultan Suleyman Training and Research Hospital,All,25 Years to 55 Years   (Adult),200.0,Other,Observational,2020-03-26,22/05/20,2020-05-28,31/03/20,05/06/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,Respiratory Diseases,1,2,63.0
1097.0,NCT04366141,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,,Completed,COVID-19,,,,,,,Device: COVID-19 barrier box,University of British Columbia,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-05,01/02/21,2021-01-02,28/04/20,24/02/21,"Providence Health Care, Vancouver, British Columbia",Canada,Respiratory Diseases,1,1,363.0
1098.0,NCT04542343,COVID-19 Risk Reduction Among African American Parishioners,,Recruiting,Coronavirus,,,,,,,"Behavioral: Change in knowledge, motivation, skills, resources",Charles Drew University of Medicine and Science,All,65 Years and older   (Older Adult),265.0,Other,Interventional,2020-01-11,30/09/21,2021-09-30,09/09/20,26/01/21,"Charles R. Drew University of Medicine & Science, Los Angeles, California",United States,Respiratory Diseases,1,1,628.0
1099.0,NCT04510454,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,ONCOVID-21,Recruiting,Cancer,COVID-19,,,,,,Diagnostic Test: Nasopharyngeal and throat/oropharyngeal swabs analyses by RT-PCR and ddPCR,Centre Leon Berard,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-02-11,01/05/21,2021-01-05,12/08/20,09/02/21,"Centre Leon Berard, Lyon",France,"Respiratory Diseases, Cancers",1,2,329.0
1100.0,NCT04329507,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),,Recruiting,COVID-19,Respiratory Disease,,,,,,Diagnostic Test: Breath test,NHS Lothian,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-03-25,25/03/21,2021-03-25,01/04/20,14/09/20,"NHS Lothian, Edinburgh",United Kingdom,Respiratory Diseases,1,2,365.0
1101.0,NCT04668469,Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Drug: Ivermectin|Drug: Hydroxychloroquine|Behavioral: personal protective Measures,Benha University,All,"18 Years to 80 Years   (Adult, Older Adult)",600.0,Other,Interventional,2020-08-06,15/09/20,2020-10-30,16/12/20,16/12/20,"Benha Faculty of Medicine, Benha University, Banhā, Qaluopia",Egypt,Respiratory Diseases,1,1,85.0
1102.0,NCT04353596,Stopping ACE-inhibitors in COVID-19,ACEI-COVID,Completed,COVID-19,COVID-19,,,,,,"Drug: ACE inhibitor, angiotensin receptor blocker",Medical University Innsbruck|Ludwig-Maximilians - University of Munich|Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK),All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2020-04-20,16/02/21,2021-02-24,20/04/20,02/03/21,"Medical University Innsbruck, University Hospital of Internal Medicine III, Innsbruck, Tyrol, Austria|Medical University of Graz, Graz, Austria|Landeskrankenhaus Hall, Hall In Tirol, Austria|Medical University Innsbruck, Intensive Care and Emergency Medicine Department, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine II, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine IV, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine I, Innsbruck, Austria|Medical University Innsbruck, University Hospital of Internal Medicine V, Innsbruck, Austria|Klinikum Klagenfurt, Klagenfurt, Austria|Bezirkskrankenhaus Kufstein, Kufstein, Austria|Klinikum Lienz, Lienz, Austria|Bezirkskrankenhaus St. Johann, Sankt Johann In Tirol, Austria|Bezirkskrankenhaus Schwaz, Schwaz, Austria|Krankenhaus St. Vinzenz Zams, Zams, Austria|LMU Klinikum, Medizinische Klinik I, Munich, Bavaria, Germany|University Hospital Aachen, Aachen, Germany|University Hospital Augsburg, Augsburg, Germany|Asklepios Stadtklinik Bad Tölz, Bad Tölz, Germany|Klinikum Dachau, Dachau, Germany|University Hospital Erlangen, Erlangen, Germany|University Hospital Essen, Essen, Germany|University of Freiburg, Freiburg, Germany|Klinikum Memmingen, Memmingen, Germany|LMU Klinikum, Medizinische Klinik III, Munich, Germany|LMU Klinikum, Medizinische Klinik II, Munich, Germany|LMU Klinikum, Medizinische Klinik IV, Munich, Germany|München Klinik Bogenhausen und Schwabing, Munich, Germany|Rotkreuzklinikum Munich, Munich, Germany|Krankenhaus Mühldorf, Mühldorf, Germany|Klinikum Rosenheim, Rosenheim, Germany|Krankenhaus Weiden, Weiden",Germany,Respiratory Diseases,1,2,310.0
1103.0,NCT04408209,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Procedure: Convalescent Plasma,National and Kapodistrian University of Athens|Hellenic Society of Hematology,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-23,30/08/21,2021-09-15,29/05/20,04/11/20,"Evangelismos General Hospital, Athens, Attiki, Greece|Agios Savas Oncology Hospital, Athens, Attiki, Greece|Alexandra General Hospital, Athens, Attiki, Greece|Sotiria General Hospital, Athens, Attiki, Greece|Attikon University General Hospital, Athens, Chaidari, Greece|University General Hospital of Patras, Patra, Rio",Greece,Respiratory Diseases,1,1,510.0
1104.0,NCT04816656,An Integrated Digital PROM-platform for Cancer Patients During the COVID-19 Pandemic,COVID-ONCO,Completed,COVID-19,Oncology,PROMs,Chemotherapeutic Toxicity,,,,Other: ePROMs assessment,Jessa Hospital|Hasselt University,All,"18 Years and older   (Adult, Older Adult)",43.0,Other,Interventional,2020-03-08,01/02/21,2021-03-22,25/03/21,26/03/21,"Hasselt University, Hasselt, Limburg, Belgium|Jessa Ziekenhuis, Hasselt, Limburg",Belgium,Respiratory Diseases,1,4,379.0
1105.0,NCT04392141,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Standard Treatment|Drug: Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions,Kermanshah University of Medical Sciences,All,"10 Years and older   (Child, Adult, Older Adult)",200.0,Other,Interventional,2020-01-04,01/11/20,2020-01-11,18/05/20,03/11/20,"Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran",Islamic Republic of,Respiratory Diseases,1,1,7.0
1106.0,NCT04355234,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",COVIPREG,"Active, not recruiting",Pregnancy,,,,,,,Diagnostic Test: identify SARS-CoV-2 infection by serology|Biological: collection of biological samples,Assistance Publique - Hôpitaux de Paris,Female,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Interventional,2020-04-05,31/08/21,2021-08-31,21/04/20,05/04/21,"Tsastaris Vassillis, Paris",France,Others,0,1,513.0
1107.0,NCT04695457,Correlation Between the Incidence of COVID-19 in Nursing-homes and the Profile of Nursing Homes in the French Alps,PROCOPAD,Completed,COVID-19,Nursing Home,,,,,,,Centre Hospitalier Annecy Genevois,All,"Child, Adult, Older Adult",74.0,Other,Observational,2020-07-15,16/11/20,2020-11-16,05/01/21,05/01/21,"Ch Annecy Genevois, Pringy",France,Respiratory Diseases,1,2,124.0
1108.0,NCT04703452,poSt Covid-19 Infection centraL sENsitisaTion,SILENT 1,Recruiting,COVID-19,,,,,,,Other: Indicators of central sensitisation,Universitair Ziekenhuis Brussel,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-19,01/01/22,2022-01-01,11/01/21,22/01/21,"Universitair Ziekenhuis Brussel, Jette, Brussel",Belgium,Respiratory Diseases,1,1,347.0
1109.0,NCT04391127,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Ivermectin|Drug: Placebo,Centenario Hospital Miguel Hidalgo,All,"16 Years to 90 Years   (Child, Adult, Older Adult)",108.0,Other,Interventional,2020-04-05,06/11/20,2020-06-11,18/05/20,09/11/20,"Jose Manuel Arreola Guerra, Aguascalientes",Mexico,Respiratory Diseases,1,1,67.0
1110.0,NCT04525443,Endothelial Function and COVID-19,,Completed,COVID-19,,,,,,,,"Hospital San Carlos, Madrid|Mayo Clinic",All,"Child, Adult, Older Adult",110.0,Other,Observational,2020-03-06,11/11/20,2021-11-02,25/08/20,26/02/21,"Mayo Clinic, Rochester, Minnesota, United States|Hospital Clínico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,606.0
1111.0,NCT04562246,SARS-CoV-2 IgG and IgM Serologic Assays,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Serologic assays for antibodies to SARS-CoV-2,Henry Ford Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-08-14,01/08/21,2021-01-08,24/09/20,24/09/20,"Henry Ford Health System, Detroit, Michigan",United States,Respiratory Diseases,1,1,147.0
1112.0,NCT04796584,Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication,,Not yet recruiting,Multiple Sclerosis,,,,,,,Other: Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus,Providence Health & Services,All,18 Years to 55 Years   (Adult),40.0,Other,Observational,2021-03-17,17/03/22,2022-06-17,15/03/21,15/03/21,"Providence Neurological Specialties West, Portland, Oregon",United States,Immunological Disorders,1,1,457.0
1113.0,NCT04659187,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - An Epidemiological Study From Germany,CORONA Germany,Recruiting,COVID-19,,,,,,,,Asklepios proresearch|Asklepios Kliniken GmbH & Co. KGaA,All,"Child, Adult, Older Adult",4000.0,Industry|Other,Observational,2020-03-26,30/05/21,2021-01-07,09/12/20,17/12/20,"Asklepios Fachkliniken München-Gauting, Gauting, Bavaria, Germany|Asklepios Klinik St. Georg, Hamburg, Germany|Asklepios Klinik Wandsbek, Hamburg, Germany|Asklepios Klinik Barmbek, Hamburg, Germany|Asklepios Kliniken GmbH & Co. KGaA, Hamburg, Germany|Asklepios Klinik Nord, Hamburg, Germany|Asklepios Westklinikum Hamburg, Hamburg, Germany|Asklepios Klinik Altona, Hamburg",Germany,Respiratory Diseases,1,1,287.0
1114.0,NCT04555187,Cardiovascular Risk Stratification in Covid-19,CaVaR-Co19,"Active, not recruiting",COVID-19,Cardiovascular Risk Factor,,,,,,,Oregon Health and Science University,All,"18 Years and older   (Adult, Older Adult)",60000.0,Other,Observational,2020-08-06,01/12/21,2021-01-12,18/09/20,21/09/20,"Oregon Health and Science University, Portland, Oregon",United States,Respiratory Diseases,1,2,159.0
1115.0,NCT04474067,COVID-19 - Cytokine Storm,,Recruiting,COVID-19,,,,,,,Other: No intervention,Hadassah Medical Organization|Barzilai Medical Center|The Chaim Sheba Medical Center,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-06-28,01/03/21,2021-01-03,16/07/20,22/12/20,"Hadassah Medical Center, Jerusalem",Israel,Respiratory Diseases,1,1,189.0
1116.0,NCT04433013,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Lianhua Qingwen|Drug: Placebo,"Nanyang Technological University|Ministry of Health, Singapore",All,"21 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-07,01/12/20,2021-01-02,16/06/20,17/06/20,,,Respiratory Diseases,1,1,361.0
1117.0,NCT04318314,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,COVID19-HCW,Recruiting,Health Care Worker Patient Transmission,Coronavirus,Coronavirus Infections,Immunological Abnormality,,,,Diagnostic Test: COPAN swabbing and blood sample collection,"University College, London|St. Bartholomew's Hospital|Royal Free Hospital NHS Foundation Trust|UCLH",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-03-18,31/12/20,2021-12-31,23/03/20,21/05/20,"Barts Heart Center, London, United Kingdom|Royal Free London NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,4,653.0
1118.0,NCT04366180,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Probiotic|Dietary Supplement: Control,Biosearch S.A.,All,"20 Years and older   (Adult, Older Adult)",314.0,Industry,Interventional,2020-04-24,01/06/20,2020-01-10,28/04/20,30/04/20,"Raquel Rodriguez Blanque, Granada",Spain,Respiratory Diseases,1,1,-105.0
1119.0,NCT04701892,poSt Covid-19 Infection centraL Sensitisation 2,SILENT 2,Recruiting,COVID-19,,,,,,,Other: Indicators of central sensitisation,Universitair Ziekenhuis Brussel,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-19,01/01/23,2023-01-01,08/01/21,22/01/21,"Universitair Ziekenhuis Brussel, Jette, Brussel",Belgium,Respiratory Diseases,1,1,712.0
1120.0,NCT04544033,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,,Recruiting,COVID-19,,,,,,,Diagnostic Test: interleuken 6 level measurment|Diagnostic Test: Interleukin-6 Gene-174C detection,Tanta University,All,"Child, Adult, Older Adult",120.0,Other,Observational,2020-09-15,01/04/21,2021-01-05,10/09/20,30/03/21,"Bsant Safwat Kasem, Tanta, El Gharbyia",Egypt,Respiratory Diseases,1,1,112.0
1121.0,NCT04356534,Convalescent Plasma Trial in COVID -19 Patients,,Completed,SARS-CoV 2,COVID-19,,,,,,Other: plasma therapy using convalescent plasma with antibody against SARS-CoV-2|Other: Routine care for COVID-19 patients,"Royal College of Surgeons in Ireland - Medical University of Bahrain|Salmaniya Medical Complex|Bahrain Defence Force Hospital|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali",All,"21 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-19,15/06/20,2020-09-07,22/04/20,28/07/20,"Royal College of Surgeons in Ireland - Bahrain, Manama",Bahrain,Respiratory Diseases,1,2,141.0
1122.0,NCT04765839,Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations,CERC,"Active, not recruiting",Vaccine Preventable Disease,,,,,,,"Other: Educational, culturally appropriate COVID-19 messages",Mayo Clinic,All,"18 Years to 101 Years   (Adult, Older Adult)",90.0,Other,Interventional,2021-12-02,22/03/21,2021-03-22,23/02/21,23/02/21,"Mayo Clinic, Rochester, Minnesota",United States,Others,0,1,-255.0
1123.0,NCT04349618,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,VT4COVID,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,Sars-CoV2,Pneumonia,,,,Other: PROTECTIVE VENTILATION|Other: ULTRAPROTECTIVE VENTILATION,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-15,15/04/23,2023-04-15,16/04/20,15/02/21,"Service de Médecine Intensive Réanimation CHU Gabriel Montpied, Clermont-Ferrand, France|Service de Médecine Intensive Réanimation Hôpital Michallon - CHU Grenoble Alpes, La Tronche, France|Service de Médecine Intensive Réanimation Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital Edouard Herriot Hospices Civils de Lyon, Lyon, France|Service de Médecine Intensive Réanimation Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de Réanimation Chirurgicale Hôpital de la Croix Rousse Hospices Civils de Lyon, Lyon, France|Service de réanimation Polyvalente Centre Hospitalier Saint Joseph-Saint Luc, Lyon, France|Service de Réanimation Clinique de la Sauvegarde, Lyon, France|Service de Réanimation Polyvalente Centre Hospitalier Lyon Sud Hospices Civils de Lyon, Pierre-Bénite, France|Service de Réanimation Centre hospitalier Annecy Genevois, Pringy, France|Service de Médecine Intensive Réanimation Hôpital Nord - CHU Saint-Etienne, Saint-Priest-en-Jarez",France,Respiratory Diseases,1,4,1095.0
1124.0,NCT04389489,Postpartum Sexual Function in Pregnant Women With COVID-19,,Recruiting,COVID-19,Dyspareunia,Postpartum Period,,,,,,Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),140.0,Other,Observational,2020-05-14,25/09/20,2020-09-30,15/05/20,02/09/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali",Turkey,Respiratory Diseases,1,3,139.0
1125.0,NCT04371692,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,EXPOCOVIA,Not yet recruiting,Sars-CoV2,,,,,,,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,"University Hospital, Lille|Fondation Santé Roquette",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,01/09/20,2020-01-09,01/05/20,01/05/20,,,Respiratory Diseases,1,1,5.0
1126.0,NCT04449042,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,,Recruiting,Airway Management,COVID-19,,,,,,Procedure: airway management during sedation or general anesthesia,Boston Children's Hospital|Children's Hospital of Philadelphia|Children's Hospital Colorado|Istituto Giannina Gaslini|The Hospital for Sick Children|Perth Children's Hospital of Western Austrailia|Lurie Children's Hospital of Chicago,All,"up to 18 Years   (Child, Adult)",15000.0,Other,Observational,2020-01-04,01/12/25,2025-01-12,26/06/20,26/06/20,"Boston Children's Hopsital, Boston, Massachusetts",United States,Respiratory Diseases,1,2,1835.0
1127.0,NCT04716465,Dysautonomia in Patients Post COVID-19 Infection,DYSCO,Recruiting,COVID-19,,,,,,,Other: Dysautonomia,Moens Maarten|Universitair Ziekenhuis Brussel,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-19,01/01/23,2023-01-01,20/01/21,22/01/21,"Universitair Ziekenhuis Brussel, Jette, Brussel",Belgium,Respiratory Diseases,1,1,712.0
1128.0,NCT04622826,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,,Recruiting,COVID-19,,,,,,,Biological: immune plasma,Azienda USL Toscana Nord Ovest,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-15,31/12/20,2020-12-31,10/11/20,10/11/20,"Ospedale delle Apuane, Massa, Toscana",Italy,Respiratory Diseases,1,1,230.0
1129.0,NCT04367857,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,,Recruiting,COVID-19,Coronavirus Infection,Coronavirus,,,,,Other: COVID-19 Serology|Behavioral: Health Care Worker Survey,Columbia University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-18,01/10/21,2021-01-10,29/04/20,30/04/20,"NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center, New York, New York",United States,Respiratory Diseases,1,3,267.0
1130.0,NCT04565080,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),,Recruiting,Parkinson's Disease,Functional Movement Disorders,COVID-19,,,,,,National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",150.0,NIH,Observational,2021-04-19,31/12/21,2021-12-31,25/09/20,14/04/21,"National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland",United States,Respiratory Diseases,1,3,256.0
1131.0,NCT04379479,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),FUTURE-T,Not yet recruiting,COVID-19,COVID-19,,,,,,Drug: Dialyzable Leukocyte Extract|Drug: Placebo oral,"National Polytechnic Institute, Mexico",All,"18 Years and older   (Adult, Older Adult)",562.0,Other,Interventional,2020-01-05,01/08/20,2020-01-12,07/05/20,07/05/20,"Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City",Mexico,Respiratory Diseases,1,2,7.0
1132.0,NCT04583306,The Salivary Raman COVID-19 Fingerprint,DISCOVER,Recruiting,COVID-19,,,,,,,"Other: Raman analysis of saliva, characterization of the Raman database and building of the classification model",Fondazione Don Carlo Gnocchi Onlus,All,"18 Years to 90 Years   (Adult, Older Adult)",120.0,Other,Observational,2020-01-06,15/12/20,2021-01-06,12/10/20,12/10/20,", IRCCS Fondazione Don Carlo Gnocchi, Centro Spalenza, Rovato, BS, Italy|IRCCS Fondazione Don Carlo Gnocchi, Santa Maria Nascente Hospital (Milano), Milano, MI",Italy,Respiratory Diseases,1,1,366.0
1133.0,NCT04397822,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,CO-QUETTES,Recruiting,COVID-19,,,,,,,Biological: Blood samples,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Observational,2020-04-16,01/10/21,2022-01-04,21/05/20,30/11/20,"CHU Toulouse, Toulouse",France,Respiratory Diseases,1,1,628.0
1134.0,NCT04376853,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,CoronaWatch,Recruiting,COVID-19,,,,,,,Device: Apple Watch Series 5,University Hospital Heidelberg|The German Heart Foundation|Klaus Tschira Stiftung|Freunde und Förderer der Kardiologie Heidelberg,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-15,01/06/20,2020-01-07,06/05/20,06/05/20,"Department III of Internal Medicine, University Hospital Heidelberg, Heidelberg, Baden-Württemberg",Germany,Respiratory Diseases,1,1,-99.0
1135.0,NCT04537559,Impact of COVID-19 Outbreak on Non-COVID-19 Patients,NoCOVImpact,Enrolling by invitation,COVID-19,,,,,,,,"University Hospital, Geneva|Thomas Agoritsas|Sebastian Carballo|Pauline Darbellay|Olivier Grosgurin|Christophe Marti|Mathieu Nendaz|Jean-Luc Reny|Jacques Serratrice|Aimad Ourahmoune|Delphine Courvoisier|Virginie Prendki|Christine Serratrice|Dina Zekry|Omar Kherad|Eric Gerstel",All,"16 Years and older   (Child, Adult, Older Adult)",40000.0,Other,Observational,2020-01-03,31/07/20,2020-10-31,03/09/20,07/09/20,"Geneva University Hospital, Geneva, Canton De Genève",Switzerland,Respiratory Diseases,1,1,302.0
1136.0,NCT04387760,Favipiravir vs Hydroxychloroquine vs Control in COVID -19,,Recruiting,SARS-CoV 2,COVID-19,,,,,,Drug: Hydroxychloroquine|Drug: Favipiravir|Other: Routine care for COVID-19 patients,"Royal College of Surgeons in Ireland - Medical University of Bahrain|Ebrahim Khalil Kanoo Community Medical Center|Hereditary blood Disorder Centre - Salmaniya Medical Complex|Mohammed Bin Khalifa Bin Sulman Al Khalifa Cardiac Centre, Awali|Jidhafs COVID-19 Centre|Sitra FICU|Salmaniya Medical Complex- 6th Floor|Salmaniya Medical Complex- Helipad",All,"21 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-11-08,14/04/21,2021-05-14,14/05/20,09/03/21,"Royal College of Surgeons in Ireland - Bahrain, Manama",Bahrain,Respiratory Diseases,1,2,187.0
1137.0,NCT04381845,Immunity and Infections in the Psychiatric Population,COVIDIMMUNOPSY,Not yet recruiting,COVID-19,Psychiatric Disorders,,,,,,Diagnostic Test: COVID19 immunization testing,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-12,10/03/21,2021-10-03,11/05/20,26/10/20,,,Respiratory Diseases,1,2,356.0
1138.0,NCT04379466,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,CovRep,Recruiting,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-05-05,11/10/20,2021-01-04,07/05/20,18/08/20,"Hôpital Pitie Salpétrère, Paris",France,Respiratory Diseases,1,1,244.0
1139.0,NCT04345510,Testing for COVID-19 Infection in Asymptomatic Persons,,Recruiting,COVID-19,,,,,,,,German Cancer Research Center,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-20,30/09/21,2021-09-30,14/04/20,10/03/21,"German Cancer Research Center, Heidelberg, Baden-Württemberg",Germany,Respiratory Diseases,1,1,528.0
1140.0,NCT04469153,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,,Recruiting,the Prognostic Value of Ferritin,COVID-19,,,,,,Other: No intervention / Evaluation of the ferritin and glycosylated ferritin by standard approved serological tests,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",57.0,Other,Observational,2020-06-29,01/09/20,2020-12-31,13/07/20,13/07/20,"hopital de la Croix Rousse, Lyon 4, Rhone Alpes",France,Respiratory Diseases,1,2,185.0
1141.0,NCT04725097,A Study to Evaluate Rapid Throughput Screening for Human COVID-19 Infection,,Recruiting,COVID-19,,,,,,,,Mayo Clinic,All,"18 Years to 89 Years   (Adult, Older Adult)",10000.0,Other,Observational,2020-10-12,31/07/21,2021-08-30,26/01/21,26/01/21,"Mayo Clinic, Rochester, Minnesota, United States|Sri Jayadeva, Bengaluru, Karnataka, India|Gregorio Marañon Hospital, Madrid, Spain|Imperial College, London, England",United Kingdom,Respiratory Diseases,1,1,322.0
1142.0,NCT04414098,Ruxolitinib in the Treatment of Covid-19,,Not yet recruiting,COVID-19,,,,,,,Drug: INC424 / Ruxolitinib,Marcelo Iastrebner|Novartis|Clinica Zabala,All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-01-06,15/08/20,2020-09-15,04/06/20,04/06/20,,,Respiratory Diseases,1,1,253.0
1143.0,NCT04550338,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,TXACOVIDPREV,Not yet recruiting,COVID-19,,,,,,,Drug: Tranexamic acid|Drug: Placebo,University of Alabama at Birmingham,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-08,31/12/22,2023-03-31,16/09/20,16/02/21,,,Respiratory Diseases,1,1,812.0
1144.0,NCT04377464,COVID-19 - Quality of Life After Infection,,Not yet recruiting,COVID-19,Quality of Life,,,,,,"Other: SF12, EQ-5D-5L and work status standardized quantitative assessments",Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-05-05,30/04/21,2022-04-30,06/05/20,06/05/20,,,Respiratory Diseases,1,2,725.0
1145.0,NCT04431466,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,IFORS,Recruiting,Coronavirus Infection,,,,,,,Drug: Ivermectin|Other: Standard treatment for COVID-19,Universidade Federal de Sao Carlos,All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Interventional,2020-01-07,01/12/20,2021-01-07,16/06/20,02/09/20,"Hospital Univeristário da Universidade Federal de São Carlos (HU-UFSCar), São Carlos, São Paulo, Brazil|Hospital Universitário da Universidade Federal de São Carlos (HU-UFSCar), São Carlos, São Paulo",Brazil,Respiratory Diseases,1,1,366.0
1146.0,NCT04393974,COVID-19 and Cancer Patients,OnCovid,Recruiting,Cancer,Sars-CoV2,,,,,,,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-24,24/03/22,2022-03-24,19/05/20,21/05/20,"Imperial College Healthcare NHS Trust, London",United Kingdom,"Respiratory Diseases, Cancers",1,2,730.0
1147.0,NCT04492904,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,,Recruiting,COVID-19,,,,,,,Other: Home-use Test and Follow-up Questionnaire,"Clinical Nutrition Research Centre, Singapore|National University Hospital, Singapore",All,"21 Years to 70 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-07-23,31/03/21,2021-03-31,30/07/20,30/07/20,"Clinical Nutrition Research Centre, Singapore, Singapore",Singapore,Respiratory Diseases,1,1,251.0
1148.0,NCT04816942,Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt,,Completed,Convalescent Plasma,COVID-19,Immunoglobulins,Plasma,Egypt,,,Biological: Convalescent Plasma,"Ministry of Health and Population, Egypt",All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-04-23,21/07/20,2020-12-10,25/03/21,25/03/21,"Ministry of Health, Cairo, Giza",Egypt,Respiratory Diseases,1,5,231.0
1149.0,NCT04364802,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,PIIPPI,Recruiting,COVID-19,SARS-CoV 2,,,,,,Drug: Povidone-Iodine Nasal Spray and Gargle,Alexandra Kejner|University of Kentucky,All,"18 Years to 99 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-04-29,01/05/21,2021-01-05,28/04/20,24/11/20,"University of Kentucky, Lexington, Kentucky",United States,Respiratory Diseases,1,2,251.0
1150.0,NCT04704466,Impact of Covid-19 Pandemic on Management of Head and Neck Cancers,VADS-Covid,Recruiting,Head and Neck Cancer,COVID-19,Patient Care,,,,,,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-07-01,01/06/21,2021-01-07,11/01/21,01/02/21,"CHU Amiens, Amiens",France,"Respiratory Diseases, Cancers",1,3,-175.0
1151.0,NCT04690816,Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases,,Recruiting,Systemic Autoimmune Diseases,,,,,,,,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|National Institutes of Health Clinical Center (CC),All,"15 Years and older   (Child, Adult, Older Adult)",350.0,NIH,Observational,2021-11-02,31/12/24,2024-12-31,31/12/20,19/03/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Others,0,1,1155.0
1152.0,NCT04528368,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma,D'Or Institute for Research and Education|Hospital do Coracao,All,"Child, Adult, Older Adult",60.0,Other,Interventional,2020-11-12,30/04/21,2021-05-30,27/08/20,01/02/21,"D'Or Institute for Research and Education, Rio de Janeiro",Brazil,Respiratory Diseases,1,1,199.0
1153.0,NCT04712175,Diagnostic Validation of Rapid Detection of the COVID-19 Causative Virus (SARS-CoV-2) in Saliva Samples by Mass Spectrometry,SALICOV,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Nasopharyngeal sampling|Diagnostic Test: Saliva sampling,Centre Hospitalier Universitaire de Nīmes|Technological Innovations for Detection and Diagnosis Laboratory,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2021-01-01,01/07/21,2021-01-07,15/01/21,15/01/21,"CHU de Nîmes, Nîmes",France,Respiratory Diseases,1,1,6.0
1154.0,NCT04531111,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,,Recruiting,Type 1 Diabetes,COVID-19,,,,,,,Ain Shams University,All,"2 Years to 18 Years   (Child, Adult)",150.0,Other,Observational,2020-07-07,01/08/20,2020-01-08,28/08/20,28/08/20,"Pediatrics and Adolescents Diabetes Unit (PADU), Pediatrics Hospital, Faculty of Medicine, Ain Shams University, Cairo",Egypt,"Respiratory Diseases, Metabolic Disorders",1,2,-181.0
1155.0,NCT04462393,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,,Completed,COVID-19,Critical Illness,,,,,,Other: Admission to ICU for COVID-19,Linkoeping University|Region Östergötland,All,"18 Years and older   (Adult, Older Adult)",1563.0,Other,Observational,2020-06-03,06/05/20,2020-06-05,08/07/20,09/07/20,"Department of Anaesthesia and Intensive Care, Linkoeping University Hospital, Region Östergötland, Linköping, Östergötland",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,2,2.0
1156.0,NCT04359615,Favipiravir in Hospitalized COVID-19 Patients,FIC,Not yet recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Hydroxychloroquine,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-20,03/05/20,2020-05-05,24/04/20,28/04/20,"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,15.0
1157.0,NCT04381819,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",,Recruiting,SARS Virus,Severe Acute Respiratory Syndrome,,,,,,Diagnostic Test: SARS-CoV-2 PCR,"Oslo University Hospital|University Hospital, Akershus|Vestre Viken Hospital Trust|Østfold Hospital Trust|Haukeland University Hospital|University Hospital of North Norway|St. Olavs Hospital",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-02-03,28/02/22,2023-12-31,11/05/20,11/05/20,"Vestre Viken Drammen Hospital, Drammen, Viken, Norway|Haukeland University Hospital, Bergen, Norway|Østfold Hospital Trust, Fredrikstad, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|University Hospital North Norway, Tromsø, Norway|St Olavs Hospital, Trondheim",Norway,Others,0,2,1427.0
1158.0,NCT04685213,Electrical Stimulation for Critically Ill Covid-19 Patients,COVID-19,Recruiting,COVID-19,Pain,Muscle Atrophy,,,,,Device: Electrical Stimulation|Device: Electrical Stimulation - Sham,"Baylor College of Medicine|Avazzia, Inc",All,"18 Years to 100 Years   (Adult, Older Adult)",20.0,Other|Industry,Interventional,2020-08-18,18/08/21,2021-08-18,28/12/20,28/12/20,"Baylor College of Medicine, Houston, Texas",United States,Respiratory Diseases,1,3,365.0
1159.0,NCT04380766,Covid-19 Pandemic and Pancreatic Surgery in Italy,PanCOVID,Completed,Pancreatic Cancer,,,,,,,Procedure: Evaluation of changes in the diagnostic-therapeutic pathway for patients affected by pancreatic cancer,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,All,"18 Years and older   (Adult, Older Adult)",730.0,Other,Observational,2019-01-01,31/07/20,2020-07-31,08/05/20,03/08/20,"Fondazione Policlinico Universitario Agostino Gemelli IRCCS di Roma, Roma, Lazio",Italy,Cancers,1,1,577.0
1160.0,NCT04312243,NO Prevention of COVID-19 for Healthcare Providers,NOpreventCOVID,"Active, not recruiting",Coronavirus Infections,Healthcare Associated Infection,,,,,,Drug: Inhaled nitric oxide gas,Massachusetts General Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-07-04,07/04/21,2022-07-04,18/03/20,10/03/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,2,730.0
1161.0,NCT04842435,Clinical Study in the Treatment of Patients With Moderate Course of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: COVID-globulin|Drug: Placebo,Microgen Scientific Industrial Company for Immunobiological Medicines,All,"18 Years to 65 Years   (Adult, Older Adult)",376.0,Other,Interventional,2021-09-04,30/09/21,2021-05-10,13/04/21,13/04/21,,,Respiratory Diseases,1,1,-117.0
1162.0,NCT04355624,Kidney Involvement in COVID-19 Disease (COVKID),COVKID,Recruiting,COVID-19,Kidney Injury,,,,,,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-04-15,30/04/20,2020-07-30,21/04/20,13/05/20,"Centre hospitalier d'Antibes Juan les pins, Antibes, France|Centre hospitalier de Cannes, Cannes, France|Centre hospitalier de Grasse, Grasse, France|CHU de Nice, Nice",France,Respiratory Diseases,1,2,106.0
1163.0,NCT04371510,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,PredictCovid-D,Recruiting,COVID-19,,,,,,,Other: blood sample,Centre Hospitalier Universitaire de Nice,All,"18 Years to 85 Years   (Adult, Older Adult)",115.0,Other,Interventional,2020-04-22,22/10/20,2021-02-22,01/05/20,01/05/20,"CHU de nice, Nice, Alpes-Maritimes",France,Respiratory Diseases,1,1,306.0
1164.0,NCT04359316,Azithromycin in Hospitalized COVID-19 Patients,AIC,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-20,03/05/20,2020-05-05,24/04/20,24/04/20,"Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,15.0
1165.0,NCT04827160,Prediction of Thrombosis Using D-dimer Trends in COVID-19,TRENDS,Completed,COVID-19,,,,,,,,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",280.0,Other,Observational,2020-02-03,11/08/20,2020-11-08,01/04/21,01/04/21,"CHRU Nancy, Nancy",France,Respiratory Diseases,1,1,279.0
1166.0,NCT04731051,The Potential Use of Inhaled Hydroxychloroquine for the Treatment of COVID-19 in Cancer Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: HCQ01|Drug: standard of care (SOC) for COVID-19,King Hussein Cancer Center|Amman Pharmaceutical Industries (API)|Sana Pharmaceutical Industry|ACDIMA Center for Bioequivalence and Pharmaceutical Studies (ACDIMA BioCenter),All,"18 Years and older   (Adult, Older Adult)",28.0,Other,Interventional,2021-01-03,01/09/21,2021-01-09,29/01/21,01/02/21,"King Hussein Cancer Center, Amman",Jordan,Respiratory Diseases,1,1,6.0
1167.0,NCT04789460,The Relationship Between Laboratory Features of Covid-19 Patients in the Hospital With Prognosis,,Not yet recruiting,COVID-19,,,,,,,,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2021-05-03,28/03/21,2021-03-28,09/03/21,09/03/21,,,Respiratory Diseases,1,1,-36.0
1168.0,NCT04560608,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",GERIA-COVID,Recruiting,COVID-19,,,,,,,,"University Hospital, Angers",All,70 Years and older   (Older Adult),255.0,Other,Observational,2020-03-15,31/01/21,2021-01-31,23/09/20,02/12/20,"Angers University Hospital, Angers",France,Respiratory Diseases,1,1,322.0
1169.0,NCT04402814,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,,Recruiting,SARS-CoV 2,,,,,,,Diagnostic Test: Clungene rapid test cassette,"Fadi Haddad, M.D.|Sharp HealthCare",All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Observational,2020-05-05,01/10/20,2020-01-12,27/05/20,27/07/20,"Fadi A. Haddad MD Inc., La Mesa, California, United States|Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hosptial, San Diego, California",United States,Respiratory Diseases,1,1,-114.0
1170.0,NCT04354519,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,UKMSRCV19,Recruiting,Multiple Sclerosis,COVID-19,,,,,,,Swansea University,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-03-14,14/07/21,2022-07-14,21/04/20,22/06/20,"Swansea Univeristy, Swansea",United Kingdom,"Respiratory Diseases, Immunological Disorders",1,2,852.0
1171.0,NCT04537117,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",,Completed,COVID-19,,,,,,,Other: Questionaire,Fayoum University,All,"Child, Adult, Older Adult",202.0,Other,Observational,2020-04-20,05/05/20,2020-05-05,03/09/20,03/09/20,"Fayoum University, Fayoum",Egypt,Respiratory Diseases,1,1,15.0
1172.0,NCT04345536,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,CovidRegOUH,Recruiting,COVID-19,,,,,,,,Oslo University Hospital,All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-03-15,01/01/22,2022-01-05,14/04/20,25/02/21,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,1,661.0
1173.0,NCT04490486,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,COVID-19,Not yet recruiting,COVID-19,Acute Respiratory Distress Syndrome,Corona Virus Infection,,,,,Biological: UCMSCs|Other: Placebo,Joshua M Hare|University of Miami,All,"18 Years and older   (Adult, Older Adult)",21.0,Other,Interventional,2021-01-09,01/06/24,2024-01-06,29/07/20,05/02/21,"University of Miami, Miami, Florida",United States,Respiratory Diseases,1,3,1092.0
1174.0,NCT04473261,Efficacy of Iodine Complex Against COVID-19 Patients,I-COVID-PK,Recruiting,COVID-19,COVID-19,Corona Virus Infection,,,,,Drug: Iodine Complex|Drug: Placebo|Drug: Idoine Complex,Sohaib Ashraf|Sheikh Zayed Federal Postgraduate Medical Institute,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-07-14,15/07/21,2021-08-15,16/07/20,11/01/21,"Shaikh Zayed Hospital, Lahore",Pakistan,Respiratory Diseases,1,3,397.0
1175.0,NCT04334928,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,EPICOS,Recruiting,Coronavirus Infection,,,,,,,Drug: Emtricitabine/tenofovir disoproxil|Drug: Hydroxychloroquine|Drug: Placebo: Emtricitabine/tenofovir disoproxil Placebo|Drug: Placebo: Hydroxychloroquine,Plan Nacional sobre el Sida (PNS)|Effice Servicios Para la Investigacion S.L.,All,"18 Years to 70 Years   (Adult, Older Adult)",4000.0,Other|Industry,Interventional,2020-04-15,31/12/20,2020-12-31,06/04/20,25/08/20,"Hospital Universitario de Ferrol, Ferrol, A Coruña, Spain|Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain|Hospital General de Elche, Elche, Alicante, Spain|Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Sant Joan de Deu de Esplugues, Esplugues De Llobregat, Barcelona, Spain|Parc Sanitari Sant Joan de Déu de Sant Boi, Sant Boi De Llobregat, Barcelona, Spain|Hospital Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Hospital Infanta Margarita, Cabra, Córdoba, Spain|Hospital Insular de Las Palmas, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Canarias, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital de Donostia, San Sebastián, Guipuzcoa, Spain|Hospital San Pedro, Logroño, La Rioja, Spain|Hospital Principe de Asturias, Alcalá De Henares, Madrid, Spain|Hospital Fundación de Alcorcón, Alcorcón, Madrid, Spain|Hospital Colllado Villalba, Collado-Villalba, Madrid, Spain|Hospital de Getafe, Getafe, Madrid, Spain|Hospital Severo Ochoa, Leganés, Madrid, Spain|Hospital de Móstoles, Móstoles, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Quirón Pozuelo, Pozuelo De Alarcón, Madrid, Spain|Hospital de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital Virgen del Castillo, Yecla, Murcia, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Reina Sofía, Tudela, Navarra, Spain|Hospital Arnau de Vilanova, Llíria, Valencia, Spain|Hospital de Araba, Alava, Vitoria, Spain|Hospital General Universitario de Albacete, Albacete, Spain|Centro Médico Teknon, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Dexeus, Barcelona, Spain|Hospital Quirón Barcelona, Barcelona, Spain|Hospital Universitario Sagrat Cor, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Virgen de la Luz, Cuenca, Spain|Hospital Clínico San Cecilio, Granada, Spain|Hospital Universitario de León, León, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Infanta Leonor, Madrid, Spain|Hospital La Princesa, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario Gregorio Marañon, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Puerta de Hierro, Madrid, Spain|Hospital Reina Sofía, Murcia, Spain|Hospital Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Virgen de la Victoria, Málaga, Spain|Complejo Asistencial de Palencia, Palencia, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocio, Sevilla, Spain|Hospital Virgen Macarena, Sevilla, Spain|Hospital Clinico Universitario, Valencia, Spain|Hospital Dr. Peset, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital La Fe, Valencia, Spain|Hospital de Valladolid, Valladolid, Spain|Hospital Rio Hortega, Valladolid, Spain|Hospital Lozano Blesa, Zaragoza, Spain|Hospital Miguel Servet, Zaragoza, Spain|Hospital Nuestra Señora de Sonsoles, Ávila",Spain,Respiratory Diseases,1,1,260.0
1176.0,NCT04550403,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,,Recruiting,Diabetes Mellitus,COVID-19,,,,,,,Azienda Ospedaliero-Universitaria di Parma,All,"Child, Adult, Older Adult",700.0,Other,Observational,2020-07-30,30/05/21,2021-12-31,16/09/20,13/01/21,"Endocrinology and metabolic diseases Unit, Parma",Italy,"Respiratory Diseases, Metabolic Disorders",1,2,519.0
1177.0,NCT04349228,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,COVID_2Pro,Withdrawn,COVID-19,Sars-CoV2,Hydroxychloroquine,Prophylaxis,Healthcare Worker,,,Drug: Hydroxychloroquine (HCQ)|Drug: Placebo oral tablet,Abderrahmane Mami Hospital|Eshmoun Clinical Research Centre|Datametrix,All,"18 Years to 65 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-28,15/07/20,2020-07-15,16/04/20,28/08/20,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Tunis",Tunisia,Respiratory Diseases,1,5,78.0
1178.0,NCT04328272,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Covid,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 500Mg Oral Tablet|Dietary Supplement: Glucose tablets,"Prof. Dr. Umar Farooq|Ayub Medical College, Abbottabad",All,18 Years to 50 Years   (Adult),75.0,Other,Interventional,2020-03-28,28/05/20,2020-06-28,31/03/20,02/04/20,"Ayub Teaching Institution, Abbottābād, K.p.k",Pakistan,Respiratory Diseases,1,1,92.0
1179.0,NCT04429620,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,IIF,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: Immunfluorescence,"Szeged University|Bilogical Research Centre, Szeged",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-30,31/12/20,2020-12-31,12/06/20,25/06/20,"University of Szeged, Albert Szent-Györgyi Health Center, Szeged",Hungary,Respiratory Diseases,1,1,215.0
1180.0,NCT04640402,A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),,Recruiting,COVID-19,,,,,,,Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (18-59 years) & Three dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: Low-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Two dose regimen|Biological: High-dose Recombinant COVID-19 vaccine (Sf9 cells) (60-85 years) & Three dose regimen|Biological: Low-dose placebo (18-59 years) & Two dose regimen|Biological: Low-dose placebo (18-59 years) & Three dose regimen|Biological: High-dose placebo (18-59 years) & Two dose regimen|Biological: High-dose placebo (18-59 years) & Three dose regimen|Biological: Low-dose placebo (60-85 years) & Two dose regimen|Biological: Low-dose placebo (60-85 years) & Three dose regimen|Biological: High-dose placebo (60-85 years) & Two dose regimen|Biological: High-dose placebo (60-85 years) & Three dose regimen,Jiangsu Province Centers for Disease Control and Prevention|West China Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",960.0,Other,Interventional,2020-11-17,18/02/21,2021-11-18,23/11/20,30/03/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,366.0
1181.0,NCT04459455,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",,Completed,Anxiety,,,,,,,Behavioral: Contain COVID Anxiety SSI|Behavioral: Remain COVID Free SSI,Stony Brook University,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-08-19,15/10/20,2020-10-15,07/07/20,20/10/20,"Stony Brook University, Stony Brook, New York",United States,Mental Health,1,1,57.0
1182.0,NCT04426084,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,,"Active, not recruiting",COVID-19,,,,,,,Other: Hypertension|Other: Diabetes type 2|Other: Obesity|Drug: Antihypertensive Agents|Drug: Statins (Cardiovascular Agents),Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",22784.0,Other,Observational,2020-01-03,11/05/20,2022-12-31,11/06/20,11/06/20,"Södersjukhuset, Stockholm",Sweden,Respiratory Diseases,1,1,1093.0
1183.0,NCT04694716,Determination of Serum Trace Element and Physical Activity Levels in COVID-19,,Recruiting,COVID-19,,,,,,,Other: No intervention,Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,All,"35 Years to 65 Years   (Adult, Older Adult)",40.0,Other,Observational,2021-06-01,01/02/21,2021-01-03,05/01/21,11/02/21,"Kadirhan Ozdemir, İzmir",Turkey,Respiratory Diseases,1,1,-149.0
1184.0,NCT04476602,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,CROWN,Recruiting,COVID-19,,,,,,,,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-27,31/12/20,2020-12-31,20/07/20,16/09/20,"410 Lakeville Road, Suite 107, New Hyde Park, New York",United States,Respiratory Diseases,1,1,248.0
1185.0,NCT04366245,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,,Recruiting,SARS-CoV 2,,,,,,,Biological: Hyperimmune plasma|Drug: Standard of care for SARS-CoV-2 infection,Andalusian Network for Design and Translation of Advanced Therapies,All,"18 Years to 80 Years   (Adult, Older Adult)",72.0,Other,Interventional,2020-04-23,01/12/21,2021-01-12,28/04/20,11/06/20,"Hospital U. Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital U. Puerto Real, Puerto Real, Cádiz, Spain|Hospital Costa del Sol, Marbella, Málaga, Spain|Hospital U. Torrecárdenas, Almería, Spain|Hospital U. Puerta del Mar, Cádiz, Spain|Hospital U. Virgen de las Nieves, Granada, Spain|Hospital U. San Cecilio, Granada, Spain|Hospital Juan Ramón Jiménez, Huelva, Spain|Hospital Regional U. de Málaga, Málaga, Spain|Hospital U. Virgen de la Victoria, Málaga, Spain|Hospital Unversitario Virgen Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital U. Nuestra Señora de Valme, Sevilla, Spain|Hospital San Juan de Dios, Sevilla",Spain,Respiratory Diseases,1,1,264.0
1186.0,NCT04508712,Long-term Outcomes in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,,RenJi Hospital,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-10-08,31/08/21,2021-08-31,11/08/20,23/10/20,"Renji Hospital, Shanghai Jiaotong University School of Medicine, Pudong, Shanghai",China,Respiratory Diseases,1,1,327.0
1187.0,NCT04665193,An Approach to Screening for COVID-19 at Vancouver Airport,,Recruiting,Asymptomatic Condition,Healthy,,,,,,Diagnostic Test: Rapid Antigen Test,University of British Columbia|Vancouver Airport Authority|WestJet Airlines|Providence Health & Services,All,"19 Years to 80 Years   (Adult, Older Adult)",900.0,Other,Interventional,2020-11-23,30/04/21,2021-04-30,11/12/20,11/12/20,"Vancouver International Airport, WestJet Domestic Terminal, Level 3, Richmond, British Columbia",Canada,Others,0,2,158.0
1188.0,NCT04407169,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,CRITICoVid,Completed,COVID-19,,,,,,,Other: no intervention,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",617.0,Other,Observational,2020-01-06,17/11/20,2020-11-17,29/05/20,20/11/20,"Valentin Simon, Vandoeuvre Les Nancy",France,Respiratory Diseases,1,1,316.0
1189.0,NCT04770467,"A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19",,Not yet recruiting,COVID-19,,,,,,,Drug: BRII-196 and BRII-198|Drug: Placebo,"Brii Biosciences, Inc.|Brii Biosciences Limited",All,"18 Years and older   (Adult, Older Adult)",56.0,Industry,Interventional,2021-01-03,01/10/22,2022-01-10,25/02/21,12/03/21,"Investigative Site 1, Hong Kong",China,Respiratory Diseases,1,1,372.0
1190.0,NCT04677283,"Study of Symptoms Linked to Covid-19 in Residents and Professionals in EHPAD, Associated With a Dual Diagnostic Approach by PCR and Serology: a Cohort in Île-de-France.",COVID - EHPAD,Recruiting,COVID-19,,,,,,,,Gérond'if,All,"18 Years and older   (Adult, Older Adult)",2020.0,Other,Observational,2020-05-04,01/12/20,2021-01-03,21/12/20,21/12/20,"Autonomy Department; ARS Île-de-France, Paris, ARS Île-de-France",France,Respiratory Diseases,1,1,244.0
1191.0,NCT04618861,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,,Completed,COVID-19,Pneumonia,Surfactant Protein Deficiency,,,,,,Kafkas University,,"18 Years and older   (Adult, Older Adult)",127.0,Other,Observational,2020-10-13,02/11/20,2020-02-11,06/11/20,06/11/20,"Aylin Koseler, Denizli, Outside Of The US",Turkey,Respiratory Diseases,1,3,-245.0
1192.0,NCT04344288,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,CORTI-Covid,Terminated,Viral Pneumonia Human Coronavirus,COVID-19,,,,,,Drug: Prednisone|Other: Control group,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",11.0,Other,Interventional,2020-04-21,18/08/20,2020-08-18,14/04/20,26/10/20,"Hôpital Pneumologique et Cardiovasculaire Louis Pradel, Bron, France|Groupement Hospitalier Nord, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital St Joseph Saint Luc, Lyon, France|Hôpital St Joseph, Marseille, France|Centre hospitalier Lyon Sud, Pierre-Bénite, France|CHU St Etienne, Saint-Étienne, France|Clinique Charcot, Sainte-Foy-lès-Lyon, France|CHG Vienne, Vienne, France|Médipôle, Villeurbanne, France|Clinique des Portes du Sud, Vénissieux, France|CH Annecy-Genevois, Épagny",France,Respiratory Diseases,1,2,119.0
1193.0,NCT04403906,Somerset and South Essex Coronavirus Antigen Testing,SOCRATES,Not yet recruiting,COVID-19,SARS-CoV 2,,,,,,Diagnostic Test: PCL COV05 - COVID 19 Ag Rapid FIA test (Rapid Antigen Test),Somerset NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-06,01/06/21,2021-01-08,27/05/20,27/05/20,"Musgrove Park Hospital, Taunton, Somerset",United Kingdom,Respiratory Diseases,1,2,368.0
1194.0,NCT04346355,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,,Terminated,COVID-19,,,,,,,Drug: Tocilizumab,Azienda Unità Sanitaria Locale Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",126.0,Other,Interventional,2020-03-31,06/06/20,2020-06-06,15/04/20,22/06/20,"Ospedale di Guastalla, Guastalla, RE, Italy|Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy|Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|Policlinico Sant'Orsola Malpighi, Bologna, Italy|ASST Cremona, Cremona, Italy|Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy|Azienda Ospedaliero Universitaria Ferrara, Ferrara, Italy|Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|Ospedale Evangelico Internazionale di Genova, Genova, Italy|Azienda Sociosanitaria ASL 1 ,Imperia, Imperia, Italy|Azienda Sociosanitaria ASL 5 La Spezia, La Spezia, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|IRCCS Istituto Auxologico Italiano Milano, Milano, Italy|Azienda Ospedaliero-Universitaria Maggiore della Carità di Novara, Novara, Italy|Ospedali Riuniti Padova Sud - ULSS 6 Euganea, Padova, Italy|Azienda Ospedaliero-Universitaria Parma, Parma, Italy|Azienda Unità Sanitaria Locale di Piacenza, Piacenza, Italy|Azienda Ospedaliera Universitaria Pisana, Pisa, Italy|AO Ordine Mauriziano di Torino, Torino, Italy|ASST Bergamo Ovest -Treviglio, Treviglio, Italy|AULSS 2 Marca Trevigiana, Treviso, Italy|AULSS2 Marca Trevigiana - Ospedale Vittorio Veneto, Treviso, Italy|AULSS 3 Serenissima Ospedale Dell'Angelo, Venezia, Italy|Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy|IRCCS Sacro Cuore Don Calabria, Verona",Italy,Respiratory Diseases,1,1,67.0
1195.0,NCT04644146,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),COVIDGEN,Recruiting,COVID-19,,,,,,,Genetic: GENETIC,Hospices Civils de Lyon,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-01-12,01/06/21,2021-01-12,25/11/20,25/11/20,"University Hospital LYON (Hospices Civils de LYON), Lyon",France,Respiratory Diseases,1,1,366.0
1196.0,NCT04765254,COVID-19 Infection in Diabetic Patients,,Recruiting,COVID-19,Diabete Type 2,Non Diabetic Patients,Chest CT Scan,,,,Other: no intervention as it is an observational study,Cairo University,All,"30 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-02-20,20/03/21,2021-10-04,21/02/21,21/02/21,"Cairo University teaching hospitals, Cairo, Kasr Al Ainy",Egypt,Respiratory Diseases,1,4,226.0
1197.0,NCT04366778,Thrombosis and Covid-19,COVBIO,Completed,Thrombosis,COVID-19,SARS-CoV 2,,,,,Diagnostic Test: TEM-tPA,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",341.0,Other,Observational,2020-01-05,01/01/21,2021-01-01,29/04/20,25/01/21,"Hôpital Louis Pradel, Bron",France,Respiratory Diseases,1,3,362.0
1198.0,NCT04353154,The RAPID COVID TRIAGE Algorithm,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Spartan Cube Point-of Care Covid-19 test,Ottawa Heart Institute Research Corporation,All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Observational,2020-04-15,31/01/21,2021-02-28,20/04/20,15/02/21,"University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,319.0
1199.0,NCT04838093,COVID-19 Testing in Patients With Vascular Disorders,,Completed,COVID-19,,,,,,,Diagnostic Test: PCR,Medical University of Vienna,All,"Child, Adult, Older Adult",2243.0,Other,Observational,2020-01-03,01/12/20,2021-01-01,08/04/21,08/04/21,"Medical University of Vienna, Vienna",Austria,Respiratory Diseases,1,1,364.0
1200.0,NCT04340479,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,,Recruiting,COVID-19,Trauma,Ultrasound,,,,,Diagnostic Test: Ultrasound lung imaging as part of FAST+ evaluation,"University of Colorado, Denver",All,"Child, Adult, Older Adult",20.0,Other,Observational,2020-07-30,01/05/22,2022-01-05,09/04/20,24/08/20,"Children's Hospital Colorado, Aurora, Colorado",United States,Respiratory Diseases,1,3,524.0
1201.0,NCT04828460,Monitoring of COVID-19 Vaccine Response in Organ Transplant Patients,COVATRANS,Recruiting,COVID-19,Kidney Transplantation,,,,,,,"University Hospital, Strasbourg, France",All,"Child, Adult, Older Adult",3500.0,Other,Observational,2021-09-02,01/06/21,2023-01-02,02/04/21,02/04/21,"Hôpitaux Universitaires de Strasbourg, Strasbourg",France,Respiratory Diseases,1,2,487.0
1202.0,NCT04377672,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),,Recruiting,Corona Virus Infection,,,,,,,Biological: Anti-SARS-CoV-2 Human Convalescent Plasma,Johns Hopkins University,All,"1 Month to 18 Years   (Child, Adult)",30.0,Other,Interventional,2020-05-28,28/05/21,2022-05-28,06/05/20,02/06/20,"Johns Hopkins Hospitals, Baltimore, Maryland",United States,Respiratory Diseases,1,1,730.0
1203.0,NCT04399252,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,,Recruiting,Microbiome,,,,,,,Dietary Supplement: Lactobaciltus rhamnosus GG|Dietary Supplement: Lactobaciltus rhamnosus GG Placebo,Duke University,All,"1 Year and older   (Child, Adult, Older Adult)",1132.0,Other,Interventional,2020-06-24,25/05/22,2022-05-25,22/05/20,01/04/21,"Duke University, Durham, North Carolina",United States,Others,0,1,700.0
1204.0,NCT04587323,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,,Recruiting,COVID-19,,,,,,,,University of Alabama at Birmingham,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-22,20/03/23,2023-05-20,14/10/20,14/10/20,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,1,1093.0
1205.0,NCT04590274,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),,Not yet recruiting,COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Hydroxychloroquine|Dietary Supplement: Vitamins and Minerals|Drug: Azithromycin,International Brain Research Foundation,All,"Child, Adult, Older Adult",5000.0,Other,Interventional,2020-01-11,01/12/21,2021-01-12,19/10/20,19/10/20,,,Respiratory Diseases,1,2,367.0
1206.0,NCT04534712,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: LYMPHOCYTE MONOCYTE RATIO,Postgraduate Institute of Medical Education and Research|Sir Ganga Ram Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-09,01/12/20,2021-01-02,01/09/20,01/09/20,"Sir Ganga Ram Hospital, New delhi, Delhi",India,Respiratory Diseases,1,1,359.0
1207.0,NCT04292327,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,2019-nCoV,"Active, not recruiting",Pneumonia Caused by Human Coronavirus,,,,,,,,Fujian Provincial Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-01-01,30/04/20,2020-07-31,03/03/20,03/03/20,"Fujian Provincial Hospital, Fuzhou, Fujian",China,Respiratory Diseases,1,1,212.0
1208.0,NCT04669938,"Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients",MicrobioCOVID,Recruiting,COVID-19,,,,,,,Other: oropharyngeal and intestinal microbiota|Other: host genotype|Other: host immune factors|Other: viral sequence,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-12,31/03/22,2022-03-31,17/12/20,17/12/20,"LESCURE, Paris",France,Respiratory Diseases,1,1,718.0
1209.0,NCT04780321,JS016 (Anti-SARS-CoV-2 Monoclonal Antibody)With Mild and Moderate COVID-19 or SARS-CoV-2 Asymptomatic Infection Subects,,Recruiting,COVID-19,,,,,,,Biological: Recombinant Human Anti-SARS-CoV-2 Monoclonal Antibody(25mg/kg;50mg/kg;100mg/kg)|Drug: Placebo,"Shanghai Junshi Bioscience Co., Ltd.",All,"18 Years to 65 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-10-30,31/03/21,2021-06-30,03/03/21,03/03/21,"Beijing Ditan Hospital affiliated to Capital Medical University, Beijing, China|Huashan Hospital affiliated to Fudan University, Shanghai",China,Respiratory Diseases,1,1,243.0
1210.0,NCT04633980,Hydrogen Therapy in Patients With Moderate Covid-19,H2Covid,Not yet recruiting,COVID-19,,,,,,,"Drug: Mixture 3,6% H2 in N2 (96.4%)","University Hospital, Grenoble",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-12,30/08/21,2021-09-30,18/11/20,18/11/20,,,Respiratory Diseases,1,1,627.0
1211.0,NCT04422613,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,PULCO-19,"Active, not recruiting","Pneumonia, Viral",,,,,,,Diagnostic Test: pulmonary anomalies 4 months after documented COVID-19 pneumonia,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",73.0,Other,Interventional,2020-05-28,01/05/21,2022-01-05,09/06/20,05/11/20,"University Hospital of Toulouse, Toulouse",France,Respiratory Diseases,1,1,587.0
1212.0,NCT04354389,DAS181 for STOP COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: DAS181|Drug: Placebo,"Ansun Biopharma, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-07-25,30/09/20,2020-11-30,21/04/20,11/08/20,"Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|A.O.U Policlinico Di Modena, Modena",Italy,Respiratory Diseases,1,1,128.0
1213.0,NCT04373824,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,Max Healthcare Insititute Limited,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-25,25/07/20,2020-07-25,04/05/20,04/05/20,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi",India,Respiratory Diseases,1,1,91.0
1214.0,NCT04407156,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,,Completed,COVID-19,AKI,,,,,,Other: acute kidney injury,University Hospitals of Derby and Burton NHS Foundation Trust,All,"18 Years to 110 Years   (Adult, Older Adult)",724.0,Other,Observational,2020-01-06,07/06/20,2020-07-20,29/05/20,09/09/20,"Derby Hospital NHS Foundation Trust, Derby, Derbyshire",United Kingdom,Respiratory Diseases,1,2,196.0
1215.0,NCT04534803,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),,Not yet recruiting,COVID-19,,,,,,,Drug: BCG Vaccine|Other: Placebo,"Harvard Medical School|Texas Medical Research Associates, L.L.C.",All,70 Years and older   (Older Adult),2100.0,Other,Interventional,2021-01-09,30/10/22,2022-11-30,01/09/20,18/02/21,,,Respiratory Diseases,1,1,690.0
1216.0,NCT04365231,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,HASCOPT,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine and azithromycin treatment|Other: conventional management of patients,"Hospital St. Joseph, Marseille, France",Female,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,01/06/20,2021-01-04,28/04/20,20/11/20,,,Respiratory Diseases,1,1,366.0
1217.0,NCT04806867,Selection of Patients With Chronic Inflammatory Rheumatism Requiring Management During the COVID-19 Pandemia,SePaRIC,Completed,COVID-19,Inflammatory Rheumatism,Rheumatoid Arthritis,Spondyloarthritis,Inflammatory Arthritis,,,Other: SePaRIC-Covid19 cohort,"University Hospital, Limoges",All,"18 Years and older   (Adult, Older Adult)",918.0,Other,Observational,2020-01-05,01/07/20,2020-07-31,19/03/21,01/04/21,"Service de Rhumatologie, CHu de Limoges, Limoges",France,"Respiratory Diseases, Immunological Disorders",1,5,208.0
1218.0,NCT04416464,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,,Recruiting,Quality of Life,Long-term Outcomes,Coronavirus Infection,Morality,Rehospitalization,,,Other: COVID-19 Pneumonia,"Universidade do Porto|Centro Hospitalar De São João, E.P.E.|Centro Hospitalar do Porto|Universidade do Algarve|Centro Hospitalar Lisboa Ocidental",All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Observational,2020-06-15,31/07/22,2022-01-10,04/06/20,30/03/21,"Centro Hospitalar Universitário do Algarve, Faro, Algarve, Portugal|Hospital de São Francisco Xavier, Lisbon, Portugal|Centro Hospitalar Universitário de São João, Porto, Portugal|Centro Hospitalar Universitário do Porto - Hospital de Santo António, Porto",Portugal,Respiratory Diseases,1,5,574.0
1219.0,NCT04841707,Total-Body Parametric 18F-FDG PET of COVID-19,,Recruiting,COVID-19,,,,,,,Device: uEXPLORER/mCT,"University of California, Davis",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2021-04-22,22/02/22,2023-02-22,12/04/21,14/04/21,"University of California, Davis, Sacramento, California",United States,Respiratory Diseases,1,1,671.0
1220.0,NCT04710199,Trial to Evaluate the Safety and Efficacy of Maraviroc in Patients Hospitalized for Coronavirus Disease 2019 (COVID-19),COVIMAR,Recruiting,Virus Diseases,,,,,,,Drug: Maraviroc experimental group|Other: Standard treatment,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-08-02,01/08/21,2021-01-10,14/01/21,06/04/21,"Hospital Universitario Virgen del Rocio, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla",Spain,Others,0,1,-204.0
1221.0,NCT04416308,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),AntiCoV-HB,Completed,Coronavirus,,,,,,,Diagnostic Test: NG test|Diagnostic Test: Blood test|Behavioral: Self-questionnary,Rennes University Hospital|Fonds NOMINOE,All,"18 Years and older   (Adult, Older Adult)",9453.0,Other,Interventional,2020-05-29,10/07/20,2020-12-10,04/06/20,14/04/21,"CENTRE HOSPITALIER de VITRE_ Saint Jean (La Guerche), La Guerche de Bretagne, La Guerche-de-Bretagne, France|Centre Hospitalier de Fougeres, Fougères, France|Centre Hospitalier Grand Fougeray, Grand-Fougeray, France|Centre Hospitalier de La Roche Aux Fees, Janzé, France|Centre Hospitalier Montfort-Sur-Meu, Montfort sur Meu, France|Centre Hospitalier de Redon Carentoir, Redon, France|Chu Rennes, Rennes, France|Centre Hospitalier St Meen Le Grand, Saint-Méen-le-Grand, France|CENTRE HOSPITALIER VITRE_Simone Veil, Vitré",France,Respiratory Diseases,1,1,195.0
1222.0,NCT04542850,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",,Recruiting,SARS-CoV 2,COVID-19,,,,,,Dietary Supplement: 5-ALA-Phosphate + SFC (5-ALA + SFC),Royal College of Surgeons in Ireland - Medical University of Bahrain|Bahrain Defence Force Hospital|Salmaniya Medical Complex,All,"21 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-11-15,15/06/21,2021-09-15,09/09/20,26/02/21,"Bahrain Defense Force Royal Medical Services, Military Hospital, Manama, Bahrain|Salmaniya Medical Complex, Manama",Bahrain,Respiratory Diseases,1,2,304.0
1223.0,NCT04381988,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,,Recruiting,COVID-19,Cancer,,,,,,Drug: Hydroxychloroquine|Other: Placebo|Radiation: Radiation therapy,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",132.0,Other,Interventional,2020-07-05,01/05/21,2021-01-05,11/05/20,13/05/20,"Memoral Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (All protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (All protocol activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York",United States,"Respiratory Diseases, Cancers",1,2,184.0
1224.0,NCT04790994,COVID-19 Prevalence in UNIVI Geriatric Institutions: Epidemiological Study of Immunological Status With Rapid Serological Tests,,"Active, not recruiting",COVID-19,,,,,,,,Centre Médical Porte Verte,All,"Child, Adult, Older Adult",1145.0,Other,Observational,2020-07-24,16/10/20,2021-04-16,10/03/21,10/03/21,"CentreMédicalPorteVerte, Versailles",France,Respiratory Diseases,1,1,266.0
1225.0,NCT04585945,COVID-19 on Placental Gene Expression and Pathology,PROSPER,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Positive for SARS-CoV-2 infection,Prisma Health-Upstate,Female,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-08,31/03/21,2021-09-30,14/10/20,03/02/21,"Prisma Health Upstate, Greenville, South Carolina",United States,Respiratory Diseases,1,2,540.0
1226.0,NCT04681430,Reconvalescent Plasma/Camostat Mesylate Early in SARS-CoV-2 Q-PCR (COVID-19) Positive High-risk Individuals,RES-Q-HR,Recruiting,Corona Virus Infection,COVID-19,COVID-19,COVID-19,,,,Biological: Convalescent plasma|Drug: Camostat Mesilate|Drug: Placebo for Camostat Mesilate|Other: Standard of Care (SoC),"Heinrich-Heine University, Duesseldorf|The Federal Ministry of Health, Germany (Bundesministerium für Gesundheit, BMG)",All,"18 Years and older   (Adult, Older Adult)",1094.0,Other,Interventional,2021-08-01,01/05/21,2021-01-11,23/12/20,01/02/21,"Abteilung Infektiologie Klinik für Innere Medizin II Department Innere Medizin Universitätsklinikum Freiburg, Freiburg im Breisgau, Baden-Württemberg, Germany|Klinik und Poliklinik für Innere Medizin II Klinikum rechts der Isar Technische Universität München, München, Bavaria, Germany|Universitätsklinikum Frankfurt Medizinische Klinik 2: Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie/HIV, Frankfurt am Main, Hessen, Germany|Universitätsklinikum Düsseldorf Klinik für Hepatologie und Infektiologie, Duesseldorf",Germany,Respiratory Diseases,1,4,-202.0
1227.0,NCT04446065,Previfenon® as Chemoprophylaxis of COVID-19 in Health Workers,HERD,Not yet recruiting,COVID-19,SARS-CoV2,,,,,,Drug: Previfenon®|Drug: Placebo,MELISA Institute Genomics & Proteomics Research SpA|Universidad Austral,All,"25 Years and older   (Adult, Older Adult)",524.0,Industry|Other,Interventional,2020-09-30,30/09/21,2021-10-30,24/06/20,09/09/20,,,Respiratory Diseases,1,2,395.0
1228.0,NCT04667923,Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome,COVID-NIV,Recruiting,COVID-19,ARDS,,,,,,Diagnostic Test: Respiratory monitoring|Diagnostic Test: Respiratory muscles ultrasound|Diagnostic Test: Electro impedance tomography|Diagnostic Test: Capnography|Diagnostic Test: Arterial blood gas|Diagnostic Test: Quasistatic pressure-volume curve,I.M. Sechenov First Moscow State Medical University,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-01-10,01/06/21,2021-01-08,16/12/20,08/04/21,"Sechenov University clinic #4, Moscow",Russian Federation,Respiratory Diseases,1,2,364.0
1229.0,NCT04483635,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,PROTECT,Recruiting,COVID-19,,,,,,,Dietary Supplement: Placebo|Dietary Supplement: Vitamin D,St. Justine's Hospital|Canadian Institutes of Health Research (CIHR)|Laboratoire RIVA,All,"18 Years to 69 Years   (Adult, Older Adult)",2414.0,Other,Interventional,2021-08-02,30/09/21,2021-12-31,23/07/20,21/02/21,"CHUM, Montreal, Quebec, Canada|CHU Sainte-Justine (CHUSJ), Montreal, Quebec",Canada,Respiratory Diseases,1,1,151.0
1230.0,NCT04331106,Survey of the Anxiety Associated With the COVID-19 Pandemic,CORA,Recruiting,COVID-19,,,,,,,Diagnostic Test: Online Questionnaire,"Charite University, Berlin, Germany",All,"18 Years and older   (Adult, Older Adult)",7500.0,Other,Observational,2020-03-27,01/04/22,2022-01-04,02/04/20,27/01/21,"Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy, Berlin",Germany,Respiratory Diseases,1,1,648.0
1231.0,NCT04516811,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,,Recruiting,COVID-19,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,Biological: COVID-19 convalescent plasma (CCP) plus standard of care (SOC)|Biological: Standard of care (SOC) plus placebo,South African National Blood Service,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-09-21,30/12/21,2022-07-31,18/08/20,25/09/20,"Universitas Hospital, Bloemfontein, Free State, South Africa|Mitchells Plain Hospital, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,3,678.0
1232.0,NCT04838834,Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children,RECONN,"Active, not recruiting",COVID-19,COVID-19,Inflammatory Bowel Diseases,,,,,,Connecticut Children's Medical Center|The Jackson Laboratory,All,"2 Years to 27 Years   (Child, Adult)",472.0,Other,Observational,2020-05-15,31/12/24,2024-12-31,09/04/21,09/04/21,"Connecticut Children's Medical Center, Hartford, Connecticut",United States,Respiratory Diseases,1,3,1691.0
1233.0,NCT04561063,COVID-19 Prophylaxis South Africa (COVER HCW),COVER,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Nitazoxanide|Drug: Sofosbuvir/Daclatasvir,"University of Witwatersrand, South Africa",All,"18 Years to 99 Years   (Adult, Older Adult)",1950.0,Other,Interventional,2020-08-12,01/07/21,2021-01-07,23/09/20,16/12/20,"Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa|Sunnyside Office Park, Johannesburg, Gauteng",South Africa,Respiratory Diseases,1,2,148.0
1234.0,NCT04463264,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo,Laboratorios Roemmers S.A.I.C.F.,All,18 Years to 59 Years   (Adult),135.0,Industry,Interventional,2020-06-26,15/11/20,2020-12-26,09/07/20,08/10/20,"Hospital Universitario Austral, Presidente Derqui, Buenos Aires, Argentina",Argentina,Respiratory Diseases,1,1,183.0
1235.0,NCT04793984,Efficacy and Safety Evaluation of Inhaleen Inhalation in Hospitalized COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Device: Carragelose|Device: NaCl,Marinomed Biotech AG|Austian Research Promotion Agency,All,"18 Years and older   (Adult, Older Adult)",228.0,Industry|Other,Interventional,2021-08-03,30/06/21,2021-10-30,11/03/21,11/03/21,"Gesundheitsverbund, Klinik Floridsdorf, Vienna",Austria,Respiratory Diseases,1,1,88.0
1236.0,NCT04576351,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,NeuroCovid,Recruiting,COVID-19,,,,,,,Other: Observation,"Oslo University Hospital|University Hospital, Akershus|Haukeland University Hospital|Helse Stavanger HF|St. Olavs Hospital|University Hospital of North Norway|Vestre Viken Hospital Trust|Sykehuset Telemark|Sykehuset Innlandet HF|Ostfold Hospital Trust|The Hospital of Vestfold|Sorlandet Hospital HF|Nordlandssykehuset HF|Møre og Romsdal Hospital Trust",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-01-09,31/12/23,2023-12-31,06/10/20,03/03/21,"Sørlandet Hospital Trust, Arendal, Norway|Haukeland University Hospital, Bergen, Norway|Nordlandssykehuset, Bodo, Norway|Vestre Viken Hospital Trust Drammen, Drammen, Norway|Østfold Hospital Trust Kalnes, Grålum, Norway|Sørlandet Hospital Trust, Kristiansand, Kristiansand, Norway|Innlandet Hospital Trust, Lillehammer, Norway|Akershus University Hospital, Lørenskog, Norway|Møre og Romsdal Hospital Trust, Molde, Norway|Oslo University Hospital, Oslo, Norway|Ostfold Hospital Trust, Sarpsborg, Norway|Skien Hospital, Skien, Norway|Stavanger University Hospital, Stavanger, Norway|University Hospital of North Norway, Tromsø, Norway|St. Olav Hospital, Trondheim",Norway,Respiratory Diseases,1,1,1452.0
1237.0,NCT04431856,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Co-PARENT,Completed,Anxiety,Depression,Traumatic Stress Disorder,,,,,Behavioral: Unified Protocol for COVID-19 Parenting Stress (UP-COVID)|Behavioral: SHG,University of Miami,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-05-15,17/11/20,2020-11-17,16/06/20,01/12/20,"University of Miami, Miami, Florida",United States,Mental Health,1,3,186.0
1238.0,NCT04643860,Differential Leucocyte Count and Covid-19 Diagnosis,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Differential Leucocyte Count (CLDC) device and algorithm,Neuromed IRCCS,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-12,01/02/21,2021-01-05,25/11/20,30/11/20,"IRCCS INM Neuromed, Department of Epidemiology and Prevention, Pozzilli, IS",Italy,Respiratory Diseases,1,1,359.0
1239.0,NCT04632615,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,Sleep&Covid19,"Active, not recruiting",Sleep,Athlete,Training,Exercise,COVID-19,"Isolation, Social",,,Istituto Ortopedico Galeazzi,All,18 Years to 40 Years   (Adult),84.0,Other,Observational,2020-05-22,31/03/21,2021-03-31,17/11/20,05/03/21,"IRCCS Istituto Ortopedico Galeazzi, Milan",Italy,Respiratory Diseases,1,6,313.0
1240.0,NCT04584697,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19",,Withdrawn,COVID-19,,,,,,,Biological: COVI-AMG|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-12,01/04/21,2021-01-04,14/10/20,12/02/21,,,Respiratory Diseases,1,1,358.0
1241.0,NCT04337918,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,NOCOVID,Completed,Corona Virus Infection,,,,,,,Drug: NORS (Nitric Oxide Releasing Solution),"Sanotize Research and Development corp.|The Emmes Company, LLC|Keyrus Life Science",All,"19 Years and older   (Adult, Older Adult)",143.0,Industry|Other,Interventional,2020-08-05,31/01/21,2021-02-02,08/04/20,10/02/21,"BC Diabetes, Vancouver, British Columbia, Canada|LMC Manna, Pointe-Claire, Quebec, Canada|Diex Recherche Québec, Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Diex Recherche Sherbrooke, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,1,181.0
1242.0,NCT04715607,"COVID-19: SARS-CoV-2 Detection in Saliva, Oropharyngeal and Nasopharyngeal Specimens",,Recruiting,SARS-CoV Infection,COVID-19,Coronavirus,,,,,Diagnostic Test: Sequence of testing.,"Rigshospitalet, Denmark|Hvidovre University Hospital|Region Hovedstaden",All,"16 Years to 120 Years   (Child, Adult, Older Adult)",22000.0,Other,Interventional,2021-01-22,05/05/21,2021-05-30,20/01/21,10/03/21,"Valby COVID-19 teststed, Copenhagen, Valby",Denmark,Respiratory Diseases,1,3,128.0
1243.0,NCT04331600,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,,Completed,COVID-19,,,,,,,Drug: Chloroquine phosphate|Other: Telemedicine,Wroclaw Medical University,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Interventional,2020-04-16,17/12/20,2020-12-17,02/04/20,11/02/21,"Uniwersytecki Szpital Kliniczny, Wrocław, Ul. Borowska 213, Poland|Wielospecjalistyczny Szpital Miejski, Poznań, Ul. Szwajcarska 3",Poland,Respiratory Diseases,1,1,245.0
1244.0,NCT04559100,Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus,,Enrolling by invitation,COVID-19,,,,,,,Radiation: chest radiography|Radiation: thoracic computed tomography scan|Diagnostic Test: spirometry|Diagnostic Test: Diffusing capacity of carbon monoxide|Diagnostic Test: 6 minute walk test|Diagnostic Test: saint george respiratory questionnaire,Fundacion Clinica Valle del Lili,All,"18 Years to 100 Years   (Adult, Older Adult)",112.0,Other,Observational,2020-11-15,01/10/21,2021-01-10,22/09/20,11/02/21,"Fundacion Valle del Lili, Cali, Valle Del Cauca",Colombia,Respiratory Diseases,1,1,56.0
1245.0,NCT04547127,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),,Completed,COVID-19,,,,,,,Biological: Convalescent anti-SARS-CoV-2 MBT Plasma|Drug: Standard Medical Treatment,"Instituto Grifols, S.A.|Grifols Therapeutics LLC",All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2020-04-29,04/02/21,2021-04-02,14/09/20,03/03/21,"Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Spain|Hospital Universitari Arnau de Vilanova, Lleida, Spain|Fundación Jimenez Diaz, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario La Princesa, Madrid, Spain|Complejo Hospitalario Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital Clínico Universitario de Santiago -CHUS, Santiago, Spain|Hospital Universitari Joan XXIII, Tarragona",Spain,Respiratory Diseases,1,1,338.0
1246.0,NCT04582266,PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,,Recruiting,COVID-19,,,,,,,Drug: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),Female,"Child, Adult, Older Adult",40.0,NIH,Observational,2021-12-02,15/01/22,2022-01-15,09/10/20,25/03/21,"USC/Los Angeles County Medical Center NICHD CRS (5048), Los Angeles, California, United States|David Geffen School of Medicine at UCLA (CRS 5112), Los Angeles, California, United States|University California, San Diego (CRS 4601), San Diego, California, United States|Childrens Hospital (U. Colorado, Denver) NICHD CRS (5052), Denver, Colorado, United States|University of Florida (5051), Jacksonville, Florida, United States|Univ of Miami Pediatric/Perinatal HIV/AIDS (4201), Miami, Florida, United States|Emory University School of Medicine (CRS 5030), Atlanta, Georgia, United States|Ann & Robert H Lurie Children's Hospital of Chicago (4001), Chicago, Illinois, United States|Rush University Cook County Hospital NICHD CRS (5083), Chicago, Illinois, United States|Johns Hopkins University NICHD CRS (5092), Baltimore, Maryland, United States|Boston Medical Center Ped. HIV Program NICHD CRS (5011), Boston, Massachusetts, United States|Bronx-Lebanon Hospital Center (CRS 5114), Bronx, New York, United States|Jacobi Med. Ctr. Bronx NICHD CRS (5013), Bronx, New York, United States|Stony Brook University Medical Center (CRS 5040), Stony Brook, New York, United States|St. Jude Childrens Research Hosp, Memphis (6501), Memphis, Tennessee, United States|Texas Children's Hospital, Houston, Texas, United States|University of Puerto Rico Pediatric HIV/AIDS CRS (6601), San Juan",Puerto Rico,Respiratory Diseases,1,1,44.0
1247.0,NCT04552340,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",,Recruiting,COVID-19,,,,,,,Other: Patient with SAR-CoV-2 infection,Istituto Clinico Humanitas,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-03-16,01/03/23,2023-01-07,17/09/20,17/09/20,"Humanitas Research Hospital, Rozzano, Milan",Italy,Respiratory Diseases,1,1,1027.0
1248.0,NCT04324489,DAS181 for Severe COVID-19: Compassionate Use,,Completed,COVID-19,,,,,,,Drug: DAS181,"Renmin Hospital of Wuhan University|Ansun Biopharma, Inc.",All,"18 Years to 70 Years   (Adult, Older Adult)",4.0,Other|Industry,Interventional,2020-06-03,16/04/20,2020-04-30,27/03/20,05/05/20,"Renmin Hospital of Wuhan University, Wuhan, Hubei",China,Respiratory Diseases,1,1,-34.0
1249.0,NCT04691947,Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC,ERUCOV-VAC,Recruiting,COVID-19,,,,,,,Biological: ERUCOV-VAC|Other: Placebo Vaccine,Health Institutes of Turkey|TC Erciyes University,All,18 Years to 55 Years   (Adult),44.0,Other,Interventional,2020-05-11,01/03/21,2022-03-15,31/12/20,05/01/21,"Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri",Turkey,Respiratory Diseases,1,1,673.0
1250.0,NCT04834739,Comparison of Functional Capacities of Healthcare Workers With and Without Covid-19,,Recruiting,COVID-19,Functional Capacity,,,,,,Other: 6 minute walk test|Other: 1 minute Sit to Stand Test|Other: Fatigue Severity Scale|Other: Medical Research Council (MRC) dyspnea scale|Other: SF-12|Other: Beck Depression Inventory|Other: Beck Anxiety Inventory|Other: 5 times sit to stand test|Other: 6 point Likert Scale,Gaziosmanpasa Research and Education Hospital,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-04-01,28/03/21,2021-04-30,08/04/21,08/04/21,"Gaziosmanpasa Training and Research Hospital, Istanbul, Turkey|Gaziosmanpasa Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,29.0
1251.0,NCT04473053,Rapid Experimental Medicine for COVID-19,DEFINE,Recruiting,COVID-19,,,,,,,Drug: Nafamostat Mesilate|Drug: TD139|Other: Standard care,University of Edinburgh|University of Oxford|Latus Therapeutics,All,"16 Years and older   (Child, Adult, Older Adult)",60.0,Other,Interventional,2020-03-07,03/07/21,2021-03-12,16/07/20,21/08/20,"NHS Lothian, Edinburgh",United Kingdom,Respiratory Diseases,1,1,370.0
1252.0,NCT04429724,Health Professional Exposure Assessment to Covid-19,SERODRON,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Diagnostic test Covid-19,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",2129.0,Other,Interventional,2020-06-07,01/04/21,2021-01-12,12/06/20,26/01/21,"CH Roubaix, Roubaix, France|CH Tourcoing, Tourcoing, France|CH Wasquehal, Wasquehal, France|CH Wattrelos, Wattrelos",France,Respiratory Diseases,1,1,219.0
1253.0,NCT04320017,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,JOCOVID,Recruiting,COVID-19,Myocardial Injury,Myocarditis,,,,,"Diagnostic Test: Electrocardiogram, transthoracic echocardiography and clinico-biological parameters in routine care",Groupe Hospitalier Pitie-Salpetriere,All,"16 Years and older   (Child, Adult, Older Adult)",500.0,Other,Observational,2020-03-20,20/05/20,2020-05-20,24/03/20,22/04/20,"Clinical Investigation Center Pitié-Salpêtrière, Paris",France,Respiratory Diseases,1,3,61.0
1254.0,NCT04498286,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,COMS-19,Recruiting,Multiple Sclerosis,,,,,,,Diagnostic Test: Testing of SARS-CoV-2 antibodies,Zoé van Kempen|VU University Medical Center,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-06-08,01/11/21,2021-01-12,04/08/20,04/08/20,"VU medical center, Amsterdam",Netherlands,Immunological Disorders,1,1,218.0
1255.0,NCT04558437,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",Covid-Impact,Recruiting,Post Traumatic Stress Disorder (PTSD),Anxiety,Depression,Epidemic Disease,COVID-19,,,Other: Questionnaire,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",20000.0,Other,Observational,2020-12-06,31/12/20,2020-12-31,22/09/20,22/09/20,"Assistance Publique - Hôpitaux de Paris, Paris, Ile De France",France,"Mental Health, Respiratory Diseases",1,5,25.0
1256.0,NCT04544150,Gastrointestinal Manifestations Among Patients With COVID19,,Completed,COVID-19,,,,,,,,Assiut University,All,"Child, Adult, Older Adult",220.0,Other,Observational,2020-01-06,01/09/20,2020-01-09,10/09/20,10/09/20,"Ahmed, Al Minyā, Alminya",Egypt,Respiratory Diseases,1,1,3.0
1257.0,NCT04364984,"ARB, ACEi, DRi in COVID-19",BIRCOV,Recruiting,Hypertension,COVID-19,,,,,,Drug: Angiotensin converting enzyme inhibitor,Medical Practice Prof D. Ivanov,All,"18 Years to 90 Years   (Adult, Older Adult)",10.0,Other,Observational,2020-01-04,01/05/21,2021-01-08,28/04/20,19/03/21,"Medical Practice Prof D.Ivanov, Kiev, Please Select",Ukraine,"Cardiovascular Diseases, Respiratory Diseases",1,2,370.0
1258.0,NCT04707534,Dexamethasone for COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Dexamethasone,University of Oklahoma,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2021-01-21,21/05/21,2021-06-21,13/01/21,28/01/21,"University of Oklahoma Medical Center, Oklahoma City, Oklahoma",United States,Respiratory Diseases,1,1,151.0
1259.0,NCT04813562,Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells),,Recruiting,COVID-19,,,,,,,"Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose recombinant COVID-19 vaccine (CHO Cell) (60-85 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (18-59 years) at the schedule of day 0, 28, 56|Biological: a middle-dose placebo (60-85 years) at the schedule of day 0, 28, 56|Biological: a high-dose placebo (60-85 years) at the schedule of day 0, 28, 56","Jiangsu Province Centers for Disease Control and Prevention|Academy of Military Medical Sciences，Academy of Military Sciences，PLA ZHONGYIANKE Biotech Co, Ltd. LIAONINGMAOKANGYUAN Biotech Co, Ltd",All,"18 Years to 85 Years   (Adult, Older Adult)",480.0,Other,Interventional,2021-03-23,30/07/21,2022-06-30,24/03/21,24/03/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,464.0
1260.0,NCT04433910,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,CAPSID,Completed,COVID-19,,,,,,,Drug: Convalesscent Plasma,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,All,"18 Years to 75 Years   (Adult, Older Adult)",106.0,Other,Interventional,2020-08-30,21/01/21,2021-02-22,16/06/20,17/03/21,"University Hospital Ulm, Ulm, Baden-Württmberg, Germany|University Hopsital Frankfurt, Frankfurt, Hessia, Germany|Saarland University Hospital, Homburg, Saarland, Germany|University Hospital Berlin, Charite, Berlin, Germany|Universitiy Hospital Dresden, Dresden, Germany|University Düsseldorf, Düsseldorf, Germany|University Hospital Freiburg, Freiburg, Germany|University Hospital Gießen, Gießen, Germany|University Hopsital Greifswald, Greifswald, Germany|Städtisches Klinikum Karslruhe, Karlsruhe, Germany|Universtity Hospital Schleswig-Holstein, Kiel, Germany|Universtity Hospital Schleswig-Holstein, Lübeck, Germany|University Hospital Mannheim, Mannheim, Germany|University Hospital Marburg, Marburg, Germany|Klinikum Stuttgart, Stuttgart, Germany|University Hospital Tübingen, Tübingen",Germany,Respiratory Diseases,1,1,176.0
1261.0,NCT04389710,Convalescent Plasma for the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Convalescent Plasma,Thomas Jefferson University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-15,14/04/21,2021-04-14,15/05/20,25/06/20,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,364.0
1262.0,NCT04362267,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,PRECOVIA,Recruiting,Sars-CoV2,,,,,,,Other: self-administered questionnaire|Diagnostic Test: SARS-Cov2 testing,"University Hospital, Lille|Fondation Santé Roquette",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-06-15,01/09/20,2020-01-09,24/04/20,06/08/20,"Hôpital Claude Huriez, CHU, Lille",France,Respiratory Diseases,1,1,-158.0
1263.0,NCT04587219,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",,"Active, not recruiting",Coronavirus Infection,,,,,,,Biological: Gam-COVID-Vac,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",All,"60 Years to 111 Years   (Adult, Older Adult)",110.0,Other,Interventional,2020-10-22,30/03/21,2021-04-30,14/10/20,22/01/21,"Federal state budgetary institution Central clinical hospital with polyclinic Of the office Of the President of the Russian Federation, Moscow",Russian Federation,Respiratory Diseases,1,1,190.0
1264.0,NCT04480411,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,,Not yet recruiting,Diagnoses Disease,COVID-19,,,,,,Behavioral: Doctorgram Patient Kit,Stanford University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-03,01/02/22,2022-01-02,21/07/20,01/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,2,364.0
1265.0,NCT04581746,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),coVIHd-19,Recruiting,Virus-HIV,COVID-19,,,,,,Other: questionnaire,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",1800.0,Other,Interventional,2020-11-25,01/12/21,2021-01-12,09/10/20,26/01/21,"CHU Amiens Picardie, Amiens, France|CH Lens, Lens, France|CH Tourcoing, Tourcoing",France,Respiratory Diseases,1,2,48.0
1266.0,NCT04379336,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,,Recruiting,COVID-19,Sars-CoV2,,,,,,Biological: Bacille Calmette-Guérin (BCG)|Other: Placebo Comparator,TASK Applied Science,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-05,28/04/21,2021-04-28,07/05/20,07/05/20,"TASK Foundation, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,2,388.0
1267.0,NCT04716985,Evaluation of the Daily Intake of 0.5 L of Water Saturated With Molecular Hydrogen for 21 Days in COVID-19 Patients Treated in Ambulatory Care,HYDRO COVID,Recruiting,COVID-19,COVID-19,AMBULATORY CARE,,,,,Dietary Supplement: MOLECULAR HYDROGEN|Dietary Supplement: PLACEBO MAGNESIUM,"AGIR à Dom|Laboratoire TIMC-IMAG|DrinkHRW, British Columbia, Canada",All,"60 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2021-01-22,22/07/21,2022-12-22,20/01/21,26/01/21,"Timc-Imag (Umr5525 Uga-Cnrs), Grenoble",France,Respiratory Diseases,1,3,699.0
1268.0,NCT04542213,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,Covid19DPP4i,Completed,Hyperglycemia,COVID-19,,,,,,Drug: Linagliptin tablet|Drug: Insulin,Hospital Regional de Alta Especialidad del Bajio,All,"18 Years to 75 Years   (Adult, Older Adult)",70.0,Other,Interventional,2020-01-08,28/02/21,2021-02-28,09/09/20,23/03/21,"Hospital Regional de Alta Especialidad del Bajìo, Leòn, Guanajuato",Mexico,Respiratory Diseases,1,2,417.0
1269.0,NCT04689399,Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test,,Completed,COVID-19,Rapid Antigen Test,COVID-19,,,,,"Diagnostic Test: Standard Q COVID-19 Ag - test, produced by SD Biosensor INC.","Rigshospitalet, Denmark|Testcenter Danmark, Statens Serum Institut|Copenhagen Emergency Medical Services",All,"18 Years and older   (Adult, Older Adult)",4697.0,Other,Interventional,2020-12-26,25/03/21,2021-03-25,30/12/20,30/03/21,"Christian von Buchwald, MD, DMSc, Professor, Copenhagen",Denmark,Respiratory Diseases,1,3,89.0
1270.0,NCT04780594,Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital,,Completed,COVID-19,Surgery--Complications,Nosocomial Infection,,,,,"Procedure: The study evaluates all surgical patients operated, both elective scheduled and emergent cases",Hospital Universitari de Bellvitge,All,"18 Years and older   (Adult, Older Adult)",2530.0,Other,Observational,2020-02-13,15/05/20,2020-09-12,03/03/21,03/03/21,"Marta Caballero, Hospitalet de Llobregat, Barcelona",Spain,Respiratory Diseases,1,3,212.0
1271.0,NCT04844541,Prophylaxis and Treatment of COVID-19,PROTECT-APT,Not yet recruiting,COVID-19,,,,,,,,"Henry M. Jackson Foundation for the Advancement of Military Medicine|Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-01-04,01/09/22,2022-01-12,14/04/21,14/04/21,"Johns Hopkins University, Baltimore, Maryland, United States|Duke Global Health Institute, Durham, North Carolina",United States,Respiratory Diseases,1,1,373.0
1272.0,NCT04469179,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",,"Active, not recruiting",COVID-19,SARS-CoV2,,,,,,Biological: SAB-185|Other: Normal Saline,"SAb Biotherapeutics, Inc.|Biomedical Advanced Research and Development Authority|Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)",All,18 Years to 60 Years   (Adult),21.0,Industry|U.S. Fed|Other,Interventional,2020-08-20,01/03/21,2021-01-04,13/07/20,04/03/21,"Quantum Clinical Trials, Miami Beach, Florida, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Sanford Health, Sioux Falls, South Dakota",United States,Respiratory Diseases,1,2,137.0
1273.0,NCT04828148,Incidence of Infection and Mortality by COVID-19 in Specialists,,Recruiting,COVID-19,Health Care Associated Infection,"Infection, Coronavirus",Death,,,,Behavioral: Survey,Instituto Mexicano del Seguro Social,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2021-01-03,30/05/21,2021-01-06,01/04/21,05/04/21,"Centro Médico Nacional de Occidente, Guadalajara, Jalisco",Mexico,Respiratory Diseases,1,4,3.0
1274.0,NCT04485130,DISulfiram for COvid-19 (DISCO) Trial,DISCO,Not yet recruiting,COVID-19,,,,,,,Drug: Disulfiram|Drug: Placebo,"University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-04-15,30/10/21,2022-03-15,24/07/20,17/03/21,"University of California San Francisco, Fresno, Fresno, California, United States|San Francisco General Hospital, San Francisco, California",United States,Respiratory Diseases,1,1,334.0
1275.0,NCT04357574,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,CORONA-SHIELD,Enrolling by invitation,COVID-19,Cancer,,,,,,Other: Telehealth,Duke University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-14,01/04/21,2021-01-04,22/04/20,02/04/21,"Duke Cancer Center, Durham, North Carolina",United States,"Respiratory Diseases, Cancers",1,2,265.0
1276.0,NCT04581161,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,,Recruiting,Acute Respiratory Failure,COVID-19,,,,,,Device: Life2000® Ventilator,Hill-Rom,All,"18 Years and older   (Adult, Older Adult)",10.0,Industry,Interventional,2020-08-28,01/10/20,2020-01-10,09/10/20,09/10/20,"Park Nicolette, Bloomington, Minnesota",United States,Respiratory Diseases,1,2,-231.0
1277.0,NCT04600440,Convalescent Plasma in the Treatment of Covid-19,COP 20,Recruiting,COVID-19,Respiratory Insufficiency,,,,,,Biological: Convalescent plasma,Skane University Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-25,31/12/21,2022-02-28,23/10/20,23/10/20,"Skåne University Hospital, Lund",Sweden,Respiratory Diseases,1,2,674.0
1278.0,NCT04715360,Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy,,Recruiting,COVID-19,Sars-CoV-2 Infection,"ARDS, Human",COVID-19,,,,Combination Product: autologous activated platelet-rich plasma|Drug: Avigan,Hayandra Peduli Foundation|Koja Regional Public Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-12-29,29/11/21,2021-12-27,20/01/21,20/01/21,"Koja Regional Public Hospital, Jakarta, DKI Jakarta",Indonesia,Respiratory Diseases,1,4,363.0
1279.0,NCT04608266,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,CAMOVID,Recruiting,COVID-19,,,,,,,Drug: Camostat Mesylate|Drug: Placebo,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",596.0,Other,Interventional,2020-03-12,01/01/22,2022-01-03,29/10/20,05/04/21,"Centre Hospitalier Victor Dupouy, Argenteuil, France|AP-HP Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Sud Ile de France - Melun, Melun, France|AP-HP Hôpital Bichat, Paris, France|APHP - Saint Louis, Paris, France|Centre de Santé Richerand, Paris",France,Respiratory Diseases,1,1,662.0
1280.0,NCT04630054,Face Masks to Reduce COVID-19 in Bangladesh,,Recruiting,COVID-19,,,,,,,Device: Face mask|Behavioral: Face mask awareness,Yale University|Stanford University|Innovations for Poverty Action|North South University,All,"18 Years and older   (Adult, Older Adult)",450000.0,Other,Interventional,2020-11-15,15/02/21,2021-02-15,16/11/20,22/01/21,"Innovations for Poverty Action, Dhaka",Bangladesh,Respiratory Diseases,1,1,92.0
1281.0,NCT04583969,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Lenzilumab|Other: Placebo|Drug: Remdesivir,"National Institute of Allergy and Infectious Diseases (NIAID)|Gritstone Oncology, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,NIH|Industry,Interventional,2020-10-19,31/12/21,2021-12-31,12/10/20,12/04/21,"St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic, Phoenix - Infectious Diseases, Phoenix, Arizona, United States|The University of Arizona - Banner University Medical Center Tucson Campus - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kern Medical Center, Bakersfield, California, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|Hoag Hospital Newport Beach, Newport Beach, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Penrose Hospital - Emergency Medicine, Colorado Springs, Colorado, United States|St. Francis Medical Center, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|St. Anthony Hospital North Health Campus, Westminster, Colorado, United States|Nuvance Health Danbury Hospital - Infectious Disease, Danbury, Connecticut, United States|Yale School of Medicine - The Anlyan Center for Medical Research & Education - Immunobiology, New Haven, Connecticut, United States|Nuvance Health - Norwalk Hospital - Asthma Pulmonary and Critical Care Medicine, Norwalk, Connecticut, United States|MedStar Washington Hospital Center - Infectious Diseases, Washington, District of Columbia, United States|Advent Health Orlando - Critical Care, Orlando, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine - Central DuPage Hospital - Infectious Disease, Winfield, Illinois, United States|University of Louisville - Division of Infectious Diseases, Louisville, Kentucky, United States|Pikeville Medical Center - Department of Infectious Disease, Pikeville, Kentucky, United States|Brigham and Women's Hospital - Infectious Diseases, Boston, Massachusetts, United States|Boston Medical Center - Center for Infectious Diseases - Shapiro Center, Boston, Massachusetts, United States|Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States|Englewood Hospital, Englewood, New Jersey, United States|Virtua Health - Virtua Voorhees Hospital - Pulmonology, Voorhees, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|The State University of New York - University at Buffalo - Department of Medicine, Buffalo, New York, United States|Mount Sinai School of Medicine - Medicine - Infectious Diseases, New York, New York, United States|Nuvance Health - Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Stony Brook Medicine - Stony Brook University Hospita, Stony Brook, New York, United States|East Carolina University Brody School of Medicine - Adult Specialty Care, Greenville, North Carolina, United States|Wake Forest Baptist Health - Infectious Diseases, Winston-Salem, North Carolina, United States|University of Toledo Medical Center - Ruppert Clinic, Toledo, Ohio, United States|St. Charles Health System - St. Charles Bend Hospital, Bend, Oregon, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States|Monument Health - Clinical Research, Rapid City, South Dakota, United States|Hendrick Health - Hendrick Medical Center, Abilene, Texas, United States|Texas Tech University Health Science Center, Amarillo, Texas, United States|Baptist Hospitals of Southeast Texas Site, Beaumont, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at Tyler, Tyler, Texas, United States|West Virginia University - Infectious Diseases Clinic, Morgantown, West Virginia",United States,Respiratory Diseases,1,1,438.0
1282.0,NCT04476888,Convalescent Plasma Treatment in COVID-19,COLLATE,Completed,COVID-19,,,,,,,Biological: Convalescent Plasma (CP)|Other: Drugs and supportive care,Aga Khan University,All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Interventional,2020-04-26,15/09/20,2020-10-10,20/07/20,20/01/21,"Aga Khan University Hospital, Karachi, Sind",Pakistan,Respiratory Diseases,1,1,167.0
1283.0,NCT04422509,Lanadelumab for Treatment of COVID-19 Disease,COVID_LAN,Recruiting,COVID-19,,,,,,,Biological: lanadelumab|Other: regular care,Radboud University|Takeda,All,"16 Years and older   (Child, Adult, Older Adult)",80.0,Other|Industry,Interventional,2020-03-10,03/08/21,2021-03-08,09/06/20,14/09/20,"Jereoen Bosch hospital, 's-Hertogenbosch, Netherlands|Amsterdam UMC, Amsterdam, Netherlands|Rijnstate hospital, Arnhem, Netherlands|Tergooi ziekenhuizen, Blaricum, Netherlands|Amphia hospital, Breda, Netherlands|Haga hospital, Den Haag, Netherlands|Radboudumc, Nijmegen, Netherlands|Elisabeth-Tweesteden ziekenhuis, Tilburg, Netherlands|UMC Utrecht, Utrecht, Netherlands|Isala klinieken, Zwolle",Netherlands,Respiratory Diseases,1,1,363.0
1284.0,NCT04626076,International Registry of Healthcare Workers Exposed to COVID-19 Patients,UNITY Global,Recruiting,SARS-CoV Infection,COVID-19,,,,,,Other: Comparative Observational Cohort Study,Certara|Bill and Melinda Gates Foundation|Parexel,All,"18 Years and older   (Adult, Older Adult)",10000.0,Industry|Other,Observational,2020-08-13,30/06/21,2021-10-31,12/11/20,12/11/20,"Aga Khan University, Karachi",Pakistan,Respiratory Diseases,1,2,444.0
1285.0,NCT04328285,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,COVIDAXIS,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo of Hydroxychloroquine|Drug: Lopinavir and ritonavir|Drug: Placebo of LPV/r Tablets,Centre Hospitalier Universitaire de Saint Etienne|Institut Pasteur,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other|Industry,Interventional,2020-04-14,30/03/21,2021-03-30,31/03/20,28/12/20,"CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|CHU de Clermont-Ferrand, Clermont-ferrand, France|CHU de Montpellier, Montpellier, France|CHU de Nancy, Nancy, France|CHU de Nantes, Nantes, France|AP-HP - Hôpital Bichat, Paris, France|CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de Saint-Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,350.0
1286.0,NCT04536298,Vitamin D and COVID-19 Trial,VIVID,Recruiting,COVID-19,,,,,,,Dietary Supplement: vitamin D|Dietary Supplement: Placebo,Brigham and Women's Hospital|Harvard Medical School|Harvard School of Public Health|Fenway Health and Beth Israel Deaconess Medical Center|Tishcon Corporation|Takeda|Quest Diagnostics-Nichols Insitute|Karolinska Institutet|Philanthropic donations,All,"18 Years and older   (Adult, Older Adult)",2700.0,Other|Industry,Interventional,2020-12-28,30/06/21,2021-06-30,02/09/20,06/04/21,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,184.0
1287.0,NCT04478539,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,,Recruiting,COVID-19,,,,,,,Device: Extracorporeal blood purification using the oXiris® (AN69ST) hemofilter,Zan Mitrev Clinic,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Interventional,2020-01-06,01/06/21,2021-01-07,20/07/20,20/07/20,"Zan Mitrev Clinic, Skopje",North Macedonia,Respiratory Diseases,1,1,367.0
1288.0,NCT04599959,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR,,Completed,COVID-19,,,,,,,Diagnostic Test: Sampling of SARS-CoV-2 RNA from nasopharyngeal swab specimen or saliva collected via Salivette Cortisol,Boehringer Ingelheim,All,"18 Years and older   (Adult, Older Adult)",144.0,Industry,Interventional,2020-10-26,20/01/21,2021-01-20,23/10/20,26/01/21,"Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico",Mexico,Respiratory Diseases,1,1,86.0
1289.0,NCT04578509,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,SALICOV,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva sample|Diagnostic Test: axillary sweat sample|Other: Data collection,Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",2750.0,Other,Observational,2020-10-19,01/04/21,2021-01-06,08/10/20,23/03/21,"SARS-CoV-2 screening device of Assistance Publique des Hôpitaux de Paris (AP-HP), Paris",France,Respiratory Diseases,1,2,79.0
1290.0,NCT04681040,Risk Stratification of COVID-19 Using Urine Biomarkers,,Recruiting,COVID-19,Urine,Biomarker,Acute Respiratory Failure With Hypoxia,,,,,"National Center for Global Health and Medicine, Japan",All,"20 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-12-19,31/03/22,2023-08-31,23/12/20,15/03/21,"MD Mount Sinai, Baltimore, Maryland, United States|Hospital das Clinicas Ribeirao Preto, Ribeirão Preto, San Paulo, Brazil|Danish National Biobank, København, Denmark|Shonan General Hospital, Kamakura, Kanagawa, Japan|National Center Global Health and Medicine, Shinjuku, Tokyo, Japan|Yamanashi Prefectural Central Hospital, Kōfu, Yamanashi, Japan|Unilab Group, Manila",Philippines,Respiratory Diseases,1,4,985.0
1291.0,NCT04410263,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,MICRO-COV,Recruiting,Corona Virus Infection,ARDS,Coinfection,,,,,"Diagnostic Test: Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine)",University of Zurich,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-09-04,30/12/23,2023-12-31,01/06/20,01/06/20,"University Hospital Zurich, Zürich, Zurich",Switzerland,Respiratory Diseases,1,3,1213.0
1292.0,NCT04703790,Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods,,Not yet recruiting,COVID-19,Vaccine Acceptability,,,,,,,Columbia University|Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other|Industry,Observational,2021-01-02,01/08/22,2022-01-08,11/01/21,19/01/21,,,Respiratory Diseases,1,2,371.0
1293.0,NCT04393558,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,,Recruiting,COVID-19,Healthy Control,,,,,,Device: ADAM Sensor,Shirley Ryan AbilityLab,All,"18 Years to 95 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-04-20,31/12/22,2022-12-31,19/05/20,21/05/20,"Shirley Ryan AbilityLab, Chicago, Illinois",United States,Respiratory Diseases,1,2,985.0
1294.0,NCT04344015,COVID-19 Plasma Collection,,Recruiting,COVID-19,,,,,,,Other: Plasma Donation,Thomas Jefferson University,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-04-13,12/04/21,2021-12-04,14/04/20,11/05/20,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,600.0
1295.0,NCT04377763,Developement and Evaluation of Serological Assays for COVID-19,SEROCOV,Recruiting,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-07-15,01/03/21,2021-01-03,06/05/20,25/02/21,"Laboratory of microbiology of hospital hygiene, Ambroise Paré Hospital, APHP, Boulogne-Billancourt",France,Respiratory Diseases,1,1,172.0
1296.0,NCT04456036,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,RECOVER-19,Recruiting,COVID-19,,,,,,,,Università Politecnica delle Marche|Maria Gabriella Ceravolo|Michela Coccia|Lauredana Ercolani|Elisa Andrenelli|Lucia Pepa|Rossella Cima|Michela Aringolo,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,31/12/20,2021-06-30,02/07/20,01/12/20,"Neurorehabilitation Clinic, University Hospital Ospedali Riuniti di Ancona, Ancona",Italy,Respiratory Diseases,1,1,540.0
1297.0,NCT04691609,Assiut University Registry for ACS Patients During COVID-19 Pandemic,,Recruiting,COVID-19,,,,,,,,Assiut University,All,"Child, Adult, Older Adult",2500.0,Other,Observational,2020-01-03,01/03/23,2023-01-09,31/12/20,31/12/20,"Samah ObiedAllah Fouad, Assiut, Resident",Egypt,Respiratory Diseases,1,1,1102.0
1298.0,NCT04521296,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,,Not yet recruiting,COVID-19,,,,,,,Drug: DWJ1248|Drug: Placebo,Daewoong Pharmaceutical Co. LTD.,All,"19 Years and older   (Adult, Older Adult)",90.0,Industry,Interventional,2020-01-08,01/12/20,2020-01-12,20/08/20,20/08/20,,,Respiratory Diseases,1,1,4.0
1299.0,NCT04513210,Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection,,Enrolling by invitation,COVID-19,,,,,,,,Jagiellonian University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-10-10,30/10/21,2022-02-28,14/08/20,19/10/20,"Jagiellonian University Medical College, Department of Neurology, Kraków",Poland,Respiratory Diseases,1,1,506.0
1300.0,NCT04501796,A Trial of NT-I7 in COVID-19 (SPESELPIS),,Recruiting,COVID-19,,,,,,,Drug: Double-Blind NT-I7|Drug: Double-Blind Placebo,NeoImmuneTech,All,"19 Years to 75 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-11-27,01/10/21,2021-01-12,06/08/20,18/03/21,"Nih/Niaid, Bethesda, Maryland, United States|University of Nebraska Medical Center, Omaha, Nebraska",United States,Respiratory Diseases,1,1,46.0
1301.0,NCT04607941,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",ComCor,Recruiting,COVID-19,,,,,,,Other: Questionnaires|Other: Phone interviews,Institut Pasteur|National Health Insurance Fund|IPSOS,All,"18 Years and older   (Adult, Older Adult)",57720.0,Industry|Other,Observational,2020-10-27,04/06/21,2021-06-30,29/10/20,02/11/20,"Caisse Nationale d'Assurance Maladie, Paris, France|IPSOS, Paris",France,Respiratory Diseases,1,1,246.0
1302.0,NCT04318015,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),PHYDRA,Recruiting,COVID-19,Severe Acute Respiratory Syndrome,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"National Institute of Respiratory Diseases, Mexico|Sanofi",All,"18 Years and older   (Adult, Older Adult)",400.0,Other|Industry,Interventional,2020-04-14,31/12/20,2021-03-31,23/03/20,17/04/20,"Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico, City",Mexico,Respiratory Diseases,1,2,351.0
1303.0,NCT04392089,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,NIRS-COV,Recruiting,COVID-19,Respiratory Failure,,,,,,"Device: Masimo, LidCO",Hvidovre University Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-01-05,01/05/21,2021-01-05,18/05/20,18/05/20,"Hvidovre Hospital, Copenhagen",Denmark,Respiratory Diseases,1,2,366.0
1304.0,NCT04502667,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,COVID-19,Recruiting,COVID-19,Vitamin D,"Children, Only",,,,,Drug: Cholecalciferol,"Coordinación de Investigación en Salud, Mexico|Hospital Infantil de Mexico Federico Gomez|Hospital General de México Dr. Eduardo Liceaga",All,1 Month to 17 Years   (Child),40.0,Other,Interventional,2020-07-15,01/02/21,2021-01-04,06/08/20,06/08/20,"Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal",Mexico,Respiratory Diseases,1,3,173.0
1305.0,NCT04743349,Steam Inhalations in COVID-19 Patients,Steam-COVID,Recruiting,COVID-19,Coronavirus Infection,Coronavirus,,,,,Procedure: Steam inhalations,Meyer Children's Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-26,31/10/21,2021-10-31,08/02/21,08/02/21,"Meyer Children's Hospital, Florence",Italy,Respiratory Diseases,1,3,278.0
1306.0,NCT04340544,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease,COMIHY,Terminated,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine,All,"18 Years to 99 Years   (Adult, Older Adult)",17.0,Other,Interventional,2020-04-22,12/10/20,2020-12-10,09/04/20,02/11/20,"Institute for Tropical Medicine, Tübingen",Germany,Respiratory Diseases,1,1,232.0
1307.0,NCT04384380,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,,Completed,Coronavirus Infection,,,,,,,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil],"Taoyuan General Hospital|Center for Drug Evaluation, Taiwan|Centers for Disease Control, Taiwan|Taiwan Food and Drug Administration|National Health Research Institutes, Taiwan",All,"20 Years to 79 Years   (Adult, Older Adult)",33.0,Other,Interventional,2020-01-04,31/05/20,2020-05-31,12/05/20,04/08/20,"Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan City",Taiwan,Respiratory Diseases,1,1,148.0
1308.0,NCT04487665,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,,Not yet recruiting,COVID-19,,,,,,,,Cairo University,All,18 Years to 40 Years   (Adult),50.0,Other,Observational,2020-09-15,15/11/20,2020-12-15,27/07/20,27/07/20,,,Respiratory Diseases,1,1,91.0
1309.0,NCT04422626,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,CYTOAID,Not yet recruiting,COVID-19,COVID-19,,,,,,,University of Pecs,All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Observational,2020-01-07,01/07/22,2022-01-12,09/06/20,11/06/20,,,Respiratory Diseases,1,2,736.0
1310.0,NCT04389567,Famotidine Outpatient COVID-19 Treatment Study,,Completed,COVID-19,,,,,,,Drug: Famotidine,Northwell Health|Cold Spring Harbor Laboratory,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-12-05,25/05/20,2020-05-25,15/05/20,04/06/20,"Cold Spring Harbor Laboratory, Cold Spring Harbor, New York",United States,Respiratory Diseases,1,1,-194.0
1311.0,NCT04659707,Hyperpolarized 129Xe MRI of Survivors of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Hyperpolarized Xe129,University of Kansas Medical Center,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-02-22,31/12/21,2021-12-31,09/12/20,24/02/21,"University of Kansas Medical Center, Kansas City, Kansas",United States,Respiratory Diseases,1,1,312.0
1312.0,NCT04373200,Human Ab Response & immunoMONItoring of COVID-19 Patients,HARMONICOV,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Biological: Blood samples collection|Other: Saliva collection,Rennes University Hospital,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2020-05-25,25/05/21,2021-09-25,04/05/20,11/03/21,"CHU Rennes, Rennes",France,Respiratory Diseases,1,2,488.0
1313.0,NCT04595773,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",,Recruiting,COVID-19,,,,,,,Other: Aerobic Exercise Training|Other: Education,National Institutes of Health Clinical Center (CC),All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,NIH,Interventional,2021-01-22,31/12/23,2023-12-31,22/10/20,25/03/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,1073.0
1314.0,NCT04408391,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,ANOSIRM,Withdrawn,COVID-19,Anosmia,,,,,,Other: Brain MRI scan,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Observational,2020-05-20,06/07/20,2020-06-07,29/05/20,05/08/20,"CHU de Nimes, Nîmes",France,Respiratory Diseases,1,2,18.0
1315.0,NCT04348396,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,,Recruiting,COVID-19,,,,,,,,Istituto Nazionale di Ricovero e Cura per Anziani,All,65 Years and older   (Older Adult),300.0,Other,Observational,2020-03-04,01/12/20,2020-01-12,16/04/20,22/09/20,"IRCCS INRCA Hospital, Ancona, Italy|IRCCS INRCA Hospital, Casatenovo, Italy|IRCCS INRCA Hospital, Fermo",Italy,Respiratory Diseases,1,1,-52.0
1316.0,NCT04670328,Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity,,Completed,COVID-19,,,,,,,Diagnostic Test: not required,FMH College of Medicine and Dentistry,All,"17 Years to 75 Years   (Child, Adult, Older Adult)",101.0,Other,Observational,2020-01-05,31/07/20,2020-07-31,17/12/20,17/12/20,"FMH college of medicine and dentistry, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,208.0
1317.0,NCT04679272,Prognostic Evaluation of COVID-19 in Rheumatoid Arthritis Patients,ProCOVRA,Completed,COVID-19,Rheumatoid Arthritis,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-12,30/01/21,2021-01-02,22/12/20,01/03/21,"UH Montpellier, Montpellier",France,"Respiratory Diseases, Immunological Disorders",1,2,356.0
1318.0,NCT04481360,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,,Not yet recruiting,Coronavirus,,,,,,,Device: CT of the chest,Assiut University,All,"18 Years to 99 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-08,01/08/21,2021-01-09,22/07/20,22/07/20,,,Respiratory Diseases,1,1,367.0
1319.0,NCT04357457,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,AIRVM-COVID,Recruiting,COVID-19,Hypoxemic Respiratory Failure,,,,,,Drug: Almitrine|Drug: Placebo,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 80 Years   (Adult, Older Adult)",212.0,Other,Interventional,2020-03-09,01/07/21,2021-01-07,22/04/20,22/03/21,"Hospital Pitié-Salpêtrière, Paris",France,Respiratory Diseases,1,2,304.0
1320.0,NCT04668235,Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected),,Not yet recruiting,COVID-19,,,,,,,Drug: AZVUDINE|Drug: AZVUDINE placebo,"HRH Holdngs Limited|GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil|SANTA CASA DE MISERICORDIA DE CAMPOS HOSPITAL (SCMCH), Brazil|UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE (UENF), Brazil",All,"18 Years and older   (Adult, Older Adult)",342.0,Other,Interventional,2021-01-04,01/07/21,2021-01-10,16/12/20,19/03/21,"Santa Casa de Misericórdia de Campos, Campos Dos Goytacazes, RJ",Brazil,Respiratory Diseases,1,1,6.0
1321.0,NCT04581083,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",,Completed,COVID-19,,,,,,,Diagnostic Test: RT-PCR|Diagnostic Test: LAMP|Diagnostic Test: POOL RT-PCR|Diagnostic Test: POOL LAMP,Hunter College of City University of New York|Universidad Autonoma Juan Misael Saracho|Gobierno Autonomo Departamental De Tarija|SEDES - Tarija|CAINCO - Bolivia,All,21 Years to 64 Years   (Adult),30.0,Other,Observational,2020-08-10,10/10/20,2020-10-30,09/10/20,22/01/21,"Universidad Autónoma Juan Misael Saracho, Tarija",Bolivia,Respiratory Diseases,1,1,81.0
1322.0,NCT04367870,COVID-19 Detection Test in Oncology,EVIDENCE,Recruiting,Oncology,,,,,,,,UNICANCER,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-05-23,31/05/21,2021-01-10,29/04/20,02/04/21,"Centre Hospitalier de Boulogne sur Mer, Boulogne-sur-Mer, France|Centre Jean Perrin, Clermont-Ferrand, France|Hopitaux Civils de Colmar, Colmar, France|Hôpital Universitaire Pitié Salpêtrière, Paris, France|Institut Curie, Paris, France|Centre Eugène Marquis, Rennes, France|Institut Curie, Saint-Cloud",France,Others,0,1,232.0
1323.0,NCT04365530,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,COVIDGHPSJCite,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-01-04,01/04/22,2022-12-31,28/04/20,29/04/20,"Hôpital Marie Lannelongue, Le Plessis-Robinson, France|AURA Paris Plaisance, Paris, France|Fondation Sainte-Marie, Paris, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Hôpital Bellan, Paris",France,Respiratory Diseases,1,1,1092.0
1324.0,NCT04460703,"COVID-19 Vaccine Messaging, Part 1",,Completed,Vaccination,COVID-19,,,,,,Other: Control message|Other: Baseline message|Other: Personal freedom message|Other: Economic freedom message|Other: Self-interest message|Other: Community interest message|Other: Economic benefit message|Other: Guilt message|Other: Embarrassment message|Other: Anger message|Other: Trust in science message|Other: Not bravery message,Yale University,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Interventional,2020-03-07,08/07/20,2020-08-07,07/07/20,21/07/20,"Yale University, New Haven, Connecticut",United States,Respiratory Diseases,1,2,153.0
1325.0,NCT04568031,Study of AZD1222 for the Prevention of COVID-19 in Japan,,"Active, not recruiting",COVID-19,,,,,,,Drug: AZD1222|Drug: 0.9% (w/v) saline,AstraZeneca|Iqvia Pty Ltd,All,"18 Years and older   (Adult, Older Adult)",256.0,Industry,Interventional,2020-08-23,15/11/21,2021-11-15,29/09/20,17/03/21,"Research Site, Fukuoka-shi, Japan|Research Site, Hachioji-shi, Japan|Research Site, Minato-ku, Japan|Research Site, Sumida-ku, Japan|Research Site, Toshima-ku",Japan,Respiratory Diseases,1,1,449.0
1326.0,NCT04354597,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,MOPHYDA,Not yet recruiting,COVID-19,,,,,,,Drug: HCQ & AZ,King Hussein Cancer Center,All,"25 Years to 70 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-05,15/08/20,2020-10-15,21/04/20,05/05/20,"King Hussein Cancer Center, Amman",Jordan,Respiratory Diseases,1,1,284.0
1327.0,NCT04377711,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: Ciclesonide|Drug: Placebo,Covis Pharma S.à.r.l.,All,"12 Years to 100 Years   (Child, Adult, Older Adult)",400.0,Industry,Interventional,2020-08-06,05/01/21,2021-05-01,06/05/20,14/04/21,"University of Buffalo, Buffalo, New York",United States,Respiratory Diseases,1,1,268.0
1328.0,NCT04537299,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,COVID-FIS,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Fisetin|Drug: Placebo,Mayo Clinic|National Institute on Aging (NIA),All,65 Years and older   (Older Adult),150.0,Other|NIH,Interventional,2021-01-04,01/12/23,2023-01-12,03/09/20,06/04/21,"Mayo Clinic, Rochester, Minnesota",United States,Respiratory Diseases,1,2,738.0
1329.0,NCT04401046,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,COVID-TRAUMA,Recruiting,Cancer,,,,,,,Other: Survey to assess Post traumatic stress and anxiety at inclusion and 6 months later,Institut Paoli-Calmettes,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Interventional,2020-05-20,30/10/20,2020-10-30,26/05/20,28/07/20,"Institut Paoli-Calmettes, Marseille",France,Cancers,1,1,163.0
1330.0,NCT04341922,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,,"Active, not recruiting",Dysfunctional Worry,,,,,,,Behavioral: Internet-delivered cognitive behavior therapy (ICBT) for dysfunctional worry related to the Covid-19 pandemic,Karolinska Institutet,All,"16 Years and older   (Child, Adult, Older Adult)",670.0,Other,Interventional,2020-09-05,20/08/20,2021-10-09,10/04/20,19/10/20,"Karolinska Institutet, Stockholm",Sweden,Others,0,1,399.0
1331.0,NCT04466462,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,,Completed,COVID-19,,,,,,,,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-05-26,30/06/20,2020-06-30,10/07/20,10/07/20,"Germans Trias i Pujol Hospital, Badalona, Barcelona, Spain|Hospital Municipal de Badalona, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,35.0
1332.0,NCT04424134,BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization,BISCUIT,Recruiting,COVID-19,,,,,,,Drug: Bromhexine and Spironolactone|Drug: Base therapy,Lomonosov Moscow State University Medical Research and Educational Center,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-05-16,18/07/20,2020-08-23,09/06/20,09/06/20,"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region",Russian Federation,Respiratory Diseases,1,1,99.0
1333.0,NCT04779021,Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department,,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Other: Hospitalisation for SARS-COV2 infection,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Observational,2020-02-15,31/12/21,2022-12-31,03/03/21,03/03/21,"CHU de NICE - Infectiologie, Nice, France|CHU de NICE - Urgences, Nice",France,Respiratory Diseases,1,2,1050.0
1334.0,NCT04303507,Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,COPCOV,Recruiting,COVID-19,Coronavirus,Acute Respiratory Illnesses,,,,,Drug: Chloroquine or Hydroxychloroquine|Drug: Placebo,University of Oxford,All,"16 Years and older   (Child, Adult, Older Adult)",40000.0,Other,Interventional,2020-04-29,01/04/21,2021-01-04,11/03/20,05/10/20,"RSUPN Cipto Mangunkusumo Hospital, Jakarta Pusat, Jakarta, Indonesia|Istituto Sacro Cuore Don Calabria, Negrar, Negrar Di Valpolicella VR, Italy|Mahosot hospital, Vientiane, Lao People's Democratic Republic|The Aga Khan University Hospital, Karachi, Pakistan|Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand|University Hospitals Of Morecambe Bay NHS Foundation Trust, Kendal, Cumbria, United Kingdom|Torbay and South Devon NHS Foundation Trust, Torquay, Devon, United Kingdom|The Princess Alexandra Hospital NHS Trust, Harlow, Essex, United Kingdom|West Hertfordshire Hospitals NHS Trust, Watford, Hertfordshire, United Kingdom|Lewisham and Greenwich NHS Trust, Woolwich, London, United Kingdom|Sherwood Forest Hospitals NHS Foundation Trust, Sutton In Ashfield, Nottinghamshire, United Kingdom|The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, West Yorkshire, United Kingdom|Brighton and Sussex University Hospitals NHS Trust, Brighton, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Oxford University Hospital NHS Foundation Trust, Oxford",United Kingdom,Respiratory Diseases,1,3,250.0
1335.0,NCT04756479,Mortality Due to COVID-19 in the COVID-AGEBRU Study,COVID-AGEBRU,Completed,COVID-19,Old Age; Debility,"Morbidity, Multiple",,,,,,Brugmann University Hospital,All,70 Years and older   (Older Adult),160.0,Other,Observational,2020-01-03,30/06/20,2020-06-30,16/02/21,16/02/21,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,3,179.0
1336.0,NCT04570202,Health cAre woRkers exposeD to COVID-19,HARD-COVID19,Recruiting,Depression,"Burnout, Professional",Post Traumatic Stress Disorder,,,,,Behavioral: EMDR,"University Hospital, Tours|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Interventional,2020-11-20,20/08/21,2022-08-20,30/09/20,23/03/21,"Centre Investigation Clinique 1415, Tours, Centre Val De Loire, France|Bretonneau Regional Universitary Hospital, Tours",France,Mental Health,1,3,638.0
1337.0,NCT04407143,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,SOLID,Recruiting,Lung Cancer,COVID-19,Corona Virus Infection,,,,,Diagnostic Test: IgG test,Fundación GECP,All,"18 Years and older   (Adult, Older Adult)",128.0,Other,Observational,2020-04-15,30/09/21,2021-09-30,29/05/20,02/02/21,"Hospital General Universitario de Elche, Elche, Alicante, Spain|ICO Hospitalet, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Insular de Gran canaria, Las Palmas De Gran Canaria, Gran Canaria, Spain|Hospital Universitario de Torrejón, Torrejón, Madrid, Spain|Hospital Universitario Son Llàtzer, Palma De Mallorca, Mallorca, Spain|Complexo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain|Complejo Hospitalario de A Coruña, A Coruña, Spain|Hospital La Esperanza, A Coruña, Spain|Hospital Universitario de Ferrol, A Coruña, Spain|Hospital Virgen de los Lirios, Alicante, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Dexeus, Barcelona, Spain|Hospital Universitario Cruces, Bilbao, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Puerto Real, Cadiz, Spain|Hospital General La Mancha Centro, Ciudad Real, Spain|Hospital Universitario San Pedro de Alcántara, Cáceres, Spain|Hospital Universitario Puerta del Mar, Cádiz, Spain|Hospital Universitario Reina Sofía, Córdoba, Spain|Hospital Universitario de Vinalopó, Elche, Spain|Hospital Dr. Josep Trueta, Girona, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Complejo Hospitalario de Jaén, Jaén, Spain|Complejo Asistencial Universitario de León, León, Spain|Hospital universitari Arnau de Vilanova, Lleida, Spain|Hospital San Pedro, Logroño, Spain|Hospital Universitario Lucus Augusti, Lugo, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Puerta de Hierro, Madrid, Spain|Clínica Universidad de Navarra, Madrid, Spain|Hospital de Sanchinarro, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Severo Ochoa, Madrid, Spain|Hospital Universitario de Móstoles, Madrid, Spain|Hospital Universitario del Henares, Madrid, Spain|Hospital Universitario Fundación Alcorcón, Madrid, Spain|Hospital Universitario Infanta Cristina, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Madrid, Spain|Hospital General Universitario de Málaga, Málaga, Spain|Hospital Costa del Sol, Málaga, Spain|Complejo Hospitalario Universitario de Ourense Santa María Nai, Ourense, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Sant Joan de Reus, Reus, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital General de Segovia, Segovia, Spain|Hospital Virgen del Rocío, Sevilla, Spain|Hospital Sant Pau i Santa Tecla, Tarragona, Spain|Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain|Hospital Universitari i Politécnic La Fe, Valencia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital General de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital de Manises, Valencia, Spain|Hospital General Universitario de Valencia, Valencia, Spain|Hospital Lluís Alcanyís, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Río Ortega, Valladolid, Spain|Complejo Hospitalario Zamora, Zamora",Spain,"Respiratory Diseases, Cancers",1,3,533.0
1338.0,NCT04423770,COVID-19 Related Health and Infection Control Practices Among Dentists,,"Active, not recruiting",Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Other: No intervention,American Dental Association,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-08-06,08/06/21,2021-08-06,09/06/20,27/08/20,"American Dental Association, Chicago, Illinois",United States,Respiratory Diseases,1,1,365.0
1339.0,NCT04410562,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy and Postpartum,COVID-Preg,Recruiting,Pregnancy Related,COVID-19,COVID-19,,,,,Drug: Hydroxychloroquine|Drug: Placebo,Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|University Hospital of Torrejon|Fundación de investigación HM|Hospital Sant Joan de Deu|Hospital del Mar|Hospital Universitario Infanta Leonor|Hospital Universitario Fundación Alcorcón|Hospital General de Segovia|Institut Català de la Salut,Female,"Child, Adult, Older Adult",714.0,Other,Interventional,2020-05-13,13/05/21,2021-01-08,01/06/20,22/01/21,"Hospital General de Segovia, Segovia, Cartilla Y León, Spain|Hospital del Mar, Barcelona, Catalunya, Spain|Hospital Clínic de Barcelona, Barcelona, Catalunya, Spain|Hospital de la Sant Creu i Sant Pau, Barcelona, Catalunya, Spain|Hospital Sant Joan de Déu, Esplugues De Llobregat, Catalunya, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|HM Puerta del Sur, Móstoles, Madrid, Spain|Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid",Spain,Respiratory Diseases,1,3,240.0
1340.0,NCT04727424,Repurposed Approved Therapies for Outpatient Treatment of Patients With Early-Onset COVID-19 and Mild Symptoms,,Recruiting,COVID-19,SARS-Associated Coronavirus,,,,,,Drug: Fluvoxamine Maleate 100 MG [Luvox]|Drug: Metformin Extended Release Oral Tablet|Drug: Ivermectin oral tablets or sublingual waffles|Drug: Placebo,Cardresearch,All,"18 Years and older   (Adult, Older Adult)",2724.0,Other,Interventional,2021-01-19,01/02/22,2022-01-03,27/01/21,24/03/21,"City of Ibirité, Ibirité, MG, Brazil|City of Sete Lagoas, Sete Lagoas, MG, Brazil|CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|City of Brumadinho, Brumadinho, Minas Gerais, Brazil|Centro Universitário FIPMOC, Montes Claros, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais",Brazil,Respiratory Diseases,1,2,349.0
1341.0,NCT04504240,Role of Famotidine in the Clinical Improvement of COVID-19 Patients.,,"Active, not recruiting",COVID-19,,,,,,,Drug: Famotidine 20 MG,Chattogram General Hospital|M Abdur Rahim Medical College and Hospital|First Affiliated Hospital Xi'an Jiaotong University,All,"16 Years to 80 Years   (Child, Adult, Older Adult)",200.0,Other,Interventional,2020-01-08,10/04/21,2021-10-04,07/08/20,11/03/21,"Chattogram General Hospital, Chittagong, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinājpur",Bangladesh,Respiratory Diseases,1,1,635.0
1342.0,NCT04389554,D-dimer Levels in Pregnant With COVID-19,,Completed,COVID-19,D-dimer,,,,,,Other: Blood D-dimer assay,Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),300.0,Other,Observational,2020-05-14,28/05/20,2020-05-29,15/05/20,01/06/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Turgut Ozal",Turkey,Respiratory Diseases,1,2,15.0
1343.0,NCT04371640,Sirolimus in COVID-19 Phase 1,SirCO-1,Withdrawn,COVID-19,COVID-19,,,,,,Drug: Sirolimus 1 MG/ML|Drug: Placebo,Walter K. Kraft|Thomas Jefferson University,All,"18 Years to 65 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-06-07,01/07/21,2021-01-08,01/05/20,07/12/20,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,215.0
1344.0,NCT04384900,Accelerated Prone Position Ventilation of Patients With COVID-19,PROVENT-COVID,Recruiting,COVID-19,,,,,,,Procedure: Prone position ventilation,Nordsjaellands Hospital,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-11-05,01/11/20,2020-01-12,12/05/20,14/05/20,"Nordsjællands Hospital, Hillerød, Region Hovedstanden",Denmark,Respiratory Diseases,1,1,-298.0
1345.0,NCT04395664,Arrhythmias in Patients With COVID-19,ACOVID,Completed,COVID-19,,,,,,,Device: C3+ Holter Monitor,Herlev and Gentofte Hospital,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-16,01/09/20,2020-01-09,20/05/20,09/09/20,"Department of Cardiology, Herlev & Gentofte Hospital, Copenhagen, Hellerup",Denmark,Respiratory Diseases,1,1,-98.0
1346.0,NCT04542954,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,OMC-KTR,Completed,COVID-19,Kidney Transplant Infection,"Risk Factor, Cardiovascular",Immunosuppression,"Outcome, Fatal",Graft Failure,,Other: Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience from the Middle East,"Hamid Al-Essa Organ Transplant Center|Ministry of Health, Kuwait",,"Child, Adult, Older Adult",104.0,Other,Observational,2020-01-03,31/08/20,2020-08-31,09/09/20,09/09/20,"OTC, MOH , Kuwait, Kuwait",Kuwait,Respiratory Diseases,1,6,241.0
1347.0,NCT04762680,Study of Recombinant Protein Vaccine With Adjuvant Against COVID-19 in Adults 18 Years of Age and Older,VAT00002,"Active, not recruiting",COVID-19,,,,,,,Biological: SARS-CoV-2 recombinant protein vaccine Formulation 1|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 2|Biological: SARS-CoV-2 recombinant protein vaccine Formulation 3,"Sanofi Pasteur, a Sanofi Company|GlaxoSmithKline|Sanofi",All,"18 Years and older   (Adult, Older Adult)",722.0,Industry,Interventional,2021-02-24,01/04/22,2022-01-04,21/02/21,05/04/21,"Investigational Site Number 8400251, Chandler, Arizona, United States|Investigational Site Number 8400220, Los Angeles, California, United States|Investigational Site Number 8400094, Rolling Hills Estates, California, United States|Investigational Site Number 8400173, San Diego, California, United States|Investigational Site Number 8400239, New Haven, Connecticut, United States|Investigational Site Number 8400212, Washington, District of Columbia, United States|Investigational Site Number 8400089, Hollywood, Florida, United States|Investigational Site Number 8400057, Melbourne, Florida, United States|Investigational Site Number 8400179, Orlando, Florida, United States|Investigational Site Number 8400201, Decatur, Georgia, United States|Investigational Site Number 8400187, Peoria, Illinois, United States|Investigational Site Number 8400048, Rockville, Maryland, United States|Investigational Site Number 8400199, Boston, Massachusetts, United States|Investigational Site Number 8400030, Omaha, Nebraska, United States|Investigational Site Number 8400230, New York, New York, United States|Investigational Site Number 8400203, New York, New York, United States|Investigational Site Number 8400207, Rochester, New York, United States|Investigational Site Number 8400233, Pittsburgh, Pennsylvania, United States|Investigational Site Number 8400097, North Charleston, South Carolina, United States|Investigational Site Number 8400191, Austin, Texas, United States|Investigational Site Number 3400002, Municipio Del Distrito Central, Honduras|Investigational Site Number 3400001, San Pedro Sula",Honduras,Respiratory Diseases,1,1,314.0
1348.0,NCT04395976,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,,Withdrawn,COVID-19,,,,,,,Other: Ayurveda,British Ayurvedic Medical Council|All Party Parliamentary Group - Indian Traditional Sciences|University of Warwick,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-10-05,10/06/20,2020-01-09,20/05/20,02/03/21,"British Ayurvedic Medical Council, London",United Kingdom,Respiratory Diseases,1,1,-270.0
1349.0,NCT04641806,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,LYMPHO-Cov-2,Not yet recruiting,B-cell Lymphoma,COVID-19,,,,,,,Versailles Hospital,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-12-15,16/04/21,2021-09-16,24/11/20,24/11/20,,,Respiratory Diseases,1,2,275.0
1350.0,NCT04583956,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Other: Placebo|Drug: Remdesivir|Biological: Risankizumab,"National Institute of Allergy and Infectious Diseases (NIAID)|Gritstone Oncology, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,NIH|Industry,Interventional,2020-10-14,31/12/21,2021-12-31,12/10/20,12/04/21,"St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Mayo Clinic, Phoenix - Infectious Diseases, Phoenix, Arizona, United States|The University of Arizona - Banner University Medical Center Tucson Campus - Tucson, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Kern Medical Center, Bakersfield, California, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|Hoag Hospital Newport Beach, Newport Beach, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Penrose Hospital - Emergency Medicine, Colorado Springs, Colorado, United States|St. Francis Medical Center, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|St. Anthony Hospital North Health Campus, Westminster, Colorado, United States|Nuvance Health Danbury Hospital - Infectious Disease, Danbury, Connecticut, United States|Yale School of Medicine - The Anlyan Center for Medical Research & Education - Immunobiology, New Haven, Connecticut, United States|Nuvance Health - Norwalk Hospital - Asthma Pulmonary and Critical Care Medicine, Norwalk, Connecticut, United States|MedStar Washington Hospital Center - Infectious Diseases, Washington, District of Columbia, United States|Advent Health Orlando - Critical Care, Orlando, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Northwestern Medicine - Central DuPage Hospital - Infectious Disease, Winfield, Illinois, United States|University of Louisville - Division of Infectious Diseases, Louisville, Kentucky, United States|Pikeville Medical Center - Department of Infectious Disease, Pikeville, Kentucky, United States|Tulane University - Section of Pulmonary Diseases, Critical Care, and Environmental Medicine, New Orleans, Louisiana, United States|Louisiana State University Health Shreveport - Infectious Diseases, Shreveport, Louisiana, United States|TidalHealth - Peninsula Regional - Pulmonary and Critical Care, Salisbury, Maryland, United States|Brigham and Women's Hospital - Infectious Diseases, Boston, Massachusetts, United States|Boston Medical Center - Center for Infectious Diseases - Shapiro Center, Boston, Massachusetts, United States|Hennepin Healthcare Research Institute, Minneapolis, Minnesota, United States|Englewood Hospital, Englewood, New Jersey, United States|Virtua Health - Virtua Voorhees Hospital - Pulmonology, Voorhees, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|The State University of New York - University at Buffalo - Department of Medicine, Buffalo, New York, United States|Mount Sinai School of Medicine - Medicine - Infectious Diseases, New York, New York, United States|Nuvance Health - Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Stony Brook Medicine - Stony Brook University Hospita, Stony Brook, New York, United States|East Carolina University Brody School of Medicine - Adult Specialty Care, Greenville, North Carolina, United States|Wake Forest Baptist Health - Infectious Diseases, Winston-Salem, North Carolina, United States|University of Toledo Medical Center - Ruppert Clinic, Toledo, Ohio, United States|St. Charles Health System - St. Charles Bend Hospital, Bend, Oregon, United States|Geisinger Medical Center-Department of Pulmonary and Critical Care Medicine, Danville, Pennsylvania, United States|Doylestown Hospital, Doylestown, Pennsylvania, United States|Kent County Memorial Hospital, Warwick, Rhode Island, United States|Monument Health - Clinical Research, Rapid City, South Dakota, United States|Hendrick Health - Hendrick Medical Center, Abilene, Texas, United States|Texas Tech University Health Science Center, Amarillo, Texas, United States|Baptist Hospitals of Southeast Texas Site, Beaumont, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at Tyler, Tyler, Texas, United States|West Virginia University - Infectious Diseases Clinic, Morgantown, West Virginia",United States,Respiratory Diseases,1,1,443.0
1351.0,NCT04414904,Determining the Reproductive Health of Men Post-COVID-19 Infection,,Withdrawn,"Infertility, Male",Testosterone Deficiency,,,,,,Other: Exposure: Covid-19 infection,Imperial College London,Male,18 Years to 50 Years   (Adult),0.0,Other,Observational,2020-10-06,10/06/20,2020-10-06,04/06/20,24/11/20,"Channa Jayasena, London, Outside U.S./Canada",United Kingdom,Others,0,2,0.0
1352.0,NCT04638842,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,,Recruiting,Grief,Anxiety,Depression,Sleep Disturbance,Quality of Life,,,Behavioral: Online Intervention Grief COVID-19,Universidad Internacional de Valencia|Universidad Nacional Autonoma de Mexico|Universidad Autonoma de Ciudad Juarez|University of Buenos Aires,All,18 Years to 60 Years   (Adult),42.0,Other,Interventional,2020-12-24,01/06/21,2021-01-06,20/11/20,15/01/21,"Universidad Autónoma de Ciudad Juárez, Juárez, Chihuahua",Mexico,Mental Health,1,5,13.0
1353.0,NCT04726137,European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) SARS-CoV-2 Antibody Study Protocol. Covid-19,SARS-Cov2,Not yet recruiting,Sars-Cov2 Antibodies in Children and Adolescents Living With HIV,,,,,,,,"PENTA Foundation|Hospital st pierre, Belgium|University of Athens|University of Cape Town|Hospital General Universitario Gregorio Marañon|Hospital Sant Joan de Deu|Karolinska Institutet|Great Ormond Street Hospital for Children NHS Foundation Trust|Guy's and St Thomas' NHS Foundation Trust|North Manchester General Hospital (Northern Care Alliance NHS Group), Manchester|University Hospital Birmingham NHS Foundation Trust|Imperial College Healthcare NHS Trust|King's College Hospital NHS Trust|St George's University Hospitals NHS Foundation Trust|CHIPS+ cohort|Medical Research Council",All,"up to 24 Years   (Child, Adult)",1150.0,Other,Observational,2021-03-30,31/07/21,2022-04-30,27/01/21,27/01/21,,,Respiratory Diseases,1,1,396.0
1354.0,NCT04382495,The Impact of COVID-19 Pandemic on Cancer Care,,Recruiting,Cancer,,,,,,,Other: survey,El Zaitoun Specialized Hospital|Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-06-15,01/06/21,2021-01-06,11/05/20,01/03/21,"EgyBrit Medical Centre, Cairo",Egypt,Cancers,1,1,205.0
1355.0,NCT04628143,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: Nafamostat Mesilate,Chong Kun Dang Pharmaceutical,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-11-20,30/05/21,2021-06-30,13/11/20,13/11/20,,,Respiratory Diseases,1,1,222.0
1356.0,NCT04331665,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,,Not yet recruiting,COVID-19,Pneumonia,,,,,,Drug: Ruxolitinib,"University Health Network, Toronto",All,"12 Years and older   (Child, Adult, Older Adult)",64.0,Other,Interventional,2020-04-20,30/10/20,2021-01-31,02/04/20,13/04/20,"Princess Margaret Cancer Centre, Toronto, Ontario",Canada,Respiratory Diseases,1,2,286.0
1357.0,NCT04428801,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: autologous adipose-derived stem cells,Celltex Therapeutics Corporation,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2021-01-06,01/06/22,2024-06-15,11/06/20,01/04/21,,,Respiratory Diseases,1,1,1256.0
1358.0,NCT04320732,Risk Factors for Community- and Workplace Transmission of COVID-19,,Recruiting,Coronavirus,,,,,,,Behavioral: Observation of behavior and COVID-19 infection will be conducted.,Oslo University Hospital|Age Labs AS,All,"18 Years and older   (Adult, Older Adult)",250000.0,Other,Observational,2020-03-27,27/03/22,2030-03-20,25/03/20,25/06/20,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,1,3645.0
1359.0,NCT04728919,Nasal and Pulmonary Nitric Oxide Output in COVID-19 Infection,,Recruiting,COVID-19,COVID-19,,,,,,,Tampere University Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",80.0,Other,Observational,2021-01-15,15/01/22,2024-01-15,28/01/21,28/01/21,"Tampere University Hospital, Tampere",Finland,Respiratory Diseases,1,2,1095.0
1360.0,NCT04408235,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,COVID-19 HD,Not yet recruiting,COVID-19,"Pneumonia, Viral",Coagulation Disorder,,,,,Drug: Enoxaparin,Azienda Ospedaliero-Universitaria di Modena,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-06,01/06/21,2021-01-06,29/05/20,29/05/20,"Azienda Ospedaliero-Universitaria, Modena",Italy,Respiratory Diseases,1,3,366.0
1361.0,NCT04521010,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Other: COVID-19 pandemic,Poznan University of Medical Sciences,All,"Child, Adult, Older Adult",700.0,Other,Observational,2020-01-01,30/04/20,2020-04-30,20/08/20,20/08/20,"Department of Rehabilitation and Physiotherapy Rehabilitation,, Poznań",Poland,Respiratory Diseases,1,1,120.0
1362.0,NCT04623047,Using Smart Watches to Detect and Monitor COVID-19,CovIdentify,Not yet recruiting,COVID-19,,,,,,,,Duke University,All,"18 Years and older   (Adult, Older Adult)",100000.0,Other,Observational,2021-01-07,01/02/23,2023-01-02,10/11/20,09/03/21,"Duke University, Durham, North Carolina",United States,Respiratory Diseases,1,1,725.0
1363.0,NCT04312997,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,,Recruiting,COVID-19,,,,,,,Drug: PUL-042 Inhalation Solution|Drug: Placebo,"Pulmotect, Inc.|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|U.S. Fed,Interventional,2020-06-16,01/04/21,2021-01-05,18/03/20,17/03/21,"University of California Irvine, Orange, California, United States|Premeir Urgent Care of California, San Bernardino, California, United States|Clinical Research of South Florida Alliance for Multispecialty Research, Coral Gables, Florida, United States|Invesclinic US LLC, Fort Lauderdale, Florida, United States|DBC Research Corp., Tamarac, Florida, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Ascension St. John, Bartlesville, Oklahoma, United States|Ascension St. John, Tulsa, Oklahoma, United States|MD Anderson Cancer Center, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas",United States,Respiratory Diseases,1,1,203.0
1364.0,NCT04655612,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,COVID-RIC1,Recruiting,COVID-19,SARS-CoV Infection,Rheumatoid Arthritis,Spondyloarthritis,Ankylosing Spondylitis,Psoriatic Arthritis,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-01-12,01/07/21,2021-07-30,07/12/20,29/12/20,"Centre hopsitalier universitaire de Montpellier, Montpellier, Occitanie",France,"Respiratory Diseases, Immunological Disorders",1,6,565.0
1365.0,NCT04346589,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,,Recruiting,"Pneumonia, Ventilator-Associated",Coronavirus Infection,,,,,,Biological: Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients,A.O. Ospedale Papa Giovanni XXIII|Aferetica - Italy (BO),All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-15,01/08/20,2020-01-08,15/04/20,09/06/20,"IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG, Italy|ASST HPG23 - Unit of Nephrology, Bergamo, Italy|ASST Papa Giovanni XXIII - Microbiology and Virology Unit, Bergamo, Italy|Asst Pg23 - S.I.M.T, Bergamo, Italy|ASST-PG23 - Intensive Care Unit, Bergamo",Italy,Respiratory Diseases,1,2,-98.0
1366.0,NCT04497987,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,BLAZE-2,Recruiting,COVID-19,SARS-CoV2,,,,,,Drug: LY3819253|Drug: Placebo|Drug: LY3832479,"Eli Lilly and Company|National Institute of Allergy and Infectious Diseases (NIAID)|AbCellera Biologics Inc.|Shanghai Junshi Bioscience Co., Ltd.",All,"18 Years and older   (Adult, Older Adult)",5000.0,Industry|NIH|Other,Interventional,2020-02-08,08/03/21,2021-06-29,04/08/20,23/02/21,"Unv of AL Sch of Med Div of Infectious Diseases, Birmingham, Alabama, United States|Care Access Research, Phoenix, Arizona, United States|Allergy and Asthma Clin of NW Ark, Bentonville, Arkansas, United States|Care Access Research LLC, Huntington Beach, California, United States|Alta Bates SMC, Oakland, California, United States|University of Colorado-Anschultz Medical Campus, Aurora, Colorado, United States|NIAID, Miami, Florida, United States|NIAID, Decatur, Georgia, United States|Belmont Village Lincoln Park, Lincoln Park, Illinois, United States|Family Medicine, Indianapolis, Indiana, United States|University of Louisville, Louisville, Kentucky, United States|Care Access Rch Lake Charles, Lake Charles, Louisiana, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|NIAID - National Institute of Allergy & Infectious Diseases, Bethesda, Maryland, United States|Care Access, Boston, Massachusetts, United States|St. Paul IDA-CARe, Saint Paul, Minnesota, United States|Care Access, Jackson, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Children's Hospital & Medical Center, Omaha, Nebraska, United States|Care Access Research - Bronx, Bronx, New York, United States|NIAD, Chapel Hill, North Carolina, United States|Valley Medical Primary Care, Centerville, Ohio, United States|Univ of Cin College of Med, Cincinnati, Ohio, United States|OSU Med Intl Med Houston Ctr, Tulsa, Oklahoma, United States|Donahoe Manor, Bedford, Pennsylvania, United States|Belmont Village, West Univ, Houston, Texas",United States,Respiratory Diseases,1,2,507.0
1367.0,NCT04481685,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",,"Active, not recruiting",COVID-19,,,,,,,Drug: ATI-450|Drug: Placebo,University of Kansas Medical Center,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-07-20,25/02/21,2022-01-07,22/07/20,05/04/21,"The University of Kansas Medical Center, Kansas City, Kansas",United States,Respiratory Diseases,1,1,536.0
1368.0,NCT04329832,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,HAHPS,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,"Intermountain Health Care, Inc.|University of Utah",All,"18 Years and older   (Adult, Older Adult)",85.0,Other,Interventional,2020-03-30,18/12/20,2021-12-31,01/04/20,02/09/20,"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah",United States,Respiratory Diseases,1,1,641.0
1369.0,NCT04757831,Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children),,Not yet recruiting,COVID-19,,,,,,,,Duke University,All,"up to 21 Years   (Child, Adult)",1000000.0,Other,Observational,2021-05-15,15/02/26,2026-02-15,17/02/21,23/03/21,,,Respiratory Diseases,1,1,1737.0
1370.0,NCT04703205,Study in COvid-19 Patients With iveRmectin (CORVETTE-01),,Recruiting,COVID-19,,,,,,,Drug: Ivermectin 3 MG|Drug: Placebo,Kitasato University,All,"20 Years and older   (Adult, Older Adult)",240.0,Other,Interventional,2020-09-16,30/09/21,2021-09-30,11/01/21,08/03/21,"Kitasato University, Sagamihara, Kanagawa",Japan,Respiratory Diseases,1,1,379.0
1371.0,NCT04498065,MYocardial DOmmages Related to COVID-19,DOMY COVID,"Active, not recruiting",COVID-19,Non Ischemic Myocardial Injury,Myocardial Infarction,Myocarditis,Troponin Elevation,,,Biological: Biological data|Other: Clinical data,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-03,01/07/20,2021-01-07,04/08/20,04/08/20,"Chu Dijon Bourgogne, Dijon",France,Respiratory Diseases,1,5,370.0
1372.0,NCT04545060,VIR-7831 for the Early Treatment of COVID-19 in Outpatients,COMET-ICE,"Active, not recruiting",COVID-19,,,,,,,Biological: VIR-7831|Drug: Placebo,"Vir Biotechnology, Inc.|GlaxoSmithKline",All,"18 Years and older   (Adult, Older Adult)",1360.0,Industry,Interventional,2020-08-27,01/03/21,2021-01-07,10/09/20,29/03/21,"Investigative Site, Anniston, Alabama, United States|Investigative Site, Cullman, Alabama, United States|Investigative Site, Mesa, Arizona, United States|Investigative Site, Tucson, Arizona, United States|Investigative Site, Los Angeles, California, United States|Investigative Site, Los Angeles, California, United States|Investigative Site, Northridge, California, United States|Investigative Site, Oxnard, California, United States|Investigative Site, Rolling Hills Estates, California, United States|Investigative Site, Sacramento, California, United States|Investigative Site, Doral, Florida, United States|Investigative Site, Gainesville, Florida, United States|Investigative Site, Hialeah, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miami, Florida, United States|Investigative Site, Miramar, Florida, United States|Investigative Site, North Miami, Florida, United States|Investigative Site, Palmetto Bay, Florida, United States|Investigative Site, Pembroke Pines, Florida, United States|Investigative Site, Pompano Beach, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Tampa, Florida, United States|Investigative Site, Atlanta, Georgia, United States|Investigative Site, Atlanta, Georgia, United States|Investigative Site, Decatur, Georgia, United States|Investigative Site, Stockbridge, Georgia, United States|Investigative Site, Idaho Falls, Idaho, United States|Investigative Site, Mishawaka, Indiana, United States|Investigative Site, Lake Charles, Louisiana, United States|Investigative Site, Marrero, Louisiana, United States|Investigative Site, Baltimore, Maryland, United States|Investigative Site, Caro, Michigan, United States|Investigative Site, Hazelwood, Missouri, United States|Investigative Site, Las Vegas, Nevada, United States|Investigative Site, Las Vegas, Nevada, United States|Investigative Site, Santa Fe, New Mexico, United States|Investigative Site, Bronx, New York, United States|Investigative Site, Asheboro, North Carolina, United States|Investigative Site, Charlotte, North Carolina, United States|Investigative Site, Columbus, Ohio, United States|Investigative Site, Smithfield, Pennsylvania, United States|Investigative Site, Chattanooga, Tennessee, United States|Investigative Site, Austin, Texas, United States|Investigative Site, Baytown, Texas, United States|Investigative Site, Beaumont, Texas, United States|Investigative Site, Denton, Texas, United States|Investigative Site, El Paso, Texas, United States|Investigative Site, Forney, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Houston, Texas, United States|Investigative Site, Humble, Texas, United States|Investigative Site, Laredo, Texas, United States|Investigative Site, McAllen, Texas, United States|Investigative Site, Mesquite, Texas, United States|Investigative Site, Sugar Land, Texas, United States|Investigative Site, Kirkland, Washington, United States|Investigative Site, Seattle, Washington, United States|Investigative Site, Vienna, Austria|Investigative Site, Vienna, Austria|Investigative Site, Belo Horizonte, Minas Gerais, Brazil|Investigative Site, Maringá, Parana, Brazil|Investigative Site, Natal, Rio Grande Do Norte, Brazil|Investigative Site, Passo Fundo, Rio Grande Do Sul, Brazil|Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil|Investigative Site, Porto Alegre, Rio Grande Do Sul, Brazil|Investigative Site, Chapecó, Santa Catarina, Brazil|Investigative Site, Santo André, Sao Paulo, Brazil|Investigative Site, Vila Assuncao, Sao Paulo, Brazil|Investigative Site, Campinas, São Paulo, Brazil|Investigative Site, Sarnia, Ontario, Canada|Investigative Site, Toronto, Ontario, Canada|Investigative Site, Québec, Quebec, Canada|Investigative Site, Bellavista, Callao, Peru|Investigative Site, El Agustino, Lima, Peru|Investigative Site, Huaral, Lima, Peru|Investigative Site, San Isidro, Lima, Peru|Investigative Site, Bella Vista, Peru|Investigative Site, Lima, Peru|Investigative Site, Terrassa, Barcelona, Spain|Investigative Site, Albacete, Spain|Investigative Site, Centelles, Spain|Investigative Site, Girona, Spain|Investigative Site, Granada, Spain|Investigative Site, Granada, Spain|Investigative Site, Vigo, Spain|Investigative Site, Belfast",United Kingdom,Respiratory Diseases,1,1,133.0
1373.0,NCT04716088,Rapid Antigen Testing for SARS-CoV-2 Among Healthcare Workers to Prevent Spread of COVID-19,,Completed,COVID-19,,,,,,,Diagnostic Test: Rapid antigen test for SARS CoV2,"The University Clinic of Pulmonary and Allergic Diseases Golnik|Insitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana",All,"18 Years to 65 Years   (Adult, Older Adult)",36.0,Other,Observational,2020-11-18,02/12/20,2020-12-22,20/01/21,22/01/21,"Universitiy Clinic for respiratory and allergic diseases, Golnik",Slovenia,Respiratory Diseases,1,1,34.0
1374.0,NCT04371107,Proactive Care of Ambulatory COVID19 Patients,AMBU-COVID,Not yet recruiting,COVID-19,Azithromycin,Ambulatory,,,,,Other: consultation|Drug: Azithromycin,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Interventional,2020-04-29,01/06/20,2020-01-07,01/05/20,06/05/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,3,-113.0
1375.0,NCT04651374,COVID-19 And Geko Evaluation: The CAGE Study,CAGE,Not yet recruiting,COVID-19,,,,,,,Device: geko T3,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-12,01/03/21,2021-01-04,03/12/20,24/12/20,"London Health Sciences Centre, London, Ontario",Canada,Respiratory Diseases,1,1,358.0
1376.0,NCT04374487,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,,"Active, not recruiting",COVID-19,,,,,,,Drug: Convalescent Plasma|Other: Standard Care Therapy,Max Healthcare Insititute Limited,All,"18 Years to 85 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-05,09/08/21,2021-09-08,05/05/20,22/07/20,"Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi",India,Respiratory Diseases,1,1,368.0
1377.0,NCT04647305,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,COVPROSHIELD,"Active, not recruiting",COVID-19,,,,,,,Other: Closed face shield with Surgical face mask use|Other: Surgical face mask use only,"University of Los Andes, Columbia|United Nations",All,"18 Years and older   (Adult, Older Adult)",233.0,Other,Interventional,2021-01-16,01/03/21,2021-01-03,30/11/20,03/03/21,"Universidad de los Andes, Bogotá",Colombia,Respiratory Diseases,1,1,-13.0
1378.0,NCT04770649,Vaccine Observation to Include All Communities for Equitable Science,VOICES,Recruiting,Vaccine Response Impaired,Vaccine Adverse Reaction,,,,,,Biological: COVID-19 vaccine,Persephone Biosciences,All,"18 Years and older   (Adult, Older Adult)",10000.0,Industry,Observational,2021-01-04,01/12/22,2023-01-12,25/02/21,25/02/21,"Persephone Biosciences, Inc., San Diego, California",United States,Others,0,2,738.0
1379.0,NCT04350671,Interferon Beta 1a in Hospitalized COVID-19 Patients,IB1aIC,Enrolling by invitation,COVID-19,,,,,,,Drug: Interferon Beta-1A|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine,Shahid Beheshti University of Medical Sciences,All,"50 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-15,20/04/20,2020-04-24,17/04/20,20/04/20,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,9.0
1380.0,NCT04567953,COVID-19 Tests With Saliva Specimens,,"Active, not recruiting",COVID-19,,,,,,,Other: Saliva collection,Paradigm Laboratories LLC,All,"18 Years and older   (Adult, Older Adult)",2000.0,Industry,Interventional,2020-07-28,30/01/21,2021-06-27,29/09/20,29/09/20,"Paradigm Laboratories, Tucson, Arizona",United States,Respiratory Diseases,1,1,334.0
1381.0,NCT04382391,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,SAVIORII,Recruiting,COVID-19,Corona Virus Infection,Respiratory Failure,"Respiratory Distress Syndrome, Adult","ARDS, Human",SARS (Severe Acute Respiratory Syndrome),,Device: gammaCore® Sapphire (non-invasive vagus nerve stimulator)|Other: Standard of care therapies,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)|ElectroCore INC,All,"18 Years and older   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2020-08-05,01/09/21,2022-06-30,11/05/20,10/03/21,"AHN Allegheny General Hospital, Pittsburgh, Pennsylvania, United States|AHN West Penn Hospital, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,6,694.0
1382.0,NCT04382651,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,MAS-COVID,"Active, not recruiting",COVID-19,,,,,,,Drug: MAS825|Drug: Matching placebo,Novartis Pharmaceuticals|Novartis,All,"18 Years and older   (Adult, Older Adult)",140.0,Industry,Interventional,2020-07-06,06/01/21,2021-04-14,11/05/20,25/01/21,"Novartis Investigative Site, Chula Vista, California, United States|Novartis Investigative Site, Glendale, California, United States|Novartis Investigative Site, Irvine, California, United States|Novartis Investigative Site, La Mesa, California, United States|Novartis Investigative Site, Mission Hills, California, United States|Novartis Investigative Site, Santa Monica, California, United States|Novartis Investigative Site, Torrance, California, United States|Novartis Investigative Site, Denver, Colorado, United States|Novartis Investigative Site, Washington, District of Columbia, United States|Novartis Investigative Site, Idaho Falls, Idaho, United States|Novartis Investigative Site, Alexandria, Louisiana, United States|Novartis Investigative Site, Baton Rouge, Louisiana, United States|Novartis Investigative Site, Lafayette, Louisiana, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Boston, Massachusetts, United States|Novartis Investigative Site, Brooklyn, New York, United States|Novartis Investigative Site, Asheville, North Carolina, United States|Novartis Investigative Site, Columbus, Ohio, United States|Novartis Investigative Site, Bend, Oregon, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, United States|Novartis Investigative Site, Houston, Texas, United States|Novartis Investigative Site, Mesquite, Texas",United States,Respiratory Diseases,1,1,282.0
1383.0,NCT04566965,Serology to Covid for Recording Exposures and Evaluating Needs,SCREEN,Recruiting,COVID-19,Coronavirus,SARS-CoV Infection,,,,,Diagnostic Test: SARS-CoV-2,"Children's Hospital Medical Center, Cincinnati",All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Observational,2020-08-18,31/12/22,2023-12-31,28/09/20,28/09/20,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio",United States,Respiratory Diseases,1,3,1230.0
1384.0,NCT04577105,Risk Factors and Computed Tomography Findings in COVID-19.,,Completed,COVID-19,ARDS,"Pneumonia, Viral",Computed Tomography,,,,Diagnostic Test: Simple chest tomography,Instituto Nacional de Cardiologia Ignacio Chavez,All,"Child, Adult, Older Adult",233.0,Other,Observational,2020-01-04,31/08/20,2020-01-10,06/10/20,08/10/20,"Instituto Nacional Ignacio Chavez, Ciudad de mexico",Mexico,Respiratory Diseases,1,4,6.0
1385.0,NCT04415086,Treatment of Patients With COVID-19 With Convalescent Plasma,COOPCOVID-19,Recruiting,COVID-19,,,,,,,Biological: convalescent plasma,"University of Sao Paulo General Hospital|Ministério da Ciência, Tecnologia, Inovações e Comunicações|Faculty of Medicine of Ribeirão Preto (FMRP-USP)|Hospital de Clínicas, Faculdade de Medicina Universidade Estadual de Campinas|Hospital Sirio-Libanes|Hospital Israelita Albert Einstein|Grupo Hospitalar Conceição|Hospital Ernesto Dornelles",All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-01-06,20/04/22,2022-05-22,04/06/20,29/10/20,"University of Sao Paulo - General Hospital, São Paulo, SP",Brazil,Respiratory Diseases,1,1,867.0
1386.0,NCT04631861,Physical Activity and the Risk of COVID-19 Infection and Mortality,,Completed,COVID-19,,,,,,,,Wonju Severance Christian Hospital,All,"18 Years and older   (Adult, Older Adult)",132069.0,Other,Observational,2014-01-01,31/07/20,2020-07-31,17/11/20,17/11/20,,,Respiratory Diseases,1,1,2403.0
1387.0,NCT04426279,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,CORhum,Recruiting,Sars-CoV2,Rheumatoid Arthritis,Rheumatic Diseases,,,,,Other: questionnaire assesment,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-08-18,01/02/21,2021-01-02,11/06/20,07/01/21,"Lille University Hospital, Lille",France,"Respiratory Diseases, Immunological Disorders",1,3,137.0
1388.0,NCT04691908,"Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine",,"Active, not recruiting",COVID-19,SARS-CoV Infection,Vaccine Adverse Reaction,,,,,Biological: QazCovid-in®-vaccine against COVID-19|Other: Placebo,Research Institute for Biological Safety Problems|City polyclinic No. 4 of the UZO of Almaty|Clinic of the International Institute of Postgraduate Education|City Multidisciplinary Hospital of the Health Department of the Akimat of Zhambyl Region,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2020-12-25,31/03/21,2021-07-30,31/12/20,24/02/21,"Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy, Jambul",Kazakhstan,Respiratory Diseases,1,3,217.0
1389.0,NCT04718220,"Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19",STOPCOVID19,Recruiting,COVID-19,Pregnancy Related,Maternal Complication of Pregnancy,Coronavirus,Neonatal Infection,Prenatal Stress,Preterm Birth,Diagnostic Test: Antibody testing for SARS-CoV-2 IgG|Diagnostic Test: Testing for SARS-CoV-2 RNA|Diagnostic Test: Testing for SARS-CoV-2 IgM/IgG,Washington University School of Medicine|Mercy Research,Female,"Child, Adult, Older Adult",420.0,Other,Interventional,2021-01-03,01/11/22,2022-01-11,22/01/21,08/04/21,"Washington University Medical Center, Saint Louis, Missouri",United States,"Mental Health, Respiratory Diseases",1,7,373.0
1390.0,NCT04564287,An Observational Study of Neurologic Function After COVID-19 Infection,,Enrolling by invitation,COVID-19,,,,,,,,National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",100.0,NIH,Observational,2020-10-28,01/12/21,2022-01-12,25/09/20,17/12/20,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,441.0
1391.0,NCT04382586,Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Drug: Zanubrutinib|Drug: Supportive Care|Drug: Placebo,BeiGene,All,"18 Years and older   (Adult, Older Adult)",93.0,Industry,Interventional,2020-06-07,02/02/21,2021-04-30,11/05/20,12/02/21,"Honor Health, Scottsdale, Arizona, United States|St. Jude Medical Center, Fullerton, California, United States|Olive View - UCLA Medical Center, Sylmar, California, United States|MedStar Heath Research Institute/ MedStar Washington Hospital Center, Washington, District of Columbia, United States|Augusta University, Augusta, Georgia, United States|John D. Archbold Memorial Hospital, Thomasville, Georgia, United States|Loyola University Medical Center, Maywood, Illinois, United States|SIU School of Medicine, Springfield, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham And Women's Hospital, Boston, Massachusetts, United States|Morristown Medical Center, Morristown, New Jersey, United States|Rutgers University Hospital, Newark, New Jersey, United States|Atlantic Health System, Inc. / Chilton Medical Center, Pompton Plains, New Jersey, United States|Overlook Medical Center, Summit, New Jersey, United States|Therapeutic Concepts, Houston, Texas, United States|Covenant Health System, Lubbock, Texas, United States|Medical College of Wisconsin, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,2,327.0
1392.0,NCT04365439,Convalescent Plasma for COVID-19,,"Active, not recruiting",Blood Plasma Therapy,COVID-19,,,,,,Biological: Blood plasma,"Enos Bernasconi|Ente Ospedaliero Cantonale, Bellinzona",All,"18 Years to 75 Years   (Adult, Older Adult)",11.0,Other,Interventional,2020-07-20,20/12/20,2021-06-30,28/04/20,29/03/21,"Ospedale Regionale Locarno, Locarno, Ticino",Switzerland,Respiratory Diseases,1,2,345.0
1393.0,NCT04444310,Antibody Responses in Contacts of COVID-19 Patients,,"Active, not recruiting",COVID-19,,,,,,,,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-06-15,18/06/20,2020-09-30,23/06/20,23/06/20,"AssiutU, Assiut",Egypt,Respiratory Diseases,1,1,107.0
1394.0,NCT04724395,Disability Following Hospitalization in People of Working-age Surviving SARS-CoV-2 Infection - COVID-19,DisCOVID,Not yet recruiting,COVID-19,,,,,,,Other: Hospitalization,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 70 Years   (Adult, Older Adult)",800.0,Other,Observational,2021-01-01,01/01/23,2023-01-01,26/01/21,26/01/21,"Cochin Hospital, Paris",France,Respiratory Diseases,1,1,730.0
1395.0,NCT04554264,Complicated Grief in ICU in the Aftermath of COVID-19,DEPARTS,Recruiting,Complicated Grief,Intensive Care,COVID-19,,,,,Other: questionnaire,"Centre Hospitalier Universitaire, Amiens|University Hospital, Lille|University Hospital, Rouen",All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-01-09,01/09/21,2022-01-09,18/09/20,18/09/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,3,731.0
1396.0,NCT04508985,The McGill RAAS-COVID-19 Trial,RAAS-COVID,Not yet recruiting,COVID-19,Cardiovascular Diseases,,,,,,Other: Temporarily holding the RAAS inhibitor [intervention]|Other: RAAS inhibitor [continued standard of care],"McGill University Health Centre/Research Institute of the McGill University Health Centre|Jewish General Hospital (Montreal, Quebec, Canada)|Montreal General Hospital (Montreal, Quebec, Canada)|Université de Lorraine, Centre d'Investigation Clinique- Plurithématique Inserm",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-09,01/01/21,2021-01-09,11/08/20,19/08/20,,,Respiratory Diseases,1,2,366.0
1397.0,NCT04629638,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,,Completed,COVID-19,"Depression, Anxiety",Pregnancy Related,,,,,"Other: Maternal attachment, Edinburgh depression scoring and postpartum anxiety scale scores",Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),500.0,Other,Observational,2020-01-08,15/11/20,2020-11-20,16/11/20,22/12/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,"Mental Health, Respiratory Diseases",1,3,317.0
1398.0,NCT04509999,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Bicalutamide 150 Mg Oral Tablet|Drug: Placebo,University of Florida,Male,"18 Years to 99 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-26,01/09/22,2022-01-09,12/08/20,27/01/21,"University of Florida Clinincal Research Vehicle, Gainesville, Florida",United States,Respiratory Diseases,1,1,440.0
1399.0,NCT04563689,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,,Completed,COVID-19,,,,,,,Other: CHX0.12+CPC0.05 oral rinse (PerioAidActive Control)|Other: placebo rinse,Dentaid SL,All,"18 Years to 90 Years   (Adult, Older Adult)",23.0,Industry,Interventional,2020-06-18,22/10/20,2020-10-23,24/09/20,20/11/20,"Escuela odontologia. Facultad de Salud Hospital del Valle, Cali",Colombia,Respiratory Diseases,1,1,127.0
1400.0,NCT04840459,Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting,,Recruiting,COVID-19,,,,,,,Biological: BAMLANIVIMAB|Biological: CASIRIVIMAB|Biological: IMDEVIMAB,Sohail Rao|DHR Health Institute for Research and Development,All,"12 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Interventional,2020-11-20,31/12/21,2022-01-31,12/04/21,12/04/21,"DHR Health Institute for Research and Development, Edinburg, Texas, United States|DHR Health, Edinburg, Texas, United States|Starr County Memorial Hospital, Rio Grande City, Texas",United States,Respiratory Diseases,1,1,437.0
1401.0,NCT04331171,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,COVID CALL 15,Completed,COVID-19,,,,,,,Device: Web application users,Weprom|Institut Pasteur|Assistance Publique - Hôpitaux de Paris|DOCAPOST|Direction Générale de l'Offre de Soins,All,"18 Years and older   (Adult, Older Adult)",12000000.0,Other|Industry,Observational,2020-03-17,15/11/20,2020-11-15,02/04/20,08/04/21,"All French Emergency services, Le Mans",France,Respiratory Diseases,1,1,243.0
1402.0,NCT04559009,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,,Recruiting,COVID-19,Amyotrophic Lateral Sclerosis,,,,,,,Atrium Health,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-10-15,31/12/23,2024-04-30,22/09/20,04/11/20,"Neurosciences Institute, Neurology - Charlotte, Charlotte, North Carolina",United States,Respiratory Diseases,1,2,1293.0
1403.0,NCT04445233,COVID-19 Household Transmission Study,CO-HOST,"Active, not recruiting",COVID-19,,,,,,,,"University of North Carolina, Chapel Hill|North Carolina Translational and Clinical Sciences Institute",All,"1 Year and older   (Child, Adult, Older Adult)",315.0,Other,Observational,2020-04-29,01/06/21,2021-01-06,24/06/20,07/12/20,"University of North Carolina Health Care, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,1,252.0
1404.0,NCT04527614,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,PICOV,Enrolling by invitation,"Influenza, Human",SARS Virus,COVID-19,Espiratory Tract Infections,,,,Diagnostic Test: qRT-PCR and serology,"Sciensano|Mensura EDPB|Institute of Tropical Medicine, Belgium|Université Libre de Bruxelles",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-09-24,30/05/21,2021-05-30,26/08/20,19/10/20,"Sciensano, Brussels",Belgium,"Infectious Diseases, Respiratory Diseases",1,4,248.0
1405.0,NCT04447144,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",,Recruiting,COVID-19,Chronic Inflammation,Non-Communicable Chronic Diseases,,,,,,Cairo University,All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,01/08/20,2020-01-09,25/06/20,30/06/20,"Faculty of Medicine Cairo University, Cairo",Egypt,Respiratory Diseases,1,3,3.0
1406.0,NCT04704388,Study Project Comparing the Sequelae of COVID-19 Infection in Patients Who Have and Have Not Received Ventilatory Support in Critical Care,COMEBAC,Completed,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",478.0,Other,Observational,2020-01-06,01/10/20,2020-01-10,11/01/21,01/04/21,"Bicêtre Hospital, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,1,4.0
1407.0,NCT04386083,Neurologic Manifestations of COVID-19,CORONA,Recruiting,Coronavirus Disease 2019,,,,,,,,"University of the Philippines|Asian Hospital and Medical Center, Muntinlupa City, Philippines|Baguio General Hospital and Medical Center, Baguio City, Philippines|Cagayan Valley Medical Center, Tuguegarao City, Philippines|Capitol Medical Center, Quezon City, Philippines|Cardinal Santos Medical Center, San Juan City, Philippines|Chong Hua Hospital, Cebu City, Philippines|De La Salle University Medical Center|East Avenue Medical Center, Philippines|Jose B. Lingad Memorial Regional Hospital, San Fernando, Pampanga, Philippines|Jose R. Reyes Memorial Medical Center|Lung Center of the Philippines|Manila Doctors Hospital, Philippines|Manila Medical Center, Philippines|Makati Medical Center|New Era General Hospital, Philippines|Quirino Memorial Medical Center, Philippines|Ospital ng Makati, Philippines|Dr. Pablo O. Torre Memorial Hospital, Bacolod City, Philippines|Philippine Heart Center|Research Institute for Tropical Medicine, Philippines|San Juan De Dios Educational Foundation Inc. - Hospital, Philippines|San Lazaro Hospital, Philippines|Southern Isabela Medical Center, Philippines|St. Luke's Medical Center, Philippines|St Lukes Medical Center, Bonifacio Global City, Philippines|Southern Philippines Medical Center|The Medical City, Philippines|University of the East Ramon Magsaysay Memorial Medical Center, Inc, Philippines|University of Santo Tomas Hospital, Philippines|Veterans Memorial Medical Center, Philippines|Jose N. Rodriguez Memorial Hospital, Caloocan City|Zamboanga City Medical Center, Zamboanga City|Western Visayas Medical Center, Iloilo City|Northern Mindanao Medical Center, Cagayan de Oro City|Vicente Sotto Memorial Medical Center, Cebu City|Perpetual Succor Hospital, Cebu City",All,"19 Years and older   (Adult, Older Adult)",1342.0,Other,Observational,2020-10-06,01/12/20,2021-01-03,13/05/20,28/07/20,"Philippine General Hospital - University of the Philippines Manila, Manila",Philippines,Respiratory Diseases,1,1,89.0
1408.0,NCT04673162,Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients,,Not yet recruiting,COVID-19,,,,,,,"Drug: Methylprednisolone, Placebo",Azienda Unità Sanitaria Locale Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",260.0,Other,Interventional,2020-01-12,01/04/21,2021-01-06,17/12/20,17/12/20,"SOC Pneumologia, SOC Malattie Infettive, SOC Reumatologia, Az USL-IRCCS di Reggio Emilia, Reggio Emilia",Italy,Respiratory Diseases,1,1,360.0
1409.0,NCT04501783,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: Favipiravir|Drug: Standard of care (SOC)|Drug: standard concomitant therapy,R-Pharm,All,18 Years to 60 Years   (Adult),168.0,Industry,Interventional,2020-05-20,29/07/20,2020-01-08,06/08/20,06/08/20,"Medical center LLC Neuroprofi, Korolev, Russian Federation|Federal budgetary institution of science Central Research Institute of Epidemiology of Russian Federal Supervision Service for Consumer Rights Protection and People's Welfare, Moscow, Russian Federation|Medical centers JSC Medsi Group of Companies, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow City Clinical Hospital №57 of the Moscow City Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow City Clinical Hospital №67 n.a. LA Vorokhobova of the Moscow City Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Infectious Diseases Clinical Hospital №1 of the Moscow City Healthcare Department, Moscow, Russian Federation|Medical center LLC Medical Center Eco-safety, Saint Petersburg, Russian Federation|St. Petersburg State Budgetary Healthcare Institution City Hospital No. 40 of the Kurortny District, Saint Petersburg, Russian Federation|Budgetary healthcare institution of the Voronezh region Voronezh Regional Clinical Hospital No. 1, Voronezh, Russian Federation|State Budgetary Healthcare Institution of the Moscow Region Zhukovskaya City Clinical Hospital., Zhukovskiy",Russian Federation,Respiratory Diseases,1,1,-133.0
1410.0,NCT04482621,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,DART,Recruiting,COVID-19,,,,,,,Drug: Decitabine|Other: Placebo Saline,Johns Hopkins University,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-09-14,01/05/21,2021-01-07,22/07/20,25/09/20,"Johns Hopkins University, Baltimore, Maryland",United States,Respiratory Diseases,1,1,115.0
1411.0,NCT04828135,Dual MRI for Cardiopulmonary COVID-19 Long Haulers,,Not yet recruiting,COVID-19,,,,,,,Drug: Hyperpolarized 129Xenon gas,Bastiaan Driehuys|Duke University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-05-29,30/12/22,2022-12-30,01/04/21,01/04/21,"Duke Asthma, Allergy, and Airway Center, Durham, North Carolina",United States,Respiratory Diseases,1,1,580.0
1412.0,NCT04648709,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,COVIMMUNITY,Recruiting,COVID-19,,,,,,,Diagnostic Test: ELISPOT|Diagnostic Test: QUANTIFERON,Centre Hospitalier Universitaire de Saint Etienne,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-09-03,01/06/21,2022-01-12,01/12/20,08/04/21,"CHU Saint-Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,131.0
1413.0,NCT04338672,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,,Recruiting,"Emergency Service, Hospital",General Surgery,,,,,,Other: COVID-19 Pandemic,Sheba Medical Center,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-05-04,01/04/21,2022-01-04,08/04/20,21/04/20,"Sheba Medical Center, Ramat Gan",Israel,Others,0,2,610.0
1414.0,NCT04836754,The Effect of Covid-19 on Breast Milk Microbiome and Its Bioactive Components,,Not yet recruiting,COVID-19,Human Milk,,,,,,,Aysu Yıldız Karaahmet|The Scientific and Technological Research Council of Turkey|Halic University,Female,18 Years to 35 Years   (Adult),30.0,Other,Observational,2021-01-05,01/07/21,2021-01-09,08/04/21,08/04/21,"Haseki Training and Research Hospital, Sultangazi, Istanbul",Turkey,Respiratory Diseases,1,2,4.0
1415.0,NCT04343248,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),,"Active, not recruiting",COVID-19,Viral Respiratory Illnesses,,,,,,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,Romark Laboratories L.C.,All,"55 Years to 120 Years   (Adult, Older Adult)",800.0,Industry,Interventional,2020-12-05,30/06/21,2021-06-30,13/04/20,01/04/21,"The Chappel Group Research, Kissimmee, Florida, United States|Clinical Trial Specialists, Inc., Acworth, Georgia, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Centex Studies, Inc., Houston, Texas",United States,Respiratory Diseases,1,2,207.0
1416.0,NCT04488562,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,HOMECOMIN',Recruiting,COVID-19,Pulmonary Fibrosis,,,,,,,Erasmus Medical Center|Leiden University Medical Center|VU University Medical Center|Dutch Society of Physicians for Pulmonology and Tuberculosis,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-08-05,01/12/21,2021-12-31,28/07/20,28/07/20,"Amsterdam University Center - location VUmc, Amsterdam, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Erasmus MC, Rotterdam",Netherlands,Respiratory Diseases,1,2,513.0
1417.0,NCT04844242,"A Cross Sectional Study of the Systems Immunology and Viral Diversity of SARS-CoV2 Infection, COVID-19 Disease and Multisystem Inflammatory Syndrome in Children",MISC-COVID,Recruiting,SARS-CoV2 Infection,Multisystem Inflammatory Syndrome in Children,,,,,,,"Tuberculosis Research Centre, India|National Institutes of Health (NIH)",All,1 Year to 15 Years   (Child),180.0,Other|NIH,Observational,2020-12-23,22/06/21,2021-06-22,14/04/21,14/04/21,"Tuberculosis Research Centre, Chennai, Tamilnadu",India,Respiratory Diseases,1,2,181.0
1418.0,NCT04681001,"Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers",,Recruiting,Respiratory Viral Infection,Common Cold,Severe Acute Respiratory Syndrome (SARS) Pneumonia,COVID-19,Corona Virus Disease,,,Device: nasal spray,Marinomed Biotech AG,All,"18 Years to 70 Years   (Adult, Older Adult)",300.0,Industry,Interventional,2020-12-20,30/05/21,2021-06-30,23/12/20,11/01/21,"Gesundheitsverbund, Klinik Favoriten, Vienna, Austria|Gesundheitsverbund Klinik Floridsdorf, Vienna",Austria,Respiratory Diseases,1,5,192.0
1419.0,NCT04423692,Knowledge About Covid-19 Infection in Pregnant Women,,Recruiting,Viral Infection,,,,,,,Other: labs,Aljazeera Hospital,Female,18 Years to 42 Years   (Adult),30.0,Other,Observational,2020-01-06,15/08/20,2020-08-20,09/06/20,21/07/20,"Aljazeera( Al Gazeera) hospital, Giza",Egypt,Others,0,1,227.0
1420.0,NCT04459312,National Covid-19 Surveillance Physicians,NAT-COV-SURV,Recruiting,COVID-19,,,,,,,Diagnostic Test: Antibody test (SARS-CoV2),"Heinrich-Heine University, Duesseldorf|Dr. Wetzchewald",All,"18 Years to 99 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-01-06,10/07/20,2020-09-30,07/07/20,08/07/20,"University Hospital Duesseldorf, Dept. of Anesthesiology, Duesseldorf",Germany,Respiratory Diseases,1,1,268.0
1421.0,NCT04361500,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,COSA,Recruiting,COVID-19,,,,,,,Device: Seraph 100,"Hannover Medical School|Medical Clinic V Nephrology, Academic Teaching Hospital Brunswick",All,"18 Years to 99 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-04-15,01/10/20,2021-01-10,24/04/20,24/04/20,"Academic Teaching Hospital Brunswick, Brunswick, Lower Saxony, Germany|Hannover Medical School, Hannover",Germany,Respiratory Diseases,1,1,270.0
1422.0,NCT04326036,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,GARM-COVID19,Recruiting,Pulmonary Alveolar Proteinosis,COPD,Idiopathic Pulmonary Fibrosis,Viral Pneumonia,Coronavirus Infection,Interstitial Lung Disease,,Procedure: Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)|Device: Centricyte 1000|Procedure: IV Deployment Of cSVF In Sterile Normal Saline IV Solution|Drug: Liberase Enzyme (Roche)|Drug: Sterile Normal Saline for Intravenous Use,"Black Tie Medical, Inc.|Robert W. Alexander, MD",All,"18 Years to 90 Years   (Adult, Older Adult)",10.0,Industry|Other,Interventional,2020-03-25,01/11/21,2021-12-31,30/03/20,12/10/20,"Robert W. Alexander, MD, FICS, LLC, Stevensville, Montana",United States,Respiratory Diseases,1,6,646.0
1423.0,NCT04332991,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,ORCHID,Completed,Coronavirus,Acute Respiratory Infection,SARS-CoV Infection,,,,,Drug: Hydroxychloroquine|Drug: Placebo,"Massachusetts General Hospital|National Heart, Lung, and Blood Institute (NHLBI)",All,"18 Years and older   (Adult, Older Adult)",479.0,Other|NIH,Interventional,2020-02-04,19/06/20,2020-07-23,03/04/20,17/03/21,"University of Arizona, Tucson, Arizona, United States|UCSF Fresno, Fresno, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|UCSF Medical Center, San Francisco, California, United States|Stanford University, Stanford, California, United States|Medical Center of Aurora, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|St. Joseph Hospital, Denver, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Kentucky, Lexington, Kentucky, United States|University Medical Center, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|St. Vincent's Hospital, Worcester, Massachusetts, United States|University of Michigan Medical Center, Ann Arbor, Michigan, United States|Henry Ford Medical Center, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Montefiore Medical Center-Weiler, Bronx, New York, United States|Montefiore Medical Center-Moses, Bronx, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|UPMC Presbyterian/Mercy/Shadyside, Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Health Science Center, Houston, Texas, United States|Intermountain Medical Center, Murray, Utah, United States|University of Utah Hospital, Salt Lake City, Utah, United States|VCU Medical Center, Richmond, Virginia, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Hospital First Hill, Seattle, Washington",United States,Respiratory Diseases,1,3,170.0
1424.0,NCT04401475,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With COVID-19",,Recruiting,COVID-19,ARDS,,,,,,Biological: SOC plus 15mg/kg EB05 IV|Other: SOC plus Placebo IV,Edesa Biotech Inc.|JSS Medical Research Inc.,All,"18 Years and older   (Adult, Older Adult)",396.0,Industry,Interventional,2020-11-25,01/04/21,2021-01-04,26/05/20,12/01/21,"St. Jude Medical Center/ Providence, Fullerton, California, United States|St. Joseph Hospital, Orange - Providence, Orange, California, United States|University of Miami Hospital, Coral Gables, Florida, United States|Methodist Medical Center IL, Peoria, Illinois, United States|Providence Regional Medical Center - Everett, Everett, Washington, United States|UW Medicine Valley Medical Center, Renton, Washington, United States|West Virginia University Medicine Heart & Vascular Institute, Morgantown, West Virginia, United States|North York General Hospital, Toronto, Ontario, Canada|Hôpital Maisonneuve Rosemont, Montréal, Quebec",Canada,Respiratory Diseases,1,2,40.0
1425.0,NCT04581928,Patients Reactions Towards Their Diagnosis as Having COVID-19,,Recruiting,COVID-19,,,,,,,,ClinAmygate,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-10-10,10/04/21,2021-04-15,09/10/20,16/02/21,"Asalam, Maadi, Cairo",Egypt,Respiratory Diseases,1,1,187.0
1426.0,NCT04771351,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adults With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: COVI-AMG|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",280.0,Industry,Interventional,2021-01-04,01/08/21,2021-01-10,25/02/21,12/04/21,"Teradan Clinical Trials, Brandon, Florida",United States,Respiratory Diseases,1,1,6.0
1427.0,NCT04405102,COVID-19 Ozanimod Intervention Study,COZI,Recruiting,COVID-19,,,,,,,Drug: Ozanimod|Other: Standard of care,"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|Celgene|Bristol-Myers Squibb|Institut universitaire de cardiologie et de pneumologie de Québec, University Laval",All,"18 Years to 85 Years   (Adult, Older Adult)",48.0,Other|Industry,Interventional,2020-09-16,01/01/23,2024-01-01,28/05/20,30/09/20,"Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Québec",Canada,Respiratory Diseases,1,1,1202.0
1428.0,NCT04331509,COVID-19 Symptom Tracker,,Recruiting,COVID-19,,,,,,,Other: No Intervention,King's College London|Zoe Global Limited|Massachusetts General Hospital|Harvard School of Public Health|Stanford University,All,"18 Years and older   (Adult, Older Adult)",10000000.0,Other,Observational,2020-03-23,23/03/22,2022-03-23,02/04/20,07/04/20,"Massachusetts General Hospital, Boston, Massachusetts, United States|King's College London, London",United Kingdom,Respiratory Diseases,1,1,730.0
1429.0,NCT04742569,Wearable Diagnostic for Detection of COVID-19 Infection,,Recruiting,COVID-19,,,,,,,,"ClinOne, Inc.|BioIntelliSense, Inc|Phillips North America, LLC|University of Colorado, Denver|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",2352.0,Industry|Other|U.S. Fed,Observational,2020-12-21,01/06/21,2021-01-12,08/02/21,08/02/21,"ClinOne, Inc, Greenwood Village, Colorado",United States,Respiratory Diseases,1,1,22.0
1430.0,NCT04544605,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Other: Individualized-Chinese herbal medicine,Hong Kong Baptist University|The University of Hong Kong|Chinese University of Hong Kong,All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-07-09,30/09/21,2021-12-31,10/09/20,16/09/20,"School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, Hong Kong",China,Respiratory Diseases,1,1,540.0
1431.0,NCT04540484,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,,Recruiting,COVID-19,SARS-CoV Infection,Communicable Disease,,,,,,Advocate Health Care|Terika Richardson- President's Fund|Medical Staff Fund- Dr. John Ruge|Advocate Foundation- Ally Regnier and Chrisy Santos,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-08-26,24/09/21,2021-09-24,07/09/20,09/09/20,"Advocate Lutheran General Hospital, Park Ridge, Illinois",United States,Respiratory Diseases,1,3,394.0
1432.0,NCT04534673,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Lambda 180 mcg S.C,Soroka University Medical Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-05-08,31/12/21,2021-12-31,01/09/20,01/09/20,"Soroka UMC, Be'er Sheva",Israel,Respiratory Diseases,1,1,602.0
1433.0,NCT04425317,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,COVID_OFF,Recruiting,Infertility,COVID-19,IVF,,,,,Diagnostic Test: Blood sample,CRG UZ Brussel,Female,"up to 45 Years   (Child, Adult)",20.0,Other,Interventional,2020-06-24,15/06/21,2021-06-15,11/06/20,07/09/20,"Uz Brussels, Brussels",Belgium,Respiratory Diseases,1,3,356.0
1434.0,NCT04614948,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,ENSEMBLE 2,Recruiting,COVID-19,,,,,,,Biological: Ad26.COV2.S|Other: Placebo,Janssen Vaccines & Prevention B.V.,All,"18 Years and older   (Adult, Older Adult)",30000.0,Industry,Interventional,2020-11-16,10/05/22,2023-05-23,04/11/20,14/04/21,"Achieve Clinical Research, LLC, Vestavia Hills, Alabama, United States|Hope Research Institute, Phoenix, Arizona, United States|Central Phoenix Medical Clinic, Phoenix, Arizona, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Synexus Clinical Research US, Inc, Tucson, Arizona, United States|Woodland International Research Group, Little Rock, Arkansas, United States|Synexus Clinical Research US, Inc, Cerritos, California, United States|eStudySite, Chula Vista, California, United States|Ark Clinical Research, Long Beach, California, United States|Anthony Mills Medical, Inc, Los Angeles, California, United States|Catalina Research Institute, Montclair, California, United States|Benchmark Research, Sacramento, California, United States|Artemis Institute for Clinical Research, San Diego, California, United States|Paradigm Clinical Research Centers, Inc., Wheat Ridge, Colorado, United States|JEM Research, LLC, Atlantis, Florida, United States|Prestige Clinical Research Center, Inc., Coral Gables, Florida, United States|Avail Clinical Research, LLC, DeLand, Florida, United States|Velocity Clinical Research, Hallandale Beach, Hallandale Beach, Florida, United States|Health Awareness inc., Jupiter, Florida, United States|Altus Research, Inc, Lake Worth, Florida, United States|Compass Research, Melbourne, Melbourne, Florida, United States|Suncoast Research Group, Miami, Florida, United States|Behavioral Clinical Research , Inc, North Miami, Florida, United States|Advent Health Orlando, Orlando, Florida, United States|Clinical NeuroScience Solutions, Inc, Orlando, Florida, United States|Progressive Medical Research, Port Orange, Florida, United States|Meridien Research, Saint Petersburg, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|Accel Research Sites, Eatonton, Georgia, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|The South Bend Clinic Center for Research, South Bend, Indiana, United States|Buynak Clinical Research, Valparaiso, Indiana, United States|Heartland Research Associates, LLC, Newton, Kansas, United States|University of Kentucky, Lexington, Kentucky, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Centennial Medical Group, Elkridge, Maryland, United States|Optimal Research, Rockville, Maryland, United States|Meridian Clinical Research, LLC, Rockville, Maryland, United States|Henry Ford Health Systems, Detroit, Michigan, United States|Cherry Street Services, Inc., Grand Rapids, Michigan, United States|Abbott Northwestern Hospital Clinic, Minneapolis, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Hassman Research Institute, LLC., Berlin, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|Medpharmics, LLC, Albuquerque, New Mexico, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Allergy Asthma Immunology of Rochester, PC (AAIR) - Research Center, Rochester, New York, United States|Richmond Behavioral Associates, Staten Island, New York, United States|American Health Network, LLC, Charlotte, North Carolina, United States|Wilmington Health Associates, Wilmington, North Carolina, United States|CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|Clinical NeuroScience Solutions, Inc, Memphis, Tennessee, United States|Centennial Medical Center, Nashville, Tennessee, United States|Tekton Research Inc., Austin, Texas, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Centex Studies, Inc., McAllen, Texas, United States|Endeavor Clinical Trials, LLC, San Antonio, Texas, United States|JBR Clinical Research, Salt Lake City, Utah, United States|Alliance for Multispeciality Research, Norfolk, Virginia, United States|Anima, Alken, Belgium|Institute of Tropical Medicine Antwerp, Antwerpen, Belgium|AZ Sint-Jan, Brugge, Belgium|Hopital Erasme, Brussel, Belgium|Center for Vaccinology (CEVAC), Gent, Belgium|UZ Leuven, Leuven, Belgium|Az Sint-Maarten, Mechelen, Belgium|Private Practice RESPISOM Namur, Namur, Belgium|Hospital Nossa Senhora da Conceicao, Porto Alegre, Brazil|Hospital federal dos servidores do estado, Rio de Janeiro, Brazil|Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ, Rio de Janeiro, Brazil|Centro de Referencia E Treinamento Dst/Aids, Sao Paulo, Brazil|Instituto de infectologia Emilio Ribas, São Paulo, Brazil|Fundacion Cardiomet CEQUIN, Armenia, Colombia|IPS Centro Cientifico Asisitencial Jose Luis Accini S.A.S., Barranquilla, Colombia|Caja de Compensacion Familiar Cafam, Bogota, Colombia|Asistencia Cientifica de Alta Complejidad S.A.S, Bogota, Colombia|CAIMED Aguazul, Casanare, Colombia|Centro Medico Imbanaco de Cali S.A., Casanare, Colombia|Asociacion IPS Medicos Internistas de Caldas, Manizales, Colombia|Hospital General de Medellin Luz Castro de Gutierrez E.S.E, Medellin, Colombia|T Y C Inversiones S A S Grupsalud, Santa Marta, Colombia|Centro de Atencion e Investigacion Medica S.A. - CAIMED, Yopal - Casanare, Colombia|CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Grenoble - Hôpital Albert Michallon, La Tronche, France|CHU de Montpellier, Hopital Saint-Eloi, Montpellier, France|Hopital Saint-Antoine, Paris Cedex 12, France|Hopital Cochin, Paris, France|Groupe Hospitalier Sud Hôpital Haut-Leveque Service d'hematologie, Pessac, France|CHU Saint-Etienne - Hôpital Nord, Saint-Etienne Cedex 2, France|Hopital Purpan, Toulouse Cedex 09, France|Hopital Rangueil, Toulouse, France|Centre Hospitalier Universitaire de Tours, Tours Cedex, France|Hôpital de Brabois Adultes, Vandoeuvre les Nancy, France|Uniklinik Köln, Köln, Germany|Klinikum rechts der Isar der TU Munchen, München, Germany|Riverside Medical Center, Bacolod, Philippines|West Visayas State University Medical Center, Iloilo City, Philippines|Tropical Disease Foundation, Makati, Philippines|Makati Medical Center, Manila, Philippines|Medical Center Manila, Manila, Philippines|TREAD Research Tygerberg Hospital, Cape Town, South Africa|Centre of Tuberculosis Research Innovation, Cape Town, South Africa|Worthwhile Clinical trials, Johannesburg, South Africa|Peermed Clinical Trial Centre, Kempton Park, South Africa|Dr AA Mahomed Medical Centre, Moloto, South Africa|VX Pharma, Pretoria, South Africa|Dr J.M. Engelbrecht Trial Site, Somerset West, South Africa|Be Part Yoluntu Centre, Western Cape, South Africa|Hosp. Univ. Germans Trias I Pujol, Badalona, Spain|Hospital Quiron Barcelona, Barcelona, Spain|Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain|Hosp. Univ. Vall D Hebron, Barcelona, Spain|Hosp. Univ. de La Princesa, Madrid, Spain|Clinica Univ. de Navarra, Madrid, Spain|Hosp. Univ. de La Paz, Madrid, Spain|Hosp. Quiron Madrid Pozuelo, Madrid, Spain|Clinica Univ. de Navarra, Pamplona, Spain|Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital, Birmingham, United Kingdom|Powys Teaching Local Health Board - Bronllys Hospital, Brecon, United Kingdom|Brighton & Sussex University Hospitals NHS Trust, Brighton, United Kingdom|University Hospitals Bristol NHS Trust, Bristol, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Ninewells Hospital, Dundee, United Kingdom|Royal Free Hospital, Hampstead, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Guy's and St Thomas' Hospital, London,,",United Kingdom,Respiratory Diseases,1,1,918.0
1435.0,NCT04473118,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,BADS-PTSD,Recruiting,COVID-19,,,,,,,Other: Survey,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",25000.0,Industry,Observational,2020-11-07,01/09/20,2021-01-06,16/07/20,16/07/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,1,60.0
1436.0,NCT04756466,Effect of the Consumption of a Lactobacillus Strain on the Incidence of Covid-19 in the Elderly,,"Active, not recruiting",SARS CoV-2 Infection,Elderly,,,,,,Dietary Supplement: Placebo|Dietary Supplement: Lactobacillus,Biosearch S.A.,All,"60 Years and older   (Adult, Older Adult)",201.0,Industry,Interventional,2021-01-01,30/04/21,2021-12-31,16/02/21,05/03/21,"Residencia San Marcos, Santiago De Compostela, A Coruña, Spain|Residencia Santa Olalla, Santiago De Compostela, A Coruña, Spain|Residencia San Simon de Ons, Santiago De Compostela, A Coruña",Spain,Others,0,2,364.0
1437.0,NCT04510038,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,COLHEART-19,Suspended,COVID-19,Myocardial Injury,,,,,,Drug: Colchicine|Other: Covid-19 Standard of Care,"Miami Cardiac and Vascular Institute|University of California, Los Angeles",All,"18 Years to 100 Years   (Adult, Older Adult)",75.0,Other,Interventional,2020-01-01,12/03/21,2022-01-01,12/08/20,16/03/21,"Baptist Health South Florida, Miami, Florida",United States,Respiratory Diseases,1,2,731.0
1438.0,NCT04432350,Assessment of Mortality Rates in COVID-19 Infected Populations Treated With Repurposed Medications,,"Active, not recruiting",COVID-19,Drug Effect,Drug Interaction,Risk Reduction,,,,,Tabula Rasa HealthCare,All,"Child, Adult, Older Adult",50000.0,Industry,Observational,2020-06-15,31/12/21,2022-05-31,16/06/20,16/03/21,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida",United States,Respiratory Diseases,1,4,715.0
1439.0,NCT04699851,Optimization of the Management of COVID-19 Through Tailored Recommendations to the Citizens,VIGIE-COVID,Recruiting,COVID-19,Tailored Recommendations,Citizen Self-reported Symptoms,,,,,Behavioral: Tailored recommendations|Behavioral: General recommendation,Laval University|Réseau-1 Québec|Réseau de recherche en santé des populations du Québec,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Interventional,2020-11-18,18/04/21,2021-05-18,07/01/21,08/01/21,"Laval University, Quebec",Canada,Respiratory Diseases,1,3,181.0
1440.0,NCT04734860,Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms,,Recruiting,COVID-19,,,,,,,Biological: COVI-AMG|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",500.0,Industry,Interventional,2021-01-04,01/09/21,2021-01-11,02/02/21,13/04/21,"Collaborative NeuroScience Research, LLC, Garden Grove, California, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Med-Care Research, Miami, Florida, United States|ETNA Medical Center, Tamarac, Florida",United States,Respiratory Diseases,1,1,7.0
1441.0,NCT04391309,COVID-19 and Anti-CD14 Treatment Trial,CaTT,Recruiting,COVID-19,COVID-19,,,,,,Biological: anti-CD14|Other: Placebo|Drug: remdesivir,National Institute of Allergy and Infectious Diseases (NIAID)|University of Washington|Implicit Bioscience|Vanderbilt University Medical Center|PPD,All,"18 Years and older   (Adult, Older Adult)",300.0,NIH|Other|Industry,Interventional,2021-12-04,01/11/21,2022-01-02,18/05/20,14/04/21,"Harbor - UCLA Medical Center, Torrance, California, United States|University of Miami Medical Center, Miami Beach, Florida, United States|Sarasota Memorial Health Care System, Sarasota, Florida, United States|Emory University Medical Center, Atlanta, Georgia, United States|Ochsner Health, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Cleveland Clinic, Cleveland, Ohio, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Virginia Mason Medical Center, Seattle, Washington, United States|Harborview Medical Center, Seattle, Washington, United States|Swedish Medical Center, Seattle, Washington, United States|University of Washington Medical Center, Seattle, Washington",United States,Respiratory Diseases,1,2,29.0
1442.0,NCT04552366,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,,"Active, not recruiting",COVID-19,,,,,,,Biological: Ad5-nCoV,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China|Zhongnan Hospital",All,"18 Years and older   (Adult, Older Adult)",149.0,Other,Interventional,2020-09-29,31/12/20,2021-06-30,17/09/20,07/12/20,"Zhongnan Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,1,274.0
1443.0,NCT04816682,Silymarin in COVID-19 Patients Admitted to Hospital With Elevated Liver Enzymes,SILCOVINT-21,Recruiting,COVID-19,Liver Diseases,,,,,,Drug: Silymarin,F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica,All,"19 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-03-17,30/06/21,2021-12-30,25/03/21,25/03/21,"F.D.Roosevelt Teaching Hospital, Banska Bystrica, Slovakia|University Hospital Bratislava, Bratislava",Slovakia,Respiratory Diseases,1,2,288.0
1444.0,NCT04361344,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,MARNEVO-Covid,Terminated,COVID-19,Encephalitis,,,,,,Biological: blood samples,Centre Hospitalier de PAU,All,"18 Years and older   (Adult, Older Adult)",2.0,Other,Interventional,2020-05-19,25/10/20,2020-10-25,24/04/20,04/02/21,"CH de Pau, Pau",France,Respiratory Diseases,1,2,159.0
1445.0,NCT04747769,COVID-19. CT-Scan Modeling in COVID19 Sequelae,SILICOVILUNG,Not yet recruiting,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2021-01-02,01/04/21,2021-01-10,10/02/21,10/02/21,"Hôpital Avicenne APHP, Bobigny",France,Respiratory Diseases,1,1,8.0
1446.0,NCT04689711,Prognostic Models for COVID-19 Care,,Enrolling by invitation,COVID-19,,,,,,,,Tufts Medical Center|Northwell Health|Erasmus Medical Center,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Observational,2020-07-12,31/08/21,2021-08-31,30/12/20,30/12/20,"Tufts Medical Center, Boston, Massachusetts, United States|Northwell Health (The Feinstein Institutes for Medical Research), Manhasset, New York",United States,Respiratory Diseases,1,1,415.0
1447.0,NCT04743388,Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System,,Recruiting,COVID-19,Healthy Volunteers,Chronic Disease,Hematological Malignancies,Solid Tumor,,,Biological: BNT162b2|Biological: Other vaccine against SARS-Cov-2,National and Kapodistrian University of Athens,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-04-01,01/11/21,2022-01-04,08/02/21,11/02/21,"Department of Clinical Therapeutics, General Hospital of Athens ALEXANDRA, Athens",Greece,Respiratory Diseases,1,5,278.0
1448.0,NCT04439045,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,COBRA,"Active, not recruiting",COVID-19,,,,,,,Biological: VPM1002|Other: Placebo,"University Health Network, Toronto|Serum Institute of India Pvt. Ltd.|Max Planck Institute for Infection Biology|Verity Pharmaceuticals",All,"18 Years and older   (Adult, Older Adult)",122.0,Other|Industry,Interventional,2020-06-24,02/09/21,2021-01-12,19/06/20,22/03/21,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,1,202.0
1449.0,NCT04655638,HFNT vs. COT in COVID-19,COVID-HIGH,Recruiting,COVID-19,Acute Respiratory Failure,,,,,,Device: High Flow Nasal Therapy|Device: Conventional Oxygen Therapy,"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo|Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele",All,"18 Years and older   (Adult, Older Adult)",364.0,Other,Interventional,2021-10-02,10/01/22,2022-01-03,07/12/20,19/03/21,"Pulmonology and Respiratory Intensive Care Unit, S. Donato Hospital, Arezzo, Italy, Arezzo, Italy|Respiratory Medicine Unit, Policlinico-Vittorio Emanuele San Marco University Hospital, Catania, Italy, Catania, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy G. Giglio Foundation, Cefalù, Italy, Cefalù, Italy|Department of Human Pathology of the Adult and Evolutive Age Gaetano Barresi, Division of Anesthesia and Intensive Care, University of Messina, Policlinico G. Martino, Messina, Italy, Messina, Italy|IRCCS MultiMedica, Value-Based Healthcare Unit, Sesto San Giovanni, Milan, Italy, Milan, Italy|University Hospital of Modena Policlinico, Respiratory Diseases Unit, Department of Medical and Surgical Sciences SMECHIMAI, University of Modena Reggio Emilia, Italy, Modena, Italy|AOU San Luigi Gonzaga, Orbassano, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy Department of Anesthesia Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy, Palermo, Italy|Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy Department of Anesthesia Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy, Palermo, Italy|Department of Medicina e Chirurgia Università Insubria Varese-Como, Italy, Pavia, Italy|Emergency Department, S. Maria della Misericordia Hospital, Perugia, Italy., Perugia, Italy|Department of Pneumology, A.O.U. Città della Salute e della Scienza of Turin, Italy., Turin, Italy|U.O. Medicina Respiratoria del Policlinico G.B. Rossi, Verona",Italy,Respiratory Diseases,1,2,93.0
1450.0,NCT04414267,Bacillus Calmette-guérin Vaccination to Prevent COVID-19,ACTIVATEII,Recruiting,COVID-19,Virus Diseases,Corona Virus Infection,Coronary Heart Disease,Chronic Obstructive Pulmonary Disease,,,Biological: BCG vaccine|Biological: Placebo,Hellenic Institute for the Study of Sepsis,All,"50 Years and older   (Adult, Older Adult)",900.0,Other,Interventional,2020-05-26,25/05/21,2021-05-25,04/06/20,14/07/20,"General Hospital of Argolida - Nafplion Unit, Náfplio, Argos, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Therapeutics, Alexandra General Hospital, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens, Medical School, Athens, Greece|Department of Pulmonary Medicine- General Hospital of Kerkyra, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, General Hospital of Karditsa, Kardítsa, Greece|General Hospital of Korinthos, Kórinthos, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Greece|General Hospital of Ptolemaida MPODOSAKEIO, Ptolemaḯda, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|General Hospital of Imathia - Veria Unit, Véria",Greece,Respiratory Diseases,1,5,364.0
1451.0,NCT04584710,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,,"Active, not recruiting",COVID-19,,,,,,,Drug: RTB101|Drug: Placebo,Restorbio Inc.|National Institute on Aging (NIA),All,65 Years and older   (Older Adult),60.0,Industry|NIH,Interventional,2020-10-13,01/02/21,2021-01-02,14/10/20,09/02/21,"University of Connecticut, UConn Center on Aging, Farmington, Connecticut, United States|Hebrew Senior Life, Marcus Institute for Aging Research, Roslindale, Massachusetts",United States,Respiratory Diseases,1,1,81.0
1452.0,NCT04709068,Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization,RiskSEARCH,Recruiting,COVID-19,,,,,,,Device: Current Health,Current Health|Biomedical Advanced Research and Development Authority,All,"21 Years and older   (Adult, Older Adult)",2050.0,Industry|U.S. Fed,Observational,2021-08-02,19/03/21,2021-01-07,14/01/21,11/02/21,"Current Health, New York, New York",United States,Respiratory Diseases,1,1,-207.0
1453.0,NCT04314232,Mechanisms for Covid-19 Disease Complications,COVID MECH,Recruiting,COVID-19,Coronavirus Infection,,,,,,,"University Hospital, Akershus",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-03-18,31/12/21,2021-12-31,19/03/20,26/06/20,"Akershus University Hospital, Lørenskog",Norway,Respiratory Diseases,1,2,653.0
1454.0,NCT04718480,Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected Patients,,Recruiting,COVID-19,,,,,,,Drug: Placebo|Drug: Fluvoxamine,SigmaDrugs Research Ltd.,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2020-11-27,01/08/21,2021-01-12,22/01/21,22/01/21,"Dél-pesti Centrumkórház, Budapest, Hungary|Semmelweis Egyetem Pulmonológiai Klinika, Budapest, Hungary|Országos Korányi Pulmonológiai Intézet, Budapest, Hungary|Debreceni Egyetem Kenézy Gyula Kórház Infektológia, Debrecen",Hungary,Respiratory Diseases,1,1,46.0
1455.0,NCT04328129,Household Transmission Investigation Study for COVID-19 in Tropical Regions,EPI-COVID-19,Recruiting,Coronavirus Infections,Severe Acute Respiratory Syndrome,SARS-CoV Infection,,,,,Procedure: Human biological samples,Institut Pasteur|Institut Pasteur de la Guyane|Centre Hospitalier Andrée Rosemon de Cayenne|Institut Pasteur de la Guadeloupe|Centre Hospitalier de la Guadeloupe|Institut Pasteur de Nouvelle-Calédonie|Centre Hospitalier Territorial de Nouvelle Calédonie,All,"Child, Adult, Older Adult",1300.0,Industry|Other,Interventional,2020-03-23,23/03/22,2022-03-23,31/03/20,23/09/20,"Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana|Institut Pasteur de la Guyane, Cayenne, French Guiana|Institut Pasteur de Guadeloupe, Les Abymes, Guadeloupe|Institut Pasteur de Nouvelle-Calédonie, Nouméa",New Caledonia,Respiratory Diseases,1,3,730.0
1456.0,NCT04383587,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,,Completed,SARS-CoV 2,COVID-19,,,,,,Other: Serologic testing,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-06-05,01/07/20,2020-07-31,12/05/20,01/09/20,"Mayo Clinic in Florida, Jacksonville, Florida",United States,Respiratory Diseases,1,2,56.0
1457.0,NCT04788459,"Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers",,Recruiting,COVID-19,COVID-19,COVID-19,,,,,Biological: COVID-eVax|Device: Cliniporator® and EPSGun,Takis|Rottapharm Biotech,All,"18 Years to 65 Years   (Adult, Older Adult)",160.0,Industry,Interventional,2021-02-25,01/09/21,2022-01-06,09/03/21,16/03/21,"San Gerardo Hospital, Monza, Italy|Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy|INMI Lazzaro Spallanzani, Rome",Italy,Respiratory Diseases,1,3,315.0
1458.0,NCT04499300,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,,Recruiting,COVID-19,,,,,,,Other: Data collection from medical files,Murielle Surquin|Brugmann University Hospital,All,90 Years and older   (Older Adult),50.0,Other,Observational,2020-09-06,01/12/20,2020-01-12,05/08/20,07/08/20,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,-238.0
1459.0,NCT04311697,Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,COVID-AIV,Completed,COVID-19,Acute Respiratory Distress Syndrome (ARDS),Corona Virus Infection,Acute Lung Injury,,,,Drug: Aviptadil by intravenous infusion + standard of care|Drug: Normal Saline Infusion + standard of care,"NeuroRx, Inc.|Lavin Consulting, LLC",All,"18 Years to 100 Years   (Adult, Older Adult)",196.0,Industry|Other,Interventional,2020-05-15,22/02/21,2021-02-22,17/03/20,26/02/21,"St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Heartland/Mosaic Health, Saint Joseph, Missouri, United States|Hendrick Health, Abilene, Texas, United States|Texas Health Harris Methodist Hospital, Fort Worth, Texas, United States|Texas Health Hospital Frisco, Frisco, Texas, United States|Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,4,283.0
1460.0,NCT04510441,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,AI-COV-19,Recruiting,Coronavirus,,,,,,,Other: Nil intervention,Imperial College London|Imperial College Healthcare NHS Trust|Chelsea and Westminster Hospital NHS Foundation Trust|LONDON NORTH WEST UNIVERSITY HEALTHCARE NHS TRUST,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-05-26,01/05/22,2022-01-05,12/08/20,12/08/20,"London North West University Healthcare NHS Trust, London, United Kingdom|Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Imperial College London (Hammersmith campus), London, United Kingdom|St Mary's Hospital, London",United Kingdom,Respiratory Diseases,1,1,589.0
1461.0,NCT04406038,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",,"Active, not recruiting",COVID-19,,,,,,,,European University at St. Petersburg,All,"18 Years and older   (Adult, Older Adult)",1038.0,Other,Observational,2020-05-27,28/10/21,2021-10-28,28/05/20,03/02/21,"Clinic Scandinavia, Saint Petersburg",Russian Federation,Respiratory Diseases,1,1,519.0
1462.0,NCT04824651,Covid-19 Vaccine Cohort in Specific Populations,COV-POPART,Not yet recruiting,Immune Deficiency,,,,,,,Biological: COVID-19 vaccine,"ANRS, Emerging Infectious Diseases|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",10500.0,Other,Observational,2021-03-25,25/09/24,2024-09-25,01/04/21,01/04/21,,,Others,0,1,1280.0
1463.0,NCT04448145,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,,Recruiting,COVID-19,Corona Virus Infection,SARS-CoV 2,,,,,,Columbia University,All,"7 Years and older   (Child, Adult, Older Adult)",325.0,Other,Observational,2020-03-26,01/05/22,2022-01-05,25/06/20,12/04/21,"Columbia University Medical Center, New York, New York",United States,Respiratory Diseases,1,3,650.0
1464.0,NCT04403243,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,COLORIT,Recruiting,COVID-19,,,,,,,Drug: Colchicine|Drug: Ruxolitinib 5 MG|Drug: Secukinumab 150 MG/ML Subcutaneous Solution [COSENTYX]|Other: standard therapy,Lomonosov Moscow State University Medical Research and Educational Center,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-08-05,22/07/20,2020-08-23,27/05/20,27/05/20,"Lomonosov Moscow State University Medical Research and Educational Center, Moscow, Moscow Region",Russian Federation,Respiratory Diseases,1,1,18.0
1465.0,NCT04360707,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,TX-COVID,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"1 Year and older   (Child, Adult, Older Adult)",300.0,Other,Observational,2020-08-04,08/04/21,2021-08-04,24/04/20,05/05/20,"Service de Néphrologie et Transplantation, Strasbourg",France,Respiratory Diseases,1,1,365.0
1466.0,NCT04828161,"A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19",EMPATHY,Not yet recruiting,COVID-19,,,,,,,Drug: ensovibep|Drug: Placebo,Molecular Partners AG|Novartis Pharmaceuticals|Iqvia Pty Ltd|Datamap|SYNLAB Analytics & Services Switzerland AG|Q2 Solutions,All,"18 Years and older   (Adult, Older Adult)",2100.0,Industry|Other,Interventional,2021-04-15,01/05/22,2022-01-06,01/04/21,01/04/21,,,Respiratory Diseases,1,1,266.0
1467.0,NCT04621149,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,PROFACT-01,Recruiting,COVID-19,,,,,,,"Other: chlorine dioxide|Dietary Supplement: zinc acetate|Drug: Famotidine|Other: placebo|Dietary Supplement: lactoferrin, green tea extract","Profact, Inc.",All,"20 Years to 70 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-11-15,31/03/21,2021-03-31,09/11/20,29/12/20,"AZ Good Health Center, Tempe, Arizona",United States,Respiratory Diseases,1,1,136.0
1468.0,NCT04394208,Silymarin in COVID-19 Pneumonia,SCOPE,Recruiting,COVID-19,Viral Pneumonia Human Coronavirus,,,,,,Drug: Silymarin|Drug: Placebo,Cairo University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-08-16,30/01/21,2021-02-28,19/05/20,18/08/20,"Cairo University, Giza, Cairo",Egypt,Respiratory Diseases,1,2,196.0
1469.0,NCT04470609,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ⩾60 Years,,Enrolling by invitation,COVID-19,,,,,,,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Placebo on a 0- and 28-day schedule,Chinese Academy of Medical Sciences|West China Second University Hospital|Yunnan Center for Disease Control and Prevention,All,"60 Years and older   (Adult, Older Adult)",471.0,Other,Interventional,2020-10-07,01/11/20,2021-01-11,14/07/20,14/07/20,"West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan",China,Respiratory Diseases,1,1,96.0
1470.0,NCT04478019,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,SHIELD,Recruiting,COVID-19,SARS-CoV 2,,,,,,Drug: 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse,"University of Wisconsin, Madison",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2020-07-07,30/04/22,2022-04-30,20/07/20,08/04/21,"University of Wisconsin-Madison, Madison, Wisconsin",United States,Respiratory Diseases,1,2,662.0
1471.0,NCT04313322,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,,Recruiting,COVID-19,,,,,,,Biological: WJ-MSCs,Stem Cells Arabia,All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-03-16,30/06/20,2020-09-30,18/03/20,18/03/20,"Stem Cells Arabia, Amman",Jordan,Respiratory Diseases,1,1,198.0
1472.0,NCT04411680,Study of Sargramostim in Patients With COVID-19,iLeukPulm,"Active, not recruiting",COVID-19,Sars-CoV2,,,,,,Drug: Sargramostim|Drug: Standard of care,"Partner Therapeutics, Inc.|United States Department of Defense",All,"18 Years and older   (Adult, Older Adult)",122.0,Industry|U.S. Fed,Interventional,2020-08-18,01/03/21,2021-01-05,02/06/20,02/03/21,"St. Jude Medical Center, Fullerton, California, United States|St. Joseph Hospital of Orange, Orange, California, United States|California Pacific Medical Center - Van Ness Campus, San Francisco, California, United States|TidalHealth Peninsula Regional, Inc, Salisbury, Maryland, United States|University of Missouri Health Care, Columbia, Missouri, United States|Great Plains Health, North Platte, Nebraska, United States|Richmond University Medical Center, Staten Island, New York, United States|Brody School of Medicine at East Carolina University, Greenville, North Carolina, United States|University of Toledo Medical Center, Toledo, Ohio, United States|Memorial Hermann Hospital Affiliated with the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States|University of Utah Health, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,140.0
1473.0,NCT04348435,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",,"Active, not recruiting",COVID-19,,,,,,,Drug: HB-adMSCs|Drug: Placebos,Hope Biosciences|Hope Biosciences Stem Cell Research Foundation,All,"Child, Adult, Older Adult",100.0,Industry|Other,Interventional,2020-05-14,30/05/21,2021-07-30,16/04/20,25/03/21,"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas",United States,Respiratory Diseases,1,1,442.0
1474.0,NCT04378777,Immunophenotyping Assessment in a COVID-19 Cohort,IMPACC,"Active, not recruiting",COVID-19,COVID-19,,,,,,Procedure: Biological sample collection|Procedure: Data Collection: Clinical Care Assessments,National Institute of Allergy and Infectious Diseases (NIAID)|Benaroya Research Institute|Boston Children's Hospital,All,"18 Years and older   (Adult, Older Adult)",1227.0,NIH|Other,Observational,2020-01-05,19/03/21,2022-01-03,07/05/20,02/04/21,"University of Arizona (UA) College of Medicine - Tucson: UA Health Sciences Asthma and Airway Disease Research Center, Tucson, Arizona, United States|University of California, Los Angeles: Department of Medicine, Los Angeles, California, United States|University of California San Francisco School of Medicine, San Francisco, California, United States|Stanford Medicine: Sean N. Parker Center for Allergy & Asthma Research, Stanford, California, United States|Yale School of Medicine, New Haven, Connecticut, United States|University of Florida Health Gainesville, Gainesville, Florida, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|University of South Florida Health Tampa, Tampa, Florida, United States|Emory University School of Medicine, Atlanta, Georgia, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|University of Oklahoma ,Oklahoma Health Sciences Center: Pulmonary/Critical Care, Department of Medicine, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Drexel University College of Medicine, Philadelphia, Pennsylvania, United States|University of Texas at Austin: UT Health Austin, Austin, Texas, United States|Baylor College of Medicine: Department of Medicine, Houston, Texas",United States,Respiratory Diseases,1,2,729.0
1475.0,NCT04351646,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),,Not yet recruiting,COVID-19,,,,,,,,"St George's, University of London",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-15,15/04/22,2022-04-15,17/04/20,17/04/20,"St. Georges Hospital Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,730.0
1476.0,NCT04538469,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",VINCI,Not yet recruiting,Cardiovascular Diseases,Delirium,Critical Illness,Intensive Care Unit Delirium,Thoracic Diseases,Respiratory Failure,Cardiac Disease,Other: COVID visitation restrictions,University of Glasgow|Golden Jubilee National Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-09,01/12/21,2021-01-12,04/09/20,04/09/20,,,"Cardiovascular Diseases, Respiratory Diseases",1,7,369.0
1477.0,NCT04632043,Early Versus Delayed Intubation of Patients With COVID-19,EUDOCO,Recruiting,COVID-19,Acute Hypoxemic Respiratory Failure,,,,,,Other: Endotracheal intubation,Evangelismos Hospital,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-11-18,01/05/21,2021-01-06,17/11/20,03/03/21,"Evangelismos Hospital, Athens, Attiki",Greece,Respiratory Diseases,1,2,49.0
1478.0,NCT04370015,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,,Not yet recruiting,COVID-19,Healthcare Workers,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"Services Institute of Medical Sciences, Pakistan",All,18 Years to 60 Years   (Adult),374.0,Other,Interventional,2020-05-15,30/06/20,2020-10-15,30/04/20,06/05/20,,,Respiratory Diseases,1,2,153.0
1479.0,NCT04703777,Relationship Between Social Status and Use of Healthcare Services During the Confinement Period Linked to the COVID-19 Epidemic,,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-04,04/04/21,2021-04-04,11/01/21,11/01/21,"Adult Emergency Department - Strasbourg University Hospitals, Strasbourg",France,Respiratory Diseases,1,1,365.0
1480.0,NCT04345315,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",CORSA,Recruiting,COVID-19,COVID-19,,,,,,Other: serological test|Other: Rapid molecular test|Genetic: Next generation Sequencing (NGS) analysis|Other: serum chemistry analysis,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|AUSL Romagna,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-27,01/03/21,2022-01-03,14/04/20,15/04/20,"UO Microbiologia,Centro Servizi Pievesestina, AUSL Romagna, Cesena, FC, Italy|Irst Irccs, Meldola, FC",Italy,Respiratory Diseases,1,2,647.0
1481.0,NCT04452669,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,VPCOVID,Recruiting,COVID-19,,,,,,,Drug: VentaProst (inhaled epoprostenol delivered via a dedicated delivery system),Aerogen Pharma Limited|Ohio State University,All,"18 Years and older   (Adult, Older Adult)",20.0,Industry|Other,Interventional,2020-09-15,01/05/21,2021-01-09,30/06/20,01/02/21,"Ohio State University, Columbus, Ohio",United States,Respiratory Diseases,1,1,116.0
1482.0,NCT04357834,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,WAVE,Recruiting,COVID-19,COVID-19,SARS-CoV 2,,,,,Other: Equipment with smartwatch throughout hospital stay on the general ward,"University Hospital Inselspital, Berne|ETH Zurich",All,"18 Years to 120 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-05,31/12/21,2021-12-31,22/04/20,05/11/20,"Emergency Department, University Hospital Bern, Inselspital, Bern",Switzerland,Respiratory Diseases,1,3,726.0
1483.0,NCT04410510,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,,Recruiting,COVID-19,Coronavirus Infection,SARS-CoV 2,COVID-19,,,,Drug: P2Et (Caesalpinia spinosa extract)|Other: Placebo,Hospital Universitario San Ignacio|Pontificia Universidad Javeriana,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-30,01/12/20,2021-01-06,01/06/20,05/10/20,"Hospital Universitario San Ignacio, Bogotá",Colombia,Respiratory Diseases,1,4,98.0
1484.0,NCT04551378,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,,,,,Other: Quality-of-Life Assessment|Other: Survey Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,18 Years to 39 Years   (Adult),600.0,Other|NIH,Observational,2020-07-13,31/12/21,2021-12-31,16/09/20,01/04/21,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,3,536.0
1485.0,NCT04421612,COVID-19 - No Health Without Mental Health,Co-COVID-19,Recruiting,COVID-19,Anxiety,,,,,,Behavioral: Co-mestring (co-coping),Haukeland University Hospital,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-02-04,01/03/21,2021-12-31,09/06/20,26/02/21,"Haukeland University Hospital, Bergen",Norway,"Mental Health, Respiratory Diseases",1,2,696.0
1486.0,NCT04366024,A Novel Nomogram to Predict Severity of COVID-19,,Recruiting,COVID-19,Nomogram Model,,,,,,Other: other,Xinqiao Hospital of Chongqing,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-17,30/08/20,2021-12-31,28/04/20,14/07/20,"Xinqiao Hospital of Chongqing, Chongqing, Chongqing",China,Respiratory Diseases,1,2,714.0
1487.0,NCT04534608,COVID-19 Child Health Investigation of Latent Disease in Hamburg,C19CHILD,"Active, not recruiting",COVID-19,COVID-19,,,,,,,Universitätsklinikum Hamburg-Eppendorf|Altona Children's Hospital|Wilhelmstift Children´s Hospital|Helios Mariahilf Klinik Hamburg|Asklepios Klinik Nord - Heidberg,All,"up to 18 Years   (Child, Adult)",6000.0,Other,Observational,2020-11-05,30/06/20,2021-03-31,01/09/20,01/09/20,"Universitätsklinikum Hamburg-Eppendorf, Hamburg",Germany,Respiratory Diseases,1,2,146.0
1488.0,NCT04806529,"An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older",,Withdrawn,Influenza,,,,,,,Drug: Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2)|Drug: Comparator,Seqirus,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-12-15,15/12/20,2022-09-04,19/03/21,23/03/21,,,Infectious Diseases,0,1,628.0
1489.0,NCT04371835,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,,Recruiting,HIV-infection/Aids,Coronavirus Infection,,,,,,,"Kirby Institute|University of Witwatersrand, South Africa|University of Liverpool|Université Montpellier|UNITAID|ViiV Healthcare",All,"18 Years and older   (Adult, Older Adult)",1500.0,Other|Industry,Observational,2020-12-08,31/12/21,2021-12-31,01/05/20,08/04/21,"Hospital G de Agudos JM Ramos Mejia, Buenos Aires, Ciudad De Buenos Aires, Argentina|Laboratório de Pesquisa Clinica Em Hiv/Aids - Instituto Nacional de Infectologia - Fiocruz, Rio de Janeiro, Brazil|Central Hospital of Yaoundé, Yaoundé, Cameroon|Cité Verte Hospital, Yaoundé, Cameroon|Hôpital Militaire de Région N°1, Yaoundé, Cameroon|CART CRS, VHS Hospital, Chennai, Tamil Nadu, India|Univerity of Malaya Medical Centre, Kuala Lumpur, Malaysia|Institute of Human Virology, Nigeria (IHVN), Abuja, Nigeria|Desmond Tutu HIV Foundation, Cape Town, South Africa|Perinatal HIV Research Unit (PHRU), Johannesburg, South Africa|Clinical HIV Research Unit (CHRU), Wits Health Consotium (Pty) Ltd, Johannesburg, South Africa|Ezintsha, Parktown, South Africa|HIV-NAT (The HIV Netherlands Australia Thailand Research Collaboration), Thai Red Cross AIDS Research Centre, Bangkok, Thailand|Infectious Diseases Institute, Kampala, Uganda|University of Zimbabwe Clinical Research Centre, Harare",Zimbabwe,Respiratory Diseases,1,2,388.0
1490.0,NCT04401033,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),DECORE,Completed,SARS-CoV 2,COVID-19,,,,,,Behavioral: Telephonic medical visit|Procedure: Gastrointestinal endoscopy|Procedure: Abdominal ultrasound,Hospital del Río Hortega,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-11-05,30/06/20,2020-06-30,26/05/20,28/07/20,"Hospital Rio Hortega, Valladolid",Spain,Respiratory Diseases,1,2,-128.0
1491.0,NCT04708327,Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Naltrexone Hydrochloride,"Cytocom, Inc.",All,"18 Years and older   (Adult, Older Adult)",75.0,Industry,Interventional,2021-01-04,01/04/22,2022-01-04,13/01/21,13/01/21,,,Respiratory Diseases,1,1,365.0
1492.0,NCT04644341,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,,Recruiting,COVID-19,,,,,,,Combination Product: cardiovascular and respiratory systems monitoring,University of Manitoba|Function Four Ltd.,All,"18 Years to 90 Years   (Adult, Older Adult)",20.0,Other,Observational,2021-01-15,31/08/21,2021-01-11,25/11/20,26/02/21,"University of Manitoba, Winnipeg, Manitoba",Canada,Respiratory Diseases,1,1,-4.0
1493.0,NCT04344600,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,PROTECT,Recruiting,Sars-CoV2,,,,,,,Drug: Peginterferon lambda alfa-1a subcutaneous injection|Other: Saline,Johns Hopkins University|Eiger BioPharmaceuticals,All,"18 Years to 80 Years   (Adult, Older Adult)",164.0,Other|Industry,Interventional,2020-05-29,01/06/21,2021-01-12,14/04/20,20/08/20,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,1,228.0
1494.0,NCT04500626,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Oxygen,Ottawa Hospital Research Institute|Climate Foundation,All,"18 Years and older   (Adult, Older Adult)",234.0,Other,Interventional,2021-01-04,01/08/22,2022-01-08,05/08/20,23/02/21,"The Ottawa Hospital, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,369.0
1495.0,NCT04484545,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Prognostic score,Glasgow Royal Infirmary,All,"18 Years to 100 Years   (Adult, Older Adult)",250.0,Other,Observational,2020-01-04,01/06/21,2021-01-06,23/07/20,23/07/20,"Glasgow Royal Infirmary, Glasgow",United Kingdom,Respiratory Diseases,1,1,368.0
1496.0,NCT04659889,Clinical and Haematological Phenotypes in Long COVID,,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Blood sampling (venesection),HCA International Limited,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-12,01/06/21,2021-01-06,09/12/20,09/12/20,"The Physicians' Clinic, London",United Kingdom,Respiratory Diseases,1,2,360.0
1497.0,NCT04632537,BCG Vaccination to Prevent COVID-19,NUEVA,Withdrawn,COVID-19,,,,,,,Drug: Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine|Drug: Preservative-free saline,"Henry M. Jackson Foundation for the Advancement of Military Medicine|Harvard Medical School|Uniformed Services University of the Health Sciences|United States Department of Defense|Immunization HealthCare Division, Defense Health Agency",All,18 Years to 64 Years   (Adult),0.0,Other|U.S. Fed,Interventional,2020-07-12,23/03/21,2021-03-23,17/11/20,26/03/21,,,Respiratory Diseases,1,1,254.0
1498.0,NCT04388410,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,EPCOvid-1,Recruiting,COVID-19,,,,,,,Biological: convalescent plasma,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Hospital San Jose Tec de Monterrey|Instituto Nacional de Enfermedades Respiratorias|Instituto Nacional de Cardiologia Ignacio Chavez|Hospital General Dr. Manuel Gea González|Hospital Regional de Alta Especialidad del Bajio|Instituto Nacional de Cancerologia de Mexico,All,"18 Years and older   (Adult, Older Adult)",410.0,Other,Interventional,2020-08-25,30/11/20,2020-12-31,14/05/20,26/08/20,"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Tlalpan",Mexico,Respiratory Diseases,1,1,128.0
1499.0,NCT04598347,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,,Recruiting,COVID-19,Pregnancy Related,,,,,,,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Female,"18 Years to 90 Years   (Adult, Older Adult)",225.0,Other,Observational,2020-08-08,08/01/22,2022-01-23,22/10/20,26/10/20,"Hospital de la Santa Creu i Sant Pau, Barcelona",Spain,Respiratory Diseases,1,2,533.0
1500.0,NCT04668170,Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management,IMMUNOMARKCOV,Recruiting,COVID-19,,,,,,,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,"University Hospital, Toulouse",All,"18 Years to 110 Years   (Adult, Older Adult)",340.0,Other,Observational,2020-05-05,31/12/21,2021-12-31,16/12/20,16/12/20,"University Hospital Bordeaux, Bordeau, France|University Hospital Toulouse, Toulouse",France,Respiratory Diseases,1,1,605.0
1501.0,NCT04517136,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,COVID-TRUST,Recruiting,COVID-19,SARS-CoV Infection,"Burnout, Caregiver","Burnout, Professional",,,,Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Device: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,Direction Centrale du Service de Santé des Armées,All,18 Years to 60 Years   (Adult),60.0,Other,Observational,2020-09-14,14/03/21,2021-03-14,18/08/20,09/03/21,"Groupement Hospitalier Régional de Mulhouse Sud Alsace, Mulhouse",France,Respiratory Diseases,1,4,181.0
1502.0,NCT04472585,Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients,SIZI-COVID-PK,Recruiting,Coronavirus Infection,COVID-19,Sars-CoV2,,,,,Drug: Ivermectin Injectable Solution|Other: Injectable Placebo|Drug: Zinc|Drug: Placebo empty capsule|Drug: Oral Ivermectin,Sohaib Ashraf|Sheikh Zayed Federal Postgraduate Medical Institute,All,18 Years to 60 Years   (Adult),180.0,Other,Interventional,2020-11-14,15/08/21,2021-10-30,15/07/20,17/02/21,"Ali Clinic, Lahore, MA, Pakistan|Shaikh Zayed Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,3,350.0
1503.0,NCT04472572,Expanded Access to Convalescent Plasma for Treatment of COVID-19,,Available,COVID-19,,,,,,,Biological: Convalescent Plasma,Hackensack Meridian Health,All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Treatment IND/Protocol,,,,15/07/20,01/09/20,"Hackensack University Medical Center, Hackensack, New Jersey",United States,Respiratory Diseases,1,1,
1504.0,NCT04434131,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Convalescent Plasma,University of New Mexico,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-28,28/04/21,2025-04-28,16/06/20,16/06/20,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico",United States,Respiratory Diseases,1,1,1826.0
1505.0,NCT04629183,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,CODED,Recruiting,COVID-19,,,,,,,Other: integrated clinical evaluation,"Azienda Ospedaliera Città della Salute e della Scienza di Torino|University of Turin, Italy",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-11,30/04/21,2021-07-31,16/11/20,09/02/21,"Ospedale Maria Vittoria, D.E.A., Torino, Piemonte, Italy|A.O.U.C. Azienda Ospedaliero-Universitaria Careggi, D.E.A., Firenze, Toscana, Italy|Ospedale U. Parini, Medicina e Chirurgia d'accettazione e Urgenza (MeCAU), Aosta, Italy|A.O. S. Croce e Carle, Medicina e Chirurgia d'Urgenza, Cuneo, Italy|A.O.U. Careggi, Medicina e Chirurgia d'Urgenza e Accettazione, Firenze, Italy|A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, S.C. Medicina d'Urgenza U (MECAU), Torino, Italy|Ospedale San Giovanni Bosco, Medicina e Chirurgia d'accettazione e urgenza (MeCAU), Torino",Italy,Respiratory Diseases,1,1,567.0
1506.0,NCT04686773,"Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19.",,Not yet recruiting,COVID-19,,,,,,,Biological: AZD1222|Biological: rAd26-S,R-Pharm|AstraZeneca|The Russian Direct Investment Fund (RFIF)|The Gamaleya National Center of Epidemiology & Microbiology,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2021-10-02,09/04/21,2021-09-20,29/12/20,14/01/21,"Baki Saglamic Merkezi, Baku",Azerbaijan,Respiratory Diseases,1,1,-12.0
1507.0,NCT04596839,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: Remdesivir|Other: Standard of Care,Dr. Md. Alimur Reza|Beximco Pharmaceuticals Ltd.,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-04-09,28/02/21,2021-04-30,22/10/20,27/01/21,"Combined Military Hospital, Dhaka",Bangladesh,Respiratory Diseases,1,1,386.0
1508.0,NCT04789512,Respiratory Muscle Strength in Volleyball Players Suffered From COVID-19,,Completed,COVID-19,,,,,,,Other: Respiratory functions,Gazi University,Female,"15 Years to 35 Years   (Child, Adult)",42.0,Other,Observational,2021-01-03,26/03/21,2021-03-29,09/03/21,01/04/21,"Gazi University, Ankara, Çankaya",Turkey,Respiratory Diseases,1,1,85.0
1509.0,NCT04685655,RescuE pLAsma eXchange in Severe COVID-19,RELAX,Recruiting,Therapeutic Plasma Exchange,COVID-19,,,,,,Other: Therapeutic plasma exchange,Heidelberg University,All,"18 Years to 85 Years   (Adult, Older Adult)",228.0,Other,Interventional,2020-07-01,31/12/21,2022-12-31,28/12/20,26/02/21,"Christian Nusshag, Heidelberg, Baden-Württemberg",Germany,Respiratory Diseases,1,2,913.0
1510.0,NCT04374591,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,,"Active, not recruiting",Pneumonia,COVID-19,,,,,,Drug: Sodium Bicarbonate,Mansoura University,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-01-08,01/11/20,2020-01-11,05/05/20,06/10/20,"Gomhoria Street, Mansoura, Outside U.S./Canada",Egypt,Respiratory Diseases,1,2,3.0
1511.0,NCT04803227,Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Emricasan|Other: Placebo,Histogen,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-11-03,01/04/21,2021-01-06,17/03/21,17/03/21,"SUNY Downstate Health Sciences University, Brooklyn, New York",United States,Respiratory Diseases,1,1,-301.0
1512.0,NCT04479124,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,,Completed,Trauma,COVID-19,,,,,,Diagnostic Test: COVID-19 PCR,Kanuni Sultan Suleyman Training and Research Hospital,All,"up to 50 Years   (Child, Adult)",2000.0,Other,Observational,2020-10-03,30/06/20,2020-07-14,21/07/20,21/07/20,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece",Turkey,Respiratory Diseases,1,2,-81.0
1513.0,NCT04836767,Evaluation of Physical and Functional Status in Patients With COVID-19 in Long Term,,"Active, not recruiting",Corona Virus Infection,COVID-19,,,,,,,Hacettepe University,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Observational,2021-02-16,01/01/22,2022-01-02,08/04/21,13/04/21,"Hacettepe University, Ankara",Turkey,Respiratory Diseases,1,2,320.0
1514.0,NCT04560855,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,SECURADOM,Recruiting,COVID-19,,,,,,,Device: Connected devices measurements,Withings,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry,Observational,2020-09-14,14/06/21,2021-09-14,23/09/20,23/09/20,"CHU Grenoble-Alpes, Grenoble, Auvergne-Rhône-Alpes, France|CHU d'Amiens, Amiens, Hauts-de-France, France|Hôpital d'Instruction des Armées Bégin, Saint-Mandé, Ile De France, France|Hôpital d'Instruction des Armées Percy, Clamart, Ile-de-France",France,Respiratory Diseases,1,1,365.0
1515.0,NCT04705753,"Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients",COVID-19-IAMA,Completed,COVID-19,Viral Infection,Respiratory Viral Infection,,,,,Dietary Supplement: Cretan IAMA,University of Crete|Galenica SA|Olvos Science SA,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-04,15/10/20,2020-10-15,12/01/21,12/01/21,"Cretan Medicare, Heraklion, Crete",Greece,Respiratory Diseases,1,3,285.0
1516.0,NCT04386668,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,LIO-C,Terminated,COVID-19,,,,,,,Other: Let It Out (LIO)-C|Other: Neutral writing control,"University College, London",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-05-26,12/07/20,2020-08-31,13/05/20,08/10/20,"University College London, London, Kent",United Kingdom,Respiratory Diseases,1,1,97.0
1517.0,NCT04583761,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),NICORISCOVID,"Active, not recruiting",COVID-19,,,,,,,Behavioral: questionnaire,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-12-10,01/02/21,2021-01-03,12/10/20,11/01/21,"Hotel-Dieu Hospital, Paris",France,Respiratory Diseases,1,1,24.0
1518.0,NCT04706260,Clinical Evolution and Becoming of Adult Patients Infected With Covid-19 Hospitalized at Strasbourg University Hospitals,,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-04-14,14/04/21,2021-04-14,12/01/21,12/01/21,"Adult Emergency Department - Strasbourg University Hospitals, Strasbourg",France,Respiratory Diseases,1,1,365.0
1519.0,NCT04584437,Treatment of Covid-19 Using Infrared and/or Vitamin C,,Withdrawn,COVID-19,,,,,,,Other: Infrared Energy and Dietary Supplement,GAAD Medical Research Institute Inc.,All,"Child, Adult, Older Adult",0.0,Other,Interventional,2021-01-31,10/05/21,2021-10-07,14/10/20,08/03/21,"GAAD Medical Research Institute Inc. O/A The Centre for Incurable Diseases, Toronto, Ontario",Canada,Respiratory Diseases,1,1,249.0
1520.0,NCT04377815,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,FORECAST,Completed,COVID-19,Anosmia,,,,,,Other: General Public cohort,"University College, London",All,"18 Years and older   (Adult, Older Adult)",569.0,Other,Observational,2020-04-23,14/05/20,2020-06-24,06/05/20,19/01/21,"University College London Hospital, London, United Kingdom|GP Practices, London",United Kingdom,Respiratory Diseases,1,2,62.0
1521.0,NCT04386044,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,,Not yet recruiting,COVID-19,Vitamin D Deficiency,,,,,,,Tameside General Hospital,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-06,31/12/20,2021-01-06,13/05/20,13/05/20,"Tameside Hospital NHS Foundation Trust, Ashton-under-Lyne, Greater Manchester",United Kingdom,Respiratory Diseases,1,2,366.0
1522.0,NCT04560205,Tocilizumab in COVID-19 Lahore General Hospital,TC19LGH,Recruiting,SARS-CoV Infection,,,,,,,Drug: Tocilizumab,Lahore General Hospital,All,"15 Years to 80 Years   (Child, Adult, Older Adult)",50.0,Other,Interventional,2020-01-05,30/12/20,2020-12-30,23/09/20,08/12/20,"Lahore General Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,360.0
1523.0,NCT04375124,Treatment of Angiotensin Peptide (1-7) for COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Biological/Vaccine: Angiotensin peptide (1-7) derived plasma,Kanuni Sultan Suleyman Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-25,31/08/20,2020-09-30,05/05/20,15/05/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,158.0
1524.0,NCT04472078,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",,Completed,COVID-19,,,,,,,Diagnostic Test: Serological Assay or IgG for SARS-CoV-2,Hospital Italiano de Buenos Aires|Hospital de Niños R. Gutierrez de Buenos Aires|Salud Comunitaria Ministerio de Salud GCBA,All,"14 Years and older   (Child, Adult, Older Adult)",873.0,Other,Observational,2020-10-06,26/06/20,2020-11-12,15/07/20,17/12/20,"Hospital de Niños Ricardo Gutierrez, Buenos Aires, Caba",Argentina,Respiratory Diseases,1,1,37.0
1525.0,NCT04719182,Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19,PRoAcT-COVID,"Active, not recruiting",COVID-19,Pneumonia,Thrombosis,Thromboembolism,Anticoagulants; Increased,"ARDS, Human",,Other: Adjunctive therapies,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-09,01/01/21,2021-01-07,22/01/21,22/01/21,"Amsterdam UMC location AMC, Amsterdam, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam",Netherlands,Respiratory Diseases,1,6,364.0
1526.0,NCT04838795,Sisonke (Together): OPEN LABEL TRIAL COVID-19,Sisonke,Recruiting,SARS (Severe Acute Respiratory Syndrome),,,,,,,Biological: To monitor the effectiveness of the single dose Ad26.COV2.S COVID-19 vaccine,"Wits Health Consortium (Pty) Ltd|National Department of Health of South Africa|National Institute for Communicable Diseases, South Africa|KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP|Fred Hutchinson Cancer Research Center|Hutchinson Center Research Institute of South Africa (HCRISA)|Janssen Vaccines & Prevention B.V.|Bio Analytical Research Corporation|Dis-Chem Pharmacy",All,"18 Years to 105 Years   (Adult, Older Adult)",500000.0,Other|Industry,Interventional,2021-02-18,31/03/22,2022-03-31,09/04/21,09/04/21,"Nelson Mandela Academic Clinical Research Unit (NeMACRU), Mthatha, Eastern Cape, South Africa|PHOENIX Pharma Pty Ltd, Port Elizabeth, Eastern Cape, South Africa|Josha Research, Bloemfontein, Free State, South Africa|The Aurum Institute: Tembisa Clinical Research Centre, Johannesburg, Gauteng - South, South Africa|Perinatal HIV Research Unit Kliptown, Johannesburg, Gauteng - South, South Africa|CRISMO Research Centre, Dr Bhekithemba, Germiston, Gauteng, South Africa|Perinatal HIV Research Unit (PHRU), SOWETO, Johannesburg, Gauteng, South Africa|Wits RHI: Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Themba Lethu HIV Research Unit (CHRU), Dr, Johannesburg, Gauteng, South Africa|Synexus SA - Stanza Clinical Research Centre, Pretoria, Gauteng, South Africa|Setshaba Research Centre,, Pretoria, Gauteng, South Africa|Synexus Watermeyer Clinical Research Centre,, Pretoria, Gauteng, South Africa|Ndlovu Research Centre, Pretoria, Gauteng, South Africa|Botha's Hill Clinical Research Site, Bothas Hill, KWA ZULU Natal, South Africa|CAPRISA eThekwini Clinical Research Site, Dr, Durban, KWA ZULU Natal, South Africa|Chatsworth Clinical Research Site, Durban, Kwa Zulu Natal, South Africa|CAPRISA Vulindlela Clinical Research Site, Dr, Durban, KWA ZULU Natal, South Africa|Qhakaza Mbokodo Research Clinic, Ladysmith, KWA ZULU Natal, South Africa|Tongaat Clinical Research Site, Dr, Tongaat, Kwa Zulu Natal, South Africa|Mzansi Ethical Research Centre, Middleburg, Mpumalanga, South Africa|The Aurum Institute Klerksdorp Clinical Research Centre, Klerksdorp, North WEST Province, South Africa|FAMCRU (Family Clinical Research Unit),, Cape Town, Western Cape, South Africa|TASK Central, Cape Town, Western Cape, South Africa|TASK Clinical Research Centre, Cape Town, Western Cape, South Africa|Emavundleni Research Centre, Cape Town, Western CAPE, South Africa|Khayelitsha CRS, Dr Amy Ward / Dr Graeme Meintjes, Cape Town, Western CAPE, South Africa|Desmond Tutu Health Foundation CTU J52 Old Main Building Groote SchuurHospital, Cape Town, Western Cape, South Africa|Synexus Helderberg Clinical Research Centre, Dr Vera, Somerset West, Western CAPE, South Africa|South African Vaccine Initiative (SATVI), Dr Angelique Kany Kany, Worcester, Western Cape, South Africa|Desmond Tutu Health Foundation - Masiphumelele Research Office, Cape Town, South Africa|The Aurum Institute: Rustenburg Clinical Research Centre, Dr Lawrence, Rustenburg",South Africa,Others,0,1,406.0
1527.0,NCT04581031,COntinuous Signs Monitoring In Covid-19 Patients,COSMIC-19,Recruiting,COVID-19,,,,,,,Device: Continuous vital sign monitoring - Isansys Patient Status Engine|Other: Machine Learning/AI Algorithm,The Christie NHS Foundation Trust|Manchester University NHS Foundation Trust|Aptus Clinical Ltd.|Zenzium Ltd.,All,"16 Years and older   (Child, Adult, Older Adult)",60.0,Other,Interventional,2020-11-07,01/02/21,2021-01-02,09/10/20,09/10/20,"The Christie NHS Foundation Trust, Manchester, United Kingdom|Manchester University NHS Foundation Trust, Manchester",United Kingdom,Respiratory Diseases,1,1,56.0
1528.0,NCT04701905,The Offer of Neurosurgery Care in the Grand Est of France During the Health Crisis Linked to Covid-19,NeurochirCOVID,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-04-30,30/04/21,2021-04-30,08/01/21,08/01/21,"Department of Neurosurgery - Strasbourg University Hospitals, Strasbourg",France,Respiratory Diseases,1,1,365.0
1529.0,NCT04350684,Umifenovir in Hospitalized COVID-19 Patients,UAIIC,Enrolling by invitation,COVID-19,,,,,,,Drug: Umifenovir|Drug: Interferon-β 1a|Drug: Lopinavir / Ritonavir|Drug: Single Dose of Hydroxychloroquine|Drug: Standards of Care,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-15,22/04/20,2020-04-24,17/04/20,20/04/20,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,9.0
1530.0,NCT04473365,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),Profile-Cov,Recruiting,COVID-19,COVID-19,,,,,,,Mekelle University|Ethiopian Public Health Institute|Liverpool School of Tropical Medicine|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),All,"Child, Adult, Older Adult",186.0,Other,Observational,2020-07-20,30/06/21,2021-06-30,16/07/20,11/08/20,"Mekelle University College of Health Sciences, Mekelle",Ethiopia,Respiratory Diseases,1,2,345.0
1531.0,NCT04560231,Remdesivir in COVID-19 Lahore General Hospital,RC19LGH,Recruiting,SARS-CoV Infection,,,,,,,Drug: Remdesivir,Lahore General Hospital,All,"15 Years to 80 Years   (Child, Adult, Older Adult)",30.0,Other,Interventional,2020-01-06,30/11/20,2020-11-30,23/09/20,25/09/20,"Muhammad Irfan Malik, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,329.0
1532.0,NCT04841785,Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients,LESS CoV-2,Not yet recruiting,COVID-19,SARS-CoV Infection,Chronic Kidney Diseases,,,,,Diagnostic Test: mailer-based finger-prick,University Medical Center Groningen,All,"18 Years and older   (Adult, Older Adult)",14300.0,Other,Observational,2021-12-04,01/05/23,2023-12-31,12/04/21,12/04/21,,,Respiratory Diseases,1,3,757.0
1533.0,NCT04457570,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,ONCOVID-AURA,Recruiting,COVID-19,,,,,,,Other: mortality,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-06-15,15/12/20,2021-02-15,07/07/20,07/07/20,"Centre de lutte contre le Cancer JEAN PERRIN, Clermont-Ferrand, France|Centre Hospitalier Uniersitaire de Clermont-Ferrand, Clermont-Ferrand, France|Centre Leon Berard, Lyon, France|Institut de Cancérologie de la Loire Lucien Neurwirth, Saint-Priest-en-Jarez, France|Centre Hospitalier Universitaire de St Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,245.0
1534.0,NCT04395807,Helmet CPAP Versus HFNC in COVID-19,COVID HELMET,Recruiting,COVID-19,Acute Hypoxemic Respiratory Failure,,,,,,Device: Helmet CPAP|Device: HFNC,Lund University|Region Skane,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-03-06,31/12/20,2021-01-05,20/05/20,05/06/20,"Helsingborg's Hospital, Helsingborg, Region Skane",Sweden,Respiratory Diseases,1,2,305.0
1535.0,NCT04646525,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,,Recruiting,COVID-19,Immune Deficiency,Tonsillitis,Tonsil Hypertrophy,Adenoiditis,Adenoid Hypertrophy,,Diagnostic Test: Physical examination,Selcuk University,All,1 Year to 16 Years   (Child),300.0,Other,Observational,2020-01-10,01/02/21,2021-01-02,30/11/20,30/11/20,"Selcuk University, Konya, Selcuklu",Turkey,Respiratory Diseases,1,6,358.0
1536.0,NCT04811339,Studies of COVID-19 Patients Treated With Oral Bismuth Subsalicylate (Pepto-Bismol),SABER-C,Recruiting,Diarrhea,COVID-19,,,,,,Drug: open label BSS (pepto Bismol),University of Louisville|Procter and Gamble,All,"18 Years to 85 Years   (Adult, Older Adult)",35.0,Other|Industry,Interventional,2020-02-09,31/08/23,2023-08-31,23/03/21,26/03/21,"University of Louisville, Louisville, Kentucky",United States,Respiratory Diseases,1,2,1299.0
1537.0,NCT04753346,Comparison of Cardiopulmonary Fitness Level With Normal Values After COVID-19,,Not yet recruiting,COVID-19,,,,,,,Other: Physical Activity Level|Other: Anxiety and Depression Assessment|Diagnostic Test: Exercise Capacity|Diagnostic Test: Pulmonary Function Test|Diagnostic Test: Cardiopulmonary Fitness Level,Ankara University,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Observational,2021-02-15,01/01/23,2023-01-01,15/02/21,15/02/21,"Ankara University, Faculty of Medicine, Physical Medicine and Rehabilitation Department, Ankara",Turkey,Respiratory Diseases,1,1,685.0
1538.0,NCT04347408,Seroprevalence of SARS-Cov-2 Antibodies in Children,,Completed,COVID-19,Corona Virus Infection,,,,,,Diagnostic Test: Covid-19 Antibody testing (IgG and IgM),"Queen's University, Belfast|Belfast Health and Social Care Trust",All,2 Years to 15 Years   (Child),1000.0,Other,Observational,2020-06-05,13/12/20,2020-12-13,15/04/20,10/03/21,"Royal Belfast Hospital for Sick Children, Belfast, United Kingdom|University Hospital of Wales, Cardiff, United Kingdom|Royal Hospital for Children, Glasgow, United Kingdom|Public Health England, London, United Kingdom|Public Health England, Manchester",United Kingdom,Respiratory Diseases,1,2,191.0
1539.0,NCT04590586,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,,Recruiting,COVID-19,,,,,,,Drug: Standard of care|Drug: Apremilast|Drug: Apremilast placebo|Drug: Lanadelumab|Drug: Lanadelumab placebo|Drug: Zilucoplan|Drug: Zilucoplan placebo,Amgen,All,"18 Years and older   (Adult, Older Adult)",1400.0,Industry,Interventional,2020-11-24,17/02/22,2022-02-17,19/10/20,13/04/21,"Research Site, Anniston, Alabama, United States|Research Site, Bakersfield, California, United States|Research Site, Chula Vista, California, United States|Research Site, El Centro, California, United States|Research Site, Orange, California, United States|Rsearch Site, Riverside, California, United States|Research Site, S. El Monte, California, United States|Research Site, Sacramento, California, United States|Research Site, Gainesville, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Atlanta, Georgia, United States|Research Site, Chicago, Illinois, United States|Research Site, Iowa City, Iowa, United States|Research Site, Memphis, Tennessee, United States|Research Site, Fort Worth, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Sherman, Texas, United States|Research Site, Tacoma, Washington, United States|Research Site, Ramos Mejia, Buenos Aires, Argentina|Research Site, Ciudad Autonoma Buenos Aires, Argentina|Research Site, Ciudad Autonoma Buenos Aires, Argentina|Research Site, Rosario, Argentina|Research Site, Brasília, Distrito Federal, Brazil|Research Site, Goiânia, Goiás, Brazil|Research Site, Belo Horizonte, Minas Gerais, Brazil|Research Site, Porto Alegre, Rio Grande Do Sul, Brazil|Research Site, Botucatu, Sao Paulo, Brazil|Research Site, Santo André, Sao Paulo, Brazil|Research Site, Osorno, Chile|Research Site, Centurion, Gauteng, South Africa|Research Site, Johannesburg, Gauteng, South Africa|Research Site, Durban, KwaZulu-Natal, South Africa|Research Site, Cape Town, Western Cape, South Africa|Research Site, Cape Town, Western Cape, South Africa|Research Site, Cape Town, Western Cape, South Africa|Research Site, Somerset West, Western Cape, South Africa|Research Site, Worcester, Western Cape, South Africa|Research Site, Dnipro, Ukraine|Research Site, Kharkiv, Ukraine|Research Site, Kremenchuk, Ukraine|Research Site, Odesa, Ukraine|Research Site, Rivne, Ukraine|Recruiting, Vinnytsia",Ukraine,Respiratory Diseases,1,1,450.0
1540.0,NCT04843917,Immunity Against Covid19 Vaccine in Healthcare Workers in Argentine,,Recruiting,Coronavirus 2019,Healthcare Workers,Vaccine,,,,,Diagnostic Test: Immunoglobulin G detection,Hospital Italiano de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-09-04,09/06/22,2022-09-08,14/04/21,14/04/21,"Hospital Italiano de Buenos Aires, Buenos Aires, Caba",Argentina,Respiratory Diseases,1,3,369.0
1541.0,NCT04535128,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",CORONA-VTE NET,Recruiting,COVID-19,Thrombosis Embolism,DVT,Pulmonary Embolism,Myocardial Infarction,Stroke,,Other: No intervention,"Brigham and Women's Hospital|Bristol-Myers Squibb|University of Colorado, Denver|Anne Arundel Medical Center|Beth Israel Deaconess Medical Center|Jefferson Medical College of Thomas Jefferson University",All,"18 Years and older   (Adult, Older Adult)",10000.0,Other|Industry,Observational,2020-03-24,31/12/20,2021-03-30,01/09/20,01/09/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,"Cardiovascular Diseases, Respiratory Diseases",1,6,371.0
1542.0,NCT04359914,Neurocognitive Impairment in Patients With COVID-19,NCoV,Recruiting,Critical Illness,COVID-19,Central Nervous System Injury,Delirium,Encephalopathy,,,,"University of Rostock|Ludwig-Maximilians - University of Munich|University College, London",All,"Child, Adult, Older Adult",80.0,Other,Observational,2020-04-15,31/12/20,2021-01-04,24/04/20,24/04/20,"Department of Anesthesiology and Intensive Care Medicine, University Medical Center Rostock, Rostock, Mecklenburg-Vorpommern",Germany,"Cardiovascular Diseases, Respiratory Diseases",1,5,264.0
1543.0,NCT04668222,Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents,,Not yet recruiting,COVID-19,Herbal Medicine,,,,,,"Drug: Yu-Ping-Feng formula|Drug: Xiang-Sha-Liu-Jun formula|Drug: Liu-Wei-Di-Huang formula|Drug: Placebo for ""Deficiency of Qi and Yang""|Drug: Placebo for ""Deficiency of Qi and Yin""",The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",480.0,Other,Interventional,2020-12-15,30/11/22,2022-11-30,16/12/20,19/12/20,"The University of Hong Kong, Hong Kong, Hong Kong, China",Hong Kong,Respiratory Diseases,1,2,715.0
1544.0,NCT04664010,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,"Drug: Alpha-interferon alpha, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste, fumigation/inhalation of vitamin C|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and 5% glucose|Drug: Alpha-interferon, abidol, ribavirin, Buzhong Yiqi plus and minus formula, Huhuang Detoxicity Paste, Baimu Qingre Jiedu Paste and high-dose vitamin C treatment",Xi'an International Medical Center Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-02,14/01/21,2021-01-31,11/12/20,11/12/20,"Xi'an International Medical Center Hospital, Xi'an, Shaanxi",China,Respiratory Diseases,1,1,243.0
1545.0,NCT04408014,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo,,Not yet recruiting,COVID-19,SARS-CoV 2,,,,,,Diagnostic Test: Serological test|Diagnostic Test: Nasopharyngeal Swab|Diagnostic Test: Oropharyngeal Swab,Butantan Institute,All,"6 Months to 100 Years   (Child, Adult, Older Adult)",18901.0,Other,Observational,2020-01-06,15/07/20,2020-07-30,29/05/20,29/05/20,,,Respiratory Diseases,1,2,206.0
1546.0,NCT04353284,Camostat Mesylate in COVID-19 Outpatients,,Recruiting,COVID-19,,,,,,,Drug: Camostat Mesilate|Other: Placebo,Yale University,All,"18 Years and older   (Adult, Older Adult)",114.0,Other,Interventional,2020-06-19,31/05/21,2021-05-31,20/04/20,24/11/20,"Yale University, New Haven, Connecticut",United States,Respiratory Diseases,1,1,346.0
1547.0,NCT04786808,Risk Factors for COVID-19 Mortality,RF-COVID,Recruiting,COVID-19,Population at Risk,Acute Respiratory Distress Syndrome,,,,,,Teodoro Marcianò|Azienda Unità Sanitaria Locale di Piacenza,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-15,31/12/21,2021-12-31,08/03/21,09/03/21,"Azienda USL di Piacenza, Piacenza, Emilia-Romagna",Italy,Respiratory Diseases,1,3,350.0
1548.0,NCT04394429,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,TubeObs-Covid,Recruiting,Sars-CoV2,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",184.0,Other,Observational,2020-04-24,24/06/21,2021-06-24,19/05/20,08/01/21,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg",France,Respiratory Diseases,1,1,426.0
1549.0,NCT04707742,Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients,BUCOSARS,Completed,COVID-19,,,,,,,Drug: Betadine© bucal 100 mg/ml|Drug: Oximen® 3%|Drug: Clorhexidine Dental PHB©|Drug: Vitis Xtra Forte©|Drug: Distilled Water,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana|Hospital Universitario Fundación Jiménez Díaz|Hospital Universitario General de Villalba|Hospital Universitario Infanta Elena|Hospital Universitario Virgen de la Arrixaca|Hospital Clínico Universitario de Valencia|Dentaid SL,All,"18 Years and older   (Adult, Older Adult)",84.0,Other|Industry,Interventional,2020-06-15,18/11/20,2020-11-18,13/01/21,13/01/21,"Alejandro Mira, Valencia",Spain,Respiratory Diseases,1,1,156.0
1550.0,NCT04559113,Methylprednisolone in COVID-19 Patients (Methyl19LGH),Methyl19LGH,Recruiting,SARS-CoV Infection,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Methylprednisolone Injectable Product,Lahore General Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-05,30/12/20,2020-12-30,22/09/20,08/12/20,"Muhammad Irfan Malik, Lahore, Punjab",Pakistan,Respiratory Diseases,1,2,360.0
1551.0,NCT04411459,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,,Completed,COVID-19,Mechanical Ventilation,Quality of Life,Radiologic Increased Density of Lung,Sedation,Complication of Treatment,,Other: Invasive mechanical ventilation,Azienda Usl di Bologna|Lorenzo Gamberini,All,"18 Years and older   (Adult, Older Adult)",470.0,Other,Observational,2020-01-02,30/06/20,2020-10-16,02/06/20,19/10/20,"Ospedale Santa Maria Annunziata - Anestesia e Rianimazione, Bagno A Ripoli, FI, Italy|A.O. SS. Antonio, Biagio e Cesare Arrigo - Anestesia e Rianimazione, Alessandria, Italy|Anestesia e Rianimazione - Ospedale Civile di Baggiovara, Baggiovara, Italy|Anestesia e Rianimazione - Ospedale di Bentivoglio, Bentivoglio, Italy|Azienda Unità Sanitaria Locale, Bologna, Italy|Anestesia e Rianimazione - Ospedale Bellaria, Bologna, Italy|Anestesia e Rianimazione - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Anestesia e Terapia intensiva dei trapianti addominali e chirurgia epatobiliare - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Anestesia e Terapia Intensiva Polivalente - Policlinico Universitario S.Orsola - Malpighi, Bologna, Italy|Ospedale SS. Trinità - Anestesia e Rianimazione, Borgomanero, Italy|Anestesia e Rianimazione - Ospedale M. Bufalini, Cesena, Italy|Anestesia e Rianimazione - Ospedale degli Infermi, Faenza, Italy|Anestesia e Rianimazione Universitaria - Arcispedale Sant'Anna Ferrara, Ferrara, Italy|Anestesia e Rianimazione - Ospedale Morgagni - Pierantoni, Forlì, Italy|Anestesia e Rianimazione - Ospedale di Imola S.Maria della Scaletta, Imola, Italy|Ospedale Santo Stefano - Anestesia e Rianimazione, Prato, Italy|Anestesia e Rianimazione - Ospedale S. Maria delle Croci, Ravenna, Italy|Anestesia e Rianimazione - Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|Anestesia e Rianimazione - Ospedale di Riccione, Riccione, Italy|Anestesia e Rianimazione - Ospedale Infermi, Rimini",Italy,Respiratory Diseases,1,6,288.0
1552.0,NCT04817397,The Lymphocyte/Neutrophil Ratio as a Prognostic Index for Short Term Outcome in the ICU Admitted COVID-19 Adult Patients,,Recruiting,COVID-19,,,,,,,,Assiut University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-03-20,01/06/21,2021-01-08,26/03/21,08/04/21,"Assuit University, Assiut",Egypt,Respiratory Diseases,1,1,-71.0
1553.0,NCT04524663,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,COPS-2002,Recruiting,COVID-19,,,,,,,Drug: Camostat Mesilate|Drug: Placebo|Other: Standard of Care Treatment,Stanford University,All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-12-19,01/06/21,2021-01-06,24/08/20,07/01/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,18.0
1554.0,NCT04445610,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,,Not yet recruiting,COVID-19,,,,,,,,Ain Shams University,All,"Child, Adult, Older Adult",60.0,Other,Observational,2020-01-07,01/09/20,2020-01-11,24/06/20,26/06/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,4.0
1555.0,NCT04474236,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,QUICK,Recruiting,COVID-19,Acute Respiratory Failure,Triage,Lung Ultrasound,CT Scan,,,Other: thoracic lung ultrasound,"University Hospital, Toulouse",All,"17 Years and older   (Child, Adult, Older Adult)",148.0,Other,Observational,2020-05-27,27/02/21,2021-03-27,16/07/20,16/07/20,"University Hospital Toulouse, Toulouse",France,Respiratory Diseases,1,5,304.0
1556.0,NCT04732637,Concordance Between Buccal Cavity Swab and Nasopharyngeal Swab for SARS-CoV-2 (COVID-19) Detection by RT-PCR and ELISA,,Not yet recruiting,COVID-19,,,,,,,"Diagnostic Test: Test At Home's Proprietary ""Lollipop"" Buccal Cavity Swab","Datar Cancer Genetics Limited|Test At Home Pte. Ltd|National University, Singapore",All,"18 Years to 70 Years   (Adult, Older Adult)",300.0,Industry|Other,Observational,2021-03-31,31/05/21,2021-08-31,01/02/21,30/03/21,"Datar Cancer Genetics, Nashik, Maharashtra",India,Respiratory Diseases,1,1,153.0
1557.0,NCT04629222,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,,Completed,COVID-19,,,,,,,,"Pierre Yves MARIE|Central Hospital, Nancy, France",All,"Child, Adult, Older Adult",10.0,Other,Observational,2020-11-03,20/07/20,2020-07-23,16/11/20,16/11/20,"CHRU of Nancy, Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,1,-103.0
1558.0,NCT04567979,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,,"Active, not recruiting",COVID-19,Cancer,Tumor,,,,,,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Instituto Nacional de Medicina Genomica,All,"Child, Adult, Older Adult",149.0,Other,Observational,2020-11-06,30/09/20,2020-10-30,29/09/20,29/09/20,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City",Mexico,"Respiratory Diseases, Cancers",1,3,-7.0
1559.0,NCT04597034,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,oXAKI-COV,Recruiting,COVID-19,AKI,,,,,,Procedure: AN69-Oxiris|Procedure: AN69-Standard,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years to 75 Years   (Adult, Older Adult)",35.0,Other,Interventional,2020-02-10,30/12/21,2022-03-30,22/10/20,22/10/20,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City",Mexico,Respiratory Diseases,1,2,779.0
1560.0,NCT04601012,OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection,,Completed,COVID-19,,,,,,,Diagnostic Test: Optical coherence tomography angiography,Federico II University,All,18 Years to 60 Years   (Adult),40.0,Other,Observational,2020-09-20,20/10/20,2020-10-22,23/10/20,19/01/21,"University of Naples Federico II, Naples",Italy,Respiratory Diseases,1,1,32.0
1561.0,NCT04429828,COVID-19 Psychological Wellbeing for Healthcare Students,PoWerS,Not yet recruiting,Psychological Wellbeing,,,,,,,Other: COVID-19 e-package: Psychological wellbeing for healthcare workers,University of Nottingham,All,"Child, Adult, Older Adult",45.0,Other,Interventional,2020-06-13,30/09/20,2020-12-30,12/06/20,12/06/20,,,Others,0,1,200.0
1562.0,NCT04651400,"Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",,Recruiting,COVID-19,,,,,,,Drug: Antithrombin III,Octapharma,All,"Child, Adult, Older Adult",300.0,Industry,Observational,2020-10-19,01/06/21,2021-01-06,03/12/20,14/04/21,"Octapharma Research Site, Innsbruck, Austria|Octapharma Research Site, Wien, Austria|Octapharma Research Site, Strasbourg, France|Octapharma Research Site, Aachen, Germany|Octapharma Research Site, Essen",Germany,Respiratory Diseases,1,1,79.0
1563.0,NCT04422873,The Impact of COVID-19 on Dialysis Users,,Recruiting,End Stage Renal Disease,Sars-CoV2,,,,,,,University of Portsmouth|Portsmouth Hospitals NHS Trust|University of Reading,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-03-06,01/01/21,2021-01-01,09/06/20,05/11/20,"School of Sport, Health and Exercise Science, Portsmouth, Outside The United States Or Canada",United Kingdom,Respiratory Diseases,1,2,301.0
1564.0,NCT04377802,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: molecular testing for virus RNA using RT-PCR,King Fahad Specialist Hospital Dammam,All,"18 Years to 65 Years   (Adult, Older Adult)",400.0,Other,Interventional,2020-05-17,16/11/20,2020-12-30,06/05/20,06/05/20,"king Fahad specialist hospital, Dammam, Eastern Province",Saudi Arabia,Respiratory Diseases,1,1,227.0
1565.0,NCT04343690,COPING With COVID-19( CWC-19),,Withdrawn,COVID-19,,,,,,,Behavioral: Crisis management coaching,Duke University,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-03-27,01/05/20,2020-01-05,13/04/20,23/09/20,"Duke University, Durham, North Carolina",United States,Respiratory Diseases,1,1,-82.0
1566.0,NCT04498936,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,,Completed,COVID-19,,,,,,,Drug: Sofosbuvir and Ledipasvir|Drug: Nitazoxanide,Assiut University|Helwan University,All,"12 Years to 65 Years   (Child, Adult, Older Adult)",240.0,Other,Interventional,2020-07-15,30/10/20,2020-10-30,05/08/20,12/11/20,"15th May Hospital, Helwan, Cairo, Egypt|Assiut University Hospital, Assiut",Egypt,Respiratory Diseases,1,1,107.0
1567.0,NCT04568525,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,,Completed,COVID-19,,,,,,,Diagnostic Test: Passive Microwave Radiometry,Kyrgyz State Medical Academy|The University of Edinburgh|International Medical University,All,"18 Years to 75 Years   (Adult, Older Adult)",195.0,Other,Interventional,2020-01-07,25/07/20,2020-01-08,29/09/20,29/09/20,"Educational - clinical - scientific medical center of KSMA, Bishkek, Chui",Kyrgyzstan,Respiratory Diseases,1,1,1.0
1568.0,NCT04413955,Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA,,Recruiting,COVID-19,SARS-CoV 2,,,,,,Device: Seraph®-100 Microbind® Affinity Blood Filter,"Children's Hospital Medical Center, Cincinnati|ExThera Medical Corporation",All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Observational,2020-01-06,31/12/21,2021-12-31,04/06/20,01/09/20,"AdventHealth Orlando, Orlando, Florida",United States,Respiratory Diseases,1,2,725.0
1569.0,NCT04418284,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Other: survey,South Valley University,All,"17 Years to 35 Years   (Child, Adult)",1517.0,Other,Observational,2020-05-06,05/11/20,2020-05-11,05/06/20,16/03/21,"South Valley University, Qinā",Egypt,Respiratory Diseases,1,1,5.0
1570.0,NCT04843878,COVID-19 Testing Pilot Study,,Completed,"Diagnostic Test, Routine",Coronavirus,Diagnoses Disease,Rapid Coronavirus Test,,,,Diagnostic Test: COVID Detect,"University of Pennsylvania|Benjamin S. Abella, MD, MPhil|Marcelo Der Torossian Torres, Ph.D.|Cesar De La Fuente, Ph.D.",All,"18 Years and older   (Adult, Older Adult)",326.0,Other,Observational,2021-05-01,12/03/21,2021-12-03,14/04/21,14/04/21,"Penn Presbyterian Medical Center, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,4,216.0
1571.0,NCT04346264,CoVid-19 - Infection and Antibody Formation in the Viennese Population,,Enrolling by invitation,Virus Diseases,COVID-19,,,,,,Diagnostic Test: NO intervention planned due to the observational study design only a diagnostic testing,Ludwig Boltzmann Institute for Lung Health,All,"6 Years to 85 Years   (Child, Adult, Older Adult)",5500.0,Other,Observational,2020-04-27,01/06/20,2020-09-30,15/04/20,16/04/20,"The LEAD Study Center, Vienna",Austria,Respiratory Diseases,1,2,156.0
1572.0,NCT04346056,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Explore,Recruiting,COVID-19,COVID-19,,,,,,,Ain Shams University,All,"1 Year to 80 Years   (Child, Adult, Older Adult)",500.0,Other,Observational,2020-04-14,01/10/20,2020-01-12,15/04/20,20/04/20,"Faculty of Medicine Ain Shams University, Cairo, Non-US, Egypt|Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,2,-93.0
1573.0,NCT04354766,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,ANTI-COV-2,Recruiting,COVID-19,,,,,,,Other: Blood sample,Hospices Civils de Lyon|Eurobio Scientific,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-04-29,01/07/20,2020-01-07,21/04/20,04/05/20,"Hôpital de la Croix-Rousse, Lyon",France,Respiratory Diseases,1,1,-113.0
1574.0,NCT04335123,Study of Open Label Losartan in COVID-19,,Completed,COVID-19,,,,,,,Drug: Losartan,University of Kansas Medical Center,All,"18 Years and older   (Adult, Older Adult)",34.0,Other,Interventional,2020-04-04,21/06/20,2020-08-17,06/04/20,03/11/20,"University of Kansas Medical Center, Kansas City, Kansas",United States,Respiratory Diseases,1,1,135.0
1575.0,NCT04347538,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Other: Saline Nasal Irrigation|Other: Saline with Baby Shampoo Nasal Irrigation,Vanderbilt University Medical Center,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-05,01/06/21,2022-01-06,15/04/20,19/01/21,"Vanderblt University Medical Center, Nashville, Tennessee",United States,Respiratory Diseases,1,1,732.0
1576.0,NCT04442191,Convalescent Plasma as a Possible Treatment for COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma|Biological: Placebo,University of Illinois at Chicago,All,"40 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-05,05/05/21,2021-05-05,22/06/20,22/06/20,"University of Illinois at Chicago, Chicago, Illinois",United States,Respiratory Diseases,1,1,365.0
1577.0,NCT04387955,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),ACROVID,Recruiting,COVID-19,Chilblains,,,,,,Diagnostic Test: Biological Sample Collection,Poitiers University Hospital,All,"12 Years and older   (Child, Adult, Older Adult)",30.0,Other,Interventional,2020-04-30,01/05/21,2021-01-06,14/05/20,17/11/20,"CHU de Poitiers, Poitiers",France,Respiratory Diseases,1,2,251.0
1578.0,NCT04356417,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,TRAPSAH,Not yet recruiting,COVID-19,,,,,,,Other: - Synthetic anti-malarial drugs,Assistance Publique - Hôpitaux de Paris|GIS EPI-PHARE,All,"18 Years and older   (Adult, Older Adult)",6000000.0,Other,Observational,2020-01-04,01/06/20,2020-01-06,22/04/20,22/04/20,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil",France,Respiratory Diseases,1,1,2.0
1579.0,NCT04368065,COVID-19 Active Research Experience (CARE),,Recruiting,COVID-19,,,,,,,,Iqvia Pty Ltd,All,"18 Years and older   (Adult, Older Adult)",100000.0,Industry,Observational,2020-02-04,31/12/22,2023-01-06,29/04/20,06/01/21,"IQVIA, Cambridge, Massachusetts, United States|IQVIA, London",United Kingdom,Respiratory Diseases,1,1,1067.0
1580.0,NCT04362124,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,,Withdrawn,COVID-19,,,,,,,Biological: vaccine BCG|Other: Placebo,Universidad de Antioquia,All,"18 Years to 65 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-08,01/06/21,2021-01-11,24/04/20,27/11/20,"Program for Research and Control in Tropical Diseases - PECET, Medellín, Antioquia",Colombia,Respiratory Diseases,1,1,369.0
1581.0,NCT04511949,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,FAMICOV,Completed,Coronavirus Infection,,,,,,,"Diagnostic Test: COVID-19 IgG / IgM rapid test (whole blood, serum, plasma)",Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,All,"3 Years and older   (Child, Adult, Older Adult)",500.0,Other,Interventional,2020-12-07,30/09/20,2020-11-30,13/08/20,03/02/21,"Christine KATLAMA, Paris, Ile De France",France,Respiratory Diseases,1,1,-7.0
1582.0,NCT04358380,Liver Injury in Patients With COVID-19,,Enrolling by invitation,Liver Injury,,,,,,,Other: Liver injury,"Austral University, Argentina",All,"17 Years and older   (Child, Adult, Older Adult)",320.0,Other,Observational,2020-04-15,31/12/20,2020-12-31,24/04/20,21/07/20,"Universidad Austral, Pilar, Buenos Aires",Argentina,Others,0,1,260.0
1583.0,NCT04351919,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),COVID+PA,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,Abderrahmane Mami Hospital|Eshmoun Clinical Research Centre|Dacima Consulting,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-05-05,15/07/20,2020-07-15,17/04/20,28/08/20,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmen Mami-Ariana, Tunis",Tunisia,Respiratory Diseases,1,1,71.0
1584.0,NCT04624503,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,CARDIO-COVID,Recruiting,COVID-19,Myocardial Injury,Cardiovascular Diseases,Heart Failure,Cardiovascular Morbidity,,,,"Humanitas Hospital, Italy|Centro Cardiologico Monzino|IRCCS Policlinico S. Donato|Istituti Clinici Scientifici Maugeri SpA|Istituto Auxologico Italiano",All,"18 Years to 85 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-01-10,01/06/21,2021-01-10,10/11/20,10/11/20,"Humanitas Research Hospital, Rozzano, Milan, Italy|Centro Cardiologico Monzino, Milan, Italy|IRCCS Auxologico San Luca, Milan, Italy|IRCCS San Donato, Milan, Italy|IRCCS Istituti Clinici Scientifici Maugeri, Pavia",Italy,Respiratory Diseases,1,5,366.0
1585.0,NCT04592510,Impact of COVID-19 on Pediatric Dental Practice During First and Second Wave.,,Not yet recruiting,SARS-CoV2,,,,,,,,Cairo University,All,"18 Years to 75 Years   (Adult, Older Adult)",345.0,Other,Observational,2021-01-04,01/10/21,2022-01-01,19/10/20,09/03/21,,,Respiratory Diseases,1,1,362.0
1586.0,NCT04735744,Evaluation of Allied Healthcare in Patients Recovering From COVID-19,ParaCOV,Not yet recruiting,COVID-19,Allied Health Professionals,Primary Care,Retrospective Cohort,PROMs,Performance Measures,Prospective Cohort,Other: Patients recovering from COVID19 receive usual care by allied health professionals,Radboud University,All,"18 Years and older   (Adult, Older Adult)",1315.0,Other,Observational,2021-02-15,17/07/22,2024-01-01,03/02/21,03/02/21,,,Respiratory Diseases,1,7,1050.0
1587.0,NCT04346212,Oropharyngeal Dysphagia in Patients With COVID-19,,Recruiting,Oropharyngeal Dysphagia,COVID-19,Sars-CoV2,Nutrition,,,,Diagnostic Test: Swallowing evaluation with the EAT-10 and the volume-viscosity swallowing test (V-VST),Hospital de Mataró|Centro Investigación Biomédica en Red de Enfermedades Hepáticas Digestivas,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-04-14,01/12/20,2021-01-01,15/04/20,23/09/20,"Consorci Sanitari del Maresme (Hospital de Mataró), Mataró, Barcelona",Spain,Respiratory Diseases,1,4,262.0
1588.0,NCT04519411,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Transpulmonary pressure measurements,Mayo Clinic,All,up to 17 Years   (Child),10.0,Other,Interventional,2020-05-21,31/12/21,2022-01-31,19/08/20,01/02/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,1,620.0
1589.0,NCT04378595,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,,Recruiting,Food Insecurity,,,,,,,Other: During COVID-19 Pandemic|Other: After COVID-19 Pandemic,University of Texas at Austin,All,"18 Years to 100 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-10-04,30/12/20,2021-07-30,07/05/20,08/05/20,"Dell Medical School, Austin, Texas, United States|CommUnity Care Clinic - Southeast Health and Wellness Clinic, Austin, Texas, United States|CommUnity Care Clinic - Rundberg, Austin, Texas",United States,Others,0,1,299.0
1590.0,NCT04693026,Efficacy of Ramdicivir and Baricitinib for the Treatment of Severe COVID 19 Patients,,Recruiting,COVID-19,COVID-19,,,,,,Drug: Remdesivir|Drug: Baricitinib|Drug: Tocilizumab,M Abdur Rahim Medical College and Hospital|First affiliated Hospital Xi'an Jiaoting University,All,"Child, Adult, Older Adult",150.0,Other,Interventional,2020-10-09,15/02/21,2021-05-03,05/01/21,05/01/21,"M. Abdur Rahim Medical College Hospital, Dinajpur",Bangladesh,Respiratory Diseases,1,2,206.0
1591.0,NCT04553705,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",,Recruiting,COVID-19,Immunodeficiency,,,,,,Drug: Omega 3/Nigella Sativa Oil|Drug: Omega 3/Nigella Sativa Oil/Indian Costus|Drug: Omega 3/Nigella Sativa Oil/Quinine pills|Drug: Omega 3/Nigella Sativa Oil/Anise seed capsule|Drug: Omega 3/Nigella Sativa Oil/Deglycyrrhizinated Licorice|Drug: Active Comparator,"Beni-Suef University|Maternity and Children Hospital, Makkah|Department of clinical pharmacy, faculty of pharmacy, Beni-suef univeristy|University of Arizona|College of Pharmacy,Department of Pharmacy Practice,University of Arizona",All,25 Years to 40 Years   (Adult),200.0,Other,Interventional,2020-09-20,04/11/20,2020-04-12,17/09/20,18/09/20,"Maternity and Children hospital, Mecca, Makkah",Saudi Arabia,Respiratory Diseases,1,2,-161.0
1592.0,NCT04634409,A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,BLAZE-4,Recruiting,COVID-19,,,,,,,Drug: LY3819253|Drug: LY3832479|Drug: Placebo|Drug: VIR-7831,"Eli Lilly and Company|AbCellera Biologics Inc.|Shanghai Junshi Bioscience Co., Ltd.",All,18 Years to 64 Years   (Adult),700.0,Industry|Other,Interventional,2020-01-29,08/03/21,2021-06-29,18/11/20,24/02/21,"The Institute for Liver Health, Mesa, Arizona, United States|Perseverance Research Center, Scottsdale, Arizona, United States|CRI of Arizona, LLC, Sun City West, Arizona, United States|Fiel Family Medicine, Tempe, Arizona, United States|The Institute for Liver Health, Tucson, Arizona, United States|KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States|Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States|Smart Cures Clin Research, Anaheim, California, United States|Hope Clinical Research, Canoga Park, California, United States|VCT-Covina, Covina, California, United States|AMCR Institute, Escondido, California, United States|Chemidox Clinical Trials, Lancaster, California, United States|Ark Clinical Research, Long Beach, California, United States|Long Beach Clinical Trials LLC, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|Central Valley Research, LLC, Modesto, California, United States|Inland Empire CT, LLC, Rialto, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Wolverine Clinical Trials, LLC, Santa Ana, California, United States|St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States|Stanford University Hospital, Stanford, California, United States|Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States|Infect Disease Doctors Med Grp, Walnut Creek, California, United States|Allianz Research Institute, Westminster, California, United States|Georgetown Univ Sch of Med, Washington, District of Columbia, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|I R & Health Center, Inc., Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Elixia CRC, Hollywood, Florida, United States|Panax Clinical Research, Miami Lakes, Florida, United States|Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States|Testing Matters Lab, Sunrise, Florida, United States|Advent Health Tampa, Tampa, Florida, United States|Triple O Research Inst, West Palm Beach, Florida, United States|Cleveland Clinic of Weston Florida, Weston, Florida, United States|Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States|Gwinnett Research Inst, Buford, Georgia, United States|Paramount Rch Sol - College Pk, College Park, Georgia, United States|IACT Health - VHC, Columbus, Georgia, United States|Central Georgia Infectious Disease, Macon, Georgia, United States|Rophe Adult and Pediatric Medicine, Union City, Georgia, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Franciscan Health Hammond, Dyer, Indiana, United States|Qualmedica Research Evansville, Evansville, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|St.Vincent - Indy, Indianapolis, Indiana, United States|Qualmedica Research, LLC, Owensboro, Kentucky, United States|Tandem Clinical Research,LLC, Marrero, Louisiana, United States|Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|U of MA Mem Med Ctr, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Great Lakes Research Group, Inc., Bay City, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Revival Research Institute, Sterling Heights, Michigan, United States|Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States|Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States|Quality Clinical Research, Omaha, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Prime Global Research, LLC, Bronx, New York, United States|Monroe Biomed Research, Monroe, North Carolina, United States|Carteret Medical Group, Morehead City, North Carolina, United States|Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Columbus, Ohio, United States|Remington-Davis, Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Dayton, Ohio, United States|META Medical Research Institute, LLC, Dayton, Ohio, United States|Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|VITALINK - Anderson, Anderson, South Carolina, United States|VITALINK - Gaffney, Gaffney, South Carolina, United States|VITALINK - Greenville, Greenville, South Carolina, United States|VITALINK - Spartanburg, Spartanburg, South Carolina, United States|VITALINK - Union, Union, South Carolina, United States|Univ Diab & Endo Consult, Chattanooga, Tennessee, United States|New Phase R and D, Knoxville, Tennessee, United States|Central Texas Clinical Rch, Austin, Texas, United States|Gadolin Research, LLC, Beaumont, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|B S & W Med Center, Dallas, Texas, United States|Baylor - Fort Worth, Fort Worth, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States|1960 Family Practice, PA, Houston, Texas, United States|B S & W Med Center, Irving, Texas, United States|BioPharma Family Practice Center McAllen, McAllen, Texas, United States|BRCR Medical Center, Inc, McAllen, Texas, United States|North Hills Medical Research, North Richland Hills, Texas, United States|Bay Area Infectious Diseases Associates, Pasadena, Texas, United States|Baylor - Round Rock, Round Rock, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Consano Clinical Research, LLC, Shavano Park, Texas, United States|APD Clinical Research, Splendora, Texas, United States|Crossroads Clin Rch-Victoria, Victoria, Texas, United States|CLS Research Ctr, PLLC, Webster, Texas, United States|CARE ID, Annandale, Virginia, United States|Evergreen Health Research, Kirkland, Washington, United States|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|Dorado Medical Complex Inc, Dorado, Puerto Rico|GCM Medical Group, PSC - Hato Rey Site, San Juan",Puerto Rico,Respiratory Diseases,1,1,517.0
1593.0,NCT04561180,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: EG-HPCP-03a|Drug: EG-HPCP-03a Placebo|Drug: Standard of Care|Drug: Dexamethasone,"Evergreen Therapeutics, Inc.",All,"18 Years to 65 Years   (Adult, Older Adult)",96.0,Industry,Interventional,2021-01-06,01/10/21,2021-01-12,23/09/20,21/02/21,,,Respiratory Diseases,1,1,6.0
1594.0,NCT04594356,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",NET_COV,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",126.0,Other,Observational,2020-11-19,31/01/21,2021-06-30,20/10/20,31/12/20,"CHU Bichat Claude Bernard, Paris",France,Respiratory Diseases,1,1,223.0
1595.0,NCT04686578,The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia,,Recruiting,Fibromyalgia,COVID-19,COVID-19,Daily Life,Sleep Quality,Anxiety Depression,,,Diskapi Yildirim Beyazit Education and Research Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-12,15/02/21,2021-02-28,28/12/20,03/02/21,"Diskapi Education and Research Hospital, Ankara, Altındag",Turkey,"Mental Health, Respiratory Diseases",1,6,413.0
1596.0,NCT04754113,Effect of Prone Position onV/Q Matching in Non-intubated Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Other: prone position,"Southeast University, China",All,"18 Years to 75 Years   (Adult, Older Adult)",10.0,Other,Interventional,2021-07-02,20/02/21,2021-02-27,15/02/21,15/02/21,"Ling Liu, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,-125.0
1597.0,NCT04500418,Charité Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Cenicriviroc (CVC)|Drug: Placebo,"Charite University, Berlin, Germany|Allergan",All,"18 Years and older   (Adult, Older Adult)",183.0,Other|Industry,Interventional,2020-08-25,30/09/21,2021-09-30,05/08/20,26/08/20,"Medical Department of Hepatology and Gastroenterology, Charité University Medicine, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Berlin",Germany,Respiratory Diseases,1,1,401.0
1598.0,NCT04818801,"Safety, Reactogenicity and Immunogenicity Study of ReCOV",,Not yet recruiting,COVID-19,,,,,,,Biological: Recombinant two-component COVID-19 vaccine (CHO cell)|Other: Placebo,"Jiangsu Rec-Biotechnology Co., Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",160.0,Industry,Interventional,2021-01-04,01/07/21,2022-01-06,26/03/21,26/03/21,"Auckland Clinical Studies, Auckland, New Zealand|Christchurch Clinical Studies Trust, Christchurch",New Zealand,Respiratory Diseases,1,1,367.0
1599.0,NCT04487639,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,FERTICOVID,Recruiting,Sperm Preservation in Oncological Patients,Fertility,Cryopreservation,,,,,"Diagnostic Test: SARS-CoV-2 research in nasopharyngeal swab, sperm and serologics","University Hospital, Clermont-Ferrand|Agence de La Biomédecine",Male,18 Years to 60 Years   (Adult),250.0,Other,Interventional,2020-10-07,01/07/21,2021-01-07,27/07/20,27/07/20,"AP-Hôpitaux de Paris - Hôpital Jean Verdier - Service de Biologie de la reproduction, Bondy, France|AP-Hôpitaux de Paris - Hôpital Antoine Béclére - Service de Biologie de la reproduction et AMP DPI CECOS, Clamart, France|CHU de Clermont-Ferrand - Laboratoire de Virologie, Clermont-Ferrand, France|CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Dijon - Laboratoire de Biologie de la Reproduction-CECOS, Dijon, France|CHU de Grenoble - Laboratoire d'Aide à la Procréation CECOS, Grenoble, France|Hospices Civils de Lyon - Service AMP-CECOS, Lyon, France|Hôpital de la Conception - AP-Hôpitaux de Marseille - Service AMP-CECOS, Marseille, France|CHU de Nancy - Laboratoire de biologie de la reproduction - CECOS, Nancy, France|AP-Hôpitaux de Paris - Hôpital Tenon - Service de Biologie de la reproduction - CECOS, Paris, France|AP-Hôpitaux de Paris - Hôpital Cochin - Service d'Histologie-Embryologie-Biologie de la reproduction, Paris, France|Centre Hospitalier intercommunal (CHI) de Poissy Saint Germain en Laye, Poissy, France|CHU de Reims - Service de Biologie de la Reproduction - CECOS Champagne-Ardenne de Reims, Reims, France|CHU de Rouen Normandie - Service Biologie de la Reproduction-CECOS, Rouen, France|CHU de Strasbourg - Service de Biologie de la reproduction, Strasbourg, France|CHU de Toulouse - CECOS Midi-Pyrénées, Toulouse",France,Others,0,3,92.0
1600.0,NCT04256395,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,COVID-19,Completed,Susceptibility to Viral and Mycobacterial Infection,,,,,,,Other: mobile internet survey on self-test,Beijing Tsinghua Chang Gung Hospital|Institute for precision medicine of Tsinghua University|Institute for artificial intelligent of Tsinghua University|Chinese Medical Doctor Association|Institute for network behavior of Tsinghua University|school of clinical medicine of Tsinghua University,All,"Child, Adult, Older Adult",102456.0,Other,Observational,2020-01-02,01/07/20,2020-01-07,05/02/20,07/07/20,"Beijing Tsinghua Changgung Hospital, Beijing, Beijing",China,Others,0,1,5.0
1601.0,NCT04497649,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Sofosbuvir|Drug: Daclatasvir,Tanta University,All,"Child, Adult, Older Adult",100.0,Other,Interventional,2020-01-07,01/04/21,2021-10-04,04/08/20,03/12/20,"Cairo and Tanta Universitities, Tanta",Egypt,Respiratory Diseases,1,1,636.0
1602.0,NCT04568850,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Plasma IgG levels,Lahore General Hospital,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-01-07,28/02/21,2021-02-28,29/09/20,09/02/21,"Lahore General Hospital, Lahore, Punjab, Pakistan|Lahore General Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,418.0
1603.0,NCT04633915,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,COV-HD,"Active, not recruiting",Dialysis,COVID-19,,,,,,,"Saint Petersburg State University, Russia",All,"18 Years and older   (Adult, Older Adult)",51.0,Other,Observational,2020-11-26,01/08/21,2021-01-08,18/11/20,18/03/21,"Saint-Petersburg State University Hospital, Saint Petersburg",Russian Federation,Respiratory Diseases,1,2,43.0
1604.0,NCT04721535,A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2,,Not yet recruiting,COVID-19,SARS-COV-2 Infection,,,,,,Drug: DWJ1248|Drug: Placebo,Daewoong Pharmaceutical Co. LTD.,All,"19 Years and older   (Adult, Older Adult)",1012.0,Industry,Interventional,2021-01-01,01/04/21,2021-01-07,22/01/21,01/02/21,,,Respiratory Diseases,1,2,6.0
1605.0,NCT04623671,Intravenous Infusion of CAP-1002 in Patients With COVID-19,INSPIRE,Recruiting,COVID-19,,,,,,,Biological: CAP-1002|Biological: Placebo,Capricor Inc.,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-11-15,30/04/21,2021-06-30,10/11/20,16/03/21,"Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California Davis, Sacramento, California, United States|Henry Ford Health System, Detroit, Michigan, United States|PharmaTex Research, LLC, Amarillo, Texas",United States,Respiratory Diseases,1,1,227.0
1606.0,NCT04390191,Early CPAP in COVID-19 Confirmed or Suspected Patients,PAP-COVID,Recruiting,COVID-19,COVID-19,Coronavirus,,,,,Device: Continuous Positive Airway Pressure,"Icahn School of Medicine at Mount Sinai|Itamar Medical LTD|Community Surgical Supply of Toms River, Inc|Philips Healthcare",All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Interventional,2020-07-05,01/04/22,2022-01-04,15/05/20,11/03/21,"Icahn School of Medicine at Mount Sinai, New York, New York",United States,Respiratory Diseases,1,3,548.0
1607.0,NCT04639440,Impact of Adipose Tissue in COVID-19,COVIFAT,Not yet recruiting,COVID-19,,,,,,,Other: Adipose tissue,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-11-23,22/11/21,2021-11-23,20/11/20,20/11/20,"Hôpital de la Pitié Salpêtrière, Paris",France,Respiratory Diseases,1,1,365.0
1608.0,NCT04385251,International SARS-CoV-2 (COVID-19) Infection Observational Study,ICOS,Recruiting,COVID-19,COVID-19,SARS-CoV 2,Dyspnea,,,,Other: Data Collection,University of Minnesota|National Institutes of Health (NIH)|National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years and older   (Adult, Older Adult)",10000.0,Other|NIH,Observational,2020-06-18,30/06/21,2021-06-30,12/05/20,19/10/20,"Denver Public Health, Denver, Colorado, United States|Hospital General de Agudos JM Ramos Mejia Servicio de Inmunocomprometidos, Buenos Aires, Argentina|CHIP Department of Infectious Diseases, Copenhagen, Denmark|University College London Medical School Centre for Sexual Health and HIV Research, London, England",United Kingdom,Respiratory Diseases,1,4,377.0
1609.0,NCT04370262,Multi-site Adaptive Trials for COVID-19,,Completed,COVID-19,,,,,,,Drug: SOC + Intravenous Famotidine|Drug: SOC + Placebo,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",233.0,Other,Interventional,2020-07-04,07/09/20,2020-07-09,30/04/20,11/12/20,"Southside Hospital, Bay Shore, New York, United States|North Shore University Hospital, Manhasset, New York, United States|Northern Westchester Hospital, Mount Kisco, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York",United States,Respiratory Diseases,1,1,5.0
1610.0,NCT04405999,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,,Completed,COVID-19,,,,,,,Drug: Bromhexine Hydrochloride,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-14,09/08/20,2020-08-31,28/05/20,03/09/20,"Almazov National Medical Research Centre, Saint Petersburg",Russian Federation,Respiratory Diseases,1,1,109.0
1611.0,NCT04723459,Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff,,Recruiting,COVID-19,,,,,,,Other: ivermectin impregnated mask,South Valley University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-01-23,19/02/21,2021-03-28,25/01/21,17/03/21,"Zaky Aref, Qina",Egypt,Respiratory Diseases,1,1,64.0
1612.0,NCT04473157,COVID-19 in Patients With Anosmia in Egypt,,Completed,Anosmia,COVID-19,Dysgeusia,,,,,,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2020-01-07,30/11/20,2020-12-30,16/07/20,15/01/21,"Ain Shams University, Cairo",Egypt,Respiratory Diseases,1,3,358.0
1613.0,NCT04800120,Use of Hyperbaric Oxygen Therapy to Treat COVID-19 Patients With Respiratory Distress,HBOT,Recruiting,COVID-19,,,,,,,Other: Hyperbaric Oxygen Therapy,"Steward St. Elizabeth's Medical Center of Boston, Inc.",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2021-02-15,01/12/21,2021-01-12,16/03/21,16/03/21,"Morton Hospital, Taunton, Massachusetts",United States,Respiratory Diseases,1,1,-34.0
1614.0,NCT04784754,Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Melatonin|Drug: Placebo,State University of New York at Buffalo|National Center for Advancing Translational Science (NCATS),All,"18 Years and older   (Adult, Older Adult)",50.0,Other|NIH,Interventional,2021-01-04,30/09/21,2021-12-31,05/03/21,05/03/21,"University at Buffalo, Buffalo, New York",United States,Respiratory Diseases,1,1,361.0
1615.0,NCT04328454,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,,Recruiting,Coronavirus,,,,,,,Other: retrospective analysis,"Shanghai 10th People's Hospital|Chibi People's Hospital, Hubei Province",All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-01-30,02/04/20,2020-04-15,31/03/20,31/03/20,"Shanghai 10th People's Hospital, Shanghai, Shanghai",China,Respiratory Diseases,1,1,76.0
1616.0,NCT04810689,"Pilot Trial of XFBD, a TCM, in Persons With COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Xuanfei Baidu Granules|Other: Placebo,Darcy Spicer|University of Southern California,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-03,01/03/22,2022-01-09,23/03/21,23/03/21,"University of Southern California, Los Angeles, California",United States,Respiratory Diseases,1,1,371.0
1617.0,NCT04512079,FREEDOM COVID-19 Anticoagulation Strategy,FREEDOM COVID,Recruiting,COVID-19,COVID-19,,,,,,Drug: Enoxaparin|Drug: Apixaban,Valentin Fuster|Icahn School of Medicine at Mount Sinai,All,"18 Years and older   (Adult, Older Adult)",3600.0,Other,Interventional,2020-08-09,01/12/21,2022-01-03,13/08/20,11/02/21,"Icahn School of Medicine at Mount Sinai, New York, New York, United States|Instituto do Coração - INCOR, São Paulo, Brazil|Instituto Prevent Senior - IPS, São Paulo, Brazil|Clínica de la Costa, Barranquilla, Colombia|Clínica Shaio, Bogotá, Colombia|Fundación Cardioinfantil, Bogotá, Colombia|Fundacion Oftalmológica de Santander - Foscal, Bucaramanga, Colombia|Centro Médico Imbanaco, Cali, Colombia|CardioVid, Medellín, Colombia|Eternal Heart Care Centre and Research Ins Pvt Ltd., Jaipur, India|Jaipur National University, Jaipur, India|Sawai Mann Singh Hospital, Jaipur, India|Jaslok Hospital & Research Center, Mumbai, India|Saifee Hospital, Mumbai, India|Sengupta Hospital & Research Institute, Nagpur, India|D Y Patil University School of Medicine & D Y Patil Hospital, Navi Mumbai, India|Hospital Cardiológica Aguascalientes, Aguascalientes, Mexico|Centro Médico Nacional 20 de Noviembre, Mexico City, Mexico|Christus Muguerza Hospital Alta Especialidad, Monterrey, Mexico|Centro de Estudios Clinicos de Querétaro S.C., Santiago de Querétaro, Mexico|Centro Medico Hospital del Prado, Tijuana",Mexico,Respiratory Diseases,1,2,512.0
1618.0,NCT04709835,Study to Evaluate the Effects of AT-527 in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: AT-527|Drug: Placebo,"Hoffmann-La Roche|Atea Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",220.0,Industry,Interventional,2021-03-02,03/06/21,2021-03-06,14/01/21,08/04/21,"Central Alabama Research, Birmingham, Alabama, United States|Midland Florida Clinical Research Center LLC, DeLand, Florida, United States|Miami Clinical Research - ClinEdge - PPDS, Miami, Florida, United States|Agile Clinical Research Trials, Atlanta, Georgia, United States|PanAmerican Clinical Research LLC, Brownsville, Texas, United States|The Crofoot Research Facility, Houston, Texas, United States|Multiprofile Hospital for Active Treatment Puls AD PPDS, Blagoevgrad, Bulgaria|Multiprofile Hospital For Active Treatment Dr. Tota Venkova JSC, Gabrovo, Bulgaria|MHAT Dr. Atanas Dafovski AD, Kardzhali, Bulgaria|Multiprofile Hospital for Active Treatment - Prof. Dr. Paraskev Stoyanov AD, Lovech, Bulgaria|Medical center Medconsult Pleven OOD, Pleven, Bulgaria|University Multiprofile Hospital for Active Treatment Sveta Marina Pleven OOD, Pleven, Bulgaria|Multiprofile Hospital for Active Treatment Plovdiv, Plovdiv, Bulgaria|MHAT Sv. Ivan Rilski - Razgrad AD; Department of pnemology and phthisiatry, Razgrad, Bulgaria|Specialized Hospital for Active Treatment of Pneumophthisiatric Diseases Dr. D. Gramatikov - Ruse, Ruse, Bulgaria|Multiprofile Hospital for Active Treatment - Samokov EOOD, Samokov, Bulgaria|Diagnostic and Consulting Center Aleksandrovska EOOD, Sofia, Bulgaria|Diagnostic Consultative CTR XX Sofia EOOD, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment (MHAT) - Targovishte, Targovishte, Bulgaria|Vancouver Infectious Diseases Centre, Vancouver, British Columbia, Canada|Hamilton Medical Research Group, Hamilton, Ontario, Canada|Manna Research Toronto, Toronto, Ontario, Canada|Connolly Hospital, Dublin, Ireland|Krakowskie Centrum Medyczne Sp. z o.o., Krakow, Poland|Centrum Medyczne Pulawska SP. z o.o., Piaseczno, Poland|Centrum Badań Klinicznych, Wrocław, Poland|Radiodiagnostic CETIR - Clinica del Pilar, Esplugues de Llobregat, Barcelona, Spain|Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón, Madrid, Spain|Hospital Costa del Sol; Servicio de Oncologia, Marbella, Malaga, Spain|Centro de Salud Quart de Poblet, Manises, Valencia, Spain|IDIAPJGol_Fundacion Instituto Universitario Investigacion AP Salud Jordi Gol i Gurina, Barcelona, Spain|Hospital Universitario La Paz - PPDS, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Virgen de La Arrixaca, Murcia, Spain|Chapel Street Medical Centre, Ashton-under-Lyne, United Kingdom|Tower Family Healthcare - Moorgate Primary Care Ce, Bury, United Kingdom|CPS Research, Glasgow, United Kingdom|Chelsea and Westminster NHS Trust, London",United Kingdom,Respiratory Diseases,1,1,4.0
1619.0,NCT04729491,EAT-DUTA AndroCoV Trial,,Completed,COVID-19,,,,,,,Drug: Dutasteride 0.5 mg|Drug: Azithromycin|Drug: Nitazoxanide|Drug: Placebo,Corpometria Institute,Male,"18 Years and older   (Adult, Older Adult)",138.0,Other,Interventional,2020-06-30,15/09/20,2020-07-10,28/01/21,28/01/21,"Corpometria Institute, Brasília, DF",Brazil,Respiratory Diseases,1,1,10.0
1620.0,NCT04426253,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",,"Active, not recruiting",COVID-19,Sars-CoV2,,,,,,,Szeged University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-05-06,31/12/20,2021-07-31,11/06/20,11/06/20,"University of Pécs 1st Department of Internal Medicine Intensive Care Unit, Pécs, Hungary|University of Pécs First Department of Internal Medicine, Pécs, Hungary|University of Pécs Infection Department of the Coronavirus Center, Pécs, Hungary|University of Pécs Institute of Laboratory Medicine, Pécs, Hungary|University of Pécs Szentágotahi Research Centre, Pécs, Hungary|University of Pécs Szentágothai Research Centre Genomics and Bioinformatics Core Facility, Pécs, Hungary|University of Szeged Szentágothai Research Centre Virology Research Group, Pécs, Hungary|University of Szeged Department of Anaesthesiology And Inthensive Therapy, Szeged, Hungary|University of Szeged Department of Dermatology and Allergology, Szeged, Hungary|University of Szeged Department of Medical Biology, Szeged, Hungary|University of Szeged Department of Paediatrics, Szeged, Hungary|University of Szeged First Department of Medicine, Szeged, Hungary|University of Szeged Institute of Clinical Microbiology, Szeged, Hungary|University of Szeged Institute of Medical Microbiology and Immunobiology, Szeged",Hungary,Respiratory Diseases,1,2,451.0
1621.0,NCT04825093,Vitamin D Supplementarion in Pregnant Women at Risk and COVID-19,VID-WOMAN,Not yet recruiting,Pregnancy Complications,COVID-19,,,,,,Dietary Supplement: Vitamin D supplementation in pregnant women,Universidad de Granada,Female,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2021-01-05,30/10/22,2023-12-30,01/04/21,01/04/21,"Maria Jose Aguilar Cordero, Granada",Spain,Respiratory Diseases,1,2,1089.0
1622.0,NCT04337190,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),COVID-ARA2,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Biological: blood sampling,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-04,06/10/20,2020-06-12,07/04/20,10/04/20,"University Hospital Angers, Angers",France,Respiratory Diseases,1,2,100.0
1623.0,NCT04771624,Assessment of Executive Functions After Covid-19,,Recruiting,COVID-19,Cognitive Impairment,,,,,,,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-10-30,30/04/21,2021-07-30,25/02/21,25/02/21,"Sağlık Bilimleri Üniversitesi Gazi Yaşargil Training and Research Hospital, Diyarbakır",Turkey,Respiratory Diseases,1,2,273.0
1624.0,NCT04445272,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Drug: Tocilizumab,Fundacion SEIMC-GESIDA|Roche Pharma AG|Dynamic Science S.L.,All,"18 Years and older   (Adult, Older Adult)",495.0,Other|Industry,Interventional,2020-05-22,23/12/20,2020-12-23,24/06/20,03/02/21,"Hospital Universitario de Cabueñes, Gijón, Asturias, Spain|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Sant Joan de Déu de Manresa, Manresa, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital Universitario de Galdakao, Galdakao, Bizkaia, Spain|Hospital Universitario Marqués Valdecilla, Santander, Cantabria, Spain|Hospital Público General del Tomelloso, Tomelloso, Ciudad Real, Spain|Hospital Jerez de la Frontera, Jerez De La Frontera, Cádiz, Spain|Hospital Universitari Son Espases, Palma De Mallorca, Islas Baleares, Spain|Hospital Universitario Fundación Alcorcón, Alcorcón, Madrid, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Rey Juan Carlos, Móstoles, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital Nuestra Señora del Prado, Talavera De La Reina, Toledo, Spain|Complejo Hospitalario Universitario de Albacete, Albacete, Spain|Hospital Infanta Cristina, Badajoz, Spain|Hospital Clínic i Provincial Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Burgos, Burgos, Spain|Hospital Universitario Dr. Josep Trueta, Gerona, Spain|Hospital Universitario Clínico San Cecilio, Granada, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain|Hospital Universitario HM Sanchinarro, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain|Hospital Regional Universitario de Málaga, Málaga, Spain|Complexo Hospitalario Universitario de Ourense, Orense, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitario Virgen de la Macarena, Sevilla, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Spain|Hospital Virgen de la Salud, Toledo, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Hospital Universitari i Poliectenic La Fe, Valencia, Spain|Hospital Universitario Dr. Peset, Valencia, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain|Hospital Universitario Miguel Servet, Zaragoza",Spain,Respiratory Diseases,1,1,215.0
1625.0,NCT04832828,Sensitivity and Specificity of the Roth Test in Patients With COVID-19 Positive,,Completed,COVID-19,,,,,,,Diagnostic Test: Roth´s Test,Universidad Autonoma de Madrid,All,"12 Years to 99 Years   (Child, Adult, Older Adult)",114.0,Other,Observational,2020-01-06,28/11/20,2020-11-28,06/04/21,06/04/21,"CS Entrevías, Madrid",Spain,Respiratory Diseases,1,1,327.0
1626.0,NCT04449081,"Knowledge, Attitude and Practice of Dental Students About COVID-19",,Completed,Acute Respiratory Distress Syndrome,Corona Virus Infection,Acute Lung Injury,Fever,Myalgia,Cough,Dyspnea,"Behavioral: Knowledge, Attitude, Practice, Awareness, Preference",Melaka Manipal Medical College,All,18 Years to 30 Years   (Adult),215.0,Other,Observational,2020-04-25,10/06/20,2020-06-20,26/06/20,02/09/20,"Faculty of Dentistry, Melaka-Manipal Medical College, Melaka Tengah, Melaka",Malaysia,Respiratory Diseases,1,7,56.0
1627.0,NCT04505722,A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,ENSEMBLE,"Active, not recruiting",COVID-19,,,,,,,Biological: Ad26.COV2.S|Other: Placebo,Janssen Vaccines & Prevention B.V.,All,"18 Years and older   (Adult, Older Adult)",44325.0,Industry,Interventional,2020-07-09,22/01/21,2023-02-01,10/08/20,09/04/21,"Synexus Clinical Research US, Inc, Birmingham, Alabama, United States|University of Alabama Birmingham, Birmingham, Alabama, United States|Alabama Vaccine Research Clinic at UAB, Birmingham, Alabama, United States|Optimal Research, Huntsville, Alabama, United States|Synexus Clinical Research US, Inc, Glendale, Arizona, United States|VA Medical Center, Phoenix, Arizona, United States|Central Phoenix Medical Clinic, Phoenix, Arizona, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Synexus Clinical Research US, Inc, Tucson, Arizona, United States|University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States|Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States|Anaheim Clinical Trials, LLC, Anaheim, California, United States|Ark Clinical Research, Long Beach, California, United States|Anthony Mills Medical, Inc, Los Angeles, California, United States|Stanford University Medical Center, Palo Alto, California, United States|UCSD Antiviral Research Center AVRC, San Diego, California, United States|Wr-McCr, Llc, San Diego, California, United States|VA Medical Center, San Francisco, California, United States|Childrens Hospital Colorado, Aurora, Colorado, United States|Rocky Mountain Regional VA Medical Center, Denver, Colorado, United States|Avail Clinical Research, LLC, DeLand, Florida, United States|North Florida South Georgia Veteran Health System, Gainesville, Florida, United States|Velocity Clinical Research, Hallandale Beach, Hallandale Beach, Florida, United States|Research Centers of America, LLC, Hollywood, Florida, United States|Suncoast Research Group, Miami, Florida, United States|University of Miami - Miller School of Medicine, Miami, Florida, United States|Orlando Immunology Center, Orlando, Florida, United States|Advent Health Orlando, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Orlando, Florida, United States|Synexus Clinical Research US, Inc, Pinellas Park, Florida, United States|James A Haley VA Hospital GNS, Tampa, Florida, United States|Synexus Clinical Research US, Inc, The Villages, Florida, United States|Emory University of Medicine, Atlanta, Georgia, United States|The Hope Clinic at Emory University, Decatur, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northwestern University, Chicago, Illinois, United States|Jesse Brown VAMC Department of Surgery, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of IL Chicago, Chicago, Illinois, United States|The University Of Chicago Medicine, Chicago, Illinois, United States|Optimal Research, Peoria, Illinois, United States|Buynak Clinical Research, Valparaiso, Indiana, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|University of Kentucky, Lexington, Kentucky, United States|University of Louisville, Louisville, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Clinical Trials Management, LLC, Metairie, Louisiana, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Optimal Research, Rockville, Maryland, United States|Meridian Clinical Research, LLC, Rockville, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|The Brigham and Women's Hospital, Inc., Boston, Massachusetts, United States|University of Michigan Neuorsurgery A. Alfred Taubman Health Care Center, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Cherry Street Services, Inc., Grand Rapids, Michigan, United States|Abbott Northwestern Hospital Clinic, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|MediSync Clinical Research, Petal, Mississippi, United States|The Center For Pharmaceutical Research, Kansas City, Missouri, United States|Saint Louis University, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Synexus Clinical Research US, Inc, Saint Louis, Missouri, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Clinical Research Consortium, an AMR company, Las Vegas, Nevada, United States|VA Sierra Nevada Health Care System, Reno, Nevada, United States|Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|Saint Michael's Medical Center, Newark, New Jersey, United States|Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico, United States|Bronx Veterans Affairs Medical Center, Bronx, New York, United States|Meridian Clinical Research, LLC, Endwell, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Harlem Hospital Center, New York, New York, United States|New York Blood Center, New York, New York, United States|Rochester Clinical Research, Inc, Rochester, New York, United States|Tryon Medical Group, Charlotte, North Carolina, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Durham VAMC, Raleigh, North Carolina, United States|Wake Research Associates, Raleigh, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Synexus Clinical Research US, Inc, Akron, Ohio, United States|CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc, Cincinnati, Ohio, United States|New Horizons Clinical Research, Cincinnati, Ohio, United States|Rapid Medical Research, Cleveland, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|Corvallis Clinic PC, Corvallis, Oregon, United States|Clinical Research Institute of Southern Oregon, P.C., Medford, Oregon, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Synexus Clinical Research US, Inc, Anderson, South Carolina, United States|VA Medical Center, Columbia, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|PMG Research of Charleston, LLC, Mount Pleasant, South Carolina, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|St Jude Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Benchmark Research, Austin, Texas, United States|Optimal Research, LLC, Austin, Texas, United States|AIDS Arms Incorporated Trinity Health and Wellness Center, Dallas, Texas, United States|Synexus Clinical Research US, Inc, Dallas, Texas, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|North Texas Infectious Diseases Consultants, Dallas, Texas, United States|Texas Center for Drug Development, Inc, Houston, Texas, United States|Gordon Crofoot, MD, Houston, Texas, United States|Clinical Trials of Texas, Inc, San Antonio, Texas, United States|Synexus Clinical Research US, Inc, San Antonio, Texas, United States|Synexus Clinical Research US, Inc, Murray, Utah, United States|University of Utah, Salt Lake City, Utah, United States|Advanced Clinical Research, West Jordan, Utah, United States|Kaiser Permanente Washington Health Research Institute, Seattle, Washington, United States|CIPREC, Buenos Aires, Argentina|Helios Salud Sa, Buenos Aires, Argentina|CEMEDIC, Buenos Aires, Argentina|Centro Medico Viamonte SRL, Ciudad Autonoma Buenos Aires, Argentina|Clinical Trials Division-Stamboulian Servicios de Salud, Ciudad Autonoma Buenos Aires, Argentina|Clínica y Maternidad Suizo",South Africa,Respiratory Diseases,1,1,937.0
1628.0,NCT04801017,A Study to Evaluate the Safety and Efficacy of OT-101+Artemisinin in Hospitalized COVID-19 Subjects,,Not yet recruiting,COVID-19,,,,,,,Drug: OT-101|Drug: Artemisinin|Drug: Placebo,Oncotelic Inc.|Mateon Therapeutics,All,"18 Years to 80 Years   (Adult, Older Adult)",18.0,Industry,Interventional,2021-01-04,01/08/21,2021-01-10,16/03/21,16/03/21,"Praxis Pesquisa Medica S / S Ltda, Jardim",Brazil,Respiratory Diseases,1,1,6.0
1629.0,NCT04625296,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,COVecu,Recruiting,COVID-19,,,,,,,Behavioral: Semi-directive interview|Behavioral: Questionnaire : Preparedness for Caregiving Scale,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Observational,2020-09-17,01/01/21,2021-01-01,12/11/20,12/11/20,"URC/CIC Paris Centre, Paris",France,Respiratory Diseases,1,1,106.0
1630.0,NCT04460547,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,,Not yet recruiting,COVID-19,,,,,,,Drug: Convalescent Plasma Transfusion|Drug: Hydroxychloroquine|Drug: DAS181|Drug: Ivermectin|Drug: Interferon Beta-1A,Qassim University,All,"1 Year and older   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-07-25,15/08/20,2020-09-20,07/07/20,07/07/20,,,Respiratory Diseases,1,1,57.0
1631.0,NCT04670094,Comorbidities and Risk Score in COVID-19 Patients,Comorbidities,"Active, not recruiting",COVID-19,,,,,,,,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2020-12-30,01/12/21,2021-01-12,17/12/20,22/01/21,"ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy|ASST Spedali Civili, Montichiari, Italy|ASST Monza-Ospedale San Gerardo, Monza, Italy|Humanitas Clinical and Research Hospital, Rozzano, Italy|Centre for Tropical and Infectious Diseases and Microbiology, IRCCS Sacro Cuore, Verona",Italy,Respiratory Diseases,1,1,13.0
1632.0,NCT04385914,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,,Not yet recruiting,Corona Virus Infection,,,,,,,Other: COVID positive via testing,Atlantic Health System,Female,18 Years to 50 Years   (Adult),200.0,Other,Observational,2020-01-05,01/09/20,2020-01-12,13/05/20,13/05/20,,,Respiratory Diseases,1,1,7.0
1633.0,NCT04406389,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),IMPACT,Recruiting,COVID-19,,,,,,,Drug: Enoxaparin sodium|Drug: Unfractionated heparin|Drug: Fondapariniux|Drug: Argatroban,Weill Medical College of Cornell University,All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Interventional,2020-10-13,01/06/21,2021-01-12,28/05/20,26/01/21,"Weill Cornell Medicine, New York, New York",United States,Respiratory Diseases,1,1,91.0
1634.0,NCT04757792,Back to the Traditional: Anti-COX Drugs Can Improve the Outcome of COVID-19 Patients Admitted to ICU,,Completed,COVID-19,,,,,,,Other: File inquiry,Benha University|Tanta University|Cairo University,All,"Child, Adult, Older Adult",475.0,Other,Observational,2020-06-06,01/02/21,2021-11-02,17/02/21,17/02/21,"Faculty of Medicine, Banhā, Qalubia",Egypt,Respiratory Diseases,1,1,514.0
1635.0,NCT04832945,SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study,,Completed,COVID-19,,,,,,,Drug: Ivermectin 6 Mg Oral Tablet,Grupo Rescue S.A.S República Dominicana,All,"18 Years and older   (Adult, Older Adult)",713.0,Other,Observational,2020-06-29,20/09/20,2021-10-04,06/04/21,13/04/21,"Centro Medico Bournigal, Puerto Plata, Dominican Republic|Centro Médico Punta Cana, Punta Cana",Dominican Republic,Respiratory Diseases,1,1,462.0
1636.0,NCT04828538,"Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19",,Recruiting,COVID-19,,,,,,,"Dietary Supplement: Vitamin D|Dietary Supplement: Omega DHA / EPA|Dietary Supplement: Vitamin C, Vitamin B complex and Zinc Acetate",Hospital de la Soledad|Microclinic International,All,"18 Years and older   (Adult, Older Adult)",3600.0,Other,Interventional,2021-01-03,01/07/21,2021-01-07,02/04/21,02/04/21,"Hospital de Soledad, San Luis Potosí, SLP",Mexico,Respiratory Diseases,1,1,4.0
1637.0,NCT04427865,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: prophylactic lactoferrin daily,Cairo University,All,"18 Years to 65 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-07,01/09/20,2020-01-11,11/06/20,16/06/20,,,Respiratory Diseases,1,1,4.0
1638.0,NCT04790786,Evaluation of Monoclonal Antibodies in COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: Lilly Bamlanivimab|Biological: Regeneron Casirivimab + Imdevimab|Biological: Lilly Bamlanivimab + Etesevimab,"David T. Huang, MD, MPH|University of Pittsburgh Medical Center|Berry Consultants|University of Pittsburgh",All,"18 Years to 120 Years   (Adult, Older Adult)",5000.0,Other,Observational,2021-01-03,22/02/22,2022-12-30,10/03/21,10/03/21,"UPMC, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,1,726.0
1639.0,NCT04808882,ANTIcoagulation in Severe COVID-19 Patients,ANTICOVID,Not yet recruiting,COVID-19,,,,,,,"Drug: Tinzaparin, Low dose prophylactic anticoagulation|Drug: Tinzaparin, High dose prophylactic anticoagulation|Drug: Tinzaparin,Therapeutic anticoagulation",Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",353.0,Other,Interventional,2021-01-05,01/12/21,2022-01-02,22/03/21,22/03/21,,,Respiratory Diseases,1,1,362.0
1640.0,NCT04542694,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,,Completed,COVID-19,,,,,,,Drug: Favipiravir|Drug: Standard of care,"Promomed, LLC",All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-21,10/08/20,2020-08-20,09/09/20,05/11/20,"State Clinical Hospital №50, Moscow, Russian Federation|Regional Clinic Hospital of Ryazan, Ryazan', Russian Federation|City Hospital N40 of Kurortny District, Saint Petersburg, Russian Federation|Medical institute Ogarev Mordovia State university, Saransk, Russian Federation|Smolensk clinical hospital №1, Smolensk",Russian Federation,Respiratory Diseases,1,1,91.0
1641.0,NCT04368260,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,,Recruiting,COVID-19,,,,,,,Device: Control swab|Device: Prototype swab,University of Virginia,All,"up to 99 Years   (Child, Adult, Older Adult)",40.0,Other,Interventional,2020-04-24,31/07/20,2020-07-31,29/04/20,29/04/20,"University of Virginia, Charlottesville, Virginia",United States,Respiratory Diseases,1,1,98.0
1642.0,NCT04740372,"Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ",,Recruiting,COVID-19,,,,,,,Other: No intervention. Method study. Psychometric testing,Oslo University Hospital|European Organisation for Research and Treatment of Cancer - EORTC|Medical University Innsbruck|Johannes Gutenberg University Mainz|Servicio de Navarro de Salud|University of Southampton|Skane University Hospital|Haukeland University Hospital|University of the East Ramon Magsaysay Memorial Medical Center|Sumandeep Vidyapeeth|Birzeit University|National Centre for Infectious Diseases|Komfo Anokye Teaching Hospital,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Observational,2020-11-20,01/06/21,2021-01-11,05/02/21,05/02/21,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,1,52.0
1643.0,NCT04573153,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine + Metabolic cofactor supplementation|Drug: Hydroxychloroquine + Sorbitol,ScandiBio Therapeutics AB|Istanbul Medipol University Hospital|Istanbul Umraniye Training and Research Hospital|Bakirkoy Dr. Sadi Konuk Research and Training Hospital|Dr. Lutfi Kirdar Kartal Training and Research Hospital|Bagcilar Training and Research Hospital|Kanuni Sultan Suleyman Training and Research Hospital|Alanya Alaaddin Keykubat University Alanya Training and Research Hospital|Canakkale 18 Mart University Health Research and Application Hospital|Monitor CRO,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|Other,Interventional,2020-09-21,31/01/21,2021-03-31,05/10/20,06/10/20,"University of Health Sciences Istanbul Ümraniye Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,191.0
1644.0,NCT04801030,COVID-19 Vaccine Hesitancy Among African Americans,,Not yet recruiting,COVID-19,Vaccine Refusal,Communication,,,,,Behavioral: CoVax Facts,Meharry Medical College|St. Jude Children's Research Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2021-01-06,30/05/23,2023-05-30,16/03/21,16/03/21,,,Respiratory Diseases,1,3,874.0
1645.0,NCT04613245,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,COVID-19,Recruiting,Asthma Chronic,Bronchial Asthma,,,,,,,Cairo University,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-05,30/01/21,2021-01-03,03/11/20,10/12/20,"Egypt, Cairo",Egypt,Others,0,2,364.0
1646.0,NCT04779541,National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units,VACOVID-SENIOR,Recruiting,COVID-19,COVID-19,,,,,,Other: observation,"University Hospital, Angers",All,75 Years and older   (Older Adult),1000.0,Other,Observational,2021-08-02,08/04/21,2021-08-04,03/03/21,19/03/21,"Angers University Hospital, Angers",France,Respiratory Diseases,1,2,2.0
1647.0,NCT04547114,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Multicapillary column coupled ion mobility spectrometry,Klinikum Bayreuth GmbH,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Observational,2020-09-14,31/12/20,2021-04-30,14/09/20,14/09/20,"Klinikum Bayreuth/ Bayreuth General Hospital, Bayreuth",Germany,Respiratory Diseases,1,1,228.0
1648.0,NCT04802018,Clinical Decision Support System Based on Non-invasive Tele-monitoring of COVID-19 Patients,SOY+,"Active, not recruiting",COVID-19,,,,,,,Device: Clinical decision support system based on non-invasive multimodal monitoring,Increase-Tech|Hospital Clínico Universitario de Valladolid|University of Valladolid|Sanidad de Castilla y León,All,"16 Years and older   (Child, Adult, Older Adult)",500.0,Other,Interventional,2021-09-03,01/06/21,2021-01-09,17/03/21,26/03/21,"Faculty of Medicine of Valladolid, Valladolid",Spain,Respiratory Diseases,1,1,-237.0
1649.0,NCT04441710,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,CoVid3S,Recruiting,COVID-19,,,,,,,Other: Questionnaire,Hospices Civils de Lyon,All,"Child, Adult, Older Adult",2500.0,Other,Observational,2020-10-27,01/04/22,2024-01-04,22/06/20,03/12/20,"CHU de Grenoble - Hôpital Nord, La Tronche, France|Hôpital de la Croix Rousse, Lyon, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|CHU de Saint Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,1164.0
1650.0,NCT04563650,COVID-19 Serology and Immunosenescence,SERO-CoV-OLD,Recruiting,COVID-19,Geriatric Medicine,Seroconversion,Immunosenescence,,,,Biological: blood sample,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",330.0,Other,Interventional,2020-09-18,01/05/21,2021-01-11,24/09/20,24/09/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,4,115.0
1651.0,NCT04511819,Losmapimod Safety and Efficacy in COVID-19,LOSVID,"Active, not recruiting",COVID-19,,,,,,,Drug: Losmapimod oral tablet|Drug: Placebo oral tablet,Fulcrum Therapeutics,All,"50 Years and older   (Adult, Older Adult)",410.0,Industry,Interventional,2020-08-28,01/06/21,2021-01-06,13/08/20,05/04/21,"University of California Irvine - Irvine Medical Center, Irvine, California, United States|University of Miami, Miami, Florida, United States|University of South Florida, Tampa, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Memorial Hermann Hospital South West, Houston, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|United Medical Memorial Hospital, Houston, Texas, United States|Hospital Universitario Cassiano Antonio de Moraes-HUCAM/Hospital das Clinicas, Vitória, ES, Brazil|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Irmandade de Santa Casa de Misericordia de Porto Alegre, Porto Alegre, SC, Brazil|Hospital Santa Paula, San Paolo, SP, Brazil|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Nuevo Hospital Civil de Guadalajara, Guadalajara, JC, Mexico|JM Research Cuernavaca, Cuernavaca, Morelos, Mexico|Centro para el Desarrollo de la Medicina y de Asistencia Médica Especializada, S.C., Culiacán, Sinaloa, Mexico|Hospital Nacional Carlos Alberto Seguín Escobedo - EsSalud Arequipa, Arequipa, AR",Peru,Respiratory Diseases,1,1,131.0
1652.0,NCT04475211,LILLE COVID RESEARCH NETWORK (Covid-19),LICORNE,Recruiting,Sars-CoV2,,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-10-08,01/08/22,2022-01-08,17/07/20,19/11/20,"Hop Claude Huriez Chr Lille, Lille",France,Respiratory Diseases,1,1,457.0
1653.0,NCT04809480,COVID-19 and Acute Invasive Fungal Rhinosinusitis,,Completed,COVID-19,,,,,,,Diagnostic Test: Fungal rhinosinusitis,Al-Azhar University,All,"15 Years to 90 Years   (Child, Adult, Older Adult)",56.0,Other,Observational,2017-01-01,31/12/20,2020-12-31,22/03/21,22/03/21,,,Respiratory Diseases,1,1,1460.0
1654.0,NCT04328493,The Vietnam Chloroquine Treatment on COVID-19,VICO,Recruiting,COVID-19,COVID-19,,,,,,Drug: Chloroquine phosphate,"Oxford University Clinical Research Unit, Vietnam|Ministry of Health, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Vietnam|Can Gio COVID Hospital, Vietnam|Cho Ray Hospital|National Hospital for Tropical Diseases, Hanoi, Vietnam|Department of Health, Ho Chi Minh city",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2020-07-04,01/04/21,2022-01-04,31/03/20,29/05/20,"National Hospital for Tropical Diseases, Hanoi, Vietnam|Can Gio COVID Hospital, Ho Chi Minh City, Vietnam|Cho Ray Hospital, Ho Chi Minh City, Vietnam|Cu Chi COVID Hospital, Ho Chi Minh City, Vietnam|Hospital for Tropical Diseases, Ho Chi Minh City",Vietnam,Respiratory Diseases,1,2,549.0
1655.0,NCT04346186,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: IgM and IgG diagnostic kits to SARS-CoV-2|Diagnostic Test: Elisa-test for IgM and IgG to SARS-CoV-2,"Herlev Hospital|Nordsjaellands Hospital|Hvidovre University Hospital|Rigshospitalet, Denmark|Mental Health Services in the Capital Region, Denmark|University Hospital Bispebjerg and Frederiksberg",All,"Child, Adult, Older Adult",30000.0,Other,Observational,2020-04-15,01/10/20,2021-01-08,15/04/20,25/09/20,"Herlev Hospital, Herlev, Region Hovedstaden, Denmark|Bispebjerg Hospital, København NV, Region Hovedstaden, Denmark|Psykiatrisk Center Ballerup, Ballerup, Denmark|Psykiatrisk Center København, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Psykiatrisk Center Amager, Copenhagen, Denmark|Psykiatrisk Center Stolpegaard, Gentofte, Denmark|Børne- og Ungdomspsykiatrisk Center, Glostrup, Denmark|Psykiatrisk Center Glostrup, Glostrup, Denmark|Nordsjaellands Hospital, Hillerød, Denmark|Psykiatrisk Center Nordsjælland, Hillerød, Denmark|Psykiatrisk Center Sankt Hans, Roskilde, Denmark|Bornholms Hospital, Rønne, Denmark|Psykiatrisk Center Bornholm, Rønne",Denmark,Respiratory Diseases,1,1,268.0
1656.0,NCT04596085,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",,Recruiting,COVID-19,,,,,,,Dietary Supplement: Investigational Product - ViraCide|Other: Placebo - Starch Powder Soft gels,"The Herb, Inc|ProRelix Services LLP",All,"50 Years to 90 Years   (Adult, Older Adult)",124.0,Industry|Other,Interventional,2020-09-16,30/11/20,2021-01-30,22/10/20,29/10/20,"Department of General medicine/ clinical research. Government medical college and Government general hospital, Srikakulam, Andhra Pradesh, India|Gunjkar Multispeciality Hospital, Pune, Maharashtra",India,Respiratory Diseases,1,1,136.0
1657.0,NCT04328961,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),,Completed,COVID-19,Corona Virus Infection,SARS (Severe Acute Respiratory Syndrome),COVID-19,,,,Drug: Hydroxychloroquine Sulfate|Drug: Ascorbic Acid,University of Washington|Bill and Melinda Gates Foundation,All,"18 Years to 80 Years   (Adult, Older Adult)",829.0,Other,Interventional,2020-03-31,24/09/20,2020-08-10,01/04/20,29/10/20,"University of California Los Angeles, Los Angeles, California, United States|Tulane, New Orleans, Louisiana, United States|University of Maryland, Baltimore, Baltimore, Maryland, United States|Boston University, Boston, Massachusetts, United States|NYU Langone Health, New York, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington, Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington",United States,Respiratory Diseases,1,4,132.0
1658.0,NCT04397614,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,,Recruiting,Sars-CoV2,COVID-19,,,,,,Other: mHealth Assessments,University of Oklahoma,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-07-22,01/12/21,2021-01-12,21/05/20,24/03/21,"Stephenson Cancer Center, Oklahoma City, Oklahoma",United States,Respiratory Diseases,1,2,174.0
1659.0,NCT04811885,The Effects of Covid-19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,ASD,"Active, not recruiting",Autism Spectrum Disorder,Cardiovascular Health,,,,,,Other: The Effects of Covid 19 Pandemic on the Cardiovascular Heath of Children With Autism Spectrum Disorder,"Institute of Technology, Carlow",All,"4 Years to 18 Years   (Child, Adult)",120.0,Other,Observational,2019-10-14,14/10/21,2021-10-14,23/03/21,24/03/21,"Institute of Technology Carlow, Carlow, Lenister",Ireland,Others,0,2,731.0
1660.0,NCT04646109,Ivermectin for Severe COVID-19 Management,,Completed,COVID-19,,,,,,,Drug: Ivermectin,Afyonkarahisar Health Sciences University|NeuTec Pharma,All,"18 Years and older   (Adult, Older Adult)",66.0,Other|Industry,Interventional,2020-11-05,02/09/20,2020-02-09,27/11/20,27/01/21,"Afyonkarahisar Health Science University, Afyonkarahisar, Turkey|Gulhane Faculty of Medicine, University of Health Sciences, Ankara, Turkey|Yıldırım Beyazıt University, Ankara City Hospital, Ankara, Turkey|Haydarpasa Sultan Abdulhamid Han Training and Research Hospital, İstanbul",Turkey,Respiratory Diseases,1,1,-270.0
1661.0,NCT04757857,COVID-19 Antithrombotic Rivaroxaban Evaluation,CARE,Recruiting,COVID-19,,,,,,,Drug: Rivaroxaban 10 mg,Hospital Alemão Oswaldo Cruz|Bayer|Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Brazilian Research In Intensive Care Network|Brazilian Clinical Research Institute,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other|Industry,Interventional,2020-09-29,28/02/21,2021-04-30,17/02/21,25/02/21,"Clínica Senhor do Bonfim, Feira de Santana, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital de Base do Distrito Federal, Brasília, Distrito Federal, Brazil|Hospital de Campanha Covid-19 Goiânia/Sesgo, Goiânia, Goias, Brazil|Hospital Estadual de Urgências de Trindade/SESGO, Trindade, Goias, Brazil|Núcleo de Pesquisa Clínica do Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Hospital São Lucas, Belo Horizonte, Minas Gerais, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Gerais, Brazil|Hospital Universitário Regional de Maringá, Maringá, Paraná, Brazil|Beneficencia Nipo Brasileira Da Amazonia, Belém, Para, Brazil|Hospital Adventista de Belém, Belém, Para, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital das Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Universitario de Santa Maria, Santa Maria, Rio Grande Do Sul, Brazil|Clínica Procárdio Ltda, Blumenau, Santa Catarina, Brazil|H&W Cardiologia LTDA, Joinville, Santa Catarina, Brazil|Irmandade santa Casa de Araras, Araras, São Paulo, Brazil|Alphacor Cardiologia Clínica e Diagnóstica LTDA, Barueri, São Paulo, Brazil|Maestri e Kormann Consultoria Medico-Cientifica LTDA - EPP, Blumenau, São Paulo, Brazil|Hospital Regional do Litoral Norte - Instituto Sócrates Guanaes, Caraguatatuba, São Paulo, Brazil|Hospital Santos Dumont Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital de Corderiopolis, Cordeiropolis, São Paulo, Brazil|Hospital Regional Jorge Rossman - Instituto Sócrates Guanaes, Itanhaém, São Paulo, Brazil|Hospital Carlos Fernando Malzoni, Matão, São Paulo, Brazil|Hospital Moinhos de Vento, Porto Alegre, São Paulo, Brazil|Hospital Regional de Registro - Instituto Sócrates Guanaes, Registro, São Paulo, Brazil|Hospital Unimed Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Kaiser Clinica e Hospital Dia, São José do Rio Preto, São Paulo, Brazil|Braile Hospital Dia Ltda, São José Do Rio Preto, São Paulo, Brazil|Hospital Policlin, São José Dos Campos, São Paulo, Brazil|Hospital Regional de São José dos Campos - Instituto Sócrates Guanaes, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|International Research Center - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital Leforte Liberdade, São Paulo, Brazil|Incor - Instituto do Coração do Hospital das Clínicas da FMUSP, São Paulo",Brazil,Respiratory Diseases,1,1,213.0
1662.0,NCT04765449,Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: Cytotoxic T Lymphocytes,Thomas Jefferson University|Tevogen Bio Inc,All,70 Years and older   (Older Adult),24.0,Other,Interventional,2021-03-30,31/08/23,2024-02-29,21/02/21,05/03/21,"Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,1066.0
1663.0,NCT04615026,Prevalence of Thrombosis in COVID-Patients,,Recruiting,COVID-19,,,,,,,Diagnostic Test: duplex sonography,University Hospital Augsburg,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-04-11,30/06/21,2021-06-30,04/11/20,04/11/20,"University Hospital Augsburg, Augsburg",Germany,Respiratory Diseases,1,1,445.0
1664.0,NCT04429867,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,WellStar Health System,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2020-07-05,07/12/20,2020-07-12,12/06/20,16/06/20,"Wellstar Kennestone Hospital, Marietta, Georgia",United States,Respiratory Diseases,1,1,7.0
1665.0,NCT04460651,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial,PREPARE-IT,Recruiting,COVID-19,,,,,,,Drug: Icosapent ethyl (IPE)|Drug: Placebo,Estudios Clínicos Latino América|Amarin Pharma Inc.,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other|Industry,Interventional,2020-08-14,01/01/21,2021-01-01,07/07/20,23/11/20,"Instituto de Investigaciones Clínicas - Rosario, Rosario, Santa Fe",Argentina,Respiratory Diseases,1,1,140.0
1666.0,NCT04779827,Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks,,Not yet recruiting,Vaccination Refusal,COVID-19,Contraception Behavior,Heart Diseases,,,,Behavioral: Online Social Network and Collective Intelligence Intervention|Behavioral: Independent Control,"University of Pennsylvania|University of California, Davis|University of California, San Francisco|University of California, Berkeley",All,"18 Years and older   (Adult, Older Adult)",1920.0,Other,Interventional,2021-04-19,30/10/22,2022-12-30,03/03/21,08/04/21,,,Respiratory Diseases,1,4,620.0
1667.0,NCT04531319,Immune Cell Subgroups in Covid 19 Patients,,Completed,COVID-19,,,,,,,Diagnostic Test: Flow cytometric analysis,Istanbul Training and Research Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-08-15,01/10/20,2020-01-10,28/08/20,12/01/21,"Istanbul Training and Reseach Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,-218.0
1668.0,NCT04452643,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,Bacmune,Withdrawn,COVID-19,,,,,,,Biological: BACMUNE (MV130)|Other: Placebo,Inmunotek S.L.,All,"18 Years to 65 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-10,01/12/21,2021-01-12,30/06/20,02/11/20,"Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de México, Mexico|Hospital General de Pachuca, Pachuca de Soto, Mexico|Hospital de Ciudad Valles, San Luis Potosí",Mexico,Respiratory Diseases,1,1,368.0
1669.0,NCT04348448,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",,Not yet recruiting,COVID-19,,,,,,,Drug: Canakinumab 150 MG/ML [Ilaris],AUSL Romagna Rimini,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,01/07/20,2020-01-09,16/04/20,16/04/20,,,Respiratory Diseases,1,1,5.0
1670.0,NCT04357535,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,,Completed,COVID-19,,,,,,,Drug: Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB),Hakeam Abdulaziz Hakeam|Buraidah Central Hospital|King Khalid University Hospital|Princess Nourah Bint Abdulrahman University|King Faisal Specialist Hospital & Research Center,All,"18 Years and older   (Adult, Older Adult)",314.0,Other,Observational,2020-10-05,01/07/20,2020-01-08,22/04/20,04/08/20,"King Faisal Specialist Hospital & Research Centre, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,-271.0
1671.0,NCT04598256,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,,Completed,COVID-19,,,,,,,Procedure: Endoscopic procedure,Tepecik Training and Research Hospital,All,"1 Year to 18 Years   (Child, Adult)",77.0,Other,Observational,2020-01-06,31/08/20,2020-08-31,22/10/20,02/11/20,"Tepecik Trh, İzmir, İ̇zmi̇r",Turkey,Respiratory Diseases,1,1,238.0
1672.0,NCT04409522,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Melatonin|Drug: The usual treatment,Mohammad Sadegh Bagheri Baghdasht|Baqiyatallah Medical Sciences University,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",55.0,Other,Interventional,2020-12-05,05/06/20,2020-09-25,01/06/20,01/06/20,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,-71.0
1673.0,NCT04466371,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,,Not yet recruiting,COVID-19,,,,,,,Other: Questionnaire,Misr International University,All,"18 Years and older   (Adult, Older Adult)",9209.0,Other,Observational,2021-07-15,01/01/22,2022-01-03,10/07/20,24/03/21,,,Respiratory Diseases,1,1,172.0
1674.0,NCT04485338,Chest Radiography in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|University of Bari Aldo Moro|Mahidol University|Universitair Ziekenhuis Brussel|Chonburi Hospital,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-08,31/12/20,2021-01-03,24/07/20,20/01/21,"Amsterdam UMC location AMC, Amsterdam",Netherlands,Respiratory Diseases,1,1,361.0
1675.0,NCT04682912,Blood Types in Children With COVID-19,,Recruiting,COVID-19,,,,,,,,Mersin Training and Research Hospital|Mersin University|Dicle University|Bezmialem Vakif University|Uludag University,All,"1 Month to 18 Years   (Child, Adult)",2000.0,Other,Observational,2021-01-30,01/02/21,2021-01-02,24/12/20,03/02/21,"Mersin City Training & Research Hospital, Mersi̇n",Turkey,Respiratory Diseases,1,1,-28.0
1676.0,NCT04425252,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,CRISIS,Completed,COVID-19,,,,,,,Drug: Brequinar|Other: Standard of Care,"Clear Creek Bio, Inc.",All,"18 Years and older   (Adult, Older Adult)",23.0,Industry,Interventional,2020-01-08,29/12/20,2020-12-29,11/06/20,19/01/21,"Hartford Hospital, Hartford, Connecticut, United States|Baptist Medical Center, Jacksonville, Florida, United States|University of South Florida/Tampa General, Tampa, Florida, United States|University of New Mexico, Albuquerque, New Mexico, United States|Temple University, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,356.0
1677.0,NCT04336254,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Biological: allogeneic human dental pulp stem cells (BSH BTC & Utooth BTC)|Other: Intravenous saline injection (Placebo),"Renmin Hospital of Wuhan University|Beijing SH Bio-Tech Corporation, Beijing (CN)|Utooth Biological Technology Co., Ltd. Hubei (CN)",All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-06-05,30/11/21,2021-12-31,07/04/20,10/03/21,"Renmin Hospital of Wuhan University (East Campus), Wuhan, Hubei",China,Respiratory Diseases,1,1,574.0
1678.0,NCT04539262,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",,Completed,COVID-19,,,,,,,Drug: Remdesivir (RDV)|Drug: Placebo,Gilead Sciences,All,"18 Years and older   (Adult, Older Adult)",156.0,Industry,Interventional,2020-09-14,26/02/21,2021-03-22,04/09/20,09/04/21,"The Institute for Liver Health, Mesa, Arizona, United States|The Institute for Liver Health, Tucson, Arizona, United States|Franco Felizarta, MD, Bakersfield, California, United States|Aurora FDRC Inc., Costa Mesa, California, United States|Elevated Health, Huntington Beach, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|Western Clinical Research, Placentia, California, United States|UC Davis Health/Medical Center, Sacramento, California, United States|Bradenton Research Center, Inc., Bradenton, Florida, United States|Integrity Clinical Research, LLC, Doral, Florida, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Evolution Clinical Trials, Inc., Hialeah Gardens, Florida, United States|Research in Miami, Inc., Hialeah, Florida, United States|Optimus U Corporation, Miami, Florida, United States|L & C Professional Medical Research Institute, Miami, Florida, United States|Westchester Research Center at Westchester General Hospital, Miami, Florida, United States|MedBio Trials, Miami, Florida, United States|Nuovida Research Center, Corp, Miami, Florida, United States|IMIC Inc, Palmetto Bay, Florida, United States|Triple O Research Institute, PA, West Palm Beach, Florida, United States|Family Care Research, Boise, Idaho, United States|CTU Covid Research Center, New Orleans, Louisiana, United States|STAT Research, Vandalia, Ohio, United States|Inquest Clinical Research, Baytown, Texas, United States|DFW Clinical Research, Dallas, Texas, United States|Baylor Research Institute, Dallas, Texas, United States|PCP for Life-Tidwell, Houston, Texas, United States|Providence Regional Medical Center Everett, Everett, Washington",United States,Respiratory Diseases,1,1,189.0
1679.0,NCT04452487,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),COVID-19-LAT,Recruiting,Patient Hospitalized in Disease Infectious Unit,Patient Hospitalized in Intensive Reanimation Unit,Patient Hopsitalized in Internal Medicine Unit,,,,,Behavioral: decisions of limitations and stop processing,"University Hospital, Clermont-Ferrand",All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2020-01-06,01/06/21,2021-01-06,30/06/20,30/06/20,"CHU de Clermont-Ferrand, Clermont-Ferrand, France|Hospices Civiles de Lyon, Lyon, France|CH de Vichy, Vichy",France,Others,0,3,366.0
1680.0,NCT04733729,Covid-19 in Hematological Malignancies,EPICOVIDEHA,Recruiting,COVID-19,,,,,,,,Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne|European Hematology Association,All,"18 Years to 99 Years   (Adult, Older Adult)",3000.0,Other,Observational,2020-01-03,30/01/21,2021-12-31,02/02/21,05/02/21,"ASST-Spedali Civili, Brescia, Italy|AOU Policlinico Federico II, Napoli, Italy|Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy|Istituto Nazionale Tumori Regina Elena IFO, Rome, Italy|Osp. di Circolo-Fondazione Macchi, Varese, Italy|AOUI Verona, Verona",Italy,Respiratory Diseases,1,1,728.0
1681.0,NCT04636333,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),,Recruiting,COVID-19,,,,,,,"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 14 #middle-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#|Biological: Two doses of placebo at the schedule of day 0, 14 #High-dose group#|Biological: Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group#","Jiangsu Province Centers for Disease Control and Prevention|Academy of Military Medical Sciences，Academy of Military Sciences，PLA|ZHONGYIANKE Biotech Co, Ltd.|LIAONINGMAOKANGYUAN Biotech Co, Ltd",All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2020-10-30,07/04/21,2022-07-01,19/11/20,08/01/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,609.0
1682.0,NCT04348305,Hydrocortisone for COVID-19 and Severe Hypoxia,COVID STEROID,"Active, not recruiting",COVID-19,Hypoxia,,,,,,Drug: Hydrocortisone|Drug: Sodium Chloride 9mg/mL,"Scandinavian Critical Care Trials Group|Rigshospitalet, Denmark|Copenhagen Trial Unit, Center for Clinical Intervention Research|University of Copenhagen|Aarhus University Hospital",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-04-17,10/09/20,2021-08-06,16/04/20,09/03/21,"Aarhus University Hospital - Dept of Intensive care, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Rigshospitalet, Copenhagen, Denmark|Herlev Hospital - Dept. of Intensive Care, Herlev, Denmark|North Zealand Hospital, Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Køge Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Slagelse Hospital, Slagelse, Denmark|Viborg Hospital, Viborg",Denmark,Respiratory Diseases,1,2,476.0
1683.0,NCT04546841,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,pVAC,Recruiting,COVID-19,,,,,,,Biological: multipeptide cocktail,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Interventional,2020-11-27,30/09/21,2021-12-20,14/09/20,01/12/20,"University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg",Germany,Respiratory Diseases,1,1,388.0
1684.0,NCT04372017,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,,"Active, not recruiting",COVID-19,SARS-CoV 2,,,,,,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin D,Sanford Health,All,"18 Years and older   (Adult, Older Adult)",1.0,Other,Interventional,2020-05-14,04/06/20,2021-04-06,01/05/20,09/06/20,"Sanford Health, Sioux Falls, South Dakota",United States,Respiratory Diseases,1,2,327.0
1685.0,NCT04482205,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,,Completed,Economic Burden,,,,,,,,Aga Khan University,All,"Child, Adult, Older Adult",840.0,Other,Observational,2020-03-16,31/05/20,2020-05-31,22/07/20,22/07/20,"Aga Khan University Hospital, Karachi, Sindh",Pakistan,Others,0,1,76.0
1686.0,NCT04638634,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects",,Recruiting,COVID-19,,,,,,,Biological: CSL760,CSL Behring,All,"18 Years to 65 Years   (Adult, Older Adult)",24.0,Industry,Interventional,2021-02-02,01/05/21,2021-01-05,20/11/20,15/02/21,"CMAX Clinical Research, Adelaide",Australia,Respiratory Diseases,1,1,-28.0
1687.0,NCT04439084,COVID-19 in Patients With Chronic Liver Diseases,COLD,Enrolling by invitation,COVID-19,Chronic Liver Disease,,,,,,Other: Prospective Chart Review,Stanford University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-06-03,01/06/21,2021-01-06,19/06/20,27/07/20,"University of Arizona,, Phoenix, Arizona, United States|Mayo Clinic, Scottsdale, Arizona, United States|UCSF Fresno, Fresno, California, United States|University of Southern California, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Georgetown University, Washington, District of Columbia, United States|VA Medical Center, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Oschner Medical Center, Baton Rouge, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Hennepin County Medical Center (HCMC), Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mount Sinai School of Medicine, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Duke University, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,2,217.0
1688.0,NCT04409834,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,COVID-PACT,Recruiting,COVID-19,Venous Thromboembolism,Arterial Thrombosis,,,,,Drug: Unfractionated Heparin IV|Drug: Enoxaparin 1 mg/kg|Drug: Clopidogrel|Drug: Unfractionated heparin SC|Drug: Enoxaparin 40 Mg/0.4 mL Injectable Solution,The TIMI Study Group,All,"18 Years and older   (Adult, Older Adult)",750.0,Other,Interventional,2020-05-08,01/05/21,2021-01-05,01/06/20,18/08/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,3,242.0
1689.0,NCT04323332,Traditional Chinese Medicine for Severe COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Traditional Chinese Medicine Prescription,Xiyuan Hospital of China Academy of Chinese Medical Sciences,All,"up to 85 Years   (Child, Adult, Older Adult)",50.0,Other,Interventional,2020-01-03,01/03/20,2020-01-04,26/03/20,26/03/20,"Hao Li, Beijing, Beijing",China,Respiratory Diseases,1,1,1.0
1690.0,NCT04410328,Aggrenox To Treat Acute Covid-19,ATTAC-19,Recruiting,COVID-19,,,,,,,Drug: Dipyridamole ER 200mg/ Aspirin 25mg orally/enterally AND Standard of care|Other: Standard of care,"Rutgers, The State University of New Jersey|Boehringer Ingelheim",All,"19 Years and older   (Adult, Older Adult)",132.0,Other|Industry,Interventional,2020-10-21,15/03/21,2021-12-15,01/06/20,23/10/20,"Rutgers New Jersey Medical School University Hospital, Newark, New Jersey",United States,Respiratory Diseases,1,1,420.0
1691.0,NCT04569851,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019),,Enrolling by invitation,COVID-19,,,,,,,,Medsavana|Castilla-La Mancha Health Service,All,"Child, Adult, Older Adult",100000.0,Other,Observational,2020-01-01,01/10/21,2021-10-30,30/09/20,30/09/20,"Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitario La Princesa, Madrid",Spain,Respiratory Diseases,1,1,668.0
1692.0,NCT04443270,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Chloroquine phosphate,"CMN ""20 de Noviembre""",All,18 Years to 59 Years   (Adult),200.0,Other,Interventional,2020-07-27,31/10/20,2021-01-31,23/06/20,14/07/20,"Centro Médico Nacional 20 de Noviembre, Mexico City, Benito Juárez",Mexico,Respiratory Diseases,1,1,188.0
1693.0,NCT04808921,Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test,,Completed,COVID-19,COVID-19,Coronavirus,,,,,"Diagnostic Test: Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test","Sky Medical Supplies & Equipments, LLC",All,"Child, Adult, Older Adult",151.0,Industry,Interventional,2021-09-01,18/01/21,2021-01-28,22/03/21,08/04/21,"D&H National Research Centers INC, Miami, Florida",United States,Respiratory Diseases,1,3,-216.0
1694.0,NCT04745611,Neurological and Neuropsychological Sequelae of COVID-19 Infection,NeNeSCo,Recruiting,COVID-19,,,,,,,Diagnostic Test: MRI|Diagnostic Test: Neuropsychological assessment|Diagnostic Test: Questionnaires Patient|Diagnostic Test: Questionnaires Family,Maastricht University|Hersenstichting|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|UMC Utrecht,All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-12-12,01/09/21,2021-01-09,09/02/21,09/02/21,"Maastricht University, Maastricht, Limburg, Netherlands|Amsterdam Universitair Medische Centra, Amsterdam, Netherlands|Universitair Medische Centra Utrecht, Utrecht",Netherlands,Respiratory Diseases,1,1,28.0
1695.0,NCT04843722,COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,,Recruiting,COVID-19,,,,,,,Biological: hAd5-S-Fusion+N-ETSD vaccine,"ImmunityBio, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",540.0,Industry,Interventional,2021-01-04,01/09/21,2022-01-08,13/04/21,13/04/21,"Chan Soon-Shiong Institute for Medicine, El Segundo, California",United States,Respiratory Diseases,1,1,369.0
1696.0,NCT04421534,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Lactoferrin,Cairo University,All,"18 Years to 65 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-06,01/09/20,2020-01-11,09/06/20,09/06/20,,,Respiratory Diseases,1,1,5.0
1697.0,NCT04344080,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,CYTOCOV-19,"Active, not recruiting",COVID-19,,,,,,,Device: CytoSorb-Therapy,Universitätsklinikum Hamburg-Eppendorf,All,"18 Years to 90 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-01-04,01/05/21,2021-01-05,14/04/20,14/04/21,"University Medical Center Hamburg-Eppendorf, Hamburg",Germany,Respiratory Diseases,1,1,367.0
1698.0,NCT04449094,Emergence of the COVID 19 Epidemic in the City of Nice,,Completed,COVID-19,,,,,,,,Centre Hospitalier Universitaire de Nice,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-02-28,30/03/20,2020-04-04,26/06/20,26/06/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,36.0
1699.0,NCT04492943,To Observe Whether Isoflurane Can Treat COVID-19 Patients,,Completed,COVID-19,,,,,,,,Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Observational,2020-04-20,30/06/20,2020-06-30,30/07/20,02/09/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,71.0
1700.0,NCT04339426,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Atovaquone/Azithromycin,HonorHealth Research Institute,All,"18 Years to 95 Years   (Adult, Older Adult)",25.0,Other,Interventional,2020-04-20,01/07/21,2021-01-12,09/04/20,02/12/20,"HonorHealth, Scottsdale, Arizona",United States,Respiratory Diseases,1,1,267.0
1701.0,NCT04824495,Evaluation of Inflammatory Cytokines During COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Blood sample,University of Vienna,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-07-01,31/08/21,2021-12-31,01/04/21,06/04/21,"Medical University of Vienna, Vienna",Austria,Respiratory Diseases,1,1,183.0
1702.0,NCT04682548,Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients,,Recruiting,Multiple Sclerosis,COVID-19,,,,,,,NYU Langone Health,All,18 Years to 60 Years   (Adult),1000.0,Other,Observational,2021-05-01,01/12/21,2021-01-12,23/12/20,13/04/21,"NYU Langone Health, New York, New York",United States,"Respiratory Diseases, Immunological Disorders",1,2,-109.0
1703.0,NCT04342182,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ConCoVid-19,"Active, not recruiting",COVID-19,,,,,,,Biological: Convalescent plasma,Erasmus Medical Center|Sanquin Plasma Products BV,All,"18 Years and older   (Adult, Older Adult)",426.0,Other,Interventional,2020-08-04,01/07/21,2021-07-31,10/04/20,16/11/20,"Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|NoordWest Ziekenhuisgroep, Alkmaar, Netherlands|Onze Lieve Vrouwen Gasthuis, Amsterdam, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|Martini Hospital, Groningen, Netherlands|Spaarna Gasthuis, Haarlem, Netherlands|Alrijne Ziekenhuis, Leiderdorp, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Maasstad Ziekenhuis, Rotterdam, Netherlands|ZorgSaam Hospital, Terneuzen, Netherlands|Bernhoven Hospital, Uden, Netherlands|VieCuri, Venlo",Netherlands,Respiratory Diseases,1,1,361.0
1704.0,NCT04627194,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,,"Active, not recruiting",COVID-19,"Pneumonia, Viral",,,,,,,Semey State Medical University,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-02-20,30/04/20,2020-01-12,13/11/20,13/11/20,"Semey Medical University, Semey, East Kazakhstan",Kazakhstan,Respiratory Diseases,1,2,-39.0
1705.0,NCT04384250,Genetic Basis of COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Whole Exome Sequencing,Mansoura University,All,"up to 50 Years   (Child, Adult)",50.0,Other,Observational,2020-10-05,31/08/20,2021-01-05,12/05/20,12/05/20,"Mansoura University, Mansoura, Dakahlyia",Egypt,Respiratory Diseases,1,1,92.0
1706.0,NCT04782427,COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave,,"Active, not recruiting",COVID-19,Death,Infection Viral,"Infections, Respiratory","Infection, Coronavirus",Elderly Infection,Old Age; Dementia,Other: COVID-19 infection,Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal|Université de Montréal,All,"Child, Adult, Older Adult",1200.0,Other,Observational,2021-01-01,13/04/21,2021-05-13,04/03/21,05/03/21,"CIUSSS Centre-Sud-de-l'Île-de-Montréal, Montreal, Quebec",Canada,Respiratory Diseases,1,7,132.0
1707.0,NCT04364763,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),,Recruiting,COVID-19,,,,,,,Drug: RBT-9 (90 mg)|Drug: 0.9% sodium chloride (normal saline),"Renibus Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",252.0,Industry,Interventional,2020-05-08,30/06/21,2021-12-31,28/04/20,14/01/21,"New Smyrna Beach, FL, New Smyrna Beach, Florida, United States|Berkley, MI, Berkley, Michigan, United States|El Paso, TX, El Paso, Texas, United States|Fort Worth, TX, Fort Worth, Texas, United States|Houston, Houston, Texas",United States,Respiratory Diseases,1,1,602.0
1708.0,NCT04730323,TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience,,Completed,COVID-19,,,,,,,Drug: Tocilizumab,FMH College of Medicine and Dentistry,All,"16 Years to 85 Years   (Child, Adult, Older Adult)",93.0,Other,Interventional,2020-12-05,12/06/20,2020-12-06,29/01/21,29/01/21,"Fatima Memorial Hospital College of Medicine & Dentistry, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,1.0
1709.0,NCT04346446,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: Convalescent Plasma Transfusion|Other: Supportive Care|Drug: Random Donor Plasma,"Institute of Liver and Biliary Sciences, India",All,"18 Years and older   (Adult, Older Adult)",29.0,Other,Interventional,2020-04-20,30/05/20,2020-05-30,15/04/20,12/06/20,"Maulana Azad medical College, New Delhi, Delhi, India|Institute of Liver and Biliary Sciences, New Delhi, Delhi",India,Respiratory Diseases,1,1,40.0
1710.0,NCT04395859,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,COVIDIV,Recruiting,Age Related Macular Degeneration,Diabetic Macular Edema,Retinal Vein Occlusion,,,,,Procedure: Questionnaire|Other: Data collection up to 1 year,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-05-27,01/12/21,2021-01-12,20/05/20,23/06/20,"Centre Pôle Vision du val d'Ouest, Ecully, France|Fondation Adolphe de Rothschild, Paris, France|Hôpital Lariboisière, Paris, France|Centre ophtalmologique Maison Rouge, Strasbourg",France,Others,0,3,230.0
1711.0,NCT04570501,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Angiotensin-(1-7)|Drug: Placebo,Stanford University,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2021-01-03,01/08/21,2021-01-08,30/09/20,01/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,5.0
1712.0,NCT04488588,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,,Completed,COVID-19,Coronavirus Disease,COVID-19,,,,,Other: Kaplan Meier analysis,Assiut University,All,36 Years to 63 Years   (Adult),1064.0,Other,Observational,2020-03-15,01/05/20,2020-01-07,28/07/20,28/07/20,"AssiutU, Assiut, Egypt|Aliae Mohamed-Hussein, Assiut",Egypt,Respiratory Diseases,1,3,-68.0
1713.0,NCT04801888,Study on Combined Vaccination With SARS-CoV-2 Inactivated Vaccine and Quadrivalent Influenza Vaccine,,Not yet recruiting,COVID-19,Influenza,,,,,,"Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.|Biological: Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 14.","Sinovac Research and Development Co., Ltd.|Sinovac Biotech Co., Ltd",All,18 Years to 59 Years   (Adult),480.0,Industry,Interventional,2021-01-03,01/07/21,2021-01-07,17/03/21,17/03/21,"Kaihua county Center for Disease Control and Prevention, Quzhou, Zhejiang",China,"Infectious Diseases, Respiratory Diseases",1,2,4.0
1714.0,NCT04412369,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,MIIC-MI,Not yet recruiting,COVID-19,Cardiovascular Diseases,,,,,,Diagnostic Test: Non-invasive cardiac imaging,University of Cambridge|Cambridge University Hospitals NHS Foundation Trust|British Heart Foundation|Wellcome Trust,All,"18 Years to 99 Years   (Adult, Older Adult)",20.0,Other,Observational,2020-01-06,01/06/21,2021-01-06,02/06/20,02/06/20,"Cambridge Univeristy Hospitals NHS Foundation Trust, Cambridge",United Kingdom,Respiratory Diseases,1,2,366.0
1715.0,NCT04834856,"Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients",,Recruiting,COVID-19,,,,,,,Drug: ensovibep,Molecular Partners AG,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2021-01-04,31/10/21,2021-10-31,08/04/21,08/04/21,"Centre for Human Drug Research, Leiden",Netherlands,Respiratory Diseases,1,1,300.0
1716.0,NCT04746443,Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey,,Recruiting,COVID-19,,,,,,,Other: NOT APPLICABLE (NA),King Khalid University,All,18 Years to 30 Years   (Adult),40.0,Other,Observational,2020-08-12,08/03/21,2021-08-03,09/02/21,09/02/21,"King Khalid University, Abha, Aseer",Saudi Arabia,Respiratory Diseases,1,1,356.0
1717.0,NCT04838119,Preop COVID Testing Patterns,,Not yet recruiting,COVID-19,,,,,,,,Wake Forest University Health Sciences,All,"18 Years and older   (Adult, Older Adult)",300000.0,Other,Observational,2021-01-04,01/05/21,2021-01-07,08/04/21,08/04/21,"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina",United States,Respiratory Diseases,1,1,3.0
1718.0,NCT04762056,CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge,,Not yet recruiting,Post Intensive Care Unit Syndrome,COVID-19,,,,,,Other: Chelsea Critical Care Physical Assessment Tool,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",26.0,Other,Observational,2021-02-20,30/05/21,2021-05-30,21/02/21,24/02/21,"Koç Univercity Hospital, Istanbul, None Selected, Turkey|Gaziosmanpasa Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,99.0
1719.0,NCT04665258,COVID-19 Vaccine and Impact on Fertility Study,,Recruiting,"Infertility, Male",,,,,,,,University of Miami,Male,18 Years to 50 Years   (Adult),60.0,Other,Observational,2020-12-14,14/06/21,2021-06-14,11/12/20,31/12/20,"University of Miami, Miami, Florida",United States,Others,0,1,182.0
1720.0,NCT04826770,Adaptive Immune Response Against Corona Virus Vaccination,AICOVI,Recruiting,COVID-19,,,,,,,Other: anti-SARS-CoV-2 antibody testing,University Medicine Greifswald,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2021-06-01,31/10/21,2022-12-31,01/04/21,01/04/21,"University Medicine Greifswald, Greifswald, MV",Germany,Respiratory Diseases,1,1,578.0
1721.0,NCT04363385,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,,Recruiting,COVID-19,,,,,,,Biological: Biological test,Centre Hospitalier Intercommunal Creteil,All,"Child, Adult, Older Adult",500.0,Other,Interventional,2020-05-31,31/05/21,2021-05-31,27/04/20,24/07/20,"Centre hospitalier intercommunal de Créteil, Créteil",France,Respiratory Diseases,1,1,365.0
1722.0,NCT04418609,Neuro-COVID-19: Neurological Complications of COVID-19,Neuro-COVID,Recruiting,Neurologic Complication,,,,,,,Other: further processing of health data,Emanuela Keller|University of Zurich,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-05,30/04/22,2022-05-30,05/06/20,05/06/20,"University Hospital Zurich, Zürich",Switzerland,Others,0,1,876.0
1723.0,NCT04468139,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Quercetin|Dietary Supplement: bromelain|Drug: Zinc|Drug: Vitamin C,"Ministry of Health, Saudi Arabia",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-20,20/07/20,2020-07-30,13/07/20,13/07/20,"Ministry of health.First health cluster ,Riaydh, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,40.0
1724.0,NCT04845191,COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines,,Not yet recruiting,COVID-19,,,,,,,Biological: hAd5-S-Fusion+N-ETSD vaccine,"ImmunityBio, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",540.0,Industry,Interventional,2021-01-04,01/09/21,2022-01-08,14/04/21,14/04/21,"Chan Soon-Shiong Institute for Medicine, El Segundo, California",United States,Respiratory Diseases,1,1,369.0
1725.0,NCT04779775,Best Practices in Perinatal Mental Health During COVID-19,,Not yet recruiting,COVID-19,,,,,,,,University of Minho|Universidad Loyola Andalucia|Catholic University of Croatia|University of Coimbra,All,"Child, Adult, Older Adult",70.0,Other,Observational,2021-03-15,30/04/21,2021-06-30,03/03/21,08/03/21,,,Respiratory Diseases,1,1,107.0
1726.0,NCT04433039,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,,Completed,COVID-19,,,,,,,,Alexandria University,All,"4 Years to 80 Years   (Child, Adult, Older Adult)",130.0,Other,Observational,2020-05-22,12/06/20,2020-06-14,16/06/20,16/06/20,"Faculty of Medicine, University of Alexandria, Alexandria",Egypt,Respiratory Diseases,1,1,23.0
1727.0,NCT04544176,COVID-19 Risk From Attending Outpatient Radiology Appointments,,Completed,COVID-19,,,,,,,Other: Observational,Nottingham University Hospitals NHS Trust|University Hospital of Wales,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",48000.0,Other,Observational,2020-01-01,30/06/20,2021-01-01,10/09/20,12/02/21,"Nottingham University Hospitals, NHS Trust, Nottingham, Nottinghamshire",United Kingdom,Respiratory Diseases,1,1,366.0
1728.0,NCT04373759,Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,ACICOVID,Completed,Sars-CoV2,COVID-19,,,,,,Other: Cardiopulmonary resuscitation|Other: Modified Rankin score,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Observational,2020-02-05,30/09/20,2020-09-30,04/05/20,14/12/20,"CHU Caen, Caen, Calvados, France|Hôpital Privé St Martin, Caen, Calvados, France|CH Angoulème, Angoulême, Charente, France|CH Brive, Brive-la-Gaillarde, Corrèze, France|CHU Dijon, Dijon, Côte-d'Or, France|CH Etampes, Étampes, Essonne, France|CHU Antoine Béclère AP-HP, Clamart, Haut-de-Seine, France|CHU Ambroise Paré AP-HP, Boulogne-Billancourt, Hauts-de-Seine, France|CH Louis Mourier AP-HP, Colombes, Hauts-de-Seine, France|CHU Montpellier, Montpellier, Hérault, France|CHU Lariboisière AP-HP, Paris, Ile-de-France, France|CHU Saint Louis AP-HP, Paris, Ile-de-France, France|CHU St Antoine, Paris, Ile-de-France, France|Groupe Hospitalier Saint Joseph, Paris, Ile-de-France, France|CHU Necker Enfants Malades, Paris, Ile-de-France, France|CHU Pitié Salpétrière, Paris, Ile-de-France, France|CHU Felix Guyon, Saint-Denis, La Reunion, France|CHR Orléans, Orléans, Loiret, France|CH Cahors, Cahors, Lot, France|CHRU Roger Salengro, Lille, Nord, France|CH Bethune, Beuvry, Pas-de-Calais, France|CH Lens, Lens, Pas-de-Calais, France|Grand Hôpital de l'Est Francilien, Jossigny, Seine-et-Marne, France|CHU Meaux, Meaux, Seine-et-Marne, France|Groupe Hospitalier Sud Ile de France, Melun, Seine-et-Marne, France|CHU Rouen, Rouen, Seine-Maritime, France|CHU Amiens Picardie, Amiens, Somme, France|Hôpital Nord Franche Comté, Trévenans, Territoire De Belfort, France|CH Argenteuil, Argenteuil, Val-d'Oise, France|CHU Henri Mondor AP-HP, Créteil, Val-de-Marne, France|CHU Kremlin Bicêtre, Le Kremlin-Bicêtre, Val-de-Marne, France|CH de la Dracénie, Draguignan, Var, France|CHI Frejus St Raphael, Fréjus, Var, France|Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, Var, France|CH Versailles, Le Chesnay, Yvelines, France|CHU Martinique - Fort de France, Fort-de-France",Martinique,Respiratory Diseases,1,2,238.0
1729.0,NCT04330495,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",,Not yet recruiting,COVID-19,Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors,,,,,,Drug: Hidroxicloroquina|Drug: Control group,Instituto de Investigación Marqués de Valdecilla,All,"18 Years to 75 Years   (Adult, Older Adult)",800.0,Other,Interventional,2020-06-04,06/11/20,2020-06-11,01/04/20,13/04/20,,,Respiratory Diseases,1,2,7.0
1730.0,NCT04623385,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,,Not yet recruiting,COVID-19,,,,,,,Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone|Drug: The standard therapy,Kafrelsheikh University,All,"18 Years to 70 Years   (Adult, Older Adult)",1000.0,Other,Interventional,2020-01-11,01/12/20,2021-01-12,10/11/20,10/11/20,,,Respiratory Diseases,1,1,367.0
1731.0,NCT04509713,Canine COVID-19 Detection,,Recruiting,COVID-19,,,,,,,Behavioral: Collection of odour samples,ARCTEC|Durham University|Cardiff University|Medical Detection Dogs,All,"16 Years and older   (Child, Adult, Older Adult)",16250.0,Industry|Other,Observational,2020-02-07,30/09/20,2020-10-31,12/08/20,12/08/20,"ARCTEC, London",United Kingdom,Respiratory Diseases,1,1,267.0
1732.0,NCT04337541,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,,Completed,COVID-19,,,,,,,Other: Surgical facial mask,"Rigshospitalet, Denmark|Nordsjaellands Hospital|Hvidovre University Hospital|Herlev Hospital|Technical University of Denmark",All,"18 Years and older   (Adult, Older Adult)",6000.0,Other,Interventional,2020-02-04,02/06/20,2020-02-06,07/04/20,03/08/20,"Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,1,2.0
1733.0,NCT04330599,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,COVIDENCE UK,Recruiting,COVID-19,,,,,,,,"Queen Mary University of London|King's College London|London School of Hygiene and Tropical Medicine|University of Edinburgh|Swansea University|Queen's University, Belfast|Barts & The London NHS Trust",All,"16 Years and older   (Child, Adult, Older Adult)",12000.0,Other,Observational,2020-01-05,01/04/25,2025-01-04,01/04/20,30/10/20,"Queen Mary University of London, London, County (optional)",United Kingdom,Respiratory Diseases,1,1,1826.0
1734.0,NCT04487119,Hematology and Clinical Picture in Pediatric COVID-19 Infection,,Completed,COVID-19,,,,,,,,Benha University,All,"up to 18 Years   (Child, Adult)",29.0,Other,Observational,2020-12-08,20/08/20,2020-08-23,27/07/20,09/09/20,"Benha Faculty of Medicine, Banhā, Qalubia",Egypt,Respiratory Diseases,1,1,-107.0
1735.0,NCT04729075,"Associations Between COVID-19 ARDS Treatment, Clinical Trajectories and Liberation From Mechanical Ventilator - an Analysis of the NorthCARDS Dataset",NorthCARDS,Completed,"ARDS, Human",COVID-19,,,,,,Other: ARDS and COVID19 treatments,Northwell Health|BioSymetrics|Feinstein Institute for Medical Research,All,"Child, Adult, Older Adult",1800.0,Other,Observational,2021-01-19,19/01/21,2021-01-19,28/01/21,28/01/21,"Feinstein Institutes for Medical Research, Manhasset, New York",United States,Respiratory Diseases,1,2,0.0
1736.0,NCT04477668,Helmet Non-Invasive Ventilation for COVID-19 Patients,Helmet-COVID,Recruiting,COVID-19,Acute Hypoxemic Respiratory Failure,,,,,,Device: Helmet non-invasive ventilation,King Abdullah International Medical Research Center,All,"14 Years and older   (Child, Adult, Older Adult)",320.0,Other,Interventional,2021-08-02,01/12/21,2022-01-01,20/07/20,18/02/21,"Intensive Care Department, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh",Saudi Arabia,Respiratory Diseases,1,2,152.0
1737.0,NCT04552483,Effects of Early Use of Nitazoxanide in Patients With COVID-19,,Completed,COVID-19,Coronavirus,,,,,,Drug: Nitazoxanide|Drug: Placebo,"Universidade Federal do Rio de Janeiro|Ministry of Science and Technology, Brazil|National Research Council, Brazil|ATCGen|Complexo Hospitalar Municipal de São Caetano do Sul|Hospital de Transplante Doutor Euryclides de Jesus Zerbini|Secretaria Municipal de Saúde de Bauru|Santa Casa de Misericórdia de Sorocaba|Secretaria Municipal de Saúde de Guarulhos|Hospital e Maternidade Therezinha de Jesus|Secretaria de Estado de Saúde do Distrito Federal",All,"18 Years and older   (Adult, Older Adult)",392.0,Other,Interventional,2020-08-06,20/08/20,2020-05-09,17/09/20,03/11/20,"Universidade Federal do Rio de Janeiro, Rio De Janeiro",Brazil,Respiratory Diseases,1,2,-89.0
1738.0,NCT04424771,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,,Completed,COVID-19,Post Traumatic Stress Disorder,,,,,,Behavioral: Maslach Burnout Inventory (MBI),Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,All,"18 Years to 70 Years   (Adult, Older Adult)",800.0,Other,Observational,2020-01-03,30/06/20,2020-01-07,11/06/20,27/07/20,"Ospedale Perrino Asl Brindisi, Brindisi, Italy|Piazza della Vittoria 14 Studio medico - Ginecologia e Ostetricia, Genoa",Italy,"Mental Health, Respiratory Diseases",1,2,4.0
1739.0,NCT04709146,The Influence of Covid-19 on the Audio-vestibular System,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Audio-Vestibular evaluation,"HaEmek Medical Center, Israel",All,"18 Years to 80 Years   (Adult, Older Adult)",70.0,Other,Interventional,2021-01-03,28/02/22,2022-06-30,14/01/21,14/01/21,,,Respiratory Diseases,1,1,543.0
1740.0,NCT04372602,Duvelisib to Combat COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Duvelisib|Procedure: Peripheral blood draw|Drug: Placebo,"Washington University School of Medicine|Verastem, Inc.",All,"18 Years and older   (Adult, Older Adult)",28.0,Other|Industry,Interventional,2020-12-10,30/11/21,2022-04-30,04/05/20,10/02/21,"Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri",United States,Respiratory Diseases,1,1,506.0
1741.0,NCT04555005,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,,Completed,Mindfulness,COVID-19,Healthcare Worker,,,,,Other: Mindfulness based intervention,Instituto de Investigación Hospital Universitario La Paz|Hospital Universitario La Paz,All,"Child, Adult, Older Adult",1000.0,Other,Interventional,2020-10-03,26/04/20,2020-04-26,18/09/20,18/09/20,"La Paz University Hospital, Madrid",Spain,Respiratory Diseases,1,3,-160.0
1742.0,NCT04623255,Randomised Study of Plasma Exchange in Severe COVID-19,COVIPLEX,Recruiting,COVID-19,,,,,,,Drug: OCTAPLAS,"University College, London",All,"18 Years to 70 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-10-16,15/10/21,2021-01-11,10/11/20,10/11/20,"University College London Hospital, London",United Kingdom,Respiratory Diseases,1,1,87.0
1743.0,NCT04716569,Evaluation of Ivermectin Mucoadhesive Nanosuspension as Nasal Spray in Management of Early Covid-19,,Recruiting,COVID-19,,,,,,,Drug: intranasal ivermectin spray,South Valley University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-01-20,20/02/21,2021-03-20,20/01/21,17/03/21,"Zaky Aref, Qinā, Qina",Egypt,Respiratory Diseases,1,1,59.0
1744.0,NCT04329923,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),PATCH,Terminated,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate 400 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg twice a day|Drug: Hydroxychloroquine Sulfate 600 mg once a day|Drug: Placebo oral tablet,"Ravi Amaravadi, MD|University of Pennsylvania",All,"18 Years and older   (Adult, Older Adult)",173.0,Other,Interventional,2020-09-04,11/11/20,2020-11-13,01/04/20,10/12/20,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,70.0
1745.0,NCT04526405,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,ThalaCoV,Completed,Thalassemia Major,COVID-19,,,,,,Diagnostic Test: SARS-CoV-2 S1/S2 IgG,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",63.0,Other,Observational,2020-07-14,03/11/20,2020-03-11,25/08/20,09/11/20,"ASST Monza - Ospedale San Gerardo, Monza, MB",Italy,Respiratory Diseases,1,2,-125.0
1746.0,NCT04392531,Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19,,Recruiting,COVID-19,,,,,,,Drug: Cyclosporine|Drug: Standard treatment,Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz,All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-16,01/03/21,2021-01-03,19/05/20,10/02/21,"Complejo Hospitalario Universitario La Coruña, La Coruña, Galicia, Spain|Hospital Quiron La Coruña, La Coruña, Galicia, Spain|Hospital Rey Juan Carlos, Mostoles, Madrid, Spain|Hospital Infanta Elena, Valdemoro, Madrid, Spain|Hospital General de Villalba, Villalba, Madrid, Spain|Fundacion Jimenez Diaz, Madrid, Spain|Clinica Universitaria de Navarra, Madrid",Spain,Respiratory Diseases,1,1,262.0
1747.0,NCT04510467,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,MentCovid19RMD,Not yet recruiting,COVID-19,Systemic Autoimmune Disease,Inflammatory Rheumatism,Auto Inflammatory Diseases,,,,,"University Hospital, Lille|FAI²R (Auto-immune and auto-inflammatory rare diseases French network)",All,"18 Years and older   (Adult, Older Adult)",1313.0,Other,Observational,2021-01-01,01/08/21,2021-01-08,12/08/20,17/11/20,,,Respiratory Diseases,1,4,7.0
1748.0,NCT04509752,Dysphagia Management During COVID-19 Pandemic,,Recruiting,Dysphagia,COVID-19,,,,,,Other: Survey,Hacettepe University,All,25 Years to 60 Years   (Adult),50.0,Other,Observational,2020-08-10,15/02/21,2021-02-28,12/08/20,08/02/21,"Hacetttepe University, Ankara",Turkey,Respiratory Diseases,1,2,202.0
1749.0,NCT04527562,Colchicine in Moderate Symptomatic COVID-19 Patients,COLCOVIDBD,Completed,COVID-19,,,,,,,Drug: Colchicine|Drug: Placebo,Dhaka Medical College,All,"18 Years and older   (Adult, Older Adult)",299.0,Other,Interventional,2020-07-14,15/11/20,2020-10-12,26/08/20,11/01/21,"Dhaka Medical College Hospital, Dhaka-1000",Bangladesh,Respiratory Diseases,1,1,90.0
1750.0,NCT04695379,Follow-up of a Cohort of Patients With Myasthenic Syndrome and COVID-19 Infection,CO-MY-COVID,Recruiting,Myasthenia Gravis,,,,,,,,"University Hospital, Bordeaux",All,"1 Year to 99 Years   (Child, Adult, Older Adult)",150.0,Other,Observational,2020-05-26,26/11/22,2022-11-26,05/01/21,05/01/21,"CHU d'Angers, Angers, France|CHU de Bordeaux, Bordeaux, France|Hospices Civils de Lyon, Bron, France|APHP - Hopital Raymond Poincarré, Garches, France|CHRU de Lille, Lille, France|Assistance Publique Hôpitaux de Marseille, Marseille, France|CHU de Nantes, Nantes, France|APHP GH Pitié Salpétrière, Paris, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse",France,Others,0,1,914.0
1751.0,NCT04663906,Oral Isotretinoin and Covid-19 Infection,,Not yet recruiting,Isotretinoin Adverse Reaction,COVID-19,,,,,,,University of Aberdeen,All,"16 Years to 40 Years   (Child, Adult)",300.0,Other,Observational,2021-01-15,31/05/21,2021-05-31,11/12/20,11/12/20,,,Respiratory Diseases,1,2,136.0
1752.0,NCT04628000,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,,Recruiting,Vitamin D Deficiency,COVID-19,,,,,,Other: Vitamin D,Parkview Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-10-27,14/10/21,2022-04-14,13/11/20,16/11/20,"Parkview Medical Center, Pueblo, Colorado",United States,Respiratory Diseases,1,2,534.0
1753.0,NCT04715815,COVID-19 and Its Effects on Chronic Pain Patients,,Not yet recruiting,Chronic Pain,,,,,,,Other: No intervention (only interview),Prince of Songkla University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2021-01-02,01/12/21,2022-01-06,20/01/21,29/01/21,,,Others,0,1,369.0
1754.0,NCT04540393,AZD1222 Vaccine for the Prevention of COVID-19,,Suspended,COVID-19,,,,,,,Biological: AZD1222,AstraZeneca|Iqvia Pty Ltd|Covance,All,"18 Years to 130 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2020-02-09,11/05/21,2021-11-05,07/09/20,11/02/21,"Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, St. Petersburg",Russian Federation,Respiratory Diseases,1,1,635.0
1755.0,NCT04675281,Pathological Findings of Fatal COVID-19,HISTOCOVID,Recruiting,COVID-19,COVID-19,Pathology,Intensive Care Units,Respiratory Distress Syndrome,,,Other: 2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks,"Nantes University Hospital|National Research Agency, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-24,24/04/21,2021-04-24,19/12/20,19/12/20,"CH Amiens, Amiens, France|Angers University Hospital, Angers, France|CH Angoulême, Angoulême, France|CH Annecy, Annecy, France|Hopital Privé d'Antony, Antony, France|CH Argenteuil, Argenteuil, France|CH Belfort, Belfort, France|CHU Bordeaux, Bordeaux, France|Hopital Sainte Camille, Bry-sur-Marne, France|CH Cahors, Cahors, France|CH Cergy Pontoise, Cergy-Pontoise, France|CH Cholet, Cholet, France|CHU Clermont-Ferrand, Clermont-Ferrand, France|CH Compiègne-Noyon, Compiègne, France|CHD Vendée, La Roche-sur-Yon, France|Hopital Lyon Sud, Lyon, France|Hôpital Lyon Sud, Lyon, France|Marseille Hopital Nord APHM, Marseillette, France|CH Melun, Melun, France|CH Montélimar, Montélimar, France|Nantes University Hospital, Nantes, France|CHU Nice, Nice, France|CHR Orléans, Orléans, France|CH Ambroise Paré APHP, Paris, France|GHEF Marne La Vallée, Paris, France|Hopital Antoine Béclère APHP, Paris, France|Hopital Cochin APHP, Paris, France|Hopital Georges Pompidou APHP, Paris, France|Hopital La Pitié Salpetrière APHP, Paris, France|Hopital Louis Mourier APHP, Paris, France|Hopital Necker APHP, Paris, France|Hopital Saint-Antoine APHP, Paris, France|Hopital Saint-Louis APHP, Paris, France|CH Poissy, Poissy, France|Hopital Privé Claude Galien, Quincy-sous-Sénart, France|CH Reims, Reims, France|CHU Rennes, Rennes, France|CH Saint-Brieuc, Saint-Brieuc, France|CHU Saint-Etienne, Saint-Étienne, France|Hopital Foch, Suresnes, France|CHRU Tours, Tours, France|CH Troyes, Troyes, France|CH Vannes, Vannes, France|CH Versailles, Versailles",France,Respiratory Diseases,1,5,365.0
1756.0,NCT04377477,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),COLOR-19,Recruiting,COVID-19,,,,,,,Radiation: Single fraction whole lung radiotherapy,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,All,"50 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-10-05,10/08/21,2022-08-30,06/05/20,22/07/20,"Radiation Oncology Department, ASST SpedaliCivili, Brescia, Brescia",Italy,Respiratory Diseases,1,1,694.0
1757.0,NCT04636203,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,,Not yet recruiting,COVID-19,COVID-19,,,,,,,Neuromed IRCCS,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-12-15,15/09/21,2022-06-15,19/11/20,23/11/20,,,Respiratory Diseases,1,2,547.0
1758.0,NCT04375670,COVID19-FOIE National Observatory,,Recruiting,Liver Diseases,COVID-19,,,,,,,Assistance Publique - Hôpitaux de Paris|Association Française pour l'Etude du Foie (AFEF),All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-11-05,31/12/20,2020-12-31,05/05/20,21/05/20,"Ganne, Bondy",France,Respiratory Diseases,1,2,56.0
1759.0,NCT04745442,Pilot Study of Antithrombin as Prophylaxis of Acute Respiratory Distress Syndrome in Patients With COVID-19,,Completed,COVID-19,Severe Acute Respiratory Syndrome,Distress Respiratory Syndrome,,,,,Drug: Antithrombin + best available treatment|Drug: Best available treatment,Maimónides Biomedical Research Institute of Córdoba,All,"18 Years to 85 Years   (Adult, Older Adult)",48.0,Other,Interventional,2020-04-27,20/12/20,2021-01-15,09/02/21,09/02/21,"Hospital Universitario Reina Sofía, Córdoba",Spain,Respiratory Diseases,1,3,263.0
1760.0,NCT04315298,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,,Completed,COVID-19,,,,,,,Drug: Sarilumab|Drug: Placebo,Regeneron Pharmaceuticals|Sanofi,All,"18 Years and older   (Adult, Older Adult)",1912.0,Industry,Interventional,2020-03-18,24/07/20,2020-02-09,19/03/20,01/10/20,"Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Denver, Colorado, United States|Regeneron Study Site, New Haven, Connecticut, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Ann Arbor, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Edison, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Livingston, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, Elmhurst, New York, United States|Regeneron Study Site 1, Manhasset, New York, United States|Regeneron Study Site 2, Manhasset, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site 1, New York, New York, United States|Regeneron Study Site 2, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Stony Brook, New York, United States|Regeneron Study Site, Valhalla, New York, United States|Regeneron Study Site, Tulsa, Oklahoma, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Scranton, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Renton, Washington",United States,Respiratory Diseases,1,1,-38.0
1761.0,NCT04694612,Efficacy of Favipiravir in Treatment of Mild & Moderate COVID-19 Infection in Nepal,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Placebo|Drug: Remdesivir,Nepal Health Research Council,All,"18 Years to 80 Years   (Adult, Older Adult)",676.0,Other,Interventional,2021-01-01,31/03/21,2021-05-31,05/01/21,05/01/21,"Armed Police Force Hospital, Kathmandu, Bagmati, Nepal|Charak Memorial Hospital, Pokhara, Gandaki",Nepal,Respiratory Diseases,1,1,150.0
1762.0,NCT04434144,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,,Completed,Ivermectin,Hydroxychloroquine,COVID-19,,,,,Drug: Ivermectin + Doxycycline|Drug: Hydroxychloroquine + Azithromycin,"Upazila Health & Family Planning Officer's (UHFPO) Office, Chakoria, Cox's Bazar",All,"16 Years to 80 Years   (Child, Adult, Older Adult)",116.0,Other,Observational,2020-02-05,05/06/20,2020-05-06,16/06/20,16/06/20,"Chakoria Upazilla Health Complex, Cox's Bazar",Bangladesh,Respiratory Diseases,1,3,91.0
1763.0,NCT04492267,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,MICI-Covid-19,Recruiting,Inflammatory Bowel Disease,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-07-07,07/01/21,2021-07-01,30/07/20,30/07/20,"Service Hépato-Gastroentérologie et Assistance Nutritive Hôpitaux Univesitaires de Strasbourg, Strasbourg",France,Others,0,1,359.0
1764.0,NCT04498325,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",,Not yet recruiting,COVID-19,COVID-19,,,,,,"Drug: NT-I7|Drug: Placebo|Procedure: Blood for research purposes|Procedure: Blood for pharmacokinetic samples|Procedure: Nasopharyngeal, oropharyngeal, or saliva swab|Procedure: Blood for anti-drug antibody (ADA)",Washington University School of Medicine|NeoImmune Tech,All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Interventional,2021-04-30,31/01/22,2022-01-31,04/08/20,16/03/21,"Saint Louis University Hospital, Saint Louis, Missouri",United States,Respiratory Diseases,1,2,276.0
1765.0,NCT04350593,Dapagliflozin in Respiratory Failure in Patients With COVID-19,DARE-19,"Active, not recruiting",COVID-19,,,,,,,Drug: Dapagliflozin 10 MG|Drug: Placebo,Saint Luke's Health System|Saint Luke's Hospital of Kansas City|AstraZeneca|George Clinical Pty Ltd,All,"18 Years and older   (Adult, Older Adult)",1250.0,Other|Industry,Interventional,2020-04-22,01/04/21,2021-01-06,17/04/20,28/01/21,"Heart Group of the Eastern Shore, Fairhope, Alabama, United States|Baptist Hospital of Miami, Miami, Florida, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Loyola University, Maywood, Illinois, United States|Ascension - St. Vincent, Indianapolis, Indiana, United States|Lahey Health, Burlington, Massachusetts, United States|McLaren Health Care, Auburn Hills, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Jacobi Medical Center, Bronx, New York, United States|SUNY Downstate Medical Center, Brooklyn, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|St. Francis Hospital, Roslyn, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Lancaster General Hospital, Lancaster, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Clinical Trials Network of Tennessee, Memphis, Tennessee, United States|DHR Health Institute for Research and Development, Edinburg, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Sentara Healthcare, Norfolk, Virginia, United States|Fundación Favaloro, Buenos Aires, Argentina|Hospital Español, Buenos Aires, Argentina|Hospital Fernández, Buenos Aires, Argentina|Hospital Pirovano, Buenos Aires, Argentina|Hospital Santojanni, Buenos Aires, Argentina|Sanatorio Anchorena, Buenos Aires, Argentina|Sanatorio Güemes, Buenos Aires, Argentina|Hospital San Roque, Córdoba, Argentina|Sanatorio Privado Duarte Quiros, Córdoba, Argentina|Centro de Pesquisa Dr. Marco Mota, Maceió, Alagoas, Brazil|Hospital EMEC e Hospital da Cidade, Feira de Santana, Bahia, Brazil|Hospital e Clínica São Roque, Ipiaú, Bahia, Brazil|Hospital Regional Deputado Luis Eduardo Magalhães, Porto Seguro, Bahia, Brazil|Hospital Cárdio Pulmonar, Salvador, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Unimed de Fortaleza, Fortaleza, Ceará, Brazil|Hospital de Messejana dr Carlos Alberto Studart Gomes, Fortaleza, Ceará, Brazil|Hospital Coração do Brasil, Brasília, Distrito Federal, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, Espírito Santo, Brazil|Liga de Hipertensão Arterial, Goiania, Goias, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Gerais, Brazil|Hospital São Domingos - Unimed Uberaba, Uberaba, Minas Gerais, Brazil|PROCAPE, Recife, Pernambuco, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Mãe de Deus, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São José - Criciuma, Criciuma, Santa Catarina, Brazil|IPEMI- Instituto de Pesquisas Médicas de Itajaí, Itajai, Santa Catarina, Brazil|Hospital Municipal São José, Joinville, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Centro de Pesquisa Clínica do Coração, Aracaju, Sergipe, Brazil|Faculdade de Medicina de Botucatu, UNESP, Botucatu, São Paulo, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, São Paulo, Brazil|Unimed Ribeirao Preto, Ribeirão Preto, São Paulo, Brazil|Fundação do ABC (Hospital Estadual Mário Covas), Santo André, São Paulo, Brazil|Centro Integrado de Pesquisas, São José do Rio Preto, São Paulo, Brazil|Santa Casa de Votuporanga, Votuporanga, São Paulo, Brazil|Fundação Pio XII, Barretos, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|InCor - Instituto do Coração do Hospital das Clínicas FMUSP, São Paulo, Brazil|Halton Healthcare Services, Oakville, Ontario, Canada|Lakeridge Health, Oshawa, Ontario, Canada|CIMS Hospital Pvt. Ltd, Sola, Ahmedabad, India|All India Institute of Medical Science, New Delhi, Delhi, India|Lokmanya Tilak General Hospital, Mumbai, Maharashtra, India|Max Smart Super Speciality Hospital, Saket, New Delhi, India|Max Super Speciality Hospital (A unit of Devki Devi Foundation), Saket, New Delhi, India|Dayanand Medical College & Hospital, Ludhiāna, Punjab, India|Grupo Medico del Prado, Acapulco, Mexico|Icaro, Chihuahua, Mexico|Hospital General de Cuernavaca, Cuernavaca, Mexico|JM Research, Cuernavaca, Mexico|Instituto de Investigaciones Aplicadas, Durango, Mexico|Hospital Civil, Guadalajara, Mexico|Hospital San Javier, Guadalajara, Mexico|Invesclinica Mx, Guanajuato, Mexico|CIMEZAP, Jalisco, Mexico|Medica Sur, Mexico City, Mexico|Clinica Nova, Monterrey, Mexico|Hospital San Jose, Monterrey, Mexico|Estudios Clinicos Internacionales, Puebla, Mexico|Hospital SMIQ, Queretaro, Mexico|Investigacion Medica, Sonora, Mexico|Sanatorio Santa Cruz, Toluca, Mexico|Addenbrooke's Hospital, Cambridge, Cb2 0qq",United Kingdom,Respiratory Diseases,1,1,259.0
1766.0,NCT04377308,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,,Recruiting,COVID-19,Cytokine Storm,,,,,,Drug: Fluoxetine,University of Toledo Health Science Campus,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-01-05,20/04/21,2021-10-20,06/05/20,06/05/20,"University of Toledo, Toledo, Ohio",United States,Respiratory Diseases,1,2,654.0
1767.0,NCT04501952,Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,,"Active, not recruiting",COVID-19,,,,,,,Drug: RDV|Drug: Placebo to Match RDV,Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",585.0,Industry,Interventional,2020-09-18,01/05/21,2021-01-05,06/08/20,14/04/21,"Arizona Liver Health, Chandler, Arizona, United States|Arizona Clinical Trials, Tucson, Arizona, United States|St Joseph Hospital Eureka, Eureka, California, United States|St. Joseph Heritage Healthcare, Fullerton, California, United States|Elevated Health, Huntington Beach, California, United States|Ruane Clinical Research Group, Los Angeles, California, United States|LA Universal Center, INC., Los Angeles, California, United States|Mills Clinical Research, Los Angeles, California, United States|Kaiser Permanente Northern California, Oakland, California, United States|FOMAT Medical Research, Oxnard, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Northern California, 6600 Bruceville Road, Sacramento, California, United States|Kaiser Permanente Northern California, 2025 Morse Ave, Sacramento, California, United States|Kaiser Permanente Northern California, 1200 El Camino Real, San Francisco, California, United States|Kaiser Permanente Northern California, 2425 Geary Blvd, San Francisco, California, United States|UCSF Medical Center, San Francisco, California, United States|Kaiser Permanente Northern California, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Northern California, 2500 Merced St, San Leandro, California, United States|St. Joseph Heritage Healthcare, Santa Rosa, California, United States|Premiere Medical Center of Burbank, Inc, Toluca Lake, California, United States|Kaiser Permanente Northern California, 975 Sereno Drive, Vallejo, California, United States|New Hope Research Development DBA HCD, Whittier, California, United States|Centura Health Porter Place, Denver, Colorado, United States|Nuvance Health, Danbury, Connecticut, United States|RecioMed Clinical Research Network, Boynton Beach, Florida, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|Invesclinic, Fort Lauderdale, Florida, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Evolution Clinical Trials, Hialeah Gardens, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States|L&C Professional Medical Research Institute, Miami, Florida, United States|Laguna Clinical Research Associates, Miami, Florida, United States|CTMD Research, Inc, Palm Springs, Florida, United States|IMIC Inc, Palmetto Bay, Florida, United States|Luminous Clinical Research - South Florida Urgent Care, Pembroke Pines, Florida, United States|St. Josephs Comprehensive Research Institute, Tampa, Florida, United States|AIDS Research and Treatment Center of the Treasure Coast, Vero Beach, Florida, United States|Triple O Research Institute PA, West Palm Beach, Florida, United States|Agile Clinical Research Trials, Atlanta, Georgia, United States|Mercer University School of Medicine, Macon, Georgia, United States|Infectious Disease Associates of Kansas City, P.C.Infectious Disease Associates of Kansas City, P.C., Burr Ridge, Illinois, United States|Metro Infectious Disease Consultants, Burr Ridge, Illinois, United States|NorthStar Medical Center, Chicago, Illinois, United States|NorthShore University Healthsystem, Evanston, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Holy Cross Hospital, Inc., Baltimore, Maryland, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|South Shore Hospital, South Weymouth, Massachusetts, United States|VA Boston Healthcare System, West Roxbury, Massachusetts, United States|Be Well Medical Center, Berkley, Michigan, United States|Onyx Research Institute, Flint, Michigan, United States|Memorial Hospital of Gulfport, Gulfport, Mississippi, United States|Metro Infectious Disease Consultants, Kansas City, Missouri, United States|Quality Clinical Research Inc., Omaha, Nebraska, United States|AB Clinical Trials, Las Vegas, Nevada, United States|AXCES Research Group, Santa Fe, New Mexico, United States|New York Presbyterian Hospital, Flushing, New York, United States|Northwell Health, New Hyde Park, New York, United States|Atrium Health Carolinas Medical Center, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Rosedale Infectious Diseases, Huntersville, North Carolina, United States|Christ Hospital, Cincinnati, Ohio, United States|Cherokee Nation WW Hastings Hospital, Tahlequah, Oklahoma, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Temple University, Philadelphia, Pennsylvania, United States|Avera Research Institute, Sioux Falls, South Dakota, United States|University of Tennessee Health Science Center, Knoxville, Tennessee, United States|Central Texas Clinical Research, Austin, Texas, United States|UT Physicians, Bellaire, Texas, United States|Baylor University Medical Center, 700 Scott and White Dr., College Station, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Care United Research, LLC, Forney, Texas, United States|VIP Trials, Harlingen, Texas, United States|University of Texas, Houston, Texas, United States|The Crofoot Research Center, Inc, Houston, Texas, United States|Baylor University Medical Center, 1901 North McArthur Blvd, Irving, Texas, United States|Laguna Clinical Research Associates, Laredo, Texas, United States|Diagnostic Clinic of Longview - Center for Clinical Research, Longview, Texas, United States|STAAMP Research, San Antonio, Texas, United States|Sugar Lakes Family Practice, Sugar Land, Texas, United States|Baylor University Medical Center, 2201 MacArthur Dr., Suite 100, Waco, Texas, United States|ClinPoint Trials, Waxahachie, Texas, United States|Intermountain Healthcare, Murray, Utah, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Sound Medical Research, Port Orchard, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Providence Medical Research Center, Spokane, Washington, United States|Wisconsin Corporation for Biomedical Research, Milwaukee, Wisconsin, United States|Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Aarhus N, Denmark|Rigshospitalet, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense University Hospital, Odense, Denmark|Hospital Senhora da Oliveira, Guimaraes, Portugal|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom|University College Hospital, London, United Kingdom|St Mary's Hospital, London, United Kingdom|Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne",United Kingdom,Respiratory Diseases,1,1,109.0
1768.0,NCT04595240,Semen Analysis Changes in Covid-19 Positivepatients,,Completed,COVID-19,,,,,,,Diagnostic Test: semen analysis,Assiut University,Male,20 Years to 45 Years   (Adult),100.0,Other,Observational,2020-01-05,15/10/20,2020-10-15,20/10/20,20/10/20,"Mostafa Kamel, Assiut",Egypt,Respiratory Diseases,1,1,284.0
1769.0,NCT04714515,Montelukast - a Treatment Choice for COVID-19,,Completed,COVID-19,COVID-19,,,,,,Drug: Montelukast|Drug: Hydroxychloroquine|Drug: Ivermectin,"University of Sargodha|Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine|Shaukat Khanum Memorial Cancer Hospital & Research Centre|Shanghai Jiao Tong University School of Medicine|Teesside University",All,"20 Years to 80 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-02-20,30/03/20,2020-04-20,19/01/21,19/01/21,"Department of Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China, Shanghai, China|Shaukat Khanum Memorial Cancer Hospital & Research Centre, Johar Town, Lahore, Pakistan, Lahore, Punjab",Pakistan,Respiratory Diseases,1,2,60.0
1770.0,NCT04380519,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),,Completed,COVID-19,,,,,,,Biological: RPH-104 80 mg|Drug: Olokizumab 64 mg|Drug: Placebo,"R-Pharm International, LLC|Data Management 365 LLC|K-Research, LLC|R-Pharm",All,"18 Years to 100 Years   (Adult, Older Adult)",372.0,Industry|Other,Interventional,2020-04-23,10/07/20,2020-07-24,08/05/20,29/09/20,"Federal State Budget Institution National Medical Surgery Center named after N.I. Pirogov of Ministry of Health of Russian Federation, Moscow, Russian Federation|State Budget Healthcare Institution City Clinical Hospital № 15 named after O.M. Filatov of Moscow City Healthcare Department, Moscow, Russian Federation|Federal State Budgetary Institution Federal Center for Cerebrovascular Pathology and Stroke of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Federal State Autonomous Education Insitution of High Education the First Moscow State Medical University named after I.M. Sechenov of Ministry of Healthcare of Russian Federation (Sechenov University), Moscow, Russian Federation|Federal State Budget Institution National Medicine Research Center on Cardiology By Ministry of Healthcare of Russian Federation, Moscow, Russian Federation|State Budget Institution of Healthcare City Clinical Hospital #52, Moscow City Healthcare Department, Moscow, Russian Federation|Moscow State Budget Institution of Healthcare Scientific Research Institute of Emergency Medicine named after N.V. Sklifosovsky of Moscow Department of Healthcare, Moscow, Russian Federation|State Budget Healthcare Institution City Clinical Hospital #40, Moscow City Healthcare Department, Communarca Division, Moscow, Russian Federation|АО State Company Medsi based on Clinical Hospital №1, Moscow, Russian Federation|Saint Petersburg State Budget Institution of Healthcare Clinical infectious diseases hospital named after S.P. Botkin, Saint Petersburg, Russian Federation|Saint-Petersburg State Budget Institution of Healthcare City Hospital №40, Saint Petersburg",Russian Federation,Respiratory Diseases,1,1,92.0
1771.0,NCT04561089,Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: COVIDSeq Test,"Illumina, Inc.|Helix OpCo, LLC",All,"18 Years and older   (Adult, Older Adult)",2000.0,Industry|Other,Observational,2020-02-13,28/02/21,2021-04-30,23/09/20,16/02/21,"Illumina Laboratory Services, Foster City, California, United States|Illumina Hayward, Hayward, California, United States|Illumina Laboratory Services, San Diego, California",United States,Respiratory Diseases,1,1,442.0
1772.0,NCT04425538,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,,Completed,COVID-19,,,,,,,Drug: Infliximab,Tufts Medical Center|National Institutes of Health (NIH),All,"18 Years and older   (Adult, Older Adult)",17.0,Other|NIH,Interventional,2020-01-06,22/01/21,2021-01-22,11/06/20,18/02/21,"Tufts Medical Center, Boston, Massachusetts",United States,Respiratory Diseases,1,1,382.0
1773.0,NCT04413747,Yoga Pranayama Adjuvant to Treat Burden COVID-19,YOCO,Not yet recruiting,Coronavirus Infection,Cytokine Storm,Mental Disorder,,,,,Behavioral: morning Yoga-based breathing support|Behavioral: pre_lunch Yoga-based breathing support|Behavioral: pre_dinner Yoga-based breathing support,"Health Ricerca e Sviluppo S.R.L.|Swami Vivekananda Yoga Anusandhana Samsthana, Bangaluru , India|Yoga Experience Association,Cervia (Ra), Italy|EJTN GEIE, Brussellese, Belgium|Casa di Riposo e Ambulatorio Giardino St Lucia, Massa Lomabarda (Ra) Italy|Halnet Srl, Faenza (Ra), Italy",All,"18 Years to 75 Years   (Adult, Older Adult)",1000.0,Industry|Other,Interventional,2020-08-15,01/06/21,2021-09-30,04/06/20,07/08/20,"Ambulatorio Telemedicina Giardino St Lucia, Massa Lombarda, Ravenna",Italy,Respiratory Diseases,1,3,411.0
1774.0,NCT04333407,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,C-19-ACS,Recruiting,COVID-19,,,,,,,Drug: Aspirin 75mg|Drug: Clopidogrel 75mg|Drug: Rivaroxaban 2.5 MG|Drug: Atorvastatin 40mg|Drug: Omeprazole 20mg,Imperial College London,All,"18 Years to 85 Years   (Adult, Older Adult)",3170.0,Other,Interventional,2020-03-04,30/03/21,2021-03-30,03/04/20,09/04/20,"Charing Cross Hospital, London",United Kingdom,Respiratory Diseases,1,1,391.0
1775.0,NCT04352946,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,HERO,Not yet recruiting,Prophylaxis,COVID-19,Health Care Worker,Hydroxychloroquine,,,,Drug: Hydroxychloroquine Pre-Exposure Prophylaxis|Drug: Placebo oral tablet,GeoSentinel Foundation,All,"18 Years and older   (Adult, Older Adult)",374.0,Other,Interventional,2020-04-24,24/06/20,2020-08-24,20/04/20,22/04/20,"The New York Center for Travel and Tropical Medicine, New York, New York",United States,Respiratory Diseases,1,4,122.0
1776.0,NCT04327570,In-depth Immunological Investigation of COVID-19.,COntAGIouS,Recruiting,Coronavirus Infections,,,,,,,Other: Patient sampling,Universitaire Ziekenhuizen Leuven,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-27,30/09/20,2020-09-30,31/03/20,29/05/20,"UZ Leuven, Leuven",Belgium,Respiratory Diseases,1,1,187.0
1777.0,NCT04516915,IMU-838 and Oseltamivir in the Treatment of COVID-19,IONIC,Recruiting,COVID-19,,,,,,,Drug: IMU-838|Drug: Oseltamivir,University Hospitals Coventry and Warwickshire NHS Trust|Immunic AG|University of Warwick|MODEPHARMA,All,"18 Years to 90 Years   (Adult, Older Adult)",120.0,Other|Industry,Interventional,2020-06-15,01/05/21,2021-01-07,18/08/20,21/08/20,"University Hospital Coventry and Warwickshire NHS Trust, Coventry, West Midlands",United Kingdom,Respiratory Diseases,1,1,206.0
1778.0,NCT04363541,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,TherMoCoV,Recruiting,COVID-19,Thermotherapy,,,,,,Device: Electric pad for human external pain therapy,"Instituto Nacional de Perinatologia|Direccion General de Calidad y Educacion en Salud|Instituto Mexicano del Seguro Social|Hospital Regional de Alta Especialidad Juan Graham Tabasco|Hospital Dr. Ángel Leaño|National Polytechnic Institute, Mexico|Universidad Juárez Autónoma de Tabasco",All,"18 Years and older   (Adult, Older Adult)",274.0,Other,Interventional,2020-08-27,01/04/22,2022-01-06,27/04/20,05/11/20,"Hospital Dr. Ángel Leaño, Guadalajara, Jalisco, Mexico|Hospital Regional de Alta Especialidad Dr. Juan Graham Casasus, Villahermosa, Tabasco, Mexico|Unidad Temporal Movil COVID-19 Autódromo Hermanos Rodríguez IMSS, Mexico City",Mexico,Respiratory Diseases,1,2,497.0
1779.0,NCT04385121,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Familles-COVID,Recruiting,COVID-19,"Stress Disorders, Post-Traumatic",Anxiety,Depression,,,,Other: Questionnary,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-04-16,16/04/20,2021-01-03,12/05/20,21/07/20,"Les Hôpitaux Universitaires de Strasbourg, Strasbourg",France,"Mental Health, Respiratory Diseases",1,4,262.0
1780.0,NCT04528667,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,,Recruiting,COVID-19,,,,,,,Drug: STI-5656|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",400.0,Industry,Interventional,2021-06-01,01/05/21,2021-01-05,27/08/20,01/02/21,"Hospital e Maternidade Christovão da Gama, Santo André, SP",Brazil,Respiratory Diseases,1,1,-147.0
1781.0,NCT04344327,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,CCF,Completed,Infection Viral,"Infection, Hospital",COVID-19,,,,,,"French Cardiology Society|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",2878.0,Other,Observational,2020-10-04,21/04/20,2020-04-21,14/04/20,28/04/20,"CHU d'Amiens, Amiens, France|CHU Annecy, Annecy, France|CHU de Bordeaux, Bordeaux, France|CHU de Caen, Caen, France|Cotentin hospital, Cherbourg, France|CHU Dijon, Dijon, France|Elbeuf Louviers Val de Reuil, Elbeuf, France|CHU de Fréjus / Saint-Raphael, Fréjus, France|Lille Catholic Institute Hospital Group, Lille, Lille, France|CHU de Lyon, Lyon, France|APHM, Marseille, France|Jacques Cartier Private Hospital, Massy, Massy, France|CHR d'Orléans, Orléans, France|Bichat (APHP), Paris, France|Georges Pompidou European Hospital (AP-HP), Paris, France|Institut Mutualiste Montsouris, Paris, Paris, France|CHU de Reims, Reims, France|CHU de Rouen, Rouen, France|CHU Saint Etienne, Saint-Étienne, France|CHU de Strasbourg, Strasbourg, France|CHU de Toulouse, Toulouse, France|Saint Gatien hospital, Tours, France|CHU de Nancy, Vandœuvre-lès-Nancy",France,Respiratory Diseases,1,3,-166.0
1782.0,NCT04345848,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,COVID-HEP,Recruiting,COVID-19,Sars-CoV2,,,,,,Drug: Enoxaparin,"University Hospital, Geneva",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-28,31/03/21,2021-03-31,15/04/20,23/12/20,"Geneva University Hospitals, Geneva, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Locarno, Locarno, Switzerland|Hôpital du Valais, Sion",Switzerland,Respiratory Diseases,1,2,337.0
1783.0,NCT04344197,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",,Completed,Surgery,COVID-19,Asymptomatic Patient,COVID-19,Preventive Measures,,,Other: global survey,University of Rome Tor Vergata,All,"Child, Adult, Older Adult",1200.0,Other,Observational,2020-02-04,08/04/20,2020-04-15,14/04/20,29/12/20,"Tor Vergata Hospital, Rome",Italy,Respiratory Diseases,1,5,71.0
1784.0,NCT04657497,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: FOY-305|Drug: Placebo,Ono Pharmaceutical Co. Ltd,All,"18 Years and older   (Adult, Older Adult)",110.0,Industry,Interventional,2020-09-11,31/05/21,2021-05-31,08/12/20,11/03/21,"Aichi Clinical Site 1, Tokoname, Aichi, Japan|Chiba Clinical Site 1, Narita, Chiba, Japan|Fukuoka Clinical Site 1, Okawa, Fukuoka, Japan|Ibaraki Clinical Site 1, Tsuchiura, Ibaraki, Japan|Ishikawa Clinical Site 1, Kanazawa, Ishikawa, Japan|Kanagawa Clinical Site 3, Kawasaki, Kanagawa, Japan|Kanagawa Clinical Site 1, Yokohama, Kanagawa, Japan|Kanagawa Clinical Site 2, Yokosuka, Kanagawa, Japan|Mie Clinical Site 1, Yokkaichi, Mie, Japan|Niigata Clinical Site 1, Nagaoka, Niigata, Japan|Osaka Clinical Site 2, Daito, Osaka, Japan|Saitama Clinical Site 3, Kawagoe, Saitama, Japan|Saitama Clinical Site 1, Kuki, Saitama, Japan|Saitama Clinical Site 2, Kumagaya, Saitama, Japan|Tokyo Clinical Site 5, Bunkyo-ku, Tokyo, Japan|Tokyo Clinical Site 9, Bunkyo-ku, Tokyo, Japan|Tokyo Clinical Site1, Hachioji, Tokyo, Japan|Tokyo Clinical Site 7, Itabashi-ku, Tokyo, Japan|Tokyo Clinical Site 3, Meguro-ku, Tokyo, Japan|Tokyo Clinical Site 4, Shinagawa-ku, Tokyo, Japan|Tokyo Clinical Site 8, Sibuya-ku, Tokyo, Japan|Tokyo Clinical Site2, Sibuya-ku, Tokyo, Japan|Tokyo Clinical Site 6, Tachikawa, Tokyo, Japan|Okayama Clinical Site 1, Okayama, Japan|Osaka Clinical Site 1, Osaka",Japan,Respiratory Diseases,1,1,262.0
1785.0,NCT04365699,Cardiovascular Effects of COVID-19,,Completed,COVID-19,,,,,,,Drug: AT-001,NYU Langone Health,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-08-04,31/01/21,2021-01-31,28/04/20,24/02/21,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,180.0
1786.0,NCT04363060,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,AziA,Not yet recruiting,COVID-19,,,,,,,Combination Product: Azithromycin with amoxicillin/clavulanate|Drug: amoxicillin/clavulanate,Nantes University Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",104.0,Other,Interventional,2020-04-30,30/07/20,2020-07-30,27/04/20,29/04/20,"Chu Angers, Angers, France|CHD Vendée, La Roche-sur-Yon, France|CHU Poitiers, Poitiers",France,Respiratory Diseases,1,1,91.0
1787.0,NCT04354441,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,HyPreC,Withdrawn,COVID-19,COVID-19,Pregnant Women,Hydroxychloroquine,,,,Drug: hydroxychloroquine sulfate 200 MG|Drug: Placebo oral tablet,Sir Mortimer B. Davis - Jewish General Hospital,Female,18 Years to 50 Years   (Adult),0.0,Other,Interventional,2020-01-05,01/05/20,2020-01-05,21/04/20,25/06/20,,,Respiratory Diseases,1,4,0.0
1788.0,NCT04365634,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,,Completed,COVID-19,,,,,,,,Tongji Hospital,All,"Child, Adult, Older Adult",306.0,Other,Observational,2020-02-02,15/03/20,2020-01-04,28/04/20,28/04/20,"Tongji Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,1,-29.0
1789.0,NCT04613310,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),RaDiCo,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Rapid Diagnostic Test vs PCR,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland|Centre Hospitalier Universitaire Vaudois",All,"18 Years and older   (Adult, Older Adult)",1250.0,Other,Interventional,2020-09-25,31/12/20,2020-12-31,03/11/20,12/11/20,"Unisanté, Lausanne, Vaud",Switzerland,Respiratory Diseases,1,2,97.0
1790.0,NCT04551690,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),CONSCIENCE,Completed,Pregnancy,COVID-19,Labor (Obstetrics)--Complications,Demography,,,,,"Hospital San Juan de Dios, Santiago",Female,18 Years to 45 Years   (Adult),720.0,Other,Observational,2020-04-15,15/07/20,2020-07-15,16/09/20,16/09/20,"Hospital San Juan de Dios, Santiago",Chile,Respiratory Diseases,1,4,91.0
1791.0,NCT04805970,REsearching Covid-19 Outcomes in Diabetes (RECODE),RECODE,Recruiting,COVID-19,Diabetes,,,,,,,"Translational Research Institute for Metabolism and Diabetes, Florida",All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Observational,2021-01-04,01/01/22,2022-01-01,18/03/21,08/04/21,"AdventHealth Translational Research Institute, Orlando, Florida",United States,"Metabolic Disorders, Respiratory Diseases",1,2,362.0
1792.0,NCT04454372,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Other: demographic and clinical data obtained from hospital's electronic medical record.,Hospital Sao Domingos,All,"1 Year and older   (Child, Adult, Older Adult)",187.0,Other,Observational,2020-07-15,20/09/20,2020-11-30,01/07/20,02/07/20,,,Respiratory Diseases,1,1,138.0
1793.0,NCT04456556,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),,Completed,Endophthalmitis and Orbital Cellulitis,,,,,,,,Minia University,All,"Child, Adult, Older Adult",5.0,Other,Observational,2020-04-27,20/06/20,2020-06-30,02/07/20,02/07/20,"Minia university Hospital, Minya, Minia",Egypt,Others,0,1,64.0
1794.0,NCT04782700,P-Co-Li (Pulmonary Covid-19 Study),,Recruiting,COVID-19,Lung Inflammation,Hypoxemic Respiratory Failure,,,,,Other: Steroid Taper (Prednisone),Northwell Health,All,"18 Years and older   (Adult, Older Adult)",522.0,Other,Interventional,2021-03-15,03/03/25,2025-03-03,04/03/21,04/03/21,"Northwell Health, Manhasset, New York",United States,Respiratory Diseases,1,3,1449.0
1795.0,NCT04418544,Vocal Feature Analysis Algorithm for COVID-19 Detection,,Recruiting,COVID-19,,,,,,,Device: Device used to record voice for screening,Soniphi LLC|UserWise,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|Other,Observational,2020-01-06,01/12/20,2020-01-12,05/06/20,30/10/20,"Soniphi, Sebastopol, California",United States,Respiratory Diseases,1,1,6.0
1796.0,NCT04632602,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,ProneSpontCov,Recruiting,Respiratory Failure,,,,,,,Other: physiological effects of awake prone position in COVID 19 patients,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-04,31/12/20,2021-01-31,17/11/20,17/11/20,"Assistance Publique Höpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,302.0
1797.0,NCT04729452,Characterisation of the Immune Response to SARS-CoV-2,,Recruiting,COVID-19,,,,,,,Other: blood test,Lucy Jones|Cardiff University|University of Oxford|Cwm Taf University Health Board (NHS),All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,01/10/23,2023-01-12,28/01/21,28/01/21,"Cwm Taf Morgannwg University Health board, Llantrisant, Rhondda Cynon Taf",United Kingdom,Respiratory Diseases,1,1,1102.0
1798.0,NCT04384926,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,CovidSurg-Can,Recruiting,COVID-19,Coronavirus,Cancer,Surgery,,,,Procedure: Elective Cancer Surgery,University of Birmingham,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-30,31/12/20,2020-12-31,12/05/20,12/05/20,"Hospital del Henares, Madrid",Spain,"Respiratory Diseases, Cancers",1,4,276.0
1799.0,NCT04715932,Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN),Hesperidin,Recruiting,COVID-19,Anosmia,Fever,Cough,Shortness of Breath,Sore Throat,Nausea,Drug: Hesperidin|Drug: Placebo,Montreal Heart Institute|Ingenew Pharmaceuticals Inc.,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2021-02-18,01/05/21,2021-01-05,20/01/21,11/03/21,"Montreal Heart Institute, Montréal, Quebec",Canada,Respiratory Diseases,1,7,-44.0
1800.0,NCT04734886,The Effect of Probiotic Supplementation on SARS-CoV-2 Antibody Response After COVID-19,,Recruiting,COVID-19,,,,,,,Dietary Supplement: L. reuteri DSM 17938 + vitamin D|Dietary Supplement: Placebo + vitamin D,"Örebro University, Sweden|BioGaia AB",All,18 Years to 60 Years   (Adult),400.0,Other|Industry,Interventional,2020-11-27,30/08/21,2021-12-31,02/02/21,02/02/21,"Örebro University, Örebro, Örebro Län",Sweden,Respiratory Diseases,1,1,399.0
1801.0,NCT04346628,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,,"Active, not recruiting",Sars-CoV2,COVID-19,,,,,,Drug: Favipiravir|Drug: Placebo|Other: Standard of care treatment,Stanford University,All,"18 Years and older   (Adult, Older Adult)",149.0,Other,Interventional,2020-12-07,01/04/21,2021-01-04,15/04/20,30/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,2,28.0
1802.0,NCT04786041,the Impact of COVID-19 Pandemic on the Incidence and Outcome of Complicated Appendicitis,,Completed,COVID-19,Appendicitis,,,,,,Procedure: laparoscopic appendectomy,Meir Medical Center,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-03,30/05/20,2020-05-30,08/03/21,08/03/21,"Meir medical center, Kfar Saba",Israel,Respiratory Diseases,1,2,148.0
1803.0,NCT04470739,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,,Recruiting,COVID-19,Thymic Hypoplasia,,,,,,Diagnostic Test: chest x-ray,Kanuni Sultan Suleyman Training and Research Hospital,All,up to 7 Hours   (Child),20.0,Other,Interventional,2020-05-30,30/09/20,2020-10-30,14/07/20,14/07/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,153.0
1804.0,NCT04411511,"COVID-19, Obesity and Lifestyle in Children",COLC,Recruiting,COVID-19,"Obesity, Childhood",Lifestyle,"Lifestyle, Healthy","Overweight, Childhood","Children, Only",Family,Other: Exposure to the Dutch measures due to the Covid-19 pandemic.,Maastricht University Medical Center,All,4 Years to 17 Years   (Child),4000.0,Other,Observational,2020-06-05,06/11/21,2022-06-05,02/06/20,12/03/21,"Maastricht University Medical Center, Maastricht, Limburg",Netherlands,"Metabolic Disorders, Respiratory Diseases",1,7,730.0
1805.0,NCT04432922,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",,Completed,COVID-19,,,,,,,Other: Hospitalized Patients for COVID-19 Infection,Centre Hospitalier Intercommunal Creteil,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-01-11,15/11/20,2020-11-15,16/06/20,23/02/21,"Centre hospitalier intercommunal de Villeneuve St Georges, Villeneuve St Georges",France,Respiratory Diseases,1,1,309.0
1806.0,NCT04442087,Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP,FamilyPEDCOVID,Recruiting,SARS-CoV2,,,,,,,Biological: Serology SARS-CoV2|Behavioral: Data collection,Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",400.0,Other,Interventional,2020-06-19,01/09/21,2021-01-09,22/06/20,06/10/20,"Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital, Paris",France,Respiratory Diseases,1,1,204.0
1807.0,NCT04794088,Intravenous Imatinib in Mechanically Ventilated COVID-19 Patients,INVENT COVID,Recruiting,ARDS,Acute Respiratory Distress Syndrome,COVID-19,Endothelial Dysfunction,Pulmonary Edema,,,Drug: Imatinib Mesylate intravenous solution|Drug: Placebo,Dr. Jurjan Aman|Simbec Orion|Exvastat Ltd.|KABS laboratories|VU University Medical Center,All,"18 Years and older   (Adult, Older Adult)",90.0,Other|Industry,Interventional,2021-03-14,01/12/21,2022-01-02,11/03/21,24/03/21,"Amsterdam Universitair Medische Centra, location VUmc, Amsterdam, Noord-Holland, Netherlands|Amsterdam Universitair Medische Centra, location AMC, Amsterdam, Noord-Holland",Netherlands,Respiratory Diseases,1,5,294.0
1808.0,NCT04347382,Honey & Nigella Sativa Trial Against COVID-19,HNS-COVID-PK,Completed,Coronavirus Infection,Sars-CoV2,,,,,,Drug: Honey|Drug: Nigella Sativa / Black Cumin|Drug: Placebos,Sohaib Ashraf|Sheikh Zayed Federal Postgraduate Medical Institute,All,"18 Years and older   (Adult, Older Adult)",313.0,Other,Interventional,2020-04-30,30/08/20,2020-08-30,15/04/20,12/11/20,"Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital, Lahore, Punjab, Pakistan|Services Institute of Medical Sciences, Services Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,2,122.0
1809.0,NCT04661839,A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults,,Recruiting,COVID-19,,,,,,,Biological: COVID-HIGIV|Other: Placebo (saline),Emergent BioSolutions|United States Department of Defense,All,18 Years to 60 Years   (Adult),56.0,Industry|U.S. Fed,Interventional,2020-12-24,01/09/21,2021-01-09,10/12/20,10/02/21,"Icahn School of Medicine at Mount Sinai, New York, New York",United States,Respiratory Diseases,1,1,16.0
1810.0,NCT04584424,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,,Not yet recruiting,Epidemiology,Clinical,Nutritional-status,Immunologic Defect,,,,Other: The study does not required,"Ethiopian Public Health Institute|Netherlands: Ministry of Health, Welfare and Sports",All,"Child, Adult, Older Adult",6390.0,Other,Observational,2020-10-30,14/09/21,2021-11-14,14/10/20,14/10/20,"Saro Abdella, Addis Ababa",Ethiopia,Others,0,4,380.0
1811.0,NCT04422678,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: Imatinib Mesylate|Drug: Standard of Care,"Alexandria University|Science, Technology & Innovation Funding Authority (STIFA), Egypt",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-06,01/09/20,2020-01-10,09/06/20,09/06/20,,,Respiratory Diseases,1,1,4.0
1812.0,NCT04619407,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",COKITS,Completed,COVID-19,,,,,,,Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Serum testing,"University Medicine Greifswald|Ministry of Education, Science and Culture of the State of Mecklenburg-Vorpommern|Ministry of Social Affairs, Integration and Equality of the State of Mecklenburg-Vorpommern|State Office for Health and Social Affairs of the State of Mecklenburg-Vorpommern",All,"3 Years to 67 Years   (Child, Adult, Older Adult)",142.0,Other,Observational,2020-04-11,26/03/21,2021-03-26,06/11/20,14/04/21,"Greifswald University Medicine, Greifswald",Germany,Respiratory Diseases,1,1,349.0
1813.0,NCT04385108,Predictive Immune Biomarkers for COVID-19 Pathogenesis,COVIDBioToul,Recruiting,COVID-19,,,,,,,Biological: Blood collection on admission and longitudinally|Biological: Blood collection on their first consultation and 10 to 14 days later,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-04-03,31/12/21,2021-12-31,12/05/20,28/12/20,"Purpan University Hospital, Toulouse",France,Respiratory Diseases,1,1,637.0
1814.0,NCT04336904,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: Favipiravir|Other: Placebo,Giuliano Rizzardini|ASST Fatebenefratelli Sacco,All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-03-25,01/07/20,2020-01-07,07/04/20,08/04/20,"Asst Fatebenefratelli Sacco, Milano",Italy,Respiratory Diseases,1,1,-78.0
1815.0,NCT04475991,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,COMVIVIR,Not yet recruiting,COVID-19,,,,,,,Drug: Maraviroc + Currently used therapy|Procedure: Curently used therapy for COVID-19 non-critical patients|Drug: Favipiravir + Currently used therapy|Drug: Maraviroc+Favipiravir+CT,"Hospital General de México Dr. Eduardo Liceaga|CCINSHAE. Secretaría de Salud. México|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Centro de Investigación en. Enfermedades Infecciosas, Mexico",All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-05,01/07/21,2021-01-09,17/07/20,09/04/21,"Hospital General de México Dr. Eduardo Liceaga, Mexico City, Cdmx",Mexico,Respiratory Diseases,1,1,4.0
1816.0,NCT04668625,"Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures",,Completed,COVID-19,,,,,,,Behavioral: Participate in a massive musical event,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Dr. Bonaventura Clotet Sala|Dr. Josep Mª LLibre Codina|Dr. Boris Revollo Barriga|Dra. Lidia Ruiz Tabuenca|Dr. Ignacio Blanco Guillermo|Dra. Andrea Alemany Ortiz|Dr. Roger Paredes Deiros",All,18 Years to 59 Years   (Adult),1000.0,Other,Interventional,2020-11-30,20/12/20,2021-08-01,16/12/20,08/02/21,"Germans Trias i Pujol Hospital, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,244.0
1817.0,NCT04452422,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,VT-Covid-19,Recruiting,Deep Venous Thrombosis,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-06-23,23/09/20,2020-09-23,30/06/20,30/06/20,"Service Unité Neurovasculaire, Strasbourg",France,Others,0,1,92.0
1818.0,NCT04512300,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,,Cairo University,All,"Child, Adult, Older Adult",267.0,Other,Observational,2020-06-15,25/06/20,2020-06-25,13/08/20,13/08/20,"faculty of dentistry, Cairo university , Egypt, Cairo",Egypt,Respiratory Diseases,1,1,10.0
1819.0,NCT04547257,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,CP022,Not yet recruiting,COVID-19,,,,,,,Device: Seraph 100,ExThera Medical Europe BV|ExThera Medical Corporation,All,"18 Years to 90 Years   (Adult, Older Adult)",42.0,Industry,Interventional,2021-01-02,15/08/21,2021-10-15,14/09/20,06/01/21,"Carla Kikken-Jussen, Vaals, Limburg",Netherlands,Respiratory Diseases,1,1,286.0
1820.0,NCT04324866,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,,Not yet recruiting,Coronavirus Infection,,,,,,,Diagnostic Test: Nasopharyngeal swab,Universita di Verona|Azienda Ospedaliera Universitaria Integrata Verona,All,"18 Years to 75 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-01-04,01/11/20,2020-01-12,27/03/20,27/03/20,,,Respiratory Diseases,1,1,8.0
1821.0,NCT04446169,COVID-19 (SARS-CoV-2) in Urine and Semen,,"Active, not recruiting",SARS-CoV 2,Sexual Function and Fertility Disorders,Urinary Function Disorders,Urine,Semen,,,Diagnostic Test: SARS-CoV 2 RNA PCR Urine|Diagnostic Test: SARS-CoV 2 RNA PCR Semen|Diagnostic Test: Semen Qualitative Analysis|Diagnostic Test: IIEF-5 questionnaire|Diagnostic Test: Male Sexual Health Questionnaire (MSHQ)|Diagnostic Test: IPSS questionnaire|Diagnostic Test: SECRET questionnaire|Diagnostic Test: Interleukin assessment in semen,University of Florence|Azienda Ospedaliero-Universitaria Careggi,Male,"18 Years to 80 Years   (Adult, Older Adult)",43.0,Other,Observational,2020-06-27,01/09/20,2021-02-05,24/06/20,01/04/21,"AOU Careggi, Florence, Tuscany",Italy,Respiratory Diseases,1,5,223.0
1822.0,NCT04391400,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: nasal pharyngeal (NP) swab samples|Diagnostic Test: peripheral blood draw,"Invivoscribe, Inc.",All,"Child, Adult, Older Adult",500.0,Industry,Observational,2020-01-06,30/06/21,2021-06-30,18/05/20,18/05/20,,,Respiratory Diseases,1,1,541.0
1823.0,NCT04414410,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,ECHO-COVID,Enrolling by invitation,COVID-19,Sars-CoV2,,,,,,,Hospital Ambroise Paré Paris,All,"Child, Adult, Older Adult",1500.0,Other,Observational,2020-12-05,30/09/20,2020-09-30,04/06/20,04/06/20,"University Hospital Ambroise Pare, Boulogne-Billancourt, Hauts De Seine",France,Respiratory Diseases,1,2,-66.0
1824.0,NCT04462120,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,,"Active, not recruiting",COVID-19,,,,,,,,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-06-16,18/06/20,2020-07-30,08/07/20,08/07/20,"AssiutU, Assiut, Egypt|Assiut University Hospitals, Assiut",Egypt,Respiratory Diseases,1,1,44.0
1825.0,NCT04561024,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: AI model,"Ensemble Group Holdings, LLC",All,"18 Years to 120 Years   (Adult, Older Adult)",4000.0,Industry,Observational,2020-01-03,30/10/20,2020-12-31,23/09/20,24/09/20,"University of Hong Kong, Hong Kong",Hong Kong,Respiratory Diseases,1,1,363.0
1826.0,NCT04581044,Impact of COVID-19 on Psoriasis Practice,,Completed,Psoriasis,COVID-19,,,,,,,Cairo University,All,"25 Years and older   (Adult, Older Adult)",197.0,Other,Observational,2020-09-17,23/10/20,2020-10-23,09/10/20,13/11/20,"Department of Dermatology, Cairo University, Cairo",Egypt,Respiratory Diseases,1,2,36.0
1827.0,NCT04397328,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,Lawson Health Research Institute,All,"40 Years and older   (Adult, Older Adult)",336.0,Other,Interventional,2020-05-19,30/04/21,2021-04-30,21/05/20,21/05/20,,,Respiratory Diseases,1,1,346.0
1828.0,NCT04325412,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,CAPACITY-COVID,Recruiting,COVID-19,,,,,,,,UMC Utrecht,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-23,23/03/21,2021-06-23,27/03/20,10/11/20,"University Medical Center Utrecht, Utrecht",Netherlands,Respiratory Diseases,1,1,457.0
1829.0,NCT04665752,Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors,,Recruiting,COVID-19,,,,,,,,National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",150.0,NIH,Observational,2021-02-02,30/06/23,2023-06-30,14/12/20,02/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,878.0
1830.0,NCT04387253,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,,Recruiting,Identification of the Mother or Fetus Contamination by SARS Cov-2,Research the Presence of Viruses at Different Sites of the Mother and the Fetus or Father,The Survey Builds on a Network Work Already Organized Around the CPDPN of Poitou-Charentes,Analysis Laboratories of the Poitiers CHU,,,,Diagnostic Test: Identification by PCR of the SARS-COV-2 virus in samples taken from the fetus,Poitiers University Hospital,All,"Child, Adult, Older Adult",80.0,Other,Interventional,2020-05-23,23/07/21,2021-07-23,13/05/20,09/06/20,"CHU de Poitiers, Poitiers",France,Others,0,4,426.0
1831.0,NCT04723524,Jinhua Qinggan Granules in the Treatment of COVID-19,RCT,Recruiting,COVID-19,,,,,,,"Combination Product: Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine|Other: Placebo Comparator","University of Karachi|Indus Hospital|Dow University Hospital, Mission Rd, Gulzar-e-Hijri, Scheme 33, Karachi. Tel: (92-21) 38771111|Dr. Ruth K.M. Pfau Civil Hospital, Karachi",All,"18 Years to 75 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-09-22,01/06/21,2021-01-08,25/01/21,29/01/21,"Center for Bioequivalence Studies and Clinical Research (CBSCR), ICCBS, university of Karachi, Karachi",Pakistan,Respiratory Diseases,1,1,108.0
1832.0,NCT04379544,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,CLUSCO,"Active, not recruiting",Coronavirus,Respiratory Failure,,,,,,Other: Observation only,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",125.0,Other,Observational,2020-04-23,01/09/20,2021-01-12,07/05/20,15/01/21,"University of Pennsylvania Health System, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,264.0
1833.0,NCT04316884,Mechanisms for Organ Dysfunction in Covid-19,UMODCOVID19,Recruiting,COVID-19,Organ Dysfunction Syndrome Sepsis,"Organ Dysfunction Syndrome, Multiple",Septic Shock,Acute Kidney Injury,Acute Respiratory Distress Syndrome,,,Uppsala University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-12-03,31/12/21,2021-12-31,20/03/20,05/04/21,"Uppsala University Hospital, Uppsala",Sweden,Respiratory Diseases,1,6,393.0
1834.0,NCT04527211,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,IveprofCovid19,Not yet recruiting,COVID-19,Healthcare Worker Patient Transmission,,,,,,Drug: Ivermectin,Javeriana University,All,"18 Years and older   (Adult, Older Adult)",550.0,Other,Interventional,2020-07-09,30/11/20,2020-12-16,26/08/20,26/08/20,"Pontificia Universidad Javeriana, Cali, Valle Del Cauca",Colombia,Respiratory Diseases,1,2,160.0
1835.0,NCT04567810,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",,Completed,COVID-19,,,,,,,Drug: anti-SARS-CoV-2 IgY|Drug: Placebo,Stanford University,All,18 Years to 45 Years   (Adult),48.0,Other,Interventional,2020-09-18,14/12/20,2020-12-14,29/09/20,21/12/20,"Linear Clinical Research - Harry Perkins Research Institute, Nedlands, Western Australia",Australia,Respiratory Diseases,1,1,87.0
1836.0,NCT04353323,COVID 19-Caregivers IGg Seroconversion,CoSigS,Not yet recruiting,COVID-19,,,,,,,Other: Blood sampling,"University Hospital, Limoges",All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Observational,2020-05-25,25/06/20,2020-12-25,20/04/20,11/05/20,"CHU de Limoges, Limoges",France,Respiratory Diseases,1,1,214.0
1837.0,NCT04448418,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,,"Active, not recruiting",Transgender Persons,Coronavirus,Coronavirus Infection,COVID-19,COVID-19,,,Other: web based survey,Unita Complessa di Ostetricia e Ginecologia,All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-05-20,20/06/20,2020-11-20,25/06/20,11/08/20,"1Gynecology and Physiopathology of Human Reproduction, S. Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna",Italy,Respiratory Diseases,1,5,184.0
1838.0,NCT04840966,Flavor Test for COVID-19 Patiens,,Completed,COVID-19,,,,,,,Diagnostic Test: Flavor test|Other: Self-assesment questionnaire,Federico II University,All,"18 Years and older   (Adult, Older Adult)",111.0,Other,Observational,2020-05-05,15/01/21,2021-01-15,12/04/21,12/04/21,"Dipartimento di Medicina Clinica e Chirurgia, Napoli",Italy,Respiratory Diseases,1,1,255.0
1839.0,NCT04343768,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",COVIFERON,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir|Drug: Interferon Beta-1A|Drug: Interferon Beta-1B,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-04,27/04/20,2020-04-27,13/04/20,05/05/20,"Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,-130.0
1840.0,NCT04412252,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,,Withdrawn,COVID-19,,,,,,,Drug: Tofacitinib|Other: Placebo,Pfizer,All,"18 Years to 99 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-06-07,16/09/20,2020-10-18,02/06/20,31/07/20,"Hartford Hospital (HH), Hartford, Connecticut, United States|University of Iowa Hospitals & Clinics Investigational Drug Services, Iowa City, Iowa, United States|University of Iowa, Iowa City, Iowa, United States|LSUHSC-Shreveport, Shreveport, Louisiana, United States|Ochsner LSU Health Shreveport Academic Medical Center, Shreveport, Louisiana, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio",United States,Respiratory Diseases,1,1,133.0
1841.0,NCT04732949,Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19,SPRINTER,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,COVID-19,,,,,,Drug: SNG001|Drug: Placebo,Synairgen Research Ltd.,All,"18 Years and older   (Adult, Older Adult)",610.0,Industry,Interventional,2021-12-01,01/06/21,2021-01-09,01/02/21,03/03/21,"PharmaTex Research, LLC, Amarillo, Texas, United States|Hull Royal Infirmary, Hull, North Humberside, East Riding Of Yorkshire, United Kingdom|Royal Victoria Infirmary, Newcastle, Newcastle, England, United Kingdom|Southampton General Hospital, Southampton, Hampshire, United Kingdom|Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom|The Royal Bournemouth & Christ, Bournemouth, United Kingdom|Glenfield Hospital, Leicester, United Kingdom|Plymouth Hospitals NHS Trust, Plymouth, United Kingdom|Morriston Hospital Swansea NHS, Swansea",United Kingdom,Respiratory Diseases,1,2,-326.0
1842.0,NCT04476927,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,,Not yet recruiting,COVID-19,,,,,,,Device: DiaNose,Nanose Medical Ltd.,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry,Interventional,2020-01-08,30/05/21,2021-06-30,20/07/20,20/07/20,,,Respiratory Diseases,1,1,539.0
1843.0,NCT04750629,"Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 CoviDx™ Rapid Antigen Test",CoviDx,Not yet recruiting,COVID-19,COVID-19,,,,,,Device: POC CoviDx™ Rapid Antigen Test,Lumos Diagnostics|Rapid Pathogen Screening,All,"1 Year and older   (Child, Adult, Older Adult)",100.0,Industry,Observational,2021-08-02,28/02/21,2021-03-26,11/02/21,11/02/21,"Comprehensive Clinical Research, West Palm Beach, Florida",United States,Respiratory Diseases,1,2,-129.0
1844.0,NCT04456010,COVID-19 in ART: Perception and Experience,COVAPEX,Completed,COVID-19,Fertility Issues,ART,,,,,Other: Questionnaire,"University Hospital, Montpellier",All,18 Years to 60 Years   (Adult),600.0,Other,Observational,2020-01-06,30/07/20,2020-07-30,02/07/20,29/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,206.0
1845.0,NCT04382417,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,,Completed,COVID-19,Critical Illness,,,,,,Other: Observational study,Region Västmanland,All,"18 Years and older   (Adult, Older Adult)",57.0,Other,Observational,2020-03-26,12/11/20,2020-12-11,11/05/20,15/03/21,"Intensive Care Unit, Västerås Hospital, Västerås, Västmanland",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,2,260.0
1846.0,NCT04582903,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,,Recruiting,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"up to 99 Years   (Child, Adult, Older Adult)",500.0,NIH,Observational,2021-04-19,31/08/25,2025-08-31,12/10/20,14/04/21,"Niaid/Lcim, Rockville, Maryland",United States,Respiratory Diseases,1,1,1595.0
1847.0,NCT04371354,Outcomes of Covid-19 Protective Measures in Endoscopy,,"Active, not recruiting",COVID-19,Endoscopy Unit,,,,,,,Fundacion Miguel Servet,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-27,14/06/21,2021-07-27,01/05/20,23/02/21,"Complejo Hospitalario de Navarra, Pamplona, Navarra",Spain,Respiratory Diseases,1,2,456.0
1848.0,NCT04360759,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,CQOTE,Withdrawn,COVID-19,HIV,,,,,,Drug: Chloroquine or hydroxychloroquine,University of Cape Town,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-05,30/05/21,2021-06-30,24/04/20,18/08/20,"Khayelitsha Hospital, Cape Town, Western Cape, South Africa|Groote Schuur Hospital, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,2,542.0
1849.0,NCT04456426,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",,Not yet recruiting,COVID-19,SARS-CoV 2,SARS Pneumonia,SARS (Disease),SARS (Severe Acute Respiratory Syndrome),,,,Hospital Departamental de Villavicencio|Clínica Primavera|Clínica Meta|Cooperative University of Colombia|Grupo de Investigación de Villavicencio,All,"up to 120 Years   (Child, Adult, Older Adult)",250.0,Other,Observational,2020-01-07,01/08/20,2020-01-08,02/07/20,02/07/20,,,Respiratory Diseases,1,5,1.0
1850.0,NCT04335188,COVID-19 Registry Rhineland-Palatinate (Germany),,Recruiting,COVID-19,,,,,,,Other: Prospective oberservational registry,"IHF GmbH - Institut für Herzinfarktforschung|Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz",All,"Child, Adult, Older Adult",4000.0,Other,Observational,2020-06-04,31/07/21,2021-09-30,06/04/20,08/04/20,"Klinikum der Stadt Ludwigshafen am Rhein GmbH, Klinik für Herzchirurgie, Ludwigshafen, RLP",Germany,Respiratory Diseases,1,1,483.0
1851.0,NCT04327206,BCG Vaccination to Protect Healthcare Workers Against COVID-19,BRACE,"Active, not recruiting",COVID-19,Respiratory Illness,Corona Virus Infection,COVID-19,,,,Drug: BCG Vaccine|Drug: 0.9%NaCl,Murdoch Childrens Research Institute|Royal Children's Hospital,All,"18 Years and older   (Adult, Older Adult)",10078.0,Other,Interventional,2020-03-30,30/06/21,2022-03-30,31/03/20,12/04/21,"St Vincent's Hospital, Sydney, Sydney, New South Wales, Australia|Prince of Wales Hospital, Sydney, New South Wales, Australia|Sydney Children's Hospital, Randwick, Sydney, New South Wales, Australia|The Children's Hospital at Westmead, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Women's and Children's Hospital, North Adelaide, South Australia, Australia|Royal Children's Hospital, Melbourne, Victoria, Australia|Epworth Richmond, Melbourne, Victoria, Australia|Monash Health- Monash Medical Centre, Melbourne, Victoria, Australia|Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Perth Children's Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|Fundação de Medicina Tropical Dr Heitor Vieira Dourado (FMT-HVD), Manaus, Amazonas, Brazil|Santa Casa Hospital, Campo Grande, Mato Grosso Do Sul, Brazil|CASSEMS Hospital, Campo Grande, Mato Grosso Do Sul, Brazil|Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso Do Sul, Brazil|Hospital Regional de Mato Grosso do Sul, Campo Grande, Mato Grosso Do Sul, Brazil|Centro de Estudos da Saúde do Trabalhador e Ecologia Humana, Rio de Janeiro, RJ, Brazil|Centro de Referência Prof Hélio Fraga, Rio de Janeiro, RJ, Brazil|Noord West Ziekenhuis, Alkmaar, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Amphia Hospital, Breda, Netherlands|St Antonius Hospital, Nieuwegein, Netherlands|Radboud UMC, Nijmegen, Netherlands|University hospital in Utrecht (UMCU), Utrecht, Netherlands|University Hospital German Trias I Pujol, Badalona, Barcelona, Spain|Mutua Terrassa Univeristy Hospital, Terrassa, Barcelona, Spain|University Hospital Cruces, Barakaldo, Bizkaia, Spain|Marqués de Valdecilla University Hospital, Santander, Spain|University Hospital Virgen Macarena, Sevilla, Spain|Ide Lane Surgery, Alphington, Exeter, United Kingdom|St Leonard's Practice, St Leonards, Exeter, United Kingdom|Travel Clinic, Exeter",United Kingdom,Respiratory Diseases,1,4,730.0
1852.0,NCT04641481,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,,"Active, not recruiting",COVID-19,SARS-CoV Infection,,,,,,Biological: BBV152|Biological: Placebo,Bharat Biotech International Limited|Indian Council of Medical Research|Iqvia Pty Ltd,All,"18 Years to 99 Years   (Adult, Older Adult)",25800.0,Industry|Other,Interventional,2020-11-16,08/01/21,2022-01-12,23/11/20,19/03/21,"Pt BD SHARMA,PGIMS/UHS, Rohtak, Haryana",India,Respiratory Diseases,1,2,422.0
1853.0,NCT04568096,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Combination Product: Aerosolized All-Trans Retinoic acid plus oral Tamoxifen|Other: Standard treatment,Kafrelsheikh University,All,"18 Years to 80 Years   (Adult, Older Adult)",160.0,Other,Interventional,2020-01-11,01/12/20,2020-01-12,29/09/20,26/10/20,,,Respiratory Diseases,1,1,1.0
1854.0,NCT04834869,COVID-19 Vaccines Safety Tracking (CoVaST),,Not yet recruiting,Adverse Reaction to Vaccine,COVID-19,,,,,,Biological: BNT162b2|Biological: mRNA-1273|Biological: AZD1222|Biological: CoronaVac|Biological: Sinopharm|Biological: Gam-COVID-Vac|Biological: JNJ-78436735|Biological: CVnCoV|Biological: NVX-CoV2373|Biological: BBV152,Masaryk University,All,"18 Years and older   (Adult, Older Adult)",30000.0,Other,Observational,2021-01-04,31/12/21,2022-01-31,08/04/21,12/04/21,,,Respiratory Diseases,1,2,392.0
1855.0,NCT04332016,COVID-19 Biological Samples Collection,COLCOV19-BX,Recruiting,Infection Viral,,,,,,,Other: biological samples collection,"University Hospital, Bordeaux",All,"up to 100 Years   (Child, Adult, Older Adult)",2000.0,Other,Observational,2020-02-04,01/03/23,2023-01-03,02/04/20,03/04/20,"Centre Hospitalier Universitaire de Bordeaux, Bordeaux",France,Others,0,1,1064.0
1856.0,NCT04499391,COVID-19 Project ECHO in Nursing Homes,,Recruiting,COVID-19,,,,,,,Other: Project ECHO,Milton S. Hershey Medical Center,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-12,01/07/22,2022-01-07,05/08/20,23/12/20,"Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania",United States,Respiratory Diseases,1,1,635.0
1857.0,NCT04497948,Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,,Terminated,COVID-19,,,,,,,Drug: Acalabrutinib,Acerta Pharma BV|AstraZeneca,All,"18 Years to 100 Years   (Adult, Older Adult)",8.0,Industry,Interventional,2020-09-21,18/11/20,2020-11-18,04/08/20,02/12/20,"Research Site, Baltimore, Maryland, United States|Research Site, Rochester, Minnesota, United States|Research Site, Chapel Hill, North Carolina, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Sao Paulo",Brazil,Respiratory Diseases,1,1,58.0
1858.0,NCT04409327,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,,Terminated,COVID-19,,,,,,,Drug: RTB101|Drug: Placebo,Restorbio Inc.,All,65 Years and older   (Older Adult),36.0,Industry,Interventional,2020-11-07,27/12/20,2021-01-24,01/06/20,10/02/21,"Nursing Home, Middletown, Rhode Island",United States,Respiratory Diseases,1,1,78.0
1859.0,NCT04347954,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),,Completed,COVID-19,,,,,,,Drug: Povidone-Iodine 2%|Drug: Povidone-Iodine 0.5%|Drug: Isotonic saline 0.9%,Stanford University,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-08-15,13/12/20,2020-12-13,15/04/20,19/01/21,"Stanford Health Care, Stanford, California",United States,Respiratory Diseases,1,1,120.0
1860.0,NCT04409574,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,,Not yet recruiting,"Infection, Coronavirus",,,,,,,,Assiut University,All,18 Years to 50 Years   (Adult),31.0,Other,Observational,2020-01-06,01/03/21,2021-01-06,01/06/20,04/06/20,,,Respiratory Diseases,1,1,366.0
1861.0,NCT04642638,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",,"Active, not recruiting",Coronavirus Infection,COVID-19,COVID-19,,,,,Drug: INO-4800|Device: CELLECTRA® 2000|Drug: Placebo,Inovio Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",401.0,Industry,Interventional,2020-11-30,01/09/22,2022-01-09,24/11/20,29/03/21,"Synexus Clinical Research US, Inc - Phoenix Southeast, Chandler, Arizona, United States|Central Phoenix Synexus Clinical Research, Phoenix, Arizona, United States|AMR Tempe, Tempe, Arizona, United States|Optimal Research, LLC, San Diego, California, United States|AMR South Florida, Coral Gables, Florida, United States|Clinical Research Trials of Florida, Inc, Tampa, Florida, United States|AMR Lexington, Lexington, Kentucky, United States|Walter Reed Army Institute of Research, Silver Spring, Maryland, United States|Ascension St. John Hospital, Detroit, Michigan, United States|AMR Kansas City, Kansas City, Missouri, United States|AMR, Clinical Research Consortium- Las Vegas, Las Vegas, Nevada, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Tekton Research, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Advanced Clinical Research, West Jordan, Utah",United States,Respiratory Diseases,1,3,405.0
1862.0,NCT04364009,Anakinra for COVID-19 Respiratory Symptoms,ANACONDA,Terminated,COVID-19,ANAKINRA Treatment,Optimized Standard of Care (oSOC),,,,,Drug: Anakinra plus oSOC|Drug: oSOC,"University Hospital, Tours|INSERM CIC-P 1415, University Hospital Center of Tours|Swedish Orphan Biovitrum (SOBI)",All,"18 Years and older   (Adult, Older Adult)",71.0,Other,Interventional,2020-04-27,20/10/20,2020-03-11,27/04/20,15/01/21,"CHRU de TOURS, Tours",France,Respiratory Diseases,1,3,-47.0
1863.0,NCT04442165,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,AfriCoVER,Recruiting,COVID-19,,,,,,,,"Institute of Tropical Medicine, Belgium|EDCTP|Instituto Nacional de Saude, Mozambique|Institut de Recherche pour le Developpement|UMC Utrecht",All,"Child, Adult, Older Adult",15393.0,Other,Observational,2020-12-15,14/07/21,2021-07-14,22/06/20,12/02/21,"INS, Maputo",Mozambique,Respiratory Diseases,1,1,211.0
1864.0,NCT04661462,Health After Covid-19 in Tyrol,,Recruiting,COVID-19,,,,,,,Other: online survey,Medical University Innsbruck|Claudiana Landesfachhochschule,All,"16 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-09-30,30/09/21,2021-12-31,10/12/20,10/12/20,"Medizinische Universität Innsbruck, Innsbruck, Tyrol",Austria,Respiratory Diseases,1,1,457.0
1865.0,NCT04799743,The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients,HKCOVID19Res,Not yet recruiting,COVID-19,,,,,,,Drug: Resveratrol|Drug: Placebo capsules,"Hong Kong Baptist University|Hospital Authority, Hong Kong",All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,01/05/22,2022-01-05,16/03/21,16/03/21,"Linda Zhong, Kowloon Tong, Kowloon",Hong Kong,Respiratory Diseases,1,1,366.0
1866.0,NCT04795557,Efficacy of Adaptogens in Patients With Long COVID-19,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: ADAPT-232 oral solution|Other: Placebo oral solution,"Swedish Herbal Institute AB|National Family Medicine Training Centre, Georgia|Tbilisi State Medical University|Phytomed AB",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2021-01-04,01/12/21,2022-01-01,12/03/21,12/03/21,,,Respiratory Diseases,1,1,362.0
1867.0,NCT04627584,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,"Mabwell (Shanghai) Bioscience Co., Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",150.0,Industry,Interventional,2020-12-29,01/05/21,2021-01-09,13/11/20,26/02/21,"Shanghai Public Health Clinical Center, Shanghai",China,Respiratory Diseases,1,1,11.0
1868.0,NCT04382196,Impact of COVID-19 on Mental Health of Health Care Workers,COVID-Impact,"Active, not recruiting",Mental Health,Quality of Life,,,,,,Other: Online survey,"University Hospital, Ghent",All,"Child, Adult, Older Adult",497.0,Other,Observational,2020-04-17,31/12/22,2022-12-31,11/05/20,11/05/20,"Ghent University Hospital, Ghent",Belgium,Others,0,2,988.0
1869.0,NCT04355767,Convalescent Plasma in Outpatients With COVID-19,C3PO,"Active, not recruiting",COVID-19,,,,,,,Biological: Convalescent Plasma|Biological: Saline,"Stanford University|National Heart, Lung, and Blood Institute (NHLBI)|Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) - Network|University of Pittsburgh|Medical University of South Carolina",All,"18 Years and older   (Adult, Older Adult)",511.0,Other|NIH,Interventional,2020-11-08,01/04/21,2021-01-04,21/04/20,03/03/21,"Chandler Regional Medical Center, Chandler, Arizona, United States|Valleywise Health Medical Center, Phoenix, Arizona, United States|UCSD Health La Jolla, La Jolla, California, United States|Loma Linda University Medical Center, Loma Linda, California, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|UC Davis Medical Center, Sacramento, California, United States|Stanford University, Stanford, California, United States|Harbor-UCLA Medical Center, Torrance, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|UF Health Shands Hospital, Gainesville, Florida, United States|Jackson Memorial Hospital, Miami, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois Hospital, Chicago, Illinois, United States|University of Chicago Medical Center, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Maine Medical Center, Portland, Maine, United States|Tufts Medical Center, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan University Hospital, Ann Arbor, Michigan, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Harper University Hospital, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Sinai-Grace Hospital, Detroit, Michigan, United States|Spectrum Health Hospitals Butterworth Hospital, Grand Rapids, Michigan, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|William Beaumont Hospital-Troy, Troy, Michigan, United States|HealthPartners Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Barnes Jewish Hospital, Saint Louis, Missouri, United States|Cooper University Hospital, Camden, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|SUNY Downstate Medical Center, Brooklyn, New York, United States|Duke University Hospital, Durham, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|OSU Wexner Medical Center, Columbus, Ohio, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Oregon Health & Science University Hospital, Portland, Oregon, United States|Geisinger Medical Center, Danville, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Einstein Medical Center, Philadelphia, Pennsylvania, United States|UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States|William P. Clements Jr. University Hospital, Dallas, Texas, United States|Ben Taub General Hospital, Houston, Texas, United States|Memorial Hermann Texas Medical Center, Houston, Texas, United States|University of Utah Healthcare, Salt Lake City, Utah, United States|Froedtert Hospital, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,1,57.0
1870.0,NCT04560257,High Flow Nasal Cannula HFNC In Covid-19 Patients,HFNC19LGH,Recruiting,SARS-CoV Infection,SARS (Severe Acute Respiratory Syndrome),,,,,,Device: High flow nasal cannula HFNC,Lahore General Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-05,30/12/20,2020-12-30,23/09/20,08/12/20,"Muhammad Irfan Malik, Lahore, Punjab",Pakistan,Respiratory Diseases,1,2,360.0
1871.0,NCT04684433,Surgery in the Time of COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Other: Data extraction from medical files,Brugmann University Hospital,All,"Child, Adult, Older Adult",707.0,Other,Observational,2020-04-14,15/03/21,2021-03-15,24/12/20,16/03/21,"St Pierre, Brussels, Belgium|CHU Brugmann, Brussels, Belgium|Erasme, Brussels, Belgium|UZ Brussel, Brussel",Belgium,Respiratory Diseases,1,1,335.0
1872.0,NCT04468009,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,,Recruiting,SARS-Associated Coronavirus,COVID-19,SARS-CoV Infection,,,,,Biological: Convalescent plasma,Hospital de Infecciosas Francisco Javier Muniz,All,"18 Years to 100 Years   (Adult, Older Adult)",36.0,Other,Interventional,2020-06-25,19/01/21,2021-01-02,13/07/20,22/01/21,"Hospital Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aire",Argentina,Respiratory Diseases,1,3,191.0
1873.0,NCT04326075,Early CPAP in COVID-19 Patients With Respiratory Failure.,EC-COVID-RCT,Recruiting,CPAP Ventilation,COVID-19,Emergency Departments,,,,,Device: CPAP treatment,Mario Negri Institute for Pharmacological Research,All,"18 Years to 70 Years   (Adult, Older Adult)",900.0,Other,Interventional,2020-01-12,31/03/21,2021-05-31,30/03/20,17/12/20,"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan",Italy,Respiratory Diseases,1,3,505.0
1874.0,NCT04764747,Effectiveness of Convalescent Plasma in Hospitalized Patients With COVID-19,,Recruiting,COVID-19,,,,,,,,Kufa University,All,"18 Years to 95 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-01-11,01/04/21,2021-01-04,21/02/21,21/02/21,"Al-Amal Hospital, Najaf, Iraq|Al-Hakeem Hospital, Najaf",Iraq,Respiratory Diseases,1,1,359.0
1875.0,NCT04818853,COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI),CAPA IFI,Recruiting,COVID-19,Aspergillosis,Fungal Infection,,,,,Other: Observation to monitor patients for these infections,University of Alabama at Birmingham|Centers for Disease Control and Prevention|Astellas Pharma Inc,All,"18 Years and older   (Adult, Older Adult)",400.0,Other|U.S. Fed|Industry,Observational,2021-09-03,01/03/23,2024-01-03,26/03/21,08/04/21,"The University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,3,852.0
1876.0,NCT04446104,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Ivermectin 3mg Tab|Drug: Zinc|Drug: Povidone-Iodine|Dietary Supplement: Vitamin C,"National University Hospital, Singapore",Male,21 Years to 60 Years   (Adult),4257.0,Other,Interventional,2020-05-13,31/08/20,2020-08-31,24/06/20,19/10/20,"Tuas South Dormitory, Singapore",Singapore,Respiratory Diseases,1,1,110.0
1877.0,NCT04363346,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,,"Active, not recruiting",COVID-19,,,,,,,Drug: FT516,"Masonic Cancer Center, University of Minnesota",All,"18 Years to 76 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-05-14,01/01/22,2022-01-01,27/04/20,02/02/21,"University of Minnesota, Minneapolis, Minnesota",United States,Respiratory Diseases,1,1,597.0
1878.0,NCT04430062,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,,Completed,General Surgery,Disease Outbreaks,,,,,,Procedure: Surgical procedures performed under general anesthesia,Azienda Socio Sanitaria Territoriale di Lodi,All,"Child, Adult, Older Adult",14.0,Other,Observational,2020-01-05,20/05/20,2020-05-30,12/06/20,16/06/20,"Ospedale di Lodi - ASST Lodi, Lodi, Lombardia",Italy,Others,0,2,146.0
1879.0,NCT04330144,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine as post exposure prophylaxis|Other: Others(No intervention),Gangnam Severance Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",2486.0,Other,Interventional,2020-01-04,30/03/21,2022-03-30,01/04/20,01/04/20,,,Respiratory Diseases,1,1,816.0
1880.0,NCT04712357,Clinical Experimentation With Tenofovir Disoproxyl Fumarate and Emtricitabine for COVID-19,ARTAN-C19,Recruiting,COVID-19,,,,,,,Drug: Vitamin C 500 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG Oral Tablet|Drug: Tenofovir disoproxyl fumarate 300 MG plus emtricitabine 200 MG Oral Tablet,Universidade Federal do Ceara|Conselho Nacional de Desenvolvimento Científico e Tecnológico|São José Hospital for Infectious Diseases - HSJ|Central Laboratory of Public Health of Ceará - Lacen-CE,All,"18 Years and older   (Adult, Older Adult)",219.0,Other,Interventional,2020-09-11,01/01/22,2023-01-01,15/01/21,15/01/21,"Núcleo de Biomedicina - NUBIMED, Fortaleza, Ceará",Brazil,Respiratory Diseases,1,1,842.0
1881.0,NCT04797975,Off-the-shelf NK Cells (KDS-1000) as Immunotherapy for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: KDS-1000|Other: Placebo,Kiadis Pharma,All,"18 Years to 70 Years   (Adult, Older Adult)",54.0,Industry,Interventional,2021-01-04,01/11/21,2021-01-11,15/03/21,18/03/21,,,Respiratory Diseases,1,1,7.0
1882.0,NCT04517188,Halodine Nasal Antiseptic in Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Povidone-Iodine Solution 1.25% w/w [0.125% available iodine] USP,Halodine LLC,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2021-01-04,01/07/21,2021-01-07,18/08/20,10/02/21,,,Respiratory Diseases,1,1,3.0
1883.0,NCT04410939,COVID-19 PCR Test Results in Asymptomatic Pregnants,,Completed,COVID-19,Asymptomatic Pregnant,,,,,,Diagnostic Test: Reverse transcription polymerase chain reaction,Istanbul Medipol University Hospital,Female,"Child, Adult, Older Adult",179.0,Other,Observational,2020-10-04,20/05/20,2020-05-21,01/06/20,01/06/20,"Istanbul Medipol University, Istanbul",Turkey,Respiratory Diseases,1,2,-136.0
1884.0,NCT04494204,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,,Completed,COVID-19,,,,,,,Combination Product: Immunofree tablets and Reginmune capsule,PUNEET MITTAL|Nutrin GmbH,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-08,01/12/20,2020-12-20,31/07/20,22/12/20,"Govt Medical College and Govt General Hospital (Old RIMSGGH), Srikakulam, Andhra Pradesh, India|Parul Institute of Ayurveda and Research Parul University, Vadodara, Gujrat, India|Lokmanya Hospital, Pune, Maharashtra",India,Respiratory Diseases,1,1,165.0
1885.0,NCT04360122,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Levamisole|Drug: Isoprinosine|Drug: Levamisole and Isoprinosine,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-20,01/11/20,2020-01-12,24/04/20,05/05/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,-129.0
1886.0,NCT04732858,"Educational Interventions for Surgeons During COVID-19 Pandemic: Cross-sectional, E-survey",EDUCOVID,"Active, not recruiting",COVID-19,,,,,,,Other: Cross sectional e-Survey on surgeons exposed to any educational intervention,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-01-03,31/08/20,2021-01-06,01/02/21,09/02/21,"Assistance Publique Hôpitaux de Paris - GHU AP-HP Hôpitaux Universitaires Henri-Mondor, Créteil",France,Respiratory Diseases,1,1,369.0
1887.0,NCT04405310,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,CPC-SARS,Completed,SARS Pneumonia,,,,,,,Biological: Convalescent Plasma of patients with COVID-19|Other: placebo (hartmann plus albumine),"Grupo Mexicano para el Estudio de la Medicina Intensiva|Hospital General Naval de Alta Especialidad - Escuela Medico Naval|National Institute of Pediatrics, Mexico|Instituto Nacional de Enfermedades Respiratorias",All,"18 Years to 70 Years   (Adult, Older Adult)",42.0,Other,Interventional,2020-05-20,20/11/20,2020-10-12,28/05/20,21/12/20,"Hospital Nava de Alta Especialidad, Mexico City, Mexico|Hospital General de Mexico Dr Eduardo Liceaga, Mexico City",Mexico,Respiratory Diseases,1,1,145.0
1888.0,NCT04407689,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,ILIAD-7-FR,Recruiting,COVID-19,Lymphocytopenia,,,,,,Drug: Interleukin-7|Drug: Placebo,"Revimmune|University Hospital, Limoges|Amarex Clinical Research",All,"25 Years to 80 Years   (Adult, Older Adult)",48.0,Industry|Other,Interventional,2020-08-06,30/07/21,2021-12-30,29/05/20,15/01/21,"University Hospital of Limoges, Limoges, France|Hôpital Edouard Herriot, Lyon, France|hopital Edouard Herriot, Lyon, France|Chr Orleans La Source, Orléans, France|hopital COCHIN, Paris, France|Chru Tours, Tours",France,Respiratory Diseases,1,2,511.0
1889.0,NCT04379076,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,ILIAD-7-UK,Recruiting,COVID-19,Lymphocytopenia,,,,,,Drug: Interleukin-7|Drug: Placebos,Revimmune|Amarex Clinical Research,All,"25 Years to 80 Years   (Adult, Older Adult)",48.0,Industry|Other,Interventional,2020-05-14,30/10/21,2021-12-30,07/05/20,17/02/21,"Sandwell Birmingham Hospital, Birmingham, United Kingdom|Sandwell Birmingham Hospital, Birmingham, United Kingdom|Bradford Institute for Health Research, Bradford, United Kingdom|ST JAMES's UNIVERSITY HOSPITAL, Leeds, United Kingdom|Medway Maritime Hospital, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King'S College Hospital, London, United Kingdom|Wythenshawe Hospital/ Manchester Royal Infirmary, Manchester, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom|Royal Victoria Infirmary and Freeman Hospital, Newcastle, United Kingdom|Royal Preston Hospital, Preston, United Kingdom|Sunderland Royal Hospital, Sunderland, United Kingdom|Watford General Hospital, Watford",United Kingdom,Respiratory Diseases,1,2,595.0
1890.0,NCT04340232,Safety and Efficacy of Baricitinib for COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Baricitinib,"University of Colorado, Denver",All,"18 Years to 89 Years   (Adult, Older Adult)",0.0,Other,Interventional,2021-01-03,01/08/21,2021-01-10,09/04/20,08/03/21,"University of Colorado, Denver, Aurora, Colorado",United States,Respiratory Diseases,1,1,7.0
1891.0,NCT04348071,Safety and Efficacy of Ruxolitinib for COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Ruxolitinib,"University of Colorado, Denver",All,"18 Years to 89 Years   (Adult, Older Adult)",0.0,Other,Interventional,2021-01-07,01/08/21,2021-01-10,15/04/20,08/03/21,,,Respiratory Diseases,1,1,3.0
1892.0,NCT04487873,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,,Recruiting,COVID-19,Bronchiectasis,,,,,,,Hacettepe University,All,18 Years to 60 Years   (Adult),28.0,Other,Observational,2020-07-23,18/12/20,2020-12-31,27/07/20,21/12/20,"Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara",Turkey,Respiratory Diseases,1,2,161.0
1893.0,NCT04443140,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,,Completed,COVID-19,Preeclampsia,Pregnancy Related,,,,,"Diagnostic Test: PCR, lung ultrasound",Zeynep Kamil Maternity and Pediatric Research and Training Hospital,Female,18 Years to 40 Years   (Adult),131.0,Other,Observational,2020-03-15,01/07/20,2020-10-07,23/06/20,28/07/20,"Zeynep Kamil Maternity and Childrens Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,206.0
1894.0,NCT04344379,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,PREP-COVID,Suspended,COVID-19,,,,,,,Drug: hydroxychloroquine|Drug: azithromycin|Drug: hydroxychloroquine placebo,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",122.0,Other,Interventional,2020-04-17,30/06/20,2020-07-15,14/04/20,12/06/20,"Hopial Avicenne, Bobigny, France|Hôpital GHU Paris Saclay, Le Kremlin-Bicêtre, France|Hôpital Saint Antoine, Paris, France|Hôpital Broca, Paris, France|Hôpital La Pitié-Salpétrière, Paris, France|Hôpital Cochin, Paris, France|Hôpital européen Georges Pompidou, Paris, France|Hôpital Necker, Paris",France,Respiratory Diseases,1,1,89.0
1895.0,NCT04561154,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,REPERCOV,Recruiting,SARS-COV2,COVID-19,,,,,,Other: questionnaire,Centre Hospitalier le Mans,All,"18 Years and older   (Adult, Older Adult)",134.0,Other,Interventional,2020-11-06,11/06/21,2022-11-06,23/09/20,23/09/20,"Centre Hospitalier du Mans, Le Mans",France,Respiratory Diseases,1,2,730.0
1896.0,NCT04775784,Determination of COVID-19 Related Virus in Central Nervous System,,Recruiting,COVID-19,CNS Disease,CNS Infection,,,,,Diagnostic Test: Determination of SARS-CoV2 presence in CNS,IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-12-17,20/09/22,2022-12-20,01/03/21,03/03/21,"IRCCS San Raffaele Scientific Institute, Milan",Italy,Respiratory Diseases,1,3,733.0
1897.0,NCT04416399,STerOids in COVID-19 Study,STOIC,Terminated,Coronavirus Infection,,,,,,,Drug: Budesonide dry powder inhaler,University of Oxford,All,"18 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-07-16,12/01/21,2021-12-01,04/06/20,08/02/21,"Oxford Respiratory Trials Unit, Oxford, Oxfordshire",United Kingdom,Respiratory Diseases,1,1,503.0
1898.0,NCT04487197,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",,Completed,Kidney Transplant,Pancreatic Transplat,Pancreatic Islets Langerhans,,,,,Procedure: blood sample for seroepidemiological investigation,Antonio Secchi|IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",282.0,Other,Observational,2020-07-15,15/01/21,2021-01-15,27/07/20,10/02/21,"IRCCS San Raffaele, Milan",Italy,Others,0,3,184.0
1899.0,NCT04407273,Statin Therapy and COVID-19 Infection,STACOV,Completed,COVID-19,Statin,Cardiovascular Diseases,,,,,Drug: observational,Institut Investigacio Sanitaria Pere Virgili,All,"18 Years and older   (Adult, Older Adult)",2159.0,Other,Observational,2020-05-14,20/08/20,2020-12-30,29/05/20,11/03/21,"Facultat de Medicina i Ciències de la Salut de Reus, Reus, Tarragona",Spain,Respiratory Diseases,1,3,230.0
1900.0,NCT04443803,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,,Not yet recruiting,COVID-19,,,,,,,,Randy Loftus|University of Iowa,All,"18 Years to 120 Years   (Adult, Older Adult)",9.0,Other,Observational,2020-01-07,31/08/20,2020-08-31,23/06/20,23/06/20,,,Respiratory Diseases,1,1,237.0
1901.0,NCT04784897,A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Brilacidin|Drug: Placebo|Drug: Standard of Care (SoC),"Innovation Pharmaceuticals, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Industry,Interventional,2021-02-22,01/06/21,2021-01-07,05/03/21,19/03/21,"IPI Investigator Site, Winfield, Illinois, United States|IPI Investigator Site, Metairie, Louisiana, United States|IPI Investigator Site, Toledo, Ohio, United States|IPI Investigator Site, Barnaul, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Moscow, Russian Federation|IPI Investigator Site, Nizniy Novgorod, Russian Federation|IPI Investigator Site, Pushkin, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation|IPI Investigator Site, Saint Petersburg, Russian Federation|IPI Investigator Site, Saint Petersburg",Russian Federation,Respiratory Diseases,1,1,-46.0
1902.0,NCT04699578,COVID-19 Infection and Fetal-neonatal Outcomes,,Recruiting,COVID-19,Obstetric Complication,SARS-CoV Infection,Preterm Birth,Miscarriage,Placenta Diseases,,Diagnostic Test: Covid-19 positive,"University of Campania ""Luigi Vanvitelli""",Female,"18 Years and older   (Adult, Older Adult)",230.0,Other,Observational,2020-12-28,31/12/21,2022-01-05,07/01/21,07/01/21,"University of Campania Luigi Vanvitelli, Naples",Italy,Respiratory Diseases,1,6,373.0
1903.0,NCT04664309,Understanding Immunity to the COVID-19 Vaccines,,Recruiting,COVID-19,Immunity,Vaccine,,,,,Other: No intervention,Stanford University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-03-26,01/01/23,2023-01-01,11/12/20,01/04/21,"Stanford University, Hospital, and Clinics, Stanford, California",United States,Respiratory Diseases,1,3,646.0
1904.0,NCT04570449,Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),,Withdrawn,COVID-19,,,,,,,Drug: Fluoxetine|Drug: Placebo,Milton S. Hershey Medical Center,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-11,01/11/21,2021-01-12,30/09/20,24/12/20,"Milton S. Hershey Medical Center Clinical Research Center, Hershey, Pennsylvania",United States,Respiratory Diseases,1,1,367.0
1905.0,NCT04393311,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Ulinastatin|Drug: Placebo,Stanford University,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2021-01-03,01/09/21,2021-01-09,19/05/20,01/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,6.0
1906.0,NCT04379297,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),CON-VINCE,"Active, not recruiting",COVID-19,,,,,,,,Luxembourg Institute of Health|Luxembourg National Research Funds|University of Luxembourg/ Luxembourg Centre for Systems Biomedicine|Centre Hospitalier du Luxembourg|TNS-Ilres|Laboratoires Réunis|BioneXt Lab|Ketterthill|Laboratoire National de santé,All,"18 Years and older   (Adult, Older Adult)",1800.0,Other,Observational,2020-10-04,28/05/21,2021-12-31,07/05/20,07/05/20,"Luxembourg Institute of Health, Strassen",Luxembourg,Respiratory Diseases,1,1,453.0
1907.0,NCT04353271,Trial of Hydroxychloroquine In Covid-19 Kinetics,THICK,Terminated,COVID-19,Corona Virus Infection,,,,,,Drug: Hydroxychloroquine|Other: Placebo,University of South Alabama,All,"19 Years to 85 Years   (Adult, Older Adult)",58.0,Other,Interventional,2020-04-17,08/07/20,2020-08-07,20/04/20,20/08/20,"University of South Alabama, Mobile, Alabama",United States,Respiratory Diseases,1,2,112.0
1908.0,NCT04831866,COVID-19 Surveillance and Exposure Testing in School Communities,,Not yet recruiting,COVID-19,,,,,,,,Duke University,All,"Child, Adult, Older Adult",1000000.0,Other,Observational,2021-04-30,15/04/23,2023-04-15,05/04/21,05/04/21,,,Respiratory Diseases,1,1,715.0
1909.0,NCT04419571,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,,Completed,COVID-19,Emergency General Surgery,,,,,,Procedure: Emergency Laparotomy,"Barking, Havering and Redbridge University Hospitals NHS Trust",All,"18 Years and older   (Adult, Older Adult)",94.0,Other,Observational,2020-03-23,16/06/20,2020-06-16,05/06/20,23/07/20,"Queen's Hospital, Romford",United Kingdom,Respiratory Diseases,1,2,85.0
1910.0,NCT04432987,Dornase Alpha for the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Pulmozyme,Acibadem University|The Scientific and Technological Research Council of Turkey,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-05-25,25/08/20,2020-09-25,16/06/20,16/06/20,"Acıbadem Altunizade Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,123.0
1911.0,NCT04699227,Can RIC Prevent Deterioration to Critical Care in Covid19,,Recruiting,COVID-19,Ischemia,,,,,,Procedure: Cuff application with inflation|Other: Sham inflation,Derek Yellon|University College London Hospitals,All,"18 Years to 80 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-23,30/04/21,2021-04-30,07/01/21,07/01/21,"Royal Free London NHS Foundation Trust,, London, United Kingdom|East and North Hertfordshire NHS TrusEast and North Hertfordshire NHS Trus, Stevenage",United Kingdom,Respiratory Diseases,1,2,372.0
1912.0,NCT04649658,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,PRINCESS,Completed,COVID-19,,,,,,,Behavioral: Prone position,University of Modena and Reggio Emilia,All,"18 Years to 80 Years   (Adult, Older Adult)",93.0,Other,Observational,2020-01-03,01/06/20,2020-11-30,02/12/20,14/12/20,"Azienda Ospedaliero Universitaria Policlinico di Modena, Modena",Italy,Respiratory Diseases,1,1,332.0
1913.0,NCT04519125,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,,Not yet recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,COVID-19,,,,,,Drug: Tenofovir/ Emtricitabine ( 300 mg / 200 mg daily during 60 days) + Personal Protective Equipment (PPE)|Other: Placebo (1 tablet daily during 60 days) + Personal Protective Equipment (PPE),"Hospital Universitario San Ignacio|Pontificia Universidad Javeriana|Hospital Universitario Nacional de Colombia|Hospital de la Samaritana, Sede Bogotá y Sede Zipaquirá|Hospital Universitario San Jorge, Pereira.|Fundación Universitaria Autónoma de Las Américas|Universidad Tecnológica de Pereira|Colsanitas",All,"18 Years to 70 Years   (Adult, Older Adult)",950.0,Other,Interventional,2020-08-30,31/12/20,2021-01-04,19/08/20,19/08/20,,,Respiratory Diseases,1,2,127.0
1914.0,NCT04813939,Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?,,Recruiting,COVID-19,,,,,,,"Device: IB10 sphingotest® bio-ADM® apparatus (Sphingotec GmbH, Hennigsdorf, Germany)",Medical University of Warsaw,All,"18 Years and older   (Adult, Older Adult)",65.0,Other,Observational,2021-03-22,31/12/21,2022-01-31,24/03/21,24/03/21,"Medical University of Warsaw, Warszawa",Poland,Respiratory Diseases,1,1,315.0
1915.0,NCT04480632,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,PLASMA,Not yet recruiting,COVID-19,,,,,,,Biological: Convalescent plasma,Fundación Cardiovascular de Colombia,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2020-01-08,01/08/21,2022-01-08,21/07/20,22/07/20,"Hospital Internacional de Colombia, Piedecuesta, Santander",Colombia,Respiratory Diseases,1,1,731.0
1916.0,NCT04523181,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,,Recruiting,COVID-19,,,,,,,Drug: Antroquinonol|Drug: Placebo,Golden Biotechnology Corporation,All,"18 Years to 80 Years   (Adult, Older Adult)",174.0,Industry,Interventional,2020-08-10,30/04/21,2021-05-31,21/08/20,22/01/21,"Franciscan Health Michigan City, Michigan City, Indiana, United States|Ascension.Via Christi Research, Wichita, Kansas, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Centro Gallego, Buenos Aires, Capital Federal, Argentina|Clinica de los Virreyes, Buenos Aires, Capital Federal, Argentina|Hospital Rawson, Cordoba, Cuidad De Cordoba, Argentina|Clínica Internacional S.A. - Sede Lima, Lima Cercado, Lima, Peru|Hospital de Chancay, Chancay",Peru,Respiratory Diseases,1,1,294.0
1917.0,NCT04304053,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,HCQ4COV19,Completed,COVID-19,,,,,,,Drug: Treatment and prophylaxis|Other: Standard Public Health measures,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Germans Trias i Pujol Hospital|Department of Health, Generalitat de Catalunya|Laboratorios Gebro Pharma SA|Laboratorios Rubió|Institut Catala de Salut",All,"18 Years and older   (Adult, Older Adult)",2300.0,Other,Interventional,2020-03-18,15/06/20,2020-06-15,11/03/20,30/06/20,"Departament de Salut, Barcelona",Spain,Respiratory Diseases,1,1,89.0
1918.0,NCT04418505,Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,COVIDLight,Recruiting,COVID-19,,,,,,,Device: Vielight RX Plus,Vielight Inc.,All,"18 Years to 65 Years   (Adult, Older Adult)",280.0,Industry,Interventional,2020-02-09,01/06/21,2021-01-08,05/06/20,29/03/21,"Progressive Medical Research, Port Orange, Florida, United States|Dr. Michael Zahavi, Oshawa, Ontario",Canada,Respiratory Diseases,1,1,334.0
1919.0,NCT04396067,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,Antibodies,Not yet recruiting,COVID-19,,,,,,,Drug: Aerosolized 13 cis retinoic acid|Drug: Aerosolized All trans retinoic acid|Other: Placebo,Kafrelsheikh University|Damietta University,All,"18 Years to 70 Years   (Adult, Older Adult)",360.0,Other,Interventional,2020-01-10,01/10/20,2020-01-12,20/05/20,27/10/20,,,Respiratory Diseases,1,1,2.0
1920.0,NCT04796402,A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19,B-EPIC,Recruiting,COVID-19,,,,,,,Biological: Bamlanivimab|Other: Standard of Care,"Fraser Health|Fraser Health Authrority Department of Evaluation and Research Services|Surrey Memorial Hospital Clinical Research Unit|Centre for Health Evaluation and Outcome Sciences|Surrey Hospital Foundation|BC Support Unit|University of British Columbia|Ministry of Health, British Columbia|Clinical Trials BC (part of the BC Academic Health Science Network)",All,"18 Years and older   (Adult, Older Adult)",576.0,Other,Interventional,2021-03-17,30/06/21,2021-12-31,12/03/21,09/04/21,"Fraser Health Authority, Fraser Health Region, British Columbia",Canada,Respiratory Diseases,1,1,289.0
1921.0,NCT04472611,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,COLSTAT,Recruiting,COVID-19,,,,,,,Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin,Yale University,All,"18 Years and older   (Adult, Older Adult)",466.0,Other,Interventional,2020-10-30,30/10/21,2022-01-08,15/07/20,02/03/21,"Bridgeport Hospital, Bridgeport, Connecticut, United States|Greenwich Hospital, Greenwich, Connecticut, United States|Yale New Haven Hosptial System, New Haven, Connecticut, United States|Lawrence & Memorial Hospital, New London, Connecticut",United States,Respiratory Diseases,1,1,435.0
1922.0,NCT04572412,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Radiation: Low dose Radiotherapy,Lancashire Teaching Hospitals NHS Foundation Trust|NIHR Lancashire Clinical Research Facility,All,"50 Years and older   (Adult, Older Adult)",13.0,Other,Interventional,2020-11-25,01/04/21,2021-01-04,01/10/20,25/01/21,"Lancashire Teaching Hospitals NHS, Preston",United Kingdom,Respiratory Diseases,1,1,40.0
1923.0,NCT04352959,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,BBCovid,Completed,COVID-19,Mouthwash,Saliva,,,,,Device: mouthrinse with bêta-cyclodextrin and citrox|Device: mouthrinse without bêta-cyclodextrin and citrox,Claude Bernard University|Hospices Civils de Lyon,All,"18 Years to 85 Years   (Adult, Older Adult)",176.0,Other,Interventional,2020-04-27,11/12/20,2020-11-12,20/04/20,11/02/21,"Clinic of the Protestant Infirmary in Lyon, Caluire-et-Cuire, France|Hospital Center Emile Roux, Le Puy en Velay, France|Hospital Center Saint Luc Saint Joseph, Lyon, France|Intercommunal Hospital Center of Mont de Marsan, Mont de Marsan",France,Respiratory Diseases,1,3,199.0
1924.0,NCT04510662,Telmisartan in Respiratory Failure Due to COVID-19,STAR-COVID,Recruiting,COVID-19,Respiratory Insufficiency,Telmisartan,"Respiratory Distress Syndrome, Adult",,,,Drug: Telmisartan,"Abraham Edgar Gracia-Ramos|National Polytechnic Institute, Mexico|Hospital Regional de Alta Especialidad de Zumpango",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-08,01/03/21,2021-01-04,12/08/20,12/08/20,"Hospital Regional de Alta Especialidad de Zumpango, Zumpango, Estado De Mexico",Mexico,Respiratory Diseases,1,4,362.0
1925.0,NCT04355793,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,,Available,COVID-19,,,,,,,Drug: Ruxolitinib,Incyte Corporation,All,"12 Years and older   (Child, Adult, Older Adult)",,Industry,Expanded Access:Treatment IND/Protocol,,,,21/04/20,24/04/20,,,Respiratory Diseases,1,1,
1926.0,NCT04357327,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),,Completed,COVID-19,SARS-CoV 2,Corona Virus Infection,,,,,Diagnostic Test: rapid salivary test,Università degli Studi dell'Insubria,All,"Child, Adult, Older Adult",122.0,Other,Interventional,2020-04-16,31/05/20,2020-07-31,22/04/20,04/11/20,"ASST dei Sette Laghi, Varese, VA",Italy,Respiratory Diseases,1,3,106.0
1927.0,NCT04546191,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,,Completed,COVID-19,,,,,,,,Landspitali University Hospital,All,"18 Years and older   (Adult, Older Adult)",1580.0,Other,Observational,2020-01-07,01/09/20,2020-01-09,11/09/20,16/09/20,"Landspitali National University Hospital, Reykjavík, Ísland",Iceland,Respiratory Diseases,1,1,2.0
1928.0,NCT04764981,Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19),,Enrolling by invitation,COVID-19,SARS-CoV Infection,Olfactory Disorder,Anosmia,,,,Other: Essence oils,Universidade do Estado do Pará,All,"18 Years to 65 Years   (Adult, Older Adult)",350.0,Other,Interventional,2021-01-05,01/05/22,2024-01-05,21/02/21,21/02/21,"Unidade de Ensino E Assistência Em Fisioterapia E Terapia Ocupacional, Belém, PA",Brazil,Respiratory Diseases,1,4,1095.0
1929.0,NCT04739449,4C' Intervention to Reduce SARS-CoV-2 (Covid-19) Transmission,,Not yet recruiting,SARS-CoV Infection,COVID-19,,,,,,"Behavioral: Coaching, Cleaning, Communication, Collaboration",University of Michigan|National Institute on Aging (NIA),All,"18 Years and older   (Adult, Older Adult)",100.0,Other|NIH,Interventional,2021-07-05,01/10/21,2022-01-01,04/02/21,13/04/21,,,Respiratory Diseases,1,2,180.0
1930.0,NCT04507282,Eosinophil and Anticoagulation in COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: LMWH,Bursa Postgraduate Hospital,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-05-15,01/07/20,2020-07-15,11/08/20,18/08/20,"Bursa Yüksek İhtisas Hastanesi, Yıldırım",Turkey,Respiratory Diseases,1,1,61.0
1931.0,NCT04367883,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",,Recruiting,COVID-19,Influenza Vaccination,ACE Inhibitors,ARB,,,,Drug: ACE inhibitor|Drug: ARB,Consorci Sanitari de Terrassa|Jordi Gol i Gurina Foundation|Institut Català de la Salut,All,"Child, Adult, Older Adult",2574.0,Other,Observational,2020-01-03,30/09/22,2023-08-31,29/04/20,02/02/21,"Hospital de Terrassa, Terrassa, Barcelona",Spain,"Infectious Diseases, Respiratory Diseases",1,4,1336.0
1932.0,NCT04728802,Proxalutamide Treatment for Hospitalized COVID-19 Patients,,"Active, not recruiting",COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Proxalutamide|Drug: Standard of Care,"Applied Biology, Inc.",All,"18 Years and older   (Adult, Older Adult)",590.0,Industry,Interventional,2021-02-02,22/03/21,2021-04-22,28/01/21,19/03/21,"Centro Clínico Advance, SGAS 915, Lote 69/70, Sala 262, Brasília, DF",Brazil,Respiratory Diseases,1,2,79.0
1933.0,NCT04340349,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,ELEVATE,Enrolling by invitation,Hydroxychloroquine,Antimalarials,Enzyme Inhibitors,Antirheumatic Agents,,,,Drug: Hydroxychloroquine Sulfate|Drug: Bromhexine 8 MG,Instituto Nacional de Rehabilitacion,All,18 Years to 59 Years   (Adult),214.0,Other,Interventional,2021-01-02,30/05/21,2021-06-30,09/04/20,05/04/21,"National Institute of Rehabilitation, Luis Guillermo Ibarra Ibarra, Mexico City, Cdmx",Mexico,Others,0,4,179.0
1934.0,NCT04495907,COVID-19 Progression in End-Stage Kidney Disease,COPE,Recruiting,COVID-19,COVID-19,,,,,,,Davita Clinical Research,All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Industry,Observational,2020-06-08,01/03/21,2021-01-06,03/08/20,07/01/21,"DCR Victorville, Victorville, California, United States|DCR Connecticut, Bridgeport, Connecticut, United States|DCR Twin Cities, Minneapolis, Minnesota, United States|DCR Las Vegas, Las Vegas, Nevada, United States|DCR Bronx, Bronx, New York, United States|DCR Canton, Canton, Ohio, United States|DCR El Paso, El Paso, Texas, United States|DCR Lewisville, Lewisville, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR Norfolk, Norfolk, Virginia, United States|DCR Milwaukee, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,2,212.0
1935.0,NCT04609501,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",,"Active, not recruiting",Delivery; Trauma,COVID-19,,,,,,,Hillel Yaffe Medical Center,Female,18 Years to 50 Years   (Adult),440.0,Other,Observational,2020-01-06,30/06/23,2024-06-30,30/10/20,30/10/20,"Department of Obstetrics and Gynecology, Hillel-Yaffe Medical Center, Hadera",Israel,Respiratory Diseases,1,2,1637.0
1936.0,NCT04416334,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,COLCHI-COVID,Recruiting,COVID-19,,,,,,,Drug: Colchicine plus symptomatic treatment (paracetamol)|Drug: Symptomatic treatment (paracetamol or best symptomatic treatment based on doctor recommendations),Instituto de Investigación Marqués de Valdecilla|Gerencia de atención primaria área 1|Gerencia de atención primaria área 2|Gerencia Atencion Primaria Area 3|Gerencia de atención primaria área 4,All,"60 Years and older   (Adult, Older Adult)",954.0,Other,Interventional,2020-08-19,25/08/21,2021-12-31,04/06/20,20/11/20,"Atención primaria (Área 2), Laredo, Cantabria, Spain|Gerencia de atención primaria (Área 3), Reinosa, Cantabria, Spain|Atencion primaria (AREA 1), Santander, Cantabria, Spain|Gerencia de atención primaria (área 4), Torrelavega, Cantabria",Spain,Respiratory Diseases,1,1,499.0
1937.0,NCT04371471,Covid-19 Pandemic Triage Score,STC-19,Completed,Sars-CoV2,COVID-19,,,,,,Diagnostic Test: STC-19 score,Groupe Hospitalier de la Rochelle Ré Aunis|Numa Health International,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-03,30/04/20,2020-04-30,01/05/20,25/06/20,"Groupe Hospitalier de la Rochelle Ré Aunis, La Rochelle",France,Respiratory Diseases,1,2,118.0
1938.0,NCT04820803,Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19,,Recruiting,COVID-19,COVID-19,,,,,,Other: ORAL INTERVENTION WITH CETYLPYRIDINIUM CHLORIDE|Other: PLACEBO,Rosa Tarrago|Dentaid SL|Instituto de Investigación Sanitaria Aragón,All,"18 Years to 80 Years   (Adult, Older Adult)",80.0,Other|Industry,Interventional,2021-03-02,23/04/21,2021-05-05,29/03/21,29/03/21,"Seminario Health Center and Lozano Blesa University Clinical Hospital, Zaragoza",Spain,Respiratory Diseases,1,2,64.0
1939.0,NCT04369794,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",BATTLE,Recruiting,COVID-19,Therapeutic Vaccine,BCG,SARS-CoV 2,Transmission,,,Biological: BCG|Biological: Placebo,"University of Campinas, Brazil|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Instituto de Infectologia Emílio Ribas|Pontifícia Universidade Católica de Campinas, PUC-Campinas|Faculty of Medicine of Ribeirão Preto (FMRP-USP)|Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil|Federal University of São Paulo|State Hospital Dr. Leandro Franceschini, Sumaré, Unicamp|Paulinia Municipal Hospital",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-10-08,01/06/21,2023-01-08,30/04/20,07/08/20,"Hospital das Clínicas Unicamp, Campinas, SP",Brazil,Respiratory Diseases,1,5,822.0
1940.0,NCT04391881,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,,Recruiting,COVID-19,,,,,,,,Cairo University,All,18 Years to 60 Years   (Adult),500.0,Other,Observational,2020-05-30,30/08/20,2020-08-30,18/05/20,16/07/20,"Cairo university, Cairo",Egypt,Respiratory Diseases,1,1,92.0
1941.0,NCT04426201,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),ILIAD-7-US-O,Recruiting,COVID-19,Lymphocytopenia,,,,,,Drug: CYT107|Drug: Placebo,"Revimmune|Memorial Sloan Kettering Cancer Center|Amarex Clinical Research|M.D. Anderson Cancer Center|Cancer Research Institute, New York City",All,"25 Years to 80 Years   (Adult, Older Adult)",48.0,Industry|Other,Interventional,2020-12-20,30/04/21,2021-12-31,11/06/20,16/02/21,"Memorail sloan kettering, New York, New York",United States,Respiratory Diseases,1,2,376.0
1942.0,NCT04809389,A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19,,Recruiting,COVID-19,,,,,,,Biological: DelNS1-nCoV-RBD LAIV|Biological: Matching placebo,The University of Hong Kong,All,18 Years to 55 Years   (Adult),115.0,Other,Interventional,2021-03-29,01/09/22,2022-01-09,22/03/21,01/04/21,"HKU Phase 1 Clinical Trials Centre, Hong Kong",Hong Kong,Respiratory Diseases,1,1,286.0
1943.0,NCT04522466,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,PREAVIS,Terminated,Sars-CoV2,,,,,,,Drug: Hydroxychloroquine (HCQ),Centre Hospitalier Universitaire de Saint Etienne|CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang,All,"18 Years and older   (Adult, Older Adult)",7.0,Other,Interventional,2020-03-04,28/05/20,2020-05-28,21/08/20,07/09/20,"Groupement Hospitalier des Portes de Province, Montélimar, France|Centre Hospitalier de Roanne, Roanne, France|CHU Saint-Etienne, Saint-Étienne, France|Clinique Mutualiste, Saint-Étienne",France,Respiratory Diseases,1,1,85.0
1944.0,NCT04479150,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,COVIDCIR,Completed,COVID-19,Surgery--Complications,,,,,,,Hospital Universitari de Bellvitge|Institut d'Investigació Biomèdica de Bellvitge,All,"18 Years and older   (Adult, Older Adult)",5307.0,Other,Observational,2020-01-03,31/08/20,2020-08-31,21/07/20,23/02/21,"Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona",Spain,Respiratory Diseases,1,2,241.0
1945.0,NCT04421391,QuadraMune(TM) for Prevention of COVID-19,,Recruiting,COVID-19,Coronavirus,SARS-CoV 2,,,,,Dietary Supplement: QuadraMune(TM),Therapeutic Solutions International,All,"18 Years to 120 Years   (Adult, Older Adult)",500.0,Industry,Interventional,2020-08-06,01/11/20,2020-08-11,09/06/20,09/06/20,"Therapeutic Solutions International, Oceanside, California",United States,Respiratory Diseases,1,3,5.0
1946.0,NCT04442178,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),ILIAD-7-US-I,Recruiting,COVID-19,Lymphocytopenia,,,,,,Drug: CYT107|Drug: Placebo,Revimmune|Washington University School of Medicine|Amarex Clinical Research,All,"25 Years to 80 Years   (Adult, Older Adult)",48.0,Industry|Other,Interventional,2020-09-15,30/10/21,2021-12-31,22/06/20,16/02/21,"University of Florida College of Medicine, Gainesville, Florida, United States|Missouri Baptist Medical Center, Saint Louis, Missouri, United States|Rutgers Health, New Brunswick, New Jersey, United States|Stony Brook Medicine, Stony Brook, New York, United States|Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio",United States,Respiratory Diseases,1,2,472.0
1947.0,NCT04738175,Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) to Treat COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: COVI-AMG|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",209.0,Industry,Interventional,2021-01-04,01/11/21,2021-01-11,04/02/21,04/02/21,,,Respiratory Diseases,1,1,7.0
1948.0,NCT04723706,Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients,,Recruiting,"Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)",,,,,,,Diagnostic Test: COVID-19 serology IgG,Henry Ford Health System,All,"18 Years to 80 Years   (Adult, Older Adult)",150.0,Other,Observational,2021-03-19,01/03/22,2022-01-04,26/01/21,23/03/21,"Henry Ford Health System, Detroit, Michigan",United States,Others,0,1,291.0
1949.0,NCT04588909,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,,"Active, not recruiting",Colo-rectal Cancer,,,,,,,Procedure: Colorectal resections,Sheri Kashmir Institute of Medical Sciences,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-03-23,22/09/20,2020-10-22,19/10/20,19/10/20,"Sher i Kashmir Institute of Medical Sciences, Srinagar, J&K",India,Cancers,1,1,213.0
1950.0,NCT04318444,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),,Recruiting,COVID-19,Corona Virus Infection,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,Columbia University,All,"18 Years and older   (Adult, Older Adult)",1600.0,Other,Interventional,2020-03-29,01/03/21,2022-01-03,24/03/20,27/04/20,"Columbia University Irving Medical Center, New York, New York",United States,Respiratory Diseases,1,2,645.0
1951.0,NCT04775134,Residual SARS-CoV-2 Presence in the Respiratory Tract and Lung Parenchyma (After SARS-CoV-2 Infection or COVID-19),REASSURE,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lung biopsy,Universitaire Ziekenhuizen Leuven,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Observational,2021-01-31,31/01/22,2022-01-31,01/03/21,10/03/21,"UZ Leuven, Leuven",Belgium,Respiratory Diseases,1,1,365.0
1952.0,NCT04824638,BNT162b2 Vaccination With Two Doses in COVID-19 Negative Adult Volunteers and With a Single Dose in COVID-19 Positive Adult Volunteers,CoviCompareP,Recruiting,Healthy,Immunization; Infection,,,,,,Biological: two doses of BNT162b2 vaccine|Biological: one dose of BNT162b2 vaccine,"ANRS, Emerging Infectious Diseases|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2021-08-03,08/08/21,2023-08-12,01/04/21,01/04/21,"CIC1412, CHRU Brest, Brest, France|Centre de Recherche Clinique, CHU Côte de Nacre, Caen, France|CIC 1405 , CHU Clermont-Ferrand, Clermont-Ferrand, France|CIC1430, Hôpital Henri Mondor, Creteil, France|CIC1413 , Hôtel Dieu - CHU Nantes, Nantes, France|Service des maladies infectieuses, CHU de Caremeau, Nîmes, France|CIC1417, hôpital Cochin, Paris, France|CIC 1427, Hopital Saint-Louis, Paris, France|URCI, Hôpital Lyon Sud, Pierre-Bénite, France|CIC1434, Nouvel Hôpital Civil - Hôpitaux Universitaires de Strasbourg, Strasbourg, France|CIC1415, CHRU Tours Hôpital Bretonneau, Tours",France,Others,0,2,739.0
1953.0,NCT04542200,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,,Enrolling by invitation,COVID-19,,,,,,,Biological: Antibody testing,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",70812.0,Other,Observational,2021-01-01,31/12/22,2022-12-31,09/09/20,08/02/21,"Feinstein Institutes for Medical Research, Northwell Health, Great Neck, New York",United States,Respiratory Diseases,1,1,729.0
1954.0,NCT04530357,"Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine",,Completed,COVID-19,SARS-CoV Infection,Vaccine Adverse Reaction,,,,,Biological: QazCovid-in® - COVID-19 inactivated vaccine|Other: Placebo,Research Institute for Biological Safety Problems|National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan,All,"18 Years to 100 Years   (Adult, Older Adult)",244.0,Other,Interventional,2020-09-19,25/11/20,2020-11-30,28/08/20,09/03/21,"Research Institute for Biological Safety Problems Committee of Science of the Ministry of Education and Science of the Republic of Kazakhstan, Gvardeyskiy, Jambul",Kazakhstan,Respiratory Diseases,1,3,72.0
1955.0,NCT04371029,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,COVISLEEP,Recruiting,ARDS,COVID-19,,,,,,Other: PSG,"University Hospital, Bordeaux",All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2020-04-28,28/09/20,2020-12-28,01/05/20,12/06/20,"Hopital Pellegrin, Bordeaux",France,Respiratory Diseases,1,2,244.0
1956.0,NCT04824625,Incidence of Infection Reported by COVID-19 in Attendees of a Commercial Music Concert,,Not yet recruiting,COVID-19,,,,,,,,"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Festivals per la Cultura Segura AIE",All,"18 Years to 65 Years   (Adult, Older Adult)",5000.0,Other,Observational,2021-01-03,27/03/21,2021-10-04,01/04/21,01/04/21,"Germans Trias i Pujol Hospital, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,274.0
1957.0,NCT04342884,COVID-19 Community Research Partnership,,Recruiting,Coronavirus,COVID-19,,,,,,,Wake Forest University Health Sciences,All,"Child, Adult, Older Adult",150000.0,Other,Observational,2020-08-04,01/12/21,2021-01-12,13/04/20,11/06/20,"Wake Forest Baptist Medical Center, Winston-Salem, North Carolina",United States,Respiratory Diseases,1,2,161.0
1958.0,NCT04684550,Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19),,Not yet recruiting,SARS-CoV Infection,COVID-19,Infection Viral,,,,,Drug: Stabilized hypochlorous acid|Drug: Placebo,Hospital Universitario San Ignacio|Pontificia Universidad Javeriana,All,"18 Years to 80 Years   (Adult, Older Adult)",556.0,Other,Interventional,2021-02-15,15/06/21,2021-08-15,24/12/20,28/12/20,,,Respiratory Diseases,1,3,181.0
1959.0,NCT04403438,Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic,,Enrolling by invitation,Behcet Disease,COVID-19,FMF,,,,,"Other: ıt will be compared pain, sleep, fatigue, physical activity level and quality of life and questioning exercise habits before and after the covid-19 outbreak in patients with Behçet and FMF.",Istanbul University,All,"18 Years to 65 Years   (Adult, Older Adult)",45.0,Other,Observational,2020-01-04,01/05/20,2020-06-15,27/05/20,27/05/20,"IstanbulU, Istanbul, Bakırköy",Turkey,Respiratory Diseases,1,3,163.0
1960.0,NCT04573270,Mesenchymal Stem Cells for the Treatment of COVID-19,,Completed,COVID-19,Prophylaxis,,,,,,Biological: PrimePro|Other: Placebo,Thomas Advanced Medical LLC|HeartStem Institute,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-04-24,20/08/20,2020-01-09,05/10/20,05/10/20,"Southern California Hospital at Culver City / Southern California Hospital at Hollywood, Culver City, California",United States,Respiratory Diseases,1,2,-106.0
1961.0,NCT04333550,Application of Desferal to Treat COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Deferoxamine,Kermanshah University of Medical Sciences,All,"3 Years to 99 Years   (Child, Adult, Older Adult)",50.0,Other,Interventional,2020-01-04,01/09/20,2021-01-03,03/04/20,04/05/20,"Regenerative Medicine Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah, Iran",Islamic Republic of,Respiratory Diseases,1,1,365.0
1962.0,NCT04542122,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,XPHI-COVID19,Not yet recruiting,Morals,,,,,,,Behavioral: Choices and judgements,"University Hospital, Caen|University of Geneva, Switzerland",All,"18 Years to 99 Years   (Adult, Older Adult)",500.0,Other,Interventional,2020-03-09,30/04/21,2021-02-08,09/09/20,09/09/20,,,Others,0,1,336.0
1963.0,NCT04347928,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,PHYSIO-COVID,Completed,COVID-19,ARDS,Sars-CoV2,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-04-20,06/11/20,2020-06-11,15/04/20,17/11/20,"Hopital Roger Salengro, CHU Lille, Lille",France,Respiratory Diseases,1,3,52.0
1964.0,NCT04523090,Catalysing the Containment of COVID-19,C3-RCT,Recruiting,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo,"University of Cape Town|Medical Research Council, South Africa|Aurum Institute|National Institutes of Health (NIH)|Texas Tech University Health Sciences Center|University of KwaZulu|Perinatal HIV Research Unit of the University of the Witswatersrand",All,"18 Years to 120 Years   (Adult, Older Adult)",960.0,Other|NIH,Interventional,2020-08-27,01/12/21,2022-01-02,21/08/20,01/04/21,"The Aurum Institute, Tembisa, Gauteng, South Africa|University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa|Perinatal HIV Research Unit, Klerksdorp, North West, South Africa|University of Cape Town, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,1,493.0
1965.0,NCT04814914,"An Observational Clinical Study to Evaluate COVID-19 Symptoms in ""Long Hauler"" Patients Who Participated in K031-120 or K032-120",,Recruiting,COVID-19,,,,,,,Other: KB109 + Self Supportive Care|Other: Self Supportive Care (SSC) Alone,Kaleido Biosciences,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry,Observational,2021-01-03,01/04/21,2021-01-08,24/03/21,24/03/21,"HealthStar Research, LLC, Hot Springs, Arkansas, United States|Quad Clinical Research, Chicago, Illinois",United States,Respiratory Diseases,1,1,5.0
1966.0,NCT04639375,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: Vaccinated with polio vaccine (IPV),E-MO Biology Inc,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Industry,Interventional,2020-11-15,18/04/21,2021-04-18,20/11/20,02/02/21,"Rac Ii Md, National City, California",United States,Respiratory Diseases,1,1,154.0
1967.0,NCT04587375,Diagnosis of Endocrine Dysfunctions in Covid-19,Dyhor-19,Completed,COVID-19,,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-03,01/05/20,2020-05-30,14/10/20,14/10/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,148.0
1968.0,NCT04327674,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,,Recruiting,COVID-19,,,,,,,,University of Aarhus,All,"18 Years and older   (Adult, Older Adult)",375.0,Other,Observational,2020-03-14,15/05/20,2020-05-15,31/03/20,31/03/20,"Lungemedicinsk Forskningsafdeling. Aarhus University Hospital, Aarhus, Denmark|Regionshospitalet Horsens., Horsens",Denmark,Respiratory Diseases,1,1,62.0
1969.0,NCT04452435,Safety and Efficacy of C21 in Subjects With COVID-19,,Completed,COVID-19,,,,,,,Drug: C21|Drug: Placebo,Vicore Pharma AB|Orphan Reach,All,"18 Years to 70 Years   (Adult, Older Adult)",106.0,Industry|Other,Interventional,2020-07-21,13/10/20,2020-10-13,30/06/20,21/02/21,"Department of Medicine, Civil Hospital and B J Medical College, Ahmadabad, Gujarat, India|Infectious Disease, Metas Adventist Hospital, Surat, Gujarat, India|Clinical Research Department, Basement, Unity Trauma Centre and ICU (Unity Hospital, Surat, Gujarat, India|First Floor Clinical Research Department Rhythm Heart Institute, Vadodara, Gujarat, India|Internal Medicine S.L. Raheja Hospital, Mumbai, Maharashtra, India|Department of Medicine, Government Medical College and Hospital, Nagpur, Maharashtra, India|Neuro Critical Care, Grant Medical Foundation Ruby Hall Clinic, Pune, Maharashtra, India|Department of Medicine, Noble Hospitals Pvt. Ltd, Pune, Maharashtra, India|Respiratory Medicine, University College Hospital, London",United Kingdom,Respiratory Diseases,1,1,84.0
1970.0,NCT04324606,A Study of a Candidate COVID-19 Vaccine (COV001),,"Active, not recruiting",Coronavirus,,,,,,,Biological: ChAdOx1 nCoV-19|Biological: MenACWY|Biological: ChAdOx1 nCoV-19 full boost|Biological: ChAdOx1 nCoV-19 half boost|Biological: MenACWY boost|Drug: Paracetamol|Biological: ChAdOx1 nCoV-19 0.5mL boost|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine (LV)|Biological: ChAdOx1 nCoV-19 0.5mL (3.5-6.5x10^10vp) late vaccine two (LVT),University of Oxford,All,18 Years to 55 Years   (Adult),1090.0,Other,Interventional,2020-04-23,01/10/21,2021-01-10,27/03/20,13/04/21,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford",United Kingdom,Respiratory Diseases,1,1,262.0
1971.0,NCT04840940,Presepsin Biomarker for Ventilator-associated Pneumonia Diagnosis in COVID-19 Patients,,Recruiting,Ventilator Associated Pneumonia,COVID-19,,,,,,,San Luigi Gonzaga Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-12-21,21/12/21,2021-12-21,12/04/21,12/04/21,"SCDU Anestesia e Rianimazione, AOU San Luigi Gonzaga, Orbassano, Turin",Italy,Respiratory Diseases,1,2,365.0
1972.0,NCT04490772,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,,Not yet recruiting,Infectious,,,,,,,Diagnostic Test: Laboratory tests,Assiut University,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-07,01/09/20,2020-01-09,29/07/20,29/07/20,,,Others,0,1,2.0
1973.0,NCT04400890,"Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19",,"Active, not recruiting",COVID-19,,,,,,,Drug: Resveratrol|Dietary Supplement: Vitamin D3,"Marvin McCreary, MD|Mount Carmel Health System",All,"45 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-12-09,11/01/21,2021-01-03,26/05/20,09/03/21,"Mt Carmel HealthSystems, Columbus, Ohio",United States,Respiratory Diseases,1,1,25.0
1974.0,NCT04336761,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,INCOVPED,Completed,Coronavirus,COVID-19,Infection Viral,,,,,Diagnostic Test: nasopharyngeal swab,"University Hospital, Lille",All,"up to 18 Years   (Child, Adult)",901.0,Other,Observational,2020-04-15,01/01/21,2021-01-01,07/04/20,11/03/21,"CH Louis MOURIER, Colombes, France|Hôpital Jeanne de Flandres, CHU, Lille, France|Hôpital Mère Enfant CHU, Nantes, France|Hôpitaux Pédiatriques de Nice CHU-Lenval, Nice, France|Hôpital des enfants - CHU, Toulouse, France|CHU de Tours, Tours",France,Respiratory Diseases,1,3,261.0
1975.0,NCT04459689,COVID-19 in PID Survey,COPID19,Recruiting,Primary Immune Deficiency,COVID-19,,,,,,,Imagine Institute,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-03-15,31/03/22,2022-03-31,07/07/20,07/07/20,"Imagine Institute, Paris",France,Respiratory Diseases,1,2,746.0
1976.0,NCT04649957,Profiling Recovery of Those Discharged Into the Community With COVID-19,,Not yet recruiting,"Infections, Respiratory",Respiratory Physiology,Respiratory Muscle,Symptoms and General Pathology,,,,,University of Derby|Sheffield Hallam University|University Hospitals of Derby and Burton NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-04-01,17/12/21,2021-12-17,02/12/20,02/12/20,"University of Derby, Derby",United Kingdom,Others,0,4,260.0
1977.0,NCT04628104,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,,Not yet recruiting,Myocardial Infarction,,,,,,,Radiation: cardiac magnetic resonance,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Observational,2021-01-01,01/10/22,2023-01-10,13/11/20,16/11/20,,,Others,0,1,739.0
1978.0,NCT04444401,Registry on NEN Patients and COVID-19,,Recruiting,Neuroendocrine Tumors,COVID-19,,,,,,,European Institute of Oncology,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-06-15,15/06/21,2021-12-15,23/06/20,22/01/21,"European Institute of Oncology, IEO, IRCCS, Milan, MI",Italy,Respiratory Diseases,1,2,548.0
1979.0,NCT04762771,Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19),Colheart-19,Suspended,COVID-19,,,,,,,Drug: Colchicine,"Baptist Health South Florida|University of California, Los Angeles",All,"18 Years to 99 Years   (Adult, Older Adult)",75.0,Other,Interventional,2020-01-12,12/03/21,2021-01-11,21/02/21,08/04/21,"Baptist Hospital of Miami, Miami, Florida",United States,Respiratory Diseases,1,1,365.0
1980.0,NCT04366167,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,CardiacCovid,Recruiting,Cardiac Surgery,COVID-19,,,,,,Other: Cardiac surgery,Barts & The London NHS Trust|Queen Mary University of London,All,"18 Years to 120 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-04-18,19/04/21,2021-12-31,28/04/20,28/04/20,"St Bartholomew's Hospital, London",United Kingdom,Respiratory Diseases,1,2,622.0
1981.0,NCT04444271,Mesenchymal Stem Cell Infusion for COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Mesenchymal stem cells|Other: Placebo,"Dr. Zaineb Akram|National Institute of Blood and Marrow Transplant (NIBMT), Pakistan",All,"10 Years and older   (Child, Adult, Older Adult)",20.0,Other,Interventional,2020-01-05,30/08/20,2020-09-30,23/06/20,30/06/20,"NIBMT, Rawalpindi, Punjab",Pakistan,Respiratory Diseases,1,1,269.0
1982.0,NCT04622891,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,,Completed,COVID-19,,,,,,,Drug: Clarithromycin 500mg|Drug: Azithromycin|Drug: Placebo,South Valley University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-04,30/07/20,2020-07-30,10/11/20,10/11/20,"south-Vally University faculty of medicine, Qena",Egypt,Respiratory Diseases,1,1,208.0
1983.0,NCT04537663,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,BCG-PRIME,Recruiting,Respiratory Tract Infections,COVID-19,,,,,,Drug: Bacille Calmette-Guérin (BCG)|Drug: Placebo,UMC Utrecht,All,"60 Years and older   (Adult, Older Adult)",5200.0,Other,Interventional,2020-08-25,01/11/20,2021-01-04,03/09/20,03/09/20,"Meander Medical Center, Amersfoort, Netherlands|Amsterdam University Medical Center, Amsterdam, Netherlands|OLVG, Amsterdam, Netherlands|Rijnstate hospital, Arnhem, Netherlands|Amphia hospital, Breda, Netherlands|Hagahospital, Den Haag, Netherlands|Catharina hospital, Eindhoven, Netherlands|Zuyderland Hospital, Geleen, Netherlands|Martini hospital, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|St. Antonius hospital, Nieuwegein, Netherlands|Canisius-Wilhelmina Hospital, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|Ikazia Hospital, Rotterdam, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Bernhoven hospital, Uden, Netherlands|University Medical Center Utrecht, Utrecht",Netherlands,Respiratory Diseases,1,2,132.0
1984.0,NCT04738136,"Safety, Tolerability and Efficacy Of S-1226 in Moderate Severity Covid-19 Bronchiolitis/Pneumonia",,Not yet recruiting,COVID-19,COVID-19,,,,,,Drug: S-1226,SolAeroMed Inc.,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2021-02-15,31/05/21,2021-12-31,04/02/21,04/02/21,,,Respiratory Diseases,1,2,319.0
1985.0,NCT04806113,COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases,COVIAAD,Recruiting,COVID-19,Rheumatic Diseases,Rheumatoid Arthritis,SLE,,,,Biological: Moderna COVID-19 vaccine,McGill University Health Centre/Research Institute of the McGill University Health Centre|CHU de Quebec-Universite Laval|Ministere de la Sante et des Services Sociaux,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2021-11-03,11/03/22,2022-03-15,19/03/21,19/03/21,"McGill University Health Centre, Montreal, Quebec",Canada,"Respiratory Diseases, Immunological Disorders",1,4,132.0
1986.0,NCT04333472,Piclidenoson for Treatment of COVID-19,,Recruiting,COVID-19,Coronavirus Infection,,,,,,Drug: Piclidenoson|Drug: Placebo,Can-Fite BioPharma|Rabin Medical Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2021-06-01,06/03/22,2022-06-07,03/04/20,24/03/21,"Hadassah Medical Center, Jerusalem, Israel|Shaare Zedek Medical Center, Jerusalem",Israel,Respiratory Diseases,1,2,371.0
1987.0,NCT04437706,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,Snowball,Enrolling by invitation,COVID-19,SARS-CoV 2,,,,,,,Duke University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-11-12,30/06/22,2022-06-30,18/06/20,23/12/20,"Duke University Medical Center, Durham, North Carolina",United States,Respiratory Diseases,1,2,595.0
1988.0,NCT04390594,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,SEN-CoV-Fadj,Recruiting,COVID-19,,,,,,,Drug: Nafamostat Mesilate,"Institut Pasteur de Dakar|Fann Hospital, Senegal|Ministry of Health, Senegal|Diamniadio Children Hospital, Senegal|Dalal Jamm Hospital, Senegal|Institut Pasteur Korea",All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Interventional,2020-08-13,12/02/21,2021-12-08,15/05/20,07/09/20,"Infectious and Tropical Diseases Department, Fann Hospital, Dakar, Senegal|Diamniadio Children Hospital, Diamniadio, Senegal|Dalal Jamm Hospital, Guédiawaye",Senegal,Respiratory Diseases,1,1,482.0
1989.0,NCT04445285,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,DAMPENCOVID,Recruiting,COVID-19,,,,,,,Drug: Pulmozyme/ Recombinant human deoxyribonuclease (rh-DNase)|Drug: 0.9%sodium chloride,Jon Simmons|University of South Alabama,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2020-04-28,30/11/20,2021-02-28,24/06/20,21/08/20,"University of South Alabama, Mobile, Alabama",United States,Respiratory Diseases,1,1,306.0
1990.0,NCT04383002,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),,Recruiting,COVID-19,,,,,,,Drug: Nitric Oxide,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-02-09,01/08/21,2021-01-08,11/05/20,01/04/21,"University Health Network, Toronto General Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,1,334.0
1991.0,NCT04403100,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",,Recruiting,COVID-19,Coronavirus Infection,Virus Disease,Acute Respiratory Infection,SARS-CoV Infection,,,Drug: Hydroxychloroquine Sulfate Tablets|Drug: Lopinavir/ Ritonavir Oral Tablet|Drug: Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets|Drug: Placebo,Cardresearch|Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA|Cytel Inc.,All,"18 Years and older   (Adult, Older Adult)",1968.0,Other|Industry,Interventional,2020-03-06,01/02/21,2021-01-02,27/05/20,26/01/21,"CARDRESEARCH - Cardiologia Assistencial e de Pesquisa, Belo Horizonte, Minas Gerais, Brazil|Pontificia Universidade Catolica de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Fundo Municipal de Saúde de Betim, Betim, Minas Gerais, Brazil|Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais",Brazil,Respiratory Diseases,1,5,302.0
1992.0,NCT04700163,RU Anti-SARS-CoV-2 (COVID-19) mAbs in Healthy Volunteers,RU,"Active, not recruiting",COVID-19,,,,,,,Biological: C144-LS and C-135-LS,Rockefeller University,All,"18 Years and older   (Adult, Older Adult)",23.0,Other,Interventional,2021-11-01,15/06/21,2022-04-15,07/01/21,25/03/21,"The Rockefeller University, New York, New York",United States,Respiratory Diseases,1,1,165.0
1993.0,NCT04619706,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: FSD201|Drug: Placebo,"FSD Pharma, Inc.",All,"18 Years and older   (Adult, Older Adult)",350.0,Industry,Interventional,2020-12-14,14/08/21,2021-05-12,06/11/20,03/03/21,"St. Petersburg, Florida, Saint Petersburg, Florida, United States|Idaho Falls, Idaho, Idaho Falls, Idaho, United States|Winfield, Illinois, Winfield, Illinois, United States|Mesquite, Texas, Mesquite, Texas",United States,Respiratory Diseases,1,1,149.0
1994.0,NCT04359680,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,,"Active, not recruiting",COVID-19,Viral Respiratory Illnesses,,,,,,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,Romark Laboratories L.C.,All,"18 Years to 120 Years   (Adult, Older Adult)",1407.0,Industry,Interventional,2020-05-13,29/03/21,2021-03-29,24/04/20,08/02/21,"HealthStar Research LLC, Hot Springs, Arkansas, United States|So Cal Clinical Research, Huntington Beach, California, United States|Long Beach Clinical Trials, LLC, Long Beach, California, United States|Meris Clinical Research, Brandon, Florida, United States|Invesclinica US LLC, Fort Lauderdale, Florida, United States|The Chappel Group Research, Kissimmee, Florida, United States|New Horizon Research Center, Miami, Florida, United States|Clinical Neuroscience Solutions, Inc., Orlando, Florida, United States|DMI Research, Pinellas Park, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|Chicago Clinical Research Institute, Inc., Chicago, Illinois, United States|Chicago Medical Research Institute, Inc., Chicago, Illinois, United States|Quad Clinical Research, Chicago, Illinois, United States|Chicago Medical Research, LLC, Hazel Crest, Illinois, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Vida Clinical Studies, Dearborn, Michigan, United States|Beacom Family Health Connection, Fremont, Nebraska, United States|North Jersey Community Research Initiative, Newark, New Jersey, United States|RH Medical Urgent Care Professional PLLC, Bronx, New York, United States|Integrative Clinical Trials LLC, Brooklyn, New York, United States|The New York Center for Travel and Tropical Medicine, New York, New York, United States|Centex Studies, Inc., Houston, Texas, United States|SMS Clinical Research LLC, Mesquite, Texas, United States|LinQ Research LLC, Pearland, Texas, United States|Rio Grande Valley Clinical Research Institute, Pharr, Texas, United States|BFHC Research, San Antonio, Texas",United States,Respiratory Diseases,1,2,320.0
1995.0,NCT04386265,Compassionate Use of Hyperbaric Oxygen Therapy,,Enrolling by invitation,COVID-19,,,,,,,,"SerenaGroup, Inc.|SerenaGroup Research Foundation",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-15,11/05/22,2022-11-05,13/05/20,23/10/20,"White River Wound Healing Center, Batesville, Arkansas, United States|Community Hospital, Monterey, California, United States|Innovative Healing Systems, Tampa, Florida, United States|Decatur Memorial Hospital, Decatur, Indiana, United States|Providence Medical Wound Care Center, Kansas City, Kansas, United States|West Jefferson Medical Center, Marrero, Louisiana, United States|The Wound Treatment Center, Opelousas, Louisiana, United States|Christus Shreveport Bossier Hyperbaric & Wound Care Center, Shreveport, Louisiana, United States|Ascension Providence Rochester Hospital Wound Care Center, Rochester, Michigan, United States|CHI, Chattanooga, Tennessee, United States|Klinika Baromedical, Poznan, Wielkopolskie",Poland,Respiratory Diseases,1,1,934.0
1996.0,NCT04381351,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,MiRCOVID,Recruiting,COVID-19,,,,,,,,"Heinrich-Heine University, Duesseldorf",All,"18 Years to 90 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-04-16,01/03/21,2021-07-31,08/05/20,27/05/20,"Klinik für Anästhesiologie, Düsseldorf",Germany,Respiratory Diseases,1,1,471.0
1997.0,NCT04348370,BCG Vaccine for Health Care Workers as Defense Against COVID 19,BADAS,Recruiting,Coronavirus,Coronavirus Infection,Coronavirus as the Cause of Diseases Classified Elsewhere,,,,,Biological: BCG Vaccine|Biological: Placebo Vaccine,Texas A&M University|Baylor College of Medicine|M.D. Anderson Cancer Center|Cedars-Sinai Medical Center|Harvard University,All,"18 Years to 75 Years   (Adult, Older Adult)",1800.0,Other,Interventional,2020-04-20,01/05/21,2021-01-11,16/04/20,27/05/20,"Cedars-Sinai Medical Center, Los Angeles, California, United States|Texas A&M Family Care Clinic, Bryan, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Harris Health System - Ben Taub Hospital, Houston, Texas, United States|MD Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,3,266.0
1998.0,NCT04377035,The Role of Ultrasound in COVID-19,,Recruiting,COVID-19,,,,,,,,"University Hospital, Gentofte, Copenhagen",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-31,01/03/21,2021-01-03,06/05/20,16/11/20,"Cardiovascular Non-Invasive Imaging Research Laboratory, department of Cardiology, Herlev & Gentofte Hospital, Hellerup",Denmark,Respiratory Diseases,1,1,278.0
1999.0,NCT04834401,Effect of Disease Modifying Therapy on Antibody Response to COVID19 Vaccination in Multiple Sclerosis,,Recruiting,Multiple Sclerosis,COVID-19,,,,,,,St. Barnabas Medical Center,All,"18 Years to 65 Years   (Adult, Older Adult)",120.0,Other,Observational,2021-03-22,15/02/23,2023-04-15,08/04/21,08/04/21,"Saint Barnabas Medical Center, Livingston, New Jersey",United States,"Respiratory Diseases, Immunological Disorders",1,2,754.0
2000.0,NCT04779996,Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment,,Recruiting,COVID-19,Cancer,HIV Infections,,,,,Diagnostic Test: Laboratory Samples,Auxilio Mutuo Cancer Center,All,"21 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2021-02-16,31/08/21,2022-02-28,03/03/21,03/03/21,"Auxilio Mutuo Cancer Center, San Juan",Puerto Rico,"Respiratory Diseases, Cancers",1,3,377.0
2001.0,NCT04368728,"Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",,Recruiting,COVID-19,COVID-19,,,,,,Biological: BNT162b1|Biological: BNT162b2|Other: Placebo|Biological: BNT162b2SA,BioNTech SE|Pfizer,All,"12 Years and older   (Child, Adult, Older Adult)",43998.0,Industry,Interventional,2020-04-29,29/10/21,2023-06-04,30/04/20,12/04/21,"North Alabama Research Center, LLC, Athens, Alabama, United States|Birmingham Clinical Research Unit, Birmingham, Alabama, United States|Medical Affiliated Research Center, Huntsville, Alabama, United States|Optimal Research, LLC, Huntsville, Alabama, United States|Alliance for Multispecialty Research, LLC, Mobile, Alabama, United States|Chinle Comprehensive Health Care Facility, Chinle, Arizona, United States|Johns Hopkins Center for American Indian Health, Chinle, Arizona, United States|The Pain Center of Arizona, Phoenix, Arizona, United States|HOPE Research Institute, Phoenix, Arizona, United States|Alliance for Multispecialty Research, LLC, Tempe, Arizona, United States|Whiteriver Indian Hospital, Whiteriver, Arizona, United States|Anaheim Clinical Trials, LLC, Anaheim, California, United States|Collaborative Neuroscience Research, LLC, Long Beach, California, United States|Long Beach Clinical Trials Services Inc., Long Beach, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|National Research Institute, Los Angeles, California, United States|Providence Clinical Research, North Hollywood, California, United States|Paradigm Clinical Research Center, Redding, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|UC Davis Medical Center, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Kaiser Permanente Santa Clara, Santa Clara, California, United States|Bayview Research Group, Valley Village, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Lynn Institute of Denver, Aurora, Colorado, United States|Clinical Research Consulting, LLC, Milford, Connecticut, United States|Yale Center for Clinical Investigations (CSRU), New Haven, Connecticut, United States|Alliance for Multispecialty Research, LLC-Miami, Coral Gables, Florida, United States|Clinical Research of South Florida, Coral Gables, Florida, United States|DeLand Clinical Research Unit, DeLand, Florida, United States|Fleming Island Center for Clinical Research, Fleming Island, Florida, United States|Indago Research & Health Center, Inc., Hialeah, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Neuroscience Solutions, Inc., Jacksonville, Florida, United States|Acevedo Clinical Research Associates, Miami, Florida, United States|Clinical Neuroscience Solutions, Inc, Orlando, Florida, United States|Atlanta Center for Medical Research, Atlanta, Georgia, United States|IACT Health, Columbus, Georgia, United States|Meridian Clinical Research, LLC, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Optimal Research, LLC, Peoria, Illinois, United States|University of Iowa Hospitals & Clinics Investigational Drug Servces, Iowa City, Iowa, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Meridian Clinical Research, LLC, Sioux City, Iowa, United States|Alliance for Multispecialty Research, LLC, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|LSUHSC-Shreveport Clinical Trials Office, Shreveport, Louisiana, United States|LSUHSC-Shreveport, Shreveport, Louisiana, United States|Pharmaron CPC, Inc., Baltimore, Maryland, United States|University of Maryland, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States|Center for Immunization Research Inpatient Unit, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Michigan Center for Medical Research, Farmington Hills, Michigan, United States|MedPharmics, Limited Liability Company, Gulfport, Mississippi, United States|MedPharmics, LLC, Gulfport, Mississippi, United States|Clinical Research Professionals, Chesterfield, Missouri, United States|Sundance Clinical Research, LLC, Saint Louis, Missouri, United States|Methodist Physicians Clinic / CCT Research, Fremont, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Wake Research-Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Amici Clinical Research, Raritan, New Jersey, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Johns Hopkins Center for American Indian Health, Gallup, New Mexico, United States|Johns Hopkins Center for American Indian Health, Shiprock, New Mexico, United States|Meridian Clinical Research, LLC, Binghamton, New York, United States|Meridian Clinical Research LLC, Endwell, New York, United States|NYU Langone Health, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Rochester Clinical Research, Inc., Rochester, New York, United States|Rochester Regional Health/Rochester General Hospital, Rochester, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|SUNY Upstate Medical University, Syracuse, New York, United States|PMG Research of Raleigh, LLC d/b/a PMG Research of Cary, Cary, North Carolina, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|Clinical Research Pickett Road, Durham, North Carolina, United States|Accessioning Unit and Repository, Durham, North Carolina, United States|Duke University Medicine Circle- Duke Early Phase Clinical Research Unit, Durham, North Carolina, United States|PharmQuest, Greensboro, North Carolina, United States|PMG Research of Hickory, LLC, Hickory, North Carolina, United States|PMG Research of Raleigh, LLC, Raleigh, North Carolina, United States|M3 Wake Research, Inc., Raleigh, North Carolina, United States|PMG Research of Salisbury, LLC, Salisbury, North Carolina, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|Lillestol Research LLC, Fargo, North Dakota, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Sterling Research Group, Ltd., Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|VA Northeast Ohio Healthcare System, Cleveland, Ohio, United States|Rapid Medical Research, Inc., Cleveland, Ohio, United States|Aventiv Research Inc., Columbus, Ohio, United States|Dayton Clinical Research, Dayton, Ohio, United States|PriMED Clinical Research, Dayton, Ohio, United States|Senders Pediatrics, South Euclid, Ohio, United States|Lynn Institute of Norman, Norman, Oklahoma, United States|Kaiser Permanente Northwest-Center for Health Research, Portland, Oregon, United States|Lehigh Valley Health Network/Network Office of Research and Innovation, Allentown, Pennsylvania, United States|Omega Medical Research, Warwick, Rhode Island, United States|Main Street Physician's Care, Little River, South Carolina, United States|Main Street Physician's Care, Loris, South Carolina, United States|Holston Medical Group, Bristol, Tennessee, United States|Holston Medical Group, Kingsport, Tennessee, United States|Alliance for Multispecialty Research, LLC., Knoxville, Tennessee, United States|Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States|Clinical Neuroscience Solutions, Inc., Memphis, Tennessee, United States|Clinical Research Associates, Inc., Nashville, Tennessee, United States|",Turkey,Respiratory Diseases,1,2,1131.0
2002.0,NCT04477993,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,RUXO-COVID,Terminated,Severe Acute Respiratory Syndrome Coronavirus 2,SARS-CoV2,,,,,,Drug: Janus Kinase Inhibitor (ruxolitinib)|Other: Placebo,Vanderson Geraldo Rocha|University of Sao Paulo General Hospital,All,"18 Years to 95 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-08-14,29/03/21,2021-03-29,20/07/20,08/04/21,"Hospital das Clínicas, Sao Paulo",Brazil,Respiratory Diseases,1,2,227.0
2003.0,NCT04757285,Copeptin and Psychological Stress of Medic During COVID-19 Pandemic,COVID-19,Completed,Psychological Stress,Hemostatic Disorder,,,,,,,Alexandria University,All,24 Years to 37 Years   (Adult),90.0,Other,Observational,2020-10-05,30/10/20,2020-10-30,17/02/21,17/02/21,"Alexandria University Faculty of Medicine, Alexandria",Egypt,Mental Health,1,2,25.0
2004.0,NCT04354428,Treatment for COVID-19 in High-Risk Adult Outpatients,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Drug: Ascorbic Acid|Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Folic Acid|Drug: Lopinavir 200 MG / Ritonavir 50 MG [Kaletra],University of Washington|Bill and Melinda Gates Foundation,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-04-16,01/12/20,2021-01-01,21/04/20,12/11/20,"Ruth M. Rothstein CORE Center - Cook County Health, Chicago, Illinois, United States|Tulane University, New Orleans, Louisiana, United States|Boston University, Boston, Massachusetts, United States|SUNY Upstate Medical University, Syracuse, New York, United States|University of Washington Coordinating Center, Seattle, Washington, United States|UW Virology Research Clinic, Seattle, Washington",United States,Respiratory Diseases,1,2,260.0
2005.0,NCT04444609,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,PROSAIC-19,Recruiting,COVID-19,SARS-CoV 2,"ARDS, Human",Immune System Disorder,,,,"Other: Blood tests sputum, nasal lavage and brushing",Imperial College London|Royal Brompton & Harefield NHS Foundation Trust|Chelsea and Westminster NHS Foundation Trust|Imperial College Healthcare NHS Trust,All,"16 Years and older   (Child, Adult, Older Adult)",230.0,Other,Observational,2020-06-18,01/06/21,2022-01-06,23/06/20,19/08/20,"Royal Brompton & Harefileld NHS Trusts, London",United Kingdom,Respiratory Diseases,1,4,567.0
2006.0,NCT04756323,A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,"Beijing Minhai Biotechnology Co., Ltd|Shenzhen Kangtai Biological Products Co., LTD|Jiangsu Province Centers for Disease Control and Prevention",All,"18 Years and older   (Adult, Older Adult)",1000.0,Industry|Other,Interventional,2020-10-27,30/06/21,2022-02-28,16/02/21,17/02/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,489.0
2007.0,NCT04712279,The (HD)IVACOV Trial (The High-Dose IVermectin Against COVID-19 Trial),,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin 0.6mg/kg/day|Drug: Ivermectin 1.0mg/kg/day|Drug: Placebo|Drug: Hydroxychloroquine,Corpometria Institute,All,"18 Years and older   (Adult, Older Adult)",294.0,Other,Interventional,2021-01-25,21/03/21,2021-04-20,15/01/21,15/01/21,,,Respiratory Diseases,1,1,85.0
2008.0,NCT04746092,The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19,,Recruiting,CLL,Multiple Myeloma,Lymphoma,,,,,,Tel-Aviv Sourasky Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",550.0,Other,Observational,2021-06-01,24/05/22,2022-05-24,09/02/21,09/02/21,"Tel-Aviv Sourasky Medical Center, Tel Aviv",Israel,Others,0,3,357.0
2009.0,NCT04344145,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,,Completed,COVID-19,,,,,,,,Université Libre de Bruxelles,All,"18 Years and older   (Adult, Older Adult)",693.0,Other,Observational,2020-04-16,25/05/20,2020-05-29,14/04/20,09/09/20,"Hôpital de Warquignies, Boussu, Hainaut, Belgium|Hôpital de Jolimont, Haine-Saint-Paul, Hainaut, Belgium|Hôpital de Lobbes, Lobbes, Hainaut, Belgium|Hôpital de Mons, Mons, Hainaut, Belgium|Erasme Hospital CUB, Brussels",Belgium,Respiratory Diseases,1,1,43.0
2010.0,NCT04549337,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,,Recruiting,COVID-19,,,,,,,Behavioral: Exercise training,"Rigshospitalet, Denmark",All,"40 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-09-25,01/05/21,2021-01-05,16/09/20,30/11/20,"Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,1,102.0
2011.0,NCT04819802,MIcrovascular Dysfunction in CRitically Ill cOVID-19 Patients,MICROVID,Recruiting,COVID-19,Critical Illness,Hemodynamics,SARS-CoV Infection,,,,Other: Measurement of sublingual microcirculation|Other: Plasma sampling,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2021-03-28,01/04/22,2022-01-10,29/03/21,01/04/21,"Surgical Intensive Care Unit - Kremlin Bicêtre Hospital, APHP, Le Kremlin Bicêtre",France,"Cardiovascular Diseases, Respiratory Diseases",1,4,288.0
2012.0,NCT04371328,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,RECOP,"Active, not recruiting",Emergencies,,,,,,,Other: RECOP unit patient,"University Hospital, Toulouse",All,"15 Years and older   (Child, Adult, Older Adult)",1860.0,Other,Observational,2020-03-13,05/06/20,2021-01-03,01/05/20,09/06/20,"University Hospital of Toulouse, Toulouse",France,Others,0,1,296.0
2013.0,NCT04435314,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo,Azidus Brasil|Farmoquimica S.A.,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2020-01-06,01/08/20,2020-01-08,17/06/20,17/06/20,,,Respiratory Diseases,1,1,2.0
2014.0,NCT04522986,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,COVID-19,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Biological: Mesenchymal stem cell,"Rohto Pharmaceutical Co., Ltd.",All,"20 Years and older   (Adult, Older Adult)",6.0,Industry,Interventional,2020-08-21,02/02/21,2021-02-02,21/08/20,18/03/21,"Osaka University Hospital, Suita, Osaka",Japan,Respiratory Diseases,1,1,165.0
2015.0,NCT04464408,Favipiravir Therapy in Adults With Mild COVID-19,Avi-Mild,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Placebo,"King Abdullah International Medical Research Center|Ministry of Health, Saudi Arabia",All,"18 Years to 100 Years   (Adult, Older Adult)",576.0,Other,Interventional,2020-07-23,01/12/21,2021-01-12,09/07/20,05/03/21,"Prince Mohammed Bin Abdul Aziz Hospital - Al Madinah, Al Madinah, Saudi Arabia|King Fahad Hospital - Madinah, Al Madīnah, Saudi Arabia|Primary Health Care-Safiyah, Al Madīnah, Saudi Arabia|King Abdullah Medical City - Makkah, Mecca, Saudi Arabia|King Abdulaziz Medical City - Riyadh, Riyadh, Saudi Arabia|Primary Health Care-Al Mansoura, Riyadh, Saudi Arabia|Primary Health Care-Al Urijah, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,173.0
2016.0,NCT04546776,COVID-19 Persistence in Stool,CoPS,Enrolling by invitation,SARS-CoV Infection,,,,,,,,Quadram Institute Bioscience|Norfolk and Norwich University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-08-09,01/06/22,2022-01-06,14/09/20,14/09/20,"Quadram Institute Bioscience, Norwich, Norfolk, United Kingdom|Norfolk and Norwich University Hospital Foundation Trust, Norwich, Norfolk",United Kingdom,Respiratory Diseases,1,1,515.0
2017.0,NCT04567836,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,STORM-HCW,Recruiting,COVID-19,,,,,,,Other: Investigation of the prevalence of test positivity,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-01-06,01/12/20,2020-01-12,29/09/20,09/11/20,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,6.0
2018.0,NCT04844515,The ESPERES Prospective Cohort of Healthcare Workers in France: Study on COVID-19 Vaccine and the COVID-19 Pandemic (ESPERES_COVID19),,Not yet recruiting,Healthcare Workers,COVID-19,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 99 Years   (Adult, Older Adult)",15000.0,Other,Observational,2021-09-04,23/04/21,2021-04-23,14/04/21,14/04/21,"Pitié-Salpêtrière - Charles Foix, AP-HP, Paris",France,Respiratory Diseases,1,2,-134.0
2019.0,NCT04643691,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,COVIDANCE,Recruiting,COVID-19,ARDS,,,,,,Drug: Losartan 50 mg and Spironolactone 25 mg pillules oral use,Assistance Publique Hopitaux De Marseille,All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-11-09,30/09/22,2022-10-30,25/11/20,25/11/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,2,720.0
2020.0,NCT04448782,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,,Completed,Mechanical Ventilation Complication,,,,,,,Diagnostic Test: Asynchronies detection,Corporacion Parc Tauli,All,"18 Years and older   (Adult, Older Adult)",32.0,Other,Observational,2020-09-03,30/06/20,2020-06-30,26/06/20,14/07/20,"Candelaria de Haro, Sabadell, Barcelona",Spain,Others,0,1,-65.0
2021.0,NCT04374461,A Study of N-acetylcysteine in Patients With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: N-acetylcysteine|Other: Peripheral Blood,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",84.0,Other,Interventional,2020-01-05,01/05/23,2023-01-05,05/05/20,10/03/21,"Memorial Sloan Kettering Cancer Center, New York, New York",United States,Respiratory Diseases,1,1,1096.0
2022.0,NCT04671017,"Dose Finding Study to Evaluate Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults",,"Active, not recruiting",Sars-Cov-2 Virus Infection,,,,,,,Biological: VLA2001,"Valneva Austria GmbH|National Institute for Health Research, United Kingdom",All,18 Years to 55 Years   (Adult),153.0,Industry|Other,Interventional,2020-12-16,26/02/21,2021-08-28,17/12/20,09/03/21,"Queen Elizabeth Hospital, Birmingham, United Kingdom|University Hospital Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|Newcastle University Medical School, Newcastle, United Kingdom|Southampton NIHR Clinical Research Facility, Southampton",United Kingdom,Others,0,1,255.0
2023.0,NCT04784546,"Evaluation of Muscle Strength, Functional Independence, Myalgia, Fatigue and Dyspnea in COVID-19 Infection",,Recruiting,COVID-19,,,,,,,,Gazi University,All,"18 Years to 85 Years   (Adult, Older Adult)",60.0,Other,Observational,2021-01-03,01/10/21,2022-01-01,05/03/21,05/03/21,"Gazi University Faculty of Medicine, Physical Medicine and Rehabilitation Department, Ankara",Turkey,Respiratory Diseases,1,1,363.0
2024.0,NCT04802278,Gestational Immunity for Transfer,GIFT,Recruiting,COVID-19,Breastfeeding,Vaccine Exposure Via Breast Milk,,,,,Biological: COVID-19 vaccine,"National University Hospital, Singapore|National University, Singapore|Agency for Science, Technology and Research",All,"Child, Adult, Older Adult",120.0,Other,Observational,2020-01-05,01/06/21,2021-01-12,17/03/21,17/03/21,"National University Hospital, Singapore",Singapore,Respiratory Diseases,1,3,373.0
2025.0,NCT04486313,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,,Completed,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo|Dietary Supplement: Vitamin Super B-Complex,Romark Laboratories L.C.,All,"12 Years to 120 Years   (Child, Adult, Older Adult)",1092.0,Industry,Interventional,2020-08-13,08/02/21,2021-08-02,24/07/20,01/04/21,"Invesclinic US LLC, Fort Lauderdale, Florida, United States|RH Medical Urgent Care, Bronx, New York",United States,Respiratory Diseases,1,1,354.0
2026.0,NCT04344548,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,,Not yet recruiting,COVID-19,,,,,,,Biological: Allogeneic NK transfer,Universidad Nacional de Colombia|Fundación Salud de los Andes,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-13,10/06/20,2020-10-11,14/04/20,14/04/20,"Fundacion Salud De Los Andes, Bogotá, Bogotá Distrito Capital, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,1,181.0
2027.0,NCT04335084,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",HELPCOVID-19,Recruiting,COVID-19,Coronavirus Infection,Sars-CoV2,Corona Virus Infection,COVID-19,Coronavirus,Coronavirus-19,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,ProgenaBiome|DSCS CRO,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-06-22,01/12/21,2021-01-12,06/04/20,09/02/21,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,7,204.0
2028.0,NCT04377503,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,,Not yet recruiting,Cytokine Release Syndrome,COVID-19,,,,,,Drug: Tocilizumab 180 MG/ML|Drug: Methylprednisolone Sodium Succinate,Hospital Sao Domingos,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-05,01/08/20,2020-01-11,06/05/20,06/05/20,,,Respiratory Diseases,1,2,6.0
2029.0,NCT04497623,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",SabanaHerons,Completed,COVID-19,,,,,,,Device: Invasive mechanical ventilation using the Unisabana-Herons Ventilator during 24 hours,Fundación Neumologica Colombiana|Universidad de la Sabana|Fundación Cardioinfantil Instituto de Cardiología|Clínica Universidad de La Sabana,All,"18 Years to 70 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-07-28,13/08/20,2020-09-20,04/08/20,24/09/20,"Fundacion Neumologica Colombiana, Bogotá, Bogota, Colombia|Universidad de la Sabana, Chia, Cundinamarca, Colombia|Clinica Universidad de la Sabana, Chía, Cundinamarca",Colombia,Respiratory Diseases,1,1,54.0
2030.0,NCT04526977,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,CoVIHDis,Recruiting,COVID-19,Immune Suppression,HIV-1-infection,,,,,Diagnostic Test: Immune response study,Asociacion para el Estudio de las Enfermedades Infecciosas,All,"18 Years to 85 Years   (Adult, Older Adult)",90.0,Other,Observational,2021-10-01,30/06/21,2021-09-30,26/08/20,12/01/21,"Hospital Ramon y Cajal, Madrid",Spain,Respiratory Diseases,1,3,-1.0
2031.0,NCT04408040,Use of Convalescent Plasma for COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma,"Northside Hospital, Inc.",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2020-07-14,31/07/24,2024-07-31,29/05/20,21/02/21,"Northside Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,1,1478.0
2032.0,NCT04745923,Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic,,Recruiting,COVID-19,Chronic Kidney Diseases,,,,,,,Hacettepe University,All,"18 Years to 65 Years   (Adult, Older Adult)",28.0,Other,Observational,2021-01-20,28/02/21,2021-03-30,09/02/21,09/02/21,"Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Ankara",Turkey,Respiratory Diseases,1,2,69.0
2033.0,NCT04530656,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),,"Active, not recruiting",COVID-19,,,,,,,"Biological: Two doses of middle-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Two doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 28|Biological: Three doses of high-dose recombinant SARS-CoV-2 vaccine (Sf9 Cell) at the schedule of day 0, 14, 28|Biological: Two doses of placebo at the schedule of day 0, 28（middle-dose group）|Biological: Two doses of placebo at the schedule of day 0, 28（high-dose group）|Biological: Three doses of placebo at the schedule of day 0, 14, 28（high-dose group）",Jiangsu Province Centers for Disease Control and Prevention|West China Hospital,All,"18 Years and older   (Adult, Older Adult)",168.0,Other,Interventional,2020-08-28,28/10/20,2021-08-28,28/08/20,11/02/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,365.0
2034.0,NCT04331886,An Observational Study of Patients With Coronavirus Disease 2019,COVID-19,Recruiting,COVID-19,Coronavirus,,,,,,,"Target PharmaSolutions, Inc.",All,"18 Years and older   (Adult, Older Adult)",5000.0,Industry,Observational,2020-04-13,01/03/22,2022-01-03,02/04/20,08/04/21,"University of Washington, Seattle, Washington",United States,Respiratory Diseases,1,2,630.0
2035.0,NCT04762628,"Trial Efficacy of Saisei Pharma Dietary Supplements MAF Capsules, 148 mg and M Capsules, 148 mg in Hospitalized COVID-19 Patients",SaiseiCovUKR,"Active, not recruiting",COVID-19,,,,,,,Dietary Supplement: MAF capsules 148 mg|Dietary Supplement: M capsules 148 mg|Other: Standard of care,Saisei Pharma,All,"18 Years and older   (Adult, Older Adult)",600.0,Industry,Interventional,2020-10-27,01/11/21,2022-10-01,21/02/21,24/02/21,"The Central Hospital of Rubizhne, Infection Disease Department, Rubizhne, Luhansk Region, Ukraine|Municipal Kharkiv Regional Infectious Diseases Clinical Hospital, Kharkiv",Ukraine,Respiratory Diseases,1,1,704.0
2036.0,NCT04408365,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",,Recruiting,COVID-19,Shock,,,,,,,Guy's and St Thomas' NHS Foundation Trust|King's College Hospital NHS Trust,All,"18 Years and older   (Adult, Older Adult)",82.0,Other,Observational,2020-05-08,31/05/21,2021-05-31,29/05/20,01/12/20,"Guy's & St Thomas' Hospital, London",United Kingdom,Respiratory Diseases,1,2,388.0
2037.0,NCT04622748,Neurocognitive Functions of Recovered COVID-19 Patients,,Recruiting,Cognition,COVID-19,,,,,,Behavioral: Trier Social Stress Test,"National Institute on Drug Dependence, China|Peking University Sixth Hospital|Wuhan Wuchang Hospital",All,"18 Years to 65 Years   (Adult, Older Adult)",160.0,Other,Observational,2020-10-07,10/12/20,2020-10-12,10/11/20,10/11/20,"Wuhan Wuchang Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,2,5.0
2038.0,NCT04470323,Functional Exhaustion of T Cells in COVID19 Patients,,Recruiting,T Cell Deficiency,,,,,,,Diagnostic Test: Flow cytometry,Assiut University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-07-22,01/10/20,2020-01-11,14/07/20,06/08/20,"Faculty of Medicine, Assiut",Egypt,Others,0,1,-193.0
2039.0,NCT04824391,"Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19",,Recruiting,COVID-19,,,,,,,Biological: ERUCOV-VAC 3 µg/0.5 ml Vaccine|Biological: ERUCOV-VAC 6 µg/0.5 ml Vaccine|Other: Placebo,Health Institutes of Turkey|Erciyes University Scientific Research Projects Coordination,All,18 Years to 64 Years   (Adult),250.0,Other,Interventional,2021-10-02,30/04/21,2022-04-30,01/04/21,01/04/21,"Erciyes University, Kayseri",Turkey,Respiratory Diseases,1,1,210.0
2040.0,NCT04494984,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",,Completed,COVID-19,,,,,,,Drug: INM005|Drug: Placebo,Inmunova S.A.,All,"18 Years to 79 Years   (Adult, Older Adult)",242.0,Other,Interventional,2020-07-27,23/11/20,2020-12-30,31/07/20,11/02/21,"Hospital de Cuenca Alta, Cañuelas, Buenos Aires, Argentina|Hospital Alta Complejidad El Cruce Dr. Néstor Carlos Kirchner, Florencio Varela, Buenos Aires, Argentina|Hospital Prof. Dr. Bernardo A. Houssay, Florida, Buenos Aires, Argentina|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina|Hospital Municipal Emilio Zerboni, San Antonio de Areco, Buenos Aires, Argentina|Hospital Municipal Dr. Diego E. Thompson, San Martín, Buenos Aires, Argentina|Hospital Pablo Soria, San Salvador De Jujuy, Jujuy, Argentina|Hospital Provincial Neuquén Dr. Eduardo Castro Rendón, Neuquén, Neuquen, Argentina|Hospital Centro de Salud Zenón J. Santillán, San Miguel De Tucumán, Tucuman, Argentina|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Muñiz, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Pirovano, Ciudad Autonoma de Buenos Aires, Argentina|Centro Gallego de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Adventista Belgrano, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Pasteleros, Ciudad Autonoma de Buenos Aire, Argentina|Clínica Zabala, Ciudad Autonoma de Buenos Aire, Argentina|Fundación Favaloro, Ciudad Autonoma de Buenos Aire, Argentina|Hospital Español de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina|Hospital G. A. Carlos G. Durand, Ciudad Autonoma de Buenos Aire, Argentina|Sanatorio Agote, Ciudad Autonoma de Buenos Aire, Argentina|Sanatorio Sagrado Corazón, Ciudad Autonoma de Buenos Aire",Argentina,Respiratory Diseases,1,1,156.0
2041.0,NCT04661631,Surgery and Lung Ultrasound in COVID-19 Infection,SOUNDS,Recruiting,Ultrasonography,Lung Diseases,Surgical Procedure,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,,,Diagnostic Test: Lung ultrasound,Fundacion Clinica Valle del Lili,All,"18 Years and older   (Adult, Older Adult)",451.0,Other,Observational,2020-08-05,31/07/21,2021-11-30,10/12/20,17/12/20,"Fundación Valle del Lili, Cali, Valle Del Cauca",Colombia,Respiratory Diseases,1,5,482.0
2042.0,NCT04615390,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,,Recruiting,COVID-19,,,,,,,Behavioral: Early rehabilitation|Behavioral: Subacute rehabilitation|Behavioral: Mindfulness training|Behavioral: Personalized ambulatory training,University Hospital of Ferrara,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-03-30,03/06/21,2021-03-06,04/11/20,04/11/20,"Department of Neuroscience and Rehabilitation, University Hospital of Ferrara, Ferrara, Emilia Romagna",Italy,Respiratory Diseases,1,1,341.0
2043.0,NCT04275947,The COVID-19 Mobile Health Study (CMHS),CMHS,Recruiting,COVID-19,,,,,,,"Other: nCapp, a cell phone-based auto-diagnosis system",Chinese Alliance Against Lung Cancer|Shanghai Respiratory Research Institution,All,"18 Years to 90 Years   (Adult, Older Adult)",450.0,Other,Observational,2020-02-14,30/04/20,2020-05-31,19/02/20,19/02/20,"Renmin Hospital of Wuhan University, Wuhan, Hubei",China,Respiratory Diseases,1,1,107.0
2044.0,NCT04445389,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",,Recruiting,COVID-19,,,,,,,Drug: GX-19|Drug: Saline,"Genexine, Inc.",All,18 Years to 50 Years   (Adult),210.0,Industry,Interventional,2020-06-17,17/03/21,2022-06-17,24/06/20,28/07/20,"Severance hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,730.0
2045.0,NCT04619719,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia,,Recruiting,COVID-19,,,,,,,Device: Hyperbaric Oxygen Therapy (HBOT),Legacy Health System,All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Interventional,2021-03-15,15/06/21,2022-02-15,06/11/20,17/03/21,"Greenwich Hospital - Yale New Haven Health, Greenwich, Connecticut, United States|Bozeman Health, Bozeman, Montana, United States|NYU Winthrop Hospital, Mineola, New York, United States|Legacy Emanuel Medical Center, Portland, Oregon",United States,Respiratory Diseases,1,1,337.0
2046.0,NCT04830046,Covid-19 Vaccine Responsiveness in MM and Waldenstrom,,Not yet recruiting,Multiple Myeloma,Waldenstrom Macroglobulinemia,Immune System Disorder,COVID-19,,,,,Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Observational,2021-01-09,01/11/21,2022-01-08,02/04/21,02/04/21,"Brigham and Women's Hospital, Boston, Massachusetts, United States|Dana-Farber Cancer Institute, Boston, Massachusetts",United States,Respiratory Diseases,1,4,364.0
2047.0,NCT04395768,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin C|Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Zinc Citrate|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin B12,"National Institute of Integrative Medicine, Australia",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-09,30/09/21,2021-12-31,20/05/20,11/09/20,"National Institute of Integrative Medicine, Melbourne, Victoria",Australia,Respiratory Diseases,1,1,478.0
2048.0,NCT04832841,IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA),TASMANIA,Recruiting,Kidney Transplantation,,,,,,,Diagnostic Test: anti-spike SARS-CoV-2 IgG,Institute for Clinical and Experimental Medicine,All,"18 Years to 100 Years   (Adult, Older Adult)",1000.0,Other,Observational,2021-03-18,30/09/21,2021-09-30,06/04/21,06/04/21,"Institute for Clinical and Experimental Medicine, Prague",Czechia,Others,0,1,196.0
2049.0,NCT04394117,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,CLARITY,Recruiting,SARS-Cov-2,COVID-19,,,,,,Drug: Angiotensin Receptor Blockers|Other: Placebo,The George Institute,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Interventional,2020-06-19,30/06/21,2021-08-30,19/05/20,24/12/20,"Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Royal prince Alfred Virtual Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|The Sutherland Hospital, Caringbah, New South Wales, Australia|Concord Hospital, Concord, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Northern Health, Epping, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Alfred Health, Melbourne, Victoria, Australia|Western Health, St Albans, Victoria, Australia|Lok Nayak Jai Prakash, Delhi, India|Christian Hospital, Nabarangpur, India|All India Institute of Medical Science, Raipur",India,Respiratory Diseases,1,2,437.0
2050.0,NCT04280913,Clinical Outcomes of Patients With COVID19,,Withdrawn,Coronavirus Disease 2019,,,,,,,Other: retrospective analysis,Guangzhou Institute of Respiratory Disease|Huizhou Municipal Central Hospital,All,"Child, Adult, Older Adult",0.0,Other,Observational,2020-02-22,31/03/20,2020-03-31,21/02/20,19/03/20,"HuiZhou Municipal Central Hospital, Huizhou, Guangdong",China,Respiratory Diseases,1,1,38.0
2051.0,NCT04724850,Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura,COVIXTREM,Not yet recruiting,Coronavirus Disease 2019,,,,,,,,Juan Fernando Masa Jiménez|University of Extremadura,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2021-01-02,01/07/22,2023-01-07,26/01/21,01/02/21,,,Respiratory Diseases,1,1,735.0
2052.0,NCT04431869,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,,Recruiting,Pregnancy Related,COVID-19,Intestinal Atresia,Limb Anomaly,,,,,"University of Colorado, Denver",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-08-18,01/07/22,2022-01-07,16/06/20,24/08/20,"Children's Hospital Colorado, Aurora, Colorado",United States,Respiratory Diseases,1,4,507.0
2053.0,NCT04668950,Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2),,Recruiting,COVID-19,Coronavirus,,,,,,Drug: Fluvoxamine|Drug: Placebo,Washington University School of Medicine|Covid-19 Early Treatment Fund|McGill University Health Centre Department of Medicine Clinical Practice Assessment Unit,All,"30 Years and older   (Adult, Older Adult)",1100.0,Other,Interventional,2020-12-22,01/07/21,2021-01-09,16/12/20,03/03/21,"Northwestern University, Evanston, Illinois, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|University of Utah, Salt Lake City, Utah, United States|Fred Hutchinson, Seattle, Washington, United States|McGill University Health Center, Montreal, Quebec",Canada,Respiratory Diseases,1,2,18.0
2054.0,NCT04805931,VEText Message Framing and Covid-19 Vaccine Uptake Among at Risk Veterans,VEText,Recruiting,COVID-19,Vaccine Refusal,,,,,,Behavioral: Behavioral economics,VA Puget Sound Health Care System,All,"18 Years and older   (Adult, Older Adult)",4311.0,U.S. Fed,Interventional,2021-03-15,01/05/21,2021-01-11,18/03/21,18/03/21,"VA Puget Sound Health Care System, Seattle, Washington",United States,Respiratory Diseases,1,2,-63.0
2055.0,NCT04467918,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,CANDIDATE,"Active, not recruiting",SARS-CoV2,,,,,,,Drug: Cannabidiol|Other: PLACEBO,University of Sao Paulo|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Fundação de Amparo à Pesquisa do Estado de São Paulo,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-07,16/11/20,2020-12-16,13/07/20,03/11/20,"Serviço de Assistência Médica e Social do Pessoal do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brazil|Unidade de Pronto Atendimento/UPA - 13 de Maio/Dr. Luis Atílio Losi Viana (UPA Covid), Ribeirão Preto, São Paulo",Brazil,Respiratory Diseases,1,1,192.0
2056.0,NCT04555148,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),,Recruiting,COVID-19,,,,,,,Biological: GC5131|Other: Placebo,Green Cross Corporation,All,"19 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-09-20,30/12/20,2021-01-08,18/09/20,18/09/20,"Samsung Medical Center, Seoul, Korea, Republic of|Samsung Medical Center, Seoul, Korea",Republic of,Respiratory Diseases,1,1,110.0
2057.0,NCT04352582,COVID-19 and Vaccination Attitudes,VACAT,Completed,COVID-19,,,,,,,Other: Survey,"University Hospital, Geneva|University of Zurich|University of Lausanne",All,"Child, Adult, Older Adult",1194.0,Other,Observational,2020-04-14,30/04/20,2020-04-30,20/04/20,13/11/20,"Survey, London",United Kingdom,Respiratory Diseases,1,1,16.0
2058.0,NCT04716647,Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,,Completed,COVID-19,,,,,,,Other: Ayurveda,Aarogyam UK|University of Warwick|Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University,All,"20 Years to 70 Years   (Adult, Older Adult)",28.0,Other,Interventional,2020-09-10,12/12/20,2020-12-18,20/01/21,20/01/21,"Aarogyam UK, Leicester, Leicestershire",United Kingdom,Respiratory Diseases,1,1,99.0
2059.0,NCT04409509,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),,Completed,COVID-19,,,,,,,"Biological: Garadacimab, Factor XIIa Antagonist Monoclonal Antibody|Drug: Placebo",CSL Behring,All,"18 Years and older   (Adult, Older Adult)",124.0,Industry,Interventional,2020-01-07,12/01/21,2021-12-01,01/06/20,22/01/21,"Nova Clinical Research, LLC, Bradenton, Florida, United States|Theia Clinical Research, LLC, Saint Petersburg, Florida, United States|MercyOne North Iowa Medical Center, Mason City, Iowa, United States|Northeast Iowa Medical Education Foundation, Waterloo, Iowa, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Holy Name Hospital, Teaneck, New Jersey, United States|Inspira Health Center Vineland, Vineland, New Jersey, United States|Sisters of Charity Hospital/ St. Joseph's Campus, Buffalo, New York, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Monument Health Clinical Research, Rapid City, South Dakota, United States|PharmaTex Research, Amarillo, Texas, United States|UT Health Science Center, McGovern Medical School, Houston, Texas, United States|Inova Alexandria Hospital, Alexandria, Virginia",United States,Respiratory Diseases,1,1,694.0
2060.0,NCT04416113,Photodynamic Therapy for the Treatment of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Procedure: photobiomodulation and photodynamic therapy,Cairo University,All,"Child, Adult, Older Adult",60.0,Other,Interventional,2020-01-08,01/12/20,2021-01-02,04/06/20,05/06/20,,,Respiratory Diseases,1,1,360.0
2061.0,NCT04521400,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",,Not yet recruiting,COVID-19,,,,,,,Drug: High dose Interferon-beta 1a|Drug: Lopinavir/Ritonavir|Drug: Low dose Interferon-beta 1a,Shahid Beheshti University of Medical Sciences,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-20,04/09/20,2020-11-09,20/08/20,20/08/20,,,Respiratory Diseases,1,1,81.0
2062.0,NCT04785144,Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults,,Recruiting,COVID-19,COVID-19,,,,,,Biological: mRNA-1273|Biological: mRNA-1273.351,"National Institute of Allergy and Infectious Diseases (NIAID)|ModernaTX, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",210.0,NIH|Industry,Interventional,2021-03-29,31/08/22,2022-08-31,05/03/21,12/04/21,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington",United States,Respiratory Diseases,1,2,520.0
2063.0,NCT04326920,Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),SARPAC,Completed,COVID-19,,,,,,,Drug: Sargramostim|Other: Control,"University Hospital, Ghent|Flanders Institute of Biotechnology",All,"18 Years to 80 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-03-24,28/09/20,2021-02-26,30/03/20,02/03/21,"AZ Sint Jan Brugge, Brugge, Belgium|University Hospital Ghent, Gent, Belgium|UZ Brussel, Jette, Belgium|AZ Delta Roeselare, Roeselare",Belgium,Respiratory Diseases,1,1,339.0
2064.0,NCT04760704,Covid-19 Vaccine Response in Elderly Subjects,MONITOCOVAGING,Recruiting,COVID-19,,,,,,,Biological: Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration,"University Hospital, Lille",All,"40 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2021-02-19,01/05/23,2023-01-05,18/02/21,30/03/21,"CHU lille, Lille",France,Respiratory Diseases,1,1,685.0
2065.0,NCT04383678,Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,,Recruiting,COVID-19,Extracorporeal Membrane Oxygenation Complication,Acute Respiratory Distress Syndrome,,,,,Device: Extracorporeal membrane oxygenation,Helsinki University Central Hospital,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-03,01/04/21,2021-01-04,12/05/20,01/04/21,"Helsinki University Hospital, Helsinki, Finland|University Hospital Jean Minjoz, Besançon, France|Nancy University Hospital, Nancy, France|Henri Mondon Unoversity Hospital, Paris, France|Robert Debré University Hospital, Reims, France|Hamburg University Heart Center, Hamburg, Germany|Münster University Hospital, Münster, Germany|S. Orsola Hospital, Bologna, Italy|Lecco Hospital, Lecco, Italy|Karolinska University Hospital, Stockholm, Sweden|University Hospitals of Leicester, Leicester",United Kingdom,Respiratory Diseases,1,3,367.0
2066.0,NCT04402905,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",COVID-PSL,Completed,Coronavirus Infection,,,,,,,,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-06-15,15/07/20,2020-08-15,27/05/20,03/02/21,"Yasmine Dudoit, Paris",France,Respiratory Diseases,1,1,61.0
2067.0,NCT04354701,COVID-19 and Cancer Consortium Registry,CCC19,Recruiting,COVID-19,Invasive Malignancy (Any Type),,,,,,Other: Web-based REDCap survey,Vanderbilt-Ingram Cancer Center,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-03-17,01/12/21,2022-01-12,21/04/20,19/11/20,"Vanderbilt University Medical Center, Nashville, Tennessee",United States,Respiratory Diseases,1,2,666.0
2068.0,NCT04376944,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,EMBELLIE,Recruiting,Caregivers,COVID-19,,,,,,Other: Survey,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-04,01/12/20,2020-12-30,06/05/20,06/05/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,361.0
2069.0,NCT04383613,Prone Positioning for Patients on General Medical Wards With COVID19,COVID-PRONE,Recruiting,COVID-19,ARDS,,,,,,Other: Prone positioning,"Unity Health Toronto|Sunnybrook Health Sciences Centre|Sinai Health System|Toronto General Hospital|University Health Network, Toronto|William Osler Health System",All,"18 Years and older   (Adult, Older Adult)",340.0,Other,Interventional,2020-05-15,01/06/21,2021-01-06,12/05/20,19/03/21,"William Osler Health System, Brampton, Ontario, Canada|William Osler Health System, Etobicoke, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|St. Joseph's Health Centre, Toronto, Ontario",Canada,Respiratory Diseases,1,2,236.0
2070.0,NCT04546737,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",NSpectroCovid,Recruiting,COVID-19,Neurological Manifestations,Brain Damage,,,,,Other: Magnetic Resonance Spectroscopy (MRS).,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-08-09,01/07/21,2022-01-05,14/09/20,17/09/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,3,514.0
2071.0,NCT04446377,A Study of LAM-002A for the Prevention of Progression of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Apilimod Dimesylate Capsule|Other: Placebo,"AI Therapeutics, Inc.|Yale University",All,"18 Years and older   (Adult, Older Adult)",142.0,Industry|Other,Interventional,2020-07-15,31/03/21,2021-04-30,24/06/20,04/11/20,"Yale University, New Haven, Connecticut",United States,Respiratory Diseases,1,1,289.0
2072.0,NCT04700462,COVID-19 Preventive Behavior in African Americans,,Recruiting,COVID-19,Health Behavior,,,,,,Behavioral: Sm-EMA,Johns Hopkins University|National Institute on Aging (NIA),All,"60 Years and older   (Adult, Older Adult)",250.0,Other|NIH,Interventional,2021-05-02,30/10/21,2021-10-30,07/01/21,24/02/21,"Johns Hopkins School of Nursing, Baltimore, Maryland",United States,Respiratory Diseases,1,2,181.0
2073.0,NCT04350931,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: intradermal injection of BCG Vaccine|Other: placebo,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Interventional,2020-04-20,01/10/20,2020-01-12,17/04/20,20/04/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,-99.0
2074.0,NCT04821674,Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects,,Recruiting,COVID-19,,,,,,,Biological: DS-5670a|Biological: Placebo,"Daiichi Sankyo Co., Ltd.|Daiichi Sankyo, Inc.",All,"20 Years to 74 Years   (Adult, Older Adult)",152.0,Industry,Interventional,2021-03-15,31/07/22,2022-12-31,29/03/21,01/04/21,"SOUSEIKAI Hakata Clinic, Hakata, Fukuoka",Japan,Respiratory Diseases,1,1,656.0
2075.0,NCT04603079,Nurse Leadership for Hospital Infection Control,,Not yet recruiting,Nurse's Role,Infection,,,,,,Behavioral: Intervention for COVID-19 preventive protocols,"Forman Christian College, Pakistan|King Edward Medical University",Female,"Child, Adult, Older Adult",200.0,Other,Interventional,2021-01-04,01/08/21,2021-01-09,26/10/20,03/02/21,,,Others,0,2,5.0
2076.0,NCT04715295,Safety and Efficacy of Doxycycline and Rivaroxaban in COVID-19,DOXYCOV,Recruiting,COVID-19,,,,,,,Drug: Doxycycline Tablets|Drug: Rivaroxaban 15Mg Tab|Combination Product: Hydroxychloroquine and Azithromycin,Yaounde Central Hospital,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-10,30/05/21,2021-05-09,20/01/21,20/01/21,"Yaounde Central Hospital, Yaounde, Centre",Cameroon,Respiratory Diseases,1,1,364.0
2077.0,NCT04445402,Pediatrics HOT COVID-19 Database in NY Tristate,,Recruiting,Pediatric Cancer,Immune System Disorder,COVID-19,Hemoglobinopathies,,,,,Columbia University,All,"up to 21 Years   (Child, Adult)",1500.0,Other,Observational,2020-04-30,01/05/21,2022-01-05,24/06/20,24/06/20,"Connecticut Children's Hospital, Hartford, Connecticut, United States|Yale New Haven Children's Hospital, New Haven, Connecticut, United States|Hackensack Meridian Health, Hackensack, New Jersey, United States|Steven Halpern, Morristown, New Jersey, United States|Archana Sharma, New Brunswick, New Jersey, United States|Mount Sinai Beth Israel, Newark, New Jersey, United States|St. Joseph's Regional Medical Center, New Jersey, Paterson, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|Maimondes Medical Center, Brooklyn, New York, United States|Mount Sinai, New York, New York, United States|NYU Langone Health, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Stephen Roberts, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|Cohen Children's Northwell Health, Queens, New York, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Westchester Medical Center, Valhalla, New York",United States,"Respiratory Diseases, Cancers",1,4,615.0
2078.0,NCT04542993,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,Reszinate,"Active, not recruiting",COVID-19,SARS-CoV Infection,,,,,,Dietary Supplement: Zinc Picolinate|Dietary Supplement: Resveratrol|Dietary Supplement: Zinc Picolinate Placebo|Dietary Supplement: Resveratrol Placebo,Swedish Medical Center,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-08-09,05/02/21,2022-01-06,09/09/20,03/03/21,"Swedish Medical Center, Seattle, Washington",United States,Respiratory Diseases,1,2,515.0
2079.0,NCT04434157,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,,Completed,COVID-19,,,,,,,,Hospital Regional de Alta especialidad de Ixtapaluca|Hospital General de México Dr. Eduardo Liceaga,All,"Child, Adult, Older Adult",221.0,Other,Observational,2020-03-28,05/05/20,2020-05-05,16/06/20,16/06/20,"Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, State Of Mexico",Mexico,Respiratory Diseases,1,1,38.0
2080.0,NCT04409951,Pharmacy Education During Covid-19 Outbreak,,Not yet recruiting,"Event, Life Change",,,,,,,,Damanhour University,All,"16 Years to 40 Years   (Child, Adult)",100.0,Other,Observational,2020-01-11,01/03/21,2021-01-09,01/06/20,22/07/20,"Damanhour university, Beheira, Damanhour",Egypt,Others,0,1,364.0
2081.0,NCT04756674,The Impact of Covid-19 on Skeletal Muscle,,Not yet recruiting,COVID-19,Muscle Loss,Mitochondrial Alteration,,,,,Other: No intervetion will be used,University of Nottingham,All,"40 Years and older   (Adult, Older Adult)",36.0,Other,Observational,2021-09-02,01/10/22,2023-04-30,16/02/21,16/02/21,,,Respiratory Diseases,1,3,605.0
2082.0,NCT04726111,COVID-19 and Pregnancy: Placental and Immunological Impacts,MaterCov,Recruiting,COVID-19,,,,,,,Other: Specimens specific for the study,Hopital Foch,Female,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-12-30,30/07/21,2021-08-30,27/01/21,27/01/21,"Hopital Foch, Suresnes",France,Respiratory Diseases,1,1,243.0
2083.0,NCT04721236,Early Use of Hyperimmune Plasma in COVID-19,COV-II-PLA,Recruiting,COVID-19,,,,,,,Other: hyperimmune plasma,Catherine Klersy|Policlinico San Matteo Pavia Fondazione IRCCS|IRCCS Policlinico S. Matteo,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-11-19,19/11/21,2022-05-19,22/01/21,22/01/21,"Catherine Klersy, Pavia",Italy,Respiratory Diseases,1,1,546.0
2084.0,NCT04541979,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,,Recruiting,COVID-19,,,,,,,Drug: aerosolized DNase|Drug: NaCl,Region Skane,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-06,01/05/21,2021-01-06,09/09/20,25/02/21,"Lund ED, Lund",Sweden,Respiratory Diseases,1,1,275.0
2085.0,NCT04555096,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,,Recruiting,COVID-19,COVID-19,,,,,,Drug: GC4419|Drug: Placebo,"Galera Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-09-09,01/11/21,2021-01-12,18/09/20,02/03/21,"University of Iowa, Iowa City, Iowa, United States|Saint Louis University, Saint Louis, Missouri, United States|Mercy Research, Saint Louis, Missouri",United States,Respiratory Diseases,1,2,125.0
2086.0,NCT04401371,Distance Learning for Dental Student During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,,Cairo University,All,"Child, Adult, Older Adult",418.0,Other,Observational,2020-01-05,10/05/20,2020-10-05,26/05/20,27/01/21,"Faculty of Dentistry, Cairo",Egypt,Respiratory Diseases,1,1,274.0
2087.0,NCT04413435,Clinical Characteristics of Critically Ill Patients With COVID-19,,Completed,Coronavirus Infection,Critical Illness,Characteristics Disease,,,,,Other: File Scanning,Nevsehir Public Hospital,All,"18 Years and older   (Adult, Older Adult)",105.0,Other,Observational,2020-10-30,15/12/20,2020-12-25,04/06/20,05/01/21,"Konya Trainig and Research Hospital, Konya",Turkey,"Cardiovascular Diseases, Respiratory Diseases",1,3,56.0
2088.0,NCT04590170,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,COREADOM,Recruiting,COVID-19,,,,,,,Behavioral: Post-intensive Care unit syndrome,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-10-30,30/10/22,2023-04-30,19/10/20,08/01/21,"Department of Physical Medicine and Rehabilitation, Issy-les-Moulineaux, France|Department of Rehabilitation, Institute of Rheumatology Cochin, Paris",France,Respiratory Diseases,1,1,912.0
2089.0,NCT04669990,Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection in Nepal : A Registry Study,,Recruiting,COVID-19,,,,,,,Drug: Remdesivir,Nepal Health Research Council,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-11-19,31/10/21,2021-11-19,17/12/20,17/12/20,"Narayani Hospital, Birgunj, Nepal|Seti Provincial Hospital, Dhangadi, Nepal|BP Koirala Institute of Health Sciences (BPKIHS), Dharān Bāzār, Nepal|Bheri Provincial Hospital, Nepalgunj",Nepal,Respiratory Diseases,1,1,365.0
2090.0,NCT04391920,Registry of CytoSorb Therapy in COVID-19 ICU Patients,CTC REGISTRY,Recruiting,COVID-19,,,,,,,Device: CytoSorb 300 mL device,"CytoSorbents, Inc|CytoSorbents Europe GmbH",All,"18 Years and older   (Adult, Older Adult)",500.0,Industry,Observational,2020-08-28,01/08/22,2022-01-10,18/05/20,08/02/21,"Medical Center of Aurora, Aurora, Colorado, United States|University of Chicago Medicine, Chicago, Illinois, United States|Baptist Memorial Hospital, Southaven, Mississippi, United States|New York University Medical Center, New York, New York, United States|Medical College of Wisconsin, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,1,500.0
2091.0,NCT04374032,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,,Completed,COVID-19,,,,,,,Drug: metenkefalin + tridecactide|Drug: The standard of care,Bosnalijek D.D,All,"18 Years and older   (Adult, Older Adult)",120.0,Industry,Interventional,2020-01-05,07/10/20,2020-03-11,05/05/20,24/12/20,"Clinical Center University of Sarajevo, Sarajevo, Sarajevo Canton, Bosnia and Herzegovina|University Clinical Centre of the Republic of Srpska, Banja Luka, Bosnia and Herzegovina|University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina|Hospital Travnik, Travnik, Bosnia and Herzegovina|Cantonal Hospital Zenica, Zenica",Bosnia and Herzegovina,Respiratory Diseases,1,1,66.0
2092.0,NCT04793269,Characteristics of Long COVID-19 Syndrome,,Recruiting,COVID-19,,,,,,,Other: No intervention,Christian Clarenbach|University of Zurich,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-02-23,31/12/23,2024-04-30,11/03/21,11/03/21,"University Hospital Zurich, Zurich",Switzerland,Respiratory Diseases,1,1,1162.0
2093.0,NCT04445961,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,COVID-VENT,Completed,SARS Pneumonia,,,,,,,Diagnostic Test: Respiratory mechanics measurement|Diagnostic Test: Gas exchange measurement,I.M. Sechenov First Moscow State Medical University,All,"18 Years to 90 Years   (Adult, Older Adult)",117.0,Other,Observational,2020-01-05,14/08/20,2020-08-14,24/06/20,27/08/20,"Sechenov University Clinic #1, Moscow, Russian Federation|Sechenov University Clinic #3, Moscow, Russian Federation|Sechenov University Clinic #4, Moscow",Russian Federation,Respiratory Diseases,1,1,222.0
2094.0,NCT04777981,(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC,,Not yet recruiting,COVID-19,SAR,,,,,,Dietary Supplement: CBDRA60 supplement|Dietary Supplement: Placebo,Anewsha Therapeutics Inc.|University of Michigan|Biologics Consulting,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry|Other,Interventional,2021-01-04,05/05/21,2021-05-28,02/03/21,08/03/21,"Anewsha Therapeutics / Comco R&D, Hanover, Michigan",United States,Respiratory Diseases,1,2,144.0
2095.0,NCT04724720,Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Famotidine|Drug: Placebo,Northwell Health|Cold Spring Harbor Laboratory,All,"18 Years and older   (Adult, Older Adult)",84.0,Other,Interventional,2021-01-19,01/12/21,2021-01-12,26/01/21,23/02/21,"Northwell Health, Lake Success, New York",United States,Respiratory Diseases,1,1,-7.0
2096.0,NCT04320277,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",BARI-COVID,Not yet recruiting,Pharmacological Action,,,,,,,Drug: Baricitinib,Hospital of Prato,All,"18 Years to 85 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-16,30/06/20,2020-07-30,24/03/20,22/04/20,"Fabrizio Cantini, Prato, Tuscany",Italy,Others,0,1,75.0
2097.0,NCT04453553,CICERO- A Care Home Study of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Q16 testing|Diagnostic Test: Nasopharyngeal swab and main laboratory,Queen Mary University of London,All,"18 Years to 130 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-02-07,28/08/20,2020-09-28,01/07/20,01/07/20,"Queen Mary University London, London",United Kingdom,Respiratory Diseases,1,1,234.0
2098.0,NCT04341480,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,,"Active, not recruiting",Gynecological Cancer,,,,,,,Drug: Chemotherapy,Tongji Hospital,Female,"18 Years to 80 Years   (Adult, Older Adult)",305.0,Other,Observational,2020-01-07,10/12/20,2021-10-01,10/04/20,08/10/20,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Cancers,1,1,633.0
2099.0,NCT04362969,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",,Not yet recruiting,COVID-19,,,,,,,,"Hospital San Carlos, Madrid|Universidad Catolica Santiago de Guayaquil",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-05,01/05/20,2020-01-05,27/04/20,07/05/20,"GastroMuñoz, Guayaquil, Guayas",Ecuador,Respiratory Diseases,1,1,0.0
2100.0,NCT04401540,Characteristics of Neonatal Covid-19 in Turkey,,Recruiting,COVID-19,Neonatal Disease,Healthy,,,,,,Recep Tayyip Erdogan University Training and Research Hospital|Turkish Neonatal Society,All,up to 28 Days   (Child),90.0,Other,Observational,2020-01-05,30/10/20,2020-12-30,26/05/20,14/07/20,"Recep Tayyip Erdogan University Medical School, Rize",Turkey,Respiratory Diseases,1,3,360.0
2101.0,NCT04466540,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),COALITION-V,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,Hospital Alemão Oswaldo Cruz|EMS S/A|Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Brazilian Research In Intensive Care Network,All,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Interventional,2020-12-05,28/01/21,2021-03-30,10/07/20,27/11/20,"Centro de Pesquisas Clínicas Dr. Marco Mota HCOR, Maceió, Alagoas, Brazil|Hospital e Clínica São Roque, Ipiaú, Bahia, Brazil|Clínica Otorhinus, Salvador, Bahia, Brazil|Hospital da Bahia, Salvador, Bahia, Brazil|Hospital Santa Izabel, Salvador, Bahia, Brazil|Instituto Cárdio Pulmonar da Bahia, Salvador, Bahia, Brazil|Hospital SAMUR, Vitória Da Conquista, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital Unimed Cariri, Juazeiro Do Norte, Ceará, Brazil|Unimed Sul Capixaba, Cachoeiro De Itapemirim, Espírito Santo, Brazil|Hospital das Clínicas Universidade Federal de Goiás, Goiânia, Goiás, Brazil|Santa Casa de Misericórdia de Passos, Passos, Minas Agerais, Brazil|Hospital Júlia Kubitschek, Belo Horizonte, Minas Gerais, Brazil|Instituto da Pequenas Missionárias de Maria Imaculada - Hospital Madre Teresa, Belo Horizonte, Minas Gerais, Brazil|Casa de Caridade de Carangola, Carangola, Minas Gerais, Brazil|Hospital Maternidade e Pronto Socorro Santa Lucia, Poços De Caldas, Minas Gerais, Brazil|Hospital da Unimed, São João Del Rei, Minas Gerais, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, Minas Gerais, Brazil|Hospital de Clínicas da Universidade Federal do Triangulo Mineiro, Uberaba, Minas Gerais, Brazil|Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brazil|Hospital do Rocio, Campo Largo, Paraná, Brazil|Clínica Clinilive, Maringá, Paraná, Brazil|Hospital Universitário Regional de Maringá, Maringá, Paraná, Brazil|PROCAPE, Recife, Pernambuco, Brazil|Real Hospital Português de Beneficência em Pernambuco, Recife, Pernambuco, Brazil|SECRETARIA MUNICIPAL DE SAÚDE DE SAIRÉ (Unidade Mista Olília Mendonça Souto Maior), Sairé, Pernambuco, Brazil|Complexo Hospitalar de Niterói, Niterói, Rio De Janeiro, Brazil|Hospital Unimed Volta Redonda, Volta Redonda, Rio De Janeiro, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, Rio Grande Do Sul, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Santa Casa de Misericórdia de Porto Alegre (ISCMPA), Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria, Santa Maria, Rio Grande Do Sul, Brazil|CEPEM Centro de Pesquisa de Medicina Tropical de Rondônia, Porto Velho, Rondônia, Brazil|Irmandade de Misericórdia Do Hospital Da Santa Casa de Monte Alto, Monte alto, Salto Alto, Brazil|Maestri e Kormann Consultoria Medico Cientifica, Blumenau, Santa Catarina, Brazil|Imigrantes Hospital e Maternidade, Brusque, Santa Catarina, Brazil|Hospital São José, Criciúma, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Santa Casa de Araras, Araras, São Paulo, Brazil|Hospital de Amor, Barretos, São Paulo, Brazil|Santa Casa de Misericórdia de Barretos, Barretos, São Paulo, Brazil|Alphacor Cardiologia Clinica E Diagnóstica LTDA, Barueri, São Paulo, Brazil|Faculdade de Medicina de Botucatu, UNESP, Botucatu, São Paulo, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital de Cordeirópolis, Cordeirópolis, São Paulo, Brazil|Centro de Combate ao Coronavírus de Itapevi, Itapevi, São Paulo, Brazil|Dux Medicina, Jundiaí, São Paulo, Brazil|Hospital Carlos Fenando Malzoni, Matão, São Paulo, Brazil|Centro de Atendimento Para O Enfrentamento A Covid-19 Da Prefeitura Municipal de Monte Altoprefeitura de Monte Alto, Monte alto, São Paulo, Brazil|Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Unimed Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil|Hospital Casa de Saúde de Santos, Santos, São Paulo, Brazil|Kaiser Clínica e Hospital Dia, São José Do Rio Preto, São Paulo, Brazil|Hospital Policlin, São José Dos Campos, São Paulo, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|ESF Dr. João Paccola Primo, Lençois Paulista, Brazil|Cardioclinica da Ilha do Governador, Rio De Janeiro, Brazil|International Research Center - Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital do Coração, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Hospital Leforte, São Paulo, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Samaritano, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Hospital São Camilo Pompéia, São Paulo, Brazil|Hospital São Paulo - UNIFESP, São Paulo, Brazil|Hospital Sírio-Libanês, São Paulo",Brazil,Respiratory Diseases,1,1,115.0
2102.0,NCT04689490,Prospective Study of Persistent Dyspnea in Recovered COVID-19 Patients,DISCOVID19,Recruiting,COVID-19,Dyspnea,,,,,,Diagnostic Test: Cardiopulmonary exercise test,Hospital Clínico Universitario de Valladolid,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-08,31/12/20,2020-12-31,30/12/20,30/12/20,"Hospital Clínico Universitario de Valladolid, Valladolid",Spain,Respiratory Diseases,1,2,358.0
2103.0,NCT04689464,COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients,,Recruiting,COVID-19,Anxiety,Depression,,,,,,"Alhasan Mujtaba Al-Mudhaffer|University of Basrah|Ministry of Health, Iraq|AlFayhaa General Hospital",All,"15 Years and older   (Child, Adult, Older Adult)",500.0,Other,Observational,2020-01-12,28/05/21,2021-01-06,30/12/20,16/03/21,"AlFayhaa Teaching hospital, Basra",Iraq,"Mental Health, Respiratory Diseases",1,3,360.0
2104.0,NCT04385186,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,,Not yet recruiting,"Infections, Coronavirus",,,,,,,Drug: Inactivated convalescent plasma|Drug: Support treatment,"National Blood Center Foundation, Hemolife",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-20,30/11/20,2020-12-30,12/05/20,02/06/20,"Clínica Antioquía, Medellín, Antioquía, Colombia|Clínica Sagrado Corazón, Medellín, Antioquía, Colombia|IPS Universitaria, Medellín, Antioquía, Colombia|Universidad de Antioquía, Medellín, Antioquía, Colombia|National Blood Center Foundation, Hemolife/Fundación Banco Nacional de Sangre Hemolife, Bogotá, Cundinamarca, Colombia|Clínica Rosales, Pereira, Risaralda, Colombia|Clinica Nuestra, Cali, Valle, Colombia|Clínica Corpas, Bogotá, Colombia|E.S.E Hospital San Rafael Facatativa, Facatativa, Colombia|Clínica la Estancia, Popayán",Colombia,Respiratory Diseases,1,1,193.0
2105.0,NCT04732663,Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19,,Recruiting,COVID-19,Dyspnea,,,,,,Other: No Intervention,University of Alberta,All,"18 Years to 70 Years   (Adult, Older Adult)",225.0,Other,Observational,2021-04-03,01/02/23,2023-01-12,01/02/21,10/03/21,"Clinical Physiology Laboratory, Edmonton, Alberta",Canada,Respiratory Diseases,1,2,649.0
2106.0,NCT04794985,Post-COVID-Health Study: Multidimensional Health Status of COVID-19 Survivors One Year After a SARS-CoV-2 Infection,,Not yet recruiting,COVID-19,,,,,,,,Maastricht University Medical Center|VieCuri Medical Centre,All,"18 Years and older   (Adult, Older Adult)",125.0,Other,Observational,2021-01-04,03/04/21,2021-03-04,12/03/21,12/03/21,,,Respiratory Diseases,1,1,59.0
2107.0,NCT04706416,N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19),,"Active, not recruiting",Coronavirus,COVID-19,,,,,,Dietary Supplement: N-acetyl glucosamine (NAG),Quantinosis.ai LLC,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-11-14,15/01/21,2021-01-15,12/01/21,12/01/21,"Valley Baptist Medical Center, Harlingen, Texas",United States,Respiratory Diseases,1,2,62.0
2108.0,NCT04400448,Acceptance of Telemedicine During the COVID-19 Pandemic,,Not yet recruiting,COVID-19,,,,,,,,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,31/08/20,2020-10-31,22/05/20,28/05/20,,,Respiratory Diseases,1,1,299.0
2109.0,NCT04460183,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,,Recruiting,COVID-19,,,,,,,"Drug: RESP301, a Nitric Oxide generating solution|Other: Standard of Care",Thirty Respiratory Limited,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry,Interventional,2020-07-29,27/01/21,2021-04-23,07/07/20,12/01/21,"Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom|Imperial College Healthcare NHS Trust, St. Mary's Hospital, London, United Kingdom|Pennine Acute Hospitals Trust (Nroth Manchester General Hospital), Manchester, United Kingdom|Royal Preston Hospital, Preston",United Kingdom,Respiratory Diseases,1,1,268.0
2110.0,NCT04787588,COVID-19 Infection and Epithelial Cell Markers,,Recruiting,Asthma,COVID-19,,,,,,,McMaster University,All,"18 Years and older   (Adult, Older Adult)",235.0,Other,Observational,2021-02-14,01/12/21,2022-01-02,08/03/21,08/03/21,"McMaster Cardio-Respiratory Research Lab, Hamilton, Ontario",Canada,Respiratory Diseases,1,2,322.0
2111.0,NCT04573335,Diabetes Outcomes in COVID-19 Pandemic,,Completed,Diabetes,COVID-19,"Isolation, Social",,,,,,"Services Institute of Medical Sciences, Pakistan",All,"18 Years to 70 Years   (Adult, Older Adult)",1282.0,Other,Observational,2020-01-06,15/07/20,2020-07-30,05/10/20,05/10/20,"Services Hospital, Lahore, Punjab",Pakistan,"Respiratory Diseases, Metabolic Disorders",1,3,206.0
2112.0,NCT04460534,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),COVISPERM,Recruiting,COVID-19,,,,,,,Diagnostic Test: diagnostic,GCS Ramsay Santé pour l'Enseignement et la Recherche,Male,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-05,31/07/21,2021-08-31,07/07/20,07/07/20,"Hôpital Privé de Parly II, Le Chesnay",France,Respiratory Diseases,1,1,422.0
2113.0,NCT04713150,HEALthy Brain and Child Development Study - COVID-19 Supplement,,Recruiting,Child Development,Prenatal Infection,Prenatal Stress,COVID-19,,,,Other: No Intervention,Boston Children's Hospital|Brigham and Women's Hospital|Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Observational,2020-05-10,01/09/21,2021-01-11,19/01/21,19/01/21,"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Laboratories of Cognitive Neuroscience, Boston Children's Hospital, Boston, Massachusetts",United States,"Mental Health, Respiratory Diseases",1,4,246.0
2114.0,NCT04466670,Hemostasis in COVID-19: an Adaptive Clinical Trial,,Recruiting,COVID-19,,,,,,,Drug: unfractionated Heparin|Drug: Unfractionated heparin nebulized|Drug: acetylsalicylic acid|Drug: Enoxaparin,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",310.0,Other,Interventional,2020-08-07,30/12/20,2021-04-30,10/07/20,10/07/20,"Vanderson Rocha, Sao Paulo",Brazil,Respiratory Diseases,1,1,266.0
2115.0,NCT04425629,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19",,Recruiting,COVID-19,,,,,,,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,Regeneron Pharmaceuticals,All,"Child, Adult, Older Adult",6420.0,Industry,Interventional,2020-06-16,10/04/21,2021-08-28,11/06/20,05/04/21,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Canoga Park, California, United States|Regeneron Study Site, La Mesa, California, United States|Regeneron Study Site, La Palma, California, United States|Regeneron Study Site 1, Long Beach, California, United States|Regeneron Study Site 2, Long Beach, California, United States|Regeneron Study Site 3, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Montclair, California, United States|Regeneron Study Site, Rolling Hills Estates, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Loxahatchee Groves, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Saint Petersburg, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Haven, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Augusta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 1, Downers Grove, Illinois, United States|Regeneron Study Site 2, Downers Grove, Illinois, United States|Regeneron Study Site, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Shreveport, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Jackson, Mississippi, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Ridgewood, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Santa Fe, New Mexico, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Jamaica, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Durham, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site, Memphis, Tennessee, United States|Regeneron Study Site, Amarillo, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Falls Church, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Las Condes, Santiago De Chile, Chile|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Zapopan, Jalisco, Mexico|Regeneron Study Site, Monterrey, Nuevo Leon, Mexico|Regeneron Study Site, Merida, Yucatan, Mexico|Regeneron Study Site, Chihuahua, Mexico|Regeneron Study Site, Ciudad de Mexico, Mexico|Regeneron Study Site, Durango, Mexico|Regeneron Study Site, Mérida, Mexico|Regeneron Study Site, Veracruz, Mexico|Regeneron Study Site, Bucuresti",Romania,Respiratory Diseases,1,1,438.0
2116.0,NCT04824443,Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19,,Recruiting,COVID-19,Coronavirus,Cancer,,,,,Other: Aerobic Exercise Therapy,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-03-29,29/03/23,2023-03-29,01/04/21,08/04/21,"Memoral Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States|Memoral Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States|Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States|Memoral Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States|Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States|Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York",United States,"Respiratory Diseases, Cancers",1,3,730.0
2117.0,NCT04503057,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),,Recruiting,COVID-19,"ARDS, Human",ALI,,,,,,Lund University Hospital,All,"16 Years to 90 Years   (Child, Adult, Older Adult)",300.0,Other,Observational,2020-01-05,01/05/23,2024-01-05,06/08/20,06/08/20,"Region Skåne, Lund, Skåne Län",Sweden,Respiratory Diseases,1,3,1461.0
2118.0,NCT04532931,COVID-19 Treatment in South Africa,,Recruiting,COVID-19,,,,,,,Other: Standard of care (Paracetamol)|Drug: Artesunate-amodiaquine|Drug: Pyronaridine-artesunate|Drug: Favipiravir plus Nitazoxanide|Drug: Sofosbuvir/daclatasvir,Shin Poong Pharmaceutical Co. Ltd.|Medicines for Malaria Venture,All,"18 Years to 65 Years   (Adult, Older Adult)",250.0,Industry|Other,Interventional,2020-03-09,01/06/21,2021-01-10,31/08/20,23/12/20,"Ezintsha, Wits Reproductive Health & HIV Institute University of the Witwatersrand, Johannesburg",South Africa,Respiratory Diseases,1,1,307.0
2119.0,NCT04628039,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",LAUREL,Not yet recruiting,COVID-19,,,,,,,Other: Rehabilitation-focused program,VA Office of Research and Development,All,"18 Years to 89 Years   (Adult, Older Adult)",506.0,U.S. Fed,Interventional,2021-04-15,01/08/24,2024-10-31,13/11/20,23/03/21,"VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington",United States,Respiratory Diseases,1,1,1295.0
2120.0,NCT04487964,Complementary Intervention for COVID-19,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Licorice extract,Egyptian Biomedical Research Network,All,"12 Years to 65 Years   (Child, Adult, Older Adult)",70.0,Other,Interventional,2020-01-01,01/12/20,2021-01-01,27/07/20,28/07/20,"Faculty of Medicine, Assiut University, Assiut",Egypt,Respiratory Diseases,1,1,366.0
2121.0,NCT04324996,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,,Recruiting,COVID-19,,,,,,,"Biological: NK cells,IL15-NK cells,NKG2D CAR-NK cells,ACE2 CAR-NK cells,NKG2D-ACE2 CAR-NK cells",Chongqing Public Health Medical Center|Chongqing Sidemu Biotech|Zhejiang Qixin Biotech,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-02-21,20/02/22,2022-08-31,27/03/20,17/11/20,"Chongqing Public Health Medical Center, Chongqing",China,Respiratory Diseases,1,1,922.0
2122.0,NCT04481620,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",PREDICTCovid19,Recruiting,COVID-19,,,,,,,,"University Hospital, Bordeaux|Programme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)",All,"18 Years and older   (Adult, Older Adult)",1315.0,Other,Observational,2020-08-31,31/05/21,2021-05-31,22/07/20,26/03/21,"CHU Bordeaux, Bordeaux, France|Clinique Bordeaux Nord, Bordeaux, France|Clinique Saint Augustin, Bordeaux, France|CHU de Grenoble Alpes, Grenoble, France|Hôpital Arnaud-de-Villeneuve CHU de Montpellier, Montpellier, France|Hôpitaux de Brabois CHU de Nancy, Nancy, France|Hôpital de la Milétrie CHU de Poitiers, Poitiers",France,Respiratory Diseases,1,1,273.0
2123.0,NCT04558749,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,,Recruiting,COVID-19,,,,,,,Other: State-trait anxiety inventory scale|Other: Edinburgh Postnatal Depression Scale (EDPS),Assiut University,Female,"Child, Adult, Older Adult",150.0,Other,Observational,2020-01-10,01/04/21,2021-01-06,22/09/20,07/01/21,"Assiut Faculty of Medicine, Assiut",Egypt,Respiratory Diseases,1,1,362.0
2124.0,NCT04472013,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",,Recruiting,COVID-19,,,,,,,Other: Data collection from lumbar puncture|Other: Data collection from blood draw|Other: CNS magnetic resonance imaging (MRI) imaging|Other: Microscopy of defined brain regions on autopsy specimens,"University Hospital, Basel, Switzerland|Botnar Research Centre for Child Health",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-12-08,01/12/22,2022-01-12,15/07/20,06/01/21,"Neurosurgery, University Hospital Basel, Basel",Switzerland,Respiratory Diseases,1,1,400.0
2125.0,NCT04528901,Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),PRESAGE,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",1080.0,Other,Observational,2020-04-09,01/12/22,2022-01-12,27/08/20,27/01/21,"Les Hôpitaux Universitaires de Strasbourg, Strasbourg, Bas-Rhin",France,Respiratory Diseases,1,1,643.0
2126.0,NCT04425850,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,IVERCAR,Completed,COVID-19,,,,,,,Combination Product: Iota carrageenan nasal spray and Ivermectin oral drops (used as buccal drops),Eurnekian Public Hospital,All,"18 Years and older   (Adult, Older Adult)",229.0,Other,Observational,2020-01-06,10/08/20,2020-10-08,11/06/20,19/10/20,"Hospital Eurnekian, Buenos Aires",Argentina,Respiratory Diseases,1,1,276.0
2127.0,NCT04609423,Cod Liver Oil for Covid-19 Prevention Study,,Recruiting,COVID-19,Respiratory Tract Infections,,,,,,Dietary Supplement: Cod liver oil|Dietary Supplement: Corn oil (placebo),Oslo University Hospital|University of Oslo|Norwegian Institute of Public Health,All,"18 Years to 75 Years   (Adult, Older Adult)",80000.0,Other,Interventional,2020-10-11,01/05/21,2023-01-05,30/10/20,12/11/20,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,2,816.0
2128.0,NCT04346342,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),,Completed,COVID-19,Mechanical Ventilation,Acute Respiratory Failure,,,,,,Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA),All,"18 Years and older   (Adult, Older Adult)",1122.0,Other,Observational,2020-06-03,01/09/20,2020-01-09,15/04/20,22/09/20,"Flevoziekenhuis, Almere, Netherlands|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam, Netherlands|Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands|Gelre ziekenhuizen, Apeldoorn, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Reinier de Graaf Gasthuis, Delft, Netherlands|Haaglanden Medisch Centrum, Den Haag, Netherlands|HagaZiekenhuis, Den Haag, Netherlands|Ziekenhuis Gelderse Vallei, Ede, Netherlands|Catharina Ziekenhuis, Eindhoven, Netherlands|Maxima Medical Center, Eindhoven, Netherlands|St Anna Ziekenhuis, Geldrop, Netherlands|Universitair Medisch Centrum Groningen, Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Dijklander Ziekenhuis, Hoorn, Netherlands|Leeuwarden Medisch Centrum, Leeuwarden, Netherlands|Maastricht Universitair Medisch Centrum, Maastricht, Netherlands|St Antonius Ziekenhuis, Nieuwegein, Netherlands|Maasstad Hospital, Rotterdam, Netherlands|Zuyderland Medisch Centrum, Sittard, Netherlands|Isala Ziekenhuis, Zwolle",Netherlands,Respiratory Diseases,1,3,-146.0
2129.0,NCT04361786,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,,Completed,COVID-19,,,,,,,,"University Hospital, Montpellier|Lyon Civil Hospitals - Lyon Sud Hospital Center|Marseille University Hospital - Assistance-Publique Hôpitaux de Marseille.",All,"Child, Adult, Older Adult",10.0,Other,Observational,2020-01-04,30/06/20,2020-10-30,24/04/20,29/12/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,1,300.0
2130.0,NCT04715919,Long Term Outcomes of Coronavirus Disease-19 (COVID-19),,Recruiting,COVID-19,,,,,,,Diagnostic Test: Chest Computed Tomography|Diagnostic Test: Pulmonary Function Tests|Other: Six Minutes Walk Test|Other: Quality of Life,Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital|Turkish Respiratory Society,All,"18 Years to 90 Years   (Adult, Older Adult)",80.0,Other,Observational,2021-01-15,01/06/21,2021-01-06,20/01/21,20/01/21,"1University of Health Sciences Turkey, Dr Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, Intensive Care Unit, İzmir",Turkey,Respiratory Diseases,1,1,-9.0
2131.0,NCT04653844,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,ReCOV,"Active, not recruiting",COVID-19,SARS-CoV Infection,,,,,,,"University Hospital, Montpellier|Laboratoire CERBA-MPL|CNRS (MIVEGEC)|Nîmes University Hospital",All,"Child, Adult, Older Adult",7000000.0,Other,Observational,2020-01-02,20/02/21,2021-03-30,04/12/20,07/12/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,453.0
2132.0,NCT04567576,Predictive Factors for COVID-19 in Rheumatology,,Not yet recruiting,Rheumatic Diseases,COVID-19,,,,,,Drug: Disease-modifying antirheumatic drugs (DMARDs),Fundación Santa Fe de Bogota,All,"18 Years to 100 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-01-10,01/05/21,2021-10-31,28/09/20,28/09/20,,,Respiratory Diseases,1,2,660.0
2133.0,NCT04805645,Risk Factors for Mortality for COVID-19 Admitted to an Intensive Care Unit,ICUCOVID-KK,Not yet recruiting,COVID-19,Critically Ill,,,,,,Other: No intervention (Retrospective Cohort Observational),"Clinical Research Centre, Malaysia|Hospital Queen Elizabeth, Malaysia",All,"Child, Adult, Older Adult",50.0,Other,Observational,2021-01-04,01/04/21,2021-01-05,18/03/21,23/03/21,,,Respiratory Diseases,1,2,1.0
2134.0,NCT04530474,Outpatient Use of Ivermectin in COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin Pill|Drug: Placebo,Temple University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-10,30/06/21,2021-12-31,28/08/20,28/08/20,"Temple University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,721.0
2135.0,NCT04600895,The Prevent Severe COVID-19 (PRESECO) Study,PRESECO,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Placebo,Appili Therapeutics Inc.,All,"18 Years and older   (Adult, Older Adult)",826.0,Industry,Interventional,2020-11-30,01/08/21,2021-01-10,23/10/20,25/03/21,"Cahaba Research, Inc., Pelham, Alabama, United States|Absolute Clinical Research, Phoenix, Arizona, United States|B.G Clinical Research Center, LLC, Little Rock, Arkansas, United States|Xera Med Research, Boca Raton, Florida, United States|Synergy Healthcare, Bradenton, Florida, United States|Best Quality Research,Inc., Hialeah, Florida, United States|Elixia Clinical Research Collaborative, Hollywood, Florida, United States|Homestead Associates In Research, Miami, Florida, United States|Verus Clinical Research Corporation, Miami, Florida, United States|Quality Professional HealthCare, Miami, Florida, United States|Continental Clinical Research, LLC, Miami, Florida, United States|Global Life Research Network, Llc, Miami, Florida, United States|Sanitas Research, LLC, Miami, Florida, United States|US Associates in Research, LLC, Miami, Florida, United States|Biore'Search Institute Llc, Pembroke Pines, Florida, United States|Luminous Clinical Research - South Florida Urgent Care, Pembroke Pines, Florida, United States|Alliance Clinical Research of Tampa, Tampa, Florida, United States|University of Massachusettts Medical School, Worcester, Massachusetts, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, United States|New Phase Research & Development, Knoxville, Tennessee, United States|Clinical Trial Network, Houston, Texas, United States|Frontier Clinical Research, Kingwood, West Virginia",United States,Respiratory Diseases,1,1,41.0
2136.0,NCT04378881,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,,"Active, not recruiting",COVID-19,Drug Effect,Drug Interaction,Adverse Drug Event,,,,,Tabula Rasa HealthCare|Cambia Health Solutions,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|Other,Observational,2020-01-06,30/12/20,2021-04-30,07/05/20,30/06/20,"Tabula Rasa HealthCare Precision Pharmacotherapy Research and Development Institute, Orlando, Florida",United States,Respiratory Diseases,1,4,480.0
2137.0,NCT04372628,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,TREATNOW,Recruiting,COVID-19,,,,,,,Drug: Lopinavir/Ritonavir 400 mg/100 mg|Other: Placebo,Vanderbilt University Medical Center|AbbVie,All,"18 Years and older   (Adult, Older Adult)",600.0,Other|Industry,Interventional,2020-01-06,01/04/21,2021-01-05,04/05/20,16/12/20,"University of Colorado School of Medicine, Aurora, Colorado, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Oregon Health & Science University, Portland, Oregon, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Wisconsin, Madison, Wisconsin",United States,Respiratory Diseases,1,1,365.0
2138.0,NCT04634370,Fase I Clinical Trial on NK Cells for COVID-19,,Not yet recruiting,COVID-19,Sars-cov 2,,,,,,Biological: Natural Killer Cells infusion,Hospital de Clinicas de Porto Alegre,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2021-02-01,30/03/21,2021-03-30,18/11/20,18/11/20,"Hospital de Clinicas de Porto Alegre, Porto Alegre, RS",Brazil,Respiratory Diseases,1,2,57.0
2139.0,NCT04760639,COVID Breath Test - Ancon,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Breath test,Medical University of South Carolina,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-12-16,16/03/21,2021-04-16,18/02/21,18/02/21,"Medical University of South Carolina, Charleston, South Carolina",United States,Respiratory Diseases,1,1,121.0
2140.0,NCT04352842,Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19）,,Completed,COVID-19,Echocardiography,,,,,,Other: Echocardiography,RenJi Hospital,All,"18 Years and older   (Adult, Older Adult)",51.0,Other,Observational,2020-01-21,08/04/20,2020-08-04,20/04/20,19/05/20,"Ren Ji Hospital Affliated to School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai",China,Respiratory Diseases,1,2,196.0
2141.0,NCT04810065,SingStrong: Strong Lungs Through Song - Long COVID-19 Study,ss,Recruiting,COVID-19,,,,,,,Other: SingStrong: Strong lungs through Song,University of Limerick,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Interventional,2021-03-29,01/07/21,2021-09-30,22/03/21,14/04/21,"University of Limerick, Limerick",Ireland,Respiratory Diseases,1,1,185.0
2142.0,NCT04331795,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",COVIDOSE,Completed,COVID-19,,,,,,,Drug: Tocilizumab,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",32.0,Other,Interventional,2020-04-04,05/06/20,2020-05-06,02/04/20,09/03/21,"University of Chicago Medicine, Chicago, Illinois",United States,Respiratory Diseases,1,1,32.0
2143.0,NCT04446429,Anti-Androgen Treatment for COVID-19,,Completed,COVID-19,SARS-CoV2,Androgenetic Alopecia,Prostate Cancer,Benign Prostatic Hyperplasia,SARS (Severe Acute Respiratory Syndrome),,Drug: Proxalutamide|Other: Standard of Care,"Applied Biology, Inc.",Male,"18 Years and older   (Adult, Older Adult)",262.0,Industry,Interventional,2020-09-15,24/12/20,2021-01-21,24/06/20,03/02/21,"Corpometria Institute, Brasilia",Brazil,"Respiratory Diseases, Cancers",1,6,128.0
2144.0,NCT04411433,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,,"Active, not recruiting",Sars-CoV2,COVID-19,,,,,,Drug: Favipiravir (3200 mg + 1200 mg)|Drug: Favipiravir (3600 mg + 1600 mg)|Drug: Favipiravir (3200 mg + 1200 mg) combined with Hydroxychloroquine|Drug: Favipiravir (3200 mg + 1200 mg) combined with Azithromycin|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine combined with Azithromycin,"Ministry of Health, Turkey|Hacettepe University, Faculty of Medicine|Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization|Umraniye Education and Research Hospital|SB Istanbul Education and Research Hospital|Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey|Tepecik Training and Research Hospital|Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine|Ankara University|Ankara City Hospital Bilkent|Ankara Training and Research Hospital|Ege University Hospital (Application and Research Center)|Kocaeli Derince Education and Research Hospital|Istanbul University, Istanbul Faculty of Medicine|Kayseri City Hospital",All,"18 Years to 70 Years   (Adult, Older Adult)",1008.0,Other,Interventional,2020-08-05,31/12/20,2021-01-06,02/06/20,01/02/21,"Hacettepe University, School of Medicine, Ankara",Turkey,Respiratory Diseases,1,2,154.0
2145.0,NCT04348656,CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),CONCOR-1,"Active, not recruiting",COVID-19,,,,,,,Biological: Convalescent plasma,Hamilton Health Sciences Corporation|Canadian Blood Services|Héma-Québec|University of Toronto|Université de Montréal|Weill Medical College of Cornell University|New York Blood Centre|McMaster University,All,"16 Years and older   (Child, Adult, Older Adult)",1200.0,Other,Interventional,2020-05-14,31/03/21,2021-03-31,16/04/20,04/03/21,"Brooklyn Hospital, Brooklyn, New York, United States|Lower Manhattan Hospital, New York, New York, United States|Weill Cornell Medical Center, New York, New York, United States|Hospital Universitário Antônio Pedro (HUAP), Niterói, Brazil|Hemario, Rio De Janeiro, Brazil|Peter Lougheed Center, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|University of Alberta - Royal Alexandra Hospital, Edmonton, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Sturgeon Community Hospital, St. Albert, Alberta, Canada|Fraser Health Authority - Abbotsford Regional Hospital and Cancer Centre, Abbotsford, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|St. Paul's Hospital, Vancouver, British Columbia, Canada|Royal Jubilee Hospital, Victoria, British Columbia, Canada|Victoria General Hospital, Victoria, British Columbia, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|Vitalité Health Network - Acadie-Bathurst, Bathurst, New Brunswick, Canada|Vitalité Health Network - Restigouche, Campbellton, New Brunswick, Canada|Vitalité Health Network- Northwest, Edmundston, New Brunswick, Canada|Dr. Georges-L.-Dumont University Hospital Centre, Moncton, New Brunswick, Canada|Lakeridge Health Ajax Pickering, Ajax, Ontario, Canada|Hamilton General Hospital, Hamilton, Ontario, Canada|Juravinski Hospital, Hamilton, Ontario, Canada|St. Joseph's Healthcare, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's Hospital, Kitchener, Ontario, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Markham Stouffville Hospital, Markham, Ontario, Canada|Trillium Health Partners - Mississauga Hospital, Mississauga, Ontario, Canada|Trillium Health Partners - Credit Valley, Mississauga, Ontario, Canada|North York General Hospital, North York, Ontario, Canada|Lakeridge Health Oshawa, Oshawa, Ontario, Canada|Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Bluewater Health, Sarnia, Ontario, Canada|Scarborough Health Network, Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network, General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network, Birchmount Hospital, Scarborough, Ontario, Canada|Niagara Health System - St. Catherines, St. Catherines, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Unity Health St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Unity Health, St. Joseph's Health Care Centre, Toronto, Ontario, Canada|Windsor Regional Hospital - Metropolitan Campus, Windsor, Ontario, Canada|Windsor Regional Hospital - Ouellette Campus, Windsor, Ontario, Canada|L'Hopital Chicoutimi, Chicoutimi, Quebec, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Hôpital Charles-Le Moyne, Longueuil, Quebec, Canada|Hotel Dieu Hospital of Lévis, Lévis, Quebec, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Montréal General Hospital, Montréal, Quebec, Canada|Centre hospitalier universitaire Sainte-Justine, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hôpital du Sacré-Coeur de Montreal, Montréal, Quebec, Canada|Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec, Canada|Institut Universitaire de cardiologie et pneumologie de Québec, Quebec City, Quebec, Canada|Centre hospitalier régional de St-Jérôme, Saint-Jérôme, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hôpital Hôtel-Dieu, Sherbrooke, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke (CHUS) - Hôpital Fleurimont, Sherbrooke, Quebec, Canada|Centre hospitalier affilié universitaire régional de Trois-Rivières, Trois-Rivières, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Pasqua Hospital, Regina, Saskatchewan, Canada|St. Paul's Hospital, Saskatoon, Saskatchewan, Canada|Royal University Hospital, Saskatoon, Saskatchewan",Canada,Respiratory Diseases,1,1,321.0
2146.0,NCT04321421,Hyperimmune Plasma for Critical Patients With COVID-19,COV19-PLASMA,Completed,COVID-19,,,,,,,Other: hyperimmune plasma,Foundation IRCCS San Matteo Hospital|OSPEDALE CARLO POMA ASST MANTOVA,All,"18 Years and older   (Adult, Older Adult)",49.0,Other,Interventional,2020-03-17,28/04/20,2020-07-05,25/03/20,28/05/20,"Catherine Klersy, Pavia, PV, Italy|Ospedale Asst Carlo Poma Mantova, Mantova",Italy,Respiratory Diseases,1,1,110.0
2147.0,NCT04608305,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",,Recruiting,COVID-19,,,,,,,"Biological: IIBR-100, low dose (prime)|Biological: IIBR-100 medium dose (prime)|Biological: IIBR-100 high-dose (prime)|Biological: IIBR-100 low-dose (prime-boost)|Other: Saline Placebo",Israel Institute for Biological Research (IIBR),All,"18 Years to 85 Years   (Adult, Older Adult)",1040.0,Other,Interventional,2020-10-28,01/05/21,2022-01-06,29/10/20,05/01/21,"Assuta - University Hospital, Ashdod, Israel|Barzilai MC, Ashkelon, Israel|Rambam MC, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|Meir MC, Kfar Saba, Israel|Rabin MC, Petach Tikva, Israel|Sheba Medical Center Hospital- Tel Hashomer, Ramat Gan, Israel|Sourasky MC, Tel Aviv",Israel,Respiratory Diseases,1,1,435.0
2148.0,NCT04383886,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,COVER-PRO,Recruiting,COVID-19,Emergency Department Staff's Level of Stress,,,,,,Other: stress and anxiety questionnaire,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-18,18/08/20,2020-08-18,12/05/20,12/05/20,"SAMU Hospices Civils de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital Edouard Herriot, Hospices Civlis de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France|Service d'accueil des urgences, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France|Hôpital de Villefranche-sur-Saône, Villefranche-sur-Saône",France,"Mental Health, Respiratory Diseases",1,2,122.0
2149.0,NCT04407299,COVID-19 Impact on Rheumatic Patients,,Completed,COVID-19,,,,,,,Behavioral: self-administered structured questionnaire,Cairo University|Zagazig University,All,"16 Years and older   (Child, Adult, Older Adult)",360.0,Other,Observational,2020-04-20,10/05/20,2020-05-20,29/05/20,15/07/20,"Kasr Alainy Hospital, Cairo, Non-US/Non-Canadian",Egypt,Respiratory Diseases,1,1,30.0
2150.0,NCT04636086,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Cholecalciferol|Other: Placebo,University of Liege|Laboratoires SMB S.A.,All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-12-11,31/01/21,2021-02-28,19/11/20,19/11/20,"CHU Liège, Liège",Belgium,Respiratory Diseases,1,1,79.0
2151.0,NCT04352556,COVID19-hematological Malignancies: the Italian Hematology Alliance,,Recruiting,COVID-19,Hematological Malignancies,,,,,,,Ospedale di Circolo - Fondazione Macchi,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-07-04,30/04/21,2021-04-30,20/04/20,04/05/20,"SC Ematologia Ospedale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy|UOC Ematologia, Ospedali Riuniti, Ancona, Italy|UOC Ematologia e Terapia Cellulare, Ospedale Mazzoni, Ascoli Piceno, Italy|SC Oncologia Medica, CRO, Aviano, Italy|SC Ematologia, Policlinico Bari, Bari, Italy|UOC Ematologia, I.R.C.C.S Istituto Tumori Giovanni Paolo II, Bari, Italy|SSD Ematologia, Ospedale degli Infermi, Biella, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Policlinico S.Orsola-Malpighi,, Bologna, Italy|Ematologia e Centro Trapianto Midollo Osseo, Ospedale di Bolzano, Bolzano, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UO Ematologia e CTMO, ASST Spedali Civili, Brescia, Italy|UOC Onco-Ematologia ASST Valle Olona, Busto Arsizio, Italy|SC Ematologia e CTMO AZIENDA OSPEDALIERA G. BROTZU - OSPEDALE ONCOLOGICO BUSINCO, Cagliari, Italy|UOC Ematologia, AOU Policlinico Vittorio Emanuele, Catania, Italy|Ematologia, Ospedale Valduce, Como, Italy|UOC Ematologia, Azienda Ospedaliera di Cosenza, Cosenza, Italy|UO Ematologia e CTMO, ASST Cremona, Cremona, Italy|SC Ematologia Ospedale S. Croce, Cuneo, Italy|UOC, Ematologia Azienda Ospedaliero Universitaria Arcispedale S. Anna, Ferrara, Italy|S.O.D. Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy|UOC Ematologia, Policlinico Ospedali Riuniti, Foggia, Italy|IRST-IRCC di Meldola, Forlì, Italy|UO Ematologia, Ospedale Policlinico S.Martino IRCCS, Genova, Italy|UO Ematologia, Ospedale Policlinico San Martino, Genova, Italy|UOC di Ematologia e Trapianto di Cellule Staminali, P.O. Vito Fazzi, Lecce, Italy|UOC di Ematologia, Ospedale di Legnano, Legnano, Italy|UO Dipartimento di Ematologia, USL 6, Livorno, Italy|UOC Oncologia ASST Lodi, Lodi, Italy|UOC Ematologia Azienda Ospedaliera Universitaria G.Martino, Messina, Italy|UO Ematologia, Ospedale dell'Angelo di Mestre, Mestre, Italy|Ematologia, IEO, Milano, Italy|SC Ematologia, Istituto Nazionale dei Tumori, Milano, Italy|SC Ematologia, Ospedale Niguarda, Milano, Italy|UO Ematologia, IRCCS Ospedale San Raffaele, Milano, Italy|UO Servizio di Ematologia e Medicina Trasfusionale, Ospedale Luigi Sacco, Milano, Italy|UOC Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy|UO Ematologia Policlinico di Modena, Modena, Italy|UOC Ematologia, Ospedale S. Gerardo, Monza, Italy|SC Ematologia Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale,, Napoli, Italy|UOC Ematologia e Trapianti di Midollo, AOU Federico II, Napoli, Italy|UOC Ematologia, Ospedale Antonio Cardarelli, Napoli, Italy|UOC Ematologia, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy|Ospedale san Luigi Gonzaga, Orbassano, Italy|Ematologia Azienda Ospedaliera di Padova, Padova, Italy|UO Ematologia, Policlinico Paolo Giaccone, Palermo, Italy|UOC Ematologia e CTMO, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy|SC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|SC Ematologia e Trapianto di Midollo Osseo, Azienda Ospedaliera di Perugia, Perugia, Italy|UO Ematologia e CTMO, Azienda Ospedaliera Ospedali Riuniti, Pesaro, Italy|UOC di Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy|UO Ematologia e CTMO, Presidio Ospedaliero di Piacenza, Piacenza, Italy|UO Ematologia, AOU Pisana- Santa Chiara, Pisa, Italy|UO Ematologia dell'Ospedale Santa Maria delle Croci, Ravenna, Italy|UOC Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy|SC Ematologia, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy|UO Ematologia, Ospedale Infermi, Rimini, Italy|AOU Azienda Ospedaliera Universitaria Sant'Andrea, Roma, Italy|IFO - Ematologia e Trapianto Cellule -Istituto Nazionale del Cancro di Regina Elena, Roma, Italy|SC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UO Ematologia e Trapianti di Cellule Staminali, A.O. S. Camillo-Forlanini, Roma, Italy|UO Ematologia, Policlinico Tor Vergata, Roma, Italy|UOC Ematologia e trapianto di cellule staminali, Policlinico Universitario Campus Bio-Medico, Roma, Italy|UOC Ematologia Policlinico Umberto I, Roma, Italy|UOC Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy|UOC Ematologia- Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy|UO Ematologia, Istituto Clinico Humanitas, Rozzano, Italy|UOC Ematologia e centro trapianti cellule staminali emopoietiche, AOU San Giovanni Di Dio e Ruggi D'aragona, Salerno, Italy|Ematologia ASL Imperiese, Sanremo, Italy|Medicina Interna ed Ematologia, Asl 1, Savona, Italy|UOC Ematologia, Policlinico Santa Maria alle Scotte, Siena, Italy|UOC Ematologia e Trapianto Midollo Osseo, Ospedale S. G. Moscati, Taranto, Italy|SCDU Ematologia e terapie cellulari, Ospedale Mauriziano Umberto I, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Universitario Molinette San Giovanni Battista, Torino, Italy|UO Ematologia, Ospedale Civili Ca' Foncello, Treviso, Italy|SC Ematologia, Azienda sanitaria universitaria Giuliano Isontina, Trieste, Italy|Clinica Ematologia, Azienda Ospedaliera-Universitaria Santa Maria della Misericordia, Udine, Italy|UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione Macchi, Varese, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Azienda Ospedaliera Integrata di Verona, Verona, Italy|UOC Ematologia, Ospedale San Bortolo, Vicenza",Italy,Respiratory Diseases,1,2,300.0
2152.0,NCT04738760,Clinical Outcomes of High Dose Vitamin D Versus Standard Dose in COVID-19 Egyptian Patients,,Recruiting,COVID-19,Corona Virus Infection,Cytokine Storm,Vitamin D Deficiency,,,,,Ain Shams University|Misr International University,All,"18 Years to 65 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-01-12,01/04/21,2021-01-06,04/02/21,05/02/21,"Teachers Hospital, Cairo, Please Select",Egypt,Respiratory Diseases,1,4,360.0
2153.0,NCT04497779,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,,Recruiting,COVID-19,COVID-19,,,,,,Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,City of Hope Medical Center|National Cancer Institute (NCI)|California Institute for Regenerative Medicine (CIRM),All,"18 Years and older   (Adult, Older Adult)",800.0,Other|NIH,Observational,2020-07-13,21/08/21,2022-08-21,04/08/20,21/09/20,"City of Hope Medical Center, Duarte, California",United States,Respiratory Diseases,1,2,769.0
2154.0,NCT04830943,Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia,,Completed,COVID-19,,,,,,,Drug: Cerebrolysin,Assiut University,All,20 Years to 60 Years   (Adult),100.0,Other,Interventional,2020-01-08,28/02/21,2021-03-30,05/04/21,05/04/21,"Assiut University Hospitals, Faculty of Medicine, Assiut",Egypt,Respiratory Diseases,1,1,447.0
2155.0,NCT04701515,Cardiovascular Manifestations of COVID-19,,Recruiting,COVID-19,,,,,,,Other: Chart review,Methodist Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-10-06,31/12/22,2022-12-31,08/01/21,08/01/21,"Methodist Dallas Medical Center, Dallas, Texas",United States,Respiratory Diseases,1,1,816.0
2156.0,NCT04397718,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,HITCH,Recruiting,COVID-19,,,,,,,Drug: Degarelix|Other: Saline,VA Office of Research and Development,Male,"18 Years to 85 Years   (Adult, Older Adult)",198.0,U.S. Fed,Interventional,2020-06-07,06/07/21,2021-06-07,21/05/20,08/03/21,"Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States|Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR, Little Rock, Arkansas, United States|VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California, United States|VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States|Miami VA Healthcare System, Miami, FL, Miami, Florida, United States|St. Louis VA Medical Center John Cochran Division, St. Louis, MO, Saint Louis, Missouri, United States|Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, Brooklyn, New York, United States|Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, New York, United States|Philadelphia MultiService Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States|Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States|Memphis VA Medical Center, Memphis, TN, Memphis, Tennessee, United States|VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States|VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington",United States,Respiratory Diseases,1,1,365.0
2157.0,NCT04681053,Inhaled Ivermectin and COVID-19,CCOVID-19,Recruiting,COVID-19,,,,,,,Drug: Ivermectin Powder,Mansoura University,All,"18 Years to 80 Years   (Adult, Older Adult)",80.0,Other,Interventional,2021-02-25,30/04/21,2021-12-31,23/12/20,24/02/21,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia",Egypt,Respiratory Diseases,1,1,309.0
2158.0,NCT04578236,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",,Not yet recruiting,COVID-19,,,,,,,Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg|Drug: Drug: Standard treatment Standard treatment,Kafrelsheikh University,All,"18 Years to 80 Years   (Adult, Older Adult)",360.0,Other,Interventional,2020-01-11,01/12/20,2021-01-01,08/10/20,26/10/20,,,Respiratory Diseases,1,1,356.0
2159.0,NCT04363866,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),,Withdrawn,COVID-19,COVID-19,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,Oregon Health and Science University|OHSU Knight Cancer Institute,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-08,01/03/21,2021-01-09,27/04/20,29/10/20,"Oregon Health and Science University, Portland, Oregon",United States,Respiratory Diseases,1,2,367.0
2160.0,NCT04510012,Characterizing the Immune Response and Neuronal Damage in COVID-19,,Recruiting,SARS-CoV Infection,COVID-19,,,,,,"Other: Analysis of cytokine response, innate and adaptive immune response, complement activation, and serum neurofilaments as a marker of neurological damage.","University Hospital Inselspital, Berne|University of Bern",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-05-03,05/03/21,2021-05-03,12/08/20,12/08/20,"Bern University Hospital, Bern",Switzerland,Respiratory Diseases,1,2,365.0
2161.0,NCT04432805,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,LUSCOVIDPREG,Recruiting,COVID-19,,,,,,,Device: Performing of lung ultrasound,Assistance Publique Hopitaux De Marseille,Female,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-06-15,15/06/21,2021-06-15,16/06/20,16/06/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,365.0
2162.0,NCT04358042,PSYCHIATRIC Disorders and Covid-19,PSYCHIC,Recruiting,Psychiatric Disorder,COVID-19,,,,,,"Other: Brief Psychiatric Rating Scale|Other: Depression, Anxiety and Stress Scale|Other: Impact of Event Scale-Revised|Other: Connor-Davidson Resilience Scale 10 items (CD-RISC 10)",Nantes University Hospital,All,"15 Years and older   (Child, Adult, Older Adult)",250.0,Other,Observational,2020-04-24,01/01/22,2023-01-01,22/04/20,21/07/20,"Nantes University Hospital - IFAC, Nantes",France,Respiratory Diseases,1,2,982.0
2163.0,NCT04368156,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,SAVIOR,"Active, not recruiting",COVID-19,,,,,,,Device: gammaCore® (Vagus nerve stimulation),Carlos Tornero|Hospital Clínico Universitario de Valencia,All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Interventional,2020-04-20,23/02/21,2021-02-23,29/04/20,16/02/21,"Hospital Clínico Universitario de Valencia, Valencia",Spain,Respiratory Diseases,1,1,309.0
2164.0,NCT04508959,The McMaster Multi-Regional COVID-19 Hospital Case Registry,COREG,Recruiting,Coronavirus Infection,Coronavirus,COVID-19,COVID-19,,,,,McMaster University|Canadian Institutes of Health Research (CIHR)|Hamilton Academic Health Sciences Organization|Grand River Hospital|Niagara Health System|St. Mary's General Hospital|Hamilton Health Sciences Corporation|St. Joseph's Healthcare Hamilton,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-04-15,01/07/21,2021-01-07,11/08/20,24/11/20,"Hamilton General Hospital, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's General Hospital, Kitchener, Ontario, Canada|Niagara Health System, St. Catharines, Ontario",Canada,Respiratory Diseases,1,4,267.0
2165.0,NCT04322513,Biomarkers for Identification of COVID-19 Infection,B-DT-COV2,Recruiting,Coronavirus,,,,,,,Diagnostic Test: Biomarkers expression,"University of Catanzaro|Azienda Ospedaliera Pugliese Ciaccio|Azienda Ospedaliera Universitaria Mater Domini, Catanzaro",All,"14 Years to 75 Years   (Child, Adult, Older Adult)",110.0,Other,Observational,2020-03-24,30/06/20,2020-12-30,26/03/20,16/09/20,"Luca Gallelli, Catanzaro",Italy,Respiratory Diseases,1,1,281.0
2166.0,NCT04386447,Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,OsCOVID19,Withdrawn,COVID-19,Corona Virus Infection,SARS-CoV 2,,,,,Drug: Oxytocin|Drug: Standard of Care,Azienda Ospedaliero-Universitaria di Parma|University of Parma,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-09,31/10/20,2020-12-31,13/05/20,14/01/21,"CNRS, Lyon, France|Azienda Ospedaliero Universitaria di Parma, Parma, PR, Italy|Ospedale San Francesco, Nuoro",Italy,Respiratory Diseases,1,3,357.0
2167.0,NCT04665960,Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2,IC-COVID-19,Enrolling by invitation,COVID-19,SARS-CoV Infection,SARS Pneumonia,Coronavirus Infection,Infection,,,,NMC Specialty Hospital,All,"25 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Observational,2021-03-29,25/04/21,2021-05-15,14/12/20,08/04/21,"NMC Specialty Hospital, Dubai",United Arab Emirates,Respiratory Diseases,1,5,47.0
2168.0,NCT04403386,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",,Recruiting,COVID-19,,,,,,,,National Institute of Environmental Health Sciences (NIEHS)|National Institutes of Health Clinical Center (CC),All,30 Years to 55 Years   (Adult),200.0,NIH,Observational,2020-01-06,31/05/22,2022-05-31,27/05/20,05/03/21,"NIEHS Clinical Research Unit (CRU), Research Triangle Park, North Carolina",United States,Respiratory Diseases,1,1,876.0
2169.0,NCT04821934,Tele-rehabilitation Program After Hospitalization for COVID-19,,Recruiting,COVID-19,,,,,,,Other: TR|Other: TSu,Istituti Clinici Scientifici Maugeri SpA|Istituto Auxologico Italiano,All,"18 Years and older   (Adult, Older Adult)",74.0,Other,Interventional,2021-03-26,01/06/21,2021-01-12,30/03/21,30/03/21,"S Maugeri IRCCS, U.O. Emergenza Coronavirus di Lumezzane, Brescia, Italy|ICS Maugeri IRCCS, U.O. Emergenza Coronavirus di Tradate, Varese",Italy,Respiratory Diseases,1,1,-73.0
2170.0,NCT04425044,AiM Covid Self Monitoring,,Completed,COVID-19,,,,,,,Other: Other,Aarogyam UK|University of Warwick|NMP Medical Research Institute|Mothers Touch Foundation,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-12-04,18/05/20,2020-05-28,11/06/20,11/06/20,"Mothers Touch Foundation, Mumbai, Maharashtra, India|NMP Medical Research Institite, Jaipur, Rajasthan",India,Respiratory Diseases,1,1,-190.0
2171.0,NCT04435795,Inhaled Ciclesonide for Outpatients With COVID19,CONTAIN,Recruiting,COVID-19,,,,,,,Drug: Normal Saline intranasal,McGill University Health Centre/Research Institute of the McGill University Health Centre,All,"18 Years and older   (Adult, Older Adult)",454.0,Other,Interventional,2020-09-14,25/02/21,2021-03-25,17/06/20,19/10/20,"McGill University Health Center, Montreal, Quebec",Canada,Respiratory Diseases,1,1,192.0
2172.0,NCT04353180,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized),Isotretinoin,Not yet recruiting,COVID-19,,,,,,,Drug: Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment|Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) +standard treatment|Drug: Isotretinoin (13 cis retinoic acid ) capsules|Drug: Aerosolized 13 cis retinoic acid|Drug: Standard treatment,Kafrelsheikh University|Foshan University Laboratory of Emerging Infectious Disease Institute of Translational Medicine The First Hospital of Jilin University China,All,"18 Years to 80 Years   (Adult, Older Adult)",100000.0,Other,Interventional,2021-01-04,01/06/21,2021-01-07,20/04/20,09/04/21,"Faculty of Medicine, Kafr El-sheikh University, Cairo, Kafr El-sheikh, Egypt|Faculty of Medicine, Kafr El-sheikh University, Cairo",Egypt,Respiratory Diseases,1,1,3.0
2173.0,NCT04386070,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,PROTECT-Surg,Not yet recruiting,Pulmonary Complications in Surgical Patients,COVID-19,Severe Acute Respiratory Syndrome,,,,,Drug: Lopinavir-Ritonavir|Drug: Hydroxychloroquine,"University of Birmingham|Christian Medical College and Hospital, Ludhiana, India|Tamale Teaching Hospital, Ghana.|University of Lagos, Nigeria|Kigali University Teaching Hospital|Hospital Español Veracruz|Université d'Abomey-Calavi|University of Witwatersrand, South Africa|University of Edinburgh|Istituto Clinico Humanitas|University of Cape Town",All,"16 Years and older   (Child, Adult, Older Adult)",6400.0,Other,Interventional,2020-11-15,14/05/21,2026-05-14,13/05/20,05/11/20,,,Respiratory Diseases,1,3,2006.0
2174.0,NCT04468087,Antiviral Agents Against COVID-19 Infection,REVOLUTIOn,Not yet recruiting,COVID-19,,,,,,,Drug: Atazanavir|Drug: Daclatasvir 60 mg|Drug: Sofusbuvir + Daclastavir 60 mg|Drug: Placebo Atazanavir|Drug: Placebo Daclatasvir 60 mg|Drug: Placebo Sofusbuvir + Daclatasvir 60 mg,Hospital do Coracao,All,"18 Years to 90 Years   (Adult, Older Adult)",1005.0,Other,Interventional,2020-01-12,28/02/21,2021-04-30,13/07/20,16/11/20,"Hospital do Coracao, Sao Paulo, SP",Brazil,Respiratory Diseases,1,1,474.0
2175.0,NCT04531501,COVID-19 Saliva Test Research Study,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Saliva and NPS test,Chronomics Limited,All,"18 Years to 117 Years   (Adult, Older Adult)",400.0,Industry,Observational,2020-06-29,29/09/20,2020-09-29,28/08/20,28/08/20,"Gloucestershire Royal Hospital, Gloucester, United Kingdom|Salford Royal NHS Foundation Trust, Salford",United Kingdom,Respiratory Diseases,1,1,92.0
2176.0,NCT04342221,Hydroxychloroquine for COVID-19,COV-HCQ,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate|Drug: Placebo,University Hospital Tuebingen|Robert Bosch Medical Center|Universitätsklinikum Hamburg-Eppendorf|Bernhard Nocht Institute for Tropical Medicine,All,"18 Years to 99 Years   (Adult, Older Adult)",220.0,Other,Interventional,2020-03-29,01/03/21,2022-01-02,10/04/20,06/11/20,"Zollernalb Klinikum Balingen, Balingen, Germany|Klinikum Darmstadt, Darmstadt, Germany|Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Johannes Wesling Klinikum Minden, Minden, Germany|Klinikum am Steinenberg, Reutlingen, Germany|RoMed Klinikum Rosenheim, Rosenheim, Germany|Robert-Bosch-Krankenhaus, Stuttgart, Germany|Institute for Tropical Medicine, Tübingen",Germany,Respiratory Diseases,1,1,644.0
2177.0,NCT04625257,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",,Recruiting,COVID-19,,,,,,,Other: Saliva based assay: crude RNA extraction|Other: Validation of the NGS method|Other: Validation of the LAMP assays|Other: Validation of the POCT Antigen and Antibody tests,"University Hospital, Basel, Switzerland|ETH Zurich Department for Biosystems, Science and Engineering|Kanton Basel- Landschaft",All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-10-24,01/03/21,2021-01-03,12/11/20,21/02/21,"Cantonal Office of Public Health, Economics and Health Directorate, Canton Basel-Landschaft, Liestal",Switzerland,Respiratory Diseases,1,1,71.0
2178.0,NCT04606498,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,PURIFY-OBS-1,Recruiting,COVID-19,,,,,,,Other: Observational,Henry M. Jackson Foundation for the Advancement of Military Medicine|Uniformed Services University of the Health Sciences,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|U.S. Fed,Observational,2020-12-18,31/12/21,2022-01-02,28/10/20,09/04/21,"VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|Advent Health, Orlando, Florida, United States|Southeast Georgia Health System - Brunswick Campus, Brunswick, Georgia, United States|Eisenhower Army Medical Center (EAMC), Fort Gordon, Georgia, United States|Uniformed Services University, Bethesda, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Forrest General Hospital, Hattiesburg, Mississippi, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Baylor Scott & White, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Methodist Hospital, San Antonio, Texas, United States|University Of Texas Health San Antonio (UTHSA)- University Health, San Antonio, Texas, United States|Brooke Army Medical Center, San Antonio, Texas",United States,Respiratory Diseases,1,1,380.0
2179.0,NCT04479358,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,COVIDOSE-2,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab|Other: Standard of Care,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",332.0,Other,Interventional,2020-10-09,01/12/20,2021-01-03,21/07/20,23/09/20,"University of Chicago Medicine, Chicago, Illinois",United States,Respiratory Diseases,1,1,86.0
2180.0,NCT04355611,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,COVISEP,Recruiting,Multiple Sclerosis,NMO Spectrum Disorder,COVID-19,,,,,Other: Evaluation of the epidemiological characteristics of coronavirus infection (SARS-CoV-2),Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-04-20,20/04/22,2022-04-20,21/04/20,29/04/20,"Hôpital Pitié Salpétrière, Paris",France,"Respiratory Diseases, Immunological Disorders",1,3,730.0
2181.0,NCT04751617,Pulmonary Rehabilitation of Patients With a History of COVID-19,,Enrolling by invitation,COVID-19,,,,,,,Procedure: Pulmonary rehabilitation,University of Rzeszow,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-01,31/01/21,2021-03-31,12/02/21,12/02/21,"University of Rzeszów / Podkarpackie Center for Lung Diseases in Rzeszów, Rzeszów",Poland,Respiratory Diseases,1,1,89.0
2182.0,NCT04438993,The COVID-19 Disease and CARdiac Events Study,COVICARE,Recruiting,COVID-19,Coronavirus,,,,,,,NHS Lanarkshire,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-29,01/10/20,2020-01-11,19/06/20,19/06/20,"University Hospital Hairmyres, Glasgow, Scotland",United Kingdom,Respiratory Diseases,1,2,-139.0
2183.0,NCT04470622,Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),,Recruiting,COVID-19,,,,,,,Drug: Aprepitant injectable emulsion|Drug: Saline Placebo,Heron Therapeutics,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-07-20,01/06/21,2021-01-07,14/07/20,09/03/21,"Helen Keller Hospital, Sheffield, Alabama, United States|University of California, Irvine Medical Center, Orange, California, United States|Yale University School of Medicine, New Haven, Connecticut, United States|Stony Brook University Hospital, Stony Brook, New York, United States|Memorial Hermann - Memorial City Medical Center, Houston, Texas, United States|Ponce Medical School Foundation, Ponce",Puerto Rico,Respiratory Diseases,1,1,171.0
2184.0,NCT04750278,"A Phase 2/3, Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of FP-025 in Patients With Severe to Critical COVID 19 With Associated Acute Respiratory Distress Syndrome (ARDS)",,Not yet recruiting,COVID-19,,,,,,,Drug: FP-025 100 mg|Drug: FP-025 300 mg|Drug: Placebo,"Foresee Pharmaceuticals Co., Ltd.",All,"18 Years to 65 Years   (Adult, Older Adult)",403.0,Industry,Interventional,2021-01-02,01/04/22,2022-01-08,11/02/21,11/02/21,,,Respiratory Diseases,1,1,371.0
2185.0,NCT04397237,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,Euro-COVIMID,"Active, not recruiting",COVID-19,Systemic Lupus Erythematosus,Sjogren's Syndrome,Axial Spondyloarthritis,Rheumatoid Arthritis,Giant Cell Arteritis,,,"Pitié-Salpêtrière Hospital|Università degli Studi di Ferrara|Rheumazentrum Ruhrgebiet|University College, London|University of Coimbra|Universidad Complutense de Madrid",All,"18 Years and older   (Adult, Older Adult)",3100.0,Other,Observational,2020-10-06,08/12/20,2021-01-01,21/05/20,21/12/20,"Saadoun, Paris, Ile De France",France,"Respiratory Diseases, Immunological Disorders",1,6,87.0
2186.0,NCT04551547,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,,Recruiting,COVID-19,,,,,,,"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28","Sinovac Research and Development Co., Ltd.|Sinovac Biotech Co., Ltd",All,3 Years to 17 Years   (Child),552.0,Industry,Interventional,2020-10-31,01/02/21,2021-01-09,16/09/20,09/11/20,"Zanhuang county Center for Disease Control and Prevention, Shijiazhuang, Hebei",China,Respiratory Diseases,1,1,70.0
2187.0,NCT04358510,COVID-19 Mortality Prediction Model,,Completed,COVID-19,Pneumonia,Mechanical Ventilation,,,,,Device: COViage,Dascena,All,"18 Years and older   (Adult, Older Adult)",114.0,Industry,Observational,2020-01-04,17/04/20,2020-04-17,24/04/20,24/04/20,"Dascena, Oakland, California",United States,Respiratory Diseases,1,3,104.0
2188.0,NCT04351854,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,ReCovER,Recruiting,Corona Virus Infection,SARS-CoV 2,,,,,,Other: Retrospective data collection,University of Cologne,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-04-20,31/12/25,2026-08-31,17/04/20,10/12/20,"University Hospital of Cologne, Cologne",Germany,Respiratory Diseases,1,2,2324.0
2189.0,NCT04646031,Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19,,Available,COVID-19,,,,,,,Drug: T89 capsule,"Tasly Pharmaceuticals, Inc.|Tasly Pharmaceutical Group Co., Ltd",All,"Child, Adult, Older Adult",,Industry,Expanded Access:Intermediate-size Population,,,,27/11/20,27/11/20,"MultiCare Health System, Tacoma, Washington",United States,Respiratory Diseases,1,1,
2190.0,NCT04758299,Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits,,Recruiting,COVID-19,Decision Making,,,,,,Other: decision science-based design,Barry Dewitt|Dartmouth College|University of Pittsburgh|Carnegie Mellon University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-03-13,31/03/21,2021-03-31,17/02/21,17/03/21,"Carnegie Mellon University, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,2,18.0
2191.0,NCT04464486,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,,Enrolling by invitation,Oncology,,,,,,,Other: SCH Intervention,University of Utah,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-04-21,31/03/21,2021-05-31,09/07/20,09/07/20,"Huntsman Cancer Institute, Salt Lake City, Utah",United States,Others,0,1,405.0
2192.0,NCT04608214,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),CYCLOVID,Not yet recruiting,COVID-19,,,,,,,Drug: Alisporivir|Other: Standard of care (SOC),Assistance Publique - Hôpitaux de Paris|Debiopharm International SA,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-01-11,06/05/21,2021-04-08,29/10/20,29/10/20,"Assistance Publique Hôpitaux de Paris - CHU Henri Mondor, Créteil",France,Respiratory Diseases,1,1,453.0
2193.0,NCT04724629,Survival TRial Using CytoKines in COVID-19 (STRUCK Trial),STRUCK,Recruiting,COVID-19,,,,,,,Biological: Ixekizumab|Biological: Aldesleukin|Drug: Colchicine|Drug: Standard of care (SOC),University of Sao Paulo|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Science Valley Research Institute,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-05-01,31/03/21,2021-07-30,26/01/21,26/01/21,"Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP, Brazil|Hospital e Maternidade Christovão da Gama, Santo André, SP",Brazil,Respiratory Diseases,1,1,90.0
2194.0,NCT04285801,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,,Completed,COVID-19,,,,,,,,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",8.0,Other,Observational,2020-02-14,25/02/20,2020-02-25,26/02/20,10/03/20,"Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong|Prince of Wales Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,11.0
2195.0,NCT04844710,The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms,,Completed,Acupuncture,COVID-19,,,,,,Combination Product: acupuncture and standard care|Drug: standard care,Indonesia University,All,"18 Years and older   (Adult, Older Adult)",22.0,Other,Interventional,2020-01-09,15/11/20,2020-11-20,14/04/21,14/04/21,"Medical Acupuncture Department FKUI-RSCM, Jakarta",Indonesia,Respiratory Diseases,1,2,316.0
2196.0,NCT04306497,TCM Differentiation and Treatment Protocol of COVID-19,TDATPOC,Completed,COVID-19,,,,,,,Drug: TCM prescriptions,"Jiangsu Famous Medical Technology Co., Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",340.0,Industry,Observational,2020-01-22,30/04/20,2020-05-30,13/03/20,04/06/20,"Huai'an fourth people's Hospital, Huaian, Jiangsu",China,Respiratory Diseases,1,1,129.0
2197.0,NCT04714125,Prognostic Value of Flow-mediated Dilation in Hospitalized COVID-19 Patients,,Recruiting,COVID-19,SARS-CoV Infection,,,,,,,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-06-19,01/02/21,2022-01-06,19/01/21,19/01/21,"Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP, Sao Paulo",Brazil,Respiratory Diseases,1,2,566.0
2198.0,NCT04377776,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",,Completed,Kidney Transplant,Pancreas Tranplant,Pancreatic Islet Transplantation,,,,,Other: Practice details,IRCCS San Raffaele,All,"18 Years to 90 Years   (Adult, Older Adult)",644.0,Other,Observational,2020-04-05,18/05/20,2020-05-18,06/05/20,22/06/20,"IRCCS San Raffaele, Milano",Italy,Others,0,3,43.0
2199.0,NCT04338828,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,NO COV-ED,"Active, not recruiting",COVID-19,,,,,,,Drug: Nitric Oxide Gas|Other: Inhaled Supplemental Oxygen,"Massachusetts General Hospital|Department of Anesthesia, MGH",All,"18 Years and older   (Adult, Older Adult)",47.0,Other,Interventional,2020-04-18,01/04/21,2022-01-04,08/04/20,16/02/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,626.0
2200.0,NCT04377620,Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),,Terminated,COVID-19,,,,,,,Drug: Placebo|Drug: Ruxolitinib,Incyte Corporation,All,"12 Years and older   (Child, Adult, Older Adult)",211.0,Industry,Interventional,2020-05-24,26/02/21,2021-02-26,06/05/20,15/03/21,"Honor Health Research Institute, Scottsdale, Arizona, United States|Sharp Memorial Hospital, San Diego, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|Teradan Clinical Trials, Brandon, Florida, United States|University of Florida, Gainesville, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|Northshore University Health System, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Indiana University Simon Cancer Center, Indianapolis, Indiana, United States|Indiana University Health Central Indiana Cancer Centers, Indianapolis, Indiana, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Johns Hopkins University, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Lahey Hospital & Medical Center, Burlington, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Healthpartners Cancer Care Center - Regions Hospital, Saint Paul, Minnesota, United States|Mercy Research, Springfield, Missouri, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Rutgers Njms Clinical Research Unit, Newark, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|University of Rochester Medical Center, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|Kettering Cancer Care, Dayton, Ohio, United States|Jefferson University Hospitals, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|West Penn Hospital, Pittsburgh, Pennsylvania, United States|Allegheny Health Network, Wexford, Pennsylvania, United States|St David'S Medical Center, Austin, Texas, United States|University of Texas Health Science Center At Houston - McGovern Medical School, Houston, Texas, United States|University of Texas Health Science Cente, San Antonio, Texas, United States|Wenatchee Valley Hospital and Clinics, Wenatchee, Washington, United States|Aurora Research Institute, Milwaukee, Wisconsin, United States|Sbih City Hospital 15, Saint Petersburg",Russian Federation,Respiratory Diseases,1,1,278.0
2201.0,NCT04739345,New Immune-inflammation Index for Predicting Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection,,Recruiting,COVID-19,Corona Virus Infection,Cytokine Storm,,,,,,Ain Shams University|Misr International University,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-01-12,01/04/21,2021-01-07,04/02/21,04/02/21,"Teachers Hospital, Cairo, Please Select",Egypt,Respiratory Diseases,1,3,361.0
2202.0,NCT04726098,Low or High Dose of Dexamethasone in Patients With Respiratory Failure by COVID-19,HIGHLOWDEXA,Recruiting,COVID-19,Corticosteroids,,,,,,Drug: Dexamethasone high dose|Drug: Dexamethasone low dose,Manuel Taboada Muñiz|Hospital Clinico Universitario de Santiago,All,"18 Years and older   (Adult, Older Adult)",198.0,Other,Interventional,2021-01-15,30/06/21,2022-12-31,27/01/21,27/01/21,"University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, A Coruña",Spain,Respiratory Diseases,1,2,715.0
2203.0,NCT04634318,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),REHABCOVID,Recruiting,COVID-19,,,,,,,Other: Respiratory rehabilitation program (RR).|Other: Respiratory tele-rehabilitation program (TRR).,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,All,"18 Years and older   (Adult, Older Adult)",118.0,Other,Interventional,2020-10-12,01/12/21,2022-01-12,18/11/20,14/12/20,"Hôpital Renée Sabran, Hyères, Var, France|HIA Sainte Anne, Toulon, Var",France,Respiratory Diseases,1,1,457.0
2204.0,NCT04734717,Coordination and Locomotor Problems in Patients With Covid-19 Virus,,Enrolling by invitation,COVID-19,Motility Disorder,Balance,,,,,Diagnostic Test: Neurology test,Somogy Megyei Kaposi Mór Teaching Hospital,All,"20 Years to 65 Years   (Adult, Older Adult)",2.0,Other,Interventional,2021-12-01,12/04/21,2021-12-04,02/02/21,02/02/21,"Dr. József Tollár, Kaposvár, Somogy",Hungary,Respiratory Diseases,1,3,3.0
2205.0,NCT04348500,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,,"Active, not recruiting",COVID-19,,,,,,,Drug: Clazakizumab,Cedars-Sinai Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",17.0,Other,Interventional,2020-04-24,31/12/20,2021-03-31,16/04/20,24/03/21,"Cedars-Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,1,341.0
2206.0,NCT04823351,Clinical Efficiency of Surgical Masks and Filtering Face-piece 2 Masks,,Not yet recruiting,COVID-19,,,,,,,Behavioral: Surgical Mask,"University of Zurich|Swiss National Science Foundation|ETH Zurich|Kantonsspital Winterthur KSW|University Hospital, Zürich",All,"18 Years to 65 Years   (Adult, Older Adult)",1200.0,Other,Interventional,2021-08-04,08/07/21,2021-01-11,30/03/21,30/03/21,"Gesundheitszentren für das Alter, Zürich",Switzerland,Respiratory Diseases,1,1,-205.0
2207.0,NCT04686734,Long-term Effects of COVID-19 in Adolescents,LoTECA,Recruiting,COVID-19,,,,,,,Other: No active intervention (observational only),"University Hospital, Akershus",All,"12 Years to 25 Years   (Child, Adult)",500.0,Other,Observational,2021-06-01,30/05/21,2021-01-12,29/12/20,08/04/21,"Vegard Bratholm Wyller, Oslo",Norway,Respiratory Diseases,1,1,-140.0
2208.0,NCT04376775,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,COWAIT,"Active, not recruiting",Transplantation,,,,,,,Other: Transplant patient,"University Hospital, Bordeaux|Société Francophone de Transplantation",All,"18 Years and older   (Adult, Older Adult)",3602.0,Other,Observational,2020-11-05,11/12/20,2020-11-12,06/05/20,18/06/20,"Hopital Pellegrin, Bordeaux",France,Others,0,1,7.0
2209.0,NCT04497389,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,,Recruiting,SARS CoV-2,,,,,,,Biological: Human Amniotic Fluid,University of Utah,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-10-28,15/09/21,2021-09-15,04/08/20,06/11/20,"University of Utah Health, Salt Lake City, Utah",United States,Others,0,1,322.0
2210.0,NCT04792021,Effect of N-acetylcysteine on Oxidative Stress in COVID-19 Patients,,Recruiting,COVID-19,Corona Virus Infection,Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2),,,,,Drug: N-acetylcysteine,Ain Shams University|Misr International University,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-09-03,01/06/21,2021-01-11,10/03/21,10/03/21,"Al Assema Hospital, Cairo",Egypt,Respiratory Diseases,1,3,-235.0
2211.0,NCT04362995,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,,Recruiting,COVID-19,Coronavirus Infection,Coronavirus,COVID-19,,,,,St. Jude Children's Research Hospital,All,"18 Years and older   (Adult, Older Adult)",1517.0,Other,Observational,2020-04-23,01/04/22,2025-01-03,27/04/20,02/02/21,"St. Jude Children's Research Hospital, Memphis, Tennessee",United States,Respiratory Diseases,1,4,1716.0
2212.0,NCT04635605,Methylene Blue Treatment of COVID-19,,Recruiting,SARS-CoV2,,,,,,,Drug: Methylene Blue|Drug: Control Test,Fondazione Epatocentro Ticino,All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Interventional,2020-05-11,31/12/21,2022-12-31,19/11/20,02/02/21,"Fondazione Epatocentro Ticino, Lugano, Ticino",Switzerland,Respiratory Diseases,1,1,964.0
2213.0,NCT04748614,Analysis Before and After COVID 19,,Not yet recruiting,Cost of ICU,,,,,,,Other: Cost,Kocaeli Derince Education and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-02-15,15/03/21,2021-03-30,10/02/21,10/02/21,,,Others,0,1,43.0
2214.0,NCT04502056,Covid-19 Messaging to Underserved Communities - 2nd Experiment,,"Active, not recruiting",COVID-19,,,,,,,Behavioral: Acknowledgement Racial Injustice AMA|Behavioral: African American Sender Acknowledgement|Behavioral: African American Sender in Informational Videos.|Behavioral: Racial Inequality Highlighted|Behavioral: AMA Acknowledgement Drug Pricing|Behavioral: White Sender in Acknowledgement|Behavioral: White Sender in Informational Videos|Behavioral: No Racial Inequality Highlighting|Behavioral: Placebo videos,"National Bureau of Economic Research, Inc.|Massachusetts General Hospital|Stanford University|Yale University|Harvard University",All,"18 Years and older   (Adult, Older Adult)",20000.0,Other,Interventional,2020-07-31,21/09/20,2021-01-09,06/08/20,17/11/20,"JPAL North America, Cambridge, Massachusetts",United States,Respiratory Diseases,1,1,162.0
2215.0,NCT04603105,CCP Cancer UK Companion Study,,Not yet recruiting,Cancer,COVID-19,,,,,,,The Clatterbridge Cancer Centre NHS Foundation Trust|University of Edinburgh|University of Oxford|University of Liverpool,All,"Child, Adult, Older Adult",9000.0,Other,Observational,2021-02-28,31/10/21,2022-10-31,26/10/20,05/01/21,,,"Respiratory Diseases, Cancers",1,2,610.0
2216.0,NCT04505761,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",COVRehab,Completed,Coronavirus,Post Intensive Care Unit Syndrome,,,,,,Device: Virtual Reality,Radboud University,All,"16 Years and older   (Child, Adult, Older Adult)",48.0,Other,Interventional,2020-01-08,01/02/21,2021-03-31,10/08/20,06/04/21,"Radboud university medical center, Nijmegen, Gelderland",Netherlands,Respiratory Diseases,1,2,448.0
2217.0,NCT04841746,Efficacy of FES Cycling After a Severe Form of COVID-19,FESrehabCoV,Not yet recruiting,COVID-19,,,,,,,Behavioral: Physical therapy that include a standardized cycling training with functional electrical stimulation|Behavioral: Physical therapy that include a standardized cycling training with no additional functional electrical stimulation,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2021-01-06,16/09/22,2022-09-16,12/04/21,12/04/21,,,Respiratory Diseases,1,1,618.0
2218.0,NCT04351763,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,ReCOVery-SIRIO,Recruiting,COVID-19,,,,,,,Drug: Amiodarone|Drug: Verapamil,Nicolaus Copernicus University,All,"18 Years to 99 Years   (Adult, Older Adult)",804.0,Other,Interventional,2020-04-27,02/03/21,2021-10-04,17/04/20,17/04/20,"Nicolaus Copernicus University, Bydgoszcz",Poland,Respiratory Diseases,1,1,525.0
2219.0,NCT04732767,Evaluation of COVID-19 IgG Antibodies in Maternal and Cord Blood Samples,,Not yet recruiting,COVID-19,Pregnancy Related,Antibody Response,,,,,,Atrium Health,Female,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2021-01-20,30/06/21,2021-06-30,01/02/21,01/02/21,,,Respiratory Diseases,1,3,161.0
2220.0,NCT04291053,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Huaier Granule,Tongji Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",550.0,Other,Interventional,2020-01-04,01/08/20,2020-01-09,02/03/20,17/03/20,,,Respiratory Diseases,1,1,5.0
2221.0,NCT04519255,Study for Quantitative Analysis of the Recovered COVID-19 Patients by 18F-FDG-PET/CT,,"Active, not recruiting",PET/CT,COVID-19,Respiratory Function,Inflammatory Lesions,,,,,"Fifth Affiliated Hospital, Sun Yat-Sen University",All,"18 Years to 85 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-01-07,31/12/22,2023-07-31,19/08/20,05/02/21,"Hongjun Jin, Zhuhai, Guangzhou",China,Respiratory Diseases,1,4,1301.0
2222.0,NCT04489446,Sildenafil in COVID-19,,Recruiting,COVID-19,SARS-COV2 Infection,,,,,,Drug: Sildenafil|Drug: Placebo,"Universidad Nacional Andres Bello|Hospital Naval Almirante Nef, Viña del Mar, Chile",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-08-19,01/12/20,2021-01-03,28/07/20,03/11/20,"Hospital Naval Almirante Nef, Viña Del Mar, Valparaiso",Chile,Respiratory Diseases,1,2,137.0
2223.0,NCT04551781,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,,Completed,COVID-19,,,,,,,Drug: 20 Mg Prednisone for 14 days|Drug: control,South Valley University,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2020-01-04,30/07/20,2020-07-30,16/09/20,16/09/20,"south-Vally University faculty of medicine, Qena, Kena",Egypt,Respiratory Diseases,1,1,208.0
2224.0,NCT04383652,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,COSiN,Recruiting,COVID-19,,,,,,,Other: Biological sample and clinical data collection,Kirby Institute,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-06-05,30/06/21,2021-06-30,12/05/20,12/05/20,"NSW Health Pathology, Randwick, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Sydney Children's Hospital, Randwick, New South Wales, Australia|Blacktown Hospital, Blacktown, Australia|Royal Prince Alfred Hospital, Camperdown, Australia|St Vincent's Hospital, Darlinghurst, Australia|Northern Beaches Hospital, Frenchs Forest, Australia|Royal North Shore Hospital, Saint Leonards, Australia|Westmead Hospital, Westmead",Australia,Respiratory Diseases,1,1,390.0
2225.0,NCT04387214,COVID-19 Pandemic and Academic Performance of Veterinary Students,,Completed,COVID-19,,,,,,,Other: survey,South Valley University,All,18 Years to 60 Years   (Adult),1426.0,Other,Observational,2020-04-13,10/08/20,2020-10-08,13/05/20,09/09/20,"South Valley University, Qinā",Egypt,Respiratory Diseases,1,1,178.0
2226.0,NCT04530578,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,NEBUHEPA,Recruiting,COVID-19,Pneumonia,,,,,,Drug: Heparin sodium|Drug: Enoxaparin,"Clinica San Camilo, Argentina",All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-06,30/10/20,2021-01-06,28/08/20,31/08/20,"Clinica San Camilo, Ciudad Autonoma de Buenos Aire, Buenos Aires",Argentina,Respiratory Diseases,1,2,366.0
2227.0,NCT04540120,Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,,Recruiting,COVID-19,Cytokine Release Syndrome,,,,,,Drug: dapansutrile capsules|Drug: placebo capsules,Olatec Therapeutics LLC|CTI Clinical Trial and Consulting Services,All,"18 Years and older   (Adult, Older Adult)",80.0,Industry|Other,Interventional,2020-09-25,01/06/21,2021-01-07,07/09/20,02/04/21,"National Jewish Health, Denver, Colorado, United States|Atrium Health/Charlotte-Mecklenburg Hospital Authority, Charlotte, North Carolina, United States|PanAmerican Clinical Research LLC, Brownsville, Texas, United States|J & S Studies, Inc., College Station, Texas, United States|VieCuri Medisch Centrum, Venlo, Netherlands|University Hospital Basel, Basel",Switzerland,Respiratory Diseases,1,2,104.0
2228.0,NCT04527432,COVID-19 Health Professional Impact Study,CHIP,Recruiting,Coronavirus Infection,Severe Acute Respiratory Syndrome,,,,,,Other: Survey|Diagnostic Test: SARS-CoV-2 antibody test,The Royal Wolverhampton Hospitals NHS Trust|University of Wolverhampton,All,"Child, Adult, Older Adult",3000.0,Other,Interventional,2020-12-16,31/03/22,2022-03-31,26/08/20,20/01/21,"The Royal Wolverhampton NHS Trust, Wolverhampton",United Kingdom,Respiratory Diseases,1,2,470.0
2229.0,NCT04695301,Functional Outcomes in COVID-19 Survivors and Use of a Digital Platform for Rehabilitation,,Recruiting,COVID-19,Coronavirus Infections,Exercise Therapy,,,,,Other: Rehabilitation protocol through a digital platform,Hospital Israelita Albert Einstein,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-07,01/07/21,2021-01-08,05/01/21,29/01/21,"Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP), São Paulo",Brazil,Respiratory Diseases,1,3,367.0
2230.0,NCT04631536,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,MEDIC-LAUMC,Recruiting,COVID-19,,,,,,,Drug: Atorvastatin + L-arginine + Folic acid + Nicorandil + Nebivolol|Drug: Placebo,Lebanese American University Medical Center,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-10-01,31/05/21,2021-01-06,17/11/20,29/03/21,"LAUMCRH, Beirut",Lebanon,Respiratory Diseases,1,1,-268.0
2231.0,NCT04740125,SURVEY ABOUT STRESS-COVID IN HEALTH CARE WORKERS IN NORTH AFRICA COUNTRY,COVID-STRESS,Completed,HEALTH CARE WORKERS,,,,,,,,"General Administration of Military Health, Tunisia",All,"18 Years to 70 Years   (Adult, Older Adult)",368.0,Other,Observational,2020-01-05,31/07/20,2020-11-30,05/02/21,05/02/21,"Military Hospital of Tunis, Tunis, Montfleury",Tunisia,Others,0,1,330.0
2232.0,NCT04445935,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,,Recruiting,COVID-19,,,,,,,Drug: Bivalirudin Injection|Drug: Standard treatment,Hamad Medical Corporation,All,"18 Years to 99 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2020-06-28,28/09/20,2021-03-28,24/06/20,24/06/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,1,273.0
2233.0,NCT04771611,COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications,COVFIS-HOME,Not yet recruiting,COVID-19,Coronavirus Infection,,,,,,Drug: Fisetin,"James L. Kirkland, MD, PhD|Mayo Clinic",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-01-03,01/12/22,2023-01-06,25/02/21,08/03/21,"Mayo Clinic, Rochester, Minnesota",United States,Respiratory Diseases,1,2,733.0
2234.0,NCT04401150,Lessening Organ Dysfunction With VITamin C - COVID-19,LOVIT-COVID,Recruiting,Vitamin C,COVID-19,Hospitalized Patients,,,,,Drug: Vitamin C|Drug: Control,Université de Sherbrooke|Lotte & John Hecht Memorial Foundation,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-08-14,01/11/21,2022-01-01,26/05/20,24/03/21,"Research Center of the CHUS, Sherbrooke, Quebec, Canada|Research Centre of the CHUS, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,3,505.0
2235.0,NCT04530422,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,,Completed,COVID-19,,,,,,,Drug: Sofosbuvir plus Ledipasvir,Almaza Military Fever Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",250.0,Other,Interventional,2020-04-15,08/07/20,2020-07-23,28/08/20,28/08/20,"Almaza Military Fever Hospital, Cairo",Egypt,Respiratory Diseases,1,1,99.0
2236.0,NCT04682873,A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19,,Recruiting,COVID-19,,,,,,,Drug: Enisamium Iodide|Drug: Placebo,"Joint Stock Company ""Farmak""",All,"18 Years to 99 Years   (Adult, Older Adult)",700.0,Industry,Interventional,2020-05-15,01/06/21,2021-01-07,24/12/20,24/12/20,"Municipal Enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Dept. Pulmonology, Lutsk, Volynsk, Ukraine|Municipal Non-Commercial Enterprise 'City Clinical Hospital #3' Chernivtsi City Council, Dept. Therapeutics #1, Dept. Therapeutics #2, Higher State Educational Institution of Ukraine 'Bukovinian State University', Chernivtsi, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Infection Hospital Ivano-Frankivsk Regional Council', Dept. #2, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Hospital Ivano-Frankivsk Regional Council', Dept. Allergology, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise 'City Clinical Hospital #1 Ivano-Frankivsk City Council', Dept. Therapeutics, Ivano-Frankivsk, Ukraine|Municipal Non-Commercial Enterprise Kharkiv Regional Council 'Regional Clinical Infection Hospital', 1st Department, Kharkiv National Medical University, Chair of Infectious Diseases, Kharkiv, Ukraine|Municipal Non-Commercial Enterprise 'Olexandrivska Clinical Hospital of Kyiv' Executive Authority of Kyiv City Council, Dept. Infections, Kyiv, Ukraine|Municipal Non-Commercial Enterprise Kyiv City Clinical Hospital #9 Executive Authority of Kyiv City Council, Dept. Infections, Kyiv, Ukraine|Municipal Non-Commercial Enterprise Lviv Regional Council 'Lviv Regional Infection Hospital', Fourth Diagnostic Department, Lviv, Ukraine|Ukraine Medical Stomatological Academy, Chair of Infectious Diseases with Epidemiology, Municipal Non-Commercial Enterprise 'Poltava Regional Infection Hospital Poltava Regional Council', Dept. Respiratory Infections, Poltava, Ukraine|Municipal Non-Commercial Enterprise 'Central Clinical Hospital' of Rivne City Council, Hepatic Centre - Infections, Rivne, Ukraine|Municipal Non-Commercial Enterprise 'Regional Clinical Infectional Hospital' Transcarpathian Regional Council, Dept. Infections (Adult), Uzhhorod, Ukraine|Municipal Non-Сommercial Enterprise 'Vinnytsya City Clinical Hospital #1', Infectious Department, National Pirogov Memorial Medical University, Dept. Infections, Vinnytsya",Ukraine,Respiratory Diseases,1,1,237.0
2237.0,NCT04405466,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,,Recruiting,COVID-19,,,,,,,Procedure: Blood sampling|Procedure: Throat swab,Miltenyi Biomedicine GmbH,All,"18 Years and older   (Adult, Older Adult)",500.0,Industry,Observational,2020-04-22,28/08/20,2021-01-31,28/05/20,07/07/20,"Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, NRW",Germany,Respiratory Diseases,1,1,284.0
2238.0,NCT04446286,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,ECMO-SL-CoV-2,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-06-18,18/08/20,2020-08-18,24/06/20,31/07/20,"Service de Chirurgie Thoracique Nouvel Hôpital Civil Hôpitaux Universitaires de Strasbourg, Strasbourg",France,Respiratory Diseases,1,1,61.0
2239.0,NCT04805632,Immune Response in Dialysis Patients Vaccinated Against SARS-CoV-2,Sputnik-HD,Recruiting,COVID-19,Chronic Kidney Disease 5D,,,,,,,"Saint Petersburg State University, Russia",All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Observational,2021-03-23,01/09/21,2021-01-10,18/03/21,30/03/21,"Saint-Petersburg State University Hospital, Saint Petersburg",Russian Federation,Respiratory Diseases,1,2,-72.0
2240.0,NCT04400812,Attitude and Perception Towards COVID-19 Pandemic,,Enrolling by invitation,COVID-19,,,,,,,Other: questionnaire,Zagazig University,All,"16 Years to 70 Years   (Child, Adult, Older Adult)",5000.0,Other,Observational,2020-05-19,01/09/20,2020-01-10,26/05/20,04/08/20,"Zagazig University, Zagazig, Sharkia",Egypt,Respiratory Diseases,1,1,-130.0
2241.0,NCT04529525,Ivermectin to Prevent Hospitalizations in COVID-19,IVERCORCOVID19,Recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: Placebo,Instituto de Cardiología de Corrientes,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-08-19,28/02/21,2021-03-15,27/08/20,16/02/21,"Ministry of Public Health of the Province of Corrientes, Corrientes",Argentina,Respiratory Diseases,1,1,208.0
2242.0,NCT04586140,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,ETHICOVID,Recruiting,COVID-19,Ethics,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-09-11,30/04/21,2022-04-30,14/10/20,31/12/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,2,596.0
2243.0,NCT04618042,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,FX-COVID,Recruiting,Ards,COVID-19,Pneumonia,,,,,Drug: FX06|Drug: Placebo of FX06,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-11-13,01/07/21,2021-01-07,05/11/20,11/01/21,"Service de Médecine Intensive Réanimation - CHU Angers, Angers, France|Service de Médecine Intensive Réanimation - CHI de Poissy, Chambourcy, France|Hôpital Pitié Salpêtrière, Paris",France,Respiratory Diseases,1,3,55.0
2244.0,NCT04381962,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),ATOMIC2,Recruiting,COVID-19,,,,,,,Drug: Azithromycin Capsule,University of Oxford|Pfizer,All,"19 Years and older   (Adult, Older Adult)",800.0,Other|Industry,Interventional,2020-05-29,13/09/20,2020-10-13,11/05/20,09/06/20,"Horton General Hospital, Banbury, Oxfordshire, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Ninewells Hospital, Dundee, Scotland, United Kingdom|Birmingham City Hospital, Birmingham, United Kingdom|Sandwell General Hospital, West Bromwich",United Kingdom,Respiratory Diseases,1,1,137.0
2245.0,NCT04666207,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",,Recruiting,COVID-19,,,,,,,Diagnostic Test: PCR,"Rigshospitalet, Denmark",All,up to 17 Years   (Child),20.0,Other,Observational,2020-05-25,31/01/21,2021-06-30,14/12/20,14/12/20,"Copenhagen University Hospital Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,1,401.0
2246.0,NCT04382066,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,APLICOV-PC,Completed,COVID-19,,,,,,,Drug: Plitidepsin 1.5 mg/day|Drug: Plitidepsin 2.0 mg/day|Drug: Plitidepsin 2.5 mg/day,PharmaMar|Apices Soluciones S.L.,All,"18 Years and older   (Adult, Older Adult)",46.0,Industry,Interventional,2020-12-05,23/12/20,2020-12-23,11/05/20,28/12/20,"Hospital Universitario Hm Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Ciudad Real, Ciudad Real, Spain|Hospital Universitario de Getafe, Getafe, Spain|Hospital Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitari Arnau de Vilanova, Lleida, Spain|Hospital La Princesa, Madrid, Spain|Hospital Gregorio Marañón, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hosptial Quironsalud Madrid, Madrid",Spain,Respiratory Diseases,1,1,18.0
2247.0,NCT04742946,Telerehabilitation in Covid-19 After Hospital Discharge,TRCovidA,Not yet recruiting,COVID-19,,,,,,,Other: Standard Physiotherapy program|Other: Telerehabilitation,Universidad de Granada,All,"18 Years and older   (Adult, Older Adult)",237.0,Other,Interventional,2021-02-15,30/05/21,2021-09-30,08/02/21,10/02/21,"Facultad Ciencias de la Salud, Melilla",Spain,Respiratory Diseases,1,1,227.0
2248.0,NCT04422691,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,COVIDUS-NOR,Recruiting,COVID-19,"Pneumonia, Viral",Pulmonary Infection,,,,,Diagnostic Test: Lung ultrasound,"St. Olavs Hospital|Haukeland University Hospital|Ullevaal University Hospital|Nordlandssykehuset HF|Sorlandet Hospital HF|Drammen sykehus|Sykehuset Telemark|Helse Stavanger HF|University Hospital, Akershus",All,"17 Years and older   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-01-07,01/12/20,2025-01-12,09/06/20,25/11/20,"Haukeland universitetssykehus, Bergen, Norway|Nordland Hospital, Bodø, Norway|Drammen sykehus, Drammen, Norway|Sørlandet sykehus, Kristiansand, Kristiansand, Norway|Akershus University Hospital, Oslo, Norway|Ullevål University Hospital, Oslo, Norway|Sykehuset Telemark HF, Skien, Norway|Stavanger Universitetssjukehus, Stavanger, Norway|St Olavs Hospital, Trondheim",Norway,Respiratory Diseases,1,3,1832.0
2249.0,NCT04356937,Efficacy of Tocilizumab on Patients With COVID-19,,Completed,SARS-CoV 2,,,,,,,Drug: Tocilizumab|Drug: Placebos,"Massachusetts General Hospital|Genentech, Inc.",All,"18 Years to 85 Years   (Adult, Older Adult)",243.0,Other|Industry,Interventional,2020-04-20,13/07/20,2020-08-27,22/04/20,16/12/20,"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts",United States,Respiratory Diseases,1,1,129.0
2250.0,NCT04494893,ImmuneRACE - Immune Response Action to COVID-19 Events,,"Active, not recruiting",COVID-19,,,,,,,,Adaptive Biotechnologies|Covance,All,"18 Years to 89 Years   (Adult, Older Adult)",808.0,Industry,Observational,2020-04-24,23/03/21,2021-06-30,31/07/20,06/04/21,"Adaptive Biotechnologies, Seattle, Washington",United States,Respiratory Diseases,1,1,432.0
2251.0,NCT04321993,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,,Recruiting,COVID-19,,,,,,,Drug: Baricitinib (janus kinase inhibitor),Lisa Barrett|Nova Scotia Health Authority|Dalhousie University,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-04-17,01/02/22,2022-01-03,26/03/20,24/07/20,"Nova Scotia Health Authority, Halifax, Nova Scotia",Canada,Respiratory Diseases,1,1,626.0
2252.0,NCT04697927,A Study of Risk Factors for the COVID-19 Virus Infection,,Recruiting,COVID-19,,,,,,,Other: Questionnaires,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-12-30,01/12/22,2022-01-12,06/01/21,08/01/21,"Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Rockville Centre, New York",United States,Respiratory Diseases,1,1,378.0
2253.0,NCT04418518,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,CONCOR-1,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma,Weill Medical College of Cornell University|Hamilton Health Sciences Corporation,All,"18 Years to 70 Years   (Adult, Older Adult)",1200.0,Other,Interventional,2020-06-24,01/06/21,2021-01-12,05/06/20,07/07/20,"Brooklyn Methodist Hospital, Brooklyn, New York, United States|Weill Cornell Medicine, New York, New York, United States|Lower Manhattan Hospital, New York, New York",United States,Respiratory Diseases,1,1,202.0
2254.0,NCT04334980,"Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",,"Active, not recruiting",COVID-19,,,,,,,Biological: bacTRL-Spike,Symvivo Corporation,All,"18 Years and older   (Adult, Older Adult)",24.0,Industry,Interventional,2020-02-11,08/02/22,2022-02-28,06/04/20,04/03/21,"Nucleus Network Pty Ltd (Trading as Centre for Clinical Studies), Melbourne, Victoria",Australia,Respiratory Diseases,1,1,748.0
2255.0,NCT04733833,A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: VB-201 + Standard of care|Drug: Standard of care,Vascular Biogenics Ltd. operating as VBL Therapeutics,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2021-01-26,30/06/22,2022-06-30,02/02/21,02/02/21,"Chaim Sheba Medical Center, Ramat Gan",Israel,Respiratory Diseases,1,1,520.0
2256.0,NCT04492410,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),NEOSCREENCOVID,"Active, not recruiting",Cancer,,,,,,,Other: rapid serological test,Centre Antoine Lacassagne,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-07-21,01/05/21,2021-01-05,30/07/20,16/02/21,"Centre Antoine Lacassagne, Nice",France,Cancers,1,1,168.0
2257.0,NCT04351516,Test and Treat COVID 65plus+,COVID65plus,Withdrawn,SARS-CoV 2,COVID-19,,,,,,Drug: Hydroxychloroquine|Other: Placebo,University Hospital Tuebingen,All,65 Years and older   (Older Adult),0.0,Other,Interventional,2020-04-21,31/12/20,2021-01-05,17/04/20,15/01/21,"Uniklinikum Tuebingen, Tuebingen, Germany|Uniklinikum Ulm, Ulm",Germany,Respiratory Diseases,1,2,259.0
2258.0,NCT04577534,COVID-19: Salvage TOcilizumab as a Rescue Measure,COVIDSTORM,Recruiting,COVID-19,,,,,,,Drug: iv Tocillizumab (TCZ),Jarmo Oksi|Turku University Hospital,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-08-14,31/12/21,2021-12-31,08/10/20,08/10/20,"Turku University Hospital, Turku",Finland,Respiratory Diseases,1,1,504.0
2259.0,NCT04684615,Mental Health Impact of the COVID-19 Pandemic on Amish and Mennonite Participants in AMBiGen,,Enrolling by invitation,Depression,Anxiety,Bipolar Disorder,,,,,,National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1000.0,NIH,Observational,2021-04-19,31/07/22,2022-07-31,24/12/20,14/04/21,"National Institute of Mental Health (NIMH), Bethesda, Maryland",United States,Mental Health,1,3,468.0
2260.0,NCT04344509,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,,Not yet recruiting,Ventilator Associated Pneumonia,,,,,,,Other: Bacterial species isolated,Poitiers University Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",10000.0,Other,Observational,2020-01-06,01/09/20,2020-01-12,14/04/20,02/06/20,,,Respiratory Diseases,1,1,6.0
2261.0,NCT04400877,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,,Completed,COVID-19,Venous Thromboembolism,Pulmonary Embolism,Deep Vein Thrombosis,SARS-CoV 2,,,Diagnostic Test: Diagnostic examination for venous thromboembolism,"University Hospital, Linkoeping",All,"18 Years and older   (Adult, Older Adult)",7795.0,Other,Observational,2020-08-06,30/07/20,2020-09-30,26/05/20,27/11/20,"University Hospital Linköping, Linköping, Östergötland",Sweden,Respiratory Diseases,1,5,55.0
2262.0,NCT04732819,Improving COVID-19 Vaccine Uptake in Nursing Homes,,Recruiting,COVID-19,,,,,,,Behavioral: High touch multi-pronged behavioral intervention,"Brown University|National Institute on Aging (NIA)|Hebrew SeniorLife|Insight Therapeutics, LLC|New York University",All,"Child, Adult, Older Adult",22500.0,Other|NIH,Interventional,2021-04-01,19/04/21,2021-04-19,01/02/21,01/02/21,"Mission Health, Tampa, Florida, United States|Nexion Health, Sykesville, Maryland, United States|Vetter Senior Living, Elkhorn, Nebraska, United States|Genesis HealthCare, Kennett Square, Pennsylvania",United States,Respiratory Diseases,1,1,18.0
2263.0,NCT04358939,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Other: Prone decubitus,"University Hospital, Tours",All,"18 Years and older   (Adult, Older Adult)",404.0,Other,Interventional,2020-04-27,10/11/21,2021-11-24,24/04/20,11/01/21,"Intensive Care Unit, University Hospital, Aix, Aix-en-Provence, France|Medical Intensive Care Unit, University Hospital, Amiens, Amiens, France|Intensive Care Unit, Hospital, Argenteuil, Argenteuil, France|Intensive Care Unit, Hospital,, Blois, France|Medical Intensive Care Unit, University Hospital, Bordeaux, Bordeaux, France|Medical Intensive Care Unit, University Hospital, Brest, Brest, France|Medical Intensive Care Unit, Hospital, Béthune, Béthune, France|Medical Intensive Care Unit, University Hospital, Caen, Caen, France|Intensive Care Unit, Louis Mourier-APHP, Colombes, France|Intensive Care Unit, Hospital, Dax, Dax, France|Medical Intensive Care Unit, University Hospital, Dijon, Dijon, France|Medical Intensive Care Unit, University Hospital, Grenoble, Grenoble, France|Intensive Care Unit, Hospital, La Roche-sur-Yon, La Roche-sur-Yon, France|Intensive Care Unit, Hospital, Le Mans, Le Mans, France|Intensive Care Unit, University Hospital, Lille, Lille, France|Intensive Care Unit, Hospital, Lorient, Lorient, France|Medical Intensive Care Unit, Hospital, Mont-de-Marsan, Mont-de-Marsan, France|Medical Intensive Care Unit, University Hospital, Montpellier, Montpellier, France|Medical Intensive Care Unit, University Hospital, Nantes, Nantes, France|Medical Intensive Care Unit, University Hospital, Nice, NIce, France|Medical Intensive Care Unit, Hospital, Orléans, Orléans, France|Medical Intensive Care Unit, Tenon-APHP, Paris, France|Medical Intensive Care Unit, University Hospital, Poitiers, Poitiers, France|Medical Intensive Care Unit, University Hospital, Tours, Tours, France|Surgical Intensive Care Unit, University Hospital, Tours, Tours, France|Intensive Care Unit, Hospital, Valence, Valence, France|Medical Intensive Care Unit, University Hospital, Nancy, Vandœuvre-lès-Nancy, France|Intensive Care Unit, Hospital, Vannes, Vannes",France,Respiratory Diseases,1,2,576.0
2264.0,NCT04587258,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,,Recruiting,Breast Cancer,Colorectal Cancer,COVID-19,,,,,Behavioral: Informational videos and social media campaigns encouraging cancer screening.,Rhode Island Hospital|Blackstone Valley Community Health Care,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-08-28,01/09/22,2022-01-09,14/10/20,14/10/20,"Blackstone Valley Community Health Center, Pawtucket, Rhode Island",United States,"Respiratory Diseases, Cancers",1,3,499.0
2265.0,NCT04361643,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,GETAFE,Not yet recruiting,COVID-19,,,,,,,"Drug: Lenalidomide as a 5 mg capsule PO daily, days 1, 3, and 5.|Drug: Placebo",Hospital Universitario Getafe,All,"60 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-10-27,31/08/21,2021-12-31,24/04/20,31/07/20,"Hospital Universitario de Getafe, Getafe",Spain,Respiratory Diseases,1,1,430.0
2266.0,NCT04408183,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,,Recruiting,SARS-CoV 2,Infection,,,,,,Drug: GLS-1200|Drug: Placebo,"GeneOne Life Science, Inc.",All,"18 Years and older   (Adult, Older Adult)",225.0,Industry,Interventional,2020-01-06,01/08/21,2021-01-09,29/05/20,25/03/21,"Sinus and Nasal Specialists of Louisiana, Baton Rouge, Louisiana, United States|University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,369.0
2267.0,NCT04328012,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19,COVIDMED,Recruiting,COVID-19,,,,,,,Drug: Losartan|Drug: Placebo,Bassett Healthcare|Reid Health|Goshen Health System,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-04,01/06/21,2021-01-08,31/03/20,16/02/21,"Bassett Medical Center, Cooperstown, New York",United States,Respiratory Diseases,1,1,218.0
2268.0,NCT04348214,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,SARAH,Recruiting,COVID-19,,,,,,,,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-04-22,01/10/20,2020-01-12,16/04/20,02/06/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,-101.0
2269.0,NCT04609462,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,HiFlo-COVID,Completed,COVID-19,Acute Hypoxemic Respiratory Failure,,,,,,Procedure: Conventional oxygen therapy|Procedure: High flow nasal cannula,Fundacion Clinica Valle del Lili,All,"18 Years and older   (Adult, Older Adult)",199.0,Other,Interventional,2020-11-08,13/01/21,2021-10-02,30/10/20,01/04/21,"Fundacion Valle del Lili, Cali, Valle Del Cauca",Colombia,Respiratory Diseases,1,2,328.0
2270.0,NCT04709172,Pilot Study of Cefditoren Pivoxil in COVID-19 Patients With Mild to Moderate Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: Cefditoren pivoxil 400mg,Meiji Pharma Spain S.A.,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Interventional,2021-05-01,05/04/21,2021-09-30,14/01/21,20/01/21,"HU Henares, Coslada, Madrid",Spain,Respiratory Diseases,1,1,152.0
2271.0,NCT04354870,COVID-19 PrEP HCW HCQ Study,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine (HCQ),NYU Langone Health,All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Interventional,2020-03-04,15/09/20,2020-01-10,21/04/20,05/10/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,-54.0
2272.0,NCT04304690,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",SEROCOV,"Active, not recruiting",Sars-CoV2,,,,,,,Other: blood sample,Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",1000.0,Other,Interventional,2020-03-16,16/05/21,2021-10-16,11/03/20,01/12/20,"Hopital Pitié Salpetrière, Paris",France,Respiratory Diseases,1,1,579.0
2273.0,NCT04495803,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),,Recruiting,Perinatal Anxiety,COVID-19,,,,,,Other: Cognitive Behavioural Group Therapy for Perinatal Anxiety,St. Joseph's Healthcare Hamilton,Female,18 Years to 45 Years   (Adult),120.0,Other,Interventional,2020-01-09,01/08/22,2022-01-08,03/08/20,17/03/21,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,"Mental Health, Respiratory Diseases",1,2,730.0
2274.0,NCT04365725,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",REMDECO-19,Recruiting,COVID-19,,,,,,,Drug: Remdesivir,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-05-05,01/06/20,2020-01-06,28/04/20,13/05/20,"Hôpital Cochin, Paris",France,Respiratory Diseases,1,1,-120.0
2275.0,NCT04703114,Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV),AMBUCOV,Not yet recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Blood count|Diagnostic Test: Blood collection|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Saliva samples|Diagnostic Test: Faeces samples|Genetic: Genetic blood collection|Other: Data collection,Assistance Publique - Hôpitaux de Paris|Fonds IMMUNOV,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-02,01/10/21,2021-01-12,11/01/21,11/01/21,"Hôpital Cochin, Paris, Île-de-France",France,Respiratory Diseases,1,2,10.0
2276.0,NCT04435119,Covid-19 and Vitamin D in Nursing-home,COVIT-EHPAD,Completed,Coronavirus,,,,,,,,"University Hospital, Angers",All,70 Years and older   (Older Adult),96.0,Other,Observational,2020-03-15,15/05/20,2020-05-15,17/06/20,17/06/20,"Angers University Hospital, Angers",France,Respiratory Diseases,1,1,61.0
2277.0,NCT04383470,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,COH-FIT,Recruiting,Mental Health Wellness 1,Pandemic,,,,,,,University of Padova|Northwell Health|Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,All,"6 Years and older   (Child, Adult, Older Adult)",100000.0,Other,Observational,2020-04-26,01/12/21,2022-01-06,12/05/20,14/05/20,"Aristotle University of Thessaloniki, Thessaloníki",Greece,Others,0,2,620.0
2278.0,NCT04346615,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,,Recruiting,COVID-19,,,,,,,Drug: Zavegepant (BHV-3500)|Drug: Placebo,"Biohaven Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",120.0,Industry,Interventional,2020-04-25,01/07/21,2021-01-07,15/04/20,17/02/21,"Georgetown University Medical Center, Washington, District of Columbia, United States|Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States|Roper Hospital, Charleston, South Carolina",United States,Respiratory Diseases,1,1,257.0
2279.0,NCT04569188,Convalescent Plasma in COVID-19 Elderly Patients,RESCUE,Completed,COVID-19,,,,,,,Biological: Convalescent plasma,Azienda Socio Sanitaria Territoriale di Mantova,All,65 Years and older   (Older Adult),21.0,Other,Interventional,2020-05-15,15/08/20,2020-03-09,29/09/20,05/10/20,"Transfusion Service, Mantova",Italy,Respiratory Diseases,1,1,-67.0
2280.0,NCT04499313,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,,Recruiting,COVID-19,ARDS,,,,,,Drug: Dexamethasone|Drug: Methylprednisolone,Chattogram General Hospital|Health Science Center of Xi'an Jiaotong University,All,"20 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-02-08,15/11/20,2020-11-30,05/08/20,18/08/20,"Chattogram General Hospital, Chittagong, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur",Bangladesh,Respiratory Diseases,1,2,296.0
2281.0,NCT04688372,Hospital COVID-19 Surge and Associated Mortality Risk,,Completed,COVID-19,,,,,,,Other: Surge Index,National Institutes of Health Clinical Center (CC)|Emory University|Harvard Medical School|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",144116.0,NIH|Other,Observational,2020-01-10,15/02/21,2021-02-15,30/12/20,06/04/21,"National Institutes of Health Clinical Center (primary center conducting large database study), Bethesda, Maryland",United States,Respiratory Diseases,1,1,402.0
2282.0,NCT04339660,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Biological: UC-MSCs|Other: Placebo,"Puren Hospital Affiliated to Wuhan University of Science and Technology|Shanghai University|Qingdao Co-orient Watson Biotechnology group co. LTD|Basic Medical Sciences, Chinese Academy of Medical Sciences",All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-02,30/06/20,2020-06-30,09/04/20,09/04/20,"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,1,180.0
2283.0,NCT04681092,Anti-COVID19 AKS-452 - ACT Study,ACT,Recruiting,COVID-19,,,,,,,Biological: AKS-452,University Medical Center Groningen|Akston Biosciences Corporation,All,"18 Years to 65 Years   (Adult, Older Adult)",130.0,Other,Interventional,2021-12-04,30/06/21,2021-06-30,23/12/20,12/04/21,"University Medical Center Groningen, Groningen",Netherlands,Respiratory Diseases,1,1,-157.0
2284.0,NCT04650035,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,,Completed,COVID-19,,,,,,,,Yarmouk University,All,"Child, Adult, Older Adult",60.0,Other,Observational,2020-01-11,04/11/20,2020-10-11,02/12/20,03/12/20,"Yarmouk University, Irbid",Jordan,Respiratory Diseases,1,1,274.0
2285.0,NCT04367545,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,MolCOVID,Completed,COVID-19,RT-ddPCR Multiplex,,,,,,Diagnostic Test: Saliva collection,"University Hospital, Rouen",All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Interventional,2020-04-16,17/05/20,2020-05-17,29/04/20,05/11/20,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,2,31.0
2286.0,NCT04775069,Antibody Response to COVID-19 Vaccines in Liver Disease Patients,,Not yet recruiting,Chronic Liver Disease,,,,,,,Biological: BNT162b2|Biological: CoronaVac|Biological: AZD1222,Humanity & Health Medical Group Limited,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Interventional,2021-03-15,31/12/21,2022-03-31,01/03/21,01/03/21,"Humanity & Health Medical Group Limited, Hong Kong",Hong Kong,Others,0,1,381.0
2287.0,NCT04373798,C-reactive Protein Levels Among Individuals With COVID-19,,Recruiting,Coronavirus Infection,,,,,,,Diagnostic Test: C-reactive protein,Henning Bliddal|Frederiksberg University Hospital,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-04-05,30/11/20,2020-11-30,04/05/20,11/06/20,"The Parker Institute, Frederiksberg Hospital, Copenhagen",Denmark,Respiratory Diseases,1,1,239.0
2288.0,NCT04735588,"Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP",,Not yet recruiting,Immune Thrombocytopenia,ITP,COVID-19,ITP Secondary to Infection,,,,,Gruppo Italiano Malattie EMatologiche dell'Adulto,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2021-01-04,01/01/22,2023-01-10,03/02/21,16/02/21,,,Respiratory Diseases,1,4,736.0
2289.0,NCT04761718,Covid-19 Epidemic Lockdown Impact on Psychomotor Performance,,Not yet recruiting,COVID-19,,,,,,,,Delta University for Science and Technology,All,"6 Years to 18 Years   (Child, Adult)",300.0,Other,Observational,2021-01-03,30/05/21,2021-05-30,21/02/21,21/02/21,,,Respiratory Diseases,1,1,147.0
2290.0,NCT04385004,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",PR-Covid-19,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",320.0,Other,Observational,2020-04-27,01/07/20,2020-01-07,12/05/20,28/05/20,"Service Reanimation Medicale, Strasbourg",France,Respiratory Diseases,1,1,-111.0
2291.0,NCT04411563,Epigenetic Tools as Prognostic Predictors in Covid19,,Recruiting,Prognosis,,,,,,,Other: Taking biological samples,Bakirkoy Dr. Sadi Konuk Research and Training Hospital|Istanbul University,All,"18 Years to 65 Years   (Adult, Older Adult)",105.0,Other,Observational,2020-05-21,01/09/20,2020-01-12,02/06/20,02/06/20,"Bakirkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul",Turkey,Others,0,1,-130.0
2292.0,NCT04798001,Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults,,Recruiting,COVID-19,,,,,,,"Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 2, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Two Doses, Intranasal Drops|Biological: Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 3, Single Dose, Intranasal Spray","Meissa Vaccines, Inc.",All,"18 Years to 69 Years   (Adult, Older Adult)",130.0,Industry,Interventional,2021-12-04,31/10/22,2022-10-31,15/03/21,14/04/21,"Johnson County Clin-Trials, Lenexa, Kansas, United States|Meridian Clinical Research, Rockville, Maryland",United States,Respiratory Diseases,1,1,331.0
2293.0,NCT04625218,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study,CHLORO-VID,Not yet recruiting,COVID-19,,,,,,,,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2021-01-01,01/05/21,2021-01-05,12/11/20,12/11/20,,,Respiratory Diseases,1,1,4.0
2294.0,NCT04745416,Clinical Characteristics of Patients With Leukemia and COVID-19,,Completed,"Leukemia, Acute",COVID-19,"Leukemia, Lymphoblastic",,,,,,Hospital General de Mexico,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-01,31/12/20,2021-01-25,09/02/21,09/02/21,"Hospital Regional de Alta Especialidad de Ixtapaluca, Ixtapaluca, State Of Mexico, Mexico|Hospital General de México Dr. Eduardo Liceaga, Mexico City",Mexico,"Respiratory Diseases, Cancers",1,3,390.0
2295.0,NCT04409847,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),OBELIX,Recruiting,COVID-19,Hypertension,,,,,,Diagnostic Test: ABPM|Diagnostic Test: ECG|Diagnostic Test: FMD|Diagnostic Test: PWV|Diagnostic Test: Rarefaction,NHS Greater Glasgow and Clyde|University of Glasgow,All,30 Years to 60 Years   (Adult),70.0,Other,Observational,2020-01-06,30/04/21,2021-05-31,01/06/20,04/02/21,"NHS Greater Glasgow and Clyde, Glasgow",United Kingdom,"Cardiovascular Diseases, Respiratory Diseases",1,2,511.0
2296.0,NCT04520880,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,No-SARS,Not yet recruiting,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection),Hospitalized Patients,Laboratory-confirmed SARS-CoV 2 Infection,,,,,Diagnostic Test: Testing procedure for Binding antibodies|Diagnostic Test: Neutralizing antibodies,Dammam University|Dammam Medical Complex|Institute for Research and medical consultations (IRMC),All,"18 Years and older   (Adult, Older Adult)",158.0,Other,Observational,2020-01-08,01/12/20,2021-01-02,20/08/20,20/08/20,"Imam Abdulrahman Bin Faisal University, Dammam, Eastern",Saudi Arabia,Respiratory Diseases,1,3,360.0
2297.0,NCT04357431,COVID-19 Among Egyptian Health Care Providers,,Completed,COVID-19,,,,,,,Other: self-administered questionnaire,Assiut University,All,"Child, Adult, Older Adult",565.0,Other,Observational,2020-04-22,26/05/20,2020-05-30,22/04/20,07/07/20,"Ahmed Abbas, Assiut, Cairo",Egypt,Respiratory Diseases,1,1,38.0
2298.0,NCT04387292,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,SOCOVID,Recruiting,COVID-19,Ophthalmopathy,,,,,,Procedure: Ophthalmologic exam,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-09,01/05/21,2021-01-05,13/05/20,14/09/20,"Fondation A de Rothschild, Paris",France,Respiratory Diseases,1,2,180.0
2299.0,NCT04734678,Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome,,Recruiting,COVID-19,Cytokine Storm,Corona Virus Infection,,,,,Drug: Tocilizumab|Drug: Infliximab,Ain Shams University|Misr International University,All,"18 Years to 65 Years   (Adult, Older Adult)",84.0,Other,Observational,2020-01-12,01/03/21,2021-01-06,02/02/21,02/02/21,"Teachers Hospital, Cairo, Please Select",Egypt,Respiratory Diseases,1,3,360.0
2300.0,NCT04494867,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,,Recruiting,COVID-19,,,,,,,Device: Core Warming|Other: Standard of Care,"Sharp HealthCare|Advanced Cooling Therapy, Inc., d/b/a Attune Medical",All,"18 Years and older   (Adult, Older Adult)",20.0,Other|Industry,Interventional,2020-08-19,01/12/20,2020-01-12,31/07/20,25/09/20,"Sharp Memorial Hospital, San Diego, California",United States,Respiratory Diseases,1,1,-220.0
2301.0,NCT04793243,Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico,,Completed,COVID-19,,,,,,,Dietary Supplement: Vitamin D3,University of Guadalajara,All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Interventional,2020-08-17,10/10/20,2020-10-24,11/03/21,11/03/21,"Universidad de Guadalajara, Guadalajara, Jalisco",Mexico,Respiratory Diseases,1,1,68.0
2302.0,NCT04540029,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,MOM-COPE,Recruiting,Prenatal Stress,,,,,,,Other: Maternal stress,"IRCCS National Neurological Institute ""C. Mondino"" Foundation",All,up to 12 Months   (Child),600.0,Other,Observational,2020-06-05,31/10/22,2023-05-31,07/09/20,07/09/20,"IRCCS Mondino Foundation, Pavia, PV",Italy,Mental Health,1,1,1090.0
2303.0,NCT04400305,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",COVID-19,Recruiting,"Physical Activity, Healthy Promotion",,,,,,,Behavioral: Digital Health Online Platform,University of Victoria,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-05-20,31/07/21,2021-07-31,22/05/20,29/03/21,"Behavioural Medicine Lab, University of Victoria, Victoria, British Columbia, Canada|University of Victoria, Victoria, British Columbia",Canada,Others,0,1,437.0
2304.0,NCT04410692,Can the Prediction Market Improve Predictions of COVID-19?,,Completed,"Health Knowledge, Attitudes, Practice",,,,,,,Other: Prediction Market,"National University, Singapore",All,"18 Years and older   (Adult, Older Adult)",560.0,Other,Interventional,2020-05-15,16/05/20,2020-05-17,01/06/20,02/06/20,"National University of Singapore, Singapore",Singapore,Others,0,1,2.0
2305.0,NCT04393324,The Critical Care Response to the COVID-19 Pandemic in Madrid,Tetrix,Recruiting,COVID-19,"ARDS, Human",,,,,,,"Hospital San Carlos, Madrid|Fundación de Investigación Hospital Clínico San Carlos",All,"Child, Adult, Older Adult",2500.0,Other,Observational,2020-04-24,31/05/20,2020-06-30,19/05/20,28/05/20,"Hospital Clinico San Carlos, Madrid",Spain,Respiratory Diseases,1,2,67.0
2306.0,NCT04666285,Southampton Women's Survey COVID-19 Study,SWS_COVID-19,Not yet recruiting,Mental Health Wellness 1,,,,,,,Other: Experience of pandemic,University of Southampton,All,"12 Years to 57 Years   (Child, Adult)",1000.0,Other,Observational,2020-01-12,01/12/20,2020-01-12,14/12/20,14/12/20,"MRC Lifecourse Epidemiology Unit, Southampton",United Kingdom,Others,0,1,0.0
2307.0,NCT04519424,CSL324 in COVID-19,,Withdrawn,COVID-19,,,,,,,Biological: CSL324|Drug: Placebo,CSL Behring,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-09,01/04/21,2021-01-05,19/08/20,14/10/20,,,Respiratory Diseases,1,1,362.0
2308.0,NCT04798027,Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older,VAW00001,Recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 mRNA vaccine formulation 1|Biological: SARS-CoV-2 mRNA vaccine formulation 2|Biological: SARS-CoV-2 mRNA vaccine formulation 3|Biological: Placebo (0.9% normal saline),"Sanofi Pasteur, a Sanofi Company|Sanofi",All,"18 Years and older   (Adult, Older Adult)",415.0,Industry,Interventional,2021-12-03,01/05/22,2022-01-05,15/03/21,16/03/21,"Investigational Site Number 8400003, Rolling Hills Estates, California",United States,Respiratory Diseases,1,1,33.0
2309.0,NCT04815109,Prospective Electroencephalography Evaluation of Sedation in COVID-19,,Not yet recruiting,Conscious Sedation,Pathologic Processes,Electroencephalogram,Acute Respiratory Distress Syndrome,Corona Virus Infection,,,Other: Encephalography measurement,Goethe University,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2021-01-04,30/06/21,2021-08-30,24/03/21,01/04/21,,,Respiratory Diseases,1,5,238.0
2310.0,NCT04394104,COVID-19 Wellness Survey,,Terminated,Health Behavior,,,,,,,Other: Survey,"Rutgers, The State University of New Jersey",All,"18 Years and older   (Adult, Older Adult)",593.0,Other,Observational,2020-05-27,31/05/20,2020-05-31,19/05/20,07/12/20,"Rutgers, The State University of New Jersey, New Brunswick, New Jersey",United States,Others,0,1,4.0
2311.0,NCT04537585,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",Tomeka,Not yet recruiting,COVID-19,,,,,,,"Combination Product: Tomeka®|Drug: ""Vernonia amygdalina""","Guyguy K Tshima, MD|Centre Médical de Kinshasa (CMK)|University of Kinshasa",All,"15 Years to 65 Years   (Child, Adult, Older Adult)",2000.0,Other,Interventional,2020-01-11,01/11/22,2022-01-12,03/09/20,03/09/20,"Cliniques Universitaires de Kinshasa, Kinshasa, Congo",The Democratic Republic of the,Respiratory Diseases,1,1,732.0
2312.0,NCT04547218,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,,Completed,Age Problem,Surgery,"Depression, Anxiety",,,,,,University of Malaya,All,65 Years and older   (Older Adult),150.0,Other,Observational,2020-06-22,31/12/20,2020-12-31,14/09/20,19/01/21,"Department of Anesthesiology & Intensive Care, Faculty of Medicine, University of Malaya, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur",Malaysia,Mental Health,1,3,192.0
2313.0,NCT04350476,COVID-19 Remote Monitoring,,Withdrawn,COVID-19,Cardiac Arrhythmias,,,,,,Diagnostic Test: VitalConnect Vital Sign Patch,Vivek Reddy|Icahn School of Medicine at Mount Sinai,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-17,01/05/20,2020-01-05,17/04/20,20/08/20,,,Respiratory Diseases,1,2,-103.0
2314.0,NCT04337346,Evaluation of Covid 19 Anxiety in Endometriosis Patients,,Completed,Endometriosis,COVID-19,,,,,,,Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),80.0,Other,Observational,2020-05-04,20/04/20,2020-04-25,07/04/20,20/05/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,Respiratory Diseases,1,2,-9.0
2315.0,NCT04514016,Cross Sectional CFAR HIV/COVID-19 Study,,Completed,SARS-CoV Infection,COVID-19,,,,,,,University of Miami|Miami Center for AIDS Research (CFAR),All,"3 Years to 25 Years   (Child, Adult)",64.0,Other,Observational,2020-12-08,17/03/21,2021-03-17,14/08/20,23/03/21,"Batchelor's Children's Research Institute, Miami, Florida",United States,Respiratory Diseases,1,2,99.0
2316.0,NCT04701528,Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients,VOCOVID,Recruiting,COVID-19,Kidney Transplant Infection,,,,,,Drug: Voclosporin|Drug: Tacrolimus,Leiden University Medical Center|Aurinia Pharmaceuticals Inc.,All,"18 Years and older   (Adult, Older Adult)",20.0,Other|Industry,Interventional,2020-11-15,25/03/22,2022-10-25,08/01/21,08/01/21,"Leiden University Medical Center, Leiden",Netherlands,Respiratory Diseases,1,2,709.0
2317.0,NCT04441996,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,,Completed,COVID-19,,,,,,,Biological: Therapeutic plasma exchange (TPE)|Other: Standard of care,Emory University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-07-17,18/03/21,2021-03-18,22/06/20,29/03/21,"Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,1,244.0
2318.0,NCT04385199,Convalescent Plasma for Patients With COVID-19,,Recruiting,Coronavirus Infection,Coronavirus,COVID-19,,,,,Biological: Convalescent plasma,Henry Ford Health System,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-05,01/08/20,2020-01-08,12/05/20,12/05/20,"Henry Ford Hospital, Detroit, Michigan",United States,Respiratory Diseases,1,3,-88.0
2319.0,NCT04805216,Covid-19 Vaccine Response in Immunocompromised Haematology Patients,COVAC-IC,Recruiting,COVID-19,Haematological Disorders,Immune Suppression,,,,,Procedure: Blood test,University Hospitals of North Midlands NHS Trust|University Hospitals of North Midlands NHS Trust Charity|Staffordshire University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2021-03-15,15/11/21,2021-11-15,18/03/21,18/03/21,"University Hospitals of North Midlands NHS Trust, Stoke-on-Trent",United Kingdom,Respiratory Diseases,1,3,245.0
2320.0,NCT04640233,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Сov-2) Infection,,Recruiting,COVID-19,,,,,,,Biological: Gam-COVID-Vac|Other: Placebo,"Dr. Reddy's Laboratories Limited|Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|RDIF (Russian Direct Investment Fund)|CRO: JSS Medical Research India Pvt. Ltd.",All,"18 Years and older   (Adult, Older Adult)",1600.0,Industry|Other,Interventional,2020-11-30,01/08/21,2021-01-09,23/11/20,29/01/21,"S N Medical College, Agra, India|MGM Medical College and Hospital, Aurangabad, India|KLE Prabhakar Kore Hospital, Belgaum, India|Apollo Hospital, Delhi, India|Batra Hospital, Delhi, India|HIMSR with CHRD-SAS, Delhi, India|ESIC Medical College & Hospital, Faridabad, India|AIG hospital, Hyderabad, India|Maharaja Agrasen Superspecialty Hospital, Jaipur, India|GSVM Medical College, Kanpur, India|Peerless Hospital, Kolkata, India|Atharva Hospital, Lucknow, India|St. George's Hospital, Mumbai, India|JSS Hospital, Mysore, India|INCLEN trust and Gurunanak Hospital, Palwal, India|PIMS, Puducherry, India|BJ Sassoon Hospital, Pune, India|KEM Hospital, Pune, India|Noble Hospital Private Limited, Pune, India|BAPS hospital, Sūrat, India|Rhythm Heart Institute, Vadodara, India|Sumandeep Vidyapeeth, Vadodara, India|Christian Medical College, Vellore",India,Respiratory Diseases,1,1,40.0
2321.0,NCT04341610,ASC Therapy for Patients With Severe Respiratory COVID-19,ASC COVID-19,Withdrawn,Respiratory Tract Diseases,,,,,,,Drug: Stem Cell Product,"Rigshospitalet, Denmark",All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-20,30/01/21,2021-04-30,10/04/20,27/05/20,"2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen",Denmark,Others,0,1,375.0
2322.0,NCT04799652,Are Surgeons Ready to Get the COVID-19 Vaccine?,,Recruiting,COVID-19,,,,,,,Other: Survey,Brugmann University Hospital,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2021-01-15,30/04/21,2021-04-30,16/03/21,16/03/21,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,105.0
2323.0,NCT04558021,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,NICLONEX,Recruiting,COVID-19,,,,,,,Drug: Niclosamide suspension|Other: Placebo,Imuneks Farma ilac San. Tic. A.S.,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2020-08-10,30/01/21,2021-02-14,22/09/20,12/10/20,"Akdeniz Üniversitesi Tıp Fakültesi Hastanesi, Antalya, Turkey|Antalya Eğitim ve Araştırma Hastanesi, Antalya, Turkey|Gaziantep Üniversitesi Tıp Fakültesi Hastanesi, Gaziantep, Turkey|Gaziosmanpaşa Taksim Eğitim ve Araştırma Hastanesi, Istanbul, Turkey|Dokuz Eylül Üniversitesi Hastanesi, İzmir, Turkey|İzmir SBÜ Tepecik Eğitim ve Araştırma Hastanesi, İzmir, Turkey|SBÜ Dr. Suat Seren Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma Hastanesi, İzmir, Turkey|İzmir Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi, İzmir",Turkey,Respiratory Diseases,1,1,188.0
2324.0,NCT04402983,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,,Completed,COVID-19,Telerehabilitation,Physical Therapy,,,,,Other: Physiotherapy,Istanbul Medipol University Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",34.0,Other,Interventional,2020-05-27,01/12/20,2020-01-12,27/05/20,14/12/20,"University of Health Sciences Turkey, İstanbul",Turkey,Respiratory Diseases,1,3,-136.0
2325.0,NCT04619628,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",,Recruiting,COVID-19,,,,,,,Biological: COVI-VAC|Other: Placebo,"Codagenix, Inc",All,18 Years to 30 Years   (Adult),48.0,Industry,Interventional,2020-11-12,01/06/21,2022-01-05,06/11/20,17/12/20,"hVIVO, London",United Kingdom,Respiratory Diseases,1,1,419.0
2326.0,NCT04359511,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,CORTICOVIDHUGO,Not yet recruiting,COVID-19,,,,,,,Drug: Prednisone|Drug: Hydrocortisone,"University Hospital, Tours",All,"18 Years and older   (Adult, Older Adult)",210.0,Other,Interventional,2020-01-06,01/12/20,2020-01-12,24/04/20,04/06/20,,,Respiratory Diseases,1,1,6.0
2327.0,NCT04542031,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,,Not yet recruiting,COVID-19,Rheumatic Diseases,,,,,,Other: Questionnaire,The Royal Wolverhampton Hospitals NHS Trust,All,"18 Years and older   (Adult, Older Adult)",7911.0,Other,Interventional,2020-01-10,01/10/21,2021-01-10,09/09/20,16/09/20,"The Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands",United Kingdom,Respiratory Diseases,1,2,366.0
2328.0,NCT04445454,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,,Recruiting,Coronavirus Infection,,,,,,,Biological: Mesenchymal stromal cells,University of Liege,All,"18 Years to 70 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-12-06,30/09/22,2022-09-30,24/06/20,24/06/20,"CHU de Liège, Liège",Belgium,Respiratory Diseases,1,1,663.0
2329.0,NCT04779047,Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.,,Recruiting,COVID-19,Pneumonia,,,,,,Drug: Remdesivir|Drug: Hydroxychloroquine|Drug: Tocilizumab|Drug: Lopinavir/ Ritonavir|Drug: Ivermectin,October 6 University|Beni-Suef University,All,"18 Years to 88 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-10,10/03/21,2021-05-04,03/03/21,17/03/21,"Beni-suef University, Banī Suwayf",Egypt,Respiratory Diseases,1,2,480.0
2330.0,NCT04516486,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,COMETS,"Active, not recruiting","Respiratory Distress Syndrome, Adult",COVID-19,,,,,,Other: retrospective metagenomics on clinical samples collected during hospitalization,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Observational,2020-09-03,24/05/20,2020-12-31,18/08/20,18/08/20,"CHU Henri Mondor, Créteil",France,Respiratory Diseases,1,2,119.0
2331.0,NCT04389645,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,,Completed,COVID-19,,,,,,,Diagnostic Test: IP-10 in CDS protocol,MeMed Diagnostics Ltd.,All,"18 Years and older   (Adult, Older Adult)",52.0,Industry,Observational,2020-07-04,12/05/20,2020-12-05,15/05/20,15/05/20,"Rabin Medical Center, Petach Tikva",Israel,Respiratory Diseases,1,1,154.0
2332.0,NCT04366232,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation,JAKINCOV,Terminated,COVID-19,,,,,,,Drug: Anakinra alone (stages 2b/3)|Drug: Anakinra and Ruxolitinib (overcome stage 3)|Other: Standard of care,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer|Hôpital d'instruction des armées Sainte-Anne|Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",2.0,Other,Interventional,2020-08-19,02/10/20,2020-02-10,28/04/20,16/12/20,"AP-HM, Hôpital de la Conception, Marseille, Bouches-du-Rhône, France|Hôpital Sainte-Musse, Toulon, VAR, France|Sainte Anne Teaching Military Hospital, Toulon, Var",France,Respiratory Diseases,1,1,-191.0
2333.0,NCT04392232,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,,Recruiting,Coronavirus,COVID-19,Convalescent Plasma,,,,,Drug: Convalescent Plasma,TriHealth Inc.,All,"16 Years and older   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-05-05,31/12/20,2020-12-31,18/05/20,20/05/20,"Good Samaritan Hospital, Cincinnati, Ohio, United States|Bethesda North Hospital, Cincinnati, Ohio",United States,Respiratory Diseases,1,3,240.0
2334.0,NCT04438980,Glucocorticoids in COVID-19 (CORTIVID),CORTIVID,Recruiting,COVID-19,,,,,,,Drug: Methylprednisolone|Other: Placebo,Fundacion Miguel Servet|Complejo Hospitalario de Navarra|Hospital Sant Joan Despí Moisès Broggi,All,"18 Years to 75 Years   (Adult, Older Adult)",72.0,Other,Interventional,2020-05-15,01/12/20,2021-01-02,19/06/20,22/06/20,"Hospital Sant Joan Despí Moisès Broggi, Sant Joan Despí, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra",Spain,Respiratory Diseases,1,1,232.0
2335.0,NCT04363593,Serology COVID-19 From the Cornwall Hospital Union,ROCOCO,Completed,Corona Virus Infection,,,,,,,Biological: Serological test|Biological: Serum test,Centre Hospitalier de Cornouaille|Centre Hospitalier Régional et Universitaire de Brest,All,"18 Years and older   (Adult, Older Adult)",2587.0,Other,Interventional,2020-04-05,16/11/20,2020-11-16,27/04/20,10/12/20,"CH de Cornouaille, Quimper",France,Respiratory Diseases,1,1,225.0
2336.0,NCT04377568,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,CONCOR-KIDS,Recruiting,Hospitalized Children,COVID-19,,,,,,Biological: Convalescent plasma (CP),The Hospital for Sick Children|C17 Council (regulatory sponsor),All,"up to 18 Years   (Child, Adult)",100.0,Other,Interventional,2020-07-10,01/12/21,2022-01-05,06/05/20,19/11/20,"Alberta Children's Hospital, Calgary, Alberta, Canada|Stollery Children's Hospital, Edmonton, Alberta, Canada|BC Children's Hospital, Vancouver, British Columbia, Canada|Winnipeg Children's Hospital, Winnipeg, Manitoba, Canada|IWK Health Centre, Halifax, Nova Scotia, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|Kingston Health Sciences Centre, Kingston, Ontario, Canada|Children's Hospital, London, Ontario, Canada|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec, Canada|McGill Univ Health Ctr - Montreal Children's Hospital, Montréal, Quebec, Canada|Jim Pattison Children's Hospital, Saskatoon, Saskatchewan",Canada,Respiratory Diseases,1,2,544.0
2337.0,NCT04643444,Police COVID-19 Serosurvey,PoliCOV,Enrolling by invitation,COVID-19,Volunteers,Healthy,,,,,Diagnostic Test: Blood sampling|Other: Online Questionnaire,University of Bern|Interregionale Blutspende SRK Bern,All,"18 Years to 65 Years   (Adult, Older Adult)",1000.0,Other,Observational,2021-09-02,01/01/22,2022-01-06,25/11/20,16/02/21,"University of Bern, Institute for Infectious Diseases, Bern, BE",Switzerland,Respiratory Diseases,1,3,126.0
2338.0,NCT04652765,Camostat With Bicalutamide for COVID-19,COMBO,Recruiting,COVID-19,SARS-CoV Infection,Coronavirus Infection,,,,,Drug: Camostat Mesilate|Drug: Bicalutamide 150 mg,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,All,"60 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-03-02,01/01/23,2023-01-01,03/12/20,11/02/21,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,3,670.0
2339.0,NCT04382547,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,,Enrolling by invitation,COVID-19,COVID-19,Coronavirus,Pneumonia,"Pneumonia, Viral","Pneumonia, Interstitial",Sars-CoV2,Biological: Allogenic pooled olfactory mucosa-derived mesenchymal stem cells|Other: Standard treatment according to the Clinical protocols,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus|Belarusian State Medical University,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-11-05,30/06/21,2021-06-30,11/05/20,28/05/20,"Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Minsk",Belarus,Respiratory Diseases,1,7,237.0
2340.0,NCT04787211,"A Phase 2 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",,Not yet recruiting,COVID-19,,,,,,,Drug: BRII-196 and BRII-198|Drug: Placebo,Brii Biosciences Limited|TSB Therapeutics (Beijing) CO.LTD,All,"18 Years and older   (Adult, Older Adult)",24.0,Industry,Interventional,2021-01-03,01/12/21,2021-01-12,08/03/21,11/03/21,"Investigative Site 1, Beijing, Beijing",China,Respiratory Diseases,1,1,9.0
2341.0,NCT04348513,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Thy-Support,Recruiting,Pulmonary Infection,COVID-19,,,,,,Drug: T3 solution for injection|Drug: Placebo,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.|ATTIKON University Hospital,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry|Other,Interventional,2020-05-29,02/05/21,2021-05-31,16/04/20,02/06/20,"Attikon University General Hospital, Haidari/Athens",Greece,Respiratory Diseases,1,2,367.0
2342.0,NCT04346043,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Strain,Not yet recruiting,COVID-19,,,,,,,,Ain Shams University,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-04-20,01/10/20,2020-01-12,15/04/20,20/04/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,-99.0
2343.0,NCT04706533,"Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19",M2C2,Recruiting,COVID-19,Kidney Diseases,Inflammation,SARS-CoV Infection,,,,Diagnostic Test: Biomarkers of inflammation,University of Michigan,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-03-23,01/06/21,2021-01-06,13/01/21,30/03/21,"University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,4,289.0
2344.0,NCT04344535,Convalescent Plasma vs. Standard Plasma for COVID-19,,Enrolling by invitation,COVID-19,,,,,,,Biological: Convalescent Plasma|Biological: Standard Donor Plasma,Stony Brook University,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-08-04,30/04/21,2021-08-31,14/04/20,17/04/20,"Stony Brook University Hospital, Stony Brook, New York",United States,Respiratory Diseases,1,1,392.0
2345.0,NCT04842721,Effect of Hypertonic Saturated Saline Mouth Rinse on Covid-19 Virus in Vivo.,,Not yet recruiting,COVID-19,,,,,,,Drug: Hypertonic Saturated Saline Mouth Rinse Active Arm|Other: Placebo Plain Water Mouth Rinse Arm,"Rafik Batroussy|Batroussy, Rafik",All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-07,01/10/21,2021-01-12,13/04/21,13/04/21,"Rafik Batroussy, Calgary, Alberta",Canada,Respiratory Diseases,1,1,5.0
2346.0,NCT04427735,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,,Recruiting,STEMI,,,,,,,,Beijing Friendship Hospital,All,"Child, Adult, Older Adult",200.0,Other,Observational,2019-01-24,24/07/21,2021-07-24,11/06/20,11/06/20,"Beijing Friendship Hospital, Capital Medical University, Beijing",China,Others,0,1,912.0
2347.0,NCT04481646,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,COVMASK,Recruiting,COVID-19,,,,,,,Diagnostic Test: Face mask sampling,"University of Leicester|University Hospitals, Leicester",All,"16 Years and older   (Child, Adult, Older Adult)",630.0,Other,Observational,2020-12-06,01/06/22,2025-01-06,22/07/20,22/07/20,"University Hospitals of Leicester NHS Trust, Leicester",United Kingdom,Respiratory Diseases,1,1,1492.0
2348.0,NCT04449978,TARGet Kids! COVID-19 Study of Children and Families,,Recruiting,Coronavirus,COVID-19,Virus,Family and Household,Infection Viral,,,,The Hospital for Sick Children|Unity Health Toronto,All,up to 10 Years   (Child),1082.0,Other,Observational,2020-09-04,30/06/22,2022-12-31,29/06/20,29/06/20,"St Michael's Hospital, Toronto, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario",Canada,Respiratory Diseases,1,5,848.0
2349.0,NCT04460443,Sofosbuvir in Treatment of COVID 19,,Recruiting,COVID-19,,,,,,,Drug: sofosbuvir|Drug: Sofosbuvir ledipsavir|Drug: Daclatasvir,Tanta University,All,"Child, Adult, Older Adult",60.0,Other,Interventional,2020-01-08,01/08/21,2021-08-31,07/07/20,08/12/20,"Sherief Abd-Elsalam, Tanta",Egypt,Respiratory Diseases,1,1,601.0
2350.0,NCT04401449,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,,Recruiting,COVID-19,COVID-19,COVID-19,COVID-19,COVID-19,,,,National Institutes of Health Clinical Center (CC),All,"18 Years to 80 Years   (Adult, Older Adult)",180.0,NIH,Observational,2020-08-01,01/05/24,2024-01-05,26/05/20,13/01/21,"MedStar Health Research Institute /MedStar Washington Hospital Center, Washington, District of Columbia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,5,1252.0
2351.0,NCT04382625,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,,Withdrawn,COVID-19,COVID-19,,,,,,Drug: Hydroxychloroquine,Kootenai Health|Washington State University,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-10,01/01/22,2022-01-06,11/05/20,05/02/21,"Kootenai Health, Coeur d'Alene, Idaho",United States,Respiratory Diseases,1,2,727.0
2352.0,NCT04695197,Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso,MALCOV,Recruiting,COVID-19,Malaria,,,,,,Drug: Artemether-lumefantrine (AL)|Drug: Pyronaridine-artesunate (PA),"Liverpool School of Tropical Medicine|London School of Hygiene and Tropical Medicine|Kenya Medical Research Institute|Groupe de Recherche Action en Sante|Centres for Disease Control and Prevention, Kenya.|Bill and Melinda Gates Foundation|Centers for Disease Control and Prevention",All,"6 Months to 100 Years   (Child, Adult, Older Adult)",142.0,Other|U.S. Fed,Interventional,2021-08-01,01/11/22,2023-07-31,05/01/21,24/02/21,"Ouagadougou Hospitals, Ouagadougou, Burkina Faso|Kisumu County Referral Hospital, Kisumu",Kenya,"Infectious Diseases, Respiratory Diseases",1,2,729.0
2353.0,NCT04327349,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,,Enrolling by invitation,Coronavirus Infections,,,,,,,Biological: Convalescent Plasma,Mazandaran University of Medical Sciences,All,"30 Years to 70 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-03-28,20/05/20,2020-09-30,31/03/20,31/03/20,"Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran",Islamic Republic of,Respiratory Diseases,1,1,186.0
2354.0,NCT04497311,Tomographic Findings in COVID-19 and Influenza,TOMOCOVIDMX,Recruiting,COVID-19,COVID-19,H1N1 Influenza,Computed Tomography,,,,Diagnostic Test: Thoraxic computed tomography,Universidad de Guanajuato|Hospital General Regional de León|University Medical Center Groningen,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-06-15,30/04/21,2022-04-30,04/08/20,06/08/20,"Hospital General León-Milenio, León, Guanajuato",Mexico,"Infectious Diseases, Respiratory Diseases",1,4,684.0
2355.0,NCT04343092,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,,Completed,COVID-19,,,,,,,Drug: Ivermectin (IVM),University of Baghdad,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Interventional,2020-04-18,31/05/20,2020-01-06,13/04/20,04/11/20,"General Directorate of Medical City, Bagdad, Baghdad",Iraq,Respiratory Diseases,1,1,-103.0
2356.0,NCT04368988,Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,,"Active, not recruiting",COVID-19,,,,,,,"Biological: SARS-CoV-2 rS - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 1|Other: Normal saline solution (NSS), Placebo - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 1|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 1|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Days 0 and 21 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 189 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant, Day 0 - Phase 2|Other: Normal saline solution (NSS), Placebo, Day 21 - Phase 2|Biological: SARS-CoV-2 rS/Matrix-M Adjuvant - Day 189 - Phase 2",Novavax|Coalition for Epidemic Preparedness Innovations,All,"18 Years to 84 Years   (Adult, Older Adult)",1419.0,Industry|Other,Interventional,2020-05-25,01/12/20,2021-11-18,30/04/20,09/10/20,"Meridian Clinical Research-(Savannah Georgia) - Platinum - PPDS - Phase 2, Savannah, Georgia, United States|Advanced Clinical Research - Meridian - ERN-PPDS - Phase 2, Meridian, Idaho, United States|Alliance for Multispecialty Research, LLC - Phase 2, Newton, Kansas, United States|Alliance for Multispecialty Research, LLC - Phase 2, Wichita, Kansas, United States|Central Kentucky Research Associates Inc - Phase 2, Lexington, Kentucky, United States|Meridian Clinical Research-(Rockville Maryland) - Platinum - PPDS - Phase 2, Rockville, Maryland, United States|Synexus Clinical Research US, Inc. - Cincinnati - Phase 2, Cincinnati, Ohio, United States|Rapid Medical Research Inc - ERN-PPDS - Phase 2, Cleveland, Ohio, United States|Paratus Clinical Research - Canberra - Phase 2, Bruce, Australian Capital Territory, Australia|Paratus Clinical Research - Western Sydney - Phase 2, Blacktown, New South Wales, Australia|Paratus Clinical Research - Central Coast - Phase 2, Kanwal, New South Wales, Australia|Australian Clinical Research Network - Phase 2, Maroubra, New South Wales, Australia|Scientia Clinical Research Limited - Phase 2, Randwick, New South Wales, Australia|Q Pharm Pty Limited - Phase 1, Herston, Queensland, Australia|University of the Sunshine Coast, Health Hub Morayfield - Phase 2, Morayfield, Queensland, Australia|University of the Sunshine Coast - Phase 2, Sippy Downs, Queensland, Australia|Barwon Health - Phase 2, Geelong, Victoria, Australia|Center for Clinical Studies - Phase 1 and Phase 2, Melbourne, Victoria",Australia,Respiratory Diseases,1,1,542.0
2357.0,NCT04421664,Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),,Terminated,Corona Virus Infection,SARS-CoV Infection,Coronavirus,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,McGill University Health Centre/Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta|University of British Columbia|McMaster University|Lawson Health Research Institute|Eastern Health|University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-03-25,17/08/20,2020-08-17,09/06/20,22/09/20,"University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of British Columbia, Vancouver, British Columbia, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Eastern Health, Saint John's, Newfoundland and Labrador, Canada|McMaster University, Hamilton, Ontario, Canada|Lawson Health Research Institute, London, Ontario, Canada|Research Institute of the McGill University Health Centre, Montréal, Quebec",Canada,Respiratory Diseases,1,3,145.0
2358.0,NCT04623697,Covid-19 Infection and New Onset Type 1 Diabetes,,Recruiting,COVID-19,type1diabetes,,,,,,,Hospital of South West Jutland|Steno Diabetes Center Odense|Steno Diabetes Center Nordjylland|Steno Diabetes Center Aarhus|Steno Diabetes Center Sjaelland|Steno Diabetes Center Copenhagen,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-01-11,30/10/23,2023-10-30,10/11/20,10/11/20,"Hospital of South West Jutland, Esbjerg",Denmark,Respiratory Diseases,1,2,1388.0
2359.0,NCT04678739,Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial,,Completed,COVID-19,COVID-19,,,,,,Drug: Remdesivir|Drug: Tocilizumab,M Abdur Rahim Medical College and Hospital|First Affiliated Hospital Xi'an Jiaotong University|Cox's Bazar 250 Bed District Sadar Hospital|Chattogram General Hospital,All,"16 Years to 80 Years   (Child, Adult, Older Adult)",205.0,Other,Interventional,2020-08-15,30/01/21,2021-10-02,22/12/20,02/04/21,"Chattogram General Hospital, Chittagong, Bangladesh|Cox's Bazar 250 Bed District Sadar Hospital, Cox's Bazar, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh|M. Abdur Rahim Medical College Hospital, Dinajpur",Bangladesh,Respiratory Diseases,1,2,413.0
2360.0,NCT04353674,Modulation of Hyperinflammation in COVID-19,,Recruiting,COVID-19,SARS,,,,,,Device: Control group|Device: SLEDD with a L-MOD,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-28,01/12/21,2021-01-12,20/04/20,01/04/21,"University Hospital, London, Ontario, Canada|Victoria Hospital - Critical Care Trauma Centre, London, Ontario",Canada,Respiratory Diseases,1,2,259.0
2361.0,NCT04333420,"Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",PANAMO,Recruiting,COVID-19,,,,,,,Drug: SOC + IFX-1|Drug: SOC + Placebo,InflaRx GmbH,All,"18 Years and older   (Adult, Older Adult)",390.0,Industry,Interventional,2020-03-31,31/05/21,2021-08-31,03/04/20,07/12/20,"University of Aachen, Aachen, Germany|University Amsterdam, Amsterdam, Netherlands|University Amsterdam, Amsterdam, Netherlands|University Maastricht, Maastricht",Netherlands,Respiratory Diseases,1,1,518.0
2362.0,NCT04529408,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,EARSATS-19,Recruiting,COVID-19,Pulmonary Disease,,,,,,Device: EarSats Pulse Oximeter Probe,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-08-26,26/08/20,2020-08-26,27/08/20,27/08/20,"Imperial College Healthcare NHS Trust, London, Non-US/Non-Canadian",United Kingdom,Respiratory Diseases,1,2,0.0
2363.0,NCT04691934,Obstetric Anesthesia Experiences in COVID-19 Positive Patients,,Completed,COVID-19,Obstetric Anesthesia,,,,,,Procedure: Anesthesia management,Turkiye Yuksek Ihtisas Education and Research Hospital,Female,"18 Years and older   (Adult, Older Adult)",61.0,Other,Observational,2020-11-03,25/12/20,2020-12-25,31/12/20,31/12/20,"University of Health Sciences Turkey, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa, Yıldırım",Turkey,Respiratory Diseases,1,2,52.0
2364.0,NCT04434417,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,I-GLOBAL,Recruiting,COVID-19,,,,,,,Device: 2019-nCoV IgG/IgM Rapid Test Cassette,European Institute of Oncology|Azienda Socio-Sanitaria Territoriale di Cremona|Azienda Ospedaliera Niguarda Cà Granda|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|Papa Giovanni XXIII Hospital,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-15,31/07/21,2021-12-31,16/06/20,22/12/20,"Papa Giovanni XXIII Hospital, Bergamo, Italy|Azienda Socio-Sanitaria Territoriale di Cremona, Cremona, Italy|Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy|Azienda Ospedaliera Niguarda Cà Granda, Milano, Italy|European IO, Division of Early Drug Development for Innovative Therapies, Milan",Italy,Respiratory Diseases,1,1,625.0
2365.0,NCT04556318,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),,Recruiting,COVID-19,,,,,,,Device: Ion Mobility Spectrometry (IMS),B. Braun Melsungen AG,All,"18 Years and older   (Adult, Older Adult)",392.0,Industry,Observational,2020-09-23,01/04/21,2021-01-04,21/09/20,14/04/21,"Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany|Technical University of Munich, Klinikum rechts der Isar, Munich",Germany,Respiratory Diseases,1,1,103.0
2366.0,NCT04487769,Lung Ultrasound in COVID-19 Patients,LUS-COVID,Recruiting,COVID-19,Ultrasound,ARDS,,,,,,"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Centre Hospitalier Universitaire de Brussels, Brussels, Belgium|Miulli Regional Hospital, Acquaviva delle Fonti, Italy|University of Foggia|University of Bari Aldo Moro",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-06,01/08/21,2021-01-10,27/07/20,20/01/21,"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Amsterdam",Netherlands,Respiratory Diseases,1,3,370.0
2367.0,NCT04273581,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: placebo|Drug: Thalidomide,First Affiliated Hospital of Wenzhou Medical University|Second Affiliated Hospital of Wenzhou Medical University|Wenzhou Central Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-02-18,30/04/20,2020-05-30,18/02/20,21/02/20,,,Respiratory Diseases,1,1,102.0
2368.0,NCT04779359,Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease,,Not yet recruiting,COVID-19,,,,,,,,Shanghai Public Health Clinical Center,All,"18 Years and older   (Adult, Older Adult)",1.0,Other,Observational,2021-01-04,01/08/21,2021-01-12,03/03/21,03/03/21,,,Respiratory Diseases,1,1,8.0
2369.0,NCT04620798,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,,"Active, not recruiting",COVID-19,Serology,Students,,,,,Behavioral: Immediate vs. delayed provision of antibody test results,Indiana University,All,"18 Years to 100 Years   (Adult, Older Adult)",1700.0,Other,Interventional,2020-09-14,01/12/20,2020-01-12,09/11/20,09/11/20,"Indiana University, Bloomington, Indiana",United States,Respiratory Diseases,1,3,-246.0
2370.0,NCT04445493,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),EPISODE-PH-COV,Not yet recruiting,"Stroke, Acute",COVID-19,,,,,,Device: MindRhythm Harmony,"MindRhythm, Inc.|Wayne State University",All,"18 Years and older   (Adult, Older Adult)",250.0,Industry|Other,Observational,2021-01-03,01/07/21,2021-01-09,24/06/20,02/03/21,,,"Cardiovascular Diseases, Respiratory Diseases",1,2,6.0
2371.0,NCT04365738,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,,Completed,COVID-19,,,,,,,Other: Rehabilitation,Istanbul Bilgi University,All,28 Years to 45 Years   (Adult),270.0,Other,Interventional,2020-11-03,10/04/20,2020-04-26,28/04/20,28/04/20,"Istanbul Bilgi University, Istanbul",Turkey,Respiratory Diseases,1,1,-191.0
2372.0,NCT04568018,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Surfactant,Biosurf LLC.,All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Industry,Observational,2020-03-07,31/12/20,2021-01-12,29/09/20,29/09/20,"FSAEI of Higher Education I.M. Sechenov First Moscow State Medical University, Moscow",Russian Federation,Respiratory Diseases,1,1,311.0
2373.0,NCT04551898,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),,Completed,COVID-19,,,,,,,Drug: BGB-DXP593|Drug: Placebo,BeiGene,All,"18 Years to 65 Years   (Adult, Older Adult)",181.0,Industry,Interventional,2020-02-12,25/01/21,2021-01-25,16/09/20,04/03/21,"Elixia, Hollywood, California, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|Baptist Medical Center, Jacksonville, Florida, United States|Homestead Associates in Research Inc., Miami, Florida, United States|Medical Research Center of Miami II, Inc., Miami, Florida, United States|US Associates in Research, Miami, Florida, United States|Continental Research Network, Miami, Florida, United States|Omega Research Orlando, Orlando, Florida, United States|Revival Research Institute, LLC., Dearborn, Michigan, United States|New Phase Research & Development, Knoxville, Tennessee, United States|Amarillo Center for Clinical Research, Amarillo, Texas, United States|PanAmerican Clinical Research, Brownsville, Texas, United States|The Royal Prince Alfred Hospital, Camperdown, Australia|Fundação Universidade de Caxias do Sul - Instituto de Pesquisas em Saúde, Petropolis, Caxias Do Sul, Brazil|Hospital das Clínicas da Faculdade de Medicina de Botucatu, Botucatu, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil|Hospital Universitáro de Santa Maria / UFSM, Santa Maria, Brazil|CMPC Pesquisa Clinica, Sorocaba, Brazil|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|JM Research, Cuernavaca, Mexico|Hospital General Dr. Manuel Gea Gonzalez, Mexico, Mexico|Iecsi S.C., Monterrey, Mexico|Clinica de Enfermedades Cronicas y de Procedimientos Especiales, S.C., Morelia, Mexico|Kohler & Milstein Research, Mérida, Mexico|PanAmerican Clinical Research, Querétaro, Mexico|East Rand Research T/A Worthwhile Clinical Trials, Benoni, South Africa|TASK, Cape Town, South Africa|TREAD Research CC, Cape Town, South Africa|Langeberg Clinical Trials, Cape Town, South Africa|Wits Clinical Research, Soweto",South Africa,Respiratory Diseases,1,1,348.0
2374.0,NCT04452942,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,,,,,,,,EicOsis Human Health Inc.,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Observational,2020-01-07,01/09/20,2021-01-04,01/07/20,21/07/20,"Stony Brook University Hospital, New York, New York",United States,Respiratory Diseases,1,1,363.0
2375.0,NCT04323839,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),PRIORITY,Enrolling by invitation,Pregnancy,Coronavirus,COVID-19,,,,,Other: Pregnant women under investigation for Coronavirus or diagnosed with COVID-19|Other: Postpartum women under investigation for Coronavirus or diagnosed with COVID-19,"University of California, San Francisco|University of California, Los Angeles",Female,"13 Years and older   (Child, Adult, Older Adult)",2000.0,Other,Observational,2020-03-20,31/03/24,2024-03-31,27/03/20,19/10/20,"University of California, San Francisco, San Francisco, California",United States,Respiratory Diseases,1,3,1472.0
2376.0,NCT04540185,A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,OPV-NA831,Enrolling by invitation,COVID-19,SARS (Severe Acute Respiratory Syndrome),SARS-CoV Infection,COVID-19,,,,Biological: Biological: oral polio vaccine|Biological: Comparable Placebo|Drug: NA-831|Drug: Comparable Placebo of drug|Combination Product: Combination of oral polio vaccine and NA-831|Combination Product: Comparable Placebo of Oral Polio Vaccine and Placebo of drug,"NeuroActiva, Inc.|Biomed Industries, Inc.",All,"18 Years and older   (Adult, Older Adult)",3600.0,Industry,Interventional,2020-01-11,01/11/22,2022-12-31,07/09/20,09/09/20,"Coronavirus Research Institute- Testing Site, Los Angeles, California, United States|Coronavirus Research Institute, Orange, California, United States|Coronavirus Research Institute-Testing Site, Palo Alto, California, United States|Coronavirus Research Testing Site, San Francisco, California, United States|Coronavirus Research Institute-Testing Site, Sunnyvale, California, United States|Coronavirus Research Institute, Sunnyvale, California, United States|Coronavirus Research Institute-Testing Site, Naperville, Illinois, United States|Coronavirus Research Institute-Testing Site-, Bronx, New York, United States|NeuroActiva-Clinical Research Unit, Auckland, New Zealand|NeuroActiva Testing Facility of NeuroActiva (New Zealand) Ltd, Auckland",New Zealand,Respiratory Diseases,1,4,1085.0
2377.0,NCT04844346,Plant Stanol Esters and COVID-19 Vaccination Response,,Not yet recruiting,Overweight and Obesity,,,,,,,Dietary Supplement: Plant stanol mini drinks|Dietary Supplement: Placebo mini drinks|Biological: COVID-19 vaccine,Maastricht University Medical Center|Raisio Nutrition Ltd.,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-05,31/08/21,2021-08-31,14/04/21,14/04/21,"Maastricht University Medical Center, Maastricht, Limburg",Netherlands,Metabolic Disorders,1,1,238.0
2378.0,NCT04362137,"Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)",RUXCOVID,Completed,COVID-19,,,,,,,Drug: Ruxolitinib|Drug: Placebo,Novartis Pharmaceuticals|Incyte Corporation|Novartis,All,"12 Years and older   (Child, Adult, Older Adult)",432.0,Industry,Interventional,2020-02-05,17/10/20,2020-10-17,24/04/20,12/11/20,"Novartis Investigative Site, Fullerton, California, United States|Novartis Investigative Site, Aurora, Colorado, United States|Novartis Investigative Site, Denver, Colorado, United States|Novartis Investigative Site, Atlanta, Georgia, United States|Novartis Investigative Site, Idaho Falls, Idaho, United States|Novartis Investigative Site, Ann Arbor, Michigan, United States|Novartis Investigative Site, Newark, New Jersey, United States|Novartis Investigative Site, Bronx, New York, United States|Novartis Investigative Site, Mesquite, Texas, United States|Novartis Investigative Site, Seattle, Washington, United States|Novartis Investigative Site, Madison, Wisconsin, United States|Novartis Investigative Site, C A B A, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Rio de Janeiro, RJ, Brazil|Novartis Investigative Site, Blumenau, Santa Catarina, Brazil|Novartis Investigative Site, Barretos, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Sorocaba, SP, Brazil|Novartis Investigative Site, Rionegro, Antioquia, Colombia|Novartis Investigative Site, Barranquilla, Atlantico, Colombia|Novartis Investigative Site, Barranquilla, Colombia|Novartis Investigative Site, Colombes Cedex, France|Novartis Investigative Site, Eaubonne, France|Novartis Investigative Site, Nantes Cedex 1, France|Novartis Investigative Site, Pessac, France|Novartis Investigative Site, Pierre Benite, France|Novartis Investigative Site, Lubeck, Germany|Novartis Investigative Site, Muenchen, Germany|Novartis Investigative Site, Nuernberg, Germany|Novartis Investigative Site, México, Distrito Federal, Mexico|Novartis Investigative Site, Ciudad de Mexico, Mexico CP, Mexico|Novartis Investigative Site, Estado de Mexico, Mexico|Novartis Investigative Site, San Isidro, Lima, Peru|Novartis Investigative Site, San Miguel, Lima, Peru|Novartis Investigative Site, Lima, Peru|Novartis Investigative Site, Lima, Peru|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, S-Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, Sestroretsk, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, Salamanca, Castilla Y Leon, Spain|Novartis Investigative Site, Barcelona, Cataluna, Spain|Novartis Investigative Site, Badalona, Catalunya, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Istanbul, TUR, Turkey|Novartis Investigative Site, Ankara, Turkey|Novartis Investigative Site, Istanbul, Turkey|Novartis Investigative Site, Yenisehir/Izmir, Turkey|Novartis Investigative Site, Harrow, United Kingdom|Novartis Investigative Site, Leeds, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, Manchester",United Kingdom,Respiratory Diseases,1,1,255.0
2379.0,NCT04341038,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,TACROVID,Recruiting,COVID-19,Lung Injury,,,,,,Drug: Tacrolimus|Drug: Methylprednisolone,Hospital Universitari de Bellvitge|Institut d'Investigació Biomèdica de Bellvitge,All,"18 Years and older   (Adult, Older Adult)",84.0,Other,Interventional,2020-01-04,01/06/20,2020-01-07,10/04/20,10/04/20,"Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona",Spain,Respiratory Diseases,1,2,3.0
2380.0,NCT04394793,Low Dose Radiation Therapy for Covid-19 Pneumonia,,"Active, not recruiting",COVID-19,Pneumonia,,,,,,Radiation: Low dose radiation therapy,"All India Institute of Medical Sciences, New Delhi",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-06-13,27/08/20,2020-01-09,19/05/20,01/09/20,"All India Institute of Medical Sciences, New Delhi, New Delhi, Delhi",India,Respiratory Diseases,1,2,-156.0
2381.0,NCT04363034,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,,Temporarily not available,COVID-19,,,,,,,Biological: Convalescent Plasma,University of Arkansas,All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Intermediate-size Population,,,,27/04/20,05/04/21,,,Respiratory Diseases,1,1,
2382.0,NCT04680949,suPAR-Guided Anakinra Treatment for Management of Severe Respiratory Failure by COVID-19,SAVE-MORE,"Active, not recruiting",COVID-19,,,,,,,Drug: Anakinra|Drug: Placebo,Hellenic Institute for the Study of Sepsis,All,"18 Years and older   (Adult, Older Adult)",606.0,Other,Interventional,2020-12-23,31/03/21,2021-12-20,23/12/20,05/04/21,"2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|10th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|1st Department of Internal Medicine, AMALIA FLEMING Prefecture General Hospital of Melissia, Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|1st Department of Internal Medicine, General Hospital of Nea Ionia CONSTANTOPOULIO-PATISION, Athens, Greece|1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|1st University Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|2nd Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens, Greece|4th Department of Internal Medicine, ATTIKON University General Hospital, Athens, Greece|4th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|5th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|Department of COVID-19, Evangelismos General Hospital, Athens, Greece|Department of Internal Medicine, General Hospital of Athens Elpis, Athens, Greece|• 1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|• Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens, Greece|Department of Pulmonary Medicine, General Hospital of Kerkyra, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, University General Hospital of Larissa,, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki, Greece|1st Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloníki, Greece|2nd Department of Propedeutic Medicine, Ippokrateion University General Hospital of Thessaloniki, Thessaloníki, Greece|3rd University Department of Internal Medicine, PAPAGEORGIOU General Hospital of Thessaloniki, Thessaloníki, Greece|Dipartimento di Medicina Dipartimento di Malattie Infettive, ASST Spedali civili, Brescia, Italy|Unità Operativa Clinica Malattie Infettive, Ospedale Policlinico San Martino, Genova, Italy|Dipartimento di Medicina Interna, Istituto Clinico Humanitas, Milano, Italy|Medicina Interna, Reumatologia, Immunologia, IRCCS San Raffaele, Milano, Italy|Dipartimento di Malattie Infettive e Tropicali e Microbiologia, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy|Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose, IRCCS Lazzaro Spallanzani, Roma, Italy|Dipartimento Scienze di laboratorio e infettivologiche, Policlinico Universitario Agostino Gemelli, Roma, Italy|Dipartimento di Malattie infettive e tropicali-Università dell'Insubria, ASST dei Sette Laghi, Varese",Italy,Respiratory Diseases,1,1,362.0
2383.0,NCT04388605,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,ASPIRE,Recruiting,Corona Virus Infection,COVID-19,Pregnancy Related,Early Pregnancy,,,,,"University of California, San Francisco",Female,"18 Years and older   (Adult, Older Adult)",11000.0,Other,Observational,2020-04-21,01/09/21,2022-01-09,14/05/20,15/05/20,"University of California, San Francisco, San Francisco, California",United States,Respiratory Diseases,1,4,628.0
2384.0,NCT04600141,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection,HEPMAB,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab|Drug: Heparin - Therapeutic dosage|Drug: Heparin - Prophylactic dosage,University of Sao Paulo|Conselho Nacional de Desenvolvimento Científico e Tecnológico,All,"18 Years and older   (Adult, Older Adult)",308.0,Other,Interventional,2020-10-11,20/10/21,2021-12-31,23/10/20,21/02/21,"Fundação São Francisco Xavier, Ipatinga, Minas Gerais, Brazil|UNIMED Varginha, Varginha, Minas Gerais, Brazil|Universidade Federal de Sergipe, Aracaju, Sergipe",Brazil,Respiratory Diseases,1,1,446.0
2385.0,NCT04497324,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma,Universidad Peruana Cayetano Heredia,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-21,30/04/21,2021-05-15,04/08/20,18/03/21,"Hospital Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito Unanue, Lima",Peru,Respiratory Diseases,1,1,236.0
2386.0,NCT04650191,Surfactant Protein Genetic Variants in COVID-19 Infection,,Recruiting,Coronavirus Infection,,,,,,,Other: Identification of genetic variants,Milton S. Hershey Medical Center,All,"up to 90 Years   (Child, Adult, Older Adult)",300.0,Other,Observational,2020-01-03,01/06/21,2021-01-12,02/12/20,02/12/20,"Milton S. Hershey Medical center, Hershey, Pennsylvania",United States,Respiratory Diseases,1,1,375.0
2387.0,NCT04375644,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),COVIDPROIMPACT,Completed,COVID-19,"Stress, Psychological",,,,,,Other: Questionnaires on psychological quality of life,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",1565.0,Other,Observational,2020-07-05,15/07/20,2020-07-15,05/05/20,21/12/20,"Gynécologie-Obstétrique CHU de Angers, Angers, France|Gynécologie-Obstétrique Hôpital Pellegrin, Bordeaux, France|Gynécologie-Obstétrique CHRU de Brest, Brest, France|Gynaecology Department, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Bron, France|Gynécologie-Obstétrique Hôpital Antoine Béclère (APHP), Clamart, France|Gynécologie-Obstétrique CHU Grenoble-Alpes, Hôpital Couple Enfant, La Tronche, France|Gynécologie-Obstétrique Hôpital BICETRE (APHP), Le Kremlin-Bicêtre, France|Gynécologie-Obstétrique Hôpital Jeanne de Flandre - CHRU Lille, Lille, France|Gynécologie-Obstétrique Hôpital de la Mère et de l'Enfant, Limoges, France|Gynécologie-Obstétrique Hôpital de la Croix Rousse, Lyon, France|Gynécologie-Obstétrique Hôpital La Conception, Marseille, France|Gynécologie-Obstétrique Hôpital de la Pitié Salpêtrière (APHP), Paris, France|Gynécologie-Obstétrique Maternité Port-Royal, Groupe Hospitalier Cochin-Broca- Hotel Dieu (APHP), Paris, France|Gynécologie-Obstétrique CHU de Poitiers, Poitiers, France|Gynécologie-Obstétrique CHU Reims - Institut Mère Enfant Alix de Champagne, Reims, France|Gynécologie-Obstétrique CHU de Rennes, Rennes, France|Gynécologie-Obstétrique CHU de Saint Etienne, Saint-Étienne, France|Gynécologie-Obstétrique Hôpital de Hautepierre, Strasbourg",France,"Mental Health, Respiratory Diseases",1,2,10.0
2388.0,NCT04397796,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,,Recruiting,COVID-19,,,,,,,Biological: BM-Allo.MSC|Biological: Placebo,"ImmunityBio, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",45.0,Industry,Interventional,2020-03-08,01/06/21,2021-01-06,21/05/20,16/03/21,"St. Francis Medical Center, Lynwood, California",United States,Respiratory Diseases,1,1,304.0
2389.0,NCT04417335,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,,"Active, not recruiting",COVID-19,,,,,,,Biological: BCG vaccine|Biological: Placebo,Radboud University,All,"60 Years and older   (Adult, Older Adult)",2014.0,Other,Interventional,2020-04-16,01/05/21,2021-01-05,04/06/20,04/06/20,"Radboud University, Nijmegen, Gelderland, Netherlands|UMC Utrecht, Utrecht",Netherlands,Respiratory Diseases,1,1,264.0
2390.0,NCT04403880,Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Other: Sample collection,HIV Vaccine Trials Network|National Institute of Allergy and Infectious Diseases (NIAID)|HIV Prevention Trials Network,All,"18 Years and older   (Adult, Older Adult)",727.0,Other|NIH,Observational,2020-05-13,01/08/21,2021-01-08,27/05/20,14/04/21,"Alabama Vaccine CRS, Birmingham, Alabama, United States|UCLA CARE Center CRS, Los Angeles, California, United States|Bridge HIV CRS, San Francisco, California, United States|George Washington University CRS, Washington, District of Columbia, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|Adolescent & Young Adult Research at The CORE Center (AYAR at CORE), Chicago, Illinois, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health Clinical Research Site CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Bronx Prevention Research Center CRS, Bronx, New York, United States|Harlem Prevention Center CRS, New York, New York, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Vanderbilt Vaccine CRS, Nashville, Tennessee, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Malawi CRS, Lilongwe, Malawi|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Callao, Peru|San Miguel CRS, San Miguel, Lima, Peru|Asociacion Civil Selva Amazonica (ACSA) CRS, Iquitos, Maynas, Peru|Via Libra CRS, Lima, Peru|Barranco CRS, Lima, Peru|Josha Research CRS, Bloemfontein, South Africa|Emavundleni CRS, Cape Town, South Africa|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Synexus Stanza Clinical Research Centre CRS, Pretoria, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CRS, Tembisa, South Africa|The Aurum Institute Tembisa Clinical Research Centre CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|Matero Reference Clinic CRS, Lusaka, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Zengeza CRS, Chitungwiza, Zimbabwe|Seke South CRS, Harare",Zimbabwe,Respiratory Diseases,1,2,240.0
2391.0,NCT04754633,Comparison of Chest CT Findings Related to COVID-19 With RSNA and BSTI Guidelines,,Completed,COVID-19,Infection Viral,CT Scan,,,,,,Seyhmus Kavak|Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",764.0,Other,Observational,2020-01-07,20/07/20,2020-07-20,15/02/21,15/02/21,"Sağlik Bilimleri Üniversitesi Training and Research Hospital, Diyarbakır",Turkey,Respiratory Diseases,1,3,195.0
2392.0,NCT04383717,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,,Not yet recruiting,Respiratory Tract Infections,,,,,,,Drug: Levamisole and isoprinosine|Drug: Azithromycin and hydroxychloroquine,Cairo University,All,"6 Years to 90 Years   (Child, Adult, Older Adult)",60.0,Other,Interventional,2020-05-05,30/08/20,2020-10-30,12/05/20,13/05/20,,,Others,0,1,178.0
2393.0,NCT04826718,SARS-CoV-2 Infection Among Health Care Workers,,Not yet recruiting,SARS-CoV Infection,BCG,Health Care Worker,,,,,Diagnostic Test: SARS-CoV-2 Serology,"Universidade de Cabo Verde|University of Southern Denmark|Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal|National Institute of Public Health of Cape Verde, Praia, Cape Verde|Centro de Investigacao em Saude de Manhica|European and Developing Countries Clinical Trials Partnership (EDCTP)|Bandim Health Project, Bissau, Guinea-Bissau",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-04-19,30/09/21,2021-11-30,01/04/21,01/04/21,"Universidade de Cabo Verde, Praia, Santiago",Cape Verde,Respiratory Diseases,1,3,225.0
2394.0,NCT04611269,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,SATICOVID19,Completed,Respiratory Failure,COVID-19,Mechanical Ventilation,,,,,,Argentinian Intensive Care Society,All,"18 Years and older   (Adult, Older Adult)",950.0,Other,Observational,2020-03-20,31/10/20,2020-10-31,02/11/20,13/11/20,"Hospital Interzonal General de Agudos Gral. San Martín, La Plata, BA, Argentina|Sanatorio Las Lomas, san Isidro, BA, Argentina|Hospital General de Agudos Juan A. Fernández, Buenos Aires, Caba, Argentina|Sanatorio Anchorena Recoleta, Buenos Aires, Caba, Argentina|Sanatorio Otamendi, Buenos Aires, Ciudad Autonoma De Buenos Aires",Argentina,Respiratory Diseases,1,3,225.0
2395.0,NCT04746066,Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19,,"Active, not recruiting",Haemoglobinopathies,,,,,,,,Società Italiana Talassemie ed Emoglobinopatie,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-03-31,01/12/30,2030-01-12,09/02/21,10/02/21,"Ospedali Galliera - S.S.D. Microcitemia, anemie congenite e dismetabolismo del ferro, Genova",Italy,Others,0,1,3574.0
2396.0,NCT04358068,Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,,Terminated,COVID-19,SARS-CoV 2,,,,,,Drug: Hydroxychloroquine (HCQ)|Drug: Azithromycin (Azithro)|Drug: Placebo for Hydroxychloroquine|Drug: Placebo for Azithromycin,National Institute of Allergy and Infectious Diseases (NIAID)|Teva Pharmaceuticals Industries LTD,All,"18 Years and older   (Adult, Older Adult)",20.0,NIH|Other,Interventional,2020-05-13,07/07/20,2020-07-07,22/04/20,12/04/21,"Alabama CRS, Birmingham, Alabama, United States|UCSD Antiviral Research Center CRS, San Diego, California, United States|Harbor-UCLA CRS, Torrance, California, United States|Whitman-Walker Health CRS, Washington, District of Columbia, United States|Northwestern University CRS, Chicago, Illinois, United States|Rush University CRS, Chicago, Illinois, United States|Greensboro CRS, Greensboro, North Carolina, United States|Cincinnati Clinical Research Site, Cincinnati, Ohio, United States|University of Pittsburgh CRS, Pittsburgh, Pennsylvania, United States|Trinity Health and Wellness Center CRS, Dallas, Texas, United States|University of Washington AIDS CRS, Seattle, Washington",United States,Respiratory Diseases,1,2,55.0
2397.0,NCT04374279,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,RECOVER,Withdrawn,COVID-19,SARS-CoV 2,,,,,,Drug: Bicalutamide 150 Mg Oral Tablet,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2021-01-04,01/01/22,2022-01-01,05/05/20,05/03/21,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,2,362.0
2398.0,NCT04787614,2019 NSECE COVID-19 Follow-up,,Enrolling by invitation,Child Care,,,,,,,Other: No intervention,"National Opinion Research Center|Child Trends|Office of Planning, Research and Evaluation (ACF, DHHS)",All,"Child, Adult, Older Adult",15200.0,Other,Observational,2020-01-11,30/06/21,2021-06-30,08/03/21,08/03/21,"NORC at the University of Chicago, Chicago, Illinois",United States,Others,0,1,536.0
2399.0,NCT04742725,A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Drug: Placebo|Drug: Prothione™ (6g),"Prothione, LLC",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-02-15,16/03/21,2021-03-26,08/02/21,09/02/21,,,Respiratory Diseases,1,1,39.0
2400.0,NCT04635813,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,,Completed,Thyroid Disease,,,,,,,Procedure: Thyroidectomy,University of Cagliari,All,"Child, Adult, Older Adult",3800.0,Other,Observational,2020-10-03,30/09/20,2020-12-11,19/11/20,19/11/20,"AOU Cagliari, Cagliari, CA",Italy,Others,0,1,69.0
2401.0,NCT04603794,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: 0.5% Povidone Iodine|Drug: 0.12% Chlorhexidine Gluconate Mouth Rinse|Drug: 1% Hydrogen Peroxide|Drug: 0.9% Normal Saline,Ohio State University,All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-10,01/11/20,2020-01-11,27/10/20,27/10/20,"The Ohio State University Wexner Medical Center, Columbus, Ohio",United States,Respiratory Diseases,1,1,1.0
2402.0,NCT04834128,TCB008 in Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: TCB008,TC Biopharm,All,"18 Years to 65 Years   (Adult, Older Adult)",12.0,Industry,Interventional,2021-01-08,01/08/22,2022-01-08,06/04/21,06/04/21,,,Respiratory Diseases,1,1,365.0
2403.0,NCT04511429,COVID-19 in Immunosuppressed Children,,Recruiting,"Infections, Coronavirus",Kidney Transplantation,Liver Transplantation,Cancer,COVID-19,,,,D'Or Institute for Research and Education|Hospital Estadual da Criança|Hospital Federal de Bonsucesso|Rio de Janeiro State Research Supporting Foundation (FAPERJ),All,"1 Month to 18 Years   (Child, Adult)",200.0,Other,Observational,2020-06-30,01/10/20,2021-01-04,13/08/20,13/08/20,"Hospital Federal de Bonsucesso, Rio de Janeiro, RJ, Brazil|Hospital Estadual da Criança, Rio De Janeiro, RJ",Brazil,"Respiratory Diseases, Cancers",1,5,188.0
2404.0,NCT04818463,Characterization and Verification of the Intensive Care Standard Operating Procedure (SOP) Adherence of the Treated COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,"Charite University, Berlin, Germany",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-01-04,31/12/21,2021-12-31,26/03/21,13/04/21,"Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Campus Virchow-Klinikum, Berlin",Germany,Respiratory Diseases,1,1,361.0
2405.0,NCT04646239,Biomarkers of Trained Immunity Following MMR Vaccination,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Heterologous stimuli|Diagnostic Test: Neutralization assay,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-12-17,01/05/21,2021-01-06,27/11/20,16/03/21,"Washington University School of Medicine, Saint Louis, Missouri",United States,Respiratory Diseases,1,1,20.0
2406.0,NCT04527133,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: Aprotinin,Aviron LLC,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Interventional,2020-11-06,11/08/20,2020-08-31,26/08/20,26/08/20,"Regional State Budgetary Healthcare Institution Clinical Hospital №1, Smolensk",Russian Federation,Respiratory Diseases,1,1,-67.0
2407.0,NCT04308668,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,COVID-19 PEP,Completed,Corona Virus Infection,Acute Respiratory Distress Syndrome,SARS-CoV Infection,Coronavirus,Coronavirus Infections,,,Drug: Hydroxychloroquine|Other: Placebo,University of Minnesota|McGill University Health Centre/Research Institute of the McGill University Health Centre|University of Manitoba|University of Alberta,All,"18 Years and older   (Adult, Older Adult)",1309.0,Other,Interventional,2020-03-17,20/05/20,2020-05-20,16/03/20,17/07/20,"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Alberta, Edmonton, Alberta, Canada|University of Manitoba, Winnipeg, Manitoba, Canada|Research Institute of the McGill University Heath Centre, Montréal, Quebec",Canada,Respiratory Diseases,1,5,64.0
2408.0,NCT04378842,COVID-19 and ICU-acquired MDR Bacteria,COVID-BMR,Recruiting,Sars-CoV2,Critical Illness,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",690.0,Other,Observational,2020-05-18,01/05/21,2021-01-05,07/05/20,28/05/20,"Hôpital Roger Salengro, ICU, CHU Lille, Lille",France,"Cardiovascular Diseases, Respiratory Diseases",1,2,232.0
2409.0,NCT04780685,A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19,,Recruiting,COVID-19,,,,,,,Biological: hMSC,"Stemedica Cell Technologies, Inc.|bioRASI, LLC",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2021-03-20,31/08/21,2021-12-31,03/03/21,03/03/21,"Providence Saint John's Health Center - Saint John's Cancer Institute, Santa Monica, California, United States|PRX Research, Dallas Regional Medical Center, Mesquite, Texas",United States,Respiratory Diseases,1,1,286.0
2410.0,NCT04524715,LLLT Treatment of Lung Inflammation in COVID-19,,Not yet recruiting,COVID-19,,,,,,,Device: Non-invasive red LLLT treatment to chest of patient.|Device: Sham Device Treatment,Ward Photonics LLC,All,"18 Years and older   (Adult, Older Adult)",64.0,Industry,Interventional,2021-03-31,31/03/22,2022-03-31,24/08/20,04/12/20,"Wellness Junction, Millsboro, Delaware",United States,Respiratory Diseases,1,1,365.0
2411.0,NCT04379037,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Device: Transcutaneous Auricular Vagus Nerve Stimulation,Nemechek Technologies,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-06-27,01/09/20,2020-01-11,07/05/20,07/07/20,"Hospital Zonal Virgen del Carmen de Zárate, Zárate, Buenos Aires",Argentina,Respiratory Diseases,1,1,-168.0
2412.0,NCT04597047,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,CAPTURE-2,Recruiting,COVID-19,,,,,,,Diagnostic Test: Capillary Collection & Testing|Diagnostic Test: Venous Draw & Testing,LumiraDx UK Limited,All,"2 Years and older   (Child, Adult, Older Adult)",200.0,Industry,Interventional,2020-08-20,31/10/22,2022-12-31,22/10/20,22/10/20,"Eclipse Clinical Research, Tucson, Arizona, United States|Centura Health Physician Group, Northglenn Office, Northglenn, Colorado, United States|Professional Research Network of Kansas, Wichita, Kansas, United States|Physicians Quality Care of Jackson, Jackson, Tennessee",United States,Respiratory Diseases,1,1,863.0
2413.0,NCT04427501,A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,BLAZE-1,Recruiting,COVID-19,,,,,,,Drug: LY3819253|Drug: LY3832479|Drug: Placebo,"Eli Lilly and Company|AbCellera Biologics Inc.|Shanghai Junshi Bioscience Co., Ltd.",All,"Child, Adult, Older Adult",3160.0,Industry|Other,Interventional,2020-06-17,20/09/20,2021-05-31,11/06/20,14/04/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Arizona Clin Trials-Mesa, Mesa, Arizona, United States|Perseverance Research Center, Scottsdale, Arizona, United States|CRI of Arizona, LLC, Sun City West, Arizona, United States|Fiel Family Medicine, Tempe, Arizona, United States|Orange Grove Banner Clinic, Tucson, Arizona, United States|Arizona Clin Trials-Tucson, Tucson, Arizona, United States|KLR Business Group, Inc. dba Arkansas Clinical Research, Little Rock, Arkansas, United States|Applied Rsch Ctr - Arkansas Inc., Little Rock, Arkansas, United States|Smart Cures Clin Research, Anaheim, California, United States|Hope Clinical Research, Canoga Park, California, United States|VCT-Covina, Covina, California, United States|AMCR Institute, Escondido, California, United States|Valley Research, Fresno, California, United States|Chemidox Clinical Trials, Lancaster, California, United States|Ark Clinical Research, Long Beach, California, United States|Long Beach Clinical Trials LLC, Long Beach, California, United States|Cedars Sinai Medical Center, Los Angeles, California, United States|UCLA Mattel Children's Hospital, Los Angeles, California, United States|Central Valley Research, LLC, Modesto, California, United States|Catalina Research Institute, LLC, Montclair, California, United States|University of CA, Irvine, Orange, California, United States|Inland Empire CT, LLC, Rialto, California, United States|Sutter Institute For Medical Research, Sacramento, California, United States|Zion Medical Center, San Diego, California, United States|Kaiser Permanente - SD Med Ctr, San Diego, California, United States|Wolverine Clinical Trials, LLC, Santa Ana, California, United States|St. Joe Heritage HC-Santa Rosa, Santa Rosa, California, United States|Stanford University Hospital, Stanford, California, United States|Mazur, Statner, Dutta, Nathan, Thousand Oaks, California, United States|South Bay Clinical Research Institute, Torrance, California, United States|Infect Disease Doctors Med Grp, Walnut Creek, California, United States|Allianz Research Institute, Westminster, California, United States|Future Innovative Treatments LLC, Colorado Springs, Colorado, United States|Georgetown Univ Sch of Med, Washington, District of Columbia, United States|Synergy Healthcare LLC, Bradenton, Florida, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|I R & Health Center, Inc., Hialeah, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Elixia CRC, Hollywood, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|Lakeland Regional Medical Center, Lakeland, Florida, United States|Panax Clinical Research, Miami Lakes, Florida, United States|Miami Cancer Institute at Baptist Health, Inc., Miami, Florida, United States|GCPR, Saint Petersburg, Florida, United States|Testing Matters Lab, Sunrise, Florida, United States|Advent Health Tampa, Tampa, Florida, United States|Triple O Research Inst, West Palm Beach, Florida, United States|Clinical Site Partners, LLC DBA CSP Orlando, Winter Park, Florida, United States|Gwinnett Research Inst, Buford, Georgia, United States|Paramount Rch Sol - College Pk, College Park, Georgia, United States|IACT Health - VHC, Columbus, Georgia, United States|Central Georgia Infectious Disease, Macon, Georgia, United States|Rophe Adult and Pediatric Medicine, Union City, Georgia, United States|Rocky Mountain Clinical Research, Idaho Falls, Idaho, United States|Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|J H. Stroger Hosp of Cook Co, Chicago, Illinois, United States|University of Chi Med Center, Chicago, Illinois, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Franciscan Health Hammond, Dyer, Indiana, United States|Qualmedica Research Evansville, Evansville, Indiana, United States|Community Hospital South, Indianapolis, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|St.Vincent - Indy, Indianapolis, Indiana, United States|Qualmedica Research, LLC, Owensboro, Kentucky, United States|Tandem Clinical Research,LLC, Marrero, Louisiana, United States|Imperial Health Urgent Care Center - Moss Bluff, Moss Bluff, Louisiana, United States|Nola Research Works, LLC, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|U of MA Mem Med Ctr, Worcester, Massachusetts, United States|University of Michigan Health Systems, Ann Arbor, Michigan, United States|Great Lakes Research Group, Inc., Bay City, Michigan, United States|Childrens Hospital of Michigan, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Revive Research Institute, Farmington Hills, Michigan, United States|Revival Research Institute, Sterling Heights, Michigan, United States|Sky Clinical Prime and Health Wellness Clinic, Fayette, Mississippi, United States|Olive Branch Family Medical Center, Olive Branch, Mississippi, United States|Sky Clin Resch - Quinn HC, Ridgeland, Mississippi, United States|Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States|Children's Hospital & Medical Center, Omaha, Nebraska, United States|Quality Clinical Research, Omaha, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Las Vegas Medical Research, Las Vegas, Nevada, United States|SG Clinical Research - PC, Las Vegas, Nevada, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Care Access Research - Bronx, Bronx, New York, United States|Icahn Sch of Med at Mt. Sinai, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Monroe Biomed Research, Monroe, North Carolina, United States|Carteret Medical Group, Morehead City, North Carolina, United States|Carolina Research Center, Inc., Shelby, North Carolina, United States|PMG Research of Wilmington, Wilmington, North Carolina, United States|Hometown UC and Rch- Cincy, Cincinnati, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|OH State Univ College of Med, Columbus, Ohio, United States|Aventiv Research Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Columbus, Ohio, United States|Remington-Davis, Inc, Columbus, Ohio, United States|Urgent Care Specialists, LLC, Dayton, Ohio, United States|META Medical Research Institute, LLC, Dayton, Ohio, United States|Ascension St. John Tulsa OK, Tulsa, Oklahoma, United States|Jefferson Hosp for Neurosci, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|VITALINK - Anderson, Anderson, South Carolina, United States|Carolina Medical Research - Clinton, Clinton, South Carolina, United States|VITALINK - Gaffney, Gaffney, South Carolina, United States|VITALINK - Greenville, Greenville, South Carolina, United States|Carolina Medical Research - Greenville, Greenville, South Carolina, United States|VITALINK - Spartanburg, Spartanburg, South Carolina, United States|VITALINK - Union, Union, South Carolina, United States|Univ Diab & Endo Consult, Chattanooga, Tennessee, United States|New Phase Research and Development, Knoxville, Tennessee, United States|St Jude Childrens Research Hospital, Memphis, Tennessee, United States|Central Texas Clinical Rch, Austin, Texas, United States|Gadolin Research, LLC, Beaumont, Texas, United States|Driscoll Children's Hospital, Corpus Christi, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|B S & W Med Center, Dallas, Texas, United States|Baylor Scott & White Rsch Inst Dallas, Dallas, Texas, United States|Baylor - Fort Worth, Fort Worth, Texas, United States|North Texas Clinical Trials, LLC, Fort Worth, Texas, United States|Houston Methodist Research Ins, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas,",Puerto Rico,Respiratory Diseases,1,1,348.0
2414.0,NCT04591717,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral-COVID-19 in Normal Healthy Volunteers,,Recruiting,COVID-19,,,,,,,Biological: hAd5-S-Fusion+N-ETSD vaccine,"ImmunityBio, Inc.",All,18 Years to 55 Years   (Adult),60.0,Industry,Interventional,2020-10-19,19/11/21,2021-11-19,19/10/20,30/03/21,"Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California",United States,Respiratory Diseases,1,1,396.0
2415.0,NCT04429763,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,CELMA,Not yet recruiting,COVID-19,,,,,,,Biological: Umbilical cord derived mesenchymal stem cells|Biological: Placebo,Trustem|Fundación Universitaria de Ciencias de la Salud|Hospital de San Jose|Hospital Infantil Universitario de San Jose,All,"18 Years to 79 Years   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2020-01-07,01/09/20,2020-01-11,12/06/20,12/06/20,,,Respiratory Diseases,1,1,4.0
2416.0,NCT04400032,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome,CIRCA-19,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Biological: Mesenchymal Stromal Cells,Ottawa Hospital Research Institute|Stem Cell Network|Ontario Research Fund,All,"18 Years and older   (Adult, Older Adult)",21.0,Other,Interventional,2020-05-15,30/04/21,2021-01-06,22/05/20,13/04/21,"The Ottawa Hospital, Ottawa, Ontario",Canada,Respiratory Diseases,1,2,236.0
2417.0,NCT04348942,"A COVID-19 Symptom, Exposure and Immune Response Registry",,"Active, not recruiting",COVID-19,,,,,,,,ObvioHealth,All,"18 Years and older   (Adult, Older Adult)",10000.0,Industry,Observational,2020-05-29,01/05/21,2021-01-05,16/04/20,09/10/20,"ObvioHealth, Orlando, Florida",United States,Respiratory Diseases,1,1,221.0
2418.0,NCT04844580,A Clinical Study Evaluating Inhaled Aviptadil on COVID-19,HOPE,Recruiting,COVID-19,,,,,,,Drug: Inhaled Aviptadil|Drug: Placebo,Centurion Pharma|Klinar CRO,All,"18 Years to 70 Years   (Adult, Older Adult)",80.0,Industry|Other,Interventional,2021-10-03,01/09/22,2022-01-12,14/04/21,14/04/21,"Başkent University School of Medicine, Ankara, Turkey|Hacettepe University School of Medicine, Ankara, Turkey|Health Sciences University Yedikule Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,101.0
2419.0,NCT04666025,SARS-CoV-2 Donor-Recipient Immunity Transfer,,Recruiting,"Accelerated Phase CML, BCR-ABL1 Positive",Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia,Chronic Lymphocytic Leukemia,"Chronic Phase CML, BCR-ABL1 Positive",COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Procedure: Biospecimen Collection|Other: Diagnostic Laboratory Biomarker Analysis|Other: Electronic Health Record Review|Other: Questionnaire Administration,City of Hope Medical Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",36.0,Other|NIH,Observational,2020-09-23,23/09/22,2022-09-23,14/12/20,14/12/20,"City of Hope Medical Center, Duarte, California",United States,"Respiratory Diseases, Cancers",1,7,730.0
2420.0,NCT04362150,Long-term Impact of Infection With Novel Coronavirus (COVID-19),LIINC,"Active, not recruiting",COVID-19,,,,,,,,"University of California, San Francisco",All,"18 Years to 100 Years   (Adult, Older Adult)",800.0,Other,Observational,2020-04-21,31/12/22,2024-12-21,24/04/20,18/11/20,"Zuckerberg San Francisco General Hospital (ZSFG), San Francisco, California",United States,Respiratory Diseases,1,1,1705.0
2421.0,NCT04396353,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,WHO,Completed,COVID-19,SARS-CoV 2,Corona Virus Infection,Sedentary Behavior,,,,Other: Electronic questionnaire,University of Sao Paulo General Hospital,All,"Child, Adult, Older Adult",1574.0,Other,Observational,2020-04-06,01/10/20,2020-01-10,20/05/20,22/10/20,"Marcelo Rodrigues dos Santos, São Paulo, Sao Paulo",Brazil,Respiratory Diseases,1,4,-87.0
2422.0,NCT04527315,COVID-19 Survivorship Registry,,Recruiting,COVID-19,,,,,,,Other: Questionnaires,NYU Langone Health,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Observational,2020-07-17,01/08/23,2023-01-08,26/08/20,17/11/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,905.0
2423.0,NCT04373148,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",,Recruiting,Coronavirus,,,,,,,Other: There is no intervention,Stanford University|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI)|National Institute of Environmental Health Sciences (NIEHS),All,"2 Years and older   (Child, Adult, Older Adult)",1000.0,Other|NIH,Observational,2020-08-04,30/04/22,2022-04-30,04/05/20,09/04/21,"Stanford Health Care - ValleyCare, Pleasanton, California, United States|Stanford University, Hospital, and Clinics, Stanford, California",United States,Respiratory Diseases,1,1,634.0
2424.0,NCT04347993,"A Prospective ""Universal"" Observational Database for COVID-19",,Recruiting,COVID-19,,,,,,,,Hackensack Meridian Health,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-03-27,01/04/21,2021-01-04,15/04/20,24/04/20,"Hackensack Meridian Health - John Theurer Cancer Center, Hackensack, New Jersey",United States,Respiratory Diseases,1,1,283.0
2425.0,NCT04348240,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,,Recruiting,COVID-19,,,,,,,,National Institute of Dental and Craniofacial Research (NIDCR)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",90.0,NIH,Observational,2020-04-16,28/02/22,2022-02-28,16/04/20,19/03/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,683.0
2426.0,NCT04648800,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,,Recruiting,COVID-19,BCG Vaccination Reaction,SARS-CoV Infection,,,,,Drug: BCG-10 vaccine|Drug: 0.9% saline,Hanna Czajka|Medical Research Agency - Agencja Badań Medycznych|University of Rzeszow,All,"25 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-07-07,01/12/20,2021-01-04,02/12/20,02/12/20,"Department of Anesthesiology and Intensive Care, University Clinical Center, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland|Stefan Żeromski Specialist Hospital, Kraków, Poland|Voivodeship Hospital nr 2 in the Name of The Saint Queen Jadwiga, University of Rzeszów, Poland, Rzeszów, Poland|Saint Jadwiga Śląska Hospital, Trzebnica, Poland|Department of Pediatrics, Bielanski Hospital,, Warsaw, Poland|Praski Hospital, Warsaw",Poland,Respiratory Diseases,1,3,181.0
2427.0,NCT04343053,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,ATTAC-Co,"Active, not recruiting",Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Other: SARS-Cov-2 infection,University Hospital of Ferrara,All,"18 Years and older   (Adult, Older Adult)",54.0,Other,Interventional,2020-08-04,09/06/20,2021-09-06,13/04/20,11/06/20,"Azienda Ospedaliera Universitaria di Ferrara, Ferrara",Italy,Respiratory Diseases,1,1,398.0
2428.0,NCT04393948,Lung Irradiation for COVID-19 Pneumonia,,Recruiting,SARS-CoV 2,,,,,,,Radiation: Phase 1|Radiation: Phase 2,Brigham and Women's Hospital,All,"40 Years and older   (Adult, Older Adult)",48.0,Other,Interventional,2020-01-06,01/10/20,2020-01-11,19/05/20,25/06/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,5.0
2429.0,NCT04698382,"Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis",,"Active, not recruiting",Sepsis,Septic Shock,,,,,,,National Institutes of Health Clinical Center (CC)|Emory University,All,"Child, Adult, Older Adult",5000.0,NIH|Other,Observational,2020-01-08,01/04/21,2021-01-05,06/01/21,06/01/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Others,0,2,363.0
2430.0,NCT04426292,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,COVEMUZ,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: Serological testing,Universitair Ziekenhuis Brussel,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Interventional,2020-12-05,23/10/20,2021-12-05,11/06/20,11/06/20,"UZ Brussel, Jette, Brussel",Belgium,Respiratory Diseases,1,1,365.0
2431.0,NCT04373889,COVID-19 Among Healthcare Workers in Belgian Hospitals,COVHECBEHO,"Active, not recruiting",COVID-19,COVID-19,,,,,,,"Sciensano|Institute of Tropical Medicine, Belgium",All,"18 Years and older   (Adult, Older Adult)",850.0,Other,Observational,2020-04-22,30/04/21,2021-04-30,05/05/20,05/02/21,"Sciensano, Brussels",Belgium,Respiratory Diseases,1,2,373.0
2432.0,NCT04323644,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),CovidSurg,Recruiting,COVID-19,Coronavirus,Surgery,,,,,Procedure: Surgery,University of Birmingham,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-01-01,30/09/20,2020-09-30,26/03/20,12/05/20,"Hospital del Henares, Madrid",Spain,Respiratory Diseases,1,3,273.0
2433.0,NCT04769258,Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD),ESCAPE-IBD,Not yet recruiting,Inflammatory Bowel Diseases,,,,,,,Biological: Pfizer Comirnaty vaccine,Italian Group for the study of Inflammatory Bowel Disease (IG-IBD),All,"18 Years and older   (Adult, Older Adult)",1380.0,Other,Observational,2021-01-03,01/03/22,2022-01-06,24/02/21,24/02/21,,,Others,0,1,368.0
2434.0,NCT04441385,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,MARACOVID,Recruiting,COVID-19,,,,,,,Drug: Maraviroc 300 mg|Other: Standard care therapy,Hospital Universitario Infanta Leonor|Hospital Clínic de Barcelona|ViiV Healthcare,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Interventional,2020-06-26,30/11/20,2020-12-20,22/06/20,09/07/20,"Hospital Clínic, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid",Spain,Respiratory Diseases,1,1,177.0
2435.0,NCT04367363,Social Media and COVID-19,,Completed,Coronavirus,Depression,Anxiety,Stress,,,,Behavioral: Social media & news consumption,Jean Liu|Yale-NUS College,All,"21 Years and older   (Adult, Older Adult)",151.0,Other,Observational,2020-03-17,07/05/20,2020-05-31,29/04/20,29/12/20,"Yale-NUS College, Singapore",Singapore,"Mental Health, Respiratory Diseases",1,4,75.0
2436.0,NCT04411667,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,,"Active, not recruiting",Sars-CoV2,,,,,,,Drug: Octagam,"George Sakoulas, MD|Octapharma|Sharp HealthCare",All,"18 Years and older   (Adult, Older Adult)",34.0,Other|Industry,Interventional,2020-04-28,01/11/20,2020-11-30,02/06/20,04/11/20,"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Memorial Hospital, San Diego, California",United States,Respiratory Diseases,1,1,216.0
2437.0,NCT04779749,Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19,,Recruiting,COVID-19,,,,,,,Other: Data extraction from medical files,Brugmann University Hospital,Female,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-08-12,01/12/21,2021-01-12,03/03/21,05/03/21,"CHU Brugmann, Brussels, Belgium|Antoine Béclère Hospital, Clamart, France|Hôpital Louis Mourier, Colombes, France|Fondazione Policlinico Universitario Agostino Gemelli, Roma",Italy,Respiratory Diseases,1,1,153.0
2438.0,NCT04823182,Study of HEarT DiseAse and ImmuNiTy After COVID-19 in Ireland,SETANTA,Recruiting,SARS-CoV Infection,COVID-19,Cardiomyopathies,,,,,Diagnostic Test: Cardiovascular Magnetic Resonance Imaging,Cardiovascular Research Institute Dublin,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-02-16,16/06/21,2022-06-16,30/03/21,01/04/21,"Cardiovascular Research Institute Dublin, Dublin",Ireland,Respiratory Diseases,1,3,485.0
2439.0,NCT04548557,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,,Not yet recruiting,COVID-19,,,,,,,Biological: intravenous immunoglobulin therapy,University of Health Sciences Lahore|University of Lahore|Amson Vaccine and Pharma (Pvt) Limited,All,"18 Years to 90 Years   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2020-09-15,15/10/20,2020-11-15,14/09/20,14/09/20,"University of Health Sciences, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,61.0
2440.0,NCT04565392,Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19),Pepcid4COV19,Not yet recruiting,COVID-19,,,,,,,Drug: Famotidine 20 milligram tablet,drpykessupplements.com,All,"18 Years and older   (Adult, Older Adult)",150.0,Industry,Interventional,2021-01-05,01/11/21,2022-01-31,25/09/20,19/01/21,"Pykonsult headquarters, New Fairfield, Connecticut",United States,Respiratory Diseases,1,1,391.0
2441.0,NCT04802382,Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19,CimetrA,Not yet recruiting,Corona Virus Infection,COVID-19,SARS-CoV Infection,,,,,Drug: Placebo administration|Diagnostic Test: Confirm SARS-CoV-2 infection|Procedure: Physical Examination|Procedure: Vital Signs|Diagnostic Test: Hematology blood test|Diagnostic Test: Biochemistry blood test|Other: NEWS score|Diagnostic Test: PK test|Diagnostic Test: blood test for inflammatory markers|Diagnostic Test: D-dimer test|Other: VAS scale|Diagnostic Test: Urine pregnancy test for women of childbearing potential|Procedure: ECG|Other: COVID-19-Impact on Quality of Life Questionnaire|Drug: CimetrA-1|Drug: CimetrA-2,MGC Pharmaceuticals d.o.o,All,"18 Years and older   (Adult, Older Adult)",252.0,Industry,Interventional,2021-01-04,01/12/21,2021-01-12,17/03/21,17/03/21,,,Respiratory Diseases,1,3,8.0
2442.0,NCT04370236,INB03 for the Treatment of Pulmonary Complications From COVID-19,,Recruiting,COVID-19,,,,,,,Drug: INB03|Drug: Placebo,"Inmune Bio, Inc.",All,"18 Years and older   (Adult, Older Adult)",366.0,Industry,Interventional,2020-10-21,01/02/21,2021-01-02,30/04/20,05/02/21,"NEA Baptist, Jonesboro, Arkansas, United States|St. Bernard's, Jonesboro, Arkansas, United States|Jewish Hospital, Louisville, Kentucky, United States|Mississippi Baptist, Kosciusko, Mississippi, United States|Baptist Memorial Hospital-DeSoto, Southard, Missouri, United States|Richmond University Medical Center, Staten Island, New York, United States|Baptist Clinical Research Institute, Memphis, Tennessee, United States|Memorial Hermann, Houston, Texas, United States|Memorial Hermann Southeast, Houston, Texas",United States,Respiratory Diseases,1,1,73.0
2443.0,NCT04657445,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",,Recruiting,Olfactory and Taste Dysfunction in SARS-CoV2 Infection,,,,,,,Diagnostic Test: visual analogue scale,"University Hospital, Ioannina|OTORHINOLARYNGOLOGY DEPARTMENT, UNIVERSITY GENERAL HOSPITAL OF IOANNINA|1st DIVISION OF INTERNAL MEDICINE, UNIVERSITY GENERAL HOSPITAL OF IOANNINA",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-11-17,01/05/21,2021-01-06,08/12/20,21/12/20,"University General Hospital of Ioannina, Ioannina, Epirus",Greece,Respiratory Diseases,1,1,50.0
2444.0,NCT04361214,Leflunomide in Mild COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Leflunomide,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-05-05,01/02/21,2021-01-02,24/04/20,29/10/20,"University of Chicago, Chicago, Illinois",United States,Respiratory Diseases,1,1,242.0
2445.0,NCT04394416,Trial of Imatinib for Hospitalized Adults With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Imatinib|Drug: Placebo oral tablet,"University of Maryland, Baltimore",All,"18 Years and older   (Adult, Older Adult)",204.0,Other,Interventional,2020-02-06,01/06/22,2023-01-06,19/05/20,04/06/20,"University of Maryland Medical Center, Baltimore, Maryland",United States,Respiratory Diseases,1,1,1065.0
2446.0,NCT04766931,The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: FB2001|Drug: FB2001 Placebo,Frontier Biotechnologies Inc.,All,18 Years to 60 Years   (Adult),32.0,Industry,Interventional,2021-03-27,01/08/21,2021-01-12,23/02/21,02/04/21,"Frontage Clinical Services, Inc., Secaucus, New Jersey",United States,Respiratory Diseases,1,1,-74.0
2447.0,NCT04369807,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,COVERSCAN,Recruiting,COVID-19,,,,,,,Diagnostic Test: Outpatient MRI,Perspectum,All,"18 Years and older   (Adult, Older Adult)",507.0,Industry,Observational,2020-04-21,31/05/23,2023-05-31,30/04/20,30/04/20,"Mayo Clinic Healthcare, London, United Kingdom|Gemini, Oxford",United Kingdom,Respiratory Diseases,1,1,1135.0
2448.0,NCT04539275,COVID-19 (VA CURES-1),VA CURES-1,Recruiting,COVID-19,,,,,,,Drug: Convalescent Plasma|Other: Masked Saline Placebo,VA Office of Research and Development,All,"18 Years and older   (Adult, Older Adult)",702.0,U.S. Fed,Interventional,2020-11-16,20/06/22,2022-07-18,04/09/20,24/11/20,"Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States|Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States|Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States|North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida, United States|Orlando VA Medical Center, Orlando, FL, Orlando, Florida, United States|James A. Haley Veterans' Hospital, Tampa, FL, Tampa, Florida, United States|Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States|VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan, United States|John D. Dingell VA Medical Center, Detroit, MI, Detroit, Michigan, United States|VA Southern Nevada Healthcare System, North Las Vegas, NV, Las Vegas, Nevada, United States|James J. Peters VA Medical Center, Bronx, NY, Bronx, New York, United States|Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio, United States|Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City, Oklahoma, United States|VA Portland Health Care System, Portland, OR, Portland, Oregon, United States|Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston, South Carolina, United States|VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States|South Texas Health Care System, San Antonio, TX, San Antonio, Texas, United States|Hunter Holmes McGuire VA Medical Center, Richmond, VA, Richmond, Virginia, United States|William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison, Wisconsin",United States,Respiratory Diseases,1,1,609.0
2449.0,NCT04597775,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,APCC-19,Not yet recruiting,SARS-CoV Infection,,,,,,,Drug: hydroxychloroquine,"Regional Center for Disease Control and Prevention, Jordan|Farhat Hached Hospital, Tunisia|Fattouma Bourguiba, Tunisia",All,"18 Years to 65 Years   (Adult, Older Adult)",93.0,Other,Interventional,2020-10-27,15/01/21,2021-01-31,22/10/20,22/10/20,,,Respiratory Diseases,1,1,96.0
2450.0,NCT04261517,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,,Completed,"Pneumonia, Pneumocystis",Coronavirus,COVID-19,,,,,Drug: Hydroxychloroquine,Shanghai Public Health Clinical Center,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-02,25/02/20,2020-02-25,07/02/20,13/04/20,"Shanghai Public Health Clinical Center, Shanghai, Shanghai, China|Shanghai Public Health Clinical Center, Shanghai, Shanghai",China,Respiratory Diseases,1,3,-98.0
2451.0,NCT04611230,"A Study to Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois",CONTACT,Recruiting,COVID-19,,,,,,,,AbbVie,All,"18 Years and older   (Adult, Older Adult)",1250.0,Industry,Observational,2020-05-11,24/09/21,2021-09-24,02/11/20,06/01/21,"Great Lakes Clinical Trials /ID# 224874, Chicago, Illinois",United States,Respiratory Diseases,1,1,501.0
2452.0,NCT04770740,Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19,KOVIT,Recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin K2 in the form of Menaquinone-7 (MK-7)|Dietary Supplement: Placebo,Canisius-Wilhelmina Hospital|Kappa Bioscience,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-02-22,01/06/21,2021-01-10,25/02/21,03/03/21,"Canisius Wilhelmina Hospital, Nijmegen, Gelderland",Netherlands,Respiratory Diseases,1,1,-43.0
2453.0,NCT04418531,Convalescent Antibodies Infusion in COVID 19 Patients,,Not yet recruiting,"Pneumonia, Viral",Corona Virus Infection,,,,,,Biological: Anti-coronavirus antibodies (immunoglobulins) obtained with DFPP form convalescent patients,Piero Luigi Ruggenenti|Aferetica|A.O. Ospedale Papa Giovanni XXIII,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-06,01/09/20,2020-01-09,05/06/20,05/06/20,"ASST - Papa Giovanni XXIII - Unit of Nephrology, Bergamo, BG, Italy|Asst Hpg23 - Eas, Bergamo, BG, Italy|ASST HPG23 - Intensive Care Unit, Bergamo, BG, Italy|ASST HPG23 - Microbioly and Virology Unit, Bergamo, BG, Italy|Sst Hpg23 - S.I.M.T., Bergamo, BG, Italy|IRFMN - Clinical Research Center for Rare Diseases, Ranica, BG",Italy,Respiratory Diseases,1,2,3.0
2454.0,NCT04412785,Cyclosporine in Patients With Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Cyclosporine,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-06-30,01/04/21,2021-01-12,02/06/20,23/10/20,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,196.0
2455.0,NCT04548895,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,,Recruiting,COVID-19,Community-Acquired Respiratory Tract Infection,,,,,,Device: Observational measurement of biometric data. No change to health care provided.,"Health Stream Analytics, LLC",All,"Child, Adult, Older Adult",30.0,Industry,Observational,2020-12-30,30/06/21,2021-10-26,16/09/20,06/01/21,"Avalon Health & Rehabilitation Center, Pasco, Washington",United States,Respiratory Diseases,1,2,300.0
2456.0,NCT04352465,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Methotrexate,Azidus Brasil|InCor Heart Institute|Hospital Santa Marcelina|Prevent Senior Institute,All,"18 Years and older   (Adult, Older Adult)",42.0,Industry|Other,Interventional,2020-01-05,30/06/20,2020-11-30,20/04/20,29/04/20,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo",Brazil,Respiratory Diseases,1,1,330.0
2457.0,NCT04724681,Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection,WARD COVID-19,Recruiting,Clinical Deterioration,,,,,,,Device: WARD CSS,"University Hospital Bispebjerg and Frederiksberg|Rigshospitalet, Denmark",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2021-01-02,31/12/21,2021-12-31,26/01/21,26/01/21,"Bispebjerg and Frederiksberg Hospital, Copenhagen",Denmark,Others,0,1,363.0
2458.0,NCT04409483,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,TRASCOV,Withdrawn,COVID-19,,,,,,,Drug: Lopinavir-Ritonavir Drug Combination|Combination Product: Standard Care,"Epicentre|Université Abdou Moumouni|Centre de Recherche Médicale et Sanitaire|Ministry of Public Health, Republic of Niger",All,"12 Years and older   (Child, Adult, Older Adult)",0.0,Other,Interventional,2020-01-06,31/12/20,2020-12-31,01/06/20,10/02/21,,,Respiratory Diseases,1,1,360.0
2459.0,NCT04844489,Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People,COVIVAC-ID,Not yet recruiting,Autoimmune or Autoinflammatory Diseases,HIV,Multiple Sclerosis,Solid Tumors or Cancers,Solid Organ Transplant,,,Other: Blood samples for the study of the humoral response to SARS-CoV-2 variants and of the cellular response after vaccination against COVID-19,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",485.0,Other,Interventional,2021-04-15,15/09/22,2022-12-31,14/04/21,14/04/21,"Hospital Pitié-Salpêtrière - AP-HP, Paris",France,Immunological Disorders,1,5,625.0
2460.0,NCT04711954,HIV/COV in Ukraine-NL,,Recruiting,Hiv,COVID-19,,,,,,,Erasmus Medical Center|Lviv Regional AIDS Health Center,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-11,01/11/21,2022-01-11,15/01/21,15/01/21,"Erasmus MC, Rotterdam, Netherlands|Lviv Regional AIDS Health Center, Lviv",Ukraine,Respiratory Diseases,1,2,731.0
2461.0,NCT04377724,Spread and Course of COVID-19 Infections,CoV-ETH,"Active, not recruiting",COVID-19,Virus Disease,,,,,,,Goldhahn Jörg|ETH Zurich,All,18 Years to 64 Years   (Adult),3000.0,Other,Observational,2020-04-27,30/06/21,2021-06-30,06/05/20,01/07/20,"ETH, Zürich",Switzerland,Respiratory Diseases,1,2,429.0
2462.0,NCT04752085,Prognosis and Course of COVID-19 Infection in Hospitalised Patients,,"Active, not recruiting",COVID-19,SARS-CoV Infection,,,,,,Diagnostic Test: Chitotriosidase activity,I.M. Sechenov First Moscow State Medical University,All,"18 Years and older   (Adult, Older Adult)",345.0,Other,Observational,2020-01-11,01/03/21,2021-09-30,12/02/21,09/03/21,"University Hospital #1, Moscow, Russian Federation|University Hospital #4, Moscow",Russian Federation,Respiratory Diseases,1,2,628.0
2463.0,NCT04821973,Respiratory Tele Monitoring COVID 19 (TMR COVID-19),,Recruiting,COVID-19,,,,,,,Device: Radius PPG Tetherless Pulse Oximetry (Masimo)|Device: usual monitoring,Assistance Publique Hopitaux De Marseille,All,"10 Years and older   (Child, Adult, Older Adult)",80.0,Other,Interventional,2020-09-22,15/05/21,2021-11-15,30/03/21,30/03/21,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,419.0
2464.0,NCT04468217,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,,Recruiting,COVID-19,SARS-CoV2,Corona Virus Infection,,,,,"Diagnostic Test: Obtainment of nasopharyngeal, oropharyngeal, buccal, nasal and saliva samples",Neurognos,All,"18 Years to 75 Years   (Adult, Older Adult)",150.0,Industry,Observational,2020-02-06,15/09/20,2020-09-25,13/07/20,13/07/20,"Laboratorio Neurognos, Santiago, Providencia",Chile,Respiratory Diseases,1,3,232.0
2465.0,NCT04393038,ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Mir-Age,Recruiting,COVID-19,,,,,,,Drug: ABX464|Drug: Placebo,Abivax S.A.,All,"18 Years and older   (Adult, Older Adult)",1034.0,Industry,Interventional,2020-01-05,30/12/20,2021-04-30,19/05/20,20/07/20,"Centre hospitalier Saint Pierre, Brussels, Belgium|Hôpital Erasme, Brussels, Belgium|UZ Gent, Gent, Belgium|Fundacao de Medicina Tropical Doutor Heitor Vieira Dourado - Instituto de Pesquisa Clínica Carlos Borborema, Manaus, Amazonas, Brazil|Centro Oncológico de Roraima - CECOR - NAP, Boa Vista, Roraima, Brazil|Hospital das Clinicas da FMUSP, São Paulo, Sao Paulo, Brazil|Instituto Nacional de Infectologia Evandro Chagas - FIOCRUZ Rio de Janeiro, Rio De Janeiro, Brazil|Conjunto Hospitalar do Mandaqui, Sao Paulo, Brazil|Hôpital Nord, Amiens, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|Centre Hospitalier Universitaire de Nice, Nice, France|Hôpital Saint-Antoine, Paris, France|Universitätsmedizin Mannheim Ruprecht-Karls-Universität Heid, Mannheim, Baden-Württemberg, Germany|Universitätsklinikum Bonn, Bonn, Nordrhein-Westfalen, Germany|Asklepios Klinik St. Georg, Hamburg, Germany|Asklepios Klinik Altona, Hamburg, Germany|Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico - Infectious Diseases, Milano, Lombardia, Italy|Ospedale San Paolo, Milano, Lombardia, Italy|Ospedale Luigi Sacco, AO-PU, Milano, Lombardia, Italy|Ospedale di Vittorio Veneto - Medecina generale, Vittorio Veneto, Treviso, Italy|Ospedale A. Manzonidi Lecco - ASST Lecco, Lecco, Italy|Ospedale Niguarda, Milano, Italy|Consultorio médico, Mérida, Yucatan, Mexico|Centro de Prevención y Rehabilitación de Enfermedades Pulmon, Nuevo León, Mexico|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|H.G.U. Alicante, Alicante, Spain|Hospital del Mar, Barcelona, Spain|Hospital de La Princesa, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Royal Free Hospital, London",United Kingdom,Respiratory Diseases,1,1,481.0
2466.0,NCT04449718,Vitamin D Supplementation in Patients With COVID-19,,Completed,COVID-19,,,,,,,Dietary Supplement: Vitamin D|Dietary Supplement: Placebo,University of Sao Paulo,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Interventional,2020-01-06,07/10/20,2020-07-10,29/06/20,17/11/20,"Clinical Hospital of the School of Medicine, University of Sao Paulo, Sao Paulo",Brazil,Respiratory Diseases,1,1,186.0
2467.0,NCT04451291,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,,Not yet recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Biological: Decidual Stromal Cells (DSC),"University Health Network, Toronto|Oslo University Hospital",All,"18 Years to 75 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-08-24,24/02/21,2021-02-24,30/06/20,11/08/20,"Toronto General Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,2,184.0
2468.0,NCT04385849,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Biological: N-803|Other: Saline,"ImmunityBio, Inc.",All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Interventional,2020-01-06,11/07/20,2020-11-07,13/05/20,01/06/20,,,Respiratory Diseases,1,1,306.0
2469.0,NCT04529499,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,,"Active, not recruiting",COVID-19,,,,,,,Drug: AVIGAN|Drug: Placebo Comparator,Dr. Reddy's Laboratories Limited,All,"21 Years to 80 Years   (Adult, Older Adult)",780.0,Industry,Interventional,2020-08-20,31/03/21,2021-03-31,27/08/20,03/02/21,"Jaber Al-Ahmad Al-Sabah Hospital (South Surra), Kuwait City, Kuwait|Mishref Field Hospital (Mishref), Kuwait City",Kuwait,Respiratory Diseases,1,1,223.0
2470.0,NCT04568148,COVID-19 Biorepository,,Recruiting,COVID-19,SARS-CoV 2,Coronavirus,COVID-19,,,,,University of Kansas Medical Center,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-15,31/12/21,2021-12-31,29/09/20,29/09/20,"University of Kansas Medical Center, Kansas City, Kansas",United States,Respiratory Diseases,1,4,625.0
2471.0,NCT04360278,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,,National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1500.0,NIH,Observational,2020-04-21,06/04/30,2030-06-04,24/04/20,01/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,3696.0
2472.0,NCT04449380,Clinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients,INTERCOP,Recruiting,COVID-19,,,,,,,Drug: Interferon-ß-1a|Combination Product: Standard of Care (SOC),Emanuele Bosi|IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",126.0,Other,Interventional,2020-02-11,01/04/21,2021-01-06,26/06/20,10/11/20,"IRCCS Ospedale San Raffaele, Milano",Italy,Respiratory Diseases,1,1,330.0
2473.0,NCT04492449,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",(COVID-19,Not yet recruiting,Exposure During Pregnancy,Corona Virus Infection,,,,,,Other: congenital malformation,University of Sao Paulo|Maria Aparecida de Andrade Moreira Machado|Thais Marchini de Oliveira Valarelli,Female,"16 Years to 40 Years   (Child, Adult)",260.0,Other,Observational,2021-01-01,01/04/21,2022-01-12,30/07/20,11/12/20,,,Respiratory Diseases,1,2,376.0
2474.0,NCT04400838,Investigating a Vaccine Against COVID-19,,Recruiting,Coronavirus,,,,,,,Biological: ChAdOx1 nCoV-19 (Abs 260)|Biological: MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (Abs 260) + 2.2x10^10vp (qPCR) boost|Biological: Two dose MenACWY vaccine|Biological: ChAdOx1 nCoV-19 (qPCR)|Biological: ChAdOx1 nCoV-19 0.5mL prime plus boost|Biological: Two dose MenACWY vaccine min. 4 weeks apart|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.5mL|Biological: Two dose ChAdOx1 nCoV-19/Covishield 0.25mL & 0.5mL,University of Oxford,All,"18 Years and older   (Adult, Older Adult)",12390.0,Other,Interventional,2020-05-28,01/09/21,2021-01-09,26/05/20,10/12/20,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|Castle Hill Hospital, Cottingham, Hull, United Kingdom|St Georges University Hospital NHS Foundation Trust, London, Tooting, United Kingdom|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|NIHR Cambridge Clinical Research Facility, Cambridge, United Kingdom|NHS Lothian, Western General Hospital, Edinburgh, United Kingdom|Glasgow University and NHS Greater Glasgow & Clyde, New Lister Building, Glasgow Royal Infirmary & Queen Elizabeth University Hospital, Glasgow, United Kingdom|Liverpool School of Tropical Medicine (LSTM), Accelerator Research Clinic. Clinical Sciences Accelerator, LIverpool, United Kingdom|London North West University Healthcare Trust (LNWUH), Northwick Park Hospital, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, Department of Infection, St Thomas Hospital, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom|Public Health Wales, Newport, United Kingdom|University of Nottingham Health Service, Cripps Health Centre, University Park, Nottingham, United Kingdom|CCVTM, University of Oxford, Churchill Hospital, Oxford, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield",United Kingdom,Respiratory Diseases,1,1,226.0
2475.0,NCT04324684,Prognostic Factors Keeping Track for COVID-19 Pneumonia,NIKE_C19,Completed,"Pneumonia, Viral",Hypertension,Diabetes Mellitus,Obesity,Cardiovascular Diseases,Obstructive Lung Disease,,,Catholic University of the Sacred Heart,All,"18 Years to 100 Years   (Adult, Older Adult)",198.0,Other,Observational,2020-03-31,07/05/20,2020-07-05,27/03/20,14/05/20,"Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma",Italy,"Metabolic Disorders, Cardiovascular Diseases, Respiratory Diseases",1,6,96.0
2476.0,NCT04463433,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,,Recruiting,COVID-19,,,,,,,Behavioral: Cognitive and behavioral intervention.|Behavioral: Problem-solving and relationship improvement intervention.,Beijing Normal University,All,30 Years to 60 Years   (Adult),300.0,Other,Interventional,2020-01-02,31/12/21,2022-01-31,09/07/20,09/07/20,"Beijing Normal University, Beijing, Beijing",China,Respiratory Diseases,1,1,760.0
2477.0,NCT04659876,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,,Completed,COVID-19,,,,,,,Diagnostic Test: clinical features and laboratory values,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",445.0,Other,Observational,2020-03-22,01/09/20,2020-08-12,09/12/20,09/12/20,"Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır",Turkey,Respiratory Diseases,1,1,143.0
2478.0,NCT04784481,Ivermectin Reproposing for Mild Stage COVID-19 Outpatients,IVER-Leve,Completed,COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Ivermectin,"Ministry of Public Health, Argentina",All,"18 Years to 75 Years   (Adult, Older Adult)",240.0,Other,Interventional,2020-09-20,20/12/20,2021-01-18,05/03/21,09/03/21,"SI.PRO.SA, Ministerio de Salud Pública, Tucumán",Argentina,Respiratory Diseases,1,2,120.0
2479.0,NCT04366206,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,,Recruiting,COVID-19,SARS-CoV 2,,,,,,,Centre Hospitalier Intercommunal Robert Ballanger|Groupe Hospitalier Pitie-Salpetriere,All,"Child, Adult, Older Adult",143.0,Other,Observational,2020-03-14,31/07/20,2020-07-31,28/04/20,28/04/20,"Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-sous-Bois, France|Groupe Hospitalier Pitie Salpetriere, Paris",France,Respiratory Diseases,1,2,139.0
2480.0,NCT04662086,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,,Enrolling by invitation,COVID-19,,,,,,,Drug: Acebilustat|Drug: Camostat,Stanford University,All,"18 Years to 80 Years   (Adult, Older Adult)",240.0,Other,Interventional,2021-01-04,01/03/22,2022-01-03,10/12/20,13/04/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,364.0
2481.0,NCT04412538,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Low dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: Medium dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 28-day schedule|Biological: High dosage Inactivated SARS-CoV-2 Vaccine on a 0- and 14-day schedule|Biological: Placebo on a 0- and 28-day schedule|Biological: Placebo on a 0- and 14-day schedule,Chinese Academy of Medical Sciences|West China Second University Hospital|Yunnan Center for Disease Control and Prevention,All,18 Years to 59 Years   (Adult),942.0,Other,Interventional,2020-05-15,01/09/20,2021-01-09,02/06/20,04/06/20,"West China Second University Hospital, Sichuan University / West China women's and children's Hospital, Chengdu, Sichuan",China,Respiratory Diseases,1,1,239.0
2482.0,NCT04453501,Anti Infective Agents Impact in COVID-19 Pneumonia,AZITHROVID,Completed,COVID-19,"Pneumonia, Viral",,,,,,Drug: favorable outcome,Centre d'Investigation Clinique et Technologique 805,All,"18 Years and older   (Adult, Older Adult)",132.0,Other,Observational,2020-02-03,25/04/20,2020-04-25,01/07/20,01/07/20,"Benjamin Davido, Garches",France,Respiratory Diseases,1,2,82.0
2483.0,NCT04662073,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,COPPS,Enrolling by invitation,COVID-19,,,,,,,Drug: Camostat|Drug: Placebo,Stanford University,All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-04,01/03/22,2022-01-03,10/12/20,13/04/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,364.0
2484.0,NCT04708236,A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: ORTD-1 low dose|Drug: ORTD-1 mid dose|Drug: ORTD-1 high dose|Other: Vehicle control,"Oryn Therapeutics, LLC",All,"18 Years and older   (Adult, Older Adult)",18.0,Industry,Interventional,2021-01-04,01/05/21,2021-01-07,13/01/21,24/02/21,"UC Irvine Medical Center, Orange, California",United States,Respiratory Diseases,1,1,3.0
2485.0,NCT04794829,Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination,,Recruiting,Influenza,COVID-19,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",150.0,NIH,Observational,2021-04-19,31/12/26,2026-12-31,12/03/21,14/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,"Infectious Diseases, Respiratory Diseases",1,2,2082.0
2486.0,NCT04467931,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,,"Active, not recruiting",Hypertension,COVID-19,,,,,,Drug: ACEI/ARB|Drug: Non-ACEI/ARB|Drug: ACEI|Drug: ARB,University of Utah|VA Salt Lake City Health Care System|University of Pennsylvania|Wake Forest University Health Sciences|University of Florida|Johns Hopkins Bloomberg School of Public Health|Boston University|Northwestern University|Edith Nourse Rogers Memorial Veterans Hospital|Columbia University|MedStar Georgetown University Hospital,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other|U.S. Fed,Observational,2020-01-19,21/10/20,2020-12-31,13/07/20,03/11/20,"University of Utah, Salt Lake City, Utah",United States,"Cardiovascular Diseases, Respiratory Diseases",1,2,347.0
2487.0,NCT04659473,Spanish Survey on Third Wave of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Other: Online survey,University of Salamanca,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-09-12,20/12/20,2020-12-20,09/12/20,14/12/20,"Universidad de Salamanca, Salamanca",Spain,Respiratory Diseases,1,1,99.0
2488.0,NCT04701710,Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan,Ivercar-Tuc,Completed,COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Ivermectin / Iota-Carrageenan,"Maria de los Angeles Peral de Bruno|Ministry of Public Health, Argentina",All,18 Years to 60 Years   (Adult),300.0,Other,Interventional,2020-10-15,18/12/20,2020-12-31,08/01/21,23/02/21,"SI.PRO.SA, Ministerio de Salud Pública, Tucumán",Argentina,Respiratory Diseases,1,2,77.0
2489.0,NCT04338347,CAP-1002 in Severe COVID-19 Disease,,No longer available,COVID-19,,,,,,,Biological: CAP-1002 Allogeneic Cardiosphere-Derived Cells,Capricor Inc.,All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,,08/04/20,01/12/20,"Cedars-Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,1,
2490.0,NCT04324190,DIgital Online SuPport for COVID-19 StrEss,DISPOSE,Recruiting,COVID-19,Psychosocial Stress,Mental Health,,,,,Behavioral: Guided online support program|Behavioral: WHO recommendations (waiting condition),Gunther Meinlschmidt|Selfapy GmbH|International Psychoanalytic University Berlin,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-08-04,01/06/20,2021-01-12,27/03/20,14/04/20,"Selfapy GmbH, Berlin",Germany,"Mental Health, Respiratory Diseases",1,3,161.0
2491.0,NCT04646616,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,CRISOL Contigo,Not yet recruiting,COVID-19,Mental Health Issue,Violence,,,,,Other: Community popular opinion leader (POL) based intervention,Drexel University,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2021-06-01,31/10/21,2021-10-31,30/11/20,02/12/20,"Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,3,152.0
2492.0,NCT04377490,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,THROMBCOVID2,Recruiting,COVID-19,Hemostasis,Coagulation,,,,,Other: venous ultrasound|Biological: blood sample,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-05,01/10/20,2020-01-11,06/05/20,08/05/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,3,-85.0
2493.0,NCT04345640,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,,Recruiting,Liver Cirrhoses,,,,,,,Other: no intervention,"Institute of Liver and Biliary Sciences, India",All,"18 Years to 70 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-10-04,31/12/20,2020-12-31,14/04/20,03/09/20,"Institute of Liver and Biliary Sciences, New Delhi, Delhi",India,Others,0,1,88.0
2494.0,NCT04497636,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,STRING-COVID,Recruiting,Anxiety,Depression,"Stress, Psychological",Loneliness,Social Isolation,,,,"Pontificia Universidad Catolica de Chile|Fondo Nacional de Desarrollo Científico y Tecnológico, Chile",All,"18 Years and older   (Adult, Older Adult)",1092.0,Other,Observational,2020-03-07,30/04/21,2021-05-31,04/08/20,29/03/21,"Pontificia Universidad Catolica de Chile, Santiago, RM",Chile,Mental Health,1,5,450.0
2495.0,NCT04437901,COVIDAR - Arrhythmias in COVID-19,COVIDAR,Not yet recruiting,COVID-19,Arrhythmia,Torsades de Pointe Caused by Drug,"Qt Interval, Variation in",Atrioventricular Block,Atrial Fibrillation,Bradyarrhythmia,,"Hospital Clinic of Barcelona|Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)|Istituto Auxologico Italiano|St George's University Hospitals NHS Foundation Trust|University Hospital, Antwerp|European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART)|European Society of Cardiology",All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-01-06,01/12/20,2021-01-12,18/06/20,18/06/20,"Antwerp University Hospital, Antwerpen, Belgium|Istituto Auxologico Italiano, IRCCS, Milan, Italy|Amsterdam UMC, Amsterdam, AZ, Netherlands|Hospital Clinic of Barcelona, Barcelona, Spain|St. Georges University Hospitals, London",United Kingdom,Respiratory Diseases,1,7,372.0
2496.0,NCT04518410,ACTIV-2: A Study for Outpatients With COVID-19,,Recruiting,Coronavirus,COVID-19,,,,,,Biological: bamlanivimab|Drug: Placebo (IV)|Biological: BRII-196/BRII-198|Biological: AZD7442 (IV)|Biological: AZD7442 (IM)|Drug: SNG001|Drug: Camostat|Drug: Placebo (IM)|Drug: Placebo (Inhaled solution)|Drug: Placebo (oral tablet)|Biological: C135-LS + C144-LS|Drug: Placebo (SC injections),National Institute of Allergy and Infectious Diseases (NIAID)|Eli Lilly and Company|AIDS Clinical Trials Group|Brii Biosciences Limited|AstraZeneca|Sagent Pharmaceuticals|Synairgen Research Ltd.|Bristol-Myers Squibb,All,"18 Years and older   (Adult, Older Adult)",2000.0,NIH|Industry|Other,Interventional,2020-08-19,01/05/23,2023-01-05,19/08/20,08/04/21,"Pinnacle Research Group (Site 1082), 321 E. 10th Street, Anniston, Alabama, United States|North Alabama Research Center LLC (Site 1194), 721 W. Market St., Ste. B, Athens, Alabama, United States|University of Alabama at Birmingham (Site 1005), 908 20th Street South, Birmingham, Alabama, United States|Cullman Clinical Trials (Site 1140), 501 Clark St. NE., Cullman, Alabama, United States|Jasper Summit Research, LLC. (Site 1056), 1280 Summit, Jasper, Alabama, United States|Absolute Clinical Research, LLC. (Site 1186), 7725 North 43rd Avenue, Ste. 211, Phoenix, Arizona, United States|University of Arizona (Site 1043), 1501 N. Campbell Ave., Rm. 6410, Tucson, Arizona, United States|Franco A. Felizarta MD (Site 1174), 3535 San Dimas St., Bakersfield, California, United States|St. Jude Heritage Medical Group (Site 1093), 2151 N. Harbor Blvd., Fullerton, California, United States|University of California San Diego (Site 1160), 9350 Campus Point Drive, Perlman Cancer Cancer, La Jolla, California, United States|Fadi A. Haddad, MD, Inc. (Site 1146), 8860 Center Dr., Ste. 320, La Mesa, California, United States|Atella Clinical Research (Site 1111), 5451 La Palma Avenue, La Palma, California, United States|Loma Linda University Health (Site 1110), 11374 Mountain View, Dover Bldg, Ste. C, Loma Linda, California, United States|University of Southern California (Site 1057), 1300 N. Mission Rd., Rm 349, Los Angeles, California, United States|UCLA CARE Center (Site 1003), 11075 Santa Monica Blvd., Suite 100, Los Angeles, California, United States|Science 37, Inc. (Site 1124), 12121 Bluff Creek Dr., Ste. 100, Los Angeles, California, United States|VA Northern California Health Care System (NAVREF) (Site 1137), 10535 Hospital Way, Mather, California, United States|Central Valley Research, LLC (Site 1085), 400 E. Orangeburg Ave., Ste. 5, Modesto, California, United States|Valley Clinical Research, Inc. (Site 1059), 18433 Roscoe Blvd., Ste 210, Northridge, California, United States|University of California Irvine (Site 1083), 843 Health Sciences Road, Orange, California, United States|FOMAT Medical Research (Site 1136), 300 South A Street, Oxnard, California, United States|Eisenhower Medical Center (Site 1040), 39000 Bob Hope Drive, Rancho Mirage, California, United States|Paradigm Research (Site 1150), 3652 Eureka Way, Redding, California, United States|University of California Davis Medical Center (Site 1097), 2315 Stockton Blvd., Sacramento, California, United States|Premier Urgent Care Centers of California, Inc. (Site 1176), 284 E. Highland Ave., San Bernardino, California, United States|University of California San Diego (Site 1002), 220 Dickinson Street, San Diego, California, United States|Zion Medical Center (Site 1063), 4647 Zion Avenue, San Diego, California, United States|VA San Diego Health System (Stie 1127), 3350 La Jolla, San Diego, California, United States|University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84, San Francisco, California, United States|San Francisco Research Institute (Site 1210), 2435 Ocean Ave., San Francisco, California, United States|Stanford University (Site 1213), 1201 Welch Road, Stanford, California, United States|Office of Ramesh V. Nathan, MD (Site 1073), 2220 Lynn Rd., Ste. 301, Thousand Oaks, California, United States|Harbor UCLA (Site 1022), 1124 West Carson Street, Torrance, California, United States|Allianz Research Institute Inc. (Site 1159), 14120 Beach Blvd., Ste. 101, Westminster, California, United States|University of Colorado (Site 1007), 12401 East 17th Avenue, Aurora, Colorado, United States|UConn - Institute for Collaboration on Health (Site 1169), 2006 Hillside Rd., Unit 1248, Storrs, Connecticut, United States|Whitman-Walker Health (Site 1027), 1337 R Street NW., Washington, District of Columbia, United States|Bradenton Research Center Inc. (Site 1109), 3924 9th Ave. W, Bradenton, Florida, United States|Synergy Healthcare (Site 1099), 300 Riverside Drive E., Ste. 1350, Bradenton, Florida, United States|Midland Florida Clinical Research Center LLC (Site 1130), 665 Peachwood Drive, DeLand, Florida, United States|Universal Axon Clinical Research (Site 1077), 3650 NW 82nd Ave., Doral, Florida, United States|Holy Cross Health (Site 1072), 4725 North Federal Highway, Fort Lauderdale, Florida, United States|NW FL Clinical Research Group, LLC. (Site 1046), 400 Gulf Breeze Parkway, Gulf Breeze, Florida, United States|Indago Research and Health Center (Site 1050), 3700 W. 12th Ave., Ste. 300, Hialeah, Florida, United States|AGA Clinical Trials (Site 1026), 900 West 49th Street, Hialeah, Florida, United States|Community Research of South Florida (Site 1197), 7100 W. 20th Ave., Ste. 403, Hialeah, Florida, United States|New Generation Medical Research (Site 1204), 7600 W. 20th Ave., Ste. 106, Hialeah, Florida, United States|Innovative Health Medical Center (Site 1222), 6750 Taft Street, Hollywood, Florida, United States|University of Florida Jacksonville (Site 1039), 655 West 8th Street, Jacksonville, Florida, United States|QC Trials (Site 1117), 300 W. 41st Street, Ste. 203, Miami Beach, Florida, United States|Lakes Research (Site 1037), 5801 NW 151 Street, Miami Lakes, Florida, United States|Savin Medical Group, LLC. (Site 1212), 5789B NW. 151st Street, Miami Lakes, Florida, United States|Amber Clinical Research, LLC. (Site 1206), 9000 NE. 2nd Avenue, Miami Shores, Florida, United States|Advance Medical Research Center (Site 1193) 330 SW. 27th Ave., Ste. 701, Miami, Florida, United States|D&H National Research Centers (Site 1205), 8485 Bird Road, Miami, Florida, United States|Allied Biomedical Research Institute (Site 1227), 7100 SW. 47th St., Ste. 220, Miami, Florida, United States|Miami Clinical Research (Site 1089), 2400 SW. 69th Ave., Miami, Florida, United States|RM Medical Research, Inc. (Site 1230), 10346 W. Flagler St., Miami, Florida, United States|Pro Live Medical Research Corp (Site 1219), 12781 SW. 42nd Street, Miami, Florida, United States|Orlando Immunology Center (Site 1045), 1707 North Mills Avenue, Orlando, Florida, United States|Clintheory (Site 1203), 7350 Sandlake Commons Blvd., Orlando, Florida, United States|IMIC, Inc. (Site 1141), 18320 Franjo Rd, Palmetto Bay, Florida, United States|Family Clinical Trials (Site 1236), 1601 N. Palm Ave., Ste. 102, Pembroke Pines, Florida, United States|ETNA Medical Center (Site 1225), 7401 N. University Drive, Tamarac, Florida, United States|Moore Clinical Research, Inc. (Site 1164), 4257 W. Kennedy Blvd., Tampa, Florida, United States|Tampa General Hospital Family Care Center Healthpark (Site 1088), 5802 N. 30th Street, Tampa, Florida, United States|Infectious Disease Consultants of the Treasure Coast (Site 1171), 3735 11th Cir., Ste. 201, Vero Beach, Florida, United States|AIDS Research and Treatment Center of the Treasure Coast (Site 1095), 981 37th Place, Vero Beach, Florida, United States|Triple O Research Institute PA (Site 1121), 2580 Metrocentre Blvd., Ste. 4, West Palm Beach, Florida, United States|The Ponce de Leon Center (site 1015), 341 Ponce De Leon Avenue Northeast, Atlanta, Georgia, United States|Agile Clinical Rsearch Trials, LLC (Site 1051), 750 Hammond Drive, Atlanta, Georgia, United States|IACT Health (Site 1035), 800 Talbotton Road, Columbus, Georgia, United States|Renew Health Clinical Research, LLC. (Site 1161), 1550 Janmar Rd., Snellville, Georgia, United States|Snake River Research, PLLC (Site 1120), 2900 Cortez Ave., Idaho Falls, Idaho, United States|Metro Infectious Disease Consultants (Site 1106), 901 McClintock Dr., Ste. 201, Burr Ridge, Illinois, United States|Chicago Clinical Research Institute (Site 1132), 611 W. Roosevelt Rd., Chicago, Illinois, United States|Northwestern University (Site 1025), 645 North Michigan Ave, Chicago, Illinois, United States|Rush University Medical Center (Site 1017), 600 Paulina St., Chicago, Illinois, United States|University of Chicago (Site 1064), 5841 S. Maryland Ave., Chicago, Illinois, United States|Great Lakes Clinical Trials (Site 1049), 5149 N. Ashland Ave., Chicago, Illinois, United States|Roudebush VA Medical Center (Site 1217), 550 University Blv",Puerto Rico,Respiratory Diseases,1,2,869.0
2497.0,NCT04630015,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,,,,,Other: Survey Administration,"University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-08-31,01/08/23,2023-12-31,16/11/20,17/11/20,"University of California, San Francisco, San Francisco, California",United States,Respiratory Diseases,1,3,1217.0
2498.0,NCT04392778,Clinical Use of Stem Cells for the Treatment of Covid-19,,Recruiting,COVID-19,Pneumonia,Multiple Organ Failure,Corona Virus Infection,,,,Biological: MSC Treatment|Biological: Saline Control,SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi|Istinye University|Regenerative Medicine and Stem Cell Production Center Liv MedCell|Liv Hospital (Ulus),All,40 Years to 60 Years   (Adult),30.0,Other,Interventional,2020-01-04,01/07/20,2020-01-09,19/05/20,19/05/20,"Istinye University, Istanbul, Turkey|SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi, Istanbul",Turkey,Respiratory Diseases,1,4,5.0
2499.0,NCT04659200,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,,Completed,COVID-19,Thyroid Function Tests,Inflammation; Thyroid,Inflammatory Markers,,,,Diagnostic Test: Venous blood was collected for biochemistry testing.,Bezmialem Vakif University,All,"18 Years to 100 Years   (Adult, Older Adult)",20.0,Other,Observational,2020-01-09,05/12/20,2020-07-12,09/12/20,26/01/21,"Sabahattin Destek, Fatih, Istanbul",Turkey,Respiratory Diseases,1,4,185.0
2500.0,NCT04758273,A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: medium dosage inactivated SARS-CoV-2 vaccine|Biological: high dosage inactivated SARS-CoV-2 vaccine|Biological: Placebo,"Beijing Minhai Biotechnology Co., Ltd|Shenzhen Kangtai Biological Products Co., LTD|Jiangsu Province Centers for Disease Control and Prevention",All,"18 Years and older   (Adult, Older Adult)",180.0,Industry|Other,Interventional,2020-07-10,30/06/21,2022-02-28,17/02/21,17/02/21,"Jiangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,598.0
2501.0,NCT04420299,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Bemiparin,"Fundación de investigación HM|Syntax for Science, S.L",All,"18 Years and older   (Adult, Older Adult)",120.0,Other|Industry,Interventional,2020-04-06,31/03/21,2021-03-31,09/06/20,11/06/20,"Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario HM Puerta del Sur, Móstoles, Madrid",Spain,Respiratory Diseases,1,1,359.0
2502.0,NCT04525287,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,,Recruiting,Coronavirus Infection,COVID-19,,,,,,,"Second Affiliated Hospital, School of Medicine, Zhejiang University",All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-02-20,20/08/20,2020-08-20,25/08/20,25/08/20,"2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou, Zhejiang",China,Respiratory Diseases,1,2,182.0
2503.0,NCT04588441,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,,Not yet recruiting,Acute Respiratory Distress,,,,,,,Drug: Adenosine,University of Florida,All,"18 Years to 105 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-03,01/12/22,2022-01-12,19/10/20,22/01/21,,,Others,0,1,374.0
2504.0,NCT04568135,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,,Not yet recruiting,COVID-19,,,,,,,Other: survey,Siyan Clinical Corporation,All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-10-31,31/12/21,2021-12-31,29/09/20,14/10/20,,,Respiratory Diseases,1,1,426.0
2505.0,NCT04448743,Role of Microparticles in Covid-19 Infection,MICO,Not yet recruiting,COVID-19,,,,,,,Other: Blood sample,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",175.0,Other,Observational,2020-01-06,01/11/21,2021-01-11,26/06/20,26/06/20,,,Respiratory Diseases,1,1,371.0
2506.0,NCT04346017,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Cytokines dosage|Diagnostic Test: Complement dosage,Francis Corazza|Brugmann University Hospital,All,"Child, Adult, Older Adult",200.0,Other,Interventional,2020-03-20,01/12/20,2020-01-12,15/04/20,15/04/20,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,-68.0
2507.0,NCT04681755,Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection,REHABCOV,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",55.0,Other,Observational,2020-05-19,19/05/21,2021-05-19,23/12/20,28/12/20,"Strasbourg University Hospitals - Anesthesia and surgical resuscitation service, Strasbourg",France,Respiratory Diseases,1,1,365.0
2508.0,NCT04397666,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,P20/09,Recruiting,SARS-CoV Infection,Pinkeye,,,,,,Diagnostic Test: conjunctival RT PCR,Versailles Hospital,All,"18 Years and older   (Adult, Older Adult)",68.0,Other,Interventional,2020-05-15,15/09/20,2020-11-15,21/05/20,18/08/20,"Centre Hospitalier de versailles, Le Chesnay",France,Respiratory Diseases,1,2,184.0
2509.0,NCT04789226,Psychological Impact of Covid-19 Assiut University Hospital Experience,,Not yet recruiting,COVID-19,,,,,,,,Assiut University,All,"18 Years to 90 Years   (Adult, Older Adult)",239.0,Other,Observational,2021-01-03,01/03/22,2022-01-03,09/03/21,09/03/21,,,Respiratory Diseases,1,1,365.0
2510.0,NCT04447638,Percutaneous Tracheostomy With COVID-19,,Completed,Tracheostomy,,,,,,,Procedure: Tracheostomy with aerosol box in COVID-19 positive patients,Çanakkale Onsekiz Mart University,All,"18 Years to 90 Years   (Adult, Older Adult)",24.0,Other,Observational,2020-03-20,01/06/20,2020-01-06,25/06/20,24/09/20,"Canakkale Onsekiz Mart University, Canakkale",Turkey,Others,0,1,-74.0
2511.0,NCT04414293,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,COVRTE-19,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Radiation: Lung Low Dose Radiation,Hospital Provincial de Castellon,All,65 Years and older   (Older Adult),41.0,Other,Interventional,2020-01-10,31/07/21,2021-12-31,04/06/20,15/02/21,"Hospital Provincial de Castellon, Castellón De La Plana, Castellon",Spain,Respiratory Diseases,1,2,721.0
2512.0,NCT04797871,Resistance Training and Clinical Status in Patients With Post Discharge Symptoms After Covid-19,EXER-COVID,Enrolling by invitation,COVID-19,SARS-CoV2,"Fatigue Syndrome, Chronic","Stress, Psychological","Pain, Chronic",,,Behavioral: Resistance training|Behavioral: Standard care,Universidad Pública de Navarra|Fundacion Miguel Servet|Complejo Hospitalario de Navarra,All,18 Years to 60 Years   (Adult),100.0,Other,Interventional,2021-08-03,15/03/22,2022-03-15,15/03/21,15/03/21,"Robinson Ramírez-Vélez, Ph.D, Pamplona",Spain,"Mental Health, Respiratory Diseases",1,5,224.0
2513.0,NCT04479488,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),SARS-Brazil,"Active, not recruiting",COVID-19,SARS-CoV Infection,,,,,,Other: Hospital admission|Other: Non-hospitalization procedures,"Hospital Israelita Albert Einstein|Ministry of Health, Brazil",All,"18 Years and older   (Adult, Older Adult)",1587.0,Other,Observational,2020-07-27,30/03/21,2021-01-04,21/07/20,08/04/21,"Hospital de Emergencia Dr. Daniel Houly, Arapiraca, Alagoas, Brazil|Universidade Federal da Bahia, Vitória Da Conquista, Bahia, Brazil|Alencar Serviços Médicos Ltda, Barbalha, Ceará, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, Espirito Santo, Brazil|Hospital Santa Rita de Cássia, Vitória, Espirito Santo, Brazil|Fundação Educacional Lucas Machado, Belo Horizonte, Minas Gerais, Brazil|Fundação Hopitalar São Francisco de Assis, Belo Horizonte, Minas Gerais, Brazil|Hospital Santa Lucia, Poços De Caldas, Minas Gerais, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Santa Casa de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Municipal Vila Santa Catarina, São Paulo, Brazil|Hospital São Camilo - Ipiranga, São Paulo, Brazil|Hospital São Camilo - Pompéia, São Paulo",Brazil,Respiratory Diseases,1,2,161.0
2514.0,NCT04329546,Understanding COVID-19,,Recruiting,COVID-19,,,,,,,Other: NA (no intervention),"University Hospital, Geneva|University of Geneva, Switzerland",All,"Child, Adult, Older Adult",250.0,Other,Observational,2020-03-27,31/01/22,2022-03-31,01/04/20,13/04/20,"University Hospitals of Geneva, Geneva",Switzerland,Respiratory Diseases,1,1,734.0
2515.0,NCT04361396,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,LAPTRANSCOV,Recruiting,Coronavirus Infection,,,,,,,Other: Collection of samples,Centre Hospitalier René Dubos,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-16,01/06/21,2021-01-06,24/04/20,22/12/20,"CH Victor Dupouy, Argenteuil, France|CH Intercommunal, Créteil, France|Department of General and Digestive Surgery, Hospital René Dubos, Pontoise, France|Department of Gynecology-Obstetrics, Hospital René Dubos, Pontoise, France|CH Delafontaine, Saint-Denis",France,Respiratory Diseases,1,1,204.0
2516.0,NCT04597736,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),COVIDCOLLECT,Not yet recruiting,COVID-19,Contact Case,,,,,,"Biological: Biological collection with nasopharyngeal samples, saliva, blood, stool and urine","University Hospital, Clermont-Ferrand",All,"Child, Adult, Older Adult",100.0,Other,Interventional,2020-01-11,01/11/21,2022-01-02,22/10/20,22/10/20,"CHU de Clermont-Ferrand, Clermont-Ferrand",France,Respiratory Diseases,1,2,722.0
2517.0,NCT04355481,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,ENVIROREA,Recruiting,COVID-19,Viral Infection,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-04-17,17/10/20,2020-12-17,21/04/20,24/04/20,"Service de réanimation Hôpital Avicenne, Bobigny, France|Service de réanimation Hôpital Bichat, Paris, France|Service de réanimation Hôpital Tenon, Paris",France,Respiratory Diseases,1,2,244.0
2518.0,NCT04362111,Early Treatment of Cytokine Storm Syndrome in Covid-19,,Recruiting,Cytokine Storm,COVID-19,,,,,,Drug: Anakinra|Drug: Normal saline,University of Alabama at Birmingham,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-29,01/01/21,2021-01-03,24/04/20,11/09/20,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,2,158.0
2519.0,NCT04549636,COVID-19 Related Lung Ventilation and Perfusion Injury,,Recruiting,COVID-19,Asthma,Healthy,,,,,Other: V/Q SPECT-CT|Other: St. George's Respiratory Questionnaire (SGRQ)|Other: mMRC (Modified Medical Research Council) Dyspnea Scale|Other: Six-minute walk test (6MWT)|Other: Spirometry|Other: Plethysmography & DLCO|Other: Airwave Oscillometry,McMaster University|Research St. Joseph's - Hamilton|Cyclomedica Australia Pty Ltd,All,"18 Years and older   (Adult, Older Adult)",92.0,Other,Observational,2020-09-18,01/12/21,2021-01-12,16/09/20,24/09/20,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,Respiratory Diseases,1,3,116.0
2520.0,NCT04669925,COVID-19 Impact on the Lombardy Region's Emergency System,,"Active, not recruiting",COVID-19,,,,,,,,Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-01-09,01/07/21,2021-01-07,17/12/20,08/04/21,"Ospedale Papa Giovanni XXIII, Bergamo, Italy|Presidio Ospedaliero di Lodi, Lodi, Italy|Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy|Ospedale San Carlo Borromeo, Milan",Italy,Respiratory Diseases,1,1,364.0
2521.0,NCT04637893,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,COVID_CRC,Not yet recruiting,Colorectal Cancer,,,,,,,Other: Colonoscopy,Istituto Clinico Humanitas,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-12-16,31/03/21,2021-03-31,20/11/20,20/11/20,,,Cancers,1,1,105.0
2522.0,NCT04510194,Outpatient Treatment of COVID-19 With Metformin,,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Metformin|Drug: Placebo,"University of Minnesota|UnitedHealth Group|Northwestern University|Hennepin County Medical Center, Minneapolis|University of Colorado, Denver|Olive View-UCLA Education & Research Institute",All,"30 Years to 85 Years   (Adult, Older Adult)",750.0,Other|Industry,Interventional,2021-01-01,01/06/21,2021-01-08,12/08/20,21/02/21,"University of Minnesota, Minneapolis, Minnesota",United States,Respiratory Diseases,1,2,7.0
2523.0,NCT04652102,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults for COVID-19,,Recruiting,COVID-19,COVID-19,,,,,,Biological: CVnCoV|Biological: Placebo,CureVac AG,All,"18 Years and older   (Adult, Older Adult)",36500.0,Industry,Interventional,2020-12-14,05/03/21,2023-04-03,03/12/20,26/02/21,"Centre for Vaccinology - Ghent University Hospital, Ghent, Belgium|University Hospital, Cologne, Germany|Ludwig-Maximilians-Universität München, München, Germany|University Hospital Tübingen Institut für Tropenmedizin, Tübingen, Germany|Panamerican Clinical research Mexico (Guadalajara), Guadalajara, Mexico|Panamerican Clinical Research Mexico S.A. DE C.V., Juriquilla, Mexico|Unidad de Medicina Especializada SMA, San Juan Del Río, Mexico|Centro Medico Zambrano Hellion, San Pedro Garza Garcia, Mexico|Noordwest Ziekenhuisgroep, Alkmaar, Netherlands|Universitair Medische Centra - Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|University of Utrecht, Utrecht, Netherlands|Hospital de Chancay y Servicios básicos de Salud, Chancay, Peru|Centro de Investigación para ensayos Clínicos UPCH, Lima, Peru|OSI Eskerraldea-Enkarterri-Cruces/Hospital Universitario Cruces, Barakaldo, Spain|Hospital Universitario Donostia, Donostia-San Sebastián, Spain|Hospital Clínico San Carlos, Madrid",Spain,Respiratory Diseases,1,2,840.0
2524.0,NCT04419610,RAS and Coagulopathy in COVID19,,Recruiting,COVID-19,,,,,,,Biological: TRV027|Other: sodium chloride 0.9%,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-10,01/04/21,2021-01-06,05/06/20,19/03/21,"Imperial College NHS Trust, London",United Kingdom,Respiratory Diseases,1,1,118.0
2525.0,NCT04354805,Administration of Chlorpromazine as a Treatment for COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Chlorpromazine,Cairo University|Noha Mahmoud Nasreldin Hassan,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-08,01/10/20,2020-01-11,21/04/20,08/07/20,"Cairo University, Cairo",Egypt,Respiratory Diseases,1,1,3.0
2526.0,NCT04799691,Comparison of 2 Ventilatory Support Strategies During Coronavirus Disease 2019 (Covid-19) Pneumonia,STRATIC,Recruiting,COVID-19,,,,,,,Procedure: Invasive ventilation strategy|Procedure: Non-invasive ventilation strategies,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2021-01-02,01/12/21,2021-01-12,16/03/21,22/03/21,"Hôpital Sainte Musse, Toulon, Var",France,Respiratory Diseases,1,1,10.0
2527.0,NCT04689542,Surgical Face Mask Effects in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Other: Sit-To-Stand test,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-01,01/08/21,2021-01-08,30/12/20,28/01/21,"Cliniques universitaires Saint-Luc, Brussels",Belgium,Respiratory Diseases,1,1,7.0
2528.0,NCT04329650,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: Siltuximab|Drug: Methylprednisolone,Judit Pich Martínez|Fundacion Clinic per a la Recerca Biomédica,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-15,20/05/20,2020-05-20,01/04/20,17/04/20,"Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Hospital Universitari Mútua de Terrassa, Terrassa",Spain,Respiratory Diseases,1,1,35.0
2529.0,NCT04385901,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,,Completed,SARS-CoV 2,SARS Pneumonia,,,,,,Behavioral: Therapy Intervention,University of Missouri-Columbia,All,"18 Years and older   (Adult, Older Adult)",26.0,Other,Interventional,2020-05-19,19/09/20,2020-09-19,13/05/20,08/02/21,"Missouri Orthopedic Institute, Columbia, Missouri",United States,Respiratory Diseases,1,2,123.0
2530.0,NCT04727294,"MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey",,Recruiting,Multiple Myeloma,Smoldering Multiple Myeloma,Monoclonal Gammopathy of Undetermined Significance,Coronavirus,,,,Behavioral: Questionnaire,HealthTree Foundation|GlaxoSmithKline,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other|Industry,Observational,2021-01-22,01/06/21,2021-01-12,27/01/21,27/01/21,"HealthTree.org (Online), Lehi, Utah",United States,Respiratory Diseases,1,4,-10.0
2531.0,NCT04244591,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,,Completed,COVID-19,,,,,,,Drug: methylprednisolone therapy|Other: Standard care,Peking Union Medical College Hospital|Zhongda Hospital|Zhongnan Hospital|Renmin Hospital of Wuhan University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-01-26,13/04/20,2020-04-13,28/01/20,16/06/20,"Medical ICU,Peking Union Medical College Hospital, Beijing, Beijing",China,Respiratory Diseases,1,1,78.0
2532.0,NCT04450277,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,,Completed,COVID-19,Emergency Surgery,,,,,,Procedure: Emergency surgery,Khoo Teck Puat Hospital,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-01-04,31/05/20,2020-05-31,29/06/20,07/07/20,"Khoo Teck Puat Hospital, Singapore",Singapore,Respiratory Diseases,1,2,148.0
2533.0,NCT04487574,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,,Completed,COVID-19,,,,,,,Drug: XC221|Drug: Placebo,RSV Therapeutics LLC,All,"18 Years to 75 Years   (Adult, Older Adult)",118.0,Industry,Interventional,2020-07-25,29/10/20,2020-10-29,27/07/20,13/11/20,"Regional State Budgetary Institution of Healthcare City Hospital No. 5, Barnaul, Barnaul, Altai Region, Russian Federation|State Budgetary Institution of Healthcare of Moscow Region Zhukovskaya City Clinical Hospital, Zhukovskiy, Moscow Region, Russian Federation|Municipal Budgetary Institution of Healthcare Central City Hospital of Novoshakhtinsk, Novoshakhtinsk, Rostov Region, Russian Federation|State Budgetary Institution of Healthcare of Moscow City Clinical Hospital No. 15 of the Moscow Department of Healthcare, Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation (Sechenov University), Department of Faculty Therapy No. 2, Moscow, Russian Federation|State Budgetary Institution of Healthcare of Moscow City Clinical Hospital No. 52 of the Moscow Department of Healthcare, Moscow, Russian Federation|State Budgetary Institution of Healthcare of Moscow City Clinical Hospital No. 40 of the Moscow Department of Healthcare, Moscow, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare City Multidisciplinary Hospital, Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare City Hospital No. 40 of Kurortny District, Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare City Hospital No. 15, Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare City Pokrovskaya Hospital (4th Cardiology Department), Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Institution of Healthcare City Pokrovskaya Hospital, Saint Petersburg, Russian Federation|Regional State Budgetary Institution of Healthcare Medical-Sanitary Unit No. 2, Tomsk",Russian Federation,Respiratory Diseases,1,1,96.0
2534.0,NCT04447222,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,,Recruiting,COVID-19,Malignant Solid Neoplasm,,,,,,Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Survey Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"Child, Adult, Older Adult",1242.0,Other|NIH,Observational,2020-12-05,21/07/21,2021-07-21,25/06/20,25/06/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,2,228.0
2535.0,NCT04820751,Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial,,Not yet recruiting,Viral Pneumonia,Serotonin Syndrome,Platelet Dysfunction,,,,,Drug: Cyproheptadine Hydrochloride 4 MG,Ciusss de L'Est de l'Île de Montréal|Covid-19 Early Treatment Fund,All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Other,Interventional,2021-10-04,01/11/21,2022-01-01,29/03/21,02/04/21,,,Respiratory Diseases,1,3,89.0
2536.0,NCT04362085,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,,Recruiting,COVID-19,,,,,,,Drug: Therapeutic Anticoagulation,Unity Health Toronto|University of Vermont Medical Center,All,"18 Years and older   (Adult, Older Adult)",462.0,Other,Interventional,2020-11-05,01/03/22,2022-01-04,24/04/20,29/01/21,"St. Michael's Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,1,425.0
2537.0,NCT04609085,SARS-COV2 Pandemic Serosurvey in a Rare Disease Population,,Enrolling by invitation,SARS-COV2 Virus,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"up to 89 Years   (Child, Adult, Older Adult)",5000.0,NIH,Observational,2021-04-19,30/04/23,2023-04-30,30/10/20,14/04/21,"National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States|University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,1,741.0
2538.0,NCT04273529,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: thalidomide|Drug: placebo,First Affiliated Hospital of Wenzhou Medical University|Second Affiliated Hospital of Wenzhou Medical University|Wenzhou Central Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-02-20,30/05/20,2020-06-30,18/02/20,21/02/20,,,Respiratory Diseases,1,1,131.0
2539.0,NCT04344730,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,COVIDICUS,"Active, not recruiting",Acute Hypoxemic Respiratory Failure,COVID-19,,,,,,Drug: Dexamethasone injection|Drug: placebo|Procedure: conventional oxygen|Procedure: CPAP|Procedure: HFNO|Procedure: mechanical ventilation,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",550.0,Other,Interventional,2020-10-04,31/12/21,2021-12-31,14/04/20,09/02/21,"Hopital Bichat - Aphp, Paris",France,Respiratory Diseases,1,2,453.0
2540.0,NCT04518969,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,,Recruiting,COVID-19,,,,,,,Device: CytoSorb,Dr David DE BELS|Brugmann University Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-03-05,01/12/20,2020-01-12,19/08/20,19/08/20,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,-53.0
2541.0,NCT04360980,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Colchicine Tablets,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-03-20,01/09/21,2021-11-30,24/04/20,31/12/20,"SBMU, Tehran, Iran, Islamic Republic of|Nooshin Dalili, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,620.0
2542.0,NCT04470999,Changes in Cellular Immune Profile During COVID-19 Infection,,Recruiting,COVID-19,COVID-19,,,,,,Other: Leukapheresis,"Serhat Gumrukcu, MD PhD|The Scripps Research Institute|Seraph Research Institute",All,18 Years to 60 Years   (Adult),25.0,Other,Interventional,2020-04-15,30/09/21,2021-12-31,14/07/20,17/03/21,"Seraph Research Institute, Los Angeles, California",United States,Respiratory Diseases,1,2,625.0
2543.0,NCT04746183,AGILE (Early Phase Platform Trial for COVID-19),,Recruiting,COVID-19,,,,,,,Drug: CST-2: EIDD-2801|Drug: CST-2: Placebo|Drug: Nitazoxanide|Drug: VIR-7832|Drug: VIR-7831|Drug: CST-5: Placebo,University of Liverpool|University of Southampton|Liverpool School of Tropical Medicine|Lancaster University|Liverpool University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-03-07,18/11/21,2022-04-30,09/02/21,13/04/21,"Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton",United Kingdom,Respiratory Diseases,1,1,784.0
2544.0,NCT04366934,Study of the Pathogenesis of Olfactory Disorders in COVID-19,COVIDSMELL,Completed,Coronavirus Infection,Severe Acute Respiratory Syndrome,Sars-CoV2,,,,,Other: Nasal swab|Other: Taste and olfactory function evaluation,"Institut Pasteur|Hôpital Lariboisière, AP-HP",All,"18 Years and older   (Adult, Older Adult)",26.0,Industry|Other,Observational,2020-04-05,29/10/20,2020-10-29,29/04/20,29/01/21,"Hôpital Lariboisière, Policlinique, Paris, France|Hôpital Lariboisière, Service ORL, Paris",France,Respiratory Diseases,1,3,207.0
2545.0,NCT04358549,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: Favipiravir + Standard of Care|Drug: Standard of Care,"Fujifilm Pharmaceuticals U.S.A., Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Industry,Interventional,2020-04-17,01/11/20,2021-01-05,24/04/20,05/02/21,"HonorHealth, Scottsdale, Arizona, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Boston Medical Center, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|UMass Memorial Health Care, Worcester, Massachusetts, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,1,263.0
2546.0,NCT04553055,Antibiotic Misuse During COVID-19 Pandemic,,Completed,COVID-19,,,,,,,Other: online questionnaires,Beni-Suef University,All,"20 Years and older   (Adult, Older Adult)",413.0,Other,Observational,2020-07-20,15/09/20,2020-09-15,17/09/20,10/12/20,"BeniSuefU, Cairo, BeniSuef",Egypt,Respiratory Diseases,1,1,57.0
2547.0,NCT04685629,Covid-19 Long-term Revalidation Follow-up,Colonel,Recruiting,COVID-19,,,,,,,Diagnostic Test: 25 post ICU-patients|Other: 25 post non-ICU patients,"University Hospital, Antwerp",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-07-05,22/05/22,2022-01-12,28/12/20,04/02/21,"Antwerp University Hospital, Edegem, Antwerpen",Belgium,Respiratory Diseases,1,1,556.0
2548.0,NCT04395742,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",TMX COVID,Not yet recruiting,Coronavirus Disease 2019,,,,,,,Other: Data collection,Poitiers University Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",93.0,Other,Observational,2020-01-05,01/12/20,2020-01-12,20/05/20,20/05/20,,,Respiratory Diseases,1,1,7.0
2549.0,NCT04475601,Enzalutamide Treatment in COVID-19,COVIDENZA,Recruiting,COVID-19,Corona Virus Infection,,,,,,Drug: Enzalutamide Pill,"Andreas Josefsson|Umeå University|Sahlgrenska University Hospital, Sweden|University Hospital, Umeå|Uppsala University Hospital|Skane University Hospital|Jonkoping County Hospital|Sundsvall Hospital|Helsingborgs Hospital|Göteborg University|Astellas Pharma Europe Ltd.|Norrlands University Hospital|Västerbotten County Council",All,"50 Years and older   (Adult, Older Adult)",500.0,Other|Industry,Interventional,2020-07-15,08/07/21,2022-08-05,17/07/20,17/07/20,"Anders Bjartell, Malmö, Skåne, Sweden|Ryhovs Hospital, Jönköping, Småland",Sweden,Respiratory Diseases,1,2,751.0
2550.0,NCT04347369,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,,Recruiting,COVID-19,,,,,,,Other: other,Xinqiao Hospital of Chongqing,All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-17,30/08/20,2020-12-31,15/04/20,14/07/20,"Xinqiao Hospital of Chongqing, Chongqing",China,Respiratory Diseases,1,1,349.0
2551.0,NCT04591613,Late Clinical Events Associated With COVID-19 Infection,COCO-LATE,Recruiting,COVID-19,,,,,,,Other: Questionnaire|Other: Biocollection|Other: Follow-up visit,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-12-31,01/08/22,2022-01-08,19/10/20,28/01/21,"Ch Auxerre, Auxerre, France|CHU Caen, Caen, France|CHRU Lille, Lille, France|CH Melun Marc Jacquet, Melun, France|AP-HP Hôpital Hôtel-Dieu, Paris, France|CHU de Saint-Etienne, Saint-Priest-en-Jarez, France|CH Tourcoing, Tourcoing, France|CHRU Tours, Tours, France|CHRU Nancy, Vandœuvre-lès-Nancy, France|Centre Hospitalier Bretagne Atlantique, Vannes, France|CH André Rosemon de Cayenne, Cayenne",French Guiana,Respiratory Diseases,1,1,373.0
2552.0,NCT04379440,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),GEROCOVIDobs,Recruiting,COVID-19,,,,,,,,Raffaele Antonelli Incalzi|Italian Society of Gerontology and Geriatrics|BLUECOMPANION FRANCE|BLUECOMPANION LTD|Campus Bio-Medico University,All,"60 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-04-25,30/09/20,2020-11-30,07/05/20,07/05/20,"RSA La Quiete, Castiglione Cosentino, Calabria, Italy|ASP Catanzaro, Catanzaro Lido, Calabria, Italy|AOU Ferrara, Ferrara, Emilia Romagna, Italy|Policlinico Campus Bio-Medico, Rome, Roma, Italy|AOU Careggi, Firenze, Toscana, Italy|AOU Pisana Geriatria, Pisa, Toscana, Italy|Ospedale di Comunita' ULSS 6 Euganea- COVID Center, Camposampiero, Veneto",Italy,Respiratory Diseases,1,1,219.0
2553.0,NCT04780295,COvid-19 REgistry on THROMBOSIS Complications,CORE-THROMB,Recruiting,COVID-19,,,,,,,,"Prof. Stavros Konstantinides, MD|University of Zurich|Johannes Gutenberg University Mainz",All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-04-15,01/12/21,2021-01-12,03/03/21,03/03/21,"Unicamp (Universidade Estadual de Campinas; University of Campinas), Campinas, Brazil|Hospital Sírio-Libanês, São Paulo, Brazil|Hospital de Campanha Anhembi, São Paulo, Brazil|Amager and Hvidovre Hospital, Hvidovre, Denmark|DRK Kliniken Berlin Köpenick, Berlin Köpenick, Germany|DRK Kliniken Berlin Westend, Berlin Westend, Germany|Universitätsklinikum Koeln, Cologne, Germany|Augusta-Krankenhaus Duesseldorf, Duesseldorf, Germany|Universitäts-Herzzentrum Freiburg, Freiburg, Germany|Universitätsklinikum des Saarlandes und Medizinische Fakultät der Universität des Saarlandes, Homburg, Germany|Universitätsmedizin Mainz, Mainz, Germany|Krankenhaus Neuwittelsbach, Munich, Germany|Paracelsus Medizinische Privatuniversität am Klinikum Nuernberg, Nuremberg, Germany|Mater Misericordiae University Hospital, Dublin, Ireland|University of Bologna, Bologna, Italy|Azienda Socio Sanitaria Territoriale (ASST) Lariana, Como, Italy|Ospedale Sacra Famiglia Fatebenefratelli, Erba, Italy|Presidio Ospedaliero Santa Croce di Fano, Fano, Italy|IRCCS Ospedale Policlinico San Martino, Genova, Italy|Ospedale Civile di Guastalla - Azienda Unità Sanitaria Locale (AUSL) Reggio Emilia, Guastalla, Italy|Azienda Ospedaliera di Padova, Padova, Italy|Ospedale Maggiore di Parma - Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Ospedale Maggiore di Parma - Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Ospedale Civile di Castel San Giovanni - Azienda Unità Sanitaria Locale (AUSL) di Piacenza, Piacenza, Italy|Santa Maria Nuova Hospital - Azienda Unità Sanitaria Locale (AUSL) IRCCS di Reggio Emilia, Reggio Emilia, Italy|IRCCS Humanitas Clinical and Research Hospital, Rozzano, Italy|Università degli studi dell' Insubria (University of Insubria), Varese, Italy|Instituto Nacional de Cardiologia Ignacio Chavez (National Institute of Cardiology Igancio Chavez), Mexico City, Mexico|Hospital Quirónsalud, Málaga, Spain|Erdem Medical Center, Istanbul",Turkey,Respiratory Diseases,1,1,272.0
2554.0,NCT04710771,Effect of Prone Positioning in Patients With COVID-19,,Completed,COVID-19,,,,,,,Other: Prone Lying Position|Other: alternate nostril breathing,Sialkott College of Physical Therapy,All,"40 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Observational,2020-11-23,15/01/21,2021-01-29,15/01/21,09/02/21,"DHQ Hospital, Faisalabad, Punjab",Pakistan,Respiratory Diseases,1,1,67.0
2555.0,NCT04355936,Telmisartan for Treatment of COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: Telmisartan arm will receive 80 mg Telmisartan twice daily plus standard care.,"Laboratorio Elea Phoenix S.A.|Carlos R. Rojo, MD|Facultad de Medicina, Universidad de Buenos Aires, UBA",All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|Other,Interventional,2020-05-19,02/11/20,2020-11-30,21/04/20,24/12/20,"Hospital de Clínicas 'José de San Martín', Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Ciudad De Buenos Aires, Argentina|Hospital Español de Buenos Aires, Ciudad Autonoma de Buenos Aires",Argentina,Respiratory Diseases,1,1,195.0
2556.0,NCT04747405,Evaluation of Psychological Impact of Group Therapy for Patients Who Have Been Hospitalized in Intensive Care During COVID-19 Pandemic: Exploratory Study,GPR COVID,Not yet recruiting,Intensive Care Unit Syndrome,COVID-19,Anxiety,Depression,,,,Other: therapy group,Centre Hospitalier Metropole Savoie,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-02-22,22/06/22,2022-08-22,10/02/21,15/02/21,,,"Mental Health, Respiratory Diseases",1,4,546.0
2557.0,NCT04401423,TXA127 for the Treatment of Severe COVID-19,,Recruiting,COVID-19,,,,,,,Drug: TXA127|Drug: Placebo,Columbia University|Constant Therapeutics LLC,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-10-02,01/06/21,2021-01-12,26/05/20,02/04/21,"Columbia University Irving Medical Center, New York, New York",United States,Respiratory Diseases,1,1,-263.0
2558.0,NCT04735757,"Effects of COVID-19 Infection and Critical Illness on Diaphragm Tissue Characteristics and Movement, Visualized With MRI",,Recruiting,Diaphragm Disease,COVID-19,,,,,,Other: Contrast-enhanced MRI|Other: Measurement of respiratory muscle force,VU University Medical Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2021-03-02,19/01/23,2023-01-19,03/02/21,18/03/21,"Amsterdam UMC, location VUmc, Amsterdam, Noord-Holland",Netherlands,Respiratory Diseases,1,2,688.0
2559.0,NCT04391712,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,,Completed,COVID-19,,,,,,,Device: MLS Laser|Other: Regular Inpatient Medical Care,Lowell General Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-30,15/05/20,2020-07-16,18/05/20,05/08/20,"Lowell General Hospital, Lowell, Massachusetts",United States,Respiratory Diseases,1,1,77.0
2560.0,NCT04470297,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,,Not yet recruiting,COVID-19,Lung Injury,,,,,,Drug: Ramelteon 8mg,Associação Fundo de Incentivo à Pesquisa,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-09,01/11/20,2021-01-03,14/07/20,24/07/20,,,Respiratory Diseases,1,2,360.0
2561.0,NCT04708912,Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19),8796,Recruiting,COVID-19,,,,,,,Other: Observation,Basaksehir Cam & Sakura Şehir Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-12-15,30/03/21,2021-01-04,14/01/21,24/03/21,"Bakirkoy Dr.sadi Konuk Training and Research Hospital, Istanbul, Turkey|Bakirkoy Dr.sadi Konuk Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,20.0
2562.0,NCT04661527,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,STRIKESARS,Recruiting,COVID-19,,,,,,,Drug: Sarilumab,"Clinica Universidad de Navarra, Universidad de Navarra|Sanofi|Hospital Universitario Infanta Leonor",All,"18 Years and older   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2020-04-22,30/12/20,2020-12-30,10/12/20,16/12/20,"Clínica Universidad de Navarra, Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario Infanta Leonor, Madrid",Spain,Respiratory Diseases,1,1,252.0
2563.0,NCT04681157,Retrospective Study on Anosmias and Ageusias Linked to Infection by Covid-19,STras-Cov-2,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-03-04,03/04/21,2021-03-04,23/12/20,28/12/20,"Strasbourg University Hospitals - Otorhino-Laryngology Department, Strasbourg, Starsbourg",France,Respiratory Diseases,1,1,365.0
2564.0,NCT04475068,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,,Recruiting,Sars-CoV2,ARDS,,,,,,Procedure: Lateral Position (left and right lateral decubitus),Hospital Nacional Edgardo Rebagliati Martins|Universidad de Piura,All,"18 Years and older   (Adult, Older Adult)",12.0,Other,Observational,2020-07-17,01/09/20,2020-01-10,17/07/20,01/09/20,"Hospital Rebagliati, Jesús María, Lima",Peru,Respiratory Diseases,1,2,-189.0
2565.0,NCT04466241,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,INTENSE-COV,Recruiting,COVID-19,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,Drug: Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet|Drug: Telmisartan 40Mg Oral Tablet|Drug: Atorvastatin 20 Mg Oral Tablet,"ANRS, Emerging Infectious Diseases|Université de Bordeaux|PACCI Program",All,"18 Years and older   (Adult, Older Adult)",294.0,Other,Interventional,2020-11-27,26/03/21,2021-03-26,10/07/20,04/02/21,"Service des Maladies Infectieuses et Tropicales, Centre Hospitalier et Universitaire (CHU) Treichville, Abidjan, Côte D'Ivoire|Centre de Traitement des Maladies Infectieuses (CTMI), CHU de Yopougon, Abidjan",Côte D'Ivoire,Respiratory Diseases,1,3,119.0
2566.0,NCT04335201,Defibrotide in COVID-19 Pneumonia,DEFI-VID19,Recruiting,COVID-19,,,,,,,Drug: Defibrotide Injection,IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-20,20/06/21,2021-08-31,06/04/20,16/02/21,"Ospedale San Raffaele, Milano, Lombardia",Italy,Respiratory Diseases,1,1,468.0
2567.0,NCT04530682,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,COVIDRIC 2,Recruiting,Rheumatoid Arthritis,,,,,,,,"University Hospital, Montpellier|French Society of Rheumatology",All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2021-05-03,20/07/23,2024-01-07,28/08/20,11/03/21,"Centre hopsitalier universitaire de Montpellier, Montpellier, Occitanie",France,Immunological Disorders,1,1,979.0
2568.0,NCT04589949,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),CoV-Early,Recruiting,COVID-19,,,,,,,Biological: ConvP|Biological: FFP,Erasmus Medical Center|Sanquin Plasma Products BV|ZonMw: The Netherlands Organisation for Health Research and Development|Leiden University Medical Center,All,"50 Years and older   (Adult, Older Adult)",690.0,Other,Interventional,2020-12-10,01/11/22,2023-01-11,19/10/20,19/10/20,"Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|Meander Medisch Centrum, Amersfoort, Netherlands|Rijnstate Ziekenhuis, Arnhem, Netherlands|Amphia Ziekenhuis, Breda, Netherlands|Groene Hart Ziekenhuis, Gouda, Netherlands|University Medical Center Groningen (UMCG), Groningen, Netherlands|Spaarne Gasthuis, Haarlem, Netherlands|Medisch Centrum Leeuwarden, Leeuwarden, Netherlands|Leids Universitair Medisch Centrum, Leiden, Netherlands|Sint Antonius Ziekenhuis, Nieuwegein, Netherlands|Bernhoven Hospital, Uden",Netherlands,Respiratory Diseases,1,1,762.0
2569.0,NCT04315896,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),HYDRA,"Active, not recruiting",COVID-19,Severe Acute Respiratory Syndrome,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"National Institute of Respiratory Diseases, Mexico|Sanofi",All,"18 Years to 80 Years   (Adult, Older Adult)",500.0,Other|Industry,Interventional,2020-04-14,01/07/20,2020-08-15,20/03/20,27/07/20,"Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío Villegas, Mexico, City",Mexico,Respiratory Diseases,1,2,123.0
2570.0,NCT04480398,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,,Completed,COVID-19,Asymptomatic Condition,,,,,,Drug: Guduchi Ghan Vati,"Aarogyam UK|Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University|Samta Ayurveda Prakoshtha, India",All,"18 Years to 75 Years   (Adult, Older Adult)",91.0,Other,Observational,2020-12-05,15/06/20,2020-03-07,21/07/20,22/07/20,"Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan",India,Respiratory Diseases,1,2,-273.0
2571.0,NCT04279899,The Investigation of the Neonates With or With Risk of COVID-19,,Recruiting,Neonatal Infection,Perinatal Problems,Infectious Disease,,,,,,Children's Hospital of Fudan University,All,up to 28 Days   (Child),100.0,Other,Observational,2020-01-02,30/11/23,2023-12-31,21/02/20,09/03/21,"Maternal and Child Health Hospital of Hubei Province, Wuhan, Hubei, China|Children Hospital of Fudan University, Shanghai, Shanghai",China,Others,0,3,1459.0
2572.0,NCT04784559,Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection,Neptuno,Not yet recruiting,COVID-19,,,,,,,Drug: Plitidepsin|Drug: Dexamethasone|Drug: Remdesivir,PharmaMar,All,"18 Years and older   (Adult, Older Adult)",609.0,Industry,Interventional,2021-01-03,01/08/21,2021-01-08,05/03/21,09/03/21,"Hospital General de Agudos, Buenos Aires, Argentina|Hospital Muñiz, Ciudad autónoma de Buenos Aires, Argentina|Hospital Felício Rocho, Belo Horizonte, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, São Bernardo Do Campo, Brazil|University Multiprofile Hospital for Active Treatment Sveta Ekaterina EAD, Dimitrovgrad, Bulgaria|Specialized Hospital for Active Treatment of Pneumo-Phthisiatric Diseases - Haskovo, Haskovo, Bulgaria|SHATPPD Dr. Dimitar Gramatikov, Ruse Ltd., Ruse, Bulgaria|MHAT Sveta Anna - Sofia AD, Sofia, Bulgaria|Azienda Ospedaliera di Rilievo Nazional Santobono Pausilipon, Napoli, Italy|Istituto Nazionale per le Malattie Infettive IRCCS Lazzaro Spallanzani, Roma, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Hospital Central Universitario de Chihuahua, Chihuahua, CHH, Mexico|Sanatorio Palmore, A.C., Chihuahua, CHH, Mexico|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, DIF, Mexico|niversidad Autonoma de Nuevo Leon - Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, NL, Mexico|Hospital Alberto Sabogal Sologuren, Bellavista, Lima, Peru|Hospital de Chancay, Chancay, Lima, Peru|Hospital Militar Central, Lima, Peru|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitario HM Montepríncipe, Boadilla Del Monte, Madrid, Spain|Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Quirón Madrid, Pozuelo De Alarcón, Madrid, Spain|Hospital Civil de Guadalajara, Guadalajara, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario Virgen del Rocío, Sevilla",Spain,Respiratory Diseases,1,1,5.0
2573.0,NCT04368208,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,DEPRECOVID,Completed,Postnatal Depression,,,,,,,Other: Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery,Poitiers University Hospital,Female,18 Years to 50 Years   (Adult),501.0,Other,Observational,2020-04-29,21/10/20,2020-11-27,29/04/20,26/01/21,"Bertrand GACHON, Poitiers",France,Mental Health,1,1,212.0
2574.0,NCT04751721,"Oxidative Stress Parameters, Trace Element and Quality of Life in Women Before and After Covid-19 Vaccines",,Not yet recruiting,COVID-19,,,,,,,Biological: CoronoVac Vaccine,Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,Female,"35 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-02,01/03/21,2021-01-04,12/02/21,12/02/21,"Kadirhan Ozdemir, İzmir",Turkey,Respiratory Diseases,1,1,2.0
2575.0,NCT04342104,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,,Recruiting,Respiratory Failure,COVID-19,,,,,,Other: Monitoring for aggravation|Other: Evaluate HACOR score effectivity in this patients,Hospital General Universitario Morales Meseguer,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,31/07/21,2021-11-15,10/04/20,16/02/21,"Hospital General Universitario Morales Meseguer, Murcia",Spain,Respiratory Diseases,1,2,681.0
2576.0,NCT04354753,AiM COVID for Covid 19 Tracking and Prediction,,Completed,COVID-19,,,,,,,Other: No Intervention,Aarogyam UK|University of Warwick|Igor Sikorsky Kyiv Polytechnic Institute|ClickMedix LLC,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-03-28,14/04/20,2020-04-17,21/04/20,21/04/20,"Aarogyam (UK), Leicester",United Kingdom,Respiratory Diseases,1,1,20.0
2577.0,NCT04617483,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",,Recruiting,COVID-19,,,,,,,"Biological: Two doses of commercial scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14|Biological: Two doses of pilot scale inactivated SARS-CoV-2 vaccine at the schedule of day 0,14 in elderly","Sinovac Research and Development Co., Ltd.|Sinovac Biotech Co., Ltd",All,"18 Years and older   (Adult, Older Adult)",1040.0,Industry,Interventional,2020-10-31,28/11/20,2021-05-31,05/11/20,05/11/20,"Dafeng District Center for Disease Prevention and Control, Yancheng, Jiangsu",China,Respiratory Diseases,1,1,212.0
2578.0,NCT04459975,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,,Recruiting,on Occurrence of Acurate Kidney Injury During Intensive Care Unit,Abnormalities of Urinary Analysis,,,,,,Other: Non interventional study,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-04,01/10/20,2020-01-11,07/07/20,07/07/20,"Intensive care units attached to the Hospices Civils de Lyon (HCL), Lyon",France,Others,0,2,7.0
2579.0,NCT04352803,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,,Not yet recruiting,COVID-19,Cyotokine Storm,,,,,,Biological: Autologous Adipose MSC's,Regeneris Medical,All,"18 Years to 90 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-04,01/04/24,2026-01-04,20/04/20,21/04/20,,,Respiratory Diseases,1,2,2192.0
2580.0,NCT04358614,Baricitinib Therapy in COVID-19,,Completed,COVID-19,Pneumonia,,,,,,Drug: Baricitinib 4 MG Oral Tablet,Fabrizio Cantini|Hospital of Prato,All,"18 Years to 85 Years   (Adult, Older Adult)",12.0,Other,Interventional,2020-03-16,05/04/20,2020-07-04,24/04/20,24/04/20,"Fabrizio Cantini, Prato, Tuscany",Italy,Respiratory Diseases,1,2,110.0
2581.0,NCT04425382,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,DOLCI,Recruiting,Coronavirus,COVID-19,Pneumonia,,,,,Drug: Darunavir/Cobicistat|Drug: Lopinavir/Ritonavir,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Observational,2020-01-03,01/07/20,2020-01-09,11/06/20,11/06/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,3,6.0
2582.0,NCT04686747,COVID - 19 and Advanced Gastro-intestinal Cancer Treatment,COVID - AGICT,Enrolling by invitation,Pancreatic Cancer,Gastric Cancer,Esophagus Cancer,Colorectal Cancer,,,,,S.M. Misericordia Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",2000.0,Other,Observational,2021-01-01,01/03/21,2021-06-30,29/12/20,29/12/20,"Department of General and Emergency Surgery. Misericordia Hospital. Director: Coratti Andrea, MD, Grosseto, Tuscany",Italy,Cancers,1,4,180.0
2583.0,NCT04726371,Best Practices to Prevent COVID-19 Illness in Staff and People With Serious Mental Illness and Developmental Disabilities in Congregate Living Settings,,Recruiting,Intellectual Disability,Developmental Disability,Axis I Diagnosis,Mental Illness,COVID-19,Coronavirus,,Behavioral: Generic Best Practices|Behavioral: Tailored Best Practices,"Massachusetts General Hospital|Patient-Centered Outcomes Research Institute|Advocates|Bay Cove Human Services|North Suffolk Mental Health Association|Open Sky Community Services|Riverside Community Care, Inc.|Dartmouth College|Vinfen Corporation",All,"18 Years and older   (Adult, Older Adult)",5350.0,Other,Interventional,2021-08-01,01/10/22,2022-01-10,27/01/21,27/01/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,6,162.0
2584.0,NCT04380727,Almitrine and COVID-19 Related Hypoxemia,,Completed,COVID-19,Hypoxic Respiratory Failure,,,,,,,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",17.0,Other,Observational,2020-03-20,14/04/20,2020-04-25,08/05/20,30/07/20,"Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy",France,Respiratory Diseases,1,2,36.0
2585.0,NCT04359329,Estrogen Patch for COVID-19 Symptoms,,Recruiting,COVID-19,,,,,,,Drug: Estradiol patch,Sharon Nachman|Stony Brook University,All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Interventional,2020-04-20,15/11/20,2020-11-15,24/04/20,24/04/20,"Stony Brook University Hospital, Stony Brook, New York",United States,Respiratory Diseases,1,1,209.0
2586.0,NCT04371822,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,SnPPIX,Not yet recruiting,COVID-19,,,,,,,Drug: SnPP Protoporphyrin plus Sunlight exposure|Drug: Sulfonatoporphyrin(TPPS) plus Sunlight exposure.|Other: placebo,Kafrelsheikh University,All,"18 Years to 80 Years   (Adult, Older Adult)",56.0,Other,Interventional,2020-01-08,01/10/20,2020-01-11,01/05/20,24/06/20,"Kafr El-sheikh University, Cairo, Kafr El-sheikh",Egypt,Respiratory Diseases,1,1,3.0
2587.0,NCT04729374,COVID-19 Vaccine Induced Adaptive Immune Responses,,Recruiting,COVID-19,Vaccine,COVID-19,,,,,,The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School,All,18 Years to 59 Years   (Adult),200.0,Other,Observational,2021-01-27,31/12/23,2023-12-31,28/01/21,05/02/21,"Nanjing Drum Tower Hospital, Nanjing, Jiangsu",China,Respiratory Diseases,1,3,1068.0
2588.0,NCT04517695,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Device: BVA-100,NYU Langone Health,All,"18 Years to 95 Years   (Adult, Older Adult)",30.0,Other,Observational,2020-01-08,01/02/21,2021-01-02,18/08/20,18/08/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,2,360.0
2589.0,NCT04338074,TXA and Corona Virus 2019 (COVID19) in Outpatients,TCOutpatient,Recruiting,COVID-19,,,,,,,Drug: Tranexamic acid tablets|Drug: Placebo oral tablet,University of Alabama at Birmingham,All,"19 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-06,15/12/21,2021-12-31,08/04/20,16/02/21,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,1,725.0
2590.0,NCT04454398,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,,Withdrawn,COVID-19,,,,,,,Biological: COVI-GUARD|Other: Standard of Care|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-09,01/01/21,2021-01-01,01/07/20,08/01/21,,,Respiratory Diseases,1,1,358.0
2591.0,NCT04375046,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Bacterial ACE2,Not yet recruiting,COVID-19,,,,,,,Drug: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2),Kafrelsheikh University,All,"18 Years to 80 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-01-09,01/09/20,2020-01-10,05/05/20,30/09/20,,,Respiratory Diseases,1,1,1.0
2592.0,NCT04805671,Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19,STAMP,Recruiting,COVID-19,,,,,,,Drug: ADG20|Drug: Normal saline,"Adagio Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",1728.0,Industry,Interventional,2021-01-03,01/12/21,2023-01-01,18/03/21,30/03/21,"Adagio Investigative site, Miami Lakes, Florida, United States|Adagio Investigative site, Miami, Florida, United States|Adagio Investigative site, Atlanta, Georgia",United States,Respiratory Diseases,1,1,728.0
2593.0,NCT04830852,Pediatric SARS-CoV-2 and MIS-C Long-term Follow-up,,Not yet recruiting,COVID-19,,,,,,,,Children's National Research Institute|National Institute of Allergy and Infectious Diseases (NIAID),All,"up to 21 Years   (Child, Adult)",5000.0,Other|NIH,Observational,2021-01-05,01/05/24,2027-01-05,05/04/21,05/04/21,,,Respiratory Diseases,1,1,2191.0
2594.0,NCT04537572,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: comparison of sample collection methods,Salveo Diagnostics,All,"18 Years to 99 Years   (Adult, Older Adult)",300.0,Industry,Interventional,2020-01-09,01/09/22,2022-01-09,03/09/20,03/09/20,,,Respiratory Diseases,1,1,731.0
2595.0,NCT04497610,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Breath sample,Instituto Costarricense de Investigaciones Clínicas ICIC,All,"7 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-04-08,15/08/20,2020-08-15,04/08/20,04/08/20,"Instituto Costarricense de Investigaciones Clínicas, San José",Costa Rica,Respiratory Diseases,1,1,129.0
2596.0,NCT04594330,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,,Recruiting,Coronavirus Infections,,,,,,,Drug: virgin coconut oil (VCO)|Other: placebo,Gadjah Mada University,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-06,31/12/20,2020-12-31,20/10/20,20/10/20,"Central Public Hospital Dr. Sardjito, Yogyakarta, Indonesia|RSUD Wonosari, Yogyakarta, Indonesia|RSUP Sleman, Yogyakarta, Indonesia|Teaching Hospital of Universitas Gadjah Mada (UGM), Yogyakarta",Indonesia,Respiratory Diseases,1,1,360.0
2597.0,NCT04359706,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,MICROVID,Recruiting,Sars-CoV2,,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-08-05,01/09/20,2020-01-09,24/04/20,06/08/20,"Hôpital Roger Salengro, CHU Lille, Lille",France,Respiratory Diseases,1,1,-209.0
2598.0,NCT04741061,"Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light",SPUTNIK-LIGHT,Recruiting,COVID-19,,,,,,,Biological: Sputnik Light|Other: Placebo,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|RDIF (Russian Direct Investment Fund)|CRO: iPharma|Government of the city of Moscow",All,"18 Years to 111 Years   (Adult, Older Adult)",6000.0,Other,Interventional,2021-02-19,31/12/21,2022-01-31,05/02/21,21/02/21,"Federal State Autonomous Educational Institution for Higher Education Immanuel Kant Baltic Federal University, Kaliningrad, Russian Federation|State Budgetary Healthcare Institution, Moscow, Consultation and Diagnosis Polyclinic No. 121, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 210, Moscow Healthcare Department, Moscow, Russian Federation|State Budgetary Healthcare Institution, Moscow, Municipal Polyclinic No. 219, Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow diagnostic centre № 5 associated with policlinic department of Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow diagnostic clinical centre № 1 Moscow Healthcare Department , Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Municipal Polyclinic № 2 Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Municipal Polyclinic № 36 Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Municipal Polyclinic № 6 Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Municipal Polyclinic № 62 Moscow Healthcare Department, Moscow, Russian Federation|State budgetary institution of health care of the city of Moscow Municipal Polyclinic № 64 Moscow Healthcare Department, Moscow, Russian Federation|St. Petersburg's state budgetary health care Institution Municipal hospital № 40 of Kurortniy area, Saint Petersburg, Russian Federation|St. Petersburg's state budgetary health care Institution Municipal hospital №117, Saint Petersburg, Russian Federation|Federal state budgetary educational Institution for Higher Education Saratov State Medical University named after V.I. Razumovskiy Ministry of Health of Russian Federation, Saratov, Russian Federation|LLC Uromed, Smolensk",Russian Federation,Respiratory Diseases,1,1,346.0
2599.0,NCT04335552,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",,Terminated,COVID-19,,,,,,,Other: Standard of care|Drug: Hydroxychloroquine|Drug: Azithromycin,Duke University,All,"12 Years and older   (Child, Adult, Older Adult)",11.0,Other,Interventional,2020-04-17,17/06/20,2020-06-26,06/04/20,31/07/20,"Duke Regional Hospital, Durham, North Carolina, United States|Duke University Hospital, Durham, North Carolina, United States|Durham VA Medical Center, Durham, North Carolina, United States|Duke Raleigh Hospital, Raleigh, North Carolina",United States,Respiratory Diseases,1,1,70.0
2600.0,NCT04446338,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,CovidImmunEye,Recruiting,COVID-19,,,,,,,Diagnostic Test: Antibody Test,"University Hospital Tuebingen|Institute of Clinical Chemistry and Pathobiochemistry, Department of Internal Medicine",All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-05-13,30/06/20,2020-01-08,24/06/20,24/06/20,"University Tuebingen, Tuebingen, BW",Germany,Respiratory Diseases,1,1,-126.0
2601.0,NCT04428268,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,,Withdrawn,COVID-19,,,,,,,Drug: Chloroquine Phosphate Tablets,Hospital Universitario Dr. Jose E. Gonzalez,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-10-03,10/06/20,2021-02-16,11/06/20,18/02/21,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,1,136.0
2602.0,NCT04355884,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,,Not yet recruiting,COVID-19,,,,,,,"Diagnostic Test: Standard 12-lead ECG, NT-proBNP, echocardiography",The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-20,01/05/20,2020-01-05,21/04/20,24/04/20,"The University of Hong Kong, Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,-106.0
2603.0,NCT04575038,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,CRISIS2,"Active, not recruiting",COVID-19,,,,,,,Drug: Brequinar|Drug: Placebo,"Clear Creek Bio, Inc.",All,"18 Years and older   (Adult, Older Adult)",115.0,Industry,Interventional,2020-11-19,28/04/21,2021-04-28,05/10/20,12/03/21,"Central Alabama Research, Homewood, Alabama, United States|Ark Clinical Research, Long Beach, California, United States|Doral Medical Research, Doral, Florida, United States|South Jersey Infectious Disease, Somers Point, New Jersey, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Wilmington Health, Wilmington, North Carolina, United States|Remington-Davis, Inc., Columbus, Ohio, United States|Toledo Institute of Clinical Research, Toledo, Ohio, United States|VitaLink - Gaffney, Gaffney, South Carolina, United States|Self Regional Healthcare Research Center - Self Medical Group, Greenwood, South Carolina, United States|VitaLink Research, Spartanburg, South Carolina, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Centex Studies, Inc. - McAllen, McAllen, Texas, United States|Synexus Clinical Research US, Inc. - Olympus Family Medicine, Salt Lake City, Utah",United States,Respiratory Diseases,1,1,160.0
2604.0,NCT04751604,Improvement of the Nutritional Status Regarding Nicotinamide (Vitamin B3) and the Disease Course of COVID-19,COVit-2,Recruiting,COVID-19,,,,,,,Dietary Supplement: Nicotinamide|Dietary Supplement: Placebo,University Hospital Schleswig-Holstein,All,"18 Years and older   (Adult, Older Adult)",840.0,Other,Interventional,2021-01-02,01/09/21,2021-01-12,12/02/21,12/02/21,"University Hospital Schleswig-Holstein, Kiel, Schleswig-Holstein",Germany,Respiratory Diseases,1,1,10.0
2605.0,NCT04374656,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,,Recruiting,Conjunctivitis,COVID-19,COVID-19,"Ocular Infection, Viral",Ocular Inflammation,,,,Johns Hopkins University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-05-18,01/05/21,2021-01-05,05/05/20,22/05/20,"Wilmer Eye Institute, Baltimore, Maryland",United States,Respiratory Diseases,1,5,232.0
2606.0,NCT04369365,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",,Recruiting,COVID-19,,,,,,,Drug: Azithromycin 500 milligram (mg) oral Tablet|Drug: Placebo,Prof. Dr. Matthias Preusser|Medical University of Vienna,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-27,27/08/20,2020-12-27,30/04/20,01/05/20,"AKH Vienna, Department for Internal Medicine I, Oncology, Vienna",Austria,Respiratory Diseases,1,1,244.0
2607.0,NCT04345289,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,CCAP,Recruiting,COVID-19,Corona Virus Infection,Viral Pneumonia,,,,,Biological: Convalescent anti-SARS-CoV-2 plasma|Other: Infusion placebo,Thomas Benfield|Hvidovre University Hospital,All,"18 Years and older   (Adult, Older Adult)",1100.0,Other,Interventional,2020-01-05,15/06/21,2021-06-15,14/04/20,31/07/20,"Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Arhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Rigshospitalet, Copenhagen, Denmark|Herlev Gentofte Hospital, Herlev, Denmark|Herning Hospital, Herning, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Kolding Hospital, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Roskilde Hospital, Roskilde, Denmark|Vejle Hospital, Vejle",Denmark,Respiratory Diseases,1,3,527.0
2608.0,NCT04547660,Convalescent Plasma for Severe COVID-19 Patients,PLACOVID,Completed,COVID-19,,,,,,,Biological: Convalescent Plasma|Other: Best Supportive Care,"Hospital de Clinicas de Porto Alegre|Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil|Instituto Cultural Floresta",All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-07-16,07/01/21,2021-07-01,14/09/20,09/02/21,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,Respiratory Diseases,1,1,350.0
2609.0,NCT04449783,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,CHICANE,Recruiting,COVID-19,Cancer,,,,,,Other: pre-operative screening|Other: telephone consult,Liverpool University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-06-25,25/08/20,2020-09-25,29/06/20,20/07/20,"Liverpool University Hospitals NHS Foundation Trust, Liverpool, Merseyside",United Kingdom,"Respiratory Diseases, Cancers",1,2,92.0
2610.0,NCT04830033,ENO Breathe vs Usual Care in COVID-19 Recovery: An RCT,SHIELD ENO,Not yet recruiting,COVID-19,,,,,,,Other: ENO Breathe group,Imperial College London|Imperial College Healthcare NHS Trust,All,"18 Years to 100 Years   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-04,01/12/21,2021-01-12,02/04/21,02/04/21,,,Respiratory Diseases,1,1,8.0
2611.0,NCT04443868,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,,Not yet recruiting,SARS-CoV Infection,,,,,,,Drug: Nitric Oxide-Releasing Drug,Sanotize Research and Development corp.,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-01-01,01/04/21,2021-01-07,23/06/20,08/10/20,,,Respiratory Diseases,1,1,6.0
2612.0,NCT04787510,COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection,,Recruiting,SARS-COV2 Infection,COVID-19,Hospitalized Patients,,,,,Drug: low molecular weight Heparin as standard of care treatment,"University Hospital, Ioannina|INTERNAL MEDICINE DEPARTMENT, 1ST WARD",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-12-23,23/05/21,2021-06-23,08/03/21,08/03/21,"University General Hospital of Ioannina, Ioánnina, Epirus",Greece,Respiratory Diseases,1,3,182.0
2613.0,NCT04476823,European Pathology Laboratories and COVID-19,,Completed,COVID-19,,,,,,,Other: Activity,Centre Hospitalier Universitaire de Nice,All,"Child, Adult, Older Adult",71.0,Other,Observational,2020-03-15,31/05/20,2020-05-31,20/07/20,20/07/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,77.0
2614.0,NCT04345653,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate (HCQ),Hackensack Meridian Health,All,"18 Years to 99 Years   (Adult, Older Adult)",44.0,Other,Interventional,2020-04-14,05/06/20,2021-08-06,14/04/20,17/03/21,"Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey",United States,Respiratory Diseases,1,1,479.0
2615.0,NCT04510025,Capturing MultiORgan Effects of COVID-19,C-MORE,Recruiting,Coronavirus Infection,Multi-Organ Disorder,,,,,,Diagnostic Test: Magnetic Resonance Imaging,University of Oxford,All,"18 Years to 100 Years   (Adult, Older Adult)",616.0,Other,Observational,2020-05-13,01/05/23,2023-01-05,12/08/20,18/08/20,"University of Oxford, Oxford",United Kingdom,Respiratory Diseases,1,2,967.0
2616.0,NCT04751643,Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections,CovidEP,Not yet recruiting,Intensive Care Units,"ARDS, Human",COVID-19,,,,,Other: Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)|Other: Usual treatments in intensive care unit according to the current state of knowledge,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",132.0,Other,Interventional,2021-01-02,01/09/22,2022-01-11,12/02/21,12/02/21,"Centre Hospitalier William Morey, Chalon-sur-Saône, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Croix Rousse, Lyon, France|Clinique de la Sauvegarde, Lyon, France|Groupement Hospitalier Porte de Valence - Montélimar, Montelimar, France|Hôpital Pitié Salpétrière - Assistante Publique des Hôpitaux de Paris, Paris, France|Centre Hospitalier Lyon Sud, Pierre-Bénite, France|Medipole Villeurbanne, Villeurbanne",France,Respiratory Diseases,1,3,374.0
2617.0,NCT04758286,Anesthetic & Surgical Protocol for Emergency Surgeries During the Era of COVID-19,,Completed,COVID-19,,,,,,,Procedure: Emergency surgical procedures,Benha University|Tanta University,All,"Child, Adult, Older Adult",209.0,Other,Interventional,2020-01-07,01/02/21,2021-11-02,17/02/21,17/02/21,"Faculty of Medicine, Banhā, Qalubia",Egypt,Respiratory Diseases,1,1,665.0
2618.0,NCT04287686,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Recombinant human angiotensin-converting enzyme 2 (rhACE2),The First Affiliated Hospital of Guangzhou Medical University,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-02,01/04/20,2020-01-04,27/02/20,17/03/20,"GCP Office of The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,2.0
2619.0,NCT04545541,Nebulised Heparin in Patients With Severe COVID-19,CHARTER-MT,Recruiting,COVID-19,Respiratory Failure,,,,,,Drug: Nebulised unfractionated heparin (UFH),Australian National University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-11,01/04/22,2022-01-06,11/09/20,19/01/21,"Frederick Health Hospital, Frederick, Maryland",United States,Respiratory Diseases,1,2,726.0
2620.0,NCT04472793,Repeated Employee Testing for Understanding Our Recovery to Normal,RETURN,Recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2,"Children's Hospital Medical Center, Cincinnati",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-11-05,01/12/22,2023-01-12,15/07/20,15/07/20,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio",United States,Respiratory Diseases,1,1,798.0
2621.0,NCT04351620,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine,University of Chicago,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-04,01/06/20,2020-01-06,17/04/20,17/04/20,"University of Chicago, Chicago, Illinois",United States,Respiratory Diseases,1,1,2.0
2622.0,NCT04383574,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),,"Active, not recruiting",COVID-19,,,,,,,"Biological: Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28|Other: Two doses of placebo at the schedule of day 0,28","Sinovac Research and Development Co., Ltd.|Sinovac Biotech Co., Ltd",All,"60 Years and older   (Adult, Older Adult)",422.0,Industry,Interventional,2020-05-22,28/08/20,2021-05-30,12/05/20,10/09/20,"Renqiu City Center for Disease Control and Prevention, Renqiu, Hebei",China,Respiratory Diseases,1,1,373.0
2623.0,NCT04390464,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),TACTIC-R,Recruiting,COVID-19,,,,,,,Drug: Ravulizumab|Drug: Baricitinib|Other: Standard of care,Cambridge University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",1167.0,Other,Interventional,2020-08-05,07/05/21,2022-01-05,15/05/20,18/05/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire",United Kingdom,Respiratory Diseases,1,1,518.0
2624.0,NCT04789447,"Evaluation of Prognosis of COVID-19 Patients With Only CT Findings, Only RT-PCR Positivity and Both of Them Positive",,Recruiting,COVID-19,SARS-CoV Infection,"Pneumonia, Viral",,,,,,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2021-04-03,28/03/21,2021-03-28,09/03/21,09/03/21,"Sultan Abdülhamid Han Training and Research Hospital, Istanbul, Turkey|Sultan Abdülhamid Han Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,-6.0
2625.0,NCT04393805,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,HETHICO,Completed,COVID-19,Hypercoagulability,,,,,,Drug: Low Molecular Weight Heparin,Quovadis Associazione|University of Padova,All,"18 Years and older   (Adult, Older Adult)",744.0,Other,Observational,2020-01-06,26/02/21,2021-02-26,19/05/20,18/03/21,"Giuseppe Camporese, Padova",Italy,Respiratory Diseases,1,2,417.0
2626.0,NCT04409925,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),DISCONNECT-1,Recruiting,COVID-19,,,,,,,Drug: rhDNase I,McGill University Health Centre/Research Institute of the McGill University Health Centre|Hamilton Health Sciences Corporation|Hoffmann-La Roche|Exactis Innovation,All,"18 Years and older   (Adult, Older Adult)",25.0,Other|Industry,Interventional,2020-12-25,01/04/21,2021-01-08,01/06/20,22/01/21,"Hamilton General Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada|McGill University Health Centre, Montreal, Quebec",Canada,Respiratory Diseases,1,1,14.0
2627.0,NCT04462757,SCIL-1Ra in COVID-19 Feasibility & PK/PD,SCIL_COV19,Suspended,COVID-19,,,,,,,Drug: Anakinra 100Mg/0.67Ml Inj Syringe,University of Manchester,All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-05-28,31/08/20,2020-12-31,08/07/20,23/10/20,"Manchester Univesity NHS Foundation Trust, Manchester, United Kingdom|Salford Royal NHS Foundation Tust, Salford",United Kingdom,Respiratory Diseases,1,1,217.0
2628.0,NCT04433000,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,USCovid,Recruiting,COVID-19,,,,,,,Diagnostic Test: Butterfly,University of Siena,All,"Child, Adult, Older Adult",34.0,Other,Observational,2020-03-15,10/06/20,2020-10-06,16/06/20,16/06/20,"Azienda Ospedaliera Universitaria Senese, Siena, Si",Italy,Respiratory Diseases,1,1,205.0
2629.0,NCT04669015,Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19,NOVATION-1,Not yet recruiting,COVID-19,,,,,,,Biological: Novaferon|Biological: Placebo,Genova Inc.,All,"18 Years and older   (Adult, Older Adult)",914.0,Industry,Interventional,2021-01-04,01/08/21,2021-01-08,16/12/20,05/04/21,,,Respiratory Diseases,1,1,4.0
2630.0,NCT04705597,"Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Participants ≥ 60 Years of Age and Hospitalized With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure",,Recruiting,COVID-19,,,,,,,Drug: BGE-175|Other: Placebo,"BioAge Labs, Inc.",All,"60 Years and older   (Adult, Older Adult)",132.0,Industry,Interventional,2021-03-18,01/05/21,2021-01-09,12/01/21,22/03/21,"University of Maryland Medical System, Baltimore, Maryland",United States,Respiratory Diseases,1,1,-68.0
2631.0,NCT04338932,COVID-19 and Deep Venous Thrombosis,,Completed,COVID-19,Deep Vein Thrombosis (DVT)/Thrombophlebitis,,,,,,,Jessa Hospital,All,"18 Years and older   (Adult, Older Adult)",12.0,Other,Observational,2020-04-17,15/05/20,2020-05-15,08/04/20,19/05/20,"Jessa hospital, Hasselt",Belgium,Respiratory Diseases,1,2,28.0
2632.0,NCT04743401,Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients,,Not yet recruiting,COVID-19,Rehabilitation,,,,,,Other: Tele-exergaming Tablet,VA Office of Research and Development|Baylor College of Medicine,All,"18 Years and older   (Adult, Older Adult)",60.0,U.S. Fed|Other,Interventional,2021-04-30,30/09/22,2023-03-31,08/02/21,14/04/21,"Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas",United States,Respiratory Diseases,1,2,700.0
2633.0,NCT04390022,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,SAINT,Completed,COVID-19,Coronavirus Infection,COVID-19,,,,,Drug: Ivermectin|Drug: Placebo,"Clinica Universidad de Navarra, Universidad de Navarra|Barcelona Institute for Global Health",All,18 Years to 59 Years   (Adult),24.0,Other,Interventional,2020-07-31,17/09/20,2020-09-10,15/05/20,17/12/20,"Clinica Universidad de Navarra, Pamplona, Navarra",Spain,Respiratory Diseases,1,3,41.0
2634.0,NCT04450004,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",,"Active, not recruiting",SARS-CoV 2,,,,,,,Biological: Intramuscular Vaccine,Medicago,All,18 Years to 55 Years   (Adult),180.0,Industry,Interventional,2020-10-07,20/09/21,2021-12-31,29/06/20,23/10/20,"Syneos Health, Montréal, Quebec, Canada|Syneos Health, Québec, Quebec",Canada,Respiratory Diseases,1,1,450.0
2635.0,NCT04610541,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,,"Active, not recruiting",COVID-19,,,,,,,Drug: Remdesivir-HU,University of Pecs|HECRIN Consortium|Hungarian Ministry of Innovation and Technology,All,"12 Years to 100 Years   (Child, Adult, Older Adult)",2000.0,Other,Interventional,2020-12-10,30/10/21,2021-11-30,30/10/20,27/11/20,"Department of Pulmonology Semmelweis University, Budapest, Hungary|National Korányi Institute for Pulmonology, Budapest, Hungary|North - Central Buda Center New St. János Hospital, Budapest, Hungary|Institute of Infectology, University of Debrecen, Debrecen, Hungary|1st Department of Medicine, University of Pécs, Pécs, Hungary|Department of Internal Medicine University of Szeged, Szeged, Hungary|First Department of Internal Medicine, University of Szeged, Szeged",Hungary,Respiratory Diseases,1,1,355.0
2636.0,NCT04332094,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",TOCOVID,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab|Drug: Hydroxychloroquine|Drug: Azithromycin,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Instituto de Salud Carlos III,All,"18 Years and older   (Adult, Older Adult)",276.0,Other,Interventional,2020-02-04,01/09/20,2020-01-10,02/04/20,07/04/20,"Hospital de la Santa Creu i Sant Pau, Barcelona",Spain,Respiratory Diseases,1,1,-25.0
2637.0,NCT04326114,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,,Not yet recruiting,"Disease, Infectious",Respiratory Disease,Safety Issues,Effectiveness,,,,Device: Inspiratory training device|Device: Expiratory training device,Universidad Complutense de Madrid,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Interventional,2020-07-26,15/12/20,2020-12-20,30/03/20,02/06/20,,,Others,0,4,147.0
2638.0,NCT04344171,CovidDB: The Covid-19 Inpatient Database,,Recruiting,COVID-19,,,,,,,,ClarData,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-03-30,31/12/22,2023-06-30,14/04/20,21/04/20,"RoMed - Klinikum Bad Aibling, Bad Aibling, Germany|DONAUISAR Klinikum Deggendorf, Deggendorf, Germany|DONAUISAR Klinikum Dingolfing, Dingolfing, Germany|RoMed - Klinikum Prien am Chiemsee, Prien, Germany|RoMed - Klinikum Rosenheim, Rosenheim, Germany|Universitätsklinikum Ulm, Ulm, Germany|RoMed - Klinikum Wasserburg Am Inn, Wasserburg Am Inn, Germany|Klinikum Altmühlfranken, Weißenburg, Germany|Timiş County Emergency Clinical Hospital, Timisoara",Romania,Respiratory Diseases,1,1,1187.0
2639.0,NCT04666753,Retrospective Study of ImmunoFormulation for COVID-19,,Completed,COVID-19,,,,,,,Dietary Supplement: ImmunoFormulation,Fagron Iberica S.A.U.,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Observational,2020-02-07,29/09/20,2020-09-29,14/12/20,14/12/20,"Clinic Bascoy, Barcelona, Spain|Clínica Arvila Magna, Barcelona",Spain,Respiratory Diseases,1,1,235.0
2640.0,NCT04736901,Effect of Prophylactic and Therapeutic Anticoagulants in Egyptian Patients With COVID-19,,Recruiting,COVID-19,Corona Virus Infection,Hypercoagulability,,,,,Drug: Enoxaparin|Drug: Rivaroxaban|Drug: Apixaban,Ain Shams University|Misr International University,All,"18 Years to 65 Years   (Adult, Older Adult)",90.0,Other,Observational,2020-01-12,01/04/21,2021-01-06,03/02/21,04/02/21,"Teachers Hospital, Cairo, Please Select",Egypt,Respiratory Diseases,1,3,360.0
2641.0,NCT04349371,Saved From COVID-19,,Terminated,COVID-19,Coronavirus Infection,,,,,,Drug: Chloroquine|Drug: Placebo oral tablet,Columbia University,All,"18 Years and older   (Adult, Older Adult)",8.0,Other,Interventional,2020-04-21,07/01/21,2021-07-01,16/04/20,10/02/21,"Columbia University Irving Medical Center/NYP, New York, New York",United States,Respiratory Diseases,1,2,436.0
2642.0,NCT04647682,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,Cov-activity,Recruiting,COVID-19,,,,,,,Other: physical activity program,"University Hospital, Toulouse",All,75 Years and older   (Older Adult),30.0,Other,Observational,2020-01-11,30/06/21,2021-12-31,01/12/20,29/01/21,"University Hospital Toulouse, Toulouse",France,Respiratory Diseases,1,1,720.0
2643.0,NCT04652648,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,,Completed,COVID-19,Hydroxychloroquine,Coronavirus Infection,Transmission,Prophylaxis,,,Drug: Hydroxychloroquine,Bryn Mawr Hospital|Sharpe-Strumia Research Foundation|Bryn Mawr Hospital Foundation|Cotswold Foundation,All,"18 Years and older   (Adult, Older Adult)",54.0,Other,Interventional,2020-05-27,31/10/20,2020-11-15,03/12/20,03/12/20,"Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States|Paoli Hospital, Paoli, Pennsylvania, United States|Lankenau Medical Center, Wynnewood, Pennsylvania",United States,Respiratory Diseases,1,5,172.0
2644.0,NCT04523051,Rehabilitation After Admission in Intensive Care Unit for COVID-19,RECOVER,Recruiting,COVID-19,,,,,,,,Centre Hospitalier Régional Metz-Thionville,All,"Child, Adult, Older Adult",40.0,Other,Observational,2020-01-04,01/04/21,2021-01-05,21/08/20,25/08/20,"Etablissement de santé Filieris, Freyming-Merlebach, Moselle, France|Hopital Legouest, Metz, Moselle, France|CHR Metz Thionville, Metz, Moselle",France,Respiratory Diseases,1,1,367.0
2645.0,NCT04341103,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Al-COVE,Not yet recruiting,Solid Organ Transplant Rejection,COVID-19,,,,,,,CareDx,All,"Child, Adult, Older Adult",500.0,Industry,Observational,2020-01-04,01/12/20,2021-01-03,10/04/20,10/04/20,,,Respiratory Diseases,1,2,365.0
2646.0,NCT04497246,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",,Recruiting,COVID-19,,,,,,,Other: Questionnaire,Murielle Surquin|Brugmann University Hospital,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-05-29,01/12/20,2020-01-12,04/08/20,04/08/20,"CHU Brugmann, Brussels",Belgium,Respiratory Diseases,1,1,-138.0
2647.0,NCT04720612,COVID-19 Immunologic Antiviral Therapy With Omalizumab,CIAO,Not yet recruiting,COVID-19,,,,,,,Biological: Omalizumab|Other: Placebo,McGill University Health Centre/Research Institute of the McGill University Health Centre,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-02,01/07/21,2022-01-01,22/01/21,22/01/21,"Research Institute of the McGill University Health Centre, Montreal, Quebec",Canada,Respiratory Diseases,1,1,364.0
2648.0,NCT04495764,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,RePAiR,Completed,COVID-19,COVID-19,,,,,,,Davita Clinical Research,All,"18 Years to 80 Years   (Adult, Older Adult)",2504.0,Industry,Observational,2020-07-20,12/02/21,2021-12-02,03/08/20,21/02/21,"DCR Victorville, Victorville, California, United States|DCR Connecticut, Bridgeport, Connecticut, United States|DCR Twin Cities, Minneapolis, Minnesota, United States|DCR Las Vegas, Las Vegas, Nevada, United States|DCR Bronx, Bronx, New York, United States|DCR Canton, Canton, Ohio, United States|DCR El Paso, El Paso, Texas, United States|DCR Lewisville, Lewisville, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR San Antonio, San Antonio, Texas, United States|DCR Norfolk, Norfolk, Virginia, United States|DCR Milwaukee, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,2,500.0
2649.0,NCT04724434,Follow-up Study of COVID-19 Patients in the District Konstanz,FSC19-KN,Enrolling by invitation,COVID-19,,,,,,,,Hegau-Bodensee-Klinikum Singen|Department of Health and Human Services,All,"18 Years and older   (Adult, Older Adult)",400.0,Other|U.S. Fed,Observational,2020-04-12,01/06/21,2026-01-06,26/01/21,02/02/21,"Hegau-Bodensee-Klinikum Singen, Singen, Baden-Württemberg",Germany,Respiratory Diseases,1,1,2095.0
2650.0,NCT04455243,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,INFECT-19,Not yet recruiting,COVID-19,,,,,,,Drug: N-Acetyl cysteine|Drug: Placebo,Dr. Tariq Alhawassi|King Saud University,All,"18 Years and older   (Adult, Older Adult)",1180.0,Other,Interventional,2020-01-08,30/08/21,2021-08-30,02/07/20,21/07/20,,,Respiratory Diseases,1,1,600.0
2651.0,NCT04382053,Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Drug: DFV890|Drug: Standard of Care (SoC),Novartis Pharmaceuticals|Novartis,All,"18 Years to 80 Years   (Adult, Older Adult)",143.0,Industry,Interventional,2020-05-27,10/12/20,2020-12-24,11/05/20,09/03/21,"Novartis Investigative Site, Caba, Buenos Aires, Argentina|Novartis Investigative Site, Buenos Aires, Argentina|Novartis Investigative Site, Porto Alegre, RS, Brazil|Novartis Investigative Site, Sao Paulo, SP, Brazil|Novartis Investigative Site, Hvidovre, Denmark|Novartis Investigative Site, Regensburg, Bavaria, Germany|Novartis Investigative Site, Hannover, Germany|Novartis Investigative Site, Wuerzburg, Germany|Novartis Investigative Site, Budapest, Hungary|Novartis Investigative Site, Coimbatore, Tamil Nadu, India|Novartis Investigative Site, Kolkata, West Bengal, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, Ciudad de Mexico, Mexico CP, Mexico|Novartis Investigative Site, Monterrey, Nuevo Leon, Mexico|Novartis Investigative Site, Harderwijk, Netherlands|Novartis Investigative Site, San Martin de Porres, Lima, Peru|Novartis Investigative Site, San Miguel, Lima, Peru|Novartis Investigative Site, Barnaul, Russian Federation|Novartis Investigative Site, Chelyabinsk, Russian Federation|Novartis Investigative Site, Ekaterinburg, Russian Federation|Novartis Investigative Site, Krasnoyarsk, Russian Federation|Novartis Investigative Site, Moscow, Russian Federation|Novartis Investigative Site, Ryazan, Russian Federation|Novartis Investigative Site, Saint Petersburg, Russian Federation|Novartis Investigative Site, St Petersburg, Russian Federation|Novartis Investigative Site, George, Western Cape, South Africa|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Madrid",Spain,Respiratory Diseases,1,1,211.0
2652.0,NCT04369456,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,PredictCovidT,Recruiting,Kidney Transplant; Complications,Coronavirus Infection,,,,,,Other: blood sample,Centre Hospitalier Universitaire de Nice,All,"18 Years to 85 Years   (Adult, Older Adult)",115.0,Other,Interventional,2020-04-22,22/10/20,2020-10-22,30/04/20,01/05/20,"Lyon Univerity Hospital, Lyon, France|APHM, Marseille, France|Montpellier University Hospital, Montpellier, France|University Nice Hospital, Nice, France|APHP, Paris, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg Univeristy Hospital, Strasbourg",France,Respiratory Diseases,1,2,183.0
2653.0,NCT04714008,Covid-19 and ONline GAmbling,CONGA,Recruiting,Gambling,COVID-19,,,,,,,Nantes University Hospital,All,"18 Years and older   (Adult, Older Adult)",180000.0,Other,Observational,2020-01-12,31/12/22,2022-12-31,19/01/21,19/01/21,"Nantes University Hospital, Nantes",France,Respiratory Diseases,1,2,1084.0
2654.0,NCT04475471,WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,WHF,Recruiting,COVID-19,Cardiovascular Diseases,,,,,,,"Public Health Foundation of India|Centre for Chronic Disease Control, India|University of Cape Town|World Heart Federation, Geneva, Switzerland",All,"18 Years and older   (Adult, Older Adult)",5200.0,Other,Observational,2020-11-06,30/06/21,2021-12-30,17/07/20,07/09/20,"Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Hospital de Clinicas of the University, Buenos Aires, Argentina|Sanatorio Güemes Hospital, Buenos Aires, Argentina|University Clinical Center Republic of Srpska, Srpska, Bosnia and Herzegovina|Komfo Anokye Teaching Hospital, Kumasi, Ghana|Kumasi South Regional Hospital, Kumasi, Ghana|Dayanand medical college hospital, Ludhiyana, Punjab, India|Amin Hospital, Isfahan, Iran, Islamic Republic of|Amin Hospital, Isfahan, Iran, Islamic Republic of|Khorshid Hospital, Isfahan, Iran, Islamic Republic of|Fedail Hospital, Khartoum",Sudan,Respiratory Diseases,1,2,419.0
2655.0,NCT04394182,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,ULTRA-COVID,Recruiting,"Pneumonia, Viral",Cytokine Storm,,,,,,Radiation: Ultra-Low-dose radiotherapy|Device: ventilatory support with oxygen therapy|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Piperacillin/tazobactam|Drug: Low molecular weight heparin|Drug: Corticosteroid injection|Drug: Tocilizumab,Fundacion GenesisCare|Hospital La Milagrosa|Hospital Vithas Valencia Consuelo,All,"18 Years to 120 Years   (Adult, Older Adult)",15.0,Other,Interventional,2020-04-21,31/12/20,2021-04-21,19/05/20,19/05/20,"Hospital La Milagrosa, GenesisCare, Madrid, Spain|Hospital Vithas Valencia Consuelo, Valencia",Spain,Respiratory Diseases,1,2,365.0
2656.0,NCT04465474,"Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",,Recruiting,COVID-19,,,,,,,Other: Non Intervention,"Chinese University of Hong Kong|Peking University First Hospital|Hospital Universitario de Torrejón|Queen Mary Hospital, Hong Kong|Pamela Youde Nethersole Eastern Hospital|Queen Elizabeth Hospital, Hong Kong|United Christian Hospital|Kwong Wah Hospital|Princess Margaret Hospital, Hong Kong|Tuen Mun Hospital",Female,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-01-05,30/04/22,2022-12-31,10/07/20,27/01/21,"Peking University First Hospital, Beijing, Beijing, China|Kwong Wah Hospital, Hong Kong, Hong Kong|Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Elizabeth Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong|Tuen Mun Hospital, Hong Kong, Hong Kong|United Christian Hospital, Hong Kong, Hong Kong|Hospital Universitario de Torrejón, Torrejón De Ardoz, Madrid",Spain,Respiratory Diseases,1,1,1091.0
2657.0,NCT04360486,Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),,Available,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Biological: Anti-Sars-CoV-2 Convalescent Plasma,U.S. Army Medical Research and Development Command,All,"Child, Adult, Older Adult",,U.S. Fed,Expanded Access:Treatment IND/Protocol,,,,24/04/20,19/01/21,"Naval Hospital Camp Pendleton, Oceanside, California, United States|Navy Medical Center San Diego, San Diego, California, United States|USS Abraham Lincoln, San Diego, California, United States|USS Carl Vinson, San Diego, California, United States|USS Essex, San Diego, California, United States|USS Makin Island, San Diego, California, United States|USS Nimitz, San Diego, California, United States|USS Theodore Roosevelt, San Diego, California, United States|Evans Army Community Hospital, Fort Carson, Colorado, United States|Eglin Air Force Base, Eglin Air Force Base, Florida, United States|Naval Hospital Jacksonville, Jacksonville, Florida, United States|Martin Army Community Hospital, Fort Benning, Georgia, United States|Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Tripler Army Medical Center, Honolulu, Hawaii, United States|Keesler Medical Center, Biloxi, Mississippi, United States|Nellis Air Force Base, Las Vegas, Nevada, United States|Naval Medical Center Camp Lejeune, Camp Lejeune, North Carolina, United States|Wright Patterson Medical Center, Wright-Patterson Air Force Base, Ohio, United States|William Beaumont Army Medical Center, El Paso, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Fort Belvoir Community Hospital, Fort Belvoir, Virginia, United States|Naval Surface Force Atlantic, Norfolk, Virginia, United States|USS Dwight D. Eisenhower, Norfolk, Virginia, United States|USS Gerald R. Ford, Norfolk, Virginia, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center, Lakewood, Washington, United States|Craig Joint Theatre Hospital Bagram AFGH, Bagram, Afghanistan|Djibouti Expeditionary Medical Facility, Djibouti, Djibouti|Landstuhl Regional Medical Center, Landstuhl, Germany|Naval Hospital Guam, Agaña, Guam|Baghdad Diplomat Support Center Iraq, Baghdad, Iraq|Misawa Air Force Base, Aomori, Japan|Yokota Air Base, Fussa, Japan|US Naval Hospital Okinawa, Okinawa, Japan|Naval Hospital Yokosuka, Yokosuka, Japan|USS America, Yokosuka, Japan|USS Ronald Reagan, Yokosuka, Japan|US Military Hospital Kuwait, Kuwait",Kuwait,Respiratory Diseases,1,1,
2658.0,NCT04357847,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Covid-Thelium,Recruiting,COVID-19,Endothelial Dysfunction,Thrombosis,Critically Ill,,,,,"University Hospital, Rouen",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-09-04,31/07/21,2021-08-31,22/04/20,03/11/20,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,4,361.0
2659.0,NCT04374045,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,COVIDANS,Completed,SARS-CoV 2,,,,,,,Other: ECG-Holter,Centre Hospitalier Universitaire de Saint Etienne,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-30,17/06/20,2020-06-18,05/05/20,14/01/21,"CHU Hopital nord, Saint-Étienne",France,Respiratory Diseases,1,1,49.0
2660.0,NCT04492891,Cyclosporine For The Treatment Of COVID-19(+),,Recruiting,SARS (Disease),,,,,,,Drug: Cyclosporine|Other: Standard of Care Treatment,"Bryan Burt, MD|Brigham and Women's Hospital|Baylor College of Medicine",All,"18 Years to 90 Years   (Adult, Older Adult)",75.0,Other,Interventional,2020-11-23,23/11/25,2025-11-23,30/07/20,27/11/20,"Baylor College of Medicine, Houston, Texas",United States,Others,0,1,1826.0
2661.0,NCT04453488,Clinical Trial to Evaluate the Efficacy of RUTI® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,,Not yet recruiting,COVID-19,Sars-CoV2,,,,,,Biological: RUTI® vaccine|Biological: Placebo,Fundació Institut Germans Trias i Pujol,All,"18 Years and older   (Adult, Older Adult)",315.0,Other,Interventional,2020-07-30,01/12/20,2020-01-12,01/07/20,29/07/20,"Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona",Spain,Respiratory Diseases,1,2,-200.0
2662.0,NCT04378582,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,EpiCoV-Brazil,Completed,SARS-CoV 2,"Respiratory Distress Syndrome, Adult",Corona Virus Infection,Critical Illness,,,,Other: risk factors,University of Sao Paulo General Hospital,All,"14 Years to 100 Years   (Child, Adult, Older Adult)",1589.0,Other,Observational,2020-07-05,28/07/20,2020-05-08,07/05/20,26/08/20,"Hospital das Clínicas -HCFMUSP, Sao Paulo, SP",Brazil,"Cardiovascular Diseases, Respiratory Diseases",1,4,-58.0
2663.0,NCT04305457,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,NoCovid,"Active, not recruiting",Coronavirus Infections,"Pneumonia, Viral",Acute Respiratory Distress Syndrome,,,,,Drug: Nitric Oxide,Massachusetts General Hospital|University of Alabama at Birmingham,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-03-21,01/04/21,2022-01-04,12/03/20,29/12/20,"Providence HealthCare Network, Anchorage, Alaska, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,3,654.0
2664.0,NCT04805125,Immunocompromised Swiss Cohorts Based Trial Platform,COVERALL,Not yet recruiting,Immunocompromised Patients,,,,,,,"Biological: Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)|Biological: Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)","University Hospital, Basel, Switzerland|Swiss National Science Foundation",All,"18 Years and older   (Adult, Older Adult)",380.0,Other,Interventional,2021-01-04,01/07/22,2022-01-07,18/03/21,22/03/21,"University Hospital Basel, Basel, Switzerland|University Hospital Bern, Bern, Switzerland|University Hospital Lausanne CHUV, Lausanne, Switzerland|University Hospital Zurich, Zurich",Switzerland,Others,0,1,368.0
2665.0,NCT04732468,COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA,,Recruiting,COVID-19,,,,,,,Biological: hAd5-S-Fusion+N-ETSD (Suspension for injection)|Drug: hAd5-SFusion+ N-ETSD (Oral capsule),"ImmunityBio, Inc.",All,18 Years to 55 Years   (Adult),65.0,Industry,Interventional,2021-02-24,01/04/22,2022-01-04,01/02/21,12/04/21,"Chan Soon - Shiong Institute for Medicine, El Segundo, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California",United States,Respiratory Diseases,1,1,314.0
2666.0,NCT04840082,Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs,,Completed,COVID-19,,,,,,,Diagnostic Test: Nasopharyngeal swab for COVID-19 testing,"Rigshospitalet, Denmark",All,"16 Years and older   (Child, Adult, Older Adult)",109.0,Other,Interventional,2021-07-03,08/03/21,2021-08-03,09/04/21,09/04/21,"Rigshospitalet, Copenhagen, Copenhagen East",Denmark,Respiratory Diseases,1,1,31.0
2667.0,NCT04405986,Exploring Brain Damages After COVID-19 Infection,BRAINCOV,Completed,SARS-CoV 2,,,,,,,Procedure: Auditory Evoked Potentials (AEP)|Procedure: Blink and Masseter Inhibitory Reflex,"University Hospital, Bordeaux",All,"18 Years and older   (Adult, Older Adult)",38.0,Other,Interventional,2020-05-19,10/03/21,2021-10-03,28/05/20,08/04/21,"CHU de Bordeaux, Bordeaux",France,Respiratory Diseases,1,1,502.0
2668.0,NCT04469114,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,,"Active, not recruiting",COVID-19,,,,,,,Drug: Tofacitinib 10 mg|Drug: Placebo,Hospital Israelita Albert Einstein|Pfizer,All,"18 Years and older   (Adult, Older Adult)",260.0,Other|Industry,Interventional,2020-09-16,01/03/21,2021-01-03,13/07/20,02/02/21,"Centro de Pesquisa Clínica do Coração, Aracaju, Brazil|Hospital Universitário São Francisco de Assis Na Providência de Deu, Bragança Paulista, Brazil|Irmandade do Sr. Bom Jesus dos Passos da Santa Casa de Misericórdia de Bragança Paulista, Bragança Paulista, Brazil|Hospital do Coração do Brasil, Brasilia, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, Brazil|Unimed Fortaleza Sociedade Corporativa Médica LTD, Fortaleza, Brazil|Hospital Regional Jorge Rossmann, Itanhaem, Brazil|Hospital Bruno Born, Lajeado, Brazil|Hospital São Vicente de Paulo, Passo Fundo, Brazil|Hospital Israelita Albert Einstein, Sao Paulo, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José Do Rio Preto, Brazil|Hospital Regional de Registro, São José Dos Campos, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, Brazil|Beneficência Portuguesa, São Paulo, Brazil|BP Mirante, São Paulo, Brazil|Instituto do Coração, São Paulo",Brazil,Respiratory Diseases,1,1,109.0
2669.0,NCT04650178,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,Neuropathy,,,,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"Child, Adult, Older Adult",274.0,Other|NIH,Observational,2020-05-26,01/07/21,2021-01-07,02/12/20,02/12/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,4,226.0
2670.0,NCT04709328,To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19,MAOP3,Not yet recruiting,COVID-19,COVID-19,,,,,,Drug: SCTA01|Other: Placebo,Sinocelltech Ltd.,All,"18 Years and older   (Adult, Older Adult)",690.0,Industry,Interventional,2021-03-28,01/01/22,2022-01-03,14/01/21,29/03/21,,,Respiratory Diseases,1,2,281.0
2671.0,NCT04454333,COVID-19 in Pain Perspective,,Completed,Infection,COVID-19,Pain,,,,,,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years to 95 Years   (Adult, Older Adult)",466.0,Other,Observational,2020-03-06,18/06/20,2020-06-20,01/07/20,01/07/20,"Şişli Hamidiye Etfal Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,106.0
2672.0,NCT04393246,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,,Recruiting,COVID-19,,,,,,,Drug: EDP1815|Drug: Dapagliflozin|Drug: Ambrisentan|Other: Standard of care,Cambridge University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",1407.0,Other,Interventional,2020-03-07,15/02/22,2022-06-15,19/05/20,19/03/21,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire",United Kingdom,Respiratory Diseases,1,1,830.0
2673.0,NCT04463758,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,Coropreg,Recruiting,COVID-19,Pregnancy Complications,Neonatal Complications,,,,,Other: An auto-questionnaire comprising three psychometric scales,"Assistance Publique - Hôpitaux de Paris|INSERM, Epopé team",Female,"Child, Adult, Older Adult",3060.0,Other,Observational,2020-11-05,01/02/22,2022-01-10,09/07/20,09/07/20,"AP-HP Cochin, Paris",France,Respiratory Diseases,1,3,431.0
2674.0,NCT04495101,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: Prolastin|Drug: Standard Medical Treatment,"Instituto Grifols, S.A.|Grifols Therapeutics LLC",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-07-29,01/04/21,2021-01-05,31/07/20,25/03/21,"Hospital Universitario de Burgos, Burgos, Castilla León, Spain|Hospital Universitari Germans Trias i Pujol, Badalona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Hospital Universitario Valle de Hebrón, Barcelona, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital General Gregorio Marañón, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Príncipe de Asturias, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid",Spain,Respiratory Diseases,1,1,160.0
2675.0,NCT04270383,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,,Not yet recruiting,COVID-19,,,,,,,,"Beijing Children's Hospital|Capital Institute of Pediatrics, China|The First Affiliated Hospital of Anhui Medical University|China-Japan Friendship Hospital|The First Affiliated Hospital of Xiamen University|Guangzhou Women and Children's Medical Center|Shenzhen Children's Hospital|First Affiliated Hospital of Guangxi Medical University|The Affiliated Hospital Of Guizhou Medical University|Hainan People's Hospital|Children's Hospital of Hebei Province|Wuhan Women and Children's Medical Center|Changchun Children's Hospital|Children's Hospital of Nanjing Medical University|Jiangxi Province Children's Hospital|Shengjing Hospital|Shanxi Provincial Maternity and Children's Hospital|Xian Children's Hospital|Children's Hospital of Chongqing Medical University|Tianjin Children's Hospital|Tianjin Medical University Second Hospital|Kunming Children's Hospital|Second Affiliated Hospital of Wenzhou Medical University",All,"up to 18 Years   (Child, Adult)",500.0,Other,Observational,2020-02-15,31/12/20,2020-12-31,17/02/20,17/02/20,"Beijing Children's Hospital,, Beijing",China,Respiratory Diseases,1,1,320.0
2676.0,NCT04360954,Evaluation of Antibody Tests for COVID-19,,Completed,COVID-19,Coronavirus,,,,,,Diagnostic Test: Diagnostic test,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",461.0,Other,Observational,2020-04-23,08/07/20,2020-08-07,24/04/20,31/12/20,"Washington University School of Medicine, Saint Louis, Missouri",United States,Respiratory Diseases,1,2,106.0
2677.0,NCT04412473,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,CRASH,Recruiting,Sars-CoV2,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-30,01/06/21,2021-01-06,02/06/20,11/01/21,"Service Médecine Intensive et Réanimation, Strasbourg",France,Respiratory Diseases,1,1,251.0
2678.0,NCT04444336,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,,Not yet recruiting,Depression,Anxiety,,,,,,Behavioral: Cross-sectional study examining the impact of information sources to obtain information about COVID-19 on depression and anxiety symptoms,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,24/06/20,,,Mental Health,1,2,21.0
2679.0,NCT04432298,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease",,Terminated,COVID-19,,,,,,,Drug: Pamrevlumab|Drug: Placebo,FibroGen,All,"40 Years to 85 Years   (Adult, Older Adult)",22.0,Industry,Interventional,2020-06-20,22/03/21,2021-03-22,16/06/20,02/04/21,"Research Center, Detroit, Michigan, United States|Research Center, Greensboro, North Carolina, United States|Research Center, Philadelphia, Pennsylvania, United States|Research Center, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,275.0
2680.0,NCT04542876,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,,Completed,COVID-19,,,,,,,Drug: Guduchi Ghan Vati,Aarogyam UK|Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University,All,"18 Years and older   (Adult, Older Adult)",46.0,Other,Interventional,2020-01-05,31/07/20,2020-08-18,09/09/20,09/09/20,"Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan",India,Respiratory Diseases,1,1,226.0
2681.0,NCT04423003,Endoscopic Interventions in Patients With COVID-19,,Completed,COVID-19,,,,,,,Procedure: Endoscopic intervention,University Hospital Tuebingen,All,"Child, Adult, Older Adult",10.0,Other,Observational,2020-01-03,15/05/20,2020-05-15,09/06/20,09/06/20,"University Hospital of Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,1,133.0
2682.0,NCT04357808,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),SARCOVID,Completed,COVID-19,,,,,,,Drug: Sarilumab|Other: Standar of care,Maria del Rosario Garcia de Vicuña Pinedo|Instituto de Investigación Sanitaria Hospital Universitario de la Princesa|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-13,30/11/20,2020-04-12,22/04/20,11/02/21,"Hospital Universitario de la Princesa, Madrid",Spain,Respiratory Diseases,1,1,-1.0
2683.0,NCT04576728,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,ESsCOVID,Recruiting,COVID-19,,,,,,,Drug: Trimodulin|Other: Placebo (human albumin 1%),Biotest,All,"18 Years and older   (Adult, Older Adult)",164.0,Industry,Interventional,2020-06-10,01/05/21,2021-01-05,06/10/20,22/01/21,"Investigational site # 5503, Porto Alegre, Brazil|Investigational site # 5502, Santo André, Brazil|Investigational site # 5505, Santo André, Brazil|Investigational site # 5501, São Paulo, Brazil|Investigational Site # 3301, Paris, France|Investigational site # 3305, Saint-Étienne, France|Investigational site # 0702, Moscow, Russian Federation|Investigational Site # 0704, Moscow, Russian Federation|Investigational site # 0701, Saint Petersburg, Russian Federation|Investigational Site # 3401, Barcelona, Spain|Investigational Site # 3402, Madrid",Spain,Respiratory Diseases,1,1,209.0
2684.0,NCT04457609,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,,Recruiting,COVID-19,Pulmonary Infection,Sars-CoV2,,,,,Drug: Oseltamivir|Drug: Azithromycin|Biological: Umbilical Cord Mesenchymal Stem Cells,Indonesia University,All,"18 Years to 95 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-07,01/08/20,2020-01-09,07/07/20,07/07/20,"Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia|Persahabatan General Hospital, Jakarta, DKI Jakarta, Indonesia|Sulianti Saroso Center for Infectious Disease, Jakarta, DKI Jakarta, Indonesia|Universitas Indonesia Hospital, Depok, West Java",Indonesia,Respiratory Diseases,1,3,2.0
2685.0,NCT04358081,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,,Completed,COVID-19,,,,,,,Drug: HCQ|Drug: HCQ+AZT|Drug: Placebo,Novartis Pharmaceuticals|Novartis,All,"18 Years and older   (Adult, Older Adult)",20.0,Industry,Interventional,2020-01-05,27/07/20,2020-07-27,22/04/20,02/04/21,"Novartis Investigative Site, Fullerton, California, United States|Novartis Investigative Site, Los Angeles, California, United States|Novartis Investigative Site, Chicago, Illinois, United States|Novartis Investigative Site, Baton Rouge, Louisiana, United States|Novartis Investigative Site, Baltimore, Maryland, United States|Novartis Investigative Site, Chapel Hill, North Carolina, United States|Novartis Investigative Site, Seattle, Washington",United States,Respiratory Diseases,1,1,204.0
2686.0,NCT04723537,"Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 Disease",,Recruiting,COVID-19,,,,,,,Drug: Part A: Upamostat 200 mg|Drug: Part A: Upamostat 400 mg|Drug: Part A and B: Placebo|Drug: Part B: Upamostat 200 or 400 mg,RedHill Biopharma Limited,All,"18 Years and older   (Adult, Older Adult)",310.0,Industry,Interventional,2021-02-16,01/09/21,2021-01-09,25/01/21,02/04/21,"RecioMed Clinical Research Network, Inc., Boynton Beach, Florida, United States|South Florida Research Phase I-IV, Inc., Miami Springs, Florida, United States|Floridian Research Institute, Miami, Florida, United States|Henry Ford Hospital, emergency department, Detroit, Michigan, United States|University Hospitals Cleveland, Cleveland, Ohio, United States|DM Clinical Research, Tomball, Texas",United States,Respiratory Diseases,1,1,-38.0
2687.0,NCT04384471,Covid-19 Pandemic: Patients' Experience in T1D,,Completed,Type1diabetes,COVID-19,,,,,,Other: Online survey,McGill University|Juvenile Diabetes Research Foundation|Canadian Institutes of Health Research (CIHR),All,"1 Year and older   (Child, Adult, Older Adult)",384.0,Other,Observational,2020-04-29,01/07/20,2020-01-07,12/05/20,24/02/21,"Institut de Recherches Cliniques de Montréal, Montreal, Quebec",Canada,Respiratory Diseases,1,2,-113.0
2688.0,NCT04723563,Nebulized Heparin for the Treatment of COVID-19,INHALE-HEP,Enrolling by invitation,COVID-19,"Pneumonia, Viral",,,,,,Drug: Heparin|Drug: 0.9%sodium chloride,Frederick Health,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-02-22,01/05/21,2021-05-29,25/01/21,24/02/21,"Frederick Health Hospital, Frederick, Maryland",United States,Respiratory Diseases,1,2,96.0
2689.0,NCT04542512,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,ChoCO-W,Recruiting,"Cholecystitis, Acute",Cholecystitis; Gangrenous,Cholecystitis Suppurative,COVID-19,,,,,"Poissy-Saint Germain Hospital|World Society of Emergency Surgery|Intercontinental society of Natural Orifice, Endoscopic, and Laparoscopic Surgery",All,"18 Years to 100 Years   (Adult, Older Adult)",800.0,Other,Observational,2020-01-10,30/09/21,2021-01-12,09/09/20,26/03/21,"Centre Hospitalier Intercommunal Poissy-Saint Germain en Laye, Poissy",France,Respiratory Diseases,1,4,368.0
2690.0,NCT04479280,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,,Completed,Coagulation Disorder,,,,,,,"Device: Sonclot Coagulation and platelet function Analyzer SCP1, Sienco, USA",Assiut University,All,"Child, Adult, Older Adult",70.0,Other,Observational,2020-07-20,16/08/20,2020-08-16,21/07/20,09/09/20,"Assiut university, Assiut",Egypt,Others,0,1,27.0
2691.0,NCT04508972,The VOICE-COVID-19,,Recruiting,COVID-19,,,,,,,Device: Alexa Amazon,McGill University Health Centre/Research Institute of the McGill University Health Centre|Amazon Web Services (AWS) Canada|University of California,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-07,01/10/20,2020-01-11,11/08/20,28/09/20,"Muhc-Rimuhc, Montreal, Quebec",Canada,Respiratory Diseases,1,1,4.0
2692.0,NCT04327804,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,,Recruiting,SARS-CoV Infection,,,,,,,Diagnostic Test: Odd/Even birth year intervention groups,Dr. Deneen Vojta|PATH|Mayo Clinic|Bill and Melinda Gates Foundation|UnitedHealth Group,All,"Child, Adult, Older Adult",120.0,Industry|Other,Observational,2020-03-25,03/04/20,2020-10-04,31/03/20,14/04/20,"Everett Clinic, Seattle, Washington",United States,Respiratory Diseases,1,1,193.0
2693.0,NCT04393415,Using PRP and Cord Blood in Treatment of Covid -19,,Recruiting,Virus,,,,,,,Combination Product: stem cells,Aljazeera Hospital,All,"20 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-25,25/08/20,2020-01-09,19/05/20,27/07/20,"Aljazeera( Al Gazeera) hospital, Giza",Egypt,Others,0,1,-137.0
2694.0,NCT04456049,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Enzalutamide,"Ricardo Pereira Mestre|Oncology Institute of Southern Switzerland|Institute of Oncology Research|Institute for Research in Biomedicine|Ente Ospedaliero Cantonale, Bellinzona",Male,"50 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-07,01/12/21,2021-01-12,02/07/20,02/07/20,"Oncology Institute of Southern Switzerland (IOSI), Bellinzona",Switzerland,Respiratory Diseases,1,1,371.0
2695.0,NCT04339998,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),,Recruiting,Coronavirus Infection,COVID-19,COVID-19,COVID-19,,,,Diagnostic Test: Point-of-Care Ultrasonography (POCUS),University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-15,01/10/20,2020-01-10,09/04/20,03/09/20,"University of Minnesota Medical Center (UMMC), Minneapolis, Minnesota, United States|M Health Fairview Bethesda Hospital, Saint Paul, Minnesota",United States,Respiratory Diseases,1,4,-96.0
2696.0,NCT04460469,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,,Recruiting,Anxiety,COVID-19,Oral Hygiene,,,,,,Cairo University,All,"Child, Adult, Older Adult",1500.0,Other,Observational,2020-01-07,01/09/20,2020-01-09,07/07/20,08/07/20,"Faculty of Dentistry, Cairo University, Cairo",Egypt,"Mental Health, Respiratory Diseases",1,3,2.0
2697.0,NCT04360824,Covid-19 Associated Coagulopathy,,Recruiting,COVID-19,,,,,,,Drug: Intermediate dose thromboprophylaxis|Drug: Standard of Care thromboprophylaxis,University of Iowa,All,"18 Years to 100 Years   (Adult, Older Adult)",170.0,Other,Interventional,2020-06-05,16/04/21,2021-04-16,24/04/20,19/06/20,"University of Iowa, Iowa City, Iowa, United States|Gundersen Health System, La Crosse, Wisconsin",United States,Respiratory Diseases,1,1,315.0
2698.0,NCT04816760,Immune Cells Phenotypes During COVID-19,IMMUNO-COVID,Recruiting,Sars-CoV2,Innate Immunity,Immunization; Infection,Alveolar Lung Disease,Endothelial Dysfunction,,,Biological: Peripheral blood samples,"Institut Hospitalo-Universitaire Méditerranée Infection|Hôpital Européen Marseille|Assistance Publique Hopitaux De Marseille|Institut Paoli-Calmettes|Beckman Coulter, Inc.",All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Observational,2020-03-25,01/06/21,2021-01-12,25/03/21,25/03/21,"Hopital Europeen Marseille, Marseille, France|Hopital Nord, Marseille",France,Respiratory Diseases,1,5,293.0
2699.0,NCT04456361,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,,"Active, not recruiting","ARDS, Human",COVID-19,,,,,,Biological: Mesenchymal Stem Cells derived from Wharton Jelly of Umbilical cords,Instituto de Medicina Regenerativa,All,"18 Years and older   (Adult, Older Adult)",9.0,Industry,Interventional,2020-04-16,15/10/20,2020-12-15,02/07/20,04/08/20,"Instituto de Medicina Regenerativa, Tijuana, Baja California",Mexico,Respiratory Diseases,1,2,243.0
2700.0,NCT04368000,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,PAPR,Terminated,Respiratory Failure,COVID-19,,,,,,Behavioral: Intermittent prone positioning instructions|Behavioral: Usual care positioning with no instructions,University of Utah,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-29,06/08/20,2020-06-08,29/04/20,03/12/20,"University of Utah Health Sciences Center, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,40.0
2701.0,NCT04373044,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Baricitinib|Drug: Hydroxychloroquine|Drug: Placebo Administration,University of Southern California|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",144.0,Other|NIH,Interventional,2020-01-05,01/05/21,2022-01-05,04/05/20,02/06/20,"Los Angeles County-USC Medical Center, Los Angeles, California, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California",United States,Respiratory Diseases,1,1,731.0
2702.0,NCT04701606,The Safety and Efficacy of Pyronaridine-artesunate (Pyramax® or Artecom®)in COVID-19 Patients,PROVIDENCE,Recruiting,COVID-19,,,,,,,Drug: Artecom® (pyronaridine-artesunate)|Drug: Placebo,Shin Poong Pharmaceutical Co. Ltd.,All,"19 Years and older   (Adult, Older Adult)",402.0,Industry,Interventional,2021-03-29,15/10/21,2021-10-15,08/01/21,30/03/21,"Lung Center of the Philippines, Quezon City, Quezon Avenue, Quezon City, 1100 Philippines, Philippines|Philippine General Hospital, Manila, Taft Ave, Ermita, Manila, 1000 Metro",Philippines,Respiratory Diseases,1,1,200.0
2703.0,NCT04335097,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,HSC19,Recruiting,COVID-19,,,,,,,Device: Biosensors,Lars Wik|University of Stavanger|Oslo University Hospital|Norwegian Telemedicine|University of Basque Country (UPV/EHU),All,"18 Years and older   (Adult, Older Adult)",214.0,Other,Interventional,2020-04-22,08/04/21,2025-12-20,06/04/20,13/05/20,"Lillestrom legevakt, Lillestrom",Norway,Respiratory Diseases,1,1,2068.0
2704.0,NCT04641858,BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,EDCTP,Recruiting,COVID-19,Morbidity,Absenteeism,,,,,Biological: BCG-Denmark|Biological: Saline,"University of Southern Denmark|Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal|University of Cape Verde, Praia, Cape Verde|National Institute of Public Health of Cape Verde, Praia, Cape Verde|Centro de Investigacao em Saude de Manhica|European and Developing Countries Clinical Trials Partnership (EDCTP)|Bandim Health Project, Bissau, Guinea-Bissau",All,"18 Years and older   (Adult, Older Adult)",1050.0,Other,Interventional,2020-03-12,01/02/22,2022-01-03,24/11/20,04/12/20,"Cape Verde, Praia, Santiago, Cape Verde|Bandim Health Project, Bissau, SAB, Guinea-Bissau|Manhiça Health Research Centre, Manhiça, Maputo",Mozambique,Respiratory Diseases,1,3,662.0
2705.0,NCT04684446,AstraZeneca Vax - Sputnik V Combination Study,,Not yet recruiting,COVID-19,,,,,,,Biological: AZD1222|Biological: rAd26-S,AstraZeneca|R-Pharm|The Russian Direct Investment Fund (RDIF)|The Gamaleya National Center of Epidemiology & Microbiology,All,"18 Years to 130 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2021-03-30,12/10/21,2021-12-10,24/12/20,11/03/21,"Research Site, Vitebsk, Belarus|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, Saint-Petersburg, Russian Federation|Research Site, St. Petersburg",Russian Federation,Respiratory Diseases,1,1,255.0
2706.0,NCT04508933,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",,Not yet recruiting,"Respiratory Distress Syndrome, Adult",Ventilation Perfusion Mismatch,Pulmonary Edema,COVID-19,,,,Device: Extravascular Lung Water Index|Device: Pulmonary Vascular Permeability Index,Istanbul University-Cerrahpasa,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-01-09,30/09/20,2020-12-31,11/08/20,11/08/20,"Istanbul University-Cerrahpaşa, Istanbul",Turkey,Respiratory Diseases,1,4,357.0
2707.0,NCT04591600,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: Ivermectin and Doxycyline|Drug: Standard of care,Alkarkh Health Directorate-Baghdad,All,"16 Years to 86 Years   (Child, Adult, Older Adult)",140.0,Other,Interventional,2020-01-07,30/09/20,2020-10-14,19/10/20,19/10/20,"Akarkh Healt hdirectorate, Baghdad",Iraq,Respiratory Diseases,1,1,281.0
2708.0,NCT04517682,COVID-19 and SARS-CoV-2 Detection in Saliva,,Enrolling by invitation,RNA Virus Infections,,,,,,,Diagnostic Test: RT-PCR,Ambry Genetics|The Saratoga Hospital|St. Joseph Hospital of Orange|Crozer-Keystone Health System,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry|Other,Observational,2020-05-21,15/12/20,2020-12-30,18/08/20,25/08/20,"Ambry Genetics, Aliso Viejo, California",United States,Others,0,1,223.0
2709.0,NCT04366765,COVID-19 Survival - The COVIVA Study,COVIVA,Recruiting,COVID-19,SARS-CoV 2,,,,,,,"University Hospital, Basel, Switzerland",All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-03-19,30/06/21,2021-06-30,29/04/20,04/05/20,"University Hospital Basel, Basel",Switzerland,Respiratory Diseases,1,2,468.0
2710.0,NCT04728698,Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress,,Not yet recruiting,COVID-19,ARDS,,,,,,Drug: COVI-MSC|Drug: Placebo,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2021-01-03,01/09/21,2021-01-09,28/01/21,02/02/21,"Fresno Community Hospital, Fresno, California",United States,Respiratory Diseases,1,2,6.0
2711.0,NCT04344938,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,,Not yet recruiting,COVID-19,,,,,,,Other: questionnair about Emerging Legal and Ehical Disputes Over Patient Confidentiality,Assiut University|Doaa M.EL Shehaby,All,18 Years to 60 Years   (Adult),874.0,Other,Observational,2020-01-04,01/06/20,2020-01-07,14/04/20,17/04/20,,,Respiratory Diseases,1,1,3.0
2712.0,NCT04357886,Awareness of COVID-19 in Turkey,,Completed,Healthy,,,,,,,,Istanbul University-Cerrahpasa,All,"15 Years to 65 Years   (Child, Adult, Older Adult)",2605.0,Other,Observational,2020-05-15,01/06/20,2020-01-06,22/04/20,26/03/21,"Istanbul University-Cerrahpasa, Istanbul",Turkey,Others,0,1,-130.0
2713.0,NCT04410016,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,COVID-WELL,Recruiting,Mental Health Wellness 1,,,,,,,Other: Staff Wellbeing Centres,University of Nottingham|Nottingham University Hospitals NHS Trust,All,"Child, Adult, Older Adult",45.0,Other,Interventional,2020-05-25,31/07/20,2020-11-30,01/06/20,12/06/20,"Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire",United Kingdom,Others,0,1,189.0
2714.0,NCT04327180,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,PREDICT,Recruiting,Infection Viral,Coronavirus,ARDS,Pneumonia,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-30,01/09/21,2021-01-09,30/03/20,06/04/20,"Hôpital Roger Salengro, ICU, CHU Lille, Lille",France,Respiratory Diseases,1,4,285.0
2715.0,NCT04753619,Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management,,Recruiting,COVID-19,SARS Pneumonia,,,,,,Drug: Niclosamide Oral Tablet,University of Baghdad,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-03-01,03/05/21,2021-03-05,15/02/21,17/02/21,"Ahmed S. Abdulamir, Baghdad, Baghdada",Iraq,Respiratory Diseases,1,2,4.0
2716.0,NCT04715438,Vaccination Against COVID-19 in Cancer,VOICE,Recruiting,Cancer,,,,,,,,University Medical Center Groningen,All,"18 Years and older   (Adult, Older Adult)",873.0,Other,Observational,2021-08-01,01/07/21,2023-01-04,20/01/21,29/01/21,"NKI-AvL, Amsterdam, Netherlands|UMCG, Groningen, Netherlands|Erasmus MC, Rotterdam",Netherlands,Cancers,1,1,521.0
2717.0,NCT04432324,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),,Completed,COVID-19,,,,,,,Biological: Intravenous Immune Globulin|Drug: Standard Medical Treatment,"Instituto Grifols, S.A.|Grifols Therapeutics LLC",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-02-06,03/03/21,2021-03-03,16/06/20,10/03/21,"Hospital Universitario Infanta Sofía, San Sebastián De Los Reyes, Madrid, Spain|Hospital Germans Trias i Pujol, Badalona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Universitari de Bellvitge, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario de Getafe, Getafe, Spain|Hospital Arnau de Vilanova, Lleida, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Clinico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,391.0
2718.0,NCT04369742,Treating COVID-19 With Hydroxychloroquine (TEACH),,Suspended,COVID-19,,,,,,,Drug: Hydroxychloroquine (HCQ)|Other: Pacebo: Calcium citrate,NYU Langone Health|State University of New York - Downstate Medical Center,All,"18 Years and older   (Adult, Older Adult)",626.0,Other,Interventional,2020-04-15,01/06/21,2021-01-06,30/04/20,02/07/20,"State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York, United States|NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,266.0
2719.0,NCT04581915,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,PHRUCov01,Recruiting,COVID-19,,,,,,,Drug: Triazavirin (Riamilovir)|Other: Placebo,Wits Health Consortium (Pty) Ltd|PharmaCentrix (Pty) Ltd|Perinatal HIV Research Unit of the University of the Witwatersrand,All,"18 Years and older   (Adult, Older Adult)",420.0,Other,Interventional,2020-08-09,31/12/21,2021-12-31,09/10/20,12/04/21,"The Perinatal HIV Research Unit - Matlosana, Klerksdorp, North West Province",South Africa,Respiratory Diseases,1,1,509.0
2720.0,NCT04779879,"Safety, Tolerability and Pharmacokinetics of Second Generation VIR-7831 Material in Non-hospitalized Participants With Mild to Moderate COVID-19",COMET-PEAK,Recruiting,COVID-19,,,,,,,Biological: VIR-7831 (Gen1)|Biological: VIR-7831 (Gen2),"Vir Biotechnology, Inc.|GlaxoSmithKline",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2021-02-18,01/04/21,2021-01-09,03/03/21,03/03/21,"Investigative Site, Anniston, Alabama, United States|Investigative Site, Bakersfield, California, United States|Investigative Site, Fort Pierce, Florida, United States|Investigative Site, Winfield, Illinois, United States|Investigative Site, Rockville, Maryland",United States,Respiratory Diseases,1,1,-40.0
2721.0,NCT04359602,COVID-19 Recovered Volunteer Research Participant Pool Registry,,Recruiting,COVID-19,,,,,,,,"University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-08-04,20/04/22,2042-04-20,24/04/20,04/05/20,"Ronald Reagan UCLA Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,1,7929.0
2722.0,NCT04730427,Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: GX-I7|Drug: GX-I7 vehicle,"Genexine, Inc.",All,"19 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2021-01-01,01/05/21,2022-01-04,29/01/21,29/01/21,"Borame Medical Center, Seoul, Korea",Republic of,Respiratory Diseases,1,1,368.0
2723.0,NCT04441424,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,,Completed,IMMUNOTHERAPY,,,,,,,Biological: Convalescent plasma|Drug: Hydroxychloroquin with Azithromycin,Alkarkh Health Directorate-Baghdad,All,"18 Years and older   (Adult, Older Adult)",49.0,Other,Interventional,2020-03-04,01/06/20,2020-01-06,22/06/20,23/06/20,"Akarkh Healt hdirectorate, Baghdad",Iraq,Others,0,1,-58.0
2724.0,NCT04404361,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,,Recruiting,COVID-19,COVID-19,COVID-19,,,,,Drug: Pacritinib|Drug: Placebo,CTI BioPharma,All,"18 Years and older   (Adult, Older Adult)",364.0,Industry,Interventional,2020-05-22,31/07/21,2021-10-31,27/05/20,19/01/21,"St. Jude Hospital Yorba Linda dba St. Joseph Heritage Healthcare, Orange, California, United States|Ascension St. Vincent's Riverside Hospital, Jacksonville, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|St. Vincent Medical Group, Inc, Indianapolis, Indiana, United States|St. Agnes Healthcare, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Ascension St. John Hospital, Detroit, Michigan, United States|Ascension Providence Hospital - Novi Campus, Novi, Michigan, United States|Providence Cancer Institute, Southfield, Michigan, United States|Atlantic Melanoma Center, Morristown, New Jersey, United States|Overlook Medical Center, Morristown, New Jersey, United States|Chilton Medical Center, Pompton Plains, New Jersey, United States|Mount Sinai Medical Center, New York, New York, United States|The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, Cincinnati, Ohio, United States|St. John Medical Center, Tulsa, Oklahoma, United States|Albert Einstein Medical Center, Philadelphia, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|The Miriam Hospital, Providence, Rhode Island, United States|Ascension St. Francis Hospital, Milwaukee, Wisconsin, United States|Ascension All Saints, Racine, Wisconsin",United States,Respiratory Diseases,1,3,527.0
2725.0,NCT04808284,Neuromodulation in COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Device: Transcranial direct-current stimulation|Device: Sham Transcranial direct-current stimulation,D'Or Institute for Research and Education|Rio de Janeiro State Research Supporting Foundation (FAPERJ)|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.,All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-04,01/04/22,2022-01-04,22/03/21,22/03/21,"D'Or Institute for Research and Education (IDOR), Rio de Janeiro, RJ",Brazil,Respiratory Diseases,1,1,365.0
2726.0,NCT04449588,Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,,Recruiting,COVID-19,,,,,,,Drug: BDB-001 Injection|Other: Conventional treatment,"Staidson (Beijing) Biopharmaceuticals Co., Ltd|Beijing Defengrui Biotechnology Co. Ltd",All,"18 Years to 80 Years   (Adult, Older Adult)",368.0,Industry|Other,Interventional,2020-07-23,07/08/21,2022-07-08,29/06/20,11/02/21,"Asgar Ali Hospital, Dhaka, Bangladesh|Bangladesh Specialized Hospital, Dhaka, Bangladesh|Southwest Hospital Chongqing, Chongqing, Chongqing, China|Noble Hospital Pvt Ltd, Nagpur, India|Government Medical College and Hospital, Pune, India|RSUP Persahabatan(Persahabatan General Hospital), East Jakarta, Jakarta, Indonesia|RSUD Pasar Minggu(Pasar Minggu General Hospital), South Jakarta, Jakarta, Indonesia|RSUD Cengkareng(Cengkareng General Hospital), West Jakrata, Jakrata, Indonesia|Hospital Universitario 12 De Octubre, Madrid, Spain|Hospital Universitario Clínico San Carlos, Madrid, Spain|Hospital Universitario de la Princesa, Madrid, Spain|Hospital Universitario Fundación Díaz, Madrid",Spain,Respiratory Diseases,1,1,715.0
2727.0,NCT04793464,COVID-19: Healthy Oregon (Oregon Saludable): Together We Can (Juntos Podemos),OSJP,Recruiting,Health Behavior,Health Care Utilization,,,,,,Behavioral: Promotores de Salud|Behavioral: Services as usual,University of Oregon|National Institute on Drug Abuse (NIDA)|National Institutes of Health (NIH),All,"3 Years and older   (Child, Adult, Older Adult)",3600.0,Other|NIH,Interventional,2021-04-02,31/08/21,2022-08-31,11/03/21,01/04/21,"University of Oregon, Eugene, Oregon",United States,Others,0,2,516.0
2728.0,NCT04500067,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",,Completed,COVID-19,Pneumonia,,,,,,Drug: IVIG,Biopharma Plasma LLC|Lviv National Medical University|Vinnitsa National Medical University,All,"18 Years and older   (Adult, Older Adult)",76.0,Industry|Other,Interventional,2020-07-05,15/09/20,2020-09-15,05/08/20,14/10/20,"Site 08 - Central City Clinical Hospital of Ivano-Frankivsk City Council, Ivano-Frankivs'k, Ivano-Frankivs'k Region, Ukraine|Site 02 - Bila Tserkva City Hospital №3, Bila Tserkva, Kyiv Region, Ukraine|Site 03 - Lviv Regional Infectious Diseases Clinical Hospital, Lviv, Lviv Region, Ukraine|Site 04 - City Clinical Infectious Diseases Hospital, Odesa, Odesa, Odesa Region, Ukraine|Site 07 - Ternopil City Municipal Ambulance Hospital, Ternopil', Ternopil' Region, Ukraine|Site 06 - Vinnytsia City Clinical Hospital №1, Vinnitsia, Vinnitsia Region, Ukraine|Site 09 - Volyn Regional Clinical Hospital, Luts'k, Volyn Region, Ukraine|Site 01 - Kyiv City Clinical Hospital №17, Kyiv, Ukraine|Site 05 - Kyiv City Clinical Hospital №4, Kyiv",Ukraine,Respiratory Diseases,1,2,72.0
2729.0,NCT04491201,National Survey of the Impact of COVID-19 Pandemics,CMDA-SURVEY2,Recruiting,COVID-19,Obstetrics and Gynecology,Workload,Questionnaire,National Survey,China,,Other: Customized questionnaire,Lei Li|Peking Union Medical College Hospital,All,"18 Years and older   (Adult, Older Adult)",6000.0,Other,Observational,2020-07-27,27/09/20,2020-09-27,29/07/20,29/07/20,"Lei Li, Beijing, Beijing",China,Respiratory Diseases,1,6,62.0
2730.0,NCT04410354,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,,Terminated,COVID-19,,,,,,,Drug: Merimepodib|Drug: Matching Placebo|Drug: Remdesivir,"ViralClear Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",44.0,Industry,Interventional,2020-06-16,01/12/20,2020-01-12,01/06/20,08/12/20,"Mayo Clinic in Arizona, Phoenix, Arizona, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mayo Clinic, Rochester, Minnesota, United States|Atlantic Health System / Morristown Medical Center, Morristown, New Jersey, United States|Atlantic Health System / Overlook Medical Center, Summit, New Jersey, United States|St. David's South Austin Medical Center, Austin, Texas, United States|St. David's Medical Center, Austin, Texas, United States|HCA Houston Healthcare Medical Center, Houston, Texas, United States|HCA Houston Healthcare Mainland, Texas City, Texas",United States,Respiratory Diseases,1,1,-156.0
2731.0,NCT04672395,A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19,SCB-2019,Not yet recruiting,COVID-19,,,,,,,Biological: CpG 1018/Alum-adjuvanted SCB-2019 vaccine|Biological: Placebo; 0.9% saline,Clover Biopharmaceuticals AUS Pty Ltd|Coalition for Epidemic Preparedness Innovations|International Vaccine Institute,All,"18 Years and older   (Adult, Older Adult)",22000.0,Industry|Other,Interventional,2021-01-03,01/07/22,2022-01-07,17/12/20,09/02/21,"Anima, Alken, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|Private Practice RESPISOM Namur, Namur, Belgium|Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro, Rio Do Janeiro, Brazil|Instituto Atena de Pesquisa Clinica, Natal, Rio Grande Do Norte, Brazil|CPCLIN - Centro de Pesquisas Clínicas de Natal, Natal, Rio Grande Do Norte, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital da Universidade Federal de Santa Maria CEP/UFSM, Santa Maria, Rio Grande Do Sul, Brazil|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Bogotá D.C., Bogotá, Cundinamarca, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Acacías, Acacías, Colombia|Clínica de la Costa Ltda., Barranquilla, Colombia|Centro de Estudios en Infectología Pediátrica S.A.S. - CEIP S.A.S., Cali, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Aguazul, Casanare, Colombia|Centro de Atención e investigación Médica S.A.S, CAIMED S.A.S - sede Yopal, Yopal, Colombia|Centro Sanitario de Santo Domingo (Satellite Site), Santo Domingo, Dominican Republic|Hospital Universitario Maternidad Nuestra Senora de la Altagracia., Santo Domingo, Dominican Republic|Klinikum Würzburg Mitte gGmbH - Standort Juliusspital, Wuerzburg, Bayern, Germany|IKF Pneumologie GmbH & Co. KG, Frankfurt am Main, Hessen, Germany|IKF Pneumologie Mainz, Mainz, Rheinland Pfalz, Germany|Berliner Centrum f. Reise- und Tropenmedizin (BCRT), Berlin, Germany|Institute of Medicine, Maharajgunj, Kathmandu, Nepal|Dhulikhel Hospital, Dhulikhel, Nepal|Cevaxin David, David, Doleguita, Panama|Cevaxin 24 de diciembre, Ciudad de Panamá, Panama|Cevaxin Panama Clinic, Ciudad de Panamá, Panama|CEVAXIN Chorrera, Panama, Panama|Instituto de Investigaciones Cientificas y Servicios de Alta Tecnologia INDICASAT, Panama, Panama|Cevaxin Av Mexico, Panamá, Panama|De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite, Philippines|Las Pinas Doctors Hospital, Las Piñas, Philippines|Tropical Disease Foundation, Makati, Philippines|Manila Doctors Hospital, Manila, Philippines|University of the Philippines Manila - College of Public Health, Manila, Philippines|Asian Hospital and Medical Center, Muntinlupa, Philippines|UERM Memorial Medical Center, Quezon City, Philippines|University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines|FEU-NRMF Medical Center, Quezon City, Philippines|St. Luke's Medical Center, Taguig, Philippines|KO-MED Centra Kliniczne Lublin II, Lublin, Poland|KO-MED Centra Kliniczne Pulawy, Puławy, Poland|Centrum Medyczne Medyk, Rzeszów, Poland|Centrum Medyczne Pratia Poznan, Skórzewo, Poland|KO-MED Centra Kliniczne Staszow, Staszów, Poland|ETG Warszawa, Warszawa, Poland|Wits Clinical Research, Johannesburg, Gauteng, South Africa|DJW Research, Krugersdorp, Gauteng, South Africa|Soweto Clinical Trials Centre, Soweto, Gauteng, South Africa|Dr JM Engelbrecht Trial Site, Somerset West, Western Cape",South Africa,Respiratory Diseases,1,1,369.0
2732.0,NCT04318431,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,COVILLE,Completed,COVID-19,,,,,,,Diagnostic Test: Data collection and rhinopharyngeal swab,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne,All,up to 15 Years   (Child),605.0,Other,Interventional,2020-04-14,12/05/20,2020-01-06,24/03/20,09/07/20,"Cabinet du Dr Belaroussi, Boulogne, France|Cabinet du Dr Derkx, Champigny-sur-Marne, France|Cabinet du Dr Coicadan, Chennevières-sur-Marne, France|14 Av rené Samuel, Clamart, France|Cabinet du Dr Corrard, Combs-la-Ville, France|10 rue Delambre, Lagny-sur-Marne, France|157 Avenue du Général Leclerc, Maisons-Alfort, France|21 Grande Rue Charles de Gaulle, Nogent-sur-Marne, France|Cabinet du Dr Deberdt, Nogent-sur-Marne, France|Cabinet du Dr Wollner, Nogent-sur-Marne, France|4 allée des Norottes, Noisy-le-Grand, France|Cabinet du Dr D'acremont, Paris, France|146 Avenue Ledru Rollin, Paris, France|132 Boulevard du Montparnasse, Paris, France|Cabinet du Dr Romain, Paris, France|Cabinet du Dr Turberg-Romain, Paris, France|15 Quai Louis Blériot, Paris, France|Cabinet du Dr Michot, Paris, France|24 rue Volta, Puteaux, France|Cabinet du Dr Cohen, Saint-Maur-des-Fossés, France|Cabinet de Pédiatrie des Docteurs Ravilly et Bessa, Villejuif, France|13 Villa Beauséjour, Vincennes",France,Respiratory Diseases,1,1,-99.0
2733.0,NCT04579549,Repeat Testing for SARS-CoV-2,,Enrolling by invitation,COVID-19,Sars-CoV-2,,,,,,Device: Saliva Assay,"University of Wisconsin, Madison|National Institutes of Health (NIH)",All,"5 Years and older   (Child, Adult, Older Adult)",10000.0,Other|NIH,Interventional,2020-09-29,01/09/21,2021-01-09,08/10/20,14/10/20,"University of Wisconsin, Madison, Wisconsin",United States,Respiratory Diseases,1,2,102.0
2734.0,NCT04385095,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,,"Active, not recruiting",COVID-19,,,,,,,Drug: SNG001|Drug: Placebo,Synairgen Research Ltd.,All,"18 Years and older   (Adult, Older Adult)",820.0,Industry,Interventional,2020-03-16,17/02/21,2021-05-31,12/05/20,23/03/21,"Belfast City Hospital, Belfast, United Kingdom|Queen Elizabeth Hospital,, Birmingham, United Kingdom|Bradford Royal Infirmary, Bradford, United Kingdom|Park and St Francis Surgery, Chandler's Ford, United Kingdom|Hull and East Yorkshire NHS Trust, Castle Hill Hospital,, Hull, United Kingdom|Glenfield Hospital,, Leicester, United Kingdom|Wythenshawe Hospital, Manchester, United Kingdom|City Campus of Nottingham University, Nottingham, United Kingdom|John Radcliffe Hospital, Oxford, United Kingdom|The Adam Practice, Poole, United Kingdom|The Virtual Team, Southampton, United Kingdom|University Hospital Southampton Nhs Foundation Trust, Southampton, United Kingdom|Oaks Healthcare, Waterlooville",United Kingdom,Respiratory Diseases,1,1,441.0
2735.0,NCT04743011,Enriched Heparin Anti COVID-19 Trial,EnHanCed,Not yet recruiting,COVID-19,,,,,,,Drug: Heparin sodium|Drug: Placebo,UPECLIN HC FM Botucatu Unesp,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-02-15,30/07/21,2021-12-31,08/02/21,10/02/21,"School of Medicine at Botucatu- Paulista State University- UNESP, São Paulo, Brazil, Botucatu, SP",Brazil,Respiratory Diseases,1,1,319.0
2736.0,NCT04317092,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),TOCIVID-19,"Active, not recruiting",COVID-19,,,,,,,Drug: Tocilizumab Injection,"National Cancer Institute, Naples",All,"Child, Adult, Older Adult",402.0,Other,Interventional,2020-03-19,19/12/21,2022-12-19,20/03/20,03/03/21,"Azienda Ospedaliera SS. Antonio e Biagio e C. Arrigo (Dipartimento Internistico SSD Reumatologia), Alessandria, Italy|Ospedale di Busto Arsizio ASST Valle Olona (U.O.C. Malattie Infettive), Busto Arsizio, Italy|A.O.U. Policlinico V. Emanuele (U.O. di Malattie infettive, U.O. di Anestesia e Rianimazione, U.O. di Medicina d'Urgenza), Catania, Italy|AOE Cannizzaro di Catania (U.O. di Malattie Infettive, U.O. di Anestesia e Rianimazione, U.O., Catania, Italy|Ospedale Annunziata Azienda Ospedaliera di Cosenza (U.O.C. Malattie Infettive), Cosenza, Italy|ASST OVEST MILANESE presidi Legnano - Magenta, Magenta, Italy|Azienda Ospedaliero-Universitaria di Modena, Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione I), Modena, Italy|A.O.U. di Modena (Dipartimento Chirurgie Generali e Specialità Chirurgiche - Struttura Complessa di Anestesia e Rianimazione II), Modena, Italy|A.O.U. di Modena (Dipartimento Medicine Specialistiche - Struttura Complessa Malattie Infettive), Modena, Italy|Dipartimento Medicine Specialistiche - Struttura Complessa Malattie dell'Apparato Respiratorio, Modena, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Oncologia), Naples, Italy|National Cancer Institute, Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Anestesia Rianimazione e terapia intensiva), Naples, Italy|A.O.R.N. Ospedale dei Colli Monaldi-Cotugno-CTO (U.O.C. Malattie Infettive ad indirizzo respiratorio), Naples, Italy|A.O. Ospedali Riuniti Marche Nord - Presidio Ospedaliero San Salvatore di Pesaro (UOC Pronto Soccorso e Medicina d'Urgenza), Pesaro, Italy|Denominazione: UOC di Medicina e Chirurgia d'Accettazione e d'Urgenza dell'Ospedale Santa Maria delle Grazie di Pozzuoli, Pozzuoli, Italy|Ospedale Santa Maria delle Croci, AUSL della Romagna (U.O. Anestesia e Rianimazione), Ravenna, Italy|Grande Ospedale Metropolitano, Reggio Calabria, Reggio Calabria, Italy|Ospedale Infermi, AUSL della Romagna (U.O. Malattie Infettive), Rimini, Italy|Policlinico Gemelli (U.O.C. Dipartimento Scienze di Laboratorio e Infettivologiche), Rome, Italy|ASST Sette Laghi (Dipartimento di Medicina Interna), Varese, Italy|ASST Sette Laghi (Dipartimento Emergenze ed Urgenze), Varese, Italy|ASST Sette Laghi (U.O.C. Anestesia e Rianimazione Neurochirurgica e Generale), Varese, Italy|ASST Sette Laghi (U.O.C. Malattie Infettive e Tropicali), Varese, Italy|A.O.U. Integrata di Verona (Dip. Malattie Infettive), Verona, Italy|Ospedale Magalini (U.O. Malattie Infettive), Villafranca Di Verona",Italy,Respiratory Diseases,1,1,1005.0
2737.0,NCT04547140,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: Liquid Alpha1-Proteinase Inhibitor (Human)|Drug: Placebo|Drug: Standard Medical Treatment,Grifols Therapeutics LLC,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2021-01-29,01/04/21,2021-01-09,14/09/20,02/04/21,"Birmingham VA, Birmingham, Alabama, United States|St. Joseph's Hospital, Phoenix, Arizona, United States|Hannibal Clinic, Hannibal, Missouri, United States|CHI Health Center, Omaha, Nebraska, United States|Columbia University Medical Center, New York, New York, United States|University of Utah, Salt Lake City, Utah, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|AngioCor Blumenau, Blumenau, Santa Catarina, Brazil|Hospital Sao Jose, Criciúma, Santa Catarina, Brazil|Hospital das Clinicas da Faculdade de Medicina de Botucatu, Botucatu, São Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo",Brazil,Respiratory Diseases,1,1,-20.0
2738.0,NCT04351581,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,RASCOVID-19,Recruiting,COVID-19,,,,,,,Other: Discontinuation of ACEi/ARB|Other: Continuation of ACEi/ARB,"University Hospital, Gentofte, Copenhagen",All,"18 Years and older   (Adult, Older Adult)",215.0,Other,Interventional,2020-05-18,01/12/20,2020-01-12,17/04/20,05/06/20,"Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Capital Region Of Denmark, Denmark|Department of Medicine, Herlev Hospital, University of Copenhagen, Herlev, Capital Region Of Denmark",Denmark,Respiratory Diseases,1,1,-127.0
2739.0,NCT04541485,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",,Not yet recruiting,COVID-19,,,,,,,Drug: DWRX2003|Drug: Placebo,Daewoong Pharmaceutical Co. LTD.,All,"18 Years to 65 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2020-06-10,20/10/20,2021-01-29,09/09/20,09/09/20,,,Respiratory Diseases,1,1,233.0
2740.0,NCT04369066,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Curie-O-SA,Recruiting,COVID-19,,,,,,,Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)|Diagnostic Test: Nasopharyngeal swabs,Institut Curie,All,"18 Years and older   (Adult, Older Adult)",2800.0,Other,Interventional,2020-04-28,28/04/21,2022-04-28,30/04/20,03/02/21,"Institut Curie, Paris, France|Institut Pasteur, Paris",France,Respiratory Diseases,1,1,730.0
2741.0,NCT04381052,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: Clazakizumab|Other: Placebo,Columbia University|NYU Langone Health|CSL Behring,All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-01-05,01/08/20,2020-01-08,08/05/20,08/05/20,"Columbia University Medical Center / New York Presbyerian Hospital, New York, New York",United States,Respiratory Diseases,1,1,3.0
2742.0,NCT04561141,Post Covid Syndrome: Clinical Pattern and Functional Assessment,,Not yet recruiting,COVID-19,,,,,,,,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",85.0,Other,Observational,2020-01-12,01/12/21,2022-01-01,23/09/20,25/09/20,,,Respiratory Diseases,1,1,720.0
2743.0,NCT04802642,"Evaluation of COVID-19 Fear, Anxiety and Their Effects in Physiotherapy Technician Students",,Completed,COVID-19,Anxiety and Fear,,,,,,Other: Survey,Ufuk University,All,"18 Years to 65 Years   (Adult, Older Adult)",80.0,Other,Observational,2021-01-01,01/03/21,2021-01-03,17/03/21,17/03/21,"Ufuk University, Ankara, Çankaya",Turkey,"Mental Health, Respiratory Diseases",1,2,2.0
2744.0,NCT04744415,Hospitalizations During Pandemia in the Italian Coronary Care Unit Network,BLITZ-COVID19,Recruiting,Management and Epidemiology of Patients Admitted in ICU,,,,,,,Other: Epidemiology of admissions,Heart Care Foundation,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-09-11,09/02/21,2021-09-02,09/02/21,09/02/21,"Ospedale Santo Spirito - Sc Cardiologia, Casale Monferrato, AL, Italy|Istituto Scientifico Inrca - Uo Cardiologia/Utic/Telecardiologia, Ancona, AN, Italy|Ospedale Generale Regionale-Po U. Parini - U.O. Cardiologia E Cure Intensive Card., Aosta, AO, Italy|Po Sant'Ottone Frangipane - U.O.C. Cardiologia - Utic, Ariano Irpino, AV, Italy|Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti', Avellino, AV, Italy|Ospedale Miulli - U.O.C. Cardiologia - Utic, Acquaviva Delle Fonti, BA, Italy|Aou Policlinico - Uoc Cardiologia Ospedaliera, Bari, BA, Italy|Ospedale Di Venere - U.O.C. Di Cardiologia, Bari, BA, Italy|Ospedale San Paolo - Cardiologia-Utic, Bari, BA, Italy|Ospedale Di Bentivoglio - U.O. Di Cardiologia, Bentivoglio, BO, Italy|Ospedale Maggiore - U.O. Di Cardiologia, Bologna, BO, Italy|Asst Spedali Civili - Cardiologia, Brescia, BS, Italy|Ospedale L. Bonomo - Cardiologia - Utic, Andria, BT, Italy|Ospedale Generale Regionale - Divisione Di Cardiologia, Bolzano, BZ, Italy|Arnas G. Brotzu - Cardiologia Con Utic, Cagliari, CA, Italy|A.O.U. Cagliari Policlinico Monserrato - Sc Cardiologia Utic Emodinamica, Monserrato, CA, Italy|Ospedale A. Cardarelli - U.O. Cardiologia E Utic, Campobasso, CB, Italy|Presidio Ospedaliero Moscati - U.O.C. Cardiologia-Utic, Aversa, CE, Italy|Az. Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia-Utic, Caserta, CE, Italy|Ospedale Civile Ave Gratia Plena - U.O. Di Cardiologia E Utic, Piedimonte Matese, CE, Italy|Ospedale San Giuseppe E Melorio - U.O.C. Cardiologia Utic, Santa Maria Capua Vetere, CE, Italy|Presidio Ospedaliero San Rocco - U.O.C. Cardiologia - Utic, Sessa Aurunca, CE, Italy|Ospedale San Pio Da Pietrelcina - Cardiologia, Vasto, CH, Italy|Ospedale Regina Montis Regalis - U.O. Cardiologia-Utic, Mondovì, CN, Italy|Ospedale Maggiore Ss. Annunziata - Sc Cardiologia, Savigliano, CN, Italy|Ospedale Moriggia Pelascini - Unita' Operativa Di Cardiologia, Gravedona, CO, Italy|Ospedale S. Anna - U.O.C. Di Cardiologia, San Fermo Della Battaglia, CO, Italy|P.O. Garibaldi Centro - U.O.C. Cardiologia, Catania, CT, Italy|Centro Cuore Morgagni - U.F. Utic Ed Emodinamica, Pedara, CT, Italy|Arcispedale Sant'Anna - U.O. Cardiologia - Utic, Ferrara, FE, Italy|Ospedali Riuniti - S.C. Di Cardiologia Univ.-Utic, Foggia, FG, Italy|Ospedale Casa Sollievo Della Sofferenza - Cardiologia - Utic - Riabil Cardiologica, San Giovanni Rotondo, FG, Italy|Presidio Ospedaliero T. Masselli Mascia - S.C. Cardiologia - Utic - Riabil. Card., San Severo, FG, Italy|Ospedale Santa Maria Annunziata - Cardiologia, Bagno A Ripoli, FI, Italy|Ospedale San Giuseppe - Cardiologia, Empoli, FI, Italy|Aou Careggi - Cardiologia Interventistica, Firenze, FI, Italy|Ospedale San Giovanni Di Dio - Cardiologia, Firenze, FI, Italy|Ospedale Santa Maria Nuova - Hdu Cardiologica/Utic, Firenze, FI, Italy|E.O. Ospedali Galliera - S. C. Cardiologia, Genova, GE, Italy|Presidio Ospedaliero - U.O. Cardiologia, Sanremo, IM, Italy|Ospedale Civile Sacro Cuore Di Gesu' - Uo Cardiologia Utic, Gallipoli, LE, Italy|Ospedale Ignazio Veris Delli Ponti - Uoc Cardiologia-Utic, Scorrano, LE, Italy|Azienda Osp. Cardinale G. Panico - U.O. Cardiologia - Utic, Tricase, LE, Italy|Ospedali Riuniti - U.O.C. Cardiologia E Utic, Livorno, LI, Italy|Nuovo Ospedale Versilia - Sc Cardiologia, Lido Di Camaiore, LU, Italy|Ospedale San Gerardo - U.O. Cardiologia-Utic, Monza, MB, Italy|Aor Papardo - U.O. Cardiologia Con Utic, Messina, ME, Italy|Ospedale Piemonte - Cardiologia E Utic, Messina, ME, Italy|Centro Cardiologico Monzino - Terapia Intensiva Cardiologica (Utic), Milano, MI, Italy|Irccs Policlinico Multimedica - Uo Di Cardiologia, Sesto San Giovanni, MI, Italy|Ospedale Civile Di Baggiovara - U.O. Di Cardiologia, Modena, MO, Italy|Ospedale San Francesco - Cardiologia - Utic, Nuoro, NU, Italy|Fondazione G. Giglio - U.O. Cardiologia E Utic, Cefalù, PA, Italy|Aor Villa Sofia-Cervello P.O. Cervello - U.O. Cardiologia - Cervello, Palermo, PA, Italy|Aor Villa Sofia-Cervello Po Villa Sofia - U.O.C. Cardiologia E Utic - Villa Sofia, Palermo, PA, Italy|Ospedale Civile 'Guglielmo Da Saliceto' - Uo Cardiologia, Piacenza, PC, Italy|Ospedale Civile Dello Spirito Santo - Utic E Cardiologia Interventistica, Pescara, PE, Italy|Presidio Ospedaliero Citta' Di Castello - U.O. Di Cardiologia, Città Di Castello, PG, Italy|Ospedale Gubbio-Gualdo Tadino - U.O. Di Utic E Cardiologia, Gubbio, PG, Italy|Ospedale Generale Provinciale Lotti - U.O. Malattie Cardiovascolari Vde E Avc, Pontedera, PI, Italy|Ospedale Di Pordenone - S.O.C. Cardiologia, Pordenone, PN, Italy|Ospedale Ss. Cosma E Damiano - U. O. Cardiologia - Utic, Pescia, Point, Italy|Ospedale Santo Stefano - U.O. Cardiologia, Prato, PO, Italy|Ospedale Generale Di Zona - U.O. Cardiologia - Utic, Lagonegro, PZ, Italy|Azienda Ospedaliera San Carlo - Ssd Utic, Potenza, PZ, Italy|Ospedale Per Gli Infermi - U.O. Cardiologia - Utic, Faenza, RA, Italy|Ospedale Civile Santa Maria Delle Croci - U.O. Di Cardiologia, Ravenna, RA, Italy|P.O. San Camillo de Lellis - U.O.C. Cardiologia, Rieti, RI, Italy|Ospedale Civile San Paolo - U.O. Cardiologia - Utic, Civitavecchia, RM, Italy|Ospedale S. Maria Goretti - Uoc Malattie Cardiovascolari, Latina, RM, Italy|Aurelia Hospital - U.O.C Cardiologia, Roma, RM, Italy|Clinica Citta' Di Roma - Cardiologia-Utic, Roma, RM, Italy|European Hospital - U.O. Cardiologia Interventistica, Roma, RM, Italy|Ospedale Fatebenefratelli - U.O.C. Cardiologia, Roma, RM, Italy|Ospedale San Camillo - Uoc Cardiologia, Roma, RM, Italy|Ospedale Sandro Pertini - Uoc Cardiologia, Roma, RM, Italy|Ospedale Sant'Andrea Di Roma - U.O.C. Cardiologia, Roma, RM, Italy|Ospedale Santa Maria Della Misericordia - U.O.C. Cardiologia, Rovigo, RO, Italy|Presidio Osped. S. Maria Della Speranza - U.O. Di Cardiologia, Battipaglia, SA, Italy|P.O. Nocera-Pagani - Osp. Umberto I - Uoc Cardiologia - Utic, Nocera Inferiore, SA, Italy|Presidio Ospedaliero Luigi Curto - Uo Cardiologia-Utic, Polla, SA, Italy|Aou S. Giovanni Di Dio-Ruggi D'Aragona - U.O.C. Utic, Salerno, SA, Italy|Ospedale San Luca - U.O. Utic - Cardiologia, Vallo Della Lucania, SA, Italy|Ospedale Dell'Alta Val D'Elsa - Uosd Cardiologia-Utic, Poggibonsi, SI, Italy|Aou Senese Ospedale S. Maria Alle Scotte - U.O.C. Cardiologia Clinico-Chirurg. Utic, Siena, SI, Italy|Ospedale Civile - U.O. Cardiologia, Sondrio, SO, Italy|Ospedale S. Andrea - S.C. Cardiologia, La Spezia, SP, Italy|Ospedale E. Muscatello - U.O. Di Cardiologia - Utic, Augusta, SR, Italy|Ospedale G. Di Maria - Cardiologia Utic, Avola, SR, Italy|P.O. Lentini - U.O. Di Cardiologia Con Utic, Lentini, SR, Italy|Ospedale Nostra Signora Di Bonaria - U.O.C. Cardiologia E Utic, San Gavino Monreale, SU, Italy|Ospedale Santa Maria Del Carmine - Cardiologia, Rovereto, TN, Italy|Ospedale Santa Chiara - Divisione Di Cardiologia, Trento, TN, Italy|Po S. Antonio Abate Di Trapani - U.O.C. Di Cardiologia E Utic, Erice, TP, Italy|Ospedale Santa Maria Dei Battuti - U.O. Di Cardiologia, Conegliano, TV, Italy|Pou Santa Maria Della Misericordia - S.O.C. Cardiologia, Udine, UD, Italy|Presidio Ospedaliero Di Saronno - U.O.C. Di Cardiologia, Saronno, VA, Italy|Ospedale Civile - U.O. Cardiologia, Mirano, VE, Italy|Ospedale Civile - U.O.C. Cardiologia, Arzignano, VI, Italy|Ospedale Civile San Bortolo - U.O.C. Cardiologia, Vicenza, VI, Italy|Ospedale Mater Salutis - U.O.C. Cardiologia, Legnago, VR, Italy|Casa Di Cura Dr. Pederzoli - Servizio Di Cardiologia, Peschiera Del Garda, VR, Italy|Ospedale Ss. Trinita' - S.C. Di Cardiologia, Borgomanero, Italy|Ospedale San Leonardo - U.O. Di Cardiologia-Utic, Castellammare Di Stabia, Italy|Ospedale San Giovanni Di Dio - Uo Cardiologia - Utic, Frattamaggiore, Italy|Ospedale Generale Di Zona - U.O. Cardiologia - Utic, Giugliano In Campania, Italy|Ospedale Anna Rizzoli - Cardiologia-Utic, Lacco Ameno, Italy|Aorn Cardarelli - U.O. Cardiologia Con Utic, Napoli, Italy|Clinica Mediterranea - U.O. Di Cardiologia, Napoli, Italy|Ospedale Dei Pellegrini - Uoc Cardiologia-Utic, Napoli, Italy|Ospedale Del Mare - U.O. Cardiologia Con Utic, Napoli, Italy|Pres. Ospedaliero S. Maria Della Pieta' - U.O. Cardiologia E Utic, Nola, Italy|Aou Maggiore Dell",Italy,Others,0,1,356.0
2745.0,NCT04584606,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lab workup (on admission and regularly during follow up).,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-06-27,31/10/20,2020-12-30,14/10/20,14/10/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,186.0
2746.0,NCT04325633,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,ENACOVID,Terminated,COVID-19,,,,,,,Drug: 1: Naproxen|Drug: 2: Standard of care,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-24,15/12/20,2020-12-15,27/03/20,25/02/21,"Réanimation médico-chirurgicale, Avicenne Hospital, Bobigny, France|Urgences, Avicenne Hospital, Bobigny",France,Respiratory Diseases,1,1,235.0
2747.0,NCT04355962,Sevoflurane in COVID-19 ARDS (SevCov),,Recruiting,"ARDS, Human",Coronavirus,,,,,,Drug: Sevoflurane|Drug: Intravenous drug,University of Zurich|Kantonsspital Münsterlingen|Triemli Hospital|Cantonal Hospital of St. Gallen,All,"18 Years to 85 Years   (Adult, Older Adult)",64.0,Other,Interventional,2020-04-23,31/03/22,2022-03-31,21/04/20,23/02/21,"Kantonsspital Münsterlingen, Münsterlingen, Switzerland|Cantonal Hospital of St. Gallen, Sankt Gallen, Switzerland|Stadtspital Triemli, Zurich, Switzerland|University Hospital Zuirch, Zurich",Switzerland,Respiratory Diseases,1,2,707.0
2748.0,NCT04839094,Dry Versus Wet Nasopharyngeal Rapid Test for the Detection of COVID-19.,RESTART,Completed,COVID-19,,,,,,,Diagnostic Test: rapid antigen testing versus RT-PCR,Centre Hospitalier Universitaire Vaudois,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2020-10-12,01/02/21,2021-01-02,09/04/21,09/04/21,"Centre Hospitalier Universitaire Vaudois, Lausanne, Vaud",Switzerland,Respiratory Diseases,1,1,82.0
2749.0,NCT04399356,Niclosamide for Mild to Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Niclosamide|Drug: Placebo|Other: Telehealth monitoring,Tufts Medical Center,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-10,30/04/21,2021-06-30,22/05/20,12/03/21,"Tufts Medical Center, Boston, Massachusetts",United States,Respiratory Diseases,1,1,537.0
2750.0,NCT03891420,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19",,Recruiting,COVID-19,Yellow Fever,,,,,,Drug: Galidesivir|Drug: Placebo,BioCryst Pharmaceuticals|National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years and older   (Adult, Older Adult)",132.0,Industry|NIH,Interventional,2020-09-04,31/05/21,2021-05-31,27/03/19,23/07/20,"Hospital de Clinicas da Universidade Federal do Parana, Curitiba, Parana, Brazil|Hospital Sao Vicente de Paulo-PPDS, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Sao Lucas da Pucrs, Porto Alegre, Rio Grande Do Sul, Brazil|Foundation Regional Faculty of Medicine of São José do Rio Preto, São José Do Rio Preto, SP, Brazil|Clinical Research Unit and Department of Infectious and Parasitic Diseases Hospital das Clínicas, School of Medicine, USP, São Paulo, SP",Brazil,Respiratory Diseases,1,2,269.0
2751.0,NCT04477083,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",,"Active, not recruiting",COVID-19,Hydroxychloroquine Adverse Reaction,,,,,,Drug: inhalable hydroxychloroquine (HCQ)|Drug: supportive and symptomatic treatment,Mansoura University,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-07-15,15/08/20,2020-08-15,20/07/20,20/07/20,"Mansoura University Hospital, Mansoura, Outside U.S./Canada",Egypt,Respiratory Diseases,1,2,31.0
2752.0,NCT04498091,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,EPI CV COVID,"Active, not recruiting",Acute Myocardial Infarction,,,,,,,Biological: Biological data|Other: Clinical data,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Observational,2020-03-15,01/07/20,2021-01-07,04/08/20,04/08/20,"Chu Dijon Bourgogne, Dijon",France,Others,0,1,298.0
2753.0,NCT04410718,Glycaemia and Cardiac Function in Patients With COVID-19,GLYCOVID-19,Recruiting,Diabetes Mellitus,"Diabetes Mellitus, Type 2","Diabetes Mellitus, Type 1",COVID-19,,,,Other: Glycaemic levels,Steno Diabetes Center Copenhagen,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-20,30/05/21,2021-11-30,01/06/20,24/03/21,"Herlev and Gentofte Hospital, Hellerup, Please Select, Denmark|Hvidovre Hospital, Hvidovre, Please Select",Denmark,"Respiratory Diseases, Metabolic Disorders",1,4,589.0
2754.0,NCT04440007,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,SOC,"Active, not recruiting",COVID-19,,,,,,,Drug: Abivertinib|Other: Standard of Care,"Sorrento Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",80.0,Industry,Interventional,2020-09-10,05/05/21,2021-01-07,19/06/20,12/04/21,"MedStar Washington Hospital Center, Washington, District of Columbia, United States|Teradan Clinical Trials, Brandon, Florida, United States|Alexandria Cardiology Clinic, Alexandria, Louisiana, United States|Clinical Trials of SWLA, Lake Charles, Louisiana, United States|Quality Clinical Research, Omaha, Nebraska, United States|Memorial Hermann Memorial City Hospital, Houston, Texas",United States,Respiratory Diseases,1,1,119.0
2755.0,NCT04477954,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,,Terminated,COVID-19,,,,,,,Combination Product: Hyperbaric Oxygen,Asociación Argentina de Medicina Hiperbárica e Investigación|Hospital de Infecciosas Francisco Javier Muniz|Hospital General de Agudos D. F. Santojanni|Hospital Central de San Isidro Dr. Melchor Angel Posse,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-06-07,06/11/20,2020-12-30,20/07/20,15/01/21,"Hospital Central de San Isidro Dr. Angel Melchor Posse, San Isidro, Buenos Aires, Argentina|Hospital de Infecciosas F. J. Muñiz, Ciudad Autonoma de Buenos AIres, Caba, Argentina|Hospital General de Agudos D.F Santojanni, Ciudad Autonoma de Buenos AIres, Caba",Argentina,Respiratory Diseases,1,1,206.0
2756.0,NCT04351191,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,PRECISE,Terminated,Sars-CoV2,Symptomatic Condition,COVID-19,,,,,Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo,"Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Hospital, Lahore|Pakistan Kidney and Liver Institute",All,20 Years to 50 Years   (Adult),137.0,Other,Interventional,2020-04-15,23/08/20,2020-08-30,17/04/20,10/03/21,"Expo Covid Isolation Center / Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan|Mayo Hospital / King Edward Medical University, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan|Services Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,3,137.0
2757.0,NCT04387643,Protecting Health Care Workers During the COVID-19 Outbreak,,Completed,COVID-19,,,,,,,Dietary Supplement: Ayurvedic Kadha,"Aarogyam UK|Samta Ayurveda Prakoshtha, India",All,18 Years to 60 Years   (Adult),52.0,Other,Observational,2020-01-03,02/04/20,2020-02-04,14/05/20,14/05/20,"Samta Ayurveda Prakoshtha, Jaipur, Rajasthan",India,Respiratory Diseases,1,1,32.0
2758.0,NCT04344444,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,RCT,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,LCMC Health,All,"18 Years to 100 Years   (Adult, Older Adult)",600.0,Other,Interventional,2020-04-13,10/04/21,2021-10-12,14/04/20,24/08/20,"University Medical Center New Orleans, New Orleans, Louisiana",United States,Respiratory Diseases,1,1,547.0
2759.0,NCT04443712,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),,Recruiting,COVID-19,,,,,,,,Samia Girgis|Ain Shams University,All,"Child, Adult, Older Adult",1900.0,Other,Observational,2020-05-29,01/06/21,2021-01-12,23/06/20,23/06/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,228.0
2760.0,NCT04363814,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Biological: Bactek-R,Inmunotek S.L.|BioClever 2005 S.L.,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2020-10-06,01/07/21,2021-07-31,27/04/20,30/06/20,"Hospital Metropolitano Santiago, Santiago De Los Caballeros",Dominican Republic,Respiratory Diseases,1,1,298.0
2761.0,NCT04349592,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin|Other: Placebo Tablet|Other: Placebo capsules,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",456.0,Industry,Interventional,2020-04-14,14/08/20,2020-08-30,16/04/20,23/02/21,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,1,138.0
2762.0,NCT04305574,Social Media Use During COVID-19,,Completed,Coronavirus,Depression,Anxiety,Stress,,,,Behavioral: Use of social media during COVID-19,Jean Liu|Yale-NUS College,All,"21 Years and older   (Adult, Older Adult)",1145.0,Other,Observational,2020-07-03,21/04/20,2020-04-21,12/03/20,07/07/20,"Yale-NUS College, Singapore",Singapore,"Mental Health, Respiratory Diseases",1,4,-73.0
2763.0,NCT04843761,ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19,TESICO,Not yet recruiting,COVID-19,,,,,,,Biological: Remdesivir|Drug: Remdesivir placebo|Biological: VIP|Drug: VIP Placebo|Drug: Corticosteroid,"National Institute of Allergy and Infectious Diseases (NIAID)|International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury (PETAL)|Cardiothoracic Surgical Trials Network (CTSN)|NeuroRx, Inc.",All,"18 Years and older   (Adult, Older Adult)",640.0,NIH|Other|U.S. Fed|Industry,Interventional,2021-01-04,01/10/22,2023-01-04,14/04/21,14/04/21,,,Respiratory Diseases,1,1,730.0
2764.0,NCT04276896,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,,Recruiting,COVID-19,,,,,,,Biological: Injection and infusion of LV-SMENP-DC vaccine and antigen-specific CTLs,Shenzhen Geno-Immune Medical Institute|Shenzhen Third People's Hospital|Shenzhen Second People's Hospital,All,"6 Months to 80 Years   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-03-24,31/07/23,2024-12-31,19/02/20,19/03/20,"Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China|Shenzhen Second People's Hospital, Shenzhen, Guangdong, China|Shenzhen Third People's Hospital, Shenzhen, Guangdong",China,Respiratory Diseases,1,1,1743.0
2765.0,NCT04501965,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,PHYTCOVID-19,Enrolling by invitation,COVID-19,,,,,,,Combination Product: Hydroxychloroquine/Azithromycine|Combination Product: Quinquina-Stevia/Azythromycin|Combination Product: 4Plants/Azythromycin,Institute for Research and Development of Medicinal and Food Plants of Guinea,All,"18 Years and older   (Adult, Older Adult)",231.0,Other,Interventional,2020-01-06,30/08/20,2020-09-30,06/08/20,07/08/20,"Support Centers of Donka, Kenien and Gbessia, Conakry",Guinea,Respiratory Diseases,1,1,268.0
2766.0,NCT04374019,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,,Recruiting,COVID-19,Sars-CoV2,,,,,,Drug: Ivermectin|Drug: Camostat Mesilate|Dietary Supplement: Artemesia annua|Drug: Artesunate,Susanne Arnold|University of Kentucky,All,"18 Years to 99 Years   (Adult, Older Adult)",240.0,Other,Interventional,2020-01-05,01/05/21,2021-01-05,05/05/20,06/11/20,"University of Kentucky Markey Cancer Center, Lexington, Kentucky",United States,Respiratory Diseases,1,2,366.0
2767.0,NCT04623021,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Drug: Nafamostat Mesilate,Chong Kun Dang Pharmaceutical,All,"18 Years and older   (Adult, Older Adult)",104.0,Industry,Interventional,2020-09-25,12/12/20,2020-12-12,10/11/20,02/02/21,"A108_02CVD2014 Site# 9, Barnaul, Russian Federation|A108_02CVD2014 Site# 26, Krasnoyarsk, Russian Federation|A108_02CVD2014 Site# 5, Moscow, Russian Federation|A108_02CVD2014 Site# 8, Moscow, Russian Federation|A108_02CVD2014 Site# 31, Ryazan, Russian Federation|A108_02CVD2014 Site# 25, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 29, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 30, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 3, St. Petersburg, Russian Federation|A108_02CVD2014 Site# 4, St. Petersburg, Russian Federation|A108_02CVD2014 site#1, Ufa",Russian Federation,Respiratory Diseases,1,1,78.0
2768.0,NCT04802083,COVID-19 Soliris Expanded Access Protocol,,Available,COVID-19,,,,,,,Biological: Eculizumab,Alexion Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,17/03/21,17/03/21,,,Respiratory Diseases,1,1,
2769.0,NCT04416438,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,COVIM,Recruiting,Myeloproliferative Neoplasm,COVID-19,,,,,,,French Innovative Leukemia Organisation|French Intergroup of Myeloproliferative syndromes,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-05-18,31/12/20,2020-12-31,04/06/20,12/08/20,"Paris Saint Louis, Paris",France,Respiratory Diseases,1,2,227.0
2770.0,NCT04352985,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,,Available,Septic Shock,Endotoxemia,COVID-19,Corona Virus Infection,"Sepsis, Severe",,,Device: Toraymyxin PMX-20R (PMX Cartridge),Spectral Diagnostics (US) Inc.,All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,20/04/20,28/08/20,"University of Connecticut Health Center, Farmington, Connecticut, United States|George Washington University, Washington, District of Columbia, United States|Stony Brook University Hospital, Stony Brook, New York",United States,Respiratory Diseases,1,5,
2771.0,NCT04398004,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,ACHIEVE,Completed,COVID-19,Virus Diseases,Corona Virus Infection,,,,,Drug: Clarithromycin,Hellenic Institute for the Study of Sepsis,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-06-05,30/11/20,2020-11-30,21/05/20,11/01/21,"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Nikaia, Piraeus, Attica, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|1st University Department of Internal Medicine, LAIKO General Hospital of Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus Tzaneio, Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki",Greece,Respiratory Diseases,1,3,178.0
2772.0,NCT04388579,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,PRAISE@COVID,Completed,Respiratory Disease,,,,,,,Other: Pulmonary Rehabilitation,"University of Lisbon|Centro Hospitalar Lisboa Norte|Fundação para a Ciência e a Tecnologia|Nippon Gases Portugal, Unipessoal, Lda.",All,"18 Years to 88 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-03-20,27/03/20,2020-03-27,14/05/20,14/05/20,"Nippon Gases Portugal Unipessoal Lda, Maia, Porto, Portugal|Universidade de Lisboa, Faculdade de Medicina, Instituto de Saúde Ambiental (ISAMB), Lisboa, Portugal|Centro Hospitalar Universitário Lisboa Norte, Hospital Pulido Valente, Unidade de Reabilitação Respiratória, Lisboa",Portugal,Others,0,1,7.0
2773.0,NCT04493268,HYPONATREMIA IN COVID-19 PATIENTS,,Completed,Hyponatremia,COVID-19,Corona Virus Infection,,,,,,Hospital Nacional Profesor Alejandro Posadas,All,"1 Month to 100 Years   (Child, Adult, Older Adult)",250.0,Other,Observational,2020-07-03,20/07/20,2020-07-21,30/07/20,30/07/20,"Hospital Posadas, Buenos Aires",Argentina,Respiratory Diseases,1,3,18.0
2774.0,NCT04590261,Myeloid Cells in Patients With Covid-19 Pneumonia,MyeloidCovid,Not yet recruiting,COVID-19,,,,,,,Other: Blood sampling|Other: Nasal Brushing,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years to 70 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-01-11,01/11/22,2023-01-11,19/10/20,19/10/20,,,Respiratory Diseases,1,1,1096.0
2775.0,NCT04644185,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,,Recruiting,COVID-19,,,,,,,Drug: SCTA01|Other: Placebo,Sinocelltech Ltd.,All,"18 Years and older   (Adult, Older Adult)",795.0,Industry,Interventional,2021-03-27,27/06/21,2021-12-27,25/11/20,12/04/21,"SCT study site, Somers Point, New Jersey, United States|SCT study site, Ciudad Autonoma de Buenos aires, Argentina|SCT study site, Uberlândia, Brazil|SCT study site, Talca, Chile|SCT study site, Rionegro, Colombia|SCT study site, Monterrey, Mexico|SCT study site, Lima",Peru,Respiratory Diseases,1,1,275.0
2776.0,NCT04402827,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,CoVEX,Recruiting,Health Care Worker Patient Transmission,Receptor Site Alteration,"Susceptibility, Disease",Immune Response,,,,Diagnostic Test: Susceptibility to infection,Asociacion para el Estudio de las Enfermedades Infecciosas,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-01-08,30/12/20,2021-01-30,27/05/20,25/08/20,"Hospital Ramon y Cajal, Madrid",Spain,Others,0,4,388.0
2777.0,NCT04280705,Adaptive COVID-19 Treatment Trial (ACTT),,Completed,COVID-19,,,,,,,Other: Placebo|Drug: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years to 99 Years   (Adult, Older Adult)",1062.0,NIH,Interventional,2020-02-21,21/05/20,2020-05-21,21/02/20,09/12/20,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Annapolis, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|The University of Washington - Virology Research Clinic, Seattle, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|University of Copenhagen - Centre of Excellence for Health, Immunity and Infections (CHIP) - Department of Infectious Diseases, Copenhagen, Denmark|Universitatsklinikum Bonn, Medizinische Klinik I - Bereich Infektiologie/HIV der Medizinischen Klinik, Bonn, Nordrhein-Westfalen, Germany|Universitatsklinikum Koeln Klinik I fur Innere Medizin Klinisches Studienzentrum fur Infektiologie I, Cologne, Germany|Universitätsklinikum Frankfurt -Medizinische Klinik II - Infektiologie, Frankfurt, Germany|AHEPA University Hospital - 1st Department of Internal Medicine, Thessaloniki, Central Macedonia, Greece|Medical School of Athens University - Evangelismos Hospital - Department of Critical Care and Pulmonary Services, Athens, Greece|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Hospital Clinic Barcelona, Servicio de Salud Internacional, Barcelona, Cataluña, Spain|Hospital Germans Trias i Pujol - Servei Malalties Infeccioses, Barcelona, Cataluña, Spain|Royal Sussex County Hospital - Department of Intensive Care Medicine, East Sussex, Brighton, United Kingdom|Saint Thomas' Hospital - Directorate of Infection, London, London, City Of, United Kingdom|Royal Victoria Infirmary - Department of Infectious Diseases, Level 6, Ward 19, Newcastle Upon Tyne, United Kingdom|St. James's University Hospital - Infectious Diseases, Leeds, West Yorkshire, United Kingdom|John Radcliffe Hospital, Headington, Oxford",United Kingdom,Respiratory Diseases,1,1,90.0
2778.0,NCT04486001,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,CoronaStem1,Recruiting,COVID-19,,,,,,,Biological: PSC-04,"Sorrento Therapeutics, Inc.|VetStem Biopharma, Inc.|Fresno Community Hospital and Medical Center",All,"18 Years to 80 Years   (Adult, Older Adult)",20.0,Industry|Other,Interventional,2020-12-15,15/01/22,2022-01-15,24/07/20,02/02/21,"Fresno Community Hospital, Fresno, California",United States,Respiratory Diseases,1,1,396.0
2779.0,NCT04779424,Prevalence and Incidence of Antibodies Against SARS-CoV-2 Among Primary Healthcare Providers in Belgium (COVID-19),CHARMING,"Active, not recruiting",COVID-19,COVID-19,,,,,,Other: POCT,Universiteit Antwerpen|Sciensano|University of Liege,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-11-15,31/12/21,2022-06-30,03/03/21,03/03/21,"Niels Adriaenssens, Wilrijk, Antwerp",Belgium,Respiratory Diseases,1,2,592.0
2780.0,NCT04528641,GRAd-COV2 Vaccine Against COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: GRAd-COV2,ReiThera Srl|Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,All,"18 Years to 85 Years   (Adult, Older Adult)",90.0,Industry|Other,Interventional,2020-10-08,31/07/21,2021-07-31,27/08/20,05/04/21,"INMI Spallanzani, Rome, Italy|Centro Ricerche Cliniche, Verona",Italy,Respiratory Diseases,1,1,296.0
2781.0,NCT04492228,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,ketocovidiet,Recruiting,COVID-19,Ketogenic Dieting,,,,,,Other: Ketogenic diet,Ospedale Policlinico San Martino,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-09,31/12/20,2021-05-30,30/07/20,30/09/20,"Samir Giuseppe Sukkar, Genova",Italy,Respiratory Diseases,1,2,507.0
2782.0,NCT04773665,"Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidate (VBI-2902a)",,Not yet recruiting,COVID-19,,,,,,,Biological: VBI-2902a|Biological: Placebo,VBI Vaccines Inc.,All,"18 Years and older   (Adult, Older Adult)",780.0,Industry,Interventional,2021-01-03,01/06/22,2022-01-06,26/02/21,26/02/21,"Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|LMC Manna - Bayview CPU, Toronto, Ontario, Canada|Manna Toronto, Toronto, Ontario, Canada|Manna Montreal, Montreal, Quebec, Canada|Manna Research Quebec, Quebec City, Quebec",Canada,Respiratory Diseases,1,1,368.0
2783.0,NCT04801056,Study of TB006 in Outpatient Patients With Mild to Moderate COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: TB006|Other: Placebo,"TrueBinding, Inc.",All,"18 Years and older   (Adult, Older Adult)",27.0,Industry,Interventional,2021-01-03,01/09/21,2021-01-09,16/03/21,16/03/21,"Gabrail Cancer Center, Canton, Ohio",United States,Respiratory Diseases,1,1,6.0
2784.0,NCT04438863,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: home spirometry,Sheba Medical Center,All,"18 Years to 85 Years   (Adult, Older Adult)",90.0,Other,Observational,2020-08-08,01/09/21,2021-01-09,19/06/20,03/02/21,"Sheba Medical Center, Ramat Gan",Israel,Respiratory Diseases,1,1,154.0
2785.0,NCT04751669,Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial,CoVIT,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin and trace elements|Dietary Supplement: Placebo,Fundació Institut Germans Trias i Pujol|Germans Trias i Pujol Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Interventional,2021-01-04,31/10/21,2021-12-31,12/02/21,08/04/21,"Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,361.0
2786.0,NCT04798677,Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine,,Recruiting,Immunity,Vaccine Reaction,Influenza,COVID-19,Cytokine Storm,Immunologic Deficiency Syndromes,,Dietary Supplement: ABBC1 Immunoessential|Dietary Supplement: Placebo,AB Biotek,All,"18 Years and older   (Adult, Older Adult)",90.0,Industry,Interventional,2020-10-29,01/04/21,2021-01-04,15/03/21,29/03/21,"Hospital Mare de Déu de la Mercè - Germanes Hospitalàries, Barcelona",Spain,"Infectious Diseases, Respiratory Diseases",1,6,67.0
2787.0,NCT04747366,"Analysis of the Pathophysiology and Pathology of Coronavirus Disease 2019 (COVID-19), Including Chronic Morbidity",,Recruiting,COVID-19,,,,,,,,"Charite University, Berlin, Germany|Network University Medicine NUM|Berlin Institute of Health",All,"18 Years and older   (Adult, Older Adult)",750.0,Other,Observational,2020-06-11,01/11/25,2025-11-30,10/02/21,10/02/21,"University Medical Center Freiburg Department of Internal Medicine II Department of Infectiology, Freiburg, Baden-Württemberg, Germany|University Hospital Heidelberg Clinic for Gastroenterology, Infections, Poisoning, Heidelberg, Baden-Württemberg, Germany|Clinic of the University of Munich Medical Clinic and Polyclinic III, Munich, Bayern, Germany|University Hospital Frankfurt Medical Clinic II Department of infectiology, Frankfurt, Hessen, Germany|University Hospital Giessen (+Marburg) Medical Clinic II Pneumology and internal intensive care medicine Infectiology, Gastroenterology, Nephrology, Gießen, Hessen, Germany|Hanover Medical School Clinic for Pneumology, Hannover, Niedersachsen, Germany|University Hospital Cologne Internal Medicine I and Hematology and Oncology, Infectiology, additional qualification in Emergency Medicine, Cologne, Nordrhein-Westfalen, Germany|University Medical Center Schleswig-Holstein (Campus Kiel): Internal medicine, gastroenterology, pneumology, allergology, sleep medicine, emergency medicine, intensive care, Kiel, Schleswig-Holstein, Germany|University Medical Center Schleswig-Holstein (Campus Lübeck): Internal medicine, gastroenterology, pneumology, allergology, sleep medicine, emergency medicine, intensive care, Lübeck, Schleswig-Holstein, Germany|University Hospital Jena Department of Internal Medicine IV, Jena, Thüringen, Germany|Charité University Hospital Berlin Medical Clinic Infectiology and Pneumology CCM/CVK, Berlin",Germany,Respiratory Diseases,1,1,1998.0
2788.0,NCT04385771,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,CYCOV-II,Suspended,Coronavirus Infection,COVID-19,SARS-CoV 2,Respiratory Failure,Cytokine Storm,Extracorporeal Membrane Oxygenation,,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),"Dr. Alexander Supady|Klinikum Ibbenbüren|Ludwig-Maximilians - University of Munich|University Hospital, Saarland|Klinikum Ludwigsburg|University of Ulm|SLK-Kliniken Heilbronn|Martin-Luther-Universität Halle-Wittenberg|University Hospital Freiburg",All,"18 Years to 100 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-01-09,31/05/21,2021-10-31,13/05/20,15/03/21,"University Clinic Freiburg, Freiburg, Germany|Klinikum Ibbenbueren, Ibbenbueren, Germany|Klinikum Ludwigsburg, Ludwigsburg",Germany,Respiratory Diseases,1,6,661.0
2789.0,NCT04611256,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: MSC|Drug: Control,Hospital Reg. Lic. Adolfo Lopez Mateos|Instituto de Terapia Celular: ITC,All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-08,30/11/20,2020-12-30,02/11/20,12/11/20,"Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City)",Mexico,Respiratory Diseases,1,1,357.0
2790.0,NCT04557241,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,,Completed,COVID-19,,,,,,,Behavioral: Brief informational infographic|Behavioral: Placebo control (non-behavioral infographic),Indiana University|Indiana Clinical and Translational Sciences Institute,All,"18 Years and older   (Adult, Older Adult)",1017.0,Other,Interventional,2020-01-14,14/01/21,2021-01-31,21/09/20,09/02/21,"Digital Intervention (Prolific Study Panel), Bloomington, Indiana",United States,Respiratory Diseases,1,1,383.0
2791.0,NCT04602507,Ivermectin in Adults With Severe COVID-19.,,Recruiting,COVID-19,Severe Acute Respiratory Syndrome,,,,,,Drug: Ivermectin|Other: Placebo,CES University,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-12,01/03/21,2021-01-03,26/10/20,10/12/20,"Clinica CES, Medellín, Antioquia",Colombia,Respiratory Diseases,1,2,175.0
2792.0,NCT04361565,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,,Enrolling by invitation,COVID-19,,,,,,,,Centre Hospitalier Universitaire de Nice,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-03-20,10/04/20,2020-05-31,24/04/20,13/05/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,72.0
2793.0,NCT04517422,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,,Completed,SARS-CoV Infection,,,,,,,Dietary Supplement: Probiotics|Other: Placebo,"AB Biotics, SA|Innovacion y Desarrollo de Estrategias en Salud|Hospital General Dr. Manuel Gea González|Hospital Angeles del Pedregal",All,18 Years to 60 Years   (Adult),300.0,Industry|Other,Interventional,2020-08-19,02/02/21,2021-02-02,18/08/20,17/02/21,"Hospital General Dr. Manuel Gea Gonzalez, Mexico city",Mexico,Respiratory Diseases,1,1,167.0
2794.0,NCT04836260,Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19,,Recruiting,COVID-19,Immuno-Deficiency,Old Age; Debility,,,,,Drug: SARS-CoV-2 convalescent plasma,"University Hospital, Geneva|University Hospital, Basel, Switzerland|Ospedale Regionale di Lugano|Hôpital Fribourgeois",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-08-04,31/12/21,2021-12-31,08/04/21,08/04/21,"Universitätsspital Basel, Basel, Switzerland|HFR-Fribourg Hôpital Cantonal, Fribourg, Switzerland|Geneva University Hospitals, Geneva, Switzerland|Ospedale Regionale di Lugano, Lugano",Switzerland,Respiratory Diseases,1,3,149.0
2795.0,NCT04662437,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,,Completed,COVID-19,Parathyroid Gland,Parathyroid Hormone,Calcium,Phosphorus,Alkaline Phosphatase,,Diagnostic Test: Venous blood was collected for biochemistry testing,Bezmialem Vakif University|Didem Ertorul,All,"18 Years to 100 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-10-09,01/12/20,2020-09-12,10/12/20,10/12/20,"Bezmialem VU, Istanbul",Turkey,Respiratory Diseases,1,6,-27.0
2796.0,NCT04791072,Tele-coaching in Patients With COVID-19,,Not yet recruiting,COVID-19,Rehabilitation,,,,,,Other: Exercise,Izmir Katip Celebi University,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Interventional,2021-01-03,01/03/21,2021-01-03,10/03/21,10/03/21,,,Respiratory Diseases,1,2,0.0
2797.0,NCT04747522,Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19),SCV-KTx-imm,Recruiting,Kidney Transplant Infection,SARS-CoV Infection,,,,,,Drug: SARS-CoV-2 vaccine,Oslo University Hospital,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-22,30/06/21,2021-06-30,10/02/21,10/02/21,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,2,159.0
2798.0,NCT04568876,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,"Dietary Supplement: Micronized and ultra-micronized Palmitoylethanolamide (mPEA and umPEA, 300mg + 600mg) oral suspension|Combination Product: Standard Therapy","Epitech Group SpA|Azienda Ospedaliera ""Sant'Andrea""",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-10-23,01/11/21,2021-01-11,29/09/20,28/10/20,"Anestesia e Rianimazione Azienda Ospedaliera Universitaria Sant'Andrea, Roma",Italy,Respiratory Diseases,1,1,80.0
2799.0,NCT04361123,Atrium COVID-19 Syndromic and Serologic Surveillance,,Enrolling by invitation,Coronavirus,COVID-19,,,,,,Other: daily syndromic surveillance|Diagnostic Test: monthly serologic IgM/G test,"Michael Runyon, MD|Atrium Health",All,"18 Years and older   (Adult, Older Adult)",450000.0,Other,Observational,2020-06-05,01/12/21,2021-01-12,24/04/20,08/07/20,"Atrium Health, Charlotte, North Carolina",United States,Respiratory Diseases,1,2,221.0
2800.0,NCT04661657,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,,Recruiting,COVID-19,Cardiac Disease,Cardiac Arrhythmia,Myocarditis,Left Ventricular Dysfunction,,,Other: Transthoracic echocardiogram (TTE)|Other: Cardiovascular Magnetic Resonance (CMR) Imaging,Columbia University|GE Healthcare,All,"18 Years and older   (Adult, Older Adult)",70.0,Other|Industry,Observational,2020-12-28,31/12/21,2022-09-30,10/12/20,02/02/21,"Columbia University Irving Medical Center, New York, New York",United States,Respiratory Diseases,1,5,641.0
2801.0,NCT04347941,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,APPROVE-CARE,Recruiting,"ARDS, Human",Mechanical Ventilation Complication,COVID-19,,,,,Procedure: Prone Positioning|Procedure: Standard of care.,University College Hospital Galway,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-11-07,11/06/21,2021-11-09,15/04/20,13/08/20,"Galway University Hospital, Galway, Ireland|Galway University Hospital, Galway",Ireland,Respiratory Diseases,1,3,367.0
2802.0,NCT04659122,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Biological: AT-100,"Airway Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",9.0,Industry,Interventional,2021-01-01,01/06/21,2021-01-07,09/12/20,09/12/20,,,Respiratory Diseases,1,1,6.0
2803.0,NCT04487886,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),DAMPEN-CI,Recruiting,COVID-19,,,,,,,Drug: Duvelisib|Drug: Placebo,"Emory University|Verastem, Inc.|University of Pennsylvania",All,"18 Years and older   (Adult, Older Adult)",80.0,Other|Industry,Interventional,2020-11-18,01/02/22,2022-01-02,27/07/20,16/12/20,"Emory Saint Joseph's Hospital, Atlanta, Georgia, United States|Emory University Hospital Midtown, Atlanta, Georgia, United States|Emory University Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,1,410.0
2804.0,NCT04362345,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,,Recruiting,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-09-04,09/01/21,2021-09-01,24/04/20,28/12/20,"Service des Maladies Infectieuses et Tropicales, Strasbourg",France,Respiratory Diseases,1,1,362.0
2805.0,NCT04662060,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,COPPS,Enrolling by invitation,COVID-19,,,,,,,Drug: Acebilustat|Drug: Placebo,Stanford University,All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-04,01/03/22,2022-01-03,10/12/20,13/04/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,364.0
2806.0,NCT04634799,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,,Recruiting,COVID-19,,,,,,,Drug: TM5614|Other: Placebo,Northwestern University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-08-01,30/11/21,2022-06-30,18/11/20,22/01/21,"Northwestern University, Chicago, Illinois",United States,Respiratory Diseases,1,1,333.0
2807.0,NCT04359251,Different PEEP Settings of COVID-19 Induced ARDS,,Completed,COVID-19,Mechanical Ventilation Pressure High,Acute Respiratory Distress Syndrome,,,,,Other: Gas exchanges at different PEEP|Other: lung mechanics at different PEEP|Other: Hemodynamics changes at different PEEP,"Southeast University, China",All,"18 Years to 80 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-05-03,25/03/20,2020-03-25,24/04/20,24/04/20,"Zhongda Hospital, Southeast University, Nanjing, Jiangsu",China,Respiratory Diseases,1,3,-39.0
2808.0,NCT04359654,Nebulised Dornase Alfa for Treatment of COVID-19,COVASE,Recruiting,COVID-19,Hypoxia,,,,,,Drug: Dornase Alfa Inhalation Solution [Pulmozyme],"University College, London",All,"18 Years to 100 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-06-16,01/08/21,2021-01-11,24/04/20,19/10/20,"University College London Hospital, London",United Kingdom,Respiratory Diseases,1,2,209.0
2809.0,NCT04559035,Nasal Irrigation to Reduce COVID-19 Morbidity,,Enrolling by invitation,COVID-19,,,,,,,Other: Nasal lavage,Augusta University,All,"55 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-24,31/12/20,2020-12-31,22/09/20,22/09/20,"Augusta University, Augusta, Georgia",United States,Respiratory Diseases,1,1,98.0
2810.0,NCT04335773,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",,Recruiting,Pediatric Respiratory Diseases,COVID-19,Fatigue Post Viral,,,,,,"University Hospital, Akershus|St. Olavs Hospital|Helse Stavanger HF|Haukeland University Hospital|University Hospital of North Norway|Alesund Hospital|Norwegian Institute of Public Health|The University of New South Wales|University of Bristol|Sykehuset Ostfold|Nordlandssykehuset HF|Vestre Viken Hospital Trust|Helse Fonna|Levanger Hospital|Oslo University Hospital|Sykehuset Innlandet HF",All,"up to 18 Years   (Child, Adult)",350.0,Other,Observational,2020-03-04,31/12/30,2030-12-31,06/04/20,17/04/20,"Akershus universistetssykehus, Lørenskog",Norway,Respiratory Diseases,1,3,3954.0
2811.0,NCT04536441,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,,Completed,Mental Health Wellness,Psychological Security,Psychological Distress,,,,,Behavioral: Ultra Brief Online Mindfulness-based Intervention|Behavioral: Control,Universiti Tunku Abdul Rahman|Sunway University,All,"18 Years to 99 Years   (Adult, Older Adult)",161.0,Other,Interventional,2020-01-04,30/05/20,2020-06-30,02/09/20,02/09/20,"Universiti Tunku Abdul Rahman, Kampar, Perak",Malaysia,Others,0,3,178.0
2812.0,NCT04505605,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,LPSARS2,"Active, not recruiting",Community-acquired Pneumonia,COVID-19,,,,,,Other: Blood samples,Groupe Hospitalier Paris Saint Joseph|Centre Hospitalier Victor Dupouy,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-05-14,30/11/20,2020-11-30,10/08/20,11/08/20,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,2,200.0
2813.0,NCT04745351,Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: Remdesivir|Drug: RDV Placebo|Drug: Standard of Care,Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",1116.0,Industry,Interventional,2021-01-03,01/07/21,2021-01-09,09/02/21,23/03/21,"Hoag Memorial Hospital Presbyterian, 16200 Sand Canyon Ave, Irvine, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Jacobi Medical Center, Bronx, New York",United States,Respiratory Diseases,1,1,6.0
2814.0,NCT04556565,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,,Recruiting,COVID-19,Mental Health Disorder,Mental Health Conditions,,,,,,Jordi Alonso|Hospital Universitario 12 de Octubre|Instituto de Salud Carlos III|Universitat Pompeu Fabra|Public Health Agency of Barcelona|Jordi Gol i Gurina Foundation|Sistema de Emergencias Médicas de Cataluña (SEM)|Agència de Qualitat i Avaluació Sanitàries|Gerencia de Atención Primaria de Madrid-FIIBAP|Hospital del Mar|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Fundacion Clinic per a la Recerca Biomédica|Hospital Vall d'Hebron|Hospital Clínico Universitario de Valencia|Hospital General Universitario Gregorio Marañon|Hospital Universitario Principe de Asturias|Hospital El Bierzo|Hospital Universitario Araba|Hospital Universitario Donostia|Hospital de Cruces|Hospital Universitario Torrecárdenas|Parc Sanitari Sant Joan de Déu|Hospital del Mar Research Institute (IMIM),All,"18 Years and older   (Adult, Older Adult)",16000.0,Other,Observational,2020-08-05,01/05/21,2021-01-05,21/09/20,19/10/20,"Hospital Universitario Príncipe Asturias, Alcalá De Henares, Spain|Hospital Universitario Torrecárdenas, Almería, Spain|Agència de Salut Pública Barcelona, Barcelona, Spain|Fundació Clínic per a la Recerca Biomèdica, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Institut d'Investigación en Atenció Primària, IDIAP Jordi Gol, Barcelona, Spain|Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Parc Sanitari Sant Joan de Déu, Barcelona, Spain|Psmar-Imim, Barcelona, Spain|Sistema de Emergencias Médicas de Cataluña, Barcelona, Spain|Hospital Universitario Cruces, Bilbao, Spain|Hospital El Bierzo, León, Spain|Gerencia de Atención Primaria de Madrid-FIIBAP, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 Octubre, Madrid, Spain|Hospital Universitario Donostia, San Sebastián, Spain|Hospital Clínic Universitari, Valencia, Spain|Hospital Universitario Araba-Santiago, Vitoria",Spain,Respiratory Diseases,1,3,153.0
2815.0,NCT04834115,Efficacy of Ivermectin in Outpatients With Non-severe COVID-19,,Recruiting,COVID-19,Coronavirus Infection,,,,,,Drug: Ivermectin Tablets|Other: Placebo,"Universidad Nacional de Asunción|Consejo Nacional de Ciencias y Tecnologia, Paraguay|Ministerio de Salud Pública y Bienestar Social, Paraguay|Centro de información y recursos para el desarrollo, Paraguay|Centro para el Desarrollo de la Investigación Científica, CEDIC, Paraguay|Instituto Desarrollo, Paraguay",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-11-17,30/04/21,2021-05-30,06/04/21,06/04/21,"Facultad de Ciencias Médicas - Universidad Nacional de Asunción, Asunción",Paraguay,Respiratory Diseases,1,2,194.0
2816.0,NCT04460664,Coagulation Changes Associated With COVID-19 Infection,,Enrolling by invitation,COVID-19,Disseminated Intravascular Coagulation,Coagulation Disorder,,,,,Diagnostic Test: Quantra System,HemoSonics LLC,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Observational,2020-08-14,31/01/21,2021-02-15,07/07/20,01/09/20,"Texas Tech University Health Sciences Center El Paso, El Paso, Texas",United States,Respiratory Diseases,1,3,185.0
2817.0,NCT04756141,CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)),,Recruiting,Diabetes Mellitus,COVID-19,,,,,,Device: Continuous Glucose Monitor (CGM),Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-03-03,28/01/22,2022-01-28,16/02/21,25/03/21,"Mayo Clinic in Florida, Jacksonville, Florida",United States,"Respiratory Diseases, Metabolic Disorders",1,2,331.0
2818.0,NCT04361253,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,(ESCAPE),Recruiting,COVID-19,Infectious Disease,,,,,,Biological: High-Titer COVID-19 Convalescent Plasma (HT-CCP)|Biological: Standard Plasma (FFP),Brigham and Women's Hospital,All,"12 Months and older   (Child, Adult, Older Adult)",220.0,Other,Interventional,2020-04-30,01/06/21,2021-01-12,24/04/20,18/05/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,2,257.0
2819.0,NCT04375748,Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,MYOCOVID,Recruiting,Acute Myocarditis,,,,,,,Diagnostic Test: Performing routine care (clinical and paraclinical tests)|Diagnostic Test: Examinations for the research:,"University Hospital, Toulouse",All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-04-15,15/10/21,2021-10-15,05/05/20,23/11/20,"Cardiology, Aix-en-Provence, France|Reanimation, Amiens, France|Cardiology, Angers, France|Reanimation, Angers, France|Cardiology, Avignon, France|Cardiology, Bordeaux, France|Pediatric cardiology, Bordeaux, France|Reanimation, Bordeaux, France|Cardiology, Brest, France|Cardiology, Caen, France|Pediatric Cardiology, Caen, France|Cardiology, Clermont-Ferrand, France|Pediatric cardilogy, Clermont-Ferrand, France|Reanimation, Clermont-Ferrand, France|Pediatric cardiology, Dijon, France|Cardiology, Grenoble, France|Pediatric cardiology, Grenoble, France|Reanimation, Grenoble, France|Cardiology, Lille, France|Pediatric cardiology, Lille, France|Pediatric cardiology, Limoges, France|Cardiology, Lyon, France|Pediatric cardiology, Lyon, France|Cardiology, Marseille, France|Pediatric cardiology, Marseille, France|Cardiology, Metz, France|Cardiology, Montpellier, France|Millénaire Clinical - Cardiology, Montpellier, France|Pediatric cardiology, Montpellier, France|Reanimation, Montpellier, France|Cardiology, Nancy, France|Cardiology, Nancy, France|Pediatric cardiology, Nancy, France|Cardiology, Nantes, France|Pediatric cardiology, Nantes, France|Cardiology, Nice, France|Pediatric cardiology, Nice, France|Cardiology, Nîmes, France|Cardiology, Henri Mondor Hospital, Paris, France|Cardiology, Paris, France|Cardiology, Paris, France|Henri Mondor Hospital Reanimation, Paris, France|Marie Lannelongue Hospital - Pediatric Cardiology, Paris, France|Marie Lannelongue Hospital Cardiology, Paris, France|Reanimation, Paris, France|Reanimation, Paris, France|Robert Debré Hospital - Pediatric cardiology, Paris, France|Saint Antoine Hospital - Cardiology, Paris, France|Cardiology, Poitiers, France|Reanimation, Poitiers, France|Pediatric cardiology, Reims, France|Cardiology, Rennes, France|Pediatric reanimation, Rennes, France|Cardiology, Rouen, France|Pediatric cardiology, Rouen, France|Pédiatric cardiology, Strasbourg, France|Reanimation, Strasbourg, France|CHU de TOULOUSE, Toulouse, France|Croix du Sud Clinical, Toulouse, France|Pasteur Clinical - Cardiology, Toulouse, France|Pasteur Clinical - Pediatric cardiology, Toulouse, France|Pediatric Cardiology, Toulouse, France|Cardiolgy, Tours, France|Pediatric Cardiology, Tours, France|Cardiology, Valenciennes, France|Cardiology, Martinique, Martinique|Cardiology, Mamoudzou, Mayotte|Pédiatric cardiology, Réunion",Réunion,Others,0,1,548.0
2820.0,NCT04343183,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,,Not yet recruiting,COVID-19,,,,,,,Device: Hyperbaric Oxygen Therapy,Ochsner Health System,All,"18 Years and older   (Adult, Older Adult)",48.0,Other,Interventional,2020-01-04,01/06/20,2020-01-06,13/04/20,13/04/20,"Ochsner Medical Center, New Orleans, Louisiana",United States,Respiratory Diseases,1,1,2.0
2821.0,NCT04716023,Physiology and Structure of the Small Airways in Patients With Chronic Airflow Obstruction or COVID-19,PASSPORT,Recruiting,Copd,COVID-19,Asthma,Small Airways Disease,,,,,Imperial College London,All,"16 Years and older   (Child, Adult, Older Adult)",42.0,Other,Observational,2019-08-23,22/08/21,2022-02-02,20/01/21,20/01/21,"The Royal Brompton, London",United Kingdom,Respiratory Diseases,1,4,894.0
2822.0,NCT04374084,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,,Recruiting,COVID-19,Convalescence,,,,,,Other: Moxibustion plus Cupping,Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Hubei Hospital of Traditional Chinese Medicine|Hubei Provincial Hospital of Integrated Chinese & Western Medicine|Wuhan Hospital of Traditional Chinese Medicine|The Third Hospital of Wuhan|Huangshi Hospital of Traditional Chinese Medicine|Yichang Hospital of Traditional Chinese Medicine|Ezhou Hospital of Traditional Chinese Medicine|The First Hospital of Hunan University of Chinese Medicine|The Hospital of Jiangxi University of Traditional Chinese Medicine|Shenzhen Bao'an Traditional Chinese Medicine Hospital Group,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-10-05,01/12/21,2021-01-12,05/05/20,05/06/20,"Hubei Province Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,2,99.0
2823.0,NCT04843787,"A Randomized, Double Blind, Placebo-Controlled, Multiple Ascending Dose Phase 2a Study of SLV213 in Ambulatory Individuals Positive for COVID-19",,Not yet recruiting,COVID-19,,,,,,,Drug: SLV213|Drug: Placebo,"Kenneth Krantz, MD, PhD|FHI Clinical, Inc.|Selva Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",81.0,Industry|Other,Interventional,2021-01-05,01/10/21,2021-01-10,14/04/21,14/04/21,,,Respiratory Diseases,1,1,5.0
2824.0,NCT04465695,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Interferon beta-1b|Drug: Clofazimine,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",81.0,Other,Interventional,2020-07-14,30/06/21,2021-09-30,10/07/20,15/07/20,"The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong",China,Respiratory Diseases,1,1,443.0
2825.0,NCT04344925,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,,Terminated,COVID-19,,,,,,,Device: Aerosol-reducing Mask|Device: Standard Mask,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",21.0,Other,Observational,2020-04-18,27/11/20,2020-11-27,14/04/20,01/03/21,"London Health Science Centre, London, Ontario",Canada,Respiratory Diseases,1,1,223.0
2826.0,NCT04537130,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,COVINVAC,Not yet recruiting,Pulmonary Fibrosis,COVID-19,,,,,,Biological: IN01 vaccine,Instituto Oncológico Dr Rosell|IN3BIO|PANGAEA,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-12,01/06/21,2022-01-06,03/09/20,24/09/20,"Hospital El Pilar, Barcelona",Spain,Respiratory Diseases,1,2,725.0
2827.0,NCT04452773,Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Manremyc|Dietary Supplement: Placebo,Reig Jofre Group,All,"18 Years and older   (Adult, Older Adult)",315.0,Industry,Interventional,2020-07-14,01/09/20,2021-01-12,30/06/20,15/07/20,"CAP Cornellà (La Gavarra), Cornellà De Llobregat, Barcelona, Spain|CAP Maresme, Mataró, Barcelona, Spain|Cap Sant Fèlix, Sabadell, Barcelona, Spain|EAP Riu Nord, Santa Coloma De Gramenet, BArcelona, Spain|Hospital Universitari Germans Trias i Pujol UBP Riscos Laborals, Badalona,, Badalona",Spain,Respiratory Diseases,1,1,182.0
2828.0,NCT04730895,Isotretinoin (13- Cis-Retinoic Acid) Versus Spike Protein Based Vaccine for Providing Complete Protection Against COVID-19 and Preventing the Expected Long Term Serious Side Effects Which May Caused by Spike Protein Based Vaccine-An Urgent Protective Clinical Trial,Isotretinoin,Not yet recruiting,COVID-19,,,,,,,Drug: Oral 13 cis retinoic acid|Drug: Aerosolized 13 cis retinoic acid|Combination Product: 13 cis retinoic acid doses orally in combination with spike protein based vaccine|Combination Product: Aerosolized 13 cis retinoic acid in combination with spike protein based vaccine|Biological: Biological: spike protein based vaccine such as ChAdOx1 nCoV-19 vaccine,Kafrelsheikh University,Male,18 Years to 40 Years   (Adult),360.0,Other,Interventional,2021-01-02,01/04/21,2023-01-12,29/01/21,04/02/21,,,Respiratory Diseases,1,1,740.0
2829.0,NCT04806061,Urine Alkalinisation in COVID-19,,Not yet recruiting,COVID-19,Acute Kidney Injury,,,,,,Drug: Sodium bicarbonate|Drug: standard care,Guy's and St Thomas' NHS Foundation Trust|University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-04-15,15/05/22,2022-12-31,19/03/21,19/03/21,,,Respiratory Diseases,1,2,625.0
2830.0,NCT04647695,IFN-beta 1b and Remdesivir for COVID19,,Recruiting,COVID-19,,,,,,,Drug: Interferon beta-1b|Drug: Remdesivir,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-11-20,31/07/21,2021-09-30,01/12/20,10/12/20,"Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,314.0
2831.0,NCT04694651,Potential Acceptance of COVID-19 Vaccines in Healthcare Workers in Egypt,,Recruiting,COVID-19,,,,,,,,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-12-15,30/01/21,2021-02-15,05/01/21,05/01/21,"AssiutU, Assiut, Egypt|Aliae AR Mohamed-Hussein, Assiut",Egypt,Respiratory Diseases,1,1,62.0
2832.0,NCT04644198,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma Infusion,The University of The West Indies,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,01/12/21,2021-01-12,25/11/20,17/02/21,"University of the West Indies, Kingston",Jamaica,Respiratory Diseases,1,1,8.0
2833.0,NCT04367714,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,COVCKD,Recruiting,COVID-19,Terminal Renal Insufficiency,,,,,,,Region MidtJylland Denmark|Aarhus University Hospital|Central Jutland Regional Hospital|Aalborg University Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-03-15,01/12/21,2021-01-12,29/04/20,30/12/20,"Godstrup Hospital, Herning",Denmark,Respiratory Diseases,1,2,303.0
2834.0,NCT04359407,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,COVID-19_EIT,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,Electric Impedance,Prone Positioning,,,,,Other: Prone positioning,"Walid HABRE|University Hospital, Geneva",All,"18 Years to 80 Years   (Adult, Older Adult)",16.0,Other,Observational,2020-04-27,31/12/20,2021-01-31,24/04/20,02/06/20,"University Hospitals of Geneva, Geneva",Switzerland,Respiratory Diseases,1,3,279.0
2835.0,NCT04565197,Convalescent Plasma Therapy for COVID-19 Patients,,"Active, not recruiting",SARS-CoV Infection,,,,,,,Biological: convalescent plasma,Lahore General Hospital,All,"15 Years to 80 Years   (Child, Adult, Older Adult)",20.0,Other,Interventional,2020-01-05,30/12/20,2020-12-30,25/09/20,08/12/20,"Muhammad Irfan Malik, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,360.0
2836.0,NCT04642196,COVID-19 in Home Healthcare,,Completed,COVID-19,,,,,,,,"University Hospital, Linkoeping",All,"Child, Adult, Older Adult",155.0,Other,Observational,2020-02-05,10/10/20,2020-10-10,24/11/20,24/11/20,"Dept of anesthesia, Linköping",Sweden,Respiratory Diseases,1,1,248.0
2837.0,NCT04435808,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,,Terminated,COVID-19,,,,,,,Drug: Hydroxychloroquine,University of New Mexico,All,"18 Years and older   (Adult, Older Adult)",1.0,Other,Interventional,2020-04-14,15/07/20,2020-07-15,17/06/20,16/11/20,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico",United States,Respiratory Diseases,1,1,92.0
2838.0,NCT04719208,[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse,,Recruiting,COVID-19,,,,,,,Other: Water (E) Mouth rinse with the solution provided|Other: Chlorhexidine gluconate (A) Mouth rinse with the solution provided|Other: Hydrogen peroxide (B) Mouth rinse with the solution provided|Other: Betadine (C) Mouth rinse with the solution provided|Other: Alcohol mouthwash (Listerine) (D) Mouth rinse with the solution provided,Augusta University,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-10,01/05/21,2021-01-06,22/01/21,22/01/21,"Augusta University, Augusta, Georgia, United States|Augusta University-Dental College of Georgia, Augusta, Georgia",United States,Respiratory Diseases,1,1,210.0
2839.0,NCT04690114,COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity,,Recruiting,COVID-19,,,,,,,,"Shaare Zedek Medical Center|Ministry of Health, Israel",All,"up to 18 Years   (Child, Adult)",2000.0,Other,Observational,2020-01-10,31/05/21,2021-07-31,30/12/20,31/12/20,"Shaare Zedek Medical Center, Jerusalem",Israel,Respiratory Diseases,1,1,568.0
2840.0,NCT04836780,DEXamethasone EARLY Administration in Hospitalized Patients With Covid-19 Pneumonia,EARLYDEXCoV2,Not yet recruiting,COVID-19,Acute Respiratory Distress Syndrome,"Pneumonia, Viral",,,,,Drug: Dexamethasone,"Hospital Universitario Infanta Leonor|Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Leonor|Kern Pharma, S.L.",All,"18 Years and older   (Adult, Older Adult)",126.0,Other|Industry,Interventional,2021-01-04,30/06/21,2021-06-30,08/04/21,08/04/21,"Hospital Universitario Infanta Leonor, Madrid",Spain,Respiratory Diseases,1,3,177.0
2841.0,NCT04616001,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: IVIG,Sharp HealthCare,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-11,30/06/21,2021-06-30,04/11/20,04/11/20,"Sharp Memorial Hospital, San Diego, California",United States,Respiratory Diseases,1,2,536.0
2842.0,NCT04498442,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",,Completed,COVID-19,Stress,Anxiety Depression,,,,,Behavioral: Simha Kriya|Behavioral: Reading a Book,Beth Israel Deaconess Medical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",8519.0,Other,Interventional,2020-05-22,22/10/20,2020-10-22,04/08/20,01/02/21,"Beth Israel Deaconess Medical Centre, Boston, Massachusetts",United States,"Mental Health, Respiratory Diseases",1,3,153.0
2843.0,NCT04386551,Detection of COVID-19 in Saliva Collection,SALICOV,Completed,Sars-CoV2,RT-PCR,Saliva Collection,Nasopharyngeal Sample,,,,,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",501.0,Other,Observational,2020-06-05,05/08/20,2020-05-08,13/05/20,11/12/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,4,-28.0
2844.0,NCT04377581,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",,Completed,Public Health,Demography,Pandemics,Corona Virus Infection,News,Global Health,Perception,,"Milton S. Hershey Medical Center|The Huck Institutes of the Life Sciences|The Social Science Research Institute|The Department of Family and Community Medicine, Penn State College of Medicine|The College of Healthcare Information Management Executives (CHIME)",All,"18 Years and older   (Adult, Older Adult)",18251.0,Other,Observational,2020-09-04,10/07/20,2020-10-07,06/05/20,16/07/20,"Penn State College of Medicine, Hershey, Pennsylvania",United States,Respiratory Diseases,1,7,33.0
2845.0,NCT04363333,Obstructive Sleep Apnea & Covid-19 Outcomes,OSACOVID-19,"Active, not recruiting",COVID-19,Obstructive Sleep Apnea,Pneumonia,,,,,Diagnostic Test: Home Sleep Apnea Testing or In-hospital Polysomnography,"Koç University|Koc Healthcare Istanbul American Hospital, Marmara University Hospital",All,"18 Years and older   (Adult, Older Adult)",320.0,Other,Observational,2020-04-27,31/05/21,2021-07-31,27/04/20,17/02/21,"Marmara University Hospital, Istanbul, Basibuyuk, Turkey|Koc University, Istanbul, Turkey|Koc Healthcare Istanbul American Hospital, İstanbul",Turkey,Respiratory Diseases,1,3,460.0
2846.0,NCT04723576,Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19),COVER-HCW,Recruiting,Healthy,,,,,,,Behavioral: Stress First Aid,RAND|Stanford University|Clinical Directors Network|Vizient,All,"Child, Adult, Older Adult",2132.0,Other,Interventional,2020-03-12,01/02/22,2023-11-30,25/01/21,25/01/21,"Clinical Directors Network, Inc, New York, New York, United States|Vizient Inc., Irving, Texas",United States,Others,0,1,1358.0
2847.0,NCT04635241,Inhaled Heparin for Hospitalised COVID-19 Patients,INHALE-HEP,Recruiting,COVID-19,,,,,,,Drug: Unfractionated heparin,"Australian National University|Helwan University|Clinica San Camilo, Argentina",All,"18 Years and older   (Adult, Older Adult)",712.0,Other,Interventional,2020-01-06,01/04/21,2021-01-06,19/11/20,16/12/20,"San Camilo Clinic, Buenos Aires, Argentina|15th May hospital, Cairo",Egypt,Respiratory Diseases,1,1,366.0
2848.0,NCT04793997,Microbiome Therapy in Covid-19 Primary Care Support,MiCel,Recruiting,SARS-CoV Infection,Corona Virus Infection,,,,,,Biological: Microbiome spray|Biological: Placebo spray,"University Hospital, Antwerp",All,"18 Years to 65 Years   (Adult, Older Adult)",150.0,Other,Interventional,2021-01-02,01/02/22,2022-01-02,11/03/21,11/03/21,"Veronique Verhoeven, Antwerp",Belgium,Respiratory Diseases,1,2,365.0
2849.0,NCT04823234,Lung Ultrasound Signs and Patterns in COVID-19 Pregnant Women,PINK-CO,Recruiting,Pregnancy Complications,COVID-19,,,,,,Diagnostic Test: Lung ultrasound,Azienda Sanitaria-Universitaria Integrata di Udine,Female,18 Years to 55 Years   (Adult),40.0,Other,Observational,2021-10-03,30/06/21,2021-09-30,30/03/21,30/03/21,"Anesthesiology and Intensive Care Clinic - Department of Medicine - ASUIUD, Udine",Italy,Respiratory Diseases,1,2,-3.0
2850.0,NCT04409249,Prognosis in Pregnant With COVID-19,,Completed,COVID-19,Prognostic Factors,Pregnancy,,,,,"Diagnostic Test: imaging, blood tests",Kanuni Sultan Suleyman Training and Research Hospital,Female,18 Years to 45 Years   (Adult),155.0,Other,Observational,2020-03-15,25/05/20,2020-05-28,01/06/20,02/07/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Halkali",Turkey,Respiratory Diseases,1,3,74.0
2851.0,NCT04324736,"""COVID-19 and Diabetes Outcomes""",CORONADO,Completed,Coronavirus,Diabetes,,,,,,Other: no interventional study,Nantes University Hospital,All,"Child, Adult, Older Adult",5309.0,Other,Observational,2020-10-03,10/04/20,2020-12-31,27/03/20,23/02/21,"CHU Nantes, Nantes",France,"Metabolic Disorders, Respiratory Diseases",1,2,89.0
2852.0,NCT04387786,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),DACOVID,Completed,COVID-19,Mechanical Ventilation,,,,,,Drug: Dornase Alfa,Feinstein Institute for Medical Research|Cold Spring Harbor Laboratory|Northwell Health,All,"18 Years to 85 Years   (Adult, Older Adult)",5.0,Other,Observational,2020-03-31,24/04/20,2020-04-09,14/05/20,13/11/20,"Feinstein Insitute for Medical Research at Northwell Health, Manhasset, New York",United States,Respiratory Diseases,1,2,9.0
2853.0,NCT04713553,"A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 Against COVID-19 in Healthy Participants",,Recruiting,COVID-19,COVID-19,,,,,,Biological: BNT162b2,BioNTech SE|Pfizer,All,"12 Years to 50 Years   (Child, Adult)",1530.0,Industry,Interventional,2021-02-15,11/05/21,2021-11-05,19/01/21,24/03/21,"Kaiser Permanente Oakland, Oakland, California, United States|Clinical Research Consulting, Milford, Connecticut, United States|Indago Research & Health Center, Inc., Hialeah, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Kentucky Pediatric/Adult Research, Bardstown, Kentucky, United States|Amici Clinical Research LLC, Raritan, New Jersey, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Texas Center for Drug Development, Inc., Houston, Texas, United States|Clinical Trials of Texas, Inc., San Antonio, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,263.0
2854.0,NCT04737161,Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome,,Not yet recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Biological: T regulatory cells,Stanford University,All,"18 Years to 75 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-03,01/09/22,2022-01-09,03/02/21,01/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,2,371.0
2855.0,NCT04798716,The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19,ARDOXSO,Not yet recruiting,COVID-19,COVID-19,Acute Respiratory Distress Syndrome,,,,,Drug: MSC-exosomes delivered intravenously every other day on an escalating dose: (2:4:8)|Drug: MSC-exosomes delivered intravenously every other day on an escalating dose (8:4:8)|Drug: MSC-exosomes delivered intravenously every other day (8:8:8),AVEM HealthCare,All,"18 Years and older   (Adult, Older Adult)",55.0,Industry,Interventional,2021-01-04,01/09/21,2021-01-12,15/03/21,16/03/21,"Mission Community Hospital, Panorama City, California",United States,Respiratory Diseases,1,3,8.0
2856.0,NCT04734873,CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: CPI-006 2 mg/kg + SOC|Drug: CPI-006 1 mg/kg + SOC|Drug: Placebo + SOC,"Corvus Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",1000.0,Industry,Interventional,2021-02-25,30/12/21,2022-01-30,02/02/21,13/04/21,"Sharp Chula Vista Medical Center, Chula Vista, California, United States|El Centro Regional Medical Center, El Centro, California, United States|Sharp Grossmont Hospital, La Mesa, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Mayo Clinic - Jacksonville, Jacksonville, Florida, United States|Cambridge Medical Trials, Alexandria, Louisiana, United States|MedPharmics, Metairie, Louisiana, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan, United States|Mayo Clinic - Rochester, Rochester, Minnesota, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Clínica Adventista Belgrano, Estomba, Buenos Aires, Argentina|Instituto Medico Platense, La Plata, Buenos Aires, Argentina|Clinica Independencia, Munro, Buenos Aires, Argentina|Instituto Médico Río Cuarto, Río Cuarto, Córdoba, Argentina|Centro de Investigación Clínica - Clínica Viedma, Viedma, Río Negro, Argentina|Centro Médico IPAM, Rosario, Santa Fe, Argentina|Hospital Provincial Del Centenario, Rosario, Santa Fe, Argentina|Clinica Mayo de U.M.C.B. S.R.L, San Miguel de Tucumán, Tucumán, Argentina|Hospital de Clínicas Presidente Dr. Nicolás Avellaneda, San Miguel De Tucumán, Tucumán, Argentina|Fundación Sanatorio Güemes, Ciudad Autónoma de Buenos Aires, Argentina|Hospital Rawson, Córdoba, Argentina|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Hospital Agamenon Magalhães, Recife, Pernambuco, Brazil|Santa Casa de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Dia do Pulmão, Blumenau, Santa Catarina, Brazil|Clínica Supera, Chapecó, Santa Catarina, Brazil|Hospital Municipal de Barueri Dr. Francisco Moran, Barueri, São Paulo, Brazil|Centro Hospitalar Nossa Saúde, Curitiba, Brazil|Hospital Anchieta, São Paulo, Brazil|Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto, São Paulo, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, São Paulo, Brazil|Toronto General Hospital, Toronto, Ontario, Canada|Rodrigo Botero S.A.S, Medellín, Antioquia, Colombia|Fundacion Santa Fe de Bogota, Bogotá, Cundinamarca, Colombia|Clínica Universidad De la Sabana, Chía, Cundinamarca, Colombia|Fundacion Centro de Excelencia en Enfermedades Cronicas No Transmisibles, Monteria, Córdoba, Colombia|Clínica de la Mujer S.A.S., Bogotá, Colombia|Hospital Universitario Clinica San Rafael, Bogotá, Colombia|Fundacion Hospitalaria San Vicente de Paul, Medellín, Colombia|Promotora Medica Las Américas S.A- Clínica Las Américas, Medellín, Colombia|Fundación Valle Del Lili, Santiago de Cali, Colombia|CHRU Dijon, Dijon, Côte-d'Or, France|Hôpital Saint-André, Bordeaux, Gironde, France|Amiens University Hospital, Dreuil-lès-Amiens, Somme, France|Centre Hospitalier Departemental de Vendee, La Roche-sur-Yon, Vendée, France|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Tel-Aviv, Israel|Edith Wolfson Medical Center, Holon, Tel-Avov, Israel|Shamir Medical Center Assaf Harofeh, Be'er Ya'aqov, Israel|Rambam Medical Center, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|ZIV Medical Center, Safed, Israel|Sheba Medical Center, Tel HaShomer, Israel|Azienda Ospedaliera Cotugno, Napoli, Campania, Italy|Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Emilia-Romagna, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda, Milano, Lombardia, Italy|ASST Santi Paolo e Carlo - Azienda Universitaria-Polo Universitario San Paolo, Milano, Lombardia, Italy|Ospedale San Raffaele S.r.l., Milano, Lombardia, Italy|ASST di Monza - Azienda Ospedaliera San Gerardo, Monza, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia, Pavia, Lombardia, Italy|Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio González, Monterrey, Nuevo Leon, Mexico|Hospital Civil de Culiacán, Culiacán, Sinaloa, Mexico|Hospital General de Culiacán, Culiacán, Sinaloa, Mexico|Hospital Nacional Sergio E. Bernales, Comas, Lima, Peru|Hospital Chancay y Servicios Basicos de Salud, Huaral, Lima, Peru|Hospital Central Fuerza Aérea del Perú, Miraflores, Lima, Peru|Hospital María Auxiliadora, San Juan De Miraflores, Lima, Peru|Clínica Providencia, San Miguel, Lima, Peru|Clínica San Pablo, Santiago De Surco, Lima, Peru|Hospital Nacional Adolfo Guevara Velasco Essalud, Cusco, Peru|Hospital Militar Central, Lima, Peru|Merc SiReN - MeDiNova Clinical Research, Johannesburg, Gauteng, South Africa|Peermed Clinical Trial Centre, Kempton Park, Gauteng, South Africa|Dr JM Engelbrecht Trial Site, Cape Town, Western Cape, South Africa|Excellentis Clinical Trial Consultants, George, Western Cape, South Africa|Task Eden Research Centre, George, Western Cape, South Africa|Clinical Projects Research SA Pty Ltd, Worcester, Western Cape, South Africa|Hospital Costa del Sol, Marbella, Málaga, Spain|Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain|Municipal Institution City Clinical Hospital #6 of Dnipropetrovsk Regional Council, Dnipro, Dnipropetrovs'ka Oblast, Ukraine|Kharkiv Regional Clinical Infectious Diseases Hospital, Kharkiv, Kharkivs'ka Oblast, Ukraine|Poltava Regional Clinical Infectious Hospital, Poltava, Poltavs'ka Oblast, Ukraine|Communal Non-Commercial Enterprise Vinnytsia City Clinical Hospital 1, Vinnytsya, Vinnytsia Oblast, Ukraine|Municipal enterprise Volyn Regional Clinical Hospital of Volyn Regional Council, Lutsk, Volyn Oblast, Ukraine|MNPE City Hospital No. 6 of Zaporizhzhia City Council, Zaporizhzhia, Zaporiz'ka Oblast, Ukraine|Municipal Institution City Hospital #7, Zhaporizhzhya, Zaporiz'ka Oblast",Ukraine,Respiratory Diseases,1,1,339.0
2857.0,NCT04486144,Impact Nerium Oleander on Immune Function,,Completed,COVID-19,COVID-19,Immune Function,,,,,Other: Proprietary extract of Nerium oleander,"HealthQuilt|The Schull Institute|Texas A&M University|The Hildebrand Fund at the Greater Houston Community Foundation|Baylor College of Medicine|The University of Texas Health Science Center, Houston|University of Maryland, College Park",All,"18 Years and older   (Adult, Older Adult)",82.0,Other,Interventional,2020-05-20,23/07/20,2020-07-23,24/07/20,09/03/21,"KDunn and Associates, PA, dba Healthquilt, Houston, Texas",United States,Respiratory Diseases,1,3,64.0
2858.0,NCT04713878,Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Other: Mesenchymal stem cells,Kanuni Sultan Suleyman Training and Research Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",21.0,Other,Interventional,2020-08-05,30/06/20,2020-07-15,19/01/21,20/01/21,"University of Health Sciences, Istanbul",Turkey,Respiratory Diseases,1,1,-21.0
2859.0,NCT04801836,Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection,,Recruiting,COVID-19,,,,,,,Drug: Estetrol monohydrate 15 mg|Drug: Placebo,NEURALIS s.a.,All,"18 Years and older   (Adult, Older Adult)",300.0,Industry,Interventional,2020-11-19,30/06/21,2021-06-30,17/03/21,17/03/21,"ERASME Hospital, Brussels, Belgium|CHR Citadelle, Liège, Belgium|Koranyi National Institute of Pulmonology, Budapest, Hungary|University of Pecs Medical Center, Pécs, Hungary|University of Szeged Medical Center, Szeged, Hungary|Szent Borbala Korhaz, Tatabánya, Hungary|Wojewódzki Szpital Specjalistyczny w Białej Podlaskiej Oddział Kardiologiczny Pododdział Kardiologii Zachowawczej, Biała Podlaska, Poland|Zespół Opieki Zdrowotnej w Bolesławcu Oddział Chorób Wewnętrznych, Boleslawiec, Poland|Arion Med. Sp z o.o. Zespół Opieki Zdrowotnej w Gostyninie Oddział Chorób Wewnętrznych, Gorzewo, Poland|Samodzielny Publiczny Zakad Opieki Zdrowotnej w Pulawach Oddział Obserwacyjno-Zakaźny, Puławy, Poland|Samodzielny Publiczny Zespół Zakładów Opieki Zdrowotnej w Staszowie Oddział Chorób Wewnętrznych, Staszów, Poland|Wielospecjalistycznego Szpitala im. J. Strusia z Zakładem Opiekuńczo - Leczniczym SP ZOZ Oddział Chorób Wewnętrznych, Szczecin, Poland|Szpital Matki Bożej Nieustającej Pomocy w Wołominie Oddział Chorób Wewnętrznych, Wołomin, Poland|Wojewódzki Szpital Specjalistyczny im. J. Gromkowskiego I Oddział Chorób Zakaźnych, Wrocław, Poland|City Clinical Hospital #15 n.a. Filatov, Moscow, Russian Federation|State budgetary healthcare institution of Moscow City Clinical Hospital No 52 of the Department of Healhcare of Moscow, Moscow, Russian Federation|State Budgetary Healthcare Institution Clinical Infectious Disease Hospital No. 1 of the Moscow City Health Department, Moscow, Russian Federation|Saint-Petersburg state budgetary healthcare institution Clinical infectious hospital n.a. S.P. Botkin, Saint Petersburg, Russian Federation|City Hospital #15, Saint Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution Pokrovskaya City Hospital, Saint Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution Alexandrovskaya City Hospital, Saint-Petersburg, Russian Federation|Saint-Petersburg state budgetary healthcare institution City hospital No 40 of resort region, Sestroretsk, Russian Federation|Budgetary healthcare institution of Voronezh Region Voronezh regional clinical hospital, Voronezh, Russian Federation|State budgetary healthcare institution of the Yaroslavl Region Yaroslavl regional clinical hospital of the war veterans - international center for health problems of aged people Healthy longevity, Yaroslavl, Russian Federation|State budgetary healthcare institution of Moscow Region Zhukovskaya City Clinical Hospital, Zhukovskiy",Russian Federation,Respiratory Diseases,1,1,223.0
2860.0,NCT04368897,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,,Recruiting,SARS-CoV 2,COVID-19,COVID-19,Androgenetic Alopecia,Androgen Receptor Abnormal,Androgen Deficiency,,Diagnostic Test: CAG length <22|Diagnostic Test: CAG length >=22,"Applied Biology, Inc.|Hospital Universitario Ramon y Cajal",Male,"18 Years and older   (Adult, Older Adult)",200.0,Industry|Other,Observational,2020-01-05,01/04/21,2021-01-06,30/04/20,14/01/21,"Hospital Universitario Ramon y Cajal, Madrid",Spain,Respiratory Diseases,1,6,367.0
2861.0,NCT04832061,Respiratory Supports and COVID-19 Mortality,,Not yet recruiting,COVID-19,,,,,,,Other: Respiratory supports,Yale University,All,"18 Years and older   (Adult, Older Adult)",2100.0,Other,Observational,2021-01-04,30/06/21,2021-08-31,05/04/21,05/04/21,"Yale University School of Medicine, New Haven, Connecticut",United States,Respiratory Diseases,1,1,239.0
2862.0,NCT04402840,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Procedure: Stellate Ganglion Block,West Virginia University,All,"18 Years to 80 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-04-24,01/12/21,2021-01-12,27/05/20,03/11/20,"West Virginia University Rockefeller Neuroscience Institute, Morgantown, West Virginia",United States,Respiratory Diseases,1,2,263.0
2863.0,NCT04773899,COVID-19 Associated Endothelial Dysfunction Study,CAUSED,Not yet recruiting,COVID-19,Microcirculation,,,,,,Diagnostic Test: Procedure : Multimodal microvascular assessment at study inclusion,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2021-09-04,09/04/22,2022-09-06,26/02/21,26/02/21,,,Respiratory Diseases,1,2,367.0
2864.0,NCT04641988,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),COROBIOCHIC,Completed,COVID-19,,,,,,,,"University Hospital, Montpellier",All,"18 Years to 99 Years   (Adult, Older Adult)",111.0,Other,Observational,2020-01-02,01/03/20,2020-06-30,24/11/20,24/11/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,180.0
2865.0,NCT04380402,Atorvastatin as Adjunctive Therapy in COVID-19,STATCO19,Recruiting,COVID-19,,,,,,,Drug: Atorvastatin,Mount Auburn Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-06-25,31/12/21,2022-08-05,08/05/20,19/03/21,"Mount Auburn Hospital, Cambridge, Massachusetts",United States,Respiratory Diseases,1,1,771.0
2866.0,NCT04380688,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,CALAVI US,Completed,COVID-19,,,,,,,Drug: Acalabrutinib,AstraZeneca|Acerta Pharma B.V.,All,"18 Years to 130 Years   (Adult, Older Adult)",62.0,Industry|Other,Interventional,2020-06-13,16/11/20,2020-11-16,08/05/20,02/12/20,"Research Site, Anniston, Alabama, United States|Research Site, Escondido, California, United States|Research Site, Fullerton, California, United States|Research Site, Glendale, California, United States|Research Site, Newport Beach, California, United States|Research Site, Washington, District of Columbia, United States|Research Site, Fort Lauderdale, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Jacksonville, Florida, United States|Research Site, Loxahatchee Groves, Florida, United States|Research Site, Peoria, Illinois, United States|Research Site, Fort Wayne, Indiana, United States|Research Site, Louisville, Kentucky, United States|Research Site, Annapolis, Maryland, United States|Research Site, Baltimore, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Bethesda, Maryland, United States|Research Site, Silver Spring, Maryland, United States|Research Site, Hackensack, New Jersey, United States|Research Site, Albany, New York, United States|Research Site, Bronx, New York, United States|Research Site, Buffalo, New York, United States|Research Site, New York, New York, United States|Research Site, New York, New York, United States|Research Site, Philadelphia, Pennsylvania, United States|Research Site, Nashville, Tennessee, United States|Research Site, Houston, Texas, United States|Research Site, Houston, Texas, United States|Research Site, Tyler, Texas, United States|Research Site, Richmond, Virginia, United States|Research Site, Renton, Washington",United States,Respiratory Diseases,1,1,156.0
2867.0,NCT04346199,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,CALAVI,Completed,COVID-19,,,,,,,Drug: Acalabrutinib,AstraZeneca|Acerta Pharma B.V.,All,"18 Years to 130 Years   (Adult, Older Adult)",177.0,Industry|Other,Interventional,2020-12-06,17/11/20,2020-11-17,15/04/20,02/02/21,"Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Ciudad de Buenos Aires, Argentina|Research Site, Monte Grande, Argentina|Research Site, Ramos Mejía, Argentina|Research Site, Botucatu, Brazil|Research Site, Florianópolis, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Porto Alegre, Brazil|Research Site, Ribeirão Preto, Brazil|Research Site, Salvador, Brazil|Research Site, Sao Bernardo do Campo, Brazil|Research Site, Sao Paulo, Brazil|Research Site, Sao Paulo, Brazil|Research Site, São Paulo, Brazil|Research Site, Curico, Chile|Research Site, Santiago, Chile|Research Site, Talca, Chile|Research Site, Villejuif Cedex, France|Research Site, Frankfurt, Germany|Research Site, Gauting, Germany|Research Site, Hamburg, Germany|Research Site, Köln, Germany|Research Site, Bangalore, India|Research Site, New Delhi, India|Research Site, Milano, Italy|Research Site, Roma, Italy|Research Site, Shinjuku-ku, Japan|Research Site, D.F, Mexico|Research Site, Monterrey, Mexico|Research Site, México, Mexico|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Lima, Peru|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Moscow, Russian Federation|Research Site, Murmansk, Russian Federation|Research Site, Cape Town, South Africa|Research Site, George, South Africa|Research Site, Johannesburg, South Africa|Research Site, Johannesburg, South Africa|Research Site, Pretoria, South Africa|Research Site, Ankara, Turkey|Research Site, Bakirkoy, Turkey|Research Site, Istanbul, Turkey|Research Site, Istanbul, Turkey|Research Site, Umraniye",Turkey,Respiratory Diseases,1,1,-19.0
2868.0,NCT04516759,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,ARCADIA,Recruiting,COVID-19,,,,,,,Drug: AZD1656|Other: Placebo,St George Street Capital,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-12-08,01/04/21,2021-01-04,18/08/20,25/03/21,"Masarykova Univerzita - Fakultni Nemocnice U SV Anny V Brne (308), Brno, Czechia|Nemocnice Hořovice (309), Hořovice, Czechia|Oblastni Nemocnice Kolín (306), Kolín, Czechia|Klaudianova Nemonice (302), Mladá Boleslav, Czechia|Fakultni Nemocnice V Motole (303), Prague, Czechia|Thomayerova Nemonice (310), Prague, Czechia|Nemocnice Třebíč (305), Třebíč, Czechia|Colentina Clinical Hospital (204), Bucharest, Romania|Spitalul Clinic de Boli Infectioase Cluj-Napoca (203), Cluj-Napoca, Romania|Spitalul Clinic de Pneumoftiziologie Leon Daniello Cluj-Napoca (202), Cluj-Napoca, Romania|Spitalul Clinic de Boli Infectioase Constanţa (207), Constanţa, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr Victor Babes Craiova (206), Craiova, Romania|Spitalul Judetean de Urgenta Deva (208), Deva, Romania|Spitalul Clinic de Boli Infectioase Sfanta Parascheva Iaşi (205), Iaşi, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr Victor Babes Timişoara (201), Timişoara, Romania|Barnsley Hospital NHS Foundation Trust (105), Barnsley, United Kingdom|Bolton NHS Foundation Trust (122), Bolton, United Kingdom|Bradford Teaching Hospitals NHS Foundation Trust (103), Bradford, United Kingdom|North Bristol NHS Trust (116), Bristol, United Kingdom|County Durham and Darlington NHS Foundation Trust (121), Darlington, United Kingdom|The Dudley Group NHS Foundation Trust (107), Dudley, United Kingdom|Medway NHS Foundation Trust (108), Gillingham, United Kingdom|Hull & East Yorkshire NHS Trust (102), Hull, United Kingdom|Barts Health NHS Trust (101 and 111), London, United Kingdom|Royal Free London NHS Foundation Trust (119), London, United Kingdom|St George's University Hospitals NHS Foundation Trust (114), London, United Kingdom|Penine Acute Hospitals NHS Trust (106), Salford, United Kingdom|Sheffield Hospitals NHS Foundation Trust (104), Sheffield, United Kingdom|Somerset NHS Foundation Trust (109), Taunton, United Kingdom|Walsall Healthcare NHS Trust (113), Walsall",United Kingdom,Respiratory Diseases,1,1,27.0
2869.0,NCT04788407,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts,PENTZ,Recruiting,COVID-19,COVID-19,Households Contacts,,,,,Drug: Nitazoxanide|Drug: Placebo,Fundación Huésped|Ministerio de Salud de Ciudad Autónoma de Buenos Aires|Laboratorios Roemmers S.A.I.C.F.,All,"18 Years to 65 Years   (Adult, Older Adult)",456.0,Other|Industry,Interventional,2020-01-12,30/04/21,2021-04-30,09/03/21,10/03/21,"Fundación Huésped., Buenos Aires, Ciudad Autonoma De Buenos Aires",Argentina,Respiratory Diseases,1,3,474.0
2870.0,NCT04422353,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,PTT-Online,Recruiting,Parkinson Disease,Parkinson Disease 10,,,,,,Other: Video Dance classes|Other: Unsupervised physical activities,Federal University of Rio Grande do Sul|Aline Nogueira Haas|Flávia Gomes Martinez|Elren Passos Monteiro,All,"50 Years to 80 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-05,30/12/20,2024-12-30,09/06/20,11/06/20,"Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul",Brazil,Others,0,2,1821.0
2871.0,NCT04377750,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab,Hadassah Medical Organization|Sheba Medical Center|Wolfson Medical Center,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-08-04,29/04/20,2021-08-05,06/05/20,06/05/20,"Hadassah Medical Orginisation, Jerusalem, Please Select:, Israel|Barzilai Medical Center, Ashkelon, Israel|Wolfson Medical Center, H̱olon, Israel|Sheba Medical Center, Ramat Gan",Israel,Respiratory Diseases,1,1,366.0
2872.0,NCT04420247,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,,Completed,COVID-19,COVID-19,SARS-CoV 2,Coronavirus,Corona Virus Infection,,,Drug: Chloroquine|Drug: Hydroxychloroquine|Other: standard care,Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva,All,"18 Years and older   (Adult, Older Adult)",142.0,Other,Interventional,2020-04-16,20/08/20,2020-03-09,09/06/20,27/10/20,"Centro de Estudos e Pesquisa em Emergencias Clinicas e Terapia Intensiva, Curitiba, Parana",Brazil,Respiratory Diseases,1,5,-38.0
2873.0,NCT04349631,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: HB-adMSCs,Hope Biosciences,All,"Child, Adult, Older Adult",56.0,Industry,Interventional,2020-04-22,24/11/20,2021-01-05,16/04/20,25/03/21,"Sherry Diers, Sugar Land, Texas",United States,Respiratory Diseases,1,1,258.0
2874.0,NCT04432870,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,,Enrolling by invitation,Colon Cancer,,,,,,,,Massachusetts General Hospital|Patient-Centered Outcomes Research Institute,All,"45 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-09-06,30/05/21,2021-06-30,16/06/20,07/12/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Cancers,1,1,297.0
2875.0,NCT04558463,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Oseltamivir 75mg,Indonesia University,All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-16,30/09/20,2020-10-30,22/09/20,22/09/20,"Cipto Mangunkusumo National Referral Hospital, Jakarta, DKI Jakarta",Indonesia,Respiratory Diseases,1,1,197.0
2876.0,NCT04501978,ACTIV-3: Therapeutics for Inpatients With COVID-19,TICO,Recruiting,COVID-19,,,,,,,Biological: LY3819253|Drug: Placebo|Biological: Remdesivir|Biological: VIR-7831|Biological: BRII-196/BRII-198|Biological: AZD7442,"National Institute of Allergy and Infectious Diseases (NIAID)|International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)|University of Copenhagen|Medical Research Council|Kirby Institute|Washington D.C. Veterans Affairs Medical Center|AIDS Clinical Trials Group|National Heart, Lung, and Blood Institute (NHLBI)|US Department of Veterans Affairs|Prevention and Early Treatment of Acute Lung Injury (PETAL)|Cardiothoracic Surgical Trials Network (CTSN)|Eli Lilly and Company|Vir Biotechnology, Inc.|GlaxoSmithKline|Brii Biosciences Limited|AstraZeneca",All,"18 Years and older   (Adult, Older Adult)",10000.0,NIH|Other|U.S. Fed|Industry,Interventional,2020-04-08,01/07/22,2022-01-07,06/08/20,06/04/21,"Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue, Tucson, Arizona, United States|Southern Arizona VA Health Care System (Site 074-009), 3601 S. 6th Ave., Tucson, Arizona, United States|Community Regional Medical Center (Site 203-005), 2823 Fresno Street, Fresno, California, United States|VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street, Loma Linda, California, United States|Keck Hospital of USC (Site 301-020), 1500 San Pablo Street, Los Angeles, California, United States|Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Blvd., Los Angeles, California, United States|Ronald Reagan UCLA Medical Center (Site 203-002), 757 Westwood Plaza, Los Angeles, California, United States|VA Northern California Health Care System - Sacramento VAMC (Site 074-023), 10535 Hospital Way, Mather, California, United States|Mount Zion Hospital, UCSF Medical Center (Site 203-007), 1600 Divisadero St., San Francisco, California, United States|San Francisco VA Healthcare System (Site 074-002), 4150 Clement St., San Francisco, California, United States|Moffitt-Long Hospital, UCSF Medical Center (Site 203-001), 505 Parnassus Ave., San Francisco, California, United States|Stanford University Hospital & Cinics (Site 203-003), 300 Pasteur Dr., Stanford, California, United States|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (Site 066-002), 1124 W. Carson Street, Torrance, California, United States|University of Colorado Hospital (Site 204-001), 12605 E. 16th Avenue, Aurora, Colorado, United States|Denver Public Health (Site 017-004), 605 Bannock St., MC2600 (Infectious Disease Clinic), Denver, Colorado, United States|National Jewish Health (Site 204-003), 1400 Jackson Street, Denver, Colorado, United States|MedStar Georgetown University Hospital (Site 067-001), 3800 Reservoir Road NW, Washington, District of Columbia, United States|VA Medical Center (Site 009-004), 50 Irving Street NW, Washington, District of Columbia, United States|Bay Pines VA Healthcare System (Site 074-004), 10000 Bay Pines Blvd., Bldg. 100, Room 5B-104, Bay Pines, Florida, United States|Baycare Health System (Site 301-025), Morton Plant Hospital, 300 Pinellas Street, Clearwater, Florida, United States|Memorial Healthcare System (Site 648-002), Memorial Regional Hospital, 3501 Johnson Street, Hollywood, Florida, United States|Miami VA Healthcare System (Site 074-003), 1201 NW 16 Street, Miami, Florida, United States|The Emory Clinic (Site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., NE, Atlanta, Georgia, United States|Lutheran Medical Group (Site 301-010), 7916 W. Jefferson Boulevard, Fort Wayne, Indiana, United States|University of Kentucky Hospital (Site 210-004), 1000 South Limestone St., Lexington, Kentucky, United States|Ochsner Clinic Foundation (Site 301-015), 1514 Jefferson Highway, New Orleans, Louisiana, United States|University of Maryland Medical Center (Site 301-019), 22 South Greene Street, Baltimore, Maryland, United States|Massachusetts General Hospital (Site 202-002), 55 Fruit Street, Boston, Massachusetts, United States|Baystate Medical Center (Site 201-001), 759 Chestnut Street, Springfield, Massachusetts, United States|University of Michigan (Site 205-001), 1500 East Medical Center Drive, Ann Arbor, Michigan, United States|Henry Ford Health System, Henry Ford Hospital (Site 014-001), 2799 W. Grand Blvd., Detroit, Michigan, United States|Allina Health System, dba Abbott Northwestern Hospital (Site 301-026), 800 East 28th Street, Minneapolis, Minnesota, United States|Hennepin Healthcare (Site 027-001), 701 Park Avenue, Minneapolis, Minnesota, United States|Minneapolis VA Health Care System (Site 105-001), 1 Veterans Drive, Bldg 70, Minneapolis, Minnesota, United States|University of Mississippi Medical Center (Site 202-005), 2500 North State Street, Jackson, Mississippi, United States|Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital (Site 301-024), One Medical Center Drive, Lebanon, New Hampshire, United States|Cooper University Hospital (Site 019-001), One Cooper Plaza, Camden, New Jersey, United States|Lincoln Medical Center (New York Health and Hospitals/Lincoln) (Site 003-016), 234 E. 149th Street, Bronx, New York, United States|Montefiore Medical Center Weiler Hospital (Site 206-003), 1825 Eastchester Road, Bronx, New York, United States|Montefiore Medical Center Moses Hospital (Site 206-001), 111 E. 210th Street, Bronx, New York, United States|Duke University Hospital (Site 301-006), 2301 Erwin Road, Durham, North Carolina, United States|Wake Forest University Health Sciences (Site 210-001), Medical Center Blvd, Winston-Salem, North Carolina, United States|University of Cincinnati Medical Center (Site 207-003), 234 Goodman Ave., Cincinnati, Ohio, United States|Cleveland Clinic Fairview Hospital (Site 207-005), 18101 Lorain Avenue, Cleveland, Ohio, United States|Cleveland Clinic Foundation (Site 207-001), 9500 Euclid Avenue, Cleveland, Ohio, United States|Cleveland Clinic Marymount Hospital (Site 207-006), 12300 McCraken Road, Garfield Heights, Ohio, United States|Oregon Health & Science University (Site 208-003), 3181 SW Sam Jackson Park Rd., Portland, Oregon, United States|UPMC Magee-Womens Hospital (Site 209-003), 300 Halket Street, Pittsburgh, Pennsylvania, United States|UPMC Presbyterian Hospital (Site 209-001), 200 Lothrop Street, Pittsburgh, Pennsylvania, United States|UPMC Shadyside Hospital (Site 209-005), 5230 Centre Avenue, Pittsburgh, Pennsylvania, United States|Rhode Island Hospital (Site 080-036), 593 Eddy Street, Providence, Rhode Island, United States|The Miriam Hospital (Site 080-039), 164 Summit Ave., Providence, Rhode Island, United States|Medical University of South Carolina (Site 210-002), 171 Ashley Avenue, Charleston, South Carolina, United States|VA Tennessee Valley Healthcare System (TVHS) Nashville Campus (Site 074-022), 1310 24th Avenue South, Nashville, Tennessee, United States|Vanderbilt University Medical Center (Site 212-001), 1211 Medical Center Drive, Nashville, Tennessee, United States|UT Southwestern Medical Center (Site 084-001), 1936 Amelia Court, 2nd Floor, Dallas, Texas, United States|Baylor, Scott and White Health (Site 301-003), Baylor University Medical Center, 3500 Gaston Ave., Dallas, Texas, United States|Memorial Hermann Hospital (Site 203-006), 6411 Fannin Street, Houston, Texas, United States|Michael E. DeBakey Veterans Affairs Medical Center (MEDV AMC) (Site 074-006), 2002 Holcombe Blvd., Houston, Texas, United States|Texas Heart Institute (Site 301-017), 6770 Bertner, MC4-266, Houston, Texas, United States|Intermountain Medical Center (Site 211-001), 5121 South Cottonwood Street, Murray, Utah, United States|University of Utah Health (Site 211-002), 419 Wakara Way, Suite 207, Salt Lake City, Utah, United States|LDS Hospital (Site 211-004), 8th Ave. C Street, Salt Lake City, Utah, United States|University of Virginia (Site 301-021), 1215 Lee Street, Charlottesville, Virginia, United States|Virginia Commonwealth University Health System (Site 210-005), 1250 East Marshall Street, Richmond, Virginia, United States|Salem VA Medical Center (Site 074-014), 1970 Roanoke Blvd., Salem, Virginia, United States|Harborview Medical Center (Site 208-001), 325 9th Avenue, Seattle, Washington, United States|Swedish Medical Center (Site 208-005), 747 Broadway, Seattle, Washington, United States|University of Washington Medical Center - Montlake (Site 208-006), 1959 NE Pacific Street, Seattle, Washington, United States|WVU Medicine (Site 301-023), One Medical Center Drive, Morgantown, West Virginia, United States|Aalborg University Hospital (Site 625-005), Hobrovej 18, Aalborg, Denmark|Department of Infectious Diseases (Site 625-002), Aarhus University Hospital, Skejby, Palle Juul-Hensens Boulevard 99, Aarhus N, Denmark|Righospitalet (Site 625-006), Blegdamsvej 9,, Copenhagen Ø, Denmark|Bispebjerg Hospital (Site 625-013), Bispebjerg Bakke 23, Copenhagen, Denmark|Herlev Hospital (Site 625-012), Medicinsk Afdeling, Herlev Ringvej 75, Herlev, Denmark|Nordsjællands Hospital (Site 625-009), Dyrehavevej 29, Hillerød, Denmark|Hvidovre Hospital (S",United Kingdom,Respiratory Diseases,1,1,639.0
2877.0,NCT04360551,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Telmisartan 40mg|Drug: Placebo,University of Hawaii,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-07,30/06/21,2021-06-30,24/04/20,03/08/20,"University of Hawaii - Manoa, John A Burns School of Medicine UH Clinics at Kakaako, Honolulu, Hawaii",United States,Respiratory Diseases,1,1,540.0
2878.0,NCT04346667,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,PEACE,Terminated,COVID-19,Coronavirus Infection,Asymptomatic Condition,COVID-19,,,,Drug: Hydroxychloroquine Sulfate Regular dose|Drug: Hydroxychloroquine Sulfate Loading Dose|Drug: Chloroquine|Drug: Placebo,"Government of Punjab, Specialized Healthcare and Medical Education Department|Mayo Hospital Lahore|Services Institute of Medical Sciences, Pakistan|Pakistan Kidney and Liver Institute|Forman Christian College, Pakistan|Harvard School of Public Health",All,20 Years to 50 Years   (Adult),125.0,Other,Interventional,2020-04-14,23/08/20,2020-08-30,15/04/20,10/03/21,"Expo Covid Center, Lahore, Punjab, Pakistan|Mayo Hospital, Lahore, Punjab, Pakistan|Pakistan Kidney and Liver Institute, Lahore, Punjab",Pakistan,Respiratory Diseases,1,4,138.0
2879.0,NCT04703036,"Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19",,Recruiting,COVID-19,,,,,,,Dietary Supplement: Glycine|Dietary Supplement: N-acetylcysteine|Dietary Supplement: Alanine,Baylor College of Medicine,All,"55 Years to 85 Years   (Adult, Older Adult)",64.0,Other,Interventional,2021-11-01,31/12/21,2021-12-31,11/01/21,04/02/21,"Baylor College of Medicine, Houston, Texas",United States,Respiratory Diseases,1,1,60.0
2880.0,NCT04376593,PET/CT Imaging in COVID-19 Patients,,Enrolling by invitation,COVID-19,COVID-19,,,,,,Drug: 18F-αvβ6-BP,"University of California, Davis",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-05,01/05/21,2022-01-05,06/05/20,07/07/20,"University of California Davis, Sacramento, California",United States,Respiratory Diseases,1,2,731.0
2881.0,NCT04397562,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,CORONA,Completed,COVID-19,,,,,,,Drug: Levilimab|Drug: Placebo,Biocad,All,"18 Years and older   (Adult, Older Adult)",206.0,Industry,Interventional,2020-04-29,03/07/20,2020-03-08,21/05/20,18/11/20,"State Budgetary Healthcare Institution Kaluga region Kaluga Regional Clinical Hospital, Kaluga, Russian Federation|State Budget Institution of the Republic of Dagestan Republican Clinical Hospital, Machačkala, Russian Federation|A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russian Federation|City Clinical Hospital No. 40 of the Department of Health of the city of Moscow, Moscow, Russian Federation|City Clinical Hospital No.52, Moscow, Russian Federation|City Clinical Hospital № 15 named. O.M. Filatov, Moscow, Russian Federation|City Clinical Hospital №1 named after N.I. Pirogov, Moscow City Health Department, Moscow, Russian Federation|Federal State Budgetary Institution Central Clinical Hospital with Clinic, Office of the President of the Russian Federation, Moscow, Russian Federation|I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation|Pirogov Russian National Research Medical University, Moscow, Russian Federation|Railway clinical hospital named after N.A. Semashko, Moscow, Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|Clinical Infectious Disease Hospital named after S.P. Botkin, Saint Petersburg, Russian Federation|North-western State Medical University named after I.I.Mechnikov, Saint Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Healthcare of the Russian Federation, Ufa, Russian Federation|Federal State Budgetary Educational Institution of Higher Education North Ossetian State Medical Academy of the Ministry of Health of the Russian Federation (FSBEI HE SOGMA of the Ministry of Health of Russia), Vladikavkaz",Russian Federation,Respiratory Diseases,1,1,-52.0
2882.0,NCT04603742,"Anakinra, COVID-19, Cytokine Storm",SOBI,Not yet recruiting,COVID-19,Cytokine Storm,Mechanical Ventilation Complication,,,,,Drug: Anakinra|Drug: 0.9% Saline,Weill Medical College of Cornell University|Swedish Orphan Biovitrum,All,"18 Years to 89 Years   (Adult, Older Adult)",170.0,Other|Industry,Interventional,2021-01-07,01/12/21,2022-01-02,27/10/20,25/03/21,"Weill Cornell Medcine, New York, New York",United States,Respiratory Diseases,1,3,360.0
2883.0,NCT04375709,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,,Recruiting,COVID-19,,,,,,,Other: Physical exercise|Behavioral: Education sessions,Kantonsspital Winterthur KSW,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-03-15,30/06/21,2021-08-31,05/05/20,12/05/20,"Kantonsspital Winterthur, Winterthur, Zürich",Switzerland,Respiratory Diseases,1,1,534.0
2884.0,NCT04639427,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,Co-VIS,Not yet recruiting,Oral-Linguo-Facial Praxies,COVID-19,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",4.0,Other,Observational,2020-01-11,01/02/21,2021-01-02,20/11/20,20/11/20,"Unité de Soins de Rééducation Post Réanimation, Service de Médecine Physique et de Réadaptation, Hôpital Raymond Poincaré, APHP, Garches",France,Respiratory Diseases,1,2,357.0
2885.0,NCT04437121,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,COV-EAT,Completed,Eating Behavior,COVID-19,,,,,,Other: Online Survey about Dietary and Lifestyle Habits,University of Thessaly,All,"24 Months to 18 Years   (Child, Adult)",397.0,Other,Observational,2020-04-30,24/05/20,2020-05-24,18/06/20,18/06/20,"Department of Nutrition-Dietetics, Tríkala, Thessaly",Greece,Respiratory Diseases,1,2,24.0
2886.0,NCT04373135,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",UC-COVID,"Active, not recruiting",COVID-19,Critical Illness,Attitude of Health Personnel,Attitude to Health,Health Behavior,Health Care Utilization,,Behavioral: Brief educational video,"University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Interventional,2020-08-05,01/02/21,2021-01-03,04/05/20,14/10/20,"University of California, Los Angeles, Los Angeles, California",United States,"Cardiovascular Diseases, Respiratory Diseases",1,6,151.0
2887.0,NCT04647604,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,,Recruiting,COVID-19,,,,,,,Drug: Omegaven®|Drug: Sodium chloride,Karolinska University Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-06-23,30/04/21,2021-04-30,01/12/20,01/12/20,"Karolinska Universitetssjuhuset, Stockholm, Sweden|Södersjukhuset, Stockholm",Sweden,Respiratory Diseases,1,1,311.0
2888.0,NCT04352400,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),RACONA,Not yet recruiting,COVID-19,,,,,,,Drug: Nafamostat Mesilate|Drug: Placebo,University Hospital Padova|Yokohama City University|University of Zurich,All,"18 Years to 85 Years   (Adult, Older Adult)",256.0,Other,Interventional,2020-01-04,01/12/21,2021-01-12,20/04/20,20/04/20,,,Respiratory Diseases,1,1,374.0
2889.0,NCT04322487,"Simple, Safe, Same: Lung Ultrasound for COVID-19",LUSCOVID19,Recruiting,Coronavirus,Epidemic Disease,"Pneumonia, Viral",,,,,Diagnostic Test: Lung ultrasound,"Catholic University of the Sacred Heart|Valle del Serchio General Hospital, Lucca, Italy|University of Trento, Trento, Italy|Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy|Bresciamed, Brescia, Italy|118 USL Nordovest Toscana, Lucca, Italy|General Hospital, Voghera, Italy|Lodi General Hospital, Lodi, Italy",All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-08-04,31/12/20,2021-01-15,26/03/20,17/04/20,"Bresciamed, Brescia, Italy|Pulmonary Medicine Unit, Lodi General Hospital, Lodi, Italy|118 USL Nordovest Toscana, Lucca, Italy|Diagnostic and Interventional Ultrasound Unit, Valle del Serchio General Hospital, Lucca, Italy|Emergency Department, Fondazione IRCCS Policlinico San Matteo, and Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy|Department of woman and child health and public health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Pulmonary Medicine Unit, Dept. Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy|Department of Information Engineering and Computer Science, Ultrasound Laboratory Trento, University of Trento, Trento, Italy|Emergency Medicine Unit, General Hospital, Voghera",Italy,Respiratory Diseases,1,3,164.0
2890.0,NCT04673149,GLS-5310 Vaccine for the Prevention of SARS-CoV-2 (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: GLS-5310|Biological: Placebo,"GeneOne Life Science, Inc.",All,"19 Years to 65 Years   (Adult, Older Adult)",345.0,Industry,Interventional,2020-12-23,31/07/22,2022-12-31,17/12/20,24/12/20,"Korea University Guro Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,738.0
2891.0,NCT04375202,Colchicine in COVID-19: a Pilot Study,COLVID-19,Recruiting,COVID-19,,,,,,,Drug: Colchicine 1 MG Oral Tablet,University Of Perugia,All,"18 Years and older   (Adult, Older Adult)",308.0,Other,Interventional,2020-04-18,30/06/21,2021-10-31,05/05/20,05/11/20,"Associazione Italiana Pneumologi Ospedalieri, Milan, Italy|Società Italiana di Reumatologia, Milan",Italy,Respiratory Diseases,1,1,561.0
2892.0,NCT04655521,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,DIRECTOR,Recruiting,COVID-19,COVID-19,Viral Infection,,,,,,Universität des Saarlandes|MeMed Diagnostics Ltd.,All,"3 Months and older   (Child, Adult, Older Adult)",300.0,Other|Industry,Observational,2020-02-12,01/08/21,2021-01-11,07/12/20,16/12/20,"Saarland University, Homburg",Germany,Respiratory Diseases,1,3,334.0
2893.0,NCT04399889,hCT-MSCs for COVID19 ARDS,,Recruiting,COVID-19,Corona Virus Infection,COVID-19,,,,,Biological: human cord tissue mesenchymal stromal cells,"Joanne Kurtzberg, MD|The Marcus Foundation|Duke University",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-18,01/04/21,2021-07-31,22/05/20,22/06/20,"Duke Hospital, Durham, North Carolina",United States,Respiratory Diseases,1,3,408.0
2894.0,NCT04354779,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,SARS-CoV 2,Coronavirus Infection,COVID-19,,,,Diagnostic Test: a specifically designed self-administered questionnaire,AUVA|Paracelsus Medical University,All,"15 Years to 90 Years   (Child, Adult, Older Adult)",3301.0,Other,Observational,2020-11-05,23/08/20,2020-09-28,21/04/20,30/09/20,"Allgemeine Unfallversicherungsanstalt, Vienna",Austria,Respiratory Diseases,1,4,-38.0
2895.0,NCT04325646,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,CORSER,Recruiting,SARS (Severe Acute Respiratory Syndrome),COVID-19,,,,,,Other: Human Biological samples,Institut Pasteur,All,"5 Years and older   (Child, Adult, Older Adult)",2000.0,Industry,Observational,2020-03-13,28/02/21,2023-02-28,27/03/20,27/01/21,"CHU Amiens-Picardie, Amiens, France|EHPAD Villa Concorde, Asnieres sur seine, France|CHU François Mitterand, Dijon, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|CHU Limoges, Limoges, France|Hôpital de la Croix Rousse, Lyon, France|EHPAD Les Etangs, Mennecy, France|CHRU de Nancy, Nancy, France|Hôpitaux de Brabois, Nancy, France|CHR Orléans, Orléans, France|Institut Mutualiste, Paris, France|Institut Pasteur, Paris, France|EHPAD Villa Lecourbe, Paris, France|Hôpital la Pitié Salpetrière, Paris, France|CHU Poitiers, Poitiers, France|Hôpital Pontchaillou, Rennes, France|CHU Saint-Etienne, Saint-Étienne, France|CHRU de Strasbourg, Strasbourg, France|CH de Tourcoing, Tourcoing, France|Hôpital Bretonneau, Tours",France,Respiratory Diseases,1,2,1082.0
2896.0,NCT04290858,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,NoCovid,Withdrawn,Coronavirus Infections,"Pneumonia, Viral",Dyspnea,,,,,Drug: Nitric Oxide,"Xijing Hospital|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-03,01/03/21,2022-01-02,02/03/20,24/03/20,,,Respiratory Diseases,1,3,730.0
2897.0,NCT04405921,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",PACTT,Not yet recruiting,COVID-19,COVID-19,,,,,,Drug: Hydroxychloroquine 200 Mg Oral Tablet|Drug: Azithromycin 250 MG,Centre Hôpital Universitaire Farhat Hached,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-07,01/12/20,2021-01-03,28/05/20,19/06/20,"University Hospital Farhat Hached, Sousse",Tunisia,Respiratory Diseases,1,2,362.0
2898.0,NCT04326387,Evaluation of Novel Diagnostic Tests for COVID-19,COVIDx,Recruiting,Acute Disease,Coronavirus,Respiratory Viral Infection,,,,,Diagnostic Test: SAMBA II (Diagnostic for the Real World)|Diagnostic Test: Public Health England Gold Standard|Diagnostic Test: Cambridge Validated Viral Detection Method|Diagnostic Test: Radiological Detection,CCTU- Cancer Theme|Cambridge University Hospitals NHS Foundation Trust,All,"16 Years and older   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-06-04,07/04/21,2021-07-10,30/03/20,18/05/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire",United Kingdom,Respiratory Diseases,1,3,401.0
2899.0,NCT04351711,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,ACTICOV-2,Recruiting,COVID-19,COVID-19,,,,,,Other: Immunological profiling,"Centre Hospitalier Universitaire de Nīmes|Institute of Human Genetics, Montpellier",All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Observational,2020-09-04,01/04/23,2023-01-04,17/04/20,19/03/21,"CHU de Nimes, Nîmes",France,Respiratory Diseases,1,2,852.0
2900.0,NCT04500600,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,,,,,Other: Quality-of-Life Assessment|Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",50000.0,Other|NIH,Observational,2020-11-06,01/07/21,2021-01-07,05/08/20,05/08/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,3,62.0
2901.0,NCT04724707,Russian Cardiovascular Registry of COVID-19,,Recruiting,COVID-19,Acute Cardiovascular Disease,Cardiovascular Diseases,,,,,,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-11-09,01/12/21,2022-01-12,26/01/21,26/01/21,"Almazov National Medical Research Centre, Saint Petersburg",Russian Federation,Respiratory Diseases,1,3,429.0
2902.0,NCT04537351,The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19,MEND,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Biological: CYP-001,Cynata Therapeutics Limited|Cerebral Palsy Alliance Research Institute,All,"18 Years and older   (Adult, Older Adult)",24.0,Industry|Other,Interventional,2020-08-24,31/03/21,2021-03-31,03/09/20,19/11/20,"Nepean Hospital, Kingswood, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Footscray Hospital, Footscray, Victoria, Australia|Sunshine Hospital, Saint Albans, Victoria",Australia,Respiratory Diseases,1,2,219.0
2903.0,NCT04413071,Cardiac COVID-19 Health Care Workers,CCC,Completed,SARS-CoV 2,COVID-19,Coronavirus,Cardiac Magnetic Resonance,Myocarditis,Cardiac Anomaly,,Other: Passed infection of SARS-CoV-2,AORTICA Group|Salamanca University Hospital|Instituto de Investigación Biomédica de Salamanca,All,"18 Years to 71 Years   (Adult, Older Adult)",142.0,Other,Observational,2020-05-25,12/06/20,2020-12-06,02/06/20,16/06/20,"University Hospital of Salamanca, Salamanca",Spain,Respiratory Diseases,1,6,195.0
2904.0,NCT04392388,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",SAPRIS-SERO,Recruiting,SARS-CoV 2,,,,,,,Biological: Non applicable,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",110000.0,Other,Observational,2020-01-05,31/12/20,2020-12-31,18/05/20,05/08/20,"Inserm, Paris",France,Respiratory Diseases,1,1,361.0
2905.0,NCT04356950,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,COVID-TGT,"Active, not recruiting",Sepsis,Blood Coagulation Disorders,Thrombin,Disseminated Intravascular Coagulation,COVID-19,,,Other: Thrombin generation test assay|Other: Fibrin generation markers assays,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",175.0,Other,Observational,2020-04-28,01/04/22,2022-01-07,22/04/20,22/01/21,"CHU de Bordeaux, Bordeaux, France|CHU de Limoges, Limoges, France|CHU de Montpellier, Montpellier, France|CHU de Nimes, Nîmes",France,Respiratory Diseases,1,5,619.0
2906.0,NCT04718506,Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention,RECOVE,Recruiting,COVID-19,COVID-19,,,,,,Behavioral: Exercise|Behavioral: Controls,Universidad de Murcia,All,"18 Years and older   (Adult, Older Adult)",56.0,Other,Interventional,2021-12-01,12/06/21,2021-12-12,22/01/21,22/01/21,"Faculty of Sport Sciences, Murcia, San Javier",Spain,Respiratory Diseases,1,2,11.0
2907.0,NCT04371289,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,CARDICoVRISK,"Active, not recruiting",COVID-19,Cardiovascular Risk Factor,,,,,,,Istituto Auxologico Italiano,All,"18 Years and older   (Adult, Older Adult)",5500.0,Other,Observational,2020-08-04,10/07/20,2021-10-09,01/05/20,12/02/21,"Istituto Auxologico Italiano, Milan",Italy,Respiratory Diseases,1,2,431.0
2908.0,NCT04422587,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,EPRICOD,Completed,Emergencies,,,,,,,Other: RECOP unit patient,"University Hospital, Toulouse",All,"15 Years and older   (Child, Adult, Older Adult)",1860.0,Other,Observational,2020-03-13,05/06/20,2020-07-06,09/06/20,05/11/20,"University Hospital of Toulouse, Toulouse",France,Others,0,1,115.0
2909.0,NCT04596579,SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida,,Enrolling by invitation,Coronavirus Infection,,,,,,,Diagnostic Test: SARS-CoV-2 Antibody Analysis|Diagnostic Test: Weck-cel Swab Collection|Behavioral: Web Based Questionnaire,H. Lee Moffitt Cancer Center and Research Institute|Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other|Industry,Observational,2020-09-10,09/10/21,2022-09-10,22/10/20,03/03/21,"Moffitt Cancer Center, Tampa, Florida",United States,Respiratory Diseases,1,1,730.0
2910.0,NCT04462848,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,,Not yet recruiting,Corona Virus Infection,,,,,,,Biological: anti-SARS-CoV-2 human convalescent plasma,"University of California, Los Angeles",All,1 Month to 17 Years   (Child),30.0,Other,Interventional,2020-01-08,01/09/24,2024-01-12,08/07/20,08/07/20,"University of California, Los Angeles (UCLA), Los Angeles, California",United States,Respiratory Diseases,1,1,1465.0
2911.0,NCT04590469,Improving Wellbeing and Health for Care Home Residents During COVID-19,COVIDWHELD,Not yet recruiting,Dementia,,,,,,,Other: COVID WHELD,University of Exeter|King's College London|London School of Economics and Political Science|University of East Anglia|University of Hull|Alzheimer's Society,All,"60 Years and older   (Adult, Older Adult)",2880.0,Other,Interventional,2020-11-20,01/09/21,2022-01-01,19/10/20,19/10/20,,,Others,0,1,407.0
2912.0,NCT04479202,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,BOIFIM,Completed,Berberine,COVID-19,,,,,,Drug: Berberine|Drug: Montmorrillonite,Chinese Medical Association,All,"18 Years to 80 Years   (Adult, Older Adult)",76.0,Other,Interventional,2020-08-02,18/04/20,2020-04-23,21/07/20,21/07/20,"Nanjing Drum Tower Hospital, Nanjing, Jiangsu",China,Respiratory Diseases,1,2,-101.0
2913.0,NCT04802408,SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial,SNOW,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,Combination Product: Shampoo and saline|Combination Product: Saline and Listerine|Combination Product: Shampoo and Listerine|Combination Product: Saline and Saline,Milton S. Hershey Medical Center|AXIOM Real Time Metrics|Analytica Ventures LLC,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-04,30/08/21,2022-04-30,17/03/21,17/03/21,,,Respiratory Diseases,1,2,481.0
2914.0,NCT04551339,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,ZnCOVID-19,"Active, not recruiting",Healthy,Health Care Worker Patient Transmission,Aging,,,,,Dietary Supplement: PreserVision AREDS formulation soft gels or tablets|Dietary Supplement: Multivitamin with 11mg of zinc,Mayo Clinic,All,"18 Years to 90 Years   (Adult, Older Adult)",4500.0,Other,Interventional,2020-09-28,14/06/21,2021-09-14,16/09/20,18/03/21,"Mayo Clinic in Scottsdale, Scottsdale, Arizona, United States|Mayo Clinic in Jacksonville, Jacksonville, Florida, United States|Mayo Clinic in Rochester, Rochester, Minnesota",United States,Others,0,3,351.0
2915.0,NCT04346329,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Chloroquine UN,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,Universidad Nacional de Colombia|Fundación Salud de los Andes,All,"18 Years and older   (Adult, Older Adult)",86.0,Other,Interventional,2020-04-20,01/06/20,2020-01-10,15/04/20,15/04/20,"Facultad de Medicina - Universidad Nacional de Colombia, Bogota, Cundinamarca, Colombia|Universidad Nacional de Colombia, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,1,-101.0
2916.0,NCT04740320,COVID-19 SARS-CoV-2 Screening Protocol,,Recruiting,COVID-19,,,,,,,,Imperial College London|Hvivo,All,18 Years to 30 Years   (Adult),250.0,Other|Industry,Observational,2020-12-15,01/05/21,2021-01-05,05/02/21,11/02/21,"hVIVO Services Ltd, QMB Bioenterprise building, London",United Kingdom,Respiratory Diseases,1,1,21.0
2917.0,NCT04649931,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),,Recruiting,SARS (Severe Acute Respiratory Syndrome),COVID-19,,,,,,Device: Ion Mobility Spectrometry (IMS),B. Braun Melsungen AG|CeGaT GmbH,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry|Other,Observational,2020-12-14,01/05/21,2021-01-05,02/12/20,17/12/20,"University Hospital Gießen and Marburg (UKGM), site Marburg, Marburg",Germany,Respiratory Diseases,1,2,22.0
2918.0,NCT04453982,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,,Recruiting,Sars-CoV2,Breastmilk,,,,,,Other: Human milk donors,Deborah O'Connor|University of Toronto|Sinai Health System|The Hospital for Sick Children,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-06-21,01/02/21,2021-01-02,01/07/20,23/10/20,"Sinai Health System, Toronto, Ontario",Canada,Respiratory Diseases,1,2,195.0
2919.0,NCT04484493,Corticosteroid Nasal Spray in COVID-19 Anosmia,,Completed,COVID-19,Anosmia,,,,,,Drug: mometasone furoate nasal spray,Benha University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-08,25/10/20,2020-03-11,23/07/20,13/11/20,"Benha University Hospital, Faculty of Medicine, Banhā, Qalubia",Egypt,Respiratory Diseases,1,2,-150.0
2920.0,NCT04445428,OPV as Potential Protection Against COVID-19,,Enrolling by invitation,"Poliovirus Vaccine, Oral",COVID-19,Mortality,Morbidity,Non-Specific Effects of Vaccines,,,Biological: oral polio vaccine + information|Behavioral: Information,Bandim Health Project,All,"50 Years and older   (Adult, Older Adult)",3400.0,Other,Interventional,2020-07-15,01/09/21,2021-01-12,24/06/20,22/12/20,"Bandim Health Project, Bissau",Guinea-Bissau,Respiratory Diseases,1,5,181.0
2921.0,NCT04834882,"Burnout, Stress and Coping Strategies: Impact of the Covid-19 Epidemic",Au20-15,Recruiting,COVID-19,"Burnout, Professional",,,,,,Other: Data collection (,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-20,20/05/21,2022-05-20,08/04/21,08/04/21,"Chu Reims, Reims",France,Respiratory Diseases,1,2,485.0
2922.0,NCT04610489,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Quidel Sofia SARS Antigen FIA,Carilion Clinic,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-01-11,31/01/21,2021-01-31,30/10/20,30/10/20,,,Respiratory Diseases,1,1,386.0
2923.0,NCT04503434,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,,Completed,Patient Preference,COVID-19,,,,,,,Hospital Clinic of Barcelona,All,"Child, Adult, Older Adult",517.0,Other,Observational,2020-05-15,31/05/20,2020-06-06,07/08/20,07/08/20,"Carme Hernández, Barcelona",Spain,Respiratory Diseases,1,2,22.0
2924.0,NCT04401111,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),CO-Qo-ICU,Recruiting,COVID-19,ARDS,Quality of Life,,,,,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-06-16,15/06/21,2021-06-15,26/05/20,25/09/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,3,364.0
2925.0,NCT04336332,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Combination Product: Hydroxychloroquine Sulfate + Azithromycin|Drug: Hydroxychloroquine Sulfate,"Rutgers, The State University of New Jersey",All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-01-04,30/04/21,2021-04-30,07/04/20,12/02/21,"Saint Barnabas Medical Center, Livingston, New Jersey, United States|Robert Wood Johnson University Hopsital, New Brunswick, New Jersey, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey",United States,Respiratory Diseases,1,2,482.0
2926.0,NCT04747782,COVID-19 Longitudinal Biomarkers in Lung Injury,COLOBILI,Recruiting,COVID-19,Respiratory Disease,Critical Illness,,,,,"Other: no interventions performed. Just collecting data, blood samples and post-mortem biopsies.",Dr. Andrew Baker|Unity Health Toronto,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-03-23,01/10/21,2021-12-31,10/02/21,10/02/21,"St Michael's Hospital, Toronto, Ontario",Canada,"Cardiovascular Diseases, Respiratory Diseases",1,3,648.0
2927.0,NCT04399317,Flow Controlled Ventilation in ARDS Associated With COVID-19,,Recruiting,COVID-19,,,,,,,Device: Flow controlled ventilation (Evone-ventilator),Hamad Medical Corporation,All,"18 Years to 99 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-05-28,01/07/20,2020-01-08,22/05/20,25/06/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,1,-141.0
2928.0,NCT04403477,Convalescent Plasma Therapy in Severe COVID-19 Infection,,Recruiting,COVID-19,Convalescence,,,,,,Biological: Convalescent plasma,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh|Dhaka Medical College",All,"16 Years and older   (Child, Adult, Older Adult)",20.0,Other,Interventional,2020-05-20,20/07/20,2020-10-30,27/05/20,27/05/20,"Bangabandhu Sheikh Mujib Medical University, Dhaka",Bangladesh,Respiratory Diseases,1,2,163.0
2929.0,NCT04472494,Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,,Recruiting,COVID-19,COVID-19,,,,,,Biological: Abatacept|Other: Placebo,Bristol-Myers Squibb,All,"18 Years and older   (Adult, Older Adult)",129.0,Industry,Interventional,2020-08-24,13/01/21,2021-01-14,15/07/20,17/11/20,"Norton Infectious Disease Institute, Louisville, Kentucky, United States|Local Institution, Boston, Massachusetts, United States|Local Institution, Boston, Massachusetts, United States|Atlantic Health System, Morristown, New Jersey, United States|Local Institution, New Brunswick, New Jersey, United States|Local Institution, Dallas, Texas, United States|Local Institution, Guaynabo, Puerto Rico|Local Institution, Monterrey Ponce, Puerto Rico|Local Institution, San Juan",Puerto Rico,Respiratory Diseases,1,2,143.0
2930.0,NCT04420637,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,RetroCov,Enrolling by invitation,COVID-19,,,,,,,,Medical University of Graz,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-06-15,01/09/21,2021-01-12,09/06/20,16/03/21,"Department of Internal Medicine, Medical University of Graz, Graz",Austria,Respiratory Diseases,1,1,211.0
2931.0,NCT04299152,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,,Not yet recruiting,Severe Acute Respiratory Syndrome (SARS) Pneumonia,,,,,,,Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis,Tianhe Stem Cell Biotechnologies Inc.,All,18 Years to 60 Years   (Adult),20.0,Industry,Interventional,2020-10-11,09/10/21,2021-10-11,06/03/20,27/10/20,,,Respiratory Diseases,1,1,365.0
2932.0,NCT04502342,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",CANCOVID-19,Enrolling by invitation,COVID-19,,,,,,,Combination Product: Hydroxycloroquine and Azythromycine|Combination Product: Cospherunate/Azythromycine|Combination Product: Cospherunate/Phytomedicine/Azythromycien,Institute for Research and Development of Medicinal and Food Plants of Guinea,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-06,30/08/20,2020-09-30,06/08/20,07/08/20,"Donka; Kenien; Gbessia, Conakry",Guinea,Respiratory Diseases,1,1,268.0
2933.0,NCT04540406,NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes,COVGUT20,Recruiting,COVID-19,,,,,,,Drug: NBT-NM108|Other: Usual Care Only,Notitia Biotechnologies Company|University of South Florida|Rutgers University,All,"18 Years to 69 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2021-08-02,01/05/21,2021-01-06,07/09/20,16/02/21,"University of South Florida Morsani College of Medicine, Tampa, Florida",United States,Respiratory Diseases,1,1,-208.0
2934.0,NCT04538586,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",,Recruiting,COVID-19,,,,,,,,"University Hospital, Clermont-Ferrand|Faculty of Medicine and Paramedical Professions, Clermont-Ferrand, France",All,"16 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-05,01/12/20,2025-01-12,04/09/20,04/09/20,"Univeristy Hospital, Clermont-Ferrand, Clermont-Ferrand",France,Respiratory Diseases,1,1,1834.0
2935.0,NCT04603924,Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients,,Recruiting,COVID-19,,,,,,,Drug: Niclosamide|Drug: Placebo,NeuroBo Pharmaceuticals Inc.,All,"18 Years and older   (Adult, Older Adult)",436.0,Industry,Interventional,2020-07-10,01/06/21,2022-01-06,27/10/20,25/03/21,"Helen Keller Hospital, Sheffield, Alabama, United States|Baptist Health Research Institute, Jacksonville, Florida, United States|AdventHealth Tampa, Tampa, Florida, United States|Therapeutic Concepts, PA, Houston, Texas, United States|Memorial Hermann Memorial City Medical Center, Houston, Texas",United States,Respiratory Diseases,1,1,545.0
2936.0,NCT04476667,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",,Recruiting,Mental Health Issue,COVID-19,Anxiety Disorders,Depression,,,,Behavioral: e-Psychotherapy,Queen's University|Online PsychoTherapy Clinic,All,"18 Years to 65 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-06-15,01/05/21,2021-01-05,20/07/20,18/02/21,"Hotel Dieu Hospital, Kingston, Ontario",Canada,"Mental Health, Respiratory Diseases",1,4,204.0
2937.0,NCT04560530,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,,Completed,COVID-19,,,,,,,Radiation: Non-enhanced CT scan of the chest,Tanta University,All,"18 Years and older   (Adult, Older Adult)",76.0,Other,Observational,2020-01-03,30/07/20,2020-01-09,23/09/20,23/09/20,"Security Forces Hospital, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,6.0
2938.0,NCT04334382,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,HyAzOUT,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,"Intermountain Health Care, Inc.|University of Utah|Utah Department of Health",All,"45 Years and older   (Adult, Older Adult)",1550.0,Other,Interventional,2020-02-04,31/12/20,2021-12-31,06/04/20,09/04/20,"Intermountain Medical Center, Murray, Utah, United States|University of Utah, Salt Lake City, Utah",United States,Respiratory Diseases,1,1,696.0
2939.0,NCT04371952,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),DYNAMIC,Not yet recruiting,COVID-19,,,,,,,Drug: Doxycycline|Drug: Placebo,Nantes University Hospital,All,"46 Years and older   (Adult, Older Adult)",330.0,Other,Interventional,2020-01-06,01/12/20,2020-01-12,01/05/20,18/05/20,"CHU Avicenne - APHP, Bobigny, France|CHU Bordeaux, Bordeaux, France|CHU Caen, Caen, France|CHU Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CHU Nantes, Nantes",France,Respiratory Diseases,1,1,6.0
2940.0,NCT04438967,Brain Health in the Time of COVID-19,,Recruiting,Brain Health,,,,,,,,Miro Health|Johns Hopkins University|University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-06-16,31/12/21,2021-12-31,19/06/20,06/01/21,"Miro Health, San Francisco, California",United States,Others,0,1,563.0
2941.0,NCT04613050,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,,Recruiting,COVID-19,,,,,,,Other: Respiratory Training|Other: Aerobic training,Cairo University,All,35 Years to 45 Years   (Adult),80.0,Other,Interventional,2020-02-07,24/12/21,2022-02-20,03/11/20,27/01/21,"Police hospital-Nasr city, Cairo",Egypt,Respiratory Diseases,1,1,744.0
2942.0,NCT04390477,Study to Evaluate the Effect of a Probiotic in COVID-19,,Recruiting,COVID-19,Coronavirus Infection,,,,,,Dietary Supplement: Probiotic,Bioithas SL,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-04-05,01/07/21,2021-01-09,15/05/20,27/01/21,"Hospital Universitario del Vinalopó, Elche, Alicante, Spain|Hospital Universitario de Torrevieja, Torrevieja, Alicante",Spain,Respiratory Diseases,1,2,279.0
2943.0,NCT04355351,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),CovImmune,Recruiting,COVID-19,,,,,,,Other: blood sampling|Other: additional blood tubes,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-05-05,22/10/20,2020-10-22,21/04/20,12/06/20,"Antibes Hospital, Antibes, France|Cannes Hospital, Cannes, France|Nice Hospital, Nice",France,Respiratory Diseases,1,1,170.0
2944.0,NCT04474301,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,,Recruiting,COVID-19,Melanoma,,,,,,Other: Survey Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"Child, Adult, Older Adult",1152.0,Other|NIH,Observational,2020-11-06,01/07/21,2021-01-07,16/07/20,16/07/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,2,62.0
2945.0,NCT04414124,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,Kaleido Biosciences,All,"18 Years and older   (Adult, Older Adult)",350.0,Industry,Interventional,2020-02-08,01/02/21,2021-01-02,04/06/20,22/01/21,"Healthstar Research, Hot Springs, Arkansas, United States|Axon Clinical Research, Riverside, California, United States|Medical Center for Clinical Research, San Diego, California, United States|Vista Health Research, Miami, Florida, United States|Bio-Medical Research, Miami, Florida, United States|Mount Vernon Clinical Research, Atlanta, Georgia, United States|Centex Studies, Inc. - Lake Charles, Lake Charles, Louisiana, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Wake Research - Clinical Research Center of Nevada, LLC, Las Vegas, Nevada, United States|Carolina Institute For Clinical Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc, Raleigh, North Carolina, United States|TruCare Internal Medicine and Infectious Diseases, DuBois, Pennsylvania, United States|ClinSearch LLC, Chattanooga, Tennessee, United States|Global Medical Research, DeSoto, Texas, United States|Centex Studies, Houston, Texas, United States|Infectious Diseases Associates of Central Virginia, Lynchburg, Virginia",United States,Respiratory Diseases,1,1,329.0
2946.0,NCT04530435,PEP Flute-selfcare in COVID-19,PEP-CoV,"Active, not recruiting",COVID-19,COVID-19,,,,,,Device: PEP flute,Bispebjerg Hospital|Hvidovre University Hospital,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-06-10,30/04/21,2021-04-30,28/08/20,08/03/21,"Research Unit for Dietary Studies at the Parker Institute, Bispebjerg and Frederiksberg Hospitals, Frederiksberg",Denmark,Respiratory Diseases,1,2,324.0
2947.0,NCT04466800,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),RECOVER-19,Recruiting,COVID-19,,,,,,,Other: Intervention group_rehabilitation program,Rennes University Hospital,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-07-30,30/08/21,2022-07-30,10/07/20,01/04/21,"Hôtel Dieu Paris, Paris, France|Centre Hospitalier de Cornouaille, Quimper, France|CHU Rennes, Rennes, France|Centre Hospitalier de Saint-Brieuc, Saint-Brieuc, France|Centre Hospitalier Bretagne Atlantique, Vannes",France,Respiratory Diseases,1,1,730.0
2948.0,NCT04568122,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",,Recruiting,COVID-19,,,,,,,Device: Saliva test kit,Stanford University,All,"2 Years and older   (Child, Adult, Older Adult)",3015.0,Other,Interventional,2020-11-20,01/04/21,2021-01-08,29/09/20,22/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,49.0
2949.0,NCT04366986,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,IRCEP,Recruiting,COVID-19,,,,,,,Other: Tested for SARS-CoV-2 (regardless of the result)|Other: Clinical diagnosis of COVID-19 by a health care professional,Pregistry|Harvard School of Public Health,Female,"18 Years and older   (Adult, Older Adult)",25000.0,Industry|Other,Observational,2020-06-23,30/04/24,2024-04-30,29/04/20,25/06/20,"Pregistry, Los Angeles, California",United States,Respiratory Diseases,1,1,1407.0
2950.0,NCT04415151,Tofacitinib for Treatment of Moderate COVID-19,I-TOMIC,Recruiting,COVID-19,,,,,,,Drug: Tofacitinib 10 mg|Drug: Placebo,Yale University,All,"18 Years to 99 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-07-29,31/03/21,2021-03-31,04/06/20,24/02/21,"Yale New Haven Health System, New Haven, Connecticut",United States,Respiratory Diseases,1,1,245.0
2951.0,NCT04557046,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,ASPIRE,Recruiting,COVID-19,,,,,,,Diagnostic Test: Nasal Swab|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Throat swab|Diagnostic Test: Fingerstick|Diagnostic Test: Saliva specimen,LumiraDx UK Limited,All,"Child, Adult, Older Adult",400.0,Industry,Interventional,2020-06-26,30/11/21,2021-12-31,21/09/20,29/01/21,"Children's Pediatric Associates of Altamonte Springs, Altamonte Springs, Florida, United States|Chappel Group, Kissimmee, Florida, United States|Good Samaritan Minute Clinic, Georgia Tech, Atlanta, Georgia, United States|Gvozden Pediatrics, Millersville, Maryland, United States|Ardmore Family Practice, Winston-Salem, North Carolina, United States|Physicians Quality Care of Jackson, Jackson, Tennessee, United States|Village Health Partners, Plano, Texas",United States,Respiratory Diseases,1,1,553.0
2952.0,NCT04414059,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,COVELEC,Not yet recruiting,SARS-CoV 2,Hospitalisation-Associated Infection,,,,,,,Elsan,All,"18 Years and older   (Adult, Older Adult)",155.0,Other,Observational,2021-01-03,01/06/21,2021-01-08,04/06/20,26/10/20,"Clinique de l'Estrée, Stains",France,Respiratory Diseases,1,2,5.0
2953.0,NCT04435184,Crizanlizumab for Treating COVID-19 Vasculopathy,CRITICAL,Completed,COVID-19,,,,,,,Drug: Crizanlizumab|Other: 0.9% saline,Johns Hopkins University|Novartis|Socar Research SA|Brigham and Women's Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other|Industry,Interventional,2020-09-07,28/11/20,2021-04-01,17/06/20,19/01/21,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,1,206.0
2954.0,NCT04389840,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,,Recruiting,COVID-19,Acute Lung Injury,COVID-19,,,,,Drug: Dociparstat sodium|Drug: Placebo,Chimerix,All,"18 Years to 85 Years   (Adult, Older Adult)",525.0,Industry,Interventional,2020-03-06,01/02/21,2021-01-06,15/05/20,17/02/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Advanced Pulmonary Research Institute/Wellington Regional Medical Center, Loxahatchee Groves, Florida, United States|Augusta University, Augusta, Georgia, United States|Our Lady of the Lake, Baton Rouge, Louisiana, United States|Tulane University, New Orleans, Louisiana, United States|University Medical Center, New Orleans, Louisiana, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Texas Health Harris Methodist Hospital Fort Worth, Dallas, Texas, United States|Sentara Clinical Trials, Norfolk, Virginia, United States|Ascension St. Francis Hospital, Milwaukee, Wisconsin, United States|Ascension All Saints Hospital, Racine, Wisconsin",United States,Respiratory Diseases,1,3,306.0
2955.0,NCT04410159,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,GARGLES,Completed,COVID-19,,,,,,,Drug: Povidone-Iodine|Drug: Essential oils|Other: Tap water,Universiti Sains Islam Malaysia|Universiti Kebangsaan Malaysia Medical Centre,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-06-22,29/06/20,2020-06-07,01/06/20,21/07/20,"Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Wilayah Persekutuan Kuala Lumpur",Malaysia,Respiratory Diseases,1,1,-15.0
2956.0,NCT04252118,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: MSCs,"Beijing 302 Hospital|Innovative Precision Medicine Group (IPM), Hangzhou, China.|Huoshenshan Hospital|Tianjin Haihe Hospital|VCANBIO CELL & GENE ENGINEERING CORP.,LTD, China|Shenzhen Third People's Hospital|Fifth Affiliated Hospital, Sun Yat-Sen University",All,"18 Years to 70 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-27,01/12/20,2021-01-12,05/02/20,15/04/20,"Beijing 302 Military Hospital of China, Beijing",China,Respiratory Diseases,1,1,351.0
2957.0,NCT04646044,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,,Recruiting,COVID-19,Coronavirus Disease 2019,,,,,,Drug: Bempegaldesleukin|Drug: Standard of Care|Other: Placebo,Nektar Therapeutics,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Interventional,2020-11-13,28/01/21,2021-03-27,27/11/20,27/11/20,"Investigator Site, Hialeah, Florida, United States|Investigator site, Mesquite, Texas",United States,Respiratory Diseases,1,2,134.0
2958.0,NCT04696562,"The Effect of Deep Breathing Exercise on Dyspnea, Anxiety and Quality of Life in Patients Treated for COVID-19",,Not yet recruiting,COVID-19,,,,,,,Behavioral: Deep Breathing Exercise with Triflo,Ankara University,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2021-01-01,31/03/21,2021-03-31,06/01/21,06/01/21,,,Respiratory Diseases,1,1,89.0
2959.0,NCT04377997,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,,Not yet recruiting,Cardiovascular Diseases,COVID-19,,,,,,Drug: Enoxaparin,Massachusetts General Hospital|Beth Israel Deaconess Medical Center|Dartmouth-Hitchcock Medical Center,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-05-15,01/01/21,2022-01-01,07/05/20,07/05/20,,,Respiratory Diseases,1,2,596.0
2960.0,NCT04652518,LYT-100 in Post-acute COVID-19 Respiratory Disease,,Recruiting,COVID-19,,,,,,,Drug: LYT-100|Other: Placebo,PureTech|Clinipace Worldwide|Novotech (Australia) Pty Limited,All,"18 Years to 80 Years   (Adult, Older Adult)",168.0,Industry,Interventional,2020-11-12,01/08/21,2021-01-12,03/12/20,26/02/21,"University of Southern California - Keck School of Medicine, Los Angeles, California, United States|Central Florida Pulmonary Group, Orlando, Florida, United States|Southeastern Research Center, Winston-Salem, North Carolina, United States|Site Coordinator, Austin, Texas, United States|Institutul de Pneumoftiziologie Marius Nasta (Marius Nasta Pneumoftiziology Institute), Bucharest, Romania|National Institute for Infectious Diseases Prof. Dr. Matei Balş (Arensia Eploratory Medicine), Bucharest, Romania|Spitalul Clinic De Pneumoftiziologie Leon Daniello Cluj-Napoca, Cluj-Napoca, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes Craiova, Craiova, Romania|Spitalul Clinic de Boli Infectioase si Pneumoftiziologie Dr. Victor Babes - Timisoara, Timişoara",Romania,Respiratory Diseases,1,1,61.0
2961.0,NCT04356508,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,,Not yet recruiting,COVID-19,COVID-19,COVID-19,"Pneumonia, Viral",,,,Drug: Nivolumab,"Dr Gerry Gin Wai Kwok|The University of Hong Kong|Queen Mary Hospital, Hong Kong",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-04-14,30/06/20,2021-08-31,22/04/20,22/04/20,,,Respiratory Diseases,1,4,504.0
2962.0,NCT04707703,Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis,Isavu-CAPA,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,Aspergillosis Invasive,,,,,,Drug: Isavuconazonium Injection [Cresemba]|Drug: Placebo,"Jeffrey Jenks, MD, MPH|Astellas Pharma Global Development, Inc.|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",162.0,Other|Industry,Interventional,2021-03-16,01/01/22,2022-01-03,13/01/21,22/03/21,"University of California Irvine, Orange, California, United States|University of California Davis, Sacramento, California, United States|University of California San Diego, San Diego, California",United States,Respiratory Diseases,1,2,293.0
2963.0,NCT04330690,Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial,CATCO,Recruiting,COVID-19,,,,,,,Drug: Interferon beta-1a|Drug: Remdesivir,Sunnybrook Health Sciences Centre|AbbVie|Apotex Inc.,All,"18 Years and older   (Adult, Older Adult)",2900.0,Other|Industry,Interventional,2020-03-18,18/03/22,2022-05-18,01/04/20,05/03/21,"Peter Lougheed Centre, Calgary, Alberta, Canada|Foothills Medical Centre, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta, Canada|Royal Alexandra Hospital, Edmonton, Alberta, Canada|Misericordia Community Hospital, Edmonton, Alberta, Canada|University of Alberta Hopsital, Edmonton, Alberta, Canada|Grey Nuns Community Hospital, Edmonton, Alberta, Canada|Interior Health Royal Inland Hospital, Kamloops, British Columbia, Canada|Lions Gate Hospital, North Vancouver, British Columbia, Canada|Richmond Hospital, Richmond, British Columbia, Canada|Vancouver General Hospital, Vancouver Coastal Health, Univeristy of British Columbia, Vancouver, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Island Health - Royal Jubilee Hospital, Victoria, British Columbia, Canada|Island Health - Victoria General Hospital, Victoria, British Columbia, Canada|Island Health - Nanaimo Regional General Hospital, Victoria, British Columbia, Canada|St. Boniface Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|Eastern Regional Health Authority, Saint John's, Newfoundland and Labrador, Canada|Royal Victoria Regional Health Centre, Barrie, Ontario, Canada|William Osler Health System - Brampton Civic Hospital, Brampton, Ontario, Canada|William Osler Health System - Etobicoke General Hospital, Etobicoke, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Grand River Hospital, Kitchener, Ontario, Canada|St. Mary's General Hospital, Kitchener, Ontario, Canada|St.Joseph's Health Care, London, Ontario, Canada|University Hospital, London, Ontario, Canada|Victoria Hospital, London, Ontario, Canada|Markham Stouffville Hospital, Markham, Ontario, Canada|Trillium Health Partners -Mississauga Site, Mississauga, Ontario, Canada|Trillium Health Partners-Credit Valley Hospital, Mississauga, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital - Civic Campus, Ottawa, Ontario, Canada|Queensway Carleton Hospital, Ottawa, Ontario, Canada|Niagara Health, Saint Catharines, Ontario, Canada|Scarborough Health Network - Centenary Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - General Hospital, Scarborough, Ontario, Canada|Scarborough Health Network - Birchmount Hospital, Scarborough, Ontario, Canada|Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|Humber River Hospital, Toronto, Ontario, Canada|Michael Garron Hospital, Toronto, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Toronto Western Hospital, Toronto, Ontario, Canada|Unity Health Toronto - St. Joseph's Health Centre, Toronto, Ontario, Canada|CISSS de la Montérégie Centre, Greenfield Park, Quebec, Canada|Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec, Canada|McGill University Health Centre-Glen Site Royal Victoria Hospital, Montréal, Quebec, Canada|CHU de Québec - Université Laval, Québec, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Québec- Université Laval, Québec, Quebec, Canada|Centre Intégré Universitaire de Santé et de Services Sociaux de l'Estrie - Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Royal University Hospital, Saskatoon, Saskatchewan",Canada,Respiratory Diseases,1,1,791.0
2964.0,NCT04593654,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,,Completed,COVID-19,Thromboembolism,,,,,,Drug: Dose of tinzaparin or dalteparin,Karolinska Institutet,All,"Child, Adult, Older Adult",257.0,Other,Observational,2020-01-03,15/08/20,2020-10-15,20/10/20,20/10/20,"Södersjukhuset, Stockholm",Sweden,Respiratory Diseases,1,2,286.0
2965.0,NCT04598581,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",COVID-RT-01,"Active, not recruiting",COVID-19,,,,,,,Radiation: Low Dose Radiation Therapy (LD-RT)|Other: Sham irradiation,"University Hospital, Basel, Switzerland",All,"40 Years and older   (Adult, Older Adult)",22.0,Other,Interventional,2020-02-11,01/10/21,2021-01-11,22/10/20,05/01/21,"Department of Radiooncology, University Hospital Basel, Basel",Switzerland,Respiratory Diseases,1,1,335.0
2966.0,NCT04409535,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,,"Active, not recruiting",Activities,Mental Health Issue,Life Style,,,,,Other: WHOQOL-BREF survey,University of New Mexico,All,"18 Years to 85 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-07-05,25/02/21,2021-03-31,01/06/20,01/06/20,"University of New Mexico Department of Pediatrics, Albuquerque, New Mexico",United States,Others,0,3,269.0
2967.0,NCT04452097,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,,Not yet recruiting,COVID-19,ARDS,Acute Respiratory Distress Syndrome,,,,,Biological: Human umbilical cord mesenchymal stem cells + best supportive care|Other: Placebo control + best supportive care,Baylx Inc.,All,"18 Years to 80 Years   (Adult, Older Adult)",39.0,Industry,Interventional,2021-01-07,31/03/22,2022-03-31,30/06/20,18/03/21,,,Respiratory Diseases,1,3,448.0
2968.0,NCT04532411,COVID-19 Testing Sample Acquisition Throughput and Efficiency,HexapodBooth,Completed,SARS-CoV Infection,Respiratory Viral Infection,Personal Protective Equipment,COVID-19,,,,Other: Personal Protective Testing Booth,Massachusetts General Hospital,All,"Child, Adult, Older Adult",28948.0,Other,Observational,2020-01-03,30/09/20,2020-09-30,31/08/20,24/02/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,4,271.0
2969.0,NCT04375735,London's Exogenous Surfactant Study for COVID19,LESSCOVID,Not yet recruiting,"ARDS, Human",COVID-19,,,,,,Drug: Bovine Lipid Extract Surfactant,Lawson Health Research Institute|London Health Sciences Centre,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-07,01/01/21,2021-01-07,05/05/20,11/06/20,,,Respiratory Diseases,1,2,366.0
2970.0,NCT04443257,REassessement After Hospitalization for Sars-COV-2 disordER,REHCOVER,Enrolling by invitation,Sars-CoV2,,,,,,,Other: assessment of the sequelae after hospitalization for Sars-COV-2,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-08-07,25/07/21,2021-07-25,23/06/20,16/09/20,"University hospital of Montpellier, Montpellier",France,Respiratory Diseases,1,1,352.0
2971.0,NCT04490811,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,AP-PEDCOVID,Recruiting,COVID-19,,,,,,,Other: no intervention. observational cohort study,Hôpital Necker-Enfants Malades,All,"up to 18 Years   (Child, Adult)",800.0,Other,Observational,2020-09-04,31/12/21,2021-12-31,29/07/20,29/07/20,"Necker Hospital, Paris",France,Respiratory Diseases,1,1,483.0
2972.0,NCT04806880,Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application,COVIDANOSMIA,Recruiting,COVID-19,,,,,,,Device: Web-application,"Weprom|Kelindi|Centre National de la Recherche Scientifique, France|Hospital of Tours",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2021-01-02,01/08/21,2021-01-08,19/03/21,19/03/21,"ILC, Le Mans",France,Respiratory Diseases,1,1,6.0
2973.0,NCT04797091,Kidney in Coronavirus Disease 2019 Registry,KidneyCOVID19,Recruiting,Corona Virus Infection,SARS-CoV 2,,,,,,Other: Retrospective data collection,University of Cologne,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-04-20,31/12/25,2026-08-31,15/03/21,18/03/21,"University Hospital of Cologne, Cologne",Germany,Respiratory Diseases,1,2,2324.0
2974.0,NCT04551755,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin and Doxycycline|Other: Placebo,Bangladesh Medical Research Council (BMRC),All,"18 Years and older   (Adult, Older Adult)",188.0,Other,Interventional,2020-01-09,01/11/20,2020-01-12,16/09/20,16/09/20,,,Respiratory Diseases,1,1,3.0
2975.0,NCT04775017,Delirium in Covid-19: Germany-wide Covid-19 Intensive Register,,Recruiting,Intensive Care Unit Delirium,COVID-19,Post Intensive Care Unit Syndrome,,,,,,"Charite University, Berlin, Germany",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-01,01/12/21,2021-01-12,01/03/21,01/03/21,"Department of Anesthesiology and Operative Intensive Care Medicine Campus Virchow-Klinikum, Berlin",Germany,Respiratory Diseases,1,3,11.0
2976.0,NCT04459351,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,PHENOTYPE,Recruiting,Coronavirus,Corona Virus Infection,COVID-19,2019nCoV,COVID-19,,,,Chelsea and Westminster NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-19,01/05/23,2023-01-06,07/07/20,09/07/20,"Chelsea and Westminster Hospital, London",United Kingdom,Respiratory Diseases,1,5,931.0
2977.0,NCT04412291,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",,Recruiting,COVID-19,,,,,,,Drug: Anakinra Prefilled Syringe|Drug: Tocilizumab Prefilled Syringe|Drug: Standard-of-care treatment,Karolinska University Hospital|Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-11-06,01/03/21,2021-01-06,02/06/20,18/02/21,"Karolinska University Hospital, Huddinge, Stockholm",Sweden,Respiratory Diseases,1,1,61.0
2978.0,NCT04813328,The Effect of Helminth Infection Plus COVID-19 Infection on the Immune Response and Intestinal Microorganisms,,Not yet recruiting,COVID-19,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID),All,"5 Years and older   (Child, Adult, Older Adult)",600.0,NIH,Observational,2021-01-04,01/04/22,2022-01-04,24/03/21,30/03/21,,,Respiratory Diseases,1,1,365.0
2979.0,NCT04756817,Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece,GREVAXIMO,Recruiting,"Immunogenicity, Vaccine",,,,,,,,G.Gennimatas General Hospital|Aristotle University Of Thessaloniki,All,85 Years to 100 Years   (Older Adult),500.0,Other,Observational,2021-02-13,30/08/21,2021-09-30,16/02/21,16/02/21,"G. Gennimatas General Hospital, Thessaloníki, Thessaloniki",Greece,Others,0,1,229.0
2980.0,NCT04616950,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,KOVID,Recruiting,COVID-19,Cancer,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-01-12,30/06/21,2021-12-31,05/11/20,31/12/20,"Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph",France,"Respiratory Diseases, Cancers",1,2,719.0
2981.0,NCT04799977,COVID-19: Post-covid Olfactory Disorders Assessment,,Recruiting,Olfaction Disorders,,,,,,,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-10,01/02/21,2022-12-31,16/03/21,18/03/21,"IUFC, Nice",France,Others,0,1,1086.0
2982.0,NCT04352608,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the emergency vaccination schedule|Biological: Two doses of placebo at the emergency vaccination schedule|Biological: Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of high dosage inactivated SARS-CoV-2 vaccine at the routine vaccination schedule|Biological: Two doses of placebo at the routine vaccination schedule,"Sinovac Research and Development Co., Ltd.|Sinovac Biotech Co., Ltd",All,18 Years to 59 Years   (Adult),744.0,Industry,Interventional,2020-04-16,10/07/20,2020-12-13,20/04/20,04/08/20,"Suining County Center for Disease Control and Prevention, Xuzhou, Jiangsu",China,Respiratory Diseases,1,1,241.0
2983.0,NCT04392128,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),HYACINTHE,Withdrawn,COVID-19,Hematologic Malignancy,,,,,,Drug: Hydroxychloroquine Sulfate 200 MG [Plaquenil]|Drug: Azithromycin 250 MG Oral Capsule|Drug: Placebo oral tablet|Drug: Placebo oral capsule,Institut de cancérologie Strasbourg Europe,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-02-09,02/09/20,2020-02-09,18/05/20,04/09/20,"Institut de Cancérologie Strasbourg Europe, Strasbourg",France,Respiratory Diseases,1,2,0.0
2984.0,NCT04535700,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,,Recruiting,Type 2 Diabetes,,,,,,,Drug: Pioglitazone 30 mg|Other: standard of care,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,All,"18 Years and older   (Adult, Older Adult)",76.0,Other,Interventional,2020-09-18,10/03/21,2021-10-04,02/09/20,17/11/20,"Hospital Ramón y Cajal, Madrid",Spain,Metabolic Disorders,1,1,381.0
2985.0,NCT04665115,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,B-Cell Neoplasm,Chronic Lymphocytic Leukemia,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Mantle Cell Lymphoma,Marginal Zone Lymphoma,Small Lymphocytic Lymphoma,Drug: Ibrutinib|Other: Quality-of-Life Assessment,Academic and Community Cancer Research United|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",134.0,Other|NIH,Interventional,2021-06-30,01/05/22,2025-01-05,11/12/20,22/01/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,"Respiratory Diseases, Cancers",1,7,1285.0
2986.0,NCT04479163,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,,Completed,COVID-19,,,,,,,Biological: Convalescent Plasma|Other: Placebo,Fundacion Infant,All,65 Years and older   (Older Adult),165.0,Other,Interventional,2020-04-06,25/10/20,2020-10-25,21/07/20,22/12/20,"Hospital Militar Central, Caba, Buenos Aires, Argentina|CEMIC, Caba, Buenos Aires, Argentina|Centro de Investigacion Clinica OSECAC, Caba, Buenos Aires, Argentina|Centro Gallego de Buenos Aires, Caba, Buenos Aires, Argentina|Sanatorio Anchorena, Caba, Buenos Aires, Argentina|Sanatorio de Los Arcos, Caba, Buenos Aires, Argentina|Hospital Simplemente Evita, González Catán, Buenos Aires, Argentina|Hospital Especializado de Agudos y Crónicos San Juan de Dios, La Plata, Buenos Aires, Argentina|Clinica Olivos, Buenos Aires, Argentina|Hospital Central de San Isidro, Buenos Aires, Argentina|Hospital General de Agudos Dr. Carlos Bocalandro, Buenos Aires",Argentina,Respiratory Diseases,1,1,202.0
2987.0,NCT04399603,Mechanisms of Multi-organ Failure in COVID-19,,Recruiting,COVID-19,,,,,,,Other: no intervention-mechanistic study,Imperial College London,All,"18 Years to 90 Years   (Adult, Older Adult)",120.0,Other,Observational,2020-01-06,17/11/21,2021-11-17,22/05/20,24/03/21,"Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom|Imperial College NHS Trust, London",United Kingdom,Respiratory Diseases,1,1,681.0
2988.0,NCT04779944,Impact of SARS-CoV-2 Pandemic on Psychological State of Health Care Workers,,Completed,COVID-19,,,,,,,Other: other,Assiut University,All,"25 Years to 70 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-07-04,30/07/20,2020-08-15,03/03/21,03/03/21,"heba Yassa, Assiut",Egypt,Respiratory Diseases,1,1,42.0
2989.0,NCT04374942,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,HEROs,Enrolling by invitation,Pre-Exposure Prophylaxis,Coronavirus,SARS-CoV 2,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"Megan Landes|University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",988.0,Other,Interventional,2020-04-30,27/08/20,2022-01-30,05/05/20,08/05/20,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,3,640.0
2990.0,NCT04435223,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,COVIDOLIP,Completed,COVID-19,Severe Pneumonia Due to Other Pathogene,,,,,,Biological: biological assays in particular on the lipid metabolism,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",62.0,Other,Observational,2020-07-04,07/05/20,2020-07-05,17/06/20,23/06/20,"Chu Dijon Bourgogne, Dijon",France,Respiratory Diseases,1,2,1.0
2991.0,NCT04403035,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: ID NOW vs. Accula,Ascension South East Michigan,All,"18 Years to 95 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-10-05,01/07/20,2021-09-05,27/05/20,09/07/20,"Ascension St. John Hospital, Detroit, Michigan",United States,Respiratory Diseases,1,1,335.0
2992.0,NCT04408339,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,COVIDHELP,Recruiting,Cancer,COVID-19,,,,,,Other: No Intervention,"Universitätsklinikum Hamburg-Eppendorf|University of Schleswig-Holstein, Campus Lübeck|Universitätsklinikum Schleswig-Holstein, Campus Kiel",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-15,14/04/21,2022-04-14,29/05/20,16/06/20,"University Hospital Hamburg Eppendorf, Hamburg",Germany,"Respiratory Diseases, Cancers",1,2,729.0
2993.0,NCT04530409,Timing of Corticosteroids in COVID-19,,Recruiting,COVID-19,Corticosteroids,,,,,,Drug: Early-Dexamethasone|Drug: Late-Dexamethasone,ClinAmygate,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2020-08-26,01/04/21,2021-01-05,28/08/20,16/02/21,"Asalam, Maadi, Cairo",Egypt,Respiratory Diseases,1,2,132.0
2994.0,NCT04683328,The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care,,Not yet recruiting,COVID-19,,,,,,,Biological: SCTA01|Biological: SCTA01 Placebo,Sinocelltech Ltd.,All,"18 Years and older   (Adult, Older Adult)",560.0,Industry,Interventional,2021-02-25,25/05/21,2021-11-25,24/12/20,20/01/21,,,Respiratory Diseases,1,1,273.0
2995.0,NCT04445376,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,,Completed,COVID-19,,,,,,,Other: Physical Exercises,Government College University Faisalabad,All,"18 Years to 75 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-03-07,10/09/20,2020-03-10,24/06/20,08/10/20,"Bin Inam Rehabilitation Center., Faisalābad, Punjab",Pakistan,Respiratory Diseases,1,1,3.0
2996.0,NCT04739410,Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients,,Completed,COVID-19,,,,,,,Drug: Ivermectin,FMH College of Medicine and Dentistry,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-05,30/06/20,2020-06-30,04/02/21,04/02/21,"Aijaz Zeeshan Khan Chachar, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,177.0
2997.0,NCT04641195,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin D3 (cholecalciferol)|Dietary Supplement: Zinc (zinc gluconate)|Dietary Supplement: Zinc (zinc gluconate) & Vitamin D (cholecalciferol)|Other: Placebo,"Harvard School of Public Health|Foundation for Medical Research|University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2021-01-03,30/11/21,2022-03-31,23/11/20,10/02/21,"Saifee Hospital, Mumbai, Maharashtra, India|King Edward Memorial (KEM) Hospital, Pune, Maharashtra",India,Respiratory Diseases,1,1,452.0
2998.0,NCT04389411,The COvid-19 Symptom MOntelukast Trial,COSMO,Not yet recruiting,COVID-19,,,,,,,Drug: Montelukast 10mg,McGill University|Lady Davis Institute,All,"40 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-01-10,01/09/21,2021-01-12,15/05/20,01/09/20,,,Respiratory Diseases,1,1,368.0
2999.0,NCT04292899,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19),,Completed,COVID-19,,,,,,,Drug: Remdesivir|Drug: Standard of Care,Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",4891.0,Industry,Interventional,2020-06-03,09/04/20,2020-06-30,03/03/20,31/12/20,"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center, 27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center, 13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale-New Haven Hospital, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|John H. Stroger Jr. Hospital of Cook County, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center-New York Presbyterian Hospital, New York, New York, United States|New York Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Regional Medical Center Everett, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United Stat",United Kingdom,Respiratory Diseases,1,1,27.0
3000.0,NCT04653831,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,,Recruiting,COVID-19,ARDS,,,,,,Drug: Pirfenidone|Other: Standard of care,Soroka University Medical Center|Roche Pharma AG,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-08-11,01/11/21,2021-01-12,04/12/20,04/12/20,"Soroka Medical Center, Be'er Sheva",Israel,Respiratory Diseases,1,2,154.0
3001.0,NCT04475120,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,,Completed,COVID-19,,,,,,,Drug: liposomal lactoferrin,University of Rome Tor Vergata,All,"20 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-15,02/07/20,2020-02-07,17/07/20,17/07/20,"University of Rome Tor Vergata, Rome",Italy,Respiratory Diseases,1,1,-68.0
3002.0,NCT04426695,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",,Recruiting,COVID-19,,,,,,,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,Regeneron Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",6900.0,Industry,Interventional,2020-11-06,16/04/21,2021-04-16,11/06/20,06/04/21,"Regeneron Study Site, Birmingham, Alabama, United States|Regeneron Study Site, Chandler, Arizona, United States|Regeneron Study Site, Phoenix, Arizona, United States|Regeneron Study Site 1, Tucson, Arizona, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Mission Hills, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regneron Study Site, Hartford, Connecticut, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Gainesville, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Pensacola, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Augusta, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site, Glenview, Illinois, United States|Regeneron Study Site, Urbana, Illinois, United States|Regeneron Study Site, Indianapolis, Indiana, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, Louisville, Kentucky, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Grand Rapids, Michigan, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Rochester, Minnesota, United States|Regeneron Study Site, Chesterfield, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Omaha, Nebraska, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Englewood, New Jersey, United States|Regeneron Study Site, Hackensack, New Jersey, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Neptune, New Jersey, United States|Regeneron Study Site, Pennington, New Jersey, United States|Regeneron Study Site, Summit, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Albuquerque, New Mexico, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Brooklyn, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site 1, Buffalo, New York, United States|Regeneron Study Site 2, Buffalo, New York, United States|Regeneron Study Site, Jamaica, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Rochester, New York, United States|Regeneron Study Site, Syracuse, New York, United States|Regeneron Study Site, West Islip, New York, United States|Regeneron Study Site, White Plains, New York, United States|Regeneron Study Site, Chapel Hill, North Carolina, United States|Regeneron Study Site, Concord, North Carolina, United States|Regeneron Study Site, Greensboro, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Portland, Oregon, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site 1, Amarillo, Texas, United States|Regeneron Study Site 2, Amarillo, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Lubbock, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Sugar Land, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Murray, Utah, United States|Regeneron Study Site, Salt Lake City, Utah, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site 1, Seattle, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Salvador, Bahia, Brazil|Regeneron Study Site, Fortaleza, Ceara, Brazil|Regeneron Study Site, Curitiba, Paraná, Brazil|Regeneron Study Site, Porto Alegre, Rio Grande Do Sul, Brazil|Regeneron Study Site, Passo Fundo, RS, Brazil|Regeneron Study Site, Chapeco, Santa Catarina, Brazil|Regeneron Study Site, Criciuma, Santa Catarina, Brazil|Regeneron Study Site, Botucatu, Sao Paolo, Brazil|Regeneron Study Site, Campinas, Sao Paolo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site, São Paulo, Brazil|Regeneron Study Site 1, Las Condes, Santiago De Chile, Chile|Regeneron Study Site 2, Las Condes, Santiago De Chile, Chile|Regeneron Study Site, Vitacura, Santiago De Chile, Chile|Regeneron Study Site, Santiago de Chile, Chile|Regeneron Study Site, Guadalajara, Jalisco, Mexico|Regeneron Study Site, Monterrey, Nuevo Leon, Mexico|Regeneron Study Site, Culiacan, Mexico|Regeneron Study Site, Monterrey, Mexico|Regeneron Study Site 1, Mérida, Mexico|Regeneron Study Site 2, Mérida, Mexico|Regeneron Study Site, Veracruz, Mexico|Regeneron Study Site, Zapopan, Mexico|Regeneron Study Site, Chisinau, Moldova, Republic of|Regeneron Study Site, Bucuresti",Romania,Respiratory Diseases,1,1,161.0
3003.0,NCT04771013,Safety and Efficacy of Thymic Peptides in the Treatment of Hospitalized COVID-19 Patients in Honduras,,Recruiting,COVID-19,,,,,,,Biological: Thymic peptides,Universidad Católica de Honduras|Pontificia Universidad Catolica de Chile,All,"21 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-10-02,01/05/21,2021-01-05,25/02/21,25/02/21,"Hospital de Santa Bárbara Integrado, Santa Bárbara",Honduras,Respiratory Diseases,1,1,-270.0
3004.0,NCT04416100,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),CovILD,Recruiting,COVID-19,Pulmonary Fibrosis,,,,,,Diagnostic Test: Pulmonary function tests|Diagnostic Test: Imaging|Biological: Blood sampling,Medical University Innsbruck|Boehringer Ingelheim,All,"18 Years and older   (Adult, Older Adult)",130.0,Other|Industry,Observational,2020-04-29,28/04/22,2022-04-28,04/06/20,02/12/20,"Medical University of Innsbruck, Innsbruck",Austria,Respiratory Diseases,1,2,729.0
3005.0,NCT04769245,The Effectiveness of ACB-IP 1.0 Convalescent Plasma in COVID-19 Infection,,Recruiting,COVID-19,,,,,,,,Acibadem University|Acıbadem Labcell,All,"18 Years to 75 Years   (Adult, Older Adult)",40.0,Other,Observational,2021-02-18,01/04/21,2021-01-06,24/02/21,24/02/21,"Acıbadem Labcell Cellular Therapy Laboratories, Istanbul, Turkey|Acibadem Altunizade Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,-43.0
3006.0,NCT04371965,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",KILLER,Completed,COVID-19,,,,,,,Drug: Povidone-Iodine,Poitiers University Hospital,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2020-01-09,23/10/20,2020-10-23,01/05/20,26/10/20,"University Hospital of Poitiers, Poitiers",France,Respiratory Diseases,1,1,288.0
3007.0,NCT04637295,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",PEACE,Recruiting,Neoplasms Malignant,,,,,,,,University of Nebraska,All,"19 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-27,30/06/21,2021-06-30,19/11/20,29/01/21,"University of Nebraska Medical Center, Omaha, Nebraska",United States,Others,0,1,154.0
3008.0,NCT04452474,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,,Not yet recruiting,COVID-19,,,,,,,Drug: Olokizumab 64 mg|Drug: Placebo,"R-Pharm|Cromos Pharma, LLC|Covance",All,"18 Years to 100 Years   (Adult, Older Adult)",376.0,Industry|Other,Interventional,2020-06-30,16/11/20,2021-01-29,30/06/20,30/06/20,"George Washington University Medical Center, Washington, District of Columbia, United States|Center For Haptitis C/ Atlanta Medical Center, Atlanta, Georgia, United States|PMG Research of DuPage Medical Group, Downers Grove, Illinois, United States|Northwest Indiana Center for Clinical Research, Portage, Indiana, United States|Baystate Infectious Diseases Clinical Research, Springfield, Massachusetts, United States|PMG Research, Inc., Winston-Salem, North Carolina",United States,Respiratory Diseases,1,1,213.0
3009.0,NCT04340466,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,FRENCH CORONA,Completed,"Pneumonia, Viral",Critically Ill,Corona Virus Infection,,,,,Other: No intervention,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",1003.0,Other,Observational,2020-03-04,03/07/20,2020-03-07,09/04/20,19/12/20,"CHU Nimes, Nîmes",France,Respiratory Diseases,1,3,3.0
3010.0,NCT04332107,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,ACTION,"Active, not recruiting",COVID-19,COVID-19,,,,,,Drug: Azithromycin|Drug: Placebos,"Thomas M. Lietman|Bill and Melinda Gates Foundation|Pfizer|Stanford University|University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",2271.0,Other|Industry,Interventional,2020-05-22,30/09/21,2021-12-30,02/04/20,18/03/21,"University of California San Francisco, San Francisco, California",United States,Respiratory Diseases,1,2,587.0
3011.0,NCT04542915,COVID-19-Related Health and Practices Among Dental Hygienists,,"Active, not recruiting",SARS-CoV Infection,Anxiety,Depression,Occupational Problems,Severe Acute Respiratory Syndrome,Coronavirus Infection,,Other: No intervention,American Dental Association|American Dental Hygienists Association,All,"18 Years and older   (Adult, Older Adult)",4776.0,Other,Observational,2020-09-29,01/10/21,2021-01-10,09/09/20,15/01/21,"American Dental Association, Chicago, Illinois",United States,"Mental Health, Respiratory Diseases",1,6,103.0
3012.0,NCT04527354,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,,Completed,COVID-19,Fibrosis Lung,,,,,,Drug: Treamid|Drug: Placebo,PHARMENTERPRISES LLC,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-01-09,10/02/21,2021-10-02,26/08/20,05/04/21,"Federal State-Funded Research Institution Research Institute of Complex Cardiovascular Diseases, Kemerovo, Russian Federation|Federal State Budgetary Institution N.N. Burdenko Military Clinical Hospital, Moscow, Russian Federation|SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow, Russian Federation|Moscow State Medical-Dentist University n.a. A.I. Evdokimov on basis of SMHI City Hospital № 62, branch 5, Moscow, Russian Federation|State Budgetary Health Institution Republican Hospital named V.A.Baranov, Petrozavodsk, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Rostov State Medical University, Rostov-on-Don, Russian Federation|LLC Medical Center Reavita Med St. Petersburg, Saint Petersburg, Russian Federation|State autonomous healthcare institution of Yaroslavl Region Сlinical hospital for emergency medical care n. a. N.V. Solovyov, Yaroslavl",Russian Federation,Respiratory Diseases,1,2,632.0
3013.0,NCT04639466,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Placebo Administration|Biological: Vaccine Therapy,City of Hope Medical Center|National Cancer Institute (NCI),All,18 Years to 55 Years   (Adult),129.0,Other|NIH,Interventional,2020-11-12,10/11/22,2022-10-11,20/11/20,07/01/21,"City of Hope Medical Center, Duarte, California",United States,Respiratory Diseases,1,1,698.0
3014.0,NCT04640428,COVID-19 Stroke Apical Lung Examination Study,,Recruiting,COVID-19,"Stroke, Acute","Stroke, Ischemic",Stroke Hemorrhagic,,,,,"King's College Hospital NHS Trust|National Institute for Health Research, United Kingdom",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-10-07,31/10/21,2021-10-31,23/11/20,01/04/21,"Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom|North Bristol NHS Trust, Bristol, United Kingdom|University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom|Cardiff and Vale University Health Board, Cardiff, United Kingdom|University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom|Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|King's College Hospital NHS FT (KCH), London, United Kingdom|King's College Hospital NHS FT (PRUH), London, United Kingdom|University College London NHS Foundation Trust, London",United Kingdom,"Cardiovascular Diseases, Respiratory Diseases",1,4,389.0
3015.0,NCT04654416,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,,Completed,COVID-19,,,,,,,Drug: Corticosteroid with or without colchicine,Clínica Medellín - Grupo Quirónsalud,All,"18 Years and older   (Adult, Older Adult)",301.0,Other,Observational,2020-03-20,07/08/20,2020-08-20,04/12/20,04/12/20,"Clínica Medellín - Grupo Quirónsalud, Medellín, Antioquia",Colombia,Respiratory Diseases,1,1,153.0
3016.0,NCT04730661,Efficacy of the Sit to Stand Test in the Decision to Hospitalize a Patient Consulting the Emergency Dept for COVID 19,SITCOV,Recruiting,SARS-CoV Infection,,,,,,,Diagnostic Test: Sit to stand test,"University Hospital, Rouen",All,"18 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-12-21,21/12/21,2021-12-28,29/01/21,09/02/21,"Rouen university hospital, Rouen",France,Respiratory Diseases,1,1,372.0
3017.0,NCT04810637,A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: GX-I7,"PT Kalbe Genexine Biologics|Genexine, Inc.",All,"50 Years and older   (Adult, Older Adult)",210.0,Industry,Interventional,2020-01-11,01/06/21,2021-01-09,23/03/21,24/03/21,"Mitra Keluarga Kelapa Gading, Jakarta Pusat, Indonesia|Mitra Keluarga Kemayoran, Jakarta Pusat",Indonesia,Respiratory Diseases,1,1,364.0
3018.0,NCT04491292,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,,Recruiting,COVID-19,,,,,,,Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",20000.0,Other|NIH,Observational,2020-05-18,30/04/21,2021-04-30,29/07/20,29/07/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,1,347.0
3019.0,NCT04398303,ACT-20 in Patients With Severe COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Biological: ACT-20-MSC|Biological: ACT-20-CM|Biological: Placebo,Aspire Health Science,All,"18 Years to 85 Years   (Adult, Older Adult)",70.0,Other,Interventional,2020-01-05,01/10/20,2020-01-10,21/05/20,21/05/20,,,Respiratory Diseases,1,1,5.0
3020.0,NCT04786249,Impact of Rapid Screening for COVID-19 in Delocalized Biology in the Emergency Department,DELOCOVID,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",2400.0,Other,Observational,2021-02-24,26/02/21,2021-04-30,08/03/21,16/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,1,65.0
3021.0,NCT04834089,Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases,SOROCOV,Not yet recruiting,Immunosuppression,Cancer,COVID-19,Other Complication of Kidney Transplant,Chemotherapy,Renal Disease,Diabetes Mellitus,Biological: AntiSARS-CoV-2 Serum|Other: Placebo,Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",618.0,Other,Interventional,2021-01-05,01/05/22,2022-01-05,06/04/21,08/04/21,"Hospital do Rim, Sao Paulo, SP, Brazil|Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo",Brazil,"Metabolic Disorders, Respiratory Diseases, Cancers",1,7,365.0
3022.0,NCT04807699,Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL,Recoversus,Enrolling by invitation,COVID-19,Hospitalization,,,,,,Other: Data collection,Evandro Chagas National Institute of Infectious Disease|Hospital Universitario Pedro Ernesto|Universidade Federal do Rio de Janeiro|Hospital Couto Maia/SES/BA|Hospital São José de Doenças Infecciosas - HSJ / Secretaria de Saúde Fortaleza|Hospital Estadual Sumaré Dr. Leandro Francheschini|Universidade Federal de Santa Maria|Hospital Regional de São José - Dr. Homero de Miranda Gomes|Hospital dos Servidores do Estado do Rio de Janeiro|Federal University of Minas Gerais|Hospital Universitário Gaffrée Guinle|Hospital Nossa Senhora da Conceicao|Instituto de Infectologia Emílio Ribas,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-07-25,25/10/21,2022-03-25,19/03/21,19/03/21,"Hospital Couto Maia/SES/BA, Salvador, Bahia, Brazil|Hospital São José de Doenças Infecciosas - HSJ / Secretaria de Saúde Fortaleza, Fortaleza, Ceará, Brazil|Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria/ Pró-Reitoria de PósGraduação e Pesquisa, Santa Maria, Rio Grande Do Sul, Brazil|Hospital dos Servidores do Estado/RJ, Rio de Janeiro, RJ, Brazil|Hospital Universitário Gaffree e Guinle/HUGG/UNIRIO, Rio de Janeiro, RJ, Brazil|Hospital Universitário Pedro Ernesto/UERJ, Rio de Janeiro, RJ, Brazil|Instituto Nacional de Infectologia Evandro Chagas (Fiocruz), Rio de Janeiro, RJ, Brazil|Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil|Hospital Regional de São José, São José, Santa Catarina, Brazil|Hospital Estadual Sumaré Dr. Leandro Francheschini, Sumaré, São Paulo, Brazil|Instituto de Infectologia Emílio Ribas, São Paulo",Brazil,Respiratory Diseases,1,2,608.0
3023.0,NCT04537858,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,,"Active, not recruiting",COVID-19,Inpatient,,,,,,Device: Virtual reality therapy first|Device: Conventional therapy first,University of Sao Paulo|Federal University of São Paulo,All,"20 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-06-18,20/08/20,2020-01-12,03/09/20,03/09/20,"Comitê de Ética da Universidade Federal, São Paulo",Brazil,Respiratory Diseases,1,2,-158.0
3024.0,NCT04365257,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),PREVENT,Recruiting,COVID-19,,,,,,,Drug: Prazosin|Other: Standard of care,Johns Hopkins University|Fast Grants,All,"45 Years to 85 Years   (Adult, Older Adult)",220.0,Other,Interventional,2020-05-13,30/06/21,2021-06-30,28/04/20,10/12/20,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,1,413.0
3025.0,NCT04485429,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: Methylprednisolone|Drug: Heparin,D'Or Institute for Research and Education,All,"18 Years and older   (Adult, Older Adult)",268.0,Other,Interventional,2020-07-20,31/12/20,2020-12-31,24/07/20,24/07/20,"D'Or Institute for Research and Education, Rio de Janeiro",Brazil,Respiratory Diseases,1,1,164.0
3026.0,NCT04395300,Sleep Quality in Healthcare Personnel During COVID-19,,Completed,COVID-19,Sleep Quality,General Health,,,,,Other: Web Based Survey,Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",143.0,Other,Observational,2020-03-30,30/04/20,2020-05-16,20/05/20,23/06/20,"AssiutU, Assiut",Egypt,Respiratory Diseases,1,3,47.0
3027.0,NCT04372199,SEVERITY SCORE FOR COVID-19 PNEUMONIA,,Recruiting,COVID-19,Pneumonia,,,,,,,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,All,"18 Years and older   (Adult, Older Adult)",248.0,Other,Observational,2020-04-29,27/05/20,2020-05-27,01/05/20,01/05/20,"Massimo Montalto, Roma",Italy,Respiratory Diseases,1,2,28.0
3028.0,NCT04349241,Efficacy and Safety of Favipiravir in Management of COVID-19,FAV-001,Completed,COVID-19,,,,,,,Drug: favipiravir|Drug: Standard of care therapy,Ain Shams University,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-18,01/06/20,2020-06-20,16/04/20,25/06/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,63.0
3029.0,NCT04436458,Niclosamide In Moderate COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Niclosamide Oral Tablet|Drug: Placebo,"First Wave Bio, Inc.",All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2021-01-06,01/08/21,2021-01-12,18/06/20,16/02/21,,,Respiratory Diseases,1,1,6.0
3030.0,NCT04354259,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,ILIAD,Recruiting,Sars-CoV2,COVID-19,,,,,,Drug: Peginterferon Lambda-1A|Other: placebo,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Interventional,2020-05-13,01/08/20,2020-11-30,21/04/20,18/05/20,"Toronto General Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,2,201.0
3031.0,NCT04351295,Efficacy of Faviprevir in COVID-19 Treatment,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Placebos,Tanta University,All,"Child, Adult, Older Adult",90.0,Other,Interventional,2020-04-20,01/12/20,2020-01-12,17/04/20,29/09/20,"Tanta University, Ainshams University, Tanta",Egypt,Respiratory Diseases,1,1,-99.0
3032.0,NCT04615429,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,,"Active, not recruiting",Acute Respiratory Distress Syndrome,COVID-19,,,,,,Biological: Mesenchymal stromal cells|Other: Placebo,Cristina Avendaño Solá|Puerta de Hierro University Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-09-15,04/01/21,2022-01-01,04/11/20,08/02/21,"Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid",Spain,Respiratory Diseases,1,2,473.0
3033.0,NCT04834726,COVID Vaccine Text Outreach,,Not yet recruiting,COVID-19,,,,,,,Behavioral: Opt-In|Behavioral: Preference|Behavioral: Standard Message|Behavioral: Clinician Endorsement|Behavioral: Scarcity|Behavioral: Opt-Out Framing|Behavioral: Phone Call,University of Pennsylvania,All,"16 Years and older   (Child, Adult, Older Adult)",21000.0,Other,Interventional,2021-01-04,01/05/21,2021-01-06,08/04/21,08/04/21,"Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,2.0
3034.0,NCT04347239,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),,Recruiting,Coronavirus Disease 2019,,,,,,,Drug: Placebos|Drug: Leronlimab (700mg),"CytoDyn, Inc.",All,"18 Years and older   (Adult, Older Adult)",394.0,Industry,Interventional,2020-04-15,15/06/21,2021-10-15,15/04/20,14/04/21,"Advanced Cardiovascular, LLC, Alexander City, Alabama, United States|St. Jude Medical Center, Fullerton, California, United States|UCLA, Los Angeles, California, United States|James A. Haley Veterans' Hospital, Tampa, Florida, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|St. Barnabas, Livingston, New Jersey, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|New York Community Hospital of Brooklyn, Brooklyn, New York, United States|Novant Health, Winston-Salem, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Good Samaritan Hospital Corvallis, Corvallis, Oregon, United States|Oregon Health and Sciences University, Portland, Oregon, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|University of Texas, Houston, Texas",United States,Respiratory Diseases,1,1,548.0
3035.0,NCT04806620,Comparison of ME/CFS and Long COVID-19 Patients,,Recruiting,ME/CFS,COVID-19,,,,,,,Solve ME/CFS Initiative,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-01-05,01/05/25,2025-01-05,19/03/21,06/04/21,"Solve ME/CFS Initiative, Los Angeles, California",United States,Respiratory Diseases,1,2,1827.0
3036.0,NCT04844554,Protocol of Assistance to Patients With Covid-19 Submitted to Treatment With HD-tDCS,,Not yet recruiting,COVID-19,High-definition Transcranial Direct Current Stimulation,,,,,,Other: HD-tDCS 4mA|Other: HD-tDCS 2mA,Federal University of Paraíba|City University of New York|University of Michigan|Rio de Janeiro State University,All,"20 Years to 90 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-04-19,12/04/22,2022-12-10,14/04/21,14/04/21,"Federal University of Paraíba,Department of Psychology, João Pessoa, Paraíba",Brazil,Respiratory Diseases,1,2,600.0
3037.0,NCT04351490,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,ZnD3-CoVici,Withdrawn,SARS-CoV 2,,,,,,,Dietary Supplement: Zinc gluconate|Dietary Supplement: 25-OH cholecalciferol,"University Hospital, Lille",All,"60 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,01/07/20,2020-01-07,17/04/20,11/03/21,,,Respiratory Diseases,1,1,3.0
3038.0,NCT04522817,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,,Withdrawn,COVID-19,,,,,,,Biological: CLBS119,"Caladrius Biosciences, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-05-10,01/05/21,2021-01-05,21/08/20,17/12/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,240.0
3039.0,NCT04325048,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,,Recruiting,Coronavirus Infection,,,,,,,Device: Cordio App,Cordio Medical,All,"18 Years and older   (Adult, Older Adult)",5000.0,Industry,Observational,2020-04-23,01/06/21,2021-01-09,27/03/20,25/02/21,"Rambam Medical Center, Haifa",Israel,Respiratory Diseases,1,1,261.0
3040.0,NCT04343664,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,New,Not yet recruiting,Mental Stress,Mental Health Wellness 1,Depression,Anxiety,Behavior Problem,Emotional Problem,,,Tjhin Wiguna|Fakultas Kedokteran Universitas Indonesia|Dr Cipto Mangunkusumo General Hospital,All,"4 Years and older   (Child, Adult, Older Adult)",10000.0,Other,Observational,2021-01-02,01/11/21,2021-12-31,13/04/20,09/02/21,"dr. Cipto Mangunkusumo General Hospital, Jakarta Pusat, DKI Jakarta",Indonesia,Mental Health,1,6,363.0
3041.0,NCT04794062,Myocardial Injury and Quality of Life After COVID-19,,Recruiting,COVID-19,Myocardial Injury,Myocarditis Post Infection,,,,,,"Voronezh Regional Clinical Consultative and Diagnostic Center|Voronezh State Medical University named after N.N. Burdenko|Charles University, Czech Republic",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-09-16,31/03/21,2021-12-31,11/03/21,11/03/21,"Voronezh Region Clinical, Consultative and Diagnostic Center, Voronezh, Voronezh Region",Russian Federation,Respiratory Diseases,1,3,471.0
3042.0,NCT04456075,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,CROWNLESS,Recruiting,SARS-CoV2,COVID-19,,,,,,,Heidelberg University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,01/04/22,2022-01-04,02/07/20,02/07/20,"Thoraxklinik at Heidelberg University, Heidelberg",Germany,Respiratory Diseases,1,2,731.0
3043.0,NCT04644120,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: ABBV-47D11|Drug: Placebo for ABBV-47D11|Drug: ABBV-2B04|Drug: Placebo for ABBV-2B04,AbbVie,All,"18 Years and older   (Adult, Older Adult)",54.0,Industry,Interventional,2020-10-12,05/09/21,2021-05-09,25/11/20,15/03/21,"Glendale Adventist Medical Center /ID# 225188, Glendale, California, United States|University of Miami /ID# 225038, Miami, Florida, United States|AdventHealth Orlando /ID# 225965, Orlando, Florida, United States|Triple O Research Institute /ID# 228612, West Palm Beach, Florida, United States|University of Illinois Hospital and Health Sciences System /ID# 224323, Chicago, Illinois, United States|Pikeville Medical Center /ID# 224539, Pikeville, Kentucky, United States|Univ Maryland School Medicine /ID# 227066, Baltimore, Maryland, United States|Michigan State University /ID# 224907, East Lansing, Michigan, United States|Saint Peter's University Hospital /ID# 225183, New Brunswick, New Jersey, United States|Prime Healthcare Services- St.Michael's LLC d/b/a Saint Michael's Medical Center /ID# 225258, Newark, New Jersey, United States|The Christ Hospital /ID# 224541, Cincinnati, Ohio, United States|Prisma Health Upstate /ID# 224556, Greenville, South Carolina, United States|St. David's Healthcare Partnership, L.P., LLP /ID# 225053, Austin, Texas, United States|Budai Irgalmasrendi Korhaz /ID# 226015, Budapest, Hungary|Semmelweis Egyetem /ID# 226016, Budapest, Hungary|Hadassah Ein Kerem Hospital /ID# 225827, Jerusalem, Yerushalayim, Israel|Sheba Medical Center /ID# 225857, Ramat Gan, Israel|Universitair Medisch Centrum Utrecht /ID# 225919, Utrecht, Netherlands|San Juan Bautista School of Medicine /ID# 225963, Caguas, Puerto Rico|Manati Medical Center /ID# 225936, Manati",Puerto Rico,Respiratory Diseases,1,1,209.0
3044.0,NCT04525404,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,MOIST,Recruiting,COVID-19,Coronavirus Infection,SARS-CoV Infection,,,,,"Diagnostic Test: MRI (heart, brain, lungs, liver)|Diagnostic Test: Bloodwork|Other: Cognitive testing|Other: Olfaction testing|Diagnostic Test: Spirometry|Other: Walk Test",University of Alberta|Canadian VIGOUR Centre,All,"18 Years and older   (Adult, Older Adult)",228.0,Other,Observational,2020-12-11,01/09/21,2021-01-09,25/08/20,25/11/20,"University of Alberta, Edmonton, Alberta",Canada,Respiratory Diseases,1,3,29.0
3045.0,NCT04773067,"A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers",,Recruiting,COVID-19,,,,,,,Biological: UB-612|Biological: Placebo,"United Biomedical Inc., Asia|COVAXX",All,"12 Years to 85 Years   (Child, Adult, Older Adult)",3850.0,Industry,Interventional,2021-01-30,30/06/21,2022-06-30,26/02/21,26/02/21,"Changhua Christian Hospital, Changhua, Taiwan|Chang-Geng Medical Foundation Kaoshiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Far Eastern Memorial Hospital, New Taipei City, Taiwan|China Medical University Hospital, Taichung, Taiwan|National Cheng Kung University Hospital, Tainan, Taiwan|Taipei Medical University Hospital, Taipei, Taiwan|Taipei Veterans General Hospital, Taipei, Taiwan|Tri-Service General Hospital, Taipei, Taiwan|Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospital, Taoyuan",Taiwan,Respiratory Diseases,1,1,516.0
3046.0,NCT04292730,Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,,Completed,COVID-19,,,,,,,Drug: Remdesivir|Drug: Standard of Care,Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",1113.0,Industry,Interventional,2020-03-15,29/04/20,2020-06-26,03/03/20,26/01/21,"Kaiser Permanente Los Angeles Medical Center, 3340 E. La Palma Avenue, Anaheim, California, United States|Alta Bates Summit Medical Center, Berkeley, California, United States|Mills-Peninsula Medical Center, Burlingame, California, United States|Eden Medical Center, Castro Valley, California, United States|Kaiser Permanente Los Angeles Medical Center, 9333 Imperial Highway, Downey, California, United States|Kaiser Permanente Los Angeles Medical Center, 9961 Sierra Ave, Fontana, California, United States|St Joseph Hospital Eureka, Fortuna, California, United States|Kaiser Permanente Los Angeles Medical Center, 25825 S. Vermont Ave., Harbor City, California, United States|Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 6041 Cadillac Ave., Los Angeles, California, United States|Kaiser Permanente Los Angeles Medical Center, 5601 De Soto Avenue, Los Angeles, California, United States|Mission Hospital Regional Medical Center, Mission Viejo, California, United States|Kaiser Permanente Los Angeles Medical Center,27300 Iris Avenue, Moreno Valley, California, United States|El Camino Hospital, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Kaiser Permanente Oakland Medical Center, Oakland, California, United States|Kaiser Permanente Los Angeles Medical Center, 2295 S. Vineyard Avenue, Ontario, California, United States|The Center for Cancer Prevention and Treatment at St. Joseph Hospital of Orange, Orange, California, United States|Kaiser Permanente Los Angeles Medical Center,13651 Willard Street, Panorama City, California, United States|Kaiser Permanente Los Angeles Medical Center, 10800 Magnolia Avenue, Riverside, California, United States|Sutter Medical Center Sacramento, One Medical Plaza, Roseville, California, United States|Sutter Medical Center Sacramento, Sacramento, California, United States|Kaiser Permanente Los Angeles Medical Center, 4647 Zion Avenue, San Diego, California, United States|Kaiser Permanente Los Angeles Medical Center, 9455 Clairemont Mesa Blvd, San Diego, California, United States|Kaiser Permanente Oakland Medical Center, 1200 El Camino Real, San Francisco, California, United States|California Pacific Medical Center-Infectious Disease Associates Medical Group, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 2425 Geary Blvd, San Francisco, California, United States|Kaiser Permanente Oakland Medical Center, 250 Hospital Parkway, Suite 850, San Jose, California, United States|Kaiser Permanente Oakland Medical Center, 2500 Merced St, San Leandro, California, United States|Kaiser Permanente Oakland Medical Center, 700 Lawrence Expressway, Santa Clara, California, United States|Providence St. Johns Medical Center, Santa Monica, California, United States|Sutter Santa Rosa Regional Hospital, Santa Rosa, California, United States|Stanford Hospital, Stanford, California, United States|University of Colorado Denver, University of Colorado Hospital, Aurora, Colorado, United States|SCL Health St. Joseph Hospital, 1375 East 19th Ave, Denver, Colorado, United States|SCL Health St. Joseph Hospital, Denver, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|SCL Health St. Joseph Hospital, 200 Exempla Circle., Lafayette, Colorado, United States|Yale University, New Haven, Connecticut, United States|Kaiser Permanente Hawaii Moanalua Medical Center, Honolulu, Hawaii, United States|Cook County General Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|IU Health Methodist Hospital, Indianapolis, Indiana, United States|University of Iowa Hospitals & Clinics, Iowa City, Iowa, United States|Tulane University, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States|Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|The University of Michigan Hospitals and Health Systems, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Providence St Patrick Hospital and International Heart Institute of MT Foundation, Missoula, Montana, United States|Darmouth-Hitchhock Medical Center, Lebanon, New Hampshire, United States|Hackensack Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, Hillsborough, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 1 RWJ Place, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital Somerset, 201 Lyons Avenue, Newark, New Jersey, United States|St. Joseph's University Medical Center, Paterson, New Jersey, United States|Jacobi Medical Center, Bronx, New York, United States|James J. Peters Veterans Administration Medical Center, Bronx, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Danbury Hospital, Lagrangeville, New York, United States|North Shore University Hospital, Manhasset, New York, United States|North Shore University Hospital, 270-05 76th Ave, New Hyde Park, New York, United States|Icahn School of Medicine at Mount Sinai, 350 East 17th Street, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 1000 10th Avenue, New York, New York, United States|Icahn School of Medicine at Mount Sinai, 440 West 114th St., New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Irving Medical Center, New York, New York, United States|Weill Cornell Medical College/NYU Presbyterian Hospital, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Kaiser Sunnyside Medical Center, 2875 NW Stucki Ave, Hillsboro, Oregon, United States|Providence Portland Medical Center, Portland, Oregon, United States|Providence St. Vincent Medical Center, Portland, Oregon, United States|Kaiser Sunnyside Medical Center, Portland, Oregon, United States|Hospital of the University of Pennsylvania, 51 N. 31st Street, Philadelphia, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|The Miriam Hospital, Providence, Rhode Island, United States|Prisma Health Richland Hospital, Columbia, South Carolina, United States|Prisma Health Richland Hospital, 701 Grove Road, Greenville, South Carolina, United States|The Liver Institute of Methodist Dallas Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 5201 Harry Hines Blvd., Dallas, Texas, United States|UT Southwestern Medical Center Amelia Court, HIV Research Clinic, 6201 Harry Hines Blvd, Dallas, Texas, United States|Baylor University Medical Center, 1400 8th Ave, Fort Worth, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor University Medical Center, 2401 S. 31st St., Temple, Texas, United States|University of Utah Health, Salt Lake City, Utah, United States|Virginia Hospital Center, Arlington, Virginia, United States|Inova Fairfax Hospital, Falls Church, Virginia, United States|VCU Health Medical Center, Richmond, Virginia, United States|Providence Medical Research Center, Everett, Washington, United States|Kadlec Regional Medical Center, Kennewick, Washington, United States|Providence St. Peter Hospital, Ol",United Kingdom,Respiratory Diseases,1,1,103.0
3047.0,NCT04591158,COVID-19 and Lung Ultrasound Utility,,Recruiting,COVID-19,Lung Infection,,,,,,Device: Butterfly iQ,Bridge to Health Medical and Dental USA,All,"18 Years to 120 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-15,01/09/21,2021-01-09,19/10/20,19/10/20,"Markham Stouffville Hospital, Markham, Ontario",Canada,Respiratory Diseases,1,2,116.0
3048.0,NCT04604184,ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: BI 764198|Drug: Placebo,Boehringer Ingelheim,All,"50 Years and older   (Adult, Older Adult)",130.0,Industry,Interventional,2020-03-11,20/03/21,2021-05-26,27/10/20,09/03/21,"University of California Irvine, Orange, California, United States|Rapides Regional Medical Center, Alexandria, Louisiana, United States|St. Elizabeth's Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mercy Health St. Vincent Medical Center, Toledo, Ohio, United States|Providence Regional Medical Center, Everett, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington, United States|Hospital Luxemburgo, Belo Horizonte, Brazil|IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|Hospital Sao Jose, Criciuma, Brazil|Hospital Ernesto Dornelles, Porto Alegre, Brazil|Hospital Regional Hans Dieter Schmidt, Santa Catarina, Brazil|Hospital de Base - Fac Med de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil|Hospital Padre Alberto Hurtado, Santiago, Chile|Hospital Carlos Van Buren, Valparaiso, Chile|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|Hospital General de Culiacán Dr. Bernardo J. Gastellum, Culiacán, Mexico|Hospital Universitario Dr Jose Eleuterio Gonzalez, Monterrey, Mexico|Hospital Auxilio Mutuo, Hato Rey, Puerto Rico|Hospital Municipal de San Juan, Rio Piedras, Puerto Rico|VA Caribbean Healthcare System, San Juan, Puerto Rico|Hospital A Coruña, A Coruña, Spain|Hospital General Universitario de Alicante, Alicante, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Son Espases, Palma de Mallorca",Spain,Respiratory Diseases,1,1,441.0
3049.0,NCT04365322,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),COV-CREM,Recruiting,COVID-19,,,,,,,Other: Additional biological samples,Centre Hospitalier Universitaire de Besancon,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Observational,2020-04-20,01/09/20,2025-04-20,28/04/20,14/07/20,"CHU Jean Minjoz, Besançon",France,Respiratory Diseases,1,1,1826.0
3050.0,NCT04363203,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),VA-REACH,Suspended,COVID-19,COVID-19,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Placebo oral tablet,Salomeh Keyhani MD|San Francisco VA Health Care System,All,"216 Months and older   (Adult, Older Adult)",300.0,U.S. Fed,Interventional,2020-04-30,01/03/21,2021-01-08,27/04/20,22/06/20,"San Francisco VA, San Francisco, California",United States,Respiratory Diseases,1,2,253.0
3051.0,NCT04713488,"An Open Study on the Safety, Tolerability, and Immunogenicity of ""Sputnik Light"" Vaccine",,"Active, not recruiting",COVID-19,,,,,,,Biological: Sputnik Light,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation|RDIF (Russian Direct Investment Fund)",All,"18 Years to 111 Years   (Adult, Older Adult)",110.0,Other,Interventional,2021-01-15,20/07/21,2021-07-31,19/01/21,02/02/21,"ECO-Safety, Sankt Peterburg",Russian Federation,Respiratory Diseases,1,1,197.0
3052.0,NCT04686565,Covid-19 Pandemic and Cerebral Palsy,,Recruiting,Cerebral Palsy,COVID-19,Telemedicine,Caregiver Quality of Life,"Disability, Developmental",,,,Diskapi Yildirim Beyazit Education and Research Hospital,All,"3 Years to 18 Years   (Child, Adult)",100.0,Other,Observational,2020-02-15,28/02/21,2021-02-28,28/12/20,03/02/21,"Diskapi Education and Research Hospital, Ankara, Altındag",Turkey,Respiratory Diseases,1,5,379.0
3053.0,NCT04578197,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,,Recruiting,COVID-19,,,,,,,,Karolinska University Hospital|Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-08-18,01/06/22,2022-01-11,08/10/20,08/10/20,"Karolinska Universitetssjukhuset Solna, Stockholm",Sweden,Respiratory Diseases,1,1,511.0
3054.0,NCT04563208,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,DuACT,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Placebo|Drug: DuACT,"University of Witwatersrand, South Africa|Synavir Corporation",All,"18 Years to 75 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-09-12,01/02/21,2021-01-03,24/09/20,16/12/20,"Sunnyside Office Park, Johannesburg, Gauteng",South Africa,Respiratory Diseases,1,2,113.0
3055.0,NCT04441918,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",,Recruiting,COVID-19,,,,,,,Combination Product: JS016 (anti-SARS-CoV-2 monoclonal antibody),"Shanghai Junshi Bioscience Co., Ltd.",All,"15 Years to 45 Years   (Child, Adult)",40.0,Other,Interventional,2020-05-06,11/12/20,2020-11-12,22/06/20,22/06/20,"Huashan Hospital affiliated to Fudan University, Shanghai",China,Respiratory Diseases,1,1,190.0
3056.0,NCT04575571,MAVIPAN: My Life and the COVID-19 Pandemic,,Recruiting,COVID-19,,,,,,,"Other: No intervention, this is an observational study that uses validated questionnaires and qualitative interviews..",Laval University|VITAM: Research Center on Sustainable Health|Centre de recherche CERVO|Centre interdisciplinaire de recherche en réadaptation et intégration sociale|Centre de recherche universitaire sur les jeunes et les familles|Réseau québécois de recherche sur le vieillissement|Participation sociale et villes inclusives|Société inclusive|CISSS de Chaudière-Appalaches|Centre intégré de santé et de services sociaux de la Côte-Nord|Fondation Mirella et Lino Saputo|Ville de Québec|Living Lab de Charlevoix|Centre intégré de santé et de services sociaux du Bas St-Laurent|Réseau provincial de recherche en adaptation réadaptation|Réseau international sur le Processus de production du handicap|Centre de recherche intégrée pour un système apprenant en santé et services sociaux|Regroupement des organismes de personnes handicapées de la région 03,All,"14 Years and older   (Child, Adult, Older Adult)",5000.0,Other,Observational,2020-04-29,29/04/25,2025-04-29,05/10/20,05/10/20,"VITAM-Research Center in Sustainable Health, Québec",Canada,Respiratory Diseases,1,1,1826.0
3057.0,NCT04829552,Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19 Infection at the Time of Admission To Critical Care Units,,Completed,COVID-19,,,,,,,,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",704.0,Other,Observational,2020-10-03,15/04/20,2020-04-15,02/04/21,02/04/21,"Beaumont Health System (BHS), Royal Oak, Michigan",United States,Respiratory Diseases,1,1,-171.0
3058.0,NCT04682093,Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED,EUROCOV,Enrolling by invitation,COVID-19,,,,,,,,European Society for Emergency Medicine (EUSEM) Research Network,All,"18 Years to 130 Years   (Adult, Older Adult)",8000.0,Other,Observational,2020-09-03,31/01/21,2021-02-28,23/12/20,24/12/20,"EUSEM RN Country lead, Zagreb, Croatia|EUSEM RN Country lead, Hämeenlinna, Finland|EUSEM RN Country lead, Tours, France|EUSEM RN Country lead, Athens, Greece|EUSEM RN Country lead, Forlì",Italy,Respiratory Diseases,1,1,178.0
3059.0,NCT04494724,Clazakizumab vs. Placebo - COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Clazakizumab|Drug: Placebo,The Methodist Hospital System,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-07-13,31/12/20,2021-07-31,31/07/20,31/07/20,"Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,1,383.0
3060.0,NCT04811859,The Effect of Inspiratory Muscle Training in Post COVID-19 Patients,,Recruiting,COVID-19,Infective Pneumonia,,,,,,Other: Inspiratory Muscle Training,Istinye University,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-10-01,10/01/22,2022-10-03,23/03/21,23/03/21,"Istinye University, İstanbul",Turkey,Respiratory Diseases,1,2,367.0
3061.0,NCT04431453,"Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",CARAVAN,Recruiting,COVID-19,,,,,,,Drug: Remdesivir,Gilead Sciences,All,"up to 18 Years   (Child, Adult)",52.0,Industry,Interventional,2020-07-21,01/02/22,2022-01-02,16/06/20,01/04/21,"Children's Hospital of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Ronald Reagan University of California, Los Angeles Medical Center, Los Angeles, California, United States|Valley Children's Hospital, Madera, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Tampa General Hospital (Inpatient Visits), Tampa, Florida, United States|Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States|Norton Children's Hospital, Louisville, Kentucky, United States|Tulane University School of Medicine, New Orleans, Louisiana, United States|Johns Hopkins Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|UMass Memorial Medical Center - University Campus, Worcester, Massachusetts, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|Spectrum Health/Helen De Vos Children's Hospital, Grand Rapids, Michigan, United States|Children's Minnesota, Minneapolis, Minnesota, United States|Children's Hospital and Medical Center, Omaha, Nebraska, United States|NYC Health + Hospitals/Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|Northwell Health-Cohen Children's Medical Center, New Hyde Park, New York, United States|Carolinas Medical Center-Levine Children's Hospital, Charlotte, North Carolina, United States|Lehigh Valley Hospital/Lehigh Valley Health Network (LVH/LVHN), Allentown, Pennsylvania, United States|St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States|Children's Medical Center, Dallas, Texas, United States|Texas Children's Hospital, Houston, Texas, United States|Azienda Ospedaliero Universitaria Meyer, Florence, Italy|University Hospital of Padova, Clinic of Pediatric Hematology-Oncology, Padova, Italy|University Hospital of Parma, Parma, Italy|Hospital Universitari Vall D'Hebron, Barcelona, Spain|Hospital Sant Joan de Déu, Esplugues de llobregat, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain|University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|King's College NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,530.0
3062.0,NCT04353336,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,,Recruiting,COVID-19,Coronavirus Infection,,,,,,Drug: Chloroquine or Hydroxychloroquine,Tanta University,All,"Child, Adult, Older Adult",200.0,Other,Interventional,2020-03-23,23/09/30,2030-12-23,20/04/20,03/12/20,"Tanta University, Assiut University, Tanta",Egypt,Respiratory Diseases,1,2,3927.0
3063.0,NCT04617119,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,,Not yet recruiting,COVID-19,Severe Systemic Illness Respiratory Muscle Fatigue,,,,,,Device: Threshold IMT device|Other: Conventional physical therapy,"DR. JASSIM ALGHAITH|Ministry of Health, Kuwait",All,21 Years to 60 Years   (Adult),38.0,Other,Interventional,2020-01-11,06/02/21,2021-06-04,05/11/20,05/11/20,"Jaber Al-Ahmed Hospital, Kuwait city",Kuwait,Respiratory Diseases,1,2,510.0
3064.0,NCT04451902,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,,Not yet recruiting,Rare Diseases,,,,,,,,Imagine Institute,All,"Child, Adult, Older Adult",80.0,Other,Observational,2020-06-30,30/12/20,2021-06-30,30/06/20,30/06/20,,,Others,0,1,365.0
3065.0,NCT04334954,SARS-COV2 Pandemic Serosurvey and Blood Sampling,,"Active, not recruiting",SARS-COV2 Virus,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",11363.0,NIH,Observational,2020-08-26,31/03/22,2022-03-31,06/04/20,30/03/21,"University of Alabama, Birmingham, Alabama, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,1,582.0
3066.0,NCT04322279,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,,Recruiting,Coronavirus,,,,,,,Diagnostic Test: Serology|Genetic: Sequencing,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-09-03,01/03/21,2021-01-06,26/03/20,22/05/20,"Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Hôpital Cochin CIC 1417 Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Département maladie infectieux CHU Saint Etienne, Saint Etienne, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Centre Investigation Clinique 1433 CHRU de NANCY, Vandœuvre-lès-Nancy, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne",French Guiana,Respiratory Diseases,1,1,125.0
3067.0,NCT04813718,Post COVID-19 Syndrome and the Gut-lung Axis,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Omni-Biotic Pro Vi 5|Dietary Supplement: Placebo,Medical University of Graz|CBmed Ges.m.b.H.,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-05,01/05/22,2022-12-31,24/03/21,24/03/21,"Medical University Graz, Graz",Austria,Respiratory Diseases,1,1,725.0
3068.0,NCT04694742,Ventilatory Efficiency in Critically Ill COVID-19 Patients,,Recruiting,ARDS,,,,,,,Other: data collecting,"ASST Fatebenefratelli Sacco|Ospedale Infermi Rimini|S. Anna Hospital|Azienda Ospedaliero, Universitaria Ospedali Riuniti",All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-09,31/03/21,2021-04-15,05/01/21,05/01/21,"Arcispedale Sant'Anna, Ferrara, Emilia Romagna, Italy|Ospedale Infermi, Rimini, Emilia Romagna, Italy|ASST Fatebenefratelli Sacco, Milan, Lombardy, Italy|Azienda Ospedaliero Universitaria Ospedali Riuniti, Ancona, Marche",Italy,Respiratory Diseases,1,1,462.0
3069.0,NCT04328441,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,BCG-CORONA,"Active, not recruiting",COVID-19,,,,,,,Drug: BCG Vaccine|Drug: Placebo,UMC Utrecht|Radboud University,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Interventional,2020-03-25,31/03/21,2021-04-30,31/03/20,19/08/20,"Jeroen Bosch ziekenhuis, Den Bosch, Brabant, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands|Radboud UMC, Nijmegen, Gelderland, Netherlands|Sint Maartenskliniek, Nijmegen, Gelderland, Netherlands|Noordwest Ziekenhuisgroep locatie Alkmaar, Alkmaar, Noord Holland, Netherlands|Hagaziekenhuis, Den Haag, Zuid-Holland, Netherlands|Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands|Erasmus Medical Center, Rotterdam, Zuid-Holland, Netherlands|University Medical Center Utrecht, Utrecht",Netherlands,Respiratory Diseases,1,1,401.0
3070.0,NCT04608201,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,NICOVID,Recruiting,SARS-COV2,,,,,,,Drug: Nicotine 7 mg/ 24h Transdermal Patch - 24 Hour|Drug: Placebo of NICOTINE Transdermal patch,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2020-09-12,01/12/21,2021-01-12,29/10/20,14/12/20,"Hospital Pitié-Salpêtrière - AP-HP, Paris",France,Respiratory Diseases,1,1,122.0
3071.0,NCT04811456,MultiOrgan Inflammatory Syndromes COVID-19 Related Study,MOIS-CoR,Recruiting,COVID-19,,,,,,,Other: multisystem inflammatory syndrome in children (MIS-C),Medical University of Warsaw|Wrocław Medical University|University of Warsaw,All,"up to 18 Years   (Child, Adult)",1000.0,Other,Observational,2020-05-25,25/05/25,2025-08-25,23/03/21,26/03/21,"Medical University of Warsaw Children's Hospital, Warsaw, Poland|Wroclaw Medical University, Wrocław",Poland,Respiratory Diseases,1,1,1918.0
3072.0,NCT04712292,Effects of COVID-19 Pandemic on the Diagnosis and Outcomes of Colorectal Cancer (COVID-CRC),COVID-CRC,Recruiting,Colorectal Neoplasms Malignant,,,,,,,Procedure: Surgical procedure for cancer,Matteo Rottoli|University of Bologna,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-08-09,31/01/21,2021-02-28,15/01/21,15/01/21,"Rho Memorial Hospital, Rho, Milan, Italy|Humanitas Research Center, Rozzano, Milan, Italy|Humanitas Gavazzeni Hospital, Bergamo, Italy|Policlinico San Marco, Bergamo, Italy|Maggiore Hospital, Bologna, Italy|Fondazione Poliambulanza, Brescia, Italy|Spedali Civili, Brescia, Italy|Spedali Civili, Brescia, Italy|Istituto Europeo di Oncologia, Milan, Italy|Sacco Hospital, Milan, Italy|San Raffaele Hospital, Milan, Italy|Istituto Nazionale dei Tumori, Milan, Italy|Policlinic of Milan, Milan, Italy|San Paolo Hospital, Milan, Italy|Istituto Oncologico Veneto, Padova, Italy|Padova University Hospital, Padova, Italy|San Matteo Hospital, Pavia, Italy|Città della salute, Turin, Italy|Mauriziano Hospital, Turin",Italy,Others,0,1,203.0
3073.0,NCT04778033,Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine,,Recruiting,COVID-19,Fertility Issues,,,,,,Other: Sperm collection,Sheba Medical Center,Male,18 Years to 45 Years   (Adult),75.0,Other,Observational,2021-09-02,10/04/21,2021-01-05,02/03/21,02/03/21,"Sheba medical center, Ramat Gan",Israel,Respiratory Diseases,1,2,-240.0
3074.0,NCT04443725,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,,Not yet recruiting,COVID-19,,,,,,,"Drug: Hydroxychloroquine , Sofosbuvir, daclatasvir|Drug: Standard of care treatment",Cairo University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-07,01/10/20,2020-01-12,23/06/20,25/06/20,,,Respiratory Diseases,1,1,5.0
3075.0,NCT04699097,The Effect of Azithromycin Use on Conduction System of Heart in COVID-19 Positive Children,,Completed,Azithromycin Adverse Reaction,COVID-19,Long QT Syndrome,,,,,Drug: Azithromycin,Kayseri City Hospital,All,"1 Year to 18 Years   (Child, Adult)",105.0,Other,Observational,2020-01-07,01/09/20,2020-01-11,07/01/21,07/01/21,"Süleyman Sunkak, Kayseri, In The USA Or Canada, Please Select...",Turkey,Respiratory Diseases,1,3,4.0
3076.0,NCT04397380,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,COVID3T,Not yet recruiting,Pyrexia,COVID-19,,,,,,Device: Thermography|Device: Tympanic Temperature,NHS Greater Clyde and Glasgow,All,"16 Years and older   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-05-20,03/06/20,2020-01-07,21/05/20,22/05/20,"Queen Elizabeth University Hospital, Glasgow",United Kingdom,Respiratory Diseases,1,2,-134.0
3077.0,NCT04389671,The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),,,,,,Drug: Lucinactant,Windtree Therapeutics,All,"18 Years to 75 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-02-11,01/05/21,2021-01-07,15/05/20,30/03/21,"University of California - Jacobs Medical Center, La Jolla, California, United States|Augusta University Health, Augusta, Georgia, United States|Brigham and Womens, Boston, Massachusetts, United States|Duke University Medical Center, Durham, North Carolina",United States,Respiratory Diseases,1,2,331.0
3078.0,NCT04373733,Early Intervention in COVID-19: Favipiravir Verses Standard Care,PIONEER,Recruiting,Coronavirus Infection,,,,,,,Drug: Favipiravir|Other: Standard of care management,"Chelsea and Westminster NHS Foundation Trust|NEAT ID Foundation|FUJIFILM Toyama Chemical Co., Ltd.|Imperial College London|Universitaire Ziekenhuizen Leuven",All,"18 Years and older   (Adult, Older Adult)",500.0,Other|Industry,Interventional,2020-01-05,31/03/21,2021-03-31,04/05/20,16/02/21,"Chelsea and Westminster Hospital, London, United Kingdom|West Middlesex University Hospital, London",United Kingdom,Respiratory Diseases,1,1,451.0
3079.0,NCT04746430,COVID-19 Primary Care Platform for Early Treatment and Recovery (COPPER) Study,COPPER,Recruiting,COVID-19,Corona Virus Infection,,,,,,Drug: Dexamethasone,General Practitioners Research Institute|Huisartsenzorg Drenthe,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2021-02-16,01/02/22,2022-01-03,09/02/21,05/04/21,"GPRI, Groningen",Netherlands,Respiratory Diseases,1,2,321.0
3080.0,NCT04537208,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,,"Active, not recruiting",COVID-19,,,,,,,Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 1 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 1|Biological: SARS-CoV-2 vaccine formulation 2 with adjuvant 2|Biological: SARS-CoV-2 vaccine formulation 2 without adjuvant|Biological: Placebo (0.9% normal saline),"Sanofi Pasteur, a Sanofi Company|GlaxoSmithKline|Sanofi",All,"18 Years and older   (Adult, Older Adult)",440.0,Industry,Interventional,2020-03-09,01/11/21,2021-01-11,03/09/20,27/01/21,"Investigational Site Number 8400004, Birmingham, Alabama, United States|Investigational Site Number 8400012, Rolling Hills Estates, California, United States|Investigational Site Number 8400011, Hollywood, Florida, United States|Investigational Site Number 8400019, Melbourne, Florida, United States|Investigational Site Number 8400016, Boston, Massachusetts, United States|Investigational Site Number 8400002, Omaha, Nebraska, United States|Investigational Site Number 8400001, Rochester, New York, United States|Investigational Site Number 8400007, Rochester, New York, United States|Investigational Site Number 8400008, Cleveland, Ohio, United States|Investigational Site Number 8400003, Philadelphia, Pennsylvania, United States|Investigational Site Number 8400014, Mount Pleasant, South Carolina",United States,Respiratory Diseases,1,1,308.0
3081.0,NCT04373005,Screening of Cancer Patients to Assess Impact of COVID-19,,"Active, not recruiting",COVID-19,Cancer,,,,,,Diagnostic Test: Nasopharyngeal (NP) swab,"University Health Network, Toronto",All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-11-05,30/06/21,2021-06-30,04/05/20,09/09/20,"Princess Margaret Cancer Centre, Toronto, Ontario",Canada,"Respiratory Diseases, Cancers",1,2,237.0
3082.0,NCT04363372,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,,Recruiting,COVID-19,,,,,,,Drug: MRx-4DP0004|Drug: Placebo,4D pharma plc,All,"18 Years and older   (Adult, Older Adult)",90.0,Industry,Interventional,2020-01-06,01/08/20,2020-01-09,27/04/20,01/07/20,"University Hospitals Plymouth NHS Trust, Plymouth",United Kingdom,Respiratory Diseases,1,1,3.0
3083.0,NCT04468308,VRQOL in Cataract Patients During the COVID-19 Pandemic,,Recruiting,Senile Cataract,,,,,,,Other: Questionnaire,Medical University Innsbruck,All,"50 Years and older   (Adult, Older Adult)",116.0,Other,Observational,2020-08-09,01/03/21,2021-01-03,13/07/20,23/09/20,"Medical University Innsbruck, Innsbruck, Tyrol",Austria,Others,0,1,147.0
3084.0,NCT04337788,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,COVIDeHPAD,Not yet recruiting,Coronavirus Infection,,,,,,,Other: telehealth applications,"University Hospital, Limoges",All,75 Years and older   (Older Adult),200.0,Other,Interventional,2020-01-05,01/07/20,2020-01-09,08/04/20,01/06/20,,,Respiratory Diseases,1,1,4.0
3085.0,NCT04408248,AKI Biomarkers in Coronavirus(COVID)-19,,Recruiting,COVID-19,Acute Respiratory Failure,Acute Kidney Injury,,,,,,Guy's and St Thomas' NHS Foundation Trust|University Hospital Muenster,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-08-20,31/05/21,2021-06-30,29/05/20,07/12/20,"Guy's & St Thomas' Hospital, London",United Kingdom,Respiratory Diseases,1,3,314.0
3086.0,NCT04667247,Mushroom-based Product for COVID-19,MACH19,Recruiting,COVID-19,,,,,,,Drug: FoTv,"Gordon Saxe|University of California, Los Angeles|University of California, Irvine|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Interventional,2020-03-12,01/06/21,2021-01-08,14/12/20,10/03/21,"University of California, Los Angeles, Los Angeles, California, United States|University of California, San Diego, San Diego, California",United States,Respiratory Diseases,1,1,302.0
3087.0,NCT04388813,Predictors of Severe COVID-19 Outcomes,PRESCO,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,,Verily Life Sciences LLC,All,"18 Years and older   (Adult, Older Adult)",1500.0,Industry,Observational,2020-05-28,01/09/21,2021-01-10,14/05/20,01/04/21,"The University of Arizona, Tucson, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of Illinois at Chicago, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Weill Cornell Medical College, New York, New York, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Inova Health Care Services, Falls Church, Virginia",United States,Respiratory Diseases,1,2,227.0
3088.0,NCT04347226,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,,Recruiting,Solid Tumor,Sars-CoV2,Hematological Malignancy,,,,,Drug: BMS-986253,Matthew Dallos|Bristol-Myers Squibb|Columbia University,All,"18 Years and older   (Adult, Older Adult)",138.0,Other|Industry,Interventional,2020-04-16,01/09/21,2022-01-09,15/04/20,08/10/20,"Columbia University Irving Medical Center, New York, New York",United States,Respiratory Diseases,1,3,633.0
3089.0,NCT04635943,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,SAINT-PERU,Recruiting,COVID-19,Coronavirus Infection,SARS-CoV Infection,,,,,Drug: Ivermectin|Drug: Placebo,Universidad Peruana Cayetano Heredia|Barcelona Institute for Global Health,All,"18 Years to 90 Years   (Adult, Older Adult)",186.0,Other,Interventional,2020-08-29,30/04/21,2021-04-30,19/11/20,18/03/21,"Hospital Nacional Cayetano Heredia, Lima",Peru,Respiratory Diseases,1,3,244.0
3090.0,NCT04452812,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,PROMETEO,Not yet recruiting,COVID-19,Convalescent Plasma,,,,,,Biological: Convalescent plasma,"Universidad Autonoma de Coahuila|National Council of Science and Technology, Mexico",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-06-07,01/03/21,2021-01-04,30/06/20,07/07/20,"Hospital Universitario Dr. Gonzalo Valdés Valdés, Saltillo, Coahuila",Mexico,Respiratory Diseases,1,2,211.0
3091.0,NCT04649151,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",TeenCove,"Active, not recruiting",COVID-19,,,,,,,Biological: mRNA-1273|Biological: Placebo,"ModernaTX, Inc.|Biomedical Advanced Research and Development Authority",All,12 Years to 17 Years   (Child),3000.0,Industry|U.S. Fed,Interventional,2020-09-12,30/06/22,2022-06-30,02/12/20,05/03/21,"Velocity Clinical Research - Banning, Banning, California, United States|Paradigm Clinical Research, La Mesa, California, United States|Accel Research Sites - Nona Pediatric Center, DeLand, Florida, United States|Tekton Research, Chamblee, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Velocity Clinical Research - Boise, Meridian, Idaho, United States|Velocity Clinical Research - Valparaiso, Valparaiso, Indiana, United States|Johnson County Clinical Trials, Lenexa, Kansas, United States|Medpharmics - Metairie, Metairie, Louisiana, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|Clinical Research Institute, Minneapolis, Minnesota, United States|Medpharmics - Gulfport, Gulfport, Mississippi, United States|Medpharmics - Albuquerque, Albuquerque, New Mexico, United States|Child Healthcare Associates, Liverpool, New York, United States|Velocity Clinical Research - Cincinnati, Cincinnati, Ohio, United States|Lynn Health Sciences Institute, Oklahoma City, Oklahoma, United States|Velocity Clinical Research - Providence, Warwick, Rhode Island, United States|Coastal Pediatric Associates, Charleston, South Carolina, United States|Benchmark Research, Austin, Texas, United States|Crossroads Clinical Research, Corpus Christi, Texas, United States|Kool Kids Pediatrics, Houston, Texas, United States|ACRC Trials, Plano, Texas, United States|Tekton Research, San Antonio, Texas, United States|Tekton Research, San Antonio, Texas, United States|Velocity Clinical Research - Salt Lake City - Jordan Valley, West Jordan, Utah",United States,Respiratory Diseases,1,1,656.0
3092.0,NCT04778020,International COVID-19 Clinical Evaluation Registry -2 (HOPE-2),HOPE-2,Not yet recruiting,COVID-19,,,,,,,,"St Carlos Hospital, Madrid, Spain",All,"Child, Adult, Older Adult",10000.0,Other,Observational,2021-01-03,01/06/21,2022-01-01,02/03/21,05/03/21,,,Respiratory Diseases,1,1,363.0
3093.0,NCT04482647,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,,Recruiting,COVID-19,,,,,,,Other: Media Intervention|Procedure: Meditation Therapy|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Procedure: Yoga,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"up to 70 Years   (Child, Adult, Older Adult)",50.0,Other|NIH,Interventional,2020-06-17,01/07/21,2021-01-07,22/07/20,29/03/21,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,1,204.0
3094.0,NCT04542434,Niclosamide in COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Niclosamide Oral Tablet|Drug: Placebo,"First Wave Bio, Inc.",All,"18 Years and older   (Adult, Older Adult)",148.0,Industry,Interventional,2021-01-06,01/10/21,2021-01-12,09/09/20,16/02/21,,,Respiratory Diseases,1,1,6.0
3095.0,NCT04403555,Ivermectin as a Novel Therapy in COVID-19 Treatment,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,Tanta University,All,"Child, Adult, Older Adult",160.0,Other,Interventional,2020-01-06,01/12/30,2030-03-12,27/05/20,05/03/21,"Sherief Abd-Elsalam, Tanta",Egypt,Respiratory Diseases,1,1,3718.0
3096.0,NCT04649021,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b2) in Chinese Healthy Population,,"Active, not recruiting",COVID-19,,,,,,,Biological: BNT162b2|Other: Placebo,"BioNTech SE|Shanghai Fosun Pharmaceutical Development Co, Ltd.",All,"18 Years to 85 Years   (Adult, Older Adult)",950.0,Industry,Interventional,2020-04-12,01/12/21,2021-01-12,02/12/20,15/02/21,"Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu",China,Respiratory Diseases,1,1,275.0
3097.0,NCT04513990,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),END CoV-2,Recruiting,COVID-19,,,,,,,Procedure: Biospecimen Collection|Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI)|William Marsh Rice University,All,"Child, Adult, Older Adult",1500.0,Other|NIH,Interventional,2020-09-04,30/04/21,2021-04-30,14/08/20,17/08/20,"Lyndon Baines Johnson General Hospital, Houston, Texas, United States|M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,1,238.0
3098.0,NCT04812496,Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV),TEDHICOV,Completed,COVID-19,SARS-CoV Infection,Tenofovir,,,,,,Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-03,30/05/20,2021-01-15,23/03/21,25/03/21,"Hospital Nacional CASE - EsSalud, Arequipa",Peru,Respiratory Diseases,1,3,378.0
3099.0,NCT04456153,Atovaquone for Treatment of COVID-19,,Completed,COVID-19,,,,,,,Drug: Experimental Group|Drug: Placebo Group,University of Texas Southwestern Medical Center,All,"18 Years and older   (Adult, Older Adult)",61.0,Other,Interventional,2020-07-22,31/01/21,2021-01-31,02/07/20,21/02/21,"University of Texas Medical Center, Dallas, Texas",United States,Respiratory Diseases,1,1,193.0
3100.0,NCT04517123,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",PRONE,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Other: Prone Positioning,"Johns Hopkins University|Duke University|University of North Carolina|University of Miami|University of Pittsburgh|Smith & Nephew, Inc.|Nox Medical Iceland",All,"18 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-01-09,31/12/21,2021-12-31,18/08/20,12/10/20,"Johns Hopkins Univeristy, Baltimore, Maryland, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Duke University, Durham, North Carolina, United States|UPMC, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,2,722.0
3101.0,NCT04666246,Inspiratory Effort in COVID-19,PERSIA,Recruiting,Acute Respiratory Failure,COVID-19,,,,,,,University of Modena and Reggio Emilia,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-01-03,01/02/21,2022-01-02,14/12/20,14/12/20,"University Hospital of Modena, Modena",Italy,Respiratory Diseases,1,2,730.0
3102.0,NCT04321096,The Impact of Camostat Mesilate on COVID-19 Infection,CamoCO-19,"Active, not recruiting",Corona Virus Infection,,,,,,,Drug: Camostat Mesilate|Drug: Placebo oral tablet,University of Aarhus,All,"18 Years to 110 Years   (Adult, Older Adult)",580.0,Other,Interventional,2020-04-04,31/01/21,2021-01-05,25/03/20,19/01/21,"Region Hospital North Jutland, Hjørring, Region Nord, Denmark|Department of Infectious Diseases, Aalborg, Denmark|Department for Infectious Diseases, Aarhus University Hospital, Aarhus N, Denmark|Herning Regional Hospital, Herning, Denmark|Northzealands hospital - Hillerød, Hillerød, Denmark|Horsens Regional Hospital, Horsens, Denmark|Bispebjerg hospital, København, Denmark|Dept. of Infectious Diseases, Odense University Hospital, Odense, Denmark|Randers Regional Hospital, Randers, Denmark|Silkeborg Hospital, Silkeborg, Denmark|Örebro Hsopital, Örebro, Örebrolan",Sweden,Respiratory Diseases,1,1,276.0
3103.0,NCT04513184,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: IV Dexamethasone|Drug: Nasal Dexamethasone,Edda Sciutto Conde|Hospital General de México Dr. Eduardo Liceaga|Instituto Nacional de Cardiologia Ignacio Chavez|El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez|Universidad Nacional Autonoma de Mexico,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-07-14,30/03/21,2021-07-31,14/08/20,12/11/20,"Hospital General de Mexico Dr. Eduardo Liceaga, Mexico City, Cdmx, Mexico|Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Cdmx, Mexico|El Instituto Nacional de Neurologia Y Neurocirugia Manuel Velasco Suarez, Mexico City, Cdmx",Mexico,Respiratory Diseases,1,1,382.0
3104.0,NCT04756271,Safety and Immunogenicity of Inactivated Vaccine Against COVID-19 Infection,,Recruiting,Vaccine Adverse Reaction,Seroconversion,,,,,,Biological: SARS-Cov-2 neutralizing antibody titer,Zagazig University,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Interventional,2021-11-02,01/08/21,2021-01-08,16/02/21,21/02/21,"Zagazig University Faculty of Medicine, Zagazig, Sharkia",Egypt,Others,0,2,-298.0
3105.0,NCT04387240,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,,Not yet recruiting,COVID-19,Corona Virus Infection,,,,,,Drug: Artemisinin / Artesunate|Other: placebo,Princess Nourah Bint Abdulrahman University,All,18 Years to 60 Years   (Adult),22.0,Other,Interventional,2022-01-01,01/09/22,2022-01-12,13/05/20,16/03/21,"Princess Nourah Bint Abdulrahman Univeristy, Riyadh, Central",Saudi Arabia,Respiratory Diseases,1,2,11.0
3106.0,NCT04485351,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,CONFI-DIAB,Recruiting,Diabetes Mellitus,Coronavirus Infection,Metabolic Disease,Glucose Metabolism Disorders,,,,Other: no intervention,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-01-07,01/08/20,2020-01-09,24/07/20,24/07/20,"University Regional Hospital of Nancy, Nancy",France,"Respiratory Diseases, Metabolic Disorders",1,4,2.0
3107.0,NCT04705766,KIDney Injury in Times of COVID-19 (KIDCOV),KIDCOV,Recruiting,SARS-CoV Infection,COVID-19,Corona Virus Infection,Acute Kidney Injury,Kidney Injury,,,Other: Urine Collection,"University of California, San Francisco|Rush University Medical Center|University of Michigan|University of California|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other|NIH,Observational,2021-01-03,01/03/22,2022-01-03,12/01/21,18/03/21,"University of California, San Francisco, California, United States|Rush University, Chicago, Illinois, United States|University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,5,365.0
3108.0,NCT04508439,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,,Recruiting,COVID-19,Pneumonia,Coagulation Disorder,Pulmonary Embolism,,,,Drug: Enoxaparin,Hospital Regional de Alta especialidad de Ixtapaluca,All,"18 Years to 90 Years   (Adult, Older Adult)",130.0,Other,Interventional,2020-06-20,30/08/20,2020-12-30,11/08/20,11/08/20,"Hospital Regional de Alta Especialidad de Ixtapaluca, Mexico City, Ixtapaluca",Mexico,Respiratory Diseases,1,4,193.0
3109.0,NCT04794920,Post-Covid-19 Emotional Aspects of Hospital Staff,EMOCOV,"Active, not recruiting",COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",780.0,Other,Observational,2020-10-07,03/10/20,2021-05-31,12/03/21,12/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,1,236.0
3110.0,NCT04433871,COVID-19 in Pediatric Oncology and Hematology Centers in France,PEDONCOVID,Recruiting,COVID-19,Cancer,,,,,,"Other: No intervention, observational","University Hospital, Caen",All,"1 Month to 30 Years   (Child, Adult)",300.0,Other,Observational,2020-04-27,27/04/22,2023-04-27,16/06/20,16/06/20,"Jérémie Rouger-Gaudichon, Caen",France,"Respiratory Diseases, Cancers",1,2,1095.0
3111.0,NCT04557358,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in México During the COVID-19 Pandemic,,Enrolling by invitation,Rheumatoid Arthritis,Quality of Life,,,,,,Other: COVID-19 survey|Other: RAPID-3|Other: WHOQOL-BREF|Other: DASS-21 instrument (depression and anxiety)|Other: IER-R (posttraumatic stress),"National Institute of Medical Sciences and Nutrition, Salvador Zubiran",All,"18 Years and older   (Adult, Older Adult)",346.0,Other,Observational,2020-01-10,31/12/22,2022-12-31,21/09/20,25/02/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Tlalpan",Mexico,Immunological Disorders,1,2,1086.0
3112.0,NCT04370821,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",CHAMPS,Recruiting,COVID-19,COVID-19,,,,,,,Villanova University,All,"18 Years and older   (Adult, Older Adult)",20000.0,Other,Observational,2020-09-05,27/04/40,2040-04-27,01/05/20,28/09/20,"Villanova University, Villanova, Pennsylvania",United States,Respiratory Diseases,1,2,7174.0
3113.0,NCT04477473,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,,Recruiting,COVID-19,Vulnerable Subjects,Long-term Non-invasive Ventilation,,,,,Other: Questionnaire-based observational study,"University Hospital, Geneva",All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-06-30,30/07/20,2020-08-31,20/07/20,22/07/20,"Centre antituberculeux; Geneva University Hospital, Geneva, Geneva 14",Switzerland,Respiratory Diseases,1,3,62.0
3114.0,NCT04385147,Advanced Endoscopy During COVID-19,,Completed,"Cholangitis, Secondary Biliary",Cholangiocarcinoma,Obstructive Jaundice,Pancreas Cancer,COVID-19,COVID-19,,Other: Endoscopic management according to standard of care,"Al-Azhar University|Helwan University|National Liver Institute, Egypt",All,"Child, Adult, Older Adult",670.0,Other,Observational,2020-05-18,01/07/20,2020-05-07,12/05/20,08/07/20,"Kings County Hospital Center, Brooklyn, NY, USA, Albertson, New York, United States|Al-Azhar Univerisity, Cairo, Egypt|University Medicine Greifswald, Greifswald, Germany|2- Hospital Guillermo Kaelin De la Fuente - EsSalud, Lima, Peru|Singapore General Hospital, Singapore",Singapore,"Respiratory Diseases, Cancers",1,6,-11.0
3115.0,NCT04379232,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,SurgiCovid,Completed,Digestive Cancer,Gynaecological Cancer,Head and Neck Cancer,,,,,Biological: Screening test for covid ( RT PCR and CT Chest),Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",112.0,Other,Observational,2020-03-19,20/04/20,2020-04-25,07/05/20,07/05/20,"Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon",France,Cancers,1,3,37.0
3116.0,NCT04482712,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,RAPA-CARDS,Not yet recruiting,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),Respiratory Failure,Sars-CoV2,,,,,Drug: Rapamycin|Drug: Placebo,The University of Texas Health Science Center at San Antonio|Claude D. Pepper Older Americans Independence Center,All,"60 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-04,01/01/22,2023-01-01,22/07/20,09/02/21,"University Hospital System, San Antonio, Texas, United States|Audie L Murphy Memorial Veterans Hospital, San Antonio, Texas",United States,Respiratory Diseases,1,3,727.0
3117.0,NCT04357613,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,IMAGE-19,Not yet recruiting,SARS Virus,,,,,,,Drug: Experimental drug,Versailles Hospital,All,70 Years and older   (Older Adult),99.0,Other,Interventional,2020-01-09,01/12/20,2021-01-12,22/04/20,07/08/20,"CHU Bordeaux, Bordeaux, France|CH de Versailles, Le Chesnay",France,Others,0,1,369.0
3118.0,NCT04635787,Vital Sensor Monitors for CV19 Detection,,Enrolling by invitation,COVID-19,,,,,,,Device: ANNE One,Northwestern University|United States Department of Defense,All,"18 Years and older   (Adult, Older Adult)",300.0,Other|U.S. Fed,Observational,2020-05-11,30/09/22,2022-10-30,19/11/20,19/11/20,"Northwestern Memorial Hospital, Chicago, Illinois",United States,Respiratory Diseases,1,1,902.0
3119.0,NCT04803409,UNITE Study (UCSD-SW) for COVID-19,UNITE,Recruiting,COVID-19,,,,,,,Device: Splenic Ultrasound,"Imanuel Lerman|SecondWave Systems Inc.|MCDC (Unites States Department of Defense)|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2021-03-22,22/09/21,2021-01-10,17/03/21,24/03/21,"University of California San Diego, San Diego, California",United States,Respiratory Diseases,1,1,-71.0
3120.0,NCT04816669,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Lyophilized Formulation of BNT162b2 Against COVID-19 in Healthy Adults",,Recruiting,COVID-19,COVID-19,,,,,,Biological: BNT162b2,BioNTech SE|Pfizer,All,18 Years to 55 Years   (Adult),550.0,Industry,Interventional,2021-01-04,30/05/21,2021-05-30,25/03/21,12/04/21,"Anaheim Clinical Trials, LLC, Anaheim, California, United States|Diablo Clinical Research, Inc., Walnut Creek, California, United States|Indago Research & Health Center, Inc, Hialeah, Florida, United States|Research Centers of America ( Hollywood ), Hollywood, Florida, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida, United States|Clinical Neuroscience Solutions, Orlando, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|East-West Medical Research Institute, Honolulu, Hawaii, United States|Solaris Clinical Research, Meridian, Idaho, United States|Kentucky Pediatric/ Adult Research, Bardstown, Kentucky, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Amici Clinical Research LLC, Raritan, New Jersey, United States|PMG Research of Wilmington, LLC, Wilmington, North Carolina, United States|Aventiv Research Inc, Columbus, Ohio, United States|Benchmark Research, Austin, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Texas Center For Drug Development, Inc., Houston, Texas, United States|DM Clinical Research (Administrative and Storage Office only), Tomball, Texas, United States|Martin Diagnostic Clinic, Tomball, Texas, United States|J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City, Utah",United States,Respiratory Diseases,1,2,146.0
3121.0,NCT04511650,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",RESCUE,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Drug: Razuprotafib Subcutaneous Solution|Drug: Placebo Subcutaneous Solution,Aerpio Therapeutics|Medical Technology Enterprise Consortium (MTEC),All,"18 Years and older   (Adult, Older Adult)",180.0,Industry|Other,Interventional,2020-10-21,01/02/21,2021-01-02,13/08/20,17/11/20,"University of Southern California, Los Angeles, California, United States|University of California- Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Snake River Research, Idaho Falls, Idaho, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Cincinnati, Cincinnati, Ohio, United States|Rhode Island Hospital, Providence, Rhode Island",United States,Respiratory Diseases,1,2,73.0
3122.0,NCT04821570,To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment,CANINE,Recruiting,Breast Cancer,Lung Cancer,Melanoma (Skin),,,,,Biological: COVID-19 Vaccine,University of Kansas Medical Center,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-02-23,28/03/22,2023-03-28,29/03/21,29/03/21,"The University of Kansas Cancer Center, Westwood Campus, Kansas City, Kansas",United States,Cancers,1,3,763.0
3123.0,NCT04333953,COVID-19 in Patients With HIV,,Recruiting,HIV/AIDS,COVID-19,COVID-19,,,,,Other: No intervention,University of Missouri-Columbia,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-01-04,01/10/20,2020-01-10,03/04/20,07/04/20,"University of Missouri-Columbia, Columbia, Missouri",United States,Respiratory Diseases,1,3,6.0
3124.0,NCT04841681,Video-based Psychotherapy for COVID-19 Patients in Isolation Ward in Jakarta,,Completed,COVID-19,"Distress, Emotional",,,,,,Behavioral: Video-based Psychotherapy,"Indonesia University|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia",All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Interventional,2020-07-06,25/08/20,2020-08-26,12/04/21,12/04/21,"dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta",Indonesia,Respiratory Diseases,1,2,51.0
3125.0,NCT04407429,Vienna Versus SARS-CoV-2 Virus Study,VIVI,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Laboratory Analyses,Medical University of Vienna,All,"Child, Adult, Older Adult",12000.0,Other,Observational,2020-05-27,27/06/21,2021-06-27,29/05/20,29/05/20,"Medical University of Vienna, Vienna",Austria,Respiratory Diseases,1,2,396.0
3126.0,NCT04385940,Vitamin D and COVID-19 Management,,Not yet recruiting,COVID-19,,,,,,,"Dietary Supplement: Ddrops® products, 50,000 IU, Oral|Dietary Supplement: Vitamin D3",University of Alberta,All,"17 Years and older   (Child, Adult, Older Adult)",64.0,Other,Interventional,2020-01-06,01/08/20,2020-01-12,13/05/20,05/06/20,,,Respiratory Diseases,1,1,6.0
3127.0,NCT04338100,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,POCUSCO,Not yet recruiting,COVID-19,Coronavirus Infection,,,,,,Procedure: Follow-up at 14 days,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-06-04,29/12/20,2021-01-29,08/04/20,08/04/20,,,Respiratory Diseases,1,2,239.0
3128.0,NCT04425759,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),SERO-MARES,Recruiting,COVID-19,Corona Virus Infection,SARS-CoV 2,COVID-19,,,,Diagnostic Test: Blood sample,Hospital de Mataró,All,"18 Years and older   (Adult, Older Adult)",2400.0,Other,Observational,2020-08-06,30/06/21,2021-06-30,11/06/20,16/06/20,"Hospital de Mataró, Mataró, Barcelona",Spain,Respiratory Diseases,1,4,328.0
3129.0,NCT04469491,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,COV-NI,Recruiting,COVID-19,INTERFERON,NEBULIZATION,,,,,Drug: inhaled type I interferon|Drug: WFI water nebulization,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-09-20,01/09/21,2021-01-09,14/07/20,04/03/21,"CH d'Abbeville, Abbeville, France|CHU Amiens, Amiens, France|CH Compiègne-Noyon, Compiegne, France|CH de l'Arrondissement de Montreuil-sur-mer, Rang-du-Fliers, France|CH de Saint-Quentin, Saint-Quentin, France|CH de Tourcoing, Tourcoing, France|CH de valenciennes, Valenciennes",France,Respiratory Diseases,1,3,111.0
3130.0,NCT04362189,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: HB-adMSC|Drug: Placebo,Hope Biosciences|Advanced Diagnostics Healthcare|Hope Biosciences Stem Cell Research Foundation|United Memorial Medical Center,All,"Child, Adult, Older Adult",100.0,Industry|Other,Interventional,2020-06-30,31/10/21,2021-10-31,24/04/20,25/03/21,"River Oaks Hospital and Clinics, Houston, Texas, United States|United Memorial Medical Center, Houston, Texas",United States,Respiratory Diseases,1,1,488.0
3131.0,NCT04365582,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,OUTCOV,Suspended,COVID-19,,,,,,,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Lopinavir 200Mg/Ritonavir 50Mg Tab,Groupe Hospitalier Paris Saint Joseph,All,"50 Years and older   (Adult, Older Adult)",640.0,Other,Interventional,2020-07-05,31/12/20,2021-07-02,28/04/20,31/12/20,"Hôpital Privé d'Antony, Antony, France|Hôpital Avicenne, Bobigny, France|Centre Hospitalier Intercommunal de Créteil, Créteil, France|Groupe Hospitalier Paris Saint-Joseph, Paris, France|Institut Mutualiste Montsouris, Paris",France,Respiratory Diseases,1,1,362.0
3132.0,NCT04341688,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,GARGLES,Not yet recruiting,COVID-19,,,,,,,Drug: Gargle/Mouthwash,Aga Khan University|University of Karachi,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-02,30/06/21,2021-07-31,10/04/20,13/01/21,,,Respiratory Diseases,1,1,210.0
3133.0,NCT04353401,WGS Analysis of COVID-19 Positive Patients,CALYPSO,Enrolling by invitation,Coronavirus Infection,COVID-19,,,,,,,Vanda Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",5000.0,Industry,Observational,2020-03-08,01/04/21,2021-01-05,20/04/20,21/12/20,"Vanda Investigational Site, Cleveland, Ohio",United States,Respiratory Diseases,1,2,303.0
3134.0,NCT04487444,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,Ta1,Recruiting,COVID-19,,,,,,,Drug: Thymalfasin,Rhode Island Hospital,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-10-09,01/03/21,2021-01-06,27/07/20,14/09/20,"The Miriam Hospital, Providence, Rhode Island",United States,Respiratory Diseases,1,1,89.0
3135.0,NCT04561219,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,,Completed,COVID-19,Corona Virus Infection,"Pneumonia, Viral",,,,,Drug: Nitazoxanide|Drug: Placebo,"Universidade Federal do Rio de Janeiro|Ministry of Science and Technology, Brazil|National Research Council, Brazil|Financiadora de Estudos e Projetos|ATCGen|Hospital Central da Aeronáutica, Rio de Janeiro|Hospital da Força Aérea do Galeão|Hospital Naval Marcilio Dias|Hospital Universitario Pedro Ernesto|Hospital de Força Aérea de São Paulo|Hospital das Clínicas Luzia de Pinho Melo|Complexo Hospitalar Municipal de São Caetano do Sul|Hospital Municipal de Barueri Dr Francisco Moran|Hospital Regional de Sorocaba Dr Adib Domingos Jatene|Hospital Geral de São Mateus Dr Manoel Bifulco|Santa Casa de Misericórdia de Belo Horizonte|Mater Dei Hospital, Brazil|Hospital Eduardo de Menezes|Hospital das Clínicas da Universidade Federal de Pernambuco|Hospital das Forças Armadas, Brazil|Hospital Regional da Asa Norte, Brazil|Complexo Hospitalar do Trabalhador de Curitiba|Hospital Estadual de Doenças Tropicais Dr Anuar Auad|Hospital Geral de Fortaleza",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-19,02/10/20,2020-02-10,23/09/20,28/10/20,"Universidade Federal do Rio de Janeiro, Rio De Janeiro",Brazil,Respiratory Diseases,1,3,-69.0
3136.0,NCT04351789,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,PISCA,Recruiting,COVID-19,Mental Health,Psychoeducation,Anxiety,,,,Other: Psychoeducational intervention,"Copenhagen University Hospital, Hvidovre",All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Interventional,2020-01-05,01/04/23,2023-01-04,17/04/20,24/08/20,"Copenhagen University Hospital, Hvidovre, Hvidovre",Denmark,"Mental Health, Respiratory Diseases",1,4,1095.0
3137.0,NCT04319445,Mindfulness During COVID-19,,Completed,Migraine Disorders,Stress,Anxiety,,,,,Behavioral: Mindfulness session(s),Wake Forest University Health Sciences,All,"Child, Adult, Older Adult",233.0,Other,Interventional,2020-03-22,31/08/20,2021-03-30,24/03/20,01/04/21,"Wake Forest Health Sciences, Winston-Salem, North Carolina",United States,"Mental Health, Neurological Disorders",1,3,373.0
3138.0,NCT04460170,COVID-19 Follow up Intensive Care Studies,COFICS,Recruiting,Quality of Life,COVID-19,,,,,,,University Medical Center Groningen|Hanze University of Applied Sciences Groningen,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,01/02/22,2022-01-02,07/07/20,28/07/20,"University Medical Center Groningen, Groningen",Netherlands,Respiratory Diseases,1,2,726.0
3139.0,NCT04341142,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,COVID-SER,Recruiting,CoV2 Positive Caregivers,,,,,,,Diagnostic Test: Serological tests will be applied on patients blood sampling,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",550.0,Other,Interventional,2020-09-04,09/04/23,2024-09-04,10/04/20,31/07/20,"Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet, Pierre-Bénite cedex",France,Others,0,1,1461.0
3140.0,NCT04336774,CAPTION AI to Minimize Risk of COVID Exposure,CAPTION AI,Withdrawn,COVID-19,,,,,,,Device: Caption AI,"Duke University|Caption Health, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Other|Industry,Interventional,2020-01-07,01/11/20,2020-09-11,07/04/20,10/08/20,"Duke Health, Durham, North Carolina, United States|Duke University Medical Center, Durham, North Carolina",United States,Respiratory Diseases,1,1,248.0
3141.0,NCT04843930,Improving Cognitive Health in COVID-19 Survivors,,Not yet recruiting,Cognitive Dysfunction,COVID-19,,,,,,Device: AKL-T01,"Weill Medical College of Cornell University|Akili Interactive Labs, Inc.",All,"18 Years to 89 Years   (Adult, Older Adult)",125.0,Other|Industry,Interventional,2021-01-04,01/07/22,2022-01-10,14/04/21,14/04/21,"Weill Cornell Medicine, New York, New York",United States,Respiratory Diseases,1,2,371.0
3142.0,NCT04836052,Omega-3 Oil Use in COVID-19 Patients in Qatar,Omega3,Recruiting,COVID-19,,,,,,,Drug: Omega 3 fatty acid,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",372.0,Industry,Interventional,2020-12-24,24/08/21,2021-12-24,08/04/21,08/04/21,"Hamad Medical Corporation, Doha, DC",Qatar,Respiratory Diseases,1,1,365.0
3143.0,NCT04780672,Clinical Study in the Treatment of Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Molixan|Drug: Placebo,Pharma VAM,All,"18 Years to 75 Years   (Adult, Older Adult)",330.0,Other,Interventional,2021-09-03,19/08/21,2021-10-19,03/03/21,15/03/21,"Yaroslavl Regional Clinical Hospital for War Veterans - The International Center for the Elderly Healthy Longevity, Yaroslavl",Russian Federation,Respiratory Diseases,1,1,46.0
3144.0,NCT04361448,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,,Terminated,COVID-19,COVID-19,Diagnosis,Polymerase Chain Reaction,,,,Other: samling of oropharynx and nasopharynx,Jessa Hospital,All,"Child, Adult, Older Adult",30.0,Other,Interventional,2020-04-20,30/06/20,2020-06-30,24/04/20,15/02/21,"Jessa Hospital, Hasselt",Belgium,Respiratory Diseases,1,4,71.0
3145.0,NCT04368923,Management of Covid-19 Patients During Home Isolation,,"Active, not recruiting",COVID-19,,,,,,,Device: Oxygen Therapy|Procedure: Physical Therapy,Cairo University,All,21 Years to 40 Years   (Adult),60.0,Other,Interventional,2020-03-15,21/06/20,2020-06-23,30/04/20,23/06/20,"M. Sedky, Cairo",Egypt,Respiratory Diseases,1,1,100.0
3146.0,NCT04527198,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,BRAINSTEM-COV,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Brainstem Responses Assessment Sedation Score (BRASS)|Diagnostic Test: Electroencephalogram with EKG lead,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-09,01/06/21,2021-01-06,26/08/20,09/09/20,"Hôpital Cochin, Paris, France|HEGP, Paris",France,Respiratory Diseases,1,1,363.0
3147.0,NCT04351633,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,OsPsyCOVID,Completed,Sars-CoV2,Osteoporosis,,,,,,Other: questionnaire assesment,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",52.0,Other,Observational,2020-04-23,30/04/20,2020-04-30,17/04/20,11/12/20,"Hopital Roger Salengro, CHU Lille, Lille",France,Respiratory Diseases,1,2,7.0
3148.0,NCT04325919,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,,Recruiting,Coronavirus Infections,,,,,,,Other: No intervention,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",170.0,Other,Observational,2020-02-24,28/02/21,2021-06-17,30/03/20,30/03/20,"Prince of Wales Hospital, Sha Tin",Hong Kong,Respiratory Diseases,1,1,479.0
3149.0,NCT04752839,Evaluation of the Psychosocial Impact on Health Professionals Exposed During COVID 19 Coronavirus Pandemic,,Not yet recruiting,Psychological Stress,Psychosocial Impairment,Anxiety,Depression,Post Traumatic Stress Disorder,Coronavirus Infection,COVID-19,,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,All,"Child, Adult, Older Adult",300.0,Other,Observational,2021-01-02,01/03/21,2021-01-05,12/02/21,12/02/21,"Hospital de la Santa Creu i Sant Pau, Barcelona",Spain,"Mental Health, Respiratory Diseases",1,7,3.0
3150.0,NCT04374110,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,COR-CARDIO,Recruiting,COVID-19,Hypertension,Cardiovascular Diseases,Cardiovascular Risk Factor,,,,Other: Clinical data,"Institute of Cardiology, Warsaw, Poland",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-05-05,24/06/20,2021-08-24,05/05/20,06/05/20,"National Institute of Cardiology, Warsaw",Poland,"Cardiovascular Diseases, Respiratory Diseases",1,4,476.0
3151.0,NCT04431414,A Study of Immune Responses to the Virus That Causes COVID-19,CoVPN 5001,Recruiting,COVID-19,COVID-19,,,,,,Other: Sample collection,COVID-19 Prevention Network|National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years and older   (Adult, Older Adult)",800.0,Other|NIH,Observational,2020-07-20,01/09/21,2021-01-09,16/06/20,14/04/21,"Alabama CRS, Birmingham, Alabama, United States|Bridge HIV CRS, San Francisco, California, United States|University of Miami Infectious Disease Research Unit at Jackson Memorial Hospital CRS, Miami, Florida, United States|The Ponce de Leon Center CRS, Atlanta, Georgia, United States|The Hope Clinic of the Emory Vaccine Center CRS, Decatur, Georgia, United States|New Orleans Adolescent Trials Unit CRS, New Orleans, Louisiana, United States|Johns Hopkins University CRS, Baltimore, Maryland, United States|Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts, United States|Fenway Health (FH) CRS, Boston, Massachusetts, United States|New Jersey Medical School Clinical Research Center CRS, Newark, New Jersey, United States|Columbia P&S CRS, New York, New York, United States|New York Blood Center CRS, New York, New York, United States|University of Rochester Vaccines to Prevent HIV Infection CRS, Rochester, New York, United States|Chapel Hill CRS, Chapel Hill, North Carolina, United States|Case CRS, Cleveland, Ohio, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Seattle Vaccine and Prevention CRS, Seattle, Washington, United States|Fundacion Huesped CRS, Buenos Aires, Argentina|Hospital General de Agudos JM Ramos Mejía CRS, Buenos Aires, Argentina|Gaborone CRS, Gaborone, Botswana|SOM Federal University Minas Gerais Brazil NICHD CRS, Belo Horizonte, Brazil|Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil|Kisumu Crs, Kisumu, Kenya|Malawi CRS, Lilongwe, Malawi|Merida CRS, Mérida, Mexico|Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS, Maputo, Mozambique|CITBM - UNIDEC, Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales CRS, Bellavista, Peru|Asociacion Civil Selva Amazonica (ASCA) CRS, Iquitos, Peru|Barranco CRS, Lima, Peru|San Miguel CRS, Lima, Peru|Via Libre CRS, Lima, Peru|Groote Schuur HIV CRS, Cape Town, South Africa|Khayelitsha CRS / (CIDRI UCT), Cape Town, South Africa|Masiphumelele Clinical Research Site (MASI) CRS, Cape Town, South Africa|Chatsworth CRS, Chatsworth, South Africa|Botha's Hill CRS, Durban, South Africa|CAPRISA eThekwini CRS, Durban, South Africa|Vulindlela CRS, Durban, South Africa|Ndlovu Research Centre CoVPN CRS, Elandsdoorn, South Africa|Isipingo CRS, Isipingo, South Africa|Kliptown Soweto CRS, Johannesburg, South Africa|Soweto HVTN CRS, Johannesburg, South Africa|Aurum Institute Klerksdorp CRS, Klerksdorp, South Africa|Qhakaza Mbokodo Research Clinic CRS, Ladysmith, South Africa|MeCRU CRS, Medunsa, South Africa|Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa|Rustenburg CRS, Rustenburg, South Africa|Setshaba Research Centre CRS, Soshanguve, South Africa|Tembisa Clinic 4 CoVPN CRS, Tembisa, South Africa|Tongaat CRS, Tongaat, South Africa|Verulam CRS, Verulam, South Africa|National Institute for Medical Research (NIMR) - Mbeya Medical Research Center (MMRC) Network CRS, Mbeya, Tanzania|Matero Reference Clinic CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Lusaka CoVPN CRS, Lusaka, Zambia|Zambia Emory HIV Research Project - Ndola CoVPN CRS, Ndola, Zambia|St Mary's CRS, Chitungwiza, Zimbabwe|Milton Park CRS, Harare, Zimbabwe|Seke South CRS, Harare",Zimbabwe,Respiratory Diseases,1,2,173.0
3152.0,NCT04451239,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,,Not yet recruiting,Keratonjunctivitis,,,,,,,Drug: topical steroids and cyclosporin-A,"Ameera Gamal Abdelhameed|Ministry of Health, Kuwait|Mansoura University",All,"Child, Adult, Older Adult",12.0,Other,Interventional,2020-06-30,01/07/20,2020-01-07,30/06/20,30/06/20,"Farawanyia hospital, Kuwait, Farawanyia",Kuwait,Others,0,1,-175.0
3153.0,NCT04324528,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,CYCOV,Completed,Coronavirus,COVID-19,SARS-CoV Infection,Respiratory Failure,Cytokine Storm,,,Device: vv-ECMO + cytokine adsorption (Cytosorb adsorber)|Device: vv-ECMO only (no cytokine adsorption),Dr. Alexander Supady|University Hospital Freiburg,All,"18 Years to 100 Years   (Adult, Older Adult)",34.0,Other,Interventional,2020-03-27,27/01/21,2021-01-27,27/03/20,15/03/21,"University Clinic Freiburg, Freiburg",Germany,Respiratory Diseases,1,5,306.0
3154.0,NCT04673292,Community Collaboration to Combat COVID-19 (C-FORWARD),,Enrolling by invitation,Coronavirus Infection,,,,,,,"Behavioral: Fixed site standard of care testing|Behavioral: Community-based, mobile van testing|Behavioral: Self-collected, home-based testing",Johns Hopkins University|National Institute of Allergy and Infectious Diseases (NIAID),All,"5 Years and older   (Child, Adult, Older Adult)",3000.0,Other|NIH,Interventional,2021-08-02,01/08/21,2021-01-08,17/12/20,18/02/21,"2212 McElderry Street, Baltimore, Maryland",United States,Respiratory Diseases,1,1,-206.0
3155.0,NCT04423978,Implications of Covid-19 on the Lifestyle Changes,,Completed,COVID-19,,,,,,,,Azienda Unità Sanitaria Locale Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",1826.0,Other,Observational,2020-04-05,15/06/20,2020-06-15,09/06/20,20/07/20,"Elisa Mazzini, Reggio Emilia",Italy,Respiratory Diseases,1,1,71.0
3156.0,NCT04377165,Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities,,Terminated,COVID-19,Influenza,Gastroenteritis,,,,,Behavioral: Gamification|Behavioral: Newsfeed function,The University of Queensland,All,"18 Years to 90 Years   (Adult, Older Adult)",34.0,Other,Interventional,2020-06-05,26/08/20,2020-08-26,06/05/20,09/03/21,,,"Infectious Diseases, Respiratory Diseases",1,3,82.0
3157.0,NCT04426006,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic,PRO-SERO-COV,"Active, not recruiting",Sars-CoV2,Serum; Disease,,,,,,Other: PRO-SERO-COV,Institut Bergonié,All,"18 Years and older   (Adult, Older Adult)",550.0,Other,Interventional,2020-01-06,01/06/21,2021-01-12,11/06/20,30/11/20,"Institut Bergonié, Bordeaux",France,Respiratory Diseases,1,2,372.0
3158.0,NCT04354714,Ruxolitinib to Combat COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Ruxolitinib|Procedure: Peripheral blood draw,Washington University School of Medicine|Incyte Corporation,All,"18 Years and older   (Adult, Older Adult)",0.0,Other|Industry,Interventional,2020-06-30,31/07/21,2021-12-31,21/04/20,21/05/20,,,Respiratory Diseases,1,1,549.0
3159.0,NCT04422561,Prophylactic Ivermectin in COVID-19 Contacts,,Completed,COVID-19,,,,,,,Drug: Ivermectin Tablets,Zagazig University,All,"16 Years to 70 Years   (Child, Adult, Older Adult)",340.0,Other,Interventional,2020-05-31,14/07/20,2020-07-27,09/06/20,27/08/20,"Zagazig University, Zagazig, Sharkia",Egypt,Respiratory Diseases,1,1,57.0
3160.0,NCT04455347,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,CARDOVID,Recruiting,COVID-19,,,,,,,,Imagine Institute,All,"up to 20 Years   (Child, Adult)",80.0,Other,Observational,2020-06-15,01/06/22,2022-01-06,02/07/20,02/07/20,"Hôpital Necker, Paris",France,Respiratory Diseases,1,1,570.0
3161.0,NCT04491214,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),,Completed,COVID-19,Follow up,Rehabilitation,,,,,Other: quality of live assessment,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",112.0,Other,Observational,2020-07-24,21/01/21,2021-01-21,29/07/20,12/02/21,"Hôpitaux Universitaires de Strasbourg (Nouvel Hôpital Civil), Strasbourg",France,Respiratory Diseases,1,3,181.0
3162.0,NCT04746521,Cellular-Mediated Immunity in COVID-19,DEMETRA,Recruiting,COVID-19,,,,,,,Diagnostic Test: Multitest 6 color TBNK and BD Lyotubes,"University of Campania ""Luigi Vanvitelli""",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-03,01/01/22,2022-01-12,09/02/21,10/02/21,"U.O.C. Division of Clinical Immunology, Immunohematology, Transfusion Medicine and Transplant Immunology, Regional Reference Laboratory of Transplant Immunology, Department of Internal and Specialty Medicine, A.O.U., UniversityofCampania Luigi Vanvitelli, Napoli",Italy,Respiratory Diseases,1,1,374.0
3163.0,NCT04529421,Assocation Between In-person Instruction and COVID-19 Risk,Campus&Corona,Enrolling by invitation,Infection,Infection Control,,,,,,Behavioral: Online instruction|Behavioral: In-person instruction,Oslo Metropolitan University|Norwegian Institute of Public Health,All,"18 Years and older   (Adult, Older Adult)",70000.0,Other,Observational,2020-04-09,31/12/20,2021-01-08,27/08/20,03/03/21,"Oslo Metropolitan University, Oslo",Norway,Others,0,2,274.0
3164.0,NCT04629105,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),RECOVER,Recruiting,"ARDS, Human",COVID-19,,,,,,Biological: Longeveron Mesenchymal Stem Cells (LMSCs)|Other: Placebo,Longeveron LLC,All,"18 Years and older   (Adult, Older Adult)",70.0,Industry,Interventional,2020-07-24,01/08/21,2025-01-07,16/11/20,16/11/20,"Miami VA Healthcare System, Miami, Florida, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina",United States,Respiratory Diseases,1,2,1628.0
3165.0,NCT04711863,Fluvoxamine for Adults With Mild to Moderate COVID-19,,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,Coronavirus Infection,COVID-19,,,,,Drug: Fluvoxamine|Drug: Placebo,Asan Medical Center,All,"18 Years to 85 Years   (Adult, Older Adult)",400.0,Other,Interventional,2021-01-16,31/05/21,2021-07-31,15/01/21,20/01/21,"Asan Medical Center, Seoul, Korea",Republic of,Respiratory Diseases,1,3,196.0
3166.0,NCT04750369,Enhanced Triage for COVID-19,ETC-19,Recruiting,COVID-19,SARS-CoV 2,,,,,,,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-04,31/03/21,2021-03-31,11/02/21,11/02/21,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,2,452.0
3167.0,NCT04681079,Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: albuterol sulfate (MDI)|Drug: albuterol sulfate (nebulizer),Theravance Biopharma,All,"18 Years and older   (Adult, Older Adult)",10.0,Industry,Observational,2021-01-02,01/04/21,2021-01-04,23/12/20,02/03/21,"Theravance Biopharma Investigational Site, Kansas City, Kansas",United States,Respiratory Diseases,1,1,2.0
3168.0,NCT04330638,Treatment of COVID-19 Patients With Anti-interleukin Drugs,COV-AID,"Active, not recruiting",COVID-19,,,,,,,Other: Usual Care|Drug: Anakinra|Drug: Siltuximab|Drug: Tocilizumab,"University Hospital, Ghent|Belgium Health Care Knowledge Centre",All,"18 Years and older   (Adult, Older Adult)",342.0,Other,Interventional,2020-03-04,18/12/20,2021-12-04,01/04/20,02/03/21,"AZ Sint-Jan Brugge, Brugge, Belgium|University Hospital Saint-Pierre, Brussels, Belgium|Erasmus University Hospital, Brussels, Belgium|University Hospital Saint-Luc, Brussels, Belgium|University Hospital Antwerp, Edegem, Belgium|Ziekenhuis Oost-Limurg, Genk, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jessa ZH, Hasselt, Belgium|University Hospital Brussels, Jette, Belgium|CHU Tivoli, La Louvière, Belgium|CHR de la Citadelle, Liège, Belgium|University Hospital Liège, Liège, Belgium|Cliniques Saint-Pierre Ottignies, Ottignies-Louvain-la-Neuve, Belgium|AZ Delta, Roeselare",Belgium,Respiratory Diseases,1,1,640.0
3169.0,NCT04441372,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,PRIORITISE,Recruiting,SARS-CoV2,COVID-19,,,,,,,"Medecins Sans Frontieres, Spain|Mahidol Oxford Tropical Medicine Research Unit (MORU)|International Centre for Diarrhoeal Disease Research, Bangladesh|Foundation for Innovative New Diagnostics, Switzerland",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-01-10,01/05/21,2021-01-05,22/06/20,26/02/21,"All India Institute of Medical Sciences Patna (AIIMS), Patna, Bihar, India|Christian Medical College, Vellore, Vellore, Tamil Nadu",India,Respiratory Diseases,1,2,361.0
3170.0,NCT04425031,Handling Oxygenation Targets in COVID-19,HOT-COVID,Recruiting,Hypoxemic Respiratory Failure,Oxygen Toxicity,,,,,,Drug: Oxygen,"Aalborg University Hospital|Rigshospitalet, Denmark|Copenhagen Trial Unit, Center for Clinical Intervention Research",All,"18 Years and older   (Adult, Older Adult)",780.0,Other,Interventional,2020-08-25,01/12/22,2024-01-03,11/06/20,14/09/20,"Dept. of Intensive Care, Aalborg University Hospital, Aalborg, Denmark|Dept. of Intensive Care 4131, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Herlev Hospital, Herlev, Denmark|Dept. of Intensive Care, Hillerød Hospital, Hillerød, Denmark|Dept. of Intensive Care, Holbæk Hospital, Holbæk, Denmark|Dept. of Intensive Care, Kolding Hospital, Kolding, Denmark|Dept. of Intensive Care, Køge Hospital, Køge, Denmark|Dept. of Intensive Care, Slagelse Hospital, Slagelse",Denmark,Respiratory Diseases,1,2,1226.0
3171.0,NCT04619693,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,CortiCORONA,Recruiting,"Pneumonia, Viral",SARS-Cov-2,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-11-18,18/09/21,2021-09-18,06/11/20,14/01/21,"Clinique du Parc, Montpellier, France|University Hospitals of Montpellier, Montpellier",France,Respiratory Diseases,1,2,304.0
3172.0,NCT04363736,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,MARIPOSA,Completed,COVID-19,,,,,,,Drug: Tociliuzumab,Hoffmann-La Roche,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-05-05,12/08/20,2020-12-08,27/04/20,11/09/20,"Mayo Clinic - Arizona, Phoenix, Arizona, United States|St. Jude Medical Center, Fullerton, California, United States|LAC + USC Medical Center, Los Angeles, California, United States|USC Keck Medical Center of USC, Los Angeles, California, United States|Norwalk Hospital, Norwalk, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Mayo Clinic, Jacksonville, Florida, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|MedPharmics, Metairie, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Renown Institute for Heart & Vascular Health, Reno, Nevada, United States|St Joseph's Regional Medical Center, Wayne, New Jersey, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Vassar Brothers Medical Center, Poughkeepsie, New York, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Houston Methodist Hospital, Houston, Texas, United States|Michael E. DeBakey VA Medical Center, Houston, Texas, United States|Houston Methodist Sugar Land Hospital, Sugar Land, Texas",United States,Respiratory Diseases,1,1,217.0
3173.0,NCT04731116,Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection,,Recruiting,COVID-19,,,,,,,Drug: Cannabidiol,Rabin Medical Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-10-01,31/12/21,2022-04-30,29/01/21,29/01/21,"Rabin Medical Center, Petach Tikva",Israel,Respiratory Diseases,1,1,211.0
3174.0,NCT04407468,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,APRONOX,Completed,COVID-19,ARDS,Pneumonia,,,,,Procedure: Prone position,Hospital General San Juan del Rio|Instituto Nacional de Cancerologia de Mexico,All,"18 Years and older   (Adult, Older Adult)",827.0,Other,Observational,2020-01-05,13/07/20,2020-07-13,29/05/20,15/07/20,"Hospital Materno Celaya, Celaya, Guanajuato, Mexico|Hospital Santo Tomas, Querétaro City, Queretaro, Mexico|Hospital General San Juan del Rio, Querétaro City, Queretaro, Mexico|ISSSTE Hospital Regional Merida, Mérida, Yucatan, Mexico|Hospital General de Zona 48 San PEDRO Xalpa IMSS, Estado De México, Mexico|Hospital Fernando Quiroz Gutierrez, Mexico City",Mexico,Respiratory Diseases,1,3,190.0
3175.0,NCT04588480,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",,"Active, not recruiting",COVID-19,COVID-19,,,,,,Biological: BNT162b2|Other: Placebo,BioNTech SE|Pfizer,All,"20 Years to 85 Years   (Adult, Older Adult)",160.0,Industry,Interventional,2020-10-21,30/11/21,2021-11-30,19/10/20,19/03/21,"SOUSEIKAI Sumida Hospital, Sumida-ku, Tokyo, Japan|SOUSEIKAI PS Clinic, Fukuoka",Japan,Respiratory Diseases,1,2,405.0
3176.0,NCT04826822,Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19,SPIDEX-II,Recruiting,Coronavirus Infection,"Pneumonia, Viral",,,,,,Drug: Spironolactone + Dexamethasone|Drug: Standard-of-care SARS-CoV-2 treatment,Chita State Regional Clinical Hospital Number 1,All,"18 Years and older   (Adult, Older Adult)",440.0,Other,Interventional,2021-02-24,08/07/21,2021-02-09,01/04/21,01/04/21,"Chita State Regional Clinical Hospital Number 1, Chita",Russian Federation,Respiratory Diseases,1,2,-15.0
3177.0,NCT04394442,Hydroxychloroquine in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine,Samah Lutfy|Zagazig University,All,"18 Years to 70 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-21,01/08/20,2020-01-08,19/05/20,19/05/20,"SNH, Mecca",Saudi Arabia,Respiratory Diseases,1,1,-73.0
3178.0,NCT04517630,Renal Biomarkers in AKI and COVID-19,,Recruiting,Coronavirus Infection,COVID-19,SARS (Severe Acute Respiratory Syndrome),AKI,,,,"Diagnostic Test: urinary NGAL, TIMP-2, IGFBP7, IL-6, viral load and metabolomic",Instituto Nacional de Enfermedades Respiratorias,All,"18 Years to 70 Years   (Adult, Older Adult)",90.0,Other,Observational,2020-01-06,30/09/21,2022-09-30,18/08/20,09/02/21,"Centro de Investigacion en Enfermedades Infecciosas, Mexico City",Mexico,Respiratory Diseases,1,4,998.0
3179.0,NCT04324463,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,ACTCOVID19,Recruiting,Coronavirus,Severe Acute Respiratory Syndrome,,,,,,Drug: Colchicine|Drug: Interferon-Beta|Drug: Aspirin|Drug: Rivaroxaban,Population Health Research Institute|Bayer,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other|Industry,Interventional,2020-04-21,31/12/20,2021-06-30,27/03/20,08/10/20,"Prodal Saude S/A, Salvador, BA, Brazil|Hospital das Clinicas de Vitoria (Hospital Universitario Cassiano Antonio Moraes), Vitoria, ES, Brazil|Hospital das Clinicas da Universidade Federal de Goias, Goiania, GO, Brazil|Ubermed Serviços em Saúde Eireli - Hospital São Domingos, Uberaba, MG, Brazil|Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, MG, Brazil|Hospital Universitario Julio Muller, Cuiabá, Mount, Brazil|Hospital Universitario da UFPI - Filial EBSERH, Teresina, PI, Brazil|Hospital Universitario Gaffree e Guinle, Rio de Janeiro, RJ, Brazil|Hospital Universitario Prof. Dr. Horacio Carlos Panepucci da Universidade Federal de Sao Carlos (HU-UFSCar), São Carlos, SP, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil|Hospital de Doencas Tropicais - HDT/UFT, Araguaina, TO, Brazil|Hamilton Health Sciences, Hamilton, Ontario, Canada|London Health Sciences Centre, London, Ontario, Canada|CIUSSS de L'est-de-l'ile de Montreal, Hopital Maisonneuve-Rosemont, Montreal, Ontario, Canada|Southlake Regional Health Centre, Newmarket, Ontario, Canada|Halton Healthcare/Oakville Trafalgar Memorial Hospital, Oakville, Ontario, Canada|Niagara Health System-St. Catharine's, St. Catharines, Ontario, Canada|Toronto Western Hospital Family Health Team, Toronto, Ontario, Canada|Windsor Regional Hospital, Windsor, Ontario, Canada|Woodstock Hospital, Woodstock, Ontario, Canada|Estudios Clinicos Barros Luco Spa, Santiago, Region Metropolitana, Chile|Hospital El Pino, Santiago, Region Metropolitana, Chile|Biomelab SAS, Barranquilla, Atlantico, Colombia|Clinica de la Costa LTDA, Barranquilla, Atlantico, Colombia|Hospital Universidad del Norte, Barranquilla, Atlantico, Colombia|Centro de Diagnostico Cardiologico, Cartagena, Bolivar, Colombia|Clinica de Marly - Sede UniMarly, Bogota, Cundinamarca, Colombia|Fundacion Cometa, Pasto, Narino, Colombia|Fundacion Cardiomet CEQUIN, Armenia, Quindio, Colombia|Fundacion Oftalmologica de Santander - FOSCAL, Bucaramanga, Santander, Colombia|Fundacion Centro de Investigaciones Biomedicas Riescard, El Espinal, Tolima, Colombia|Clinica Internacional La Misericordia, Barranquilla, Colombia|Unicormed, Guayaquil, Guayas, Ecuador|Hospital de Especialidades Eugenio Espejo, Quito, Pichincha, Ecuador|Hospital Enrique Garces, Quito, Pichincha, Ecuador|Hospital General Docente de Calderon, Quito, Pichincha, Ecuador|Hospital General Pablo Arturo Suarez, Quito, Pichincha, Ecuador|Giza Chest Hospital, Giza, Cairo, Egypt|Al Rajhi University Hospital, Assiut, Egypt|Abbasia Chest Hospital, Cairo, Egypt|Abbasia Fever Hospital, Cairo, Egypt|National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt|Fayoum General Hospital, Fayoum, Egypt|Fayoum University Hospital, Fayoum, Egypt|CIMS Hospital, Ahmedabad, Gujarat, India|City Plus Hospital, Ahmedabad, Gujarat, India|Sanjivani Hospital, Ahmedabad, Gujarat, India|GMERS Medical College & Hospital, Vadodara, Gujarat, India|Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, Haryana, India|Mazumdar Shaw Medical Centre a Unit of Narayana, Bangalore, Karnataka, India|Bharathi Hospital and Research Center, Pune, Maharashtra, India|Sidhu Hospital Pvt.Ltd, Doraha, Punjab, India|Vijaya Medical & Educational Trust, Chennai, Tamil Nadu, India|SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, India|AIG Hospital, Hyderabad, Telangana, India|KIMS, Hyderabad, Telangana, India|Mahavir Hospital & Research Centre, Hyderabad, Telangana, India|Jinnah Postgraduate Medical Center, Karachi, Pakistan|Tabba Heart Institute, Karachi, Pakistan|Philippine General Hospital, Manila, Metro Manila, Philippines|Altai Regional Center for Medical Prevention, Barnaul, Russian Federation|Altai Regional Hospital for War Veterans, Barnaul, Russian Federation|City Clinical Hospital No. 15 named after O.M. Filatova, Moscow, Russian Federation|National Medical Research Center for Therapy and Preventive Medicine, Moscow, Russian Federation|City Clinical Hospital No. 10, Nizhny Novgorod, Russian Federation|City Clinical Hospital No. 3, Nizhny Novgorod, Russian Federation|Rostov State Medical University, Rostov-on-Don, Russian Federation|King Saud Medical City, Riyadh, Saudi Arabia|Thumbay Hospital Dubai, Al Qusais, Dubai, United Arab Emirates|Hatta Hospital, Hatta, Dubai, United Arab Emirates|Rashid Hospital, Dubai Health Authority, Umm Hurair, Dubai",United Arab Emirates,Respiratory Diseases,1,2,435.0
3180.0,NCT04818320,Favipiravir in High-risk COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir,"Penang Hospital, Malaysia|Enche' Besar Hajjah Khalsom Hospital|Jasin Hospital|Kepala Batas Hospital|Melaka Hospital|Permai Hospital|Queen Elizabeth Hospital|Raja Perempuan Zainab II Hospital|Raja Permaisuri Bainun Hospital|Sultanah Aminah Hospital|Sultanah Nur Zahirah Hospital|Sungai Buloh Hospital|Tampin Hospital|Tengku Ampuan Afzan Hospital|Tuanku Fauziah Hospital|Tuanku Jaafar Hospital|Tumpat Hospital|Institute for Clinical Research",All,"50 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2021-02-16,31/08/21,2021-12-31,26/03/21,06/04/21,"Penang General Hospital, George Town, Pulau Pinang",Malaysia,Respiratory Diseases,1,1,318.0
3181.0,NCT04359277,A Randomized Trial of Anticoagulation Strategies in COVID-19,,Terminated,COVID-19,,,,,,,Drug: Enoxaparin Higher Dose|Drug: Lower-dose prophylactic anticoagulation,NYU Langone Health,All,"18 Years to 75 Years   (Adult, Older Adult)",77.0,Other,Interventional,2020-04-21,20/09/20,2020-09-20,24/04/20,08/10/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,152.0
3182.0,NCT04649333,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,,Completed,COVID-19,,,,,,,,Medical University Innsbruck|Universitaet Innsbruck,All,"18 Years and older   (Adult, Older Adult)",1336.0,Other,Observational,2020-06-15,31/08/20,2020-08-31,02/12/20,04/12/20,"Medical University Innsbruck, Innsbruck, Tyrol",Austria,Respiratory Diseases,1,1,77.0
3183.0,NCT04334460,Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,,"Active, not recruiting",Sars-CoV-2,COVID-19,,,,,,Drug: BLD-2660,Blade Therapeutics|Clinipace Worldwide,All,"18 Years and older   (Adult, Older Adult)",120.0,Industry,Interventional,2020-04-05,11/11/20,2021-01-11,06/04/20,23/02/21,"Blade Research Site, Irvine, California, United States|Blade Research Site, Los Angeles, California, United States|Blade Reseach Site, San Jose, California, United States|Blade Research Site, Washington, District of Columbia, United States|Blade Research Site, Washington, District of Columbia, United States|Blade Research Site, Brandon, Florida, United States|Blade Research Site, Fort Pierce, Florida, United States|Blade Research Site, Panama City, Florida, United States|Blade Research Site, Tampa, Florida, United States|Blade Research Site, Idaho Falls, Idaho, United States|Blade Research Site, Peoria, Illinois, United States|Blade Research Site, Ames, Iowa, United States|Blade Research Site, Lexington, Kentucky, United States|Blade Research Site, Louisville, Kentucky, United States|Blade Research Site, Baltimore, Maryland, United States|Blade Research Site, Detroit, Michigan, United States|Blade Research Site, Farmington Hills, Michigan, United States|Blade Research Site, Omaha, Nebraska, United States|Blade Research Site, Ridgewood, New Jersey, United States|Blade Research Site, Charleston, North Carolina, United States|Blade Research Site, Durham, North Carolina, United States|Blade Research Site, Fayetteville, North Carolina, United States|Blade Research Site, Philadelphia, Pennsylvania, United States|Blade Research Site, Charleston, South Carolina, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Blade Research Site, Dallas, Texas, United States|Blade Research Site, Spokane, Washington, United States|Blade Research Site, Campinas, Sao Paulo, Brazil|Blade Research Site, Bahia, Brazil|Blade Research Site, Belo Horizonte, Brazil|Blade Research Site, Botucatu, Brazil|Blade Research Site, Porto Velho, Brazil|Blade Research Site, Ribeirão Preto, Brazil|Blade Research Site, São José Do Rio Preto, Brazil|Blade Research Site, Vitória",Brazil,Respiratory Diseases,1,2,281.0
3184.0,NCT04406532,Home-Based Covid-19 Rehabilitation Program,,Not yet recruiting,COVID-19,,,,,,,Behavioral: PT-Pal|Behavioral: Self-guided exercises,Albert Einstein College of Medicine,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-05,01/01/22,2022-01-03,28/05/20,04/03/21,,,Respiratory Diseases,1,1,363.0
3185.0,NCT04534790,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,,Completed,COVID-19,,,,,,,Radiation: Low Dose Radiotherapy,Instituto Mexicano del Seguro Social,All,"18 Years to 100 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-24,12/12/20,2021-08-01,01/09/20,09/02/21,"Social Secure Mexican Institute, Leon, Guanajuato",Mexico,Respiratory Diseases,1,1,373.0
3186.0,NCT04427566,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,VENTED,Recruiting,COVID-19,,,,,,,Radiation: Radiation therapy,Ohio State University Comprehensive Cancer Center,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2020-07-23,31/12/21,2021-12-31,11/06/20,15/03/21,"Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus, Ohio",United States,Respiratory Diseases,1,1,526.0
3187.0,NCT04351347,The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,Tanta University,All,"Child, Adult, Older Adult",300.0,Other,Interventional,2020-06-16,01/12/30,2030-01-12,17/04/20,10/03/21,"Tanta University, Tanta",Egypt,Respiratory Diseases,1,1,3497.0
3188.0,NCT04693052,Attitudes Towards Receiving Mental Health Care Using Telehealth During the COVID-19 Pandemic,,Enrolling by invitation,Psychiatric Disorder,Mental Health Disorder,Stress,Adjustment Disorders,,,,Other: No interventions,Northwestern University,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-10-12,01/02/21,2021-06-30,05/01/21,05/01/21,"Feinberg School of Medicine, Chicago, Illinois",United States,Mental Health,1,4,261.0
3189.0,NCT04485364,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,BIOCOVID,"Active, not recruiting",Coronavirus,COVID-19,,,,,,,Groupe Hospitalier Paris Saint Joseph|Versailles Hospital|Centre Hospitalier Victor Dupouy,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-14,14/04/20,2020-10-31,24/07/20,24/07/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,2,200.0
3190.0,NCT04380376,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,MICOV,Recruiting,COVID-19,Viral Pneumonia,,,,,,Drug: Melphalan|Other: Standard of care,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute|Medsi Clinic #1, Moscow|Moscow State University of Medicine and Dentistry",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-30,30/10/20,2020-10-30,08/05/20,12/05/20,"Kirill Zykov, Moscow, Russian Federation|Clinical hospital, Moscow",Russian Federation,Respiratory Diseases,1,2,183.0
3191.0,NCT04477642,Abatacept for Patients With COVID-19 and Respiratory Distress,,Withdrawn,COVID-19,,,,,,,Drug: Abatacept,Beth Israel Deaconess Medical Center|Boston Children's Hospital|Bristol-Myers Squibb|Brigham and Women's Hospital,All,"18 Years and older   (Adult, Older Adult)",0.0,Other|Industry,Interventional,2020-01-08,01/10/20,2020-01-12,20/07/20,20/07/20,"Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Boston Children's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,4.0
3192.0,NCT04746339,Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19,APOLLO,Recruiting,COVID-19,Thrombosis,,,,,,Drug: Apixaban 2.5 MG|Drug: Placebo,Brazilian Clinical Research Institute|Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Hospital Alemão Oswaldo Cruz|Beneficência Portuguesa de São Paulo|Brazilian Research In Intensive Care Network,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-04-03,01/08/21,2021-01-12,09/02/21,17/03/21,"Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Hospital Israelita Albert Einstein, São Paulo, SP, Brazil|Hospital Universitário São Francisco de Assis, Bragança Paulista, São Paulo, Brazil|Hospital Santa Paula, São Paulo",Brazil,Respiratory Diseases,1,2,-81.0
3193.0,NCT04355247,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,,Recruiting,COVID-19,,,,,,,Drug: MethylPREDNISolone 80 Mg/mL Injectable Suspension,Auxilio Mutuo Cancer Center,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-14,31/07/20,2021-04-30,21/04/20,21/04/20,"San Juan City Hospital / Puerto Rico Medical Center, San Juan, Puerto Rico|Hospital Auxilio Mutuo Cancer Center, San Juan",Puerto Rico,Respiratory Diseases,1,1,381.0
3194.0,NCT04390217,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,,Not yet recruiting,COVID-19,Coronavirus Disease 2019,COVID-19,COVID-19,,,,Drug: LB1148|Drug: Placebo,"Leading BioSciences, Inc",All,"18 Years and older   (Adult, Older Adult)",120.0,Industry,Interventional,2021-10-31,31/12/21,2022-03-31,15/05/20,18/02/21,,,Respiratory Diseases,1,4,151.0
3195.0,NCT04420390,Low Dose Radiotherapy for COVID-19 Pneumonitis,LOWRAD-Cov19,Recruiting,COVID-19,,,,,,,Radiation: Radiotherapy,"Hospital San Carlos, Madrid",All,"60 Years and older   (Adult, Older Adult)",41.0,Other,Interventional,2020-01-05,31/07/20,2020-08-09,09/06/20,09/06/20,"Servicio de Oncología Radioterápica. Hospital Clínico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,217.0
3196.0,NCT04370782,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin|Drug: Zinc Sulfate|Drug: Doxycycline,"St. Francis Hospital, New York",All,"30 Years and older   (Adult, Older Adult)",18.0,Other,Interventional,2020-04-28,30/09/20,2020-09-30,01/05/20,09/12/20,"St Francis Hospital, Roslyn, New York",United States,Respiratory Diseases,1,1,155.0
3197.0,NCT04330521,Impact of the Coronavirus (COVID-19) on Patients With Cancer,,Recruiting,Cancer,COVID-19,,,,,,,Stanford University,All,"18 Years to 99 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-08-04,01/05/22,2022-01-05,01/04/20,24/08/20,"Stanford University School of Medicine, Stanford, California",United States,"Respiratory Diseases, Cancers",1,2,519.0
3198.0,NCT04407923,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,RHUMAJICOVID,Recruiting,Juvenile Idiopathic Arthritis,COVID-19,Treatment,,,,,,"University Hospital, Brest",All,up to 17 Years   (Child),150.0,Other,Observational,2020-05-25,25/11/20,2020-11-25,29/05/20,29/05/20,"CH de Belfort, Belfort, France|CHU de Bordeaux, Bordeaux, France|CHRU de Brest, Brest, France|AP-HP Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France|CHU de Poitiers, Poitiers, France|CHU de Rennes, Rennes, France|CHU de Strasbourg, Strasbourg, France|CHU de Nancy, Vandœuvre les Nancy",France,Respiratory Diseases,1,3,184.0
3199.0,NCT04376840,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,,Recruiting,Severe SARS-CoV2 Pneumonia,,,,,,,Other: Blood sample and data record,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",270.0,Other,Interventional,2020-05-28,28/01/22,2022-10-28,06/05/20,30/11/20,"Damien JOLLY, Reims",France,Respiratory Diseases,1,1,883.0
3200.0,NCT04615871,Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,SEMPATICO,Not yet recruiting,COVID-19,Myocardial Injury,,,,,,Drug: semaglutide,"Vladimír Džavík|Unity Health Toronto|Canadian Institutes of Health Research (CIHR)|University of Toronto|University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-11-30,31/12/21,2022-03-31,04/11/20,04/11/20,"Instituto Prevent Senior, São Paulo, Brazil|State University of Campinas, São Paulo, Brazil|Trillium Health Partners, Mississauga, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|University Health Network - Peter Munk Cardiac Centre, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Hospital de Infectologia, Mexico City, Mexico|Hospital General Regional, Mexico City, Mexico|Hospital Regional 2, Querétaro, Mexico|Sandwell and West Birmingham NHS Trust, Birmingham",United Kingdom,Respiratory Diseases,1,2,486.0
3201.0,NCT04366323,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,,"Active, not recruiting",Sars-CoV2,,,,,,,Drug: ALLOGENEIC AND EXPANDED ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS,Andalusian Network for Design and Translation of Advanced Therapies,All,"18 Years to 80 Years   (Adult, Older Adult)",26.0,Other,Interventional,2020-04-27,01/10/21,2021-01-10,28/04/20,30/11/20,"Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Cádiz, Spain|Hospital Reina Sofía, Córdoba, Spain|Hospital Universitario Virgen de las Nieves, Granada, Spain|Hospital Universitario Virgen Macarena, Sevilla, Spain|Hospital Unversitario Virgen del Rocío, Sevilla, Spain|Hospital Nuestra Señora de Valme, Sevilla",Spain,Respiratory Diseases,1,1,258.0
3202.0,NCT04355507,Computed Tomography for COVID-19 Diagnosis,STOIC,Completed,COVID-19,,,,,,,Diagnostic Test: Chest computed tomography (CT)|Diagnostic Test: Reverse-transcription polymerase chain reaction (RT-PCR),"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France|GE Healthcare|Orange healthcare|TheraPanacea",All,"18 Years and older   (Adult, Older Adult)",10735.0,Other|Industry,Observational,2020-01-03,16/10/20,2020-10-16,21/04/20,21/12/20,"Cochin Hospital, Paris",France,Respiratory Diseases,1,1,287.0
3203.0,NCT04335071,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),CORON-ACT,Terminated,COVID-19,,,,,,,Drug: Tocilizumab (TCZ)|Drug: Placebo,"University Hospital Inselspital, Berne|Roche Pharma AG",All,"30 Years to 80 Years   (Adult, Older Adult)",5.0,Other|Industry,Interventional,2020-04-26,27/09/20,2020-09-27,06/04/20,14/10/20,"University Hospital Bern (Inselspital), Bern, Switzerland|Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano (EOC), Viganello, Switzerland|University Hospital Zurich, Zurich",Switzerland,Respiratory Diseases,1,1,154.0
3204.0,NCT04532554,Growth Hormone in Obese Cases With Covid-19,,Withdrawn,COVID-19,,,,,,,Drug: Growth Hormone|Drug: Placebo,ClinAmygate,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-10-26,10/12/20,2020-12-20,31/08/20,16/09/20,"Asalam, Maadi, Cairo",Egypt,Respiratory Diseases,1,1,55.0
3205.0,NCT04403607,Cardiac Imaging in SARS-CoV-2 (COVID-19),CISCO-19,Recruiting,COVID-19,,,,,,,,NHS Greater Glasgow and Clyde|University of Glasgow,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Observational,2020-05-22,30/09/20,2021-01-08,27/05/20,06/08/20,"Royal Alexandra Hospital, Paisley, Renfrewshire, United Kingdom|Royal Infirmary, Glasgow, United Kingdom|Queen Elizabeth University Hospital, Glasgow",United Kingdom,Respiratory Diseases,1,1,231.0
3206.0,NCT04364893,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,BRACE-CORONA,Recruiting,Corona Virus Infection,COVID-19,,,,,,Other: Suspension or Maintenance of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors,D'Or Institute for Research and Education|Brazilian Clinical Research Institute,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2020-09-04,01/10/20,2020-01-12,28/04/20,02/07/20,"Idor, São Paulo",Brazil,Respiratory Diseases,1,2,-236.0
3207.0,NCT04621461,Placebo Controlled Trial to Evaluate Zinc for the Treatment of COVID-19 in the Outpatient Setting,,Completed,Corona Virus Infection,,,,,,,Dietary Supplement: Zinc Sulfate 220 MG|Drug: Placebo,"St. Francis Hospital, New York",All,"30 Years and older   (Adult, Older Adult)",3.0,Other,Interventional,2020-12-20,08/02/21,2021-08-02,09/11/20,11/02/21,"St. Francis Hospital - The Heart Center, Roslyn, New York",United States,Respiratory Diseases,1,1,225.0
3208.0,NCT04782336,"Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test",INFORM,Recruiting,COVID-19,RSV Infection,Influenza Type A,Influenza Type B,,,,Other: Group A (Sample Collection)|Other: Group B (Sample Collection)|Diagnostic Test: On-Site Testing (LumiraDx),LumiraDx UK Limited,All,"Child, Adult, Older Adult",3500.0,Industry,Interventional,2020-12-12,31/03/22,2022-05-31,04/03/21,04/03/21,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Homerton University Hospital NHS Foundation Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|St George's University Hospitals NHS Foundation, London",United Kingdom,"Infectious Diseases, Respiratory Diseases",1,4,535.0
3209.0,NCT04813471,Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH,,Recruiting,COVID-19,Endothelial Dysfunction,,,,,,Drug: Endothelial Protocol,Lebanese American University Medical Center,All,"18 Years to 99 Years   (Adult, Older Adult)",70.0,Other,Interventional,2021-01-20,20/03/21,2021-04-30,24/03/21,24/03/21,"LAUMCRH, Beirut",Lebanon,Respiratory Diseases,1,2,100.0
3210.0,NCT04465604,Hypertonic Saline for COVID-19 Symptoms,,Recruiting,COVID-19,,,,,,,Other: Wearing surgical face mask sprayed with hypertonic saline,King Faisal Specialist Hospital & Research Center,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-02,01/11/21,2022-01-05,10/07/20,05/03/21,"King Faisal Specialist Hospital and Research Center, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,368.0
3211.0,NCT04347824,Predict Adverse Events by Covid-19 Nephritis,,Recruiting,COVID-19,,,,,,,,"University Hospital Goettingen|Universitätsklinikum Hamburg-Eppendorf|University Hospital, Aachen|Transplantationszentrum Köln-Merheim",All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-04-27,31/12/20,2021-12-31,15/04/20,04/06/20,"University Medical Center Goettingen, Göttingen",Germany,Respiratory Diseases,1,1,613.0
3212.0,NCT04613817,Sero-prevalence COVID-19 Among Belgian Children,SeCoBelChild,Recruiting,COVID-19,SARS-CoV Infection,COVID-19,,,,,,Sciensano|KU Leuven|McGill University,All,8 Years to 14 Years   (Child),1640.0,Other,Observational,2020-03-12,30/06/21,2021-08-31,03/11/20,04/02/21,"Sciensano, Brussels",Belgium,Respiratory Diseases,1,3,537.0
3213.0,NCT04380961,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,,Recruiting,COVID-19,,,,,,,Drug: Sirukumab|Drug: Placebo|Other: Standard of Care (SOC),"Janssen Pharmaceutica N.V., Belgium",All,"18 Years to 84 Years   (Adult, Older Adult)",111.0,Industry,Interventional,2020-04-24,09/04/21,2021-02-07,08/05/20,14/04/21,"UCSF Fresno, Fresno, California, United States|MemorialCare Research Miller Children's and Women's Hospital Long Beach, Long Beach, California, United States|Hoag Memorial Hospital, Newport Beach, California, United States|Sutter Institute for Medical Research, Roseville, California, United States|Sutter Medical Foundation, Sacramento, California, United States|Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States|The Corporation of Mercer University, Macon, Georgia, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States|Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States|Henry Ford Hospital, Detroit, Michigan, United States|Beaumont Health Systems, Royal Oak, Michigan, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Saint Michael's Medical Center - Infectious Disease, Newark, New Jersey, United States|SUNY Upstate Medical University, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina, United States|Baylor Scott & White Research Institute, Dallas, Texas, United States|Baylor All Saints Medical Center at Fort Worth, Fort Worth, Texas",United States,Respiratory Diseases,1,1,289.0
3214.0,NCT04357938,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,SCout,"Active, not recruiting",Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Device: CT-imaging,Jena University Hospital,All,"18 Years and older   (Adult, Older Adult)",145.0,Other,Observational,2020-04-15,20/04/21,2021-04-30,22/04/20,09/06/20,"Jena University Hospital, Jena, Thuringia",Germany,Respiratory Diseases,1,1,380.0
3215.0,NCT04427280,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),CARDS,Recruiting,Infectious Disease,Cancer,Coronavirus Infection,,,,,,"Royal Marsden NHS Foundation Trust|St George's, University of London|Mologic Ltd|The Royal Marsden Cancer Charity|National Institute for Health Research Biomedical Research Centre",All,"18 Years and older   (Adult, Older Adult)",60.0,Other|Industry,Observational,2020-05-26,01/10/20,2021-01-04,11/06/20,11/06/20,"The Royal Marden NHS Foundation Trust, Sutton, Surrey",United Kingdom,"Respiratory Diseases, Cancers",1,3,223.0
3216.0,NCT04544891,TREM-1 Pathway Activation in COVID-19,CoviTrem1,Not yet recruiting,COVID-19,,,,,,,Other: blood sampling,"Central Hospital, Nancy, France|University Hospital, Limoges|Inotrem",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other|Industry,Observational,2020-01-10,01/10/22,2023-01-04,10/09/20,10/09/20,"CHRU Limoges, Limoges, France|Central hospital, Nancy",France,Respiratory Diseases,1,1,1090.0
3217.0,NCT04686539,Synthetic CBD as a Therapy for COVID-19,,Not yet recruiting,COVID-19,CBD,,,,,,Drug: CBD|Drug: Placebo,Sheba Medical Center,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-12-20,01/11/21,2022-01-01,28/12/20,28/12/20,,,Respiratory Diseases,1,2,377.0
3218.0,NCT04463823,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",MONITOR,Recruiting,COVID-19,,,,,,,,"Oslo University Hospital|St. Olavs Hospital|Sykehuset Telemark|Sykehuset Ostfold|University Hospital, Akershus|Sorlandet Hospital HF|Helse Fonna HF",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-07,31/05/22,2025-05-31,09/07/20,05/03/21,"Helse Fonna, Haugesund, Norway|Sorlandet hospital, Kristiansand, Norway|Akershus University Hospital, Lørenskog, Norway|Oslo University Hospital, Oslo, Norway|Sykehuset Ostfold, Sarpsborg, Norway|Sykehuset Telemark, Skien, Norway|St.Olavs Hospital, Trondheim",Norway,Respiratory Diseases,1,1,1819.0
3219.0,NCT04650087,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,,Recruiting,COVID-19,,,,,,,Drug: Apixaban 2.5 MG|Drug: Placebo,"Thomas Ortel, M.D., Ph.D.|National Heart, Lung, and Blood Institute (NHLBI)|Duke University",All,"18 Years and older   (Adult, Older Adult)",5320.0,Other|NIH,Interventional,2021-02-15,01/08/21,2021-01-09,02/12/20,23/03/21,"University of Illinois at Chicago, Chicago, Illinois, United States|Mercury Street medical Group, Butte, Montana, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Blood Center of Wisconsin, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,1,-37.0
3220.0,NCT04839107,Institutional Registry on Outpatient and Hospitalized COVID-infected Patients,IRCIP,Recruiting,COVID-19,,,,,,,,Hospital Italiano de Buenos Aires,All,"18 Years to 100 Years   (Adult, Older Adult)",20000.0,Other,Observational,2020-04-14,31/12/21,2021-12-31,09/04/21,09/04/21,"Hospital Italiano, Caba, Ciudad Autónoma De Buenos Aires",Argentina,Respiratory Diseases,1,1,626.0
3221.0,NCT04445623,Prasugrel in Severe COVID-19 Pneumonia,PARTISAN,Not yet recruiting,COVID-19,Thrombosis,,,,,,Drug: Prasugrel Hydrochloride 10 MG Oral Tablet|Drug: Placebo,Azienda Ospedaliera Universitaria Integrata Verona|University of Milan,All,"18 Years to 99 Years   (Adult, Older Adult)",128.0,Other,Interventional,2020-01-07,01/10/20,2021-01-01,24/06/20,26/06/20,"Azienda Ospedaliera Universitaria Integrata Verona, Verona",Italy,Respiratory Diseases,1,2,360.0
3222.0,NCT04575610,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),,Recruiting,COVID-19,,,,,,,Drug: PF-06650833|Drug: Placebo,Yale University|Pfizer,All,"18 Years to 75 Years   (Adult, Older Adult)",68.0,Other|Industry,Interventional,2020-11-30,31/03/21,2021-03-31,05/10/20,03/12/20,"Yale New Haven Hospital, New Haven, Connecticut",United States,Respiratory Diseases,1,1,121.0
3223.0,NCT04655716,Urine Alkalinisation to Prevent AKI in COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Sodium Bicarbonate 150Meq/L/D5W Inj,Guy's and St Thomas' NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-02,31/01/22,2022-03-30,07/12/20,07/12/20,,,Respiratory Diseases,1,1,452.0
3224.0,NCT04771598,Breathing Exercise After COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Other: Breathing exercise with the phone application|Other: Breathing exercise,Tokat Gaziosmanpasa University,All,"18 Years and older   (Adult, Older Adult)",52.0,Other,Interventional,2021-02-25,30/06/21,2021-07-30,25/02/21,01/03/21,,,Respiratory Diseases,1,1,155.0
3225.0,NCT04509973,Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,COVIDSTEROID2,Recruiting,COVID-19,Hypoxia,,,,,,Drug: Dexamethasone,"Scandinavian Critical Care Trials Group|Copenhagen Trial Unit, Center for Clinical Intervention Research|Centre for Research in Intensive Care (CRIC)|Aarhus University Hospital|Aalborg University Hospital|Rigshospitalet, Denmark|The George Institute for Global Health, Australia",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-08-27,17/09/21,2022-02-17,12/08/20,01/09/20,"Dept. of Anaesthesia and Intensive Care, Aalborg University Hospital, Denmark., Aalborg, Denmark|Dept. of Intensive care, Aarhus University Hospital, Aarhus, Denmark|Dept. of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Neuroanaesthesiology, Copenhagen, Denmark|Dept. of Thoracic Anaesthesiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept of Infectious diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark|Dept. of Intensive Care, Gentofte Hospital, Hellerup, Denmark|Dept. of Anaesthesia and Intensive Care, Herlev Hospital, Herlev, Denmark|Dept. of Anaesthesia, Regional Hospital West Jutland, Herning, Herning, Denmark|Dept. of Intensive Care, Nordsjællands Hospital - Hillerød, Denmark., Hillerød, Denmark|Hvidovre Hospital - Dept of Infectious diseases, Hvidovre, Denmark|Hvidovre Hospital - Dept of Intensive Care, Hvidovre, Denmark|Hvidovre Hospital - Dept of Pulmonary Medicine, Hvidovre, Denmark|Dept. of Anaesthesia and Intensive Care, Lillebaelt Hospital, Kolding, Denmark|Dept. of Intensive Care, Køge University Hospital, Køge, Denmark|Dept of Intensive Care, Odense University Hospital, Odense, Denmark|Dept. of Anaesthesia and Intensive Care, Zealand University Hospital Roskilde, Roskilde, Denmark|Dept. of Anaesthesia, Slagelse Hospital, Slagelse, Denmark|Dept. of Anaesthesia and Intensive Care, Viborg Hospital, Viborg, Denmark|Jawahar Lal Nehru Medical Collega, AMU, Aligarh, India|Apollo Hospital, Chennai, India|Amrita Institute of Medical Sciences, Kochi, India|Bombay Hospital & Medical Research Centre, Mumbai, India|K. J. Somaiya Super Specialty Hospital, Mumbai, India|P. D. Hinduja National Hospital & Medical Research Centre, Mumbai, India|S L Raheja Fortis Hospital, Mumbai, India|Tata Memorial Hospital, Mumbai, India|Wockhardt hospitals, Mumbai, India|Indraprastha Apollo Hospital, New Delhi, India|Max Super Specialty Hospital, Saket, New Delhi, India|Symbiosis University Hospital and Research Centre, Pune, India|Vishwaraj Hospital, Pune, India|Rajendra Institute of Medical Sciences, Ranchi, India|Gotri General Hospital, Vadodara, India|Christian Medical College Vellore, Vellore, India|Dept. of Anaesthesia and Intensive Care, Sahlgranska Universitetssjukhuset, Göteborg, Sweden|Dept. of Infectious Diseases, Sahlgranska Universitetssjukhuset, Göteborg, Sweden|Dept. of Anaesthesia and Intensive Care, Universitetssjukhuset i Linköping, Linköping, Sweden|Dept. of Anaesthesia and Intensive Care, Skånes Universitetssjukhus (SUS) Malmö, Malmö, Sweden|Dept. of Infectious Diseases, Skånes Universitetssjukhus (SUS) Malmö, Malmö, Sweden|Dept. of Anaesthesia and Intensive Care, Vrinnevisjukhuset, Norrköping, Norrköping, Sweden|Dept. of Anaesthesia and Intensive Care, Capio St Görans Sjukhus, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden|Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Dept. of Cardiology, Södersjukhuset, Stockholm, Sweden|Dept. of Infectious Diseases, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Infectious Diseases, Karolinska Universitetssjukhuset, Solna, Stockholm, Sweden|Dept. of Infectious Diseases, Södersjukhuset, Stockholm, Sweden|Dept. of Internal Medicine, Danderyds Sjukhuset, Stockholm, Sweden|Dept. of Internal Medicine, Södersjukhuset, Stockholm, Sweden|Södersjukhuset, Stockholm, Sweden|Dept. of Intensive Care Medicine, Bern University Hospital (Inselspital), Bern",Switzerland,Respiratory Diseases,1,2,539.0
3226.0,NCT04604145,Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR,,Recruiting,SARS-CoV Infection,Polymerase Chain Reaction,Laboratory Testing,,,,,Diagnostic Test: SARS-CoV-2 testing on the Eppendorf Thermal Cycler PCR system using self-collected saliva as the specimen,David Grant U.S. Air Force Medical Center,All,"18 Years and older   (Adult, Older Adult)",65.0,U.S. Fed,Interventional,2021-03-02,01/06/21,2021-01-06,27/10/20,01/03/21,"David Grant U.S. Airforce Medical Center, Travis Air Force Base, California",United States,Respiratory Diseases,1,3,-55.0
3227.0,NCT04360863,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,,Recruiting,Smoking Cessation,,,,,,,Other: Telephone survey,The University of Hong Kong,All,"up to 25 Years   (Child, Adult)",150.0,Other,Observational,2020-04-24,30/12/21,2021-12-30,24/04/20,04/11/20,"The University of Hong Kong, Hong Kong",Hong Kong,Others,0,1,615.0
3228.0,NCT04757272,Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?,,Recruiting,Corona Virus Infection,Hepatitis,,,,,,,Zagazig University,All,"21 Years to 80 Years   (Adult, Older Adult)",1150.0,Other,Observational,2020-01-05,30/03/21,2021-04-30,17/02/21,16/03/21,"Zagazig University Hospitals, Zagazig, Sharkia",Egypt,"Infectious Diseases, Respiratory Diseases",1,2,481.0
3229.0,NCT04278963,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,,Suspended,COVID-19,Chinese Medicine,,,,,,Drug: YinHu QingWen Decoction|Drug: YinHu QingWen Decoction(low dose)|Other: Chinese medicine treatment|Other: standard western medicine treatment,China Academy of Chinese Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-02-27,01/01/21,2021-01-01,20/02/20,11/05/20,"Jingzhou Hospital of Traditional Chinese Medicine, Jingzhou, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei, China|Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, Hubei",China,Respiratory Diseases,1,2,309.0
3230.0,NCT04421027,A Study of Baricitinib (LY3009104) in Participants With COVID-19,COV-BARRIER,Recruiting,COVID-19,,,,,,,Drug: Baricitinib|Drug: Placebo,Eli Lilly and Company,All,"18 Years and older   (Adult, Older Adult)",1400.0,Industry,Interventional,2020-12-06,19/05/21,2021-06-20,09/06/20,18/02/21,"Mercy Gilbert Medical Center, Gilbert, Arizona, United States|Valleywise Health, Phoenix, Arizona, United States|St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|Sharp Memorial Hospital, San Diego, California, United States|San Francisco VA Medical Center, San Francisco, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Holy Cross Hospital Inc., Fort Lauderdale, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Community Hospital South, Indianapolis, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|South Shore Hospital, Weymouth, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Renown Regional Med. Center, Reno, Nevada, United States|SUNY Downstate, Brooklyn, New York, United States|East Carolina University, Greenville, North Carolina, United States|OSU Med Intl Med Houston Ctr, Tulsa, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple Univ School of Med, Philadelphia, Pennsylvania, United States|Swedish Medical Center, Seattle, Washington, United States|Multicare Health System, Tacoma, Washington, United States|Sanatorio Sagrado Corazón, Ciudad de Buenos Aires, AR, Argentina|ClÃ-nica Zabala, Ciudad de Buenos Aires, AR, Argentina|Hospital Z.G.A.D Evita Pueblo, Berazategui, Buenos Aires, Argentina|Sanatorio de la Trinidad Mitre, Caba, Buenos Aires, Argentina|Fundacion Sanatorio Guemes, Caba, Buenos Aires, Argentina|Casa Hospital San Juan de Dios, Ramos Mejía, Buenos Aires, Argentina|Hospital Interzonal General de Agudos Eva Peron, San Martin, Buenos Aires, Argentina|Clinica Adventista Belgrano, Caba, Ciudad Autónoma De Buenos Aire, Argentina|Centros de Investigaciones Cli-nicas. Clinica Viedma, Viedma, Rio Negro, Argentina|Clinica Central S.A., Villa Regina, Rio Negro, Argentina|Hospital San Roque, Cordoba, Argentina|Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Centro Hospitalar de Reabilitacao Ana Carolina Moura Xavier, Curitiba, Parana, Brazil|CEPETI Centro de Ensino e Pesquisa em Terapia Intensiva, Curitiba, Paraná, Brazil|CPCLIN, Natal, Rio Grande Do Norte, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Hospital Carlos Fernando Malzoni Matao, Matao, Sao Paulo, Brazil|Pesquisare, Santo Andre, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo André, Sao Paulo, Brazil|Faculdade de Medicina do ABC, Santo Andre, SP, Brazil|Upeclin - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - UNESP, Botucatu, São Paulo, Brazil|IPECC - Instituto de Pesquisa Clinica de Campinas, Campinas, São Paulo, Brazil|Hospital PUC-CAMPINAS, Campinas, São Paulo, Brazil|CECIP - Centro de Estudos do Interior Paulista, Jaú, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos EPP Ltda, São Bernardo do Campo, São Paulo, Brazil|Real e Benemerita Associação Portuguesa de Beneficiencia, São Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Universidade Federal de São Paulo - Escola Paulista de Medicina, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Casa de Saude Santa Marcelina - Centro de Pesquisa Clinica, São Paulo, Brazil|Universitätsklinikum Erlangen, Erlangen, Bayern, Germany|Klinikum Rechts der Isar der TU München, München, Bayern, Germany|Universitätsklinikum Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany|Klinikum Chemnitz gGmbH, Chemnitz, Germany|Sir Ganga Ram Hospital, New Delhi, Delhi, India|Unity Hospital, Surat, Gujarat, India|Medanta-The Medicity, Gurgaon, Haryana, India|Government Medical College (GMC) Aurangabad, Aurangabad, Maharashtra, India|Government Medical College, Nagpur, Maharashtra, India|Ruby Hall Clinic and Grant Medical Foundation, Pune, Maharashtra, India|Medica Superspecialty Hospital, Kolkata, West Bengal, India|Aakash Healthcare Super Speciality Hospital, New Delhi, India|Ospedale SS Annunziata, Chieti Scalo, Chieti, Italy|INMI Lazzaro Spallanzani, Roma, Rome, Italy|Ospedale Luigi Sacco, Milano, Italy|Ospedale Niguarda Ca Granda, Milano, Italy|Nuovo Ospedale di Prato S. Stefano, Prato, Italy|Yokohama Municipal Citizen's Hospital, Yokohama, Kanagawa, Japan|Edogawa Medicare Hospital, Edogawa-ku, Tokyo, Japan|Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan|Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Korea, Republic of|Ajou University Hospital, Suwon, Gyeonggi-do, Korea, Republic of|Seoul National University Boramae Medical Center, Seoul, Seoul, Korea, Korea, Republic of|Seoul Medical Center, Seoul, Korea, Republic of|Instituto Nacional de Cardiologia Ignacio Chavez, Mexico, DF, Mexico|Instituto Nacional de Enfermedades Respiratorias, Mexico, DF, Mexico|Instituto Nacional de Cancerologia, Mexico City, FD, Mexico|Hospital General Agustín O'Horán, Yucatan, Merida, Mexico|ITESM Campus Monterrey, Monterrey, Nuevo Leon, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran- Medicina Critica, Federal District, Mexico|Advanced Clinical Research, LLC, Bayamon, Puerto Rico|City Clinical Hospital #15 named after O.M. Filatov, Moscow, Russian Federation|First Moscow State Medical University n.a. Sechenov, Moscow, Russian Federation|Saint-Petersburg City Pokrovskaya Hospital, Saint-Petersburg, Russian Federation|Hospital Txagorritxu, Vitoria, Alava, Spain|Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcon, Madrid, Spain|Hospital Universitario Infanta Leonor-INTERNAL MED, Madrid, Spain|Hospital Clinico San Carlos, Madrid, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|The Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|Barnet Hospital, Barnet, Herts, United Kingdom|St. George's University Hospitals NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,196.0
3231.0,NCT04512118,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,,Completed,COVID-19,,,,,,,Diagnostic Test: PET-CT of 18F-FDG,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",22.0,Other,Observational,2020-03-15,30/06/20,2020-07-30,13/08/20,13/08/20,"CHRU of Nancy, Vandœuvre-lès-Nancy, Grand Est",France,Respiratory Diseases,1,1,137.0
3232.0,NCT04470427,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",,"Active, not recruiting",COVID-19,,,,,,,Biological: mRNA-1273|Biological: Placebo,"ModernaTX, Inc.|Biomedical Advanced Research and Development Authority|National Institute of Allergy and Infectious Diseases (NIAID)",All,"18 Years and older   (Adult, Older Adult)",30420.0,Industry|U.S. Fed|NIH,Interventional,2020-07-27,27/10/22,2022-10-27,14/07/20,25/02/21,"Ascension St. Vincent Birmingham, Birmingham, Alabama, United States|Synexus Clinical Research US, Inc. - Birmingham, Birmingham, Alabama, United States|Hope Research Institute, Chandler, Arizona, United States|Synexus Clinical Research US, Inc. - Phoenix West, Glendale, Arizona, United States|Hope Research Institute, Peoria, Arizona, United States|Hope Research Institute, Phoenix, Arizona, United States|Quality of Life Medical and Research Center, Tucson, Arizona, United States|Baptist Health Center for Clinical Research, Little Rock, Arkansas, United States|Advanced Clinical Research - Rancho Paseo, Banning, California, United States|University of California San Diego, La Jolla, California, United States|eStudySite - La Mesa, La Mesa, California, United States|UCLA Vine Street Clinic CRS, Los Angeles, California, United States|VA Greater Los Angeles Healthcare (veterans only), Los Angeles, California, United States|Paradigm Clinical Research Institute Inc, Redding, California, United States|Benchmark Research - Sacramento, Sacramento, California, United States|Medical Center For Clinical Research - M3 Wake Research, San Diego, California, United States|University of Colorado Hospital, Aurora, Colorado, United States|Lynn Institute of The Rockies, Colorado Springs, Colorado, United States|George Washington University, Washington, District of Columbia, United States|Accel Research Site, DeLand, Florida, United States|Research Centers of America, Hollywood, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Synexus - Optimal Research - Melbourne, Melbourne, Florida, United States|Suncoast Research Group, Miami, Florida, United States|University of Miami, Miami, Florida, United States|Synexus Clinical Research US, Inc. - Orlando, Orlando, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Grady Health System, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Hope Clinic of The Emory Vaccine Center, Decatur, Georgia, United States|Meridian Clinical Research, Savannah, Georgia, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Synexus Clinical Research US, Inc. - Chicago, Chicago, Illinois, United States|UIC Project WISH CRS, Chicago, Illinois, United States|University of Chicago-Hospital, Chicago, Illinois, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Alliance for Multispecialty Research, Newton, Kansas, United States|Alliance for Multispecialty Research- East Wichita, Wichita, Kansas, United States|Meridian Clinical Research, Baton Rouge, Louisiana, United States|Benchmark Research - Metairie, Metairie, Louisiana, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Synexus - Optimal Research - Rockville, Rockville, Maryland, United States|Meridian Clinical Research, Rockville, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|MediSync Clinical Research Hattiesburg Clinic, Petal, Mississippi, United States|Saint Louis University, Saint Louis, Missouri, United States|Sundance Clinical Research, Saint Louis, Missouri, United States|Meridian Clinical Research, Grand Island, Nebraska, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|AB Clinical Trials, Las Vegas, Nevada, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|New Jersey Medical School, Newark, New Jersey, United States|Meridian Clinical Research, Binghamton, New York, United States|Weill Cornell Chelsea - (CRS), New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Tryon Medical Partners, Charlotte, North Carolina, United States|Carolina Institute for Clinical Research - M3 Wake Research, Fayetteville, North Carolina, United States|M3 Wake Research, Inc - M3 Wake, Raleigh, North Carolina, United States|Trial Management Associates, Wilmington, North Carolina, United States|Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States|Synexus Clinical Research US, Inc. - Cincinnati, Cincinnati, Ohio, United States|New Horizons Clinical Research, Cincinnati, Ohio, United States|Cincinnati CRS, Cincinnati, Ohio, United States|Rapid Medical Research Inc, Cleveland, Ohio, United States|Lynn Health Science Institute, Oklahoma City, Oklahoma, United States|Crisor, Medford, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|UPMC University Center, Pittsburgh, Pennsylvania, United States|Keystone VitaLink Research, Anderson, South Carolina, United States|Keystone VitaLink Research - Greenville, Greenville, South Carolina, United States|Coastal Carolina Research Center, Mount Pleasant, South Carolina, United States|Keystone VitaLink Research - Spartanburg, Spartanburg, South Carolina, United States|Meridian Clinical Research, Dakota Dunes, South Dakota, United States|WR-ClinSearch, Chattanooga, Tennessee, United States|Alliance for Multispecialty Research, Knoxville, Tennessee, United States|Vanderbilt University Medical Center, Medical Arts Building, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Medical Center North, Nashville, Tennessee, United States|Benchmark Research - Austin, Austin, Texas, United States|Synexus - Optimal Research - Austin, Austin, Texas, United States|Tekton Research, Austin, Texas, United States|Advanced Clinical Research - Be Well MD, Cedar Park, Texas, United States|Global Medical Research - M3 Wake Research, Dallas, Texas, United States|Synexus Clinical Research US, Inc. - Dallas, Dallas, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|University of Texas Medical Branch at Galveston, Galveston, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|DM Clinical Research - Texas Center For Drug Development, Houston, Texas, United States|Laguna Clinical Research, Laredo, Texas, United States|Centex Studies, McAllen, Texas, United States|Benchmark Research - San Angelo, San Angelo, Texas, United States|Clinical Trials of Texas, Inc, San Antonio, Texas, United States|DM Clinical Research, Tomball, Texas, United States|Synexus Clinical Research US, Inc. - Salt Lake City, Murray, Utah, United States|Foothill Family Clinic - North, Salt Lake City, Utah, United States|Foothill Family Clinic-South Clinic, Salt Lake City, Utah, United States|Kaiser Permanente - Seattle, Seattle, Washington",United States,Respiratory Diseases,1,1,822.0
3233.0,NCT04487691,Nebulized PL for Post-COVID-19 Syndrome,,"Active, not recruiting",COVID-19,,,,,,,Biological: Nebulized Platelet Lysate|Other: Nebulized Sterile Saline,"Regenexx, LLC",All,"18 Years to 85 Years   (Adult, Older Adult)",1.0,Industry,Interventional,2020-08-12,01/06/21,2021-12-30,27/07/20,17/03/21,"Centeno-Schultz Clinic, Broomfield, Colorado",United States,Respiratory Diseases,1,1,505.0
3234.0,NCT04768153,Prioritising Prevention of COVID-19 in Persons With Cancer in the French West Indies,RESILIENCE,Recruiting,Cancer,,,,,,,Biological: Serology,University Hospital Center of Martinique,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-06-29,29/06/21,2021-12-29,24/02/21,24/02/21,"CHU Martinique, Fort-de-France",Martinique,Cancers,1,1,548.0
3235.0,NCT04365309,Protective Effect of Aspirin on COVID-19 Patients,PEAC,Enrolling by invitation,COVID-19,Aspirin,Treatment,,,,,Drug: Aspirin 100mg,Xijing Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",128.0,Other,Interventional,2020-10-02,01/04/20,2020-01-06,28/04/20,28/04/20,"Cai Yue, Xi'an, Shaanxi",China,Respiratory Diseases,1,3,-270.0
3236.0,NCT04353011,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,DolPsyCOVID,Completed,Sars-CoV2,Chronic Pain,,,,,,Other: questionnaire assesment,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",312.0,Other,Observational,2020-04-20,27/04/20,2020-04-27,20/04/20,11/12/20,"Hopital Roger Salengro, CHU Lille, Lille",France,Respiratory Diseases,1,2,7.0
3237.0,NCT04558203,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",,Recruiting,COVID-19,,,,,,,,ClinAmygate,All,"Child, Adult, Older Adult",450.0,Other,Observational,2020-09-22,25/05/21,2021-05-30,22/09/20,16/02/21,"Asalam, Maadi, Cairo",Egypt,Respiratory Diseases,1,1,250.0
3238.0,NCT04316299,Acute Kidney Injury in Patients Hospitalized With COVID-19,,Completed,COVID-19,Acute Kidney Injury,Kidney Function,,,,,,Zhenhua Zen|Nanfang Hospital of Southern Medical University,All,"18 Years and older   (Adult, Older Adult)",287.0,Other,Observational,2020-02-26,28/02/20,2020-08-03,20/03/20,30/03/20,"Hankou Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,3,159.0
3239.0,NCT04716972,Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes,,Not yet recruiting,COVID-19,,,,,,,Other: survey|Other: Interview,The Royal Wolverhampton Hospitals NHS Trust,All,"Child, Adult, Older Adult",200.0,Other,Observational,2021-01-04,01/12/21,2021-01-12,20/01/21,05/02/21,,,Respiratory Diseases,1,1,8.0
3240.0,NCT04647747,Silent Hypoxia and Awake Proning in COVID-19 Patients,SHYCOV,Recruiting,COVID-19,Hypoxemia,,,,,,Other: Self measurement with pulse oximeter,Ostfold Hospital Trust,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-11-30,30/03/21,2021-12-31,01/12/20,04/02/21,"Ostfold Hospital, Sarpsborg, Grålum",Norway,Respiratory Diseases,1,2,396.0
3241.0,NCT04338568,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,SCOUT,Recruiting,COVID-19,Lung Ultrasound,,,,,,Diagnostic Test: Lung ultrasound,Hasselt University|Ziekenhuis Oost-Limburg,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-16,30/11/20,2020-12-30,08/04/20,17/08/20,"Ziekenhuis Oost Limburg, Genk, Limburg",Belgium,Respiratory Diseases,1,2,258.0
3242.0,NCT04442230,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),,Recruiting,Coronavirus Infection,,,,,,,Biological: NasoVAX|Other: Placebo,"Altimmune, Inc.",All,"18 Years and older   (Adult, Older Adult)",96.0,Industry,Interventional,2020-10-10,01/02/21,2021-01-02,22/06/20,14/12/20,"Miami Dade Medical Research Institute, Miami, Florida, United States|Infinite Clinical Trials, Morrow, Georgia, United States|Cedar Crosse Research Center, Chicago, Illinois, United States|MedPharmics, Metairie, Louisiana, United States|Columbia University, New York, New York, United States|Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States|Centex Studies, Houston, Texas, United States|Centex Studies, McAllen, Texas",United States,Respiratory Diseases,1,1,84.0
3243.0,NCT04603690,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Colchicine,Liaquat University of Medical & Health Sciences|Universidad de Murcia,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-12-15,14/05/21,2021-06-14,27/10/20,10/12/20,,,Respiratory Diseases,1,1,181.0
3244.0,NCT04359121,COVID-19 and the Developement of Phobic Fears of Disease,,Recruiting,COVID-19,,,,,,,Other: Questionnaires for specific phobia,Medical University of Graz,All,"18 Years to 90 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-04-15,15/04/23,2024-04-15,24/04/20,06/05/20,"Medical University of Graz, Graz, Styria",Austria,Respiratory Diseases,1,1,1461.0
3245.0,NCT04542408,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,HERO-19,Recruiting,COVID-19,,,,,,,Drug: Anticoagulation Agents (Edoxaban and/or high dose LMWH)|Drug: Low dose Low molecular weight heparin or Placebo,Universitätsklinikum Hamburg-Eppendorf,All,"18 Years and older   (Adult, Older Adult)",172.0,Other,Interventional,2020-12-11,31/05/21,2021-09-30,09/09/20,18/11/20,"Universitätsklinikum Düsseldorf, Düsseldorf, Germany|Universitätsklinikum Freiburg, Freiburg, Germany|Marienkrankenhaus, Hamburg, Germany|Universitärsklinikum Hamburg-Eppendorf, Hamburg, Germany|Medizinische Hochschule Hannover, Hanover, Germany|Krankenhaus Köln-Merheim, Köln, Germany|TU München Klinikum rechts der Isar, München, Germany|Universitätsklinikum Münster, Münster",Germany,Respiratory Diseases,1,1,293.0
3246.0,NCT04799873,Alpha-1-Antitrypsin-Deficiency in COVID-19,CORSAAR-AAT,Completed,COVID-19,,,,,,,Drug: AAT( Alpha 1 Antitrypsin),Universität des Saarlandes,All,"18 Years to 110 Years   (Adult, Older Adult)",10.0,Other,Observational,2020-08-04,01/12/20,2020-01-12,16/03/21,16/03/21,"Saarland University, Homburg, Saarland",Germany,Respiratory Diseases,1,1,-205.0
3247.0,NCT04382755,Zilucoplan® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,ZILU-COV,"Active, not recruiting",COVID-19,,,,,,,Drug: Zilucoplan®|Drug: Placebo,"University Hospital, Ghent|UCB Pharma",All,"18 Years and older   (Adult, Older Adult)",81.0,Other|Industry,Interventional,2020-05-22,29/12/20,2021-04-30,11/05/20,02/03/21,"OLVZ Aalst, Aalst, Belgium|AZ Sint Jan Brugge, Brugge, Belgium|Erasmus University Hospital, Brussels, Belgium|AZ Sint-Lucas, Gent, Belgium|University Hospital Ghent, Gent, Belgium|Jan Yperman Ziekenhuis Ieper, Ieper, Belgium|University Hospital Liège, Liège, Belgium|AZ Delta, Roeselare, Belgium|AZ Vesalius, Tongeren",Belgium,Respiratory Diseases,1,1,343.0
3248.0,NCT04417257,Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,RESOLUTION,Recruiting,COVID-19,,,,,,,Drug: LAU-7b|Drug: Placebo oral capsule,Laurent Pharmaceuticals Inc.,All,"18 Years and older   (Adult, Older Adult)",240.0,Industry,Interventional,2020-06-29,30/04/21,2021-05-30,04/06/20,30/03/21,"Chandler Regional Medical Center / Mercy Gilbert Medical Center, Chandler, Arizona, United States|Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States|St Lukes Hospital, Boise, Idaho, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Rapides Regional Medical Center, Alexandria, Louisiana, United States|Anne Arundel Medical Center, 2001 Medical Parkway, Belcher Pavillion, Annapolis, Maryland, United States|Wayne State University, Harper University Hospital and Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Roper St. Francis Healthcare, Charleston, South Carolina, United States|Houston Methodist Hospital, Houston, Texas, United States|Centre d'études cliniques CIUSS SLJ, Hôpital Chicoutimi, Chicoutimi, Quebec, Canada|CIUSSSS de l'Est-de-l'Ile-de-Montréal, Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|McGill University Health Centre, Montréal, Quebec, Canada|CISSS Des Laurentides, Saint-Jérôme, Quebec",Canada,Respiratory Diseases,1,1,335.0
3249.0,NCT04372472,SQuISH-COVID: A Pilot Study,,"Active, not recruiting",Sepsis,COVID-19,,,,,,,"Cytovale, Inc.|Biomedical Advanced Research and Development Authority",All,"18 Years and older   (Adult, Older Adult)",300.0,Industry|U.S. Fed,Observational,2020-07-04,29/05/20,2020-05-29,04/05/20,04/05/20,"Our Lady of the Lake Regional Medical Center, Baton Rouge, Louisiana",United States,Respiratory Diseases,1,2,-36.0
3250.0,NCT04483960,Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial,ASCOT ADAPT,Recruiting,COVID-19,,,,,,,Drug: Nafamostat Mesilate|Biological: Convalescent plasma|Drug: Enoxaparin|Drug: Dalteparin|Drug: Tinzaparin|Drug: Aspirin,University of Melbourne|The Peter Doherty Institute for Infection and Immunity|Australasian Society for Infectious Diseases|Middlemore Clinical Trials|The George Institute|Hunter Medical Research Institute|The University of Queensland,All,"18 Years and older   (Adult, Older Adult)",2400.0,Other,Interventional,2020-07-28,31/12/21,2022-12-31,23/07/20,25/01/21,"Calvary Public Bruce Hospital, Bruce, Australian Capital Territory, Australia|The Canberra Hospital, Canberra, Australian Capital Territory, Australia|Armidale Hospital, Armidale, New South Wales, Australia|Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia|Blacktown Hospital, Blacktown, New South Wales, Australia|Campbelltown Hospital, Campbelltown, New South Wales, Australia|Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia|Canterbury Hospital, Campsie, New South Wales, Australia|The Sutherland Hospital, Caringbah, New South Wales, Australia|Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia|Concord Repatriation General Hospital, Concord, New South Wales, Australia|St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia|Northern Beaches Hospital, Frenchs Forest, New South Wales, Australia|Griffith Base Hospital, Griffith, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|St George Hospital, Kogarah, New South Wales, Australia|Lismore Base Hospital, Lismore, New South Wales, Australia|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital, New Lambton Heights, New South Wales, Australia|Orange Health Service, Orange, New South Wales, Australia|Port Macquarie Base Hospital, Port Macquarie, New South Wales, Australia|Prince of Wales Hospital, Randwick, New South Wales, Australia|Royal North Shore Hospital, St Leonards, New South Wales, Australia|The Tweed Hospital, Tweed Heads, New South Wales, Australia|Wagga Wagga Base Hospital, Wagga Wagga, New South Wales, Australia|Calvary Mater Newcastle, Waratah, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Royal Darwin Hospital, Tiwi, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Caboolture Hospital, Caboolture, Queensland, Australia|Cairns Hospital, Cairns, Queensland, Australia|The Prince Charles Hospital, Chermside, Queensland, Australia|Royal Brisbane and Women's Hospital, Herston, Queensland, Australia|Mackay Base Hospital, Mackay, Queensland, Australia|Logan Hospital, Meadowbrook, Queensland, Australia|Redcliffe Hospital, Redcliffe, Queensland, Australia|Mater, South Brisbane, Queensland, Australia|Gold Coast University Hospital, Southport, Queensland, Australia|Townsville University Hospital, Townsville, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Launceston General Hospital, Launceston, Tasmania, Australia|Ballarat Health Services, Ballarat Central, Victoria, Australia|St John of God Ballarat Hospital, Ballarat, Victoria, Australia|Bendigo Health, Bendigo, Victoria, Australia|Eastern Health (Box Hill Hospital), Box Hill, Victoria, Australia|Monash Health, Clayton, Victoria, Australia|Northern Health, Epping, Victoria, Australia|St. Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|Frankston Hospital - Penninsula Health, Frankston, Victoria, Australia|Peninsula Private Hospital, Frankston, Victoria, Australia|Barwon Health - University Hospital Geelong, Geelong, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|Cabrini Health, Malvern, Victoria, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Epworth Richmond, Richmond, Victoria, Australia|Goulburn Valley Health, Shepparton, Victoria, Australia|Western Health, St Albans, Victoria, Australia|Latrobe Regional Hospital, Traralgon, Victoria, Australia|West Gippsland Hospital, Warragul, Victoria, Australia|Albury Wodonga Health, Wodonga, Victoria, Australia|Rockingham General Hospital, Cooloongup, Western Australia, Australia|Joondalup Health Campus, Joondalup, Western Australia, Australia|Armadale Health Service, Mount Nasura, Western Australia, Australia|Fiona Stanley Hospita, Murdoch, Western Australia, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Knox Private Hospital, Wantirna",Australia,Respiratory Diseases,1,1,886.0
3251.0,NCT04822701,A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: BI 767551 intravenous|Drug: BI 767551 inhaled|Drug: Placebo intravenous|Drug: Placebo inhaled,Boehringer Ingelheim,All,"18 Years and older   (Adult, Older Adult)",1440.0,Industry,Interventional,2021-04-16,22/05/21,2022-03-03,30/03/21,08/04/21,,,Respiratory Diseases,1,1,321.0
3252.0,NCT04351243,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),,Completed,COVID-19,,,,,,,Drug: Gimsilumab|Drug: Placebo,"Kinevant Sciences GmbH|Roivant Sciences, Inc.",All,"18 Years and older   (Adult, Older Adult)",227.0,Industry,Interventional,2020-12-04,01/12/20,2021-01-04,17/04/20,05/04/21,"Banner University Medical Center, Phoenix, Arizona, United States|HonorHealth John C. Lincoln Medical Center, Phoenix, Arizona, United States|HonorHealth Scottsdale Osborn Medical Center, Scottsdale, Arizona, United States|HonorHealth, Scottsdale, Arizona, United States|HonorHealth Scottsdale Shea Medical Center, Scottsdale, Arizona, United States|Banner University Medical Center, Tucson, Arizona, United States|UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|University of Florida, Gainesville, Florida, United States|Miami Cancer institute, Miami, Florida, United States|Piedmont Healthcare, Atlanta, Georgia, United States|Emory University School of Medicine, Atlanta, Georgia, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|East Jefferson General Hospital, Metairie, Louisiana, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beaumont Hospital - Royal Oak, Royal Oak, Michigan, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|Mount Sinai Beth Israel, New York, New York, United States|Mount Sinai West, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Baylor Jack & Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor Scott & White All Saints Medical Center, Fort Worth, Texas, United States|Memorial Hermann Hospital Affiliated with University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, United States|Baylor Scott & White Medical Center, Irving, Texas, United States|Baylor Scott & White Medical Center, Plano, Texas, United States|Baylor Scott & White Medical Center, Temple, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia",United States,Respiratory Diseases,1,1,31.0
3253.0,NCT04445337,Stellate Ganglion Blockade in COVID-19 Positive Patients,,Not yet recruiting,COVID-19,ARDS,,,,,,Procedure: Stellate Ganglion Block,University of Nebraska,All,"19 Years to 85 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-07,01/07/21,2021-01-07,24/06/20,24/06/20,,,Respiratory Diseases,1,2,366.0
3254.0,NCT04344587,Awake Prone Position for Early Hypoxemia in COVID-19,APPEX-19,"Active, not recruiting",COVID-19,,,,,,,Other: Self-prone position recommendation|Other: Usual care,Boston University,All,"18 Years and older   (Adult, Older Adult)",305.0,Other,Interventional,2020-04-23,01/05/21,2021-01-05,14/04/20,01/04/21,"Long Beach Medical Center - MemorialCare, Long Beach, California, United States|Alvarado Hospital, San Diego, California, United States|St. Joseph's Hospital National Jewish Health, Denver, Colorado, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Piedmont Atlanta, Atlanta, Georgia, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Boston Medical Center, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Creighton University, Omaha, Nebraska, United States|Michael E. DeBakey Veteran Affairs Medical Center, Houston, Texas, United States|VCU Medical Center, Richmond, Virginia, United States|Hospital Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,1,257.0
3255.0,NCT04363671,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),AdoPro-Cov19,Not yet recruiting,Remote Consultation,COVID-19,,,,,,,"Hôpital Cochin|Institut National de la Santé Et de la Recherche Médicale, France",All,"11 Years and older   (Child, Adult, Older Adult)",30.0,Other,Observational,2020-01-05,01/06/20,2020-01-12,27/04/20,27/04/20,"Maison de Solenn, Cochin Hospital, Paris",France,Respiratory Diseases,1,2,7.0
3256.0,NCT04405076,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",,"Active, not recruiting",COVID-19,,,,,,,Biological: Biological: mRNA-1273|Biological: Placebo|Biological: mRNA-1273.351,"ModernaTX, Inc.|Biomedical Advanced Research and Development Authority",All,"18 Years and older   (Adult, Older Adult)",660.0,Industry|U.S. Fed,Interventional,2020-05-29,31/03/21,2021-06-10,28/05/20,24/03/21,"Meridian Clinical Research, Savannah, Georgia, United States|Alliance for Multispecialty Research, Newton, Kansas, United States|Alliance for Multispecialty Research, Kansas City, Missouri, United States|Meridian Clinical Research, Norfolk, Nebraska, United States|Trial Management Associates, Wilmington, North Carolina, United States|Meridian Clinical Research, Dakota Dunes, South Dakota, United States|Benchmark Research, Austin, Texas, United States|Benchmark Research, San Angelo, Texas",United States,Respiratory Diseases,1,1,377.0
3257.0,NCT04436484,Immune Biomarkers of Outcome From COVID-19,IBOC,Recruiting,COVID-19,,,,,,,Diagnostic Test: Peripheral blood sampling,University Hospital Plymouth NHS Trust,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-29,19/02/21,2021-02-19,18/06/20,03/12/20,"University Hospitals Plymouth NHS Trust, Plymouth, Devon",United Kingdom,Respiratory Diseases,1,1,296.0
3258.0,NCT04304313,A Pilot Study of Sildenafil in COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Sildenafil citrate tablets,Tongji Hospital,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-09-02,01/03/20,2020-09-11,11/03/20,17/03/20,"Department and Institute of Infectious Disease, Wuhan, Hubei",China,Respiratory Diseases,1,1,9.0
3259.0,NCT04598594,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,NICOVID-REA,"Active, not recruiting",COVID-19,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,,,,,,"Drug: Patch, Nicotine|Drug: Patch, Placebo",Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2020-06-11,01/04/21,2021-01-11,22/10/20,09/04/21,"Centre Hospitalier Victor Dupouy - Service de Réanimation polyvalente et USC, Argenteuil, France|CHRU de Besançon - Service de Médecine Intensive Réanimation, Besançon, France|Centre Hospitalier Sud Francilien - Service de réanimation, Corbeil-Essonnes, France|CHU Dijon - Hôpital François Miterrand Service de Médecine Intensive Réanimation, Dijon, France|Hôpital Simone VEIL - Service d'Anesthésie-Réanimation, Eaubonne, France|Grand Hôpital de l'Est Francilien - Site Jossigny - Réanimation, Jossigny, France|Hôpital Bicêtre - Service de Médecine Intensive Réanimation, Le Kremlin-Bicêtre, France|Grand Hôpital de l'Est Francilien Site Meaux - Service de Réanimation Médico-Chirurgicale, Meaux, France|Groupement Hospitalier de la Région de Mulhouse Sud Alsace - Hop Emile MULLER, Mulhouse, France|CHU Nice - Hôpital L'Archet 1 - Service de Médecine Intensive Réanimation, Nice, France|CHR Orléans Service de Médecine Intensive Réanimation, Orléans, France|Hôpital Pitié Salpêtrière - ICU, Paris, France|Hôpital Pitié Salpêtrière - Intensive care unit, Paris, France|Institut Mutualiste Montsouris Service de Réanimation Polyvalente, Paris, France|Hôpital Tenon - Service de Médecine Intensive Réanimation, Paris, France|Centre Hospitalier René Dubos - Service de Réanimation Médico-Chirurgicale, Pontoise, France|Hôpital DELAFONTAINE Service de Médecine Intensive Réanimation, Saint-Denis, France|Médipôle Hôpital Privé - MHP Service de Médecine Intensive Réanimation, Villeurbanne",France,Respiratory Diseases,1,2,214.0
3260.0,NCT04453475,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,AnhandCOV19,Recruiting,Psychosomatic Disorder,Parkinson,Psychological Distress,Psychological Stress,Psychological Disease,Psychological Disorder,Psychological Impairment,Behavioral: Training session adressing information and health literacy,Jacobs University Bremen gGmbH|Dr. Becker Klinikgruppe|Dr. Becker Burg-Klinik (Burg)|Dr. Becker Klinik Norddeich (NOR)|Dr. Becker Klinik Juliana (JUL)|Dr. Becker Klinik Möhnesee|Paracelsus Klinik Bremen,All,"18 Years and older   (Adult, Older Adult)",1230.0,Other,Interventional,2020-01-07,31/07/21,2021-12-31,01/07/20,27/08/20,"Jacobs University Bremen gGmbH, Bremen",Germany,Mental Health,1,7,724.0
3261.0,NCT04458298,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,PRANA,"Active, not recruiting",COVID-19,,,,,,,Drug: OP-101|Drug: Placebo,"Orpheris, Inc.",All,"18 Years and older   (Adult, Older Adult)",24.0,Industry,Interventional,2020-11-08,14/05/21,2021-05-14,07/07/20,02/04/21,"Research Site, Loma Linda, California, United States|Research site, Fort Lauderdale, Florida, United States|Research Site, Atlanta, Georgia, United States|Research site, Baltimore, Maryland, United States|Research Site, Sioux Falls, South Dakota, United States|Research Site, Houston, Texas",United States,Respiratory Diseases,1,1,187.0
3262.0,NCT04816786,COVID-19 Patients Admitted to the ICU,,Recruiting,COVID-19,,,,,,,"Other: no intervention will be administered, this is a retrospective observational study.","Ministry of Health, Kuwait",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-01,01/06/21,2021-01-07,25/03/21,25/03/21,"Mubarak al Kabeer hospital, Kuwait, Outside U.S./Canada",Kuwait,Respiratory Diseases,1,1,6.0
3263.0,NCT04616846,Thromboembolic Risk Screening in Patients With Cancer and COVID-19,NEOTHROCOVID,Recruiting,Neoplasms Malignant,COVID-19,Thromboembolism,,,,,Diagnostic Test: Peripheral venous ultrasound,Centre Antoine Lacassagne,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-08,15/09/21,2021-09-15,05/11/20,05/11/20,"Clinique Saint-Jean, Cagnes-sur-Mer, Alpes-Maritimes, France|Centre Azuréen de Cancérologie, Mougins, Alpes-Maritimes, France|CHU Nice, Nice, Alpes-Maritimes, France|Clinique Saint-Georges, Nice, Alpes-Maritimes, France|Centre Antoine Lacassagne, Nice, Alpes-Maritimes, France|CHPG, Monaco",Monaco,Respiratory Diseases,1,3,525.0
3264.0,NCT04410107,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",,Recruiting,COVID-19,COVID-19,,,,,,"Diagnostic Test: Lung Function tests|Diagnostic Test: Exercise capacity|Diagnostic Test: Exercise physiology|Diagnostic Test: Health-related quality of life|Diagnostic Test: Respiratory symptoms, symptoms of anxiety and depression, and post-traumatic stress screening",Federal University of Rio Grande do Sul|Hospital de Clinicas de Porto Alegre|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Hospital Moinhos de Vento|Federal University of Health Science of Porto Alegre|Universidade de Passo Fundo|Hospital Nossa Senhora da Conceicao,All,"Child, Adult, Older Adult",134.0,Other,Observational,2020-05-15,31/12/20,2022-02-08,01/06/20,01/06/20,"Universidade de Passo Fundo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital de Clínicas de Porto Alegre/Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande Do Sul, Brazil|Univesidade de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Nossa Senhora da Conceição, Porto Alegre, Rio Grande Do Sul",Brazil,Respiratory Diseases,1,2,634.0
3265.0,NCT04692129,Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients,PRONECOVID19,Recruiting,COVID-19,"ARDS, Human",,,,,,,Corporacion Parc Tauli|Institut de Ciències Fotòniques (ICFO)|Centre de Recerca Matemàtica|Institute of Physics University of Campinas,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-29,31/12/21,2021-12-31,31/12/20,01/02/21,"Hospital de Clñinicas da UNICAMP, Campinas, Sao Paulo, Brazil|Hospital General de México, México, Mexico|Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain|Hospital Clínic i Provincial de Barcelona, Barcelona, Spain|Hospital Parc Salut Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona",Spain,Respiratory Diseases,1,2,581.0
3266.0,NCT04527497,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,,Recruiting,COVID-19,,,,,,,,Wissenschaftliches Institut Bethanien e.V,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-08,30/05/21,2021-08-31,26/08/20,26/08/20,"Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V., Solingen, Nordrhein-Westfalen",Germany,Respiratory Diseases,1,1,601.0
3267.0,NCT04498273,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,,Recruiting,COVID-19,,,,,,,Drug: Apixaban 2.5 MG|Drug: Apixaban 5MG|Drug: Aspirin|Drug: Placebo,"Frank C Sciurba|National Heart, Lung, and Blood Institute (NHLBI)|University of Pittsburgh",All,"40 Years to 80 Years   (Adult, Older Adult)",7000.0,Other|NIH,Interventional,2020-07-09,01/09/21,2021-01-09,04/08/20,13/04/21,"University of Southern California, Los Angeles, California, United States|Stanford University School of Medicine, Palo Alto, California, United States|Zuckerberg San Francisco General, San Francisco, California, United States|Olive View-UCLA Medical Center, Sylmar, California, United States|Midland Florida Clinical Research Center, LLC, DeLand, Florida, United States|University of Florida at Gainesville, Gainesville, Florida, United States|Advanced Research for Health Improvement, LLC, Immokalee, Florida, United States|University of Floridia at Jacksonville, Jacksonville, Florida, United States|Lakeland Regional, Lakeland, Florida, United States|Jackson Memorial, Miami, Florida, United States|Innovation Clinical Trials, Palmetto Bay, Florida, United States|Bond Community Health Center, Tallahassee, Florida, United States|Tallahassee Memorial, Tallahassee, Florida, United States|USF Tampa General Hospital, Tampa, Florida, United States|Hawaii Pacific Health, Honolulu, Hawaii, United States|Fox Valley Clinical Research Center, LLC, Aurora, Illinois, United States|UIC - Mile Square, Chicago, Illinois, United States|Jesse Brown VA, Chicago, Illinois, United States|University of Illinois at Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|OSF Saint Francis Medical Center, Peoria, Illinois, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Jadestone Clinical Research, LLC, Gaithersburg, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|SRI International, Plymouth, Michigan, United States|Metro Health-University of Michigan Health, Wyoming, Michigan, United States|Montefiore Medical Center, Bronx, New York, United States|Duke, Durham, North Carolina, United States|Peters Medical Research, High Point, North Carolina, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States|UPMC Passavant Cranberry, Cranberry, Pennsylvania, United States|UPMC McKeesport, McKeesport, Pennsylvania, United States|UPMC East, Monroeville, Pennsylvania, United States|UPMC Magee, Pittsburgh, Pennsylvania, United States|UPMC Presby, Pittsburgh, Pennsylvania, United States|UPMC Mercy, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|UPMC Shadyside, Pittsburgh, Pennsylvania, United States|UPMC Passavant McCandless, Pittsburgh, Pennsylvania, United States|Preferred Primary Care Physicians, Pittsburgh, Pennsylvania, United States|Ascension Seton Medical Center, Austin, Texas, United States|Baptist Beaumont, Beaumont, Texas, United States|McGoven Medical School - UT- Houston, Houston, Texas, United States|Next Level Urgent Care, Houston, Texas, United States|University of Texas at Tyler, Tyler, Texas, United States|University of Texas at Rio Grande Valley, Weslaco, Texas, United States|Intermountain Healthcare, Murray, Utah, United States|Community Care of Clay, Clay, West Virginia, United States|University Healthcare Physicians, Harpers Ferry, West Virginia, United States|Community Care of Weston, Weston, West Virginia",United States,Respiratory Diseases,1,1,184.0
3268.0,NCT04447781,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",,Recruiting,Coronavirus Infection,SARS-CoV 2,,,,,,Biological: INO-4800|Device: CELLECTRA® 2000|Other: Saline-sodium citrate (SSC) buffer,International Vaccine Institute|Coalition for Epidemic Preparedness Innovations|Inovio Pharmaceuticals,All,19 Years to 64 Years   (Adult),160.0,Other|Industry,Interventional,2020-07-15,22/02/22,2022-02-22,25/06/20,19/08/20,"Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,2,587.0
3269.0,NCT04780061,Dietary Supplements for COVID-19,,Not yet recruiting,COVID-19,,,,,,,"Drug: Vitamin D3 50,000 IU|Dietary Supplement: Vitamin C/Zinc|Dietary Supplement: Vitamin K2/D|Other: Microcrystalline Cellulose Capsule|Other: Medium Chain Triglyceride Oil",The Canadian College of Naturopathic Medicine|Ottawa Hospital Research Institute,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-04,01/10/21,2021-01-12,03/03/21,22/03/21,"The Centre for Health Innovation, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,8.0
3270.0,NCT04504032,A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Drug: Rivaroxaban|Drug: Placebo,Bill & Melinda Gates Medical Research Institute,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-02-09,01/04/21,2021-01-04,07/08/20,10/03/21,"Woodland Research Northwest LLC - ERG - PPDS, Rogers, Arkansas, United States|Science 37, Inc, Los Angeles, California, United States|Allergy and Asthma Medical Group and Research Center - CRN - PPDS, San Diego, California, United States|Invesclinic, LLC, Fort Lauderdale, Florida, United States|Advanced Pulmonary Research Institute, Loxahatchee Groves, Florida, United States|LCC Medical Research - Miami - BTC - PPDS, Miami, Florida, United States|Adult Medicine of Lake County, Mount Dora, Florida, United States|Providea Health Partners LLC, Evergreen Park, Illinois, United States|Clinical Research Institute, Inc - CRN - PPDS, Minneapolis, Minnesota, United States|Encompass Care, North Las Vegas, Nevada, United States|Riverside Medical Group - Circuit- PPDS, Secaucus, New Jersey, United States|NYC Health + Hospitals/Lincoln, Bronx, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Harlem Hospital Center, New York, New York, United States|Premier Family Physicians - Austin - Hunt - PPDS, Austin, Texas, United States|Village Health Partners - Plano - Hunt - PPDS, Plano, Texas, United States|South Texas Allergy and Asthma Medical Professionals, San Antonio, Texas, United States|Boundary House Medical Centre, Sale, Cheshire, United Kingdom|St Mary's Hospital - PPDS, London, City Of London, United Kingdom|Royal Free Hospital, London",United Kingdom,Respiratory Diseases,1,1,330.0
3271.0,NCT04432961,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),,Not yet recruiting,COVID-19,,,,,,,,Cambridge University Hospitals NHS Foundation Trust|University of Cambridge,All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-01-07,01/09/20,2021-01-07,16/06/20,16/06/20,,,Respiratory Diseases,1,1,366.0
3272.0,NCT04528771,S-Nitrosylation Therapy of COVID-19,,Not yet recruiting,SARS-CoV2 Infection,COVID-19,,,,,,Drug: SNO|Drug: Nitrogen gas,Robert Schilz|Case Western Reserve University|University Hospitals Cleveland Medical Center,All,"18 Years to 89 Years   (Adult, Older Adult)",21.0,Other,Interventional,2020-10-31,31/03/21,2021-04-30,27/08/20,27/08/20,"University Hospitals Cleveland Medical Center, Cleveland, Ohio",United States,Respiratory Diseases,1,2,181.0
3273.0,NCT04726150,Effect of CoVid-19 (CoronaVirusDisease-19) and Exercise on Myocardial Fibrosis and Ventricular Arrhythmias,CoViDEx,Not yet recruiting,COVID-19,Athletes Heart,Myocarditis Viral,Ventricular Arrythmia,,,,Other: ILR implantation,"University Hospital, Antwerp|Medtronic",All,"18 Years and older   (Adult, Older Adult)",250.0,Other|Industry,Observational,2021-01-04,01/04/23,2026-01-04,27/01/21,27/01/21,,,Respiratory Diseases,1,4,1826.0
3274.0,NCT04494399,IFN Beta-1b and Ribavirin for Covid-19,,Recruiting,COVID-19,,,,,,,Drug: Interferon beta-1b|Drug: Ribavirin,"The University of Hong Kong|Hospital Authority, Hong Kong",All,"18 Years and older   (Adult, Older Adult)",96.0,Other,Interventional,2020-07-29,01/07/22,2022-01-08,31/07/20,31/07/20,"The University of Hong Kong, Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,528.0
3275.0,NCT04424940,COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach,MD,Not yet recruiting,COVID-19,,,,,,,,University of Kinshasa|University Ghent|Université de Montréal,All,"15 Years to 75 Years   (Child, Adult, Older Adult)",800.0,Other,Observational,2020-01-09,01/06/21,2021-01-09,11/06/20,16/06/20,"Cliniques Universitaires de Kinshasa, Kinshasa, Congo",The Democratic Republic of the,Respiratory Diseases,1,1,366.0
3276.0,NCT04794400,Improved Oxygen Therapy in Covid-19,,Recruiting,COVID-19,,,,,,,Other: oxygen mask,Region Skane,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-04-02,31/12/21,2021-12-31,12/03/21,06/04/21,"Skåne University Hospital, Malmö, Skåne",Sweden,Respiratory Diseases,1,1,273.0
3277.0,NCT04425863,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19",IDEA,Completed,Severe Acute Respiratory Syndrome,Ventilation Pneumonitis,,,,,,"Drug: Ivermectin 5 MG/ML oral solution, Aspirin 250 mg tablets|Other: Ivermectin 5 mg/mL oral solution, Dexamethasone 4-mg injection, Aspirin 250 mg tablets|Other: Ivermectin 5 MG/ML oral solution, Dexamethasone 4-mg injection, Enoxaparin injection. Inpatient treatment with mechanical ventilation in ICU.",Eurnekian Public Hospital,All,"5 Years and older   (Child, Adult, Older Adult)",167.0,Other,Observational,2020-01-05,30/08/20,2020-08-30,11/06/20,19/10/20,"Hospital Eurnekian, Buenos Aires",Argentina,Others,0,2,238.0
3278.0,NCT04581096,Mapping COVID-19 Spread in a Tertiary Hospital,MEDyMAP,Recruiting,COVID-19,Spatial Visualization,Neural Network,Respiratory Disease,Pandemic,Disease Spread,,Other: no intervention,Hospital General Universitario de Valencia|University of Valencia,All,"18 Years to 100 Years   (Adult, Older Adult)",3000.0,Other,Observational,2020-02-10,15/02/21,2021-06-15,09/10/20,12/10/20,"CHGUV, Valencia, Spain|CHGUV, Valencia",Spain,Respiratory Diseases,1,6,491.0
3279.0,NCT04344834,Short and Long-term Psychological Impact of Covid-19 on The Egyptians,,Recruiting,Mental Health Issue,,,,,,,Diagnostic Test: A questionnaire or scales,Assiut University,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-06-15,30/03/21,2021-06-30,14/04/20,18/03/21,"Faculty of Medicine, Assiut",Egypt,Others,0,1,380.0
3280.0,NCT04647669,World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments,SOLIDARITY,Not yet recruiting,COVID-19,,,,,,,Drug: Remdesivir|Drug: Acalabrutinib|Drug: Interferon beta-1a|Other: Standard of Care,The University of The West Indies,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-02,30/11/21,2021-12-31,01/12/20,05/01/21,"Univeristy of the West Indies, Kingston",Jamaica,Respiratory Diseases,1,1,363.0
3281.0,NCT04779346,Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 Disease (COVID-19) in the Oncology Outpatient Setting,COVIDOUT,Recruiting,Cancer,COVID-19,Immunity,,,,,,Universitätsklinikum Hamburg-Eppendorf,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-12-21,31/12/21,2022-12-31,03/03/21,22/03/21,"Universitätsklinikum Hamburg-Eppendorf, Hamburg",Germany,"Respiratory Diseases, Cancers",1,3,740.0
3282.0,NCT04409873,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),AMPoL,Recruiting,COVID-19,SARS-CoV 2,Severe Acute Respiratory Syndrome Coronavirus 2,Virus Disease,Coronavirus Infections,Pharyngeal Diseases,,Drug: Oral-B Mouth Sore mouthwash|Drug: Crest Pro-Health Multi-Protection mouthwash|Drug: CloSYS Ultra Sensitive Rinse mouthwash|Drug: Distilled water|Drug: Listerine Zero Mouthwash Product,"University of California, San Francisco|Rowpar Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",150.0,Other|Industry,Interventional,2021-03-31,30/09/21,2021-09-30,01/06/20,08/04/21,"University Of California, San Francisco, San Francisco, California",United States,Respiratory Diseases,1,6,183.0
3283.0,NCT04409821,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,CO-CarES,Recruiting,Posttraumatic Stress Disorder,Prolonged Grief Disorder,COVID-19,,,,,Behavioral: Tele-delivered psychological intervention,"Rigshospitalet, Denmark",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-29,01/02/22,2022-01-02,01/06/20,03/02/21,"Skejby Hospital, Aarhus, Denmark|Rigshospitalet, Copenhagen, Denmark|Hospitalsenheden Vest, Horsens, Horsens, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Sygehus Lillebælt, Kolding, Kolding, Denmark|Odense University Hospital, Odense",Denmark,"Mental Health, Respiratory Diseases",1,3,583.0
3284.0,NCT04560413,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",,Completed,COVID-19,Post-stroke Depression,Anxiety and Fear,,,,,,Fatih Sultan Mehmet Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",77.0,Other,Observational,2020-01-06,25/07/20,2020-10-08,23/09/20,30/09/20,"Fatih Sultan Mehmet Training and Research Hospital, İstanbul",Turkey,"Mental Health, Cardiovascular Diseases, Respiratory Diseases",1,3,276.0
3285.0,NCT04694664,COVID-19 Vaccine Confidence Among Pregnant Women and Mothers,VCCOVID,Completed,Pregnancy Related,Mothers,,,,,,Other: This is an online survey with no intervention.,Pregistry|Harvard School of Public Health,Female,"18 Years to 65 Years   (Adult, Older Adult)",18000.0,Industry|Other,Observational,2020-01-10,01/12/20,2020-01-12,05/01/21,05/01/21,"Pregistry, Los Angeles, California",United States,Others,0,2,2.0
3286.0,NCT04396197,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,,Completed,COVID-19,Critical Illness,Ards,ICU Acquired Weakness,,,,Other: Physiotherapy,University Hospital Birmingham NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",92.0,Other,Observational,2020-01-03,08/05/20,2020-08-05,20/05/20,20/05/20,"UHB NHS Foundation Trust, Birmingham",United Kingdom,"Cardiovascular Diseases, Respiratory Diseases",1,4,215.0
3287.0,NCT04343898,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,STOP-COVID,"Active, not recruiting",Coronavirus Infection,,,,,,,Other: No intervention,"Brigham and Women's Hospital|Icahn School of Medicine at Mount Sinai|Montefiore Medical Center|Baylor College of Medicine|Baylor Health Care System|Beth Israel Deaconess Medical Center|University of Colorado, Denver|Cook County Hospital|The Cooper Health System|Duke University|Georgetown University|Hackensack mountainside hospital|Hackensack Meridian Health|Indiana University Health Methodist Hospital|Johns Hopkins University|Loma Linda University|Mayo Clinic|Medical College of Wisconsin|Northwestern|Weill Medical College of Cornell University|NYU Langone Health|Ochsner Health System|Oregon Health and Science University|Renown Health|Rush University Medical Center|New Jersey Medical School|Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University|Stanford University|Temple University|Tufts Medical Center|Tulane University|University of California, Davis|University of California, Los Angeles|University of California, San Diego|University of California, San Francisco|University of North Carolina, Chapel Hill|University Hospitals Cleveland Medical Center|University Medical Center of Southern Nevada|University of Alabama at Birmingham|University of Chicago|University of Florida|University of Illinois at Chicago|University of Kentucky|University of Miami|University of Michigan|University of Oklahoma|University of Pennsylvania|University of Pittsburgh Medical Center|University of Tennessee Health Science Center|University of Washington|University of Texas, Southwestern Medical Center at Dallas|Yale University",All,"18 Years and older   (Adult, Older Adult)",5154.0,Other,Observational,2020-01-04,01/08/20,2022-01-08,13/04/20,08/04/21,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,735.0
3288.0,NCT04363268,ACCESS A Master Digital Surveillance Protocol for COVID-19,ACCESS,Recruiting,Coronavirus,COVID-19,COVID-19,COVID-19,Corona Virus Infection,Coronavirus Infection,,,Medable Inc.|Datavant|American Heart Association|BioIntelliSense|PWNHealth,All,"18 Years and older   (Adult, Older Adult)",1000000.0,Other|Industry,Observational,2020-04-20,20/04/30,2031-01-10,27/04/20,28/04/20,"Medable Inc., Palo Alto, California",United States,Respiratory Diseases,1,6,3917.0
3289.0,NCT04435717,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),COVITOZ-01,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1|Drug: Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]_#1 (2 doses),Hospital Universitario Ramon y Cajal,All,"18 Years and older   (Adult, Older Adult)",78.0,Other,Interventional,2020-04-05,04/08/20,2020-04-08,17/06/20,17/06/20,"Hospital Universitario Ramón y Cajal, Madrid",Spain,Respiratory Diseases,1,1,3.0
3290.0,NCT04480424,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: GAMUNEX-C|Drug: Standard Medical Treatment,Grifols Therapeutics LLC,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-09-17,01/04/21,2021-01-05,21/07/20,26/03/21,"Via Christi Research, Wichita, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States|McLaren Flint, Flint, Michigan, United States|McLaren Health Care-Macomb, Mount Clemens, Michigan, United States|McLaren Health Care Oakland, Pontiac, Michigan, United States|CHI Health, Omaha, Nebraska, United States|Columbia University Medical Center, New York, New York, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Summa Health, Akron, Ohio, United States|Allegheny Health Network Research Institute, Pittsburgh, Pennsylvania, United States|CHRISTUS Health, Tyler, Texas, United States|MultiCare Deaconess Hospital, Spokane, Washington, United States|MultiCare Tacoma General Hospital, Tacoma, Washington",United States,Respiratory Diseases,1,1,110.0
3291.0,NCT04748172,COVID-19 Vaccine and Ovarian Reserve,,Recruiting,Fertility Issues,Vaccine Adverse Reaction,,,,,,Biological: SARS-CoV-2 virus vaccines|Diagnostic Test: AMH sampling,Sheba Medical Center,Female,18 Years to 42 Years   (Adult),200.0,Other,Observational,2021-01-02,01/02/22,2022-01-02,10/02/21,26/03/21,"Sheba Medical Center, Ramat-Gan",Israel,Others,0,2,365.0
3292.0,NCT04412317,Use of PCR-Sars-CoV-2 in Children,VIGIL,Recruiting,COVID-19,,,,,,,,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne|GPIP|AFPA|GFRUP,All,up to 14 Years   (Child),600.0,Other,Observational,2020-03-06,30/05/21,2021-05-31,02/06/20,25/02/21,"ACTIV network, Créteil, France|PARI network, Créteil",France,Respiratory Diseases,1,1,451.0
3293.0,NCT04761692,"Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake",,Not yet recruiting,COVID-19,Influenza,Pneumonia,Vaccine Refusal,,,,Behavioral: Full VEPMP Intervention|Behavioral: Partial VEPMP Intervention|Behavioral: Delayed VEPMP Intervention,Charles Drew University of Medicine and Science,All,65 Years and older   (Older Adult),570.0,Other,Interventional,2021-01-10,31/10/26,2026-12-31,21/02/21,21/02/21,"Charles R. Drew University of Medicine & Science, Los Angeles, California",United States,"Infectious Diseases, Respiratory Diseases",1,4,2181.0
3294.0,NCT04615728,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,observational,Completed,Acute Appendicitis,,,,,,,Procedure: laparoscopic or open appendicectomy,"Cambridge University Hospitals NHS Foundation Trust|R Antakia, A Xanthis, F Georgiades, V Hudson, J Ashcroft, S Rooney, AA Singh, JR O'Neill, N Fearnhead, RH Hardwick, RJ Davies, John M Bennett",All,"16 Years and older   (Child, Adult, Older Adult)",207.0,Other,Observational,2019-01-11,05/07/20,2020-06-10,04/11/20,04/11/20,"Addenbrooke's University Hospital, Cambridge, Cambridgeshire",United Kingdom,Others,0,1,516.0
3295.0,NCT04798066,Intermediate Size Expanded Access Protocol Evaluating HB-adMSC's for the Treatment of Post-COVID-19 Syndrome,LongHaulers,No longer available,COVID-19,,,,,,,Biological: Autologous HB-adMSC's,Hope Biosciences Stem Cell Research Foundation|Hope Biosciences,All,"18 Years to 65 Years   (Adult, Older Adult)",,Other,Expanded Access:Intermediate-size Population,,,,15/03/21,26/03/21,"Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas",United States,Respiratory Diseases,1,1,
3296.0,NCT04397575,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,CACOVID-19,"Active, not recruiting",Cancer,COVID-19,Solid Tumor,Social Inequality,French National Cohort,Chemotherapy,Immunotherapy,,Federation Francophone de Cancerologie Digestive|ARCAGY/ GINECO GROUP|GERCOR - Multidisciplinary Oncology Cooperative Group|GORTEC|IFCT|Association de Neuro-Oncologues d'Expression Francaise,All,"18 Years and older   (Adult, Older Adult)",1509.0,Other,Observational,2020-03-04,01/12/21,2021-01-12,21/05/20,25/02/21,"Ch D'Abbeville, Abbeville, France|CHU - Hôpital Sud, Amiens, France|CHU - Hôtel Dieu, Angers, France|Hôpital Privé, Antony, France|CH Victor Dupouy, Argenteuil, France|CH - Metz Thionville Mercy, Ars-Laquenexy, France|Hôpital Général d'Auch, Auch, France|Ch-Ght Unyon Auxerre, Auxerre, France|CH - Henri Duffaut, Avignon, France|PRIVE - Sainte Catherine, Avignon, France|CH, Bayeux, France|CH - Côte Basque, Bayonne, France|CH, Beauvais, France|CHU - Jean Minjoz, Besançon, France|PRIVE - Franche Comté, Besançon, France|PRIVE - Centre Pierre Curie, Beuvry, France|CH, Blois, France|PRIVE - Tivoli, Bordeaux, France|CH - Duchenne, Boulogne-sur-Mer, France|CHU - Ambroise Paré, Boulogne, France|CH - Fleyriat, Bourg-en-Bresse, France|CHU - Morvan, Brest, France|CHU - Pierre Wertheimer, Bron, France|CH - Germon et Gauthier - Service de Gastroentérologie, Béthune, France|CH, Béziers, France|CHU - Côte de Nacre, Caen, France|PRIVE - François Baclesse, Caen, France|CH, Calais, France|PRIVE - Infirmerie protestante, Caluire-et-Cuire, France|CH, Cannes, France|PRIVE - Médipole de Savoie, Challes-les-Eaux, France|PRIVE - Pôle Santé Léonard de Vinci, Chambray-lès-Tours, France|CH, Charleville-Mézières, France|CH, Chauny, France|CHP du Cotentin, Cherbourg, France|CH, Cholet, France|CH, Châlons-en-Champagne, France|CH - HIA Percy, Clamart, France|CHU - Estaing, Clermont-Ferrand, France|PRIVE - CAC Jean PERRIN, Clermont-Ferrand, France|CHU - Beaujon, Clichy, France|CH - Hôpitaux civils de Colmar, Colmar, France|CHU - Louis MOURIER, Colombes, France|CH - Compiegne, Compiègne, France|PRIVE - Saint Côme, Compiègne, France|CH - Sud Francilien, Corbeil-Essonnes, France|PRIVE - Cédres, Cornebarrieu, France|PRIVE - Clinique de Flandre, Coudekerque-Branche, France|CH - GHPSO Site de Creil, Creil, France|Ch - C.H.I.C., Créteil, France|CHU - Henri Mondor, Créteil, France|PRIVE - Centre Léonard de Vinci, Dechy, France|CHU - Hôpital François Mitterand, Dijon, France|PRIVE - CAC GF Leclerc, Dijon, France|PRIVE - Institut de Cancérologie de Bourgogne GRReCC, Dijon, France|CH - Louis Pasteur, Dole, France|CH, Douai, France|CH - Victor Jousselin, Dreux, France|PRIVE - Clinique Claude Bernard, Ermont, France|CH - Frejus Saint Raphael, Fréjus, France|PRIVE - Forcilles, Férolles-Attilly, France|CH, Grasse, France|CHU - Grenoble Alpes, Grenoble, France|PRIVE - GHM Daniel Hollard, Grenoble, France|CH - Marne La Vallée/Jossigny, Jossigny, France|CH - CHD Vendée, La Roche-sur-Yon, France|CH - Louis Pasteur, Le Coudray, France|PRIVE - L'Estuaire, Le Havre, France|PRIVE - Centre Jean Bernard, Le Mans, France|CH - Docteur Schaffner, Lens, France|CH - Saint Vincent, Lille, France|CHU - Claude Huriez, Lille, France|PRIVE - CAC Oscar Lambret, Lille, France|PRIVE - La Louvière Institut de Cancérologie Lille Métropole, Lille, France|CH - Robert Bisson, Lisieux, France|PRIVE - Teissier, Liévin, France|CH - GH Nord Essone, Longjumeau, France|CH - CHBS Hôpital du Scrorff, Lorient, France|CHU - Edouard Herriot, Lyon, France|CHU - La Croix Rousse, Lyon, France|PRIVE - La Sauvegarde Lyon, Lyon, France|CH - La Conception, Marseille, France|CH - Saint Joseph, Marseille, France|CHU - La Timone, Marseille, France|CH - GHI de l'Est Francilien Site de Meaux, Meaux, France|CH - Layné, Mont-de-Marsan, France|CH - Site du Mittan, Montbéliard, France|CH, Montélimar, France|CH - Emile Muller, Mulhouse, France|CH - Les Chanaux, Mâcon, France|PRIVE - Oncologie Gentilly, Nancy, France|PRIVE - Confluent SAS, Nantes, France|PRIVE - Hartmann, Neuilly-sur-Seine, France|CH - Pierre Beregovoy, Nevers, France|CH, Niort, France|CHU - Caremeau, Nîmes, France|CHR - Centre Hospitalier Régional La Source, Orléans, France|AP - HP - Pitié Salpêtrière, Paris, France|Bichat, Paris, France|CHU - Cochin, Paris, France|CHU - Lariboisière, Paris, France|CHU - Saint Antoine, Paris, France|CHU - Saint Louis, Paris, France|CHU - Tenon, Paris, France|Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France|Hôpital Européen Georges Pompidou, Paris, France|PRIVE - Saint Joseph, Paris, France|Privé - Montsouris, Paris, France|PRIVE - Centre Oncologie Catalan, Perpignan, France|CHU - Haut Lévêque, Pessac, France|CHU - Lyon Sud, Pierre-Bénite, France|PRIVE - Centre Cario HPCA, Plérin, France|CHU - La Miletrie, Poitiers, France|CH - René Dubos, Pontoise, France|CH, Périgueux, France|PRIVE - Clinique La Croix du Sud, Quint-Fonsegrives, France|CHU - Robert Debré, Reims, France|PRIVE - Polyclinique Courlancy, Reims, France|PRIVEE - Jean Godinot, Reims, France|PRIVEE - Polyclinique Courlancy, Reims, France|CHU - Charles Nicolle, Rouen, France|CAC - Institut Curie R. Huguenin, Saint-Cloud, France|PRIVE - Saint Grégoire, Saint-Grégoire, France|CH - Centre Hospitalier de Saint Malo, Saint-Malo, France|CH - Begin, Saint-Mandé, France|PRIVE - Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France|CHU - Hôpital Nord CHU Saint Etienne, Saint-Priest-en-Jarez, France|PRIVE - Ramsay Sainte Loire, Saint-Étienne, France|PRIVE - Trenel, Sainte-Colombe, France|CHU - Hautepierre, Strasbourg, France|ICAN - Institut de Cancérologie de Strasbourg Europe, Strasbourg, France|PRIVE - Strasbourg Oncologie Libérale, Strasbourg, France|CH - Foch, Suresnes, France|CH - Maison Santé Protestante, Talence, France|CH - Birgorre, Tarbes, France|CH - Leman, Thonon-les-Bains, France|CH - Sainte Musse, Toulon, France|CAC - Oncopole, Toulouse, France|CHU - Rangueil, Toulouse, France|CH - Gustave Dron, Tourcoing, France|CHU - Bretonneau, Tours, France|CH, Valence, France|CH, Valenciennes, France|PRIVE - Dentellières, Valenciennes, France|CHU - Brabois, Vandœuvre-lès-Nancy, France|PRIVE - Robert Schuman, Vantoux, France|CH - Paul Morel, Vesoul, France|CAC - Gustave Roussy, Villejuif",France,"Respiratory Diseases, Cancers",1,7,314.0
3297.0,NCT04358627,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,COVID-DEX,Not yet recruiting,Acute Respiratory Distress Syndrome,Inflammation,Dexmedetomidine,Cytokine Storm,"Delirium, Emergence",,,Drug: Dexmedetomidine Injectable Product,Hospital Clinic of Barcelona,All,"18 Years to 99 Years   (Adult, Older Adult)",80.0,Other,Observational,2020-04-15,30/05/20,2020-06-30,24/04/20,24/04/20,,,Respiratory Diseases,1,5,76.0
3298.0,NCT04527471,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,,"Active, not recruiting",Coronavirus Infection,COVID-19,COVID-19,,,,,Drug: Ensifentrine Dose 1|Drug: Placebo pMDI,Verona Pharma Inc|Verona Pharma plc,All,"18 Years to 80 Years   (Adult, Older Adult)",45.0,Industry,Interventional,2020-04-09,01/02/21,2021-01-03,26/08/20,15/01/21,"The University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,3,269.0
3299.0,NCT04549922,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,ASKCOV,"Active, not recruiting",COVID-19,,,,,,,Drug: ISIS 721744|Drug: Normal Saline,"Hospital do Coracao|Ionis Pharmaceuticals, Inc.|Hospital Moinhos de Vento",All,"18 Years to 80 Years   (Adult, Older Adult)",111.0,Other|Industry,Interventional,2020-10-22,01/02/21,2021-01-12,16/09/20,14/12/20,"Hospital Naval Marcílio Dias, Rio De Janeiro, Brazil|BP-A Beneficiência Portuguesa de São Paulo, São Paulo, Brazil|Hospital São Paulo - UNIFESP, São Paulo",Brazil,Respiratory Diseases,1,1,82.0
3300.0,NCT04339790,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,,"Active, not recruiting",Healthy Volunteer,Mood Disorder,Anxiety Disorder,Preexisting Medical Condition,,,,,National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",10000.0,NIH,Observational,2020-07-04,01/04/22,2022-01-04,09/04/20,23/02/21,"National Institute of Mental Health (NIMH), Bethesda, Maryland",United States,Mental Health,1,4,549.0
3301.0,NCT04459247,"Short Term, High Dose Vitamin D Supplementation for COVID-19",SHADE,"Active, not recruiting",COVID-19,,,,,,,Drug: Vit D,Postgraduate Institute of Medical Education and Research,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-15,30/08/21,2021-10-09,07/07/20,08/04/21,"Deptt of Endocrinology, Chandigarh",India,Respiratory Diseases,1,1,481.0
3302.0,NCT04346160,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",,Not yet recruiting,COVID-19,Conjunctivitis,,,,,,Diagnostic Test: Schirmer Test I,G. d'Annunzio University,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Observational,2020-04-14,30/04/20,2020-04-30,15/04/20,20/04/20,"Ophtalmology Clinic, G.d'Annunzio University, Chieti",Italy,Respiratory Diseases,1,2,16.0
3303.0,NCT03376854,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,CHILL-pilot,Recruiting,"Respiratory Distress Syndrome, Adult",Sars-CoV2,,,,,,Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of Care,"University of Maryland, Baltimore",All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2018-01-05,30/11/20,2020-12-31,19/12/17,16/06/20,"University of Maryland Medical Center, Baltimore, Maryland",United States,Respiratory Diseases,1,2,1091.0
3304.0,NCT04592354,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,AEO,Recruiting,COVID-19,,,,,,,Dietary Supplement: Oxaloacetate Medical Food/Dietary Supplement,Terra Biological LLC,Female,"18 Years to 65 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2020-10-15,15/04/21,2021-06-15,19/10/20,19/10/20,"Energy Medicine research Institute, Boulder, Colorado",United States,Respiratory Diseases,1,1,243.0
3305.0,NCT04355026,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: Bromhexine Oral Tablet and/or hydroxychloroquine tablet,General and Teaching Hospital Celje,All,"19 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-10-04,30/06/20,2020-07-31,21/04/20,21/04/20,"SB Celje, Celje",Slovenia,Respiratory Diseases,1,1,-65.0
3306.0,NCT04424797,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,,Recruiting,COVID-19,,,,,,,Other: Prone Positioning|Other: Supine Positioning,Poudre Valley Health System,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-13,01/12/20,2020-01-12,11/06/20,16/07/20,"UCHealth Poudre Valley Hospital, Fort Collins, Colorado, United States|UCHealth Greeley Hospital, Greeley, Colorado, United States|UCHealth Medical Center of the Rockies, Loveland, Colorado",United States,Respiratory Diseases,1,1,-183.0
3307.0,NCT04662684,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,MICHELLE,Recruiting,COVID-19,Venous Thromboembolism,,,,,,Drug: Rivaroxaban 10 MG,Science Valley Research Institute|Bayer,All,"18 Years to 90 Years   (Adult, Older Adult)",320.0,Other|Industry,Interventional,2020-10-16,30/04/21,2021-06-30,10/12/20,10/12/20,"Science Valley Research Institute, Santo André, São Paulo",Brazil,Respiratory Diseases,1,2,257.0
3308.0,NCT04359797,COVID-19 Patient Positioning Pragmatic Trial,,"Active, not recruiting",COVID-19,,,,,,,Other: Prone|Other: Usual Care,Vanderbilt University Medical Center,All,"18 Years and older   (Adult, Older Adult)",503.0,Other,Interventional,2020-04-27,17/12/20,2021-01-06,24/04/20,31/12/20,"NorthShore University HealthSystem, Highland Park, Illinois, United States|Vanderbilt University Medical Center, Nashville, Tennessee",United States,Respiratory Diseases,1,1,254.0
3309.0,NCT04842292,Nebulized Heparin for COVID19-associated Acute Respiratory Failure,,Recruiting,COVID-19,,,,,,,Drug: Heparin|Drug: Placebo,University of Kentucky,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-12-04,28/02/22,2022-03-31,13/04/21,13/04/21,"UK Healthcare, Lexington, Kentucky",United States,Respiratory Diseases,1,1,117.0
3310.0,NCT04750317,Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia,TOFA-COV-2,Completed,COVID-19,,,,,,,Drug: Tofacitinib,I.M. Sechenov First Moscow State Medical University,All,"18 Years and older   (Adult, Older Adult)",414.0,Other,Interventional,2020-11-05,01/08/20,2020-01-09,11/02/21,15/02/21,"Sechenov First Moscow State Medical University (Sechenov University) - University Clinical Hospital, Moscow",Russian Federation,Respiratory Diseases,1,1,-301.0
3311.0,NCT04756856,Muscle-targeted Nutritional Therapy for the Recovery From COVID-19,RE-COVID,Not yet recruiting,Sarcopenia,,,,,,,Other: Muscle-target oral nutritional supplementation,IRCCS Policlinico S. Matteo,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-03,01/12/21,2021-01-12,16/02/21,16/02/21,,,Others,0,1,9.0
3312.0,NCT04527224,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: AstroStem-V,Nature Cell Co. Ltd.,All,"19 Years to 80 Years   (Adult, Older Adult)",10.0,Industry,Interventional,2021-01-12,01/10/22,2023-01-04,26/08/20,01/04/21,,,Respiratory Diseases,1,1,722.0
3313.0,NCT04520191,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement,,Not yet recruiting,COVID-19,,,,,,,,University of New Mexico|Albuquerque area indian health board (AAIHB),All,"21 Years to 80 Years   (Adult, Older Adult)",529.0,Other,Observational,2020-01-09,01/08/21,2021-09-30,20/08/20,20/08/20,,,Respiratory Diseases,1,1,630.0
3314.0,NCT04714138,Remote Video Consultation for Quality of Life Assessment in Patients Hospitalised After COVID-19 Infection,TELECOVID,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier du Havre,All,"18 Years and older   (Adult, Older Adult)",190.0,Other,Observational,2021-05-01,20/02/21,2021-03-15,19/01/21,25/01/21,"Groupe Hospitalier Du Havre, Montivilliers, Normandie",France,Respiratory Diseases,1,1,-47.0
3315.0,NCT04757870,Macro-scale Estimators of Covid-19's Worldwide Cases and Deaths,,Not yet recruiting,COVID-19,,,,,,,Other: frequency,Dr. Servet Akar|Dokuz Eylul University|Hacettepe University|Izmir Katip Celebi University,All,"Child, Adult, Older Adult",1790.0,Other,Observational,2021-01-03,30/06/21,2021-12-31,17/02/21,18/02/21,,,Respiratory Diseases,1,1,362.0
3316.0,NCT04591210,The COVID-RASi Trial (COVID-19),,Recruiting,COVID-19,Cardiovascular Diseases,,,,,,Drug: Angiotensin converting enzyme inhibitor|Drug: Angiotensin II Receptor Blockers,Ottawa Heart Institute Research Corporation,All,65 Years and older   (Older Adult),1155.0,Other,Interventional,2021-01-27,01/12/21,2022-01-08,19/10/20,15/02/21,"University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,2,346.0
3317.0,NCT04495816,COVID-19 Anosmia Study,,Recruiting,Anosmia,COVID-19,,,,,,Drug: Omega-3 Fatty Acid Supplement|Drug: Placebo/Control,Icahn School of Medicine at Mount Sinai,All,"18 Years and older   (Adult, Older Adult)",126.0,Other,Interventional,2020-07-15,01/08/21,2021-01-08,03/08/20,01/03/21,"Mount Sinai Hospital, New York, New York",United States,Respiratory Diseases,1,2,177.0
3318.0,NCT04470531,Role of Co-trimoxazole in Severe COVID-19 Patients,,Recruiting,COVID-19,COVID-19,,,,,,Drug: oral co-trimoxazole,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh|Anwar Khan Mordern Medical College and Hospital, Dhaka|Mugda Medical College and Hospital, Dhaka",All,"18 Years to 70 Years   (Adult, Older Adult)",94.0,Other,Interventional,2020-12-07,12/10/20,2021-01-30,14/07/20,16/07/20,"Bangabandhu Sheikh Mujib Medical University, Dhaka",Bangladesh,Respiratory Diseases,1,2,54.0
3319.0,NCT04356690,Etoposide in Patients With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Etoposide,Boston Medical Center,All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Interventional,2020-08-05,01/12/21,2022-01-06,22/04/20,05/01/21,"Boston Medical Center, Boston, Massachusetts",United States,Respiratory Diseases,1,1,519.0
3320.0,NCT04838106,Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales,OPTIC-19,"Active, not recruiting",COVID-19,Myocardial Infarction,Stroke,Critical Illness,Heart Failure,Deep Vein Thrombosis,Pulmonary Embolism,Other: Not applicable as observational study,University of Oxford|Intensive Care National Audit & Research Centre,All,"16 Years and older   (Child, Adult, Older Adult)",319600.0,Other,Observational,2020-01-08,01/11/21,2021-01-11,08/04/21,08/04/21,"Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire",United Kingdom,"Cardiovascular Diseases, Respiratory Diseases",1,7,369.0
3321.0,NCT04746365,Ivermectin Role in Covid-19 Clinical Trial,IRICT,Completed,COVID-19,,,,,,,Drug: ivermectin|Drug: hydroxychloroquine|Drug: Placebo,Elaraby Hospital|Shebin El-Kom Teaching Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-06-12,31/01/21,2021-06-02,09/02/21,09/02/21,"Shebin-Elkom teaching hospital, Shibīn Al Kawm, Menoufia",Egypt,Respiratory Diseases,1,1,355.0
3322.0,NCT04338958,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,RuxCoFlam,Recruiting,COVID-19,,,,,,,Drug: Ruxolitinib,University of Jena,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-22,31/07/21,2021-07-31,08/04/20,28/01/21,"Universitätsmedizin Göttingen - Klinik für Hämatologie und Onkologie, Göttingen, Germany|University Hospital Jena, Jena, Germany|Klinikum der Landeshauptstadt Stuttgart gKöR, Stuttgart, Germany|Universitätsklinikum Ulm, Ulm, Germany|Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen, Germany|Universitätsklinikum Würzburg, Würzburg",Germany,Respiratory Diseases,1,1,465.0
3323.0,NCT04473105,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,,Recruiting,COVID-19,,,,,,,,Nottingham University Hospitals NHS Trust|East Midlands Academic Health Sciences Network,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-05,31/12/20,2021-01-31,16/07/20,08/10/20,"Nottingham University Hospitals NHS Trust, Nottingham",United Kingdom,Respiratory Diseases,1,1,392.0
3324.0,NCT04643054,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Ovotransferrin,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-12,28/02/21,2021-03-30,24/11/20,24/11/20,"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo",Italy,Respiratory Diseases,1,1,443.0
3325.0,NCT04430374,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,,Recruiting,Cardiovascular Diseases,,,,,,,Other: No interverntion,Hamad Medical Corporation,All,"Child, Adult, Older Adult",100.0,Industry,Observational,2020-02-06,31/12/20,2020-12-31,12/06/20,26/06/20,"Hamad Medical Corporation, Doha, Unlisted (UL)",Qatar,Others,0,1,329.0
3326.0,NCT04342897,A Study of LY3127804 in Participants With COVID-19,,Terminated,COVID-19,Pneumonia,,,,,,Drug: LY3127804|Drug: Placebo,Eli Lilly and Company,All,"18 Years and older   (Adult, Older Adult)",95.0,Industry,Interventional,2020-04-20,12/10/20,2020-12-10,13/04/20,29/10/20,"Banner Univ Med Ctr Phoenix, Phoenix, Arizona, United States|Banner Univ Med Ctr Tucson, Tucson, Arizona, United States|National Jewish Medical and Research Center, Denver, Colorado, United States|Nuvance Danbury Hospital, Danbury, Connecticut, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Parkview Research Center, Fort Wayne, Indiana, United States|Franciscan St. Francis Health, Indianapolis, Indiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Lahey Hospital and Medical Center, Burlington, Massachusetts, United States|Henry Ford Hospital Detroit, Detroit, Michigan, United States|Allina Hospital Network, Minneapolis, Minnesota, United States|State University of New York Hospital, Syracuse, New York, United States|East Carolina University, Greenville, North Carolina",United States,Respiratory Diseases,1,2,234.0
3327.0,NCT04352517,Influence Physical Activity Psychological Responses COVID-19 Pandemic,,Completed,Sedentary Behavior,Mental Health Wellness 1,,,,,,Other: Online Survey,University of Extremadura,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-03-16,31/08/20,2020-09-30,20/04/20,21/02/21,"Universidade da Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil|Universidad Autonoma de Chile, Santiago, Región Metropolitana, Chile|Universidad de la República, Rivera",Uruguay,Others,0,2,198.0
3328.0,NCT04341792,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,BIOCOVU,Recruiting,Infection Viral,Coronavirus,COVID-19,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-11-04,01/04/21,2021-01-04,10/04/20,25/09/20,"Hôpital Roger Salengro, CHU Lille, Lille",France,Respiratory Diseases,1,3,61.0
3329.0,NCT04666233,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,,Completed,Neonates Needing Resuscitation at Birth,,,,,,,Procedure: Neonatal resuscitation with PPE for the prevention of SARS-Cov-2 infection|Procedure: Neonatal resuscitation without PPE for the prevention of SARS-Cov-2 infection,University Hospital Padova,All,"Child, Adult, Older Adult",48.0,Other,Interventional,2021-03-16,23/03/21,2021-03-23,14/12/20,01/04/21,"Central Teaching Hospital of Bolzano/Bozen, Bolzano, Italy|Daniele Trevisanuto, Padova",Italy,Others,0,1,7.0
3330.0,NCT04756193,Evaluate Long Term Cardiovascular and Pulmonary Complications After COVID-19 With Point of Care Ultrasound,,Recruiting,COVID-19,Echocardiography,Ultrasound,,,,,"Diagnostic Test: Point of care ultrasound including echocardiography, lung ultrasound, vascular ultrasound",University of Louisville,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2021-01-04,31/12/22,2022-12-31,16/02/21,16/02/21,"University of Louisville Health, Louisville, Kentucky",United States,Respiratory Diseases,1,3,726.0
3331.0,NCT04333628,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,,Terminated,COVID-19,,,,,,,Drug: chloroquine|Other: standard care,"HaEmek Medical Center, Israel|T MAY BIOPHARMA LTD.",All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-01-06,01/09/20,2020-01-09,03/04/20,14/10/20,"Haemek Medical Center, Afula",Israel,Respiratory Diseases,1,1,3.0
3332.0,NCT04366921,European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,EuroECMO-COVID,Recruiting,COVID-19,COVID-19,"ARDS, Human",Refractory Hypoxemia,Cardiogenic Shock,Septic Shock,Extracorporeal Membrane Oxygenation,,"Maastricht University Medical Center|European chapter of the Extracorporeal Life Support Organization|Erasmus Medical Center|Leiden University Medical Center|UMC Utrecht|IRCCS Azienda Ospedaliero-Universitaria di Bologna|Papa Giovanni XXIII Hospital|Niguarda Hospital|Ospedale San Donato|Ospedale S. Giovanni Bosco|IRCCS Policlinico S. Matteo|The Mediterranean Institute for Transplantation and Advanced Specialized Therapies|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Ospedale dell'Angelo, Venezia-Mestre|University Hospital, Udine, Italy|San Gerardo Hospital|Ospedali Riuniti Ancona|San Camillo Hospital, Rome|San Giorgio Clinic|GVM Care & Research|San Raffaele University Hospital, Italy|Ospedale San Bortolo di Vicenza|Klinik Hirslanden, Zurich|University of Zurich|Cardiocentro Ticino|Vilnius University Hospital Santaros Klinikos|Universitätsklinikum Düsseldorf|Klinikum Nürnberg|Hannover Medical School|Heart Center Leipzig - University Hospital|University Hospital Regensburg|University Hospital, Essen|German Heart Center|University Hospital, Aachen|University Heart Center Freiburg - Bad Krozingen|Klinikum Kassel|General University Hospital, Prague|Universitaire Ziekenhuizen Leuven|Onze Lieve Vrouwziekenhuis Aalst|Erasme University Hospital|University Hospital, Antwerp|Hôpital Civil Marie Curie de Charleroi|University Hospital, Ghent|Centre Hospitalier Universitaire Saint Pierre|Hospital Vall d'Hebron|Hospital Universitario Ramon y Cajal|Hospital Miguel Servet|Henri Mondor University Hospital|Hospices Civils de Lyon|Pitié-Salpêtrière Hospital|Rennes University Hospital|Guy's and St Thomas' NHS Foundation Trust|Karolinska University Hospital|Hospital Sao Joao|Medical University of Warsaw|Universitätskliniken Innsbruck|Medical University of Vienna|University Hospital, Alexandroupolis|Novosibirsk City Hospital #2|City Clinical Hospital No. 67, Moscow, Russia|City Hospital No 40, Saint Petersburg, Russia|Krasnodar Regional Hospital no 1|Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash|City Hospital No 41, Ekaterinburg, Russia|G. Pasquinucci Heart Hospital, Massa|Charles University, Czech Republic|University Hospital, Bordeaux|Bambino Gesù Hospital and Research Institute|Policlinico Hospital Milan|Gaslini Children's Hospital|Children's Medical Hospital, University of Essen, Essen, Germany|University Hospital, Geneva|Newcastle-upon-Tyne Hospitals NHS Trust|Paediatric Intensive Care Glasgow|Paris South University Hospitals|University of Groningen|Great Ormond Street Hospital for Children NHS Foundation Trust|Hospital Sant Joan de Deu|Heim Pal Children's Hospital|University Hospital, Montpellier|Royal Brompton & Harefield NHS Foundation Trust|Lund University Hospital|Landesklinikum Sankt Polten|Chelyabinsk Regional Clinical Hospital|ECMO Centers Israel|Copenhagen University Hospital at Herlev|Ospedale Maurizio Bufalini|A.O.U. Città della Salute e della Scienza - Molinette Hospital|Mauriziano Umberto I Hospital|University of Bern|University Hospital, Basel, Switzerland|University of Lausanne Hospitals|University Hospital Tuebingen|Universitätsklinikum Köln|Chirec|Universitair Ziekenhuis Brussel|CHU de Liege|La Louvière Hopital|Leicester Royal Infirmary NHS Trust",All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-10-04,01/04/21,2021-01-04,29/04/20,29/04/20,"Universitätskliniken Innsbruck, Innsbruck, Austria|Landesklinikum Sankt Polten, St.Pölten, Austria|Medical University of Vienna, Vienna, Austria|Onze Lieve Vrouwziekenhuis Aalst, Aalst, Belgium|University Hospital, Antwerp, Antwerp, Belgium|Centre Hospitalier Universitaire Saint Pierre, Brussels, Belgium|Chirec, Brussels, Belgium|Erasme University Hospital, Brussel, Belgium|Universitair Ziekenhuis Brussel, Brussel, Belgium|Hôpital Civil Marie Curie de Charleroi, Charleroi, Belgium|University Hospital, Ghent, Ghent, Belgium|La Louvière Hopital, La Louvière, Belgium|Universitaire Ziekenhuizen Leuven, Leuven, Belgium|CHU de Liege, Liège, Belgium|Charles University, Czech Republic, Praha, Czechia|General University Hospital, Prague, Praha, Czechia|Copenhagen University Hospital at Herlev, Copenhagen, Denmark|University Hospital, Bordeaux, Bourdeaux, France|Hospices Civils de Lyon, Lyon, France|University Hospital, Montpellier, Montpellier, France|Henri Mondor University Hospital, Paris, France|Paris South University Hospitals, Paris, France|Pitié-Salpêtrière Hospital, Paris, France|Rennes University Hospital, Rennes, France|University Hospital, Aachen, Aachen, Germany|German Heart Center, Berlin, Germany|Universitätsklinikum Düsseldorf, Düsseldorf, Germany|Children's Medical Hospital, University of Essen, Essen, Germany, Essen, Germany|University Hospital, Essen, Essen, Germany|University Heart Center Freiburg - Bad Krozingen, Freiburg, Germany|Hannover Medical School, Hannover, Germany|Klinikum Kassel, Kassel, Germany|Universitätsklinikum Köln, Köln, Germany|Heart Center Leipzig - University Hospital, Leipzig, Germany|Klinikum Nürnberg, Nürnberg, Germany|University Hospital Regensburg, Regensburg, Germany|University Hospital Tuebingen, Tuebingen, Germany|University Hospital, Alexandroupolis, Alexandroupolis, Greece|Heim Pal Children's Hospital, Budapest, Hungary|ECMO Centers Israel, Jerusalem, Israel|San Giorgio Clinic, Alessandria, Italy|Ospedali Riuniti Ancona, Ancona, Italy|Papa Giovanni XXIII Hospital, Bergamo, Italy|St. Orsola Hospital, Bologna, Italy|Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy|Ospedale Maurizio Bufalini, Cesena, Italy|Gaslini Children's Hospital, Genua, Italy|G. Pasquinucci Heart Hospital, Massa, Massa, Italy|Policlinico Hospital Milan, Milano, Italy|Niguarda Hospital, Milan, Italy|Ospedale San Donato, Milan, Italy|San Raffaele University Hospital, Italy, Milan, Italy|San Gerardo Hospital, Monza, Italy|IRCCS Policlinico S. Matteo, Pavia, Italy|GVM Care & Research, Puglia, Italy|Bambino Gesù Hospital and Research Institute, Roma, Italy|San Camillo Hospital, Rome, Roma, Italy|A.O.U. Città della Salute e della Scienza - Molinette Hospital, Turin, Italy|Mauriziano Umberto I Hospital, Turin, Italy|Ospedale S. Giovanni Bosco, Turin, Italy|University Hospital, Udine, Italy, Udine, Italy|Ospedale dell'Angelo, Venezia-Mestre, Venice, Italy|Ospedale San Bortolo di Vicenza, Vicenza, Italy|Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania|University of Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Maastricht University Medical Center, Maastricht, Netherlands|Erasmus Medical Center, Rotterdam, Netherlands|UMC Utrecht, Utrecht, Netherlands|Medical University of Warsaw, Warsaw, Poland|Hospital Sao Joao, Porto, Portugal|Chelyabinsk Regional Clinical Hospital, Chelyabinsk, Russian Federation|City Hospital No 41, Ekaterinburg, Russia, Ekaterinburg, Russian Federation|Kemerovo Regional Clinical Cardiological Center named after academician L.S. Barbarash, Kemerovo, Russian Federation|Krasnodar Regional Hospital no 1, Krasnodar, Russian Federation|City Clinical Hospital No. 67, Moscow, Russia, Moscow, Russian Federation|Novosibirsk City Hospital #2, Novosibirsk, Russian Federation|City Hospital No 40, Saint Petersburg, Russia, Saint Petersburg, Russian Federation|Hospital Sant Joan de Deu, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital Miguel Servet, Zaragoza, Spain|Lund University Hospital, Lund, Sweden|Karolinska University Hospital, Stockholm, Sweden|University Hospital, Basel, Switzerland, Basel, Switzerland|University of Bern, Bern, Switzerland|University Hospital, Geneva, Geneva, Switzerland|University of Lausanne Hospitals, Lausanne, Switzerland|Cardiocentro Ticino, Lugano, Switzerland|Klinik Hirslanden, Zurich, Zürich, Switzerland|University of Zurich, Zürich, Switzerland|Royal Brompton & Harefield NHS Foundation Trust, Brompton, United Kingdom|Paediatric Intensive Care Glasgow, Glasgow, United Kingdom|Leicester Children's Hospital, Leicester, United Kingdom|Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Newcastle-upon-Tyne Hospitals NHS Trust, Newcastle Upon Tyne",United Kingdom,Respiratory Diseases,1,7,92.0
3333.0,NCT04500132,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: EC-18|Drug: Placebo EC-18,Enzychem Lifesciences Corporation,All,"19 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-05-28,01/08/21,2022-01-05,05/08/20,06/08/20,"Chungbuk National University Hospital, Cheongju-si, Korea",Republic of,Respiratory Diseases,1,1,587.0
3334.0,NCT04536090,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Isoquercetin (IQC-950AN),"Institut de Recherches Cliniques de Montreal|Pharmascience Inc.|SCiAN Services, Inc.|Quercis Pharma AG",All,"18 Years and older   (Adult, Older Adult)",150.0,Other|Industry,Interventional,2020-01-11,01/04/21,2021-01-05,02/09/20,26/10/20,,,Respiratory Diseases,1,1,360.0
3335.0,NCT04476680,Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion,IMPACTCOVID,Recruiting,SARS-CoV Infection,Vitamin D Deficiency,COVID-19,Acute Respiratory Tract Infection,,,,Dietary Supplement: Vitamin D,Royal Centre for Defence Medicine|Leeds Beckett University|Liverpool John Moores University,All,18 Years to 30 Years   (Adult),900.0,Other,Interventional,2020-01-09,28/04/21,2021-04-28,20/07/20,23/03/21,"Headingley and City campuses, Leeds Beckett University, Leeds, Yorkshire, United Kingdom|Infantry Training Centre Catterick, Catterick Garrison",United Kingdom,Respiratory Diseases,1,4,475.0
3336.0,NCT04491227,Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,,Enrolling by invitation,COVID-19,AKI,CKD,ESRD,"Transplant;Failure,Kidney",,,,"University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-05-05,30/04/22,2023-03-31,29/07/20,29/07/20,"University of Alabama, Birmingham, Birmingham, Alabama, United States|University of California, San Diego, San Diego, California, United States|University of Colorado, Aurora, Colorado, United States|St. Peter's Hospital, Albany, New York, United States|Jacobi Medical Center, New York, New York, United States|Hospital Obrero #2, Cochabamba, Bolivia|Hopital Sacre Coeur & Universite de Montreal, Montreal, Quebec, Canada|Universidad de Los Andes, Santiago, Chile|Postgraduate Institute of Research, Chandigarh, Chandigarh, India|Royal Free Hospital, London, United Kingdom|Guy's & St Thomas's Hospital, London, United Kingdom|University of Nottingham, Nottingham",United Kingdom,Respiratory Diseases,1,5,1060.0
3337.0,NCT04593069,The COGCOV Study in ICU Patients,COGCOV,Recruiting,COVID-19,Cognitive Impairment,,,,,,Behavioral: Neurocognitive assessment,Ziekenhuis Oost-Limburg,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-07-10,28/02/21,2021-02-28,19/10/20,22/10/20,"Ziekenhuis Oost-Limburg, Genk",Belgium,Respiratory Diseases,1,2,233.0
3338.0,NCT04615052,Home-based Exercise in COVID-19 Survivors,,Recruiting,COVID-19,SARS (Severe Acute Respiratory Syndrome),SARS-CoV Infection,,,,,Other: Exercise training,University of Sao Paulo,All,"40 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-26,31/10/21,2021-12-21,04/11/20,04/11/20,"University of Sao Paulo, Sao Paulo",Brazil,Respiratory Diseases,1,3,451.0
3339.0,NCT04800224,Brazilian Green Propolis Extract (EPP-AF) as an Adjunct Treatment for Hospitalized COVID-19 Patients (BeeCovid2),BeeCovid2,Recruiting,COVID-19,Inflammation,,,,,,Drug: Standardized Brazilian Green Propolis Extract|Drug: Placebo,D'Or Institute for Research and Education|Apis Flora Industrial e Comercial Ltda,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-12-04,30/06/21,2021-07-30,16/03/21,14/04/21,"Hospital Sao Rafael, Salvador, BA",Brazil,Respiratory Diseases,1,2,-127.0
3340.0,NCT04358406,Rhu-pGSN for Severe Covid-19 Pneumonia,,"Active, not recruiting",Sars-CoV2,,,,,,,Drug: Recombinant human plasma gelsolin (Rhu-pGSN)|Other: Placebo,BioAegis Therapeutics Inc.,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-07-30,01/05/21,2021-01-06,24/04/20,16/03/21,"Spitalul Clinic de Boli Infecţioase şi Pneumoftiziologie, Timişoara, Romania|Sant Joan de Reus SAM University Hospital, Reus, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona",Spain,Respiratory Diseases,1,1,160.0
3341.0,NCT04537949,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,,"Active, not recruiting",COVID-19,COVID-19,,,,,,Biological: BNT162b3,BioNTech SE,All,"18 Years to 85 Years   (Adult, Older Adult)",96.0,Industry,Interventional,2020-09-09,01/03/21,2022-01-02,03/09/20,26/02/21,"Contract Research Organization, Berlin, Germany|Contract Research Organization, Mannheim",Germany,Respiratory Diseases,1,2,480.0
3342.0,NCT04602351,Communication in ICU During COVID-19,,Enrolling by invitation,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,Severe Acute Respiratory Syndrome,,,,,Behavioral: Communication,NMC Specialty Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",200.0,Other,Observational,2021-03-22,07/04/21,2021-04-15,26/10/20,08/04/21,"NMC Specialty Hospital, Dubai",United Arab Emirates,Respiratory Diseases,1,3,24.0
3343.0,NCT04365816,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,,Completed,COVID-19,,,,,,,Other: Interview,"University Hospital, Grenoble|University Grenoble Alps",All,"18 Years and older   (Adult, Older Adult)",403.0,Other,Observational,2020-04-30,10/07/20,2020-10-07,28/04/20,28/07/20,"Marie-France VAILLANT, Grenoble",France,Respiratory Diseases,1,1,160.0
3344.0,NCT04537650,Swallowing Impairment After COVID-19 Infection,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Videofluoroscopic Swallowing Study (VFSS),"University Health Network, Toronto|National Institute on Deafness and Other Communication Disorders (NIDCD)|McMaster University|University of Florida",All,"18 Years and older   (Adult, Older Adult)",75.0,Other|NIH,Observational,2021-01-01,31/08/21,2021-12-31,03/09/20,14/04/21,"University of Florida, Gainesville, Florida, United States|McMaster University, Hamilton, Ontario",Canada,Respiratory Diseases,1,1,364.0
3345.0,NCT04611841,Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2,COV2020,Enrolling by invitation,COVID-19,,,,,,,,"Federal Research and Clinical Center of Physical-Chemical Medicine|Burnasyan Federal Medical Biophysical Center|Federal Research Clinical Center of Federal Medical & Biological Agency, Russia|Moscow city hospital named after S.I. Spasokukotskiy|Federal State Public Scientific Institution, Scientific Center for Family Health and Human Reproduction Problems|Federal State Budgetary Healthcare Institution, Hospital RAS",All,"18 Years to 75 Years   (Adult, Older Adult)",250.0,Other,Observational,2020-07-21,01/12/22,2022-01-12,02/11/20,02/11/20,"Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow",Russian Federation,Respiratory Diseases,1,1,540.0
3346.0,NCT04613271,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,FVR,Suspended,Infectious Disease,SARS-CoV Infection,COVID-19,,,,,Drug: Favipiravir|Drug: Azithromycin,"Ina-Respond|Center for Research and Development of Health Resources and Services, National Institute of Health Research and Development (NIHRD), Indonesia",All,18 Years to 59 Years   (Adult),210.0,Other,Interventional,2020-10-15,30/06/21,2021-06-30,03/11/20,27/01/21,"RSJ Soerodjo, Magelang, Central Java, Indonesia|RSUP Dr. Kariadi, Semarang, Central Of Java, Indonesia|RSPI Sulianti Saroso, Jakarta, DKI Jakarta",Indonesia,Respiratory Diseases,1,3,258.0
3347.0,NCT04674189,A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19,,Recruiting,Coronavirus,COVID-19,COVID-19,Severe Acute Respiratory Syndrome,,,,Biological: CVnCoV Vaccine|Drug: Placebo,CureVac AG,All,"18 Years and older   (Adult, Older Adult)",2520.0,Industry,Interventional,2020-12-23,30/06/21,2022-04-30,19/12/20,14/01/21,"Universitätsmedizin der Johannes Gutenberg-Universität Mainz Langenbeckstr. 1, Mainz",Germany,Respiratory Diseases,1,4,493.0
3348.0,NCT04743947,Vaccination Against COVID-19 in Chronic Kidney Disease,,Recruiting,Chronic Kidney Disease Stage 5 on Dialysis,Chronic Kidney Disease Stage 5 With Transplant,Vaccine Response Impaired,,,,,Other: No intervention; observational study,"Heinrich-Heine University, Duesseldorf",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-12-21,31/12/24,2025-12-31,08/02/21,10/02/21,"MVZ DaVita Rhein-Ruhr, Düsseldorf, Germany|KfH Kuratorium für Dialyse und Nierentransplantation e.V., Düsseldorf, Germany|University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf, Germany|Nephrocare Mettmann, Mettmann, Germany|Hospital Solingen, Solingen",Germany,Others,0,3,1836.0
3349.0,NCT04328480,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,COLCOVID,Recruiting,COVID-19,,,,,,,Drug: Colchicine|Other: Local standard of care,Estudios Clínicos Latino América|Population Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Interventional,2020-04-17,30/03/21,2021-03-30,31/03/20,01/03/21,"Sanatorio Parque, Rosario, Santa Fe",Argentina,Respiratory Diseases,1,1,347.0
3350.0,NCT04738331,Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database,CovPCR,Recruiting,COVID-19,SARS-CoV Infection,,,,,,,"University Hospital, Montpellier",All,"Child, Adult, Older Adult",10000000.0,Other,Observational,2021-01-02,20/05/22,2022-06-30,04/02/21,04/02/21,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,544.0
3351.0,NCT04498377,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,,Recruiting,COVID-19,,,,,,,Biological: F-652|Biological: Placebo,Generon (Shanghai) Corporation Ltd.,All,"18 Years and older   (Adult, Older Adult)",38.0,Industry,Interventional,2021-01-26,30/09/21,2021-12-31,04/08/20,28/01/21,"Tulane University School of Medicine, New Orleans, Louisiana",United States,Respiratory Diseases,1,1,339.0
3352.0,NCT04573764,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,KetoCOVID,Recruiting,COVID-19,,,,,,,"Dietary Supplement: D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester|Dietary Supplement: Placebo",Steno Diabetes Center Copenhagen,All,"18 Years and older   (Adult, Older Adult)",12.0,Other,Interventional,2021-01-02,01/10/21,2022-01-01,05/10/20,13/04/21,"Bispebjerg Hospital, Copenhagen, Please Select",Denmark,Respiratory Diseases,1,1,364.0
3353.0,NCT04791423,Study of GRAd-COV2 for the Prevention of COVID-19 in Adults,COVITAR,"Active, not recruiting",COVID-19,,,,,,,Biological: GRAd-COV2|Other: Placebo,ReiThera Srl|Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani,All,"18 Years and older   (Adult, Older Adult)",10300.0,Industry|Other,Interventional,2021-03-15,30/05/21,2022-04-30,10/03/21,14/04/21,"Ospedale Vittorio Emanuele Ii, Bisceglie, Barletta- Andria-Trani, Italy|Istituto per le Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, RM, Italy|Azienda Ospedaliera San Giuseppe Moscati, Avellino, Italy|A.O. Sant'Anna E San Sebastiano Caserta, Caserta, Italy|Asst Di Cremona, Cremona, Italy|Azienda Ospedaliero-Universitaria Di Ferrara, Ferrara, Italy|Ao Ospedali Riuniti - Foggia, Foggia, Italy|E.O. Ospedali Galliera, Genova, Italy|Presidio Ospedaliero Nord-Ospedale Santa Maria Goretti Latina, Latina, Italy|Fondaz.Irccs Ca' Granda - Ospedale Maggiore Policlinico, Milano, Italy|Asst Fatebenefratelli Sacco, Milano, Italy|Ospedale S.Gerardo - Monza, Monza, Italy|Azienda Ospedaliera Dei Colli - P Cotugno, Napoli, Italy|Azienda Ospedaliera Universitaria Della Universita' Vanvitelli I Di Napoli, Napoli, Italy|Az.Osp.Univ.P.Giaccone, Palermo, Italy|Azienda Ospedaliero-Universitaria Di Parma, Parma, Italy|Policlinico S. Matteo - Pavia, Pavia, Italy|Azienda Usl Di Piacenza, Piacenza, Italy|Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy|Azienda Ospedaliera Policlinico Umberto I, Roma, Italy|Policlinico A. Gemelli E C.I.C.- Policlinico Universitario A. Gemelli, Roma, Italy|Ospedale Amedeo Di Savoia, Torino, Italy|Azienda Sanitaria Universitaria Integrata Di Trieste, Trieste, Italy|Asst Dei Sette Laghi, Varese, Italy|Ospedale Unico Del Vercellese - Ospedale Sant'Andrea, Vercelli, Italy|Centro Ricerche Cliniche Di Verona Srl, Verona",Italy,Respiratory Diseases,1,1,411.0
3354.0,NCT04355728,Use of UC-MSCs for COVID-19 Patients,,Completed,Corona Virus Infection,ARDS,"ARDS, Human",Acute Respiratory Distress Syndrome,COVID-19,,,Biological: Umbilical Cord Mesenchymal Stem Cells + Heparin along with best supportive care.|Other: Vehicle + Heparin along with best supportive care,Camillo Ricordi|University of Miami,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2020-04-25,31/10/20,2020-10-31,21/04/20,01/03/21,"Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida",United States,Respiratory Diseases,1,5,189.0
3355.0,NCT04539795,COVID-19 Study of Safety and Tolerability of Alvelestat,COSTA,Recruiting,COVID-19,,,,,,,Drug: Alvelestat|Drug: Placebo,University of Alabama at Birmingham|Mereo BioPharma,All,"18 Years and older   (Adult, Older Adult)",15.0,Other|Industry,Interventional,2020-01-11,30/09/21,2021-09-30,07/09/20,19/10/20,"UAB Lung Health Center, Birmingham, Alabama",United States,Respiratory Diseases,1,1,628.0
3356.0,NCT04404218,The Açaí Berry COVID-19 Anti-Inflammation Trial,ACAI,Recruiting,COVID-19,,,,,,,Dietary Supplement: Açaí palm berry extract - natural product|Other: Placebo,"University Health Network, Toronto|University of Toronto",All,"40 Years and older   (Adult, Older Adult)",480.0,Other,Interventional,2020-04-08,01/03/21,2021-01-05,27/05/20,07/08/20,"Heart Health Institute Research Inc, Toronto, Ontario",Canada,Respiratory Diseases,1,1,272.0
3357.0,NCT04360876,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,,Withdrawn,COVID-19,ARDS,,,,,,Drug: Dexamethasone injection|Drug: Placebos,"University of Colorado, Denver",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-09,31/12/20,2021-01-30,24/04/20,28/10/20,,,Respiratory Diseases,1,2,387.0
3358.0,NCT04631666,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion,,Recruiting,COVID-19,,,,,,,Biological: DZIF-10c|Other: Placebo,University of Cologne|ZKS Köln|Boehringer Ingelheim,All,"18 Years to 70 Years   (Adult, Older Adult)",57.0,Other|Industry,Interventional,2020-08-12,31/07/21,2021-07-31,17/11/20,22/03/21,"University Hospital Cologne, Cologne, NRW",Germany,Respiratory Diseases,1,1,353.0
3359.0,NCT04715997,"Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults",,Recruiting,COVID-19,,,,,,,Drug: GX-19N,"Genexine, Inc.",All,18 Years to 55 Years   (Adult),170.0,Industry,Interventional,2020-12-30,30/05/21,2022-03-30,20/01/21,20/01/21,"KyungHee University Medical Center, Seoul, Korea, Republic of|Severance Hospital, Seoul, Korea, Republic of|Hanyang University Hospital, Seoul, Korea, Republic of|Gangnam Severance Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea",Republic of,Respiratory Diseases,1,1,455.0
3360.0,NCT04594343,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Disulfiram|Drug: Placebo,ETICA|Spring Research Foundation,All,"50 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-11-20,20/07/21,2021-01-09,20/10/20,08/04/21,"ETICA, Salvador, Bahia",Brazil,Respiratory Diseases,1,1,50.0
3361.0,NCT04444115,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,,Not yet recruiting,COVID-19,,,,,,,,Modum Bad|University of Oslo,All,"18 Years and older   (Adult, Older Adult)",10084.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,23/06/20,,,Respiratory Diseases,1,1,21.0
3362.0,NCT04656444,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID-19 Epidemic in France,COVIDTEL,Not yet recruiting,COVID-19,,,,,,,,Fondation Lenval,All,up to 17 Years   (Child),250.0,Other,Observational,2021-01-04,01/06/21,2021-01-06,07/12/20,05/02/21,"Hôpitaux Pédiatrique de Nice CHU Lenval, Nice",France,Respiratory Diseases,1,1,2.0
3363.0,NCT04358952,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,COCARDE,Recruiting,Cardiomyopathies,,,,,,,Diagnostic Test: Global Longitudinal Strain,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-04,04/04/21,2021-04-04,24/04/20,03/03/21,"UHToulouse, Toulouse",France,Others,0,1,365.0
3364.0,NCT04643561,Using Travelan to Boost Immune Response in Vitro to COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Other: Travelan OTC,Hadassah Medical Organization,Male,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-01-11,31/12/20,2020-12-31,25/11/20,27/11/20,"Hadassah Medical Organization, Jerusalem, Israel, Jerusalem",Israel,Respiratory Diseases,1,1,355.0
3365.0,NCT04336748,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,,Not yet recruiting,Sars-CoV2,Infection Viral,Healthcare Worker,Prophylaxis,,,,Drug: Hydroxychloroquine,Medical University of Vienna,All,"18 Years and older   (Adult, Older Adult)",440.0,Other,Interventional,2020-01-04,01/07/20,2020-01-08,07/04/20,07/04/20,,,Respiratory Diseases,1,4,4.0
3366.0,NCT04579562,Regional COVID Epidemiology in England (RECEDE),RECEDE,Not yet recruiting,Acute Kidney Injury,,,,,,,Other: No intervention,University Hospitals of Derby and Burton NHS Foundation Trust,All,"18 Years to 110 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-01-11,31/03/21,2021-10-31,08/10/20,08/10/20,,,Others,0,1,659.0
3367.0,NCT04343001,Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,CRASH-19,Withdrawn,COVID-19,,,,,,,Drug: Aspirin|Drug: Losartan|Drug: Simvastatin,London School of Hygiene and Tropical Medicine,All,"40 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-10,01/04/21,2021-01-08,13/04/20,19/11/20,"University College Hospital, Ibadan, Oyo, Nigeria|Shifa Tameer-e-Millat University, Rawalpindi",Pakistan,Respiratory Diseases,1,1,364.0
3368.0,NCT04307693,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),,Terminated,COVID-19,,,,,,,Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine sulfate,Asan Medical Center,All,"16 Years to 99 Years   (Child, Adult, Older Adult)",65.0,Other,Interventional,2020-11-03,30/04/20,2020-04-30,13/03/20,27/05/20,"Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea",Republic of,Respiratory Diseases,1,1,-187.0
3369.0,NCT04259892,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Cov-CONTACT,Recruiting,Coronavirus,,,,,,,Biological: 2019-nCoV PCR,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",345.0,Other,Observational,2020-04-02,04/10/20,2021-04-02,07/02/20,22/05/20,"Service de maladies infectieuses et tropicales Hôpital Jean Minjoz CHRU Besançon, Besançon, France|Service des Maladies infectieuses et tropicales, Pôle Spécialités médicales, CHU Pellegrin, Bordeaux, France|Service des maladies infectieuses Hôpital Gabriel Montpied CHU de Clermont Ferrand, Clermont-Ferrand, France|Centre d'investigation clinique 1432 Hôpital François Mitterrand CHU Bourgogne, Dijon, France|Centre d'investigation clinique 1406 CHU Grenoble, Grenoble, France|Centre d'Investigation Clinique 1403 -CHU Lille, Lille, France|Centre Investigation Clinique 1433 CHRU de NANCY, Nancy, France|Centre d'investigation clinique Infectiologie Hôtel-Dieu CHU Nantes, Nantes, France|Centre d'Investigation Clinique Hôpital Saint Louis, Paris, France|Centre d'investigation Clinique 1425, Hôpital Bichat Claude Bernard, Paris, France|Centre Investigation Clinique 1417 Hôpital Cochin Bâtiment Lavoisier, Paris, France|Centre d'investigation clinique 1414 Service de Pharmacologie clinique CHU Rennes Hôpital Pontchaillou, Rennes, France|Centre Hospitalier Félix Guyon Ile de la Réunion CHU nord, Saint Denis, France|Centre d'Investigation Clinique Ile de la Réunion CHU sud, Saint-Pierre, France|Département maladie infectieux CHU Saint Etienne, Saint-Étienne, France|Centre Investigation Clinique 1415 CHRU Tours - Hôpital Bretonneau, Tours, France|Service de Maladies infectieuses et tropicales Centre hospitalier, Cayenne",French Guiana,Respiratory Diseases,1,1,365.0
3370.0,NCT04382729,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,,Recruiting,COVID-19,,,,,,,Other: Neuromuscular Electrical Stimulation|Other: Physical Therapy Exercise,"University of Turin, Italy|San Luigi Gonzaga Hospital",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-04-17,01/07/20,2020-01-07,11/05/20,11/05/20,"San Luigi Gonzaga Hospital, Orbassano, TO",Italy,Respiratory Diseases,1,1,-101.0
3371.0,NCT04554251,Global Impact of COVID-19 on Pulmonology Special Units,,Enrolling by invitation,COVID-19,Global Impact,Pulmonology,,,,,Other: Survey,Assiut University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-01-09,01/12/20,2020-12-30,18/09/20,18/09/20,"Aliae Mohamed-Hussein, Assiut",Egypt,Respiratory Diseases,1,3,356.0
3372.0,NCT04392245,Proctologic Practice and Covid-19,PROCTOLOCK,Completed,COVID-19,,,,,,,,Societa Italiana di Chirurgia ColoRettale|Gaetano Gallo|Alessandro Sturiale|Veronica De Simone|Gian Luca Di Tanna|Iacopo Giani|Ugo Grossi,All,"Child, Adult, Older Adult",1050.0,Other,Observational,2020-04-15,26/04/20,2020-04-26,18/05/20,18/05/20,"Gallo Gallo, Catanzaro",Italy,Respiratory Diseases,1,1,11.0
3373.0,NCT04400461,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,,Completed,COVID-19,,,,,,,Other: Data collection and clinical testing of subjects,Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,All,"18 Years to 80 Years   (Adult, Older Adult)",71.0,Other,Observational,2020-05-15,25/02/21,2021-01-03,22/05/20,13/04/21,"Medical ICU. Hospital Universitario Ramón y Cajal, Madrid, Spain|Surgical ICU. Hospital Universitario Ramón y Cajal, Madrid",Spain,Respiratory Diseases,1,1,233.0
3374.0,NCT04653727,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,AtemNHK,Recruiting,COVID-19,Influenza A,Respiratory Disease,,,,,Other: Cross-sectional survey,"Charite University, Berlin, Germany",All,"18 Years to 99 Years   (Adult, Older Adult)",3000.0,Other,Observational,2021-06-01,01/05/21,2021-01-12,04/12/20,03/02/21,"Charite University, Berlin",Germany,"Infectious Diseases, Respiratory Diseases",1,3,-140.0
3375.0,NCT04385264,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,#StayHome,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Mannitol,"Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-12-05,01/08/20,2020-01-10,12/05/20,12/05/20,"Unisanté, Lausanne, Vaud",Switzerland,Respiratory Diseases,1,1,-330.0
3376.0,NCT04675086,Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection,,Withdrawn,COVID-19,"Pneumonia, Viral",,,,,,Drug: alpha1-proteinase inhibitor|Drug: Antiviral Agents,"Blessing Corporate Services, Inc|Takeda Pharmaceuticals North America, Inc.",All,"18 Years and older   (Adult, Older Adult)",0.0,Other|Industry,Interventional,2021-01-01,01/09/21,2021-01-12,19/12/20,21/12/20,"Blessing Corporate Services, Inc, Hannibal, Missouri",United States,Respiratory Diseases,1,2,11.0
3377.0,NCT04481529,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,SEROCO,"Active, not recruiting",Infection Viral,,,,,,,Other: Health Questionnaire,"University Hospital, Limoges",All,"18 Years and older   (Adult, Older Adult)",1576.0,Other,Observational,2020-07-29,15/12/20,2021-01-15,22/07/20,13/01/21,"CH Argenteuil - Service de Réanimation, Argenteuil, France|Ch Belfort, Belfort, France|CHU Dijon - Serve de Réanimation, Dijon, France|CHU de Limoges, Limoges",France,Others,0,1,170.0
3378.0,NCT04463602,Desidustat in the Management of COVID-19 Patients,,"Active, not recruiting",COVID-19,,,,,,,Drug: Desidustat|Other: Standard of Care,Cadila Healthcare Limited,All,"18 Years and older   (Adult, Older Adult)",24.0,Industry,Interventional,2020-07-25,25/01/21,2021-02-28,09/07/20,14/12/20,"Avant Sante Site 1, Monterrey",Mexico,Respiratory Diseases,1,1,218.0
3379.0,NCT04800770,The Effect of COVID-19 Patients' Serum Phosphate Level on Mortality in ICU,,Recruiting,Phosphate Deficiency,COVID-19,Mortality,,,,,Diagnostic Test: 4C mortality score,Ankara City Hospital Bilkent,All,"Child, Adult, Older Adult",160.0,Other,Observational,2021-03-03,15/06/21,2021-07-31,16/03/21,16/03/21,"Ankara City Hospital, Ankara",Turkey,Respiratory Diseases,1,3,150.0
3380.0,NCT04535674,Asunercept in Patients With Severe COVID-19,ASUNCTIS,Recruiting,COVID-19,COVID-19,,,,,,Biological: Asunercept,Apogenix AG,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry,Interventional,2020-09-10,01/02/21,2021-01-05,02/09/20,01/03/21,"Federal State Budgetary Educational Institution of Higher Education Kuban State Medical University of the Ministry of Health of the Russian Federation, Krasnodar, Russian Federation|State Budgetary Healthcare Institution Scientific Research Institute - Regional clinical hospital No. 1 n.a. professor S.V. Ochapovsky of the Ministry of Healthcare of Krasnodar Krai, Krasnodar, Russian Federation|State Budgetary Institution of Health of the Nizhny Novgorod Region Infectious Clinical Hospital No. 2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Saint Petersburg state budgetary healthcare institution Botkin clinical infectious diseases hospital, Saint Petersburg, Russian Federation|Saint Petersburg state budgetary healthcare institution City hospital of Saint George the great Martyr, Saint Petersburg, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution Mariinskaya City hospital, Saint Petersburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation, Ufa, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Bashkir State Medical University of the Ministry of Healthcare of the Russian Federation, Ufa, Russian Federation|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain|Hospital Universitario Infanta Sofia, San Sebastián De Los Reyes, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza",Spain,Respiratory Diseases,1,2,117.0
3381.0,NCT04496128,COVID19 Neurological Manifestation,,"Active, not recruiting",SARS-CoV 2,Neurologic Manifestations,,,,,,,University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-13,31/03/21,2021-04-30,03/08/20,08/04/21,"University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,2,382.0
3382.0,NCT04519320,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,COV-RECUP,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: Pulmonary function testing,Centre Hospitalier Universitaire de Besancon,All,"18 Years to 79 Years   (Adult, Older Adult)",140.0,Other,Interventional,2020-05-18,18/08/21,2025-08-18,19/08/20,24/08/20,"CHU Besançon, Besançon, Franche-Comté",France,Respiratory Diseases,1,1,1918.0
3383.0,NCT04655586,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",ASPEN,Recruiting,COVID-19,,,,,,,Drug: rNAPc2|Drug: Heparin,"ARCA Biopharma, Inc.|Colorado Prevention Center",All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2020-10-12,30/04/21,2021-05-31,07/12/20,05/04/21,"ARCA Investigational Site #119, Fairhope, Alabama, United States|ARCA Investigational Site #104, Aurora, Colorado, United States|ARCA Investigational Site #101, Jacksonville, Florida, United States|ARCA Investigational Site #113, New Orleans, Louisiana, United States|ARCA Investigational Site #105, Falls Church, Virginia, United States|ARCA Investigational Site #114, Richmond, Virginia, United States|ARCA Investigational Site #103, Tacoma, Washington",United States,Respiratory Diseases,1,1,231.0
3384.0,NCT04338906,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,CLOCC,Withdrawn,COVID-19,,,,,,,Drug: Camostat Mesilate|Drug: Placebo|Drug: Hydroxychloroquine,"Heinrich-Heine University, Duesseldorf|Universitätsklinikum Hamburg-Eppendorf|University Hospital, Frankfurt|St. Georg Hospital Leipzig, Germany|Hospital Schwabing Munich, Germany|Missioklinik, Wuerzburg, Germany",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-05,01/12/21,2021-01-12,08/04/20,21/12/20,,,Respiratory Diseases,1,1,373.0
3385.0,NCT04522037,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,CODYS,Recruiting,Patients Hospitalized in the Hospices Civils of Lyon,COVID-19,Moderate to Severe Dyspnea,Without Resuscitation Objective Management,,,,Other: No intervention / Compare the difference in respiratory rate between H0 and H12 of the initiation of morphine between the control and interventional groups,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,01/09/20,2021-01-02,21/08/20,21/08/20,"Hôpital de la Croix Rousse / GHN, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Lyon Sud, Pierre-Bénite",France,Respiratory Diseases,1,4,362.0
3386.0,NCT04445207,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,,Available,COVID-19,Sars-CoV2,Corona Virus Infection,,,,,Biological: Convalescent Plasma,"Jonathan Gerber|University of Massachusetts, Worcester",All,"12 Years and older   (Child, Adult, Older Adult)",,Other,Expanded Access:Treatment IND/Protocol,,,,24/06/20,24/06/20,"UMass Medical School, Worcester, Massachusetts",United States,Respiratory Diseases,1,3,
3387.0,NCT04604327,Comparison of Two Different Doses of Bemiparin in COVID-19,BEMICOP,Recruiting,COVID-19,,,,,,,Drug: Bemiparin sodium,"Clinica Universidad de Navarra, Universidad de Navarra",All,"18 Years and older   (Adult, Older Adult)",164.0,Other,Interventional,2020-10-26,31/05/21,2021-07-31,27/10/20,27/10/20,"Hospital Rey Juan Carlos, Móstoles, Madrid, Spain|Clinica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Clinic, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Hospital Universitario Bellvitge, L'Hospitalet De Llobregat, Spain|Fundación Jiménez Díaz, Madrid, Spain|Hospital Clínico San carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario de Salamanca, Salamanca, Spain|Complejo Hospitalario de Toledo, Toledo, Spain|Hospital Universitario Río Hortega, Valladolid",Spain,Respiratory Diseases,1,1,278.0
3388.0,NCT04374149,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,,Completed,Cytokine Release Syndrome,COVID-19,,,,,,Procedure: Therapeutic Plasma Exchange|Drug: Ruxolitinib,Prisma Health-Upstate,All,"12 Years to 80 Years   (Child, Adult, Older Adult)",20.0,Other,Interventional,2020-04-30,30/09/20,2020-01-12,05/05/20,25/03/21,"Prisma Health, Greenville, South Carolina",United States,Respiratory Diseases,1,2,-109.0
3389.0,NCT04492254,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,ETHIC,Not yet recruiting,COVID-19,,,,,,,Drug: Enoxaparin,Thrombosis Research Institute|Sanofi,All,"55 Years and older   (Adult, Older Adult)",1370.0,Other|Industry,Interventional,2020-01-07,01/01/21,2021-01-07,30/07/20,30/07/20,,,Respiratory Diseases,1,1,366.0
3390.0,NCT04368221,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,MY-CO-VID,Completed,COVID-19,,,,,,,,Rennes University Hospital,All,"18 Years and older   (Adult, Older Adult)",576.0,Other,Observational,2020-04-05,23/02/21,2021-02-23,29/04/20,30/03/21,"CHU Angers, Angers, France|CHU de Brest, Brest, France|CHU de Dijon, Dijon, France|CHU Grenoble, Grenoble, France|CHU Lille, Lille, France|CHU Lyon, Lyon, France|CHU Marseille, Marseille, France|CHU Nantes, Nantes, France|CHU de Nice, Nice, France|CHU Paris - Avicenne, Paris, France|CHU Paris - Bichat, Paris, France|CHU Paris - HEGP, Paris, France|CHU Paris - Mondor, Paris, France|CHU Paris - Tenon, Paris, France|Hôpital Lariboisière/ St Louis, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Pitié-Salpêtrière, Paris, France|CHU Poitiers, Poitiers, France|CHU Rennes, Rennes, France|CHU Strasbourg, Strasbourg, France|CHU Toulouse, Toulouse, France|CHU Tours, Tours",France,Respiratory Diseases,1,1,324.0
3391.0,NCT04555213,A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,NOXCOVID,Recruiting,COVID-19,,,,,,,Drug: NOX66,Noxopharm Limited,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-09-30,01/05/21,2021-01-12,18/09/20,03/03/21,"Institute of Emergency Medicine, Chisinau, Moldova",Republic of,Respiratory Diseases,1,1,104.0
3392.0,NCT04319315,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,,Recruiting,COVID-19,,,,,,,Other: survey,Assiut University,All,"25 Years to 65 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-11-03,01/04/20,2020-04-16,24/03/20,07/04/20,"Assiut University Hospitals, Assiut",Egypt,Respiratory Diseases,1,1,-201.0
3393.0,NCT04363216,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,,Not yet recruiting,COVID-19,,,,,,,Drug: Ascorbic Acid,Thomas Jefferson University,All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Interventional,2020-01-05,01/05/21,2021-01-05,27/04/20,05/05/20,,,Respiratory Diseases,1,1,366.0
3394.0,NCT04406181,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,,Recruiting,Anxiety and Fear,Anxiety Depression,Anxiety Postoperative,Psychological Stress,,,,Behavioral: HADS|Behavioral: a survey,Universitair Ziekenhuis Brussel,All,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-18,31/12/20,2021-01-01,28/05/20,01/06/20,"universitair Ziekenhuis Brussel, Jette, Vlaams Brabant",Belgium,Mental Health,1,4,228.0
3395.0,NCT04468893,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,,Recruiting,Anxiety,Depression,Sleep Disturbance,,,,,Behavioral: Online Intervention Mental Health COVID-19,Universidad Internacional de Valencia|Universidad Nacional Autonoma de Mexico|Universidad Autonoma de Ciudad Juarez,All,"18 Years to 70 Years   (Adult, Older Adult)",128.0,Other,Interventional,2020-05-20,31/12/20,2021-01-15,13/07/20,04/11/20,"Universidad Autónoma de Ciudad Juárez, Juarez, Chihuahua",Mexico,Mental Health,1,3,240.0
3396.0,NCT04602481,COVID-19 in People With Primary Ciliary Dyskinesia,,Recruiting,Primary Ciliary Dyskinesia,,,,,,,,University of Bern|Selbsthilfegruppe Kartagener Syndrom und Primäre Ciliäre Dyskinesie|Verein Kartagener Syndrom und PCD|PCD Family Support Group|PCD Foundation|PCD Australia|European Lung Foundation|University of Southampton|University of Lucerne,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-05-31,31/05/22,2025-05-31,26/10/20,26/10/20,"Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern",Switzerland,Others,0,1,1826.0
3397.0,NCT04296643,Medical Masks vs N95 Respirators for COVID-19,,Recruiting,Coronavirus,N95,Medical Mask,,,,,Device: Medical Mask|Device: N95 respirator,McMaster University|University of Alberta,All,"18 Years and older   (Adult, Older Adult)",576.0,Other,Interventional,2020-01-04,01/02/21,2021-01-04,05/03/20,12/02/21,"Foothills Medical Centre, Calgary, Alberta, Canada|University of Alberta Hospital, Edmonton, Alberta, Canada|Brantford General Hospital, Brantford, Ontario, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|St. Joseph's Healthcare, Hamilton, Ontario, Canada|Ottawa Hospital, Ottawa, Ontario, Canada|Hopital Montfort, Ottawa, Ontario, Canada|Niagara Health Services, St. Catherines, Ontario, Canada|St. Joe's Unity Health, Toronto, Ontario, Canada|St. Mike's Unity Health, Toronto, Ontario, Canada|Montreal University Health Centre, Montréal, Quebec, Canada|The Jewish General Hospital, Montréal, Quebec, Canada|Golden Care LTCF, Tzrifin",Israel,Respiratory Diseases,1,3,366.0
3398.0,NCT04568889,Minnesota COVID-19 Testing Project,,"Active, not recruiting",COVID-19,Infectious Disease,,,,,,Behavioral: A $10 Survey Incentive|Behavioral: A $20 Survey Incentive|Behavioral: Emphasis of Government Involvement|Behavioral: Emphasis of Academic Researchers Involvement|Behavioral: Cost-Benefit Frame|Behavioral: Duty Frame|Behavioral: Racial/Ethnic Frame|Behavioral: No Messaging,Harvard University|Abdul Latif Jameel Poverty Action Lab|Government of Minnesota,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-09-28,26/10/20,2021-06-30,29/09/20,10/02/21,"Volunteers Enlisted to Assist People, Bloomington, Minnesota, United States|Southern Anoka Community Assistance, Columbia Heights, Minnesota, United States|People Reaching Out to People Food Shelf, Eden Prairie, Minnesota, United States|Fridley Covenant Church, Fridley, Minnesota, United States|Calvary Lutheran Church Food Shelf, Minneapolis, Minnesota, United States|NorthPoint Health and Wellness, Minneapolis, Minnesota, United States|Community Emergency Assistance Programs, Minneapolis, Minnesota, United States|Intercongregation Communities Association, Minnetonka, Minnesota, United States|Valley Outreach, Stillwater, Minnesota, United States|White Bear Area Foodshelf, White Bear Lake, Minnesota",United States,Respiratory Diseases,1,2,275.0
3399.0,NCT04386395,Immune Changes in Severe COVID-19 Pulmonary Infections,COVIDIMM,"Active, not recruiting",COVID-19,Immune System Disorder,,,,,,,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-03-30,01/05/20,2020-05-30,13/05/20,13/05/20,"Centre Hospitalier Universitaire NANCY, Vandoeuvre-les-Nancy",France,Respiratory Diseases,1,2,61.0
3400.0,NCT04374071,Early Short Course Corticosteroids in COVID-19,,Completed,COVID-19,"Pneumonia, Viral",,,,,,Drug: Methylprednisolone,Henry Ford Health System,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-12-03,27/03/20,2020-04-30,05/05/20,05/05/20,"Henry Ford Hospital, Detroit, Michigan",United States,Respiratory Diseases,1,2,-217.0
3401.0,NCT04806815,"Menstrual Cycle-induced Pain, Fatigue, Anxiety and Physical Inactivity in Women Suffered From COVID-19",,Enrolling by invitation,Menstrual Problem,COVID-19,Fatigue,,,,,Other: A survey of 60 questions was created through the internet-based 'Google Forms surveys' site.,Biruni University,Female,18 Years to 45 Years   (Adult),180.0,Other,Observational,2021-03-25,30/04/21,2021-04-30,19/03/21,29/03/21,"Biruni University, Istanbul",Turkey,Respiratory Diseases,1,3,36.0
3402.0,NCT04613739,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,AFFORD COVID,Recruiting,Asthma,,,,,,,Behavioral: insurance navigation,"Harvard Pilgrim Health Care|Patient-Centered Outcomes Research Institute|Asthma and Allergy Foundation of America|University of North Carolina, Chapel Hill|Harvard School of Public Health",All,"4 Years to 64 Years   (Child, Adult)",430.0,Other,Interventional,2020-08-12,01/09/21,2023-01-31,03/11/20,02/03/21,"Harvard Pilgrim Health Care, Wellesley, Massachusetts",United States,Others,0,1,902.0
3403.0,NCT04397900,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,,Completed,COVID-19,COVID-19,,,,,,,"TScan Therapeutics, Inc.",All,"Child, Adult, Older Adult",80.0,Industry,Observational,2020-09-04,12/04/21,2021-12-04,21/05/20,14/04/21,"Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Atlantic Health System, Morristown, New Jersey",United States,Respiratory Diseases,1,2,456.0
3404.0,NCT04399967,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",QTW2020,Recruiting,Smoking Cessation,,,,,,,Behavioral: Chat-based support|Behavioral: AWARD plus COVID-specific advice|Behavioral: AWARD advice|Behavioral: COVID-19 related health warning leaflet|Behavioral: Health warning leaflet|Behavioral: SMS-based support|Behavioral: Referral card|Behavioral: COSH Self-help smoking cessation booklet,The University of Hong Kong|Hong Kong Council on Smoking and Health,All,"18 Years and older   (Adult, Older Adult)",842.0,Other,Interventional,2020-06-13,30/06/21,2022-06-30,22/05/20,30/09/20,"Hong Kong Council on Smoking and Health (COSH), Hong Kong, Hong Kong",China,Others,0,1,747.0
3405.0,NCT04813731,COVID-19 And Lingering Symptoms In Primary Care Patients,CALIP,Recruiting,COVID-19,Symptoms and Signs,,,,,,,"Katarina Hedin|Research Unit of General Practice, Aalborg|Utrecht University|National University of Ireland, Galway, Ireland|Region Jönköping County",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-12-12,31/12/21,2021-12-31,24/03/21,24/03/21,"Department of General Practice, Melbourne Medical School, University of Melbourne, Vic., Melbourne, Australia|Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium|the Academic Centre for General Practice (ACHG), Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium|Centro de Saúde Ana Rodrigues Matoso, Campinas, Brazil|Center for General Practice at Aalborg University, Aalborg, Denmark|Département de Santé Publique, Université Côte d'Azur, Centre Hospitalier Universitaire de Nice, Nice, France, Nice, France|R. Lugar Center for Public Health Research, Tbilisi, Georgia|Institut für Allgemeinmedizin Universitätsklinikum Würzburg Josef-Schneider-Str. 2/D7 97080 Würzburg, Würzburg, Germany|School of Medicine, National University of Ireland, Galway, Ireland|Covid-19 primary care special unit Sassuolo, Azienda Unità Sanitaria locale di Modena, Modena, Italy, Modena, Italy|Julius Center, University Medical Center Utrecht, Utrecht, Netherlands|Medical University of Lodz, Lodz, Łódź, Poland|Balan Medfam SRL, Cluj Napoca, Romania|Wetterhälsan Primary Health Care Centre, Jönköping, Sweden|Kärna Primary Health Care Centre, Linköping, Sweden|CPHC of Mukachevo United Territorial Community, Practice Mukachevo, Mukačeve, Ukraine|School of Medicine, University of St Andrews North Haugh, St Andrews KY16 9TF, Saint Andrews",United Kingdom,Respiratory Diseases,1,2,384.0
3406.0,NCT04407533,Dietary Intake and Eating Habits During the COVID-19 Pandemic,COVIDiet,"Active, not recruiting",COVID-19,,,,,,,Other: Diet tracking and survey,McGill University,All,"18 Years and older   (Adult, Older Adult)",2020.0,Other,Observational,2020-05-25,31/08/22,2022-08-31,29/05/20,17/03/21,"McGill University - School of Human Nutrition, Montréal, Quebec",Canada,Respiratory Diseases,1,1,828.0
3407.0,NCT04425772,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）,,Not yet recruiting,COVID-19,,,,,,,Drug: FNC+Standard of Care|Drug: FNC dummy tablet+Standard of Care,"HeNan Sincere Biotech Co., Ltd",All,"18 Years to 99 Years   (Adult, Older Adult)",342.0,Industry,Interventional,2020-12-06,12/08/20,2020-12-08,11/06/20,11/06/20,,,Respiratory Diseases,1,1,2.0
3408.0,NCT04583592,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),,Completed,COVID-19,,,,,,,Drug: Camostat Mesilate|Drug: Placebo,Sagent Pharmaceuticals Inc.,All,"18 Years and older   (Adult, Older Adult)",295.0,Industry,Interventional,2020-09-11,31/03/21,2021-03-31,12/10/20,02/04/21,"Palmtree Clinical Research, Inc. (Site 125), Palm Springs, California, United States|Synergy Healthcare, LLC (Site 124), Bradenton, Florida, United States|Clinical Research of Brandon, LLC (Site 123), Brandon, Florida, United States|Reliable Clinical Research, LLC (Site 100), Hialeah, Florida, United States|A+ Research (Site 112), Miami, Florida, United States|NextPhase Research Alliance at CANO HEALTH (Site 107), Miami, Florida, United States|Ezy Medical Research (Site 106), Miami, Florida, United States|Eminat LLC (Site 117), Plantation, Florida, United States|Invictus Clinical Research Group, LLC (Site 101), Pompano Beach, Florida, United States|Visionaries Clinical Research, LLC (Site 121), Atlanta, Georgia, United States|Family Care Research (Site 114), Boise, Idaho, United States|Cedar Crosse Research Center (Site 122), Chicago, Illinois, United States|Massachusetts General Hospital (Site 110), Boston, Massachusetts, United States|Oakland Medical Research Center (Site 108), Troy, Michigan, United States|Cary Research Group (Site 111), Cary, North Carolina, United States|Onsite Solutions (Site 118), Charlotte, North Carolina, United States|STAT Research (Site 109), Springboro, Ohio, United States|Toledo Institute of Clinical Research, Inc.(Site 105), Toledo, Ohio, United States|Advanced Medical Trials (Site 104), Georgetown, Texas, United States|Next Innovative Clinical Research (Site 115), Houston, Texas, United States|Rio Grand Valley Clinical Research Institute (Site 120), Pharr, Texas",United States,Respiratory Diseases,1,1,201.0
3409.0,NCT04350580,Polyvalent Immunoglobulin in COVID-19 Related ARds,ICAR,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Drug: Human immunoglobulin|Drug: Placebo,Centre Hospitalier St Anne|Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences|Laboratoire français de Fractionnement et de Biotechnologies,All,"18 Years and older   (Adult, Older Adult)",138.0,Other|Industry,Interventional,2020-11-04,01/04/21,2021-01-06,17/04/20,22/09/20,"CHU Sud Amiens, Amiens, France|CHU Angers, Angers, France|Service de réanimation polyvalente, rond point de Girac, Angoulême, France|CH Aulnay, Aulnay-sous-Bois, France|Centre hospitalier de Béthune, Beuvry, France|Hopital Avicenne, Bobigny, France|CH Chalons en champagne, Chalons en champagne, France|CH-Nord-Ardennes, Charleville-Mézières, France|Hopital d'instruction des armées Percy, Clamart, France|Centre Hospitalier de Dieppe, Dieppe, France|Hôpital Raymond Poincaré, Garches, France|CHU de Grenoble, Grenoble, France|Grand hopital de l'est Francilien - site de Jossigny, Jossigny, France|Hopital Robert Boulin, Libourne, France|Pôle de Médecine intensive/réanimation Hôpital Salengro, CHRU de Lille, Lille, France|Groupement Hospitalier Edouar Herriot, Lyon, France|Hôpital de la Croix Rousse Novembre 2019, Lyon, France|Hopital Jacques Cartier, Massy, France|Hopital Jacques Monod, Montivilliers, France|Service de Médecine Intensive-Réanimation, CHU, Nantes, France|CHR Orléans, Orléans, France|Centre Hospitalier Sainte-Anne, Paris, France|CHU Lariboisiere, Paris, France|CHU Pitié Salpétriere Service de réanimation chirurgicale, Paris, France|CHU Saint Antoine, Paris, France|Fondation ophtalmologique Rotschild, Paris, France|Hôpital Paris Saint-Joseph, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|Institut Mutualiste Montsouris, Paris, France|CHU Robert Débré, Reims, France|CH Poissy, Saint-Germain-en-Laye, France|Groupe hospitalier Saint Vincent, Strasbourg, France|Hôpital de Hautepierre, Strasbourg, France|Hopital de Tarbes, Tarbes, France|Hôpital Nord Franche-Comté, Trévenans, France|CH Valenciennes, Valenciennes, France|Chu Nancy - Brabois, Vandœuvre-lès-Nancy, France|Hopital de Vannes, Vannes, France|Institut Gustave Roussy, Villejuif, France|CH Etampes, Étampes",France,Respiratory Diseases,1,2,63.0
3410.0,NCT04385069,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,COV-HI,Recruiting,COV-HI,COVID-19,COVID-19,,,,,,"University College, London|Newcastle-upon-Tyne Hospitals NHS Trust|Sheffield Teaching Hospitals NHS Foundation Trust|The Leeds Teaching Hospitals NHS Trust|Nottingham University Hospitals NHS Trust|University College London Hospitals",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-16,05/07/20,2020-05-07,12/05/20,12/05/20,"The Leeds Teaching Hospitals NHS Trust, St James University Hospital, Leeds, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital, Newcastle Upon Tyne, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Sheffield",United Kingdom,Respiratory Diseases,1,3,21.0
3411.0,NCT04391686,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,RECOVERY,Recruiting,COVID-19,Obesity,,,,,,Diagnostic Test: indirect calorimetry,Centre Hospitalier Arras,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Observational,2020-03-07,02/11/21,2021-02-11,18/05/20,27/01/21,"Arras general hospital, Arras",France,"Metabolic Disorders, Respiratory Diseases",1,2,341.0
3412.0,NCT04319731,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,,Recruiting,SARS CoV-2 Infection,,,,,,,Biological: Human Amniotic Fluid,University of Utah,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-03-20,20/03/21,2021-03-20,24/03/20,17/04/20,"University of Utah Health, Salt Lake City, Utah",United States,Others,0,1,365.0
3413.0,NCT04425460,"A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",,Not yet recruiting,COVID-19,,,,,,,Drug: Favipiravir|Other: Placebo,"Zhejiang Hisun Pharmaceutical Co. Ltd.|Opera CRO, a TIGERMED Group Company",All,"18 Years to 75 Years   (Adult, Older Adult)",256.0,Industry|Other,Interventional,2020-01-06,01/08/20,2020-01-09,11/06/20,11/06/20,"The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Shangcheng District, China|Peking University First Hospital, Beijing, Xicheng District, China|Department of Internal Medicine Pneumology and infectious diseases Neukölln Clinic, Berlin, Germany|Medical clinic and polyclinic IV Hospital of the University of Munich, München, Germany|Infectious Diseases Hospital Cluj-Napoca, Cluj-Napoca, Cluj, Romania|National Institute of Infectious Diseases Prof.Dr.Matei Bals, Bucharest, Ilfov, Romania|Dr.Victor Babes Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timisoara, Timis, Romania|Dr.Victor Babes Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Dr.Victor Babes Infectious Diseases and Pneumoftiziology Clinical Hospital Timisoara, Timişoara, Timis, Romania|Emergency County Hospital Pius BrinzeuTimisoara, Timişoara, Timis",Romania,Respiratory Diseases,1,1,3.0
3414.0,NCT04498299,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,ECHO-vid,Recruiting,"Echocardiography, Stress",COVID-19,"Hypertension, Pulmonary",,,,,Diagnostic Test: echocardiogram 2D,Miguel Ayala León|Hospital Beneficencia Espanola de Puebla,All,18 Years to 45 Years   (Adult),30.0,Other,Observational,2020-01-09,01/10/20,2020-11-30,04/08/20,04/08/20,"Hospital Beneficencia Española de Puebla, Puebla",Mexico,"Mental Health, Cardiovascular Diseases, Respiratory Diseases",1,3,326.0
3415.0,NCT04447495,Self-sampling for the Study of COVID-19,,Not yet recruiting,Coronavirus,,,,,,,Diagnostic Test: iAMP test,Medical College of Wisconsin,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-07,31/12/20,2020-12-31,25/06/20,25/06/20,,,Respiratory Diseases,1,1,359.0
3416.0,NCT04505774,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),,Recruiting,COVID-19,,,,,,,Drug: theraputic heparin|Drug: prophylactic heparin|Drug: P2Y12,"Matthew Neal MD|National Heart, Lung, and Blood Institute (NHLBI)|University of Pittsburgh",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other|NIH,Interventional,2020-04-09,01/09/21,2021-01-12,10/08/20,02/03/21,"University of Alabama, Birmingham, Alabama, United States|Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|UC San Diego Hillcrest, San Diego, California, United States|Zuckerberg San Francisco General Hospital, San Francisco, California, United States|UCSF San Francisco, San Francisco, California, United States|Stanford University Medical Center, Stanford, California, United States|Denver Health and Hospital Authority, Denver, Colorado, United States|Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States|University of Florida, Gainesville, Florida, United States|Cook County Health, Chicago, Illinois, United States|University of Illinois at Chicago Health (UIH), Chicago, Illinois, United States|Kansas University Medical Center, Kansas City, Kansas, United States|Boston University, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Wayne State University, Detroit, Michigan, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, ACCS Research, Saint Louis, Missouri, United States|Rutgers New Jersey Medical School, Newark, New Jersey, United States|Albany Medical College, Albany, New York, United States|Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|VA New York Harbor Healthcare System, New York, New York, United States|NYU Langone, New York, New York, United States|Duke University Hospital, Durham, North Carolina, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|The MetroHealth System, Cleveland, Ohio, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|Ascension St. John Clinical Research Institute, Tulsa, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States|UPMC Presbyterian, Pittsburgh, Pennsylvania, United States|Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott and White Medical Center - Temple, Temple, Texas, United States|Swedish Hospital, Seattle, Washington, United States|University of Wisconsin Hospital; Meriter Hospital (UW affiliated), Madison, Wisconsin, United States|Hospital Universitario Ramon Y Cajal, Madrid, Spain|Hospital Clínico Universitario de Salamanca, Salamanca",Spain,Respiratory Diseases,1,1,278.0
3417.0,NCT04407221,COVID-19 Research in Organ Transplant Recipients,CORONA,Enrolling by invitation,Transplant Recipients,,,,,,,,Vastra Gotaland Region,All,"18 Years and older   (Adult, Older Adult)",1100.0,Other,Observational,2020-06-16,01/05/24,2024-01-05,29/05/20,05/01/21,"The Transplant Institute, Gothenburg, Vastra Gotaland",Sweden,Others,0,1,1298.0
3418.0,NCT04453891,Hexoskin Feasibility Study With COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Device: Monitoring physiological data with the Hexoskin smart shirt,Nguyen Thu Ngan Trinh|Hexoskin,All,"55 Years and older   (Adult, Older Adult)",16.0,Industry,Observational,2021-07-15,15/12/21,2021-12-15,01/07/20,10/02/21,,,Respiratory Diseases,1,1,153.0
3419.0,NCT04320615,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,COVACTA,Completed,COVID-19,,,,,,,Drug: Tocilizumab (TCZ)|Drug: Placebo,Hoffmann-La Roche,All,"18 Years and older   (Adult, Older Adult)",450.0,Industry,Interventional,2020-03-04,24/06/20,2020-07-28,25/03/20,25/09/20,"University of California San Diego, La Jolla, California, United States|eStudySite, La Mesa, California, United States|David Geffen School of Medicine UCLA, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Denver Health Medical Center, Denver, Colorado, United States|University of Miami Miller School of Medicine, Miami, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic Foundation, Baton Rouge, Louisiana, United States|Baystate Health System, Springfield, Massachusetts, United States|Mayo Clinic - PPDS, Rochester, Minnesota, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Robert Wood Johnson University Hospital/Rutgers, New Brunswick, New Jersey, United States|James J Peters Veterans Administration Medical Center - NAVREF, Bronx, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cleveland Clinic Foundation; Pulmonary, Allergy & Critical Care Medicine, Cleveland, Ohio, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Intermountain Medical Group, Saint George, Utah, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|Evergreen Health Infectious Disease, Kirkland, Washington, United States|Swedish Hospital Medical Center, Seattle, Washington, United States|Hamilton General Hospital; Pharmacy, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|Clinical Research Institute of Montreal, Montreal, Quebec, Canada|Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense Universitetshospital, Odense C, Denmark|Sjællands Universitetshospital, Roskilde, Roskilde, Denmark|Centre Hospitalier Departemental de Vendee, La Roche Sur Yon, France|Centre Hospitalier et Universitaire de Limoges, Limoges, France|Hôpital de La Croix Rousse, Lyon, France|Hotel Dieu - Nantes, Nantes, France|Hopital de la Pitie Salpetriere, Paris, France|HOPITAL COCHIN university hospital, Paris, France|CHRU de Tours, Pharmacie, Tours, France|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Uniklinik Köln, Köln, Germany|LMU Klinikum der Universitat Munchen, Munchen, Germany|Azienda Ospedaliera Dei Colli, Napoli, Campania, Italy|Istituto Nazionale Malattie Infettive Lazzaro Spallanzani IRCCS, Roma, Lazio, Italy|ASST Papa Giovanni XXIII; Dipartimento Interaziendale di Farmacia Clinica, Bergamo, Lombardia, Italy|ASST Fatebenefratelli Sacco - Ospedale Luigi Sacco, Milano, Lombardia, Italy|Azienda Ospedaliera San Gerardo di Monza, Monza MI, Lombardia, Italy|Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, Pavia, Lombardia, Italy|Amphia Ziekenhuis, Breda, Netherlands|St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Netherlands|Erasmus MC, Rotterdam, Netherlands|Universitair Medisch Centrum Utrecht, Utrecht, Netherlands|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Hospital Universitario HM Sanchinarro-CIOCC, Madrid, Spain|Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|University College Hospital, London, United Kingdom|Royal Free Hospital, London, United Kingdom|St George's Clinical Research Facility, London, United Kingdom|Imperial College London, London, United Kingdom|North Manchester General Hospital, Manchester, United Kingdom|Salford Royal Hospital, Salford",United Kingdom,Respiratory Diseases,1,1,146.0
3420.0,NCT04716998,Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19,,Recruiting,COVID-19,,,,,,,Biological: MesenCure,BonusBio Group Ltd,All,"18 Years to 80 Years   (Adult, Older Adult)",35.0,Industry,Interventional,2021-01-01,01/01/22,2022-01-01,20/01/21,22/01/21,"Rambam Health campus, Haifa",Israel,Respiratory Diseases,1,1,365.0
3421.0,NCT04452604,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,COVLA,Not yet recruiting,Acute Myeloblastic Leukemia,Acute Lymphoblastic Leukemia,COVID-19,,,,,,French Innovative Leukemia Organisation|Acute Leukemia French Association|Group for Research in Adult Acute Lymphoblastic Leukemia,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-08,01/08/23,2023-01-12,30/06/20,30/06/20,,,"Respiratory Diseases, Cancers",1,3,1100.0
3422.0,NCT04344236,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Saline oral/nasal rinse|Drug: 0.5% Povidone/Iodine oral/nasal rinse|Drug: 0.12% Chlorhexidine oral/nasal rinse,NYU Langone Health,All,"18 Years to 79 Years   (Adult, Older Adult)",48.0,Other,Interventional,2020-09-04,01/05/20,2020-09-05,14/04/20,14/04/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,1.0
3423.0,NCT04647734,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,,Not yet recruiting,COVID-19,,,,,,,Behavioral: High intensity interval training|Behavioral: Standard care,"Rigshospitalet, Denmark",All,"40 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-01,31/12/21,2021-12-31,01/12/20,01/12/20,"Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,1,364.0
3424.0,NCT04563702,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,,"Active, not recruiting",COVID-19,,,,,,,Biological: VXA-CoV2-1,Vaxart,All,18 Years to 54 Years   (Adult),35.0,Industry,Interventional,2020-09-21,10/05/21,2021-01-10,24/09/20,08/04/21,"WCCT, Cypress, California",United States,Respiratory Diseases,1,1,111.0
3425.0,NCT04341389,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),CTII-nCoV,"Active, not recruiting",COVID-19,,,,,,,Biological: Recombinant novel coronavirus vaccine (Adenovirus type 5 vector)|Other: Placebo,"Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China|CanSino Biologics Inc.|Jiangsu Province Centers for Disease Control and Prevention|Hubei Provincial Center for Disease Control and Prevention|Zhongnan Hospital",All,"18 Years and older   (Adult, Older Adult)",508.0,Other|Industry,Interventional,2020-12-04,31/01/21,2021-01-31,10/04/20,18/05/20,"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei",China,Respiratory Diseases,1,1,58.0
3426.0,NCT04480138,Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: Pegylated Interferon-α2b|Other: Standard of Care,Cadila Healthcare Limited,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-11-08,15/04/21,2021-05-30,21/07/20,28/01/21,"Avant Sante Site 1, Monterrey",Mexico,Respiratory Diseases,1,1,203.0
3427.0,NCT04344431,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),OHB10cov,Recruiting,COVID-19,,,,,,,Combination Product: Hyperbaric oxygen treatment (HBOT) i.e. inhalation of pressurized oxygen delivered by a hyperbaric chamber (drug/device),Direction Centrale du Service de Santé des Armées,All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-14,01/04/22,2022-01-04,14/04/20,27/10/20,"Hôpital d'Instruction des Armées Laveran, Marseille, France|Centre Hospitalier Intercommunal de Toulon - La Seyne-sur-Mer, Toulon, France|Hôpital d'Instruction des Armées Sainte-Anne, Toulon",France,Respiratory Diseases,1,1,630.0
3428.0,NCT04676971,Efficacy and Safety of hzVSF-v13 in Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),"ImmuneMed, Inc.",All,"18 Years and older   (Adult, Older Adult)",105.0,Industry,Interventional,2020-11-12,07/07/21,2021-10-18,21/12/20,08/01/21,"UOC Pneumologia, Bergamo, Italy|Dipartimento di Medicina Interna, Milano, Italy|Federal Siberian Scientific and Clinical Center of the Federal Medical and Biological Agency, Krasnoyarsk, Russian Federation|Central City Hospital of Novoshakhtinsk, Novoshakhtinsk, Russian Federation|Regional Clinical Hospital, Saratov, Russian Federation|Federal State Budgetary Educational Institution of Higher Education, Ufa",Russian Federation,Respiratory Diseases,1,1,340.0
3429.0,NCT04371978,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,,Recruiting,COVID-19,Coronavirus,"Diabetes Mellitus, Type 2",Diabetes Mellitus,Glucose Metabolism Disorders,Metabolic Disease,Endocrine System Diseases,Drug: Linagliptin 5 MG,Rabin Medical Center,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-10,30/06/21,2021-09-30,01/05/20,15/03/21,"Shamir Medical Center, Be'er Ya'aqov, Israel|Rabin Medical Center, Beilinson Campus, Petah tikva, Israel|Rabin Medical Center, Hasharon Campus, Petah tikva",Israel,"Metabolic Disorders, Respiratory Diseases",1,7,629.0
3430.0,NCT04647656,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,HBOTpCOVID,Not yet recruiting,COVID-19,Neurocognitive Dysfunction,,,,,,Device: Hyperbaric oxygen|Device: Sham,Assaf-Harofeh Medical Center,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2021-01-01,01/01/22,2023-01-01,01/12/20,01/12/20,"Assaf-Harofeh medical center, Zerifin",Israel,Respiratory Diseases,1,2,730.0
3431.0,NCT04429711,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin Oral Product,Sheba Medical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-12-05,30/09/20,2020-10-31,12/06/20,16/06/20,"Sheba Medical Center, Ramat-Gan",Israel,Respiratory Diseases,1,1,-35.0
3432.0,NCT04471701,Italian Web-based Cross-sectional Survey on COVID-19,EPICOVID19,Recruiting,COVID-19,SARS-CoV Infection,"Survey, Family Life",Epidemic Disease,Self-Assessment,,,Behavioral: Environmental exposure and clinical features,"Institute of Biomedical Technologies-National Research Council, Italy|National Research Council, Institute of Clinical Physiology, Italy|Institute of Neuroscience-National Research Council|University of Milan|Italian Society of Geriatrics and Gerontology|Italian Society of Infectious and Tropical Diseases",All,"18 Years and older   (Adult, Older Adult)",200000.0,Other,Observational,2020-04-13,31/07/20,2020-08-31,15/07/20,16/07/20,"Institute of Biomedical Technologies-National Research Council, Segrate, MI",Italy,Respiratory Diseases,1,5,140.0
3433.0,NCT04783311,"Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults",,Recruiting,COVID-19,,,,,,,Biological: EuCorVac-19|Other: Normal Saline,"EuBiologics Co.,Ltd",All,"19 Years to 75 Years   (Adult, Older Adult)",280.0,Industry,Interventional,2021-02-23,01/03/22,2023-01-01,05/03/21,05/03/21,"The Catholic University of Eunpyeong St.Mary's Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,677.0
3434.0,NCT04332081,Hyperbaric Oxygen for COVID-19 Patients,,Terminated,COVID-19,,,,,,,Device: hyperbaric oxygen therapy (HBOT),NYU Langone Health,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-06-04,29/05/20,2020-05-29,02/04/20,04/06/20,"NYU Winthrop Hospital, Mineola, New York",United States,Respiratory Diseases,1,1,-6.0
3435.0,NCT04338126,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,TCInpatient,Not yet recruiting,COVID-19,,,,,,,Drug: Tranexamic acid|Drug: Placebo oral tablet,University of Alabama at Birmingham,All,"19 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-09-30,15/12/21,2021-12-31,08/04/20,20/11/20,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,1,92.0
3436.0,NCT04468646,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: NK-1R antagonist,Prof. Dr. Fridoon Jawad Ahmad|University of Lahore|bahria international hospital|University of Health Sciences Lahore,All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-15,15/07/20,2020-08-30,13/07/20,13/07/20,"Bahria International Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,76.0
3437.0,NCT04776005,COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies,COVIDVAC OH,Not yet recruiting,Solid Tumor,Hematologic Malignancy,Thoracic Cancer,"Cancer, Treatment-Related",Vaccine Response Impaired,,,Other: Data collection,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-01-03,01/09/22,2022-01-12,01/03/21,04/03/21,"Saint-Louis Hospital, AP-HP, Paris, France|Bichat Hospital, AP-HP, Paris",France,Cancers,1,5,374.0
3438.0,NCT04377659,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Drug: Tocilizumab,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",9.0,Other,Interventional,2020-01-05,01/05/22,2022-01-05,06/05/20,27/11/20,"Memorial Sloan Kettering Cancer Center, New York, New York",United States,Respiratory Diseases,1,1,731.0
3439.0,NCT04839965,Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen,,Recruiting,COVID-19,,,,,,,Biological: Ampion|Other: Saline,Ampio Pharmaceuticals. Inc.,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2021-01-04,01/10/21,2021-01-11,09/04/21,13/04/21,"Research Site, Colorado Springs, Colorado",United States,Respiratory Diseases,1,1,7.0
3440.0,NCT04452617,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,,Completed,COVID-19,,,,,,,,Institut Mutualiste Montsouris,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-03-19,08/04/20,2020-01-07,30/06/20,01/09/20,"Institut Mutualiste Montsouris, Paris",France,Respiratory Diseases,1,1,-72.0
3441.0,NCT04738045,Comparison of Remdesivir Versus Lopinavir/ Ritonavir and Remdesivir Combination in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Remdesivir|Drug: Lopinavir/ Ritonavir and Remdesivir combination,Ahmed Essam|Beni-Suef University|October 6 University,All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-11,28/03/21,2021-01-04,04/02/21,17/03/21,"Beni-suef University, Banī Suwayf",Egypt,Respiratory Diseases,1,1,359.0
3442.0,NCT04816071,Essential Amino Acid Supplementation in Older Adult COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Essential amino acids|Dietary Supplement: Maltodextrin,University of Arkansas,All,"55 Years and older   (Adult, Older Adult)",104.0,Other,Interventional,2021-01-05,01/03/22,2022-01-03,25/03/21,08/04/21,"University of Arkansas for Medical Sciences, Little Rock, Arkansas",United States,Respiratory Diseases,1,1,363.0
3443.0,NCT04334005,Vitamin D on Prevention and Treatment of COVID-19,COVITD-19,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Vitamin D,Universidad de Granada,All,"40 Years to 70 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-04,30/06/20,2020-06-30,03/04/20,07/04/20,"Universidad de Granada, Granada, Andalucia, Spain|Medicine Faculty, Granada",Spain,Respiratory Diseases,1,1,-96.0
3444.0,NCT04362332,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",ARCHAIC,Terminated,COVID-19,,,,,,,Drug: Chloroquine Sulfate|Drug: Hydroxychloroquine|Other: Standard supportive care,UMC Utrecht|ZonMw: The Netherlands Organisation for Health Research and Development,All,"18 Years to 110 Years   (Adult, Older Adult)",25.0,Other,Interventional,2020-04-14,08/06/20,2020-08-06,24/04/20,19/06/20,"UMCU, Utrecht",Netherlands,Respiratory Diseases,1,1,114.0
3445.0,NCT04391101,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),,Not yet recruiting,SARS-Cov-2,,,,,,,Drug: Convalescent plasma,Hospital San Vicente Fundación|Clínica León XIII|Grupo de Inmunodeficiencias primarias Universidad de Antioquia|Clínica Universitaria Bolivariana|Hospital Pablo Tobón Uribe|Clínica Rosario El Tesoro|Clínica Las Américas|Clínica Cardiovid,All,"18 Years and older   (Adult, Older Adult)",231.0,Other,Interventional,2020-01-06,01/06/21,2021-01-12,18/05/20,20/05/20,"Hospital San Vicente Fundacion, Medellín, Antioquia",Colombia,Others,0,1,372.0
3446.0,NCT04699058,COVID-19 Sero-prevalence Health Care Workers Kinshasa,PRESTACOV,"Active, not recruiting",SARS-CoV Infection,Seroprevalence,,,,,,Diagnostic Test: COVID-antibody test,"Institute of Tropical Medicine, Belgium|Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo",All,"Child, Adult, Older Adult",1650.0,Other,Observational,2020-07-17,31/01/21,2021-04-30,07/01/21,03/03/21,"Institut Nationale de recherche Biomédicale, Kinshasa, Congo",The Democratic Republic of the,Respiratory Diseases,1,2,287.0
3447.0,NCT04713852,Predictive Value of SOFA and APACHE Scores for In-hospital Mortality in COVID-19 ICU Patients,,Completed,COVID-19,,,,,,,,Jessa Hospital,All,"18 Years and older   (Adult, Older Adult)",116.0,Other,Observational,2020-03-13,30/09/20,2020-12-31,19/01/21,19/01/21,"Jessa hospital, Hasselt",Belgium,Respiratory Diseases,1,1,293.0
3448.0,NCT04729595,Study to Evaluate Tempol (MBM-02) to Help Prevent Hospitalizations in COVID-19 Patients.,,Not yet recruiting,COVID-19,,,,,,,Drug: Tempol|Other: Placebo,Adamis Pharmaceuticals Corporation,All,"18 Years and older   (Adult, Older Adult)",310.0,Industry,Interventional,2021-01-05,30/12/21,2022-01-30,28/01/21,26/02/21,,,Respiratory Diseases,1,1,390.0
3449.0,NCT04522310,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,PAMOCOS,Recruiting,COVID-19,,,,,,,Other: MR-Pro-ADM,Centre Hospitalier de Lens,All,"18 Years and older   (Adult, Older Adult)",183.0,Other,Observational,2020-05-20,03/03/21,2021-06-28,21/08/20,03/03/21,"Hospital of Arras, Arras, France|Hospital of Boulogne/mer, Boulogne-sur-Mer, France|Hospital of DOUAI, Douai, France|Hospital of Dunkerque, Dunkerque, France|Hospital Dr Schaffner, Lens, France|Hospital of Roubaix, Roubaix, France|Hospital of Tourcoing, Tourcoing, France|Hospitalier of Valenciennes, Valenciennes",France,Respiratory Diseases,1,1,404.0
3450.0,NCT04776044,Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19,RESPIRE,Recruiting,COVID-19,,,,,,,Drug: ATR-002|Drug: Placebo,Atriva Therapeutics GmbH,All,"18 Years and older   (Adult, Older Adult)",220.0,Industry,Interventional,2021-01-03,01/12/21,2022-01-03,01/03/21,16/03/21,"Atriva study site 49001, Berlin, Germany|Atriva study site 49003, Frankfurt, Germany|Atriva study site 49002, Hemer, Germany|Atriva study site 49005, Homburg, Germany|Atriva study site 49004, Münster, Germany|Atriva study site 91002, Ahmedabad, India|Atriva study site 91001, Alīgarh, India|Atriva study site 91003, New Delhi, India|Atriva study site 91004, Raipur, India|Atriva study site 31001, Eindhoven, Netherlands|Atriva study site 31002, Tilburg, Netherlands|Atriva study site 27005, Benoni, South Africa|Atriva study site 27002, Cape Town, South Africa|Atriva study site 27003, George, South Africa|Atriva study site 27001, Mpumalanga, South Africa|Atriva study site 27004, Vereeniging, South Africa|Atriva study site 34001, Barcelona, Spain|Atriva study site 34002, Madrid, Spain|Atriva study site 34005, Madrid, Spain|Atriva study site 34004, Valencia",Spain,Respiratory Diseases,1,1,365.0
3451.0,NCT04380935,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Biological: Convalescent plasma|Drug: Standard of care,Indonesia University|Dr Cipto Mangunkusumo General Hospital|Fakultas Kedokteran Universitas Indonesia,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-05-18,31/10/20,2020-10-31,08/05/20,18/08/20,"Dr. Cipto Mangunkusumo General Hospital, Jakarta, DKI Jakarta, Indonesia|St. Carolus Hospital, Jakarta, DKI Jakarta, Indonesia|Ciputra Hospital CitraRaya, Jakarta, DKI Jakarta",Indonesia,Respiratory Diseases,1,2,166.0
3452.0,NCT04573348,T Cells Response to SARS COV 2 Peptides,,Recruiting,COVID-19,Corona Virus Infection,,,,,,Diagnostic Test: Savicell's ImmunoBiopsy™,Savicell Diagnostics Ltd,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-10-14,10/05/21,2021-10-10,05/10/20,02/11/20,"Carmel Medical Center, Haifa, North",Israel,Respiratory Diseases,1,2,361.0
3453.0,NCT04662671,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",,Completed,COVID-19,,,,,,,Device: RD-X19,EmitBio Inc.|KNOWBio Inc.,All,"18 Years to 65 Years   (Adult, Older Adult)",31.0,Industry,Interventional,2020-11-18,09/12/20,2021-01-30,10/12/20,11/02/21,"Site 2, Miami, Florida, United States|Site 1, College Station, Texas",United States,Respiratory Diseases,1,1,73.0
3454.0,NCT04569227,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,,Not yet recruiting,COVID-19,,,,,,,Drug: EC-18|Drug: Placebo,Enzychem Lifesciences Corporation,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-11-16,01/09/21,2021-01-11,29/09/20,29/10/20,,,Respiratory Diseases,1,1,56.0
3455.0,NCT04451174,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,PREDCOVID,Recruiting,COVID-19,,,,,,,Drug: Prednisone,University of Chile,All,"18 Years to 90 Years   (Adult, Older Adult)",184.0,Other,Interventional,2020-06-23,30/11/20,2020-12-30,30/06/20,20/10/20,"Hospital Santiago Oriente, Santiago, Peñalolen",Chile,Respiratory Diseases,1,1,190.0
3456.0,NCT04679350,Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),"ImmuneMed, Inc.",All,"19 Years and older   (Adult, Older Adult)",48.0,Industry,Interventional,2021-01-03,01/06/21,2021-01-07,22/12/20,22/12/20,"Yeungnam University Medical Center, Daegu, Korea, Republic of|Keimyung University Dongsan Hospital, Daegu, Korea, Republic of|Chungnam National University Hospital, Daejeon, Korea",Republic of,Respiratory Diseases,1,1,4.0
3457.0,NCT04406246,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,,Completed,Coronavirus Infection,,,,,,,Drug: Nitazoxanide 500Mg Oral Tablet,Materno-Perinatal Hospital of the State of Mexico|Laboratorios Liomont,All,"18 Years to 80 Years   (Adult, Older Adult)",150.0,Other|Industry,Interventional,2020-05-21,31/12/20,2020-12-31,28/05/20,30/03/21,"Materno-Perinatal Hospital Mónica Pretelini, Toluca",Mexico,Respiratory Diseases,1,1,224.0
3458.0,NCT04337359,Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,,No longer available,COVID-19,,,,,,,Drug: Ruxolitinib,Novartis Pharmaceuticals|Novartis is the Marketing Authorization Holder for Jakavi outside the US.|Novartis,All,"6 Years to 90 Years   (Child, Adult, Older Adult)",,Industry|Other,Expanded Access:Intermediate-size Population,,,,07/04/20,26/01/21,,,Respiratory Diseases,1,1,
3459.0,NCT04372186,A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,EMPACTA,Recruiting,COVID-19,,,,,,,Drug: Placebo|Drug: Tocilizumab,"Genentech, Inc.",All,"18 Years and older   (Adult, Older Adult)",379.0,Industry,Interventional,2020-05-14,18/08/20,2021-01-12,01/05/20,08/03/21,"Banner - University Medical Center Phoenix; In-Patient Pharmacy, Phoenix, Arizona, United States|Univ of AZ Coll of Med, Tucson, Arizona, United States|El Centro Regional Medical Center, El Centro, California, United States|Harper University Hospital, Fountain Valley, California, United States|eStudySite, La Mesa, California, United States|Highland Hospital Oakland, Oakland, California, United States|St. Joseph'S Hospital, Orange, California, United States|San Leandro Hospital; Inpatient Pharmacy, San Leandro, California, United States|Howard University, Washington, District of Columbia, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|Miami Veterans Administration Healthcare System - NAVREF, Miami, Florida, United States|University of Miami Pulmonary, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|St. Lukes Boise Medical Center, Boise, Idaho, United States|Great Lakes Clinical Trials, Chicago, Illinois, United States|Ochsner Clinic, New Orleans, Louisiana, United States|LSU-Shreveport, Shreveport, Louisiana, United States|Holy Cross Germantown Hospital, Germantown, Maryland, United States|Holy Cross Hospital, Silver Spring, Maryland, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|Sinai Grace Hospital, Detroit, Michigan, United States|Optum Health Care, Las Vegas, Nevada, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|St. Barnabas Hospital, Bronx, New York, United States|Kings County Hospital Center, Brooklyn, New York, United States|SUNY Downstate Medical Center., Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|Flushing Hospital, Flushing, New York, United States|Jamaica Hospital Medical Center, Jamaica, New York, United States|NYC Health and Hospitals Queens, Jamaica, New York, United States|Harlem Hospital, New York, New York, United States|Canton-Potsdam Hospital, Potsdam, New York, United States|Novant Health Presbyterian Medical Center (Presbyterian Hospital), Charlotte, North Carolina, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Novant Health Rowan Medical Center, Salisbury, North Carolina, United States|Novant Health Foryth Medical Center, Winston-Salem, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|JPS Health Network, Fort Worth, Texas, United States|Valley Baptist Medical Center, Harlingen, Texas, United States|Michael E Debakey VA Medical Center, Houston, Texas, United States|McAllen Medical Center, McAllen, Texas, United States|Crossroads Clinical Research, LLC, Victoria, Texas, United States|Sentara Medical Group, Virginia Beach, Virginia, United States|Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Hospital Unversitario Walter Cantidio, Fortaleza, CE, Brazil|Hospital Agamenon Magalhães, Recife, PE, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil|Centro Multidisciplinar de Estudos Clínicos CEMEC FMABC, Sao Bernardo Do Campo, SP, Brazil|BR Trials - Pesquisa Clínica, Sao Paulo, SP, Brazil|Escola Paulista de Medicina Da Universidade Federal de São Paulo - EPMUNIFESP, Sao Paulo, SP, Brazil|Hospital Heliópolis, Sao Paulo, SP, Brazil|Aga Khan University Hospital, Nairobi, Kenya|Organismo Publico Descentralizado Hospital Juarez de Mexico, Ciudad De México, Mexico|Hospital General de Culiacan, Culiacan, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Hospital Militar Central, Jesus Maria, Peru|Hospital Nacional Sergio E. Bernales, Lima, Peru|Hospital Nacional Arzobispo Loayza; Oncology, Lima, Peru|Hospital Nacional Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito; Unanue, Lima, Peru|Hospital Maria Auxiliadora, Lima, Peru|Hospital Nacional Dos de Mayo, Lima, Peru|University of the Free State, Bloemfontein, South Africa|George Provincial Hospital, George, South Africa|Peermed Clinical Trial Centre, Kempton Park, South Africa|Mzansi Ethical Research Centre, Middelburg, South Africa|Milpark Hospital, Parktown West, South Africa|University of Stellenbosch; Respiratory Research, Parow, South Africa|Phoenix Pharma, Port Elizabeth",South Africa,Respiratory Diseases,1,1,243.0
3460.0,NCT04344951,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",HOPE,Recruiting,"Pneumonia, Viral",COVID-19,,,,,,Drug: UNIKINON (Chloroquine phosphate) 200mg tablets,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.|Athens General Hospital Hippokrateio|Athens General Hospital of Thoracic Diseases SOTIRIA|General Hospital of Athens Sismanoglio|Divine Providence Hospital Pammakaristos|AHEPA University Hospital|University General Hospital of Ioannina|Corfu General Hospital Agia Irini,All,"18 Years to 90 Years   (Adult, Older Adult)",60.0,Industry|Other,Interventional,2020-06-04,01/04/21,2021-04-30,14/04/20,02/06/20,"Divine Providence Hospital Pammakaristos, Athens, Greece|Athens General Hospital Hippokrateio, Athens, Greece|Athens General Hospital of Thoracic Diseases SOTIRIA, 1st University Pulmonary Clinic, Athens, Greece|Athens General Hospital of Thoracic Diseases SOTIRIA, 3rd University Pathology Clinic, Athens, Greece|Corfu General Hospital Agia Irini, Corfu, Greece|University General Hospital of Ioannina, Ioánnina, Greece|General Hospital of Athens Sismanoglio, Maroúsi, Greece|University General Hospital of Thessaloniki AHEPA, Thessaloníki",Greece,Respiratory Diseases,1,2,330.0
3461.0,NCT04322565,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,ColCOVID-19,Recruiting,Coronavirus Infections,"Pneumonia, Viral",,,,,,Drug: Colchicine,Azienda Ospedaliero-Universitaria di Parma,All,"18 Years to 100 Years   (Adult, Older Adult)",310.0,Other,Interventional,2020-04-20,20/12/20,2020-12-21,26/03/20,10/07/20,"Azienda Ospedaliero Universitaria di Parma, Parma, PR",Italy,Respiratory Diseases,1,2,245.0
3462.0,NCT04405544,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,,Completed,Encephalopathy,COVID-19,,,,,,Diagnostic Test: CT-scan|Diagnostic Test: EEG|Diagnostic Test: EP|Diagnostic Test: Pulse oximetry|Diagnostic Test: Blood tests,"State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia",All,18 Years to 60 Years   (Adult),51.0,Other,Interventional,2020-05-22,22/07/20,2020-10-29,28/05/20,30/10/20,"N.I. Pirogov National Medical and Surgical Center, Moscow",Russian Federation,Respiratory Diseases,1,2,160.0
3463.0,NCT04659304,"Study Evaluating Safety, Tolerability and Efficacy of Allocetra-OTS in Patients With COVID-19",,Not yet recruiting,COVID-19,,,,,,,Drug: Allocetra-OTS|Other: Ringer's lactate,Enlivex Therapeutics Ltd.,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Industry,Interventional,2021-01-03,01/12/21,2022-01-03,09/12/20,10/12/20,,,Respiratory Diseases,1,1,365.0
3464.0,NCT04384458,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,,Recruiting,Coronavirus Infections,,,,,,,Drug: Hydroxychloroquine|Drug: Ivermectin,Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara,All,"18 Years to 70 Years   (Adult, Older Adult)",400.0,Other,Interventional,2020-07-20,10/09/20,2021-01-04,12/05/20,06/10/20,"Drug Research and Development Center (NPDM), Federal University of Ceará (UFC), Fortaleza, Ceará",Brazil,Respiratory Diseases,1,1,168.0
3465.0,NCT04379375,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,,Terminated,Health Behavior,COVID-19,,,,,,Behavioral: Nudge,Medical College of Wisconsin|Advancing a Healthier Wisconsin Endowment,All,"18 Years and older   (Adult, Older Adult)",45.0,Other,Interventional,2020-07-27,30/09/20,2020-09-30,07/05/20,05/10/20,"Medical College of Wisconsin, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,2,65.0
3466.0,NCT04637828,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,CureCovid-2019,Recruiting,COVID-19,,,,,,,Drug: GNS561,Genoscience Pharma,All,"18 Years and older   (Adult, Older Adult)",178.0,Industry,Interventional,2020-11-18,30/07/21,2021-10-30,20/11/20,20/11/20,"Genoscience Pharma, Marseille",France,Respiratory Diseases,1,1,346.0
3467.0,NCT04606784,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,,"Active, not recruiting",COVID-19,,,,,,,Biological: Ampion|Other: Standard of Care,Ampio Pharmaceuticals. Inc.,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-10-28,18/03/21,2021-06-18,28/10/20,24/03/21,"Research Site, Colorado Springs, Colorado",United States,Respiratory Diseases,1,1,233.0
3468.0,NCT04716556,TranSfUsion of coNvalescent plAsma for the Early Treatment of pneuMonIa in COVID-19 Patients,,"Active, not recruiting",COVID-19,Coronavirus Infection,"Pneumonia, Viral",,,,,Biological: Convalescent plasma,Istituto Superiore di Sanità|Gruppo Italiano Malattie EMatologiche dell'Adulto|Agenzia Italiana del Farmaco,All,"18 Years and older   (Adult, Older Adult)",474.0,Other,Interventional,2020-07-16,01/05/21,2021-01-05,20/01/21,05/03/21,"SOD Clinica Malattie Infettive Tropicali, Parassitologia, Epatiti Croniche - AOU Ospedali Riuniti di Ancona, Ancona, Italy|Ospedale di Arezzo, Arezzo, Italy|Clinica Malattie Infettive, Università degli Studi di Bari, Bari, Italy|Ospedale Papa Giovanni XXIII-Dip. emergenza, Urgenza e area critica, Bergamo, Italy|UOC Malattie Infettive - AOU Bologna, Bologna, Italy|UO PID Tossicologia Applicata - Dip. Scienze Biomediche e Biotecnologiche - Università di Catania - AOU Policlinico Vittorio Emanuele, Catania, Italy|Ospedale Città di Castello, Città Di Castello, Italy|Ospedale di Empoli, Empoli, Italy|UOC Malattie Infettive - ASUR Marche Area Vasta 4, Fermo, Italy|UOC Malattie Infettive - AOU Ferrara, Ferrara, Italy|Ospedale Santa Maria Annunziata, Firenze, Italy|SOD Malattie Infettive e Tropicali - AOU Careggi, Firenze, Italy|Dip.Medicina Clinica e Sperimentale - Policlinico Riuniti di Foggia, Foggia, Italy|Nuovo Ospedale S. Giovanni Battista Usl Umbria2, Foligno, Italy|U.O.C. Malattie Infettive ASL Frosinone, Frosinone, Italy|U.O. Malattie Infettive IRCCS-Ospedale Policlinico San Martino, Genova, Italy|Ospedale di Grosseto, Grosseto, Italy|ASL 5 Spezzina - SC Malattie Infettive, La Spezia, Italy|ASST Lecco - Malattie Infettive, Lecco, Italy|Ospedale di Livorno, Livorno, Italy|Ospedale di Lucca, Lucca, Italy|S.C. Pneumologia e Utir ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|Ospedale Dell'Angelo - UOC Malattie Infettive, Mestre, Italy|ASST Santi Paolo e Carlo, Milano, Italy|Ospedale Luigi Sacco, Milano, Italy|SC Malattie Infettive ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|Ospedale San Gerardo, Monza, Italy|Malattie Infettive - AOU Federico II di Napoli, Napoli, Italy|UOC Malattie Infettive ad indirizzo Respiratorio - PO Cotugno - AORN Dei Colli, Napoli, Italy|UOC Malattie Infettive e Tropicali - AOU Policlinico, Palermo, Italy|Dip. Medicina Diagnost. e Servizi Fondazione IRCCS Policlinico San Matteo, Pavia, Italy|Azienda Ospedaliero-Universitaria di Perugia, Perugia, Italy|UOC Malattie Infettive - Azienda Ospedali Riuniti Marche Nord, Pesaro, Italy|AOU Pisana, Pisa, Italy|Ospedale Pistoia, Pistoia, Italy|Ospedale Prato, Prato, Italy|Malattie Infettive Ravenna, Ravenna, Italy|UOC Malattie Infettive - AUSL Reggio Emilia, Reggio Emilia, Italy|Malattie Infettive - Rimini Forlì Cesena, Rimini, Italy|Campus Bio Medico - UO Anestesia e Rianimazione, Roma, Italy|ASL 1 Imperiese - SC Malattie Infettive, Sanremo, Italy|ASL 2 Savonese - SC Malattie Infettive, Savona, Italy|Ospedale di Siena, Siena, Italy|Ospedale di Sondrio - dipartimento di Medicina, Sondrio, Italy|AOU di Terni, Terni, Italy|Ospedale Ca Foncello - UOC Malattie Infettive, Treviso, Italy|A.O. Integrata Università di Verona, Verona, Italy|Ospedale Viareggio, Viareggio",Italy,Respiratory Diseases,1,3,173.0
3469.0,NCT04615975,Ketogenic Diet as Protective Factor During COVID-19,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Ketogenic diet with phytoextracts,University of Padova|San Bortolo Hospital - Vicenza,All,"18 Years to 100 Years   (Adult, Older Adult)",28.0,Other,Interventional,2020-01-11,30/07/21,2021-08-30,04/11/20,04/11/20,"Ospedale San Bortolo, Vicenza",Italy,Respiratory Diseases,1,1,597.0
3470.0,NCT04359875,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,COVIQuest,Completed,Cardiovascular Diseases,Mental Disorder,,,,,,Behavioral: Phone-call screening and management by a medical student/general practitioner tandem,"University Hospital, Tours|INSERM CIC-P 1415",All,"18 Years to 110 Years   (Adult, Older Adult)",22000.0,Other,Interventional,2020-04-30,30/06/20,2020-12-31,24/04/20,12/04/21,"Dibao-Dina, Tours",France,Others,0,2,245.0
3471.0,NCT04601077,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,,Recruiting,COVID-19,,,,,,,"Drug: Nitric Oxide lozenges, 30 mg|Drug: Placebo",Nitric Oxide Innovations LLC,All,"50 Years to 85 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2020-01-11,01/06/21,2021-07-31,23/10/20,09/12/20,"American Institute of Therapeutics, Lake Bluff, Illinois",United States,Respiratory Diseases,1,1,567.0
3472.0,NCT04807075,"A Wearable, Battery-free Screening System for SARS-CoV-2, the Virus Causing COVID-19, Infection",,Not yet recruiting,COVID-19,,,,,,,,University of Nebraska,All,"19 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2021-01-05,25/06/21,2021-06-30,19/03/21,19/03/21,,,Respiratory Diseases,1,1,176.0
3473.0,NCT04741282,Pulmonary Tele-rehabilitation and Progressive Muscle Relaxation on Discharged Covid-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Other: Pulmonary telerehabilitation|Other: progressive muscle relaxation training,Iran University of Medical Sciences,All,"18 Years to 65 Years   (Adult, Older Adult)",52.0,Other,Interventional,2021-09-15,15/08/22,2022-08-15,05/02/21,17/03/21,,,Respiratory Diseases,1,1,334.0
3474.0,NCT04455815,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,,Recruiting,COVID-19,,,,,,,Drug: Camostat,Cancer Research UK|Latus Therapeutics,All,"50 Years and older   (Adult, Older Adult)",389.0,Other,Interventional,2020-09-25,31/08/21,2021-08-31,02/07/20,20/01/21,"The University of Edinburgh, Edinburgh, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|Preston Lantern Centre, Preston, United Kingdom|Clarence Medical Centre, Rhyl, United Kingdom|Velindre Cancer Centre, Wales",United Kingdom,Respiratory Diseases,1,1,340.0
3475.0,NCT04659486,Adolescents With COVID-19/MIS-C at HCFMUSP,,Enrolling by invitation,COVID-19,Corona Virus Infection,SARS (Severe Acute Respiratory Syndrome),SARS-CoV Infection,,,,Behavioral: Home-based exercise training,University of Sao Paulo|Hospital das Clínicas da Faculdade de Medicina da USP|Fundação de Amparo à Pesquisa do Estado de São Paulo,All,"7 Years to 18 Years   (Child, Adult)",100.0,Other,Interventional,2020-09-24,30/04/21,2021-04-30,09/12/20,09/12/20,"Hospital das Clinicas Faculdade de Medicina USP, Sao Paulo, SP",Brazil,Respiratory Diseases,1,4,218.0
3476.0,NCT04456452,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,,Completed,COVID-19,,,,,,,Biological: Ampion|Other: Standard of Care,Ampio Pharmaceuticals. Inc.,All,"18 Years to 89 Years   (Adult, Older Adult)",10.0,Industry,Interventional,2020-07-27,08/09/20,2020-11-30,02/07/20,13/01/21,"Research Site, Colorado Springs, Colorado",United States,Respiratory Diseases,1,1,126.0
3477.0,NCT04331366,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,GO2 PEEP,Completed,COVID-19,,,,,,,Device: GO2 PEEP MOUTHPIECE,Emory University,All,"18 Years and older   (Adult, Older Adult)",2.0,Other,Interventional,2020-08-04,31/08/20,2020-08-31,02/04/20,18/02/21,"Emory University Hospital, Atlanta, Georgia, United States|Emory St. Joseph's Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,1,27.0
3478.0,NCT04372693,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,(COVID-19),Enrolling by invitation,Distance Learning-Online Learning,Traditional Classroom-Based Learning,Coronavirus Disease Social Distancing Measures,Nursing Students' Perception and Achievement,,,,Other: impliminting Online Distance Learning,Cairo University,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-01-09,30/01/21,2021-02-28,04/05/20,03/11/20,"Cairo University, Cairo",Egypt,Respiratory Diseases,1,4,416.0
3479.0,NCT04354155,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,,Recruiting,Infection Viral,"Thromboses, Venous",COVID-19,,,,,Drug: Enoxaparin Prefilled Syringe [Lovenox],Johns Hopkins All Children's Hospital,All,"up to 18 Years   (Child, Adult)",38.0,Other,Interventional,2020-02-06,01/09/22,2022-10-15,21/04/20,27/01/21,"Children's of Alabama, Birmingham, Alabama, United States|Children's Hospital Los Angeles, Los Angeles, California, United States|Hemostasis and Thrombosis Center UC Davis, Sacramento, California, United States|Rady Children's Hospital, San Diego, California, United States|Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States|Children's Hospital of Atlanta, Atlanta, Georgia, United States|Lurie Children's Hospital, Chicago, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Children's Hospital New Orleans, New Orleans, Louisiana, United States|Johns Hopkins Hospital and Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Children's Hospital of Michigan, Detroit, Michigan, United States|Cohen Children's Medical Center, New Hyde Park, New York, United States|Akron Children's Hospital, Akron, Ohio, United States|Children's Hospital Pittsburgh, Pittsburgh, Pennsylvania, United States|Children's Medical Center of Dallas, Dallas, Texas",United States,Respiratory Diseases,1,3,982.0
3480.0,NCT04366752,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,THROMBOCOVID,Recruiting,COVID-19,Pneumonia,ARDS,Hemostasis,Coagulation,,,Other: venous ultrasound|Other: blood sample,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-22,22/08/20,2020-09-22,29/04/20,29/04/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,5,153.0
3481.0,NCT04629157,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,LAVA,Recruiting,COVID-19,COVID-19,,,,,,Device: Innova Lateral Flow Device,Alder Hey Children's NHS Foundation Trust,All,up to 17 Years   (Child),400.0,Other,Interventional,2020-05-11,19/11/20,2020-11-19,16/11/20,16/11/20,"Alder Hey in the Park, Liverpool, United Kingdom|Royal Manchester Children's Hospital, Manchester",United Kingdom,Respiratory Diseases,1,2,192.0
3482.0,NCT04589104,Expressive Writing for COVID-19 Resilience,,Completed,COVID-19,,,,,,,Behavioral: Expressive writing,Duke University,All,"18 Years and older   (Adult, Older Adult)",63.0,Other,Interventional,2020-05-26,17/08/20,2020-08-17,19/10/20,19/10/20,"Duke Integrative Medicine, Durham, North Carolina",United States,Respiratory Diseases,1,1,83.0
3483.0,NCT04634422,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,COVID-PLEX,Recruiting,Respiratory Failure,"Renal Failure, Acute",,,,,,Procedure: Plasma exchange and convalescent plasma,"Wladimir Szpirt|Aalborg University Hospital|Aarhus University Hospital|Odense University Hospital|Zealand University Hospital|Rigshospitalet, Denmark",All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2020-11-16,30/06/21,2022-06-30,18/11/20,21/12/20,"Rigshospitalet, Copenhagen",Denmark,Respiratory Diseases,1,2,591.0
3484.0,NCT04679415,Efficacy and Safety of hzVSF-v13 in Moderate to Severe Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: hzVSF-v13|Drug: Placebo (Normal saline solution),"ImmuneMed, Inc.",All,"18 Years and older   (Adult, Older Adult)",63.0,Industry,Interventional,2020-12-17,01/04/21,2021-01-05,22/12/20,06/01/21,"Rumah Sakit Pusat Pertamina (include RSPP Extension Simprug), Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|Rumah Sakit Pasar Minggu, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|Rumah Sakit Umum Persahabatan, Jakarta, Daerah Khusus Ibukota Jakarta",Indonesia,Respiratory Diseases,1,1,19.0
3485.0,NCT04275245,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,,Completed,COVID-19,,,,,,,Drug: Meplazumab for Injection,Tang-Du Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",17.0,Other,Interventional,2020-03-02,09/03/20,2020-09-03,19/02/20,09/04/21,"Tangdu Hospital, Xi'an, Shaanxi",China,Respiratory Diseases,1,1,185.0
3486.0,NCT04570462,Mild Hypothermia for COVID-19 ARDS,,Recruiting,COVID-19,,,,,,,Other: Hypothermia Via Cooling Machine- Arctic Sun 5000,Northwell Health,All,"18 Years to 100 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-05-18,31/12/20,2020-12-31,30/09/20,30/09/20,"North Shore University Hospital, Manhasset, New York",United States,Respiratory Diseases,1,1,227.0
3487.0,NCT04558424,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: zinc gluconate and ascorbic acid,"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh",All,"18 Years to 70 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-10,01/09/21,2021-01-09,22/09/20,22/09/20,"Bangabandhu Sheikh Mujib Medical University, Dhaka",Bangladesh,Respiratory Diseases,1,1,365.0
3488.0,NCT04738435,"Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina",COVID-19,Recruiting,COVID-19,,,,,,,,Hospital Italiano de Buenos Aires|Ministerio de Salud de Ciudad Autónoma de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-05-01,01/03/21,2021-01-03,04/02/21,08/02/21,"Hospital Italiano de Buenos Aires, Buenos Aires, Caba",Argentina,Respiratory Diseases,1,1,-118.0
3489.0,NCT04344756,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",CORIMMUNO-COAG,Not yet recruiting,COVID-19,,,,,,,Drug: Tinzaparin or unfractionated heparin,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",808.0,Other,Interventional,2020-04-20,31/07/20,2020-09-30,14/04/20,15/04/20,"Réanimation hôpital Louis Mourier, Colombes, Hauts De Seine, France|réanimation hôpital Cochin, Paris, France|Médecine vasculaire, Hôpital Européen Georges Pompidou, Paris",France,Respiratory Diseases,1,1,163.0
3490.0,NCT04394169,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,PAIN-COVID,Recruiting,Post ICU Syndrome,Chronic Pain,COVID-19,,,,,Behavioral: Intervention program,Hospital Clinic of Barcelona,All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-05-25,25/09/20,2021-03-25,19/05/20,14/07/20,"Tomás Cuñat, Barcelona",Spain,Respiratory Diseases,1,3,304.0
3491.0,NCT04583293,Acute kIDnEy Injury in coviD-19,AIDED,Recruiting,Acute Kidney Injury,,,,,,,Other: No intervention,University Hospitals of Derby and Burton NHS Foundation Trust,All,"18 Years to 90 Years   (Adult, Older Adult)",220.0,Other,Observational,2020-08-12,01/10/22,2022-01-10,12/10/20,17/12/20,"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, Derbyshire",United Kingdom,Others,0,1,516.0
3492.0,NCT04667286,Awake Pronation for Covid-19 Treatment,,Not yet recruiting,COVID-19,,,,,,,Procedure: Prone Position (PP),IRCCS Azienda Ospedaliero-Universitaria di Bologna|Azienda Unità Sanitaria Locale Reggio Emilia|Azienda Ospedaliera di Bolzano|Azienda Ospedaliero-Universitaria di Modena,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-12-30,01/06/21,2021-01-07,14/12/20,14/12/20,,,Respiratory Diseases,1,1,8.0
3493.0,NCT04405843,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),EPIC,Completed,COVID-19,,,,,,,Drug: Ivermectin Oral Product|Drug: Placebo,Centro de Estudios en Infectogía Pediatrica,All,"18 Years and older   (Adult, Older Adult)",476.0,Other,Interventional,2020-07-14,21/12/20,2020-12-21,28/05/20,28/12/20,"Centro de Estudios en Infectología Pediátrica, Cali, Valle",Colombia,Respiratory Diseases,1,1,160.0
3494.0,NCT04355143,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),COLHEART-19,Recruiting,COVID-19,,,,,,,Drug: Colchicine Tablets|Other: Current care per UCLA treating physicians,"University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-05,25/04/21,2021-04-25,21/04/20,21/05/20,"UCLA Ronald Reagan Medical Center, Los Angeles, California, United States|UCLA Santa Monica Hospital, Santa Monica, California",United States,Respiratory Diseases,1,1,476.0
3495.0,NCT04280588,Fingolimod in COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Fingolimod 0.5 mg,First Affiliated Hospital of Fujian Medical University,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-02-22,01/07/20,2020-01-07,21/02/20,13/11/20,"Wan-Jin Chen, Fuzhou",China,Respiratory Diseases,1,1,-46.0
3496.0,NCT04394195,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,COVIDsFlt1,Completed,CORONAVIRUS INFECTIONS,,,,,,,Other: measurement of circulating sFlt1 concentration,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Observational,2020-03-04,01/05/20,2020-01-09,19/05/20,01/04/21,"Chu Reims, Reims",France,Respiratory Diseases,1,1,-55.0
3497.0,NCT04482634,Tele-rehabilitation Versus Home Exercise Program in COVID-19,,Recruiting,Pulmonary Rehabilitation,COVID-19,,,,,,Other: Remote controlled exercise|Other: Home exercise,Koç University,All,"18 Years and older   (Adult, Older Adult)",122.0,Other,Interventional,2020-01-09,01/08/22,2022-01-08,22/07/20,05/11/20,"Koc University School of Medicine, Istanbul",Turkey,Respiratory Diseases,1,2,730.0
3498.0,NCT04283461,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),,"Active, not recruiting",COVID-19,COVID-19,,,,,,Biological: mRNA-1273,"National Institute of Allergy and Infectious Diseases (NIAID)|ModernaTX, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",120.0,NIH|Industry,Interventional,2020-03-16,22/11/22,2022-11-22,25/02/20,09/04/21,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|National Institutes of Health - Clinical Center - Vaccine Research Center Clinical Trials Program, Bethesda, Maryland, United States|Kaiser Permanente Washington Health Research Institute - Vaccines and Infectious Diseases, Seattle, Washington",United States,Respiratory Diseases,1,2,981.0
3499.0,NCT04473183,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,,Recruiting,COVID-19,SARS-CoV Infection,COVID-19,Corona Virus Infection,,,,Diagnostic Test: Specimen Collection|Diagnostic Test: Surveys,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2020-07-21,01/01/22,2022-01-01,16/07/20,13/08/20,"University of Minnesota, Minneapolis, Minnesota",United States,Respiratory Diseases,1,4,529.0
3500.0,NCT04632381,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,PROPEL,Not yet recruiting,Corona Virus Infection,,,,,,,Drug: Zotatifin|Drug: Placebo,"Effector Therapeutics|Medpace, Inc.",All,18 Years to 64 Years   (Adult),36.0,Industry,Interventional,2021-04-16,29/10/21,2021-12-31,17/11/20,01/04/21,"Synergy Healthcare, Bradenton, Florida, United States|Global Health Research Center, Miami Lakes, Florida, United States|Tampa General Hospital, Tampa, Florida, United States|National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,259.0
3501.0,NCT04468035,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,CognitiVID,Recruiting,COVID-19,,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-06,31/12/21,2021-12-31,13/07/20,17/07/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,1,725.0
3502.0,NCT04252664,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,,Suspended,COVID-19,COVID-19,,,,,,Drug: Remdesivir|Drug: Remdesivir placebo,Capital Medical University|Chinese Academy of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",308.0,Other,Interventional,2020-12-02,10/04/20,2020-04-27,05/02/20,15/04/20,"Jin Yin-tan hospital, Wuhan, Hubei",China,Respiratory Diseases,1,2,-219.0
3503.0,NCT04483752,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,PREDISCAN,Recruiting,CoV2 SARS Pneumonia,,,,,,,Other: CHEST CT SCAN,Centre Chirurgical Marie Lannelongue,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-06,08/02/21,2021-08-11,23/07/20,23/07/20,"Hôpital Marie Lannelongue, Le Plessis-Robinson, France|Hôpital Saint Joseph, Paris, France|Institut Gustave Roussy (IGR), Villejuif",France,Respiratory Diseases,1,1,370.0
3504.0,NCT04407546,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,,Recruiting,Immunosuppression,,,,,,,,Jonsson Comprehensive Cancer Center,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-05-27,28/05/22,2023-05-28,29/05/20,04/03/21,"University of California at Los Angeles, Los Angeles, California",United States,Others,0,1,1096.0
3505.0,NCT04784767,SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults,,Recruiting,COVID-19,,,,,,,"Biological: 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)|Drug: Sodium chloride, USP, for injection (0.9% NaCl)|Biological: 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)",U.S. Army Medical Research and Development Command|Walter Reed Army Institute of Research (WRAIR)|Henry M. Jackson Foundation for the Advancement of Military Medicine,All,18 Years to 55 Years   (Adult),72.0,U.S. Fed|Other,Interventional,2021-05-04,30/10/22,2023-10-30,05/03/21,06/04/21,"WRAIR Clinical Trials Center, Silver Spring, Maryland",United States,Respiratory Diseases,1,1,909.0
3506.0,NCT04649424,COVID-19 Nasal Swab Trial,,Recruiting,COVID-19,,,,,,,Device: CanSwab,Orthopaedic Innovation Centre,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Interventional,2020-12-22,30/04/21,2021-05-30,02/12/20,03/03/21,"St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Health Sciences Centre, Winnipeg, Manitoba",Canada,Respiratory Diseases,1,1,159.0
3507.0,NCT04483375,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",,Completed,COVID-19,,,,,,,Biological: SCTA01|Other: Placebo,Sinocelltech Ltd.,All,"18 Years and older   (Adult, Older Adult)",33.0,Industry,Interventional,2020-07-24,17/11/20,2020-11-17,23/07/20,23/03/21,"Beijing SHIJITAN Hospital, Beijing, Beijing",China,Respiratory Diseases,1,1,116.0
3508.0,NCT04320472,Acute Encephalopathy in Critically Ill Patients With COVID-19,NeuroCOVID19,"Active, not recruiting",COVID-19,Encephalopathy,Critically Ill,,,,,Other: Follow up,Ictal Group,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-03-23,30/09/20,2020-12-31,25/03/20,22/10/20,"Jackson Memorial Health System; University of Miami, Miller School of Medicine, Miami, Florida, United States|Wellstar Atlanta Medical Center, Atlanta, Georgia, United States|Universidade Federal de São Paulo, São Paulo, Brazil|Fundación Valle del Lili, University Hospital, Cali, Colombia|Cairo University Hospitals, Cairo, Egypt|Centre Hospitalier d'Argenteuil, Argenteuil, France|Centre Hospitalier de Beauvais, Beauvais, France|Centre Hospitalier Universitaire Ambroise Paré, Boulogne, France|Centre Hospitalier de Bourg en Bresse, Bourg-en-Bresse, France|Centre Hospitalier Régional Universitaire de Brest, Brest, France|Centre Hospitalier de Brives, Brive-la-Gaillarde, France|Centre Hospitalier Universitaire Beaujon, Clichy, France|Centre Hospitalier Universitaire Louis Mourier, Colombes, France|Centre Hospitalier Universitaire Henri Mondor, Créteil, France|Centre hospitalier de Dieppe, Dieppe, France|Centre Hospitalier Universitaire de Dijon, Dijon, France|Centre Hospitalier d'Etampes, Etampes, France|Grand Hôpital de l'Est Francilien - Site de Marne-la-Vallée, Jossigny, France|Centre Hospitalier de la Roche-sur-Yon, La Roche-sur-Yon, France|Centre Hospitalier de La Rochelle, La Rochelle, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Universitaire de Lille, Lille, France|Centre Hospitalier Universitaire Hôpital Edouard Herriot, Lyon, France|Hôpital privé Jacques Cartier, Massy, France|Groupe Hospitalier Sud Ile-de-France, Melun, France|Centre Hospitalier Régional d'Orléans, Orléans, France|Centre Hospitalier Universitaire Cochin, Paris, France|Groupe hospitalier Paris Saint-Joseph, Paris, France|Hôpital Fondation Adolphe de Rothschild, Paris, France|Hopital Privé Claude Galien, Quincy-sous-Sénart, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Centre Hospitalier de Roanne, Roanne, France|Hopital Foch, Suresnes, France|Centre Hospitalier de Toulon, Toulon, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Tours, Tours, France|Gustave-Roussy, Villejuif, France|Hospital Regional De Alta Especialidad Del Bajío, Guanajuato, Mexico|Hospital Clinic Universitari, Valencia",Spain,Respiratory Diseases,1,3,283.0
3509.0,NCT04780581,Glucocorticoid Therapy in Coronavirus Disease COVID-19 Patients,,Recruiting,Corona Virus Infection,,,,,,,Drug: Dexamethasone|Drug: Methylprednisolone,Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León|Instituto de Investigación Biomédica de Salamanca,All,"18 Years and older   (Adult, Older Adult)",290.0,Other,Interventional,2021-01-02,01/12/21,2021-12-31,03/03/21,03/03/21,"Complejo Asistencial Universitario de Burgos, Burgos, Spain|Complejo Asistencial Universitario de León, León, Spain|Complejo Asistencial Universitario de Salamanca, Salamanca, Spain|Hospital Clínico Universitario de Valladolid, Valladolid, Spain|Hospital Universitario Río Hortega, Valladolid",Spain,Respiratory Diseases,1,1,363.0
3510.0,NCT04368845,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,ATHLOS,Recruiting,COVID-19,Comorbidities and Coexisting Conditions,,,,,,Device: Telerehabilitation,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory|University of Athens|University of Ioannina|University of Thessaly,All,"20 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-11-05,31/03/21,2021-03-31,30/04/20,28/01/21,"Clinical exercise Physiology and rehabilitation research laboratory, Lamia",Greece,Respiratory Diseases,1,2,146.0
3511.0,NCT04640181,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),XACT,Recruiting,COVID-19,,,,,,,Drug: Enoxaparin|Drug: Rivaroxaban,St. David's HealthCare,All,"18 Years to 100 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-12,30/06/21,2021-07-31,23/11/20,02/04/21,"St. David's Medical Center, Austin, Texas",United States,Respiratory Diseases,1,1,566.0
3512.0,NCT04305106,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,BEST-RCT,Recruiting,COVID-19,,,,,,,Drug: Bevacizumab,Qilu Hospital of Shandong University|Renmin Hospital of Wuhan University|Ialy Moriggia Pelascini Gravedona Hospital S.p.A|Wuhan University|Jiangbei Union Hospital of Huazhong University of science and technology|Shandong Provincial Chest Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",140.0,Other,Interventional,2020-03-17,30/06/20,2020-07-31,12/03/20,26/03/20,"Qilu Hospital of Shandong University, Jinan, Shandong",China,Respiratory Diseases,1,1,136.0
3513.0,NCT04424056,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",INFLAMMACOV,Not yet recruiting,COVID-19,,,,,,,Drug: Anakinra +/- Ruxolitinib (stages 2b/3)|Drug: Anakinra and Ruxolitinib (Advanced stage 3)|Drug: Tocilizumab +/- ruxolitinib (stages 2b/3)|Drug: Tocilizumab and Ruxolitinib (Advanced stage 3)|Other: Standard of care,Assistance Publique Hopitaux De Marseille,All,"18 Years to 75 Years   (Adult, Older Adult)",216.0,Other,Interventional,2020-01-09,30/09/22,2022-01-11,09/06/20,23/06/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,733.0
3514.0,NCT04584684,Mouth Rinses for Inactivation of COVID-19,MOR,Recruiting,COVID-19,Coronavirus Infection,COVID-19,,,,,Drug: 1.5-2% w/v Hydrogen Peroxide|Drug: 0.12% Chlorhexidine Gluconate|Drug: 21% Ethanol plus essential oils|Drug: 1% w/v Povidone-iodide|Drug: 0.075% Cetylpyridinium Chloride|Other: Saline,"University of North Carolina, Chapel Hill",All,"18 Years to 65 Years   (Adult, Older Adult)",480.0,Other,Interventional,2020-12-18,01/09/22,2023-01-09,14/10/20,11/01/21,"General and Oral Health Center, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,3,752.0
3515.0,NCT04402866,TD-0903 for ALI Associated With COVID-19,,Recruiting,COVID-19,COVID-19,,,,,,Drug: TD-0903|Drug: Placebo,Theravance Biopharma,All,"18 Years to 80 Years   (Adult, Older Adult)",222.0,Industry,Interventional,2020-06-24,01/04/21,2021-01-04,27/05/20,09/03/21,"Theravance Biopharma Investigational Site, Duarte, California, United States|Theravance Biopharma Investigational Site, Denver, Colorado, United States|Theravance Biopharma Investigational Site, Sebring, Florida, United States|Theravance Biopharma Investigational Site, Boston, Massachusetts, United States|Theravance Biopharma Investigational Site, Fall River, Massachusetts, United States|Theravance Biopharma Investigational Site, Kalispell, Montana, United States|Theravance Biopharma Investigational Site, Glens Falls, New York, United States|Theravance Biopharma, Hyde Park, New York, United States|Theravance Biopharma Investigational Site, Columbus, Ohio, United States|Theravance Biopharma Investigational Site, Allentown, Pennsylvania, United States|Theravance Biopharma Investigational Site, Bethlehem, Pennsylvania, United States|Theravance Biopharma Investigational Site, Wenatchee, Washington, United States|Theravance Biopharma Investigational Site, Bela Vista, Brazil|Theravance Biopharma Investigational Site, Botucatu, Brazil|Theravance Biopharma Investigational Site, Caxias Do Sul, Brazil|Theravance Biopharma Investigational Site, São José Do Rio Preto, Brazil|Theravance Biopharma Investigational Site, Helsinki, Finland|Theravance Biopharma Investigational Site, Turku, Finland|Theravance Biopharma Investigational Site, Chisinau, Moldova, Republic of|Theravance Biopharma Investigational Site, Bucharest, Romania|Theravance Biopharma Investigational Site, Brovary, Ukraine|Theravance Biopharma Investigational Site, Kyiv, Ukraine|Theravance Biopharma Investigational Site, Manchester",United Kingdom,Respiratory Diseases,1,2,194.0
3516.0,NCT04375501,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,,Completed,Femoral Neck Fractures,SARS-CoV 2,,,,,,"Other: Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail","Barts & The London NHS Trust|University College London Hospitals|Barking, Havering and Redbridge University Hospitals NHS Trust|Mid and South Essex NHS Foundation Trust|Frimley Park Hospital NHS Trust|The Hillingdon Hospitals NHS Foundation Trust",All,"18 Years and older   (Adult, Older Adult)",442.0,Other,Observational,2020-01-02,15/04/20,2020-04-15,05/05/20,20/05/20,"Barts Health NHS Trust, London",United Kingdom,Respiratory Diseases,1,2,104.0
3517.0,NCT04351568,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,,Recruiting,COVID-19,,,,,,,Other: quesionnair,Assiut University,All,18 Years to 60 Years   (Adult),874.0,Other,Observational,2020-01-04,01/07/20,2020-01-08,17/04/20,02/06/20,"Assiut, Assiut",Egypt,Respiratory Diseases,1,1,4.0
3518.0,NCT04389320,Antimalarial and Covid 19 in Rheumatoid Arthritis,,Completed,Rheumatoid Arthritis,,,,,,,Drug: Hydroxychloroquine,Assiut University,All,"20 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-03-15,01/05/20,2020-01-05,15/05/20,15/05/20,"Manal Hassanien, Assiut, Yes",Egypt,Immunological Disorders,1,1,-70.0
3519.0,NCT04337424,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2,EasyCoV,Completed,COVID-19,,,,,,,Diagnostic Test: Sampling salivary,"University Hospital, Montpellier|societe SkillCell - 97198 Jarry|CNRS Alcediag UMR9005 - societe Sys2Diag - 34184 Montpellier",All,"18 Years to 90 Years   (Adult, Older Adult)",627.0,Other,Observational,2020-04-13,07/10/20,2020-07-10,07/04/20,04/11/20,"UCH Montpellier, Montpellier",France,Respiratory Diseases,1,1,88.0
3520.0,NCT04695821,Feasibility of Remote Evaluation and Monitoring of Acoustic Pathophysiological Signals With External Sensor Technology in Covid-19,REMAP-WEST-COV,Not yet recruiting,COVID-19,,,,,,,Device: Senti V1.0 Device,Senti Tech Ltd|Liverpool University Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",10.0,Industry|Other,Interventional,2021-01-01,01/02/21,2021-01-03,05/01/21,05/01/21,"Senti Tech, Liverpool, Merseyside",United Kingdom,Respiratory Diseases,1,1,2.0
3521.0,NCT04348409,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Nitazoxanide Tablets|Drug: Placebo,Azidus Brasil|Farmoquimica S.A.|Hospital Vera Cruz|Hospital Casa de Saúde - Vera Cruz - Campinas - SP - Brazil|Centro de Genomas - UNIFESP|Emilio Ribas Institute of Infectious Diseases,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry|Other,Interventional,2020-05-25,31/07/20,2020-07-31,16/04/20,09/06/20,"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Centro de Genomas, São Paulo, Brazil|Hospital Emílio Ribas, São Paulo",Brazil,Respiratory Diseases,1,1,67.0
3522.0,NCT04577378,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,Isotretinoin,Not yet recruiting,COVID-19,,,,,,,Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid) plus Aerosolized Itraconazole|Drug: Drug: Isotretinoin(Aerosolized 13 cis retinoic acid),Kafrelsheikh University,All,"15 Years to 80 Years   (Child, Adult, Older Adult)",45.0,Other,Interventional,2020-10-20,20/11/20,2020-11-20,06/10/20,06/10/20,"Kafr El-sheikh University, Cairo, Kafr El-sheikh",Egypt,Respiratory Diseases,1,1,31.0
3523.0,NCT04798053,Impact of COVID-19 Pandemic and Social Distancing on Mental Health of Chronic Inflammatory Rheumatism Affected Patients,EMOPTION,Recruiting,COVID-19,Rheumatic Fever,Mental Disorder,,,,,Behavioral: Questionnaire|Biological: blood sample and salivary sample,"University Hospital, Bordeaux|Societe Francaise de Rhumatologie",All,"18 Years and older   (Adult, Older Adult)",318.0,Other,Interventional,2021-08-04,01/10/22,2022-01-10,15/03/21,09/04/21,"CHU de Bordeaux - service de rhumatologie, Bordeaux, France|AP-HP - Hopital Henri Mondor - service de rhumatologie, Créteil, France|CHRU de Lille - Service de rhumatologie, Lille, France|CHU de Montpellier - service de rhumatologie, Montpellier, France|AP-HP - Hopital Cochin - service de rhumatologie, Paris, France|CHU de Saint-Etienne - service de rhumatologie, Saint-Étienne, France|CHU de Toulouse - service de rhumatologie, Toulouse",France,Respiratory Diseases,1,3,159.0
3524.0,NCT04706325,COVID-19 RELATED KIDNEY DAMAGE,,Recruiting,Acute Kidney Injury,,,,,,,Other: ACUTE KIDNEY INJURY,Kocaeli Derince Education and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-01,01/05/21,2021-05-15,12/01/21,12/01/21,"Akif Şahin, Kocaeli",Turkey,Others,0,1,134.0
3525.0,NCT04401163,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,,Not yet recruiting,Sars-CoV2,COVID-19,,,,,,Diagnostic Test: Imaging of the lungs,University of Aarhus,All,"18 Years to 85 Years   (Adult, Older Adult)",180.0,Other,Observational,2020-01-05,01/12/21,2022-01-12,26/05/20,26/05/20,"Aarhus University Hospital, Aarhus",Denmark,Respiratory Diseases,1,2,738.0
3526.0,NCT04713176,Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: DWJ1248 with Remdesivir|Drug: Placebo with Remdesivir,Daewoong Pharmaceutical Co. LTD.,All,"19 Years and older   (Adult, Older Adult)",1022.0,Industry,Interventional,2021-02-02,30/06/21,2021-06-30,19/01/21,03/03/21,"National Medical Center, Seoul, Korea",Republic of,Respiratory Diseases,1,1,148.0
3527.0,NCT04815850,Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study,,Recruiting,End Stage Kidney Disease,,,,,,,,University of Leicester|Leicester Hospitals Charity|The Francis Crick Institute,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-03,01/10/21,2021-12-31,25/03/21,25/03/21,"University Hospital Leicester NHS Trust, Leicester, Leicestershire",United Kingdom,Others,0,1,362.0
3528.0,NCT04551768,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,,Recruiting,COVID-19,,,,,,,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,"Bausch Health Americas, Inc.",All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-10-02,01/07/21,2021-01-07,16/09/20,23/02/21,"Bausch Health Site 201, Athens, Attika, Greece|Bausch Health Site 203, Athens, Attika, Greece|Bausch Health Site 204, Alexandroupoli, Evros",Greece,Respiratory Diseases,1,1,-268.0
3529.0,NCT04334044,Treatment of SARS Caused by COVID-19 With Ruxolitinib,,Recruiting,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,Drug: Ruxolitinib Oral Tablet,Grupo Cooperativo de Hemopatías Malignas,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-09,01/03/21,2021-01-05,03/04/20,02/02/21,"Grupo Cooperativo de Hemopatías Malignas, Huixquilucan, Estado De México",Mexico,Respiratory Diseases,1,2,362.0
3530.0,NCT04423861,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo,Azidus Brasil|Farmoquimica S.A.|Hospital Casa de Saúde - Vera Cruz - Campinas - SP - Brazil,All,"18 Years and older   (Adult, Older Adult)",380.0,Industry|Other,Interventional,2020-01-12,01/04/21,2021-01-05,09/06/20,27/11/20,,,Respiratory Diseases,1,1,359.0
3531.0,NCT04751695,"Oxidative Stress Parameters, Trace Element and Quality of Life in Men Before and After Covid-19 Vaccines",,Not yet recruiting,COVID-19,,,,,,,Biological: CoronoVac Vaccine,Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,Male,"35 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-02,01/03/21,2021-01-04,12/02/21,12/02/21,"Kadirhan Ozdemir, İzmir",Turkey,Respiratory Diseases,1,1,2.0
3532.0,NCT04441489,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,,Completed,COVID-19,FDG PET/CT,Inflammation,,,,,,Centre Hospitalier Princesse Grace,All,"18 Years to 99 Years   (Adult, Older Adult)",13.0,Other,Observational,2020-03-27,03/05/20,2020-05-27,22/06/20,22/06/20,"Centre Hospitalier Princesse Grace, Monaco",Monaco,Respiratory Diseases,1,3,61.0
3533.0,NCT04700254,"Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece",,Completed,Diabetes Mellitus,COVID-19,,,,,,Other: DASS questionnaire|Other: EAT-26 questionnaire,"Chania General Hospital ""St. George""|AHEPA University Hospital of Thessaloniki Thessaloniki, Greece",All,"18 Years to 85 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-12-28,11/01/21,2021-11-01,07/01/21,25/01/21,"General Hospital of Chania, Chania, Crete",Greece,"Respiratory Diseases, Metabolic Disorders",1,2,308.0
3534.0,NCT04589117,Expressive Writing for COVID-19 Resilience for Parents,,Completed,COVID-19,,,,,,,Behavioral: Expressive writing,Duke University,All,"18 Years and older   (Adult, Older Adult)",11.0,Other,Interventional,2020-05-27,02/08/20,2020-02-08,19/10/20,19/10/20,"Duke Integrative Medicine, Durham, North Carolina",United States,Respiratory Diseases,1,1,-109.0
3535.0,NCT04435041,Remote-by-Default Care in the COVID-19 Pandemic,,"Active, not recruiting",COVID-19,,,,,,,,University of Oxford|University of Plymouth|Nuffield Trust,All,"Child, Adult, Older Adult",1.0,Other,Observational,2020-01-06,31/05/21,2021-11-30,17/06/20,17/06/20,"University of Oxford, Oxford",United Kingdom,Respiratory Diseases,1,1,694.0
3536.0,NCT04408222,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,,"Active, not recruiting",Oxygen Deficiency,Coronavirus Infection,,,,,,Other: Awake proning,Columbia University,All,"18 Years and older   (Adult, Older Adult)",29.0,Other,Observational,2020-04-16,01/04/21,2021-01-05,29/05/20,29/05/20,"Columbia University Medical Center, New York, New York",United States,Respiratory Diseases,1,2,264.0
3537.0,NCT04468971,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,RESOLVE,Recruiting,COVID-19,ARDS,,,,,,Biological: CK0802|Drug: Placebo,"Cellenkos, Inc.",All,"18 Years and older   (Adult, Older Adult)",45.0,Industry,Interventional,2020-09-29,30/09/21,2021-09-30,13/07/20,16/11/20,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Columbia University, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Baylor College of Medicine, St Luke's Hospital, Houston, Texas",United States,Respiratory Diseases,1,2,366.0
3538.0,NCT04579627,"Facial Hair, PPE and COVID-19",FACIAL HAIR,Completed,COVID-19,Safety Issues,,,,,,Behavioral: Questionnaire,Royal Cornwall Hospitals Trust,All,"Child, Adult, Older Adult",358.0,Other,Observational,2020-05-14,08/06/20,2020-08-06,08/10/20,08/10/20,"Royal Cornwall Hospital, Truro, Cornwall",United Kingdom,Respiratory Diseases,1,2,84.0
3539.0,NCT04686721,Observational Study for the Evaluation of Tracheal Stenosis in COVID-19 Patients,TS1,Recruiting,Tracheal Stenosis,,,,,,,Diagnostic Test: Chest CT scan + baseline spirometry,Istituto Clinico Humanitas,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-12-20,01/09/21,2021-01-10,29/12/20,11/03/21,"Humanitas Research Hospital, Rozzano",Italy,Others,0,1,21.0
3540.0,NCT04334148,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,HERO-HCQ,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,Adrian Hernandez|Patient-Centered Outcomes Research Institute|Duke University,All,"18 Years and older   (Adult, Older Adult)",1363.0,Other,Interventional,2020-04-22,10/12/20,2021-09-01,06/04/20,25/03/21,"Children's Hospital Colorado/University of Colorado Denver, Aurora, Colorado, United States|University of Florida, Gainesville, Florida, United States|University of Florida Jacksonville, Jacksonville, Florida, United States|University of Florida Health Central Florida, Leesburg, Florida, United States|University of Miami Florida, Miami, Florida, United States|Advent Health, Orlando, Florida, United States|University of South Florida, Tampa, Florida, United States|Northwestern Medicine, Chicago, Illinois, United States|Rush University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|University Medical Center New Orleans, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Johns Hopkins, Baltimore, Maryland, United States|University of Michigan, Ann Arbor, Michigan, United States|Allina Health, Minneapolis, Minnesota, United States|Mayo Clinic Hospital Rochester, Rochester, Minnesota, United States|University of Missouri-Columbia, Columbia, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hospital for Special Surgery, New York, New York, United States|Columbia University, Irving Medical Center, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Medical Center, Durham, North Carolina, United States|Wake Forest Baptist Health Sciences, Winston-Salem, North Carolina, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|Clinical Trials Center of Middle Tennessee, Franklin, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Baylor Scott & White Medical Center-Temple, Temple, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|Marshfield Clinic Health System, Marshfield, Wisconsin",United States,Respiratory Diseases,1,1,497.0
3541.0,NCT04350450,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,,Withdrawn,COVID-19,Coronavirus,COVID-19,,,,,Drug: Hydroxychloroquine,Montefiore Medical Center,All,"18 Years to 99 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,01/08/20,2020-01-08,17/04/20,27/05/20,"Montefiore Medical Center, Bronx, New York",United States,Respiratory Diseases,1,3,4.0
3542.0,NCT04499378,Tomographic Findings in COVID-19 and Influenza H1N1,,Not yet recruiting,COVID-19,Influenza A H1N1,Intubation Complication,Morality,"Lung Injury, Acute",,,Diagnostic Test: Lung CT,Universidad de Guanajuato|University Medical Center Groningen,All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-08-15,30/04/21,2022-04-30,05/08/20,05/08/20,,,"Infectious Diseases, Respiratory Diseases",1,5,623.0
3543.0,NCT04441398,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Nitazoxanide|Drug: Placebo,Azidus Brasil|Farmoquimica S.A.,All,"50 Years and older   (Adult, Older Adult)",300.0,Industry,Interventional,2020-01-07,01/09/20,2020-01-09,22/06/20,22/06/20,,,Respiratory Diseases,1,1,2.0
3544.0,NCT04822025,A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults,,Not yet recruiting,COVID-19,,,,,,,Biological: MVC-COV1901 (High-Dose)|Biological: MVC-COV1901(Mid-Dose),Medigen Vaccine Biologics Corp.,All,65 Years and older   (Older Adult),400.0,Industry,Interventional,2021-01-05,01/09/21,2022-01-01,30/03/21,30/03/21,"Hualien Tzu Chi Hospital, Hualien City, Taiwan|Shuang H Hospital, New Taipei City, Taiwan|National Taiwan University Hospital, Taipei, Taiwan|Chang Gung Medical Hospital Linkou, Taoyuan",Taiwan,Respiratory Diseases,1,1,361.0
3545.0,NCT04380792,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,SCREENING,Completed,COVID-19,,,,,,,,Manuel Monreal|Foundation for the study of VTE diseases. (FUENTE),All,"Child, Adult, Older Adult",2497.0,Other,Observational,2020-04-13,13/10/20,2020-10-13,08/05/20,14/12/20,"Manuel Monreal, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,183.0
3546.0,NCT04356677,Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: 50 mg/mL Virazole|Drug: 100 mg/mL Virazole,"Bausch Health Americas, Inc.",All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-01-04,01/08/21,2021-01-08,22/04/20,08/04/21,,,Respiratory Diseases,1,1,4.0
3547.0,NCT04576312,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Drug: UNI911 INHALATION,UNION therapeutics,All,"18 Years to 65 Years   (Adult, Older Adult)",64.0,Industry,Interventional,2020-06-29,31/12/20,2021-04-30,06/10/20,20/01/21,"DanTrials, Copenhagen",Denmark,Respiratory Diseases,1,1,305.0
3548.0,NCT04476706,Canakinumab MAP in COVID-19 Pneumonia With CRS,,No longer available,COVID-19,,,,,,,Drug: canakinumab,Novartis Pharmaceuticals|Novartis,All,"18 Years to 100 Years   (Adult, Older Adult)",,Industry,Expanded Access,,,,20/07/20,03/02/21,,,Respiratory Diseases,1,1,
3549.0,NCT04526717,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: MPT0B640,Joseah Bio,All,"18 Years and older   (Adult, Older Adult)",15.0,Industry,Interventional,2021-01-12,01/12/22,2022-01-12,26/08/20,10/02/21,,,Respiratory Diseases,1,1,365.0
3550.0,NCT04347980,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,DHYSCO,Recruiting,"Respiratory Distress Syndrome, Adult",COVID-19,,,,,,Drug: Dexamethasone and Hydroxychloroquine|Drug: Hydroxychloroquine,Centre Chirurgical Marie Lannelongue,All,"18 Years to 80 Years   (Adult, Older Adult)",122.0,Other,Interventional,2020-01-04,01/06/20,2020-01-08,15/04/20,17/04/20,"Reanimation adulte. Hopital Marie Lannelongue, Le Plessis-Robinson",France,Respiratory Diseases,1,2,4.0
3551.0,NCT04368143,COVID-19 Immune Repertoire Sequencing,IMSEQ,Recruiting,COVID-19,SARS-CoV 2,Corona Virus Infection,RDT,B Cell,,,,"Institute of Tropical Medicine, Belgium|University Hospital, Antwerp",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,30/12/21,2021-12-31,29/04/20,10/02/21,"Universitairy hospital of Antwerp, Antwerp",Belgium,Respiratory Diseases,1,5,727.0
3552.0,NCT04545008,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Famotidine|Drug: N-Acetyl cysteine,Prisma Health-Upstate|Clemson University,All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Interventional,2020-10-20,30/09/21,2021-10-31,10/09/20,10/03/21,"Prisma Health Baptist Easley Hospital, Easley, South Carolina, United States|Prisma Health Greenville Memorial Hospital, Greenville, South Carolina, United States|Prisma Health Greer Memorial Hospital, Greer, South Carolina",United States,Respiratory Diseases,1,1,376.0
3553.0,NCT04568863,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,MELCOVID,Completed,COVID-19,SARS-CoV 2,Coronavirus Infection,,,,,Drug: Melatonin intravenous|Drug: Placebo intravenous,Pharmamel S.L.|Hospital Universitario La Paz|Instituto de Investigación Hospital Universitario La Paz,All,"18 Years and older   (Adult, Older Adult)",18.0,Industry|Other,Interventional,2020-06-20,30/11/20,2020-11-30,29/09/20,18/03/21,"Hospital Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,3,163.0
3554.0,NCT04348474,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,,Suspended,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets,Azidus Brasil,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2020-04-20,30/06/20,2020-07-31,16/04/20,22/04/20,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo",Brazil,Respiratory Diseases,1,1,102.0
3555.0,NCT04383899,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,RISC,Withdrawn,Coronavirus Infection,,,,,,,Other: Questionnaire,"University Hospital, Bordeaux|Bordeaux PharmacoEpi",All,"Child, Adult, Older Adult",0.0,Other,Observational,2020-09-30,31/10/20,2020-11-30,12/05/20,25/02/21,,,Respiratory Diseases,1,1,61.0
3556.0,NCT04504734,Bucillamine in Treatment of Patients With COVID-19,,Enrolling by invitation,COVID-19,,,,,,,Drug: Bucillamine|Drug: Placebo,"Revive Therapeutics, Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Industry,Interventional,2020-11-27,01/05/21,2021-01-06,07/08/20,13/04/21,"ASCADA Research, Huntington Beach, California, United States|Samuel Ross MD Inc., Los Angeles, California, United States|C & R Research Services USA, Coral Gables, Florida, United States|Encore Medical Research, Hollywood, Florida, United States|Entrust Clinical Research, Kendall, Florida, United States|Columbus Clinical Services, Miami, Florida, United States|Verus Clinical Research, Miami, Florida, United States|Amavita Clinical Research, North Miami Beach, Florida, United States|Encore Medical Research of Weston LLC, Weston, Florida, United States|American Clinical Trials LLC, Acworth, Georgia, United States|Quad Clinical Research LLC, Chicago, Illinois, United States|Machuca Family Medicine, Las Vegas, Nevada, United States|OnSite Clinical Solutions, Charlotte, North Carolina, United States|OnSite Clinical Solutions, LLC, Charlotte, North Carolina, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Encore Imaging and Medical Research, Houston, Texas, United States|Family Practice Center, McAllen, Texas",United States,Respiratory Diseases,1,1,40.0
3557.0,NCT04365517,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,SIDIACO,Not yet recruiting,COVID-19,"Diabetes Mellitus, Type 2",CKD,,,,,Drug: Sitagliptin,University of Milan,All,"18 Years and older   (Adult, Older Adult)",170.0,Other,Interventional,2020-12-29,30/03/21,2021-12-30,28/04/20,03/11/20,"ASST FBF Sacco, Milan",Italy,"Metabolic Disorders, Respiratory Diseases",1,3,366.0
3558.0,NCT04360837,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,,Recruiting,COVID-19,Virus; Pneumonia,Atelectasis,,,,,Procedure: alveolar recruitment,Szeged University|Furtwangen University|BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS,All,"18 Years to 99 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-06-05,01/06/21,2021-01-06,24/04/20,21/05/20,"University of Szeged, Szeged",Hungary,Respiratory Diseases,1,3,215.0
3559.0,NCT04552379,The Containing Coronavirus Disease 19 (COVID-19) Trial,ConCorD-19,Recruiting,SARS-CoV Infection,Interferon,COVID-19,,,,,Biological: Peginterferon beta-1a,Pontificia Universidad Catolica de Chile|Telethon Kids Institute,All,"18 Years to 79 Years   (Adult, Older Adult)",1240.0,Other,Interventional,2020-01-12,01/04/21,2021-01-12,17/09/20,02/12/20,"Pontificia Universidad Católica de Chile, Santiago",Chile,Respiratory Diseases,1,3,366.0
3560.0,NCT04505631,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,SISCOVID,Recruiting,COVID-19,Dyspnea,,,,,,,Groupe Hospitalier de la Region de Mulhouse et Sud Alsace,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-10-06,01/06/21,2021-01-06,10/08/20,10/08/20,"Groupe Hospitalier de Mulhouse et de la Région Sud-Alsace, Mulhouse, Alsace, France|Centre Hospitalier de la Côte Basque - Bayonne, Bayonne, France|Centre Hospitalier Métropole Savoie, Chambéry, France|Centre Hospitalier Colmar, Colmar, France|Centre Hospitalier Douai, Douai, France|Centre Hospitalier de Dunkerque, Dunkerque, France|Centre Hospitalier Départemental Vendée - La Roche sur Yon, La Roche-sur-Yon, France|Centre Hospitalier du Mans, Le Mans, France|Centre Hospitalier Robert Boulin - Libourne, Libourne, France|Centre Hospitalier Annecy Genevois, Metz-Tessy, France|Centre Hospitalier Régional Metz-Thioville, Metz, France|Centre Hospitalier Le Raincy Montfermeil, Montfermeil, France|Centre Hospitalier Régional Orléans, Orléans, France|Centre Hospitalier de Soissons, Soissons",France,Respiratory Diseases,1,2,92.0
3561.0,NCT04661930,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,FENOC,Recruiting,COVID-19,Respiratory Distress Syndrome,COVID-19,,,,,Drug: TriCor® 145mg tablets|Other: Usual Care|Other: Placebo,Hebrew University of Jerusalem|Barzilai Medical Center,All,"18 Years to 85 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-12-13,01/04/21,2021-01-12,10/12/20,10/12/20,"Barzilai Medical Center, Ashkelon",Israel,Respiratory Diseases,1,3,30.0
3562.0,NCT04528927,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",THINC,Withdrawn,COVID-19,Patients Hospitalized,,,,,,Drug: HCQ|Drug: Azithromycin|Drug: Doxycycline|Dietary Supplement: Zinc,Abderrahmane Mami Hospital|Eshmoun Clinical Research Centre|Datametrix,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-05-15,15/07/20,2020-07-15,27/08/20,27/08/20,"Eshmoun Clinical Research Centre, Tunis",Tunisia,Respiratory Diseases,1,2,61.0
3563.0,NCT04374552,Asymptomatic COVID-19 Trial,ACT,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine sulfate &Azithromycin|Drug: Placebo,"Rutgers, The State University of New Jersey",All,"20 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-05-05,01/11/20,2021-01-04,05/05/20,02/11/20,"Robert Wood Johnson University Hospital, New Brunswick, New Jersey",United States,Respiratory Diseases,1,1,244.0
3564.0,NCT04412668,Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,,Completed,COVID-19,,,,,,,Drug: ATYR1923 1 mg/kg|Drug: ATYR1923 3 mg/kg|Drug: Placebo,"aTyr Pharma, Inc.",All,"18 Years to 75 Years   (Adult, Older Adult)",32.0,Industry,Interventional,2020-12-06,21/12/20,2020-12-21,02/06/20,29/01/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|aTyr Investigative Site, Washington, District of Columbia, United States|University of Miami, Miami, Florida, United States|University of Iowa, Iowa City, Iowa, United States|Anne Arundel Medical Center, Annapolis, Maryland, United States|aTyr Investigative Site, Vineland, New Jersey, United States|aTyr Investigative Site, Toledo, Ohio, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Alliance Medical Service, Cardio Pulmonary Research, Guaynabo, Puerto Rico|Manati Medical Center, Manatí",Puerto Rico,Respiratory Diseases,1,1,15.0
3565.0,NCT04315987,NestaCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,HOPE,Not yet recruiting,COVID-19,,,,,,,Biological: NestaCell®|Biological: Placebo,Azidus Brasil|Cellavita Pesquisa Científica Ltda|Hospital Vera Cruz,All,"18 Years and older   (Adult, Older Adult)",90.0,Industry|Other,Interventional,2020-01-06,01/08/20,2020-01-08,20/03/20,09/06/20,"Hospital Vera Cruz, Campinas, São Paulo, Brazil|Hospital de Barueri, São Paulo, Brazil|IncCOR, São Paulo, Brazil|UNIFESP, São Paulo",Brazil,Respiratory Diseases,1,1,2.0
3566.0,NCT04329572,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,,Suspended,COVID-19,,,,,,,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin Tablets,Azidus Brasil,All,"18 Years and older   (Adult, Older Adult)",400.0,Industry,Interventional,2020-04-23,31/05/20,2020-06-30,01/04/20,22/04/20,"Prevent Senior Private Operadora de Saúde LTDA., São Paulo",Brazil,Respiratory Diseases,1,1,68.0
3567.0,NCT04416009,Extracellular Water in Covid 19 Pneumonia,,Recruiting,Extracellular Fluid Alteration,Corona Virus Infection,,,,,,Device: NİCaS,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",52.0,Other,Observational,2020-05-07,20/12/20,2021-02-20,04/06/20,04/06/20,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa",Turkey,Respiratory Diseases,1,2,289.0
3568.0,NCT04371367,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",FORCE,"Active, not recruiting",COVID-19,,,,,,,Biological: avdoralimab|Other: Placebo,Assistance Publique Hopitaux De Marseille|Innate Pharma,All,"18 Years to 80 Years   (Adult, Older Adult)",208.0,Other|Industry,Interventional,2020-04-27,01/03/21,2021-01-03,01/05/20,12/01/21,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,251.0
3569.0,NCT04412772,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,ARCHITECTS,Recruiting,COVID-19,,,,,,,Drug: Tocilizumab|Drug: Placebo,Queen's Medical Centre,All,"18 Years to 95 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-12-06,31/12/21,2021-12-31,02/06/20,17/11/20,"Queen's Medical Center, Honolulu, Hawaii",United States,Respiratory Diseases,1,1,390.0
3570.0,NCT04486482,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,,Recruiting,COVID-19,,,,,,,Other: KB109 + Self Supportive Care (SSC)|Other: Self Supportive Care (SSC) Alone,Kaleido Biosciences,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-12-01,01/03/21,2021-01-03,24/07/20,23/02/21,"Cullman Clinical Trials, Cullman, Alabama, United States|American Institute of Research, Los Angeles, California, United States|Rancho Cucamonga Clinical Research, Rancho Cucamonga, California, United States|Next Phase Research Alliance, Boca Raton, Florida, United States|Advanced Pharma CR, LLC, Miami, Florida, United States|Hope Clinical Trials, Miami, Florida, United States|Kendall South Medical Center, Inc., Miami, Florida, United States|Quad Clinical Research, Chicago, Illinois, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Inquest Research, Baytown, Texas, United States|Olympus Family Medicine, Salt Lake City, Utah, United States|South Ogden Family Medicine Center, South Ogden, Utah",United States,Respiratory Diseases,1,1,-332.0
3571.0,NCT04586153,Study to Assess the Effect of Meplazumab on COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Meplazumab for Injection|Drug: Sterile normal saline (0.9%),Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,All,"18 Years and older   (Adult, Older Adult)",456.0,Industry,Interventional,2020-12-30,28/04/21,2021-09-30,14/10/20,17/11/20,,,Respiratory Diseases,1,1,274.0
3572.0,NCT04341675,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,SCOPE,Recruiting,COVID-19,,,,,,,Drug: Sirolimus|Drug: Placebo,University of Cincinnati,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-24,01/07/20,2020-01-09,10/04/20,20/05/20,"Loyola University Medical Center, Chicago, Illinois, United States|University of Cincinnati, Cincinnati, Ohio",United States,Respiratory Diseases,1,1,-106.0
3573.0,NCT04698083,"Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19",,Completed,COVID-19,,,,,,,"Diagnostic Test: Electrocardiography ,Tomographic imaging",Ankara Education and Research Hospital,All,"Child, Adult, Older Adult",160.0,Other,Observational,2020-07-22,15/10/20,2020-05-11,06/01/21,06/01/21,"Şahbender Koç, Ankara",Turkey,Respiratory Diseases,1,1,-72.0
3574.0,NCT04453579,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",,Completed,Obese,Morbid Obesity,,,,,,Behavioral: Telephonic interview during the Italian lockdown.,University of Rome Tor Vergata,All,"18 Years to 65 Years   (Adult, Older Adult)",116.0,Other,Observational,2020-09-03,04/05/20,2020-05-30,01/07/20,01/07/20,"Michela Campanelli, Rome, RM",Italy,Metabolic Disorders,1,2,-96.0
3575.0,NCT04345601,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),,Recruiting,Sars-CoV2,Acute Respiratory Distress Syndrome,COVID-19,,,,,Biological: Mesenchymal Stromal Cells|Other: Supportive Care,"Baylor College of Medicine|Center for Cell and Gene Therapy, Baylor College of Medicine|The Methodist Hospital System",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-12-02,01/10/22,2022-01-10,14/04/20,04/03/21,"Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,3,39.0
3576.0,NCT04461925,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,,Recruiting,COVID-19,,,,,,,Procedure: Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells|Drug: Antibiotics|Drug: Hormones|Drug: Anticoagulant Therapy|Device: Оxygen therapy,Institute of Cell Therapy|Kyiv City Clinical Hospital # 4,All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2020-02-05,02/05/21,2021-01-12,08/07/20,08/07/20,"Institute of Cell Therapy, Kyiv",Ukraine,Respiratory Diseases,1,1,342.0
3577.0,NCT04812041,Relationship Between Delirium Severity by CAM-ICU 7 and 4C Mortality Score of the COVID-19 Patients in ICU,,Recruiting,Delirium,COVID-19,Intensive Care Unit Delirium,,,,,Other: CAM-ICU 7 score|Other: 4C Mortality Score,Ankara City Hospital Bilkent,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-21,15/05/21,2021-05-25,23/03/21,23/03/21,"Ankara City Hospital, Ankara",Turkey,Respiratory Diseases,1,3,124.0
3578.0,NCT04364737,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,,"Active, not recruiting",COVID-19,Coronavirus,Coronavirus Infection,,,,,Biological: Convalescent Plasma|Other: Saline solution,"NYU Langone Health|National Center for Advancing Translational Science (NCATS)|Albert Einstein College of Medicine|Yale University|The University of Texas Health Science Center, Houston|The University of Texas Health Science Center at Tyler|University of Miami",All,"18 Years and older   (Adult, Older Adult)",384.0,Other|NIH,Interventional,2020-04-17,29/03/21,2021-06-14,28/04/20,30/03/21,"Yale University School of Medicine, New Haven, Connecticut, United States|University of Miami Hospital and Clinics, Miami, Florida, United States|Montefiore Medical Center, Bronx, New York, United States|NYU Langone Health, New York, New York, United States|University of Texas Rio Grande Valley, Edinburg, Texas, United States|The University of Texas Health Science Center, Houston, Texas, United States|The University of Texas Health Science Center, Tyler, Texas, United States|Aurora St. Luke's Medical Center, Milwaukee, Wisconsin, United States|Medical College of Wisconsin / Froedtert Memorial Lutheran Hospital, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,3,423.0
3579.0,NCT04672564,Study to Evaluate Safety and Efficacy of Carrimycin for Treatment of Severe Coronavirus Disease 2019 (COVID-19) in Hospitalized Patients,,Recruiting,Coronavirus Disease 2019,,,,,,,Drug: Carrimycin|Drug: Placebo,"Shenyang Tonglian Group CO., Ltd",All,"18 Years and older   (Adult, Older Adult)",300.0,Industry,Interventional,2021-03-30,30/06/21,2021-06-30,17/12/20,08/04/21,"PharmaTex Research, LLC, Amarillo, Texas, United States|Instituto Médico Platense, La Plata, Buenos Aires, Argentina|Clínica Monte Grande, Monte Grande, Buenos Aires, Argentina|Instituto Medico Rio Cuarto, Rio Cuarto, Córdoba, Argentina|Hospital General de Agudos Donación F. Santojanni, Buenos Aires, Argentina|Sanatorio Mayo Privado SA, Córdoba, Argentina|Instituto Goiano de Oncologia e Hematologia - INGOH, Aparecida de Goiânia, Goiás, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, São Paulo, Brazil|Clinica SOMER, Rionegro, Antioquia, Colombia|Hospital Universitario Clínica San Rafael, Bogota, Colombia|Paarthiv Lung Care Centre - Internal Medicine, Hyderabad, Andhra Pradesh, India|King George Hospital, Visakhapatnam, Andhra Pradesh, India|Unity Hospital, Surat, Gujarat, India|Rhythm Heart Institute, Vadodara, Gujarat, India|Adichunchanagiri Hospital and Research Centre, Mandya, Karnataka, India|Government Medical College - Department of Internal Medicine, Nagpur, Maharashtra, India|Suretech Hospital and Research Centre - Internal Medicine, Nagpur, Maharashtra, India|Shalinitai Meghe Hospital & Research centre, Nagpur, Maharashtra, India|Universal Hospital, Pune, Maharashtra, India|Sawai Man Singh Medical College & Attached Hospitals, Jaipur, Rajasthan, India|Saveetha Medical College & Hospital, Chennai, Tamil Nadu, India|St.Theresa's Hospital, Hyderabad, Telangana, India|Nuevo Hospital Civil de Guadalajara Juan I. Menchaca, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Nuevo Leon, Nuevo León, Mexico|Kohler & Milstein Research, Merida, Yucatán, Mexico|Clinica Ricardo Palma, Lima, Peru|Hospital Central FAP, Lima, Peru|De La Salle Health Sciences Institute, Cavite City, Cavite, Philippines|St. Paul's Hospital of Iloilo, Inc., Iloilo City, Iloilo, Philippines|Makati Medical Center - Infectious Diseases, Makati City, National Capital Region, Philippines|San Juan De Dios Hospital, Pasay City, National Capital Region, Philippines|Veterans Memorial Medical Center, Quezon City, National Capital Region, Philippines|St. Lukes Hospital, Quezon City, National Capital Region, Philippines|Quirino Memorial Medical Center, Quezon, National Capital Region, Philippines|Chernihivska miska likarnia #2, Chernihiv, Chernihivs'ka Oblast', Ukraine|Ivano-Frankivsk Central City Clinical Hospital, Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine|Oblasnyi klinichnyi ftyziopulmonolohichnyi tsentr, Ivano-Frankivsk, Ivano-Frankivs'ka Oblast', Ukraine|Kyivska miska likarnia #8, Kyiv, Kyïv, Ukraine|Vinnytskyi natsionalnyi medychnyi universytet imeni M.I. Pyr, Vinnytsia, Vinnyts'ka Oblast, Ukraine|Volyn Regional Clinical Hospital, Lutsk, Volyns'ka Oblast'",Ukraine,Respiratory Diseases,1,1,92.0
3580.0,NCT04366050,Ramipril for the Treatment of COVID-19,RAMIC,Recruiting,COVID-19,,,,,,,Drug: Ramipril 2.5 MG Oral Capsule|Drug: Placebo oral capsule,"University of California, San Diego|Pfizer",All,"18 Years and older   (Adult, Older Adult)",560.0,Other|Industry,Interventional,2020-11-05,01/05/21,2021-01-05,28/04/20,20/01/21,"University of California, San Diego, La Jolla, California",United States,Respiratory Diseases,1,1,61.0
3581.0,NCT04355494,SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19,,No longer available,COVID-19,"Pneumonia, Viral",Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),,,,,Biological: eculizumab,Alexion Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,21/04/20,09/03/21,"Cedars-Sinai Medical Center, Los Angeles, California, United States|Boston Medical Center, Boston, Massachusetts, United States|Newton-Wellesley Hospital, Newton, Massachusetts, United States|Mayo Clinic, Rochester, Minnesota, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Hôpital Henri Mondor, Creteil, France|Hôpital Garches Raymond Poincaré, Garches, France|Hôpital de Bicêtre, Le Kremlin Bicêtre, France|Hôpital Saint Louis, Paris, France|Hôpital Paul Brousse, Villejuif",France,Respiratory Diseases,1,3,
3582.0,NCT04363502,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: Clazakizumab|Drug: Placebo,Johns Hopkins University,All,"18 Years to 100 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-05,01/06/21,2021-01-06,27/04/20,16/02/21,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,1,185.0
3583.0,NCT04666012,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,,Recruiting,COVID-19,,,,,,,Biological: AdCLD-CoV19,"Cellid Co., Ltd.",All,19 Years to 64 Years   (Adult),150.0,Industry,Interventional,2020-12-29,01/03/21,2022-01-04,14/12/20,29/03/21,"Korea University Ansan Hospital, Ansan, Province, Korea, Republic of|The Catholic University of Korea, ST. Vincent's Hospital, Suwon, Province, Korea, Republic of|Hallym University Kangnam Sacred Heart Hospital, Seoul, State, Korea, Republic of|The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul, State, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,371.0
3584.0,NCT04581291,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,,Completed,COVID-19,,,,,,,Other: Moderate Intensity Aerobic Exercises,Istanbul Gelisim University,All,24 Years to 45 Years   (Adult),30.0,Other,Interventional,2020-01-01,01/06/20,2020-01-10,09/10/20,09/10/20,"Motaz Alawna, Istanbul",Turkey,Respiratory Diseases,1,1,9.0
3585.0,NCT04365127,Progesterone for the Treatment of COVID-19 in Hospitalized Men,,Completed,COVID-19,Sars-CoV2,,,,,,Drug: Progesterone 100 MG,Sara Ghandehari|IBSA Institut Biochimique SA|Cedars-Sinai Medical Center,Male,"18 Years and older   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2020-04-27,20/08/20,2020-08-20,28/04/20,27/01/21,"Cedars Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,2,115.0
3586.0,NCT04565379,Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients,,Recruiting,COVID-19,,,,,,,Drug: NuSepin® 0.1 mg|Drug: NuSepin® 0.2 mg|Drug: Placebo,Shaperon,All,"18 Years to 79 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-09-25,30/04/21,2021-04-30,25/09/20,17/03/21,"Leon Daniello Clinical Hospital of Pneumophtisiology Cluj-Napoca Pneumology Clinic, Cluj-Napoca, Romania|Clinical Hospital for Infectious Diseases and Pneumophtisiology Victor Babes, Craiova Infectious Diseases Clinic for Adults, Craiova, Romania|Sf. Parascheva Infectious Diseases Clinical Hospital Iasi Infectious Diseases Department, Iaşi, Romania|Ramnicu Sarat Clinical Hospital, Ramnicu Sarat, Romania|Sf. Ioan cel Nou Suceava County Emergency Hospital Infectious Diseases Department, Suceava",Romania,Respiratory Diseases,1,1,217.0
3587.0,NCT04455308,COVID-19 and Chilblains,ECCES,Completed,Chilblains,COVID-19,,,,,,Diagnostic Test: Biological sample collection,Rennes University Hospital,All,"Child, Adult, Older Adult",269.0,Other,Interventional,2020-07-21,19/10/20,2020-10-19,02/07/20,04/11/20,"CHU Angers, Angers, France|CHRU Brest, Brest, France|CHU Nantes, Nantes, France|CHU Rennes, Rennes, France|CHRU Tours, Tours",France,Respiratory Diseases,1,2,90.0
3588.0,NCT04359992,Study of Hemostasis in Case of Severe COVID-19,THROMBOVID,Not yet recruiting,COVID-19,,,,,,,Other: Extra blood sample,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-17,17/04/21,2021-01-05,24/04/20,24/04/20,,,Respiratory Diseases,1,1,263.0
3589.0,NCT04486508,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,INSPIRATION,Recruiting,COVID-19,,,,,,,Drug: intermediate dose Enoxaparin/ unfractionated heparin|Drug: standard prophylactic dose Enoxaparin/ unfractionated heparin|Drug: Atorvastatin 20mg|Drug: Matched placebo,"Rajaie Cardiovascular Medical and Research Center|Brigham and Women's Hospital|Tehran Heart Center|Masih Daneshvari Hospital|Hazrat Rasool Hospital|Modarres Hospital|Firuzgar hospital affiliated to Iran University of Medical Sciences|Imam Khomeini Hospital|Sina Hospital, Iran|Tabriz University of Medical Sciences|Shariati Hospital|Imam Ali Hospital|Labbafinejhad Hospital",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-07-30,07/04/21,2021-07-05,24/07/20,09/04/21,"Masih Daneshvari Hospital, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,340.0
3590.0,NCT04308317,Tetrandrine Tablets Used in the Treatment of COVID-19,TT-NPC,Enrolling by invitation,COVID-19,,,,,,,Drug: Tetrandrine,Henan Provincial People's Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-05-03,01/03/21,2021-01-05,16/03/20,16/03/20,"Tetrandrine Tablets, Jinhua, Zhejiang",China,Respiratory Diseases,1,1,247.0
3591.0,NCT04375137,Correlation Between Oxidative Stress Status and COVID-19 Severity,,Recruiting,Oxidative Stress,,,,,,,Diagnostic Test: Oxidative Stress ELISA Kit,Shahid Beheshti University of Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Observational,2020-04-20,01/04/21,2021-05-30,05/05/20,31/12/20,"Nooshin Dalili, Tehran, Iran",Islamic Republic of,Mental Health,1,1,405.0
3592.0,NCT04809974,Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID),,Not yet recruiting,COVID-19,Sequelae of; Infection,Cognitive Symptom,,,,,Dietary Supplement: Niagen,Massachusetts General Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-04,31/12/22,2022-12-31,22/03/21,22/03/21,"Clinical Translational Research Unit, Boston, Massachusetts",United States,Respiratory Diseases,1,3,726.0
3593.0,NCT04421508,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,COViNOX,"Active, not recruiting",COVID-19,Coronavirus,Coronavirus Infection,,,,,Combination Product: INOpulse|Combination Product: Placebo,Bellerophon Pulse Technologies|Bellerophon,All,"18 Years and older   (Adult, Older Adult)",500.0,Industry,Interventional,2020-12-07,28/12/20,2021-01-06,09/06/20,12/01/21,"Banner University Medical Center, Phoenix, Arizona, United States|Kaiser Permanente - Zion Medical Center, San Diego, California, United States|Kaiser Permanente - San Diego Medical Center, San Diego, California, United States|University of Miami Health System, Miami, Florida, United States|The Lung Research Center (St. Luke's), Chesterfield, Missouri, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|The Ohio State University Wexner Medical Center, Columbus, Ohio, United States|Mercy Health St. Vincent Medical Center, Toledo, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist, Houston, Texas, United States|INOVA, Falls Church, Virginia, United States|St. Francis Medical Center, Richmond, Virginia, United States|Memorial Regional Medical Center, Richmond, Virginia, United States|Chippenham Medical Center, Richmond, Virginia, United States|Pulmonary Associates of Richmond, Richmond, Virginia, United States|St. Mary's Hospital, Richmond, Virginia, United States|Johnston-Willis Hospital, Richmond, Virginia",United States,Respiratory Diseases,1,3,30.0
3594.0,NCT04390061,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,TOFACoV-2,Not yet recruiting,"Pneumonitis, Interstitial",COVID-19,,,,,,Drug: Tofacitinib|Drug: Hydroxychloroquine,"Università Politecnica delle Marche|Azienda Ospedaliera Ospedali Riuniti Marche Nord|Ospedale Civile Santo Spirito, Pescara|Università Magna Grecia, Catanzaro|ASST Papa Giovanni XXIII, Bergamo|Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma|ASST Cremona, Cremona|Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano|Ospedale di Circolo e Fondazione Macchi, Varese",All,"18 Years to 65 Years   (Adult, Older Adult)",116.0,Other,Interventional,2020-01-06,01/09/20,2020-01-10,15/05/20,15/05/20,,,Respiratory Diseases,1,2,4.0
3595.0,NCT04412304,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,,Completed,COVID-19,Thromboembolic Events,Bleeding,,,,,Drug: Dose of Tinzaparin or Dalteparin,Karolinska Institutet,All,"Child, Adult, Older Adult",166.0,Other,Observational,2020-06-03,30/04/20,2020-05-28,02/06/20,22/06/20,"South General Hospital, Stockholm, Stockholms Län",Sweden,Respiratory Diseases,1,3,-6.0
3596.0,NCT04637867,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),,Recruiting,Infection Viral,,,,,,,"Other: Collection of blood, salivary and nasopharyngeal samples.",Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-11-23,01/11/21,2021-01-11,20/11/20,11/12/20,"hopital Edouard Herriot, Lyon",France,Others,0,1,49.0
3597.0,NCT04325672,Convalescent Plasma to Limit Coronavirus Associated Complications,,Withdrawn,Coronavirus,,,,,,,Biological: Convalescent Plasma,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-04,31/12/22,2022-12-31,27/03/20,08/04/20,,,Respiratory Diseases,1,1,1092.0
3598.0,NCT04561193,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),,Recruiting,COVID-19,,,,,,,Other: Observational,Methodist Health System,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-05-30,01/12/20,2021-01-05,23/09/20,23/09/20,"Methodist Dallas Medical Center, Dallas, Texas",United States,Respiratory Diseases,1,1,220.0
3599.0,NCT04623619,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Acetyl L-Carnitine,Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-12-15,29/04/21,2021-07-31,10/11/20,17/11/20,,,Respiratory Diseases,1,1,228.0
3600.0,NCT04398290,iNOPulse for COVID-19,NO-COVER,Withdrawn,COVID-19,Hypoxemia,Hypoxemic Respiratory Failure,,,,,Drug: Inhaled nitric oxide (iNO)|Drug: Nitrogen gas|Drug: Oxygen gas,Roger Alvarez|Bellerophon Therapeutics|University of Miami,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-12,01/06/21,2021-07-15,21/05/20,19/08/20,"University of Miami Hospitals & Clinics, Miami, Florida",United States,Respiratory Diseases,1,3,550.0
3601.0,NCT04590222,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,MAOi-COV19,Not yet recruiting,SARS-CoV2 Infection,,,,,,,Other: blood sample,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-01-11,01/11/21,2021-01-11,19/10/20,19/10/20,"CHU Bicêtre, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,1,366.0
3602.0,NCT04460105,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,,Withdrawn,COVID-19,,,,,,,Drug: Lanadelumab|Other: Placebo,"Shire|Takeda Development Center Americas, Inc.|Takeda",All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-10-31,27/01/21,2021-01-27,07/07/20,12/10/20,,,Respiratory Diseases,1,1,88.0
3603.0,NCT04696601,Rapid Screening for Olfactory Disorders in Covid-19 Infection,OLFASCAN,Not yet recruiting,Olfaction Disorders,COVID-19,,,,,,Diagnostic Test: Olfactory test,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2021-10-01,10/02/21,2022-10-02,06/01/21,06/01/21,"CHU de Nice, Nice",France,Respiratory Diseases,1,2,366.0
3604.0,NCT04703478,RespiraConNosotros:a Mobile Application for COVID-19 Respiratory Rehabilitation.,,Not yet recruiting,COVID-19,,,,,,,Other: Breathing exercise,University of Salamanca,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-20,20/04/21,2021-04-20,11/01/21,12/01/21,"Ines Llamas-Ramos, Salamanca",Spain,Respiratory Diseases,1,1,90.0
3605.0,NCT04355052,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",COSTA,Recruiting,COVID-19,,,,,,,Drug: hydroxychloroquine in combination with camostat mesylate|Drug: Hydroxychloroquine in combination of Azithromycin,Sheba Medical Center,All,"18 Years to 120 Years   (Adult, Older Adult)",250.0,Other,Interventional,2020-11-04,11/10/20,2020-11-12,21/04/20,21/04/20,"Sheba Medical Center, Ramat Gan, Israel|Sheba Medical Center, Tel HaShomer",Israel,Respiratory Diseases,1,1,8.0
3606.0,NCT04477902,Long-Term Experience and Health Effects of COVID-19,,Suspended,COVID-19,Corona Virus Infection,Quality of Life,Risk Reduction,,,,Other: none - observational,Altura,All,"18 Years to 100 Years   (Adult, Older Adult)",50000.0,Industry,Observational,2020-01-07,01/07/22,2022-01-07,20/07/20,24/03/21,"Altura, Mission Viejo, California",United States,Respiratory Diseases,1,4,731.0
3607.0,NCT04802044,"COVID-19, Aging, and Cardiometabolic Risk Factors Study",CARAMEL,Recruiting,COVID-19,Obesity,Diabetes Mellitus,Aging,Cardiometabolic Syndrome,Immune System Disorder,,,Indonesia University|Leiden University Medical Center,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-08-12,28/02/22,2022-12-31,17/03/21,17/03/21,"Dr. Cipto Mangunkusumo National General Hospital, Jakarta Pusat, DKI Jakarta, Indonesia|Metabolic Disorder, Cardiovascular, and Aging Research Cluster IMERI-FKUI, Research Tower, 5th Floor, Jakarta Pusat, DKI Jakarta",Indonesia,"Metabolic Disorders, Respiratory Diseases",1,6,871.0
3608.0,NCT04731870,Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines,,Not yet recruiting,Coronavirus,,,,,,,Other: Survey research,East Carolina University,All,"18 Years to 100 Years   (Adult, Older Adult)",632.0,Other,Observational,2021-01-02,01/01/23,2023-01-01,01/02/21,01/02/21,,,Respiratory Diseases,1,1,729.0
3609.0,NCT04488575,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: EDP1815|Drug: Placebo,"Evelo Biosciences, Inc.",All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-08-26,06/07/21,2021-06-07,28/07/20,01/02/21,"Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|The University Hospital, Newark, New Jersey",United States,Respiratory Diseases,1,1,285.0
3610.0,NCT04703140,COVIDISC: Rapid Diagnostic Tests on Nasopharyngeal Swabs for the Detection of COVID-19,COVIDISC,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: Rapid Diagnostic Test vs PCR,CMC Ambroise Paré,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2021-11-02,11/08/22,2022-11-09,11/01/21,15/02/21,"CHI Robert Ballanger, Aulnay-sous-Bois",France,Respiratory Diseases,1,2,372.0
3611.0,NCT04407130,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,,Completed,COVID-19,,,,,,,Drug: Ivermectin + Doxycycline + Placebo|Drug: Ivermectin + Placebo|Drug: Placebo,"International Centre for Diarrhoeal Disease Research, Bangladesh",All,"40 Years to 65 Years   (Adult, Older Adult)",72.0,Other,Interventional,2020-06-16,30/10/20,2020-11-20,29/05/20,04/02/21,"Icddr,B, Dhaka",Bangladesh,Respiratory Diseases,1,1,157.0
3612.0,NCT04412226,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,,Completed,"Intubation, Intratracheal",COVID-19,,,,,,Device: aerosol box|Device: transparent sheet,Derince Training and Research Hospital,All,"Child, Adult, Older Adult",13.0,Other,Observational,2020-10-06,30/06/20,2020-06-30,02/06/20,04/12/20,"Kocaeli Derince Training and Research Hospital, Kocaeli, Izmit",Turkey,Respiratory Diseases,1,2,-98.0
3613.0,NCT04794803,Reparixin in COVID-19 Pneumonia - Efficacy and Safety,,Terminated,Severe Pneumonia,,,,,,,Drug: Reparixin|Drug: Standard of care,Dompé Farmaceutici S.p.A,All,"18 Years to 90 Years   (Adult, Older Adult)",55.0,Industry,Interventional,2020-05-05,30/11/20,2021-02-02,12/03/21,16/03/21,"Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina de São Paulo, São Paulo, Brazil|Ospedale San Paolo, Milan, Lombardy, Italy|Ospedale San Raffaele, Milan, Lombardy, Italy|Ospedale di Varese, Varese, Lombardy",Italy,Respiratory Diseases,1,1,273.0
3614.0,NCT04365101,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,CYNKCOVID,Recruiting,Coronavirus,Coronavirus Infection,Severe Acute Respiratory Syndrome Coronavirus 2,Pneumonia,"Pneumonia, Viral",Lung Diseases,Respiratory Tract Disease,Biological: CYNK-001,Celularity Incorporated|IDRI|Lung Biotechnology PBC|California Institute for Regenerative Medicine (CIRM),All,"18 Years and older   (Adult, Older Adult)",86.0,Industry|Other,Interventional,2020-05-13,30/12/21,2022-06-30,28/04/20,16/03/21,"Banner University Medical Center Phoenix, Phoenix, Arizona, United States|University of Arkansas, Little Rock, Arkansas, United States|UC Irvine, Irvine, California, United States|UC Davis Medical Center, Sacramento, California, United States|Scripps Health, San Diego, California, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Atlantic Health, Morristown, New Jersey, United States|Atlantic Health, Summit, New Jersey, United States|Multicare Health System, Tacoma, Washington",United States,Respiratory Diseases,1,7,778.0
3615.0,NCT04358926,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),HBOTCOVID19,Completed,COVID-19,Desaturation of Blood,,,,,,Device: Hyperbaric oxygen therapy,Assaf-Harofeh Medical Center,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-30,15/10/20,2020-01-11,24/04/20,03/02/21,"Amir Hadanny, Zerifin",Israel,Respiratory Diseases,1,2,-110.0
3616.0,NCT04481516,Yoga in NHS Health Care Workers With COVID-19 Related Stress,,Recruiting,Stress,,,,,,,Other: Yoga,Doncaster And Bassetlaw Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-07,31/12/20,2021-01-02,22/07/20,22/07/20,"Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, South Yorkshire",United Kingdom,Mental Health,1,1,361.0
3617.0,NCT04435353,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,,Recruiting,Respiratory Distress Syndrome,Hypoxemia,,,,,,Device: VibroLUNG,Astana Medical University,All,"18 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-22,31/12/20,2021-01-02,17/06/20,17/06/20,"Mukatova Irina, Astana, Nur-Sultan, Kazakhstan|Center of pulmonology Astana, Astana",Kazakhstan,Others,0,2,286.0
3618.0,NCT04686409,App-based Symptom Tracking After Corona Vaccination (CoCoV),,Not yet recruiting,COVID-19,,,,,,,Biological: COVID-19 vaccines,University of Ulm,All,"18 Years to 95 Years   (Adult, Older Adult)",500.0,Other,Observational,2021-11-01,31/01/22,2022-08-31,28/12/20,28/12/20,"Universitätsklinikum Ulm, Ulm",Germany,Respiratory Diseases,1,1,303.0
3619.0,NCT04340219,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",ONCOVID,Completed,Cancer,,,,,,,Other: Survey administration,"University Hospital, Ghent",All,"18 Years and older   (Adult, Older Adult)",394.0,Other,Observational,2020-03-30,10/04/20,2020-09-18,09/04/20,25/09/20,"University Hospital Gent, Gent",Belgium,Cancers,1,1,172.0
3620.0,NCT04393233,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,RHUMACOVID,Recruiting,Rheumatoid Arthritis,COVID-19,,,,,,,"University Hospital, Brest",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-23,23/05/20,2020-05-23,19/05/20,29/05/20,"CHRU de Brest, Brest",France,"Respiratory Diseases, Immunological Disorders",1,2,30.0
3621.0,NCT04625114,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,,Recruiting,COVID-19,,,,,,,Drug: Camostat|Drug: Placebo,"University Hospital, Ghent",All,"18 Years to 100 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-04-11,01/10/22,2023-01-01,12/11/20,12/11/20,"Ghent University Hospital, Algemene Inwendige Ziekten, Gent",Belgium,Respiratory Diseases,1,1,995.0
3622.0,NCT04307459,Acute Respiratory Failure and COVID-19 in Real Life,,Recruiting,Coronavirus Infections,Respiratory Failure,Ventilator Lung,,,,,Other: standard operating procedures,University of Milan,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-03-19,01/09/20,2020-12-31,13/03/20,13/05/20,"Luigi Sacco University Hospital, Milan, Lombardia",Italy,Respiratory Diseases,1,3,287.0
3623.0,NCT04411628,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,,Completed,COVID-19,,,,,,,Drug: LY3819253|Drug: Placebo,Eli Lilly and Company|AbCellera Biologics Inc.,All,"18 Years to 75 Years   (Adult, Older Adult)",24.0,Industry|Other,Interventional,2020-05-28,26/08/20,2020-08-26,02/06/20,30/10/20,"Cedars Sinai Medical Center, Los Angeles, California, United States|Veterans Affairs Medical Center San Diego, San Diego, California, United States|Emory University, Atlanta, Georgia, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts Medical Center, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Quality Clinical Research, Inc., Omaha, Nebraska, United States|Alexandria Center for Life - NYC/ NYCEDC, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Unified Research Enterprise Brody School of Medicine at ECU, Greenville, North Carolina, United States|Temple Univ School of Med, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,90.0
3624.0,NCT04396106,Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: AT-527|Other: Placebo,"Atea Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",190.0,Industry,Interventional,2020-05-26,01/03/21,2021-01-05,20/05/20,17/12/20,"Atea Study Site, Scottsdale, Arizona, United States|Atea Study Site, Davis, California, United States|Atea Study Site, Los Angeles, California, United States|Atea Study Site, Washington, District of Columbia, United States|Atea Study Site, Orlando, Florida, United States|Atea Study Site, Atlanta, Georgia, United States|Atea Study Site, Chicago, Illinois, United States|Atea Study Site, Chicago, Illinois, United States|Atea Study Site, Boston, Massachusetts, United States|Atea Study Site, Butte, Montana, United States|Atea Study Site, Charlotte, North Carolina, United States|Atea Study Site, Cincinnati, Ohio, United States|Atea Study Site, Columbus, Ohio, United States|Atea Study Site, Charleston, South Carolina, United States|Atea Study Site, Columbia, South Carolina, United States|Atea Study Site, Brussels, Belgium|Atea Study Site, Mechelen, Belgium|Atea Study Site, Belo Horizonte, Brazil|Atea Study Site, Brasília, Brazil|Atea Study Site, Campo Largo, Brazil|Atea Study Site, Porto Alegre, Brazil|Atea Study Site, São Paulo, Brazil|Atea Study Site, Chisinau, Moldova, Republic of|Atea Study Site, Bucharest, Romania|Atea Study Site, Bloemfontein, South Africa|Atea Study Site, Cape Town, South Africa|Atea Study Site, Centurion, South Africa|Atea Study Site, George, South Africa|Atea Study Site, Worcester, South Africa|Atea Study Site, Brovary, Ukraine|Atea Study Site, Kyiv",Ukraine,Respiratory Diseases,1,1,224.0
3625.0,NCT04830735,Dasatinib for the Treatment of Moderate and Severe COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Dasatinib Anhydrous|Drug: Placebo Administration,University of Southern California|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",144.0,Other|NIH,Interventional,2021-04-15,15/04/23,2024-04-15,05/04/21,05/04/21,"USC / Norris Comprehensive Cancer Center, Los Angeles, California",United States,Respiratory Diseases,1,1,1096.0
3626.0,NCT04273646,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,,Not yet recruiting,COVID-19,COVID-19,,,,,,Biological: UC-MSCs|Drug: Placebo,"Wuhan Union Hospital, China|Wuhan Hamilton Bio-technology Co., Ltd, China.",All,"18 Years to 65 Years   (Adult, Older Adult)",48.0,Other,Interventional,2020-04-20,30/06/20,2022-02-15,18/02/20,14/04/20,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,2,666.0
3627.0,NCT04697030,Burnout Among Adolescent Population During Covid-19 Lockdown in Pakistan,,Completed,"Burnout, Psychological",COVID-19,,,,,,,Sialkott College of Physical Therapy,All,"13 Years to 19 Years   (Child, Adult)",443.0,Other,Observational,2020-09-15,15/10/20,2020-12-22,06/01/21,06/01/21,"Sialkot College of Physical Therapy, Amin Welfare & Teaching Hospital, Sialkot, Punjab",Pakistan,Respiratory Diseases,1,2,98.0
3628.0,NCT04315870,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,I-COVID,Recruiting,Infection Viral,,,,,,,Other: pregnant women with laboratory-confirmed 2019-n-CoV,Federico II University,Female,18 Years to 50 Years   (Adult),20.0,Other,Observational,2020-01-01,20/04/20,2020-04-30,20/03/20,20/03/20,"University of Naples Federico II, Napoli",Italy,Others,0,1,120.0
3629.0,NCT04480515,Does COVID-19 Pandemic Reduce In-hospital Mortality?,,Completed,COVID-19,In-hospital Cardiac Arrest,,,,,,Other: in-hospital mortality rate,Kanuni Sultan Suleyman Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-11-03,15/06/20,2020-06-30,21/07/20,21/07/20,"Kanuni Sultan Suleyman Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,-126.0
3630.0,NCT04322396,Proactive Protection With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,ProPAC-COVID,Completed,Virus Diseases,Infection Viral,Corona Virus Infection,,,,,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo oral tablet,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark",All,"Child, Adult, Older Adult",117.0,Other,Interventional,2020-06-04,02/02/21,2021-02-02,26/03/20,15/02/21,"Aalborg Sygehus, Aalborg, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|Herlev-Gentofte Hospital, Copenhagen, Denmark|Hvidovre Hospital, Copenhagen, Denmark|Nordsjællands Hospital, Hillerød, Denmark|Odense Universitetshospital, Odense, Denmark|Roskilde Sygehus, Roskilde, Denmark|Slagelse Sygehus, Slagelse",Denmark,Respiratory Diseases,1,3,243.0
3631.0,NCT04445467,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,VIRCO,Recruiting,COVID-19,,,,,,,Drug: Favipiravir,Bayside Health,All,"18 Years and older   (Adult, Older Adult)",190.0,Other,Interventional,2020-01-08,01/11/20,2020-01-11,24/06/20,19/08/20,"Alfred Health, Melbourne, Victoria",Australia,Respiratory Diseases,1,1,3.0
3632.0,NCT04694014,Emotional Intelligence Skills Health Leaders Need During Covid-19,,Enrolling by invitation,Emotional Intelligence,Leadership,Health Personnel Attitude,COVID-19,,,,Behavioral: EI Open ended Pre-Survey and Semi Structured Interview|Behavioral: Behavioral and Cognitive Assessment|Behavioral: Geneva Emotional Competence Test (GECO),African Wood Inc|Alupe University College,All,"25 Years to 67 Years   (Adult, Older Adult)",20.0,Other,Observational,2020-10-15,30/05/21,2021-06-30,05/01/21,05/01/21,"Alupe University College, Busia",Kenya,Respiratory Diseases,1,4,258.0
3633.0,NCT04432766,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: BAT2020,Bio-Thera Solutions,All,"18 Years and older   (Adult, Older Adult)",174.0,Industry,Interventional,2020-10-20,20/01/21,2021-08-18,16/06/20,29/09/20,"Snake River Research, Idaho Falls, Idaho",United States,Respiratory Diseases,1,1,302.0
3634.0,NCT04832880,Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial),AMMURAVID,Not yet recruiting,COVID-19,,,,,,,Drug: Baricitinib Oral Tablet [Olumiant]|Drug: Remdesivir|Drug: Dexamethasone,ASST Fatebenefratelli Sacco,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Interventional,2021-06-04,01/03/22,2022-01-12,06/04/21,06/04/21,"Ospedali Riuniti delle Marche, Ancona, Italy|Ospedale Parini, Aosta, Italy|Ospedale SS Annunziata -Chieti, Chieti, Italy|Ospedale S Anna, Como, Italy|Ospedale di Ferrara, Ferrara, Italy|Ospedale di Firenze and Empoli, Firenze, Italy|Ospedali Galliera, Genova, Italy|H Goretti, Latina, Italy|Ospedale Manzoni, Lecco, Italy|Ospedale di Legnago, Legnago, Italy|Ospedale di Legnano, Legnano, Italy|ASST Fatebenefratelli-Sacco, Milan, Italy|ASST Santi Paolo e Carlo, Milan, Italy|IRCCS San Raffaele, Milan, Italy|Ospedale di Perugia, Perugia, Italy|Ospedale San Salvatore, Pesaro, Italy|Ospedali di Prato e Pistoia, Prato, Italy|Policlinico Tor Vergata, Roma, Italy|Ospedale Cattinara e Maggiore, Trieste, Italy|Ospedale di Udine, Udine, Italy|Azienda Ospedaliera Integrata -Verona, Verona",Italy,Respiratory Diseases,1,1,222.0
3635.0,NCT04344782,"Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",CORIMMUNO-BEVA,Not yet recruiting,COVID-19,,,,,,,Drug: Bevacizumab Injection,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Interventional,2020-04-15,30/09/20,2020-11-30,14/04/20,17/04/20,,,Respiratory Diseases,1,1,229.0
3636.0,NCT04632173,Head and Neck cancERs International cOviD-19 collabOraTion,,Not yet recruiting,Head and Neck Cancer,COVID-19,,,,,,Other: non interventional study,"Hellenic Cooperative Oncology Group|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|National Cancer Centre, Singapore|Emory University|University of Toronto|University of Birmingham|The University of Queensland",All,"18 Years to 100 Years   (Adult, Older Adult)",750.0,Other,Observational,2020-01-12,31/01/21,2021-06-30,17/11/20,17/11/20,,,"Respiratory Diseases, Cancers",1,2,535.0
3637.0,NCT04558320,COVID-19 and Lactating Mothers,,Recruiting,Coronavirus Infection,,,,,,,,University of Rochester|National Institute of Allergy and Infectious Diseases (NIAID)|New York University,All,"Child, Adult, Older Adult",100.0,Other|NIH,Observational,2020-02-07,01/04/21,2021-01-04,22/09/20,22/09/20,"University of Rochester Medical Center, Rochester, New York",United States,Respiratory Diseases,1,1,332.0
3638.0,NCT04379661,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,,Completed,MS (Multiple Sclerosis),COVID-19,Support Groups,,,,,Behavioral: Online support Group,Columbia University,All,"18 Years and older   (Adult, Older Adult)",32.0,Other,Interventional,2020-07-05,07/07/20,2020-08-31,07/05/20,08/01/21,"Columbia University Medical Center, New York, New York",United States,"Respiratory Diseases, Immunological Disorders",1,3,57.0
3639.0,NCT04341870,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",CORIMUNO-VIRO,Suspended,COVID-19,COVID-19,,,,,,Drug: Sarilumab|Drug: Azithromycin|Drug: Hydroxychloroquine,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 80 Years   (Adult, Older Adult)",27.0,Other,Interventional,2020-11-04,08/05/20,2020-01-08,10/04/20,06/05/20,"AP-HP Hôpital Avicenne, Bobigny, France|AP-HP Hôpital Ambroise Paré, Boulogne-Billancourt, France|AP-HP Hôpital Beaujon, Clichy, France|AP-HP Hôpital Pitié Salpétrière, Paris, France|AP-HP Hôpital Saint Antoine, Paris",France,Respiratory Diseases,1,2,-301.0
3640.0,NCT04414241,Hydroxychloroquine to Prevent SARS-CoV-2 Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine,Universidad Peruana Cayetano Heredia,All,"18 Years and older   (Adult, Older Adult)",320.0,Other,Interventional,2020-01-06,01/09/20,2020-01-10,04/06/20,04/06/20,"Centro Médico Naval Cirujano Mayor Santiago Távara, Callao, Peru|Hospital Nacional Hipólito Unanue, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Cayetano Heredia, Lima",Peru,Respiratory Diseases,1,1,4.0
3641.0,NCT04319016,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,COVID-preg,Recruiting,Infection Viral,,,,,,,Other: pregnant women with laboratory-confirmed 2019-n-CoV,Federico II University,Female,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-01,30/04/20,2020-01-05,24/03/20,28/04/20,"Gabriele Saccone, Napoli",Italy,Others,0,1,4.0
3642.0,NCT04323631,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine|Other: The control group will not receive hydroxychloroquine,Rambam Health Care Campus|Rabin Medical Center,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-30,30/04/20,2020-04-30,26/03/20,30/06/20,,,Respiratory Diseases,1,1,0.0
3643.0,NCT04363853,Tocilizumab Treatment in Patients With COVID-19,,"Active, not recruiting",Sars-CoV2,,,,,,,Drug: Tocilizumab,Instituto Nacional de Cancerologia de Mexico|Roche Pharma AG,All,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other|Industry,Interventional,2020-01-06,01/06/21,2021-01-08,27/04/20,30/11/20,"National Cancer Institute of Mexico, Mexico city, Distrito Federal",Mexico,Respiratory Diseases,1,1,368.0
3644.0,NCT04492501,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,,Completed,COVID-19,Cytokine Release Syndrome,Critical Illness,ARDS,,,,Procedure: Therapeutic Plasma exchange|Biological: Convalescent Plasma|Drug: Tocilizumab|Drug: Remdesivir|Biological: Mesenchymal stem cell therapy,UNICEF|Pak Emirates Military Hospital Rawalpindi,All,"18 Years to 90 Years   (Adult, Older Adult)",600.0,Other,Interventional,2020-01-04,20/07/20,2020-07-20,30/07/20,30/07/20,"Pak Emirates Military Hospital, Rawalpindi, Punjab",Pakistan,"Cardiovascular Diseases, Respiratory Diseases",1,4,198.0
3645.0,NCT04581018,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,,Recruiting,COVID-19,Microbiota,,,,,,Other: Health supplements,Siew Chien NG|Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-08-13,30/10/21,2022-04-30,09/10/20,14/10/20,"The Chinese University of Hong Kong, Sha Tin",Hong Kong,Respiratory Diseases,1,2,625.0
3646.0,NCT04351724,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),ACOVACT,Recruiting,COVID-19,,,,,,,Drug: Chloroquine or Hydroxychloroquine|Drug: Lopinavir/Ritonavir|Other: Best standard of care|Drug: Rivaroxaban|Drug: Thromboprophylaxis|Drug: Candesartan|Drug: non-RAS blocking antihypertensives|Drug: Remdesivir|Drug: Asunercept 400mg|Drug: Asunercept 100mg|Drug: Asunercept 25mg|Drug: Pentaglobin,Medical University of Vienna|Kaiser Franz Josef Hospital|SMZ-Ost Donauspital|Otto Wagner Hospital|Hospital Hietzing|Wilhelminenspital Vienna|Medical University Innsbruck|Medical University of Graz|Kepler University Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-16,01/12/21,2022-03-31,17/04/20,02/03/21,"Medical University of Innsbruck, Innsbruck, Tirol, Austria|Medical University of Graz, Graz, Austria|Kepler University Hospital, Linz, Austria|Medical University of Vienna, Vienna, Austria|Wilhelminenspital, Vienna, Austria|SMZ Süd Kaiser Franz Josef Spital, Vienna, Austria|KH Hietzing, Vienna, Austria|SMZ Baumgartner Höhe Otto Wagner Spital, Vienna, Austria|SMZ Ost Donauspital, Vienna",Austria,Respiratory Diseases,1,1,714.0
3647.0,NCT04600999,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir,University of Pecs|HECRIN Consortium|Hungarian Ministry of Innovation and Technology,All,"18 Years to 74 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-07-10,01/06/21,2021-01-06,23/10/20,23/10/20,"Department of Pulmonology Semmelweis University, Budapest, Hungary|National Korányi Institute for Pulmonology, Budapest, Hungary|Institute of Infectology, University of Debrecen, Debrecen, Hungary|1st Department of Medicine, University of Pécs, Pécs, Hungary|First Department of Internal Medicine, University of Szeged, Szeged",Hungary,Respiratory Diseases,1,1,180.0
3648.0,NCT04694638,"Use of Combined Prone Positioning and High-Flow Nasal Cannula, and Non-invasive Positive Pressure Ventilation to Prevent Intubation in COVID-19 Infection",,Recruiting,Prone Positioning,COVID-19,Hypoxemic Respiratory Failure,ARDS,Non Invasive Ventilation,High Flow Nasal Cannulla,,Other: Body position change,Mayo Clinic,All,"18 Years to 110 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-05-21,01/05/21,2021-01-05,05/01/21,05/01/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,6,229.0
3649.0,NCT04330300,Coronavirus (COVID-19) ACEi/ARB Investigation,CORONACION,Suspended,Hypertension,COVID-19,,,,,,Drug: Thiazide or Thiazide-like diuretics|Drug: Calcium Channel Blockers|Drug: ACE inhibitor|Drug: Angiotensin receptor blocker,"National University of Ireland, Galway, Ireland",All,"60 Years and older   (Adult, Older Adult)",2414.0,Other,Interventional,2020-04-30,31/07/21,2021-01-12,01/04/20,30/06/20,"University Hospital Galway, Galway",Ireland,"Cardiovascular Diseases, Respiratory Diseases",1,2,257.0
3650.0,NCT04747574,Evaluation of the Safety of CD24-Exosomes in Patients With COVID-19 Infection,,Recruiting,COVID-19,,,,,,,Drug: EXO-CD24,Tel-Aviv Sourasky Medical Center,All,"18 Years to 85 Years   (Adult, Older Adult)",35.0,Other,Interventional,2020-09-25,25/02/21,2021-03-25,10/02/21,04/03/21,"Tel Aviv Medical Center, Tel Aviv",Israel,Respiratory Diseases,1,1,181.0
3651.0,NCT04771000,A Study of Micro Dose Ambrisentan in Hospitalized Patients With Respiratory Insufficiency Due to COVID-19,,Recruiting,COVID-19,Hypoxemia,,,,,,Drug: Ambrisentan|Drug: Placebo,Noorik Biopharmaceuticals AG,All,"50 Years to 85 Years   (Adult, Older Adult)",150.0,Industry,Interventional,2021-08-02,31/07/21,2021-10-31,25/02/21,12/04/21,"Hospital Universitario Virgen de las Nieves, Granada, Comunidad De Andalucia, Spain|Hospital Universitario San Cecilio, Granada, Comunidad De Andalucia, Spain|Hospital Universitario de Jaén, Jaén, Comunidad De Andalucía, Spain|Hospital Universitario de Galdakao-Usansolo, Galdakao, Comunidad De Bizkaia, Spain|Complejo Hospitalario de Navarra, Pamplona, Comunidad De Navarra, Spain|University Hospital 12 de Octubre, Madrid, Spain|Hospital Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,2,90.0
3652.0,NCT04595084,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,,Not yet recruiting,Depression,Anxiety,Substance Use,"Stress, Psychological","Stress, Emotional","Alcohol Use, Unspecified",Drug Use,Behavioral: Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell|Behavioral: Internet Cognitive Behavioral Therapy plus CHAMindWell|Behavioral: CHAMindWell,Cambridge Health Alliance|National Center for Complementary and Integrative Health (NCCIH)|Penn State University,All,"18 Years to 70 Years   (Adult, Older Adult)",240.0,Other|NIH,Interventional,2021-02-15,01/11/21,2022-01-11,20/10/20,26/01/21,,,Mental Health,1,7,330.0
3653.0,NCT04371302,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,,Not yet recruiting,"Burnout, Professional",Medical Errors,Depression,,,,,Diagnostic Test: Questionnaire,University of Malaya,All,"18 Years and older   (Adult, Older Adult)",145.0,Other,Observational,2020-01-05,30/06/20,2020-06-30,01/05/20,05/05/20,,,Mental Health,1,3,177.0
3654.0,NCT04459403,Psychiatric Disturbances and COVID-19 Infection,,Completed,Corona Virus Infection,,,,,,,,"Cairo University|Ministry of Health and Population, Egypt|National Hepatology & Tropical Medicine Research Institute",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-08-06,30/12/20,2020-12-30,07/07/20,28/01/21,"15 Mayo Smart Hospital, Cairo, Egypt|National hepatology and tropical medicine research institute, Cairo, Egypt|Students hospital, Giza",Egypt,Respiratory Diseases,1,1,146.0
3655.0,NCT04354272,Evaluation of Dental Emergency Treatments During COVID19 Crisis,URGDENTCOVID,Completed,Orofacial Pain,Orofacial Edema,Dental Trauma,Oral Infection,,,,Other: Questionnaire,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",503.0,Other,Observational,2020-04-21,29/04/20,2020-06-29,21/04/20,02/03/21,"Service d'odontologie, Hôpital Pitié-Salpêtrière, Paris",France,Others,0,4,69.0
3656.0,NCT04339816,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,AZIQUINE-ICU,Terminated,COVID-19,Respiratory Failure,,,,,,Drug: Azithromycin|Drug: Hydroxychloroquine|Drug: Placebo,"Frantisek Duska, MD, PhD|Masaryk Hospital Usti nad Labem|University Hospital Pilsen|The Faculty Hospital Na Bulovce|St. Anne's University Hospital Brno, Czech Republic|University Hospital, Motol|General University Hospital, Prague|University Hospital Olomouc|Charles University, Czech Republic",All,"18 Years and older   (Adult, Older Adult)",3.0,Other,Interventional,2020-05-13,04/11/20,2020-04-11,09/04/20,06/11/20,"František Duška, Praha, Česká Republika",Czechia,Respiratory Diseases,1,2,-32.0
3657.0,NCT04526990,Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,,Recruiting,COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,CanSino Biologics Inc.|Beijing Institute of Biotechnology,All,"18 Years and older   (Adult, Older Adult)",40000.0,Industry|Other,Interventional,2020-09-15,30/12/21,2022-01-30,26/08/20,22/01/21,"Fundación Socolinsky Centro de Vacunación Proteger - Recoleta, Caba, Buenos Aires, Argentina|Hospital Pirovano, Caba, Buenos Aires, Argentina|Htal de Alta Complejidad Cuenca Alta Néstor Kirchner, Cañuelas, Buenos Aires, Argentina|Hospital Interzonal de Agudos San Juan de Dios de La Plata, La Plata, Buenos Aires, Argentina|Hospital Rossi, La Plata, Buenos Aires, Argentina|Inst. Médico Platense, La Plata, Buenos Aires, Argentina|Instituto de Investigaciones Clínicas, Mar Del Plata, Buenos Aires, Argentina|Htal Mariano y Luciano de la Vega, Moreno, Buenos Aires, Argentina|Hospital Houssay, Vicente López, Buenos Aires, Argentina|Hospital Zonal General de Agudos Cetrangolo, Vicente López, Buenos Aires, Argentina|Instituto Cer, Vicente López, Quilmes, Argentina|Previvax Centro de Vacunación, Córdoba, Argentina|Hospital Dr. Hernan Henriquez Aravena Temuco, Temuco, IX Region, Chile|CIMER Centro de Investigaciones Medicas Respiratorias Santiago, Providencia, Region Metropolitana, Chile|Hospital San Borja Arriarán Santiago, Santiago, Region Metropolitana, Chile|Clínica Andes Salud Concepción, Concepción, VII Región, Chile|Hospital de Puerto Montt Dr. Eduardo Schütz Schoroeder Puerto Montt, Puerto Montt, X Región De Los Lagos, Chile|Hospital Base de Osorno, Osorno, XIV Región, Chile|Clinica Alemana de Valdivia Valdivia, Valdivia, XIV Región, Chile|Centro de investigación Médica Aguascalientes (CIMA), Aguascalientes, Ags, Mexico|Instituto de Servicios de Salud del Estado de Baja California, Mexicali, Baja California Norte, Mexico|Instuto de Ciencias Médicas y de la Nutrición Salvador Subirán (INCMNSZ), Tlalpan, Cdmx, Mexico|Instituto Nacional de Medicina Genómica, Tlalpan, Cdmx, Mexico|Centro de Investigacion Integral MEDIVEST SC, Chihuahua, Chhihuahia, Mexico|Centro de Investigacion Clinica Chapultepec SA de CV (Hidra), Coyoacán, Ciudad De Mexico, Mexico|Instituto Mexicano del Seguro Social (IMSS), Cuahtemoc, Ciudad De Mexico, Mexico|Clinical Research Institute Saltillo SA de CV, Saltillo, Cuahuila, Mexico|Centro de Investigación Clínica del Pacifico S.A. de C.V. (CICPA), Acapulco, Guerrero, Mexico|Asociación Mexicana para la investigación clínica (AMIC), Pachuca de Soto, Hidalgo, Mexico|Instituto Jaliscience de Metabolismo, S. C., Guadalajara, Jalisco, Mexico|Asociación de investigación pediátrica y adultos (AINPAD), Morelia, Mochoacán De Ocampo, Mexico|JM Research, Cuernavaca, Morelos, Mexico|Hospital Metropolitano Dr. Bernardo Sepúlveda, San Nicolás De Los Garza, Nuevo León, Mexico|Oaxaca site management organization (OSMO), Oaxaca, Oax, Mexico|Centro de Investigación y Avances Médicos Especializados (CIAME), Cancún, Quintana Roo, Mexico|FAICIC, Veracruz, Veracrua, Mexico|Kohler & Milstein Research, Mérida, Yucatan, Mexico|PEMEX, Ciudad de mexico, Mexico|Instituto Nacional de Pediatría (INP), Ciudad de México, Mexico|Instituto de Investigaciones aplicada a las Neurociencias (IIAN), Durango, Mexico|Administración de Especialistas de Puebla S.C. (UDEP), Puebla, Mexico|Shifa International Hospital, Islamabad, Islamabad Capital Territory, Pakistan|Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Punajb, Pakistan|University of Health Scinces, Lahore, Lahore, Punjab, Pakistan|Aga Khan University Hospital, Karachi, Sindh, Pakistan|The Indus Hospital, Karachi, Sindh, Pakistan|Research Center Eco-safety, Saint Petersburg, Saint-Petersburg, Russian Federation|OOO Meditsinskie Tekhnologii, Saint Petersburg, Saint-Petersburg, Russian Federation|OOO Baltijskaya Meditsina, Saint Petersburg, Saint-Petersburg, Russian Federation|Research Center Eco-safety, Saint Petersburg, Saint-Petersburg, Russian Federation|Federal State Budgetary Institution Scientific Research Institute of Influenza named after A. A. Smorodintsev of the Ministry of Healthcare of the Russian Federation named after A. A. Smorodintsev of the Ministry of Healthcare of the Russian Federation, Saint Petersburg, Saint-Petersburg, Russian Federation|Saint Petersburg State Budgetary Healthcare Institution City Polyclinic #106, Saint Petersburg, Saint-Petersburg, Russian Federation|Saint-Petersburg State Healthcare Institution Nikolaev Hospital, Saint Petersburg, Saint-Petersburg, Russian Federation|OOO Piterclinica, Saint Petersburg, Saint-Petersburg, Russian Federation|State Budgetary Healthcare Institution of Sverdlovsk Region Aramil City Hospital, Aramil, Sverdlovsk, Russian Federation|Non-state Institution of Healthcare Road Clinical Hospital at Chelyabinsk station of open corporate society Russian Railways, Chelyabinsk, Russian Federation|State Budgetary Educational Institution of Higher Professional Education Chita State Medical Academy of the Ministry of Healthcare of the Russian Federation, Chita, Russian Federation|Federal State Budgetary Institution Main Military Clinical Hospital n.a. N.N. Burdenko Ministry of Defense of Russian Federation, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution City Polyclinic #2 of the Moscow City Healthcare Department, Moscow, Russian Federation|Health Central Clinical Hospital of Russian Academy of Sciences, Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of Ministry of Healthcare of the Russian Federation (Sechenovsky University), Moscow, Russian Federation|Private Healthcare Institution Central Clinical Hospital RZhD-Medicine, Moscow, Russian Federation|State Regional Budgetary Healthcare Institution Murmansk Regional Clinical Hospital n.a.P.A. Bayandin, Murmansk, Russian Federation|State Regional Autonomous Healthcare Institution Monchegorsk Central District Hospital, Murmansk, Russian Federation|Private Healthcare Institution Clinical Hospital RZHD-Meditsina of Nizhniy Novgorod, Nizhniy Novgorod, Russian Federation|Life Benefits Service, Ltd', Novosibirsk, Russian Federation|Budgetary Institution of Heathcare of Omsk region City Clinical Hospital #1 n.a. Kabanova A.N., Omsk, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Perm State Medical University named after E.A. Vagnera Ministry of Healthcare of Russian Federation, Perm, Russian Federation|OOO Zvyezdnaya Klinika, Saint Petersburg, Russian Federation|Limited Liability Company Hospital OrKli, Saint-Petersburg, Russian Federation|OOO Tsentr DNK issledivaniy, Saratov, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Saratov State Medical University named after V.I. Razumovsky the Ministry of Health of the Russian Federation - Clinical hospital n.a. S.R.Mirotvortseva, Saratov, Russian Federation|OOO Zdorovye, Tomsk, Russian Federation|State Autonomous Healthcare Institution of Yaroslavl region Clinical Emergency Hospital named after N.V. Solovyev, Yaroslavl",Russian Federation,Respiratory Diseases,1,1,502.0
3658.0,NCT04354584,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,COV2ICU-DK,Recruiting,COVID-19,Respiratory Failure,,,,,,,Hvidovre University Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-06-04,06/04/21,2021-06-04,21/04/20,18/02/21,"Dept. of Intensive Care 542, University Hospital Hvidovre, Hvidovre, Copenhagen",Denmark,Respiratory Diseases,1,2,365.0
3659.0,NCT04359693,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,COVAPID,Completed,SARS-CoV 2,,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1576.0,Other,Observational,2020-04-22,01/07/20,2020-01-07,24/04/20,22/07/20,"Hôpital Roger Salengro, ICU, CHU Lille, Lille",France,Respiratory Diseases,1,1,-106.0
3660.0,NCT04570488,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,,Recruiting,COVID-19,Corona Virus Infection,Adverse Event,,,,,Other: EPIC risk score display,NYU Langone Health,All,"18 Years to 100 Years   (Adult, Older Adult)",1200.0,Other,Interventional,2020-05-15,30/12/20,2021-05-15,30/09/20,14/10/20,"NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,3,365.0
3661.0,NCT04695704,Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:,E-SPERANZA,Not yet recruiting,COVID-19,SARS (Disease),,,,,,Drug: Montelukast|Other: placebo,Jordi Gol i Gurina Foundation|Institut Català de la Salut,All,"18 Years to 80 Years   (Adult, Older Adult)",284.0,Other,Interventional,2021-01-04,31/03/22,2022-12-31,05/01/21,08/03/21,,,Respiratory Diseases,1,2,726.0
3662.0,NCT04565106,Automatic Oxygen Titration With O2matic® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,O2matic-COVI,Completed,COVID-19,Hypoxemic Respiratory Failure,Hypoxemia,,,,,Device: Closed-loop control of oxygen supplementation by O2matic,Hvidovre University Hospital|Innovation Fund Denmark,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Observational,2020-04-15,31/05/20,2020-05-31,25/09/20,25/09/20,"Hvidovre University Hospital, Copenhagen",Denmark,Respiratory Diseases,1,3,46.0
3663.0,NCT04565509,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,,Recruiting,COVID-19,Intellectual Disability,Developmental Disability,Child Development Disorder,,,,Behavioral: General Communication Message|Behavioral: Focused/Targeted Message|Behavioral: Best Message Alone|Behavioral: Best Message + Augmented Message or Implementation Strategy,"Washington University School of Medicine|University of Missouri, Kansas City|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|National Institutes of Health (NIH)",All,"5 Years to 90 Years   (Child, Adult, Older Adult)",2500.0,Other|NIH,Interventional,2020-11-20,30/06/22,2022-09-21,25/09/20,30/11/20,"Hugo W. Moser Research Institute at Kennedy Krieger, Inc., Baltimore, Maryland, United States|University of Missouri, Kansas City, Missouri, United States|Special School District, Saint Louis, Missouri",United States,Respiratory Diseases,1,4,670.0
3664.0,NCT04386616,A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,COVASTIL,Completed,COVID-19,,,,,,,Drug: MSTT1041A|Drug: MSTT1041A-matched Placebo|Drug: UTTR1147A|Drug: UTTR1147A-matched Placebo,"Genentech, Inc.",All,"18 Years and older   (Adult, Older Adult)",410.0,Industry,Interventional,2020-02-06,02/01/21,2021-12-02,13/05/20,17/02/21,"University of Arkansas For Medical Sciences, Little Rock, Arkansas, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|eStudySite, La Mesa, California, United States|Alta Bates Summit Medical Center, Oakland, California, United States|Torrance Memorial Medical Center, Torrance, California, United States|Denver Health Medical Center, Denver, Colorado, United States|Bay Pines VA Medical Center - NAVREF, Bay Pines, Florida, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|Northside Hospital; Peachtree Dunwoody Medical Center, Atlanta, Georgia, United States|WellStar Research Institute, Marietta, Georgia, United States|University Of Iowa Hospitals And Clinics, Coralville, Iowa, United States|DM Clinical Research - Alexandria Cardiology Clinic - ERN - PPDS, Alexandria, Louisiana, United States|MedPharmics, Metairie, Louisiana, United States|Southeast Louisiana Veterans Health Care System - NAVREF, New Orleans, Louisiana, United States|Henry Ford Health System, Detroit, Michigan, United States|St. Joseph'S Regional Medical Center, Paterson, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|Albany Medical Center, Albany, New York, United States|Lincoln Medical Mental Health Center, Bronx, New York, United States|Jacobi Medical Center; Lewis M. Fraad Department of Pediatrics, Bronx, New York, United States|Staten Island University Hospital; Department of Pharmacy, Staten Island, New York, United States|Cape Fear Valley Health System, Fayetteville, North Carolina, United States|Mercy St. Vincent Medical Center, Toledo, Ohio, United States|Providence Portland Medical Center; Investigational Drug Services/Regional Research, Portland, Oregon, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, United States|Temple Uni Medical Center; Pulmonary & Critical Care Medicine, Philadelphia, Pennsylvania, United States|Parkland Health & Hospital System, Dallas, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Virginia Mason Medical Center, Seattle, Washington, United States|MultiCare Institute for Research and Innovation; Clinic/Outpatient Facility, Tacoma, Washington, United States|Instituto de Pesquisa Clinica Evandro Chagas FIOCRUZ, Rio de Janeiro, RJ, Brazil|Centro De Estudos Pesquisas em Molestias Infecciosas - CPCLIN, Natal, RN, Brazil|Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital E Maternidade Celso Pierro PUCCAMP, Campinas, SP, Brazil|Hospital de Base Da Faculdade de Medicina de Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, SP, Brazil|Hospital Alemao Oswaldo Cruz, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil|Nuevo Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey, Nuevo LEON, Mexico|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico|Instituto Nacional De Enfermedades Respiratorias INER National Institute of Respiratory Diseases, Mexico, Mexico|Hospital General de Tijuana, Tijuana, Mexico|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Mutua de Terrassa, Terrassa, Barcelona, Spain|Hospital Universitario A Coruña, Coruna, LA Coruña, Spain|Hospital San Pedro, Logroño, LA Rioja, Spain|Hospital Costa del Sol; Servicio de Oncologia, Marbella, Malaga, Spain|Hospital del Mar, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Hospital General Universitario Gregorio Maranon, Madrid, Spain|Complejo Asistencial Universitario de Salamanca - H. Clinico, Salamanca, Spain|Hospital Clinico Universitario Valladolid, Valladolid",Spain,Respiratory Diseases,1,1,665.0
3665.0,NCT04457817,Compensatory Reserve Index (CRI) for Management of COVID-19,,Enrolling by invitation,COVID-19,,,,,,,Device: CRI management,"University of Colorado, Denver|Children's Hospital Colorado",All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-12,01/07/21,2021-01-07,07/07/20,19/01/21,"University of Colorado, Aurora, Colorado",United States,Respiratory Diseases,1,1,361.0
3666.0,NCT04700137,"Mental Health Among Patients, Providers, and Staff During the COVID-19 Era",MHAPPS,Enrolling by invitation,COVID-19,Mental Health,,,,,,Other: Caring Contacts Plus Introductory Phone Call (CC+)|Other: Caring Contacts without an introductory phone call (CC),"St. Luke's Health System, Boise, Idaho|Patient-Centered Outcomes Research Institute|Idaho Suicide Prevention Hotline (Jannus, Inc.)|University of Washington",All,"12 Years and older   (Child, Adult, Older Adult)",660.0,Other,Interventional,2021-01-18,17/01/22,2022-01-17,07/01/21,22/01/21,"St. Luke's Health System, Boise, Idaho",United States,Respiratory Diseases,1,2,364.0
3667.0,NCT04542447,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,,Recruiting,COVID-19,,,,,,,Drug: Nuvastatic,Natureceuticals Sdn Bhd,All,"18 Years to 65 Years   (Adult, Older Adult)",10.0,Industry,Interventional,2020-01-09,30/09/20,2020-09-30,09/09/20,10/09/20,"Navin Hospital, Ghaziabad, Uttar Pradesh",India,Respiratory Diseases,1,1,265.0
3668.0,NCT04834102,COVID-19 Induced Telogen Effluvium,,Recruiting,COVID-19,Telogen Effluvium,SARS-CoV Infection,Alopecia,,,,Diagnostic Test: Blood Tests,Istanbul Medeniyet University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-27,27/04/21,2021-04-27,06/04/21,06/04/21,"Istanbul Medeniyet University, Istanbul, Kadıköy",Turkey,Respiratory Diseases,1,4,90.0
3669.0,NCT04337008,Renin Angiotensin System - CoronaVirus,SRA-COV,Recruiting,COVID-19,,,,,,,Other: blood draw,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-03-04,03/06/20,2020-07-31,07/04/20,24/04/20,"ASSISTANCE PUBLIQUE HÖPITAUX de MARSEILLE, Marseille",France,Respiratory Diseases,1,1,149.0
3670.0,NCT04373213,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,,Not yet recruiting,Pleth Variability Index,,,,,,,Diagnostic Test: Pleth variability index,Erzincan University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-05-05,05/06/20,2020-06-15,04/05/20,04/05/20,"Erzincan University, Erzincan",Turkey,Others,0,1,41.0
3671.0,NCT04524520,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",,Recruiting,COVID-19,,,,,,,,Western Sussex Hospitals NHS Trust,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-05-05,08/05/21,2022-08-05,24/08/20,24/08/20,"Dr Luke Hodgson, Worthing",United Kingdom,Respiratory Diseases,1,1,822.0
3672.0,NCT04673279,Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina,,Recruiting,Coronavirus Disease 2019,,,,,,,Diagnostic Test: serology,Hospital Italiano de Buenos Aires|Hospital de Niños R. Gutierrez de Buenos Aires|Ministerio de Salud GCBA,All,"14 Years to 90 Years   (Child, Adult, Older Adult)",189.0,Other,Observational,2020-02-12,10/04/21,2021-01-07,17/12/20,17/12/20,"Hospital de Niños Ricardo Gutierrez, Buenos Aires, Ciudad De Buenos Aires",Argentina,Respiratory Diseases,1,1,330.0
3673.0,NCT04754594,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of SARS CoV-2 RNA Vaccine Candidate (BNT162b2) Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older",,Recruiting,COVID-19,COVID-19,Maternal Immunization,,,,,Biological: BNT162b2|Other: Placebo,BioNTech SE|Pfizer,All,"Child, Adult, Older Adult",4000.0,Industry,Interventional,2021-02-16,27/06/22,2022-06-27,15/02/21,14/04/21,"Children's of Alabama, Birmingham, Alabama, United States|University of Alabama at Birmingham Women & Infant Center, Birmingham, Alabama, United States|University of Alabama at Birmingham/Center for Women's Reproductive Health, Birmingham, Alabama, United States|MedPharmics, Mobile, Alabama, United States|Arrowhead Hospital, Glendale, Arizona, United States|Abrazo West Campus Hospital, Goodyear, Arizona, United States|St. Joseph Hospital, Phoenix, Arizona, United States|MedPharmics, LLC, Phoenix, Arizona, United States|Chemidox Clinical Trials Inc., Lancaster, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|University of Colorado Academic Office Building One, Aurora, Colorado, United States|University of Colorado Anschutz Inpatient Pavilion 2, Aurora, Colorado, United States|University of Colorado Hospital Inpatient Pavilion, Aurora, Colorado, United States|University of Colorado Hospital Outpatient Pavilion, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|University of Colorado Leprino Building, Aurora, Colorado, United States|University of Colorado Research II Building, Aurora, Colorado, United States|Axcess Medical Research, Loxahatchee Groves, Florida, United States|Idaho Falls Pediatrics, Ammon, Idaho, United States|Bingham Memorial Hospital, Blackfoot, Idaho, United States|Idaho Falls Pediatrics, Idaho Falls, Idaho, United States|Clinical Research Prime, Idaho Falls, Idaho, United States|Eastern Idaho Regional Medical Center, Idaho Falls, Idaho, United States|Mountain View Hospital, Idaho Falls, Idaho, United States|ASR, LLC, Nampa, Idaho, United States|Medpharmics, LLC, Covington, Louisiana, United States|Women's Health & Wellness, Covington, Louisiana, United States|MedPharmics LLC, Lafayette, Louisiana, United States|MedPharmics, LLC, Metairie, Louisiana, United States|Covenant Healthcare, Saginaw, Michigan, United States|Saginaw Valley Medical Research Group, LLC, Saginaw, Michigan, United States|MedPharmics, LLC, Gulfport, Mississippi, United States|Community Hospital of Anaconda, Anaconda, Montana, United States|Boeson Research (BUT), Butte, Montana, United States|SCL St. James Healthcare Hospital, Butte, Montana, United States|Benefis Hospital, Great Falls, Montana, United States|Boeson Research (GTF), Great Falls, Montana, United States|Marcus Daly Memorial Hospital, Hamilton, Montana, United States|Boeson Research (HLN), Helena, Montana, United States|St. Peter's Health Hospital, Helena, Montana, United States|Providence St. Patrick Hospital, Missoula, Montana, United States|The Birth Center, Missoula, Montana, United States|Boeson Research, Missoula, Montana, United States|Community Medical Center, Missoula, Montana, United States|Community Physicians Group-Maternal Fetal Medicine, Missoula, Montana, United States|St. Luke Community Healthcare Hospital, Ronan, Montana, United States|Meridian Clinical Research, LLC, Grand Island, Nebraska, United States|Meridian Clinical Research, LLC, Hastings, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Allegheny Health and Wellness Pavilion, Erie, Pennsylvania, United States|OBGYN Associates of Erie, Erie, Pennsylvania, United States|Liberty Family Practice, Erie, Pennsylvania, United States|Saint Vincent Hospital, Erie, Pennsylvania, United States|Reading Hospital - Children's Health Center, West Reading, Pennsylvania, United States|Reading Hospital Clinical Trials Office, West Reading, Pennsylvania, United States|Reading Hospital-Family Health Care Center, West Reading, Pennsylvania, United States|Reading Hospital-Womens Health Center, West Reading, Pennsylvania, United States|Tower Health Medical Group-Maternal Fetal Medicine, West Reading, Pennsylvania, United States|Tekton Research, Inc., Austin, Texas, United States|Tekton Research, Inc., Austin, Texas, United States|Ventavia Research Group LLC, Dallas, Texas, United States|DHR Health Institute for Research and Development, Edinburg, Texas, United States|8th Avenue Obstetrics & Gynecology, Fort Worth, Texas, United States|Ventavia Research Group, LLC, Fort Worth, Texas, United States|University of Texas Medical Branch, Galveston, Texas, United States|Chisholm Trail Pediatrics, Georgetown, Texas, United States|FMC Science., Georgetown, Texas, United States|St. David's Georgetown Hospital, Georgetown, Texas, United States|Memorial Hermann Memorial City - Labor and Delivery Unit, Houston, Texas, United States|UT Physicians Women's Center at Memorial City, Houston, Texas, United States|UTHealth Women's Research Program at Memorial City, Houston, Texas, United States|The University of Texas Medical School at Houston, Houston, Texas, United States|FMC Science, Lampasas, Texas, United States|Dr. Ruben Aleman & Associates, McAllen, Texas, United States|UTMB Health RMCHP Pasadena, Pasadena, Texas, United States|UTMB Health RMCHP Pearland, Pearland, Texas, United States|Ventavia Research Group, LLC, Plano, Texas, United States|Ventavia Research Group, LLC, Weatherford, Texas, United States|Weatherford OBGYN, Weatherford, Texas, United States|University of Utah Hospital, Salt Lake City, Utah, United States|University of Utah, Salt Lake City, Utah, United States|The Group for Women- MAWC, Norfolk, Virginia, United States|Tidewater Physicians for Women- MAWC, Norfolk, Virginia",United States,Respiratory Diseases,1,3,496.0
3674.0,NCT04337489,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),REMOTE-COVID,Not yet recruiting,Coronavirus,,,,,,,Device: SensiumVitals wearable sensor,Imperial College London|CW+ Charity,All,"18 Years to 95 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-07-28,01/04/21,2021-01-04,07/04/20,31/07/20,,,Respiratory Diseases,1,1,160.0
3675.0,NCT04677660,A Study of TAK-919 in Healthy Japanese Adults (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: TAK-919|Biological: Placebo,Takeda,All,"20 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2021-01-21,03/03/22,2022-03-03,21/12/20,25/02/21,"Sumida Hospital, Sumida-ku, Tokyo, Japan|PS Clinic, Fukuoka",Japan,Respiratory Diseases,1,1,406.0
3676.0,NCT04331470,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Levamisole Pill + Budesonide+Formoterol inhaler|Drug: Lopinavir/Ritonavir + hydoxychloroquine,Fasa University of Medical Sciences,All,"15 Years to 100 Years   (Child, Adult, Older Adult)",30.0,Other,Interventional,2020-04-04,20/04/20,2020-05-20,02/04/20,13/04/20,"Vali-Asr Hospital, Fasa, Fars, Iran",Islamic Republic of,Respiratory Diseases,1,1,46.0
3677.0,NCT04581954,Inflammatory Signal Inhibitors for COVID-19 (MATIS),MATIS,Recruiting,Coronavirus,COVID-19,Pneumonia,,,,,Drug: Ruxolitinib|Drug: Fostamatinib|Other: Standard of care,Imperial College London|Imperial College Healthcare NHS Trust|Rigel Pharmaceuticals|Novartis,All,"18 Years and older   (Adult, Older Adult)",456.0,Other|Industry,Interventional,2020-02-10,30/06/21,2021-07-31,09/10/20,17/11/20,"Imperial College Healthcare NHS Trust, London",United Kingdom,Respiratory Diseases,1,3,537.0
3678.0,NCT04409262,A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,REMDACTA,Completed,COVID-19,,,,,,,Drug: Remdesivir|Drug: Tocilizumab|Drug: Placebo,Hoffmann-La Roche|Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",649.0,Industry,Interventional,2020-06-16,01/02/21,2021-08-03,01/06/20,11/03/21,"Valleywise Health Medical Center, Phoenix, Arizona, United States|eStudySite - Chula Vista - PPDS, Chula Vista, California, United States|Hoag Hospital Irvine, Irvine, California, United States|Providence St. John's Health Center, Santa Monica, California, United States|Yale University School of Medicine; HIV Clinical Trials Program, New Haven, Connecticut, United States|Medstar Georgetown University Hospital, Washington, District of Columbia, United States|Holy Cross Hospital Inc, Fort Lauderdale, Florida, United States|Larkin Community Hospital Palm Springs Campus (Hialeah), Hialeah, Florida, United States|University of Miami Miller School of Medicine; Clinical Reseach Building, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida, United States|St Luke's Health System; Rheumatology Research, Boise, Idaho, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Louisiana State University Health Sciences Center/Ochsner, Shreveport, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Boston Medical Center, Boston, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Henry Ford Medical Center, Novi, Michigan, United States|Saint Elizabeth Regional Medical Center, Lincoln, Nebraska, United States|St. Michael'S Medical Center, Newark, New Jersey, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|Wyckoff Heights Medical Center, Staten Island, New York, United States|Novant Health Clinical Research, Charlotte, North Carolina, United States|OhioHealth Research Institute, Columbus, Ohio, United States|Providence Saint Vincent's Medical Center, Portland, Oregon, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Prisma Health-Midlands, Columbia, South Carolina, United States|The Liver Institute at Methodist Dallas, Arlington, Texas, United States|Baylor Scott and White Medical Center - College Station, College Station, Texas, United States|Baylor University Medical Center, Dallas, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Ben Taub General Hospital - HCHD, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor Scott & White Medical Center - Irving, Irving, Texas, United States|Baylor Scott & White Hospital - Plano, Plano, Texas, United States|Baylor Scott & White Health, Temple, Texas, United States|Intermountain LDS Hospital, Salt Lake City, Utah, United States|The Providence Regional Medical Center Everett, Everett, Washington, United States|West Virginia University Hospital, Morgantown, West Virginia, United States|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, MG, Brazil|Hospital Nossa Senhora das Graças; Setor de Pesquisa em Neurologia, Curitiba, PR, Brazil|Instituto de Pesquisa Clinica Evandro Chagas - IPEC FIOCRUZ, Rio de Janeiro, RJ, Brazil|Faculdade de Medicina do ABC - FMABC, Santo Andre, SP, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos, Sao Bernardo Do Campo, SP, Brazil|Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, SP, Brazil|Instituto de Infectologia Emilio Ribas, Sao Paulo, SP, Brazil|Instituto do Coração - HCFMUSP, Sao Paulo, SP, Brazil|Medsi Clinic, Moscow, Adygeja, Russian Federation|Clinical Infectious Diseases Hospital #1; Chair of Infectious Disease and Epidemiology, Moskva, Moskovskaja Oblast, Russian Federation|City Clinical Hospital #15, Moscow, Russian Federation|City Clinical Hospital # 52, Moscow, Russian Federation|Pokrovsky City Hosptial, St Petersburg, Russian Federation|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital Universitario Principe de Asturias; Medicina Interna - Servicio de Enfermedades Infecciosas, Alcala de Henares, Madrid, Spain|Hospital Universitario HM Torrelodones, Torrelodones, Madrid, Spain|Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital General Universitario de Guadalajara, Guadalajara, Spain|Hospital Universitario Fundacion Jimenez Diaz., Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Universitario de Salamanca, Salamanca",Spain,Respiratory Diseases,1,1,413.0
3679.0,NCT04371744,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,QT-Logs,Completed,COVID-19,,,,,,,,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-17,04/06/20,2020-05-06,01/05/20,09/06/20,"Assistance Publique Hôpitaux de Marseille, Marseille",France,Respiratory Diseases,1,1,19.0
3680.0,NCT04815135,Effect of Covid-19 Pandemic on Emergency Surgery Practice,,Completed,Emergencies,,,,,,,Other: Observational study,Ibrahim Khrais|University of Jordan,All,"Child, Adult, Older Adult",344.0,Other,Observational,2019-01-03,31/05/20,2021-01-18,24/03/21,24/03/21,"Ibrahim Khrais, Amman, Please Select",Jordan,Others,0,1,746.0
3681.0,NCT04395781,Pediatric Acute and Critical Care COVID-19 Registry of Asia,PACCOVRA,Recruiting,COVID-19,Pediatric Disorder,,,,,,,"KK Women's and Children's Hospital|King Chulalongkorn Memorial Hospital|Ramathibodi Hospital|Postgraduate Institute of Medical Education and Research, Chandigarh|Rumah Sakit Anak dan Bunda Harapan Kita|National University Hospital, Singapore|St. Marianna University School of Medicine|Tokyo Metropolitan Children's Medical Center, Japan|Aichi Children's Health and Medical Center, Japan|RS H Adam Malik|Children's Hospital of Chongqing Medical University|Zhengzhou Children's Hospital, China|Universiti Kebangsaan Malaysia Medical Centre|Penang Hospital, Malaysia|Vicente Sotto Memorial Medical Center|Hyogo Prefectural Kobe Children's Hospital|Singapore Clinical Research Institute",All,"up to 21 Years   (Child, Adult)",2000.0,Other,Observational,2020-05-18,31/12/22,2023-12-31,20/05/20,06/10/20,"Chongqing Hospital Children's Medical Center, Chongqing, China|Zhengzhou Children's hospital, Zhengzhou, China|Post Graduate Institute of Medical Education and Research, Chandigarh, India|General Hospital H. Adam Malik, Medan, Indonesia|Murni Teguh Memorial Hospital, Medan, Indonesia|St. Marianna University School of Medicine, Kanagawa, Japan|Universiti Kebangsaan Malaysia Medical Centre, Bandar Tun Razak, Kuala Lumpur, Malaysia|Hospital Enche' Besar Hajjah Khalsom, Kluang, Malaysia|University Malaya Medical Centre, Kuala Lumpur, Malaysia|Penang General Hospital, Pulau Pinang, Malaysia|Hospital Tuanku Ja'afar, Seremban, Malaysia, Seremban, Malaysia|Aga Khan University Hospital, Karachi, Pakistan|KK Women's and Children's Hospital, Singapore, Singapore|National University Hospital, Singapore, Singapore",Singapore,Respiratory Diseases,1,2,1322.0
3682.0,NCT04386694,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,,Completed,COVID-19,Respiratory Failure,,,,,,Device: Active PBMT/sMF|Device: Placebo PBMT/sMF,University of Nove de Julho|Hospital Tacchini/RS,All,"15 Years and older   (Child, Adult, Older Adult)",30.0,Other,Interventional,2020-05-18,17/09/20,2020-09-17,13/05/20,29/10/20,"Hospital Tacchini, Bento Gonçalves, RS",Brazil,Respiratory Diseases,1,2,122.0
3683.0,NCT04411446,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,CARED,Recruiting,COVID-19,,,,,,,Drug: Vitamin D|Drug: Placebo,"Vitamin D Study Group|Ag Nac Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación",All,"18 Years and older   (Adult, Older Adult)",1264.0,Other,Interventional,2020-11-08,15/05/21,2021-10-28,02/06/20,01/04/21,"Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires",Argentina,Respiratory Diseases,1,1,354.0
3684.0,NCT04573322,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,,Recruiting,COVID-19,,,,,,,Drug: Trans Sodium Crocetinate|Drug: Normal saline,Diffusion Pharmaceuticals Inc,All,"18 Years and older   (Adult, Older Adult)",224.0,Industry,Interventional,2020-10-09,14/11/21,2021-12-14,05/10/20,05/10/20,"National Institute of Infectious Diseases- Prof. Dr. Matei Balş, Bucharest",Romania,Respiratory Diseases,1,1,431.0
3685.0,NCT04667936,Evaluation of Sedation in COVID-19 ARDS,,Recruiting,Prone Position,Severe Acute Respiratory Syndrome Coronavirus 2,Hypnotics and Sedatives,Pulmonary Ventilation,,,,Other: Treatment group,Goethe University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-03,15/12/20,2021-01-01,16/12/20,16/12/20,"University Hospital Frankfurt, Frankfurt, Hessen",Germany,Respiratory Diseases,1,4,364.0
3686.0,NCT04708158,Novaferon for COVID-19 Treatment Trial (NCTT-005),,Not yet recruiting,COVID-19,,,,,,,Biological: Novaferon|Biological: Placebo,Genova Inc.,All,"20 Years and older   (Adult, Older Adult)",385.0,Industry,Interventional,2021-01-01,01/05/21,2021-01-06,13/01/21,13/01/21,,,Respiratory Diseases,1,1,5.0
3687.0,NCT04438850,COVidIVERmectin: Ivermectin for Treatment of Covid-19,COVER,Recruiting,COVID-19,,,,,,,Drug: Ivermectin|Other: Placebo,IRCCS Sacro Cuore Don Calabria di Negrar|Istituto Di Ricerche Farmacologiche Mario Negri,All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-07-31,01/02/21,2021-01-05,19/06/20,19/01/21,"IRCCS Sacro Cuore Don Calabria hospital, Negrar, Verona, Italy|Policlinico S. Orsola, Bologna, Italy|Ospedale Luigi Sacco, Milan, Italy|Ospedale di Rovereto, Rovereto, Italy|Ospedale Amedeo di Savoia, Turin, Italy|Hospital Clinic/ISGlobal, Barcelona, Spain|Hospital La Paz-Carlos III, Madrid",Spain,Respiratory Diseases,1,1,158.0
3688.0,NCT04397939,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,,Recruiting,COVID-19,Myocardial Reperfusion Injury,Cardiovascular Diseases,,,,,,Icahn School of Medicine at Mount Sinai,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-08-05,01/03/22,2023-01-03,21/05/20,01/04/21,"Mount Sinai Hospital, New York, New York",United States,Respiratory Diseases,1,3,881.0
3689.0,NCT04652674,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial,,Recruiting,COVID-19,"Satisfaction, Patient",Telemedicine,,,,,Behavioral: Telemedicine visit|Behavioral: In-person postoperative visit,Cedars-Sinai Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",70.0,Other,Interventional,2020-09-28,30/06/21,2021-06-30,03/12/20,03/12/20,"Cedars Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,3,275.0
3690.0,NCT04349410,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,FMTVDM,Completed,COVID-19,,,,,,,"Drug: Hydroxychloroquine, Azithromycin|Drug: Hydroxychloroquine, Doxycycline|Drug: Hydroxychloroquine, Clindamycin|Drug: Hydroxychloroquine, Clindamycin, Primaquine - low dose.|Drug: Hydroxychloroquine, Clindamycin, Primaquine - high dose.|Drug: Remdesivir|Drug: Tocilizumab|Drug: Methylprednisolone|Drug: Interferon-Alpha2B|Drug: Losartan|Drug: Convalescent Serum",The Camelot Foundation,All,"Child, Adult, Older Adult",1800.0,Other,Interventional,2020-11-04,14/09/20,2020-09-14,16/04/20,12/11/20,"FHHI-OI-Camelot; QME, Los Angeles, California",United States,Respiratory Diseases,1,1,-51.0
3691.0,NCT04738032,Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic,S4C - COVID-19,Completed,Type2 Diabetes,,,,,,,Other: Digital Storytelling Intervention,Mayo Clinic|Hennepin Healthcare Research Institute|Mountain Park Health Center,All,"18 Years to 70 Years   (Adult, Older Adult)",76.0,Other,Observational,2020-08-26,07/01/21,2021-07-01,04/02/21,04/02/21,"Mountain Park Health Center, Phoenix, Arizona, United States|Hennepin Healthcare, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota",United States,Metabolic Disorders,1,1,309.0
3692.0,NCT04569825,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,,Recruiting,Clinical Trial,,,,,,,Drug: Ophtamesone,University Of Anbar,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2020-01-08,30/09/20,2020-10-15,30/09/20,30/09/20,"Raid Muhmid Al-Ani, Ramadi, Anbar",Iraq,Others,0,1,281.0
3693.0,NCT04789499,Smell in Covid-19 and Efficacy of Nasal Theophylline,SCENT2,Recruiting,COVID-19,Anosmia,Olfactory Disorder,COVID-19,COVID-19,Hyposmia,Ageusia,Drug: Theophylline Powder,Washington University School of Medicine,All,"18 Years to 70 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-03-15,01/07/21,2021-01-12,09/03/21,08/04/21,"Washington University School of Medicine in Saint Louis, Saint Louis, Missouri",United States,Respiratory Diseases,1,7,-62.0
3694.0,NCT04596943,RGD PET/CT Imaging in COVID-19 Patients,,Recruiting,COVID-19,Endothelial Dysfunction,PET Imaging,,,,,Diagnostic Test: [68Ga]Ga-DOTA-(RGD)2 PET/CT,Radboud University,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-10-15,31/12/20,2021-01-30,22/10/20,22/10/20,"Radboudumc, Nijmegen",Netherlands,Respiratory Diseases,1,3,107.0
3695.0,NCT04606563,Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,ARBs CORONA II,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Losartan,University of British Columbia|Canadian Institutes of Health Research (CIHR),All,"18 Years and older   (Adult, Older Adult)",1372.0,Other,Interventional,2020-09-10,30/06/21,2021-06-30,28/10/20,28/10/20,"University of Nebraska, Omaha, Nebraska, United States|Brown University, Providence, Rhode Island, United States|Vanderbilt University, Nashville, Tennessee, United States|St. Luc University Hospital, Brussels, Belgium|Clinique Saint-Pierre, Ottignies, Belgium|University of Calgary - Foothills, Calgary, Alberta, Canada|Royal Columbian Hospital, New Westminster, British Columbia, Canada|Surrey Memorial Hospital, Surrey, British Columbia, Canada|St Paul's Hospital, Vancouver, British Columbia, Canada|Vancouver General Hospital, Vancouver, British Columbia, Canada|Queens University, Kingston, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|St Michael's Hospital, Toronto, Ontario, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|McGill University Health Center, Montréal, Quebec, Canada|Université de Sherbrooke, Sherbrooke, Quebec, Canada|Centre Hospitalier Universitaire d'Angers, Angers, France|Chiba University, Chiba, Japan|Hospital Clínico San Carlos, Madrid",Spain,Respiratory Diseases,1,2,293.0
3696.0,NCT04463420,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: PHR160 Spray|Drug: Placebo|Drug: Standard treatment,Baqiyatallah Medical Sciences University,All,"18 Years to 75 Years   (Adult, Older Adult)",224.0,Other,Interventional,2020-08-15,15/11/20,2020-12-15,09/07/20,04/11/20,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,122.0
3697.0,NCT04357275,The RIsk Stratification in COVID-19 Patients in the ICU Registry,RISC-19-ICU,Recruiting,Critical Illness,ARDS,Inflammatory Response,COVID-19,Circulatory Shock,,,Other: ICU treatment,University of Zurich,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-03-13,01/03/21,2022-01-03,22/04/20,22/04/20,"University Hospital of Zurich, Zurich",Switzerland,"Cardiovascular Diseases, Respiratory Diseases",1,5,661.0
3698.0,NCT04351152,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: Lenzilumab|Drug: Standard of Care,"Humanigen, Inc.",All,"18 Years and older   (Adult, Older Adult)",520.0,Industry,Interventional,2020-05-05,01/03/21,2021-01-03,17/04/20,03/03/21,"Mayo Clinic, Phoenix, Arizona, United States|University of California, Irvine, Irvine, California, United States|University of Southern California (USC) Medical Center, Los Angeles, California, United States|USC - Los Angeles County Medical Center, Los Angeles, California, United States|MedStar Washington Hospital Center, Washington, District of Columbia, United States|Mayo Clinic, Jacksonville, Florida, United States|AdventHealth Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|St. Elizabeth Healthcare, Edgewood, Kentucky, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Mercy Medical Center, Rockville Centre, New York, United States|Atrium Health, Charlotte, North Carolina, United States|St. David's Healthcare, Austin, Texas, United States|St. David's North Austin Medical Center, Austin, Texas, United States|Texas Health, Dallas, Texas, United States|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|CPCLIN - Centro de Pesquisas Clínicas de Natal, Natal, Rio Grande Do Norte, Brazil|Hospital São Lucas - PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Hospital Dia do Pulmão, Blumenau, São Paulo, Brazil|Hospital Guilherme Alvaro, Santos, São Paulo, Brazil|Clinica de Alergia Martti Antila S/S LTDA, Sorocaba, São Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clínicos LTDA-EPP, São Bernardo do Campo, São Paulo, Brazil|Escola Paulista de Medicina (UNIFESP), São Paulo, Brazil|Hospital Heliópolis, São Paulo, Brazil|Hospital São Luiz do Jabaquara/IDOR, São Paulo",Brazil,Respiratory Diseases,1,1,243.0
3699.0,NCT04646590,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,,Recruiting,COVID-19,Safety and Efficacy,,,,,,Biological: Recombinant new coronavirus vaccine (CHO cell) group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",All,"18 Years and older   (Adult, Older Adult)",29000.0,Industry,Interventional,2020-12-16,01/04/22,2022-01-04,30/11/20,16/02/21,"Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China|Biodimed Guayaquil Clinical Research Center, Guayaquil, Guayas, Ecuador|Biodimed Alemania Clinical Research Center, Quito, Pichincha, Ecuador|Biodimed Eloy Alfaro Clinical Research Center, Quito, Pichincha, Ecuador|Fkui-Rscm, Jakarta, Daerah Khusus Ibukota Jakarta, Indonesia|FK Unpad/RSHS, Bandung, Jawa Barat, Indonesia|Aziz Fatimah Hospital, Faisalabad, Punjab, Pakistan|Avicenna Hospital, Lahore, Punjab, Pakistan|Central Park Medical college, Lahore, Punjab, Pakistan|Chughtai Lab, Lahore, Punjab, Pakistan|National Hospital & Medical Center, Lahore, Punjab, Pakistan|Shaukat Khanum Hospital, Lahore, Punjab, Pakistan|University of Health Sciences, Lahore, Punjab, Pakistan|Agha Khan Hospital, Karachi, Sindh, Pakistan|Indus Hospital, Karachi, Sindh, Pakistan|Shifa International Hospital, Islamabad, Pakistan|Family Hospital No.15, Tashkent, Uzbekistan|GUVD Poliklinika, Tashkent, Uzbekistan|IIV Markaziy Poliklinika, Tashkent, Uzbekistan|Toshkent viloyat IIV Poliklinika, Tashkent",Uzbekistan,Respiratory Diseases,1,2,384.0
3700.0,NCT04748783,Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19,COL,Terminated,COVID-19,Coronavirus Infection,SARS CoV-2 Infection,,,,,Other: Water|Other: Peroxyl|Drug: Periogard|Other: Colgate Total Zero,"University of North Carolina, Chapel Hill|Colgate Palmolive",All,"18 Years to 65 Years   (Adult, Older Adult)",2.0,Other|Industry,Interventional,2021-03-26,07/04/21,2021-07-04,10/02/21,12/04/21,"Adams School of Dentistry, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,3,100.0
3701.0,NCT04542226,Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,,Completed,"Infections, Coronavirus",,,,,,,Drug: Polyoxidonium,NPO Petrovax,All,"18 Years and older   (Adult, Older Adult)",81.0,Industry,Observational,2020-03-31,15/07/20,2020-10-30,09/09/20,09/12/20,"Healthcare Institution Grodno Regional Infectious Clinical Hospital, Grodno, Belarus|State-Funded Healthcare Institution Emergency Hospital of Ministry of Health of Chuvash Republic, Cheboksary, Chuvashia, Russian Federation|State-Funded Healthcare Institution Infectious Disease Hospital No.3 of Ministry of Health of Krasnodar Krai, Novorossiysk, Krasnodar Krai, Russian Federation|State-Funded Institution of Mari El Republic Yoshkar-Ola City Hospital, Yoshkar-Ola, Mari El Republic, Russian Federation|State-Funded Healthcare Institution of Voronezh Region Novaya Usman District Hospital, Novaya Usman, Voronezh Region",Russian Federation,Respiratory Diseases,1,1,213.0
3702.0,NCT04743232,COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment,CORDEAL,Recruiting,COVID-19,Cardiac Arrest,,,,,,Other: Decision tool for clinicians,Erasmus Medical Center,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-01-03,31/12/21,2022-01-31,08/02/21,10/02/21,"OLVG, Amsterdam, Noord-Holland, Netherlands|Maasstad Ziekenhuis, Rotterdam, Zuid-Holland, Netherlands|Amsterdam UMC, Amsterdam, Netherlands|Rijnstate, Arnhem, Netherlands|Medisch Spectrum Twente, Enschede, Netherlands|Radboud UMC, Nijmegen, Netherlands|Erasmus MC, Rotterdam",Netherlands,Respiratory Diseases,1,2,393.0
3703.0,NCT04402918,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,TRANSCOVID,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: biological samples day of delivery,Centre Hospitalier Universitaire de Besancon,Female,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-05-17,19/05/20,2021-02-28,27/05/20,05/03/21,"Chu Besancon, Besancon",France,Respiratory Diseases,1,1,287.0
3704.0,NCT04380818,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,,Recruiting,"Pneumonia, Viral",,,,,,,Radiation: Low-dose radiotherapy|Drug: Hydroxychloroquine Sulfate|Drug: Ritonavir/lopinavir|Drug: Tocilizumab Injection [Actemra]|Drug: Azithromycin|Drug: Corticosteroid|Drug: Low molecular weight heparin|Device: Oxygen supply,Grupo de Investigación Clínica en Oncología Radioterapia|Hospital Universitario Madrid Sanchinarro|Hospital del Mar|Hospital Universitari Sant Joan de Reus,All,"18 Years to 99 Years   (Adult, Older Adult)",106.0,Other,Interventional,2020-05-06,04/05/21,2021-01-07,08/05/20,18/06/20,"Hospital Sant Joan de Reus, Reus, Tarragona, Spain|Hospital Del Mar, Barcelona, Spain|Hospital Universitario Madrid Sanchinarro, Madrid",Spain,Respiratory Diseases,1,1,246.0
3705.0,NCT04374539,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,REP-COVID,Recruiting,Coronavirus,,,,,,,Biological: Plasma exchange|Drug: Standar medical treatmen,Fundacion Clinic per a la Recerca Biomédica,All,"18 Years to 80 Years   (Adult, Older Adult)",116.0,Other,Interventional,2020-04-29,05/05/21,2021-08-29,05/05/20,07/07/20,"Hospital Clinic i Provincial de Barcelona, Barcelona",Spain,Respiratory Diseases,1,1,487.0
3706.0,NCT04279197,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,,Recruiting,COVID-19,,,,,,,Drug: Fuzheng Huayu Tablet|Drug: Vitamin C tablets|Other: Placebo|Other: respiratory function rehabilitation training,"ShuGuang Hospital|Hubei Hospital of Traditional Chinese Medicine|Jingmen No.1 People's Hospital|Tongji Hospital|Wenzhou Central Hospital|Wuhan No.1 Hospital|Wuhan Union Hospital, China|Wuhan Third Hospital",All,"18 Years to 70 Years   (Adult, Older Adult)",160.0,Other,Interventional,2020-04-23,01/12/21,2021-01-12,21/02/20,23/09/20,"Shuguang Hospital, Shanghai, Shanghai",China,Respiratory Diseases,1,1,264.0
3707.0,NCT04343989,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Drug: Clazakizumab 25 mg|Drug: Clazakizumab 12.5 mg|Other: Placebo,NYU Langone Health,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-03-31,30/01/21,2021-01-30,14/04/20,24/12/20,"New York University School of Medicine, New York, New York",United States,Respiratory Diseases,1,1,305.0
3708.0,NCT04393142,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,,Completed,Coronavirus Infection,,,,,,,,Hospital Universitario Dr. Jose E. Gonzalez,All,"1 Year and older   (Child, Adult, Older Adult)",96.0,Other,Observational,2020-05-05,16/02/21,2021-02-16,19/05/20,18/02/21,"Hospital Universitario José E. Gonzalez, Monterrey, Nuevo Leon",Mexico,Respiratory Diseases,1,1,287.0
3709.0,NCT04459325,Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,,Completed,COVID-19,Coronavirus Disease 2019,,,,,,Biological: Tigerase® and best available care|Other: Best available care,AO GENERIUM,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-01-06,20/07/20,2020-07-20,07/07/20,14/10/20,"City Clinical Hospital #15, Moscow, Russian Federation|I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation|City Clinical Hospital #51, Moscow, Russian Federation|City Clinical Hospital #52, Moscow, Russian Federation|N.V. Sklifosovsky Scientific Research Institute of First Aid, Moscow, Russian Federation|Siberian State Medical University (SibMed), Moscow",Russian Federation,Respiratory Diseases,1,2,196.0
3710.0,NCT04459676,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,Pneumonia,,,,,,Drug: Standard of Care (SOC) + ANG-3777|Drug: Standard Of Care (SOC) + Placebo,Angion Biomedica Corp|CTI Clinical Trial and Consulting Services,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|Other,Interventional,2020-07-31,01/10/20,2020-01-10,07/07/20,04/08/20,"UPCLIN - Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP), Ribeirão Preto, Brazil|Hospital Guilherme Alvaro, Santos, Brazil|Escola Paulista de Medicina (Universidade Federal de São Paulo), São Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Brazil|Hospital Heliópolis-SP, São Paulo, Brazil|Santa Casa de Misericordia de Sao Paulo, São Paulo",Brazil,Respiratory Diseases,1,2,-203.0
3711.0,NCT04418128,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,,Not yet recruiting,Corona Virus Infection,COVID-19,,,,,,Drug: Nafamostat Mesylate,Gyeongsang National University Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",84.0,Other,Interventional,2020-10-06,30/03/21,2021-04-30,05/06/20,09/06/20,,,Respiratory Diseases,1,2,206.0
3712.0,NCT04606069,Treat COVID-19 Patients With Regadenoson,,Not yet recruiting,COVID-19,Lung Inflammation,,,,,,Drug: Regadenoson|Other: Placebo Control,"University of Maryland, Baltimore",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-11,30/11/21,2022-01-31,28/10/20,28/10/20,"University of Maryland Medical Center, Baltimore, Maryland",United States,Respiratory Diseases,1,2,751.0
3713.0,NCT04627233,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,,Not yet recruiting,COVID-19,Treatment,Corona Virus Infection,,,,,Drug: Human Ezrin Peptide 1 (HEP1)|Drug: Placebo,Shahid Beheshti University of Medical Sciences|praxisgemeinschaft für zelltherapie,All,"18 Years to 70 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-12-20,01/03/21,2021-01-04,13/11/20,13/11/20,"Shahid Beheshti University of Medical Sciences, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,3,15.0
3714.0,NCT04360733,Precision Immunology to Determine the Immune Response in Patients With COVID-19,,Recruiting,SARS-CoV 2,COVID-19,,,,,,Other: Blood draw,University of Bonn,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-20,01/04/22,2022-01-09,24/04/20,24/04/20,"University Hospital Bonn, Bonn",Germany,Respiratory Diseases,1,2,629.0
3715.0,NCT04316377,Norwegian Coronavirus Disease 2019 Study,NO COVID-19,"Active, not recruiting",Corona Virus Infection,,,,,,,Drug: Hydroxychloroquine Sulfate,"University Hospital, Akershus",All,"18 Years and older   (Adult, Older Adult)",53.0,Other,Interventional,2020-03-25,25/05/20,2025-03-03,20/03/20,05/06/20,"Akershus University Hospital, Lørenskog",Norway,Respiratory Diseases,1,1,1804.0
3716.0,NCT04502108,Behavior During and After COVID-19 Crisis,,Recruiting,Exercise,Nutritional Status,Sleep,,,,,Behavioral: Covid19,Slavko Rogan|Bern University of Applied Sciences,All,"18 Years to 65 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-04,31/12/22,2022-12-31,06/08/20,10/08/20,"Bern University of Applied Sciences, Department of Health Professions, Bern",Switzerland,Others,0,3,1092.0
3717.0,NCT04550390,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19,SAMILCOV,Completed,SARS-CoV Infection,,,,,,,Diagnostic Test: Saliva collection,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",329.0,Other,Observational,2020-09-15,19/10/20,2020-10-19,16/09/20,10/03/21,"Hôpital d'Instruction des Armées Percy, Clamart, France|Hôpital d'Instruction des Armées Laveran, Marseille, France|Hôpital d'Instruction des Armées Bégin, Saint-Mandé, France|Hôpital d'Instruction des Armées Sainte-Anne, Toulon",France,Respiratory Diseases,1,1,34.0
3718.0,NCT04642703,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,,Recruiting,Mechanical Ventilation,COVID-19,Tracheostomy,,,,,,University of Chile,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-03,30/11/20,2021-11-30,24/11/20,27/11/20,"Intensive Care Unit, Hospital Clínico Universidad de Chile, Santiago",Chile,Respiratory Diseases,1,3,637.0
3719.0,NCT04420676,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,SynCov,Recruiting,COVID-19,,,,,,,Dietary Supplement: Omnibiotic AAD|Dietary Supplement: Placebo,Medical University of Graz,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-09-24,01/12/21,2022-01-12,09/06/20,20/01/21,"Department of Internal Medicine, Medical University of Graz, Graz",Austria,Respiratory Diseases,1,1,475.0
3720.0,NCT04352699,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,,Completed,Surgery,Complication of Surgical Procedure,COVID-19,,,,,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-03-15,17/04/20,2020-01-05,20/04/20,15/05/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,3,-70.0
3721.0,NCT04748588,Treatment of Nosocomial COVID-19,CATCO-NOS,Not yet recruiting,COVID-19,Nosocomial Infection,,,,,,Drug: Bamlanivimab,University of Calgary|Sunnybrook Research Institute,All,"18 Years and older   (Adult, Older Adult)",648.0,Other,Interventional,2021-01-02,31/01/23,2023-03-31,10/02/21,10/02/21,,,Respiratory Diseases,1,2,818.0
3722.0,NCT04429334,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",,Not yet recruiting,COVID-19,,,,,,,Drug: nangibotide|Drug: placebo,Inotrem,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-01-08,01/03/21,2021-01-03,12/06/20,28/07/20,"Réanimation Médicale, Hôpital Central, Nancy",France,Respiratory Diseases,1,1,361.0
3723.0,NCT04456101,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",,Recruiting,COVID-19,,,,,,,,"Wuhan Union Hospital, China",All,"18 Years to 80 Years   (Adult, Older Adult)",240.0,Other,Observational,2020-06-19,01/12/20,2022-01-06,02/07/20,15/07/20,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,1,566.0
3724.0,NCT04579640,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,CORONAVIT,"Active, not recruiting",COVID-19,Acute Respiratory Tract Infection,,,,,,Dietary Supplement: Vitamin D,Queen Mary University of London|Barts & The London NHS Trust|Pharma Nord|Fischer Family Trust|The AIM Foundation|Synergy Biologics Ltd|Cytoplan Ltd,All,"16 Years and older   (Child, Adult, Older Adult)",6200.0,Other|Industry,Interventional,2020-10-27,30/06/21,2021-06-30,08/10/20,01/12/20,"Queen Mary University of London, London, County (optional)",United Kingdom,Respiratory Diseases,1,2,246.0
3725.0,NCT04414618,A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,COVID-19,Completed,Coronavirus Infections,,,,,,,Drug: Opaganib|Drug: Placebo,RedHill Biopharma Limited,All,"18 Years to 80 Years   (Adult, Older Adult)",42.0,Industry,Interventional,2020-02-07,26/11/20,2020-12-23,04/06/20,10/03/21,"HonorHealth Research Institute, Scottsdale, Arizona, United States|Miami Cancer Institute, Miami, Florida, United States|Henry Ford Hospital, Detroit, Michigan, United States|Ascension St. John Hospital, Detroit, Michigan, United States|Albany Medical Center, Albany, New York, United States|Oregon Health & Science University, Portland, Oregon, United States|Memorial Herman Southeast Hospital, Houston, Texas, United States|Memorial Hermann, Memorial City Medical Center, Houston, Texas, United States|Ziv Medical Center, Safed",Israel,Respiratory Diseases,1,1,320.0
3726.0,NCT04487990,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,,Recruiting,Acute Kidney Injury,COVID-19,,,,,,Drug: unfractionated Heparin,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-06-29,01/12/20,2021-01-07,27/07/20,27/07/20,"University of São Paulo General Hospital, São Paulo, SP",Brazil,Respiratory Diseases,1,2,192.0
3727.0,NCT04429854,Donated Antibodies Working Against nCoV,DAWN-Plasma,"Active, not recruiting",COVID-19,,,,,,,Biological: Convalescent Plasma|Drug: Standard of care,Universitaire Ziekenhuizen Leuven|Federal Knowledge Centre (KCE),All,"18 Years and older   (Adult, Older Adult)",483.0,Other,Interventional,2020-02-05,30/04/21,2021-02-11,12/06/20,18/03/21,"ZNA, Antwerpen, Belgium|Imelda Ziekenhuis Bonheiden, Bonheiden, Belgium|Institut Bordet, Brussel, Belgium|UMC Sint-Pieter, Brussel, Belgium|CHU Brugmann, Brussel, Belgium|Erasmus Ziekenhuis, Brussel, Belgium|UZ Brussel, Brussel, Belgium|Cliniques Universitaires St Luc, Brussel, Belgium|AZ Sint-Vincentius, Deinze, Belgium|AZ Maria Middelares, Gent, Belgium|AZ Sint-Lucas, Gent, Belgium|AZ Groeninge, Kortrijk, Belgium|UZ Leuven, Leuven, Belgium|CHC Liège Mont Légia, Liège, Belgium|CHR Citadelle Liège, Liège, Belgium|CHU Liège Sart-Tilman, Liège, Belgium|CHU Ambroise Paré, Mons, Belgium|CHR Jolimont Mons-Hainaut, Mons, Belgium|AZ Delta, Roeselare, Belgium|Sint-Trudo Ziekenhuis, Sint-Truiden, Belgium|Centre Hospitalier de Wallonie Picarde (CHwapi), Tournai",Belgium,Respiratory Diseases,1,1,372.0
3728.0,NCT04321616,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,,Recruiting,SARS-CoV Infection,COVID-19,Acute Respiratory Distress Syndrome ARDS,,,,,Drug: Hydroxychloroquine|Drug: Remdesivir|Other: (Standard of Care) SoC,Oslo University Hospital,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2020-03-28,01/08/20,2020-01-11,25/03/20,14/04/20,"Andreas Barratt-Due, Oslo",Norway,Respiratory Diseases,1,3,-77.0
3729.0,NCT04413058,Menstrual Cycle Characteristics of Healthcare Professionals,,Completed,Menstrual Irregularity,COVID-19,,,,,,,Haydarpasa Numune Training and Research Hospital,Female,18 Years to 47 Years   (Adult),260.0,Other,Observational,2020-10-04,10/09/20,2020-10-09,02/06/20,19/11/20,"University of Health Sciences Turkey, Istanbul",Turkey,Respiratory Diseases,1,2,5.0
3730.0,NCT04644302,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,,Recruiting,Viral Pneumonia,Sepsis,,,,,,Diagnostic Test: microcirculation recording,University Hospital Hradec Kralove,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Observational,2020-01-02,01/07/21,2021-01-12,25/11/20,30/11/20,"University Hospital Hradec Kralove, Hradec Králové, Třebeš",Czechia,Respiratory Diseases,1,2,376.0
3731.0,NCT04407572,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,,Completed,COVID-19,Zinc Deficiency,Vitamin D Deficiency,,,,,"Other: Serum zinc, vitamin d vitamin b12 levels .",Kanuni Sultan Suleyman Training and Research Hospital|Ayşegül Bestel|İbrahim Polat|Merve Aldıkaçtıoğlu Talmaç,Female,18 Years to 45 Years   (Adult),44.0,Other,Observational,2020-04-20,01/06/20,2020-06-14,29/05/20,23/06/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,Respiratory Diseases,1,3,55.0
3732.0,NCT04368351,Bacteriotherapy in the Treatment of COVID-19,BACT-ovid,"Active, not recruiting",COVID-19,Pneumonia,Diarrhea,,,,,Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine,University of Roma La Sapienza,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Observational,2020-01-03,30/06/20,2020-07-31,29/04/20,04/05/20,"Department of Public Heath and Infectious Diseases. University of Rome Sapienza (Italy), Rome",Italy,Respiratory Diseases,1,3,210.0
3733.0,NCT04576299,Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,,"Active, not recruiting",Patient Safety,,,,,,,Other: Group 1,Universidad Miguel Hernandez de Elche|Universidad de Santander|Universidad Antonio Nariño|University of Sao Paulo|Universidad Catolica Santiago de Guayaquil|Pontificia Universidad Catolica de Chile,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-01-09,30/10/20,2020-12-15,06/10/20,06/10/20,"Pontificia Universidad Católica de Chile, Santiago, Chile|Universidad de Santander, Bucaramanga, Santander, Colombia|Universidad Católica de Santiago de Guayaquil, Guayaquil, Guayas, Ecuador|Miguel Hernández University, Elche, Alicante",Spain,Others,0,1,341.0
3734.0,NCT04342195,Acquiring Convalescent Specimens for COVID-19 Antibodies,,Recruiting,COVID-19,Coronavirus Infection,Corona Virus Infection,,,,,Procedure: Blood draw,Columbia University,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-03-25,01/03/21,2021-01-03,10/04/20,09/07/20,"Columbia University Irving Medical Center/NYP, New York, New York",United States,Respiratory Diseases,1,3,284.0
3735.0,NCT04534478,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,NORCOVID,Not yet recruiting,COVID-19,,,,,,,Drug: Prednisone,Hospital Universitari Vall d'Hebron Research Institute,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-07-09,02/05/21,2021-12-15,01/09/20,01/09/20,,,Respiratory Diseases,1,1,524.0
3736.0,NCT04430608,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,CGM-ISO,Recruiting,Diabetes,COVID-19,Infection,,,,,Device: Dexcom G6,Nordsjaellands Hospital,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Interventional,2020-05-25,25/04/21,2021-05-25,12/06/20,12/06/20,"Nordsjællands Hospital, Hillerød",Denmark,"Respiratory Diseases, Metabolic Disorders",1,3,365.0
3737.0,NCT04366830,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",,No longer available,COVID-19,,,,,,,Drug: Remestemcel-L,"Mesoblast International Sàrl|Mesoblast, Ltd.",All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,,29/04/20,18/02/21,"Mount Sinai Hospital, New York, New York",United States,Respiratory Diseases,1,1,
3738.0,NCT04784624,Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),,Not yet recruiting,Cardiometabolic Syndrome,Weight Loss,,,,,,Behavioral: Lifestyle program,"University of Manitoba|Chronic Disease Innovation Centre, Seven Oaks Hospital",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-03,30/12/21,2022-03-31,05/03/21,05/03/21,,,Others,0,2,452.0
3739.0,NCT04710303,COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults,,Recruiting,COVID-19,,,,,,,Biological: hAd5-S-Fusion+N-ETSD vaccine,"ImmunityBio, Inc.",All,18 Years to 50 Years   (Adult),35.0,Industry,Interventional,2021-02-03,01/04/22,2022-01-04,14/01/21,11/03/21,"Khayelitsha Clinical Research Site, Khayelitsha",South Africa,Respiratory Diseases,1,1,335.0
3740.0,NCT04510402,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,,Not yet recruiting,COVID-19,Povidone Iodine Adverse Reaction,,,,,,Drug: Povidine iodine nasal swabs,Brigham and Women's Hospital|3M,All,"18 Years to 70 Years   (Adult, Older Adult)",50.0,Other|Industry,Interventional,2020-01-08,01/02/21,2021-01-04,12/08/20,12/08/20,,,Respiratory Diseases,1,2,362.0
3741.0,NCT04551911,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,,Recruiting,COVID-19,Coronavirus,COVID-19,,,,,Drug: Rayaldee 30Mcg Extended-Release (ER) Capsule|Drug: Placebo,"OPKO Health, Inc.",All,"18 Years and older   (Adult, Older Adult)",160.0,Industry,Interventional,2020-10-26,01/05/21,2021-01-05,16/09/20,04/03/21,"OPKO Investigative Site, Miami, Florida",United States,Respiratory Diseases,1,3,71.0
3742.0,NCT04438057,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,,Recruiting,COVID-19,,,,,,,Biological: CCP,Metro Infectious Disease Consultants,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-12-08,12/08/20,2021-12-08,18/06/20,21/08/20,"Metro Infectious Disease Consultants, Burr Ridge, Illinois",United States,Respiratory Diseases,1,1,365.0
3743.0,NCT04405362,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,QUARCOPSY,Not yet recruiting,SARS-CoV 2,Traumatic Stress Disorder,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",753.0,Other,Observational,2020-01-05,01/05/21,2021-01-05,28/05/20,28/05/20,,,"Mental Health, Respiratory Diseases",1,2,366.0
3744.0,NCT04657484,Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease,COLDSTER,Recruiting,COVID-19,,,,,,,Drug: Medium dose prednisolone|Drug: Low dose prednisolone,Postgraduate Institute of Medical Education and Research,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-12,07/12/21,2021-07-12,08/12/20,22/12/20,"Postgraduate Institute of Medical Education and Research, Chandigarh",India,Respiratory Diseases,1,1,334.0
3745.0,NCT04382040,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",,Completed,COVID-19,Corona Virus Infection,SARS-CoV 2,Coronavirus,Coronavirus Infection,,,Drug: ArtemiC|Drug: Placebo,MGC Pharmaceuticals d.o.o,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-08-05,05/11/20,2020-12-21,11/05/20,03/03/21,"Mahatma Gandhi Mission Medical College and Hospital, Aurangabad, Maharashtra, India|Hillel Yaffe Medical Center, Hadera, Haifa, Israel|Nazareth Hospital EMMS, Nazareth, North, Israel|Rambam Health Care Campus, Haifa",Israel,Respiratory Diseases,1,5,138.0
3746.0,NCT04791436,Oral and Olfactory Complications of Recovered COVID-19 Patients,,Not yet recruiting,Oral Complication,Dysgeusia,Olfactory Disorder,,,,,Diagnostic Test: Gustatory and olfactory function test|Diagnostic Test: Molecular assessment of saliva,University of Giessen|Masaryk University|University of Kiel,All,"18 Years and older   (Adult, Older Adult)",402.0,Other,Observational,2021-01-03,30/12/21,2022-02-28,10/03/21,10/03/21,,,Others,0,3,421.0
3747.0,NCT04326790,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,GRECCO-19,Terminated,COVID-19,,,,,,,Drug: Colchicine|Drug: Standard treatment,National and Kapodistrian University of Athens,All,"18 Years and older   (Adult, Older Adult)",105.0,Other,Interventional,2020-03-04,27/04/20,2020-04-27,30/03/20,06/04/21,"National and Kapodistrian University of Athens, Athens",Greece,Respiratory Diseases,1,1,54.0
3748.0,NCT04573868,"National Study ""AEC COVID-19""",,Recruiting,Mortality,,,,,,,,Hospitales Universitarios Virgen del Rocío,All,"14 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-03,30/06/20,2020-09-30,05/10/20,05/10/20,"Salvador Morales-Conde, Sevilla",Spain,Others,0,1,271.0
3749.0,NCT04535856,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,DW-MSC,Completed,COVID-19,Corona Virus Infection,SAR,,,,,Drug: allogeneic mesenchymal stem cell|Other: Placebo,"Ina-Respond|National Institute of Health Research and Development, Ministry of Health Republic of Indonesia|Daewoong Pharmaceutical Co. LTD.",All,"19 Years and older   (Adult, Older Adult)",9.0,Other|Industry,Interventional,2020-11-14,14/01/21,2021-01-14,02/09/20,27/01/21,"Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar",Indonesia,Respiratory Diseases,1,3,61.0
3750.0,NCT04394000,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,,Completed,COVID-19,Thromboembolism,,,,,,Other: thromboprofylaxis protocol|Other: standard protocol,Jessa Hospital,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Observational,2020-04-05,15/05/20,2020-05-15,19/05/20,19/05/20,"Jessa hospital, Hasselt",Belgium,Respiratory Diseases,1,2,40.0
3751.0,NCT04334850,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,MultiCov,Recruiting,COVID-19,Pneumonia,,,,,,Procedure: Combined use of a respiratory broad panel multiplex PCR and procalcitonin|Other: Usual antibiotic treatment,Assistance Publique - Hôpitaux de Paris|BioMérieux,All,"18 Years and older   (Adult, Older Adult)",194.0,Other|Industry,Interventional,2020-04-20,01/07/20,2020-01-08,06/04/20,27/05/20,"Intensive care department-Hospital Tenon, Paris",France,Respiratory Diseases,1,2,-103.0
3752.0,NCT04311177,Losartan for Patients With COVID-19 Not Requiring Hospitalization,,Completed,Corona Virus Infection,Acute Respiratory Distress Syndrome,SARS-CoV Infection,,,,,Drug: Losartan|Other: Placebo,University of Minnesota|The Minnesota Foundation,All,"18 Years and older   (Adult, Older Adult)",580.0,Other,Interventional,2020-09-04,01/02/21,2021-01-02,17/03/20,15/02/21,"Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|Mayo Clinic Health System, Rochester, Minnesota",United States,Respiratory Diseases,1,3,120.0
3753.0,NCT04367337,Health Behavior Change During COVID-19 Pandemic,,"Active, not recruiting",Health Behavior,,,,,,,Other: No intervention,"University of Social Sciences and Humanities, Warsaw",All,"18 Years and older   (Adult, Older Adult)",6079.0,Other,Observational,2020-03-25,24/03/21,2021-03-24,29/04/20,24/08/20,"the University of Melbourne, Melbourne, Australia|University of New Brunswick, Fredericton, Canada|Peking University, Beijing, China|University of Bordeaux, Bordeaux, France|London School of Hygiene and Tropical Medicine (in collaboration with MRC Unit The Gambia at LSHTM), Fajara, Gambia|Freie Universität Berlin, Berlin, Germany|Bar-Ilan University, Ramat Gan, Israel|University of Padova, Padova, Italy|Perdana University, Serdang, Malaysia|SWPS University of Social Sciences and Humanities, Wroclaw, Lower Silezia, Poland|University of Lisbon, Lisbon, Portugal|Babes-Bolyai Unversity, Cluj-Napoca, Romania|Nanyang Technological University, Singapore, Singapore|University of Zurich, Zürich",Switzerland,Others,0,1,364.0
3754.0,NCT04390269,Immunogenetics Predictors With COVID-19,,Recruiting,Genetic Predisposition to Disease,,,,,,,,Mansoura University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-10-09,10/10/21,2022-09-05,15/05/20,24/02/21,"Mansoura Faculty of Medicine, Mansoura, Dakahlyia",Egypt,Others,0,1,696.0
3755.0,NCT04445259,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,,Recruiting,COVID-19,Acute Kidney Injury,Critical Illness,,,,,,Guy's and St Thomas' NHS Foundation Trust|Harvard Medical School,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-06-20,31/05/21,2021-05-31,24/06/20,24/06/20,"Guy's & St Thomas' Hospital, London",United Kingdom,"Cardiovascular Diseases, Respiratory Diseases",1,3,345.0
3756.0,NCT04801134,Interventions to Manage Food Insecurity and Inappropriate Feeding Practices Related to the COVID-19 Pandemic,AMISTAD,Not yet recruiting,Food Insecurity,"Children, Only",COVID-19,,,,,Other: Education,University of Texas at Austin|Perrigo Company,All,up to 2 Years   (Child),50.0,Other|Industry,Interventional,2021-03-22,22/03/22,2022-05-30,16/03/21,23/03/21,"CommUnityCare Health Center, Austin, Texas",United States,Respiratory Diseases,1,3,434.0
3757.0,NCT04360096,Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Moderate and Severe COVID-19,AVICOVID-2,Recruiting,SARS-CoV 2,COVID-19,ARDS,ALI,Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS),Dyspnea,,Drug: ZYESAMI™ (aviptadil acetate)|Drug: Placebo|Device: Nebulized administration of ZYESAMI™ or Placebo,"NeuroRx, Inc.",All,"12 Years to 85 Years   (Child, Adult, Older Adult)",288.0,Industry,Interventional,2021-02-15,15/08/21,2021-01-09,24/04/20,01/04/21,"St. Jude Medical Center, Fullerton, California, United States|University of California - Irvine, Irvine, California, United States|University of Louisville Hospital, Louisville, Kentucky",United States,Respiratory Diseases,1,6,-37.0
3758.0,NCT04397510,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,,Enrolling by invitation,COVID-19,"ARDS, Human",Acute Lung Injury,,,,,Drug: Heparin|Drug: 0.9% Sodium-chloride,Frederick Health,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-06,31/12/21,2021-12-31,21/05/20,23/02/21,"Frederick Health Hospital, Frederick, Maryland",United States,Respiratory Diseases,1,3,725.0
3759.0,NCT04605692,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,MBI,Completed,Burnout,COVID-19,Dentistry,Filiation,Pandemic,,,,Akdeniz University,All,"Child, Adult, Older Adult",706.0,Other,Observational,2020-09-03,20/05/20,2020-05-20,28/10/20,28/10/20,"Akdeniz Üniversitesi, Antalya, Konyaaltı",Turkey,Respiratory Diseases,1,5,-106.0
3760.0,NCT04505592,Tenecteplase in Patients With COVID-19,,Recruiting,COVID-19,Respiratory Failure,ARDS,,,,,Drug: Tenecteplase|Drug: Placebo,"Hooman Poor|Genentech, Inc.|Icahn School of Medicine at Mount Sinai",All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2020-09-25,01/06/21,2021-01-12,10/08/20,24/12/20,"Mount Sinai Hospital, New York, New York",United States,Respiratory Diseases,1,3,109.0
3761.0,NCT04367831,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,IMPROVE,Recruiting,COVID-19,Venous Thromboses,Arterial Thrombosis,,,,,Drug: Enoxaparin Prophylactic Dose|Drug: Heparin Infusion|Drug: Heparin SC|Drug: Enoxaparin/Lovenox Intermediate Dose,Columbia University,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-02-05,01/11/20,2021-01-04,29/04/20,19/05/20,"Columbia University Medical Center, New York, New York",United States,Respiratory Diseases,1,3,334.0
3762.0,NCT04828668,Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.,"""BAC-PAC""",Recruiting,COVID-19,,,,,,,Dietary Supplement: Targeted Wellness Formula C™ Sublingual Drops - 1200mg - 30 mL (Formula C),"Endourage, LLC",All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2021-02-04,31/10/21,2021-11-30,02/04/21,06/04/21,"Thomas P Young, PhD, NP, Novato, California",United States,Respiratory Diseases,1,1,299.0
3763.0,NCT04511780,Psychological Impact of COVID-19 Outbreak on Caregivers,PSY-CO-ICU,Not yet recruiting,Critical Illness,COVID-19,"Stress Disorders, Post-Traumatic",,,,,Other: questionnaire filling,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2021-01-01,01/09/22,2022-01-09,13/08/20,19/12/20,"Intensive Care Unit, CHU d'Amiens, Amiens, France|Intensive Care Unit, CHU d'Angers, Angers, France|CHU de Besançon, Besançon, France|CHU de Bordeaux, Hôpital Pellegrin, Bordeaux, France|Intensive care Unit CHU de Brest Hôpital Cavale Blanche, Brest, France|CHU de Caen, Caen, France|CHU de Clermont Ferrand, Clermont-Ferrand, France|AP-HP, Hôpital Henri Mondor, Créteil, France|CHU de dijon, Dijon, France|CHU de Grenoble, Hôpital Michalon, La Tronche, France|AP_HP, Hôpital du Kremlin Bicêtre, Le Kremlin-Bicêtre, France|Intensive Care Unit, CHRU de Lille, Lille, France|Intensive Care Unit, CHU de Limoges, Limoges, France|Hôpitaux civils de Lyon, Hôpital de la Croix Rousse, Lyon, France|Hôpitaux civils de Lyon, Hôpital Louis Pradel, Lyon, France|Hôpitaux civils de Lyon, Hôpital Edouard Herriot, Lyon, France|AP-HM, Hôpital Nord, Marseille, France|AP-HM, Hôpital Timone adultes, Intensive Care Unit, Marseille, France|AP-HM, Hôpital Timone adultes, Neurotraumatology, Marseille, France|AP-HM, Hôpital e la Conception, Marseille, France|CHU de Montpellier, Hôpital Guy de chauliac, Montpellier, France|CHU de Montpellier, Hôpital Lapeyronie, Montpellier, France|CHU de Montpellier, Hôpital St Eloi SAR B, Montpellier, France|CHU De Montpellier, Hôpital St Eloi-DAR B, Montpellier, France|CHU De Montpellier, Hôpital St Eloi, Montpellier, France|Intensive Care Unit, CHU de Mulhouse, Mulhouse, France|Intensive CAre Unit CHRU de Nancy, Hôpital Central, Nancy, France|Intensive Care Unit, CHU de Nantes, Hôtel Dieu, Nantes, France|Intensive Care Unit, CHU de Nantes, Nantes, France|CHU de Nice, Nice, France|Intensive care Unit CHU Nîmes, Nîmes, France|AP-HP, Hôpital de la Pitié, Paris, France|AP-HP, Hôpital Bichât, Paris, France|AP-HP, Hôpital Lariboisière, Paris, France|AP6HP, Hôpital St Loui, Paris, France|AP_HP, Hôpital G Pompidou, Paris, France|AP-HP, Hôpital St Antoine, Paris, France|CH de Perpignan, Perpignan, France|CHU de Bordeaux, Hôpital Haut Leveque, Pessac, France|Intensive care Unit, Hôpitaux civils de Lyon, Lyon Sud, Pierre-Bénite, France|CHU de Poitiers, Poitiers, France|Intensive care Unit CHU de Rennes, Rennes, France|CHU de Rouen, Rouen, France|Intensive Care Unit, CHU de Nantes, Hôpital Laennec, Saint-Herblain, France|CHU de St Etienne, Hôpital Nord, Saint-Étienne, France|Intesive Care Unit CHRU de Strasbourg, Hôpital civil, Strasbourg, France|Intesive Care Unit CHRU de Strasbourg, Hôpital Hautepierre, Strasbourg, France|CHU de Toulouse, Toulouse, France|Intensive care unit CHU de Tours, Tours, France|Intensive CAre Unit CHRU de Nancy, Hôpital de Brabois, Vandœuvre-lès-Nancy, France|CH de Vesoul, Vesoul",France,"Mental Health, Cardiovascular Diseases, Respiratory Diseases",1,3,373.0
3764.0,NCT04603963,Inspiratory Muscle Training in Patients With COVID-19,,Terminated,COVID-19,Respiratory Disease,,,,,,Device: power breathe,Elaine Cristina Pereira <elaine.cpereira@einstein.br>|Hospital Israelita Albert Einstein,All,"18 Years and older   (Adult, Older Adult)",55.0,Other,Interventional,2020-01-06,10/10/20,2020-10-23,27/10/20,28/10/20,"Municipal Hospital Vila Santa Catarina, São Paulo",Brazil,Respiratory Diseases,1,2,291.0
3765.0,NCT04366219,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",CBP-COVID,Not yet recruiting,COVID-19,SARS-CoV 2,Lung Cancer,,,,,,Centre Hospitalier le Mans|ONCOPL,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-06,28/08/20,2022-08-28,28/04/20,14/05/20,,,"Respiratory Diseases, Cancers",1,3,965.0
3766.0,NCT04392401,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,RICO,Recruiting,Intensive Care Unit,SARS-Cov-2,,,,,,Biological: Collection of blood samples in order to create a biocollection,Hospices Civils de Lyon|BioMérieux,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Observational,2020-11-05,01/02/21,2021-01-02,18/05/20,18/05/20,"Hôpital Pierre Wertheimer, Bron, France|Hôpital Gabriel Montpied, Clermont-Ferrand, France|Centre hospitalier universitaire de Grenoble Alpes, Grenoble, France|Hôpital Edouard Herriot, Lyon, France|Hôpital Edouard Herriot, Lyon, France|Hôpial de la Croix Rousse, Lyon, France|Hôpital Lyon Sud, Pierre-Bénite, France|CH de St Etienne, Saint-Étienne",France,Others,0,2,58.0
3767.0,NCT04466280,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Mucodentol|Device: Personal protective equipment,Baqiyatallah Medical Sciences University,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-07-15,15/11/20,2020-12-15,10/07/20,10/07/20,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,153.0
3768.0,NCT04456439,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",,Available,COVID-19,,,,,,,Biological: Remestemcel-L|Drug: Hydrocortisone|Drug: Diphenhydramine,"Mesoblast International Sàrl|Mesoblast, Ltd.",All,2 Months to 17 Years   (Child),,Industry,Expanded Access:Intermediate-size Population,,,,02/07/20,18/02/21,,,Respiratory Diseases,1,1,
3769.0,NCT04382846,Novel Regimens in COVID-19 Treatment,,Recruiting,COVID-19,Corona Virus Infection,,,,,,Drug: Nitazoxanide,Tanta University,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-08-05,01/12/30,2030-01-12,11/05/20,04/12/20,"Tanta University, Assiut University, Tanta, Egypt|Sherief Abd-Elsalam, Tanta",Egypt,Respiratory Diseases,1,2,3447.0
3770.0,NCT04433260,COVID19 and Physical and Emotional Wellbeing of HCP,CoPE-HCP,Recruiting,Mental Health,,,,,,,"Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index|Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.|Other: Informed consent",Queen Mary University of London,All,"18 Years and older   (Adult, Older Adult)",1050.0,Other,Observational,2020-07-25,01/05/21,2021-01-09,16/06/20,16/09/20,"Ajay K Gupta, London",United Kingdom,Others,0,1,168.0
3771.0,NCT04343144,"Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",CORIMUNO-NIVO,Not yet recruiting,COVID-19,,,,,,,Drug: Nivolumab Injection,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",92.0,Other,Interventional,2020-04-15,31/07/20,2020-09-30,13/04/20,14/04/20,"Pneumologie hôpital Tenon, Paris",France,Respiratory Diseases,1,1,168.0
3772.0,NCT04312100,Sequential Oxygen Therapy Strategy for Patients With COVID-19,SOTSPC,Recruiting,Coronavirus Disease-2019,,,,,,,Other: oxygen treatment,Henan Provincial People's Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Other,Observational,2020-01-02,01/10/20,2021-01-02,18/03/20,18/03/20,"Henan Provincial People's Hospital, Zhengzhou, Henan",China,Respiratory Diseases,1,1,366.0
3773.0,NCT04594668,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,COVIPOC,Recruiting,"ARDS, Human",COVID-19,,,,,,Drug: Senicapoc,University of Aarhus|Aarhus University Hospital|Odense University Hospital|Aalborg University Hospital|Hvidovre University Hospital,All,"18 Years and older   (Adult, Older Adult)",46.0,Other,Interventional,2020-04-24,24/04/21,2021-12-31,20/10/20,20/10/20,"Aalborg University Hospital, Aalborg, Denmark|Aarhus University Hospital, Aarhus, Denmark|Hvidovre Hospital, Hvidovre, Denmark|Odense University Hospital, Odense",Denmark,Respiratory Diseases,1,2,616.0
3774.0,NCT04582214,Oscillation and Lung Expansion Therapy in Patients With COVID-19,,Recruiting,COVID-19,Oscillation and Lung Expansion,Ventilation,,,,,Device: MetaNeb® System,Hill-Rom|Emory University|Northwestern University,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2020-09-28,01/01/21,2021-01-01,09/10/20,09/10/20,"Emory University, Atlanta, Georgia, United States|Northwestern University, Evanston, Illinois",United States,Respiratory Diseases,1,3,95.0
3775.0,NCT04707820,Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection,ImmuCoV,Recruiting,Corona Virus Infection,,,,,,,Diagnostic Test: ELISPOT,"University Hospital, Rouen",All,"18 Years to 80 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-04-16,10/06/21,2021-10-06,13/01/21,13/01/21,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,1,538.0
3776.0,NCT04321928,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,PROACTIVE-19,Recruiting,COVID-19,Coronavirus,COVID-19,COVID-19,2019nCoV,,,Behavioral: Personalized health education|Behavioral: General health education,University of Pecs,All,"60 Years and older   (Adult, Older Adult)",7576.0,Other,Interventional,2020-01-04,21/04/21,2021-08-21,25/03/20,09/06/20,"Institute for Translational Medicine, University of Pécs, Pécs",Hungary,Respiratory Diseases,1,5,595.0
3777.0,NCT04836793,Study of Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination to Predict Immune Responses in Cancer Patients,CACO-VAC,Not yet recruiting,Cancer,Elderly Without Cancer,Healthy Aging,,,,,Other: Additional biological samples,Centre Hospitalier Universitaire de Besancon,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-04-15,25/03/22,2023-03-25,08/04/21,08/04/21,,,Cancers,1,3,709.0
3778.0,NCT04365595,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),,Completed,SARS-CoV 2,COVID-19,,,,,,"Other: Questionnaires, spirometry",University of Zurich,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2020-03-06,17/02/21,2021-02-17,28/04/20,23/02/21,"University Hospital Zurich, Zurich",Switzerland,Respiratory Diseases,1,2,348.0
3779.0,NCT04335019,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,eChoVid,Not yet recruiting,COVID-19,Interstitial Pneumonia,,,,,,Other: Pulmonary ultrasound,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-04,01/04/20,2020-01-05,06/04/20,06/04/20,,,Respiratory Diseases,1,2,1.0
3780.0,NCT04736524,Immune Response Following COVID-19 Vaccination,IFVAC,Recruiting,IgM and IgG in Blood,,,,,,,Other: Rapid antibody test,Texas Cardiac Arrhythmia Research Foundation,All,"16 Years to 85 Years   (Child, Adult, Older Adult)",500.0,Other,Observational,2021-01-15,01/03/22,2022-01-03,03/02/21,03/02/21,"Texas Cardiac arrhythmia Institute, St. David's Hospital, Austin, Texas",United States,Others,0,1,353.0
3781.0,NCT04369989,Observational Study of COVID-19 Treatment Efficacy,,Enrolling by invitation,Coronavirus,Coronavirus Infection,Corona Virus Infection,COVID-19,Sars-CoV2,Coronavirus as the Cause of Diseases Classified Elsewhere,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Other: No intervention,OSF Healthcare System,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-14,14/04/21,2021-04-14,30/04/20,30/04/20,"OSF HealthCare St Francis Medical Center, Peoria, Illinois",United States,Respiratory Diseases,1,7,365.0
3782.0,NCT04631380,Prayer in Commbate to Corona Virus - Covid -19,,Recruiting,COVID-19,,,,,,,Other: PRAYER,Hospital do Coracao,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-08,01/01/21,2021-01-01,17/11/20,17/11/20,"Hospital do Coracao, Sao Paulo, SP",Brazil,Respiratory Diseases,1,1,359.0
3783.0,NCT04379492,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,,Withdrawn,COVID-19,COVID-19,Sars-CoV2,SARS-Cov-2,,,,Drug: Hydroxychloroquine|Other: Placebo,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-05-05,25/09/20,2020-09-25,07/05/20,30/10/20,"Memorial Sloan - Kettering Cancer Center, New York, New York",United States,Respiratory Diseases,1,4,143.0
3784.0,NCT04368013,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",CoVUm,Not yet recruiting,COVID-19,,,,,,,Procedure: Extended sampling and procedures,Johan Normark|Umeå University|Västerbotten County Council,All,"15 Years to 100 Years   (Child, Adult, Older Adult)",400.0,Other,Interventional,2020-04-28,14/04/26,2026-04-14,29/04/20,29/04/20,"Incectious Diseases Clinic, Umeå, Västerbotten",Sweden,Respiratory Diseases,1,1,2177.0
3785.0,NCT04565665,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,,Recruiting,COVID-19,COVID-19,,,,,,Other: Best Practice|Biological: Mesenchymal Stem Cell,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",70.0,Other|NIH,Interventional,2020-07-29,30/04/21,2021-04-30,25/09/20,19/03/21,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,2,275.0
3786.0,NCT04751630,Effects of COVID-19 Hospitalization on Physical Performance,,Not yet recruiting,COVID-19,Physical Disability,,,,,,Other: Therapeutic Exercise,Universitat Internacional de Catalunya,All,"18 Years and older   (Adult, Older Adult)",78.0,Other,Interventional,2021-01-05,01/10/21,2022-01-02,12/02/21,16/02/21,,,Respiratory Diseases,1,2,362.0
3787.0,NCT04708340,Tolerability and Efficacy of RJX in Patients With COVID-19,RJX,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,COVID-19,Hypoxemia,,,,Drug: Rejuveinix (RJX) Active Comparator|Drug: Placebo Comparator,"Reven Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",237.0,Industry,Interventional,2021-03-25,01/10/22,2023-01-02,13/01/21,30/03/21,"Memorial Hermann Memorial City Medical Center, Houston, Texas",United States,Respiratory Diseases,1,4,648.0
3788.0,NCT04441814,FOUND - Ancillary Study to Smile Protocol NCT03654105,FOUND,Enrolling by invitation,COVID-19,Inflammatory Status,,,,,,,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|University of Parma|University of Milan|University of Milano Bicocca",All,"50 Years to 75 Years   (Adult, Older Adult)",960.0,Other,Observational,2019-07-23,01/07/21,2021-01-07,22/06/20,23/06/20,"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan",Italy,Respiratory Diseases,1,2,534.0
3789.0,NCT04390139,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,COVIDMES,Recruiting,COVID-19,SARS-CoV 2,Adult Respiratory Distress Syndrome,,,,,Drug: XCEL-UMC-BETA|Other: Placebo,Banc de Sang i Teixits,All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-05-13,01/10/21,2021-01-12,15/05/20,08/04/21,"Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Mútua de Terrassa, Terrassa, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona",Spain,Respiratory Diseases,1,3,244.0
3790.0,NCT04478071,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),,Recruiting,Acute Respiratory Distress Syndrome,Coronavirus Infection,,,,,,Drug: vadadustat|Drug: placebo,"The University of Texas Health Science Center, Houston|Akebia Therapeutics Inc.",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-08-22,01/08/22,2022-01-08,20/07/20,10/09/20,"The University of Texas Health Science Center at Houston, Houston, Texas",United States,Respiratory Diseases,1,2,504.0
3791.0,NCT04640038,Contrast Enhanced Ultrasound in COVID-19,,Recruiting,COVID-19,MIS-C,,,,,,Drug: Sulfur hexafluoride lipid-type A microspheres,Children's Hospital of Philadelphia,All,up to 17 Years   (Child),30.0,Other,Interventional,2020-12-18,01/12/22,2022-01-12,23/11/20,27/01/21,"The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,390.0
3792.0,NCT04378686,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,,Recruiting,SARS-CoV 2,End Stage Renal Failure on Dialysis,,,,,,Other: dialysis,Universitaire Ziekenhuizen Leuven,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-23,01/05/21,2022-01-05,07/05/20,12/05/20,"Jessa Ziekenhuis, Hasselt, Limburg, Belgium|University Hospitals Leuven, Leuven",Belgium,Respiratory Diseases,1,2,622.0
3793.0,NCT04286503,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: Carrimycin|Drug: lopinavir/ritonavir tablets or Arbidol or chloroquine phosphate|Drug: basic treatment,"Beijing YouAn Hospital|Shenyang Tonglian Group CO., Ltd|Institute of Medicine and Biotechnology, Chinese Academy of Medical Sciences|Huangshi Central Hospital|Shenyang Pharmaceutical University|First Affiliated Hospital of Chongqing Medical University|The Second Affiliated Hospital of Harbin Medical University|No.2 People's Hospital of Fuyang City|First Affiliated Hospital Bengbu Medical College|Renmin Hospital of Wuhan University|The sixth people's hospital of Shenyang|Nanyang Central Hospital",All,"18 Years to 75 Years   (Adult, Older Adult)",520.0,Other|Industry,Interventional,2020-02-23,28/02/21,2021-02-28,27/02/20,27/02/20,,,Respiratory Diseases,1,1,371.0
3794.0,NCT04376710,Surgical Telemedicine in the COVID-19 Pandemic Era,,Completed,COVID-19,Surgery,,,,,,Other: Completion of pre-pandemic survey|Other: Completion of survey after peak of pandemic|Other: Completion of post telemedicine encounter survey,"University of Colorado, Denver",All,"31 Days to 18 Years   (Child, Adult)",180.0,Other,Observational,2020-01-07,01/10/20,2020-01-10,06/05/20,28/10/20,"Children's Hospital Colorado, Aurora, Colorado",United States,Respiratory Diseases,1,2,3.0
3795.0,NCT04461379,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",,"Active, not recruiting",BCG,COVID-19,SARS-CoV2,Corona Virus Infection,,,,Biological: BCG vaccine|Other: Placebo,Hospital Universitario Dr. Jose E. Gonzalez,All,"18 Years and older   (Adult, Older Adult)",908.0,Other,Interventional,2020-07-21,01/01/21,2021-01-01,08/07/20,13/11/20,"Hospital Universitario José E. González, Monterrey, Nuevo León",Mexico,Respiratory Diseases,1,4,164.0
3796.0,NCT03944447,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,OMNI-Can,Recruiting,Chronic Pain,Chronic Pain Syndrome,Chronic Pain Due to Injury,Chronic Pain Due to Trauma,Fibromyalgia,Seizures,Hepatitis C,"Drug: Cannabis, Medical","OMNI Medical Services, LLC|OMNI Medical Services Inc",All,"7 Years and older   (Child, Adult, Older Adult)",200000.0,Other,Interventional,2018-01-12,31/12/25,2025-12-31,09/05/19,09/12/20,"OMNI Medical Services, Boca Raton, Florida, United States|OMNI Medical Services, Bradenton, Florida, United States|OMNI Medical Services, Fort Lauderdale, Florida, United States|OMNI Medical Services, Fort Myers, Florida, United States|OMNI Medical Services, Gainesville, Florida, United States|OMNI Medical Services, Merritt Island, Florida, United States|OMNI Medical Services, Miami, Florida, United States|OMNI Medical Services, Ocoee, Florida, United States|OMNI Medical Services, Pensacola, Florida, United States|OMNI Medical Services, Pompano Beach, Florida, United States|OMNI Medical Services, Tampa, Florida, United States|OMNI Medical Services, Wesley Chapel, Florida, United States|OMNI Medical Services, Beechwood, Ohio, United States|OMNI Medical Services, Bowling Green, Ohio, United States|OMNI Medical Services, Sandusky, Ohio, United States|OMNI Medical Services, Toledo, Ohio, United States|OMNI Medical Services, Toledo, Ohio",United States,Infectious Diseases,0,7,2910.0
3797.0,NCT04321265,Outcomes and Prognostic Factors in COVID-19,COVIP,Recruiting,COVID-19,Elderly Patients,Critical Illness,Survival,Old Age,,,,"Heinrich-Heine University, Duesseldorf",All,70 Years and older   (Older Adult),4000.0,Other,Observational,2020-03-19,01/09/21,2021-01-12,25/03/20,19/12/20,"Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark|Hôpitaux de Paris, Hôpital Saint-Antoine, service de réanimation médicale, Paris, France|INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France|Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France|Division of Cardiology, Pulmonary Disease and Vascular Medicine, Duesseldorf, Germany|Department of Anaestesia and Intensive Care, Haukeland University Hospital, Bergen, Norway|Department of Clinical Medecine,University of Bergen, Bergen",Norway,"Cardiovascular Diseases, Respiratory Diseases",1,5,299.0
3798.0,NCT04465513,Investigation of Safety and Efficacy of CARDIO Softgels in Former Smokers and Asthma Patients With COVID-19 Infection,,Not yet recruiting,Asthma; Eosinophilic,COVID-19,COVID-19,,,,,Dietary Supplement: Best Standard of Care + CARDIO|Dietary Supplement: Best Standard of Care,Hofseth Biocare ASA|KGK Science Inc.,All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Industry,Interventional,2020-08-31,31/08/21,2021-08-31,10/07/20,10/07/20,"KGK Science Inc., London, Ontario",Canada,Respiratory Diseases,1,3,365.0
3799.0,NCT04349982,ICU Trial in Critical Ill COVID-19 Patients,POINT-C,Recruiting,"Risk Factor, Cardiovascular",COVID-19,Critical Illness,Course Illness,,,,"Diagnostic Test: Biomarker (TropT, Myoglobin, CK, CK-MB, LDH, D-dimer, CRP, PCT)",Medical University of Graz,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-08-04,30/06/22,2022-07-31,16/04/20,20/10/20,"Medical University of Graz, Graz, Styria",Austria,"Cardiovascular Diseases, Respiratory Diseases",1,4,726.0
3800.0,NCT04768998,Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON),SUEP-NAPKON,Recruiting,COVID-19,,,,,,,Other: Observational of different courses of SARS-CoV-2 infection in different phases (acute vs. post-acute) and settings,Goethe University|Nationwide Network of University Medicine (NUM) on Covid-19,All,"18 Years and older   (Adult, Older Adult)",6550.0,Other,Observational,2020-04-11,01/03/21,2023-01-09,24/02/21,24/02/21,"RWTH Aachen, Aachen, Germany|University Hospital Augsburg, Augsburg, Germany|Charité Berlin, Berlin, Germany|Klinikum Bielefeld, Bielefeld, Germany|University Hospital Ruhr-University Bochum, Bochum, Germany|University Hospital Bonn, Bonn, Germany|University Hospital Cologne, Cologne, Germany|University Hospital Carl Gustav Carus Dresden, Dresden, Germany|University Hospital Dusseldorf, Dusseldorf, Germany|University Hospital Erlangen, Erlangen, Germany|University Hospital Essen, Essen, Germany|Johann Wolfgang Goethe University, Frankfurt am Main, Germany|University Hospital Freiburg, Freiburg, Germany|University Hospital Greifswald, Greifswald, Germany|University Hospital Göttingen, Göttingen, Germany|University Hospital Halle, Halle/Saale, Germany|University Hospital Hamburg-Eppendorf, Hamburg, Germany|University Hospital MMH Hannover, Hannover, Germany|University Hospital Heidelberg, Heidelberg, Germany|University Hospital UKS Homburg, Homburg, Germany|University Hospital Jena, Jena, Germany|University Hospital UKSH Schleswig-Holstein, Kiel, Germany|University Hospital Leipzig, Leipzig, Germany|University Hospital UKSH Schleswig-Holstein, Lübeck, Germany|University Hospital Mannheim, Mannheim, Germany|University Hospital Giessen/Marburg, Marburg, Germany|University Hospital LMU Munich, Munich, Germany|University Hospital TUM Munich, Munich, Germany|University Hospital Münster, Münster, Germany|Klinikum Oldenburg, Oldenburg, Germany|University Hospital Regensburg, Regensburg, Germany|University Hospital Tübingen, Tübingen, Germany|University Hospital Ulm, Ulm, Germany|University Hospital Würzburg, Würzburg",Germany,Respiratory Diseases,1,1,1003.0
3801.0,NCT04831853,Self- Versus Conventional-swabbing for COVID-19 Screening (COVISWAB),COVISWAB,Not yet recruiting,COVID-19,,,,,,,Other: nasopharyngeal swabbing procedure (self swabbing first)|Other: nasopharyngeal swabbing procedure (conventionnal swabbing first),"University Hospital, Clermont-Ferrand",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2021-01-04,01/10/21,2021-01-12,05/04/21,05/04/21,"CHU de Clermont-Ferrand, Clermont-Ferrand",France,Respiratory Diseases,1,1,8.0
3802.0,NCT04343339,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,EPILOGUE,Completed,"Addiction, Substance",COVID-19,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-08-04,30/07/20,2020-09-30,13/04/20,08/10/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,2,57.0
3803.0,NCT04524234,Cardiac Dysfunction in Critically Ill Patients With COVID-19,CARDYCOVID,Completed,COVID-19,Left Ventricular Dysfunction,Right Ventricular Dysfunction,Pulmonary Hypertension,,,,Diagnostic Test: Echocardiography,"Sahlgrenska University Hospital, Sweden",All,"18 Years to 99 Years   (Adult, Older Adult)",132.0,Other,Observational,2020-04-20,31/08/20,2020-09-30,24/08/20,24/12/20,"Södersjukhuset, Stockholm, Region Stockholm, Sweden|North Älvsborg County Hospital, Trollhättan, Västra Götalandsregionen, Sweden|Sahlgrenska University Hospital/Mölndal, Gothenburg, Västra Götaland, Sweden|Sahlgrenska University Hospital/Östra, Gothenburg, Västra Götaland, Sweden|Sahlgrenska University Hospital, Gothenburg, Västra Götaland",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,4,163.0
3804.0,NCT04366817,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,COVMUM,Not yet recruiting,Post Partum Depression,,,,,,,Behavioral: psychological assessment,Assistance Publique - Hôpitaux de Paris,Female,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-01-04,01/04/20,2020-01-06,29/04/20,29/04/20,"Service médecine foetale-Hôpital Trousseau, Paris",France,Mental Health,1,1,2.0
3805.0,NCT04356378,Long Term Physical Functional Limitations in Daily Living in SARS-CoV2 Infected Patients Hospitalized in the Acute Phase Then Requiring Rehabilitation,CAPACoV19,Recruiting,Infection With Coronavirus SARS-CoV2,,,,,,,Other: Data record,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-02-06,02/10/21,2022-02-03,22/04/20,11/06/20,"Damien JOLLY, Reims",France,Respiratory Diseases,1,1,728.0
3806.0,NCT04386512,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),LymphoCov1,Completed,COVID-19,Lymphoma,,,,,,,Versailles Hospital,All,"18 Years and older   (Adult, Older Adult)",89.0,Other,Observational,2020-05-15,01/06/20,2020-07-15,13/05/20,07/08/20,"CH de Versailles, Le Chesnay",France,Respiratory Diseases,1,2,61.0
3807.0,NCT04393051,Baricitinib Compared to Standard Therapy in Patients With COVID-19,BARICIVID-19,Not yet recruiting,COVID-19,SARS-CoV 2,SARS Pneumonia,,,,,Drug: Baricitinib Oral Tablet,"Azienda Ospedaliero, Universitaria Pisana",All,"18 Years and older   (Adult, Older Adult)",126.0,Other,Interventional,2020-05-20,30/06/20,2020-07-30,19/05/20,20/05/20,"Azienda Ospedaliero Universitaria Pisana, Pisa",Italy,Respiratory Diseases,1,3,71.0
3808.0,NCT04395755,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,,Completed,"Infertility, Female",ART,IVF,COVID-19,,,,Behavioral: Generalized Anxiety Disorder-7 (GAD-7)|Behavioral: Patient Health Questionnaire-9 (PHQ-9),Ospedale Policlinico San Martino,Female,"18 Years and older   (Adult, Older Adult)",503.0,Other,Observational,2020-01-04,15/05/20,2020-05-15,20/05/20,28/07/20,"IRCCS Ospedale Policlinico San Martino, Genoa",Italy,Respiratory Diseases,1,4,132.0
3809.0,NCT04444531,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,,Completed,COVID-19,,,,,,,,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,,"Child, Adult, Older Adult",18.0,Other,Observational,2020-03-20,19/05/20,2020-05-26,23/06/20,25/11/20,"Policlinic Ibiza Hospital, Ibiza",Spain,Respiratory Diseases,1,1,67.0
3810.0,NCT04389463,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,,Recruiting,Patients Undergoing Cardiac or Thoracic Surgery,,,,,,,Other: No intervention,Nantes University Hospital,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Observational,2020-11-05,11/05/22,2022-06-30,15/05/20,20/11/20,"University Hospital, Nantes",France,Others,0,1,602.0
3811.0,NCT04530539,The Effect of Melatonin and Vitamin C on COVID-19,,Recruiting,COVID-19,SARS-CoV Infection,,,,,,Dietary Supplement: Vitamin C|Dietary Supplement: melatonin|Dietary Supplement: Placebo|Other: Symptom Survey,Lancaster General Hospital,All,"50 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-05-10,01/09/21,2021-01-12,28/08/20,16/02/21,"Lancaster General Health, Lancaster, Pennsylvania",United States,Respiratory Diseases,1,2,247.0
3812.0,NCT04346927,Telerehabilitation for Patients Diagnosed With Coronavirus,COVID-19,Completed,Telerehabilitation,Coronavirus,,,,,,Other: Telerehabilitation|Other: exercise brochure,Yasemin Çırak|Istinye University,All,"18 Years to 70 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-10-08,10/10/20,2020-11-30,15/04/20,26/03/21,"Istinye University, İstanbul",Turkey,Respiratory Diseases,1,2,53.0
3813.0,NCT03808922,Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,,Recruiting,Lower Respiratory Tract Infection,Parainfluenza,Immunocompromised,COVID-19,,,,Drug: DAS181|Drug: Placebo|Drug: DAS181 COVID-19|Drug: DAS181 OL,"Ansun Biopharma, Inc.",All,"Child, Adult, Older Adult",274.0,Industry,Interventional,2019-05-23,30/04/21,2023-12-31,18/01/19,25/03/21,"City of Hope cancer Center, Duarte, California, United States|UCLA, Los Angeles, California, United States|University of California Davis Health System, Sacramento, California, United States|University of California San Diego Medical Center, San Diego, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|University of Kansas Medical Center, Fairway, Kansas, United States|Louisiana State University, Shreveport, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|The Johns Hopkins Hospital, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Universtiy of Michigan, Ann Arbor, Michigan, United States|Washington University, Saint Louis, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Duke University, Durham, North Carolina, United States|Novant Health, Winston-Salem, North Carolina, United States|The Lindner Center- The Christ Hospital, Cincinnati, Ohio, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Cincinnati, Cincinnati, Ohio, United States|The Cleveland Clinic Foundation, Cleveland, Ohio, United States|St. Elizabeth Youngstown Hospital, Youngstown, Ohio, United States|Oregon Health & Science University, Portland, Oregon, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, United States|Kent Hospital, Warwick, Rhode Island, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Cook Children's, Fort Worth, Texas, United States|Texas Health, Fort Worth, Texas, United States|Therapeutic Concepts, Houston, Texas, United States|MD Anderson, Houston, Texas, United States|VCU Health System, Richmond, Virginia, United States|Seattle Children's Hospital, Seattle, Washington, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Froedtert Medical College Pulmonary Clinic, Milwaukee, Wisconsin, United States|Westmead Hospital, Sydney, New South Wales, Australia|The Wesley Hospital, Auchenflower, Queensland, Australia|Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|Shanghai Pulmonary Hospital, Yangpu, Shanghai, China|West China Hospital, Chengdu, Sichuan, China|Shulan (Hangzhou) Hospital co., LTD, Hangzhou, Zhejiang, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Rigshospitalet, Copenhagen, Denmark|Hôpital Henri Mondor, Créteil, Ile-de-France, France|Prince of Wales Hospital, Sha Tin, New Territories, Hong Kong|Samsung Medical Center, Gangnam-gu, Seoul, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Jongno-gu, Seoul, Gyeonggi-do, Korea, Republic of|The Catholic University of Korea, Seoul St. Mary's Hospital, Seocho-gu, Seoul, Gyeonggi-do, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of|Asan Medical Center, Songpa-gu, Seoul, Gyeonggi-do, Korea, Republic of|National Cheng Kung University Hospital, North District, Tainan, Taiwan|National Taiwan University Hospital, Zhongzheng, Taipei City",Taiwan,Respiratory Diseases,1,4,1683.0
3814.0,NCT04823988,"Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic.",,Not yet recruiting,Healthy Volunteer,,,,,,,,National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",3000.0,NIH,Observational,2021-04-19,30/11/21,2022-01-27,01/04/21,14/04/21,"National Institute of Mental Health (NIMH), Bethesda, Maryland",United States,Others,0,1,283.0
3815.0,NCT04368637,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,JoCORE,Recruiting,Acute Myocardial Infarction,Ventricular Tachycardia,Sudden Cardiac Death,"Stroke, Acute",,,,,Jordan Collaborating Cardiology Group,All,"18 Years to 100 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-03-05,30/07/20,2020-08-30,30/04/20,05/05/20,"Istishari Hospital, Amman, Jordan|Abdelhadi Hospital, Amman, Jordan|Farah Hospital, Amman, Jordan|Jordan Hospital, Amman, Jordan|Specialty Hospital, Amman",Jordan,Cardiovascular Diseases,1,4,178.0
3816.0,NCT04636034,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,,Recruiting,Headache,COVID-19,Sphenopalatine Ganglion Block,COVID-19,,,,"Procedure: Sphenopalatine Ganglion Block with Local Anesthetic|Procedure: Sphenopalatine Ganglion Block with Placebo (Isotone NaCl)|Procedure: ""Sham""-block with Placebo (Isotone NaCl)",University Hospital Bispebjerg and Frederiksberg,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-12-01,01/08/21,2021-01-11,19/11/20,14/01/21,"Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen",Denmark,Respiratory Diseases,1,4,-324.0
3817.0,NCT04405570,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",,Completed,SARS-CoV 2,,,,,,,Drug: EIDD-2801|Drug: Placebo (PBO),"Ridgeback Biotherapeutics, LP",All,"18 Years and older   (Adult, Older Adult)",204.0,Industry,Interventional,2020-06-16,21/02/21,2021-02-21,28/05/20,23/02/21,"Benchmark Research, Colton, California, United States|Valley Clinical Trials, Inc., Northridge, California, United States|FOMAT Medical Research, Oxnard, California, United States|Indago Research and Health Center, Inc., Hialeah, Florida, United States|NOLA Research, New Orleans, Louisiana, United States|University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States|Duke, Durham, North Carolina, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Care United Research, LLC, Forney, Texas, United States|Laguna Clinical Research, Laredo, Texas, United States|Fred Hutch, Seattle, Washington",United States,Respiratory Diseases,1,1,250.0
3818.0,NCT04604223,Effect of Pioglitazone on T2DM Patients With COVID-19,PIOQ8,Recruiting,COVID-19,Type 2 Diabetes,,,,,,Drug: Pioglitazone 45 mg,"Dasman Diabetes Institute|Ministry of Health, Kuwait|Texas Diabetes Institute|Kuwait University",All,"21 Years and older   (Adult, Older Adult)",1506.0,Other,Interventional,2021-01-18,29/06/21,2021-06-29,27/10/20,17/03/21,"Al-Amiri Hospital, Kuwait City, (Pick From List), Kuwait|Jaber Al Ahmad Al Sabah Hospital, Kuwait City, (Pick From List), Kuwait|Mishrif Field Hospital, Kuwait City, (Pick From List), Kuwait|Mubarak Al-Kabeer Hospital, Kuwait City, (Pick From List), Kuwait|Hamad Medical Corporation, Doha",Qatar,"Metabolic Disorders, Respiratory Diseases",1,2,162.0
3819.0,NCT04477655,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,PRO-CARF,Completed,COVID-19,,,,,,,Procedure: Awake prone positioning|Procedure: Standard oxygen therapy,Hospital Civil de Guadalajara,All,"18 Years to 80 Years   (Adult, Older Adult)",430.0,Other,Interventional,2020-03-05,26/01/21,2021-01-26,20/07/20,13/04/21,"Hospital Civil Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico|Hospital General de Occidente, Guadalajara, Jalisco",Mexico,Respiratory Diseases,1,1,327.0
3820.0,NCT04710329,High-Dose Vitamin C Treatment in Critically Ill COVID-19 Patients,,Completed,"Respiratory Distress Syndrome, Adult",COVID-19,,,,,,Drug: Ascorbic acid,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",78.0,Other,Observational,2021-01-16,25/01/21,2021-10-02,14/01/21,15/02/21,"Sisli etfal training and resource hospital, Sisli, İstanbul",Turkey,Respiratory Diseases,1,2,259.0
3821.0,NCT04336657,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,,Recruiting,COVID-19,,,,,,,Other: Questionnaire|Diagnostic Test: IgG,Assiut University,All,"8 Years to 80 Years   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-01-04,01/05/20,2020-01-05,07/04/20,07/04/20,"AssiutU, Assiut",Egypt,Respiratory Diseases,1,1,1.0
3822.0,NCT04322188,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,SISCO,Completed,Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection,,,,,,,,A.O. Ospedale Papa Giovanni XXIII,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Observational,2020-03-19,08/05/20,2020-08-05,26/03/20,01/06/20,"ASST - Papa Giovanni XXIII, Bergamo",Italy,Respiratory Diseases,1,1,139.0
3823.0,NCT04542083,"Covid-19, Acute Myocardial Infarctions and Strokes in France",COVUSI,Not yet recruiting,COVID-19,Acute Cardiovascular Condition,Acute Neurovascular Condition,Stroke,Acute Myocardial Infarction,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2021-01-20,01/06/21,2021-06-30,09/09/20,29/12/20,"Uh Montpellier, Montpellier",France,"Cardiovascular Diseases, Respiratory Diseases",1,5,161.0
3824.0,NCT04458337,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),SUROCO,Recruiting,COVID-19,SARS-CoV2,Surgery,"Surgical Procedure; Complications, Late Effect of Complications",Postoperative Complications,,,,Centre hospitalier de l'Université de Montréal (CHUM)|Hôpital Maisonneuve-Rosemont|Centre de recherche du Centre hospitalier universitaire de Sherbrooke|Hopital du Sacre-Coeur de Montreal|St. Justine's Hospital|Institut de Cardiologie de Montréal|McGill University Health Centre/Research Institute of the McGill University Health Centre|CHU de Quebec-Universite Laval|Institut universitaire de cardiologie et de pneumologie de Québec,All,"Child, Adult, Older Adult",120.0,Other,Observational,2020-03-13,13/03/22,2022-04-13,07/07/20,18/03/21,"Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec",Canada,Respiratory Diseases,1,5,761.0
3825.0,NCT04667962,Impact of the Change in Hospital Service of Caregivers During COVID-19 Health Crisis on Operational Strain,CovIdeDocS,Recruiting,"Burnout, Caregiver",,,,,,,Other: Online questionnaire,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",302.0,Other,Observational,2020-12-23,01/09/21,2021-01-09,16/12/20,09/03/21,"Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge, France|Ecole du Val-de-Grâce, Paris",France,Others,0,1,17.0
3826.0,NCT04348383,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,DEFACOVID,Recruiting,COVID-19,,,,,,,Drug: Defibrotide 25 mg/kg 24 hours continuous infusion for 15 days|Drug: Placebo 250 cc 24 hours continuous infusion for 15 days,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-08-04,15/04/21,2021-05-15,16/04/20,09/02/21,"Hospital General Universitario Santa Lucía, Cartagena, Murcia, Spain|Hospital Clinico y Provincial de Barcelona, Barcelona, Spain|Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain|Hospital General Universitario Morales Meseguer, Murcia, Spain|Hospital General Universitario Reina Sofía, Murcia, Spain|Hospital Universitario Salamanca, Salamanca",Spain,Respiratory Diseases,1,1,284.0
3827.0,NCT04556513,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,RECOVIDS,Recruiting,COVID-19,ARDS,Functional Recovery,,,,,Other: Paraclinical examination|Other: Clinical Examination|Other: Semi-directive interview|Other: quality of life questionnaires,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-09-18,01/12/21,2022-01-11,21/09/20,08/04/21,"Chu Dijon Bourgogne, Dijon",France,Respiratory Diseases,1,3,480.0
3828.0,NCT04494646,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),,Completed,COVID-19,,,,,,,Drug: Bardoxolone Methyl|Drug: Placebo,"NYU Langone Health|Reata Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2020-08-09,08/01/21,2021-08-01,31/07/20,24/02/21,"HSHS St. John's Hospital (Prairie Education and Research Cooperative), Springfield, Illinois, United States|SIU School of Medicine, Springfield, Illinois, United States|NYU Langone Hospital - Brooklyn, Brooklyn, New York, United States|Coney Island Hospital, Brooklyn, New York, United States|Elmhurst Hospital Center, Elmhurst, New York, United States|NYU Winthrop Hospital, Mineola, New York, United States|NYU Bellevue Hospital Center, New York, New York, United States|NYU Langone Health, New York, New York",United States,Respiratory Diseases,1,1,357.0
3829.0,NCT04310865,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,,Suspended,COVID-19,Severe Pneumonia,Chinese Medicine,,,,,Drug: Yinhu Qingwen Granula|Drug: Yin Hu Qing Wen Granula(low does)|Other: standard medical treatment,Zhong Wang|Wuhan Leishenshan Hospital|The First Affiliated Hospital of Dalian Medical University|Tanshan People's Hospital|North China University of Science and Technology Affiliated Hospital|Jizhong Energy Fengfeng Group Hospital|China Academy of Chinese Medical Sciences,All,"18 Years and older   (Adult, Older Adult)",116.0,Other,Interventional,2020-01-11,30/03/21,2021-06-30,17/03/20,11/05/20,"Wuhan No.7 Hospital/Jizhong Energy Fengfeng Group Hospital, Wuhan, Hubei, China|Wuhan No.7 Hospital/North China University of Science and Technology Affiliated Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University/Tanshan People's Hospital, Wuhan, Hubei, China|Wuhan Leishenshan (Thunder God Mountain) Hospital/The First Affiliated Hospital of Dalian Medical University, Wuhan, Hubei",China,Respiratory Diseases,1,3,536.0
3830.0,NCT04389996,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,COPICADS,"Active, not recruiting",Cancer,,,,,,,Other: No intervention,Odense University Hospital,All,"18 Years to 125 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-05-14,21/07/20,2023-01-05,15/05/20,23/07/20,"Department of Haemotology, Odense University Hospital, Odense, Region Of Southern Denmark, Denmark|Department of Oncology, Odense University Hospital, Odense C",Denmark,Cancers,1,1,966.0
3831.0,NCT04361435,Lung Recruitment Device for COVID-19,,Not yet recruiting,COVID-19,Physiotherapy,,,,,,Procedure: Chest physiotherapy using a non-invasive oscillating device,St. Justine's Hospital|Dymedso Inc.|Réseau de Recherche en Santé Respiratoire du Québec|Fonds de la Recherche en Santé du Québec,All,"Child, Adult, Older Adult",50.0,Other,Interventional,2020-01-05,31/07/20,2020-12-31,24/04/20,28/04/20,,,Respiratory Diseases,1,2,361.0
3832.0,NCT04341116,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,,,,,,,Drug: TJ003234|Drug: Placebo,I-Mab Biopharma Co. Ltd.,All,"18 Years and older   (Adult, Older Adult)",384.0,Industry,Interventional,2020-11-04,01/12/21,2021-01-12,10/04/20,14/12/20,"Olive View-UCLA Medical Center, Sylmar, California, United States|Georgetown University Hospital, Washington, District of Columbia, United States|The GW Medical Faculty Associates, Washington, District of Columbia, United States|OSF Healthcare Saint Francis Medical Center, Peoria, Illinois, United States|Indiana University Health, Indianapolis, Indiana, United States|Medpharmics, LLC, Metairie, Louisiana, United States|Ochsner Medical Center, New Orleans, Louisiana, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Henry Ford Health System, Detroit, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|UNM Hospitals, Albuquerque, New Mexico, United States|Oregon Health and Science University, Portland, Oregon, United States|Temple Univeristy Hospital, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,1,69.0
3833.0,NCT04663555,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,REMED,Recruiting,COVID-19,ARDS,,,,,,Drug: Dexamethasone,"Brno University Hospital|Masaryk University|Vascular surgery, University hospital Královské Vinohrady, Prague|General University Hospital in Prague|University Hospital Ostrava|St. Anne's University Hospital Brno|University Hospital Motol Prague|University Hospital Olomouc|University Hospital Plzeň|Tomáš Baťa Regional Hospital|Military University Hospital Praha",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2021-02-02,31/03/22,2023-03-31,11/12/20,04/02/21,"University Hospital Brno, Brno",Czechia,Respiratory Diseases,1,2,787.0
3834.0,NCT04718285,Investigation the Effect of Montelukast in COVID-19,,Not yet recruiting,COVID-19,COVID-19,,,,,,Drug: Montelukast Oral Tablet|Drug: Montelukast plus Favicovir (Favipiravir)|Drug: Favicovir (Standard Treatment),Bahçeşehir University|Medipol University|The Scientific and Technological Research Council of Turkey,All,"18 Years and older   (Adult, Older Adult)",380.0,Other,Interventional,2021-01-30,30/04/21,2021-05-30,22/01/21,22/01/21,"Bahcesehir University, School of Medicine, Department of Biophysics,, Istanbul",Turkey,Respiratory Diseases,1,2,120.0
3835.0,NCT04437823,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,,Recruiting,Corona Virus Infection,,,,,,,Biological: Intravenous Infusions of Stem Cells,Jinnah Hospital|Johns Hopkins University,All,"30 Years to 70 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-06,31/05/21,2021-06-30,18/06/20,18/06/20,"Jinnah Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,541.0
3836.0,NCT04433325,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,TOCCIP,Not yet recruiting,COVID-19,Intensive Care Unit Syndrome,,,,,,,Rennes University Hospital,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-01-06,01/07/20,2020-01-09,16/06/20,16/06/20,"CHU Poitiers, Poitiers, France|CHU Tours, Tours",France,Respiratory Diseases,1,2,3.0
3837.0,NCT04818866,International Study of Inflammation in COVID-19,ISIC,Recruiting,COVID-19,"Outcome, Fatal",Respiratory Failure,Acute Kidney Injury,Inflammation,,,"Diagnostic Test: SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase","University of Michigan|Rush University|Copenhagen University Hospital, Hvidovre|University of Athens|Heinrich-Heine University, Duesseldorf|University of Thessaly|Charite University, Berlin, Germany",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-02,30/12/21,2021-12-30,26/03/21,30/03/21,"University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,5,728.0
3838.0,NCT04541680,Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis,NINTECOR,Recruiting,SARS-Cov-2 Induced Pulmonary Fibrosis,,,,,,,Drug: Nintedanib 150 MG [Ofev]|Other: Placebo,Assistance Publique - Hôpitaux de Paris|Boehringer Ingelheim,All,"18 Years to 89 Years   (Adult, Older Adult)",250.0,Other|Industry,Interventional,2020-10-29,01/03/21,2021-01-12,09/09/20,02/03/21,"Pneumologie, Paris",France,Others,0,1,75.0
3839.0,NCT04646642,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",,Completed,Coping Skills,Healthcare Workers,COVID-19,,,,,,David Grant U.S. Air Force Medical Center,All,"Child, Adult, Older Adult",21.0,U.S. Fed,Observational,2020-12-14,01/02/21,2021-01-02,30/11/20,02/04/21,"David Grant Medical Center (DGMC), Travis Air Force Base, California",United States,Respiratory Diseases,1,3,19.0
3840.0,NCT04408326,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,ACES,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Drug: Angiotensin II|Drug: Interleukin-1 receptor antagonist,Guy's and St Thomas' NHS Foundation Trust|Australian and New Zealand Intensive Care Research Centre|Monash University|Royal Surrey County Hospital NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-06,01/05/21,2021-01-05,29/05/20,05/06/20,"Guy's & St Thomas' Hospital, London",United Kingdom,Respiratory Diseases,1,2,365.0
3841.0,NCT04476953,COVID-FISETIN: Pilot in SARS-CoV-2 of Fisetin to Alleviate Dysfunction and Inflammation,,Enrolling by invitation,COVID-19,,,,,,,Drug: Placebo|Drug: Fisetin,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-03-08,01/07/21,2021-01-07,20/07/20,18/02/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,1,305.0
3842.0,NCT04359290,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,RuXoCoil,"Active, not recruiting","ARDS, Human",COVID-19,,,,,,Drug: Ruxolitinib administration,Philipps University Marburg Medical Center,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-01-07,01/12/20,2021-01-07,24/04/20,01/12/20,"Andreas Neubauer, Marburg",Germany,Respiratory Diseases,1,2,366.0
3843.0,NCT04345159,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,COVCALL,Completed,COVID-19,Systemic Lupus Erythematosus,Rheumatoid Arthritis,Sjogren's Syndrome,Psoriatic Arthritis,,,Other: Questionnaire by phone call,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",572.0,Other,Observational,2020-04-17,30/11/20,2020-11-30,14/04/20,07/01/21,"Fondation Adolphe de Rothschild, Paris",France,"Respiratory Diseases, Immunological Disorders",1,5,227.0
3844.0,NCT04815031,Drug Use Investigation of COMIRNATY Intramuscular Injection,,Not yet recruiting,COVID-19,,,,,,,Biological: BNT162b2,Pfizer,All,"16 Years and older   (Child, Adult, Older Adult)",20000.0,Industry,Observational,2021-07-04,12/12/22,2022-12-12,24/03/21,24/03/21,"PfizerLocal Country Office, Tokyo",Japan,Respiratory Diseases,1,1,526.0
3845.0,NCT04366115,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,AVM0703,Not yet recruiting,ARDS,COVID-19,"Influenza, Human",,,,,Drug: AVM0703|Drug: Placebo,"AVM Biotechnology LLC|Medpace, Inc.",All,"18 Years and older   (Adult, Older Adult)",16.0,Industry,Interventional,2021-01-01,01/06/22,2023-01-06,28/04/20,07/01/21,,,"Infectious Diseases, Respiratory Diseases",1,3,735.0
3846.0,NCT04468802,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,,Completed,COVID-19,Measles Vaccine,Mortality,,,,,Other: Case fatality rate,Kanuni Sultan Suleyman Training and Research Hospital,All,"Child, Adult, Older Adult",32.0,Other,Observational,2020-01-02,30/06/20,2020-01-07,13/07/20,14/07/20,"Istanbul Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece",Turkey,Respiratory Diseases,1,3,5.0
3847.0,NCT04288102,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),,Completed,COVID-19,,,,,,,Biological: UC-MSCs|Biological: Saline containing 1% Human serum albumin（solution without UC-MSCs）,"Beijing 302 Hospital|Huoshenshan Hospital|Maternal and Child Health Hospital of Hubei Province|General Hospital of Central Theater Command, Wuhan, China|VCANBIO CELL & GENE ENGINEERING CORP.,LTD, China",All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-03,12/05/20,2020-09-07,28/02/20,19/08/20,"General Hospital of Central Theater Command, Wuhan, Hubei, China|Maternal and Child Hospital of Hubei Province, Wuhan, Hubei, China|Wuhan Huoshenshan Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,1,127.0
3848.0,NCT04420338,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",SeroCOVIDial,Recruiting,Chronic Hemodialysis Patients,Caregivers of Chronic Hemodialysis Patients,,,,,,Biological: Blood sample|Biological: Serum tube collection,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-05-06,15/12/20,2020-12-15,09/06/20,17/06/20,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca",France,Others,0,2,223.0
3849.0,NCT04402944,Pulmozyme to Improve COVID-19 ARDS Outcomes,,Recruiting,COVID-19,,,,,,,Drug: Pulmozyme|Drug: Placebo,Boston Children's Hospital|Brigham and Women's Hospital,All,"3 Years and older   (Child, Adult, Older Adult)",60.0,Other,Interventional,2020-05-07,31/05/21,2021-12-31,27/05/20,09/04/21,"Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,603.0
3850.0,NCT04323592,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,MP-C19,Completed,Severe Acute Respiratory Syndrome (SARS) Pneumonia,Coronavirus Infections,"ARDS, Human",,,,,Drug: Methylprednisolone|Other: standard care,University of Trieste,All,"18 Years to 80 Years   (Adult, Older Adult)",173.0,Other,Observational,2020-03-23,10/05/20,2020-10-05,26/03/20,24/06/20,"Marco Confalonieri, Trieste, TS",Italy,Respiratory Diseases,1,3,196.0
3851.0,NCT04374370,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),,Available,COVID-19,SARSCoV2 Convalescent Plasma,,,,,,Biological: SARSCoV2 Convalescent Plasma,AdventHealth,All,"6 Years to 99 Years   (Child, Adult, Older Adult)",,Other,Expanded Access:Intermediate-size Population,,,,05/05/20,05/05/20,"AdventHealth Orlando, Orlando, Florida",United States,Respiratory Diseases,1,2,
3852.0,NCT04346368,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Biological: BM-MSCs|Biological: Placebo,"Guangzhou Institute of Respiratory Disease|Guangzhou Eighth People's Hospital|Tongji Hospital, Huazhong University of Science & Technology|Guangzhou Cellgenes Biotechnology Co.,Ltd",All,"18 Years to 75 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-04,01/12/20,2020-01-12,15/04/20,15/04/20,"Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,8.0
3853.0,NCT04631705,SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation,,Recruiting,COVID-19,,,,,,,Biological: DZIF-10c|Drug: Placebo,University of Cologne|ZKS Köln|Boehringer Ingelheim,All,"18 Years to 70 Years   (Adult, Older Adult)",78.0,Other|Industry,Interventional,2020-12-14,31/07/21,2021-07-31,17/11/20,24/03/21,"University Hospital Cologne, Cologne, NRW",Germany,Respiratory Diseases,1,1,229.0
3854.0,NCT04680858,Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19,EndoCom,Enrolling by invitation,Endoscopy,Communication,,,,,,Other: DECT,University of Ulm,All,"18 Years to 68 Years   (Adult, Older Adult)",500.0,Other,Interventional,2020-01-07,31/01/21,2021-02-15,23/12/20,31/12/20,"Universitätsklinikum Ulm, Ulm",Germany,Others,0,2,405.0
3855.0,NCT04412031,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,PredictCovid19,Completed,COVID-19,,,,,,,Other: non applicable,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",802.0,Other,Observational,2019-11-11,14/05/20,2020-05-15,02/06/20,02/06/20,"Hôpital E Herriot - Hospices Civils de LYON, Lyon",France,Respiratory Diseases,1,1,186.0
3856.0,NCT04548505,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,CovEx,Recruiting,SARS-CoV Infection,,,,,,,,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-10,05/04/23,2023-05-04,14/09/20,09/03/21,"Institut de Recherche Biomédicale des Armées, Brétigny-sur-Orge",France,Respiratory Diseases,1,1,1089.0
3857.0,NCT04574869,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,,Not yet recruiting,Acute Lung Injury,ALI,COVID-19,,,,,Drug: RLS-0071|Drug: Placebo,"ReAlta Life Sciences, Inc.",All,"18 Years to 69 Years   (Adult, Older Adult)",42.0,Industry,Interventional,2020-01-10,01/03/21,2021-01-07,05/10/20,05/10/20,"Prestige Clinical Research Center, Coral Gables, Florida",United States,Respiratory Diseases,1,3,363.0
3858.0,NCT04409886,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,HBOT,Not yet recruiting,COVID-19,,,,,,,Device: Hyperbaric Chamber,Maimonides Medical Center,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-06,31/12/20,2021-03-30,01/06/20,11/06/20,,,Respiratory Diseases,1,1,449.0
3859.0,NCT04346797,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",CORIMUNO19-ECU,Recruiting,COVID-19,COVID-19,,,,,,Drug: Eculizumab,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-16,30/09/20,2020-12-31,15/04/20,27/04/20,"Saint Louis, Paris, Ile De France, France|Réanimation médicale, Paris, France|saint Louis, Paris",France,Respiratory Diseases,1,2,259.0
3860.0,NCT04345419,Remdesivir Efficacy in Coronavirus Disease,,Recruiting,COVID-19,,,,,,,Drug: Remdesivir|Other: Standard of care treatment,Tanta University,All,"Child, Adult, Older Adult",120.0,Other,Interventional,2020-06-16,01/12/29,2029-01-12,14/04/20,10/03/21,"Tanta university hospital, Assuit University, Ainshams University, Tanta",Egypt,Respiratory Diseases,1,1,3132.0
3861.0,NCT04497194,Registry of COVID-19 Patients at AOUI Verona,,Recruiting,Coronavirus Disease 2019,,,,,,,Other: not applicable (observational study),Azienda Ospedaliera Universitaria Integrata Verona,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-01-03,30/08/20,2020-09-30,04/08/20,04/08/20,"University Hospital of Verona, Verona",Italy,Respiratory Diseases,1,1,271.0
3862.0,NCT04492514,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,,Recruiting,COVID-19,SARS-CoV 2,Pneumonia,,,,,Drug: Mavrilimumab|Drug: Placebo,"Kristin Hudock|Kiniksa Pharmaceuticals, Ltd.|University of Cincinnati",All,"18 Years and older   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2020-05-20,31/05/21,2021-05-31,30/07/20,30/07/20,"University of Cincinnati, Cincinnati, Ohio",United States,Respiratory Diseases,1,3,376.0
3863.0,NCT04712110,A Study of TAK-019 in Healthy Japanese Adults (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: TAK-019|Biological: Placebo,Takeda,All,"20 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2021-02-24,04/04/22,2022-04-04,15/01/21,05/04/21,"Sumida Hospital, Sumida-ku, Tokyo, Japan|Nishi Kumamoto Hospital, Kumamoto",Japan,Respiratory Diseases,1,1,404.0
3864.0,NCT04404426,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,CACOLAC,Recruiting,COVID-19,,,,,,,Dietary Supplement: L-citrulline|Other: Placebo,Rennes University Hospital,All,"18 Years and older   (Adult, Older Adult)",32.0,Other,Interventional,2020-02-11,15/09/21,2021-09-15,27/05/20,05/02/21,"Rennes University Hospital, Rennes, Britanny",France,Respiratory Diseases,1,1,582.0
3865.0,NCT04543760,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,DeCOPO,Recruiting,COVID-19,,,,,,,Other: Prone position|Other: Supine position,"Hospital St. Joseph, Marseille, France",All,"18 Years and older   (Adult, Older Adult)",18.0,Other,Interventional,2020-01-10,01/03/21,2021-01-05,10/09/20,08/10/20,"Hopital Saint Joseph, Marseille",France,Respiratory Diseases,1,1,361.0
3866.0,NCT04356482,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,COPLASCOV19,Recruiting,COVID-19,SARS-CoV 2,Convalescence,Plasma,Doses,,,Biological: convalescent plasma,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado|SECRETARIA DE SALUD DEL ESTADO DE SONORA|CENTRO ESTATAL DE LA TRANSFUSION SANGUINEA|HOSPITAL CENTRAL NACIONAL PEMEX NORTE|HOSPITAL DE ZONA No. 2 IMSS|HOSPITAL DE ZONA No.14 IMSS|HOSPITAL GENERAL DEL ESTADO DE SONORA,All,"16 Years and older   (Child, Adult, Older Adult)",90.0,Other,Interventional,2020-05-20,01/11/20,2020-01-12,22/04/20,05/06/20,"Hospital Del Issste Regional En Guadalajara Jalisco, Guadalajara, Jalisco, Mexico|Secretaria de Salud Del Estado de Sonora, Hospital General Del Estado, Hermosillo, Sonora, Mexico|Hospital Central Norte Pemex, Mexico City",Mexico,Respiratory Diseases,1,5,-129.0
3867.0,NCT04435457,Cardiovascular Implications of COVID-19,,Recruiting,SARS-CoV 2,SARS Pneumonia,COVID-19,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Cardiac Complication,,,,University of Texas Southwestern Medical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",70.0,Other,Observational,2020-01-09,30/06/21,2021-06-30,17/06/20,04/02/21,"University of Texas Southwestern Medical Center, Dallas, Texas",United States,Respiratory Diseases,1,5,538.0
3868.0,NCT04320511,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,,Recruiting,SARS-COV2,Severe Acute Respiratory Syndrome,COVID-19,,,,,Device: CT-V,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Observational,2020-06-24,01/06/21,2022-01-06,25/03/20,13/04/21,"Beaumont Health, Royal Oak, Michigan",United States,Respiratory Diseases,1,3,561.0
3869.0,NCT04519307,Evaluation of Newborns Presenting With Suspected COVID 19,,"Active, not recruiting",Viral Infection,,,,,,,,Dr. Behcet Uz Children's Hospital,All,up to 1 Month   (Child),72.0,Other,Observational,2020-01-03,01/08/20,2020-08-31,19/08/20,19/08/20,"İzmir Dr. Behcet Uz Training and Research Hospital, İzmir",Turkey,Others,0,1,241.0
3870.0,NCT04492384,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,ACTIV,Completed,COVID-19,COVID-19,Pneumonia,Copd,CKD,Cardiac Event,Overweight and Obesity,Other: non-interventional,Eurasian Association of Therapists,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-11-06,14/01/21,2021-01-14,30/07/20,19/01/21,"Eurasian Association of Therapists, Moscow",Russian Federation,"Metabolic Disorders, Respiratory Diseases",1,7,69.0
3871.0,NCT04429555,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",,Recruiting,"Pneumonia, Viral",,,,,,,Drug: Ibudilast|Drug: Placebo,MediciNova,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2021-11-01,30/06/21,2021-01-12,12/06/20,23/02/21,"Denver Health and Hospital Authority, Denver, Colorado, United States|Yale University School of Medicine, New Haven, Connecticut",United States,Respiratory Diseases,1,1,-293.0
3872.0,NCT04462367,Northeast COVID-19 and Pregnancy Study Group,NCOVIP,Recruiting,COVID-19,Coronavirus Infection,Pregnancy Disease,Severe Acute Respiratory Syndrome,,,,,Instituto Materno Infantil Prof. Fernando Figueira,Female,"Child, Adult, Older Adult",180.0,Other,Observational,2020-01-07,30/06/22,2022-12-20,08/07/20,10/02/21,"Instituto Materno Infantil Prof. Fernando Figueira, Recife, Pernambuco",Brazil,Respiratory Diseases,1,4,1078.0
3873.0,NCT04776317,Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults,,Recruiting,COVID-19,,,,,,,"Biological: ChAdV68-S|Biological: ChAdV68-S-TCE|Biological: SAM-LNP-S|Biological: SAM-LNP-S-TCE|Other: Sodium Chloride, 0.9%","National Institute of Allergy and Infectious Diseases (NIAID)|Gritstone Oncology, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",130.0,NIH|Industry,Interventional,2021-03-25,19/09/22,2022-09-19,01/03/21,02/04/21,"Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|The University of Washington - Virology Research Clinic, Seattle, Washington",United States,Respiratory Diseases,1,1,543.0
3874.0,NCT04605887,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Angiotensin 1-7,Rambam Health Care Campus|Constant Therapeutics,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-18,01/11/23,2024-01-04,28/10/20,22/01/21,"Rambam Medical Center, Haifa",Israel,Respiratory Diseases,1,1,1081.0
3875.0,NCT04621214,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,,Completed,Audio-Visual Triage System,Anxiety Levels,COVID-19,GAD-7 Score,Healthcare Professionals,Screening Strategy,,Device: Audio-Visual Triage System (AVT),University of Lahore,All,20 Years to 38 Years   (Adult),60.0,Other,Observational,2020-03-21,28/04/20,2020-04-28,09/11/20,09/11/20,"The University of Lahore, Lahore, Punjab",Pakistan,"Mental Health, Respiratory Diseases",1,6,38.0
3876.0,NCT04649736,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,WAYRA,Recruiting,COVID-19,Respiratory Disease,Mental Health Disorder,,,,,Other: Respiratory and psychological rehabilitation,Universidad Peruana Cayetano Heredia|Johns Hopkins University|London School of Hygiene and Tropical Medicine,All,"50 Years and older   (Adult, Older Adult)",108.0,Other,Interventional,2020-10-26,30/03/21,2021-03-30,02/12/20,02/12/20,"Hospital Nacional Cayetano Heredia, Lima",Peru,Respiratory Diseases,1,3,155.0
3877.0,NCT04332913,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,TOSCA,Recruiting,COVID-19,,,,,,,,University of L'Aquila,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-04,31/12/20,2021-03-31,03/04/20,13/04/20,"Ospedale San Salvatore, L'Aquila",Italy,Respiratory Diseases,1,1,452.0
3878.0,NCT04492475,Adaptive COVID-19 Treatment Trial 3 (ACTT-3),,Completed,COVID-19,,,,,,,Drug: Interferon beta-1a|Other: Placebo|Drug: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years to 99 Years   (Adult, Older Adult)",969.0,NIH,Interventional,2020-05-08,21/12/20,2020-12-21,30/07/20,09/02/21,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of HIV, ID, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Florida Health - Jacksonville - Department of Emergency Medicine, Jacksonville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago Division of Infectious Diseases, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics - Department of Internal Medicine, Iowa City, Iowa, United States|Ochsner Medical Center - Kenner - Department of Infectious Diseases, Kenner, Louisiana, United States|Southeast Louisiana Veterans Health Care System - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Seongnam, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore",Singapore,Respiratory Diseases,1,1,227.0
3879.0,NCT04353141,International Lung UltraSound Analysis (ILUSA) Study,ILUSA,Recruiting,COVID-19,"Pregnancy Complications, Infectious",Pregnancy Related,"Pregnancy, High Risk",Pregnancy Disease,Pneumonia,"Pneumonia, Viral",Diagnostic Test: standardized Lung Ultrasound (LUS) examination,KU Leuven,Female,"Child, Adult, Older Adult",1850.0,Other,Observational,2020-04-28,31/05/20,2020-12-31,20/04/20,07/05/20,"University Hospitals Leuven, Leuven, Belgium|University of Brescia, Brescia, Italy|University of Foggia, Foggia, Italy|University of Milan, Milan, Italy|University of Parma, Parma, Italy|Fondazione Policlinico Universitario A. Gemelli, Roma, Italy|Queen Charlotte's & Chelsea Hospital, London",United Kingdom,Respiratory Diseases,1,7,247.0
3880.0,NCT04395105,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",,Recruiting,"Respiratory Distress Syndrome, Adult",COVID-19,,,,,,Drug: Dexamethasone (high dose),Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,All,"18 Years and older   (Adult, Older Adult)",284.0,Other,Interventional,2020-05-21,31/12/20,2021-01-31,20/05/20,20/07/20,"CEMIC (Centro de Educación Médica e Investigaciones Clínicas), Ciudad Autonoma de Buenos Aires, Argentina|Sanatorio Sagrado Corazon, Ciudad Autonoma de Buenos Aires, Argentina|Clínica Bazterrica, Ciudad Autónoma de Buenos Aires",Argentina,Respiratory Diseases,1,2,255.0
3881.0,NCT04399980,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,,"Active, not recruiting",COVID-19,SARS-CoV 2,Pneumonia,,,,,Drug: Mavrilimumab|Drug: Placebos,"The Cleveland Clinic|Kiniksa Pharmaceuticals, Ltd.",All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-05-20,31/05/21,2021-05-31,22/05/20,06/10/20,"Cleveland Clinic Florida, Weston, Florida, United States|Cleveland Clinic Health System, Cleveland, Ohio",United States,Respiratory Diseases,1,3,376.0
3882.0,NCT04403646,Tannin Specific Natural Extract for COVID-19 Infection,TanCOVID,Terminated,COVID-19,SARS-CoV 2,Coronavirus Infection,,,,,Dietary Supplement: ARBOX|Other: PLACEBO,Hospital de Clinicas José de San Martín|SILVATEAM,All,"18 Years and older   (Adult, Older Adult)",124.0,Other,Interventional,2020-12-06,20/10/20,2020-01-11,27/05/20,22/12/20,"Hospital de Clinicas, Buenos Aires",Argentina,Respiratory Diseases,1,3,-330.0
3883.0,NCT04377100,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,,Recruiting,Anxiety,Healthy Volunteers,,,,,,Behavioral: Computer task questionnaires,National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",6000.0,NIH,Interventional,2021-04-19,28/02/22,2022-02-28,06/05/20,14/04/21,"National Institute of Mental Health (NIMH), Bethesda, Maryland",United States,Mental Health,1,2,315.0
3884.0,NCT04449627,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,FeelGood,Not yet recruiting,Anxiety Disorders,Post Traumatic Stress Disorder,Depressive Disorder,COVID-19,,,,Other: Feeling Good Digital App,"Royal Free Hospital NHS Foundation Trust|University College, London",All,"18 Years and older   (Adult, Older Adult)",125.0,Other,Observational,2020-08-31,31/10/20,2021-01-31,29/06/20,28/08/20,,,"Mental Health, Respiratory Diseases",1,4,153.0
3885.0,NCT04401579,Adaptive COVID-19 Treatment Trial 2 (ACTT-2),,Completed,COVID-19,,,,,,,Other: Placebo|Drug: Remdesivir|Drug: Baricitinib,National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years to 99 Years   (Adult, Older Adult)",1034.0,NIH,Interventional,2020-08-05,31/07/20,2020-07-31,26/05/20,02/12/20,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine, San Francisco, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Georgetown University Medical Center - Division of Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago College of Medicine - Division of Infectious Diseases, Chicago, Illinois, United States|Indiana University School of Medicine - Infectious Diseases, Indianapolis, Indiana, United States|Ochsner Medical Center - Kenner - Department of Infectious Diseases, Kenner, Louisiana, United States|Southeast Louisiana Veterans Health Care System (SLVHCS) - Section of Infectious Diseases, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|University of Pennsylvania Perelman School of Medicine - Penn Institute for Immunology, Philadelphia, Pennsylvania, United States|Vanderbilt University Medical Center - Infectious Diseases, Nashville, Tennessee, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|University of Copenhagen - Centre of Excellence for Health, Immunity and Infections (CHIP) - Department of Infectious Diseases, Copenhagen, Denmark|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore, Singapore|Hospital Clinic Barcelona, Servicio de Salud Internacional, Barcelona, Cataluña, Spain|Hospital Germans Trias i Pujol - Servei Malalties Infeccioses, Barcelona, Cataluña, Spain|Hospital Clinico San Carlos - Enfermedades Infecciosas, Madrid, Spain|Royal Sussex County Hospital - Department of Intensive Care Medicine, Brighton, United Kingdom|Saint Thomas' Hospital - Directorate of Infection, City Of London, United Kingdom|St. James's University Hospital - Infectious Diseases, Leeds, United Kingdom|Royal Victoria Infirmary - Department of Infectious Diseases, Newcastle Upon Tyne, United Kingdom|John Radcliffe Hospital, Oxford",United Kingdom,Respiratory Diseases,1,1,-5.0
3886.0,NCT04412278,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,,Completed,COVID-19,"Isolation, Social",,,,,,Other: Online Survey,Okan University,All,"15 Years to 65 Years   (Child, Adult, Older Adult)",392.0,Other,Observational,2020-01-06,08/06/20,2020-08-06,02/06/20,11/06/20,"Istanbul Okan University, Istanbul",Turkey,Respiratory Diseases,1,2,213.0
3887.0,NCT04761107,Impact of COVID-19 on GU Disease,,Recruiting,COVID-19,Genitourinary Cancer,Benign Urologic Conditions,,,,,,Icahn School of Medicine at Mount Sinai,All,"40 Years and older   (Adult, Older Adult)",15240.0,Other,Observational,2021-02-18,01/02/23,2026-01-02,18/02/21,08/04/21,"Icahn School of Medicine at Mount Sinai, New York, New York",United States,"Respiratory Diseases, Cancers",1,3,1779.0
3888.0,NCT04570982,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,CPT-R-Nepal,Recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma,"Dr. Pradip Gyanwali,MD|Ministry of Health and Population, Nepal|Nepal Health Research Council",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-07-30,30/10/20,2020-12-30,30/09/20,30/09/20,"Narayani Hospital, Birgunj, Nepal|Seti Provincial Hospital, Dhangadi, Nepal|BP Koirala Institute of Health Sciences (BPKIHS), Dharān Bāzār, Nepal|Sukraraj Tropical Disease Hospital, Kathmandu, Nepal|TU Teaching Hospital, Kathmandu, Nepal|Bheri Provincial Hospital, Nepalgunj",Nepal,Respiratory Diseases,1,1,153.0
3889.0,NCT04502069,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,Opaganib-RHB,Withdrawn,COVID-19,Lung Infection,,,,,,Drug: Opaganib,RedHill Biopharma Limited,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-08,01/02/21,2021-01-06,06/08/20,11/08/20,"Shaare Zedek Medical Center, Jerusalem",Israel,Respiratory Diseases,1,2,364.0
3890.0,NCT04597853,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,LungMechCoV-19,Not yet recruiting,COVID-19,ARDS,,,,,,Diagnostic Test: Assessment of lung mechanics and heart-lung interactions,University of Zurich,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Observational,2020-10-20,31/10/21,2021-12-31,22/10/20,22/10/20,,,Respiratory Diseases,1,2,437.0
3891.0,NCT04445311,Ivermectin in Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,Zagazig University,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-31,30/07/20,2020-08-15,24/06/20,24/06/20,"Waheed Shouman, Zagazig, Sharkia",Egypt,Respiratory Diseases,1,1,76.0
3892.0,NCT04372082,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,HYdILIC,Withdrawn,Sars-CoV2,,,,,,,Other: Standard of care (SOC)|Drug: Hydroxychloroquine|Drug: Association of diltiazem and niclosamide,"University Hospital, Lille|I-site University Lille North Europe",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-05,01/05/23,2023-01-05,01/05/20,11/03/21,,,Respiratory Diseases,1,1,1096.0
3893.0,NCT04713111,Stress and Recovery in Frontline COVID-19 Workers,,Completed,COVID-19,Stress,Wearables,,,,,Behavioral: Lifestyle (Meditation)|Behavioral: Lifestyle (Exercise),4YouandMe|Center for International Emergency Medical Services|Evidation Health|Vector Institute for Artificial Intelligence|Cambridge Cognition Ltd|Bill and Melinda Gates Foundation,All,"18 Years and older   (Adult, Older Adult)",383.0,Other|Industry,Interventional,2020-04-05,30/11/20,2020-11-30,19/01/21,12/03/21,"4YouandMe, Seattle, Washington",United States,"Mental Health, Respiratory Diseases",1,3,239.0
3894.0,NCT04772703,DNA Damage in Critically Ill COVID-19 Patients,,Recruiting,COVID-19,"Organ Failure, Multiple",DNA Damage,,,,,Diagnostic Test: COMET ASSAY,University Hospital Hradec Kralove,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-11-23,28/02/21,2021-07-30,26/02/21,26/02/21,"University Hospital Hradec Kralove, Hradec Králové, Třebeš",Czechia,Respiratory Diseases,1,3,249.0
3895.0,NCT04387409,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,,"Active, not recruiting","Infection, Respiratory Tract",,,,,,,Biological: VPM1002|Biological: Placebo,Vakzine Projekt Management GmbH|FGK Clinical Research GmbH,All,"18 Years and older   (Adult, Older Adult)",59.0,Industry,Interventional,2020-05-25,01/05/21,2021-01-05,13/05/20,30/09/20,"Ludwig-Maximilians-Universität München, München, Bayern, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen",Germany,Others,0,1,225.0
3896.0,NCT04379245,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,COVIDHIVPrEP,Completed,HIV,Pre-exposure Prophylaxis,,,,,,"Other: Data research, database analysis",Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",4200.0,Other,Observational,2020-04-30,30/04/20,2020-04-05,07/05/20,07/05/20,"Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon",France,Others,0,2,-25.0
3897.0,NCT04725084,Comparison of Non-invasive Oxygenation Strategies in Patients Admitted for Covid-19 Acute Respiratory Distress Syndrome,SONIC-19,Completed,COVID-19,,,,,,,Other: Use of High Flow Nasal Cannula alone|Other: Use of Non-invasive Ventilation|Other: Use of Continuous Positive Airway Pressure,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-07,15/12/20,2020-12-15,26/01/21,26/01/21,"Centre Hospitalier de Bethune, Béthune, Nord-Pas-de-Calais, France|Grand Hôpital de l'Est Francilien, Jossigny, Seine-et-Marne, France|Groupe Hospitalier Sud Ile de France, Melun, Seine-et-Marne, France|Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, Toulon, Var",France,Respiratory Diseases,1,1,343.0
3898.0,NCT04530617,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,,Recruiting,COVID-19,Diabetes,Hypertension,Obesity,,,,Drug: Camostat Mesilate|Drug: Artemisia Annua Leaf,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Interventional,2020-05-10,30/04/21,2021-04-30,28/08/20,15/02/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, None - Non-US/Canada",Mexico,"Metabolic Disorders, Cardiovascular Diseases, Respiratory Diseases",1,4,355.0
3899.0,NCT04412551,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,,Recruiting,Corona Virus Infection,Virus Diseases,Coronaviridae Infections,,,,,,"Dalarna County Council, Sweden",All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-05-20,31/12/20,2020-12-31,02/06/20,02/06/20,"Falun Hospital, Falun",Sweden,Respiratory Diseases,1,3,225.0
3900.0,NCT04442048,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,COV-IMMUNO,Recruiting,Cancer,COVID-19,,,,,,Biological: IMM-101|Other: Observation,Canadian Cancer Trials Group|Immodulon Therapeutics Ltd|BioCan Rx|Canadian Cancer Society (CCS)|ATGen Canada Inc|Canadian Centre for Applied Research in Cancer Control (ARCC)|Ontario Institute for Cancer Research,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other|Industry,Interventional,2020-06-25,31/12/21,2022-03-31,22/06/20,13/04/21,"Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada|London Regional Cancer Program, London, Ontario, Canada|Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|Odette Cancer Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada|The Research Institute of the McGill University, Montreal, Quebec, Canada|CIUSSS de l'Estrie - Centre hospitalier, Sherbrooke, Quebec",Canada,"Respiratory Diseases, Cancers",1,2,644.0
3901.0,NCT04388709,Interferon Lambda Therapy for COVID-19,,Withdrawn,COVID-19,,,,,,,Drug: Peginterferon Lambda-1A,Icahn School of Medicine at Mount Sinai|Eiger BioPharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",0.0,Other|Industry,Interventional,2020-01-09,05/02/21,2021-05-02,14/05/20,26/02/21,,,Respiratory Diseases,1,1,479.0
3902.0,NCT04357769,COVID-19 Pandemic Burden in Severe Mental Disease Patients,PsyCOVID,Completed,Psychological Distress,COVID-19,Severe Mental Disorder,,,,,Other: PSS (Perceived Stress Scale)|Other: GAD-7 (7-item Generalized Anxiety Disorder)|Other: PHQ-9 (9-item Patient Health Questionnaire)|Other: SPEQ (Specific Psychotic Experiences Questionnaire) - Paranoia and Grandiosity Subscales|Other: Zaritt Burden Interview,Federico II University,All,"18 Years to 70 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-10-04,20/04/20,2020-04-25,22/04/20,03/02/21,"University of Naples Federico II, Napoli",Italy,Respiratory Diseases,1,3,-162.0
3903.0,NCT04588792,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,FaST-1,Recruiting,COVID-19,Respiratory Failure,,,,,,Drug: Nebulized Furosemide|Drug: Nebulized Saline,"Queen's University|University Health Network, Toronto",All,"18 Years to 100 Years   (Adult, Older Adult)",640.0,Other,Interventional,2021-01-02,01/10/21,2021-01-10,19/10/20,02/02/21,"University of Alberta, Edmonton, Alberta, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Kingston Health Sciences Center, Kingston, Ontario, Canada|Hôpital Maisonneuve-Rosemont, Montréal, Quebec",Canada,Respiratory Diseases,1,2,8.0
3904.0,NCT04590352,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,MuCo,Completed,COVID-19,,,,,,,Procedure: nasopharyngeal and throat swab|Procedure: collection of mucosal lining fluid|Procedure: blood collection via fingerprick,Radboud University,All,"Child, Adult, Older Adult",187.0,Other,Observational,2020-03-26,13/05/20,2020-05-13,19/10/20,29/01/21,"Radboudumc, Nijmegen, Gelderland",Netherlands,Respiratory Diseases,1,1,48.0
3905.0,NCT04403932,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,COVIT-D,Completed,COVID-19,,,,,,,,"Hospital San Carlos, Madrid",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-17,01/06/20,2020-01-08,27/05/20,01/02/21,"Hospital Clínico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,-100.0
3906.0,NCT04730206,The DAWN Camostat Trial for Ambulatory COVID-19 Patients,DAWN,Not yet recruiting,COVID-19,SARS-CoV Infection,,,,,,Drug: Camostat|Drug: Placebo,KU Leuven|Universiteit Antwerpen|University Ghent|Université de Liège|Vrije Universiteit Brussel,All,"50 Years and older   (Adult, Older Adult)",1306.0,Other,Interventional,2021-01-03,01/05/22,2023-01-05,29/01/21,12/02/21,,,Respiratory Diseases,1,2,732.0
3907.0,NCT04401293,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,,Recruiting,Sars-CoV2,COVID-19,,,,,,Drug: Enoxaparin|Drug: Prophylactic/Intermediate Dose Enoxaparin,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",308.0,Other,Interventional,2020-04-26,26/04/21,2021-04-26,26/05/20,03/12/20,"Beth Israel Newark, Newark, New Jersey, United States|Southside Hospital, Bay Shore, New York, United States|Huntington Hospital, Huntington, New York, United States|Lenox Hill Hospital, New York, New York, United States|Long Island Jewish Medical Center, Queens, New York, United States|Staten Island University Hospital, Staten Island, New York",United States,Respiratory Diseases,1,2,365.0
3908.0,NCT04649086,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,CovExc,Recruiting,COVID-19,Sarcopenia,Muscle Weakness,,,,,Other: Rehabilitation by Eccentric exercises|Other: Rehabilitation by Concentric exercises,"University Hospital, Clermont-Ferrand|GIRCI Auvergne Rhône-Alpes|Ministry of Health, France",All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-05-06,05/10/21,2021-05-12,02/12/20,18/03/21,"CHU de Clermont-Ferrand, Clermont-Ferrand, France|CHU de Dijon, Dijon, France|Centre Médico-Chirurgical de Réadaptation (CMCR) des Massues, Lyon, France|CHU de Saint-Etienne, Saint-Étienne",France,Respiratory Diseases,1,3,371.0
3909.0,NCT04535154,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,PROLUN,"Active, not recruiting",COVID-19,Lung Function Decreased,,,,,,Other: No interventions,"University Hospital, Akershus|Oslo University Hospital|Ostfold Hospital Trust|Haukeland University Hospital|St. Olavs Hospital|The National Association for Heart and Lung Disease, Jessheim, Norway",All,"18 Years and older   (Adult, Older Adult)",264.0,Other,Observational,2020-03-31,01/06/21,2022-01-06,01/09/20,01/09/20,"Dept Pulmonary Medicine, Lørenskog, Viken",Norway,Respiratory Diseases,1,2,646.0
3910.0,NCT04405908,SCB-2019 as COVID-19 Vaccine,,"Active, not recruiting",COVID-19,,,,,,,Biological: SCB-2019|Biological: SCB-2019 with AS03 adjuvant|Biological: SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant,Clover Biopharmaceuticals AUS Pty Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",150.0,Industry,Interventional,2020-06-19,16/10/20,2021-05-25,28/05/20,12/01/21,"Linear Clinical Research Ltd, Nedlands, Western Australia",Australia,Respiratory Diseases,1,1,340.0
3911.0,NCT04657458,Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,,Available,COVID-19,ARDS,Hypoxia,Cytokine Storm,,,,Biological: Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment,"Direct Biologics, LLC",All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,08/12/20,08/12/20,,,Respiratory Diseases,1,4,
3912.0,NCT04355364,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),COVIDORNASE,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Drug: Dornase Alfa Inhalation Solution [Pulmozyme]|Procedure: standard procedure,"Fondation Ophtalmologique Adolphe de Rothschild|University Hospital, Strasbourg, France|Centre Hospitalier Régional Metz-Thionville",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-21,21/11/20,2021-04-21,21/04/20,03/12/20,"Hôpital Fondation A. de Rotschhild, Paris",France,Respiratory Diseases,1,2,365.0
3913.0,NCT04353037,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,,Terminated,Coronavirus,Corona Virus Infection,,,,,,Drug: Group A HCQ|Drug: Group B Control,UnitedHealth Group|ProHealth Care Associates|University of Pennsylvania Perelman School of Medicine,All,"50 Years to 75 Years   (Adult, Older Adult)",21.0,Industry|Other,Interventional,2020-07-04,11/07/20,2020-11-07,20/04/20,12/03/21,"ProHealth New York, New York, New York",United States,Respiratory Diseases,1,2,126.0
3914.0,NCT04640168,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),,Recruiting,COVID-19,,,,,,,Drug: Baricitinib|Drug: Dexamethasone|Other: Placebo|Drug: Remdesivir,National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years to 99 Years   (Adult, Older Adult)",1500.0,NIH,Interventional,2020-11-24,30/04/21,2021-06-30,23/11/20,26/03/21,"University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham, Alabama, United States|UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno, California, United States|University of California San Diego Health - Jacobs Medical Center, La Jolla, California, United States|University of California Los Angeles Medical Center - Westwood Clinic, Los Angeles, California, United States|University of California Irvine Medical Center - Infectious Disease, Orange, California, United States|VA Palo Alto Health Care System - Infectious Diseases, Palo Alto, California, United States|University of California Davis Medical Center - Internal Medicine - Infectious Disease, Sacramento, California, United States|Kaiser Permanente San Diego Medical Center, San Diego, California, United States|Naval Medical Center San Diego - Infectious Disease Clinic, San Diego, California, United States|University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of HIV, ID, and Global Medicine, San Francisco, California, United States|Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford, California, United States|Cedars Sinai Medical Center, West Hollywood, California, United States|VA Eastern Colorado Health Care System, Aurora, Colorado, United States|Denver Health Division of Hospital Medicine - Main Campus, Denver, Colorado, United States|Georgetown University Medical Center - Division of Infectious Diseases, Washington, District of Columbia, United States|University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville, Florida, United States|University of Florida Health - Jacksonville - Department of Emergency Medicine, Jacksonville, Florida, United States|University of Miami Miller School of Medicine - Infectious Diseases, Miami, Florida, United States|Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States|Atlanta VA Medical Center - Infectious Diseases Clinic, Decatur, Georgia, United States|Tripler Army Medical Center (TAMC), Honolulu, Hawaii, United States|Northwestern Hospital - Infectious Disease, Chicago, Illinois, United States|University of Illinois at Chicago Division of Infectious Diseases, Chicago, Illinois, United States|University of Iowa Hospitals & Clinics - Department of Internal Medicine, Iowa City, Iowa, United States|Tulane University - Section of Pulmonary Diseases, Critical Care, and Environmental Medicine, New Orleans, Louisiana, United States|University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States|Johns Hopkins Hospital - Medicine - Infectious Diseases, Baltimore, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|National Institutes of Health - Clinical Center, National Institute of Allergy and Infectious Diseases Laboratory Of Immunoregulation, Clinical Research Section, Bethesda, Maryland, United States|Massachusetts General Hospital - Infectious Diseases, Boston, Massachusetts, United States|University of Massachusetts Medical School - Infectious Diseases and Immunology, Worcester, Massachusetts, United States|University of Michigan - Infectious Disease Clinic at Taubman Center, Ann Arbor, Michigan, United States|University of Minnesota Medical Center, Fairview - Infectious Diseases and International Medicine, Minneapolis, Minnesota, United States|Saint Louis University - Center for Vaccine Development, Saint Louis, Missouri, United States|CHI Health Creighton University Medical Center - Bergan Mercy - Pulmonary Medicine, Omaha, Nebraska, United States|University of Nebraska Medical Center - Infectious Diseases, Omaha, Nebraska, United States|Atlantic Health System - Morristown Medical Center, Morristown, New Jersey, United States|University of New Mexico Clinical and Translational Science Center, Albuquerque, New Mexico, United States|Montefiore Medical Center - Infectious Diseases, Bronx, New York, United States|New York University School of Medicine - Langone Medical Center - Microbiology - Parasitology, New York, New York, United States|University of Rochester Medical Center - Vaccine Research Unit, Rochester, New York, United States|Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Womack Army Medical Center - Pulmonary and Respiratory Services, Fort Bragg, North Carolina, United States|University of Oklahoma Health Science Center - Surgery, Oklahoma City, Oklahoma, United States|Kaiser Permanente Northwest - Center for Health Research, Portland, Oregon, United States|Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey, Pennsylvania, United States|Hospital of the University of Pennsylvania - Infectious Diseases, Philadelphia, Pennsylvania, United States|University of Pittsburgh - Medicine - Infectious Diseases, Pittsburgh, Pennsylvania, United States|Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas, Texas, United States|University of Texas Southwestern Medical Center - Internal Medicine - Infectious Diseases, Dallas, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|University of Texas Medical Branch - Division of Infectious Disease, Galveston, Texas, United States|Baylor College of Medicine - Molecular Virology and Microbiology, Houston, Texas, United States|Methodist Hospital - Houston, Houston, Texas, United States|University of Texas Health Science Center at San Antonio - Infectious Diseases, San Antonio, Texas, United States|University of Utah - Infectious Diseases, Salt Lake City, Utah, United States|University of Virginia - Acute Care Surgery, Charlottesville, Virginia, United States|Naval Medical Center Portsmouth - Infectious Disease Division, Portsmouth, Virginia, United States|EvergreenHealth Infectious Disease Service, Kirkland, Washington, United States|Providence Sacred Heart Medical Center, Spokane, Washington, United States|Madigan Army Medical Center - Infectious Disease Clinic, Tacoma, Washington, United States|Tokyo Medical and Dental University - Medical Hospital - Department of Respiratory Medicine, Tokyo, Japan|National Center for Global Health and Medicine Hospital - Disease Control and Prevention Center, Tokyo, Japan|Seoul National University Bundang Hospital - Division of Infectious Diseases, Seongnam, Gyeonggi-do, Korea, Republic of|Seoul National University Hospital, Seoul, Korea, Republic of|Instituto Nacional de Enfermedades Respiratorias (INER) - Ismael Cosío Villegas, Mexico City, Mexico|Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán - Departamento de Infectologia, Mexico City, Mexico|National University Health System - Division of Infectious Diseases, Singapore, Singapore|National University Health System - Alexandra Hospital - Division of Infectious Diseases, Singapore, Singapore|National Centre for Infectious Diseases (NCID), Singapore, Singapore|Changi General Hospital - Clinical Trials and Research Unit (CTRU), Singapore, Singapore|Ng Teng Fong General Hospital - Infectious Disease Service, Singapore",Singapore,Respiratory Diseases,1,1,218.0
3915.0,NCT04636554,Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia,,Available,COVID-19,Bacteremia,Septicemia,Acinetobacter Baumannii Infection,Pseudomonas Aeruginosa Infection,Staph Aureus Infection,,Other: Phage Therapy,"Adaptive Phage Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,,19/11/20,21/02/21,,,Respiratory Diseases,1,6,
3916.0,NCT04724642,"COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency",,Recruiting,Allogenic Hematopoietic Cell Transplant,CAR-T Therapy,Primary Immunodeficiency,,,,,,Tel-Aviv Sourasky Medical Center,All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Observational,2020-12-28,28/05/21,2021-12-28,26/01/21,28/01/21,"Tel-Aviv Sourasky Medical Center, Tel-Aviv",Israel,Others,0,3,365.0
3917.0,NCT04409184,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,,Withdrawn,COVID-19,Sars-CoV2,,,,,,,Medical College of Wisconsin|Versiti,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Observational,2020-08-14,14/08/20,2020-08-14,01/06/20,18/08/20,,,Respiratory Diseases,1,2,0.0
3918.0,NCT04537806,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Drug: Brexanolone|Drug: Placebo,Sage Therapeutics,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry,Interventional,2020-12-18,01/10/21,2021-01-10,03/09/20,06/04/21,"Sage Investigational Site, Fresno, California, United States|Sage Investigational Site, Augusta, Georgia, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Burlington, Massachusetts, United States|Sage Investigational Site, Lansing, Michigan, United States|Sage Investigational Site, Charleston, South Carolina, United States|Sage Investigational Site, Richmond, Virginia, United States|Sage Investigational Site, Seattle, Washington",United States,Respiratory Diseases,1,2,23.0
3919.0,NCT04844567,Virtual Reality Intervention to Alleviate Breathlessness (COVID-19),,Recruiting,COVID-19,Dyspnea,,,,,,Device: COVVR,Ecole Polytechnique Fédérale de Lausanne|Mindmaze SA,All,"18 Years and older   (Adult, Older Adult)",35.0,Other|Industry,Interventional,2020-11-26,31/12/21,2021-12-31,14/04/21,14/04/21,"Hopitaux Universitaires de Geneve (HUG), Geneva",Switzerland,Respiratory Diseases,1,2,400.0
3920.0,NCT04321369,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,,Completed,"Infections, Respiratory",Fever,Cough,,,,,Diagnostic Test: Testing Sensitivity for SARS-CoV-2 Virus in Symptomatic Individuals,Dr. Deneen Vojta|Quest Diagnostics-Nichols Insitute|Bill and Melinda Gates Foundation|UnitedHealth Group,All,"Child, Adult, Older Adult",533.0,Industry|Other,Observational,2020-09-03,23/03/20,2020-03-23,25/03/20,13/04/20,"Everett Clinic, Seattle, Washington",United States,Others,0,3,-164.0
3921.0,NCT04356586,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,,Completed,COVID-19,Serology,,,,,,,Sciensano|Jessa Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",287.0,Other,Observational,2020-04-05,21/08/20,2020-08-21,22/04/20,07/09/20,"Sciensano, Brussels",Belgium,Respiratory Diseases,1,2,138.0
3922.0,NCT04582201,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,,Recruiting,"Respiratory Distress Syndrome, Adult",,,,,,,Drug: agenT-797,"AgenTus Therapeutics, Inc.|Agenus Inc.",All,"18 Years and older   (Adult, Older Adult)",55.0,Industry,Interventional,2020-09-21,24/04/21,2021-10-15,09/10/20,10/02/21,"Weill Cornell Medicine New York Presbyterian, New York, New York",United States,Others,0,1,389.0
3923.0,NCT04595123,Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),,Recruiting,Post Traumatic Stress Disorder,Depression,Anxiety,Psychological Distress,,,,,"University of Minho|Universidad Loyola Andalucia|Beder College University. Albania|Mackenzie Presbiterian University, São Paulo, Brazil|Medical University of Sofia|European University Cyprus|Groupe Hospitalier du Havre|University of Athens|Bar-Ilan University, Israel|University of Malta|Mount Carmel Health System|University of Coimbra|Universidade Católica Portuguesa|Instituto de Saude Publica da Universidade do Porto|University of Huelva|Instituto de Investigação Biomédica de Malaga. Spain|Universidad Nacional de Educación a Distancia|Kırklareli University|King's College London|Universidad de Concepcion",Female,"18 Years and older   (Adult, Older Adult)",3900.0,Other,Observational,2020-06-15,01/11/20,2021-06-15,20/10/20,12/02/21,"Beder College University, Tirana, Albania|Universidade Presbiteriana Mackenzie, São Paulo, Brazil|Sofia University, Sofia, Bulgaria|Universidad de Concepción, Concepción, Chile|European University Cyprus, Nicosia, Cyprus|Groupe Hospitalier du Havre, Le Havre, France|University of Athens, Athens, Greece|Bar-Ilan University, Ramat Gan, Israel|University of Malta, Imsida, Malta|Universidade do Minho, Braga, Portugal|Universidad Loyola Andalucia, Sevilla, Spain|Kırklareli Üniversitesi, Kırklareli, Turkey|King'S College London, London",United Kingdom,Mental Health,1,4,365.0
3924.0,NCT04395456,A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),SAVE,Not yet recruiting,COVID-19,,,,,,,Drug: AMY-101|Other: WFI 5% glucose,Amyndas Pharmaceuticals S.A.,All,"18 Years and older   (Adult, Older Adult)",144.0,Industry,Interventional,2021-01-09,01/09/22,2022-01-12,20/05/20,21/02/21,,,Respiratory Diseases,1,1,368.0
3925.0,NCT04379258,Analysis of Mortality of Critically Ill Patients With COVID-19,,Completed,COVID-19,Critical Illness,Effectiveness,"Outcome, Fatal",,,,,Hospital Universitario Getafe|Hospital Universitario del Tajo|Puerta de Hierro University Hospital|Hospital de Henares|Hospital Universitario Ramon y Cajal|Hospital Universitario de Móstoles|Hospital Universitario Severo Ochoa|Fundación de Investigación Biomédica - Hospital Universitario de La Princesa|Hospital Universitario Madrid Sanchinarro|Hospital Universitario Santa Creu i Sant Pau|Hospital Universitario Infanta Cristina|Hospital General Universitario Gregorio Marañon|Hospital Universitario de Torrejón|Hospital Universitario La Paz|Hospital Universitario 12 de Octubre,All,"18 Years to 99 Years   (Adult, Older Adult)",868.0,Other,Observational,2021-08-02,08/02/21,2021-08-02,07/05/20,11/02/21,"Hospital Universitario de Getafe, Getafe, Madrid",Spain,"Cardiovascular Diseases, Respiratory Diseases",1,4,0.0
3926.0,NCT04692779,A Prospective Clinical Study to Explore Response to Prone Positioning in ARDS Patients,,Recruiting,COVID-19,ARDS,,,,,,Other: Lung Ultrasound (LUS),Rush University Medical Center,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2021-01-31,30/10/21,2021-10-30,05/01/21,18/02/21,"Rush University Medical Center, Chicago, Illinois",United States,Respiratory Diseases,1,2,272.0
3927.0,NCT04344210,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,,Completed,COVID-19,"Diabetes Mellitus, Type 2","Diabetes Mellitus, Type 1",,,,,Behavioral: Tele-interventions related to diabetes management and mental well-being,Federal University of Rio Grande do Sul,All,"18 Years and older   (Adult, Older Adult)",149.0,Other,Interventional,2020-04-17,20/09/20,2020-09-20,14/04/20,14/10/20,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,"Metabolic Disorders, Respiratory Diseases",1,3,156.0
3928.0,NCT04412057,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,,Completed,COVID-19,Acute Lung Injury,ARDS,,,,,Drug: CERC-002|Drug: Placebo,"Aevi Genomic Medicine, LLC, a Cerecor company|Cerecor Inc",All,"18 Years and older   (Adult, Older Adult)",83.0,Industry,Interventional,2020-09-06,02/12/20,2021-01-19,02/06/20,02/03/21,"Hoag Memorial Hospital, Newport Beach, California, United States|Midway Immunology and Research Center, Fort Pierce, Florida, United States|Triple O Research Institute, P.A., West Palm Beach, Florida, United States|Parkview Research Center, Fort Wayne, Indiana, United States|MedPharmics, LLC, Metairie, Louisiana, United States|LSUHSC - Shreveport, Shreveport, Louisiana, United States|Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|AnMed Health Medical Center, Anderson, South Carolina, United States|Lowcountry Infectious Diseases, P.A., Charleston, South Carolina, United States|BRCR Global Texas, McAllen, Texas",United States,Respiratory Diseases,1,3,135.0
3929.0,NCT04681950,Assessment of Self-Collected Sample Compared to Clinician Collected Sample in COVID-19 and Influenza Program,,Recruiting,COVID-19,,,,,,,,Biocerna LLC,All,"Child, Adult, Older Adult",500.0,Industry,Observational,2020-11-24,30/12/20,2020-12-31,23/12/20,23/12/20,"Biocerna LLC, Fulton, Maryland",United States,Respiratory Diseases,1,1,37.0
3930.0,NCT04586114,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,CoCovSDRA,"Active, not recruiting",COVID-19,,,,,,,Drug: Corticosteroids and Derivatives,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-03,31/05/20,2020-12-31,14/10/20,19/10/20,"Hopital Central, Service de Reanimation Medicale, Nancy",France,Respiratory Diseases,1,1,363.0
3931.0,NCT04321174,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,CORIPREV-LR,Recruiting,Coronavirus Infections,Post-exposure Prophylaxis,,,,,,Drug: Lopinavir/ritonavir,Darrell Tan|Unity Health Toronto,All,"18 Months and older   (Child, Adult, Older Adult)",1220.0,Other,Interventional,2020-04-17,31/03/21,2022-03-31,25/03/20,21/04/20,"St. Paul's Hospital, Vancouver, British Columbia, Canada|Sunnybrook Hospital, Toronto, Ontario, Canada|St. Michael's Hospital, Toronto, Ontario, Canada|Toronto General Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,2,713.0
3932.0,NCT04467840,"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",,Recruiting,COVID-19,Lung Infection,,,,,,Drug: Opaganib|Drug: Placebo,RedHill Biopharma Limited,All,"18 Years to 80 Years   (Adult, Older Adult)",464.0,Industry,Interventional,2020-08-21,01/06/21,2021-01-06,13/07/20,14/04/21,"ABC-201 Site 408, Belo Horizonte, Brazil|ABC-201 Site 411, Belo Horizonte, Brazil|ABC-201 Site 405, Joinville, Brazil|ABC-201 Site 404, Paraná, Brazil|ABC-201 Site 410, Passo Fundo, Brazil|ABC-201 Site 409, Porto Alegre, Brazil|ABC-201 Site 401, Sao Paulo, Brazil|ABC-201 Site 402, São Bernardo Do Campo, Brazil|ABC-201 Site 403, São Paulo, Brazil|ABC-201 Site 407, Tubarão, Brazil|ABC-201 Site 604, Medellín, Antioquia, Colombia|ABC-201 Site 603, Bogotá, Colombia|ABC-201 Site 605, Cundinamarca, Colombia|ABC-201 Site 602, Medellín, Colombia|ABC-201 Site 601, Santiago de Cali, Colombia|ABC-201 Site 702, Ashdod, Israel|ABC-201 Site 704, Holon, Israel|ABC-201 Site 701, Jerusalem, Israel|ABC-201,Site 709, Kfar Saba, Israel|ABC-201 Site 705, Nahariya, Israel|ABC-201 Site 706, Nazareth, Israel|ABC-201 Site 703, Safed, Israel|ABC-201 Site 203, Alessandria, Italy|ABC-201 Site 201, Lecco, Italy|ABC-201 Site 202, Milano, Italy|ABC-201 Site 204, Torino, Italy|ABC-201 Site 501, Mexico City, Mexico|ABC-201 Site 503, Sinaloa, Mexico|ABC-201 Site 303, Bolesławiec, Poland|ABC-201 Site 302, Ostróda, Poland|ABC-201 Site 301, Racibórz, Poland|ABC-201 Site 305, Wrocław, Poland|ABC-201 Site 110, Barnaul, Russian Federation|ABC-201 Site 122, Kirovsk, Russian Federation|ABC-201 Site 101, Moscow, Russian Federation|ABC-201 Site 132, Moscow, Russian Federation|ABC-201 Site 120, Murmansk, Russian Federation|ABC-201 Site 103, Ryazan, Russian Federation|ABC-201 Site 114, Ryazan, Russian Federation|ABC-201 Site 129, Saint Petersburg, Russian Federation|ABC-201 Site 108, Saratov, Russian Federation|ABC-201 Site 102, Smolensk, Russian Federation|ABC-201 Site 109, St Petersburg, Russian Federation|ABC-201 Site 111, St Petersburg, Russian Federation|ABC-201 Site 104, Tver, Russian Federation|ABC-201 Site 118, Volgograd, Russian Federation|ABC-201 Site 112, Yaroslavl, Russian Federation|ABC-201 Site 251, Gillingham, United Kingdom|ABC-201 Site 252, Taunton",United Kingdom,Respiratory Diseases,1,2,138.0
3933.0,NCT04712045,Rational Use of Personal Protective Equipment During COVID-19 Pandemic,RUPERT,Completed,COVID-19,Personal Protective Equipment,,,,,,Other: New PPE|Other: Old PPE,University of Oxford,All,"Child, Adult, Older Adult",67.0,Other,Interventional,2020-01-08,12/12/20,2020-12-12,15/01/21,15/01/21,"Professor Peter McCulloch, Oxford, Oxfordshire",United Kingdom,Respiratory Diseases,1,2,339.0
3934.0,NCT04720378,Safety and Tolerability Study of IV ST266 in COVID-19 Subjects,,Recruiting,Cytokine Release Syndrome,,,,,,,Biological: ST266,"Noveome Biotherapeutics, formerly Stemnion|IQVIA Biotech",All,"18 Years to 70 Years   (Adult, Older Adult)",12.0,Industry,Interventional,2021-01-03,01/08/21,2021-01-08,22/01/21,05/03/21,"Innovative Research of West Florida, Clearwater, Florida, United States|WR-ClinSearch, LLC, Chattanooga, Tennessee",United States,Others,0,1,5.0
3935.0,NCT04418193,Patient Preference Trial for COVID-19 (PPT-COVID),PPT-COVID,Withdrawn,Coronavirus,,,,,,,,Centre Hospitalier Princesse Grace,All,"18 Years to 99 Years   (Adult, Older Adult)",0.0,Other,Observational,2020-06-04,04/02/21,2021-04-02,05/06/20,09/02/21,"Centre Hospitalier Princesse Grace, Monaco",Monaco,Respiratory Diseases,1,1,302.0
3936.0,NCT04815304,Clinical Features of COVID-19 Patients,,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,Ventilatory Failure,,,,,Diagnostic Test: peripheral lymphocytes subsets,San Salvatore Hospital of L'Aquila,All,"18 Years to 90 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-03-13,28/06/21,2022-03-13,25/03/21,25/03/21,"San Salvatore Academic Hospital, L'Aquila",Italy,Respiratory Diseases,1,3,730.0
3937.0,NCT04583319,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",EasyCov,Recruiting,SARS-CoV,,,,,,,Diagnostic Test: EasyCov POC,"Firalis SA|Istanbul University, Istanbul Faculty of Medicine",All,"18 Years and older   (Adult, Older Adult)",160.0,Industry|Other,Observational,2020-01-10,01/11/20,2021-01-03,12/10/20,20/10/20,"Istanbul University Istanbul Faculty of Medicine (ITF), Istanbul",Turkey,Others,0,1,359.0
3938.0,NCT04558645,Evaluation of Quality of Life in Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,,Completed,Type 1 Diabetes Mellitus,COVID-19,,,,,,Other: Online Survey,Gazi University,All,"18 Years to 65 Years   (Adult, Older Adult)",118.0,Other,Observational,2020-09-18,18/12/20,2020-12-26,22/09/20,29/12/20,"Zeliha ÇELİK, Ankara, Çankaya",Turkey,"Respiratory Diseases, Metabolic Disorders",1,2,99.0
3939.0,NCT04525378,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,,Recruiting,COVID-19,"ARDS, Human",,,,,,Other: Mesenchymal stromal cell-based therapy,D'Or Institute for Research and Education,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-07,30/09/20,2020-10-31,25/08/20,26/08/20,"Hospital São Rafael, Salvador, Bahia",Brazil,Respiratory Diseases,1,2,298.0
3940.0,NCT04402203,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,,Recruiting,COVID-19,Favipiravir (Favipira),,,,,,Drug: Favipiravir|Drug: Only Standard Treatment,Bangladesh Medical Research Council (BMRC),All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-05,01/07/20,2020-01-07,26/05/20,26/05/20,"Mahanagar General Hospital, Dhaka (Site-1), Mugda Medical College Hospital, Dhaka (Site-2), Kurmitola General Hospital, Dhaka (Site-3), Dhaka Medical College Hospital, Dhaka (Site-4), Dhaka",Bangladesh,Respiratory Diseases,1,2,2.0
3941.0,NCT04636671,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),MEDEAS,Not yet recruiting,COVID-19,Viral Pneumonia Human Coronavirus,Severe Acute Respiratory Syndrome,,,,,Drug: Methylprednisolone|Drug: Dexamethasone,University of Trieste|Centro di Riferimento Oncologico - Aviano|National Institute for the Infectious Diseases (L. Spallanzani) - Rome,All,"18 Years and older   (Adult, Older Adult)",680.0,Other,Interventional,2020-11-25,31/03/21,2021-04-30,19/11/20,19/11/20,,,Respiratory Diseases,1,3,156.0
3942.0,NCT04273321,Efficacy and Safety of Corticosteroids in COVID-19,,Completed,COVID-19,COVID-19,,,,,,Drug: Methylprednisolone,Beijing Chao Yang Hospital,All,"18 Years and older   (Adult, Older Adult)",86.0,Other,Interventional,2020-02-14,15/04/20,2020-04-15,18/02/20,11/05/20,"Hubei province hospital of integrated Chinese & Western Medicine, Wuhan, Hubei, China|Yichang first people's Hospital, Yichang, Hubei, China|Beijing YouAn Hospital, Beijing, China|Renmin Hospital of Wuhan University, Wuhan, China|Tianyou Hospital Affiliated to Wuhan University of science and technology, Wuhan, China|Union Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, Wuhan, China|the first peopel hospital of Xiangyang, Xiangyang",China,Respiratory Diseases,1,2,61.0
3943.0,NCT04595097,Inspiratory Muscle Training in COVID-19 Patients,ADDIMTCOVID,Not yet recruiting,COVID-19,Exercise,,,,,,Device: inspiratory muscle traiing,Escola Superior de Ciencias da Saude|University of Brasilia|JBS/CNPq,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-02,20/08/21,2021-09-30,20/10/20,13/01/21,"Secretaria de Saúde do Distrito Federal, Brasilia, DF",Brazil,Respiratory Diseases,1,2,271.0
3944.0,NCT04677478,Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19,ISO-BK,Not yet recruiting,Tuberculosis,COVID-19,,,,,,Other: Impact of respiratory isolation on quality of life,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-01-12,01/01/22,2022-01-01,21/12/20,21/12/20,,,"Infectious Diseases, Respiratory Diseases",1,2,720.0
3945.0,NCT04372589,Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC),ATTACC,"Active, not recruiting",COVID-19,Pneumonia,,,,,,Drug: Heparin,"University of Manitoba|University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",1203.0,Other,Interventional,2020-05-20,01/01/21,2021-01-01,04/05/20,01/02/21,"Emory University Hospital Midtown, Atlanta, Georgia, United States|University of Chicago, Chicago, Illinois, United States|Ochsner Clinic, Jefferson, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Henry Ford University, Dearborn, Michigan, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Saint Louis University School of Medicine/Saint Louis Veterans Affairs Medical Center, Saint Louis, Missouri, United States|Cooper University Health Care, Camden, New Jersey, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|Saint Barnabas Medical Center, Livingston, New Jersey, United States|Montefiore-Einstein Center for Heart and Vascular Care, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Santa Casa de Misericordia de Itabuna, Itabuna, BA, Brazil|Hospital Unimed do Cariri, Juazeiro do Norte, CE, Brazil|Instituto Goiano de Oncologia e Hematologia - INGOH, Goiania, Goias, Brazil|Centro de Pesquisas Clínicas Humap - UFMS, Campo Grande, Mato Grosso Do Sul, Brazil|Hospital Felício Rocho, Belo Horizonte, MG, Brazil|Clinica de Campo Grande S/A, Campo Grande, MS, Brazil|Unimed Campo Grande, Campo Grande, MS, Brazil|Hospital Agamenon Magalhaes, Recife, Pernanbuco, Brazil|Hospital das Clinicas da UFPR, Curitiba, PR, Brazil|Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil|Parana Medical Research Center, Maringa, PR, Brazil|Hospital Sao Vicente de Paulo, Passo Fundo, Rio Grande Do Sul, Brazil|Hospital Universitario Pedro Ernesto, Rio de Janeiro, RJ, Brazil|Hospital de Clinicas de Porto Alegre, Porto Alegre, RS, Brazil|Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, RS, Brazil|Instituto de Medicina Vascular, Porto Alegre, RS, Brazil|AngioCor Blumenau, Blumenau, Santa Catarina, Brazil|Instituto de Cardiologia de Santa Catarina, Sao Jose, Santa Catarina, Brazil|Instituto de Pesquisa Clínica de Campinas, Campinas, Sao Paulo, Brazil|Praxis Pesquisa Medica, Santo Andre, Sao Paulo, Brazil|Santa Casa de Votuporanga, Votuporanga, Sao Paulo, Brazil|Casa de Saúde Santa Marcelina, Sao Paulo, SP, Brazil|Instituto de Molestias Cardio Vasculares de Tatui, Tatui, SP, Brazil|Hospital 9 de Julho, São Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil|Instituto de Infectologia Emilio Ribas, São Paulo, Brazil|Instituto do Coração do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente Israelita Hospital Albert Einstein, São Paulo, Brazil|Victoria General Hospital, Victoria, British Columbia, Canada|Health Sciences Center Winnipeg, Winnipeg, Manitoba, Canada|Grace General Hospital, Winnipeg, Manitoba, Canada|St. Boniface General Hospital, Winnipeg, Manitoba, Canada|Hamilton Health Sciences, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Hôpital Montfort, Ottawa, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|University Health Network, Toronto, Ontario, Canada|McGill University Health Centre, Montréal, Quebec, Canada|Centre Hospitalier de l'université de Montréal (CHUM), Montréal, Quebec, Canada|Jewish General Hospital, Montréal, Quebec, Canada|CHU de Quebec-University Laval, Québec, Quebec, Canada|Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Québec, Quebec, Canada|Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada|Regina General Hospital, Regina, Saskatchewan, Canada|Hospital de Infectolog´ñia Centro Médico Nacional La Raza, Azcapotzalco, Mexico City, Mexico|Hospital General Regional 1 Carlos MacGregor Sánchez Navarro, Benito Juárez, Mexico City, Mexico|Hospital General regional 2 El Marqués, Querétaro",Mexico,Respiratory Diseases,1,2,226.0
3946.0,NCT04385810,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,DOCOV,Completed,COVID-19,Sars-CoV2,,,,,,Procedure: Ophthalmologic exam,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",23.0,Other,Interventional,2020-04-27,29/07/20,2020-07-29,13/05/20,16/11/20,"Fondation Adolphe de Rothschild, Paris",France,Respiratory Diseases,1,2,93.0
3947.0,NCT04672291,Nasal Poly-ICLC (Hiltonol®) for Prophylaxis of COVID-19 in Healthy Adults,,Not yet recruiting,COVID-19,,,,,,,Drug: Poly-ICLC (Hiltonol®),"Oncovir, Inc.|University of Calgary",All,18 Years to 40 Years   (Adult),43.0,Industry|Other,Interventional,2021-01-04,31/12/23,2024-01-16,17/12/20,21/02/21,"Health Research Innovation Centre, Calgary, Alberta",Canada,Respiratory Diseases,1,1,1107.0
3948.0,NCT04816643,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children <12 Years of Age",,Recruiting,COVID-19,,,,,,,Biological: Biological/Vaccine: BNT162b2 10mcg|Biological: BNT162b2 20mcg|Biological: BNT162b2 30mcg,BioNTech SE|Pfizer,All,6 Months to 11 Years   (Child),4644.0,Industry,Interventional,2021-03-24,01/03/22,2023-08-29,25/03/21,02/04/21,"Center for Immunization Research Inpatient Unit, Baltimore, Maryland, United States|Boston Medical Center Investigational Pharmacy, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Clinical Research Pickett Road, Durham, North Carolina, United States|Duke Vaccine and Trials Unit, Durham, North Carolina, United States|Accessioning Unit and Repository, Durham, North Carolina, United States|Duke Investigational Drug Service Pharmacy, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Senders Pediatrics, South Euclid, Ohio",United States,Respiratory Diseases,1,1,888.0
3949.0,NCT04354558,French Single Centre Experience of Critically Ill Patients With Covid 19,CovidAmiens20,Recruiting,Epidemiology,Sars-CoV2,COVID-19,Critical Care,Prognostic,Survival,,,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-07,01/07/21,2021-01-08,21/04/20,11/09/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,6,367.0
3950.0,NCT04761913,Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic,,Not yet recruiting,Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2,,,,,,,,Anglia Ruskin University,All,3 Months to 16 Years   (Child),100.0,Other,Observational,2021-01-04,01/09/21,2021-01-12,21/02/21,04/03/21,,,Others,0,1,8.0
3951.0,NCT04361526,Pilot Study on Cytokine Filtration in COVID-19 ARDS,CytokCOVID19,Recruiting,Coronavirus Infection,Acute Respiratory Distress Syndrome,COVID-19,,,,,Device: Cytokine Adsorption,Manuel Castellà|Hospital Clinic of Barcelona,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-17,01/07/20,2020-01-07,24/04/20,24/04/20,"Hospital Clínic de Barcelona, Barcelona",Spain,Respiratory Diseases,1,3,-101.0
3952.0,NCT04381364,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),HALT,Recruiting,COVID-19,"Pneumonia, Viral",Sars-CoV2,,,,,Drug: Ciclesonide Inhalation Aerosol,"Ola Blennow, MD, PhD|Karolinska University Hospital|Danderyd Hospital|Centrallasarettet Västerås|St Goran's Hospital",All,"18 Years and older   (Adult, Older Adult)",446.0,Other,Interventional,2020-05-29,01/12/21,2022-01-05,08/05/20,01/04/21,"Danderyd Hospital, Danderyd, Sweden|Capio S:t Görans Hospital, Stockholm, Sweden|Karolinska University Hospital, Stockholm, Sweden|Visby Hospital, Visby, Sweden|Västmanland County Hospital Västerås, Västerås, Sweden|Örebro University Hospital, Örebro",Sweden,Respiratory Diseases,1,3,586.0
3953.0,NCT04463628,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",MUCONFIN,Recruiting,Cystic Fibrosis in Children,Cystic Fibrosis,,,,,,Behavioral: Questionnaire|Behavioral: Interview,Centre Hospitalier Intercommunal Creteil,All,"14 Years and older   (Child, Adult, Older Adult)",1200.0,Other,Observational,2020-05-15,30/11/20,2021-06-30,09/07/20,09/07/20,"Intercommunal hospital of Créteil, Creteil, IDF, France|TROUSSEAU Hospital, Paris, IDF, France|FOCH Hospital, Suresnes, IDF",France,Others,0,2,411.0
3954.0,NCT04721457,The Efficacy of Pre-procedural Mouth Rinses on COVID-19 Saliva Viral Load,,Recruiting,COVID-19,COVID-19,Mouthwashes,Viral Load,Polymerase Chain Reaction,,,Drug: Distilled Water|Drug: 1% Povidone Iodine (PVP-I)|Drug: 1.5% Hydrogen Peroxide (H2O2)|Drug: 0.075% Cetylpyridinium Chloride (CPC)|Drug: 0.1% Sodium Hypochlorite,King Abdulaziz University,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-03-01,28/02/21,2021-06-30,22/01/21,26/01/21,"Alhamra TETAMMAN clinic (PHC), Jeddah",Saudi Arabia,Respiratory Diseases,1,5,121.0
3955.0,NCT04480034,Obesity Surgery During 2020 Italian Pandemic,,Recruiting,Bariatric Surgery Candidate,COVID-19,Complication of Surgical Procedure,"Pneumonia, Viral",Viral Infection,"Obesity, Morbid",Safety Issues,Procedure: Bariatric procedures,"University of Roma La Sapienza|Azienda Ospedaliero, Universitaria Pisana|Azienda Ospedaliera di Padova|IRCCS Azienda Ospedaliero-Universitaria di Bologna|IRCCS Policlinico S. Donato|University of Rome Tor Vergata|Azienda Ospedaliera Città della Salute e della Scienza di Torino|Humanitas Clinical and Research Center|Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine, Italy",All,18 Years to 60 Years   (Adult),1600.0,Other,Observational,2020-07-15,31/01/21,2021-05-30,21/07/20,05/11/20,"University La Sapienza of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Latina, LT",Italy,"Metabolic Disorders, Respiratory Diseases",1,7,319.0
3956.0,NCT04393727,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,TSUNAMI,Terminated,COVID-19,SARS-CoV 2,,,,,,Biological: CONVALESCENT PLASMA,"Azienda Ospedaliero, Universitaria Pisana",All,"18 Years and older   (Adult, Older Adult)",1.0,Other,Interventional,2020-01-05,30/09/20,2020-09-30,19/05/20,12/11/20,"Azienda Ospedaliero Universitaria Pisana, Pisa",Italy,Respiratory Diseases,1,2,269.0
3957.0,NCT04358588,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,,No longer available,Coronavirus Infection,COVID-19,"Pneumonia, Viral",,,,,Drug: iNO (inhaled nitric oxide) delivered via the INOpulse Delivery System,Bellerophon,All,"18 Years to 95 Years   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,24/04/20,12/06/20,,,Respiratory Diseases,1,3,
3958.0,NCT04623177,Thromboprophylaxis for Patients in ICU With COVID-19,,"Active, not recruiting",COVID-19,Anticoagulant Therapy,Thrombosis,,,,,,Instituto de Investigacion Sanitaria La Fe|Hospital Universitario Doctor Peset|Hospital Clinic of Barcelona|Hospital Universitario La Paz|Hospital Universitario La Fe|Hospital de Sant Joan Despí Moisès Broggi|University of Navarrra Hospital (Clinica Universitaria)|Hospital Universitario Cruces,All,"18 Years and older   (Adult, Older Adult)",950.0,Other,Observational,2020-01-03,30/09/20,2020-01-11,10/11/20,10/11/20,"Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain|Hospital General de Ciudad Real, Ciudad Real, Castilla La Mancha, Spain|Complejo Asistencial Universitario de León, León, Castilla Y León, Spain|Hospital Universitario Rio Ortega, Valladolid, Castilla Y León, Spain|Hospital Clinic Barcelona, Barcelona, Cataluña, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluña, Spain|Hospital de Terrasa, Barcelona, Cataluña, Spain|Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, Spain|Hospital Universitario San Juan de Alicante, Alicante, Comunidad Valenciana, Spain|Complejo Hospitalario de Cáceres, Cáceres, Extramedura, Spain|Hospital Unversitario A Coruña, A Coruña, Galicia, Spain|Complexo Hospitalario Universitario de Ferrol, A Coruña, Galicia, Spain|Complexo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain|Hospital Povisa, Pontevedra, Galicia, Spain|Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Gran Canaria, Spain|Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital Universitario de Araba, Álava, País Vasco, Spain|Hospital del Mar, Barcelona, Spain|Hospital Sanitas Cima, Barcelona, Spain|Hospital Sant Joan Despí, Barcelona, Spain|Hospital Universitario La Princesa, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Clínico San Carlos, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Hospital Universitario Infanta Sofia, Madrid, Spain|Hospital Rafael Méndez, Murcia, Spain|Hospital Clínico Universitario de Valencia, Valencia, Spain|Hospital Arnau de Vilanova, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia, Spain|Hospital Universitari La Fe, Valencia",Spain,Respiratory Diseases,1,3,8.0
3959.0,NCT04531202,CORE Study COVID-19,,Recruiting,COVID-19,,,,,,,,D'Or Institute for Research and Education,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-02-03,30/09/20,2021-09-30,28/08/20,28/08/20,"D'Or Institute for Research and Education (IDOR), Rio de Janeiro",Brazil,Respiratory Diseases,1,1,605.0
3960.0,NCT04673318,Physical Rehabilitation of COVID-19 Survivors by Heat Therapy,,Not yet recruiting,COVID-19,Physical Disability,,,,,,Behavioral: heat therapy|Behavioral: exercise training,"University of Massachusetts, Amherst",All,"55 Years to 85 Years   (Adult, Older Adult)",87.0,Other,Interventional,2021-01-01,01/12/23,2023-01-12,17/12/20,17/12/20,,,Respiratory Diseases,1,2,741.0
3961.0,NCT04400929,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,,Recruiting,COVID-19,Sars-CoV2,"ARDS, Human",,,,,Drug: Sargramostim|Other: Normal Saline 0.9%,Singapore General Hospital,All,"21 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-02-06,01/06/21,2022-01-06,26/05/20,07/07/20,"Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,3,700.0
3962.0,NCT04453566,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",,Recruiting,COVID-19,Life Satisfaction,Anxiety,Mental Health Wellness 1,Athlete,Stress,,Other: Online Survey,Uskudar University|New York Medical College,All,18 Years to 35 Years   (Adult),120.0,Other,Observational,2020-05-27,24/08/20,2020-01-12,01/07/20,27/08/20,"Uskudar University, Istanbul",Turkey,"Mental Health, Respiratory Diseases",1,6,-136.0
3963.0,NCT04508023,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",PREVENT-HD,Recruiting,COVID-19,,,,,,,Drug: Rivaroxaban|Other: Placebo|Other: Standard of Care (SOC),"Janssen Research & Development, LLC",All,"18 Years and older   (Adult, Older Adult)",4000.0,Industry,Interventional,2020-08-13,03/03/21,2022-01-31,11/08/20,08/03/21,"University of Arizona, Tucson, Arizona, United States|Southern California Permanente Medical Group, Los Angeles, California, United States|Kaiser Permanente Northern California, Oakland, California, United States|University of Colorado Denver, Aurora, Colorado, United States|Florida Hospital Orlando, Orlando, Florida, United States|Emory University, Atlanta, Georgia, United States|Morehouse School of Medicine, Atlanta, Georgia, United States|Atlanta VA Medical Center, Decatur, Georgia, United States|Northshore Universite Healthsystem, Evanston, Illinois, United States|Meritus Center for Clinical Research, Hagerstown, Maryland, United States|Brigham & Women's Hospital, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Lenox Hill Hospital -Northwell Health, New York, New York, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Texas Health Physicians Group, Fort Worth, Texas",United States,Respiratory Diseases,1,1,536.0
3964.0,NCT04348695,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Ruxo-Sim-20,Recruiting,Coronavirus Infection,,,,,,,Drug: Ruxolitinib plus simvastatin|Other: Standard of Care,Fundación de investigación HM|Apices Soluciones S.L.,All,"18 Years and older   (Adult, Older Adult)",94.0,Other|Industry,Interventional,2020-12-04,13/05/20,2020-05-13,16/04/20,17/04/20,"Hospital Universitario Madrid Sanchinarro, Madrid",Spain,Respiratory Diseases,1,1,-205.0
3965.0,NCT04730856,Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID),,Not yet recruiting,COVID-19,Thrombosis,,,,,,Drug: Tinzaparin,Hospital Universitario Infanta Leonor,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2021-01-29,01/06/21,2021-07-31,29/01/21,29/01/21,"Hospital Clínico San Carlos, Madrid, Spain|Hospital General Universitario Gregorio Marañón, Madrid, Spain|Hospital Universitario 12 Octubre, Madrid, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Infanta Sofía, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Álvaro Cunqueiro, Vigo",Spain,Respiratory Diseases,1,2,183.0
3966.0,NCT04581577,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,CLASSIC,Recruiting,Neuromuscular Diseases,Neurological Diseases or Conditions,,,,,,Other: Semi-structured telephone questionnaire,Royal Brompton & Harefield NHS Foundation Trust,All,"16 Years and older   (Child, Adult, Older Adult)",75.0,Other,Observational,2020-11-09,31/12/20,2021-04-30,09/10/20,09/03/21,"Royal Brompton Hospital, London",United Kingdom,Others,0,2,172.0
3967.0,NCT04826731,Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients,,Recruiting,COVID-19,Respiratory Function Loss,Coronavirus Infection,"Pneumonia, Viral",,,,Other: Incentive Spirometer/Respiratory Exerciser,Diskapi Yildirim Beyazit Education and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-04,01/06/21,2021-01-07,01/04/21,06/04/21,"Dışkapı Yıldırım Beyazıt Training and Research Hospital Pulmonary Medicine Clinic, Ankara, Çankaya",Turkey,Respiratory Diseases,1,4,3.0
3968.0,NCT04547283,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,,Recruiting,COVID-19,Respiratory Failure,,,,,,Other: Usual Care|Other: APPS,Atrium Health,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-06-14,20/09/20,2020-09-30,14/09/20,14/09/20,"Carolinas Medical Center, Charlotte, North Carolina",United States,Respiratory Diseases,1,2,108.0
3969.0,NCT04646603,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Drug: MRG-001|Drug: Placebo,MedRegen LLC|ICON plc,All,18 Years to 45 Years   (Adult),18.0,Industry,Interventional,2021-01-28,01/04/21,2021-05-06,30/11/20,02/02/21,"ICON Early Phase Services, San Antonio, Texas",United States,Respiratory Diseases,1,1,98.0
3970.0,NCT04319211,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",COVID-19,Not yet recruiting,Healthy People,,,,,,,"Other: Determination of physical activity, quality of life, stress levels of isolated people at home with the danger of coronavirus.",Istanbul University-Cerrahpasa,All,18 Years to 55 Years   (Adult),200.0,Other,Observational,2020-03-25,15/05/20,2020-07-20,24/03/20,24/03/20,"Istanbul University Cerrahpasa, Istanbul",Turkey,Others,0,1,117.0
3971.0,NCT04392713,Efficacy of Ivermectin in COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin 6 MG Oral Tablet (2 tablets),"Combined Military Hospital, Pakistan",All,"15 Years to 65 Years   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-04-15,01/07/20,2020-01-07,19/05/20,19/05/20,"Combined Military Hospital Lahore, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,-99.0
3972.0,NCT04666441,COVID-19 Study Assessing the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,,"Active, not recruiting",COVID-19,,,,,,,Drug: REGN10933+REGN10987 combination therapy|Drug: Placebo,Regeneron Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",1164.0,Industry,Interventional,2020-12-15,04/03/21,2021-08-13,14/12/20,16/03/21,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Canoga Park, California, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Rolling Hills Estates, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Santa Monica, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Saint Petersburg, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Haven, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Iowa City, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, Shreveport, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Durham, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Amarillo, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Splendora, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Falls Church, Virginia",United States,Respiratory Diseases,1,1,241.0
3973.0,NCT04257656,A Trial of Remdesivir in Adults With Severe COVID-19,,Terminated,COVID-19,Remdesivir,COVID-19,,,,,Drug: Remdesivir|Drug: Remdesivir placebo,Capital Medical University,All,"18 Years and older   (Adult, Older Adult)",237.0,Other,Interventional,2020-06-02,30/03/20,2020-10-04,06/02/20,15/04/20,"Bin Cao, Beijing, Beijing",China,Respiratory Diseases,1,3,124.0
3974.0,NCT04799808,"Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis Patients, Solid Organ Recipients and Staff",DIA-Vacc,Recruiting,COVID-19,Active Immunization,Immune Response,Immunosuppression,,,,,"Technische Universität Dresden|Universitätsklinikum Leipzig|Klinikum St. Georg gGmbH|Charite University, Berlin, Germany|DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH / Dresden|DRK-Blutspendedienst Nord-Ost gemeinnützige GmbH / Institut Plauen",All,"18 Years to 100 Years   (Adult, Older Adult)",2500.0,Other,Observational,2021-01-15,15/07/22,2022-12-31,16/03/21,16/03/21,"Univercity Hospital Carl Gustav Carus, Dresden, Saxony",Germany,Respiratory Diseases,1,4,715.0
3975.0,NCT04397172,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,,Recruiting,COVID-19,Corona Virus Infection,Sars-CoV2,,,,,Procedure: Study Arm,"University Hospital Inselspital, Berne",All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-09-04,01/04/21,2021-01-12,21/05/20,22/05/20,"Inselspital Bern, Bern",Switzerland,Respiratory Diseases,1,3,130.0
3976.0,NCT04371523,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,PROVIDE,Not yet recruiting,Corona Virus Infection,,,,,,,Drug: Apo-Hydroxychloroquine|Drug: Matched Placebo,St. Joseph's Healthcare Hamilton,All,"18 Years and older   (Adult, Older Adult)",1100.0,Other,Interventional,2020-01-05,31/07/20,2020-08-30,01/05/20,01/05/20,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,Respiratory Diseases,1,1,238.0
3977.0,NCT04459364,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,,Completed,"Hypertension, Pulmonary",Right Ventricular Overload,COVID-19,,,,,,Attgeno AB,All,"18 Years and older   (Adult, Older Adult)",67.0,Industry,Observational,2020-01-06,07/07/20,2020-07-15,07/07/20,11/01/21,"Karolinska University Hospital, Stockholm",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,3,191.0
3978.0,NCT04769284,Psychological State of Students of Health Sciences During COVID-19,,Completed,"Stress, Psychological",Anxiety,Depression,COVID-19,,,,Other: Mental health student,Yolanda Marcen Roman|Universidad de Zaragoza|Instituto de Investigación Sanitaria Aragón,All,"Child, Adult, Older Adult",332.0,Other,Observational,2021-12-02,20/02/21,2021-02-21,24/02/21,24/02/21,"Faculty of Health Sciences. Zaragoza's University, Zaragoza",Spain,"Mental Health, Respiratory Diseases",1,4,-284.0
3979.0,NCT04629989,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,,Completed,COVID-19,Hypoxemia,,,,,,Other: Standard Oxygen Delivery System|Other: Double-Trunk Mask|Other: Surgical Mask,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,"18 Years and older   (Adult, Older Adult)",27.0,Other,Interventional,2020-11-13,05/03/21,2021-05-03,16/11/20,09/03/21,"Cliniques universitaires Saint-Luc, Brussels",Belgium,Respiratory Diseases,1,2,171.0
3980.0,NCT04442152,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,,Enrolling by invitation,Gender Relations,Partner Communication,Division of Carework,Couple Conflict,Stress,,,Behavioral: MenCare+/Bandebereho fathers'/couples' group education,"Promundo, United States|Rwanda Men's Resource Center (Rwamrec)|Ministry of Health/Rwanda Biomedical Center",All,26 Years to 40 Years   (Adult),1000.0,Other,Interventional,2020-01-06,01/08/20,2020-01-08,22/06/20,22/06/20,"Rwanda Men's Resource Centre (Rwamrec), Kigali",Rwanda,Mental Health,1,5,2.0
3981.0,NCT04412330,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,OPTIMAL,Recruiting,COVID-19,Critical Illness,Post Intensive Care Unit Syndrome,Muscle Weakness,,,,Other: ICU Recovery + Physical Therapy,University of Kentucky|Ashley Montgomery-Yates,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-05,01/05/21,2021-01-05,02/06/20,24/06/20,"University of Kentucky, Lexington, Kentucky",United States,"Cardiovascular Diseases, Respiratory Diseases",1,4,366.0
3982.0,NCT04368793,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,,Recruiting,COVID-19,Pulmonary Rehabilitation,,,,,,Behavioral: Remote pulmonary rehabilitation,China-Japan Friendship Hospital|Wuhan lung Hospital|Wuhan Central Hospital|Wuhan University|Ai You Foundation,All,"20 Years to 85 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-06-04,31/12/20,2021-12-31,30/04/20,17/07/20,"Wuhan Lung Hospital, Wuhan, Hubei, China|Wuhan Central Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei",China,Respiratory Diseases,1,2,575.0
3983.0,NCT04372680,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,INVICTUS,Recruiting,COVID-19,"ARDS, Human",Mechanical Ventilation,,,,,Diagnostic Test: CTUS examination,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-22,22/10/21,2021-10-22,04/05/20,04/03/21,"CHU de LIMOGES, Limoges, France|CHU de TOULOUSE, Toulouse",France,Respiratory Diseases,1,3,548.0
3984.0,NCT04791462,COVID-19 in Osteoarthritis Patients,,Not yet recruiting,Osteoarthritis,,,,,,,,"University Hospital, Montpellier",All,"18 Years to 100 Years   (Adult, Older Adult)",500.0,Other,Observational,2021-10-03,30/12/21,2021-12-30,10/03/21,10/03/21,"Uhmontpellier, Montpellier",France,Others,0,1,88.0
3985.0,NCT04285190,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,,Withdrawn,Coronavirus Disease 2019,COVID-19,,,,,,Drug: T89,"Tasly Pharmaceuticals, Inc.",All,"18 Years to 85 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-02-26,15/04/20,2020-04-20,26/02/20,16/06/20,,,Respiratory Diseases,1,2,54.0
3986.0,NCT04616989,Mental Health in Communities Affected by COVID-19 in Uganda,,Not yet recruiting,Community Mental Health,,,,,,,Behavioral: Psycho-education|Behavioral: Comparator,Makerere University,All,"18 Years and older   (Adult, Older Adult)",840.0,Other,Interventional,2021-01-01,30/06/21,2021-07-30,05/11/20,06/01/21,,,Others,0,1,210.0
3987.0,NCT04842448,Safety and Efficacy of Hyperbaric Oxygen Therapy for Long COVID Syndrome,HOT-LoCO,Not yet recruiting,COVID-19,,,,,,,Drug: Hyperbaric oxygen|Procedure: Sham treatment,Karolinska University Hospital|Karolinska Institutet|Karolinska Trial Alliance,All,18 Years to 60 Years   (Adult),80.0,Other,Interventional,2021-01-06,01/06/22,2023-01-12,13/04/21,13/04/21,"Karolinska University Hospital, Stockholm",Sweden,Respiratory Diseases,1,1,736.0
3988.0,NCT04447534,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Chloroquine|Drug: zinc,Tanta University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-06-23,01/10/30,2030-01-10,25/06/20,03/12/20,"Tanta university hospital, Assuit University, Ainshams University, Tanta",Egypt,Respiratory Diseases,1,1,3488.0
3989.0,NCT04430322,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,COMETE-19,Recruiting,COVID-19,,,,,,,,Centre Hospitalier Régional Metz-Thionville,All,"Child, Adult, Older Adult",330.0,Other,Observational,2020-01-03,31/12/20,2021-06-30,12/06/20,18/06/20,"CHR Metz Thionville, Metz",France,Respiratory Diseases,1,1,544.0
3990.0,NCT04370678,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,,Completed,Arthroscopy,,,,,,,Behavioral: Change in preference to surgery under COVID-19 pandemic.,Region Zealand,All,"18 Years and older   (Adult, Older Adult)",79.0,Other,Observational,2020-04-17,24/04/20,2020-04-24,01/05/20,07/05/20,"Zealand University Hospital, Køge, Zealand Region",Denmark,Others,0,1,7.0
3991.0,NCT04406571,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,CAPANCOVID-19,Recruiting,Pancreatic Adenocarcinoma,,,,,,,Other: Data record,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-01-04,01/11/21,2022-01-04,28/05/20,28/05/20,"Damien JOLLY, Reims",France,Others,0,1,731.0
3992.0,NCT04359901,Sarilumab for Patients With Moderate COVID-19 Disease,,"Active, not recruiting",COVID-19,,,,,,,Biological: SARILUMAB,Westyn Branch-Elliman|VA Boston Healthcare System,All,"18 Years and older   (Adult, Older Adult)",50.0,U.S. Fed,Interventional,2020-10-04,01/04/22,2023-01-04,24/04/20,08/03/21,"VA Connecticut Healthcare System, West Haven, Connecticut, United States|VA Maine Healthcare System, Augusta, Maine, United States|VA Boston Healthcare System, Boston, Massachusetts, United States|Providence VA Medical Center, Providence, Rhode Island, United States|VA Medical Center - White River Junction, White River Junction, Vermont",United States,Respiratory Diseases,1,1,822.0
3993.0,NCT04507230,COVID-19 Associated Coagulopathy in Egypt,,Completed,Coagulopathy,,,,,,,,Assiut University,All,"Child, Adult, Older Adult",106.0,Other,Observational,2020-07-08,31/10/20,2020-10-31,11/08/20,11/03/21,"Assiut University Hospitals, Assiut",Egypt,Others,0,1,115.0
3994.0,NCT04522089,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,,Recruiting,COVID-19,,,,,,,Biological: AdimrSC-2f,Adimmune Corporation,All,20 Years to 60 Years   (Adult),70.0,Industry,Interventional,2020-08-24,20/11/20,2021-03-20,21/08/20,13/01/21,"National Taiwan University Hospital, Taipei",Taiwan,Respiratory Diseases,1,1,208.0
3995.0,NCT04447469,Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,,Recruiting,COVID-19,,,,,,,Drug: mavrilimumab|Other: Placebo,"Kiniksa Pharmaceuticals, Ltd.",All,"18 Years and older   (Adult, Older Adult)",588.0,Industry,Interventional,2020-07-27,01/12/21,2022-01-02,25/06/20,09/03/21,"UCLA Medical Center, Los Angeles, California, United States|Sharp Health Care, San Diego, California, United States|Affinity Health, Oak Brook, Illinois, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Allina Health System, Minneapolis, Minnesota, United States|Mercy Hospital, Springfield, Missouri, United States|University of Cincinnati, Cincinnati, Ohio, United States|Bryn Mawr, Bryn Mawr, Pennsylvania, United States|University of Texas Health Sciences, Houston, Texas, United States|Instituto Mário Penna, Belo Horizonte, Brazil|Hospital Adventista de Belem, Belém, Brazil|UPECLIN - Unidade de Pesquisa Clínica, Botucatu, Brazil|IPECC - Instituto de Pesquisa Clínica de Campinas, Campinas, Brazil|IEP HGF - Instituto de Estudos e Pesquisas Clinicas do Ceará, Fortaleza, Brazil|Hospital Bruno Born, Lajeado, Brazil|Centro de Pesquisas Clínicas, Natal, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, Brazil|Hospital Cardio Pulmonar, Salvador, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Clinica Providencia, Santiago, Chile|Clinica Las Condes, Santiago, Chile|Hospital Essalud Alberto Sabogal Sologuren, Bellavista, Peru|Essalud - Hospital de Emergencias Grau, Lima Cercado, Peru|Hospital Nacional Cayetano Heredia, San Martín De Porres, Peru|Clinica Providencia, San Miguel, Peru|IATROS International, Bloemfontein, South Africa|Tiervlei Trial Center, Cape Town, South Africa|TASK Eden, George, South Africa|Into Research - Little Company of Mary Medical Center, Pretoria, South Africa|Limpopo Clinical Research Initiative, Rustenburg",South Africa,Respiratory Diseases,1,1,524.0
3996.0,NCT04412239,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Coronavirus19,Recruiting,TB - Tuberculosis,Patient Satisfaction,,,,,,Behavioral: Patient-centred advice on Telephone Consultation in TB Patients:,Health Science Center of Xi'an Jiaotong University|Pakistan Institute of Medical Sciences Islamabad Pakistan|District Headquarter Hospital Bannu Pakistan,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-20,20/12/20,2020-12-20,02/06/20,18/11/20,"Dhq Bannu Kpk, Bannu, KPK, Pakistan|District Bannu TB Control Center, Bannu, KPK",Pakistan,Infectious Diseases,0,2,244.0
3997.0,NCT04604119,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,,Completed,Sars-CoV2,Anxiety,Burnout,,,,,,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",104.0,Other,Observational,2020-01-05,30/05/20,2020-01-06,27/10/20,28/10/20,"Sisli Hamidiye Etfal Education and Training Hospital, Istanbul",Turkey,"Mental Health, Respiratory Diseases",1,3,1.0
3998.0,NCT04838847,A Study to Evaluate the Immunogenicity and Safety of the SARS-CoV-2 mRNA Vaccine CVnCoV in Elderly Adults Compared to Younger Adults for COVID-19,,Not yet recruiting,Coronavirus,COVID-19,COVID-19,Severe Acute Respiratory Syndrome,,,,Biological: CVnCoV Vaccine,CureVac AG,All,"18 Years and older   (Adult, Older Adult)",180.0,Industry,Interventional,2021-05-14,01/08/21,2022-01-06,09/04/21,09/04/21,,,Respiratory Diseases,1,4,237.0
3999.0,NCT04432051,The Use of Lung Ultrasonography in COVID-19 Patients,,Recruiting,Ultrasonography,,,,,,,Behavioral: mechanical ventilator settings and position,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-26,08/08/20,2020-10-08,16/06/20,07/08/20,"Gazoosmanpasa Education and Research Hospital, Istanbul",Turkey,Others,0,1,135.0
4000.0,NCT04394390,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,COVIDVIT,Enrolling by invitation,COVID-19,,,,,,,Dietary Supplement: vitamin d,Bursa City Hospital,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-01-05,15/06/20,2020-06-30,19/05/20,19/05/20,"Bursa City Hospital, Bursa, Dogankoy",Turkey,Respiratory Diseases,1,1,177.0
4001.0,NCT04336787,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",,Not yet recruiting,COVID-19,Coronavirus Infection,Pregnancy Related,,,,,Other: Survey,Istanbul Kültür University|Istanbul University-Cerrahpasa,Female,18 Years to 45 Years   (Adult),100.0,Other,Observational,2020-12-04,10/05/20,2020-10-06,07/04/20,13/04/20,"Istanbul University - Cerrahpaşa, Istanbul",Turkey,Respiratory Diseases,1,3,-59.0
4002.0,NCT04424901,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,TOLD,Recruiting,COVID-19,Vascular Complications,,,,,,Drug: Dipyridamole,UConn Health,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-03-05,01/05/21,2021-05-30,11/06/20,11/06/20,"UConn Health, Farmington, Connecticut",United States,Respiratory Diseases,1,2,451.0
4003.0,NCT04579393,Fostamatinib for Hospitalized Adults With COVID-19,,"Active, not recruiting",Coronavirus Disease 2019,,,,,,,Drug: Placebo|Drug: fostamatinib,"National Heart, Lung, and Blood Institute (NHLBI)|National Institutes of Health Clinical Center (CC)",All,"18 Years and older   (Adult, Older Adult)",80.0,NIH,Interventional,2020-01-27,30/03/21,2021-06-30,08/10/20,09/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland, United States|INOVA Health Systems, Falls Church, Virginia",United States,Respiratory Diseases,1,1,520.0
4004.0,NCT04558450,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),CARTESIAN,Not yet recruiting,COVID-19,Arterial Stiffness,Endothelial Dysfunction,Diastolic Dysfunction,,,,Diagnostic Test: carotid-femoral pulse-wave velocity,"Assistance Publique - Hôpitaux de Paris|The Association for Research into Arterial Structure and Physiology|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Interventional,2020-01-09,01/06/22,2032-01-06,22/09/20,22/09/20,"CHU Lille, Lille, France|CHRU Nancy, Nancy, France|Hôpital Européen Georges Pompidou - APHP, Paris, France|CHU Rouen, Rouen",France,Respiratory Diseases,1,4,4380.0
4005.0,NCT04515147,"A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",,"Active, not recruiting",Coronavirus,COVID-19,COVID-19,Severe Acute Respiratory Syndrome,,,,Biological: CVnCoV 6 μg|Biological: CVnCoV 12 μg|Biological: Hepatitis A vaccine|Biological: Pneumococcal vaccine|Biological: CVnCoV 12μg,CureVac AG,All,"18 Years and older   (Adult, Older Adult)",674.0,Industry,Interventional,2020-09-28,09/11/21,2021-09-11,17/08/20,12/01/21,"Centro de vacunación internacional - CEVAXIN Panama Clinic, Panama city, Panama|Instituto de Investigación Nutricional, Lima",Peru,Respiratory Diseases,1,4,348.0
4006.0,NCT04511962,"Feasibility, of Tele-rehabilitation Following COVID-19",,Not yet recruiting,Pulmonary Disease,,,,,,,Other: Tele-Pulmonary rehabilitation,Hull University Teaching Hospitals NHS Trust,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-12-08,25/11/21,2022-01-20,13/08/20,13/08/20,"Castle Hill Hospital, Cottingham, East Yorkshire",United Kingdom,Others,0,1,408.0
4007.0,NCT04356495,Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation,COVERAGEFrance,Recruiting,Corona Virus Infection,Sars-CoV2,,,,,,Dietary Supplement: Vitamins|Drug: Telmisartan|Drug: Ciclesonide|Drug: interferon β-1b,"University Hospital, Bordeaux|University of Bordeaux",All,"50 Years and older   (Adult, Older Adult)",820.0,Other,Interventional,2020-07-29,15/08/21,2021-08-31,22/04/20,22/01/21,"CH de Bastia, Bastia, France|Bordeaux university Hospital, Bordeaux, France|CHU de Dijon-Bourgogne, Dijon, France|CHU de Montpellier, Montpellier, France|CHRU de Nancy, Nancy, France|Groupe hospitalier Paris Saint Joseph, Paris, France|IMEA, Paris, France|CHU de Toulouse, Toulouse",France,Respiratory Diseases,1,2,398.0
4008.0,NCT04473898,Telerehabilitation After Coronavirus,,Completed,COVID-19,,,,,,,Other: Aerobic Exercise Training|Behavioral: Patient Education|Other: Respiratory Exercise Training,KTO Karatay University,All,"25 Years to 70 Years   (Adult, Older Adult)",35.0,Other,Interventional,2020-06-19,19/10/20,2021-02-17,16/07/20,18/02/21,"KTO Karatay University, Konya, Karatay",Turkey,Respiratory Diseases,1,1,243.0
4009.0,NCT04625985,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",DMMETCOV19-2,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Drug: Metformin Glycinate|Drug: Placebo oral tablet,Laboratorios Silanes S.A. de C.V.,All,"18 Years and older   (Adult, Older Adult)",20.0,Industry,Interventional,2020-07-14,08/03/21,2021-03-18,12/11/20,08/04/21,"The American British Cowdray Medical Center, I.A.P, Mexico City",Mexico,Respiratory Diseases,1,1,247.0
4010.0,NCT04343651,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,,"Active, not recruiting",Coronavirus Disease 2019,,,,,,,Drug: Placebos|Drug: Leronlimab (700mg),"CytoDyn, Inc.",All,"18 Years to 99 Years   (Adult, Older Adult)",86.0,Industry,Interventional,2020-01-04,21/07/20,2020-08-31,13/04/20,20/08/20,"University of California, Los Angeles, Los Angeles, California, United States|Palmtree Clinical Research, Inc., Palm Springs, California, United States|Eisenhower Health, Rancho Mirage, California, United States|Yale, New Haven, Connecticut, United States|Center for Advanced Research & Education (CARE), Gainesville, Georgia, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Atlantic Health System Hospital, Morristown, New Jersey, United States|Montefiore Medical Center, Bronx, New York, United States|White Plains Hospital, White Plains, New York, United States|Novant Health, Charlotte, North Carolina, United States|Ohio Health, Columbus, Ohio, United States|Oregon Health and Science University, Portland, Oregon",United States,Respiratory Diseases,1,1,240.0
4011.0,NCT04542330,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,,Recruiting,COVID-19,Non-specific Effects of Vaccines,Heterologous Immunity,Morbidity,Immunosenescence,Vaccine Preventable Disease,,Biological: BCG-Denmark|Biological: Saline,Bandim Health Project|Odense Patient Data Explorative Network|Odense University Hospital|Municipality of Odense,All,65 Years to 110 Years   (Older Adult),1900.0,Other,Interventional,2020-09-15,01/01/22,2022-01-03,09/09/20,24/11/20,"Seniorhuset, Odense",Denmark,Respiratory Diseases,1,6,475.0
4012.0,NCT04373811,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,COVENTRY,"Active, not recruiting",COVID-19,ICU Acquired Weakness,Weaning Failure,,,,,Diagnostic Test: Lung ultrasound|Diagnostic Test: Muscle ultrasound,Groupe Hospitalier Paris Saint Joseph|Hopital Forcilles,All,"18 Years to 100 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-04-16,13/07/21,2021-07-13,04/05/20,18/02/21,"Centre Hospitalier de Béthune, Beuvry, Hauts-de-France, France|APHP - Hôpital Universitaire Pitié-Salpétrière, Paris, Ile De France, France|Hôpital Forcilles, Férolles-Attilly, Ile-de-France",France,Respiratory Diseases,1,3,453.0
4013.0,NCT04558476,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,CONFIDENT,Recruiting,COVID-19,Mechanical Ventilation Complication,Corona Virus Infection,Respiratory Failure,SARS (Severe Acute Respiratory Syndrome),,,Biological: Convalescent Plasma|Other: Standard of Care,University of Liege|KCE,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-01-09,01/09/22,2022-01-09,22/09/20,22/09/20,"OLVZ Aalst, Aalst, Belgium|UZ Antwerpen, Antwerp, Belgium|Imelda ZH Bonheiden, Bonheiden, Belgium|AZ Sint-Jan Brugge, Bruges, Belgium|CHU Saint Pierre, Brussels, Belgium|Erasme, Brussels, Belgium|UZ Brussel, Brussel, Belgium|CHU Charleroi Marie Curie, Charleroi, Belgium|AZ Sint Blasius, Dendermonde, Belgium|UZ Gent, Gent, Belgium|AZ Groeningen Kortrijck, Kortrijk, Belgium|CHR Citadelle, Liège, Belgium|CHU Liège, Liège, Belgium|UC Louvain, Louvain, Belgium|AZ Delta, Roeselare, Belgium|CHU UCL Namur-Godinne, Yvoir",Belgium,Respiratory Diseases,1,5,731.0
4014.0,NCT04658433,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,,Recruiting,Cardiovascular Risk Factor,COVID-19,,,,,,Dietary Supplement: 300 mg of omega3-FA,Applied Science Private University,All,"35 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-12,15/02/21,2021-03-30,08/12/20,08/12/20,"Mahmoud S Abu-Samak, Amman",Jordan,Respiratory Diseases,1,2,322.0
4015.0,NCT04373291,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,,"Active, not recruiting",COVID-19,Non-specific Effects of Vaccines,Morbidity,Absenteeism,Heterologous Immunity,,,Biological: BCG-Denmark|Biological: Saline,Bandim Health Project|University of Southern Denmark,All,"18 Years to 100 Years   (Adult, Older Adult)",1293.0,Other,Interventional,2020-05-18,31/07/21,2021-12-31,04/05/20,02/02/21,"Hvidovre Hospital, Hvidovre",Denmark,Respiratory Diseases,1,5,592.0
4016.0,NCT04472728,Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,COVA,Recruiting,COVID-19,SARS-CoV2,,,,,,Drug: BIO101|Drug: Placebo,Biophytis,All,"45 Years and older   (Adult, Older Adult)",310.0,Industry,Interventional,2020-06-16,01/07/21,2021-01-09,15/07/20,23/02/21,"Abrazo Health, Phoenix, Arizona, United States|University of California, Irvine, Irvine, California, United States|Barnum Medical Research, Inc. 1029 Keyser Ave Suite H, Natchitoches, Louisiana, United States|Beaumont Health, Royal Oak, Michigan, United States|United Health Services Hospitals, Johnson City, New York, United States|WellSpan Health, York, Pennsylvania, United States|CHU Saint-Pierre, Brussels, Belgium|CHU Saint-Pierre, Brussel, Belgium|AZ-Sint Maarten, Mechelen, Belgium|CHU CLU Namur (Saint-Elisabeth) Place Louise Godin, Namur, Belgium|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Santa Casa de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Municipal de Barueri Dr. Francisco Moran, Barueri, São Paulo, Brazil|Hospital e Maternidade Celso Pierro - PUCCAMP, Campinas, São Paulo, Brazil|Hospital de Base Da Faculdade de Medicina de São José Do Rio Preto, São José Do Rio Preto, São Paulo, Brazil|Avenida Dr. Enéas de Carvalho Aguiar, 44 - Centro de Pesquisa Clínica Prof. Dr. Fúlvio Pileggi - Bloco 1 - 1º Andar, São Paulo, Brazil|Unité ambulatoire Service de Pneumologie, Médecine Intensive et Réanimation (SPMIR) 47-83 Boulevard de l'Hôpital, Paris, Paris Cedex 13, France|Centre Hospitalier Argenteuil, Argenteuil, France|Centre Hospitalier Universitaire Bordeaux, Bordeaux, France|Centre Hospitalier Rene Dubos, Cergy-Pontoise, France|Centre Hospitalier Départemental de Vendée, La Roche-sur-Yon, France|Hôpital Pitié-Salpêtrière, 47 bd de l'Hôpital, 75013 Paris, Paris, France|FDI Clinical Research - San Juan City Hospital, San Juan",Puerto Rico,Respiratory Diseases,1,2,207.0
4017.0,NCT04377412,Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,MindCOVID,Recruiting,Anxiety,Depression,Pregnancy Related,,,,,Other: Pandemic control measures,"Żelazna Medical Centre, LLC|University of Medicine, Tirana|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Czech Republic|Hôpital Necker-Enfants Malades|Charite University, Berlin, Germany|Chinese University of Hong Kong|Meir Medical Center|Università degli Studi di Brescia|American University of Beirut Medical Center|Karolinska Institutet|Pomeranian Medical University Szczecin|Nicolaus Copernicus University|Centre of Postgraduate Medical Education|Polish Academy of Sciences|Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland|Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal ""iMaterna"", Madrid|Taiji Clinic, Taipei|Wayne State University|Chang Gung University|University of Tromso",Female,"18 Years and older   (Adult, Older Adult)",8500.0,Other,Observational,2020-01-05,31/08/20,2020-10-31,06/05/20,06/05/20,"Wayne State University, Detroit, Michigan, United States|University of Medicine Tirana, Tirana, Albania|Royal Prince Alfred Hospital, Sydney, Australia|Charles University, Prague, Czechia|Université de Paris, Paris, France|Charité - University Medicine Berlin, Berlin, Germany|The Chinese University of Hong Kong, Hong Kong, Hong Kong|Meir Medical Center, Kafr Saba, Israel|University of Brescia, Brescia, Italy|American University of Beirut, Beirut, Lebanon|The Arctic University of Norway, Tromsø, Norway|Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland|Pomeranian Medical University, Szczecin, Poland|Centre of Postgraduate Medical Education, Warsaw, Poland|11. Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal iMaterna, Madrid, Spain|Karolinska Institutet, Stockholm, Sweden|Taiji Clinic, Taipei",Taiwan,Mental Health,1,3,300.0
4018.0,NCT04405869,Thromboembolic Events in Severe COVID-19 Patients,COVICLOT,Recruiting,Pulmonary Thromboembolism,,,,,,,,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-29,01/04/21,2021-01-04,28/05/20,29/05/20,"Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil, Strasbourg",France,Others,0,1,250.0
4019.0,NCT04605926,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,EQUINOX,Withdrawn,Coronavirus,,,,,,,Biological: EQ001|Biological: EQ001 Placebo,Equillium|Biocon Limited,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-11,01/04/21,2021-01-06,28/10/20,27/01/21,"Inv Site CO01, Medellín",Colombia,Respiratory Diseases,1,1,361.0
4020.0,NCT04370210,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,CONFIDODO,Completed,Sleep Disturbance,,,,,,,Behavioral: Questionnaires,Centre Hospitalier René Dubos,All,7 Years to 12 Years   (Child),247.0,Other,Observational,2020-04-05,04/06/20,2020-04-06,30/04/20,02/07/20,"Centre Hospitalier René Dubos, Pontoise",France,Others,0,1,1.0
4021.0,NCT04840953,"Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients",,Completed,Subcutaneous Emphysema,COVID-19,,,,,,Device: Vçac,Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,All,"Child, Adult, Older Adult",2.0,Other,Observational,2020-01-12,01/01/21,2021-01-02,12/04/21,12/04/21,"Hospital General Universitario de Elche, Elche, Alicante",Spain,Respiratory Diseases,1,2,356.0
4022.0,NCT04575597,Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),,Recruiting,COVID-19,,,,,,,Drug: Molnupiravir|Drug: Placebo,Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",1450.0,Industry,Interventional,2020-10-19,23/06/21,2021-12-26,05/10/20,12/04/21,"Phoenix Medical Group ( Site 1822), Peoria, Arizona, United States|Ruane Clinical Research Group, Inc. ( Site 2406), Los Angeles, California, United States|Men's Health Foundation ( Site 1820), Los Angeles, California, United States|UC Davis Medical Center ( Site 1833), Sacramento, California, United States|Emerson Clinical Research Institute ( Site 1828), Washington, District of Columbia, United States|Midway Immunology and Research Center ( Site 1837), Fort Pierce, Florida, United States|Indago Research & Health Center, Inc ( Site 1809), Hialeah, Florida, United States|Advanced Research For Health Improvement LLC ( Site 1816), Immokalee, Florida, United States|Advanced Research For Health Improvement LLC ( Site 1813), Naples, Florida, United States|Bliss Healthcare Services ( Site 1847), Orlando, Florida, United States|Javara Inc. ( Site 1869), Albany, Georgia, United States|IACT Health ( Site 1818), Columbus, Georgia, United States|Javara Inc. ( Site 1868), Fayetteville, Georgia, United States|Loretto Hospital ( Site 1886), Chicago, Illinois, United States|University of Nebraska Medical Center ( Site 2414), Omaha, Nebraska, United States|University of New Mexico, Health Sciences Center ( Site 1819), Albuquerque, New Mexico, United States|Saint Hope Foundation, Inc. ( Site 1830), Bellaire, Texas, United States|The Crofoot Research Center, Inc. ( Site 1812), Houston, Texas, United States|Javara Inc. ( Site 1866), Sugar Land, Texas, United States|Swedish Medical Center First Hill ( Site 1807), Seattle, Washington, United States|Multicare Health System ( Site 1811), Spokane, Washington, United States|Multicare Health System ( Site 1814), University Place, Washington, United States|Chronos Pesquisa Clínica ( Site 0155), Brasilia, Distrito Federal, Brazil|Santa Casa de Misericordia de Belo Horizonte ( Site 0150), Belo Horizonte, Minas Gerais, Brazil|Hospital de Clinicas da Universidade Federal do Parana ( Site 0154), Curitiba, Parana, Brazil|Hospital Tacchini ( Site 0157), Bento Goncalves, Rio Grande Do Sul, Brazil|Instituto de Infectologia Emilio Ribas ( Site 0153), Sao Paulo, Brazil|University Health Network - Toronto General Hospital ( Site 0201), Toronto, Ontario, Canada|Clinica Universidad de los Andes ( Site 0302), Santiago, Region M. De Santiago, Chile|Fundacion Arturo Lopez Perez ( Site 0305), Santiago, Region M. De Santiago, Chile|Espacio EME ( Site 0304), Santiago, Region M. De Santiago, Chile|Clinica Bicentenario Spa ( Site 0306), Santiago, Region M. De Santiago, Chile|Hospital Pablo Tobon Uribe ( Site 0405), Medellin, Antioquia, Colombia|Clinica de la Costa Ltda. ( Site 0403), Barranquilla, Atlantico, Colombia|Oncomedica S.A. ( Site 0407), Monteria, Cordoba, Colombia|Caja de Compensación Familiar CAFAM. Sede Centro de Atención en Salud CAFAM Floresta ( Site 0406), Bogota, Cundinamarca, Colombia|Fundacion Cardiovascular de Colombia ( Site 0402), Bucaramanca, Santander, Colombia|Fundacion Valle del Lili ( Site 0401), Cali, Valle Del Cauca, Colombia|Groupe Hospitalier Pellegrin ( Site 0511), Bordeaux, Gironde, France|C.H.U. de Toulouse Hopital Purpan ( Site 0501), Toulouse, Midi-Pyrenees, France|Centre Hospitalier de Tourcoing ( Site 0502), Tourcoing, Nord, France|CHU Hopital Saint Antoine ( Site 0505), Paris, France|Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 0504), Paris, France|Hopital Bichat Claude Bernard ( Site 0503), Paris, France|Universitaetsklinikum Essen ( Site 2305), Essen, Baden-Wurttemberg, Germany|Universitaetsklinikum Frankfurt ( Site 2302), Frankfurt a main, Hessen, Germany|ZIBP-Zentrum fur Infektiologie Berlin Prenzlauer Berg GmbH ( Site 2301), Berlin, Germany|Hadassah Medical Center. Ein Kerem ( Site 2100), Jerusalem, Israel|ASST Fatebenefratelli-Ospedale Sacco ( Site 0601), Milano, Italy|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0802), Ciudad de mexico, Distrito Federal, Mexico|Hospital Regional de Alta Especialidad del Bajio ( Site 0807), Leon, Guanajuato, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0803), Monterrey, Nuevo Leon, Mexico|Lung Center of the Philippines ( Site 0902), Quezon City, National Capital Region, Philippines|Central Scientific Research Institute of Epidemiology ( Site 1104), Moscow, Moskva, Russian Federation|Central Clinical Hospital with Polyclinic ( Site 1105), Moscow, Moskva, Russian Federation|Medical Research Institute LLC ( Site 1116), Saint Petersburg, Sankt-Peterburg, Russian Federation|St.Petersburg Outpatient Clinic #109 ( Site 1119), Saint-Petersburg, Sankt-Peterburg, Russian Federation|Limited liability company Scientific research center Eco-safety ( Site 1117), Saint-Petersburg, Sankt-Peterburg, Russian Federation|Smolensk State Medical University ( Site 1110), Smolensk, Smolenskaya Oblast, Russian Federation|Strategic Medical System LLC ( Site 1114), Saint-Petersburg, Russian Federation|IATROS International ( Site 1212), Bloemfontein, Free State, South Africa|Mzansi Ethical Research Centre ( Site 1225), Mpumalanga, Gauteng, South Africa|Jongaie Research ( Site 1223), Pretoria-West, Gauteng, South Africa|Wits Baragwanath Clinical Trial Site ( Site 1214), Soweto, Gauteng, South Africa|Enhancing Care Foundation-DICRS ( Site 1216), Durban, Kwazulu-Natal, South Africa|Limpopo Clinical Research Initiative ( Site 1227), Thabazimbi, Limpopo, South Africa|TREAD Research ( Site 1211), Cape Town, Western Cape, South Africa|Desmond Tutu HIV Foundation Clinical Trial Unit ( Site 1219), Cape Town, Western Cape, South Africa|Be Part Yoluntu Centre ( Site 1218), Paarl, Western Cape, South Africa|Clinical Projects Research Centre ( Site 1215), Worcester, Western Cape, South Africa|Hospital General Universitario Gregorio Maranon ( Site 1302), Madrid, Madrid, Comunidad De, Spain|CAP Sardenya - Barcelona ( Site 1307), Barcelona, Spain|Hospital Clinic ( Site 1304), Barcelona, Spain|Hospital Universitari Germans Trias i Pujol ( Site 1303), Barcelona, Spain|Hospital Universitario Ramon y Cajal ( Site 1301), Madrid, Spain|Hospital Universitario La Paz ( Site 1300), Madrid, Spain|Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital ( Site 1605), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNE Central city clinical hospital of Ivano-Frankivsk city council ( Site 1604), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|MNE Ivano-Frankivsk Regional Phthisiology-Pulmonology Center ( Site 1603), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|Non profit municipal enterprise City hospital student of Kharkiv city council ( Site 1621), Kharkiv, Kharkivska Oblast, Ukraine|LLC Adonis plus ( Site 1619), Kyiv, Kyivska Oblast, Ukraine|Kyiv railway clinical hospital 2 of Branch Health center ( Site 1602), Kyiv, Kyivska Oblast, Ukraine|ARTEM. State Holding Company ( Site 1618), Kyiv, Kyivska Oblast, Ukraine|Layton Medical Centre ( Site 1705), Blackpool, Lancashire (England), United Kingdom|Royal Free London NHS Foundation Trust ( Site 1700), London, London, City Of, United Kingdom|King's College Hospital ( Site 1707), London, London, City Of, United Kingdom|Newcastle upon Tyne Hospitals NHS Foundation Trust ( Site 1704), Newcastle upon Tyne",United Kingdom,Respiratory Diseases,1,1,433.0
4023.0,NCT04494386,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,ULSC,Recruiting,COVID-19,Corona Virus Infection,SARS-CoV Infection,ARDS,Coronavirus,,,Biological: Umbilical Cord Lining Stem Cells (ULSC)|Other: Placebo (carrier control),"Restem, LLC.",All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-07-23,30/10/21,2021-12-30,31/07/20,09/03/21,"Miami Baptist Hospital, Miami, Florida, United States|Sanford Research, Sioux Falls, South Dakota",United States,Respiratory Diseases,1,5,525.0
4024.0,NCT04371562,Predicting Death and ICU Admission in COVID-19 Patients in ED,,Completed,COVID-19,,,,,,,,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-03,31/03/20,2020-04-15,01/05/20,05/05/20,"Marcello Covino, Roma, RM",Italy,Respiratory Diseases,1,1,103.0
4025.0,NCT04382924,Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,,"Active, not recruiting",COVID-19,,,,,,,Drug: NP-120 (Ifenprodil),Algernon Pharmaceuticals|Novotech (Australia),All,"18 Years and older   (Adult, Older Adult)",682.0,Industry|Other,Interventional,2020-05-08,01/01/22,2022-01-02,11/05/20,10/12/20,"Westchester Research Center, Miami, Florida, United States|Affinity Health - Loretto Hospital, Chicago, Illinois, United States|Heartland Regional Medical Center, Saint Joseph, Missouri, United States|Promedica Health: Toledo Hospital and BayPark Hospital, Toledo, Ohio, United States|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Makati Medical Center, Manila, Philippines|Philippine General Hospital, Manila, Philippines|Lung Center of the Philippines, Quezon City, Philippines|National Institute of Infectious Diseases, Bucharest",Romania,Respiratory Diseases,1,1,604.0
4026.0,NCT04306055,Blood Donor Recruitment During Epidemic of COVID-19,,Completed,Blood Donation,,,,,,,Other: Questionnaire with precaution information|Other: Experimental: Questionnaire without precaution information,Guangzhou Blood Center,All,18 Years to 60 Years   (Adult),19491.0,Other,Interventional,2020-03-13,13/03/20,2020-03-04,12/03/20,13/04/20,"Guangzhou Blood Center, Guangzhou, Guangdong",China,Others,0,1,-9.0
4027.0,NCT04678024,Sensitivity Evaluation of Serological Tests for Covid-19,COVIDIAGNOSTIX,Enrolling by invitation,COVID-19,,,,,,,,Istituto Ortopedico Galeazzi,All,"Child, Adult, Older Adult",410.0,Other,Observational,2020-11-18,01/08/21,2021-01-11,21/12/20,24/12/20,"Istituto Ortopedico Galeazzi, Milan",Italy,Respiratory Diseases,1,1,54.0
4028.0,NCT04701502,Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19,,Completed,COVID-19,Respiratory Disease,Immune System,Immunomodulator,Antiseptic,Supportive Care,,Dietary Supplement: Viusid|Dietary Supplement: Asbrip|Drug: Standard Care,Catalysis SL,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2020-09-11,15/02/21,2021-02-15,08/01/21,26/02/21,"MBAL, Sv. Mina, Plovdiv, Bulgaria|MTB Plovdiv, Plovdiv",Bulgaria,Respiratory Diseases,1,6,157.0
4029.0,NCT04362956,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,,Completed,COVID-19,Pregnancy Related,Neonatal Infection,,,,,,Fundacion Infant,Female,"Child, Adult, Older Adult",114.0,Other,Observational,2020-10-07,01/10/20,2020-01-10,27/04/20,09/02/21,"Hospital Italiano, Buenos Aires",Argentina,Respiratory Diseases,1,3,-271.0
4030.0,NCT04350086,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,PRODEX,Withdrawn,COVID-19,Sars-cov-2,Respiratory Failure,Palliative Situation,,,,Drug: Treatment with Dexmedetomidine,"University Hospital, Limoges",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-20,20/11/20,2020-11-20,16/04/20,02/09/20,"University Hospital, Limoges",France,Respiratory Diseases,1,4,214.0
4031.0,NCT04400019,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),PREVICHARM,Not yet recruiting,Sars-CoV2,Coronavirus Infection,Prevention & Control,Nursing Home,Hydroxychloroquine,,,Drug: Hydroxychloroquine Only Product in Oral Dose Form,University of Malaga|Instituto de Investigacion Biomedica de Malaga|Carlos III Health Institute,All,"18 Years and older   (Adult, Older Adult)",1930.0,Other,Interventional,2020-01-09,15/12/20,2021-01-04,22/05/20,29/09/20,,,Respiratory Diseases,1,5,361.0
4032.0,NCT04466982,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,ODYSSI,Recruiting,Olfactory Disorder,COVID-19,COVID-19,Anosmia,Microsomia,Smell Disorder,Quality of Life,,Cambridge University Hospitals NHS Foundation Trust|Imperial College Healthcare NHS Trust|Royal Cornwall Hospitals Trust,All,"18 Years to 85 Years   (Adult, Older Adult)",90.0,Other,Observational,2020-02-07,01/08/21,2022-01-01,10/07/20,14/12/20,"Addenbrookes Hospital, Cambridge, United Kingdom|Charing Cross Hospital, London, United Kingdom|Royal Cornwall Hospital, Truro",United Kingdom,Respiratory Diseases,1,7,694.0
4033.0,NCT04681859,Evaluation of a Low-cost CPAP Device on Hospitalized COVID-19 Patients,OxyJet-CPAP,Not yet recruiting,COVID-19,Hypoxemia,,,,,,Device: High Flow Nasal Oxygen (HFNO) treatment|Device: Continuous Positive Airway Pressure (CPAP) therapy using OxyJet,Bangladesh University of Engineering and Technology|Dhaka Medical College,All,18 Years to 60 Years   (Adult),40.0,Other,Interventional,2021-01-04,01/07/21,2021-01-07,23/12/20,05/04/21,"Dhaka Medical College, Dhaka",Bangladesh,Respiratory Diseases,1,2,3.0
4034.0,NCT04433949,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,RESCUE1-19,Recruiting,Pneumonia,Severe Acute Respiratory Syndrome,COVID-19,,,,,Other: Best Practice|Radiation: Low Dose Radiation Therapy,Emory University,All,"18 Years and older   (Adult, Older Adult)",52.0,Other,Interventional,2020-12-06,30/05/22,2022-05-30,16/06/20,16/06/20,"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia",United States,Respiratory Diseases,1,3,540.0
4035.0,NCT04469634,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,ImmCoV,"Active, not recruiting",SARS-CoV2,COVID-19,,,,,,"Diagnostic Test: Assessing antibody responses, neutralizing capacity and memory B-cell function","Institute of Tropical Medicine, Belgium|Jessa Hospital|University Hospital, Antwerp|Universiteit Antwerpen|Sciensano|Mensura",All,"18 Years to 99 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-07-31,01/07/21,2021-01-07,14/07/20,06/01/21,"University Hospital Antwerp, Antwerpen, Belgium|Jessa Hospital, Hasselt",Belgium,Respiratory Diseases,1,2,160.0
4036.0,NCT04371419,COVID-19 Health Messaging to Underserved Communities,,Completed,Coronavirus,,,,,,,Behavioral: Messaging,"National Bureau of Economic Research, Inc.|Massachusetts General Hospital|Stanford University|Yale University|Massachusetts Institute of Technology|Harvard University",All,"18 Years and older   (Adult, Older Adult)",15475.0,Other,Interventional,2020-05-13,24/05/20,2020-05-24,01/05/20,19/06/20,"JPAL North America, Cambridge, Massachusetts",United States,Respiratory Diseases,1,1,11.0
4037.0,NCT04773756,Evaluation of Sofosbuvir and Daclatasvir Combo in COIVD-19 Patients in Egypt,,Completed,COVID-19,,,,,,,Drug: Sofosbuvir 400 MG/ Daclatasvir 60mg,Alexandria University,All,"12 Years to 90 Years   (Child, Adult, Older Adult)",54.0,Other,Interventional,2020-01-11,30/11/20,2020-12-12,26/02/21,26/02/21,"Amr Aly Abd elmoety, Alexandria",Egypt,Respiratory Diseases,1,1,336.0
4038.0,NCT04355429,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),CAPTOCOVID,Not yet recruiting,Pneumonia,Coronavirus Infection,COVID-19,,,,,Drug: captopril 25mg,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Interventional,2020-05-05,01/07/20,2020-01-08,21/04/20,28/04/20,"CH Victor Dupuy- Argenteuil, Argenteuil, France|Hôpital Avicenne,, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Avicenne, Bobigny, France|Hôpital Antoine Béclère, Clamart, France|CH de Compiègne-Noyon, Compiègne, France|Groupe hospitalier Sud Ile de France, Melun, France|Hôpital de la Pitié- Salpêtrière, Paris, France|Hôpital Tenon, Paris, France|CHRU de Tours, Hôpital Bretonneau, Tours, France|Hôpital de Tours, Tours",France,Respiratory Diseases,1,3,-118.0
4039.0,NCT04750343,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 1|Biological: GBP510 (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose) - Stage 1|Biological: GBP510 (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with AS03 (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with AS03 (RBD 25μg/dose)- Stage 2|Biological: GBP510 (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,"SK Bioscience Co., Ltd.|Coalition for Epidemic Preparedness Innovations|GlaxoSmithKline|SK Chemicals Co., Ltd.",All,"19 Years to 85 Years   (Adult, Older Adult)",320.0,Industry|Other,Interventional,2021-03-02,01/07/21,2022-01-06,11/02/21,11/02/21,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea",Republic of,Respiratory Diseases,1,1,310.0
4040.0,NCT04742738,Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With Aluminum Hydroxide (COVID-19),,Recruiting,COVID-19,,,,,,,Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1|Other: Normal saline (0.9% sodium chloride solution) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose) - Stage 1|Biological: GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 2|Biological: GBP510 adjuvanted with Alum (RBD 25μg/dose)- Stage 2|Other: Normal saline (0.9% sodium chloride solution)- Stage 2,"SK Bioscience Co., Ltd.|Coalition for Epidemic Preparedness Innovations|SK Chemicals Co., Ltd.",All,"19 Years to 85 Years   (Adult, Older Adult)",260.0,Industry|Other,Interventional,2021-01-20,01/08/21,2022-01-04,08/02/21,08/02/21,"Korea University Ansan Hospital, Ansan, Korea, Republic of|Inha University Hospital, Incheon, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea",Republic of,Respiratory Diseases,1,1,349.0
4041.0,NCT04602637,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,,"Active, not recruiting",Monitor Training Load,,,,,,,Other: Training load,Kine Kinesiologia Deportiva y Funcional,Male,"Child, Adult, Older Adult",3.0,Other,Observational,2019-12-15,15/12/20,2021-01-15,26/10/20,26/10/20,"KINÉ kinesiología deportiva y funcional, Caba",Argentina,Others,0,1,397.0
4042.0,NCT04336215,Rutgers COVID-19 Cohort Study,,Recruiting,Coronavirus,COVID-19,,,,,,Other: Non-Interventional,"Rutgers, The State University of New Jersey",All,"20 Years and older   (Adult, Older Adult)",750.0,Other,Observational,2020-07-04,01/05/21,2021-10-21,07/04/20,10/02/21,"Clinical Research Center Rutgers-Robert Wood Johnson Medical School RWJUH East Tower -, New Brunswick, New Jersey, United States|Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States|Clinical Research Unit Rutgers New Jersey Medical School, Newark, New Jersey, United States|Rutgers School of Dental Medicine, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, United States|RUCDR Infinite Biologics, Piscataway, New Jersey",United States,Respiratory Diseases,1,2,474.0
4043.0,NCT04544072,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,,Recruiting,SARS-CoV Infection,Antimicrobial Stewardship,Respiratory Tract Infections,Antibiotic Resistance,,,,,Universitair Ziekenhuis Brussel,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-05,01/12/20,2021-01-03,10/09/20,10/09/20,"UZ Brussel, Brussel",Belgium,Respiratory Diseases,1,4,364.0
4044.0,NCT04669054,Hospital Interns Psychological State During the COVID-19,RESICOV,"Active, not recruiting",COVID-19,Depression,"Stress Disorders, Post-Traumatic",,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Observational,2020-01-12,30/05/21,2021-07-30,16/12/20,16/12/20,"University hospital, Montpellier",France,"Mental Health, Respiratory Diseases",1,3,565.0
4045.0,NCT04357860,Clinical Trial of Sarilumab in Adults With COVID-19,SARICOR,Not yet recruiting,SARS-CoV 2,SARS,,,,,,Drug: Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA]|Drug: Sarilumab 400 MG/2.28 ML Subcutaneous Solution [KEVZARA]|Drug: Best available treatment,Maimónides Biomedical Research Institute of Córdoba|Consejería de Salud y Familias - Junta de Andalucía|Red Andaluza de Ensayos Clínicos en Enfermedades Infecciosas (Red ANCRAID),All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-04-27,27/07/20,2020-07-27,22/04/20,27/04/20,"Hospital Universitario Reina Sofía, Córdoba",Spain,Respiratory Diseases,1,2,91.0
4046.0,NCT04347512,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,TEACHCOVID,Withdrawn,COVID-19,,,,,,,Drug: Hydroxychloroquine and azithromycin treatment arm.|Drug: Hydroxychloroquine|Drug: Control arm,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-02-06,02/06/20,2020-02-06,15/04/20,04/06/20,,,Respiratory Diseases,1,1,0.0
4047.0,NCT04572438,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,COVIDTrach,Recruiting,Tracheostomy Complication,COVID-19,Ventilator Lung,,,,,Procedure: Tracheostomy,"University College, London",All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2020-01-08,01/04/21,2021-01-08,01/10/20,01/10/20,"University College London NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,3,366.0
4048.0,NCT04351399,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,PRPsyCOVID,Completed,Sars-CoV2,Rheumatic Diseases,Rheumatoid Arthritis,Chronic Pain,,,,Other: questionnaire assesment,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",318.0,Other,Observational,2020-04-27,04/05/20,2020-04-05,17/04/20,11/12/20,"Hopital Roger Salengro, CHU Lille, Lille",France,"Respiratory Diseases, Immunological Disorders",1,4,-22.0
4049.0,NCT04273763,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),,"Active, not recruiting",COVID-19,COVID-19,,,,,,Drug: Bromhexine Hydrochloride Tablets|Drug: Arbidol Hydrochloride Granules|Drug: Recombinant Human Interferon α2b Spray,"Second Affiliated Hospital of Wenzhou Medical University|Wanbangde Pharmaceutical Group Co., LTD",All,"18 Years to 80 Years   (Adult, Older Adult)",18.0,Other|Industry,Interventional,2020-02-16,10/05/20,2020-01-06,18/02/20,01/05/20,"The Second AffIliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang",China,Respiratory Diseases,1,2,-41.0
4050.0,NCT04538456,Impact of COVID-19 on Lung Cancer Patients,,Recruiting,Lung Cancer,PROM,COVID-19,Psychological,,,,Other: questionnaire and optional interview,The Christie NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-10-15,01/04/21,2021-01-04,04/09/20,29/01/21,"The Christie NHS Foundation, Manchester",United Kingdom,"Respiratory Diseases, Cancers",1,4,81.0
4051.0,NCT04720404,Mindful Prevention of Psychopathology in Healthcare Workers During the COVID-19 Crisis (COVID-19 MindPreP),,Recruiting,Mindfulness,Randomized Controlled Trial,Psychopathology,Health Personnel,,,,Behavioral: Mindfulness-Based Stress Reduction|Other: Self-help mindfulness/compassion exercises|Other: Support as usual,Radboud University,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2020-06-23,01/02/22,2022-01-02,22/01/21,22/01/21,"Radboud university medical center, Nijmegen",Netherlands,Others,0,4,558.0
4052.0,NCT04381377,Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19,,"Active, not recruiting","Infections, Coronavirus",,,,,,,Drug: azoximer bromide|Other: Placebo,NPO Petrovax,All,"18 Years to 85 Years   (Adult, Older Adult)",394.0,Industry,Interventional,2020-04-29,01/04/21,2021-01-04,08/05/20,16/02/21,"Regional state budgetary institution of public health City hospital No. 5 of Barnaul, Barnaul, Russian Federation|Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation|The state healthcare institution of the city of Moscow City Clinical Hospital No. 15 named after OM Filatov in Moscow City Department of Health, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution Infectious Clinical Hospital No. 1 of the Moscow Department of Healthcare, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution City Clinical Hospital No. 24 of the Moscow Department of Healthcare, Moscow, Russian Federation|State budgetary institution Research Institute of Emergency Care named after N.V. Sklifosovsky in Department of Health of the city of Moscow, Moscow, Russian Federation|Moscow State Budgetary Healthcare Institution City Clinical Hospital No. 40 of the Moscow Department of Healthcare, Moscow, Russian Federation|State budgetary institution of health care of the Nizhny Novgorod region Infectious clinical hospital No. 2 of Nizhny Novgorod, Nizhny Novgorod, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Orenburg State Medical University of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation|Federal State Budgetary Educational Institution of Higher Education First St. Petersburg State Medical University named after Academician I.P. Pavlov, Saint Petersburg, Russian Federation|State budgetary health institution of the Vladimir region Regional Clinical Hospital, Vladimir, Russian Federation|Yaroslavl State Medical University of Ministry of Health of the Russian Federation, Yaroslavl, Russian Federation|Clinics of Infectious Diseases, University Hospital in Nitra, Nitra, Slovakia|Clinics of Infectious Diseases, University Hospital in Trnava, Trnava",Slovakia,Respiratory Diseases,1,1,250.0
4053.0,NCT04448756,Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE),,Recruiting,Coronavirus Disease 2019,,,,,,,Drug: M5049|Drug: Placebo,"EMD Serono Research & Development Institute, Inc.|Merck KGaA, Darmstadt, Germany|EMD Serono",All,"18 Years to 75 Years   (Adult, Older Adult)",150.0,Industry,Interventional,2020-07-29,06/06/21,2021-06-06,26/06/20,01/04/21,"University of Alabama-Birmingham Hospital, Birmingham, Alabama, United States|LAC-USC Medical Center, Los Angeles, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Henry Ford Medical Center, Detroit, Michigan, United States|Saint Louis University - Saint Louis University Hospital, Saint Louis, Missouri, United States|Holy Name Hospital - Dept of Multiple Sclerosis Comp Care Center, Teaneck, New Jersey, United States|Christus Spohn Hospital Corpus Christi-Memorial, Corpus Christi, Texas, United States|Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil|Hospital Dia do Pulmão, Blumenau, Brazil|Hospital São José - Sociedade Literária e Caritativa Santo Agostinho, Criciúma, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|HMCG - Hospital e Maternidade Dr. Christovão da Gama, Santo André, Brazil|Pesquisare, Santo André, Brazil|Hospital Leforte Morumbi, Sao Paulo, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, Brazil|Hospital Bandeirantes / Hospital Leforte Liberdade, São Paulo, Brazil|Instituto de Infectologia Emílio Ribas, São Paulo, Brazil|Lung Center of the Philippines - Medicine, Quezon",Philippines,Respiratory Diseases,1,1,312.0
4054.0,NCT04362319,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,,Completed,"Burnout, Professional",Depression,Medical Errors,COVID-19,,,,Diagnostic Test: Questionnaire forms,"University of Malaya|Ministry of Health, Malaysia",All,"18 Years and older   (Adult, Older Adult)",85.0,Other,Observational,2020-05-15,31/05/20,2020-05-31,24/04/20,16/06/20,"Sungai Buloh Hospital, Sungai Buloh, Selangor",Malaysia,"Mental Health, Respiratory Diseases",1,4,16.0
4055.0,NCT04451317,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,PhysiCOVID,Recruiting,Physical Activity,COVID-19,,,,,,"Other: Questionnaire, phone call","University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-12-06,01/08/21,2021-01-08,30/06/20,27/10/20,"CHU Toulouse, Toulouse",France,Respiratory Diseases,1,2,33.0
4056.0,NCT04399746,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,IvAzCol,Recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: Azithromycin|Drug: Cholecalciferol,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,All,"18 Years to 90 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-03-15,20/05/20,2020-10-06,22/05/20,22/05/20,"Outpatient treatment, Mexico City",Mexico,Respiratory Diseases,1,1,205.0
4057.0,NCT04583449,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,,Recruiting,Viral Infection,COVID-19,,,,,,Behavioral: Mental imagery,University of East London|University of Manchester,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2020-08-19,01/12/20,2020-01-12,12/10/20,12/10/20,"University of East London, London",United Kingdom,Respiratory Diseases,1,2,-220.0
4058.0,NCT04379453,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,,Recruiting,Coronary Artery Disease,,,,,,,Procedure: Robot Assisted Percutaneous Cardiovascular Intervention,Hospital Israelita Albert Einstein,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-27,27/04/20,2020-04-27,07/05/20,08/05/20,"Hospital Israelita Albert Einstein, São Paulo",Brazil,Cardiovascular Diseases,1,1,0.0
4059.0,NCT04357977,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,,Not yet recruiting,Coronavirus,COVID-19,,,,,,Diagnostic Test: RBA-2,"Kaligia Biosciences, LLC|University of South Florida",All,"18 Years and older   (Adult, Older Adult)",300.0,Industry|Other,Observational,2020-01-04,01/08/20,2020-01-12,22/04/20,22/04/20,"Tampa General Hospital, Tampa, Florida, United States|University of South Florida, Tampa, Florida, United States|AdventHealth Tampa, Tampa, Florida",United States,Respiratory Diseases,1,2,8.0
4060.0,NCT04476992,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,NICOR,"Active, not recruiting",Hypoxemia,"Pneumonia, Viral",Coronavirus Infection,,,,,Drug: Nitric Oxide-Sessions|Drug: Nitric Oxide-Continuous and Sessions,Tomsk National Research Medical Center of the Russian Academy of Sciences|Siberian State Medical University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-07-24,17/07/21,2021-09-17,20/07/20,06/04/21,"Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, Tomsk",Russian Federation,Respiratory Diseases,1,3,420.0
4061.0,NCT04785807,STRESS From in Charge Relative Facing the Announcement of Decisions Limiting or Stopping Treatments in Emergency Room During the COVID-19 Epidemic,COVER ACC,Not yet recruiting,COVID-19,Post Traumatic Stress Disorder,Anxiety,,,,,"Other: Post traumatic, Anxiety and depression evaluation",Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Interventional,2021-01-03,01/01/22,2022-01-01,08/03/21,08/03/21,,,"Mental Health, Respiratory Diseases",1,3,363.0
4062.0,NCT04415060,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,SAVE-ICU,Recruiting,COVID-19,Hypoxic Respiratory Failure,,,,,,Drug: Isoflurane Inhalant Product|Drug: Sevoflurane inhalant product,Sunnybrook Health Sciences Centre,All,"18 Years and older   (Adult, Older Adult)",752.0,Other,Interventional,2020-06-15,15/06/23,2023-06-15,04/06/20,14/04/21,"University of Alberta Hospital, Edmonton, Alberta, Canada|London Health Sciences Centre - University Hospital, London, Ontario, Canada|London Health Sciences Centre - Victoria Hospital, London, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network - Toronto General Hospital, Toronto, Ontario, Canada|University Health Network - Toronto Western Hopsital, Toronto, Ontario, Canada|Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada|McGill University Health Centre - Royal Victoria Hospital, Montréal, Quebec, Canada|Hôpital Sacré-Coeur de Montréal, Montréal, Quebec, Canada|Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ), Québec, Quebec, Canada|Universite de Sherbrooke, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,2,1095.0
4063.0,NCT04769349,Effectiveness of Supportive Housing on COVID-19 Related Outcomes for People Experiencing Homelessness,,Recruiting,Housing,COVID-19,Mental Health,Physical Health,Social Interaction,Healthcare,,,"University of Southern California|University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2021-01-29,15/12/21,2022-12-15,24/02/21,24/02/21,"Los Angeles Homeless Services Authority (LAHSA), Los Angeles, California",United States,Respiratory Diseases,1,6,685.0
4064.0,NCT04498507,Psychosocial Outcomes in Families of COVID-19 ICU Patients,,Completed,Critical Illness,Family,Psychological Stress,COVID-19,,,,Diagnostic Test: HADS questionnaire,University of Liege,All,"18 Years and older   (Adult, Older Adult)",39.0,Other,Observational,2020-04-16,30/10/20,2020-10-30,04/08/20,03/11/20,"University Hospital of Liège, Liège",Belgium,"Mental Health, Cardiovascular Diseases, Respiratory Diseases",1,4,197.0
4065.0,NCT04445220,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,,Recruiting,COVID-19,Acute Kidney Injury,,,,,,Biological: SBI-101,"Sentien Biotechnologies, Inc.",All,"18 Years and older   (Adult, Older Adult)",22.0,Industry,Interventional,2020-11-19,01/06/21,2021-01-12,24/06/20,16/03/21,"University of New Mexico School of Medicine, Albuquerque, New Mexico",United States,Respiratory Diseases,1,2,54.0
4066.0,NCT04703270,Understanding COVID-19 Infection in Pregnant Women and Their Babies,periCOVID,Recruiting,Corona Virus Infection,Pregnancy Related,Neonatal Infection,Breastfeeding,,,,,"St George's, University of London",Female,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2021-04-01,03/01/23,2023-03-01,11/01/21,11/01/21,"St George's, University of London, London",United Kingdom,Respiratory Diseases,1,4,699.0
4067.0,NCT04487171,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,COVIE-19/20,Recruiting,Postpartum Depression,COVID-19,Prevalence,Social Distance,,,,Other: Questionnaire,"Centre Hospitalier Universitaire, Amiens|Centre Hospitaler Beauvais|Central Hospital Saint Quentin|Centre Hospitalier Compiègne",Female,"18 Years and older   (Adult, Older Adult)",248.0,Other,Interventional,2020-07-21,01/07/21,2021-01-08,27/07/20,27/07/20,"CHU Amiens, Amiens",France,"Mental Health, Respiratory Diseases",1,4,171.0
4068.0,NCT04334512,A Study of Quintuple Therapy to Treat COVID-19 Infection,HAZDpaC,Recruiting,COVID-19,Corona Virus Infection,Coronavirus-19,Sars-CoV2,,,,Drug: Hydroxychloroquine|Drug: Azithromycin|Dietary Supplement: Vitamin C|Dietary Supplement: Vitamin D|Dietary Supplement: Zinc,ProgenaBiome|DSCS CRO,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-06-22,01/06/21,2021-01-09,06/04/20,08/04/21,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,4,201.0
4069.0,NCT04471831,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",,Not yet recruiting,Corona Virus Infection,Stroke,,,,,,Other: Rehabilitation exercise protocol,"University of Lagos, Nigeria",All,"18 Years to 120 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-13,21/06/21,2021-12-31,15/07/20,15/07/20,,,"Cardiovascular Diseases, Respiratory Diseases",1,2,536.0
4070.0,NCT04736004,Hearts of Athletes,,Not yet recruiting,COVID-19,,,,,,,,Duke University|The Joel Cornette Foundation,All,18 Years to 30 Years   (Adult),500.0,Other,Observational,2021-05-15,30/04/22,2022-04-30,03/02/21,08/04/21,"Duke University, Durham, North Carolina",United States,Respiratory Diseases,1,1,350.0
4071.0,NCT04349098,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Coronavirus,Completed,Coronavirus Infection,,,,,,,Drug: Selinexor|Other: Placebo,Karyopharm Therapeutics Inc,All,"18 Years and older   (Adult, Older Adult)",202.0,Industry,Interventional,2020-04-17,05/10/20,2020-05-10,16/04/20,24/12/20,"UCLA, Los Angeles, California, United States|Kaiser Permanente Oakland, Oakland, California, United States|UC Davis Health, Sacramento, California, United States|Kaiser Permanente Sacramento, Sacramento, California, United States|Kaiser Permanente San Francisco, San Francisco, California, United States|Miami Cancer Institute at Baptist Health, Miami, Florida, United States|Emory University, Atlanta, Georgia, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Norton Healthcare, Louisville, Kentucky, United States|Boston Medical Center, Boston, Massachusetts, United States|Karmanos, Detroit, Michigan, United States|Michigan Center of Medical Research, Farmington Hills, Michigan, United States|Michigan Center of Medical Research, Royal Oak, Michigan, United States|Columbia University, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Levine Cancer Institute-Atrium Health University City, Charlotte, North Carolina, United States|Lehigh Valley Hospital, Allentown, Pennsylvania, United States|Baylor Scott & White Dallas, Dallas, Texas, United States|MultiCare Institute for Research & Innovation (Puget Sound), Tacoma, Washington, United States|Hospital Hietzing, 2. Medical department - Center for Diagnosis and Therapy of Rheumatic Diseases, Vienna, Austria|CHU Bordeaux, Bordeaux, France|CHU Lyon, Lyon, France|CHU Nantes, Nantes, France|Hadassah MC, Jerusalem, Israel|Hasharon Medical Center, Petah Tiqva, Israel|Sheba Medical Center, Tel HaShomer, Israel|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Servicio de Medicina Interna, Hospital Universitario de Salamanca, Universidad de Salamanca, Salamanca, Spain|Princess Royal University Hospital, Kent, United Kingdom|Kings College Hospital, London, United Kingdom|The Royal Marsden Hospital, London, United Kingdom|University Hospitals Plymouth NHS Trust, Plymouth",United Kingdom,Respiratory Diseases,1,1,23.0
4072.0,NCT04581889,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in Tübingen Children,Coro-Buddy,Recruiting,Severe Acute Respiratory Syndrome,,,,,,,Other: Diagnostic test,University Hospital Tuebingen,All,"1 Year to 18 Years   (Child, Adult)",2380.0,Other,Observational,2020-02-07,01/07/21,2021-01-12,09/10/20,14/10/20,"Institute of Tropical Medicine, Tübingen, Deutschland",Germany,Others,0,1,340.0
4073.0,NCT04462783,Emergency Department (ED) Self-Monitoring Pilot COVID-19,,Not yet recruiting,COVID-19,COVID-19,SARS-CoV 2,,,,,Other: Symptoms entered into the CovidX application,University of Michigan|Vironix Health Incorporated,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-04,01/08/21,2021-01-09,08/07/20,30/03/21,,,Respiratory Diseases,1,3,5.0
4074.0,NCT04748471,Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y),CoviCompareM,Not yet recruiting,COVID-19,,,,,,,Biological: mRNA-1273,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2021-10-02,01/07/21,2023-01-25,10/02/21,10/02/21,,,Respiratory Diseases,1,1,480.0
4075.0,NCT04501991,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,,Completed,Type 2 Diabetes,Metabolic Control,,,,,,Other: antidiabetic treatment,University of Pisa,All,"18 Years to 85 Years   (Adult, Older Adult)",114.0,Other,Observational,2020-11-03,04/05/20,2020-06-30,06/08/20,06/08/20,"University of Pisa, Pisa",Italy,Metabolic Disorders,1,2,-126.0
4076.0,NCT04371393,MSCs in COVID-19 ARDS,,"Active, not recruiting",Mesenchymal Stromal Cells,Remestemcel-L,Acute Respiratory Distress Syndrome,COVID-19,,,,Biological: Remestemcel-L|Drug: Placebo,"Icahn School of Medicine at Mount Sinai|Mesoblast, Inc.|National Heart, Lung, and Blood Institute (NHLBI)",All,"18 Years and older   (Adult, Older Adult)",223.0,Other|Industry|NIH,Interventional,2020-04-30,14/01/21,2022-01-02,01/05/20,05/04/21,"Dignity Health, Gilbert, Arizona, United States|University of Southern California, Los Angeles, California, United States|Stanford University, Stanford, California, United States|Emory University, Atlanta, Georgia, United States|Lutheran Hospital, Fort Wayne, Indiana, United States|Ochsner Clinic, New Orleans, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|University of Maryland, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Dartmouth-Hitchcock, Lebanon, New Hampshire, United States|New York University Langone Health, New York, New York, United States|Mount Sinai Health, New York, New York, United States|Northwell Health, New York, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|WakeMed, Raleigh, North Carolina, United States|Cleveland Clinic Foundation, Cleveland, Ohio, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States|Houston Methodist Hospital, Houston, Texas, United States|Baylor, Smith & White, Plano, Texas, United States|University of Virginia, Charlottesville, Virginia",United States,Respiratory Diseases,1,4,612.0
4077.0,NCT04355676,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,,Withdrawn,Coronavirus Infection,,,,,,,Drug: Selinexor,Karyopharm Therapeutics Inc,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-04-30,30/08/20,2020-08-30,21/04/20,07/12/20,,,Respiratory Diseases,1,1,122.0
4078.0,NCT04401527,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,,Withdrawn,COVID-19,Acute Respiratory Distress Syndrome,Acute Respiratory Failure,,,,,Drug: Sodium Nitrite|Drug: Normal Saline,Hope Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-07-22,15/08/20,2020-08-15,26/05/20,16/09/20,"Participating Research Facility, Tampa, Florida, United States|Participating Research Facility, Fort Worth, Texas",United States,Respiratory Diseases,1,3,24.0
4079.0,NCT04384731,Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Caards-1,Recruiting,COVID-19,"ARDS, Human",,,,,,Drug: poractant alfa,Dr Christophe LENCLUD|Versailles Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-05-29,29/05/21,2021-07-31,12/05/20,03/02/21,"CH Francois Quesnay, Mantes la Jolie",France,Respiratory Diseases,1,2,428.0
4080.0,NCT04324047,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,CORIMUNO-19,Recruiting,Corona Virus Infection,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-27,27/03/21,2021-12-31,27/03/20,01/04/20,"Kremlin Bictre APHP, Le Kremlin-Bicêtre, Ile De France, France|Cochin Aphp, Paris, Ile De France, France|Hegp Aphp, Paris, Ile De France",France,Respiratory Diseases,1,1,644.0
4081.0,NCT04288713,Eculizumab (Soliris) in Covid-19 Infected Patients,SOLID-C19,Available,Coronavirus,,,,,,,Drug: Eculizumab,Hudson Medical,All,"18 Years and older   (Adult, Older Adult)",,Other,Expanded Access:Individual Patients|Treatment IND/Protocol,,,,28/02/20,30/03/20,,,Respiratory Diseases,1,1,
4082.0,NCT04701489,UNITE Study (UMN-GE) for COVID-19,,Enrolling by invitation,COVID-19,Cytokine Storm,Inflammation,,,,,Device: Splenic ultrasound,University of Minnesota|General Electric Research|DARPA (Department of Defense),All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2021-01-14,01/04/21,2021-01-06,08/01/21,09/03/21,"M Health Fairview St. Joseph's Hospital, Saint Paul, Minnesota",United States,Respiratory Diseases,1,3,-8.0
4083.0,NCT04292964,Prognostic Factors of Patients With COVID-19,,Completed,COVID-19,"Outcome, Fatal",,,,,,,Chongqing Medical University,All,"18 Years and older   (Adult, Older Adult)",201.0,Other,Observational,2020-01-03,13/03/20,2020-03-13,03/03/20,17/03/20,"The First Affiliated Hospital of Chongqing Medical University, Chongqing",China,Respiratory Diseases,1,2,70.0
4084.0,NCT04433988,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,,Not yet recruiting,COVID-19,,,,,,,Drug: Pentoxifylline|Drug: Placebo,Sadat City University,All,18 Years to 60 Years   (Adult),200.0,Other,Interventional,2021-06-13,30/12/21,2021-12-30,16/06/20,05/01/21,"Faculty of Medicine, Shibīn Al Kawm",Egypt,Respiratory Diseases,1,1,200.0
4085.0,NCT04796064,Low Versus High-Intensity Aerobic Training in Community-dwelling Older Men With Post-COVID 19 (SARS-CoV-2) Sarcopenia,,Completed,Sarcopenia,,,,,,,Other: low-intensity aerobic training,Cairo University,Male,"60 Years to 80 Years   (Adult, Older Adult)",76.0,Other,Interventional,2020-03-30,05/11/20,2020-12-15,12/03/21,12/03/21,"Marwa Eid, Cairo",Egypt,Others,0,1,260.0
4086.0,NCT04766983,Incidence of VAP in Patients With Severe COVID-19,CoV-AP,Recruiting,Ventilator Associated Pneumonia,COVID-19,,,,,,Diagnostic Test: bronchoalveolar lavage,"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-22,31/01/22,2022-04-30,23/02/21,23/02/21,"IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation, Milan, MI",Italy,Respiratory Diseases,1,2,463.0
4087.0,NCT04361032,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",TRONCHER,Not yet recruiting,COVID-19,Intensive Care Unit,,,,,,Drug: Tocilizumab Injection|Drug: Deferoxamine,Abderrahmane Mami Hospital|Eshmoun Clinical Research Centre|Datametrix,All,"18 Years to 80 Years   (Adult, Older Adult)",260.0,Other,Interventional,2020-04-09,04/09/20,2020-04-10,24/04/20,27/08/20,"Eshmoun Clinical Research Centre/ Hôpital Abderrahmane Mami-Ariana, Ariana",Tunisia,Respiratory Diseases,1,2,1.0
4088.0,NCT04400058,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,,Completed,COVID-19,,,,,,,Biological: Octagam 10%|Other: Placebo,Octapharma,All,"18 Years and older   (Adult, Older Adult)",208.0,Industry,Interventional,2020-01-06,07/01/21,2021-01-31,22/05/20,10/03/21,"Octapharma Research Site, Sheffield, Alabama, United States|Octapharma Research Site, Loma Linda, California, United States|Octapharma Research Site, Loma Linda, California, United States|Octapharma Research Site, Newport Beach, California, United States|Octapharma Research Site, Orange, California, United States|Octapharma Research Site, San Diego, California, United States|Octapharma Research Site, Washington, District of Columbia, United States|Octapharma Research Site, Honolulu, Hawaii, United States|Octapharma Research Site, Iowa City, Iowa, United States|Octapharma Research Site, Covington, Louisiana, United States|Octapharma Research Site, Midland, Michigan, United States|Octapharma Research Site, Las Vegas, Nevada, United States|Octapharma Research Site, Minot, North Dakota, United States|Octapharma Research Site, Charleston, South Carolina, United States|Octapharma Research Site, Tyler, Texas, United States|Octapharma Research Site, Ivanovo, Russian Federation|Octapharma Research Site, Moscow, Russian Federation|Octapharma Research Site, Moscow, Russian Federation|Octapharma Research Site, Ryazan', Russian Federation|Octapharma Research Site, Ivano-Frankivs'k, Ukraine|Octapharma Research Site, Kharkiv, Ukraine|Octapharma Research Site, Kremenchuk",Ukraine,Respiratory Diseases,1,1,391.0
4089.0,NCT04808895,Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients With COVID-19,Asperum,Not yet recruiting,COVID-19,Thrombosis Pulmonary,,,,,,Drug: Acetylsalicylic acid|Drug: Placebo,Azienda Ospedaliera Universitaria Integrata Verona,All,"18 Years to 99 Years   (Adult, Older Adult)",204.0,Other,Interventional,2021-01-04,01/07/21,2021-08-31,22/03/21,22/03/21,"Azienda Ospedaliera Universitaria Integrata Verona, Verona",Italy,Respiratory Diseases,1,2,239.0
4090.0,NCT04613986,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,PExCoV,Not yet recruiting,COVID-19,,,,,,,Device: therapeutic plasmaexchnage,University of Zurich,All,"18 Years to 99 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-12,01/08/21,2021-01-12,03/11/20,03/11/20,,,Respiratory Diseases,1,1,366.0
4091.0,NCT04463004,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,,"Active, not recruiting",COVID-19,Sars-CoV2,Pneumonia,,,,,Drug: Mavrilimumab|Drug: Placebos,"Virginia Commonwealth University|Kiniksa Pharmaceuticals, Ltd.",All,"18 Years and older   (Adult, Older Adult)",2.0,Other|Industry,Interventional,2020-02-09,01/08/21,2021-01-08,09/07/20,17/02/21,"Virginia Commonwealth University, Richmond, Virginia",United States,Respiratory Diseases,1,3,334.0
4092.0,NCT04622865,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,,Recruiting,SARS-CoV 2,COVID-19,Coronavirus Disease 2019,,,,,Drug: Masitinib|Drug: Isoquercetin|Drug: Best Supportive Care,AB Science,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry,Interventional,2020-01-06,01/06/21,2021-01-06,10/11/20,10/11/20,"Centre Hospitalier du Pays d'Aix, Aix-en-Provence, France|Le Tripode, Groupe hospitalier Pellegrin CHU de Bordeaux, Bordeaux, France|CHU Clermont-Ferrand: Site Gabriel-Montpied, Clermont-Ferrand, France|Hopital Nord, AP-HM, Marseille, France|CHR Orleans, Hopital de la Source, Orléans, France|Hopital Larrey, CHU du Toulouse, Toulouse",France,Respiratory Diseases,1,3,366.0
4093.0,NCT04398277,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,,Recruiting,Psychological Stress,,,,,,,Behavioral: Daily Coping Toolkit,Kent State University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-01-05,01/04/21,2021-01-04,21/05/20,21/05/20,"Akron Children's Hospital, Akron, Ohio, United States|Summa Health Systems, Akron, Ohio, United States|Kent State University, Kent, Ohio",United States,Mental Health,1,1,365.0
4094.0,NCT04516941,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,CONVINCE,Not yet recruiting,SARS-CoV Infection,COVID-19,,,,,,Drug: Edoxaban Tablets|Drug: Colchicine Tablets,"University Hospital Inselspital, Berne|Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company",All,"18 Years and older   (Adult, Older Adult)",420.0,Other|Industry,Interventional,2020-01-10,01/10/21,2021-12-31,18/08/20,18/08/20,"Bern University Hospital, Bern, Switzerland|Ospedale regionale Lugano, Lugano",Switzerland,Respiratory Diseases,1,2,721.0
4095.0,NCT04594395,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,,Not yet recruiting,Healthy Volunteers,,,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years to 65 Years   (Adult, Older Adult)",2700.0,NIH,Observational,2021-04-19,31/12/23,2023-12-31,20/10/20,14/04/21,"Cambodian Center for Communicable Disease (CCDC), Ministry of Health (MOH), Phnom Penh, Cambodia|National Malaria Center (CNM), Ministry of Health (MOH), Phnom Penh",Cambodia,Others,0,1,986.0
4096.0,NCT04388657,"COVID-19, bLOod Coagulation and Thrombosis",CLOT,Recruiting,COVID-19,Embolism and Thrombosis,"Pneumonia, Viral",,,,,Diagnostic Test: Echo-Doppler,"Ramsay Générale de Santé|Hôpital Privé Jacques Cartier, service réanimation Dr Bougouin",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-05,01/09/20,2020-01-09,14/05/20,14/05/20,"Hôpital Ambroise Paré, Boulogne-Billancourt, IDF, France|Hôpital Privé Jacques Cartier, Massy, IDF, France|Centre Cardiologique du Nord, Saint-Denis, IDF",France,Respiratory Diseases,1,3,4.0
4097.0,NCT04760743,Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19),,"Active, not recruiting",COVID-19,,,,,,,Biological: NBP2001 adjuvanted with alum (RBD 30μg/dose)|Biological: NBP2001 adjuvanted with alum (RBD 50μg/dose)|Other: Normal Saline,"SK Bioscience Co., Ltd.|SK Chemicals Co., Ltd.",All,19 Years to 55 Years   (Adult),50.0,Industry,Interventional,2020-12-17,01/04/21,2022-01-04,18/02/21,18/02/21,"Seoul National University Bundang Hospital, Seongnam-si, Bundang, Korea, Republic of|Seoul National University Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,383.0
4098.0,NCT04394078,Impact of COVID-19 Pandemic on Depression and Quality of Life,,Completed,Depression,Quality of Life,COVID-19,Social Isolation,,,,Other: Online survey,Okan University|Yuksek Ihtisas University,All,"15 Years to 65 Years   (Child, Adult, Older Adult)",543.0,Other,Observational,2020-06-05,18/05/20,2020-05-18,19/05/20,11/06/20,"Okan University, Istanbul",Turkey,"Mental Health, Respiratory Diseases",1,4,-18.0
4099.0,NCT04570384,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,,Recruiting,Acute Hypoxemic Respiratory Failure,,,,,,,Drug: L-Citrulline|Drug: Placebo,"Asklepion Pharmaceuticals, LLC",All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-10-15,28/07/21,2021-10-28,30/09/20,14/04/21,"University of Arkansas for Medical Sciences, Little Rock, Arkansas",United States,Respiratory Diseases,1,1,378.0
4100.0,NCT04564274,COV2Base-A Rare Disease by COVID Study,,Recruiting,Chronic Health Conditions,Older Age is Associated With Increased Pathogenicity,,,,,,,"National Heart, Lung, and Blood Institute (NHLBI)|National Institutes of Health Clinical Center (CC)",All,"1 Month and older   (Child, Adult, Older Adult)",5000.0,NIH,Observational,2021-04-19,01/09/21,2021-01-09,25/09/20,14/04/21,"National Heart, Lung and Blood Institute (NHLBI), Bethesda, Maryland",United States,Others,0,2,-100.0
4101.0,NCT04347694,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,CONEC,Recruiting,SARS-CoV 2,Immunization; Infection,,,,,,,Medical University of Vienna,All,"18 Years to 100 Years   (Adult, Older Adult)",400.0,Other,Observational,2020-11-04,11/04/21,2021-11-04,15/04/20,02/09/20,"Medical University of Vienna, Division for Nephrology and Dialysis, Vienna",Austria,Respiratory Diseases,1,2,365.0
4102.0,NCT04575558,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,HOPE_BRAZIL,Withdrawn,Sars-CoV2,,,,,,,Drug: Hydroxychloroquine and Azithromycin,Latin American Cooperative Oncology Group|Oncoclínicas,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-06-30,01/09/20,2020-10-30,05/10/20,05/10/20,"Núcleo de Oncologia da Bahia - NOB, Salvador, BA, Brazil|Oncoclínicas BH, Belo Horizonte, MG, Brazil|Centro Oncológico do Triângulo - COT, Uberlândia, MG, Brazil|Multihemo, Recife, PE, Brazil|Oncoclinicas RJ, Rio De Janeiro, RJ, Brazil|Centro de Pesquisa em Oncologia PUCRS, Porto Alegre, RS, Brazil|Centro Paulista de Oncologia, São Paulo, SP",Brazil,Respiratory Diseases,1,1,122.0
4103.0,NCT04788355,Prevention of Complications (SARS-CoV-2): Clinical Study,,Completed,Complication,,,,,,,Drug: Control group (standard hospital treatment)|Drug: Group Hydroxychloroquine|Drug: Group Hydroxychloroquine and apixaban|Drug: Group Apixaban,Universidade do Vale do Sapucai|Pfizer|Apsen Farmaceutica S.A.|Dermadia|Methodos Laboratory|Biofarma,All,"18 Years and older   (Adult, Older Adult)",176.0,Other|Industry,Interventional,2020-01-07,15/11/20,2020-12-23,09/03/21,09/03/21,"Univás, Pouso Alegre, Minas Gerais",Brazil,Others,0,1,351.0
4104.0,NCT04605965,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,WEAICOR,Recruiting,COVID-19,Cardiovascular Complication,Behavioral Changes,,,,,,Tulane University|Biostrap,All,"18 Years to 120 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-09-06,01/06/22,2022-01-06,28/10/20,07/12/20,"Tulane University, TRIAD Center, New Orleans, Louisiana, United States|Tulane University, New Orleans, Louisiana",United States,Respiratory Diseases,1,3,487.0
4105.0,NCT04329195,ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic,ACORES-2,Terminated,COVID-19,,,,,,,Drug: 1: discontinuation of RAS blocker therapy|Drug: 2: continuation of RAS blocker therapy,Assistance Publique - Hôpitaux de Paris|Groupe Hospitalier Pitié-Salpêtrière,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2020-09-04,09/12/20,2021-09-01,01/04/20,09/04/21,"Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Paris",France,Respiratory Diseases,1,1,362.0
4106.0,NCT04654481,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,,Recruiting,Chronic Obstructive Pulmonary Disease,Chronic Cough,COVID-19,,,,,Device: HCFWO|Other: Standard Care Plus Monitoring,Icahn School of Medicine at Mount Sinai|International Biophysics Corporation|SPARK Healthcare,All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-01-12,01/02/21,2021-01-11,04/12/20,04/12/20,"Mount Sinai Beth Israel, New York, New York",United States,Respiratory Diseases,1,3,365.0
4107.0,NCT04694768,Implementation of Rehabilitation Program for Post COVID-19,,Recruiting,COVID-19,Rehabilitation,,,,,,Behavioral: Rehabilitation,Assiut University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,01/01/21,2021-01-31,05/01/21,05/01/21,"Aliae AR Mohamed-Hussein, Assiut, Egypt|Aliae AR Mohamed-Hussein, Assiut",Egypt,Respiratory Diseases,1,2,390.0
4108.0,NCT04357366,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),SAVE,Recruiting,COVID-19,Virus Diseases,Corona Virus Infection,Lower Respiratory Tract Infection Viral,,,,Drug: Anakinra,Hellenic Institute for the Study of Sepsis,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-04-15,15/04/22,2022-04-15,22/04/20,15/02/21,"COVID-19 Department, General Hospital of Attica SISMANOGLEIO-AMALIA FLEMING, Marousi, Athens, Greece|2nd Department of Internal Medicine, University General Hospital of Alexandroupolis, Alexandroupolis, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|1st Department of InternalMedicine, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Internal Medicine, General Hospital of Athens G. GENNIMATAS, Athens, Greece|1st University Department of Internal Medicine, General Hospital of Athens LAIKO, Athens, Greece|1st University Departmentof Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseasesof Athens, Athens, Greece|2nd University Department of Internal Medicine, IPPOKRATEION General Hospital of Athens, Athens, Greece|3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Internal Medicine, General Hospital of Chest Diseases of Athens I SOTIRIA, Athens, Greece|Department of Clinical Therapeutics, ALEXANDRA General Hospital of Athens, Athens, Greece|1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|1st Department of Internal Medicine, General Hospital of Nea Ionia CONSTANTOPOULIO-PATISION, Athens, Greece|1st Department of Internal Medicine, General Hospital of Voula ASKLEPIEIO, Athens, Greece|2nd Department of Internal Medicine, 251 Air Force General Hospital, Athens, Greece|2nd Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens, Greece|3rd Department of Internal Medicine, General Hospital of Athens KORGIALENEIO-BENAKEIO E.E.S., Athens, Greece|5th Department of Pulmonary Medicine, SOTIRIA General Hospital of Chest Diseases of Athens, Athens, Greece|Department of Internal Medicine, General Hospital of Athens ELPIS, Athens, Greece|Department of Infectious Diseases, General Hospital of Kerkira, Corfu, Greece|1st Department of Internal Medicine, General University Hospital of Ioannina, Ioánnina, Greece|Department of Internal Medicine, General Hospital of Katerini, Kateríni, Greece|Department of Internal Medicine, University General Hospital of Larissa, Larissa, Greece|Department of Internal Medicine, General Hospital of Larisa KOUTLIMBANEIO & ΤΡΙΑΝΤΑFΥLLΕΙΟ, Larissa, Greece|Department of Internal Medicine, University General Hospital of Patras PANAGIA I VOITHIA, Patra, Greece|2nd Department of Internal Medicine, General Hospital of Piraeus TZANEIO, Piraeus, Greece|1st Department of Internal Medicine, AHEPA University General Hospital of Thessaloniki, Thessaloníki",Greece,Respiratory Diseases,1,4,730.0
4109.0,NCT04794036,Efficacy of an Asynchronous Telerehabilitation Programme in Post-COVID-19 Patient,,Recruiting,Coronavirus,Fatigue,Musculoskeletal Complication,,,,,Other: Asynchronous telerehabilitation programme|Other: Rehabilitation programme,Universidad San Jorge|Hospital Real Nuestra Señora de Gracia|Hospital Royo Villanova,All,"18 Years to 75 Years   (Adult, Older Adult)",32.0,Other,Interventional,2021-05-04,30/06/21,2021-09-30,11/03/21,12/04/21,"Hospital Real Nuestra Señora de Gracia, Zaragoza, Spain|Hospital Royo Villanova, Zaragoza",Spain,Respiratory Diseases,1,3,149.0
4110.0,NCT04414657,USZ BioResource COVID,,Recruiting,COVID-19,,,,,,,Other: blood sampling for biobank,Regina Grossmann|University of Zurich,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-09-04,30/04/22,2022-04-30,04/06/20,04/06/20,"University Hospital Zurich, Clinical Trials Center, Zurich",Switzerland,Respiratory Diseases,1,1,603.0
4111.0,NCT04519385,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,,Completed,"Pneumonia, Viral",,,,,,,Drug: Tocilizumab|Drug: Dexamethasone,South Valley University,All,"18 Years and older   (Adult, Older Adult)",69.0,Other,Interventional,2020-01-03,01/07/20,2020-05-08,19/08/20,25/08/20,"Qena faculty medicine, Qinā",Egypt,Respiratory Diseases,1,1,126.0
4112.0,NCT04750356,"SARS-CoV-2 (COVID-19) Longitudinal Study: Understanding Susceptibility, Transmission and Disease Severity (Legacy Study)",,Recruiting,SARS-CoV Infection,,,,,,,,"University College, London|The Francis Crick Institute",All,"18 Years and older   (Adult, Older Adult)",6000.0,Other,Observational,2021-01-27,31/12/24,2024-12-31,11/02/21,11/02/21,"The Francis Crick Institute, London, United Kingdom|UCLH, London",United Kingdom,Respiratory Diseases,1,1,1434.0
4113.0,NCT04536350,Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS,,Not yet recruiting,COVID-19,Corona Virus Infection,ARDS,Aviptadil,,,,Drug: Aviptadil 67μg|Drug: Placebo 0.9% NaCl solution,"Prof. Dr. Jörg Leuppi|Cantonal Hosptal, Baselland",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-01,01/12/21,2022-01-03,02/09/20,09/11/20,"Cantonal Hospital Baselland Liestal, Liestal, BL, Switzerland|Cantonal Hospital St.Gallen, St.Gallen",Switzerland,Respiratory Diseases,1,4,367.0
4114.0,NCT04382950,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,,Not yet recruiting,COVID-19,,,,,,,Combination Product: Recombinant Bacterial ACE2 receptors -like enzyme of B38-CAP (rbACE2) plus Aerosolized 13 cis retinoic acid,Kafrelsheikh University,All,18 Years to 60 Years   (Adult),24.0,Other,Interventional,2020-01-07,01/11/20,2020-01-12,11/05/20,04/06/20,,,Respiratory Diseases,1,1,5.0
4115.0,NCT04546581,Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),,"Active, not recruiting",COVID-19,COVID-19,COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,Drug: Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)|Other: Placebo|Drug: Remdesivir,University of Minnesota|National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health (NIH)|The International Network for Strategic Initiatives in Global HIV Trials,All,"18 Years and older   (Adult, Older Adult)",593.0,Other|NIH,Interventional,2020-08-10,01/07/21,2021-01-07,14/09/20,15/02/21,"Penrose Hospital, Colorado Springs, Colorado, United States|St. Francis Health Services, Colorado Springs, Colorado, United States|St. Anthony Hospital, Lakewood, Colorado, United States|Saint Anthony North Health Campus, Westminster, Colorado, United States|Washington VA Medical Center, Washington, District of Columbia, United States|Redmond Regional Medical Center, Rome, Georgia, United States|National Institutes of Health Clinical Center, Bethesda, Maryland, United States|University of Massachusetts, Worcester, Massachusetts, United States|Hennepin Healthcare Research Institute/HCMC, Minneapolis, Minnesota, United States|University of Missouri, Columbia, Missouri, United States|Cox Medical Centers, Springfield, Missouri, United States|FirstHealth Moore Regional Hospital, Pinehurst, North Carolina, United States|Ohio Health Research Institute, Columbus, Ohio, United States|Hendrick Medical Center, Abilene, Texas, United States|CHRISTUS Spohn Shoreline Hospital, Corpus Christi, Texas, United States|University of Texas Southwestern Medical Center, Dallas, Texas, United States|CJW Chippenham Medical Center, Richmond, Virginia, United States|Henrico Doctors' Hospital (HCA), Richmond, Virginia, United States|Aarhus Universitetshospital, Skejby, Aarhus, Denmark|Bispebjerg Hospital, Copenhagen, Denmark|CHIP, Department of Infectious Diseases, Section 2100, Copenhagen, Denmark|Herlev-Gentofte Hospital, Hellerup, Denmark|Nordsjællands Hospital, Hillerød, Hillerød, Denmark|Hvidovre University Hospital, Department of Infectious Diseases, Hvidovre, Denmark|Kolding Sygehus, Kolding, Denmark|Odense University Hospital, Odense, Denmark|Democritus University of Thrace, Alexandroupoli, Thrace, Greece|3rd Dept of Medicine, Medical School, NKUA, Athens, Greece|1st Respiratory Medicine Dept, Athens University Medical School, Athens, Greece|Attikon University General Hospital, Athens, Greece|Dept. of Critical Care & Pulmonary Medicine, Evangelismos General Hospital, Athens, Greece|NCGM, Tokyo, Japan|Fujita Health University Hospital, Toyoake, Japan|Institute of Human Virology-Nigeria (IHVN), Abuja, Nigeria|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain|Hospital del Mar, Barcelona, Spain|Hospital Clínic de Barcelona, Barcelona, Spain|Royal Free Hospital, London",United Kingdom,Respiratory Diseases,1,4,150.0
4116.0,NCT04351503,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,,Recruiting,COVID-19,,,,,,,Other: Study A|Other: Study B|Other: Study C|Other: Study D,"University Hospital, Basel, Switzerland|sciCORE University of Basel|Leonhard Med IT ETH Zurich|Swiss Institute of Bioinformatics",All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-09-04,01/04/22,2022-01-04,17/04/20,11/06/20,"Viollier AG, Allschwil, Switzerland|University Hospital Basel, Basel, Switzerland|Biozentrum University of Basel, Basel, Switzerland|sciCore University of Basel, Basel, Switzerland|Department of Biosystems Science and Engineering ETH Zurich, Basel, Switzerland|Swiss Institute of Bioinformatics, Geneva",Switzerland,Respiratory Diseases,1,1,487.0
4117.0,NCT04445246,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,ILOCOVID,Recruiting,COVID-19,"ARDS, Human",Hypoxemic Respiratory Failure,,,,,Drug: Inhaled ILOPROST,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-05-23,31/05/21,2021-05-31,24/06/20,24/06/20,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,3,373.0
4118.0,NCT04344119,Assessment of Chilbains Occuring During Covid-19 Infection,ChilblainCOVID,Recruiting,Skin Manifestations,COVID-19,Chilblains,,,,,,Centre Hospitalier Universitaire de Nice,All,"up to 90 Years   (Child, Adult, Older Adult)",30.0,Other,Observational,2020-09-04,30/04/21,2021-04-30,14/04/20,20/01/21,"CHU de Nice, Nice",France,Respiratory Diseases,1,3,238.0
4119.0,NCT04390152,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,"Drug: Wharton's jelly derived Mesenchymal stem cells.|Drug: Hydroxychloroquine, lopinavir/ritonavir or azithromycin and placebo (standard therapy)",BioXcellerator|Clinical Somer,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-01-13,01/12/21,2022-01-04,15/05/20,15/01/21,"BioXcellerator, Medellin, Antioquia-CO, Colombia|Clinical Somer, Rionegro, Antioquia",Colombia,Respiratory Diseases,1,1,722.0
4120.0,NCT04401202,Nigella Sativa in COVID-19,,Recruiting,COVID-19,COVID-19,,,,,,Dietary Supplement: Nigella sativa,King Abdulaziz University,All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-21,31/12/20,2020-12-31,26/05/20,26/05/20,"King Abdulaziz University Hospital, Jeddah",Saudi Arabia,Respiratory Diseases,1,2,224.0
4121.0,NCT04772586,Sarcopenia and Mechanical Ventilation in Older Patients Admitted Due to COVID-19,SARCO-V,Recruiting,Sarcopenia,,,,,,,,Brugmann University Hospital,All,"60 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-01-09,01/03/22,2022-01-03,26/02/21,26/02/21,"Brugmann university hospital, Brussels",Belgium,Others,0,1,725.0
4122.0,NCT04794946,"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis",,Recruiting,Liver Cirrhosis,,,,,,,Biological: Covishield,"Institute of Liver and Biliary Sciences, India",All,18 Years to 60 Years   (Adult),2200.0,Other,Interventional,2021-03-19,19/03/22,2022-03-19,12/03/21,23/03/21,"Institute of Liver & Biliary Sciences, New Delhi, Delhi",India,Others,0,1,365.0
4123.0,NCT04587921,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,MoxiCov,Recruiting,Oximetry,COVID-19,,,,,,Device: Digital oximeter monitoring,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-06-22,22/01/21,2021-06-22,14/10/20,14/10/20,"Fundação Zerbini - Instituto do Coração (InCor), São Paulo, SP",Brazil,Respiratory Diseases,1,2,365.0
4124.0,NCT04584580,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: low-molecular-weight heparin,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-08,31/10/20,2020-12-31,14/10/20,14/10/20,"Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center, Cairo, Non-US",Egypt,Respiratory Diseases,1,1,358.0
4125.0,NCT04366856,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),PROVID,Recruiting,COVID-19,ARDS,,,,,,Behavioral: 1: Prone positioning|Behavioral: 2: No instruction regarding positioning,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 80 Years   (Adult, Older Adult)",500.0,Other,Interventional,2020-06-26,01/12/20,2021-01-01,29/04/20,19/08/20,"Département d'Anesthésie Réanimation - Kremlin Bicêtre, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,2,189.0
4126.0,NCT04792086,Disease Containment Measures Among Older Adults During the Covid-19 Pandemia,Co-AiT,Recruiting,Dementia,Cognitive Impairment,"Depression, Anxiety",Loneliness,,,,,Norwegian Centre for Ageing and Health,All,70 Years and older   (Older Adult),12000.0,Other,Observational,2021-02-18,01/11/23,2024-12-31,10/03/21,10/03/21,"Norwegian National Advisory Unit of Ageing and Health, Tønsberg",Norway,Mental Health,1,4,1412.0
4127.0,NCT04341493,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,,Terminated,Coronavirus Infection,,,,,,,Drug: Nitazoxanide 500 MG|Drug: Hydroxychloroquine,Hugo Mendieta Zeron|Materno-Perinatal Hospital of the State of Mexico,All,"5 Years and older   (Child, Adult, Older Adult)",44.0,Other,Interventional,2020-06-04,30/08/20,2020-12-30,10/04/20,01/04/21,"Materno-Perinatal Hospital Mónica Pretelini, Toluca",Mexico,Respiratory Diseases,1,1,209.0
4128.0,NCT04569383,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",,Recruiting,COVID-19,,,,,,,Biological: MVA-SARS-2-S vaccinations (days 0 & 28),Universitätsklinikum Hamburg-Eppendorf|German Center for Infection Research|Philipps University Marburg Medical Center|Ludwig-Maximilians - University of Munich,All,18 Years to 55 Years   (Adult),30.0,Other,Interventional,2020-05-10,01/05/21,2021-01-05,29/09/20,01/12/20,"CTC North GmbH & Co KG at the University Medical Center Hamburg-Eppendorf, Hamburg",Germany,Respiratory Diseases,1,1,240.0
4129.0,NCT04381936,Randomised Evaluation of COVID-19 Therapy,RECOVERY,Recruiting,Severe Acute Respiratory Syndrome,,,,,,,Drug: Lopinavir-Ritonavir|Drug: Corticosteroid|Drug: Hydroxychloroquine|Drug: Azithromycin|Biological: Convalescent plasma|Drug: Tocilizumab|Biological: Immunoglobulin|Drug: Synthetic neutralising antibodies|Drug: Aspirin|Drug: Colchicine|Drug: Baricitinib|Drug: Anakinra|Drug: Dimethyl fumarate,"University of Oxford|UK Research and Innovation|National Institute for Health Research, United Kingdom|Wellcome|Bill and Melinda Gates Foundation|Department for International Development, United Kingdom|Health Data Research UK|Medical Research Council Population Health Research Unit|NIHR Clinical Trials Unit Support Funding|NIHR Health Protection Research Unit in Emerging and Zoonotic Infections",All,"Child, Adult, Older Adult",40000.0,Other,Interventional,2020-03-19,01/12/21,2031-01-12,11/05/20,02/03/21,"Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta, Indonesia|Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal|Nuffield Department of Population Health, University of Oxford, Oxford",United Kingdom,Others,0,1,3951.0
4130.0,NCT04333654,Hydroxychloroquine in Outpatient Adults With COVID-19,,Terminated,Coronavirus Infection,,,,,,,Drug: Hydroxychloroquine SAR321068|Drug: Placebo,Sanofi,All,"18 Years to 80 Years   (Adult, Older Adult)",8.0,Industry,Interventional,2020-12-04,26/05/20,2020-05-26,03/04/20,14/07/20,"Investigational Site Number 8400001, Boston, Massachusetts, United States|Investigational Site Number 0561001, Bruxelles, Belgium|Investigational Site Number 0561002, Lodelinsart, Belgium|Investigational Site Number 2501001, Bordeaux Cedex, France|Investigational Site Number 2501002, Paris, France|Investigational Site Number 5281001, Groningen, Netherlands|Investigational Site Number 5281002, Harderwijk",Netherlands,Respiratory Diseases,1,1,-192.0
4131.0,NCT04378257,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,,Not yet recruiting,Depressive Symptoms,Generalized Anxiety,,,,,,Behavioral: Therapist Guided E-Therapy|Behavioral: Self-Help Therapy,Sultan Qaboos University|The Research Council|Oman Medical Specialty Board,All,"18 Years to 65 Years   (Adult, Older Adult)",70.0,Other,Interventional,2020-01-06,30/09/20,2020-10-20,07/05/20,08/05/20,,,Mental Health,1,2,288.0
4132.0,NCT04367129,Electrocardiogram Analysis in COVID-19 Patients,ELCOVID,Recruiting,SARS-CoV Infection,,,,,,,Diagnostic Test: ECG,University Hospital of Ferrara,All,"18 Years to 100 Years   (Adult, Older Adult)",1014.0,Other,Observational,2020-04-14,01/04/21,2021-01-04,29/04/20,09/02/21,"Arcispedale S. Anna, Ferrara",Italy,Respiratory Diseases,1,1,265.0
4133.0,NCT04488510,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,COVAP,"Active, not recruiting",COVID-19,Ventilator Associated Pneumonia,Nosocomial Pneumonia,,,,,,Groupe Hospitalier Paris Saint Joseph|Centre Hospitalier Victor Dupouy,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-06-05,06/05/20,2020-11-30,28/07/20,03/08/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,3,178.0
4134.0,NCT04512027,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,Prolectin-M,Completed,COVID-19,,,,,,,Other: Prolectin-M; a (1-6)-alpha-D-Mannopyranose class|Other: Standard of Care,Composite Interceptive Med Science|Pharmalectin Inc,All,18 Years to 45 Years   (Adult),10.0,Industry|Other,Interventional,2020-09-15,19/09/20,2020-10-16,13/08/20,19/10/20,"Mazumdar Shaw Medical Centre, Bangalore, Karnataka",India,Respiratory Diseases,1,1,31.0
4135.0,NCT04403685,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,TOCIBRAS,Terminated,COVID-19,SARS Pneumonia,Cytokine Release Syndrome,,,,,Drug: Tocilizumab,Beneficência Portuguesa de São Paulo|Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Hospital Alemão Oswaldo Cruz|Brazilian Research In Intensive Care Network|Hospital Moinhos de Vento|Brazilian Clinical Research Institute|Federal University of São Paulo,All,"18 Years and older   (Adult, Older Adult)",129.0,Other,Interventional,2020-08-05,08/07/20,2020-07-21,27/05/20,26/08/20,"UNIFESP, São Paulo, Sao Paulo, Brazil|HCOR -Hospital do Coracao, Sao Paulo, SP, Brazil|HAOC - Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil|Beneficência Portuguesa de Sao Paulo, Sao Paulo, Brazil|HAOC - Hospital Alemao Oswaldo Cruz - unidade Vergueiro, Sao Paulo, Brazil|HIAE - Hospital Israelita Albert Einstein, Sao Paulo, Brazil|HSL - Hospital Sírio Libanês, Sao Paulo",Brazil,Respiratory Diseases,1,3,-15.0
4136.0,NCT04342169,University of Utah COVID-19 Hydrochloroquine Trial,,Recruiting,Coronavirus Infection,Coronavirus,Infectious Disease,,,,,Drug: Hydroxychloroquine|Drug: Placebo oral tablet,University of Utah,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-04-04,01/04/21,2022-01-04,10/04/20,13/11/20,"University of Utah, Salt Lake City, Utah",United States,Respiratory Diseases,1,3,640.0
4137.0,NCT04468412,Influence of COVID-19 on Vascular Endothelial Function,COVAS,"Active, not recruiting",COVID-19,Vascular; Damage,,,,,,Diagnostic Test: Carotid Artery Reactivity Testing,Radboud University|Bernhoven Hospital,All,"16 Years and older   (Child, Adult, Older Adult)",203.0,Other,Observational,2020-07-14,30/09/21,2021-09-30,13/07/20,16/09/20,"Bernhoven, Uden",Netherlands,Respiratory Diseases,1,2,443.0
4138.0,NCT04668313,COVID-19 Advanced Respiratory Physiology (CARP) Study,CARP,Recruiting,Respiratory Failure,COVID-19,Biosensor,,,,,,NHS Greater Glasgow and Clyde|Altair Medical|Storm ID,All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-09-29,30/12/20,2021-09-29,16/12/20,16/12/20,"NHS Greater Glasgow and Clyde, Glasgow",United Kingdom,Respiratory Diseases,1,3,365.0
4139.0,NCT04832867,Pulmonary Rehabilitation in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-01-01,01/04/21,2021-01-05,06/04/21,06/04/21,"Bakirkor Dr. Sadi Konuk Research and Training hospital, Istanbul",Turkey,Respiratory Diseases,1,1,4.0
4140.0,NCT04395885,Sexual Function During COVID 19 Pandemic,,Completed,Sexual Dysfunction,,,,,,,Other: Electronic questionnaire,Assiut University,All,18 Years to 40 Years   (Adult),306.0,Other,Observational,2020-01-06,31/08/20,2020-09-15,20/05/20,06/10/20,"Ahmed Abbas, Assiut, Cairo, Egypt|Assiut Faculty of Medicine, Assiut",Egypt,Others,0,1,253.0
4141.0,NCT04366154,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,COVIPACT,"Active, not recruiting",COVID-19,Cancer,,,,,,Other: Questionnaire,Centre Francois Baclesse,All,"18 Years and older   (Adult, Older Adult)",809.0,Other,Observational,2020-04-15,15/07/20,2021-01-05,28/04/20,14/12/20,"Centre François Baclesse, Caen, France|Centre Henri Becquerel, Rouen",France,"Respiratory Diseases, Cancers",1,2,265.0
4142.0,NCT04378920,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,,,,,,Drug: LEAF-4L6715,"Institut de cancérologie Strasbourg Europe|LEAF4Life, Inc.",All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-04-14,30/06/21,2021-06-30,07/05/20,16/02/21,"Hôpitaux Universitaires de Strasbourg, Strasbourg, France|Institut de cancérologie Strasbourg Europe, Strasbourg",France,Respiratory Diseases,1,2,442.0
4143.0,NCT04789395,Evaluation of Post-covid 19 Patients Who Receive Ozonetheraphy With Thorax CT,,Recruiting,COVID-19,,,,,,,,Gaziosmanpasa Research and Education Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",25.0,Other,Observational,2020-02-09,20/09/21,2021-12-20,09/03/21,09/03/21,"Gaziosmanpaşa TREH, Istanbul, Gaziosmanpaşa",Turkey,Respiratory Diseases,1,1,680.0
4144.0,NCT04733625,The Effect of Vitamin D Therapy on Morbidity and Moratlity in Patients With SARS-CoV 2 Infection,,Completed,COVID-19,SARS-CoV Infection,,,,,,Drug: Cholecalciferol|Drug: Placebo,Kasr El Aini Hospital,All,"18 Years and older   (Adult, Older Adult)",56.0,Other,Interventional,2020-09-15,17/12/20,2020-12-17,02/02/21,02/02/21,"Cairo university hospitals, Cairo",Egypt,Respiratory Diseases,1,2,93.0
4145.0,NCT04397848,Mental Health Outcomes in Healthcare Workers During COVID-19,,Completed,Mental Health Wellness 1,PTSD,Anxiety,Stress,Depression,COVID-19,Healthcare Workers,,"University Health Network, Toronto|William Osler Health System|University of Toronto|Sunnybrook Health Sciences Centre",All,"18 Years and older   (Adult, Older Adult)",3852.0,Other,Observational,2020-05-14,03/07/20,2020-03-07,21/05/20,03/11/20,"University Health Network, Toronto, Ontario",Canada,"Mental Health, Respiratory Diseases",1,7,-68.0
4146.0,NCT04532372,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,,Recruiting,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,COVID-19,,,,,Other: Best Practice|Drug: Leflunomide|Drug: Placebo Administration,City of Hope Medical Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",30.0,Other|NIH,Interventional,2021-07-01,18/09/22,2022-09-18,31/08/20,27/01/21,"City of Hope Medical Center, Duarte, California",United States,Respiratory Diseases,1,3,444.0
4147.0,NCT04344561,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,UPSAT,Recruiting,COVID-19,Hypoxic Respiratory Failure,,,,,,Other: Postural Positioning,Johns Hopkins University,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-05-25,01/05/21,2021-01-05,14/04/20,24/06/20,"Johns Hopkins Bayview Hospital, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,2,225.0
4148.0,NCT04558125,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,,Recruiting,Pulmonary Embolism,COVID-19,,,,,,Drug: TNKase,"Cedars-Sinai Medical Center|Genentech, Inc.",All,"18 Years to 75 Years   (Adult, Older Adult)",45.0,Other|Industry,Interventional,2020-08-09,31/12/21,2022-06-30,22/09/20,09/04/21,"Cedars-Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,2,690.0
4149.0,NCT04575064,An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY,,"Active, not recruiting",COVID-19,COVID-19,COVID-19,,,,,Other: Standard of Care (SoC)|Drug: Remdesivir,"Professor Dr. Bernd Mühlbauer|Dept. of Statistics and Medical Biometry, University of Bremen|INSERM (Institut national de la santé et de la recherche médicale), Paris, France|World Health Organization (WHO), R&D Blueprint, Geneva, Switzerland|Klinikum Bremen-Mitte, gGmbH",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-06-29,01/03/22,2022-01-11,05/10/20,05/10/20,"Gesundheit Nord gGmbH, Bremen, Germany|Universitätsklinikum Gießen, Gießen, Germany|Medizinische Hochschule Hannover (MHH), Hannover, Germany|Technische Universität München (TUM), München",Germany,Respiratory Diseases,1,3,561.0
4150.0,NCT04495842,The Effect of Aromatherapy on COVID-19-induced Anxiety,,Recruiting,Stress,COVID-19,Anxiety,,,,,Other: Essential Oil Blend|Other: Control Blend,Franklin School of Integrative Health Sciences,All,"18 Years to 65 Years   (Adult, Older Adult)",65.0,Other,Interventional,2020-01-10,31/03/21,2021-06-30,03/08/20,19/10/20,"Franklin School of Integrative Health Sciences, Franklin, Tennessee",United States,"Mental Health, Respiratory Diseases",1,3,537.0
4151.0,NCT04315948,Trial of Treatments for COVID-19 in Hospitalized Adults,DisCoVeRy,"Active, not recruiting",Corona Virus Infection,,,,,,,Drug: Remdesivir|Drug: Lopinavir/ritonavir|Drug: Interferon Beta-1A|Drug: Hydroxychloroquine|Other: Standard of care,"Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",3100.0,Other,Interventional,2020-03-22,01/03/23,2023-01-03,20/03/20,03/02/21,"Medizinische Universität Innsbruck, Innsbruck, Austria|Kepler Universitätsklinikum Linz, Linz, Austria|Landeskrankenhaus Salzburg Universitätsklinikum der Paracelsus Medizinischen Privatuniversität, Salzburg, Austria|Hôpital Erasme - Cliniques universitaires de Bruxelles, Brussels, Belgium|Hôpital Saint Luc, Brussels, Belgium|Hôpital La Citadelle, Liège, Belgium|Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France|Centre Hospitalier Regional Metz-Thionville, Ars-Laquenexy, France|Centre Hospitalier Régional Universitaire de Besançon, Besançon, France|Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France|CHU APHP Ambroise-Paré, Boulogne-Billancourt, France|Centre Hospitalier Andrée Rosemon, Cayenne, France|CHU Clermont-Ferrand, Clermont-Ferrand, France|Hospices Civil, Colmar, France|APHP - hôpital Henri-Mondor, Créteil, France|Centre Hospitalier Universitaire Dijon-Bourgogne, Dijon, France|Centre Hospitalier Universitaire de Martinique, Fort De France, France|AP-HP Hôpital Bicêtre, Kremlin-Bicêtre, France|Centre Hospitalo-Universitaire de Grenoble, La Tronche, France|Centre Hospitalier Régional Universitaire de Lille, Lille, France|Hospices Civils de Lyon, Lyon, France|Centre Hospitalier Universitaire de Montpellier, Montpellier, France|Groupe Hospitalier de la Région de Mulhouse Sud Alsace, Mulhouse, France|Centre Hospitalier Régional et Universitaire de Nancy, Nancy, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|Centre Hospitalo-Universitaire de Nice, Nice, France|CHU Nîmes, Nîmes, France|APHP - Hôpital Saint Antoine, Paris, France|APHP - Hôpital Universitaire Pitié Salpêtrière, Paris, France|APHP - Hôpital Cochin, Paris, France|Hôpital Paris Saint-Joseph et Marie Lannelongue, Paris, France|APHP- Hôpital Européen Georges-Pompidou, Paris, France|APHP - Hôpital Bichat Claude Bernard, Paris, France|CHU Poitiers, Poitiers, France|CH Cornouaille, Quimper, France|Centre Hospitalier Universitaire de Rennes, Rennes, France|Hopital DELAFONTAINE, Saint-Denis, France|Hôpital d'Instruction des Armées BEGIN, Saint-Mandé, France|Centre Hospitalier Universitaire de Saint Etienne, Saint-Étienne, France|Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier Universitaire de Toulouse, Toulouse, France|Centre Hospitalier de Tourcoing, Tourcoing, France|Centre Hospitalier Universitaire de Tours, Tours, France|CH Bretagne Atlantique, Vannes, France|Centre Hospitalier Annecy Genevois, Épagny, France|Centre Hospitalier Luxembourg, Luxembourg, Luxembourg|Hôpitaux Robert Schuman, Luxembourg, Luxembourg|Hospital de Abrantes (CHMT), Abrantes, Portugal|Hospital de Cascais, Cascais, Portugal|CHULN- Hospital de Santa Maria, Lisboa, Portugal|Centro Hospitalar Universitário de São João, EPE, Porto",Portugal,Respiratory Diseases,1,1,1017.0
4152.0,NCT04494776,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,,Recruiting,COVID-19,Kidney Transplant Infection,,,,,,,Helio Tedesco Silva Junior|Hospital do Rim e Hipertensão,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-05-21,03/11/21,2022-02-04,31/07/20,09/02/21,"Hospital do Rim, São Paulo, Aão Paulo",Brazil,Respiratory Diseases,1,2,624.0
4153.0,NCT04609865,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,LidoCovid,Recruiting,Acute Respiratory Distress Syndrome (ARDS),COVID-19,Corona Virus Infection,,,,,Drug: Lidocaine 2%|Drug: Control,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-11,31/12/21,2024-04-02,30/10/20,20/01/21,"University Hospital of Hautepierre, Strasbourg, Bas-Rhin",France,Respiratory Diseases,1,3,1452.0
4154.0,NCT04412460,Echocardiography in Patients With Covid-19,,Recruiting,COVID-19,"ARDS, Human",,,,,,,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-20,31/12/21,2021-12-31,02/06/20,02/06/20,"University Hospital Tubingen, Tubingen, BW",Germany,Respiratory Diseases,1,2,651.0
4155.0,NCT04455451,Intensive Care Therapy of Covid-19 Disease in Germany,,Recruiting,COVID-19,ARDS,,,,,,,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-06-08,01/12/22,2023-01-06,02/07/20,28/12/20,"RWTH Aachen - Department for operative Intensive Care Medicine and intermediate Care, Aachen, Germany|Zollernalbklinikum, Balingen, Germany|Charité Universitätsmedizin Berlin, Berlin, Germany|UH Bochum - Department for Anesthesiology and Intensive Care Medicine, Bochum, Germany|Universitätsklinikum Bonn, Bonn, Germany|Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany|Ev. Krankenhaus Bethesda Duisburg Klinik für Anästhesiologie und Intensivmedizin, Duisburg, Germany|Univerrsitätsklinikum Düsseldorf, Düsseldorf, Germany|Universitätsklinikum Essen, Essen, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Hospital Freiburg - Department for Anesthesiology and Intensive Care Medicine, Freiburg, Germany|Universitätsklinikum Giessen Klinik für Anaesthesiologie und operative Intensivmedizin, Gießen, Germany|Universitätsklinikum Greifswald, Greifswald, Germany|Universitätsmedizin Göttingen Klinik für Anästhesiologie, Göttingen, Germany|Universitätsklinikum Halle, Halle/Saale, Germany|University Hospital Heidelberg - Department for Anesthesiologie and Intensive Care Medicine, Heidelberg, Germany|Universitätsklinikum des Saarlandes, Homburg/Saar, Germany|Klinikum der Universität Witten/Herdecke - Köln / Klinik für Anästhesiologie und operative Intensivmedizin, Köln, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|UKSH Campus Lübeck - Department for Anesthesiology and Intensive Care Medicine, Lübeck, Germany|University Hospital Magdeburg - Department for Anesthesiology and Intensive Care Medicine, Magdeburg, Germany|Universitätsklinikum Marburg, Marburg, Germany|Technische Universität München, München, Germany|Oberschwabenklinik Ravensburg Klinik für Anästhesie-, Intensiv-, Notfall- und Schmerzmedizin, Ravensburg, Germany|University Hospital Tübingen - Department for Anesthesiology and Intensive Care Medicine, Tübingen, Germany|Universitätsklinikum Ulm, Ulm, Germany|Universitätsklinikum Würzburg Klinik und Poliklinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Würzburg",Germany,Respiratory Diseases,1,2,942.0
4156.0,NCT04579588,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,,Enrolling by invitation,Corona Virus Infection,Flu Vaccine,Immunity,,,,,Biological: Flu shot,Stanford University|National Institute of Allergy and Infectious Diseases (NIAID),All,18 Years to 64 Years   (Adult),100.0,Other|NIH,Observational,2020-10-29,01/12/22,2022-01-12,08/10/20,19/01/21,"Stanford University, Hospital, and Clinics, Stanford, California",United States,Respiratory Diseases,1,3,440.0
4157.0,NCT04663659,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,,Completed,COVID-19,Diabetes Mellitus,,,,,,Other: no intervention,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-03-15,15/05/20,2020-05-15,11/12/20,14/12/20,"SisliHamidiye Etfal Education and Training Hospital, Istanbul",Turkey,"Metabolic Disorders, Respiratory Diseases",1,2,61.0
4158.0,NCT04279795,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,,Recruiting,Coronavirus,,,,,,,,"Third Affiliated Hospital, Sun Yat-Sen University",All,"Child, Adult, Older Adult",20.0,Other,Observational,2020-01-20,31/01/21,2021-02-28,21/02/20,21/02/20,"The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,405.0
4159.0,NCT04792567,Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC),AMA-VACC,Not yet recruiting,Secondary Progressive Multiple Sclerosis,,,,,,,Drug: BAF312|Drug: Baseline disease modifying therapies (DMTs),Novartis Pharmaceuticals|Novartis,All,"18 Years to 100 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2021-04-19,17/01/22,2022-02-04,11/03/21,06/04/21,,,Immunological Disorders,1,1,291.0
4160.0,NCT04302688,Accurate Classification System for Patients With COVID-19 Pneumonitis,,Completed,Pneumonitis,,,,,,,,Renmin Hospital of Wuhan University,All,"Child, Adult, Older Adult",669.0,Other,Observational,2019-10-12,10/02/20,2020-04-03,10/03/20,10/03/20,"Renmin Hospital of Wuhan University, Wuhan, Hubei",China,Others,0,1,174.0
4161.0,NCT04365881,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,,Completed,"Loneliness, Worry, Rumination, Health Anxiety, Depression, Anxiety",,,,,,,Other: Cross-sectional observational study,Modum Bad|University of Oslo,All,"18 Years and older   (Adult, Older Adult)",10084.0,Other,Observational,2020-03-31,07/04/20,2020-07-04,28/04/20,28/04/20,"University of Oslo, Oslo",Norway,Mental Health,1,1,95.0
4162.0,NCT04326725,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,,"Active, not recruiting",Pneumonitis,Coronavirus Infection,,,,,,Drug: Plaquenil 200Mg Tablet,Istinye University,All,"20 Years to 90 Years   (Adult, Older Adult)",80.0,Other,Observational,2020-03-20,01/07/20,2020-01-09,30/03/20,28/07/20,"Istinye University Medical School, Istanbul",Turkey,Respiratory Diseases,1,2,-71.0
4163.0,NCT04339712,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,ESCAPE,Completed,COVID-19,Virus Diseases,Macrophage Activation Syndrome,Corona Virus Infection,,,,Drug: Anakinra|Drug: Tocilizumab,Hellenic Institute for the Study of Sepsis,All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-02-04,01/12/20,2021-08-01,09/04/20,11/01/21,"2nd Department of Critical Care Medicine, ATTIKON University Hospital, Athens, Haidari, Greece|Intensive Care Unit, Ioannina University Hospital, Ioánnina, Ioannina, Greece|Department of Internal Medicine, Patras University Hospital, Patras, Rion, Greece|Department of Internal Medicine, I PAMMAKARISTOS Hospital, Athens, Greece|Intensive Care Unit, General Hospital of Athens KORGIALENIO-BENAKIO E.E.S., Athens, Greece|1st Department of Pulmonary Medicine and Intensive Care Unit, Athens, Greece|Intensive Care Unit, General Hospital of Athens IPPOKRATEIO, Athens, Greece|4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece|Intensive Care Unit, General Hospital ASKLEPIEIO Voulas, Athens, Greece|Intensive Care Unit, Latsio, Thriasio Elefsis General Hospital, Elefsína, Greece|Intensive Care Unit, Koutlimbaneio & Triantafylleio Larissa General Hospital, Larissa, Greece|Department of Internal Medicine, Larissa University Hospital, Larissa, Greece|Intensive Care Unit, AGIOS DIMITRIOS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, G. GENNIMATAS General Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, Theageneio Oncological Hospital of Thessaloniki, Thessaloniki, Greece|Intensive Care Unit, General Hospital of Thessaloniki IPPOKRATEIO, Thessaloniki, Greece|Department of Anesthesiology and Intensive Care Medicine, University General Hospital of Thessaloniki AHEPA, Thessaloniki",Greece,Respiratory Diseases,1,4,544.0
4164.0,NCT04629703,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",,Recruiting,COVID-19,SARS (Severe Acute Respiratory Syndrome),SARS Pneumonia,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Pneumonia,"Pneumonia, Viral",,Drug: Fostamatinib|Drug: Placebo,Rigel Pharmaceuticals,All,"18 Years to 100 Years   (Adult, Older Adult)",308.0,Industry,Interventional,2021-02-22,01/08/21,2021-01-10,16/11/20,01/04/21,"Sutter Health - Mills Peninsula Medical Center, Burlingame, California, United States|University of California Irvine, Orange, California, United States|Loyola University Medical School, Maywood, Illinois, United States|Harvard Medical School- Bringham and Women's Hospital, Boston, Massachusetts, United States|Ascension Medical Group- St. John Clinic Infectious Disease, Tulsa, Oklahoma, United States|Providence Portland Medical Center, Portland, Oregon, United States|Houston Methodist Research Institute, Houston, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia, United States|Hospital de Alta Complejidad Cuenta Alta, Buenos Aires, Argentina|Hospital Del Bicentenario - Dr. Luis Federico Leloir, Buenos Aires, Argentina|Clinica Zabala, Buenos Aires, Argentina|CEMIC, Buenos Aires, Argentina|Clinica Adventista Belgrano, Buenos Aires, Argentina|Clinica Monte Grande, Buenos Aires, Argentina|Hospital de Infecciosas Francisco Javier Muñiz., Buenos Aires, Argentina|Sanatorio Guemes, Buenos Aires, Argentina|Sanatorio Sagrado Corazon, Buenos Aires, Argentina|Hospital San Roque, Córdoba, Argentina|Sanatorio Mayo Privado, Córdoba, Argentina|Hospital das Clínicas da Universidade Federal de Goiás (HC/UFG), Goiânia, Goiás, Brazil|Hospital Luxenburgo-Associação Mário Penna, Belo Horizonte, Minas Gerais, Brazil|Hospital Universitario de Maringa, Maringá, Parana, Brazil|Irmandade da Santa Casa de Misericórdia de Porto Alegre - ISCMPA, Porto Alegre, Rio Grande Do Sul, Brazil|Complexo de Prevenção, Diagnóstico, Terapia e Reabilitação Respiratória LTDA, Blumenau, Santa Catarina, Brazil|Hospital Alemão Oswaldo Cruz (HAOC), Bela Vista, Sao Paolo, Brazil|Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP), Campinas, Sao Paolo, Brazil|Hospital Bandeirantes (LeForte), Liberdade, Sao Paolo, Brazil|Clinica de Alergia Martti Antila S/S Ltda, Sorocaba, Sao Paulo, Brazil|Fundação Faculdade Reg. de Med de SJRP, São José Do Rio Preto, Sao Paulo, Brazil|Unidad Medica para la Salud Integral (UMSI), Monterrey, Nuevo Leon, Mexico|Hospital Cardiologica Aguascalientes, Aguascalientes, Mexico|Nuevo Hospital Civil de Guadalajara, Guadalajara, Mexico|Centro Medico Issemym Toluca, Metepec, Mexico|The American British Cowdray Medical Center I.A.P., Mexico City, Mexico|Hospital Ángeles Roma, Mexico, Mexico|CEPREP Centro de Prevención y Rehabilitación de Enfermedades Pulmonares Crónicas, Nuevo León, Mexico|Hospital Civil de Culiacan, Sinaloa, Mexico|EsSalud - Hospital Nacional Alberto Sabogal Sologuren, Lima, Peru|Hospital de Chancay, Lima, Peru|Hospital Nacional Arzobispo Loayza, Lima, Peru|Hospital Nacional Cayetano Heredia, Lima, Peru|Hospital Nacional Hipolito Unanue, Lima",Peru,Respiratory Diseases,1,6,-43.0
4165.0,NCT04501432,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,CODIS,Completed,Cardiac Rehabilitation,,,,,,,Other: No intervention,"Ludwig Boltzmann Institute for Digital Health and Prevention|Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg, Austria",All,"18 Years and older   (Adult, Older Adult)",27.0,Other,Observational,2020-07-14,24/10/20,2020-10-24,06/08/20,03/12/20,"Institute of Sports Medicine, Prevention and Rehabilitation, Salzburg",Austria,Others,0,1,102.0
4166.0,NCT04402229,Psychological Impact of the Covid-19 Pandemic on Student Nurses,StudentCov,Completed,Nurse,Student,Post Traumatic Stress Disorder,COVID-19,,,,,Versailles Hospital,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-12-05,31/07/20,2020-07-31,26/05/20,19/11/20,"Versailles hospital, Le Chesnay, France|Toulouse University Hospital, Toulouse",France,"Mental Health, Respiratory Diseases",1,4,-127.0
4167.0,NCT04637906,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),,Recruiting,COVID-19,,,,,,,Dietary Supplement: Bioarginina®,"University of Campania ""Luigi Vanvitelli""",All,"19 Years and older   (Adult, Older Adult)",290.0,Other,Interventional,2020-11-18,18/04/21,2021-09-18,20/11/20,16/03/21,"Azienda Ospedaliera Specialistica Dei Colli, Napoli",Italy,Respiratory Diseases,1,1,304.0
4168.0,NCT04406233,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,,Recruiting,SARS-CoV 2,,,,,,,,University of Sao Paulo,All,"18 Years and older   (Adult, Older Adult)",176.0,Other,Observational,2020-05-23,23/05/22,2022-05-23,28/05/20,28/05/20,"Univsersity of Sao Paulo, Sao Paulo",Brazil,Respiratory Diseases,1,1,730.0
4169.0,NCT04760821,Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19,PREMIER,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,Myocardial Injury,,,,,Drug: Trimetazidine,"Ministry of Health, Brazil|InCor Heart Institute",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-10-12,30/04/21,2021-04-30,18/02/21,21/02/21,"Heart Institute (InCor-HCFMUSP), Sao Paulo, SP",Brazil,Respiratory Diseases,1,3,200.0
4170.0,NCT04245631,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",,Recruiting,New Coronavirus,,,,,,,Diagnostic Test: Recombinase aided amplification (RAA) assay,Beijing Ditan Hospital,All,"1 Year to 90 Years   (Child, Adult, Older Adult)",50.0,Other,Observational,2020-01-01,31/12/20,2020-12-31,29/01/20,10/04/20,"Department of Hepatology Division 2, Beijing Ditan Hospital, Beijing, Beijing",China,Respiratory Diseases,1,1,365.0
4171.0,NCT03183570,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",,Recruiting,Idiopathic Pulmonary Fibrosis,Primary Sclerosing Cholangitis,COVID-19,,,,,Drug: [18F]FP-R01-MG-F2,"Stanford University|Pliant Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2017-08-11,14/04/22,2023-04-14,12/06/17,16/03/21,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,3,2072.0
4172.0,NCT04760561,Self-prone Positioning for Awake Non-intubated Patients With COVID-19,,Not yet recruiting,Prone Position,Coronavirus Disease 2019,Oxygenation,,,,,Procedure: prone position group,Damanhour University,All,"18 Years to 75 Years   (Adult, Older Adult)",82.0,Other,Interventional,2021-02-20,20/03/21,2021-04-20,18/02/21,18/02/21,,,Respiratory Diseases,1,3,59.0
4173.0,NCT04672590,COVID-19 Neurological Disease: A Prospective Study,,Not yet recruiting,Diseases of the Nervous System,Other Specified Viral Diseases,,,,,,Other: Primary exposure is hypoxia (no intervention),"University of Liverpool|Christian Medical College, Vellore, India|Instituto Autoimune, Brazil|University College London Hospitals|Oswaldo Cruz Foundation|University of Malawi College of Medicine|National Institute of Mental Health and Neuro Sciences, India|Encephalitis Society, UK",All,"18 Years and older   (Adult, Older Adult)",681.0,Other,Observational,2021-01-01,01/12/21,2021-01-12,17/12/20,06/01/21,,,Others,0,2,11.0
4174.0,NCT04517162,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,,Recruiting,COVID-19,Cytokine Storm,Regulation of Inflammatory Response,Pulmonary Fibrosis,,,,Drug: Collagen-Polyvinylpyrrolidone,Janette Furuzawa Carballeda|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-08-19,19/02/21,2021-06-19,18/08/20,17/02/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico, Cdmx",Mexico,Respiratory Diseases,1,4,304.0
4175.0,NCT04821908,Consequences of COVID 19 Pandemic on Childhood Asthma,VIRASTHCOVID,Not yet recruiting,Asthma in Children,,,,,,,,"University Hospital, Lille",All,3 Years to 16 Years   (Child),577.0,Other,Observational,2021-01-07,01/07/25,2025-01-07,30/03/21,30/03/21,,,Others,0,1,1461.0
4176.0,NCT04398043,SARS-CoV 2 in Personal Protective Equipment,,Not yet recruiting,rt PCR,COVID-19,Personal Protective Equipment PPE,SARS-CoV 2,Health Personnel Attitude,Virus Diseases,,,Hospital de Clinicas José de San Martín|Claudio Yaryour|Fermepin Marcelo|Luis Sarotto|Federico Rodriguez Cairoli|Angela Famiglieti|Francisco Appiani|Lucía Gallo Vaulet,All,"16 Years and older   (Child, Adult, Older Adult)",16.0,Other,Observational,2020-05-15,30/06/20,2020-07-30,21/05/20,21/05/20,,,Respiratory Diseases,1,6,76.0
4177.0,NCT04568551,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",CAASP,Recruiting,Anxiety State,,,,,,,,Martin-Luther-Universität Halle-Wittenberg,Female,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-10,31/03/21,2021-07-31,29/09/20,29/09/20,"University Hospital of Halle, Halle, Saxony Anhalt",Germany,Mental Health,1,1,568.0
4178.0,NCT04397497,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),COMBAT-19,Not yet recruiting,COVID-19,Acute Respiratory Failure,"ARDS, Human",Sars-CoV2,Viral Pneumonia,,,Drug: Mavrilimumab|Drug: Placebo,Ospedale San Raffaele,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-05-22,22/09/20,2020-11-22,21/05/20,26/05/20,"IRCCS Policlinico San Donato, San Donato, MI, Italy|IRCCS Ospedale San Raffaele, Milano, Italy|IRCCS Istituto Ortopedico Galeazzi, Milano",Italy,Respiratory Diseases,1,5,184.0
4179.0,NCT04412356,Timing of Tracheotomy in Covid-19 Patients,TTCOV19,Recruiting,COVID-19,ARDS,Tracheostomy Complication,Respiratory Insufficiency,Corona Virus Infection,,,Procedure: Tracheotomy,"Sahlgrenska University Hospital, Sweden",All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2020-04-06,01/06/21,2021-01-09,02/06/20,01/04/21,"Sahlgrenska University Hospital, Gothenburg",Sweden,Respiratory Diseases,1,5,278.0
4180.0,NCT04361019,Physical Activity in University Students Around COVID-19 Confinement,,Recruiting,Physical Activity,,,,,,,Other: On-Line Survey,Basque Country University|University of Cadiz|University of Extremadura|Universidad de Zaragoza|Universidad de Granada|University of Castilla-La Mancha|University of Las Palmas de Gran Canaria|Universidad de León|University of Seville|University of Valencia|Universidad Miguel Hernandez de Elche|Technical University of Madrid|Universidad Pública de Navarra|University of the Balearic Islands|Universitat Jaume I|University of Cantabria,All,"Child, Adult, Older Adult",25000.0,Other,Observational,2020-04-16,20/10/20,2020-10-20,24/04/20,27/07/20,"Basque Country University (UPV-EHU),, Bilbao, Bizkaia",Spain,Others,0,1,187.0
4181.0,NCT04425720,Use of Remote Monitoring for COVID-19 Patient,RPM,Recruiting,COVID-19,,,,,,,Device: LifeSignals Biosensor 1AX*|Other: Standard of Care,Montefiore Medical Center,All,"18 Years to 90 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-01-09,01/06/21,2021-01-06,11/06/20,12/11/20,"Montefiore Medical Center, Bronx, New York",United States,Respiratory Diseases,1,1,363.0
4182.0,NCT04720118,Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic,,Recruiting,Parkinson Disease,COVID-19,"Satisfaction, Patient",Quality of Life,,,,Other: No Intervention,Towson University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-03,01/04/21,2021-01-05,22/01/21,01/04/21,"Towson University, Towson, Maryland",United States,Respiratory Diseases,1,4,2.0
4183.0,NCT04452565,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",NATADEX,Recruiting,Coronavirus Infection,Severe Acute Respiratory Infection,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,Drug: Drug: NA-831|Combination Product: NA-831 and Atazanavir|Combination Product: NA-831and Dexamethasone|Combination Product: Atazanavir and Dexamethasone,"NeuroActiva, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",525.0,Industry,Interventional,2020-10-15,31/12/20,2021-02-15,30/06/20,07/09/20,"Coronavirus Research Institute- Testing Site, Los Angeles, California, United States|Coronavirus Research Institute, Orange, California, United States|Coronavirus Research Institute-Testing Site, Palo Alto, California, United States|Coronavirus Research Institute-Testing Site, Sacramento, California, United States|Coronavirus Research Institute-Testing Site, San Diego, California, United States|Coronavirus Research Testing Site, San Francisco, California, United States|Coronavirus Research Institute-Testing Site, Sunnyvale, California, United States|Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States|Coronavirus Research Institute-Testing Site, Washington, District of Columbia, United States|Coronavirus Research Institute-Testing Site, Fort Lauderdale, Florida, United States|Coronavirus Research Institute-Testing Site, Tampa, Florida, United States|Coronavirus Research Institute- Testing Site, Chicago, Illinois, United States|Coronavirus Research Institute-Testing Site, Naperville, Illinois, United States|Coronavirus Research Institute-Testing Site, Baltimore, Maryland, United States|Coronavirus Research Institute-Testing Site, Bethesda, Maryland, United States|Coronavirus Research Institute-Testing Site, Boston, Massachusetts, United States|Coronavirus Research Institute-Testing Site, Worcester, Massachusetts, United States|Coronavirus Research Institute-Testing Site, Ann Arbor, Michigan, United States|Coronavirus Research Institute-Testing Site, Detroit, Michigan, United States|Coronavirus Research Institute-Testing Site, Newark, New Jersey, United States|Coronavirus Research Institute-Testing Site-, Bronx, New York, United States|Coronavirus Research Institute-Testing Site, New York, New York, United States|Coronavirus Research Institute- Testing Site, Rochester, New York, United States|Coronavirus Research Institute-Testing Site, Durham, North Carolina, United States|Coronavirus Research Institute-Testing Site, Philadelphia, Pennsylvania, United States|Coronavirus Research Institute- Testing Site, Fort Sam Houston, Texas, United States|Coronavirus Research Institute-Testing Site, Galveston, Texas, United States|Coronavirus Research Institute-Testing Site, Houston, Texas, United States|Coronavirus Research Institute-Testing Site, Kirkland, Washington, United States|Coronavirus Research Institute-Testing Site, Seattle, Washington, United States|Coronavirus Research Institute-Testing Site, Tacoma, Washington",United States,Respiratory Diseases,1,3,123.0
4184.0,NCT04329533,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,,Completed,Perceived Stress,Anxiety,Sleep Disturbance,,,,,"Other: ""Calm"" is a mindfulness meditation mobile app",University of Arizona,Female,"18 Years to 99 Years   (Adult, Older Adult)",101.0,Other,Interventional,2020-04-13,01/11/20,2020-01-11,01/04/20,13/11/20,"Banner University Medicine Women's Institute, Phoenix, Arizona",United States,Mental Health,1,3,-93.0
4185.0,NCT04748757,Annexin A5 in Patients With Severe COVID-19 Disease,AX-COVID,Not yet recruiting,Coronavirus Infection,Sepsis,,,,,,Drug: recombinant human annexin A5|Drug: Placebo,Lawson Health Research Institute|Ontario Ministry of Colleges and Universities|London Health Sciences Foundation,All,"19 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-03,01/03/22,2022-01-12,10/02/21,10/02/21,"London Health Sciences Centre, London, Ontario",Canada,Respiratory Diseases,1,2,374.0
4186.0,NCT04292340,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,,Recruiting,Coronavirus,,,,,,,,Shanghai Public Health Clinical Center,All,"Child, Adult, Older Adult",15.0,Other,Observational,2020-01-02,31/07/20,2020-12-31,03/03/20,03/03/20,"Shanghai Public Health Clinical Center, Shanghai, Shanghai",China,Respiratory Diseases,1,1,364.0
4187.0,NCT04602260,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,,Recruiting,COVID-19,Corona Virus Infection,Mobility Limitation,Frailty,,,,,McMaster University,All,"40 Years and older   (Adult, Older Adult)",211.0,Other,Observational,2020-09-06,01/09/21,2021-01-09,26/10/20,26/10/20,"McMaster University, Hamilton, Ontario",Canada,Respiratory Diseases,1,4,125.0
4188.0,NCT04483973,SPI-1005 Treatment in Severe COVID-19 Patients,,Not yet recruiting,COVID-19,Coronavirus,Coronavirus Infection,Corona Virus Infection,,,,Drug: Ebselen|Drug: Placebo,"Sound Pharmaceuticals, Incorporated",All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2021-01-05,01/06/22,2022-01-06,23/07/20,29/03/21,,,Respiratory Diseases,1,4,366.0
4189.0,NCT04511923,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,CHARTER-Irl,Recruiting,COVID-19,"ARDS, Human","Lung Injury, Acute",Ventilation Perfusion Mismatch,,,,Drug: Nebulised heparin,University College Hospital Galway,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-12-23,01/12/21,2022-01-01,13/08/20,10/02/21,"University Hospital Galway, Galway",Ireland,Respiratory Diseases,1,4,374.0
4190.0,NCT04766788,Studying Students at Risk for COVID-19,,"Active, not recruiting",COVID-19,,,,,,,"Other: Wearable devices, saliva samples, survey measures",University of Michigan,All,"18 Years and older   (Adult, Older Adult)",2494.0,Other,Observational,2020-03-09,01/05/21,2021-01-08,23/02/21,23/02/21,"Michigan Medicine, Ann Arbor, Michigan",United States,Respiratory Diseases,1,1,305.0
4191.0,NCT04368975,ARDS Caused by COVID-19,,Recruiting,Acute Respiratory Failure With Hypoxia,,,,,,,,Hospital Clinic of Barcelona|Ubikare company,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-12-03,21/04/20,2020-12-31,30/04/20,30/04/20,"Ricard Mellado, Barcelona",Spain,Respiratory Diseases,1,1,28.0
4192.0,NCT04484025,SPI-1005 Treatment in Moderate COVID-19 Patients,,Not yet recruiting,COVID-19,Corona Virus Infection,Coronavirus,Coronavirus Infection,,,,Drug: Ebselen|Drug: Placebo,"Sound Pharmaceuticals, Incorporated",All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Interventional,2021-01-05,01/06/22,2022-01-06,23/07/20,29/03/21,,,Respiratory Diseases,1,4,366.0
4193.0,NCT04381286,Transpulmonary Driving Pressure in ARDS COVID19 Patients,TRANSPULMONARY,Recruiting,Mechanical Ventilation,COVID-19,COVID-19,,,,,,"University Hospital, Montpellier",All,"18 Years to 90 Years   (Adult, Older Adult)",40.0,Other,Observational,2019-01-04,01/04/21,2021-12-31,08/05/20,12/05/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,1092.0
4194.0,NCT04628195,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,,Completed,COVID-19,Acute Cor Pulmonale,Cardiac Failure,,,,,,Pontificia Universidad Catolica de Chile|Clinica Alemana de Santiago|Hospital Barros Luco Trudeau|University of Chile,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-04,30/06/20,2020-01-08,13/11/20,13/11/20,"Pontificia Universidad Católica de Chile, Santiago, Región Metropolitana",Chile,Respiratory Diseases,1,3,4.0
4195.0,NCT04339881,NOsocomial Dissemination Risk of SARS-Cov2,NODS-Cov2,Completed,Sars-CoV2,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",2523.0,Other,Observational,2020-04-17,10/07/20,2020-12-07,09/04/20,23/11/20,"Didier Guillemot, Garches",France,Respiratory Diseases,1,1,234.0
4196.0,NCT04350281,Double Therapy With IFN-beta 1b and Hydroxychloroquine,,Completed,COVID-19,,,,,,,Drug: Interferon Beta-1B|Drug: Hydroxychloroquine,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-04,01/07/20,2020-07-07,17/04/20,28/07/20,"The University of Hong Kong, Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,-59.0
4197.0,NCT04392973,FAvipiravir and HydroxyChloroquine Combination Therapy,FACCT,Recruiting,COVID-19,,,,,,,Combination Product: Favipiravir and Hydroxychloroquine,King Abdullah International Medical Research Center,All,"18 Years and older   (Adult, Older Adult)",520.0,Other,Interventional,2020-05-21,01/11/21,2021-01-11,19/05/20,28/07/20,"King Abdulaziz Hospital - Al Ahsa, Hasa, Eastern Region, Saudi Arabia|AlMadina General Hospital, Al Madīnah, Saudi Arabia|Al-Qatif Central Hospital, Al-Qatif, Saudi Arabia|Imam Abdulrahman Al Faisal Hospital - Dammam, Dammam, Saudi Arabia|King Abdulaziz Medical City, Jeddah, Saudi Arabia|King Abdulaziz Hospital - Makkah, Mecca, Saudi Arabia|King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia|Imam Abdulrahman Alfaisal Hospital, Riyadh",Saudi Arabia,Respiratory Diseases,1,1,235.0
4198.0,NCT04844658,"Covid-19, Hospitalized, PatIents, Nasafytol",,Recruiting,Coronavirus Infection,,,,,,,Drug: NASAFYTOL®|Drug: FULTIUM® -D3 800,Tilman S.A.|Artialis,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2021-02-17,01/09/21,2021-01-09,14/04/21,14/04/21,"Delta Hospital, Brussels",Belgium,Respiratory Diseases,1,1,-39.0
4199.0,NCT04642326,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,,"Active, not recruiting",COVID-19,,,,,,,Device: Test Group: experimental - UVC Therapy applied,RD Global Araştirma Geliştirme Sağlik Ilaç Inşaat Yatirimlari A.Ş.,All,"40 Years to 75 Years   (Adult, Older Adult)",50.0,Industry,Interventional,2020-06-26,01/07/20,2021-04-05,24/11/20,24/11/20,"Diyarbakır SBÜ Gazi Yaşargil Eğitim Ve Araştırma Hastanesi, Diyarbakır, Kayapınar",Turkey,Respiratory Diseases,1,1,283.0
4200.0,NCT04670003,Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application,SourceCOVID,Completed,COVID-19,,,,,,,Other: users,Weprom|Kelindi,All,"18 Years and older   (Adult, Older Adult)",4975.0,Other,Observational,2021-02-01,30/03/21,2021-03-30,17/12/20,08/04/21,"Institut Interrégional de Cancérologie, Le Mans",France,Respiratory Diseases,1,1,57.0
4201.0,NCT04427176,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Masq-Aute,Completed,Nurse,,,,,,,Device: ARFC mask,Centre Hospitalier Universitaire de Saint Etienne,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-04-29,28/05/20,2020-05-28,11/06/20,29/06/20,"CHU Saint-Etienne, Saint-Étienne",France,Others,0,1,29.0
4202.0,NCT04412018,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,,Recruiting,COVID-19,Inflammatory Response,,,,,,Drug: Icosapent ethyl,"Canadian Medical and Surgical Knowledge Translation Research Group|Amarin Corporation|HLS Therapeutics, Inc",All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-06,01/12/20,2020-01-12,02/06/20,11/09/20,"North York Diagnostic and Cardiology Clinic, Toronto, Ontario",Canada,Respiratory Diseases,1,2,-85.0
4203.0,NCT04366063,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,,Recruiting,COVID-19,,,,,,,Biological: Cell therapy protocol 1|Biological: Cell therapy protocol 2,Royan Institute|Tehran University of Medical Sciences|Shahid Beheshti University of Medical Sciences,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-05-04,06/06/20,2020-10-12,28/04/20,30/04/20,"Royan Institute, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,1,161.0
4204.0,NCT04590209,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,ACROCOVID,Not yet recruiting,Adult Patients With Lesions on Fingers or Toes,,,,,,,Other: Blood sampling|Other: Skin biopsy,Assistance Publique - Hôpitaux de Paris|Institut Cochin,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2020-01-10,01/12/20,2020-01-12,19/10/20,19/10/20,"Department of Dermatology, Tarnier hospital, AP-HP, Paris",France,Others,0,1,2.0
4205.0,NCT04439071,A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),FITE19,Recruiting,Pneumonia,COVID-19,Coronavirus,,,,,Drug: PTC299|Other: SOC|Drug: Placebo,PTC Therapeutics,All,"18 Years and older   (Adult, Older Adult)",380.0,Industry,Interventional,2020-09-07,31/07/21,2021-07-31,19/06/20,08/04/21,"University of California, Irvine, Orange, California, United States|Augusta University, Augusta, Georgia, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|University of Massachusetts Memorial Health Care, Worcester, Massachusetts, United States|Salisbury VA Medical Center, Salisbury, North Carolina, United States|University Hospitals Cleveland, Cleveland, Ohio, United States|Ralph H. Johnson VA Medical Center, Charleston, South Carolina, United States|Columbia VA Health Care System, Columbia, South Carolina, United States|Westmead Hospital, Westmead, New South Wales, Australia|Monash Medical Centre, Clayton, Victoria, Australia|Sunshine Hospital, St. Albans, Victoria, Australia|St. Pierre University Hospital, Brussels, Belgium|Clinique Saint Pierre, Ottignies, Belgium|Hospital Vera Cruz, Belo Horizonte, MG, Brazil|Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu, SP, Brazil|Hospital Guilherme Alvaro, Santos, SP, Brazil|Hospital Santa Casa de Misecórdia de Sorocoba, Sorocaba, SP, Brazil|Instituto de Infectologia Emílio Ribas, São Paulo, SP, Brazil|Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, SP, Brazil|Escola Paulista de Medicina (UNIFESP), São Paulo, SP, Brazil|Hospital General Dr. Manuel Gea González, Ciudad de Mexico, Cdmx, Mexico|Centro Hospitalario MAC, Irapuato, Guanajuato, Mexico|Hospital Universitario Dr. José Eleuterio Gonzalez, Monterrey, Nuevo León, Mexico|Centro Hospitalar Universitário de Lisboa Norte (CHULN), E.P.E - Hospital de Santa Maria, Lisboa, Portugal|Centro Hospitalar de Entre o Douro e Vouga, EPE (CHEDV), Santa Maria da Feira, Portugal|Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (CHVNG/E), Vila Nova de Gaia, Portugal|Hospital Del Mar, Barcelona, Spain|Hospital Universitario de Bellvitge, Barcelona, Spain|Hospital Universitario Infanta Leonor, Madrid, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital 12 de Octubre, Madrid, Spain|Hospital Universitario Infanta Sofía, San Sebastián de los Reyes",Spain,Respiratory Diseases,1,3,327.0
4206.0,NCT04365764,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,,Recruiting,COVID-19,ARDS,Pneumonia,,,,,,Groupe Hospitalier Pitie-Salpetriere|Centre Hospitalier Intercommunal Robert Ballanger|Centre Hospitalier Intercommunal Montfermeil-Le Raincy|CMC Ambroise Paré,All,"Child, Adult, Older Adult",400.0,Other,Observational,2020-03-14,31/12/22,2022-12-31,28/04/20,01/04/21,"Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-sous-Bois, France|Centre Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil",France,Respiratory Diseases,1,3,1022.0
4207.0,NCT04544878,Pediatric Intensive Care and COVID-19,CLOVIS,Recruiting,COVID-19,Pediatric ALL,Infection,Critical Illness,SARS-CoV Infection,,,,Bicetre Hospital,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-03-26,01/06/21,2021-01-06,10/09/20,10/09/20,"Pediatric Intensive Care and Neonatal Medicine, Bicêtre Hospital, AP-HP PAris Saclay University, Le Kremlin-Bicêtre",France,"Cardiovascular Diseases, Respiratory Diseases",1,5,286.0
4208.0,NCT04528888,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,STAUNCH-19,Not yet recruiting,COVID-19,SARS-CoV Infection,"Pneumonia, Viral",Coagulopathy,,,,Drug: Enoxaparin|Drug: Methylprednisolone|Drug: unfractionated heparin,Massimo Girardis|University of Modena and Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",210.0,Other,Interventional,2020-01-09,30/06/21,2021-07-30,27/08/20,27/08/20,,,Respiratory Diseases,1,4,568.0
4209.0,NCT04422470,Registry of Patients With Hematologic Disease and COVID-19 in Russia,CHRONOS19,Recruiting,Coronavirus Infection and Hematologic Diseases,,,,,,,Other: Non-interventional study,"National Research Center for Hematology, Russia|Foundation for Cancer Research Support (RakFond)|Enrollme.ru LLC",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-06-22,22/01/21,2021-07-22,09/06/20,13/11/20,"Regional Clinical Hospital No1, Ekaterinburg, Russian Federation|Republican Clinical Hospital of Tatarstan, Kazan, Russian Federation|City Hospital n.a. V.V. Veresaev, Moscow, Russian Federation|Clinical Hospital n.a. S.P. Botkin, Moscow, Russian Federation|National Research Center for Hematology, Moscow, Russian Federation|Regional Clinical Hospital N.A. Semashko, Nizhny Novgorod, Russian Federation|Regional Hospital, Novosibirsk, Russian Federation|Regional Clinical Hospital, Omsk, Russian Federation|Republican Clinical Hospital No4, Saransk, Russian Federation|Republic Clinical Hospital n.a. N.A. Semashko, Ulan-Ude, Russian Federation|Regional Clinical Hospital, Vladimir, Russian Federation|Regional Clinical Hospital No2, Vladivostok, Russian Federation|Republican Hospital No1, Yakutsk, Russian Federation|Regional Clinical Hospital, Yaroslavl",Russian Federation,Respiratory Diseases,1,1,395.0
4210.0,NCT04355442,Evolution of Facial Trauma During COVID Containment Measures,Traumax,Completed,Maxillofacial Injuries,Skull Fractures,COVID-19,,,,,Procedure: Facial fractures reduction or osteosynthesis,"University Hospital, Montpellier|Unités de CMF des CHU de Paris (Dr Davrou - Pitié salpetrière)|Amiens (Dr Dapke)|Nantes (Pr Corre)|Toulouse (Pr Lauwers - Purpan)|Marseille (Dr Foletti - La conception)|Nice (Dr Savoldelli)|Clermont Ferrand (Dr Sesque)|Perpignan (Dr Llobet)|Lyon (Dr Bourlet - Croix Rousse)",All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-01-04,01/05/20,2020-05-30,21/04/20,29/07/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,3,147.0
4211.0,NCT04336345,Outcomes of Patients With COVID-19 in the Intensive Care Unit,MexCOVID-19,Completed,Coronavirus Infections,COVID-19,Viral Pneumonia Human Coronavirus,,,,,,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2020-01-04,30/04/20,2020-04-06,07/04/20,10/11/20,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico|All centres from Mexico willing to contribute are Welcome., Mexico",Mexico,Respiratory Diseases,1,3,93.0
4212.0,NCT04517396,FEnofibRate as a Metabolic INtervention for COVID-19,FERMIN,Enrolling by invitation,COVID-19,,,,,,,Other: Fenofibrate/fenofibric acid|Other: Placebo|Other: Usual care,"University of Pennsylvania|University of Arizona|Universidad Católica de Santa María (National Sponsor in Perú)|Hospital Adolfo Guevara Velasco, Peru|Hospital Nacional Edgardo Rebagliati Martins|Hospital Nacional Alberto Sabogal Sologuren, Peru|Hospital Nacional Guillermo Almenara Irigoyen, Peru|Hospital Nacional Carlos Seguín Escobedo, Peru|Universidad de Santander, Bucaramanga, Colombia (National Sponsor in Colombia)|National Center for Advancing Translational Science (NCATS)|Hospitales Civiles de Guadalajara, Mexico",All,"18 Years and older   (Adult, Older Adult)",700.0,Other|NIH,Interventional,2020-08-18,31/10/21,2021-10-31,18/08/20,08/03/21,"University of Pennsylvania Health System, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,439.0
4213.0,NCT04641182,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,,Completed,COVID-19,Ards,Respiratory Failure,,,,,Other: Prone position,Pontificia Universidad Catolica de Chile,All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Observational,2020-06-07,16/08/20,2020-09-16,23/11/20,23/11/20,"Hospital Clinico Red de Salud UC - Christus, Santiago, Region Metropolitana",Chile,Respiratory Diseases,1,3,101.0
4214.0,NCT04374422,COVID-19 Pandemic and Female Sexual Behavior,,Completed,Sexual Behavior,COVID-19,,,,,,Behavioral: fsfi survey,Acibadem University,Female,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2020-10-04,12/04/20,2020-12-04,05/05/20,05/05/20,"Haseki Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,61.0
4215.0,NCT04786483,The Effect of Laughter Therapy on Students in the COVID-19 Pandemic,,"Active, not recruiting",Laughter Yoga,Anxiety,Life Satisfaction,Psychological Well-being,COVID-19,,,Other: Laughter Theraphy,Zonguldak Bulent Ecevit University|Prof. Dr. Şule Ecevit Alpar,All,"Child, Adult, Older Adult",80.0,Other,Interventional,2020-01-11,30/01/21,2021-10-05,08/03/21,08/03/21,"Zonguldak Bülent Ecevit University, Zonguldak",Turkey,"Mental Health, Respiratory Diseases",1,5,633.0
4216.0,NCT04805086,The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19,MONACO,Recruiting,Pulmonary Fibrosis,Interstitial Lung Disease,COVID-19,,,,,Biological: MON002,Guy's and St Thomas' NHS Foundation Trust|King's College London,All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2021-08-03,01/06/22,2023-05-03,18/03/21,18/03/21,"Guy's & St Thomas' NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,3,638.0
4217.0,NCT04515225,COVID-19 Prevalence in HIV-infected Patients,SeCoVIHA,Not yet recruiting,HIV Infections,,,,,,,Other: Blood Sample,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-09-15,15/09/20,2020-09-15,17/08/20,17/08/20,,,Others,0,1,0.0
4218.0,NCT04380714,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,,Completed,People Incarcerated,COVID-19,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",700.0,Other,Observational,2020-01-05,30/05/20,2020-01-08,08/05/20,29/12/20,"UH Montpellier, Montpellier",France,Respiratory Diseases,1,2,3.0
4219.0,NCT04660422,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,ACP-COVID,Recruiting,Advanced Care Planning,Shared Decision Making,Video Decision Aids,Communication Skills,Advance Directives,Natural Language Processing,COVID-19,Other: VitalTalk communication skills training|Other: ACP Decisions Video Program|Other: Intervention training:|Other: Medical Record Review,Dana-Farber Cancer Institute|National Institute on Aging (NIA),All,65 Years and older   (Older Adult),13150.0,Other|NIH,Observational,2020-12-15,14/05/21,2021-05-14,09/12/20,05/01/21,"Northwell Health, New Hyde Park, New York",United States,Respiratory Diseases,1,7,150.0
4220.0,NCT04780113,Evolution of Perceived Stress in General Practice Residents During COVID-19 Sanitary Crisis,,Recruiting,Stress,,,,,,,,Centre Hospitalier Eure-Seine,All,"18 Years and older   (Adult, Older Adult)",285.0,Other,Observational,2021-02-25,25/10/21,2021-10-25,03/03/21,03/03/21,"CH Eure-Seine, Évreux",France,Mental Health,1,1,242.0
4221.0,NCT04419025,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,,Recruiting,COVID-19,Sars-CoV2,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Oxidative Stress,,,,Drug: N-acetylcysteine,Cambridge Health Alliance,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-23,31/03/21,2021-06-30,05/06/20,16/02/21,"CHA Cambridge Hospital, Cambridge, Massachusetts, United States|CHA Everett Hospital, Everett, Massachusetts, United States|CHA Respiratory Clinic, Somerville, Massachusetts, United States|CHA Somerville campus, Somerville, Massachusetts",United States,"Mental Health, Respiratory Diseases",1,4,280.0
4222.0,NCT04556864,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,,Not yet recruiting,COVID-19,Hemodynamic Instability,"ARDS, Human",,,,,,Juan Victor Lorente|Edwards Lifesciences|Andalusian Network for Design and Translation of Advanced Therapies,All,"18 Years and older   (Adult, Older Adult)",67.0,Other|Industry,Observational,2020-01-10,30/12/20,2021-01-04,21/09/20,21/09/20,"1. A.H. Juan Ramón Jiménez., Huelva, Andalucia, Spain|5. Hospital Virgen de la Victoria, Málaga, Andalucía, Spain|3. Hospital Universitario. Jerez de la Frontera., Jerez De La Frontera, Cádiz, Spain|4. Hospital Universitario de Álava., Alava, País Vasco, Spain|2. Hospital Universitario Infanta Leonor, Madrid",Spain,Respiratory Diseases,1,3,360.0
4223.0,NCT04435522,Maraviroc in Patients With Moderate and Severe COVID-19,,Completed,COVID-19,,,,,,,Drug: Maraviroc,Rhode Island Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",9.0,Other,Interventional,2020-01-10,31/12/20,2020-12-31,17/06/20,04/02/21,"Rhode Island Hospital, Providence, Rhode Island",United States,Respiratory Diseases,1,1,356.0
4224.0,NCT04401124,Status of Management of Surgery in Beijing During COVID-19,,Not yet recruiting,Gastric Cancer,Colorectal Cancer,Gastrointestinal Disease,,,,,Other: no intervention,"Beijing Friendship Hospital|Peking University First Hospital|Peking University People's Hospital|Peking University Third Hospital|Chinese PLA General Hospital|Beijing Hospital|Xuanwu Hospital, Beijing|Peking Union Medical College Hospital|Beijing Chao Yang Hospital|Beijing Cancer Hospital|China-Japan Friendship Hospital|Peking University Shougang Hospital",All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-05-25,31/05/20,2020-07-06,26/05/20,27/05/20,,,Cancers,1,3,42.0
4225.0,NCT04534569,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),,Completed,COVID-19,Acute Respiratory Failure,Acute Respiratory Distress Syndrome,,,,,Other: Experts consensus,NMC Specialty Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-04-09,03/10/20,2020-06-10,01/09/20,08/10/20,"NMC Specialty Hospital, Dubai",United Arab Emirates,Respiratory Diseases,1,3,62.0
4226.0,NCT04780555,Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19,,Not yet recruiting,COVID-19,,,,,,,,Abant Izzet Baysal University,All,"18 Years to 70 Years   (Adult, Older Adult)",150.0,Other,Observational,2021-01-03,01/05/21,2021-01-06,03/03/21,03/03/21,,,Respiratory Diseases,1,1,3.0
4227.0,NCT04476914,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,,Recruiting,Respiratory Failure,SARS-CoV 2,Corona Virus Infection,Post Intensive Care Unit Syndrome,Family Members,Post Traumatic Stress Disorder,Anxiety,,"University of Colorado, Denver|University of Washington|Tulane University|University of Vermont|Penn State University|Columbia University|South Shore Hospital|Evergreen Hospital|Brigham and Women's Hospital",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-06-29,31/12/21,2021-12-31,20/07/20,09/02/21,"Eastern Colorado Veterans Affairs Health Care System, University Of Colorado, Aurora, Colorado, United States|University of Colorado Hospital, Aurora, Colorado, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Brigham and Women's Medical Center, Boston, Massachusetts, United States|South Shore Medical Center, Weymouth, Massachusetts, United States|Columbia Milstein and Allen Hospitals, New York, New York, United States|Penn State Hershey Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|University of Vermont Medical Center, Burlington, Vermont, United States|University of Washington, Seattle, Washington",United States,"Mental Health, Respiratory Diseases",1,7,550.0
4228.0,NCT04358640,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,PSY_CO_CHU,Completed,Critical Illness,Sars-CoV2,SARS Pneumonia,Coronavirus Infection,"Stress Disorders, Post-Traumatic",,,,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",1784.0,Other,Observational,2020-09-04,27/04/20,2020-04-27,24/04/20,19/12/20,"Intensive care unit CHU Nimes, Nîmes",France,"Mental Health, Cardiovascular Diseases, Respiratory Diseases",1,5,-130.0
4229.0,NCT04322123,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Coalition-I,"Active, not recruiting",Coronavirus Infections,,,,,,,Drug: Hydroxychloroquine Oral Product|Drug: Hydroxychloroquine + azithromycin,Hospital do Coracao|Hospital Israelita Albert Einstein|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network|EMS,All,"18 Years and older   (Adult, Older Adult)",630.0,Other|Industry,Interventional,2020-01-04,30/08/20,2020-08-30,26/03/20,01/06/20,"Hospital Geral Clériston Andrade, Feira De Santana, BA, Brazil|Hospital Ana Nery - HAN/SESAB, Salvador, BA, Brazil|HHospital SAMUR, Vitória Da Conquista, BA, Brazil|Hospital Geral de Vitória da Conquista, Vitória Da Conquista, BA, Brazil|Hospital de Brasília, Brasilia, DF, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, DF, Brazil|Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina, Colatina, ES, Brazil|Hospital Vila da Serra, Nova Lima, MG, Brazil|Santa Casa de Misericórdia de São João Del Rei, São João Del Rei, MG, Brazil|Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina, Londrina, PR, Brazil|Instituto Estadual do Cérebro Paulo Niemeyer, Rio De Janeiro, RJ, Brazil|Hospital Geral de Caxias do Sul, Caxias do Sul, RS, Brazil|Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São Francisco - Irmandade Santa Casa de Porto Alegre, Porto Alegre, RS, Brazil|Hospital São José, Criciuma, SC, Brazil|Hospital Baía Sul - Baía Sul Medical Center, Florianópolis, SC, Brazil|Hospital Nereu Ramos, Florianópolis, Sc, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital de Amor - Unidade Barretos (Fundação PIO XII), Barretos, SP, Brazil|Casa de Saúde Santa Marcelina, São Paulo, SP, Brazil|Hospital Albert Einstein, São Paulo, SP, Brazil|Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, SP, Brazil|Hospital BP Mirante - Real e Benemérita, São Paulo, SP, Brazil|Hospital das Clínicas da FMUSP, São Paulo, SP, Brazil|Hospital do Servidor Público Estadual - HSPE - IAMSPE, São Paulo, SP, Brazil|Hospital São Paulo - UNIFESP, São Paulo, SP, Brazil|Hospital Sírio-Libanês, São Paulo, SP, Brazil|Hospital SEPACO, São Paulo, S",Brazil,Respiratory Diseases,1,1,239.0
4230.0,NCT04615949,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,,Not yet recruiting,COVID-19,Cardiovascular Diseases,Cardiovascular Risk Factor,,,,,"Drug: Cannabidiol, pharmaceutically produced with < 5 ppm THC|Drug: Placebo",Cardiol Therapeutics Inc.,All,"18 Years and older   (Adult, Older Adult)",422.0,Industry,Interventional,2020-01-12,01/09/21,2021-01-09,04/11/20,06/11/20,,,Respiratory Diseases,1,3,363.0
4231.0,NCT04312009,Losartan for Patients With COVID-19 Requiring Hospitalization,,Completed,Corona Virus Infection,Acute Respiratory Distress Syndrome,SARS-CoV Infection,,,,,Drug: Losartan|Other: Placebo,University of Minnesota|Bill and Melinda Gates Foundation,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-13,01/02/21,2021-01-02,17/03/20,13/04/21,"University of Florida Health Gainesville, Gainesville, Florida, United States|University of Florida Health Jacksonville, Jacksonville, Florida, United States|Grady Memorial Hospital, Atlanta, Georgia, United States|Henry Ford Hospital, Detroit, Michigan, United States|M Health Fairview Ridges Hospital, Burnsville, Minnesota, United States|M Health Fairview Southdale Hospital, Edina, Minnesota, United States|Hennepin County Medical Center, Minneapolis, Minnesota, United States|M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|North Memorial Health Hospital, Robbinsdale, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper University Hospital, Camden, New Jersey, United States|University of Cincinnati Medical Center, Cincinnati, Ohio",United States,Respiratory Diseases,1,3,264.0
4232.0,NCT04325906,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,,Recruiting,Prone Positioning,High Flow Nasal Cannula,Acute Respiratory Distress Syndrome,Corona Virus Infection,,,,Device: high flow nasal cannula (HFNC)|Procedure: Prone positioning (PP),Rush University Medical Center,All,"18 Years and older   (Adult, Older Adult)",346.0,Other,Interventional,2020-02-04,30/03/21,2021-06-30,30/03/20,21/12/20,"Rush University Medical Center, Chicago, Illinois",United States,Respiratory Diseases,1,4,512.0
4233.0,NCT04468958,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",,"Active, not recruiting",COVID-19,SARS-CoV2,,,,,,Biological: SAB-185|Other: Normal saline,"SAb Biotherapeutics, Inc.|Department of Health and Human Services|Joint Program Executive Office (JPEO) Chemical, Biological, Radiological, and Nuclear Defense (CBRND) Enabling Biotechnologies (EB)",All,18 Years to 60 Years   (Adult),28.0,Industry|U.S. Fed|Other,Interventional,2020-05-08,23/02/21,2021-01-04,13/07/20,04/03/21,"Alliance for Multispecialty Research, LLC, Wichita, Kansas, United States|SUNY Upstate Medical University, Syracuse, New York, United States|ICON Early Phase Services, San Antonio, Texas",United States,Respiratory Diseases,1,2,241.0
4234.0,NCT04380870,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,,Recruiting,Coronavirus Infection,,,,,,,Dietary Supplement: Chinese Herbal Medicine,"Center for Integrated Care|University of Utah|University of California, San Francisco",All,"18 Years to 114 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-11-04,11/04/21,2025-11-04,08/05/20,08/05/20,"Seattle Intstitute of East Asian Medicine, Seattle, Washington",United States,Respiratory Diseases,1,1,1826.0
4235.0,NCT04397471,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,COMET20d,Not yet recruiting,Healthy Volunteers for Bone Marrow Donation,,,,,,,Procedure: Bone Marrow Harvest,CCTU- Cancer Theme|Cambridge Cellular Therapies Laboratory|The Evelyn Trust|Cambridge University Hospitals NHS Foundation Trust,All,18 Years to 40 Years   (Adult),10.0,Other,Observational,2020-01-05,01/12/21,2021-01-12,21/05/20,21/05/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire",United Kingdom,Others,0,1,373.0
4236.0,NCT04361838,The COVID-19 ICU PRAYER Study,,Recruiting,Coronavirus Infection,,,,,,,Behavioral: prayer,Kansas City Heart Rhythm Institute,All,"18 Years to 110 Years   (Adult, Older Adult)",1000.0,Other,Interventional,2020-05-21,30/06/21,2021-08-31,24/04/20,21/02/21,"Research Medical Center, Kansas City, Missouri",United States,Respiratory Diseases,1,1,467.0
4237.0,NCT04413968,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",COVIDOCRECHE,Completed,Coronavirus,Coronavirus Infection,COVID-19,Sars-CoV2,,,,Diagnostic Test: Rapid detection test|Diagnostic Test: Nasopharyngeal swab|Diagnostic Test: Stool collection,Assistance Publique - Hôpitaux de Paris,All,"1 Month and older   (Child, Adult, Older Adult)",600.0,Other,Interventional,2020-02-06,02/07/20,2020-02-10,04/06/20,26/10/20,"Hopital Avicenne, Bobigny, France|Hôpital Jean Verdier - Service de Pédiatrie, Bondy, France|Hôpital Jean Verdier, Bondy, France|Hôpital Antoine béclère, Clamart, France|Hôpital Louis Mourier, Colombes, France|CH intercommunal de Créteil, Créteil, France|Hôpital Andé Mignot, Le Chesnay, France|Hôpital Trousseau, Paris, France|Hôpital Robert debré, Paris, France|CHU de Rouen, Rouen, France|Hôpital Annecy Genevois, Épagny",France,Respiratory Diseases,1,4,4.0
4238.0,NCT04668196,Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR),CATCOVID-AIR,Completed,COVID-19,Acute Respiratory Failure,Corona Virus Infection,,,,,Device: High-flow nasal cannula treatment|Device: Continuous positive airway pressure (CPAP) treatment|Device: Noninvasive ventilation treatment,Hospital Universitari Vall d'Hebron Research Institute|Barcelona Institute for Global Health,All,"18 Years and older   (Adult, Older Adult)",367.0,Other,Observational,2020-05-22,25/01/21,2021-01-25,16/12/20,13/04/21,"Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital General de Granollers, Granollers, Barcelona, Spain|Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Fundació Althaia, Manresa, Barcelona, Spain|Corporació Sanitària Parc Taulí, Sabadell, Barcelona, Spain|Hospital Universitari Mútua Terrassa, Terrassa, Bardelona, Spain|Hospital del Mar, Parc de Salut Mar, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Dr.Josep Trueta, Girona",Spain,Respiratory Diseases,1,3,248.0
4239.0,NCT04406688,Prediction of Acute Kidney Injury in Patients With COVID-19,,Recruiting,Acute Kidney Injury,COVID-19,ARDS,,,,,,University Hospital Muenster,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-06-22,01/02/21,2021-01-03,28/05/20,06/01/21,"University Hospital Münster, Münster, Germany|Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal|Centro Hospitalar e Universitário do Porto, Porto, Portugal|Hospital de la Vall d'Hebron, Barcelona, Spain|Hospital Germans Trias i Pujol, Barcelona, Spain|Hospital Sant Pau, Barcelona, Spain|Complejo Hospitalario de Navarra, Pamplona, Spain|Hospital Universitario Mutua Terrassa, Terrassa, Spain|Hospital la Fe, Valencia, Spain|Guy's & St. Thomas Hospital, London",United Kingdom,Respiratory Diseases,1,3,195.0
4240.0,NCT04663945,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,AFTER,Recruiting,COVID-19,Deconditioning,,,,,,Behavioral: Biobehavioral Tele-rehabilitation Sessions,"University of Colorado, Denver",All,"35 Years to 100 Years   (Adult, Older Adult)",45.0,Other,Interventional,2020-11-12,01/06/21,2021-01-08,11/12/20,05/02/21,"University of Colorado Hospital, Aurora, Colorado",United States,Respiratory Diseases,1,2,57.0
4241.0,NCT04719234,Lung Ultrasonography in COVID-19 Pneumonia,,Completed,Lung Ultrasound,Pneumonia,COVID-19,,,,,Device: lung ultrasonography,Bursa Yüksek İhtisas Education and Research Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-15,01/12/20,2020-01-12,22/01/21,22/01/21,"University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa",Turkey,Respiratory Diseases,1,3,-155.0
4242.0,NCT04815759,Dental Anxiety Among Children Pre and Post COVID 19 Pandemic,,Recruiting,Dental Anxiety,,,,,,,Other: routine dental restorative procedures,Hams Hamed Abdelrahman|Alexandria University,All,4 Years to 6 Years   (Child),82.0,Other,Observational,2021-01-03,27/04/21,2021-04-30,25/03/21,25/03/21,"Faculty of Dentistry, Alexandria University, Alexandria",Egypt,Mental Health,1,1,117.0
4243.0,NCT04391179,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,DICER,Completed,COVID-19,Corona Virus Infection,COVID-19,COVID-19,,,,Drug: Dipyridamole 100 Milligram(mg)|Drug: Placebo oral tablet,University of Michigan,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-31,22/02/21,2021-02-22,18/05/20,18/03/21,"University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,4,267.0
4244.0,NCT04375397,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,iNSPIRE,Recruiting,COVID-19,,,,,,,Drug: Ibrutinib|Drug: Placebo,"AbbVie|Janssen Research & Development, LLC|Pharmacyclics LLC (An AbbVie Company)",All,"18 Years and older   (Adult, Older Adult)",46.0,Industry|Other,Interventional,2020-06-06,19/03/21,2021-08-25,05/05/20,05/03/21,"Desert Regional Medical Center /ID# 224276, Palm Springs, California, United States|Stanford Univ School Medicine /ID# 221954, Stanford, California, United States|Medstar Washington Hospital Center /ID# 221886, Washington, District of Columbia, United States|GW Medical Faculty Associates /ID# 222023, Washington, District of Columbia, United States|Midway Immunology and Research /ID# 222004, Fort Pierce, Florida, United States|University of Miami /ID# 223227, Miami, Florida, United States|Triple O Research Institute /ID# 222944, West Palm Beach, Florida, United States|Brigham & Women's Hospital /ID# 221847, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center /ID# 222994, Boston, Massachusetts, United States|Intermountain Healthcare /ID# 221955, Salt Lake City, Utah",United States,Respiratory Diseases,1,1,445.0
4245.0,NCT04363528,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,COVIDOP-DVT,Recruiting,Deep Vein Thrombosis,,,,,,,Other: Doppler Echo,Versailles Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-24,30/10/20,2020-10-30,27/04/20,04/08/20,"Centre Hospitalier de Versailles, Le Chesnay",France,Others,0,1,189.0
4246.0,NCT04747249,Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19,COVIPACT 2,Not yet recruiting,Solid Carcinoma,Post Traumatic Stress Disorder,COVID-19,,,,,Other: Psychological support,Centre Francois Baclesse,All,"18 Years and older   (Adult, Older Adult)",115.0,Other,Interventional,2021-01-03,01/08/21,2022-01-03,10/02/21,10/02/21,"Centre Francois Baclesse, Caen",France,"Mental Health, Respiratory Diseases",1,3,365.0
4247.0,NCT04537975,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,,Withdrawn,Continuous Renal Replacement Therapy,Pulmonary Edema,COVID-19,,,,,Device: C2Rx|Other: Standard of Care (SOC),SeaStar Medical,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-09-15,15/11/20,2021-01-15,03/09/20,14/12/20,,,Respiratory Diseases,1,3,122.0
4248.0,NCT04427267,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,,Completed,COVID-19,,,,,,,Other: Personal protective equipment from biological hazard,"Federal State Budgetary Scientific Institution ""Izmerov Research Institute of Occupational Health""",All,18 Years to 45 Years   (Adult),6.0,Other,Observational,2020-03-06,27/06/20,2020-06-27,11/06/20,28/07/20,"Federal State Budgetary Scientific Institution Izmerov Research Institute of Occupational Health, Moscow",Russian Federation,Respiratory Diseases,1,1,113.0
4249.0,NCT04698044,Anxiety and Depression Perceived by Individuals With and Without Cancer During the COVID-19 Pandemic Period,,Completed,Anxiety,Depression,COVID-19,Cancer,Chronic Disease,,,Diagnostic Test: Hospital Anxiety Depression Scale,"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",All,"18 Years and older   (Adult, Older Adult)",1107.0,Other,Observational,2020-08-05,25/06/20,2020-06-25,06/01/21,07/01/21,"Sultan Abdülhamid Han Training and Research Hospital, Istanbul",Turkey,"Mental Health, Respiratory Diseases, Cancers",1,5,-41.0
4250.0,NCT04775966,CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic,COVADENE,Completed,Sleep Apnea Syndromes,,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",8477.0,Other,Observational,2021-01-15,15/02/21,2021-02-15,01/03/21,03/03/21,"Adene Group, Montpellier",France,Others,0,1,31.0
4251.0,NCT04696679,Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic,GPE-QolVID,Completed,Very Preterm Children With Dysexecutive Disorders,,,,,,,Other: Patient Quality of life assessment|Other: Control group Quality of life assessment,Assistance Publique Hopitaux De Marseille,All,7 Years to 9 Years   (Child),170.0,Other,Observational,2020-06-19,30/11/20,2020-12-31,06/01/21,29/01/21,"Assistance Publique des Hopitaux de Marseille, Marseille",France,Others,0,1,195.0
4252.0,NCT04316949,Predictors of Respiratory Failure in SARS-Cov-2 Infection,,Recruiting,COVID-19,,,,,,,,University of Bologna,All,"18 Years to 99 Years   (Adult, Older Adult)",350.0,Other,Observational,2020-03-20,30/04/20,2020-05-31,20/03/20,07/04/20,"University of Bologna - Department of Medical and Surgical Sciences, Bologna",Italy,Respiratory Diseases,1,1,72.0
4253.0,NCT04614025,Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,,Recruiting,COVID-19,ARDS,,,,,,Biological: PLX-PAD,Pluristem Ltd.,All,"18 Years to 85 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2020-01-11,01/05/21,2022-01-03,03/11/20,03/11/20,"University of hospital Bonn, Bonn, Germany|Hospital Cologne-Merheim, Köln, Germany|Emek Medical Center, Afula, Israel|University Hospital Samson Assuta Ashdod, Ashdod, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Health Care Campus, Haifa, Israel|Galilee Medical Center, Nahariya, Israel|Baruch Padeh Medical Center, Poriya, Tiberias",Israel,Respiratory Diseases,1,2,723.0
4254.0,NCT04636697,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,,Recruiting,COVID-19,,,,,,,Drug: Intramuscular injection|Biological: Intramuscular vaccine,Medicago,All,"18 Years and older   (Adult, Older Adult)",30918.0,Industry,Interventional,2020-11-19,31/12/21,2022-04-30,19/11/20,13/04/21,"Fiel Family and Sports Medicine/CCT, Tempe, Arizona, United States|Alliance for Multispecialty Research, Coral Gables, Florida, United States|Research Centers of America, Hollywood, Florida, United States|ASR, LLC, Nampa, Idaho, United States|Benchmark Research, Covington, Louisiana, United States|Methodist Physicians, Fremont, Nebraska, United States|Meridian Clinical Research LLC, Norfolk, Nebraska, United States|Meridian Clinical Research LLC, Omaha, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Benchmark Research, Austin, Texas, United States|Tekton Research, Austin, Texas, United States|Global Medical Research, Dallas, Texas, United States|DM Clinical Research/Martin Diagnostic Clinic, Tomball, Texas, United States|South Ogden Family Medicine, Ogden, Utah, United States|IWK Health Centre- Dalhousie University-Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada|Dawson Clinical Research Inc., Guelph, Ontario, Canada|Manna Research (Mirabel), Mirabel, Quebec, Canada|McGill University Health Centre Vaccine Study Centre, Pierrefonds, Quebec, Canada|CHU de Québec-Université Laval, Québec City, Quebec, Canada|Diex Research Quebec Inc., Québec, Quebec, Canada|Diex Recherche Joliette, Saint-Charles-Borromée, Quebec, Canada|Q&T Research Sherbrooke Inc., Sherbrooke, Quebec",Canada,Respiratory Diseases,1,1,527.0
4255.0,NCT04406844,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,,Recruiting,Oncology Patients,,,,,,,,Max Healthcare Insititute Limited,All,"12 Years to 98 Years   (Child, Adult, Older Adult)",150.0,Other,Observational,2020-09-05,30/06/21,2021-06-30,28/05/20,22/07/20,"Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre, New Delhi",India,Others,0,1,298.0
4256.0,NCT04429529,"Safety of TY027, a Treatment for COVID-19, in Humans",,Completed,COVID-19,,,,,,,Biological: TY027|Other: 0.9% Saline,Tychan Pte Ltd.,All,21 Years to 50 Years   (Adult),32.0,Industry,Interventional,2020-09-06,19/11/20,2021-01-20,12/06/20,08/04/21,"SingHealth Investigational Medicine Unit, Singapore",Singapore,Respiratory Diseases,1,1,136.0
4257.0,NCT04320238,Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff,,Recruiting,COVID-19,,,,,,,Drug: recombinant human interferon Alpha-1b|Drug: thymosin alpha 1,Shanghai Jiao Tong University School of Medicine,All,"18 Years to 65 Years   (Adult, Older Adult)",2944.0,Other,Interventional,2020-01-21,01/05/20,2020-01-06,24/03/20,31/03/20,"Taihe Hospital, Shiyan, Hubei",China,Respiratory Diseases,1,1,-15.0
4258.0,NCT04335279,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,SPIN-CHAT,Completed,Scleroderma,"Scleroderma, Systemic",Systemic Sclerosis,,,,,Other: SPIN-CHAT Program,Lady Davis Institute,All,"18 Years and older   (Adult, Older Adult)",172.0,Other,Interventional,2020-09-04,03/06/20,2020-07-24,06/04/20,30/11/20,"Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec",Canada,Others,0,3,-42.0
4259.0,NCT04609722,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,,Recruiting,Anxiety,Parents,COVID-19,,,,,Other: Solution-Focused Support Program,Adiyaman University Research Hospital,All,18 Years to 45 Years   (Adult),60.0,Other,Interventional,2020-01-07,01/02/21,2021-02-15,30/10/20,13/01/21,"Online- Data will be collected through the form created with the Google-Forms, Adıyaman",Turkey,"Mental Health, Respiratory Diseases",1,3,405.0
4260.0,NCT04348461,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,,Suspended,COVID-19,Respiratory Distress Syndrome,,,,,,Drug: Allogeneic and expanded adipose tissue-derived mesenchymal stromal cells,"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|Instituto de Investigación Sanitaria y Biomédica de Alicante|Hospital General Universitario Gregorio Marañon|Clinica Universidad de Navarra, Universidad de Navarra|Hospital Universitario de Salamanca|Hospital General Universitario de Alicante|Hospital Clínico Universitario Virgen de la Arrixaca",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-05,15/09/20,2021-09-30,16/04/20,17/03/21,"Fundacion Jimenez Diaz, Madrid",Spain,Respiratory Diseases,1,2,482.0
4261.0,NCT04705831,Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection,,Recruiting,Post-Viral Fatigue Syndrome,Post-Viral Disorder (Disorder),COVID-19,,,,,Drug: Ruconest,IMMUNOe Research Centers,All,"18 Years to 75 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2020-12-30,01/01/22,2022-01-01,12/01/21,12/01/21,"IMMUNOe Research Centers, Centennial, Colorado",United States,Respiratory Diseases,1,3,367.0
4262.0,NCT04373096,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,,Recruiting,COVID-19,,,,,,,Device: current IPAC-UHN PPE|Device: modified IPAC-UHN PPE,"University Health Network, Toronto",All,"20 Years to 75 Years   (Adult, Older Adult)",42.0,Other,Interventional,2020-07-12,31/08/21,2021-10-31,04/05/20,11/01/21,"Toronto Western Hospital, Toronto, Ontario",Canada,Respiratory Diseases,1,1,476.0
4263.0,NCT04750265,Robotic Assisted Early Mobilization in Ventilated ICU Patients With COVID-19,,Recruiting,COVID-19,Critical Illness,Critical Illness Polyneuromyopathy,Early Mobilization,Rehabilitation,Robotics,,Device: Robotic assisted early mobilization,"Charite University, Berlin, Germany|Reactive Robotics GmbH",All,"18 Years to 100 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-21,01/11/21,2021-01-12,11/02/21,18/03/21,"Charité - Univiversitätsmedizin Berlin, Berlin-Mitte, Berlin",Germany,"Cardiovascular Diseases, Respiratory Diseases",1,6,-9.0
4264.0,NCT04699916,EEG-based Sedation Protocol for Patients on Mechanical Ventilation Due to SARS-CoV-2 Pneumonia,,Not yet recruiting,Sedation Complication,COVID-19,,,,,,Other: EEG based protocol for deep sedation,University of Chile,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2021-04-01,30/06/21,2021-12-31,07/01/21,08/01/21,,,Respiratory Diseases,1,2,274.0
4265.0,NCT04389450,"Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",,Recruiting,COVID-19,ARDS,,,,,,Biological: PLX-PAD|Biological: Placebo,Pluristem Ltd.,All,"40 Years to 80 Years   (Adult, Older Adult)",140.0,Industry,Interventional,2020-01-10,01/05/21,2022-01-03,15/05/20,29/10/20,"University of California Irvine, Irvine, California, United States|University of Southern California (USC) - Keck School of Medicine (KSOM), Los Angeles, California, United States|University Of California Davis,4860 Y Street, Sacramento, California, United States|Baptist Health Medical Center, Jacksonville, Florida, United States|Medical College of Georgia at Augusta University, Augusta, Georgia, United States|Sarah Cannon Research Institute, LLC (Mercer University School of Medicine), Macon, Georgia, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Cooper Research Institute, Camden, New Jersey, United States|Holy Medical Center, Teaneck, New Jersey, United States|Montefiore Medical Center, New York, New York, United States|Maimonides Medical Center, New York, New York, United States|Mercy Medical Center, New York, New York, United States|Thomas Jefferson University, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,724.0
4266.0,NCT04504877,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,BONSAI,"Active, not recruiting",COVID-19,Burn Out,Post Traumatic Stress Disorder,,,,,Drug: Cannabidiol,University of Sao Paulo,All,24 Years to 60 Years   (Adult),120.0,Other,Interventional,2020-06-16,16/11/20,2020-12-16,07/08/20,04/11/20,"Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, SP",Brazil,"Mental Health, Respiratory Diseases",1,3,183.0
4267.0,NCT04728880,Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience,,Recruiting,"Pneumonia, Viral",,,,,,,Drug: Remdesivir,Mansoura University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2021-01-26,31/03/21,2021-05-30,28/01/21,28/01/21,"Mansoura University Hospital, Mansoura, Dakahliya",Egypt,Respiratory Diseases,1,1,124.0
4268.0,NCT04469660,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,,Recruiting,Psychological Stress,,,,,,,,Max Healthcare Insititute Limited,All,"18 Years to 90 Years   (Adult, Older Adult)",1300.0,Other,Observational,2020-05-18,30/08/20,2020-09-30,14/07/20,14/07/20,"Max Super Speciality Hospital Saket, New Delhi, Delhi",India,Mental Health,1,1,135.0
4269.0,NCT04380779,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,BLEEDING,Completed,COVID-19,,,,,,,,Manuel Monreal|Foundation for the study of VTE diseases. (FUENTE),All,"Child, Adult, Older Adult",2430.0,Other,Observational,2020-04-13,13/10/20,2020-10-13,08/05/20,14/12/20,"Manuel Monreal, Badalona, Barcelona",Spain,Respiratory Diseases,1,1,183.0
4270.0,NCT04322344,Escin in Patients With Covid-19 Infection,add-on-COV2,Recruiting,Coronavirus Infections,,,,,,,Drug: Escin|Drug: standard therapy,"University of Catanzaro|Azienda Ospedaliera Pugliese Ciaccio|Azienda Ospedaliera Universitaria Mater Domini, Catanzaro",All,"18 Years to 75 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-03-23,30/06/20,2020-12-30,26/03/20,16/09/20,"Luca Gallelli, Catanzaro",Italy,Respiratory Diseases,1,1,282.0
4271.0,NCT04408131,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,COVIDHomeless,Recruiting,Homeless,,,,,,,Biological: Blood sample,Assistance Publique Hopitaux De Marseille,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-05-28,27/01/21,2021-01-27,29/05/20,29/05/20,"Assistance Publique Hôpitaux de Marseille, Marseille, Paca",France,Others,0,1,244.0
4272.0,NCT04389801,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: Desferal 500 MG Injection,Hesham Al-Inany|Cairo University,All,"Child, Adult, Older Adult",200.0,Other,Interventional,2020-01-06,30/09/20,2020-12-31,15/05/20,15/05/20,,,Respiratory Diseases,1,1,360.0
4273.0,NCT04373109,Stroke Rehabilitation Outcome During COVID-19 Lockdown,SROCL,Completed,Stroke,Rehabilitation,COVID-19,Cohort Studies,,,,Behavioral: Observation,Jeremia Held|University of Zurich,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Observational,2020-04-16,12/10/20,2020-12-10,04/05/20,20/10/20,"University Hospital Zurich, Zurich",Switzerland,"Cardiovascular Diseases, Respiratory Diseases",1,4,238.0
4274.0,NCT04668209,Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19),CX4945,Recruiting,Coronavirus,,,,,,,Drug: Silmitasertib,"University of Arizona|Senhwa Biosciences, Inc.",All,"18 Years and older   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2021-01-01,30/09/21,2021-09-30,16/12/20,06/04/21,"Banner University Medical Center Phoenix, Phoenix, Arizona, United States|Banner University Medical Center Tucson, Tucson, Arizona",United States,Respiratory Diseases,1,1,272.0
4275.0,NCT04496869,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,PsyCovART,Not yet recruiting,Infertility Treatment,Women,,,,,,Other: Online questionnaire,Hospices Civils de Lyon,Female,18 Years to 43 Years   (Adult),600.0,Other,Observational,2020-01-07,01/09/20,2020-01-12,03/08/20,03/08/20,"Hôpital Femme Mère Enfant, Bron",France,Others,0,2,5.0
4276.0,NCT04440098,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,,Completed,Loneliness,Depression,Anxiety,Alcohol Abuse,Drug Abuse,,,,University of Miami,All,18 Years to 35 Years   (Adult),1008.0,Other,Observational,2020-04-22,11/05/20,2020-11-05,19/06/20,19/06/20,"University of Miami, Miami, Florida",United States,Mental Health,1,5,197.0
4277.0,NCT04374786,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,,Enrolling by invitation,Perceived Stress,Anxiety,Sleep Disturbance,Burnout,PTSD,,,Device: Calm Meditation App,University of Arizona,All,"18 Years to 99 Years   (Adult, Older Adult)",328.0,Other,Interventional,2020-05-15,01/09/20,2020-01-10,05/05/20,04/06/20,"Banner University Medical Center Phoenix, Phoenix, Arizona",United States,Mental Health,1,5,-126.0
4278.0,NCT04435080,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,,Completed,COVID-19,Acute Respiratory Distress Syndrome,Rehabilitation,Intensive Care Unit Acquired Weakness,Critical Illness Polyneuromyopathy,,,,Koç University,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Observational,2020-03-15,11/06/20,2020-11-06,17/06/20,17/06/20,"Koc University School of Medicine, Istanbul",Turkey,"Cardiovascular Diseases, Respiratory Diseases",1,5,236.0
4279.0,NCT04390412,Low Dose Radiotherapy in COVID-19 Pneumonia,,"Active, not recruiting",COVID-19,SARS (Severe Acute Respiratory Syndrome),,,,,,Radiation: Low Dose Radiotherapy,Shahid Beheshti University of Medical Sciences,All,"60 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-04-05,30/08/20,2020-01-12,15/05/20,10/11/20,"Imam Hossein Hospital, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,2,-84.0
4280.0,NCT04420364,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,,Not yet recruiting,COVID-19,Kidney Transplant; Complications,Immunosuppression,,,,,Other: Maintenance or reduction of immunosuppression,Brigham and Women's Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-03,30/09/21,2021-12-31,09/06/20,01/02/21,,,Respiratory Diseases,1,3,362.0
4281.0,NCT04359836,A Study to Explore the Role of Gut Flora in COVID-19 Infection,,Recruiting,Gut Microbiome,Gastrointestinal Microbiome,COVID-19,COVID-19,Corona Virus Infection,Coronavirus,Coronaviridae Infections,Other: There is no intervention in this study,ProgenaBiome,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-04-16,30/04/21,2021-07-31,24/04/20,08/04/21,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,7,471.0
4282.0,NCT04410835,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,,Recruiting,Corona Virus Infection,Psychiatric Disorder,Psychological Distress,,,,,Diagnostic Test: Online Survey,Medical University of Graz,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-28,31/12/20,2021-04-28,01/06/20,11/06/20,"Medical University Graz, Department of Psychiatry and Psychotherapeutic Medicine, Graz, Styria",Austria,Respiratory Diseases,1,3,365.0
4283.0,NCT04395716,A Study of ResCure™ to Treat COVID-19 Infection,,Withdrawn,COVID-19,COVID-19,Corona Virus Infection,Sars-CoV2,Coronavirus-19,SARS Pneumonia,SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere,Biological: ResCure™,"ProgenaBiome|Rinati Skin, LLC",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-01,01/06/21,2021-01-11,20/05/20,08/04/21,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,7,376.0
4284.0,NCT04525820,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",VitCov,Recruiting,COVID-19,Vitamin D Deficiency,Corona Virus Infection,ARDS,Coronavirus,SARS-CoV Infection,,Drug: Single high dose vitamin D|Drug: Placebo|Drug: Treatment as usual vitamin D,"Prof. Dr. Jörg Leuppi|Cantonal Hosptal, Baselland",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-12-15,31/05/21,2021-06-30,25/08/20,12/03/21,"Cantonal Hospital Aarau, Aarau, AG, Switzerland|Cantonal Hospital Baselland Liestal, Liestal, BL, Switzerland|Cantonal Hospital St. Gallen, Saint Gallen, SG",Switzerland,Respiratory Diseases,1,6,197.0
4285.0,NCT04425733,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),,Withdrawn,COVID-19,Pneumonia,Hypoxemia,,,,,Drug: MK-5475|Drug: Placebo,Merck Sharp & Dohme Corp.,All,"18 Years to 80 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-07-07,10/11/20,2020-10-11,11/06/20,14/08/20,,,Respiratory Diseases,1,3,96.0
4286.0,NCT04433546,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",VANGARD,Terminated,Acute Respiratory Distress Syndrome,Coronavirus,Hypoxic Respiratory Failure,Hypoxemic Respiratory Failure,Respiratory Complication,Respiratory Insufficiency,Cardiac Dysfunction,Drug: Pemziviptadil (PB1046)|Drug: Low Dose (10 mg) Control,PhaseBio Pharmaceuticals Inc.,All,"18 Years to 85 Years   (Adult, Older Adult)",54.0,Industry,Interventional,2020-07-15,02/12/20,2020-02-12,16/06/20,11/12/20,"Baptist Health Research Institute, Jacksonville, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|The University of Kansas Medical Center, Kansas City, Kansas, United States|Adventist Healthcare White Oak Medical Center, Silver Spring, Maryland",United States,Respiratory Diseases,1,7,-154.0
4287.0,NCT04775056,A Study to Evaluate Vaccines Against COVID-19 in the Real World,,Not yet recruiting,Chronic Liver Disease,Hepatic Carcinoma,,,,,,,Humanity & Health Medical Group Limited,All,"18 Years and older   (Adult, Older Adult)",30000.0,Other,Observational,2021-03-15,31/12/21,2022-03-31,01/03/21,02/03/21,"Humanity & Health Medical Group, Hong Kong",Hong Kong,Others,0,2,381.0
4288.0,NCT04615676,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,COPREG,Completed,SARS-CoV2,,,,,,,Other: Follow-up phone call,"University Hospital, Toulouse",All,"15 Years and older   (Child, Adult, Older Adult)",4734.0,Other,Observational,2020-04-27,17/07/20,2020-07-17,04/11/20,09/11/20,"University Hospital of Toulouse, Toulouse",France,Respiratory Diseases,1,1,81.0
4289.0,NCT04595903,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With Hemopurifier® Device,,Not yet recruiting,SARS (Severe Acute Respiratory Syndrome),,,,,,,Device: Hemopurifier,Aethlon Medical Inc.,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2021-01-01,01/08/21,2021-01-08,22/10/20,14/01/21,"Hoag Hospital - Irvine, Irvine, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California",United States,Others,0,1,7.0
4290.0,NCT04331613,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,,Recruiting,COVID-19,Acute Respiratory Distress Syndrome,Virus; Pneumonia,Acute Lung Injury,,,,Biological: CAStem,Chinese Academy of Sciences|Beijing YouAn Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",9.0,Other,Interventional,2020-01-27,01/12/20,2020-01-12,02/04/20,02/04/20,"Beijing YouAn Hospital, Capital Medical University, Beijing, Beijing, China",China,Respiratory Diseases,1,4,-15.0
4291.0,NCT04403269,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",GERONIMO 19,Recruiting,Sars-CoV2,,,,,,,Drug: IgIV,Versailles Hospital,All,75 Years and older   (Older Adult),35.0,Other,Interventional,2020-05-05,05/05/21,2021-05-05,27/05/20,27/05/20,"Centre Hospitalier de Versailles, Le Chesnay",France,Respiratory Diseases,1,1,365.0
4292.0,NCT04331054,Protective Role of Inhaled Steroids for Covid-19 Infection,INHASCO,Recruiting,COVID-19,Hospitalization in Respiratory Disease Department,,,,,,Drug: 2: Usual practice + SYMBICORT RAPIHALER|Other: 1: Usual practice,Assistance Publique - Hôpitaux de Paris,All,"18 Years to 75 Years   (Adult, Older Adult)",436.0,Other,Interventional,2020-04-13,13/01/22,2022-01-13,02/04/20,16/09/20,"Hôpital Bichat - Service de Pneumologie, Paris",France,Respiratory Diseases,1,2,640.0
4293.0,NCT04374474,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),,Withdrawn,Olfactory Disorder,,,,,,,Other: Olfactory retraining|Drug: corticosteroid nasal irrigation|Other: smell household Items|Other: Nasal Irrigation,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2021-10-01,10/12/21,2022-10-03,05/05/20,21/02/21,"St. Joseph's Health Care, London, Ontario",Canada,Others,0,1,367.0
4294.0,NCT04337502,Clinical and Radiomic Model of COVID-19,,Completed,Coronavirus,Machine Learning,,,,,,Diagnostic Test: Machine learning model,Maastricht University|Wuhan Central Hospital,All,"Child, Adult, Older Adult",300.0,Other,Observational,2019-12-23,20/01/20,2020-03-03,07/04/20,07/04/20,"The central hospital of Wuhan, Wuhan, Hubei",China,Respiratory Diseases,1,2,71.0
4295.0,NCT04535167,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.",,Recruiting,Viral Disease,,,,,,,Drug: PF-07304814|Drug: Placebo,Pfizer,All,"18 Years to 79 Years   (Adult, Older Adult)",72.0,Industry,Interventional,2020-09-09,19/05/21,2021-05-19,01/09/20,29/03/21,"El Camino Health, Mountain View, California, United States|Palo Alto Medical Foundation, Mountain View, California, United States|Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States|UC Davis Medical Center, Sacramento, California, United States|Holy Cross Hospital, Fort Lauderdale, Florida, United States|University of Iowa, Iowa City, Iowa, United States|Henry Ford Health System, Detroit, Michigan, United States|Sisters of Charity Hospital St. Joseph Campus, Cheektowaga, New York, United States|Trinity Medical WNY, Williamsville, New York, United States|University Hospital Brugmann, Brussels, Belgium|Hopital Erasme, Brussels, Belgium|Hospital Universitario Puerta de Hierro de Majadahonda, Majadahonda, Madrid, Spain|Hospital Universitario Vall d'Hebron, Barcelona, Spain|Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain|Hospital Universitario Virgen Del Rocio, Sevilla",Spain,Others,0,1,252.0
4296.0,NCT04378244,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,CORONA,Not yet recruiting,COVID-19,Cytokine Storm,Acute Respiratory Distress Syndrome,,,,,Drug: DeltaRex-G,Aveni Foundation,All,"18 Years to 100 Years   (Adult, Older Adult)",18.0,Other,Interventional,2021-12-01,12/01/22,2022-12-03,07/05/20,12/11/20,,,Respiratory Diseases,1,3,367.0
4297.0,NCT04487210,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: MVC-COV1901,Medigen Vaccine Biologics Corp.,All,20 Years to 50 Years   (Adult),45.0,Industry,Interventional,2020-07-10,30/06/21,2021-06-30,27/07/20,25/03/21,"National Taiwan University Hospital, Taipei",Taiwan,Respiratory Diseases,1,1,355.0
4298.0,NCT04581070,"The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic""",,Terminated,Cancer,COVID-19,,,,,,,Cancer Trials Ireland,All,"18 Years and older   (Adult, Older Adult)",4.0,Other,Observational,2020-04-29,09/10/20,2020-09-10,09/10/20,30/10/20,"Mater Misericordiae University Hospital, Dublin, Ireland|University Hospital Limerick, Limerick, Ireland|University Hospital Waterford, Waterford",Ireland,"Respiratory Diseases, Cancers",1,2,134.0
4299.0,NCT04530461,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,,Recruiting,SARS-CoV Infection,Systemic Disease,Systemic Lupus Erythematosus,Sjogren's Syndrome,Sarcoidosis,Inflammatory Myopathy,Behçet Disease,Diagnostic Test: Serological test,faida agili|UR17DN02 : Autoimmune Diseases Research Unit|Military Hospital of Tunis,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,30/11/20,2021-01-31,28/08/20,22/09/20,"Military Hospital of Tunis, Tunis",Tunisia,"Respiratory Diseases, Immunological Disorders",1,7,391.0
4300.0,NCT04726865,COVID-19 Pandemic and Medical Students,,Completed,COVID-19,,,,,,,Other: Naser Al-Husban,University of Jordan|Aysha Alkhayat|Mariam Aljweesri|Reem Alharbi|Zahraa Aljazzaf,All,18 Years to 24 Years   (Adult),415.0,Other,Observational,2020-01-10,20/12/20,2020-12-31,27/01/21,27/01/21,"Al-Husban University Naser, Amman",Jordan,Respiratory Diseases,1,1,356.0
4301.0,NCT04313127,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,CTCOVID-19,"Active, not recruiting",COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),"CanSino Biologics Inc.|Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China|Jiangsu Province Centers for Disease Control and Prevention|Hubei Provincial Center for Disease Control and Prevention|Tongji Hospital",All,18 Years to 60 Years   (Adult),108.0,Industry|Other,Interventional,2020-03-16,30/12/20,2022-12-20,18/03/20,19/05/20,"Hubei Provincial Center for Disease Control and Prevention, Wuhan, Hubei",China,Respiratory Diseases,1,1,1009.0
4302.0,NCT04343963,Pyridostigmine in Severe SARS-CoV-2 Infection,PISCO,Recruiting,COVID-19,COVID-19,,,,,,Drug: Pyridostigmine Bromide|Drug: Placebo,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years and older   (Adult, Older Adult)",436.0,Other,Interventional,2020-04-04,30/09/20,2021-04-30,14/04/20,07/07/20,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Tlalpan",Mexico,Respiratory Diseases,1,2,391.0
4303.0,NCT04431284,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,CIO,Completed,Feeding and Eating Disorders,,,,,,,Other: Questionnaires,Hospices Civils de Lyon,All,"18 Years and older   (Adult, Older Adult)",37.0,Other,Observational,2020-06-16,16/12/20,2020-12-16,16/06/20,01/02/21,"Centre Intégré de l'obésité de Lyon / HCL, Pierre-Bénite",France,Others,0,1,183.0
4304.0,NCT04791241,A Check-list Including Lung Ultrasound for ED Patients With ARF,CHECKIRA-COVID,Recruiting,Acute Respiratory Failure,,,,,,,Other: check-list including lung ultrasound,Centre Hospitalier Metropole Savoie,All,"18 Years and older   (Adult, Older Adult)",105.0,Other,Interventional,2021-03-03,03/05/21,2021-04-05,10/03/21,10/03/21,"CH Annecy Genevois, Annecy, France|Centre Hospitalier Metropole Savoie, Chambéry, France|CHUGA, Grenoble",France,Respiratory Diseases,1,1,33.0
4305.0,NCT04455958,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,,Not yet recruiting,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,COVID-19,,,,,Drug: Lopinavir/Ritonavir|Drug: Placebo Administration|Other: Questionnaire Administration,OHSU Knight Cancer Institute|Oregon Health and Science University,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2020-01-11,01/11/21,2021-01-11,02/07/20,18/09/20,"OHSU Knight Cancer Institute, Portland, Oregon",United States,Respiratory Diseases,1,3,366.0
4306.0,NCT04321278,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),,Completed,Coronavirus Infections,"Pneumonia, Viral",,,,,,Drug: Hydroxychloroquine + azithromycin|Drug: Hydroxychloroquine,Hospital Israelita Albert Einstein|EMS|Hospital do Coracao|Hospital Sirio-Libanes|Brazilian Research In Intensive Care Network,All,"18 Years and older   (Adult, Older Adult)",440.0,Other|Industry,Interventional,2020-03-28,14/06/20,2020-06-14,25/03/20,20/01/21,"Hospital de Urgência e Emergência de Rio Branco, Rio Branco, AC, Brazil|Hospital e Clínica São Roque, Ipiaú, BA, Brazil|Hospital da Cidade, Salvador, BA, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, CE, Brazil|Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza, CE, Brazil|Hospital Unimed Cariri, Juazeiro Do Norte, CE, Brazil|Hospital Brasilia, Brasilia, DF, Brazil|Hospital Estadual Jayme dos Santos Neves, Serra, ES, Brazil|Hospital Evangélico de Vila Velha, Vila Velha, ES, Brazil|Secretaria de Estado de Saúde de Goias, Goiânia, GO, Brazil|Santa Casa de Misericórdia de Belo Horizonte Santa Casa de BH, Belo Horizonte, MG, Brazil|Hospital Santa Paula, Passos, MG, Brazil|Santa Casa da Misericordia - UTI (São João Del Rey), São João Del Rei, MG, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Hospital Adventista de Belém, Belém, Pará, Brazil|Hospital Adventista de Belem, Belem, PA, Brazil|Procape - Pronto S.Cardiologico de Pe.Prof.Luiz Tavares-, Recife, PE, Brazil|Liga Paranaense de Combate ao Câncer, Curitiba, PR, Brazil|Hospital Giselda Trigueiro, Natal, Rio Grande Do Norte, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, RJ, Brazil|Hospital São Lucas, Rio De Janeiro, RJ, Brazil|Hospital Maternidade PROMATER, Natal, RN, Brazil|Associação Dr. Bartholomeu Tacchini, Bento Gonçalves, RS, Brazil|Hospital Geral de Caxias do Sul, Caxias Do Sul, RS, Brazil|Hospital Bruno Born, Lajeado, RS, Brazil|Hospital São Vicente de Paulo, Passo Fundo, RS, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Hospital Nereu Ramos, Florianópolis, SC, Brazil|Hospital Universitário Polydoro Ernani de São Thiago/HU - UFSC, Florianópolis, SC, Brazil|Centro Hospitalar Unimed, Joinville, SC, Brazil|Hospital Dona Helena, Joinville, SC, Brazil|Hospital Municipal Sao Jose, Joinville, SC, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, SC, Brazil|Faculdade de Medicina de Botucatu, Botucatu, SP, Brazil|nstituto de Pesquisa Clínica de Campinas, Campinas, SP, Brazil|Fundação do ABC (Hospital Estadual Mário Covas), Santo André, SP, Brazil|AC Camargo Cancer Center - Fundação Antonio Prudente, São Paulo, SP, Brazil|Casa de Saude Santa Marcelina, São Paulo, SP, Brazil|Hospital Alemão Oswaldo Cruz, São Paulo, SP, Brazil|Hospital Moriah, São Paulo, SP, Brazil|Hospital Nove de Julho, São Paulo, SP, Brazil|Hospital Santa Paula, São Paulo, SP, Brazil|Hospital São Camilo Pompeia, São Paulo, SP, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|A Beneficência Portuguesa de São Paulo - BP, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital Vila Santa Catarina, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP - 1, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Serv Social da Industria do papel, papelão e cortiça do estado de SP, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo",Brazil,Respiratory Diseases,1,2,78.0
4307.0,NCT04500652,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,,Recruiting,Anxiety,Depression,Insomnia,COVID-19,Coronavirus,,,,Dokuz Eylul University,All,"24 Years to 80 Years   (Adult, Older Adult)",310.0,Other,Observational,2020-06-27,30/08/20,2020-01-10,05/08/20,05/08/20,"Dokuz Eylul University, Izmir",Turkey,"Mental Health, Respiratory Diseases",1,5,-169.0
4308.0,NCT04423289,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,,Completed,Face-to-face Reconsultation to Emergency Room,,,,,,,Other: Farmalarm,Hospital Universitari Vall d'Hebron Research Institute,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-03-31,04/05/20,2020-05-18,09/06/20,09/06/20,"Vall d'Hebron Hospital Universitari, Barcelona",Spain,Others,0,1,48.0
4309.0,NCT04363463,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,PROVID-19,Recruiting,COVID-19,Oxygen Therapy,Prone Position,Spontaneous Ventilation,Respiratory Distress Syndrome,,,Other: prone position,Centre Hospitalier Régional d'Orléans,All,"18 Years to 85 Years   (Adult, Older Adult)",400.0,Other,Interventional,2020-08-28,28/08/22,2022-08-28,27/04/20,05/03/21,"CH de Blois, Blois, France|CH de DAX, Dax, France|CHD de VENDEE, La Roche sur Yon, France|CH de LA ROCHELLE, La Rochelle, France|CH Le Mans, Le Mans, France|CH Mont de MArsan, Mont-de-Marsan, France|CHR d'Orléans - Service Pneumologie, Orléans, France|CHR d'Orleans - Service Maladies Infectieuses, Orléans, France|HOPITAL LARIBOISIERE - Service diabétologie, endocrinologie, nutrition, Paris, France|Hopital Européen Georges Pompidou, Paris, France|Hopital Lariboisiere - Medecine Interne, Paris, France|Hopital Lariboisiere, Paris, France|CH de PERPIGNAN - Service Maladies infectieuses, Perpignan, France|Centre Hospitalier Intercommunal de Cornouaille - Quimper Concarneau, Quimper, France|CHRU de Tours - Service Médecine interne et immunologie Clinique, Tours, France|CHRU de Tours - Service Pneumologie, Tours, France|CHRU DE TOURS - Service Médecine interne et maladies infectieuses, Tours, France|CH Bretagne Atlantique, Vannes, France|centre Hospitalier Princesse Grace, Monaco",Monaco,Respiratory Diseases,1,5,730.0
4310.0,NCT04422340,Senior-COVID-Rea Multicentric Survey,SeniorCOVIDRea,Recruiting,COVID-19,,,,,,,Other: Group1,Hospices Civils de Lyon,All,"60 Years and older   (Adult, Older Adult)",185.0,Other,Observational,2020-01-04,15/08/20,2020-08-15,09/06/20,30/07/20,"Resuscitation unit at Hospital Emile Roux, Le Puy-en-Velay, France|- Resuscitation unit of the Groupement Hospitalier Nord - Hospices Civils de Lyon, Lyon, France|- Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Centre - Hospices Civils de Lyon, Lyon, France|Resuscitation unit of the Groupement Hospitalier Sud - Hospices Civils de Lyon, Lyon, France|Service de Réanimation de l'Hôpital Nord Ouest, Villefranche-sur-Saône, France|Medipole Resuscitation unit, Villeurbanne",France,Respiratory Diseases,1,1,224.0
4311.0,NCT04709120,Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection,ACTIV-2,Recruiting,COVID-19,Comorbidities and Coexisting Conditions,"Risk Factor, Cardiovascular",Death,Diabetes,COPD,Atrial Fibrillation,,Eurasian Association of Therapists,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2021-11-01,31/03/21,2021-12-31,14/01/21,19/01/21,"Eurasian Association of Therapists, Moscow",Russian Federation,"Metabolic Disorders, Respiratory Diseases",1,7,60.0
4312.0,NCT04375410,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,,Completed,Hand Eczema,Hand Dermatitis,COVID-19,,,,,,Vendsyssel Hospital|Aalborg University Hospital,All,up to 13 Years   (Child),6273.0,Other,Observational,2020-04-22,30/04/20,2020-10-05,05/05/20,01/04/21,"Tine Caroc Warner, Hjørring, Nordjylland",Denmark,Respiratory Diseases,1,3,166.0
4313.0,NCT04619290,Outpatient Treatment With CoVid-19 With Prexablu,,Recruiting,Sars Cov 2,,,,,,,Drug: Sublingual Methylene blue|Other: Control patients,Hospital Reg. Lic. Adolfo Lopez Mateos,All,"18 Years and older   (Adult, Older Adult)",46.0,Other,Interventional,2020-12-10,30/11/20,2020-12-30,06/11/20,12/11/20,"Hospital Regional Lic Adolfo Lopez Mateos, Mexico City, Ciudad De Mexico CDMX (Mexico City)",Mexico,Others,0,1,20.0
4314.0,NCT04604769,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,ICUcovid,Completed,Coronavirus,Nurse's Role,Professional Stress,,,,,,University of Liege,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2019-06-26,01/09/20,2020-01-09,27/10/20,27/10/20,"University of Liège, Liège, Province De Liège",Belgium,"Mental Health, Respiratory Diseases",1,3,197.0
4315.0,NCT04275414,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,BEST-CP,Completed,Coronavirus Infections,,,,,,,Drug: Bevacizumab Injection,Qilu Hospital of Shandong University|Renmin Hospital of Wuhan University|Moriggia-Pelascini Gravedona Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",27.0,Other,Interventional,2020-02-15,05/04/20,2020-02-05,19/02/20,14/09/20,"Renmin Hospital of Wuhan University, Wuhan, Hubei, China|Qilu Hospital of Shandong University, Jinan, Shandong, China|Moriggia-Pelascini Gravedona Hospital, Gravedona",Italy,Respiratory Diseases,1,1,-10.0
4316.0,NCT04466683,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,PREVENT,Recruiting,COVID-19,Sars-CoV2,Pneumonia,,,,,Radiation: Low dose radiation 35 cGy|Radiation: High dose radiation 100 cGy,Ohio State University Comprehensive Cancer Center|Varian Medical Systems,All,"50 Years and older   (Adult, Older Adult)",100.0,Other|Industry,Interventional,2020-08-28,31/12/21,2022-12-31,10/07/20,15/03/21,"Boca Raton Regional Hospital Lynn Cancer Institute, Boca Raton, Florida, United States|Miami Cancer Institute, Miami, Florida, United States|Loyola University Chicago, Maywood, Illinois, United States|Indiana University School of Medicine, Indianapolis, Indiana, United States|Lowell General Hospital Cancer Center, Lowell, Massachusetts, United States|Beaumont Hospital, Royal Oak, Michigan, United States|Ohio State University James Cancer Hospital, Columbus, Ohio, United States|Hospital Universitario San Ignacio, Bogotá",Colombia,Respiratory Diseases,1,3,855.0
4317.0,NCT04357730,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,,"Active, not recruiting",Severe Acute Respiratory Syndrome,Respiratory Failure,Acute Respiratory Distress Syndrome,,,,,Drug: Alteplase 50 MG [Activase],"Denver Health and Hospital Authority|Genentech, Inc.|University of Colorado, Denver|National Jewish Health|Beth Israel Deaconess Medical Center|Long Island Jewish Medical Center|Scripps Health|St. Mary's Medical Center|University of Miami|Ben Taub Hospital|Methodist Dallas Medical Center",All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other|Industry,Interventional,2020-05-14,22/03/21,2021-01-11,22/04/20,04/03/21,"Scripps Memorial Hospital La Jolla, La Jolla, California, United States|University of Colorado, Denver, Aurora, Colorado, United States|Denver Health Medical Center, Denver, Colorado, United States|National Jewish Health, Denver, Colorado, United States|St. Mary's Medical Center, West Palm Beach, Florida, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Long Island Jewish Medical Center, New York, New York, United States|Methodist Dallas Medical Center, Dallas, Texas, United States|Ben Taub Hospital, Houston, Texas",United States,Respiratory Diseases,1,3,242.0
4318.0,NCT04556604,Surgical Consent During the COVID-19 Pandemic,,Completed,Consent,,,,,,,Behavioral: Educational meetings and visual prompts,Medway Primary Care Trust,All,"18 Years and older   (Adult, Older Adult)",45.0,Other,Observational,2020-10-04,14/08/20,2020-08-14,21/09/20,21/09/20,"Medway NHS Foundation Trust, Gillingham",United Kingdom,Others,0,1,-51.0
4319.0,NCT04565249,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Drug: PLN-74809|Drug: Placebo,"Pliant Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",36.0,Industry,Interventional,2020-10-22,31/08/21,2021-10-31,25/09/20,22/03/21,"Valleywise Health Medical Center, Phoenix, Arizona, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|National Jewish Health, Denver, Colorado, United States|Advent Health, Orlando, Florida, United States|Augusta University Medical Center, Augusta, Georgia, United States|Atlantic Health System, Summit, New Jersey",United States,Respiratory Diseases,1,2,374.0
4320.0,NCT04353583,Renal Outcome in Patients With COVID-19,,Recruiting,Acute Kidney Injury,Corona Virus Infection,,,,,,,University of Giessen,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-04-21,31/03/21,2021-06-30,20/04/20,28/01/21,"University Hospital Giessen and Marburg, Giessen, Giessen, Hessen",Germany,Respiratory Diseases,1,2,435.0
4321.0,NCT04367350,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,,Recruiting,COVID-19,Sars-CoV2,Corona Virus Infection,Myositis,Myocarditis,,,Diagnostic Test: laboratory biomarkers|Diagnostic Test: muscle ultrasound,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-20,31/03/21,2022-03-31,29/04/20,29/04/20,"University Hospital Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,5,741.0
4322.0,NCT04366791,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,RESCUE 1-19,Suspended,Pneumonia,COVID-19,Severe Acute Respiratory Syndrome (SARS) Pneumonia,,,,,Radiation: Low Dose Radiation Therapy,Emory University,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-23,15/04/21,2021-04-15,29/04/20,19/12/20,"Emory University Hospital Midtown/Winship Cancer Institute, Atlanta, Georgia, United States|Emory Saint Joseph's Hosptial, Atlanta, Georgia",United States,Respiratory Diseases,1,3,357.0
4323.0,NCT04500366,GERAS Frailty Rehabilitation at Home During COVID-19,,Recruiting,Frailty,,,,,,,Behavioral: Socialization|Behavioral: Virtual Group Exercise|Combination Product: Nutrition Consult and Protein Supplementation|Behavioral: Medication Review,McMaster University,All,65 Years and older   (Older Adult),70.0,Other,Interventional,2020-08-26,01/04/21,2021-01-05,05/08/20,10/11/20,"McMaster University - Hamilton Health Sciences (St. Peter's Site), Hamilton, Ontario",Canada,Others,0,1,132.0
4324.0,NCT04384445,Zofin (Organicell Flow) for Patients With COVID-19,,Recruiting,Corona Virus Infection,COVID-19,SARS,Acute Respiratory Distress Syndrome,,,,Biological: Zofin|Other: Placebo,Organicell Regenerative Medicine,All,"18 Years and older   (Adult, Older Adult)",20.0,Industry,Interventional,2020-08-09,30/06/21,2021-07-31,12/05/20,23/02/21,"Larkin Community Hospital, Miami, Florida, United States|Larkin Community Hospital, South Miami, Florida",United States,Respiratory Diseases,1,4,356.0
4325.0,NCT04535297,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,,Completed,Parkinson Disease,Stroke,,,,,,Other: exposure,University of Haifa,All,"18 Years and older   (Adult, Older Adult)",198.0,Other,Observational,2020-10-05,30/05/20,2020-06-30,01/09/20,01/09/20,"Galit Yogev-Seligmann, Haifa, Please Select...",Israel,Cardiovascular Diseases,1,2,-97.0
4326.0,NCT04378712,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),,Completed,COVID-19,Hydrogen/Oxygen Mixed Gas,Dyspnea,,,,,Device: Hydrogen Oxygen Generator with Nebulizer|Other: Standard-of-care,Guangzhou Institute of Respiratory Disease,All,"18 Years to 75 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-21,23/03/20,2020-03-23,07/05/20,15/05/20,"First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,3,62.0
4327.0,NCT04425213,Obesity and Mortality of Critically Ill Patients With COVID-19,COV-OB-ICU,Completed,COVID-19,Severe Acute Respiratory Syndrome,Obesity,Comorbidities and Coexisting Conditions,,,,,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-12-05,25/05/20,2020-05-26,11/06/20,16/06/20,"Centre hospitalo-universitaire régional de Nancy, Vandœuvre-lès-Nancy",France,"Metabolic Disorders, Respiratory Diseases",1,4,-193.0
4328.0,NCT04353128,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,MeCOVID,Recruiting,COVID-19,SARS-CoV 2,Coronavirus Infection,,,,,Drug: Melatonin 2mg|Drug: Placebo oral tablet,Instituto de Investigación Hospital Universitario La Paz,All,"18 Years to 65 Years   (Adult, Older Adult)",450.0,Other,Interventional,2020-04-20,01/10/20,2020-01-12,20/04/20,16/06/20,"Hospital Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,3,-99.0
4329.0,NCT04444674,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,,"Active, not recruiting",Coronavirus,,,,,,,Biological: ChAdOx1 nCoV-19|Biological: Normal saline 0.9%,"University of Oxford|Medical Research Council, South Africa|Bill and Melinda Gates Foundation|Wits Health Consortium (Pty) Ltd|University of Witwatersrand, South Africa",All,"18 Years to 65 Years   (Adult, Older Adult)",2130.0,Other,Interventional,2020-06-24,01/12/20,2021-01-12,23/06/20,27/11/20,"PHRU Kliptown, Johannesburg, Gauteng, South Africa|Soweto Clinical Trials Centre, Johannesburg, Gauteng, South Africa|Wits RHI Shandukani Research Centre, Johannesburg, Gauteng, South Africa|Setshaba Research Centre (SRC), Soshanguve, Gauteng, South Africa|Chris Hani Baragwanath Academic Hospital - DST/NRF VPD RMPRU, Soweto, Gauteng, South Africa|FAMCRU, Cape Town, Western Cape, South Africa|Groote Schuur hospital, Lung infection and immunity unit, UCT, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,1,202.0
4330.0,NCT04818216,Nicotinamide Riboside in SARS-CoV-2 (COVID-19) Patients for Renal Protection,NIRVANA,Not yet recruiting,COVID-19,Acute Kidney Injury,,,,,,Drug: Placebo|Drug: Nicotinamide riboside,The University of Texas Health Science Center at San Antonio|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),All,"18 Years and older   (Adult, Older Adult)",100.0,Other|NIH,Interventional,2021-01-04,01/06/22,2023-01-06,26/03/21,30/03/21,"Icahn School of Medicine at Mount Sinai, New York, New York, United States|The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States|Harborview Medical Center, Seattle, Washington",United States,Respiratory Diseases,1,2,732.0
4331.0,NCT04710836,NoRCoRP Assessment Clinic,NoRCoRP,Recruiting,COVID-19,,,,,,,,Nottingham University Hospitals NHS Trust,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-12,31/08/32,2032-08-31,15/01/21,17/02/21,"Nottingham City Hospital, Nottingham",United Kingdom,Respiratory Diseases,1,1,4555.0
4332.0,NCT04791085,Investigation of Stress Levels and Lifestyle of a Sample of Greek General Surgeons in Covid-19,,Recruiting,"Stress, Psychological","Stress, Emotional",Life Style Induced Illness,Anxiety Depression,COVID-19,,,,National and Kapodistrian University of Athens|Amalia Fleming General Hospital,All,"23 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Observational,2021-08-02,08/05/21,2021-08-05,10/03/21,10/03/21,"Sismanoglio-Amalia Fleming Hospital, Athens, Melissia",Greece,"Mental Health, Respiratory Diseases",1,5,3.0
4333.0,NCT04377334,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),,Not yet recruiting,ARDS,COVID-19,,,,,,Biological: MSC,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-10,01/04/21,2021-01-07,06/05/20,29/06/20,"University Hospital Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,2,363.0
4334.0,NCT04472052,Frequency of Perforated Appendicitis in Times of COVID-19,,Completed,Perforated Appendicitis,COVID-19,,,,,,Other: appendectomy,University Hospital Tuebingen,All,"16 Years and older   (Child, Adult, Older Adult)",143.0,Other,Observational,2020-03-16,31/05/20,2020-05-31,15/07/20,15/07/20,"University Hospital of Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,2,76.0
4335.0,NCT04326452,Treating COVID-19 With a Bidirectional Oxygenation Valve,,Recruiting,Coronavirus Infection,,,,,,,Device: bidirectional oxygenation mouthpiece,"TMC HealthCare|PEEP Medical, LLC",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-03-27,27/03/21,2021-03-27,30/03/20,06/10/20,"TMC HealthCare, Tucson, Arizona, United States|Stanford University, Stanford, California, United States|Emory Saint Joseph's Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,1,365.0
4336.0,NCT04610515,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),INSPIRE,Recruiting,COVID-19,ME/CFS,SARS COV2,COVID-19,Neurocognitive Disorders,Cardiovascular Diseases,,,"Rush University Medical Center|Yale University|University of Washington|Thomas Jefferson University|University of California, Los Angeles|University of California, San Francisco|University of Texas Southwestern Medical Center|The University of Texas Health Science Center, Houston",All,"18 Years and older   (Adult, Older Adult)",4800.0,Other,Observational,2020-12-15,14/11/22,2022-11-14,30/10/20,24/02/21,"UCLA, Los Angeles, California, United States|UCSF, San Francisco, California, United States|Yale, New Haven, Connecticut, United States|Rush University Medical Center, Chicago, Illinois, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|University of Texas Southwestern, Dallas, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Washington, Seattle, Washington",United States,Respiratory Diseases,1,6,699.0
4337.0,NCT04733105,Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure,ANTICOV,Recruiting,Acute Respiratory Failure,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",530.0,Other,Observational,2020-11-19,20/11/21,2022-02-20,01/02/21,10/03/21,"Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR, Créteil",France,Respiratory Diseases,1,1,458.0
4338.0,NCT04382469,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,,Completed,COVID-19,,,,,,,,Alexandria University,All,"Child, Adult, Older Adult",48.0,Other,Observational,2020-01-02,30/04/20,2020-01-05,11/05/20,12/05/20,"Faculty of Medicine, University of Alexandria, Alexandria",Egypt,Respiratory Diseases,1,1,3.0
4339.0,NCT04385823,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,,Completed,"Respiratory Syndrome, Acute, Severe",Hypoxic Respiratory Failure,Viral Pneumonia,,,,,Device: patients receiving nasal high flow,Hôpital Louis Mourier,All,"18 Years and older   (Adult, Older Adult)",62.0,Other,Observational,2020-01-03,04/05/20,2020-04-05,13/05/20,13/05/20,"Hôpital Louis Mourier, Assistance Publique - Hôpitaux de Paris, Colombes",France,Respiratory Diseases,1,3,93.0
4340.0,NCT04328467,Pre-exposure Prophylaxis for SARS-Coronavirus-2,,"Active, not recruiting",COVID-19,Corona Virus Infection,ARDS,Acute Respiratory Distress Syndrome,,,,Drug: Hydroxychloroquine|Other: Placebo,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Interventional,2020-06-04,01/08/20,2020-01-08,31/03/20,27/05/20,"Nationwide Enrollment via Internet, please email: covid19@umn.edu, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota",United States,Respiratory Diseases,1,4,-148.0
4341.0,NCT04397588,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,ECMO-SARS,Recruiting,ARDS Related to Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 2,Acute Refractory Heart Failure Related to SARS-CoV 2,,,,,,,Rennes University Hospital,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-04-21,21/10/20,2020-10-21,21/05/20,31/08/20,"Angers University Hospital, Angers, France|Besançon Hospital, Besançon, France|Brest university Hospital, Brest, France|Caen University Hospital, Caen, France|Clermont ferrand University hospital, Clermont-Ferrand, France|APHP Henri Mondor Paris University Hospital, Créteil, France|Dijon University Hospital, Dijon, France|Vendée Hospital, La Roche-sur-Yon, France|Grenoble University Hospital, La Tronche, France|APHP Kremli Bicetre Paris University Hospital, Le Kremlin-Bicêtre, France|Marie Lannelongue Hospital, Le Plessis-Robinson, France|Lens Hospital, Lens, France|Lille University Hospital, Lille, France|Limoges University Hospital, Limoges, France|Clinique de la Sauvegarde, Lyon, France|Lyon University Hospital, Lyon, France|Marseille Européen Hospital, Marseille, France|APHM la Timone- Marseille University Hospital, Marseille, France|Clairval Hospital, Marseille, France|Metz University Hospital, Metz, France|Montpellier University Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy University Hospital, Nancy, France|Nantes University Hospital, Nantes, France|Ambroise Paré Hospital, Neuilly-sur-Seine, France|Nimes University Hospital, Nimes, France|Institut Mutualiste Montsouris, Paris, France|APHP Hopital Européen Georges Pompidou - Paris University Hospital, Paris, France|APHP necker Paris University Hospital, Paris, France|APHP Bichat - Paris University Hospital, Paris, France|APHP La Pitié Salpêtrière Paris University Hospital, Paris, France|Bordeaux University Hospital, Pessac, France|Poitiers University hospital, Poitiers, France|Reims University hospital, Reims, France|Rennes University hospital, Rennes, France|Rouen University Hospital, Rouen, France|Saint brieuc Hospital, Saint brieuc, France|La Réunion University Hospital, Saint-Denis, France|Saint Nazaire Hospital, Saint-Nazaire, France|Saint Etienne University Hospital, Saint-Étienne, France|Strasbourg University Hospital, Strasbourg, France|Toulouse University Hospital - Rangueil Hospital, Toulouse, France|Tours University Hospital, Tours, France|Bretagne Atlantique Hospital, Vannes",France,Respiratory Diseases,1,2,183.0
4342.0,NCT04594460,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),,Not yet recruiting,COVID-19,Hydrogen-oxygen Gas,AMS-H-03,,,,,"Device: Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03|Device: OLO-1 Medical Molecular Sieve Oxygen Generator",Guangzhou Institute of Respiratory Disease,All,"18 Years to 75 Years   (Adult, Older Adult)",198.0,Other,Interventional,2020-10-31,31/10/21,2021-12-31,20/10/20,22/10/20,"Guangzhou Institute of Respiratory Disease, Guangzhou, Guangdong, China|First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong",China,Respiratory Diseases,1,3,426.0
4343.0,NCT04370938,Provider Burnout During COVID-19,,Withdrawn,"Perceived Organizational Support, Anxiety, Burnout",,,,,,,Behavioral: Coping strategies video,University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-04-29,29/10/20,2020-10-29,01/05/20,29/12/20,"UPMC, Pittsburgh, Pennsylvania",United States,Mental Health,1,1,183.0
4344.0,NCT04734561,Effects of Respiratory Muscle Training in People Who Have Had COVID-19 Disease,,Recruiting,COVID-19,Respiratory Muscle Training,Respiratory Function Test,Quality of Life,Psychosocial Factor,,,Other: Inspiratory muscle training group|Other: Inspiratory muscle training placebo group|Other: Inspiratory + expiratory muscle training group|Other: Inspiratory + expiratory muscle training placebo group,"Universidad Complutense de Madrid|Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid, Madrid, Spain",All,"18 Years and older   (Adult, Older Adult)",88.0,Other,Interventional,2021-08-02,30/07/22,2022-07-30,02/02/21,09/04/21,"UComplutenseMadrid, Madrid",Spain,Respiratory Diseases,1,5,362.0
4345.0,NCT04327401,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,CoDEX,Terminated,Coronavirus Infection,"Pneumonia, Viral",Acute Respiratory Distress Syndrome,,,,,Drug: Dexamethasone,Hospital Sirio-Libanes|Hospital Israelita Albert Einstein|Hospital do Coracao|Brazilian Research In Intensive Care Network|Ache Laboratorios Farmaceuticos S.A.,All,"18 Years and older   (Adult, Older Adult)",299.0,Other|Industry,Interventional,2020-04-13,22/07/20,2020-07-22,31/03/20,07/08/20,"Hospital Ana Nery, Salvador, Bahia, Brazil|Instituto de Cardiologia do Distrito Federal, Brasília, Distrito Federal, Brazil|Fundação Social Rural de Colatina, Colatina, Esoírito Santo, Brazil|Hospital Vera Cruz AS, Belo Horizonte, Minas Gerais, Brazil|Hospital Maternidade E Pronto Socorro Santa Lucia Ltda, Poços De Caldas, Minas Gerais, Brazil|Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Eurolatino Natal Pesquisas Médicas Ltda, Natal, Rio Grande Do Norte, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Maestri E Kormann Consultoria Medico-Cientifica, Blumenau, Santa Catarina, Brazil|Sociedade Literaria e Caritativa Santo Agostinho, Criciúma, Santa Catarina, Brazil|Fundação Pio XII, Barretos, São Paulo, Brazil|Santa Casa de Misericordia de Votuporanga, Votuporanga, São Paulo, Brazil|Associacao Beneficente Siria, São Paulo, Brazil|Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da USP - HCFMRP, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Prevent Senior Private Operadora de Saude Ltda, São Paulo, Brazil|Real e Benemérita Associação Portuguesa de Beneficência/SP, São Paulo, Brazil|Santa Casa de Misericórdia, São Paulo, Brazil|Secretaria de Saúde do Estado de São Paulo, São Paulo, Brazil|Sociedade Beneficente de Senhoras Hospital Sírio-Libanês, São Paulo, Brazil|Universidade Federal de São Paulo, São Paulo",Brazil,Respiratory Diseases,1,3,100.0
4346.0,NCT04839042,"A Phase 1, First-In-Human Study, to Assess the Safety, Reactogenicity, and Immunogenicity of the Adenovirus Vector SARS-CoV-2 Investigational Product SC-Ad6-1 in Healthy Volunteers",,Not yet recruiting,COVID-19,,,,,,,Biological: SC-Ad6-1,Tetherex Pharmaceuticals Corporation,All,18 Years to 55 Years   (Adult),40.0,Industry,Interventional,2021-01-06,30/09/21,2021-09-30,09/04/21,09/04/21,"Tetherex Study Site, Brisbane, Queensland",Australia,Respiratory Diseases,1,1,267.0
4347.0,NCT04769154,Airway Management in the Intensive Care and Regular Hospital Units During COVID-19 Pandemic,,Not yet recruiting,Airway Management,Intensive Care Unit,COVID-19,,,,,,American University of Beirut Medical Center,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-02,01/02/23,2023-01-02,24/02/21,26/02/21,,,Respiratory Diseases,1,3,730.0
4348.0,NCT04769297,"Micro-Dose, Macro-Impact: Leveraging Psychedelics in Frontline Healthcare Workers During the COVID-19 Pandemic",,"Active, not recruiting",Acute Stress Disorder,,,,,,,Drug: Sublingual Micro-Dose Ketamine,Limbic Medical|Enovex Pharmacy,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-04-15,01/04/21,2021-01-04,24/02/21,24/02/21,"Limbic Medical, Toluca Lake, California",United States,Mental Health,1,1,264.0
4349.0,NCT04513314,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,,Not yet recruiting,COVID-19,Hyperactive Delirium,"Pneumonia, Viral",,,,,Drug: Valproate|Drug: Quetiapine|Other: Standard of Care,University of Miami,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-11,01/11/22,2022-01-11,14/08/20,10/11/20,"Jackson Memorial Hospital, Miami, Florida",United States,Respiratory Diseases,1,3,365.0
4350.0,NCT04836299,"Clinical Trial to ""Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)",SAINTBO,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: Placebo,Universidad Mayor de San Simón|Barcelona Institute for Global Health|Université Catholique de Louvain,All,"18 Years to 75 Years   (Adult, Older Adult)",90.0,Other,Interventional,2021-08-05,08/07/21,2021-05-12,08/04/21,08/04/21,"Universidad Mayor de San Simón, Cochabamba",Bolivia,Respiratory Diseases,1,1,-85.0
4351.0,NCT04350736,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",,Completed,COVID-19,COVID-19,,,,,,Drug: TD-0903|Drug: Placebo,Theravance Biopharma,All,18 Years to 50 Years   (Adult),54.0,Industry,Interventional,2020-04-23,24/06/20,2020-06-24,17/04/20,02/09/20,"Theravance Biopharma Investigational Site, Manchester",United Kingdom,Respiratory Diseases,1,2,62.0
4352.0,NCT04268537,Immunoregulatory Therapy for 2019-nCoV,,Not yet recruiting,"2019 nCoV, PD-1",,,,,,,Drug: PD-1 blocking antibody+standard treatment|Drug: Thymosin+standard treatment|Other: standard treatment,"Southeast University, China",All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-10-02,30/04/20,2020-10-31,13/02/20,13/02/20,,,Others,0,1,29.0
4353.0,NCT04603755,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,COVIDEIT,Recruiting,SARS-CoV Infection,Acute Respiratory Distress Syndrome,,,,,,Device: Electrical Impedance tomography,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-10-26,01/04/22,2022-01-04,27/10/20,09/03/21,"Hôpital d'Instruction des Armées Sainte-Anne, Toulon",France,Respiratory Diseases,1,2,435.0
4354.0,NCT04397705,Remote Monitoring of Cancer Patients With Suspected Covid-19,RECAP,Recruiting,COVID-19,Oncology,Haematological Malignancy,,,,,Device: Patient Status Engine,The Christie NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-12-10,01/04/21,2021-01-04,21/05/20,11/02/21,"The Christie NHS Foundation Trust, Manchester, Greater Manchester",United Kingdom,Respiratory Diseases,1,3,25.0
4355.0,NCT04497415,The COVID-19 and Healthcare Workers: An Active Intervention,,Recruiting,Brief Video-based Intervention,Non Intervention Control,,,,,,Other: Video-Based intervention,"Research Foundation for Mental Hygiene, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",1200.0,Other,Interventional,2020-10-21,30/11/20,2021-01-30,04/08/20,23/10/20,"New York State Psychiatric Institute, New York, New York",United States,Others,0,2,101.0
4356.0,NCT04290871,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,NOSARSCOVID,Withdrawn,Coronavirus,SARS (Severe Acute Respiratory Syndrome),,,,,,Drug: Nitric Oxide Gas,"Xijing Hospital|Massachusetts General Hospital|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico",All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-03-23,01/03/21,2022-01-03,02/03/20,24/03/20,,,Respiratory Diseases,1,2,651.0
4357.0,NCT04484207,Addressing COVID-19 Mental Health Problems Among US Veterans,,Recruiting,Brief Video-based Intervention,Vignette Based Intervention,Non Intervention Control Arm,,,,,Other: A short video intervention|Other: A vignette intervention,"Research Foundation for Mental Hygiene, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-06-07,20/10/20,2020-10-26,23/07/20,14/10/20,"New York State Psychiatric Institute, New York, New York",United States,Others,0,3,141.0
4358.0,NCT04251767,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,,Withdrawn,COVID-19,,,,,,,Other: washed microbiota transplantation|Other: placebo,The Second Hospital of Nanjing Medical University,All,"14 Years to 70 Years   (Child, Adult, Older Adult)",0.0,Other,Interventional,2020-05-02,30/04/20,2020-04-30,05/02/20,17/03/20,"Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,-2.0
4359.0,NCT04411784,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",PROTECT-ASUC,"Active, not recruiting",Inflammatory Bowel Diseases,COVID-19,,,,,,,Hull University Teaching Hospitals NHS Trust,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-05-20,01/07/20,2020-01-07,02/06/20,02/06/20,"Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull",United Kingdom,Respiratory Diseases,1,2,-134.0
4360.0,NCT04451993,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,,Completed,Obstructive Sleep Apnea-hypopnea Syndrome,,,,,,,,Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital,All,"19 Years to 70 Years   (Adult, Older Adult)",63.0,Other,Observational,2020-06-25,01/09/20,2020-09-30,30/06/20,05/02/21,"Trabzon Ahi Evren Thoracic and Cardiovascular Surgery Training and Research Hospital, Trabzon",Turkey,Others,0,1,97.0
4361.0,NCT04805684,Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia,,Completed,Lung Ultrasound,Pneumonia,COVID-19,,,,,Device: LUS Twelve area|Device: LUS Fourteen area,Bursa Yüksek İhtisas Education and Research Hospital,All,"18 Years to 85 Years   (Adult, Older Adult)",59.0,Other,Interventional,2021-01-01,05/03/21,2021-05-03,18/03/21,18/03/21,"University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital, Bursa",Turkey,Respiratory Diseases,1,3,122.0
4362.0,NCT04380909,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,ROCO,"Active, not recruiting",Psychological Distress,"Adjustment, Psychological",Coronavirus,,,,,Behavioral: Internet-based self-help|Behavioral: Internet-based self-help after 3 weeks,University of Bern,All,"18 Years and older   (Adult, Older Adult)",107.0,Other,Interventional,2020-06-05,01/04/21,2021-01-04,08/05/20,02/03/21,"Universität Bern, Bern",Switzerland,Respiratory Diseases,1,3,213.0
4363.0,NCT04572399,UVA Light Device to Treat COVID-19,,Completed,Coronavirus,,,,,,,Device: UV Light Treatment,"Cedars-Sinai Medical Center|Aytu BioScience, Inc.",All,"18 Years and older   (Adult, Older Adult)",5.0,Other|Industry,Interventional,2020-10-30,28/12/20,2020-12-28,01/10/20,30/12/20,"Cedars-Sinai Medical Center, Los Angeles, California",United States,Respiratory Diseases,1,1,59.0
4364.0,NCT04608097,Understanding Reactions to Emotional Material in the Media During COVID-19,,Recruiting,Healthy Participants,Intrusive Memories,,,,,,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,Uppsala University,All,"18 Years to 65 Years   (Adult, Older Adult)",66.0,Other,Interventional,2020-10-28,15/01/21,2021-01-15,29/10/20,25/01/21,"Uppsala University, Uppsala",Sweden,Others,0,2,79.0
4365.0,NCT04400006,Ozone Therapy in the Prevention of COVID-19 Infection,,Completed,Corona Virus Infection,,,,,,,,Marmara University,All,"18 Years to 90 Years   (Adult, Older Adult)",71.0,Other,Observational,2020-06-05,16/05/20,2020-05-17,22/05/20,22/05/20,"Kardelen Gencer Atalay, Istanbul",Turkey,Respiratory Diseases,1,1,-19.0
4366.0,NCT04368026,SARS-CoV-2 (COVID-19) and Surgery,,Completed,"Surgical Procedure, Unspecified",,,,,,,Other: No intervention (survey study for medical doctors).,Jagiellonian University,All,"25 Years and older   (Adult, Older Adult)",70.0,Other,Observational,2020-03-30,01/12/20,2020-01-12,29/04/20,10/02/21,"2nd Department of General Surgery, Jagiellonian University Medical College, Cracovia, Małopolska",Poland,Others,0,1,-78.0
4367.0,NCT04609488,Surfactant Levels in the Lungs of COVID-19 Patients,,Not yet recruiting,To Assess Surfactant Levels in Lung Fluid,,,,,,,Diagnostic Test: Surfactant assessment,Zealand University Hospital,All,"19 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-01-11,30/09/22,2022-01-10,30/10/20,30/10/20,,,Others,0,1,730.0
4368.0,NCT04350099,Emotional Burden of Healthcare Professionals and Covid Infection 19,Emocovid,Recruiting,COVID-19,,,,,,,Other: quetionnary,"University Hospital, Limoges",All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-04-15,15/02/21,2021-06-15,16/04/20,13/01/21,"CH Esquirol, Limoges, France|CHU de Limoges, Limoges, France|HCL LYON, Lyon",France,Respiratory Diseases,1,1,426.0
4369.0,NCT04429477,Cerebral Compliance Impairment in COVID-19,,Completed,Intracranial Hypertension,Cerebral Circulatory Failure,,,,,,Device: Cerebral compliance and hemodynamics monitoring,University of Sao Paulo,All,"1 Year and older   (Child, Adult, Older Adult)",50.0,Other,Observational,2020-01-05,15/07/20,2020-07-31,12/06/20,22/09/20,"Hospital das Clínicas da Faculdade de Medicina da USP., São Paulo",Brazil,Cardiovascular Diseases,1,2,208.0
4370.0,NCT04435015,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,,Not yet recruiting,Coagulopathy,Cardiovascular Complication,COVID-19,,,,,"Drug: Camostat Mesylate|Drug: Microcrystalline Cellulose, NF",Yale University|Ono Pharmaceutical Co. Ltd,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Interventional,2021-01-02,30/07/21,2021-07-30,17/06/20,28/10/20,,,Respiratory Diseases,1,3,209.0
4371.0,NCT04367077,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),MACoVIA,Recruiting,ARDS,,,,,,,Biological: MultiStem|Biological: Placebo,"Athersys, Inc",All,"18 Years to 89 Years   (Adult, Older Adult)",400.0,Industry,Interventional,2020-04-28,01/01/23,2023-01-12,29/04/20,13/04/21,"Athersys Investigational Site 107, Chicago, Illinois, United States|Athersys Investigational Site 103, Akron, Ohio, United States|Athersys Investigational Site 101, Cleveland, Ohio, United States|Athersys Investigational Site 102, Cleveland, Ohio",United States,Respiratory Diseases,1,1,989.0
4372.0,NCT04326400,Active Monitoring And Determinants of Incidence Infection of COVDI-19,,Recruiting,Coronavirus Infection,,,,,,,,"Fundación Teófilo Hernando, Spain",All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2020-03-23,20/07/20,2020-09-20,30/03/20,01/04/20,"Hospital Universitario de la Princesa, Madrid",Spain,Respiratory Diseases,1,1,181.0
4373.0,NCT04341935,Effects of DPP4 Inhibition on COVID-19,,Not yet recruiting,Coronavirus Infection,Type 2 Diabetes,,,,,,Drug: Linagliptin|Drug: Insulin regimen,University of Miami,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-06-30,30/12/21,2021-12-30,10/04/20,12/01/21,"University of Miami, Miami, Florida",United States,"Metabolic Disorders, Respiratory Diseases",1,2,183.0
4374.0,NCT04369469,Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,,"Active, not recruiting",COVID-19,Acute Lung Injury,Acute Respiratory Distress Syndrome,"Pneumonia, Viral",,,,Biological: Ravulizumab|Other: Best Supportive Care,Alexion Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",270.0,Industry,Interventional,2020-11-05,01/05/21,2021-01-07,30/04/20,03/02/21,"Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States|LAC/USC Health Center, Los Angeles, California, United States|UC Irvine Medical Center, Orange, California, United States|MedStar Georgetown University Hospital, Washington, District of Columbia, United States|Alternative Research Associates, LLC, Hialeah, Florida, United States|University of Florida, Jacksonville, Florida, United States|Mayo Clinic Florida, Jacksonville, Florida, United States|Jupiter Medical Center, Jupiter, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Norton Healthcare, Louisville, Kentucky, United States|Baltimore VA Medical Center, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Boston Medical Center, Boston, Massachusetts, United States|Henry Ford Hospital, Detroit, Michigan, United States|Mayo Clinic Health System, Mankato, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|NYU Langone Health Center, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Westchester Medical Center, Valhalla, New York, United States|Medical University of South Carolina, Charleston, South Carolina, United States|Baptist Memorial Hospital, Memphis, Tennessee, United States|Houston Methodist Hospital, Houston, Texas, United States|VA Puget Sound Health Care System, Seattle, Washington, United States|Mayo Clinic Health System in Eau Claire, Eau Claire, Wisconsin, United States|Mayo Clinic Health System, La Crosse, Wisconsin, United States|Hôpital Raymond Poincaré, Garches, Hauts De Seine, France|Hôpital Henri Mondor, Créteil, Val De Marne, France|Hôpital Bicêtre, Le Kremlin-Bicêtre cedex, Val De Marne, France|Hôpital Saint-Louis, Paris cedex, France|Medical Hospital, Tokyo Medical and Dental University, Bunkyō-Ku, Tokyo-To, Japan|Jikei University Hospital, Minato-Ku, Tokyo, Japan|Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo, Japan|Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic de Barcelona, Barcelona, Spain|Hospital Universitario Ramon y Cajal, Madrid, Spain|King's College Hospital, London, Greater London, United Kingdom|Hammersmith Hospital, London, Greater London, United Kingdom|Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom|Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom|St James's University Hospital, Leeds, West Yorkshire",United Kingdom,Respiratory Diseases,1,4,63.0
4375.0,NCT04363827,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),PROTECT,"Active, not recruiting",COVID-19,Hydroxychloroquine,Prophylaxis,Treatment,COVID-19,,,Drug: Hydroxychloroquine,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori|University of Bologna,All,"18 Years and older   (Adult, Older Adult)",2300.0,Other,Interventional,2020-05-14,01/06/21,2021-01-09,27/04/20,12/02/21,"Irst Irccs, Meldola, FC",Italy,Respiratory Diseases,1,5,240.0
4376.0,NCT04762173,Self-Help for Stress Related to COVID-19,,"Active, not recruiting",Stress,,,,,,,Device: Online self-help intervention,Penn State University,All,"18 Years and older   (Adult, Older Adult)",585.0,Other,Interventional,2020-06-11,03/06/21,2021-03-06,21/02/21,14/04/21,"The Pennsylvania State University, University Park, Pennsylvania",United States,Mental Health,1,1,268.0
4377.0,NCT04407208,Convalescent Plasma Therapy in Patients With COVID-19,,Completed,Convalescence,Corona Virus Infection,Plaque,,,,,Biological: Convalescent plasma,Biofarma|Rumah Sakit Pusat Angkatan Darat Gatot Soebroto|Eijkman Institute for Molecular Biology,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-05,22/06/20,2020-06-22,29/05/20,30/06/20,"Gatot Soebroto central army presidential hospital, Jakarta Pusat",Indonesia,Respiratory Diseases,1,3,169.0
4378.0,NCT04406064,Viral Specific T-cells for Treatment of COVID-19,,Withdrawn,Viral Infection,,,,,,,Biological: Viral Specific T-cells (VSTs),"Children's Hospital Medical Center, Cincinnati|Hoxworth Blood Center",All,"Child, Adult, Older Adult",0.0,Other,Interventional,2021-01-01,01/06/24,2025-01-06,28/05/20,19/01/21,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio",United States,Others,0,1,1466.0
4379.0,NCT04611243,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",,Recruiting,Lung Function,Exercise Capacity,Quality of Life,COVID-19,,,,Drug: Kaletra and beta interferon,Chinese University of Hong Kong|The University of Hong Kong|Health and Medical Research Fund,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-05-22,21/05/22,2022-05-21,02/11/20,02/11/20,"Prince of Wales Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,4,729.0
4380.0,NCT04750018,Influence of Co-Vid 19 Pandemic on Screening Mammography Single Institution,,Recruiting,COVID-19,Breast Cancer,,,,,,Other: surgery,Chen-Pin Chou|Kaohsiung Veterans General Hospital.,Female,"30 Years to 80 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-03-07,28/09/20,2021-01-06,11/02/21,11/02/21,"Radiology depart, Kaohsiung",Taiwan,"Respiratory Diseases, Cancers",1,2,305.0
4381.0,NCT04619576,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,COVISTRESSWork,Recruiting,Occupational Health,,,,,,,Behavioral: Occupational health workers,"University Hospital, Clermont-Ferrand|Faculty of Medicine and Paramedical Professions, Clermont-Ferrand, France",All,"10 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-06,21/12/25,2025-12-21,06/11/20,06/11/20,"Clermont-Ferrand University Hospital, Clermont-Ferrand, Aura",France,Others,0,1,2176.0
4382.0,NCT04169542,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",,Recruiting,Breast Ductal Carcinoma In Situ,COVID-19,Hereditary Breast Carcinoma,Invasive Breast Carcinoma,,,,Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),Female,"18 Years and older   (Adult, Older Adult)",600.0,Other|NIH,Observational,2019-05-21,31/03/22,2022-03-31,20/11/19,09/12/20,"MD Anderson in The Woodlands, Conroe, Texas, United States|M D Anderson Cancer Center, Houston, Texas, United States|MD Anderson League City, League City, Texas, United States|MD Anderson in Sugar Land, Sugar Land, Texas",United States,Respiratory Diseases,1,4,1045.0
4383.0,NCT04602000,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,,Recruiting,COVID-19,,,,,,,Biological: CT-P59/Placebo,Celltrion,All,"18 Years and older   (Adult, Older Adult)",1020.0,Industry,Interventional,2020-09-25,01/12/20,2021-01-09,26/10/20,26/10/20,"Chungnam National University Hospital, Daejeon, Jung-gu, Korea",Republic of,Respiratory Diseases,1,1,106.0
4384.0,NCT04507256,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Combination Product: AZD7442|Other: Placebo,AstraZeneca|Parexel,All,18 Years to 55 Years   (Adult),60.0,Industry,Interventional,2020-08-18,25/10/21,2021-10-25,11/08/20,08/04/21,"Research Site, Harrow",United Kingdom,Respiratory Diseases,1,1,433.0
4385.0,NCT04818970,Adaptive Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients,,Not yet recruiting,COVID-19,Corona Virus Infection,Autoimmune Diseases,"Coagulation Disorder, Blood",,,,Device: Narrow Band ultraviolet B-Band Light|Device: non Narrow Band ultraviolet B-Band Light,"Cytokind, Inc.|Louisiana State University Health Sciences Center in New Orleans|Baylor College of Medicine",All,"50 Years to 110 Years   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2021-10-04,31/08/21,2021-08-31,26/03/21,05/04/21,"West Jefferson Medical Center and LSUHSC-NO, New Orleans, Louisiana",United States,Respiratory Diseases,1,4,-34.0
4386.0,NCT04390516,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,READY,Completed,COVID-19,Coronavirus,Mortality,Mechanical Ventilation,,,,Device: COViage,Dascena,All,"18 Years and older   (Adult, Older Adult)",197.0,Industry,Interventional,2020-03-24,04/05/20,2020-05-30,15/05/20,12/06/20,"Dascena, Oakland, California",United States,Respiratory Diseases,1,4,67.0
4387.0,NCT04335786,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,COVID-19,COVID-19,Severe Acute Respiratory Syndrome,,,Drug: Valsartan (Diovan)|Drug: Placebo oral tablet,Radboud University,All,"18 Years and older   (Adult, Older Adult)",651.0,Other,Interventional,2020-04-17,01/12/20,2021-01-12,06/04/20,09/06/20,"Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands|Rijnstate, Arnhem, Netherlands|Radboudumc, Nijmegen, Netherlands|Laurentius Ziekenhuis, Roermond, Netherlands|Erasmus MC, Rotterdam, Netherlands|Franciscus Gasthuis, Rotterdam, Netherlands|Ikazia Ziekenhuis, Rotterdam",Netherlands,Respiratory Diseases,1,5,270.0
4388.0,NCT04442789,Sequelae of Sars-CoV-2 Infections,,Recruiting,Lung Diseases,Cardiac Disease,Inflammatory Reaction,,,,,,University of Giessen,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-05-20,31/12/21,2023-12-31,23/06/20,24/06/20,"Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University, Giessen",Germany,Others,0,3,1320.0
4389.0,NCT04354792,Asymptomatic COVID-19 Infection Among Healthcare Workers,,Completed,Immunologic Activity Alteration,,,,,,,Diagnostic Test: Serum SARs COV 2 IGg screening in health care workers,Kasr El Aini Hospital,All,25 Years to 60 Years   (Adult),500.0,Other,Observational,2020-01-05,10/06/20,2020-10-06,21/04/20,17/06/20,"Cairo University Hospital, Cairo",Egypt,Others,0,1,275.0
4390.0,NCT04393818,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,PsyCovid_App,Completed,Mental Health Disorder,Depression,Posttraumatic Stress Disorder,Burnout,Anxiety Disorders,,,Behavioral: Intervention App,Fundació d'investigació Sanitària de les Illes Balears|Universidad de las Islas Baleares|Hospital Universitario Miguel Servet|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Andalusian School of Public Health|Hospital Son Espases,All,"18 Years and older   (Adult, Older Adult)",560.0,Other,Interventional,2020-05-05,24/08/20,2020-08-24,19/05/20,10/09/20,"Ignacio Ricci-Cabello, Palma De Mallorca, Balearic Islands",Spain,Mental Health,1,5,111.0
4391.0,NCT04363437,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,COMBATCOVID19,Recruiting,Coronavirus Infection,,,,,,,Drug: Colchicine|Drug: Usual Care,Maimonides Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",70.0,Other,Interventional,2020-04-26,31/05/20,2020-06-14,27/04/20,08/05/20,"Maimonides Medical Center, Brooklyn, New York",United States,Respiratory Diseases,1,1,49.0
4392.0,NCT04335032,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),,Not yet recruiting,COVID-19,,,,,,,Drug: Eicosapentaenoic acid gastro-resistant capsules|Drug: Placebo,S.L.A. Pharma AG,All,"18 Years and older   (Adult, Older Adult)",284.0,Industry,Interventional,2020-09-11,13/07/21,2021-07-31,06/04/20,02/11/20,,,Respiratory Diseases,1,1,323.0
4393.0,NCT04160975,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,,Completed,"Flu, Human","Influenza, Human",COVID-19,,,,,Behavioral: Video about safety and effectiveness of adult seasonal flu vaccination|Behavioral: Message directing subjects to information on COVID-19 vaccine safety and efficacy,Harvard University|Stanford University|Massachusetts Institute of Technology,Male,18 Years to 51 Years   (Adult),2902.0,Other,Interventional,2019-12-20,19/02/21,2021-02-19,13/11/19,24/02/21,"Harvard University, Cambridge, Massachusetts",United States,"Infectious Diseases, Respiratory Diseases",1,3,427.0
4394.0,NCT04541472,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),,Recruiting,Dental Surgeon,,,,,,,,"University Hospital, Clermont-Ferrand|Faculty of Medicine and Paramedical Professions, Clermont-Ferrand, France",All,"16 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-05,01/12/20,2020-01-12,09/09/20,09/09/20,"University Hospital, Clermont Ferrand, Clermont-Ferrand",France,Others,0,1,7.0
4395.0,NCT04539873,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,(COLCOVID19),Not yet recruiting,Corona Virus Infection,,,,,,,Drug: Colchicine 0.5 MG|Combination Product: CONTROL GROUP,Fundación Universitaria de Ciencias de la Salud|Hospital de San Jose,All,"18 Years and older   (Adult, Older Adult)",128.0,Other,Interventional,2021-03-15,15/07/21,2021-09-15,07/09/20,24/02/21,"Fundación Universitaria de Ciencias de La Salud, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,1,184.0
4396.0,NCT04407117,Appendicitis During the National Lockdown During the COVID-19 Pandemic,,Completed,Appendicitis,,,,,,,Behavioral: Lock-down and social distancing,"Claus Anders Bertelsen, PhD, MD|Nordsjaellands Hospital",All,"Child, Adult, Older Adult",6000000.0,Other,Observational,2017-03-23,19/04/20,2020-04-19,29/05/20,19/06/20,"Nordsjaellands Hospital, Hillerød",Denmark,Others,0,1,1123.0
4397.0,NCT04772404,"Repercussion of the COVID-19 Pandemic on Physical Activity, Psychological State and Sleep",,Recruiting,Healthy,,,,,,,,Universidad de Granada,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-07-03,15/05/21,2021-06-15,26/02/21,30/03/21,"Department of Physical Therapy, Granada",Spain,Others,0,1,-18.0
4398.0,NCT04397692,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),,Recruiting,Corona Virus Infection,COVID-19,SARS-CoV 2,Nitric Oxide,Respiratory Disease,"Pneumonia, Viral",Inhaled Nitric Oxide,Device: Nitric Oxide delivered via LungFit™ system,Beyond Air Inc.,All,"22 Years to 65 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-06-13,30/09/20,2020-09-30,21/05/20,08/07/20,"Baptist Health Center for Clinical Research, Little Rock, Arkansas",United States,Respiratory Diseases,1,7,109.0
4399.0,NCT04357418,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,ICOS,Completed,Anxiety State,COVID-19,"Isolation, Social",Health Personnel Attitude,,,,Other: it is a survey,"Centre hospitalier de Ville-Evrard, France",All,"18 Years and older   (Adult, Older Adult)",187.0,Other,Observational,2020-01-04,30/06/20,2020-06-30,22/04/20,03/08/20,"URC Ville Evrard, Neuilly-sur-Marne",France,"Mental Health, Respiratory Diseases",1,4,178.0
4400.0,NCT04649775,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,AirFLO2,Not yet recruiting,Corona Virus Infection,Respiratory Rate,Hypoxia,COVID-19,,,,Device: AirFLO2,Duke University|MEDEX,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-30,01/05/21,2021-01-06,02/12/20,12/01/21,,,Respiratory Diseases,1,4,-24.0
4401.0,NCT04583345,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,,Recruiting,Hypertension,Social Isolation,COVID-19,,,,,Behavioral: Questionnaires,Ebru Calik Kutukcu|Hacettepe University,All,"18 Years to 65 Years   (Adult, Older Adult)",32.0,Other,Observational,2020-01-06,01/07/21,2021-01-09,12/10/20,08/04/21,"Hacettepe University, Ankara",Turkey,"Cardiovascular Diseases, Respiratory Diseases",1,3,369.0
4402.0,NCT04325867,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,eCardioCovid19,Recruiting,Angina Pectoris,Acute Coronary Syndrome,Coronary Syndrome,Coronary Artery Disease,Angioplasty,Stent Restenosis,Hypertension,Other: Tele-medicine platform,Professor Adrian Covic|Medical Sciences Academy - Romania|Victor Babes Clinical Hospital of Infectious Diseases - Bucharest|Grigore T. Popa University of Medicine and Pharmacy,All,"Child, Adult, Older Adult",200.0,Other,Interventional,2020-03-31,01/10/20,2020-01-10,30/03/20,01/04/20,"Medical Sciences Academy, Bucharest, Romania|University of Medicine and Pharmacy Gr T Popa, Iasi",Romania,Cardiovascular Diseases,1,7,-81.0
4403.0,NCT04530604,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),,Recruiting,COVID-19,Sars-CoV2,COVID-19,Acute Respiratory Distress Syndrome,,,,Drug: Defibrotide,Gregory Yanik|Jazz Pharmaceuticals|University of Michigan,All,"18 Years to 70 Years   (Adult, Older Adult)",12.0,Other|Industry,Interventional,2020-01-10,01/10/21,2021-01-10,28/08/20,14/10/20,"University of Michigan, Ann Arbor, Michigan",United States,Respiratory Diseases,1,4,366.0
4404.0,NCT04338698,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",PROTECT,Recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Oseltamivir|Drug: Azithromycin,Shehnoor Azhar|University of Health Sciences Lahore,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-22,01/09/20,2020-11-30,08/04/20,15/07/20,"Faislabad Medical University, Faisalābad, Pakistan|Gujranwala Medical College, Gujrānwāla, Pakistan|Nawaz Sharif Medical College, Gujrāt, Pakistan|Szabmu-Pims, Islamabad, Pakistan|Akram Medical Complex, Lahore, Pakistan|Fatima Jinnah Medical University, Lahore, Pakistan|King Edward Medical University-Mayo Hospital, Lahore, Pakistan|Lahore General Hospital, Lahore, Pakistan|Khyber Teaching Hospital, Peshawar, Pakistan|Rawalpindi Medical University, Rawalpindi, Pakistan|Sargodha Medical College, Sargodha",Pakistan,Respiratory Diseases,1,1,222.0
4405.0,NCT04490200,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,,Recruiting,COVID-19,SARS-CoV Infection,"Worker-Patient Transmission, Healthcare",,,,,Device: VESTA respirator|Device: Conventional N95 respirator,"University of Brasilia|University of Campinas, Brazil|Centro de Pesquisa em Biotecnologia Ltda|Hospital Regional da Asa Norte (HRAN)|Hospital da Região Leste (HRL)|Hospital Universitário de Brasília (HUB/UnB)",All,20 Years to 59 Years   (Adult),1000.0,Other|Industry,Interventional,2021-01-03,30/12/21,2022-02-15,29/07/20,03/03/21,"HRAN (Hospital Regional da Asa Norte), Brasília",Brazil,Respiratory Diseases,1,3,408.0
4406.0,NCT04710394,Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell,VOLT,"Active, not recruiting",Anosmia,COVID-19,Ageusia,Hyposmia,Hypogeusia,COVID-19,COVID-19,Behavioral: Smell Training,Washington University School of Medicine,All,"18 Years to 70 Years   (Adult, Older Adult)",240.0,Other,Interventional,2021-11-01,11/03/22,2022-11-03,14/01/21,05/04/21,"Washington University School of Medicine in Saint Louis, Saint Louis, Missouri",United States,Respiratory Diseases,1,7,367.0
4407.0,NCT04507867,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,,Not yet recruiting,COVID-19,Diabetes Mellitus,Hypertension,Obesity,,,,Dietary Supplement: Nutritional support system (NSS)|Other: Control,Anahuac University,All,"30 Years to 75 Years   (Adult, Older Adult)",240.0,Other,Interventional,2020-01-08,01/10/20,2020-01-12,11/08/20,11/08/20,,,"Metabolic Disorders, Cardiovascular Diseases, Respiratory Diseases",1,4,4.0
4408.0,NCT04590547,GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19),,Recruiting,Pneumonitis,SARS-CoV Infection,,,,,,Drug: GLS-1027|Drug: Placebo,"GeneOne Life Science, Inc.",All,"18 Years and older   (Adult, Older Adult)",132.0,Industry,Interventional,2021-01-04,01/10/21,2021-01-11,19/10/20,08/04/21,"Baton Rouge General Medical Center, Baton Rouge, Louisiana",United States,Respiratory Diseases,1,2,7.0
4409.0,NCT04581187,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,,Not yet recruiting,Hematologic Malignancies,,,,,,,Other: Quality of life assessment,Gruppo Italiano Malattie EMatologiche dell'Adulto,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-01-10,01/10/22,2024-01-10,09/10/20,09/10/20,,,Others,0,1,1461.0
4410.0,NCT04748185,Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies,,Recruiting,Monoclonal B-Cell Lymphocytosis,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,B-cell Non Hodgkin Lymphoma,Hodgkin Lymphoma,,,,,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",650.0,Other,Observational,2021-01-18,30/01/23,2023-01-30,10/02/21,10/02/21,"Mayo Clinic, Rochester, Minnesota",United States,Cancers,1,4,742.0
4411.0,NCT04475081,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,,Not yet recruiting,Sepsis Syndrome,,,,,,,Biological: MMR vaccine,Louisiana State University Health Sciences Center in New Orleans|Parsemus Foundation,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-08-17,31/10/21,2021-01-12,17/07/20,20/07/20,,,Others,0,1,148.0
4412.0,NCT04626089,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",DMMETCOV19,Withdrawn,Severe Acute Respiratory Syndrome Coronavirus 2,Metabolic Syndrome,Type 2 Diabetes,,,,,Drug: metformin glycinate|Drug: Placebo oral tablet,Laboratorios Silanes S.A. de C.V.,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2021-01-02,01/02/21,2021-01-02,12/11/20,08/04/21,"Hospital Juárez de México, OPD, Mexico City",Mexico,"Metabolic Disorders, Respiratory Diseases",1,3,0.0
4413.0,NCT04668339,A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults,,"Active, not recruiting",COVID-19,SARS-CoV Infection,Corona Virus Infection,,,,,"Biological: ARCT-021 single dose priming|Biological: ARCT-021 two lower dose priming|Biological: ARCT-021 two higher dose priming|Biological: Placebo (two doses), priming|Biological: Randomized booster|Biological: Placebo booster","Arcturus Therapeutics, Inc.",All,"18 Years and older   (Adult, Older Adult)",600.0,Industry,Interventional,2021-07-01,30/04/22,2022-04-30,16/12/20,29/03/21,"Arcturus Investigational Site 103, Chandler, Arizona, United States|Arcturus Investigational Site 107, Tucson, Arizona, United States|Arcturus Investigational Site 112, San Diego, California, United States|Arcturus Investigational Site 104, Melbourne, Florida, United States|Arcturus Investigational Site 105, Orlando, Florida, United States|Arcturus Investigational Site 106, Pinellas Park, Florida, United States|Arcturus Investigational Site 109, The Villages, Florida, United States|Arcturus Investigational Site 101, Peoria, Illinois, United States|Arcturus Investigational Site 110, Rockville, Maryland, United States|Arcturus Investigational Site 102, Anderson, South Carolina, United States|Arcturus Investigational Site 111, Austin, Texas, United States|Arcturus Investigational Site 108, Dallas, Texas, United States|Arcturus Investigational Site 204, Singapore, Singapore|Arcturus Investigational Site 201, Singapore, Singapore|Arcturus Investigational Site 203, Singapore",Singapore,Respiratory Diseases,1,3,303.0
4414.0,NCT04366089,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,PROBIOZOVID,Recruiting,COVID-19,SARS-CoV 2,"Pneumonia, Viral",Coronavirus Infection,,,,"Other: Oxygen-ozone therapy, probiotic supplementation and Standard of care|Dietary Supplement: SivoMixx (200 billion)|Drug: Azithromycin|Drug: hydroxychloroquine","Roberto Poscia MD, PhD|Azienda Policlinico Umberto I",All,"18 Years and older   (Adult, Older Adult)",152.0,Other,Interventional,2020-03-26,30/10/20,2020-12-31,28/04/20,28/04/20,"Francesco Pugliese, Rome, RM",Italy,Respiratory Diseases,1,4,280.0
4415.0,NCT04666311,Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,TB TRIAGE+,Recruiting,Pulmonary Tuberculosis,Tuberculosis Diagnosis,COVID-19,HIV,,,,Diagnostic Test: Accuracy of CAD4TB and Afinion CRP assay for pulmonary TB|Diagnostic Test: CAD4COVID+WBC and COVID-19 RDT for SARS-CoV-2 infection,"Klaus Reither|SolidarMed|Human Sciences Research Council|Institute of Tropical Medicine, Belgium|Radboud University|Charite University, Berlin, Germany|University Hospital, Basel, Switzerland|Foundation for Innovative New Diagnostics, Switzerland|European and Developing Countries Clinical Trials Partnership (EDCTP)|Ministry of Health, Lesotho|Swiss Tropical & Public Health Institute",All,"18 Years and older   (Adult, Older Adult)",1400.0,Other,Observational,2021-01-03,01/11/21,2022-01-05,14/12/20,18/03/21,"Butha-Buthe District Hospital, Butha-Buthe, Lesotho|Caluza Clinic, Pietermaritzburg, KwaZulu-Natal",South Africa,"Infectious Diseases, Respiratory Diseases",1,4,367.0
4416.0,NCT04403009,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,,Recruiting,Coronavirus Disease 2019,Character of the Severe Patients,,,,,,Other: no intervention,The First Affiliated Hospital of Guangzhou Medical University,All,"20 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-02,06/06/20,2020-06-20,27/05/20,27/05/20,"The First Affiliated Hospital of Guangzhou Medical University, Guanzhou, Guangdong, China|Hankou Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,2,170.0
4417.0,NCT04486404,"Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",,Enrolling by invitation,Acute Stress Disorder,,,,,,,Other: Online survey,Universidad Miguel Hernandez de Elche|Universidad Catolica Santiago de Guayaquil|Universidad de Santander|University of Sao Paulo|Pontificia Universidad Catolica de Chile,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Observational,2020-01-04,30/06/20,2020-11-30,24/07/20,29/10/20,"Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina|Pontificia Universidad Católica de Chile, Santiago, Chile|Universidad de Santander, Bucaramanga, Santander, Colombia|Universidad Católica de Santiago de Guayaquil, Guayaquil, Guayas, Ecuador|Universidad Miguel Hernández de Elche, Elche, Alicante",Spain,Mental Health,1,1,331.0
4418.0,NCT04456088,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),,Withdrawn,COVID-19,SARS-CoV 2,Respiratory Disease,"Pneumonia, Viral",Corona Virus Infection,,,Combination Product: 150 ppm Nitric Oxide delivered through LungFit Delivery System|Combination Product: 80 ppm Nitric Oxide delivered through LungFit Delivery System,Beyond Air Inc.,All,"22 Years to 75 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-07-15,15/11/20,2020-12-15,02/07/20,22/01/21,,,Respiratory Diseases,1,5,153.0
4419.0,NCT04536051,A Study of a Candidate COVID-19 Vaccine (COV003),,Recruiting,Coronavirus,,,,,,,Biological: ChAdOx1 nCoV-19 single dose + paracetamol|Biological: MenACWY single dose + paracetamol|Biological: ChAdOx1 nCoV-19 two dose + paracetamol|Biological: MenACWY prime & saline placebo boost + paracetamol,University of Oxford,All,"18 Years and older   (Adult, Older Adult)",10300.0,Other,Interventional,2020-02-06,01/09/21,2021-01-09,02/09/20,27/11/20,"Instituto D'Or de Pesquisa e Ensino - I'Dor, Salvador, Bahia, Brazil|Centro de Pesquisas Clinicas de Natal (CPCLIN), Natal, Rio Grande Do Norte, Brazil|Hospital das Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande Do Sul, Brazil|Instituto D'Or de Pesquisa e Ensino - I'Dor, Rio de Janeiro, Brazil|CRIE, Universidade Federal de São Paulo, São Paulo",Brazil,Respiratory Diseases,1,1,338.0
4420.0,NCT04346277,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),,Available,COVID-19,"ARDS, Human",Ards,SARS-CoV2,,,,"Biological: IC14, a monoclonal antibody against CD14",Implicit Bioscience,All,"18 Years to 70 Years   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,15/04/20,24/06/20,"IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano",Italy,Respiratory Diseases,1,4,
4421.0,NCT04443673,Glycine Supplement for Severe COVID-19,,Recruiting,COVID-19,SARS-CoV Infection,SARS (Severe Acute Respiratory Syndrome),SARS Pneumonia,"ARDS, Human","Pneumonia, Viral",,Dietary Supplement: Glycine,Instituto Nacional de Enfermedades Respiratorias,All,"Child, Adult, Older Adult",82.0,Other,Interventional,2020-08-20,28/02/21,2021-06-30,23/06/20,24/08/20,"Instituto Nacional de Enfermedades Respiratorias, Mexico DF",Mexico,Respiratory Diseases,1,6,314.0
4422.0,NCT04291729,Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,,Completed,COVID-19,,,,,,,Drug: Ganovo+ritonavir+/-Interferon nebulization,"The Ninth Hospital of Nanchang|Ascletis Pharmaceuticals Co., Ltd.",All,"18 Years to 75 Years   (Adult, Older Adult)",11.0,Other|Industry,Interventional,2020-02-17,19/03/20,2020-03-19,02/03/20,13/04/20,"The Ninth Hospital of Nanchang, Nanchang, Jiangxi",China,Respiratory Diseases,1,1,31.0
4423.0,NCT04677270,Evaluation of Two Versions of a Digital Problem Solving Tool for the General Public Specific for the COVID-19 Pandemic,COVIDPROBLEM,Completed,Problem Solving,,,,,,,Behavioral: Digital problem solving tool,"Karolinska Institutet|Stockholm County Council, Sweden",All,"16 Years and older   (Child, Adult, Older Adult)",397.0,Other,Interventional,2020-08-31,30/11/20,2020-11-30,21/12/20,21/12/20,"Centrum för Psykiatriforskning, Stockholm",Sweden,Others,0,1,91.0
4424.0,NCT04334967,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,,Suspended,COVID-19,Corona Virus Infection,COVID-19,COVID-19,COVID-19,,,Drug: Hydroxychloroquine|Dietary Supplement: Vitamin C,"Providence Health & Services|Center for Outcomes Research and Education|Providence Cancer Center, Earle A. Chiles Research Institute",All,"45 Years and older   (Adult, Older Adult)",13.0,Other,Interventional,2020-03-30,27/05/21,2022-05-27,06/04/20,16/09/20,"Portland Providence Medical Center, Portland, Oregon",United States,Respiratory Diseases,1,5,788.0
4425.0,NCT04466306,Pediatric Acute Kidney Injury in COVID-19,SPARC-1,Enrolling by invitation,Acute Kidney Injury,COVID-19,,,,,,,"Children's Healthcare of Atlanta|Children's Hospital Medical Center, Cincinnati|Children's of Alabama|The Hospital for Sick Children",All,"up to 25 Years   (Child, Adult)",250.0,Other,Observational,2020-04-15,08/07/20,2021-01-07,10/07/20,10/07/20,"Children's Hospital of Alabama, Birmingham, Alabama, United States|Arkansas Children's Research Institute, Little Rock, Arkansas, United States|Cedars-Sinai Maxine Dunitz Children's Health Center, Los Angeles, California, United States|UCLA Mattel Children's Hospital, Los Angeles, California, United States|Lucile Packard Children's Hospital Standford, Palo Alto, California, United States|Rady Children's Hospital San Diego, San Diego, California, United States|Children's Hospital Colorado, Aurora, Colorado, United States|Yale New Haven Children's Hospital, New Haven, Connecticut, United States|UF Health Shands Children's Hospital, Gainesville, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Comer Children's Hospital - UChicago Medicine, Chicago, Illinois, United States|Riley Hospital for Children, Indianapolis, Indiana, United States|University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States|Children's Mercy, Kansas City, Kansas, United States|John Hopkins Children's Center, Baltimore, Maryland, United States|Boston Children's Hospital, Boston, Massachusetts, United States|C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States|Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States|Beaumont Children's Hospital, Royal Oak, Michigan, United States|St. Louis Children's Hospital of Washington University, Saint Louis, Missouri, United States|Oishei Children's Hospital of Buffalo, Buffalo, New York, United States|Golisano Children's Hospital - University of Rochester Medicine, Rochester, New York, United States|Stony Brook Children's Hospital, Stony Brook, New York, United States|Levine Children's Hospital, Charlotte, North Carolina, United States|Duke Children's Hospital and Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Nationwide Children's Hospital, Columbus, Ohio, United States|Penn State Children's Hospital, Hershey, Pennsylvania, United States|Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States|Lifespan Hasbro Children's Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, United States|Seattle Children's Hospital, Seattle, Washington, United States|Stollery Children's Hospital, Edmonton, Alberta, Canada|McMaster Children's Hospital, Hamilton, Ontario, Canada|The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada|Soroka University Medical Center, Be'er Sheva, Israel|Dana-Dwek Children's Hospital, Tel Aviv, Israel|Shizuoka Children's Hospital, Shizuoka, Japan|Institute for Mother and Child Healthcare, Belgrade, Serbia|University Children's Hospital, Belgrade, Serbia|Hospital 12 de Octubre, Madrid, Spain|Birmingham Children's Hospital NHS, Birmingham, United Kingdom|Alder Hey Children's Hospital NHS, Liverpool, United Kingdom|King's College Hospital NHS, London, United Kingdom|St. George's University Hospital NHS, London, United Kingdom|Great Ormond Street Hospital NHS, London",United Kingdom,Respiratory Diseases,1,2,267.0
4426.0,NCT04448704,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,,Completed,Mental Health Issue,,,,,,,,Yale-NUS College,All,"21 Years and older   (Adult, Older Adult)",1011.0,Other,Observational,2020-06-22,11/10/20,2020-11-10,26/06/20,23/02/21,"EXPO, Singapore",Singapore,Others,0,1,141.0
4427.0,NCT04345276,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,,Completed,COVID-19,,,,,,,Drug: Danoprevir+Ritonavir,"Huoshenshan Hospital|Ascletis Pharmaceuticals Co., Ltd.",All,"18 Years to 75 Years   (Adult, Older Adult)",10.0,Other|Industry,Interventional,2020-03-18,15/04/20,2020-04-15,14/04/20,02/06/20,"Huoshenshan Hostipal, Wuhan, Hubei",China,Respiratory Diseases,1,1,28.0
4428.0,NCT04657406,Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19,,Available,COVID-19,Corona Virus Infection,SARS (Severe Acute Respiratory Syndrome),Acute Respiratory Distress Syndrome,,,,Drug: ZofinTM,"Organicell Regenerative Medicine|bioRASI, LLC",All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Treatment IND/Protocol,,,,08/12/20,05/01/21,,,Respiratory Diseases,1,4,
4429.0,NCT04633941,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,,Completed,"Diabetes Mellitus, Type 2","Obesity, Morbid",Bariatric Surgery Candidate,,,,,Other: Standard Care,Singapore General Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",272.0,Other,Observational,2020-01-06,30/07/20,2020-07-30,18/11/20,20/11/20,"Singapore General Hospital, Singapore",Singapore,Metabolic Disorders,1,3,206.0
4430.0,NCT04718519,Migrant Workers' Responses to the COVID-19 Pandemic,,Completed,Coronavirus,Trust,Misinformation,,,,,,Yale-NUS College,Male,21 Years to 60 Years   (Adult),1011.0,Other,Observational,2020-06-22,11/10/20,2020-11-10,22/01/21,23/03/21,"Yale NUS, Singapore",Singapore,Respiratory Diseases,1,3,141.0
4431.0,NCT04382534,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,,Recruiting,COVID-19,Respiratory Rehabilitation,Cross-sectional Study,Cohort Study,,,,Combination Product: Respiratory rehabilitation,Peking University Third Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-10-03,30/09/20,2020-12-31,11/05/20,11/05/20,"Huarunwugang general hospital, Wuhan, Hubei",China,Respiratory Diseases,1,4,89.0
4432.0,NCT04334434,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),,Completed,Telerehabilitation,,,,,,,Other: Telerehabilitation,"Kubra Koce, MSc PT|Istanbul University-Cerrahpasa",All,65 Years and older   (Older Adult),30.0,Other,Interventional,2020-07-30,15/09/20,2020-12-15,06/04/20,03/02/21,"Istanbul university Cerrahpasa, Istanbul",Turkey,Others,0,1,138.0
4433.0,NCT04306705,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,TACOS,Recruiting,COVID-19,SARS,Cytokine Storm,Cytokine Release Syndrome,Tocilizumab,,,Drug: Tocilizumab|Other: Standard of care|Procedure: Continuous renal replacement therapy,Tongji Hospital|Hubei Xinhua Hospital|Wuhan No.1 Hospital|Wuhan Central Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Observational,2020-02-20,30/05/20,2020-06-20,13/03/20,17/03/20,"Tongji Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,5,121.0
4434.0,NCT04765371,"Comparison Between Prednisolone and Dexamethasone on Mortality in Patients on Oxygen Therapy, With CoViD-19",COPreDex,Not yet recruiting,Coronavirus Infection,,,,,,,Drug: DEXAMETHASONE|Drug: PREDNISOLONE,Centre Hospitalier René Dubos,All,"18 Years and older   (Adult, Older Adult)",220.0,Other,Interventional,2021-01-03,01/10/21,2021-01-10,21/02/21,01/03/21,"Department of Emergency, Hospital Victor Dupouy, Argenteuil, France|Department of Pneumology and Infectious Medicine, Hospital Carnelle Portes de l'Oise, Beaumont, France|Department of Infectious and Tropical Diseases, Hospital Simone Veil, Eaubonne, France|Department of Infectious Medicine, Hospital of Gonesse, Gonesse, France|Department of Infectious and Tropical Diseases, Hospital René Dubos,, Pontoise, France|Department of Infectious and respiratory Diseases, Hospital Delafontaine, Saint-Denis",France,Respiratory Diseases,1,1,7.0
4435.0,NCT04335305,Checkpoint Blockade in COVID-19 Pandemic,COPERNICO,Recruiting,COVID-19,"Pneumonia, Viral",,,,,,Drug: Tocilizumab|Biological: Pembrolizumab (MK-3475),MedSIR,All,"18 Years to 80 Years   (Adult, Older Adult)",24.0,Other,Interventional,2020-09-04,31/12/20,2021-06-30,06/04/20,27/11/20,"Hospital Quirónsalud Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Arnau de Vilanova de Lleida, Lleida, Spain|Hospital Universitario Ramón y Cajal, Madrid, Spain|Hospital Ruber Juan Bravo, Madrid, Spain|Hospital Ruber Internacional, Madrid, Spain|Hospital Arnau de Vilanova-Lliria, Valencia, Spain|Hospital Universitario Doctor Peset, Valencia",Spain,Respiratory Diseases,1,2,299.0
4436.0,NCT04356443,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,,Recruiting,Respiratory Failure,Ventilatory Failure,COVID-19,Pneumonia,"ARDS, Human",,,Device: AirGo Respiratory Monitor,Massachusetts General Hospital,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-04-15,31/12/20,2020-12-31,22/04/20,22/04/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,5,260.0
4437.0,NCT04717089,Extended Post Anaesthetic Care in PACU During COVID-19: Multi-perspective Value-based Analysis,,Recruiting,Overnight Intensive Recovery,Postoperative Care,,,,,,Other: overnight intensive recovery / extended post anaesthetic care in PACU,"Tuen Mun Hospital|Anaesthesia & Operation Theatre Service, Tuen Mun Hospital, Hong Kong|Intensive Care Unit, Tuen Mun Hospital, Hong Kong",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-10-02,28/02/21,2021-06-30,20/01/21,05/03/21,"Operation Theatre, Tuen Mun Hospital, Tuen Mun",Hong Kong,Others,0,2,271.0
4438.0,NCT04272710,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,,Withdrawn,COVID-19,,,,,,,,Chongqing Medical University,All,"18 Years to 100 Years   (Adult, Older Adult)",0.0,Other,Observational,2020-01-25,31/03/20,2020-04-30,17/02/20,17/03/20,"The First Affiliated Hospital of Chongqing Medical University, Chongqing",China,Respiratory Diseases,1,1,96.0
4439.0,NCT04460677,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,,Recruiting,Psychological Distress,"Stress, Psychological",Autism Spectrum Disorder,,,,,Behavioral: Emotional Support Plan|Behavioral: Daily Monitoring,"Rutgers, The State University of New Jersey",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-12-08,31/03/21,2021-03-31,07/07/20,09/09/20,"Rutgers University, Piscataway, New Jersey",United States,Mental Health,1,3,113.0
4440.0,NCT04522128,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,,Recruiting,COVID-19,Quality of Life,Behavior,Social Isolation,,,,Behavioral: Behaviour Change Technique Intervention to Improve Quality of Life,University of Manchester,All,"18 Years and older   (Adult, Older Adult)",969.0,Other,Interventional,2020-05-22,31/03/22,2022-12-31,21/08/20,21/08/20,"University of Manchester - online, Manchester, Cheshire",United Kingdom,Respiratory Diseases,1,4,953.0
4441.0,NCT04333914,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,IMMUNONCOVID,Recruiting,COVID-19,Advanced or Metastatic Hematological or Solid Tumor,,,,,,Drug: Autophagy inhibitor (GNS651)|Other: Standard of care|Drug: Avdoralimab|Drug: Monalizumab,Centre Leon Berard,All,"18 Years and older   (Adult, Older Adult)",219.0,Other,Interventional,2020-04-15,01/06/21,2021-01-08,03/04/20,04/12/20,"Centre Léon Bérard, Lyon, Rhône, France|CHU Clermont Ferrand, Clermont Ferrand, France|Centre Oscar Lambret, Lille, France|AP-HP Hôpital Saint Antoine, Paris, France|AP-HP La Pitié Salpétrière, Paris, France|Hôpital Saint-Joseph, Paris, France|AP-HP Tenon, Paris, France|AP-HP Hôpital Bichat Claude Bernard, Paris, France|GH Diaconesses Croix Saint Simon, Paris, France|Institut Gustave Roussy, Villejuif",France,Respiratory Diseases,1,2,268.0
4442.0,NCT04581811,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),,Recruiting,ARDS,COVID-19,Acute Hypoxemic Respiratory Failure,,,,,Other: Prolonged Proned Positioning|Other: Traditional Proning Arm,University of Alabama at Birmingham,All,"18 Years to 99 Years   (Adult, Older Adult)",52.0,Other,Interventional,2020-10-11,01/05/21,2021-01-06,09/10/20,13/11/20,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,3,87.0
4443.0,NCT04645433,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,,Completed,Mortality,Intensive Care Unit,,,,,,,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-03-15,15/05/20,2020-05-15,27/11/20,27/11/20,"SisliHamidiye Etfal Education and Training Hospital, Istanbul",Turkey,Others,0,2,61.0
4444.0,NCT04395911,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,,Recruiting,AKI,ARDS,COVID-19,,,,,Device: SCD,SeaStar Medical,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-10-09,01/06/21,2021-01-12,20/05/20,23/03/21,"University of Kentucky, Lexington, Kentucky, United States|University of Michigan, Ann Arbor, Michigan, United States|Henry Ford Health System, Detroit, Michigan",United States,Respiratory Diseases,1,3,95.0
4445.0,NCT04601090,Survival Rates and Longterm Outcomes After COVID-19,,Recruiting,COVID-19,Acute Respiratory Failure,Acute Respiratory Distress Syndrome,Post Intensive Care Unit Syndrome,Survivorship,,,Other: ICU treatment,Oslo University Hospital|The Research Council of Norway,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-09-16,01/09/22,2022-01-09,23/10/20,26/10/20,"Oslo University Hospital, Oslo",Norway,Respiratory Diseases,1,5,480.0
4446.0,NCT04798625,Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication,Nor-vaC,Recruiting,Rheumatoid Arthritis,Psoriatic Arthritis,Spondyloarthritis,Crohn Disease,Ulcerative Colitis,Autoimmune Hepatitis,Liver Transplant; Complications,,"Diakonhjemmet Hospital|University Hospital, Akershus",All,"18 Years and older   (Adult, Older Adult)",1600.0,Other,Observational,2021-02-15,15/02/26,2027-02-15,15/03/21,15/03/21,"Akershus University Hospital, Lørenskog, Norway|Diakonhjemmet Hospital, Oslo",Norway,"Infectious Diseases, Immunological Disorders",1,7,2191.0
4447.0,NCT04381923,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,COVIDNOCHE,Not yet recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,Hypoxemic Respiratory Failure,"Pneumonia, Viral",COVID-19,,,,Device: Helmet Continuous Positive Airway Pressure (CPAP)|Device: High Flow Nasal Oxygen (HFNO),University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-02-15,15/02/22,2022-05-15,11/05/20,10/11/20,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,4,454.0
4448.0,NCT04395833,National Survey on the Lockdown of Children With Disabilities,ECHO,Completed,COVID-19,,,,,,,,"University Hospital, Brest",All,"up to 18 Years   (Child, Adult)",2500.0,Other,Observational,2020-07-04,11/05/20,2020-11-05,20/05/20,20/05/20,"CHRU de Brest, Brest",France,Respiratory Diseases,1,1,124.0
4449.0,NCT04723407,Assessment of the Psychological Impact of the COVID19 (SARS-CoV-2) Pandemic on Patients With Chronic Inflammatory Rheumatism,RICOVID19,Not yet recruiting,Rheumatism,,,,,,,Other: questionnaires,"University Hospital, Limoges",All,"18 Years and older   (Adult, Older Adult)",950.0,Other,Observational,2021-01-02,01/01/22,2022-01-03,25/01/21,26/01/21,"Département de Rhumatologie, Limoges",France,Others,0,1,366.0
4450.0,NCT04659135,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,,Recruiting,Neoplasms,Coronavirus,,,,,,,American Society of Clinical Oncology,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-04-19,01/12/22,2022-01-12,09/12/20,09/12/20,"Anchorage Oncology Center, Anchorage, Alaska, United States|AIS Cancer Center, Bakersfield, California, United States|Long Beach Memorial Medical Center, Fountain Valley, California, United States|Orange Coast Medical Center, Fountain Valley, California, United States|Saddleback Memorial Medical Center, Fountain Valley, California, United States|Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, United States|Gene Upshaw Memorial Tahoe Forest Cancer Center, Truckee, California, United States|PIH Health, Whittier, California, United States|Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States|Hartford HealthCare Cancer Institute, Hartford, Connecticut, United States|Bayhealth Medical Center, Dover, Delaware, United States|Florida Precision Oncology, A Division of 21st Centry Oncology, Fort Myers, Florida, United States|Florida Cancer Specialists & Research Institute, LLC, Sarasota, Florida, United States|Emory University Winship Cancer Institute, Atlanta, Georgia, United States|Augusta University, Augusta, Georgia, United States|Hawaii Cancer Care, Honolulu, Hawaii, United States|NorthShore University HealthSystem, Evanston, Illinois, United States|Joliet Oncology-Hematology Associates, Joliet, Illinois, United States|Edward-Elmhurst Healthcare, Naperville, Illinois, United States|Illinois Cancer Care, Peoria, Illinois, United States|Goshen Center for Cancer Care, Goshen, Indiana, United States|Michiana Hematology Oncology, Mishawaka, Indiana, United States|MidAmerica Oncology Associates, Overland Park, Kansas, United States|University of Kansas Medical Center, Westwood, Kansas, United States|Baptist Health Madisonville, Madisonville, Kentucky, United States|Greater Baltimore Medical Center, Baltimore, Maryland, United States|LifeBridge Health, Baltimore, Maryland, United States|Tufts Medical Center, Boston, Massachusetts, United States|Great Lakes Cancer Management Specialists, Grosse Pointe Woods, Michigan, United States|Lakeland Hospitals, Saint Joseph, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Mosaic Cancer Care, Saint Joseph, Missouri, United States|Nebraska Hematology Oncology, Lincoln, Nebraska, United States|Callahan Cancer Center, North Platte, Nebraska, United States|Nebraska Cancer Specialists, Omaha, Nebraska, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Bayonne Medical Center, Bayonne, New Jersey, United States|CarePoint Health - Christ Hospital, Jersey City, New Jersey, United States|Penn Medicine, Princeton Health, Plainsboro, New Jersey, United States|Hematology Oncology Associates of Central New York, East Syracuse, New York, United States|Northwell Health Cancer Institute, Lake Success, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Levine Cancer Institute Atrium Health, Charlotte, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|Carteret Health Care, Morehead City, North Carolina, United States|CarolinaEast Medical Center, New Bern, North Carolina, United States|Aultman Hospital, Canton, Ohio, United States|Cincinnati Children's Hospital, Cincinnati, Ohio, United States|Oncology Hematology Care, Cincinnati, Ohio, United States|Florida Cancer Specialists, Massillon, Ohio, United States|Columbia Memorial Hospital, Astoria, Oregon, United States|Samaritan Health Services Corvallis, Corvallis, Oregon, United States|Penn Medicine, Lancaster General Health, Lancaster, Pennsylvania, United States|University of Pennsylvania, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States|Monument Health, Rapid City, South Dakota, United States|Baptist Clinical Research Institute, Memphis, Tennessee, United States|Tennessee Oncology, Nashville, Tennessee, United States|BSA Harrington Cancer Center, Amarillo, Texas, United States|Virginia Cancer Specialists, Fairfax, Virginia, United States|Hematology Oncology Associates of Fredericksburg, Fredericksburg, Virginia, United States|Virginia Cancer Institute, Richmond, Virginia",United States,Respiratory Diseases,1,2,633.0
4451.0,NCT04355637,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,,Recruiting,Coronavirus Infection,,,,,,,Drug: Inhaled budesonide,Sara Varea|Fundacion Clinic per a la Recerca Biomédica,All,"18 Years to 79 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-04-21,31/08/21,2021-08-31,21/04/20,12/01/21,"Hospital de Infecciosas Francisco Javier Muñiz, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|CEMIC (Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno), Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina|Hospital de Rehabilitación Respiratoria María Ferrer, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Hospital Donación Francisco Santojanni, Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina|Clínica Monte Grande, Monte Grande, Buenos Aires, Argentina|Hospital Centro de Salud Zenón J. Santillán, San Miguel De Tucumán, Tucumán, Argentina|Hospital San Juan de Dios, La plata, Argentina|Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, Spain|Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Sabadell-Parc Tauli, Sabadell, Barcelona, Spain|Hospital del Mar, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Hospital Clinic of Barcelona, Barcelona, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona",Spain,Respiratory Diseases,1,1,497.0
4452.0,NCT04445506,Short Term Corticosteroids in SARS-CoV2 Patients,,Completed,Corticosteroids,COVID-19,SARS-CoV 2,Steroids,Dexamethasone,,,Drug: Dexamethasone,The Miriam Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-01-04,31/05/20,2020-05-31,24/06/20,24/06/20,"The Miriam Hospital, Providence, Rhode Island",United States,Respiratory Diseases,1,5,148.0
4453.0,NCT04611425,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",REHSCU,Recruiting,Acute Respiratory Failure,COVID-19,Trauma,Stroke,Sepsis,Shock,,Drug: Remimazolam,Nantes University Hospital|Paion UK Ltd.,All,"18 Years to 85 Years   (Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-11-30,01/05/21,2021-01-05,02/11/20,14/04/21,"CHU de Nantes, Nantes",France,"Cardiovascular Diseases, Respiratory Diseases",1,6,36.0
4454.0,NCT04402879,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,CORONA,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,COVID-19,Acute Respiratory Distress Syndrome,ARDS,Hypoxemic Respiratory Failure,,,Procedure: Prone Positioning (PP),University of Calgary|Alberta Health Services,All,"18 Years and older   (Adult, Older Adult)",596.0,Other,Interventional,2020-10-11,01/12/21,2022-01-06,27/05/20,17/12/20,"Peter Lougheed Centre (PLC), Calgary, Alberta, Canada|Foothills Hospital Intensive Care Unit, Calgary, Alberta, Canada|Rockyview General Hospital, Calgary, Alberta, Canada|South Health Campus, Calgary, Alberta",Canada,Respiratory Diseases,1,5,452.0
4455.0,NCT04452695,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,,Completed,COVID-19,Telemedicine,Robotics,Emergencies,Emerging Infectious Disease,,,Device: Doctor Spot,Brigham and Women's Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-10-03,03/08/20,2020-10-08,30/06/20,26/01/21,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,5,5.0
4456.0,NCT04351542,Ayurveda for Flu Like Illness During Covid-19 Outbreak,,Completed,Flu Like Illness,,,,,,,Dietary Supplement: Ayurveda|Other: Usual Care,Aarogyam UK,All,18 Years to 60 Years   (Adult),32.0,Other,Interventional,2020-06-03,06/04/20,2020-12-04,17/04/20,17/04/20,"Aarogyam, Leicester",United Kingdom,Others,0,1,184.0
4457.0,NCT04293692,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,,Withdrawn,COVID-19,,,,,,,Biological: UC-MSCs|Other: Placebo,"Puren Hospital Affiliated to Wuhan University of Science and Technology|Wuhan Hamilton Bio-technology Co., Ltd",All,"18 Years to 75 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-02-24,25/02/20,2020-02-25,03/03/20,18/03/20,"Puren Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,1,1.0
4458.0,NCT04753632,Status of People With Cerebral Palsy and Their Caregivers During COVID-19 Pandemic,,Recruiting,Cerebral Palsy,,,,,,,,Universidad de Granada,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2021-09-03,15/05/21,2021-06-15,15/02/21,26/03/21,"Department of Physical Therapy, Granada",Spain,Others,0,1,-80.0
4459.0,NCT04593641,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",,"Active, not recruiting",COVID-19,,,,,,,Biological: CT-P59,Celltrion,All,18 Years to 60 Years   (Adult),18.0,Industry,Interventional,2020-04-09,22/10/20,2020-12-23,20/10/20,20/10/20,"Incheon Medical Center, Incheon, Korea",Republic of,Respiratory Diseases,1,1,258.0
4460.0,NCT04615936,Nasal Photodisinfection COVID Proof of Concept Study,,Recruiting,COVID-19,Corona Virus Infection,SARS-CoV 2,,,,,Other: Methylene-Blue Photodisinfection,Sunnybrook Health Sciences Centre,All,"Child, Adult, Older Adult",100.0,Other,Interventional,2020-10-07,31/05/21,2021-05-31,04/11/20,04/11/20,"Sunnybrook Health Sciences Centre, Toronto, Ontario",Canada,Respiratory Diseases,1,3,236.0
4461.0,NCT04403061,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,Resistir,Completed,"Disease, Viral",Cytokine Release Syndrome,TLRs,,,,,Diagnostic Test: Cytokines measurement|Diagnostic Test: Cellular response|Diagnostic Test: TLRs activation measurement|Diagnostic Test: KIR phenotype evaluation,Asociacion para el Estudio de las Enfermedades Infecciosas|Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal,All,"18 Years to 100 Years   (Adult, Older Adult)",106.0,Other,Observational,2020-05-22,22/12/20,2021-10-01,27/05/20,12/01/21,"Hospital Ramon y Cajal, Madrid",Spain,Others,0,3,497.0
4462.0,NCT04588415,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,,Enrolling by invitation,Bereavement,Severe Grief Reaction,,,,,,Other: Bereavement Virtual Support Group,Ottawa Hospital Research Institute,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-03-01,01/12/21,2022-01-01,19/10/20,01/03/21,"Ottawa Hospital, Ottawa, Ontario",Canada,Others,0,2,306.0
4463.0,NCT04575584,Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),,Recruiting,COVID-19,,,,,,,Drug: Molnupiravir|Drug: Placebo,Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",1300.0,Industry,Interventional,2020-10-19,27/06/21,2021-12-30,05/10/20,02/04/21,"Kaiser Foundation Hospital - South Bay ( Site 1832), Harbor City, California, United States|Cedars-Sinai Medical Center ( Site 1822), Los Angeles, California, United States|University of California Davis Health ( Site 1809), Sacramento, California, United States|University Of Florida ( Site 1810), Gainesville, Florida, United States|Wellstar Kennestone Hospital ( Site 1801), Marietta, Georgia, United States|Loretto Hospital ( Site 1838), Chicago, Illinois, United States|LSU-HSC Shreveport ( Site 1824), Shreveport, Louisiana, United States|Henry Ford Health System ( Site 1821), Detroit, Michigan, United States|University of Mississippi Medical Center ( Site 1846), Jackson, Mississippi, United States|University of Nebraska Medical Center ( Site 1835), Omaha, Nebraska, United States|University of New Mexico, Health Sciences Center ( Site 1806), Albuquerque, New Mexico, United States|Carolinas Medical Center ( Site 1850), Charlotte, North Carolina, United States|ECU Adult Specialty Care ( Site 1865), Greenville, North Carolina, United States|Sanford Health ( Site 1851), Fargo, North Dakota, United States|Temple University ( Site 1836), Philadelphia, Pennsylvania, United States|CHRISTUS Institute for Innovation & Advanced Clinical Care ( Site 1864), Corpus Christi, Texas, United States|Houston Methodist Hospital ( Site 1863), Houston, Texas, United States|Swedish Medical Center ( Site 1812), Edmonds, Washington, United States|Valley Medical Center ( Site 1815), Renton, Washington, United States|Swedish Medical Center ( Site 1861), Seattle, Washington, United States|Chronos Pesquisa Clínica ( Site 0105), Brasilia, Distrito Federal, Brazil|Santa Casa de Misericordia de Belo Horizonte ( Site 0100), Belo Horizonte, Minas Gerais, Brazil|Hospital de Clinicas da Universidade Federal do Parana ( Site 0104), Curitiba, Parana, Brazil|Hospital Tacchini ( Site 0107), Bento Goncalves, Rio Grande Do Sul, Brazil|FUNFARME Hospital de Base Centro Integrado de Pesquisa ( Site 0101), Sao Jose do Rio Preto, Sao Paulo, Brazil|University Health Network - Toronto General Hospital ( Site 0201), Toronto, Ontario, Canada|Hospital Clinico Fusat ( Site 0300), Rancagua, Libertador General Bernardo O Higgins, Chile|Clinica Universidad de los Andes ( Site 0301), Santiago, Region M. De Santiago, Chile|Hospital Sotero del Rio [Santiago, Chile] ( Site 0304), Santiago, Region M. De Santiago, Chile|Complejo Hospitalario San Jose ( Site 0306), Santiago, Region M. De Santiago, Chile|Servicio de Salud Sur Hospital Lucio Cordova ( Site 0305), Santiago, Region M. De Santiago, Chile|Hospital Pablo Tobon Uribe ( Site 0404), Medellin, Antioquia, Colombia|Clinica de la Costa Ltda. ( Site 0402), Barranquilla, Atlantico, Colombia|Oncomedica S.A. ( Site 0406), Monteria, Cordoba, Colombia|Hospital Universitario San Ignacio ( Site 0401), Bogota, Distrito Capital De Bogota, Colombia|Fundacion Cardiovascular de Colombia ( Site 0403), Bucaramanca, Santander, Colombia|Fundacion Valle del Lili ( Site 0400), Cali, Valle Del Cauca, Colombia|Groupe Hospitalier Pellegrin ( Site 0511), Bordeaux, Gironde, France|Pitie Salpetriere University Hospital-Infectious Disease - Tropical Diseases ( Site 0504), Paris, Ile-de-France, France|C.H.U. de Toulouse, Hopital de Purpan ( Site 0501), Toulouse, Midi-Pyrenees, France|Centre Hospitalier de Tourcoing ( Site 0502), Tourcoing, Nord, France|CHU Hopital Saint Antoine ( Site 0505), Paris, France|Hopital Bichat - Claude Bernard ( Site 0503), Paris, France|Rambam Medical Center ( Site 2102), Haifa, Israel|Hadassah Medical Center. Ein Kerem ( Site 2103), Jerusalem, Israel|Chaim Sheba Medical Center ( Site 2100), Ramat Gan, Israel|ASST Fatebenefratelli-Ospedale Sacco ( Site 0601), Milano, Italy|Chungnam National University Hospital ( Site 2202), Daejeon, Taejon-Kwangyokshi, Korea, Republic of|Inha University Hospital ( Site 2204), Incheon, Korea, Republic of|The Catholic University of Korea Eunpyeong St Mary s Hospital ( Site 2205), Seoul, Korea, Republic of|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0802), Ciudad de mexico, Distrito Federal, Mexico|Hospital Regional de Alta Especialidad del Bajio ( Site 0807), Leon, Guanajuato, Mexico|Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0800), Guadalajara, Jalisco, Mexico|Hospital Universitario Dr. Jose Eleuterio Gonzalez ( Site 0803), Monterrey, Nuevo Leon, Mexico|University of the Philippines-Philippine General Hospital ( Site 0900), Manila, National Capital Region, Philippines|Lung Center of the Philippines ( Site 0902), Quezon City, National Capital Region, Philippines|Wojewodzki Szpital Specjalistyczny im. dr. Wladyslawa Bieganskiego ( Site 1001), Lodz-Baluty, Lodzkie, Poland|Samodzielny Publiczny Szpital Kliniczny Nr 1 w Lublinie ( Site 1004), Lublin, Lubelskie, Poland|Centrum Medyczne Pratia, Mazowiecki Szpital Specjalistyczny, Oddział Obserwacyjno - Zakaźny ( Site 1, Ostroleka, Mazowieckie, Poland|Centrum Medyczne w Lancucie Sp.zo.o. ( Site 1000), Lancut, Podkarpackie, Poland|Krasnogorsk City Hospital Number 1 ( Site 1119), Krasnogorsk, Moskovskaya Oblast, Russian Federation|City Clinical Hospital #40 ( Site 1109), Moscow, Moskva, Russian Federation|FSBI Central Hospital with Policlinics ( Site 1105), Moscow, Moskva, Russian Federation|Moscow Clinical Hospital #52 ( Site 1103), Moscow, Moskva, Russian Federation|City Hospital #40 ( Site 1113), Saint Petersburg, Sankt-Peterburg, Russian Federation|City Pokrovskaya hospital ( Site 1116), Saint-Petersburg, Sankt-Peterburg, Russian Federation|City Clinical Hospital #1 ( Site 1112), Smolensk, Smolenskaya Oblast, Russian Federation|Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 1100), Kazan, Tatarstan, Respublika, Russian Federation|IATROS International ( Site 1202), Bloemfontein, Free State, South Africa|Wits Baragwanath Clinical Trial Site ( Site 1204), Soweto, Gauteng, South Africa|TREAD Research ( Site 1201), Cape Town, Western Cape, South Africa|Clinical Projects Research Centre ( Site 1205), Worcester, Western Cape, South Africa|Hospital Universitari Vall d Hebron ( Site 1305), Barcelona, Cataluna, Spain|Hospital Clinic ( Site 1304), Barcelona, Spain|Hospital Universitari Germans Trias i Pujol ( Site 1303), Barcelona, Spain|Hospital Universitario Gregorio Maranon ( Site 1302), Madrid, Spain|Hospital Universitario Ramon y Cajal ( Site 1301), Madrid, Spain|Hospital Universitario La Paz ( Site 1300), Madrid, Spain|Ivano-Frankivsk Regional Clinical Infectious Diseases Hospital ( Site 1605), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNE Central city clinical hospital of Ivano-Frankivsk city council ( Site 1604), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|MNE Ivano-Frankivsk Regional Phthisiology-Pulmonology Center ( Site 1603), Ivano-Frankivsk, Ivano-Frankivska Oblast, Ukraine|CNPE of Kharkiv RC Regional Clinical Infectious Diseases Hospital ( Site 1606), Kharkiv, Kharkivska Oblast, Ukraine|Сommunal non-com. Institution Oleksandrivska clinical hospital Kyiv ( Site 1600), Kyiv, Kyivska Oblast, Ukraine|Odesa City Clinical Infectious Hospital ( Site 1611), Odesa, Odeska Oblast, Ukraine|Communal Non-Commercial Enterprise Central City Hospital ( Site 1615), Rivne, Rivnenska Oblast, Ukraine|Volyn Regional Clinical Hospital ( Site 1613), Lutsk, Volynska Oblast, Ukraine|Royal Free London NHS Foundation Trust ( Site 1700), London, London, City Of, United Kingdom|King's College Hospital ( Site 1705), London, London, City Of, United Kingdom|North Manchester General Hospital ( Site 1701), Manchester",United Kingdom,Respiratory Diseases,1,1,437.0
4464.0,NCT04405739,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),,Recruiting,SARS-CoV 2,,,,,,,Drug: EIDD-2801|Drug: Placebo (PB0),"Ridgeback Biotherapeutics, LP",All,"18 Years and older   (Adult, Older Adult)",80.0,Industry,Interventional,2020-06-16,28/05/21,2021-05-28,28/05/20,21/02/21,"Ronald Reagan UCLA Medical Center, Los Angeles, California, United States|Cook County Hospital, Chicago, Illinois, United States|Advocate Christ Medical Center, Oak Lawn, Illinois, United States|Advocate Lutheran General Hospital, Park Ridge, Illinois, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|John Hopkins Hospital, Baltimore, Maryland, United States|Suburban Hospital, Bethesda, Maryland, United States|Howard County General Hospital, Columbia, Maryland, United States|Wake Forest Baptist Health, Winston-Salem, North Carolina, United States|Vanderbilt University, Nashville, Tennessee, United States|Houston Methodist Hospital, Houston, Texas",United States,Respiratory Diseases,1,1,346.0
4465.0,NCT04488549,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),DECOR-19,Completed,Colo-rectal Cancer,Colon Cancer,Rectal Cancer,Oncology,Surgery,,,Other: Survey,Treviso Regional Hospital|Gaetano Gallo|Gian Luca Di Tanna,All,"Child, Adult, Older Adult",1051.0,Other,Observational,2020-05-20,10/06/20,2020-10-06,28/07/20,28/07/20,"Treviso Regional Hospital, Treviso",Italy,Cancers,1,5,139.0
4466.0,NCT04390555,The Global PCHF-COVICAV Registry,PCHF-COVICAV,Recruiting,COVID-19,Cardiovascular Diseases,Cardiovascular Risk Factor,Heart Failure,,,,,University of Zurich|Wroclaw Medical University,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-04-30,01/12/20,2021-01-07,15/05/20,15/05/20,"Zurich Heart Center, Unispital Zurich, Zurich",Switzerland,Respiratory Diseases,1,4,252.0
4467.0,NCT04842734,Comparison of the Effect of Online Physical Exercise and Computerized Cognitive Stimulation in Patients With Alzheimer's Disease During the Covid-19 Pandemic,,"Active, not recruiting",Alzheimer Disease,Telerehabilitation,Online Physical Exercise,Computerized Cognitive Stimulation,COVID-19,,,Other: Physical exercise|Other: Physical exercise and computerized cognitive training,Yeditepe University,All,65 Years and older   (Older Adult),60.0,Other,Interventional,2021-03-27,27/06/21,2021-06-27,13/04/21,13/04/21,"Yeditepe University, İstanbul, Eyalet/Yerleşke",Turkey,Respiratory Diseases,1,5,92.0
4468.0,NCT04603781,CBD Oil for Reducing Emotional Impact of COVID-19,CBDOIL,Recruiting,Anxiety Depression,Alcohol Abuse,Substance Abuse,Anger,Sleep Disturbance,Stress Reaction,,Dietary Supplement: CBD Isolate|Dietary Supplement: Full Spectrum CBD Oil|Dietary Supplement: Broad-Spectrum CBD Oil|Dietary Supplement: Placebo Oil,University of Texas at Austin|Way West Hemp Inc.|SunFlora.Inc,All,"18 Years to 75 Years   (Adult, Older Adult)",160.0,Other,Interventional,2020-04-12,31/12/21,2021-12-31,27/10/20,26/02/21,"University of Texas at Austin, Laboratory for the Study of Anxiety Disorders, Austin, Texas",United States,Mental Health,1,6,628.0
4469.0,NCT04499677,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,FLARE,Recruiting,COVID-19,,,,,,,Drug: Favipiravir|Drug: Lopinavir/ Ritonavir|Other: Favipiravir Placebo|Other: Lopinavir/ Ritonavir Placebo,"University College, London|LifeArc",All,"18 Years to 70 Years   (Adult, Older Adult)",240.0,Other,Interventional,2020-09-24,11/12/20,2021-01-03,05/08/20,30/10/20,"Royal Free Hospital, London",United Kingdom,Respiratory Diseases,1,1,101.0
4470.0,NCT04604743,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,,Not yet recruiting,Vaccine Refusal,,,,,,,"Behavioral: Intervention, TBN",University of Alabama at Birmingham,All,15 Years to 17 Years   (Child),4.0,Other,Interventional,2021-01-05,30/06/23,2023-06-30,27/10/20,23/02/21,"University of Alabama at Birmingham (UAB), Birmingham, Alabama",United States,Others,0,1,906.0
4471.0,NCT04264858,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,,Not yet recruiting,COVID-19,Immunoglobulin of Cured Patients,,,,,,Drug: Immunoglobulin of cured patients|Drug: γ-Globulin,"Wuhan Union Hospital, China",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-03-17,30/04/20,2020-05-31,11/02/20,17/03/20,"Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei",China,Respiratory Diseases,1,2,75.0
4472.0,NCT04422522,Fibromyalgia During the COVID-19 Pandemic,,"Active, not recruiting","Fibromyalgia, Primary",,,,,,,,Al-Azhar University,All,"19 Years and older   (Adult, Older Adult)",45.0,Other,Observational,2020-03-15,15/05/20,2020-06-30,09/06/20,11/06/20,"Al-Azhar Faculty of medicine, Rheumatology Department, Cairo",Egypt,Others,0,1,107.0
4473.0,NCT04452708,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,,Recruiting,Respiratory Failure,,,,,,,Device: HFNC,Chinese University of Hong Kong|Health and Medical Research Fund,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-11-06,10/06/21,2021-10-06,30/06/20,30/06/20,"Prince of Wales Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,334.0
4474.0,NCT04338802,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,,Not yet recruiting,COVID-19,Nintedanib,Safety,Effect of Drugs,,,,Drug: Nintedanib 150 MG|Other: Placebo,Huilan Zhang|Tongji Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",96.0,Other,Interventional,2020-02-04,04/05/20,2020-01-08,08/04/20,08/04/20,,,Respiratory Diseases,1,4,-27.0
4475.0,NCT04643678,Anakinra in the Management of COVID-19 Infection,,Recruiting,COVID-19,Pneumonia,Cytokine Release Syndrome,Corona Virus Infection,Viral Infection,,,Drug: Anakinra|Other: Standard of Care,Hamad Medical Corporation,All,"18 Years and older   (Adult, Older Adult)",80.0,Industry,Interventional,2020-10-30,30/04/21,2021-10-30,25/11/20,10/02/21,"Hamad Medical Corporation, Doha",Qatar,Respiratory Diseases,1,5,365.0
4476.0,NCT04394377,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,ACTION,"Active, not recruiting",Coronavirus Infection,,,,,,,Drug: Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed|Drug: Group 2: control group with enoxaparin 40mg/d,Brazilian Clinical Research Institute|Hospital Israelita Albert Einstein|Hospital do Coracao|Hospital Sirio-Libanes|Hospital Moinhos de Vento|Hospital Alemão Oswaldo Cruz|Beneficência Portuguesa de São Paulo|Brazilian Research In Intensive Care Network,All,"18 Years and older   (Adult, Older Adult)",615.0,Other,Interventional,2020-06-21,01/03/21,2021-01-03,19/05/20,16/03/21,"Centro de Estudos Clínicos do Hospital Cárdio Pulmonar, Salvador, Bahia, Brazil|Instituto de Ensino e Pesquisa do Hospital da Bahia, Salvador, Bahia, Brazil|Santa Casa de Misericórdia da Bahia - Hospital Santa Izabel, Salvador, Bahia, Brazil|Hospital Maternidade São Vicente de Paulo, Barbalha, Ceará, Brazil|Centro de Ensino e Aperfeiçoamento em Pesquisa - CEAP, Serra, Espirito Santo, Brazil|Centro de Pesquisas Cardiológicas de Goiânia do Hospital das Clínicas (UFG), Goiânia, Goiás, Brazil|Hospital Vera Cruz, Belo Horizonte, Minas Gerais, Brazil|Núcleo de Ciências de Saúde - Unidade de Pesquisa - Hospital Felício Rocho, Belo Horizonte, Minas Gerais, Brazil|Centro de Pesquisa Clínica do Hospital de Clínicas da Universidade Federal de Uberlândia, Uberlândia, Minas Gerais, Brazil|Hospital Universitário da Universidade Estadual de Londrina, Londrina, Paraná, Brazil|Hospital Agamenon Magalhães, Recife, Pernambuco, Brazil|Real Hospital Português de Beneficência em Pernambuco, Recife, Pernambuco, Brazil|Hospital Moinhos de Vento, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Nereu Ramos, Florianópolis, Santa Catarina, Brazil|Instituto Baia Sul de Ensino E Pesquisa Dr. Irineu May Brodbeck / Hospital Baía Sul, Florianópolis, Santa Catarina, Brazil|Hospital Regional Hans Dieter Schmidt, Joinville, Santa Catarina, Brazil|Hospital de Amor de Barretos - (Pio XII), Barretos, São Paulo, Brazil|Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - Unesp, Botucatu, São Paulo, Brazil|Hospital Universitário São Francisco de Assis, Bragança Paulista, São Paulo, Brazil|Hospital Regional do Litoral Norte, Caraguatatuba, São Paulo, Brazil|Hospital Regional de Registro, Registro, São Paulo, Brazil|Praxis Pesquisa Médica, Santo André, São Paulo, Brazil|Centro Integrado de Pesquisa (CIP) - Hospital de Base de Rio Preto, São José Do Rio Preto, São Paulo, Brazil|Hospital Regional de São José dos Campos, São José Dos Campos, São Paulo, Brazil|Santa Casa de Misericórdia de Votuporanga, Votuporanga, São Paulo, Brazil|Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil|BP - A Beneficência Portuguesa de São Paulo, São Paulo, Brazil|Hcor - Hospital do Coração, São Paulo, Brazil|Hospital Israelita Albert Einstein, São Paulo, Brazil|Hospital Moriah, São Paulo, Brazil|Hospital Samaritano Paulista, São Paulo, Brazil|Hospital Santa Paula, São Paulo, Brazil|Hospital São Paulo, São Paulo, Brazil|Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil|Instituto de Assistência Médica ao Servidor Público Estadual de S. Paulo, São Paulo, Brazil|Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da USP-InCor-HCFMUSP, São Paulo",Brazil,Respiratory Diseases,1,1,196.0
4477.0,NCT04332666,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",ATCO,Not yet recruiting,Coronavirus,Respiratory Failure,Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere,COVID-19,,,,Drug: Angiotensin 1-7|Drug: Placebos,Erasme University Hospital|Fonds Erasme pour la Recherche Médicale,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-30,30/12/20,2021-06-15,03/04/20,19/08/20,,,Respiratory Diseases,1,4,258.0
4478.0,NCT04830800,A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC,,Recruiting,COVID-19,SARS Pneumonia,"Pneumonia, Viral",COVID-19,,,,Biological: COVIVAC|Biological: Phosphate-buffered saline,"Institute of Vaccines and Medical Biologicals, Vietnam|National Institute of Hygiene and Epidemiology, Vietnam|Hanoi Medical University|Center for Disease Control of Thai Binh Province",All,"18 Years to 75 Years   (Adult, Older Adult)",420.0,Industry|Other,Interventional,2021-10-03,30/05/22,2022-09-30,05/04/21,05/04/21,"Hanoi Medical University, Hanoi, Vietnam|Thai Binh Center of Disease Control, Thai Binh",Vietnam,Respiratory Diseases,1,4,362.0
4479.0,NCT04498247,"A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",,Terminated,COVID-19,,,,,,,Biological: V591|Other: Placebo,Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",263.0,Industry,Interventional,2020-08-27,05/03/21,2021-05-03,04/08/20,11/03/21,"Research Centers of America, LLC ( Site 0014), Hollywood, Florida, United States|Alliance for Multispecialty Research, LLC ( Site 0013), Wichita, Kansas, United States|Central Kentucky Research Associates, Inc. ( Site 0011), Lexington, Kentucky, United States|The Center for Pharmaceutical Research PC ( Site 0012), Kansas City, Missouri, United States|SCRI-CCCIT GesmbH ( Site 0006), Salzburg, Austria|Medizinische Universitaet Wien ( Site 0007), Wien, Austria|Universitair Ziekenhuis Gent ( Site 0003), Gent, Oost-Vlaanderen, Belgium|SGS Life Science Services ( Site 0001), Antwerpen, Belgium|ATC - Clinical Pharmacology Unit ( Site 0002), Liege",Belgium,Respiratory Diseases,1,1,249.0
4480.0,NCT04445324,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,,"Active, not recruiting",Psychotic Disorders,Anxiety Depression,,,,,,"Behavioral: Transitional Online Peer Support Group (n=20)|Other: Control Group (pharmacotherapy and/or psychotherapy, n=10)",Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal|Yale University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-08-25,25/08/20,2020-01-12,24/06/20,23/11/20,"CR-IUSMM, Montreal, Quebec",Canada,Mental Health,1,2,-226.0
4481.0,NCT04631497,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",,Recruiting,Depression,,,,,,,Diagnostic Test: test,Jagiellonian University,All,"18 Years to 70 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,31/12/21,2021-12-31,17/11/20,10/02/21,"University Hospital in Cracow, Kraków",Poland,Mental Health,1,1,724.0
4482.0,NCT04531254,Back to School COVID-19 Simulation Study,,Completed,COVID-19,Schools,,,,,,Behavioral: Personal behaviours,The Hospital for Sick Children,All,"4 Years to 18 Years   (Child, Adult)",190.0,Other,Observational,2020-10-08,31/08/20,2020-08-31,28/08/20,08/03/21,"The Hospital for Sick Children, Toronto, Ontario",Canada,Respiratory Diseases,1,2,-38.0
4483.0,NCT04361461,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),,Withdrawn,Coronavirus Infections,SARS-CoV 2,SARS (Severe Acute Respiratory Syndrome),Pulmonary Disease,,,,Drug: Hydroxychloroquine Sulfate|Drug: Hydroxychloroquine Sulfate + Azythromycin,Apsen Farmaceutica S.A.|Federal University of São Paulo,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry|Other,Interventional,2020-04-30,04/11/20,2020-04-11,24/04/20,19/11/20,"Apsen Farmacêutica S.A., São Paulo",Brazil,Respiratory Diseases,1,4,-19.0
4484.0,NCT04346810,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,,Not yet recruiting,COVID-19,"Burnout, Caregiver",Intensive Care Unit,"Stress, Psychological",,,,Other: Patient management suffering of coronavirus infection,Hôpital Raymond Poincaré|Dominique FLETCHER MD-PhD|Guillaume GERI MD-PhD|Clement DURET MD,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-04-15,15/08/20,2020-01-09,15/04/20,17/04/20,,,"Mental Health, Respiratory Diseases",1,4,-97.0
4485.0,NCT04356365,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),,Completed,Depression,Generalized Anxiety,Adherence to Non-pharmacological Epidemiological Interventions (NPIs),,,,,Other: Cross-sectional study investigating the association of NPIs with mental health,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",10084.0,Other,Observational,2020-03-31,07/04/20,2020-07-04,22/04/20,24/04/20,"University of Oslo, Oslo",Norway,Mental Health,1,3,95.0
4486.0,NCT04388514,Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure,CORMOR,Recruiting,COVID-19,,,,,,,Procedure: Medical Ozone procedure,"Azienda Sanitaria-Universitaria Integrata di Udine|Fondazione Toscana Gabriele Monasterio|Policlinico Militare, Roma - Italy|Ospedale San Liberatore di Atri|Ospedale Umberto I di Torino|Università di Siena|Ospedale Civile di Lucca|Ospedale di Siracusa|Azienda Sanitaria Locale di Vercelli",All,"18 Years to 99 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-08-04,08/10/20,2020-08-10,14/05/20,14/05/20,"Dott. Amato De Monte, Udine",Italy,Respiratory Diseases,1,1,6.0
4487.0,NCT04397835,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,PSYCOV-CV,Recruiting,COVID-19,Anxiety,Depression,Stress,,,,,"University Hospital, Toulouse",All,"50 Years to 89 Years   (Adult, Older Adult)",800.0,Other,Observational,2020-04-17,20/04/21,2021-04-20,21/05/20,21/05/20,"CHU de Toulouse, Toulouse, Occitanie",France,"Mental Health, Respiratory Diseases",1,4,368.0
4488.0,NCT04349163,Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort.,Resi-CoV,Completed,Psychological,,,,,,,Other: Questionnaire,"University Hospital, Angers",All,"Child, Adult, Older Adult",280.0,Other,Observational,2020-10-05,15/06/20,2020-06-25,16/04/20,23/09/20,"CHU, Angers",France,Others,0,1,-102.0
4489.0,NCT04415073,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,,Suspended,Coronavirus,COVID-19,ARDS,Cytokine Storm,Cytokine Release Syndrome,,,Drug: SNDX-6352|Drug: Placebo,Syndax Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",186.0,Industry,Interventional,2020-05-30,15/11/20,2020-11-15,04/06/20,11/08/20,"HonorHealth, Scottsdale, Arizona, United States|Montefiore Medical Center, Bronx, New York",United States,Respiratory Diseases,1,5,169.0
4490.0,NCT04251871,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,,Recruiting,Pneumonia Caused by Human Coronavirus (Disorder),,,,,,,"Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir) and Traditional Chinese Medicines (TCMs) granules|Drug: Conventional medicines (Oxygen therapy, alfa interferon via aerosol inhalation, and lopinavir/ritonavir)",Beijing 302 Hospital,All,"14 Years to 80 Years   (Child, Adult, Older Adult)",150.0,Other,Interventional,2020-01-22,22/01/21,2021-01-22,05/02/20,05/05/20,"The Fifth Medical Center, General Hospital of PLA, Beijing, Beijing",China,Respiratory Diseases,1,1,366.0
4491.0,NCT04496076,COVID-19 Brain Injury,,"Active, not recruiting",Sars-CoV2,Severe Neurologic Injury,Ischemic Stroke,Hemorrhagic Stroke,Intracerebral Hemorrhage,Subarachnoid Hemorrhage,Traumatic Brain Injury,,University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-02-04,31/03/21,2021-04-30,03/08/20,08/04/21,"University of Pittsburgh, Pittsburgh, Pennsylvania",United States,"Cardiovascular Diseases, Respiratory Diseases",1,7,451.0
4492.0,NCT04408027,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,,Recruiting,Anxiety Disorder of Childhood or Adolescence,,,,,,,Behavioral: Virtual-Care Cognitive Behavioural Therapy,The Hospital for Sick Children,All,12 Years to 17 Years   (Child),20.0,Other,Interventional,2020-01-06,01/06/21,2021-01-06,29/05/20,09/02/21,"The Hospital for Sick Children (SickKids), Toronto, Ontario",Canada,Mental Health,1,1,366.0
4493.0,NCT04682197,Cereset Research In Healthcare Workers During COVID-19,,Not yet recruiting,Health Personnel,Stress,Anxiety,Insomnia,Hyperarousal,Corona Virus Infection,COVID-19,Device: Cereset Research,"Wake Forest University Health Sciences|William Madison Satterwhite III, MD",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-04,01/04/22,2022-01-04,23/12/20,24/02/21,,,"Mental Health, Respiratory Diseases",1,7,365.0
4494.0,NCT04453384,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,POLYCOR,Recruiting,SARS Virus,,,,,,,Drug: XAV-19|Drug: Placebo,Nantes University Hospital|BPIfrance|Xenothera SAS,All,"18 Years to 85 Years   (Adult, Older Adult)",414.0,Other|Industry,Interventional,2020-01-09,01/12/20,2021-01-12,01/07/20,07/12/20,"CHU Angers, Angers, France|Hospices Civils Lyon, Lyon, France|CHU Nantes, Nantes, France|Hôpital Saint Antoine, Paris",France,Others,0,1,369.0
4495.0,NCT04335630,Cardiovascular Manifestations of COVID-19,,Recruiting,Cardiovascular Diseases,COVID-19,,,,,,"Diagnostic Test: Electrocardiogram, telemetry, echocardiogram, laboratory values",Memorial Hermann Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-30,01/03/21,2022-01-03,06/04/20,07/04/20,"Memorial Hermann Hospital-Texas Medical Center, Houston, Texas",United States,Respiratory Diseases,1,2,644.0
4496.0,NCT04482686,Trial of Combination Therapy to Treat COVID-19 Infection,,Recruiting,COVID-19,COVID-19,Corona Virus Infection,Coronavirus Infection,Coronavirus-19,SARS-CoV2,SARS-CoV Infection,Drug: Ivermectin|Drug: Doxycycline Hcl|Dietary Supplement: Zinc|Dietary Supplement: Vitamin D3|Dietary Supplement: Vitamin C,ProgenaBiome|Topelia Therapeutics,All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-09-12,01/05/21,2021-01-07,22/07/20,16/12/20,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,7,117.0
4497.0,NCT04381013,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),,Not yet recruiting,COVID-19,,,,,,,Device: Emergency Ventilator Splitter,Stanford University,All,"18 Years and older   (Adult, Older Adult)",4.0,Other,Interventional,2021-01-03,01/04/21,2021-01-04,08/05/20,14/12/20,"Stanford University, Stanford, California",United States,Respiratory Diseases,1,1,1.0
4498.0,NCT04817280,COVID-19 in Polish Ice Swimmers.,ICE,Completed,COVID-19,SARS-CoV Infection,"Resistance, Disease",Hypothermia,Hypothermia Due to Cold Environment,,,Other: Ice Swimming,Wroclaw Medical University,All,"Child, Adult, Older Adult",2534.0,Other,Observational,2020-01-12,17/01/21,2021-01-03,26/03/21,09/04/21,"Department of Public Health at Wroclaw Medical University, Wrocław, Dolny Slask, Poland|Department of Radiotherapy of Multidisciplinary Provincial Hospital, Gorzów Wielkopolski, Lubuskie, Poland|Treasury Medical Company, Zielona Góra, Lubuskie",Poland,Respiratory Diseases,1,5,357.0
4499.0,NCT04435327,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),SequelaeCov,Recruiting,COVID-19,"Pneumonia, Viral",Barotrauma,Interstitial Lung Disease,Bronchiectasis Adult,Emphysema,,,University of Milano Bicocca,All,"18 Years to 80 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-08-17,01/04/21,2021-01-04,17/06/20,09/11/20,"San Gerardo Hospital, Monza, MB",Italy,Respiratory Diseases,1,6,140.0
4500.0,NCT04767477,Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors,,Not yet recruiting,COVID-19,Exercise Tolerance,Quality of Life,Lung Function,Fatigue Intensity,,,Other: Face-to-face rehabilitation|Other: Telerehabilitation,Universidade Federal de Pernambuco,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-03-28,01/06/21,2021-01-08,23/02/21,23/02/21,"Universidade Federal de Pernambuco, Recife, PE",Brazil,Respiratory Diseases,1,5,-79.0
4501.0,NCT04523246,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,NH-Shingrix,Recruiting,Herpes Zoster,Allergy and Immunology,Corona Virus Infection,,,,,"Biological: SHINGRIX (Zoster Vaccine REcombinant, Adjuvanted)|Drug: Normal Saline",Barbara Carlson|Oklahoma Medical Research Foundation|University of Oklahoma,All,65 Years to 100 Years   (Older Adult),250.0,Other,Interventional,2020-01-09,01/07/21,2021-01-09,21/08/20,29/03/21,"Fran and Earl Ziegler College of Nursing, Oklahoma City, Oklahoma",United States,Respiratory Diseases,1,3,366.0
4502.0,NCT04530136,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,,Recruiting,Confirmed Coronavirus Disease,,,,,,,Drug: Ruconest,Pharming Technologies B.V.,All,"18 Years to 85 Years   (Adult, Older Adult)",120.0,Industry,Interventional,2020-11-30,15/08/21,2021-11-30,28/08/20,10/12/20,"The Valley Hospital, Ridgewood, New Jersey",United States,Respiratory Diseases,1,1,365.0
4503.0,NCT04523571,Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects,,"Active, not recruiting",COVID-19,,,,,,,Biological: BNT162b1|Other: Placebo,"BioNTech RNA Pharmaceuticals GmbH|Shanghai Fosun Pharmaceutical Development Co, Ltd.|BioNTech SE",All,"18 Years to 85 Years   (Adult, Older Adult)",144.0,Industry,Interventional,2020-07-28,30/09/20,2021-01-08,21/08/20,18/11/20,"Jiangsu Provincial Center for Disease Control and Prevention, Jiangsu",China,Respiratory Diseases,1,1,164.0
4504.0,NCT04661813,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,AAIM-High,Recruiting,HIV-1-infection,Hypertension,,,,,,Other: EXTRA-CVD Virtual Care,"Case Western Reserve University|Duke University|Metro Health, Michigan|National Heart, Lung, and Blood Institute (NHLBI)|University Hospitals Cleveland Medical Center",All,"18 Years and older   (Adult, Older Adult)",75.0,Other|NIH,Interventional,2021-01-03,31/12/22,2022-12-31,10/12/20,22/03/21,"Duke Health, Durham, North Carolina, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States|MetroHealth Medical Center, Cleveland, Ohio",United States,Cardiovascular Diseases,1,2,727.0
4505.0,NCT04822818,EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19,BEVA,Not yet recruiting,Corona Virus Infection,SARS (Severe Acute Respiratory Syndrome),Virus Diseases,Coronaviridae Infections,Nidovirales Infections,RNA Virus Infections,Respiratory Tract Infections,Drug: BEVA+SOC|Drug: SOC,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",174.0,Other,Interventional,2021-01-04,01/02/22,2022-01-06,30/03/21,30/03/21,,,Respiratory Diseases,1,7,367.0
4506.0,NCT04414631,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,,Recruiting,Coronavirus Infections,,,,,,,Drug: Conestat alfa,"University Hospital, Basel, Switzerland|Pharming Technologies B.V.",All,"18 Years to 85 Years   (Adult, Older Adult)",120.0,Other|Industry,Interventional,2020-06-08,01/06/21,2021-01-07,04/06/20,17/02/21,"Práxis Pesquisa Medica, São Paulo, Brazil|Hospital Universitario Dr. José Eleiterio González, Colinia Mitras Centro, Monterey, Nuevo Leon Mexico, Mexico|University Hospital Basel, Division of Internal Medicine, Basel, Switzerland|Kantonsspital St. Gallen, Klinik für Infektiologie/Spitalhygiene, St. Gallen, Switzerland|Stadtspital Triemli, Departement Innere Medizin, Zürich",Switzerland,Respiratory Diseases,1,1,213.0
4507.0,NCT04748120,Operative vs Non-Operative Management of Acute Appendicitis and Acute Cholecystitis in COVID-19 Positive Patients,,Enrolling by invitation,COVID-19,Appendicitis,"Cholecystitis, Acute",Cholecystitis; Gallstone,Cholecystitis,,,Procedure: Operative management|Procedure: Non-operative management,The Cleveland Clinic,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-12-28,28/06/21,2021-09-28,10/02/21,10/02/21,"Cleveland Clinic Foundation, Cleveland, Ohio",United States,Respiratory Diseases,1,5,274.0
4508.0,NCT04341285,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),ECMO-VID,Not yet recruiting,"ARDS, Human",COVID-19,,,,,,Procedure: ECMO Implantation,University Hospital Tuebingen|University Hospital Freiburg|RWTH Aachen University|University Hospital Muenster,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-08,01/04/22,2022-01-05,10/04/20,23/06/20,"University Hospital Tuebingen, Tuebingen",Germany,Respiratory Diseases,1,2,728.0
4509.0,NCT04844307,Comparing Inpatient COVID-19 Outcomes in 2 Different PT Dosing Groups,CCPT,Not yet recruiting,COVID-19,Cardiopulmonary Disease,"Weakness, Muscle",Hypoxia,Debility Due to Disease,,,Other: Shorter duration higher frequency PT|Other: Standard PT,Montefiore Medical Center,All,"18 Years to 89 Years   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-05,01/10/21,2022-01-02,14/04/21,14/04/21,,,Respiratory Diseases,1,5,362.0
4510.0,NCT04516824,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,,Completed,Orthopaedic Disorders,,,,,,,Procedure: Orthopaedic Surgical Procedures,Ghurki Trust and Teaching Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",2160.0,Other,Observational,2020-03-19,13/07/20,2020-08-15,18/08/20,18/08/20,"Ghurki trust hospital, Lahore, Punjab",Pakistan,Others,0,1,149.0
4511.0,NCT04531735,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,,"Active, not recruiting",RSV Infection,COVID-19,,,,,,,Dr. Behcet Uz Children's Hospital,All,up to 1 Month   (Child),28.0,Other,Observational,2020-01-03,01/08/20,2020-08-31,28/08/20,28/08/20,"Behçet Uz Children's Hospital, İzmirli, Izmir, Turkey|İzmir Dr. Behcet Uz Training and Research Hospital, İzmir",Turkey,Respiratory Diseases,1,2,241.0
4512.0,NCT04366297,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,,Completed,Cardiac Arrest,Emergencies,,,,,,Device: Intravenous access|Device: Intraosseous access,Lazarski University|Poznan University of Medical Sciences|Medical University of Bialystok|Wroclaw Medical University,All,"18 Years and older   (Adult, Older Adult)",41.0,Other,Interventional,2020-12-01,25/02/20,2020-02-25,28/04/20,28/04/20,"Lazarski Univeristy, Warsaw",Poland,Others,0,2,-280.0
4513.0,NCT04452318,COVID-19 Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,,"Active, not recruiting",Healthy Participants,,,,,,,Drug: REGN10933 + REGN10987|Drug: Placebo,Regeneron Pharmaceuticals,All,"Child, Adult, Older Adult",3750.0,Industry,Interventional,2020-07-13,15/06/21,2021-08-15,30/06/20,08/04/21,"Regeneron Study Site, Mesa, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, Tucson, Arizona, United States|Regeneron Study Site, La Mesa, California, United States|Regeneron Study Site, La Palma, California, United States|Regeneron Study Site, Long Beach, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Los Angeles, California, United States|Regeneron Study Site, Montclair, California, United States|Regeneron Study Site, Northridge, California, United States|Regeneron Study Site, Oxnard, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, San Diego, California, United States|Regeneron Study Site, San Francisco, California, United States|Regeneron Study Site, Stanford, California, United States|Regeneron Study Site, Torrance, California, United States|Regeneron Study Site, Torrance, California, United States|Regeneron Study Site, Aurora, Colorado, United States|Regeneron Study Site, Colorado Springs, Colorado, United States|Regeneron Study Site, Washington, District of Columbia, United States|Regeneron Study Site, Boca Raton, Florida, United States|Regeneron Study Site, Clearwater, Florida, United States|Regeneron Study Site, DeLand, Florida, United States|Regeneron Study Site, Fort Pierce, Florida, United States|Regeneron Study Site, Hialeah, Florida, United States|Regeneron Study Site, Jacksonville, Florida, United States|Regeneron Study Site, Lakeland, Florida, United States|Regeneron Study Site, Loxahatchee Groves, Florida, United States|Regeneron Study Site, Maitland, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Orlando, Florida, United States|Regeneron Study Site, Sarasota, Florida, United States|Regeneron Study Site, Tampa, Florida, United States|Regeneron Study Site, West Palm Beach, Florida, United States|Regeneron Study Site, Winter Park, Florida, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Atlanta, Georgia, United States|Regeneron Study Site, Columbus, Georgia, United States|Regeneron Study Site, Decatur, Georgia, United States|Regeneron Study Site, Eatonton, Georgia, United States|Regeneron Study Site, Marietta, Georgia, United States|Regeneron Study Site, Sandy Springs, Georgia, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 2, Chicago, Illinois, United States|Regeneron Study Site 3, Chicago, Illinois, United States|Regeneron Study Site, Chicago, Illinois, United States|Regeneron Study Site 1, Downers Grove, Illinois, United States|Regeneron Study Site 2, Downers Grove, Illinois, United States|Regeneron Study Site, Ames, Iowa, United States|Regeneron Study Site, Lake Charles, Louisiana, United States|Regeneron Study Site, Marrero, Louisiana, United States|Regeneron Study Site, Metairie, Louisiana, United States|Regeneron Study Site, New Orleans, Louisiana, United States|Regeneron Study Site, Baltimore, Maryland, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Boston, Massachusetts, United States|Regeneron Study Site, Detroit, Michigan, United States|Regeneron Study Site, Royal Oak, Michigan, United States|Regeneron Study Site, Minneapolis, Minnesota, United States|Regeneron Study Site, Gulfport, Mississippi, United States|Regeneron Study Site, Jackson, Mississippi, United States|Regeneron Study Site, Hazelwood, Missouri, United States|Regeneron Study Site, Saint Louis, Missouri, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Las Vegas, Nevada, United States|Regeneron Study Site, Morristown, New Jersey, United States|Regeneron Study Site, Newark, New Jersey, United States|Regeneron Study Site, Summit, New Jersey, United States|Regeneron Study Site, Teaneck, New Jersey, United States|Regeneron Study Site 1, Bronx, New York, United States|Regeneron Study Site 2, Bronx, New York, United States|Regeneron Study Site, Bronx, New York, United States|Regeneron Study Site, Buffalo, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, New York, New York, United States|Regeneron Study Site, Chapel Hill, North Carolina, United States|Regeneron Study Site, Charlotte, North Carolina, United States|Regeneron Study Site, Fayetteville, North Carolina, United States|Regeneron Study Site, Raleigh, North Carolina, United States|Regeneron Study Site, Wilmington, North Carolina, United States|Regeneron Study Site, Winston-Salem, North Carolina, United States|Regeneron Study Site, Cincinnati, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Columbus, Ohio, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Danville, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Philadelphia, Pennsylvania, United States|Regeneron Study Site, Wilkes-Barre, Pennsylvania, United States|Regeneron Study Site, Providence, Rhode Island, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Charleston, South Carolina, United States|Regeneron Study Site, Clinton, South Carolina, United States|Regeneron Study Site, Gaffney, South Carolina, United States|Regeneron Study Site, Sioux Falls, South Dakota, United States|Regeneron Study Site, Chattanooga, Tennessee, United States|Regeneron Study Site, Knoxville, Tennessee, United States|Regeneron Study Site, Memphis, Tennessee, United States|Regeneron Study Site, Nashville, Tennessee, United States|Regeneron Study Site, Bellaire, Texas, United States|Regeneron Study Site, Corpus Christi, Texas, United States|Regeneron Study Site, Dallas, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Houston, Texas, United States|Regeneron Study Site, Pearland, Texas, United States|Regeneron Study Site, Red Oak, Texas, United States|Regeneron Study Site, San Antonio, Texas, United States|Regeneron Study Site, Tyler, Texas, United States|Regeneron Study Site, Charlottesville, Virginia, United States|Regeneron Study Site, Richmond, Virginia, United States|Regeneron Study Site, Everett, Washington, United States|Regeneron Study Site, Seattle, Washington, United States|Regeneron Study Site, Yakima, Washington, United States|Regeneron Study Site, Madison, Wisconsin, United States|Regeneron Study Site, Chisinau, Moldova, Republic of|Regeneron Study Site, Bucharest",Romania,Others,0,1,398.0
4514.0,NCT04290780,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,NOSO-COR,Recruiting,Infection Viral,,,,,,,Other: nosocomial infection/hospital acquired infection,Hospices Civils de Lyon,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-09-03,31/12/21,2021-12-31,02/03/20,29/01/21,"Service Hygiène, Epidémiologie et Prévention, Lyon, France|Service Hygiène, Epidémiologie et Prévention, Lyon",France,Others,0,1,484.0
4515.0,NCT04341519,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",BURDENCOV,Recruiting,Corona Virus Infection,Post-traumatic Stress Disorder,,,,,,Behavioral: PTSD|Behavioral: Burnout,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",1464.0,Other,Observational,2020-06-04,30/11/20,2021-12-31,10/04/20,06/10/20,"Saint-Louis Hospital, Paris, Ile De France, France|Cochin, Paris, France|Pitié Salpetrière, Paris",France,"Mental Health, Respiratory Diseases",1,2,575.0
4516.0,NCT04741412,"Pediatric SARS-CoV-2 Infections: Course of COVID-19, Immune Responses, Complications and Long-term Consequences",PEDCOVID-19,Recruiting,Hypohidrotic Ectodermal Dysplasia,,,,,,,,University Hospital Erlangen,All,"Child, Adult, Older Adult",230.0,Other,Observational,2020-03-06,31/05/21,2021-05-31,05/02/21,05/02/21,"University Hospital Erlangen, Erlangen",Germany,Others,0,1,451.0
4517.0,NCT04627675,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),CORVax12,"Active, not recruiting",COVID-19,,,,,,,Drug: CORVax|Drug: IL-12 plasmid|Device: Cliniporator,Providence Health & Services|OncoSec Medical Incorporated,All,"18 Years and older   (Adult, Older Adult)",36.0,Other|Industry,Interventional,2020-12-30,01/05/21,2022-01-05,13/11/20,15/03/21,"Providence Portland Medical Center, Portland, Oregon",United States,Respiratory Diseases,1,1,371.0
4518.0,NCT04366908,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,COVIDIOL,Recruiting,SARS-CoV 2,COVID-19,SARS (Severe Acute Respiratory Syndrome),Cytokine Release Syndrome,Cytokine Storm,,,Drug: BAT + Calcifediol|Drug: BAT,"Maimónides Biomedical Research Institute of Córdoba|Junta de Andalucía - Consejería de Salud y Familias, Spain|Dynamic Solutions|Faes Farma, S.A.",All,"18 Years to 90 Years   (Adult, Older Adult)",1008.0,Other|Industry,Interventional,2020-07-05,30/06/21,2021-06-30,29/04/20,15/02/21,"Hospital Universitario Reina Sofía, Cordoba",Spain,Respiratory Diseases,1,5,360.0
4519.0,NCT04395144,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,COVAYDE,Completed,Coronavirus Infection,COVID-19,Severe Acute Respiratory Syndrome,Respiratory Failure,Respiratory Insufficiency,Respiratory Distress Syndrome,ARDS,Procedure: Awake Prone Positioning|Procedure: Standard care,Hôpital de Verdun,All,"18 Years and older   (Adult, Older Adult)",13.0,Other,Interventional,2020-05-15,15/03/21,2021-03-15,20/05/20,23/03/21,"Hôtel-Dieu de Gaspé, Gaspé, Quebec, Canada|Hôpital de la Cité-de-la-Santé, Laval, Quebec, Canada|Montreal General Hospital, McGill University Healthcare Center, Montréal, Quebec, Canada|Royal Victoria Hospital, McGill University Healthcare Center, Montréal, Quebec, Canada|Hôpital de Verdun, Montréal, Quebec",Canada,Respiratory Diseases,1,7,304.0
4520.0,NCT04409743,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,,Recruiting,Sleep Disturbance,Insomnia,,,,,,Behavioral: Remote Cognitive Behavioral Therapy for Insomnia,Stanford University,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-07-06,01/10/21,2022-01-04,01/06/20,01/04/21,"Stanford University, Palo Alto, California",United States,Others,0,2,547.0
4521.0,NCT04742712,A Feasibility Study Using the CoronaCheck Device to Identify Incident Cases of SARS CoV-2 Covid-19,,Recruiting,SARS-CoV Infection,,,,,,,Device: CoronaCheck Device,Portsmouth Hospitals NHS Trust,All,"16 Years and older   (Child, Adult, Older Adult)",40.0,Other,Observational,2020-10-27,01/11/21,2021-01-12,08/02/21,08/02/21,"Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire",United Kingdom,Respiratory Diseases,1,1,77.0
4522.0,NCT04396210,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,,Completed,Coronavirus,COVID-19,ART,Fertility Issues,,,,Other: Questionnaire,"University Hospital, Ghent",All,18 Years to 47 Years   (Adult),389.0,Other,Observational,2020-05-14,18/06/20,2020-06-18,20/05/20,18/11/20,"Ghent University Hospital, Ghent",Belgium,Respiratory Diseases,1,4,35.0
4523.0,NCT04632368,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,,Recruiting,"Burnout, Professional","Stress, Psychological",,,,,,Behavioral: Transcendental Meditation,Duke University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-11-20,01/04/21,2021-01-04,17/11/20,16/12/20,"Duke University health system, Durham, North Carolina",United States,Mental Health,1,2,45.0
4524.0,NCT04728594,Emails Promoting COVID-19 Vaccination Among Healthcare Workers,,Completed,Vaccination Refusal,Communication,,,,,,Behavioral: Social Proof|Behavioral: Reframing|Behavioral: Scarcity Message,Geisinger Clinic,All,"Child, Adult, Older Adult",9656.0,Other,Interventional,2021-01-15,17/01/21,2021-01-20,28/01/21,01/02/21,"Geisinger, Danville, Pennsylvania",United States,Others,0,2,5.0
4525.0,NCT04453371,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),AtTAC,Withdrawn,Acute Respiratory Distress Syndrome,,,,,,,Drug: Tissue plasminogen activator|Drug: Ringer solution,Negovsky Reanimatology Research Institute|Demikhov Municipal Clinical Hospital 68,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-10-15,15/01/21,2021-02-15,01/07/20,12/03/21,,,Respiratory Diseases,1,1,123.0
4526.0,NCT04537962,"Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study",,Enrolling by invitation,Corona Virus Infection,,,,,,,Other: Colgate periogard mouthwash|Other: Colgate Peroxyl mouthwash|Other: Colgate Total mouthwash|Other: Placebo mouthwash (water),Hospital Israelita Albert Einstein|Colgate Palmolive,All,"18 Years to 90 Years   (Adult, Older Adult)",70.0,Other|Industry,Interventional,2020-11-06,30/09/20,2021-08-30,03/09/20,03/09/20,"Hospital israelita Albert Einstein, Sao Paulo",Brazil,Respiratory Diseases,1,1,297.0
4527.0,NCT04506515,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,PSIMCOV,Completed,COVID-19,"Stress, Psychological",Work Related Stress,Epidemic Disease,SARS-CoV Infection,,,Diagnostic Test: Psychological stress and adaptation at work score (PSAS),Hospital General Universitario de Valencia,All,"18 Years to 70 Years   (Adult, Older Adult)",3000.0,Other,Observational,2020-09-04,19/04/20,2020-04-30,10/08/20,10/08/20,"CHGUV, Valencia",Spain,"Mental Health, Respiratory Diseases",1,5,-127.0
4528.0,NCT04392869,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,CRAFTftiugr,Completed,Psychological Distress,Life Stress,Anxiety,Perfectionism,Emotional Intelligence,Creativity,Attention,Behavioral: The CRAFT program (adapted due to COVID-19)|Behavioral: The MBSR program (adapted due to COVID-19),"Universidad de Granada|Chair in Conscience and Development (UGR)|Mind, Brain and Behaviour Research Centre (CIMCYC)",All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2019-10-23,31/07/20,2020-10-31,19/05/20,03/11/20,"Department of Translation and Interpreting of the University of Granada, Granada",Spain,Mental Health,1,7,374.0
4529.0,NCT04780152,TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic,,Recruiting,Major Depressive Disorder,,,,,,,Device: Transcranial Direct Current Stimulation|Device: Placebo-simulation of transcranial direct current stimulation|Drug: Fluoxetine Tablets,"El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez|Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico",All,10 Years to 17 Years   (Child),172.0,Other,Interventional,2021-01-03,01/08/22,2022-01-09,03/03/21,08/03/21,"Instituto Nacional de Neurología y Neurocirugía, Mexico City, Ciudad De México",Mexico,Others,0,1,371.0
4530.0,NCT04306393,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,NOSARSCOVID,Recruiting,SARS (Severe Acute Respiratory Syndrome),Coronavirus,,,,,,Drug: Nitric Oxide Gas,"Massachusetts General Hospital|Xijing Hospital|Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico|Niguarda Hospital",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-21,21/03/21,2022-03-21,12/03/20,14/07/20,"University of Alabama, Birmingham, Alabama, United States|Louisiana State University Health Shreveport, Shreveport, Louisiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts",United States,Respiratory Diseases,1,2,730.0
4531.0,NCT04617535,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,,Available,COVID-19,,,,,,,Drug: REGN10933+REGN10987 combination therapy,Regeneron Pharmaceuticals,,"Child, Adult, Older Adult",,Industry,Expanded Access:Individual Patients,,,,05/11/20,05/11/20,,,Respiratory Diseases,1,1,
4532.0,NCT04466098,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),,"Active, not recruiting",Acute Respiratory Distress Syndrome,ARDS (Moderate or Severe),COVID-19,,,,,Biological: Mesenchymal stromal cells|Other: Placebo,"Masonic Cancer Center, University of Minnesota",All,"18 Years to 80 Years   (Adult, Older Adult)",9.0,Other,Interventional,2020-07-30,01/12/21,2021-01-12,10/07/20,23/03/21,"University of Minnesota, Minneapolis, Minnesota, United States|University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,3,166.0
4533.0,NCT04420806,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,,Completed,Exercise,Detraining,Muscle Weakness,Muscle Atrophy,,,,Other: HIT-exercise|Other: Sham intervention,University of Erlangen-Nürnberg Medical School,Female,48 Years to 60 Years   (Adult),21.0,Other,Interventional,2020-03-14,30/07/20,2020-10-30,09/06/20,13/11/20,"Institute of Medical Physics, Friedrich-Alexanden University Erlangen-Nürnberg, Erlangen",Germany,Others,0,4,230.0
4534.0,NCT04364711,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,MERMAIDS 2,Not yet recruiting,COVID-19,SARS-CoV 2,,,,,,,UMC Utrecht,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-01-05,30/04/22,2022-04-30,28/04/20,28/04/20,,,Respiratory Diseases,1,2,846.0
4535.0,NCT04459702,A Study of Combination Therapies to Treat COVID-19 Infection,,Withdrawn,COVID-19,COVID-19,Corona Virus Infection,Coronavirus Infection,Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere,Coronavirus-19,SARS-CoV 2,Drug: hydroxychloroquine|Drug: Azithromycin|Drug: Ritonavir|Drug: Lopinavir,ProgenaBiome|Big Corona Ltd.,All,"18 Years to 65 Years   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-07,01/07/21,2021-01-12,07/07/20,08/04/21,"ProgenaBiome, Ventura, California",United States,Respiratory Diseases,1,7,371.0
4536.0,NCT04496245,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,COVIDRASP,"Active, not recruiting",Respiratory Viral Infection,COVID-19,,,,,,Drug: Broncho-Vaxom®,"The University of Queensland|Griffith University|The Prince Charles Hospital|Princess Alexandra Hospital, Brisbane, Australia|Telethon Kids Institute|Queensland Children's Hospital, Brisbane, Australia",All,"18 Years to 100 Years   (Adult, Older Adult)",59.0,Other,Interventional,2020-08-24,30/06/21,2021-06-30,03/08/20,01/04/21,"The Prince Charles Hospital, Brisbane, Queensland, Australia|The Princess Alexandra Hospital, Brisbane, Queensland, Australia|Queensland Children's Hospital, South Brisbane, Queensland",Australia,Respiratory Diseases,1,2,310.0
4537.0,NCT04346693,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,,Completed,Acute Respiratory Tract Infection,Acute Respiratory Insufficiency,Pneumonia,Septic Shock,Hypoxemia,,,Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation.|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin inhalation|Procedure: Standard therapy recommended by the Ministry of Health of the Russian Federation and Dalargin intramuscular injection combined with Dalargin inhalation,Burnasyan Federal Medical Biophysical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",320.0,Other,Interventional,2020-08-04,01/11/20,2020-11-20,15/04/20,27/01/21,"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow",Russian Federation,Respiratory Diseases,1,5,108.0
4538.0,NCT04659772,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,,Completed,COVID-19,Respiratory Failure,,,,,,Drug: Clazakizumab|Drug: Placebo,Ayan Sen|Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",1.0,Other,Interventional,2020-03-12,01/02/21,2021-01-02,09/12/20,03/03/21,"Mayo Clinic in Arizona, Phoenix, Arizona",United States,Respiratory Diseases,1,2,296.0
4539.0,NCT04778059,Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19,,Not yet recruiting,COVID-19,COVID-19,SARS Coronavirus 2 Infection,COVID-19,"Respiratory Distress Syndrome, Adult",Adult Respiratory Distress Syndrome,,Drug: USB002|Drug: Placebo,"US Biotest, Inc.",All,"18 Years and older   (Adult, Older Adult)",184.0,Industry,Interventional,2021-01-04,01/03/22,2022-01-03,02/03/21,08/03/21,,,Respiratory Diseases,1,6,364.0
4540.0,NCT04402957,LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),,Recruiting,COVID-19,Severe Acute Respiratory Syndrome,Sars-CoV2,Acute Kidney Injury,,,,Drug: LSALT peptide|Drug: Placebo,Arch Biopartners Inc.,All,"45 Years to 80 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-10-14,31/03/21,2021-06-30,27/05/20,01/03/21,"VA San Diego Healthcare System, San Diego, California, United States|Broward Health Medical Center, Fort Lauderdale, Florida, United States|LSU Health Shreveport, Shreveport, Louisiana, United States|University of Calgary - Foothills Medical Centre, Calgary, Alberta, Canada|University of Calgary - Peter Lougheed Centre, Calgary, Alberta, Canada|Ankara City Hospital, Ankara, Turkey|Istanbul University Cerrahpasa, Istanbul",Turkey,Respiratory Diseases,1,4,259.0
4541.0,NCT04726163,Tele-expertise in Patients With Diabetes Hospitalized for Covid-19 Infection,COVIDEX,Recruiting,"Diabetic Patient (Type 1,2, MODY, Secondary) or With Corticosteroid-induced Diabetes Following Initiation of Corticosteroid Treatment",,,,,,,Device: Continuous blind glucose measurement device (Free style Pro),"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-29,14/06/21,2021-06-14,27/01/21,01/02/21,"Hopitaux Universitaires de Strasbourg, Strasbourg",France,Metabolic Disorders,1,1,136.0
4542.0,NCT04361877,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),,Recruiting,Cardiovascular Prevention Behaviour,,,,,,,,Klinikum der Universitaet Muenchen,All,"18 Years and older   (Adult, Older Adult)",1900.0,Other,Observational,2020-03-30,20/04/20,2020-04-20,24/04/20,01/05/20,"University Hospital Munich (LMU Klinikum), Munich",Germany,Others,0,1,21.0
4543.0,NCT04674566,Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19,,Not yet recruiting,COVID-19,,,,,,,Drug: COR-101|Drug: Placebo,Corat Therapeutics Gmbh,All,"18 Years and older   (Adult, Older Adult)",45.0,Industry,Interventional,2021-01-04,30/06/21,2021-06-30,19/12/20,17/03/21,,,Respiratory Diseases,1,1,177.0
4544.0,NCT04361474,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,COVIDORL,"Active, not recruiting",Budesonide,Olfaction Disorders,COVID-19,Anosmia,,,,Drug: Budesonide Nasal|Other: Physiological serum,Fondation Ophtalmologique Adolphe de Rothschild|Hopital Lariboisière,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-05-18,24/11/20,2021-05-25,24/04/20,25/11/20,"Amélie YAvchitz, Paris",France,Respiratory Diseases,1,4,372.0
4545.0,NCT04323761,Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),,Approved for marketing,SARS-CoV2 Infection,,,,,,,Drug: Remdesivir,Gilead Sciences,All,"12 Years and older   (Child, Adult, Older Adult)",,Industry,Expanded Access:Treatment IND/Protocol,,,,27/03/20,13/11/20,"University of Alabama- Birmingham, Birmingham, Alabama, United States|Banner- University Medical Center Phoenix, Phoenix, Arizona, United States|Community Regional Medical Centers (CRMC), Fresno, California, United States|St. Jude Medical Center, Fullerton, California, United States|Scripps Memorial Hospital La Jolla, La Jolla, California, United States|Long Beach Memorial Medical Center, Long Beach, California, United States|Huntington Hospital, Pasadena, California, United States|Scripps Mercy Hospital, San Diego, California, United States|California Pacific Medical Center, San Francisco, California, United States|University of California, Medical Center (Parnassus Campus), San Francisco, California, United States|Regional Medical Center, San Jose, California, United States|San Mateo Medical Center, San Mateo, California, United States|Santa Rosa Memorial Hospital, Santa Rosa, California, United States|Los Robles Regional Medical Center, Thousand Oaks, California, United States|PIH Health Whittier Hospital, Whittier, California, United States|The Medical Center Of Aurora, Aurora, Colorado, United States|Rose Medical Center, Denver, Colorado, United States|Swedish Medical Center, Englewood, Colorado, United States|Greenwich Hospital, Greenwich, Connecticut, United States|Middlesex Health, Middletown, Connecticut, United States|The Hospital of Central Connecticut, New Britain, Connecticut, United States|The Stamford Health Medical Group- Pulmonary Associates, Stamford, Connecticut, United States|George Washington University Hospital, Washington, District of Columbia, United States|Aventura Hospital and Medical Center, Aventura, Florida, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Memorial Regional Hospital, Hollywood, Florida, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Mount Sinai Medical Center, Miami Beach, Florida, United States|AdventHealth Orlando, Investigational Drug Services, Orlando, Florida, United States|Sarasota Memorial Hospital, Sarasota, Florida, United States|Piedmont Atlanta Hospital, Atlanta, Georgia, United States|Wellstar Atlanta Medical Center, Atlanta, Georgia, United States|Piedmont Columbus Regional-Midtown Hospital, Columbus, Georgia, United States|Grady Health System- Grady Memorial Hospital, Decatur, Georgia, United States|Piedmont Fayette Hospital, Fayetteville, Georgia, United States|Memorial Health University Medical Center, Savannah, Georgia, United States|John D. Archbold Memorial Hospital, Thomasville, Georgia, United States|Swedish Hospital, Chicago, Illinois, United States|Mercy Hospital & Medical Center, Chicago, Illinois, United States|Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Northwestern Medicine Central DuPage Hospital, Winfield, Illinois, United States|St. Vincent Hospital and Health Care Center, Inc., Carmel, Indiana, United States|Richard L Roudebush Indianapolis VA, Indianapolis, Indiana, United States|Riverview Health, Noblesville, Indiana, United States|Our Lady of the Lakes Regional Medical Center, Baton Rouge, Louisiana, United States|Touro Infirmary, New Orleans, Louisiana, United States|Ochsner Clinic Foundation, New Orleans, Louisiana, United States|Slidell Memorial Hospital, Slidell, Louisiana, United States|University of Maryland, Baltimore, Maryland, United States|Mercy Medical Center, Baltimore, Maryland, United States|CalvertHealth Medical Center, Prince Frederick, Maryland, United States|University of Maryland St. Joseph Medical Center, Towson, Maryland, United States|Steward St. Elizabeth's Medical Center of Boston, Inc., Boston, Massachusetts, United States|Cambridge Health Alliance, Cambridge, Massachusetts, United States|Charlton Memorial Hospital, Fall River, Massachusetts, United States|Lawrence General Hospital, Lawrence, Massachusetts, United States|Lowell General Hospital, Lowell, Massachusetts, United States|South Shore Hospital, South Weymouth, Massachusetts, United States|UMass Memorial Medical Center, Worcester, Massachusetts, United States|St. Joseph Mercy Hospital, Ann Arbor, Michigan, United States|Huron Valley-Sinai Hospital, Commerce, Michigan, United States|Wayne Statue University/ Detroit Receiving Hospital, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|McLaren Health Care Corporation, Flint, Michigan, United States|Bronson Methodist Hospital, Kalamazoo, Michigan, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|CarePoint Health Bayonne Medical Center, Bayonne, New Jersey, United States|Clara Maass Medical Center, Belleville, New Jersey, United States|Cooper University Hospital, Camden, New Jersey, United States|Hackensack Meridian Health - JFK Medical Center, Edison, New Jersey, United States|Trinitas Regional Medical Center, Elizabeth, New Jersey, United States|Englewood Health, Englewood, New Jersey, United States|Hunterdon Medical Center, Flemington, New Jersey, United States|CentraState Medical Center, Freehold, New Jersey, United States|Robert Wood Johnson University Hospital Hamilton, Hamilton, New Jersey, United States|Jersey City Medical Center, Jersey City, New Jersey, United States|Christ Hospital- Carepoint Health, Jersey City, New Jersey, United States|Monmouth Medical Center, Long Branch, New Jersey, United States|Atlantic Health System/ Morristown Medical Center, Morristown, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|Saint Peter's University Hospital, New Brunswick, New Jersey, United States|Saint Michael's Medical Center, Newark, New Jersey, United States|University Hospital, Newark, New Jersey, United States|Ocean Medical Center, Oakhurst, New Jersey, United States|Bayshore Medical Center, Red Bank, New Jersey, United States|The Valley Hospital, Ridgewood, New Jersey, United States|Atlantic Health System/Overlook Medical Center, Summit, New Jersey, United States|Holy Name Medical Center, Teaneck, New Jersey, United States|Capital Health, Trenton, New Jersey, United States|Virtua Health Voorhees Campus, Voorhees, New Jersey, United States|St. Peter's Hospital, Albany, New York, United States|Mount Sinai Queens, Astoria, New York, United States|Good Samaritan Hospital Medical Center, Bay Shore, New York, United States|Southside Hospital, Bay Shore, New York, United States|Lincoln Medical Center, Bronx, New York, United States|St Barnabus Hospital, Bronx, New York, United States|Montefiore Medical Center, Weiler Campus, Bronx, New York, United States|Montefiore Health System Moses Medical Center, Bronx, New York, United States|The Brooklyn Hospital Center, Brooklyn, New York, United States|Kingsbrook Jewish Medical Center, Brooklyn, New York, United States|University Hospital Brooklyn (SUNY Downstate), Brooklyn, New York, United States|Woodhull Medical Center, Brooklyn, New York, United States|Kings County Hospital Center, Brooklyn, New York, United States|New York Harbor VA Medical Center, Brooklyn, New York, United States|Brookdale University Hospital and Medical Center, Brooklyn, New York, United States|Interfaith Medical Center, Brooklyn, New York, United States|NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York, United States|Maimonides Medical Center, Brooklyn, New York, United States|NYU Langone Hospital - Brooklyn, Brooklyn, New York, United States|Mount Sinai Brooklyn, Brooklyn, New York, United States|New York City Health and Hospitals - Coney Island, Brooklyn, New York, United States|Kaleida Health System, Buffalo, New York, United States|Nassau University Medical Center, East Meadow, New York, United States|New York Presbyterian- Queens, Flushing, New York, United States|Glens Falls Hospital, Glens Falls, New York, United States|Queens Hospital Center, Jamaica, New York, United States|NYU Langone Health, New York, New York, United States|Hospital for Special Surgery, New York, New York, United States|New York City Health and New Y",United Kingdom,Respiratory Diseases,1,1,
4546.0,NCT04632706,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: Placebo,MedinCell S.A|MAC Clinical Research,Male,18 Years to 45 Years   (Adult),24.0,Industry|Other,Interventional,2020-09-22,01/02/21,2021-01-05,17/11/20,17/11/20,"MAC Clinical Research Manchester (Early Phase Unit), Neuroscience Centre of Excellence, Manchester, Greater Mancherster",United Kingdom,Respiratory Diseases,1,1,105.0
4547.0,NCT04379271,"A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",,Recruiting,COVID-19,,,,,,,Drug: IMU-838|Other: Placebo,Immunic AG|FGK Clinical Research GmbH,All,"18 Years and older   (Adult, Older Adult)",230.0,Industry,Interventional,2020-11-06,01/09/20,2020-01-10,07/05/20,01/07/20,"Military Medical Academy, Clinic of Infectious Diseases, Sofia, Bulgaria|UMHATEM N.I.Pirogov, Clinic of internal diseases, Sofia, Bulgaria|University Hospital Frankfurt, Infectious Diseases, Frankfurt, Germany|Clinic of the Hannover Medical School, Pneumology Clinic, Hannover",Germany,Respiratory Diseases,1,1,-301.0
4548.0,NCT04284046,CT Scores Predict Mortality in 2019-nCoV Pneumonia,,Completed,COVID-19,,,,,,,Other: CT score,"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",All,"Child, Adult, Older Adult",39.0,Other,Observational,2020-01-31,18/02/20,2020-02-18,25/02/20,25/02/20,"Wuhan third hospital, Wuhan, Hubei",China,Respiratory Diseases,1,1,18.0
4549.0,NCT04508920,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,,Recruiting,Cardiovascular Diseases,Heart Failure,,,,,,"Other: Symptomatology, Treatment. daily Activities and Anxiety for Cardiovascular patients Survey (STRATA)","Centro en Insuficiencia Cardiaca, Mexico|Instituto Nacional de Cardiologia Ignacio Chavez|Medica Sur Clinic & Foundation",All,"18 Years to 80 Years   (Adult, Older Adult)",76.0,Other,Observational,2019-05-15,15/06/21,2021-07-15,11/08/20,11/08/20,"Centro de Insuficiencia Cardiaca Instituto Nacional de Cardiologia, Mexico City",Mexico,Others,0,2,792.0
4550.0,NCT04497454,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),COVEN,Recruiting,Respiratory Distress Syndrome,Severe Acute Respiratory Syndrome Due to Coronavirus (SARS-CoV2),Mechanical Ventilation,,,,,Other: EIT-Group|Other: ARDSNet,University of Sao Paulo General Hospital|InCor Heart Institute,All,"18 Years and older   (Adult, Older Adult)",128.0,Other,Interventional,2020-08-05,01/07/21,2021-01-12,04/08/20,04/08/20,"USP Instituto do Coração, São Paulo",Brazil,Respiratory Diseases,1,3,160.0
4551.0,NCT04433286,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,SURG-SAT-19,Not yet recruiting,Physical Stress,Career Burnout,Satisfaction,,,,,Other: Questionnaire,Mansoura University,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-06-15,31/07/20,2020-08-31,16/06/20,16/06/20,"Faculty of Medicine Mansoura University, Mansoura",Egypt,Mental Health,1,3,77.0
4552.0,NCT04540419,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,NPO Petrovax|CanSino Biologics Inc.,All,"18 Years to 85 Years   (Adult, Older Adult)",500.0,Industry,Interventional,2020-11-09,30/05/21,2021-07-31,07/09/20,16/02/21,"Municipal budgetary institution Central City Hospital No. 7, Ekaterinburg, Russian Federation|Federal budgetary institution of science Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protectionand Human Welfare, Moscow, Russian Federation|State Budgetary Institution of Healthcare of the City of Moscow City Polyclinic No. 2of the Department of Healthcare of the City of Moscow, Moscow, Russian Federation|Federal State Autonomous Educational Institution of Higher Education First MoscowState Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation, Moscow, Russian Federation|Limited Liability Company Research Center Eco-safety, Saint Petersburg, Russian Federation|Federal State Budgetary Institution Research Institute of Influenza named after A.A.Smorodintsev of the Ministry of Health of the Russian Federation, Saint Petersburg, Russian Federation|Private health care institution Clinical hospital 'Russian Railways - Medicine' of the city of Yaroslavl, Yaroslavl",Russian Federation,Respiratory Diseases,1,1,264.0
4553.0,NCT04348929,Birth Experience During COVID-19 Confinement,CONFINE,Recruiting,Postpartum Depression,,,,,,,Other: Self-administered questionnaires,"Central Hospital, Nancy, France",Female,"18 Years and older   (Adult, Older Adult)",927.0,Other,Interventional,2020-04-16,16/08/21,2021-01-10,16/04/20,05/10/20,"Centre Hospitalier Régional Universitaire de Nancy, Nancy",France,Mental Health,1,1,269.0
4554.0,NCT04597242,Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia,,Available,MRSA Bloodstream Infection,MRSA Bacteremia,MRSA Right-sided Endocarditis,COVID-19,,,,Drug: Exebacase,ContraFect,All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Intermediate-size Population,,,,22/10/20,27/10/20,"CF-301-107 Study Site, Butte, Montana",United States,Respiratory Diseases,1,4,
4555.0,NCT04412655,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,ISACS-STEMI,"Active, not recruiting",ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion,,,,,,,Device: Percutaneous Coronary Revascularization for STEMI,"Università degli Studi del Piemonte Orientale ""Amedeo Avogadro""",All,"Child, Adult, Older Adult",6609.0,Other,Observational,2020-05-05,30/05/20,2020-02-06,02/06/20,11/06/20,"Giuseppe De Luca, Novara",Italy,Others,0,1,-89.0
4556.0,NCT04453540,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,FAP-REA,Not yet recruiting,Infectious Disease,Pneumonia,Molecular Diagnosis,COVID-19,Antibiotic Stewardship,,,Diagnostic Test: FilmArray PCR on respiratory samples,"Central Hospital, Nancy, France|Reims University Hospital",All,"18 Years to 100 Years   (Adult, Older Adult)",150.0,Other,Observational,2020-01-07,30/08/20,2020-08-30,01/07/20,01/07/20,,,Respiratory Diseases,1,5,236.0
4557.0,NCT04548531,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,,Enrolling by invitation,Colon Cancer,,,,,,,Behavioral: Shared Decision Making,Massachusetts General Hospital|Patient-Centered Outcomes Research Institute,All,"45 Years to 75 Years   (Adult, Older Adult)",800.0,Other,Interventional,2020-10-09,30/04/21,2021-05-30,14/09/20,30/09/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Cancers,1,1,233.0
4558.0,NCT04391816,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,,Recruiting,Alcohol Drinking,Alcohol-Related Disorders,Pandemic,Psychological Stress,,,,,National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",700.0,NIH,Observational,2021-04-19,31/12/22,2024-12-31,18/05/20,14/04/21,"NIAAA Section on Human Psychopharmacology, Bethesda, Maryland",United States,Mental Health,1,4,1352.0
4559.0,NCT04545749,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",,Recruiting,COVID-19,,,,,,,Biological: UB-612,"United Biomedical Inc., Asia|COVAXX",All,20 Years to 55 Years   (Adult),60.0,Industry,Interventional,2020-09-25,18/01/21,2021-08-31,11/09/20,01/03/21,"China Medical University Hospital, Taichung",Taiwan,Respiratory Diseases,1,1,340.0
4560.0,NCT04782739,Evaluation of the Impact of the COVID-19 Pandemic on Provision and Uptake of Services for the Prevention of Mother-to-child Transmission of HIV and Syphilis in Zimbabwe,,Not yet recruiting,HIV Infections,Syphilis,,,,,,Other: None - Descriptive study,"University of Zimbabwe|Ministry of Health and Child Care, Zimbabwe|Centre for Sexual Health and HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe)|PENTA Foundation|ViiV Healthcare|University College, London",All,"Child, Adult, Older Adult",30.0,Other|Industry,Observational,2021-01-03,19/04/22,2022-04-19,04/03/21,04/03/21,,,Others,0,2,471.0
4561.0,NCT04826588,Randomised Evaluation of COVID-19 Therapy (RECOVERY) in Children With PIMS-TS in Switzerland (SWISSPED-RECOVERY),,Recruiting,COVID-19,,,,,,,Drug: Methylprednisolone sodium succinate|Biological: Human normal immunoglobulin (IVIg),University Children's Hospital Basel,All,"44 Weeks to 18 Years   (Child, Adult)",75.0,Other,Interventional,2021-01-04,01/04/22,2022-01-04,01/04/21,09/04/21,"Cantonal Hospital Aarau, Department of Paediatrics, Aarau, Switzerland|University of Basel Children's Hospital, Basel, Switzerland|Ente Ospedaliero Cantonale Ticino (EOC) Pediatrica, Bellinzona, Switzerland|Department of Pediatrics, University of Bern, Bern, Switzerland|Department of Child, Woman and, Adolescent Medecine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland|Department of Pediatrics,University Hospital of Lausanne (CHUV), Lausanne, Switzerland|Department of Pediatrics, Cantonal Hospital Luzern, Luzern 16, Switzerland|Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland|Department of Pediatrics, Cantonal Hospital Fribourg, Villars-sur-Glâne, Switzerland|University Children's Hospital Zuerich, Zuerich",Switzerland,Respiratory Diseases,1,1,365.0
4562.0,NCT04532294,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",,Recruiting,COVID-19,,,,,,,Drug: BGB DXP593|Drug: Placebo,BeiGene,All,18 Years to 60 Years   (Adult),30.0,Industry,Interventional,2020-08-09,19/02/21,2021-06-15,31/08/20,25/11/20,"Q Pharm Pty Limited, Herston, Queensland",Australia,Respiratory Diseases,1,1,310.0
4563.0,NCT04594525,Maternal Telemental Health Interventions in Response to Covid-19*,CoronaVirus,Not yet recruiting,Perinatal Depression,Specific Phobia,Perinatal Anxiety,,,,,Other: Low-Intensity Psychosocial Interventions through Telemental health,Hamad Medical Corporation,Female,18 Years to 49 Years   (Adult),58.0,Industry,Interventional,2021-01-06,01/09/21,2022-01-06,20/10/20,21/02/21,,,Mental Health,1,3,365.0
4564.0,NCT04384705,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,H-Cov-Run,Recruiting,SARS-CoV Infection,,,,,,,Other: research specific blood sample,Centre Hospitalier Universitaire de la Réunion,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-17,01/06/21,2021-01-07,12/05/20,17/07/20,"Centre Hospitalier Universitaire Réunion, Saint-Denis, France|Centre Hospitalier Universitaire de la Réunion, Saint-Pierre",France,Respiratory Diseases,1,1,204.0
4565.0,NCT03042143,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),REALIST,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,Biological: Human umbilical cord derived CD362 enriched MSCs|Biological: Placebo (Plasma-Lyte 148),"Belfast Health and Social Care Trust|Queen's University, Belfast|Northern Ireland Clinical Trials Unit|NHS Blood and Transplant",All,"16 Years and older   (Child, Adult, Older Adult)",75.0,Other,Interventional,2019-07-01,01/09/20,2022-01-10,03/02/17,15/04/20,"Belfast Health and Social Care Trust, Royal Hospitals, Belfast, Northern Ireland",United Kingdom,Respiratory Diseases,1,1,924.0
4566.0,NCT04410432,Immune Response and Risk of Serious Infection to SARS-Cov2,,Recruiting,"SARS Cov2, Immune Response",,,,,,,Biological: Blood sample collection,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",63.0,Other,Observational,2020-09-29,01/08/21,2021-01-08,01/06/20,19/01/21,"Chu Dijon Bourogne, Dijon",France,Others,0,1,101.0
4567.0,NCT04402060,A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,,Recruiting,COVID-19,COVID-19,Coronavirus,Coronavirus Infection,Severe Acute Respiratory Syndrome,Severe Acute Respiratory Syndrome Coronavirus 2,Sars-CoV2,Drug: APL-9|Other: Vehicle Control,"Apellis Pharmaceuticals, Inc.",All,"18 Years and older   (Adult, Older Adult)",66.0,Industry,Interventional,2020-05-28,01/01/21,2021-01-01,26/05/20,19/12/20,"University of California at San Francisco - Fresno, Fresno, California, United States|California Pacific Medical Center, San Francisco, California, United States|Baptist Medical Center Beaches, Jacksonville Beach, Florida, United States|Westchester General Hospital, Miami, Florida, United States|Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States|Loyola University Medical Center, Maywood, Illinois, United States|Lutheran Health Physicians, Fort Wayne, Indiana, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|Norton Women's and Children's Hospital, Louisville, Kentucky, United States|Norton Audobon Hospital, Louisville, Kentucky, United States|Cambridge Medical Trials, Alexandria, Louisiana, United States|Ascension Providence Hospital, Southfield, Michigan, United States|Rutgers University - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States|University at Buffalo, Buffalo, New York, United States|Columbia University, New York, New York, United States|Texas A&M College of Medicine - Scott and White, Temple, Texas, United States|Hospital Angelina Caron, Campina Grande Do Sul, Paraná, Brazil|Irmandade da Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil|Hospital Estadual Mario Covas, Santo André, Sao Paulo, Brazil|CEMEC - Centro Multidisciplinar de Estudos Clinicos LTDA EPP, São Bernardo Do Campo, Sao Paulo, Brazil|Hospital Alemao Oswaldo Cruz, São Paulo, Sao Paulo, Brazil|Hospital Santa Marcelina, São Paulo, Sao Paulo, Brazil|UPECLIN - Unidade de Pesquisa Clínica da Faculdade de Medicina de Botucatu - FMB/UNESP, Botucatu, São Paulo",Brazil,Respiratory Diseases,1,7,218.0
4568.0,NCT04725110,Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome,,Not yet recruiting,COVID-19,SARS-CoV Infection,ARDS,"ARDS, Human",,,,Drug: Instilled T3|Other: Placebo Therapy,University of Minnesota,All,"18 Years to 80 Years   (Adult, Older Adult)",250.0,Other,Interventional,2021-01-03,01/03/21,2024-01-03,26/01/21,26/01/21,,,Respiratory Diseases,1,4,1095.0
4569.0,NCT04419870,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",,Recruiting,Mitochondrial Disease,,,,,,,,National Human Genome Research Institute (NHGRI)|National Institutes of Health Clinical Center (CC),All,"2 Months and older   (Child, Adult, Older Adult)",200.0,NIH,Observational,2021-04-19,01/05/25,2025-01-05,09/06/20,14/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Others,0,1,1357.0
4570.0,NCT04345861,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),COVIDOC,Terminated,Coronavirus Infection,"Pneumonia, Viral",,,,,,Drug: Hydroxychloroquine + placebo|Drug: hydroxychloroquine + azithromycin,"University Hospital, Montpellier",All,"18 Years to 75 Years   (Adult, Older Adult)",7.0,Other,Interventional,2020-11-04,08/06/20,2020-08-06,15/04/20,11/06/20,"Montpellier University hospital, Montpellier",France,Respiratory Diseases,1,2,-90.0
4571.0,NCT04486417,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,,Recruiting,Obesity,Telemedicine,Bariatric Surgery,,,,,,University of Roma La Sapienza,All,"18 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Observational,2020-01-06,22/07/20,2020-07-31,24/07/20,24/07/20,"Gianfranco Silecchia, Latina",Italy,Metabolic Disorders,1,3,207.0
4572.0,NCT04407260,"Use of Oxygen Hoods in Patients Failing on Conventional High-flow Oxygen Delivery Systems, Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic COVID-19 Patients. Prospective Cohort Study.",,Completed,COVID-19,Respiratory Failure,Hypoxia,,,,,Device: Oxygen Hood,Northwell Health,All,"Child, Adult, Older Adult",136.0,Other,Observational,2020-06-03,01/05/20,2020-01-05,29/05/20,16/02/21,"Phelps Hospital, Sleepy Hollow, New York",United States,Respiratory Diseases,1,3,-150.0
4573.0,NCT04834583,Corona And Manual Professions,CAMP,"Active, not recruiting",COVID-19,,,,,,,,Karolinska Institutet|Sophiahemmet University,All,"20 Years to 65 Years   (Adult, Older Adult)",703.0,Other,Observational,2020-02-11,31/12/21,2023-12-31,08/04/21,08/04/21,"Karolinska Institutet, Stockholm",Sweden,Respiratory Diseases,1,1,1419.0
4574.0,NCT04844268,"Phase 1 Study to Assess Safety, Reactogenicity and Immunogenicity of the HDT-301 Vaccine Against COVID-19",,Not yet recruiting,COVID-19,,,,,,,Biological: Cohort 1 HDT 301 vaccine|Biological: Cohort 2 HDT 301 vaccine|Biological: Cohort 3 HDT 301 vaccine,SENAI CIMATEC,All,18 Years to 55 Years   (Adult),78.0,Other,Interventional,2021-01-05,01/09/21,2022-01-07,14/04/21,14/04/21,,,Respiratory Diseases,1,1,367.0
4575.0,NCT04672343,Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2,CodePRONUT,Recruiting,COVID-19,,,,,,,Other: Data collection|Other: Querying the INSEE database,Centre Hospitalier Universitaire Dijon,All,70 Years and older   (Older Adult),300.0,Other,Observational,2020-10-19,01/04/21,2022-01-01,17/12/20,17/12/20,"Chu Dijon Bourogne, Dijon",France,Respiratory Diseases,1,1,439.0
4576.0,NCT04556149,"imPulse™ Una Full-spectrum, Over Clothing E-stethoscope",,Completed,Corona Virus Infection,Coronavirus,,,,,,Device: imPulse™ Una e-stethoscope|Device: Philips Lumify Ultrasound System,"Level 42 AI, Inc.|Schmidt Futures|Johns Hopkins University",All,"18 Years to 90 Years   (Adult, Older Adult)",34.0,Industry|Other,Observational,2020-01-10,02/12/20,2020-02-12,21/09/20,21/12/20,"Johns Hopkins School of Medicine, Baltimore, Maryland",United States,Respiratory Diseases,1,2,33.0
4577.0,NCT04584541,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,COVIRIC,Recruiting,Spondyloarthritis,Rheumatoid Arthritis,COVID-19,,,,,Biological: blood tests|Biological: Nasopharyngeal swabs|Biological: Stools,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-11-06,01/07/23,2023-01-12,14/10/20,14/10/20,"Cochin hospital, Paris",France,"Respiratory Diseases, Immunological Disorders",1,3,797.0
4578.0,NCT04416360,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,CLIECO,Recruiting,Autism Spectrum Disorder,Attention-deficit Hyperactivity Disorder,,,,,,Other: Interview by psychologists,"University Hospital, Toulouse|Institut National de la Santé Et de la Recherche Médicale, France",All,6 Years to 17 Years   (Child),40.0,Other,Interventional,2020-05-05,01/07/20,2021-01-01,04/06/20,04/06/20,"University hospital of Toulouse, Toulouse, Occitanie, France|Centre Hospitalier de Versailles, Le Chesnay, France|Centre Hospitalier Esquirol, Limoges, France|Hôpital Robert-Debré (AP-HP), Paris, France|Maison de Solenn (Hôpital Cochin AP-HP), Paris",France,Others,0,2,241.0
4579.0,NCT04376684,Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,OSCAR,Recruiting,Severe Acute Respiratory Syndrome,,,,,,,Biological: Otilimab|Biological: Placebo 1|Biological: Placebo 2|Drug: Standard of care,GlaxoSmithKline,All,"18 Years and older   (Adult, Older Adult)",1150.0,Industry,Interventional,2020-05-28,23/08/21,2021-08-23,06/05/20,02/04/21,"GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, Torrance, California, United States|GSK Investigational Site, Fort Lauderdale, Florida, United States|GSK Investigational Site, Gainesville, Florida, United States|GSK Investigational Site, Winfield, Illinois, United States|GSK Investigational Site, Portland, Maine, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Germantown, Maryland, United States|GSK Investigational Site, Silver Spring, Maryland, United States|GSK Investigational Site, Saint Louis Park, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Jackson, Mississippi, United States|GSK Investigational Site, Reno, Nevada, United States|GSK Investigational Site, Buffalo, New York, United States|GSK Investigational Site, Charlotte, North Carolina, United States|GSK Investigational Site, Toledo, Ohio, United States|GSK Investigational Site, Doylestown, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Roanoke, Virginia, United States|GSK Investigational Site, Tacoma, Washington, United States|GSK Investigational Site, Milwaukee, Wisconsin, United States|GSK Investigational Site, Munro, Buenos Aires, Argentina|GSK Investigational Site, Cordoba, Córdova, Argentina|GSK Investigational Site, Buenos Aires, Argentina|GSK Investigational Site, Buenos Aires, Argentina|GSK Investigational Site, Cordoba, Argentina|GSK Investigational Site, Cordoba, Argentina|GSK Investigational Site, Corrientes, Argentina|GSK Investigational Site, Brussel, Belgium|GSK Investigational Site, Yvoir, Belgium|GSK Investigational Site, Belo Horizonte, Minas Gerais, Brazil|GSK Investigational Site, Porto Alegre, Rio Grande Do Sul, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, São Paulo, Brazil|GSK Investigational Site, Vancouver, British Columbia, Canada|GSK Investigational Site, Ottawa, Ontario, Canada|GSK Investigational Site, Montréal, Quebec, Canada|GSK Investigational Site, QC, Quebec, Canada|GSK Investigational Site, St-Jerome, Quebec, Canada|GSK Investigational Site, Talca, Región Del Maule, Chile|GSK Investigational Site, Quillota, Valparaíso, Chile|GSK Investigational Site, Santiago, Chile|GSK Investigational Site, Amiens Cedex 1, France|GSK Investigational Site, Angers Cedex 9, France|GSK Investigational Site, Argenteuil, France|GSK Investigational Site, Ars-Laquenexy, France|GSK Investigational Site, La Roche-Sur-Yon, France|GSK Investigational Site, La Tronche, France|GSK Investigational Site, Limoges Cedex, France|GSK Investigational Site, Melun, France|GSK Investigational Site, Paris, France|GSK Investigational Site, Pierre-Bénite, France|GSK Investigational Site, Strasbourg cedex, France|GSK Investigational Site, Strasbourg, France|GSK Investigational Site, Valenciennes Cedex, France|GSK Investigational Site, Aurangabad, India|GSK Investigational Site, Aurangabad, India|GSK Investigational Site, Hyderabad, India|GSK Investigational Site, Kolkata, India|GSK Investigational Site, Kolkata, India|GSK Investigational Site, Mumbai, India|GSK Investigational Site, Nagpur, India|GSK Investigational Site, New Delhi, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Pune, India|GSK Investigational Site, Surat, India|GSK Investigational Site, Aichi, Japan|GSK Investigational Site, Kanagawa, Japan|GSK Investigational Site, Kanagawa, Japan|GSK Investigational Site, Osaka, Japan|GSK Investigational Site, Osaka, Japan|GSK Investigational Site, Saitama, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Tokyo, Japan|GSK Investigational Site, Mexico City, Ciudad De Mexico, Mexico|GSK Investigational Site, Guadalajara, Jalisco, Mexico|GSK Investigational Site, Monterrey, Nuevo León, Mexico|GSK Investigational Site, DF, Mexico|GSK Investigational Site, Breda, Netherlands|GSK Investigational Site, Den Bosch, Netherlands|GSK Investigational Site, Enschede, Netherlands|GSK Investigational Site, Nijmegen, Netherlands|GSK Investigational Site, Rotterdam, Netherlands|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Lima, Peru|GSK Investigational Site, Bydgoszcz, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Poznan, Poland|GSK Investigational Site, Warszawa, Poland|GSK Investigational Site, Wroclaw, Poland|GSK Investigational Site, Ekaterinburg, Russian Federation|GSK Investigational Site, Moscow, Russian Federation|GSK Investigational Site, Nizhniy Novgorod, Russian Federation|GSK Investigational Site, Omsk, Russian Federation|GSK Investigational Site, Perm, Russian Federation|GSK Investigational Site, St. Petersburg, Russian Federation|GSK Investigational Site, Ufa, Russian Federation|GSK Investigational Site, Voronezh, Russian Federation|GSK Investigational Site, Benoni, Gauteng, South Africa|GSK Investigational Site, Johannesburg, Gauteng, South Africa|GSK Investigational Site, Durban, KwaZulu- Natal, South Africa|GSK Investigational Site, Muckleneuk Pretoria, South Africa|GSK Investigational Site, Panorama,, South Africa|GSK Investigational Site, Tygerberg, South Africa|GSK Investigational Site, Worcester, South Africa|GSK Investigational Site, Barcelona, Spain|GSK Investigational Site, L'Hospitalet de Llobregat, Spain|GSK Investigational Site, Logroño, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, Madrid, Spain|GSK Investigational Site, San Sebastián De Los Reyes/Madrid, Spain|GSK Investigational Site, Manchester, Greater Manchester, United Kingdom|GSK Investigational Site, Bradford, United Kingdom|GSK Investigational Site, Liverpool, United Kingdom|GSK Investigational Site, Middlesbrough, United Kingdom|GSK Investigational Site, Newcastle Upon Tyne",United Kingdom,Others,0,1,452.0
4580.0,NCT04391140,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,,Recruiting,COVID-19,ARDS,Acute Respiratory Distress Syndrome,Acute Respiratory Failure,Corona Virus Infection,,,Other: Prone position,Hospital Universitari Vall d'Hebron Research Institute,All,"18 Years and older   (Adult, Older Adult)",248.0,Other,Interventional,2020-05-13,01/12/20,2021-01-06,18/05/20,18/08/20,"Hospital Universitari Vall d'Hebron, Barcelona",Spain,Respiratory Diseases,1,5,238.0
4581.0,NCT04382768,Inhaled Ibuprofen to Treat COVID-19,CórdobaTrail,Recruiting,Coronavirus Infection,Respiratory Disease,SARS (Disease),,,,,Drug: Inhaled Hypertonic ibuprofen,"Química Luar SRL|National Council of Scientific and Technical Research, Argentina|Centro de Excelencia en Productos y Procesos Córdoba",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-01-05,01/01/21,2021-01-01,11/05/20,11/06/20,"Centro de Excelencia en Productos y Procesos Córdoba, Córdoba",Argentina,Respiratory Diseases,1,3,362.0
4582.0,NCT04748445,Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.,,Not yet recruiting,Healthy,,,,,,,Diagnostic Test: SARS-CoV-2/Influenza/RSV RT-PCR,Pfizer,All,"18 Years and older   (Adult, Older Adult)",6250.0,Industry,Observational,2021-03-15,15/10/21,2021-10-15,10/02/21,15/03/21,,,Others,0,1,214.0
4583.0,NCT04594291,MRI Changes of Acute Kidney Injury in COVID-19,MRI-AIDED,Recruiting,Acute Kidney Injury,,,,,,,Procedure: MRI scans,University Hospitals of Derby and Burton NHS Foundation Trust|Nottingham Biomedical Research Centre,All,"18 Years to 90 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-07-10,01/09/23,2023-01-09,20/10/20,20/10/20,"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, Derbyshire",United Kingdom,Others,0,1,913.0
4584.0,NCT04433754,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,,Completed,Pancreatitis,,,,,,,Other: biochemical analysis,Uşak University,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-03,11/06/20,2020-12-06,16/06/20,16/06/20,"Usak University Training and Research Hospital, Usak",Turkey,Others,0,1,338.0
4585.0,NCT04510493,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,CanCovDia,Recruiting,Coronavirus Infection,"Diabetes Mellitus, Type 2",,,,,,Drug: Canakinumab|Drug: Placebo,"University Hospital, Basel, Switzerland|Novartis|Swiss National Science Foundation",All,"18 Years and older   (Adult, Older Adult)",116.0,Other|Industry,Interventional,2020-10-23,01/09/23,2023-01-09,12/08/20,04/11/20,"University Medical Clinic Aarau, Aarau, Switzerland|University Hospital Basel, Basel, Switzerland|University Hospital Bern, Bern, Switzerland|University Hospital Geneva, Geneva, Switzerland|University Hospital Lausanne, Lausanne, Switzerland|Cantonal Hospital Lucerne, Luzern, Switzerland|Cantonal Hospital St Gallen, St. Gallen, Switzerland|University Hospital Zürich, Zürich",Switzerland,"Metabolic Disorders, Respiratory Diseases",1,2,808.0
4586.0,NCT04669912,COVID-19 Pandemic Lockdown Effect in Adolescents and Young Adults With Type 1 Diabetes: Positive Results of an Unpreceded Challenge for Telemedicine and Patient Self-management,COVIDIABADO,Completed,Type 1 Diabetes,,,,,,,Other: glucose control and sensor usage,Centre Hospitalier Sud Francilien,All,"13 Years to 25 Years   (Child, Adult)",77.0,Other,Observational,2021-01-15,22/01/21,2021-01-22,17/12/20,02/02/21,"Centre Hospitalier Sud Francilien, Corbeil-Essonnes",France,Metabolic Disorders,1,1,7.0
4587.0,NCT04490473,Turkish of the SARS-CoV-2 Anxiety Scale,,Recruiting,Anxiety,SARS-CoV Infection,,,,,,Other: survey work,DILEK SAYIK|Eskisehir Osmangazi University,All,18 Years to 60 Years   (Adult),300.0,Other,Interventional,2020-07-24,24/03/21,2021-04-24,29/07/20,23/12/20,"Eskisehir Osmangazi University, Eskisehir",Turkey,"Mental Health, Respiratory Diseases",1,2,274.0
4588.0,NCT04333368,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,STROMA-CoV2,"Active, not recruiting",Severe Acute Respiratory Syndrome Coronavirus 2,Severe Acute Respiratory Distress Syndrome,,,,,,Biological: Umbilical cord Wharton's jelly-derived human|Other: NaCl 0.9%,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",47.0,Other,Interventional,2020-06-04,30/01/21,2022-06-04,03/04/20,04/12/20,"Hôpital Pitié-Salpêtrière - APHP, Paris, France|Hôpital Européen Georges Pompidou - APHP, Paris",France,Respiratory Diseases,1,2,730.0
4589.0,NCT04338841,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,HOME-CoV,Completed,Coronavirus Infection,,,,,,,Other: HOME-CoV rule implementation,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",3133.0,Other,Interventional,2020-09-04,17/06/20,2020-06-17,08/04/20,23/09/20,"Clinique Universitaire Saint-Luc, Bruxelles, Belgium|CHU de Liège, Liege, Belgium|Ch Argenteuil, Argenteuil, France|CH Cholet, Cholet, France|CHU Clermont Ferrand, Clermont Ferrand, France|Ch Colmar, Colmar, France|CH Alpes Lemant, Contamine-sur-Arve, France|CHU Dijon, Dijon, France|CH Le Mans, Le Mans, France|CH Libourne, Libourne, France|CH Limoges, Limoges, France|Ch Longjumeau, Longjumeau, France|Chu Montpellier, Montpellier, France|Centre Hospitalier Universitaire de Nantes, Nantes, France|CH Niort, Niort, France|Hopital Paris Saint Joseph, Paris, France|Hopital Saint Antoine, Paris, France|Hôpital Bichat, Paris, France|Hôpital Lariboisière, Paris, France|CHU de Poitiers, Poitiers, France|CH Reims, Reims, France|Ch Remiremont, Remiremont, France|Chu Rennes, Rennes, France|CHU de Rouen, Rouen, France|CHU de St Etienne, Saint Etienne, France|CH de Saint-Brieuc, Saint-Brieuc, France|Ch Troyes, Troyes, France|CH VICHY, Vichy, France|CH Princesse Grace, Monaco",Monaco,Respiratory Diseases,1,1,-79.0
4590.0,NCT04584658,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),DYADS,Recruiting,Dysphagia,Dysphonia,Subglottic Stenosis,Voice Disorders,Swallowing Disorder,COVID-19,SARS (Severe Acute Respiratory Syndrome),Diagnostic Test: Fibreoptic Endoscopic Evaluation of Swallowing (FEES)|Diagnostic Test: Videofluoroscopy|Other: Dysphagia Handicap Index (DHI)|Other: Voice Symptom Scale (VoiSS),Cambridge University Hospitals NHS Foundation Trust,All,"18 Years to 85 Years   (Adult, Older Adult)",36.0,Other,Observational,2020-09-15,01/10/21,2021-01-12,14/10/20,14/12/20,"Cambridge University Hospitals NHS Foundation Trust, Cambridge",United Kingdom,Respiratory Diseases,1,7,119.0
4591.0,NCT04491071,Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,SCEI,Not yet recruiting,Stress Disorder,,,,,,,Diagnostic Test: Generalized Anxiety Disorder-7 (GAD 7)|Diagnostic Test: Background questionnaire|Diagnostic Test: Impact of COVID-19 questionnaire|Diagnostic Test: Confinement and Communication During the COVID-19 Pandemic|Diagnostic Test: Mental Health questionnaire|Diagnostic Test: Patient Health Questionnaire (PHQ-9)|Diagnostic Test: Post Traumatic Stress Disorder questionnaire (PTSD-8)|Diagnostic Test: Experiences in Close Relationship Scale questionnaire (ECR-S),Centre Hospitalier Universitaire de Saint Etienne,All,"18 Years and older   (Adult, Older Adult)",405.0,Other,Observational,2020-01-09,01/12/20,2020-01-12,29/07/20,23/09/20,"Centre Hospitalier Universitaire de Saint-Etienne, Saint-Étienne, France|Centre de Recherche et d'Innovation Clinique, Glasgow",United Kingdom,Mental Health,1,1,3.0
4592.0,NCT04727372,Social Acceptability of COVID-19 Vaccines in Pakistan,,Completed,"Social Acceptance, Social Anxiety",,,,,,,Other: Questionnaire,Islamia University of Bahawalpur,All,"16 Years and older   (Child, Adult, Older Adult)",986.0,Other,Observational,2021-01-23,23/02/21,2021-02-23,27/01/21,24/02/21,"Islamabad City, Islamabad, Capital Territory, Pakistan|Bahawalpur Rural and Urban Areas, Bahawalpur, Punjab, Pakistan|Faisalabad city, Faisalābad, Punjab, Pakistan|Lahore City, Lahore, Punjab",Pakistan,Mental Health,1,1,31.0
4593.0,NCT04340557,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,,Recruiting,SARS-CoV Infection,,,,,,,Drug: Losartan,Sharp HealthCare,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-27,06/10/20,2020-12-31,09/04/20,02/06/20,"Sharp Grossmont Hospital, La Mesa, California, United States|Sharp Chula Vista Medical Center, San Diego, California, United States|Sharp Coronado Hospital, San Diego, California, United States|Sharp Memorial Hospital, San Diego, California",United States,Respiratory Diseases,1,1,279.0
4594.0,NCT04370834,Tocilizumab for Patients With Cancer and COVID-19 Disease,,Terminated,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,Pneumonia,Pneumonitis,Severe Acute Respiratory Distress Syndrome,COVID-19,,Biological: Tocilizumab,National Cancer Institute (NCI),All,"2 Years and older   (Child, Adult, Older Adult)",1.0,NIH,Interventional,2020-05-28,14/01/21,2021-01-14,01/05/20,19/01/21,"National Cancer Institute, Rockville, Maryland, United States|University Medical Center of Southern Nevada, Las Vegas, Nevada, United States|Summerlin Hospital Medical Center, Las Vegas, Nevada, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Valley Medical Center, Renton, Washington",United States,Respiratory Diseases,1,6,231.0
4595.0,NCT04723550,COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes,,Recruiting,Type 2 Diabetes Mellitus,,,,,,,Device: Hospital telemedicine management system|Other: Usual care,Wenwen Yin|Xuzhou No.1 Peoples Hospital,All,18 Years to 55 Years   (Adult),120.0,Other,Interventional,2021-05-01,05/11/21,2022-05-01,25/01/21,26/01/21,"Department of Endocrinology, Xuzhou NO.1 Peoples Hospital, Xuzhou, Jiangsu",China,Metabolic Disorders,1,1,365.0
4596.0,NCT04420416,Mental Health and Academic Performance in COVID-19,PANDEMIC,Recruiting,"Depression, Anxiety",,,,,,,Other: Survey,Instituto Mexicano del Seguro Social,All,"18 Years and older   (Adult, Older Adult)",720.0,Other,Observational,2020-01-04,30/07/20,2020-07-30,09/06/20,28/07/20,"Instituto Mexicano del Seguro Social, Guadalajara, Jalisco",Mexico,Mental Health,1,1,208.0
4597.0,NCT04659460,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,,Not yet recruiting,COVID-19,Corona Virus Infection,Acute Lung Injury,Ischemia Limb,Acute Respiratory Distress Syndrome,,,Device: Remote Ischemic Conditioning,Unity Health Toronto|Defence Research and Development Canada,All,"16 Years and older   (Child, Adult, Older Adult)",30.0,Other|Industry,Interventional,2020-12-15,31/03/21,2021-01-09,09/12/20,09/12/20,,,Respiratory Diseases,1,5,25.0
4598.0,NCT04279782,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,,Recruiting,Coronavirus,,,,,,,Other: Comprehensive treatment,"Third Affiliated Hospital, Sun Yat-Sen University",All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-01-20,31/01/21,2021-02-28,21/02/20,24/02/20,"The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong",China,Respiratory Diseases,1,1,405.0
4599.0,NCT04408287,Improving Activity Engagement Among Persons With SCI During COVID-19,,Recruiting,Spinal Cord Injuries,,,,,,,Other: WebEx Physical Activity Program,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-09-15,28/02/21,2021-10-31,29/05/20,21/02/21,"St. Josephs Parkwood Institute, London, Ontario",Canada,Others,0,1,411.0
4600.0,NCT04357314,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,MODIF,Completed,Myocardial Infarction,,,,,,,,"French Cardiology Society|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",6332.0,Other,Observational,2020-01-03,31/05/20,2020-05-31,22/04/20,19/08/20,"Hôpital Universitaire Carémeau, Nîmes",France,Others,0,1,149.0
4601.0,NCT04712448,Serum Prevalence of Dars-Cov-2 Antibodies in Pre-pandemic Blood Samples (SPARE),SPARE,"Active, not recruiting",Healthy,Chronic Disease,,,,,,Diagnostic Test: Anti-COVID test,"IRCCS San Raffaele|Department of Transfusion Medicine Venice Area|Istituto per lo Studio, la Prevenzione e la Rete Oncologica",All,"18 Years to 80 Years   (Adult, Older Adult)",3500.0,Other,Observational,2020-12-30,30/06/21,2021-09-30,15/01/21,15/01/21,"IRCCS San Raffaele, Rome",Italy,Others,0,2,274.0
4602.0,NCT04619680,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,ENDCOV-I,Recruiting,Pulmonary Fibrosis,Interstitial Lung Disease,Respiratory Disease,,,,,Drug: Nintedanib|Drug: Placebo,Icahn School of Medicine at Mount Sinai|Boehringer Ingelheim,All,"18 Years and older   (Adult, Older Adult)",120.0,Other|Industry,Interventional,2020-11-18,01/04/24,2024-01-04,06/11/20,01/04/21,"Mount Sinai Beth Israel, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York",United States,Others,0,3,1142.0
4603.0,NCT04582318,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",,Recruiting,COVID-19,,,,,,,Biological: NGM621|Biological: Placebo,"NGM Biopharmaceuticals, Inc",All,"18 Years to 70 Years   (Adult, Older Adult)",48.0,Industry,Interventional,2020-08-11,01/06/21,2021-01-09,09/10/20,23/11/20,"NGM Clinical Study Site, Brisbane",Australia,Respiratory Diseases,1,1,151.0
4604.0,NCT04406545,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,,Recruiting,Coronavirus Infection,Endothelial Dysfunction,Microvascular Rarefaction,,,,,Other: evaluation of skin microvascular flow and reactivity,"National Institute of Cardiology, Laranjeiras, Brazil",All,"18 Years to 80 Years   (Adult, Older Adult)",25.0,Other,Observational,2020-05-15,01/12/21,2021-01-12,28/05/20,09/03/21,"National Institute of Cardiology, Rio de Janeiro",Brazil,Respiratory Diseases,1,3,242.0
4605.0,NCT04324021,Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,,Terminated,COVID-19,,,,,,,Biological: Emapalumab|Biological: Anakinra,Swedish Orphan Biovitrum,All,"18 Years to 85 Years   (Adult, Older Adult)",16.0,Industry,Interventional,2020-02-04,13/11/20,2020-11-13,27/03/20,14/12/20,"Regions hospital, Saint Paul, Minnesota, United States|The Valley hospital, Ridgewood, New Jersey, United States|NewYork-Presbyterian Queens, Flushing, New York, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|University of Utah Health, Salt Lake City, Utah, United States|ASST Spedali Civili di Brescia Dipartimento di Reumatologia e Immunologia Clinica, Brescia, Italy|S.C. Malattie Infettive, Ospedale Galliera, Genova, Italy|Ospedale Maggiore Policlinico, Dipartimento di Anestesia-Rianimazione e Medicina di Urgenza, Milano, Italy|Dipartimento di Medicina - DIMED, Azienda Ospedale - Università Padova, Padova, Italy|Azienda Ospedaliero-Universitaria di Parma, Dipartimento di Malattie infettive ed epatologia, Parma, Italy|Ospedale Lazzaro Spallanzani, Dipartimento di Malattie Infettive ad alta Intensità di cura ed altamente contagiose,Ospedale Lazzaro Spallanzani, Roma, Italy|ASL Città di Torino, Unit of Infectious Diseases, Medicine, Rheumatology, Torino",Italy,Respiratory Diseases,1,1,283.0
4606.0,NCT04323345,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,,Recruiting,COVID-19,,,,,,,Dietary Supplement: Natural Honey|Other: Standard Care,Misr University for Science and Technology,All,"5 Years to 75 Years   (Child, Adult, Older Adult)",1000.0,Other,Interventional,2020-04-15,15/12/20,2021-01-15,26/03/20,21/04/20,"Mahmoud Tantawy, Cairo",Egypt,Respiratory Diseases,1,1,275.0
4607.0,NCT04444700,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,RAPID-BRAZIL,Recruiting,COVID-19,Coronavirus Infection,Severe Acute Respiratory Syndrome,"Thromboembolism, Venous",Anticoagulants and Bleeding Disorders,,,Drug: Therapeutic anticoagulation,University of Sao Paulo General Hospital|Unity Health Toronto|University of Vermont Medical Center,All,"18 Years and older   (Adult, Older Adult)",462.0,Other,Interventional,2020-04-07,30/11/20,2020-12-31,23/06/20,19/08/20,"Hospital das Clínicas da FMUSP, São Paulo, SP",Brazil,Respiratory Diseases,1,5,268.0
4608.0,NCT04335162,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),CovCardioVasc,Recruiting,COVID-19,Acute Coronary Syndrome,Myocardial Infarction,Myocarditis,Venous Thromboembolism,Deep Vein Thrombosis,Pulmonary Embolism,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-02-28,31/08/21,2021-08-31,06/04/20,24/11/20,"Centre Hospitalier de Cannes, Cannes, France|CHU de Dijon, Dijon, France|Centre Hospitalier de Draguignan, Draguignan, France|Centre Hospitalier de Grasse, Grasse, France|Clinique Ambroise-Paré, Neuilly, France|CHU de Nice, Nice, France|Hôpitaux Universitaires Paris Centre - Hôpital Cochin, Paris, France|CHU de REIMS, Reims",France,Respiratory Diseases,1,7,550.0
4609.0,NCT04393792,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,,Recruiting,Coronavirus Infection,,,,,,,Drug: Povidone-Iodine|Drug: Normal saline,Hampshire Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-05,01/08/20,2020-01-08,19/05/20,19/05/20,"Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire",United Kingdom,Respiratory Diseases,1,1,3.0
4610.0,NCT04383730,Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),ISCA,Recruiting,Critically Illness,Sedation,Invasive Mechanical Ventilation,Acute Respiratory Distress Syndrome,,,,Drug: Intravenous sedation|Drug: Inhaled sedation,"University Hospital, Clermont-Ferrand|Hospital Clínico Universitario de Valencia|University Hospital Schleswig-Holstein|Groupe Hospitalier Pitie-Salpetriere",All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-06-26,30/04/21,2021-05-31,12/05/20,11/02/21,"Beth Israel Deaconess Medical Center, Inc., Boston, Massachusetts, United States|CHU, Brest, France|CHU, Clermont-Ferrand, France|Centre Hospitalier, Dunkerque, France|Pitié-Salpêtrière Hospital - APHP, Paris, France|CH Privé de la Loire, Saint-Étienne, France|Universitätsklinikum, Bochum, Germany|University Medical Center Schleswig-Holstein, Kiel, Germany|Universitätsklinikum, Oldenburg, Germany|Hospital Clínico Universitario de Valencia, Valencia, Spain|Cantonal Hospital, Münsterlingen, Switzerland|Universitätsspital, Zürich",Switzerland,Respiratory Diseases,1,4,339.0
4611.0,NCT04834375,Randomized Open Investigation Determining Steroid Dose,ROIDS-Dose,Recruiting,COVID-19,,,,,,,Drug: Weight-based dexamethasone dose,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",142.0,Other,Interventional,2021-03-19,19/03/22,2022-04-19,08/04/21,08/04/21,"Northwell Health, New Hyde Park, New York",United States,Respiratory Diseases,1,1,396.0
4612.0,NCT04374617,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,,Completed,COVID-19,Critical Illness,Venous Thromboembolism,Venous Thromboses,"Venous Thromboses, Deep",Venous Thrombosis Pulmonary,Pulmonary Embolism,Diagnostic Test: Duplex ultrasound and Computed Tomography Angiography,Hospital Universitari Vall d'Hebron Research Institute,All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Observational,2020-01-04,25/04/20,2020-01-05,05/05/20,06/05/20,"Vall d´Hebron Research Institute VHIR, Barcelona, Catalunya, Spain|Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona, Badalona, Spain|Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona, Barcelona",Spain,"Cardiovascular Diseases, Respiratory Diseases",1,7,1.0
4613.0,NCT04342806,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",,Recruiting,Health Care Worker (HCW),COVID-19,,,,,,,Duke University|Patient-Centered Outcomes Research Institute,All,"18 Years to 89 Years   (Adult, Older Adult)",100000.0,Other,Observational,2020-10-04,31/12/99,1999-12-31,13/04/20,30/03/21,"Duke Clinical Research Institute, Durham, North Carolina",United States,Respiratory Diseases,1,2,-7583.0
4614.0,NCT04686708,COVID-19 Pandemic and General Surgery Emergencies,,Completed,Emergencies,,,,,,,Other: Emergency general surgical admissions,Gulhane Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",750.0,Other,Observational,2019-11-03,11/09/20,2020-11-09,29/12/20,29/12/20,"Gulhane Training and Research Hospital, Ankara",Turkey,Others,0,1,372.0
4615.0,NCT04642950,A Phase II/III Study of Sargramostim,,Recruiting,COVID-19,,,,,,,Drug: Sargramostim|Drug: Placebo,Nobelpharma,All,"20 Years to 80 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-12-17,31/10/21,2021-10-31,24/11/20,10/02/21,"IUHW Narita Hospital, Narita City, Chiba, Japan|Kanagawa Cardiovascular and Respiratory Center, Yokohama City, Kanagawa, Japan|Japanese Red Cross Society Saitama Red Cross Hospital, Saitama City, Saitama, Japan|St. Luke's International Hospital, Chuo-ku, Tokyo, Japan|Mishuku Hospital, Meguro-ku, Tokyo, Japan|Japanese Red Cross Medical Center, Shibuya-ku, Tokyo, Japan|Center Hospital of the National Center for Global Health and Medicine, Shinjuku-Ku, Tokyo",Japan,Respiratory Diseases,1,1,318.0
4616.0,NCT04517097,Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic,canSEROcov,Completed,Cancer,,,,,,,Biological: blood sample,Centre Georges Francois Leclerc,All,"18 Years and older   (Adult, Older Adult)",1680.0,Other,Observational,2020-12-05,30/06/20,2020-06-30,18/08/20,18/08/20,"Centre Georges-François LECLERC, Dijon",France,Cancers,1,1,-158.0
4617.0,NCT04797624,Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients?,,Completed,Stomach Cancer,Corona Virus Infection,,,,,,Procedure: Gastric cancer surgery,Adana City Training and Research Hospital,All,"18 Years to 95 Years   (Adult, Older Adult)",146.0,Other,Observational,2021-01-15,15/02/21,2021-02-15,15/03/21,15/03/21,"Adana City Training and Research Hospital, Adana, Yuregir",Turkey,"Respiratory Diseases, Cancers",1,2,31.0
4618.0,NCT04354818,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),CORIA,Recruiting,HIV-1-infection,Cancer,Primary Immune Deficiency Disorder,Immunosuppression Disorders,COVID-19,,,,"Kirby Institute|St Vincent's Hospital, Sydney|Garvan Institute of Medical Research|Westmead Hospital, Sydney, Australia|Blacktown Hospital, Sydney, Australia|Holdsworth House Medical Practice|Royal North Shore Hospital|Melanoma Institute Australia|Prince of Wales Hospital, Sydney|Gilead Sciences|Cancer Institute NSW|Cancer Council New South Wales|Positive Life NSW|St George Hospital, Australia|Liverpool Hospital, Sydney",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other|Industry,Observational,2020-11-05,27/04/22,2022-04-27,21/04/20,28/07/20,"St Vincent's Hospital, Darlinghurst, New South Wales, Australia|East Sydney Doctors, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Blacktown Hospital, Sydney, New South Wales, Australia|Liverpool Hospital, Sydney, New South Wales, Australia|St George Hospital, Sydney, New South Wales, Australia|Concord Hospital, Sydney, New South Wales, Australia|Holdsworth House Medical Practice, Sydney, New South Wales, Australia|Melanoma Institute Australia, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Westmead Hospital, Sydney, New South Wales",Australia,"Respiratory Diseases, Cancers",1,5,538.0
4619.0,NCT04645563,Using Whatsapp for the Consultation,,Completed,COVID-19,,,,,,,Other: Sending thorax ct video images via smartphone applications,Kafkas University,All,"18 Years and older   (Adult, Older Adult)",144.0,Other,Observational,2020-11-03,30/05/20,2020-05-31,27/11/20,27/11/20,"Ramazan Sabirli, Kars, Outside Of The US",Turkey,Respiratory Diseases,1,1,-156.0
4620.0,NCT04797936,BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19,,Completed,COVID-19,Nasopharyngitis,Anosmia,Fever,Myalgia,Cough,Nasal Congestion,Drug: BNO 1030|Other: Standard care,Ivano-Frankivsk National Medical University,All,"18 Years to 70 Years   (Adult, Older Adult)",133.0,Other,Interventional,2020-01-05,19/12/20,2021-08-01,15/03/21,15/03/21,"Ivano-Frankivsk National Medical University, Ivano-Frankivsk",Ukraine,Respiratory Diseases,1,7,574.0
4621.0,NCT04443361,Insomnia After the COVID-19 Pandemic,,Not yet recruiting,Insomnia,Metacognitive Beliefs,Anxiety,Depression,Sleep,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,23/06/20,,,Mental Health,1,5,21.0
4622.0,NCT04448405,Covid-19 Lockdown and Deviant Sexual Fantasies,,Completed,Deviant Sexual Fantasies,,,,,,,Behavioral: Questionnaire for evaluation of confinement on deviant sexual fantasies,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-06-18,01/10/20,2020-10-30,25/06/20,29/12/20,"Uhmontpellier, Montpellier",France,Others,0,1,134.0
4623.0,NCT04385238,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,,Completed,COVID-19,Pregnancy Complications,Mental Health Wellness 1,Anxiety,Depression,Ptsd,Coronavirus,Other: This is an online survey with no intervention.,Pregistry|Harvard School of Public Health,Female,"18 Years and older   (Adult, Older Adult)",6894.0,Industry|Other,Observational,2020-05-15,20/06/20,2020-06-20,12/05/20,07/01/21,"Pregistry, Los Angeles, California",United States,"Mental Health, Respiratory Diseases",1,7,36.0
4624.0,NCT04269525,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,,Recruiting,"Pneumonia, Viral","Pneumonia, Ventilator-Associated",,,,,,Biological: UC-MSCs,ZhiYong Peng|Tuohua Biological Technology Co. Ltd|Zhongnan Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",16.0,Other,Interventional,2020-06-02,01/12/20,2020-12-30,13/02/20,01/07/20,"Zhongnan Hospital of Wuhan University, Wuhan, Hubei",China,Respiratory Diseases,1,2,211.0
4625.0,NCT04382131,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),,Recruiting,Upper Respiratory Tract Infections,Virus,COVID-19,Virus Shedding,Virus Diseases,,,Other: NaCl Solution,University of Edinburgh,All,"18 Years and older   (Adult, Older Adult)",405.0,Other,Interventional,2020-06-23,31/10/20,2020-10-31,11/05/20,02/09/20,"NHS Lothian, Edinburgh",United Kingdom,Respiratory Diseases,1,5,130.0
4626.0,NCT04373707,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,COVI-DOSE,Recruiting,COVID-19,Thrombosis,Pulmonary Embolism,Deep Vein Thrombosis,,,,Drug: Enoxaparin,"Central Hospital, Nancy, France|Ministry of Health, France|Grand Est Region|University Hospital of Saint-Etienne",All,"18 Years and older   (Adult, Older Adult)",602.0,Other,Interventional,2020-05-13,01/11/21,2021-01-11,04/05/20,23/11/20,"Amiens Academic Hospital, Amiens, France|Besançon Academic Hospital, Besançon, France|Brest Academic Hospital, Brest, France|Civil Hospital, Colmar, France|Dijon Academic Hospital, Dijon, France|Kremlin Bicêtre Academic Hospital, Le Kremlin-Bicêtre, France|Lille Academic Hospital, Lille, France|Groupe Hospitalier Unéos, Metz, France|Metz-Thionville Regional Hospital, Metz, France|Montpellier Academic Hospital, Montpellier, France|Emile Muller Hospital, Mulhouse, France|Nancy Academic Hospital, Nancy, France|George Pompidou European Hospital, Paris, France|Lariboisière Academic Hospital, Paris, France|St Etienne Academic Hospital, Saint-Étienne, France|Strasbourg Academic Hospital, Strasbourg, France|Toulouse Academic Hospital, Toulouse",France,Respiratory Diseases,1,4,243.0
4627.0,NCT04732702,Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents,,Recruiting,Mother-Child Interaction,,,,,,,Other: no intervention,University of Cologne,All,6 Months to 9 Months   (Child),30.0,Other,Observational,2020-10-29,31/01/21,2021-04-30,01/02/21,04/02/21,"University hospital of Cologne, Department of Neonatology, Cologne, Northrhine-westfalia",Germany,Others,0,1,183.0
4628.0,NCT04460027,W-SUDs for COVID-19,,Completed,Substance Use Disorders,Alcohol Use Disorder,,,,,,Other: Woebot Substance Use Disorder,"Athena Robinson|Stanford University|Woebot Labs, Inc.",All,"18 Years to 65 Years   (Adult, Older Adult)",180.0,Industry|Other,Interventional,2020-06-22,30/11/20,2020-11-30,07/07/20,17/12/20,"Stanford University, Palo Alto, California",United States,Others,0,2,161.0
4629.0,NCT04376905,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),PiCCOVID,Completed,COVID-19,Pneumonia,Acute Respiratory Distress Syndrome,,,,,,"University Hospital, Montpellier",All,"18 Years to 99 Years   (Adult, Older Adult)",30.0,Other,Observational,2020-01-04,01/09/20,2020-09-30,06/05/20,29/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,270.0
4630.0,NCT04750759,Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat,NICCAM,Recruiting,COVID-19,,,,,,,Drug: Niclosamide + Camostat|Other: Placebo,Charité Research Organisation GmbH|Bayer,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other|Industry,Interventional,2021-03-02,30/06/21,2021-06-30,11/02/21,18/02/21,"Charité Research Organisation GmbH, Berlin",Germany,Respiratory Diseases,1,1,120.0
4631.0,NCT04587245,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,,Recruiting,COVID-19,Financial Disclosure,,,,,,Other: Online questionnaire and interviews,"ND Sciences, LLC|University of California, Irvine",All,"Child, Adult, Older Adult",100.0,Industry|Other,Observational,2020-01-10,15/10/21,2021-10-15,14/10/20,19/10/20,"University of California Irvine Beall Applied Innovation, Irvine, California",United States,Respiratory Diseases,1,2,644.0
4632.0,NCT04698798,Skeletal Muscle Wasting in SARS-CoV-2,SMW,Recruiting,Cachexia,Muscle Loss,Muscle Wasting,Muscle Atrophy,Critical Illness,,,Procedure: Muscle Biopsy,Hasselt University|Jessa Hospital,All,"18 Years and older   (Adult, Older Adult)",16.0,Other,Interventional,2021-02-01,01/05/21,2021-01-05,07/01/21,18/02/21,"Jessa Ziekenhuis, Hasselt",Belgium,Cardiovascular Diseases,1,5,-27.0
4633.0,NCT04506632,Burden for STaff Working in the NHS,COST-NHS,Recruiting,COVID-19,Mental Health Burden,,,,,,,Sheffield Teaching Hospitals NHS Foundation Trust|University of Sheffield,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-02-06,02/04/21,2022-04-26,10/08/20,10/08/20,"Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield",United Kingdom,Respiratory Diseases,1,2,810.0
4634.0,NCT04401644,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,COLIDE,Not yet recruiting,Diagnoses Disease,Coronavirus,,,,,,Diagnostic Test: Novel laser inferometry test for CORONA virus,Somerset NHS Foundation Trust|University of Exeter|University of Plymouth,All,"18 Years to 100 Years   (Adult, Older Adult)",250.0,Other,Interventional,2020-01-06,01/12/21,2021-01-12,26/05/20,26/05/20,"Somerset NHS Foundation Trust, Taunton, Somerset",United Kingdom,Respiratory Diseases,1,2,372.0
4635.0,NCT04417673,Living With Sickle Cell Disease in the COVID-19 Pandemic,,Not yet recruiting,Isolation,Anxiety,Health Care Utilization,Sickle Cell Disease,Pain,,,,National Human Genome Research Institute (NHGRI)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1000.0,NIH,Observational,2021-04-19,31/12/24,2024-12-31,05/06/20,14/04/21,"National Human Genome Research Institute (NHGRI), Bethesda, Maryland",United States,Mental Health,1,5,1352.0
4636.0,NCT04659746,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,MejoraCare_P,Recruiting,Quality of Life,Stress,Emotional Adjustment,,,,,Device: MejoraCare,Universidad Autónoma de Encarnación|Salumedia Labs|University of Valencia,All,"18 Years and older   (Adult, Older Adult)",96.0,Other|Industry,Interventional,2020-09-12,28/02/21,2021-09-12,09/12/20,30/12/20,"Hospital Regional de Encarnación, Encarnación, Itapúa",Paraguay,Mental Health,1,3,365.0
4637.0,NCT04365166,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),REACOVIM,Recruiting,Respiratory Tract Infections,Respiratory Tract Disease,,,,,,,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-21,21/04/22,2022-04-21,28/04/20,09/03/21,"Percy Military Teaching Hospital, Clamart, France|Bégin Military Teaching Hospital, Saint-Mandé",France,Others,0,2,730.0
4638.0,NCT04439006,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,,Recruiting,Aplastic Anemia,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,Monoclonal B-Cell Lymphocytosis,Monoclonal Gammopathy of Undetermined Significance,Myelodysplastic Syndrome,COVID-19,Other: Best Practice|Drug: Ibrutinib,"Jennifer Woyach|National Cancer Institute (NCI)|Janssen Scientific Affairs, LLC|Ohio State University Comprehensive Cancer Center",All,"18 Years and older   (Adult, Older Adult)",72.0,Other|NIH|Industry,Interventional,2020-07-22,31/12/21,2022-12-31,19/06/20,19/08/20,"Ohio State University Comprehensive Cancer Center, Columbus, Ohio",United States,Respiratory Diseases,1,7,892.0
4639.0,NCT04471519,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,BBV152,"Active, not recruiting",COVID-19,COVID-19,,,,,,Biological: BBV152A - Phase I|Biological: BBV152B - Phase I|Biological: BBV152C - Phase I|Biological: Placebo - Phase I|Biological: BBV152A - Phase II|Biological: BBV152B - Phase II,Bharat Biotech International Limited|Indian Council of Medical Research,All,"12 Years to 65 Years   (Child, Adult, Older Adult)",755.0,Industry|Other,Interventional,2020-07-15,31/07/20,2021-06-30,15/07/20,26/03/21,"King George Hospital, Visakhapatnam, Andhra Pradesh, India|All India Institute of Medical Sciences, Patna, Bihar, India|Pt BD SHARMA,PGIMS/UHS, Rohtak, Haryana, India|Jeevan Rekha Hospital, Belgaum, Karnataka, India|Gillukar Multispeciality Hospital, Nagpur, Maharastra, India|All India Institute of Medical Sciences, Delhi, New Delhi, India|Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Orissa, India|SRM Hospital & Research center, Chennai, Tamilnadu, India|Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India|Rana Hospital and Trauma Center, Gorakhpur, Uttar Pradesh, India|Prakhar Hospital, Kanpur, Uttar Pradesh, India|Redkar Hospital and Research Centre, Goa",India,Respiratory Diseases,1,2,350.0
4640.0,NCT04365153,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),,"Active, not recruiting",COVID-19,SARS-CoV 2,,,,,,Drug: Canakinumab Injection 600mg|Drug: Canakinumab Injection 300mg|Drug: Placebos,The Cleveland Clinic|Novartis,All,"18 Years and older   (Adult, Older Adult)",45.0,Other|Industry,Interventional,2020-04-24,28/02/21,2021-04-30,28/04/20,01/02/21,"Cleveland Clinic Florida, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio",United States,Respiratory Diseases,1,2,371.0
4641.0,NCT04491318,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,HemoCov,Recruiting,Hemophilia Arthropathy,,,,,,,Other: Observational,Investigación en Hemofilia y Fisioterapia,Male,"18 Years to 65 Years   (Adult, Older Adult)",27.0,Other,Observational,2020-01-07,25/07/20,2020-07-29,29/07/20,29/07/20,"European University of Madrid, Madrid",Spain,Others,0,1,204.0
4642.0,NCT04356833,Nebulised Rt-PA for ARDS Due to COVID-19,PACA,Recruiting,COVID-19,,,,,,,Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 IMV|Drug: nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 2 NIV,"University College, London",All,"16 Years to 70 Years   (Child, Adult, Older Adult)",66.0,Other,Interventional,2020-04-22,30/04/21,2021-04-30,22/04/20,06/04/21,"Barnet Hospital, London, United Kingdom|The Royal Free Hospital, London",United Kingdom,Respiratory Diseases,1,1,373.0
4643.0,NCT04531774,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,,Recruiting,Stress,Burnout,Anxiety,Depression,COVID-19,,,Behavioral: RECHARGE|Behavioral: Self Study,Naser Morina|The University of New South Wales|University of Zurich,All,"18 Years and older   (Adult, Older Adult)",160.0,Other,Interventional,2020-08-28,01/06/21,2021-01-06,28/08/20,19/10/20,"Klinik für Konsiliarpsychiatrie und Psychosomatik, Zürich",Switzerland,"Mental Health, Respiratory Diseases",1,5,131.0
4644.0,NCT04371848,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study,,Completed,Eating Habits,,,,,,,,Laval University,All,"18 Years and older   (Adult, Older Adult)",2465.0,Other,Observational,2020-04-16,07/05/20,2020-07-05,01/05/20,05/03/21,"Université Laval, Québec",Canada,Others,0,1,80.0
4645.0,NCT04715763,INvestigating TELmisartin Study,INTEL,Not yet recruiting,COVID-19,,,,,,,Drug: Telmisartan Oral Product|Drug: Placebo,University of Hawaii|Queens Medical Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-02,31/01/22,2022-12-31,20/01/21,01/02/21,,,Respiratory Diseases,1,1,728.0
4646.0,NCT04479332,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),,Not yet recruiting,Corona Virus Infection,Critical Illness,,,,,,Procedure: Tracheal intubation and cardiopulmonary resuscitation,National Taiwan University Hospital,All,"20 Years and older   (Adult, Older Adult)",334.0,Other,Interventional,2020-01-08,31/07/22,2022-07-31,21/07/20,21/07/20,,,"Cardiovascular Diseases, Respiratory Diseases",1,2,935.0
4647.0,NCT04573062,Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health,,Recruiting,Post-Coronavirus Disease 19,,,,,,,,National Institute of Neurological Disorders and Stroke (NINDS)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1200.0,NIH,Observational,2021-04-19,31/12/24,2024-12-31,05/10/20,14/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,1,1352.0
4648.0,NCT04339387,COVID-19 Risk Stratification,,Completed,Coronavirus,Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere,,,,,,,Brigham and Women's Hospital,All,"18 Years and older   (Adult, Older Adult)",1326.0,Other,Observational,2020-01-03,26/04/20,2020-04-26,09/04/20,30/11/20,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,2,114.0
4649.0,NCT04345614,A Study of Auxora in Patients With Severe COVID-19 Pneumonia,,Recruiting,Pneumonia,,,,,,,Drug: Auxora|Drug: Placebo,"CalciMedica, Inc.",All,"18 Years and older   (Adult, Older Adult)",346.0,Industry,Interventional,2020-08-04,01/07/21,2021-01-07,14/04/20,12/04/21,"Long Beach Memorial, Long Beach, California, United States|University of Southern California / LA County, Los Angeles, California, United States|Sharp Memorial San Diego, San Diego, California, United States|University of Colorado, Aurora, Colorado, United States|National Jewish Health / St. Joseph's Hospital, Denver, Colorado, United States|Northwestern University, Chicago, Illinois, United States|Baton Rouge General, Baton Rouge, Louisiana, United States|Maine Medical Center, Portland, Maine, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Detroit Receiving Hospital, Detroit, Michigan, United States|Harper Hospital, Detroit, Michigan, United States|Henry Ford Hospital, Detroit, Michigan, United States|Sinai Grace, Detroit, Michigan, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Temple University, Philadelphia, Pennsylvania, United States|Texas Tech University Medical Center, El Paso, Texas, United States|John Peter Smith Hospital, Fort Worth, Texas, United States|Ben Taub (Baylor), Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Aurora Baycare, Green Bay, Wisconsin, United States|Hospital San Cristobal, Ponce",Puerto Rico,Respiratory Diseases,1,1,156.0
4650.0,NCT04486521,Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19,,Recruiting,Critical Illness,Corona Virus Infection,Cytokine Release Syndrome,,,,,Drug: Interleukin 6 (IL6) Antagonist|Drug: Interleukin 6 (IL6) Antagonist and corticosteroids|Drug: corticosteroid alone,King Faisal Specialist Hospital & Research Center|Society of Critical Care Medicine,All,"14 Years and older   (Child, Adult, Older Adult)",860.0,Other,Observational,2020-07-22,22/07/21,2021-07-22,24/07/20,08/03/21,"King Faisal Specialist Hospital and Research Center, Riyadh",Saudi Arabia,"Cardiovascular Diseases, Respiratory Diseases",1,3,365.0
4651.0,NCT04642040,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,,Recruiting,COVID-19,COVID-19,SARS-CoV 2 Pneumonia,,,,,Other: Pulmonary Rehabilitation,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-30,01/01/21,2021-01-01,24/11/20,24/11/20,"Sisli Hamidiye Etfal Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,185.0
4652.0,NCT04426266,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,,Completed,Questionnaire Designs,COVID-19,Psychological Stress,Coping Skills,Two-Item Generalised Anxiety Disorder Scale,Patient Health Questionnaire Anxiety and Depression Scale,Health Status Index,,Szeged University,All,"18 Years and older   (Adult, Older Adult)",441.0,Other,Observational,2020-01-05,28/09/20,2020-09-28,11/06/20,29/09/20,"University of Szeged Department of Dermatology and Allergology, Szeged",Hungary,"Mental Health, Respiratory Diseases",1,7,267.0
4653.0,NCT04520620,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,COV-ENOX,Withdrawn,Sars-CoV2,,,,,,,Drug: Lovenox 40 MG in 0.4 mL Prefilled Syringe|Device: Ultrasound of the lower limbs,Centre Hospitalier Universitaire de Saint Etienne|CHU Saint-Etienne - Laboratoire de Pharmacologie - Toxicologie - Gaz du sang,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-02-05,10/07/20,2020-10-07,20/08/20,20/08/20,"Groupement Hospitalier des portes de Province, Montélimar, France|Centre Hospitalier de Roanne, Roanne, France|CHU de Saint-Etienne, Saint-Étienne, France|Clinique Mutualiste, Saint-Étienne",France,Respiratory Diseases,1,1,245.0
4654.0,NCT04703907,Auricular Stimulation for Relief of Stress and Anxiety,AA_COVID,Recruiting,Stress and Anxiety,,,,,,,Other: Auricular stimulation,University Medicine Greifswald,All,"19 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-03-12,01/08/21,2021-01-08,11/01/21,11/01/21,"University Medicine of Greifswald, Greifswald",Germany,Mental Health,1,1,302.0
4655.0,NCT04749121,Ultraviolet Germicidal Irradiation on the New Silicone Half-Piece Elastometric Respirators,,Completed,COVID-19,,,,,,,Device: UVC Irradiation|Drug: UVC Irradiation|Device: Fit test|Device: Tensile strength,Bangkok Metropolitan Administration Medical College and Vajira Hospital,All,18 Years to 60 Years   (Adult),20.0,Other,Interventional,2020-01-04,05/02/21,2021-05-02,11/02/21,11/02/21,"Faculty of Medicine ,Vajira hospital,Navamindradhiraj University, Bangkok",Thailand,Respiratory Diseases,1,1,484.0
4656.0,NCT04587414,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,MySteps-CoV,"Active, not recruiting",Type2 Diabetes,,,,,,,Behavioral: eHealth +counselling contacts|Behavioral: eHealth|Behavioral: Usual care,UKK Institute|North Karelia Hospital District|University of Eastern Finland,All,"20 Years to 69 Years   (Adult, Older Adult)",122.0,Other,Interventional,2019-06-03,31/10/20,2020-10-31,14/10/20,14/10/20,"North Karelia Hospital District, Joensuu",Finland,Metabolic Disorders,1,1,516.0
4657.0,NCT04365361,The Psychological Impact of the COVID-19 on Students.,,Recruiting,Mental Health Wellness 1,,,,,,,,The University of Hong Kong,All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-04-26,30/12/20,2021-03-31,28/04/20,19/05/20,"LAI Agnes, Hong Kong",Hong Kong,Others,0,1,339.0
4658.0,NCT04811781,Epidemiological Features and Clinical Course of SARS-CoV-2 Infection in Cancer Patients: The Rovid Study,,Recruiting,"Solid Tumor, Adult",,,,,,,,Istituto Oncologico Veneto IRCCS,All,"18 Years to 65 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-04-06,04/06/21,2021-04-12,23/03/21,23/03/21,"istituto Oncologico Veneto -UOSD Melanoma, Padova, PD, Italy|Aulss1 Dolomiti, Belluno, Italy|Istituto Oncologico Veneto -UOC Oncologia 1, Padova",Italy,Others,0,1,371.0
4659.0,NCT04344041,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),,Recruiting,Coronavirus,,,,,,,"Drug: cholecalciferol 200,000 IU|Drug: cholecalciferol 50,000 IU","University Hospital, Angers|Mylan Laboratories",All,65 Years and older   (Older Adult),260.0,Other|Industry,Interventional,2020-04-15,01/05/21,2021-01-05,14/04/20,05/10/20,"CHU Angers, Angers, France|CHU Bordeaux, Bordeaux, France|CH Le Mans, Le Mans, France|CHU Lille, Lille, France|CHU Limoges, Limoges, France|CHU Nantes, Nantes, France|CHU Nice, Nice, France|CHU Saint Etienne, Saint Etienne, France|CH Saumur, Saumur, France|CHU Tours, Tours",France,Respiratory Diseases,1,1,265.0
4660.0,NCT04614844,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),,Recruiting,Physician Stress Levels,,,,,,,Behavioral: Simulation Intervention|Behavioral: Control,Yale University|Agency for Healthcare Research and Quality (AHRQ),All,"18 Years and older   (Adult, Older Adult)",84.0,Other|U.S. Fed,Interventional,2021-06-01,15/09/22,2022-11-15,04/11/20,25/02/21,"Yale New Haven Hospital, New Haven, Connecticut",United States,Mental Health,1,1,532.0
4661.0,NCT04376814,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,,Completed,COVID-19,Favipiravir,Kaletra,Hydroxychloroquine,Lopinavir/Ritonavir,,,Drug: Favipiravir|Drug: Hydroxychloroquine|Drug: Lopinavir / Ritonavir,Baqiyatallah Medical Sciences University,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",40.0,Other,Interventional,2020-03-29,05/04/20,2020-05-25,06/05/20,16/06/20,"Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,5,57.0
4662.0,NCT04325893,Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,HYCOVID,Terminated,Coronavirus,,,,,,,Drug: Hydroxychloroquine|Drug: Placebo,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",259.0,Other,Interventional,2020-01-04,18/06/20,2020-06-18,30/03/20,06/10/20,"CH Agen, Agen, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Auxerre, Auxerre, France|APHP Avicenne, Bobigny, France|CHU Brest, Brest, France|CHU Caen, Caen, France|CH Chalon Sur Saône, Chalon Sur Saône, France|CH Cherbroug, Cherbourg, France|CH Cholet, Cholet, France|CH Colmar, Colmar, France|CH Compiègne, Compiègne, France|APHP Henri Mondor, Créteil, France|CH Intercommunal Créteil, Créteil, France|CHU Dijon, Dijon, France|APHP Joffre Dupuytren, Draveil, France|CHD Vendée, La Roche-sur-Yon, France|CH Laval, Laval, France|CH Le Mans, Le Mans, France|CH Emile Roux, Le Puy-en-Velay, France|APHP Emile ROUX, Limeil-Brevannes, France|CHU Limoges, Limoges, France|CH Lorient, Lorient, France|Hôpital Européen - Marseille, Marseille, France|Hôpital Saint-Joseph, Marseille, France|CH Melun, Melun, France|CHU Nantes, Nantes, France|Hôpital Privé du Confluent, Nantes, France|CH Niort, Niort, France|CHR Orléans, Orléans, France|APHP Saint-Antoine, Paris, France|GH Croix Saint Simon, Paris, France|La Pitié-Salpétrière, Paris, France|CHU Poitiers, Poitiers, France|CH Pointoise, Pontoise, France|CH Quimper, Quimper, France|CH Saint-Brieuc, Saint-Brieuc, France|CH Saint-Nazaire, Saint-Nazaire, France|CHU Saint-Etienne, Saint-Étienne, France|CHU Toulouse, Toulouse, France|CH Tourcoing, Tourcoing, France|CHU Tours, Tours, France|CH Valenciennes, Valenciennes, France|Clinique Tessier Valenciennes, Valenciennes, France|CH Vannes, Vannes, France|CH Versailles, Versailles, France|CH Princesse Grace, Monaco",Monaco,Respiratory Diseases,1,1,166.0
4663.0,NCT04615416,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,ERT-P,Recruiting,"Distress, Emotional",Emotional Dysfunction,Anxiety,Depression,,,,Behavioral: Emotion Regulation Training via Telehealth,"Teachers College, Columbia University|University of Michigan",All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-05,01/01/21,2023-01-01,04/11/20,04/11/20,"Teachers College, Columbia University, New York, New York",United States,Mental Health,1,4,1092.0
4664.0,NCT04821531,Feasibility of a Self-guided Exercise Program Among Hospitalized COVID-19 Patients,,Not yet recruiting,Corona Virus Infection,,,,,,,Other: PT Pal|Other: Exercise Manual,Montefiore Medical Center,All,"18 Years to 89 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-04,01/03/22,2022-01-12,29/03/21,29/03/21,"Montefiore Medical Center, New York, New York",United States,Respiratory Diseases,1,1,373.0
4665.0,NCT04594278,COVID-19 Burnout Study,,Not yet recruiting,Stress,,,,,,,Behavioral: Mindfulness Based Intervention,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-11,01/04/22,2022-01-07,20/10/20,02/04/21,,,Mental Health,1,1,361.0
4666.0,NCT04698837,Understanding Potential Airborne Transmission and the Protective Value of Type II Surgical Masks in SARS-CoV-2,aeroCOVID1,Not yet recruiting,COVID-19,,,,,,,,"University Hospital Inselspital, Berne|University of Bern|Lucerne University of Applied Sciences and Arts",All,"18 Years to 110 Years   (Adult, Older Adult)",30.0,Other,Observational,2021-01-01,01/06/21,2021-01-06,07/01/21,11/01/21,"University Hospital Bern, Bern",Switzerland,Respiratory Diseases,1,1,5.0
4667.0,NCT04736680,Pediatric Virtual Visits as a Strategy for Access to Care During the COVID-19 Pandemic in a Pediatric Hospital,,Not yet recruiting,Telehealth,,,,,,,,Hospital General de Niños Pedro de Elizalde,All,"1 Month to 18 Years   (Child, Adult)",667.0,Other,Observational,2021-01-03,01/09/21,2021-01-09,03/02/21,03/02/21,,,Others,0,1,6.0
4668.0,NCT04813796,"A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines in Healthy Adults Between 18 Years and 55 Years of Age",,Recruiting,COVID-19,,,,,,,Biological: mRNA-1283|Biological: mRNA-1273|Biological: Placebo,"ModernaTX, Inc.",All,18 Years to 55 Years   (Adult),125.0,Industry,Interventional,2021-11-03,13/04/22,2022-04-13,24/03/21,24/03/21,"Optimal Research San Diego, LLC, San Diego, California, United States|Optimal Research Melbourne, LLC, Melbourne, Florida, United States|Optimal Research Illinois, LLC, Peoria, Illinois, United States|Optimal Research Texas, LLC, Austin, Texas",United States,Respiratory Diseases,1,1,161.0
4669.0,NCT04320953,Non-contact Endoscopy at Covid-19 Outbreak,,Completed,Gastrointestinal Disease,Infectious Disease,,,,,,Device: Non-contact MCE system,Changhai Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",5.0,Other,Interventional,2020-03-16,26/03/20,2020-09-04,25/03/20,17/04/20,"Changhai Hospital, Shanghai",China,Others,0,2,172.0
4670.0,NCT04365335,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,AUTONOMIC,Completed,Occupational Stress,,,,,,,Behavioral: Assessment of work-related stress|Biological: Saliva sample collection|Other: Cardiac and electrodermal recordings|Behavioral: Assessment of behavioral response to emotional stimulation,Direction Centrale du Service de Santé des Armées|Institut de Recherche Biomedicale des Armees,All,18 Years to 60 Years   (Adult),50.0,Other,Observational,2020-04-25,12/06/20,2020-12-06,28/04/20,09/03/21,"Elément Militaire de Réanimation (EMR), Mulhouse",France,Mental Health,1,1,225.0
4671.0,NCT04619368,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,RE-CoV-ERY,Recruiting,Human ARDS,Coronavirus Infection,,,,,,Other: Follow up calls,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-07-27,01/07/22,2022-01-07,06/11/20,06/11/20,"University Hospital of Toulouse, Toulouse",France,Respiratory Diseases,1,2,529.0
4672.0,NCT04377074,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,,Completed,Parental Stress,Depression,Anxiety,,,,,,University of Oslo|Modum Bad|Oslo Metropolitan University|University of Bergen,All,"18 Years and older   (Adult, Older Adult)",2880.0,Other,Observational,2020-03-31,07/04/20,2020-07-04,06/05/20,06/05/20,"University of Oslo, Oslo",Norway,Mental Health,1,3,95.0
4673.0,NCT04365608,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,,Completed,Intubation Complication,Intubation; Difficult or Failed,Cardiac Arrest,Influenza,Safety Issues,,,Procedure: Direct laryngoscopy|Procedure: Vie Scope laryngoscopy,Lazarski University|Poznan University of Medical Sciences|Wroclaw Medical University|Medical University of Bialystok,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-03-20,30/11/20,2020-10-12,28/04/20,19/12/20,"Emergency Medical Service, Poznan, Poland|Emergency Medical Service, Warsaw",Poland,Infectious Diseases,0,5,206.0
4674.0,NCT04426305,Community Health Workers Against COVID19,,Enrolling by invitation,COVID-19,Social Isolation,Mental Health Impairment,,,,,Other: community health worker support|Other: care as usual,University Ghent,All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Interventional,2020-05-21,20/06/20,2020-10-30,11/06/20,11/06/20,"Department of Public Health and Primary Care, Ghent",Belgium,Respiratory Diseases,1,3,162.0
4675.0,NCT04390126,COVID-19 Related Lockdown Effects On Chronic Diseases,CLEO-CD,"Active, not recruiting",Chronic Coronary Syndrome,Heart Failure,AMD and Macular Edema,Chronic Respiratory Failure,Hemophilia,Malignant Hemopathy,Multiple Sclerosis,Other: life questionnaires|Other: questionnaire,Centre Hospitalier Universitaire Dijon,All,"9 Months and older   (Child, Adult, Older Adult)",1200.0,Other,Observational,2020-04-20,07/05/21,2021-07-11,15/05/20,20/01/21,"CHU Dijon Bourgogne, Dijon",France,"Respiratory Diseases, Immunological Disorders",1,7,447.0
4676.0,NCT04772859,Evaluation of an Online Lifestyle Intervention in Mexican School Children During COVID-19 Pandemic,,Recruiting,Childhood Obesity,,,,,,,Behavioral: Online Lifestyle Intervention|Other: Control Group,Universidad de Sonora,All,9 Years to 12 Years   (Child),54.0,Other,Interventional,2021-01-02,01/07/21,2021-01-07,26/02/21,10/03/21,"Rolando Giovanni Diaz Zavala, Hermosillo, Sonora",Mexico,Metabolic Disorders,1,1,5.0
4677.0,NCT04435275,Virtual Assistant for COVID-19 PPE,,Recruiting,COVID-19,,,,,,,"Other: Virtual Assistant first, then Human Coach|Other: Human Coach first, then Virtual Assistant","University Health Network, Toronto",All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-02-01,31/03/21,2021-01-05,17/06/20,08/01/21,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,1,-27.0
4678.0,NCT04840992,Phase I/II Clinical Trial of Recombinant Novel Coronavirus (COVID-19) Vaccine (Adenovirus Type 5 Vector) for Inhalation,,Not yet recruiting,COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo for Inhalation|Biological: Placebo,CanSino Biologics Inc.|Beijing Institute of Biotechnology|Jiangsu Province Centers for Disease Control and Prevention,All,"18 Years and older   (Adult, Older Adult)",840.0,Industry|Other,Interventional,2021-04-20,15/04/22,2022-07-15,12/04/21,12/04/21,"Jiangsu Provincal Center for Disease Control and Prevention, Nanjing, Jiangsu",China,Respiratory Diseases,1,1,451.0
4679.0,NCT04474080,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,RESTORE,Not yet recruiting,Burnout,,,,,,,Behavioral: Virtual Peer Support Platform|Behavioral: Control Period,St. Joseph's Healthcare Hamilton,All,"18 Years and older   (Adult, Older Adult)",1080.0,Other,Interventional,2021-01-15,01/07/21,2021-01-07,16/07/20,22/10/20,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,Others,0,1,-8.0
4680.0,NCT04442308,Parental Stress After the Covid-19 Pandemic,,Not yet recruiting,Parenting,Anxiety,Depression,Anger,,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",1440.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,24/06/20,,,Mental Health,1,4,21.0
4681.0,NCT04674410,Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients,,"Active, not recruiting",COVID-19,Coronavirus Infection,Pneumonia,,,,,Drug: Antibiotic,National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",100000.0,NIH,Observational,2020-01-03,31/01/21,2021-03-31,19/12/20,05/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,3,453.0
4682.0,NCT04410484,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,PREPARE IBD,"Active, not recruiting",Inflammatory Bowel Diseases,Coronavirus Infection,,,,,,,Hull University Teaching Hospitals NHS Trust,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",1500.0,Other,Observational,2020-05-22,01/08/20,2020-01-08,01/06/20,04/06/20,"Gastroenterology, Hull Royal Infirmary, Hull University Teaaching Hospitals NHS Trust, Hull",United Kingdom,Respiratory Diseases,1,2,-135.0
4683.0,NCT04592549,"This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19",,Recruiting,COVID-19,,,,,,,Drug: ADM03820|Other: Placebo,Ology Bioservices|Enabling Biotechnologies (EB),All,18 Years to 55 Years   (Adult),40.0,Industry|Other,Interventional,2020-04-12,30/09/21,2021-09-30,19/10/20,10/12/20,"PMG Research of Winston-Salem, LLC, Winston-Salem, North Carolina, United States|ICON Early Phase Services, LLC, San Antonio, Texas",United States,Respiratory Diseases,1,1,536.0
4684.0,NCT04356885,COVID-19 and Psychotic Symptoms in France,SCHIZOVID-19,Completed,Mental Disorder,,,,,,,,"University Hospital, Montpellier|Epsylon Laboratory, EA 4556, University Paul Valéry Montpellier 3, France|Laboratoy LIP/PC2S, University Grenobles-Alpes, Grenoble, France|Centre référent de réhabilitation psychosociale de Grenoble, Grenoble, France",All,"18 Years to 65 Years   (Adult, Older Adult)",600.0,Other,Observational,2020-01-04,30/07/20,2020-01-08,22/04/20,29/12/20,"UH Montpellier, Montpellier",France,Others,0,1,4.0
4685.0,NCT04406909,Rapid-Cycle Re-Implementation of TRAining Facilities in Norway,TRAiN,"Active, not recruiting",Training,,,,,,,Other: Access to training facility,Norwegian Department of Health and Social Affairs,All,18 Years to 64 Years   (Adult),4000.0,Other,Interventional,2020-05-22,19/05/21,2022-05-19,29/05/20,23/06/20,"SATS Training, Oslo",Norway,Others,0,1,727.0
4686.0,NCT04761874,Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic,TELECAST-CSC,Completed,"Stroke, Acute",,,,,,,Other: Telestroke,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",296.0,Other,Observational,2019-01-12,29/06/20,2020-09-29,21/02/21,21/02/21,"M Health Fairview Southdale Hospital, Edina, Minnesota",United States,Cardiovascular Diseases,1,1,626.0
4687.0,NCT04591184,A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,,Not yet recruiting,COVID-19,,,,,,,Biological: Covigenix VAX-001 placebo|Biological: Covigenix VAX-001,Entos Pharmaceuticals Inc.|Canadian Institutes of Health Research (CIHR),All,"18 Years to 84 Years   (Adult, Older Adult)",72.0,Industry|Other,Interventional,2021-01-03,01/08/21,2022-01-08,19/10/20,21/02/21,,,Respiratory Diseases,1,1,370.0
4688.0,NCT04673331,"Physical Activity, Exercise Capacity and Coronavirus Phobia of Adult Cystic Fibrosis Patients During COVID-19 Pandemic",,Recruiting,Cystic Fibrosis,,,,,,,Other: exercise capacity,Hacettepe University,All,"18 Years to 65 Years   (Adult, Older Adult)",24.0,Other,Observational,2020-04-11,04/11/21,2021-04-11,17/12/20,17/12/20,"Hacettepe University, Ankara",Turkey,Others,0,1,365.0
4689.0,NCT04452799,Hesperidin and Diosmin for Treatment of COVID-19,,Not yet recruiting,Coronavirus Infection,,,,,,,Drug: Hesperidin and Diosmin mixture,Tanta University,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-07,01/10/20,2020-10-30,30/06/20,30/06/20,,,Respiratory Diseases,1,1,297.0
4690.0,NCT04433078,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,STORM,Recruiting,Cytokine Storm,COVID-19,,,,,,Drug: Doxycycline|Drug: Placebo,Temple University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-06-22,01/01/21,2021-01-07,16/06/20,24/06/20,"Temple University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,2,199.0
4691.0,NCT04374097,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,,Completed,Post Traumatic Stress Disorder,Anxiety,Depression,,,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",1778.0,Other,Observational,2020-03-31,07/04/20,2020-07-04,05/05/20,06/05/20,"University of Oslo, Oslo",Norway,Mental Health,1,3,95.0
4692.0,NCT04383457,Covid-19 Triage Using Camera-based AI,,Completed,Coronavirus Infections,,,,,,,Device: RIA-device (Remote Investigation and Assessment),Vastra Gotaland Region|Detectivio AB,All,"18 Years and older   (Adult, Older Adult)",214.0,Other,Observational,2020-06-15,08/10/20,2020-08-10,12/05/20,01/12/20,"Östra Sjukhuset, Gothenburg",Sweden,Respiratory Diseases,1,1,56.0
4693.0,NCT04378738,Social Media and Covid19 Pandemic,,Enrolling by invitation,Social Media,Corona Virus Infection,,,,,,Behavioral: survey,Acibadem University,All,"18 Years and older   (Adult, Older Adult)",212.0,Other,Interventional,2020-01-05,07/05/20,2020-08-05,07/05/20,07/05/20,"Bahar Yuksel, Istanbul, Turkey|Haseki Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,213.0
4694.0,NCT04683224,"A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine",,Not yet recruiting,COVID-19,COVID-19,Coronavirus,,,,,Biological: UB-612|Other: Placebo,COVAXX|Diagnósticos da América S/A (DASA),All,"18 Years and older   (Adult, Older Adult)",7320.0,Industry|Other,Interventional,2021-01-02,22/03/23,2023-03-22,24/12/20,24/12/20,,,Respiratory Diseases,1,3,809.0
4695.0,NCT04555122,COVID-19 Ad Intervention,,Not yet recruiting,Social Distance,,,,,,,Behavioral: Social Distancing Advertisements,"University of California, Irvine|City University of Hong Kong|University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",52500.0,Other,Interventional,2020-09-29,28/05/22,2022-07-28,18/09/20,23/09/20,"UC Irvine, Irvine, California",United States,Others,0,1,667.0
4696.0,NCT04454606,The New Silicone N99 Half-Piece Respirator,,Completed,COVID-19,Personal Protective Equipment,,,,,,Device: Fit test|Device: Filtration Test,Bangkok Metropolitan Administration Medical College and Vajira Hospital,All,18 Years to 60 Years   (Adult),43.0,Other,Interventional,2020-01-05,15/05/20,2020-05-31,01/07/20,01/07/20,"Bangkok Metroplitan Administration and Vajira Hospital, Bangkok",Thailand,Respiratory Diseases,1,2,147.0
4697.0,NCT04652505,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",,Recruiting,COVID-19,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,,,,,Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",700.0,Other|NIH,Observational,2020-07-13,31/03/21,2021-03-31,03/12/20,03/12/20,"M D Anderson Cancer Center, Houston, Texas",United States,Respiratory Diseases,1,3,261.0
4698.0,NCT04690920,Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins,,Completed,COVID-19,,,,,,,Drug: Tocilizumab,University of Lahore,All,"Child, Adult, Older Adult",200.0,Other,Interventional,2020-07-23,10/12/20,2020-10-12,31/12/20,31/12/20,"The University of Lahore, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,81.0
4699.0,NCT04604080,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,,Completed,"Depression, Anxiety",,,,,,,Other: service of questionnaire,Islamia University of Bahawalpur,All,"Child, Adult, Older Adult",390.0,Other,Observational,2020-01-11,18/11/20,2020-11-18,27/10/20,19/11/20,"The Islamia University of Bahawalpur, Bahāwalpur, Punjab, Pakistan|GC University Faisalabad, Faisalabad, Punjab, Pakistan|University of Veterinary and Animal Sciences, Lahore, Lahore, Punjab, Pakistan|Bahauddin Zakriya University Multan, Multan, Punjab, Pakistan|Quaid-i-Azam University Islamabad, Islamabad",Pakistan,Mental Health,1,1,312.0
4700.0,NCT04758039,Clinical Characteristics and In-hospital Death of a Chilean COVID-19 Prospective Cohort,,Completed,Corona Virus Infection,,,,,,,,University of Chile,All,"18 Years and older   (Adult, Older Adult)",395.0,Other,Observational,2020-03-13,10/07/20,2020-10-07,17/02/21,18/02/21,"Hospital Clinico de la Universidad de Chile, Santiago, Región Metropolitana",Chile,Respiratory Diseases,1,1,208.0
4701.0,NCT04345887,Spironolactone in Covid-19 Induced ARDS,,Not yet recruiting,"Respiratory Distress Syndrome, Adult",,,,,,,Drug: Spironolactone 100mg|Drug: Placebo oral tablet,Istanbul University-Cerrahpasa,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-21,21/07/20,2020-10-21,15/04/20,15/04/20,"Istanbul University-Cerrahpaşa, Istanbul",Turkey,Others,0,1,183.0
4702.0,NCT04368377,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,PIC-19,Completed,"Pneumonia, Viral",Corona Virus Infection,Respiratory Failure,Embolism and Thrombosis,,,,Drug: Tirofiban Injection|Drug: Clopidogrel|Drug: Acetylsalicylic acid|Drug: Fondaparinux,"University of Milan|Fondazione ""Un Cuore per Milano"" - a no profit foundation",All,"18 Years and older   (Adult, Older Adult)",5.0,Other,Interventional,2020-06-04,23/04/20,2020-04-23,29/04/20,29/04/20,"L. Sacco Hospital, Milano, Lombardia",Italy,Respiratory Diseases,1,4,-42.0
4703.0,NCT04358003,Plasma Adsorption in Patients With Confirmed COVID-19,,Recruiting,Respiratory Failure,ARDS,,,,,,Device: Marker Therapeutics D2000 Cartridge (D2000) for use with the Spectra Optia® Apheresis System (Optia SPD Protocol),Marker Therapeutics AG|Terumo BCT,All,"18 Years and older   (Adult, Older Adult)",2000.0,Industry,Interventional,2020-05-20,01/08/21,2021-01-12,22/04/20,23/02/21,"UNM Health Science Center, Albuquerque, New Mexico, United States|Providence Portland Medical Center, Portland, Oregon, United States|UT Southwestern/Clements Hospital, Dallas, Texas, United States|UTMB, Galveston, Texas, United States|Inova Fairfax Medical Campus, Falls Church, Virginia",United States,Respiratory Diseases,1,2,237.0
4704.0,NCT04668937,Conséquences of the COVID-19 Lockdown Measures on the CHRU Nancy Pediatric Emergency Services,,Completed,Number of Patients During the Studying Period,Reason for Consultation,,,,,,,"Central Hospital, Nancy, France",All,up to 17 Years   (Child),11000.0,Other,Observational,2020-03-18,18/03/20,2020-06-30,16/12/20,16/12/20,"CHRU Nancy's Pediatric Emergencies, Vandœuvre-lès-Nancy, Lorraine",France,Others,0,2,104.0
4705.0,NCT04664101,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training for Survivors of COVID-19",REMM-HIIT-ICU,Not yet recruiting,COVID-19,Critical Illness,High Intensity Interval Training,ICU,Intensive Care Units,Fitness Trackers,,"Behavioral: REmotely Monitored, Mhealth (REMM) supported High Intensity Interval Training (HIIT)",Duke University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,01/05/23,2023-01-05,11/12/20,22/01/21,"Duke University Medical Center, Durham, North Carolina",United States,"Cardiovascular Diseases, Respiratory Diseases",1,6,731.0
4706.0,NCT04757883,Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients,COVATRHUS,Not yet recruiting,Kidney Transplant Recipients,,,,,,,Other: Study of the synthesis of antibodies directed against SARS,"University Hospital, Strasbourg, France",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-03,01/03/23,2023-01-03,17/02/21,17/02/21,,,Others,0,1,730.0
4707.0,NCT04626050,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",,Not yet recruiting,Post-traumatic Stress Disorder,Moral Injury,,,,,,Behavioral: Medical Music|Behavioral: Narrative Writing|Behavioral: Prolonged Exposure Therapy|Behavioral: Interpersonal Psychotherapy,Weill Medical College of Cornell University,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-05,01/01/22,2022-01-01,12/11/20,25/03/21,"Weill Cornell Medicine, New York, New York",United States,Mental Health,1,2,361.0
4708.0,NCT04569786,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),,Terminated,COVID-19,,,,,,,Biological: V590|Other: Placebo,Merck Sharp & Dohme Corp.,All,"18 Years and older   (Adult, Older Adult)",232.0,Industry,Interventional,2020-10-29,18/02/21,2021-02-18,30/09/20,04/03/21,"Celerion ( Site 0002), Tempe, Arizona, United States|Clinical Pharmacology of Miami ( Site 0003), Miami, Florida, United States|QPS Miami Research Associates ( Site 0005), South Miami, Florida, United States|Bio-Kinetic Clinical Applications (QPS) ( Site 0006), Springfield, Missouri, United States|Celerion ( Site 0001), Lincoln, Nebraska, United States|Alliance for Multispecialty Reseach, LLC ( Site 0004), Knoxville, Tennessee, United States|Worldwide Clinical Trials ( Site 0007), San Antonio, Texas",United States,Respiratory Diseases,1,1,112.0
4709.0,NCT04376515,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),,"Active, not recruiting",Anxiety,,,,,,,Behavioral: HOPE intervention,"University of California, Irvine",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-03-20,01/06/21,2021-01-09,06/05/20,03/11/20,"UC Irvine, Irvine, California",United States,Mental Health,1,1,295.0
4710.0,NCT04694482,The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology,,Recruiting,Psychosis;Schizophrenic,Personality Disorders,Mood Disorders,Anxiety Disorders,Post Traumatic Stress Disorder,,,Other: Psychometric scale administration,University of Milano Bicocca|Azienda Ospedaliera San Gerardo di Monza,All,"18 Years to 65 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-12-11,31/01/21,2021-01-31,05/01/21,06/01/21,"University of Milan Bicocca - Ospedale San Gerardo, Monza, MB",Italy,Mental Health,1,5,51.0
4711.0,NCT04375774,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),VADER,Recruiting,COVID-19,,,,,,,Device: FFP2|Device: Facial mask|Device: MFS,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,18 Years to 60 Years   (Adult),10.0,Other,Interventional,2020-01-05,01/05/20,2020-01-05,05/05/20,05/05/20,"Cliniques Universitaires Saint-Luc, Brussels",Belgium,Respiratory Diseases,1,1,0.0
4712.0,NCT04563065,Active Pregnancy Against COVID-19,ACPREGCOV,Recruiting,Pregnancy Complications,"Pregnancy, High Risk",Pregnancy Induced Hypertension,Newborn Morbidity,Fetal Growth Retardation,Fetus Disorder,"Weight Gain, Maternal",Other: Exercise program|Other: Healthy lifestyle advise,Universidad Politecnica de Madrid|Hospital Severo Ochoa|Puerta de Hierro University Hospital|Hospital Vall d'Hebron|Hospital Universitario de Torrejón de Ardoz|Clínica Zuatzu de San Sebastián,Female,18 Years to 50 Years   (Adult),280.0,Other,Interventional,2020-01-08,30/11/20,2023-12-31,24/09/20,28/09/20,"Facultad de Ciencias de la Actividad Física y el Deporte (INEF), Madrid, Spain|Facultad de Ciencias de la Actividad Física y el Deporte - INEF, Madrid",Spain,Cardiovascular Diseases,1,7,1453.0
4713.0,NCT04438954,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",,Completed,Multiple Sclerosis,COVID-19,,,,,,,Ankara Yildirim Beyazıt University,All,21 Years to 58 Years   (Adult),30.0,Other,Observational,2020-05-05,05/06/20,2020-06-18,19/06/20,22/06/20,"Ankara Yıldırım Beyazıt University, Faculty of Health Sciences,Department of Physiotherapy and Rehabilitation, Ankara",Turkey,"Respiratory Diseases, Immunological Disorders",1,2,44.0
4714.0,NCT04531618,Mother-infant Bonding During COVID-19,,Recruiting,Child Development,Mother-Infant Interaction,COVID-19,,,,,Behavioral: Family Nurture Intervention (FNI),Columbia University,All,up to 72 Hours   (Child),280.0,Other,Interventional,2020-08-13,01/12/21,2021-01-12,28/08/20,31/08/20,"Morgan Stanley Children's Hopspital, New York, New York",United States,Respiratory Diseases,1,3,152.0
4715.0,NCT04497467,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,,Recruiting,Patient Preference,,,,,,,,National Taiwan University Hospital,All,"Child, Adult, Older Adult",1200000.0,Other,Observational,2020-01-08,31/12/20,2020-12-31,04/08/20,04/08/20,"National Taiwan University Hospital, Taipei",Taiwan,Others,0,1,358.0
4716.0,NCT04489628,Tele-health Enabled Clinical Trial for COVID-19,,Not yet recruiting,SARS-CoV Infection,,,,,,,Drug: Vitamin D3 or Placebo|Device: Doctella telehealth monitoring,University Hospitals Cleveland Medical Center|Northwestern University,All,"18 Years and older   (Adult, Older Adult)",110.0,Other,Interventional,2020-01-08,01/08/21,2021-01-08,28/07/20,31/07/20,"Northwestern University, Chicago, Illinois",United States,Respiratory Diseases,1,1,366.0
4717.0,NCT04583228,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",,Not yet recruiting,COVID-19,,,,,,,Drug: HLX71|Other: Placebo,Hengenix Biotech Inc,All,"18 Years to 65 Years   (Adult, Older Adult)",40.0,Industry,Interventional,2020-11-30,10/04/21,2021-05-31,12/10/20,14/10/20,,,Respiratory Diseases,1,1,182.0
4718.0,NCT04574765,A Research Platform to Screen Healthcare Workers,RESPECT,Recruiting,Healthcare Worker,COVID-19,,,,,,Diagnostic Test: Nasopharyngeal swab|Other: Questionnaire collection|Other: Optional blood completion|Other: Optional questionnaire completion,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",100000.0,Other,Observational,2020-04-16,16/04/21,2021-04-16,05/10/20,05/10/20,"University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,2,365.0
4719.0,NCT04444323,3D Telemedicine During COVID-19: Cohort Study,,Not yet recruiting,Telemedicine,"Surgery, Plastic",,,,,,Other: 3D Telemedicine,"NHS Greater Glasgow and Clyde|Jean Brown Bequest Fund, Glasgow",All,"1 Year to 95 Years   (Child, Adult, Older Adult)",50.0,Other,Interventional,2020-01-09,01/01/21,2021-01-01,23/06/20,07/07/20,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland",United Kingdom,Others,0,2,358.0
4720.0,NCT04789603,Effects of Using Mask During the 6-minute Walking Test in Times of COVID-19,,Not yet recruiting,Pulmonary Disease,COVID-19,Physical Disability,,,,,Other: 6-min-walk surgical mask|Other: 6-min-walk Fpp2|Other: 6-min-walk without mask,Universitat Internacional de Catalunya,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-09-03,30/03/21,2021-10-04,09/03/21,09/03/21,,,Respiratory Diseases,1,3,31.0
4721.0,NCT04581200,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,LIFTCOVID,Recruiting,COVID-19,Cardiorespiratory Failure,,,,,,Behavioral: Lift,Duke University|National Center for Complementary and Integrative Health (NCCIH),All,"18 Years and older   (Adult, Older Adult)",300.0,Other|NIH,Interventional,2021-01-25,31/07/21,2021-09-30,09/10/20,03/02/21,"University of Colorado - Denver, Aurora, Colorado, United States|University of Michigan, Ann Arbor, Michigan, United States|Duke University Medical Center, Durham, North Carolina, United States|Oregon Health & Sciences University, Portland, Oregon",United States,Respiratory Diseases,1,2,248.0
4722.0,NCT04453774,At Home Monitoring for Patients With Covid19,,Not yet recruiting,Coronavirus,,,,,,,Device: Covidfree@home,"University Health Network, Toronto|Sunnybrook Health Sciences Centre|University of Toronto",All,"Child, Adult, Older Adult",1000.0,Other,Interventional,2020-10-16,01/02/21,2023-01-04,01/07/20,12/10/20,"Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|University Health Network, Toronto, Ontario",Canada,Respiratory Diseases,1,1,810.0
4723.0,NCT04383483,"CoV-ICU Score, Intensive Care Unit, SARS-CoV-2",,Recruiting,Coronavirus as the Cause of Diseases Classified Elsewhere,,,,,,,Other: COVICU,Bursa Yüksek İhtisas Education and Research Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-06-15,31/01/22,2022-02-28,12/05/20,29/03/21,"Bursa Yüksek Ihtisas Training and Research Hospital, Bursa, Yildirim",Turkey,Respiratory Diseases,1,1,623.0
4724.0,NCT04373382,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,,"Active, not recruiting",Burnout,,,,,,,Behavioral: Peer Resilience Champion|Behavioral: Enriched Survey Feedback,"Mount Sinai Hospital, Canada|Canadian Institutes of Health Research (CIHR)",All,"18 Years and older   (Adult, Older Adult)",882.0,Other,Interventional,2020-07-27,01/02/22,2022-01-02,04/05/20,05/11/20,"Sinai Health System, Toronto, Ontario",Canada,Others,0,1,524.0
4725.0,NCT04365348,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,,Recruiting,Mental Health Wellness 1,,,,,,,,"The University of Hong Kong|Queen Mary Hospital, Hong Kong",All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-04-27,31/03/21,2021-06-30,28/04/20,19/05/20,"Agnes, Hong Kong",Hong Kong,Others,0,1,429.0
4726.0,NCT04412343,The Seniors COvid-19 Pandemic and Exercise Study,SCOPE,Completed,Well-Being (Psychological Flourishing),Depression,Quality of Life,Loneliness,Physical Activity,Social Identification,Physical Health,Behavioral: Virtual Group Intervention|Behavioral: Personal Exercise Intervention,University of British Columbia|University of Victoria,All,65 Years and older   (Older Adult),241.0,Other,Interventional,2020-05-23,05/10/20,2020-05-10,02/06/20,03/11/20,"University of British Columbia, Vancouver, British Columbia",Canada,Mental Health,1,7,-13.0
4727.0,NCT04368676,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness During the COVID-19 Pandemic,BREATH,"Active, not recruiting",Job Stress,Workplace Stress,Compassion Fatigue,Psychological Trauma,Healthcare Workers,Healthcare Providers,,Other: Sudarshan Kriya Yoga (SKY)|Other: Health Enhancement Program,Lawson Health Research Institute|Art of Living Foundation,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-25,30/06/22,2022-06-30,30/04/20,01/04/21,"London Health Sciences Centre, London, Ontario",Canada,Mental Health,1,6,735.0
4728.0,NCT04346420,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,,Completed,COVID-19,Hypoxemia,,,,,,Other: Standard interface|Device: Double-Trunk Mask,Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,"18 Years and older   (Adult, Older Adult)",12.0,Other,Interventional,2020-09-04,01/05/20,2020-01-05,15/04/20,09/06/20,"Cliniques universitaires Saint-Luc, Brussels, Brussels Capital",Belgium,Respiratory Diseases,1,2,-243.0
4729.0,NCT04644328,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign,,"Active, not recruiting",COVID-19,,,,,,,Behavioral: Facebook Ads on the importance of staying safe during the Thanksgiving holiday,"National Bureau of Economic Research, Inc.|Massachusetts Institute of Technology|Harvard University|Massachusetts General Hospital|Yale University|Stanford University",All,"18 Years and older   (Adult, Older Adult)",20000000.0,Other,Interventional,2020-11-14,26/11/20,2021-11-26,25/11/20,06/04/21,"JPAL North America, Cambridge, Massachusetts",United States,Respiratory Diseases,1,1,377.0
4730.0,NCT04798599,Information and Communication Technologies (ICTS) in Dentistry for SUS,,Recruiting,Dental Caries in Children,Dental Diseases,,,,,,Other: Telemonitoring and teleorientation|Other: Control Group - Waiting list,University of Sao Paulo|Federal University of Paraíba|Federal University of São Paulo,All,3 Years to 13 Years   (Child),368.0,Other,Interventional,2020-01-12,30/06/21,2022-06-30,15/03/21,15/03/21,"University of São Paulo, São Paulo",Brazil,Others,0,2,900.0
4731.0,NCT04611399,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,,Recruiting,Stress Related Disorder,,,,,,,Behavioral: VR for psychoeducation and relaxation|Behavioral: Text material for psychoeducation and audio for relaxation techniques,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta|University of Milano Bicocca,All,"18 Years to 65 Years   (Adult, Older Adult)",90.0,Other,Interventional,2021-05-03,05/03/22,2022-05-03,02/11/20,19/03/21,"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan",Italy,Mental Health,1,1,365.0
4732.0,NCT04381000,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,,Completed,Chronic Pain,,,,,,,Other: Exercise Group,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory|University of Thessaly,All,"18 Years to 80 Years   (Adult, Older Adult)",170.0,Other,Interventional,2020-01-04,29/05/20,2020-10-06,08/05/20,01/07/20,"Clinical Exercise Physiology and Rehabilitation Laboratory, Lamia, Sterea Ellada",Greece,Others,0,1,276.0
4733.0,NCT04327388,Sarilumab COVID-19,,Completed,Corona Virus Infection,,,,,,,Drug: Sarilumab SAR153191|Drug: Placebo,Sanofi|Regeneron Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",420.0,Industry,Interventional,2020-03-28,30/07/20,2020-02-09,31/03/20,29/09/20,"Investigational Site Number 0320001, Caba, Argentina|Investigational Site Number 0320003, Caba, Argentina|Investigational Site Number 0320004, Caba, Argentina|Investigational Site Number 0760003, Porto Alegre, Brazil|Investigational Site Number 0760001, Sao Paulo, Brazil|Investigational Site Number 0760002, Sao Paulo, Brazil|Investigational Site Number 0760004, São José Do Rio Preto, Brazil|Investigational Site Number 0760005, São Paulo, Brazil|Investigational Site Number 1240001, Montreal, Canada|Investigational Site Number 1240005, Montreal, Canada|Investigational Site Number 1240004, Toronto, Canada|Investigational Site Number 1240002, Toronto, Canada|Investigational Site Number 1240003, Vancouver, Canada|Investigational Site Number 1520003, Santiago, Chile|Investigational Site Number 1520002, Santiago, Chile|Investigational Site Number 1520004, Santiago, Chile|Investigational Site Number 1520001, Talca, Chile|Investigational Site Number 2500001, Bordeaux Cedex, France|Investigational Site Number 2500007, Clamart, France|Investigational Site Number 2500006, La Roche Sur Yon Cedex 9, France|Investigational Site Number 2500002, Nantes, France|Investigational Site Number 2500005, Paris Cedex 18, France|Investigational Site Number 2500003, Strasbourg, France|Investigational Site Number 2500004, Suresnes, France|Investigational Site Number 2760002, Essen, Germany|Investigational Site Number 2760004, Köln, Germany|Investigational Site Number 2760001, Münster, Germany|Investigational site number 3760003, Ashdod, Israel|Investigational Site Number 3760002, Jerusalem, Israel|Investigational Site Number 3760001, Ramat Gan, Israel|Investigational Site Number 3800005, Milano, Italy|Investigational Site Number 3800001, Milano, Italy|Investigational Site Number 3800002, Milano, Italy|Investigational Site Number 3800003, Modena, Italy|Investigational Site Number 3800004, Parma, Italy|Investigational Site Number 3800006, Rozzano, Italy|Investigational Site Number 3920002, Fuchu-Shi, Japan|Investigational Site Number 3920003, Iruma-Gun, Japan|Investigational Site Number 3920001, Kamakura-Shi, Japan|Investigational Site Number 6430003, Moscow, Russian Federation|Investigational Site Number 6430002, Moscow, Russian Federation|Investigational Site Number 6430001, Moscow, Russian Federation|Investigational Site Number 7240003, Barcelona, Spain|Investigational Site Number 7240004, Barcelona, Spain|Investigational Site Number 7240002, Madrid / Madrid, Spain|Investigational Site Number 7240005, Madrid, Spain|Investigational Site Number 7240001, Madrid",Spain,Respiratory Diseases,1,1,-48.0
4734.0,NCT04407598,COPD in the Time of COVID-19,,"Active, not recruiting",COPD Exacerbation,COPD,,,,,,,"University of Leicester|University Hospitals, Leicester",All,"40 Years and older   (Adult, Older Adult)",160.0,Other,Observational,2020-01-05,08/06/20,2021-01-06,29/05/20,03/11/20,"NIHR Leicester Biomedical Research Centre (Respiratory), Glenfield Hospital, Leicester",United Kingdom,Others,0,2,367.0
4735.0,NCT04830761,Behavior Change in Context to Contain the Spread of COVID-19,,Recruiting,Hand Hygiene,,,,,,,Behavioral: Motivation|Behavioral: Habit|Behavioral: Social,University of Bern|Ursula Wirz Stiftung,All,"18 Years and older   (Adult, Older Adult)",710.0,Other,Interventional,2021-03-26,01/04/22,2022-01-04,05/04/21,12/04/21,"University of Bern, Bern",Switzerland,Others,0,1,284.0
4736.0,NCT04479540,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,COVIDEP,Recruiting,"Pneumonia, Viral",,,,,,,Radiation: Angiography scanner,"Hopital Foch|Hospital Ambroise Paré Paris|University Hospital, Brest",All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-05-26,26/05/21,2021-08-31,21/07/20,10/09/20,"Hôpital Foch, Suresnes",France,Respiratory Diseases,1,1,462.0
4737.0,NCT04419623,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,,Recruiting,COVID-19,Sars-CoV2,Cancer,Solid Tumor,Carcinoma,Blood Cancer,,Drug: Part 1 - TL-895|Drug: Part 2 - TL-895|Drug: Part 2 - Placebo,"Telios Pharma, Inc.",All,"18 Years and older   (Adult, Older Adult)",146.0,Industry,Interventional,2020-09-07,01/07/21,2021-01-07,05/06/20,25/09/20,"University of Miami, Miami, Florida, United States|Georgia Cancer Center, Augusta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|Community Health Network, Indianapolis, Indiana, United States|Norton Cancer Institute, Louisville, Kentucky, United States|Tulane Medical Center, New Orleans, Louisiana, United States|Barbara Ann Karmanos Cancer Institute - Wertz Clinic, Detroit, Michigan, United States|Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States|University of Cincinnati Medical Center, Cincinnati, Ohio, United States|The Ohio State Comprehensive Cancer Center, Columbus, Ohio, United States|OhioHealth - Riverside Methodist Hospital, Columbus, Ohio",United States,"Respiratory Diseases, Cancers",1,6,122.0
4738.0,NCT04435106,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),,Completed,Coronavirus Infections,,,,,,,Drug: Opaganib|Drug: Standard of Care,Shaare Zedek Medical Center,All,"18 Years to 80 Years   (Adult, Older Adult)",23.0,Other,Observational,2020-03-04,01/05/20,2020-05-15,17/06/20,17/06/20,"Shaare-Zedek Medical Center, Jerusalem",Israel,Respiratory Diseases,1,1,72.0
4739.0,NCT04813692,Mechanical Complications of Acute Myocardial Infarction During COVID-19 Pandemics,CautionCov19,Recruiting,Ventricular Septal Rupture,Papillary Muscle Rupture,"Free Wall Rupture, Heart",,,,,Procedure: Surgical repair|Procedure: Percutaneous treatment|Procedure: Mitral valve surgery,Maastricht University Medical Center,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-01-03,31/05/21,2021-07-31,24/03/21,25/03/21,"Matteucci Matteo, Maastricht",Netherlands,Others,0,3,209.0
4740.0,NCT04727775,Antiviral Drugs on the Treatment of SARS-CoV-2,FavRem,Recruiting,Complication of Medical Care,"Pneumonia, Viral",,,,,,Drug: Favipiravir|Drug: Remdesivir,Astana Medical University,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-11-25,25/01/21,2021-03-20,27/01/21,10/03/21,"Aidos Konkaev, Nur-Sultan, Kazakhstan|Semey Medical University, Semey",Kazakhstan,Respiratory Diseases,1,2,115.0
4741.0,NCT04806074,FOODLIT-PRO: Improving Food Literacy and Food Sustainability Amidst the COVID-19 Pandemic,FOODLIT-PRO,"Active, not recruiting",Food Literacy,Food Habits,Behavior and Behavior Mechanisms,Eating Behavior,,,,Behavioral: Experimental Group|Behavioral: Comparison Group,"ISPA - Instituto Universitario de Ciencias Psicologicas, Sociais e da Vida|Fundação para a Ciência e a Tecnologia",All,"18 Years and older   (Adult, Older Adult)",215.0,Other,Interventional,2020-08-14,06/12/20,2021-06-09,19/03/21,22/03/21,"ISPA - Instituto Universitário, Lisboa",Portugal,Others,0,4,299.0
4742.0,NCT04664296,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),,Recruiting,Infection Viral,,,,,,,Other: Review of medical patient file|Other: Phone call interview,Hospices Civils de Lyon,All,"Child, Adult, Older Adult",75.0,Other,Observational,2020-12-21,21/03/21,2021-03-21,11/12/20,09/02/21,"Service de Reanimation Pediatrique, Lyon, Rhone",France,Others,0,1,90.0
4743.0,NCT04715477,Intensive Care Anxiety in SARS-CoV-2 Patients,,Recruiting,Anxiety,,,,,,,Behavioral: Hospital Anxiety Depression Measure,Derince Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-17,01/04/21,2021-04-15,20/01/21,20/01/21,"İlke Küpeli, İ̇zmi̇t, Kocaeli̇",Turkey,Mental Health,1,1,88.0
4744.0,NCT04821921,The Impact of the COVID-19 Pandemic on Diabetes Management,CoDiaM,Not yet recruiting,Type 2 Diabetes,Type 1 Diabetes Mellitus,,,,,,Other: No intervention,Universitätsklinikum Hamburg-Eppendorf,All,"18 Years and older   (Adult, Older Adult)",750.0,Other,Observational,2021-04-15,31/03/22,2022-06-30,30/03/21,01/04/21,,,Metabolic Disorders,1,2,441.0
4745.0,NCT04476745,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,,Enrolling by invitation,Cytokine Storm,,,,,,,Dietary Supplement: Vitamin D3,Applied Science Private University,All,"30 Years to 66 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-05-10,15/12/20,2021-02-20,20/07/20,08/12/20,"Mahmoud S Abu-Samak, Amman",Jordan,Others,0,1,286.0
4746.0,NCT04386460,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,,Recruiting,Nutrition Poor,Infection Viral,Oral Disease,,,,,,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-11-05,05/06/20,2021-11-05,13/05/20,13/05/20,"University Nice Hospital, Nice",France,Others,0,3,365.0
4747.0,NCT04455360,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,Cov-EMERALD,Recruiting,Post Traumatic Stress Disorder,Intensive Care Psychiatric Disorder,Anxiety Disorders,Depression,Critical Care,COVID-19,,Other: Eye Movement Desensitisation and Reprocessing Recent traumatic Event Protocol,University Hospital Southampton NHS Foundation Trust|Dorset HealthCare University NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",26.0,Other,Interventional,2020-01-10,01/03/21,2021-01-09,02/07/20,22/10/20,"University Hospital Southampton NHS Foundation Trust, Southampton, Hamphsire",United Kingdom,"Mental Health, Respiratory Diseases",1,6,365.0
4748.0,NCT04372576,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,,Recruiting,Ventilator Associated Pneumonia,Corona Virus Infection,,,,,,Diagnostic Test: Assessment of ventilator-associated pneumonia criteria,Semmelweis University,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-04-16,01/08/20,2020-01-08,04/05/20,04/05/20,"Semmelweis University, Budapest",Hungary,Respiratory Diseases,1,2,-99.0
4749.0,NCT04475588,Efficacy and Safety of Itolizumab in COVID-19 Complications,,Completed,Acute Respiratory Distress Syndrome,Cytokine Release Syndrome,COVID-19,,,,,"Drug: Itolizumab IV infusion|Drug: Best supportive care"" which includes antivirals /antibiotics/ hydroxychloroquine; oxygen therapy",Biocon Limited,All,"18 Years to 99 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-01-05,08/07/20,2020-08-07,17/07/20,17/07/20,"Topiwala National Medical College & B. Y. L. Nair Charitable Hospital,, Mumbai, India|Seth GS Medical College and KEM Hospital, Mumbai, India|MAMC medical college and Lok Nayak Jai Prakash Narayan Hospital hospital, New Delhi, India|All India Institute Of Medical Sciences, New Delhi",India,Respiratory Diseases,1,3,215.0
4750.0,NCT04583865,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,TéléCCCAP,"Active, not recruiting",Anesthesia,,,,,,,Other: teleconsultation,"University Hospital, Toulouse",All,"1 Month to 18 Years   (Child, Adult)",400.0,Other,Observational,2020-07-10,14/09/21,2022-03-14,12/10/20,12/10/20,"UHToulouse, Toulouse",France,Others,0,1,612.0
4751.0,NCT04733846,Corneal Wounds Repair Emergencies During COVID-19 : 10/0 Absorbable Polyglactin Sutures as a Valuable Strategy,,Not yet recruiting,Eye Trauma,,,,,,,Other: data collection,Centre Hospitalier Universitaire de Saint Etienne,All,"18 Years and older   (Adult, Older Adult)",9.0,Other,Observational,2021-01-02,01/03/21,2021-01-03,02/02/21,03/02/21,"CHU Saint-Etienne, Saint-Étienne",France,Others,0,1,1.0
4752.0,NCT04366947,Intravascular Access in Suspected/Confirmed COVID-19 Patient,,Completed,Emergency Medicine,Cardiopulmonary Arrest,Shock,,,,,Device: NIO® (Intraosseous access)|Device: Standard of Care (Intravenous access),Lazarski University|Poznan University of Medical Sciences|Medical University of Bialystok|Wroclaw Medical University,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-04-14,20/09/20,2020-10-30,29/04/20,19/12/20,"Lazarsku University, Warsaw, Masovian",Poland,Others,0,3,199.0
4753.0,NCT04368312,Psychological Impairment Due to Covid-19,,Not yet recruiting,Psychological Distress,Quality of Life,,,,,,Other: No intervention,"University Hospital, Essen",All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-06-05,30/05/20,2020-05-30,29/04/20,29/04/20,,,Others,0,2,-6.0
4754.0,NCT04470544,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,RECOVER,Recruiting,Severe Acute Respiratory Syndrome,,,,,,,Drug: Camostat Mesilate|Other: Standard of Care,Alan Bryce|Academic and Community Cancer Research United,All,"18 Years and older   (Adult, Older Adult)",264.0,Other,Interventional,2020-07-28,15/09/22,2022-09-15,14/07/20,11/01/21,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Tucson Medical Center, Tucson, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida",United States,Others,0,1,779.0
4755.0,NCT04568005,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,,Completed,Lymphedema,,,,,,,,Fatih Sultan Mehmet Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-01-06,01/08/20,2020-01-08,29/09/20,08/10/20,"Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Ataşehir",Turkey,Others,0,1,2.0
4756.0,NCT04422418,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,,Recruiting,Cardiovascular Risk Factor,Burnout,Immune Deficiency,,,,,,Khalifa University for Science and Technology|Zayed Military Hospital|Abu Dhabi University|Cleveland Clinic Abu Dhabi|Sheikh Khalifa Medical City|Sheikh Shakhbout Medical City|Mediclinic Middle East|Myriad Global Solutions,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Observational,2020-01-07,14/12/20,2020-12-31,09/06/20,03/11/20,"Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates|Mediclinic, Abu Dhabi, United Arab Emirates|Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates|Sheikh Shakhbout Medical City, Abu Dhabi",United Arab Emirates,Others,0,3,359.0
4757.0,NCT04359225,A Comparison of 3D and 2D Telemedicine During Covid 19,,Not yet recruiting,Telehealth,,,,,,,Other: 3D Telemedicine|Other: 2D Telemedicine,NHS Greater Glasgow and Clyde|University of Strathclyde|Glasgow Royal Infirmary,All,"1 Year to 95 Years   (Child, Adult, Older Adult)",80.0,Other,Interventional,2020-06-30,31/12/21,2021-12-31,24/04/20,28/04/20,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland",United Kingdom,Others,0,1,549.0
4758.0,NCT04539821,Virtual Pain Care Management (COVID-19),VCPM,Recruiting,Chronic Pain,,,,,,,Other: VCPM,VA Office of Research and Development,All,"18 Years and older   (Adult, Older Adult)",60.0,U.S. Fed,Interventional,2020-01-10,30/04/21,2021-06-30,07/09/20,01/04/21,"Rocky Mountain Regional VA Medical Center, Aurora, CO, Aurora, Colorado, United States|VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut",United States,Others,0,1,537.0
4759.0,NCT04747756,Creating a Virtual Village for People Aging With HIV During COVID-19,,Not yet recruiting,Hiv,Depression in Old Age,"Isolation, Social",Aging,,,,Other: Virtual Village,"University of California, Riverside|University of South Florida|University of Southern California|HIV+Aging Research Project-Palm Springs",All,"50 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-03,01/12/22,2022-01-12,10/02/21,10/02/21,"UC Riverside, Riverside, California",United States,Mental Health,1,4,374.0
4760.0,NCT04818164,Prone Position Improves End-Expiratory Lung Volumes in COVID-19 Acute Respiratory Distress Syndrome,,Completed,Acute Respiratory Distress Syndrome,Coronavirus,Mechanical Ventilation Complication,Ventilation Perfusion Mismatch,,,,,Istanbul University-Cerrahpasa,All,"18 Years and older   (Adult, Older Adult)",22.0,Other,Observational,2020-01-09,31/12/20,2021-03-20,26/03/21,08/04/21,"Istanbul University-Cerrahpaşa, Istanbul",Turkey,Respiratory Diseases,1,4,436.0
4761.0,NCT04570189,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",,Recruiting,COVID-19,,,,,,,Device: Auscul-X,AusculSciences Canada Inc.|Ottawa Heart Institute Research Corporation,All,"18 Years to 100 Years   (Adult, Older Adult)",40.0,Industry|Other,Observational,2020-01-10,01/01/21,2021-01-01,30/09/20,14/12/20,"The University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,357.0
4762.0,NCT04622332,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,,Recruiting,Corona Virus Infection,,,,,,,Drug: SIR1-365|Drug: Matching Placebo,"Sironax USA, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-12-18,15/12/21,2021-12-15,09/11/20,14/04/21,"OSF St. Francis Medical Center, Peoria, Illinois",United States,Respiratory Diseases,1,1,362.0
4763.0,NCT04423991,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,IDENTIFY,Completed,COVID-19,Coronavirus,Mortality,,,,,Device: COViage,Dascena,All,"Child, Adult, Older Adult",290.0,Industry,Interventional,2020-10-03,04/06/20,2020-04-06,09/06/20,09/06/20,"Dascena, Oakland, California",United States,Respiratory Diseases,1,3,-180.0
4764.0,NCT04414319,Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly,CovAged,Recruiting,SARS-CoV 2,,,,,,,,University Hospital Center of Martinique,All,70 Years and older   (Older Adult),350.0,Other,Observational,2020-04-15,15/04/21,2023-04-15,04/06/20,04/06/20,"University hospital of Rennes, Rennes, France|Va de Lys-Ramsay Gds group Clinic, Tourcoing, France|Hopsital of Valenciennes, Valenciennes, France|University hospital of Guadeloupe, Les Abymes, Guadeloupe|University hospital of Martinique, Fort-de-France",Martinique,Respiratory Diseases,1,1,1095.0
4765.0,NCT04320862,COVID-19 Pandemic Response Network,,Recruiting,COVID-19,COVID-19,Coronavirus,Influenza -Like Illness,Lower Resp Tract Infection,Upper Resp Tract Infection,,,Duke University,All,"Child, Adult, Older Adult",200000.0,Other,Observational,2020-03-04,31/12/21,2021-12-31,25/03/20,27/04/20,"Duke University Medical Center, Durham, North Carolina",United States,"Infectious Diseases, Respiratory Diseases",1,6,667.0
4766.0,NCT04447404,"DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury",,Terminated,SARS-CoV 2,,,,,,,Drug: DUR-928|Drug: Placebo,Durect,All,"18 Years to 80 Years   (Adult, Older Adult)",2.0,Industry,Interventional,2020-09-21,04/03/21,2021-04-03,25/06/20,22/03/21,"Site 03, Newark, New Jersey",United States,Respiratory Diseases,1,1,194.0
4767.0,NCT04730934,Effects of the COVID-19 Pandemic on Fibromyalgia Patients,,Completed,Fibromyalgia,Chronic Low-back Pain,,,,,,"Other: Perceived stress scale|Other: Fibromyalgia impact questionnaire|Other: The drugs used before and during the pandemic, the patient's job status, physical activity conditions, pain status",Kars State Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",1360.0,Other,Observational,2021-01-01,25/02/21,2021-02-25,29/01/21,01/03/21,"Çam and Sakura City Hospital, Istanbul",Turkey,Others,0,2,55.0
4768.0,NCT04526145,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,OUR-Project,Not yet recruiting,"Stress, Psychological",,,,,,,Behavioral: Stress and emotion management,Ohio State University,Female,"45 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,01/12/21,2022-01-30,25/08/20,01/04/21,,,Mental Health,1,1,391.0
4769.0,NCT04363229,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,,Not yet recruiting,Occupational Stress,,,,,,,Other: maslach burnout inventory questionnair,Assiut University,All,"22 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-01-07,01/05/21,2021-01-06,27/04/20,08/07/20,,,Mental Health,1,1,365.0
4770.0,NCT04442243,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,,Not yet recruiting,Post Traumatic Stress Disorder,Anxiety,Depression,,,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",889.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,24/06/20,,,Mental Health,1,3,21.0
4771.0,NCT04524754,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,,Recruiting,Anosmia,,,,,,,,Ain Shams University,All,"18 Years and older   (Adult, Older Adult)",218.0,Other,Observational,2020-11-07,11/09/20,2020-11-30,24/08/20,28/08/20,"Ain shams Univesrity, Cairo",Egypt,Others,0,1,23.0
4772.0,NCT04407182,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,,Completed,COVID-19,Sars-CoV2,Diabete Mellitus,Cardiopathy,Pulmonary Disease,Renal Disease,Liver Diseases,Dietary Supplement: Viusid and Asbrip,Catalysis SL,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-04-05,01/08/20,2020-01-10,29/05/20,08/01/21,"Hospital de Especialidades Dr. Teodoro Maldonado Carbo, Guayaquil",Ecuador,Respiratory Diseases,1,7,-86.0
4773.0,NCT04693975,Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases,,Recruiting,Chronic Obstructive Pulmonary Disease,Idiopathic Pulmonary Fibrosis,Asthma Chronic,,,,,,Universidade Estadual de Londrina,All,"Child, Adult, Older Adult",94.0,Other,Observational,2020-10-16,01/10/22,2022-01-10,05/01/21,05/01/21,"Laboratory of Reasearch in Respiratory Physiotherapy, State University of Londrina, Londrina, Paraná",Brazil,Others,0,3,451.0
4774.0,NCT04704544,Effectiveness of Tele-rheumatology for Delivering High Quality Rheumatology Care During the COVID-19 Crisis (EVOLVE),,Not yet recruiting,Rheumatic Diseases,,,,,,,Other: Tele-rheumatology,"University of Alabama at Birmingham|University of California, San Francisco|Tulane University",All,"18 Years and older   (Adult, Older Adult)",320.0,Other,Interventional,2021-01-03,30/11/22,2022-11-30,11/01/21,17/02/21,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Others,0,1,696.0
4775.0,NCT04444557,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,COST-HD,Completed,Depression,Hemodialysis,,,,,,Other: Beck Depression Inventory (BDI),Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",97.0,Other,Observational,2020-04-17,01/05/20,2020-01-05,23/06/20,23/06/20,"Sisli Hamidiye Etfal Training and Research Hospital, Istanbul",Turkey,Mental Health,1,2,-103.0
4776.0,NCT04686760,Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients,,Recruiting,Corona Virus Infection,,,,,,,Drug: Nitroglycerin,University of Lahore,All,"Child, Adult, Older Adult",30.0,Other,Interventional,2020-11-15,15/01/21,2021-01-15,29/12/20,29/12/20,"Bahria Town International Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,61.0
4777.0,NCT04350710,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Other: PEEP trial,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-03-18,20/04/20,2020-12-31,17/04/20,17/04/20,"CHU, Angers",France,Respiratory Diseases,1,2,288.0
4778.0,NCT04342208,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,,Not yet recruiting,Musculoskeletal Pain,,,,,,,,Istanbul University-Cerrahpasa,All,"18 Years to 65 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-10-04,01/06/20,2020-01-07,10/04/20,10/04/20,,,Others,0,1,-271.0
4779.0,NCT04443699,Predictors of Mental Well-being During the COVID-19 Pandemic,,Not yet recruiting,Mental Well-being,,,,,,,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,23/06/20,,,Others,0,1,21.0
4780.0,NCT04679168,Study on Kidney Disease and EnviromenTal Chemical,,Recruiting,COVID-19,Environmental Exposure,Chronic Kidney Diseases,,,,,,Seoul National University Hospital,All,"19 Years and older   (Adult, Older Adult)",310.0,Other,Observational,2020-01-06,31/12/21,2021-12-31,22/12/20,23/12/20,"Seoul National University Boramae Medical Center, Seoul, Korea",Republic of,Respiratory Diseases,1,3,725.0
4781.0,NCT04327479,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,,Recruiting,Cardiovascular Diseases,Cardiovascular Risk Factor,SARS,,,,,Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors,"University Hospital, Essen",All,"18 Years and older   (Adult, Older Adult)",728.0,Other,Observational,2020-03-26,25/03/26,2026-03-25,31/03/20,27/04/20,"University Hospital Essen, Essen, NRW",Germany,Others,0,3,2190.0
4782.0,NCT04424082,External Dead Space in Ventilated COVID-19 Patients,,Recruiting,Coronavirus,"ARDS, Human",,,,,,Other: Removal of dead space filter,"Karolinska Institutet|Stockholm County Council, Sweden",All,"Child, Adult, Older Adult",40.0,Other,Interventional,2020-09-06,07/11/20,2020-07-11,09/06/20,12/11/20,"Karolinska University Hospital, Stockholm",Sweden,Respiratory Diseases,1,2,-57.0
4783.0,NCT04682561,STEP: Building Trauma Resilience Among Nurses and Personal Support Workers During COVID-19,,Not yet recruiting,Stress,Trauma,Mental Health Issue,Healthcare Workers,,,,Behavioral: Supportive Trauma Exposure Preparation Program,Unity Health Toronto|Providence Healthcare,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-01,01/01/22,2022-01-02,23/12/20,23/12/20,"St. Michael's Hospital, Toronto, Ontario",Canada,Mental Health,1,4,366.0
4784.0,NCT04363606,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,FatCovid-19,Recruiting,Chronic Fatigue Syndrome,Intensive Care Unit,Muscle,,,,,Other: Questionnaires|Biological: blood test|Other: Maximal effort test|Device: actigraphy|Device: Neuromuscular evaluation|Other: stool analysis|Other: food diary,Centre Hospitalier Universitaire de Saint Etienne|University of Saint-Etienne|Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques,All,"35 Years to 80 Years   (Adult, Older Adult)",82.0,Other,Interventional,2020-05-27,01/04/21,2021-01-12,27/04/20,26/02/21,"CHU de Grenoble, Grenoble, France|Clinique de la Sauvegarde - Lyon, Lyon, France|Hôpital Croix Rousse - HCL, Lyon, France|Centre Hospitalier de Lyon Sud, Pierre-benite, France|Chu Saint-Etienne, Saint Etienne, France|Clinique Mutualiste Saint Etienne, Saint Etienne, France|Hôpital Henry Gabrielle, Saint-Genis-Laval, France|Hôpital privé de la Loire, Saint-Étienne",France,Others,0,3,230.0
4785.0,NCT04595175,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),CONSERVE-HCW,Recruiting,COVID-19,,,,,,,,"Brian Tiffany, MD|Chandler Regional Medical Center|Arizona General Hospital|Mercy Gilbert Medical Center|St. Joseph's Hospital and Medical Center, Phoenix",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-10-06,30/06/21,2021-12-30,20/10/20,20/10/20,"Chandler Regional Medical Center, Chandler, Arizona",United States,Respiratory Diseases,1,1,450.0
4786.0,NCT04261426,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,,Not yet recruiting,COVID-19,,,,,,,Drug: Intravenous Immunoglobulin|Other: Standard care,"Peking Union Medical College Hospital|Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-10-02,30/04/20,2020-06-30,07/02/20,07/02/20,,,Respiratory Diseases,1,1,-94.0
4787.0,NCT04501445,Psychological Symptoms and Families of COVID-19 Patients,,Recruiting,Family Members,Post Intensive Care Unit Syndrome,Post Traumatic Stress Disorder,,,,,Behavioral: Written Summary of Rounds,Rush University Medical Center|Central Michigan University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-14,01/08/21,2021-09-15,06/08/20,15/01/21,"Rush University Medical Center, Chicago, Illinois",United States,Mental Health,1,3,366.0
4788.0,NCT04476979,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,TOCIDEX,Recruiting,Coronavirus Infection,SARS (Severe Acute Respiratory Syndrome),Virus Diseases,Coronaviridae Infections,Nidovirales Infections,RNA Virus Infections,Respiratory Tract Infections,Drug: Tocilizumab|Drug: Dexamethasone,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-07-16,31/03/21,2021-12-31,20/07/20,18/08/20,"CH Andrée Rosemon, Cayenne",French Guiana,Respiratory Diseases,1,7,533.0
4789.0,NCT04319172,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,COVIDSOT,Recruiting,Transplant Recipient,"Infections, Coronavirus",,,,,,,Fundación Pública Andaluza para la gestión de la Investigación en Sevilla|Spanish Network for Research in Infectious Diseases|Grupo de Estudio de la Infección en el Trasplante (GESITRA),All,"16 Years and older   (Child, Adult, Older Adult)",50.0,Other,Observational,2020-12-03,01/03/21,2021-01-04,24/03/20,08/07/20,"Hospital Universitario Virgen del Rocio, Seville",Spain,Respiratory Diseases,1,2,32.0
4790.0,NCT04404608,Etiology of Lymphopenia in Covid19 Infection,,Not yet recruiting,Lymphopenia,,,,,,,"Diagnostic Test: Complete blood picture, bone marrow aspiration cytology",Dr Medhat Khafagy|Cairo University,All,"Child, Adult, Older Adult",90.0,Other,Observational,2020-01-06,01/06/21,2021-01-12,27/05/20,27/05/20,,,Others,0,1,372.0
4791.0,NCT04425005,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,,Completed,Bariatric Surgery,Obesity,,,,,,Other: Home-based exercise,University of Sao Paulo,All,"18 Years to 80 Years   (Adult, Older Adult)",55.0,Other,Interventional,2020-10-05,07/12/20,2020-07-12,11/06/20,22/01/21,"Univsersity of Sao Paulo, Sao Paulo",Brazil,Metabolic Disorders,1,2,-85.0
4792.0,NCT04548544,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,,Completed,Healthy,,,,,,,"Behavioral: Training for Awareness, Resilience, and Action (TARA)","University of California, San Francisco",All,"14 Years to 18 Years   (Child, Adult)",21.0,Other,Interventional,2019-10-18,20/05/20,2020-05-20,14/09/20,14/09/20,"UCSF, San Francisco, California",United States,Others,0,1,215.0
4793.0,NCT04342728,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,COVIDAtoZ,Completed,COVID-19,Corona Virus Infection,,,,,,Dietary Supplement: Ascorbic Acid|Dietary Supplement: Zinc Gluconate|Dietary Supplement: Ascorbic Acid and Zinc Gluconate|Other: Standard of Care,The Cleveland Clinic,All,"18 Years and older   (Adult, Older Adult)",214.0,Other,Interventional,2020-08-04,30/12/20,2021-11-02,13/04/20,16/02/21,"Cleveland Clinic, Weston, Florida, United States|Cleveland Clinic, Cleveland, Ohio",United States,Respiratory Diseases,1,2,455.0
4794.0,NCT04635618,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,,Enrolling by invitation,Mental Disorder,COVID-19,Emotional Distress,Depression,Anxiety,Irritable Mood,,Behavioral: Cognitive Behavioral Brief-Telepsychotherapy|Behavioral: Brief Interpersonal Telepsychotherapy|Behavioral: Telepsychoeducation,Hospital de Clinicas de Porto Alegre,All,"Child, Adult, Older Adult",999.0,Other,Interventional,2020-05-11,13/07/21,2021-07-20,19/11/20,19/11/20,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,"Mental Health, Respiratory Diseases",1,6,435.0
4795.0,NCT04341714,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,,Recruiting,"Efficacy, Self","Satisfaction, Patient",Telemedicine,,,,,Other: Satisfaction evaluation,Pierre and Marie Curie University,All,"18 Years and older   (Adult, Older Adult)",450.0,Other,Observational,2020-03-16,30/05/20,2020-06-15,10/04/20,27/05/20,"Department of Neuro- Urology, Hôpital Tenon, Paris",France,Others,0,3,91.0
4796.0,NCT04659252,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19),,Recruiting,Multiple Myeloma,,,,,,,Other: n/a - samples collected along routine care samples only,"Institute of Cancer Research, United Kingdom|Royal Marsden NHS Foundation Trust",All,"21 Years and older   (Adult, Older Adult)",70.0,Other,Observational,2021-04-03,01/12/21,2021-01-12,09/12/20,11/03/21,"The Royal Marsden NHS Foundation Trust, Sutton",United Kingdom,Others,0,1,-81.0
4797.0,NCT04357782,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,AVoCaDO,Completed,COVID-19,Hypoxia,,,,,,Drug: L-ascorbic acid,Hunter Holmes Mcguire Veteran Affairs Medical Center|McGuire Research Institute,All,"18 Years to 99 Years   (Adult, Older Adult)",20.0,U.S. Fed|Other,Interventional,2020-04-16,13/10/20,2020-10-13,22/04/20,23/12/20,"Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond, Virginia",United States,Respiratory Diseases,1,2,180.0
4798.0,NCT04414371,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,,Recruiting,Stress,Anxiety,Depression,Resilience,Wellbeing,Mood,,Other: Yoga,"Rutgers, The State University of New Jersey|Harvard Medical School",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-05-20,31/12/20,2020-12-31,04/06/20,04/06/20,"Rutgers University, New Brunswick, New Jersey",United States,Mental Health,1,6,225.0
4799.0,NCT04357041,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",CoVS,"Active, not recruiting","ALL, Adult",,,,,,,,"Clinical Nutrition Research Center, Illinois Institute of Technology",All,"18 Years and older   (Adult, Older Adult)",500.0,Industry,Observational,2020-04-17,01/04/21,2021-01-12,22/04/20,26/01/21,"Clinical Nutrition Research Center, Chicago, Illinois",United States,Others,0,1,270.0
4800.0,NCT04344964,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,,Completed,Colon Polyp,Colon Disease,"Reflux, Gastroesophageal","Varices, Esophageal",,,,Other: None - NA,Austin Health,All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Observational,2020-04-15,29/05/20,2020-03-07,14/04/20,09/07/20,"Austin Health, Melbourne, Victoria",Australia,Others,0,4,-39.0
4801.0,NCT04333849,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,TOVID-49,Completed,Coronavirus,,,,,,,,"University Hospital, Angers",All,70 Years and older   (Older Adult),132.0,Other,Observational,2020-03-25,11/05/20,2020-11-05,03/04/20,20/07/20,"Angers University Hospital, Angers",France,Respiratory Diseases,1,1,225.0
4802.0,NCT04738721,Physical Activity and Physical Fitness Parameters in COVID-19 Quarantine,,Recruiting,"Assessment, Self",,,,,,,Behavioral: Evaluation,Medipol University,All,18 Years to 22 Years   (Adult),87.0,Other,Observational,2021-05-02,05/04/21,2021-04-15,04/02/21,19/03/21,"Istanbul Medipol University, Istanbul",Turkey,Others,0,1,-17.0
4803.0,NCT04678843,Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond,vFBT,Enrolling by invitation,Anorexia Nervosa,,,,,,,Behavioral: Virtual Family-Based Treatment,Jennifer Couturier|McMaster University,All,"10 Years to 18 Years   (Child, Adult)",36.0,Other,Interventional,2021-09-02,01/10/21,2021-01-12,22/12/20,02/03/21,"Southlake Regional Health Centre, Newmarket, Ontario, Canada|St. Joseph's Care Group, Thunder Bay, Ontario, Canada|North York General Hospital, Toronto, Ontario, Canada|CMHA Waterloo Wellington, Waterloo, Ontario",Canada,Others,0,1,-233.0
4804.0,NCT04842747,VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study,VERU-111,Not yet recruiting,SARS-CoV Infection,,,,,,,Drug: VERU-111,Veru Inc.,All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Industry,Interventional,2021-04-30,05/01/22,2022-03-19,13/04/21,13/04/21,"Honor Health, Scottsdale, Arizona, United States|Inspira Medical Center Mullica Hill, Mullica Hill, New Jersey, United States|Inspira Medical Center, Vineland, New Jersey, United States|HD Research (Memorial Hermann - Memorial City Medical Center), Houston, Texas, United States|HD Research (Memorial Hermann Southeast Hospital), Houston, Texas, United States|Clinical Trial Network, Houston, Texas, United States|Hospital del Bicentenario de Esteban Echeverría, Monte Grande, Argentina|Hospital Universitário São Francisco na Providencia de Deus, Bragança Paulista, Brazil|IPECC (Instituto De Pesquisa Clínica de Campinas), Campinas, Brazil|Sociedade Hospital Angelina Caron, Campinas, Brazil|Hospital de Clínicas de Porto Alegre - Infectologia - Centro de Pesquisa Clínica, Porto Alegre, Brazil|Hospital Universitario Cementino Fraga Filho, Rio De Janeiro, Brazil|Clínica de Alergia Martti Antila S/S LTDA, Sorocaba, Brazil|Fundação Faculdade Regional de Medicina de São José do Rio Preto, São Paulo, Brazil|Unidad Médica para la Salud Integral (UMSI), Monterrey, Mexico|Hospital General de Occidente, Zapopan",Mexico,Respiratory Diseases,1,1,323.0
4805.0,NCT04385797,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,CONNECTDEM,"Active, not recruiting",Mild Cognitive Impairment,Dementia,,,,,,Other: Telephone interview,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud,All,"55 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-04-05,31/12/20,2020-12-31,13/05/20,04/12/20,"Instituto de Investigacion Biomedica de Malaga-IBIMA, Málaga",Spain,Others,0,2,270.0
4806.0,NCT04609332,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,,Recruiting,COVID-19,Angiogenesis,Endothelial Dysfunction,Cardiovascular Morbidity,,,,Diagnostic Test: Endothelial damage and angiogenic biomarkers,University of Chile,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-10-11,01/08/21,2021-01-11,30/10/20,13/11/20,"Hospital Clínico de la Universidad de Chile, Independencia, Santiago",Chile,Respiratory Diseases,1,4,92.0
4807.0,NCT04517006,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,,Not yet recruiting,Happiness,Anxiety,Depression,Morality,,,,Behavioral: Self-focused acts|Behavioral: Prosocial acts,University of Toronto,All,"18 Years and older   (Adult, Older Adult)",1542.0,Other,Interventional,2021-01-01,01/03/21,2021-01-03,18/08/20,07/01/21,,,Mental Health,1,4,2.0
4808.0,NCT04395430,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,,Recruiting,Pediatric Obesity,Clinical Trial,,,,,,Behavioral: Usual Care|Behavioral: online KKH Sports Singapore Program with Usual Care,"KK Women's and Children's Hospital|Duke University|Duke-NUS Graduate Medical School|Sport Singapore|Health Promotion Board, Singapore",All,4 Years to 7 Years   (Child),40.0,Other,Interventional,2020-09-18,01/06/21,2021-01-10,20/05/20,21/02/21,"KK Women's and Children's Hospital, Singapore",Singapore,Metabolic Disorders,1,2,114.0
4809.0,NCT04400799,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,,Recruiting,COVID-19,"Pulmonary Embolism, Deep Vein Thrombosis",,,,,,Drug: Enoxaparin 40Mg/0.4Ml Inj Syringe 0.4Ml,"University of Zurich|University Hospital Inselspital, Berne|University Hospital, Geneva|Centre Hospitalier Universitaire Vaudois|University Hospital, Basel, Switzerland|Oncology Institute of Southern Switzerland|Clinica Luganese Moncucco",All,"50 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-06-15,14/03/21,2021-04-14,26/05/20,16/07/20,"University Hospital Basel, Basel, Switzerland|Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland|University Hospital Bern, Bern, Switzerland|Hôpitaux Universitaires Genève, Geneva, Switzerland|Centre hospitalier universitaire vaudois, Lausanne, Switzerland|Clinica Luganese Moncucco, Lugano, Switzerland|University hospital zurich, Zürich",Switzerland,Respiratory Diseases,1,2,303.0
4810.0,NCT04815057,The Effects of Wellness Training Given to Fifth Grade Students During the Covid-19 Epidemic Period,,Completed,Health Behavior,,,,,,,Behavioral: Wellness Education,Sumeyra Yılmaz|Saglik Bilimleri Universitesi,All,"Child, Adult, Older Adult",176.0,Other,Interventional,2020-02-11,23/11/20,2021-08-03,24/03/21,14/04/21,"Second School, Kırşehir",Turkey,Others,0,1,539.0
4811.0,NCT04534400,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,QUANTICO-RETRO,Recruiting,COVID-19,Respiratory Failure With Hypoxia,,,,,,Radiation: thoracic CT-scan,"University Hospital, Strasbourg, France|VISIBLE PATIENT, E-MEDIA",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-09,15/01/21,2021-01-15,01/09/20,03/09/20,"GHR MULHOUSE-SUD ALSACE, Hôpital Emile Muller, Service de Radiologie, Mulhouse, France|HÔPITAUX UNIVERSITAIRES DE STRASBOURG, Hôpital de Hautepierre, Service de Réanimation Médicale, Strasbourg",France,Respiratory Diseases,1,2,372.0
4812.0,NCT04605588,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,TriACT,Recruiting,SARS-CoV Infection,COVID-19,,,,,,Drug: Nitazoxanide|Drug: Placebo Nitazoxanide|Drug: Ribavirin|Drug: Placebo Ribavirin|Drug: Hydroxychloroquine|Drug: Placebo Hydroxychloroquine,"Rutgers, The State University of New Jersey|SynaVir",All,"21 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-02-12,01/04/21,2021-01-04,28/10/20,07/12/20,"Robert Wood Johnson Medical School, New Brunswick, New Jersey",United States,Respiratory Diseases,1,2,327.0
4813.0,NCT04799704,Tear Film SARS-nCoV-2 Detection in Symptomatic and Pauci-symptomatic Patients.,Eye-Covid,Completed,COVID-19,Eye Diseases,,,,,,Diagnostic Test: swabbing of conjunctiva,Universitaire Ziekenhuizen Leuven,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-11-09,13/12/20,2020-12-13,16/03/21,16/03/21,"UZ Leuven, Leuven, Vlaams Brabant",Belgium,Respiratory Diseases,1,2,34.0
4814.0,NCT04548492,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,,Not yet recruiting,the Use of Modern Technology Applications in Home Isolation,,,,,,,Other: Survey,Ain Shams University,All,"35 Years and older   (Adult, Older Adult)",175.0,Other,Observational,2020-09-14,01/12/20,2021-01-01,14/09/20,14/09/20,,,Others,0,1,109.0
4815.0,NCT04254874,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",,Recruiting,COVID-19,,,,,,,Drug: Abidol hydrochloride|Drug: Abidol Hydrochloride combined with Interferon atomization,Tongji Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-02,01/06/20,2020-01-07,05/02/20,17/03/20,"Department and Institute of Infectious Disease, Wuhan, Hubei",China,Respiratory Diseases,1,1,5.0
4816.0,NCT04342650,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,CloroCOVID19II,Completed,COVID-19,SARS-CoV Infection,Severe Acute Respiratory Syndrome (SARS) Pneumonia,Clinical Trial,,,,Drug: Chloroquine Diphosphate|Drug: Placebo oral tablet,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,All,"18 Years and older   (Adult, Older Adult)",152.0,Other,Interventional,2020-08-04,14/05/20,2020-08-06,13/04/20,07/07/20,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas",Brazil,Respiratory Diseases,1,4,2.0
4817.0,NCT04482595,BIO 300 Oral Suspension in Discharged COVID-19 Patients,,Recruiting,Pulmonary Fibrosis,,,,,,,Drug: BIO 300 Oral Suspension|Drug: Placebo,Humanetics Corporation|NYU Langone Health|National Institute of Allergy and Infectious Diseases (NIAID),All,"18 Years and older   (Adult, Older Adult)",66.0,Industry|Other|NIH,Interventional,2020-11-11,01/08/21,2022-01-05,22/07/20,25/01/21,"NYU Langone Health, New York, New York",United States,Others,0,1,420.0
4818.0,NCT04819282,Mask Usage and Physical Performance During COVID-19 Pandemic in Geriatrics,,Completed,Exercise Capacity,Geriatric,Mask,,,,,Diagnostic Test: Senior Fitness Test,KTO Karatay University,All,65 Years to 85 Years   (Older Adult),46.0,Other,Observational,2020-10-09,30/12/20,2021-02-17,26/03/21,01/04/21,"KTO Karatay University, Konya, Karatay",Turkey,Others,0,3,131.0
4819.0,NCT04363047,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",,Enrolling by invitation,SARS Virus,,,,,,,Other: 40ml blood sample,University of Manchester,All,"18 Years and older   (Adult, Older Adult)",125.0,Other,Observational,2020-01-10,01/05/21,2021-01-05,27/04/20,05/11/20,"Universit of Manchester, Manchester, Greater Manchester",United Kingdom,Others,0,1,361.0
4820.0,NCT04261270,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",,Recruiting,COVID-19,,,,,,,Drug: ASC09F+Oseltamivir|Drug: Ritonavir+Oseltamivir|Drug: Oseltamivir,Tongji Hospital,All,18 Years to 55 Years   (Adult),60.0,Other,Interventional,2020-01-02,01/05/20,2020-01-07,07/02/20,17/03/20,"Department and Institute of Infectious Disease, Wuhan, Hubei",China,Respiratory Diseases,1,1,5.0
4821.0,NCT04332042,TOFAcitinib in SARS-CoV2 Pneumonia,,Not yet recruiting,SARS-COv2 Related Interstitial Pneumonia,,,,,,,Drug: Tofacitinib,Università Politecnica delle Marche,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-10-04,20/06/20,2020-10-07,02/04/20,02/04/20,"Ospedali Riuniti di Ancona, Ancona, Marche",Italy,Respiratory Diseases,1,1,3.0
4822.0,NCT04369378,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,,Recruiting,Anxiety,Well-being,,,,,,Behavioral: Meditation app usage,Lake Erie College of Osteopathic Medicine,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-08-19,28/02/21,2021-04-30,30/04/20,13/11/20,"LECOM, Erie, Pennsylvania",United States,Mental Health,1,2,254.0
4823.0,NCT04337151,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,,Recruiting,MAGEC Rod,,,,,,,Device: MAGEC Spine Rod|Diagnostic Test: Titanium blood test,Royal National Orthopaedic Hospital NHS Trust,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-01-04,01/01/21,2021-01-03,07/04/20,07/04/20,"Royal National Orthopaedic Hospital, Stanmore",United Kingdom,Others,0,1,365.0
4824.0,NCT04384965,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,,Recruiting,Major Depressive Disorder,,,,,,,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",Centre for Addiction and Mental Health,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-12-05,01/05/22,2022-01-11,12/05/20,15/02/21,"CAMH, Toronto, Ontario",Canada,Others,0,1,402.0
4825.0,NCT04524598,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,,Recruiting,Depression,,,,,,,Device: Limbix Spark|Other: Psychoeducation,"Limbix Health, Inc.",All,"13 Years to 21 Years   (Child, Adult)",410.0,Industry,Interventional,2020-07-20,31/12/20,2020-12-31,24/08/20,18/09/20,"Limbix Health, Inc., San Francisco, California",United States,Mental Health,1,1,164.0
4826.0,NCT04442217,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,,Not yet recruiting,Adherence to WHO-advised Hygiene-related Behavior,Adherence to Viral Mitigation Protocols,,,,,,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,23/06/20,,,Others,0,2,21.0
4827.0,NCT04427137,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,,Recruiting,Bipolar Depression,,,,,,,"Device: MagPro X100 Stimulator, B70 Fluid-Cooled Coil",Centre for Addiction and Mental Health,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-09-06,01/06/22,2022-01-12,11/06/20,23/06/20,"CAMH, Toronto, Ontario",Canada,Mental Health,1,1,493.0
4828.0,NCT04326426,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,,Enrolling by invitation,Coronavirus Infection,,,,,,,Drug: Tradipitant|Drug: Placebo,Vanda Pharmaceuticals,All,"18 Years to 90 Years   (Adult, Older Adult)",300.0,Industry,Interventional,2020-04-13,01/08/20,2020-08-31,30/03/20,20/04/20,"Lenox Hill Hospital Northwell Health, New York, New York",United States,Respiratory Diseases,1,1,140.0
4829.0,NCT04351906,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,,Recruiting,ARDS,Hypercapnic Respiratory Failure,AKI,,,,,Device: ECCO2R,University of Giessen,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-03-05,01/06/21,2021-01-10,17/04/20,30/09/20,"University Hospital Giessen and Marburg, Giessen, Giessen, Hessen",Germany,Respiratory Diseases,1,3,311.0
4830.0,NCT04556630,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,CONFIN-AMP,Not yet recruiting,Assisted Reproduction,,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Observational,2020-01-10,01/12/20,2020-01-12,21/09/20,21/09/20,,,Others,0,1,2.0
4831.0,NCT04682574,Role of Mega Dose of Vitamin C in Critical COVID-19 Patients,,Recruiting,Corona Virus Infection,,,,,,,Drug: Vitamin C,University of Lahore,All,"Child, Adult, Older Adult",15.0,Other,Interventional,2020-02-11,30/12/20,2021-10-01,23/12/20,28/12/20,"Bahria Town International Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,598.0
4832.0,NCT04255017,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",,Recruiting,COVID-19,,,,,,,Drug: Abidol hydrochloride|Drug: Oseltamivir|Drug: Lopinavir/ritonavir,Tongji Hospital,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2020-01-02,01/06/20,2020-01-07,05/02/20,17/03/20,"Department and Institute of Infectious Disease, Wuhan, Hubei",China,Respiratory Diseases,1,1,5.0
4833.0,NCT04666779,Access to Chiropractic Care During the COVID-19 Pandemic,,"Active, not recruiting",Access to Chiropractic Care Services,,,,,,,Other: Chiropractic care,Real Centro Universitario Maria Cristina|University of Birmingham|Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz|Université du Québec à Trois-Rivières,All,"16 Years and older   (Child, Adult, Older Adult)",399.0,Other,Observational,2020-12-18,21/02/21,2021-02-28,14/12/20,09/03/21,"Real Centro Universitario María Cristina, San Lorenzo De El Escorial, Madrid",Spain,Others,0,1,72.0
4834.0,NCT04516837,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),,Recruiting,Immune Thrombocytopenia,,,,,,,Drug: Eltrombopag|Drug: rhTPO,Peking University People's Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-08-31,01/08/21,2022-01-08,18/08/20,01/09/20,"Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing",China,Others,0,1,495.0
4835.0,NCT04472559,Acupressure for COVID-19 Related Quality of Life and Stress,,Not yet recruiting,Quality of Life,Stress,,,,,,Behavioral: Self-acupressure,"University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-12-25,25/01/21,2021-02-25,15/07/20,04/11/20,,,Mental Health,1,2,62.0
4836.0,NCT02735707,"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia",REMAP-CAP,Recruiting,COVID-19,,,,,,,Drug: Fixed-duration Hydrocortisone|Drug: Shock-dependent hydrocortisone|Drug: Ceftriaxone|Drug: Moxifloxacin or Levofloxacin|Drug: Piperacillin-tazobactam|Drug: Ceftaroline|Drug: Amoxicillin-clavulanate|Drug: Macrolide administered for 3-5 days|Drug: Macrolide administered for up to 14 days|Drug: Five-days oseltamivir|Drug: Ten-days oseltamivir|Drug: Lopinavir/ritonavir|Drug: Hydroxychloroquine|Drug: Hydroxychloroquine + lopinavir/ritonavir|Drug: Interferon-β1a|Drug: Anakinra|Drug: Fixed-duration higher dose Hydrocortisone|Drug: Tocilizumab|Drug: Sarilumab|Drug: Vitamin C|Drug: Therapeutic anticoagulation|Drug: Simvastatin|Biological: Convalescent plasma|Other: Protocolised mechanical ventilation strategy|Drug: Eritoran|Drug: Apremilast|Drug: Aspirin|Drug: Clopidogrel|Drug: Prasugrel|Drug: Ticagrelor,MJM Bonten|Australian and New Zealand Intensive Care Research Centre|Medical Research Institute of New Zealand|Unity Health|Berry Consultants|Global Coalition for Adaptive Research|University of Pittsburgh Medical Center|UMC Utrecht,All,"18 Years and older   (Adult, Older Adult)",7100.0,Other,Interventional,2016-11-04,01/12/21,2023-01-12,13/04/16,12/10/20,"University of Pittsburgh Medical Centre, Pittsburgh, Pennsylvania, United States|St Vincent's Hospital Sydney, Sydney, New South Wales, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, Australia|Royal North Shore Hospital, Sydney, New South Wales, Australia|Nepean Hospital, Sydney, New South Wales, Australia|Wollongong Hospital, Sydney, New South Wales, Australia|Royal Darwin Hospital,, Darwin, Northern Territory, Australia|Sunshine Coast University Hospital, Birtinya, Queensland, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Logan Hospital, Brisbane, Queensland, Australia|Toowoomba Hospital, Toowoomba, Queensland, Australia|The Queen Elizabeth Hospital, Adelaide, South Australia, Australia|Bendigo Hospital, Bendigo, Victoria, Australia|University Hosptial Geelong, Geelong, Victoria, Australia|The Alfred Hospital, Melbourne, Victoria, Australia|Royal Melbourne Hospital, Melbourne, Victoria, Australia|St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia|Royal Perth Hospital, Perth, Western Australia, Australia|Sir Charles Gairdner Hospital, Perth, Western Australia, Australia|St John of God Hospital Midland, Perth, Western Australia, Australia|Fiona Stanley Hospital, Perth, Western Australia, Australia|St John of God Hospital Murdoch, Perth, Western Australia, Australia|AZ Sint-Jan, Brugge, Belgium|CHU de Charleroi - Hôpital Civil Marie Curie, Charleroi, Belgium|Universitair Ziekenhuis Antwerp, Edegem, Belgium|Universitair Ziekenhuis Gent, Gent, Belgium|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Centre Hospitalier de l'Université de Sherbrooke, Sherbrooke, Canada|St. Michael's Hospital Unity Health Toronto, Toronto, Canada|General County Hospital Požega, Požega, Croatia|University Hospital Centre Zagreb, Zagreb, Croatia|University Hospital for Infectious Diseases, Zagreb, Croatia|Charité - Universitätsmedizin Berlin - Infektiologie und Pneumologie, Berlin, Germany|Charité - Universitätsmedizin Berlin - Nephrologie, Berlin, Germany|Vivantes Klinikum Neukölln, Berlin, Germany|Universitätsklinikum Köln, Cologne, Germany|Universitätsklinikum Frankfurt, Frankfurt, Germany|University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Jena, Jena, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Universitäts Klinikum Tübingen, Tübingen, Germany|Universitätsklinikum Würzburg, Würzburg, Germany|Jósa András County Hospital, Nyíregyháza, Hungary|Csolnoky Ferenc Kórház - Veszprem County Hospital, Veszprém, Hungary|Almási Balogh Pál Kórház, Ózd, Hungary|Beaumont Hospital, Dublin, Ireland|St. Vincent's University Hospital, Dublin, Ireland|University Hospital Galway, Galway, Ireland|Meander Medisch Centrum, Amersfoort, Netherlands|Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands|Martini Hospital Groningen, Groningen, Netherlands|University Medical Center Groningen, Groningen, Netherlands|Leiden University Medical Center, Leiden, Netherlands|Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands|Radboud University Medical Center, Nijmegen, Netherlands|University Medical Center Utrecht, Utrecht, Netherlands|North Shore Hospital, Auckland, New Zealand|CVICU, Auckland City Hospital, Auckland, New Zealand|DCCM, Auckland City Hospital, Auckland, New Zealand|Middlemore Hospital, Auckland, New Zealand|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Rotorua Hospital, Rotorua, New Zealand|Tauranga Hospital, Tauranga, New Zealand|Wellington Regional Hospital, Wellington, New Zealand|Whangarei Hospital, Whangarei, New Zealand|Centro Hospitalar do Medio Tejo, Abrantes, Portugal|Hospital Lusíadas Lisbon, Lisboa, Portugal|Clinical Hospital of Infectious and Tropical Diseases Dr. Victor Babes, Bucharest, Romania|Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain|Hospital Universitario Reina Sofia, Córdoba, Spain|Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom|Southmead Hospital, Bristol, United Kingdom|University Hospital Coventry, Coventry, United Kingdom|Darlington Memorial Hospital, Darlington, United Kingdom|University Hospital of North Durham, Durham, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Maidstone Hospital - Maidstone and Tunbridge Wells NHS Trust, Maidstone, United Kingdom|The James Cook University Hospital, Middlesbrough, United Kingdom|Milton Keynes University Hospital, Milton Keynes, United Kingdom|Northampton General Hospital, Northampton, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Poole Hospital NHS Foundation Trust, Poole, United Kingdom|Queen Alexandra Hospital - Portsmouth Hospitals NHS Trust, Portsmouth, United Kingdom|Royal Berkshire Hospital, Reading, United Kingdom|University Hospital of North Tees, Stockton-on-Tees, United Kingdom|Royal Cornwall Hospital, Truro, United Kingdom|Tunbridge Wells Hospital - Maidstone and Tunbridge Wells NHS Trust, Tunbridge Wells, United Kingdom|York Hospital, York",United Kingdom,Respiratory Diseases,1,1,2260.0
4837.0,NCT04803812,Supporting the Wellness of Ontario Physicians During COVID-19,,Recruiting,Mental Health Wellness 1,Anxiety,Happiness,,,,,"Other: Remote SMS (short message service, also known as ""text message"") delivery",Ontario Medical Association|The Behavioural Insights Team,All,"Child, Adult, Older Adult",19000.0,Other,Interventional,2021-01-26,04/05/21,2021-04-05,18/03/21,18/03/21,"Ontario Medical Association, Toronto, Ontario",Canada,Mental Health,1,3,69.0
4838.0,NCT04370886,Recruit Blood Donors Via SMS During Epidemic of COVID-19,,Completed,Blood Donation,,,,,,,Behavioral: blood donation SMS,Guangzhou Blood Center,All,18 Years to 60 Years   (Adult),456517.0,Other,Interventional,2020-04-30,30/04/20,2020-10-05,01/05/20,01/06/20,"Guangzhou Blood Center, Guangzhou, Guangdong",China,Others,0,1,158.0
4839.0,NCT04645368,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19",,Recruiting,"Fibroses, Pulmonary",,,,,,,Drug: bovhyaluronidase azoxymer,NPO Petrovax,All,"18 Years and older   (Adult, Older Adult)",160.0,Industry,Observational,2020-01-07,01/04/21,2021-01-07,27/11/20,27/11/20,"Federal State Budgetary Educational Institution of Higher Education Astrakhan State Medical University of the Ministry of Health of the Russian Federation, Astrakhan, Astrakhan Region, Russian Federation|Municipal autonomous health care institution City Clinical Polyclinic No. 8, Chelyabinsk, Chelyabinsk Region, Russian Federation|State Budgetary Healthcare Institution Regional Clinical Hospital No. 3, Chelyabinsk, Chelyabinsk Region, Russian Federation|Municipal budgetary institution Central city clinical hospital number 6 , Ekaterinburg, Ekaterinburg Region, Russian Federation|Medical center Clinic South, Krasnodar, Krasnodar Region, Russian Federation|Federal State Budgetary Scientific Institution Federal Research Center Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences  Scientific Research Institute of Medical Problems of the North, Krasnoyarsk, Krasnoyarsk Region, Russian Federation|Institute of Clinical Immunology LLC, Krasnoyarsk, Krasnoyarsk Region, Russian Federation|St. Petersburg State Budgetary Healthcare Institution City Consultative and Diagnostic Center No. 1, Saint Petersburg, Leningrad Region, Russian Federation|State Novosibirsk Regional Clinical Hospital, Novosibirsk, Novosibirsk Region, Russian Federation|CJSC Medical Center Philosophy of Beauty and Health , Perm, Perm Region, Russian Federation|State budgetary institution of health care Republican clinical hospital named after G.G. Kuvatova, Ufa, Ufa Region, Russian Federation|State health care institution Clinical Hospital No. 4, Volgograd, Volgograd Region, Russian Federation|Federal State Budgetary Educational Institution of Higher Education Volgograd State Medical University of the Ministry of Health of the Russian Federation Volgograd State Medical University of the Ministry of Health of Russia, Volgograd, Volgograd Region, Russian Federation|FSBI Main Military Clinical Hospital named after Academician N.N.Burdenko of the Ministry of Defense of the Russian Federation, Moscow, Russian Federation|State Budgetary Institution of Healthcare of the City of Moscow City Polyclinic No. 180 of the Department of Healthcare of the City of Moscow, Moscow",Russian Federation,Others,0,1,366.0
4840.0,NCT04652596,Reducing Food Insecurity During COVID-19,,Enrolling by invitation,Food Insecurity,,,,,,,Other: Produce prescription program|Other: Grocery store gift cards,Boston Medical Center|Patient-Centered Outcomes Research Institute|United States Department of Agriculture (USDA)|Krupp Family Foundation|Waldron Charitable Fund,All,"18 Years and older   (Adult, Older Adult)",250.0,Other|U.S. Fed,Interventional,2021-08-02,01/06/22,2022-01-10,03/12/20,11/02/21,"Boston Medical Center, Boston, Massachusetts",United States,Others,0,1,161.0
4841.0,NCT04274322,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,,"Active, not recruiting",Critically Ill,Coronavirus Infections,,,,,,Other: Nutrition support,"Peking University Third Hospital|School of Pharmaceutical Sciences, Peking University, Beijing, China|Department of Medicine, Queen's University, Kingston, Ontario, Canada",All,"18 Years and older   (Adult, Older Adult)",117.0,Other,Observational,2020-02-19,04/04/20,2020-01-07,18/02/20,08/04/20,"Peking University Third Hospital, Beijing",China,Respiratory Diseases,1,2,-43.0
4842.0,NCT04469621,A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,,Completed,Corona Virus Infection,,,,,,,Drug: SAR443122|Drug: Placebo,Sanofi,All,"18 Years to 80 Years   (Adult, Older Adult)",68.0,Industry,Interventional,2020-07-17,23/10/20,2020-10-23,14/07/20,13/11/20,"Investigational Site Number 0320001, Caba, Argentina|Investigational Site Number 0760003, Porto Alegre, Brazil|Investigational Site Number 0760001, São José Do Rio Preto, Brazil|Investigational Site Number 0760002, São Paulo, Brazil|Investigational Site Number 1520001, Santiago, Chile|Investigational Site Number 1520003, Santiago, Chile|Investigational Site Number 1520002, Talca, Chile|Investigational Site Number 4840001, Monterrey, Mexico|Investigational Site Number 6430001, Moscow, Russian Federation|Investigational Site Number 6430002, Moscow",Russian Federation,Respiratory Diseases,1,1,98.0
4843.0,NCT04384406,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,Handicall,Completed,Chronic Disabling,COVID-19,,,,,,,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",467.0,Other,Observational,2020-01-04,01/05/20,2020-09-05,12/05/20,21/05/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,245.0
4844.0,NCT04389333,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,,Completed,Gastrointestinal Disease,Infectious Disease,Capsule Endoscopy,,,,,Device: non-contact magnetically-controlled capsule endoscopy,Changhai Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-03-26,26/04/20,2020-05-20,15/05/20,21/07/20,"Changhai Hospital, Shanghai, Shanghai",China,Others,0,3,55.0
4845.0,NCT04457505,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,,Recruiting,Acute Respiratory Distress Syndrome,Severe Pneumonia,Respiratory Failure,,,,,,"Consorcio Centro de Investigación Biomédica en Red, M.P.|Barcelona Supercomputing Center|Carlos III Health Institute",All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-08-05,31/05/21,2021-05-31,07/07/20,07/07/20,"Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain|Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain|Hospital de Mataró, Mataró, Barcelona, Spain|Hospital General de Cataluña, Sant Cugat Del Vallès, Barcelona, Spain|Hospital Infanta Margarita de Cabra, Cabra, Córdoba, Spain|Hospital Universitario Lucus Augusti, Lugo, Galicia, Spain|Hospital Son Llatzer, Palma De Mallorca, Mallorca, Spain|Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Spain|Hospital Verge de la Cinta, Tortosa, Tarragona, Spain|Hospital Universitario Sant Joan d'Alacant, Alicante, Spain|Clínica Sagrada Família, Barcelona, Spain|Hospital Sagrat Cor, Barcelona, Spain|Hospital Universitari Vall d'Hebron, Barcelona, Spain|Vall d'Hebron University Hospital, Barcelona, Barcelona, Spain|Hospital Clinic, Barcelona, Spain|Hospital Burgos, Burgos, Spain|Hospital San Pedro de Alcantara, Cáceres, Spain|Hospital de León, León, Spain|Hospital Arnau de Vilanova Lleida, Lleida, Spain|Hospital Infanta Leonor de Madrid, Madrid, Spain|Hospital Universitario La Paz, Madrid, Spain|Complexo Hospitalario Universitario de Ourense, Ourense, Spain|Complejo Asistencial Universitario de Palencia, Palencia, Spain|Hospital Montecelo, Pontevedra, Spain|Hospital Universitario Salamanca, Salamanca, Spain|Hospital Universitari Virgen de Valme, Sevilla, Spain|Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain|Hospital Clínic Universitari de València, Valencia, Spain|Hospital Universitari i Politècnic La Fe, Valencia, Spain|Hospital Universitario Valladolid, Valladolid, Spain|Hospital Nuestra Señora de Gracia, Zaragoza",Spain,Respiratory Diseases,1,3,299.0
4846.0,NCT04263402,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,,Recruiting,COVID-19,,,,,,,Drug: Methylprednisolone,Tongji Hospital,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-02,01/06/20,2020-01-07,10/02/20,17/03/20,"Department and Institute of Infectious Disease, Wuhan, Hubei",China,Respiratory Diseases,1,1,5.0
4847.0,NCT04324073,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,CORIMUNO-SARI,"Active, not recruiting",Corona Virus Infection,,,,,,,Drug: Sarilumab,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",239.0,Other,Interventional,2020-03-27,27/03/21,2021-12-31,27/03/20,15/04/20,"Kremlin Bicetre hospital APHP, Le Kremlin-Bicêtre, Ile De France, France|Cochin Aphp, Paris, Ile De France, France|HEGP, Paris, Ile De France, France|NECKER Hospital, Paris",France,Respiratory Diseases,1,1,644.0
4848.0,NCT04460196,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,,Completed,Emergency Medicine,,,,,,,Other: survey,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-08-07,18/09/20,2020-09-18,07/07/20,23/09/20,"CHU Angers, Angers, France|CH Le Mans, Le Mans",France,Others,0,1,42.0
4849.0,NCT04566770,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),,Recruiting,COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo,CanSino Biologics Inc.|Beijing Institute of Biotechnology|Jiangsu Province Centers for Disease Control and Prevention,All,"6 Years and older   (Child, Adult, Older Adult)",481.0,Industry|Other,Interventional,2020-09-24,21/08/21,2022-10-20,28/09/20,27/11/20,"Taixing City center for Disease Control and Prevention, Taizhou, Jiangsu",China,Respiratory Diseases,1,1,756.0
4850.0,NCT04728906,Heart Patch for Myocardial Infarction COVID-19,,Not yet recruiting,Myocardial Infarction,Heart Diseases,,,,,,Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells,Rumah Sakit Pusat Angkatan Darat Gatot Soebroto,All,40 Years to 60 Years   (Adult),10.0,Other,Interventional,2021-05-03,19/10/21,2021-12-19,28/01/21,28/01/21,,,Others,0,2,230.0
4851.0,NCT04724616,CARTOON: CoronAviRus (COVID-19) educaTional prOgram fOr childreN,CARTOON,Recruiting,COVID-19,Pediatric Psychiatric Disorder,Psychological Stress,,,,,Other: Educational Program (CARTOON),Medical University of Vienna,All,3 Years to 6 Years   (Child),60.0,Other,Interventional,2021-06-01,01/06/21,2021-01-06,26/01/21,26/01/21,"Medical University of Vienna, Vienna",Austria,"Mental Health, Respiratory Diseases",1,3,-146.0
4852.0,NCT04836039,Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak,,Completed,Physical Therapy,,,,,,,Other: A questionnaire and scales.,Medipol University,All,"22 Years to 65 Years   (Adult, Older Adult)",400.0,Other,Observational,2021-01-27,27/02/21,2021-02-27,08/04/21,08/04/21,"Medipol University, Istanbul, Beykoz",Turkey,Others,0,1,31.0
4853.0,NCT04362358,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,REST,Not yet recruiting,"Stress - Prevention of Sleep Disorders, PTSD and Depression",,,,,,,Behavioral: Online cognitive behavioral therapy (CBT)|Behavioral: Online bibliotherapy programme,"University Hospital, Strasbourg, France",All,"18 Years to 70 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-01-05,01/10/21,2021-01-10,24/04/20,24/04/20,,,Mental Health,1,1,371.0
4854.0,NCT04526912,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,ALI,Recruiting,Acute Lung Injury,,,,,,,Drug: VIB7734|Drug: Placebo,Viela Bio,All,"18 Years to 80 Years   (Adult, Older Adult)",48.0,Industry,Interventional,2020-08-28,01/04/21,2021-01-07,26/08/20,13/01/21,"Research Site, Cleveland, Ohio",United States,Others,0,1,132.0
4855.0,NCT04713540,Rehabilitation in Intensive Care Unit,,Recruiting,COVID-19,,,,,,,,Bakirkoy Dr. Sadi Konuk Research and Training Hospital,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2021-01-01,01/04/21,2021-01-05,19/01/21,20/01/21,"Bakirkor Dr. Sadi Konuk Research and Training hospital, Istanbul",Turkey,Respiratory Diseases,1,1,4.0
4856.0,NCT04346953,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),,Not yet recruiting,Healthy Lifestyle,,,,,,,Behavioral: Video based exercise,Istinye University,All,40 Years to 60 Years   (Adult),128.0,Other,Interventional,2020-08-20,01/10/20,2020-11-30,15/04/20,21/07/20,,,Others,0,1,102.0
4857.0,NCT04314817,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,CovidTox,Recruiting,Coronavirus,Iatrogenic Disease,Acute Kidney Injury,"ARDS, Human",,,,Drug: Any drug used to treat Covid-19,Groupe Hospitalier Pitie-Salpetriere|CMC Ambroise Paré,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-03-17,01/01/23,2023-01-01,19/03/20,14/04/21,"AP-HP Assistance Publique Hopitaux de Paris, Paris",France,Respiratory Diseases,1,4,1020.0
4858.0,NCT04445870,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,ONCOCARE-COV,Recruiting,Cancer,,,,,,,Other: data record,CHU de Reims,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-05,01/12/21,2021-01-12,24/06/20,01/04/21,"Chu Reims, Reims",France,Cancers,1,1,373.0
4859.0,NCT04615741,Finding Wellness in the Pandemic,,"Active, not recruiting",Mental Health Wellness 1,Addiction,"Stress, Psychological",COVID-19,,,,Behavioral: Trauma Informed Yoga|Behavioral: Trauma Informed Psychotherapy,University of Lethbridge,Female,"18 Years to 75 Years   (Adult, Older Adult)",187.0,Other,Interventional,2020-09-11,22/01/21,2021-04-30,04/11/20,11/03/21,"University of Lethbridge, Lethbridge, Alberta",Canada,"Mental Health, Respiratory Diseases",1,4,231.0
4860.0,NCT04659109,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,GARDEN,Not yet recruiting,SARS-CoV Infection,Acute Respiratory Distress Syndrome,COVID-19,ARDS,,,,Drug: glenzocimab|Drug: Placebo,Acticor Biotech,All,"18 Years to 80 Years   (Adult, Older Adult)",60.0,Industry,Interventional,2020-01-12,01/04/21,2021-01-07,09/12/20,09/12/20,,,Respiratory Diseases,1,4,361.0
4861.0,NCT04442386,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,,Not yet recruiting,Parental Burnout,,,,,,,Other: Prospective study with two measurement points investigating the impact of viral mitigation protocols on parental burnout,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,23/06/20,,,Others,0,1,21.0
4862.0,NCT04410458,Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）,,Enrolling by invitation,Blood Donation,,,,,,,Behavioral: blood donation SMS,Guangzhou Blood Center,All,18 Years to 60 Years   (Adult),506517.0,Other,Interventional,2020-05-31,31/05/20,2020-12-06,01/06/20,01/06/20,"Guangzhou Blood Center, Guangzhou, Guangdong",China,Others,0,1,189.0
4863.0,NCT04417270,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,,Completed,Diabetes Mellitus,,,,,,,Device: Freestyle Libre 14 day CGM system|Device: Accuchek Inform II platform,Northwell Health,All,"18 Years to 99 Years   (Adult, Older Adult)",52.0,Other,Interventional,2020-12-06,30/11/20,2020-11-30,04/06/20,02/03/21,"Lenox Hill Hospital, New York, New York",United States,Metabolic Disorders,1,1,-6.0
4864.0,NCT04334629,LIBERATE Trial in COVID-19,LIBERATE,Recruiting,Coronavirus,Respiratory Distress Syndrome,SARS-CoV Infection,,,,,Drug: Ibuprofen,King's College London|Guy's & St Thomas NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Interventional,2020-05-26,25/05/21,2021-09-25,06/04/20,23/10/20,"Guy's and St Thomas' NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,3,487.0
4865.0,NCT04466605,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,,Completed,Chronic Musculoskeletal Pain,,,,,,,Other: Tele-yoga therapy|Other: Primary care,Aarogyam UK|NMP Medical Research Institute|Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University,All,18 Years to 60 Years   (Adult),64.0,Other,Interventional,2020-03-30,30/06/20,2020-06-07,10/07/20,10/07/20,"NMP Medical Research Institute, Jaipur, Rajasthan",India,Others,0,1,69.0
4866.0,NCT04407507,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",SILVERBULLET,Not yet recruiting,COVID-19,,,,,,,Drug: Ivermectin|Drug: Placebo,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,All,"18 Years and older   (Adult, Older Adult)",66.0,Other,Interventional,2020-01-06,01/08/20,2020-01-10,29/05/20,29/05/20,,,Respiratory Diseases,1,1,4.0
4867.0,NCT04343729,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,MetCOVID,Completed,SARS-CoV Infection,Severe Acute Respiratory Syndrome (SARS) Pneumonia,,,,,,Drug: Methylprednisolone Sodium Succinate|Drug: Placebo solution,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,All,"18 Years and older   (Adult, Older Adult)",416.0,Other,Interventional,2020-04-18,16/06/20,2020-10-20,13/04/20,09/03/21,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas",Brazil,Respiratory Diseases,1,2,185.0
4868.0,NCT04431180,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,,Enrolling by invitation,Blood Donation,,,,,,,Behavioral: blood donation SMS,Guangzhou Blood Center,All,18 Years to 60 Years   (Adult),403535.0,Other,Interventional,2020-06-13,13/06/20,2020-06-30,16/06/20,16/06/20,"Guangzhou Blood Center, Guangzhou, Guangdong",China,Others,0,1,17.0
4869.0,NCT04728958,Reflective Tasks With Healthcare Workers During COVID-19,,Not yet recruiting,Wellbeing,Psychological Distress,Psychological Stress,Emotional Distress,"Stress, Psychological",Stress,Anxiety,Behavioral: Gratitude,University of Sheffield|Sheffield Teaching Hospitals NHS Foundation Trust|The Leeds Teaching Hospitals NHS Trust|York Teaching Hospitals NHS Foundation Trust|Bradford Teaching Hospitals NHS Foundation Trust,All,"18 Years to 65 Years   (Adult, Older Adult)",219.0,Other,Interventional,2021-01-07,01/04/22,2022-01-09,28/01/21,28/01/21,,,Mental Health,1,7,367.0
4870.0,NCT04661410,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,,Recruiting,Bulimia Nervosa,Bulimia; Atypical,Binge Eating,Binge-Eating Disorder,,,,Behavioral: Reward Re-Training|Behavioral: Supportive Therapy,Drexel University|National Institute of Mental Health (NIMH),All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other|NIH,Interventional,2020-01-12,01/12/21,2022-03-30,10/12/20,22/01/21,"Drexel University, Stratton Hall, Philadelphia, Pennsylvania",United States,Others,0,4,808.0
4871.0,NCT04645407,Effects of Fuzheng Huayu Tablets on COVID-19,,Completed,COVID-19,,,,,,,Drug: Fuzheng Huayu tablet,ShuGuang Hospital|Hubei Hospital of Traditional Chinese Medicine|Jingmen No.1 People's Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",66.0,Other,Interventional,2020-01-02,15/04/20,2020-04-15,27/11/20,27/11/20,"Shuguang Hospital, Shanghai, Shanghai",China,Respiratory Diseases,1,1,104.0
4872.0,NCT04392453,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,,Recruiting,Stroke,,,,,,,Device: Robotic therapy,Fondazione Don Carlo Gnocchi Onlus,All,"18 Years to 85 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-10-26,01/12/21,2021-01-12,18/05/20,15/02/21,"Fondazione Don Carlo Gnocchi, Rome",Italy,Cardiovascular Diseases,1,1,78.0
4873.0,NCT04573361,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,,Completed,Musculoskeletal Pain,Disability Physical,Psychological Distress,,,,,Other: Chiropractic care (one visit)|Other: Chiropractic care (more than one visit),Real Centro Universitario Maria Cristina|Université du Québec à Trois-Rivières|University of Birmingham,All,"14 Years and older   (Child, Adult, Older Adult)",723.0,Other,Interventional,2020-02-05,27/05/20,2020-05-27,05/10/20,05/10/20,"Real Centro Universitario María Cristina, San Lorenzo De El Escorial, Madrid",Spain,Others,0,3,112.0
4874.0,NCT04747678,Adverse Effects of Ivermectin Used in Egypt During COVID-19,,Enrolling by invitation,COVID-19,Ivermectin Poisoning,Drug Toxicity,Drug Side Effect,,,,Drug: Ivermectin,Menoufia University,All,"16 Years to 80 Years   (Child, Adult, Older Adult)",200.0,Other,Observational,2021-03-02,28/02/21,2021-01-03,10/02/21,10/02/21,"Ahmed Mansour, Shibīn Al Kawm, Menoufia",Egypt,Respiratory Diseases,1,4,-58.0
4875.0,NCT04643548,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,NeuroCovid,Recruiting,COVID-19,Intensive Care Unit Patient,Neurological Abnormality,Delirium,Encephalopathy,,,,"University Hospital, Clermont-Ferrand",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-10-13,13/06/21,2021-08-13,25/11/20,01/12/20,"CHU, Clermont-Ferrand",France,Respiratory Diseases,1,5,304.0
4876.0,NCT04444661,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,,"Active, not recruiting",Osteoporosis,Sarcopenia,,,,,,,University of Erlangen-Nürnberg Medical School|Friedrich-Alexander-Universität Erlangen-Nürnberg,Male,74 Years to 95 Years   (Older Adult),21.0,Other,Observational,2020-10-06,11/11/20,2020-12-31,23/06/20,13/11/20,"Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Bavaria",Germany,Others,0,2,86.0
4877.0,NCT04399798,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,BREATH,Not yet recruiting,Corona Virus Infection,,,,,,,Drug: Baricitinib,IRCCS Policlinico S. Matteo,All,"18 Years to 74 Years   (Adult, Older Adult)",13.0,Other,Interventional,2020-05-15,15/09/20,2020-11-15,22/05/20,22/05/20,,,Respiratory Diseases,1,1,184.0
4878.0,NCT04391166,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,,Completed,Visual Impairment,,,,,,,Other: Non invasive visual acuity testing,Vanderbilt University Medical Center,All,"18 Years to 90 Years   (Adult, Older Adult)",108.0,Other,Observational,2020-05-20,10/07/20,2020-01-12,18/05/20,23/03/21,"Vanderbilt Eye Institute, Nashville, Tennessee",United States,Others,0,1,-129.0
4879.0,NCT04394403,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,CoronaStress,Recruiting,Stress,"Stress, Psychological",,,,,,Behavioral: Internet-based guided self-help based on CBT principles,Hebrew University of Jerusalem,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-05-14,31/12/21,2022-06-30,19/05/20,09/02/21,"Hebrew University of Jerusalem, Jerusalem",Israel,Mental Health,1,2,777.0
4880.0,NCT04402970,Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2),DORNASESARS2,Completed,SARS-CoV 2,ARDS,,,,,,Drug: Dornase Alfa Inhalation Solution,University of Missouri-Columbia,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-19,31/12/20,2020-12-31,27/05/20,14/04/21,"University of Missouri Hospital and Clinics, Columbia, Missouri",United States,Respiratory Diseases,1,2,195.0
4881.0,NCT04747132,Effectiveness of a Telegeriatric Intervention in Older Adults During the Covid-19 Contingency,,Completed,Effectiveness,,,,,,,Other: Telegeriatric intervention,"Universidad Iberoamericana A.C., Mexico",All,"60 Years and older   (Adult, Older Adult)",110.0,Other,Interventional,2020-07-20,20/10/20,2020-11-16,10/02/21,10/02/21,"Universidad Iberoamericana, Ciudad de Mexico, Ciudad De México",Mexico,Others,0,1,119.0
4882.0,NCT04702295,ERN ReCONNET Study on COVID-19 Vaccination in Rare and Complex Connective Tissue Disease (VACCINATE),VACCINATE,Not yet recruiting,Connective Tissue Diseases,Rare Diseases,Rheumatologic Disorder,,,,,,University of Pisa,All,"18 Years to 99 Years   (Adult, Older Adult)",250.0,Other,Observational,2021-01-02,01/02/23,2023-01-08,08/01/21,08/01/21,,,Others,0,3,736.0
4883.0,NCT04707339,Management of Acute Appendicitis at District General Hospital,,Recruiting,Appendicitis Acute,COVID-19,,,,,,Procedure: Appendicectomy,Princess Alexandra Hospital NHS Trust,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-30,31/10/20,2021-01-30,13/01/21,14/01/21,"The Princess Alexandra Hospital NHS Trust, Harlow, Essex",United Kingdom,Respiratory Diseases,1,2,366.0
4884.0,NCT04379518,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,,Recruiting,Malignant Neoplasm,SARS Coronavirus 2 Infection,,,,,,Biological: Recombinant Interferon Alfa-2b|Drug: Rintatolimod,Roswell Park Cancer Institute|National Cancer Institute (NCI)|AIM ImmunoTech Inc.,All,"18 Years and older   (Adult, Older Adult)",44.0,Other|NIH|Industry,Interventional,2020-04-09,04/09/21,2021-04-09,07/05/20,24/02/21,"Roswell Park Cancer Institute, Buffalo, New York",United States,Respiratory Diseases,1,2,365.0
4885.0,NCT04796896,A Study to Evaluate Safety and Effectiveness of mRNA-1273 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age,,Recruiting,COVID-19,,,,,,,Biological: mRNA-1273|Biological: Placebo,"ModernaTX, Inc.",All,6 Months to 11 Years   (Child),6750.0,Industry,Interventional,2021-03-15,10/06/23,2023-10-06,15/03/21,13/04/21,"MedPharmics, LLC, Phoenix, Arizona, United States|Emmaus Research Center Inc, Anaheim, California, United States|Carey Chronis MD Pediatric, Infant and Adolescent Medicine - FOMAT, Ventura, California, United States|Michael W Simon, MD PSC, Lexington, Kentucky, United States|MedPharmics - Platinum, Metairie, Louisiana, United States|Coastal Pediatric Associates, Charleston, South Carolina, United States|Javara Inc., Dallas, Texas, United States|BRCR Global Texas, Edinburg, Texas, United States|West Houston Clinical Research - Hunt, Houston, Texas, United States|Village Health Partners - HUNT, Plano, Texas, United States|Crossroads Clinical Research (Victoria), Port Lavaca, Texas, United States|DM Clinical Research - Pediatric Healthcare of NW Houston, Tomball, Texas, United States|Advanced Clinical Research/Velocity Clinical Research, Jordan, Utah, United States|Tanner Clinic, Layton, Utah",United States,Respiratory Diseases,1,1,935.0
4886.0,NCT04395508,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,,Available,HER2-positive Breast Cancer,,,,,,,Drug: Pertuzumab and Trastuzumab Fixed-Dose Combination for Subcutaneous Administration (PH FDC SC),"Genentech, Inc.",All,"18 Years and older   (Adult, Older Adult)",,Industry,Expanded Access:Treatment IND/Protocol,,,,20/05/20,02/04/21,"Beverly Hills Cancer Center, Beverly Hills, California, United States|UCSF Helen Diller Family CCC, San Francisco, California, United States|Stanford Univ School of Med; Oncology, Stanford, California, United States|University Of Colorado, Aurora, Colorado, United States|MedStar Washington Hosp Center, Washington, District of Columbia, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Dana Farber Cancer Institute, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Levine Cancer Institute, Charlotte, North Carolina, United States|University of Washington Seattle Cancer Care Alliance, Seattle, Washington",United States,Cancers,1,1,
4887.0,NCT04363632,Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection,ONCOVID-19,Completed,Sars-CoV2,Cancer,,,,,,,Centre Leon Berard,All,"Child, Adult, Older Adult",1231.0,Other,Observational,2020-02-04,30/06/20,2020-06-30,27/04/20,01/07/20,"Institut Bergonié, Bordeaux, France|Centre François Baclesse, Caen, France|Centre Hospitalier Métropole Savoie, Chambéry, France|Centre Jean Perrin, Clermont-Ferrand, France|Centre Georges François Leclerc, Dijon, France|Centre Oscar Lambret, Lille, France|Centre Leon Berard, Lyon, France|CH Annecy-Genevois, Metz-Tessy, France|Institut de Cancérologie de Montpellier, Montpellier, France|Groupement Hospitalier Porte de Provence, Montélimar, France|Centre Antoine Lacassagne, Nice, France|Centre Hospitalier Lyon-Sud, Pierre-Bénite, France|Institut Jean Godinot, Reims, France|Centre Henri Becquerel, Rouen, France|Institut de Cancérologie de l'Ouest, Saint-Herblain, France|Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, France|Institut Universitaire du Cancer de Toulouse - IUCT Oncopole, Toulouse, France|CH Valence, Valence",France,"Respiratory Diseases, Cancers",1,2,147.0
4888.0,NCT04372043,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,,Not yet recruiting,Sleep Hygiene,,,,,,,Other: Questionnaire,Saint-Joseph University,All,"18 Years to 100 Years   (Adult, Older Adult)",1200.0,Other,Observational,2020-04-30,30/09/20,2020-09-30,01/05/20,01/05/20,"Saint Joseph University, Beirut",Lebanon,Others,0,1,153.0
4889.0,NCT04742842,The Safety and Immunogenicity of a DNA-based Vaccine (COVIGEN) in Healthy Volunteers,COVALIA,Not yet recruiting,COVID-19,,,,,,,Biological: COVIGEN 0.8 mg ID or Placebo ID|Biological: COVIGEN 2.0 mg IM or Placebo IM|Biological: COVIGEN 4.0 mg IM or Placebo IM,"University of Sydney|Bionet Co., Ltd|Technovalia|Telethon Kids Institute|Institute for Clinical Pathology and Medical Research",All,"18 Years to 75 Years   (Adult, Older Adult)",150.0,Other|Industry,Interventional,2021-02-15,30/06/22,2022-12-31,08/02/21,08/02/21,"Scientia Clinical Research, Randwick, New South Wales, Australia|Vaccinology and Immunology Research Trials Unit, Women's and Children's Hospital, Adelaide, South Australia, Australia|Wesfarmers Centre of Vaccines and Infectious Diseases Telethon Kids Institute, Perth, Western Australia",Australia,Respiratory Diseases,1,1,684.0
4890.0,NCT04638673,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,,Recruiting,Coronavirus,COVID-19,,,,,,Device: Soterix taVNS model 0125-LTE Stimulator - Active-Active Group|Device: Soterix taVNS model 0125-LTE Stimulator - Sham-Active Group,Medical University of South Carolina|National Institutes of Health (NIH)|National Institute of General Medical Sciences (NIGMS),All,"18 Years to 70 Years   (Adult, Older Adult)",30.0,Other|NIH,Interventional,2020-11-19,01/06/21,2021-01-06,20/11/20,07/12/20,"Medical University of South Carolina, Charleston, South Carolina",United States,Respiratory Diseases,1,2,48.0
4891.0,NCT04442360,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,,Not yet recruiting,Depression,Generalized Anxiety,Health Anxiety,,,,,Behavioral: Prospective study with two measurement points investigating the impact of viral mitigation protocols on mental health,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,23/06/20,,,Mental Health,1,3,21.0
4892.0,NCT04458246,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,,Recruiting,Chronic Disease,Chronic Diseases in Adolescence,Chronic Disease of Immune System,Chronic Kidney Diseases,,,,Other: Exercise training group,University of Sao Paulo,All,"10 Years to 19 Years   (Child, Adult)",140.0,Other,Interventional,2020-01-07,01/12/20,2021-01-06,07/07/20,07/07/20,"Univsersity of Sao Paulo, Sao Paulo",Brazil,Others,0,4,365.0
4893.0,NCT04345549,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,,Completed,Flu Like Symptom,Flu Like Illness,,,,,,Other: Individualised Ayurveda,Aarogyam UK,All,18 Years to 60 Years   (Adult),18.0,Other,Interventional,2020-02-26,30/03/20,2020-03-30,14/04/20,14/04/20,"Aarogyam, Leicester",United Kingdom,Others,0,2,33.0
4894.0,NCT04442204,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,,Not yet recruiting,Depression,Anxiety,,,,,,Other: Prospective study across two time-points examining the impact of viral mitigation protocols on mental health,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,23/06/20,,,Mental Health,1,2,21.0
4895.0,NCT04320056,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),,Recruiting,Coronavirus,Pneumonia,Oxygen Toxicity,,,,,Other: Standard administration of oxygen flow|Device: Automated oxygen administration - FreeO2,Laval University,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2020-04-20,30/04/21,2021-10-31,24/03/20,21/04/20,"Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec",Canada,Respiratory Diseases,1,3,559.0
4896.0,NCT04661540,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,,Recruiting,Pneumonia,,,,,,,Drug: CM4620-IE (Injectable Emulsion)|Drug: Placebo,"CalciMedica, Inc.|Northwestern University",All,"18 Years and older   (Adult, Older Adult)",36.0,Industry|Other,Interventional,2021-02-03,01/05/21,2021-01-06,10/12/20,12/03/21,"Northwestern Memorial Hospital, Chicago, Illinois",United States,Respiratory Diseases,1,1,-28.0
4897.0,NCT04394013,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,,Completed,Mental Health Issue,,,,,,,Behavioral: Mindfulness intervention|Behavioral: Non-Mindfulness intervention,Monash University Malaysia,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-08-26,31/12/20,2020-12-31,19/05/20,24/02/21,"Monash University Malaysia, Subang Jaya, Selangor",Malaysia,Others,0,1,127.0
4898.0,NCT04685681,The Get Outside Study,GO,"Active, not recruiting",COVID-19,Risk Reduction,Stress,Sleep,,,,Behavioral: Hiking challenge|Other: Activity list,State University of New York at Buffalo,All,"18 Years and older   (Adult, Older Adult)",53.0,Other,Interventional,2021-07-01,31/03/21,2021-03-31,28/12/20,22/03/21,"State University of New York at Buffalo, Buffalo, New York",United States,"Mental Health, Respiratory Diseases",1,4,-92.0
4899.0,NCT04346082,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,,Not yet recruiting,Stress,,,,,,,Behavioral: online mindfulness group,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-08,30/07/21,2021-07-30,15/04/20,15/07/20,"School of public health and primary care, Hong Kong",Hong Kong,Mental Health,1,1,569.0
4900.0,NCT04367636,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,OCAT,Recruiting,Rumination,Anxiety,Stress,Depressive Symptoms,,,,Behavioral: Behavioral: OCAT-sham|Behavioral: Behavioral: OCAT|Other: psycho-education video,University Ghent,All,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-30,01/09/21,2021-01-09,29/04/20,21/02/21,"Ghent University, Gent, Oost-Vlaanderen",Belgium,Mental Health,1,4,254.0
4901.0,NCT04417374,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",HoCoPsy,Completed,COVID-19,Disease Outbreak,Mental Disorders,,,,,Other: Description of groups caracteristics,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",94.0,Other,Observational,2020-01-05,30/05/20,2020-06-30,04/06/20,29/07/20,"University hospital, Montpellier",France,Respiratory Diseases,1,3,177.0
4902.0,NCT04442282,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,,Not yet recruiting,Anxiety,Depression,Interpersonal Problem,Emotion Regulation,,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",5041.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,22/06/20,22/06/20,,,Mental Health,1,4,21.0
4903.0,NCT04458948,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,,"Active, not recruiting",COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Azithromycin,University of New Mexico,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Interventional,2020-03-24,24/03/21,2025-03-24,07/07/20,07/07/20,"University of New Mexico Health Sciences Center, Albuquerque, New Mexico",United States,Respiratory Diseases,1,1,1826.0
4904.0,NCT04441476,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,PsyCOVID,Completed,Psychological Strain,,,,,,,Other: Questionnaires|Other: psychological and sociological interviews,Centre Hospitalier Universitaire Dijon,All,"18 Years and older   (Adult, Older Adult)",3080.0,Other,Observational,2020-04-21,21/12/20,2020-12-21,22/06/20,30/03/21,"Chu Dijon Bourgogne, Dijon",France,Others,0,1,244.0
4905.0,NCT04385212,Outcomes in Hospitalized Older Patients With COVID-19,,Completed,Coronavirus Infection,Sars-CoV2,Elderly Infection,Old Age; Debility,,,,,"University Hospital, Geneva",All,65 Years and older   (Older Adult),230.0,Other,Observational,2020-03-13,14/04/20,2020-04-14,12/05/20,12/05/20,"Department of Rehabilitation and Geriatrics, Geneva",Switzerland,Respiratory Diseases,1,4,32.0
4906.0,NCT04488796,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,,Completed,Health Behaviour Change,,,,,,,Behavioral: Assigned Strategies: Opt-in|Behavioral: Assigned Strategies: Active Choice|Behavioral: Assigned Strategies: Enhanced Active Choice|Behavioral: Choice of Assignment: Opt-in|Behavioral: Choice of Assignment: Active Choice|Behavioral: Choice of Assignment: Enhanced Active Choice,"Western University, Canada|Duke University",All,"18 Years and older   (Adult, Older Adult)",148.0,Other,Interventional,2020-07-09,16/12/20,2020-12-16,28/07/20,08/04/21,"University of Western Ontario, London, Ontario",Canada,Others,0,1,160.0
4907.0,NCT04443764,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,,Not yet recruiting,Migrants,Anxiety,Depression,,,,,,University of Oslo|Modum Bad,All,"18 Years and older   (Adult, Older Adult)",287.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,23/06/20,,,Mental Health,1,3,21.0
4908.0,NCT04384419,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",DeathPercep,Recruiting,Mental Disorder,General Population,,,,,,,"University Hospital, Montpellier|University of Montpellier 3 (Pr. Stéphane Raffard, PhD)|University of Reims Champagne-Ardenne (Ali Oker PhD)",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-05-29,30/05/21,2021-01-06,12/05/20,29/07/20,"UH Montpellier, Montpellier",France,Others,0,2,222.0
4909.0,NCT04821037,Nurse Health Pilot: Feasibility and Acceptability of a Virtual ACT-intervention in Frontline Nurses During COVID-19,NHP,Not yet recruiting,Stress,,,,,,,Behavioral: ACT,"Prof. Dr. Andrew Gloster|State Secretariat for Education Research and Innovation, Switzerland|ETH Zurich (Switzerland)|University of Basel",All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2021-01-06,01/07/21,2021-01-08,29/03/21,29/03/21,,,Mental Health,1,1,2.0
4910.0,NCT04602312,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),,Recruiting,COVID-19,,,,,,,Other: Meditation (1 x 20-minute guided audio training),"The University of Queensland|University of Sydney|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",624.0,Other,Interventional,2020-10-28,01/03/21,2021-01-03,26/10/20,12/11/20,"Health and Behavioural Sciences, Brisbane, Queensland",Australia,Respiratory Diseases,1,1,67.0
4911.0,NCT04508868,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,CoviDep,Terminated,Depression,Depressive Symptoms,,,,,,Behavioral: Brief Behavioral Activation with Mental Imagery|Behavioral: Minimal Attention Control Intervention,"Uppsala University|Västmanland County Council, Sweden",All,65 Years and older   (Older Adult),41.0,Other,Interventional,2020-08-31,23/12/20,2020-12-23,11/08/20,31/12/20,"Adult Psychiatric Clinic, Västerås, Västmanland",Sweden,Mental Health,1,2,114.0
4912.0,NCT04425499,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,,Not yet recruiting,Advanced Suturing Skills,Surgical Education,,,,,,Other: Learning running subcuticular sutures on the Gamified Educational Network,Université de Montréal,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-06,01/06/20,2020-01-06,11/06/20,11/06/20,,,Others,0,2,0.0
4913.0,NCT04460014,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,,Recruiting,Intrusive Memories of Traumatic Event(s),Post Traumatic Stress Disorder,,,,,,Behavioral: Simple cognitive task intervention|Behavioral: Attention Placebo,Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",164.0,Other,Interventional,2020-09-30,01/03/21,2021-01-08,07/07/20,14/01/21,"Hospital units across Sweden (e.g. FO Akut, Karolinska University Hospital Huddinge), Huddinge",Sweden,Mental Health,1,2,100.0
4914.0,NCT04592705,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,,Recruiting,COVID-19,,,,,,,Device: Therapeutic plasma exchange,Larkin Community Hospital,All,"18 Years to 69 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-11-09,30/08/21,2021-08-30,19/10/20,19/10/20,"Larkin Community Hospital, South Miami, Florida",United States,Respiratory Diseases,1,1,294.0
4915.0,NCT04389684,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,COVIDICA,Recruiting,Chemeotherapy,Immunotherapy,Treatment Mofidied,Coronavirus,Quality of Life,,,Other: Psycho-Social Questionnaire,Poitiers University Hospital,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-05-27,27/07/21,2021-07-27,15/05/20,17/07/20,"MOULIN Valérie, La Rochelle, France|BOURGEOIS Hugues, Le Mans, France|RANDRIAN Violaine, Poitiers",France,Respiratory Diseases,1,5,426.0
4916.0,NCT04353245,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,PostCOVID19,Not yet recruiting,COVID-19,Corona Virus Infection,Myocardial Injury,Pneumonia,,,,Other: BIOMARKERS IN THE LONG TERM IMPACT OF CORONAVIRUS INFECTION IN THE CARDIORRESPIRATORY SYSTEM,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Observational,2020-01-06,30/09/21,2021-09-30,20/04/20,20/04/20,"Instituto do Coração - Hospital das Clínicas - Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP",Brazil,Respiratory Diseases,1,4,633.0
4917.0,NCT04618835,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,,Recruiting,COVID-19,Medical Emergencies,,,,,,Diagnostic Test: 40-Steps-test,Betsi Cadwaladr University Health Board|Oxford Brookes University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-11-01,03/11/21,2021-03-11,06/11/20,24/02/21,"Ysbyty Gwynedd, Menai Bridge, Gwynedd",United Kingdom,Respiratory Diseases,1,2,-235.0
4918.0,NCT04516668,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,COVIDDEPERINAT,Not yet recruiting,Post Partum Depression,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-01-11,01/11/20,2020-01-11,18/08/20,06/10/20,,,Mental Health,1,1,0.0
4919.0,NCT04690400,Telehealth Stretching Exercise Program for Women With Fibromyalgia During the Covid-19 Pandemic,,Not yet recruiting,Fibromyalgia,"Fibromyalgia, Primary",,,,,,Other: Experimental: Active care group|Other: Active Comparator: Self-care group,Federal University of Pelotas,Female,30 Years to 60 Years   (Adult),28.0,Other,Interventional,2021-01-18,30/04/21,2021-04-30,30/12/20,30/12/20,,,Others,0,2,102.0
4920.0,NCT04559074,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,,Recruiting,Hypertension,,,,,,,Drug: Amlodipine,Queen Mary University of London|Closed Loop Medicine Ltd|Innovate UK,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-10-23,30/04/21,2021-07-31,22/09/20,13/11/20,"Queen Mary University London, London",United Kingdom,Cardiovascular Diseases,1,1,281.0
4921.0,NCT04295551,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),,Not yet recruiting,COVID-19,,,,,,,Drug: Lopinavir / ritonavir tablets combined with Xiyanping injection|Drug: Lopinavir/ritonavir treatment,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,All,"18 Years to 100 Years   (Adult, Older Adult)",80.0,Industry,Interventional,2020-03-14,14/07/20,2021-04-14,04/03/20,04/03/20,,,Respiratory Diseases,1,1,396.0
4922.0,NCT04336410,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",,"Active, not recruiting",Coronavirus Infection,,,,,,,Drug: INO-4800|Device: CELLECTRA® 2000,Inovio Pharmaceuticals|Coalition for Epidemic Preparedness Innovations,All,"18 Years and older   (Adult, Older Adult)",120.0,Industry|Other,Interventional,2020-03-04,01/01/22,2022-01-01,07/04/20,03/03/21,"Central Kentucky Research Associates, Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|University of Pennsylvania, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,668.0
4923.0,NCT04426071,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,,Recruiting,Brain Injuries,Stroke,Spinal Cord Injuries,,,,,,Lawson Health Research Institute,All,"18 Years and older   (Adult, Older Adult)",142.0,Other,Observational,2020-01-06,01/12/21,2021-01-12,11/06/20,21/02/21,"Lawson Health Research Institute, London, Ontario",Canada,Cardiovascular Diseases,1,3,372.0
4924.0,NCT04479345,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",,Not yet recruiting,"Knowledge, Attitudes, Practice",,,,,,,Other: Questionnaire,Assiut University,All,"25 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-07,01/09/20,2020-01-09,21/07/20,21/07/20,,,Others,0,1,2.0
4925.0,NCT04844697,Resilience and Coping in a Rare Skeletal Disease Population to Face Coronavirus (COVID-19) Outbreak Distress: a Longitudinal Study,RELOAD,Not yet recruiting,Multiple Osteochondroma,Osteogenesis Imperfecta,Ollier Disease,Maffucci Syndrome,,,,,Istituto Ortopedico Rizzoli,All,"8 Years to 24 Years   (Child, Adult)",60.0,Other,Observational,2021-01-04,01/12/21,2021-01-12,14/04/21,14/04/21,,,Others,0,4,8.0
4926.0,NCT04344106,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,ProCov,Recruiting,Coronavirus Infection,Oxygen Deficiency,,,,,,Procedure: Prone positioning,ELHARRAR Xavier|Centre Hospitalier Intercommunal Aix-Pertuis,All,"18 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2020-01-04,15/04/20,2020-01-05,14/04/20,14/04/20,"CHI Aix-Pertuis, Aix-en-Provence",France,Respiratory Diseases,1,2,1.0
4927.0,NCT04488471,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,,Recruiting,Inflammatory Bowel Diseases,,,,,,,,Sheffield Teaching Hospitals NHS Foundation Trust,All,"16 Years and older   (Child, Adult, Older Adult)",232.0,Other,Observational,2020-06-30,30/06/22,2022-06-30,28/07/20,28/07/20,"Sheffield Teaching Hospitals NHS FT, Sheffield",United Kingdom,Others,0,1,730.0
4928.0,NCT04513847,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,,Completed,Psoriasis,COVID-19,,,,,,,Dermatrials Research,All,"Child, Adult, Older Adult",661.0,Other,Observational,2020-08-13,13/09/20,2020-06-10,14/08/20,08/10/20,"Dermatrials Research, Hamilton, Ontario",Canada,Respiratory Diseases,1,2,-64.0
4929.0,NCT04751682,Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19,,"Active, not recruiting",SARS-CoV Infection,,,,,,,Biological: BBV154 Vaccine,Bharat Biotech International Limited,All,18 Years to 60 Years   (Adult),175.0,Industry,Interventional,2021-01-03,25/03/21,2021-11-30,12/02/21,29/03/21,"AIIMS,Patna, Patna, Bihar, India|Apollo Hospitals,Chennai, Chennai, Tamil Nadu, India|St.Theresa Hospital, Hyderabad, Hyderabad, India|Gillurkar Multispeciality Hospital,Nagpur, Nagpur",India,Respiratory Diseases,1,1,331.0
4930.0,NCT04621084,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,COVISTRESSNutr,Recruiting,Nutrition,,,,,,,Behavioral: Eating habits,"University Hospital, Clermont-Ferrand|Faculty of Medicine and Paramedical Professions, Clermont-Ferrand, France",All,"10 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-04,31/12/25,2025-12-31,09/11/20,09/11/20,"Clermont-Ferrand University Hospital, clermont-Ferrand, Aura",France,Others,0,1,2188.0
4931.0,NCT04781400,"Bidirectional, Upbeat Communication and Differentiated, Distanced Care for Young People",BUDDY,Recruiting,HIV Infections,COVID-19,Health Care Utilization,Gender-based Violence,,,,Behavioral: Mobile phone support|Behavioral: Remote service delivery model,"Desmond Tutu HIV Foundation|ViiV Healthcare|Karolinska Institutet|University of North Carolina, Chapel Hill|University of KwaZulu",All,"13 Years to 24 Years   (Child, Adult)",600.0,Other|Industry,Interventional,2021-08-02,08/02/22,2022-08-02,04/03/21,04/03/21,"Gugulethu Community Health Centre, Cape Town, Western Cape",South Africa,Respiratory Diseases,1,4,365.0
4932.0,NCT04754698,COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS,CoronavRheum,Recruiting,Rheumatic Disease,HIV Infections,AIDS,Safety Issues,Immunogenicity,COVID-19,,Biological: CoronaVac,University of Sao Paulo General Hospital,All,"18 Years and older   (Adult, Older Adult)",2067.0,Other,Interventional,2021-09-02,01/12/21,2023-01-03,15/02/21,22/03/21,"University of Sao Paulo General Hospital, São Paulo, SP",Brazil,Respiratory Diseases,1,6,488.0
4933.0,NCT04367168,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,ColchiVID,Recruiting,COVID-19,,,,,,,Drug: Colchicine|Drug: Placebo oral tablet,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,All,"18 Years to 70 Years   (Adult, Older Adult)",174.0,Other,Interventional,2020-05-27,27/04/21,2021-04-27,29/04/20,28/05/20,"Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City",Mexico,Respiratory Diseases,1,1,335.0
4934.0,NCT04444297,3D Telemedicine During COVID-19: Non-clinical Validation,,Not yet recruiting,Telemedicine,"Surgery, Plastic",,,,,,Other: 3D Telemedicine|Other: 2D Telemedicine,"NHS Greater Glasgow and Clyde|Jean Brown Bequest Fund, Glasgow, UK",All,"16 Years to 75 Years   (Child, Adult, Older Adult)",40.0,Other,Interventional,2020-07-31,31/01/21,2021-01-31,23/06/20,07/07/20,"Canniesburn Regional Plastic Surgery and Burns Unit, Glasgow, Scotland",United Kingdom,Others,0,2,184.0
4935.0,NCT04640194,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,TRISTARDS,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,Drug: Alteplase|Procedure: Standard of care,Boehringer Ingelheim,All,"18 Years and older   (Adult, Older Adult)",270.0,Industry,Interventional,2020-12-16,29/05/22,2022-01-09,23/11/20,08/04/21,"LKH Klagenfurt am Woerthersee, Klagenfurt, Austria|Wiener Gesundheitsverbund Klinik Favoriten, Vienna, Austria|ULB Hopital Erasme, Bruxelles, Belgium|Centre Hospitalier Universitaire de Liège, Liège, Belgium|Ottignies - HOSP St-Pierre, Ottignies, Belgium|Hvidovre Hospital, Hvidovre, Denmark|HOP Bicêtre, Le Kremlin Bicêtre cedex, France|HOP Roger Salengro, Lille, France|HOP Marc Jacquet, Melun, France|HOP Européen G. Pompidou, Paris cedex 15, France|HOP Cochin, Paris, France|HOP Pierre Bénite, Pierre Bénite, France|HOP Civil, Strasbourg cedex, France|Universitätsklinikum Essen AöR, Essen, Germany|Medizinische Hochschule Hannover, Hannover, Germany|Universitätsklinikum Heidelberg, Heidelberg, Germany|Universitätsklinikum Leipzig, Leipzig, Germany|Klinikum der Universität München - Campus Großhadern, München, Germany|Fondazione Centro San Raffaele del Monte Tabor, Milano, Italy|Istituto Clinico Humanitas, Rozzano (MI), Italy|Ospedali Riuniti di Ancona, Torrette Di Ancona (AN), Italy|Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Netherlands|Rijnstate Hospital, Arnhem, Netherlands|Canisius-Wilhelmina ziekenhuis, Nijmegen, Netherlands|CHLO, EPE - Hospital Egas Moniz, Lisboa, Portugal|Centro Hospitalar Universitário do Porto, EPE - Hospital de Santo António, Porto, Portugal|ULSAM, EPE - Hospital de Santa Luzia, Viana do Castelo, Portugal|Hospital del Mar, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Puerta del Mar, Cádiz",Spain,Respiratory Diseases,1,1,389.0
4936.0,NCT04388826,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,,"Active, not recruiting","Respiratory Distress Syndrome, Adult",,,,,,,Drug: Veru-111,Veru Inc.,All,"18 Years and older   (Adult, Older Adult)",40.0,Industry,Interventional,2020-06-18,18/12/20,2021-08-05,14/05/20,15/03/21,"HonorHealth, Scottsdale, Arizona, United States|Methodist Hospital, Saint Louis Park, Minnesota, United States|Regions Hospital, Saint Paul, Minnesota, United States|Inspira Medical Center, Vineland, New Jersey, United States|Memorial Hermann Memorial City Hospital, Houston, Texas",United States,Others,0,1,413.0
4937.0,NCT04623346,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,,"Active, not recruiting",Ankle Fractures,Proximal Humeral Fracture,Wrist Fracture,,,,,Procedure: Observation for study group,Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization,All,85 Years and older   (Older Adult),262.0,Other,Observational,2020-11-03,01/11/20,2020-01-12,10/11/20,16/11/20,"SBU Prof. Cemil Tascioglu City Hospital, Istanbul",Turkey,Others,0,3,-296.0
4938.0,NCT04371250,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,,"Active, not recruiting","Resilience, Psychological",Loneliness,Youth,Surveys and Questionnaires,,,,Other: Survey and Questionnaire,Erasme University Hospital|Université Libre de Bruxelles|King Baudouin Foundation,All,18 Years to 25 Years   (Adult),800.0,Other,Observational,2020-04-30,31/05/20,2020-12-30,01/05/20,30/06/20,"Erasme University Hospital, Brussels",Belgium,Others,0,4,244.0
4939.0,NCT04540939,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,,Recruiting,Trauma,,,,,,,Behavioral: Mindfulness-Based Cognitive Therapy|Behavioral: Muscle Relaxation Therapy,University of Michigan|National Center for Complementary and Integrative Health (NCCIH),All,"18 Years to 72 Years   (Adult, Older Adult)",60.0,Other|NIH,Interventional,2020-10-19,01/12/21,2021-01-12,07/09/20,02/11/20,"University of Michigan, Ann Arbor, Michigan",United States,Others,0,1,85.0
4940.0,NCT04633772,Use of Angiotensin-(1-7) in COVID-19,,Recruiting,"Infection, Coronavirus",Respiratory Failure,,,,,,Drug: Angiotensin-(1-7)|Drug: Placebo,Erasme University Hospital|Federal University of Minas Gerais|Angitec|Fonds Erasme pour la Recherche Medicale,All,"17 Years to 81 Years   (Child, Adult, Older Adult)",130.0,Other,Interventional,2020-05-08,01/02/21,2021-02-28,18/11/20,23/11/20,"Hospital Eduardo de Menezes, Belo Horizonte, Minas Gerais, Brazil|Hospital Mater Dei, Belo Horizonte, Minas Gerais",Brazil,Respiratory Diseases,1,2,296.0
4941.0,NCT04280224,NK Cells Treatment for COVID-19,,Recruiting,COVID-19,,,,,,,Biological: NK Cells,Xinxiang medical university|First Affiliated Hospital of Xinjiang Medical University,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-02-15,30/12/21,2022-12-30,21/02/20,08/04/21,"The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan",China,Respiratory Diseases,1,1,1049.0
4942.0,NCT04811352,Drug Abuse During the COVID-19 Pandemic.,,Recruiting,Substance Abuse,"Stress, Psychological",,,,,,,Instituto Mexicano del Seguro Social,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-03,01/05/21,2021-01-06,23/03/21,23/03/21,"Centro Médico Nacional de Occidente, Guadalajara, Jalisco",Mexico,Mental Health,1,2,3.0
4943.0,NCT04372030,Health Care Use During the Covid19 Crisis,US3R,Not yet recruiting,Health Care Utilization,,,,,,,Other: Online questionnaire,Université Catholique de Louvain,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Interventional,2020-01-05,30/06/20,2021-10-31,01/05/20,01/05/20,,,Others,0,1,665.0
4944.0,NCT04453514,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,,Recruiting,Anxiety,,,,,,,Behavioral: Trauma-informed yoga video recording,National University of Natural Medicine,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-07-21,01/10/20,2020-01-10,01/07/20,24/07/20,"National University of Natural Medicine, Portland, Oregon",United States,Mental Health,1,1,-193.0
4945.0,NCT04679493,"Study to Assess Safety, Tolerability and Pharmacokinetics of XC7 (Which is Planned Use in the Treatment of COVID-19) in Healthy Volunteers",,"Active, not recruiting",COVID-19,Healthy Volunteers,,,,,,Drug: XC7 100 mg single|Drug: XC7 200 mg single|Drug: Placebo single|Drug: XC7 200 mg multiple|Drug: Placebo multiple,NP Therapeutics,Male,18 Years to 45 Years   (Adult),16.0,Other,Interventional,2020-12-24,01/04/21,2021-01-04,22/12/20,06/04/21,"Federal State Autonomous Educational Institution of Higher Education The First Moscow State Medical University named after I.M. Sechenov of the Ministry of Health of the Russian Federation, Moscow",Russian Federation,Respiratory Diseases,1,2,11.0
4946.0,NCT04365972,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,,Completed,Anxiety,,,,,,,Behavioral: Attention Bias Modification (ABM),Tel Aviv University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-23,30/04/20,2020-04-30,28/04/20,08/05/20,"Tel Aviv University, Tel-Aviv",Israel,Mental Health,1,1,7.0
4947.0,NCT04315480,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,,"Active, not recruiting",SARS Pneumonia,,,,,,,Drug: Tocilizumab,Università Politecnica delle Marche|Azienda Ospedaliera Ospedali Riuniti Marche Nord,All,"18 Years to 90 Years   (Adult, Older Adult)",38.0,Other,Interventional,2020-12-03,09/04/20,2020-01-05,19/03/20,13/04/20,"Università Politecnica delle Marche, Ancona, AN",Italy,Respiratory Diseases,1,1,-333.0
4948.0,NCT04480957,Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects,,Recruiting,COVID-19,,,,,,,Biological: ARCT-021 Dose 1|Biological: ARCT-021 Dose 2|Biological: ARCT-021 Dose 3|Biological: ARCT-021 Dose 4|Biological: ARCT-021 Dose Regimen 1|Biological: ARCT-021 Dose Regimen 2|Other: Placebo,"Arcturus Therapeutics, Inc.",All,"21 Years to 80 Years   (Adult, Older Adult)",92.0,Industry,Interventional,2020-04-08,01/12/20,2021-01-01,22/07/20,17/08/20,"SingHealth Investigational Medicine Unit (IMU), Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,268.0
4949.0,NCT04392115,The PREPARE for COVID Trial,,Not yet recruiting,Comorbidities and Coexisting Conditions,Social Isolation,,,,,,Behavioral: The PREPARE program,Ottawa Hospital Research Institute,All,65 Years and older   (Older Adult),372.0,Other,Interventional,2020-06-15,15/12/20,2021-09-15,18/05/20,18/05/20,,,Others,0,2,457.0
4950.0,NCT04382508,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,ImmunoCOVID,Enrolling by invitation,Immune Suppression,Immune Deficiency,Infection,COVID-19,"Children, Adult",,,Other: Questionnaire,"University Hospital Southampton NHS Foundation Trust|Cambridge University Hospitals NHS Foundation Trust|Alder Hey Children's Hospital|Birmingham Children's Hospital|Bradford Royal Infirmary|Bristol Royal Hospital for Children|Cardiff and Vale University Health Board|Great North Children's Hospital|Great Ormond Street Hospital for Children NHS Foundation Trust|Oxford University Hospitals NHS Trust|Leeds Teaching Hospitals NHS Trust|Norfolk and Norwich University Hospitals NHS Foundation Trust|Nottingham Children's Hospital|Royal Alexandra Children's Hospital|Royal Hospital for Sick Children, Glasgow|Royal Manchester Children's Hospital|Royal Marsden NHS Foundation Trust|Northern Care Alliance NHS Group|Royal Sussex County Hospital|Sheffield Children's NHS Foundation Trust|St George's University Hospital National Health Service Foundation Trust|Swansea Bay University Health Board|University College London Hospitals|University Hospitals Coventry and Warwickshire National Health Service Trust|East Lancashire Hospitals National Health Service Trust|Imperial College Healthcare National Health Service Trust|National Heatlh Service Ayrshire and Arran",,"Child, Adult, Older Adult",1500.0,Other,Observational,2020-03-22,21/03/21,2021-03-21,11/05/20,20/05/20,"University Hospital Southampton NHS FT, Southampton, Hampshire",United Kingdom,Respiratory Diseases,1,5,364.0
4951.0,NCT04810949,Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml,,Terminated,COVID-19,Influenza A,Influenza B,H1N1 Influenza,,,,Dietary Supplement: Vitamine D3 supplementation|Dietary Supplement: Diet and sun exposure,Hospital Clinica Nova,All,"18 Years to 90 Years   (Adult, Older Adult)",41.0,Other,Interventional,2020-05-08,01/03/21,2021-01-03,23/03/21,23/03/21,"Hospital Clinica Nova de Monterrey, San Nicolás De Los Garza, Nuevo León",Mexico,"Infectious Diseases, Respiratory Diseases",1,4,240.0
4952.0,NCT04425616,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,,Recruiting,Cancer,COVID-19,,,,,,Other: Exercise|Behavioral: Psychological and Behaviour Change Support|Other: Nutrition,University Hospital Southampton NHS Foundation Trust|Macmillan Cancer Support|CanRehab Trust|Wessex Cancer Alliance,All,"18 Years and older   (Adult, Older Adult)",1100.0,Other,Interventional,2020-04-06,30/11/21,2022-11-30,11/06/20,25/01/21,"University Hospital Southampton NHS FT, Southampton",United Kingdom,"Respiratory Diseases, Cancers",1,2,968.0
4953.0,NCT04282135,Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling,,Completed,Influenza,,,,,,,Diagnostic Test: MCC IMS,Klinikum Bayreuth GmbH,All,"18 Years and older   (Adult, Older Adult)",76.0,Industry,Observational,2020-02-15,08/05/20,2020-06-30,24/02/20,14/07/20,"Klinikum Bayreuth, Bayreuth",Germany,Infectious Diseases,0,1,136.0
4954.0,NCT04751227,Modafinil for Wakefulness in the Critical Care Units,,Completed,Critical Illness,COVID-19,Cognitive Dysfunction,,,,,Drug: Modafinil,King Faisal Specialist Hospital & Research Center,All,"18 Years to 90 Years   (Adult, Older Adult)",8.0,Other,Observational,2020-11-22,30/01/21,2021-01-30,12/02/21,12/02/21,"King Faisal Specialist Hospital and Research Center, Riyadh",Saudi Arabia,"Cardiovascular Diseases, Respiratory Diseases",1,3,69.0
4955.0,NCT04341584,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,CORIMUNO-ANA,Completed,Corona Virus Infection,,,,,,,Drug: Anakinra,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",161.0,Other,Interventional,2020-08-04,10/05/20,2020-07-25,10/04/20,01/02/21,"Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le Kremlin-Bicêtre",France,Respiratory Diseases,1,1,-10.0
4956.0,NCT04739462,SMS Maama Project COVID-19,,Recruiting,Pregnancy Complications,Birth Injuries,,,,,,Behavioral: mHealth Platform,University of Minnesota|Makerere University,Female,"18 Years and older   (Adult, Older Adult)",248.0,Other,Interventional,2021-03-02,01/02/22,2022-01-02,04/02/21,09/02/21,"University of Minnesota, Minneapolis, Minnesota, United States|Makerere University, Kampala",Uganda,Others,0,2,306.0
4957.0,NCT04519437,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",,"Active, not recruiting",Healthy,Chronic Stable Illness,,,,,,Drug: REGN10933+REGN10987|Drug: Placebo,Regeneron Pharmaceuticals,All,"18 Years to 90 Years   (Adult, Older Adult)",974.0,Industry,Interventional,2020-07-26,25/10/21,2021-10-25,19/08/20,02/12/20,"Regeneron Study Site, Tempe, Arizona, United States|Regeneron Study Site, Rogers, Arkansas, United States|Regeneron Study Site, Sacramento, California, United States|Regeneron Study Site, Miami, Florida, United States|Regeneron Study Site, Lincoln, Nebraska, United States|Regeneron Study Site, Dayton, Ohio, United States|Regeneron Study Site, Austin, Texas",United States,Others,0,2,456.0
4958.0,NCT04621058,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,,Recruiting,SAR,SARS Pneumonia,,,,,,Drug: Vitamin D|Drug: PLACEBO,Bioaraba Health Research Institute|Fundación Eduardo Anitua,All,"Child, Adult, Older Adult",108.0,Other,Interventional,2020-09-11,30/11/21,2021-11-30,09/11/20,23/12/20,"Joaquín Durán Cantolla, Vitoria-Gasteiz, Alava",Spain,Respiratory Diseases,1,2,445.0
4959.0,NCT04548934,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,,Completed,Cardiopulmonary Resuscitation,Personal Protective Equipment,,,,,,Device: Personal protective equipment (PPE)|Device: No Personal protective equipment (PPE),Institute of Mountain Emergency Medicine,All,18 Years to 60 Years   (Adult),34.0,Other,Interventional,2020-09-13,31/10/20,2021-01-31,16/09/20,02/02/21,"Headquarter of Croce Bianca EMS organization, Bolzano",Italy,Others,0,2,140.0
4960.0,NCT04486729,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,,Recruiting,COVID-19,"ARDS, Human",,,,,,Other: High PEEP with end inspiratory pause|Other: Low PEEP - FiO2 high|Other: High PEEP without end inspiratory pause|Other: Low PEEP - FiO2 low,Sanatorio Anchorena San Martin,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-01-07,10/10/20,2020-10-20,27/07/20,27/07/20,"Sanatorio Anchorena San Martin, San Martin, Buenos Aires",Argentina,Respiratory Diseases,1,2,287.0
4961.0,NCT04435379,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,,"Active, not recruiting","Infection, Respiratory Tract",,,,,,,Biological: VPM1002|Biological: Placebo,Vakzine Projekt Management GmbH|FGK Clinical Research GmbH,All,"60 Years and older   (Adult, Older Adult)",2038.0,Industry,Interventional,2020-06-18,30/09/21,2021-09-30,17/06/20,01/02/21,"Hautarztpraxis Dres. Leitz & Kollegen, Stuttgart, Baden-Württemberg, Germany|MECS Cottbus GmbH, Cottbus, Brandenburg, Germany|Studienzentrum Dr. Keller, Frankfurt, Hessen, Germany|Klinische Forschung Hannover Mitte GmbH, Hannover, Niedersachsen, Germany|Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany|Medizentrum Essen Borbeck, Essen, Nordrhein-Westfalen, Germany|BAG Dres. med. Quist PartG, Mainz, Rheinland-Pfalz, Germany|SIBAmed GmbH & Co. KG, Leipzig, Sachsen, Germany|SocraTec R&D GmbH, Erfurt, Thüringen, Germany|emovis GmbH, Berlin, Germany|Klinische Forschung Berlin GbR, Berlin, Germany|Klinische Forschung Hamburg GmbH, Hamburg",Germany,Others,0,1,469.0
4962.0,NCT04407663,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",,Completed,Bariatric Surgery Candidate,Patient Underwent Bariatric Surgery,,,,,,Other: Telemedicine to remote outpatient visit in bariatric patient,"University of Campania ""Luigi Vanvitelli""",All,"18 Years and older   (Adult, Older Adult)",138.0,Other,Observational,2020-03-03,04/05/20,2020-04-05,29/05/20,29/05/20,"University of Campania Luigi Vanvitelli, Naples",Italy,Others,0,2,33.0
4963.0,NCT04369690,"The Psychological, Social, and Economic Impacts of COVID-19",C19Survey,Recruiting,COVID-19,Chronic Disease,Psychiatric Disorder,Cardiovascular Diseases,,,,,University of Ottawa|Hopital du Sacre-Coeur de Montreal|Sunnybrook Health Sciences Centre|Southlake Regional Health Centre|The Ottawa Hospital Research Institute|Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal|Centre for Addiction and Mental Health|CHEO Research Institute|Ottawa Heart Institute Research Corporation|McGill University|Johns Hopkins University|Université de Montréal|The Royal's Institute of Mental Health Research,All,"12 Years and older   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-03-04,03/04/21,2021-03-04,30/04/20,30/04/20,"Southlake Regional Health Centre, Newmarket, Ontario, Canada|CHEO Research Institute, Ottawa, Ontario, Canada|The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada|The Centre for Addiction and Mental Health, Ottawa, Ontario, Canada|The University of Ottawa Heart Institute, Ottawa, Ontario, Canada|The Royal's Institute of Mental Health Research, Ottawa, Ontario, Canada|Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal), Montréal, Quebec, Canada|McGill University, Montréal, Quebec, Canada|University of Montréal, Montréal, Quebec",Canada,Respiratory Diseases,1,4,365.0
4964.0,NCT04492527,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,,Recruiting,Chronic Disease,Aging,Aging Problems,Health Behavior,Multiple Chronic Conditions,Chronic Illness,"Chronic Illnesses, Multiple",Behavioral: Telehealth coaching sessions,University of British Columbia,All,65 Years and older   (Older Adult),75.0,Other,Interventional,2020-07-28,30/06/21,2021-07-31,30/07/20,31/07/20,"University of British Columbia, Vancouver, British Columbia",Canada,Others,0,7,368.0
4965.0,NCT04393077,Emotional Freedom Technique (EFT) Effect on Nurses,,Completed,Stress,Anxiety,"Burnout, Caregiver",,,,,Behavioral: Emotional Freedom Technique,Istanbul Saglik Bilimleri University,All,"18 Years to 65 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-10-05,15/05/20,2020-05-20,19/05/20,24/11/20,"Medeniyet University, Istanbul",Turkey,Mental Health,1,3,-138.0
4966.0,NCT04423042,Tocilizumab in Coronavirus-19 Positive Patients,,Not yet recruiting,COVID-19,COVID-19,Severe Acute Respiratory Syndrome Coronavirus 2,Coronavirus,Inflammation,,,Biological: Tocilizumab,University of Calgary,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-30,01/06/21,2021-01-06,09/06/20,22/07/20,,,Respiratory Diseases,1,5,160.0
4967.0,NCT04693689,"Novelty, Conformity and Trust in Vaccines",,Recruiting,Trust,,,,,,,Other: RNA vaccine|Other: 20% adoption rate|Other: 40% adoption rate|Other: 60% adoption rate|Other: 80% adoption rate|Other: Conventional vaccine|Other: 0% adoption rate,"National University, Singapore",All,"18 Years and older   (Adult, Older Adult)",32400.0,Other,Interventional,2021-01-02,30/03/21,2021-03-30,05/01/21,03/03/21,"SurveyMonkey, San Mateo, California",United States,Others,0,1,87.0
4968.0,NCT04386291,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,,Recruiting,Generalized Anxiety,Health Anxiety,,,,,,Behavioral: Anxiety Reduction Training|Behavioral: Kundalini Yoga and Anxiety Reduction Training|Behavioral: Meditation and Anxiety Reduction Training,"Research Foundation for Mental Hygiene, Inc.",All,"18 Years to 70 Years   (Adult, Older Adult)",360.0,Other,Interventional,2020-05-25,19/05/21,2022-01-30,13/05/20,01/07/20,"ProofPilot (Virtual Study: https://proofpilot.com/covid-anxiety/), New York, New York, United States|Columbia University Department of Psychiatry, New York, New York",United States,Mental Health,1,2,615.0
4969.0,NCT04341012,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,,Recruiting,Liver Diseases,Liver Cancer,COVID-19,,,,,Diagnostic Test: Collection of breath sample,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2019-10-09,31/12/21,2021-12-31,10/04/20,13/04/20,"Mayo Clinic Florida, Jacksonville, Florida",United States,"Respiratory Diseases, Cancers",1,3,814.0
4970.0,NCT04388644,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,,Recruiting,Corona Virus Infection,,,,,,,,Taipei City Hospital|National Yang Ming University,All,"20 Years to 65 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-02-20,20/05/20,2020-05-30,14/05/20,14/05/20,"Branch of Chinese Medicine, Taipei City Hospital, Taipei, Taiwan|Branch of Linsen Chinese Medicine and Kunming, Taipei City Hospital, Taipei, Taiwan|Taipei City Hospital, Taipei",Taiwan,Respiratory Diseases,1,1,100.0
4971.0,NCT04337983,Hemodynamic Characteristics of Patients With SARS-CoV-2,PiCCOVID,Recruiting,Coronavirus,COVID-19,COVID-19,Acute Respiratory Distress Syndrome,Shock,Acute Circulatory Failure,Left Ventricular Dysfunction,Device: Transpulmonary thermodilution|Device: Echocardiography,Bicetre Hospital,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-03-13,01/10/20,2021-01-04,08/04/20,09/07/20,"Bicetre Hospital, Paris, Val-de-Marne",France,Respiratory Diseases,1,7,297.0
4972.0,NCT04603651,Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19,,No longer available,COVID-19,,,,,,,Drug: Bamlanivimab,Eli Lilly and Company|AbCellera Biologics Inc.,All,"12 Years and older   (Child, Adult, Older Adult)",,Industry|Other,Expanded Access:Individual Patients,,,,27/10/20,06/04/21,,,Respiratory Diseases,1,1,
4973.0,NCT04639349,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,,Recruiting,Chronic Obstructive Pulmonary Disease,,,,,,,Behavioral: exercise group|Other: control group,Cairo University,Male,"50 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-11-19,01/03/21,2021-01-03,20/11/20,20/11/20,"Faculty of Physical Therapy Cairo University, Giza, Dokki",Egypt,Others,0,1,45.0
4974.0,NCT03226886,TRACERx Renal CAPTURE Sub-study,TRACERxRenal,Recruiting,Renal Cell Carcinoma,Cancer,Healthy Volunteers,,,,,,Royal Marsden NHS Foundation Trust|The Francis Crick Institute,All,"18 Years and older   (Adult, Older Adult)",360.0,Other,Observational,2012-05-02,01/09/23,2023-01-09,24/07/17,25/08/20,"Edinburgh Western General Hospital, Edinburgh, Scotland, United Kingdom|Guy's & St Thomas Hospital, London, UK, United Kingdom|Barts Health NHS Trust, London, United Kingdom|Royal Free Hospital, London",United Kingdom,Cancers,1,3,3904.0
4975.0,NCT04322773,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,TOCIVID,Terminated,Corona Virus Disease,,,,,,,Drug: RoActemra iv|Drug: RoActemra sc|Drug: Kevzara sc|Other: Standard medical care,Marius Henriksen|Frederiksberg University Hospital,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-05-04,08/10/20,2020-08-10,26/03/20,09/10/20,"Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark|Hillerød Hospital, Hillerød",Denmark,Others,0,1,98.0
4976.0,NCT04702178,A Clinical Trial of COVAC-2 in Healthy Adults,,Recruiting,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Biological: COVAC-2|Biological: Saline Placebo,University of Saskatchewan|Government of Canada|Government of Saskatchewan|Vaccine Formulation Institute (VFI)|SEPPIC,All,"18 Years and older   (Adult, Older Adult)",108.0,Other,Interventional,2021-10-02,01/10/22,2023-01-02,08/01/21,01/04/21,"Canadian Center for Vaccinology, Dalhousie University, Halifax, Nova Scotia",Canada,Respiratory Diseases,1,1,457.0
4977.0,NCT04426318,COVID-19 and the Healthy Minds Program for Educators,CAHMP-ED,Completed,Anxiety,Depression,Psychological Stress,Psychological Distress,Well-being,,,Behavioral: Healthy Minds Program Foundations Training,"University of Wisconsin, Madison|Chan Zuckerberg Initiative|Healthy Minds Innovations|Center for Healthy Minds",All,"18 Years and older   (Adult, Older Adult)",733.0,Other,Interventional,2020-06-14,12/01/21,2021-12-01,11/06/20,26/01/21,"University of Wisconsin, Madison, Wisconsin",United States,Mental Health,1,5,535.0
4978.0,NCT04679909,Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study),,Recruiting,Healthy Volunteers,,,,,,,Biological: AdCOVID|Other: Placebo,"Altimmune, Inc.",All,18 Years to 55 Years   (Adult),180.0,Industry,Interventional,2021-01-02,01/02/22,2022-01-02,22/12/20,24/02/21,"Optimal Research, Melbourne, Florida, United States|Optimal Research, Peoria, Illinois, United States|Optimal Research, Rockville, Maryland, United States|Optimal Research, Austin, Texas",United States,Others,0,1,365.0
4979.0,NCT04255940,2019-nCoV Outbreak and Cardiovascular Diseases,,Recruiting,Cardiovascular Death; Major Adverse Cardiovascular Events,,,,,,,,Qilu Hospital of Shandong University,All,"Child, Adult, Older Adult",12000.0,Other,Observational,2020-01-20,30/04/20,2020-04-30,05/02/20,05/02/20,"Affiliated Hospital of Binzhou Medical Universty, Binzhou, Shandong, China|Heze Municipal Hospital, Heze, Shandong, China|Shandong University Qilu Hospital, Jinan, Shandong, China|Jinan Central Hospital, Shandong University, Jinan, Shandong, China|First Hospital Affiliated with Shandong First Medical University, Jinan, Shandong, China|Shandong Provincial Hospital, Shandong University, Jinan, Shandong, China|The Second Hospital of Shandong University, Jinan, Shandong, China|Jining Hospital of Traditional Chinese Medicine, Jining, Shandong, China|Qihe People's Hospital, Qihe, Shandong, China|Affiliated Hospital of Qingdao University Medical College, Qingdao, Shandong, China|Weihai Municipal Hospital, Weihai, Shandong, China|Central Hospital of Zibo, Zibo, Shandong",China,Others,0,1,101.0
4980.0,NCT04371601,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,,"Active, not recruiting",COVID-19,,,,,,,Drug: Oseltamivir|Drug: hormones|Device: oxygen therapy|Procedure: mesenchymal stem cells,Fuzhou General Hospital,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-03,31/12/21,2022-12-31,01/05/20,01/05/20,"Fuzhou General Hospital, Fuzhou, Fujian",China,Respiratory Diseases,1,1,1093.0
4981.0,NCT04323527,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,CloroCOVID19,Completed,SARS-CoV Infection,Severe Acute Respiratory Syndrome (SARS) Pneumonia,,,,,,Drug: Chloroquine diphosphate,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado|Marcus Vinícius Guimarães de Lacerda|Mayla Gabriela Silva Borba|Wuelton Marcelo Monteiro|Gisely Cardoso de Melo|Fernando Fonseca de Almeida e Val|Felipe Gomes Naveca|Maria Paula Gomes Mourão|Ludmila Abrahão Hajjar|Jorge Souza Mendonça,All,"18 Years and older   (Adult, Older Adult)",278.0,Other,Interventional,2020-03-23,07/05/20,2020-07-06,26/03/20,07/07/20,"Hospital e Pronto Socorro Delphina Rinaldi Abdel Aziz, Manaus, Amazonas",Brazil,Respiratory Diseases,1,2,105.0
4982.0,NCT04749173,"To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.",,Recruiting,COVID-19,,,,,,,Drug: DWRX2003,Daewoong Pharmaceutical Co. LTD.,All,19 Years to 55 Years   (Adult),24.0,Industry,Interventional,2020-11-21,28/03/21,2021-06-30,11/02/21,16/02/21,"Chungnam National university hospital, Daejeon, Korea",Republic of,Respiratory Diseases,1,1,221.0
4983.0,NCT04607915,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,,Not yet recruiting,Type 2 Diabetes,,,,,,,Behavioral: Intervention for TECC Model,Centre for Addiction and Mental Health,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-05-02,31/03/21,2021-03-31,29/10/20,04/02/21,,,Metabolic Disorders,1,1,-32.0
4984.0,NCT04781218,ABC Science Collaborative Registry Study,,Not yet recruiting,COVID-19,,,,,,,,Duke University,All,"Child, Adult, Older Adult",1000000.0,Other,Observational,2021-06-15,15/03/26,2026-03-15,04/03/21,09/04/21,,,Respiratory Diseases,1,1,1734.0
4985.0,NCT04460599,Neurological Features During COVID19,NeuroSARS,Recruiting,Encephalitis,,,,,,,Other: Observation,Centre d'Investigation Clinique et Technologique 805,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-08-03,30/07/20,2020-09-30,07/07/20,09/07/20,"Hopital Raymond Poincare, Garches",France,Others,0,1,58.0
4986.0,NCT04656626,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,,Completed,"Stress, Psychological",,,,,,,Behavioral: brief mindfulness based intervention|Behavioral: Progressive muscle relaxation,Imam Abdulrahman Bin Faisal University,All,"22 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-07-07,21/07/20,2020-05-09,07/12/20,10/12/20,"Imam Abdulrahman Bin Faisal University, Dammam",Saudi Arabia,Mental Health,1,1,-59.0
4987.0,NCT04480606,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,,Not yet recruiting,Exercise Program,,,,,,,Behavioral: Home exercise program,Istinye University,All,65 Years to 80 Years   (Older Adult),88.0,Other,Interventional,2020-01-08,20/11/20,2020-11-20,21/07/20,21/07/20,,,Others,0,1,317.0
4988.0,NCT04311398,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: New QIAstat-Dx fully automatic multiple PCR detection platform,Huashan Hospital,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-05-13,01/06/20,2020-01-12,17/03/20,14/05/20,"Huashan Hospital of Fudan University, Shanghai, Shanghai",China,Respiratory Diseases,1,1,-122.0
4989.0,NCT04578210,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,RELEASE,Recruiting,Corona Virus Infection,,,,,,,Biological: T memory cells and NK cells,Instituto de Investigación Hospital Universitario La Paz|Universidad Autonoma de Madrid|Universidad Miguel Hernandez de Elche|Biocruces Bizkaia Health Research Institute|Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana,All,"up to 80 Years   (Child, Adult, Older Adult)",58.0,Other,Interventional,2020-04-09,01/01/21,2021-01-03,08/10/20,19/10/20,"Hospital Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,1,269.0
4990.0,NCT04747990,coMpliAnce With evideNce-based cliniCal Guidelines in the managemenT of Acute biliaRy pancreAtitis,MANCTRA-1,Not yet recruiting,Acute Pancreatitis,Acute Pancreatic Necrosis,Acute Pancreatitis Due to Gallstones,Acute Pancreatic Fluid Collection,Acute Pancreatitis With Infected Necrosis,Acute Pancreatitis Without Necrosis or Infection,Acute Pancreatitis Due to Common Bile Duct Calculus,Procedure: Early Definitive Treatment,"University of Cagliari|Chiara Gerardi - Istituto Di Ricerche Farmacologiche Mario Negri|Federico Coccolini - General, Emergency and Trauma Surgery, Pisa|Salomone di Saverio -Department of Surgery, Varese|Gianluca Pellino - Universitá degli Studi della Campania 'Luigi Vanvitelli', Naples|Francesco Pata - General Surgery Unit, Nicola Giannettasio Hospital, Corigliano-Rossano|Benedetto Ielpo - HPB Surgery Unit, Hospital del Mar, Barcelona|Francesco Virdis - Trauma and Acute Care Surgery Unit, Milan|Dimitrios Damaskos - Royal Infirmary of Edinburgh, Edinburgh|Stavros Gourgiotis - Addenbrooke's Hospital, Cambridge|Gaetano Poillucci - Department of Surgery ""Paride Stefanini"", Rome|Daniela Pacella - University of Naples Federico II, Naples|Kumar Jayant- University of Chicago, USA|Ferdinando Agresta- Vittorio Veneto Civil Hospital, Italy|Ari Leppaniemi - University of Helsinki, Finland|Fausto Catena - Maggiore Hospital, Parma|Yoram Kluger - Rambam Health care campus, Haifa|Adolfo Pisanu - University of Cagliari, Cagliari",All,"16 Years and older   (Child, Adult, Older Adult)",600.0,Other,Observational,2021-01-03,01/07/21,2021-01-09,10/02/21,23/02/21,,,Others,0,7,6.0
4991.0,NCT04393636,Digital Cardiac Counseling Trial: DCC Trial,DCC,Recruiting,Cardiovascular Diseases,Cardiovascular Risk Factor,,,,,,Other: Digital cardiac Counseling,Academisch Ziekenhuis Maastricht,All,"18 Years and older   (Adult, Older Adult)",394.0,Other,Interventional,2020-05-06,31/12/22,2022-12-31,19/05/20,09/06/20,"Maastricht University Medical Center, Maastricht",Netherlands,Others,0,2,969.0
4992.0,NCT04408196,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,,Completed,Rehabilitation,,,,,,,,Fondazione Don Carlo Gnocchi Onlus,All,"18 Years and older   (Adult, Older Adult)",121.0,Other,Observational,2020-05-26,15/02/21,2021-02-22,29/05/20,26/02/21,"Don Gnocchi Foundation, Rome",Italy,Others,0,1,272.0
4993.0,NCT04333251,Study Testing Convalescent Plasma vs Best Supportive Care,,Not yet recruiting,"Pneumonia, Interstitial",,,,,,,Biological: high-titer anti-Sars-CoV-2 plasma|Other: oxygen therapy,Baylor Research Institute,All,"18 Years and older   (Adult, Older Adult)",115.0,Other,Interventional,2020-01-04,31/12/22,2022-12-31,03/04/20,06/04/20,,,Respiratory Diseases,1,1,1092.0
4994.0,NCT04644172,Improving Thinking in Everyday Life After Covid-19,,Recruiting,COVID-19,Cognitive Impairment,,,,,,Behavioral: Speed of Processing Training|Behavioral: Instrumental Activities of Daily Living Shaping|Behavioral: Transfer Package from CI Therapy|Other: Usual Care,University of Alabama at Birmingham,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-11,01/11/23,2024-01-11,25/11/20,25/11/20,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,2,1461.0
4995.0,NCT04760795,"Stress, Personality, Attachment and Coping During the Covid Crisis.",STERACOVID,Recruiting,Psychiatric Disorder,Aging,,,,,,Other: PTSD Check List (PCL) scale|Other: Brief COPE scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (during containment)|Other: Analog scale|Other: GAD-7 (Generalized Anxiety Disorder) scale (post containment)|Other: Big Five Inventory (BFI) scale|Other: Relationship Scales Questionnaire (RSQ),Centre Hospitalier Universitaire de Saint Etienne,All,65 Years and older   (Older Adult),118.0,Other,Observational,2020-11-15,01/06/21,2021-01-06,18/02/21,18/02/21,"CH Le Vinatier, Bron, France|Chu Saint-Etienne, Saint-Étienne",France,Others,0,2,52.0
4996.0,NCT04821986,Oral Manifestation in Patients With SARS-CoV2 Infection.,,Not yet recruiting,SARS-CoV Infection,,,,,,,,Fayoum University,All,18 Years to 60 Years   (Adult),600.0,Other,Observational,2021-01-04,30/05/21,2021-06-15,30/03/21,01/04/21,,,Respiratory Diseases,1,1,162.0
4997.0,NCT04617262,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,PM+,Recruiting,Depression,Anxiety Disorders,Psychological Distress,,,,,Behavioral: Remote Problem Management Plus,The New School|George Washington University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-05-01,01/08/21,2021-01-09,05/11/20,03/03/21,"The New School, New York, New York",United States,Mental Health,1,3,-112.0
4998.0,NCT04569266,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,RECOVER,Recruiting,Dyspnea,,,,,,,Other: specific exercise rehabilitation treatment,Groupe Hospitalier Paris Saint Joseph|Centre Hospitalier de Versailles André Mignot|Centre Hospitalier Victor Dupouy|Groupe Hospitalo-Universitaire Paris (Hôpital Saint-Anne),All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-07-08,07/11/21,2022-07-05,29/09/20,29/09/20,"Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France",France,Others,0,1,727.0
4999.0,NCT04473300,Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography,,Recruiting,Critical Illness,ARDS,,,,,,,Osaka University|Hospital Rebagliati,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-11-05,31/08/20,2020-08-31,16/07/20,16/07/20,"Osaka University Hospital, Suita, Osaka",Japan,"Cardiovascular Diseases, Respiratory Diseases",1,2,-66.0
5000.0,NCT04344184,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),,Recruiting,COVID-19,"Lung Injury, Acute",Kidney Injury,,,,,Drug: L-ascorbic acid|Other: Placebo,Virginia Commonwealth University,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-12-18,01/05/21,2021-01-05,14/04/20,09/02/21,"Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States|Virginia Commonwealth University, Richmond, Virginia",United States,Respiratory Diseases,1,3,18.0
5001.0,NCT04721444,Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19),OCTAPUS-AI,Recruiting,Lung Cancer,COVID-19,Pneumonitis,,,,,Diagnostic Test: Machine Learning Classification of parenchymal lung change cause|Diagnostic Test: Machine Learning Classification of recurrence and non-recurrence,Royal Marsden NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2021-01-03,01/08/22,2023-01-01,22/01/21,05/02/21,"Guys and St. Thomas' NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Royal Marsden NHS Foundation Trust, London",United Kingdom,"Respiratory Diseases, Cancers",1,3,728.0
5002.0,NCT04061382,Sero-epidemiological Survey of England in 2019/2020,STORY,Recruiting,Serogroup C Meningococcal Meningitis,Diphtheria,COVID-19,,,,,Procedure: Venepuncture|Procedure: Oral fluid swab,University of Oxford,All,"up to 24 Years   (Child, Adult)",2800.0,Other,Observational,2019-10-15,31/05/21,2021-06-30,19/08/19,11/03/21,"Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford, Oxfordshire",United Kingdom,Respiratory Diseases,1,3,624.0
5003.0,NCT04416919,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,,"Active, not recruiting",Coronavirus Infection,Disease Prevention,,,,,,Other: Assembled mask,University of Oklahoma|US Department of Veterans Affairs,All,"18 Years and older   (Adult, Older Adult)",20.0,Other|U.S. Fed,Interventional,2020-05-20,01/06/20,2021-01-07,04/06/20,05/03/21,"Oklahoma City VA Health Care System, Oklahoma City, Oklahoma",United States,Respiratory Diseases,1,2,232.0
5004.0,NCT04342702,A Study on the Prospective Cohort Library of COVID-19 in Southeran,,"Active, not recruiting",Follow-up,COVID-19,Infectious Diseases,Respiratory,,,,,Second Affiliated Hospital of Wenzhou Medical University|Wenzhou Medical University|First Affiliated Hospital of Wenzhou Medical University|Wenzhou Central Hospital And Sixth People's Hospital of Wenzhou Medical University|Yueqing Hospital of Wenzhou Medical University|Ruian Hospital of Wenzhou Medical University|Cangnan Hospital of Wenzhou Medical University|Pingyang Hospital of Wenzhou Medical University|Yongjia People's Hospital,All,"Child, Adult, Older Adult",504.0,Other,Observational,2020-03-16,01/03/21,2021-01-03,13/04/20,05/05/20,"Wenzhou Medical University, Wenzhou, Zhejiang, China|The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang",China,Respiratory Diseases,1,4,293.0
5005.0,NCT04424355,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,,Recruiting,Coronavirus Infections,Pneumonia,,,,,,Diagnostic Test: Chest MRI,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,All,"18 Years and older   (Adult, Older Adult)",115.0,Other,Observational,2020-05-19,19/07/21,2021-12-20,09/06/20,10/12/20,"Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department, Moscow",Russian Federation,Respiratory Diseases,1,2,580.0
5006.0,NCT04535778,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,COMPASS,Recruiting,Treatment of Illness-related Distress in Physical LTCs,,,,,,,Behavioral: COMPASS|Behavioral: Standard charity resources,King's College London|MS Society|Diabetes UK|National Rheumatoid Arthritis Society (NRAS)|Kidney Care UK,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-11-16,01/06/21,2021-01-06,02/09/20,12/02/21,"Health Psychology Section, London",United Kingdom,Others,0,1,51.0
5007.0,NCT04357340,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,,Completed,COVID-19,Pneumonia,SARS Pneumonia,,,,,Other: Pulmonary Physiotherapy Techniques,Tehran University of Medical Sciences,All,"18 Years to 75 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-02-04,30/04/20,2020-05-30,22/04/20,02/06/20,"Imam Khomeini Hospital Complex, Tehran, Iran",Islamic Republic of,Respiratory Diseases,1,3,116.0
5008.0,NCT04361552,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),,Withdrawn,Cerebrovascular Accident,Chronic Obstructive Pulmonary Disease,Chronic Renal Failure,Coronary Artery Disease,Diabetes Mellitus,Malignant Neoplasm,SARS Coronavirus 2 Infection,Other: Best Practice|Biological: Tocilizumab,Emory University|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",0.0,Other|NIH,Interventional,2020-07-04,02/06/20,2020-02-06,24/04/20,18/06/20,"Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia",United States,"Respiratory Diseases, Cardiovascular Diseases, Metabolic Disorders",1,7,-149.0
5009.0,NCT04427631,Exploring Interventions for Glue Ear During Covid-19,BIG-C,Not yet recruiting,Hearing Impaired Children,Glue Ear,"Hearing Loss, Conductive",,,,,Device: Bone conduction headphones,Cambridgeshire Community Services NHS Trust|Cambridge University Hospitals NHS Foundation Trust,All,3 Years to 11 Years   (Child),20.0,Other,Interventional,2020-06-22,01/01/21,2021-01-06,11/06/20,11/06/20,"Peacock Children's centre. Brookfields Hospital, Cambridge, Cambridgeshire",United Kingdom,Others,0,3,198.0
5010.0,NCT04347031,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,,Completed,"Pneumonia, Viral",Respiratory Failure,,,,,,Drug: Mefloquine|Drug: Hydroxychloroquine|Combination Product: Mefloquine + azithromycin + / - tocilizumab|Combination Product: Hydroxychloroquine + azithromycin + / - tocilizumab,Burnasyan Federal Medical Biophysical Center,All,18 Years to 60 Years   (Adult),320.0,Other,Interventional,2020-08-04,01/11/20,2020-11-20,15/04/20,27/01/21,"Burnasyan Federal Medical Biophysical Center FMBA of Russia, Moscow",Russian Federation,Respiratory Diseases,1,2,108.0
5011.0,NCT04389580,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Combination,Not yet recruiting,COVID-19,,,,,,,Drug: Drug: Isotretinoin plus Tamoxifen|Drug: Aerosolized Isotretinoin plus Tamoxifen,Kafrelsheikh University,All,"18 Years to 70 Years   (Adult, Older Adult)",160.0,Other,Interventional,2020-01-06,01/08/20,2020-01-09,15/05/20,04/06/20,,,Respiratory Diseases,1,1,3.0
5012.0,NCT04380701,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy and Immunocompromised Adults,,Recruiting,"Infections, Respiratory",Virus Diseases,Infection Viral,Vaccine Adverse Reaction,RNA Virus Infections,COVID-19,,Biological: BNT162a1|Biological: BNT162b1|Biological: BNT162b2|Biological: BNT162c2,BioNTech SE,All,"18 Years to 85 Years   (Adult, Older Adult)",456.0,Industry,Interventional,2020-04-23,01/04/23,2023-01-04,08/05/20,03/02/21,"Contract Research Organization, Berlin, Germany|Universitäts Klinikum, Frankfurt am Main, Germany|Universitäts Klinikum, Heidelberg, Germany|Contract Research Organization, Kiel, Germany|Contract Research Organization, Mannheim",Germany,Respiratory Diseases,1,6,986.0
5013.0,NCT04665778,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,3PU-SSE,Recruiting,COVID-19,Emergencies,,,,,,Other: hospital bedroom booking,"Centre Hospitalier Universitaire, Amiens",All,"18 Years and older   (Adult, Older Adult)",1516.0,Other,Observational,2020-04-12,01/03/21,2021-01-03,14/12/20,14/12/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,2,266.0
5014.0,NCT04615195,Effect of COVID19-related COntainment in ChildreN,E-COCCON,Recruiting,Post Traumatic Stress Disorder,,,,,,,Other: cries 13 questionnaire,"University Hospital, Toulouse",All,8 Years to 15 Years   (Child),1000.0,Other,Observational,2020-10-06,02/07/20,2020-11-30,04/11/20,04/11/20,"UHToulouse, Toulouse",France,Mental Health,1,1,55.0
5015.0,NCT04419545,Covid Radiographic Images Data-set for A.I,CORDA,Recruiting,Radiology,Artificial Intelligence,,,,,,Diagnostic Test: Neural network diagnosis algorithm,"Azienda Ospedaliera Città della Salute e della Scienza di Torino|University of Turin, Italy|Azienda Ospedaliera Ordine Mauriziano di Torino",All,"Child, Adult, Older Adult",2500.0,Other,Observational,2020-03-24,31/12/20,2021-03-31,05/06/20,05/06/20,"Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Torino, Turin",Italy,Others,0,2,372.0
5016.0,NCT04400279,The COVID-19 Pandemic and Exercise Study,COPE,Completed,Depressive Symptomatology,Psychological Distress,Health Behavior,,,,,Behavioral: Yoga group|Behavioral: High Intensity Interval Training group|Behavioral: Combination,University of British Columbia,All,18 Years to 64 Years   (Adult),334.0,Other,Interventional,2020-01-06,28/11/20,2020-11-28,22/05/20,11/01/21,"University of British Columbia, Vancouver, British Columbia",Canada,Others,0,3,327.0
5017.0,NCT04542538,The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term Outcome,,"Active, not recruiting",Sepsis,Corona Virus Infection,"ARDS, Human",,,,,"Other: No intervention, observational study","Uppsala University|Center for Clinical Research Dalarna, Sweden",All,"18 Years and older   (Adult, Older Adult)",15000.0,Other,Observational,2018-11-04,04/06/20,2020-10-12,09/09/20,05/11/20,"Björn Ahlström, Falun",Sweden,Respiratory Diseases,1,3,708.0
5018.0,NCT04376034,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,,Recruiting,COVID-19,Coronavirus Infection,Coronavirus,Virus Diseases,RNA Virus Infections,,,Biological: Convalescent Plasma 1 Unit|Biological: Convalescent Plasma 2 Units|Other: Standard of Care,West Virginia University,All,"31 Days and older   (Child, Adult, Older Adult)",240.0,Other,Interventional,2020-04-16,30/03/21,2021-03-30,06/05/20,06/05/20,"WVU Medicine, Morgantown, West Virginia",United States,Respiratory Diseases,1,5,348.0
5019.0,NCT02788903,A Patient-Centered PaTH to Addressing Diabetes,,"Active, not recruiting",Obesity,Diabetes,COVID-19,,,,,Other: Weight Counseling|Other: Telemedicine,Milton S. Hershey Medical Center|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",2000000.0,Other,Observational,2016-01-03,01/05/21,2021-01-05,02/06/16,03/03/21,,,"Respiratory Diseases, Metabolic Disorders",1,3,1829.0
5020.0,NCT04514705,Characteristics in Post Covid-19 Patients,,Recruiting,Coronavirus Infection,,,,,,,Other: Exercise,Universidade Metodista de Piracicaba,All,"18 Years to 80 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-11-08,31/12/21,2021-12-31,17/08/20,17/08/20,"Universidade do Estado do Pará, Belém, Pará",Brazil,Respiratory Diseases,1,1,418.0
5021.0,NCT04480112,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,,Enrolling by invitation,Memory Disorders,Alzheimer Disease,Mild Cognitive Impairment,,,,,Behavioral: Technology based social interactions|Other: No research related technology based social interactions,Boston University,All,"Child, Adult, Older Adult",150.0,Other,Interventional,2020-02-06,01/05/21,2021-01-05,21/07/20,04/09/20,"Boston University Alzheimer Disease Center, Boston, Massachusetts",United States,Others,0,3,334.0
5022.0,NCT04762693,Digital Acoustic Surveillance for Early Detection of Respiratory Disease Outbreaks,,Recruiting,COVID-19,Cough,,,,,,Device: Hyfe cough tracker,"Clinica Universidad de Navarra, Universidad de Navarra|Centre de Recherche du Centre Hospitalier de l'Université de Montréal",All,"13 Years to 99 Years   (Child, Adult, Older Adult)",300.0,Other,Observational,2020-11-11,01/10/21,2021-01-11,21/02/21,24/02/21,"Universidad de Navarra, Pamplona, Navarra",Spain,Respiratory Diseases,1,2,61.0
5023.0,NCT04448054,"Imaging SARS-CoV-2 Involvement of Leptomeninges, Olfactory and Limbic Areas",ICILOLA,Recruiting,COVID-19,,,,,,,Other: MRI,Fondation Ophtalmologique Adolphe de Rothschild,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-20,20/11/21,2021-11-20,25/06/20,07/12/20,"Fondation A De Rothschild, Paris",France,Respiratory Diseases,1,1,549.0
5024.0,NCT04799132,Association Between Body Mass Index and HFNC Therapy Success,,Completed,COVID-19,Obesity,Overweight,"Pneumonia, Viral",,,,,Clínica del country,All,"18 Years and older   (Adult, Older Adult)",303.0,Other,Observational,2020-11-03,01/03/21,2021-01-03,16/03/21,16/03/21,"Clínica del Country., Bogotá",Colombia,"Metabolic Disorders, Respiratory Diseases",1,4,61.0
5025.0,NCT04427813,Sexual Health and Problems During the Covid -19 Infection,,Not yet recruiting,Sexual Behavior,,,,,,,Behavioral: questionaire to husband and wife,Aljazeera Hospital|Al-Azhar University,All,18 Years to 60 Years   (Adult),400.0,Other,Observational,2020-11-06,05/07/20,2020-12-07,11/06/20,11/06/20,"Algazeerah, Giza",Egypt,Others,0,1,31.0
5026.0,NCT04385576,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",,Recruiting,COVID-19,Airway,,,,,,Device: Aerosol Box|Device: Intubation Box,University of Malaya,All,"Child, Adult, Older Adult",30.0,Other,Interventional,2020-05-15,15/09/20,2020-12-30,13/05/20,13/05/20,"University Malaya Medical Centre, Kuala Lumpur, Selangor",Malaysia,Respiratory Diseases,1,2,229.0
5027.0,NCT04264533,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,,Terminated,Vitamin C,"Pneumonia, Viral","Pneumonia, Ventilator-Associated",,,,,Drug: VC|Drug: Sterile Water for Injection,ZhiYong Peng|Zhongnan Hospital,All,"18 Years and older   (Adult, Older Adult)",56.0,Other,Interventional,2020-02-14,02/03/20,2020-03-29,11/02/20,12/10/20,"Zhongnan Hospital of Wuhan University, Wuhan, Hubei",China,Respiratory Diseases,1,3,44.0
5028.0,NCT04348227,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,,"Active, not recruiting",Ventilator Associated Pneumonia,,,,,,,Behavioral: Enhanced hygiene measures,Hôpital Universitaire Fattouma Bourguiba,All,"Child, Adult, Older Adult",120.0,Other,Observational,2019-01-01,01/01/20,2021-04-02,16/04/20,17/04/20,"Department of anesthesia and intensive care, Fattouma Bourguiba Hospital, Monastir",Tunisia,Respiratory Diseases,1,1,822.0
5029.0,NCT04424836,HFNC Treatment in COVID-19 Pneumonia,,Completed,Coronavirus Infection,"Pneumonia, Viral",Acute Respiratory Failure,,,,,Device: high flow nasal cannula device,Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",43.0,Other,Observational,2020-05-15,04/06/20,2020-05-06,11/06/20,16/07/20,"Sisli Etfal Research and Training Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,-9.0
5030.0,NCT04516564,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",,Recruiting,COVID-19,,,,,,,Drug: AK119|Drug: Placebo,Akesobio Australia Pty Ltd|Akeso,All,18 Years to 55 Years   (Adult),32.0,Industry,Interventional,2020-01-09,01/03/21,2021-01-04,18/08/20,21/09/20,"Christchurch Clinical Studies Trust, Christchurch",New Zealand,Respiratory Diseases,1,1,361.0
5031.0,NCT04429594,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),CovImmune 2,Recruiting,Coronavirus Infections,,,,,,,Other: blood sampling,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-07-28,15/07/25,2025-12-31,12/06/20,19/10/20,"University Nice Hospital, Nice",France,Respiratory Diseases,1,1,1982.0
5032.0,NCT04308187,Influence of the COvid-19 Epidemic on STRESS,COVISTRESS,Not yet recruiting,"Stress, Psychological",,,,,,,,"University Hospital, Clermont-Ferrand|Faculty of Medicine, Clermont-Ferrand, France|UMR CNRS 6024 LaPSCo, Clermont-Ferrand, France|Wittyfit, Paris, France",All,"Child, Adult, Older Adult",50000.0,Other,Observational,2020-11-03,01/03/22,2022-01-03,13/03/20,13/03/20,"University Hospital, Clermont-Ferrand, Clermont-Ferrand",France,Mental Health,1,1,426.0
5033.0,NCT04632082,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,,Enrolling by invitation,Mental Health Wellness 1,COVID-19,Emotional Distress,Depressive Symptoms,Anxiety Symptoms,Irritability,Telepsychotherapy,Behavioral: Telepsychoeducation with personalized videos|Behavioral: Telepsychoeducation without personalized videos,Hospital de Clinicas de Porto Alegre,All,"Child, Adult, Older Adult",2200.0,Other,Interventional,2020-05-11,13/07/21,2021-07-20,17/11/20,20/11/20,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,"Mental Health, Respiratory Diseases",1,7,435.0
5034.0,NCT04678778,Virtual Reality Study - COVID-19 Protocol,NRVR,Recruiting,Healthy Aging,,,,,,,Behavioral: Physical and Cognitive Activity,University of Southern California,All,"50 Years to 85 Years   (Adult, Older Adult)",11.0,Other,Interventional,2019-03-19,17/02/21,2021-02-17,22/12/20,11/01/21,"Mark and Mary Stevens Neuroimaging and Informatics Institute of the University of Southern California, Los Angeles, California",United States,Others,0,1,701.0
5035.0,NCT04379531,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,LDCTiP,Completed,Pneumonia,Coronavirus Infection,,,,,,Diagnostic Test: Low-dose Chest CT,Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department,All,"18 Years and older   (Adult, Older Adult)",230.0,Other,Interventional,2020-04-25,22/05/20,2020-05-22,07/05/20,12/06/20,"Victor Gombolevskiy, Moscow",Russian Federation,Respiratory Diseases,1,2,27.0
5036.0,NCT04532632,Taste and Smell Impairment in Critically Ill COVID-19 Patients,,Completed,Smell Disorder,Taste Disorders,Coronavirus Infection,,,,,,Pinar Ay Sayin|Sisli Hamidiye Etfal Training and Research Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Observational,2020-01-09,01/10/20,2020-09-10,31/08/20,10/11/20,"Sisli Etfal Research and Training Hospital, Istanbul",Turkey,Respiratory Diseases,1,3,245.0
5037.0,NCT04337047,Distress in Crisis Situations During COVID-19,,Completed,"Stress, Psychological",,,,,,,Other: questionnaire assesment,Wefight,All,"18 Years and older   (Adult, Older Adult)",2000.0,Industry,Observational,2020-03-31,30/04/20,2020-03-05,07/04/20,05/05/20,"Wefight, Montpellier",France,Mental Health,1,1,-26.0
5038.0,NCT04734912,Evaluation of Transnasal Endoscopy During COVID-19 Pandemic,,Recruiting,Endoscopy,,,,,,,Other: gastroscopy in transnasal techique,Johannes Gutenberg University Mainz,All,"18 Years to 75 Years   (Adult, Older Adult)",500.0,Other,Interventional,2021-01-13,15/06/21,2021-12-31,02/02/21,02/02/21,"University Hospital Mainz, Mainz, Rhenanie-Palatinate",Germany,Others,0,1,352.0
5039.0,NCT04730284,Evaluation of a Synbiotic Formula in Patient With COVID-19,,Recruiting,Coronavirus,,,,,,,Other: Health supplements,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-08-25,30/09/21,2022-03-31,29/01/21,29/01/21,"Chinese University of Hong Kong, Hong Kong",Hong Kong,Respiratory Diseases,1,1,583.0
5040.0,NCT04766333,New Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked Occupations,,Not yet recruiting,COVID-19,Health Care Seeking Behavior,Health Behavior,,,,,Behavioral: Healthcare Worker Focused Outreach|Behavioral: Community Organization Led Outreach,"Rutgers, The State University of New Jersey",All,"4 Years and older   (Child, Adult, Older Adult)",2000.0,Other,Interventional,2021-01-03,01/02/22,2022-01-08,23/02/21,23/02/21,,,Respiratory Diseases,1,3,370.0
5041.0,NCT04522492,Impact of COVID-19 on Mental Health of Patients With Skin Picking,,"Active, not recruiting",Skin Picking,,,,,,,Behavioral: Internet-based Cognitive Behavioral Therapy|Other: Quality of life promotion,Hospital de Clinicas de Porto Alegre|Federal University of Rio Grande do Sul,All,"18 Years and older   (Adult, Older Adult)",18.0,Other,Interventional,2020-11-08,01/03/21,2021-01-06,21/08/20,22/01/21,"Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,Others,0,1,59.0
5042.0,NCT04510519,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,,Not yet recruiting,Major Depressive Disorder,Generalized Anxiety,,,,,,,"Kintsugi Mindful Wellness, Inc.",All,"18 Years to 100 Years   (Adult, Older Adult)",50.0,Industry,Observational,2020-01-09,30/06/21,2021-06-30,12/08/20,13/08/20,,,Mental Health,1,2,538.0
5043.0,NCT04661423,Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era,MONIREA,Not yet recruiting,Post ICU Rehabilitation,,,,,,,Other: Remote Automated Monitoring System,IHU Strasbourg|RDS SAS (Rhythm Diagnostic Systems),All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-01,01/06/22,2022-01-06,10/12/20,10/12/20,"Anesthesia Department, Central Hospital, Nancy, France|Anesthesia, Critical Care & Perioperative Medicine, Hautepierre, Strasbourg",France,Others,0,1,370.0
5044.0,NCT04451694,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,NutriCoviDom,Recruiting,COVID-19,,,,,,,Other: nutritional intervention,"Central Hospital, Nancy, France",All,"16 Years and older   (Child, Adult, Older Adult)",800.0,Other,Observational,2020-01-04,30/07/20,2020-11-30,30/06/20,30/06/20,"Quilliot, VANDOEUVRE LES Nancy",France,Respiratory Diseases,1,1,331.0
5045.0,NCT04148430,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,,Recruiting,B Cell ALL,B-Cell Lymphoma,B-cell Non Hodgkin Lymphoma,,,,,Drug: Anakinra,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2019-10-30,01/10/22,2022-01-10,01/11/19,17/11/20,"Memorial Sloan Kettering Cancer Center, New York, New York",United States,Others,0,3,803.0
5046.0,NCT04341727,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection",WU352,Suspended,Coronavirus Infection,,,,,,,Drug: Hydroxychloroquine Sulfate|Drug: Azithromycin|Drug: Chloroquine Sulfate,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-04-04,01/04/21,2021-01-08,10/04/20,04/06/20,"Washington University School of Medicine Infectious Disease Clinical Research Unit, Saint Louis, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri",United States,Respiratory Diseases,1,1,279.0
5047.0,NCT04498546,Mask Usage and Exercise During the COVİD-19 Pandemic,,Recruiting,Exercise Test,,,,,,,,KTO Karatay University,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-07-20,30/03/21,2021-09-30,04/08/20,18/02/21,"KTO Karatay University, Konya, Karatay",Turkey,Others,0,1,437.0
5048.0,NCT04377607,Haemoglobin Concentration on COVID-19,,Recruiting,Corona Virus Infection,,,,,,,Other: File scanning,Nevsehir Public Hospital,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-11,20/11/20,2020-12-30,06/05/20,16/09/20,"Konya Training and Research Hospital, Konya",Turkey,Respiratory Diseases,1,1,354.0
5049.0,NCT04817657,Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use,,No longer available,Healthy,,,,,,,Biological: Ad26.COV2.S,"Janssen Research & Development, LLC",,"Child, Adult, Older Adult",,Industry,Expanded Access:Individual Patients,,,,26/03/21,26/03/21,,,Others,0,1,
5050.0,NCT04431297,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,,Not yet recruiting,Chronic Stress,,,,,,,Other: Mindfulness Rounds,Icahn School of Medicine at Mount Sinai,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,30/06/21,2022-01-06,16/06/20,18/02/21,"Icahn School of Medicine at Mount Sinai, New York, New York",United States,Mental Health,1,1,367.0
5051.0,NCT04706299,"Effects of Surgical Mask Use on Peak Torque, Total Work and Interset Fatigability During Isokinetic Strength Testing",,Recruiting,COVID-19,,,,,,,Other: Resistance Exercise,The Cleveland Clinic,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-12-01,01/04/21,2021-01-04,12/01/21,14/01/21,"Cleveland Clinic Sports Health, Garfield Heights, Ohio",United States,Respiratory Diseases,1,1,-331.0
5052.0,NCT04475484,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,PSICOcs,Recruiting,Investigating Psychological Impact,Confinement Measures,Coronavirus Outbreak,School-age Children,,,,Other: Online questionnaire,Hospices Civils de Lyon,All,"6 Years to 18 Years   (Child, Adult)",30000.0,Other,Observational,2020-10-06,31/12/20,2020-12-31,17/07/20,17/07/20,"hôpital Femme Mère Enfant, Bron",France,Respiratory Diseases,1,4,86.0
5053.0,NCT04447209,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,CoDDYC,Recruiting,Dietary Diversity,,,,,,,"Other: Dietary counselling on Food Groups according to IYC Feeding practices, WHO",University of Malaya,All,6 Months to 6 Years   (Child),300.0,Other,Observational,2020-06-06,31/12/20,2021-05-31,25/06/20,25/06/20,"University of Malaya Medical Center, Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur",Malaysia,Others,0,1,359.0
5054.0,NCT04839146,Safety and Tolerability of ABNCoV2,COUGH-1,Recruiting,COVID-19,Severe Acute Respiratory Syndrome,COVID-19,,,,,Biological: ABNCoV2 Vaccine,Radboud University|European Union,All,18 Years to 55 Years   (Adult),42.0,Other,Interventional,2021-11-03,20/12/21,2021-12-20,09/04/21,09/04/21,"Radboud univserity medical center, Nijmegen, Gelderland",Netherlands,Respiratory Diseases,1,3,47.0
5055.0,NCT04260594,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,,Not yet recruiting,COVID-19,,,,,,,Drug: Arbidol|Other: basic treatment,Jieming QU|Ruijin Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",380.0,Other,Interventional,2020-07-02,01/07/20,2020-12-30,07/02/20,07/02/20,,,Respiratory Diseases,1,1,181.0
5056.0,NCT04409275,LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION,INC-CVD-202001,Recruiting,Pulmonary Fibrosis,,,,,,,,Fundación para la Investigación del Hospital Clínico de Valencia,All,"18 Years to 90 Years   (Adult, Older Adult)",500.0,Other,Observational,2020-05-21,31/12/20,2021-07-31,01/06/20,11/06/20,"Pulmonary Department. Hospital Clinico., Valencia",Spain,Others,0,1,436.0
5057.0,NCT04362059,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,COVSurf,Recruiting,Respiratory Infections,,,,,,,Device: COVSurf Drug Delivery System|Other: Standard of Care,"University Hospital Southampton NHS Foundation Trust|Bill and Melinda Gates Foundation|University College, London",All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2020-06-18,27/07/21,2021-11-16,24/04/20,09/09/20,"University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom|University College London Hospitals NHS Foundation Trust, London",United Kingdom,Others,0,1,516.0
5058.0,NCT04433312,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,,Not yet recruiting,"Satisfaction, Patient",Quality of Life,,,,,,Other: Questionnaire,Mansoura University,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2020-01-07,30/10/20,2020-01-12,16/06/20,24/06/20,"Mansoura Faculty of Medicine, Mansoura",Egypt,Others,0,2,5.0
5059.0,NCT04360850,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,,Recruiting,Online Therapy,,,,,,,Behavioral: online survey,University of Washington,All,"18 Years and older   (Adult, Older Adult)",10000.0,Other,Observational,2020-04-24,01/10/25,2025-01-10,24/04/20,28/04/20,"University of Washington, Seattle, Washington",United States,Others,0,1,1722.0
5060.0,NCT04558411,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",,Recruiting,Emotional Regulation,Affect,,,,,,Behavioral: Dialectical Behavioral Therapy (DBT) Skills,"Rutgers, The State University of New Jersey",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-12-09,15/12/20,2020-12-15,22/09/20,22/09/20,"Rutgers, The State University of New Jersey, Piscataway, New Jersey",United States,Others,0,2,6.0
5061.0,NCT04666493,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,,Recruiting,Autism Spectrum Disorder,,,,,,,"Other: Cognitive behavior therapy (CBT), specifically using the Facing Your Fears (FYF) curriculum","Evdokia Anagnostou|Anagnostou, Evdokia, M.D.",All,8 Years to 13 Years   (Child),100.0,Other,Interventional,2020-04-12,30/11/21,2021-11-30,14/12/20,14/12/20,"Holland Bloorview Kids Rehabilitation Hospital, Toronto, Ontario",Canada,Others,0,1,597.0
5062.0,NCT04456062,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,,Recruiting,Psychiatric Hospitalization,,,,,,,Other: Caring Contacts,Sunnybrook Health Sciences Centre,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-04-08,01/03/21,2021-01-03,02/07/20,31/08/20,"Sunnybrook Health Sciences Centre, Toronto, Ontario",Canada,Others,0,1,270.0
5063.0,NCT04410536,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,MOHC,Recruiting,"Migraine, Hemicrania",,,,,,,Drug: Symptomatic drugs|Drug: Bridge therapy|Behavioral: Mindfulness program,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,All,"18 Years to 65 Years   (Adult, Older Adult)",25.0,Other,Interventional,2020-06-15,01/12/21,2022-01-07,01/06/20,09/10/20,"Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit, Milano",Italy,Neurological Disorders,1,1,571.0
5064.0,NCT04801667,"Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients",TXCoronavac,Not yet recruiting,SARS-CoV Infection,Coronavirus Infection,Vaccine Adverse Reaction,,,,,Biological: Coronavac,Hospital do Rim e Hipertensão,All,"18 Years to 100 Years   (Adult, Older Adult)",3780.0,Other,Interventional,2021-03-20,01/08/21,2022-01-03,17/03/21,18/03/21,,,Respiratory Diseases,1,3,289.0
5065.0,NCT04822285,Effect Psychological Triaging Intervention on Students' Psychological Distress and Resilience Capacity,Triaging,Completed,Psychological Distress,Resilience,,,,,,Behavioral: Psychological Triaging Intervention|Behavioral: Routine psychological support,Alexandria University,All,"Child, Adult, Older Adult",64.0,Other,Interventional,2020-01-22,22/04/20,2021-03-21,30/03/21,30/03/21,"Faculty of Nursing, Alexandria",Egypt,Others,0,2,424.0
5066.0,NCT04597216,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),NanoDxCoV19,Recruiting,COVID-19,,,,,,,Device: sample of blood and saliva,"University Hospital, Grenoble",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-15,31/12/20,2021-12-31,22/10/20,22/10/20,"olivier EPAULARD, Grenoble",France,Respiratory Diseases,1,1,442.0
5067.0,NCT04436276,A Study of Ad26.COV2.S in Adults (COVID-19),,"Active, not recruiting",Healthy,,,,,,,Biological: Ad26.COV2.S|Biological: Placebo,Janssen Vaccines & Prevention B.V.,All,"18 Years and older   (Adult, Older Adult)",1085.0,Industry,Interventional,2020-07-15,03/12/21,2024-02-02,18/06/20,12/04/21,"Optimal Research, San Diego, California, United States|Optimal Research, Melbourne, Florida, United States|Optimal Research, Peoria, Illinois, United States|Optimal Research, Rockville, Maryland, United States|Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|AMR New Orleans, Formerly New Orleans Center for Clinical Research - New Orleans, an AMR company, Knoxville, Tennessee, United States|Optimal Research, Austin, Texas, United States|SGS Life Science Services, Antwerpen, Belgium|Center for Vaccinology (CEVAC), Gent, Belgium|UZ Leuven, Leuven, Belgium|Clinical Pharmacology Unit, Merksem, Belgium|Universiteit Antwerpen, Wilrijk",Belgium,Others,0,1,1297.0
5068.0,NCT04519216,Breastfeeding Education in the Time of COVID-19,,Recruiting,Breastfeeding,"Breastfeeding, Exclusive",Breastfeeding Jaundice,Educational Problems,,,,Behavioral: Telesimulation,"University of California, Davis",All,"18 Years and older   (Adult, Older Adult)",39.0,Other,Interventional,2020-07-31,30/06/21,2021-09-30,19/08/20,19/08/20,"University of California - Davis, Sacramento, California",United States,Others,0,4,426.0
5069.0,NCT04357106,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,COPLA,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma,Centro de Hematología y Medicina Interna|Laboratorios Clínicos de Puebla (Laboratorios Ruiz),All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-04-13,01/07/20,2020-01-08,22/04/20,22/04/20,"Centro de Hematología y Medicina Interna, Puebla",Mexico,Respiratory Diseases,1,1,-96.0
5070.0,NCT04691180,"A Phase 1 Study of Human Monoclonal Antibodies, BRII-196 and BRII-198",,Recruiting,COVID-19,,,,,,,Drug: BRII-196 and BRII-198|Drug: Placebo,Brii Biosciences Limited|TSB Therapeutics (Beijing) CO.LTD,All,18 Years to 49 Years   (Adult),24.0,Industry,Interventional,2021-05-01,01/08/21,2021-01-08,31/12/20,27/01/21,"Investigative Site, Beijing, Beijing",China,Respiratory Diseases,1,1,-113.0
5071.0,NCT04409197,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",CO-RNPC,Completed,Comorbidities,Confinement,Obesity,,,,,,"University Hospital, Grenoble",All,"18 Years and older   (Adult, Older Adult)",4789.0,Other,Observational,2020-08-05,08/06/20,2020-11-07,01/06/20,28/08/20,"CHU Grenoble Alpes, Grenoble",France,Metabolic Disorders,1,3,94.0
5072.0,NCT04382378,Effects of NMES in Critically Ill Patients,NUMBERNMES,Recruiting,Mechanical Ventilation Complication,Muscle Weakness Condition,COVID-19,,,,,Device: neuromuscular electrical stimulation,Escola Superior de Ciencias da Saude,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2021-01-02,30/09/21,2021-12-31,11/05/20,15/03/21,"Secretaria de Saúde do Distrito Federal, Brasilia, DF",Brazil,Respiratory Diseases,1,3,363.0
5073.0,NCT04479644,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",,Completed,COVID-19,,,,,,,Drug: BRII-198|Drug: Placebo,Brii Biosciences Limited|TSB Therapeutics (Beijing) CO.LTD,All,18 Years to 49 Years   (Adult),17.0,Industry,Interventional,2020-07-13,03/02/21,2021-03-02,21/07/20,12/04/21,"Investigative Site, Beijing, Beijing",China,Respiratory Diseases,1,1,232.0
5074.0,NCT04479631,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",,Completed,COVID-19,,,,,,,Drug: BRII-196|Drug: Placebo,Brii Biosciences Limited|TSB Therapeutics (Beijing) CO.LTD,All,18 Years to 49 Years   (Adult),16.0,Industry,Interventional,2020-12-07,29/01/21,2021-01-29,21/07/20,12/04/21,"Investigative Site, Beijing, Beijing",China,Respiratory Diseases,1,1,53.0
5075.0,NCT04786080,Supporting Parents & Kids Through Lockdown Experiences (SPARKLE).,SPARKLE,Not yet recruiting,Child Behavior Problem,Mental Health Issue,,,,,,Behavioral: Parent Positive,King's College London|University of Oxford,All,"18 Years and older   (Adult, Older Adult)",616.0,Other,Interventional,2021-03-15,30/09/21,2021-11-30,08/03/21,08/03/21,"King's College London, London",United Kingdom,Others,0,2,260.0
5076.0,NCT04513561,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,CONFIMID,Completed,Inflammatory Disease,COVID-19,,,,,,,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",921.0,Other,Observational,2020-07-21,27/08/20,2020-08-27,14/08/20,15/03/21,"Hop Claude Huriez Chu Lille, Lille",France,Respiratory Diseases,1,2,37.0
5077.0,NCT04779450,"Effect of Telemonitoring on Upper Limb Function, Quality of Life and Risk of Lymphedema During and After Pandemic COVID-19 in Women Submitted to Treatment for Breast Cancer",,Recruiting,Breast Cancer,,,,,,,Other: Kinesiotherapy protocol|Other: Usual orientations,University of the State of Santa Catarina,Female,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-03,01/08/21,2021-01-12,03/03/21,03/03/21,"Santa Catarina State University, Florianópolis, Santa Catarina",Brazil,Cancers,1,1,9.0
5078.0,NCT04528329,Anosmia and / or Ageusia and Early Corticosteroid Use,,Recruiting,COVID-19,Anosmia,,,,,,Drug: Early-Dexamethasone|Drug: Late dexamethazone,ClinAmygate,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2020-08-30,01/04/21,2021-04-15,27/08/20,29/03/21,"Asalam, Maadi, Cairo",Egypt,Respiratory Diseases,1,2,228.0
5079.0,NCT04386720,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,POVA-TIE,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,,"University Hospital, Bordeaux",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Observational,2020-05-25,25/05/21,2021-05-25,13/05/20,27/05/20,"HOPITAL HAUT-LEVEQUE - Service Réanimation thoracique, Pessac",France,Respiratory Diseases,1,1,365.0
5080.0,NCT04368832,imPROving prenaTal carE During ConfinemenT,PROTECT,"Active, not recruiting",Pregnancy Related,COVID-19,,,,,,Other: Remote consultation,"Central Hospital, Nancy, France",Female,"18 Years and older   (Adult, Older Adult)",108.0,Other,Observational,2020-04-25,31/12/20,2021-09-30,30/04/20,29/07/20,"Maternité Régionale Universitaire de Nancy, Nancy",France,Respiratory Diseases,1,2,523.0
5081.0,NCT04728243,WHO QualityRights E-training in Ghana,,Not yet recruiting,Knowledge,Attitudes,Practices,,,,,Other: WHO QualityRights e-training|Other: WHO COVID-19 online training,Mental Health Society of Ghana,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2021-01-02,01/02/22,2022-01-02,28/01/21,28/01/21,,,Others,0,3,365.0
5082.0,NCT04338009,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,REPLACECOVID,Completed,COVID-19,,,,,,,Other: Discontinuation of ARB/ACEI|Other: Continuation of ARB/ACEI,"University of Pennsylvania|Jordana B. Cohen, MD, MSCE|Thomas C. Hanff, MD, MPH|Division of Cardiology, University of Arizona, Tucson, AZ, USA|Department of Medicine, Hospital Nacional Carlos Alberto Seguín Escobedo, Arequipa, Peru|Department of Nephrology, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru|Hypertension Unit, Department of Pathology, Hospital Español de Mendoza, National University of Cuyo, IMBECU-CONICET, Mendoza, Argentina|Division of Nephrology, Stanford University School of Medicine, Stanford, CA, USA|Division of Infectious Diseases, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada|Unidad de VIH, Hospital Civil de Guadalajara and Universidad de Guadalajara, Guadalajara, Mexico|Universidad Católica de Buenos Aires, Buenos Aires, Argentina|Departamento de Medicina Interna, Hospital Obrero number 3 Caja Nacional de Salud, Santa Cruz de la Sierra, Bolivia|Departamento de Medicina, Hospital Alberto Barton Thompson, Callao, Peru|Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden|Division of Cardiology, University of Miami Miller School of Medicine, Miami, FL, USA|Departamento de Emergencia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru|Division of Cardiology, Department of Medicine, Hospital Español, Buenos Aires, Argentina|Division of Cardiovascular Medicine, University of Michigan Medical School, Ann Arbor, MI, USA|Jesse Chittams, MS|Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA|Charles R Vasquez, MD",All,"18 Years and older   (Adult, Older Adult)",152.0,Other,Interventional,2020-03-31,20/08/20,2020-08-20,08/04/20,09/04/21,"University of Pennsylvania Health System, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,142.0
5083.0,NCT04453657,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",,Enrolling by invitation,"Stress, Psychological",Child Behavior,Social Competence,,,,,Device: FamilyChildCare (provisional name of app),Johns Hopkins University,All,"3 Years to 99 Years   (Child, Adult, Older Adult)",270.0,Other,Interventional,2021-04-02,01/09/21,2021-01-09,01/07/20,08/02/21,"Johns Hopkins School of Nursing, Baltimore, Maryland",United States,Mental Health,1,3,-83.0
5084.0,NCT04837755,CORONA in the Saarland,CORSAAR,Recruiting,COVID-19,,,,,,,Diagnostic Test: Cytokine measurements,Universität des Saarlandes,All,"up to 110 Years   (Child, Adult, Older Adult)",300.0,Other,Observational,2020-01-03,31/12/25,2025-12-31,08/04/21,08/04/21,"Saarland University, Homburg, Saarland",Germany,Respiratory Diseases,1,1,2189.0
5085.0,NCT04681261,"Occupational Balance, Fear and Agoraphobia",OB,Completed,COVID-19,,,,,,,Other: this study is not an intervention study,Hacettepe University,All,"19 Years to 65 Years   (Adult, Older Adult)",699.0,Other,Observational,2020-04-05,04/06/20,2020-04-06,23/12/20,23/12/20,"Özgü İnal, Edirne, Merkez",Turkey,Respiratory Diseases,1,1,1.0
5086.0,NCT04559542,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",FMAB,Recruiting,Body Weight Changes,Eating Disorder Symptom,Sexual Harassment,COVID-19,RED S,,,,Norwegian School of Sport Sciences|Ostfold University College|University of Oslo,Female,"16 Years to 40 Years   (Child, Adult)",200.0,Other,Observational,2020-10-09,30/05/21,2021-12-31,23/09/20,03/03/21,"Norwegian school of sport sciences, Oslo",Norway,Respiratory Diseases,1,5,448.0
5087.0,NCT04802187,Implementation of SARS-CoV Testing Strategies in Community Health Centers,,Recruiting,COVID-19,,,,,,,Other: RADx CHCs testing intervention strategy|Other: Usual care control,Massachusetts General Hospital|Dana-Farber Cancer Institute|Harvard School of Public Health|Massachusetts League of Community Health Centers,All,"Child, Adult, Older Adult",76300.0,Other,Interventional,2020-01-12,31/08/22,2022-08-31,17/03/21,17/03/21,"Massachusetts League of Community Health Centers, Boston, Massachusetts, United States|Massachusetts General Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,1,962.0
5088.0,NCT04334265,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,,Recruiting,COVID-19,,,,,,,Drug: Anluohuaxian,Peking University First Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",750.0,Other,Interventional,2020-01-04,01/06/20,2020-01-12,06/04/20,24/04/20,"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Hubei, China|West Hospital Union Hospital Huazhong University of Science and Technology, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang",China,Respiratory Diseases,1,1,8.0
5089.0,NCT04842331,PREvent Viral Exposure aNd Transmission Study: a SARS-CoV-2 PEP Study (PREVENT),PREVENT,Recruiting,COVID-19,Respiratory Tract Diseases,,,,,,"Drug: RESP301, a Nitric Oxide generating solution",Thirty Respiratory Limited,All,"18 Years and older   (Adult, Older Adult)",600.0,Industry,Interventional,2021-01-04,01/01/22,2022-01-01,13/04/21,13/04/21,"Imperial College Healthcare NHS Trust, London",United Kingdom,Respiratory Diseases,1,2,362.0
5090.0,NCT04566276,ChulaCov19 mRNA Vaccine in Healthy Adults,,Not yet recruiting,COVID-19,Safety Issues,,,,,,Biological: ChulaCov19 mRNA vaccine,"Chulalongkorn University|Center of Excellence in Vaccine Research and Development, Chulalongkorn University|Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University|Chula Vaccine Research Center (ChulaVRC), Faculty of Medicine, Chulalongkorn University|National Vaccine Institute (NVI), Thailand|National Research Council of Thailand|C2F Chulalongkorn University, Faculty of Medicine, Chulalongkorn University",All,"18 Years to 75 Years   (Adult, Older Adult)",96.0,Other,Interventional,2021-01-01,01/03/21,2021-01-06,28/09/20,06/10/20,"Chula Vaccine Research Center (ChulaCRC) Faculty of Medicine Chulalongkorn University, Bangkok, Thailand|Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine Mahidol University, Bangkok",Thailand,Respiratory Diseases,1,2,5.0
5091.0,NCT04302766,Expanded Access Remdesivir (RDV; GS-5734™),,No longer available,Coronavirus Disease 2019,,,,,,,Drug: Remdesivir,U.S. Army Medical Research and Development Command,All,"Child, Adult, Older Adult",,U.S. Fed,Expanded Access:Intermediate-size Population|Treatment IND/Protocol,,,,10/03/20,01/04/21,"Naval Medical Center San Diego, San Diego, California, United States|Naval Hospital Jacksonville, Jacksonville, Florida, United States|Benning Martin Army Community Hospital, Fort Benning, Georgia, United States|Eisenhower Army Medical Center, Fort Gordon, Georgia, United States|Tripler Army Medical Center, Tripler AMC, Hawaii, United States|Blanchfield Army Community Hospital, Fort Campbell North, Kentucky, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Naval Medical Center Camp Lejeune, Camp Lejeune, North Carolina, United States|Womack Army Medical Center, Fort Bragg, North Carolina, United States|William Beaumont Army Medical Center, El Paso, Texas, United States|Carl R. Darnall Army Medical Center, Fort Hood, Texas, United States|Brooke Army Medical Center, Fort Sam Houston, Texas, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center, Tacoma, Washington, United States|Craig Joint Theater Hospital, Bagrām, Afghanistan|NATO Role 3 Multinational Medical Unit Kandahar Air Field, Kandahar, Afghanistan|EMF Camp Lemonnier, Djibouti, Djibouti|Landstuhl Regional Medical Center, Landstuhl, APO Ae, Germany|US Naval Hospital Guam, Agaña, Guam|Baghdad Diplomatic Support Center, Baghdad, Iraq|US Naval Hospital Okinawa, Okinawa, Japan|US Military Hospital Kuwait 411th Hospital Center, Kuwait",Kuwait,Respiratory Diseases,1,1,
5092.0,NCT04844138,Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program,,Not yet recruiting,Perinatal Anxiety,Perinatal Depression,,,,,,Behavioral: Overcoming Anxiety in Pregnancy and Postpartum Online Self-Directed Program,University of Manitoba,Female,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-07-04,31/12/21,2021-12-31,14/04/21,14/04/21,"University of Manitoba, Winnipeg, Manitoba",Canada,Mental Health,1,2,180.0
5093.0,NCT04441632,Effect of Positive Attitudes on Behavior and Wellness,TEAM-ICU,Completed,Burnout,"Stress, Emotional",,,,,,Behavioral: Positive feedback,Cedars-Sinai Medical Center,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2020-06-15,26/07/20,2020-07-30,22/06/20,12/08/20,"Cedars-Sinai Medical Center, Los Angeles, California",United States,Mental Health,1,2,45.0
5094.0,NCT04763681,Couple HOPES (Helping Overcome PTSD and Enhance Satisfaction),HOPES,Recruiting,Posttraumatic Stress Disorder,,,,,,,"Behavioral: Couple HOPES Guided, Internet-Delivered, Self-Help Intervention",York University,All,18 Years to 64 Years   (Adult),140.0,Other,Interventional,2021-01-01,31/08/21,2021-08-31,21/02/21,21/02/21,"York University, Toronto, Ontario",Canada,Mental Health,1,1,242.0
5095.0,NCT04683744,Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation,,Recruiting,Colorectal Cancer Screening,,,,,,,Other: Semi-structured interviews-Patients|Other: Semi-structured interviews-Health system,Indiana University|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-11-01,01/07/23,2023-01-07,24/12/20,08/04/21,"Indiana University, Indianapolis, Indiana",United States,Cancers,1,1,432.0
5096.0,NCT04281693,A New Screening Strategy for 2019 Novel Coronavirus Infection,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Standard screening strategy|Diagnostic Test: New screening strategy,Affiliated Hospital to Academy of Military Medical Sciences|Beijing 302 Hospital,All,"Child, Adult, Older Adult",230.0,Other,Interventional,2020-01-02,01/03/20,2020-01-03,24/02/20,24/02/20,"the Fifth Medical Center of Chinese PLA General Hospital, Beijing, Beijing",China,Respiratory Diseases,1,1,1.0
5097.0,NCT03331445,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,,Recruiting,Respiratory Tract Infections,Corona Virus Infection,,,,,,Drug: Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation,Chris Miller|Mallinckrodt|Nitric Solutions Inc.,All,"19 Years and older   (Adult, Older Adult)",20.0,Industry,Interventional,2017-10-24,31/12/20,2021-03-31,06/11/17,09/09/20,"Nitric Solutions-Mobile Unit, Vancouver, British Columbia",Canada,Respiratory Diseases,1,2,1254.0
5098.0,NCT04298060,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),STOP-Flu,Not yet recruiting,Influenza Infection,COVID-19,,,,,,Drug: DAS181|Drug: Placebo,"Ansun Biopharma, Inc.",All,"18 Years and older   (Adult, Older Adult)",280.0,Industry,Interventional,2020-01-07,01/03/21,2022-01-09,06/03/20,09/07/20,"Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai",China,"Infectious Diseases, Respiratory Diseases",1,2,733.0
5099.0,NCT03963622,Careful Ventilation in Acute Respiratory Distress Syndrome (COVID-19),CAVIARDS,Recruiting,ARDS,,,,,,,Other: Respiratory Mechanics|Other: Standard Ventilation Strategy,Unity Health Toronto|Canadian Institutes of Health Research (CIHR)|University of Toronto|Applied Health Research Centre,All,"18 Years and older   (Adult, Older Adult)",740.0,Other,Interventional,2020-11-23,01/05/22,2022-01-11,24/05/19,19/01/21,"St. Michael's Hospital, Toronto, Ontario, Canada|CH Victor Dupouy, Argenteuil, France|CH de Beauvais, Beauvais, France|CHU Bordeaux - Haut Leveque, Bordeaux, France|Hopital de la Cavale Blanche - CHRU Brest, Brest, France|CH de Cholet, Cholet, France|Hopital Intercommunal de Creteil, Creteil, France|CHU Grenoble-Alpes, Grenoble, France|Hopital Roger Salengro - CHU Lille, Lille, France|Hopital de l'Archet 1 - CHU de Nice, Nice, France|Hopital Europeen Georges-Pompidou, Paris, France|CHU de Poitiers - La Miletrie, Poitiers, France|CH Bretagne Atlantique Vannes-Auray, Vannes, France|HIA Robert Picque, Villenave-d'Ornon, France|Vall d'Hebron University Hospital, Barcelona",Spain,Respiratory Diseases,1,1,414.0
5100.0,NCT04509947,A Study of Ad26.COV2.S in Adults (COVID-19),,"Active, not recruiting",Healthy,,,,,,,Biological: Ad26.COV2.S|Biological: Placebo,Janssen Pharmaceutical K.K.,All,"20 Years and older   (Adult, Older Adult)",250.0,Industry,Interventional,2020-11-08,22/02/21,2021-08-12,12/08/20,14/04/21,"Souseikai Hakata Clinic, Fukuoka, Japan|SOUSEIKAI PS Clinic, Fukuoka, Japan|Souseikai Fukuoka Mirai Hospital, Fukuoka",Japan,Others,0,1,277.0
5101.0,NCT04490239,Intranasal Heparin Tolerability Study,,"Active, not recruiting",COVID-19,,,,,,,Drug: Intranasal heparin sodium (porcine),"Joshua Sharp|University of Mississippi, Oxford",All,"18 Years to 65 Years   (Adult, Older Adult)",6.0,Other,Interventional,2020-09-10,01/11/20,2020-01-11,29/07/20,14/10/20,"The University of Mississippi National Center for Natural Products Research, University, Mississippi",United States,Respiratory Diseases,1,1,-243.0
5102.0,NCT04776174,Efficacy and Tolerance of Telerobotic vs Standard Ultrasound Exam in Children,,Not yet recruiting,COVID-19,,,,,,,Device: Ultrasound using the telerobotic Melody system,Centre Hospitalier Intercommunal Creteil|ADECHOTECH,All,1 Year to 10 Years   (Child),40.0,Other,Interventional,2021-01-03,30/10/21,2022-01-01,01/03/21,01/03/21,,,Respiratory Diseases,1,1,363.0
5103.0,NCT04743609,RSV Burden in Outpatient Settings,Oursyn,Recruiting,RSV Infection,"Children, Only",Outpatient,Bronchiolitis,Otitis Media,Pneumonia,,Diagnostic Test: nasopharyngeal samples,Association Clinique Thérapeutique Infantile du val de Marne|Sanofi,All,up to 24 Months   (Child),1600.0,Other|Industry,Observational,2021-08-02,11/07/21,2023-11-01,08/02/21,22/03/21,"ACTIV, Créteil",France,Respiratory Diseases,1,6,821.0
5104.0,NCT04740489,The Impact of Covid-19 on Cardiac Rehabilitation Participants and Staff,,Not yet recruiting,Heart Diseases,,,,,,,Behavioral: Phase 3 Cardiac rehabilitation,Ant Shepherd|Hampshire Hospitals NHS Foundation Trust|University of Portsmouth,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2021-01-02,01/06/22,2022-01-06,05/02/21,05/02/21,,,Others,0,1,369.0
5105.0,NCT03262051,Impact of Acute and Chronic Inflammation on Cytochromes P450 Activity Measured With Dried Blood Spot,,Recruiting,Inflammation,,,,,,,Diagnostic Test: CYP phenotyping,"University Hospital, Geneva",All,"18 Years and older   (Adult, Older Adult)",106.0,Other,Observational,2017-01-09,01/09/21,2021-01-09,25/08/17,04/03/21,"Geneva University Hospitals, HUG, Genève",Switzerland,Others,0,1,1461.0
5106.0,NCT04509986,GlobalSurg-CovidSurg Week,,Not yet recruiting,Surgery,COVID-19,Post-Op Complication,,,,,,University of Birmingham|National Institute for Health Research (NIHR) Global Health Research Unit Grant (NIHR 16.136.79)|Association of Coloproctology of Great Britain and Ireland|Bowel & Cancer Research|Association of Upper Gastrointestinal Surgeons; British Association of Surgical Oncology|Bowel Disease Research Foundation|British Gynaecological Cancer Society|European Society of Coloproctology|NIHR Academy|Sarcoma UK|Vascular Society for Great Britain and Ireland|Yorkshire Cancer Research,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-01-10,31/10/20,2020-01-12,12/08/20,12/08/20,,,Respiratory Diseases,1,3,2.0
5107.0,NCT04260308,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,,Recruiting,Virus; Pneumonia,,,,,,,,Huazhong University of Science and Technology,All,"Child, Adult, Older Adult",30000.0,Other,Observational,2020-03-02,15/04/20,2020-04-20,07/02/20,07/02/20,"Tongji Hospital，Tongji Medical College Affiliated，Huazhong University of Science ＆ Technology, Wuhan, Hubei",China,Respiratory Diseases,1,1,49.0
5108.0,NCT04485169,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,Plex,Completed,COVID-19,Cytokine Release Syndrome,,,,,,Procedure: Therapeutic Plasma Exchange,UNICEF|Pak Emirates Military Hospital Rawalpindi,All,"18 Years to 80 Years   (Adult, Older Adult)",280.0,Other,Interventional,2020-01-04,31/07/20,2020-07-31,24/07/20,28/09/20,"Pak Emirates Military Hospital, Rawalpindi, Punjab",Pakistan,Respiratory Diseases,1,2,209.0
5109.0,NCT04657809,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,,"Active, not recruiting",Anosmia,,,,,,,Combination Product: Insulin film|Device: Fast dissolving film,Soad Ali|Minia University|Deraya University,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-10,18/02/21,2021-02-20,08/12/20,21/02/21,"Soad, Minya",Egypt,Others,0,1,407.0
5110.0,NCT04449276,"A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",,"Active, not recruiting",Severe Acute Respiratory Syndrome,Coronavirus,COVID-19,COVID-19,,,,Biological: CVnCoV Vaccine|Drug: Placebo,CureVac AG|Coalition for Epidemic Preparedness Innovations,All,18 Years to 60 Years   (Adult),280.0,Industry|Other,Interventional,2020-06-18,01/12/21,2021-01-12,26/06/20,22/12/20,"Universitair Ziekenhuis Ghent, Ghent, Belgium|Ludwig-Maximilians-Universität München, München, Bavaria, Germany|Medical University Hannover (MHH), Hannover, Germany|University Hospital Tübingen Institut für Tropenmedizin, Tübingen",Germany,Respiratory Diseases,1,4,208.0
5111.0,NCT04415879,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,,Completed,COVID-19,,,,,,,Device: N-95 Respirator|Device: Cloth Face Mask|Diagnostic Test: Graded exercise test,The Cleveland Clinic,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-06,01/08/20,2020-01-08,04/06/20,13/08/20,"Cleveland Clinic, Cleveland, Ohio",United States,Respiratory Diseases,1,1,2.0
5112.0,NCT04385836,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),,Recruiting,Coronavirus,,,,,,,Drug: alpha one antitrypsin inhalation,"Ministry of Health, Saudi Arabia",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-06,01/09/20,2020-01-09,13/05/20,13/05/20,"Ministry of Health, Mecca",Saudi Arabia,Respiratory Diseases,1,1,3.0
5113.0,NCT04492189,Containment Measures and Eating Disorders,COVITA,Completed,Eating Disorders,COVID-19,,,,,,,"University Hospital, Montpellier|INSERM U1061 (Statistics)",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-01-04,30/05/20,2020-06-30,30/07/20,30/07/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,2,178.0
5114.0,NCT04374643,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,PsyConfPop,Recruiting,Depression,COVID-19,,,,,,Other: Slef questionnaires fulfilment,"University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-04,01/12/21,2021-12-30,05/05/20,29/12/20,"University hospital, Montpellier",France,"Mental Health, Respiratory Diseases",1,2,726.0
5115.0,NCT04758962,A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults,,Recruiting,Virus Diseases,,,,,,,Biological: 1 µg CoV2 SAM (LNP)|Biological: 3 µg CoV2 SAM (LNP)|Biological: 10 µg CoV2 SAM (LNP)|Biological: 30 µg CoV2 SAM (LNP),GlaxoSmithKline,All,18 Years to 50 Years   (Adult),40.0,Industry,Interventional,2021-02-15,11/06/21,2022-09-05,17/02/21,17/02/21,"GSK Investigational Site, Rochester, New York",United States,Others,0,1,567.0
5116.0,NCT04683484,A Clinical Trial to Assess the Safety and Immunogenicity of Nanocovax in Heathy Volunteers,,Recruiting,COVID-19,,,,,,,Biological: Nanocovax|Biological: Placebo,Nanogen Pharmaceutical Biotechnology Joint Stock Company,All,"12 Years to 75 Years   (Child, Adult, Older Adult)",620.0,Industry,Interventional,2020-10-12,10/06/21,2021-10-08,24/12/20,29/12/20,"Military Medical Academy, Hanoi, Ha Dong",Vietnam,Respiratory Diseases,1,1,361.0
5117.0,NCT04669509,Effect of Liver Injury on Mortality in Coronavirus Disease-2019 Patients Admitted to Intensive Care Unit,,Completed,COVID-19,,,,,,,Diagnostic Test: Liver function tests,Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",532.0,Other,Observational,2020-01-04,01/10/20,2020-12-14,16/12/20,16/12/20,"Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital, Diyarbakır",Turkey,Respiratory Diseases,1,1,345.0
5118.0,NCT04413877,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),ICOPE,Not yet recruiting,Frailty Syndrome,COVID-19,Healthy Aging,Old Age; Debility,,,,,"University of Liege|University Hospital, Toulouse",All,65 Years and older   (Older Adult),600.0,Other,Observational,2020-01-10,01/10/21,2021-01-11,04/06/20,04/06/20,,,Respiratory Diseases,1,4,367.0
5119.0,NCT04561076,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,,Not yet recruiting,COVID-19,,,,,,,Drug: HLX70|Other: Placebo,"Hengenix Biotech Inc|Sanyou Biopharmaceuticals(Shanghai)Co., Ltd|Shanghai ZJ Bio-Tech Co., Ltd",All,18 Years to 60 Years   (Adult),24.0,Industry|Other,Interventional,2020-09-12,06/09/21,2021-09-18,23/09/20,24/09/20,,,Respiratory Diseases,1,1,371.0
5120.0,NCT04483271,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,,Enrolling by invitation,Cytokine Storm,Cytokines,,,,,,Dietary Supplement: 300 mg of omega3-FA,Applied Science Private University,All,"30 Years to 66 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-02-10,15/12/20,2021-10-02,23/07/20,08/12/20,"Mahmoud S Abu-Samak, Amman",Jordan,Others,0,2,600.0
5121.0,NCT04755972,Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2,,Recruiting,Corona Virus Infection,"Pneumonia, Ventilator-Associated",,,,,,"Other: Inhalation of N-acetylcysteine|Other: Inhalation of 5% sodium chloride|Other: Inhalation of 8,4% sodium bicarbonate","Clinical Hospital Center, Split",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-29,29/07/21,2021-08-29,16/02/21,16/02/21,"Clinical Hospital Centre Split, Split",Croatia,Respiratory Diseases,1,2,212.0
5122.0,NCT04536376,First Responder Resiliency Program During COVID-19,,Recruiting,Resilience,Stress,Sleep,,,,,Behavioral: Resilience Program,Mayo Clinic|PNMedical,All,"18 Years and older   (Adult, Older Adult)",10.0,Other|Industry,Interventional,2021-01-15,02/08/21,2021-12-31,02/09/20,08/02/21,"Mayo Clinic, Rochester, Minnesota",United States,Mental Health,1,3,350.0
5123.0,NCT04567927,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,,Completed,SARS Virus,,,,,,,Other: Ultrasonography,"Chiesa Alessandro Felice|Ente Ospedaliero Cantonale, Bellinzona",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-03-03,28/05/20,2020-05-28,29/09/20,29/09/20,"Ospedale Regionale di Bellinzona e Valli, Bellinzona, Ticino",Switzerland,Others,0,1,86.0
5124.0,NCT04453527,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,,Recruiting,Coronavirus,,,,,,,,Portsmouth Hospitals NHS Trust|Akari Therapuetics,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-05-28,01/05/21,2021-01-09,01/07/20,01/07/20,"Portsmouth Hospitals NHS Trust, Portsmouth",United Kingdom,Respiratory Diseases,1,1,226.0
5125.0,NCT04398147,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,,Not yet recruiting,COVID-19,,,,,,,Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)|Biological: Placebo,CanSino Biologics Inc.|Beijing Institute of Biotechnology|Canadian Center for Vaccinology,All,"18 Years to 84 Years   (Adult, Older Adult)",696.0,Industry|Other,Interventional,2020-01-08,20/12/21,2021-12-30,21/05/20,02/07/20,"Canadian Center for Vaccinology, Halifax",Canada,Respiratory Diseases,1,1,722.0
5126.0,NCT04490278,CoV-PICS: A Virtual Post-ICU Clinic,,Recruiting,Post ICU Syndrome,,,,,,,Other: Medical Record Review - Inpatient Treatment|Other: Online Questionnaires,Washington University School of Medicine,All,"18 Years to 100 Years   (Adult, Older Adult)",80.0,Other,Interventional,2020-09-29,30/07/21,2021-07-30,29/07/20,05/10/20,"Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri",United States,Others,0,1,304.0
5127.0,NCT04708457,"The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO",REDEEM,Not yet recruiting,Mechanical Ventilation Complication,Severe Acute Respiratory Infection,COVID-19,,,,,Other: VV-ECMO,Australian and New Zealand Intensive Care Research Centre|The Alfred,All,"18 Years to 70 Years   (Adult, Older Adult)",12.0,Other,Interventional,2021-01-02,01/12/21,2022-01-31,14/01/21,19/01/21,"The Alfred Hospital, Melbourne, Victoria, Australia|Charite Universitatmedizin, Berlin",Germany,Respiratory Diseases,1,3,394.0
5128.0,NCT04786301,Severe Acute Respiratory Infection - Preparedness (COVID-19 and Influenza),SARI-PREP,Recruiting,"Pneumonia, Viral",,,,,,,,University of Washington|Centers for Disease Control and Prevention,Female,"18 Years and older   (Adult, Older Adult)",1200.0,Other|U.S. Fed,Observational,2020-04-30,01/01/22,2022-01-03,08/03/21,12/03/21,"Bellevue Hospital Center, New York, New York, United States|NYU Langone Medical Center, New York, New York",United States,Respiratory Diseases,1,1,613.0
5129.0,NCT04346121,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,PSI-RECORd-GP,Completed,Patient Safety,,,,,,,"Other: GPs reports of potential patient safety incidents, non-COVID-19 related",Nantes University Hospital,All,"Child, Adult, Older Adult",132.0,Other,Observational,2020-04-28,29/06/20,2020-06-29,15/04/20,19/10/20,"University Hospital, Nantes",France,Others,0,1,62.0
5130.0,NCT04348552,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,PSI-RECORd-XP,Recruiting,Patient Safety,,,,,,,"Other: Primary care professionals reports of potential patient safety incidents, non-COVID-19 related",Nantes University Hospital,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-04-28,28/06/20,2020-06-28,16/04/20,29/06/20,"University Hospital, Nantes",France,Others,0,1,61.0
5131.0,NCT04419064,Confirmation of Ventilation and Intubation by Determination With Ultrasonography,COVID-US,Completed,Critical Illness,Mechanical Ventilation,,,,,,Diagnostic Test: Point of care ultrasound,University of Pittsburgh|Kadlec Regional Medical Center|The Cleveland Clinic|Baylor College of Medicine|Oregon Health and Science University,All,"18 Years and older   (Adult, Older Adult)",118.0,Other,Observational,2019-01-01,20/05/20,2020-05-30,05/06/20,08/10/20,"Cleveland Clinic, Cleveland, Ohio, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Kadlec Regional Medical Center, Richland, Washington",United States,Cardiovascular Diseases,1,2,515.0
5132.0,NCT04593433,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,VGV,Not yet recruiting,Social Isolation,Quality of Life,Well Aging,Frailty,,,,Other: Museum virtual guided tours,Jewish General Hospital,All,65 Years and older   (Older Adult),40.0,Other,Interventional,2021-04-03,04/07/21,2021-04-09,20/10/20,09/02/21,"Jewish General Hospital, Montréal, Quebec",Canada,Others,0,4,6.0
5133.0,NCT04396600,The Professional Peer Resilience Initiative,PPRI,Enrolling by invitation,Stress,Stress Disorder,"Stress, Psychological","Trauma, Psychological",Anxiety,Anxiety State,Post Traumatic Stress Disorder,Behavioral: MinnRAP Peer Support Program,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-08-06,25/05/22,2022-05-25,20/05/20,04/09/20,"University of Minnesota, Minneapolis, Minnesota",United States,Mental Health,1,7,657.0
5134.0,NCT04590430,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",,"Active, not recruiting",Healthy,,,,,,,Drug: HFB30132A|Other: Placebo,HiFiBiO Therapeutics,All,18 Years to 60 Years   (Adult),24.0,Industry,Interventional,2020-10-20,01/04/21,2021-01-07,19/10/20,05/03/21,"Medpace Clinical Pharmacology Unit, Cincinnati, Ohio",United States,Others,0,1,79.0
5135.0,NCT04467112,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,,Completed,COVID-19,,,,,,,Device: Breath Biopsy face masks with removable filters and fitted PVA strip,Owlstone Ltd|Cambridge University Hospitals NHS Foundation Trust,All,"16 Years and older   (Child, Adult, Older Adult)",8.0,Industry|Other,Observational,2020-07-30,19/12/20,2020-12-19,10/07/20,30/03/21,"Cambridge University Hospital NHS, Cambridge",United Kingdom,Respiratory Diseases,1,1,142.0
5136.0,NCT04657471,Hospitalization or Outpatient ManagEment of Patients With SRAS-CoV-2 Infection - Revised HOME-CoV Score Study,,Completed,Coronavirus Infection,,,,,,,Other: revised HOME-CoV score,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Interventional,2020-08-12,08/03/21,2021-08-03,08/12/20,15/03/21,"CHU Angers, Angers",France,Respiratory Diseases,1,1,356.0
5137.0,NCT04523610,Telehealth Intervention Program for Older Adults,TIP-OA,Recruiting,"Depression, Anxiety",Cognitive Impairment,Stress,,,,,Behavioral: Telehealth phone calls|Other: Volunteer of TIP-OA Program|Other: Stakeholder of TIP-OA Program,Lady Davis Institute,All,"18 Years and older   (Adult, Older Adult)",258.0,Other,Interventional,2020-02-10,01/10/21,2022-01-10,21/08/20,18/02/21,"Institute of Community and Family Psychiatry, Montreal, Quebec",Canada,Mental Health,1,3,700.0
5138.0,NCT04394039,Post-Pandemic Perception of Public Space in Singapore,,Not yet recruiting,Stress,Anxiety,,,,,,Other: Public space exposure,"National University, Singapore|National University Hospital, Singapore",All,"21 Years to 75 Years   (Adult, Older Adult)",34.0,Other,Interventional,2020-01-06,01/08/20,2020-12-31,19/05/20,19/05/20,"Institute for Health Innovation & Technology (iHealthtech), Singapore",Singapore,Mental Health,1,2,360.0
5139.0,NCT04785781,Effects of Face Masks on Cardiopulmonary Capacity in Healthy Individuals,,Recruiting,COVID-19,,,,,,,"Other: without masks|Other: Surgical face mask (Vheal Med Co., Ltd., Istanbul, Turkey)|Other: FFP2\N95 protective face mask (Musk protective technology, Gaziantep, Turkey)",Pamukkale University,All,18 Years to 30 Years   (Adult),16.0,Other,Interventional,2021-01-02,15/03/21,2021-04-15,08/03/21,08/03/21,"Pamukkale University, Denizli",Turkey,Respiratory Diseases,1,1,103.0
5140.0,NCT04445441,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,CHLORAZ,Completed,Coronavirus Infection,,,,,,,,Centre Muraz,All,"18 Years to 99 Years   (Adult, Older Adult)",153.0,Other,Observational,2020-04-24,03/09/20,2020-11-30,24/06/20,22/01/21,"Sourou Sanon University Hospital, Bobo-Dioulasso, Burkina Faso|Tingadogo University Hospital, Ouagadougou",Burkina Faso,Respiratory Diseases,1,1,220.0
5141.0,NCT04550312,The Impact of Lifestyle Changes on Non-COVID Deaths,,Recruiting,Lifestyle Alteration,COVID-19,,,,,,,The First Affiliated Hospital with Nanjing Medical University,All,"Child, Adult, Older Adult",80000.0,Other,Observational,2020-01-09,01/10/20,2020-01-10,16/09/20,16/09/20,"Xuzhou Medical University affiliated Hospital, Xuzhou, Jiangsu",China,Respiratory Diseases,1,2,1.0
5142.0,NCT04382560,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,,Completed,"Behavior, Social",Autonomic Imbalance,,,,,,Other: Deep Breathing training|Other: Compassion focused intervention,University of Parma|University of Roma La Sapienza|King's College London,All,20 Years to 50 Years   (Adult),69.0,Other,Interventional,2020-02-05,31/05/20,2020-05-31,11/05/20,01/04/21,"Sapienza University of Rome, Rome",Italy,Others,0,2,116.0
5143.0,NCT04816708,A Self-directed Mobile Mindfulness Intervention to Address Distress and Burnout in Frontline Healthcare Workers,LIFT-HCW,Not yet recruiting,COVID-19,,,,,,,Behavioral: LIFT Mindfulness,Duke University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-04-15,31/03/22,2022-03-31,25/03/21,25/03/21,"Duke University Medical Center, Durham, North Carolina",United States,Respiratory Diseases,1,1,350.0
5144.0,NCT04495543,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',,Recruiting,Suicidal Ideation,Suicide,Mental Health Issue,Depression,,,,Behavioral: Brief Skills for Safer Living,Unity Health Toronto,All,"18 Years and older   (Adult, Older Adult)",75.0,Other,Interventional,2020-01-12,01/08/21,2021-01-08,03/08/20,24/12/20,"St. Michael's Hospital, Toronto, Ontario",Canada,Mental Health,1,4,362.0
5145.0,NCT04368299,Telemedicine for Follow-up of Systemic Lupus Erythematosus,,Recruiting,SLE,,,,,,,Other: Telemedicine|Other: Standard care,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-01-05,31/10/21,2021-12-31,29/04/20,15/07/20,"The Chinese University of Hong Kong, Hong Kong",Hong Kong,Others,0,1,726.0
5146.0,NCT04453839,ZYESAMI (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE),SAMICARE,Available,COVID-19,,,,,,,Drug: ZYESAMI (aviptadil acetate),"NeuroRx, Inc.|Cavendish Impact Foundation",All,"12 Years to 100 Years   (Child, Adult, Older Adult)",,Industry|Other,Expanded Access:Intermediate-size Population,,,,01/07/20,19/03/21,"Dignity Health-Mercy Gilbert Medical Center, Gilbert, Arizona, United States|Honor Health Shea Medical Center, Scottsdale, Arizona, United States|Kaiser Permanente, Baldwin Park, California, United States|University of California - Irvine, Irvine, California, United States|Lawnwood Regional Medical Center, Fort Pierce, Florida, United States|Lakeland Regional Health, Lakeland, Florida, United States|Miller School of Medicine / University of Miami Medical Center, Miami, Florida, United States|Baptist Hospital of Miami, Miami, Florida, United States|Baycare St. Joseph Hospital, Tampa, Florida, United States|Southeast Georgia Health system, Brunswick, Georgia, United States|Maui Health Systems, Wailuku, Hawaii, United States|St. Anthony Regional Hospital, Carroll, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|St. Tammany Parish Hospital, Covington, Louisiana, United States|Our Ladies of Lourdes Regional Hospital, Lafayette, Louisiana, United States|St. Joseph Heritage Healthcare, Saint Joseph, Missouri, United States|Great Plains Health, North Platte, Nebraska, United States|Self Regional Healthcare, Greenwood, South Carolina, United States|Hendrick Medical Center, Abilene, Texas, United States|Baptist Hospitals of Southeast Texas, Beaumont, Texas, United States|Medical City Denton, Denton, Texas, United States|HR Health Institute for Research & Development, Edinburg, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Memorial Hermann Hospital Houston, Houston, Texas, United States|Medical City McKinney, McKinney, Texas",United States,Respiratory Diseases,1,1,
5147.0,NCT04818697,"Effect of Social Isolation on Physical Activity Level, and Kinesophobia in Heart Rhythm Disorders During Pandemic",,Completed,Heart Rhythm Disorder,COVID-19,Social Isolation,,,,,,Hacettepe University,All,"18 Years and older   (Adult, Older Adult)",105.0,Other,Observational,2020-06-24,19/03/21,2021-03-19,26/03/21,30/03/21,"Hacettepe University, Ankara",Turkey,Respiratory Diseases,1,3,268.0
5148.0,NCT04598763,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,Odorat-Covid,Recruiting,Olfaction Disorders,,,,,,,Other: smell the odors of the olfactory rehabilitation kit according to the classic or intensive method,"Central Hospital, Nancy, France",All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2020-01-07,01/07/20,2021-01-01,22/10/20,22/10/20,"CHRU de Nancy, Nancy",France,Others,0,1,360.0
5149.0,NCT04662008,Offering Support and Electronic Resources for Care Partners of Those With Multiple Sclerosis,,Not yet recruiting,Multiple Sclerosis,Caregivers,,,,,,Behavioral: Tele-coaching|Behavioral: Website,Case Western Reserve University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2021-10-01,30/09/21,2021-10-31,10/12/20,10/12/20,,,Immunological Disorders,1,2,30.0
5150.0,NCT04629755,A Smartphone Intervention for Relational and Mental Well Being,,Completed,Depression,Loneliness,"Relation, Interpersonal",COVID-19,,,,Behavioral: Intervention,University of Washington,All,"18 Years and older   (Adult, Older Adult)",1765.0,Other,Interventional,2020-04-04,03/08/20,2020-03-08,16/11/20,19/11/20,"University of Washington, Seattle, Washington",United States,"Mental Health, Respiratory Diseases",1,4,-27.0
5151.0,NCT04369599,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q System,,Enrolling by invitation,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Device: V/Q System,Emory University|Georgia Tech Research Foundation|Georgia Clinical & Translational Science Alliance,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Interventional,2020-11-08,01/07/21,2021-01-07,30/04/20,12/04/21,"Emory University Hospital, Atlanta, Georgia",United States,Respiratory Diseases,1,2,60.0
5152.0,NCT04601415,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,DUO-EF-19,Not yet recruiting,Heart Failure,,,,,,,Diagnostic Test: ECG from handheld device,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",1500.0,Other,Observational,2021-01-02,01/10/22,2022-01-10,23/10/20,23/10/20,,,Others,0,1,373.0
5153.0,NCT04551274,Music Therapy in Frontline Healthcare Workers,,Not yet recruiting,Mood,Emotional Stress,,,,,,Behavioral: Music Therapy,Simon Fraser University|Music Heals Charitable Foundation,All,"19 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-01-10,30/11/20,2020-11-30,16/09/20,16/09/20,"Simon Fraser University, Burnaby, British Columbia",Canada,Mental Health,1,2,325.0
5154.0,NCT04369274,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,,Not yet recruiting,Respiratory Failure,,,,,,,Device: Mechanical ventilation with the automated BVM compressor,Massachusetts General Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-03,01/11/21,2021-01-11,30/04/20,24/02/21,,,Respiratory Diseases,1,1,8.0
5155.0,NCT04766645,ACE2 Gender Differences in NeuroCovid19 Stroke,ACEGENDER,Not yet recruiting,Neurologic Manifestations,,,,,,,Device: Robotic assisted intervention|Genetic: epigenetic analyses|Diagnostic Test: biochemical analyses,Fondazione Don Carlo Gnocchi Onlus,All,"18 Years to 90 Years   (Adult, Older Adult)",100.0,Other,Observational,2021-01-03,07/02/22,2022-07-07,23/02/21,23/02/21,,,Others,0,1,550.0
5156.0,NCT04753645,BRAC Institute of Governance and Development-Hygiene Behavioural Change and Coalition,(BIGD-HBCC),"Active, not recruiting",Hygiene Practices and Knowledge,,,,,,,Behavioral: Handwashing stations at the public places|Behavioral: No activities of the HBCC project,BRAC University|The Behavioural Insights Team|Brac,All,"10 Years and older   (Child, Adult, Older Adult)",3840.0,Other,Interventional,2020-09-19,01/05/21,2021-01-05,15/02/21,15/02/21,"BRAC, Bangladesh, Dhaka",Bangladesh,Others,0,1,108.0
5157.0,NCT04350723,Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,COVI-PRONE,Recruiting,Corona Virus Infection,COVID-19,,,,,,Procedure: Awake Proning,St. Joseph's Healthcare Hamilton|King Abdullah International Medical Research Center (KAIMRC)|McMaster University|Canadian Institutes of Health Research (CIHR),All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2020-10-06,30/07/21,2021-08-30,17/04/20,22/10/20,"St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada|Hamilton General Hospital, Hamilton, Canada|Juravinski Hospital, Hamilton, Canada|St. Catharine's General -, St. Catharines, Canada|King Fahad Hospital of the University, Khobar, Eastern Province, Saudi Arabia|King Faisal Specialist Hospital & Research Center, Riyadh",Saudi Arabia,Respiratory Diseases,1,2,328.0
5158.0,NCT04751474,"The Effect of Motivational Messages on Optimism, Hopelessness and Life Satisfaction",,"Active, not recruiting",Motivation,Optimism,Hopelessness,Life Satisfaction,,,,Other: Motivational messages,Saglik Bilimleri Universitesi,All,"18 Years and older   (Adult, Older Adult)",93.0,Other,Interventional,2021-01-02,01/03/21,2021-03-31,12/02/21,12/02/21,"Elif Gezginci, Istanbul",Turkey,Others,0,4,88.0
5159.0,NCT04644705,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,-NIC 2,Recruiting,Healthy Volunteers,,,,,,,Drug: Niclosamide|Drug: Placebo,Charité Research Organisation GmbH|Bayer,All,18 Years to 45 Years   (Adult),28.0,Other|Industry,Interventional,2020-02-11,31/05/21,2021-05-31,25/11/20,25/11/20,"Charité Research Organisation GmbH, Berlin",Germany,Others,0,1,475.0
5160.0,NCT04399005,The Efficacy Comparing Daily and After-each-case Room Disinfection.,,Completed,Daily Room Disinfection,After-each-case Room Disinfection,,,,,,Other: after-each-case room disinfection|Other: daily room disinfection,The First Affiliated Hospital of Zhejiang Chinese Medical University,All,"Child, Adult, Older Adult",240.0,Other,Interventional,2020-05-25,05/06/20,2020-10-06,22/05/20,25/06/20,"First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang",China,Others,0,2,134.0
5161.0,NCT04442958,Effectiveness of Convalescent Immune Plasma Therapy,,Completed,Acute Respiratory Distress Syndrome,,,,,,,Other: Convalescent Immune Plasma,Bagcilar Training and Research Hospital,All,"18 Years to 90 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-05-15,15/06/20,2020-06-17,23/06/20,01/07/20,"Istanbul Bagcılar Training and Research Hospital, Istanbul",Turkey,Respiratory Diseases,1,1,33.0
5162.0,NCT04524962,Study of Descartes-30 in Acute Respiratory Distress Syndrome,,Recruiting,Acute Respiratory Distress Syndrome,COVID-19,,,,,,Biological: Descartes 30,Cartesian Therapeutics,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry,Interventional,2020-09-15,25/09/21,2022-09-25,24/08/20,10/02/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|University of California-Irvine, Irvine, California, United States|University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States|University of Maryland Medical Center Medical Center, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma",United States,Respiratory Diseases,1,2,740.0
5163.0,NCT04549350,Sleep Quality Among HCWs,,Completed,Sleep Quality,,,,,,,Other: PSQI,"Zagazig University|Ministry of Health, Kuwait",All,25 Years to 60 Years   (Adult),217.0,Other,Observational,2020-05-19,18/08/20,2020-05-09,16/09/20,21/09/20,"Zagazig University, Zagazig",Egypt,Others,0,1,-10.0
5164.0,NCT04422769,Needs of Persons With Spinal Cord Injury (SCI),,"Active, not recruiting",Spinal Cord Injuries,,,,,,,,Washington University School of Medicine,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-05-22,31/03/21,2021-03-31,09/06/20,22/01/21,"Washington University School of Medicine, Saint Louis, Missouri",United States,Others,0,1,313.0
5165.0,NCT04684836,Comparative Effectiveness of Telemedicine in Primary Care,,Not yet recruiting,Asthma,Chronic Obstructive Pulmonary Disease (COPD,Congestive Heart Failure,Diabetes,Hypertension,,,"Other: Exposure to telemedicine, after the onset of the pandemic",Weill Medical College of Cornell University|Patient-Centered Outcomes Research Institute,All,"19 Years and older   (Adult, Older Adult)",216000.0,Other,Observational,2021-01-02,01/04/22,2023-01-12,28/12/20,28/12/20,"University of Florida, Gainesville, New York, United States|Mount Sinai, New York, New York, United States|Weill Cornell Medicine, New York, New York, United States|University of North Carolina, Chapel Hill, North Carolina",United States,"Cardiovascular Diseases, Metabolic Disorders",1,5,740.0
5166.0,NCT04406558,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,COVADO,Recruiting,Psychological Adaptation,"Psychology, Social",,,,,,Other: Questionnaire,Centre Hospitalier Intercommunal Creteil,All,"11 Years to 18 Years   (Child, Adult)",400.0,Other,Observational,2020-05-27,01/03/21,2021-01-04,28/05/20,12/01/21,"Camille JUNG, Creteil",France,Others,0,2,222.0
5167.0,NCT04681365,Evaluating Bubble-PAPR for Healthcare Workers,BubblePAPR,Recruiting,COVID-19,,,,,,,Other: Staff will wear and evaluate Bubble-PAPR (non-CE marked PAPR),Manchester University NHS Foundation Trust|University of Manchester,All,"18 Years to 70 Years   (Adult, Older Adult)",66.0,Other,Observational,2021-02-24,01/06/21,2021-02-06,23/12/20,08/04/21,"Manchester University NHS Foundation Trust, Manchester",United Kingdom,Respiratory Diseases,1,1,-18.0
5168.0,NCT04695743,Group CST Using Zoom: A Proof of Concept Study,,Recruiting,Dementia,,,,,,,Other: Online Cognitive Stimulation Therapy,"University College, London",All,"Child, Adult, Older Adult",50.0,Other,Interventional,2020-01-09,01/06/22,2022-01-09,05/01/21,05/01/21,"University College London, London",United Kingdom,Others,0,1,731.0
5169.0,NCT04787536,Perioperative Cognitive Trajectories in Deferred Surgery (CoTELE-SURGE),CoTELE-SURGE,Recruiting,Postoperative Cognitive Dysfunction,Depressive Symptoms,Postoperative Pain,,,,,Procedure: Non-cardiac surgery,McMaster University,All,65 Years and older   (Older Adult),300.0,Other,Observational,2020-10-06,31/12/22,2022-12-31,08/03/21,08/03/21,"McMaster University, Hamilton, Ontario",Canada,Others,0,3,816.0
5170.0,NCT04496466,Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI),CCPSEI,Enrolling by invitation,Coronavirus,,,,,,,,Johns Hopkins University,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-09-04,01/06/21,2021-01-06,03/08/20,05/08/20,"Johns Hopkins Hospital, Baltimore, Maryland",United States,Respiratory Diseases,1,1,124.0
5171.0,NCT04764422,Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand,,Recruiting,COVID-19,SARS Pneumonia,"Pneumonia, Viral",COVID-19,,,,Biological: Normal Saline|Biological: NDV-HXP-S vaccine,Mahidol University|The Government Pharmaceutical Organization,All,"18 Years to 75 Years   (Adult, Older Adult)",460.0,Other,Interventional,2021-03-20,01/04/22,2023-01-04,21/02/21,01/04/21,"Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok",Thailand,Respiratory Diseases,1,4,655.0
5172.0,NCT04363177,Global Mental Health of Urban Mothers,MUM,Not yet recruiting,Perinatal Depression,COVID-19,Anxiety,PTSD,Pregnancy Related,,,Behavioral: Web-based psychosocial peer-to-peer support,Karolinska Institutet|Swiss National Science Foundation,Female,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-01-11,01/06/21,2023-01-06,27/04/20,26/10/20,"Shanghai Women's and Children's Health Center, Shanghai, Shanghai, China|Chinese University Hong Kong, Hong Kong",Hong Kong,"Mental Health, Respiratory Diseases",1,5,1091.0
5173.0,NCT04609371,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,,Enrolling by invitation,Mental Health Wellness 1,Coaching,Pandemic,"Depression, Anxiety",Self-care Tools,,,Behavioral: self-care tools|Behavioral: lay telephone coaching,"St. Mary's Research Center, Canada",All,65 Years and older   (Older Adult),176.0,Other,Interventional,2020-10-21,01/03/21,2021-01-05,30/10/20,18/11/20,"St Mary's Hospital Research Centre, Montréal",Canada,Mental Health,1,5,76.0
5174.0,NCT04396314,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,BATEP,Not yet recruiting,PostTraumatic Stress Disorder,,,,,,,Behavioral: Basic Body Awareness Therapy|Behavioral: Psychological treatment,Universitat de Lleida|Francesc Rubí Carnacea,All,"18 Years and older   (Adult, Older Adult)",54.0,Other,Interventional,2021-01-09,30/12/21,2022-04-30,20/05/20,19/03/21,,,Mental Health,1,1,476.0
5175.0,NCT04618341,A Clinical Study of Online Active Play Program With Adolescents,,Completed,Anxiety,Depression,,,,,,,Revival Active|L.E.A.D|Aarogyam UK,All,11 Years to 17 Years   (Child),32.0,Other,Observational,2020-03-30,30/06/20,2020-07-28,05/11/20,05/11/20,"Revival Active, Leicester, Leicestershire",United Kingdom,Mental Health,1,2,120.0
5176.0,NCT04394455,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,,Enrolling by invitation,Anxiety,Depressive Symptoms,Post Traumatic Stress Symptoms,Perceived Stress,,,,Behavioral: Brief cognitive behavioral therapy|Behavioral: Crisis intervention therapy,Universidad Nacional Autonoma de Honduras,All,"18 Years and older   (Adult, Older Adult)",236.0,Other,Interventional,2020-06-30,30/11/20,2020-12-30,19/05/20,02/07/20,"Universidad Nacional Autónoma de Honduras, Tegucigalpa, Francisco Morazán",Honduras,Mental Health,1,4,183.0
5177.0,NCT04788433,Registry of Coronavirus Complications - CORRELATION WITH GLYCOMIC PROFILE,ROCCO,Recruiting,Chronic Pain,"Morbidity, Multiple",COVID-19,,,,,Diagnostic Test: glycomic analysis|Other: Phone interview,Papa Giovanni XXIII Hospital|GENOS,All,"18 Years and older   (Adult, Older Adult)",615.0,Other,Observational,2021-04-03,31/03/22,2022-03-31,09/03/21,09/03/21,"Aast Papa Giovanni Xxiii, Bergamo",Italy,Respiratory Diseases,1,3,362.0
5178.0,NCT04727762,Use of the Mask and Current Pandemic,Mask,Completed,Face Mask Squeeze,,,,,,,,University of Valencia,All,"18 Years and older   (Adult, Older Adult)",629.0,Other,Observational,2021-04-02,01/03/21,2021-03-30,27/01/21,01/04/21,"Gemma Victoria Espí-López, Valencia",Spain,Others,0,1,-3.0
5179.0,NCT04789525,Physical Training and Diet for Childhood Obesity,,Completed,"Obesity, Childhood",,,,,,,Other: High-intensity aerobic training with high protein diet,Cairo University,Male,5 Years to 12 Years   (Child),76.0,Other,Interventional,2020-10-03,01/10/20,2020-12-25,09/03/21,11/03/21,"Marwa Eid, Cairo",Egypt,Metabolic Disorders,1,1,83.0
5180.0,NCT04415359,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,AMPCOVID-19,Completed,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",Female,18 Years to 43 Years   (Adult),700.0,Other,Observational,2020-01-08,31/10/20,2020-12-31,04/06/20,01/04/21,"Service Clinico biologique d'Assistance Médicale à La Procréation, Strasbourg",France,Respiratory Diseases,1,1,358.0
5181.0,NCT04420273,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,TMD,Completed,Melanoma,,,,,,,Behavioral: SSE educational intervention|Other: Home sample collection of concerning mole with physician supervision|Behavioral: Active control:Healthy Living,Northwestern University,Female,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-02-07,01/03/21,2021-01-03,09/06/20,03/03/21,"Northwestern University Feinberg School of Medicine Department of Dermatology, Chicago, Illinois",United States,Others,0,1,331.0
5182.0,NCT04475185,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,COVRESP,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,Device: MakAir,Nantes University Hospital,All,"18 Years and older   (Adult, Older Adult)",117.0,Other,Interventional,2020-07-20,01/12/20,2020-01-12,17/07/20,27/11/20,"CHRU Brest, Brest, Finistère, France|CHU Nantes, Nantes, Loire-Atlantique",France,Respiratory Diseases,1,1,-190.0
5183.0,NCT04688502,Effects of Wearing a Face Mask During CrossFit Exercise,,Not yet recruiting,Dyspnea,,,,,,,Other: High intensity interval training|Other: Continuous exercise training,University of Saskatchewan,All,"18 Years and older   (Adult, Older Adult)",24.0,Other,Interventional,2021-11-01,28/02/21,2021-03-15,30/12/20,30/12/20,"University of Saskatchewan, Saskatoon, Saskatchewan",Canada,Others,0,1,-231.0
5184.0,NCT04457388,Tele-Yoga Therapy for Chronic Pain,,Completed,Chronic Pain,,,,,,,Other: Tele-Yoga Therapy,Aarogyam UK,All,18 Years to 60 Years   (Adult),18.0,Other,Interventional,2020-03-25,15/06/20,2020-06-15,07/07/20,08/07/20,"Aarogyam UK, Leicester, Leicestershire",United Kingdom,Others,0,1,82.0
5185.0,NCT04498416,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,CoCo-20,Recruiting,Mental Health Disorder,,,,,,,Diagnostic Test: Quantitative and qualitative assessments of mental health,Fondation Lenval,All,up to 17 Years   (Child),70.0,Other,Observational,2020-04-27,01/07/21,2021-01-07,04/08/20,03/02/21,"Hôpitaux Pédiatriques de Nice CHU-Lenval, Nice",France,Others,0,1,255.0
5186.0,NCT04821999,Diode Laser 940 nm in Management of Loss of Taste Sensation,,Not yet recruiting,SARS-CoV Infection,,,,,,,Device: a 940-nm diode laser,Fayoum University,All,18 Years to 60 Years   (Adult),150.0,Other,Interventional,2021-04-15,20/05/21,2021-01-06,30/03/21,01/04/21,,,Respiratory Diseases,1,1,-99.0
5187.0,NCT04776941,Expressive Writing for the Management of Stress in Cancer Survivors,,Recruiting,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm,,,,,,Behavioral: Behavioral Intervention|Other: Quality-of-Life Assessment|Other: Questionnaire Administration,M.D. Anderson Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",120.0,Other|NIH,Interventional,2020-07-08,31/12/21,2021-12-31,02/03/21,02/03/21,"M D Anderson Cancer Center, Houston, Texas",United States,Others,0,2,541.0
5188.0,NCT04439825,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,,Completed,Mood,,,,,,,Drug: Botulinum Neurotoxin|Drug: Placebo,DeNova Research,All,"10 Years to 75 Years   (Child, Adult, Older Adult)",45.0,Other,Interventional,2020-07-20,03/09/20,2020-01-12,19/06/20,15/03/21,"DeNova Research, Chicago, Illinois",United States,Others,0,1,-190.0
5189.0,NCT04828434,Virtual Individual Cognitive Stimulation Therapy: a Proof of Concept Study,viCST,Not yet recruiting,Dementia,"Dementia, Vascular","Dementia, Mixed",Dementia With Lewy Bodies,Dementia Frontal,"Dementia, Mild",Dementia Moderate,Other: Virtual Individual Cognitive Simulation Therapy,"University College, London|The University of Hong Kong",All,"18 Years and older   (Adult, Older Adult)",34.0,Other,Interventional,2021-01-04,01/04/23,2025-01-09,02/04/21,02/04/21,"UCL, London",United Kingdom,Others,0,7,1466.0
5190.0,NCT01306084,Viral Infections in Healthy and Immunocompromised Hosts,,Recruiting,Anogenital Herpes,COVID-19,Herpes Labialis,,,,,,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"Child, Adult, Older Adult",1000.0,NIH,Observational,2011-03-15,,,01/03/11,10/02/21,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland",United States,Respiratory Diseases,1,3,
5191.0,NCT04555954,Determining the Physical Activity Level of Healthy Adults During Pandemic,,Completed,"Health, Subjective",Healthy,,,,,,Other: surveys and questionnaires,Pamukkale University,All,"Child, Adult, Older Adult",205.0,Other,Observational,2020-11-04,31/07/20,2020-08-20,21/09/20,21/09/20,"Afyonkarahisar Health Science University, Afyonkarahisar",Turkey,Others,0,2,-76.0
5192.0,NCT04233268,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,RASCALS,Recruiting,Lower Respiratory Tract Infection,Ventilator Associated Pneumonia,COVID-19,,,,,Diagnostic Test: Rapid Pathogen Detection,Cambridge University Hospitals NHS Foundation Trust,All,up to 16 Years   (Child),250.0,Other,Observational,2020-06-04,28/02/23,2025-02-28,18/01/20,05/06/20,"Addenbrooke's Hospital, Cambridge, Cambs",United Kingdom,Respiratory Diseases,1,3,1730.0
5193.0,NCT04765215,Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.,,Not yet recruiting,Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy,,,,,,,Biological: CoronoVAC,Asoc. Prof. Erdoğan Selçuk Şeber|Namik Kemal University,All,"18 Years to 90 Years   (Adult, Older Adult)",291.0,Other,Observational,2021-03-31,31/07/21,2022-03-31,21/02/21,21/02/21,,,Others,0,1,365.0
5194.0,NCT04733677,User Experience of the OSR M-1,,Recruiting,COVID-19,,,,,,,,Wake Forest University Health Sciences,All,"Child, Adult, Older Adult",200.0,Other,Observational,2021-03-19,01/07/21,2021-01-07,02/02/21,01/04/21,"Wake Forest Baptist Health, Winston-Salem, North Carolina",United States,Respiratory Diseases,1,1,-71.0
5195.0,NCT04331808,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),CORIMUNO-TOC,"Active, not recruiting",Corona Virus Infection,,,,,,,Drug: Tocilizumab,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",228.0,Other,Interventional,2020-03-30,31/03/21,2021-12-31,02/04/20,28/04/20,"APHP- Hopital Tenon, Paris, France|APHP - Beaujon, Paris, France|APHP - Bichat, Paris, France|APHP - Hopital Necker, Paris, France|APHP - Pitié Salpêtrière, Paris, France|APHP - Saint Louis, Paris, France|CHU Strasbourg, Strasbourg, France|Institut Gustave Roussy, Villejuif",France,Respiratory Diseases,1,1,641.0
5196.0,NCT04688840,Smartphone Application: A Possible Solution for Follow up of Patients With Hip Arthroplasty,,Completed,Telemedicine,,,,,,,Procedure: hip arthropalsty,Tanta University,All,"Child, Adult, Older Adult",167.0,Other,Observational,2020-01-01,01/09/20,2020-01-12,30/12/20,30/12/20,"Ahmed Samy, Tanta",Egypt,Others,0,1,11.0
5197.0,NCT04413006,Self-compassion for Chronic Pain Virtual Group Treatment Program,,Recruiting,Chronic Pain,,,,,,,Behavioral: Self-Compassion for Chronic Pain Virtual Group Treatment Program,University of Manitoba,All,"18 Years and older   (Adult, Older Adult)",28.0,Other,Interventional,2020-05-25,31/12/20,2021-03-31,02/06/20,02/06/20,"University of Manitoba, Winnipeg, Manitoba",Canada,Others,0,1,310.0
5198.0,NCT04473599,Stay Well at Home: a Text-messaging Study Social Distancing,,Recruiting,Depressive Symptoms,Anxiety,COVID-19,,,,,Behavioral: Uniform random message delivery|Behavioral: Reinforcement learning message delivery,"University of California, Berkeley",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-04-17,01/04/21,2021-01-04,16/07/20,28/07/20,"University of California Berkeley, Berkeley, California",United States,"Mental Health, Respiratory Diseases",1,3,262.0
5199.0,NCT04545242,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,DEXA-REFINE,Not yet recruiting,Acute Hypoxemic Respiratory Failure,,,,,,,Drug: Dexamethasone,"Dr. Negrin University Hospital|Li Ka Shing Knowledge Institute|Consorcio Centro de Investigación Biomédica en Red, M.P.",All,"18 Years and older   (Adult, Older Adult)",980.0,Other,Interventional,2021-08-02,30/09/23,2023-12-30,10/09/20,22/01/21,"Hospital Universitario Mutua Terrassa (ICU), Terrassa, Barcelona, Spain|Hospital General La Mancha Centro (ICU), Alcazar de San Juan, Ciudad Real, Spain|Complejo Hospitalario Universitario de Santiago (Anesthesia), Santiago De Compostela, La Coruña, Spain|Hospital General El Bierzo (ICU), Ponferrada, León, Spain|Hospital Universitario del Henares (ICU), Coslada, Madrid, Spain|Hospital Universitario de Getafe (ICU), Getafe, Madrid, Spain|Hospital Universitario Severo Ochoa (ICU), Leganés, Madrid, Spain|Hospital Universitario Puerta de Hierro (ICU), Majadahonda, Madrid, Spain|Hospital Nuestra Señora del Prado (ICU), Talavera De La Reina, Toledo, Spain|Hospital Universitario de Cruces (Anesthesia), Barakaldo, Vizcaya, Spain|Hospital Universitario de Cruces (ICU), Barakaldo, Vizcaya, Spain|Complejo Hospitalario Universitario de Albacete (ICU), Albacete, Spain|Hospital Clinic de Barcelona (AVI), Barcelona, Spain|Hospital Clinic de Barcelona (Cardiac ICU), Barcelona, Spain|Hospital Clínic (Hepatic ICU), Barcelona, Spain|Hospital Clínic de Barcelona (Anesthesia), Barcelona, Spain|Hospital General de Ciudad Real (ICU), Ciudad Real, Spain|Hospital Virgen de la Luz (ICU), Cuenca, Spain|Hospital Universitario de A Coruña (ICU), La Coruña, Spain|Complejo Asistencial Universitario de León (ICU), León, Spain|Hospital Universitario La Princesa (ICU), Madrid, Spain|Hospital Universitario Ramón y Cajal (Anesthesia), Madrid, Spain|Hospital Clínico Universitario San Carlos (ICU), Madrid, Spain|Hospital Universitario Fundación Jiménez Díaz (ICU), Madrid, Spain|Hospital Universitario Doce de Octubre (ICU), Madrid, Spain|Hospital Universitario La Paz (Anesthesia), Madrid, Spain|Hospital Universitario La Paz (ICU), Madrid, Spain|Hospital Universitario Virgen de Arrixaca (Anesthesia), Murcia, Spain|Hospital Universitario Virgen de Arrixaca (ICU), Murcia, Spain|Hospital Universitario Regional de Malaga Carlos Haya (ICU), Málaga, Spain|Clínica Universidad de Navarra, Pamplona, Spain|Hospital Universitario Montecelo (Anesthesia), Pontevedra, Spain|Hospital Universitario Nuestra Señora de Candelaria (ICU), Santa Cruz De Tenerife, Spain|Hospital General de Segovia (ICU), Segovia, Spain|Hospital Clinico Universitario de Valencia (Anesthesia), Valencia, Spain|Hospital Clinico Universitario de Valencia (ICU), Valencia, Spain|Hospital Clínico Universitario de Valladolid (Anesthesia), Valladolid, Spain|Hospital Universitario Río Hortega (Anesthesia), Valladolid, Spain|Hospital Universitario Río Hortega (ICU), Valladolid, Spain|Hospital Virgen de la Concha (ICU), Zamora",Spain,Respiratory Diseases,1,1,880.0
5200.0,NCT04769999,Computer Assisted Lessening of Intrusive Memories in the Emergency Department,CALM-ED,Completed,Post Traumatic Stress Disorder,,,,,,,Behavioral: Simple cognitive task,University of Oxford|Oxford University Hospitals NHS Trust|Royal Berkshire NHS Foundation Trust|South Central Ambulance Service NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",14.0,Other,Interventional,2020-04-06,16/10/20,2020-10-30,25/02/21,25/02/21,"South Central Ambulance Service NHS Foundation Trust, Bicester, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|Royal Berkshire NHS Foundation Trust, Reading",United Kingdom,Mental Health,1,1,207.0
5201.0,NCT04826367,Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer,,Recruiting,Breast Cancer,,,,,,,Other: Telerehabilitation-based relaxation exercise group (EG),Hacettepe University,Female,"18 Years to 70 Years   (Adult, Older Adult)",64.0,Other,Interventional,2021-01-20,01/12/21,2022-01-02,01/04/21,02/04/21,"Florence Nightingale Hospital, Istanbul",Turkey,Cancers,1,1,347.0
5202.0,NCT04335851,Video-Based Exercises and Well-Being During Social Isolation,,Completed,Social Isolation,Physical Inactivity,Well-Being,,,,,Other: Video based aerobic exercise,Biruni University|Istanbul University-Cerrahpasa,All,18 Years to 35 Years   (Adult),68.0,Other,Interventional,2020-06-04,15/05/20,2020-03-06,06/04/20,09/06/20,"Biruni University, Istanbul, Turkey|Istanbul University Cerrahpasa, Istanbul",Turkey,Others,0,3,-90.0
5203.0,NCT04444713,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,,Not yet recruiting,Depressive Symptoms,Metacognitive Variables,,,,,,,Modum Bad|University of Oslo,All,"18 Years and older   (Adult, Older Adult)",10084.0,Other,Observational,2020-06-22,13/07/20,2020-07-13,23/06/20,23/06/20,,,Others,0,2,21.0
5204.0,NCT04443075,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,AGMFMSS,Completed,"Stress Disorders, Post-Traumatic",,,,,,,Device: faecal sample collector,First Affiliated Hospital Xi'an Jiaotong University,All,18 Years to 50 Years   (Adult),180.0,Other,Observational,2020-06-24,04/12/20,2020-12-24,23/06/20,03/03/21,"First Affiliated Hospital of Xian Jiaotong University, Xi'an, Shaanxi",China,Mental Health,1,1,183.0
5205.0,NCT04636944,Management of Depression and Anxiety in HF,,Recruiting,Heart Failure,Depression,Anxiety,,,,,Other: web-based COMPASS intervention,King's College London,All,"19 Years and older   (Adult, Older Adult)",13.0,Other,Observational,2020-02-10,16/08/21,2021-08-16,19/11/20,19/11/20,"Community Heart Failure Team: Elmcourt Health Centre, London",United Kingdom,Mental Health,1,3,553.0
5206.0,NCT04797208,Remote Glucose Monitoring in Hospital Settings,REMOTE-CGM,Not yet recruiting,"Diabetes Mellitus, Type 2",Hyperglycemia Stress,Hypoglycemia,,,,,Device: Real-Time CGM|Device: Capillary blood glucose testing with masked CGM,Manchester University NHS Foundation Trust|Manchester Academic Health Science Centre,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-06,01/12/21,2022-01-03,15/03/21,17/03/21,,,"Mental Health, Metabolic Disorders",1,3,362.0
5207.0,NCT04763213,New Predictors in Determining the Need for Invasive Treatment in Non-STEMI,non-STEMI,Completed,Myocard Infarctus,,,,,,,Diagnostic Test: Coronary Angiography,Kahramanmaras Sutcu Imam University,All,"18 Years and older   (Adult, Older Adult)",276.0,Other,Observational,2018-01-01,31/12/19,2019-12-31,21/02/21,21/02/21,"Ekrem Aksu, Kahramanmaraş",Turkey,Others,0,1,729.0
5208.0,NCT04658979,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,Tele-RehaB,Recruiting,Chronic Pulmonary Disease,,,,,,,Other: Pulmonary tele-rehabilitation,"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec|Fondation IUCPQ|Institut universitaire de cardiologie et de pneumologie de Québec, University Laval",All,"20 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-12,01/03/21,2022-01-01,09/12/20,10/12/20,"Institut universitaire de cardiologie et de pneumologie de Québec, Québec, Quebec",Canada,Others,0,1,720.0
5209.0,NCT03708718,Prednisolone in Early Diffuse Systemic Sclerosis,PRedSS,Recruiting,Systemic Sclerosis,,,,,,,Drug: Prednisolone 5 mg|Drug: Placebo oral capsule; From August 2020 'no additional treatment',Prof. Ariane herrick|Versus Arthritis|University of Manchester,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Interventional,2017-12-21,01/06/21,2021-01-09,17/10/18,06/11/20,"Aberdeen Royal Infirmary - NHS Grampian, Aberdeen, Aberdeenshire, United Kingdom|Addenbrooke's Hospital - Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom|Salford Royal NHS Foundation Trust, Salford, Greater Manchester, United Kingdom|Glasgow Royal Infirmary -, Glasgow, Lanarkshire, United Kingdom|Aintree University Hospitals NHS Foundation Trust, Liverpool, Merseyside, United Kingdom|Queen's Medical Centre - Nottingham University Hospitals NHS Trust, Nottingham, Nottinghamshire, United Kingdom|Royal National Hospital For Rheumatic Diseases - Royal United Hospitals Bath NHS Foundation Trust, Bath, Somerset, United Kingdom|Royal Hallamshire Hospital - Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom|Freeman Hospital - The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Tyne And Wear, United Kingdom|The Dudley Group NHS Foundation Trust, Dudley, West Midlands, United Kingdom|Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, West Yorkshire, United Kingdom|Southmead Hospital Bristol - North Bristol NHS Trust, Bristol, United Kingdom|Ninewells Hospital and Medical School - NHS Tayside, Dundee, United Kingdom|Royal Free London NHS Foundation Trust, London",United Kingdom,Others,0,1,1115.0
5210.0,NCT04765540,The Effect of Behaviour Change Interventions on Use of Public Handwashing Stations in Bangladesh,,"Active, not recruiting",Hand Washing,Handwashing,COVID-19,,,,,Behavioral: Low Intensity Nudges|Behavioral: High Intensity Activities|Behavioral: BRAC's business-as-usual,"The Behavioural Insights Team|Brac|BRAC Institute of Governance and Development|Unilever U.K. Central Resources Limited|D2 Technologies Ltd, Bangladesh|Foreign, Commonwealth and Development Office, U.K.",All,"Child, Adult, Older Adult",860.0,Other,Interventional,2021-03-01,01/05/21,2021-05-30,21/02/21,23/02/21,"BRAC, Dhaka, Bangladesh|BRAC Khulna, Khulna, Bangladesh|BRAC Mymensingh, Mymensingh",Bangladesh,Respiratory Diseases,1,3,90.0
5211.0,NCT04464460,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",,Withdrawn,Coronavirus Disease,,,,,,,Drug: TAK-671|Drug: TAK-671 Placebo,Takeda,All,"18 Years to 75 Years   (Adult, Older Adult)",0.0,Industry,Interventional,2020-09-25,30/10/20,2020-10-30,09/07/20,08/10/20,,,Respiratory Diseases,1,1,35.0
5212.0,NCT04664075,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),PREDICT-ILI,Not yet recruiting,Influenza,SARS (Severe Acute Respiratory Syndrome),Respiratory Viral Infection,Respiratory Tract Infections,"Infection, Bacterial",Infection Viral,COVID-19,Biological: Respiratory infections,Imperial College London,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2021-01-01,30/04/21,2021-06-30,11/12/20,05/01/21,"Imperial College London, London",United Kingdom,"Infectious Diseases, Respiratory Diseases",1,7,180.0
5213.0,NCT04828902,Influence of Postoperative Delirium on Outcome After Cardiac Surgery in Adults.,,Recruiting,Postoperative Delirium,Adult Cardiac Surgery,COVID-19,,,,,Procedure: cardiac surgery,Medical University of Gdansk,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-01-02,31/01/22,2022-08-31,02/04/21,02/04/21,"Department of Cadiac Anesthesiology, Medical University of Gdańsk, Gdańsk, Pomorskie",Poland,Respiratory Diseases,1,3,606.0
5214.0,NCT04468789,Evaluation of Six-month HIV Treatment Dispensing in South Africa,,Not yet recruiting,HIV,,,,,,,Other: Six-month ARV dispensing,"Boston University|Bill and Melinda Gates Foundation|University of Witwatersrand, South Africa",All,"18 Years and older   (Adult, Older Adult)",150945.0,Other,Observational,2021-01-04,01/10/22,2022-01-12,13/07/20,02/12/20,"Health Economics and Epidemiology Research Office, Johannesburg, Gauteng",South Africa,Others,0,1,373.0
5215.0,NCT04768413,Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis,,Recruiting,Rheumatoid Arthritis,,,,,,,Other: Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis|Other: Care modalities. Quantitative and qualitative approaches to analysis,Fundación Universitaria de Ciencias de la Salud|Biomab I.P.S. Centro de Atencion Integral en Artritis Reumatoide,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-06,30/04/21,2021-06-30,24/02/21,24/02/21,"BIOMAP IPS Centro de Atención Integral en Artritis Reumatoide, Bogota, Cundinamarca, Colombia|Colombia Fundación Universitaria de Ciencias de la Salud-FUCS, Bogota, Cundinamarca",Colombia,Immunological Disorders,1,1,541.0
5216.0,NCT04752553,Pros and Cons of Telemedicine in Diagnosis and Management,,Not yet recruiting,"the Study Focus on the Uses of Telephone and Other New Technology in Medicine, Diagnosis and Treatment",,,,,,,,Heba A Yassa|Assiut University,All,"18 Years to 80 Years   (Adult, Older Adult)",1000.0,Other,Observational,2021-09-03,10/08/21,2022-10-02,12/02/21,02/03/21,,,Others,0,1,394.0
5217.0,NCT03738774,Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID),APICS,Recruiting,Post Intensive Care Syndrome,,,,,,,,Vanderbilt University Medical Center|United States Department of Defense,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|U.S. Fed,Observational,2019-02-01,01/12/21,2022-01-07,13/11/18,22/12/20,"Johns Hopkins Hospital, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Vanderbilt University, Nashville, Tennessee, United States|Intermountain Medical Center, Murray, Utah, United States|George Wahlen Salt Lake City Veterans Administration Hospital, Salt Lake City, Utah",United States,Others,0,1,1071.0
5218.0,NCT03852537,Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia,,Completed,Pneumonia,,,,,,,Drug: Methylprednisolone|Other: Usual Care,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2019-02-12,17/11/20,2021-03-15,25/02/19,13/04/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,1,762.0
5219.0,NCT04557605,Effects of a Face Mask on Oxygenation During Exercise,,Completed,Hypoxemia,,,,,,,Other: Progressive cycling exercise test to exhaustion,University of Saskatchewan,All,"18 Years and older   (Adult, Older Adult)",14.0,Other,Interventional,2020-09-14,15/10/20,2020-10-15,21/09/20,20/10/20,"University of Saskatchewan, Saskatoon, Saskatchewan",Canada,Others,0,1,31.0
5220.0,NCT04456933,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,RIAL-COLECTOMY,Recruiting,Colon Cancer,,,,,,,Procedure: Extracorporeal left hemicolectomy anastomosis|Procedure: Intracorporeal left hemicolectomy anastomosis,Corporacion Parc Tauli|Irene Gómez Torres|Laura Mora López|Anna Pallisera-Lloveras|Sheila Serra-Pla|Albert García Nalda|Anna Serracant-Barrera|Mercedes Muñoz|Oriol Pino-Pérez,All,"18 Years and older   (Adult, Older Adult)",148.0,Other,Observational,2020-06-29,31/12/21,2022-02-28,07/07/20,17/07/20,"Hospital Universitario Parc Tauli de Sabadel, Sabadell, Barceelona",Spain,Cancers,1,1,609.0
5221.0,NCT04290754,PATH 2 Purpose: Primary Care and Community-Based Prevention of Mental Disorders in Adolescents,P2P,Recruiting,Depression,,,,,,,Behavioral: CATCH-IT|Behavioral: TEAMS,University of Illinois at Chicago|University of Illinois College of Medicine Rockford|Advocate Health Care|Katherine Shaw Bethea Hospital|University of Louisville|Wellesley College|Patient-Centered Outcomes Research Institute,All,"13 Years to 18 Years   (Child, Adult)",664.0,Other,Interventional,2020-01-01,01/01/24,2024-01-03,02/03/20,04/03/21,"UI Health, Chicago, Illinois",United States,Mental Health,1,1,1463.0
5222.0,NCT04505098,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,MITIGATE,Recruiting,COVID-19,Atherosclerosis,Cardiovascular Diseases,Upper Respiratory Tract Infections,,,,Drug: Icosapent ethyl,Kaiser Permanente|Amarin Corporation,All,"50 Years and older   (Adult, Older Adult)",16500.0,Other,Interventional,2020-07-08,07/08/21,2023-02-28,10/08/20,05/10/20,"Kaiser Permanente Northern California, Oakland, California",United States,Respiratory Diseases,1,4,965.0
5223.0,NCT04468386,Specimen Collection Study Protocol,,"Active, not recruiting",Focus in on Collecting Paired Specimens for Matrix Equivalency,,,,,,,,Biomerica,All,"21 Years and older   (Adult, Older Adult)",40.0,Industry,Observational,2020-07-07,30/03/21,2021-03-30,13/07/20,28/01/21,"Biomerica, Inc., Irvine, California",United States,Others,0,1,266.0
5224.0,NCT04393649,First Level Socio-geriatric Evaluation: ESOGER Databank,,Recruiting,COVID-19,Social Isolation,Anxiety,Frailty,,,,Other: ESOGER,Jewish General Hospital,All,70 Years and older   (Older Adult),20000.0,Other,Observational,2020-04-20,19/04/21,2021-04-19,19/05/20,20/05/20,"Jewish General Hospital, Montréal, Quebec",Canada,"Mental Health, Respiratory Diseases",1,4,364.0
5225.0,NCT04434014,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,,Recruiting,"Diet, Healthy",,,,,,,Dietary Supplement: proper diet,October University for Modern Sciences and Arts,All,20 Years to 60 Years   (Adult),300.0,Other,Observational,2020-08-06,18/06/20,2020-06-28,16/06/20,16/06/20,"October university of modern sciences and arts, Giza",Egypt,Others,0,1,-39.0
5226.0,NCT04728347,Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021,,Recruiting,COVID-19,,,,,,,Biological: ARCT-021,"Arcturus Therapeutics, Inc.",All,"21 Years to 80 Years   (Adult, Older Adult)",106.0,Industry,Interventional,2021-04-01,01/06/22,2022-01-06,28/01/21,28/01/21,"SingHealth Investigational Medicine Unit (IMU), Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,280.0
5227.0,NCT04697654,"The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers",,"Active, not recruiting",COVID-19,,,,,,,Drug: TLC19|Drug: TLC19 Vehicle,Taiwan Liposome Company,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-10-14,30/04/21,2021-04-30,06/01/21,06/01/21,"Scientia Clinical Reserach, Ltd, Randwick, Australia|Mackay Memorial Hospital Tamsui Branch, Taipei",Taiwan,Respiratory Diseases,1,1,198.0
5228.0,NCT03907891,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,Heart Up!,Recruiting,Ischemic Heart Disease,Hopelessness,Physical Activity,Motivation,Social Support,COVID-19,,Behavioral: Motivational social support from nurse|Behavioral: Motivational social support from nurse with additional support from significant other|Behavioral: Attention control,University of Illinois at Chicago|National Institute of Nursing Research (NINR),All,"18 Years and older   (Adult, Older Adult)",225.0,Other|NIH,Interventional,2019-01-08,01/05/23,2023-01-05,09/04/19,30/10/20,"Spectrum Health, Grand Rapids, Michigan",United States,Respiratory Diseases,1,6,1458.0
5229.0,NCT04387708,Care in Patients Hospitalized for Anorexia Nervosa at the Time of the Coronavirus-19 Epidemic (QUALICOVID),QUALICOVID,Not yet recruiting,Anorexia Nervosa,,,,,,,,Centre Psychothérapique de Nancy,All,"Child, Adult, Older Adult",18.0,Other,Observational,2020-05-14,08/06/20,2020-08-06,14/05/20,14/05/20,,,Others,0,1,84.0
5230.0,NCT04790851,Evaluation of Immunogenicity and Safety of Combined Immunization of COVIV and PPV23 / IIV4,,Recruiting,"Influenza, Human","Pneumonia, Pneumococcal",COVID-19,,,,,Biological: COVIV+IIV4; COVIV+PPV23|Biological: COVIV only (1st and 2nd dose)|Biological: IIV4 for the 1st dose and PPV23 for the 2nd dose,"China National Biotec Group Company Limited|Chengdu Institute of Biological Products Co.,Ltd.|Changchun Institute of Biological Products Co., Ltd.|Beijing Institute of Biological Products Co Ltd.|Shanxi Provincial Center for Disease Control and Prevention|Sichuan Center for Disease Control and Prevention|Shanghai Municipal Center for Disease Control and Prevention",All,"18 Years and older   (Adult, Older Adult)",1152.0,Industry|Other,Interventional,2021-02-23,01/10/21,2021-01-12,10/03/21,17/03/21,"Sichuan Center for Disease Control and Prevention, Chengdu, China|Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China|Shanxi Provincial Center for Disease Control and Prevention, Taiyuan",China,"Infectious Diseases, Respiratory Diseases",1,3,-42.0
5231.0,NCT04374058,Less Frequency Hemodialysis and COVID-19,,"Active, not recruiting",End Stage Renal Disease,,,,,,,Other: less-frequency hemodialysis,Dialisis Madariaga,All,"18 Years to 85 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-03-20,01/03/21,2021-01-03,05/05/20,05/05/20,"Dialisis Madariaga, General Juan Madariaga, Buenos Aires",Argentina,Others,0,1,289.0
5232.0,NCT04441047,Universal Anti-Viral Vaccine for Healthy Elderly Adults,ALLOPRIME,Not yet recruiting,Virus Diseases,,,,,,,Drug: AlloStim,"Immunovative Therapies, Ltd.|Mirror Biologics, Inc.",All,65 Years and older   (Older Adult),40.0,Industry|Other,Interventional,2021-06-03,07/03/22,2022-12-31,22/06/20,11/02/21,"Florida Medical Clinic, LLC, Zephyrhills, Florida",United States,Others,0,1,576.0
5233.0,NCT04356144,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,,Completed,Disseminated Intravascular Coagulation,Critical Illness,Sars-CoV2,Viral Infection,"Coagulation Disorder, Blood",COVID-19,,Diagnostic Test: Thrombin Generation Assay (TGA)|Diagnostic Test: Thrombomodulin Modified Thrombin Generation Assay (TGA-TM),Medical University of Vienna|Medical Scientific Fund of the Mayor of Vienna,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Observational,2020-04-15,01/02/21,2021-01-02,22/04/20,23/03/21,"Medical University Vienna, Vienna",Austria,"Cardiovascular Diseases, Respiratory Diseases",1,6,262.0
5234.0,NCT04261907,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,,Not yet recruiting,COVID-19,,,,,,,Drug: ASC09/ritonavir group|Drug: lopinavir/ritonavir group,"First Affiliated Hospital of Zhejiang University|Ascletis Pharmaceuticals Co., Ltd.",All,"18 Years to 75 Years   (Adult, Older Adult)",160.0,Other|Industry,Interventional,2020-07-02,31/05/20,2020-06-30,10/02/20,10/02/20,,,Respiratory Diseases,1,1,-2.0
5235.0,NCT04715854,Effect on paO2 of Adding an Aerosol Mask Above the Nasal Canulas,,"Active, not recruiting",Hypoxemic Respiratory Failure,Emergencies,COVID-19,,,,,Device: Mask,"Laboratory of Movement, Condorcet, Tournai, Belgium",All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2021-02-19,01/04/21,2021-01-07,20/01/21,21/02/21,"Epicura, Hornu, Hainaut",Belgium,Respiratory Diseases,1,3,-43.0
5236.0,NCT04687488,Aerosol and Droplet Dispersion During Gastrointestinal Motility Investigations,,Completed,Aerosol Generation and Droplet Dispersion and Deposition During Naso-gastric Intubation for Gastrointestinal Motility Investigations,,,,,,,Other: Fluorescein|Other: Particle measurement,Universitaire Ziekenhuizen Leuven,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Interventional,2020-07-23,09/11/20,2020-09-11,29/12/20,29/12/20,"TARGID, Leuven, Vlaams-Brabant",Belgium,Others,0,1,50.0
5237.0,NCT04812184,Adhesive Tape Placement on Patients' Masks in the ED Increases Compliance of Proper Face Mask Use,,Completed,COVID-19,,,,,,,Device: Tape Face Mask,Indiana University,All,"18 Years and older   (Adult, Older Adult)",123.0,Other,Interventional,2020-01-04,30/10/20,2020-10-30,23/03/21,23/03/21,"Eskenazi Hospital, Indianapolis, Indiana",United States,Respiratory Diseases,1,1,300.0
5238.0,NCT04659928,Evaluation of Aerosol in a Dental Clinic,,Not yet recruiting,COVID-19,,,,,,,Device: High volume evacuation (HVE)|Device: Extraoral vacuum aspirator (EVA)|Device: External evacuation device (EED)|Drug: Hydrogen Peroxide,"The University of Texas Health Science Center, Houston",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-12,01/12/22,2022-01-12,09/12/20,09/12/20,"The University of Texas Health Science Center at Houston, Houston, Texas",United States,Respiratory Diseases,1,1,731.0
5239.0,NCT04533048,A Clinical Study to Evaluate MW33 Injection,,Completed,COVID-19,,,,,,,Combination Product: MW33 injection|Combination Product: MW33 injection placebo,"Mabwell (Shanghai) Bioscience Co., Ltd.|Shanghai Public Health Clinical Center",All,18 Years to 45 Years   (Adult),42.0,Industry|Other,Interventional,2020-07-08,16/11/20,2020-02-12,31/08/20,26/02/21,"Shanghai Public Health Clinical Center, Shanghai, Shanghai",China,Respiratory Diseases,1,1,-147.0
5240.0,NCT04501172,Impact of Spectacles on Compliance to Mask-wearing Directives,,Completed,COVID-19,,,,,,,Behavioral: Questionnaire completion,Democritus University of Thrace,All,"18 Years to 85 Years   (Adult, Older Adult)",1214.0,Other,Observational,2020-06-25,24/07/20,2020-08-14,06/08/20,16/09/20,"University Hospital of Alexandroupolis, Alexandroupolis, Evros",Greece,Respiratory Diseases,1,1,50.0
5241.0,NCT04497519,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,,Completed,COVID-19,,,,,,,Drug: inhaled hydroxychloroquine,University Medical Center Groningen,All,"18 Years to 65 Years   (Adult, Older Adult)",12.0,Other,Interventional,2020-09-15,15/10/20,2020-01-11,04/08/20,10/11/20,"University Medical Center Groningen, Groningen",Netherlands,Respiratory Diseases,1,1,-248.0
5242.0,NCT04333589,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir,Peking University First Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",210.0,Other,Interventional,2020-01-04,01/06/20,2020-09-15,03/04/20,24/04/20,"The Second People's Hospital of Fuyang, Fuyang, Anhui, China|Ezhou Hospital of Traditional Chinese Medicine, Ezhou, Hubei, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei, China|Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China|Wenzhou Medical University Affiliated First Hospital, Wenzhou, Zhejiang",China,Respiratory Diseases,1,1,255.0
5243.0,NCT04310228,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,,Recruiting,COVID-19,,,,,,,Drug: Favipiravir Combined With Tocilizumab|Drug: Favipiravir|Drug: Tocilizumab,Peking University First Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",150.0,Other,Interventional,2020-08-03,01/05/20,2020-01-05,17/03/20,10/04/20,"Guiqiang Wang, Beijing, Beijing, China|Peking University First Hospital, Beijing, Beijing, China|Ezhou Central Hospital, Wuhan, Hubei, China|Huoshenshan Hospital of Wuhan, Wuhan, Hubei, China|Jinyintan Hospital of Wuhan, Wuhan, Hubei, China|Wuhan Pulmonary Hospital, Wuhan, Hubei",China,Respiratory Diseases,1,1,-211.0
5244.0,NCT04302519,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,,Not yet recruiting,COVID-19,,,,,,,Biological: Dental pulp mesenchymal stem cells,"CAR-T (Shanghai) Biotechnology Co., Ltd.",All,"18 Years to 75 Years   (Adult, Older Adult)",24.0,Industry,Interventional,2020-05-03,30/06/21,2021-07-30,10/03/20,10/03/20,,,Respiratory Diseases,1,1,453.0
5245.0,NCT02765191,MR-Evaluation of Renal Function In Septic Patients,MERSEP,Recruiting,"Sepsis, Severe",Acute Kidney Injury,COVID-19,,,,,Other: Plasma expansion with Ringer's Acetate,Uppsala University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2016-01-04,01/10/21,2025-01-10,06/05/16,17/06/20,"Uppsala University Hospital, Uppsala",Sweden,Respiratory Diseases,1,3,3294.0
5246.0,NCT04806477,Diagnostic Accuracy Comparison Between Telemedicine and Face-to-face Consultations in Respiratory Infection Patients.,,Completed,Respiratory Tract Infections,,,,,,,Other: Telemedicine Consultation|Other: Face-to-face Consultation,Hospital Israelita Albert Einstein,All,"18 Years to 65 Years   (Adult, Older Adult)",98.0,Other,Interventional,2020-01-09,01/11/20,2020-01-11,19/03/21,19/03/21,"Hospital Israelita Abert Einstein, São Paulo, SP",Brazil,Others,0,1,2.0
5247.0,NCT04514900,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,iREACH,"Active, not recruiting",Obesity,,,,,,,Behavioral: Video Chat +Personalized Feedback|Behavioral: Video Chat + Basic Feedback|Behavioral: Discussion Board for Social Support +Basic Feedback|Behavioral: Discussion Board for Social Support+Personalized Feedback,University of South Carolina|University of Vermont|University of Tennessee,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-09-23,15/09/21,2021-09-15,17/08/20,22/10/20,"University of South Carolina, Columbia, South Carolina",United States,Metabolic Disorders,1,1,357.0
5248.0,NCT04275388,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,,Not yet recruiting,COVID-19,,,,,,,"Drug: Xiyanping injection|Drug: Lopinavir / ritonavir, alpha-interferon nebulization,Abidor Hydrochloride",Jiangxi Qingfeng Pharmaceutical Co. Ltd.,All,"up to 100 Years   (Child, Adult, Older Adult)",426.0,Industry,Observational,2020-05-15,14/07/20,2021-12-14,19/02/20,20/05/20,,,Respiratory Diseases,1,1,578.0
5249.0,NCT04731324,"Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers",,Recruiting,Healthy,,,,,,,Drug: ZYIL1 capsule,Cadila Healthcare Limited,All,18 Years to 55 Years   (Adult),42.0,Industry,Interventional,2021-05-01,22/10/21,2021-12-30,29/01/21,29/01/21,"Zydus Research Centre, Ahmedabad, Gujarat",India,Others,0,1,243.0
5250.0,NCT04640064,Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group,,Not yet recruiting,Type1diabetes,Childhood ALL,,,,,,,Hospital General Puyo,All,2 Years to 17 Years   (Child),500.0,Other,Observational,2020-11-22,22/03/21,2021-04-22,23/11/20,23/11/20,"Valeria Hirschler, Buenos Aires",Argentina,Others,0,2,151.0
5251.0,NCT04409496,Chat-based Support for Preventing Smoking Relapse,,Completed,Smoking Cessation,,,,,,,Behavioral: Chat-based instant messaging support|Behavioral: SMS message support|Behavioral: Self-help booklet,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",108.0,Other,Interventional,2020-02-06,22/01/21,2021-01-22,01/06/20,04/03/21,"Tung Wah Group of Hospitals Integrated Centre on Smoking Cessation, Hong Kong",Hong Kong,Others,0,1,351.0
5252.0,NCT04363788,Needle Stick Injuries in Emergency Medical Service Practice,,Completed,Cardiac Arrest,Needle Stick,Injuries,Glowe,,,,Procedure: double gloves,Lazarski University|Medical University of Bialystok|Poznan University of Medical Sciences,,"Child, Adult, Older Adult",300.0,Other,Observational,2020-02-28,24/04/20,2020-04-24,27/04/20,28/04/20,"Lazarski Univeristy, Warsaw",Poland,Others,0,4,56.0
5253.0,NCT04346940,The Effectiveness of Telerehabilitation-Based Exercises in Elderly People,,Not yet recruiting,Telerehabilitation,Elderly People,Social Isolation,,,,,Other: Telerehabilitation|Other: Exercise brochure,Istinye University,All,"60 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-10-08,10/10/20,2020-11-30,15/04/20,21/07/20,,,Others,0,3,53.0
5254.0,NCT04640610,Angiotensin-converting Enzyme 2 (ACE2) Expression in Tonsils and Adenoids,ACE2-AVG,Not yet recruiting,Adenoidectomy,Tonsillectomy,,,,,,Other: Storage of operating waste,Assistance Publique - Hôpitaux de Paris,All,"Child, Adult, Older Adult",40.0,Other,Observational,2020-01-12,01/06/21,2021-01-09,23/11/20,23/11/20,"Hôpital Mondor, Créteil, France|Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Lariboisière, Paris, France|Hôpital Armand Trousseau, Paris, France|Hôpital Pitié Salpêtrière, Paris, France|HEGP, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Bichat, Paris, France|Hôpital Tenon, Paris",France,Others,0,2,363.0
5255.0,NCT04816019,A Study of Intranasal ChAdOx1 nCOV-19,,Enrolling by invitation,Coronavirus,,,,,,,Biological: ChAdOx1 nCov-19,University of Oxford,All,18 Years to 40 Years   (Adult),30.0,Other,Interventional,2021-01-04,01/10/21,2021-01-10,25/03/21,13/04/21,"CCVTM, University of Oxford, Churchill Hospital, Oxford",United Kingdom,Respiratory Diseases,1,1,6.0
5256.0,NCT04592835,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",,Not yet recruiting,COVID-19,,,,,,,Drug: DWRX2003,Daewoong Pharmaceutical Co. LTD.|Novotech (Australia) Pty Limited,All,"18 Years to 65 Years   (Adult, Older Adult)",24.0,Industry,Interventional,2020-10-19,13/12/20,2021-06-30,19/10/20,19/10/20,,,Respiratory Diseases,1,1,254.0
5257.0,NCT04262921,French COVID Cohort,FrenchCOVID,Recruiting,Coronavirus Infections,,,,,,,,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-08-02,07/08/20,2023-07-08,10/02/20,07/05/20,"CHG Agen, Agen, France|Centre Hospitalier Du Pays D'aix, Aix-en-Provence, France|CHU Amiens, Amiens, France|CHU Angers, Angers, France|CH Annecy Genevois, Annecy, France|Hopital privé d'Antony, Antony, France|Hôpital de Mercy. CHR METZ-THIONVILLE, Ars-Laquenexy, France|Centre Hospitalier Henri Duffaut, Avignon, France|Chu Jean Minjoz, Besançon, France|Hôpital Avicenne AP-HP, Bobigny, France|CHU Pellegrin, Bordeaux, France|CHU Ambroise Paré, Boulogne-Billancourt, France|Ch Fleyriat, Bourg-en-Bresse, France|Chru Hopital Cavale Blanche, Brest, France|CHU Brest, Brest, France|Centre hospitalier de Béziers, Béziers, France|CH Cahors, Cahors, France|Chms Chambery Nh, Chambéry, France|Centre Hospitalier De Cholet, Cholet, France|CHU Gabriel Montpied, Clermont-Ferrand, France|CH Colmar - Hopital Pasteur, Colmar, France|Centre hospitalier Alpes Leman, Contamine-sur-Arve, France|Centre hospitalier Intercommunal de Créteil, Créteil, France|Hôpital Henri Mondor, Créteil, France|Centre Hospitalier Dax, Dax, France|CHU Dijon Bourgogne, Dijon, France|Hopital Raymond Poincare, Garches, France|CHU Grenoble, Grenoble, France|Grand Hopital de l'Est Francilien site Marne-la-Vallée, Jossigny, France|Chd Les Oudairies, La Roche-sur-Yon, France|Hôpital Universitaire Bicêtre, Le Kremlin-Bicêtre, France|Centre Hospitalier Emile Roux, Le Puy-en-Velay, France|Centre Hospitalier Universitaire de Lille, Lille, France|CHRU Lille, Hôpital Salengro, Lille, France|CHU de Lille, Lille, France|Hôpital de la Croix-Rousse, Lyon, France|Hôpital Louis Raffalli, Manosque, France|Assistance publique hopitaux de Marseille, hopital Nord, Marseille, France|Hôpital Conception, Marseille, France|Groupe Hospitalier Sud Ile De France, Melun, France|CH de Mont Marsan, Mont de Marsan, France|CHU Montpellier, Montpellier, France|CHU Nantes, Nantes, France|Hopital Américain de Paris, Neuilly-sur-Seine, France|CHU de Nice, Nice, France|CHU Caremeau, Nîmes, France|APHP Bichat, Paris, France|APHP Tenon, Paris, France|CH Lariboisière, Paris, France|Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France|Hopital Cochin-CIC1417, Paris, France|Hopital Européen Georges Pompidou, Paris, France|Hopital Saint Antoine, Paris, France|Hopital Saint Louis, Paris, France|La pitié salpetrière, Paris, France|Centre Hospitalier de Pau, Pau, France|CH de Perpignan, Perpignan, France|CHU de Poitiers, Poitiers, France|Centre Hospitalier de Périgueux, Périgueux, France|Ch Cornouaille, Quimper, France|Chu Reims, Reims, France|Hôpital Pontchaillou, Rennes, France|CHU Rouen Normandie, Rouen, France|Hopital d'instruction des armées Begin 69, Saint-Mandé, France|Centre hospitalier Louis Constant Fleming, Saint-Martin, France|CHU de Saint-Etienne, Saint-Étienne, France|CH de Saintonge, Saintes, France|Centre Hospitalier de Soissons, Soissons, France|N.H.C. - Nouvel Hopital Civil, Strasbourg, France|Hopital Foch, Suresnes, France|CHR Metz-Thionville -Hopital Bel Air, Thionville, France|Hopitaux du Leman, Thonon-les-Bains, France|Centre Hospitalier Universitaire de Rangueil, Toulouse, France|CHU de Toulouse, Toulouse, France|CHU Toulouse IUCT Institut Universitaire de Cancer de Toulouse, Toulouse, France|Hôpital Gustave Dron, Tourcoing, France|Centre Hospitalier Régional Universitaire de Tours, Tours, France|CHRU de Tours, Tours, France|CHU Nancy, Vandœuvre-lès-Nancy, France|Centre Hospitalier Intercommunal, Villeneuve Saint Georges, France|CH Annecy Genevois, Épagny",France,Respiratory Diseases,1,1,1070.0
5258.0,NCT04658550,Remote vs In Person Weight Loss Study,,Recruiting,Obesity,,,,,,,Other: Remote Behaviour Modification Program|Other: In Person Behaviour Modification Program,St. Joseph's Healthcare Hamilton,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-10-16,01/10/21,2021-01-10,08/12/20,08/12/20,"St Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,Metabolic Disorders,1,1,86.0
5259.0,NCT04461353,"A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult Volunteers",,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Drug: Aerolized Hydroxychloroquine Sulfate|Other: Placebo,"Pulmoquine Therapeutics, Inc|Rockefeller University",All,"18 Years and older   (Adult, Older Adult)",12.0,Industry|Other,Interventional,2020-06-25,17/08/20,2020-08-17,08/07/20,08/10/20,"The Rockefeller University, New York, New York",United States,Respiratory Diseases,1,1,53.0
5260.0,NCT04422275,Coronavirus Smell Therapy for Anosmia Recovery,Co-STAR,Withdrawn,Anosmia,,,,,,,Drug: Budesonide|Behavioral: High-Concentration Essential Oil|Drug: Placebo|Behavioral: Low-Concentration Essential Oil,Washington University School of Medicine,All,"18 Years to 85 Years   (Adult, Older Adult)",0.0,Other,Interventional,2021-01-06,01/06/23,2023-12-31,09/06/20,02/03/21,"Washington University, Saint Louis, Missouri",United States,Others,0,1,1089.0
5261.0,NCT04379986,Remote Blood Pressure Monitoring With the Wearable SENBIOSYS Photoplethysmographic Device,,Not yet recruiting,Blood Pressure,,,,,,,Device: Sensbiosys,"Stéphane Cook, Prof|University of Freiburg",All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-05,31/05/20,2020-01-06,08/05/20,08/05/20,"University and hospital Fribourg, Fribourg",Switzerland,Others,0,1,1.0
5262.0,NCT04417153,Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes,,Recruiting,"Stress, Psychological",Sleep Initiation and Maintenance Disorders,,,,,,Behavioral: Mindfulness Based Intervention,"National University, Singapore|Potential project, www.potentialproject.com|Brahm Centre, Singapore",All,"21 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2019-09-20,30/06/22,2022-06-30,04/06/20,09/06/20,"National University Singapore, Singapore",Singapore,Mental Health,1,2,1014.0
5263.0,NCT04474444,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),ASAP,Recruiting,"Alcohol Use, Unspecified",Substance Use,Intoxication Alcohol,Emergencies,COVID-19,Treatment,,Other: attendance by ambulance crew,University of Lincoln,All,"Child, Adult, Older Adult",55000.0,Other,Observational,2019-03-23,23/03/21,2021-03-23,16/07/20,16/07/20,"University of Lincoln, Lincoln",United Kingdom,Respiratory Diseases,1,6,731.0
5264.0,NCT04025580,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,,Recruiting,Healthy Volunteer,COVID-19,,,,,,Biological: Flucelvax|Biological: Fluvirin|Biological: Fluzone High Dose,National Institute of Allergy and Infectious Diseases (NIAID)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",300.0,NIH,Interventional,2019-02-10,31/12/25,2025-12-31,19/07/19,09/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Respiratory Diseases,1,2,2516.0
5265.0,NCT04742049,"The Effects of Telerehabilitation on Muscle Function, Physical Activity and Sleep in Cystic Fibrosis During Pandemic",,Recruiting,Cystic Fibrosis,COVID-19,Social Isolation,,,,,Other: Telerehabilitation-based|Other: Follow-up based,Hacettepe University,All,8 Years to 14 Years   (Child),30.0,Other,Interventional,2020-12-28,01/03/21,2021-01-03,05/02/21,05/02/21,"Hacettepe University, Ankara",Turkey,Respiratory Diseases,1,3,6.0
5266.0,NCT04530448,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,,Recruiting,COVID-19,Coronavirus,Coronavirus Infection,AKI,Acute Kidney Injury,,,Drug: Sodium bicarbonate|Other: Standard of Care,West Virginia University,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-05-10,01/01/21,2021-01-03,28/08/20,19/10/20,"WVU Medicine Heart & Vascular Institute, Morgantown, West Virginia",United States,Respiratory Diseases,1,5,238.0
5267.0,NCT04600713,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,,Not yet recruiting,Atrial Fibrillation Paroxysmal,,,,,,,Other: PT-X and IMT,Vastra Gotaland Region,All,"40 Years to 85 Years   (Adult, Older Adult)",180.0,Other,Interventional,2021-01-09,01/08/25,2025-01-10,23/10/20,01/04/21,,,Others,0,1,1462.0
5268.0,NCT03188796,The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients,VITDALIZE,Recruiting,Critical Illness,Vitamin D Deficiency,COVID-19,,,,,Drug: Cholecalciferol|Drug: Placebo,"Medical University of Graz|Medical University of Vienna|Medical University Innsbruck|Hospital Barmherzige Brüder St. Veit|Klinikum Klagenfurt am Wörthersee|Johannes Kepler University of Linz|Krankenhaus Barmherzige Schwestern Linz|Barmherzige Brüder Vienna|Erasme University Hospital|University of Birmingham|University Hospital, Frankfurt|Kages|KABEG Management|Centre Hospitalier Régional de la Citadelle|Centre Hospitalier Universitaire de Charleroi|Centre Hospitalier Universitaire Mons|Wuerzburg University Hospital",All,"18 Years to 100 Years   (Adult, Older Adult)",2400.0,Other,Interventional,2017-10-10,01/12/22,2023-01-02,15/06/17,06/01/21,"LKH Hochsteiermark Standort Bruck, Bruck An Der Mur, Austria|LKH Enzenbach, Enzenbach, Austria|LKH Feldbach, Feldbach, Austria|LKH Fürstenfeld, Fürstenfeld, Austria|Medical University of Graz, Graz, Austria|Medical University Innsbruck, Innsbruck, Austria|Klinikum am Wörthersee, Klagenfurt, Austria|LKH Hochsteiermark Standort Leoben, Leoben, Austria|Barmherzige Brüder Konventhospital Linz, Linz, Austria|Barmherzige Schwestern, Linz, Austria|Kepler Universitätsklinikum Linz, Linz, Austria|Krankenhaus Schwarzach, Schwarzach Im Pongau, Austria|Barmherzige Brüder, Vienna, Austria|Medical University of Vienna, Vienna, Austria|LKH Villach, Villach, Austria|Kaiser Franz Josef Spital Wien, Wien, Austria|Erasme Hospital, Brussel, Belgium|CHU de Charleroi, Charleroi, Belgium|CHR Citadelle, Liège, Belgium|CHU Ambroise Pare, Mons",Belgium,"Cardiovascular Diseases, Respiratory Diseases",1,3,1910.0
5269.0,NCT04536935,Mobile Mental Health Apps for Suicide Prevention,,Enrolling by invitation,Depression,Anxiety,Emotional Regulation,,,,,Behavioral: Mobile Mental Health App - 1|Behavioral: Mobile Mental Health App - 2|Behavioral: Mobile Mental Health App - 3|Behavioral: Mobile Mental Health App - 4,University of Washington,All,"19 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2020-11-30,01/04/21,2021-01-04,03/09/20,15/03/21,"University of Washington, Seattle, Washington",United States,Mental Health,1,3,35.0
5270.0,NCT04804943,Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome),,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,Device: NOA-001,"Toray Industries, Inc",All,"16 Years and older   (Child, Adult, Older Adult)",35.0,Industry,Interventional,2021-03-19,31/08/22,2022-10-31,18/03/21,18/03/21,"Showa University Hospital, Tokyo",Japan,Respiratory Diseases,1,1,591.0
5271.0,NCT04353531,Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures,,Recruiting,"Transmission, Patient Professional",High-flow Nasal Cannula,,,,,,Device: High-flow nasal cannula|Device: Surgical mask|Procedure: bronchoscopy examination|Procedure: intubation|Procedure: tracheostomy|Device: nebulization|Diagnostic Test: Pulmonary function test,Rush University Medical Center,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Observational,2020-05-20,30/06/21,2021-09-30,20/04/20,09/03/21,"Rush university medical center, Chicago, Illinois",United States,Others,0,2,498.0
5272.0,NCT04283838,Humanistic Care in Healthcare Workers in Coronavirus Disease 2019,,Withdrawn,Coronavirus Disease 2019,,,,,,,Behavioral: Humanistic Care,Second Affiliated Hospital of Xi'an Jiaotong University,All,"Child, Adult, Older Adult",0.0,Other,Interventional,2020-02-22,30/04/20,2020-05-15,25/02/20,17/03/20,,,Respiratory Diseases,1,1,83.0
5273.0,NCT04605172,Lockdown Impact on Spontaneous Premature Birth in a Level III NICU,CONFINéo,Enrolling by invitation,Premature Birth,Preterm Labor,,,,,,Other: hospitalization for premature birth,"Central Hospital, Nancy, France",All,up to 28 Days   (Child),1000.0,Other,Observational,2020-02-11,01/04/21,2021-01-05,27/10/20,16/12/20,"Maternite Regionale Universitaire CHRU NANCY, Nancy, Lorraine",France,Others,0,2,329.0
5274.0,NCT04355754,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,,Recruiting,Respiratory Insufficiency,,,,,,,Device: Ventil - a gas flow divider,"Medical University of Gdansk|Ministry of Science and Higher Education, Poland",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-04-15,01/05/20,2020-12-31,21/04/20,27/04/20,"Medical University of Gdansk, Gdansk",Poland,Others,0,1,260.0
5275.0,NCT03793673,CoYoT1 to California,CTC,"Active, not recruiting",Type 1 Diabetes Mellitus,,,,,,,Behavioral: CoYoT1 Care|Other: Standard Care,Children's Hospital Los Angeles|University of Southern California|Rutgers University,All,"16 Years to 25 Years   (Child, Adult)",80.0,Other,Interventional,2019-01-20,01/06/21,2021-01-06,04/01/19,26/02/21,"Children's Hospital, Los Angeles, California",United States,Metabolic Disorders,1,1,717.0
5276.0,NCT04666597,Pandemic-adapted Caries Care Multicentre Case Series,,Recruiting,Dental Caries in Children,,,,,,,Procedure: Modified CariesCare International management,"Universidad El Bosque, Bogotá|King's College London|University of Leeds|University of Sheffield",All,3 Years to 8 Years   (Child),420.0,Other,Observational,2020-11-15,02/03/22,2022-02-03,14/12/20,14/12/20,"Indiana University, Indianapolis, Indiana, United States|Tufts University, Boston, Massachusetts, United States|Universidad de Buenos Aires, Buenos Aires, Argentina|Universidad Nacional de Córdoba, Córdoba, Argentina|University of Sao Paulo, São Paulo, Brazil|Universidad El Bosque, Bogotá, Bogotá DC, Colombia|Viva 1A IPS Health Provider, Barranquilla, Colombia|Fundación Universitaria de Colegios de Colombia, Bogotá, Colombia|Corporación Universitaria Rafael Núñez, Cartagena, Colombia|Universidad de Cartagena, Cartagena, Colombia|ACFF Colombian Chapter Manizales Demonstration Territory, Manizales, Colombia|Universidad Cooperativa de Colombia, Medellín, Colombia|Universidad Iberoamericamericana, Santo Domingo, Dominican Republic|Universite Cote d' Azur, Nice, France|Universidad de Guadalajara, Guadalajara, Mexico|ACTA, Amsterdam, Netherlands|Universidad Peruana Cayetano Heredia, Lima, Peru|University of Porto, Porto, Portugal|University of Moscow, Moscow, Russian Federation|University of Sheffield, Sheffield, United Kingdom|Universidad Católica de Uruguay, Buenos aires, Sanmartin",Uruguay,Others,0,1,445.0
5277.0,NCT04291534,Quality of Life and Addiction Among Hospital Night Workers,ALADDIN,Recruiting,Health Services Research,Quality of Life,Addiction,Substance-Related Disorders,Health Personnel,,,,"University Paris 7 - Denis Diderot|Institut National de la Santé Et de la Recherche Médicale, France|Assistance Publique - Hôpitaux de Paris",All,"16 Years to 67 Years   (Child, Adult, Older Adult)",1800.0,Other,Observational,2020-06-15,01/04/22,2023-01-06,02/03/20,04/11/20,"Hôpital de Bicêtre, Le Kremlin-Bicêtre, France|Assistance Publique des Hopitaux de Paris, Paris",France,Others,0,5,935.0
5278.0,NCT03966872,Comparative Effectiveness of IIMR Versus CDSMP,,"Active, not recruiting",Mental Illness,Chronic Disease,,,,,,Behavioral: Integrated Illness Management and Recovery|Behavioral: Chronic Disease Self-Management Program,Dartmouth-Hitchcock Medical Center|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2019-02-09,01/01/24,2024-01-03,29/05/19,23/11/20,"Seven Counties Services, Louisville, Kentucky, United States|Centerstone, Nashville, Tennessee",United States,Others,0,2,1789.0
5279.0,NCT04547634,Telerehabilitation in Oncology Patients,,Enrolling by invitation,Cancer Metastatic,Cancer,Survivorship,,,,,Other: Therapeutic Exercise and Education,University of Malaga,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-01-07,01/11/20,2020-01-12,14/09/20,14/09/20,"Antonio Cuesta Vargas, Málaga",Spain,Cancers,1,3,5.0
5280.0,NCT04333875,Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis,AS DEFER,"Active, not recruiting",Aortic Valve Stenosis,,,,,,,Device: TAVR or SAVR,"University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",71.0,Other,Observational,2020-03-20,01/12/20,2020-01-12,03/04/20,04/05/20,"Department of Cardiology, Bern University Hospital, Bern",Switzerland,Others,0,1,-68.0
5281.0,NCT04634903,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",,"Active, not recruiting",Depression,,,,,,,Behavioral: Supportive Therapy SSI|Behavioral: Behavioral Activation SSI|Behavioral: Growth Mindset SSI,Stony Brook University|University of Denver,All,13 Years to 16 Years   (Child),2409.0,Other,Interventional,2020-11-19,01/05/21,2021-07-31,18/11/20,08/12/20,"Stony Brook University, Stony Brook, New York",United States,Mental Health,1,1,254.0
5282.0,NCT03990662,What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?,,Recruiting,Temporomandibular Disorders,,,,,,,Other: Physiotherapy - Manual Therapy,Istituto Stomatologico Italiano|University of Birmingham,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2019-06-14,31/12/20,2020-12-31,19/06/19,28/07/20,"Istituto Stomatologico Italiano, Miano, Milano",Italy,Others,0,1,566.0
5283.0,NCT04346966,The Effectiveness of Video-Based Exercises in Young Adults,,Not yet recruiting,Social Isolation,Exercise,Healthy,,,,,Other: Study Group,Istinye University,All,18 Years to 40 Years   (Adult),128.0,Other,Interventional,2020-08-20,20/10/20,2020-11-20,15/04/20,22/07/20,,,Others,0,3,92.0
5284.0,NCT04677842,European Pregnancy and Paediatric Infections Cohort Collaboration: Paediatric Protocol,EPPICC,"Active, not recruiting",HIV Infections,Tuberculosis Infection,Hepatitis C,COVID-19,,,,Drug: ART Therapy,"PENTA Foundation|MRC Clinical Trials Unit at UCL|Centre Hospitalier Universitaire Saint Pierre|German Pediatric and Adolescent HIV Cohort (GEPIC), GERMANY|Greece Cohort, GREECE|Register for HIV infection in children, ITALY|ATHENA ,THE NETHERLANDS|Polish Paediatric Cohort, POLAND|HSM/CHLN Lisbon, PORTUGAL|Centro Hospitalar do Porto|Victor Babes Hospital Cohort, Bucharest, ROMANIA|Republican Hospital of Infectious Diseases, St Petersburg, RUSSIA|Irkutsk AIDS Centre, RUSSIA|The City HIV Centre, St Petersburg, RUSSIA|CoRISpe-cat cohort of HIV-infected children, SPAIN|CoRISpe-S cohort of HIV-infected children, SPAIN|Karolinska Institutet|Swiss Mother and Child HIV Cohort Study, SWITZERLAND|Programs for HIV Prevention and Treatment (PHPT), THAILAND|National Surveilliance of HIV in Pregnancy and Childhood and Collaborative HIV Paediatric Study (CHIPS)|Collaborative HIV Paediatric Study (CHIPS)|Ukraine Paediatric HIV Cohort, UKRAINE",All,up to 17 Years   (Child),10000.0,Other,Observational,2013-01-01,11/11/20,2025-01-01,21/12/20,21/12/20,,,"Infectious Diseases, Respiratory Diseases",1,4,4383.0
5285.0,NCT04565782,Corona Virus Infection Among Liver Transplant Recipients,,Recruiting,SARS-CoV Infection,Corona Virus Infection,Liver Transplant Recipient,COVID-19,,,,,Assiut University,All,"Child, Adult, Older Adult",150.0,Other,Observational,2020-09-15,01/11/20,2020-12-31,25/09/20,25/09/20,"Assiut University, Assiut",Egypt,Respiratory Diseases,1,4,107.0
5286.0,NCT04447833,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,ARDS-MSC-205,"Active, not recruiting","ARDS, Human",COVID-19,,,,,,Drug: Mesenchymal Stromal Stem Cells - KI-MSC-PL-205,Uppsala University|Uppsala University Hospital,All,"18 Years to 65 Years   (Adult, Older Adult)",7.0,Other,Interventional,2020-06-17,30/01/21,2025-06-30,25/06/20,04/03/21,"Uppsala University Hospital, Uppsala",Sweden,Respiratory Diseases,1,2,1839.0
5287.0,NCT04502433,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),,Recruiting,Acute Respiratory Distress Syndrome,,,,,,,Drug: CUROSURF® (poractant alfa),Chiesi Farmaceutici S.p.A.,All,"18 Years to 80 Years   (Adult, Older Adult)",85.0,Industry,Interventional,2021-06-01,31/07/21,2021-07-31,06/08/20,20/01/21,"UCLH and UCL 250 Euston Road, London",United Kingdom,Respiratory Diseases,1,1,60.0
5288.0,NCT04468581,Characteristics of TraceTogether Users,,Completed,Coronavirus,,,,,,,Behavioral: Use of mobile application,Yale-NUS College,All,"21 Years and older   (Adult, Older Adult)",505.0,Other,Observational,2020-03-04,17/07/20,2020-07-17,13/07/20,19/12/20,"Yale NUS, Singapore",Singapore,Respiratory Diseases,1,1,135.0
5289.0,NCT04721730,Prevention of Child Mental Health Problems in Southeastern Europe - Phase 3,RISE,Recruiting,Child Mental Disorder,,,,,,,Behavioral: PLH-YC|Behavioral: Lecture,"University of Bremen|Alpen-Adria-University Klagenfurt|University of Oxford|Bangor University|Babes-Bolyai University|Institute for Marriage, Family and Systemic Practice - ALTERNATIVA|Health for Youth Association|University of Cape Town|Georgia State University",All,"18 Years and older   (Adult, Older Adult)",864.0,Other,Interventional,2020-07-12,30/01/22,2022-01-30,25/01/21,21/02/21,"Health for Youth Association, Chisinau, MD, Moldova, Republic of|Institute for Marriage, Family and Systemic Practice - ALTERNATIVA, Skopje, North Macedonia|Babes Boylai University, Cluj-Napoca",Romania,Others,0,1,567.0
5290.0,NCT04392219,"COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",,Completed,Coronavirus,,,,,,,Drug: EIDD-2801|Drug: Placebo,"Ridgeback Biotherapeutics, LP",All,18 Years to 60 Years   (Adult),130.0,Industry,Interventional,2020-10-04,11/08/20,2020-11-08,18/05/20,17/08/20,"Covance Leeds Clinical Research Unit, Leeds",United Kingdom,Respiratory Diseases,1,1,35.0
5291.0,NCT04632875,Online Trial of Meditation and Behavior,,Recruiting,Meditation,,,,,,,Behavioral: Loving-Kindness Meditation|Behavioral: Relaxation Meditation,Georgetown University,All,18 Years to 55 Years   (Adult),68.0,Other,Interventional,2020-04-12,20/11/21,2021-11-20,17/11/20,17/12/20,"Georgetown University, Washington, District of Columbia",United States,Others,0,1,587.0
5292.0,NCT04809272,ePLH Pilot Study: Online Support Parent Groups - ParentChat,ePLH,Recruiting,Child Maltreatment,Positive Parenting,,,,,,Behavioral: ParentChat for parents of children ages 2-17,University of Oxford|Universiti Putra Malaysia|Health for Youth Association|Ateneo de Manila University|UNICEF Montenegro|Alternativa|University of Cape Town,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Interventional,2021-08-03,01/07/21,2021-01-09,22/03/21,22/03/21,"University of Oxford, Oxford, Oxfordshire",United Kingdom,Others,0,2,-206.0
5293.0,NCT04317365,Counseling of Pregnant Women During Corona,,Completed,Respiratory Tract Infections,,,,,,,Other: Women receiving extra remembering by healthcare,Aljazeera Hospital,Female,18 Years to 43 Years   (Adult),200.0,Other,Interventional,2020-03-24,26/04/20,2020-05-25,23/03/20,04/06/20,"Algazeerah and Kasralainy hospital, Giza",Egypt,Others,0,1,62.0
5294.0,NCT04649996,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,,Completed,Acute Appendicitis,,,,,,,Procedure: Appendectomy,University of Milano Bicocca,All,"Child, Adult, Older Adult",532.0,Other,Observational,2020-01-09,31/10/20,2020-11-30,02/12/20,04/12/20,"Policlinico San Pietro, Ponte San Pietro, BG, Italy|Ospedale Manzoni, Lecco, LC, Italy|ASST Monza, Monza, MB, Italy|Ospedale San Raffaele, Milano, Mi, Italy|ASST Lodi, Lodi, Italy|Azienda ospedaliero-universitaria Pisana,Ospedale Cisanello, Pisa",Italy,Others,0,1,326.0
5295.0,NCT04473274,"GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study",GOTCHA,Completed,Coronavirus Infection,Diabetes,,,,,,Drug: Pioglitazone,Samaritan Health Services,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-05-21,01/11/20,2020-01-12,16/07/20,04/12/20,"Good Samaritan Hospital Corvallis, Corvallis, Oregon",United States,"Metabolic Disorders, Respiratory Diseases",1,2,-130.0
5296.0,NCT04765384,A Study of Ad26.COV2.S in Healthy Pregnant Participants (COVID-19),HORIZON 1,Not yet recruiting,Healthy,,,,,,,Biological: Ad26.COV2.S,Janssen Vaccines & Prevention B.V.,Female,18 Years to 45 Years   (Adult),400.0,Industry,Interventional,2021-12-03,16/01/23,2023-06-20,21/02/21,17/03/21,"Central Research Associates, Inc., Birmingham, Alabama, United States|SEC Clinical Research, Dothan, Alabama, United States|University of Southern California, Los Angeles, California, United States|Stanford Health Care - Positive Care Clinic, Stanford, California, United States|Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida, United States|Emory University, Atlanta, Georgia, United States|Spectrum Health System, Grand Rapids, Michigan, United States|Medpharmics, LLC, Gulfport, Mississippi, United States|Meridian Clinical Research, LLC, Grand Island, Nebraska, United States|Meridian Clinical Research, LLC, Norfolk, Nebraska, United States|Excel Clinical Research, Las Vegas, Nevada, United States|Medpharmics, LLC, Albuquerque, New Mexico, United States|Columbia University Medical Center, New York, New York, United States|Monroe Biomedical Research, Monroe, North Carolina, United States|Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Synexus Clinical Research US, Inc, Columbus, Ohio, United States|University of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States|Tekton Research Inc., Austin, Texas, United States|Baylor College of Medicine and Texas Childrens Hospital, Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|Maximos OB/GYN, League City, Texas, United States|Women's and Children's Hospital, North Adelaide, Australia|Murdoch Children's Research Institute, Parkville, Australia|Mater Hospital Brisbane, South Brisbane, Australia|Hospital de Clinicas da Universidade Federal De Minas Geraisnas Gerais, Belo Horizonte, Brazil|HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas, Campinas, Brazil|Centro de Estudos e Pesquisas em Moléstias Infecciosas, Natal, Brazil|Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil|Hospital Geral de Nova Iguacu - HGNI DST/AIDS, Rio De Janeiro, Brazil|Fundacao Faculdade Regional De Medicina De Sao Jose Do Rio Preto, Sao Jose do Rio Preto, Brazil|University of Sao Paulo Brazil NICHD CRS, Sao Paulo, Brazil|CMPC - Consultoria Médica e Pesquisa Clínica, Sorocaba, Brazil|Universidade Municipal de Sao Caetano do Sul, São Caetano do Sul, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, São Paulo, Brazil|British Columbia Children's Hospital, Vancouver, British Columbia, Canada|Dalhousie University, Halifax, Nova Scotia, Canada|Alberta Children's Hospital, Calgary, Canada|Helsinki University Hospital, Helsinki, Finland|Kokkolan rokotetutkimusklinikka, Kokkola, Finland|Oulun rokotetutkimusklinikka, Oulu, Finland|Seinäjoen rokotetutkimusklinikka, Seinäjoki, Finland|Tampereen rokotetutkimusklinikka, Tampere, Finland|Turun rokotetutkimusklinikka, Turku, Finland|Shandukani Research Centre, Johannesburg, South Africa|Stanza Clinical Research Centre : Mamelodi, Mamelodi East, South Africa|Setshaba Research Centre, Soshanguve, South Africa|Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa|Vaccines and Infectious Diseases Analytics Research Unit (VIDA), Formely RMPRU, Soweto, South Africa|Hosp. Univ. 12 de Octubre, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Pta. de Hierro Majadahonda, Majadahonda, Spain|Hosp. Puerta Del Sur, Mostoles, Spain|Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcon, Spain|Hosp. Clinico Univ. de Santiago, Santiago de Compostela, Spain|University Hospitals Bristol NHS Trust, Bristol, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds,, United Kingdom|Barts Health NHS Trust, Royal London Hospital, London, United Kingdom|University College London Hospitals NHSFT, London, United Kingdom|Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom|Chelsea and Westminster NHS Foundation Trust, London, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton",United Kingdom,Others,0,1,564.0
5297.0,NCT04443179,Brain Imaging in Babies Study,BIBS,Recruiting,Autism Spectrum Disorder,Attention Deficit Hyperactivity Disorder,Neurodevelopmental Conditions,COVID-19,,,,,King's College London,All,"16 Years to 75 Years   (Child, Adult, Older Adult)",790.0,Other,Observational,2013-05-04,01/12/23,2023-01-12,23/06/20,24/06/20,"King's College London, London",United Kingdom,Respiratory Diseases,1,4,3540.0
5298.0,NCT04703400,Analysis of the Impact on Surgical Residency Programs in Times of Pandemic in Argentina,,Completed,Surgical Education,,,,,,,Other: anonymous survey,"Clinica Universitaria Reina Fabiola, Universidad Catolica de Cordoba",All,20 Years to 30 Years   (Adult),195.0,Other,Observational,2020-08-15,01/10/20,2021-03-01,11/01/21,11/01/21,"René M. Palacios Huatuco, Córdoba",Argentina,Others,0,1,198.0
5299.0,NCT04670484,Mask Hypoxia in Subjects Using Masks to Prevent Infection Spread,,Not yet recruiting,Hypoxia,,,,,,,Other: Wearing Mask,University of New Mexico,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-01,31/12/21,2021-12-31,17/12/20,17/12/20,"Department of Neurology, University of New Mexico, Albuquerque, New Mexico",United States,Others,0,1,364.0
5300.0,NCT04719468,PD-Ballet: Effectiveness and Implementation in Parkinson's Disease,,Not yet recruiting,Parkinson Disease,,,,,,,Other: Dance with ballet elements,King's College Hospital NHS Trust|King's College London,All,"18 Years to 100 Years   (Adult, Older Adult)",160.0,Other,Interventional,2021-01-02,01/03/23,2023-01-09,22/01/21,22/01/21,"King's College Hospital NHS Foundation Trust, London",United Kingdom,Others,0,1,737.0
5301.0,NCT04771585,Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19,QUELLE,Recruiting,Healthy,,,,,,,Other: Community Mask|Other: Surgical Mask|Other: FFP2 respirator|Other: FFP3 respirator,Fraunhofer-Institute of Toxicology and Experimental Medicine,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-03-15,31/01/22,2022-01-31,25/02/21,25/02/21,"Fraunhofer ITEM, Hannover, Niedersachsen",Germany,Others,0,1,322.0
5302.0,NCT04524052,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",,Not yet recruiting,Healthy,,,,,,,Drug: DWRX2003|Drug: Placebo,Daewoong Pharmaceutical Co. LTD.,All,18 Years to 45 Years   (Adult),32.0,Industry,Interventional,2020-01-08,01/12/20,2020-01-12,24/08/20,24/08/20,,,Others,0,1,4.0
5303.0,NCT04797689,Managing Our Relationship With Food and Eating,NOURISH,Not yet recruiting,Mental Health Wellness 1,Eating Behavior,"Stress, Psychological",Eating Habit,,,,Behavioral: Trauma Informed Yoga|Behavioral: Trauma Informed Psychotherapy,University of Lethbridge,Female,"18 Years to 75 Years   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-04,01/08/21,2021-01-08,15/03/21,15/03/21,"University of Lethbridge, Lethbridge, Alberta",Canada,Mental Health,1,4,4.0
5304.0,NCT04055376,Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease,,"Active, not recruiting",Alzheimer Disease,Alzheimer Dementia,,,,,,Device: GENUS device (Active Settings)|Device: GENUS device (Sham Settings),Massachusetts Institute of Technology,All,"50 Years to 100 Years   (Adult, Older Adult)",15.0,Other,Interventional,2019-08-14,30/04/25,2025-04-30,13/08/19,01/07/20,"Massachusetts Institute of Technology, Cambridge, Massachusetts",United States,Others,0,2,2086.0
5305.0,NCT04550351,Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old),,"Active, not recruiting",Coronavirus,,,,,,,Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Biological/Vaccine: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",All,"60 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-08-19,18/12/20,2021-12-31,16/09/20,27/01/21,"Hunan Provincial Center for Disease Control and Prevention, Xiangtan, Changsha",China,Respiratory Diseases,1,1,499.0
5306.0,NCT04322786,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",,"Active, not recruiting",COVID-19,,,,,,,Drug: ACE inhibitor,"University College, London",All,"18 Years and older   (Adult, Older Adult)",1302508.0,Other,Observational,1998-01-01,31/05/16,2021-03-31,26/03/20,13/11/20,,,Respiratory Diseases,1,1,8490.0
5307.0,NCT04643964,Brief Video Interventions for Depression,,Recruiting,Depressive Symptoms,,,,,,,Behavioral: Entrée: Cognitive skills|Behavioral: Entrée: Behavioral skills|Behavioral: Entrée: Interpersonal skills|Behavioral: Sampler skills,Ohio State University,All,"18 Years and older   (Adult, Older Adult)",501.0,Other,Interventional,2020-01-11,01/11/20,2020-01-11,25/11/20,25/11/20,"Department of Psychology, Columbus, Ohio",United States,Others,0,1,0.0
5308.0,NCT04107402,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,PLACCSEPS,Recruiting,Septic Shock,Platelet Signal Processing Defect,Inflammatory Response,Disseminated Intravascular Coagulation,COVID-19,Neutrophil Extracellular Trap Formation,,"Other: Assessment of coagulopathy, Platelets activation and Platelets-Neutrophils interplay",Cliniques universitaires Saint-Luc- Université Catholique de Louvain,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2019-03-15,15/11/21,2024-03-15,27/09/19,25/11/20,"Cliniques Universitaires St Luc, Bruxelles",Belgium,Respiratory Diseases,1,6,1827.0
5309.0,NCT04378803,Mindfulness Training for Seniors,,Completed,Well Aging,,,,,,,Behavioral: Mindfulness training (MT) Connect,University of Miami,All,"60 Years to 95 Years   (Adult, Older Adult)",53.0,Other,Interventional,2020-05-13,04/08/20,2020-04-08,07/05/20,17/08/20,"University of Miami, Coral Gables, Florida",United States,Others,0,1,-35.0
5310.0,NCT04799561,Teleprehabilitation for Surgical Cancer Patients,,Not yet recruiting,Abdominal Cancer,Thoracic Cancer,,,,,,Behavioral: Multimodal Teleprehabilitation,McGill University Health Centre/Research Institute of the McGill University Health Centre|Montreal General Hospital Foundation|Peri-Operative Program (POP) Foundation,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-03-15,15/09/22,2022-12-15,16/03/21,16/03/21,,,Cancers,1,2,640.0
5311.0,NCT04518514,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),,Recruiting,Patients Undergoing Elective Surgery With Anesthesia,,,,,,,Device: TAPE-Software,RWTH Aachen University|Docs in Clouds Telecare GmbH,All,"Child, Adult, Older Adult",100.0,Other,Interventional,2020-04-20,31/10/20,2020-11-30,19/08/20,19/08/20,"RWTH Aachen University Hospital, Aachen",Germany,Others,0,1,224.0
5312.0,NCT04465435,Sustainable UNiversity Life (SUN) Study,SUN,Enrolling by invitation,Mental Health Issue,Musculoskeletal Pain,,,,,,Other: Web-based self-report questionnaires|Other: Focus Group Interviews,Sophiahemmet University|Karolinska Institutet|Forte,All,"18 Years and older   (Adult, Older Adult)",5000.0,Other|Industry,Observational,2019-08-19,31/01/22,2032-01-31,10/07/20,10/07/20,"Sophiahemmet University, Stockholm, SE",Sweden,Others,0,2,4548.0
5313.0,NCT04329897,Acceptance and Commitment Therapy Delivered by Automated Software Messaging,,Completed,Hip Osteoarthritis,Knee Osteoarthritis,Mental Stress,Coronavirus,,,,Behavioral: Software Messaging,University of Iowa,All,"18 Years and older   (Adult, Older Adult)",90.0,Other,Interventional,2020-05-04,15/05/20,2020-01-06,01/04/20,16/07/20,"University of Iowa Hospitals and Clinics, Iowa City, Iowa",United States,"Mental Health, Respiratory Diseases",1,4,-119.0
5314.0,NCT04414826,Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness,,Recruiting,Loneliness,,,,,,,Behavioral: Mindfulness Alone (MO) Intervention|Behavioral: Mindfulness + Compassion Intervention (MC),University of Texas at Austin,All,"18 Years to 70 Years   (Adult, Older Adult)",120.0,Other,Interventional,2020-05-25,01/05/21,2021-01-05,04/06/20,04/06/20,"Laboratory for the Study of Anxiety Disorders, University of Texas at Austin, Austin, Texas",United States,Others,0,1,225.0
5315.0,NCT04475913,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,,Completed,Edentulous Mouth,,,,,,,Other: DIG Axial|Other: DIG Tilted|Other: CIG Axial|Other: CIG Tilted,October University for Modern Sciences and Arts,All,"50 Years to 65 Years   (Adult, Older Adult)",56.0,Other,Interventional,2018-11-07,11/07/20,2020-08-20,17/07/20,01/03/21,"OctoberUMSA, Giza",Egypt,Others,0,1,652.0
5316.0,NCT04602286,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),,Recruiting,"Pain, Intractable","Pain, Chronic",,,,,,Other: Meditation (1 x 20-minute guided audio training),"The University of Queensland|University of Sydney|University of California, San Diego",All,"18 Years and older   (Adult, Older Adult)",292.0,Other,Interventional,2020-10-28,01/03/21,2021-01-03,26/10/20,12/11/20,"Health and Behavioural Sciences, Brisbane, Queensland",Australia,Others,0,2,67.0
5317.0,NCT04748289,Integrated Platform for Multimodal Patient Monitoring and Therapy Support in ICU Patients,ICUCockpitAp,Recruiting,Clinical Decision Support System,,,,,,,Device: ICU Cockpit software testing,Emanuela Keller|University of Zurich,All,"Child, Adult, Older Adult",1000.0,Other,Interventional,2021-01-03,31/01/23,2023-01-31,10/02/21,02/04/21,"University Hospital Zurich, Zurich",Switzerland,Others,0,1,758.0
5318.0,NCT04552392,Psychological Impact of Institutional Quarantine,,Completed,Quarantine,,,,,,,Other: No intervention,Dr. Ram Manohar Lohia Hospital,All,18 Years to 60 Years   (Adult),176.0,Other,Observational,2020-09-20,20/10/20,2020-10-20,17/09/20,10/03/21,"ITBP Chawala, Delhi",India,Others,0,1,30.0
5319.0,NCT04800939,The Effect of Acupressure on the Sleep Quality and Daytime Sleepiness,,Recruiting,Sleep,,,,,,,Other: Acupressure|Other: Plasebo acupressure,Mersin University,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Interventional,2021-05-04,22/06/21,2022-07-22,16/03/21,09/04/21,"Mersin University, Mersin, Yenişehir",Turkey,Others,0,1,444.0
5320.0,NCT04340414,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,,Recruiting,COVID-19,ECMO,,,,,,Device: Low flow ECMO driving by CVVH machine,Peking Union Medical College Hospital,All,"14 Years and older   (Child, Adult, Older Adult)",10.0,Other,Interventional,2020-02-20,15/08/20,2020-10-15,09/04/20,16/06/20,"Yun Long, Beijing, Beijing",China,Respiratory Diseases,1,2,238.0
5321.0,NCT04293887,Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients,,Not yet recruiting,COVID-19,Recombinant Human Interferon α1β,,,,,,Drug: Recombinant human interferon α1β,Tongji Hospital,All,"18 Years and older   (Adult, Older Adult)",328.0,Other,Interventional,2020-01-03,30/05/20,2020-06-30,03/03/20,03/03/20,,,Respiratory Diseases,1,2,179.0
5322.0,NCT04760418,Trauma and Trauma-Focused Therapy in the University of Kentucky SMART Clinic,,Not yet recruiting,PTSD,Opioid-use Disorder,Substance Use Disorders,,,,,Behavioral: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE),University of Kentucky,All,"18 Years and older   (Adult, Older Adult)",6.0,Other,Interventional,2021-01-03,01/08/22,2022-01-08,18/02/21,18/02/21,,,Others,0,3,370.0
5323.0,NCT04513496,Telemedicine in HIV Care in Buenos Aires,,Not yet recruiting,Telemedicine,HIV-1-infection,,,,,,,Fundacion Ibis,All,"18 Years and older   (Adult, Older Adult)",4000.0,Other,Observational,2020-01-09,01/03/22,2022-01-07,14/08/20,14/08/20,,,Others,0,2,729.0
5324.0,NCT04757207,Pandemia And Exercise in Turkey in University Students of Turkey,,Recruiting,Sedentary Behavior,COVID-19,,,,,,Other: survey,GULIN FINDIKOGLU|Pamukkale University,All,"17 Years to 40 Years   (Child, Adult)",1000.0,Other,Observational,2021-02-22,01/05/21,2021-01-05,17/02/21,16/03/21,"Pamukkale University, Denizli",Turkey,Respiratory Diseases,1,2,-48.0
5325.0,NCT04644276,Mask Adhesive Institutional Study,,Recruiting,Respiratory Failure,COVID-19,,,,,,Device: Mask with Mask Adhesive/Arm 1|Device: Mask without Mask Adhesive / Arm 2,Philips Clinical & Medical Affairs Global,All,"18 Years to 85 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2021-02-17,30/05/21,2021-05-30,25/11/20,05/04/21,"Sleep Disorder Center of Alabama, Birmingham, Alabama",United States,Respiratory Diseases,1,2,102.0
5326.0,NCT04389372,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",ChroMig-Smart,Recruiting,Migraine Headache,,,,,,,Behavioral: Mindfulness,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,All,"18 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-03-15,01/03/21,2021-01-12,15/05/20,18/05/20,"UOC Neurologia 3, Milano",Italy,Neurological Disorders,1,1,303.0
5327.0,NCT04574219,Virtual Parental Presence on Induction,VPPIA,Recruiting,Anxiety,Surgery,,,,,,Other: Use of Facetime with child and parents during induction,"Children's Hospital Medical Center, Cincinnati|The Hospital for Sick Children",All,4 Years to 12 Years   (Child),184.0,Other,Interventional,2020-03-11,01/10/22,2022-01-12,05/10/20,07/01/21,"Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Hospital for Sick Children, Toronto, Ontario",Canada,Mental Health,1,2,672.0
5328.0,NCT04805489,Comparison of Hemodynamic and Respiratory Parameters During Physical Activity,PAM,Not yet recruiting,Cardiovascular Check-up,,,,,,,Other: Mask,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-03-26,25/10/21,2021-11-25,18/03/21,18/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Groupe Hospitalier Paris Saint-Joseph",France,Others,0,1,244.0
5329.0,NCT04564040,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,,Completed,Mantle Cell Lymphoma,COVID-19,,,,,,Drug: Acalabrutinib Treatment A|Drug: Acalabrutinib Treatment B|Drug: Acalabrutinib Treatment C|Drug: Acalabrutinib Treatment D,AstraZeneca|Parexel,All,18 Years to 55 Years   (Adult),20.0,Industry,Interventional,2020-12-10,11/12/20,2020-11-12,25/09/20,29/12/20,"Research Site, Berlin",Germany,Respiratory Diseases,1,2,-28.0
5330.0,NCT04604977,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,Be-Home-Kids,Recruiting,Headaches Chronic,,,,,,,Behavioral: Mindfulness,Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta,All,"12 Years to 18 Years   (Child, Adult)",25.0,Other,Interventional,2020-09-15,01/10/21,2021-01-12,27/10/20,27/10/20,"Fondazione IRCCS Istituto Neurologico C. Besta, Neuroalgology Unit, Milano",Italy,Others,0,1,119.0
5331.0,NCT04663594,Online Culture for Mental Health in People Aged 16-24,O-ACEPOP,Recruiting,Depression,Anxiety,,,,,,Other: WofB|Other: Ashmolean Website,University of Oxford,All,"16 Years to 24 Years   (Child, Adult)",400.0,Other,Interventional,2020-04-12,01/03/21,2021-01-03,11/12/20,15/01/21,"Ashmolean Museum Website, Oxford, Oxfordshire",United Kingdom,Mental Health,1,2,266.0
5332.0,NCT04418947,Project Resurgence Communication Trial,,Completed,Communication Research,,,,,,,Other: Communication type,University of Pennsylvania,All,"Child, Adult, Older Adult",11120.0,Other,Interventional,2020-06-15,17/07/20,2020-07-17,05/06/20,31/07/20,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Others,0,1,32.0
5333.0,NCT04482387,DigiVis: Self-testing Vision App for Telephone Consultations,,Recruiting,Visual Impairment,Amblyopia Suspect,,,,,,Device: DigiVis visual acuity app,Cambridge University Hospitals NHS Foundation Trust,All,"5 Years to 85 Years   (Child, Adult, Older Adult)",250.0,Other,Interventional,2020-07-24,01/07/21,2021-01-07,22/07/20,14/01/21,"Cambridge University Hospitals NHS Trust, Cambridge, Cambs",United Kingdom,Others,0,2,167.0
5334.0,NCT04404192,PH94B in the Treatment of Adjustment Disorder With Anxiety,,Not yet recruiting,Adjustment Disorder With Anxious Mood,,,,,,,Drug: PH94B,"VistaGen Therapeutics, Inc.",All,"18 Years to 75 Years   (Adult, Older Adult)",30.0,Industry,Interventional,2020-01-11,01/07/21,2021-01-09,27/05/20,27/05/20,"The Medical Research Network, New York, New York",United States,Others,0,1,364.0
5335.0,NCT04428099,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,,Recruiting,"Depressive Disorder, Treatment-Resistant",,,,,,,Behavioral: Lifestyle change promotion program|Behavioral: Mindfullness based cognitive program|Behavioral: Written Information,University of the Balearic Islands,All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Interventional,2020-01-13,12/01/22,2022-12-07,11/06/20,11/06/20,"Universitat Illes Balears, Palma de Mallorca, Illes Balears",Spain,Others,0,1,1059.0
5336.0,NCT04662021,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,,Enrolling by invitation,Anxiety Depression Disorder,,,,,,,Other: Aerobic Exercises,Cairo University,Female,18 Years to 25 Years   (Adult),40.0,Other,Interventional,2020-10-12,10/02/21,2021-02-25,10/12/20,11/01/21,"Marwa Eid, Cairo",Egypt,Mental Health,1,1,136.0
5337.0,NCT04370067,HUNgarian COronaVirus Disease-19 Epidemiological Research,,Recruiting,Coronavirus Infection,,,,,,,,Semmelweis University Heart and Vascular Center|Semmelweis University|Szeged University|University of Pecs|University of Debrecen,All,"14 Years and older   (Child, Adult, Older Adult)",11200.0,Other,Observational,2020-01-05,01/05/21,2021-01-08,30/04/20,16/06/20,"Semmelweis University - Heart and Vascular Center, Budapest, Hungary|University of Debrecen, Debrecen, Hungary|University of Pecs, Pecs, Hungary|University of Szeged, Szeged",Hungary,Respiratory Diseases,1,1,369.0
5338.0,NCT04748536,Safety and PK of Repeated Doses of IRL201104 in Healthy Volunteers,,Recruiting,Healthy Volunteer,,,,,,,Drug: IRL201104|Drug: Placebo,Immune Regulation Ltd.|Revolo Biotherapeutics,All,"18 Years to 65 Years   (Adult, Older Adult)",18.0,Industry,Interventional,2021-01-29,05/04/21,2021-05-04,10/02/21,15/02/21,"Hammersmith Medicines Research, London",United Kingdom,Others,0,1,95.0
5339.0,NCT04435028,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,,Completed,Breast Cancer,Iron Chelation,,,,,,Drug: Ketotifen 1 MG,Horus University,Female,30 Years to 60 Years   (Adult),111.0,Other,Observational,2019-01-14,13/08/19,2019-08-13,17/06/20,17/06/20,"Horus University, Damietta, Damiete Governonate",Egypt,Cancers,1,2,211.0
5340.0,NCT04780425,"Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana",SMSCOVID,"Active, not recruiting","Diabetes Mellitus, Type 2",,,,,,,Behavioral: DESMOND|Other: usual care,"Korle-Bu Teaching Hospital, Accra, Ghana|University of Leicester|Utrecht University",All,"18 Years and older   (Adult, Older Adult)",206.0,Other,Interventional,2021-01-26,22/05/21,2021-05-31,03/03/21,11/03/21,"Korle Bu Teaching Hospital, Accra, Ghana|Weija Gbawe Municipal Hospital, Accra",Ghana,Metabolic Disorders,1,1,125.0
5341.0,NCT04470869,Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement.,OLAF,Recruiting,Post Traumatic Stress Disorder,,,,,,,Other: Phone call,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",130.0,Other,Interventional,2020-12-06,12/04/21,2021-12-10,14/07/20,14/07/20,"University Hospital Toulouse, Toulouse, Occitanie",France,Mental Health,1,1,369.0
5342.0,NCT02027233,Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults,FLUVAC EV-03,Recruiting,Severe Acute Respiratory Infection,,,,,,,Other: nasopharyngeal sample,"Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Interventional,2014-01-01,01/12/22,2022-01-12,06/01/14,17/03/21,"Institut National de la Santé Et de la Recherche Médicale, Paris",France,Others,0,1,2933.0
5343.0,NCT04663776,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,,Recruiting,COVID-19,Influenza,Respiratory Tract Infections,Acute Respiratory Tract Infection,Acute Respiratory Distress Syndrome,,,,Boston Children's Hospital|Google LLC.,All,"18 Years and older   (Adult, Older Adult)",100000.0,Other|Industry,Observational,2020-04-11,08/12/21,2021-08-12,11/12/20,11/12/20,"Boston Children's Hospital, Boston, Massachusetts",United States,"Infectious Diseases, Respiratory Diseases",1,5,488.0
5344.0,NCT04737486,A First-in-Human Study of AV-001 in Healthy Subjects,,Completed,COVID-19,COVID-19,ARDS,,,,,Drug: AV-001|Other: Placebo,"Vasomune Therapeutics, Inc.",All,"18 Years to 65 Years   (Adult, Older Adult)",48.0,Industry,Interventional,2020-12-16,10/03/21,2021-10-03,03/02/21,24/03/21,"Medpace Clinical Pharmacology Unit, Cincinnati, Ohio",United States,Respiratory Diseases,1,3,291.0
5345.0,NCT04363775,Comparison of VieScope vs. Macintosh Laryngoscope for Intubation in Level Cpersonal Protective Equipment Conditions,,Completed,Tracheal Intubation,Infection,Projection,,,,,Device: The standard Macintosh laryngoscope|Device: The Vie Scope laryngoscope,Lazarski University|Poznan University of Medical Sciences|Wroclaw Medical University|Medical University of Bialystok,All,"18 Years and older   (Adult, Older Adult)",35.0,Other,Interventional,2020-01-20,23/02/20,2020-02-25,27/04/20,28/04/20,"Lazarski Univeristy, Warsaw",Poland,Others,0,3,36.0
5346.0,NCT04432038,Healthy Lifestyle or Pro-health Obsession During the Pandemic,,Recruiting,Adult,Global Health,,,,,,,"Gdansk University of Physical Education and Sport|University Hospital of Split|University of Gondar|Universidad Pablo de Olavide|Universitas Padjadjaran|University of Social Welfare and Rehabilitation Science|DPFA Academy of Work and Health, Leipzig|Instituto Piaget|University of Peradeniya|Catholic University of the Sacred Heart|University of Évora|Norwegian School of Sport Sciences|Klaipėda University|Universitatea Alexandru Ioan Cuza|Institut Catholique de Paris|University of Gdansk|Jagiellonian University|International University of Business Agriculture and Technology|Beijing Sport Uninversity|University of Nigeria, Enugu Campus|University of Sargodha|University of Brasilia|Wright State University|Vietnam National University|Taras Shevchenko National University of Kyiv|Astana Medical University|International Islamic Academy of Uzbekistan|Menoufia University|Zhengzhou University",All,"18 Years and older   (Adult, Older Adult)",50000.0,Other,Observational,2020-06-19,19/06/21,2021-06-30,16/06/20,09/04/21,"Gdansk University of Physical Education and Sport, Gdańsk",Poland,Others,0,2,376.0
5347.0,NCT04591873,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,,Not yet recruiting,Critical Illness,"Infections, Respiratory","Emergency Service, Hospital",Telemedicine,,,,Other: telemedicine|Other: traditional communication tools,National Taiwan University Hospital,All,"20 Years to 99 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-10-10,10/10/21,2021-10-30,19/10/20,19/10/20,"National Taiwan University Hospital, Taipei",Taiwan,Cardiovascular Diseases,1,4,385.0
5348.0,NCT04467086,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,PROACTIVE,Recruiting,Mechanical Ventilation,Sedation,Critical Illness,COVID-19,,,,Drug: Propranolol Hydrochloride,"Ottawa Hospital Research Institute|Hamilton Health Sciences Corporation|Toronto General Hospital|University Health Network, Toronto|The Ottawa Hospital|McMaster University|Sinai Health System",All,"19 Years and older   (Adult, Older Adult)",108.0,Other,Interventional,2020-11-12,01/04/21,2021-01-05,10/07/20,17/12/20,"Hamilton Health Sciences Centre - Hamilton General Hospital, Hamilton, Ontario, Canada|The Ottawa Hospital, Ottawa, Ontario",Canada,"Cardiovascular Diseases, Respiratory Diseases",1,4,54.0
5349.0,NCT04625465,Proximal Effects of Alcohol on Same-Sex Intimate Partner Violence,PASSION,Recruiting,Alcohol Consumption,"Violence, Domestic","Stress, Psychological",Aggression,,,,Behavioral: CBT Text Messaging|Behavioral: Attention Control Text Messaging,Georgia State University|University at Buffalo,All,"21 Years and older   (Adult, Older Adult)",480.0,Other,Interventional,2020-12-11,30/09/22,2022-09-30,12/11/20,07/01/21,"Georgia State University, Atlanta, Georgia",United States,Mental Health,1,4,658.0
5350.0,NCT04497922,Virtual White Boards for Patient Satisfaction,,Recruiting,"Satisfaction, Patient",COVID-19,Emergencies,Satisfaction,Information Disclosure,,,Device: e-ink screen|Behavioral: Treatment as usual,Brigham and Women's Hospital|E-ink corporation,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-25,30/04/21,2021-05-15,04/08/20,27/01/21,"Brigham and Women's Hospital, Boston, Massachusetts",United States,Respiratory Diseases,1,5,110.0
5351.0,NCT04346979,Telerehabilitation-based Yoga and Mindfulness Home Program in Postmenopausal Women Having Social Isolation,,Not yet recruiting,Telerehabilitation,,,,,,,Other: Telerehabilitation-Based|Other: Video-Based,Istinye University,Female,"45 Years to 65 Years   (Adult, Older Adult)",50.0,Other,Interventional,2020-01-08,01/10/20,2020-01-11,15/04/20,21/07/20,,,Others,0,1,3.0
5352.0,NCT04666558,Heal-Me Personalized Online Nutrition and Exercise Routines,PiONEeR,Recruiting,Cancer,Lung Diseases,Liver Diseases,,,,,Other: Exercise & Nutrition,University of Alberta|Alberta Innovates Health Solutions,All,"18 Years and older   (Adult, Older Adult)",216.0,Other,Interventional,2020-11-30,17/12/21,2021-12-17,14/12/20,14/12/20,"University of Alberta, Edmonton, Alberta",Canada,Cancers,1,3,382.0
5353.0,NCT04525079,"To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects",,Recruiting,COVID-19,,,,,,,Drug: CT-P59|Drug: Placebo,Celltrion,All,19 Years to 55 Years   (Adult),32.0,Industry,Interventional,2020-07-18,31/08/20,2020-11-30,25/08/20,25/08/20,"Chungnam National University Hospital, Daejeon, Korea",Republic of,Respiratory Diseases,1,1,135.0
5354.0,NCT04842175,Evaluation of Education and Equipment in the Prehospital Setting,EVAIR,Not yet recruiting,Airway Disease,,,,,,,,Johannes Gutenberg University Mainz,All,"Child, Adult, Older Adult",203.0,Other,Observational,2021-05-15,15/06/21,2021-01-07,13/04/21,13/04/21,"Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University, Mainz, Rhineland-Palatinate",Germany,Others,0,1,-128.0
5355.0,NCT04538495,Characterization of Multisystem Inflammatory Syndrome in Children (MIS-C) and Its Relationship to Kawasaki Disease,,Recruiting,Kawasaki Disease,Inflammation,,,,,,,"University of California, San Diego",All,"1 Month and older   (Child, Adult, Older Adult)",100.0,Other,Observational,2020-01-08,30/06/21,2021-01-07,04/09/20,04/09/20,"University of California, San Diego, La Jolla, California",United States,Others,0,2,365.0
5356.0,NCT03583541,Kyaterekera Project: A Combination Intervention Addressing Sexual Risk-Taking Behaviors Among Vulnerable Women in Uganda,,"Active, not recruiting",Control arm_Bolstered Care,Treatment arm_HIVRR+S+FL,Treatment arm_HIVRR+S+FLM,,,,,Behavioral: HIV Risk Reduction|Behavioral: Financial Literacy|Behavioral: Mentorship|Behavioral: Matched savings individual development account,Washington University School of Medicine|Columbia University|Johns Hopkins University|Rakai Health Sciences Program|Reach the Youth Uganda,Female,"18 Years and older   (Adult, Older Adult)",542.0,Other,Interventional,2019-04-06,01/12/22,2022-01-12,11/07/18,23/02/21,"International Center for Child Health and Development Field Office, Masaka",Uganda,Others,0,3,1012.0
5357.0,NCT03680274,Lessening Organ Dysfunction With VITamin C,LOVIT,Recruiting,Sepsis,Vitamin C,Intensive Care Unit,COVID-19,Pandemic,Coronavirus,,Drug: Vitamin C|Other: Control,Université de Sherbrooke|Lotte & John Hecht Memorial Foundation,All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2018-08-11,31/12/21,2022-12-31,21/09/18,18/03/21,"Research Center of the CHUS, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,6,1603.0
5358.0,NCT04582838,Photoplethysmographic Scaling of Dyspnoea,DYSPO,Recruiting,Respiratory Failure,,,,,,,Diagnostic Test: Pulse oximeter|Diagnostic Test: ECG,Institutul de Urgenţă pentru Boli Cardiovasculare Prof.Dr. C.C. Iliescu,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other,Observational,2020-01-10,30/05/21,2021-07-30,12/10/20,14/10/20,"Clinical Emergency Hospital Bucharest, Bucharest, Romania|Clinical Hospital of Infectious and Tropical Diseases Dr. Victor Babes, Bucharest",Romania,Respiratory Diseases,1,1,567.0
5359.0,NCT04487483,Exploring the Impact of a Sleep App on Sleep Quality,,"Active, not recruiting",Sleep,,,,,,,Behavioral: Sleep App,"University College, London|University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",101.0,Other,Interventional,2020-02-13,17/06/20,2020-08-15,27/07/20,11/08/20,"University College London, London",United Kingdom,Others,0,1,184.0
5360.0,NCT04665557,Evaluating Dove Confident Me Single Session in Indonesia,,Not yet recruiting,Body Image,,,,,,,Behavioral: Dove Confident Me Indonesia Single Session,University of the West of England|Indonesia University|University of Hawaii|UNICEF|Unilever R&D,All,11 Years to 15 Years   (Child),2000.0,Other|Industry,Interventional,2021-01-03,01/09/21,2021-01-10,11/12/20,17/02/21,"Centre for Appearance Research, UWE, Bristol",United Kingdom,Others,0,1,7.0
5361.0,NCT04761510,Mindfulness-SOS: Stress Reduction for Refugees,,Completed,"Stress Disorders, Post-Traumatic",Stress Related Disorder,,,,,,Behavioral: Mindfulness-SOS for Refugees,University of Haifa,All,"18 Years to 65 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-09-14,14/01/21,2021-01-14,21/02/21,21/02/21,"Assaf, Tel Aviv, Merkaz",Israel,Mental Health,1,2,122.0
5362.0,NCT04476719,"The Bioequivalence Study of Umifenovir 200 mg Capsul (ATABAY, Turkey) Under Fasting Conditions",Umifenovir,"Active, not recruiting",Bioequivalence,,,,,,,Drug: ATAFENOVIR 200 MG KAPSUL|Drug: ARBIDOL 100 MG KAPSUL,Atabay Kimya Sanayi Ticaret A.S.|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,20 Years to 40 Years   (Adult),18.0,Industry|Other,Interventional,2020-09-07,22/07/20,2020-08-20,20/07/20,20/07/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep",Turkey,Others,0,1,-18.0
5363.0,NCT04699942,Pilot Study to Evaluate the Revoxa™ System in Hypoxic Patients,,Not yet recruiting,Hypoxemia,,,,,,,Device: Conventional (low flow) oxygen delivery via nasal cannula|Device: Revoxa Oxygen Rebrearther,Dr. David Maslove|Ironstone Professional Development|Queen's University,All,"18 Years and older   (Adult, Older Adult)",23.0,Other,Interventional,2021-04-01,01/07/21,2021-01-07,07/01/21,07/01/21,"Kingston Health Sciences Centre, Kingston, Ontario",Canada,Others,0,1,-84.0
5364.0,NCT03117881,Tele-Exercise and Multiple Sclerosis,TEAMS,Recruiting,Multiple Sclerosis,,,,,,,Behavioral: DirectCAM|Behavioral: TeleCAM|Behavioral: rDirectCAM,University of Alabama at Birmingham|Patient-Centered Outcomes Research Institute|Lakeshore Foundation|Tanner Center for Multiple Sclerosis,All,"18 Years to 70 Years   (Adult, Older Adult)",833.0,Other,Interventional,2018-08-01,30/10/21,2023-01-31,18/04/17,19/10/20,"Upstream Rehabilitation Inc., Athens, Alabama, United States|Upstream Rehabilitation Inc., Bessemer, Alabama, United States|Tanner Foundation, Birmingham, Alabama, United States|Upstream Rehabilitation Inc., Calera, Alabama, United States|Upstream Rehabilitation Inc., Cullman, Alabama, United States|Southeast Alabama Medical Center Rehabilitation Services, Dothan, Alabama, United States|Gulf Coast Therapy, Fairhope, Alabama, United States|Gulf Coast Therapy, Foley, Alabama, United States|Encore Rehabilitation, Fort Payne, Alabama, United States|Upstream Rehabilitation Inc., Gadsden, Alabama, United States|Therapy Achievements, Huntsville, Alabama, United States|Upstream Rehabilitation Inc., Jacksonville, Alabama, United States|Upstream Rehabilitation Inc., Jasper, Alabama, United States|Gulf Coast Therapy, Mobile, Alabama, United States|Montgomery East Physical Therapy, Montgomery, Alabama, United States|Upstream Rehabilitation Inc., Muscle Shoals, Alabama, United States|Encore Rehabilitation, Phenix City, Alabama, United States|Upstream Rehabilitation Inc., Tuscaloosa, Alabama, United States|Cornerstone Rehabilitation, Batesville, Mississippi, United States|Upstream Rehabilitation Inc., Byram, Mississippi, United States|Upstream Rehabilitation Inc., Canton, Mississippi, United States|Upstream Rehabilitation Inc., Columbus, Mississippi, United States|Upstrem Rehabilitation, Forest, Mississippi, United States|Upstream Rehabilitation Inc., Fulton, Mississippi, United States|River City Rehabilitation, Greenville, Mississippi, United States|Encore Rehabilitation, Grenada, Mississippi, United States|Upstream Rehabilitation Inc., Hattiesburg, Mississippi, United States|Methodist Rehabilitation Center, Jackson, Mississippi, United States|Encore Rehabilitation, Ocean Springs, Mississippi, United States|North Sunflower Medical Center, Ruleville, Mississippi, United States|Cornerstone Rehabilitation, Southaven, Mississippi, United States|Upstream Rehabilitation Inc., Starkville, Mississippi, United States|Upstream Rehabilitation Inc., Tupelo, Mississippi, United States|Cornerstone Rehabilitation, Water Valley, Mississippi, United States|Upstream Rehabilitation Inc., Bristol, Tennessee, United States|Upstream Rehabilitation Inc., Cool Springs, Tennessee, United States|Upstream Rehabilitation Inc., Gordonsville, Tennessee, United States|Upstream Rehabilitation Inc., Knoxville, Tennessee, United States|Upstream Rehabilitation Inc., Newport, Tennessee, United States|Upstream Rehabilitation Inc., Winchester, Tennessee",United States,Immunological Disorders,1,1,1644.0
5365.0,NCT04566614,Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies,PREVAILctDNA,Recruiting,"Neoplasm, Colorectal",Neoplasm of Lung,"Neoplasm, Bladder",Neoplasms Pancreatic,Biliary Tract Neoplasms,Gastro Intestinal Stromal Tumour,,Other: ctDNA blood sampling,Royal Marsden NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",112.0,Other,Observational,2020-06-18,31/12/21,2022-12-31,28/09/20,28/09/20,"Royal Marsden Hospital, Sutton, Surrey",United Kingdom,Others,0,6,926.0
5366.0,NCT04297904,Urinary Incontinence and Sedentary Behaviour in Nursing Homes,OsoNaH,Recruiting,Urinary Incontinence in Old Age,Sedentary Behavior,,,,,,Behavioral: Sedentary behaviour|Diagnostic Test: Urinary Incontinence,University of Vic - Central University of Catalonia|Glasgow Caledonian University|University Ramon Llull|Universidade Federal do Rio Grande do Norte,All,65 Years and older   (Older Adult),458.0,Other,Observational,2020-02-20,01/07/20,2022-01-13,06/03/20,19/05/20,"Residència Sant Gabriel. Nursing home, Centelles, Barcelona, Spain|Casal Oller. Nursing home, Els Hostalets De Balenyà, Barcelona, Spain|Residència Aura. Nursing home, Manlleu, Barcelona, Spain|Residència els Tells. Nursing home, Montesquiu, Barcelona, Spain|Els Munts. Nursing home, Sant Boi de Lluçanès, Barcelona, Spain|Fundació Gallifa. Nursing home, Sant Hipòlit de Voltregà, Barcelona, Spain|Casal de la Santa Creu. Nursing home, Santa Maria De Corcó, Barcelona, Spain|Residència Cantonigròs. Nursing home, Santa Maria De Corcó, Barcelona, Spain|Els Bons Amics. Nursing home, Seva, Barcelona, Spain|Hotel Residència el Prat. Nursing home, Tona, Barcelona, Spain|Residència Prudenci. Nursing home, Tona, Barcelona, Spain|Residencia Rocapravera. Nursing home, Torello, Barcelona, Spain|Funcació Privada de Gestió Clear - Residència Centre de Dia SAITS. Nursing home, Vic, Barcelona, Spain|Residencia el Nadal. Nursing home, Vic, Barcelona, Spain|University of Vic - Central University of Catalonia. Facultat de Ciències de la Salut i el Benestar; Afiliation with the M3O research group, Vic, Barcelona",Spain,Others,0,2,693.0
5367.0,NCT04589923,The VISION-Acute Study,,Recruiting,Hypertension,Hypoxia,Hypotension,,,,,Device: Lifelight® Data Collect Blood Pressure Group|Device: Lifelight® Data Collect Oxygen Saturation Group,Xim Limited|Portsmouth Hospitals NHS Trust|Mind Over Matter Medtech Ltd,All,"18 Years and older   (Adult, Older Adult)",200.0,Industry|Other,Observational,2020-09-14,01/01/22,2022-01-01,19/10/20,15/02/21,"Portsmouth Hospitals NHS Trust, Portsmouth, England",United Kingdom,Cardiovascular Diseases,1,3,474.0
5368.0,NCT04339842,Eating Habits of Adults During the Quarantine,,Completed,Health Behavior,Eating Behavior,,,,,,Other: Assessment of Dietary Changes in Adults in the Quarantine,Eliz Arter|Cyprus Science University|Eastern Mediterranean University,All,"18 Years to 80 Years   (Adult, Older Adult)",673.0,Other,Observational,2020-10-04,31/05/20,2020-05-31,09/04/20,22/07/20,"Online, Nicosia",Cyprus,Others,0,2,-126.0
5369.0,NCT04569019,Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw,,Recruiting,Vaccnation in HCW,,,,,,,Other: Vacciantion status in health care workers,Medical University of Warsaw,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-01-09,01/08/21,2022-01-07,29/09/20,29/09/20,"Warsaw Medical Uniwerity, Warsaw",Poland,Others,0,1,729.0
5370.0,NCT03651622,ACT1ON Phase 2 (SMART Pilot) and Phase 3 (Efficacy Trial Development),ACT1ON DP3,"Active, not recruiting","Diabetes Mellitus, Type 1",Overweight and Obesity,,,,,,"Behavioral: Hypocaloric, low carbohydrate diet|Behavioral: Hypocaloric, moderate low fat diet|Behavioral: Mediterranean diet, no caloric restriction","University of North Carolina, Chapel Hill|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",All,19 Years to 30 Years   (Adult),69.0,Other|NIH,Interventional,2018-12-11,01/07/21,2021-01-07,29/08/18,29/07/20,"Stanford University, Palo Alto, California, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina",United States,Metabolic Disorders,1,2,758.0
5371.0,NCT04502368,Fiberoptic Bronchoscopy and Bronchoalveolar Lavage in Critically Ill Ventilated Patients,,Recruiting,Fiberoptic Bronchoscopy (FOB),Bronchoalveolar Lavage (BAL),Respiratory Disease,,,,,Procedure: Fiberoptic Bronchoscopy (FOB)|Procedure: Bronchoalveolar Lavage (BAL)|Diagnostic Test: Electrical Impedance Tomography (EIT)|Diagnostic Test: Arterial Blood Gas test (ABG),Erasme University Hospital,All,"18 Years and older   (Adult, Older Adult)",15.0,Other,Observational,2020-01-09,30/03/21,2021-04-30,06/08/20,08/02/21,"Erasme University Hospital - Intensive Care Unit, Brussels",Belgium,Others,0,3,477.0
5372.0,NCT03136471,Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana,,Completed,"Diabetes Mellitus, Type 2",Chronic Disease,,,,,,,Tulane University|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",22242.0,Other,Observational,2017-01-01,01/12/20,2021-01-03,02/05/17,01/04/21,"Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana",United States,Metabolic Disorders,1,2,1463.0
5373.0,NCT04591912,"The Peer-Delivered ""Mind. Body. Voice."" Program for High School Women (Mbv) - Remote",,Recruiting,Eating Disorders in Adolescence,,,,,,,Behavioral: mind. body. voice,"University of Colorado, Boulder",Female,"Child, Adult, Older Adult",140.0,Other,Interventional,2020-09-10,31/05/21,2031-05-31,19/10/20,19/10/20,"University of Colorado Boulder, Boulder, Colorado",United States,Others,0,1,3915.0
5374.0,NCT03367845,Efficacy of Family Programs for Improving Child and Family Health and Development,,Recruiting,"Behavior, Infant",,,,,,,Behavioral: Control|Behavioral: Sensitivity Intervention|Behavioral: Couples' Intervention|Behavioral: Sensitivity and Couples' Intervention,University of Notre Dame|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),All,"6 Months and older   (Child, Adult, Older Adult)",1200.0,Other|NIH,Interventional,2017-11-01,31/12/21,2023-12-31,11/12/17,27/08/20,"Fort Wayne Center for Children and Families, Fort Wayne, Indiana, United States|William J. Shaw Center for Children and Families, South Bend, Indiana",United States,Others,0,1,2251.0
5375.0,NCT04276987,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,,Completed,Coronavirus,,,,,,,Biological: MSCs-derived exosomes,"Ruijin Hospital|Shanghai Public Health Clinical Center|Wuhan Jinyintan Hospital, Wuhan, China|Cellular Biomedicine Group Ltd.",All,"18 Years to 75 Years   (Adult, Older Adult)",24.0,Other|Industry,Interventional,2020-02-15,31/05/20,2020-07-31,19/02/20,07/09/20,"Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai",China,Respiratory Diseases,1,1,167.0
5376.0,NCT04826809,New Reusable Mask Design With Superior Filtration and Fit,,Recruiting,COVID-19,Tuberculosis,Respiratory Viral Infection,,,,,Device: N95 mask|Device: Nordell single E-100 layer mask|Device: Nordell double E-100 layer mask,Mayo Clinic,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-04,01/09/21,2021-01-10,01/04/21,08/04/21,"Mayo Clinic Health System in Mankato, Mankato, Minnesota",United States,"Infectious Diseases, Respiratory Diseases",1,3,6.0
5377.0,NCT04441164,VERARE : Effectiveness of Virtual Motor Actions for Improving Walking in Patients With Post-resuscitation Muscle Weakness,VERARE,Withdrawn,Weakness of the Lower Limbs,,,,,,,Other: Observation of Virtual Actions|Other: Relaxation|Other: Acceptability questionnaire|Other: Observation of Virtual Actions (step 4)|Other: Performing Virtual Actions|Other: Haptic stimulation|Other: Without haptic stimulation,Rennes University Hospital|Institut National de Recherche en Informatique et en Automatique,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2020-01-08,01/08/22,2023-01-08,22/06/20,06/01/21,"Rennes University Hospital, Rennes, Bretagne",France,Others,0,1,1096.0
5378.0,NCT04596657,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,,Recruiting,Respiratory Tract Infections,COVID-19,Flu Like Illness,,,,,Dietary Supplement: Vitamin D supplementation,The Cooper Health System|The Won Sook Chung Foundation,All,"52 Years and older   (Adult, Older Adult)",2099.0,Other,Interventional,2020-10-27,01/10/21,2021-01-11,22/10/20,20/11/20,"Cooper University Hospital, Camden, New Jersey",United States,Respiratory Diseases,1,3,76.0
5379.0,NCT04568564,Telerehabilitation in Lung Surgery Patients,,Recruiting,Lung Cancer,Physiotherapy,,,,,,"Other: Breathing exercise, intensive spirometry use, supported cough, progressive mobilisation and ambulation|Other: Exercise booklet",Istanbul Medipol University Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-10,01/05/21,2021-01-05,29/09/20,01/10/20,"Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine Thoracic Surgery Clinic, İstanbul",Turkey,Cancers,1,2,361.0
5380.0,NCT04485741,Strados System at Center of Excellence,,Recruiting,Copd,Asthma,COVID-19,,,,,Device: RESP,"Strados Labs, Inc.",All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Industry,Observational,2020-09-23,01/06/21,2021-08-31,24/07/20,16/02/21,"Albert Einstein Medical Center, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,3,342.0
5381.0,NCT04668820,"Reliability and Acceptability of Real-time Virtual Video Pediatric Gait, Arms, Legs and Spine (V-pGALS)",,Not yet recruiting,Musculoskeletal Abnormality,Pediatric,,,,,,"Diagnostic Test: video Pediatric Gait, Arms, Legs and Spine (V-pGALS)",Marmara University,All,"7 Years to 18 Years   (Child, Adult)",15.0,Other,Interventional,2021-01-02,01/03/21,2021-01-04,16/12/20,16/12/20,"Marmara University School of Medicine Department of Physical Medicine and Rehabilitation, Istanbul",Turkey,Others,0,2,2.0
5382.0,NCT04276688,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",,Completed,COVID-19,,,,,,,Drug: Lopinavir/ritonavir|Drug: Ribavirin|Drug: Interferon Beta-1B,"The University of Hong Kong|Hospital Authority, Hong Kong",All,"18 Years and older   (Adult, Older Adult)",127.0,Other,Interventional,2020-10-02,30/03/20,2020-03-31,19/02/20,15/04/20,"University of Hong Kong, Queen Mary Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,-185.0
5383.0,NCT04743973,A Study to Asses Wellness Using a Brain Sensing Device on Physicians,,Not yet recruiting,"Stress, Emotional",Sleep,Quality of Life,,,,,Device: Muse S™ Headband system,"Mayo Clinic|InteraXon, Inc.|Cambridge Brain Sciences Inc.",All,"18 Years and older   (Adult, Older Adult)",20.0,Other|Industry,Interventional,2021-04-15,15/01/22,2023-01-15,08/02/21,29/03/21,"Mayo Clinic in Rochester, Rochester, Minnesota",United States,Mental Health,1,3,640.0
5384.0,NCT04411056,A Study Comparing Time to Intubate With and Without a Barrier Box,,Completed,Intubation,,,,,,,Other: Barrier box,The Guthrie Clinic,All,"18 Years and older   (Adult, Older Adult)",78.0,Other,Interventional,2020-07-05,19/05/20,2020-05-25,02/06/20,04/06/20,"Robert Packer Hospital, Sayre, Pennsylvania",United States,Others,0,1,-41.0
5385.0,NCT03827109,Peer Mentoring to Improve Self-management in Youth With IBD,,Recruiting,Pediatric Crohns Disease,Pediatric Ulcerative Colitis,Inflammatory Bowel Diseases,,,,,Behavioral: Group educational activities|Behavioral: IBD educational website|Behavioral: Monthly check-in calls from program coordinator|Behavioral: Mentor|Behavioral: Fun group activities|Behavioral: Parent support group,"Laura Mackner|Children's Hospital Medical Center, Cincinnati|Rosalind Franklin University of Medicine and Science|Nationwide Children's Hospital",All,10 Years to 17 Years   (Child),300.0,Other,Interventional,2019-12-06,23/02/23,2023-02-23,01/02/19,20/01/21,"Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio",United States,Others,0,3,1175.0
5386.0,NCT04411472,(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI,,Recruiting,Acute Kidney Injury Due to Sepsis,,,,,,,Biological: Recombinant human alkaline phosphatase|Other: Placebo,AM-Pharma,All,"18 Years and older   (Adult, Older Adult)",1600.0,Industry,Interventional,2020-02-11,15/08/23,2024-02-15,02/06/20,04/11/20,"Jeroen Bosch Ziekenhuis lokatie GZG, 's-Hertogenbosch",Netherlands,Others,0,1,1465.0
5387.0,NCT04783584,Agreement Between Video and In-person Airway Assessment Performed by Anaesthetists in Patients Scheduled for Elective Same-day Gynaecological Procedures,,Recruiting,Difficult Intubation,Difficult Airway Intubation,,,,,,,Michael Ma|Coombe Women and Infants University Hospital,Female,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-12,31/07/21,2021-08-15,05/03/21,05/03/21,"The Coombe Women & Infants University Hospital, Dublin",Ireland,Others,0,2,581.0
5388.0,NCT04817995,Stress Recovery Program FOREST for Healthcare Staff,FOREST,Recruiting,Perceived Stress,,,,,,,Behavioral: FOREST,Vilnius University|Linkoeping University,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2021-01-04,01/04/22,2022-01-04,26/03/21,12/04/21,"Vilnius University, Vilnius",Lithuania,Mental Health,1,1,365.0
5389.0,NCT04283825,Humanistic Care in Patients With Coronavirus Disease 2019,,Withdrawn,Coronavirus Disease 2019,,,,,,,Behavioral: Psychological and physical rehabilitation based humanistic care,Second Affiliated Hospital of Xi'an Jiaotong University,All,"Child, Adult, Older Adult",0.0,Other,Interventional,2020-02-22,30/04/20,2020-05-15,25/02/20,17/03/20,,,Respiratory Diseases,1,1,83.0
5390.0,NCT04675658,Stay Active Physical Activity Program,,"Active, not recruiting",Healthy Lifestyle,Sedentary Behavior,,,,,,Behavioral: CBPA + family support|Behavioral: CBPA,Children's Mercy Hospital Kansas City,All,"Child, Adult, Older Adult",515.0,Other,Interventional,2020-05-10,20/12/20,2021-03-30,19/12/20,27/01/21,"Children's Mercy, Kansas City, Missouri",United States,Others,0,2,324.0
5391.0,NCT04367922,Positive Affect Regulation sKills at Northwestern University,PARK-NU,Recruiting,Anxiety,Depression,Social Isolation,,,,,Behavioral: Positive Emotion Skills Course,Northwestern University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-04-27,31/12/21,2022-02-28,29/04/20,02/03/21,"Northwestern University, Chicago, Illinois",United States,Mental Health,1,3,672.0
5392.0,NCT04508114,Technology-assisted Index on Improving Hand Hygiene of Registered Nurses,,Recruiting,Hand Hygiene,,,,,,,Behavioral: Technology-assisted Index,National Taiwan University Hospital,All,"20 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-10-08,01/05/22,2022-01-05,11/08/20,09/09/20,"NTUH, Taipei, Taiwan, 10051",Taiwan,Others,0,1,454.0
5393.0,NCT04648111,Implementing Peri-operative Mobile Application for Contactless Vital Signs,MAC VITAL,Not yet recruiting,"Blood Pressure, Heart Rate, Breathing Rate, Heart Rate Variability (HRV: Stress), and Oxygen Level",,,,,,,Diagnostic Test: Vital sign measurement,"University Health Network, Toronto",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-12-15,15/12/23,2024-12-15,01/12/20,01/12/20,"399 Bathurst St.,Toronto Western Hopsital, Preadmission Clinic, Dept. of Anesthesia, Toronto, Ontario",Canada,Mental Health,1,1,1461.0
5394.0,NCT04775524,AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers,,Not yet recruiting,Stress,Post Traumatic Stress Disorder,Work Related Stress,,,,,Behavioral: Storytelling Through Music (STM)|Behavioral: Wait List / Storytelling Through Music-Hybrid,Dana-Farber Cancer Institute|Michele & David Mittelman Family Foundation,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-08,31/08/21,2022-05-31,01/03/21,01/03/21,"Dana-Farber Cancer Institute, Boston, Massachusetts",United States,Mental Health,1,3,508.0
5395.0,NCT04671602,Learning to Evaluate Blood Pressure at Home (LEANBH),LEANBH,Recruiting,Hypertension in Pregnancy,,,,,,,,University College Cork|Science Foundation Ireland,Female,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-08-19,28/02/21,2021-08-31,17/12/20,17/12/20,"Cork University Maternity Hospital, Cork",Ireland,Cardiovascular Diseases,1,1,377.0
5396.0,NCT04618926,A Comparison of Fiberoptic Endotracheal Intubation Between the Intubating Laryngeal Tube Suction and the LMA Protector,,Not yet recruiting,Difficult Airway,,,,,,,Device: Device intubating Laryngeal Tube Suction Disposable,Bnai Zion Medical Center,All,"18 Years to 75 Years   (Adult, Older Adult)",80.0,Other,Observational,2021-01-04,01/10/21,2021-12-31,06/11/20,09/02/21,,,Others,0,1,361.0
5397.0,NCT04558905,Impact of a Hybrid Medical Care Model in the Rheumatoid Arthritis Patient-reported-outcomes Measures: A Non-inferiority Study,,Enrolling by invitation,Rheumatoid Arthritis,Telehealth,,,,,,Other: Face-to-face medical visits|Other: Alternating face-to-face medical visits and video medical consultations,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran",All,"18 Years and older   (Adult, Older Adult)",156.0,Other,Interventional,2020-01-10,31/05/22,2022-05-31,22/09/20,26/02/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Tlalpan",Mexico,Immunological Disorders,1,2,872.0
5398.0,NCT04349332,Early Extubation for Patients With Acute Hypoxemic Respiratory Failure,,Recruiting,Mechanical Ventilation,Corona Virus Infection,,,,,,Device: Helmet non-invasive ventilation (NIV),University of Chicago,All,"18 Years and older   (Adult, Older Adult)",108.0,Other,Interventional,2020-08-13,01/04/21,2021-01-06,16/04/20,04/11/20,"University of Chicago Medical Center, Chicago, Illinois",United States,Respiratory Diseases,1,2,146.0
5399.0,NCT02656381,Uveitis/Intraocular Inflammatory Disease Biobank (iBank),,Recruiting,Uveitis,,,,,,,,National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC),All,"8 Years and older   (Child, Adult, Older Adult)",650.0,NIH,Observational,2016-07-26,31/12/29,2029-12-31,14/01/16,14/12/20,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland",United States,Others,0,1,4906.0
5400.0,NCT04714164,Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth,,Not yet recruiting,Major Depressive Disorder,Generalized Anxiety Disorder,Social Anxiety Disorder,Panic Disorder,,,,Behavioral: Group Cognitive Behavioral Therapy,Nova Scotia Health Authority,All,65 Years and older   (Older Adult),20.0,Other,Interventional,2021-01-02,01/04/21,2021-01-12,19/01/21,19/01/21,,,Mental Health,1,4,10.0
5401.0,NCT04715906,Project COPE (Coping Options for Parent Empowerment),,Recruiting,Anxiety Disorders,Depression,,,,,,Behavioral: UP-Caregiver,University of Miami|The Children's Trust,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2021-02-22,31/12/21,2021-12-31,20/01/21,04/03/21,"University of Miami, Miami, Florida",United States,Mental Health,1,2,312.0
5402.0,NCT04402801,Patient Outcomes of Clinic Transition From Face to Face Encounter to Telemedicine in Cystic Fibrosis,,Enrolling by invitation,Cystic Fibrosis,,,,,,,,University of Virginia,All,"18 Years to 90 Years   (Adult, Older Adult)",140.0,Other,Observational,2020-01-06,31/05/21,2021-05-31,27/05/20,11/06/20,"University of Virginia Health System, Charlottesville, Virginia",United States,Others,0,1,511.0
5403.0,NCT00571389,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,,Recruiting,"Solid Tumor, Adult",Healthy Donors,COVID-19,,,,,,"BioCytics, Inc.",All,"18 Years and older   (Adult, Older Adult)",1000.0,Industry,Observational,2007-01-11,01/02/25,2025-01-02,12/12/07,10/09/20,"Carolina BioOncology Institute, Huntersville, North Carolina",United States,Respiratory Diseases,1,3,6566.0
5404.0,NCT04818047,Adaptation and Pilot Testing of Web and Mobile Interface for the VID-KIDS Intervention,VID-KIDS,Recruiting,Post Partum Depression,,,,,,,Behavioral: VID-KIDS Intervention Program,University of Calgary|Alberta Health Services,Female,"16 Years to 49 Years   (Child, Adult)",100.0,Other,Interventional,2021-03-15,31/08/21,2021-08-31,26/03/21,01/04/21,"University of Calgary, Calgary, Alberta, Canada|Maternal Newborn Child and Youth Strategic Clinical Network, Calgary, Alberta",Canada,Mental Health,1,1,169.0
5405.0,NCT04790136,Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration,,"Active, not recruiting",Comparative Bioavailability,,,,,,,"Drug: GLA-015|Drug: DAC C-052 ""Cannabidiol"" / NRF 22.10 ""Oily cannabidiol solution 100 mg/ml""",SocraTec R&D GmbH|Glatt Pharmaceutical Services GmbH & Co. KG|SocraMetrics GmbH,All,"18 Years and older   (Adult, Older Adult)",18.0,Other|Industry,Interventional,2021-03-17,16/04/21,2021-04-29,10/03/21,08/04/21,"SocraTec R&D GmbH Clinical Pharmacology Unit, Erfurt, Thuringia",Germany,Others,0,1,43.0
5406.0,NCT04628130,Efficacy of Yoga Based Self-Management Program for Chronic Pain,,Completed,Chronic Pain,,,,,,,Other: Yoga Therapy,Aarogyam UK|Patanjali Yog Peeth (UK) Trust,All,"18 Years and older   (Adult, Older Adult)",42.0,Other,Observational,2020-09-17,05/11/20,2020-09-11,13/11/20,13/11/20,"Aarogyam UK, Leicester, Leicestershire, United Kingdom|Patanjali Yog Peeth (UK) Trust, Glasgow, Scotland",United Kingdom,Others,0,1,-6.0
5407.0,NCT04744805,Mask-associated Dry Eye Symptoms in China,,Not yet recruiting,Dry Eye Syndromes,,,,,,,Other: face mask or not,Tianjin Eye Hospital,All,"6 Years to 80 Years   (Child, Adult, Older Adult)",6262.0,Other,Observational,2021-01-29,05/02/21,2021-06-02,09/02/21,09/02/21,,,Others,0,1,124.0
5408.0,NCT04330352,"Mindfulness-based ""STOP (Stop, Take a Breath, Observe, Proceed) Touching Your Face"" Intervention",,Completed,Face-touching Behavior,,,,,,,"Behavioral: Mindfulness-based ""STOP touching your face"" practice",Sir Run Run Shaw Hospital,All,"18 Years and older   (Adult, Older Adult)",1094.0,Other,Interventional,2020-02-04,02/07/20,2020-02-07,01/04/20,30/09/20,"Yanhui Liao, Hangzhou, Zhejiang",China,Others,0,1,3.0
5409.0,NCT04114864,A Primary Prevention Intervention for the Promotion of Psycho-social Wellbeing in Adolescent Young Carers:,ME-WE,Recruiting,Adolescent - Emotional Problem,Mental Health Wellness 1,Caregivers,Primary Prevention,Cognitive Therapy,,,Behavioral: Psycho-educational sessions,"Valentina Hlebec|LINNEUNIVERSITETET (LNU), Sweden (leading the consortium)|EUROCARERS-ASSOCIATION EUROPEENNE TRAVAILLANT AVEC ET POUR LES|THE UNIVERSITY OF SUSSEX (UoS), UK|CARERS TRUST (Carers Trust), UK|STIFTUNG KALAIDOS FACHHOCHSCHULE (Kalaidos FH), SW|MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT (NLNA), NL|STICHTING VILANS (VILANS), NL|ISTITUTO NAZIONALE DI RIPOSO E CURA PER ANZIANI INRCA (INRCA), IT|ANZIANI E NON SOLO SOCIETA COOPERATIVA SOCIALE (ANZIANI E), IT|UNIVERZA V LJUBLJANI (UL), SI|Nationellt kompetenscentrum anhöriga (Nka), (Swedish Family Care Competence Centre), Kalmar, Sweden|University of Ljubljana",All,15 Years to 17 Years   (Child),600.0,Other,Interventional,2019-10-20,20/02/21,2021-05-31,03/10/19,23/02/21,"Anziani e non solo soc. coop. soc, Carpi, Italy|Stichting Vilans, Utrecht, Netherlands|University of Ljubljana, Ljubljana, Slovenia|Linnaeus University, Nationellt kompetenscentrum anhöriga (Nka), (Swedish Family Care Competence Centre), Kalmar, Sweden|Stiftung Kalaidos Fachhochschule (Kalaidos FH), Zürich, Switzerland|Carers Trust, Print Rooms, 164-180 Union Street, London, SE1 0LN. Carers Trust will be co-ordinating the completion of the interventions for the clinical trials in the UK. All trials for the ME-WE project will be completed in England., London",United Kingdom,Others,0,5,589.0
5410.0,NCT04424953,To Compare Videolaryngoscope Against Direct Laryngoscope for Intubation When Powered Air Purifying Respirator is Worn,,Completed,Coronavirus Infection,Ventilatory Failure,Anesthesia Intubation Complication,,,,,Device: McGrath videolaryngoscope|Device: Direct laryngoscope,Singapore General Hospital|Duke-NUS Graduate Medical School,All,"21 Years to 99 Years   (Adult, Older Adult)",28.0,Other,Interventional,2020-01-06,25/09/20,2020-09-25,11/06/20,17/03/21,"Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,3,263.0
5411.0,NCT03826797,Correlation Between Trans Esophageal Pressure and Non-invasive Mechanical Ventilation Failure in Patients With Acute Hypoxic Respiratory Failure,TEMPO,Recruiting,Acute Respiratory Failure,,,,,,,,University of Modena and Reggio Emilia,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Observational,2016-10-16,28/02/21,2022-12-31,01/02/19,29/03/21,"University Hospital of Modena Policlinico, Modena",Italy,Respiratory Diseases,1,1,2267.0
5412.0,NCT04518878,Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER),,Recruiting,Immune Thrombocytopenia,,,,,,,Drug: Eltrombopag|Drug: rhTPO,Peking University People's Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-08-31,01/12/21,2022-01-06,19/08/20,01/09/20,"Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing",China,Others,0,1,493.0
5413.0,NCT03209713,Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination,Edtech-HPV,Recruiting,Parents,,,,,,,Behavioral: HPV Vaccine Education|Behavioral: Text Messaging Reminder,Memorial Sloan Kettering Cancer Center,All,"21 Years to 84 Years   (Adult, Older Adult)",800.0,Other,Interventional,2017-06-28,01/06/23,2023-01-06,06/07/17,05/04/21,"Alivio Medical Center, Chicago, Illinois, United States|Research, Education and Access to Community Health (REACH), Las Vegas, Nevada, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|The University of Texas at El Paso, El Paso, Texas",United States,Others,0,1,2018.0
5414.0,NCT04489407,Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.,,Not yet recruiting,Coronavirus,Cardiac Disease,Respiratory Disease,Vascular Diseases,,,,Device: Remote Photoplethysmography (rPPG) vital sign acquisition,Lady Davis Institute|Carebook Technologies Inc.,All,"18 Years and older   (Adult, Older Adult)",350.0,Other,Interventional,2020-01-08,30/10/20,2020-11-30,28/07/20,28/07/20,,,Respiratory Diseases,1,4,327.0
5415.0,NCT04418934,Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells,,Withdrawn,Whole Blood Donations and Leukoreduction,,,,,,,Device: Hemanext One,Hemanext,All,"18 Years and older   (Adult, Older Adult)",0.0,Industry,Interventional,2020-01-07,01/05/21,2021-01-05,05/06/20,03/08/20,"Hoxworth Blood Center, University of Cincinnati, Cincinnati, Ohio, United States|American Red Cross Mid-Atlantic Research Facility, Norfolk, Virginia",United States,Others,0,1,364.0
5416.0,NCT04772820,Feasibility of Remote Home Support Coaches (SOCIAL Study),,Not yet recruiting,Malnutrition,Isolation,Depression,Anxiety,Sedentary Behavior,Loneliness,,Behavioral: Telephone-based coaching,"Brigham and Women's Hospital|University of Maryland, Baltimore|National Institute on Aging (NIA)",All,75 Years and older   (Older Adult),60.0,Other|NIH,Interventional,2021-01-04,01/12/21,2022-06-30,26/02/21,24/03/21,"University of Maryland School of Medicine, Baltimore, Maryland, United States|Brigham and Women's Hospital, Boston, Massachusetts",United States,Mental Health,1,6,542.0
5417.0,NCT04616586,SILtuximab in Viral ARds (SILVAR) Study,SILVAR,Suspended,Acute Respiratory Distress Syndrome,Lung Diseases,Pneumonia,Respiratory Tract Infections,Respiratory Tract Disease,,,Drug: Siltuximab|Other: Normal Saline,EusaPharma (UK) Limited|Syneos Health,All,"12 Years to 65 Years   (Child, Adult, Older Adult)",555.0,Industry|Other,Interventional,2020-11-13,18/12/21,2022-06-30,05/11/20,01/03/21,"Sparrow Clinical Research Institute, Lansing, Michigan, United States|Atrium Health, Charlotte, North Carolina",United States,Respiratory Diseases,1,5,594.0
5418.0,NCT04546854,Influenza 2020/2021,,Completed,Influenza Vaccine,,,,,,,Behavioral: Appeals,University of Warwick,All,"50 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-21,21/09/20,2020-09-21,14/09/20,25/09/20,"University of Warwick, Coventry",United Kingdom,Infectious Diseases,0,1,0.0
5419.0,NCT04225845,The Economic Consequences of Loneliness Among the Elderly,,Recruiting,Loneliness,,,,,,,Behavioral: Phone therapy|Behavioral: Cash transfer,"National Bureau of Economic Research, Inc.|National Institute on Aging (NIA)|Abdul Latif Jameel Poverty Action Lab",All,"55 Years and older   (Adult, Older Adult)",1250.0,Other|NIH,Interventional,2020-01-11,01/12/27,2027-01-12,13/01/20,08/04/21,"JPAL SA at IFMR, Chennai, Tamil Nadu",India,Others,0,1,2558.0
5420.0,NCT04445194,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,,"Active, not recruiting",Coronavirus,,,,,,,Biological: Recombinant new coronavirus vaccine (CHO cell) low-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) high-dose group|Biological: Recombinant new coronavirus vaccine (CHO cells) placebo group,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.|The Second Affiliated Hospital of Chongqing Medical University|Beijing Chao Yang Hospital",All,18 Years to 59 Years   (Adult),50.0,Industry|Other,Interventional,2020-06-22,22/10/20,2021-09-20,24/06/20,03/12/20,"The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing",China,Respiratory Diseases,1,1,455.0
5421.0,NCT03964142,Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity,ONCORE,Recruiting,Cardiotoxicity,Cardiac Rehabilitation,,,,,,Other: Cardiac rehabilitation,Hospital Clinico Universitario de Santiago|Instituto de Salud Carlos III,Female,"18 Years to 69 Years   (Adult, Older Adult)",340.0,Other,Interventional,2018-01-08,01/03/21,2022-01-03,28/05/19,06/11/20,"Hospital Clínico Universitario de Santiago, Santiago de Compostela, A Coruña, Spain|Hospital Universitari Vall d'Hebron, Barcelona",Spain,Others,0,2,1456.0
5422.0,NCT04473456,Combined Simultaneous EGD-colonoscopy Trial (CoSi Endoscopy),,Completed,Procedure Time,,,,,,,Procedure: Simultaneous EGD and colonoscopy,EmuraCenter LatinoAmerica|Universidad de la Sabana,All,"18 Years to 80 Years   (Adult, Older Adult)",51.0,Other,Interventional,2020-06-13,22/09/20,2020-09-23,16/07/20,08/12/20,"EmuraCenter LatinoAmerica, Bogota, Cundinamarca",Colombia,Others,0,1,102.0
5423.0,NCT04440150,Preoperative Immature Granulocyte Count and Percentage for Acute Appendisitis,,Completed,Acute Appendicitis,,,,,,,Procedure: Appendectomy,Kahramanmaras Sutcu Imam University,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2018-01-06,01/06/19,2019-01-06,19/06/20,30/06/20,"Kahramanmaraş Sütçü İmam University, Kahramanmaraş",Turkey,Others,0,1,365.0
5424.0,NCT04708509,Extubation Advisor: Initial Implementation and Evaluation of a Novel Extubation Clinical Decision Support Tool,,Not yet recruiting,Airway Extubation,,,,,,,Device: Extubation Advisor,Ottawa Hospital Research Institute,All,"18 Years and older   (Adult, Older Adult)",72.0,Other,Interventional,2021-01-03,01/05/21,2021-01-06,14/01/21,15/01/21,"The Ottawa Hospital, General Campus, Ottawa, Ontario",Canada,Others,0,1,3.0
5425.0,NCT04430387,Dental Isolation Methods in Pediatric Patients,,Not yet recruiting,Dental Plaque,"Calculus, Dental",Aerosol Disease,,,,,Device: The saliva ejector|Device: The high-volume evacuator|Device: The DryShield,"The University of Texas Health Science Center, Houston",All,4 Years to 15 Years   (Child),180.0,Other,Interventional,2021-01-11,01/11/22,2022-01-11,12/06/20,10/11/20,"The University of Texas Health Science Center at Houston, Houston, Texas",United States,Others,0,3,365.0
5426.0,NCT04690829,Biomarkers in Ocular Inflammation and Uveitis,,Enrolling by invitation,Uveitis,Ocular Inflammation,,,,,,,National Eye Institute (NEI)|National Institutes of Health Clinical Center (CC),All,"4 Years and older   (Child, Adult, Older Adult)",1000.0,NIH,Observational,2021-04-19,31/12/25,2025-12-31,31/12/20,14/04/21,"National Eye Institute (NEI), Bethesda, Maryland",United States,Others,0,2,1717.0
5427.0,NCT04562948,Community Applications of the MindShift App,,"Active, not recruiting",Anxiety,Depression,Anxiety Generalized,Anxiety Disorders and Symptoms,,,,,University of Windsor|Anxiety Canada,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Observational,2020-11-11,31/08/22,2022-10-31,24/09/20,14/04/21,"University of Windsor, Windsor, Ontario",Canada,Mental Health,1,4,719.0
5428.0,NCT04153864,Scaling Up Maternal Mental Health Care by Increasing Access to Treatment (SUMMIT),SUMMIT,Recruiting,Perinatal Depression,,,,,,,Behavioral: Brief Behavioral Activation Treatment,"Mount Sinai Hospital, Canada|University of North Carolina, Chapel Hill|NorthShore University HealthSystem|Women's College Hospital|Unity Health Toronto|Sunnybrook Health Sciences Centre|University of Colorado, Boulder|Harvard Medical School|Patient-Centered Outcomes Research Institute",Female,"18 Years and older   (Adult, Older Adult)",1368.0,Other,Interventional,2020-06-01,30/06/24,2025-12-30,06/11/19,28/10/20,"NorthShore University Health System, Evanston, Illinois, United States|University of North Carolina, Chapel Hill, North Carolina, United States|St. Michael's Hospital, Toronto, Ontario, Canada|Sinai Health System, Toronto, Ontario, Canada|Women's College Hospital, Toronto, Ontario",Canada,Mental Health,1,1,2038.0
5429.0,NCT04299711,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,,Not yet recruiting,Mental Disorder,,,,,,,Other: Exposed to the novel coronavirus disease 2019,University of Macau,All,"10 Years to 19 Years   (Child, Adult)",3428.0,Other,Observational,2020-10-15,15/11/20,2022-03-15,09/03/20,09/03/20,,,Others,0,1,516.0
5430.0,NCT03807804,Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome,ONE-BRIDGE,"Active, not recruiting","Respiratory Distress Syndrome, Adult",,,,,,,Biological: HLCM051,Healios K.K.,All,"20 Years to 90 Years   (Adult, Older Adult)",35.0,Industry,Interventional,2019-01-01,30/09/21,2021-09-30,17/01/19,08/04/21,"Investigational Site Number 027, Nagoya, Aichi, Japan|Investigational Site Number 028, Nagoya, Aichi, Japan|Investigational Site Number 005, Seto, Aichi, Japan|Investigational Site Number 020, Toyoake, Aichi, Japan|Investigational Site Number 003, Hirosaki, Aomori, Japan|Investigational Site Number 007, Iizuka, Fukuoka, Japan|Investigational Site Number 019, Ōgaki, Gifu, Japan|Investigational Site Number 011, Sapporo, Hokkaido, Japan|Investigational Site Number 010, Kobe, Hyogo, Japan|Investigational Site Number 013, Kobe, Hyogo, Japan|Investigational Site Number 017, Takarazuka, Hyogo, Japan|Investigational Site Number 025, Yokohama, Kanagawa, Japan|Investigational Site Number 029, Yokohama, Kanagawa, Japan|Investigational Site Number 018, Kashihara, Nara, Japan|Investigational Site Number 026, Suita, Osaka, Japan|Investigational Site Number 022, Ōtsu, Shiga, Japan|Investigational Site Number 014, Izumo, Shimane, Japan|Investigational Site Number 024, Bunkyō-Ku, Tokyo, Japan|Investigational Site Number 021, Chuo Ku, Tokyo, Japan|Investigational Site Number 009, Itabashi-ku, Tokyo, Japan|Investigational Site Number 006, Minato-Ku, Tokyo, Japan|Investigational Site Number 004, Shinagawa-Ku, Tokyo, Japan|Investigational Site Number 008, Shinjuku-Ku, Tokyo, Japan|Investigational Site Number 023, Shinjuku-Ku, Tokyo, Japan|Investigational Site Number 012, Hiroshima, Japan|Investigational Site Number 001, Kumamoto, Japan|Investigational Site Number 002, Kyoto, Japan|Investigational Site Number 015, Nagasaki, Japan|Investigational Site Number 016, Saga",Japan,Others,0,1,1003.0
5431.0,NCT04437966,Chronic Disease Self-management Program for Hypertension Control in Churches,CHIC,Recruiting,Hypertension,,,,,,,Behavioral: Enhanced Chronic Disease Self-management program,The University of The West Indies|Harvard School of Public Health,All,"35 Years to 70 Years   (Adult, Older Adult)",384.0,Other,Interventional,2020-11-10,01/10/21,2021-01-12,18/06/20,04/11/20,"George Alleyne Chronic Disease Research Centre, Bridgetown",Barbados,Cardiovascular Diseases,1,1,63.0
5432.0,NCT04457765,Betadine Effect on Nasal Mucosa Cilia,,Withdrawn,Rhinoplasty,,,,,,,Drug: Povidone-Iodine (PVP-I),Boston Medical Center,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Interventional,2021-01-04,01/09/22,2022-01-09,07/07/20,12/02/21,"Boston Medical Center, Boston, Massachusetts",United States,Others,0,1,370.0
5433.0,NCT04437134,On-line Neuromuscular Exercise and Education for Knee Osteoarthritis,,Recruiting,Knee Osteoarthritis,,,,,,,Other: On-line exercise and education|Other: On-site exercise and education,Slagelse Hospital|Region Zealand,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-12-06,01/06/21,2021-01-12,18/06/20,18/06/20,"University of Southern Denmark, Odense, Region Southern Denmark, Denmark|Department of Orthopedic Surgery, Næstved-Slagelse-Ringsted Hospitals, Næstved, Region Zealand, Denmark|Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Næstved, Region Zealand, Denmark|Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Slagelse, Region Zealand",Denmark,Others,0,1,37.0
5434.0,NCT04385862,The Use of a Continuous Glucose Monitoring System (Dexcom G6) in Hospitalized Patients for Acute Care,,Not yet recruiting,Continuous Glucose Monitoring,,,,,,,,Centre hospitalier de l'Université de Montréal (CHUM),All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2020-07-27,31/12/20,2021-11-01,13/05/20,21/07/20,"Centre Hospitalier de l'Université de Montréal, Montreal",Canada,Others,0,1,462.0
5435.0,NCT04673513,Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills,,Recruiting,Depression,,,,,,,Other: Psychotherapy,Ohio State University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-11-12,30/07/23,2023-12-30,17/12/20,17/12/20,"Department of Psychology, The Ohio State University, Columbus, Ohio",United States,Mental Health,1,1,1143.0
5436.0,NCT04656288,A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the Blood,,Completed,Healthy,,,,,,,Drug: BI 764198 - Formula A|Drug: BI 764198 - Formula B|Drug: BI 764198 - Formula C|Drug: BI 764198 - Formula D,Boehringer Ingelheim,Male,18 Years to 50 Years   (Adult),28.0,Industry,Interventional,2021-01-15,15/03/21,2021-03-15,07/12/20,22/03/21,"SGS Belgium NV Research Unit Stuivenberg, Antwerpen",Belgium,Others,0,1,59.0
5437.0,NCT04739540,Food Insecurity Screening and Intervention: From Hospital to Home,,Not yet recruiting,Food Insecurity,,,,,,,,Baylor College of Medicine,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-03-30,01/09/21,2021-01-09,04/02/21,18/03/21,"Texas Children's Hospital, Houston, Texas",United States,Others,0,1,-80.0
5438.0,NCT04526925,The Effects of Filter During CPET on WOB and Aerosol Particle Concentrations,,Completed,"Transmission, Patient-Professional",,,,,,,Device: Respiratory filter in-line placed with the standard mouthpiece|Other: Standard mouthpiece,Rush University Medical Center|Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center,All,"18 Years to 65 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-08-29,18/09/20,2020-09-18,26/08/20,05/11/20,"Rush University Medical Center, Chicago, Illinois",United States,Others,0,1,20.0
5439.0,NCT03029507,An ACT-enhanced Weight Management and Fitness Program for Navy Personnel,,Recruiting,Obesity,Overweight,,,,,,Behavioral: ACT Enhanced ShipShape|Behavioral: Standard ShipShape (SS),"Veterans Medical Research Foundation|San Diego Veterans Healthcare System|United States Naval Medical Center, San Diego",All,"18 Years to 69 Years   (Adult, Older Adult)",164.0,Other|U.S. Fed,Interventional,2017-08-12,01/07/22,2022-01-07,24/01/17,28/12/20,"Naval Medical Center San Diego, San Diego, California, United States|Veterans Medical Research Foundation, San Diego, California",United States,Metabolic Disorders,1,2,1609.0
5440.0,NCT04654585,"Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial",STOP,Recruiting,Smoking,Smoking Cessation,,,,,,Other: The STOP intervention|Other: Standard Care,"Société de Formation Thérapeutique du Généraliste Recherche|National Cancer Institute, France|Institut National de la Santé Et de la Recherche Médicale, France|Société de Formation Thérapeutique du Généraliste",All,"18 Years and older   (Adult, Older Adult)",528.0,Other,Interventional,2021-02-26,01/02/23,2024-01-02,04/12/20,26/03/21,"Centre municipal et universitaire de santé Marcel Trigon, Arcueil, France|Centre d'addictologie et d'alcoologie Guillaume Broutet, Avignon, France|Laura Piras (medical practice), Castelnau-d'Estrétefonds, France|Hôpital Antoine Beclere, Clamart, France|Hôpital Henri Mondor, Créteil, France|Centre Municipal de Santé Savattero, Montreuil, France|Mathilde Roze (medical practice), Paris, France|Ghislaine Hacke Mela (medical practice), Paris, France|Centre Hospitalier Sainte Anne, Paris, France|Hôpital européen Georges-Pompidou, Paris, France|Hôpital Tenon, Paris, France|Anne Kerharo-Nicolas (medical practice), Saint-Rogatien, France|Carole Plaussu (medical practice), Suresnes, France|Kinouani Shérazade (medical practice), Targon, France|Centre de Santé Pierre-Rouquès, Villejuif",France,Others,0,2,1040.0
5441.0,NCT04278404,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",POPS or POP02,Recruiting,COVID-19,Pulmonary Arterial Hypertension,Urinary Tract Infections in Children,Hypertension,Pain,Hyperphosphatemia,Primary Hyperaldosteronism,"Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:","Duke University|The Emmes Company, LLC|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",All,"up to 20 Years   (Child, Adult)",5000.0,Other|Industry|NIH,Observational,2020-05-03,24/04/24,2024-04-24,20/02/20,14/10/20,"Phoenix Children's Hospital, Phoenix, Arizona, United States|Arkansas Children's Hospital Research Institute, Little Rock, Arkansas, United States|University of California, Los Angeles, California, United States|Colorado University Denver, Aurora, Colorado, United States|Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States|University of Florida Jacksonville Shands Medical Center, Jacksonville, Florida, United States|Kapiolani Womens and Childrens Medical Center, Honolulu, Hawaii, United States|Ann and Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States|Riley Hospital for Children at Indiana University, Indianapolis, Indiana, United States|University of Iowa Stead Family Children's Hospital, Iowa City, Iowa, United States|University of Kansas Medical Center, Kansas City, Kansas, United States|Wesley Medical Center, Wichita, Kansas, United States|University of Louisville Norton Childrens Hospital, Louisville, Kentucky, United States|Tulane University Health Science Center, New Orleans, Louisiana, United States|Ochsner Baptist Clinical Trials Unit, New Orleans, Louisiana, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Massachusetts General Hospital, Lexington, Massachusetts, United States|University of Minnesota, Minneapolis, Minnesota, United States|University of Mississippi Medical Center, Jackson, Mississippi, United States|Mississippi Center for Advanced Medicine, Madison, Mississippi, United States|Children's Mercy Hospital, Kansas City, Missouri, United States|Childrens Mercy Hospital, Kansas City, Missouri, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|University of New Mexico Health Science Center, Albuquerque, New Mexico, United States|Kravis Children's Hospital at Mt. Sinai, New York, New York, United States|University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States|Duke University Health System, Durham, North Carolina, United States|East Carolina University, Greenville, North Carolina, United States|New Hanover Regional Medical Center, Wilmington, North Carolina, United States|Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States|Board of Regents of the University of Oklahoma, Oklahoma City, Oklahoma, United States|Oregon Health and Science University, Portland, Oregon, United States|Pennsylvania State University--Hershey Children's Hospital, Hershey, Pennsylvania, United States|Rhode Island Hospital, Providence, Rhode Island, United States|Medical University of South Carolina Children's Hospital, Charleston, South Carolina, United States|University of South Carolina, Columbia, South Carolina, United States|Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee, United States|Dell Children's Medical Center of Central Texas, Austin, Texas, United States|University of Texas-Southwestern Medical Center, Dallas, Texas, United States|University of Texas--Memorial Hermann Texas Medical Center, Houston, Texas, United States|Seattle Children's Hospital, Seattle, Washington, United States|University of Wisconsin, Madison, Wisconsin, United States|University of Wisconsin, Madison, Wisconsin, United States|University Wisconsin, Madison, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario, Canada|CHU Sainte-Justine, Montréal, Quebec",Canada,"Cardiovascular Diseases, Respiratory Diseases",1,7,1452.0
5442.0,NCT04655001,Revisiting A Mobile Intervention to Reduce Pain and Improve Health,MORPH-II,Recruiting,Pain,Obesity,Sedentary Behavior,,,,,Behavioral: MORPH,Wake Forest University,All,"55 Years to 85 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-01,01/06/22,2022-01-10,04/12/20,17/02/21,"Wake Forest University, Winston-Salem, North Carolina",United States,Metabolic Disorders,1,3,374.0
5443.0,NCT04450303,Social Anxiety Telehealth Therapy Study,,"Active, not recruiting",Social Anxiety,,,,,,,Behavioral: Telehealth CBT,Stanford University,All,"18 Years and older   (Adult, Older Adult)",26.0,Other,Interventional,2020-10-30,01/06/21,2021-01-06,29/06/20,17/03/21,"Stanford University, Stanford, California",United States,Mental Health,1,1,68.0
5444.0,NCT04745364,Mindful Kala: Virtual Bharatanatyam Wellness Program for Students,,"Active, not recruiting",Quality of Life,Cultural Competence,Stress,,,,,Behavioral: A 4-week Bharatanatyam course from the organization Mindful Kala,Yale University,All,"18 Years and older   (Adult, Older Adult)",53.0,Other,Interventional,2021-04-02,12/04/21,2021-12-04,09/02/21,12/03/21,"Good Life Center, Yale University, New Haven, Connecticut",United States,Mental Health,1,3,246.0
5445.0,NCT02899754,Lung Cancer Screening Decisions,VA-LCSDecTool,Recruiting,Lung Cancer Screening,,,,,,,Behavioral: Lung Cancer Screening Decision Tool|Behavioral: Control Intervention,VA Office of Research and Development,All,"55 Years to 80 Years   (Adult, Older Adult)",200.0,U.S. Fed,Interventional,2019-01-28,30/11/21,2021-11-30,14/09/16,21/02/21,"VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut, United States|Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States|Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee, Wisconsin",United States,Cancers,1,1,1037.0
5446.0,NCT04576260,"Effect of CBT Intervention to Improve Sleep on Wellbeing, Dietary Intake and Food Preference",,Recruiting,Sleep,Diet,Well Being,,,,,Behavioral: Cognitive Behavioural Therapy for Insomnia,University of Glasgow,All,"25 Years to 65 Years   (Adult, Older Adult)",40.0,Other,Interventional,2020-10-16,01/06/21,2021-01-06,06/10/20,03/11/20,"University of Glasgow, Glasgow, United Kingdom|University of Glasgow, Glasgow",United Kingdom,Others,0,3,82.0
5447.0,NCT04521920,Providing Suboxone and PrEP Using Telemedicine,,Recruiting,Opioid Use,Opioid-use Disorder,Risk Reduction,Hiv,,,,Drug: Suboxone|Drug: PrEP,Duke University,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-09-11,01/05/21,2021-01-05,21/08/20,13/11/20,"Queen City Needle Exchnge, Charlotte, North Carolina, United States|Duke Department of Population Health Sciences, Durham, North Carolina, United States|North Carolina Harm Reduction Coalition, Wilmington, North Carolina",United States,Others,0,4,116.0
5448.0,NCT04563494,"The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain",,Not yet recruiting,"Nausea and Vomiting, Postoperative",,,,,,,Drug: dexamethasone,"University of Colorado, Denver",All,3 Years to 7 Years   (Child),126.0,Other,Interventional,2021-01-10,01/01/22,2022-01-01,24/09/20,09/02/21,,,Others,0,1,356.0
5449.0,NCT04741217,Aerosolisation During Respiratory Procedures,,Not yet recruiting,Healthy,Respiratory Tract Infections,Lung Infection,Droplet Spread,,,,Other: Not an interventional study,Guy's and St Thomas' NHS Foundation Trust,All,"18 Years to 80 Years   (Adult, Older Adult)",10.0,Other,Observational,2021-01-03,01/09/21,2021-01-09,05/02/21,15/02/21,,,Others,0,4,6.0
5450.0,NCT04511390,Transparent Elastomeric Respirator for Aerosol-based Protection,,Recruiting,Personal Protective Equipment,,,,,,,"Device: Transparent, reusable respirator",Brigham and Women's Hospital|Massachusetts General Hospital|Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-07-25,01/12/20,2020-01-12,13/08/20,13/08/20,"Massachusetts General Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States|Memorial Sloan Kettering Cancer Center, New York, New York",United States,Others,0,1,-195.0
5451.0,NCT02517489,Community-Acquired Pneumonia : Evaluation of Corticosteroids,CAPE_COD,Recruiting,Community Acquired Pneumonia,,,,,,,Drug: Hydrocortisone|Drug: Placebo,"University Hospital, Tours",All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Interventional,2015-10-28,01/01/21,2021-01-03,07/08/15,15/04/20,"Service de Réanimation - Unité de Soins Continus, CH d'Angoulême, 'Angoulême, France|Service de Réanimation Polyvalente, CH d'Argenteuil, Argenteuil, France|Service de Réanimation, CHR Metz-Thionville, Ars-Laquenexy, France|Service de Réanimation, Aulnay-sous-Bois, France|Service de Réanimation, Belfort, France|Service de Réanimation, Bourg-en-Bresse, France|Service de Réanimation HIA Clermont-Tonnerre, Brest, France|Service de Réanimation Médicale, CHU de Brest, Brest, France|Service de Réanimation, CHU Côte de Nacre, Caen, France|Service de Réanimation Médicale, Hôpital Louis Pasteur, Chartres, Chartres, France|Service de Réanimation Médicale Polyvalente, Hôpital G Montpied, Clermont Ferrand, France|Service de Réanimation, Hôpital Louis Mourier, Colombes, France|Service de Réanimation Médicale, CHU de Dijon, Dijon, France|Service de Réanimation Médico-Chirurgicale, Hôpital Raymond Poincarré, APHP, Garches, France|Service de Réanimation Médicale, CHU de Grenoble, Grenoble, France|Service de Réanimation Polyvalente, CHD La Roche sur Yon, La Roche sur Yon, France|Service de Réanimation, CH Le Mans, Le Mans, France|Service de Réanimation Polyvalente, Hôpital Salengro, CHU de Lille, Lille, France|Service de Réanimation Polyvalente, CHU de Limoges, Limoges, France|Service de Réanimation Médicale, Hôpital Nord, Marseille, France|Service de Réanimation Polyvalente - Surveillance Continue, CH de Montauban, Montauban, France|Service de Réanimation Médicale, CHU de Nancy, Nancy, France|Service de Réanimation Polyvalente, Hôpital Hôtel Dieu, CHU de Nantes, Nantes, France|Service de Réanimation Médicale, CHR d'Orléans, Orléans, France|Service de Réanimation Médicale, Hôpital Cochin, APHP, Paris, France|Service de Réanimation et USC médico-chirurgicale, Hôpital Tenon, APHP, Paris, France|Service de Réanimation Médicale et Médecine Interne, CHU de Poitiers, Poitiers, France|Service des Maladies Infectieuses et Réanimation Médicale, CHU de Rennes, Rennes, France|Service de Réanimation Polyvalente, CH de Saint Malo, Saint Malo, France|Service de Réanimation, Saint-Brieuc, France|Service de Réanimation Médicale, Nouvel Hôpital Civil, CHU de Strasbourg, Strasbourg, France|Service de Réanimation Médicale, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg",France,Respiratory Diseases,1,1,1894.0
5452.0,NCT04627493,Improving Physical Activity and Mobility Via Live Online Exercise Sessions for Older Adults,,Recruiting,Aging,,,,,,,Behavioral: Online exercise,McMaster University,All,65 Years to 80 Years   (Older Adult),32.0,Other,Interventional,2020-01-11,01/08/21,2021-01-08,13/11/20,13/11/20,"Ivor Wynne Centre, Hamilton, Ontario",Canada,Others,0,1,363.0
5453.0,NCT04496713,Pilot Study of Video and Telephone Primary Care Visits,,Recruiting,Telemedicine,,,,,,,Other: Internet-connected computer tablet,Johns Hopkins University,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2021-01-24,24/05/23,2023-08-24,03/08/20,10/02/21,"Johns Hopkins Outpatient Center, Baltimore, Maryland",United States,Others,0,1,942.0
5454.0,NCT04594785,"Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection",RIPI,Recruiting,Streptococcus Pneumonia,Streptococcus Pyogenes Infection,Neisseria Meningitides Meningitis,,,,,,"University Hospital, Montpellier",All,"up to 18 Years   (Child, Adult)",150.0,Other,Observational,2020-01-10,01/12/21,2021-12-30,20/10/20,28/10/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,720.0
5455.0,NCT03398135,A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis,,Enrolling by invitation,Ulcerative Colitis (UC),,,,,,,Drug: risankizumab|Drug: placebo for risankizumab,AbbVie,All,"16 Years to 80 Years   (Child, Adult, Older Adult)",942.0,Industry,Interventional,2018-08-28,15/12/23,2024-05-23,12/01/18,25/03/21,"Southern California Res. Ctr. /ID# 169659, Coronado, California, United States|Moore UC San Diego Cancer Center /ID# 160430, La Jolla, California, United States|United Medical Doctors /ID# 158574, Los Alamitos, California, United States|Gastrointestinal Biosciences /ID# 200934, Los Angeles, California, United States|Hoag Memorial Hosp Presbyterian /ID# 218347, Newport Beach, California, United States|UCSF Center for Colitis and Crohn's Disease /ID# 201209, San Francisco, California, United States|Kaiser Permanente - San Francisco /ID# 212087, San Francisco, California, United States|Cedars-Sinai Medical Center - West Hollywood /ID# 163848, West Hollywood, California, United States|Peak Gastroenterology Associat /ID# 165838, Colorado Springs, Colorado, United States|Rocky Mountain Pediatric Gastroenterology /ID# 207173, Lone Tree, Colorado, United States|Medical Research Ctr CT /ID# 160287, Hamden, Connecticut, United States|Yale Univ Digestive Diseases /ID# 213265, New Haven, Connecticut, United States|South Lake Pain Institute, Inc /ID# 162859, Clermont, Florida, United States|Ctr for Advanced Gastroenterol /ID# 202820, Maitland, Florida, United States|Coral Research Clinic /ID# 158608, Miami, Florida, United States|South Florida Research Ph I-IV /ID# 161844, Miami, Florida, United States|Gastroenterology Group Naples /ID# 165210, Naples, Florida, United States|Advanced Research Institute /ID# 161945, New Port Richey, Florida, United States|Advent Health /ID# 160393, Orlando, Florida, United States|Endoscopic Research, Inc. /ID# 206709, Orlando, Florida, United States|Omega Research Maitland, LLC /ID# 203105, Orlando, Florida, United States|Lenus Research & Medical Group /ID# 169727, Sweetwater, Florida, United States|Clinical Research Trials of Florida, Inc. /ID# 201794, Tampa, Florida, United States|AdventHealth Tampa /ID# 170482, Tampa, Florida, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 160513, Macon, Georgia, United States|The University of Chicago Medical Center /ID# 160511, Chicago, Illinois, United States|DM Clinical Research/Southwest /ID# 165009, Oak Lawn, Illinois, United States|Indiana University /ID# 167250, Indianapolis, Indiana, United States|Cotton-O'Neil Clinical Res Ctr /ID# 160367, Topeka, Kansas, United States|Robely Rex VA Medical Center /ID# 218647, Louisville, Kentucky, United States|Houma Digestive Health Special /ID# 158377, Houma, Louisiana, United States|Delricht Research /ID# 206817, New Orleans, Louisiana, United States|Nola Research Works, LLC /ID# 161356, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 201205, Shreveport, Louisiana, United States|Johns Hopkins University School of Medicine /ID# 211792, Baltimore, Maryland, United States|MGH Digestive Health Center /ID# 164257, Boston, Massachusetts, United States|University of Michigan Health Systems /ID# 159430, Ann Arbor, Michigan, United States|Center for Digestive Health /ID# 160300, Troy, Michigan, United States|Mayo Clinic /ID# 200455, Rochester, Minnesota, United States|Quality Clinical Research Inc. /ID# 167312, Omaha, Nebraska, United States|Manhattan Clinical Research, LLC /ID# 211803, New York, New York, United States|Weill Cornell Medicine /ID# 165884, New York, New York, United States|Columbia Univ Medical Center /ID# 161929, New York, New York, United States|Lenox Hill Hospital, Northwell /ID# 168469, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 171128, North Massapequa, New York, United States|Univ Rochester Med Ctr /ID# 161660, Rochester, New York, United States|Atrium Health Carolinas Medical Center /ID# 158543, Charlotte, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 169729, Fargo, North Dakota, United States|Cleveland Clinic Main Campus /ID# 209235, Cleveland, Ohio, United States|The Ohio State University /ID# 164713, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 167112, Columbus, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201778, Mentor, Ohio, United States|ProMedica Physicians Digestive Healthcare /ID# 215622, Sylvania, Ohio, United States|Digestive Disease Specialists /ID# 170777, Oklahoma City, Oklahoma, United States|Adult Gastroenterology Associates - Main /ID# 208873, Tulsa, Oklahoma, United States|University of Pennsylvania /ID# 166262, Philadelphia, Pennsylvania, United States|Gastroenterology Associates, P.A. /ID# 160457, Greenville, South Carolina, United States|Gastro One /ID# 160373, Germantown, Tennessee, United States|East Tennessee Research Instit /ID# 168744, Johnson City, Tennessee, United States|Vanderbilt Univ Med Ctr /ID# 160567, Nashville, Tennessee, United States|Inquest Clinical Research /ID# 165686, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209799, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209951, Cedar Park, Texas, United States|DHAT Research Institute /ID# 158235, Garland, Texas, United States|Vilo Research Group Inc /ID# 207657, Houston, Texas, United States|Baylor College of Medicine /ID# 158230, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201221, Houston, Texas, United States|Caprock Gastro Research /ID# 215433, Lubbock, Texas, United States|Clinical Associates in Researc /ID# 161364, San Antonio, Texas, United States|Southern Star Research Institute, LLC /ID# 168774, San Antonio, Texas, United States|Baylor Scott & White Health - Temple /ID# 204132, Temple, Texas, United States|Tyler Research Institute, LLC /ID# 166799, Tyler, Texas, United States|Victoria gastroenterology /ID# 164308, Victoria, Texas, United States|Advanced Research Institute /ID# 160465, Ogden, Utah, United States|Gastroenterology Consultants of Southwest Virginia /ID# 218142, Roanoke, Virginia, United States|Virginia Mason Medical Center /ID# 160432, Seattle, Washington, United States|Cemic /Id# 167805, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina|Hospital Centenario /Id# 170896, Rosario, Santa Fe, Argentina|Hospital Privado Univesitario /ID# 167802, Cordoba, Argentina|Sanatorio 9 de Julio S.A. /ID# 167803, San Miguel de Tucuman, Argentina|Universitaetsklinikum St.Polten /ID# 169049, St. Polten, Niederoesterreich, Austria|Ordensklinikum Linz GmbH, Barmherzige Schwestern /ID# 216043, Linz, Oberoesterreich, Austria|Medical University of Vienna /ID# 169051, Vienna, Wien, Austria|LKH-Univ. Klinikum Graz /ID# 169052, Graz, Austria|LKH Salzburg and Paracelsus /ID# 200686, Salzburg, Austria|CUB Hospital Erasme /ID# 200256, Brussels, Bruxelles-Capitale, Belgium|Cliniques Universitaires Saint Luc /ID# 200260, Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium|Imelda Ziekenhuis /ID# 211101, Bonheiden, Belgium|UZ Leuven /ID# 170829, Leuven, Belgium|CHU de Liege /ID# 200257, Liege, Belgium|Groupe Sante CHC - Clinique du MontLegia /ID# 200255, Liege, Belgium|AZ-Delta /ID# 200258, Roeselare, Belgium|CHU Dinant Godinne - UCL Namur /ID# 200259, Yvoir, Belgium|Instituto Goiano de Gastroenterologia e Endoscopia Digestiva Ltda /ID# 157683, Goiania, Goias, Brazil|Hospital Nossa Senhora das Graças /ID# 157677, Curitiba, Parana, Brazil|Hospital de Clinicas de Porto Alegre /ID# 157670, Porto Alegre, Rio Grande Do Sul, Brazil|Upeclin Fmb - Unesp /Id# 157691, Botucatu, Sao Paulo, Brazil|Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 157668, Ribeirao Preto, Sao Paulo, Brazil|Faculdade de Medicina do ABC /ID# 163993, Santo André, Sao Paulo, Brazil|Kaiser Clinica e Hospital Dia /ID# 157686, Sao Jose Do Rio Preto, Sao Paulo, Brazil|MBAL Hadzhi Dimitar /ID# 207947, Sliven, Bulgaria|II MHAT - Sofia /ID# 200794, Sofia, Bulgaria|UMHAT Tsaritsa Joanna - ISUL /ID# 209978, Sofia, Bulgaria|UMHAT Sv. Ivan Rilski /ID# 210798, Sofia, Bulgaria|University of Calgary Cumming School of Medicine Adult Cystic Fibrosis Clinic /ID# 169125, Calgary, Alberta, Canada|Allen Whey Khye Lim Professional Corporation /ID# 169770, Edmonton, Alberta, Canada|Covenant Health /ID# 169128, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc /ID# 169116, New Westminster, British Columbia, Canada",United Kingdom,Others,0,1,2095.0
5456.0,NCT04432792,The California Home Abortion by Telehealth (CHAT) Study,CHAT,Not yet recruiting,Abortion Early,,,,,,,Other: Telehealth Consultation,"University of California, San Francisco|California Latinas for Reproductive Justice|UCGHI Women's Health, Gender, and Empowerment Center of Expertise",Female,"18 Years and older   (Adult, Older Adult)",700.0,Other,Interventional,2020-01-11,01/10/22,2022-01-10,16/06/20,16/06/20,"Mt. Zion Women's Options Center, San Francisco, California",United States,Others,0,1,730.0
5457.0,NCT04685330,Portable Ultrasound for Interventional Procedures,,Not yet recruiting,Ultrasound Therapy; Complications,,,,,,,Procedure: Ultrasound guided procedure|Device: Portable ultrasound,Massachusetts General Hospital,All,"18 Years to 120 Years   (Adult, Older Adult)",200.0,Other,Observational,2021-01-01,31/12/23,2023-12-31,28/12/20,28/12/20,,,Others,0,1,1094.0
5458.0,NCT04742426,Personal Protective Equipment Affect Team Performance During Medical Emergencies,PPE-TEAM,Not yet recruiting,Safety Issues,Communication,Cardiopulmonary Arrest,,,,,Other: WHO recommended PPE|Other: Super-safe setup,"Roman Sýkora|Charles University, Czech Republic",All,"20 Years to 65 Years   (Adult, Older Adult)",22.0,Other,Interventional,2021-01-05,31/08/21,2021-09-30,08/02/21,09/02/21,,,Others,0,3,268.0
5459.0,NCT04532112,Biocontainment Device for Aerosol Generating Procedures,,Recruiting,Protective Device (Physical Object),Aerosol Disease,Droplet Spread,,,,,Device: Biocontainment Device For Aerosol Generating Procedures (Biobox)|Device: Control for aerosol generating procedures,University of Pennsylvania|Drexel University,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-07-12,01/03/21,2021-01-04,31/08/20,11/12/20,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Others,0,3,176.0
5460.0,NCT04400734,Esophagogastroduodenoscopy (EGD) is an Aerosol-generating Procedure: Proof of Concept Study,,Recruiting,"Aerosol-generating Procedure, Esophagogastroduodenoscopy",,,,,,,"Other: No intervention, observational study",Chinese University of Hong Kong,All,"Child, Adult, Older Adult",60.0,Other,Observational,2020-07-05,31/12/20,2021-01-31,26/05/20,11/06/20,"The Chinese University of hong Kong, Hong Kong",Hong Kong,Others,0,1,210.0
5461.0,NCT04423614,Preoperative Inspiratory Muscle Training,,Not yet recruiting,Mechanical Ventilation Complication,,,,,,,Other: Inspiratory Muscle Training|Other: Relaxation Breathing,University of Florida,All,"55 Years to 80 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-02,01/07/21,2021-01-12,09/06/20,25/01/21,"University of Florida, Gainesville, Florida",United States,Others,0,1,10.0
5462.0,NCT04765813,Use of a Smartphone Application (App) to Assist a Cognitive-Behavioral Smoking Cessation Treatment,,Not yet recruiting,Smoking,,,,,,,Behavioral: Cognitive-behavioral treatment to quit smoking along with an App with active therapeutic components|Behavioral: Cognitive-behavioral treatment to quit smoking along with a control App,"University of Santiago de Compostela|Ministerio de Ciencia e Innovación, Spain",All,"18 Years and older   (Adult, Older Adult)",270.0,Other,Interventional,2021-01-04,01/06/23,2023-01-06,21/02/21,21/02/21,"Smoking Cessation and Addictive Disorders Unit, Faculty of Psychology, University of Santiago de Compostela, Santiago de Compostela, A Coruña",Spain,Others,0,1,732.0
5463.0,NCT04430231,Does Delaying Curative Surgery for Colorectal Cancer Influence Long-term Disease Free Survival.,,Completed,Colorectal Cancer,,,,,,,Other: Wait list time,Fundación para la Investigación del Hospital Clínico de Valencia,All,"Child, Adult, Older Adult",602.0,Other,Observational,2012-01-01,31/12/17,2020-01-04,12/06/20,16/06/20,,,Cancers,1,1,2925.0
5464.0,NCT04632004,Questionnaire Regarding the Effect of Wearing Face Masks on Oral Health,,Enrolling by invitation,Dry Mouth,Halitosis,,,,,,Other: Invitation to participate,University of Göttingen,All,"Child, Adult, Older Adult",3000.0,Other,Interventional,2020-11-20,01/05/21,2021-01-07,17/11/20,25/11/20,"University Medical Center Goettingen, Dept. of Preventive Dentistry, Periodontology and Cariology, Göttingen, Lower Saxony",Germany,Others,0,2,48.0
5465.0,NCT04039243,Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study,,Recruiting,Anxiety Disorder of Childhood,Fear,Shyness,,,,,Behavioral: Being Brave|Other: Parent Education,Massachusetts General Hospital,All,21 Months to 47 Months   (Child),90.0,Other,Interventional,2019-09-27,01/09/22,2022-01-09,31/07/19,03/12/20,"Massachusetts General Hospital, Boston, Massachusetts",United States,Mental Health,1,3,835.0
5466.0,NCT04497753,An Epidemiological Investigation on Correct Wearing of Mask by Hood Test,,Completed,Respiratory Infectious Diseases,,,,,,,,Fuwai Yunnan Cardiovascular Hospital,All,"7 Years and older   (Child, Adult, Older Adult)",6000.0,Other,Observational,2020-06-19,31/08/20,2020-08-31,04/08/20,19/10/20,"Fuwai hospital, Beijing, Beijing, Beijing, China|Taizhou Health Bureau, Taizhou, Jiangsu, China|Bin Health Wen, Jinzhong, Shanxi, China|Yuanqu Health Bureau, Yuncheng, Shanxi, China|Fuwai Yunnan Cardiovascular Hospital, Kunming, Yunnan, China|Luliang Health Bureau, Qujing, Yunnan, China|Shizong Health Bureau, Qujing, Yunnan, China|Luoping Health Bureau, Qujing, Yunnan",China,Others,0,1,73.0
5467.0,NCT04497675,An Epidemiological Investigation on Correct Wearing of Mask by Direct Spray Test,,Completed,Respiratory Infectious Diseases,,,,,,,,Fuwai Yunnan Cardiovascular Hospital,All,"7 Years and older   (Child, Adult, Older Adult)",6000.0,Other,Observational,2020-06-19,31/08/20,2020-08-31,04/08/20,19/10/20,"Fuwai hospital, Beijing, Beijing, Beijing, China|Taizhou Health Bureau, Taizhou, Jiangsu, China|Jiexiu Health Bureau, Jinzhong, Shanxi, China|Yuanqu Health Bureau, Yuncheng, Shanxi, China|Shizong Health Bureau, Qujing, Yunnan, China|Lin Health Duo, Qujing, Yunnan, China|Luliang Health Bureau, Qujing, Yunnan, China|Luoping Health Bureau, Qujing, Yunnan",China,Others,0,1,73.0
5468.0,NCT04812899,Implementation of a Waitlist Intervention and Clinical Care Pathway for Families Awaiting at Eating Disorders Program,WICFAS,Not yet recruiting,Eating Disorders,,,,,,,Behavioral: Parental guided self-help version of FBT-pre-recorded videos and readings from the book,McMaster University,All,"20 Years to 100 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-04,01/12/21,2021-01-12,24/03/21,24/03/21,,,Others,0,1,8.0
5469.0,NCT04474028,An Epidemiological Investigation on the Correct Wearing of Face Mask,,Completed,Respiratory Infectious Diseases,,,,,,,,Fuwai Yunnan Cardiovascular Hospital,All,"7 Years and older   (Child, Adult, Older Adult)",6000.0,Other,Observational,2020-06-19,31/08/20,2020-08-31,16/07/20,06/11/20,"Fuwai hospital, Beijing, Beijing, Beijing, China|Taizhou Health Bureau, Taizhou, Jiangsu, China|Jiexiu Health Bureau, Jinzhong, Shanxi, China|Yuanqu Health Bureau, Yuncheng, Shanxi, China|Fuwai Yunnan Cardiovascular Hospital, Kunming, Yunnan, China|Luliang Health Bureau, Qujing, Yunnan, China|Shizong Health Bureau, Qujing, Yunnan, China|Luoping Health Bureau, Qujing, Yunnan",China,Others,0,1,73.0
5470.0,NCT04804072,INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit,INTEGRA,Not yet recruiting,HIV Infections,Drug Use,Opioid Use,Opioid-use Disorder,,,,"Drug: Medication for opioid-use disorder (MOUD) for opioid-use disorder (OUD)|Diagnostic Test: HIV testing|Drug: HIV treatment for HIV-positive participants not already in care|Drug: PrEP for HIV-negative participants|Diagnostic Test: Testing and referral for vaccination or treatment for hepatitis A virus (HAV) and hepatitis B virus (HBV)|Diagnostic Test: Testing and referral for treatment for hepatitis C virus (HCV)|Diagnostic Test: Sexually transmitted infection (STI) testing and treatment|Other: Primary care|Behavioral: Harm reduction services|Behavioral: Peer navigation|Diagnostic Test: COVID-19 testing and referral for further evaluation, care and/or treatment",HIV Prevention Trials Network|National Institute of Allergy and Infectious Diseases (NIAID)|National Institute on Drug Abuse (NIDA),All,18 Years to 60 Years   (Adult),860.0,Other|NIH,Interventional,2021-01-04,01/10/24,2024-01-10,18/03/21,18/03/21,"UCLA Vine Street Clinic, Los Angeles, California, United States|George Washington University CRS, Washington, District of Columbia, United States|Bronx Prevention Center CRS, Bronx, New York, United States|Penn Prevention CRS, Philadelphia, Pennsylvania, United States|Houston AIDS Research Team CRS, Houston, Texas",United States,Others,0,4,1101.0
5471.0,NCT04714307,Neuropsychiatry and Cognition in SCA3/MJD,,Recruiting,Spinocerebellar Ataxia Type 3,Machado-Joseph Disease,SCA3,MJD,,,,Diagnostic Test: SCA3/MJD molecular diagnosis|Diagnostic Test: Cognitive Testing|Diagnostic Test: Psychiatric Evaluation|Diagnostic Test: Clinical Neurological Evaluation|Diagnostic Test: Emotional Attribution Evaluation|Diagnostic Test: Activities of Daily Living,Hospital de Clinicas de Porto Alegre,All,"18 Years and older   (Adult, Older Adult)",144.0,Other,Observational,2019-12-13,01/02/21,2023-01-08,19/01/21,19/01/21,"Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul",Brazil,Others,0,4,1122.0
5472.0,NCT04794556,Respiratory Protection Effect of Ear-loop-type KF94 Mask,,Completed,Infection,,,,,,,Device: tight-fitting of KF94 mask with clip,Samsung Medical Center,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2021-01-01,10/03/21,2021-10-03,12/03/21,15/03/21,"Samsung Medical Center, Seoul, Korea",Republic of,Others,0,1,275.0
5473.0,NCT04820387,Assessment of Remote Vital Signs for Telemedicine Applications,,Recruiting,Telemedicine,Physiology,,,,,,,Johns Hopkins University,All,"18 Years to 85 Years   (Adult, Older Adult)",300.0,Other,Observational,2021-01-04,01/09/24,2024-01-09,29/03/21,29/03/21,"Johns Hopkins Asthma & Allergy Center, Baltimore, Maryland",United States,Others,0,2,1100.0
5474.0,NCT04834700,Comparison of Hands-on Versus Online Learning About Ocular Ultrasound,,Recruiting,Emergencies,,,,,,,Other: online group,Samsung Medical Center,All,18 Years to 50 Years   (Adult),32.0,Other,Interventional,2020-12-17,01/04/21,2021-01-04,08/04/21,08/04/21,"Samsung Medical Center, Seoul, Korea",Republic of,Others,0,1,18.0
5475.0,NCT04501588,Parent Telehealth Intervention for Children With Autism,,Recruiting,Autism Spectrum Disorder,Autism,,,,,,Behavioral: Responsive training with no video feedback|Behavioral: Responsive training with video feedback,Northwestern University,All,18 Months to 48 Months   (Child),40.0,Other,Interventional,2020-06-03,30/06/21,2021-09-30,06/08/20,01/12/20,"Northwestern University, Evanston, Illinois",United States,Others,0,2,484.0
5476.0,NCT04767464,Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups,CC-V,Not yet recruiting,Breast Cancer,Breast Neoplasm,,,,,,Other: Compass Course,Mary Radomski|Allina Health System,Female,"25 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-03,01/03/22,2022-01-03,23/02/21,23/02/21,"Abbott Northwestern Hospital, Minneapolis, Minnesota",United States,Cancers,1,2,365.0
5477.0,NCT04770597,Monitors to Improve Indoor Carbon Dioxide (CO2) Concentrations in the Hospital,MICH,Enrolling by invitation,Healthcare Associated Infection,,,,,,,Device: Aranet4 Home CO2 monitor,"Imelda Hospital, Bonheiden",All,"Child, Adult, Older Adult",48.0,Other,Interventional,2021-02-21,01/04/21,2021-01-04,25/02/21,19/03/21,"Imelda Hospital, Bonheiden",Belgium,Others,0,1,-48.0
5478.0,NCT04522713,A Transdiagnostic Course for Common Mental Health Problems in Primary Care,,Recruiting,Depression,Anxiety,,,,,,"Behavioral: Behavioral activation, evidence-based sleep strategies including sleep restriction, exposure-based strategies, promotion of physical activity and recuperating activities, psychoeducational material",Karolinska Institutet,All,"18 Years and older   (Adult, Older Adult)",68.0,Other,Interventional,2020-08-24,01/03/21,2021-01-12,21/08/20,25/11/20,"Karolinska Institutet, Stockholm",Sweden,Mental Health,1,2,141.0
5479.0,NCT04654637,Multiple Interactive With Nutrition and Exercise Strategies in Frailty Cancer Patients,,Recruiting,Cancer,,,,,,,Behavioral: Nutrition and Exercise Strategies,Tzu Chi University,All,"20 Years to 85 Years   (Adult, Older Adult)",128.0,Other,Interventional,2020-01-11,30/11/23,2023-11-30,04/12/20,04/12/20,"Tzu Chi University, Hualien City",Taiwan,Cancers,1,1,1419.0
5480.0,NCT04542863,The Molecular Imaging Research of F-18 Labeled DX600 PET Probe,,Recruiting,Solid Tumor,,,,,,,Other: 18F-DX600 PET/CT,Beijing Cancer Hospital,All,"3 Years and older   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-11-09,01/09/22,2022-01-09,09/09/20,22/10/20,"Beijing Cancer Hospital, Beijing, Beijing",China,Others,0,1,426.0
5481.0,NCT03500328,Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial,TREAT-MS,Recruiting,"Multiple Sclerosis, Relapsing-Remitting",,,,,,,Other: Early Aggressive Therapy or Traditional Therapy,Johns Hopkins University|Patient-Centered Outcomes Research Institute,All,18 Years to 60 Years   (Adult),900.0,Other,Interventional,2018-02-05,01/08/23,2023-01-08,18/04/18,23/02/21,"University of Alabama at Birmingham, Birmingham, Alabama, United States|The University of South Alabama, Mobile, Alabama, United States|St. Joseph's Hospital & Medical Center - Barrow Neurological Institute, Phoenix, Arizona, United States|Dignity Health Medical Foundation, Carmichael, California, United States|Cedars-Sinai Medical Center, Los Angeles, California, United States|University of California, Los Angeles, Los Angeles, California, United States|University of California, San Diego, San Diego, California, United States|University of California, San Francisco, San Francisco, California, United States|Christiana Care Health Services, Inc., Newark, Delaware, United States|Georgetown University, Washington, District of Columbia, United States|University of Florida, Gainesville, Florida, United States|University of Miami, Miami, Florida, United States|University of South Florida Health, Tampa, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|The University of Kansas Medical Center (KUMC), Kansas City, Kansas, United States|University of Louisville, Louisville, Kentucky, United States|Norton Neurology MS Services, Louisville, Kentucky, United States|University of Maryland, Baltimore, Baltimore, Maryland, United States|The Johns Hopkins Hospital, Baltimore, Maryland, United States|Massachusetts General Hospital, Boston, Massachusetts, United States|University of Massachusetts Medical School, Worcester, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Wayne State University, Detroit, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Billings Clinic, Billings, Montana, United States|Advanced Neurology Specialists, Great Falls, Montana, United States|University of Nebraska Medical Center, Omaha, Nebraska, United States|Hackensack University Medical Center, Hackensack, New Jersey, United States|RWJBarnabas Health Multiple Sclerosis Comprehensive Care Center, Livingston, New Jersey, United States|New York University School of Medicine, New York, New York, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Columbia University Medical Center, New York, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|Stony Brook University, Stony Brook, New York, United States|Novant Health Neurology and Sleep, Charlotte, North Carolina, United States|University of Cincinnati, Cincinnati, Ohio, United States|OhioHealth Research Institute, Columbus, Ohio, United States|Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States|Providence Health and Services - Oregon, Portland, Oregon, United States|Geisinger Clinic, Danville, Pennsylvania, United States|Allegheny Health Network Research Institute, Pittsburgh, Pennsylvania, United States|Vanderbilt Comprehensive MS Center, Nashville, Tennessee, United States|Baylor Scott and White Health, Dallas, Texas, United States|Central Texas Neurology Consultants, Round Rock, Texas, United States|University of Utah, Salt Lake City, Utah, United States|The University of Vermont and State Agricultural College, Burlington, Vermont, United States|Blacksburg Neurology, Christiansburg, Virginia, United States|Neurology Consultants of Tidewater, Norfolk, Virginia, United States|Swedish Health Services, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States|Medical College of Wisconsin, Milwaukee, Wisconsin",United States,Immunological Disorders,1,1,1798.0
5482.0,NCT04422457,Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients,,Recruiting,Solid Tumor,,,,,,,Other: 68Ga-DX600 PET/CT,Beijing Cancer Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-06-13,01/06/23,2023-01-06,09/06/20,03/09/20,"Ethics Committee of Peking University Cancer Hospital, Beijing, Beijing",China,Others,0,1,937.0
5483.0,NCT04536259,Assessing People's Hospital Outpatient Appointment Preferences in the United Kingdom,,Completed,Hospital Outpatient Clinics,Chronic Disease,,,,,,Behavioral: Video Default|Behavioral: In-Person Default|Behavioral: Active Choice,University of Warwick,All,"18 Years and older   (Adult, Older Adult)",1481.0,Other,Interventional,2020-11-09,31/10/20,2020-10-31,02/09/20,05/11/20,"Kelly Schmidtke, Coventry, West Midlands",United Kingdom,Others,0,2,-9.0
5484.0,NCT04764539,Video Assisted Speech Technology to Enhance Motor Planning for Speech,VAST,Completed,Autism Spectrum Disorder,Apraxia of Speech,,,,,,Behavioral: Video Assisted Speech Therapy (VAST),"iTherapy, LLC|National Institute on Deafness and Other Communication Disorders (NIDCD)",All,4 Years to 8 Years   (Child),6.0,Other|NIH,Interventional,2019-01-12,30/11/20,2020-11-30,21/02/21,21/02/21,"All research was conducted via tele-research due to COVID-19, Vallejo, California",United States,Others,0,2,688.0
5485.0,NCT04843969,Investigation of Cigarette Cravings in Smokers,,"Active, not recruiting",Cigarette Smoking,Addiction Nicotine,Tobacco Use,,,,,Behavioral: Stress induction|Behavioral: Control stress exposure|Behavioral: Cue induction|Behavioral: Neutral cue exposure,Marco Leyton|McGill University Health Centre/Research Institute of the McGill University Health Centre,All,"18 Years to 65 Years   (Adult, Older Adult)",76.0,Other,Interventional,2018-02-20,01/05/20,2022-01-31,14/04/21,14/04/21,"McGill University, Montreal, Quebec",Canada,Others,0,3,1441.0
5486.0,NCT04844294,A Randomized Clinical Trial Testing the Effectiveness of Telemental Health for Suicidal Patients,,Not yet recruiting,Suicide,Suicidal Ideation,Suicide Attempt,,,,,Behavioral: Brief Cognitive Behavioral Therapy (BCBT)|Behavioral: Present-Centered Therapy (PCT),Ohio State University,All,"18 Years and older   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-04,01/04/22,2023-01-04,14/04/21,14/04/21,"The Ohio State University, Columbus, Ohio",United States,Others,0,3,730.0
5487.0,NCT04344665,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,PVC-RAM,"Active, not recruiting",Surgery,Perioperative Complication,COVID-19,,,,,Other: Virtual Care and Remote Automated Monitoring,Population Health Research Institute|Hamilton Health Sciences Corporation|McMaster University,All,"40 Years and older   (Adult, Older Adult)",905.0,Other,Interventional,2020-04-23,28/10/20,2021-01-01,14/04/20,23/11/20,"University of Alberta Hospital, Edmonton, Alberta, Canada|The Ottawa Hospital, Ottawa, Ontario, Canada|Hamilton General Hospital, Hamilton, Canada|Juravinski Hospital, Hamilton, Canada|St. Joseph's Healthcare Hamilton, Hamilton, Canada|Kingston Health Sciences Centre, Kingston, Canada|London Health Sciences Centre, London",Canada,Respiratory Diseases,1,3,253.0
5488.0,NCT04772677,Building Emotional Awareness and Mental Health,BEAM,Not yet recruiting,Maternal Depression,,,,,,,Behavioral: BEAM Mental Health and Parenting Program,University of Manitoba|University of Calgary|Tactica Interactive|Centre for Healthcare Innovation|Research Manitoba,Female,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2021-01-04,01/07/21,2021-01-09,26/02/21,26/02/21,"The University of Manitoba - Department of Psychology, Winnipeg, Manitoba",Canada,Mental Health,1,1,5.0
5489.0,NCT04840498,UAB AIM Virtual Magic Camp,,Recruiting,Autism,,,,,,,Behavioral: Autism Research,"Hon K. Yuen, PhD|University of Alabama at Birmingham",All,"9 Years to 18 Years   (Child, Adult)",26.0,Other,Observational,2021-07-04,30/07/21,2021-08-31,12/04/21,12/04/21,"UAB Alys Sthepens Center, Birmingham, Alabama",United States,Others,0,1,58.0
5490.0,NCT04571593,Remote Yoga Nidra for Anxiety and Sleep,,Completed,Insomnia Due to Anxiety and Fear,,,,,,,Behavioral: Yoga Nidra,National University of Natural Medicine,All,"18 Years and older   (Adult, Older Adult)",74.0,Other,Interventional,2020-04-15,05/08/20,2020-09-14,01/10/20,05/10/20,"National University of Natural Medicine, Helfgott Research Institute, Portland, Oregon",United States,Mental Health,1,1,152.0
5491.0,NCT04714606,Feasibility RCT of an 8-session Group Intervention for Siblings of Children Who Have ASD,,Recruiting,Autism Spectrum Disorder,,,,,,,Other: Sibling support group|Other: None - control condition,University of Surrey,All,7 Years to 11 Years   (Child),25.0,Other,Interventional,2020-12-14,30/04/21,2021-04-30,19/01/21,19/01/21,"The Howard Partnership Multi-Academy Trust, Leatherhead",United Kingdom,Others,0,1,137.0
5492.0,NCT04402034,Telerehabilitation in Disabled People: Proposal for Practical Intervention With Virtual Reality,,Completed,Disability Physical,,,,,,,Behavioral: Application of tele-rehabilitation,University of Sao Paulo,All,"7 Years to 80 Years   (Child, Adult, Older Adult)",40.0,Other,Interventional,2020-05-15,20/10/20,2020-10-21,26/05/20,26/10/20,"Escola de Artes,Ciencias e Humanidades da Universidade d Sao Paulo, Sao Paulo",Brazil,Others,0,1,159.0
5493.0,NCT04029194,The Causal Effects of Old Age Pensions,,"Active, not recruiting",Aging,,,,,,,Behavioral: Assistance with old age pension application,"National Bureau of Economic Research, Inc.",All,"55 Years and older   (Adult, Older Adult)",1459.0,Other,Interventional,2019-04-02,31/12/27,2027-12-31,23/07/19,23/09/20,"JPAL SA at IFMR, Chennai, Tamil Nadu",India,Others,0,1,3195.0
5494.0,NCT04617132,Online MBI for Families Affected by PPDA,,"Active, not recruiting",Postpartum Depression,Postpartum Anxiety,,,,,,Behavioral: MBCT/MBSR,British Columbia Children's Hospital,All,"19 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-10-20,01/08/22,2022-01-08,05/11/20,05/11/20,"Reproductive Mental Health Program, BC Children's Hospital, Vancouver, British Columbia",Canada,Mental Health,1,2,445.0
5495.0,NCT04687852,Comparison of the Efficacy of Pharmacology and Non-pharmacological Treatment in Women With Primary Dysmenorrhea.,,Recruiting,Pelvic Floor,Exercise,Telerehabilitation,Acupressure,Dysmenorrhea Primary,Drug Effect,,Other: Conservative and Non-conservative treatments,Istanbul Medipol University Hospital,Female,18 Years to 60 Years   (Adult),85.0,Other,Interventional,2020-09-06,09/06/21,2021-09-12,29/12/20,20/01/21,"Gizem BOZTAŞ, Istanbul, Kavacık",Turkey,Others,0,6,371.0
5496.0,NCT04485000,Online 1-Day CBT-Based Workshops for PPD,,Completed,Postpartum Depression,,,,,,,Behavioral: Online 1-Day Cognitive Behavioural Therapy (CBT)-Based Workshop,McMaster University,Female,"18 Years and older   (Adult, Older Adult)",403.0,Other,Interventional,2020-04-20,30/01/21,2021-01-30,24/07/20,16/02/21,"McMaster University, Hamilton, Ontario",Canada,Mental Health,1,1,285.0
5497.0,NCT04525521,Hand Sanitizer Effects on the Skin Barrier,,Recruiting,Dermatitis Hand,Skin Abnormalities,Atopic Dermatitis,Atopic Dermatitis Eczema,,,,Other: Hand sanitizer and hand washing,National Jewish Health,All,18 Years to 60 Years   (Adult),40.0,Other,Observational,2020-01-12,20/08/21,2021-08-20,25/08/20,02/03/21,"National Jewish Health, Denver, Colorado",United States,Others,0,4,586.0
5498.0,NCT04461769,Electrical Synchronization of Slow Oscillations to Enhance Deep Sleep,ESSOTEDS,Completed,Sleep,Sleep Hygiene,,,,,,Device: Transcranial Electrical Stimulation,Brain Electrophysiology Laboratory Company,All,"18 Years to 80 Years   (Adult, Older Adult)",13.0,Industry,Interventional,2019-01-09,30/05/20,2020-05-30,08/07/20,08/07/20,"Brain Electrophysiology Laboratory Company, Eugene, Oregon",United States,Others,0,2,507.0
5499.0,NCT04685759,Exercise Regimens and Neoadjuvant Chemotherapy,,Not yet recruiting,Cancer of Gastrointestinal Tract,,,,,,,Other: In-Person Exercise Protocol|Other: Virtual Exercise Protocol,University of Texas Southwestern Medical Center,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-03,01/10/21,2022-01-01,28/12/20,28/12/20,,,Cancers,1,1,363.0
5500.0,NCT03856749,Effectiveness of Wheelchair Skills Training for Caregivers of Manual Wheelchair Users,,Recruiting,Caregivers,,,,,,,Other: Remote wheelchair skills training,Lee Kirby|IWK Health Centre|Nova Scotia Health Authority,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2019-04-12,01/01/22,2022-01-01,27/02/19,11/03/21,"Nova Scotia Rehabilitation Centre, Halifax, Nova Scotia",Canada,Others,0,1,995.0
5501.0,NCT04818008,The Effect of the Arabic Otago Exercise Program on Falls in People With Multiple Sclerosis,,Not yet recruiting,Multiple Sclerosis,,,,,,,Other: Otago Exercise Program,University of Jordan,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2021-01-06,01/12/23,2023-01-12,26/03/21,06/04/21,,,Immunological Disorders,1,1,736.0
5502.0,NCT04586309,Improving the Mental Health of Resident Physicians and Fellows Through Transcendental Meditation,,Not yet recruiting,"Burnout, Professional","Stress, Psychological",Depression,Job Stress,,,,Behavioral: Transcendental meditation,University of Arizona|David Lynch Foundation|Tucson Transcendental Meditation Center,All,"Child, Adult, Older Adult",50.0,Other,Interventional,2020-01-11,01/06/21,2021-01-12,14/10/20,14/10/20,,,Mental Health,1,4,367.0
5503.0,NCT04173663,Advocating for Supports to Improve Service Transitions,ASSIST,"Active, not recruiting",Autism Spectrum Disorder,Autism,,,,,,Behavioral: ASSIST,"Vanderbilt University Medical Center|University of Illinois at Urbana-Champaign|University of Wisconsin, Madison",All,"16 Years and older   (Child, Adult, Older Adult)",180.0,Other,Interventional,2020-03-01,30/05/24,2024-05-30,22/11/19,04/12/20,"University of Illinois at Urbana-Champaign, Chicago, Illinois, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Waisman Center at University of Madison-Wisconsin, Madison, Wisconsin",United States,Others,0,2,1551.0
5504.0,NCT04809961,Longitudinal Observation of NHS Staff Wellbeing Following Introduction of the I-care Peer Support App,I-Care,Not yet recruiting,Peer Group,,,,,,,Other: I-care app,University of Southampton|Solent NHS Trust,All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2021-01-04,01/04/22,2022-01-07,22/03/21,22/03/21,"Lindsey Cherry, Southampton, Hampshire",United Kingdom,Others,0,1,368.0
5505.0,NCT04431323,Intervention for Young Adults With Multiple Sclerosis,ESPRIMO,Recruiting,Multiple Sclerosis,,,,,,,Behavioral: ESPRIMO,Azienda Ospedaliera Universitaria Integrata Verona,All,18 Years to 45 Years   (Adult),60.0,Other,Interventional,2020-05-13,01/08/22,2022-01-08,16/06/20,16/06/20,"Azienda Ospedaliera Universitaria Integrata Verona, Policlinico G.B. Rossi, Verona, Veneto",Italy,Immunological Disorders,1,1,605.0
5506.0,NCT03821402,Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity,JUNIPER,Completed,Upper Limb Spasticity,,,,,,,Biological: DAXI for injection dose LOW DOSE|Biological: DAXI for injection dose MEDIUM DOSE|Biological: DAXI for injection Dose HIGH DOSE|Other: Placebo,"Revance Therapeutics, Inc.",All,"18 Years to 75 Years   (Adult, Older Adult)",83.0,Industry,Interventional,2018-12-12,23/11/20,2020-11-23,29/01/19,01/03/21,"Rancho Research Institute at Rancho Los Amigos National Rehab Center, Downey, California, United States|The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States|Collaborative Neuroscience Network LLC, Long Beach, California, United States|SC3 Research, Pasadena, California, United States|Yale University, Fairfield, Connecticut, United States|Waterbury Neurologists, Middlebury, Connecticut, United States|Ki Health Partners LLC DBA New England Institute for Clinical Research, Stamford, Connecticut, United States|MedStar National Rehabilitation Hospital, Washington, District of Columbia, United States|Parkinsons Disease and Movement Disorders Center, Boca Raton, Florida, United States|NW FL Clinical Research Group, LLC, Gulf Breeze, Florida, United States|Infinity Clinical Research, Hollywood, Florida, United States|Parkinsons Disease Treatment Center of Southwest Florida, Port Charlotte, Florida, United States|Shirley Ryan AbilityLab, Chicago, Illinois, United States|Kansas Institute of Research, Overland Park, Kansas, United States|William Beaumont Hospital, Royal Oak, Michigan, United States|Rusk Rehabilitation Hospital, Columbia, Missouri, United States|Icahn School of Medicine at Mount Sinai, New York, New York, United States|Weill Cornell Medical College, New York, New York, United States|Carolinas Rehabilitation, Charlotte, North Carolina, United States|Wake Forest University School of Medicine, Salem, North Carolina, United States|MossRehab, Elkins Park, Pennsylvania, United States|University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|North Texas Institute of Neurology and Headache, Frisco, Texas, United States|University of Texas Health Science Center at Houston, Houston, Texas, United States|University of Utah, Salt Lake City, Utah",United States,Others,0,1,712.0
5507.0,NCT04386798,Stress and Anxiety Levels of Mothers Lying in the Baby Newborn Intensive Care Unit,,Recruiting,Newborn,Anxiety,,,,,,Other: survey work,Eskisehir Osmangazi University,Female,18 Years to 45 Years   (Adult),60.0,Other,Interventional,2020-07-25,22/12/20,2021-02-25,13/05/20,23/12/20,"Eskisehir City Hospital, Odunpazarı, Eskisehir, Turkey|Eskisehir City Hospital, Eskisehir",Turkey,Mental Health,1,2,215.0
5508.0,NCT04104321,A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR),ARMOR,Recruiting,Nonalcoholic Steatohepatitis (NASH),,,,,,,Drug: Aramchol|Drug: Placebo,"Galmed Research and Development, Ltd.|Galmed Pharmaceuticals Ltd",All,"18 Years to 75 Years   (Adult, Older Adult)",2000.0,Industry,Interventional,2019-09-23,01/12/24,2027-01-06,26/09/19,17/02/21,"The Public Health Trust of Miami-Dade County, Florida, dba the Jackson Health System, Miami, Florida, United States|Texas Clinical Research Institute, LLC, Arlington, Texas",United States,Others,0,1,2662.0
5509.0,NCT04362163,Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3),STRIPE-3,Completed,Healthy,,,,,,,Device: Snorkel-based improvised personal protective equipment,Guy's and St Thomas' NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Observational,2020-01-05,05/06/20,2020-05-06,24/04/20,09/06/20,"St Thomas' Hospital, London",United Kingdom,Others,0,1,122.0
5510.0,NCT04800861,Glycemic Control in Diabetic Hospitalized Patients,,Recruiting,Diabetes,Diabetes Mellitus,,,,,,,AlFayhaa General Hospital,All,"Child, Adult, Older Adult",500.0,Other,Observational,2021-01-01,01/07/21,2021-01-07,16/03/21,16/03/21,"AlFayhaa Teaching hospital, Basra",Iraq,Metabolic Disorders,1,2,6.0
5511.0,NCT04114110,RTLS Technology Study,,"Active, not recruiting",Inpatients,Staff,,,,,,Other: RTLS data,The Royal Wolverhampton Hospitals NHS Trust|La Trobe University|Cornell University,All,"Child, Adult, Older Adult",2000.0,Other,Observational,2020-06-01,01/12/20,2020-01-12,03/10/19,15/04/20,"The Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands",United Kingdom,Others,0,2,-141.0
5512.0,NCT04752683,Validation of an Employee Remote Workplace Stress Measure Embedded Within a Novel Employee Wellbeing App,,Not yet recruiting,Work Related Stress,,,,,,,Other: MyBuddy Employee Wellbeing App,Holly Risdon|BPAi|American Institute of Stress,All,"18 Years and older   (Adult, Older Adult)",220.0,Industry|Other,Observational,2021-01-03,01/04/21,2021-01-06,12/02/21,16/02/21,,,Mental Health,1,1,3.0
5513.0,NCT04719039,The Effect of Yoga Self-Practice on Sleep Disturbance,,Not yet recruiting,Yoga,,,,,,,Behavioral: Restorative Yoga Internvention,Chinese University of Hong Kong,All,18 Years to 59 Years   (Adult),30.0,Other,Interventional,2021-01-02,01/04/21,2021-01-05,22/01/21,22/01/21,"The Chinese University of Hong Kong, Sha Tin",Hong Kong,Others,0,1,3.0
5514.0,NCT04672486,"PRIDE - Pilot Trial of an Online Digital Problem-solving Intervention for School-going Adolescents in Goa, India",,Recruiting,Mental Health Issue,"Depression, Anxiety",Stress,,,,,Behavioral: POD Adventures,Sangath|Harvard Medical School|University of Sussex|London School of Hygiene and Tropical Medicine,All,"13 Years to 19 Years   (Child, Adult)",120.0,Other,Interventional,2021-01-28,31/05/21,2021-05-31,17/12/20,22/03/21,"Sangath, Goa, DL",India,Mental Health,1,3,123.0
5515.0,NCT04444128,IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION,IMPReSSION,Recruiting,Myocarditis,Heart Failure,Myocardial Fibrosis,,,,,Diagnostic Test: CMR with T1 and T2 mapping,Johann Wolfgang Goethe University Hospital|Kerckhoff Klinik|Johannes Gutenberg University Mainz|University Hospital Ulm,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Observational,2016-11-15,15/11/22,2026-11-15,23/06/20,23/06/20,"Kerckhoff Hospital, Bad Nauheim, Hessen, Germany|University Hospital Frankfurt, Frankfurt, Hessen, Germany|University Hospital Mainz, Mainz, Hessen",Germany,Others,0,3,3652.0
5516.0,NCT04539756,Writing Activities and Emotions,eWrite,Recruiting,Healthy,,,,,,,Behavioral: positive psychological intervention|Behavioral: Active control condition,University of Pittsburgh,All,"18 Years and older   (Adult, Older Adult)",250.0,Other,Interventional,2020-08-09,01/08/21,2021-01-08,07/09/20,06/10/20,"University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Others,0,1,152.0
5517.0,NCT04820257,Home-based Pulmonary Rehabilitation for COPD Patients,,Not yet recruiting,"COPD, Chronic Obstructive Pulmonary Disease",,,,,,,Behavioral: Home based exercise,Karolinska Institutet|Mayo Clinic,All,"40 Years to 100 Years   (Adult, Older Adult)",80.0,Other,Interventional,2021-01-03,01/12/22,2022-01-12,29/03/21,29/03/21,"Karolinska Institutet, Stockholm",Sweden,Others,0,1,374.0
5518.0,NCT04690517,Comparison of Tracheal Ultrasound With Capnography for Intubation Confirmation During CPR Wearing PPE,,Recruiting,Cardiopulmonary Arrest,,,,,,,Procedure: tracheal ultrasound,Samsung Medical Center,All,"18 Years to 100 Years   (Adult, Older Adult)",34.0,Other,Interventional,2021-01-30,01/04/21,2021-01-07,30/12/20,06/04/21,"Samsung Medical Center, Seoul, Korea",Republic of,Others,0,1,-23.0
5519.0,NCT04704570,Remote Exercise Programs and Preventive Training in Asymptomatic Individuals,,Not yet recruiting,Healthy People,,,,,,,"Other: Exercise|Other: Remotely and face to face evaluation of Functional Capacity Level, Quality of life, Kinesophobia, Cognitive Level",Hacettepe University,All,18 Years to 55 Years   (Adult),20.0,Other,Interventional,2021-03-25,29/06/22,2022-09-29,11/01/21,23/03/21,"Yasemin Özel Aslıyüce, Ankara, Sıhhiye",Turkey,Others,0,1,553.0
5520.0,NCT04616768,PROStep: A Feasibility Trial Using PROs and Step Data to Monitor Patients With Lung and GI Cancers,,Recruiting,Cancer,Lung Cancer,Gastro-intestinal,,,,,Other: PRO questionnaire|Other: Step monitoring|Other: Active nudge text feedback|Other: PROStep Dashboard (clinicians),University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",125.0,Other,Interventional,2020-11-19,01/11/21,2021-01-11,05/11/20,11/12/20,"Perelman Center for Advanced Medicine (PCAM), Philadelphia, Pennsylvania",United States,Cancers,1,3,53.0
5521.0,NCT04822090,Parvovirus B19 Infection in Hereditary Hemolytic Anemias Patients,,"Active, not recruiting",Parvovirus B19 Infection,,,,,,,Other: Supportive treatment with or without red cell transfusion/intravenous immune globulin (IVIG),Sohag University|Assiut University,All,"12 Years and older   (Child, Adult, Older Adult)",244.0,Other,Observational,2018-10-02,10/02/21,2024-10-02,30/03/21,30/03/21,", Faculty of Medicine, Sohag University, Sohag",Egypt,Others,0,1,2192.0
5522.0,NCT04291638,Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism,,Completed,Selective Mutism,,,,,,,Behavioral: Remote Caregiver Training|Behavioral: Remote Intensive Group Behavioral Treatment (IGBT),Florida International University,All,4 Years to 10 Years   (Child),11.0,Other,Interventional,2020-06-03,07/12/20,2020-07-12,02/03/20,16/12/20,"Florida International University, Miami, Florida",United States,Others,0,1,39.0
5523.0,NCT04406363,Confinement Effect on Low Back Pain Intensity in Chronic Low Back Pain Patients,CONFI-LOMB,Not yet recruiting,Chronic Low-back Pain,,,,,,,Other: non interventional,"University Hospital, Angers",All,"18 Years to 99 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-02-06,02/06/20,2020-06-21,28/05/20,28/05/20,"Petit, Angers",France,Others,0,1,136.0
5524.0,NCT04832152,Telehealth Intervention for Autism Spectrum Disorder,,Not yet recruiting,Autism Spectrum Disorder,,,,,,,Other: OT4ASD,Thomas Jefferson University|Montefiore Medical Center,All,4 Years to 12 Years   (Child),10.0,Other,Interventional,2021-01-05,30/04/22,2022-06-30,05/04/21,09/04/21,,,Others,0,1,541.0
5525.0,NCT04136340,Supportive Care Delivered by Telemedicine to Cancer Patients at Home,,Recruiting,Cancer,Supportive Care,,,,,,Other: In-person in clinic follow-up visit|Other: Telemedicine follow-up visit,Memorial Sloan Kettering Cancer Center,All,"18 Years and older   (Adult, Older Adult)",466.0,Other,Interventional,2019-10-24,01/10/21,2021-01-10,23/10/19,02/07/20,"Memorial Sloan Kettering Cancer Center, New York, New York",United States,Cancers,1,2,444.0
5526.0,NCT03681288,Mindful Self Compassion for Combat Deployed Veterans With Moral Injury and Co-occurring PTSD-SUD,,"Active, not recruiting",Substance Use Disorder,Post-traumatic Stress Disorder,Moral Injury,,,,,Behavioral: Mindful Self-Compassion,VA Office of Research and Development|Providence VA Medical Center,All,"18 Years and older   (Adult, Older Adult)",24.0,U.S. Fed,Interventional,2019-05-21,26/02/21,2021-03-31,24/09/18,19/01/21,"Providence VA Medical Center, Providence, RI, Providence, Rhode Island",United States,Mental Health,1,3,680.0
5527.0,NCT04801316,Steady Feet: Proof of Value,,Not yet recruiting,Community-dwelling Older Adults,Fall Risk,,,,,,Behavioral: Steady Feet exercise programme|Behavioral: Steady Feet Video,Changi General Hospital,All,"21 Years and older   (Adult, Older Adult)",290.0,Other,Interventional,2021-01-04,31/01/22,2023-03-31,17/03/21,17/03/21,"Changi General Hospital, Singapore",Singapore,Others,0,2,816.0
5528.0,NCT04020484,Making Mindfulness Matter© in Children With Epilepsy,M3Epilepsy,Recruiting,Epilepsy in Children,Mindfulness,Quality of Life,,,,,Behavioral: Making Mindfulness Matter© (M3),Lawson Health Research Institute|Canadian Institutes of Health Research (CIHR),All,4 Years to 10 Years   (Child),100.0,Other,Interventional,2019-02-12,01/09/22,2022-12-20,16/07/19,18/02/21,"Epilepsy Southwestern Ontario, London, Ontario",Canada,Neurological Disorders,1,3,1407.0
5529.0,NCT04155463,Measurement of Agricultural and Dietary Glyphosate Exposure Among Pregnant Women,,Recruiting,Exposure to Herbicides,,,,,,,Other: Organic Diet|Other: Conventional Diet,Boise State University|National Institute of Environmental Health Sciences (NIEHS),Female,18 Years to 35 Years   (Adult),40.0,Other|NIH,Interventional,2021-02-23,01/08/21,2022-01-08,07/11/19,08/04/21,"Boise State University, Boise, Idaho",United States,Others,0,1,319.0
5530.0,NCT04524286,Role of Midwifery Continuity of Care in Reducing Health Inequalities,Mi-CARE,Recruiting,"Health Knowledge, Attitudes, Practice",Social Determinants,Public Health,Pregnancy Related,,,,Other: Interviews only.,Bournemouth University|University Hospital Southampton NHS Foundation Trust,Female,"16 Years to 50 Years   (Child, Adult)",60.0,Other,Observational,2020-06-11,18/09/21,2022-03-18,24/08/20,25/11/20,"Princess Anne Hospital - University Hospital Southampton, Southampton",United Kingdom,Others,0,4,645.0
5531.0,NCT04498819,Wearable Technology and a Virtual Lifestyle Program for Type 2 Diabetics,STAND-VAT,"Active, not recruiting",Type 2 Diabetes,Comorbidities and Coexisting Conditions,,,,,,"Behavioral: Wearable Activity Trackers, Exercise Prescription and Virtual Care","Western University, Canada",All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-09-11,01/05/21,2021-01-05,05/08/20,08/04/21,"SJHC Primary Care for Diabetes Support Program, London, Ontario",Canada,Metabolic Disorders,1,2,116.0
5532.0,NCT04767568,Exploratory Study of the Relevance of a Blood Test in the Management of Patients in the Context of Colorectal Cancer Screening,PREDICT-IRFC,Not yet recruiting,Colorectal Cancer,,,,,,,Diagnostic Test: Blood sample|Other: Tumor tissue,Centre Hospitalier Universitaire de Besancon,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Interventional,2021-01-03,01/03/23,2027-01-09,23/02/21,23/02/21,"CHU de Besançon, Besançon, France|Hôpital Nord-Franche-Comté, Montbéliard, France|Centre Hospitalier Intercommunal de Haute-Saône, Vesoul",France,Cancers,1,1,2197.0
5533.0,NCT04662775,Formative Evaluation of The HERizon Project,,Completed,Physical Activity,,,,,,,Behavioral: HERizon Project,Liverpool John Moores University|University of Liverpool|Dublin City University|Radboud University,Female,13 Years to 16 Years   (Child),42.0,Other,Interventional,2020-04-15,08/07/20,2020-08-07,10/12/20,16/12/20,"Dublin City University, Dublin, Ireland|LiverpoolJMU, Liverpool, Merseyside, United Kingdom|Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology, Liverpool",United Kingdom,Others,0,1,114.0
5534.0,NCT04772521,Smoking Cessation Programme in Workplaces in Hong Kong (Phase Ⅴ),,Not yet recruiting,Smoking Cessation,,,,,,,Behavioral: General health talk|Behavioral: Personalized chat-based interactions|Behavioral: Text message|Behavioral: Phone follow-up/counselling service|Drug: Mailed nicotine replacement therapy (NRT),"The University of Hong Kong|Lok Sin Tong Benevolent Society, Kowloon",All,"18 Years and older   (Adult, Older Adult)",735.0,Other,Interventional,2021-01-04,30/06/23,2023-12-30,26/02/21,06/04/21,"School of Nursing, The University of Hong Kong, Hong Kong",Hong Kong,Others,0,1,1090.0
5535.0,NCT04379622,"Diet, Body Composition, Lifestyle and Cardiovascular Health of Healthy and Active Adults From Slovenia",SloLifestyle,Completed,"Diet, Healthy",Body Weight,Time Restricted Feeding,Sleep,Cardiovascular Risk Factor,Motivation,,"Other: Dietary intake, body composition, lifestyle, and CVD risk factors",Barbara Jakše s.p.,All,"18 Years to 80 Years   (Adult, Older Adult)",93.0,Other,Observational,2020-05-22,05/08/20,2020-05-08,07/05/20,06/08/20,"PDP Spodnje Črnuče, Ljubljana",Slovenia,Others,0,6,-14.0
5536.0,NCT04168814,Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study,NOS,Completed,Malnutrition,Oncologic Complications,Oncology,Quality of Life,,,,Other: Observational test,Universidad Pontificia Comillas|Baxter Healthcare Corporation|Iqvia Pty Ltd|SPANISH SOCIETY OF ONCOLOGY NURSING,All,"18 Years and older   (Adult, Older Adult)",586.0,Other|Industry,Observational,2020-10-06,09/10/20,2020-12-15,19/11/19,22/01/21,"Hospital Virgen de los Lirios, Alcoy, Alicante, Spain|Hospital Universitario Quirón Madrid, Pozuelo De Alarcón, Madrid, Spain|Clínica Universidad de Navarra, Pamplona, Navarra, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Spain|Hospital Universitari Vall d´Hebron, Barcelona, Spain|Universidad Pontificia Comillas, Madrid, Spain|Hospital Universitario 12 de Octubre, Madrid, Spain|Hospital Son Espases, Palma De Mallorca, Spain|Hospital Universitario Donosti, San Sebastián, Spain|Hospital Universitario de Canarias, Santa Cruz De Tenerife, Spain|Hospital Virgen del Rocío, Sevilla",Spain,Others,0,4,70.0
5537.0,NCT04323163,"Yoga, Aerobic and Stretching Exercise Effects on Neurocognition",,Recruiting,Aging,Cognitive Decline,,,,,,Behavioral: Physical Activity,University of Illinois at Urbana-Champaign|Wayne State University,All,"55 Years to 79 Years   (Adult, Older Adult)",168.0,Other,Interventional,2021-01-01,31/12/24,2025-03-31,26/03/20,16/03/21,"University of Illinois at Urbana-Champaign, Urbana, Illinois",United States,Others,0,2,1550.0
5538.0,NCT04512378,Group CBT for Intolerance of Uncertainty,,Recruiting,Generalized Anxiety Disorder,Intolerance of Uncertainty,Anxiety,,,,,Behavioral: Behavioural Experiments for Intolerance of Uncertainty,University of Manitoba,All,"18 Years to 89 Years   (Adult, Older Adult)",20.0,Other,Interventional,2021-01-02,01/08/21,2021-01-08,13/08/20,04/02/21,"Deer Lodge Centre, Winnipeg, Manitoba",Canada,Mental Health,1,3,6.0
5539.0,NCT04157296,Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety,,Recruiting,Anxiety Disorders,,,,,,,Behavioral: Cognitive behavioral therapy (CBT)|Behavioral: computerized cognitive training (CCT),University of Michigan|National Institutes of Health (NIH),All,7 Years to 17 Years   (Child),54.0,Other|NIH,Interventional,2020-04-02,01/07/21,2021-01-07,08/11/19,26/01/21,"University of Michigan, Ann Arbor, Michigan",United States,Mental Health,1,1,280.0
5540.0,NCT04562350,"XatJove Anoia, as a Tool to Bring Health Services Closer to Teenagers",,Recruiting,Healthy,,,,,,,Other: XatJove Anoia Aplication,Jordi Gol i Gurina Foundation|Institut Català de la Salut,All,12 Years to 16 Years   (Child),500.0,Other,Interventional,2020-01-10,20/06/21,2021-11-10,24/09/20,24/09/20,"SAP Anoia, Igualada, Barcelona",Spain,Others,0,1,670.0
5541.0,NCT04462250,Mobile Health (mHealth) App for Safe Opioid Use,,Not yet recruiting,Opioid Use,,,,,,,Device: Prescription Opioid Management App,"Rutgers, The State University of New Jersey",All,"18 Years to 65 Years   (Adult, Older Adult)",15.0,Other,Interventional,2021-01-03,30/06/21,2021-06-30,08/07/20,08/07/20,"North Jersey Community Research Initiative, Newark, New Jersey",United States,Others,0,1,178.0
5542.0,NCT03680287,Effects of Sleep Disruption on Drug Response,,Recruiting,"Low Back Pain, Recurrent",Healthy,,,,,,Drug: Within-Subject test of blinded study medication,Johns Hopkins University|National Institute on Drug Abuse (NIDA),All,21 Years to 60 Years   (Adult),250.0,Other|NIH,Interventional,2019-07-10,29/02/24,2024-02-29,21/09/18,19/01/21,"Johns Hopkins School of Medicine, Baltimore, Maryland",United States,Others,0,2,1695.0
5543.0,NCT03105102,A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease,,"Active, not recruiting",Crohn's Disease,,,,,,,Drug: Placebo for Risankizumab SC|Drug: Risankizumab IV|Drug: Placebo for Risankizumab IV|Drug: Risankizumab SC|Drug: Risankizumab On-Body Injector (OBI),AbbVie,All,"18 Years to 80 Years   (Adult, Older Adult)",1337.0,Industry,Interventional,2018-09-04,09/06/26,2026-09-06,07/04/17,13/04/21,"Phoenix VA Healthcare /ID# 162264, Phoenix, Arizona, United States|Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884, Tempe, Arizona, United States|University of Arizona /ID# 158502, Tucson, Arizona, United States|Atria Clinical Research /ID# 164505, Little Rock, Arkansas, United States|Southern California Res. Ctr. /ID# 211991, Coronado, California, United States|Care Access Research, Huntington Beach /ID# 213035, Huntington Beach, California, United States|UC San Diego Health Systems /ID# 155555, La Jolla, California, United States|United Medical Doctors /ID# 207888, Los Alamitos, California, United States|TLC Clinical Research Inc /ID# 212719, Los Angeles, California, United States|Gastrointestinal Biosciences /ID# 162657, Los Angeles, California, United States|United Medical Doctors - Murrieta /ID# 158300, Murrieta, California, United States|University of California, San Francisco - 16th St /ID# 157127, San Francisco, California, United States|Cedars-Sinai Medical Center - West Hollywood /ID# 163839, West Hollywood, California, United States|Peak Gastroenterology Associat /ID# 165843, Colorado Springs, Colorado, United States|Rocky Mountain Pediatric Gastroenterology /ID# 207170, Lone Tree, Colorado, United States|Western Connecticut Medical Group /ID# 165879, Danbury, Connecticut, United States|Brandon Premier Health Care, PA /ID# 162262, Brandon, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 205865, Clearwater, Florida, United States|Clinical Research of West Florida - Clearwater /ID# 208125, Clearwater, Florida, United States|South Lake Pain Institute, Inc /ID# 162808, Clermont, Florida, United States|Omega Research Maitland, LLC /ID# 171082, DeBary, Florida, United States|Universal Axon Clinical Resear /ID# 165428, Doral, Florida, United States|Nature Coast Clinical Research - Inverness /ID# 159408, Inverness, Florida, United States|SIH Research Mumtaz, Inc /ID# 163083, Kissimmee, Florida, United States|Alliance Medical Research /ID# 163837, Lighthouse Point, Florida, United States|Ctr for Advanced Gastroenterol /ID# 202479, Maitland, Florida, United States|University of Miami /ID# 155007, Miami, Florida, United States|Coral Research Clinic /ID# 158456, Miami, Florida, United States|South Florida Research Ph I-IV /ID# 161832, Miami, Florida, United States|Gastroenterology Group Naples /ID# 165204, Naples, Florida, United States|Advanced Research Institute /ID# 161966, New Port Richey, Florida, United States|Endoscopic Research, Inc. /ID# 205906, Orlando, Florida, United States|IMIC Inc. /ID# 154942, Palmetto Bay, Florida, United States|Atlanta Gastro Assoc /ID# 154724, Atlanta, Georgia, United States|Gastroenterology Associates of Central Georgia, LLC /ID# 154850, Macon, Georgia, United States|Northwestern University /ID# 158261, Chicago, Illinois, United States|The University of Chicago Medical Center /ID# 157124, Chicago, Illinois, United States|NorthShore University HealthSystem - Evanston Hospital /ID# 158265, Evanston, Illinois, United States|Southwest Gastroenterology /ID# 164781, Oak Lawn, Illinois, United States|Cotton-O'Neil Clinical Res Ctr /ID# 154722, Topeka, Kansas, United States|University of Kentucky Chandler Medical Center /ID# 157120, Lexington, Kentucky, United States|University of Louisville /ID# 210525, Louisville, Kentucky, United States|Gastroenterology Associates LLC - Jefferson Hwy /ID# 161963, Baton Rouge, Louisiana, United States|Houma Digestive Health Special /ID# 158264, Houma, Louisiana, United States|Delricht Research /ID# 206644, New Orleans, Louisiana, United States|Nola Research Works, LLC /ID# 161317, New Orleans, Louisiana, United States|Louisana Research Center, LLC /ID# 162237, Shreveport, Louisiana, United States|MGG Group Co, Inc.Chevy Chase Clinical Research /ID# 154832, Chevy Chase, Maryland, United States|Gastro Center of Maryland /ID# 165001, Columbia, Maryland, United States|University of Michigan Health Systems /ID# 157126, Ann Arbor, Michigan, United States|Clin Res Inst of Michigan, LLC /ID# 169179, Chesterfield, Michigan, United States|Center for Digestive Health /ID# 154683, Troy, Michigan, United States|Gastroenterology Associates of Western Michigan, PLC /ID# 161313, Wyoming, Michigan, United States|Mayo Clinic /ID# 163086, Rochester, Minnesota, United States|Southern Therapy and Advanced Research (STAR) LLC /ID# 154831, Jackson, Mississippi, United States|Saint Louis University School of Medicine /ID# 161883, Saint Louis, Missouri, United States|University of Nebraska Med Ctr /ID# 210058, Omaha, Nebraska, United States|Las Vegas Medical Research /ID# 160170, Las Vegas, Nevada, United States|Revival Research Institute, LLC /ID# 210985, Las Vegas, Nevada, United States|NY Scientific /ID# 158294, Brooklyn, New York, United States|Saratoga Schenectady Gastroenterology Associates - Burnt Hills /ID# 213447, Burnt Hills, New York, United States|Intercity Advanced Gastroentertology Center /ID# 215205, Fresh Meadows, New York, United States|Long Island Clinical Research /ID# 154829, Great Neck, New York, United States|Digestive Dis Care/Excel Med /ID# 211777, New Hyde Park, New York, United States|North Shore University Hospital /ID# 168738, New Hyde Park, New York, United States|NYU Langone Medical Center /ID# 160169, New York, New York, United States|Weill Cornell Medicine /ID# 165878, New York, New York, United States|The Mount Sinai Hospital /ID# 165612, New York, New York, United States|Columbia Univ Medical Center /ID# 161899, New York, New York, United States|Lenox Hill Hospital, Northwell /ID# 168467, New York, New York, United States|DiGiovanna Institute for Medical Education & Research /ID# 171126, North Massapequa, New York, United States|Univ NC Chapel Hill /ID# 154833, Chapel Hill, North Carolina, United States|Atrium Health Carolinas Medical Center /ID# 158428, Charlotte, North Carolina, United States|Wake Research Associates, LLC /ID# 154873, Raleigh, North Carolina, United States|Plains Clinical Research Center, LLC /ID# 169718, Fargo, North Dakota, United States|Tri-State Endoscopy /ID# 154927, Cincinnati, Ohio, United States|Cleveland Clinic Main Campus /ID# 209226, Cleveland, Ohio, United States|The Ohio State University /ID# 164708, Columbus, Ohio, United States|Optimed Research, Ltd. /ID# 167887, Columbus, Ohio, United States|Hometown Urgent Care and Resea /ID# 170464, Dayton, Ohio, United States|Great Lakes Gastroenterology Research LLC /ID# 201770, Mentor, Ohio, United States|Hightower Clinical /ID# 211993, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists /ID# 170775, Oklahoma City, Oklahoma, United States|Adult Gastroenterology Associates - Main /ID# 208864, Tulsa, Oklahoma, United States|Children's Hospital of Pittsburgh of UPMC /ID# 212544, Pittsburgh, Pennsylvania, United States|Digestive Disease Associates, LTD /ID# 208297, Wyomissing, Pennsylvania, United States|Medical University of South Carolina /ID# 212858, Charleston, South Carolina, United States|Gastroenterology Associates, P.A. /ID# 154904, Greenville, South Carolina, United States|Rapid City Medical Center /ID# 163838, Rapid City, South Dakota, United States|Gastro One /ID# 154726, Germantown, Tennessee, United States|East Tennessee Research Instit /ID# 168739, Johnson City, Tennessee, United States|Clinical Neuroscience /ID# 164180, Memphis, Tennessee, United States|Vanderbilt Univ Med Ctr /ID# 157121, Nashville, Tennessee, United States|TX Clinical Research Institute /ID# 159404, Arlington, Texas, United States|Inquest Clinical Research /ID# 165694, Baytown, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209797, Cedar Park, Texas, United States|Texas Digestive Disease Consultants - Cedar Park /ID# 209946, Cedar Park, Texas, United States|Baylor Scott & White Research /ID# 159406, Dallas, Texas, United States|DHAT Research Institute /ID# 158208, Garland, Texas, United States|Vilo Research Group Inc /ID# 207655, Houston, Texas, United States|Baylor College of Medicine /ID# 158203, Houston, Texas, United States|Centex Studies, Inc. - Houston /ID# 201219, Houston, Texas, United States|Clin",United Kingdom,Others,0,1,2924.0
5544.0,NCT04540679,Self-Management Across the Care Continuum,,Not yet recruiting,Spinal Cord Injuries,,,,,,,Other: VIP4SCI,"Lawson Health Research Institute|ForaHealthyMe Inc|University Health Network, Toronto|Spinal Cord Injury Ontario|The Craig H. Neilsen Foundation",All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-09,29/04/21,2021-04-29,07/09/20,07/09/20,,,Others,0,1,476.0
5545.0,NCT04375657,"Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial",TRIIM-X,Recruiting,Epigenetic Aging,Immunosenescence,,,,,,Combination Product: TRIIM Treatment|Combination Product: Active Control,"Intervene Immune, Inc.",All,"40 Years to 80 Years   (Adult, Older Adult)",85.0,Industry,Interventional,2020-01-10,01/10/21,2022-01-10,05/05/20,05/05/20,"Intervene Immune, Torrance, California",United States,Others,0,2,731.0
5546.0,NCT03581123,Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain,PACBACK,Recruiting,Acute Pain,"Low Back Pain, Mechanical",,,,,,Behavioral: Supported-Self Management (SSM)|Other: Spinal Manipulation Therapy (SMT)|Combination Product: SMT + SSM|Drug: Standard Medical Care (SMC),University of Minnesota|University of Pittsburgh|University of Washington|University of North Texas Health Science Center|Oregon Health and Science University|Duke University,All,"18 Years and older   (Adult, Older Adult)",1180.0,Other,Interventional,2018-10-25,01/12/22,2023-01-09,10/07/18,19/12/20,"University of Minnesota, Minneapolis, Minnesota, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|University of Washington, Seattle, Washington",United States,Others,0,2,1537.0
5547.0,NCT04836026,Registry for HF20 for Pediatric CRRT Under Emergency Use Authorization,,Enrolling by invitation,Pediatric Kidney Disease,Acute Kidney Injury,,,,,,Device: HF20™,"Children's Hospital Medical Center, Cincinnati|Baxter Healthcare Corporation",All,"Child, Adult, Older Adult",20.0,Other|Industry,Observational,2021-01-27,30/11/22,2022-12-31,08/04/21,09/04/21,"Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio",United States,Others,0,2,703.0
5548.0,NCT03170882,"A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma",,"Active, not recruiting",Relapsed and/or Refractory Multiple Myeloma,,,,,,,Drug: Ixazomib|Drug: Pomalidomide|Drug: Dexamethasone,"Millennium Pharmaceuticals, Inc.|Takeda",All,"18 Years and older   (Adult, Older Adult)",120.0,Industry,Interventional,2017-01-08,31/05/20,2021-06-16,31/05/17,16/02/21,"Highlands Oncology Group, Fayetteville, Arkansas, United States|St Joseph Heritage Healthcare, Santa Rosa, California, United States|Lynn Cancer Institute, Boca Raton, Florida, United States|University of Florida, Gainesville, Florida, United States|University of Maryland, Baltimore, Maryland, United States|Henry Ford Health System, Detroit, Michigan, United States|Michigan State University, Lansing, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|San Juan Oncology Associates, Farmington, New Mexico, United States|University of Toledo Medical Center, Toledo, Ohio, United States|Icon Cancer Care South Brisbane, South Brisbane, Queensland, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Box Hill Hospital, Box Hill, Victoria, Australia|St Vincents Hospital Melbourne, Fitzroy, Victoria, Australia|Royal Adelaide Hospital, Adelaide, Australia|GasthuisZusters Antwerpen, Wilrijk, Antwerpen, Belgium|AZ St Jan Brugge Oostende AV, Brugge, Belgium|Royal Victoria Regional Health Centre, Barrie, Ontario, Canada|Lakeridge Health Center, Ottawa, Ontario, Canada|Fakultni nemocnice Hradec Kralove, Hradec Kralove, Kralovehradeck Kraj, Czechia|University Hospital Olomouc, Olomouc, Olomouck Kraj, Czechia|Fakultni nemocnice Kralovske Vinohrady, Prague, Praha, Hlavni Mesto, Czechia|Vseobecna fakultni nemocnice v Praze, Praha, Praha, Hlavni Mesto, Czechia|Fakultni nemocnice Brno, Brno, Czechia|Fakultni nemocnice Ostrava, Ostrava, Czechia|Fakultni nemocnice Plzen, Plzen Lochotin, Czechia|Aalborg Universitetshospital, Aalborg, Nordjylland, Denmark|Regionshospitalet Holstebro, Holstebro, Denmark|Centre Antoine Lacassagne Centre Regional de Lutte Contre Le Cancer, Nice, Alpes-Maritimes, France|CHRU Dijon Complexe Du Bocage, Dijon, Cote-d'Or, France|CHRU de Brest - Hopital Morvan, Brest, Finistere, France|CHRU Nancy, Vandoeuvre Les Nancy, Meurthe-et-Moselle, France|Centre Hospitalier Bretagne Atlantique Vannes, Vannes, Morbihan, France|Centre Hospitalier Le Mans, Le Mans, Sarthe, France|Groupe Hospitalier du Havre, Montivilliers, Seine-Maritime, France|CHU Amiens Hopital Sud, Amiens, France|Centre Hospitalier Fleyriat, Bourg-en- Bresse Cedex, France|Centre Hospitalier (CH) William Morey, Chalon sur Saone, France|Hospital d Instructions des Armees Percy, Clamart, France|Centre Hospitalier de Dunkerque, Dunkerque, France|Centre Jean Bernard Clinique Victor Hugo, Le Mans cedex 2, France|Centre Hospitalier Regional d'Orleans, Orleans, France|Centre Hospitalier de Perigueux, Perigueux, France|CHRU de Poitiers La Miletrie, Poitiers, France|CHRU Rennes, Rennes Cedex 9, France|Centre Henri Becquerel, Rouen, France|Uberortliche Gemeinschaftspraxis Pasing und Furstenfeldbruck, Munchen, Bayern, Germany|Universitatsklinikum Dusseldorf, Dusseldorf, Germany|Asklepios Klinik Altona, Hamburg, Germany|Universitatsklinikum Tubingen, Tubingen, Germany|University General Hospital of Patras, Patra, Achaia, Greece|University Hospital of Alexandroupolis, Alexandroupoli, Greece|Evangelismos General Hospital of Athens, Athens, Greece|Alexandra Hospital, Athens, Greece|University General Hospital of Ioannina, Ioannina, Greece|Theageneio Anticancer Oncology Hospital of Thessaloniki, Thessaloniki, Greece|Soroka University Medical Centre, Beer Sheva, Israel|Bnai Zion Medical Center, Haifa, Israel|Rambam Health Corporation, Haifa, Israel|Lady Davis Carmel Medical Center, Haifa, Israel|Hadassah Medical Center, Jerusalem, Israel|Azienda Ospedaliero Universitaria Di Bologna - Policlinico S Orsola Malpighi, Bologna, Emilia-Romagna, Italy|Ospedale Santa Maria Delle Croci, Ravenna, Emilia-Romagna, Italy|Arcispedale Santa Maria Nuova, Reggio Emilia, Emilia-Romagna, Italy|Ospedale Infermi di Rimini, Rimini, Emilia-Romagna, Italy|Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro, Marche, Italy|Fondazione del Piemonte per lOncologia (IRCCS), Candiolo, Piemonte, Italy|Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano, Piemonte, Italy|Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino, Piemonte, Italy|Centro Di Riferimento Oncologico Della Basilicata, Rionero in Vulture, PZ, Italy|Centro Di Riferimento Oncologico, Aviano, Italy|ASST degli Spedali Civili di Brescia - Spedali Civili di Brescia, Brescia, Italy|Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST, Meldola, Italy|Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milano, Italy|Azienda Ospedaliero Universitaria Di Modena Policlinico, Modena, Italy|Azienda Ospedaliero Universitaria di Parma, Parma, Italy|Ospedale Santa Maria Della Misericordia, Udine, Italy|Azienda ULSS 6 Vicenza, Vicenza, Italy|Albert Schweitzer Ziekenhuis, Dordrecht, Zuid-Holland, Netherlands|Zuyderland Medisch Centrum, Sittard, Netherlands|Oslo Universitetssykehus HF Rikshospitalet, Oslo, Oppland, Norway|Haukeland Universitetssykehus, Bergen, Norway|Forde Sentralsjukehus, Forde, Norway|Stavanger Universitetssykehus, Stavanger, Norway|St Olavs Hospital, Trondheim, Norway|Kirov Research Institute of Haematology and Blood Transfusion, Kirov, Russian Federation|Moscow Clinical Scientific Center, Moscow, Russian Federation|City Clinical Hospital n a S P Botkin, Moscow, Russian Federation|City Clinical Hospital # 40, Moscow, Russian Federation|Samara State Medical University, Samara, Russian Federation|Hospital Universitario Infanta Leonor, Madrid, Madrid, Communidad Delaware, Spain|Hospital Universitari de Girona Dr Josep Trueta, Girona, Spain|Hospital Clinico Universitario de Valencia, Valencia, Spain|Helsingborg Lasarett, Helsingborg, Skane Lan, Sweden|Sodra Alvsborgs Sjukhus Boras, Boras, Sweden|Norrlands Universitetssjukhus, Umea, Sweden|Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastirma Hastanesi, Ankara, Turkey|Gazi University Medical Faculty Gazi Hospital, Ankara, Turkey|Ankara University Medical Faculty Cebeci Hospital, Ankara, Turkey|Dokuz Eylul University Medical Faculty, Izmir, Turkey|Ege Universitesi Tip Fakultesi Hastanesi, Izmir, Turkey|Erciyes Universitesi Tip Fakultesi Hastanesi, Kayseri, Turkey|Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|Betsi Cadwaladr University Health Board, Bodelwyddan, Denbighshire-SirDdinbych, United Kingdom|Royal Bournemouth Hospital, Bournemouth, Dorset, United Kingdom|Kent and Canterbury Hospital, Canterbury, Kent, United Kingdom|GenesisCare Oxford, Oxford, Oxfordshire, United Kingdom|Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire, United Kingdom|Leicester Royal Infirmary, Leicester, United Kingdom|Singleton Hospital, Swansea, United Kingdom|New Cross Hospital, Wolverhampton",United Kingdom,Others,0,1,1620.0
5549.0,NCT04545424,Trial of Therapeutic Hypothermia in Patients With ARDS,CHILL,Not yet recruiting,"Respiratory Distress Syndrome, Adult",,,,,,,Device: Hypothermia|Drug: Neuromuscular Blocking Agents|Device: Standard of care,"University of Maryland, Baltimore|US Department of Veterans Affairs Cooperative Studies Program|KAI Research|United States Department of Defense",All,"18 Years to 65 Years   (Adult, Older Adult)",340.0,Other|U.S. Fed,Interventional,2021-01-31,01/12/23,2024-05-31,11/09/20,05/01/21,"Christiana Medical Center, Newark, Delaware, United States|Emory University, Atlanta, Georgia, United States|Rush University Medical Center, Chicago, Illinois, United States|University of Illinois at Chicago, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|Loyola University Chicago, Chicago, Illinois, United States|University of Maryland Medical Center, Baltimore, Maryland, United States|Johns Hopkins Hospital, Baltimore, Maryland, United States|Mayo Clinic Rochester Minnesota, Rochester, Minnesota, United States|Cleveland Clinc, Cleveland, Ohio, United States|University of Pennsylavia, Philadelphia, Pennsylvania, United States|Thomas Jefferson University, Philadelphia, Pennsylvania, United States|Temple University, Philadelphia, Pennsylvania, United States|Brooke Army Medical Center, Fort Sam Houston, Texas",United States,Others,0,1,1216.0
5550.0,NCT03329677,An 18-Month Psychotherapy of Borderline Personality Disorder,,Recruiting,Borderline Personality Disorder,,,,,,,Other: Transference-focused Psychotherapy (TFP),Weill Medical College of Cornell University,Female,18 Years to 35 Years   (Adult),45.0,Other,Interventional,2016-01-01,01/01/22,2022-01-01,06/11/17,29/12/20,"Personality Disorders Institute of the Weill Medical College of Cornell University, White Plains, New York",United States,Others,0,1,2192.0
5551.0,NCT03797378,"Movement-2-Music: Lakeshore Examination of Activity, Disability, and Exercise Response Study",M2M LEADERS,Recruiting,Spinal Cord Injuries,Traumatic Brain Injury,Spina Bifida,Cerebral Palsy,Stroke,Parkinson Disease,Multiple Sclerosis,Other: eM2M,University of Alabama at Birmingham|Lakeshore Foundation|YMCA of Greater Birmingham,All,"18 Years to 70 Years   (Adult, Older Adult)",108.0,Other,Interventional,2019-09-08,31/05/23,2023-09-30,09/01/19,20/10/20,"UAB/Lakeshore Research Collaborative, Birmingham, Alabama",United States,"Cardiovascular Diseases, Immunological Disorders",1,7,1483.0
5552.0,NCT03786315,Exploring 'VOLITION' in Context - a Study to Inform the Implementation of a New Intervention,VOLITION,Recruiting,Decision Making,Aged,Multimorbidity,General Practice,,,,,"University of Exeter|National Institute for Health Research, United Kingdom|University of Leeds",All,65 Years and older   (Older Adult),150.0,Other,Observational,2021-04-01,01/01/22,2022-01-01,26/12/18,07/01/21,"University of Exeter Medical School, Exeter, Devon",United Kingdom,Others,0,4,275.0
5553.0,NCT04530188,Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS,,Not yet recruiting,ARDS,"ARDS, Human",,,,,,Drug: Sevoflurane|Drug: Propofol,Bicetre Hospital,All,"18 Years to 99 Years   (Adult, Older Adult)",68.0,Other,Interventional,2020-01-11,01/05/22,2022-01-11,28/08/20,28/08/20,,,Respiratory Diseases,1,2,731.0
5554.0,NCT04234815,Evaluating Impacts of CSS for Veterans and Their Families in Ukraine,,Recruiting,Psychosocial Problem,Psychological Distress,"Engagement, Patient",,,,,Behavioral: CETA Short Session (CSS)|Behavioral: Psychoeducation and Safety,Johns Hopkins Bloomberg School of Public Health|United States Agency for International Development (USAID),All,"18 Years and older   (Adult, Older Adult)",1387.0,Other|U.S. Fed,Interventional,2020-02-28,01/05/21,2021-01-06,21/01/20,07/09/20,"NaUKMA, Kyiv",Ukraine,Others,0,3,313.0
5555.0,NCT04742270,Home-Care Bronchiectasis,,Recruiting,Bronchiectasis Adult,,,,,,,Device: SIMEOX+ respiratory physiotherapy telecare,Physio-Assist|Icadom,All,"18 Years and older   (Adult, Older Adult)",22.0,Industry,Interventional,2021-04-03,01/10/21,2021-01-10,08/02/21,23/03/21,"Grenoble University-Affiliated Hospital : Pneumology department, Grenoble, France|Toulouse University-Affiliated Hospital : Pneumology department, Toulouse",France,Others,0,1,-83.0
5556.0,NCT04663685,MoveStrong at Home,,Recruiting,Arthritis,Cancer,Cardiovascular Diseases,Chronic Lung Disease,Congestive Heart Failure,Diabetes,Hypertension,Other: Exercise program|Other: Nutrition education,University of Waterloo,All,"60 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2020-05-10,01/04/21,2021-01-04,11/12/20,11/12/20,"University of Waterloo, Waterloo",Canada,"Cardiovascular Diseases, Metabolic Disorders, Cancers",1,7,239.0
5557.0,NCT04797481,Pilot Testing of an Online Rehabilitation Intervention for People With Heart Failure (PORIAS-HF).,PORIAS-HF,Not yet recruiting,Heart Failure,,,,,,,Procedure: Exercise|Procedure: Self-managed exercise,Sheffield Hallam University|King's College London|Sheffield Teaching Hospitals NHS Foundation Trust,All,"18 Years to 100 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-03-27,31/12/21,2022-03-30,15/03/21,15/03/21,"Sheffield Hallam University, Sheffield, Yorkshire",United Kingdom,Others,0,1,368.0
5558.0,NCT04744272,Exploring the Efficacy of myAsthma in Secondary Care,STEERING,Not yet recruiting,Asthma,,,,,,,Device: myAsthma,my mhealth Ltd|Bradford Teaching Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry|Other,Interventional,2021-01-03,01/12/21,2022-01-02,08/02/21,08/02/21,"Bradford Teaching Hospitals NHS Foundation Trust, Bradford Institute for Health Research, Bradford, Yorkshire",United Kingdom,Others,0,1,364.0
5559.0,NCT03881228,Patient Centered Intervention to Prevent Tuberculosis Among Children Under Five Years Old,,Recruiting,Tuberculosis,Pediatric ALL,"Behavior, Health",,,,,Behavioral: Increasing the completion of IPT,Universidad Peruana Cayetano Heredia,All,"up to 100 Years   (Child, Adult, Older Adult)",300.0,Other,Interventional,2019-01-12,01/12/22,2023-12-15,19/03/19,19/11/20,"Instituto de Medicina Tropical Alexander von Humboldt, Lima",Peru,Infectious Diseases,0,3,1798.0
5560.0,NCT03959995,Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia,ACTLIFE,Completed,"Osteopenia, Osteoporosis",,,,,,,Other: High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT)|Other: Wellness,University of Erlangen-Nürnberg Medical School,Female,48 Years to 58 Years   (Adult),27.0,Other,Interventional,2019-01-15,13/03/20,2020-05-06,22/05/19,09/06/20,"Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Bavaria",Germany,Others,0,1,477.0
5561.0,NCT04639557,Building Regulation in Dual Generations - Telehealth Model,BRIDGE,Enrolling by invitation,Dual-generation Intervention for Mothers With Depression,,,,,,,Behavioral: BRIDGE Therapy Program,University of Manitoba|Research Manitoba|Centre for Addiction and Mental Health|University of Oregon,Female,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-09,01/05/21,2021-01-05,20/11/20,20/11/20,"The University of Manitoba - Department of Psychology, Winnipeg, Manitoba",Canada,Mental Health,1,1,362.0
5562.0,NCT04763889,Cognitive Behaviour Therapy for Adults With Allergy.,,Recruiting,Allergy,Anxiety,,,,,,Behavioral: CBT,University of Surrey,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-02,30/11/21,2021-12-30,21/02/21,21/02/21,"University of Surrey, Guildford, Surrey",United Kingdom,Mental Health,1,2,362.0
5563.0,NCT04778930,"Physical Therapy for Improving Functionality, Gait and Participation in Cerebral Palsy",FIMAPACE,Not yet recruiting,Physical Therapy,Cerebral Palsy,Therapeutic Education,Telehealth,,,,Other: Physical Therapy|Other: THERAPEUTIC EDUCATION PROGRAM,University of Alcala,All,6 Years to 17 Years   (Child),66.0,Other,Interventional,2021-01-09,31/07/22,2022-12-31,03/03/21,03/03/21,,,Others,0,4,721.0
5564.0,NCT04659590,An Exploratory Study Investigating the Potential of a Rectal Mucus Sample for Development of Biomarker Assays in Subjects With Gastrointestinal Diseases,ORI-EGI-02,Recruiting,Bowel Cancer,Bowel Disease,Genomic,Epigenetic Disorder,,,,,Origin Sciences,All,"18 Years to 99 Years   (Adult, Older Adult)",600.0,Industry,Observational,2020-06-11,01/07/21,2021-01-08,09/12/20,01/04/21,"Royal Cornwall Hospital, Truro, Cornwall, United Kingdom|John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom|Royal Shrewsbury & Telford Hospitals NHS Trust, Shrewsbury, Shropshire, United Kingdom|Royal Devon & Exeter NHS Foundation Trust, Exeter",United Kingdom,Cancers,1,4,211.0
5565.0,NCT03397108,Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease,,Recruiting,Crohn's Disease,Ulcerative Colitis,Healthy Controls,,,,,,The Hospital for Sick Children|MOUNT SINAI HOSPITAL|Crohn's and Colitis Foundation,Female,"18 Years and older   (Adult, Older Adult)",160.0,Other,Observational,2017-04-07,30/06/21,2021-06-30,11/01/18,08/10/20,"Mount Sinai Hospital, Toronto, Ontario, Canada|The Hospital for Sick Children, Toronto, Ontario",Canada,Others,0,3,1545.0
5566.0,NCT04558073,Evaluation of Two Eating Disorders Prevention Interventions in At-Risk Female Students With Body Dissatisfaction,HEIDI-BP-HW,Recruiting,Body Dissatisfaction,,,,,,,Behavioral: Body Project (BP)|Behavioral: Healthy Weight Program (HW),School of Health Sciences Geneva,Female,18 Years to 25 Years   (Adult),90.0,Other,Interventional,2021-01-01,31/12/21,2022-02-28,22/09/20,17/03/21,"School of Health Sciences (HES-SO Geneva), Genève, Carouge",Switzerland,Others,0,1,423.0
5567.0,NCT03827057,RECONsolidation of Traumatic Memories to ResOLve Post Traumatic Stress Disorder (RECONTROLPTSD),RECONTROLPTSD,Recruiting,Posttraumatic Stress Disorder,Traumatic Brain Injury,,,,,,Behavioral: Reconsolidation of Traumatic Memories (RTM)|Behavioral: Prolonged Exposure (PE),Uniformed Services University of the Health Sciences|Research and Recognition Project,All,"18 Years and older   (Adult, Older Adult)",108.0,U.S. Fed|Other,Interventional,2019-12-06,30/09/21,2022-03-31,01/02/19,05/05/20,"Uniformed Services University of Health Sciences (USUHS), Bethesda, Maryland",United States,Mental Health,1,2,846.0
5568.0,NCT04840030,Preventing Cognitive Decline: The Go-On Multi-domain Intervention Study,GO-ON,Not yet recruiting,Dementia,Cognitive Decline,Prevention,Life Style,"Risk Factor, Cardiovascular",Diet Habit,Cognitive Intervention,Behavioral: Multimodal intervention (MM-int),Fundacion CITA-alzheimer|Asociacion Instituto Biodonostia|Basque Country University|Achucarro Basque Center For Neuroscience|NAVARRABIOMED|Basque Culinary Center Fundazioa|Karolinska Institutet,All,"60 Years to 85 Years   (Adult, Older Adult)",1094.0,Other,Interventional,2021-01-06,30/04/25,2025-04-30,09/04/21,09/04/21,,,Others,0,7,1575.0
5569.0,NCT03276559,Enhancing & Mobilizing the POtential for Wellness & Emotional Resilience Among Surrogate Decision-Makers of ICU Patients,EMPOWER,Recruiting,Critical Illness,Communication Disabilities,,,,,,Behavioral: EMPOWER|Other: Enhanced Usual Care,Weill Medical College of Cornell University|New York Hospital Queens|Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI),All,"18 Years and older   (Adult, Older Adult)",155.0,Other|NIH,Interventional,2017-12-07,31/05/21,2021-05-31,08/09/17,20/07/20,"NewYork-Presbyterian Queens, Flushing, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|NewYork-Presbyterian Weill Cornell Medicine, New York, New York",United States,Cardiovascular Diseases,1,2,1271.0
5570.0,NCT04833088,Exploratory Study About the Implementation of Technology in the Rehabilitation,,Not yet recruiting,Stroke,Parkinson Disease,COVID-19,"Neglect, Hemispatial",,,,Other: Focus group discussions,Vrije Universiteit Brussel|Universitair Ziekenhuis Brussel|AZ Sint Maria Halle|Odisee University college for applied sciences|Erasmushogeschool Brussels,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-04,01/04/22,2022-01-04,06/04/21,06/04/21,,,"Cardiovascular Diseases, Respiratory Diseases",1,4,365.0
5571.0,NCT03115359,Strategies to Assist With Management of Pain,STAMP,Recruiting,Chronic Low Back Pain,,,,,,,Behavioral: Mindfulness Meditation|Behavioral: Cognitive Behavioral Therapy,"University of Wisconsin, Madison|Patient-Centered Outcomes Research Institute",All,"21 Years and older   (Adult, Older Adult)",766.0,Other,Interventional,2017-06-30,30/06/21,2021-07-15,14/04/17,16/12/20,"Brigham and Women's Hospital, Boston, Massachusetts, United States|Pennsylvania State University, Hershey, Pennsylvania, United States|University of Utah, Salt Lake City, Utah, United States|University of Wisconsin-Madison, Madison, Wisconsin",United States,Others,0,1,1476.0
5572.0,NCT04725253,Nicotinamide to Prevent Delirium,,Not yet recruiting,Delirium Confusional State,,,,,,,Dietary Supplement: Nicotinamide|Other: Placebo tablets,"University of Chile|Fondo Nacional de Desarrollo Científico y Tecnológico, FONDECYT (Chile).",All,65 Years and older   (Older Adult),146.0,Other,Interventional,2021-01-21,01/04/22,2022-04-30,26/01/21,26/01/21,"Hospital Clínico Universidad de Chile, Santiago",Chile,Others,0,1,464.0
5573.0,NCT04076722,"Neurotrophic Indicators of Cognition, Executive Skills, Plasticity, and Adverse Childhood Experiences Study",NICE SPACES,Completed,Weight Loss,Wait-List Control,,,,,,Behavioral: Stress reactivity stimuli,Oklahoma State University,Female,"18 Years to 65 Years   (Adult, Older Adult)",55.0,Other,Interventional,2019-04-12,04/08/20,2020-11-12,03/09/19,19/03/21,"Oklahoma State University, Stillwater, Oklahoma",United States,Others,0,2,580.0
5574.0,NCT04595695,The Effect of Clear Masks in Improving Patient Relationships,,Completed,Communication,Trust,COVID-19,Surgery,,,,Behavioral: Transparent mask|Behavioral: Typical surgical covered mask,"University of North Carolina, Chapel Hill",All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-03-09,12/11/20,2020-12-14,20/10/20,14/01/21,"University of North Carolina at Chapel Hill, Chapel Hill, North Carolina",United States,Respiratory Diseases,1,4,280.0
5575.0,NCT04061785,Impact of Skills Acquired Through Judo Training on Risk Factors for Falling in Elderly Men and Women,J4BE,Recruiting,Aging Problems,Frailty,Fall Injury,Accidental Fall,Fear of Falling,,,Other: Judo4Balance - 12 week judo inspired exercise program,"Dalarna University|The Swedish Judo Federation|Sormland County Council, Sweden",All,"55 Years to 110 Years   (Adult, Older Adult)",200.0,Other,Interventional,2019-09-30,21/12/21,2022-07-31,20/08/19,25/01/21,"Dalarna University, Falun, Dalarna",Sweden,Others,0,5,1035.0
5576.0,NCT04737252,"Development and Initial Testing of a Couple-Based Intervention to Optimize Suicide and Self-Injury Treatment: COMPASS (Connecting, Overcoming, and Moving Past Suicide and Self-Injury)",COMPASS,Recruiting,Self-injurious Thoughts and Behaviours,Borderline Personality Disorder,,,,,,"Behavioral: Connecting, Overcoming and Moving Past Suicide and Self-Injury",York University|Ryerson University,All,"18 Years to 70 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-18,30/09/22,2022-09-30,03/02/21,03/02/21,"York University, Toronto, Ontario",Canada,Others,0,2,620.0
5577.0,NCT04763746,The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development,VISION-MD,Not yet recruiting,Respiratory Disorder,Diabetes,Cardiovascular Diseases,Critical Care,Trauma and Emergency Care,Primary Care,,Device: Lifelight Data Collect Sub-protocol 1|Device: Lifelight Data Collect Sub-protocol 2|Device: Lifelight Data Collect Sub-protocol 3|Device: Lifelight Data Collect Sub-protocol 4,Xim Limited,All,"16 Years and older   (Child, Adult, Older Adult)",9500.0,Industry,Observational,2021-01-04,01/03/22,2022-01-03,21/02/21,08/04/21,,,Metabolic Disorders,1,6,364.0
5578.0,NCT04274621,The Application Value of Non-contact Infrared Thermometers in Temperature Screening in the General Population,,Completed,Non-contact Infrared Thermometer; Rapid Screening,,,,,,,,Ningbo No. 1 Hospital,All,"18 Years and older   (Adult, Older Adult)",572.0,Other,Observational,2020-02-14,17/02/20,2020-02-20,18/02/20,03/03/20,"Ningbo first hospital, Ningbo, Zhejiang",China,Others,0,1,6.0
5579.0,NCT04799405,Home-based tDCS in Major Depressive Disorder,MoodStim,Recruiting,Major Depressive Disorder,,,,,,,Device: tDCS,Hebrew SeniorLife,All,"50 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-09-24,24/09/22,2023-09-24,16/03/21,16/03/21,"Hinda and Arthur Marcus Institute for Aging Research, Boston, Massachusetts",United States,Others,0,1,1095.0
5580.0,NCT04833010,Effects of Face Masks During Exercise,,Recruiting,Cardiopulmonary,Exercise,Cognitive Performance,COVID-19,,,,Other: Cardiopulmonary Exercise Test|Other: Cognitive Performance Test,Baylor Research Institute,All,18 Years to 39 Years   (Adult),100.0,Other,Interventional,2021-01-20,01/09/21,2021-01-09,06/04/21,06/04/21,"Baylor Scott & White Sports Therapy & Research at The Star, Frisco, Texas",United States,Respiratory Diseases,1,4,-11.0
5581.0,NCT04829188,Comparative Effectiveness of Readmission Reduction Interventions for Individuals With Sepsis or Pneumonia,ACCOMPLISH,Recruiting,Sepsis,Pneumonia,Lower Resp Tract Infection,COVID-19,,,,Behavioral: Structured Telephone Support (STS)|Behavioral: Low-intensity Remote Patient Monitoring (RPM-Low)|Behavioral: High-intensity Remote Patient Monitoring (RPM-High)|Behavioral: Standard Response Team|Behavioral: Enhanced Response Team,University of Pittsburgh|Patient-Centered Outcomes Research Institute,All,"21 Years and older   (Adult, Older Adult)",1668.0,Other,Interventional,2021-03-30,01/04/23,2023-01-07,02/04/21,02/04/21,"UPMC Presbyterian, Pittsburgh, Pennsylvania",United States,Respiratory Diseases,1,4,648.0
5582.0,NCT04790864,An Online Large-group One-session Treatment for Public Speaking Anxiety,,Recruiting,"Anxiety, Social",,,,,,,Behavioral: Online large-group one-session treatment with post-treatment exercise targeting expectancy violation|Behavioral: Online large-group one-session treatment with post-treatment control exercise,Ruhr University of Bochum,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-01,01/05/21,2021-01-10,10/03/21,16/03/21,"Ruhr-University of Bochum, Bochum",Germany,Mental Health,1,1,9.0
5583.0,NCT03710746,Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program,PH,Recruiting,Overweight and Obesity,,,,,,,Behavioral: Project Health|Behavioral: Response and Attention Training,Oregon Research Institute|Drexel University,All,"17 Years to 20 Years   (Child, Adult)",450.0,Other,Interventional,2018-08-10,31/07/23,2023-07-31,18/10/18,25/02/21,"Oregon Research Institute, Eugene, Oregon, United States|Drexel University, Philadelphia, Pennsylvania",United States,Metabolic Disorders,1,1,1816.0
5584.0,NCT04477928,General Population Level Estimation for Type 1 Diabetes Risk in Children 0-5 Years Old During Routine Care Delivery,PLEDGE,Recruiting,Type 1 Diabetes,Celiac Disease,,,,,,Diagnostic Test: Sera and whole blood sampling|Diagnostic Test: Differential Gene Expression (DGE),Sanford Health|The Leona M. and Harry B. Helmsley Charitable Trust|Pacific Northwest Research Institute|University of Exeter,All,up to 5 Years   (Child),3000.0,Other,Observational,2020-07-17,01/12/28,2030-01-12,20/07/20,27/10/20,"Sanford Clinic, Sioux Falls, South Dakota",United States,Metabolic Disorders,1,2,3466.0
5585.0,NCT03917290,A Sports Injury Prevention Program to Reduce Subsequent Injuries After Concussion,,Recruiting,Brain Concussion,Musculoskeletal Injury,Locomotion,Postural Balance,,,,Behavioral: Neuromuscular training,"University of Colorado, Denver",All,"12 Years to 18 Years   (Child, Adult)",40.0,Other,Interventional,2019-02-04,30/04/21,2022-04-30,17/04/19,19/12/20,"Children's Hospital Colorado, Aurora, Colorado",United States,Others,0,4,1181.0
5586.0,NCT03175796,Infant Mental Health-Home Visiting Randomized Controlled Trial,IMH-HV RCT,Completed,Infant Mental Health,,,,,,,Behavioral: Infant Mental Health-Home Visiting,University of Michigan|Michigan Department of Health and Human Services,All,"Child, Adult, Older Adult",148.0,Other,Interventional,2017-12-10,17/08/20,2020-09-29,05/06/17,05/10/20,"University of Michigan, Ann Arbor, Michigan",United States,Others,0,1,1024.0
5587.0,NCT03545282,Randomized Trial to Reduce Mental Health Disparities in Latina Immigrant Women,,Recruiting,Stress,Depression,Anxiety,,,,,Behavioral: Amigas Latinas Motivando el Alma (ALMA),University of Washington|National Institute on Minority Health and Health Disparities (NIMHD),Female,"18 Years and older   (Adult, Older Adult)",200.0,Other|NIH,Interventional,2018-07-03,15/12/21,2022-05-31,04/06/18,01/04/21,"Casa Latina, Seattle, Washington, United States|El Centro de la Raza, Seattle, Washington",United States,Mental Health,1,3,1428.0
5588.0,NCT04478851,EXCEL: Exercise for Cancer to Enhance Living Well,EXCEL,Recruiting,Cancer,Head and Neck Cancer,Colon Cancer,Breast Cancer,Prostate Cancer,Cancer Caregivers,,Behavioral: Group Exercise Classes,"University of Calgary|University of Alberta|Dalhousie University|Alberta Health Services|University Health Network, Toronto|Memorial University of Newfoundland|University of British Columbia|University of Prince Edward Island",All,"18 Years to 100 Years   (Adult, Older Adult)",1500.0,Other,Interventional,2020-02-09,31/12/27,2027-12-31,21/07/20,06/11/20,"Health and Wellness Lab, University of Calgary, Calgary, Alberta, Canada|University of Alberta, Edmonton, Alberta, Canada|Dalhousie University, Halifax, Nova Scotia",Canada,Cancers,1,6,2882.0
5589.0,NCT04713748,Tasso-SST OnDemand Comparator Pilot Study,,Enrolling by invitation,C3PI Study Testing Group,,,,,,,Device: Tasso-SST on Demand|Other: Regular Phlebotomy,Duke University,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-15,01/12/21,2021-01-12,19/01/21,16/03/21,"Duke CTSI Translational Population Health Office, Kannapolis, North Carolina",United States,Others,0,1,-3.0
5590.0,NCT04787380,Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure,LOVE-HF,Recruiting,Heart Failure,,,,,,,Device: Heartfelt device,Heartfelt Technologies|Blackpool Teaching Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2021-05-03,30/06/22,2022-12-31,08/03/21,19/03/21,"Department of Cardiology, Lancashire Cardiac Centre, Blackpool Teaching Hospitals NHS Foundation Trust (Blackpool Victoria Hospital), Whinney Heys Road., Blackpool, Lancashire",United Kingdom,Others,0,1,607.0
5591.0,NCT03069690,Optimizing Health From Pregnancy Through One Year Postpartum,HABIT,Recruiting,Obesity,Pregnancy Related,,,,,,Behavioral: HABITpreg|Behavioral: HABITpost,"University of Pittsburgh|National Heart, Lung, and Blood Institute (NHLBI)",Female,"14 Years and older   (Child, Adult, Older Adult)",300.0,Other|NIH,Interventional,2017-01-02,30/06/23,2023-06-30,03/03/17,04/03/21,"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania",United States,Metabolic Disorders,1,2,2370.0
5592.0,NCT04495387,Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy,,Not yet recruiting,Colon Cancer,Breast Cancer,Chemotherapeutic Toxicity,,,,,Drug: Chemotherapy,University of Florence,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Observational,2021-01-01,01/01/22,2022-01-12,31/07/20,31/07/20,,,Cancers,1,3,376.0
5593.0,NCT04592224,Cancer Information Your Way: Get What You Need to Make Your Decisions,,Recruiting,Cancer,,,,,,,,University of Southampton,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-12-11,01/08/21,2021-01-08,19/10/20,03/02/21,"Poole Hospital, Poole, Dorset",United Kingdom,Cancers,1,1,28.0
5594.0,NCT04413812,Fostering Exercise After Bariatric Surgery,FREEBASE,"Active, not recruiting",Bariatric Surgery,Physical Activity,,,,,,Behavioral: FREEBASE exercise programme,"Lia Bally|University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-01-07,17/01/21,2021-01-17,04/06/20,30/11/20,"Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital, Bern",Switzerland,Others,0,2,376.0
5595.0,NCT04831190,A Tailored Exercise Oncology Program for Neuro-Oncology Patients,ACE-Neuro,Not yet recruiting,Cancer,"Brain Tumor, Primary",,,,,,Behavioral: Tailored Exercise Intervention,University of Calgary|Alberta Cancer Foundation|University of Alberta|Tom Baker Cancer Centre|Cross Cancer Institute,All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Interventional,2021-04-15,15/04/24,2024-04-15,05/04/21,12/04/21,"Health and Wellness Lab, University of Calgary, Calgary, Alberta, Canada|Tom Baker Cancer Centre, Calgary, Alberta, Canada|Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada|Cancer Rehabilitation Clinic, Faculty of Rehabilitation Medicine, University of Alberta, Edmonton, Alberta",Canada,Cancers,1,2,1096.0
5596.0,NCT04647760,Packaging and Disseminating the JOIN for ME Program in Low-Income Settings,,Recruiting,Pediatric Obesity,,,,,,,Behavioral: JOIN for ME,"The Miriam Hospital|Brown University|University of North Carolina, Chapel Hill|Tufts University|Brandeis University",All,6 Years to 12 Years   (Child),128.0,Other,Interventional,2021-01-01,01/02/23,2023-01-02,01/12/20,20/01/21,"Weight Management and Diabetes Research Center, The Miriam Hospital/Alpert Medical School of Brown University, Providence, Rhode Island",United States,Metabolic Disorders,1,1,731.0
5597.0,NCT02793921,Exercise Program in Cancer and Cognition,EPICC,Recruiting,Breast Cancer,,,,,,,Behavioral: Moderate-Intensity Aerobic Exercise Intervention,University of Pittsburgh|National Institutes of Health (NIH)|National Cancer Institute (NCI),Female,"18 Years to 75 Years   (Adult, Older Adult)",182.0,Other|NIH,Interventional,2016-01-04,01/03/22,2022-01-03,08/06/16,08/04/21,"University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Cancers,1,1,2191.0
5598.0,NCT03584386,CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention,V-CAMS,Recruiting,Suicide,,,,,,,Device: V-CAMS (aka Jaspr),"Evidence-Based Practice Institute, Seattle, WA|Mayo Clinic|Allina Health|Aurora Health Care|Harborview Injury Prevention and Research Center|The Catholic University of America",All,"18 Years and older   (Adult, Older Adult)",303.0,Industry|Other,Interventional,2018-01-10,31/03/21,2021-03-31,12/07/18,26/02/21,"Evidence-Based Practice Institute, Seattle, Washington",United States,Others,0,1,1176.0
5599.0,NCT04779983,IL-6 as a Biomarker for Personalized Treatment of PR,REMISIX,Not yet recruiting,Rheumatoid Arthritis,,,,,,,,"University Hospital, Montpellier",All,"18 Years to 65 Years   (Adult, Older Adult)",200.0,Other,Observational,2021-03-18,30/07/21,2021-01-08,03/03/21,03/03/21,"UH Montpellier, Montpellier",France,Immunological Disorders,1,1,-69.0
5600.0,NCT02669394,Reshaping the Path of Vascular Cognitive Impairment (VCI),,Recruiting,Transient Ischemic Attack,Vascular Cognitive Impairment,Subcortical Vascular Dementia,,,,,Behavioral: Resistance exercise training|Behavioral: Control: stretching and relaxation program,University of British Columbia,All,"55 Years and older   (Adult, Older Adult)",88.0,Other,Interventional,2016-01-01,01/12/22,2022-01-12,01/02/16,21/02/21,"University of British Columbia, Vancouver, British Columbia",Canada,Others,0,3,2203.0
5601.0,NCT04564586,Developing and Testing a Technology-Based Translation of the DPP to Address Prediabetes in a Primary Care Setting,DPPFit,"Active, not recruiting",PreDiabetes,"Metabolic Syndrome, Protection Against",,,,,,Behavioral: DPPFit,Augusta University,All,18 Years to 55 Years   (Adult),32.0,Other,Interventional,2020-01-01,01/05/21,2021-01-10,25/09/20,10/02/21,"Augusta University - General Internal Medicine Clinic, Augusta, Georgia",United States,Others,0,2,375.0
5602.0,NCT04068922,Adaptability and Resilience in Aging Adults-2,ARIAA-2,Recruiting,Aging,Chronic Low-back Pain,,,,,,Behavioral: Resilience Intervention,University of Florida|National Institute on Aging (NIA),All,"60 Years and older   (Adult, Older Adult)",60.0,Other|NIH,Interventional,2020-01-21,01/05/21,2021-01-05,28/08/19,23/10/20,"University of Florida, Gainesville, Florida",United States,Others,0,2,350.0
5603.0,NCT04398472,Evaluation of the Nextdoor KIND Challenge,,Not yet recruiting,Loneliness,Social Isolation,,,,,,Behavioral: KIND Challenge,Swinburne University of Technology|Brigham Young University|University of Sydney|University of Manchester,All,"18 Years to 90 Years   (Adult, Older Adult)",9000.0,Other,Interventional,2020-07-07,01/12/20,2020-01-12,21/05/20,09/07/20,"Swinburne University of Technology, Hawthorn",Australia,Others,0,2,-177.0
5604.0,NCT03724045,Back Side of the Moon: Nutritional Therapy,,Recruiting,Nutritional Deficiency,Hospitalism,,,,,,Dietary Supplement: Back Side of the Moon,Universitair Ziekenhuis Brussel|Baxter Healthcare Corporation,All,"18 Years and older   (Adult, Older Adult)",50.0,Other|Industry,Interventional,2019-01-01,01/10/21,2021-01-10,30/10/18,08/07/20,"UZ Brussel, Jette",Belgium,Others,0,2,740.0
5605.0,NCT04405284,The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down.,,Completed,Toxicity by Bleach,,,,,,,Other: use and exposure to disinfectants during the coronavirus pandemic,Helwan University|University of Nebraska,Female,"18 Years and older   (Adult, Older Adult)",425.0,Other,Observational,2020-04-06,30/06/20,2020-01-07,28/05/20,23/11/20,"Maha M Farid, Cairo",Egypt,Others,0,1,-90.0
5606.0,NCT04055948,Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients,,Recruiting,Cancer,,,,,,,Behavioral: One-on-one teaching sessions|Behavioral: Telephone booster contact,Case Comprehensive Cancer Center,All,"18 Years and older   (Adult, Older Adult)",180.0,Other,Interventional,2019-01-12,31/10/22,2023-04-30,14/08/19,21/07/20,"University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio",United States,Cancers,1,1,1569.0
5607.0,NCT03193866,COMparison Between All immunoTherapies for Multiple Sclerosis.,COMBAT-MS,"Active, not recruiting",Relapsing-remitting Multiple Sclerosis,,,,,,,Drug: Rituximab,Karolinska Institutet|Patient-Centered Outcomes Research Institute|Kaiser Foundation Research Institute,All,"18 Years and older   (Adult, Older Adult)",3526.0,Other,Observational,2017-01-02,30/06/22,2022-12-31,21/06/17,22/10/20,"Fredrik Piehl, Stockholm",Sweden,Immunological Disorders,1,1,2189.0
5608.0,NCT01134172,"Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life",,"Active, not recruiting",Breast Cancer,,,,,,,Behavioral: survey web-based or telephone interview,Memorial Sloan Kettering Cancer Center|The City College of New York|NYC Health & Hospitals/ Lincoln Medical Center|New York Presbyterian Queens|Ralph Lauren Center for Cancer Care and Prevention|New York City Health and Hospitals Corporation|Queens Medical Associates,Female,18 Years to 64 Years   (Adult),935.0,Other,Observational,2010-01-05,01/05/21,2021-01-05,31/05/10,14/10/20,"Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|NYC Health & Hospitals /Lincoln Medical Center, Bronx, New York, United States|Woodhull Medical and Mental Health Center, Brooklyn, New York, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Queens Medical Associates, Fresh Meadows, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Bellevue Hospital Center, New York, New York, United States|Ralph Lauren Center for Cancer Care and Prevention, New York, New York, United States|New York Presbyterian Queens, Queens, New York",United States,Cancers,1,1,4018.0
5609.0,NCT04606407,Inhaled NO for the Treatment of Viral Pneumonia in Adults,,Recruiting,Viral Pneumonia,Nitric Oxide,Respiratory Disease,"Pneumonia, Viral",Inhaled Nitric Oxide,COVID-19,SARS-CoV Infection,Device: LungFit™,Beyond Air Inc.,All,"18 Years to 80 Years   (Adult, Older Adult)",90.0,Industry,Interventional,2020-11-25,07/09/21,2021-07-09,28/10/20,03/12/20,"Shaare Zedek Medical Center, Jerusalem",Israel,Respiratory Diseases,1,7,226.0
5610.0,NCT04792450,Thales Thermography Triage (3T) - Pilot Project,,"Active, not recruiting",Fever,,,,,,,Device: Thermography|Device: Tympanic Thermometer|Device: Forehead Thermometer|Device: 62 Max + Infra-red thermometer,NHS Greater Clyde and Glasgow|Thales Group,All,"16 Years and older   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-01-11,15/12/20,2021-01-05,11/03/21,11/03/21,"Queen Elizabeth University Hospital, Glasgow",United Kingdom,Others,0,1,360.0
5611.0,NCT04247620,DiaBetter Together for Young Adults With Type 1 Diabetes,DiaBetter,Enrolling by invitation,Type 1 Diabetes,,,,,,,Behavioral: DiaBetter Together|Behavioral: Peer Mentor Delivery,Baylor College of Medicine|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Children's National Research Institute,All,"17 Years to 35 Years   (Child, Adult)",186.0,Other|NIH,Interventional,2020-12-15,01/06/24,2024-01-06,30/01/20,23/12/20,"Baylor College of Medicine, Houston, Texas",United States,Metabolic Disorders,1,1,1117.0
5612.0,NCT04642807,Management of Type 1 Supracondylar Humeral Fractures,,Not yet recruiting,Elbow Fracture,Trauma,,,,,,Procedure: Long arm soft cast|Procedure: Long arm full cast,"University of British Columbia|Queensland Children's Hospital, South Brisbane",All,3 Years to 8 Years   (Child),52.0,Other,Interventional,2021-01-01,01/06/22,2023-01-01,24/11/20,30/11/20,,,Others,0,2,730.0
5613.0,NCT04670315,Validation of the Telematic Version of the Fugl-Meyer Scale,,Not yet recruiting,Stroke,,,,,,,Diagnostic Test: Telematic evaluation of motor function,University of Salamanca,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2021-01-03,30/09/21,2021-09-30,17/12/20,17/12/20,"Universidad de Salamanca, Salamanca",Spain,Cardiovascular Diseases,1,1,270.0
5614.0,NCT04634851,Video Home Visits for Dietary Counselling,,Not yet recruiting,Technology,Diet Habit,,,,,,Behavioral: Virtual home visits,"University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2021-01-04,31/03/23,2024-01-12,18/11/20,11/02/21,,,Others,0,2,1103.0
5615.0,NCT04480333,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",NEUROSIVIR,Recruiting,COVID-19,Corona Virus Infection,Severe Acute Respiratory Syndrome,Severe Acute Respiratory Infection,Severe Acute Respiratory Syndrome (SARS) Pneumonia,Severe Acute Respiratory Syndrome of Upper Respiratory Tract,Neurodegeneration,Drug: Drug: NA-831 - 0.10 mg/kg|Drug: Placebo- 0.10 mg/kg|Drug: Drug: NA-831 - 0.20 mg/kg|Drug: Placebo- 0.20 mg/kg|Drug: Drug: GS-5734 - 1.00 mg/kg|Drug: Placebo- 1.00 mg/kg|Drug: Drug: GS-5734 - 2.00 mg/kg|Drug: Placebo- 2.00 mg/kg|Combination Product: Drugs: NA-831 (0.10 mg/kg) plus GS-5734 (1.00 mg/kg)|Combination Product: Placebo 0.10 mg + 1.00 mg/kg|Combination Product: Drugs: NA-831 (0.20 mg/kg) plus GS-5734 (2.00 mg/kg)|Combination Product: Placebo 0.20 mg + 2.00 mg/kg,"NeuroActiva, Inc.",All,21 Years to 50 Years   (Adult),45.0,Industry,Interventional,2020-09-15,31/12/20,2021-03-31,21/07/20,21/07/20,"Coronavirus Research Institute, Sunnyvale, California",United States,Respiratory Diseases,1,7,197.0
5616.0,NCT04778995,Online Training Program Model for Effective Management of Nursing Services in Times of Crisis Such as Pandemic,,Completed,Pandemics,Crisis State,Nursing,Education,,,,Other: Structured online training program for effective management of nursing services,Istanbul University-Cerrahpasa|Saglik Bilimleri Universitesi,All,"Child, Adult, Older Adult",60.0,Other,Interventional,2020-01-07,01/10/20,2020-12-30,03/03/21,03/03/21,"Istanbul University-Cerrahpasa, İstanbul",Turkey,Others,0,4,358.0
5617.0,NCT04795999,Opportunities Beyond the Narrative: An Intervention for Justice-Involved Youth,,Recruiting,Study Will Examine the Impact of Project With,,,,,,,Behavioral: Project With,WestEd|Urban Strategies|Department of Health and Human Services,All,"15 Years to 19 Years   (Child, Adult)",1500.0,Other|U.S. Fed,Interventional,2021-01-02,31/12/22,2023-07-15,12/03/21,12/03/21,"Urban Strategies, Alhambra, California",United States,Others,0,1,924.0
5618.0,NCT02875301,Investigating Gains in Neurocognition in an Intervention Trial of Exercise,IGNITE,Recruiting,Healthy,"Cognitive Function 1, Social",,,,,,Behavioral: 150 Minutes Week|Behavioral: 225 Minutes Week|Behavioral: Stretch and Tone,University of Pittsburgh|National Institutes of Health (NIH)|National Institute on Aging (NIA),All,65 Years to 80 Years   (Older Adult),639.0,Other|NIH,Interventional,2017-06-09,01/12/22,2023-01-11,23/08/16,21/02/21,"University of Illinois, Champaign, Illinois, United States|University of Kansas, Kansas City, Kansas, United States|Northeastern University, Boston, Massachusetts, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Carnegie Mellon University, Pittsburgh, Pennsylvania",United States,Others,0,2,2042.0
5619.0,NCT04644640,Telerehabilitation Following Meniscectomy,,Not yet recruiting,Meniscectomy,,,,,,,Other: Telerehabilitation Therapy|Other: In-person Rehabilitation Therapy,NYU Langone Health,All,"18 Years to 75 Years   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-12,01/12/21,2022-01-12,25/11/20,25/11/20,"NYU Langone Health, New York, New York",United States,Others,0,1,731.0
5620.0,NCT04091893,The Development and Effectiveness of Museum-Based Experiences for Individuals With Chronic Pain,,"Active, not recruiting",Chronic Pain,,,,,,,Behavioral: Usual care/wait list|Behavioral: Art Rx|Behavioral: Artful Meditation,"University of California, Davis",All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Interventional,2019-12-10,27/02/21,2021-05-30,17/09/19,08/04/21,"UC Davis Ambulatory Care Center, Sacramento, California",United States,Others,0,1,537.0
5621.0,NCT04784338,Virtual Weight Management Shared Medical Visit,,Not yet recruiting,Metabolic Syndrome,Obesity,,,,,,Behavioral: Virtual shared medical visit|Behavioral: Nutritional classes,Boston Medical Center,All,"21 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2021-01-04,01/04/22,2022-01-10,05/03/21,05/03/21,,,Metabolic Disorders,1,2,371.0
5622.0,NCT04237883,Primary Care Clinical Excellence Incentive Study,PCCE,Completed,Behavioral Economics,Primary Health Care,Health Maintenance,Diabetes,Colorectal Cancer Screening,Cervical Cancer Screening,Chlamydia Screening,Behavioral: Standard communication email|Behavioral: Social comparison Intervention|Behavioral: Leadership Training,"University of California, Los Angeles",All,"18 Years and older   (Adult, Older Adult)",225.0,Other,Interventional,2019-01-11,01/11/20,2021-01-01,23/01/20,26/01/21,"UCLA Health Department of Medicine, Quality Office, Brentwood, California",United States,"Metabolic Disorders, Cancers",1,7,721.0
5623.0,NCT04485377,Safety Net Support Use in California,ACCESS,Recruiting,Households,,,,,,,,"University of California, Berkeley|University of California, San Francisco",All,"18 Years and older   (Adult, Older Adult)",530.0,Other,Observational,2020-01-08,31/03/21,2022-06-30,24/07/20,17/11/20,"UC Berkeley School of Public Health, Berkeley, California",United States,Others,0,1,904.0
5624.0,NCT04527835,"Presentation, Clinical Course and Patterns of Myocardial Damage Due to Viral Myocarditis",,Recruiting,Viral Myocarditis,,,,,,,"Diagnostic Test: ELIZA, Extraction of nucleic acid ,Determination of viral genome by using PCR, Quantitative real-time PCR to assess viral load ,Immunohistochemistry analysis of EMB.",Assiut University,All,"18 Years to 90 Years   (Adult, Older Adult)",18.0,Other,Observational,2020-01-10,01/03/21,2021-01-03,27/08/20,08/10/20,"Shery Refaat Asaad, Assiut",Egypt,Others,0,1,359.0
5625.0,NCT03037164,INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections,RedeS,Recruiting,Anemia,,,,,,,Device: INTERCEPT Blood System for Red Blood Cells|Device: Conventional (Control),Cerus Corporation,All,"4 Years and older   (Child, Adult, Older Adult)",600.0,Industry,Interventional,2017-11-05,31/12/21,2022-01-30,31/01/17,02/04/21,"Yale University, New Haven, Connecticut, United States|Mayo Clinic Jacksonville, Jacksonville, Florida, United States|Grady Health System, Atlanta, Georgia, United States|UT Southwestern Medical Center, Dallas, Texas, United States|Baylor St. Luke's Medical Center, Houston, Texas, United States|Virginia Commonwealth University, Richmond, Virginia, United States|Menonita General Hospital, Aibonito, Puerto Rico|HIMA San Pablo Hospital, Caguas, Puerto Rico|San Juan Bautista School of Medicine Clinical Research Unit, Caguas",Puerto Rico,Others,0,1,1547.0
5626.0,NCT04570917,Online Education Intervention to Reduce Ageism Among Undergraduate Students,,Not yet recruiting,Ageism,,,,,,,Behavioral: Online educational intervention to reduce ageism|Behavioral: Online educational intervention to enhance cultural competance,"University of Mississippi, Oxford",All,"18 Years and older   (Adult, Older Adult)",121.0,Other,Interventional,2020-09-28,31/10/20,2020-10-31,30/09/20,30/09/20,,,Others,0,1,33.0
5627.0,NCT04444986,Bioequivalence Study of Favir 200 mg Film Tablet Kocak Under Fasting Conditions,,Completed,Bioequivalence,,,,,,,Drug: FAVIR 200 MG FT|Drug: AVIGAN 200 mg FT,Kocak Farma|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,18 Years to 40 Years   (Adult),30.0,Industry|Other,Interventional,2020-05-06,11/06/20,2020-06-13,24/06/20,30/11/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Gaziantep",Turkey,Others,0,1,38.0
5628.0,NCT04787393,Lancashire Objective Volume Evaluation of Leg Oedema in Heart Failure Second Pilot,LOVE-HF-2,Not yet recruiting,Heart Failure,,,,,,,Device: Heartfelt device|Device: Connected weighing scales,Heartfelt Technologies|Blackpool Teaching Hospitals NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2021-03-05,30/06/22,2022-12-31,08/03/21,19/03/21,"Department of Cardiology, Lancashire Cardiac Centre, Blackpool Teaching Hospital, Blackpool, Lancashire",United Kingdom,Others,0,1,666.0
5629.0,NCT04769518,Advanced Recovery Room Care II - Improved Recovery After Surgery,ARRCII,Not yet recruiting,Postoperative Complications,Cost-Benefit Analysis,,,,,,Procedure: Advanced Recovery Room Care (ARRC),University of Adelaide|University of Southampton|Central Adelaide Local Health Network Incorporated,All,"18 Years and older   (Adult, Older Adult)",1314.0,Other,Interventional,2021-01-03,01/07/22,2022-01-12,24/02/21,24/02/21,"Royal Adelaide Hospital, Adelaide, South Australia",Australia,Others,0,2,374.0
5630.0,NCT04509206,Virtual Teaching Kitchen,,Enrolling by invitation,Cardiac Health,Metabolic Syndrome,,,,,,Behavioral: Nutritional education,Boston University,All,"30 Years and older   (Adult, Older Adult)",25.0,Other,Interventional,2020-09-28,01/09/21,2021-01-09,11/08/20,05/10/20,"Boston Medical Center, Boston, Massachusetts",United States,Others,0,2,103.0
5631.0,NCT04644367,Effects of a Biomechanical-based Tai Chi Program on Gait and Posture in People With Parkinson's Disease,,Not yet recruiting,Parkinson Disease,,,,,,,Other: Tai Chi intervention|Other: Regular Physical Activity (control) group,University of Ottawa,All,"50 Years to 75 Years   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-01,01/07/21,2021-01-12,25/11/20,30/11/20,,,Others,0,1,11.0
5632.0,NCT04714892,Mechanisms Underlying Individual Variations of Taste and Smell in Obesity,,Not yet recruiting,Obesity,,,,,,,,National Institute on Alcohol Abuse and Alcoholism (NIAAA)|National Institutes of Health Clinical Center (CC),All,18 Years to 50 Years   (Adult),248.0,NIH,Observational,2021-04-19,30/12/22,2022-12-30,20/01/21,14/04/21,"National Institutes of Health Clinical Center, Bethesda, Maryland",United States,Metabolic Disorders,1,1,620.0
5633.0,NCT04829851,The PROTEIN Project,PROTEIN,Not yet recruiting,Overweight,Nutritional Deficiency,Poor Nutrition,Iron-deficiency,,,,Device: PROTEIN Mobile App|Device: Expert Dashboard,University of Surrey|European Union,All,"18 Years and older   (Adult, Older Adult)",310.0,Other,Observational,2021-01-06,01/05/22,2022-01-12,02/04/21,02/04/21,,,Others,0,4,371.0
5634.0,NCT04816799,Efficacy of START (Startle Rehabilitation Therapy) in the Treatment Stroke-induced Aphasia/Apraxia,START,Recruiting,Stroke,Aphasia,Apraxia of Speech,,,,,Behavioral: Startle Adjuvant Rehabilitation Therapy (START),Arizona State University,All,"18 Years to 100 Years   (Adult, Older Adult)",54.0,Other,Interventional,2020-07-22,01/07/21,2021-01-12,25/03/21,25/03/21,"Arizona State University, Tempe, Arizona",United States,Cardiovascular Diseases,1,3,174.0
5635.0,NCT03758235,Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin,,"Active, not recruiting",Overactive Bladder Syndrome,,,,,,,Drug: IncobotulinumtoxinA 100 UNT Injection [Xeomin]|Drug: OnabotulinumtoxinA 100 UNT [Botox],University Of Perugia,All,"18 Years to 80 Years   (Adult, Older Adult)",140.0,Other,Interventional,2018-01-09,01/09/21,2021-01-09,29/11/18,06/11/20,"Antonella Giannantoni, Siena, SI",Italy,Others,0,1,1096.0
5636.0,NCT04532853,Optimizing Maintenance Therapy in COPD Patients,PIFOTAL,Recruiting,COPD,,,,,,,,General Practitioners Research Institute|Boehringer Ingelheim,All,"40 Years and older   (Adult, Older Adult)",1176.0,Other|Industry,Observational,2020-10-21,31/05/21,2021-08-25,31/08/20,19/01/21,"Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia|University of Crete, Heraklion, Greece|GPRI, Groningen, Netherlands|Medical University of Silesia, Katowice, Poland|Center Health Regional Administration (ARS Centro), Aveiro, Portugal|Ibsalut, Soller, Islas Baleares",Spain,Others,0,1,308.0
5637.0,NCT04581681,Group CBT For Perinatal Anxiety,,Recruiting,Perinatal Anxiety,,,,,,,Behavioral: Group Cognitive Behaviour Therapy for Perinatal Anxiety (CBT-PA)|Other: No treatment (waitlist control),University of Manitoba,Female,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-02-12,01/09/21,2021-01-09,09/10/20,20/01/21,"St. Boniface Hospital, Winnipeg, Manitoba",Canada,Mental Health,1,1,332.0
5638.0,NCT03576534,Pre Bypass Ultrafiltration (PBUF) in Children Requiring Cardiopulmonary Bypass,PBUF,Recruiting,Congenital Heart Disease,,,,,,,Other: Use of prebypass ultrafiltration (PBUF),Boston Children's Hospital,All,up to 1 Year   (Child),200.0,Other,Interventional,2019-03-10,01/09/21,2021-01-12,03/07/18,27/01/21,"Boston Children's Hospital, Boston, Massachusetts",United States,Others,0,1,674.0
5639.0,NCT04662593,Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being,KFS,Recruiting,Obesity,Overweight,"Diet, Healthy",Social Interaction,Weight Loss,,,Behavioral: Whole Health Program,"University of California, Davis",Female,21 Years to 45 Years   (Adult),120.0,Other,Interventional,2021-04-01,01/08/21,2021-01-09,10/12/20,09/02/21,"UC Davis, Sacramento, California",United States,Metabolic Disorders,1,5,-82.0
5640.0,NCT01603316,Food: A Three-Arm Study Examining Food Insecurity Interventions,,Recruiting,Cancer Patients,,,,,,,Behavioral: surveys|Behavioral: Focus groups,Memorial Sloan Kettering Cancer Center|Queens Cancer Center of Queens Hospital|The Brooklyn Hospital Center|Lincoln Medical and Mental Health Center|Jacobi Medical Center|St. Barnabas Medical Center|Montefiore Health System|Columbia University|Roswell Park Cancer Institute,All,"18 Years and older   (Adult, Older Adult)",668.0,Other,Interventional,2012-08-05,01/05/23,2023-01-05,22/05/12,02/03/21,"St. Barnabas Medical Center, Bronx, New York, United States|Jacobi Medical Center, Bronx, New York, United States|Montefiore Medical Center, Bronx, New York, United States|Lincoln Medical and Mental Health Center, Bronx, New York, United States|Brooklyn Hospital Center, Brooklyn, New York, United States|Queens Hospital Center, Jamaica, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Ralph Lauren Center for Cancer Care and Prevention, New York, New York",United States,Cancers,1,1,3805.0
5641.0,NCT03260140,DVD Lifestyle Intervention,D-ELITE,"Active, not recruiting",Obesity,,,,,,,Behavioral: behavioral lifestyle intervention,VA Office of Research and Development,All,"18 Years and older   (Adult, Older Adult)",500.0,U.S. Fed,Interventional,2018-02-15,01/04/21,2021-06-30,24/08/17,26/01/21,"VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington",United States,Metabolic Disorders,1,1,1231.0
5642.0,NCT03923504,Improving Exercise Capacity With Tailored Physical Activity in Lymphoma & Breast Cancer Patients Undergoing Tx,,Recruiting,Hodgkin Lymphoma,Non-hodgkin Lymphoma,Lymphoma,Breast Cancer,,,,Other: Physical Activity Intervention (PAI)|Other: Healthy Living Control,Virginia Commonwealth University,All,"18 Years to 85 Years   (Adult, Older Adult)",18.0,Other,Interventional,2019-10-05,30/04/22,2022-04-30,22/04/19,23/11/20,"Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States|Virginia Commonwealth University Community Memorial Health Center, South Hill, Virginia",United States,Cancers,1,4,938.0
5643.0,NCT04041453,Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients,HI4T,Completed,Trichuris Infection,Helminthiasis,,,,,,Drug: Ivermectin|Drug: Albendazole,Alejandro Krolewiecki|Brock University|Universidad Nacional del Centro de la Provincia de Buenos Aires|Universidad Nacional Autonoma de Honduras|Universidad Nacional de Salta,All,2 Years to 14 Years   (Child),176.0,Other,Interventional,2019-09-10,07/03/20,2020-07-03,01/08/19,29/07/20,"IIET, Oran, Salta, Argentina|Universidad Autónoma de Honduras, Tegucigalpa",Honduras,Others,0,2,297.0
5644.0,NCT04673825,Monitoring Spondyloarthritis With SpA-Net,TeleSpA,Recruiting,Spondyloarthritis,Ankylosing Spondylitis,Psoriatic Arthritis,Spondyloarthropathy,,,,Other: Patient initiated care + telemonitoring,Maastricht University Medical Center|Maastricht University|Medisch Spectrum Twente|Dutch Arthritis Association,All,"18 Years and older   (Adult, Older Adult)",200.0,Other|Industry,Interventional,2020-02-12,01/07/22,2022-07-31,17/12/20,17/12/20,"Maastricht University Medical Center, Maastricht, Limburg, Netherlands|Medisch Spectrum Twente, Enschede, Overijssel",Netherlands,Others,0,4,900.0
5645.0,NCT04566510,LLIN Evaluation in Uganda Project,LLINEUP2,Recruiting,Malaria,,,,,,,"Other: long lasting insecticidal nets with alpha-cypermethrin + pyriproxyfen (PPF LLIN, Royal Guard))|Other: long lasting insecticidal nets with deltamethrin + piperonyl butoxide (PBO LLIN, PermaNet 3.0))|Behavioral: Social behaviour change communication","University of California, San Francisco|National Institute of Allergy and Infectious Diseases (NIAID)",All,"Child, Adult, Older Adult",200000.0,Other|NIH,Interventional,2020-10-17,15/04/23,2023-04-15,28/09/20,17/12/20,"Infectious Diseases Research Collaboration, Kampala",Uganda,Infectious Diseases,0,1,910.0
5646.0,NCT04752787,Effect of Breastfeeding Training,Breastfeeding,Not yet recruiting,Breastfeeding,,,,,,,Other: Online breastfeeding training|Other: QR code supported online breastfeeding training,Sakarya University,Female,"19 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2021-01-03,01/03/22,2022-01-03,12/02/21,16/02/21,"Sakarya University, Sakarya, Serdivan",Turkey,Others,0,1,365.0
5647.0,NCT04702958,TRANSFORM-HF Ancillary Mechanistic Study,,Enrolling by invitation,Heart Failure,,,,,,,,"Inova Health Care Services|National Institutes of Health (NIH)|Duke University|George Mason University|University of Maryland, Baltimore|National Heart, Lung, and Blood Institute (NHLBI)",All,"18 Years and older   (Adult, Older Adult)",750.0,Other|NIH,Observational,2020-10-12,01/07/22,2022-01-07,11/01/21,11/01/21,"Inova Health System, Falls Church, Virginia",United States,Others,0,1,452.0
5648.0,NCT04039165,Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: RCT,,Recruiting,Metabolic Syndrome,,,,,,,Behavioral: PP-MI Intervention,Massachusetts General Hospital,All,"18 Years to 100 Years   (Adult, Older Adult)",64.0,Other,Interventional,2019-07-25,01/02/22,2022-01-04,31/07/19,03/12/20,"Massachusetts General Hospital- Revere Health Center, Revere, Massachusetts",United States,Others,0,1,894.0
5649.0,NCT04696107,Effectiveness of Coping Strategies on the Control of Chronic Non-Cancer Pain and Quality of Life (CNCP_CopQol),CNCP_CopQol,Not yet recruiting,Chronic Pain,Musculoskeletal Diseases,Quality of Life,Pain Measurement,,,,Behavioral: Psychoeducative intervention,Hospital San Juan de Dios del Aljarafe de Sevilla|University of Seville|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla,All,"18 Years and older   (Adult, Older Adult)",144.0,Other,Interventional,2021-01-04,28/02/22,2022-12-31,06/01/21,06/01/21,"Hospital San Juan de Dios del Aljarafe, Bormujos, Sevilla",Spain,Others,0,4,726.0
5650.0,NCT03256773,High Resolution Micro OCT Imaging,,Recruiting,Cystic Fibrosis,COPD,PCD - Primary Ciliary Dyskinesia,COVID-19,Sinusitis,,,,University of Alabama at Birmingham|Massachusetts General Hospital,All,"14 Years and older   (Child, Adult, Older Adult)",60.0,Other,Observational,2016-04-15,31/12/21,2022-12-31,22/08/17,01/03/21,"University of Alabama at Birmingham, Birmingham, Alabama",United States,Respiratory Diseases,1,5,2451.0
5651.0,NCT04660084,"Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP",CAPNOR,Recruiting,Pneumonia,,,,,,,Diagnostic Test: Ultra-rapid molecular point-of-care testing,"Haukeland University Hospital|University of Bergen|Drammen sykehus|University of Copenhagen|Rigshospitalet, Denmark|UMC Utrecht|University of Southampton|Quadram Institute Bioscience",All,"18 Years and older   (Adult, Older Adult)",1060.0,Other,Interventional,2020-09-25,31/12/22,2022-12-31,09/12/20,09/12/20,"Haukeland University Hospital, Bergen",Norway,Respiratory Diseases,1,1,827.0
5652.0,NCT04838288,Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™,OPERATOR,Not yet recruiting,Renal Transplant,,,,,,,Drug: Change from Prograf to Envarsus XR,Vanderbilt University Medical Center|Veloxis Pharmaceuticals,All,"18 Years to 70 Years   (Adult, Older Adult)",60.0,Other|Industry,Interventional,2021-01-05,31/12/22,2022-12-31,09/04/21,09/04/21,"VUMC, Nashville, Tennessee",United States,Others,0,1,725.0
5653.0,NCT04408651,Low Intensity Internet Therapy for Chronic Illness (@LIIT.CI),,"Active, not recruiting",Chronic Medical Conditions,,,,,,,Behavioral: LIIT.CI ACT|Behavioral: LIIT.CI CFT,University of Coimbra,All,"18 Years to 65 Years   (Adult, Older Adult)",54.0,Other,Interventional,2020-01-05,31/12/20,2021-08-31,29/05/20,21/02/21,"Inês Trindade, Coimbra",Portugal,Others,0,1,604.0
5654.0,NCT03301922,Metacognitive Therapy and Work Interventions for Patients on Sick Leave Due to Common Mental Disorders,,Recruiting,Anxiety,Depression,,,,,,Behavioral: Metacognitive therapy and work-focused interventions|Other: Waiting list,Norwegian University of Science and Technology|Diakonhjemmet Hospital,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Interventional,2017-10-31,01/04/23,2023-01-04,04/10/17,18/08/20,"Poliklinikken Raskere Tilbake, Diakonhjemmet Sykehus, Oslo",Norway,Mental Health,1,2,1891.0
5655.0,NCT03734237,A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD,PAIVED,Recruiting,Influenza,Influenza-like Illness,,,,,,Biological: Egg based influenza vaccines|Biological: Recombinant influenza vaccines|Biological: Cell-culture based influenza vaccines,Henry M. Jackson Foundation for the Advancement of Military Medicine|National Institute of Allergy and Infectious Diseases (NIAID)|Food and Drug Administration (FDA)|Defense Health Agency Immunization Healthcare Branch|Armed Forces Health Surveillance Branch|Naval Health Research Center|United States Air Force School of Aerospace Medicine|Uniformed Services University of the Health Sciences,All,"18 Years and older   (Adult, Older Adult)",15000.0,Other|NIH|U.S. Fed,Interventional,2018-06-11,31/05/22,2022-05-31,07/11/18,17/11/20,"Naval Medical Center San Diego, San Diego, California, United States|United States Naval Academy, Annapolis, Maryland, United States|USU, Bethesda, Maryland, United States|Walter Reed National Military Medical Center, Bethesda, Maryland, United States|Womack Army Medical Center, Fort Bragg, North Carolina, United States|Carl R. Darnall Army Medical Center, Killeen, Texas, United States|Brooke Army Medical Center, Sam Houston, Texas, United States|Lackland Airforce Base, San Antonio, Texas, United States|Naval Medical Center Portsmouth, Portsmouth, Virginia, United States|Madigan Army Medical Center, Tacoma, Washington",United States,Infectious Diseases,0,2,1450.0
5656.0,NCT02737878,Reshaping the Path of Mild Cognitive Impairment by Refining Exercise Prescription,,Recruiting,Mild Cognitive Impairment,,,,,,,Behavioral: Aerobic Training|Behavioral: Resistance Training|Behavioral: Balance and Tone Training,University of British Columbia,All,65 Years to 80 Years   (Older Adult),216.0,Other,Interventional,2016-01-04,01/12/21,2021-01-12,14/04/16,11/09/20,"University of British Columbia, Vancouver, British Columbia",Canada,Others,0,1,1835.0
5657.0,NCT04590066,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy,,Completed,"Influenza, Human",,,,,,,Behavioral: Flu shot text messages,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",734383.0,Other,Interventional,2020-09-25,31/12/20,2020-12-31,19/10/20,01/02/21,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Infectious Diseases,0,1,97.0
5658.0,NCT03885232,Presumptively Initiating Vaccines and Optimizing Talk With Motivational Interviewing (PIVOT With MI),,Enrolling by invitation,Preventive Health Services (PREV HEALTH SERV),,,,,,,Behavioral: Experimental: PIVOT with MI|Other: Active Comparator: Control,"University of Colorado, Denver|National Institutes of Health (NIH)|Seattle Children's Hospital|University of Missouri, Kansas City|Children's Mercy Hospital Kansas City|Portland State University|University of Washington|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)",All,up to 2 Months   (Child),1000.0,Other|NIH,Interventional,2019-01-09,31/08/22,2023-07-31,21/03/19,06/11/20,"University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States|Seattle Children's Hospital, Seattle, Washington",United States,Others,0,1,1664.0
5659.0,NCT03518216,Neural Mechanisms of Treatment Response to ADAPT,,Recruiting,Functional Abdominal Pain Syndrome,Anxiety,,,,,,Behavioral: ADAPT,Michigan State University|National Center for Complementary and Integrative Health (NCCIH)|Spectrum Health Hospitals,All,11 Years to 16 Years   (Child),93.0,Other|NIH,Interventional,2018-03-07,01/08/22,2022-01-08,08/05/18,09/03/21,"Michigan State University, Grand Rapids, Michigan",United States,Mental Health,1,2,1403.0
5660.0,NCT04603092,Digital Health Literacy Intervention for Disadvantaged Women During Corona,,Not yet recruiting,Health Literacy,,,,,,,Behavioral: Digital Health Literacy Intervention,"Forman Christian College, Pakistan|doctHERs|Saglik Bilimleri Universitesi",Female,"15 Years to 49 Years   (Child, Adult)",1000.0,Other|Industry,Interventional,2021-01-04,01/09/21,2021-01-10,26/10/20,03/02/21,,,Others,0,1,6.0
5661.0,NCT04571853,New Educational Tool for FM,,Recruiting,Fibromyalgia,,,,,,,Behavioral: PNE-explained group|Behavioral: PNE-read group|Behavioral: TAU group,Hospital Universitari Vall d'Hebron Research Institute|University of South Australia,All,"18 Years to 75 Years   (Adult, Older Adult)",300.0,Other,Interventional,2020-09-21,10/10/21,2021-10-10,01/10/20,01/10/20,"Mayte Serrat, Barcelona",Spain,Others,0,1,384.0
5662.0,NCT04424212,ICBT for Mental Health Problems Related to the Coronavirus Pandemic,,"Active, not recruiting",Depression and Quality of Life Related to the Coronavirus Pandemic,,,,,,,Behavioral: Intervention group CoronaCope,Linkoeping University,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2020-10-06,01/06/21,2021-01-08,09/06/20,21/02/21,"Linköping University, Linköping, Östergötland",Sweden,"Mental Health, Respiratory Diseases",1,1,94.0
5663.0,NCT04193020,"Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response",ACID LTR,Recruiting,Uveitis,,,,,,,Other: Surveillance card,Wroclaw Medical University|Wrocław University of Science and Technology,All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-01-01,01/01/25,2026-01-01,10/12/19,10/04/20,"Department of Ophthalmology, Wrocław",Poland,Others,0,1,2192.0
5664.0,NCT02901041,Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism,,"Active, not recruiting",Alcohol Dependence,,,,,,,Drug: Zonisamide|Behavioral: Take Control|Drug: Placebo (for Zonisamide),Boston University Charles River Campus|Mclean Hospital|University of Houston,All,"21 Years to 65 Years   (Adult, Older Adult)",100.0,Other,Interventional,2017-09-21,01/02/21,2021-01-08,15/09/16,28/04/20,"Center for Anxiety and Related Disorders - Boston University, Boston, Massachusetts",United States,Others,0,1,1205.0
5665.0,NCT04646421,Responsible Gambling Telephone Intervention to High-risk Gamblers by a State-owned Gambling Operator in Sweden.,,Recruiting,Problem Gambling,Gambling Disorder,,,,,,Behavioral: Motivational telephone intervention,Lund University|AB Svenska Spel,All,"18 Years and older   (Adult, Older Adult)",3626.0,Other,Observational,2021-03-15,31/10/21,2021-11-30,30/11/20,15/03/21,"Lund University, Lund",Sweden,Others,0,2,260.0
5666.0,NCT03343483,The Helping Older People Engage Project: Improving Social Well-Being in Later Life,HOPE,Recruiting,Loneliness,Quality of Life,,,,,,Behavioral: Volunteering|Behavioral: Life Review,University of Rochester|National Institute on Aging (NIA),All,"60 Years and older   (Adult, Older Adult)",300.0,Other|NIH,Interventional,2018-01-01,28/02/23,2023-02-28,17/11/17,10/03/21,"University of Rochester, Rochester, New York",United States,Others,0,2,1884.0
5667.0,NCT04651959,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Pharma Plant, Turkey) Under Fasting Conditions",,"Active, not recruiting",Bioequivalence,,,,,,,Drug: AVICOD 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,Pharma Plant|Novagenix Bioanalytical Drug R&D Center,Male,18 Years to 55 Years   (Adult),30.0,Industry|Other,Interventional,2020-11-13,18/11/20,2020-12-20,03/12/20,03/12/20,"Novagenix Drug R&D Center, Akyurt, Ankara",Turkey,Others,0,1,37.0
5668.0,NCT04406194,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (ATABAY, Turkey) Under Fasting Conditions",Favipiravir,Completed,Bioequivalence,,,,,,,Drug: FAVICOVIR 200 mg Film Tablet|Drug: AVIGAN 200 mg Film Tablets,Atabay Kimya Sanayi Ticaret A.S.|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,20 Years to 40 Years   (Adult),30.0,Industry|Other,Interventional,2020-05-14,22/05/20,2020-06-19,28/05/20,14/08/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep",Turkey,Others,0,1,36.0
5669.0,NCT04400682,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (Novelfarma, Turkey) Under Fasting Conditions",Favipiravir,Completed,Bioequivalence,,,,,,,Drug: FAVIRA 200 MG Film Tablet|Drug: AVIGAN 200 MG Film Tablets,Novelfarma Ilaç San. ve Tic. Ltd. Sti.|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,20 Years to 40 Years   (Adult),30.0,Industry|Other,Interventional,2020-05-28,05/06/20,2020-06-18,22/05/20,11/08/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep",Turkey,Others,0,1,21.0
5670.0,NCT04828070,The Heart Outcomes in Pregnancy Expectations (H.O.P.E) Registry,,Recruiting,Pregnancy Related,Cardiac Disease,,,,,,Other: Observation,Saint Luke's Health System|Massachusetts General Hospital,Female,18 Years to 55 Years   (Adult),75.0,Other,Observational,2020-01-12,30/12/22,2026-12-30,01/04/21,01/04/21,"Saint Luke's Hospital of Kansas City, Kansas City, Missouri",United States,Others,0,2,2544.0
5671.0,NCT04542642,"A Remote, Decentralized Opioid Use Disorder Study to Evaluate Patient Engagement With a Game-Based Digital Therapeutic",,Recruiting,Opioid-use Disorder,,,,,,,Device: reSET-O|Device: PEAR-008,"Pear Therapeutics, Inc.|Addiction Research and Education Foundation (AREF)|Research Foundation for Mental Hygiene, Inc.|National Institute on Drug Abuse (NIDA)",All,18 Years to 60 Years   (Adult),130.0,Industry|Other|NIH,Interventional,2021-01-02,01/07/21,2021-01-07,09/09/20,01/02/21,"The Substance and Treatment Research Service (STARS) at Columbia University Irving Medical Center and the New York State Psychiatric Institute, New York, New York, United States|Addiction Research and Education Foundation, Gig Harbor, Washington",United States,Others,0,1,5.0
5672.0,NCT03683394,Systematic Multi-domain Alzheimer's Risk Reduction Trial,SMARRT,"Active, not recruiting",Dementia,Alzheimer Disease,,,,,,Behavioral: SMARRT Intervention|Behavioral: Health Education Intervention,"Kaiser Permanente|University of California, San Francisco",All,70 Years to 89 Years   (Older Adult),172.0,Other,Interventional,2018-08-30,31/03/22,2022-03-31,25/09/18,11/03/21,"Kaiser Permanente Washington Health Research Institute, Seattle, Washington",United States,Others,0,2,1309.0
5673.0,NCT04144231,Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS),SLEEPINS,Recruiting,Insomnia,Schizophrenia,Schizoaffective Disorder,,,,,Behavioral: iCBT-I|Behavioral: GCBT-I,Helsinki University Central Hospital|University of Helsinki|Finnish Institute for Health and Welfare|Finnish Institute of Occupational Health,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Interventional,2019-12-19,06/09/24,2024-06-09,30/10/19,06/04/20,"Helsinki University Central Hospital, Helsinki, Uusimaa",Finland,Mental Health,1,3,1634.0
5674.0,NCT04624087,Go/No-Go Intervention for Weight Loss,,Recruiting,Overweight and Obesity,,,,,,,Behavioral: food-specific go/no-go computerized training|Behavioral: nonfood-specific go/no-go computerized training,University of Minnesota,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-19,01/10/21,2021-01-10,10/11/20,10/11/20,"University of Minnesota Duluth, Duluth, Minnesota",United States,Metabolic Disorders,1,1,83.0
5675.0,NCT04209998,New Oxymetry Indices in Critical Limb Ischemia,NOVICE,Recruiting,Critical Limb Ischemia,,,,,,,Diagnostic Test: transcutaneous oximetry,"University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-01-16,01/12/22,2022-01-12,24/12/19,29/04/20,"Centre hospitalier universitaire, Angers",France,Others,0,1,727.0
5676.0,NCT04448028,"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial",STOPPIT,Not yet recruiting,Liver Cirrhosis,,,,,,,Drug: Placebo|Drug: Esomeprazole 20mg,Universitätsklinikum Hamburg-Eppendorf|German Federal Ministry of Education and Research|University Hospital Heidelberg,All,"18 Years and older   (Adult, Older Adult)",476.0,Other,Interventional,2021-01-01,01/12/24,2024-01-12,25/06/20,04/11/20,"University Medical Center Hamburg-Eppendorf, Hamburg",Germany,Others,0,1,1106.0
5677.0,NCT04475718,Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women,,Recruiting,Pregnancy Related,Postpartum Sadness,,,,,,Behavioral: Fourth Trimester Mobile Tool,"HealthCore-NERI|Orange Square Design, Inc.|National Institute on Minority Health and Health Disparities (NIMHD)",Female,"21 Years and older   (Adult, Older Adult)",85.0,Other|NIH,Interventional,2020-06-07,22/09/21,2021-09-22,17/07/20,12/01/21,"HealthCore, Watertown, Massachusetts, United States|Orange Square Design Inc., Pawtucket, Rhode Island",United States,Others,0,2,472.0
5678.0,NCT03620409,Identification of Cardiovascular and Molecular Prognostic Factors for the Mid- and Long-term Outcome of Sepsis,ICROS,Recruiting,Sepsis,Septic Cardiomyopathy,Cardiomyopathies,,,,,,"Jena University Hospital|Department of Anesthesiology and Intensive Care Medicine, JUH|Department of Cardiothoracic Surgery, JUH|Department of Clinical Chemistry and Laboratory Medicine, JUH|Department of Biochemistry, Center for Molecular Biomedicine (CMB), FSU Jena|Systems Biology and Bioinformatics, Hans-Knöll Institute Jena|Institute of Pharmacy, FSU Jena",All,"18 Years and older   (Adult, Older Adult)",290.0,Other,Observational,2018-09-05,01/12/20,2021-01-06,08/08/18,27/03/20,"NWG Translational Septomics, Zentrum für Innovationskomepetenz (ZIK) Septomics, Universitätklinikum Jena, Jena, Thuringia",Germany,Others,0,3,854.0
5679.0,NCT04390542,Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy,,Not yet recruiting,Blood Cancer,,,,,,,Behavioral: Psychoeducation,Case Comprehensive Cancer Center,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-01-06,01/08/21,2021-01-09,15/05/20,26/02/21,"University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio",United States,Cancers,1,1,3.0
5680.0,NCT04240886,Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds,AEGIS,Recruiting,Invasive Fungal Infections,,,,,,,Drug: fosmanogepix,Amplyx Pharmaceuticals,All,"18 Years and older   (Adult, Older Adult)",50.0,Industry,Interventional,2020-04-01,01/07/21,2021-01-10,27/01/20,21/02/21,"Clinical Trial Site, Duarte, California, United States|Clinical Trial Site, Sacramento, California, United States|Clinical Trial Site, San Diego, California, United States|Clinical Trial Site, Boston, Massachusetts, United States|Clinical Trial Site, Durham, North Carolina, United States|Clinical Trial Site, Brussels, Belgium|Clinical Trial Site, Brussels, Belgium|Clinical Trial Site, Leuven, Belgium|Clinical Trial Site, Yvoir, Belgium|Clinical Trial Site, Koeln, Germany|Clinical Trial Site, Mainz, Germany|Clinical Trial Site, Haifa, Israel|Clinical Trial Site, Tel Aviv, Israel|Clinical Trial Site, Tel HaShomer",Israel,Others,0,1,284.0
5681.0,NCT04535453,A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,,Recruiting,Healthy,,,,,,,Biological: Ad26.COV2.S|Other: Placebo,Janssen Vaccines & Prevention B.V.,All,"12 Years and older   (Child, Adult, Older Adult)",1210.0,Industry,Interventional,2020-08-28,15/12/21,2023-08-15,02/09/20,12/04/21,"Optimal Research, Huntsville, Alabama, United States|Ark Clinical Research, Long Beach, California, United States|Optimal Research, San Diego, California, United States|Research Centers of America, LLC, Hollywood, Florida, United States|Optimal Research, Melbourne, Florida, United States|Meridian Clinical Research, LLC, Macon, Georgia, United States|University of Kentucky Medical Center, Lexington, Kentucky, United States|Meridian Clinical Research, LLC, Baton Rouge, Louisiana, United States|Meridian Clinical Research, LLC, Grand Island, Nebraska, United States|Meridian Clinical Research, LLC, Hastings, Nebraska, United States|Rutgers, The State University of NJ, New Brunswick, New Jersey, United States|Rochester Clinical Research, Inc, Rochester, New York, United States|Coastal Carolina Research Center, North Charleston, South Carolina, United States|NOCCR, Knoxville, Tennessee, United States|Seattle Children's Hospital, Seattle, Washington, United States|Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Brazil|Hospital São José, Criciúma, Brazil|Hospital Pequeno Principe, Curitiba, Brazil|Fundação De Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Brazil|Hospital Moinhos de Vento, Porto Alegre, Brazil|Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ, Rio de Janeiro, Brazil|Instituto D'Or de Pesquisa e Ensino (IDOR), Rio de Janeiro, Brazil|CMPC - Consultoria Médica e Pesquisa Clínica, Sorocaba, Brazil|Fundacao Jose Luiz Egydio Setubal, São Paulo, Brazil|Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, São Paulo, Brazil|Manna Research, Burlington, Ontario, Canada|Manna Research, Toronto, Ontario, Canada|Charité Research Organisation GmbH, Berlin, Germany|CTC North GmbH & Co. KG, Am Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany|Universitaetsmedizin Rostock, Rostock, Germany|PRA Health Sciences, Groningen, Netherlands|Centre for Human Drug Research, Leiden, Netherlands|UMCU, Utrecht, Netherlands|Hosp. Sant Joan de Deu, Esplugues De Llobregat - Barcelona, Spain|Hosp. Univ. de La Princesa, Madrid, Spain|Hosp. Infantil Univ. Niño Jesus, Madrid, Spain|Hosp. Univ. La Paz, Madrid, Spain|Hosp. Univ. Marques de Valdecilla, Santander, Spain|Hosp. Clinico Univ. de Santiago, Santiago de Compostela, Spain|Bristol Royal Hospital for Children, Bristol, United Kingdom|Alder Hey Hospital, Liverpool, United Kingdom|St George's, University of London, London, United Kingdom|Royal Manchester Children's Hospital, Manchester, United Kingdom|Oxford Vaccine Group, Oxford, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton",United Kingdom,Others,0,1,1082.0
5682.0,NCT04680845,INSPIRES Hearing Health Trial - INnovative Psychological Intervention to REduce Stigma in Hearing Health Trial,INSPIRES,Recruiting,Hearing Loss,,,,,,,Behavioral: Self-affirmation,University of Manchester,All,"60 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2021-01-18,18/07/21,2021-07-31,23/12/20,05/02/21,"YouGov, London, Greater London",United Kingdom,Others,0,1,194.0
5683.0,NCT04326309,Audio Data Collection for Identification and Classification of Coughing,,Recruiting,COVID-19,Coronavirus Infections,Hay Fever,Asthma,Chronic Obstructive Pulmonary Disease,Influenza,Common Cold,,HealthMode Inc.,All,"18 Years and older   (Adult, Older Adult)",1000.0,Industry,Observational,2020-03-25,25/09/22,2022-09-25,30/03/20,30/03/20,"Virtual Facility, Bronx, New York",United States,"Infectious Diseases, Respiratory Diseases",1,7,914.0
5684.0,NCT04302987,Vitamin D Intervention in Infants - 6 Years Follow-up (VIDI2),VIDI2,Recruiting,Bone Strength,Growth,Body Composition,Infection,Allergic Diseases,Dental Health,,,University of Helsinki,All,6 Years to 7 Years   (Child),832.0,Other,Observational,2019-01-11,01/10/21,2021-01-10,10/03/20,02/11/20,"Children's Hospital, Helsinki",Finland,Others,0,6,730.0
5685.0,NCT04586192,Digital Mental Health and Wellness Intervention for Adults: A Randomized Control Trial of COMET,COMET,Recruiting,Depressive Symptoms,Anxiety,,,,,,Other: Common Elements Toolbox- Adult version (COMET-A)|Other: Self-awareness Control,University of Pennsylvania,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Interventional,2021-01-31,01/06/21,2021-01-06,14/10/20,03/02/21,"University of Pennsylvania, Philadelphia, Pennsylvania",United States,Mental Health,1,2,-25.0
5686.0,NCT03684980,LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma - ARM A,,Recruiting,Central Nervous System Lymphoma,,,,,,,Drug: Voraxaze|Drug: Methotrexate|Drug: Rituximab|Drug: leucovorin|Drug: Glucarpidase,Memorial Sloan Kettering Cancer Center|University of Alabama at Birmingham,All,"18 Years and older   (Adult, Older Adult)",44.0,Other,Interventional,2018-11-14,01/10/21,2021-01-10,26/09/18,23/12/20,"University of Alabama at Birmingham, Birmingham, Alabama, United States|Memoral Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States|Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States|Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States|Memorial Sloan Kettering Commack, Commack, New York, United States|Memorial Sloan Kettering Westchester, Harrison, New York, United States|Memorial Sloan Kettering Cancer Center, New York, New York, United States|Memorial Sloan Kettering Nassau, Uniondale, New York",United States,Others,0,1,788.0
5687.0,NCT04378530,Mindfulness Takes Practice,,"Active, not recruiting",Stress,Habits,,,,,,Behavioral: Personalized Anchoring Strategy|Behavioral: Non-Anchoring Strategy Control|Behavioral: Fixed Anchoring Strategy,Arizona State University,All,18 Years to 60 Years   (Adult),174.0,Other,Interventional,2020-07-27,01/06/21,2021-01-06,07/05/20,14/12/20,"Arizona Biomedical Collaborative, Phoenix, Arizona",United States,Mental Health,1,2,163.0
5688.0,NCT04447690,Prevalence of Mental Health Problems Among Undergraduate Students at the Universidad de Los Andes,,Completed,Student,Mental Health,"Depression, Anxiety",Depression,Anxiety,College Drinking,Stress,,"Universidad de los Andes, Chile|Ministerio de Educación, Chile",All,"18 Years and older   (Adult, Older Adult)",5553.0,Other,Observational,2020-03-08,04/09/20,2020-12-31,25/06/20,06/04/21,"Universidad de los Andes, Santiago, Metropolitana",Chile,Mental Health,1,7,298.0
5689.0,NCT04763304,Self-contamination Following Removal of Two Personal Protective Equipment Suits: a Crossover Trial,,Completed,Personal Protective Equipment,Self Contamination,,,,,,Other: Gown personal protective equipment (PPE-G) suit|Other: Coverall personal protective equipment (PPE-C) suit,Hospital Italiano de Buenos Aires,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-01-09,29/10/20,2020-11-18,21/02/21,21/02/21,"Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aire, Buenos Aires",Argentina,Others,0,2,314.0
5690.0,NCT03925272,"Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants.",CoSImmGEn,Recruiting,Immune System and Related Disorders,,,,,,,"Procedure: Collection of samples (blood, stool, etc.)|Genetic: Genetic determinants analysis|Procedure: Sample obtained after surgery performed in the context of care",Institut Pasteur,All,"18 Years to 100 Years   (Adult, Older Adult)",2200.0,Industry,Interventional,2011-02-02,02/12/23,2023-02-12,24/04/19,04/03/21,"Centre médical de l'Institut Pasteur, Paris, France|Institut Pasteur, Paris, France|Hopital sainte Périne, Paris, France|Hôpital Tenon, Paris",France,Others,0,1,4393.0
5691.0,NCT03540706,Impact of the Use of CRP on the Prescription of Antibiotics in General Practitioners,VIP,Recruiting,Respiratory Infection,Respiratory Infections in Children,,,,,,Diagnostic Test: Care with C-reactive protein assay in micro method,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne,All,"3 Years and older   (Child, Adult, Older Adult)",406.0,Other,Interventional,2018-01-05,15/03/22,2022-06-15,30/05/18,11/03/21,"22 rue de Silly, Boulogne, France|25 avenue des frères Lumière, Cormeilles-en-Parisis, France|8 Rue Saint-Exupéry, Meudon La Forêt, France|258 Bis Rue de Paris, Montreuil, France|61bis Boulevard de Charonne, Paris, France|25 Rue de Fécamp, Paris, France|237 Rue de la Croix Nivert,, Paris, France|1 Rue Colette Magny, Paris, France|391 Rue des Pyrénées, Paris, France|50 Rue de la Justice, Paris, France|72 Boulevard Davout, Paris, France|20 avenue Gorges Sand, Stains, France|19 Rue du Midi, Vincennes",France,Others,0,2,1622.0
5692.0,NCT04696406,"Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure",DE-RISK WF,Not yet recruiting,Respiratory Failure,,,,,,,Device: RESPINOR DXT,Respinor AS|The Research Council of Norway,All,"18 Years and older   (Adult, Older Adult)",250.0,Industry|Other,Observational,2021-01-03,30/09/21,2021-09-30,06/01/21,06/01/21,"Centre Hospitalier Universitaire d'Angers, Angers, France|Centre Hospitalier Saint Joseph Saint Luc, Lyon, France|Hôpital Universitaire Pitié Salpêtrière, Paris, France|Ospedale San Carlo Borromeo, Milan, Italy|Oslo University Hospital, Oslo, Norway|St. Olavs University Hospital, Trondheim",Norway,Respiratory Diseases,1,1,270.0
5693.0,NCT04787809,Living Well: A Digital ACT Intervention,,Recruiting,Depressive Symptoms,Anxiety,Emotional Disorders,,,,,Behavioral: Living Well,University of Texas at Tyler,All,"18 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2021-02-19,01/12/22,2022-01-12,09/03/21,09/03/21,"UT Tyler, Tyler, Texas",United States,Mental Health,1,3,327.0
5694.0,NCT04661189,The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases,COVEPICARDIO,Recruiting,Cardiovascular Diseases,,,,,,,Behavioral: Physical exercise training|Behavioral: Cognitive training,Montreal Heart Institute,All,"50 Years to 100 Years   (Adult, Older Adult)",122.0,Other,Interventional,2020-05-18,01/05/22,2022-01-12,10/12/20,03/03/21,"Preventive medicine and physical activity centre (centre EPIC), Montreal Heart Institute, Montréal, Quebec",Canada,Others,0,1,604.0
5695.0,NCT04574050,SELF-BREATHE RCT for Chronic Breathlessness,,Not yet recruiting,Cancer,COPD,Asthma,Bronchiectasis Adult,Interstitial Lung Disease,Cystic Fibrosis,Chronic Heart Failure,Other: SELF-BREATHE,King's College Hospital NHS Trust|King's College London,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2020-03-12,04/04/22,2022-06-30,05/10/20,05/10/20,,,Cancers,1,7,840.0
5696.0,NCT04621552,Virtual Simulation for Woven EndoBridge Device Sizing,VS-WEB,Completed,Aneurysm,Intracranial Aneurysm,,,,,,Device: WEB embolization,"University Hospital, Montpellier|University Hospital, Bordeaux",All,"18 Years and older   (Adult, Older Adult)",186.0,Other,Observational,2015-01-01,30/06/20,2020-10-30,09/11/20,10/11/20,"Uhmontpellier, Montpellier",France,Others,0,2,2129.0
5697.0,NCT04407000,"Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions",Favipiravir,Completed,Bioequivalence,,,,,,,Drug: Test: Favipiravir 200 mg (LOQULAR)|Drug: Reference: Favipiravir 200 mg (Avigan),World Medicine ILAC SAN. ve TIC. A.S.|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,20 Years to 40 Years   (Adult),30.0,Industry|Other,Interventional,2020-06-23,20/07/20,2020-08-08,29/05/20,11/08/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep",Turkey,Others,0,1,46.0
5698.0,NCT04604821,Delivering EMT Via Telehealth to Children and Families,,Not yet recruiting,Language Impairment,,,,,,,Behavioral: Enhanced Milieu Teaching|Behavioral: Parent Education,Oregon Health and Science University|Agency for Healthcare Research and Quality (AHRQ),All,18 Months to 36 Months   (Child),28.0,Other|U.S. Fed,Interventional,2020-10-20,01/10/21,2021-12-31,27/10/20,28/10/20,,,Others,0,1,437.0
5699.0,NCT04421690,Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study,COGMA,Recruiting,Generalized Anxiety Disorder,,,,,,,Behavioral: Cognitive Training|Behavioral: Trivia Training,University of Missouri-Columbia,All,45 Years to 59 Years   (Adult),30.0,Other,Interventional,2020-08-06,31/05/21,2021-05-31,09/06/20,02/11/20,"University of Missouri, Columbia, Missouri",United States,Mental Health,1,1,298.0
5700.0,NCT04740411,Online Wellness Intervention for College Students,,Not yet recruiting,Depression,Anxiety,Well-being,,,,,Behavioral: The Common Elements Toolbox (COMET),"University of Pennsylvania|Indiana University|Ohio State University|University of Missouri, St. Louis",All,"18 Years and older   (Adult, Older Adult)",850.0,Other,Interventional,2021-02-18,01/03/22,2022-01-03,05/02/21,21/02/21,,,Mental Health,1,3,319.0
5701.0,NCT04838236,"Smoking, Stress, and Mobile Technology",,Not yet recruiting,"Smoking, Tobacco",,,,,,,Other: MASP app|Other: QuitGuide app,University of Houston|University of Oklahoma,All,18 Years to 64 Years   (Adult),225.0,Other,Interventional,2021-01-06,01/09/21,2023-01-10,09/04/21,09/04/21,"Anxiety and Health Research Lab / Substance Use Treatment Clinic, Houston, Texas",United States,Others,0,1,734.0
5702.0,NCT04592588,Evaluating an Online Wellness Intervention for Indian College Students,,Recruiting,Depressive Symptoms,Anxiety,Happiness,,,,,Behavioral: Common Elements Toolbox|Behavioral: Wait-list control,University of Pennsylvania|Ashoka University|Jindal Global University,All,"18 Years to 99 Years   (Adult, Older Adult)",500.0,Other,Interventional,2020-10-19,30/06/21,2021-06-30,19/10/20,28/01/21,"Ashoka University, New Delhi, India|Jindal Global University, Sonipat",India,Mental Health,1,3,254.0
5703.0,NCT04648293,Starling Registry Study,,Recruiting,Hemodynamic Monitoring,,,,,,,Device: Starling,Baxter Healthcare Corporation,All,"18 Years to 95 Years   (Adult, Older Adult)",1000.0,Industry,Observational,2020-02-11,31/07/22,2022-07-31,01/12/20,18/03/21,"Baxter Investigational Site, Kansas City, Kansas, United States|Baxter Investigational Site, Saint Louis, Missouri",United States,Others,0,1,901.0
5704.0,NCT04480255,NICU2HOME+: Supporting Illinois Families,,Recruiting,Premature Birth,NICU,Premature,Infant,,,,Other: Group 1: Standard of Care|Other: Group 2: NICU2HOME+ app,Craig Garfield|Blue Cross Blue Shield|Northwestern University,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Interventional,2020-03-08,01/12/21,2022-01-06,21/07/20,19/01/21,"Northwest Community Hospital, Arlington Heights, Illinois, United States|Rush University Medical Center, Chicago, Illinois, United States|Centra Dupage Hospital, Winfield, Illinois",United States,Others,0,4,669.0
5705.0,NCT04564183,Advancing Prevention of Pulmonary Fibrosis,APPLe,Recruiting,IPF,Pulmonary Fibrosis,ILD,,,,,Other: Sample collection|Other: Questionnaires|Radiation: High resolution CT scan of the chest|Diagnostic Test: Pulmonary Function Test,"University of Colorado, Denver",All,"40 Years to 75 Years   (Adult, Older Adult)",1000.0,Other,Observational,2021-01-22,01/10/24,2024-01-10,25/09/20,10/02/21,"University of Colorado Anschutz Medical Campus, Aurora, Colorado",United States,Others,0,3,1083.0
5706.0,NCT04545593,Positive Minds Strong Bodies Implementation,PMSB-E,Recruiting,Depression,Anxiety,Physical Disability,,,,,Behavioral: Positive Minds Strong Bodies Enhanced|Behavioral: Enhanced Usual Care,Massachusetts General Hospital,All,"60 Years and older   (Adult, Older Adult)",450.0,Other,Interventional,2021-11-02,30/09/24,2024-09-30,11/09/20,12/02/21,"Massachusetts General Hospital, Boston, Massachusetts",United States,Mental Health,1,3,1063.0
5707.0,NCT04025151,Nurse-led Alcohol Brief Intervention Plus Mobile Personalized Chat-based Support on Reducing Alcohol Use in University Students,,Not yet recruiting,Alcohol Misuse,,,,,,,Behavioral: Alcohol brief intervention|Behavioral: 12-page health warning leaflet|Behavioral: Regular messages through Instant Messaging (IM)|Behavioral: Real-time chat-based support through IM Apps|Behavioral: General health through IM Apps|Behavioral: AUDIT score interpretation sheet adapted from the Department of Health of Hong Kong,The University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",770.0,Other,Interventional,2020-09-30,30/09/22,2022-11-30,18/07/19,18/09/20,"School of Nursing, The University of Hong Kong, Hong Kong",Hong Kong,Others,0,1,791.0
5708.0,NCT04688567,Patient-driven Internet Delivered Psychological Treatment,,"Active, not recruiting",Anxiety Disorders and Symptoms,Internet-Based Intervention,,,,,,Behavioral: Patient-driven iCBT|Behavioral: Standardized iCBT (TAU),Vastra Gotaland Region,All,"18 Years and older   (Adult, Older Adult)",56.0,Other,Interventional,2019-01-11,30/03/21,2021-03-30,30/12/20,30/12/20,"Department of Psychology, University of Gothenburg, Gothenburg",Sweden,Mental Health,1,2,809.0
5709.0,NCT04181021,Evaluation of Values Clarification and Attitude Transformation Workshops on Abortion and Family Planning Service Provision and Client Experience,,Enrolling by invitation,Abortion,Contraception,,,,,,Behavioral: Values Clarification and Attitudes Transformation (VCAT) Workshop,Ibis Reproductive Health|Marie Stopes International|Marie Stopes Ethiopia,Female,"Child, Adult, Older Adult",100.0,Other,Interventional,2019-11-25,01/07/20,2020-01-12,29/11/19,29/05/20,"Blue Star facilities, Multiple, Addis Ababa, Oromiya, Tigray, Snnpr, Amhara",Ethiopia,Others,0,2,48.0
5710.0,NCT04772807,"Validation of Kinocardiography, a New Technology Measuring Cardiac Mechanical Activity Via Accelerometers and Gyroscopes",,Recruiting,Atrial Fibrillation,Hypertension,Heart Failure,,,,,Device: Kinocardiograph,Erasme University Hospital,All,"18 Years and older   (Adult, Older Adult)",320.0,Other,Observational,2021-05-02,01/05/22,2022-12-31,26/02/21,26/02/21,"Erasme Hospital, Brussels",Belgium,Cardiovascular Diseases,1,3,608.0
5711.0,NCT03716869,Universal vs. Targeted School Screening for Adolescent Major Depressive Disorder,,"Active, not recruiting",Major Depressive Disorder,Major Depressive Episode,,,,,,Other: Universal Screening Arm,Milton S. Hershey Medical Center|Health Resources and Services Administration (HRSA)|Patient-Centered Outcomes Research Institute,All,"Child, Adult, Older Adult",12506.0,Other|U.S. Fed,Interventional,2018-01-07,20/11/20,2021-01-02,23/10/18,24/12/20,"The Pennsylvania State University, Hershey, Pennsylvania",United States,Others,0,2,1091.0
5712.0,NCT03929393,Mindful Movement for Physical Activity and Wellbeing in Older Adults- A Hybrid Effectiveness-Implementation Study,Y-U,"Active, not recruiting",Physical Inactivty,Wellbeing,Mindfulness,,,,,Behavioral: Mindful Movement|Other: Keys to Health & Wellbeing,University of Minnesota|YMCA|National Center for Complementary and Integrative Health (NCCIH),All,"50 Years and older   (Adult, Older Adult)",176.0,Other|NIH,Interventional,2019-07-17,30/05/21,2022-03-31,26/04/19,05/04/21,"YMCA Burnsville, Burnsville, Minnesota, United States|YMCA Southdale, Edina, Minnesota, United States|YMCA Cora McCorvey, Minneapolis, Minnesota, United States|University of Minnesota, Minneapolis, Minnesota, United States|YMCA Midway, Saint Paul, Minnesota",United States,Others,0,3,988.0
5713.0,NCT04734288,LIFEHOUSE: Description of the Tent Bucket -Immune Support,LIFEHOUSE,"Active, not recruiting",Immune Response,,,,,,,"Dietary Supplement: Vit.D3 5000 IU, Immune Active","Metagenics, Inc.|MetaProteomics LLC",All,"18 Years to 69 Years   (Adult, Older Adult)",7.0,Industry,Interventional,2021-01-22,31/07/22,2023-07-31,02/02/21,18/02/21,"Personalized Lifestyle Medicine Center, Gig Harbor, Washington",United States,Others,0,1,920.0
5714.0,NCT01087333,"Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment",,Recruiting,Hairy Cell Leukemia (HCL),Chronic Lymphocytic Leukemia (CLL),Non-Hodgkins Lymphoma (NHL),Cutaneous T Cell Lymphoma (CTCL),Adult T Cell Lymphoma (ATL),,,,National Cancer Institute (NCI)|National Institutes of Health Clinical Center (CC),All,"18 Years and older   (Adult, Older Adult)",1263.0,NIH,Observational,2010-02-03,,,16/03/10,12/04/21,"National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland",United States,Cancers,1,5,
5715.0,NCT04684602,Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions,,Recruiting,Autoimmune Diseases,Cardiovascular Disorders,Diabetes Complications,Integumentary Disease,Musculoskeletal Disorders,Neurodegenerative Disorders,Neurologic Disorders,Biological: PrimePro™/ PrimeMSK™,Thomas Advanced Medical LLC|HeartStem Institute|NuStem,All,"18 Years and older   (Adult, Older Adult)",5000.0,Industry|Other,Interventional,2020-09-07,09/07/30,2030-09-12,24/12/20,24/12/20,"Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California",United States,Metabolic Disorders,1,7,3657.0
5716.0,NCT03871491,Azithromycin-Prevention in Labor Use Study (A-PLUS),,Recruiting,Maternal Death,Maternal Infections Affecting Fetus or Newborn,Neonatal SEPSIS,Maternal Sepsis During Labor,Neonatal Death,Postpartum Sepsis,,Drug: Azithromycin|Drug: Placebo,"NICHD Global Network for Women's and Children's Health|University of Alabama at Birmingham|University Teaching Hospital, Lusaka, Zambia|University of North Carolina, Chapel Hill|Kinshasa School of Public Health|University of Colorado, Denver|Institute of Nutrition of Central America and Panama|University of Virginia|International Centre for Diarrhoeal Disease Research, Bangladesh|Thomas Jefferson University|Columbia University|Aga Khan University|Boston University|Lata Medical Research Foundation, Nagpur|Indiana University School of Medicine|Moi Univeristy|RTI International|Bill and Melinda Gates Foundation|KLE University's Jawaharlal Nehru Medical College",Female,18 Years to 45 Years   (Adult),34000.0,Other,Interventional,2020-01-09,01/09/23,2023-01-09,12/03/19,16/09/20,"ICDDRB, Dhaka, Bangladesh|Kinshasa School of Public Health, Kinshasa, Congo, The Democratic Republic of the|Institute for Nutrition of Central America and Panama (INCAP), Guatemala City, Guatemala|Jawaharlal Nehru Medical College, Belagavi, India|Lata Medical Research Foundation, Nagpur, India|Moi University School of Medicine, Eldoret, Kenya|The Aga Khan University, Karachi, Pakistan|University Teaching Hospital, Lusaka",Zambia,Others,0,6,1096.0
5717.0,NCT03474965,Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients,,Recruiting,Sickle Cell Disease (SCD),,,,,,,Drug: Crizanlizumab,Novartis Pharmaceuticals|Novartis,All,6 Months to 17 Years   (Child),100.0,Industry,Interventional,2018-01-10,05/06/23,2024-11-20,23/03/18,15/03/21,"University of Alabama 1600 7th ave, Birmingham, Alabama, United States|Phoenix Childrens Hospital CVAL489A2302, Phoenix, Arizona, United States|UC Davis Medical Center, Sacramento, California, United States|Children s National Hospital, Washington, District of Columbia, United States|University of Florida College of Medicine, Gainesville, Florida, United States|Joe DiMaggio Childrens Hospital, Hollywood, Florida, United States|Childrens Healthcare of Atlanta, Atlanta, Georgia, United States|Ann and Robert H Lurie Childrens Hospital of Chicago CTBM100C2407, Chicago, Illinois, United States|University of Chicago Hospital, Chicago, Illinois, United States|Childrens Hospital Boston, Boston, Massachusetts, United States|Institute for Pediatric Cancer and Blood Disorders, Hackensack, New Jersey, United States|UMDNJ, New Brunswick, New Jersey, United States|Children's Hospital at Montefiore, Bronx, New York, United States|Duke University Medical Center Oncology, Durham, North Carolina, United States|East Carolina University SC, Greenville, North Carolina, United States|Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, United States|Medical University of South Carolina Medical Uni of South Carolina, Charleston, South Carolina, United States|St. Jude Children's Research Hosptial, Memphis, Tennessee, United States|Cook Childrens Medical Center Oncology, Fort Worth, Texas, United States|Novartis Investigative Site, Edegem, Antwerpen, Belgium|Novartis Investigative Site, Brussel, Belgium|Novartis Investigative Site, Laeken, Belgium|Novartis Investigative Site, Liege, Belgium|Novartis Investigative Site, Salvador, BA, Brazil|Novartis Investigative Site, Ribeirao Preto, SP, Brazil|Novartis Investigative Site, São Paulo, SP, Brazil|Novartis Investigative Site, Toronto, Ontario, Canada|Novartis Investigative Site, Montreal, Quebec, Canada|Novartis Investigative Site, Medellin, Antioquia, Colombia|Novartis Investigative Site, Cali, Valle Del Cauca, Colombia|Novartis Investigative Site, Monteria, Colombia|Novartis Investigative Site, Paris cedex 15, France|Novartis Investigative Site, Heidelberg, Baden Wuerttemberg, Germany|Novartis Investigative Site, Berlin, Germany|Novartis Investigative Site, Nagpur, Maharashtra, India|Novartis Investigative Site, New Delhi, India|Novartis Investigative Site, Vellore, India|Novartis Investigative Site, Modena, Italy|Novartis Investigative Site, Orbassano, Italy|Novartis Investigative Site, Padova, Italy|Novartis Investigative Site, Beirut, Lebanon|Novartis Investigative Site, Tripoli, Lebanon|Novartis Investigative Site, Muscat, Oman|Novartis Investigative Site, Esplugues de Llobregat, Barcelona, Spain|Novartis Investigative Site, Barcelona, Catalunya, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, Spain|Novartis Investigative Site, Palma De Mallorca, Islas Baleares, Spain|Novartis Investigative Site, Madrid, Spain|Novartis Investigative Site, Aarau, Aargau, Switzerland|Novartis Investigative Site, Adana, Turkey|Novartis Investigative Site, Mersin, Turkey|Novartis Investigative Site, London, United Kingdom|Novartis Investigative Site, London",United Kingdom,Others,0,1,2506.0
5718.0,NCT04386876,"Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions",Orvical,Completed,Bioequivalence,,,,,,,Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Tablet|Drug: Lopinavir/Ritonavir 200 mg/50 mg Film Coated Tablet,World Medicine ILAC SAN. ve TIC. A.S.|Novagenix Bioanalytical Drug R&D Center|Farmagen Ar-Ge Biyot. Ltd. Sti,Male,20 Years to 40 Years   (Adult),30.0,Industry|Other,Interventional,2020-04-30,22/05/20,2020-11-06,13/05/20,31/12/20,"Novagenix Drug R&D Center, Akyurt, Ankara, Turkey|Farmagen Ar-Ge Biyot. Ltd. Sti., Sahinbey, Gaziantep",Turkey,Others,0,1,190.0
5719.0,NCT02549664,Exercise in Genetic Cardiovascular Conditions,LIVE-HCM/LQT,"Active, not recruiting",Hypertrophic Cardiomyopathy,Long QT Syndrome,,,,,,,"Yale University|National Institutes of Health (NIH)|National Heart, Lung, and Blood Institute (NHLBI)",All,"8 Years to 60 Years   (Child, Adult)",4299.0,Other|NIH,Observational,2015-01-05,30/12/21,2021-12-30,15/09/15,02/02/21,"University of Arizona, Tucson, Arizona, United States|University of California Irvine, Orange, California, United States|University of California, San Diego (Rady's Children's Hospital), San Diego, California, United States|Stanford, Stanford, California, United States|Yale University, New Haven, Connecticut, United States|Children's National, Washington, District of Columbia, United States|Miami Children's (Nicklaus Children's Hospital), Miami, Florida, United States|Lurie Children's, Chicago, Illinois, United States|Indiana University, Indianapolis, Indiana, United States|University of Iowa, Iowa City, Iowa, United States|University of Louisville, Louisville, Kentucky, United States|Johns Hopkins, Baltimore, Maryland, United States|Tufts, Boston, Massachusetts, United States|Boston Children's, Boston, Massachusetts, United States|Brigham & Women's, Boston, Massachusetts, United States|University of Michigan, Ann Arbor, Michigan, United States|Mayo Clinic, Rochester, Minnesota, United States|Children's Omaha, Omaha, Nebraska, United States|NYU, New York, New York, United States|Cincinnati Children's, Cincinnati, Ohio, United States|Cleveland Clinic, Cleveland, Ohio, United States|Oregon Health & Science, Portland, Oregon, United States|Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States|University of Pittsburgh, Pittsburgh, Pennsylvania, United States|Vanderbilt University, Nashville, Tennessee, United States|UT Southwestern, Dallas, Texas, United States|Texas Children's, Houston, Texas, United States|University of Utah (Primary Children's), Salt Lake City, Utah, United States|Seattle Children's, Seattle, Washington, United States|Royal Prince Alfred Hospital/Sydney AU, Camperdown, New South Wales, Australia|University of BC, Providence Health, Vancouver, British Columbia, Canada|University of BC, Children's, Vancouver, British Columbia, Canada|University of Toronto, Toronto, Ontario, Canada|Starship Children's Hospital, Grafton, Auckland, New Zealand|St. Georges, London, London, England, United Kingdom|Royal Brompton Hospital, London, England",United Kingdom,Others,0,2,2551.0
5720.0,NCT04813068,Lung Cancer Patients' Attitudes to a Second Course of Radiotherapy,,Not yet recruiting,Lung Cancer,Recurrence,,,,,,Other: Semi-structured interview,NHS Greater Glasgow and Clyde|University of Glasgow|The Beatson Cancer Charity,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Observational,2021-01-03,01/12/21,2022-01-06,24/03/21,24/03/21,,,Cancers,1,2,368.0
5721.0,NCT04043364,Live@Home.Path: Innovating the Clinical Pathway for Home Dwelling Persons With Dementia and Their Families,LIVE,"Active, not recruiting",Dementia,Home-dwelling,Caregiver,,,,,Behavioral: LIVE,"University of Bergen|Haraldsplass Deaconal Hospital|Western Norway University of Applied Sciences|Norwegian Reseach Centre AS (NORCE)|Norwegian National Advisory Unit on Ageing and Health|Natioal Association for Public Health|Municipality of Bergen|Municipally of Kristiansund|Municipally of Bærum|The Dignity Centre|Harvard McLean University|Yale School of Medicine|University College, London|University of Leiden|Tohoku University|King's College London|The University of Hong Kong",All,65 Years and older   (Older Adult),280.0,Other,Interventional,2019-01-08,01/06/21,2021-01-06,02/08/19,08/04/21,"University of Bergen, Bergen",Norway,Others,0,3,729.0
5722.0,NCT04753307,Perioperative Inflammatory Response Assessment in High-risk Patients Undergoing Noncardiac Surgery,INSIGHT,Recruiting,Postoperative Complications,Cardiovascular Complication,Myocardial Ischemia,Inflammation,,,,Diagnostic Test: Laboratory measurements,Medical University of Vienna|Medical University of Graz,All,"45 Years and older   (Adult, Older Adult)",1400.0,Other,Observational,2021-01-19,31/01/23,2024-01-31,15/02/21,18/02/21,"Medical University of Vienna, Vienna",Austria,Others,0,4,1107.0
5723.0,NCT04449744,Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study,,Recruiting,Opioid-use Disorder,,,,,,,Other: MySafeRx Inspire Plus|Other: MySafeRx Inspire Flex,University of South Florida|Cambridge Health Alliance,All,"18 Years to 65 Years   (Adult, Older Adult)",30.0,Other,Interventional,2020-07-13,31/01/21,2021-01-03,29/06/20,17/12/20,"ACTS Adult Addiction Receiving Facility (AARF), Tampa, Florida",United States,Others,0,1,174.0
5724.0,NCT03184662,Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes,ACTIDIANE,Recruiting,Type2 Diabetes,Diabetic Kidney Disease,,,,,,Other: HIPA|Other: Counseling PA,"Poitiers University Hospital|University Hospital, Bordeaux|University Hospital, Clermont-Ferrand|Centre Hospitalier Universitaire Dijon|Centre Hospitalier Universitaire de Besancon|Hopital Lariboisière|Bichat Hospital|Centre Hospitalier Sud Francilien|University Hospital, Lille|Centre Hospitalier Universitaire de Nice|University Hospital, Caen|University Hospital, Toulouse|University Hospital, Tours|Nantes University Hospital|Groupe Hospitalier Pitie-Salpetriere|Hospices Civils de Lyon|University Hospital, Montpellier|University Hospital, Strasbourg|Central Hospital, Nancy, France|HOSPITAL, CHARTRES|University of Liege",All,"45 Years and older   (Adult, Older Adult)",300.0,Other,Interventional,2018-12-02,30/09/23,2023-12-31,12/06/17,02/02/21,"Hospital of Liège, Liège, Belgium|Besançon Hospital, Besançon, France|Bordeaux University Hospital, Bordeaux, France|Caen University Hospital, Caen, France|CH Chartres, Chartres, France|Clermont Ferrand University Hospital, Clermont Ferrand, France|CHG Sud Francilien, Corbeil-Essonnes, France|CHU Dijon, Dijon, France|CHU Lille, Lille, France|Chu de Lyon, Lyon, France|CHRU, Montpellier, France|CHU Nancy, Nancy, France|Chu de Nice, Nice, France|Bichat University Hospital, Paris, France|La Riboisière Hospital, Paris, France|Hôpital Pitié Salpétrière, Paris, France|Poitiers University Hospital, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Toulouse, Toulouse, France|CHU de TOURS, Tours",France,Metabolic Disorders,1,2,1855.0
5725.0,NCT03452774,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,,Recruiting,"Cancer, Metastatic",Cancer,Cancer of Pancreas,Cancer of Liver,Cancer of Stomach,Cancer Liver,Cancer of Rectum,Other: Clinical Trial Matching,"Massive Bio, Inc.",All,"Child, Adult, Older Adult",1500.0,Industry,Observational,2018-01-01,01/12/21,2022-01-12,02/03/18,28/04/20,"Massive Bio, Inc, New York, New York",United States,Cancers,1,7,1472.0
5726.0,NCT04231097,MBCT Delivered Via Group Videoconferencing for ACS Syndrome Patients With Depressive Symptoms,,"Active, not recruiting",Acute Coronary Syndrome,Depression,Myocardial Infarction,Unstable Angina,STEMI,NSTEMI - Non-ST Segment Elevation MI,,Other: MBCT intervention for ACS patients,Massachusetts General Hospital,All,"35 Years to 85 Years   (Adult, Older Adult)",7.0,Other,Interventional,2020-04-24,25/02/21,2021-01-04,18/01/20,03/03/21,"Mongan Institute: Health Policy Research Center, Boston, Massachusetts",United States,Mental Health,1,6,255.0
5727.0,NCT04828018,Care of the Ageing Veteran Population: Developing an Evidence Base for the Royal Hospital Chelsea Model of Care,,Not yet recruiting,Quality of Life,Aging Well,,,,,,Other: Coffee Morning|Other: Recruitment Leaflets|Other: Consent Form completion|Other: Participant Information Sheet|Other: New In-Pensioner Resident Information Pack|Other: Key Staff Interviews|Other: In-Pensioner Resident Interviews|Other: ICECAP-A Quality of Life Questionnaire|Other: WHOQOL-BREF Quality of Life Questionnaire,Northumbria University|Royal Hospital Chelsea,All,"Child, Adult, Older Adult",80.0,Other,Observational,2021-01-04,01/05/22,2022-01-05,01/04/21,08/04/21,,,Others,0,2,366.0
5728.0,NCT01435018,Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS,,Completed,HIV-1 Infection,,,,,,,Drug: Etoposide (ET)|Drug: Bleomycin and Vincristine (BV)|Drug: Paclitaxel (PTX)|Drug: Co-formulated Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF),AIDS Clinical Trials Group|National Institute of Allergy and Infectious Diseases (NIAID)|National Cancer Institute (NCI)|National Institute of Dental and Craniofacial Research (NIDCR)|AIDS Malignancy Consortium,All,"18 Years and older   (Adult, Older Adult)",334.0,Other|NIH,Interventional,2013-01-10,13/03/18,2019-08-29,15/09/11,23/11/20,"Instituto de Pesquisa Clinica Evandro Chagas (12101), Rio de Janeiro, Brazil|Moi University International Clnical Trials Unit, Eldoret, Kenya|KMRI / Walter Reed Project Clinical Research Center, Kericho, Kenya|Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460), Kisumu, Kenya|Univ. of Malawi, John Hopkins Project, Blantyre, Malawi|Malawi CRS (12001), Lilongwe, Malawi|Family Clinical Research Unit (FAM-CUR) CRS (8950), Cape Town, West Cape, South Africa|Durban Adult HIV CRS (11201), Durban, South Africa|University of Witwatersrand, Johannesburg, South Africa|Uganda Cancer Institute ACTG CRS, Kampala, Uganda|UZ-Parirenyatwa CRS (30313), Harare",Zimbabwe,Others,0,1,2422.0
5729.0,NCT03464097,A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease,,Recruiting,Crohn Disease,,,,,,,Drug: Ozanimod|Other: Placebo,Celgene,All,"12 Years to 75 Years   (Child, Adult, Older Adult)",485.0,Industry,Interventional,2018-06-27,26/06/24,2024-09-24,13/03/18,15/02/21,"Holland Center for Family Health, Peoria, Arizona, United States|Elite Clinical Studies, LLC, Phoenix, Arizona, United States|HonorHealth Research Institute, Scottsdale, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|UCSD Medical Center, La Jolla, California, United States|San Diego Clinical Trials, La Mesa, California, United States|OM Research, Lancaster, California, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Matrix Clinical Research Inc, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|VA Northern California Health Care System, Mather, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|ABS Health, LLC, Mission Viejo, California, United States|Alliance Clinical Research, Oceanside, California, United States|Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Sutter Medical Group, Roseville, California, United States|UC Davis Health - Gastroenterology and Hepatology Clinical Trials Unit, Sacramento, California, United States|Medical Associates Research Group, San Diego, California, United States|University of California at San Francisco, San Francisco, California, United States|New Hope Research Development, West Covina, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, United States|Yale University, New Haven, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|Clinical Research of West Florida, Clearwater, Florida, United States|South Lake Pain Institute, Clermont, Florida, United States|American Research Institute Inc, Cutler Bay, Florida, United States|Universal Axon Clinical Research, Doral, Florida, United States|Riverside Clinical Research, Edgewater, Florida, United States|University of Florida Health Endocrinology - Medical Specialties - Medical Plaza, Gainesville, Florida, United States|Qway Research LLC, Hialeah, Florida, United States|Floridian Clinical Research LLC, Hialeah, Florida, United States|Harmony Medical Research Institute, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Vista Health Research, Homestead, Florida, United States|SIH Research, Kissimmee, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Pioneer Clinical Research, Lighthouse Point, Florida, United States|Center For Advanced Gastroenterology, Maitland, Florida, United States|Galiz Research LLC, Miami Springs, Florida, United States|LMG Research, Miami, Florida, United States|Nova Clinical Research Center LLC, Miami, Florida, United States|LCC Medical Research Institute, LLC, Miami, Florida, United States|Research Associates of South Florida LLC, Miami, Florida, United States|Life Medical Center & Research, Inc., Miami, Florida, United States|Vista Health Research, Miami, Florida, United States|Advanced Research for Health Improvement, Naples, Florida, United States|Bayside Clinical Research, New Port Richey, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|HMD Research LLC, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Precision Clinical Research, LLC., Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Apex Clinical Research, Tampa, Florida, United States|Guardian Angel Health Svcs Inc, Tampa, Florida, United States|Asclepes Research Centers, Weeki Wachee, Florida, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Gastrointestinal Disease Research, Columbus, Georgia, United States|Atlanta Center For Gastroenterology, P.C., Decatur, Georgia, United States|Gastroenterology Associates Of Central Georgia LLC, Macon, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Chicago, Chicago, Illinois, United States|DM Clinical Research, Oak Lawn, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|Cotton ONeil Clinical Research Center Digestive Health, Topeka, Kansas, United States|University of Kentucky Health Care, Lexington, Kentucky, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|CroNOLA LLC, Houma, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Clinical Trials of SW Louisiana LLC, Lake Charles, Louisiana, United States|Tandem Clinical Research, LLC, Marrero, Louisiana, United States|Nola Research Works, New Orleans, Louisiana, United States|LSU Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Woodholme Gastroenterology Associates, Glen Burnie, Maryland, United States|Harvard Medical School - Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital - Crohn's and Colitis Center, Chestnut Hill, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Medex Research Institute, Caro, Michigan, United States|Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, United States|Henry Ford Medical Center - New Center One, Novi, Michigan, United States|Revive Research Institute, Southfield, Michigan, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Mid America Gastrointestinal Consultants, Kansas City, Missouri, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Internal Medicine Specialists, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Advantage Clinical Trials, Bronx, New York, United States|NY Scientific, Brooklyn, New York, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Northwell Health, Great Neck, New York, United States|Drug Trials America, Hartsdale, New York, United States|Weill Cornell Medical College, New York, New York, United States|Concorde Medical Group, New York, New York, United States|Cornell University, New York, New York, United States|TrialSpark, New York, New York, United States|Lenox Hill Hospital, N",United Kingdom,Others,0,1,2281.0
5730.0,NCT03440385,Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease,,Recruiting,Crohn Disease,,,,,,,Drug: Ozanimod|Other: Placebo,Celgene,All,"12 Years to 75 Years   (Child, Adult, Older Adult)",600.0,Industry,Interventional,2018-07-03,11/04/23,2023-10-07,22/02/18,03/03/21,"HonorHealth Research Institute, Scottsdale, Arizona, United States|Kindred Medical Institute for Clinical Trials, LLC, Corona, California, United States|UCSD Medical Center, La Jolla, California, United States|OM Research, Lancaster, California, United States|Southern California Research Institute Medical Group, Inc., Los Angeles, California, United States|Matrix Clinical Research Inc, Los Angeles, California, United States|Facey Medical Foundation (Parent), Mission Hills, California, United States|Havana Research Institute LLC, Pasadena, California, United States|Sutter Medical Group, Roseville, California, United States|UC Davis Health - Gastroenterology and Hepatology Clinical Trials Unit, Sacramento, California, United States|University of California at San Francisco, San Francisco, California, United States|New Hope Research Development, West Covina, California, United States|Peak Gastroenterology Associates, Colorado Springs, Colorado, United States|Connecticut Clinical Research Foundation, Bristol, Connecticut, United States|Clinical Research of West Florida, Clearwater, Florida, United States|South Lake Pain Institute, Clermont, Florida, United States|American Research Institute Inc, Cutler Bay, Florida, United States|Universal Axon Clinical Research, Doral, Florida, United States|Riverside Clinical Research, Edgewater, Florida, United States|SIH Research, Kissimmee, Florida, United States|Pioneer Clinical Research, Lighthouse Point, Florida, United States|Center For Advanced Gastroenterology, Maitland, Florida, United States|Galiz Research LLC, Miami Springs, Florida, United States|LMG Research, Miami, Florida, United States|Life Medical Center & Research, Inc., Miami, Florida, United States|Vista Health Research, Miami, Florida, United States|Bayside Clinical Research, New Port Richey, Florida, United States|Omega Research Maitland, LLC, Orlando, Florida, United States|IMIC, Inc., Palmetto Bay, Florida, United States|Theia Clinical Research, LLC, Pinellas Park, Florida, United States|Precision Clinical Research, LLC., Sunrise, Florida, United States|University of South Florida, Tampa, Florida, United States|Apex Clinical Research, Tampa, Florida, United States|Guardian Angel Health Svcs Inc, Tampa, Florida, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, United States|Emory Clinic, Atlanta, Georgia, United States|Atlanta Center For Gastroenterology, P.C., Decatur, Georgia, United States|Grand Teton Research Group, PLLC, Idaho Falls, Idaho, United States|University of Chicago, Chicago, Illinois, United States|MediSphere Medical Research Center, LLC, Evansville, Indiana, United States|Indiana University, Indianapolis, Indiana, United States|Cotton ONeil Clinical Research Center Digestive Health, Topeka, Kansas, United States|Gastroenterology Associates, LLC, Baton Rouge, Louisiana, United States|Clinical Trials of SW Louisiana LLC, Lake Charles, Louisiana, United States|Tandem Clinical Research, LLC, Marrero, Louisiana, United States|Harvard Medical School - Boston Children's Hospital, Boston, Massachusetts, United States|University of Massachusetts Memorial Medical Center, Worcester, Massachusetts, United States|Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, United States|Henry Ford Medical Center - New Center One, Novi, Michigan, United States|University of Minnesota Medical Center, Minneapolis, Minnesota, United States|Mayo Clinic, Rochester, Minnesota, United States|Mid America Gastrointestinal Consultants, Kansas City, Missouri, United States|Internal Medicine Specialists, Las Vegas, Nevada, United States|Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States|Drug Trials America, Hartsdale, New York, United States|Weill Cornell Medical College, New York, New York, United States|Concorde Medical Group, New York, New York, United States|TrialSpark, New York, New York, United States|DiGiovanna Institute for Medical Education And Research, North Massapequa, New York, United States|PMG Research of Charlotte LLC, Charlotte, North Carolina, United States|PMG Research of Winston-Salem LLC, Winston-Salem, North Carolina, United States|University Hospitals of Cleveland, Cleveland, Ohio, United States|Advance Clinical Research - Dayton Internal Medicine, Dayton, Ohio, United States|Ohio State University Wexner Medical Center, Hilliard, Ohio, United States|Paramount Medical Research & Consulting, LLC, Middleburg Heights, Ohio, United States|Cancer Care Associates of OK-N PorterAvenue, Norman, Oklahoma, United States|Allergy, Asthma and Immunology Center, PC, Tulsa, Oklahoma, United States|Central States Research, LLC, Tulsa, Oklahoma, United States|University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States|San Antonio Military Medical Center, Fort Sam Houston, Texas, United States|Centex Studies, Inc., Houston, Texas, United States|The Coastal Medical Group, Houston, Texas, United States|Gulf Coast Research Group LLC, Houston, Texas, United States|Accurate Clinical Research Inc, Pasadena, Texas, United States|DHAT Research Institute, Richardson, Texas, United States|San Antonio Gastroenterology, San Antonio, Texas, United States|Baylor Scott and White Health, Temple, Texas, United States|Blue Ridge Medical Research, Lynchburg, Virginia, United States|The Gastroenterology Group, Reston, Virginia, United States|McGuire Veterans Affairs Medical Center, Richmond, Virginia, United States|Carilion Clinic, Roanoke, Virginia, United States|Franciscan Skemp Healthcare, La Crosse, Wisconsin, United States|Liverpool Hospital, Liverpool, New South Wales, Australia|John Hunter Hospital and Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia|Coastal Digestive Health, Maroorchydore, Queensland, Australia|University of the Sunshine Coast, North Mackay, Queensland, Australia|Mater Hospital Brisbane, South Brisbane, Queensland, Australia|Flinders Medical Centre, Bedford Park, South Australia, Australia|Monash Medical Centre, Clayton, Victoria, Australia|St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia|St John of God Subiaco Hospital, Subiaco, Western Australia, Australia|Medical University Innsbruck, Innsbruck, Austria|University Hospital St. Poelten, St Polten, Austria|Medical University Vienna, Vienna, Austria|MHAT Ruse AD, Ruse, Bulgaria|Excelsior Medical Center, Sofia, Bulgaria|Multiprofile Hospital for Active Treatment Tokuda Hospital Sofia, Sofia, Bulgaria|Diagnostic and Consulting Center Alexandrovska, Sofia, Bulgaria|University Multiprofile Hospital for Active Treatment Tsaritsa Yoanna ISUL EAD, Sofia, Bulgaria|West Edmonton Gastroenterology Consultants, Edmonton, Alberta, Canada|Fraser Clinical Trials Inc., New Westminister, British Columbia, Canada|GI Research Institute, Vancouver, British Columbia, Canada|Brandon Medical Arts Clinic, Brandon, Manitoba, Canada|IWK Health Center, Halifax, Nova Scotia, Canada|Dr.Garisa Jagan Mohan Reddy MD, Sudbury, Ontario, Canada|Mount Sinai Hospital, Toronto, Ontario, Canada|Kensington Screening Clinic, Toronto, Ontario, Canada|Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada|The Ottawa Hospital - General Campus, Ottawa, Quebec, Canada|Peking University First Hospital, Beijing, China|Peking University People's Hospital, Beijing, China|Beijing YouYi Hospital-Beijing Friendship Hospital Capital Medical University, Beijing, China|The Seventh Medical Center of PLA General Hospital, Beijing, China|First Hospital of Jilin University, Changchun, China|Guangzhou First People's Hospital, Guangzhou Shi, China|Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China|Anhui Provincial Hospital, Hefei, China|The First Affiliated Hospital of Nanchang University, Nanchang, China|Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China|Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China|China Medical University Hospital, Taichung City, China|Wuhan Union Hospital, Wuhan, China|Tongji Hospital, Tongji Medical College of Huazhong University of Science and",Ukraine,Others,0,1,1922.0
5731.0,NCT03440372,Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease,,Recruiting,Crohn Disease,,,,,,,Drug: Ozanimod|Other: Placebo,Celgene,All,"12 Years to 75 Years   (Child, Adult, Older Adult)",600.0,Industry,Interventional,2018-02-27,27/06/23,2023-09-25,22/02/18,02/03/21,"Holland Center for Family Health, Peoria, Arizona, United States|Elite Clinical Studies, LLC, Phoenix, Arizona, United States|Arkansas Gastroenterology, P.A., North Little Rock, Arkansas, United States|Sharp Chula Vista Medical Center, Chula Vista, California, United States|Valley View Internal Medicine, Garden Grove, California, United States|San Diego Clinical Trials, La Mesa, California, United States|Children's Hospital of Los Angeles, Los Angeles, California, United States|Gastrointestinal Biosciences, Los Angeles, California, United States|VA Northern California Health Care System, Mather, California, United States|ABS Health, LLC, Mission Viejo, California, United States|Alliance Clinical Research, Oceanside, California, United States|Palo Alto Center-Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States|Inland Empire Liver Foundation, Rialto, California, United States|Medical Associates Research Group, San Diego, California, United States|Childrens Hospital Colorado, Aurora, Colorado, United States|Yale University, New Haven, Connecticut, United States|Gastro Florida, Clearwater, Florida, United States|University of Florida Health Endocrinology - Medical Specialties - Medical Plaza, Gainesville, Florida, United States|Qway Research LLC, Hialeah, Florida, United States|Floridian Clinical Research LLC, Hialeah, Florida, United States|Harmony Medical Research Institute, Hialeah, Florida, United States|The Center for Gastrointestinal Disorders, Hollywood, Florida, United States|Vista Health Research, Homestead, Florida, United States|Florida Center for Gastroenterology, Largo, Florida, United States|Nova Clinical Research Center LLC, Miami, Florida, United States|LCC Medical Research Institute, LLC, Miami, Florida, United States|Research Associates of South Florida LLC, Miami, Florida, United States|Advanced Research for Health Improvement, Naples, Florida, United States|NSB Research, New Smyrna Beach, Florida, United States|HMD Research LLC, Orlando, Florida, United States|Advanced Medical Research Center, Port Orange, Florida, United States|Asclepes Research Centers, Weeki Wachee, Florida, United States|Consultative Gastroenterology, Atlanta, Georgia, United States|Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, United States|Children's Center for Digestive Healthcare, Atlanta, Georgia, United States|Gastrointestinal Disease Research, Columbus, Georgia, United States|Gastroenterology Associates Of Central Georgia LLC, Macon, Georgia, United States|Rush University Medical Center - University Cardiovascular Surgeons, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|Carle Foundation Hospital, Urbana, Illinois, United States|Iowa Digestive Disease Center, Clive, Iowa, United States|University of Kentucky Health Care, Lexington, Kentucky, United States|CroNOLA LLC, Houma, Louisiana, United States|Centex Studies, Inc., Lake Charles, Louisiana, United States|Nola Research Works, New Orleans, Louisiana, United States|LSU Health Sciences Center Shreveport, Shreveport, Louisiana, United States|Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States|Digestive Disease Associates, PA, Catonsville, Maryland, United States|Woodholme Gastroenterology Associates, Glen Burnie, Maryland, United States|Brigham and Women's Hospital - Crohn's and Colitis Center, Chestnut Hill, Massachusetts, United States|Baystate Medical Center, Springfield, Massachusetts, United States|Medex Research Institute, Caro, Michigan, United States|Revive Research Institute, Southfield, Michigan, United States|Southern Therapy and Advanced Research, Jackson, Mississippi, United States|Washington University School of Medicine, Saint Louis, Missouri, United States|Englewood Hospital and Medical Center, Englewood, New Jersey, United States|University of New Mexico Hospital, Albuquerque, New Mexico, United States|Advantage Clinical Trials, Bronx, New York, United States|NY Scientific, Brooklyn, New York, United States|Adirondack Medical Research Center, Glens Falls, New York, United States|Northwell Health, Great Neck, New York, United States|Cornell University, New York, New York, United States|Lenox Hill Hospital, New York, New York, United States|Circuit Clinical, Orchard Park, New York, United States|Asheville Gastroenterology Associates, P.A., Asheville, North Carolina, United States|Carolinas HealthCare System Digestive Health, Charlotte, North Carolina, United States|Internal Medicine Research, Charlotte, North Carolina, United States|Carolina Research Center, Greenville, North Carolina, United States|Great Lakes Medical Research, LLC, Beachwood, Ohio, United States|Cleveland Clinic - Taussig Cancer Institute, Cleveland, Ohio, United States|Great Lakes Gastroenterology, Mentor, Ohio, United States|Great Lakes Medical Research, LLC, Warren, Ohio, United States|University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States|Digestive Disease Specialists, Oklahoma City, Oklahoma, United States|Oregon Health & Science University, Portland, Oregon, United States|Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, United States|Penn State University Milton S Hershey Medical Center, State College, Pennsylvania, United States|Quality Medical Research, Nashville, Tennessee, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Advanced Gastroenterology, Union City, Tennessee, United States|Avant Research Associates, LLC - Austin, Austin, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Houston Methodist Hospital, Houston, Texas, United States|Biopharma Informatic Inc. Research Center, Houston, Texas, United States|GI Specialists of Houston, Houston, Texas, United States|Premier Vein and Vascular Center, Houston, Texas, United States|Sun Research Institute, San Antonio, Texas, United States|Texas Digestive Disease Consultants - Southlake, Southlake, Texas, United States|Digestive Health Specialists of Tyler, Tyler, Texas, United States|University of Utah School of Medicine, Salt Lake City, Utah, United States|Gastroenterology Associates, PC, Gainesville, Virginia, United States|Summit Clinical Research, LLC, Petersburg, Virginia, United States|Virginia Gastroenterology Institute PC, Suffolk, Virginia, United States|University of Washington Medical Center, Seattle, Washington, United States|Dermatologist Specialists of Spokane, Spokane, Washington, United States|Aurora Health Care Aurora Research, Grafton, Wisconsin, United States|Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina|Hospital Privado Centro Medico de Cordoba, Cordoba, Argentina|Instituto Medico de la Fundacion Estudios Clinicos, Rosario, Argentina|Universidad Nacional De Rosario - Hospital Provincial Del Centenario, Rosario, Argentina|Sanatorio 9 de Julio - CICE 9 de Julio, San Miguel de Tucuman, Argentina|Concord Repatriation General Hospital, Concord, New South Wales, Australia|Nepean Hospital, Kingswood, New South Wales, Australia|Wollongong Hospital, Wollongong, New South Wales, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Royal Adelaide Hospital, Adelaide, South Australia, Australia|The Queen Elizabeth Hospital, Woodville South, South Australia, Australia|Harry Perkins Medical Research Institute, Fiona Stanley Hospital, Murdoch, Western Australia, Australia|Ballarat Base Hospital, Ballarat, Australia|Grodno City Clinical Hospital #4, Grodno, Belarus|Vitebsk Regional Clinical Specialized Center, Vitebsk, Belarus|Algemeen Ziekenhuis Klina, Brasschaat, Belgium|Universitair Ziekenhuis Brussel, Brussels, Belgium|University Hospital Brussels, Brussels, Belgium|CHU Saint-Luc, Brussels, Belgium|Queen Fabiola Children's University Hospital, Brussels, Belgium|Universitair Ziehenhuis Antwerpen, Edegem, Belgium|Universitair Ziekenhuis Gent, Ghent, Belgium|Universitair Ziekenhuis Leuven, Campus Gasthuisberg, Leuven, Belgium|Clinique du Montlegia, Liege, Belgium|Sart Tilman Hospital Department of Gastroenterology and Hepatology, Seraing, Belgium|Hospital Centre of Walloon Picarde, Tourna",United Kingdom,Others,0,1,2036.0
5732.0,NCT04807972,Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis,,Not yet recruiting,Pancreatic Cancer,,,,,,,Drug: ABBV-927|Drug: Budigalimab|Drug: modified FOLFIRINOX,AbbVie,All,"18 Years to 75 Years   (Adult, Older Adult)",129.0,Industry,Interventional,2021-04-13,15/10/24,2024-10-15,19/03/21,19/03/21,"Yale University, Yale Cancer Center /ID# 227685, New Haven, Connecticut, United States|Johns Hopkins University /ID# 226713, Baltimore, Maryland, United States|Univ Hosp Cleveland /ID# 226807, Cleveland, Ohio, United States|Pan American Center for Oncology Trials, LLC /ID# 228210, Rio Piedras",Puerto Rico,Cancers,1,1,1281.0
5733.0,NCT03916224,Adverse Events in the Tracheal Intubation in the Intensive Care Unit,INTUPROS,Completed,Intubation; Difficult or Failed,Intubation Complication,Intubation,,,,,,Spanish Network for Research in Infectious Diseases,All,"18 Years and older   (Adult, Older Adult)",1800.0,Other,Observational,2019-04-15,31/10/20,2020-10-31,16/04/19,02/04/21,"Jose Garnacho-Montero, Seville",Spain,Others,0,3,565.0
5734.0,NCT04709263,Heart Failure Patients Registry,Priority-HF,Recruiting,Heart Failure,,,,,,,,AstraZeneca,All,"18 Years and older   (Adult, Older Adult)",20000.0,Industry,Observational,2020-12-23,31/12/23,2023-12-31,14/01/21,05/04/21,"Municipal Autonomous Institution Central City Hospital No. 20, Ekaterinburg, Russian Federation|City policlinic NO 11 of Krasnodar, Krasnodar",Russian Federation,Others,0,1,1103.0
5735.0,NCT04212442,Improving Aging in Place in Subsidized Housing,,Recruiting,Physical Disability,Cognitive Impairment,Physical Activity,,,,,Behavioral: Independent Living Program for Affordable Housing.,"University of Pennsylvania|University of California, Berkeley|HumanGood|University of Maryland, Baltimore",All,"62 Years and older   (Adult, Older Adult)",70.0,Other,Interventional,2020-01-13,30/03/21,2021-06-30,27/12/19,10/02/21,"Mantua Presbyterian Apartments, Philadelphia, Pennsylvania, United States|Old City Presbyterian Apartments, Philadelphia, Pennsylvania, United States|Casa Carmen Aponte, Philadelphia, Pennsylvania, United States|Neumann Senior Housing, Philadelphia, Pennsylvania, United States|St. Francis VIlla, Philadelphia, Pennsylvania, United States|Greenway Presbyterian Apartments, Philadelphia, Pennsylvania, United States|Jackson Place, Philadelphia, Pennsylvania",United States,Others,0,3,534.0
5736.0,NCT04199169,Safety and Immunogenicity of a Nipah Virus Vaccine,,Recruiting,Nipah Virus Infection,,,,,,,Biological: HeV-sG-V|Biological: Normal Saline Placebo,Auro Vaccines LLC|PATH|Coalition for Epidemic Preparedness Innovations|Cincinnati Children's Hospital Medical Center (CCHMC),All,18 Years to 49 Years   (Adult),274.0,Industry|Other,Interventional,2020-02-18,01/10/21,2021-01-10,13/12/19,23/10/20,"Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio",United States,Others,0,1,327.0
5737.0,NCT04735835,Personalized Responses to Dietary Composition Trial 3,,Recruiting,Diabetes,Heart Diseases,Diet Habit,Diet Modification,Healthy,Obesity,Metabolism,Other: Dietary Intervention,Zoe Global Limited|Massachusetts General Hospital|Stanford University|Harvard School of Public Health,All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2020-07-20,20/12/21,2021-12-20,03/02/21,18/03/21,"Zoe US Inc., Needham, Massachusetts",United States,Metabolic Disorders,1,7,518.0
5738.0,NCT03483935,Microwave Therapy for Treatment of Precancerous Actinic Keratoses,MTAK,Completed,Actinic Keratoses,Precancerous Skin Lesion,,,,,,Other: Microwave treatment,University of Dundee|Emblation Limited,All,"18 Years and older   (Adult, Older Adult)",18.0,Other,Interventional,2018-07-03,28/02/19,2019-02-28,30/03/18,23/02/21,"NHS Tayside, Dundee",United Kingdom,Others,0,2,240.0
5739.0,NCT03983733,PREDICT 2: Personalized Responses to Dietary Composition Trial 2,,"Active, not recruiting",Diabetes,Heart Diseases,Diet Habit,Diet Modification,Microbial Colonization,Healthy,Obesity,Other: Dietary Intervention,Zoe Global Limited|Massachusetts General Hospital|Stanford University|King's College London|Tufts University,All,"18 Years to 70 Years   (Adult, Older Adult)",1139.0,Other,Interventional,2019-10-06,31/03/20,2021-01-11,12/06/19,10/03/21,"Zoe US Inc., Boston, Massachusetts",United States,Metabolic Disorders,1,7,463.0
5740.0,NCT04602520,Preserving Compassionate End of Life Care in the Pandemic,,Recruiting,Death,"Communication, Multidisciplinary",Empathy,Compassion,Family Members,Bereavement,Empowerment,Behavioral: 3 Wishes Project,McMaster University|Canadian Institutes of Health Research (CIHR),All,"18 Years and older   (Adult, Older Adult)",135.0,Other,Observational,2020-03-16,01/06/21,2021-01-06,26/10/20,28/10/20,"St Joseph's Healthcare Hamilton, Hamilton, Ontario",Canada,Others,0,7,296.0
5741.0,NCT03951454,Taking Time to Connect: A Study of Programs for Hispanic Mothers Diagnosed With Cancer and Their Children,TTTC,Enrolling by invitation,Cancer Survivorship,,,,,,,Behavioral: Conexiones|Behavioral: Taking Time,New Mexico State University|University of Washington|Fred Hutchinson Cancer Research Center,Female,18 Years to 60 Years   (Adult),156.0,Other,Interventional,2019-04-16,31/08/21,2021-08-31,15/05/19,06/11/20,"New Mexico State University, Las Cruces, New Mexico, United States|Memorial Medical Center - Family Medicine Center, Las Cruces, New Mexico, United States|Memorial Medical Center-Cancer Center, Las Cruces, New Mexico",United States,Cancers,1,1,868.0
5742.0,NCT04565353,Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates,,Recruiting,"Influenza, Human",,,,,,,Behavioral: Flu shot text messages,University of Pennsylvania|Geisinger Clinic,All,"18 Years and older   (Adult, Older Adult)",80000.0,Other,Interventional,2020-09-20,01/03/21,2021-01-03,25/09/20,01/02/21,"Geisinger Health, Danville, Pennsylvania, United States|University of Pennsylvania Health System, Philadelphia, Pennsylvania",United States,Infectious Diseases,0,1,105.0
5743.0,NCT03768544,Self-help Guided by Lay Providers for Anxiety in Older Adults,,Recruiting,Generalized Anxiety Disorder,,,,,,,Behavioral: Self-help guided by a lay provider|Behavioral: Waiting list where participants wait for delayed treatment,Laval University|Canadian Institutes of Health Research (CIHR)|CIUSSS du Centre-Sud-de-l'Île-Montréal|Estrie University Integrated Health and Social Services Center - University Hospital of Sherbrooke|Integrated University Health and Social Services Center of the Capitale-Nationale,All,"60 Years and older   (Adult, Older Adult)",130.0,Other,Interventional,2019-11-03,01/03/23,2023-01-03,07/12/18,09/02/21,"Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montréal, Quebec, Canada|École de psychologie, Université Laval, Québec, Quebec, Canada|Département de psychologie, Université de Sherbrooke, Sherbrooke, Quebec",Canada,Mental Health,1,1,1157.0
5744.0,NCT03102034,"Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age",,Completed,Respiratory Syncytial Virus Infections,,,,,,,Biological: D46/NS2/N/ΔM2-2-HindIII|Biological: Placebo,National Institute of Allergy and Infectious Diseases (NIAID),All,6 Months to 24 Months   (Child),32.0,NIH,Interventional,2017-06-04,25/05/18,2018-05-25,05/04/17,30/12/20,"Usc La Nichd Crs, Los Angeles, California, United States|David Geffen School of Medicine at UCLA NICHD CRS, Los Angeles, California, United States|Univ. of Colorado Denver NICHD CRS, Aurora, Colorado, United States|Emory University School of Medicine NICHD CRS, Atlanta, Georgia, United States|Rush Univ. Cook County Hosp. Chicago NICHD CRS, Chicago, Illinois, United States|Lurie Children's Hospital of Chicago (LCH) CRS, Chicago, Illinois, United States|Johns Hopkins University Center for Immunization Research, Baltimore, Maryland, United States|Jacobi Med. Ctr. Bronx NICHD CRS, Bronx, New York, United States|SUNY Stony Brook NICHD CRS, Stony Brook, New York, United States|St. Jude Children's Research Hospital CRS, Memphis, Tennessee",United States,Others,0,1,355.0
5745.0,NCT04781504,Exercise Training in Women With Heart Disease,EXCEED,Recruiting,Cardiovascular Diseases,Coronary Heart Disease,,,,,,Behavioral: Exercise,Ottawa Heart Institute Research Corporation,Female,"18 Years and older   (Adult, Older Adult)",172.0,Other,Interventional,2021-05-03,01/07/21,2021-01-07,04/03/21,04/03/21,"University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Others,0,2,-116.0
5746.0,NCT04608994,Long-term Follow up in Survivors of Critical Illness,,Recruiting,Post Intensive Care Unit Syndrome,,,,,,,,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia|Università degli Studi di Brescia,All,"Child, Adult, Older Adult",160.0,Other,Observational,2020-01-06,01/06/21,2021-01-07,30/10/20,30/10/20,"ASST- Spedali Civili di Brescia, Brescia",Italy,Others,0,1,367.0
5747.0,NCT04723602,"Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults",,Recruiting,Ebola Virus Disease,Marburg Virus Disease,,,,,,Biological: cAd3-Marburg|Biological: cAd3-EBO-S,Albert B. Sabin Vaccine Institute|ICON plc|Oklahoma Blood Institute,All,18 Years to 50 Years   (Adult),32.0,Other|Industry,Interventional,2021-06-01,06/12/21,2021-06-12,26/01/21,27/01/21,"Oklahoma Blood Institute (OBI), Oklahoma City, Oklahoma",United States,Others,0,2,11.0
5748.0,NCT04026152,Exercising With Anxiety: Can Cognitive Behavioural Techniques Help People With Anxiety-related Disorders Exercise More?,,Completed,Anxiety Disorders,Posttraumatic Stress Disorder,Obsessive-Compulsive Disorder,,,,,Behavioral: Resistance training|Behavioral: Unified Protocol,University of Regina,All,"18 Years to 65 Years   (Adult, Older Adult)",59.0,Other,Interventional,2019-07-14,01/08/20,2020-01-09,19/07/19,05/02/21,"University of Regina, Regina, Saskatchewan",Canada,Mental Health,1,3,179.0
5749.0,NCT04000035,HealthAtWork - a Measure for Increased Coping and Work Inclusion,HiAforsk,Recruiting,Musculoskeletal Pain,Mental Health Wellness 1,Work-Related Condition,,,,,Other: Health and work environment information and processes,University Hospital of North Norway|University of Tromso|Norwegian Labour and Welfare Administration|Helse Nord,All,"18 Years to 70 Years   (Adult, Older Adult)",1000.0,Other|Industry,Interventional,2019-01-03,30/06/23,2035-06-30,27/06/19,16/11/20,"University Hospital of Nothern Norway, Tromsø",Norway,Others,0,3,6022.0
5750.0,NCT04520815,Prevalence and Kinetics of Diaphragmatic Dysfunction in Elderly Patients With Acute Respiratory Distress,OLDIA,Recruiting,"Respiratory Distress Syndrome, Adult",,,,,,,,Centre Hospitalier Universitaire de la Réunion,All,75 Years and older   (Older Adult),200.0,Other,Observational,2020-06-24,31/12/21,2022-06-30,20/08/20,20/08/20,"Centre Hospitalier Universitaire de la Réunion, Saint-Denis",France,Others,0,1,736.0
5751.0,NCT04515771,Improving Patient-Provider Communication to Reduce Mental Health Disparities,PARTNER-MH,Recruiting,Healthcare Disparities,Mental Health,,,,,,Behavioral: PARTNER-MH,VA Office of Research and Development,All,"18 Years and older   (Adult, Older Adult)",50.0,U.S. Fed,Interventional,2020-08-17,03/01/22,2022-03-01,17/08/20,28/01/21,"Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana",United States,Others,0,2,561.0
5752.0,NCT02868983,Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems,IBHPC,"Active, not recruiting",Arthritis,Asthma,Chronic Obstructive Lung Disease,Diabetes,Heart Failure,Hypertension,Anxiety,Other: Integration,"University of Vermont|Arizona State University|State University of New York at Buffalo|Case Western Reserve University|DARTNet|National Committee for Quality Assurance|University of Massachusetts, Worcester",All,"18 Years and older   (Adult, Older Adult)",4025.0,Other,Interventional,2016-01-04,01/04/21,2021-01-04,16/08/16,29/01/21,"University of Vermont, Burlington, Vermont",United States,"Mental Health, Cardiovascular Diseases, Metabolic Disorders",1,7,1827.0
5753.0,NCT03261050,Target Engagement of a Novel Dissonance-Based Treatment for DSM-5 Eating Disorders,,Recruiting,Eating Disorder,,,,,,,Behavioral: Counter Attitudinal Therapy|Behavioral: Interpersonal Therapy,Oregon Research Institute|National Institute of Mental Health (NIMH),Female,18 Years to 34 Years   (Adult),180.0,Other|NIH,Observational,2017-10-07,01/06/22,2022-01-06,24/08/17,25/02/21,"Stanford University, Stanford, California, United States|Oregon Research Institute, Eugene, Oregon, United States|The University of Texas at Austin, Austin, Texas",United States,Others,0,1,1552.0
5754.0,NCT04646291,"Retrospective Study on the Use, Efficiency, and Safety of the At-home Mosie Kit",,Completed,Infertility,"Infertility, Female","Infertility, Male",,,,,Device: Insemination with the Mosie Baby Kit,Mosie Baby,,"Child, Adult, Older Adult",350.0,Industry,Observational,2020-05-08,31/08/20,2020-01-09,27/11/20,01/12/20,"Virtual Study - Online Data Collection, Austin, Texas",United States,Others,0,3,-120.0
5755.0,NCT04735406,The MS-LINK™ Outcomes Study,,Not yet recruiting,Multiple Sclerosis,,,,,,,,"EMD Serono Research & Development Institute, Inc.|EMD Serono",All,"18 Years and older   (Adult, Older Adult)",10000.0,Industry,Observational,2021-07-04,31/01/24,2024-01-31,03/02/21,05/03/21,"Georgetown University, Washington, District of Columbia, United States|The Multiple Sclerosis Center of Atlanta, Atlanta, Georgia",United States,Immunological Disorders,1,1,941.0
5756.0,NCT02495753,Vaginal Cleansing Before Cesarean Delivery to Reduce Infection,,"Active, not recruiting",Complications; Cesarean Section,,,,,,,Procedure: Vaginal Cleansing|Procedure: Abdominal Cleansing,Washington University School of Medicine,Female,"Child, Adult, Older Adult",608.0,Other,Interventional,2015-01-08,01/01/21,2021-01-06,13/07/15,11/02/21,"Barnes Jewish Hospital, Saint Louis, Missouri",United States,Others,0,1,2190.0
5757.0,NCT03465280,Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP),AIR:RRP,Recruiting,Recurrent Respiratory Papillomatosis,Human Papilloma Virus,,,,,,Procedure: Microdebrider|Procedure: Cold-steel surgery (forceps)|Procedure: Carbon dioxide laser|Procedure: Potassium titanyl phosphate (KTP) laser|Procedure: Pulsed dye laser|Procedure: Radiofrequency ablation|Procedure: Monopolar suction diathermy|Procedure: Plasma coagulation|Procedure: Other|Other: Adjuvant therapies,"Newcastle-upon-Tyne Hospitals NHS Trust|Alder Hey Children's NHS Foundation Trust|National Institute for Health Research, United Kingdom",All,"Child, Adult, Older Adult",400.0,Other,Observational,2018-01-04,31/08/21,2021-08-31,14/03/18,09/09/20,"NHS Grampian, Aberdeen, United Kingdom|Betsi Cadwaladr University Health Board,, Bangor, United Kingdom|Basildon & Thurrock University Hospitals NHS FT, Basildon, United Kingdom|Belfast Health and Social Care Trust, Belfast, United Kingdom|University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom|Birmingham Women's and Children's NHS Foundation Trust, Birmingham, United Kingdom|Blackpool Teaching Hospital NHS FT, Blackpool, United Kingdom|Bradford Teaching Hospitals NHS Foundation Trust, Bradford, United Kingdom|Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom|Cardiff and Vale University Local Health Board, Cardiff, United Kingdom|North Cumbria Univeristy Hospital NHS Trust, Carlisle, United Kingdom|Hywel Dda University Health Board, Carmarthen, United Kingdom|County Durham and Darlington NHS Foundation Trust, Darlington, United Kingdom|University Hospitals of Derby and Burton NHS Foundation Trust, Derby, United Kingdom|Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, United Kingdom|NHS Tayside, Dundee, United Kingdom|NHS Lothian, Edinburgh, United Kingdom|Frimley Health NHS Foundation Trust, Frimley, United Kingdom|NHS Greater Glasgow & Clyde, Glasgow, United Kingdom|London North West University Healthcare NHS Trust, Harrow, United Kingdom|Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom|Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom|Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom|Barts Health NHS Trust, London, United Kingdom|University College London Hospitals NHS Foundation Trust, London, United Kingdom|Lewisham and Greenwich NHS Trust, London, United Kingdom|St George's University Hospitals NHS Foundation Trust, London, United Kingdom|Imperial College Healthcare NHS Trust, London, United Kingdom|Great Ormond Street Hospital for Children NHS FT, London, United Kingdom|Bedfordshire Hospitals NHS Foundation Trust, Luton, United Kingdom|Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom|Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom|South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom|The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom|Isle of Wight NHS Trust, Newport, United Kingdom|Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom|Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom|University Hospital of Plymouth NHS Trust, Plymouth, United Kingdom|Swansea Bay University Health Board, Port Talbot, United Kingdom|East Sussex Healthcare NHS Trust, Saint Leonards-on-Sea, United Kingdom|Salford Royal NHS Foundation Trust, Salford, United Kingdom|Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom|The Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, United Kingdom|University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom|Stockport NHS Foundation Trust, Stockport, United Kingdom|South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom|Wirral University Teaching Hospitals NHS Foundation Trust, Wirral",United Kingdom,Others,0,2,1335.0
5758.0,NCT04576377,Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures,DRIVE,Recruiting,"Influenza, Human",,,,,,,Biological: FluBlok|Other: Placebo,The University of Hong Kong|University of Chicago|National Institute of Allergy and Infectious Diseases (NIAID),All,18 Years to 45 Years   (Adult),820.0,Other|NIH,Interventional,2020-05-10,31/12/24,2024-12-31,06/10/20,05/11/20,"The University of Hong Kong, Hong Kong",Hong Kong,Infectious Diseases,0,1,1696.0
5759.0,NCT04713735,"Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections",,Recruiting,Immune Health,,,,,,,Dietary Supplement: Control: Placebo|Dietary Supplement: bovine lactoferrin supplement,Mead Johnson Nutrition,All,"55 Years and older   (Adult, Older Adult)",140.0,Industry,Interventional,2020-12-28,30/04/21,2021-04-30,19/01/21,19/01/21,"VA Greater Los Angeles Healthcare System, Los Angeles, California",United States,Others,0,1,123.0
5760.0,NCT03873467,Group Lifestyle Balance™ for Individuals With Stroke (GLB-CVA),GLB-CVA,"Active, not recruiting",Stroke,,,,,,,Behavioral: Group Lifestyle Balance|Other: Usual Care,"Baylor Research Institute|National Institute on Disability, Independent Living, and Rehabilitation Research",All,"18 Years to 85 Years   (Adult, Older Adult)",65.0,Other|U.S. Fed,Interventional,2019-08-07,30/06/21,2021-09-30,13/03/19,23/09/20,"Baylor Scott & White Institute for Rehabilitation, Dallas, Texas",United States,Cardiovascular Diseases,1,1,785.0
5761.0,NCT03594734,Group Lifestyle Balance™ for Individuals With Traumatic Brain Injury (GLB-TBI),,"Active, not recruiting",Traumatic Brain Injury,,,,,,,Behavioral: Group Lifestyle Balance™|Other: Attention Control Group,"Baylor Research Institute|National Institute on Disability, Independent Living, and Rehabilitation Research|University of Texas Southwestern Medical Center",All,18 Years to 64 Years   (Adult),57.0,Other|U.S. Fed,Interventional,2019-08-01,30/12/21,2022-09-30,20/07/18,23/09/20,"Baylor Scott & White Institute for Rehabilitation, Dallas, Texas",United States,Others,0,1,1156.0
5762.0,NCT03728257,Lung Transplant G0 (LTGO): Improving Self-Management of Exercise After Lung Transplantation,LTGO,Recruiting,Exercise,Lung Transplantation,,,,,,Behavioral: LTGO-Home Based Exercise|Behavioral: Enhanced Usual Care,University of Pittsburgh|National Institute of Nursing Research (NINR),All,"18 Years and older   (Adult, Older Adult)",112.0,Other|NIH,Interventional,2019-01-04,31/03/22,2022-03-31,02/11/18,11/02/21,"University of Pittsburgh, School of Nursing, Pittsburgh, Pennsylvania",United States,Others,0,2,1182.0
5763.0,NCT04782518,Personalizing Exercise for Parkinson Disease,PEP,Recruiting,Parkinson Disease,,,,,,,,Washington University School of Medicine|American Parkinson Disease Association - Greater St. Louis Chapter,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2021-02-19,18/02/24,2025-02-18,04/03/21,04/03/21,"Washington University School of Medicine, Saint Louis, Missouri",United States,Others,0,1,1460.0
5764.0,NCT04783454,Preventing Neck & Back Pain in Teleworking Office Workers: a Randomized Controlled Trial,Prevent@HOME,Recruiting,Neck Pain,Low Back Pain,Back Pain,,,,,Other: Exercise program,University Ghent,All,"18 Years to 69 Years   (Adult, Older Adult)",600.0,Other,Interventional,2020-12-11,30/11/28,2028-12-31,05/03/21,05/03/21,"Ghent University, Ghent, East Flanders",Belgium,Others,0,3,2942.0
5765.0,NCT03823469,Evaluating the Impact of a Culinary Coaching Tele-medicine Program,,Recruiting,Overweight,Obesity,,,,,,Behavioral: CCTP|Behavioral: Nutritional counseling,Spaulding Rehabilitation Hospital|Sheba Medical Center,All,"25 Years to 70 Years   (Adult, Older Adult)",78.0,Other,Interventional,2019-05-20,01/02/22,2022-01-02,30/01/19,22/05/20,"Spaulding Rehabilitation hospitle, Charlestown, Massachusetts, United States|Sheba Medical Center, Ramat Gan",Israel,Metabolic Disorders,1,2,958.0
5766.0,NCT04429061,Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ,SKILLZ,Recruiting,HIV Infections,Pregnancy Related,STI,Mental Health Wellness 1,,,,Behavioral: SKILLZ-Girl Enhanced football curriculum,"University of Alabama at Birmingham|University of California, San Francisco|Centre for Infectious Disease Research in Zambia|Grassroot Soccer (GRS)|Washington University School of Medicine",Female,"16 Years and older   (Child, Adult, Older Adult)",3200.0,Other,Interventional,2020-01-03,30/03/23,2023-06-30,11/06/20,11/06/20,"Centre of Infectious Disease Research Zambia, Lusaka",Zambia,Others,0,4,1274.0
5767.0,NCT04184895,"A Study to Assess the Safety, Tolerability and Immunological Response of ASP2390 in Adult Subjects Allergic to House Dust Mites",,Recruiting,Allergic to House Dust Mites,,,,,,,Biological: ASP2390|Biological: Placebo,"Astellas Pharma Global Development, Inc.|Astellas Pharma Inc",All,"18 Years to 65 Years   (Adult, Older Adult)",28.0,Industry,Interventional,2020-07-10,31/08/26,2026-08-31,04/12/19,23/03/21,"Site DE49001, Berlin, Germany|Site DE49002, Hannover",Germany,Others,0,1,2243.0
5768.0,NCT03922334,Navigating New Motherhood 2,NNM2,Recruiting,Postpartum Health,Breastfeeding,Contraception,Preventive Care / Anticipatory Guidance,Retention in Care,,,Behavioral: Patient Navigation Program,Northwestern University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),Female,"16 Years to 50 Years   (Child, Adult)",400.0,Other|NIH,Interventional,2020-01-21,01/01/24,2024-01-12,19/04/19,03/03/21,"Northwestern Memorial Hospital, Chicago, Illinois",United States,Others,0,5,1452.0
5769.0,NCT04734795,The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma,,Recruiting,Dysfunctional Breathing,Asthma in Children,Asthma,,,,,,Kolding Sygehus|Odense Patient Data Explorative Network,All,10 Years to 17 Years   (Child),500.0,Other,Observational,2021-05-02,01/12/22,2022-01-12,02/02/21,09/02/21,"Kolding Sygehus, Kolding",Denmark,Others,0,3,255.0
5770.0,NCT04190368,Team Clinic: Virtual Expansion of an Innovative Multi-Disciplinary Care Model for Adolescents and Young Adults With Type 1 Diabetes,,Not yet recruiting,Type 1 Diabetes,,,,,,,Other: Team Clinic Care|Other: Standard Care,Children's Hospital Los Angeles|University of Southern California|Cedars-Sinai Medical Center,All,10 Years to 17 Years   (Child),200.0,Other,Interventional,2021-01-03,30/03/22,2022-12-30,09/12/19,01/03/21,"Children's Hospital Los Angeles, Los Angeles, California",United States,Metabolic Disorders,1,1,726.0
5771.0,NCT03392883,Scaling Up Science-based Mental Health Interventions in Latin America,DIADA,"Active, not recruiting",Depression,Problematic Alcohol Use,,,,,,Behavioral: Laddr,Dartmouth-Hitchcock Medical Center|Pontificia Universidad Javeriana|National Institute of Mental Health (NIMH),All,"18 Years and older   (Adult, Older Adult)",3091.0,Other|NIH,Interventional,2018-02-13,01/04/21,2021-01-04,08/01/18,19/12/20,"Salud de Tundama, Duitama, Boyaca, Colombia|Empresa Social del Estado Hospital Regional de Duitama- Santa Rosa de Viterbo Branch, Santa Rosa de Viterbo, Boyaca, Colombia|ESE Hospital San Antonio de Guatavita, Guatavita, Cundinamarca, Colombia|Hospital Mario Gaitán Yanguas, Soacha, Cundinamarca, Colombia|Empresa Social del Estado Hospital Nelson Restrepo Martinez, Guayabal, Tolima, Colombia|Javesalud, Bogotá",Colombia,Mental Health,1,2,1056.0
5772.0,NCT04301518,Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs,PRIME,Recruiting,Preterm Labor,Preterm Birth,,,,,,Other: Multimodal intervention strategy,"Sera Prognostics, Inc.|High Risk Pregnancy Center, Las Vegas, Nevada",Female,"18 Years and older   (Adult, Older Adult)",6500.0,Industry|Other,Interventional,2020-06-11,30/09/22,2025-06-30,10/03/20,14/04/21,"High Risk Pregnancy Center, Las Vegas, Nevada, United States|University of Virginia, Charlottesville, Virginia",United States,Others,0,2,1845.0
5773.0,NCT04607902,Harnessing Network Science to Personalize Scalable Interventions for Adolescent Depression (TRACK to TREAT Phase 2),,Recruiting,Depression,,,,,,,Behavioral: Supportive Therapy SSI|Behavioral: Behavioral Activation SSI|Behavioral: Growth Mindset SSI,Stony Brook University,All,11 Years to 16 Years   (Child),216.0,Other,Interventional,2021-02-15,01/07/24,2024-01-08,29/10/20,17/03/21,"Stony Brook University, Stony Brook, New York",United States,Mental Health,1,1,1057.0
5774.0,NCT04639661,Predictors of Periodontal Outcomes Post-sanative Therapy,,Enrolling by invitation,Periodontal Diseases,Periodontal Pocket,,,,,,,"Brock University|Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery",All,"19 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-11-25,01/08/21,2021-01-12,20/11/20,04/12/20,"Dr. Peter C. Fritz, Periodontal Wellness & Implant Surgery, Fonthill, Ontario, Canada|Brock University, St. Catharines, Ontario",Canada,Others,0,2,48.0
5775.0,NCT04180709,CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis,CRISP,Recruiting,Psychotic Disorders,Psychosis,Sleep,,,,,Device: Sleepio,University of Cambridge|Cambridgeshire and Peterborough NHS Foundation Trust|Cambridge Cognition Ltd|Big Health,All,"18 Years and older   (Adult, Older Adult)",44.0,Other|Industry,Interventional,2020-10-30,30/11/22,2022-11-30,27/11/19,03/11/20,"Cameo Early Intervention, Cambridge, Cambridgeshire",United Kingdom,Others,0,3,761.0
5776.0,NCT04335643,Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus,cSLE,Recruiting,Systemic Lupus Erythematosus,,,,,,,Behavioral: TEACH,Michigan State University|Arthritis Foundation|The Hospital for Sick Children,All,"12 Years to 22 Years   (Child, Adult)",75.0,Other,Interventional,2020-04-08,01/12/21,2021-01-12,06/04/20,09/03/21,"Michigan State University, Grand Rapids, Michigan, United States|The Hospital for Sick Children, Toronto, Ontario",Canada,Immunological Disorders,1,1,279.0
5777.0,NCT04589377,Mindfulness to Mitigate Psychological Threat and Improve Engagement and Learning in Introductory Physics Courses,,Recruiting,Stress,,,,,,,Behavioral: Mindfulness Training,University of Pittsburgh|U.S. National Science Foundation|James S McDonnell Foundation,All,"18 Years and older   (Adult, Older Adult)",150.0,Other|U.S. Fed,Interventional,2020-10-26,31/08/22,2022-12-31,19/10/20,10/11/20,"University of Pittsburgh, Pittsburgh, Pennsylvania",United States,Mental Health,1,1,796.0
5778.0,NCT04574466,Scaling-up Psychological Interventions With Syrian Refugees in Switzerland (STRENGTHS_CH): RCT,,Recruiting,Distress,PTSD,Anxiety,Depression,Trauma,Functional Disabilities,Common Mental Health Problems,Behavioral: Problem Management Plus,University of Zurich,All,"18 Years and older   (Adult, Older Adult)",380.0,Other,Interventional,2020-08-25,01/06/22,2022-01-06,05/10/20,05/10/20,"Klinik für Konsiliarpsychiatrie und Psychosomatik, Zürich",Switzerland,Mental Health,1,7,499.0
5779.0,NCT04011644,Mobile Health for Alcohol Use Disorders in Clinical Practice,,Recruiting,Alcohol Drinking,Telemedicine,,,,,,Behavioral: A-CHESS self-monitored|Behavioral: A-CHESS peer-supported|Behavioral: A-CHESS clinically-integrated,"University of Wisconsin, Madison|National Institute on Alcohol Abuse and Alcoholism (NIAAA)",All,"21 Years to 100 Years   (Adult, Older Adult)",566.0,Other|NIH,Interventional,2020-03-23,01/08/22,2023-01-04,08/07/19,02/04/21,"UW Health at the American Center, Madison, Wisconsin",United States,Others,0,2,1017.0
5780.0,NCT04681339,Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia,,Not yet recruiting,Community Acquired Pneumonia in Children,Antibiotic Stewardship,,,,,,Other: Antibiotic treatment|Other: No antibiotic treatment,"ARCIM Institute Academic Research in Complementary and Integrative Medicine|Gemeinschaftskrankenhaus Herdecke, Germany",All,"3 Months to 18 Years   (Child, Adult)",200.0,Other,Observational,2021-01-04,01/11/24,2024-01-12,23/12/20,10/02/21,"Die Filderklinik, Filderstadt, Baden-Württemberg, Germany|Herdecke Community Hospital, Herdecke, Nordrhein-Westfalen",Germany,Respiratory Diseases,1,2,1103.0
5781.0,NCT04740229,Moderate-intensity Flow-based Yoga Effects on Cognition and Stress,,Recruiting,Stress,Psychological,,,,,,Behavioral: Yoga,University of Illinois at Urbana-Champaign,All,18 Years to 64 Years   (Adult),88.0,Other,Interventional,2021-10-02,01/07/21,2021-01-07,05/02/21,24/02/21,"University of Illinois at Urbana-Champaign, Urbana, Illinois",United States,Mental Health,1,2,-268.0
5782.0,NCT04804917,3-year Follow-up of the Mind My Mind RCT,MindMyMindFU,Recruiting,Emotional Problem,Anxiety Disorder of Childhood,Depressive Symptoms,Behavior Problem of Childhood and Adolescence,Mental Health Disorder,,,,"Mental Health Services in the Capital Region, Denmark|Frederiksberg University Hospital|Defactum, Central Denmark Region|The Danish Mental Health Foundation",All,"8 Years to 20 Years   (Child, Adult)",396.0,Other,Observational,2021-03-22,31/05/22,2022-12-31,18/03/21,01/04/21,"Mental Health Services in the Capital Region, Denmark, Copenhagen",Denmark,Mental Health,1,5,649.0
5783.0,NCT04680000,Chronic Pain Management In Primary Care Using Behavioral Health Consultants,,Not yet recruiting,Chronic Pain,,,,,,,Behavioral: Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP)|Other: BCBT-CP Booster,The University of Texas Health Science Center at San Antonio|Uniformed Services University of the Health Sciences|Massachusetts General Hospital|Defense Health Agency|59th Medical Wing|Brooke Army Medical Center|C.R.Darnall Army Medical Center,All,"18 Years and older   (Adult, Older Adult)",716.0,Other|U.S. Fed,Interventional,2021-01-02,01/02/24,2025-01-02,22/12/20,22/12/20,"Uniformed Services University for the Health Sciences, Bethesda, Maryland, United States|University of Texas Health Science Center San Antonio, San Antonio, Texas",United States,Others,0,1,1461.0
,NCT Number,Title,Acronym,Status,Conditions,,,,,,,Interventions,Sponsor/Collaborators,Gender,Age,,Funded Bys,Study Type,,Primary Completion Date,,First Posted,Last Update Posted,Locations.1,Country,Others,0,1,
1.0,NCT04785898,Diagnostic Performance of the ID Now™ COVID-19 Screening Test Versus Simplexa™ COVID-19 Direct Assay,COVID-IDNow,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: ID Now™ COVID-19 Screening Test,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-09-11,22/12/20,2021-04-30,08/03/21,08/03/21,"Groupe Hospitalier Paris Saint-Joseph, Paris, Ile De France",France,Respiratory Diseases,1,1,231.0
2.0,NCT04595136,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,COVID-19,Not yet recruiting,COVID-19,,,,,,,Drug: Drug COVID19-0001-USR|Drug: normal saline,United Medical Specialties,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-02-11,15/12/20,2021-01-29,20/10/20,20/10/20,"Cimedical, Barranquilla, Atlantico",Colombia,Respiratory Diseases,1,1,353.0
3.0,NCT04395482,Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,TAC-COVID19,Recruiting,COVID-19,,,,,,,Other: Lung CT scan analysis in COVID-19 patients,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-07-05,15/06/21,2021-06-15,20/05/20,09/11/20,"Ospedale Papa Giovanni XXIII, Bergamo, Italy|Policlinico San Marco-San Donato group, Bergamo, Italy|Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy|ASST di Lecco Ospedale Alessandro Manzoni, Lecco, Italy|ASST Melegnano-Martesana, Ospedale Santa Maria delle Stelle, Melzo, Italy|ASST Monza, Monza, Italy|AUSL Romagna-Ospedale Infermi di Rimini, Rimini, Italy|Istituto per la Sicurezza Sociale-Ospedale della Repubblica di San Marino, San Marino",San Marino,Respiratory Diseases,1,1,345.0
4.0,NCT04416061,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,COVID-19,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: COVID 19 Diagnostic Test,Hong Kong Sanatorium & Hospital,All,"Child, Adult, Older Adult",2500.0,Industry,Observational,2020-05-25,31/07/20,2020-08-31,04/06/20,04/06/20,"Hong Kong Sanatorium & Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,98.0
5.0,NCT04395924,Maternal-foetal Transmission of SARS-Cov-2,TMF-COVID-19,Recruiting,Maternal Fetal Infection Transmission,COVID-19,SARS-CoV 2,,,,,"Diagnostic Test: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta",Centre Hospitalier Régional d'Orléans|Centre de Biophysique Moléculaire - Pr Chantal Pichon|Professeur TOUMI Hechmi,Female,18 Years to 48 Years   (Adult),50.0,Other,Observational,2020-05-05,01/05/21,2021-01-05,20/05/20,04/06/20,"CHR Orléans, Orléans",France,Respiratory Diseases,1,3,245.0
6.0,NCT04516954,Convalescent Plasma for COVID-19 Patients,CPCP,Enrolling by invitation,COVID-19,,,,,,,Biological: Convalescent COVID 19 Plasma,"Vinmec Research Institute of Stem Cell and Gene Technology|National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",All,"18 Years to 75 Years   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-08,30/11/20,2020-12-30,18/08/20,20/08/20,"Vinmec Research Institute of Stem cell and Gene Technology, Hanoi",Vietnam,Respiratory Diseases,1,1,357.0
7.0,NCT04476940,COVID-19 Breastfeeding Guideline for African-Americans,COVID-BF,Not yet recruiting,COVID-19,Exclusive Breastfeeding,,,,,,Behavioral: COVID-19 Breastfeeding Support,Meharry Medical College,Female,18 Years to 45 Years   (Adult),200.0,Other,Interventional,2020-01-09,01/10/21,2022-01-06,20/07/20,20/07/20,"Meharry Medical College, Nashville, Tennessee",United States,Respiratory Diseases,1,2,728.0
8.0,NCT04634214,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,COVID19,Not yet recruiting,COVID-19,Type2 Diabetes,,,,,,,India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals,All,"18 Years to 99 Years   (Adult, Older Adult)",1050.0,Other,Observational,2020-11-16,16/02/21,2021-05-16,18/11/20,18/11/20,"Orthomed Hospital, Chennai, Tamil Nadu, India|Medway Hospital, Chennai, Tamil Nadu, India|Venkateswara Hospital, Chennai, Tamil Nadu, India|Dr. Rela Institute & Medical Center, Chennai, Tamil Nadu",India,"Metabolic Disorders, Respiratory Diseases",1,2,181.0
9.0,NCT04602884,Early Detection of COVID-19 Using Breath Analysis,COVID-19,Suspended,COVID-19,,,,,,,Diagnostic Test: Breath biopsy sampling using the ReCIVA Breath Sampler,Scentech Medical Technologies Ltd,All,18 Years to 55 Years   (Adult),50.0,Industry,Interventional,2020-09-22,30/12/21,2021-12-30,26/10/20,13/04/21,"IDF COVID 19 Isolation Facility, Ashkelon",Israel,Respiratory Diseases,1,1,464.0
10.0,NCT04384588,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),FALP-COVID,Recruiting,COVID-19,Cancer Patients,General Population,,,,,Biological: Convalescent Plasma from COVID-19 donors,Fundacion Arturo Lopez Perez|Confederación de la Producción y del Comercio (CPC)|Bolsa de Santiago,All,"15 Years and older   (Child, Adult, Older Adult)",100.0,Other,Interventional,2020-07-04,06/04/21,2021-06-04,12/05/20,12/05/20,"Fundacion Arturo Lopez Perez, Providencia, Santiago",Chile,"Respiratory Diseases, Cancers",1,3,335.0
11.0,NCT04355897,CoVID-19 Plasma in Treatment of COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Biological: Convalescent COVID 19 Plasma,The Christ Hospital,All,"18 Years to 80 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-04-28,01/07/20,2020-01-08,21/04/20,20/05/20,"The Christ Hospital, Cincinnati, Ohio, United States|University Hospitals Cleveland Medical Center, Cleveland, Ohio",United States,Respiratory Diseases,1,1,-111.0
12.0,NCT04412265,Frailty in Elderly Patients With COVID-19,FRA-COVID,Recruiting,COVID-19,,,,,,,Other: Relation between frailty and clinical outcomes in elderly patients with COVID-19.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-04-16,01/03/21,2021-01-03,02/06/20,22/01/21,"Dipartimento di Geriatria, Fondazione Poliambulanza, Brescia, Italy|Dipartimento di Medicina e Riabilitazione, Istituto Clinico Ospedale S. Anna, Brescia, Italy|UO Malattie Infettive, Spedali Civili, Brescia, Italy|UOC Medicina I a indirizzo Geriatrico, Spedali Civili, Montichiari, Italy|ASST Monza-Ospedale San Gerardo, Monza, Italy|SCDU Geriatria, AOU Città della Salute e della Scienza - Presidio Molinette, Torino",Italy,Respiratory Diseases,1,1,262.0
13.0,NCT04659759,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",COVID-PRICE,Recruiting,COVID-19,,,,,,,Other: COVID-19 exposure|Biological: COVID-19 vaccine,Thomas Jefferson University|Nemours,Female,"Child, Adult, Older Adult",300.0,Other,Observational,2020-11-17,31/12/21,2022-06-30,09/12/20,05/03/21,"Thomas Jefferson University Hospital, Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,590.0
14.0,NCT04427332,Smell and Taste Disorders in COVID-19 Patients,COVID-19 ORL,Completed,COVID-19,,,,,,,Other: Investigation of smell and taste disorders,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",376.0,Other,Observational,2020-11-06,16/10/20,2020-10-16,11/06/20,27/01/21,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,-21.0
15.0,NCT04842708,Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis,COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: vaccination against COVID19,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",50.0,Industry,Interventional,2020-12-24,24/10/21,2021-10-24,13/04/21,13/04/21,"Shamir Medical Center, Be'er Ya'aqov",Israel,Respiratory Diseases,1,1,304.0
16.0,NCT04367805,COVID-19 Infection in Patients With Hepatocellular Carcinoma,COVID19-CHIEF,Recruiting,Hepatocellular Carcinoma,COVID-19,,,,,,Diagnostic Test: nasopharyngeal Covid 19 RT-PCR,"Centre Hospitalier Universitaire, Amiens|Centre Hospitalier-Universitaire Bondy|University Hospital, Bordeaux|Centre Hospitalier-Universitaire CLICHY|Centre Hospitalier Général CORBEIL-ESSONNE|CHU CRETEIL|University Hospital, Grenoble|University Hospital, Lille|CHU LYON|Poitiers University Hospital|Rennes University Hospital|University Hospital, Rouen|University Hospital, Toulouse|CHU VILLEJUIF|Central Hospital, Nancy, France|Centre Hospitalier Universitaire de Nice|University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-04-27,01/10/20,2020-01-10,29/04/20,29/04/20,"CHU Amiens, Amiens",France,Respiratory Diseases,1,2,-108.0
17.0,NCT04609969,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,COVID-VIRO,Completed,COVID-19,COVID-19,,,,,,Diagnostic Test: RT-qPCR test|Diagnostic Test: COVID-VIRO® test,Centre Hospitalier Régional d'Orléans,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-10-13,17/10/20,2020-10-17,30/10/20,07/12/20,"Centre Hospitalier Régional d'Orléans, France, Orléans",France,Respiratory Diseases,1,2,4.0
18.0,NCT04817553,Impact of COVID-19 on the Clinical Outcomes and Management of IgG4 Related Disease Patients,IgG4-COVID,Recruiting,IgG4 Related Disease,COVID-19,,,,,,Other: exposure to COVID19,Chinese University of Hong Kong,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2021-03-24,01/07/21,2021-01-10,26/03/21,26/03/21,"Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, New Territories",Hong Kong,Respiratory Diseases,1,2,-73.0
19.0,NCT04632355,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,Covid19-Pain,Not yet recruiting,COVID-19,,,,,,,Other: Interview,Fondazione Don Carlo Gnocchi Onlus,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-01-12,31/07/21,2021-07-31,17/11/20,19/11/20,"Jorge Hugo Villafañe, Milan",Italy,Respiratory Diseases,1,1,566.0
20.0,NCT04407585,Testing the Accuracy of a Digital Test to Diagnose Covid-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Covid-19 swab PCR test,"King's College London|Zoe Global Limited|Department of Health, United Kingdom",All,"18 Years and older   (Adult, Older Adult)",1000000.0,Other,Observational,2020-01-06,10/05/21,2021-10-05,29/05/20,24/06/20,"King's College London, London",United Kingdom,Respiratory Diseases,1,1,638.0
21.0,NCT04657510,Femoral frACturEs and COVID-19.,FACE COVID-19,Recruiting,COVID-19,Femur Fracture,Fragility Fracture,,,,,Other: COVID-19,Istituto Ortopedico Galeazzi,All,"45 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-11-14,01/12/20,2020-12-31,08/12/20,08/12/20,"IRCCS Istituto Ortopedico Galeazzi, Milano",Italy,Respiratory Diseases,1,3,47.0
22.0,NCT04473170,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,SENTAD-COVID,Completed,COVID-19,,,,,,,Biological: Autologous Non-Hematopoietic Peripheral Blood Stem Cells (NHPBSC)|Drug: COVID-19 standard care,Abu Dhabi Stem Cells Center,All,"18 Years and older   (Adult, Older Adult)",146.0,Other,Interventional,2020-04-04,20/05/20,2020-07-14,16/07/20,16/07/20,"Abu Dhabi Stem Cells Center, Abu Dhabi",United Arab Emirates,Respiratory Diseases,1,1,101.0
23.0,NCT04497298,Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,COVID-19-101,"Active, not recruiting",COVID-19,,,,,,,Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - Low dose|Biological: Two COVID-19 vaccine candidate (TMV-083) administrations - High dose|Biological: One COVID-19 vaccine candidate (TMV-083) administration - High dose|Other: Placebo,Institut Pasteur|Themis Bioscience GmbH|Coalition for Epidemic Preparedness Innovations,All,18 Years to 55 Years   (Adult),90.0,Industry|Other,Interventional,2020-10-08,01/06/21,2021-01-07,04/08/20,13/04/21,"SGS Life Sciences, Clinical Pharmacology Unit, Antwerp, Belgium|CIC Cochin - Pasteur, Paris",France,Respiratory Diseases,1,1,91.0
24.0,NCT04549831,Genetic Bases of COVID-19 Clinical Variability,GEN-COVID,Recruiting,COVID-19,,,,,,,Genetic: Massive parallel sequencing of host genome,"University of Siena|Policlinico San Matteo Pavia Fondazione IRCCS|Ospedale San Donato, Arezzo|Ospedale della Misericordia|Azienda Ospedaliera Ospedale Maggiore di Crema|University of Modena and Reggio Emilia|ASST Fatebenefratelli Sacco|Azienda Ospedaliera di Perugia|Ospedale dell'Angelo, Venezia-Mestre|Azienda Ulss 2 Marca Trevigiana|Cardarelli Hospital|Azienda Ospedaliera dei Colli|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Istituto Giannina Gaslini|Istituti Ospitalieri di Cremona|IRCSS Lazzaro Spallanzani, Roma|ASST Santi Paolo e Carlo|ASST Valtellina e Alto Lario|Azienda USL Toscana Sud Est|ULSS1 Dolomiti, Belluno|ASST Spedali Civili, Brescia|IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo|Fondazione Policlinico Universitario Agostino Gemelli IRCCS|Ospedale Luigi Curto, Polla|Istituto Auxologico Italiano|CEINGE Biotecnologie Avanzate, Napoli",All,"18 Years and older   (Adult, Older Adult)",2000.0,Other,Observational,2020-08-04,08/04/21,2026-08-04,16/09/20,17/09/20,"University of Siena, Siena",Italy,Respiratory Diseases,1,1,2191.0
25.0,NCT04706390,Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination,COVID19vac-1,Recruiting,COVID-19,,,,,,,Biological: covid-19 vaccine,University of Bergen|Haukeland University Hospital,All,"20 Years to 100 Years   (Adult, Older Adult)",2500.0,Other,Observational,2021-12-01,12/01/22,2024-12-01,12/01/21,12/01/21,"University of Bergen, Bergen",Norway,Respiratory Diseases,1,1,1096.0
26.0,NCT04632719,The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,MP-COVID,Recruiting,Cognitive Impairment,COVID-19,Cognitive Dysfunction,"Depression, Anxiety",Quality of Life,,,Device: The use of the MentalPlus® digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19,University of Sao Paulo,All,"8 Years to 88 Years   (Child, Adult, Older Adult)",200.0,Other,Interventional,2020-08-11,29/12/20,2023-12-29,17/11/20,17/11/20,"Livia Stocco Sanches Valentin, São Paulo, SP, Brazil|Livia Stocco Sanches Valentin, Sao Paulo",Brazil,"Mental Health, Respiratory Diseases",1,5,1235.0
27.0,NCT04427345,Predictive Factors COVID-19 Patients,MI-COVID,Recruiting,COVID-19,,,,,,,Other: Predictive factors for clinical response in patients with COVID-19.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-04-30,30/04/21,2021-04-30,11/06/20,09/11/20,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,365.0
28.0,NCT04424004,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,C3PI,"Active, not recruiting",COVID-19,,,,,,,Other: COVID-19 PCR and serology testing,Duke University|North Carolina Department of Health and Human Services,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-09-06,30/06/21,2021-06-30,09/06/20,17/11/20,"Duke CTSI Translational Population Health Office, Kannapolis, North Carolina",United States,Respiratory Diseases,1,1,297.0
29.0,NCT04407494,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),COVID-OLFA,Completed,COVID-19,,,,,,,"Biological: Reporting of anosmia, ageusia and other clinical symptoms","University Hospital, Montpellier",All,"18 Years and older   (Adult, Older Adult)",809.0,Other,Observational,2020-01-03,01/04/20,2020-04-30,29/05/20,01/06/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,1,118.0
30.0,NCT04360811,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",COroFet,Recruiting,Pregnancy,,,,,,,Diagnostic Test: COVID 19 diagnostic test by PCR,"University Hospital, Toulouse",Female,"18 Years and older   (Adult, Older Adult)",3600.0,Other,Interventional,2020-04-17,01/04/21,2022-01-04,24/04/20,24/04/20,"University Hospital of Toulouse, Toulouse",France,Others,0,1,627.0
31.0,NCT04403672,Performance Evaluation of RealDetect™ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,,Recruiting,COVID-19,,,,,,,Device: performance evaluation study of RealDetect RT-PCR Kit for COVID-19 detection,Bangladesh Medical Research Council (BMRC),All,"5 Years to 65 Years   (Child, Adult, Older Adult)",120.0,Other,Observational,2020-05-18,24/07/20,2020-07-24,27/05/20,28/05/20,"Institute of Epidemiology, Disease Control and Research (IEDCR), Mohakhali, Dhaka (For sample collection & sample storage), Institute for Developing Science & Health Initiatives (ideSHi); Mohakhali, Dhaka (For sample analysis, data collection, data analys, Dhaka",Bangladesh,Respiratory Diseases,1,1,67.0
32.0,NCT04363099,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,COVID AMBU 60,Recruiting,COVID-19,,,,,,,Other: observational,Maison de Sante Pluridisciplinaire de Creil,All,"up to 99 Years   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-01-03,30/06/20,2020-12-31,27/04/20,27/04/20,"Msp de Creil, Creil",France,Respiratory Diseases,1,1,363.0
33.0,NCT04377425,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Neuro-Covid,Withdrawn,Neurological Diseases or Conditions,"Stroke, Acute",Seizure Disorder,,,,,Diagnostic Test: COVID-19 swap test PCR,Aarhus University Hospital,All,"18 Years and older   (Adult, Older Adult)",0.0,Other,Observational,2020-07-05,29/11/20,2022-06-30,06/05/20,03/09/20,"Aalborg University Hospital, Aalborg, DK, Denmark|Aarhus University Hospital, Aarhus, DK, Denmark|Regional Hospital West Jutland, Hostebro, Holstebro, DK, Denmark|Regional Hospital Central Jutland, Viborg, Viborg, DK",Denmark,Cardiovascular Diseases,1,3,725.0
34.0,NCT04602871,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,COVID-19,Completed,COVID-19,,,,,,,Diagnostic Test: Breath Biopsy,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",108.0,Industry,Interventional,2020-03-07,30/01/21,2021-01-30,26/10/20,13/04/21,"Soroka Medical Center, Be'er Sheva, Israel|Meir Medical Center, Kfar Saba",Israel,Respiratory Diseases,1,1,329.0
35.0,NCT04691895,Gastrointestinal Symptoms in COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Other: SARS-CoV2 infection,University of Bologna,All,"18 Years to 85 Years   (Adult, Older Adult)",2000.0,Other,Observational,2020-01-05,30/09/20,2021-12-31,31/12/20,05/01/21,"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna",Italy,Respiratory Diseases,1,1,726.0
36.0,NCT04645498,COVID-19 and Hereditary Metabolic Diseases,COVID19-MHM,Not yet recruiting,COVID-19,"Metabolism, Inborn Errors",,,,,,,"University Hospital, Lille",All,"Child, Adult, Older Adult",77.0,Other,Observational,2021-01-01,01/01/23,2023-01-01,27/11/20,27/11/20,,,Respiratory Diseases,1,2,730.0
37.0,NCT04747821,An Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine,Projeto S,"Active, not recruiting",COVID-19,,,,,,,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",27711.0,Other,Interventional,2021-07-02,01/05/21,2022-01-02,10/02/21,08/04/21,"Hospital Estadual de Serrana, Serrana, SP",Brazil,Respiratory Diseases,1,1,184.0
38.0,NCT04372004,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),CATCH COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: diagnostic tests for COVID-19 infection,Texas Cardiac Arrhythmia Research Foundation,All,"18 Years to 85 Years   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-05,01/05/21,2021-01-06,01/05/20,11/08/20,"Texas Cardiac Arrhythmia Institute, Austin, Texas",United States,Respiratory Diseases,1,1,154.0
39.0,NCT04377685,Prediction of Clinical Course in COVID19 Patients,COVID-CTPRED,Recruiting,COVID-19,,,,,,,Other: CT-Scan,"Centre Hospitalier Universitaire de Saint Etienne|Institut National des Sciences Appliquées (INSA)|Institut National de la Santé Et de la Recherche Médicale, France|Centre National pour le Recherche Scientifique (CNRS)|Université de Lyon|Université Jean Monnet",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Observational,2020-01-03,30/06/21,2021-06-30,06/05/20,19/01/21,"Chu Saint-Etienne, Saint-Étienne",France,Respiratory Diseases,1,1,544.0
40.0,NCT04717011,Case Series Study to Detect SARS-CoV-2 in Semen of COVID-19 Patients,COVID-19CAST,Recruiting,COVID-19,,,,,,,Diagnostic Test: PCR test,Igenomix,Male,"18 Years to 65 Years   (Adult, Older Adult)",100.0,Industry,Observational,2021-01-02,01/07/21,2021-01-07,20/01/21,10/02/21,"Hospital Ruber Internacional, Madrid",Spain,Respiratory Diseases,1,1,5.0
41.0,NCT04412486,COVID-19 Convalescent Plasma (CCP) Transfusion,,Recruiting,COVID-19,,,,,,,Biological: COVID Convalescent Plasma,"Gailen D. Marshall Jr., MD PhD|University of Mississippi Medical Center",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-01-06,31/05/22,2022-05-31,02/06/20,02/07/20,"University of Mississippi Medical Center, Jackson, Mississippi",United States,Respiratory Diseases,1,1,876.0
42.0,NCT04581135,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,,Recruiting,COVID-19,,,,,,,Other: COVID-19,"University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-01-05,30/04/23,2023-01-06,09/10/20,09/10/20,"St. Claraspital AG - Department of Pulmonary Medicine, Basel, Switzerland|Universtiy Hospital Bern (Inselspital), Department of Pulmonary Medicine - Lead Center, Bern, Switzerland|University and Hospital of Fribourg, Fribourg, Switzerland|Hôpitaux Universitaires de Genève - Service de Pneumologie, Genève, Switzerland|CHUV - Service de Pneumologie, Lausanne, Switzerland|Clinica Moncucco, Lugano, Switzerland|Hôpital du Valais - Service de Pneumologie, Sion, Switzerland|Kantonspital St. Gallen - Klinik für Pneumologie und Schlafmedizin Lungenzentrum, St. Gallen, Switzerland|Universitätsspital Zürich - Klinik für Pneumologie, Zürich",Switzerland,Respiratory Diseases,1,1,1097.0
43.0,NCT04387968,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",COVIDOR,Recruiting,Coronavirus Infection,,,,,,,Diagnostic Test: Covid-19 presto test,"Raphael Serreau|François Rabelais University|Assistance Publique - Hôpitaux de Paris|University Hospital, Paris|Orléans Métropole Service de Médecine Préventive",All,"18 Years to 65 Years   (Adult, Older Adult)",5000.0,Other,Observational,2020-08-24,24/03/21,2021-03-24,14/05/20,09/12/20,"Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans, France|Unité de Recherche PARADICT-O - Service de Médecine - Orléans Métropole, Orléans",France,Respiratory Diseases,1,1,212.0
44.0,NCT04845048,Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine,,Not yet recruiting,COVID-19,,,,,,,Biological: Adsorbed COVID-19 (Inactivated) Vaccine,Butantan Institute,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2021-01-04,01/09/21,2021-01-11,14/04/21,14/04/21,"Centro de Saúde Escola da Faculdade de Medicina de Botucatu - Unesp., Botucatu, São Paulo, Brazil|Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP-USP) Dr. Joel Domingos Machado., Ribeirão Preto, São Paulo, Brazil|Centro de Referência de Imunobiológicos Especiais. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (CRIEHCFMUSP), São Paulo",Brazil,Respiratory Diseases,1,1,7.0
45.0,NCT04490837,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),YCOVID,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: ELISA and Rapid test to detect antibodies against COVID-19,Corporacion Parc Tauli,All,"18 Years and older   (Adult, Older Adult)",3500.0,Other,Observational,2020-06-22,31/07/20,2020-09-30,29/07/20,29/07/20,"Parc Tauli University Hospital, Sabadell, Barcelona",Spain,Respiratory Diseases,1,1,100.0
46.0,NCT04834908,Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection,PROTECT,Not yet recruiting,COVID-19,,,,,,,Biological: Equine COVID-19 Antiserum|Drug: Standard of care,Bharat Serums and Vaccines Limited,All,"18 Years to 65 Years   (Adult, Older Adult)",160.0,Industry,Interventional,2021-01-05,01/03/22,2022-01-09,08/04/21,08/04/21,,,Respiratory Diseases,1,1,369.0
47.0,NCT04730401,Convalescent Plasma in the Treatment of Covid-19,CP_COVID-19,Recruiting,COVID-19,,,,,,,Biological: Convalescent plasma from COVID-19 donors|Biological: Placebo,Helsinki University Central Hospital|Finnish Red Cross,All,"18 Years and older   (Adult, Older Adult)",390.0,Other,Interventional,2021-01-27,31/08/21,2021-12-31,29/01/21,08/03/21,"Helsinki University Central Hospital, Helsinki, Uusimaa",Finland,Respiratory Diseases,1,1,338.0
48.0,NCT04799444,LATE-COVID/LATE-COVID-Kids - Observational Study in Children and Adults,LATE-COVID,Recruiting,COVID-19,,,,,,,,Polish Mother Memorial Hospital Research Institute,All,"Child, Adult, Older Adult",500.0,Other,Observational,2020-01-10,30/06/22,2022-06-30,16/03/21,16/03/21,"Polish Mother Memorial Research Institute (PMMHRI) in Lodz, Poland, Lodz",Poland,Respiratory Diseases,1,1,902.0
49.0,NCT04425707,Ivermectin In Treatment of COVID 19 Patients,,Recruiting,COVID-19,,,,,,,Drug: Ivermectin,"Ministry of Health and Population, Egypt",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-09-06,01/07/20,2020-01-09,11/06/20,11/06/20,"isolation and referal hospitals for COVID 19 patients, Cairo",Egypt,Respiratory Diseases,1,1,-241.0
50.0,NCT04356560,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,,Enrolling by invitation,COVID-19,,,,,,,"Diagnostic Test: COVID-19 test, polymerase chain reaction for SARS-CoV-2","Rigshospitalet, Denmark",All,"Child, Adult, Older Adult",300.0,Other,Observational,2020-03-23,30/09/20,2020-12-31,22/04/20,24/04/20,"Rigshospitalet University Hospital of Copenhagen, Copenhagen",Denmark,Respiratory Diseases,1,1,283.0
51.0,NCT04598620,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,VTE-COVID-19,Recruiting,COVID-19,Corona Virus Infection,,,,,,,Inger Lise Gade|Aarhus University Hospital Skejby|Aalborg University Hospital,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Observational,2020-09-19,01/10/21,2021-01-10,22/10/20,30/10/20,"Aalborg Hospital, Aalborg",Denmark,Respiratory Diseases,1,2,113.0
52.0,NCT04386109,Neonatal Complications of Coronavirus Disease (COVID-19),,Recruiting,COVID-19,,,,,,,Other: No intervention - exposure is to COVID-19,"University of Oxford|Imperial College London|University of Leicester|University of Nottingham|University of Glasgow|University Hospital of Wales|Public Health England|St George's, University of London",All,up to 29 Days   (Child),500.0,Other,Observational,2020-01-04,31/03/21,2021-09-30,13/05/20,13/05/20,"Imperial College, London",United Kingdom,Respiratory Diseases,1,1,635.0
53.0,NCT04575168,Clinical Study Spartan COVID-19 V2 System,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 Test,Spartan Bioscience Inc.|Beaufort,All,"18 Years and older   (Adult, Older Adult)",100.0,Industry|Other,Observational,2020-10-30,01/11/20,2020-01-11,05/10/20,13/11/20,"Wake Research Mt. Vernon, Sandy Springs, Georgia, United States|Clinical Chemistry Research Lab, University of Maryand-Baltimore, Baltimore, Maryland, United States|Wake Research ClinSearch, Chattanooga, Tennessee",United States,Respiratory Diseases,1,1,-293.0
54.0,NCT04437940,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,,Completed,COVID-19,Sars-CoV2,,,,,,Diagnostic Test: Vaginal fluid Covid-19 PCR test,Acibadem University,Female,"18 Years to 70 Years   (Adult, Older Adult)",38.0,Other,Observational,2020-06-15,10/07/20,2020-11-30,18/06/20,12/01/21,"Acibadem Maslak Hospital, Istanbul",Turkey,Respiratory Diseases,1,2,168.0
55.0,NCT04508075,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",COVID-19,"Active, not recruiting",SARS-CoV2 Infection,,,,,,,Biological: SARS-CoV-2 vaccine (inactivated)|Biological: Placebo,"PT Bio Farma|Faculty of Medicine Universitas Padjadjaran|National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia|Sinovac Life Sciences Co., Ltd.",All,18 Years to 59 Years   (Adult),1620.0,Industry|Other,Interventional,2020-10-08,09/01/21,2021-01-09,11/08/20,10/03/21,"Hasan Sadikin Hospital/School of Medicine, Padjadjaran University, Bandung, West Java",Indonesia,Respiratory Diseases,1,1,93.0
56.0,NCT04628208,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 v2 System,Spartan Bioscience Inc.,All,"18 Years and older   (Adult, Older Adult)",60.0,Industry,Observational,2020-11-17,01/01/21,2021-01-01,13/11/20,02/12/20,"The Ottawa hospital, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,45.0
57.0,NCT04750330,Mitochondrial DNA and Nuclear SNPs to Predict Severity of COVID-19 Infection,mtDNA-COVID,Not yet recruiting,COVID-19,,,,,,,,Maastricht University|Innovative Medicines Initiative,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2021-01-04,31/03/22,2022-03-31,11/02/21,11/02/21,,,Respiratory Diseases,1,1,451.0
58.0,NCT04602949,Detection of COVID-19 Using Breath Analysis - Validation Study,COVID-19,Recruiting,COVID-19,,,,,,,Diagnostic Test: Breath Biopsy Analysis,Scentech Medical Technologies Ltd,All,"18 Years to 75 Years   (Adult, Older Adult)",4000.0,Industry,Interventional,2020-12-11,28/07/21,2021-07-28,26/10/20,14/04/21,"Shamir Medical Center, Be'er Ya'aqov",Israel,Respiratory Diseases,1,1,229.0
59.0,NCT04376398,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,COVID,Completed,COVID-19,,,,,,,,Cliniques universitaires Saint-Luc- Université Catholique de Louvain|Society for Anesthesia and Resuscitation of Belgium,All,"up to 100 Years   (Child, Adult, Older Adult)",200.0,Other,Observational,2020-06-04,30/06/20,2020-08-30,06/05/20,03/11/20,"Cliniques Universitaires Saint Luc, Brussels",Belgium,Respiratory Diseases,1,1,87.0
60.0,NCT04563247,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,,Completed,COVID-19,,,,,,,Diagnostic Test: IgG SARS CoV 2 antibodies,Lahore General Hospital,All,20 Years to 60 Years   (Adult),970.0,Other,Observational,2020-01-07,08/02/21,2021-08-02,24/09/20,18/02/21,"Lahore General Hospital, Lahore, Punjab",Pakistan,Respiratory Diseases,1,1,573.0
61.0,NCT04379310,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Covid-19,Completed,COVID-19,,,,,,,Drug: ACE Inhibitors and Calcium Channel Blockers,Nisantasi University,All,"18 Years to 99 Years   (Adult, Older Adult)",54.0,Other,Observational,2020-01-05,05/05/20,2020-08-05,07/05/20,05/06/20,"Vital Hospital, Bahcelievler, Istanbul",Turkey,Respiratory Diseases,1,1,213.0
62.0,NCT04682132,Polk COVID-19 and Flu Response,PCFR,"Active, not recruiting",COVID-19,,,,,,,"Diagnostic Test: COVID-19 antigen and antibody tests, and influenza rapid test",Polk County Fire Rescue,All,"18 Years and older   (Adult, Older Adult)",686.0,Other,Observational,2020-05-26,31/12/20,2021-01-01,23/12/20,23/12/20,"Polk County Fire Rescue, Bartow, Florida",United States,Respiratory Diseases,1,1,220.0
63.0,NCT04390074,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,,Completed,COVID-19,Critical Illness,,,,,,Other: COVID-19 and Intensive Care,"Uppsala University|Center for Clinical Research Dalarna, Sweden",All,"18 Years and older   (Adult, Older Adult)",9905.0,Other,Observational,2020-05-27,04/06/20,2020-04-06,15/05/20,25/08/20,"Björn Ahlström, Falun",Sweden,"Cardiovascular Diseases, Respiratory Diseases",1,2,-51.0
64.0,NCT04353206,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,,Recruiting,COVID-19,Sars-CoV2,,,,,,Biological: Multiple Doses of Anti-SARS-CoV-2 convalescent plasma,Noah Merin|Johns Hopkins University|Cedars-Sinai Medical Center,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Interventional,2020-06-27,01/05/21,2021-01-05,20/04/20,15/07/20,"8700 Beverly Blvd., Los Angeles, California, United States|Johns Hopkins University, Baltimore, Maryland",United States,Respiratory Diseases,1,2,192.0
65.0,NCT04460274,Forecast Number of Covid-19 Cases Worldwide,Covid19TmeSer,Completed,COVID-19,,,,,,,Other: Model Building|Other: Model validation,Turkish Ministry of Health Izmir Teaching Hospital,All,"Child, Adult, Older Adult",7882471.0,Other,Observational,2019-12-31,15/06/20,2020-06-20,07/07/20,08/07/20,"Republic of Turkey, Health Sciences University, Izmir Bozyaka Education and Training Hospital, İzmir",Turkey,Respiratory Diseases,1,1,172.0
66.0,NCT04366271,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,MESCEL-COVID19,Recruiting,COVID-19,,,,,,,Biological: Mesenchymal cells|Drug: Standard of care,"Hospital Infantil Universitario Niño Jesús, Madrid, Spain|Apices Soluciones S.L.",All,"40 Years to 80 Years   (Adult, Older Adult)",106.0,Other|Industry,Interventional,2020-07-05,31/07/20,2021-05-31,28/04/20,11/05/20,"Hospital Universitario de Getafe, Getafe, Madrid, Spain|Hospital Universitario de Cruces, Barakaldo, Spain|Hospital Universitario de La Princesa, Madrid, Spain|Hospital Infantil Universitario Niño Jesus, Madrid, Spain|Hospital Ramón Y Cajal, Madrid, Spain|Complejo Universitario La Paz, Madrid",Spain,Respiratory Diseases,1,1,330.0
67.0,NCT04345679,Anti COVID-19 Convalescent Plasma Therapy,,Recruiting,COVID-19,,,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,Orthosera Kft.|Semmelweis University|University of Pecs|Hungarian National Blood Service|Humán Bioplazma Kft - Kedrion,All,"18 Years and older   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-14,01/06/21,2021-01-09,14/04/20,25/02/21,"Semmelweis University's Department of Pulmonology, Budapest",Hungary,Respiratory Diseases,1,1,270.0
68.0,NCT04668404,Study of Coagulation Profile and Role of Heparin Like Effect in Patients With COVID-19,COVID-19,Recruiting,COVID-19,Hypercoagulable States Nec,,,,,,Diagnostic Test: Sonoclot,Postgraduate Institute of Medical Education and Research,All,"18 Years to 80 Years   (Adult, Older Adult)",50.0,Other,Observational,2020-08-24,01/01/21,2021-01-02,16/12/20,16/12/20,"PGIMER, Chandigarh",India,Respiratory Diseases,1,2,131.0
69.0,NCT04355715,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,COVID-Scan,Completed,COVID-19,SARS-Cov-2,,,,,,,"University Hospital, Montpellier",All,"18 Years to 99 Years   (Adult, Older Adult)",200.0,Other,Observational,2019-01-04,01/10/20,2020-10-20,21/04/20,29/12/20,"Uh Montpellier, Montpellier",France,Respiratory Diseases,1,2,655.0
70.0,NCT04339322,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,COVID-19,Not yet recruiting,Characteristics Diseases,"Outcome, Fatal",,,,,,Other: Follow up,Assiut University,All,"Child, Adult, Older Adult",200.0,Other,Observational,2020-01-05,30/07/20,2020-07-30,09/04/20,09/04/20,,,Others,0,2,207.0
71.0,NCT04674644,Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales,,Completed,COVID-19,,,,,,,Behavioral: The psychosocial effects of COVID-19 pandemic on dental professionals,Suleyman Demirel University,All,"23 Years and older   (Adult, Older Adult)",850.0,Other,Interventional,2020-10-16,23/10/20,2020-10-23,19/12/20,02/02/21,"Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department, Isparta",Turkey,Respiratory Diseases,1,1,7.0
72.0,NCT04453748,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",,Enrolling by invitation,COVID-19,Coronavirus Infection,Sars-CoV2,Complications,,,,Other: Complex diagnostic panel,Silesian Centre for Heart Diseases|Medical Research Agency - Agencja Badań Medycznych|Medical University of Silesia,All,"18 Years to 120 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-08-06,31/10/21,2021-11-30,01/07/20,30/09/20,"Silesian Centre for Heart Disease, Zabrze, Silesia",Poland,Respiratory Diseases,1,4,481.0
73.0,NCT04811391,COVID-19 Vaccine Effectiveness in Albanian Health Workers,COVEAL,Recruiting,COVID-19,,,,,,,Biological: COVID-19 vaccine,"Institute of Public Health, Albania|World Health Organization|Centers for Disease Control and Prevention|Southeast Europe Center for Infectious Diseases Surveillance and Control|EPICONCEPT",All,"16 Years and older   (Child, Adult, Older Adult)",1500.0,Other|U.S. Fed,Observational,2021-02-19,20/05/22,2022-05-20,23/03/21,26/03/21,"Durres Regional Hospital, Durrës, Albania|Fier Regional Hospital, Fier, Albania|Tirana University Hospital  Mother Theresa, Tirana",Albania,Respiratory Diseases,1,1,455.0
74.0,NCT04381871,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,GA&COVID19,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Acacia Senegal|Dietary Supplement: Pectin,Al-Neelain University|University of Khartoum,All,"5 Years to 90 Years   (Child, Adult, Older Adult)",110.0,Other,Interventional,2020-01-06,01/08/20,2020-01-09,11/05/20,12/05/20,"Omdurman Teaching Hospital, Khartoum, Omdurman, Sudan|Jabra Hospital,, Khartoum",Sudan,Respiratory Diseases,1,1,3.0
75.0,NCT04323787,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,COVID-19,Recruiting,Coronavirus,,,,,,,Other: observational,Mayo Clinic|Society of Critical Care Medicine|Boston University,All,"Child, Adult, Older Adult",50000.0,Other,Observational,2020-03-30,30/04/21,2021-04-30,27/03/20,11/08/20,"Mayo Clinic in Arizona, Scottsdale, Arizona, United States|Mayo Clinic in Florida, Jacksonville, Florida, United States|Society of Critical Care Medicine (150+ sites), Chicago, Illinois, United States|Rahul Kashyap, Rochester, Minnesota",United States,Respiratory Diseases,1,1,396.0
76.0,NCT04510207,"A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",COVID-19,Recruiting,COVID-19,,,,,,,Biological: Inactivated SARS-CoV-2 Vaccine (Vero cell)|Biological: Placebo,"China National Biotec Group Company Limited|G42 Healthcare company|Abu Dhabi Health Services Company|Wuhan Institute of Biological Products Co., Ltd|Beijing Institute of Biological Products Co Ltd.",All,"18 Years and older   (Adult, Older Adult)",45000.0,Industry|Other,Interventional,2020-07-16,16/06/21,2021-09-16,12/08/20,05/04/21,"Bahrain International Exhibition & Convention Centre Affiliated to Salymynia Medical Complex S, Sanabis, Bahrain|Katameya Medical Center, Cairo, Egypt|Vacsera health Care facilities , MoH, Cairo, Egypt|Prince Hamza Hospital, Amman, Jordan|Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates|Al Qarain Primary Health Care Centre-MOHAP, Sharjah",United Arab Emirates,Respiratory Diseases,1,1,427.0
77.0,NCT04760990,A Study to Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.,MS COVID-19,Recruiting,Multiple Sclerosis,COVID-19,,,,,,Other: data collection|Other: analysis of blood samples,"University Hospital, Basel, Switzerland|Swiss Multiple Sclerosis Society",All,"18 Years and older   (Adult, Older Adult)",1400.0,Other,Observational,2021-01-02,01/12/23,2023-01-12,18/02/21,02/03/21,"Kantonsspital Aarau, Aarau, Switzerland|University Hospital Basel, Department of Neurology and Department of Biomedicine, Basel, Switzerland|Inselspital Bern, Bern, Switzerland|Hôpitaux Universitaires Genève, Genève, Switzerland|Lausanne University Hospital (CHUV), Lausanne, Switzerland|Ospedale Regionale di Lugano, Lugano, Switzerland|Kantonsspital St. Gallen, St. Gallen",Switzerland,"Respiratory Diseases, Immunological Disorders",1,2,740.0
78.0,NCT04387929,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Detection of anti-COVID-19 antibody level,Istituto Clinico Humanitas,All,"18 Years to 90 Years   (Adult, Older Adult)",6000.0,Other,Observational,2020-04-05,30/05/21,2021-05-30,14/05/20,15/05/20,"Humanitas Rozzano/San Pio X, Rozzano, Lombardia",Italy,Respiratory Diseases,1,1,420.0
79.0,NCT04330261,Clinical Characteristics and Outcomes of Pediatric COVID-19,PERN-COVID-19,Recruiting,COVID-19,COVID-19,Pediatric ALL,"Pneumonia, Viral",Pandemic Response,,,Other: Exposure (not intervention) - SARS-CoV-2 infection,University of Calgary,All,"up to 18 Years   (Child, Adult)",12500.0,Other,Observational,2020-03-18,17/03/21,2022-03-17,01/04/20,01/04/20,"University of Calgary/Alberta Children's Hospital, Calgary, Alberta",Canada,Respiratory Diseases,1,5,729.0
80.0,NCT04529460,Healthy Volunteer COVID-19 Antibody Testing Study,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 antibody point of care test kit,Royal Free Hospital NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2020-01-09,29/01/21,2021-04-30,27/08/20,14/09/20,,,Respiratory Diseases,1,1,477.0
81.0,NCT04392323,Incidence of COVID-19 Test Conversion in Post-surgical Patients,,Recruiting,Sars-CoV2,,,,,,,Diagnostic Test: COVID-19 PCR and Serology,Northwell Health,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Interventional,2020-05-13,01/07/20,2020-07-31,18/05/20,18/05/20,"North Shore University Hospital, Manhasset, New York, United States|Long Island Jewish Medical Center, New Hyde Park, New York",United States,Respiratory Diseases,1,1,79.0
82.0,NCT04565522,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,DIAL-COVID-19,Not yet recruiting,COVID-19,Dialysis,Nurse-Patient Relations,,,,,Other: Prospective observation,"Simeone Andrulli, MD|A. Manzoni Hospital",All,"18 Years and older   (Adult, Older Adult)",5000.0,Other,Observational,2020-09-21,30/09/21,2021-10-31,25/09/20,25/09/20,"AOU Mater Domini, Catanzaro",Italy,Respiratory Diseases,1,3,405.0
83.0,NCT04799392,NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons,,Recruiting,COVID-19,COVID-19,Coronavirus,,,,,Device: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",All,"2 Years and older   (Child, Adult, Older Adult)",339.0,Industry,Interventional,2021-01-04,30/04/21,2021-04-30,16/03/21,05/04/21,"Goodrich Pharmacy, Anoka, Minnesota, United States|Bremo Pharmacy, Richmond, Virginia, United States|Kirk's Pharmacy, Eatonville, Washington",United States,Respiratory Diseases,1,3,116.0
84.0,NCT04816318,Policy Responses Against the COVID-19 Pandemic in Latin America,,Not yet recruiting,COVID-19,Infectious Disease,Death,SARS-CoV Infection,,,,Other: Social and public health measures against COVID-19|Other: Control,University of Chile,All,"Child, Adult, Older Adult",10000.0,Other,Observational,2021-03-22,31/05/21,2021-05-31,25/03/21,29/03/21,"Escuela de Salud Pública, Santiago, Región Metropolitana",Chile,Respiratory Diseases,1,4,70.0
85.0,NCT04690413,NOWDx Test for the Detection of Antibodies to COVID-19,,Completed,COVID-19,COVID-19,Coronavirus,,,,,Device: NOWDx COVID-19 Test,"NOWDiagnostics, Inc.",All,"18 Years and older   (Adult, Older Adult)",129.0,Industry,Interventional,2020-01-09,31/12/20,2020-12-31,30/12/20,03/03/21,"Del Sol Research Management, LLC, Tucson, Arizona, United States|Comprehensive Clinical Research, LLC, West Palm Beach, Florida, United States|Clinical Research Solutions, LLC, Jackson, Tennessee",United States,Respiratory Diseases,1,3,357.0
86.0,NCT04349202,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,BLAST COVID-19,Recruiting,COVID-19,Coronavirus Infection,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,Diagnostic Test: EUROIMMUN assay,William Beaumont Hospitals,All,"18 Years and older   (Adult, Older Adult)",56000.0,Other,Observational,2020-10-04,01/06/21,2021-01-06,16/04/20,25/08/20,"Beaumont Health System, Royal Oak, Michigan, United States|Beaumont Health, Royal Oak, Michigan",United States,Respiratory Diseases,1,3,94.0
87.0,NCT04474496,Impact of COVID-19 on Marshallese Communities in the U.S.,,Completed,COVID-19,,,,,,,Other: Assessing the impact of COVID-19,University of Arkansas|Patient-Centered Outcomes Research Institute,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-07-27,30/11/20,2020-11-30,16/07/20,05/04/21,"University of Arkansas for Medical Sciences Northwest, Fayetteville, Arkansas",United States,Respiratory Diseases,1,1,126.0
88.0,NCT04466657,Antioxidant Therapy for COVID-19 Study,GSHSOD-COVID,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Antioxidation Therapy|Other: Standard of Care,Obafemi Awolowo University|Borno State Ministry of Health|Ogun State Ministry of Health|Abia State Ministry of Health|Sokoto State Ministry of Health|Benue State Minsitry of Health|University of Calabar Teaching Hospital,All,"18 Years to 75 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-11,28/02/21,2021-04-30,10/07/20,02/09/20,"Abia State Isolation Centre, Amachara, Umuahia, Abia State, Nigeria|Benue State University Teaching Hospital, Makurdi, Benue State, Nigeria|Brigadier Abba Kyari Memorial Hospital, Borno, Borno State, Nigeria|University of Maiduguri Teaching Hospital, Maiduguri, Borno State, Nigeria|University of Calabar Teaching Hospital, Calabar, Cross River, Nigeria|Federal Medical Centre Idi-Aba, Abeokuta, Ogun State, Nigeria|Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria|Infectious Disease Hospital, Amanawa, Sokoto State, Nigeria|Murtala Muhammad Speciaist Hospital, Sokoto, Sokoto State, Nigeria|Occupational Therapy Center, Sokoto, Sokoto State, Nigeria|Usmanu Danfodiyo University Teaching Hospital, Sokoto, Sokoto State",Nigeria,Respiratory Diseases,1,1,475.0
89.0,NCT04427358,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,COVID-19GAOM,Completed,COVID-19,,,,,,,,"University Hospital, Strasbourg, France",All,70 Years and older   (Older Adult),100.0,Other,Observational,2020-07-05,07/08/20,2020-07-09,11/06/20,25/11/20,"Service SSR Gériatrique, Strasbourg",France,Respiratory Diseases,1,1,4.0
90.0,NCT04811664,A Study of SARS CoV-2 Infection and Potential Transmission in University Students Immunized With Moderna COVID-19 Vaccine,CoVPN 3006,Recruiting,COVID-19,,,,,,,Biological: Moderna COVID-19 Vaccine,National Institute of Allergy and Infectious Diseases (NIAID),All,18 Years to 26 Years   (Adult),37500.0,NIH,Interventional,2021-03-22,22/12/21,2021-12-22,23/03/21,26/03/21,"University of Arizona, Tucson, Arizona, United States|Charles Drew University, Los Angeles, California, United States|University of California, San Diego, San Diego, California, United States|University of Colorado- Boulder, Boulder, Colorado, United States|University of Florida, Gainesville, Florida, United States|Morehouse University, Atlanta, Georgia, United States|Champaign-Urbana Public Health District, Champaign, Illinois, United States|Northwestern University, Evanston, Illinois, United States|Indiana University, Bloomington, Indiana, United States|University of Kentucky, Lexington, Kentucky, United States|University of Maryland College Park, College Park, Maryland, United States|University of Nebraska, Omaha, Nebraska, United States|Stony Brook University, Stony Brook, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Wake Forest University, Winston-Salem, North Carolina, United States|Clemson University, Clemson, South Carolina, United States|Texas A&M University, College Station, Texas, United States|Texas A&M - Kingsville, Kingsville, Texas, United States|University of Virginia, Charlottesville, Virginia, United States|University of Washington, Seattle, Washington, United States|West Virginia University, Morgantown, West Virginia",United States,Respiratory Diseases,1,1,275.0
91.0,NCT04664023,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",BIOMARK-COVID,Recruiting,COVID-19,,,,,,,"Procedure: Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection",Poitiers University Hospital,All,"18 Years and older   (Adult, Older Adult)",120.0,Other,Observational,2020-09-12,30/07/22,2022-07-30,11/12/20,14/12/20,"C.H.U.de Poitiers, Poitiers",France,Respiratory Diseases,1,1,686.0
92.0,NCT04404062,Validation of COVID-19 Tests,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Covid-19 Rapid Test Kit (RAPG-COV-019)|Diagnostic Test: Quantitative IgG Test,Richmond Pharmacology Limited,All,"18 Years to 70 Years   (Adult, Older Adult)",500.0,Industry,Observational,2020-03-16,01/08/20,2020-01-08,27/05/20,27/05/20,"Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge, London",United Kingdom,Respiratory Diseases,1,1,-68.0
93.0,NCT04376996,Slovenian National COVID-19 Prevalence Study,SLO-COVID-19,Recruiting,COVID-19,COVID-19,,,,,,Diagnostic Test: NO intervention planned due to the observational study design - only a diagnostic testing,University of Ljubljana,All,"Child, Adult, Older Adult",3000.0,Other,Observational,2020-04-20,01/10/20,2020-01-12,06/05/20,07/05/20,"University of Ljubljana, Ljubljana",Slovenia,Respiratory Diseases,1,2,-99.0
94.0,NCT04370288,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Covid-19,Recruiting,COVID-19,,,,,,,"Drug: MCN (Methylene blue, vitamin C, N-acetyl cysteine)",Mashhad University of Medical Sciences,All,"18 Years to 90 Years   (Adult, Older Adult)",20.0,Other,Interventional,2020-04-19,20/09/20,2020-09-21,30/04/20,04/05/20,"Imam Reza Hospital, Mashhad, Razavi Khorasan, Iran",Islamic Republic of,Respiratory Diseases,1,1,155.0
95.0,NCT04706403,Views on COVID-19 and Vaccination,,"Active, not recruiting",COVID-19,,,,,,,Behavioral: Healthcare Providers' Communication about the COVID-19 Vaccine,"University of Massachusetts, Worcester",All,"18 Years and older   (Adult, Older Adult)",3000.0,Other,Interventional,2021-04-01,01/06/21,2021-12-26,12/01/21,08/03/21,"Meyers Primary Care Institute, Worcester, Massachusetts",United States,Respiratory Diseases,1,1,269.0
96.0,NCT04393402,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),LUS-COVID19,Recruiting,COVID-19,,,,,,,Procedure: lung ultrasound (LUS),Centre Hospitalier Universitaire de Nice,All,"18 Years to 95 Years   (Adult, Older Adult)",14.0,Other,Observational,2020-03-20,31/12/20,2020-12-31,19/05/20,19/05/20,"CHU de Nice, Nice",France,Respiratory Diseases,1,1,286.0
97.0,NCT04548908,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,POCAH-COVID,Recruiting,COVID-19,,,,,,,"Diagnostic Test: Serelogy testing, RT PCR",Centre Hospitalier Sud Essonne,All,"18 Years and older   (Adult, Older Adult)",1300.0,Other,Observational,2020-03-08,30/04/21,2021-06-30,16/09/20,16/09/20,"Centre Hospitalier Sud Essonne, Etampes",France,Respiratory Diseases,1,1,479.0
98.0,NCT04582331,Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,,Recruiting,COVID-19,,,,,,,Other: Smartphone-based voice and self-reported symptom collection,Sonde Health,All,"12 Years and older   (Child, Adult, Older Adult)",300.0,Industry,Observational,2020-10-09,30/04/21,2021-04-30,09/10/20,29/01/21,"UC San Diego Medical Center, San Diego, California, United States|Brigham & Woman's Hospital, Boston, Massachusetts, United States|Montefiore Medical Center, New York, New York, United States|Deenanath Mangeshkar Hospital & Research Centre, Pune",India,Respiratory Diseases,1,1,203.0
99.0,NCT04379284,Risks of COVID19 in the Pregnant Population,,Recruiting,COVID-19,,,,,,,Other: Biospecimen collection,Mayo Clinic,Female,18 Years to 45 Years   (Adult),100.0,Other,Observational,2020-08-05,30/04/21,2021-07-31,07/05/20,13/07/20,"Mayo Clinic Rochester, Rochester, Minnesota",United States,Respiratory Diseases,1,1,360.0
100.0,NCT04352764,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,,Recruiting,COVID-19,,,,,,,Diagnostic Test: CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test,Texas Cardiac Arrhythmia Research Foundation,All,"Child, Adult, Older Adult",5000.0,Other,Observational,2020-03-27,31/12/20,2021-01-31,20/04/20,27/04/20,"St. David's Medical Center, Austin, Texas",United States,Respiratory Diseases,1,1,310.0
101.0,NCT04780698,DCI COVID-19 Surveillance Project,,Recruiting,COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection,"Temple University|Dialysis Clinic, Inc.",All,"18 Years to 90 Years   (Adult, Older Adult)",160.0,Other|Industry,Interventional,2021-01-03,01/10/21,2022-01-03,03/03/21,03/03/21,"Dialysis Clinic, Inc., Philadelphia, Pennsylvania",United States,Respiratory Diseases,1,1,365.0
102.0,NCT04598334,Cytokine Storm Among Bangladeshi Patients With COVID-19,,Not yet recruiting,COVID-19,,,,,,,,"International Centre for Diarrhoeal Disease Research, Bangladesh",All,"18 Years to 90 Years   (Adult, Older Adult)",75.0,Other,Observational,2021-06-15,01/10/21,2021-01-10,22/10/20,30/03/21,"Icddr,B, Dhaka",Bangladesh,Respiratory Diseases,1,1,-156.0
103.0,NCT04418245,CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,COVID 19-IA,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: Imaging by thoracic scanner,Centre Hospitalier Universitaire de Nīmes,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-01-03,01/06/20,2020-01-07,05/06/20,05/06/20,"CHU la Timone, Marseille, France|CHU Montpellier, Montpellier, France|CHU de Nimes, Nîmes, France|CHU Poitiers, Poitiers, France|CHU Strasbourg, Strasbourg, France|CHU Martinique, Fort-de-France",Martinique,Respiratory Diseases,1,1,4.0
104.0,NCT04416373,COVID-19 and Pregnancy Outcomes,COVID&PREG,Recruiting,Coronavirus Infection,Pregnancy Complications,Vertical Transmission of Infectious Disease,Breastfeeding,Neonatal Infection,,,Diagnostic Test: RT PCR SARS-CoV-2,Universidade Nova de Lisboa,Female,"16 Years to 55 Years   (Child, Adult)",300.0,Other,Observational,2020-03-22,01/12/23,2023-01-12,04/06/20,04/06/20,"Nova Medical School - UNL, Lisbon",Portugal,Respiratory Diseases,1,5,1026.0
105.0,NCT04342637,COVID-19 Endoscopy Survey,COVID-19 Endo,Completed,COVID-19,,,,,,,Other: Practice details,Al-Azhar University,All,"30 Years to 70 Years   (Adult, Older Adult)",163.0,Other,Observational,2020-10-04,25/04/20,2020-01-05,13/04/20,20/05/20,"Kings County Hospital Center, Brooklyn, NY, USA, Albertson, New York, United States|Faculty of Medicine, Zagazig University, Zagazig, Sharkia, Egypt|Al-Azhar Univerisity, Cairo, Egypt|Ahvaz Imam hospital, Ahvaz, Iran",Islamic Republic of,Respiratory Diseases,1,1,-273.0
106.0,NCT04382235,Non-invasive Ventilatory Support of Patients Affected by COVID-19,WARd-COVID,"Active, not recruiting",COVID-19,,,,,,,Device: Non-invasive ventilatory support,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",900.0,Other,Observational,2020-03-26,30/12/20,2020-12-30,11/05/20,09/11/20,"Policlinico San Marco - Ospedale Zingonia, Zingonia, BG, Italy|ASST Papa Giovanni XXIII - Bergamo, Bergamo, Italy|Azienda Ospedaliera - Universitaria di Bologna, Policlinico S. Orsola Malpighi, Bologna, Italy|ASST Spedali Civili - Brescia, Brescia, Italy|ASST Valle Olona - Ospedale di Busto Arsizio, Busto Arsizio, Italy|ASST Lariana - Ospedale Sant'Anna, Como, Italy|ASST Crema - Ospedale Maggiore di Crema, Crema, Italy|ASST Cremona - Ospedale di Cremona, Cremona, Italy|Istituto Clinico Humanitas Gavazzeni, Cremona, Italy|ASST Garda - Presidio di Desenzano del Garda, Desenzano Del Garda, Italy|ASST Monza - Desio, Desio, Italy|ASST Spedali Civili -Ospedale di Gardone Val Trompia, Gardone Val Trompia, Italy|ASST Lecco - Ospedale A. Manzoni, Lecco, Italy|ASST Ovest milanese - Ospedale di Legnano, Legnano, Italy|ASST Lodi - Ospedale Maggiore di Lodi, Lodi, Italy|ASST OVEST Milanese - Ospedale di Magenta, Magenta, Italy|ASST Garda - Ospedale di Manerbio, Manerbio, Italy|ASST Mantova - Ospedale Carlo Poma, Mantova, Italy|ASST Melegnano e della Martesana - Presidio di Melzo-Gorgonzola, Melzo, Italy|ASST Fatebenefratelli - Presidi Fatebenefratelli & M. Melloni, Milano, Italy|ASST Fatebenefratelli - Sacco, Milano, Italy|ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy|Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy|Ospedale San Giuseppe, Milano, Italy|ASST Spedali Civili -Presidio Ospedaliero di Montichiari, Montichiari, Italy|ASST Monza - Ospedale San Gerardo, Monza, Italy|Fondazione IRCCS Policlinico San Matteo - Pavia, Pavia, Italy|Policlinico San Pietro, Ponte San Pietro, Italy|Istituto Clinico Humanitas Rozzano, Rozzano, Italy|ASST Valle Olona - Ospedale di Saronno, Saronno, Italy|ASST Bergamo OVEST - Ospedale Treviglio-Caravaggio di Treviglio, Treviglio, Italy|Ospedale di Circolo e Fondazione Macchi - Varese, Varese, Italy|ASST Vimercate - Ospedale di Vimercate, Vimercate, Italy|ASST Melegnano e della Martesana - Ospedale di Vizzolo Predabissi, Vizzolo Predabissi",Italy,Respiratory Diseases,1,1,279.0
107.0,NCT04694703,"Changing of Trace Element, Homocysteine, Oxidative Stress Parameters and Physical Activity Levels in Covid-19",,Recruiting,COVID-19,,,,,,,Drug: Covid-19 group,Izmir Bakircay University|Cigli Regional Training Hospital|Muğla Sıtkı Koçman University,All,"35 Years to 65 Years   (Adult, Older Adult)",20.0,Other,Observational,2021-06-01,01/02/21,2021-01-03,05/01/21,11/02/21,"Kadirhan Ozdemir, İzmir",Turkey,Respiratory Diseases,1,1,-149.0
108.0,NCT04361422,Isotretinoin in Treatment of COVID-19,Randomized,Not yet recruiting,COVID-19,,,,,,,Drug: Isotretinoin Only Product in Oral Dose Form,Tanta University,All,18 Years to 40 Years   (Adult),300.0,Other,Interventional,2020-01-12,01/08/21,2021-01-12,24/04/20,23/09/20,,,Respiratory Diseases,1,1,366.0
109.0,NCT04332380,Convalescent Plasma for Patients With COVID-19: A Pilot Study,CP-COVID-19,Completed,Coronavirus,Coronavirus Infection,,,,,,Drug: Plasma,Universidad del Rosario|CES University|Instituto Distrital de Ciencia Biotecnologia e Innovacion en salud|Fundación Universitaria de Ciencias de la Salud,All,18 Years to 60 Years   (Adult),10.0,Other,Interventional,2020-01-05,28/07/20,2020-07-28,02/04/20,17/08/20,"Universidad del Rosario, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,2,205.0
110.0,NCT04410471,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,,Recruiting,Liver Transplant Infection,COVID-19,Mortality,Immune Response,,,,Diagnostic Test: CLIA of IgG and IgM against SARS-Cov-2,Magdalena Salcedo|Hospital General Universitario Gregorio Marañon,All,"18 Years to 100 Years   (Adult, Older Adult)",300.0,Other,Observational,2020-05-29,29/05/20,2021-06-30,01/06/20,02/06/20,"Victor Fernandez Alonso, Madrid, Spain|Victor Fernández Alonso, Madrid",Spain,Respiratory Diseases,1,4,397.0
111.0,NCT04595110,Hemostatic Profile in Patients Affected by COVID-19,EMO-COVID,Recruiting,COVID-19,Thrombosis,,,,,,Other: Observational study,ANNA FALANGA|A.O. Ospedale Papa Giovanni XXIII,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-03-25,25/04/21,2021-10-05,20/10/20,20/10/20,"Papa Giovanni XXIII Hospital - S.I.M.T., Bergamo",Italy,Respiratory Diseases,1,2,559.0
112.0,NCT04713163,COVID-19 Vaccine Induced Immunity,,Not yet recruiting,COVID-19,,,,,,,Drug: covid19 vaccine,University of Manitoba|Public Health Agency of Canada (PHAC)|Cadham Provincial Lab,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Observational,2021-01-01,01/04/21,2021-01-12,19/01/21,19/01/21,,,Respiratory Diseases,1,1,11.0
113.0,NCT04481633,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,PREPCOV,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID 19 serology|Other: COVID 19 Self-Questionnaire,"University Hospital, Toulouse",All,"18 Years and older   (Adult, Older Adult)",800.0,Other,Interventional,2020-09-09,01/09/21,2021-01-09,22/07/20,12/11/20,"Limoges university Hospital, Limoges, France|Montpellier University Hospital, Montpellier, France|Pitié Salpêtrière Hospital - Hépatologie, Paris, France|Pitié Salpêtrière Hospital - Médecine interne, Paris, France|Haut-Lévêque Hospital - Gastro-entérologie, Pessac, France|Haut-Lévêque Hospital - Médecine interne, Pessac, France|Joseph Ducuing Hospital - Médecine interne, Toulouse, France|Toulouse university Hospital - Larrey Dermatologie, Toulouse, France|Toulouse University Hospital - Rhumatologie, Toulouse, France|Toulouse University Hospital, Toulouse, France|University Hospital of Toulouse - Rangueil Médecine interne, Toulouse, France|University hospital Toulouse - Purpan Médecine interne, Toulouse",France,Respiratory Diseases,1,1,122.0
114.0,NCT04780126,Sarco-COVID Study: Measuring the Loss of Skeletal Muscle Mass in the Hospitalized Patient With the Diagnosis of COVID-19,SARCO-COVID,Recruiting,Sarcopenia,COVID-19,,,,,,Other: Sarcopenia diagnosis,Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz,All,"18 Years and older   (Adult, Older Adult)",64.0,Other,Observational,2021-02-26,30/04/21,2021-05-31,03/03/21,03/03/21,"Hospital de Emergencias Isabel Zendal, Madrid",Spain,Respiratory Diseases,1,2,94.0
115.0,NCT04706039,Rapid Diagnosis of COVID-19 by Chemical Analysis of Exhaled Air,COVIDAIR,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Performance evaluation (sensitivity and specificity) for COVID-19 diagnosis of the Vocus PTR-TOF process,Hospices Civils de Lyon,All,"6 Years and older   (Child, Adult, Older Adult)",3000.0,Other,Interventional,2021-01-01,01/03/21,2021-01-03,12/01/21,12/01/21,"Centre de prélèvement COVID-19 HCL et Métropole de Lyon, Lyon",France,Respiratory Diseases,1,1,2.0
116.0,NCT04365959,The Prone Position in Covid-19 Affected Patients,PRON-COVID,"Active, not recruiting",Sars-CoV2,,,,,,,Procedure: Prone position,University of Milano Bicocca,All,"18 Years to 75 Years   (Adult, Older Adult)",56.0,Other,Observational,2020-03-20,09/04/20,2020-12-31,28/04/20,09/11/20,"ASST Monza, Monza, MB",Italy,Respiratory Diseases,1,1,286.0
117.0,NCT04332835,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",CP-COVID-19,Completed,Coronavirus,Coronavirus Infection,,,,,,Drug: Plasma|Drug: Standard Therapy,Universidad del Rosario|Fundación Universitaria de Ciencias de la Salud|CES University|Instituto Distrital de Ciencia Biotecnología e Innovacion en Salud,All,"18 Years to 100 Years   (Adult, Older Adult)",92.0,Other,Interventional,2020-08-08,31/10/20,2020-11-15,03/04/20,27/11/20,"Universidad del Rosario, Bogota, Cundinamarca",Colombia,Respiratory Diseases,1,2,99.0
118.0,NCT04834752,Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19,,Not yet recruiting,COVID-19,,,,,,,Other: No intervention (Retrospective Cohort Observational),"Seoul National University Hospital|Dong-A ST Co., Ltd.",All,"18 Years and older   (Adult, Older Adult)",400000.0,Other|Industry,Observational,2021-01-05,31/12/21,2021-12-31,08/04/21,08/04/21,"Seoul National University Hospital, Seoul, Korea",Republic of,Respiratory Diseases,1,1,360.0
119.0,NCT04384887,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",,Completed,COVID-19,Anxiety,"Depression, Postpartum",,,,,Behavioral: covid-19 positive pregnant women,Kanuni Sultan Suleyman Training and Research Hospital|Ayşegül Bestel|İbrahim Polat|Merve Aldıkaçtıoğlu Talmaç,Female,18 Years to 45 Years   (Adult),100.0,Other,Observational,2020-04-25,25/08/20,2020-08-26,12/05/20,02/09/20,"Pinar Yalcin Bahat, Istanbul, İ̇stanbul",Turkey,"Mental Health, Respiratory Diseases",1,3,123.0
120.0,NCT04363489,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),CEDiD,Recruiting,COVID-19,,,,,,,Device: Wearable Medical Device (Empatica E4)|Diagnostic Test: COVID-19 PCR Swab|Diagnostic Test: Pulse Oximeter,King's College London|Guy's and St Thomas' NHS Foundation Trust,All,"18 Years and older   (Adult, Older Adult)",60.0,Other,Observational,2020-08-20,30/05/21,2021-06-30,27/04/20,19/03/21,"Guy's and St Thomas' NHS Foundation Trust, London",United Kingdom,Respiratory Diseases,1,1,314.0
121.0,NCT04420468,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,HEART-COVID,Completed,COVID-19,,,,,,,,Assistance Publique - Hôpitaux de Paris,All,up to 17 Years   (Child),20.0,Other,Observational,2020-10-06,30/06/20,2020-06-30,09/06/20,26/03/21,"Hôpital Bicêtre, Le Kremlin-Bicêtre, France|Hôpital Armand Trousseau, Paris, France|Hôpital Necker-Enfants Malades, Paris, France|Hôpital Robert Debré, Paris",France,Respiratory Diseases,1,1,-98.0
122.0,NCT03305341,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,COV19-APTP-B,"Active, not recruiting",COVID-19,,,,,,,Biological: COVID-19 Therapeutic Biologics - Spike-GM-CSF Protein Lactated Ringer's Injection,"Han Xu, M.D., Ph.D., Sponsor-Investigator, IRB Chair|PPD|Medicine Invention Design, Inc",All,"22 Years to 72 Years   (Adult, Older Adult)",20.0,Industry,Interventional,2020-07-18,28/06/21,2021-06-28,09/10/17,24/02/21,"Medicine Invention Design Incorporation (MIDI) - IORG0007849, North Bethesda, Maryland",United States,Respiratory Diseases,1,1,345.0
123.0,NCT04441502,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,COVID_OMICS,Recruiting,COVID-19,Interstitial Pneumonia,,,,,,,IRCCS Policlinico S. Donato,All,"18 Years and older   (Adult, Older Adult)",240.0,Other,Observational,2020-03-30,30/09/21,2021-12-31,22/06/20,03/02/21,"IRCCS Policlinico San Donato, San Donato Milanese, MI",Italy,Respiratory Diseases,1,2,641.0
124.0,NCT04822012,Anti COVID-19 Antibodies in Follicular Fluid and Spermatic Fluid,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Anti COVID19 IgG Antibodies,Meir Medical Center,All,18 Years to 45 Years   (Adult),50.0,Other,Observational,2021-01-03,30/04/21,2021-01-06,30/03/21,30/03/21,"Meir Medical Center, Kfar Saba",Israel,Respiratory Diseases,1,1,3.0
125.0,NCT04364828,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,COVID-19 NGS,Recruiting,COVID-19,,,,,,,Genetic: Whole Genome Analysis|Genetic: T-cell receptor (TCR) repertoire|Genetic: SARS-CoV-2 viral composition,University Hospital Tuebingen,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2020-10-21,01/04/22,2022-01-08,28/04/20,17/02/21,"University Hospital Tübingen, Tübingen",Germany,Respiratory Diseases,1,1,444.0
126.0,NCT04410549,Pulmonary Optical Coherence Tomography in COVID-19 Patients,,Recruiting,COVID-19,Pulmonary Embolism,,,,,,Diagnostic Test: Optical Coherence Tomography (OCT),IRCCS San Raffaele,All,"18 Years and older   (Adult, Older Adult)",10.0,Other,Interventional,2020-01-06,31/12/21,2021-12-31,01/06/20,25/02/21,"Incor - Heart Institute - University of Sao Paulo, São Paulo, Brazil|IRCCS San Raffaele, Milano",Italy,Respiratory Diseases,1,2,725.0
127.0,NCT04303299,Fight COVID-19 Trial,FIGHT-COVID-19,Recruiting,SARS-COV-2 Infections,COVID-19,,,,,,Drug: Oral,Rajavithi Hospital,All,"16 Years to 100 Years   (Child, Adult, Older Adult)",320.0,Other,Interventional,2020-08-19,31/12/21,2021-12-31,11/03/20,10/03/21,"Assistant Professor Subsai Kongsaengdao, Bangkok",Thailand,Respiratory Diseases,1,2,499.0
128.0,NCT04337996,Dynamic Evaluation of COVID-19 Diagnostic Tests,TRODVID-19,Completed,COVID-19,,,,,,,Diagnostic Test: COVID-19 diagnostic test,Tourcoing Hospital,All,"18 Years and older   (Adult, Older Adult)",8.0,Other,Interventional,2020-07-13,13/01/21,2021-01-13,08/04/20,26/01/21,"CH Tourcoing, Tourcoing",France,Respiratory Diseases,1,1,184.0
129.0,NCT04716543,Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals,LACOVISS,Not yet recruiting,Influenza -Like Illness,COVID-19,,,,,,Diagnostic Test: ILI and COVID-19 detection,"ANRS, Emerging Infectious Diseases|Institut de Recherche pour le Developpement|Centre d'Infectiologie Charles Mérieux|University Hospital, Caen|Department of livestock and fisheries National animal health laboratory, Vientiane, Laos",All,"6 Months and older   (Child, Adult, Older Adult)",5400.0,Other,Observational,2021-01-03,01/03/22,2022-01-03,20/01/21,22/01/21,,,"Infectious Diseases, Respiratory Diseases",1,2,365.0
130.0,NCT04463472,Study of COVID-19 DNA Vaccine (AG0301-COVID19),,"Active, not recruiting",COVID-19,,,,,,,Biological: AG0301-COVID19,"AnGes, Inc.|Japan Agency for Medical Research and Development",All,"20 Years to 65 Years   (Adult, Older Adult)",30.0,Industry|Other,Interventional,2020-06-29,28/09/20,2021-07-31,09/07/20,16/11/20,"Osaka City University Hospital, Osaka",Japan,Respiratory Diseases,1,1,397.0
131.0,NCT04794361,Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner,COVID-19 ULD,Completed,COVID-19,,,,,,,,Centre Hospitalier Universitaire de Nīmes,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2020-05-03,05/05/20,2020-05-05,12/03/21,12/03/21,"Julien FRANDON, Nîmes",France,Respiratory Diseases,1,1,2.0
132.0,NCT04542421,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: Lung ultrasound use in patients hospitalized with COVID,"University of Colorado, Denver",All,"18 Years to 100 Years   (Adult, Older Adult)",90.0,Other,Interventional,2020-01-07,01/07/21,2021-01-12,09/09/20,28/09/20,"University of Colorado, Denver, Colorado",United States,Respiratory Diseases,1,1,371.0
133.0,NCT04771559,Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer Patients,,Not yet recruiting,COVID-19,Cancer,,,,,,Other: COVID-19 antibody test,Bezmialem Vakif University,All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Interventional,2021-01-03,01/06/21,2021-01-07,25/02/21,04/03/21,"Bezmialem University, Istanbul, Fatih, Turkey|Okmeydani Research Hospital, Istanbul, Fatih, Turkey|Acibadem University, Istanbul, Turkey|Medeniyet University, Istanbul, Turkey|Medipol University, Istanbul",Turkey,"Respiratory Diseases, Cancers",1,2,4.0
134.0,NCT04695756,Liver Transplantation and Coronavirus Disease 2019 (COVID-19),,Recruiting,COVID-19,Liver Transplant,,,,,,Other: COVID-19 pandemic,"Hospital Italiano de Buenos Aires|National Agency for Scientific and Technological Promotion, Argentina",All,"18 Years and older   (Adult, Older Adult)",1000.0,Other,Observational,2020-12-15,15/06/21,2021-07-15,05/01/21,12/01/21,"Hospital Italiano de Buenos Aires, Buenos Aires",Argentina,Respiratory Diseases,1,2,212.0
135.0,NCT04473248,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,,Completed,COVID-19,,,,,,,Device: Spartan COVID-19 System,Spartan Bioscience Inc.|Humber River Hospital|The Ottawa Hospital,All,"18 Years and older   (Adult, Older Adult)",27.0,Industry|Other,Interventional,2020-06-28,30/08/20,2020-08-30,16/07/20,13/11/20,"Humber River Hospital, North York, Ontario, Canada|The Univeristy of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,63.0
136.0,NCT04431310,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,,Recruiting,COVID-19,Health Personnel,"Personnel, Hospital",,,,,Other: Serial seroconversion measurements in hospital employees during the COVID-19 pandemic,Nordsjaellands Hospital|University of Oxford|Nykøbing Falster County Hospital,All,"18 Years and older   (Adult, Older Adult)",300.0,Other,Observational,2020-03-27,01/08/25,2025-01-08,16/06/20,16/06/20,"Nordsjællands Hospital, Hillerød, Capital Region, Denmark|Nykøbing Falster County Hospital, Nykøbing Falster, Southern Region",Denmark,Respiratory Diseases,1,3,1748.0
137.0,NCT04334291,"International COVID19 Clinical Evaluation Registry,",HOPE COVID 19,Completed,COVID-19,,,,,,,Combination Product: Observational (registry),"IVAN J NUÑEZ GIL|St Carlos Hospital, Madrid, Spain",All,"Child, Adult, Older Adult",8168.0,Other,Observational,2020-03-23,01/05/20,2020-05-31,06/04/20,23/02/21,"Hospital Lclinico San Carlos, Madrid",Spain,Respiratory Diseases,1,1,69.0
138.0,NCT04413045,"Novel COVID-19, A National Analysis",,Completed,COVID-19,,,,,,,Other: Prevalence of COVID-19,Assiut University,All,"Child, Adult, Older Adult",61.0,Other,Observational,2020-05-20,28/07/20,2020-07-28,02/06/20,04/08/20,"Assiut University Hospitals, Assiut",Egypt,Respiratory Diseases,1,1,69.0
139.0,NCT04817319,Risk of Contamination by COVID-19 During Oral Care With Aerosolization,Bu-Covid,Not yet recruiting,COVID-19,,,,,,,Procedure: Oral care with/without aerosolization,"Assistance Publique - Hôpitaux de Paris|Institut National de la Santé Et de la Recherche Médicale, France",All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Interventional,2021-03-30,30/03/21,2022-03-30,26/03/21,26/03/21,,,Respiratory Diseases,1,1,365.0
140.0,NCT04333862,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Covid-19,Recruiting,COVID-19,,,,,,,,"University Hospital Inselspital, Berne",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-19,31/01/22,2022-01-31,03/04/20,30/09/20,"Guido Beldi, Bern",Switzerland,Respiratory Diseases,1,1,683.0
141.0,NCT04521036,Convalescent Plasma for COVID-19 Patients (CPCP),CPCP,Not yet recruiting,COVID-19,,,,,,,Biological: Convalescent Plasma as Therapy for Covid-19 patients,"Vinmec Research Institute of Stem Cell and Gene Technology|National Institute of Hygiene and Epidemiology, Vietnam|National Hospital for Tropical Diseases, Hanoi, Vietnam|National Institute of Hematology and Blood Transfusion, Vietnam",All,"18 Years to 75 Years   (Adult, Older Adult)",44.0,Other,Interventional,2020-01-12,30/06/21,2021-10-30,20/08/20,01/09/20,"Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi",Vietnam,Respiratory Diseases,1,1,657.0
142.0,NCT04343781,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,COVID19PUGG2,Completed,COVID-19,COVID-19,,,,,,Other: observation,"University Hospital, Angers",All,70 Years and older   (Older Adult),353.0,Other,Observational,2020-03-22,05/04/20,2020-05-04,13/04/20,16/06/20,"Angers University Hospital, Angers",France,Respiratory Diseases,1,2,43.0
143.0,NCT04720235,A Follow On Community Testing Study To Evaluate The Performance of the Lucira COVID-19 All-In-One Test Kit,,Completed,COVID-19,Corona Virus Infection,,,,,,Device: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,All,"14 Years to 75 Years   (Child, Adult, Older Adult)",304.0,Industry,Interventional,2020-09-12,09/03/21,2021-03-30,22/01/21,12/04/21,"Neeraj Kochhar Family Medicine, Los Gatos, California",United States,Respiratory Diseases,1,2,199.0
144.0,NCT04460690,"Rapid, Onsite COVID-19 Detection",,Enrolling by invitation,COVID-19,Sars-CoV2,,,,,,Device: Rapid Onsite COVID-19 Detection,"University of Wisconsin, Madison|National Institutes of Health (NIH)|AIDS Vaccine Research Lab",All,"5 Years and older   (Child, Adult, Older Adult)",10000.0,Other|NIH,Interventional,2020-07-13,01/07/21,2021-01-07,07/07/20,28/09/20,"University of Wisconsin, Madison, Wisconsin",United States,Respiratory Diseases,1,2,178.0
145.0,NCT04424849,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,,Recruiting,COVID-19,,,,,,,Diagnostic Test: CT-Scan,Tepecik Training and Research Hospital,All,"18 Years and older   (Adult, Older Adult)",40.0,Other,Observational,2020-03-15,15/06/20,2020-07-15,11/06/20,11/06/20,"Tepecik Training and Research Hospital, Izmir, Izmir, Konak",Turkey,Respiratory Diseases,1,1,122.0
146.0,NCT04578158,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,,Recruiting,COVID-19,,,,,,,Drug: Standard COVID-19 care|Dietary Supplement: Quercetin Phytosome,Liaquat University of Medical & Health Sciences,All,"18 Years and older   (Adult, Older Adult)",200.0,Other,Interventional,2020-09-29,28/04/21,2021-06-28,08/10/20,14/04/21,"Liaquat University Hospital, Jāmshoro, Sindh",Pakistan,Respiratory Diseases,1,1,272.0
147.0,NCT04344912,Impact of COVID19 Outbreak in Cardiac Acute Care,CCU-COVID19,Recruiting,Acute Coronary Syndrome,Heart Failure,COVID-19,,,,,Other: Data collection,"Assistance Publique - Hôpitaux de Paris|Action, France",All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-03-20,01/06/20,2020-01-08,14/04/20,28/04/20,"Unité de Soins Intensifs de Cardiologie, Pitié Salpêtrière Hospital, AP-HP, Paris",France,Respiratory Diseases,1,3,-72.0
148.0,NCT04707833,Evaluation of Serological Techniques for Screening for COVID-19 Infection at the University Hospital of Rouen,SeroCOV,Recruiting,Corona Virus Infection,,,,,,,Diagnostic Test: Serological testing for COVID-19 infection,"University Hospital, Rouen",All,"18 Years to 80 Years   (Adult, Older Adult)",385.0,Other,Interventional,2020-11-26,01/12/23,2023-01-12,13/01/21,13/01/21,"Rouen University Hospital, Rouen",France,Respiratory Diseases,1,1,777.0
149.0,NCT04768244,Impact of Maternal COVID-19 Disease on Breast Milk and Infant Health,MilkCorona,Recruiting,COVID-19,,,,,,,Other: maternal SARS-CoV-2 infection,"Institute of Agrochemistry and Food Technology, National Research Council|Hospital Universitario La Fe|INCLIVA|Hospital Clínico Universitario de Valencia|Hospital Universitario Doctor Peset|Universidad de Granada|Universitat Jaume I|Hospital Sant Joan de Deu|Fetal Medicine Research Center, Spain|Instituto de Investigación Sanitaria Aragón",Female,18 Years to 45 Years   (Adult),100.0,Other|Industry,Observational,2020-01-04,01/12/21,2021-01-12,24/02/21,25/02/21,"Fundacion Investigacion Sanitaria INCLIVA, Valencia, Spain|Hospital Universitario y Politecnico la Fe, Valencia",Spain,Respiratory Diseases,1,1,374.0
150.0,NCT04347278,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,RegCOVID19,Recruiting,COVID-19,,,,,,,Drug: Patients with the treatment agains COVID19,Instituto de Investigación Marqués de Valdecilla|Hospital Universitario Marqués de Valdecilla|Hospital Universitario de Canarias|Hospital San Pedro de Alcántara,All,"1 Year to 100 Years   (Child, Adult, Older Adult)",1000.0,Other,Observational,2020-04-22,15/10/20,2021-01-01,15/04/20,02/06/20,"Hospital Universitario Marqués de Valdecilla, Santander, Cantabria",Spain,Respiratory Diseases,1,1,254.0
151.0,NCT04391738,Association Between BMI and COVID-19,BMI-SARS-CoV-2,Completed,SARS-CoV 2,,,,,,,Other: Patients admitted to Intensive Care Unit with SARS-CoV2,"University Hospital, Lille",All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-01-02,15/05/20,2020-01-09,18/05/20,26/03/21,"Centre Hospitalier Régional & Universitaire de Lille (CHRU), Lille",France,Respiratory Diseases,1,1,7.0
152.0,NCT04331834,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,PrEP_COVID,Completed,COVID-19,,,,,,,Drug: Hydroxychloroquine|Drug: Placebos,Barcelona Institute for Global Health|Hospital Clinic of Barcelona|Laboratorios Rubió|Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Hospital Plató|Hospital de Granollers,All,"18 Years and older   (Adult, Older Adult)",275.0,Other,Interventional,2020-03-04,25/06/20,2020-12-31,02/04/20,16/02/21,"ISGlobal, Barcelona",Spain,Respiratory Diseases,1,1,302.0
153.0,NCT04333732,CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,CROWN CORONA,Recruiting,COVID-19,,,,,,,Drug: MR or M-M-R II ® vaccine|Drug: Placebo,Washington University School of Medicine|COVID -19 Therapeutics Accelerator,All,"18 Years and older   (Adult, Older Adult)",30000.0,Other,Interventional,2020-04-09,01/08/21,2021-01-08,03/04/20,14/04/21,"Washington University School of Medicine, Saint Louis, Missouri, United States|University of Ghana Medical Centre, Accra, Greater Accra Region, Ghana|Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray, Cape Town, South Africa|Masiphumelele, Desmond Tutu Health Foundation, Sunnydale, Cape Town, South Africa|JOSHA Research, Bloemfontein, Free State, South Africa|Wits RHI, University of the Witwatersrand, Hillbrow, Johannesburg,Gauteng, South Africa|Clinical HIV Research Unit (CHRU), Auckland Park, Johannesburg, South Africa|Perinatal HIV Research Unit (PHRU), Diepkloof, Johannesburg, South Africa|Setshaba Research Centre, Soshanguve, Tshwane, South Africa|Groote Schuur Hospital, Cape Town, Western Cape, South Africa|FAMCRU (Family Clinical Research with Ubuntu), Cape Town, South Africa|Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth, South Africa|Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa|Aurum Institute Tembisa, Tembisa, South Africa|University College London, London, United Kingdom|Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia|Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka",Zambia,Respiratory Diseases,1,1,274.0
154.0,NCT04416256,COVID-19 Pandemic and Worldwide Organ Procurement,COVID,Recruiting,COVID-19,,,,,,,,"Paris Translational Research Center for Organ Transplantation|Agence de La Biomédecine|Eurotransplant|United Network for Organ Sharing|Deutsche Stiftung Organtransplantation|Centro Nazionale Trapianti|Brazilian Organ Transplant Association|The Canadian Association of Transplantation|Scandiatransplant|Nederlandse Transplantatie Vereniging|Austrotransplant|Centro Nacional de Trasplantes|Instituto Nacional de Donación y Trasplante de Células, Tejidos y Órganos|Donor Network of Croatia|Instituto Nacional Central Único Coordinador de Ablación e Implante|Corporación Nacional de Trasplantes de Chile|Australian Organ and Tissue Donation and Transplantation Authority|Organización Nacional de Trasplantes|Autoridade Para Services de Sangue e Transplantacáo",All,"Child, Adult, Older Adult",230000.0,Other,Observational,2020-01-02,01/02/22,2022-01-02,04/06/20,04/06/20,"Paris Transplant Group, Paris",France,Respiratory Diseases,1,1,731.0
155.0,NCT04767958,The RAPID COVID Study - Application of Point-of-Care COVID-19 Testing,RAPID COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: Spartan COVID-19 Platform,Ottawa Heart Institute Research Corporation,All,"18 Years and older   (Adult, Older Adult)",2500.0,Other,Interventional,2021-03-19,28/02/22,2022-07-31,23/02/21,25/03/21,"University of Ottawa Heart Institute, Ottawa, Ontario",Canada,Respiratory Diseases,1,1,499.0
156.0,NCT04424992,The Natural History of Hospitalized COVID-19 Patients,STORM,Recruiting,Sars-CoV2,,,,,,,Other: Observational cohort study on the natural history of hospitalized SARS-COV-2 patients.,University of Milano Bicocca,All,"18 Years and older   (Adult, Older Adult)",1433.0,Other,Observational,2020-02-28,01/12/21,2021-01-12,11/06/20,22/01/21,"ASST Monza-Ospedale San Gerardo, Monza",Italy,Respiratory Diseases,1,1,319.0
157.0,NCT04452682,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,,Completed,COVID-19,Critical Limb Ischemia,,,,,,Other: COVID 19 impact,Mansoura University,,"Child, Adult, Older Adult",998.0,Other,Observational,2020-05-25,21/06/20,2020-06-21,30/06/20,30/06/20,"Mansoura university, Mansoura",Egypt,Respiratory Diseases,1,2,27.0
158.0,NCT04808986,Seroprevalence of IgG Antibodies to SARS-CoV-2 (COVID-19) in Primary Health Care Workers and Their Household Contacts,COVID-SeroPRIM,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: Serological test for the detection of IgG anti-SARS-CoV-2,"Institut National de la Santé Et de la Recherche Médicale, France",All,"Child, Adult, Older Adult",2000.0,Other,Interventional,2021-02-04,31/08/21,2021-11-15,22/03/21,22/03/21,,,Respiratory Diseases,1,1,284.0
159.0,NCT04756869,Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology,,"Active, not recruiting",COVID-19,,,,,,,Other: COVID-19 Monitoring Using Wearable Sensors and Smartphone Technology,University of Michigan,All,"18 Years and older   (Adult, Older Adult)",226.0,Other,Observational,2020-04-28,16/01/21,2023-01-01,16/02/21,16/02/21,"Michigan Medicine, Ann Arbor, Michigan",United States,Respiratory Diseases,1,1,978.0
160.0,NCT04614883,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,VOC-COVID-Diag,Recruiting,COVID-19,,,,,,,Device: Volatile Organic Compounds analysis|Other: Canine odor detection of Volatile Organic Compounds,Hopital Foch,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-10-21,01/10/21,2021-01-10,04/11/20,04/11/20,"Foch hospital, Suresnes",France,Respiratory Diseases,1,1,81.0
161.0,NCT04378452,Assessment of the Psycho-social Impact of COVID-19 Outbreak,COM-COVID,Completed,SARS-CoV 2,COVID-19,Quality of Life,Mental Health Wellness 1,Social Distance,SARS (Disease),Psychological,Behavioral: COM-COVID anonimous survey,"Fundació Institut Germans Trias i Pujol|Anaxomics SL|Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia|Fundació Sant Joan de Déu",All,"16 Years and older   (Child, Adult, Older Adult)",56656.0,Other,Observational,2020-03-31,22/03/21,2021-07-04,07/05/20,08/04/21,"Fundació Institut Germans Trias i Pujol, Badalona, Catalonia, Spain|Fundació Lluita contra la Sida (FLS, Fight AIDS Foundation), Badalona, Catalonia, Spain|Anaxomics biotech, Barcelona, Spain|Fundació Privada per a la Recerca i la Docència Sant Joan de Déu, Esplugues De Llobregat",Spain,Respiratory Diseases,1,7,460.0
162.0,NCT04413864,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,DEXDO-COVID,Recruiting,SARS-CoV 2,,,,,,,Other: Inflammatory cytokines and chemokines profiles of patients with dexmedetomidine administration,Assistance Publique - Hôpitaux de Paris,All,"18 Years and older   (Adult, Older Adult)",50.0,Other,Interventional,2020-04-24,28/02/21,2021-02-28,04/06/20,04/06/20,"Intensive Care Unit and Respiratory division ; Groupe hospitalier Pitie-Salpetriere and Universite Pierre et Marie Curie Paris 6, Paris",France,Respiratory Diseases,1,1,310.0
163.0,NCT04649879,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,,Not yet recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 convalescent plasma|Other: Standard of care,Joakim Dillner|Karolinska Institutet|Danderyd Hospital|Falu Hospital|Karolinska University Hospital,All,"18 Years and older   (Adult, Older Adult)",920.0,Other,Interventional,2020-03-12,01/02/22,2022-01-02,02/12/20,02/12/20,"Department of Infectious Disease, Falu Hospital, Falun, Dalarn, Sweden|Department of Geriatrics, Karolinska University Hospital, Stockholm, Sweden|Danderyd Hospital, Stockholm",Sweden,Respiratory Diseases,1,1,661.0
164.0,NCT04583982,ImmuneSense™ COVID-19 Study,,Completed,COVID-19,COVID-19,,,,,,Other: T-Detect™ SARS-CoV-2 Assay,Adaptive Biotechnologies|Covance,All,"18 Years to 89 Years   (Adult, Older Adult)",180.0,Industry,Observational,2020-09-10,04/12/20,2020-04-12,12/10/20,29/12/20,"Adaptive Biotechnologies Clinical Investigational Site, Secaucus, New Jersey",United States,Respiratory Diseases,1,2,-151.0
165.0,NCT04496141,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,,"Active, not recruiting",COVID-19,,,,,,,Diagnostic Test: SARS-CoV-2 antibody immunoassays,Hong Kong Sanatorium & Hospital,All,"Child, Adult, Older Adult",70.0,Industry,Observational,2020-07-27,30/11/20,2020-11-30,03/08/20,03/08/20,"Hong Kong Sanatorium & Hospital, Hong Kong",Hong Kong,Respiratory Diseases,1,1,126.0
166.0,NCT04375098,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,,Completed,Severe Acute Respiratory Syndrome Coronavirus 2,,,,,,,Biological: COVID-19 convalescent plasma,Pontificia Universidad Catolica de Chile|Fundacion Arturo Lopez Perez,All,"18 Years and older   (Adult, Older Adult)",58.0,Other,Interventional,2020-04-05,17/08/20,2020-08-17,05/05/20,16/09/20,"Hospital Clínico Universidad Católica, Santiago",Chile,Respiratory Diseases,1,1,134.0
167.0,NCT04805892,"Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care",,Recruiting,COVID-19,,,,,,,Diagnostic Test: BIOZEK COVID-19 Antigen Rapid Test,Mach-E B.V.,All,"18 Years and older   (Adult, Older Adult)",250.0,Industry,Interventional,2021-03-17,27/04/21,2021-05-17,18/03/21,18/03/21,"Mobile Covid Services LLC, Flushing, New York",United States,Respiratory Diseases,1,1,61.0
168.0,NCT04534595,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,SBHC,Recruiting,COVID-19,,,,,,,Other: COVID-19,Unity Health Toronto,All,4 Years to 13 Years   (Child),1500.0,Other,Observational,2019-04-30,01/03/21,2021-01-03,01/09/20,01/09/20,"Unity Health Toronto, Toronto, Ontario",Canada,Respiratory Diseases,1,1,614.0
169.0,NCT04615208,Screening for COVID-19,,Recruiting,COVID-19,,,,,,,Diagnostic Test: suspected of COVID-19 infection,"University of Manitoba|Natural Sciences and Engineering Research Council, Canada|ID Fusion Software, Inc.|Function Four Ltd.",All,"18 Years to 80 Years   (Adult, Older Adult)",200.0,Other,Observational,2020-12-19,30/10/21,2021-12-30,04/11/20,01/03/21,"University of Manitoba, Winnipeg, Manitoba",Canada,Respiratory Diseases,1,1,376.0
170.0,NCT04728828,COVADIAL - Immunogenicity of COVID-19 Vaccine in Hemodialysis Patients,COVADIAL,Recruiting,COVID-19,,,,,,,Biological: Serological COVID-19 vaccine immunogenicity,Centre Hospitalier de Cornouaille|Centre Hospitalier Régional et Universitaire de Brest,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2021-01-25,15/02/23,2023-08-15,28/01/21,26/02/21,"Centre Hospitalier de Quimper, Quimper",France,Respiratory Diseases,1,1,932.0
171.0,NCT04497272,Assesment of the Metabolomic Signature in COVID-19 Patients,SignCov,Recruiting,COVID-19,,,,,,,Other: COVID-19 patients,Centre Hospitalier Universitaire de Nice,All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Interventional,2020-07-08,07/08/21,2021-07-10,04/08/20,10/11/20,"CHU de nice, Nice, Alpes-Maritimes",France,Respiratory Diseases,1,1,367.0
172.0,NCT04404179,Setting up a COVID-19 Care Facility at a Prison in Pakistan,,Completed,COVID-19,,,,,,,Other: COVID-19 FACILITY,"Services Institute of Medical Sciences, Pakistan",All,"Child, Adult, Older Adult",69.0,Other,Observational,2020-03-27,02/05/20,2020-02-05,27/05/20,29/05/20,"Camp Jail / COVID-19 CARE FACILITY/ SIMS, Lahore",Pakistan,Respiratory Diseases,1,1,-51.0
173.0,NCT04374838,Effect of COVID-19 Pandemic on Pediatric Cancer Care,,Recruiting,COVID-19,,,,,,,,South Egypt Cancer Institute,All,"Child, Adult, Older Adult",20.0,Other,Observational,2020-05-15,01/08/20,2021-01-09,05/05/20,12/08/20,"South Egypt Cancer Institute, Assiut University, Assiut",Egypt,Respiratory Diseases,1,1,239.0
174.0,NCT04367402,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",COST ACTION,Recruiting,COVID-19,,,,,,,Other: BioMedomics COVID-19 IgM-IgG Rapid Test,Azienda Ospedaliera San Paolo,All,"18 Years and older   (Adult, Older Adult)",600.0,Other,Observational,2020-03-30,24/04/20,2020-01-09,29/04/20,30/04/20,"AO San Paolo, Milan, IT",Italy,Respiratory Diseases,1,1,-81.0
175.0,NCT04347174,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,,Completed,COVID-19,,,,,,,Drug: Suspension of heat killed (autoclaved) Mycobacterium w|Drug: Placebo,"Cadila Pharnmaceuticals|Council of Scientific and Industrial Research, India",All,"18 Years and older   (Adult, Older Adult)",40.0,Industry|Other,Interventional,2020-04-30,10/08/20,2020-08-21,15/04/20,27/01/21,"All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India|All India Institute of Medical Sciences, Bhopal, Bhopal, Madhya Pradesh, India|Postgraduate Institute of Medical Education and Research, Chandigarh, India|All lndia Institute of Medical Science, Delhi, Delhi",India,Respiratory Diseases,1,1,113.0
176.0,NCT04408001,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,IMMUNO-COVID,"Active, not recruiting",Sars-CoV2,,,,,,,Other: Clinical interview|Biological: Blood collection|Biological: Saliva collection,Direction Centrale du Service de Santé des Armées,All,"18 Years and older   (Adult, Older Adult)",499.0,Other,Observational,2020-04-06,04/06/21,2021-04-06,29/05/20,09/03/21,"Hôpital d'Instuction des Armées Percy, Clamart",France,Respiratory Diseases,1,1,365.0
177.0,NCT04839068,the Impact of Covid-19 Pandemic Stress on Pregnancy Outcomes,,Not yet recruiting,COVID-19,,,,,,,Device: covid 19 on pregnancy outcomes,Assiut University,Female,"Child, Adult, Older Adult",7000.0,Other,Observational,2021-01-05,01/05/22,2022-01-06,09/04/21,09/04/21,"The Clinical Obstetrics and Gynaecology department, Assuit University Hospital, Egypt, Assiut",Egypt,Respiratory Diseases,1,1,366.0
178.0,NCT04477889,Methodist Health System COVID-19 Patient Registry,,Recruiting,COVID-19,,,,,,,Other: Treatment for COVID-19,Methodist Health System,All,"18 Years and older   (Adult, Older Adult)",500.0,Other,Observational,2020-06-20,01/12/25,2026-01-12,20/07/20,24/09/20,"Clinical Research Institute Methodist Health System, Dallas, Texas",United States,Respiratory Diseases,1,1,2032.0
179.0,NCT04470557,Relation Between Lab Finding and COVID-19 Severity,,Not yet recruiting,COVID-19,,,,,,,"Diagnostic Test: D-dimer,CBC.ESR,CRP,|Diagnostic Test: Liver function tests ,serum ferritin and PCR for COVID-19 .",Assiut University,All,"Child, Adult, Older Adult",100.0,Other,Observational,2020-07-15,01/10/20,2020-01-12,14/07/20,14/07/20,,,Respiratory Diseases,1,1,-185.0
180.0,NCT04445415,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,,Not yet recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 antibodies testing,Assiut University,All,"Child, Adult, Older Adult",250.0,Other,Observational,2020-01-07,01/06/21,2021-01-09,24/06/20,24/06/20,,,Respiratory Diseases,1,1,368.0
181.0,NCT04581148,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),SARS-CoV2_KIDS,Not yet recruiting,SARS-Cov2,,,,,,,Diagnostic Test: Blood test for IgG antibodies against SARS-CoV-2,University of Erlangen-Nürnberg Medical School,All,"up to 18 Years   (Child, Adult)",2000.0,Other,Observational,2020-05-10,01/05/22,2022-01-05,09/10/20,09/10/20,,,Respiratory Diseases,1,1,605.0
182.0,NCT04803370,Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma,,Recruiting,COVID-19,,,,,,,Other: Convalescent Plasma with antibody against SARS-CoV-2.|Other: Standard treatment for COVID-19,Hospital Son Llatzer|Fundació d'investigació Sanitària de les Illes Balears,All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Interventional,2020-08-07,01/09/21,2021-01-09,17/03/21,17/03/21,"University Hospital Son Llatzer, Palma De Mallorca, Islas De Balears",Spain,Respiratory Diseases,1,1,155.0
183.0,NCT04336956,Covid-19 Pediatric Observatory,PANDOR,Recruiting,COVID-19,,,,,,,Other: hospitalized children with Covid19,Centre Hospitalier Intercommunal Creteil|Association Clinique Thérapeutique Infantile du val de Marne|GPIP|Société Française de Pédiatrie|GFRUP,All,"up to 18 Years   (Child, Adult)",250.0,Other,Observational,2020-07-04,30/06/21,2021-06-30,07/04/20,17/07/20,"Chu Felix Guyon, Saint Denis, La Réunion, France|Ch St Esprit, Agen, France|Ch General Aix En Provence -, Aix-en-Provence, France|CHU Angers, Angers, France|CH d'ANGOULEME, Angoulème, France|Pringy - Ch D'Annecy, Annecy, France|CH Argenteuil, Argenteuil, France|Ch Armentieres, Armentières, France|CH Arpajon, Arpajon, France|Ch Auxerre, Auxerre, France|CH GENERAL Henri Duffaut, Avignon, France|CHU de BESANCON, Besançon, France|Hopital Femme Enfant, Caen, France|Ch de Pontoise, Cergy-Pontoise, France|Ch W. Morey, Chalon-sur-Saône, France|CH de CHAMBERY, Chambéry, France|Ch Hotel Dieu, Chartres, France|CHU Estaing, Clermont-Ferrand, France|Hopital Louis Pasteur, Colmar, France|Hopital Louis Mourrier, Colombes, France|CH Sud Francilien, Corbeil-Essonnes, France|Centre Hospitalier intercommunal de Creteil, Creteil, France|Ch de Dax, Dax, France|Hopital D'Enfants Chu Dijon, Dijon, France|CH Louviers Val de Reuil, Elbeuf, France|CH Gonesse, Gonesse, France|CH d'HYERES, Hyères, France|Ch de Marne La Vallee, Jossigny, France|Chru de Grenoble, La Tronche, France|CHGénéral du HAVRE, Le Havre, France|Hopital Jeanne de Flandre, Lille, France|Hopital Roger Salengro - Lille, Lille, France|Hopital Saint Vincent de Paul, Lille, France|Ch de Longjumeau, Longjumeau, France|Lorient - Ch de Bretagne Sud, Lorient, France|Hopital Femme Mere Enfant-Bron, Lyon, France|Hopital de Mantes, Mantes-la-Jolie, France|Hopital Nord Enfants, Marseille, France|Hopital de Meaux, Meaux, France|Ch de Melun, Meulin, France|CH de Montargis, Montargis, France|CH de MONTBRISON, Montbrison, France|Hopital Arnaud de Villeneuve, Montpellier, France|CHRU de Nancy, Nancy, France|Nantes - Hopital Mere Enfant, Nantes, France|Ch de Neuilly Sur Seine, Neuilly-sur-Seine, France|Hopital Lenval, Nice, France|CHU Nimes Caremeau, Nîmes, France|Chr Orleans, Orléans, France|Assistance Publique Hôpitaux de Paris, Paris, France|Hopital St Jean Roussillon, Perpignan, France|POISSY - CH de POISSY, Poissy, France|QUIMPER - CH de Cornouaille, Quimper, France|RANG du FLIERS - C.H.A.M., RANG du FLIERS, France|Hopital Américain CHU REIMS, Reims, France|CH RODEZ, Rodez, France|CH de ROMANS, Romans-sur-Isère, France|Chu Rouen, Rouen, France|Hopital Charles-Nicolle, Rouen, France|Chu St Etienne, Saint Etienne, France|Ch de Saint Denis, Saint-Denis, France|Ch de Saint Malo, Saint-Malo, France|Ch Du Pays Du Mont Blanc, Sallanches, France|Chg Salon de Provence, Salon de Provence, France|CH Hautepierre, Strasbourg, France|CH Tarbes, Tarbes, France|CH Bel Air, Thionville, France|Hopital Sainte Musse, Toulon, France|CHU Toulouse-hôpital des Enfants, Toulouse, France|Hôpital Gatien De Clocheville, Tours, France|CH de TROYES, Troyes, France|Hôpital Nord Franche-Comté, Trévenans, France|Ch Bretagne Atlantique, Vannes, France|Ch Le Chesnay, Versailles, France|Hopital de Villeneuve Saint Georges, Villeneuve-Saint-Georges, France|CH Jean Monnet, Épinal",France,Respiratory Diseases,1,1,361.0
184.0,NCT04629001,Effect of Covid-19 on Outcomes of Pregnancy,,"Active, not recruiting",COVID-19,,,,,,,"Diagnostic Test: Covid-19 PCR , IGM",Assiut University,Female,18 Years to 40 Years   (Adult),1000.0,Other,Observational,2020-01-09,01/09/21,2021-01-12,16/11/20,16/11/20,"Medicine, Assiut",Egypt,Respiratory Diseases,1,1,369.0
185.0,NCT04483622,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,COVID-19,Recruiting,COVID-19,,,,,,,,Sohag University,All,"16 Years to 90 Years   (Child, Adult, Older Adult)",30.0,Other,Observational,2020-12-06,13/01/21,2021-02-15,23/07/20,23/07/20,"Sohag University Hospital, Sohag",Egypt,Respiratory Diseases,1,1,71.0
186.0,NCT04632732,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,APEL-COVID,Recruiting,COVID-19,,,,,,,Diagnostic Test: COVID-19 test|Diagnostic Test: Blood sampling,"Centre de recherche du Centre hospitalier universitaire de Sherbrooke|University Hospital, Angers",All,"18 Years and older   (Adult, Older Adult)",140.0,Other,Observational,2020-10-26,07/10/21,2021-01-12,17/11/20,22/01/21,"Sherbrooke University, Sherbrooke, Quebec",Canada,Respiratory Diseases,1,1,78.0
187.0,NCT04420260,Primary Prevention of Infection by COVID-19 in Health Providers,PI-Covid-19,Not yet recruiting,COVID-19,,,,,,,Dietary Supplement: Group A: oropharygeal spray and immunostimulant|Dietary Supplement: Group B: Placebo oropharyngeal spray + Active principle immunostimulant|Dietary Supplement: Group C:Active principle oropharyngeal spray + Placebo taken PO|Dietary Supplement: Group D:Placebo oropharyngeal spray + Placebo taken PO,Unidad de Investigación Genética Molecular|Universidad de Antioquia,All,18 Years to 60 Years   (Adult),300.0,Other,Interventional,2020-01-07,01/09/20,2020-01-09,09/06/20,09/06/20,,,Respiratory Diseases,1,1,2.0
188.0,NCT04318301,Hypertension in Patients Hospitalized With COVID-19,HT-COVID19,Completed,COVID-19,Hypertension,,,,,,,Zhenhua Zen|Nanfang Hospital of Southern Medical University,All,"18 Years to 100 Years   (Adult, Older Adult)",275.0,Other,Observational,2020-03-21,28/03/20,2020-03-30,23/03/20,29/04/20,"Hankou Hospital, Hankou, Hubei",China,"Cardiovascular Diseases, Respiratory Diseases",1,2,9.0
189.0,NCT04366882,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,MIA-COVID-19,Recruiting,COVID-19,,,,,,,Procedure: CT-scan with minimal invasive autopsy,"Jessa Hospital|Hasselt University|University Hospital, Antwerp",All,"Child, Adult, Older Adult",45.0,Other,Interventional,2020-04-14,01/12/20,2020-01-12,29/04/20,29/04/20,"Jessa Hospital, Hasselt",Belgium,Respiratory Diseases,1,1,-93.0
190.0,NCT04420312,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,COVID-EP,Completed,Pulmonary Embolism,COVID-19,,,,,,,Groupe Hospitalier Paris Saint Joseph,All,"18 Years and older   (Adult, Older Adult)",1024.0,Other,Observational,2020-01-03,20/04/20,2020-04-20,09/06/20,25/06/20,"Groupe Hospitalier Paris Saint-Joseph, Paris",France,Respiratory Diseases,1,2,108.0
191.0,NCT04437693,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,HCQ-COVID19,Not yet recruiting,COVID-19,,,,,,,Drug: Hydroxychloroquine,Hamad Medical Corporation,All,18 Years to 60 Years   (Adult),500.0,Industry,Interventional,2020-08-31,30/08/21,2021-12-31,18/06/20,11/08/20,,,Respiratory Diseases,1,1,487.0
192.0,NCT04347070,Implementation of Physiotherapy on COVID-19 Patients in ICU,PHYSIO-COVID,"Active, not recruiting",Sars-CoV2,COVID-19,,,,,,Other: Phsyiotherapy,"University Hospital, Montpellier|Société espagnole de pneumologie (SEPAR)|Societe française de kinésithérapie en réanimation (SKR)",All,"18 Years and older   (Adult, Older Adult)",150.0,Other,Observational,2017-01-04,01/09/20,2022-01-12,15/04/20,29/12/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,2,1834.0
193.0,NCT04720794,A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion,,Completed,COVID-19,SARS (Severe Acute Respiratory Syndrome),Corona Virus Infection,,,,,Device: Lucira COVID-19 All-In-One test kit,Lucira Health Inc,All,"18 Years to 75 Years   (Adult, Older Adult)",101.0,Industry,Interventional,2020-09-25,20/10/20,2020-10-20,22/01/21,26/01/21,"Neeraj Kochhar Family Medicine, Los Gatos, California",United States,Respiratory Diseases,1,3,25.0
194.0,NCT04799834,Genotype and Susceptibility to COVID-19,ORIGIN,Recruiting,COVID-19,,,,,,,"Other: Questionnaire administration,blood sampling and genetic analyses.",Mario Negri Institute for Pharmacological Research,All,"18 Years and older   (Adult, Older Adult)",1200.0,Other,Observational,2020-11-30,01/10/21,2021-01-10,16/03/21,16/03/21,"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò, Ranica, BG",Italy,Respiratory Diseases,1,1,41.0
195.0,NCT04795414,Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers,,Recruiting,COVID-19,COVID-19,,,,,,"Biological: SARS-CoV-2 Vaccine(Vero Cell), Inactivated",Ruijin Hospital,All,18 Years to 59 Years   (Adult),1370.0,Other,Observational,2021-01-14,30/04/22,2023-01-31,12/03/21,19/03/21,"Ruijin Hospital affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai",China,Respiratory Diseases,1,2,747.0
196.0,NCT04775563,COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients,,Recruiting,COVID-19,,,,,,,Other: COVID-19 vaccine hesitancy scale in rheumatic diseases|Other: COVID-19 vaccine hesitancy associated factors,"National Institute of Medical Sciences and Nutrition, Salvador Zubiran",All,"18 Years to 99 Years   (Adult, Older Adult)",740.0,Other,Observational,2021-01-02,30/08/21,2021-01-10,01/03/21,01/03/21,"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City",Mexico,Respiratory Diseases,1,1,8.0
197.0,NCT04736732,The IRCM POST-COVID-19 (IPCO) Clinic,IPCO,Recruiting,COVID-19,,,,,,,Other: Medical follow-up,Institut de Recherches Cliniques de Montreal,All,"18 Years and older   (Adult, Older Adult)",570.0,Other,Observational,2021-01-01,01/01/23,2023-12-12,03/02/21,03/02/21,"Montreal Clinical Research Institute, Montréal, Quebec",Canada,Respiratory Diseases,1,1,1075.0
198.0,NCT04784689,Host Immune Response to Novel RNA COVID-19 Vaccination,,Recruiting,COVID-19,Cancer,,,,,,Biological: COVID-19 Vaccine,The University of Texas Health Science Center at San Antonio,All,"18 Years and older   (Adult, Older Adult)",400.0,Other,Observational,2021-02-24,01/02/23,2024-01-01,05/03/21,29/03/21,"Mays Cancer Center, UT Health San Antonio, San Antonio, Texas",United States,"Respiratory Diseases, Cancers",1,2,1041.0
199.0,NCT04350320,Trial to Study the Benefit of Colchicine in Patients With COVID-19,COL-COVID,Completed,COVID-19,,,,,,,Drug: Colchicine Tablets|Drug: Standard therapy for COVID-19 according to the stablished hospital protocols.,Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia,All,"18 Years and older   (Adult, Older Adult)",102.0,Other,Interventional,2020-04-30,20/10/20,2020-12-30,17/04/20,12/01/21,"Virgen de la Arrixaca University Clinical Hospital, Murcia",Spain,Respiratory Diseases,1,1,244.0
200.0,NCT04507893,Comparison Between Positive and Negative COVID-19 Pneumonia,,Recruiting,COVID-19,Interstitial Pneumonia,,,,,,"Other: Clinical, laboratory and imaging characteristics of pneumonia",University of Palermo,All,"18 Years to 95 Years   (Adult, Older Adult)",80.0,Other,Observational,2020-03-15,30/09/20,2022-01-12,11/08/20,23/02/21,"Infectious diseases Unit of the Cervello-Villa Sofia Hospital, Palermo, PA, Italy|Internal Medicine Division of the Cervello-Villa Sofia Hospital, Palermo, PA, Italy|Pulmonology Unit Dedicated to COVID-19 Patients, Palermo, PA",Italy,Respiratory Diseases,1,2,668.0
201.0,NCT04457726,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,,Recruiting,COVID-19,,,,,,,Biological: SARS-CoV-2 Specific T Cells,"KK Women's and Children's Hospital|Duke-NUS Graduate Medical School|National University Hospital, Singapore|Singapore General Hospital|Sengkang General Hospital|Changi General Hospital",All,"1 Year to 90 Years   (Child, Adult, Older Adult)",18.0,Other,Interventional,2020-01-07,01/03/21,2022-01-12,07/07/20,07/07/20,"Changi General Hospital, Singapore, Singapore|KK Women's and Children's Hospital, Singapore, Singapore|National University Hospital, Singapore, Singapore|Sengkang General Hospital, Singapore, Singapore|Singapore General Hospital, Singapore",Singapore,Respiratory Diseases,1,1,736.0
202.0,NCT04537338,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,RESPIRA,Not yet recruiting,COVID-19,,,,,,,Genetic: 1. Characterize the immune response after infection with SARS-CoV-2,"Agencia Costarricense de Investigaciones Biomedicas|Caja Costarricense de Seguro Social|Fundación INCIENSA (FUNIN)|Ministerio de Salud de Costa Rica|Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer|Agencia Costarricense de Investigaciones Biomedicas (ACIB)",All,"6 Months to 100 Years   (Child, Adult, Older Adult)",2000.0,Other,Observational,2020-09-14,14/09/22,2022-09-14,03/09/20,03/09/20,,,Respiratory Diseases,1,1,730.0
203.0,NCT04647994,Exploratory Study: COVID-19 and Pregnancy,,Recruiting,Pregnant Women,COVID-19,,,,,,Diagnostic Test: SARS-CoV-2 serology,University of Sao Paulo General Hospital,Female,"17 Years to 50 Years   (Child, Adult)",500.0,Other,Observational,2020-09-21,01/07/21,2022-06-13,01/12/20,02/12/20,"Rossana P Fracisco, São Paulo",Brazil,Respiratory Diseases,1,2,630.0
204.0,NCT04474483,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,COVID-19,Recruiting,COVID-19,,,,,,,Drug: Melatonin|Other: Placebo (Methylcellulose) capsule,State University of New York at Buffalo,All,"18 Years and older   (Adult, Older Adult)",30.0,Other,Interventional,2020-06-11,31/03/21,2021-03-31,16/07/20,10/11/20,"University at Buffalo, Buffalo, New York",United States,Respiratory Diseases,1,1,293.0
205.0,NCT04740658,Organizational Measures to Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents,PIANO-COVID-19,Not yet recruiting,COVID-19,,,,,,,Other: No intervention,"University Hospital, Toulouse",All,"Child, Adult, Older Adult",9600.0,Other,Observational,2021-01-02,01/07/21,2021-01-07,05/02/21,05/02/21,"University Hospital Toulouse - Gérontopôle, Toulouse",France,Respiratory Diseases,1,1,5.0
206.0,NCT04636294,Borderline COVID-19 PCR Test Result,,Completed,COVID-19,Virus,,,,,,Diagnostic Test: SARS-CoV-2 PCR,Jessa Hospital,All,"Child, Adult, Older Adult",30000.0,Other,Observational,2020-01-08,15/02/21,2021-02-15,19/11/20,16/02/21,"Clinical Laboratory Jessa Hospital, Hasselt, Limburg",Belgium,Respiratory Diseases,1,2,404.0
207.0,NCT04610502,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,SECR-01,Completed,COVID-19,,,,,,,Biological: Administration of Equine immunoglobulin anti SARS-CoV-2,Caja Costarricense de Seguro Social|Universidad de Costa Rica|Ministry of Health Costa Rica,All,"18 Years and older   (Adult, Older Adult)",26.0,Other,Interventional,2020-06-09,06/10/20,2020-06-12,30/10/20,19/03/21,"Centro Especializado de Atención COVID19 (CEACO), San José, Costa Rica|Hospital Dr. Rafael Ángel Calderón Guardia, San José, Costa Rica|Hospital México, San José, Costa Rica|Hospital San Juan de Dios, San José",Costa Rica,Respiratory Diseases,1,1,3.0
208.0,NCT04354831,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,,"Active, not recruiting",COVID-19,,,,,,,Biological: anti-SARS-CoV-2 convalescent plasma,Medical College of Wisconsin|Froedtert Hospital,All,"18 Years and older   (Adult, Older Adult)",131.0,Other,Interventional,2020-11-05,01/05/22,2023-01-05,21/04/20,08/01/21,"Froedtert Hospital, Milwaukee, Wisconsin",United States,Respiratory Diseases,1,1,791.0
209.0,NCT04780334,Rapid Detection of COVID-19 by Portable and Connected Biosensor : Biological Proof of Concept,COR-DIAL-S,Not yet recruiting,SARS-CoV Infection,COVID-19,,,,,,Diagnostic Test: COVID-19 RT-PCR|Diagnostic Test: Biosensor,"University Hospital, Lille",All,"Child, Adult, Older Adult",200.0,Other,Observational,2021-01-04,01/04/22,2022-01-04,03/03/21,03/03/21,,,Respiratory Diseases,1,2,365.0
210.0,NCT04596098,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,AcNT-COVID19,Recruiting,SARS-CoV 2,,,,,,,Other: Blood sampling,"University Hospital, Grenoble|Commissariat A L'energie Atomique",All,"18 Years and older   (Adult, Older Adult)",100.0,Other,Observational,2020-04-30,30/06/21,2021-09-30,22/10/20,15/01/21,"UniversityGrenobleHospital, Grenoble",France,Respiratory Diseases,1,1,518.0
211.0,NCT04453969,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,,Recruiting,SARS-CoV2,Breastmilk,,,,,,Other: COVID-19,Deborah O'Connor|University of Toronto|Sinai Health System|The Hospital for Sick Children,All,"Child, Adult, Older Adult",50.0,Other,Observational,2020-05-24,01/01/21,2021-01-01,01/07/20,23/10/20,"Sinai Health System, Toronto, Ontario, Canada|University of Toronto, Toronto, Ontario",Canada,Respiratory Diseases,1,2,222.0
212.0,NCT04605952,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,,Completed,COVID-19,,,,,,,Diagnostic Test: Repeat SARS-CoV-2 IgG antibodies at 45-65 days,Tata Main Hospital,All,18 Years to 60 Years   (Adult),201.0,Other,Observational,2020-01-07,30/08/20,2020-08-30,28/10/20,28/10/20,"Dr.Deb Sanjay Nag, Jamshedpur, Jharkhand",India,Respiratory Diseases,1,1,236.0
213.0,NCT04558307,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,,Enrolling by invitation,COVID-19,,,,,,,Diagnostic Test: Pilot a rapid SARS-CoV-2 testing strategy|Other: Community-driven messages to promote COVID-19 testing,Mayo Clinic,All,"Child, Adult, Older Adult",1000.0,Other,Observational,2020-03-06,01/06/21,2021-01-12,22/09/20,22/09/20,"Mayo Clinic, Rochester, Minnesota",United States,Respiratory Diseases,1,1,312.0
214.0,NCT04432103,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,,Not yet recruiting,COVID-19,,,,,,,Biological: Anti SARS-CoV 2 Convalescent Plasma in severe COVID-19 patients|Biological: Anti SARS-CoV 2 Convalescent Plasma in critical COVID-19 patients,Centro Medico ABC,All,"18 Years and older   (Adult, Older Adult)",36.0,Other,Interventional,2020-06-19,30/07/20,2020-09-30,16/06/20,17/06/20,,,Respiratory Diseases,1,1,103.0
215.0,NCT04393428,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),COVID-AKI,Completed,COVID-19,Renal Replacement Therapy,Acute Kidney Injury,,,,,Other: [TIMP-2]*[IGFBP-7],"University Hospital, Montpellier",All,"18 Years to 100 Years   (Adult, Older Adult)",100.0,Other,Observational,2020-01-03,01/06/20,2020-06-30,19/05/20,29/07/20,"Uhmontpellier, Montpellier",France,Respiratory Diseases,1,3,179.0
